Citrus Sinensis ID: 015500

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-----
Protein Sequence
MDWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGAKIADFGCAKWESEALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSILDQGIWNSVEETEESLGNLIHSTSKTSARERIERLSCSQGPSWGWDESWITIRENNNEESNAIMDGIEAKGDMICGSVSDSTSSGSEKQESFASSIRIRTICKKDSAVVSSNLNLQRHRDRLSFPLILSTSIL
Secondary Structure (PSIPRED)
cccccccccccccccEEEEEEEcccccEEEEEEEEcccHHHHHHHHHHHHcccccccEEEEccccccccccEEEEEEEEEcccccHHHHHHHccccccHHHHHHHHHHHHHHHHHHHcccccccccccccEEEcccccEEEcccccccccccccccccccccccHHHccccccccccHHHHHHHHHHHHcccccccccccHHHHHHHHHcccccccccccccHHHHHHHHHHHcccccccccHHHHHccccccccccccccccccccccccccccccccccccHHHcccccccccccccHHHHHHHHcccccccccccccEEEEccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
cccEEccEcccccccEEEEEEEcccccEEEEEEHcHHHHHHHHHHHHHHHHHccccEEEEEEEEEcccccHHHEEEEEEEccccHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEcccccEEEEcccEEEEcccccEcccHccccHHHHHccccccccHHHHHHHHHHHHHcccccccccccccEEEEEEEcccccccccccccHHHHHHHHHHHcccccHcccHHHHHcccHHHHccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccHHHHHHHHHHHHHccccccccEcHHHHHHcHHHccccccHHHHHHHHHHccccccccEEEccccccHHHHHHHHHccccccccccccEEEEEccccc
Coil and Loop (DISEMBL)
mdwtrghtigqgssATVSLATSLrsgdvfaakstelpksefLQREQKFLSslnsphivgykgcdvtsedNKLMYNLFMeyapggtlndeihrnggrldeSLIVSYTRQILQGLEylhsnrvvhcdiksrnilmAESGAKIADFGCakwesealqsggtpmfmapevargehqgfasdiWAVGCTVIemasggapwpnaadpmTVLYKIAYsrelpevpaFLSKQANDFLSNCLRRDPKERWAASqllkhpfleefcsctkqiqesncsptsildqgiWNSVEETEESLGNlihstsktSARERIERLscsqgpswgwdesWITIRENNNEESNAIMDGIeakgdmicgsvsdstssgsekqeSFASSIRIRTICKKDSAVVSSNlnlqrhrdrlsfplilstsil
Flexible Loop (DISEMBL)
mdwtrghtigqgssatvsLATSLRSGDVFAAKSTELPKSEFLQREQKFLsslnsphivgyKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGAKIADFGCAKWESEALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSILDQGIWNSVEETEESlgnlihstsktsarERIERlscsqgpswgwdeSWITIRENNNEESNAIMDGIEAKGDMICGSVSdstssgsekqesfaSSIRIRTICKKDSAVVssnlnlqrhrdrlsfplilstsil
Low Complexity Region (SEG)
MDWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGAKIADFGCAKWESEALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSILDQGIWNSVEETEESLGNLIHSTSKTSARERIERLSCSQGPSWGWDESWITIRENNNEESNAIMDGIEAKGDMICGsvsdstssgsEKQESFASSIRIRTICKKDSAVVSSNLNLQRHRDRLSFPLILSTSIL
Disordered region (IsUnstruct)
************************************************LSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGAKIADFGCAKWESEALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSILDQGIWNSV******************************GPSWGWDESWITIR******************************************IRIRTICKKDSAVVS**L********LSFPLI******
Disordered Region (DISOPRED)
MDWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK**FLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGAKIADFGCAKWES****SGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLE***************************************************************WDESWITIRE*****************************************IRIRTICKKDSA*************RLSFPLILSTSIL
Disordered Region (DISEMBL)
****************VSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGAKIADFGCAKWESEALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSILDQGIWNSVEETEESLGNLIHSTSKTSARERIERLSCSQGPSWGWDESWITIRENNNEESNAIMDGIEAKGDMICG*****************SSIRIRTICKKDSAVVSSNLNLQRHRDRLSFPLILSTSIL
Disordered Region (DISPRO)
MDWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGAKIADFGCAKWESEALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSILDQGIWNSVEETEESLGNLIHSTSKTSARERIERLSCSQGPSWGWDESWITIRENNNEESNAIMDGIEAKGDMICGSVSDSTSSGSEKQESFASSIRIRTICKKDSAVVSSNLNLQRHRDRLSFPLILST***
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MDWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGAKIADFGCAKWESEALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSILDQGIWNSVEETEESLGNLIHSTSKTSARERIERLSCSQGPSWGWDESWITIRENNNEESNAIMDGIEAKGDMICGSVSDSTSSGSEKQESFASSIRIRTICKKDSAVVSSNLNLQRHRDRLSFPLILSTSIL
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	405	2.2.26 [Sep-21-2011]
Q54R82	942	Mitogen-activated protein	yes	no	0.609	0.262	0.397	7e-51
Q9FZ36	651	Mitogen-activated protein	no	no	0.698	0.434	0.371	8e-48
O22040	666	Mitogen-activated protein	no	no	0.609	0.370	0.396	4e-47
O22042	651	Mitogen-activated protein	no	no	0.604	0.376	0.376	3e-44
E9Q3S4	1311	Mitogen-activated protein	yes	no	0.6	0.185	0.424	4e-43
Q56UN5	1328	Mitogen-activated protein	yes	no	0.602	0.183	0.408	3e-42
Q9Y6R4	1608	Mitogen-activated protein	no	no	0.6	0.151	0.376	3e-41
Q5B4Z3	1346	Cytokinesis protein sepH	yes	no	0.772	0.232	0.339	4e-41
O08648	1597	Mitogen-activated protein	no	no	0.6	0.152	0.376	1e-40
Q0CL79	1342	Cytokinesis protein sepH	N/A	no	0.6	0.181	0.392	3e-40

>sp|Q54R82|MKKA_DICDI Mitogen-activated protein kinase kinase kinase A OS=Dictyostelium discoideum GN=mkkA PE=1 SV=2

 Score =  201 bits (511), Expect = 7e-51,   Method: Compositional matrix adjust.
 Identities = 106/267 (39%), Positives = 163/267 (61%), Gaps = 20/267 (7%)

Query: 1   MDWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL------PKSEFL----QREQKFLS 50
           + W +G  +G+G   +V L  +  +G++FA K  E+      PK + +     +E + + 
Sbjct: 168 IKWQKGQILGRGGYGSVYLGLNKDTGELFAVKQLEIVDINSDPKLKNMILSFSKEIEVMR 227

Query: 51  SLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQIL 110
           SL   +IV Y G   TS D   + ++F+EY PGG+++  + + G    E++I  YT+QIL
Sbjct: 228 SLRHDNIVRYLG---TSLDQSFL-SVFLEYIPGGSISSLLGKFGA-FSENVIKVYTKQIL 282

Query: 111 QGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAK----WESEALQSGGTPMFMAPE 165
           QGL +LH+N ++H DIK  NIL+   G  K++DFGC+K      S+     GTP +MAPE
Sbjct: 283 QGLSFLHANSIIHRDIKGANILIDTKGIVKLSDFGCSKSFSGIVSQFKSMQGTPYWMAPE 342

Query: 166 VARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQA 225
           V +    G +SDIW++GC ++EMA+   PW N  +   V+Y IA S  +P +P+ +S++A
Sbjct: 343 VIKQTGHGRSSDIWSLGCVIVEMATAQPPWSNITELAAVMYHIASSNSIPNIPSHMSQEA 402

Query: 226 NDFLSNCLRRDPKERWAASQLLKHPFL 252
            DFL+ C +RDPKER  A+QLLKHPF+
Sbjct: 403 FDFLNLCFKRDPKERPDANQLLKHPFI 429

Regulates cell-type differentiation and spatial patterning, required for the proper induction and maintenance of prespore cell differentiation.
Dictyostelium discoideum (taxid: 44689)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 5

>sp|Q9FZ36|M3K2_ARATH Mitogen-activated protein kinase kinase kinase 2 OS=Arabidopsis thaliana GN=ANP2 PE=2 SV=1

 Score =  191 bits (485), Expect = 8e-48,   Method: Compositional matrix adjust.
 Identities = 117/315 (37%), Positives = 174/315 (55%), Gaps = 32/315 (10%)

Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS-----------EFLQREQKFLSS 51
           W +G  IG+G+  TV +  +L SG++ A K   +  +           + L+ E K L +
Sbjct: 68  WRKGQLIGRGAFGTVYMGMNLDSGELLAVKQVLITSNCASKEKTQAHIQELEEEVKLLKN 127

Query: 52  LNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQ 111
           L+ P+IV Y G     ED  L  N+ +E+ PGG+++  + + G    ES++ +YT Q+L 
Sbjct: 128 LSHPNIVRYLG--TVREDETL--NILLEFVPGGSISSLLEKFGA-FPESVVRTYTNQLLL 182

Query: 112 GLEYLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESE-ALQSG-----GTPMFMAP 164
           GLEYLH++ ++H DIK  NIL+   G  K+ADFG +K  +E A  SG     GTP +MAP
Sbjct: 183 GLEYLHNHAIMHRDIKGANILVDNQGCIKLADFGASKQVAELATISGAKSMKGTPYWMAP 242

Query: 165 EVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQ 224
           EV       F++DIW+VGCTVIEM +G APW      +  ++ I  ++  P +P  +S  
Sbjct: 243 EVILQTGHSFSADIWSVGCTVIEMVTGKAPWSQQYKEIAAIFHIGTTKSHPPIPDNISSD 302

Query: 225 ANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSILDQGIWNSVEET 284
           ANDFL  CL+++P  R  AS+LLKHPF+       KQ + ++   TS +D    NS    
Sbjct: 303 ANDFLLKCLQQEPNLRPTASELLKHPFV-----TGKQKESASKDLTSFMD----NSCSPL 353

Query: 285 EESLGNLIHSTSKTS 299
              L N+    + TS
Sbjct: 354 PSELTNITSYQTSTS 368

Involved in cortical microtubules organization and stabilization by regulating the phosphorylation state of microtubule-associated proteins such as MAP65-1.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|O22040|ANP1_ARATH Mitogen-activated protein kinase kinase kinase ANP1 OS=Arabidopsis thaliana GN=ANP1 PE=1 SV=2

 Score =  189 bits (479), Expect = 4e-47,   Method: Compositional matrix adjust.
 Identities = 107/270 (39%), Positives = 157/270 (58%), Gaps = 23/270 (8%)

Query: 1   MDWTRGHTIGQGSSATVSLATSLRSGDV-----------FAAKSTELPKSEFLQREQKFL 49
           + W +G  IG+G+  TV +  +L SG++           FA+K       + L+ E K L
Sbjct: 67  ISWRKGQLIGRGAFGTVYMGMNLDSGELLAVKQVLIAANFASKEKTQAHIQELEEEVKLL 126

Query: 50  SSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQI 109
            +L+ P+IV Y G     ED+ L  N+ +E+ PGG+++  + +  G   ES++ +YTRQ+
Sbjct: 127 KNLSHPNIVRYLG--TVREDDTL--NILLEFVPGGSISSLLEK-FGPFPESVVRTYTRQL 181

Query: 110 LQGLEYLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESE-ALQSG-----GTPMFM 162
           L GLEYLH++ ++H DIK  NIL+   G  K+ADFG +K  +E A  +G     GTP +M
Sbjct: 182 LLGLEYLHNHAIMHRDIKGANILVDNKGCIKLADFGASKQVAELATMTGAKSMKGTPYWM 241

Query: 163 APEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLS 222
           APEV       F++DIW+VGCTVIEM +G APW      +  ++ I  ++  P +P  LS
Sbjct: 242 APEVILQTGHSFSADIWSVGCTVIEMVTGKAPWSQQYKEVAAIFFIGTTKSHPPIPDTLS 301

Query: 223 KQANDFLSNCLRRDPKERWAASQLLKHPFL 252
             A DFL  CL+  P  R  AS+LLKHPF+
Sbjct: 302 SDAKDFLLKCLQEVPNLRPTASELLKHPFV 331

May be involved in an oxidative stress-mediated signaling cascade that phosphorylates downstream MAP kinases MPK3 and MPK6. May suppress auxin signaling that promotes cell cycle. Functionally redundant to ANP2 and ANP3 in the positive regulation of cytokinesis.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|O22042|M3K3_ARATH Mitogen-activated protein kinase kinase kinase 3 OS=Arabidopsis thaliana GN=ANP3 PE=1 SV=1

 Score =  179 bits (455), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 101/268 (37%), Positives = 149/268 (55%), Gaps = 23/268 (8%)

Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEF-----------LQREQKFLSS 51
           W +G  IG G+   V +  +L SG++ A K   +  S             L+ E + L +
Sbjct: 68  WRKGELIGCGAFGRVYMGMNLDSGELLAIKQVLIAPSSASKEKTQGHIRELEEEVQLLKN 127

Query: 52  LNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQ 111
           L+ P+IV Y G     E + L  N+ ME+ PGG+++  + + G    E +I+ YT+Q+L 
Sbjct: 128 LSHPNIVRYLG--TVRESDSL--NILMEFVPGGSISSLLEKFGS-FPEPVIIMYTKQLLL 182

Query: 112 GLEYLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESE------ALQSGGTPMFMAP 164
           GLEYLH+N ++H DIK  NIL+   G  ++ADFG +K   E      A    GTP +MAP
Sbjct: 183 GLEYLHNNGIMHRDIKGANILVDNKGCIRLADFGASKKVVELATVNGAKSMKGTPYWMAP 242

Query: 165 EVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQ 224
           EV       F++DIW+VGCTVIEMA+G  PW         +  I  ++  P +P  LS +
Sbjct: 243 EVILQTGHSFSADIWSVGCTVIEMATGKPPWSEQYQQFAAVLHIGRTKAHPPIPEDLSPE 302

Query: 225 ANDFLSNCLRRDPKERWAASQLLKHPFL 252
           A DFL  CL ++P  R +A++LL+HPF+
Sbjct: 303 AKDFLMKCLHKEPSLRLSATELLQHPFV 330

Involved in cortical microtubules organization and stabilization by regulating the phosphorylation state of microtubule-associated proteins such as MAP65-1.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|E9Q3S4|M3K19_MOUSE Mitogen-activated protein kinase kinase kinase 19 OS=Mus musculus GN=Map3k19 PE=3 SV=1

 Score =  176 bits (445), Expect = 4e-43,   Method: Compositional matrix adjust.
 Identities = 116/273 (42%), Positives = 157/273 (57%), Gaps = 30/273 (10%)

Query: 3    WTRGHTIGQGSSATVSLA-TSLRSGDVFAAKSTELPKSEFLQREQKF---------LSSL 52
            WT+G  +G+G+  TV    TSL  G + A K   L  S+ L  E+++         L +L
Sbjct: 1044 WTKGEILGRGAYGTVYCGLTSL--GQLIAVKQVALDTSDKLATEKEYRKLQEEVDLLKAL 1101

Query: 53   NSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQG 112
               +IV Y G  +  E+N L  ++FME+ PGG+++  I+R G  L E +   YTRQILQG
Sbjct: 1102 KHVNIVAYLGTCL--EENTL--SIFMEFVPGGSISSIINRFGP-LPEMVFCKYTRQILQG 1156

Query: 113  LEYLHSNRVVHCDIKSRNILMAESGA-KIADFGCAK---W------ESEALQS-GGTPMF 161
            + YLH N VVH DIK  N+++  +G  K+ DFGCAK   W       S+ L+S  GTP +
Sbjct: 1157 VAYLHDNCVVHRDIKGNNVMLMPTGIIKLIDFGCAKRLAWAGLNGTHSDMLKSMRGTPYW 1216

Query: 162  MAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSREL-PEVPAF 220
            MAPEV      G  SDIW++GCTV EMA+G  P   + D M  ++ I   R L P +PA 
Sbjct: 1217 MAPEVINESGYGRKSDIWSIGCTVFEMATGKPPL-ASMDRMAAMFYIGAHRGLMPPLPAR 1275

Query: 221  LSKQANDFLSNCLRRDPKERWAASQLLKHPFLE 253
             S+ A DF+  CL RD  ER +A QLLKH FL+
Sbjct: 1276 FSEPAADFVRLCLTRDQHERPSALQLLKHSFLK 1308

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q56UN5|M3K19_HUMAN Mitogen-activated protein kinase kinase kinase 19 OS=Homo sapiens GN=MAP3K19 PE=2 SV=1

 Score =  172 bits (437), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 111/272 (40%), Positives = 154/272 (56%), Gaps = 28/272 (10%)

Query: 3    WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS-------EF--LQREQKFLSSLN 53
            WT+G  +G+G+  TV    + + G + A K   L  S       E+  LQ E   L +L 
Sbjct: 1061 WTKGEILGKGAYGTVYCGLTSQ-GQLIAVKQVALDTSNKLAAEKEYRKLQEEVDLLKALK 1119

Query: 54   SPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGL 113
              +IV Y G  +  ++N +  ++FME+ PGG+++  I+R  G L E +   YT+QILQG+
Sbjct: 1120 HVNIVAYLGTCL--QENTV--SIFMEFVPGGSISSIINR-FGPLPEMVFCKYTKQILQGV 1174

Query: 114  EYLHSNRVVHCDIKSRNILMAESGA-KIADFGCAK---W------ESEALQS-GGTPMFM 162
             YLH N VVH DIK  N+++  +G  K+ DFGCA+   W       S+ L+S  GTP +M
Sbjct: 1175 AYLHENCVVHRDIKGNNVMLMPTGIIKLIDFGCARRLAWAGLNGTHSDMLKSMHGTPYWM 1234

Query: 163  APEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSREL-PEVPAFL 221
            APEV      G  SDIW++GCTV EMA+G  P   + D M  ++ I   R L P +P   
Sbjct: 1235 APEVINESGYGRKSDIWSIGCTVFEMATGKPPLA-SMDRMAAMFYIGAHRGLMPPLPDHF 1293

Query: 222  SKQANDFLSNCLRRDPKERWAASQLLKHPFLE 253
            S+ A DF+  CL RD  ER +A QLLKH FLE
Sbjct: 1294 SENAADFVRMCLTRDQHERPSALQLLKHSFLE 1325

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9Y6R4|M3K4_HUMAN Mitogen-activated protein kinase kinase kinase 4 OS=Homo sapiens GN=MAP3K4 PE=1 SV=2

 Score =  169 bits (429), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 101/268 (37%), Positives = 143/268 (53%), Gaps = 25/268 (9%)

Query: 3    WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEF-----LQREQKFLSSLNSPHI 57
            W RG+ IG+G    V    S+ +G++ A K      ++         E K    +  P++
Sbjct: 1343 WQRGNKIGEGQYGKVYTCISVDTGELMAMKEIRFQPNDHKTIKETADELKIFEGIKHPNL 1402

Query: 58   VGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLH 117
            V Y G ++  E+   MY +FMEY   GTL +E+ R G  L E +I  Y++QI   +  LH
Sbjct: 1403 VRYFGVELHREE---MY-IFMEYCDEGTL-EEVSRLG--LQEHVIRLYSKQITIAINVLH 1455

Query: 118  SNRVVHCDIKSRNILMAESG-AKIADFGCA--------KWESEALQSGGTPMFMAPEV-- 166
             + +VH DIK  NI +  SG  K+ DFGC+            E   + GT  +MAPEV  
Sbjct: 1456 EHGIVHRDIKGANIFLTSSGLIKLGDFGCSVKLKNNAQTMPGEVNSTLGTAAYMAPEVIT 1515

Query: 167  -ARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQA 225
             A+GE  G A+DIW++GC VIEM +G  PW        ++YK+    + P +P  LS + 
Sbjct: 1516 RAKGEGHGRAADIWSLGCVVIEMVTGKRPWHEYEHNFQIMYKVGMGHK-PPIPERLSPEG 1574

Query: 226  NDFLSNCLRRDPKERWAASQLLKHPFLE 253
             DFLS+CL  DPK RW ASQLL H F++
Sbjct: 1575 KDFLSHCLESDPKMRWTASQLLDHSFVK 1602

Component of a protein kinase signal transduction cascade. Activates the CSBP2, P38 and JNK MAPK pathways, but not the ERK pathway. Specifically phosphorylates and activates MAP2K4 and MAP2K6.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|Q5B4Z3|SEPH_EMENI Cytokinesis protein sepH OS=Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) GN=sepH PE=3 SV=2

 Score =  169 bits (428), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 118/348 (33%), Positives = 177/348 (50%), Gaps = 35/348 (10%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKS---TELPKSEF--LQREQKFLSSLNSPH 56
           D+  G  +G+G+  +V  A +  +G+  A K     +LPKSE   +  E   L +L+ P+
Sbjct: 59  DYQLGDCLGRGAFGSVYRALNWNTGETVAVKQIKLADLPKSELRVIMLEIDLLKNLDHPN 118

Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL 116
           IV Y+G   ++E      N+ +EY   G+L+  I +N GR  E+L+  Y  Q+L GL YL
Sbjct: 119 IVKYQGFVKSAE----TLNIILEYCENGSLH-SIAKNFGRFPETLVGVYMSQVLHGLLYL 173

Query: 117 HSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG--GTPMFMAPEVARGEHQG 173
           H   V+H DIK  NIL  + G  K+ADFG A   +   +S   GTP +MAPEV       
Sbjct: 174 HDQGVIHRDIKGANILTTKEGLVKLADFGVASRTTGLSESSVVGTPYWMAPEVIELSGAT 233

Query: 174 FASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCL 233
            ASDIW++GCTVIE+  G  P+ N   PM  L++I  + + P +P   S    DFL  C 
Sbjct: 234 TASDIWSLGCTVIELLEGKPPYYN-LQPMPALFRIV-NDDHPPLPQGASPAVKDFLMQCF 291

Query: 234 RRDPKERWAASQLLKHPFL--------------EEFCSCTKQIQESN---CSPTS-ILDQ 275
           ++DP  R +A +LLKHP++               E+    K +QE N    SP S  L +
Sbjct: 292 QKDPNLRVSARKLLKHPWIVNARRSDSVVPKKSTEYEEAVKSVQEWNEALRSPESNALRR 351

Query: 276 GIWNSVEETEESLGNLIHSTSKTSARERIERLSCSQ--GPSWGWDESW 321
           G  N  +       +  H+ +K +    + R+   +   PS G +++W
Sbjct: 352 GTRNENQNPPSLRLDTRHTPTKVTLPSPVSRIVADKFSSPSSGEEDNW 399

Required for early events during cytokinesis including localization of cytoskeletal components to the cytokinetic ring.

Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) (taxid: 227321)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O08648|M3K4_MOUSE Mitogen-activated protein kinase kinase kinase 4 OS=Mus musculus GN=Map3k4 PE=1 SV=2

 Score =  167 bits (424), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 101/268 (37%), Positives = 142/268 (52%), Gaps = 25/268 (9%)

Query: 3    WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEF-----LQREQKFLSSLNSPHI 57
            W RG+ IG+G    V    S+ +G++ A K      ++         E K    +  P++
Sbjct: 1332 WQRGNKIGEGQYGKVYTCISVDTGELMAMKEIRFQPNDHKTIKETADELKIFEGIKHPNL 1391

Query: 58   VGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLH 117
            V Y G ++  E+   MY +FMEY   GTL +E+ R G  L E +I  YT+QI   +  LH
Sbjct: 1392 VRYFGVELHREE---MY-IFMEYCDEGTL-EEVSRLG--LQEHVIRLYTKQITVAINVLH 1444

Query: 118  SNRVVHCDIKSRNILMAESG-AKIADFGCA--------KWESEALQSGGTPMFMAPEV-- 166
             + +VH DIK  NI +  SG  K+ DFGC+            E   + GT  +MAPEV  
Sbjct: 1445 EHGIVHRDIKGANIFLTSSGLIKLGDFGCSVKLKNNAQTMPGEVNSTLGTAAYMAPEVIT 1504

Query: 167  -ARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQA 225
             A+GE  G A+DIW++GC VIEM +G  PW        ++YK+    + P +P  LS + 
Sbjct: 1505 RAKGEGHGRAADIWSLGCVVIEMVTGKRPWHEYEHNFQIMYKVGMGHK-PPIPERLSPEG 1563

Query: 226  NDFLSNCLRRDPKERWAASQLLKHPFLE 253
              FLS+CL  DPK RW ASQLL H F++
Sbjct: 1564 KAFLSHCLESDPKIRWTASQLLDHAFVK 1591

Component of a protein kinase signal transduction cascade. Activates the CSBP2, P38 and JNK MAPK pathways, but not the ERK pathway. Specifically phosphorylates and activates MAP2K4 and MAP2K6.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|Q0CL79|SEPH_ASPTN Cytokinesis protein sepH OS=Aspergillus terreus (strain NIH 2624 / FGSC A1156) GN=sepH PE=3 SV=2

 Score =  166 bits (421), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 101/257 (39%), Positives = 146/257 (56%), Gaps = 14/257 (5%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKS---TELPKSEFLQREQKFLSSLNSPHIV 58
           D+  G  +G+G+  +V  A +  +G+  A K     +LPKSE L+ E   L +L+ P+IV
Sbjct: 60  DYQLGDCLGKGAFGSVYRALNWNTGETVAVKQIKLADLPKSE-LRLEIDLLKNLDHPNIV 118

Query: 59  GYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHS 118
            Y+G   ++E      N+ +EY   G+L+  I +N GR  E+L+  Y  Q+L GL YLH 
Sbjct: 119 KYQGFVKSAE----TLNIILEYCENGSLH-SIAKNFGRFPENLVGLYMSQVLHGLLYLHE 173

Query: 119 NRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG--GTPMFMAPEVARGEHQGFA 175
             V+H DIK  NIL  + G  K+ADFG A   +   +S   GTP +MAPEV        A
Sbjct: 174 QGVIHRDIKGANILTTKEGLVKLADFGVASRTTGLSESSVVGTPYWMAPEVIELSGATTA 233

Query: 176 SDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRR 235
           SDIW++GCTVIE+  G  P+ N   PM  L++I  + + P +P   S    DFL  C ++
Sbjct: 234 SDIWSLGCTVIELLEGKPPYYN-MQPMPALFRIV-NDDHPPLPQGASPAVKDFLMQCFQK 291

Query: 236 DPKERWAASQLLKHPFL 252
           DP  R +A +LLKHP++
Sbjct: 292 DPNLRVSARKLLKHPWI 308

Required for early events during cytokinesis including localization of cytoskeletal components to the cytokinetic ring.

Aspergillus terreus (strain NIH 2624 / FGSC A1156) (taxid: 341663)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	405
147841887	420	hypothetical protein VITISV_024689 [Viti	0.982	0.947	0.580	1e-129
255567715	436	Mitogen-activated protein kinase kinase	0.980	0.910	0.582	1e-128
225447061	420	PREDICTED: mitogen-activated protein kin	0.982	0.947	0.578	1e-128
224131610	332	predicted protein [Populus trichocarpa]	0.8	0.975	0.662	1e-119
356542808	352	PREDICTED: mitogen-activated protein kin	0.804	0.926	0.629	1e-114
356515292	357	PREDICTED: mitogen-activated protein kin	0.807	0.915	0.615	1e-111
356542080	396	PREDICTED: mitogen-activated protein kin	0.802	0.820	0.607	1e-110
356547091	398	PREDICTED: mitogen-activated protein kin	0.938	0.954	0.538	1e-109
224068982	300	predicted protein [Populus trichocarpa]	0.718	0.97	0.651	1e-108
357471365	401	MAP kinase kinase kinase SSK2 [Medicago	0.925	0.935	0.524	1e-106

>gi|147841887|emb|CAN65217.1| hypothetical protein VITISV_024689 [Vitis vinifera]

 Score =  467 bits (1202), Expect = e-129,   Method: Compositional matrix adjust.
 Identities = 244/420 (58%), Positives = 298/420 (70%), Gaps = 22/420 (5%)

Query: 1   MDWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGY 60
           MDWTRGHT+G GSSATVSLA SLRSGDVFA KS EL +SE LQRE++ LSSL SP+IVGY
Sbjct: 1   MDWTRGHTLGSGSSATVSLANSLRSGDVFAVKSVELSRSESLQREERILSSLRSPYIVGY 60

Query: 61  KGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNR 120
           KGCD+T E+ KLMYNLF+EY PGGTL D I R GG+L ES+I  Y RQI+QGL+Y+HS  
Sbjct: 61  KGCDITRENKKLMYNLFIEYMPGGTLGDAIRRGGGQLHESMIGIYARQIVQGLDYIHSRG 120

Query: 121 VVHCDIKSRNILMAESGAKIADFGCAKW----ESEALQSGGTPMFMAPEVARGEHQGFAS 176
           +VHCDIK +N+L+ E GAKIADFGCAKW    +   +Q  GTP FMAPEVARGE QG+ S
Sbjct: 121 LVHCDIKGQNVLIGEDGAKIADFGCAKWTNGKDDRKVQIAGTPFFMAPEVARGEDQGYPS 180

Query: 177 DIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRD 236
           D+WA+GCT+IEMA+GGAPWPN A+ +  LY+I +S ELP +P+FLS QA DFLS CLRRD
Sbjct: 181 DVWALGCTIIEMATGGAPWPNVANAVAALYRIGFSEELPWIPSFLSDQAKDFLSKCLRRD 240

Query: 237 PKERWAASQLLKHPFLEEFCSCTKQIQESNC-SPTSILDQGIWNSVEETEESLGNLIHST 295
           PKERW ASQLLKHPF+ E     KQ+QES   SPTSILDQ  W+S+EE+ E+ G L  ++
Sbjct: 241 PKERWTASQLLKHPFVGELNPQAKQVQESYSDSPTSILDQNFWSSLEES-EAQGYLKQAS 299

Query: 296 SKTSARERIERL-SCSQGPSWGWDESWITIRENNNEESNAIMDGIEAKGDMICGSVSDST 354
              S  ERI +L + S+  +W  D++W+TIR + NEESN   D +E +   +  S + S+
Sbjct: 300 FSNSPAERIRKLWTFSRVENWTRDDNWVTIRGSTNEESNVPADYMEDEASPVSRSEAVSS 359

Query: 355 SSGSEKQESFA----------SSIRIRTICKKDSAVVSSNLNLQRHRDRLSFPLILSTSI 404
           S   EK ES            S    RT C KDS VV SN N +  ++ L   LI STSI
Sbjct: 360 SHDVEKVESHGDGEEMEDFLDSKFSCRT-CMKDSVVV-SNFNFEIDKEHL---LITSTSI 414

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255567715|ref|XP_002524836.1| Mitogen-activated protein kinase kinase kinase, putative [Ricinus communis] gi|223535896|gb|EEF37556.1| Mitogen-activated protein kinase kinase kinase, putative [Ricinus communis]

 Score =  466 bits (1198), Expect = e-128,   Method: Compositional matrix adjust.
 Identities = 248/426 (58%), Positives = 297/426 (69%), Gaps = 29/426 (6%)

Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGYKG 62
           W RG+++G GS+ATVSLATS  S ++FA KS EL  SEFLQREQK LSS+ SPHIV Y+G
Sbjct: 4   WIRGNSVGHGSTATVSLATSFHSAEIFAVKSAELSLSEFLQREQKILSSVASPHIVSYRG 63

Query: 63  CDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
           CD+T E+NK+MYNLF+EY  GG+L D I  +GGRL ES+I  YT QI+QGL+YLHSN +V
Sbjct: 64  CDITRENNKVMYNLFLEYMSGGSLVDTIQAHGGRLGESMIGYYTCQIVQGLDYLHSNGLV 123

Query: 123 HCDIKSRNILMAESGAKIADFGCAKWESEALQS----GGTPMFMAPEVARGEHQGFASDI 178
           HCDIKS NIL+ ++GAKIADFGCAK     +      GGTPMFMAPEVARG  QGFASDI
Sbjct: 124 HCDIKSSNILIGDAGAKIADFGCAKRVVATVDVAETIGGTPMFMAPEVARGAEQGFASDI 183

Query: 179 WAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPK 238
           WA+GCT+IEMA+G APWPNA DP++V+Y+I +  +LPE P  LS+QA DFL  CLRRDPK
Sbjct: 184 WALGCTIIEMATGCAPWPNANDPVSVMYRIGFMDQLPEFPCCLSEQAKDFLEKCLRRDPK 243

Query: 239 ERWAASQLLKHPFLEEFCSCTKQIQESN-----CSPTSILDQGIWNSVEETEESLGNLIH 293
           +RW A+QLLKHPFLE+F S  KQIQE N      SPTSILDQ IWNSV++  E+L NL H
Sbjct: 244 QRWTANQLLKHPFLEKFISHGKQIQEPNNSGSSYSPTSILDQHIWNSVDDESENLDNLAH 303

Query: 294 ST-----SKTSARERIERLS-CSQGPSWGWDESWITIRENNNEESNAIMDGIEAKGDMIC 347
           S      S  SA ERI RL   S+GPSW  DE+WI +R N +EE + IMDGIE K ++  
Sbjct: 304 SCHHDHESSPSASERIRRLCLVSEGPSWELDENWIPVRGNCSEEGDTIMDGIEVKNEVAS 363

Query: 348 -GSVSDSTSSGSEKQ---------ESFASSIR--IRTICK--KDSAVVSSNLNLQRHRDR 393
            GSV      G  +Q            +S I   I   CK  KDS +V SNL L R R+ 
Sbjct: 364 YGSVYQENYCGGGEQWMDGVLTDKNIISSRISGDILGDCKYGKDSFLVCSNLRLDRDRNV 423

Query: 394 LSFPLI 399
           L  P I
Sbjct: 424 LLIPYI 429

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225447061|ref|XP_002269660.1| PREDICTED: mitogen-activated protein kinase kinase kinase A [Vitis vinifera] gi|297739169|emb|CBI28820.3| unnamed protein product [Vitis vinifera]

 Score =  464 bits (1195), Expect = e-128,   Method: Compositional matrix adjust.
 Identities = 243/420 (57%), Positives = 297/420 (70%), Gaps = 22/420 (5%)

Query: 1   MDWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGY 60
           MDWTRGHT+G GSSATVSLA SLRSGDVFA KS EL +SE LQRE++ LSSL SP+IVGY
Sbjct: 1   MDWTRGHTLGSGSSATVSLANSLRSGDVFAVKSVELSRSESLQREERILSSLRSPYIVGY 60

Query: 61  KGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNR 120
           KGCD+T E+ KLMYNLF+EY PGGTL D I R GG+L ES+I  Y RQI+QGL+Y+HS  
Sbjct: 61  KGCDITRENKKLMYNLFIEYMPGGTLGDAIRRGGGQLHESMIGIYARQIVQGLDYIHSRG 120

Query: 121 VVHCDIKSRNILMAESGAKIADFGCAKW----ESEALQSGGTPMFMAPEVARGEHQGFAS 176
           +VHCDIK +N+L+ E GAKIADFGCAKW    +   +   GTP FMAPEVARGE QG+ S
Sbjct: 121 LVHCDIKGQNVLIGEDGAKIADFGCAKWTNGKDDRKVPIAGTPFFMAPEVARGEDQGYPS 180

Query: 177 DIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRD 236
           D+WA+GCT+IEMA+GGAPWPN A+ +  LY+I +S ELP +P+FLS QA DFLS CLRRD
Sbjct: 181 DVWALGCTIIEMATGGAPWPNVANAVAALYRIGFSEELPWIPSFLSDQAKDFLSKCLRRD 240

Query: 237 PKERWAASQLLKHPFLEEFCSCTKQIQESNC-SPTSILDQGIWNSVEETEESLGNLIHST 295
           PKERW ASQLLKHPF+ E     KQ+QES   SPTSILDQ  W+S+EE+ E+ G L  ++
Sbjct: 241 PKERWTASQLLKHPFVGELNPQAKQVQESYSDSPTSILDQNFWSSLEES-EAQGYLKQAS 299

Query: 296 SKTSARERIERL-SCSQGPSWGWDESWITIRENNNEESNAIMDGIEAKGDMICGSVSDST 354
              S  ERI +L + S+  +W  D++W+TIR + NEESN   D +E +   +  S + S+
Sbjct: 300 FSNSPAERIRKLWTFSRVENWTRDDNWVTIRGSTNEESNVPADYMEDEASPVSRSEAVSS 359

Query: 355 SSGSEKQESFA----------SSIRIRTICKKDSAVVSSNLNLQRHRDRLSFPLILSTSI 404
           S   EK ES            S    RT C KDS VV SN N +  ++ L   LI STSI
Sbjct: 360 SHDVEKVESHGDGEEMEDFLDSKFSCRT-CMKDSVVV-SNFNFEIDKEHL---LITSTSI 414

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224131610|ref|XP_002321133.1| predicted protein [Populus trichocarpa] gi|222861906|gb|EEE99448.1| predicted protein [Populus trichocarpa]

 Score =  433 bits (1114), Expect = e-119,   Method: Compositional matrix adjust.
 Identities = 222/335 (66%), Positives = 264/335 (78%), Gaps = 11/335 (3%)

Query: 1   MDWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGY 60
           MDWTRGHTIG+GS+ATVS+ATS++SGDVFA KS EL +S FLQREQK LSS+ SP IV Y
Sbjct: 1   MDWTRGHTIGRGSTATVSVATSIQSGDVFAVKSVELSQSGFLQREQKILSSIISPFIVSY 60

Query: 61  KGCDVTSEDNKLMYNLFMEYAPGGTLNDEIH-RNGGRLDESLIVSYTRQILQGLEYLHSN 119
           KGCDVT ++NK+MYNLF+EY P G+L++ IH  +GG+LDESLI  +T QILQGL+YLH N
Sbjct: 61  KGCDVTRKNNKVMYNLFLEYMPNGSLSNAIHAHDGGQLDESLIRIFTYQILQGLDYLHLN 120

Query: 120 RVVHCDIKSRNILMAESGAKIADFGCAKWESEALQSGGTPMFMAPEVARGEHQGFASDIW 179
            +VHCDIKS NIL+A+SGAKIADFGCAK   +     GTPMFMAPEVARGE QGFASDIW
Sbjct: 121 GLVHCDIKSSNILVAQSGAKIADFGCAKRVEQQGPIAGTPMFMAPEVARGEEQGFASDIW 180

Query: 180 AVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKE 239
           A+GCT+IEMASGG PW N +DP++++Y+  YS  LPE P  LS+QA DFL  CLRRDPKE
Sbjct: 181 ALGCTIIEMASGGTPWHNVSDPVSIIYRAGYSGHLPEFPCCLSEQARDFLDKCLRRDPKE 240

Query: 240 RWAASQLLKHPFLEEFCSCTKQIQESN---CSPTSILDQGIWNSVEETE--ESLGNLIHS 294
           RW ASQLL+HPFL       KQI+ESN    SPTSILDQGIWNS++E+E  ESL  L+ S
Sbjct: 241 RWTASQLLEHPFL--VGELNKQIEESNPTSTSPTSILDQGIWNSLDESESLESL-VLVPS 297

Query: 295 TSKTSARERIERLSCSQG-PSWGW-DESWITIREN 327
            S++SA ERI  LS   G PSW   D++WIT RE+
Sbjct: 298 GSESSASERIRGLSLLSGAPSWDCDDQNWITARED 332

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356542808|ref|XP_003539857.1| PREDICTED: mitogen-activated protein kinase kinase kinase A-like [Glycine max]

 Score =  417 bits (1073), Expect = e-114,   Method: Compositional matrix adjust.
 Identities = 212/337 (62%), Positives = 254/337 (75%), Gaps = 11/337 (3%)

Query: 1   MDWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGY 60
           M+W RGHTIGQGSSATVS AT    G V A KS+ELP+SE L++EQK LSSL+SP++V Y
Sbjct: 1   MEWHRGHTIGQGSSATVSTATC--CGGVLAVKSSELPQSEPLKKEQKILSSLSSPYVVAY 58

Query: 61  KGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNR 120
           KGCD+T E+NKL++NLFMEY P GTL     R  GRL E  I  YTRQI+QGLEYLHS  
Sbjct: 59  KGCDITMENNKLLFNLFMEYMPFGTLAQATRRCDGRLQEPAIACYTRQIVQGLEYLHSKG 118

Query: 121 VVHCDIKSRNILMAESGAKIADFGCAKWESEALQS-GGTPMFMAPEVARGEHQGFASDIW 179
           +VHCDIK  NIL+ E+GAKI D GCAK  +++  + GGTPMFMAPEVARGE QG ASDIW
Sbjct: 119 LVHCDIKGANILIGENGAKIGDLGCAKSAADSTGAIGGTPMFMAPEVARGEEQGCASDIW 178

Query: 180 AVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKE 239
           ++GCTVIEM +GGAPWPN  DP +VLY IAYS E+PE+P FLSK+A DFL  CLRR+P+E
Sbjct: 179 SLGCTVIEMVTGGAPWPNVEDPFSVLYHIAYSSEVPEIPCFLSKEAKDFLGKCLRRNPQE 238

Query: 240 RWAASQLLKHPFLEEFCSCTKQIQESNC-SPTSILDQGIWNSVEETEESLGNLIHSTSK- 297
           RW AS+LLKHPF+E+ C   K++ ESN  SPTS+L+QG W+ VEE+ ESLG+LIH T K 
Sbjct: 239 RWKASELLKHPFIEKLCF-NKEVLESNTSSPTSVLEQGYWSCVEES-ESLGDLIHKTRKF 296

Query: 298 -TSARERIERLSCSQG-PSWGW--DESWITIRENNNE 330
            T A  R+  L+ S G P W    DE+WIT R N  E
Sbjct: 297 ETLAAGRVRMLALSSGVPYWARHDDENWITARGNGVE 333

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356515292|ref|XP_003526335.1| PREDICTED: mitogen-activated protein kinase kinase kinase A-like [Glycine max]

 Score =  407 bits (1046), Expect = e-111,   Method: Compositional matrix adjust.
 Identities = 210/341 (61%), Positives = 254/341 (74%), Gaps = 14/341 (4%)

Query: 1   MDWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGY 60
           M+W RGHTIGQGSSATVS AT    G VFA KSTELP+SE L+REQK LSSL+SP++V Y
Sbjct: 1   MEWHRGHTIGQGSSATVSTATC--RGGVFAVKSTELPQSEPLKREQKILSSLSSPYVVAY 58

Query: 61  KGCDVTSEDNKLMYNLFMEYAPGGTL-NDEIHRNGGRL-DESLIVSYTRQILQGLEYLHS 118
           KGCD+T E+NKL++NLFMEY P GTL      R  GRL +ES+I  YTRQI+QGL+YLHS
Sbjct: 59  KGCDITMENNKLLFNLFMEYMPFGTLAQAATRRCAGRLFEESVIARYTRQIVQGLDYLHS 118

Query: 119 NRVVHCDIKSRNILMAESGAKIADFGCAKWESEALQS-GGTPMFMAPEVARGEHQGFASD 177
             +VHCDIK  NIL+ E GAKI D GCAK  +++  + GGTPMF+APEVARGE QG ASD
Sbjct: 119 KGLVHCDIKGANILIGEDGAKIGDLGCAKSVADSTAAIGGTPMFLAPEVARGEEQGCASD 178

Query: 178 IWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDP 237
           IW++GCTVIEM +GGAPWPN  DP + LY IAYS E+PE+P FLS +A DFL  CLRR+P
Sbjct: 179 IWSLGCTVIEMVTGGAPWPNVEDPFSALYHIAYSSEVPEIPCFLSNEAKDFLGKCLRRNP 238

Query: 238 KERWAASQLLKHPFLEEFCSCTKQIQESN-CSPTSILDQGIWNSVEETEESLGNLIHSTS 296
           +ERW AS+LLKHPF+E+     K++ ESN  SPTS+L+QG W+S+EE+ +SLGNLIH T 
Sbjct: 239 QERWKASELLKHPFIEKTLCFNKEVLESNSSSPTSVLEQGYWSSMEES-KSLGNLIHKTR 297

Query: 297 KTSARE--RIERLSCSQG-PSWGW----DESWITIRENNNE 330
           K  A    R+  L+ S G P W      DE+WIT R N  E
Sbjct: 298 KFEALAAGRVRMLALSSGVPCWARHDDDDENWITARGNGVE 338

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356542080|ref|XP_003539499.1| PREDICTED: mitogen-activated protein kinase kinase kinase A-like [Glycine max]

 Score =  404 bits (1037), Expect = e-110,   Method: Compositional matrix adjust.
 Identities = 204/336 (60%), Positives = 247/336 (73%), Gaps = 11/336 (3%)

Query: 1   MDWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP--KSEFLQREQKFLSSLNSPHIV 58
           M+WTRG  IG+GSSATV  ATS  S  V A KS EL    SE LQREQ+ LSSL SPHIV
Sbjct: 1   MEWTRGFIIGRGSSATVYTATSSHSSTVAAVKSAELTLSNSEQLQREQRILSSLFSPHIV 60

Query: 59  GYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHS 118
            YKGC++T ++N L +NLFMEY P GTL+ E HR+GGRL E   V YTRQ+LQGL+YLH+
Sbjct: 61  TYKGCNITEDNNTLWFNLFMEYMPFGTLSQESHRHGGRLSEPATVYYTRQVLQGLQYLHN 120

Query: 119 NRVVHCDIKSRNILMAESGAKIADFGCAKWESEALQS-GGTPMFMAPEVARGEHQGFASD 177
             VVHCDIK  NIL+ E GAKI DFGCAK+ +++    GGTPMFMAPEVARGE QG+ +D
Sbjct: 121 KGVVHCDIKGGNILIGEDGAKIGDFGCAKFANDSSAVIGGTPMFMAPEVARGEEQGYPAD 180

Query: 178 IWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDP 237
           +WA+GCTV+EMA+G APWPN  DP+TVLY++AYS ++PE+P FLS++A DFL  C RR+P
Sbjct: 181 VWALGCTVLEMATGFAPWPNVEDPVTVLYRVAYSDDVPEIPCFLSEEAKDFLGKCFRRNP 240

Query: 238 KERWAASQLLKHPFLEEFCSCTKQIQESN-CSPTSILDQGIWNSVEETE----ESLGNLI 292
           KERW+  QLLKHP L EF S  K+IQESN CSPTSIL+QG WNS+EE E     +  N++
Sbjct: 241 KERWSCGQLLKHPLLGEFSSNDKKIQESNSCSPTSILEQGFWNSMEEAEVECVSASANVV 300

Query: 293 HSTS-KTSARERIERLSCSQGPSWGW--DESWITIR 325
              S + S R RI RL+   G   G   DE+WIT R
Sbjct: 301 QVKSFEDSPRGRIRRLASCSGDPIGELDDENWITAR 336

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356547091|ref|XP_003541951.1| PREDICTED: mitogen-activated protein kinase kinase kinase A-like [Glycine max]

 Score =  402 bits (1032), Expect = e-109,   Method: Compositional matrix adjust.
 Identities = 223/414 (53%), Positives = 271/414 (65%), Gaps = 34/414 (8%)

Query: 1   MDWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP--KSEFLQREQKFLSSLNSPHIV 58
           M+WTRG  IG+GSSATV   TS  S  V A KS EL    SE LQREQ+ LS L SPHIV
Sbjct: 1   MEWTRGFIIGRGSSATVYTVTSSHSSTVAAVKSAELTLSNSEQLQREQRILSCLFSPHIV 60

Query: 59  GYKGCDVTSE-DNKLMYNLFMEYAPGGTLNDEIHR-NGGRLDESLIVSYTRQILQGLEYL 116
            YKGC++T + +N L +NLFMEY P GTL+ EIHR  GGRL E   V YTRQ+LQGLEYL
Sbjct: 61  TYKGCNITEDKNNTLWFNLFMEYMPFGTLSQEIHRRGGGRLSEPATVHYTRQVLQGLEYL 120

Query: 117 HSNRVVHCDIKSRNILMAESGAKIADFGCAKWESEALQS-GGTPMFMAPEVARGEHQGFA 175
           H+N VVHCDIK  NIL+ E GAKI DFGCAK+ +++    GGTPMFMAPEVARGE QG+ 
Sbjct: 121 HNNGVVHCDIKGGNILIGEDGAKIGDFGCAKFANDSSAVIGGTPMFMAPEVARGEEQGYP 180

Query: 176 SDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRR 235
           +D+WA+GCTV+EMA+G APWPN  DP+TVLY +AYS ++PE+P FLS++A DFL  C RR
Sbjct: 181 ADVWALGCTVLEMATGFAPWPNVEDPVTVLYHVAYSDDVPEIPCFLSEEAKDFLGKCFRR 240

Query: 236 DPKERWAASQLLKHPFLEEFCSCTKQIQESN-CSPTSILDQGIWNSVEETEESL----GN 290
           +PKERW+ SQLLKHPFL EF S  K+IQESN CSPTSIL+Q  WNSVEE E       GN
Sbjct: 241 NPKERWSCSQLLKHPFLGEFSSNDKEIQESNSCSPTSILEQRFWNSVEEAEAECVSVSGN 300

Query: 291 LIHSTS-KTSARERIERLSCSQG-PSWGW-DESWITIRENNNEESNAIMDGIEAK-GDMI 346
           ++   S + S  +R+  L+ S G P W   DE+WIT R   +E   +  DG+       I
Sbjct: 301 VVQIKSFEDSPMDRVRSLALSSGDPFWELDDENWITTR--GSEAGASSCDGLNLDVNSRI 358

Query: 347 CGSVSDSTSSGSEKQESFASSIRIRTICKKDSAVVSSNLNLQRHRDRLSFPLIL 400
            G + D                     C +D +VV  N N +R    +  PL L
Sbjct: 359 SGYLCDDYYK-----------------C-RDVSVVVDNFNFERGNSEMLLPLKL 394

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224068982|ref|XP_002302871.1| predicted protein [Populus trichocarpa] gi|222844597|gb|EEE82144.1| predicted protein [Populus trichocarpa]

 Score =  398 bits (1023), Expect = e-108,   Method: Compositional matrix adjust.
 Identities = 194/298 (65%), Positives = 231/298 (77%), Gaps = 7/298 (2%)

Query: 1   MDWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGY 60
           MDWTRGH+IG GS+ATVSLATS++SGDVFA KS EL +S FLQREQ+ LSSL SP IV Y
Sbjct: 2   MDWTRGHSIGHGSTATVSLATSIQSGDVFAVKSVELFQSGFLQREQQILSSLTSPFIVSY 61

Query: 61  KGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNR 120
           +GCD+T E++K+MYNLF+EY P GTL++ IH +GGRLDE LI +YT Q+LQGL+Y+H N 
Sbjct: 62  RGCDITRENSKVMYNLFLEYMPNGTLSNAIHAHGGRLDEPLIRNYTSQVLQGLDYIHLNG 121

Query: 121 VVHCDIKSRNILMAESGAKIADFGCAKWESEALQSGGTPMFMAPEVARGEHQGFASDIWA 180
           +VHCDIKS NIL+  SGAKIADFGCAK   +  Q  GTPMFMAPEVARGE QGFASDIWA
Sbjct: 122 LVHCDIKSSNILVGPSGAKIADFGCAKRVEQVGQIAGTPMFMAPEVARGEEQGFASDIWA 181

Query: 181 VGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKER 240
           +GC +IEMASG  PW N  DP++++Y++ YS  LP+ P  LS+QA D L  CLRRDP+ER
Sbjct: 182 LGCAIIEMASGSTPWHNVNDPVSIIYRVGYSGHLPDFPCCLSEQARDLLDKCLRRDPRER 241

Query: 241 WAASQLLKHPFL---EEFCSCTKQIQE---SNCSPTSILDQGIWNSVEETEESLGNLI 292
           W ASQLLKHPFL          KQIQE   S+ SPTSILDQ  WNS+ +  ESL NL+
Sbjct: 242 WTASQLLKHPFLVGESNSHHVAKQIQESNSSSNSPTSILDQCFWNSL-DLSESLNNLV 298

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357471365|ref|XP_003605967.1| MAP kinase kinase kinase SSK2 [Medicago truncatula] gi|355507022|gb|AES88164.1| MAP kinase kinase kinase SSK2 [Medicago truncatula]

 Score =  393 bits (1009), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 222/423 (52%), Positives = 282/423 (66%), Gaps = 48/423 (11%)

Query: 1   MDWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSL--NSPHIV 58
           M W RGH IG GS++TVSLAT   SG++FA KS+EL +SE LQRE+K LSSL   +PH+V
Sbjct: 1   MKWNRGHAIGHGSTSTVSLATV--SGEIFAVKSSELSRSEPLQREEKILSSLCYPNPHVV 58

Query: 59  GYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHS 118
            YKGCD+T ++ K MYNLFMEY P GTL+    ++GG LDE  I+ YTRQ+++GLE+LHS
Sbjct: 59  SYKGCDITKDNEKFMYNLFMEYMPFGTLS----QHGGMLDEQAIMCYTRQVVKGLEHLHS 114

Query: 119 NRVVHCDIKSRNILMAESGAKIADFGCAKWESEALQS-GGTPMFMAPEVARGEHQGFASD 177
             +VHCDIK  NI++ E GAKI DFGCAK  +EA     GTP+FMAPEVARGE Q F+SD
Sbjct: 115 KGLVHCDIKGANIMIGEDGAKIGDFGCAKSVNEAAAPIRGTPVFMAPEVARGEEQEFSSD 174

Query: 178 IWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDP 237
           IW++GCT+IEMA+G +PWPN  DP++ LY IAYS ++P++P FLS QA DFL  CLRR+P
Sbjct: 175 IWSLGCTIIEMATGSSPWPNVDDPISTLYHIAYSNDVPQIPCFLSNQAKDFLGKCLRRNP 234

Query: 238 KERWAASQLLKHPFLEE-FCSCTKQIQESN-CSPTSILDQGIWNSVEETEE-SLGNLIHS 294
           KER++ASQLLKHPFL E  CS  KQ+ ESN  SPTSILDQ  W+S+EE++  S  +LIH+
Sbjct: 235 KERFSASQLLKHPFLGELLCSNDKQVLESNSISPTSILDQCFWSSMEESQSLSFCSLIHT 294

Query: 295 TS--KTSARERIERLSCSQGPSWGW-----DESWITIRENNNEESNAIMDGIEAKGDMIC 347
           TS   +   +RI+RL+     +W W     DE+WITIR            G E  G   C
Sbjct: 295 TSFENSLVDDRIKRLAGEPCLAW-WHDDHDDENWITIR------------GKEVDGFCNC 341

Query: 348 GSVSDSTSSGSEKQESFASSIRIRT----------ICKKDSAVVSSNLNLQRHRDRLSFP 397
           GS   STS      E   SS++ R           IC+  S+ V SN+N Q    ++  P
Sbjct: 342 GSEIGSTS-----DELVKSSVKDRISGHFCNDHTHICRV-SSFVGSNVNFQPDIVKMLLP 395

Query: 398 LIL 400
             L
Sbjct: 396 STL 398

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	405
TAIR|locus:2205523	339	MAPKKK18 "mitogen-activated pr	0.795	0.949	0.523	1.7e-84
TAIR|locus:2060246	372	MAPKKK17 "mitogen-activated pr	0.767	0.836	0.518	8.2e-83
TAIR|locus:2116417	444	MAPKKK16 "mitogen-activated pr	0.888	0.810	0.455	1.7e-82
TAIR|locus:2161690	448	MAPKKK15 "mitogen-activated pr	0.686	0.620	0.540	7.6e-80
TAIR|locus:2007337	499	MAPKKK13 "mitogen-activated pr	0.790	0.641	0.394	4.8e-55
TAIR|locus:2045658	463	MAPKKK14 "mitogen-activated pr	0.782	0.684	0.384	1.5e-53
TAIR|locus:2114990	336	MAPKKK21 "mitogen-activated pr	0.795	0.958	0.374	1.5e-49
TAIR|locus:2074835	342	MAPKKK20 "mitogen-activated pr	0.782	0.926	0.374	1.8e-48
DICTYBASE|DDB_G0283265	1267	mkkA "octicosapeptide/Phox/Bem	0.750	0.239	0.363	5.5e-48
TAIR|locus:2035989	666	NP1 "NPK1-related protein kina	0.609	0.370	0.4	1.5e-44

TAIR|locus:2205523 MAPKKK18 "mitogen-activated protein kinase kinase kinase 18" [Arabidopsis thaliana (taxid:3702)]

 Score = 846 (302.9 bits), Expect = 1.7e-84, P = 1.7e-84
 Identities = 180/344 (52%), Positives = 227/344 (65%)

Query:     1 MDWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGY 60
             M+WTRG T+G+GS+ATVS AT   SG+  A KS E  +SEFLQRE K LSSLNSP+++GY
Sbjct:     1 MNWTRGKTLGRGSTATVSAATCHESGETLAVKSAEFHRSEFLQREAKILSSLNSPYVIGY 60

Query:    61 KGCDVTSE---DN--KLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
             +GC++T E   +N     Y+L MEYAP GTL D   +NGG +DE+ +V YTRQIL GLEY
Sbjct:    61 RGCEITREPFHNNGEATTYSLLMEYAPYGTLTDVATKNGGFIDEARVVKYTRQILLGLEY 120

Query:   116 LHSNR-VVHCDIKSRNILMAESG-AKIADFGCAKW-ESEALQS-GGTPMFMAPEVARGEH 171
             +H+++ + HCDIK  N+L+ E+G AKIADFGCAKW E E  +   GTP FMAPE ARGE 
Sbjct:   121 IHNSKGIAHCDIKGSNVLVGENGEAKIADFGCAKWVEPEITEPVRGTPAFMAPEAARGER 180

Query:   172 QGFASDIWAVGCTVIEMASGGAPWPNA--ADPMTVLYKIAYSRELPEVPAFLSKQANDFL 229
             QG  SDIWAVGCTVIEM +G  PW  A   DP++VLY++ Y  ELPE+P  L++QA DFL
Sbjct:   181 QGKESDIWAVGCTVIEMVTGSQPWIGADFTDPVSVLYRVGYLGELPELPCSLTEQAKDFL 240

Query:   230 SNCLRRDPKERWAASQLLKHPFL--EEFCSCTKQIQESNCSPTSILDQGIWNSVEE-TEE 286
               CL+++  ERW ASQLL HPFL  +E    T  +  +N SPTS+ DQ  W SVEE   E
Sbjct:   241 GKCLKKEATERWTASQLLNHPFLVNKEPELVTGLV--TN-SPTSVTDQMFWRSVEEEVSE 297

Query:   287 SLGNL--IHSTSKTSARERIERLSCSQGPSWGWD-ESWITIREN 327
                +    H   +      I  +      +W  D E WIT+R N
Sbjct:   298 DRSSWWECHEDERIGVLSWIGHVVVES--TWDLDGEDWITVRRN 339

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2060246 MAPKKK17 "mitogen-activated protein kinase kinase kinase 17" [Arabidopsis thaliana (taxid:3702)]

 Score = 830 (297.2 bits), Expect = 8.2e-83, P = 8.2e-83
 Identities = 171/330 (51%), Positives = 217/330 (65%)

Query:     1 MDWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGY 60
             M+WTRG  +G+GS+ATV  A    S ++ A KS+E+ +SEFLQRE K LSSL+SP+++GY
Sbjct:     1 MEWTRGRILGRGSTATVYAAAGHNSDEILAVKSSEVHRSEFLQREAKILSSLSSPYVIGY 60

Query:    61 KGCDVTSEDNKL-MYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN 119
             +G +   E N + MYNL MEYAP GTL D   ++GGR+DE+ +V YTR IL+GLEY+HS 
Sbjct:    61 RGSETKRESNGVVMYNLLMEYAPYGTLTDAAAKDGGRVDETRVVKYTRDILKGLEYIHSK 120

Query:   120 RVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG--GTPMFMAPEVARGEHQGFAS 176
              +VHCD+K  N++++E G AKIADFGCAK      +S   GTP FMAPEVARGE QG  S
Sbjct:   121 GIVHCDVKGSNVVISEKGEAKIADFGCAKRVDPVFESPVMGTPAFMAPEVARGEKQGKES 180

Query:   177 DIWAVGCTVIEMASGGAPWPNA---ADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCL 233
             DIWAVGCT+IEM +G  PW  A    DP++VLY++ YS E PE+P  L+++A DFL  CL
Sbjct:   181 DIWAVGCTMIEMVTGSPPWTKADSREDPVSVLYRVGYSSETPELPCLLAEEAKDFLEKCL 240

Query:   234 RRDPKERWAASQLLKHPFLEEFCSCTKQIQE---SNCSPTSILDQGIWNSVEETEESLGN 290
             +R+  ERW A+QLL HPFL         +     SN SPTS+ DQ  W SVEE EE    
Sbjct:   241 KREANERWTATQLLNHPFLTTKPDIEPVLVPGLISN-SPTSVTDQTFWRSVEEEEEEETE 299

Query:   291 LIHSTSKTSAR--------ERIERLSCSQG 312
              I   S+   R        ERI RL C  G
Sbjct:   300 EIQKDSRDLDRLSLWGCYSERIGRLKCVGG 329

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2116417 MAPKKK16 "mitogen-activated protein kinase kinase kinase 16" [Arabidopsis thaliana (taxid:3702)]

 Score = 827 (296.2 bits), Expect = 1.7e-82, P = 1.7e-82
 Identities = 174/382 (45%), Positives = 240/382 (62%)

Query:     1 MDWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGY 60
             ++WTRG  IG+GS+ATVS+A S  SG++FA KS +L  S  LQ+EQ  LS+L+SPH+V Y
Sbjct:     3 INWTRGPIIGRGSTATVSIAIS-SSGELFAVKSADLSSSSLLQKEQSILSTLSSPHMVKY 61

Query:    61 KGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNR 120
              G  +T E N L+YN+ MEY  GG L+D I  +GG+L E  I SYTRQIL GL YLH   
Sbjct:    62 IGTGLTRESNGLVYNILMEYVSGGNLHDLIKNSGGKLPEPEIRSYTRQILNGLVYLHERG 121

Query:   121 VVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSGGTPMFMAPEVARGEHQGFASDIW 179
             +VHCD+KS N+L+ E+G  KIAD GCAK   ++ +  GTP FMAPEVARGE Q F +D+W
Sbjct:   122 IVHCDLKSHNVLVEENGVLKIADMGCAKSVDKS-EFSGTPAFMAPEVARGEEQRFPADVW 180

Query:   180 AVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKE 239
             A+GCT+IEM +G +PWP   D +  +YKI +S E P +PA++S +A DFL NCL+ D K+
Sbjct:   181 ALGCTMIEMMTGSSPWPELNDVVAAMYKIGFSGESPAIPAWISDKAKDFLKNCLKEDQKQ 240

Query:   240 RWAASQLLKHPFLE--EFCSCTKQIQESNCSPTSILDQGIWNSVEETEESLGNLIH---- 293
             RW   +LLKHPFL+  E    +  ++    SP+++LDQ  W+S E ++  L ++ H    
Sbjct:   241 RWTVEELLKHPFLDDDEESQTSDCLKNKTSSPSTVLDQRFWDSCESSKSHLVSIDHEDPF 300

Query:   294 ---STSKTSARERIERLSCSQGPSW-GWDES----WITIRENNNEESNAIMDGIEAKGDM 345
                S S  S  +RIE+L+  +  S   WD      WI +R   ++E+    DG E   D+
Sbjct:   301 AEYSESLDSPADRIEKLAGDEFSSLLDWDTEDDGGWIQVRGEKHKETEK-RDGDE---DV 356

Query:   346 ICGXXXXXXXXXXEKQESFASS 367
             IC           E+ E + S+
Sbjct:   357 IC-VEATSSSQTIEEVEDWISN 377

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2161690 MAPKKK15 "mitogen-activated protein kinase kinase kinase 15" [Arabidopsis thaliana (taxid:3702)]

 Score = 802 (287.4 bits), Expect = 7.6e-80, P = 7.6e-80
 Identities = 155/287 (54%), Positives = 200/287 (69%)

Query:     2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGYK 61
             +W RG  IG+GS+ATVSL  +  SGD FA KS E   S FLQREQ  LS L+SP+IV Y 
Sbjct:     5 NWIRGPIIGRGSTATVSLGIT-NSGDFFAVKSAEFSSSAFLQREQSILSKLSSPYIVKYI 63

Query:    62 GCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRV 121
             G +VT E++KLMYNL MEY  GG+L+D I  +GG+L E LI SYTRQIL+GL YLH   +
Sbjct:    64 GSNVTKENDKLMYNLLMEYVSGGSLHDLIKNSGGKLPEPLIRSYTRQILKGLMYLHDQGI 123

Query:   122 VHCDIKSRNILMAESGAKIADFGCAKW--ESEALQSGGTPMFMAPEVARGEHQGFASDIW 179
             VHCD+KS+N+++    AKI D GCAK   E+E L+  GTP FM+PEVARGE Q F +D+W
Sbjct:   124 VHCDVKSQNVMIGGEIAKIVDLGCAKTVEENENLEFSGTPAFMSPEVARGEEQSFPADVW 183

Query:   180 AVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKE 239
             A+GCTVIEMA+G +PWP   D +  +YKI ++ E P +P +LS++  DFL  CLR+DPK+
Sbjct:   184 ALGCTVIEMATGSSPWPELNDVVAAIYKIGFTGESPVIPVWLSEKGQDFLRKCLRKDPKQ 243

Query:   240 RWAASQLLKHPFLEEFCSCTKQIQESNC----SPTSILDQGIWNSVE 282
             RW   +LL+HPFL+E        Q  NC    SP+++LDQ  W+  E
Sbjct:   244 RWTVEELLQHPFLDE--EDNDSDQTGNCLNSSSPSTVLDQRFWDLCE 288

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2007337 MAPKKK13 "mitogen-activated protein kinase kinase kinase 13" [Arabidopsis thaliana (taxid:3702)]

 Score = 568 (205.0 bits), Expect = 4.8e-55, P = 4.8e-55
 Identities = 138/350 (39%), Positives = 200/350 (57%)

Query:     3 WTRGHTIGQGSSATVSLATSLRSGDVFAAKS----TELP-KSEFLQREQKFLSSLNS-PH 56
             W RG  IG+G    VS A S  +G+VFA KS    T LP +SE L+ E     SL   P+
Sbjct:    23 WVRGACIGRGCFGAVSTAISKTNGEVFAVKSVDLATSLPTQSESLENEISVFRSLKPHPY 82

Query:    57 IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRL-DESLIVSYTRQILQGLEY 115
             IV + G  V+ E      NL++EY P G +    HR GG++ DE+L+  YT  ++  L +
Sbjct:    83 IVKFLGDGVSKEGTTTFRNLYLEYLPNGDVAS--HRAGGKIEDETLLQRYTACLVSALRH 140

Query:   116 LHSNRVVHCDIKSRNILMAESG-AKIADFGCA---KWESEALQSGGTPMFMAPEVARGEH 171
             +HS   VHCD+K+RNIL+++S   K+ADFG A         +   G+P++MAPEV R E+
Sbjct:   141 VHSQGFVHCDVKARNILVSQSSMVKLADFGSAFRIHTPRALITPRGSPLWMAPEVIRREY 200

Query:   172 QGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSN 231
             QG  SD+W++GCT+IEM +G   W +    +  L +I++S ELP  P+ LS+   DFL  
Sbjct:   201 QGPESDVWSLGCTIIEMFTGKPAWEDHG--IDSLSRISFSDELPVFPSKLSEIGRDFLEK 258

Query:   232 CLRRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSILDQGIW-NS---VEETEES 287
             CL+RDP +RW+  QLL+HPFL + C  +   + S   P  +LD   W NS   +EE EE 
Sbjct:   259 CLKRDPNQRWSCDQLLQHPFLSQ-CHNSSPTESS---PRCVLD---WVNSGFDLEEEEEE 311

Query:   288 LGNLIHSTSKTSARERIERLSCSQGPSWGWDESWITIRENNNEESNAIMD 337
             +G    S  + +A+  I  L+ + G  W  D  W+ +R + +EE    M+
Sbjct:   312 VGR---SEFEDAAKAIICNLATTGGVIWESD-GWVEVRCHASEEEGTTME 357

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2045658 MAPKKK14 "mitogen-activated protein kinase kinase kinase 14" [Arabidopsis thaliana (taxid:3702)]

 Score = 554 (200.1 bits), Expect = 1.5e-53, P = 1.5e-53
 Identities = 132/343 (38%), Positives = 193/343 (56%)

Query:     3 WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL----P-KSEFLQREQKFLSSLNS-PH 56
             W RG  +G+G   TVS A S   G +FA KS +L    P ++E L+ E   L S+ S P+
Sbjct:    17 WIRGSCVGRGCFGTVSKALSKIDGGLFAVKSIDLATCLPSQAESLENEIVILRSMKSHPN 76

Query:    57 IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL 116
             IV + G DV+ E      NL +EY+P G +      NGG ++E+L+  Y   ++  L ++
Sbjct:    77 IVRFLGDDVSKEGTASFRNLHLEYSPEGDV-----ANGGIVNETLLRRYVWCLVSALSHV 131

Query:   117 HSNRVVHCDIKSRNILMAESGA--KIADFGCA-KWESEALQSG--GTPMFMAPEVARGEH 171
             HSN +VHCD+KS+N+L+   G+  K+ADFG A ++E   +     G+P++MAPEV R E+
Sbjct:   132 HSNGIVHCDVKSKNVLVFNGGSSVKLADFGSAVEFEKSTIHVSPRGSPLWMAPEVVRREY 191

Query:   172 QGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSN 231
             QG  SD+W++GCTVIEM +G   W +       L +I +S +LP +P  LS+   DFL  
Sbjct:   192 QGPESDVWSLGCTVIEMLTGKPAWEDHG--FDSLSRIGFSNDLPFIPVGLSELGRDFLEK 249

Query:   232 CLRRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSILDQGIWNSVEETEESLGNL 291
             CL+RD  +RW+  QLL+HPFL   C        +  SP  +LD   W + E  EE   + 
Sbjct:   250 CLKRDRSQRWSCDQLLQHPFL---CQDHHDSFFTESSPRCVLD---WVNSEFDEEEESDE 303

Query:   292 IHSTSKTSARERIERLSCSQGPSWGWDESWITIRENNNEESNA 334
                 S  SA  RI +L+ + G +W     W  +R+ + EES A
Sbjct:   304 WRPESMVSAMARISKLAITGGANWE-SNGWTEVRDTS-EESEA 344

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0009658 "chloroplast organization" evidence=IMP

GO:0045893 "positive regulation of transcription, DNA-dependent" evidence=IMP

GO:0009737 "response to abscisic acid stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009753 "response to jasmonic acid stimulus" evidence=RCA

GO:0009873 "ethylene mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

TAIR|locus:2114990 MAPKKK21 "mitogen-activated protein kinase kinase kinase 21" [Arabidopsis thaliana (taxid:3702)]

 Score = 516 (186.7 bits), Expect = 1.5e-49, P = 1.5e-49
 Identities = 127/339 (37%), Positives = 184/339 (54%)

Query:     1 MDWTRGHTIGQGSSATVSLATSLRSGD-----VFAAKSTELPKSEFLQREQKFLSSLNS- 54
             M+W R  TIG GS +TVSLAT+  S       + A KS+ +  S  L+ E+  L  L   
Sbjct:     1 MEWIRRETIGHGSFSTVSLATTSGSSSKAFPSLMAVKSSGVVCSAALRNERDVLDDLGDC 60

Query:    55 PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLE 114
               IV   G   T E+ + +YNLF+EYA GG+L D I  +G  L E  +  +TR I++GL 
Sbjct:    61 SEIVRCFGEGRTVENGEEIYNLFLEYASGGSLADRIKSSGEALPEFEVRRFTRSIVKGLC 120

Query:   115 YLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE--ALQSGGTPMFMAPE-VARGE 170
             ++H N   HCDIK  N+L+   G  KI+DFG AK  S    ++  GTP++MAPE V  GE
Sbjct:   121 HIHGNGFTHCDIKLENVLVFGDGDVKISDFGLAKRRSGEVCVEIRGTPLYMAPESVNHGE 180

Query:   171 HQGFASDIWAVGCTVIEMASGGAPW--PNAA--DPMTVLYKIAYSRELPEVPAFLSKQAN 226
              +  A DIWA+GC+V+EM+SG   W   +    + M++L +I    E+P +P  LS++  
Sbjct:   181 FESPA-DIWALGCSVVEMSSGKTAWCLEDGVMNNVMSLLVRIGSGDEVPRIPVELSEEGK 239

Query:   227 DFLSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSILDQGIWNSVEETEE 286
             DF+S C  ++  ERW A  LL HPFL       ++ +  + SP +  D   WNSV+    
Sbjct:   240 DFVSKCFVKNAAERWTAEMLLDHPFLAVDDESGEEDEACSVSPRNPFDFPGWNSVQSPVN 299

Query:   287 SLGNLIHSTSKTSARERIERLSCSQGPSWGWDESWITIR 325
                +++  +   S  ERI  L   + P W     W+ +R
Sbjct:   300 D--SVMFGSLVGSPEERISGLVSEKVPDWSVSCDWVNVR 336

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2074835 MAPKKK20 "mitogen-activated protein kinase kinase kinase 20" [Arabidopsis thaliana (taxid:3702)]

 Score = 506 (183.2 bits), Expect = 1.8e-48, P = 1.8e-48
 Identities = 131/350 (37%), Positives = 182/350 (52%)

Query:     1 MDWTRGHTIGQGSSATVSLATSLR-SGD---VFAAKSTELPKSEFLQREQKFLSSLNS-P 55
             M+W RG TIG G+ +TVS AT  R SGD   + A KST+   +  L  E+  L SL   P
Sbjct:     1 MEWVRGETIGFGTFSTVSTATKSRNSGDFPALIAVKSTDAYGAASLSNEKSVLDSLGDCP 60

Query:    56 HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGR-LDESLIVSYTRQILQGLE 114
              I+   G D T E+ + M+NL +EYA  G+L   + + GG  L ES +  +T  +L+GL 
Sbjct:    61 EIIRCYGEDSTVENGEEMHNLLLEYASRGSLASYMKKLGGEGLPESTVRRHTGSVLRGLR 120

Query:   115 YLHSNRVVHCDIKSRNILMAESGA-KIADFGCAK---WESEALQSG----GTPMFMAPEV 166
             ++H+    HCDIK  NIL+   G+ KIADFG A     +  AL+      GTP++MAPE 
Sbjct:   121 HIHAKGFAHCDIKLANILLFNDGSVKIADFGLAMRVDGDLTALRKSVEIRGTPLYMAPEC 180

Query:   167 ARGEHQGFASDIWAVGCTVIEMASGGAPWP--NAADPMTVLYKIAYSRELPEVPAFLSKQ 224
                   G A+D+WA+GC V+EM SG   W     +  M++L +I    ELP++P  LS++
Sbjct:   181 VNDNEYGSAADVWALGCAVVEMFSGKTAWSVKEGSHFMSLLIRIGVGDELPKIPEMLSEE 240

Query:   225 ANDFLSNCLRRDPKERWAASQLLKHPFL---------EEFCSCTKQIQESNCSPTSILDQ 275
               DFLS C  +DP +RW A  LL H F+         E F    K   +   SP    + 
Sbjct:   241 GKDFLSKCFVKDPAKRWTAEMLLNHSFVTIDLEDDHRENFVVKVKDEDKVLMSPKCPFEF 300

Query:   276 GIWNSVEETEESLGNLIHSTSKTSARERIERLSCSQGPSWGWDESWITIR 325
               W+S   T +S      + S  S  ER+  L     P W    SW+T+R
Sbjct:   301 DDWDSF--TLDS------NPSFDSPVERLGSLVSGSIPDWSVGGSWLTVR 342

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;IMP

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0048235 "pollen sperm cell differentiation" evidence=IEP

GO:0000302 "response to reactive oxygen species" evidence=IEP

GO:0009409 "response to cold" evidence=IEP

GO:0009414 "response to water deprivation" evidence=IMP

GO:0009651 "response to salt stress" evidence=IMP

DICTYBASE|DDB_G0283265 mkkA "octicosapeptide/Phox/Bem1p domain-containing protein" [Dictyostelium discoideum (taxid:44689)]

 Score = 513 (185.6 bits), Expect = 5.5e-48, P = 5.5e-48
 Identities = 121/333 (36%), Positives = 188/333 (56%)

Query:     3 WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL------PKSEFL----QREQKFLSSL 52
             W +G  +G+G   +V L  +  +G++FA K  E+      PK + +     +E + + SL
Sbjct:   495 WQKGQILGRGGYGSVYLGLNKDTGELFAVKQLEIVDINSDPKLKNMILSFSKEIEVMRSL 554

Query:    53 NSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQG 112
                +IV Y G   TS D   + ++F+EY PGG+++  + + G    E++I  YT+QILQG
Sbjct:   555 RHDNIVRYLG---TSLDQSFL-SVFLEYIPGGSISSLLGKFGA-FSENVIKVYTKQILQG 609

Query:   113 LEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQS----GGTPMFMAPEVA 167
             L +LH+N ++H DIK  NIL+   G  K++DFGC+K  S  +       GTP +MAPEV 
Sbjct:   610 LSFLHANSIIHRDIKGANILIDTKGIVKLSDFGCSKSFSGIVSQFKSMQGTPYWMAPEVI 669

Query:   168 RGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQAND 227
             +    G +SDIW++GC ++EMA+   PW N  +   V+Y IA S  +P +P+ +S++A D
Sbjct:   670 KQTGHGRSSDIWSLGCVIVEMATAQPPWSNITELAAVMYHIASSNSIPNIPSHMSQEAFD 729

Query:   228 FLSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSILDQGIWNSVEET--- 284
             FL+ C +RDPKER  A+QLLKHPF+    +    IQ    SPT+ L     N+   T   
Sbjct:   730 FLNLCFKRDPKERPDANQLLKHPFI---MNLDDNIQLPTISPTTTLSTNTTNTTATTTTT 786

Query:   285 EESLGNLIHSTSKTSARE---RIERLSCSQGPS 314
               +  + I+   +   ++   R +R+S S G S
Sbjct:   787 NNATNSNINQQQQQQQQQPPTRTQRVSISAGSS 819

GO:0030587 "sorocarp development" evidence=IMP

GO:0009653 "anatomical structure morphogenesis" evidence=IMP

GO:0005938 "cell cortex" evidence=IDA

GO:0004709 "MAP kinase kinase kinase activity" evidence=IEA;ISS

GO:0000186 "activation of MAPKK activity" evidence=IEA;ISS

GO:0000165 "MAPK cascade" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0046872 "metal ion binding" evidence=IEA

GO:0030435 "sporulation resulting in formation of a cellular spore" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0016021 "integral to membrane" evidence=IEA

GO:0016020 "membrane" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

TAIR|locus:2035989 NP1 "NPK1-related protein kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 469 (170.2 bits), Expect = 1.5e-44, P = 1.5e-44
 Identities = 108/270 (40%), Positives = 158/270 (58%)

Query:     1 MDWTRGHTIGQGSSATVSLATSLRSGDVFAAK---------STELPKSEF--LQREQKFL 49
             + W +G  IG+G+  TV +  +L SG++ A K         S E  ++    L+ E K L
Sbjct:    67 ISWRKGQLIGRGAFGTVYMGMNLDSGELLAVKQVLIAANFASKEKTQAHIQELEEEVKLL 126

Query:    50 SSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQI 109
              +L+ P+IV Y G     ED+ L  N+ +E+ PGG+++  + + G    ES++ +YTRQ+
Sbjct:   127 KNLSHPNIVRYLG--TVREDDTL--NILLEFVPGGSISSLLEKFGP-FPESVVRTYTRQL 181

Query:   110 LQGLEYLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESE-ALQSG-----GTPMFM 162
             L GLEYLH++ ++H DIK  NIL+   G  K+ADFG +K  +E A  +G     GTP +M
Sbjct:   182 LLGLEYLHNHAIMHRDIKGANILVDNKGCIKLADFGASKQVAELATMTGAKSMKGTPYWM 241

Query:   163 APEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLS 222
             APEV       F++DIW+VGCTVIEM +G APW      +  ++ I  ++  P +P  LS
Sbjct:   242 APEVILQTGHSFSADIWSVGCTVIEMVTGKAPWSQQYKEVAAIFFIGTTKSHPPIPDTLS 301

Query:   223 KQANDFLSNCLRRDPKERWAASQLLKHPFL 252
               A DFL  CL+  P  R  AS+LLKHPF+
Sbjct:   302 SDAKDFLLKCLQEVPNLRPTASELLKHPFV 331

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006979 "response to oxidative stress" evidence=IDA

GO:0009908 "flower development" evidence=IGI

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0007155 "cell adhesion" evidence=RCA

GO:0010090 "trichome morphogenesis" evidence=RCA

GO:0045010 "actin nucleation" evidence=RCA

GO:0048765 "root hair cell differentiation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

GO:0004709 "MAP kinase kinase kinase activity" evidence=ISS

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.737
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	405
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-132
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	4e-81
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	6e-76
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	3e-75
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	5e-75
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	3e-70
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-69
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-62
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-61
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	8e-61
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	9e-61
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	3e-58
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	7e-58
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	4e-57
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	8e-57
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	6e-56
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	9e-56
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-53
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	4e-51
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	4e-51
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-50
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	7e-48
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	4e-47
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-46
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	4e-46
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-45
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	5e-45
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-44
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-43
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-43
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-43
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	6e-43
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	6e-42
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-41
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-41
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-41
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	4e-41
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-40
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-40
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	3e-40
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-39
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	3e-39
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	4e-39
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	5e-39
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-38
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	6e-38
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	9e-38
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	9e-38
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	9e-38
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-37
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-37
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-37
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	9e-37
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	3e-36
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	4e-35
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	5e-35
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-34
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-34
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	3e-34
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	4e-34
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-33
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-33
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-33
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	8e-33
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-32
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-32
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	4e-32
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	6e-32
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	9e-32
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	1e-31
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-31
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	3e-31
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	3e-31
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	3e-31
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	4e-31
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	9e-31
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-30
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-30
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	6e-30
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-29
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-29
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-29
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-29
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-28
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-28
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-28
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-28
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-27
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-27
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	4e-27
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	7e-27
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	8e-27
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	9e-27
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-26
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-26
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	3e-26
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-26
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	4e-26
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-25
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-25
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-25
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	3e-25
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	5e-25
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	3e-24
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	3e-24
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	3e-24
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	4e-24
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	4e-24
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	6e-24
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	8e-24
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	9e-24
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	9e-24
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-23
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	3e-23
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	5e-23
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	8e-23
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	2e-22
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	5e-22
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	6e-22
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	6e-22
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	6e-22
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-21
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-21
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	3e-21
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	4e-21
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	4e-21
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-20
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-20
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-20
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	4e-20
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	7e-20
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	8e-20
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	8e-20
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	9e-20
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	1e-19
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-19
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-19
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-19
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-19
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-19
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	2e-19
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	3e-19
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	4e-19
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	4e-19
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	5e-19
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	7e-19
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	7e-19
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	8e-19
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-18
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-18
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-18
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-18
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	3e-18
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	4e-18
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	6e-18
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	7e-18
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	9e-18
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	9e-18
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-17
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-17
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-17
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-17
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	2e-17
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-17
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	3e-17
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	5e-17
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	5e-17
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	6e-17
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	7e-17
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	9e-17
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	9e-17
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	1e-16
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-16
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	1e-16
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	1e-16
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-16
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-16
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-16
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	3e-16
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	4e-16
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	5e-16
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	5e-16
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	7e-16
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	7e-16
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	9e-16
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	2e-15
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	6e-15
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	7e-15
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	8e-15
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	8e-15
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-14
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-14
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-14
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-14
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-14
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-14
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-14
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-14
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	3e-14
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	3e-14
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	4e-14
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	6e-14
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	9e-14
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	1e-13
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-13
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	1e-13
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-13
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-13
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-13
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-13
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-13
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	3e-13
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	3e-13
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	3e-13
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	4e-13
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	4e-13
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	4e-13
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	4e-13
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	4e-13
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	6e-13
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	8e-13
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	8e-13
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	1e-12
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	1e-12
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-12
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-12
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-12
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	3e-12
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	3e-12
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	3e-12
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	4e-12
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	4e-12
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	5e-12
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	5e-12
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	6e-12
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	6e-12
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	6e-12
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	8e-12
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	8e-12
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	8e-12
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	9e-12
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	1e-11
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-11
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-11
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	2e-11
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	2e-11
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-11
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	3e-11
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	3e-11
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	3e-11
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	4e-11
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	5e-11
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	7e-11
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	9e-11
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-10
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	1e-10
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-10
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-10
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-10
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-10
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	2e-10
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-10
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	2e-10
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	3e-10
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	3e-10
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	4e-10
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	5e-10
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	7e-10
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	8e-10
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	8e-10
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	1e-09
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	1e-09
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-09
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-09
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-09
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	3e-09
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	3e-09
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	3e-09
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	4e-09
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	4e-09
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	6e-09
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	1e-08
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	2e-08
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-08
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-08
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	3e-08
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	4e-08
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	5e-08
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	1e-07
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-07
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	3e-07
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	3e-07
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	3e-07
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	4e-07
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	6e-07
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	7e-07
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	1e-06
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	3e-06
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	3e-06
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	7e-06
PRK09605	535	PRK09605, PRK09605, bifunctional UGMP family prote	1e-05
TIGR03724	199	TIGR03724, arch_bud32, Kae1-associated kinase Bud3	2e-05
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	3e-05
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	3e-05
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	3e-05
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	1e-04
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	1e-04
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-04
PRK14879	211	PRK14879, PRK14879, serine/threonine protein kinas	2e-04
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	7e-04
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	7e-04
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	0.001
COG3642	204	COG3642, COG3642, Mn2+-dependent serine/threonine	0.002

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  379 bits (975), Expect = e-132
 Identities = 131/263 (49%), Positives = 167/263 (63%), Gaps = 15/263 (5%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-----SEFLQREQKFLSSLNSPH 56
           +WTRG  +G+GS  +V LA    +G++ A KS EL        E L+RE + LSSL  P+
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60

Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL 116
           IV Y G +   E N    N+F+EY  GG+L+  + + G +L E +I  YTRQIL+GL YL
Sbjct: 61  IVRYYGSERDEEKN--TLNIFLEYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYL 117

Query: 117 HSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG------GTPMFMAPEVARG 169
           HSN +VH DIK  NIL+   G  K+ADFGCAK   +           GTP +MAPEV RG
Sbjct: 118 HSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG 177

Query: 170 EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFL 229
           E  G A+DIW++GCTVIEMA+G  PW    +PM  LYKI  S E PE+P  LS++A DFL
Sbjct: 178 EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFL 237

Query: 230 SNCLRRDPKERWAASQLLKHPFL 252
             CLRRDPK+R  A +LL+HPFL
Sbjct: 238 RKCLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  248 bits (637), Expect = 4e-81
 Identities = 95/263 (36%), Positives = 130/263 (49%), Gaps = 22/263 (8%)

Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAK----STELPKSEFLQREQKFLSSLNSPHIV 58
           +     +G+GS   V LA   ++G + A K           E + RE K L  L  P+IV
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 59  GYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHS 118
                    ED   +Y L MEY  GG L D + + G RL E     Y RQIL  LEYLHS
Sbjct: 61  RLYDVF---EDEDKLY-LVMEYCEGGDLFDLLKKRG-RLSEDEARFYLRQILSALEYLHS 115

Query: 119 NRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG-------GTPMFMAPEVARGE 170
             +VH D+K  NIL+ E G  K+ADFG A+     L  G       GTP +MAPEV  G+
Sbjct: 116 KGIVHRDLKPENILLDEDGHVKLADFGLAR----QLDPGEKLTTFVGTPEYMAPEVLLGK 171

Query: 171 HQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSR-ELPEVPAFLSKQANDFL 229
             G A DIW++G  + E+ +G  P+P     + +  KI   +   P     +S +A D +
Sbjct: 172 GYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLI 231

Query: 230 SNCLRRDPKERWAASQLLKHPFL 252
              L +DP++R  A + L+HPF 
Sbjct: 232 RKLLVKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  235 bits (603), Expect = 6e-76
 Identities = 94/259 (36%), Positives = 136/259 (52%), Gaps = 15/259 (5%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKS---TELPKSEFLQREQKFLSSLNSPHIV 58
            +     IG+G    V  A   R+G   A K        K E +  E + L     P+IV
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIV 60

Query: 59  GYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHS 118
            Y G  +  + ++L   + ME+  GG+L D +      L ES I    +++L+GLEYLHS
Sbjct: 61  KYYGSYL--KKDELW--IVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS 116

Query: 119 NRVVHCDIKSRNILMAESG-AKIADFG-CAKWESEALQSG--GTPMFMAPEVARGEHQGF 174
           N ++H DIK+ NIL+   G  K+ DFG  A+      ++   GTP +MAPEV  G+   +
Sbjct: 117 NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDY 176

Query: 175 ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSR--ELPEVPAFLSKQANDFLSNC 232
            +DIW++G T IE+A G  P+     PM  L+KIA +    L   P   S +  DFL  C
Sbjct: 177 KADIWSLGITAIELAEGKPPYSE-LPPMKALFKIATNGPPGLRN-PEKWSDEFKDFLKKC 234

Query: 233 LRRDPKERWAASQLLKHPF 251
           L+++P++R  A QLLKHPF
Sbjct: 235 LQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  234 bits (598), Expect = 3e-75
 Identities = 111/263 (42%), Positives = 150/263 (57%), Gaps = 19/263 (7%)

Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEF--------LQREQKFLSSLNS 54
           W +G  +G GS  +V    +L  GD FA K   L             L++E   LS L  
Sbjct: 2   WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQH 61

Query: 55  PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLE 114
           P+IV Y G     EDN     +F+E  PGG+L  ++ +  G   E +I  YTRQIL GLE
Sbjct: 62  PNIVQYLGT-EREEDN---LYIFLELVPGGSLA-KLLKKYGSFPEPVIRLYTRQILLGLE 116

Query: 115 YLHSNRVVHCDIKSRNILMAESGA-KIADFGCAK---WESEALQSGGTPMFMAPEVARGE 170
           YLH    VH DIK  NIL+  +G  K+ADFG AK     S A    G+P +MAPEV   +
Sbjct: 117 YLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQ 176

Query: 171 HQ-GFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFL 229
              G A+DIW++GCTV+EMA+G  PW +  + +  ++KI  S+ELP +P  LS +A DF+
Sbjct: 177 GGYGLAADIWSLGCTVLEMATGKPPW-SQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFI 235

Query: 230 SNCLRRDPKERWAASQLLKHPFL 252
             CL+RDP  R  A++LL+HPF+
Sbjct: 236 LKCLQRDPSLRPTAAELLEHPFV 258

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  234 bits (598), Expect = 5e-75
 Identities = 106/269 (39%), Positives = 152/269 (56%), Gaps = 25/269 (9%)

Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEF-----LQREQKFLSSLNSPHI 57
           W RG+ IG G+   V  A +L +G++ A K   +  ++      +  E K L  L  P++
Sbjct: 2   WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNL 61

Query: 58  VGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLH 117
           V Y G +V     K+   +FMEY  GGTL +E+  +G  LDE +I  YT Q+L+GL YLH
Sbjct: 62  VKYYGVEV--HREKV--YIFMEYCSGGTL-EELLEHGRILDEHVIRVYTLQLLEGLAYLH 116

Query: 118 SNRVVHCDIKSRNILMAESGA-KIADFGCAKWES-------EALQS-GGTPMFMAPEVAR 168
           S+ +VH DIK  NI +  +G  K+ DFGCA           E +QS  GTP +MAPEV  
Sbjct: 117 SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVIT 176

Query: 169 G---EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVP--AFLSK 223
           G   +  G A+DIW++GC V+EMA+G  PW    +   +++ +  +   P +P    LS 
Sbjct: 177 GGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVG-AGHKPPIPDSLQLSP 235

Query: 224 QANDFLSNCLRRDPKERWAASQLLKHPFL 252
           +  DFL  CL  DPK+R  AS+LL+HPF+
Sbjct: 236 EGKDFLDRCLESDPKKRPTASELLQHPFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  221 bits (565), Expect = 3e-70
 Identities = 94/265 (35%), Positives = 133/265 (50%), Gaps = 20/265 (7%)

Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAK--STELPKSEFLQ---REQKFLSSLNSPHI 57
           +     +G GS  TV  A    +G + A K       KS+  Q   RE + L  L+ P+I
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60

Query: 58  VGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLH 117
           V         ED   +Y L MEY  GG L D + R G  L E        QIL+GLEYLH
Sbjct: 61  VRLIDAF---EDKDHLY-LVMEYCEGGDLFDYLSRGG-PLSEDEAKKIALQILRGLEYLH 115

Query: 118 SNRVVHCDIKSRNILMAESG-AKIADFGCAK---WESEALQSG-GTPMFMAPEV-ARGEH 171
           SN ++H D+K  NIL+ E+G  KIADFG AK     S +L +  GTP +MAPEV   G  
Sbjct: 116 SNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNG 175

Query: 172 QGFASDIWAVGCTVIEMASGGAPWPNA--ADPMTVLYKIAYSRELPEVPAFLSKQ--AND 227
            G   D+W++G  + E+ +G  P+      D + ++ +I       + P + S    A D
Sbjct: 176 YGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKD 235

Query: 228 FLSNCLRRDPKERWAASQLLKHPFL 252
            +  CL +DP +R  A ++L+HP+ 
Sbjct: 236 LIKKCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  219 bits (559), Expect = 2e-69
 Identities = 95/254 (37%), Positives = 135/254 (53%), Gaps = 17/254 (6%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTEL---PKSEF--LQREQKFLSSLNSPHIVGYKGC 63
           IG+G+   V    +L +GD  A K   L    +     + +E   L +L  P+IV Y G 
Sbjct: 8   IGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGS 67

Query: 64  DVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVH 123
            + + D+     + +EYA  G+L   I + G    ESL+  Y  Q+LQGL YLH   V+H
Sbjct: 68  -IETSDS---LYIILEYAENGSLRQIIKKFGP-FPESLVAVYVYQVLQGLAYLHEQGVIH 122

Query: 124 CDIKSRNILMAESG-AKIADFGCA----KWESEALQSGGTPMFMAPEVARGEHQGFASDI 178
            DIK+ NIL  + G  K+ADFG A        +     GTP +MAPEV        ASDI
Sbjct: 123 RDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDI 182

Query: 179 WAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPK 238
           W++GCTVIE+ +G  P+ +  +PM  L++I      P +P  +S +  DFL  C ++DP 
Sbjct: 183 WSLGCTVIELLTGNPPYYD-LNPMAALFRIVQDDHPP-LPEGISPELKDFLMQCFQKDPN 240

Query: 239 ERWAASQLLKHPFL 252
            R  A QLLKHP++
Sbjct: 241 LRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  200 bits (510), Expect = 1e-62
 Identities = 83/253 (32%), Positives = 118/253 (46%), Gaps = 49/253 (19%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAK----STELPKSEFLQREQKFLSSLNSPHIVGYKGCD 64
           +G+G   TV LA   ++G   A K           E L RE + L  LN P+IV   G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGV- 59

Query: 65  VTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHC 124
              ED   +Y L MEY  GG+L D +  N G+L E  I+    QIL+GLEYLHSN ++H 
Sbjct: 60  --FEDENHLY-LVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHR 116

Query: 125 DIKSRNILMAESG--AKIADFGCAKW----ESEALQSGGTPMFMAPEVARGEH-QGFASD 177
           D+K  NIL+       K+ADFG +K     +S      GTP +MAPEV  G+      SD
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSD 176

Query: 178 IWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDP 237
           IW++G  + E+                                   +  D +   L++DP
Sbjct: 177 IWSLGVILYEL----------------------------------PELKDLIRKMLQKDP 202

Query: 238 KERWAASQLLKHP 250
           ++R +A ++L+H 
Sbjct: 203 EKRPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  200 bits (510), Expect = 1e-61
 Identities = 102/270 (37%), Positives = 146/270 (54%), Gaps = 23/270 (8%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSE----FLQREQKFLSSLNSPHIVGYKGCD 64
           IG+GS   V  A   R+  V A K  +L ++E     +Q+E +FLS   SP+I  Y G  
Sbjct: 9   IGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSF 68

Query: 65  VTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHC 124
           +  + +KL   + MEY  GG+  D +    G+LDE+ I    R++L GLEYLH    +H 
Sbjct: 69  L--KGSKLW--IIMEYCGGGSCLDLLKP--GKLDETYIAFILREVLLGLEYLHEEGKIHR 122

Query: 125 DIKSRNILMAESG-AKIADFGCAKWESEALQSG-----GTPMFMAPEVARGEHQGFASDI 178
           DIK+ NIL++E G  K+ADFG +  +  +  S      GTP +MAPEV +       +DI
Sbjct: 123 DIKAANILLSEEGDVKLADFGVSG-QLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADI 181

Query: 179 WAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPA-FLSKQANDFLSNCLRRDP 237
           W++G T IE+A G  P  +   PM VL+ I      P +     SK   DF+S CL +DP
Sbjct: 182 WSLGITAIELAKGEPPLSD-LHPMRVLFLIP-KNNPPSLEGNKFSKPFKDFVSLCLNKDP 239

Query: 238 KERWAASQLLKHPFLEEFC---SCTKQIQE 264
           KER +A +LLKH F+++       T  I+ 
Sbjct: 240 KERPSAKELLKHKFIKKAKKTSYLTLLIER 269

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  197 bits (502), Expect = 8e-61
 Identities = 109/271 (40%), Positives = 151/271 (55%), Gaps = 28/271 (10%)

Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS---------EFLQREQKFLSSLN 53
           WT+G  +G+G+  TV    +   G + A K  EL  S         E LQ E   L SL 
Sbjct: 2   WTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK 60

Query: 54  SPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGL 113
             +IV Y G     +DN +  ++FME+ PGG+++  ++R G  L E +   YT+QIL G+
Sbjct: 61  HVNIVQYLG--TCLDDNTI--SIFMEFVPGGSISSILNRFGP-LPEPVFCKYTKQILDGV 115

Query: 114 EYLHSNRVVHCDIKSRNILMAESGA-KIADFGCAK---W------ESEALQS-GGTPMFM 162
            YLH+N VVH DIK  N+++  +G  K+ DFGCA+   W       S  L+S  GTP +M
Sbjct: 116 AYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWM 175

Query: 163 APEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSREL-PEVPAFL 221
           APEV      G  SDIW++GCTV EMA+G  P  +  D +  ++ I   R L P +P   
Sbjct: 176 APEVINESGYGRKSDIWSIGCTVFEMATGKPPLAS-MDRLAAMFYIGAHRGLMPRLPDSF 234

Query: 222 SKQANDFLSNCLRRDPKERWAASQLLKHPFL 252
           S  A DF+++CL RD  ER +A QLL+H FL
Sbjct: 235 SAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  197 bits (502), Expect = 9e-61
 Identities = 102/266 (38%), Positives = 147/266 (55%), Gaps = 22/266 (8%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAK-------STELPKS-EFLQREQKFLSSLN 53
           +W RG  +GQG+   V L   + +G   A K       S E  K    L+ E + L +L 
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62

Query: 54  SPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGL 113
              IV Y GC     D++ +  +FMEY PGG++ D++ +  G L E++   YTRQIL+G+
Sbjct: 63  HERIVQYYGCL---RDDETLS-IFMEYMPGGSVKDQL-KAYGALTETVTRKYTRQILEGV 117

Query: 114 EYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG-------GTPMFMAPE 165
           EYLHSN +VH DIK  NIL   +G  K+ DFG +K       SG       GTP +M+PE
Sbjct: 118 EYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPE 177

Query: 166 VARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQA 225
           V  GE  G  +D+W+VGCTV+EM +   PW    + M  ++KIA     P++P+ +S  A
Sbjct: 178 VISGEGYGRKADVWSVGCTVVEMLTEKPPWAE-FEAMAAIFKIATQPTNPQLPSHVSPDA 236

Query: 226 NDFLSNCLRRDPKERWAASQLLKHPF 251
            +FL      + K+R +A +LL+H F
Sbjct: 237 RNFLRRTFVENAKKRPSAEELLRHFF 262

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  191 bits (488), Expect = 3e-58
 Identities = 97/258 (37%), Positives = 142/258 (55%), Gaps = 15/258 (5%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTEL--PKSEFLQREQKFLSSLNSPHIVGYKGCDVT 66
           IG+G+S  V  AT   +G   A K   L     E +  E   +     P+IV Y      
Sbjct: 27  IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDS--- 83

Query: 67  SEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDI 126
                 ++ + MEY  GG+L D I +N  R++E  I    R++LQGLEYLHS  V+H DI
Sbjct: 84  YLVGDELW-VVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDI 142

Query: 127 KSRNILMAESGA-KIADFG-CAKWESEALQSG---GTPMFMAPEVARGEHQGFASDIWAV 181
           KS NIL+++ G+ K+ADFG  A+   E  +     GTP +MAPEV + +  G   DIW++
Sbjct: 143 KSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSL 202

Query: 182 GCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEV--PAFLSKQANDFLSNCLRRDPKE 239
           G   IEMA G  P+     P+  L+ I  ++ +P +  P   S +  DFL+ CL +DP++
Sbjct: 203 GIMCIEMAEGEPPYLR-EPPLRALFLIT-TKGIPPLKNPEKWSPEFKDFLNKCLVKDPEK 260

Query: 240 RWAASQLLKHPFLEEFCS 257
           R +A +LL+HPFL++ C 
Sbjct: 261 RPSAEELLQHPFLKKACP 278

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  190 bits (483), Expect = 7e-58
 Identities = 93/270 (34%), Positives = 152/270 (56%), Gaps = 26/270 (9%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAK---------STELPKSEFLQREQKFLSSL 52
           +W +G  +G G+ ++   A  +++G + A K         S +    E L++E + ++ L
Sbjct: 1   EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60

Query: 53  NSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQG 112
           N PHI+   G   T ED+   +NLF+E+  GG+++  +    G   E++I++YT Q+L+G
Sbjct: 61  NHPHIIRMLG--ATCEDSH--FNLFVEWMAGGSVSHLLS-KYGAFKEAVIINYTEQLLRG 115

Query: 113 LEYLHSNRVVHCDIKSRNILMAESG--AKIADFGCA-KWESEALQSG-------GTPMFM 162
           L YLH N+++H D+K  N+L+  +G   +IADFG A +  ++   +G       GT  FM
Sbjct: 116 LSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFM 175

Query: 163 APEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAA--DPMTVLYKIAYSRELPEVPAF 220
           APEV RGE  G + D+W+VGC +IEMA+   PW      + + +++KIA +   P +P  
Sbjct: 176 APEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEH 235

Query: 221 LSKQANDFLSNCLRRDPKERWAASQLLKHP 250
           LS    D    CL   P++R  + +LLKHP
Sbjct: 236 LSPGLRDVTLRCLELQPEDRPPSRELLKHP 265

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  187 bits (478), Expect = 4e-57
 Identities = 79/258 (30%), Positives = 134/258 (51%), Gaps = 19/258 (7%)

Query: 8   TIGQGSSATVSLATSLRSGDVFAAKSTELPKS-----EFLQREQKFLSSLNSPHIVGYKG 62
            IG+GS   V L      G ++  K  +L        E    E K L  LN P+I+ Y  
Sbjct: 7   QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY- 65

Query: 63  CDVTSEDNKLMYNLFMEYAPGGTLNDEIHR---NGGRLDESLIVSYTRQILQGLEYLHSN 119
            +   E  KL   + MEYA GG L+ +I +    G    E  I+ +  Q+   L+YLHS 
Sbjct: 66  -ESFEEKGKL--CIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR 122

Query: 120 RVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG----GTPMFMAPEVARGEHQGF 174
           +++H DIK +NI +  +G  K+ DFG +K  S  +       GTP +++PE+ + +   +
Sbjct: 123 KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNY 182

Query: 175 ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLR 234
            SDIW++GC + E+ +   P+    + + +  KI    + P +P+  S +  + +S+ L+
Sbjct: 183 KSDIWSLGCVLYELCTLKHPF-EGENLLELALKIL-KGQYPPIPSQYSSELRNLVSSLLQ 240

Query: 235 RDPKERWAASQLLKHPFL 252
           +DP+ER + +Q+L+ PF+
Sbjct: 241 KDPEERPSIAQILQSPFI 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  186 bits (475), Expect = 8e-57
 Identities = 95/258 (36%), Positives = 138/258 (53%), Gaps = 26/258 (10%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTEL-PKSEFLQREQKFLSSLNSPHIVGYKGCDVTS 67
           +G+GS  +V  A    +G V A K   +    + + +E   L   +SP+IV Y G     
Sbjct: 11  LGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGS--YF 68

Query: 68  EDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIK 127
           ++  L   + MEY   G+++D +      L E  I +   Q L+GLEYLHSN+ +H DIK
Sbjct: 69  KNTDLW--IVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIK 126

Query: 128 SRNILMAESG-AKIADFGCAKWESEALQSG--------GTPMFMAPEVARGEHQGFAS-- 176
           + NIL+ E G AK+ADFG     S  L           GTP +MAPEV   +  G+ +  
Sbjct: 127 AGNILLNEEGQAKLADFGV----SGQLTDTMAKRNTVIGTPFWMAPEVI--QEIGYNNKA 180

Query: 177 DIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELP--EVPAFLSKQANDFLSNCLR 234
           DIW++G T IEMA G  P+ +   PM  ++ I  ++  P    P   S + NDF+  CL 
Sbjct: 181 DIWSLGITAIEMAEGKPPYSD-IHPMRAIFMIP-NKPPPTLSDPEKWSPEFNDFVKKCLV 238

Query: 235 RDPKERWAASQLLKHPFL 252
           +DP+ER +A QLL+HPF+
Sbjct: 239 KDPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  184 bits (469), Expect = 6e-56
 Identities = 97/273 (35%), Positives = 148/273 (54%), Gaps = 30/273 (10%)

Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS------------EFLQREQKFLS 50
           W +G  IG GS  +V L  +  SG++ A K  ELP              + L RE   L 
Sbjct: 2   WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLK 61

Query: 51  SLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQIL 110
            L   +IV Y G  + ++      N+F+EY PGG++   ++ N G  +E+L+ ++ RQIL
Sbjct: 62  ELQHENIVQYLGSSLDAD----HLNIFLEYVPGGSVAALLN-NYGAFEETLVRNFVRQIL 116

Query: 111 QGLEYLHSNRVVHCDIKSRNILMAESGA-KIADFGCA-KWESEALQSG---------GTP 159
           +GL YLH+  ++H DIK  NIL+   G  KI+DFG + K E+ +L +          G+ 
Sbjct: 117 KGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSV 176

Query: 160 MFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPA 219
            +MAPEV +       +DIW++GC V+EM +G  P+P+    +  ++KI      PE+P+
Sbjct: 177 FWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPD-CTQLQAIFKIG-ENASPEIPS 234

Query: 220 FLSKQANDFLSNCLRRDPKERWAASQLLKHPFL 252
            +S +A DFL      D  +R  A++LLKHPFL
Sbjct: 235 NISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  184 bits (469), Expect = 9e-56
 Identities = 94/275 (34%), Positives = 148/275 (53%), Gaps = 32/275 (11%)

Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEF-------------LQREQKFL 49
           W +G  IG+G+   V LA ++ +G++ A K  ELP +               L+ E + L
Sbjct: 3   WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETL 62

Query: 50  SSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQI 109
             L+  +IV Y G + T E      ++F+EY PGG++     R  GR +E L+  +T Q+
Sbjct: 63  KDLDHLNIVQYLGFETTEEY----LSIFLEYVPGGSIG-SCLRTYGRFEEQLVRFFTEQV 117

Query: 110 LQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKW------ESEALQSGGTPMFM 162
           L+GL YLHS  ++H D+K+ N+L+   G  KI+DFG +K         + +   G+  +M
Sbjct: 118 LEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWM 177

Query: 163 APEVARGEHQGFAS--DIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVP-- 218
           APEV     QG+++  DIW++GC V+EM +G  PW +  + +  ++K+   R  P +P  
Sbjct: 178 APEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSD-EEAIAAMFKLGNKRSAPPIPPD 236

Query: 219 --AFLSKQANDFLSNCLRRDPKERWAASQLLKHPF 251
               LS  A DFL+ C   +P  R  A +LL+HPF
Sbjct: 237 VSMNLSPVALDFLNACFTINPDNRPTARELLQHPF 271

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  178 bits (454), Expect = 1e-53
 Identities = 93/271 (34%), Positives = 146/271 (53%), Gaps = 29/271 (10%)

Query: 5   RGHTIGQGSSATVSLATSLRSGDVFAAKSTELP-KSEFLQ---REQKFLSSLNSPHIVG- 59
           R   +GQGSS  V       +G ++A K   +    EF +   RE K L S  SP++V  
Sbjct: 5   RVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKC 64

Query: 60  ----YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
               YK  ++         ++ +EY  GG+L D + + G  + E ++    RQIL+GL+Y
Sbjct: 65  YGAFYKEGEI---------SIVLEYMDGGSLADLLKKVGK-IPEPVLAYIARQILKGLDY 114

Query: 116 LHSNR-VVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG----GTPMFMAPEVARG 169
           LH+ R ++H DIK  N+L+   G  KIADFG +K     L       GT  +M+PE  +G
Sbjct: 115 LHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQG 174

Query: 170 EHQGFASDIWAVGCTVIEMASGGAPW--PNAADPMTVLYKIAYSRELPEVPA-FLSKQAN 226
           E   +A+DIW++G T++E A G  P+  P       ++  I      P +PA   S +  
Sbjct: 175 ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDG-PPPSLPAEEFSPEFR 233

Query: 227 DFLSNCLRRDPKERWAASQLLKHPFLEEFCS 257
           DF+S CL++DPK+R +A++LL+HPF+++  +
Sbjct: 234 DFISACLQKDPKKRPSAAELLQHPFIKKADN 264

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score =  172 bits (436), Expect = 4e-51
 Identities = 103/269 (38%), Positives = 151/269 (56%), Gaps = 21/269 (7%)

Query: 1   MDWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL-PKS-------EFLQREQKFLSSL 52
           ++W RG  +GQG+   V L   + +G   AAK  +  P+S         L+ E + L +L
Sbjct: 2   INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL 61

Query: 53  NSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQG 112
               IV Y GC     +  L   +FMEY PGG++ D++ +  G L ES+   YTRQIL+G
Sbjct: 62  QHERIVQYYGCLRDRAEKTL--TIFMEYMPGGSVKDQL-KAYGALTESVTRKYTRQILEG 118

Query: 113 LEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG-------GTPMFMAP 164
           + YLHSN +VH DIK  NIL   +G  K+ DFG +K       SG       GTP +M+P
Sbjct: 119 MSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSP 178

Query: 165 EVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQ 224
           EV  GE  G  +D+W++GCTV+EM +   PW    + M  ++KIA     P++P+ +S+ 
Sbjct: 179 EVISGEGYGRKADVWSLGCTVVEMLTEKPPWAE-YEAMAAIFKIATQPTNPQLPSHISEH 237

Query: 225 ANDFLSNCLRRDPKERWAASQLLKHPFLE 253
           A DFL  C+  + + R +A +LL+HPF +
Sbjct: 238 ARDFL-GCIFVEARHRPSAEELLRHPFAQ 265

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  172 bits (437), Expect = 4e-51
 Identities = 96/264 (36%), Positives = 139/264 (52%), Gaps = 27/264 (10%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKS----EFLQREQKFLSSLNSPHIVGYKGCD 64
           IG G++A V  A  L + +  A K  +L K     + L++E + +S  N P++V Y    
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68

Query: 65  VTSEDNKLMYNLFMEYAPGGTLNDEIHR--NGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
           V    ++L   L M Y  GG+L D +      G LDE++I +  +++L+GLEYLHSN  +
Sbjct: 69  V--VGDELW--LVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQI 124

Query: 123 HCDIKSRNILMAESGA-KIADFGCAKWESEALQSG--------GTPMFMAPEVARGEHQ- 172
           H DIK+ NIL+ E G+ KIADFG +   ++             GTP +MAPEV    H  
Sbjct: 125 HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGY 184

Query: 173 GFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSR--ELPE---VPAFLSKQAND 227
            F +DIW+ G T IE+A+G AP+     PM VL     +    L        + SK    
Sbjct: 185 DFKADIWSFGITAIELATGAAPYSKYP-PMKVLMLTLQNDPPSLETGADYKKY-SKSFRK 242

Query: 228 FLSNCLRRDPKERWAASQLLKHPF 251
            +S CL++DP +R  A +LLKH F
Sbjct: 243 MISLCLQKDPSKRPTAEELLKHKF 266

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  170 bits (434), Expect = 1e-50
 Identities = 96/259 (37%), Positives = 132/259 (50%), Gaps = 23/259 (8%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTEL-PKSEF--LQREQKFLSSLNSPHIVGYKGCDV 65
           IG G+   V  A  + +G++ A K  +L P  +F  +Q+E   L     P+IV Y G  +
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70

Query: 66  TSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCD 125
               +KL   + MEY  GG+L D      G L E  I    R+ L+GL YLH    +H D
Sbjct: 71  --RRDKLW--IVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRD 126

Query: 126 IKSRNILMAESG-AKIADFGCAKWESEALQSG----GTPMFMAPEVARGEHQG---FASD 177
           IK  NIL+ E G  K+ADFG +   +  +       GTP +MAPEVA  E +G      D
Sbjct: 127 IKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCD 186

Query: 178 IWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAF-----LSKQANDFLSNC 232
           IWA+G T IE+A    P  +   PM  L+ I+ S   P  P        S   +DF+  C
Sbjct: 187 IWALGITAIELAELQPPMFD-LHPMRALFLISKSNFPP--PKLKDKEKWSPVFHDFIKKC 243

Query: 233 LRRDPKERWAASQLLKHPF 251
           L +DPK+R  A++LL+HPF
Sbjct: 244 LTKDPKKRPTATKLLQHPF 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  164 bits (417), Expect = 7e-48
 Identities = 101/261 (38%), Positives = 140/261 (53%), Gaps = 18/261 (6%)

Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL---PKSEFLQREQKFLSSLNSPHIVG 59
           +TR   IGQG+S TV  A  + +G   A K   L   PK E +  E   +     P+IV 
Sbjct: 21  YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVN 80

Query: 60  YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN 119
           Y    +  ++      + MEY  GG+L D +      +DE  I +  R+ LQ LE+LHSN
Sbjct: 81  YLDSYLVGDE----LWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSN 134

Query: 120 RVVHCDIKSRNILMAESGA-KIADFG-CAKWESEALQSG---GTPMFMAPEVARGEHQGF 174
           +V+H DIKS NIL+   G+ K+ DFG CA+   E  +     GTP +MAPEV   +  G 
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 194

Query: 175 ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAY--SRELPEVPAFLSKQANDFLSNC 232
             DIW++G   IEM  G  P+ N  +P+  LY IA   + EL   P  LS    DFL+ C
Sbjct: 195 KVDIWSLGIMAIEMVEGEPPYLN-ENPLRALYLIATNGTPELQN-PEKLSAIFRDFLNRC 252

Query: 233 LRRDPKERWAASQLLKHPFLE 253
           L  D ++R +A +LL+HPFL+
Sbjct: 253 LEMDVEKRGSAKELLQHPFLK 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  161 bits (409), Expect = 4e-47
 Identities = 89/267 (33%), Positives = 127/267 (47%), Gaps = 42/267 (15%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQR--------EQKFLSSLNSPHIVGY 60
           +G+GS   V L     +G ++A K   L K + ++R        E+  LS +N P IV  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKV--LKKKKIIKRKEVEHTLTERNILSRINHPFIV-- 56

Query: 61  KGCDVTSEDNKLMY------NLF--MEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQG 112
                     KL Y       L+  +EYAPGG L   + + G R  E     Y  +I+  
Sbjct: 57  ----------KLHYAFQTEEKLYLVLEYAPGGELFSHLSKEG-RFSEERARFYAAEIVLA 105

Query: 113 LEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG----GTPMFMAPEVA 167
           LEYLHS  +++ D+K  NIL+   G  K+ DFG AK  S          GTP ++APEV 
Sbjct: 106 LEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVL 165

Query: 168 RGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQAND 227
            G+  G A D W++G  + EM +G  P+  A D   +  KI         P FLS +A D
Sbjct: 166 LGKGYGKAVDWWSLGVLLYEMLTGKPPFY-AEDRKEIYEKILKDP--LRFPEFLSPEARD 222

Query: 228 FLSNCLRRDPKER---WAASQLLKHPF 251
            +S  L++DP +R     A ++  HPF
Sbjct: 223 LISGLLQKDPTKRLGSGGAEEIKAHPF 249

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score =  159 bits (405), Expect = 2e-46
 Identities = 97/261 (37%), Positives = 142/261 (54%), Gaps = 25/261 (9%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ---REQKFLSSLNSPHIVGYKGCDV 65
           +G+G+   V  A  L +    A K      S ++Q    E    S L   +IV Y G D 
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD- 74

Query: 66  TSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRL--DESLIVSYTRQILQGLEYLHSNRVVH 123
            SE+    + +FME  PGG+L+  +    G L  +E  I+ YT+QIL+GL+YLH N++VH
Sbjct: 75  -SENG--FFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVH 131

Query: 124 CDIKSRNILM-AESGA-KIADFGCAKW------ESEALQSGGTPMFMAPEV----ARGEH 171
            DIK  N+L+   SG  KI+DFG +K        +E     GT  +MAPEV     RG  
Sbjct: 132 RDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFT--GTLQYMAPEVIDKGPRG-- 187

Query: 172 QGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSN 231
            G  +DIW++GCT++EMA+G  P+    +P   ++K+   +  PE+P  LS +A +F+  
Sbjct: 188 YGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILR 247

Query: 232 CLRRDPKERWAASQLLKHPFL 252
           C   DP +R +A  LL+ PFL
Sbjct: 248 CFEPDPDKRASAHDLLQDPFL 268

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score =  159 bits (403), Expect = 4e-46
 Identities = 99/267 (37%), Positives = 141/267 (52%), Gaps = 21/267 (7%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL-PKS-------EFLQREQKFLSSLN 53
           +W  G  +GQG+   V L     +G   A K  +  P+S         L+ E + L +L 
Sbjct: 3   NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62

Query: 54  SPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGL 113
              IV Y GC     +  L  ++FME+ PGG++ D++ ++ G L E++   YTRQIL+G+
Sbjct: 63  HERIVQYYGCLRDPMERTL--SIFMEHMPGGSIKDQL-KSYGALTENVTRKYTRQILEGV 119

Query: 114 EYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG-------GTPMFMAPE 165
            YLHSN +VH DIK  NIL    G  K+ DFG +K       SG       GTP +M+PE
Sbjct: 120 SYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPE 179

Query: 166 VARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQA 225
           V  GE  G  +DIW+VGCTV+EM +   PW    + M  ++KIA     P +P  +S   
Sbjct: 180 VISGEGYGRKADIWSVGCTVVEMLTEKPPWAE-FEAMAAIFKIATQPTNPVLPPHVSDHC 238

Query: 226 NDFLSNCLRRDPKERWAASQLLKHPFL 252
            DFL      + K R +A +LL+H F+
Sbjct: 239 RDFLKRIF-VEAKLRPSADELLRHTFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  157 bits (398), Expect = 2e-45
 Identities = 100/266 (37%), Positives = 139/266 (52%), Gaps = 21/266 (7%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL-PKSE-------FLQREQKFLSSLN 53
           +W  G  +G+G+   V L     +G   A K     P S+        L+ E + L +L 
Sbjct: 3   NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62

Query: 54  SPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGL 113
              IV Y GC    E+ KL  ++F+EY PGG++ D++ +  G L E++   YTRQILQG+
Sbjct: 63  HDRIVQYYGCLRDPEEKKL--SIFVEYMPGGSIKDQL-KAYGALTENVTRRYTRQILQGV 119

Query: 114 EYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG-------GTPMFMAPE 165
            YLHSN +VH DIK  NIL   +G  K+ DFG +K       SG       GTP +M+PE
Sbjct: 120 SYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPE 179

Query: 166 VARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQA 225
           V  GE  G  +D+W+V CTV+EM +   PW    + M  ++KIA     P +P  +S   
Sbjct: 180 VISGEGYGRKADVWSVACTVVEMLTEKPPWAE-YEAMAAIFKIATQPTKPMLPDGVSDAC 238

Query: 226 NDFLSNCLRRDPKERWAASQLLKHPF 251
            DFL      + K R  A  LL+HPF
Sbjct: 239 RDFLKQIFVEE-KRRPTAEFLLRHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  156 bits (396), Expect = 5e-45
 Identities = 86/265 (32%), Positives = 137/265 (51%), Gaps = 26/265 (9%)

Query: 8   TIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ----REQKFLSSLNSPHIVGYKG- 62
            +G G+S  VS      +G + A K+  L  +E +Q    RE   L   NSP+IVG+ G 
Sbjct: 8   ELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGA 67

Query: 63  ----CDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHS 118
                D+         ++ MEY  GG+L+  +    GR+ E ++      +L+GL YLH 
Sbjct: 68  FYNNGDI---------SICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHE 118

Query: 119 NR-VVHCDIKSRNILMAESGA-KIADFGCAKW--ESEALQSGGTPMFMAPEVARGEHQGF 174
              ++H D+K  NIL+   G  K+ DFG +     S A    GT  +MAPE  +G     
Sbjct: 119 KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTSSYMAPERIQGNDYSV 178

Query: 175 ASDIWAVGCTVIEMASGGAPWPN-AADPMTVLYKIAY--SRELPEVPA-FLSKQANDFLS 230
            SDIW++G ++IE+A+G  P+P     P  +   + Y  +   P +P+   S    DF++
Sbjct: 179 KSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVN 238

Query: 231 NCLRRDPKERWAASQLLKHPFLEEF 255
            CL +DP+ER +  +LL+HPF++++
Sbjct: 239 LCLIKDPRERPSYKELLEHPFIKKY 263

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  155 bits (394), Expect = 1e-44
 Identities = 99/272 (36%), Positives = 144/272 (52%), Gaps = 24/272 (8%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQR---EQKFLSSLNSPHIVGYKGCDV 65
           +G G+   V  A    +G   AAK  ++   E L+    E   LS    P+IVG    + 
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGL--YEA 70

Query: 66  TSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCD 125
              +NKL   + +E+  GG L+  +      L E  I    RQ+L+ L +LHS++V+H D
Sbjct: 71  YFYENKLW--ILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRD 128

Query: 126 IKSRNILMAESG-AKIADFGC-AKWESEALQSG----GTPMFMAPEVARGEHQ-----GF 174
           +K+ NIL+   G  K+ADFG  AK +S  LQ      GTP +MAPEV   E        +
Sbjct: 129 LKAGNILLTLDGDVKLADFGVSAKNKST-LQKRDTFIGTPYWMAPEVVACETFKDNPYDY 187

Query: 175 ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELP--EVPAFLSKQANDFLSNC 232
            +DIW++G T+IE+A    P  +  +PM VL KI  S E P  + P+  S   NDFL +C
Sbjct: 188 KADIWSLGITLIELAQMEPP-HHELNPMRVLLKILKS-EPPTLDQPSKWSSSFNDFLKSC 245

Query: 233 LRRDPKERWAASQLLKHPFLEEFCSCTKQIQE 264
           L +DP +R  A++LLKHPF+ +     K I++
Sbjct: 246 LVKDPDDRPTAAELLKHPFVSDQSD-NKAIKD 276

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  152 bits (387), Expect = 1e-43
 Identities = 86/272 (31%), Positives = 130/272 (47%), Gaps = 36/272 (13%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQR--------EQKFLSSLNSPHIVG- 59
           I +G+   V LA    +GD++A K   + K++ +++        E+  LS   SP++V  
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKV--IKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58

Query: 60  YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN 119
           Y       + N  +Y L MEY PGG L   +  N G LDE +   Y  +I+  LEYLHSN
Sbjct: 59  Y--YSFQGKKN--LY-LVMEYLPGGDLASLLE-NVGSLDEDVARIYIAEIVLALEYLHSN 112

Query: 120 RVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG------------GTPMFMAPEV 166
            ++H D+K  NIL+  +G  K+ DFG +K      Q              GTP ++APEV
Sbjct: 113 GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV 172

Query: 167 ARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKI-AYSRELPEVPAFLSKQA 225
             G+      D W++GC + E   G  P+ +   P  +   I     E PE    +S +A
Sbjct: 173 ILGQGHSKTVDWWSLGCILYEFLVGIPPF-HGETPEEIFQNILNGKIEWPEDVE-VSDEA 230

Query: 226 NDFLSNCLRRDPKERWAA---SQLLKHPFLEE 254
            D +S  L  DP++R  A    ++  HPF + 
Sbjct: 231 IDLISKLLVPDPEKRLGAKSIEEIKNHPFFKG 262

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score =  153 bits (388), Expect = 1e-43
 Identities = 101/263 (38%), Positives = 145/263 (55%), Gaps = 22/263 (8%)

Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL---PKSEFLQREQKFLSSLNSPHIVG 59
           +TR   IGQG+S TV  A  + +G   A K   L   PK E +  E   +  L +P+IV 
Sbjct: 21  YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVN 80

Query: 60  YKGCDVTSEDNKLMYNLF--MEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLH 117
           +    +  ++      LF  MEY  GG+L D +      +DE+ I +  R+ LQ LE+LH
Sbjct: 81  FLDSFLVGDE------LFVVMEYLAGGSLTDVVTETC--MDEAQIAAVCRECLQALEFLH 132

Query: 118 SNRVVHCDIKSRNILMAESGA-KIADFG-CAKWESEALQSG---GTPMFMAPEVARGEHQ 172
           +N+V+H DIKS N+L+   G+ K+ DFG CA+   E  +     GTP +MAPEV   +  
Sbjct: 133 ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 192

Query: 173 GFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEV--PAFLSKQANDFLS 230
           G   DIW++G   IEM  G  P+ N  +P+  LY IA +   PE+  P  LS    DFL+
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLN-ENPLRALYLIA-TNGTPELQNPEKLSPIFRDFLN 250

Query: 231 NCLRRDPKERWAASQLLKHPFLE 253
            CL  D ++R +A +LL+HPFL+
Sbjct: 251 RCLEMDVEKRGSAKELLQHPFLK 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  153 bits (388), Expect = 1e-43
 Identities = 89/258 (34%), Positives = 125/258 (48%), Gaps = 26/258 (10%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKS---EFLQREQKFLSSLNSPHIVG-YKGCD 64
           IG+GS+  V +AT   +G   A K  +L K    E L  E   +     P+IV  Y    
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL 86

Query: 65  VTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHC 124
           V  E       + ME+  GG L D +     R++E  I +    +L+ L +LH+  V+H 
Sbjct: 87  VGDE-----LWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQGVIHR 139

Query: 125 DIKSRNILMAESG-AKIADFG-CAKWESEALQSG---GTPMFMAPEVARGEHQGFASDIW 179
           DIKS +IL+   G  K++DFG CA+   E  +     GTP +MAPEV      G   DIW
Sbjct: 140 DIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIW 199

Query: 180 AVGCTVIEMASGGAPWPNAADPMTVLYKI-----AYSRELPEVPAFLSKQANDFLSNCLR 234
           ++G  VIEM  G  P+ N   P+  + +I        + L +V   L      FL   L 
Sbjct: 200 SLGIMVIEMVDGEPPYFNEP-PLQAMKRIRDNLPPKLKNLHKVSPRLR----SFLDRMLV 254

Query: 235 RDPKERWAASQLLKHPFL 252
           RDP +R  A++LL HPFL
Sbjct: 255 RDPAQRATAAELLNHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  150 bits (382), Expect = 6e-43
 Identities = 92/276 (33%), Positives = 140/276 (50%), Gaps = 32/276 (11%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS--EFLQREQKFLSSL-NSPHIV 58
            +     IG+G+   V  A   ++G + A K  ++ +   E ++ E   L    N P+I 
Sbjct: 7   IFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIA 66

Query: 59  GYKGC----DVTSEDNKLMYNLFMEYAPGGTLND---EIHRNGGRLDESLIVSYTRQILQ 111
            + G     +    D++L   L ME   GG++ D    + + G RL E  I    R+ L+
Sbjct: 67  TFYGAFIKKNPPGNDDQLW--LVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLR 124

Query: 112 GLEYLHSNRVVHCDIKSRNILMAESG-AKIADFG-CAKWESEALQSG---GTPMFMAPEV 166
           GL YLH N+V+H DIK +NIL+ ++   K+ DFG  A+ +S   +     GTP +MAPEV
Sbjct: 125 GLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEV 184

Query: 167 ARGEHQ-----GFASDIWAVGCTVIEMASGGAPWPNAAD--PMTVLYKIAYSRELPEV-- 217
              + Q        SD+W++G T IE+A G  P     D  PM  L+KI   R  P    
Sbjct: 185 IACDEQPDASYDARSDVWSLGITAIELADGKPPL---CDMHPMRALFKIP--RNPPPTLK 239

Query: 218 -PAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFL 252
            P   SK+ NDF+S CL ++ ++R    +LL+HPF+
Sbjct: 240 SPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score =  149 bits (376), Expect = 6e-42
 Identities = 100/261 (38%), Positives = 140/261 (53%), Gaps = 18/261 (6%)

Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL---PKSEFLQREQKFLSSLNSPHIVG 59
           +TR   IGQG+S TV  A  + +G   A K   L   PK E +  E   +    +P+IV 
Sbjct: 21  YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVN 80

Query: 60  YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN 119
           Y    +  ++      + MEY  GG+L D +      +DE  I +  R+ LQ L++LHSN
Sbjct: 81  YLDSYLVGDE----LWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALDFLHSN 134

Query: 120 RVVHCDIKSRNILMAESGA-KIADFG-CAKWESEALQSG---GTPMFMAPEVARGEHQGF 174
           +V+H DIKS NIL+   G+ K+ DFG CA+   E  +     GTP +MAPEV   +  G 
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 194

Query: 175 ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEV--PAFLSKQANDFLSNC 232
             DIW++G   IEM  G  P+ N  +P+  LY IA +   PE+  P  LS    DFL+ C
Sbjct: 195 KVDIWSLGIMAIEMVEGEPPYLN-ENPLRALYLIA-TNGTPELQNPERLSAVFRDFLNRC 252

Query: 233 LRRDPKERWAASQLLKHPFLE 253
           L  D   R +A +LL+HPFL+
Sbjct: 253 LEMDVDRRGSAKELLQHPFLK 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score =  147 bits (373), Expect = 1e-41
 Identities = 98/271 (36%), Positives = 146/271 (53%), Gaps = 17/271 (6%)

Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEF----LQREQKFLSSLNSPHIV 58
           +T+   IG+GS   V      R+ +V A K  +L ++E     +Q+E   LS  +SP+I 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65

Query: 59  GYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHS 118
            Y G  +     KL   + MEY  GG+  D +    G L+E+ I +  R+IL+GL+YLHS
Sbjct: 66  RYYGSYLKG--TKLW--IIMEYLGGGSALDLL--KPGPLEETYIATILREILKGLDYLHS 119

Query: 119 NRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG----GTPMFMAPEVARGEHQG 173
            R +H DIK+ N+L++E G  K+ADFG A   ++         GTP +MAPEV +     
Sbjct: 120 ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYD 179

Query: 174 FASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCL 233
           F +DIW++G T IE+A G  P  +   PM VL+ I  +   P +    SK   +F+  CL
Sbjct: 180 FKADIWSLGITAIELAKGEPPNSD-LHPMRVLFLIPKNSP-PTLEGQYSKPFKEFVEACL 237

Query: 234 RRDPKERWAASQLLKHPFLEEFCSCTKQIQE 264
            +DP+ R  A +LLKH F+  +   T  + E
Sbjct: 238 NKDPRFRPTAKELLKHKFITRYTKKTSFLTE 268

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score =  148 bits (375), Expect = 2e-41
 Identities = 94/265 (35%), Positives = 138/265 (52%), Gaps = 34/265 (12%)

Query: 7   HTIGQGSSATVSLATSLRSGDVFAAK--------STELPKSEFLQREQKFLSSLNSPHIV 58
             IG GS   V  A  +R+ +V A K        S E  K + + +E +FL  L  P+ +
Sbjct: 21  REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNE--KWQDIIKEVRFLQQLRHPNTI 78

Query: 59  GYKGCDVTSEDNKLMYNLFMEYAPGGTLND--EIHRNGGRLDESLIVSYTRQILQGLEYL 116
            YKGC +      L+    MEY  G + +D  E+H+   +  E  I +     LQGL YL
Sbjct: 79  EYKGCYLREHTAWLV----MEYCLG-SASDILEVHKKPLQEVE--IAAICHGALQGLAYL 131

Query: 117 HSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSGGTPMFMAPEVA----RGEH 171
           HS+  +H DIK+ NIL+ E G  K+ADFG A   S A    GTP +MAPEV      G++
Sbjct: 132 HSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFVGTPYWMAPEVILAMDEGQY 191

Query: 172 QGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQAND---- 227
            G   D+W++G T IE+A    P  N  + M+ LY IA +    + P   S   +D    
Sbjct: 192 DGKV-DVWSLGITCIELAERKPPLFN-MNAMSALYHIAQN----DSPTLSSNDWSDYFRN 245

Query: 228 FLSNCLRRDPKERWAASQLLKHPFL 252
           F+ +CL++ P++R ++ +LLKH F+
Sbjct: 246 FVDSCLQKIPQDRPSSEELLKHRFV 270

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  146 bits (370), Expect = 2e-41
 Identities = 82/256 (32%), Positives = 127/256 (49%), Gaps = 17/256 (6%)

Query: 8   TIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQ-----KFLSSLNSPHIVGYKG 62
            IG+GS   V          V+A K  +L K    +RE+     + L+ L+S +I+ Y  
Sbjct: 7   KIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYE 66

Query: 63  CDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGR-LDESLIVSYTRQILQGLEYLHSNRV 121
             +  +  KL  N+ MEYA  G L+  +    GR L E  +  +  QIL GL +LHS ++
Sbjct: 67  SFL--DKGKL--NIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKI 122

Query: 122 VHCDIKSRNILM-AESGAKIADFGCAKWESE----ALQSGGTPMFMAPEVARGEHQGFAS 176
           +H DIKS N+ + A    KI D G AK  S+    A    GTP +++PE+   +     S
Sbjct: 123 LHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKS 182

Query: 177 DIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRD 236
           D+WA+G  + E  +G  P+ +A +   ++ KI      P V    S+Q    +  CL +D
Sbjct: 183 DVWALGVVLYECCTGKHPF-DANNQGALILKIIRGV-FPPVSQMYSQQLAQLIDQCLTKD 240

Query: 237 PKERWAASQLLKHPFL 252
            ++R    QLL++P L
Sbjct: 241 YRQRPDTFQLLRNPSL 256

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  145 bits (369), Expect = 4e-41
 Identities = 80/270 (29%), Positives = 120/270 (44%), Gaps = 35/270 (12%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKS--------EFLQREQKFLSSLNSPHIVG- 59
           +G G    V L         FA K   + K         E +  E++ L   N P IV  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALK--CVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL 58

Query: 60  YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN 119
           Y+    T +D K +Y L MEY  GG L   +   G   DE     Y   ++   EYLH+ 
Sbjct: 59  YR----TFKDKKYIYML-MEYCLGGELWTILRDRG-LFDEYTARFYIACVVLAFEYLHNR 112

Query: 120 RVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG-------GTPMFMAPEVARGEH 171
            +++ D+K  N+L+  +G  K+ DFG AK     L+SG       GTP ++APE+   + 
Sbjct: 113 GIIYRDLKPENLLLDSNGYVKLVDFGFAK----KLKSGQKTWTFCGTPEYVAPEIILNKG 168

Query: 172 QGFASDIWAVGCTVIEMASGGAPWPN-AADPMTVLYKIAYSRELPEVPAFLSKQANDFLS 230
             F+ D W++G  + E+ +G  P+     DPM +   I       E P ++ K A D + 
Sbjct: 169 YDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIK 228

Query: 231 NCLRRDPKERW-----AASQLLKHPFLEEF 255
             LRR+P+ER          + KH +   F
Sbjct: 229 QLLRRNPEERLGNLKGGIKDIKKHKWFNGF 258

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score =  144 bits (365), Expect = 2e-40
 Identities = 99/261 (37%), Positives = 141/261 (54%), Gaps = 18/261 (6%)

Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL---PKSEFLQREQKFLSSLNSPHIVG 59
           +TR   IGQG+S TV  A  + +G   A +   L   PK E +  E   +    +P+IV 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 60  YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN 119
           Y    +  ++      + MEY  GG+L D +      +DE  I +  R+ LQ LE+LHSN
Sbjct: 82  YLDSYLVGDE----LWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLHSN 135

Query: 120 RVVHCDIKSRNILMAESGA-KIADFG-CAKWESEALQSG---GTPMFMAPEVARGEHQGF 174
           +V+H DIKS NIL+   G+ K+ DFG CA+   E  +     GTP +MAPEV   +  G 
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195

Query: 175 ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEV--PAFLSKQANDFLSNC 232
             DIW++G   IEM  G  P+ N  +P+  LY IA +   PE+  P  LS    DFL+ C
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLN-ENPLRALYLIA-TNGTPELQNPEKLSAIFRDFLNRC 253

Query: 233 LRRDPKERWAASQLLKHPFLE 253
           L  D ++R +A +LL+H FL+
Sbjct: 254 LDMDVEKRGSAKELLQHQFLK 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  147 bits (370), Expect = 3e-40
 Identities = 94/312 (30%), Positives = 133/312 (42%), Gaps = 38/312 (12%)

Query: 8   TIGQGSSATVSLATSLRSGDV-FAAKSTELPKSEFLQ--REQKFLSSLNSP-HIVGYKGC 63
            +G+GS   V LA   +   +   AK  E    E  +  RE + L+SLN P +IV     
Sbjct: 7   KLGEGSFGEVYLARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDF 66

Query: 64  DVTSEDNKLMYNLFMEYAPGGTLNDEIHRNG--GRLDESLIVSYTRQILQGLEYLHSNRV 121
                       L MEY  GG+L D + + G  G L ES  +    QIL  LEYLHS  +
Sbjct: 67  FQDEGS----LYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGI 122

Query: 122 VHCDIKSRNILMAESG--AKIADFGCAKWESEALQSG----------GTPMFMAPEVARG 169
           +H DIK  NIL+   G   K+ DFG AK   +   +           GTP +MAPEV  G
Sbjct: 123 IHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLG 182

Query: 170 ---EHQGFASDIWAVGCTVIEMASGGAPWP--NAADPMTVLYKIAYSRELP--------E 216
               +   +SDIW++G T+ E+ +G  P+     +   +   KI      P         
Sbjct: 183 LSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPS 242

Query: 217 VPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSILDQG 276
            P  +SK A+D L   L +DPK R ++S  L H  L             +          
Sbjct: 243 NPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESD---LSDLLKPDDSAP 299

Query: 277 IWNSVEETEESL 288
           +  S+  + E+L
Sbjct: 300 LRLSLPPSLEAL 311

Length = 384

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  143 bits (364), Expect = 3e-40
 Identities = 84/290 (28%), Positives = 126/290 (43%), Gaps = 60/290 (20%)

Query: 6   GHTIGQGSSATVSLATSLRSGDVFAAKS------TELPKSEFLQREQKFLSSLN-SPHIV 58
           G  IG+GS +TV LA    +   +A K        +  K ++++ E++ L+ LN  P I+
Sbjct: 6   GKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGII 65

Query: 59  GYKGCDVTSEDNKLMY------NLF--MEYAPGGTLNDEIHRNGGRLDESLIVSYTRQIL 110
                       KL Y      NL+  +EYAP G L   I + G  LDE     Y  +IL
Sbjct: 66  ------------KLYYTFQDEENLYFVLEYAPNGELLQYIRKYG-SLDEKCTRFYAAEIL 112

Query: 111 QGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAK----------------WESEAL 153
             LEYLHS  ++H D+K  NIL+ +    KI DFG AK                     +
Sbjct: 113 LALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQI 172

Query: 154 QSG--------GTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVL 205
           +          GT  +++PE+   +  G +SD+WA+GC + +M +G  P+   ++     
Sbjct: 173 EKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPF-RGSNEYLTF 231

Query: 206 YKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKER----WAASQLLKHPF 251
            KI    E    P      A D +   L  DP++R        +L  HPF
Sbjct: 232 QKIL-KLEY-SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  142 bits (359), Expect = 1e-39
 Identities = 75/264 (28%), Positives = 114/264 (43%), Gaps = 24/264 (9%)

Query: 8   TIGQGSSATVSLATSLRSGDVFAAKS------TELPKSEFLQREQKFLSSLNSPHIVGYK 61
           TIG+GS  TV        G +   K       TE  K + L  E   L  L  P+IV Y 
Sbjct: 7   TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEK-QQLVSEVNILRELKHPNIVRYY 65

Query: 62  GCDVTSEDNKLMYNLFMEYAPGGTLNDEIHR---NGGRLDESLIVSYTRQILQGLEYLH- 117
              +    N+ +Y + MEY  GG L   I +       ++E  I     Q+L  L   H 
Sbjct: 66  DRII-DRSNQTLY-IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123

Query: 118 ----SNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG----GTPMFMAPEVAR 168
                N V+H D+K  NI +  +   K+ DFG AK             GTP +M+PE   
Sbjct: 124 RSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLN 183

Query: 169 GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDF 228
                  SDIW++GC + E+ +   P+  A + + +  KI   +    +P   S + N+ 
Sbjct: 184 HMSYDEKSDIWSLGCLIYELCALSPPF-TARNQLQLASKIKEGK-FRRIPYRYSSELNEV 241

Query: 229 LSNCLRRDPKERWAASQLLKHPFL 252
           + + L  DP +R +  +LL+ P +
Sbjct: 242 IKSMLNVDPDKRPSTEELLQLPLI 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  141 bits (356), Expect = 3e-39
 Identities = 81/259 (31%), Positives = 129/259 (49%), Gaps = 25/259 (9%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQ-----KFLSSLNSPHIVGYKGC 63
           +G+GS  +V     L     +A K  +L      +RE      + L+S+N P+I+ YK  
Sbjct: 8   LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYK-- 65

Query: 64  DVTSEDNKLMYNLFMEYAPGGTLNDEIHRN---GGRLDESLIVSYTRQILQGLEYLHSNR 120
           +   + NKL   + MEYAP G L+  I +       + E  I     Q+L+GL+ LH  +
Sbjct: 66  EAFLDGNKLC--IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK 123

Query: 121 VVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG------GTPMFMAPEVARGEHQG 173
           ++H D+KS NIL+  +   KI D G +K     L+        GTP +MAPEV +G    
Sbjct: 124 ILHRDLKSANILLVANDLVKIGDLGISK----VLKKNMAKTQIGTPHYMAPEVWKGRPYS 179

Query: 174 FASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCL 233
           + SDIW++GC + EMA+   P+  A     + YK+   +  P +P   S+   +F+ + L
Sbjct: 180 YKSDIWSLGCLLYEMATFAPPF-EARSMQDLRYKVQRGK-YPPIPPIYSQDLQNFIRSML 237

Query: 234 RRDPKERWAASQLLKHPFL 252
           +  PK R    ++L  P +
Sbjct: 238 QVKPKLRPNCDKILASPAV 256

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  141 bits (358), Expect = 4e-39
 Identities = 83/268 (30%), Positives = 127/268 (47%), Gaps = 25/268 (9%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ--------REQKFLSSLN 53
           D+    T+G GS   V L     SG  +A K   L K++ ++         E++ L S+ 
Sbjct: 2   DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKI--LSKAKIVKLKQVEHVLNEKRILQSIR 59

Query: 54  SPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGL 113
            P +V   G     +D+  +Y L MEY PGG L     R  GR  E +   Y  Q++  L
Sbjct: 60  HPFLVNLYGSF---QDDSNLY-LVMEYVPGGELFS-HLRKSGRFPEPVARFYAAQVVLAL 114

Query: 114 EYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQS-GGTPMFMAPEVARGEH 171
           EYLHS  +V+ D+K  N+L+   G  KI DFG AK       +  GTP ++APE+   + 
Sbjct: 115 EYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLCGTPEYLAPEIILSKG 174

Query: 172 QGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSN 231
            G A D WA+G  + EM +G  P+    +P+  +Y+     ++   P+F S  A D + N
Sbjct: 175 YGKAVDWWALGILIYEMLAGYPPF-FDDNPI-QIYEKILEGKV-RFPSFFSPDAKDLIRN 231

Query: 232 CLRRDPKERWA-----ASQLLKHPFLEE 254
            L+ D  +R        + +  HP+   
Sbjct: 232 LLQVDLTKRLGNLKNGVNDIKNHPWFAG 259

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  141 bits (356), Expect = 5e-39
 Identities = 82/266 (30%), Positives = 135/266 (50%), Gaps = 27/266 (10%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKS-TELPKSEFLQ---REQKFLSSLNSPHIVGYKGCD 64
           +G+G+  +V+      +G +FA K+ T  P  +  +   RE +   S  SP+IV Y G  
Sbjct: 9   LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAF 68

Query: 65  VTSEDNKLMYNLFMEYAPGGTLN---DEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRV 121
           +    +     + MEY  GG+L+    ++ + GGR+ E ++      +L+GL YLHS ++
Sbjct: 69  LDESSS--SIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKI 126

Query: 122 VHCDIKSRNILMAESGA-KIADFGCAKWESEALQSG-----GTPMFMAPEVARGEHQGFA 175
           +H DIK  NIL+   G  K+ DFG +    E + S      GT  +MAPE  +G+     
Sbjct: 127 IHRDIKPSNILLTRKGQVKLCDFGVS---GELVNSLAGTFTGTSFYMAPERIQGKPYSIT 183

Query: 176 SDIWAVGCTVIEMASGGAPWP----NAADPMTVLYKI--AYSREL---PEVPAFLSKQAN 226
           SD+W++G T++E+A    P+P        P+ +L  I    + EL   P      S++  
Sbjct: 184 SDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFK 243

Query: 227 DFLSNCLRRDPKERWAASQLLKHPFL 252
           DF+  CL +DP  R     +L+HP++
Sbjct: 244 DFIKQCLEKDPTRRPTPWDMLEHPWI 269

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  139 bits (353), Expect = 2e-38
 Identities = 86/299 (28%), Positives = 122/299 (40%), Gaps = 78/299 (26%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSE--FLQ---REQKFLSSLNSPHIVGYKGC 63
           +G+G+   V  A   ++G++ A K   L   E        RE   L  L  P+IV     
Sbjct: 7   LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLL-- 64

Query: 64  DVTSEDNKLMYNLFMEYAPGGTLNDE-----IHRNGGRLDESLIVSYTRQILQGLEYLHS 118
           DV   + KL   L  EY       D      + +  G L  +LI S   Q+L+GL Y HS
Sbjct: 65  DVIHTERKLY--LVFEYC------DMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHS 116

Query: 119 NRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSGGTPM-----------FMAPEV 166
           +R++H D+K +NIL+   G  K+ADFG A+       + G P+           + APE+
Sbjct: 117 HRILHRDLKPQNILINRDGVLKLADFGLAR-------AFGIPLRTYTHEVVTLWYRAPEI 169

Query: 167 ARGEHQ-GFASDIWAVGCTVIEMASG--------------------GAP----WPNAADP 201
             G      A DIW+VGC   EM +G                    G P    WP     
Sbjct: 170 LLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPG---- 225

Query: 202 MTVLYKIAYSRELPEVPA------F--LSKQANDFLSNCLRRDPKERWAASQLLKHPFL 252
             V     Y    P+ P          L  +  D LS  L+ +P +R +A + LKHP+ 
Sbjct: 226 --VTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  138 bits (349), Expect = 6e-38
 Identities = 88/286 (30%), Positives = 121/286 (42%), Gaps = 51/286 (17%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELP-KSEFLQ----REQKFLSSLNSPHIVGYKGC 63
           IG+G+   V  A    +G++ A K  +L  +SE +     RE K L  LN P+I+     
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLL-- 64

Query: 64  DVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVH 123
           DV      L   L  E+     L   I      L ESLI SY  Q+LQGL + HS+ ++H
Sbjct: 65  DVFRHKGDLY--LVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILH 121

Query: 124 CDIKSRNILMAESGA-KIADFGCAKWESEALQSGGTPM--------FMAPEVARGEHQ-G 173
            D+K  N+L+   G  K+ADFG A+    +  S   P         + APE+  G+    
Sbjct: 122 RDLKPENLLINTEGVLKLADFGLAR----SFGSPVRPYTHYVVTRWYRAPELLLGDKGYS 177

Query: 174 FASDIWAVGCTVIEMASG--------------------GAP----WP---NAADPMTVLY 206
              DIW+VGC   E+ S                     G P    WP   + A      +
Sbjct: 178 TPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSF 237

Query: 207 KIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFL 252
                  LP++    S QA D LS  L  DP +R  A Q L HP+ 
Sbjct: 238 PKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  136 bits (346), Expect = 9e-38
 Identities = 68/256 (26%), Positives = 113/256 (44%), Gaps = 28/256 (10%)

Query: 4   TRGHTIGQGSSATVSLATSLRSGD---------VFAAKSTELPKSEFLQREQKFLSSLNS 54
             G  +G+G+   V   T    G+              ++E  + EFL  E   +  L+ 
Sbjct: 2   ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFL-EEASIMKKLSH 60

Query: 55  PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLE 114
           P+IV   G  V ++   L   +  EY PGG L D + ++G +L    ++    QI +G+E
Sbjct: 61  PNIVRLLG--VCTQGEPLY--IVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGME 116

Query: 115 YLHSNRVVHCDIKSRNILMAESG-AKIADFGCAK---WESEALQSGGTPM---FMAPEVA 167
           YL S   VH D+ +RN L+ E+   KI+DFG ++    +    + GG  +   +MAPE  
Sbjct: 117 YLESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESL 176

Query: 168 RGEHQGF--ASDIWAVGCTVIEMASGGA-PWPNAADPMTVLYKIAYSRELPEVPAFLSKQ 224
           +     F   SD+W+ G  + E+ + G  P+P       VL  +         P     +
Sbjct: 177 K--DGKFTSKSDVWSFGVLLWEIFTLGEQPYPG-MSNEEVLELL-EDGYRLPRPENCPDE 232

Query: 225 ANDFLSNCLRRDPKER 240
             + +  C   DP++R
Sbjct: 233 LYELMLQCWAYDPEDR 248

Length = 258

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score =  137 bits (346), Expect = 9e-38
 Identities = 94/259 (36%), Positives = 141/259 (54%), Gaps = 17/259 (6%)

Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEF----LQREQKFLSSLNSPHIV 58
           +T+   IG+GS   V      R+  V A K  +L ++E     +Q+E   LS  +SP++ 
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 59  GYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHS 118
            Y G  +  +D KL   + MEY  GG+  D +    G LDE+ I +  R+IL+GL+YLHS
Sbjct: 66  KYYGSYL--KDTKLW--IIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHS 119

Query: 119 NRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG----GTPMFMAPEVARGEHQG 173
            + +H DIK+ N+L++E G  K+ADFG A   ++         GTP +MAPEV +     
Sbjct: 120 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYD 179

Query: 174 FASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCL 233
             +DIW++G T IE+A G  P  +   PM VL+ I  +   P +    SK   +F+  CL
Sbjct: 180 SKADIWSLGITAIELAKGEPP-HSELHPMKVLFLIPKNNP-PTLEGNYSKPLKEFVEACL 237

Query: 234 RRDPKERWAASQLLKHPFL 252
            ++P  R  A +LLKH F+
Sbjct: 238 NKEPSFRPTAKELLKHKFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  137 bits (348), Expect = 9e-38
 Identities = 85/285 (29%), Positives = 125/285 (43%), Gaps = 47/285 (16%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAK--STELPKSEFLQ---REQKFLSSLNSPHIVGYKGC 63
           IG+G+   V  A + ++G++ A K    E  K  F     RE K L  L  P+IV  K  
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLK-E 65

Query: 64  DVTSEDNKLMYNLFM--EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRV 121
            VTS+      +++M  EY     L   +     +  ES I  Y +Q+L+GL+YLHSN +
Sbjct: 66  IVTSKGKG---SIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGI 121

Query: 122 VHCDIKSRNILMAESG-AKIADFGCAKWESEALQSGGTPM-----FMAPEVARGEHQ-GF 174
           +H DIK  NIL+   G  K+ADFG A+  ++   +  T       +  PE+  G  + G 
Sbjct: 122 LHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGP 181

Query: 175 ASDIWAVGCTVIEMASG--------------------GAP----WPNAAD-PMTVLYKIA 209
             D+W+VGC + E+  G                    G+P    WP  +  P     K  
Sbjct: 182 EVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPK 241

Query: 210 Y---SRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPF 251
                R        +   A D L   L  DPK+R +A Q L+H +
Sbjct: 242 KPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEY 286

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  137 bits (346), Expect = 1e-37
 Identities = 86/293 (29%), Positives = 128/293 (43%), Gaps = 58/293 (19%)

Query: 7   HTIGQGSSATVSLATSLRSGDVFAAK------STELPKSEFLQREQKFLSSLNSPHIVGY 60
             +G+G+   V    +  +G++ A K        E  K +   RE K L  L   +IV  
Sbjct: 7   GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVK-KTALREVKVLRQLRHENIVNL 65

Query: 61  KGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNR 120
           K  +      +L   L  EY    TL + +  + G L    + SY  Q+LQ + Y HS+ 
Sbjct: 66  K--EAFRRKGRLY--LVFEYVER-TLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN 120

Query: 121 VVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSGGTP---------MFMAPEVARGE 170
           ++H DIK  NIL++ESG  K+ DFG A+    AL++              + APE+  G+
Sbjct: 121 IIHRDIKPENILVSESGVLKLCDFGFAR----ALRARPASPLTDYVATRWYRAPELLVGD 176

Query: 171 HQ-GFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA-------------------Y 210
              G   D+WA+GC + E+  G   +P  +D +  LY I                    +
Sbjct: 177 TNYGKPVDVWAIGCIMAELLDGEPLFPGDSD-IDQLYLIQKCLGPLPPSHQELFSSNPRF 235

Query: 211 SRE-LPEV----------PAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFL 252
           +    PE           P  +S  A DFL  CLR DPKER    +LL+HP+ 
Sbjct: 236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score =  136 bits (344), Expect = 2e-37
 Identities = 94/271 (34%), Positives = 141/271 (52%), Gaps = 17/271 (6%)

Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEF----LQREQKFLSSLNSPHIV 58
           +T+   IG+GS   V      R+  V A K  +L ++E     +Q+E   LS  +SP++ 
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 59  GYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHS 118
            Y G  +  +  KL   + MEY  GG+  D +    G  DE  I +  ++IL+GL+YLHS
Sbjct: 66  KYYGSYL--KGTKLW--IIMEYLGGGSALDLLR--AGPFDEFQIATMLKEILKGLDYLHS 119

Query: 119 NRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG----GTPMFMAPEVARGEHQG 173
            + +H DIK+ N+L++E G  K+ADFG A   ++         GTP +MAPEV +     
Sbjct: 120 EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYD 179

Query: 174 FASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCL 233
             +DIW++G T IE+A G  P  +   PM VL+ I      P +    SK   +F+  CL
Sbjct: 180 SKADIWSLGITAIELAKGEPP-NSDMHPMRVLFLIP-KNNPPTLTGEFSKPFKEFIDACL 237

Query: 234 RRDPKERWAASQLLKHPFLEEFCSCTKQIQE 264
            +DP  R  A +LLKH F+ +    T  + E
Sbjct: 238 NKDPSFRPTAKELLKHKFIVKNAKKTSYLTE 268

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  136 bits (344), Expect = 2e-37
 Identities = 93/293 (31%), Positives = 142/293 (48%), Gaps = 40/293 (13%)

Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEF----LQREQKFLSSL---NSP 55
           + R   IG+G+   V     + +G V A K   L   +     +QRE   LS L     P
Sbjct: 3   YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62

Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
           +I  Y G  +  +  +L   + MEYA GG++   +    G + E  I    R++L  L+Y
Sbjct: 63  NITKYYGSYL--KGPRLW--IIMEYAEGGSVRTLM--KAGPIAEKYISVIIREVLVALKY 116

Query: 116 LHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG--------GTPMFMAPEV 166
           +H   V+H DIK+ NIL+  +G  K+ DFG A      L           GTP +MAPEV
Sbjct: 117 IHKVGVIHRDIKAANILVTNTGNVKLCDFGVAA----LLNQNSSKRSTFVGTPYWMAPEV 172

Query: 167 AR-GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPA-FLSKQ 224
              G++    +DIW++G T+ EMA+G  P+ +  D    +  I  S+  P +     SK 
Sbjct: 173 ITEGKYYDTKADIWSLGITIYEMATGNPPYSD-VDAFRAMMLIPKSKP-PRLEDNGYSKL 230

Query: 225 ANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSILDQGI 277
             +F++ CL  +PKER +A +LLK          +K I+  + +P SIL + I
Sbjct: 231 LREFVAACLDEEPKERLSAEELLK----------SKWIKAHSKTPVSILKELI 273

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score =  135 bits (340), Expect = 9e-37
 Identities = 94/264 (35%), Positives = 140/264 (53%), Gaps = 21/264 (7%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQR---EQKFLSSLNSPHIVGYKGCDV 65
           +G G+   V  A +  +G + AAK  E    E L+    E + L++ N P+IV  K    
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIV--KLLGA 77

Query: 66  TSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCD 125
              D KL   + +E+ PGG ++  +      L E  I    RQ+L+ L+YLHS +++H D
Sbjct: 78  FYWDGKLW--IMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRD 135

Query: 126 IKSRNILMAESG-AKIADFGCAKWESEALQSG----GTPMFMAPEVARGEHQ-----GFA 175
           +K+ N+L+   G  K+ADFG +    + LQ      GTP +MAPEV   E        + 
Sbjct: 136 LKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYK 195

Query: 176 SDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEV--PAFLSKQANDFLSNCL 233
           +DIW++G T+IEMA    P  +  +PM VL KIA S E P +  P+  S +  DFL   L
Sbjct: 196 ADIWSLGITLIEMAQIEPP-HHELNPMRVLLKIAKS-EPPTLSQPSKWSMEFRDFLKTAL 253

Query: 234 RRDPKERWAASQLLKHPFLEEFCS 257
            + P+ R +A+QLL+HPF+    S
Sbjct: 254 DKHPETRPSAAQLLEHPFVSSVTS 277

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score =  134 bits (338), Expect = 3e-36
 Identities = 96/262 (36%), Positives = 137/262 (52%), Gaps = 28/262 (10%)

Query: 7   HTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSLNSPHIVGY 60
           H IG GS   V  AT+  + +V A K           K + + +E KFL  L  P+ + Y
Sbjct: 27  HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEY 86

Query: 61  KGCDVTSEDNKLMYNLFMEYAPGGTLND-EIHRNGGRLDESLIVSYTRQILQGLEYLHSN 119
           KGC +      L+    MEY  G   +  E+H+    L E  I + T   LQGL YLHS+
Sbjct: 87  KGCYLKEHTAWLV----MEYCLGSASDLLEVHKK--PLQEVEIAAITHGALQGLAYLHSH 140

Query: 120 RVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSGGTPMFMAPEVA----RGEHQGF 174
            ++H DIK+ NIL+ E G  K+ADFG A   S A    GTP +MAPEV      G++ G 
Sbjct: 141 NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFVGTPYWMAPEVILAMDEGQYDG- 199

Query: 175 ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQAND----FLS 230
             D+W++G T IE+A    P  N  + M+ LY IA +    + P   S +  D    F+ 
Sbjct: 200 KVDVWSLGITCIELAERKPPLFN-MNAMSALYHIAQN----DSPTLQSNEWTDSFRGFVD 254

Query: 231 NCLRRDPKERWAASQLLKHPFL 252
            CL++ P+ER A+++LL+H F+
Sbjct: 255 YCLQKIPQERPASAELLRHDFV 276

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  129 bits (327), Expect = 4e-35
 Identities = 72/216 (33%), Positives = 119/216 (55%), Gaps = 12/216 (5%)

Query: 43  QREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEI-HRNGGRLDESL 101
             E   LS L  P+I+ Y    +  +DN L+    MEYA GGTL D+I  + G   +E +
Sbjct: 47  LNEIVILSLLQHPNIIAYYNHFM--DDNTLLIE--MEYANGGTLYDKIVRQKGQLFEEEM 102

Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAK-WESEALQSG--- 156
           ++ Y  QI+  + Y+H   ++H DIK+ NI + ++G  K+ DFG +K   SE   +    
Sbjct: 103 VLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV 162

Query: 157 GTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPE 216
           GTP +M+PE+ +G    F SDIWA+GC + E+ +    + +A +P+ ++ KI      P 
Sbjct: 163 GTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTF-DATNPLNLVVKIVQGNYTPV 221

Query: 217 VPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFL 252
           V  + S +    + + L++DP++R  A ++L  P L
Sbjct: 222 VSVY-SSELISLVHSLLQQDPEKRPTADEVLDQPLL 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  130 bits (329), Expect = 5e-35
 Identities = 80/289 (27%), Positives = 122/289 (42%), Gaps = 56/289 (19%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSE-----FLQREQKFLSSLNSPHIVGYKGC 63
           IG+G+   V  A    +G+  A K   L + E        RE K L +   P++V  K  
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVV--KLL 65

Query: 64  DVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVH 123
           DV    +  +  L MEY P   L++ +      L E+ + SY R +L+G+ Y+H+N ++H
Sbjct: 66  DVFPHGSGFV--LVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMH 122

Query: 124 CDIKSRNILMAESG-AKIADFGCAKWESEALQSGGTPM----------FMAPEVARG-EH 171
            D+K  N+L++  G  KIADFG A+     L S   P           + APE+  G   
Sbjct: 123 RDLKPANLLISADGVLKIADFGLAR-----LFSEEEPRLYSHQVATRWYRAPELLYGARK 177

Query: 172 QGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAY-----------SRELPE---- 216
                D+WAVGC   E+ +G   +P   D   +                    LP+    
Sbjct: 178 YDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKI 237

Query: 217 -------------VPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFL 252
                         P   S +A D L   L  DP +R +A++ L+HP+ 
Sbjct: 238 TFPESKPIPLEEIFP-DASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score =  128 bits (324), Expect = 2e-34
 Identities = 89/259 (34%), Positives = 134/259 (51%), Gaps = 21/259 (8%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQR---EQKFLSSLNSPHIVGYKGCDV 65
           +G G+   V  A +  +G + AAK  +    E L+    E   L+S + P+IV  K  D 
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIV--KLLDA 70

Query: 66  TSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCD 125
              +N L   + +E+  GG ++  +      L E  I    +Q L+ L YLH N+++H D
Sbjct: 71  FYYENNLW--ILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRD 128

Query: 126 IKSRNILMAESG-AKIADFGCAKWESEALQSG----GTPMFMAPEVARGEHQ-----GFA 175
           +K+ NIL    G  K+ADFG +   +  +Q      GTP +MAPEV   E        + 
Sbjct: 129 LKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYK 188

Query: 176 SDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEV--PAFLSKQANDFLSNCL 233
           +D+W++G T+IEMA    P  +  +PM VL KIA S E P +  P+  S +  DFL  CL
Sbjct: 189 ADVWSLGITLIEMAQIEPP-HHELNPMRVLLKIAKS-EPPTLAQPSRWSSEFKDFLKKCL 246

Query: 234 RRDPKERWAASQLLKHPFL 252
            ++   RW  +QLL+HPF+
Sbjct: 247 EKNVDARWTTTQLLQHPFV 265

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  127 bits (322), Expect = 2e-34
 Identities = 76/258 (29%), Positives = 114/258 (44%), Gaps = 21/258 (8%)

Query: 9   IGQGSSATVSLATSLRSGDVFA------AKSTELPKSEFLQREQKFLSSLNSPHIVG--Y 60
           IG+G+   V +     +  +FA       K  E      +  E++ L  LN P +V   Y
Sbjct: 8   IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWY 67

Query: 61  KGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNR 120
              D   E+N  MY L ++   GG L   + +   +  E  +  +  +I+  LEYLHS  
Sbjct: 68  SFQD---EEN--MY-LVVDLLLGGDLRYHLSQKV-KFSEEQVKFWICEIVLALEYLHSKG 120

Query: 121 VVHCDIKSRNILMAESG-AKIADFGCA-KWESEALQSG--GTPMFMAPEVARGEHQGFAS 176
           ++H DIK  NIL+ E G   I DF  A K   + L +   GTP +MAPEV   +    A 
Sbjct: 121 IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAV 180

Query: 177 DIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRD 236
           D W++G T  E   G  P+   +  +    +          PA  S +A D ++  L RD
Sbjct: 181 DWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLLERD 240

Query: 237 PKERW--AASQLLKHPFL 252
           P++R       L  HP+ 
Sbjct: 241 PQKRLGDNLKDLKNHPYF 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  129 bits (325), Expect = 3e-34
 Identities = 83/270 (30%), Positives = 127/270 (47%), Gaps = 39/270 (14%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQR--------EQKFLS-SLNSPHIVG 59
           +G+GS   V LA    + +++A K   L K   LQ         E++ L+ +   P +  
Sbjct: 3   LGKGSFGKVLLAELKGTDELYAVKV--LKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60

Query: 60  YKGCDVTSEDNKLMYNLF--MEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLH 117
              C  T +       LF  MEY  GG L   I R+G R DE     Y  +I+ GL++LH
Sbjct: 61  LHSCFQTKD------RLFFVMEYVNGGDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLH 113

Query: 118 SNRVVHCDIKSRNILM-AESGAKIADFGCAKWESEALQSG-------GTPMFMAPEVARG 169
              +++ D+K  N+L+ +E   KIADFG  K   E +  G       GTP ++APE+   
Sbjct: 114 ERGIIYRDLKLDNVLLDSEGHIKIADFGMCK---EGILGGVTTSTFCGTPDYIAPEILSY 170

Query: 170 EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFL 229
           +  G A D WA+G  + EM +G +P+    D    L++     E    P +LSK+A   L
Sbjct: 171 QPYGPAVDWWALGVLLYEMLAGQSPFE--GDDEDELFQSILEDE-VRYPRWLSKEAKSIL 227

Query: 230 SNCLRRDPKERWAASQ-----LLKHPFLEE 254
            + L ++P++R          +  HPF  E
Sbjct: 228 KSFLTKNPEKRLGCLPTGEQDIKGHPFFRE 257

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score =  128 bits (323), Expect = 4e-34
 Identities = 95/261 (36%), Positives = 137/261 (52%), Gaps = 30/261 (11%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAK--------STELPKSEFLQREQKFLSSLNSPHIVGY 60
           IG GS   V  A  +R+ +V A K        S E  K + + +E KFL  +  P+ + Y
Sbjct: 33  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNE--KWQDIIKEVKFLQRIKHPNSIEY 90

Query: 61  KGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNR 120
           KGC +      L+    MEY  G + +D +  +   L E  I + T   LQGL YLHS+ 
Sbjct: 91  KGCYLREHTAWLV----MEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN 145

Query: 121 VVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSGGTPMFMAPEVA----RGEHQGFA 175
           ++H DIK+ NIL+ E G  K+ADFG A   S A    GTP +MAPEV      G++ G  
Sbjct: 146 MIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFVGTPYWMAPEVILAMDEGQYDG-K 204

Query: 176 SDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSN---- 231
            D+W++G T IE+A    P  N  + M+ LY IA +    E P   S + +D+  N    
Sbjct: 205 VDVWSLGITCIELAERKPPLFN-MNAMSALYHIAQN----ESPTLQSNEWSDYFRNFVDS 259

Query: 232 CLRRDPKERWAASQLLKHPFL 252
           CL++ P++R  + +LLKH F+
Sbjct: 260 CLQKIPQDRPTSEELLKHMFV 280

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  125 bits (317), Expect = 1e-33
 Identities = 71/256 (27%), Positives = 111/256 (43%), Gaps = 29/256 (11%)

Query: 4   TRGHTIGQGSSATVSLAT---SLRSGDVFAA-K-----STELPKSEFLQREQKFLSSLNS 54
           T G  +G+G+   V             V  A K     ++E    EFL RE + +  L+ 
Sbjct: 2   TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFL-REARIMRKLDH 60

Query: 55  PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLE 114
           P++V   G   T E+   +    MEY  GG L   + +N  +L  S ++S+  QI +G+E
Sbjct: 61  PNVVKLLGV-CTEEEPLYIV---MEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGME 116

Query: 115 YLHSNRVVHCDIKSRNILMAESG-AKIADFGCAK-WESEALQSGGTPMF----MAPEVAR 168
           YL S   +H D+ +RN L+ E+   KI+DFG ++    +              MAPE  +
Sbjct: 117 YLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLK 176

Query: 169 GEHQGFASDIWAVGCTVIEMASGGA-PWPNAADPMTVLYKIA--YSRELPEV-PAFLSKQ 224
                  SD+W+ G  + E+ + G  P+P       VL  +   Y    P   P  L   
Sbjct: 177 EGKFTSKSDVWSFGVLLWEIFTLGEQPYPG-MSNEEVLEYLKNGYRLPQPPNCPPELY-- 233

Query: 225 ANDFLSNCLRRDPKER 240
             D +  C   DP++R
Sbjct: 234 --DLMLQCWAEDPEDR 247

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score =  127 bits (319), Expect = 1e-33
 Identities = 90/261 (34%), Positives = 135/261 (51%), Gaps = 28/261 (10%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSLNSPHIVGYKG 62
           IG GS   V  A  +R+ +V A K           K + + +E +FL  L  P+ + Y+G
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82

Query: 63  CDVTSEDNKLMYNLFMEYAPGGTLND-EIHRNGGRLDESLIVSYTRQILQGLEYLHSNRV 121
           C +      L+    MEY  G   +  E+H+    L E  I + T   LQGL YLHS+ +
Sbjct: 83  CYLREHTAWLV----MEYCLGSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHSHNM 136

Query: 122 VHCDIKSRNILMAESG-AKIADFGCAKWESEALQSGGTPMFMAPEVA----RGEHQGFAS 176
           +H D+K+ NIL++E G  K+ DFG A   + A    GTP +MAPEV      G++ G   
Sbjct: 137 IHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGTPYWMAPEVILAMDEGQYDG-KV 195

Query: 177 DIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQAND----FLSNC 232
           D+W++G T IE+A    P  N  + M+ LY IA +    E PA  S   ++    F+ +C
Sbjct: 196 DVWSLGITCIELAERKPPLFN-MNAMSALYHIAQN----ESPALQSGHWSEYFRNFVDSC 250

Query: 233 LRRDPKERWAASQLLKHPFLE 253
           L++ P++R  +  LLKH F+ 
Sbjct: 251 LQKIPQDRPTSEVLLKHRFVL 271

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  126 bits (319), Expect = 2e-33
 Identities = 86/311 (27%), Positives = 123/311 (39%), Gaps = 72/311 (23%)

Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ--------REQKFLSSLNS 54
           + +G  +G+G+ A V  A    +G + A K  +L + +  +        RE K L  L  
Sbjct: 2   YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61

Query: 55  PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLE 114
           P+I+G    DV    + +  NL  E+     L   I      L  + I SY    L+GLE
Sbjct: 62  PNIIGLL--DVFGHKSNI--NLVFEFMET-DLEKVIKDKSIVLTPADIKSYMLMTLRGLE 116

Query: 115 YLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSGGTP-----------MFM 162
           YLHSN ++H D+K  N+L+A  G  K+ADFG A+       S G+P            + 
Sbjct: 117 YLHSNWILHRDLKPNNLLIASDGVLKLADFGLAR-------SFGSPNRKMTHQVVTRWYR 169

Query: 163 APEVARG-EHQGFASDIWAVGCTVIE--------------------MASGGAP----WPN 197
           APE+  G  H G   D+W+VGC   E                      + G P    WP 
Sbjct: 170 APELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPG 229

Query: 198 AADPMTVLYKIAYSRELPEVPA------F--LSKQANDFLSNCLRRDPKERWAASQLLKH 249
                     +    E    P       F   S  A D L   L  +P +R  A Q L+H
Sbjct: 230 V-------TSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282

Query: 250 PFLEEFCSCTK 260
           P+     + T 
Sbjct: 283 PYFSNDPAPTP 293

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score =  126 bits (317), Expect = 8e-33
 Identities = 85/265 (32%), Positives = 140/265 (52%), Gaps = 28/265 (10%)

Query: 5   RGHTIGQGSSATVSLATSLRSGDVFAAK----STELPKSEFLQREQKFLSSLNSPHIVGY 60
           R + IG G+  TV       +G ++A K    + E      + RE + L  +N P++V  
Sbjct: 78  RVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVV-- 135

Query: 61  KGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRL-DESLIVSYTRQILQGLEYLHSN 119
           K  D+   + ++   + +E+  GG+L       G  + DE  +    RQIL G+ YLH  
Sbjct: 136 KCHDMFDHNGEI--QVLLEFMDGGSLE------GTHIADEQFLADVARQILSGIAYLHRR 187

Query: 120 RVVHCDIKSRNILM-AESGAKIADFGCAKWESEAL----QSGGTPMFMAPE-----VARG 169
            +VH DIK  N+L+ +    KIADFG ++  ++ +     S GT  +M+PE     +  G
Sbjct: 188 HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHG 247

Query: 170 EHQGFASDIWAVGCTVIEMASGGAPWP--NAADPMTVLYKIAYSRELPEVPAFLSKQAND 227
            + G+A DIW++G +++E   G  P+      D  +++  I  S+  PE PA  S++   
Sbjct: 248 AYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQP-PEAPATASREFRH 306

Query: 228 FLSNCLRRDPKERWAASQLLKHPFL 252
           F+S CL+R+P +RW+A QLL+HPF+
Sbjct: 307 FISCCLQREPAKRWSAMQLLQHPFI 331

Length = 353

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score =  123 bits (310), Expect = 1e-32
 Identities = 93/257 (36%), Positives = 135/257 (52%), Gaps = 20/257 (7%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTEL-PKSEF--LQREQKFLSSLNSPHIVGYKGCDV 65
           IG G+   V  A ++ +G++ A K  +L P  +F  +Q+E   +      +IV Y G  +
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76

Query: 66  TSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCD 125
             +  KL   + ME+  GG+L D I+   G L ES I   +R+ LQGL YLHS   +H D
Sbjct: 77  RRD--KLW--ICMEFCGGGSLQD-IYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRD 131

Query: 126 IKSRNILMAESG-AKIADFGCAKWESEALQSG----GTPMFMAPEVARGEHQGFAS---D 177
           IK  NIL+ ++G  K+ADFG +   +  +       GTP +MAPEVA  E +G  +   D
Sbjct: 132 IKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCD 191

Query: 178 IWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQAND---FLSNCLR 234
           IWAVG T IE+A    P  +   PM  L+ +  S   P       K +N    F+   L 
Sbjct: 192 IWAVGITAIELAELQPPMFD-LHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALT 250

Query: 235 RDPKERWAASQLLKHPF 251
           ++PK+R  A +LL+HPF
Sbjct: 251 KNPKKRPTAEKLLQHPF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  123 bits (310), Expect = 1e-32
 Identities = 81/254 (31%), Positives = 118/254 (46%), Gaps = 15/254 (5%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQ--KFLSSLNSPHIVGYKGCDVT 66
           I +G+  +V LA    +GD FA K   L KS+ + + Q     +      I G       
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYFAIKV--LKKSDMIAKNQVTNVKAERAIMMIQGESPYVAK 61

Query: 67  ---SEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVH 123
              S  +K    L MEY  GG     I   GG L E     Y  +++ G+E LH   ++H
Sbjct: 62  LYYSFQSKDYLYLVMEYLNGGDCASLIKTLGG-LPEDWAKQYIAEVVLGVEDLHQRGIIH 120

Query: 124 CDIKSRNILMAESG-AKIADFGCAKWESEALQSGGTPMFMAPEVARGEHQGFASDIWAVG 182
            DIK  N+L+ ++G  K+ DFG ++   E  +  GTP ++APE   G      SD W++G
Sbjct: 121 RDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFVGTPDYLAPETILGVGDDKMSDWWSLG 180

Query: 183 CTVIEMASGGAPWPNAADPMTVLYKIAYSR-ELPE-VPAFLSKQANDFLSNCLRRDPKER 240
           C + E   G  P+ +A  P  V   I   R   PE V  F S +A D ++  L  DP +R
Sbjct: 181 CVIFEFLFGYPPF-HAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKR 239

Query: 241 WAAS---QLLKHPF 251
             A+   ++  HPF
Sbjct: 240 LGANGYQEIKSHPF 253

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score =  123 bits (310), Expect = 4e-32
 Identities = 85/287 (29%), Positives = 137/287 (47%), Gaps = 48/287 (16%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELP-KSEFLQ---REQKFLSSLNSPHIVGYKGCD 64
           +G G+   V+      SG + A K   L  K        RE K L   NSP+IVG+ G  
Sbjct: 9   LGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAF 68

Query: 65  VTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNR-VVH 123
            +  D ++  ++ ME+  GG+L D++ +  GR+ E+++   +  +L+GL YL     ++H
Sbjct: 69  YS--DGEI--SICMEHMDGGSL-DQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMH 123

Query: 124 CDIKSRNILMAESGA-KIADFGCAKW--ESEALQSGGTPMFMAPEVARGEHQGFASDIWA 180
            D+K  NIL+   G  K+ DFG +    +S A    GT  +M+PE  +G H    SDIW+
Sbjct: 124 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYTVQSDIWS 183

Query: 181 VGCTVIEMASGGAPWP--------------------------------NAADPMTVLYKI 208
           +G +++EMA G  P P                                ++  PM +   +
Sbjct: 184 LGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELL 243

Query: 209 AY--SRELPEVP-AFLSKQANDFLSNCLRRDPKERWAASQLLKHPFL 252
            Y  +   P++P    S +  DF+  CL+++PKER    +L KHPF+
Sbjct: 244 DYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFI 290

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score =  122 bits (307), Expect = 6e-32
 Identities = 93/274 (33%), Positives = 141/274 (51%), Gaps = 29/274 (10%)

Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS---EFLQREQKFLSSL-NSPHIV 58
           W    TIG+G+   V   T+ + G + A K  + P S   E ++ E   L SL N P++V
Sbjct: 24  WEIIETIGKGTYGKVYKVTNKKDGSLAAVKILD-PISDVDEEIEAEYNILQSLPNHPNVV 82

Query: 59  GYKGCDVTSED---NKLMYNLFMEYAPGGTLNDEIH---RNGGRLDESLIVSYTRQILQG 112
            + G    ++     +L   L +E   GG++ + +      G RLDE++I       L G
Sbjct: 83  KFYGMFYKADKLVGGQLW--LVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLG 140

Query: 113 LEYLHSNRVVHCDIKSRNILM-AESGAKIADFGC-AKWESEALQ---SGGTPMFMAPEVA 167
           L++LH+NR++H D+K  NIL+  E G K+ DFG  A+  S  L+   S GTP +MAPEV 
Sbjct: 141 LQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVI 200

Query: 168 RGEHQGFAS-----DIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEV---PA 219
             E Q   S     D+W++G T IE+  G  P  +   P+  L+KI   R  P     P 
Sbjct: 201 ACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFD-MHPVKTLFKI--PRNPPPTLLHPE 257

Query: 220 FLSKQANDFLSNCLRRDPKERWAASQLLKHPFLE 253
              +  N F+S CL +D + R + + LL+HPF++
Sbjct: 258 KWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  121 bits (304), Expect = 9e-32
 Identities = 80/256 (31%), Positives = 126/256 (49%), Gaps = 23/256 (8%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTEL-----PKS-EFLQREQKFLSSLNSPHIVGYKG 62
           IG+G  + V  A  L  G V A K  ++      K+ +   +E   L  L+ P+++ Y  
Sbjct: 10  IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKY-- 67

Query: 63  CDVTSEDNKLMYNLFMEYAPGGTLNDEIH--RNGGRL-DESLIVSYTRQILQGLEYLHSN 119
                E+N+L  N+ +E A  G L+  I   +   RL  E  I  Y  Q+   LE++HS 
Sbjct: 68  LASFIENNEL--NIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK 125

Query: 120 RVVHCDIKSRNILMAESGA-KIADFGCAKWES----EALQSGGTPMFMAPEVARGEHQGF 174
           R++H DIK  N+ +  +G  K+ D G  ++ S     A    GTP +M+PE        F
Sbjct: 126 RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNF 185

Query: 175 ASDIWAVGCTVIEMASGGAPWPNAADPMTV--LYKIAYSRELPEVPA-FLSKQANDFLSN 231
            SDIW++GC + EMA+  +P+    D M +  L K     + P +PA   S++  D +S 
Sbjct: 186 KSDIWSLGCLLYEMAALQSPF--YGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSR 243

Query: 232 CLRRDPKERWAASQLL 247
           C+  DP++R   S +L
Sbjct: 244 CINPDPEKRPDISYVL 259

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  120 bits (302), Expect = 1e-31
 Identities = 75/214 (35%), Positives = 113/214 (52%), Gaps = 12/214 (5%)

Query: 43  QREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGR-LDESL 101
           Q E + L  L+ P+I+ Y   +   ED  LM  + MEYAPGGTL + I +     LDE  
Sbjct: 47  QNECQVLKLLSHPNIIEY--YENFLEDKALM--IVMEYAPGGTLAEYIQKRCNSLLDEDT 102

Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILM--AESGAKIADFGCAKW---ESEALQSG 156
           I+ +  QIL  L ++H+  ++H D+K++NIL+   +   KI DFG +K    +S+A    
Sbjct: 103 ILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVV 162

Query: 157 GTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPE 216
           GTP +++PE+  G+     SDIWA+GC + E+AS    +  A  P  VL KI      P 
Sbjct: 163 GTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVL-KIMSGTFAP- 220

Query: 217 VPAFLSKQANDFLSNCLRRDPKERWAASQLLKHP 250
           +    S      + + L  DP +R   SQ++  P
Sbjct: 221 ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score =  119 bits (300), Expect = 2e-31
 Identities = 73/255 (28%), Positives = 134/255 (52%), Gaps = 16/255 (6%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQR-----EQKFLSSLNSPHIVGYKGC 63
           +G+GS   VSL      G  +  K   L  +   +R     E + LS L  P+IV Y+  
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYR-- 65

Query: 64  DVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRL-DESLIVSYTRQILQGLEYLHSNRVV 122
           +    ++ L+Y + M +  GG L  ++    G+L  E+ +V +  QI   L+YLH   ++
Sbjct: 66  ESWEGEDGLLY-IVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHIL 124

Query: 123 HCDIKSRNILMAESGA-KIADFGCAK-WESEALQSG---GTPMFMAPEVARGEHQGFASD 177
           H D+K++N+ +  +   K+ D G A+  E++   +    GTP +M+PE+   +   + SD
Sbjct: 125 HRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSD 184

Query: 178 IWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDP 237
           +WA+GC V EMA+    + NA D  +++Y+I   + LP +P   S +  + ++  L + P
Sbjct: 185 VWALGCCVYEMATLKHAF-NAKDMNSLVYRIIEGK-LPPMPKDYSPELGELIATMLSKRP 242

Query: 238 KERWAASQLLKHPFL 252
           ++R +   +L+ P++
Sbjct: 243 EKRPSVKSILRQPYI 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score =  120 bits (302), Expect = 3e-31
 Identities = 90/255 (35%), Positives = 128/255 (50%), Gaps = 20/255 (7%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKS---EFLQREQKFLSSLNSPHIVG-YKGCD 64
           IG+GS+  V +A    SG   A K  +L K    E L  E   +      ++V  YK   
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88

Query: 65  VTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHC 124
           V  E       + ME+  GG L D + +   RL+E  I +    +LQ L YLHS  V+H 
Sbjct: 89  VGEE-----LWVLMEFLQGGALTDIVSQT--RLNEEQIATVCESVLQALCYLHSQGVIHR 141

Query: 125 DIKSRNILMAESG-AKIADFG-CAKWESEALQSG---GTPMFMAPEVARGEHQGFASDIW 179
           DIKS +IL+   G  K++DFG CA+   +  +     GTP +MAPEV      G   DIW
Sbjct: 142 DIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIW 201

Query: 180 AVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAF--LSKQANDFLSNCLRRDP 237
           ++G  VIEM  G  P+ + + P+  + ++  S   P++     +S    DFL   L R+P
Sbjct: 202 SLGIMVIEMVDGEPPYFSDS-PVQAMKRLRDSPP-PKLKNAHKISPVLRDFLERMLTREP 259

Query: 238 KERWAASQLLKHPFL 252
           +ER  A +LL HPFL
Sbjct: 260 QERATAQELLDHPFL 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  119 bits (300), Expect = 3e-31
 Identities = 76/257 (29%), Positives = 117/257 (45%), Gaps = 30/257 (11%)

Query: 4   TRGHTIGQGSSATVSLAT-SLRSGDVF---AAK-----STELPKSEFLQREQKFLSSLNS 54
           T G  +G+G+   V   T   +        A K     ++E    EFL RE + +  L+ 
Sbjct: 2   TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFL-REARIMRKLDH 60

Query: 55  PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGR-LDESLIVSYTRQILQGL 113
           P+IV   G  V +E+  LM  + MEY PGG L D + +N  + L  S ++S+  QI +G+
Sbjct: 61  PNIVKLLG--VCTEEEPLM--IVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGM 116

Query: 114 EYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAK-WESEALQSGGTPMF----MAPEVA 167
           EYL S   +H D+ +RN L+ E+   KI+DFG ++    +              MAPE  
Sbjct: 117 EYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESL 176

Query: 168 RGEHQGFASDIWAVGCTVIEMASGGA-PWPNAADPMTVLYKIA--YSRELPEV-PAFLSK 223
           +       SD+W+ G  + E+ + G  P+P       VL  +   Y    P   P  L K
Sbjct: 177 KEGKFTSKSDVWSFGVLLWEIFTLGEEPYPG-MSNAEVLEYLKKGYRLPKPPNCPPELYK 235

Query: 224 QANDFLSNCLRRDPKER 240
                +  C   DP++R
Sbjct: 236 ----LMLQCWAEDPEDR 248

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  119 bits (301), Expect = 3e-31
 Identities = 61/228 (26%), Positives = 106/228 (46%), Gaps = 23/228 (10%)

Query: 38  KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLND--------E 89
           + +FL +E + +  L  P++V   G  V +E+  L   L +EY  GG L D         
Sbjct: 40  RKDFL-KEARVMKKLGHPNVVRLLG--VCTEEEPLY--LVLEYMEGGDLLDYLRKSRPVF 94

Query: 90  IHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKW 148
                  L    ++S+  QI +G+EYL S + VH D+ +RN L+ E    KI+DFG ++ 
Sbjct: 95  PSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRD 154

Query: 149 ---ESEALQSGGTPM---FMAPEVARGEHQGFASDIWAVGCTVIEMASGGA-PWPNAADP 201
              +    +  G  +   +MAPE  +       SD+W+ G  + E+ + GA P+P     
Sbjct: 155 VYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPG-LSN 213

Query: 202 MTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKH 249
             VL  +         P +   +  + + +C + DP++R   S+L++ 
Sbjct: 214 EEVLEYLR-KGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  119 bits (301), Expect = 4e-31
 Identities = 87/292 (29%), Positives = 123/292 (42%), Gaps = 63/292 (21%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKS--TELPK-SEFLQ-REQKFLSSLNS-PHIVGYKGC 63
           +G G+  +V LA +  +G++ A K    +     E +  RE K L  LN  P+IV  K  
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLK-- 64

Query: 64  DVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVH 123
           +V  E+++L      EY  G        R G    ES+I S   QILQGL ++H +   H
Sbjct: 65  EVFRENDEL--YFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFH 122

Query: 124 CDIKSRNILMAESGA-KIADFGCAKWESEALQSG-------GTPMFMAPEVA-RGEHQGF 174
            D+K  N+L++     KIADFG A+ E     S         T  + APE+  R      
Sbjct: 123 RDLKPENLLVSGPEVVKIADFGLAR-EIR---SRPPYTDYVSTRWYRAPEILLRSTSYSS 178

Query: 175 ASDIWAVGCTVIEMASG--------------------GAP----WPNAADPMTVLYKIAY 210
             DIWA+GC + E+ +                     G P    WP         YK+A 
Sbjct: 179 PVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEG-------YKLAS 231

Query: 211 S--RELPEVPAFLSKQ--------ANDFLSNCLRRDPKERWAASQLLKHPFL 252
                 P+       Q        A D + + LR DPK+R  ASQ L+HP+ 
Sbjct: 232 KLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  118 bits (299), Expect = 9e-31
 Identities = 85/304 (27%), Positives = 121/304 (39%), Gaps = 83/304 (27%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSE-----FLQREQKFLSSLNS---PHIVG- 59
           IG+G+  TV  A  L +G   A K   +P SE        RE   L  L S   P+IV  
Sbjct: 7   IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRL 66

Query: 60  YKGCDVTSEDNKLMYNLFMEY-------------APGGTLNDEIHRNGGRLDESLIVSYT 106
              C     D +L   L  E+              PG             L    I    
Sbjct: 67  LDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPG-------------LPPETIKDLM 113

Query: 107 RQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAK---WESEALQSGGTPM-- 160
           RQ+L+G+++LHS+R+VH D+K +NIL+   G  KIADFG A+   +E  AL    T +  
Sbjct: 114 RQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEM-AL----TSVVV 168

Query: 161 ---FMAPEVARGEHQGFASDIWAVGCTVIEMAS------G--------------GAP--- 194
              + APEV          D+W+VGC   E+        G              G P   
Sbjct: 169 TLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEE 228

Query: 195 -WPNAADPMTVLYKIAYSRELPE-----VPAFLSKQANDFLSNCLRRDPKERWAASQLLK 248
            WP        L + ++    P      VP  + ++  D L   L  +P +R +A + L+
Sbjct: 229 EWP----RNVSLPRSSFPSYTPRSFKSFVPE-ICEEGLDLLKKMLTFNPHKRISAFEALQ 283

Query: 249 HPFL 252
           HP+ 
Sbjct: 284 HPYF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  118 bits (297), Expect = 1e-30
 Identities = 83/288 (28%), Positives = 124/288 (43%), Gaps = 56/288 (19%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAK----STELPK-SEFLQREQKFLSSLNSPHIVGYKGC 63
           IG+GS   V    +  +G + A K    S + P   +   RE + L  L  P++V     
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLI-- 66

Query: 64  DVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVH 123
           +V     KL  +L  EY     LN E+ +N   + E LI     Q LQ + + H +  +H
Sbjct: 67  EVFRRKRKL--HLVFEYCDHTVLN-ELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIH 123

Query: 124 CDIKSRNILMAESGA-KIADFGCAKWESEALQSGG---------TPMFMAPEVARGEHQ- 172
            D+K  NIL+ + G  K+ DFG A+     + +G          T  + APE+  G+ Q 
Sbjct: 124 RDVKPENILITKQGQIKLCDFGFAR-----ILTGPGDDYTDYVATRWYRAPELLVGDTQY 178

Query: 173 GFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKI------------------------ 208
           G   D+WA+GC   E+ +G   WP  +D +  LY I                        
Sbjct: 179 GPPVDVWAIGCVFAELLTGQPLWPGKSD-VDQLYLIRKTLGDLIPRHQQIFSTNQFFKGL 237

Query: 209 ----AYSRE-LPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPF 251
                 +RE L      +S  A  FL  CL+ DP ER +  +LL+HP+
Sbjct: 238 SIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score =  118 bits (296), Expect = 2e-30
 Identities = 90/260 (34%), Positives = 128/260 (49%), Gaps = 30/260 (11%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSE 68
           IG+GS+  V +AT   SG + A K  +L K +  +RE  F    N   I+     D   E
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQ--RRELLF----NEVVIMR----DYQHE 77

Query: 69  DNKLMYNLF---------MEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN 119
           +   MYN +         ME+  GG L D +     R++E  I +    +L+ L  LH+ 
Sbjct: 78  NVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT--RMNEEQIAAVCLAVLKALSVLHAQ 135

Query: 120 RVVHCDIKSRNILMAESG-AKIADFG-CAKWESEALQSG---GTPMFMAPEVARGEHQGF 174
            V+H DIKS +IL+   G  K++DFG CA+   E  +     GTP +MAPE+      G 
Sbjct: 136 GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGP 195

Query: 175 ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAF--LSKQANDFLSNC 232
             DIW++G  VIEM  G  P+ N  +P     K+      P++     +S     FL   
Sbjct: 196 EVDIWSLGIMVIEMVDGEPPYFN--EPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRL 253

Query: 233 LRRDPKERWAASQLLKHPFL 252
           L RDP +R  A++LLKHPFL
Sbjct: 254 LVRDPAQRATAAELLKHPFL 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score =  116 bits (292), Expect = 6e-30
 Identities = 89/273 (32%), Positives = 137/273 (50%), Gaps = 29/273 (10%)

Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS--EFLQREQKFLSSL-NSPHIVG 59
           W    TIG+G+   V    + ++G   A K  +      E ++ E   L +L + P++V 
Sbjct: 20  WEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVK 79

Query: 60  YKGC----DVTSEDNKLMYNLFMEYAPGGTLNDEIH---RNGGRLDESLIVSYTRQILQG 112
           + G     DV + D      L +E   GG++ D +    + G R++E +I     + L G
Sbjct: 80  FYGMYYKKDVKNGDQLW---LVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMG 136

Query: 113 LEYLHSNRVVHCDIKSRNILM-AESGAKIADFGC-AKWESEALQ---SGGTPMFMAPEVA 167
           L++LH N+ +H D+K  NIL+  E G K+ DFG  A+  S  L+   S GTP +MAPEV 
Sbjct: 137 LQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVI 196

Query: 168 RGEHQGFAS-----DIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELP---EVPA 219
             E Q  ++     D+W++G T IE+  G  P  +   PM  L+KI   R  P     P 
Sbjct: 197 ACEQQLDSTYDARCDVWSLGITAIELGDGDPPLAD-LHPMRALFKI--PRNPPPTLHQPE 253

Query: 220 FLSKQANDFLSNCLRRDPKERWAASQLLKHPFL 252
             S + NDF+  CL +D ++R   S LL+H F+
Sbjct: 254 LWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score =  115 bits (289), Expect = 1e-29
 Identities = 94/259 (36%), Positives = 133/259 (51%), Gaps = 24/259 (9%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTEL-PKSEF--LQREQKFLSSLNSPHIVGYKGCDV 65
           +G G+   V  A +L +G++ A K  +L P  +F  +Q+E   +      +IV Y G  +
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76

Query: 66  TSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCD 125
           + E  KL   + MEY  GG+L D I+   G L E  I    R+ LQGL YLHS   +H D
Sbjct: 77  SRE--KLW--ICMEYCGGGSLQD-IYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRD 131

Query: 126 IKSRNILMAESG-AKIADFGCAKWESEALQSG----GTPMFMAPEVARGEHQGFAS---D 177
           IK  NIL+ ++G  K+ADFG A   +  +       GTP +MAPEVA  E  G  +   D
Sbjct: 132 IKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCD 191

Query: 178 IWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQA-----NDFLSNC 232
           IWAVG T IE+A    P  +   PM  L+ ++ S   P  P    K       ++F+   
Sbjct: 192 IWAVGITAIELAELQPPMFD-LHPMRALFLMSKSNFQP--PKLKDKTKWSSTFHNFVKIS 248

Query: 233 LRRDPKERWAASQLLKHPF 251
           L ++PK+R  A +LL H F
Sbjct: 249 LTKNPKKRPTAERLLTHLF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  115 bits (290), Expect = 1e-29
 Identities = 89/287 (31%), Positives = 132/287 (45%), Gaps = 54/287 (18%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKS-TELPKSEFLQ----REQKFLSSLNSPHIVGYKGC 63
           +G+GS   V       +G + A K   E    + ++    RE + L  L   ++V     
Sbjct: 9   VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNL--I 66

Query: 64  DVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVH 123
           +V     +L   L  E+    T+ D++ +    LDES +  Y  QIL+G+E+ HS+ ++H
Sbjct: 67  EVFRRKKRLY--LVFEFV-DHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIH 123

Query: 124 CDIKSRNILMAESG-AKIADFGCAKWESEALQSGG--------TPMFMAPEVARGEHQ-G 173
            DIK  NIL+++SG  K+ DFG A+     L + G        T  + APE+  G+ + G
Sbjct: 124 RDIKPENILVSQSGVVKLCDFGFAR----TLAAPGEVYTDYVATRWYRAPELLVGDTKYG 179

Query: 174 FASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA-------------YSRE------- 213
            A DIWAVGC V EM +G   +P  +D +  LY I              + +        
Sbjct: 180 RAVDIWAVGCLVTEMLTGEPLFPGDSD-IDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMR 238

Query: 214 LPEVP---------AFLSKQANDFLSNCLRRDPKERWAASQLLKHPF 251
           LPEV            LS    D    CLR DP +R ++SQLL H F
Sbjct: 239 LPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score =  115 bits (289), Expect = 2e-29
 Identities = 78/262 (29%), Positives = 136/262 (51%), Gaps = 24/262 (9%)

Query: 8   TIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQR----EQKFLSSLNSPHIVGYKGC 63
            +G G+  TV  A  L +  + A K   L  +  LQ+    E + L   +SP+I+G+ G 
Sbjct: 8   ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGA 67

Query: 64  DVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVH 123
                +N++  ++  E+  GG+L  +++R   ++ E ++      +++GL YL S +++H
Sbjct: 68  FFV--ENRI--SICTEFMDGGSL--DVYR---KIPEHVLGRIAVAVVKGLTYLWSLKILH 118

Query: 124 CDIKSRNILMAESG-AKIADFGCAKW--ESEALQSGGTPMFMAPEVARGEHQGFASDIWA 180
            D+K  N+L+   G  K+ DFG +     S A    GT  +MAPE   GE  G  SD+W+
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERISGEQYGIHSDVWS 178

Query: 181 VGCTVIEMASGGAPWPNAAD------PMTVLYKIAYSRELPEVP-AFLSKQANDFLSNCL 233
           +G + +E+A G  P+P          P+ +L  I    + P +P    S++   F++ C+
Sbjct: 179 LGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIV-DEDPPVLPVGQFSEKFVHFITQCM 237

Query: 234 RRDPKERWAASQLLKHPFLEEF 255
           R+ PKER A   L+ HPF+ ++
Sbjct: 238 RKQPKERPAPENLMDHPFIVQY 259

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score =  115 bits (288), Expect = 2e-29
 Identities = 89/264 (33%), Positives = 131/264 (49%), Gaps = 36/264 (13%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSE 68
           IG+GS+  V +AT   +G   A K  +L K +  +RE  F    N   I+     D   E
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQ--RRELLF----NEVVIMR----DYHHE 79

Query: 69  DNKLMYNLF---------MEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN 119
           +   MYN +         ME+  GG L D +     R++E  I +    +L+ L YLH+ 
Sbjct: 80  NVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHT--RMNEEQIATVCLSVLRALSYLHNQ 137

Query: 120 RVVHCDIKSRNILMAESG-AKIADFG-CAKWESEALQSG---GTPMFMAPEVARGEHQGF 174
            V+H DIKS +IL+   G  K++DFG CA+   E  +     GTP +MAPEV      G 
Sbjct: 138 GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGT 197

Query: 175 ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYS-----RELPEVPAFLSKQANDFL 229
             DIW++G  VIEM  G  P+ N   P+  + +I  +     ++  +V + L      FL
Sbjct: 198 EVDIWSLGIMVIEMIDGEPPYFNEP-PLQAMRRIRDNLPPRVKDSHKVSSVLRG----FL 252

Query: 230 SNCLRRDPKERWAASQLLKHPFLE 253
              L R+P +R  A +LL+HPFL+
Sbjct: 253 DLMLVREPSQRATAQELLQHPFLK 276

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score =  112 bits (282), Expect = 2e-28
 Identities = 77/264 (29%), Positives = 128/264 (48%), Gaps = 29/264 (10%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ----REQKFLSSLNSPHIVGYKGCD 64
           +G G+  +VS    + +G V A K   +     ++    RE + +    SP+IV + G  
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGA- 71

Query: 65  VTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHS-NRVVH 123
             +E+N  M    ME+   G+L D I++ GG +   ++      +++GL YL++ +R++H
Sbjct: 72  FLNENNICM---CMEFMDCGSL-DRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMH 127

Query: 124 CDIKSRNILMAESGA-KIADFGCAKWESEALQS-----GGTPMFMAPEVARGEHQGFASD 177
            DIK  NIL+   G  K+ DFG +    E + S      GT  +M+PE  +G      SD
Sbjct: 128 RDIKPSNILVNSRGQIKLCDFGVS---GELINSIADTFVGTSTYMSPERIQGGKYTVKSD 184

Query: 178 IWAVGCTVIEMASGGAPWPNA-------ADPMTVLYKIAY--SRELPEVPA-FLSKQAND 227
           +W++G ++IE+A G  P+  +        DPM +L  +        P +P+    +   D
Sbjct: 185 VWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRD 244

Query: 228 FLSNCLRRDPKERWAASQLLKHPF 251
           F+  CL +DP ER    QL   P 
Sbjct: 245 FVDACLLKDPTERPTPQQLCAMPP 268

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  113 bits (286), Expect = 2e-28
 Identities = 82/290 (28%), Positives = 121/290 (41%), Gaps = 56/290 (19%)

Query: 8   TIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQ--------KFLSSLNSPHIVG 59
            IG+G+   V L     +G V+A K   L KS+ ++R Q          L+  +SP IV 
Sbjct: 8   VIGRGAFGEVWLVRDKDTGQVYAMK--VLRKSDMIKRNQIAHVRAERDILADADSPWIVK 65

Query: 60  YKGCDVTSEDNKLMYNLFMEYAPGGTL-NDEIHRNGGRLDESLIVSYTRQILQGLEYLHS 118
                 + +D + +Y L MEY PGG L N  I +      E     Y  +++  L+ +H 
Sbjct: 66  LY---YSFQDEEHLY-LVMEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHK 119

Query: 119 NRVVHCDIKSRNILMAESG-AKIADFG-CAK--WESEALQSG------------------ 156
              +H DIK  NIL+   G  K+ADFG C K     +                       
Sbjct: 120 LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRD 179

Query: 157 ------------GTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTV 204
                       GTP ++APEV RG   G   D W++G  + EM  G  P+ +     T 
Sbjct: 180 HKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETY 239

Query: 205 LYKIAYSREL--PEVPAFLSKQANDFLSNCLRRDPKERW-AASQLLKHPF 251
              I +   L  P  P  +S +A D +   L  DP++R  +  ++  HPF
Sbjct: 240 NKIINWKESLRFPPDPP-VSPEAIDLICRLL-CDPEDRLGSFEEIKSHPF 287

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score =  111 bits (279), Expect = 2e-28
 Identities = 77/256 (30%), Positives = 132/256 (51%), Gaps = 18/256 (7%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPK-----SEFLQREQKFLSSLNSPHIVGYKGC 63
           IG+GS   + LA +    +    K  +L K      E  ++E   L+ +  P+IV +   
Sbjct: 8   IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFAS 67

Query: 64  DVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRL-DESLIVSYTRQILQGLEYLHSNRVV 122
               E+ +L   + MEY  GG L   I+R  G L  E  I+S+  QI  GL+++H  +++
Sbjct: 68  --FQENGRLF--IVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKIL 123

Query: 123 HCDIKSRNILMAESG--AKIADFGCAKWESEALQSG----GTPMFMAPEVARGEHQGFAS 176
           H DIKS+NI ++++G  AK+ DFG A+  +++++      GTP +++PE+ +       +
Sbjct: 124 HRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKT 183

Query: 177 DIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRD 236
           DIW++GC + E+ +   P+        VL KI      P  P F S+     +S   +  
Sbjct: 184 DIWSLGCVLYELCTLKHPFEGNNLHQLVL-KICQGYFAPISPNF-SRDLRSLISQLFKVS 241

Query: 237 PKERWAASQLLKHPFL 252
           P++R + + +LK PFL
Sbjct: 242 PRDRPSITSILKRPFL 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score =  113 bits (284), Expect = 2e-28
 Identities = 83/275 (30%), Positives = 125/275 (45%), Gaps = 54/275 (19%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQR--------EQKFLSSLNS---PHI 57
           +G+G    V LA   ++G+++A K+  L K + + R        E++   + NS   P +
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKA--LKKGDIIARDEVESLMCEKRIFETANSERHPFL 64

Query: 58  VGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLH 117
           V    C  T +    +    MEYA GG L   IH +     E   V Y   ++ GL+YLH
Sbjct: 65  VNLFACFQTEDH---VC-FVMEYAAGGDLMMHIHTD--VFSEPRAVFYAACVVLGLQYLH 118

Query: 118 SNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG-------GTPMFMAPEVARG 169
            N++V+ D+K  N+L+   G  KIADFG  K   E +  G       GTP F+APEV   
Sbjct: 119 ENKIVYRDLKLDNLLLDTEGFVKIADFGLCK---EGMGFGDRTSTFCGTPEFLAPEVLTE 175

Query: 170 EHQGFASDIWAVGCTVIEMASGGAPWP--------NAADPMTVLYKIAYSRELPEVPAFL 221
                A D W +G  + EM  G +P+P        ++     V Y           P FL
Sbjct: 176 TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRY-----------PRFL 224

Query: 222 SKQANDFLSNCLRRDPKERWAASQ-----LLKHPF 251
           S++A   +   LRR+P+ R  + +     + K PF
Sbjct: 225 SREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPF 259

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score =  109 bits (273), Expect = 2e-27
 Identities = 73/261 (27%), Positives = 130/261 (49%), Gaps = 17/261 (6%)

Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQ-----KFLSSLNSPHI 57
           + +   IG+GS     L  S   G  +  K   + K    +RE+       LS++  P+I
Sbjct: 2   YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNI 61

Query: 58  VGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRL-DESLIVSYTRQILQGLEYL 116
           V Y+    + E+N  +Y + M+Y  GG L  +I+   G L  E  I+ +  QI   L+++
Sbjct: 62  VQYQE---SFEENGNLY-IVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHV 117

Query: 117 HSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSG----GTPMFMAPEVARGEH 171
           H  +++H DIKS+NI + + G  K+ DFG A+  +  ++      GTP +++PE+     
Sbjct: 118 HDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRP 177

Query: 172 QGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSN 231
               SDIWA+GC + EM +    +  A +   ++ KI      P V +  S    + +S 
Sbjct: 178 YNNKSDIWALGCVLYEMCTLKHAF-EAGNMKNLVLKII-RGSYPPVSSHYSYDLRNLVSQ 235

Query: 232 CLRRDPKERWAASQLLKHPFL 252
             +R+P++R + + +L+  F+
Sbjct: 236 LFKRNPRDRPSVNSILEKNFI 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score =  109 bits (273), Expect = 2e-27
 Identities = 82/268 (30%), Positives = 131/268 (48%), Gaps = 33/268 (12%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELP--KSEFLQREQKFLSSLNS-PHIVGYKGCDV 65
           +G G+   V     +++G + A K  ++   + E +++E   L   +   +I  Y G  +
Sbjct: 14  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73

Query: 66  TSE----DNKLMYNLFMEYAPGGTLNDEI-HRNGGRLDESLIVSYTRQILQGLEYLHSNR 120
                  D++L   L ME+   G++ D I +  G  L E  I    R+IL+GL +LH ++
Sbjct: 74  KKNPPGMDDQLW--LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK 131

Query: 121 VVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG----GTPMFMAPEVARGEHQ--- 172
           V+H DIK +N+L+ E+   K+ DFG +      +       GTP +MAPEV   +     
Sbjct: 132 VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDA 191

Query: 173 --GFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPA------FLSKQ 224
              F SD+W++G T IEMA G  P  +   PM  L+ I      P  PA        SK+
Sbjct: 192 TYDFKSDLWSLGITAIEMAEGAPPLCD-MHPMRALFLI------PRNPAPRLKSKKWSKK 244

Query: 225 ANDFLSNCLRRDPKERWAASQLLKHPFL 252
              F+ +CL ++  +R    QL+KHPF+
Sbjct: 245 FQSFIESCLVKNHSQRPTTEQLMKHPFI 272

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score =  109 bits (273), Expect = 4e-27
 Identities = 68/202 (33%), Positives = 101/202 (50%), Gaps = 13/202 (6%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSLNSP 55
           D  R  T+G G+   V L     S   +A K   +P      + + +  E++ L  ++ P
Sbjct: 2   DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHP 61

Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
            I+       T  D + +Y L MEY PGG L   + RN GR   S  + Y  +I+  LEY
Sbjct: 62  FIIRLF---WTEHDQRFLYML-MEYVPGGELFSYL-RNSGRFSNSTGLFYASEIVCALEY 116

Query: 116 LHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQS-GGTPMFMAPEVARGEHQG 173
           LHS  +V+ D+K  NIL+ + G  K+ DFG AK   +   +  GTP ++APEV + +   
Sbjct: 117 LHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLCGTPEYLAPEVIQSKGHN 176

Query: 174 FASDIWAVGCTVIEMASGGAPW 195
            A D WA+G  + EM  G  P+
Sbjct: 177 KAVDWWALGILIYEMLVGYPPF 198

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score =  107 bits (270), Expect = 7e-27
 Identities = 77/262 (29%), Positives = 125/262 (47%), Gaps = 25/262 (9%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQR--------EQKFLSSLNSPHIVGY 60
           +G+G    V       +G ++A K  +L K    +R        E+K L  ++S  IV  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACK--KLDKKRLKKRKGEQMALNEKKILEKVSSRFIV-- 56

Query: 61  KGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGR-LDESLIVSYTRQILQGLEYLHSN 119
                 + + K    L M    GG L   I+  G     E+  + Y  QI+ GLE+LH  
Sbjct: 57  --SLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR 114

Query: 120 RVVHCDIKSRNILMAESG-AKIADFGCA---KWESEALQSGGTPMFMAPEVARGEHQGFA 175
           R+V+ D+K  N+L+ + G  +I+D G A   K   +     GTP +MAPEV +GE   F+
Sbjct: 115 RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFS 174

Query: 176 SDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELP-EVPAFLSKQANDFLSNCLR 234
            D +A+GCT+ EM +G +P+    + +        + E+  E P   S +A D     L+
Sbjct: 175 VDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQ 234

Query: 235 RDPKER-----WAASQLLKHPF 251
           +DP++R      +A ++ +HP 
Sbjct: 235 KDPEKRLGCRGGSADEVREHPL 256

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  107 bits (270), Expect = 8e-27
 Identities = 88/294 (29%), Positives = 133/294 (45%), Gaps = 69/294 (23%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTEL-------PKSEFLQREQKFLSSLNSPHIVGYK 61
           IG+G+   V  A +  +G+V A K   L       P +    RE   L  LN P+IV  K
Sbjct: 8   IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI--REISLLKELNHPNIV--K 63

Query: 62  GCDVTSEDNKLMYNLFMEYAPGGTLNDEIHR-----NGGRLDESLIVSYTRQILQGLEYL 116
             DV   +NKL   L  E+     L+ ++ +         +   LI SY  Q+LQGL + 
Sbjct: 64  LLDVIHTENKLY--LVFEF-----LHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFC 116

Query: 117 HSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSGGTPM-----------FMAP 164
           HS+RV+H D+K +N+L+   GA K+ADFG A+       + G P+           + AP
Sbjct: 117 HSHRVLHRDLKPQNLLINTEGAIKLADFGLAR-------AFGVPVRTYTHEVVTLWYRAP 169

Query: 165 EVARG-EHQGFASDIWAVGCTVIEMASGGAPWPNAAD-------------PMTVL----- 205
           E+  G ++   A DIW++GC   EM +  A +P  ++             P  V+     
Sbjct: 170 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 229

Query: 206 ----YKIAYSR----ELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPF 251
               YK ++ +    +  +V   L +   D LS  L  DP +R +A   L HPF
Sbjct: 230 SLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score =  107 bits (268), Expect = 9e-27
 Identities = 73/249 (29%), Positives = 126/249 (50%), Gaps = 16/249 (6%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKS----EFLQREQKFLSSLNSPHIVGYKGCD 64
           +G+GS     L   + S   +A K   LPKS    E  ++E   L+ +  P+IV +K   
Sbjct: 8   VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKE-- 65

Query: 65  VTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRL-DESLIVSYTRQILQGLEYLHSNRVVH 123
            + E +  +Y + MEY  GG L  +I    G+L  E  I+ +  Q+  G++++H  RV+H
Sbjct: 66  -SFEADGHLY-IVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLH 123

Query: 124 CDIKSRNILMAESG-AKIADFGCAKWESE----ALQSGGTPMFMAPEVARGEHQGFASDI 178
            DIKS+NI + ++G  K+ DFG A+  +     A    GTP ++ PE+         SDI
Sbjct: 124 RDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDI 183

Query: 179 WAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPK 238
           W++GC + E+ +   P+  A     ++ K+      P +P+  S +    +    +R+P+
Sbjct: 184 WSLGCILYELCTLKHPF-QANSWKNLILKVCQGSYKP-LPSHYSYELRSLIKQMFKRNPR 241

Query: 239 ERWAASQLL 247
            R +A+ +L
Sbjct: 242 SRPSATTIL 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  107 bits (268), Expect = 2e-26
 Identities = 67/202 (33%), Positives = 101/202 (50%), Gaps = 18/202 (8%)

Query: 9   IGQGSSATVSLATSLRSGD----VFAAK----STELPKSEFLQREQKFLSSLNSPHIVGY 60
           +G+G    V L      GD      A K    S E       +RE + L +L+  +IV Y
Sbjct: 12  LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71

Query: 61  KGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNR 120
           KG         L   L MEY P G+L D + R+  +++   ++ ++ QI +G++YL S R
Sbjct: 72  KGVCEKPGGRSLR--LIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR 129

Query: 121 VVHCDIKSRNILM-AESGAKIADFGCAKWESE------ALQSGGTPMF-MAPEVARGEHQ 172
            +H D+ +RNIL+ +E   KI+DFG AK   E        + G +P+F  APE  R    
Sbjct: 130 YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKF 189

Query: 173 GFASDIWAVGCTVIEMASGGAP 194
             ASD+W+ G T+ E+ + G P
Sbjct: 190 SSASDVWSFGVTLYELFTYGDP 211

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score =  107 bits (267), Expect = 2e-26
 Identities = 85/270 (31%), Positives = 132/270 (48%), Gaps = 37/270 (13%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLN-----SPH--IVGYK 61
           +G G+   V     +++G + A K  ++ + E    E++    +N     S H  I  Y 
Sbjct: 24  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE----EEEIKLEINMLKKYSHHRNIATYY 79

Query: 62  GCDVTS----EDNKLMYNLFMEYAPGGTLNDEIHRN-GGRLDESLIVSYTRQILQGLEYL 116
           G  +       D++L   L ME+   G++ D +    G  L E  I    R+IL+GL +L
Sbjct: 80  GAFIKKSPPGHDDQLW--LVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHL 137

Query: 117 HSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG----GTPMFMAPEVARGEH 171
           H+++V+H DIK +N+L+ E+   K+ DFG +      +       GTP +MAPEV   + 
Sbjct: 138 HAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDE 197

Query: 172 Q-----GFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQAN 226
                  + SDIW++G T IEMA G  P  +   PM  L+ I   R  P  P   SK+ +
Sbjct: 198 NPDATYDYRSDIWSLGITAIEMAEGAPPLCD-MHPMRALFLI--PRNPP--PKLKSKKWS 252

Query: 227 ----DFLSNCLRRDPKERWAASQLLKHPFL 252
               DF+  CL ++   R +  QLLKHPF+
Sbjct: 253 KKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score =  106 bits (265), Expect = 3e-26
 Identities = 75/261 (28%), Positives = 131/261 (50%), Gaps = 25/261 (9%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKST------ELPKSEFLQ--REQKFLSSLNSPHIVGY 60
           +G+GS  TV L    ++      K        EL  +E +Q  +E + LS L+ P IV +
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67

Query: 61  KGCDVTSEDNKLMYNLFMEYAPGGTLND---EIHRNGGRLDESLIVSYTRQILQGLEYLH 117
               +  +     + +  EY  G  L+    E+   G  L E+ +  +  Q+L G+ Y+H
Sbjct: 68  HASFLERDA----FCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH 123

Query: 118 SNRVVHCDIKSRNILMAESGAKIADFGCAKWE----SEALQSGGTPMFMAPEVARGEHQG 173
             R++H D+K++NI +  +  KI DFG ++        A    GTP +M+PE  +  HQG
Sbjct: 124 QRRILHRDLKAKNIFLKNNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALK--HQG 181

Query: 174 F--ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSN 231
           +   SDIW++GC + EM      +    + ++V+ +I      P +P   S+Q N  + +
Sbjct: 182 YDSKSDIWSLGCILYEMCCLAHAF-EGQNFLSVVLRIVEG-PTPSLPETYSRQLNSIMQS 239

Query: 232 CLRRDPKERWAASQLLKHPFL 252
            L +DP  R +A+++L++PF+
Sbjct: 240 MLNKDPSLRPSAAEILRNPFI 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score =  106 bits (266), Expect = 3e-26
 Identities = 78/263 (29%), Positives = 128/263 (48%), Gaps = 25/263 (9%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKST--ELPKSEFLQ--REQKFLSSLNSPHIVGYKGCD 64
           +G+G+  +V       +G   A K    EL +S+F Q   E   L    SP+IV + G  
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGA- 67

Query: 65  VTSEDNKLMYNLFMEYAPGGTLNDEIHRNG---GRLDESLIVSYTRQILQGLEYL-HSNR 120
              E    M    MEY   G+L D+++  G     + E ++   T  +++GL++L   + 
Sbjct: 68  FFIEGAVYM---CMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN 123

Query: 121 VVHCDIKSRNILMAESG-AKIADFGCAK--WESEALQSGGTPMFMAPEVARGEHQGFA-- 175
           ++H D+K  N+L+  +G  K+ DFG +     S A  + G   +MAPE  +         
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKSGGPNQNPT 183

Query: 176 ----SDIWAVGCTVIEMASGGAPWP--NAADPMTVLYKIAYSRELPEVPAFLSKQANDFL 229
               SD+W++G +++EMA G  P+P    A+    L  I    + P +P+  S  A DF+
Sbjct: 184 YTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDG-DPPTLPSGYSDDAQDFV 242

Query: 230 SNCLRRDPKERWAASQLLKHPFL 252
           + CL + P  R   +QLL+HP+L
Sbjct: 243 AKCLNKIPNRRPTYAQLLEHPWL 265

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  105 bits (265), Expect = 4e-26
 Identities = 93/301 (30%), Positives = 130/301 (43%), Gaps = 81/301 (26%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTEL-------PKSEFLQREQKFLSSLNSPHIVGYK 61
           IG+G+   V  A    +G++ A K   L       P +    RE   L  LN P+IV   
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAI--REISLLKELNHPNIVRLL 64

Query: 62  GCDVTSEDNKLMYNLFMEYAPGGTLN-------DEIHRNGGRLDESLIVSYTRQILQGLE 114
             DV   +NKL Y +F E+     L+       D     G  LD  LI SY  Q+LQG+ 
Sbjct: 65  --DVVHSENKL-YLVF-EF-----LDLDLKKYMDSSPLTG--LDPPLIKSYLYQLLQGIA 113

Query: 115 YLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSGGTPM-----------FM 162
           Y HS+RV+H D+K +N+L+   GA K+ADFG A+       + G P+           + 
Sbjct: 114 YCHSHRVLHRDLKPQNLLIDREGALKLADFGLAR-------AFGVPVRTYTHEVVTLWYR 166

Query: 163 APEVARGEHQ-GFASDIWAVGCTVIEMASG--------------------GAP----WPN 197
           APE+  G  Q     DIW++GC   EM +                     G P    WP 
Sbjct: 167 APEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPG 226

Query: 198 AADPMTVL--YKIAY----SRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPF 251
                T L  YK  +     ++L +V   L +   D LS  L  DP +R +A   L+HP+
Sbjct: 227 V----TSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPY 282

Query: 252 L 252
            
Sbjct: 283 F 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  105 bits (264), Expect = 1e-25
 Identities = 89/310 (28%), Positives = 125/310 (40%), Gaps = 66/310 (21%)

Query: 1   MDWTRGHTIGQGSSATVSLATSLRSGDVFAAK----STELPKSEF---LQREQKFLSSLN 53
            D+     +G+G+   V  A  +++G V A K      E  K  F     RE K L  L 
Sbjct: 8   RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNE--KDGFPITALREIKILKKLK 65

Query: 54  SPHIV-----GYKGCDVTSEDNKLMYNLF--MEYAPGGTL-NDEIHRNGGRLDESLIVSY 105
            P++V       +  D +      +Y +   M++   G L N  +      L ES I  Y
Sbjct: 66  HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK-----LTESQIKCY 120

Query: 106 TRQILQGLEYLHSNRVVHCDIKSRNILMAESGA-KIADFGCAK-WESEALQSGG------ 157
             Q+L+G+ YLH N ++H DIK+ NIL+   G  KIADFG A+ ++       G      
Sbjct: 121 MLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGT 180

Query: 158 ---TPM-----FMAPEVARGEHQ-GFASDIWAVGCTVIEMASG----------------- 191
              T +     +  PE+  GE +   A DIW +GC   EM +                  
Sbjct: 181 RKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240

Query: 192 ---GAP----WPNAAD-P--MTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERW 241
              G P    WP     P    V     Y R L E    L  +  D LS  L  DP +R 
Sbjct: 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRL 300

Query: 242 AASQLLKHPF 251
            AS  L+HP+
Sbjct: 301 TASDALEHPY 310

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  104 bits (260), Expect = 2e-25
 Identities = 83/288 (28%), Positives = 128/288 (44%), Gaps = 57/288 (19%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ----REQKFLSSLNSPHIVGYKGCD 64
           +G+G+ ATV    +  +G++ A K   L   E       RE   +  L   +IV     D
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLH--D 65

Query: 65  VTSEDNKLMYNLFMEYAPGGTLND-----EIHRNGGRLDESLIVSYTRQILQGLEYLHSN 119
           V   +NKLM  L  EY       D     + H   G LD + + S+T Q+L+G+ + H N
Sbjct: 66  VIHTENKLM--LVFEYMD----KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN 119

Query: 120 RVVHCDIKSRNILMAESGA-KIADFGCA--------KWESEALQSGGTPMFMAPEVARGE 170
           RV+H D+K +N+L+ + G  K+ADFG A         + +E +    T  + AP+V  G 
Sbjct: 120 RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV----TLWYRAPDVLLGS 175

Query: 171 HQGFAS-DIWAVGCTVIEMASGGAPWP--NAADPMTVLYKI----------------AYS 211
                S DIW+VGC + EM +G   +P  N  D +  +++I                 Y 
Sbjct: 176 RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK 235

Query: 212 RELPEVPAFLSKQ--------ANDFLSNCLRRDPKERWAASQLLKHPF 251
              P  P    +Q          D L   L+ +P+ R +A   L+HP+
Sbjct: 236 PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPW 283

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  104 bits (263), Expect = 2e-25
 Identities = 91/338 (26%), Positives = 131/338 (38%), Gaps = 66/338 (19%)

Query: 7   HTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ-----REQKFLSSLNSPHIVGYK 61
             IG G+   V  A   R+G   A K       + +      RE K L  L   +I+G  
Sbjct: 6   KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLL 65

Query: 62  GCDV----TSEDNKLMYNLFMEYAPGGT-LNDEIHRNGGRLDESLIVSYTRQILQGLEYL 116
             D+    + ED   +Y +  E     T L+  I ++   L +  I  +  QIL+GL+YL
Sbjct: 66  --DILRPPSPEDFNDVY-IVTELME--TDLHKVI-KSPQPLTDDHIQYFLYQILRGLKYL 119

Query: 117 HSNRVVHCDIKSRNILM-AESGAKIADFGCAKWESEALQSGGTPMFM----------APE 165
           HS  V+H D+K  NIL+ +    KI DFG A+             F+          APE
Sbjct: 120 HSANVIHRDLKPSNILVNSNCDLKICDFGLAR---GVDPDEDEKGFLTEYVVTRWYRAPE 176

Query: 166 VARGEHQ-GFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKI---------------- 208
           +     +   A DIW+VGC   E+ +    +P   D +  L  I                
Sbjct: 177 LLLSSSRYTKAIDIWSVGCIFAELLTRKPLFP-GRDYIDQLNLIVEVLGTPSEEDLKFIT 235

Query: 209 -----AYSRELPEVPA--------FLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
                 Y + LP+ P           S +A D L   L  DPK+R  A + L HP+L + 
Sbjct: 236 SEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL 295

Query: 256 CSCTKQIQESNCSPTSILDQGIWNSVEETEESLGNLIH 293
                   E         D   ++  E TEE L  LI+
Sbjct: 296 -----HDPEDEPVAKPPFDFDFFDDDELTEEELKELIY 328

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score =  104 bits (261), Expect = 3e-25
 Identities = 81/271 (29%), Positives = 135/271 (49%), Gaps = 37/271 (13%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAK--STELPKSE----FLQREQK-FLSSLNSPHIVGYK 61
           IG+GS A V L    ++  ++A K    EL   +    ++Q E+  F ++ N P +VG  
Sbjct: 3   IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62

Query: 62  GCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRV 121
            C  T  +++L +   +E+  GG L   + R   +L E     Y+ +I   L +LH   +
Sbjct: 63  SCFQT--ESRLFF--VIEFVSGGDLMFHMQRQR-KLPEEHARFYSAEISLALNFLHERGI 117

Query: 122 VHCDIKSRNILM-AESGAKIADFGCAKWESEALQSG-------GTPMFMAPEVARGEHQG 173
           ++ D+K  N+L+ AE   K+ D+G  K   E ++ G       GTP ++APE+ RGE  G
Sbjct: 118 IYRDLKLDNVLLDAEGHIKLTDYGMCK---EGIRPGDTTSTFCGTPNYIAPEILRGEDYG 174

Query: 174 FASDIWAVGCTVIEMASGGAPW-----PNAADPMT--VLYKIAYSRELPEVPAFLSKQAN 226
           F+ D WA+G  + EM +G +P+      +  D  T   L+++   +++  +P  LS +A+
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI-RIPRSLSVKAS 233

Query: 227 DFLSNCLRRDPKERWAA------SQLLKHPF 251
             L   L +DPKER           +  HPF
Sbjct: 234 SVLKGFLNKDPKERLGCHPQTGFRDIKSHPF 264

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score =  103 bits (258), Expect = 5e-25
 Identities = 63/175 (36%), Positives = 91/175 (52%), Gaps = 13/175 (7%)

Query: 25  SGDVFAAKSTELPKSEFL---QREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYA 81
           +G+V A K  +   +E L   +RE + L SL   +IV YKG  V     +    L MEY 
Sbjct: 32  TGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKG--VCYSAGRRNLRLVMEYL 89

Query: 82  PGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMA-ESGAKI 140
           P G+L D + ++  RLD   ++ Y  QI +G+EYL S R VH D+ +RNIL+  E+  KI
Sbjct: 90  PYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKI 149

Query: 141 ADFG------CAKWESEALQSGGTPMF-MAPEVARGEHQGFASDIWAVGCTVIEM 188
            DFG        K   +  + G +P+F  APE         ASD+W+ G  + E+
Sbjct: 150 GDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score =  101 bits (254), Expect = 3e-24
 Identities = 64/188 (34%), Positives = 99/188 (52%), Gaps = 12/188 (6%)

Query: 75  NLF--MEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNIL 132
           +LF  MEY  GG L   I ++ GR DE+    Y  +I+ GL++LH   +++ D+K  N+L
Sbjct: 70  HLFFVMEYLNGGDLMFHI-QSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVL 128

Query: 133 MAESG-AKIADFGCAKW----ESEALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIE 187
           + + G  KIADFG  K     E +A    GTP ++APE+ +G+    + D W+ G  + E
Sbjct: 129 LDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYE 188

Query: 188 MASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWA-ASQL 246
           M  G +P+ +  D   +   I    + P  P ++SK+A D LS    RDP +R      +
Sbjct: 189 MLIGQSPF-HGEDEDELFDSILN--DRPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDI 245

Query: 247 LKHPFLEE 254
            +HPF   
Sbjct: 246 RQHPFFRG 253

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score =  100 bits (252), Expect = 3e-24
 Identities = 57/177 (32%), Positives = 98/177 (55%), Gaps = 15/177 (8%)

Query: 90  IHRNGGRLDESLIVSYTRQILQGLEYLHSN-RVVHCDIKSRNILMAESG-AKIADFGCAK 147
           ++  G  + E ++      I++ LEYLHS   V+H D+K  N+L+  +G  K+ DFG + 
Sbjct: 93  VYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISG 152

Query: 148 WESEAL----QSGGTPMFMAPEVARGE--HQGF--ASDIWAVGCTVIEMASGGAPWPNAA 199
           +  +++     +G  P +MAPE    E   +G+   SD+W++G T+IE+A+G  P+ +  
Sbjct: 153 YLVDSVAKTIDAGCKP-YMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWK 211

Query: 200 DPMTVLYKIAY--SRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEE 254
            P   L ++    S +LP      S +  DF++ CL+++ KER    +LL+HPF E 
Sbjct: 212 TPFQQLKQVVEEPSPQLPAEK--FSPEFQDFVNKCLKKNYKERPNYPELLQHPFFEL 266

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score =  102 bits (254), Expect = 3e-24
 Identities = 83/272 (30%), Positives = 135/272 (49%), Gaps = 37/272 (13%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAK--STELPKSE----FLQREQK-FLSSLNSPHIVGYK 61
           IG+GS A V L    ++  ++A K    EL   +    ++Q E+  F  + N P +VG  
Sbjct: 3   IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62

Query: 62  GCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRV 121
            C  T  +++L +   +EY  GG L   + R   +L E     Y+ +I   L YLH   +
Sbjct: 63  SCFQT--ESRLFF--VIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLHERGI 117

Query: 122 VHCDIKSRNILM-AESGAKIADFGCAKWESEALQSG-------GTPMFMAPEVARGEHQG 173
           ++ D+K  N+L+ +E   K+ D+G  K   E L+ G       GTP ++APE+ RGE  G
Sbjct: 118 IYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPGDTTSTFCGTPNYIAPEILRGEDYG 174

Query: 174 FASDIWAVGCTVIEMASGGAPW-----PNAADPMT--VLYKIAYSRELPEVPAFLSKQAN 226
           F+ D WA+G  + EM +G +P+      +  D  T   L+++   +++  +P  LS +A 
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-RIPRSLSVKAA 233

Query: 227 DFLSNCLRRDPKERWAA------SQLLKHPFL 252
             L + L +DPKER         + +  HPF 
Sbjct: 234 SVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 265

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score =  101 bits (253), Expect = 4e-24
 Identities = 82/251 (32%), Positives = 125/251 (49%), Gaps = 27/251 (10%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAK--STELPKSE----FLQREQK-FLSSLNSPHIVGYK 61
           IG+GS A V L    ++  ++A K    EL   +    ++Q E+  F  + ++P +VG  
Sbjct: 3   IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62

Query: 62  GCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRV 121
            C  T+  ++L   L +EY  GG L   + R   +L E     Y  +I   L +LH   +
Sbjct: 63  SCFQTT--SRLF--LVIEYVNGGDLMFHMQRQR-KLPEEHARFYAAEICIALNFLHERGI 117

Query: 122 VHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG-------GTPMFMAPEVARGEHQG 173
           ++ D+K  N+L+   G  K+ D+G  K   E L  G       GTP ++APE+ RGE  G
Sbjct: 118 IYRDLKLDNVLLDADGHIKLTDYGMCK---EGLGPGDTTSTFCGTPNYIAPEILRGEEYG 174

Query: 174 FASDIWAVGCTVIEMASGGAPW---PNAADPMTVLYKIAYSRELP-EVPAFLSKQANDFL 229
           F+ D WA+G  + EM +G +P+    +  D  T  Y      E P  +P FLS +A+  L
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVL 234

Query: 230 SNCLRRDPKER 240
              L +DPKER
Sbjct: 235 KGFLNKDPKER 245

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score =  101 bits (253), Expect = 4e-24
 Identities = 78/268 (29%), Positives = 120/268 (44%), Gaps = 28/268 (10%)

Query: 8   TIGQGSSATVSLATSLRSGDVFA----AKSTELPKSE--FLQREQKFLSSLNSPHIVGYK 61
            +G+G    V +     +GD++A     KS  L +    F + E+  LS  NSP I   +
Sbjct: 8   LVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQ 67

Query: 62  GCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRV 121
                 +D   +Y L MEY PGG L   ++R   + DE +   Y  +++  +  +H    
Sbjct: 68  ---YAFQDKDNLY-LVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGY 123

Query: 122 VHCDIKSRNILMAESG-AKIADFG-CAKWESE----ALQSGGTPMFMAPEV-------AR 168
           VH DIK  N+L+  +G  K+ADFG  A+  +     +    GTP ++APEV        +
Sbjct: 124 VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGK 183

Query: 169 GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSREL--PEVPAFLSKQAN 226
           G + G   D W++G    EM  G +P+       T    + + R L  PE P  +S    
Sbjct: 184 GTY-GVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPK-VSSDFL 241

Query: 227 DFLSNCLRRDPKERWAASQLLKHPFLEE 254
           D + + L    KER     L  HPF  +
Sbjct: 242 DLIQSLL-CGQKERLGYEGLCCHPFFSK 268

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score =  101 bits (252), Expect = 6e-24
 Identities = 72/250 (28%), Positives = 114/250 (45%), Gaps = 22/250 (8%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ--------REQKFLSSLN 53
           D+  G T+G GS   V +A    +G+ +A K   L K E L+        +E+  L  L+
Sbjct: 19  DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKC--LKKREILKMKQVQHVAQEKSILMELS 76

Query: 54  SPHIVG-YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQG 112
            P IV          +D   +Y   +E+  GG L   + R  GR    +   Y  +++  
Sbjct: 77  HPFIVNMMCS----FQDENRVY-FLLEFVVGGELFTHL-RKAGRFPNDVAKFYHAELVLA 130

Query: 113 LEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE-ALQSGGTPMFMAPEVARGE 170
            EYLHS  +++ D+K  N+L+   G  K+ DFG AK   +      GTP ++APEV + +
Sbjct: 131 FEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLCGTPEYLAPEVIQSK 190

Query: 171 HQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLS 230
             G A D W +G  + E  +G  P+ +   P  +  KI   R     P +   +A D + 
Sbjct: 191 GHGKAVDWWTMGVLLYEFIAGYPPFFDDT-PFRIYEKILAGRLK--FPNWFDGRARDLVK 247

Query: 231 NCLRRDPKER 240
             L+ D  +R
Sbjct: 248 GLLQTDHTKR 257

Length = 329

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 99.8 bits (249), Expect = 8e-24
 Identities = 77/287 (26%), Positives = 129/287 (44%), Gaps = 55/287 (19%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTEL-------PKSEFLQREQKFLSSLNSPHIVGYK 61
           IG+G+  TV  A +  + ++ A K   L       P S    RE   L  L   +IV  +
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL--REICLLKELKHKNIV--R 63

Query: 62  GCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRV 121
             DV   D KL   L  EY     L        G +D  ++ S+  Q+L+GL + HS+ V
Sbjct: 64  LYDVLHSDKKLT--LVFEYC-DQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNV 120

Query: 122 VHCDIKSRNILMAESGA-KIADFGCAK--------WESEALQSGGTPMFMAPEVARGEHQ 172
           +H D+K +N+L+ ++G  K+ADFG A+        + +E +    T  +  P+V  G   
Sbjct: 121 LHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV----TLWYRPPDVLFGAKL 176

Query: 173 GFAS-DIWAVGCTVIEMASGGAP-WP--NAADPMTVLYKIAYS---------RELPEVPA 219
              S D+W+ GC   E+A+ G P +P  +  D +  ++++  +          +LP+   
Sbjct: 177 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKP 236

Query: 220 F---------------LSKQANDFLSNCLRRDPKERWAASQLLKHPF 251
           +               L+    D L N L  +P +R +A + L+HP+
Sbjct: 237 YPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 99.8 bits (249), Expect = 9e-24
 Identities = 78/264 (29%), Positives = 121/264 (45%), Gaps = 30/264 (11%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAK-----STELPKSEFLQREQKFLSSLNSPHIVGYKGC 63
           IG G+   V      ++G V A K       +      L      L S + P+IV   G 
Sbjct: 23  IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGY 82

Query: 64  DVTSEDNKLMYNLFMEYAPGGTLNDEI-HRNGGRLDESLIVSYTRQILQGLEYLHSNR-V 121
            +T  D  +     ME     T  D++  R  G + E ++   T  I++ L YL     V
Sbjct: 83  FITDSDVFIC----MELM--STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGV 136

Query: 122 VHCDIKSRNILMAESG-AKIADFGCAKW--ESEA-LQSGGTPMFMAPEVARGEHQGFA-- 175
           +H D+K  NIL+  SG  K+ DFG +    +S+A  +S G   +MAPE  R +       
Sbjct: 137 IHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPE--RIDPPDPNPK 194

Query: 176 ----SDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVP---AFLSKQANDF 228
               +D+W++G +++E+A+G  P+ N      VL KI    E P +P    F S     F
Sbjct: 195 YDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKIL-QEEPPSLPPNEGF-SPDFCSF 252

Query: 229 LSNCLRRDPKERWAASQLLKHPFL 252
           +  CL +D ++R    +LL+HPF+
Sbjct: 253 VDLCLTKDHRKRPKYRELLQHPFI 276

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score =  100 bits (250), Expect = 9e-24
 Identities = 81/269 (30%), Positives = 129/269 (47%), Gaps = 36/269 (13%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQR--------EQKFLS-SLNSPHIVG 59
           +G+GS   V LA    SG ++A K   L K   LQ         E++ LS + N P +  
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKV--LKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60

Query: 60  YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN 119
              C  T +  +L +   ME+  GG L   I ++  R DE+    Y  +I   L +LH  
Sbjct: 61  LYCCFQTPD--RLFF--VMEFVNGGDLMFHIQKSR-RFDEARARFYAAEITSALMFLHDK 115

Query: 120 RVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG-------GTPMFMAPEVARGEH 171
            +++ D+K  N+L+   G  K+ADFG  K   E + +G       GTP ++APE+ +   
Sbjct: 116 GIIYRDLKLDNVLLDHEGHCKLADFGMCK---EGIFNGKTTSTFCGTPDYIAPEILQEML 172

Query: 172 QGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSN 231
            G + D WA+G  + EM  G AP+   A+    L++   + E+   P +LS+ A D L  
Sbjct: 173 YGPSVDWWAMGVLLYEMLCGHAPF--EAENEDDLFEAILNDEVV-YPTWLSQDAVDILKA 229

Query: 232 CLRRDPKERWAA------SQLLKHPFLEE 254
            + ++P  R  +        +L+HPF +E
Sbjct: 230 FMTKNPTMRLGSLTLGGEEAILRHPFFKE 258

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 98.2 bits (244), Expect = 2e-23
 Identities = 77/250 (30%), Positives = 121/250 (48%), Gaps = 25/250 (10%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKST---ELPKSEFLQ---REQKFLSSLNSPHIVGYKG 62
           IG+G  + V  AT L      A K     E+  ++  Q   +E   L  LN P+++ Y  
Sbjct: 10  IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKY-- 67

Query: 63  CDVTSEDNKLMYNLFMEYAPGGTLNDEIH--RNGGRL-DESLIVSYTRQILQGLEYLHSN 119
            D   EDN+L  N+ +E A  G L+  I   +   RL  E  +  Y  Q+   +E++HS 
Sbjct: 68  LDSFIEDNEL--NIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR 125

Query: 120 RVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG----GTPMFMAPEVARGEHQGF 174
           RV+H DIK  N+ +  +G  K+ D G  ++ S    +     GTP +M+PE        F
Sbjct: 126 RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNF 185

Query: 175 ASDIWAVGCTVIEMASGGAPWPNAADPMTVL---YKIAYSRELPEVPA-FLSKQANDFLS 230
            SDIW++GC + EMA+  +P+    D M +     KI    + P +P    S++  + +S
Sbjct: 186 KSDIWSLGCLLYEMAALQSPF--YGDKMNLFSLCQKIEQC-DYPPLPTEHYSEKLRELVS 242

Query: 231 NCLRRDPKER 240
            C+  DP +R
Sbjct: 243 MCIYPDPDQR 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 97.8 bits (243), Expect = 3e-23
 Identities = 73/248 (29%), Positives = 122/248 (49%), Gaps = 21/248 (8%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTEL-------PKSEFLQREQKFLSSLNSPHIVGYK 61
           IG+G  + V  AT L  G   A K  ++        +++ + +E   L  LN P+++ Y 
Sbjct: 10  IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCI-KEIDLLKQLNHPNVIKYY 68

Query: 62  GCDVTSEDNKLMYNLFMEYAPGGTLNDEIH--RNGGRL-DESLIVSYTRQILQGLEYLHS 118
              +  EDN+L  N+ +E A  G L+  I   +   RL  E  +  Y  Q+   LE++HS
Sbjct: 69  ASFI--EDNEL--NIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS 124

Query: 119 NRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSG----GTPMFMAPEVARGEHQG 173
            RV+H DIK  N+ +  +G  K+ D G  ++ S    +     GTP +M+PE        
Sbjct: 125 RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYN 184

Query: 174 FASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPA-FLSKQANDFLSNC 232
           F SDIW++GC + EMA+  +P+      +  L K     + P +P+   S++    ++ C
Sbjct: 185 FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMC 244

Query: 233 LRRDPKER 240
           +  DP++R
Sbjct: 245 INPDPEKR 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 98.6 bits (245), Expect = 5e-23
 Identities = 77/304 (25%), Positives = 140/304 (46%), Gaps = 56/304 (18%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ----REQKFLSSLNSPHI 57
           D+ +   +G G+   V   +   SG + A K   L     ++    RE + L   NSP+I
Sbjct: 6   DFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 65

Query: 58  VGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL- 116
           VG+ G   +  +     ++ ME+  GG+L D++ +  GR+ E ++   +  +++GL YL 
Sbjct: 66  VGFYGAFYSDGE----ISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLR 120

Query: 117 HSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSG--GTPMFMAPEVARGEHQG 173
             ++++H D+K  NIL+   G  K+ DFG +    +++ +   GT  +M+PE  +G H  
Sbjct: 121 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYS 180

Query: 174 FASDIWAVGCTVIEMASGGAPWP------------------------------------- 196
             SDIW++G +++EMA G  P P                                     
Sbjct: 181 VQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSS 240

Query: 197 ---NAADPMTVLYKIAY--SRELPEVPA-FLSKQANDFLSNCLRRDPKERWAASQLLKHP 250
              ++  PM +   + Y  +   P++P+     +  DF++ CL ++P ER    QL+ H 
Sbjct: 241 YGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHA 300

Query: 251 FLEE 254
           F++ 
Sbjct: 301 FIKR 304

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 96.9 bits (241), Expect = 8e-23
 Identities = 61/196 (31%), Positives = 98/196 (50%), Gaps = 20/196 (10%)

Query: 9   IGQGSSATVSL----ATSLRSGDVFAAKSTELPKSEFLQ----REQKFLSSLNSPHIVGY 60
           +G+G    VSL      +  +G++ A K+ +    +       +E   L +L   +IV Y
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 61  KGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNR 120
           KGC   SE       L MEY P G+L D + ++   L + L+  + +QI +G+ YLHS  
Sbjct: 72  KGC--CSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLL--FAQQICEGMAYLHSQH 127

Query: 121 VVHCDIKSRNILMA-ESGAKIADFGCAKWESEA------LQSGGTPMF-MAPEVARGEHQ 172
            +H D+ +RN+L+  +   KI DFG AK   E        + G +P+F  A E  +    
Sbjct: 128 YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKF 187

Query: 173 GFASDIWAVGCTVIEM 188
            +ASD+W+ G T+ E+
Sbjct: 188 SYASDVWSFGVTLYEL 203

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 96.0 bits (239), Expect = 2e-22
 Identities = 79/288 (27%), Positives = 116/288 (40%), Gaps = 44/288 (15%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSE-----FLQREQKFLSSLN-SPHIVGYKG 62
           IG+G+   V  A    +G + A K T L   E        RE   L  L+ S +IV    
Sbjct: 9   IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLD 68

Query: 63  CDVTSEDN-KLMYNLFMEYAPGGTLNDEIHRNGGR----LDESLIVSYTRQILQGLEYLH 117
            +   E N K    L  EY     L   +  NG      L    I S+  Q+L+G+ + H
Sbjct: 69  VEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH 127

Query: 118 SNRVVHCDIKSRNILMAESGA--KIADFGCAKWESEALQSGG----TPMFMAPEVARG-E 170
            + V+H D+K +N+L+ +     KIAD G  +  S  ++S      T  + APEV  G  
Sbjct: 128 KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGST 187

Query: 171 HQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAY-----SRELPEVPAF----- 220
           H     DIW+VGC   EM+     +P  ++   +L+          +  P V        
Sbjct: 188 HYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHE 247

Query: 221 ---------------LSKQANDFLSNCLRRDPKERWAASQLLKHPFLE 253
                          LS +  D L   LR DP +R +A   L HP+ +
Sbjct: 248 FPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 94.4 bits (235), Expect = 5e-22
 Identities = 84/306 (27%), Positives = 131/306 (42%), Gaps = 76/306 (24%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSE-----FLQREQKFLSSLNSPH 56
           D+T+   IG+G+   V    + ++G + A K   L   E        RE   L  L  P+
Sbjct: 1   DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60

Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHR------NGGRLDESLIVSYTRQIL 110
           IV  +  DV  ++++L   L  E+     L+ ++ +       G  +D  L+ SY  QIL
Sbjct: 61  IVCLQ--DVLMQESRLY--LIFEF-----LSMDLKKYLDSLPKGQYMDAELVKSYLYQIL 111

Query: 111 QGLEYLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSGGTPM--------- 160
           QG+ + HS RV+H D+K +N+L+   G  K+ADFG A+       + G P+         
Sbjct: 112 QGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLAR-------AFGIPVRVYTHEVVT 164

Query: 161 --FMAPEVARGEHQGFAS--DIWAVGCTVIEMASG--------------------GAP-- 194
             + APEV  G    +++  DIW++G    EMA+                     G P  
Sbjct: 165 LWYRAPEVLLGS-PRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTE 223

Query: 195 --WPNAADPMTVL--YKIAYSR----ELPEVPAFLSKQANDFLSNCLRRDPKERWAASQL 246
             WP     +T L  YK  + +     L      L +   D L   L  DP +R +A + 
Sbjct: 224 DVWPG----VTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKA 279

Query: 247 LKHPFL 252
           L HP+ 
Sbjct: 280 LNHPYF 285

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 95.0 bits (236), Expect = 6e-22
 Identities = 75/261 (28%), Positives = 125/261 (47%), Gaps = 27/261 (10%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKS--------EFLQREQKFLSSLNSPHIVGY 60
           +G+GS   V LA     G+ FA K+  L K         E    E++ L+       + +
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKA--LKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60

Query: 61  KGCDVTSEDNKLMYNLF--MEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHS 118
             C   ++++     LF  ME+  GG L   I ++ GR D      Y  +I+ GL++LHS
Sbjct: 61  LYCTFQTKEH-----LFFVMEFLNGGDLMFHI-QDKGRFDLYRATFYAAEIVCGLQFLHS 114

Query: 119 NRVVHCDIKSRNILMAESG-AKIADFGCAK----WESEALQSGGTPMFMAPEVARGEHQG 173
             +++ D+K  N+++   G  KIADFG  K     ++ A    GTP ++APE+ +G    
Sbjct: 115 KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYT 174

Query: 174 FASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCL 233
           F+ D W+ G  + EM  G +P+    D    L++ +   + P  P +++K++ D L    
Sbjct: 175 FSVDWWSFGVLLYEMLIGQSPF--HGDDEDELFE-SIRVDTPHYPRWITKESKDILEKLF 231

Query: 234 RRDPKERWAASQLLK-HPFLE 253
            RDP  R      ++ HPF +
Sbjct: 232 ERDPTRRLGVVGNIRGHPFFK 252

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 95.3 bits (237), Expect = 6e-22
 Identities = 81/271 (29%), Positives = 128/271 (47%), Gaps = 39/271 (14%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQR--------EQKFLS-SLNSPHIVG 59
           +G+GS   V LA    + +V+A K   L K   LQ         E++ L+ +   P +  
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKV--LKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60

Query: 60  YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN 119
              C  T +  +L +   MEY  GG L  +I R   + DE     Y  ++   L +LH +
Sbjct: 61  LHCCFQTKD--RLFF--VMEYVNGGDLMFQIQR-SRKFDEPRSRFYAAEVTLALMFLHRH 115

Query: 120 RVVHCDIKSRNILM-AESGAKIADFGCAKWESEALQSG-------GTPMFMAPEVARGEH 171
            V++ D+K  NIL+ AE   K+ADFG  K   E + +G       GTP ++APE+ +   
Sbjct: 116 GVIYRDLKLDNILLDAEGHCKLADFGMCK---EGILNGVTTTTFCGTPDYIAPEILQELE 172

Query: 172 QGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYK-IAYSRELPEVPAFLSKQANDFLS 230
            G + D WA+G  + EM +G  P+   AD    L++ I +   L   P +LSK+A   L 
Sbjct: 173 YGPSVDWWALGVLMYEMMAGQPPF--EADNEDDLFESILHDDVL--YPVWLSKEAVSILK 228

Query: 231 NCLRRDPKERWAA-------SQLLKHPFLEE 254
             + ++P +R            + +HPF +E
Sbjct: 229 AFMTKNPNKRLGCVASQGGEDAIKQHPFFKE 259

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 95.0 bits (236), Expect = 6e-22
 Identities = 76/260 (29%), Positives = 121/260 (46%), Gaps = 23/260 (8%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQRE-------QKFLSSLNSPH-IVGY 60
           +G+GS   V LA    +   FA K+  L K   L  +       +K + SL   H  + +
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKA--LKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 61  KGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNR 120
             C   +++N       MEY  GG L   I ++  + D      Y  +I+ GL++LHS  
Sbjct: 61  LYCTFQTKENLF---FVMEYLNGGDLMFHI-QSCHKFDLPRATFYAAEIICGLQFLHSKG 116

Query: 121 VVHCDIKSRNILMAESG-AKIADFGCAK----WESEALQSGGTPMFMAPEVARGEHQGFA 175
           +V+ D+K  NIL+   G  KIADFG  K     +++     GTP ++APE+  G+    +
Sbjct: 117 IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTS 176

Query: 176 SDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRR 235
            D W+ G  + EM  G +P+ +  D   +   I      P  P +L+++A D L     R
Sbjct: 177 VDWWSFGVLLYEMLIGQSPF-HGHDEEELFQSIRMDN--PCYPRWLTREAKDILVKLFVR 233

Query: 236 DPKERWAA-SQLLKHPFLEE 254
           +P+ R      + +HPF  E
Sbjct: 234 EPERRLGVKGDIRQHPFFRE 253

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 93.7 bits (233), Expect = 2e-21
 Identities = 77/264 (29%), Positives = 118/264 (44%), Gaps = 34/264 (12%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQR--------EQKFLSSLNSPHIVGY 60
           +G+G+   V L     +G  +A K   L K   + +        E + L +   P +   
Sbjct: 3   LGKGTFGKVILVREKATGKYYAMKI--LKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60

Query: 61  KGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNR 120
           K    T +  +L +   MEYA GG L   + R      E     Y  +I+  L YLHS  
Sbjct: 61  KYSFQTHD--RLCF--VMEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALGYLHSCD 115

Query: 121 VVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG-------GTPMFMAPEVARGEHQ 172
           VV+ D+K  N+++ + G  KI DFG  K   E +  G       GTP ++APEV      
Sbjct: 116 VVYRDLKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLAPEVLEDNDY 172

Query: 173 GFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNC 232
           G A D W +G  + EM  G  P+ N       L+++    E+   P  LS +A   L+  
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLPFYN--QDHEKLFELILMEEI-RFPRTLSPEAKSLLAGL 229

Query: 233 LRRDPKERWA-----ASQLLKHPF 251
           L++DPK+R       A ++++H F
Sbjct: 230 LKKDPKQRLGGGPEDAKEIMEHRF 253

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 93.0 bits (231), Expect = 2e-21
 Identities = 78/271 (28%), Positives = 118/271 (43%), Gaps = 34/271 (12%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQR--------EQKFLSSLNSPHIVGY 60
           +G+G    VS      +G ++A K  +L K    +R        E++ L+ ++S  IV  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACK--KLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSL 58

Query: 61  KGCDVTSEDNKLMYNLFMEYAPGGTLNDEIH----RNGGRLDESLIVSYTRQILQGLEYL 116
                T  D      L M    GG L   I+     N G   E     YT QI+ GLE+L
Sbjct: 59  AYAFQTKTD----LCLVMTIMNGGDLRYHIYNVDEENPG-FPEPRACFYTAQIISGLEHL 113

Query: 117 HSNRVVHCDIKSRNILMAESG-AKIADFGCA----KWESEALQSGGTPMFMAPEVARGEH 171
           H  R+++ D+K  N+L+   G  +I+D G A      +S+     GTP FMAPE+ +GE 
Sbjct: 114 HQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEE 173

Query: 172 QGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPE---VPAFLSKQANDF 228
             F+ D +A+G T+ EM +   P+    +   V  K    R L +    P   S  +  F
Sbjct: 174 YDFSVDYFALGVTLYEMIAARGPFRARGE--KVENKELKQRILNDSVTYPDKFSPASKSF 231

Query: 229 LSNCLRRDPKERWA-----ASQLLKHPFLEE 254
               L +DP++R          L  HP   +
Sbjct: 232 CEALLAKDPEKRLGFRDGNCDGLRTHPLFRD 262

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 93.2 bits (232), Expect = 3e-21
 Identities = 79/325 (24%), Positives = 125/325 (38%), Gaps = 77/325 (23%)

Query: 9   IGQGSS--ATVSLATSLRSGDVFAAKSTELPKSE-----FLQREQKFLSSLNSPHIVGYK 61
           IG+       V LA    +  + A K   L          LQ+E      L  P+I+ Y 
Sbjct: 6   IGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYV 65

Query: 62  GCDVTSEDNKLMYNL--FMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN 119
              +   D++L Y +   M Y     L       G  L E  I    + +L  L+Y+HS 
Sbjct: 66  TSFI--VDSEL-YVVSPLMAYGSCEDLLKTHFPEG--LPELAIAFILKDVLNALDYIHSK 120

Query: 120 RVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSGG---TPMF------------MA 163
             +H  +K+ +IL++  G   ++        S ++   G     +             ++
Sbjct: 121 GFIHRSVKASHILLSGDGKVVLSGLR----YSVSMIKHGKRQRVVHDFPKSSVKNLPWLS 176

Query: 164 PEVARGEHQGF--ASDIWAVGCTVIEMASGGAPW-----------------PNAADPMTV 204
           PEV +   QG+   SDI++VG T  E+A+G  P+                 P   D  T 
Sbjct: 177 PEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTY 236

Query: 205 L------------YKIAYSRELPEVPA--FLSKQANDFLSNCLRRDPKERWAASQLLKHP 250
                         +   +R+  + P     S+  + F+  CL+RDP+ R +ASQLL H 
Sbjct: 237 PLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHS 296

Query: 251 FLEEFCSCTKQIQESNCSPTSILDQ 275
           F        KQ +  N   TS+LD 
Sbjct: 297 FF-------KQCKRRN---TSLLDL 311

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 93.2 bits (232), Expect = 4e-21
 Identities = 77/269 (28%), Positives = 119/269 (44%), Gaps = 38/269 (14%)

Query: 9   IGQGSSATVSLATSLRSGDVFA----AKSTELPKSEFLQ--REQKFLSSLNSPHIVGYKG 62
           +GQG    V LA    +G++ A     KS     +E      E+  L++  S  +V    
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLV---- 64

Query: 63  CDVTSEDNKLMYN--------LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLE 114
                   KL+Y         L MEY PGG     ++ N G L E     Y  ++ + ++
Sbjct: 65  --------KLLYAFQDDEYLYLAMEYVPGGDFRTLLN-NLGVLSEDHARFYMAEMFEAVD 115

Query: 115 YLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG-GTPMFMAPEVARGEHQ 172
            LH    +H D+K  N L+  SG  K+ DFG +K       S  G+P +MAPEV RG+  
Sbjct: 116 ALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVVGSPDYMAPEVLRGKGY 175

Query: 173 GFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVP------AFLSKQAN 226
            F  D W++GC + E   G  P+ + + P      + Y +E  + P        LS +A 
Sbjct: 176 DFTVDYWSLGCMLYEFLCGFPPF-SGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAW 234

Query: 227 DFLSNCLRRDPKERWAA-SQLLKHPFLEE 254
           D ++  +  DP  R+ +   +  HPF +E
Sbjct: 235 DLITKLI-NDPSRRFGSLEDIKNHPFFKE 262

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 91.8 bits (229), Expect = 4e-21
 Identities = 54/185 (29%), Positives = 94/185 (50%), Gaps = 13/185 (7%)

Query: 76  LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAE 135
           L M+Y   G L D + + G +L E+ +    RQ+++ L  LH + ++H DIK  N+L   
Sbjct: 86  LIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDR 144

Query: 136 SGAKI--ADFGCAKWE-SEALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGG 192
           +  +I   D+G  K   + +    GT  + +PE  +G +   + D WAVG    E+ +G 
Sbjct: 145 AKDRIYLCDYGLCKIIGTPSCYD-GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGK 203

Query: 193 APWPNAAD----PMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAA-SQLL 247
            P+    D      ++L +    ++LP     +SK ANDF+ + L+ +   R    ++++
Sbjct: 204 HPFKEDEDEELDLESLLKR--QQKKLP-FIKNVSKNANDFVQSMLKYNINYRLTNYNEII 260

Query: 248 KHPFL 252
           KHPFL
Sbjct: 261 KHPFL 265

Length = 267

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 90.7 bits (225), Expect = 1e-20
 Identities = 74/262 (28%), Positives = 113/262 (43%), Gaps = 25/262 (9%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQR--------EQKFLSSLNSPHIVGY 60
           +G+G    V       +G ++A K  +L K    +R        E++ L  +NS  +V  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACK--KLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 65

Query: 61  KGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNG-GRLDESLIVSYTRQILQGLEYLHSN 119
                 + + K    L +    GG L   I+  G    DE   V Y  +I  GLE LH  
Sbjct: 66  ----AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE 121

Query: 120 RVVHCDIKSRNILMAESG-AKIADFGCAKW--ESEALQSG-GTPMFMAPEVARGEHQGFA 175
           R+V+ D+K  NIL+ + G  +I+D G A    E E ++   GT  +MAPEV + E   F+
Sbjct: 122 RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTFS 181

Query: 176 SDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEV-PAFLSKQANDFLSNCLR 234
            D W +GC + EM  G +P+    + +         +E  E      S+ A       L 
Sbjct: 182 PDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLLT 241

Query: 235 RDPKERW-----AASQLLKHPF 251
           +DP  R       A ++  HPF
Sbjct: 242 KDPGFRLGCRGEGAEEVKAHPF 263

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 91.1 bits (226), Expect = 2e-20
 Identities = 78/292 (26%), Positives = 119/292 (40%), Gaps = 44/292 (15%)

Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP-KSEFLQ----REQKFLSSLNSPHI 57
           +T    +G G+  +V  A   R+G+  A K    P +SE       RE   L  +   ++
Sbjct: 17  YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENV 76

Query: 58  VGYKGCDVTSEDNKLMYN--LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
           +G      ++       +  L M Y       D     G  L E  +     Q+L GL+Y
Sbjct: 77  IGLLDVFTSAVSGDEFQDFYLVMPY----MQTDLQKIMGHPLSEDKVQYLVYQMLCGLKY 132

Query: 116 LHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSGG--TPMFMAPEVARG-EH 171
           +HS  ++H D+K  N+ + E    KI DFG A+  ++A  +G   T  + APEV     H
Sbjct: 133 IHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR-HADAEMTGYVVTRWYRAPEVILNWMH 191

Query: 172 QGFASDIWAVGCTVIEMASG--------------------GAPWPNAADPMTVLYKIAYS 211
                DIW+VGC + EM +G                    G P P     +      +Y 
Sbjct: 192 YNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYI 251

Query: 212 RELPEVP--------AFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
           + LP+ P           S QA D L   L  D  +R  A++ L+HP+ + F
Sbjct: 252 KSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 92.6 bits (230), Expect = 2e-20
 Identities = 76/302 (25%), Positives = 141/302 (46%), Gaps = 27/302 (8%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELP--KSEFLQREQ---------KFLSSLNSPHI 57
           +G G++ TV  A  +  G+ FA K  ++         R Q          F S +     
Sbjct: 40  LGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHED 99

Query: 58  VGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTR----QILQGL 113
              K  D  + +N LM  L ++YA  G L  EI ++  + + +           Q+L  +
Sbjct: 100 FAKK--DPRNPENVLMIALVLDYANAGDLRQEI-KSRAKTNRTFREHEAGLLFIQVLLAV 156

Query: 114 EYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG------GTPMFMAPEV 166
            ++HS  ++H DIKS NIL+  +G  K+ DFG +K  +  +         GTP ++APE+
Sbjct: 157 HHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEI 216

Query: 167 ARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQAN 226
            R +     +D++++G  + E+ +   P+ +  +   V++K    R  P +P  +S +  
Sbjct: 217 WRRKPYSKKADMFSLGVLLYELLTLKRPF-DGENMEEVMHKTLAGRYDP-LPPSISPEMQ 274

Query: 227 DFLSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSILDQGIWNSVEETEE 286
           + ++  L  DPK R ++S+LL  P  + F S   +I ++    +  L   I   +++T++
Sbjct: 275 EIVTALLSSDPKRRPSSSKLLNMPICKLFISGLLEIVQTQPGFSGPLRDTISRQIQQTKQ 334

Query: 287 SL 288
            L
Sbjct: 335 LL 336

Length = 496

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 89.7 bits (223), Expect = 4e-20
 Identities = 84/295 (28%), Positives = 125/295 (42%), Gaps = 59/295 (20%)

Query: 7   HTIGQGSSATVSLATSLRSGDVFAAKSTE-------LPKSEFLQREQKFLSSLNSPHIVG 59
           + IG+G+   V  A    SG++ A K          +P S    RE   L +L  P+IV 
Sbjct: 13  NRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSL--REITLLLNLRHPNIVE 70

Query: 60  YKGCDVTSEDNKLMYNLFMEYAPG--GTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLH 117
            K   V    + +   L MEY      +L D +        ES +     Q+L+GL+YLH
Sbjct: 71  LKEVVVGKHLDSIF--LVMEYCEQDLASLLDNMPTP---FSESQVKCLMLQLLRGLQYLH 125

Query: 118 SNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSGGTPM--------FMAPEVAR 168
            N ++H D+K  N+L+ + G  KIADFG A+           PM        + APE+  
Sbjct: 126 ENFIIHRDLKVSNLLLTDKGCLKIADFGLAR----TYGLPAKPMTPKVVTLWYRAPELLL 181

Query: 169 G-EHQGFASDIWAVGCTVIEMASG--------------------GAP----WPNAAD-PM 202
           G      A D+WAVGC + E+ +                     G P    WP  +D P+
Sbjct: 182 GCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPL 241

Query: 203 T---VLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEE 254
                L K  Y+    + P +LS+     L+  L  DPK+R  A + L+  + +E
Sbjct: 242 VGKFTLPKQPYNNLKHKFP-WLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKE 295

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 88.2 bits (219), Expect = 7e-20
 Identities = 73/256 (28%), Positives = 108/256 (42%), Gaps = 37/256 (14%)

Query: 9   IGQGSSATVSLATSLRS-GDVF--AAK--STELPK---SEFLQREQKFLSSLNSPHIVGY 60
           +G GS   V       S G V   A K   ++       +FL +E   + SL+  +++  
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFL-KEAAIMHSLDHENLIRL 61

Query: 61  KGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNG-GRLDESLIVSYTRQILQGLEYLHSN 119
            G  +T     LM  +  E AP G+L D + ++  G    S +  Y  QI  G+ YL S 
Sbjct: 62  YGVVLTH---PLM--MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK 116

Query: 120 RVVHCDIKSRNILMA-ESGAKIADFGCAKWESEALQSGG----------TPM-FMAPEVA 167
           R +H D+ +RNIL+A +   KI DFG       AL               P  + APE  
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGL----MRALPQNEDHYVMEEHLKVPFAWCAPESL 172

Query: 168 RGEHQGFASDIWAVGCTVIEMAS-GGAPWP--NAADPMTVLYKIAYSRELPEVPAFLSKQ 224
           R      ASD+W  G T+ EM + G  PW   + +    +L KI    E  E P    + 
Sbjct: 173 RTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ---ILKKIDKEGERLERPEACPQD 229

Query: 225 ANDFLSNCLRRDPKER 240
             + +  C   +P +R
Sbjct: 230 IYNVMLQCWAHNPADR 245

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 89.3 bits (221), Expect = 8e-20
 Identities = 79/263 (30%), Positives = 118/263 (44%), Gaps = 30/263 (11%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAK----STELPKSEFLQR--EQKFLSSLNSPHIVGYKG 62
           +G+G+   V L     +G  +A K       + K E      E + L +   P +   K 
Sbjct: 3   LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62

Query: 63  CDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
              T +  +L +   MEYA GG L   + R      E     Y  +I+  LEYLHS  VV
Sbjct: 63  AFQTHD--RLCF--VMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRDVV 117

Query: 123 HCDIKSRNILMAESG-AKIADFGCAKWESEALQSG-------GTPMFMAPEVARGEHQGF 174
           + DIK  N+++ + G  KI DFG  K   E +  G       GTP ++APEV      G 
Sbjct: 118 YRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLAPEVLEDNDYGR 174

Query: 175 ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLR 234
           A D W +G  + EM  G  P+ N       L+++    E+   P  LS +A   L+  L+
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPFYNQDHER--LFELILMEEI-RFPRTLSPEAKSLLAGLLK 231

Query: 235 RDPKERWA-----ASQLLKHPFL 252
           +DPK+R       A ++++H F 
Sbjct: 232 KDPKQRLGGGPSDAKEVMEHRFF 254

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 88.5 bits (219), Expect = 8e-20
 Identities = 74/266 (27%), Positives = 117/266 (43%), Gaps = 25/266 (9%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQR--------EQKFLSSLNSPHIVGY 60
           +G+G    V       +G ++A K  E  K    +R        E++ L  +NS  +V  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLE--KKRIKKRKGESMALNEKQILEKVNSRFVVSL 65

Query: 61  KGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNG-GRLDESLIVSYTRQILQGLEYLHSN 119
                 + + K    L +    GG L   I+  G    +E   V Y  +I  GLE LH  
Sbjct: 66  ----AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE 121

Query: 120 RVVHCDIKSRNILMAESG-AKIADFGCAKW--ESEALQSG-GTPMFMAPEVARGEHQGFA 175
           R+V+ D+K  NIL+ + G  +I+D G A    E + ++   GT  +MAPEV + E   F+
Sbjct: 122 RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFS 181

Query: 176 SDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELP-EVPAFLSKQANDFLSNCLR 234
            D WA+GC + EM +G +P+      +         +E+  E     S  A       L 
Sbjct: 182 PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLLC 241

Query: 235 RDPKERW-----AASQLLKHPFLEEF 255
           +DPKER       A ++ +HP  ++ 
Sbjct: 242 KDPKERLGCQGGGAREVKEHPLFKQI 267

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 89.3 bits (221), Expect = 9e-20
 Identities = 61/203 (30%), Positives = 107/203 (52%), Gaps = 13/203 (6%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ----REQKFLSSLNSPHI 57
           D+ R   +G G+   V+      SG + A K   L     ++    RE + L   NSP+I
Sbjct: 6   DFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 65

Query: 58  VGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL- 116
           VG+ G   +  +     ++ ME+  GG+L D++ +   R+ E ++   +  +L+GL YL 
Sbjct: 66  VGFYGAFYSDGE----ISICMEHMDGGSL-DQVLKEAKRIPEEILGKVSIAVLRGLAYLR 120

Query: 117 HSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSG--GTPMFMAPEVARGEHQG 173
             ++++H D+K  NIL+   G  K+ DFG +    +++ +   GT  +M+PE  +G H  
Sbjct: 121 EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYS 180

Query: 174 FASDIWAVGCTVIEMASGGAPWP 196
             SDIW++G +++E+A G  P P
Sbjct: 181 VQSDIWSMGLSLVELAIGRYPIP 203

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 87.9 bits (218), Expect = 1e-19
 Identities = 62/201 (30%), Positives = 99/201 (49%), Gaps = 19/201 (9%)

Query: 69  DNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKS 128
           D KL  +L ++Y  GG L   +++      ES +  Y  +I+  L++LH   +++ DIK 
Sbjct: 77  DTKL--HLILDYVNGGELFTHLYQRE-HFTESEVRVYIAEIVLALDHLHQLGIIYRDIKL 133

Query: 129 RNILMAESG-AKIADFGCAKW-----ESEALQSGGTPMFMAPEVARGEHQGF--ASDIWA 180
            NIL+   G   + DFG +K      E  A    GT  +MAPEV RG   G   A D W+
Sbjct: 134 ENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWS 193

Query: 181 VGCTVIEMASGGAPWPNAADPMT---VLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDP 237
           +G    E+ +G +P+    +  +   +  +I  S+  P  P  +S +A DF+   L +DP
Sbjct: 194 LGVLTFELLTGASPFTVDGEQNSQSEISRRILKSK--PPFPKTMSAEARDFIQKLLEKDP 251

Query: 238 KERWA---ASQLLKHPFLEEF 255
           K+R     A ++  HPF +  
Sbjct: 252 KKRLGANGADEIKNHPFFQGI 272

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 88.9 bits (220), Expect = 1e-19
 Identities = 73/260 (28%), Positives = 118/260 (45%), Gaps = 24/260 (9%)

Query: 8   TIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQ--------KFLSSLNSPHIVG 59
           T+G GS   V LAT  ++ D          KS+ ++++Q        K L+ +N P  V 
Sbjct: 37  TLGTGSFGRVILAT-YKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVN 95

Query: 60  YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN 119
             G   + +D   +Y L +E+  GG     + RN  R    +   Y  QI+   EYL S 
Sbjct: 96  LYG---SFKDESYLY-LVLEFVIGGEFFTFLRRNK-RFPNDVGCFYAAQIVLIFEYLQSL 150

Query: 120 RVVHCDIKSRNILMAESG-AKIADFGCAKW-ESEALQSGGTPMFMAPEVARGEHQGFASD 177
            +V+ D+K  N+L+ + G  K+ DFG AK  ++      GTP ++APE+      G A+D
Sbjct: 151 NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLCGTPEYIAPEILLNVGHGKAAD 210

Query: 178 IWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDP 237
            W +G  + E+  G  P+  A +P+ +  KI     +   P FL       +   L  D 
Sbjct: 211 WWTLGIFIYEILVGCPPF-YANEPLLIYQKIL--EGIIYFPKFLDNNCKHLMKKLLSHDL 267

Query: 238 KERW-----AASQLLKHPFL 252
            +R+      A  + +HP+ 
Sbjct: 268 TKRYGNLKKGAQNVKEHPWF 287

Length = 340

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 87.9 bits (218), Expect = 1e-19
 Identities = 86/298 (28%), Positives = 126/298 (42%), Gaps = 64/298 (21%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTEL--PKSEF---LQREQKFLSSLNSPHIVGYKGC 63
           IG+G+   V  A    +G++ A K   L   K  F     RE K L  LN  +IV     
Sbjct: 15  IGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNL--K 72

Query: 64  DVTSED--------NKLMYNLFMEYAPGGTLNDEIHRNGGRLDESL-------IVSYTRQ 108
           ++ ++         +K  + L  EY          H   G L+  L       I S+ +Q
Sbjct: 73  EIVTDKQDALDFKKDKGAFYLVFEYMD--------HDLMGLLESGLVHFSEDHIKSFMKQ 124

Query: 109 ILQGLEYLHSNRVVHCDIKSRNILMAESGA-KIADFGCAK-WESEALQSGG----TPMFM 162
           +L+GL Y H    +H DIK  NIL+   G  K+ADFG A+ + SE  +       T  + 
Sbjct: 125 LLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYR 184

Query: 163 APEVARGEHQ-GFASDIWAVGCTVIEMASG--------------------GAP----WPN 197
            PE+  GE + G A D+W+ GC + E+ +                     G+P    WP+
Sbjct: 185 PPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPD 244

Query: 198 AAD-PM--TVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFL 252
               P   T+  K  Y R L E  +F+   A D L + L  DP +R  A + L  P+L
Sbjct: 245 VIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 88.2 bits (218), Expect = 2e-19
 Identities = 78/264 (29%), Positives = 121/264 (45%), Gaps = 31/264 (11%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTE----LPKSEFLQR--EQKFLSSLNSPHIVGYKG 62
           +G+G+   V L     +G  +A K  +    + K E      E + L +   P +   K 
Sbjct: 3   LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62

Query: 63  CDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNR-V 121
              T +  +L +   MEYA GG L   + R      E     Y  +I+  L+YLHS + V
Sbjct: 63  SFQTHD--RLCF--VMEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLHSEKNV 117

Query: 122 VHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG-------GTPMFMAPEVARGEHQG 173
           V+ D+K  N+++ + G  KI DFG  K   E ++ G       GTP ++APEV      G
Sbjct: 118 VYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKTFCGTPEYLAPEVLEDNDYG 174

Query: 174 FASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCL 233
            A D W +G  + EM  G  P+ N       L+++    E+   P  LS +A   LS  L
Sbjct: 175 RAVDWWGLGVVMYEMMCGRLPFYNQDHEK--LFELILMEEI-RFPRTLSPEAKSLLSGLL 231

Query: 234 RRDPKERWA-----ASQLLKHPFL 252
           ++DPK+R       A ++++H F 
Sbjct: 232 KKDPKQRLGGGPDDAKEIMQHKFF 255

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 88.2 bits (219), Expect = 2e-19
 Identities = 83/301 (27%), Positives = 121/301 (40%), Gaps = 65/301 (21%)

Query: 8   TIGQGSSATVSLATSLRSGDVFAAK-----STELPKSEFLQREQKFLSSLNSPHIVGYKG 62
            IG G+   V  A   RSG   A K           ++   RE K L      +I+  + 
Sbjct: 12  NIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIR- 70

Query: 63  CDVTSEDNKLMYNLF-----MEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLH 117
            D+         +++     ME      L+  IH +   L E  I  +  Q+L+GL+Y+H
Sbjct: 71  -DILRPPGADFKDVYVVMDLME----SDLHHIIHSDQP-LTEEHIRYFLYQLLRGLKYIH 124

Query: 118 SNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSGGT--PMFM----------AP 164
           S  V+H D+K  N+L+ E    +I DFG A+     L S  T    FM          AP
Sbjct: 125 SANVIHRDLKPSNLLVNEDCELRIGDFGMAR----GLSSSPTEHKYFMTEYVATRWYRAP 180

Query: 165 EV--ARGEHQGFASDIWAVGCTVIEMASGGAPWPNA--------------ADPMTVLYKI 208
           E+  +  E+   A D+W+VGC   EM      +P                +    VL +I
Sbjct: 181 ELLLSLPEYTT-AIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRI 239

Query: 209 ------AYSRELPEVPAF--------LSKQANDFLSNCLRRDPKERWAASQLLKHPFLEE 254
                  Y + LP              S +A D LS  L+ DP+ER    Q L+HPFL +
Sbjct: 240 GSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQ 299

Query: 255 F 255
           +
Sbjct: 300 Y 300

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 87.8 bits (218), Expect = 2e-19
 Identities = 90/335 (26%), Positives = 138/335 (41%), Gaps = 65/335 (19%)

Query: 9   IGQGSSATVSLATSLRSGD---VFAAKSTELPKSEFLQ----REQKFLSSL-NSPHIVGY 60
           +GQG+   V  A +  + +   V   K T +   + L     RE K L       +I   
Sbjct: 8   LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCL 67

Query: 61  KGCDVTSED--NKL-MYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLH 117
              D+      N+L +Y   ME      L+ +I R+G  L ++   S+  QIL GL+Y+H
Sbjct: 68  YDMDIVFPGNFNELYLYEELMEA----DLH-QIIRSGQPLTDAHFQSFIYQILCGLKYIH 122

Query: 118 SNRVVHCDIKSRNILM-AESGAKIADFGCAKWESE-ALQSGG-------TPMFMAPEVAR 168
           S  V+H D+K  N+L+ A+   KI DFG A+  SE   ++ G       T  + APE+  
Sbjct: 123 SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIML 182

Query: 169 GEHQGF--ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKI------------------ 208
              Q +  A D+W+VGC + E+  G  P     D +  L +I                  
Sbjct: 183 -SFQSYTKAIDVWSVGCILAELL-GRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSP 240

Query: 209 ---AYSRELPEVPA--------FLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCS 257
               Y R LP +P           +  A D L   L  DP +R +  + L+HP+L  +  
Sbjct: 241 KAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW-- 298

Query: 258 CTKQIQESNCSPTSILDQGIWNSVEETEESLGNLI 292
                 E  C      D       E++ E L ++I
Sbjct: 299 -HDPDDEPVCQ--KPFD--FSFESEDSMEELRDMI 328

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 87.7 bits (218), Expect = 2e-19
 Identities = 84/293 (28%), Positives = 128/293 (43%), Gaps = 60/293 (20%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQR--------EQKFLSSLNSPHIVG- 59
           +G+G    V L     +G +FA K  +  K E ++R        EQ+ L++L+ P +   
Sbjct: 9   LGKGDVGRVFLVRLKGTGKLFALKVLD--KKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66

Query: 60  YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHR-NGGRLDESLIVSYTRQILQGLEYLHS 118
           Y      +E       L M+Y PGG L   + R  G  L E +   Y  ++L  LEYLH 
Sbjct: 67  Y--ASFQTETY---LCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHL 121

Query: 119 NRVVHCDIKSRNILMAESG-AKIADFGCAK-------WESEALQSG-------------- 156
             +V+ D+K  NIL+ ESG   ++DF  +K         S+AL+ G              
Sbjct: 122 LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETF 181

Query: 157 ------------GTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTV 204
                       GT  ++APEV  G+  G A D W +G  + EM  G  P+  +    T 
Sbjct: 182 SEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET- 240

Query: 205 LYKIAYSREL--PEVPAFLSKQANDFLSNCLRRDPKERWA----ASQLLKHPF 251
              I   +E+  P  P  +S  A D +   L +DP +R      A+++ +HPF
Sbjct: 241 FSNI-LKKEVTFPGSPP-VSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPF 291

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 86.6 bits (214), Expect = 3e-19
 Identities = 73/265 (27%), Positives = 116/265 (43%), Gaps = 29/265 (10%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQR--------EQKFLSSLNSPHIVGY 60
           +G+G    V       +G ++A K  E  K    +R        E++ L  +NS  +V  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKRLE--KKRIKKRKGESMALNEKQILEKVNSQFVVNL 65

Query: 61  KGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGR-LDESLIVSYTRQILQGLEYLHSN 119
                 + + K    L +    GG L   I+  G    +E   + Y  +IL GLE LH  
Sbjct: 66  ----AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE 121

Query: 120 RVVHCDIKSRNILMAESG-AKIADFGCAKW--ESEALQSG-GTPMFMAPEVARGEHQGFA 175
             V+ D+K  NIL+ + G  +I+D G A    E E+++   GT  +MAPEV   +    +
Sbjct: 122 NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLS 181

Query: 176 SDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNC--- 232
            D W +GC + EM  G +P+        V  +    R L     + +K + +  S C   
Sbjct: 182 PDYWGLGCLIYEMIEGQSPF--RGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKML 239

Query: 233 LRRDPKERW-----AASQLLKHPFL 252
           L +DPK+R       A ++ +HPF 
Sbjct: 240 LTKDPKQRLGCQEEGAGEVKRHPFF 264

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 86.2 bits (214), Expect = 4e-19
 Identities = 68/261 (26%), Positives = 108/261 (41%), Gaps = 38/261 (14%)

Query: 9   IGQGSSATV--SLATSLRSGDVF---AAKSTELPKS-----EFLQREQKFLSSLNSPHIV 58
           +GQGS   V   LA  +  G+     A K+     S     EFL  E   +   N  H+V
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLN-EASVMKEFNCHHVV 72

Query: 59  GYKGCDVTSEDNKLMYNLFMEYAPGGTL---------NDEIHRNGGRLDESLIVSYTRQI 109
              G  V S     +  + ME    G L           E +   G       +    +I
Sbjct: 73  RLLG--VVSTGQPTL--VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEI 128

Query: 110 LQGLEYLHSNRVVHCDIKSRNILMAESGA-KIADFGCAK--WESEALQSGGTPM----FM 162
             G+ YL + + VH D+ +RN ++AE    KI DFG  +  +E++  + GG  +    +M
Sbjct: 129 ADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188

Query: 163 APEVARGEHQGFASDIWAVGCTVIEMASGGA-PWPNAADPMTVLYKIA-YSRELPE-VPA 219
           APE  +       SD+W+ G  + EMA+    P+   ++   + + I     +LPE  P 
Sbjct: 189 APESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLDLPENCPD 248

Query: 220 FLSKQANDFLSNCLRRDPKER 240
            L     + +  C + +PK R
Sbjct: 249 KLL----ELMRMCWQYNPKMR 265

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 86.2 bits (213), Expect = 4e-19
 Identities = 67/262 (25%), Positives = 121/262 (46%), Gaps = 21/262 (8%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQR--------EQKFLSSLNSPHIVGY 60
           +G+G    V       +G ++A K  +L K    ++        E++ L  +NSP IV  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACK--KLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNL 58

Query: 61  KGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGR-LDESLIVSYTRQILQGLEYLHSN 119
                 + ++K    L M    GG L   I+  G R L+   ++ Y+ QI  G+ +LHS 
Sbjct: 59  ----AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSM 114

Query: 120 RVVHCDIKSRNILMAESG-AKIADFGCA---KWESEALQSGGTPMFMAPEVARGEHQGFA 175
            +V+ D+K  N+L+ + G  +++D G A   K      Q  GT  +MAPE+ + E   + 
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYP 174

Query: 176 SDIWAVGCTVIEMASGGAPWPNAADPMTV--LYKIAYSRELPEVPAFLSKQANDFLSNCL 233
            D +A+GC++ EM +G  P+ +  + +    L +     E+       ++++ D     L
Sbjct: 175 VDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFL 234

Query: 234 RRDPKERWAASQLLKHPFLEEF 255
            + P++R  + +    P   EF
Sbjct: 235 AKKPEDRLGSREKNDDPRKHEF 256

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 86.8 bits (215), Expect = 5e-19
 Identities = 82/289 (28%), Positives = 121/289 (41%), Gaps = 60/289 (20%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAK-------STELPKSEFLQREQKFLSSLNSPHIVGYK 61
           +G G+   V  A    +G   A K       +  L K  +  RE K L  L   +I+   
Sbjct: 18  VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTY--RELKLLKHLRHENIISL- 74

Query: 62  GCDV---TSEDNKLMYNLFMEYAPGGTLNDEIHR--NGGRLDESLIVSYTRQILQGLEYL 116
             D+     ED   +  L         L  ++HR      L++  I  +  QIL+GL+Y+
Sbjct: 75  -SDIFISPLEDIYFVTEL---------LGTDLHRLLTSRPLEKQFIQYFLYQILRGLKYV 124

Query: 117 HSNRVVHCDIKSRNILMAES-GAKIADFGCAKWESEALQSG--GTPMFMAPEVA-RGEHQ 172
           HS  VVH D+K  NIL+ E+   KI DFG A+ + +   +G   T  + APE+    +  
Sbjct: 125 HSAGVVHRDLKPSNILINENCDLKICDFGLARIQ-DPQMTGYVSTRYYRAPEIMLTWQKY 183

Query: 173 GFASDIWAVGCTVIEMASGGAPWPN--------------AADPMTVLYKIA------YSR 212
               DIW+ GC   EM  G   +P                  P  V+  I       + +
Sbjct: 184 DVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQ 243

Query: 213 ELPE---VPAFLSK------QANDFLSNCLRRDPKERWAASQLLKHPFL 252
            LP+   VP F  K       A D L   L  DP++R +A++ L HP+L
Sbjct: 244 SLPKREPVP-FSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYL 291

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 85.7 bits (213), Expect = 7e-19
 Identities = 77/289 (26%), Positives = 123/289 (42%), Gaps = 53/289 (18%)

Query: 8   TIGQGSSATVSLATSLRSGDVFAAKSTELPKSE--F----LQREQKFLSSLNSPHIVGYK 61
            I +G+   V  A   ++G++ A K  ++ K +  F    L RE   L  L  P+IV  K
Sbjct: 12  RIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSL-REINILLKLQHPNIVTVK 70

Query: 62  GCDVTSEDNKL-MYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNR 120
              V S  +K+ M   ++E+     L   +        +S +     Q+L G+ +LH N 
Sbjct: 71  EVVVGSNLDKIYMVMEYVEH----DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW 126

Query: 121 VVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSGGTPM-----FMAPEVARGEHQ-G 173
           ++H D+K+ N+L+   G  KI DFG A+     L+   T +     + APE+  G  +  
Sbjct: 127 ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKP-YTQLVVTLWYRAPELLLGAKEYS 185

Query: 174 FASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKI-------------AYSRELPEV--- 217
            A D+W+VGC   E+ +    +P  ++ +  L KI              +S ELP     
Sbjct: 186 TAIDMWSVGCIFAELLTKKPLFPGKSE-IDQLNKIFKLLGTPTEKIWPGFS-ELPGAKKK 243

Query: 218 ---------------PAFLSKQANDFLSNCLRRDPKERWAASQLLKHPF 251
                             LS    D L+  L  DP +R +A   LKHP+
Sbjct: 244 TFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPY 292

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 86.1 bits (213), Expect = 7e-19
 Identities = 77/274 (28%), Positives = 117/274 (42%), Gaps = 29/274 (10%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQR--------EQKFLSSLNSPHIVGY 60
           IG+GS   V       +  ++A K+  + K+  + R        E+  L+ +N P IV  
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKT--IRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPL 58

Query: 61  KGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNR 120
           K    + +  + +Y L + +  GG L   + R G R D S    YT ++L  LE LH   
Sbjct: 59  K---FSFQSPEKLY-LVLAFINGGELFHHLQREG-RFDLSRARFYTAELLCALENLHKFN 113

Query: 121 VVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG----GTPMFMAPEVARGEHQGFA 175
           V++ D+K  NIL+   G   + DFG  K   +         GTP ++APE+  G     A
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKA 173

Query: 176 SDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRR 235
            D W +G  + EM +G  P+ +       +Y+      L   P    + A D L   L R
Sbjct: 174 VDWWTLGVLLYEMLTGLPPFYDENVNE--MYRKILQEPL-RFPDGFDRDAKDLLIGLLSR 230

Query: 236 DPKERW---AASQLLKHPFLEEFC---SCTKQIQ 263
           DP  R     A ++  HPF  +        K IQ
Sbjct: 231 DPTRRLGYNGAQEIKNHPFFSQLSWKKLLMKGIQ 264

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 86.4 bits (214), Expect = 8e-19
 Identities = 66/225 (29%), Positives = 102/225 (45%), Gaps = 24/225 (10%)

Query: 45  EQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVS 104
           E+  L ++  P IV       T    KL   L +EY  GG L   + R G  + E     
Sbjct: 50  ERNILEAVKHPFIVDLIYAFQT--GGKLY--LILEYLSGGELFMHLEREGIFM-EDTACF 104

Query: 105 YTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG------- 156
           Y  +I   LE+LH   +++ D+K  NIL+   G  K+ DFG  K   E++  G       
Sbjct: 105 YLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCK---ESIHEGTVTHTFC 161

Query: 157 GTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPE 216
           GT  +MAPE+      G A D W++G  + +M +G  P+  A +    + KI   +    
Sbjct: 162 GTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPF-TAENRKKTIDKILKGKL--N 218

Query: 217 VPAFLSKQANDFLSNCLRRDPKERWA-----ASQLLKHPFLEEFC 256
           +P +L+ +A D L   L+R+P  R       A+++  HPF     
Sbjct: 219 LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVN 263

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 86.0 bits (213), Expect = 2e-18
 Identities = 85/281 (30%), Positives = 129/281 (45%), Gaps = 49/281 (17%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQR--------EQKFLSSLN 53
           D+     IG+G+   V L     S  V+A K   L K E ++R        E+  ++  N
Sbjct: 44  DFDVIKVIGRGAFGEVQLVRHKSSKQVYAMK--LLSKFEMIKRSDSAFFWEERDIMAHAN 101

Query: 54  SPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTL-----NDEIHRNGGRLDESLIVSYTRQ 108
           S  IV         +D+K +Y + MEY PGG L     N +I     R        YT +
Sbjct: 102 SEWIVQLH---YAFQDDKYLY-MVMEYMPGGDLVNLMSNYDIPEKWARF-------YTAE 150

Query: 109 ILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFG-CAKWESEAL----QSGGTPMFM 162
           ++  L+ +HS   +H D+K  N+L+ +SG  K+ADFG C K ++  +     + GTP ++
Sbjct: 151 VVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYI 210

Query: 163 APEVARGEHQ----GFASDIWAVGCTVIEMASGGAPWPNAADPMTVLY-KI---AYSREL 214
           +PEV + +      G   D W+VG  + EM  G  P+   AD +   Y KI     S   
Sbjct: 211 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF--YADSLVGTYSKIMDHKNSLTF 268

Query: 215 PEVPAFLSKQAND----FLSNCLRRDPKERWAASQLLKHPF 251
           P+    +SKQA D    FL++  R     R    ++  HPF
Sbjct: 269 PDDIE-ISKQAKDLICAFLTD--REVRLGRNGVDEIKSHPF 306

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 84.6 bits (209), Expect = 2e-18
 Identities = 69/260 (26%), Positives = 120/260 (46%), Gaps = 47/260 (18%)

Query: 24  RSGDVFAAKSTELPKS-----EFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFM 78
            +G+  A KS + P+S       L++E + L +L   +IV YKG  + +ED      L M
Sbjct: 31  NTGEQVAVKSLK-PESGGNHIADLKKEIEILRNLYHENIVKYKG--ICTEDGGNGIKLIM 87

Query: 79  EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILM-AESG 137
           E+ P G+L + + RN  +++    + Y  QI +G++YL S + VH D+ +RN+L+ +E  
Sbjct: 88  EFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ 147

Query: 138 AKIADFGCAKWESEALQSG----------GTPMF-MAPEVARGEHQGFASDIWAVGCTVI 186
            KI DFG  K    A+++            +P+F  APE         ASD+W+ G T+ 
Sbjct: 148 VKIGDFGLTK----AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLY 203

Query: 187 EMASGGAPWPNA-ADPMTVLYK-----------------IAYSRELPEVPAFLSKQANDF 228
           E+ +    + ++ + PMT+  K                 +   + LP  P    ++    
Sbjct: 204 ELLT----YCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLP-RPPNCPEEVYQL 258

Query: 229 LSNCLRRDPKERWAASQLLK 248
           +  C    P +R     L++
Sbjct: 259 MRKCWEFQPSKRTTFQNLIE 278

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 85.3 bits (212), Expect = 2e-18
 Identities = 74/262 (28%), Positives = 115/262 (43%), Gaps = 65/262 (24%)

Query: 44  REQKFLSSLNS-PHIVGYKGCDV-TSEDNKLMYNLFMEYAP--------GGTLNDEIHRN 93
           RE  FL  L   P+IV  K  +V  +E++K +Y +F EY             L D +H+ 
Sbjct: 55  REIMFLQELGDHPNIV--KLLNVIKAENDKDIYLVF-EYMETDLHAVIRANILED-VHKR 110

Query: 94  GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKWESEA 152
                    + Y  Q+L+ L+Y+HS  V+H D+K  NIL+ ++   K+ADFG A+  SE 
Sbjct: 111 --------YIMY--QLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160

Query: 153 LQSGGTPM---------FMAPEVARGEHQ-GFASDIWAVGCTVIEMASGGA--------- 193
            ++   P+         + APE+  G  +     D+W+VGC + EM  G           
Sbjct: 161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLN 220

Query: 194 ---------PWPNAAD--------PMTVLYKIAYSRELPEVPAFLSK---QANDFLSNCL 233
                      P+A D          T+L  +  SR    +   L K    A D L   L
Sbjct: 221 QLEKIIEVIGPPSAEDIESIKSPFAATMLDSL-PSRPRKPLDELLPKASDDALDLLKKLL 279

Query: 234 RRDPKERWAASQLLKHPFLEEF 255
             +P +R  A + L+HP++ +F
Sbjct: 280 VFNPNKRLTAEEALEHPYVAQF 301

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 85.0 bits (210), Expect = 2e-18
 Identities = 62/195 (31%), Positives = 101/195 (51%), Gaps = 20/195 (10%)

Query: 75  NLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMA 134
           +L ++Y  GG +   +++      E  +  Y+ +I+  LE+LH   +V+ DIK  NIL+ 
Sbjct: 81  HLILDYVSGGEMFTHLYQRD-NFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLD 139

Query: 135 ESG-AKIADFGCAKW----ESEALQS-GGTPMFMAPEVARGEH-QGFASDIWAVGCTVIE 187
             G   + DFG +K     E E   S  GT  +MAPE+ RG+   G A D W++G  + E
Sbjct: 140 SEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFE 199

Query: 188 MASGGAPWPNAADPMTVLYKIAYSREL----PEVPAFLSKQANDFLSNCLRRDPKER--- 240
           + +G +P+    +  T   +   SR +    P  P+F+  +A D L   LR+DPK+R   
Sbjct: 200 LLTGASPFTLEGERNT---QSEVSRRILKCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGA 256

Query: 241 --WAASQLLKHPFLE 253
               AS++ +HPF +
Sbjct: 257 GPQGASEIKEHPFFK 271

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 84.8 bits (210), Expect = 3e-18
 Identities = 80/306 (26%), Positives = 121/306 (39%), Gaps = 74/306 (24%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAK-------STELPKSEFL----------QREQKFLSS 51
           +G+G+   V  A    +G + A K       S ++ K   L           RE K ++ 
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76

Query: 52  LNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGG---TLNDEIHRNGGRLDESLIVSYTRQ 108
           +   +I+G    DV  E + +  NL M+         ++ +I     RL ES +     Q
Sbjct: 77  IKHENIMGLV--DVYVEGDFI--NLVMDIMASDLKKVVDRKI-----RLTESQVKCILLQ 127

Query: 109 ILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFG-------------CAKWESEALQ 154
           IL GL  LH    +H D+   NI +   G  KIADFG              +K E+   +
Sbjct: 128 ILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRR 187

Query: 155 SGGTP-----MFMAPEVARG-EHQGFASDIWAVGCTVIEMASG----------------- 191
              T       + APE+  G E   FA D+W+VGC   E+ +G                 
Sbjct: 188 EEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIF 247

Query: 192 ---GAP----WPNAAD-PMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAA 243
              G P    WP A   P+   +     ++L  +    S  A D L + L+ +P ER +A
Sbjct: 248 ELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISA 307

Query: 244 SQLLKH 249
            + LKH
Sbjct: 308 KEALKH 313

Length = 335

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 84.4 bits (208), Expect = 4e-18
 Identities = 74/260 (28%), Positives = 115/260 (44%), Gaps = 24/260 (9%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTE----LPKSEFLQR--EQKFLSSLNSPHIVGYKG 62
           +G+G+   V L     SG  +A K  +    + K E      E + L +   P +   K 
Sbjct: 3   LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK- 61

Query: 63  CDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
               S   K      MEY  GG L   + R      E     Y  +I+  L+YLHS ++V
Sbjct: 62  ---YSFQTKDRLCFVMEYVNGGELFFHLSRER-VFSEDRTRFYGAEIVSALDYLHSGKIV 117

Query: 123 HCDIKSRNILMAESG-AKIADFG-CAKWESEALQSG---GTPMFMAPEVARGEHQGFASD 177
           + D+K  N+++ + G  KI DFG C +  ++A       GTP ++APEV      G A D
Sbjct: 118 YRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVD 177

Query: 178 IWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDP 237
            W +G  + EM  G  P+ N       L+++    ++ + P  LS  A   LS  L +DP
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDHEK--LFELILMEDI-KFPRTLSADAKSLLSGLLIKDP 234

Query: 238 KERWA-----ASQLLKHPFL 252
            +R       A ++++H F 
Sbjct: 235 NKRLGGGPDDAKEIMRHSFF 254

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 83.9 bits (208), Expect = 6e-18
 Identities = 78/289 (26%), Positives = 124/289 (42%), Gaps = 49/289 (16%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAK-------STELPKSEFLQREQKFLSSLNSPHIVGYK 61
           +G G+   V  A   ++G   A K       S    K  +  RE + L  ++  +++G  
Sbjct: 23  VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTY--RELRLLKHMDHENVIGLL 80

Query: 62  GC---DVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHS 118
                  + ED + +Y L      G  LN+ +     +L +  I     QIL+GL+Y+HS
Sbjct: 81  DVFTPASSLEDFQDVY-LVTHLM-GADLNNIVKCQ--KLSDDHIQFLVYQILRGLKYIHS 136

Query: 119 NRVVHCDIKSRNILMAE-SGAKIADFGCAKW-ESEALQSGGTPMFMAPEVARGE-HQGFA 175
             ++H D+K  NI + E    KI DFG A+  + E      T  + APE+     H    
Sbjct: 137 AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQT 196

Query: 176 SDIWAVGCTVIEMASGGAPWPNAADPMTVLYKI---------------------AYSREL 214
            DIW+VGC + E+ +G   +P  +D +  L +I                      Y + L
Sbjct: 197 VDIWSVGCIMAELLTGKTLFP-GSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSL 255

Query: 215 PEVP------AFL--SKQANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
           P++P       F   +  A D L   L  DP +R  A++ L HP+L E+
Sbjct: 256 PQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEY 304

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 85.6 bits (211), Expect = 7e-18
 Identities = 82/284 (28%), Positives = 128/284 (45%), Gaps = 44/284 (15%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKS------TELPKSEFLQREQKFLSSLNSPHIVGYKG 62
           IG G    V L    R+ + F  K+       E  KS+ L  E   +  L   +IV Y  
Sbjct: 21  IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQ-LVIEVNVMRELKHKNIVRYID 79

Query: 63  CDVTSEDNKLMYNLFMEYAPGGTLNDEI---HRNGGRLDESLIVSYTRQILQGLEYLHS- 118
             +   + KL   + ME+   G L+  I   ++  G+++E  IV  TRQ+L  L Y H+ 
Sbjct: 80  RFLNKANQKLY--ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNL 137

Query: 119 ------NRVVHCDIKSRNILMA------------------ESGAKIADFGCAK---WESE 151
                  RV+H D+K +NI ++                     AKI DFG +K    ES 
Sbjct: 138 KDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESM 197

Query: 152 ALQSGGTPMFMAPEVARGEHQGF--ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA 209
           A    GTP + +PE+   E + +   SD+WA+GC + E+ SG  P+  A +   ++ ++ 
Sbjct: 198 AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELK 257

Query: 210 YSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLE 253
              +LP      SK+ N  + N L    KER +A Q L +  ++
Sbjct: 258 RGPDLPIKGK--SKELNILIKNLLNLSAKERPSALQCLGYQIIK 299

Length = 1021

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 82.2 bits (203), Expect = 9e-18
 Identities = 55/197 (27%), Positives = 92/197 (46%), Gaps = 13/197 (6%)

Query: 52  LNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIH---RNGGRLDESLIVSYTRQ 108
           L  P+IV Y    +  E+++L   + M+   G  L +  +       R  E  I +   Q
Sbjct: 66  LRHPNIVRYYKTFL--ENDRLY--IVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121

Query: 109 ILQGLEYLH-SNRVVHCDIKSRNILMAESG-AKIADFGCA--KWESEALQSG-GTPMFMA 163
           ++  L YLH   R+VH D+   NI++ E     I DFG A  K     L S  GT ++  
Sbjct: 122 MVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSC 181

Query: 164 PEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSK 223
           PE+ + E  G  +D+WA GC + +M +   P+  + + +++  KI  +   P      S+
Sbjct: 182 PEIVKNEPYGEKADVWAFGCILYQMCTLQPPF-YSTNMLSLATKIVEAVYEPLPEGMYSE 240

Query: 224 QANDFLSNCLRRDPKER 240
              D +++CL  D + R
Sbjct: 241 DVTDVITSCLTPDAEAR 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 83.1 bits (206), Expect = 9e-18
 Identities = 61/206 (29%), Positives = 89/206 (43%), Gaps = 26/206 (12%)

Query: 9   IGQGSSATVSLATSL--RSGDVFAAKSTELPKSE---FLQ---REQKFLSSLNSPHIVGY 60
           IG+G+   V  A     + G  +A K  +  K +     Q   RE   L  L   ++V  
Sbjct: 8   IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67

Query: 61  KGCDVTSEDNKLMYNLFMEYAP---GGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLH 117
               +   D  + Y LF +YA       +          +  S++ S   QIL G+ YLH
Sbjct: 68  VEVFLEHADKSV-YLLF-DYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH 125

Query: 118 SNRVVHCDIKSRNILM----AESGA-KIADFGCAKWESEALQS--GGTPM-----FMAPE 165
           SN V+H D+K  NIL+     E G  KI D G A+  +  L+      P+     + APE
Sbjct: 126 SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPE 185

Query: 166 VARG-EHQGFASDIWAVGCTVIEMAS 190
           +  G  H   A DIWA+GC   E+ +
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 82.9 bits (205), Expect = 1e-17
 Identities = 75/273 (27%), Positives = 120/273 (43%), Gaps = 50/273 (18%)

Query: 9   IGQGSSATVSLATSLR---SGDVFAAKSTELPKSEFLQR-------EQKFLSSLNSPHIV 58
           +GQGS   V L   +    +G ++A K   L K+    R       E+  L+ +N P IV
Sbjct: 4   LGQGSFGKVFLVRKITGPDAGQLYAMKV--LKKATLKVRDRVRTKMERDILAEVNHPFIV 61

Query: 59  GYKGCDVTSEDNKLMYN--------LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQIL 110
                       KL Y         L +++  GG L   + +      E  +  Y  ++ 
Sbjct: 62  ------------KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELA 108

Query: 111 QGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAK----WESEALQSGGTPMFMAPE 165
             L++LHS  +++ D+K  NIL+ E G  K+ DFG +K     E +A    GT  +MAPE
Sbjct: 109 LALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPE 168

Query: 166 VARGEHQGFASDIWAVGCTVIEMASGGAPW--PNAADPMTVLYKIAYSRELPEVPAFLSK 223
           V        ++D W+ G  + EM +G  P+   +  + MT++ K         +P FLS 
Sbjct: 169 VVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLG-----MPQFLSP 223

Query: 224 QANDFLSNCLRRDPKERWAAS-----QLLKHPF 251
           +A   L    +R+P  R  A      ++ +HPF
Sbjct: 224 EAQSLLRALFKRNPANRLGAGPDGVEEIKRHPF 256

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 82.0 bits (203), Expect = 2e-17
 Identities = 81/286 (28%), Positives = 121/286 (42%), Gaps = 45/286 (15%)

Query: 7   HTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ----REQKFLSSLNSPHIVGYKG 62
             +G+GS ATV    S  +G + A K   L   E       RE   L  L   +IV    
Sbjct: 11  DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLH- 69

Query: 63  CDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
            D+      L   L  EY     L   +   GG L    +  +  Q+L+GL Y H  RV+
Sbjct: 70  -DIIHTKKTL--TLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVL 125

Query: 123 HCDIKSRNILMAESGA-KIADFGCAKWESEALQSGG----TPMFMAPEVARGEHQGFAS- 176
           H D+K +N+L++E G  K+ADFG A+ +S   ++      T  +  P+V  G  +   S 
Sbjct: 126 HRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSL 185

Query: 177 DIWAVGCTVIEMASGGAPWPNAADPMTVLYKI----------------------AYS--- 211
           D+W VGC   EMA+G   +P + D    L+KI                       YS   
Sbjct: 186 DMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPF 245

Query: 212 ---RELPEVPAFLSK--QANDFLSNCLRRDPKERWAASQLLKHPFL 252
              R L      L +     +     L+ +PK+R +A++ +KHP+ 
Sbjct: 246 YPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 81.3 bits (201), Expect = 2e-17
 Identities = 52/167 (31%), Positives = 83/167 (49%), Gaps = 20/167 (11%)

Query: 40  EFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDE 99
           E L  E   ++S++ PH+V   G  ++S   ++   L  +  P G L D +  +   +  
Sbjct: 55  EIL-DEAYVMASVDHPHVVRLLGICLSS---QVQ--LITQLMPLGCLLDYVRNHKDNIGS 108

Query: 100 SLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKW----ESEALQ 154
             ++++  QI +G+ YL   R+VH D+ +RN+L+      KI DFG AK     E E   
Sbjct: 109 QYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHA 168

Query: 155 SGG-TPM-FMAPE-VARGE--HQGFASDIWAVGCTVIE-MASGGAPW 195
            GG  P+ +MA E +      H+   SD+W+ G TV E M  G  P+
Sbjct: 169 EGGKVPIKWMALESILHRIYTHK---SDVWSYGVTVWELMTFGAKPY 212

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 81.5 bits (201), Expect = 2e-17
 Identities = 83/294 (28%), Positives = 116/294 (39%), Gaps = 63/294 (21%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSE------------FLQREQKFLSSLNSPH 56
           IG G+  TV  A    SG   A KS  +  +E             L+R + F    + P+
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAF----DHPN 63

Query: 57  IVGYKG-CDVTSEDNKLMYNLFMEYAPGG--TLNDEIHRNGGRLDESLIVSYTRQILQGL 113
           IV     C  +  D +    L  E+      T  D++   G   +   I    RQ L+GL
Sbjct: 64  IVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAET--IKDLMRQFLRGL 121

Query: 114 EYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSGGTPM-----FMAPEVA 167
           ++LH+N +VH D+K  NIL+   G  K+ADFG A+  S   Q   TP+     + APEV 
Sbjct: 122 DFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYS--CQMALTPVVVTLWYRAPEVL 179

Query: 168 RGEHQGFASDIWAVGCTVIEM--------------------ASGGAP----WPNAADPMT 203
                    D+W+VGC   EM                       G P    WP       
Sbjct: 180 LQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD----V 235

Query: 204 VLYKIAYSRELPE-----VPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFL 252
            L + A+S   P      VP      A   L   L  +P +R +A + L+HPF 
Sbjct: 236 TLPRGAFSPRGPRPVQSVVPEIEESGA-QLLLEMLTFNPHKRISAFRALQHPFF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 79.0 bits (195), Expect = 2e-17
 Identities = 49/177 (27%), Positives = 71/177 (40%), Gaps = 17/177 (9%)

Query: 84  GTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGAKIADF 143
            +L D +   G  L+E  I +   Q L  L  LH         KS NIL+   G    D 
Sbjct: 1   VSLADILEVRGRPLNEEEIWAVCLQCLGALRELHRQA------KSGNILLTWDGLLKLDG 54

Query: 144 GCAKWESEALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMT 203
             A       QS   P FMAPEV +G+     +DI+++G T+ E      P  N    ++
Sbjct: 55  SVA--FKTPEQSRPDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELP-YNEERELS 111

Query: 204 VLYKIAYSRELPEVPAFLS--------KQANDFLSNCLRRDPKERWAASQLLKHPFL 252
            + +I  +    + P   S        +   DF+  C  R P+ R AA+  L H   
Sbjct: 112 AILEILLNGMPADDPRDRSNLEGVSAARSFEDFMRLCASRLPQRREAANHYLAHCRA 168

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 82.5 bits (204), Expect = 2e-17
 Identities = 69/250 (27%), Positives = 98/250 (39%), Gaps = 56/250 (22%)

Query: 105 YTRQILQGLEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKWES-----EALQSGGT 158
           +  QIL+GL+YLHS  ++H DIK  N+L+ +    KI DFG A+ E         Q   T
Sbjct: 108 FLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVT 167

Query: 159 PMFMAPEVARG-EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKI--------- 208
             + APE+  G  H   A DIW+VGC   E+      +  A  P+  L  I         
Sbjct: 168 QYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILF-QAQSPIQQLDLITDLLGTPSL 226

Query: 209 -----------AYS-RELPEVPAF-----LSKQAN----DFLSNCLRRDPKERWAASQLL 247
                      A+  R   + P+      LS QA       L   L  DP +R +A+  L
Sbjct: 227 EAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADAL 286

Query: 248 KHPFLEE--------FCSC----------TKQIQESNCSPTSILDQGIWNSVEETEESLG 289
            HP+L+E         C C          T   + S   P     +    SV + +E L 
Sbjct: 287 AHPYLDEGRLRYHTCMCKCCYTTSGGRVYTSDFEPSANPPFDDEYEKNLTSVRQVKEELH 346

Query: 290 NLIHSTSKTS 299
             I    + +
Sbjct: 347 QFILEQQQGN 356

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 81.9 bits (202), Expect = 3e-17
 Identities = 77/269 (28%), Positives = 121/269 (44%), Gaps = 34/269 (12%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQR--------EQKFL---SSLNSPHI 57
           IG+G+   V       +  ++A K   L K E + +        E+  L       SP I
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMK--VLSKKEIVAKKEVAHTIGERNILVRTLLDESPFI 58

Query: 58  VGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLH 117
           VG K    T  D   +Y L  +Y  GG L   + + G R  E     Y  +++  LE+LH
Sbjct: 59  VGLKFSFQTDSD---LY-LVTDYMSGGELFWHLQKEG-RFSEDRAKFYIAELVLALEHLH 113

Query: 118 SNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG----GTPMFMAPEVARGEHQ 172
              +V+ D+K  NIL+  +G   + DFG +K      ++     GT  ++APEV   E +
Sbjct: 114 KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDE-K 172

Query: 173 GFAS--DIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSR-ELPEVPAFLSKQANDFL 229
           G+    D W++G  V EM  G +P+  A D   +   IA+ +   P+    LS +   F+
Sbjct: 173 GYTKHVDFWSLGVLVFEMCCGWSPF-YAEDTQQMYRNIAFGKVRFPK--NVLSDEGRQFV 229

Query: 230 SNCLRRDPKERWAA----SQLLKHPFLEE 254
              L R+P+ R  A     +L +HPF  +
Sbjct: 230 KGLLNRNPQHRLGAHRDAVELKEHPFFAD 258

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 80.1 bits (198), Expect = 5e-17
 Identities = 79/260 (30%), Positives = 120/260 (46%), Gaps = 30/260 (11%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTE---LPKSEFLQREQKFLSSLNSPHIV 58
           +   G TIG+G    V L      G   A K  +        FL  E   +++L  P++V
Sbjct: 7   ELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDSTAAQAFLA-EASVMTTLRHPNLV 63

Query: 59  GYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGR----LDESLIVSYTRQILQGLE 114
              G  V  + N L   +  EY   G+L D + R+ GR    L + L   +   + +G+E
Sbjct: 64  QLLG--VVLQGNPLY--IVTEYMAKGSLVDYL-RSRGRAVITLAQQLG--FALDVCEGME 116

Query: 115 YLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSGGTPM-FMAPEVARGEHQ 172
           YL     VH D+ +RN+L++E   AK++DFG AK  S+   SG  P+ + APE  R   +
Sbjct: 117 YLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWTAPEALR--EK 174

Query: 173 GFA--SDIWAVGCTVIEMAS-GGAPWPNAADPMTVLY-KIAYSRELPE-VPAFLSKQAND 227
            F+  SD+W+ G  + E+ S G  P+P       V + +  Y  E PE  P  + K    
Sbjct: 175 KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYK---- 230

Query: 228 FLSNCLRRDPKERWAASQLL 247
            + +C   DP +R    QL 
Sbjct: 231 VMKDCWELDPAKRPTFKQLR 250

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 81.0 bits (200), Expect = 5e-17
 Identities = 66/240 (27%), Positives = 108/240 (45%), Gaps = 28/240 (11%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQR--------EQKFLSSLNSPHIVGY 60
           +G+GS   V LA    + +++A K   L K   +Q         E++ L+    P  +  
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKI--LKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQ 65

Query: 61  KGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNR 120
                 + D +L +   MEY  GG L   I + G +  E   V Y  +I  GL +LHS  
Sbjct: 66  LHSCFQTMD-RLYF--VMEYVNGGDLMYHIQQVG-KFKEPHAVFYAAEIAIGLFFLHSKG 121

Query: 121 VVHCDIKSRNILM-AESGAKIADFGCAK---WESEALQS-GGTPMFMAPEVARGEHQGFA 175
           +++ D+K  N+++ AE   KIADFG  K   +  +  ++  GTP ++APE+   +  G +
Sbjct: 122 IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKS 181

Query: 176 SDIWAVGCTVIEMASGGAPWP--------NAADPMTVLYKIAYSRELPEV-PAFLSKQAN 226
            D WA G  + EM +G  P+          +     V Y  + S+E   +    L+K   
Sbjct: 182 VDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLTKHPA 241

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 80.0 bits (197), Expect = 6e-17
 Identities = 73/247 (29%), Positives = 119/247 (48%), Gaps = 35/247 (14%)

Query: 28  VFAAKSTELPKSE--FLQ--REQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPG 83
           V  AK+TE  ++E   L+  R+  FL +L+               D KL  +L ++Y  G
Sbjct: 42  VQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF----------QTDTKL--HLILDYING 89

Query: 84  GTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIAD 142
           G L   + +   R  E  +  Y+ +I+  LE+LH   +++ DIK  NIL+  +G   + D
Sbjct: 90  GELFTHLSQRE-RFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTD 148

Query: 143 FGCAK----WESE-ALQSGGTPMFMAPEVARGEHQGF--ASDIWAVGCTVIEMASGGAPW 195
           FG +K     E E A    GT  +MAP++ RG   G   A D W++G  + E+ +G +P+
Sbjct: 149 FGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPF 208

Query: 196 PNAADPMT---VLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWA-----ASQLL 247
               +  +   +  +I  S   P  P  +S  A D +   L +DPK+R       A ++ 
Sbjct: 209 TVDGEKNSQAEISRRILKSE--PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIK 266

Query: 248 KHPFLEE 254
           KHPF ++
Sbjct: 267 KHPFFQK 273

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 80.0 bits (197), Expect = 7e-17
 Identities = 73/269 (27%), Positives = 118/269 (43%), Gaps = 33/269 (12%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQR--------EQKFLSSLNSPHIV-- 58
           +G+G    V       +G ++A K  +L K    +R        E++ L  +NS  +V  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACK--KLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL 65

Query: 59  GYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGR-LDESLIVSYTRQILQGLEYLH 117
            Y      + + K    L +    GG L   I+  G    DE   + Y  ++  GLE L 
Sbjct: 66  AY------AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ 119

Query: 118 SNRVVHCDIKSRNILMAESG-AKIADFGCAKW--ESEALQSG-GTPMFMAPEVARGEHQG 173
             R+V+ D+K  NIL+ + G  +I+D G A    E E ++   GT  +MAPEV   E   
Sbjct: 120 RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYT 179

Query: 174 FASDIWAVGCTVIEMASGGAPWPNAADPMT---VLYKIAYSRELPEVPAFLSKQANDFLS 230
           F+ D W +GC + EM  G +P+    + +    V  ++   +E  E     S+ A     
Sbjct: 180 FSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQE--EYSEKFSEDAKSICR 237

Query: 231 NCLRRDPKERW-----AASQLLKHPFLEE 254
             L ++PKER       A+ + +HP  + 
Sbjct: 238 MLLTKNPKERLGCRGNGAAGVKQHPIFKN 266

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 80.4 bits (198), Expect = 9e-17
 Identities = 80/286 (27%), Positives = 123/286 (43%), Gaps = 43/286 (15%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELP-KSEFLQ----REQKFLSSLNSPHIVGYKGC 63
           +G G+  TV  A   R+G   A K    P +SE       RE + L  +   +++G    
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGL--L 80

Query: 64  DVTSEDNKL-MYNLFMEYAP-GGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRV 121
           DV + D  L  ++ F    P  GT   ++ ++  +L E  I     Q+L+GL+Y+H+  +
Sbjct: 81  DVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHE-KLSEDRIQFLVYQMLKGLKYIHAAGI 139

Query: 122 VHCDIKSRNILMAESGA-KIADFGCAKW-ESEALQSGGTPMFMAPEVARG-EHQGFASDI 178
           +H D+K  N+ + E    KI DFG A+  +SE      T  + APEV     H     DI
Sbjct: 140 IHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDI 199

Query: 179 WAVGCTVIEMASGGAPWPNAADPMTVLYKIA---------------------YSRELPEV 217
           W+VGC + EM + G P     D +  L +I                      Y ++LP  
Sbjct: 200 WSVGCIMAEMLT-GKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRF 258

Query: 218 P--------AFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
                       +  A + L   L  D + R  A++ L HP+ EEF
Sbjct: 259 RKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 80.8 bits (199), Expect = 9e-17
 Identities = 89/326 (27%), Positives = 145/326 (44%), Gaps = 50/326 (15%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAK---STELPK---SEFLQREQKFLSSLNSP 55
           D+     IG+G+   V L     S  V+A K     E+ K   S F   E+  ++  NSP
Sbjct: 44  DYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 103

Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
            +V         +D+K +Y + MEY PGG L + +  +   + E     YT +++  L+ 
Sbjct: 104 WVVQLF---CAFQDDKYLY-MVMEYMPGGDLVNLM--SNYDVPEKWAKFYTAEVVLALDA 157

Query: 116 LHSNRVVHCDIKSRNILMAESG-AKIADFG-CAKWESEAL----QSGGTPMFMAPEVARG 169
           +HS  ++H D+K  N+L+ + G  K+ADFG C K +   +     + GTP +++PEV + 
Sbjct: 158 IHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKS 217

Query: 170 E----HQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLY-KI---AYSRELPEVPAFL 221
           +    + G   D W+VG  + EM  G  P+   AD +   Y KI     S   PE    +
Sbjct: 218 QGGDGYYGRECDWWSVGVFLFEMLVGDTPF--YADSLVGTYSKIMDHKNSLNFPE-DVEI 274

Query: 222 SKQANDFLSNCL--RRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSILDQGIWN 279
           SK A + +   L  R     R    ++ +HPF +                    DQ  W+
Sbjct: 275 SKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKN-------------------DQWNWD 315

Query: 280 SVEETEESLGNLIHSTSKTSARERIE 305
           ++ ET   +   + S   +S  + IE
Sbjct: 316 NIRETAAPVVPELSSDIDSSNFDDIE 341

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 81.2 bits (200), Expect = 1e-16
 Identities = 60/205 (29%), Positives = 101/205 (49%), Gaps = 25/205 (12%)

Query: 64  DVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESL--------IVSYTRQILQGLEY 115
           D  S+D  L   L MEY  GG LN +I +   RL E L        ++ Y  QI+  L+ 
Sbjct: 133 DFKSDDKLL---LIMEYGSGGDLNKQIKQ---RLKEHLPFQEYEVGLLFY--QIVLALDE 184

Query: 116 LHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG------GTPMFMAPEVAR 168
           +HS +++H D+KS NI +  +G  K+ DFG +K  S+++         GTP ++APE+  
Sbjct: 185 VHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWE 244

Query: 169 GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDF 228
            +     +D+W++G  + E+ +   P+   +    ++ ++ Y +  P  P  +S      
Sbjct: 245 RKRYSKKADMWSLGVILYELLTLHRPFKGPSQ-REIMQQVLYGKYDP-FPCPVSSGMKAL 302

Query: 229 LSNCLRRDPKERWAASQLLKHPFLE 253
           L   L ++P  R    QLL   FL+
Sbjct: 303 LDPLLSKNPALRPTTQQLLHTEFLK 327

Length = 478

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 80.0 bits (197), Expect = 1e-16
 Identities = 77/258 (29%), Positives = 113/258 (43%), Gaps = 26/258 (10%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQK--------FLSSLNSPHIVGY 60
           IG+GS   V LA     G  +A K  +  K+   ++EQ          L +L  P +VG 
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQ-KKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61

Query: 61  KGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNR 120
                T+E  KL + L  +Y  GG L   + R      E     Y  ++   + YLHS  
Sbjct: 62  HYSFQTAE--KLYFVL--DYVNGGELFFHLQRER-CFLEPRARFYAAEVASAIGYLHSLN 116

Query: 121 VVHCDIKSRNILMAESG-AKIADFGCAK--WESEALQSG--GTPMFMAPEVARGEHQGFA 175
           +++ D+K  NIL+   G   + DFG  K   E E   S   GTP ++APEV R E     
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRT 176

Query: 176 SDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRR 235
            D W +G  + EM  G  P+   +  ++ +Y     + L ++P   +  A D L   L +
Sbjct: 177 VDWWCLGAVLYEMLYGLPPF--YSRDVSQMYDNILHKPL-QLPGGKTVAACDLLVGLLHK 233

Query: 236 DPKERWAASQLLKHPFLE 253
           D + R  A    K  FLE
Sbjct: 234 DQRRRLGA----KADFLE 247

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 79.2 bits (195), Expect = 1e-16
 Identities = 80/291 (27%), Positives = 116/291 (39%), Gaps = 59/291 (20%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ----REQKFLSSLNSPHIVGYKGCD 64
           +G+GS ATV    S  +G + A K   +   E +     RE   L  L   +IV      
Sbjct: 13  LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII 72

Query: 65  VTSEDNKLMYNL-------FMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLH 117
            T E    ++         +M   PGG     +H    RL       +  Q+L+GL Y+H
Sbjct: 73  HTKETLTFVFEYMHTDLAQYMIQHPGG-----LHPYNVRL-------FMFQLLRGLAYIH 120

Query: 118 SNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSGG----TPMFMAPEVARGEHQ 172
              ++H D+K +N+L++  G  K+ADFG A+ +S   Q+      T  +  P+V  G   
Sbjct: 121 GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATD 180

Query: 173 -GFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKI-------------------AYSR 212
              A DIW  GC  IEM  G   +P  +D    L KI                    Y  
Sbjct: 181 YSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKP 240

Query: 213 E---LPEVPAF------LSK--QANDFLSNCLRRDPKERWAASQLLKHPFL 252
           E     +          LS+  +A D  S  L   PK+R +A   L HP+ 
Sbjct: 241 EWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 78.9 bits (195), Expect = 1e-16
 Identities = 82/292 (28%), Positives = 118/292 (40%), Gaps = 62/292 (21%)

Query: 7   HTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ-------REQKFLSSLNS-PHIV 58
             IG+G+ + V  A S ++G  +A K     K  F         RE + L  L+  P+I+
Sbjct: 5   GKIGEGTFSEVLKAQSRKTGKYYAIKCM---KKHFKSLEQVNNLREIQALRRLSPHPNIL 61

Query: 59  GYKGCDVTSEDNKLMYNLFMEYAPGGTLND----EIHRNGGR-LDESLIVSYTRQILQGL 113
                    +  +L   L  E      L D    E+ +   R L E  + SY  Q+L+ L
Sbjct: 62  RLIEVLFDRKTGRL--ALVFE------LMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSL 113

Query: 114 EYLHSNRVVHCDIKSRNILMAESGAKIADFGCAKWESEALQSGG-------TPMFMAPE- 165
           +++H N + H DIK  NIL+ +   K+ADFG  +     + S         T  + APE 
Sbjct: 114 DHMHRNGIFHRDIKPENILIKDDILKLADFGSCR----GIYSKPPYTEYISTRWYRAPEC 169

Query: 166 VARGEHQGFASDIWAVGCTVIEMASGGAPWP--NAAD------------PMTVLYKIAYS 211
           +    + G   DIWAVGC   E+ S    +P  N  D               VL K   S
Sbjct: 170 LLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKS 229

Query: 212 REL-----PEVPAFLSK-------QANDFLSNCLRRDPKERWAASQLLKHPF 251
           R +      +    L K       +  D L   L  DP ER  A Q L+HP+
Sbjct: 230 RHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPY 281

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 78.5 bits (194), Expect = 2e-16
 Identities = 52/168 (30%), Positives = 76/168 (45%), Gaps = 21/168 (12%)

Query: 38  KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRL 97
           K EFL RE   ++ L+ P IV   G  V   +      L ME AP G L   + +    +
Sbjct: 40  KKEFL-REASVMAQLDHPCIVRLIG--VCKGE---PLMLVMELAPLGPLLKYL-KKRREI 92

Query: 98  DESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKW------ES 150
             S +     Q+  G+ YL S   VH D+ +RN+L+     AKI+DFG ++         
Sbjct: 93  PVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152

Query: 151 EALQSGGTPM-FMAPE---VARGEHQGFASDIWAVGCTVIEMASGGAP 194
            A  +G  P+ + APE     +       SD+W+ G T+ E  S GA 
Sbjct: 153 RATTAGRWPLKWYAPECINYGKFSS---KSDVWSYGVTLWEAFSYGAK 197

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 79.6 bits (197), Expect = 2e-16
 Identities = 80/301 (26%), Positives = 118/301 (39%), Gaps = 69/301 (22%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTE-LPKSEFLQR---EQKFLSSLNSPHIVGYKGCD 64
           IG+G+   V  AT   +G   A K         F QR   E K L      +I+G    D
Sbjct: 13  IGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGIL--D 70

Query: 65  V----TSEDNKLMYNL--FMEYAPGGTLNDEIHR--NGGRLDESLIVSYTRQILQGLEYL 116
           +    + E    +Y +   ME         ++++      L    I  +  QIL+GL+Y+
Sbjct: 71  IIRPPSFESFNDVYIVQELME--------TDLYKLIKTQHLSNDHIQYFLYQILRGLKYI 122

Query: 117 HSNRVVHCDIKSRNILM-AESGAKIADFGCAKWESEALQSGG-------TPMFMAPEVAR 168
           HS  V+H D+K  N+L+      KI DFG A+         G       T  + APE+  
Sbjct: 123 HSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIML 182

Query: 169 GEHQGF--ASDIWAVGCTVIEMASG-----GAPW-------------PNAADPMTVLYKI 208
              +G+  A DIW+VGC + EM S      G  +             P+  D    L  I
Sbjct: 183 NS-KGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQED----LNCI 237

Query: 209 ------AYSRELPEVPAF--------LSKQANDFLSNCLRRDPKERWAASQLLKHPFLEE 254
                  Y + LP  P             +A D L   L  +P +R    + L HP+LE+
Sbjct: 238 ISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQ 297

Query: 255 F 255
           +
Sbjct: 298 Y 298

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 78.7 bits (194), Expect = 2e-16
 Identities = 62/202 (30%), Positives = 89/202 (44%), Gaps = 57/202 (28%)

Query: 98  DESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES--GAKIADFGCAKWESEALQS 155
           +  LI +Y  QIL+G+ Y HS+RV+H D+K +N+L+       K+ADFG A+       +
Sbjct: 100 NPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLAR-------A 152

Query: 156 GGTPM-----------FMAPEVARG-EHQGFASDIWAVGCTVIEMASG------------ 191
            G P+           + APE+  G  H     DIW+VGC   EM +             
Sbjct: 153 FGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE 212

Query: 192 --------GAP----WPNAADPMTVL--YKIAYSRELPE-----VPAFLSKQANDFLSNC 232
                   G P    WP     +T L  YK A+ +  P+     VP  L     D LS  
Sbjct: 213 LFKIFRILGTPNEETWPG----VTSLPDYKSAFPKWPPKDLATVVPT-LEPAGVDLLSKM 267

Query: 233 LRRDPKERWAASQLLKHPFLEE 254
           LR DP +R  A   L+H + ++
Sbjct: 268 LRLDPSKRITARAALEHEYFKD 289

Length = 294

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 77.5 bits (191), Expect = 3e-16
 Identities = 60/202 (29%), Positives = 94/202 (46%), Gaps = 19/202 (9%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKS--TELP---KSEFLQREQKFLSSLNSPHIVGYKGC 63
           IG+G+   V     L+     A K+  + LP   K +FLQ E + L   + P+IV   G 
Sbjct: 3   IGKGNFGDVYKGV-LKGNTEVAVKTCRSTLPPDLKRKFLQ-EAEILKQYDHPNIVKLIG- 59

Query: 64  DVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVH 123
            V  +   +   + ME  PGG+L   + +   RL    ++  +     G+EYL S   +H
Sbjct: 60  -VCVQKQPIY--IVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIH 116

Query: 124 CDIKSRNILMAESGA-KIADFGCAKWESEALQ--SGGT---PM-FMAPEVARGEHQGFAS 176
            D+ +RN L+ E+   KI+DFG ++ E   +   S G    P+ + APE          S
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSES 176

Query: 177 DIWAVGCTVIEMASGGA-PWPN 197
           D+W+ G  + E  S G  P+P 
Sbjct: 177 DVWSYGILLWETFSLGDTPYPG 198

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 77.7 bits (191), Expect = 4e-16
 Identities = 68/244 (27%), Positives = 108/244 (44%), Gaps = 29/244 (11%)

Query: 28  VFAAKSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLN 87
           V A K   L   +  QRE + L++L   HIV + G  V  + + L+  +  EY   G LN
Sbjct: 40  VKALKDPTLAARKDFQREAELLTNLQHEHIVKFYG--VCGDGDPLI--MVFEYMKHGDLN 95

Query: 88  DEIHRNG---------------GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNIL 132
             +  +G               G L  S ++    QI  G+ YL S   VH D+ +RN L
Sbjct: 96  KFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCL 155

Query: 133 MAES-GAKIADFGCAK--WESEALQSGGTPM----FMAPEVARGEHQGFASDIWAVGCTV 185
           +  +   KI DFG ++  + ++  + GG  M    +M PE          SD+W+ G  +
Sbjct: 156 VGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVIL 215

Query: 186 IEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAAS 244
            E+ + G  PW   +    V+  I   R L E P    K+  D +  C +R+P++R    
Sbjct: 216 WEIFTYGKQPWFQLS-NTEVIECITQGRVL-ERPRVCPKEVYDIMLGCWQREPQQRLNIK 273

Query: 245 QLLK 248
           ++ K
Sbjct: 274 EIYK 277

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 80.3 bits (198), Expect = 5e-16
 Identities = 63/237 (26%), Positives = 97/237 (40%), Gaps = 31/237 (13%)

Query: 42  LQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESL 101
            +RE    + L  P+IV             L++ +F EY PG TL + +    G L    
Sbjct: 25  FRRETALCARLYHPNIVALLDSGEAPPG--LLFAVF-EYVPGRTLREVL-AADGALPAGE 80

Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG----AKIADFGCAKWESEALQSG- 156
                 Q+L  L   H+  +VH D+K +NI+++++G    AK+ DFG        L  G 
Sbjct: 81  TGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIG-----TLLPGV 135

Query: 157 ---------------GTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADP 201
                          GTP + APE  RGE     SD++A G   +E  + G      A  
Sbjct: 136 RDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLT-GQRVVQGASV 194

Query: 202 MTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLE-EFCS 257
             +LY+     ++   P          L   L +DP++R A++  L   F   E C+
Sbjct: 195 AEILYQQLSPVDVSLPPWIAGHPLGQVLRKALNKDPRQRAASAPALAERFRALELCA 251

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 77.5 bits (191), Expect = 5e-16
 Identities = 60/219 (27%), Positives = 96/219 (43%), Gaps = 27/219 (12%)

Query: 43  QREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNG-------- 94
           +RE + L++    +IV + G   T  D  +M     EY   G LN  +  +G        
Sbjct: 56  EREAELLTNFQHENIVKFYGV-CTEGDPPIM---VFEYMEHGDLNKFLRSHGPDAAFLKS 111

Query: 95  -----GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES-GAKIADFGCAK- 147
                G L  S ++    QI  G+ YL S   VH D+ +RN L+      KI DFG ++ 
Sbjct: 112 PDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRD 171

Query: 148 -WESEALQSGGTPM----FMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADP 201
            + ++  + GG  M    +M PE          SD+W+ G  + E+ + G  PW   ++ 
Sbjct: 172 VYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE 231

Query: 202 MTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKER 240
             V+  I   R L + P     +  D +  C +RDP++R
Sbjct: 232 -EVIECITQGRLL-QRPRTCPSEVYDIMLGCWKRDPQQR 268

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 78.1 bits (192), Expect = 7e-16
 Identities = 87/330 (26%), Positives = 142/330 (43%), Gaps = 58/330 (17%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAK---STELPK---SEFLQREQKFLSSLNSP 55
           D+     IG+G+   V L     +  V+A K     E+ K   S F   E+  ++  NSP
Sbjct: 44  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 103

Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTL-----NDEIHRNGGRLDESLIVSYTRQIL 110
            +V         +D++ +Y + MEY PGG L     N ++     R        YT +++
Sbjct: 104 WVVQLF---YAFQDDRYLY-MVMEYMPGGDLVNLMSNYDVPEKWARF-------YTAEVV 152

Query: 111 QGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFG-CAKWESEAL----QSGGTPMFMAP 164
             L+ +HS   +H D+K  N+L+ +SG  K+ADFG C K   E +     + GTP +++P
Sbjct: 153 LALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISP 212

Query: 165 EVARGE----HQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLY-KIAYSRELPEVP- 218
           EV + +    + G   D W+VG  + EM  G  P+   AD +   Y KI   +     P 
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF--YADSLVGTYSKIMNHKNSLTFPD 270

Query: 219 -AFLSKQANDFLSNCL--RRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSILDQ 275
              +SK+A + +   L  R     R    ++ +H F +                    DQ
Sbjct: 271 DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN-------------------DQ 311

Query: 276 GIWNSVEETEESLGNLIHSTSKTSARERIE 305
             W ++ +T   +   + S   TS  + IE
Sbjct: 312 WAWETLRDTVAPVVPDLSSDIDTSNFDDIE 341

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 77.7 bits (191), Expect = 7e-16
 Identities = 64/201 (31%), Positives = 101/201 (50%), Gaps = 21/201 (10%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQR--------EQKFLS-SLNSPHIVG 59
           +G+GS   V LA    + +++A K   L K   +Q         E++ L+ S   P +  
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKI--LKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQ 65

Query: 60  YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN 119
              C  T +  +L +   MEY  GG L  +I + G R  E   V Y  +I  GL +LHS 
Sbjct: 66  LHSCFQTMD--RLYF--VMEYVNGGDLMYQIQQVG-RFKEPHAVFYAAEIAIGLFFLHSK 120

Query: 120 RVVHCDIKSRNILM-AESGAKIADFGCAK---WESEALQS-GGTPMFMAPEVARGEHQGF 174
            +++ D+K  N+++ +E   KIADFG  K   W+    ++  GTP ++APE+   +  G 
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGK 180

Query: 175 ASDIWAVGCTVIEMASGGAPW 195
           + D WA G  + EM +G AP+
Sbjct: 181 SVDWWAFGVLLYEMLAGQAPF 201

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 77.0 bits (189), Expect = 9e-16
 Identities = 76/294 (25%), Positives = 119/294 (40%), Gaps = 59/294 (20%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ----REQKFLSSLNSPHIVGYKGCD 64
           +G+GS ATV    S  +G + A K   L + E       RE   L  L   +IV      
Sbjct: 13  LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72

Query: 65  VTSEDNKLMYNL-------FMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLH 117
            T E   L++         +M+  PGG     +H    +L       +  Q+L+GL Y+H
Sbjct: 73  HTKETLTLVFEYVHTDLCQYMDKHPGG-----LHPENVKL-------FLFQLLRGLSYIH 120

Query: 118 SNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSGG----TPMFMAPEVARGEHQ 172
              ++H D+K +N+L++++G  K+ADFG A+ +S    +      T  +  P+V  G  +
Sbjct: 121 QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTE 180

Query: 173 -GFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELP---------EVPAFLS 222
                D+W VGC  +EM  G A +P   D    L +I      P          +P F  
Sbjct: 181 YSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKP 240

Query: 223 KQ---------------------ANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
           ++                     A D  S  L+  PK R +A   L H +  + 
Sbjct: 241 ERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 76.4 bits (188), Expect = 2e-15
 Identities = 72/270 (26%), Positives = 120/270 (44%), Gaps = 33/270 (12%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQR--------EQKFLSSLNSPHIVGY 60
           IG+G+   V++     +G V+A K   L K E L+R        E+  L + +   I   
Sbjct: 9   IGRGAFGEVAVVKMKNTGQVYAMKI--LNKWEMLKRAETACFREERDVLVNGDRRWITNL 66

Query: 61  KGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNR 120
                  +D   +Y L M+Y  GG L   + +   RL E +   Y  +++  ++ +H   
Sbjct: 67  H---YAFQDENNLY-LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG 122

Query: 121 VVHCDIKSRNILMAESG-AKIADFG-CAKWESE-ALQSG---GTPMFMAPEVARGEHQGF 174
            VH DIK  N+L+ ++G  ++ADFG C +  ++  +QS    GTP +++PE+ +    G 
Sbjct: 123 YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGK 182

Query: 175 AS-----DIWAVGCTVIEMASGGAPWPNAADPMTVLY-KIAYSRE---LPEVPAFLSKQA 225
                  D W++G  + EM  G  P+   A+ +   Y KI   +E    P     +S++A
Sbjct: 183 GRYGPECDWWSLGVCMYEMLYGETPF--YAESLVETYGKIMNHKEHFQFPPDVTDVSEEA 240

Query: 226 NDFLSN--CLRRDPKERWAASQLLKHPFLE 253
            D +    C       R        HPF E
Sbjct: 241 KDLIRRLICSPETRLGRNGLQDFKDHPFFE 270

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 73.9 bits (181), Expect = 6e-15
 Identities = 71/252 (28%), Positives = 111/252 (44%), Gaps = 26/252 (10%)

Query: 7   HTIGQGSSATVSLATSLRSGDVFAAK--STELPKSEFLQREQKFLSSLNSPHIVGYKGCD 64
            TIG+G    V L      G+  A K    +     FL  E   ++ L   ++V   G  
Sbjct: 12  QTIGKGEFGDVMLGD--YRGNKVAVKCIKNDATAQAFLA-EASVMTQLRHSNLVQLLG-- 66

Query: 65  VTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGR--LDESLIVSYTRQILQGLEYLHSNRVV 122
           V  E+   +Y +  EY   G+L D + R+ GR  L    ++ ++  + + +EYL +N  V
Sbjct: 67  VIVEEKGGLY-IVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFV 124

Query: 123 HCDIKSRNILMAESG-AKIADFGCAKWESEALQSGGTPM-FMAPEVARGEHQGFASDIWA 180
           H D+ +RN+L++E   AK++DFG  K  S    +G  P+ + APE  R +     SD+W+
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWS 184

Query: 181 VGCTVIEMAS-GGAPWPNAADPMTVL-----YKIAYSRELPEVPAFLSKQANDFLSNCLR 234
            G  + E+ S G  P+P       V      YK+      P V         D +  C  
Sbjct: 185 FGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPV-------VYDVMKQCWH 237

Query: 235 RDPKERWAASQL 246
            D   R +  QL
Sbjct: 238 LDAATRPSFLQL 249

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 74.4 bits (183), Expect = 7e-15
 Identities = 67/245 (27%), Positives = 100/245 (40%), Gaps = 41/245 (16%)

Query: 43  QREQKF-----LSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRL 97
           Q +Q F     L+   +P +V        S + K    + MEY  GG     + +N G L
Sbjct: 44  QIQQVFVERDILTFAENPFVVSMFC----SFETKRHLCMVMEYVEGGDCATLL-KNIGAL 98

Query: 98  DESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKW-------- 148
              +   Y  + +  LEYLH+  +VH D+K  N+L+   G  K+ DFG +K         
Sbjct: 99  PVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN 158

Query: 149 ------ESEAL-----QSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPW-- 195
                 E +       Q  GTP ++APEV   +  G   D WA+G  + E   G  P+  
Sbjct: 159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG 218

Query: 196 --PNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERW---AASQLLKHP 250
             P       +   I +    PE    L   A D +S  LR++P ER     A ++ +H 
Sbjct: 219 DTPEELFGQVISDDIEW----PEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHR 274

Query: 251 FLEEF 255
           F    
Sbjct: 275 FFLGL 279

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 73.5 bits (180), Expect = 8e-15
 Identities = 54/172 (31%), Positives = 92/172 (53%), Gaps = 12/172 (6%)

Query: 76  LFMEYAPGGTLNDEIHRNGGRLDESLI--VSYTRQILQGLEYLHSNRVVHCDIKSRNILM 133
           + ME    G L + + R  GR   S+I  + ++  + +G+EYL S ++VH D+ +RNIL+
Sbjct: 75  IVMELMSKGNLVNFL-RTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILV 133

Query: 134 AESG-AKIADFGCAKWESEALQSGGTPM-FMAPEVARGEHQGFASDIWAVGCTVIEMAS- 190
           +E G AK++DFG A+  S  + +   P+ + APE  + +     SD+W+ G  + E+ S 
Sbjct: 134 SEDGVAKVSDFGLARVGSMGVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSY 193

Query: 191 GGAPWPN-AADPMTVLYKIAYSRELPE-VPAFLSKQANDFLSNCLRRDPKER 240
           G AP+P  +   +    +  Y  E PE  PA         +++C   +PK+R
Sbjct: 194 GRAPYPKMSLKEVKECVEKGYRMEPPEGCPA----DVYVLMTSCWETEPKKR 241

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 73.9 bits (181), Expect = 8e-15
 Identities = 64/198 (32%), Positives = 96/198 (48%), Gaps = 22/198 (11%)

Query: 9   IGQGSSATVSLATSLRSGDVFAA------KSTE--LPKSEFLQREQKFLSSLNS---PHI 57
           IG+G+   V  A  L++G  F A      ++ E  +P S    RE   L  L +   P++
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTI--REVAVLRHLETFEHPNV 66

Query: 58  VG-YKGCDVTSEDNKLMYNLFMEYAPGG--TLNDEIHRNGGRLDESLIVSYTRQILQGLE 114
           V  +  C V+  D +    L  E+      T  D++   G  +    I     Q+L+GL+
Sbjct: 67  VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG--VPTETIKDMMFQLLRGLD 124

Query: 115 YLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWES-EALQSG--GTPMFMAPEVARGE 170
           +LHS+RVVH D+K +NIL+  SG  K+ADFG A+  S +   +    T  + APEV    
Sbjct: 125 FLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQS 184

Query: 171 HQGFASDIWAVGCTVIEM 188
                 D+W+VGC   EM
Sbjct: 185 SYATPVDLWSVGCIFAEM 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 73.5 bits (180), Expect = 1e-14
 Identities = 67/243 (27%), Positives = 106/243 (43%), Gaps = 42/243 (17%)

Query: 44  REQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLND-EIHRNGGRLDESLI 102
           RE K L +L   +IV  K  +      KL   L  EY     L   E   NG   ++  +
Sbjct: 49  RELKMLRTLKQENIVELK--EAFRRRGKLY--LVFEYVEKNMLELLEEMPNGVPPEK--V 102

Query: 103 VSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSG----- 156
            SY  Q+++ + + H N +VH DIK  N+L++ +   K+ DFG A+  SE   +      
Sbjct: 103 RSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYV 162

Query: 157 GTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAA--DPMTVLYKIA----- 209
            T  + +PE+  G   G A D+W+VGC + E++ G   +P  +  D +  + K+      
Sbjct: 163 ATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPA 222

Query: 210 ------YSR------ELPEV--PAFLSKQAN--------DFLSNCLRRDPKERWAASQLL 247
                 YS         P V  P  L ++          D + N L+ +P +R+   Q L
Sbjct: 223 EQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCL 282

Query: 248 KHP 250
            HP
Sbjct: 283 NHP 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 73.5 bits (180), Expect = 1e-14
 Identities = 58/186 (31%), Positives = 89/186 (47%), Gaps = 33/186 (17%)

Query: 49  LSSLNSPHIVGYKG-CDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTR 107
           + SL+  +IV   G C   S        L  + +P G+L D + ++   LD   ++++  
Sbjct: 63  MGSLDHAYIVRLLGICPGAS------LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCV 116

Query: 108 QILQGLEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKW-----ESEALQSGGTPM- 160
           QI +G+ YL  +R+VH ++ +RNIL+ ++S  +IADFG A       +        TP+ 
Sbjct: 117 QIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIK 176

Query: 161 FMAPE---VARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEV 217
           +MA E     R  HQ   SD+W+ G TV EM S G      A+P   +          EV
Sbjct: 177 WMALESILFGRYTHQ---SDVWSYGVTVWEMMSYG------AEPYAGM-------RPHEV 220

Query: 218 PAFLSK 223
           P  L K
Sbjct: 221 PDLLEK 226

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 73.9 bits (181), Expect = 2e-14
 Identities = 70/286 (24%), Positives = 120/286 (41%), Gaps = 43/286 (15%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ-----REQKFLSSLNSPHIVGYKGC 63
           +G G+  +V  A   ++G   A K    P    +      RE + L  +   +++G    
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL--L 82

Query: 64  DVTSEDNKLM-YN--LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNR 120
           DV +    L  +N    + +  G  LN+ +     +L +  +     QIL+GL+Y+HS  
Sbjct: 83  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHSAD 140

Query: 121 VVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSG-GTPMFMAPEVARG-EHQGFASD 177
           ++H D+K  N+ + E    KI DFG A+   + +     T  + APE+     H     D
Sbjct: 141 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVD 200

Query: 178 IWAVGCTVIEMASGGAPWPN--------------AADPMTVLYKIA------YSRELPEV 217
           IW+VGC + E+ +G   +P                     +L KI+      Y + L ++
Sbjct: 201 IWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM 260

Query: 218 P------AFL--SKQANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
           P       F+  +  A D L   L  D  +R  A+Q L H +  ++
Sbjct: 261 PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 306

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 73.7 bits (181), Expect = 2e-14
 Identities = 78/298 (26%), Positives = 122/298 (40%), Gaps = 50/298 (16%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTEL--PKS-EFLQREQKFLSSLNSPHIV------G 59
           +G GS+  V  A         A K   L  P+S +   RE K +  L+  +IV      G
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72

Query: 60  YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHR--NGGRLDESLIVSYTRQILQGLEYLH 117
             G D+T ED   +  L   Y     +  ++      G L E     +  Q+L+GL+Y+H
Sbjct: 73  PSGSDLT-EDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLKYIH 131

Query: 118 SNRVVHCDIKSRNILMAESGA--KIADFGCAK-----WESEALQSGG--TPMFMAPE-VA 167
           S  V+H D+K  N+ +       KI DFG A+     +  +   S G  T  + +P  + 
Sbjct: 132 SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLL 191

Query: 168 RGEHQGFASDIWAVGCTVIEMASGGAPWPNAAD---PMTVLYKIAYSRE------LPEVP 218
              +   A D+WA GC   EM +G   +  A +      +L  +   RE      L  +P
Sbjct: 192 SPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIP 251

Query: 219 AFLSK------------------QANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSC 258
           +F+                    +A DFL   L  +P +R  A + L HP++  + SC
Sbjct: 252 SFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY-SC 308

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 72.5 bits (178), Expect = 2e-14
 Identities = 59/214 (27%), Positives = 100/214 (46%), Gaps = 23/214 (10%)

Query: 39  SEFLQREQKFLSSLNSPHIVG-YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGR- 96
            +FL  E + +  L  P ++  Y  C  T E+   +    M+Y   G+L + +    GR 
Sbjct: 46  KDFL-AEAQIMKKLRHPKLIQLYAVC--TLEEPIYIVTELMKY---GSLLEYLQGGAGRA 99

Query: 97  LDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKW----ESE 151
           L    ++    Q+  G+ YL +   +H D+ +RN+L+ E+   K+ADFG A+       E
Sbjct: 100 LKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159

Query: 152 ALQSGGTPM-FMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMT---VLY 206
           A +    P+ + APE A        SD+W+ G  + E+ + G  P+P     MT   VL 
Sbjct: 160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPG----MTNAEVLQ 215

Query: 207 KIAYSRELPEVPAFLSKQANDFLSNCLRRDPKER 240
           ++     +P  P    K+  D + +C + DP +R
Sbjct: 216 QVDQGYRMPC-PPGCPKELYDIMLDCWKEDPDDR 248

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 73.2 bits (180), Expect = 2e-14
 Identities = 75/303 (24%), Positives = 109/303 (35%), Gaps = 73/303 (24%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKST--ELPKSEF---LQREQKFLSSLNSPHIVG-YKG 62
           IGQG+   V  A   ++  + A K    E  K  F     RE K L  L   ++V   + 
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 79

Query: 63  CDVTSEDNKLMYNL----------FMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQG 112
           C          YN           F E+   G L+++      +   S I    + +L G
Sbjct: 80  C----RTKATPYNRYKGSFYLVFEFCEHDLAGLLSNK----NVKFTLSEIKKVMKMLLNG 131

Query: 113 LEYLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSGGTPM--------FMA 163
           L Y+H N+++H D+K+ NIL+ + G  K+ADFG A+  S +  S             +  
Sbjct: 132 LYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRP 191

Query: 164 PEVARGE-HQGFASDIWAVGCTVIEM------ASGGAP------------------WPNA 198
           PE+  GE   G   D+W  GC + EM        G                     WP  
Sbjct: 192 PELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPG- 250

Query: 199 ADPMTVLYKIAYSRELPE----------VPAFLSKQANDFLSNCLRRDPKERWAASQLLK 248
                   ++    ELP+           P      A D +   L  DP +R  A   L 
Sbjct: 251 ----VDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306

Query: 249 HPF 251
           H F
Sbjct: 307 HDF 309

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 72.5 bits (178), Expect = 2e-14
 Identities = 64/213 (30%), Positives = 100/213 (46%), Gaps = 21/213 (9%)

Query: 38  KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRL 97
           + +FLQ E   +   + PHIV   G  V +E+   ++ + ME AP G L   +  N   L
Sbjct: 51  REKFLQ-EAYIMRQFDHPHIVKLIG--VITENP--VW-IVMELAPLGELRSYLQVNKYSL 104

Query: 98  DESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAE-SGAKIADFGCAKW-ESEAL-- 153
           D + ++ Y+ Q+   L YL S R VH DI +RN+L++     K+ DFG +++ E E+   
Sbjct: 105 DLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYK 164

Query: 154 -QSGGTPM-FMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPW---PNAADPMTVLYK 207
              G  P+ +MAPE         ASD+W  G  + E+   G  P+    N      V+ +
Sbjct: 165 ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN----DVIGR 220

Query: 208 IAYSRELPEVPAFLSKQANDFLSNCLRRDPKER 240
           I     LP +P          ++ C   DP +R
Sbjct: 221 IENGERLP-MPPNCPPTLYSLMTKCWAYDPSKR 252

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 72.9 bits (179), Expect = 2e-14
 Identities = 76/275 (27%), Positives = 111/275 (40%), Gaps = 50/275 (18%)

Query: 8   TIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQR-EQK--------FLSSLNSPHIV 58
            IG+GS   V LA     G  +A K   L K   L++ EQK         L ++  P +V
Sbjct: 2   VIGKGSFGKVLLAKHKADGKFYAVKV--LQKKAILKKKEQKHIMAERNVLLKNVKHPFLV 59

Query: 59  GYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHS 118
           G      T++  KL + L  +Y  GG L   + R      E     Y  +I   L YLHS
Sbjct: 60  GLHYSFQTAD--KLYFVL--DYVNGGELFFHLQRER-SFPEPRARFYAAEIASALGYLHS 114

Query: 119 NRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG----GTPMFMAPEVARGEHQG 173
             +++ D+K  NIL+   G   + DFG  K   E  ++     GTP ++APEV R +   
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYD 174

Query: 174 FASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPE-----------VPAFLS 222
              D W +G  + EM  G  P+              YSR+  E           +   +S
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPPF--------------YSRDTAEMYDNILNKPLRLKPNIS 220

Query: 223 KQANDFLSNCLRRDPKERWAAS----QLLKHPFLE 253
             A   L   L++D  +R  A     ++  H F  
Sbjct: 221 VSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFS 255

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 72.1 bits (177), Expect = 3e-14
 Identities = 61/257 (23%), Positives = 113/257 (43%), Gaps = 16/257 (6%)

Query: 1   MDWTRGHTIGQGSSATVSLATSLRSGDVF--AAKSTELPKSEFLQREQKFLSSLNSPHIV 58
            + T    +G G    V L       DV     +   + + +F++ E K +  L+ P++V
Sbjct: 4   SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIE-EAKVMMKLSHPNLV 62

Query: 59  GYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHS 118
              G  V ++   +   +  EY   G L + +    G+L    ++     + + +EYL S
Sbjct: 63  QLYG--VCTKQRPIF--IVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLES 118

Query: 119 NRVVHCDIKSRNILMAESGA-KIADFGCAKW--ESEALQSGGT--PM-FMAPEVARGEHQ 172
           N  +H D+ +RN L+ E    K++DFG A++  + +   S GT  P+ +  PEV      
Sbjct: 119 NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRF 178

Query: 173 GFASDIWAVGCTVIEMASGGA-PWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSN 231
              SD+W+ G  + E+ S G  P+   ++   V+  ++    L   P     +    + +
Sbjct: 179 SSKSDVWSFGVLMWEVFSEGKMPYERFSN-SEVVESVSAGYRLYR-PKLAPTEVYTIMYS 236

Query: 232 CLRRDPKERWAASQLLK 248
           C    P++R A  +LL 
Sbjct: 237 CWHEKPEDRPAFKKLLS 253

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 72.7 bits (178), Expect = 3e-14
 Identities = 70/249 (28%), Positives = 112/249 (44%), Gaps = 30/249 (12%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQR--------EQKFLSSLNSP-HIVG 59
           +G+GS   V LA    + +++A K   L K   +Q         E++ L+  + P  +  
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKI--LKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQ 65

Query: 60  YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN 119
              C  T +  +L +   MEY  GG L   I + G +  E   V Y  +I  GL +LH  
Sbjct: 66  LHSCFQTVD--RLYF--VMEYVNGGDLMYHIQQVG-KFKEPQAVFYAAEISVGLFFLHRR 120

Query: 120 RVVHCDIKSRNILM-AESGAKIADFGCAKWESEALQSG-------GTPMFMAPEVARGEH 171
            +++ D+K  N+++ +E   KIADFG  K   E +  G       GTP ++APE+   + 
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMVDGVTTRTFCGTPDYIAPEIIAYQP 177

Query: 172 QGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSN 231
            G + D WA G  + EM +G  P+ +  D   +   I         P  LSK+A      
Sbjct: 178 YGKSVDWWAYGVLLYEMLAGQPPF-DGEDEDELFQSIMEHN--VSYPKSLSKEAVSICKG 234

Query: 232 CLRRDPKER 240
            + + P +R
Sbjct: 235 LMTKHPSKR 243

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 71.5 bits (175), Expect = 4e-14
 Identities = 57/185 (30%), Positives = 87/185 (47%), Gaps = 20/185 (10%)

Query: 34  TELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRN 93
            E    + + RE + +  L++P+IV   G     E   LM  L ME A GG LN  +   
Sbjct: 34  NEKSVRDEMMREAEIMHQLDNPYIVRMIG---VCEAEALM--LVMEMASGGPLNKFL--- 85

Query: 94  GGRLDE---SLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMA-ESGAKIADFGCAKWE 149
            G+ DE   S +V    Q+  G++YL     VH D+ +RN+L+  +  AKI+DFG +K  
Sbjct: 86  SGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKAL 145

Query: 150 S------EALQSGGTPM-FMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADP 201
                  +A  +G  P+ + APE          SD+W+ G T+ E  S G  P+     P
Sbjct: 146 GADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP 205

Query: 202 MTVLY 206
             + +
Sbjct: 206 EVMSF 210

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 71.2 bits (175), Expect = 6e-14
 Identities = 67/270 (24%), Positives = 116/270 (42%), Gaps = 39/270 (14%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFL--------SSLNSPHIVGY 60
           IG+G+  TV+      SG + A K     +S   ++EQK L         S + P+IV +
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRI---RSTVDEKEQKRLLMDLDVVMRSSDCPYIVKF 68

Query: 61  KGCDVTSED----NKLM---YNLFMEYAPGGTLNDEIHRNG-GRLDESLIVSYTRQILQG 112
            G      D     +LM    + F +Y         ++      + E ++       ++ 
Sbjct: 69  YGALFREGDCWICMELMDISLDKFYKY---------VYEVLKSVIPEEILGKIAVATVKA 119

Query: 113 LEYLHSN-RVVHCDIKSRNILMAESGA-KIADFG-CAKWESEALQS--GGTPMFMAPE-V 166
           L YL    +++H D+K  NIL+  +G  K+ DFG   +      ++   G   +MAPE +
Sbjct: 120 LNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 179

Query: 167 ARGEHQGF--ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYS---RELPEVPAFL 221
                 G+   SD+W++G T+ E+A+G  P+P        L ++                
Sbjct: 180 DPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREF 239

Query: 222 SKQANDFLSNCLRRDPKERWAASQLLKHPF 251
           S    +F++ CL +D  +R    +LL+HPF
Sbjct: 240 SPSFVNFINLCLIKDESKRPKYKELLEHPF 269

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 71.2 bits (174), Expect = 9e-14
 Identities = 78/263 (29%), Positives = 113/263 (42%), Gaps = 28/263 (10%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQR-EQK--------FLSSLNSPHIVG 59
           IG+GS   V LA     G  +A K   L K   L R EQK         L ++  P +VG
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKV--LQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 60  YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN 119
                 T+E  KL + L  ++  GG L   + R      E     Y  +I   L YLHS 
Sbjct: 61  LHYSFQTTE--KLYFVL--DFVNGGELFFHLQRERS-FPEPRARFYAAEIASALGYLHSI 115

Query: 120 RVVHCDIKSRNILMAESG-AKIADFG-CAKWESEALQSG---GTPMFMAPEVARGEHQGF 174
            +V+ D+K  NIL+   G   + DFG C +  +++  +    GTP ++APEV R +    
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDN 175

Query: 175 ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLR 234
             D W +G  + EM  G  P+      +  +Y     + L   P   S  A   L   L 
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPF--YCRDVAEMYDNILHKPLVLRPG-ASLTAWSILEELLE 232

Query: 235 RDPKERWAAS----QLLKHPFLE 253
           +D + R  A     ++ +HPF E
Sbjct: 233 KDRQRRLGAKEDFLEIQEHPFFE 255

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 71.4 bits (175), Expect = 1e-13
 Identities = 85/312 (27%), Positives = 128/312 (41%), Gaps = 84/312 (26%)

Query: 8   TIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTS 67
           TIG G+   V L   + +  ++A K+  L K++ L R Q       + H+   +  D+ +
Sbjct: 8   TIGIGAFGEVCLVRKVDTNALYAMKT--LRKADVLMRNQ-------AAHVKAER--DILA 56

Query: 68  E-DN----KLMY------NLF--MEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLE 114
           E DN    KL Y      NL+  M+Y PGG +   + R G   +E L   Y  ++   +E
Sbjct: 57  EADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLG-IFEEDLARFYIAELTCAIE 115

Query: 115 YLHSNRVVHCDIKSRNILMAESG-AKIADFG-CA--KW--ESEALQSG------------ 156
            +H    +H DIK  NIL+   G  K+ DFG C   +W  +S+  Q G            
Sbjct: 116 SVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSE 175

Query: 157 ------------------------------GTPMFMAPEV-AR-GEHQGFASDIWAVGCT 184
                                         GTP ++APEV  R G  Q    D W+VG  
Sbjct: 176 EWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQ--LCDWWSVGVI 233

Query: 185 VIEMASGGAPWPNAADPMTVLYKIAYSRELPEVP--AFLSKQANDFLSNCLRRDPKERWA 242
           + EM  G  P+  A  P     K+        +P  A LS++A+D +   L    ++R  
Sbjct: 234 LYEMLVGQPPF-LADTPAETQLKVINWETTLHIPSQAKLSREASDLILR-LCCGAEDRLG 291

Query: 243 ---ASQLLKHPF 251
              A ++  HPF
Sbjct: 292 KNGADEIKAHPF 303

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 70.3 bits (172), Expect = 1e-13
 Identities = 53/188 (28%), Positives = 91/188 (48%), Gaps = 24/188 (12%)

Query: 83  GGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIA 141
           GG L+  + ++G    E+ +  Y  +I+ GLE++H+  VV+ D+K  NIL+ E G  +I+
Sbjct: 81  GGDLHYHLSQHG-VFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRIS 139

Query: 142 DFG--CAKWESEALQSGGTPMFMAPEV-ARGEHQGFASDIWAVGCTVIEMASGGAPW--- 195
           D G  C   + +   S GT  +MAPEV  +G     ++D +++GC + ++  G +P+   
Sbjct: 140 DLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 199

Query: 196 ----PNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKER-----WAASQL 246
                +  D MT+           E+P   S +    L   L+RD   R       A ++
Sbjct: 200 KTKDKHEIDRMTLTMA-------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEV 252

Query: 247 LKHPFLEE 254
            +HPF   
Sbjct: 253 KEHPFFRS 260

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 70.4 bits (172), Expect = 1e-13
 Identities = 64/231 (27%), Positives = 106/231 (45%), Gaps = 29/231 (12%)

Query: 32  KSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIH 91
           +++E  + +F QRE + L+ L   HIV + G  V +E   L+  +  EY   G LN  + 
Sbjct: 45  EASESARQDF-QREAELLTVLQHQHIVRFYG--VCTEGRPLL--MVFEYMRHGDLNRFLR 99

Query: 92  RNG--------------GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES- 136
            +G              G+L    +++   QI  G+ YL S   VH D+ +RN L+ +  
Sbjct: 100 SHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL 159

Query: 137 GAKIADFGCAK--WESEALQSGGTPM----FMAPEVARGEHQGFASDIWAVGCTVIEMAS 190
             KI DFG ++  + ++  + GG  M    +M PE          SDIW+ G  + E+ +
Sbjct: 160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219

Query: 191 -GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKER 240
            G  PW   ++    +  I   REL E P     +    +  C +R+P++R
Sbjct: 220 YGKQPWYQLSN-TEAIECITQGREL-ERPRTCPPEVYAIMQGCWQREPQQR 268

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 70.4 bits (172), Expect = 1e-13
 Identities = 70/284 (24%), Positives = 116/284 (40%), Gaps = 42/284 (14%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ----REQKFLSSLNSPHIVGYKGCD 64
           +G+G+ ATV    S  + ++ A K   L   E       RE   L  L   +IV     D
Sbjct: 14  LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH--D 71

Query: 65  VTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHC 124
           +   +  L   L  EY     L   +   G  ++   +  +  Q+L+GL Y H  +V+H 
Sbjct: 72  IIHTEKSL--TLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHR 128

Query: 125 DIKSRNILMAESGA-KIADFGCAKWESEALQSGG----TPMFMAPEVARGEHQGFAS-DI 178
           D+K +N+L+ E G  K+ADFG A+ +S   ++      T  +  P++  G        D+
Sbjct: 129 DLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDM 188

Query: 179 WAVGCTVIEMASG--------------------GAP----WP---NAADPMTVLYKIAYS 211
           W VGC   EM++G                    G P    WP   +  +  +  Y    +
Sbjct: 189 WGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRA 248

Query: 212 RELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
             L      L     + LS  L+ + ++R +A + +KHP+    
Sbjct: 249 DCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCL 292

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 69.9 bits (171), Expect = 2e-13
 Identities = 69/251 (27%), Positives = 110/251 (43%), Gaps = 32/251 (12%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSE 68
           +G GS        +LR G      +T+  K EFL+ E   +S+ N P+IV   G  +   
Sbjct: 20  LGPGSGPIRVAVKTLRKG------ATDQEKKEFLK-EAHLMSNFNHPNIVKLLGVCL--- 69

Query: 69  DNKLMYNLFMEYAPGGTL-----NDEIHRNGGR-LDESLIVSYTRQILQGLEYLHSNRVV 122
            N+  Y + ME   GG L     +  + R G   L    ++     + +G  YL     +
Sbjct: 70  LNEPQY-IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFI 128

Query: 123 HCDIKSRNILMAESG------AKIADFGCAK--WESEALQSGGTPM----FMAPEVARGE 170
           H D+ +RN L++E G       KI DFG A+  ++S+  +  G  +    +MAPE     
Sbjct: 129 HRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDG 188

Query: 171 HQGFASDIWAVGCTVIE-MASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFL 229
                SD+W+ G  + E +  G  P+P A +   VL  +     L + P     +    +
Sbjct: 189 KFTTQSDVWSFGVLMWEILTLGQQPYP-ALNNQEVLQHVTAGGRL-QKPENCPDKIYQLM 246

Query: 230 SNCLRRDPKER 240
           +NC  +DP ER
Sbjct: 247 TNCWAQDPSER 257

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 70.6 bits (173), Expect = 2e-13
 Identities = 81/316 (25%), Positives = 120/316 (37%), Gaps = 61/316 (19%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTE-----LPKSEFLQREQKFLSSLNSPHIVGYKGC 63
           IG+GS   V  A    +G+  A K        +  +  + RE K L  L  P IV  K  
Sbjct: 8   IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 67

Query: 64  DVTSEDN--KLMYNLF--MEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN 119
            +       K +Y +F  ME      L+  I  N     E     +  Q+L+ L+Y+H+ 
Sbjct: 68  MLPPSRREFKDIYVVFELME----SDLHQVIKANDDLTPEHHQF-FLYQLLRALKYIHTA 122

Query: 120 RVVHCDIKSRNILM-AESGAKIADFGCAKWESEALQSGGTPMF----------MAPEVAR 168
            V H D+K +NIL  A+   KI DFG A+    A     T +F           APE+  
Sbjct: 123 NVFHRDLKPKNILANADCKLKICDFGLAR---VAFNDTPTAIFWTDYVATRWYRAPELCG 179

Query: 169 GEHQGF--ASDIWAVGCTVIEMASG--------------------GAPWPNAADPMTVLY 206
                +  A DIW++GC   E+ +G                    G P P     +    
Sbjct: 180 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEK 239

Query: 207 KIAYSREL-PEVPAFLSKQ-------ANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSC 258
              Y   +  + P   S++       A   L   L  DPK+R  A + L  P+   F   
Sbjct: 240 ARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPY---FKGL 296

Query: 259 TKQIQESNCSPTSILD 274
            K  +E +  P + L+
Sbjct: 297 AKVEREPSAQPITKLE 312

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 69.7 bits (170), Expect = 2e-13
 Identities = 74/282 (26%), Positives = 115/282 (40%), Gaps = 44/282 (15%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ----REQKFLSSLNSPHIVGYKGCD 64
           +G+G+ ATV    S  + ++ A K   L   E       RE   L +L   +IV     D
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLH--D 70

Query: 65  VTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHC 124
           +   +  L   L  EY     L   +   G  +    +  +  Q+L+GL Y H  +++H 
Sbjct: 71  IIHTERCL--TLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHR 127

Query: 125 DIKSRNILMAESGA-KIADFGCAKWESEALQSGG----TPMFMAPEVARGEHQ-GFASDI 178
           D+K +N+L+ E G  K+ADFG A+ +S   ++      T  +  P+V  G  +     D+
Sbjct: 128 DLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDM 187

Query: 179 WAVGCTVIEMASG--------------------GAP----WPN-AADPMTVLYKIAYSRE 213
           W VGC + EMA+G                    G P    WP   ++     Y     R 
Sbjct: 188 WGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRA 247

Query: 214 LP---EVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFL 252
            P     P  L     D LS+ L  + K R +A   L+H + 
Sbjct: 248 QPLINHAPR-LDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 68.9 bits (168), Expect = 2e-13
 Identities = 68/246 (27%), Positives = 105/246 (42%), Gaps = 22/246 (8%)

Query: 9   IGQGSSATVSLATSLRSGDV-FAAKSTE--LP---KSEFLQREQKFLSSLNSPHIVGYKG 62
           IG+G+   V  +  LR+ +   A KS    LP   K++FLQ E + L   + P+IV   G
Sbjct: 3   IGRGNFGEV-FSGRLRADNTPVAVKSCRETLPPDLKAKFLQ-EARILKQYSHPNIVRLIG 60

Query: 63  CDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
             V ++   +   + ME   GG     +   G RL    ++        G+EYL S   +
Sbjct: 61  --VCTQKQPIY--IVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCI 116

Query: 123 HCDIKSRNILMAESGA-KIADFGCAKWESEALQSGGTPM------FMAPEVARGEHQGFA 175
           H D+ +RN L+ E    KI+DFG ++ E + + +    M      + APE          
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSE 176

Query: 176 SDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLR 234
           SD+W+ G  + E  S G  P+ N ++  T    I     LP  P          +  C  
Sbjct: 177 SDVWSFGILLWEAFSLGAVPYANLSNQQTREA-IEQGVRLP-CPELCPDAVYRLMERCWE 234

Query: 235 RDPKER 240
            DP +R
Sbjct: 235 YDPGQR 240

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 69.7 bits (170), Expect = 3e-13
 Identities = 47/155 (30%), Positives = 81/155 (52%), Gaps = 10/155 (6%)

Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWES-----EALQS 155
           +VS T Q+ +G+EYL S + +H D+ +RN+L+ E+   KIADFG A+  +     +   +
Sbjct: 139 LVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTN 198

Query: 156 GGTPM-FMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRE 213
           G  P+ +MAPE          SD+W+ G  + E+ + GG+P+P    P+  L+K+     
Sbjct: 199 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI--PVEELFKLLKEGH 256

Query: 214 LPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLK 248
             + PA  + +    + +C    P  R    QL++
Sbjct: 257 RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVE 291

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 69.6 bits (170), Expect = 3e-13
 Identities = 62/212 (29%), Positives = 98/212 (46%), Gaps = 17/212 (8%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ----REQKFLSSLNSPHIVGYKGCD 64
           +G+G+ ATV    S  + ++ A K   L   E       RE   L  L   +IV     D
Sbjct: 14  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH--D 71

Query: 65  VTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHC 124
           +   D  L   L  EY     L   +   G  +    +  +  QIL+GL Y H  +V+H 
Sbjct: 72  IVHTDKSL--TLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHR 128

Query: 125 DIKSRNILMAESGA-KIADFGCAKWESEALQSGG----TPMFMAPEVARGEHQ-GFASDI 178
           D+K +N+L+ E G  K+ADFG A+ +S   ++      T  +  P+V  G  +     D+
Sbjct: 129 DLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDM 188

Query: 179 WAVGCTVIEMASGGAPWPNAA--DPMTVLYKI 208
           W VGC   EMASG   +P +   D + +++++
Sbjct: 189 WGVGCIFFEMASGRPLFPGSTVEDELHLIFRL 220

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 70.4 bits (172), Expect = 3e-13
 Identities = 75/292 (25%), Positives = 122/292 (41%), Gaps = 47/292 (16%)

Query: 6   GHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIV-----GY 60
           G+ IG GS   V  A  + + +  A K   L   ++  RE   + +LN  +I+      Y
Sbjct: 71  GNIIGNGSFGVVYEAICIDTSEKVAIKKV-LQDPQYKNRELLIMKNLNHINIIFLKDYYY 129

Query: 61  KGCDVTSEDNKLMYNLFMEYAPGGTLNDEIH--RNGGRLDESLIVSYTRQILQGLEYLHS 118
             C   +E N +  N+ ME+ P        H  RN   L   L+  Y+ Q+ + L Y+HS
Sbjct: 130 TECFKKNEKN-IFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS 188

Query: 119 NRVVHCDIKSRNILMAES--GAKIADFGCAKWESEALQSGG---TPMFMAPEVARGEHQG 173
             + H D+K +N+L+  +    K+ DFG AK      +S     +  + APE+  G    
Sbjct: 189 KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNY 248

Query: 174 FAS-DIWAVGCTVIEMASG--------------------GAPW--------PNAADPMTV 204
               D+W++GC + EM  G                    G P         PN AD   +
Sbjct: 249 TTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYAD---I 305

Query: 205 LYKIAYSRELPEV-PAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
            +     ++L +V P      A +F+S  L+ +P +R    + L  PF ++ 
Sbjct: 306 KFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL 357

Length = 440

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 69.3 bits (169), Expect = 4e-13
 Identities = 54/172 (31%), Positives = 87/172 (50%), Gaps = 16/172 (9%)

Query: 34  TELPKS--EFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIH 91
           T  PK+  EF+  E   ++S++ PH+V   G  ++         L  +  P G L D +H
Sbjct: 47  TTGPKANVEFMD-EALIMASMDHPHLVRLLGVCLSP-----TIQLVTQLMPHGCLLDYVH 100

Query: 92  RNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKW-- 148
            +   +   L++++  QI +G+ YL   R+VH D+ +RN+L+ + +  KI DFG A+   
Sbjct: 101 EHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE 160

Query: 149 --ESEALQSGG-TPM-FMAPEVARGEHQGFASDIWAVGCTVIE-MASGGAPW 195
             E E    GG  P+ +MA E          SD+W+ G T+ E M  GG P+
Sbjct: 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPY 212

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 69.0 bits (169), Expect = 4e-13
 Identities = 52/196 (26%), Positives = 88/196 (44%), Gaps = 25/196 (12%)

Query: 76  LFMEYAPGGTLNDEIHRN---------------GGRLDESLIVSYTRQILQGLEYLHSNR 120
           + +EYA  G L D +                     L +  +VS+  Q+ +G+E+L S +
Sbjct: 93  VVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK 152

Query: 121 VVHCDIKSRNILMAESGA-KIADFGCAKWESE-----ALQSGGTPM-FMAPEVARGEHQG 173
            +H D+ +RN+L+ E    KIADFG A+            +G  P+ +MAPE        
Sbjct: 153 CIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYT 212

Query: 174 FASDIWAVGCTVIE-MASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNC 232
             SD+W+ G  + E    GG+P+P    P+  L+K+       E P   +++    + +C
Sbjct: 213 HQSDVWSFGVLLWEIFTLGGSPYPGI--PVEELFKLLKEGYRMEKPQNCTQELYHLMRDC 270

Query: 233 LRRDPKERWAASQLLK 248
               P +R    QL++
Sbjct: 271 WHEVPSQRPTFKQLVE 286

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 68.9 bits (168), Expect = 4e-13
 Identities = 62/219 (28%), Positives = 101/219 (46%), Gaps = 26/219 (11%)

Query: 42  LQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNG------- 94
             RE + L++L   HIV + G  V  E + L+  +  EY   G LN  +  +G       
Sbjct: 54  FHREAELLTNLQHEHIVKFYG--VCVEGDPLI--MVFEYMKHGDLNKFLRAHGPDAVLMA 109

Query: 95  -----GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES-GAKIADFGCAK- 147
                  L +S ++   +QI  G+ YL S   VH D+ +RN L+ E+   KI DFG ++ 
Sbjct: 110 EGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRD 169

Query: 148 -WESEALQSGGTPM----FMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADP 201
            + ++  + GG  M    +M PE          SD+W++G  + E+ + G  PW   ++ 
Sbjct: 170 VYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN 229

Query: 202 MTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKER 240
             V+  I   R L + P    K+  D +  C +R+P  R
Sbjct: 230 -EVIECITQGRVL-QRPRTCPKEVYDLMLGCWQREPHMR 266

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 68.5 bits (167), Expect = 4e-13
 Identities = 57/188 (30%), Positives = 88/188 (46%), Gaps = 18/188 (9%)

Query: 79  EYAPGGTLNDEIH-RNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES- 136
           EY   G+L D +    G  L    +V    QI  G+ Y+     VH D+++ NIL+ E+ 
Sbjct: 80  EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL 139

Query: 137 GAKIADFGCAKW----ESEALQSGGTPM-FMAPEVARGEHQGFASDIWAVGCTVIEMASG 191
             K+ADFG A+     E  A Q    P+ + APE A        SD+W+ G  + E+ + 
Sbjct: 140 VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTK 199

Query: 192 G-APWPNAADPMTVLYKIAYSRELP---EVPAFLSKQANDFLSNCLRRDPKERWAASQLL 247
           G  P+P   +   VL ++     +P   E P  L    +D +  C R++P+ER     L 
Sbjct: 200 GRVPYPGMVN-REVLDQVERGYRMPCPPECPESL----HDLMCQCWRKEPEERPTFEYL- 253

Query: 248 KHPFLEEF 255
              FLE++
Sbjct: 254 -QAFLEDY 260

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 69.3 bits (169), Expect = 4e-13
 Identities = 75/266 (28%), Positives = 119/266 (44%), Gaps = 27/266 (10%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTS- 67
           IG+G+   V++     +  VFA K   L K E L+R +          +V      +T+ 
Sbjct: 9   IGRGAFGEVAVVKLKNADKVFAMKI--LNKWEMLKRAETACFREERDVLVNGDNQWITTL 66

Query: 68  ----EDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVH 123
               +D   +Y L M+Y  GG L   + +   RL E +   Y  +++  ++ +H    VH
Sbjct: 67  HYAFQDENNLY-LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVH 125

Query: 124 CDIKSRNILMAESG-AKIADFG-CAK-WESEALQSG---GTPMFMAPEVARGEHQGFAS- 176
            DIK  NILM  +G  ++ADFG C K  E   +QS    GTP +++PE+ +    G    
Sbjct: 126 RDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKY 185

Query: 177 ----DIWAVGCTVIEMASGGAPWPNAADPMTVLY-KIAYSRELPEVPAF---LSKQANDF 228
               D W++G  + EM  G  P+   A+ +   Y KI   +E  + PA    +S+ A D 
Sbjct: 186 GPECDWWSLGVCMYEMLYGETPF--YAESLVETYGKIMNHKERFQFPAQVTDVSEDAKDL 243

Query: 229 LSN--CLRRDPKERWAASQLLKHPFL 252
           +    C R     +       +HPF 
Sbjct: 244 IRRLICSREHRLGQNGIEDFKQHPFF 269

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 68.1 bits (166), Expect = 6e-13
 Identities = 60/215 (27%), Positives = 97/215 (45%), Gaps = 37/215 (17%)

Query: 45  EQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVS 104
           E   ++ + SP++    G  +TS        L  +  P G L D +  N  R+    +++
Sbjct: 59  EAYVMAGVGSPYVCRLLGICLTS-----TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLN 113

Query: 105 YTRQILQGLEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKW----ESEALQSGG-T 158
           +  QI +G+ YL   R+VH D+ +RN+L+ + +  KI DFG A+     E+E    GG  
Sbjct: 114 WCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKV 173

Query: 159 PM-FMAPEVA---RGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSREL 214
           P+ +MA E     R  HQ   SD+W+ G TV E+ + GA  P    P         +RE+
Sbjct: 174 PIKWMALESILHRRFTHQ---SDVWSYGVTVWELMTFGAK-PYDGIP---------AREI 220

Query: 215 PEV---------PAFLSKQANDFLSNCLRRDPKER 240
           P++         P   +      +  C   D + R
Sbjct: 221 PDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECR 255

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 68.1 bits (166), Expect = 8e-13
 Identities = 66/232 (28%), Positives = 111/232 (47%), Gaps = 41/232 (17%)

Query: 42  LQREQKFLSSLNSPHIVG-YKGCDVTSEDNKLMYNLFMEYAPGGTL-------------- 86
           L  E   L  +N PH++  Y  C   S+D  L+  L +EYA  G+L              
Sbjct: 50  LLSEFNLLKQVNHPHVIKLYGAC---SQDGPLL--LIVEYAKYGSLRSFLRESRKVGPSY 104

Query: 87  -NDEIHRNGGRLDE--------SLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG 137
              + +RN   LD           ++S+  QI +G++YL   ++VH D+ +RN+L+AE  
Sbjct: 105 LGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGR 164

Query: 138 -AKIADFGCAK--WESEAL---QSGGTPM-FMAPEVARGEHQGFASDIWAVGCTVIEMAS 190
             KI+DFG ++  +E ++      G  P+ +MA E          SD+W+ G  + E+ +
Sbjct: 165 KMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224

Query: 191 -GGAPWPN-AADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKER 240
            GG P+P  A + +  L K  Y  E PE     S++  + +  C +++P +R
Sbjct: 225 LGGNPYPGIAPERLFNLLKTGYRMERPEN---CSEEMYNLMLTCWKQEPDKR 273

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 67.7 bits (165), Expect = 8e-13
 Identities = 65/266 (24%), Positives = 119/266 (44%), Gaps = 29/266 (10%)

Query: 9   IGQGSSATVSLATSLRSGDVFA-----AKSTELPKSEFLQREQKFLSSLNSPHIVGYKGC 63
           IG+G    V       +G ++A      K  ++ + E L   ++ + SL S     +  C
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 64  DVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVH 123
              +          ++   GG L+  + ++G    E  +  Y  +I+ GLE++H+  VV+
Sbjct: 62  MTYAFHTPDKLCFILDLMNGGDLHYHLSQHG-VFSEKEMRFYATEIILGLEHMHNRFVVY 120

Query: 124 CDIKSRNILMAESG-AKIADFG--CAKWESEALQSGGTPMFMAPEV-ARGEHQGFASDIW 179
            D+K  NIL+ E G  +I+D G  C   + +   S GT  +MAPEV  +G     ++D +
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGTAYDSSADWF 180

Query: 180 AVGCTVIEMASGGAPW-------PNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNC 232
           ++GC + ++  G +P+        +  D MT+   +       E+P   S +    L   
Sbjct: 181 SLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNV-------ELPDSFSPELKSLLEGL 233

Query: 233 LRRDPKERW-----AASQLLKHPFLE 253
           L+RD  +R       A ++ +H F +
Sbjct: 234 LQRDVSKRLGCLGRGAQEVKEHVFFK 259

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 67.3 bits (165), Expect = 1e-12
 Identities = 59/188 (31%), Positives = 89/188 (47%), Gaps = 18/188 (9%)

Query: 79  EYAPGGTLNDEIHRNGGR-LDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG 137
           EY   G+L D +    G+ L    +V    QI +G+ YL S   +H D+ +RNIL+ E+ 
Sbjct: 81  EYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENL 140

Query: 138 A-KIADFGCAKW----ESEALQSGGTPM-FMAPEVARGEHQGFASDIWAVGCTVIE-MAS 190
             KIADFG A+     E  A +    P+ + APE A        SD+W+ G  + E +  
Sbjct: 141 VCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTY 200

Query: 191 GGAPWPNAADPMT---VLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLL 247
           G  P+P     MT   VL ++     +P  P    ++  D +  C  +DP+ER     L 
Sbjct: 201 GRVPYPG----MTNREVLEQVERGYRMPRPPN-CPEELYDLMLQCWDKDPEERPTFEYL- 254

Query: 248 KHPFLEEF 255
              FLE++
Sbjct: 255 -QSFLEDY 261

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 68.2 bits (166), Expect = 1e-12
 Identities = 77/291 (26%), Positives = 123/291 (42%), Gaps = 53/291 (18%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ-----REQKFLSSLNSPHIVGYKGC 63
           +G G+  +V  A   R     A K    P    +      RE + L  +   +++G    
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGL--L 80

Query: 64  DV----TSEDN----KLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
           DV    TS +N     L+ NL      G  LN+ +     +L +  +     Q+L+GL+Y
Sbjct: 81  DVFTPATSIENFNEVYLVTNLM-----GADLNNIVKCQ--KLSDEHVQFLIYQLLRGLKY 133

Query: 116 LHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSG-GTPMFMAPEVARG-EHQ 172
           +HS  ++H D+K  N+ + E    +I DFG A+   + +     T  + APE+     H 
Sbjct: 134 IHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATRWYRAPEIMLNWMHY 193

Query: 173 GFASDIWAVGCTVIEMASGGAPWPN-------------AADPMT-VLYKIA------YSR 212
               DIW+VGC + E+  G A +P                 P   VL KI+      Y +
Sbjct: 194 NQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQ 253

Query: 213 ELPEVP----AFLSKQAN----DFLSNCLRRDPKERWAASQLLKHPFLEEF 255
            LP +P      + + AN    D L   L  D  +R +AS+ L HP+  ++
Sbjct: 254 SLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY 304

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 67.1 bits (164), Expect = 2e-12
 Identities = 70/263 (26%), Positives = 112/263 (42%), Gaps = 30/263 (11%)

Query: 6   GHTIGQGSSATVSLATSL---RSGDVF--AAK----STELPKSEFLQREQKFLSSLNSPH 56
           G T+G G+   V  AT+    +S  V   A K    +    + E L  E K +S L   H
Sbjct: 40  GKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHL-GNH 98

Query: 57  --IVGYKG-CDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGR-LDESLIVSYTRQILQG 112
             IV   G C +       +  +  EY   G L + + R     L    ++S++ Q+ +G
Sbjct: 99  ENIVNLLGACTIGGP----IL-VITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKG 153

Query: 113 LEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAK---WESEALQSGGTPM---FMAPE 165
           + +L S   +H D+ +RN+L+      KI DFG A+    +S  +  G   +   +MAPE
Sbjct: 154 MAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPE 213

Query: 166 VARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPM-TVLYKIAYSRELPEVPAFLSK 223
                   F SD+W+ G  + E+ S G  P+P    P+ +  YK+         P     
Sbjct: 214 SIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGM--PVDSKFYKLIKEGYRMAQPEHAPA 271

Query: 224 QANDFLSNCLRRDPKERWAASQL 246
           +  D +  C   DP +R    Q+
Sbjct: 272 EIYDIMKTCWDADPLKRPTFKQI 294

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 67.8 bits (166), Expect = 2e-12
 Identities = 77/309 (24%), Positives = 120/309 (38%), Gaps = 81/309 (26%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQ--------KFLSSLNSPHIVGY 60
           IG+G+   V L     +G ++A K   L KSE L++EQ          L+  ++P +V  
Sbjct: 9   IGRGAFGEVRLVQKKDTGHIYAMKK--LRKSEMLEKEQVAHVRAERDILAEADNPWVVKL 66

Query: 61  KGCDVTSEDNKLMYNLFMEYAPGG---TL---NDEIHRNGGRLDESLIVSYTRQILQGLE 114
                + +D   +Y L MEY PGG   TL    D       R        Y  + +  ++
Sbjct: 67  Y---YSFQDENYLY-LIMEYLPGGDMMTLLMKKDTFTEEETRF-------YIAETILAID 115

Query: 115 YLHSNRVVHCDIKSRNILMAESG-AKIADFG-C--------------------------- 145
            +H    +H DIK  N+L+   G  K++DFG C                           
Sbjct: 116 SIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFI 175

Query: 146 ----------AKWESE----ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASG 191
                       W+      A  + GTP ++APEV          D W++G  + EM  G
Sbjct: 176 SKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235

Query: 192 GAPWPNAADPMTVLYKIAYSREL----PEVPAFLSKQANDFLSNCLRRDPKERWA---AS 244
             P+  + +P     KI   +E      EVP  LS +A D +   L  + + R      +
Sbjct: 236 YPPF-CSDNPQETYRKIINWKETLQFPDEVP--LSPEAKDLIKR-LCCEAERRLGNNGVN 291

Query: 245 QLLKHPFLE 253
           ++  HPF +
Sbjct: 292 EIKSHPFFK 300

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 66.9 bits (163), Expect = 2e-12
 Identities = 50/179 (27%), Positives = 84/179 (46%), Gaps = 15/179 (8%)

Query: 78  MEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG 137
            +Y    T   E      +L    +VS   Q+ +G+EYL S R +H D+ +RN+L+ E  
Sbjct: 117 PDYTFDITKVPE-----EQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDN 171

Query: 138 A-KIADFGCAKWESE-----ALQSGGTPM-FMAPEVARGEHQGFASDIWAVGCTVIEMAS 190
             KIADFG A+   +        +G  P+ +MAPE          SD+W+ G  + E+ +
Sbjct: 172 VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Query: 191 -GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLK 248
            GG+P+P    P+  L+K+       + P+  + +    +  C    P +R    QL++
Sbjct: 232 LGGSPYPGI--PVEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 67.0 bits (163), Expect = 3e-12
 Identities = 57/203 (28%), Positives = 93/203 (45%), Gaps = 20/203 (9%)

Query: 68  EDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIK 127
           +D   +Y L M+Y  GG L   + +   RL E +   Y  +++  +  +H    VH DIK
Sbjct: 71  QDENYLY-LVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIK 129

Query: 128 SRNILMAESG-AKIADFG-CAKWESEA-LQSG---GTPMFMAPEVARGEHQGFAS----- 176
             N+L+  +G  ++ADFG C K   +  +QS    GTP +++PE+ +    G        
Sbjct: 130 PDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPEC 189

Query: 177 DIWAVGCTVIEMASGGAPWPNAADPMTVLY-KIAYSRELPEVPAFL---SKQANDFLSN- 231
           D W++G  + EM  G  P+   A+ +   Y KI    E  + P+ +   S++A D +   
Sbjct: 190 DWWSLGVCMYEMLYGETPF--YAESLVETYGKIMNHEERFQFPSHITDVSEEAKDLIQRL 247

Query: 232 -CLRRDPKERWAASQLLKHPFLE 253
            C R     +       KH F E
Sbjct: 248 ICSRERRLGQNGIEDFKKHAFFE 270

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 67.3 bits (164), Expect = 3e-12
 Identities = 57/196 (29%), Positives = 91/196 (46%), Gaps = 11/196 (5%)

Query: 61  KGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNR 120
           K  D+ S + +  Y+ ++  AP  T  D +      L    +V ++ Q+  G+E+L S  
Sbjct: 200 KYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN 259

Query: 121 VVHCDIKSRNILMAESG-AKIADFGCAK---WESEALQSGGT--PM-FMAPEVARGEHQG 173
            VH D+ +RN+L+ E    KI DFG A+    +S  +  G T  P+ +MAPE        
Sbjct: 260 CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYT 319

Query: 174 FASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEV-PAFLSKQANDFLSN 231
             SD+W+ G  + E+ + GG P+P    PM   +  A  R      PA  S +  + +  
Sbjct: 320 TLSDVWSFGILLWEIFTLGGTPYPEL--PMNEQFYNAIKRGYRMAKPAHASDEIYEIMQK 377

Query: 232 CLRRDPKERWAASQLL 247
           C     + R   SQL+
Sbjct: 378 CWEEKFEIRPDFSQLV 393

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 66.6 bits (162), Expect = 3e-12
 Identities = 73/260 (28%), Positives = 113/260 (43%), Gaps = 30/260 (11%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQK--------FLSSLNSPHIVGY 60
           IG+GS   V LA   ++ + F A      K+   ++E+K         L ++  P +VG 
Sbjct: 3   IGKGSFGKVLLARH-KAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61

Query: 61  KGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNR 120
                T+  +KL +   ++Y  GG L   + R    L E     Y  +I   L YLHS  
Sbjct: 62  HFSFQTA--DKLYF--VLDYINGGELFYHLQRERCFL-EPRARFYAAEIASALGYLHSLN 116

Query: 121 VVHCDIKSRNILMAESGAKI-ADFGCAKWESEALQSG----GTPMFMAPEVARGEHQGFA 175
           +V+ D+K  NIL+   G  +  DFG  K   E   +     GTP ++APEV   +     
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRT 176

Query: 176 SDIWAVGCTVIEMASGGAPW--PNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCL 233
            D W +G  + EM  G  P+   N A+    +Y    ++ L   P  ++  A   L   L
Sbjct: 177 VDWWCLGAVLYEMLYGLPPFYSRNTAE----MYDNILNKPLQLKPN-ITNSARHLLEGLL 231

Query: 234 RRDPKERWAASQLLKHPFLE 253
           ++D  +R  A    K  F+E
Sbjct: 232 QKDRTKRLGA----KDDFME 247

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 65.5 bits (160), Expect = 4e-12
 Identities = 56/220 (25%), Positives = 95/220 (43%), Gaps = 21/220 (9%)

Query: 32  KSTELPKSEFLQREQKFLSSLNSPHIVG-YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEI 90
           KS +L K +  Q+E + L  L   H++  +  C V          +  E    G+L   +
Sbjct: 39  KSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEP-----VYIITELMEKGSLLAFL 93

Query: 91  HRNGGR-LDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKW 148
               G+ L  + ++    Q+ +G+ YL     +H D+ +RNIL+ E    K+ADFG A+ 
Sbjct: 94  RSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARL 153

Query: 149 ESEAL---QSGGTPM-FMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMT 203
             E +        P  + APE A        SD+W+ G  + EM + G  P+P   +   
Sbjct: 154 IKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN-HE 212

Query: 204 VLYKIAYSRELP---EVPAFLSKQANDFLSNCLRRDPKER 240
           V  +I     +P   + P  + K     +  C   +P++R
Sbjct: 213 VYDQITAGYRMPCPAKCPQEIYK----IMLECWAAEPEDR 248

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 65.4 bits (159), Expect = 4e-12
 Identities = 60/212 (28%), Positives = 87/212 (41%), Gaps = 18/212 (8%)

Query: 38  KSEFLQREQKFLSSLNSPHIVGYKG-CDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGR 96
           K E L RE   +  L++P+IV   G C+  S      + L ME A  G LN  + +N   
Sbjct: 40  KDELL-REANVMQQLDNPYIVRMIGICEAES------WMLVMELAELGPLNKFLQKNK-H 91

Query: 97  LDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKWESE---- 151
           + E  I     Q+  G++YL     VH D+ +RN+L+  +  AKI+DFG +K        
Sbjct: 92  VTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY 151

Query: 152 --ALQSGGTPM-FMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKI 208
             A   G  P+ + APE          SD+W+ G  + E  S G           V   I
Sbjct: 152 YKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMI 211

Query: 209 AYSRELPEVPAFLSKQANDFLSNCLRRDPKER 240
                + E P     +  D +  C      ER
Sbjct: 212 ESGERM-ECPQRCPPEMYDLMKLCWTYGVDER 242

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 66.2 bits (161), Expect = 5e-12
 Identities = 45/155 (29%), Positives = 79/155 (50%), Gaps = 10/155 (6%)

Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGA-KIADFGCAK-----WESEALQS 155
           +VS   Q+ +G+EYL S + +H D+ +RN+L+ E    KIADFG A+        +   +
Sbjct: 142 LVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 201

Query: 156 GGTPM-FMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRE 213
           G  P+ +MAPE          SD+W+ G  + E+ + GG+P+P    P+  L+K+     
Sbjct: 202 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV--PVEELFKLLKEGH 259

Query: 214 LPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLK 248
             + P+  + +    + +C    P +R    QL++
Sbjct: 260 RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 294

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 67.1 bits (164), Expect = 5e-12
 Identities = 83/292 (28%), Positives = 115/292 (39%), Gaps = 69/292 (23%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAK-------STELPKSEFLQREQKFLSSLNSPHIVG-Y 60
           IG+G    V LA         A K          L K  FL RE K  + L  P IV  Y
Sbjct: 10  IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFL-REAKIAADLIHPGIVPVY 68

Query: 61  KGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESL------------IVSYTRQ 108
             C     D   +Y   M Y  G TL   + ++     ESL             +S   +
Sbjct: 69  SICS----DGDPVY-YTMPYIEGYTLK-SLLKSV-WQKESLSKELAEKTSVGAFLSIFHK 121

Query: 109 ILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKW---ESEALQSG-------- 156
           I   +EY+HS  V+H D+K  NIL+   G   I D+G A +   E E L           
Sbjct: 122 ICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNIC 181

Query: 157 -----------GTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVL 205
                      GTP +MAPE   G     ++DI+A+G  + +M +   P+          
Sbjct: 182 YSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR---- 237

Query: 206 YKIAYSRELP---------EVPAFLSKQANDFLSNCLRRDPKERWAASQLLK 248
            KI+Y   +          E+P FLS+ A   L+     DP ER+++ Q LK
Sbjct: 238 -KISYRDVILSPIEVAPYREIPPFLSQIAMKALAV----DPAERYSSVQELK 284

Length = 932

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 65.0 bits (158), Expect = 6e-12
 Identities = 54/185 (29%), Positives = 86/185 (46%), Gaps = 12/185 (6%)

Query: 79  EYAPGGTLNDEIHRNGGR-LDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES- 136
           EY   G+L D +    GR L    +V    Q+  G+ Y+     +H D++S NIL+ +  
Sbjct: 80  EYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGL 139

Query: 137 GAKIADFGCAKW----ESEALQSGGTPM-FMAPEVARGEHQGFASDIWAVGCTVIEMASG 191
             KIADFG A+     E  A Q    P+ + APE A        SD+W+ G  + E+ + 
Sbjct: 140 VCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTK 199

Query: 192 G-APWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHP 250
           G  P+P   +   VL ++     +P  P       ++ +  C ++DP+ER     L    
Sbjct: 200 GRVPYP-GMNNREVLEQVERGYRMP-CPQDCPISLHELMLQCWKKDPEERPTFEYL--QS 255

Query: 251 FLEEF 255
           FLE++
Sbjct: 256 FLEDY 260

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 65.5 bits (160), Expect = 6e-12
 Identities = 60/220 (27%), Positives = 88/220 (40%), Gaps = 30/220 (13%)

Query: 4   TRGHTIGQGSSATVSLAT-SLRSGDV--FAAKSTELPKSEFLQREQKFL------SSLNS 54
           T    +G G+   V       R GD          LP+S   Q E  FL      S  N 
Sbjct: 9   TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNH 68

Query: 55  PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYT------RQ 108
            +IV   G        +L   + +E   GG L   +  N  R +    ++        R 
Sbjct: 69  QNIVRLIGVSF----ERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARD 124

Query: 109 ILQGLEYLHSNRVVHCDIKSRNILMAESG----AKIADFGCAK--WESEALQSGGTPM-- 160
           + +G +YL  N  +H DI +RN L+   G    AKIADFG A+  + +   + GG  M  
Sbjct: 125 VAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLP 184

Query: 161 --FMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPN 197
             +M PE          +D+W+ G  + E+ S G  P+P 
Sbjct: 185 IKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPG 224

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 65.0 bits (158), Expect = 6e-12
 Identities = 65/255 (25%), Positives = 117/255 (45%), Gaps = 18/255 (7%)

Query: 4   TRGHTIGQGSSATVSLATSLRSGDVFAAKSTE---LPKSEFLQREQKFLSSLNSPHIVGY 60
           T    IG G    V L   L    V A K+     + + +F++ E + +  L+ P +V  
Sbjct: 7   TLVQEIGSGQFGLVWLGYWLEKRKV-AIKTIREGAMSEEDFIE-EAQVMMKLSHPKLVQL 64

Query: 61  KGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNR 120
            G  V +E + +   L  E+   G L+D +    G+  +  ++     + +G+ YL S+ 
Sbjct: 65  YG--VCTERSPIC--LVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN 120

Query: 121 VVHCDIKSRNILMAESGA-KIADFGCAKW--ESEALQSGGTPM---FMAPEVARGEHQGF 174
           V+H D+ +RN L+ E+   K++DFG  ++  + +   S GT     + +PEV        
Sbjct: 121 VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSS 180

Query: 175 ASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCL 233
            SD+W+ G  + E+ S G  P+ N ++   V    A  R     P   S+   + + +C 
Sbjct: 181 KSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYK--PRLASQSVYELMQHCW 238

Query: 234 RRDPKERWAASQLLK 248
           +  P++R + S LL 
Sbjct: 239 KERPEDRPSFSLLLH 253

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 65.9 bits (161), Expect = 8e-12
 Identities = 77/304 (25%), Positives = 118/304 (38%), Gaps = 69/304 (22%)

Query: 7   HTIGQGSSATVSLATSLRSGDVFAAKSTELP-------KSEFLQREQKFLSSLNSPHIVG 59
             IG G+   V  A    +G   A K    P       K  +  RE   +  +N  +I+G
Sbjct: 22  KPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAY--RELVLMKLVNHKNIIG 79

Query: 60  YKGC---DVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL 116
                    + E+ + +Y L ME      L   I  +   LD   +     Q+L G+++L
Sbjct: 80  LLNVFTPQKSLEEFQDVY-LVMELM-DANLCQVIQMD---LDHERMSYLLYQMLCGIKHL 134

Query: 117 HSNRVVHCDIKSRNILM-AESGAKIADFGCAKWESEALQSGGTP-----MFMAPEVARGE 170
           HS  ++H D+K  NI++ ++   KI DFG A+    +     TP      + APEV  G 
Sbjct: 135 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRYYRAPEVILG- 191

Query: 171 HQGFAS--DIWAVGCTVIEMASG--------------------GAPWP---NAADPMTVL 205
             G+    DIW+VGC + EM  G                    G P     +   P    
Sbjct: 192 -MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRN 250

Query: 206 Y--------KIAYSRELPEV--PA-------FLSKQANDFLSNCLRRDPKERWAASQLLK 248
           Y          ++    P+V  P          + QA D LS  L  DP++R +    L+
Sbjct: 251 YVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310

Query: 249 HPFL 252
           HP++
Sbjct: 311 HPYI 314

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 64.7 bits (157), Expect = 8e-12
 Identities = 51/185 (27%), Positives = 87/185 (47%), Gaps = 12/185 (6%)

Query: 79  EYAPGGTLNDEIHRNGGR-LDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES- 136
           E+   G+L D +    G+ L    +V    QI  G+ Y+     +H D+++ NIL+ ++ 
Sbjct: 80  EFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNL 139

Query: 137 GAKIADFGCAKW----ESEALQSGGTPM-FMAPEVARGEHQGFASDIWAVGCTVIEMASG 191
             KIADFG A+     E  A Q    P+ + APE A        SD+W+ G  + E+ + 
Sbjct: 140 VCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTK 199

Query: 192 G-APWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHP 250
           G  P+P   +   VL ++     +P  P    +  ++ +  C ++DP ER     +    
Sbjct: 200 GRVPYPGMVN-REVLEQVERGYRMP-CPQGCPESLHELMKLCWKKDPDERPTFEYI--QS 255

Query: 251 FLEEF 255
           FLE++
Sbjct: 256 FLEDY 260

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 65.4 bits (159), Expect = 8e-12
 Identities = 55/184 (29%), Positives = 87/184 (47%), Gaps = 18/184 (9%)

Query: 45  EQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVS 104
           E   ++S+++PH+    G  +TS        L  +  P G L D +  +   +    +++
Sbjct: 59  EAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGCLLDYVREHKDNIGSQYLLN 113

Query: 105 YTRQILQGLEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKW----ESEALQSGG-T 158
           +  QI +G+ YL   R+VH D+ +RN+L+      KI DFG AK     E E    GG  
Sbjct: 114 WCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKV 173

Query: 159 PM-FMAPEVARGEHQGFASDIWAVGCTVIE-MASGGAPWPN--AADPMTVLYKIAYSREL 214
           P+ +MA E          SD+W+ G TV E M  G  P+    A++  ++L K      L
Sbjct: 174 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK---GERL 230

Query: 215 PEVP 218
           P+ P
Sbjct: 231 PQPP 234

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 65.0 bits (158), Expect = 9e-12
 Identities = 56/199 (28%), Positives = 91/199 (45%), Gaps = 36/199 (18%)

Query: 76  LFMEYAPGGTLNDEI---------------HRNGGRLDESLIVSYTRQILQGLEYLHSNR 120
           L +EYAP G L D +               +     L    ++ +   + +G++YL   +
Sbjct: 85  LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ 144

Query: 121 VVHCDIKSRNILMAESG-AKIADFGCAKWESEALQS--GGTPM-FMAPEVARGEHQGFAS 176
            +H D+ +RNIL+ E+  AKIADFG ++ +   ++   G  P+ +MA E          S
Sbjct: 145 FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNS 204

Query: 177 DIWAVGCTVIEMAS-GGAPWPNAADPMTV--LYKIAYSRELP-----EVPAFLSKQANDF 228
           D+W+ G  + E+ S GG P+      MT   LY+     +LP     E P     +  D 
Sbjct: 205 DVWSYGVLLWEIVSLGGTPYCG----MTCAELYE-----KLPQGYRLEKPLNCDDEVYDL 255

Query: 229 LSNCLRRDPKERWAASQLL 247
           +  C R  P ER + +Q+L
Sbjct: 256 MRQCWREKPYERPSFAQIL 274

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 65.1 bits (158), Expect = 1e-11
 Identities = 52/165 (31%), Positives = 77/165 (46%), Gaps = 22/165 (13%)

Query: 44  REQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLND-EIHRNGG------R 96
           RE   L  L  P+++  +   ++  D K+   L  +YA     +  + HR         +
Sbjct: 47  REIALLRELKHPNVIALQKVFLSHSDRKVW--LLFDYAEHDLWHIIKFHRASKANKKPMQ 104

Query: 97  LDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-----AKIADFGCAKWESE 151
           L  S++ S   QIL G+ YLH+N V+H D+K  NIL+   G      KIAD G A+  + 
Sbjct: 105 LPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 164

Query: 152 ALQSGG-------TPMFMAPEVARG-EHQGFASDIWAVGCTVIEM 188
            L+          T  + APE+  G  H   A DIWA+GC   E+
Sbjct: 165 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAEL 209

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 65.1 bits (159), Expect = 1e-11
 Identities = 54/186 (29%), Positives = 77/186 (41%), Gaps = 46/186 (24%)

Query: 108 QILQGLEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKWESEALQSGGTPMFM---- 162
           Q+L+GL+Y+HS  V+H D+K  N+L+ A    KI DFG A+  SE         FM    
Sbjct: 116 QLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGD------FMTEYV 169

Query: 163 ------APEVA-RGEHQGFASDIWAVGCTVIEMASGGAPWP--NAADPMTVLYKI----- 208
                 APE+         A D+W+VGC   E+      +P  +    + ++ ++     
Sbjct: 170 VTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPS 229

Query: 209 -------------AYSRELPEVP----AFLSKQAN----DFLSNCLRRDPKERWAASQLL 247
                         Y R LP  P    A L   AN    D L   L  DP +R    + L
Sbjct: 230 EEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEAL 289

Query: 248 KHPFLE 253
            HP+L 
Sbjct: 290 AHPYLA 295

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 65.0 bits (158), Expect = 1e-11
 Identities = 33/96 (34%), Positives = 52/96 (54%), Gaps = 6/96 (6%)

Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQS----- 155
           I++  R +L+ ++YLH NR++H DIK+ NI +   G   + DFG A +  +   +     
Sbjct: 184 ILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGW 243

Query: 156 GGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASG 191
            GT    APE+   +  G A DIW+ G  + EMA+ 
Sbjct: 244 AGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATC 279

Length = 391

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 65.0 bits (158), Expect = 2e-11
 Identities = 53/193 (27%), Positives = 87/193 (45%), Gaps = 26/193 (13%)

Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
               YKG + +   N L  +       G T  D             ++S+T Q+ +G+E+
Sbjct: 210 RPASYKGSNDSEVKNLLSDDGS----EGLTTLD-------------LLSFTYQVARGMEF 252

Query: 116 LHSNRVVHCDIKSRNILMAESG-AKIADFGCAK---WESEALQSGGTPM---FMAPEVAR 168
           L S   VH D+ +RN+L+A+    KI DFG A+    +S  +  G T +   +MAPE   
Sbjct: 253 LASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIF 312

Query: 169 GEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQAND 227
                  SD+W+ G  + E+ S GG P+P      T   KI     + + P   +++  D
Sbjct: 313 DNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAK-PDHATQEVYD 371

Query: 228 FLSNCLRRDPKER 240
            +  C   +P++R
Sbjct: 372 IMVKCWNSEPEKR 384

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 63.6 bits (155), Expect = 2e-11
 Identities = 48/215 (22%), Positives = 81/215 (37%), Gaps = 24/215 (11%)

Query: 39  SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLD 98
           S         +S L+  H+V   G  V  E       +  EY   G L+  +HR    + 
Sbjct: 45  SLAFFETASLMSQLSHKHLVKLYGVCVRDE-----NIMVEEYVKFGPLDVFLHREKNNVS 99

Query: 99  ESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG--------AKIADFG---CAK 147
               +   +Q+   L YL   ++VH ++  +NIL+A  G         K++D G      
Sbjct: 100 LHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVL 159

Query: 148 WESEALQSGGTPMFMAPEVARGEHQGF--ASDIWAVGCTVIEMASGGAPWPNAADPMTVL 205
              E ++    P ++APE  R        A+D W+ G T++E+ S G    +        
Sbjct: 160 SREERVER--IP-WIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKE 216

Query: 206 YKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKER 240
                   LP        +  + ++ C   DP +R
Sbjct: 217 RFYQDQHRLPMPD---CAELANLINQCWTYDPTKR 248

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 64.3 bits (156), Expect = 2e-11
 Identities = 46/155 (29%), Positives = 78/155 (50%), Gaps = 10/155 (6%)

Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWES-----EALQS 155
           +VS   Q+ +G+EYL S + +H D+ +RN+L+ E    KIADFG A+        +   +
Sbjct: 136 LVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTN 195

Query: 156 GGTPM-FMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRE 213
           G  P+ +MAPE          SD+W+ G  + E+ + GG+P+P    P+  L+K+     
Sbjct: 196 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI--PVEELFKLLKEGH 253

Query: 214 LPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLK 248
             + PA  + +    +  C    P +R    QL++
Sbjct: 254 RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVE 288

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 64.3 bits (156), Expect = 3e-11
 Identities = 44/161 (27%), Positives = 82/161 (50%), Gaps = 19/161 (11%)

Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAK---WESEALQSGG 157
           ++ Y+ Q+ +G+E+L S + +H D+ +RNIL++E+   KI DFG A+    + + ++ G 
Sbjct: 181 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 240

Query: 158 TPM---FMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRE 213
             +   +MAPE          SD+W+ G  + E+ S G +P+P       V     + R 
Sbjct: 241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG------VKIDEEFCRR 294

Query: 214 LPE-----VPAFLSKQANDFLSNCLRRDPKERWAASQLLKH 249
           L E      P + + +    + +C   +P +R   S+L++H
Sbjct: 295 LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 64.1 bits (156), Expect = 3e-11
 Identities = 36/102 (35%), Positives = 52/102 (50%), Gaps = 6/102 (5%)

Query: 92  RNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKWES 150
           +    L     +   +QIL+GL YLH+ R++H D+K+ NI +       I D G A++  
Sbjct: 149 KRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPV 208

Query: 151 EA---LQSGGTPMFMAPEV-ARGEHQGFASDIWAVGCTVIEM 188
            A   L   GT    APEV AR ++   A DIW+ G  + EM
Sbjct: 209 VAPAFLGLAGTVETNAPEVLARDKYNSKA-DIWSAGIVLFEM 249

Length = 357

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 62.9 bits (153), Expect = 3e-11
 Identities = 59/228 (25%), Positives = 99/228 (43%), Gaps = 19/228 (8%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTE---LPKSEFLQREQKFLSSLNSPHIV 58
           D T  H +G G    V      +     A K+ +   +   EFL +E   +  +  P++V
Sbjct: 7   DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL-KEAAVMKEIKHPNLV 65

Query: 59  GYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSY-TRQILQGLEYLH 117
              G   T E     + +  E+   G L D +     +   ++++ Y   QI   +EYL 
Sbjct: 66  QLLGV-CTREPP---FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 121

Query: 118 SNRVVHCDIKSRNILMAESG-AKIADFGCAKW---ESEALQSGGT-PM-FMAPEVARGEH 171
               +H D+ +RN L+ E+   K+ADFG ++    ++    +G   P+ + APE      
Sbjct: 122 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 181

Query: 172 QGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKI--AYSRELPE 216
               SD+WA G  + E+A+ G +P+P   D   V   +   Y  E PE
Sbjct: 182 FSIKSDVWAFGVLLWEIATYGMSPYP-GIDLSQVYELLEKGYRMERPE 228

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 63.2 bits (153), Expect = 4e-11
 Identities = 51/165 (30%), Positives = 76/165 (46%), Gaps = 22/165 (13%)

Query: 44  REQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLND-EIHRNGG------R 96
           RE   L  L  P+++  +   ++  D K+   L  +YA     +  + HR         +
Sbjct: 47  REIALLRELKHPNVISLQKVFLSHADRKVW--LLFDYAEHDLWHIIKFHRASKANKKPVQ 104

Query: 97  LDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-----AKIADFGCAKWESE 151
           L   ++ S   QIL G+ YLH+N V+H D+K  NIL+   G      KIAD G A+  + 
Sbjct: 105 LPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 164

Query: 152 ALQSGG-------TPMFMAPEVARG-EHQGFASDIWAVGCTVIEM 188
            L+          T  + APE+  G  H   A DIWA+GC   E+
Sbjct: 165 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAEL 209

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 63.5 bits (154), Expect = 5e-11
 Identities = 84/330 (25%), Positives = 131/330 (39%), Gaps = 86/330 (26%)

Query: 8   TIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTS 67
           T+G G+   V LA  + +  ++A K+  L K + L R Q         H+   +  D+ +
Sbjct: 8   TLGIGAFGEVCLARKVDTKALYAMKT--LRKKDVLLRNQ-------VAHVKAER--DILA 56

Query: 68  E-DNKLMYNLF------------MEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLE 114
           E DN+ +  L+            M+Y PGG +   + R G    E L   Y  ++   +E
Sbjct: 57  EADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMG-IFPEDLARFYIAELTCAVE 115

Query: 115 YLHSNRVVHCDIKSRNILMAESG-AKIADFG-CA--KW--ESEALQSG------------ 156
            +H    +H DIK  NIL+   G  K+ DFG C   +W  +S+  QSG            
Sbjct: 116 SVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSN 175

Query: 157 ----------------------------------GTPMFMAPEVARGEHQGFASDIWAVG 182
                                             GTP ++APEV          D W+VG
Sbjct: 176 EWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235

Query: 183 CTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVP--AFLSKQANDFLSNCLRRDPKER 240
             + EM  G  P+  A  P+    K+   +    +P  A LS +A+D +   L R P++R
Sbjct: 236 VILYEMLVGQPPFL-AQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIK-LCRGPEDR 293

Query: 241 W---AASQLLKHPFLE--EFCSCTKQIQES 265
                A ++  HPF +  +F S  +Q    
Sbjct: 294 LGKNGADEIKAHPFFKTIDFSSDLRQQSAP 323

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 62.9 bits (153), Expect = 7e-11
 Identities = 74/310 (23%), Positives = 119/310 (38%), Gaps = 78/310 (25%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQ--------KFLSSLNSPHIVGY 60
           IG+G+   V L     +G ++A K+  L KSE  +++Q          L+  +SP +V  
Sbjct: 9   IGKGAFGEVRLVQKKDTGKIYAMKT--LLKSEMFKKDQLAHVKAERDVLAESDSPWVVSL 66

Query: 61  KGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNR 120
                + +D + +Y L ME+ PGG L   + +      E +   Y  + +  +E +H   
Sbjct: 67  Y---YSFQDAQYLY-LIMEFLPGGDLMTMLIKYD-TFSEDVTRFYMAECVLAIEAVHKLG 121

Query: 121 VVHCDIKSRNILMAESG-AKIADFG----------------------------------- 144
            +H DIK  NIL+   G  K++DFG                                   
Sbjct: 122 FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAV 181

Query: 145 ------------CAKWESE----ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEM 188
                        A W+      A  + GTP ++APE+   +  G   D W++G  + E 
Sbjct: 182 DSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFEC 241

Query: 189 ASGGAPWPN--AADPMTVLYKIAYSRELPEVP--AFLSKQANDFLSNCLRRDPKE---RW 241
             G   WP   + +      KI   RE    P    LS +A D +   L  + +    R 
Sbjct: 242 LIG---WPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRR-LITNAENRLGRG 297

Query: 242 AASQLLKHPF 251
            A ++  HPF
Sbjct: 298 GAHEIKSHPF 307

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 62.3 bits (151), Expect = 9e-11
 Identities = 42/155 (27%), Positives = 79/155 (50%), Gaps = 9/155 (5%)

Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAK---WESEALQSGG 157
           ++ Y+ Q+ +G+E+L S + +H D+ +RNIL++E+   KI DFG A+    + + ++ G 
Sbjct: 176 LICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGS 235

Query: 158 TPM---FMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRE 213
             +   +MAPE    +     SD+W+ G  + E+ S G +P+P          ++     
Sbjct: 236 ARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTR 295

Query: 214 LPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLK 248
           +   P   + +    +  C + DPKER   S L++
Sbjct: 296 M-RAPENATPEIYRIMLACWQGDPKERPTFSALVE 329

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 62.0 bits (150), Expect = 1e-10
 Identities = 60/235 (25%), Positives = 92/235 (39%), Gaps = 51/235 (21%)

Query: 97  LDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKWESEALQS 155
           LD   +     Q+L G+++LHS  ++H D+K  NI++ ++   KI DFG A+        
Sbjct: 120 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMM 179

Query: 156 GG---TPMFMAPEVARGEHQGFASDIWAVGCTVIEMASG--------------------G 192
                T  + APEV  G       DIW+VGC + E+  G                    G
Sbjct: 180 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLG 239

Query: 193 AP---WPNAADPMTVLY--------KIAYSRELP--------EVPAFLSKQANDFLSNCL 233
            P   + N   P    Y         I++    P        E     + QA D LS  L
Sbjct: 240 TPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKML 299

Query: 234 RRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSILDQGIWNSVEETEESL 288
             DP +R +  + L+HP++  +        E+   P  I D      +EE E ++
Sbjct: 300 VIDPDKRISVDEALRHPYITVWYDPA----EAEAPPPQIYDA----QLEEREHAI 346

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 61.0 bits (148), Expect = 1e-10
 Identities = 62/250 (24%), Positives = 102/250 (40%), Gaps = 37/250 (14%)

Query: 17  VSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGYKGC---DVTSEDNKLM 73
           V L    R+   F  K   L KS    RE+  +     PH V    C    + SED+   
Sbjct: 9   VLLVMDTRTQQTFILKG--LRKSSEYSRERLTII----PHCVPNMVCLHKYIVSEDSVF- 61

Query: 74  YNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILM 133
             L +++A GG L   I +    + E  +  +  +++  L+ LH   +V  D+   NIL+
Sbjct: 62  --LVLQHAEGGKLWSHISKFL-NIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILL 118

Query: 134 AESG-AKIADFGCAKWESEALQSGGTP---MFMAPEVARGEHQGFASDIWAVGCTVIEMA 189
            + G  ++  F   +W        G     M+ APEV     +  A D W++G  + E+ 
Sbjct: 119 DDRGHIQLTYFS--RWSEVEDSCDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELL 176

Query: 190 SGGA---PWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAA--- 243
           +G       P+  +  T L           +P ++S++A   L   L+ +P ER  A   
Sbjct: 177 TGKTLVECHPSGINTHTTL----------NIPEWVSEEARSLLQQLLQFNPTERLGAGVA 226

Query: 244 --SQLLKHPF 251
               +  HPF
Sbjct: 227 GVEDIKSHPF 236

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 61.2 bits (148), Expect = 1e-10
 Identities = 65/257 (25%), Positives = 111/257 (43%), Gaps = 30/257 (11%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKS--TELP---KSEFLQREQKFLSSLNSPHIVGYKGC 63
           +G+G+   V   T L+     A K+   +LP   K +FL  E + L   + P+IV   G 
Sbjct: 3   LGKGNFGEVFKGT-LKDKTPVAVKTCKEDLPQELKIKFLS-EARILKQYDHPNIVKLIG- 59

Query: 64  DVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVH 123
            V ++   +   + ME  PGG     + +    L    +V +      G+ YL S   +H
Sbjct: 60  -VCTQRQPIY--IVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIH 116

Query: 124 CDIKSRNILMAESGA-KIADFGCAKWESEALQSGG----TPM-FMAPEVARGEHQGFASD 177
            D+ +RN L+ E+   KI+DFG ++ E + + S       P+ + APE          SD
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESD 176

Query: 178 IWAVGCTVIEMAS-GGAPWP-----NAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSN 231
           +W+ G  + E  S G  P+P      A + +   Y+++  ++ P+            +  
Sbjct: 177 VWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPD-------DVYKVMQR 229

Query: 232 CLRRDPKERWAASQLLK 248
           C    P+ R   S+L K
Sbjct: 230 CWDYKPENRPKFSELQK 246

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 61.2 bits (148), Expect = 1e-10
 Identities = 47/178 (26%), Positives = 87/178 (48%), Gaps = 20/178 (11%)

Query: 76  LFMEYAPGGTLNDEIHRN-GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMA 134
           +  EY   G+L D +  + GG++    ++ ++ QI +G+ Y+     +H D+++ N+L++
Sbjct: 78  IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVS 137

Query: 135 ES-GAKIADFGCAKW----ESEALQSGGTPM-FMAPEVARGEHQGFASDIWAVGCTVIEM 188
           ES   KIADFG A+     E  A +    P+ + APE          SD+W+ G  + E+
Sbjct: 138 ESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEI 197

Query: 189 AS-GGAPWP--NAADPMTVL---YKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKER 240
            + G  P+P  + +D M+ L   Y++      P+       +  D +  C +   +ER
Sbjct: 198 VTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPD-------ELYDIMKTCWKEKAEER 248

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 60.9 bits (148), Expect = 2e-10
 Identities = 56/217 (25%), Positives = 92/217 (42%), Gaps = 43/217 (19%)

Query: 5   RGHTIG--QGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGYKG 62
           +G   G  +  SAT     +L+       ++ E    +  ++E + +S L  P+IV   G
Sbjct: 23  KGELTGPNERLSATSVAIKTLK-------ENAEPKVQQEFRQEAELMSDLQHPNIVCLLG 75

Query: 63  CDVTSEDNKLMYNLFMEYAPGGTLNDEIHRN---------------GGRLDESLIVSYTR 107
                +   +++    EY   G L++ + RN                  LD S  +    
Sbjct: 76  VCTKEQPTCMLF----EYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAI 131

Query: 108 QILQGLEYLHSNRVVHCDIKSRNILMAES-GAKIADFGCA---------KWESEALQSGG 157
           QI  G+EYL S+  VH D+ +RN L+ E    KI+DFG +         + +S++L    
Sbjct: 132 QIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSL---- 187

Query: 158 TPM-FMAPEVARGEHQGFASDIWAVGCTVIEMASGGA 193
            P+ +M PE          SDIW+ G  + E+ S G 
Sbjct: 188 LPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGL 224

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 61.4 bits (149), Expect = 2e-10
 Identities = 46/163 (28%), Positives = 77/163 (47%), Gaps = 15/163 (9%)

Query: 97  LDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCA---KWESEA 152
           LD   ++S++ Q+ +G+ +L S   +H D+ +RNIL+      KI DFG A   + +S  
Sbjct: 211 LDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270

Query: 153 LQSGGTPM---FMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTV---L 205
           +  G   +   +MAPE        F SD+W+ G  + E+ S G +P+P     M V    
Sbjct: 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPG----MPVDSKF 326

Query: 206 YKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLK 248
           YK+         P     +  D + +C   DP +R    Q+++
Sbjct: 327 YKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQ 369

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 61.1 bits (148), Expect = 2e-10
 Identities = 78/321 (24%), Positives = 125/321 (38%), Gaps = 89/321 (27%)

Query: 9   IGQGSS--ATVSLATSLRSGDVFAAKSTELPKSE-----FLQREQKFLSSLNSPHIVGYK 61
           IG+G     TV+LA    +G+    +   L         FLQ E       N P+IV Y+
Sbjct: 6   IGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYR 65

Query: 62  GCDVTSEDNKL-MYNLFMEYAPGGTLNDEI--HRNGGRLDESLIVSYTRQILQGLEYLHS 118
              +   DN+L +   FM Y   G+  D I  H   G + E  I    + +L+ L+Y+H 
Sbjct: 66  ATFIA--DNELWVVTSFMAY---GSAKDLICTHFMDG-MSELAIAYILQGVLKALDYIHH 119

Query: 119 NRVVHCDIKSRNILMAESGA--------------------KIADFGCAKWESEALQSGGT 158
              VH  +K+ +IL++  G                      + DF   K+  + L     
Sbjct: 120 MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDF--PKYSVKVLP---- 173

Query: 159 PMFMAPEVARGEHQGF--ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYS----- 211
             +++PEV +   QG+   SDI++VG T  E+A+G  P+ +      +L K+  +     
Sbjct: 174 --WLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL 231

Query: 212 -------REL--------------------------PEVPAF-----LSKQANDFLSNCL 233
                   EL                           E  +       S   + F+  CL
Sbjct: 232 DTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCL 291

Query: 234 RRDPKERWAASQLLKHPFLEE 254
           +R+P  R +AS LL H F ++
Sbjct: 292 QRNPDARPSASTLLNHSFFKQ 312

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 60.6 bits (147), Expect = 2e-10
 Identities = 66/258 (25%), Positives = 116/258 (44%), Gaps = 28/258 (10%)

Query: 9   IGQGSSATVSLATSLRSGDV---FAAKS----TELPKSEFLQREQKFLSSLNSPHIVGYK 61
           IG+G    V   T + S       A KS    T+L + E   +E   +   + P+++   
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62

Query: 62  GCDVTSEDNKLMYNLFMEYAPGGTLNDEIH---RNGGRLDESLIVSYTRQILQGLEYLHS 118
           G  + SE + L+   +M++   G L + I     N    D   ++ +  Q+ +G+EYL S
Sbjct: 63  GICLPSEGSPLVVLPYMKH---GDLRNFIRSETHNPTVKD---LIGFGLQVAKGMEYLAS 116

Query: 119 NRVVHCDIKSRNILMAES-GAKIADFGCAK--WESEAL-----QSGGTPM-FMAPEVARG 169
            + VH D+ +RN ++ ES   K+ADFG A+  ++ E            P+ +MA E  + 
Sbjct: 117 KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQT 176

Query: 170 EHQGFASDIWAVGCTVIE-MASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDF 228
           +     SD+W+ G  + E M  G  P+P+  D   +   +   R L + P +      + 
Sbjct: 177 QKFTTKSDVWSFGVLLWELMTRGAPPYPD-VDSFDITVYLLQGRRLLQ-PEYCPDPLYEV 234

Query: 229 LSNCLRRDPKERWAASQL 246
           + +C    P+ R   S+L
Sbjct: 235 MLSCWHPKPEMRPTFSEL 252

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 60.5 bits (147), Expect = 2e-10
 Identities = 46/170 (27%), Positives = 69/170 (40%), Gaps = 28/170 (16%)

Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES-GAKIADFGCAKWESEALQSGGTPM 160
           +V    QI  G+ YLH   V+H DI +RN ++ E    KI D         AL     PM
Sbjct: 119 LVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD--------NALSRDLFPM 170

Query: 161 --------------FMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVL 205
                         +MA E    +    ASD+W+ G  + E+ + G  P+    DP  + 
Sbjct: 171 DYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVE-IDPFEMA 229

Query: 206 YKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
             +     L + P     +    ++ C   DP+ER + SQL     L +F
Sbjct: 230 AYLKDGYRLAQ-PINCPDELFAVMACCWALDPEERPSFSQL--VQCLTDF 276

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 61.2 bits (148), Expect = 3e-10
 Identities = 62/240 (25%), Positives = 98/240 (40%), Gaps = 48/240 (20%)

Query: 97  LDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKWESEALQS 155
           LD   +     Q+L G+++LHS  ++H D+K  NI++ ++   KI DFG A+    +   
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 182

Query: 156 GG---TPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNA-------------A 199
                T  + APEV  G       DIW+VGC + EM  GG  +P                
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLG 242

Query: 200 DPMTVLYK------------------IAYSRELPEV--PA------FLSKQANDFLSNCL 233
            P     K                   ++ +  P+V  PA        + QA D LS  L
Sbjct: 243 TPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKML 302

Query: 234 RRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSILDQGIWNSVEETEESLGNLIH 293
             D  +R +  + L+HP++  +   +    E+   P  I D+ + +  E T E    LI+
Sbjct: 303 VIDASKRISVDEALQHPYINVWYDPS----EAEAPPPKIPDKQL-DEREHTIEEWKELIY 357

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 59.9 bits (145), Expect = 3e-10
 Identities = 57/223 (25%), Positives = 103/223 (46%), Gaps = 14/223 (6%)

Query: 32  KSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIH 91
           K   + + EF++ E K +  L+   +V   G  V ++   +   +  EY   G L + + 
Sbjct: 37  KEGSMSEDEFIE-EAKVMMKLSHEKLVQLYG--VCTKQRPIY--IVTEYMSNGCLLNYLR 91

Query: 92  RNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKW-- 148
            +G R   S ++   + + +G+ YL S + +H D+ +RN L+ + G  K++DFG +++  
Sbjct: 92  EHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVL 151

Query: 149 ESEALQSGGTPM---FMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTV 204
           + E   S G+     +  PEV         SD+WA G  + E+ S G  P+    +  TV
Sbjct: 152 DDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETV 211

Query: 205 LYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLL 247
             K++    L   P   S++    + +C     +ER    QLL
Sbjct: 212 E-KVSQGLRLYR-PHLASEKVYAIMYSCWHEKAEERPTFQQLL 252

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 59.5 bits (144), Expect = 4e-10
 Identities = 53/211 (25%), Positives = 99/211 (46%), Gaps = 13/211 (6%)

Query: 45  EQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVS 104
           E K +  L+ P +V   G   T +    +   FME    G L + + +  G+L + +++S
Sbjct: 49  EAKVMMKLSHPKLVQLYGV-CTQQKPLYIVTEFMEN---GCLLNYLRQRQGKLSKDMLLS 104

Query: 105 YTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKW--ESEALQSGGTPM- 160
             + + +G+EYL  N  +H D+ +RN L++ +G  K++DFG  ++  + E   S G    
Sbjct: 105 MCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFP 164

Query: 161 --FMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEV 217
             +  PEV         SD+W+ G  + E+ + G  P+   ++   V+  I+    L   
Sbjct: 165 VKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN-YEVVEMISRGFRLYR- 222

Query: 218 PAFLSKQANDFLSNCLRRDPKERWAASQLLK 248
           P   S    + + +C    P+ R   ++LL+
Sbjct: 223 PKLASMTVYEVMYSCWHEKPEGRPTFAELLR 253

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 59.7 bits (145), Expect = 5e-10
 Identities = 66/243 (27%), Positives = 105/243 (43%), Gaps = 35/243 (14%)

Query: 38  KSEFLQREQKFLSSLNSPHIVGYKG-CDVTSEDNKLMYNLFMEYAPGGTLND----EIHR 92
           + +FL +E K LS L+ P+I    G C  T +    M    MEY   G LN      +  
Sbjct: 63  REDFL-KEVKILSRLSDPNIARLLGVC--TVDPPLCM---IMEYMENGDLNQFLQKHVAE 116

Query: 93  NGGRLDESLIVSYT------RQILQGLEYLHSNRVVHCDIKSRNILMAES-GAKIADFGC 145
             G    S  +S++       QI  G+ YL S   VH D+ +RN L+ ++   KIADFG 
Sbjct: 117 TSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGM 176

Query: 146 AK--WESEALQSGGTPM----FMAPE-VARGEHQGFASDIWAVGCTVIEMASGG--APWP 196
           ++  + S+  +  G       +MA E V  G+     SD+WA G T+ E+ +     P+ 
Sbjct: 177 SRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTT-KSDVWAFGVTLWEILTLCREQPYE 235

Query: 197 NAADP-----MTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPF 251
           +  D          ++    +     P    K   + +  C RRD ++R    ++  H F
Sbjct: 236 HLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREI--HLF 293

Query: 252 LEE 254
           L+ 
Sbjct: 294 LQR 296

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 59.9 bits (145), Expect = 7e-10
 Identities = 44/161 (27%), Positives = 84/161 (52%), Gaps = 19/161 (11%)

Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAK---WESEALQSGG 157
           ++SY+ Q+ +G+E+L S + +H D+ +RNIL++E+   KI DFG A+    + + ++ G 
Sbjct: 175 LISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 234

Query: 158 TPM---FMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRE 213
             +   +MAPE    +     SD+W+ G  + E+ S G +P+P       V     + R 
Sbjct: 235 ARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPG------VQIDEEFCRR 288

Query: 214 LPE-----VPAFLSKQANDFLSNCLRRDPKERWAASQLLKH 249
           L E      P + + +    + +C   +P++R   S+L++ 
Sbjct: 289 LKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 58.9 bits (143), Expect = 8e-10
 Identities = 64/235 (27%), Positives = 111/235 (47%), Gaps = 31/235 (13%)

Query: 31  AKSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEI 90
           A S++  + +FL  E   +   + P+I+  +G  V ++   +M  +  EY   G+L+  +
Sbjct: 42  AGSSDKQRLDFL-TEASIMGQFDHPNIIRLEG--VVTKSRPVM--IITEYMENGSLDKFL 96

Query: 91  HRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAK-- 147
             N G+     +V   R I  G++YL     VH D+ +RNIL+ +    K++DFG ++  
Sbjct: 97  RENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRL 156

Query: 148 WESEA---LQSGGTPM-FMAPEVARGEHQGF--ASDIWAVGCTVIE-MASGGAP---WPN 197
            +SEA    + G  P+ + APE     ++ F  ASD+W+ G  + E M+ G  P     N
Sbjct: 157 EDSEATYTTKGGKIPIRWTAPEAI--AYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN 214

Query: 198 AADPMTVLYKIAYSRELP---EVPAFLSKQANDFLSNCLRRDPKERWAASQLLKH 249
                 V+  +     LP   + P+ L +   D    C ++D  ER   SQ++  
Sbjct: 215 ----QDVIKAVEDGYRLPPPMDCPSALYQLMLD----CWQKDRNERPTFSQIVST 261

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 59.1 bits (143), Expect = 8e-10
 Identities = 66/232 (28%), Positives = 103/232 (44%), Gaps = 39/232 (16%)

Query: 38  KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHR----N 93
           +++FL +E K +S L  P+I+      +TS D   M   +ME    G LN  + R     
Sbjct: 63  RNDFL-KEIKIMSRLKDPNIIRLLAVCITS-DPLCMITEYME---NGDLNQFLSRHEPQE 117

Query: 94  GGRLDESLIVSYTR------QILQGLEYLHSNRVVHCDIKSRNILMAESGA-KIADFGCA 146
                + + +SY+       QI  G++YL S   VH D+ +RN L+ ++   KIADFG  
Sbjct: 118 AAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGM- 176

Query: 147 KWESEALQSGG---------TPM-FMAPEVARGEHQGFASDIWAVGCTVIEMAS--GGAP 194
              S  L SG           P+ +M+ E         ASD+WA G T+ E+ +     P
Sbjct: 177 ---SRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQP 233

Query: 195 WPNAADPMTVLYKIAYSRE------LPEVPAFLSKQANDFLSNCLRRDPKER 240
           +   +D   +     + R+      LP+ PA         + +C RR+ KER
Sbjct: 234 YSQLSDEQVIENTGEFFRDQGRQVYLPK-PALCPDSLYKLMLSCWRRNAKER 284

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 61/240 (25%), Positives = 95/240 (39%), Gaps = 48/240 (20%)

Query: 97  LDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKWESEALQS 155
           LD   +     Q+L G+++LHS  ++H D+K  NI++ ++   KI DFG A+    +   
Sbjct: 116 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 175

Query: 156 GG---TPMFMAPEVARGEHQGFASDIWAVGCTVIEMASG--------------------G 192
                T  + APEV  G       DIW+VGC + EM                       G
Sbjct: 176 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG 235

Query: 193 APWP-----------NAADPMTVLYKIAYSRELPE--VPA------FLSKQANDFLSNCL 233
            P P           N  +       + + +  P+   PA        + QA D LS  L
Sbjct: 236 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKML 295

Query: 234 RRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSILDQGIWNSVEETEESLGNLIH 293
             DP +R +  + L+HP++  +        E    P  I D+ + +  E T E    LI+
Sbjct: 296 VIDPAKRISVDEALQHPYINVWYDPA----EVEAPPPQIYDKQL-DEREHTIEEWKELIY 350

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 74/305 (24%), Positives = 121/305 (39%), Gaps = 62/305 (20%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGYK 61
           D+     IG+G+   V L     +G ++A K   L K++ L++EQ          +V   
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKI--LRKADMLEKEQVAHIRAERDILVEAD 59

Query: 62  GCDVTS-----EDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL 116
           G  V       +D + +Y L ME+ PGG +   + +    L E     Y  + +  ++ +
Sbjct: 60  GAWVVKMFYSFQDKRNLY-LIMEFLPGGDMMTLLMKKD-TLSEEATQFYIAETVLAIDAI 117

Query: 117 HSNRVVHCDIKSRNILMAESG-AKIADFG------------------------------- 144
           H    +H DIK  N+L+   G  K++DFG                               
Sbjct: 118 HQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMN 177

Query: 145 ----CAKWESE----ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWP 196
                  W+      A  + GTP ++APEV          D W++G  + EM  G  P+ 
Sbjct: 178 SKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237

Query: 197 NAADPMTVLYKIAYSREL----PEVPAFLSKQANDF-LSNCLRRDPKERWAAS---QLLK 248
           +   P     K+   +E     PEVP  +S++A D  L  C   D + R  ++   ++  
Sbjct: 238 SET-PQETYRKVMNWKETLVFPPEVP--ISEKAKDLILRFCT--DSENRIGSNGVEEIKS 292

Query: 249 HPFLE 253
           HPF E
Sbjct: 293 HPFFE 297

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 58.0 bits (140), Expect = 2e-09
 Identities = 61/268 (22%), Positives = 109/268 (40%), Gaps = 39/268 (14%)

Query: 3   WTRGHTIGQGSSATV-------------SLATSLRSGDVFAAKSTELPKSEFLQREQKFL 49
           +T G  +G+G   +V              +A  +   D+F++   E    EFL RE   +
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIE----EFL-REAACM 55

Query: 50  SSLNSPHIVGYKGCDVTSEDNK-----LMYNLFMEYAPGGT--LNDEIHRNGGRLDESLI 102
              + P+++   G  + S         ++   FM++    T  L   I      L    +
Sbjct: 56  KEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTL 115

Query: 103 VSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES-GAKIADFGCAK--WESEALQSGGT- 158
           V +   I  G+EYL S   +H D+ +RN ++ E+    +ADFG +K  +  +  + G   
Sbjct: 116 VRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCAS 175

Query: 159 --PM-FMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSR-- 212
             P+ ++A E          SD+WA G T+ E+ + G  P+    +     Y I  +R  
Sbjct: 176 KLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLK 235

Query: 213 ELPEVPAFLSKQANDFLSNCLRRDPKER 240
           + P+          + +  C   +PK R
Sbjct: 236 QPPDCLE----DVYELMCQCWSPEPKCR 259

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 56/214 (26%), Positives = 94/214 (43%), Gaps = 30/214 (14%)

Query: 55  PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEI---------------HRNGGRLDE 99
           P+I+   G     E+   +Y + +EYAP G L D +               H     L  
Sbjct: 63  PNIINLLG---ACENRGYLY-IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTS 118

Query: 100 SLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES-GAKIADFGCAKWESEALQS--G 156
             ++ +   +  G++YL   + +H D+ +RN+L+ E+  +KIADFG ++ E   ++   G
Sbjct: 119 QQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMG 178

Query: 157 GTPM-FMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTV--LYKIAYSR 212
             P+ +MA E          SD+W+ G  + E+ S GG P+      MT   LY+     
Sbjct: 179 RLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCG----MTCAELYEKLPQG 234

Query: 213 ELPEVPAFLSKQANDFLSNCLRRDPKERWAASQL 246
              E P     +  + +  C R  P ER   +Q+
Sbjct: 235 YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQI 268

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 57.4 bits (138), Expect = 2e-09
 Identities = 58/214 (27%), Positives = 95/214 (44%), Gaps = 30/214 (14%)

Query: 55  PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEI---------------HRNGGRLDE 99
           P+I+   G     E    +Y L +EYAP G L D +               +     L  
Sbjct: 56  PNIINLLG---ACEHRGYLY-LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 111

Query: 100 SLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES-GAKIADFGCAKWESEALQS--G 156
             ++ +   + +G++YL   + +H D+ +RNIL+ E+  AKIADFG ++ +   ++   G
Sbjct: 112 QQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG 171

Query: 157 GTPM-FMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTV--LYKIAYSR 212
             P+ +MA E          SD+W+ G  + E+ S GG P+      MT   LY+     
Sbjct: 172 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG----MTCAELYEKLPQG 227

Query: 213 ELPEVPAFLSKQANDFLSNCLRRDPKERWAASQL 246
              E P     +  D +  C R  P ER + +Q+
Sbjct: 228 YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQI 261

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 57.6 bits (139), Expect = 3e-09
 Identities = 68/259 (26%), Positives = 107/259 (41%), Gaps = 39/259 (15%)

Query: 28  VFAAKSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLN 87
           +    + +  +++FL +E K LS L  P+I+   G  V  ED   M   +ME    G LN
Sbjct: 53  ILRPDANKNARNDFL-KEVKILSRLKDPNIIRLLGVCV-DEDPLCMITEYME---NGDLN 107

Query: 88  --------DEIHRNGGRLDE----------SLIVSYTRQILQGLEYLHSNRVVHCDIKSR 129
                   D+   NG               S ++    QI  G++YL S   VH D+ +R
Sbjct: 108 QFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATR 167

Query: 130 NILMAES-GAKIADFGCAK--WESEALQSGGTPM----FMAPEVARGEHQGFASDIWAVG 182
           N L+ E+   KIADFG ++  +  +  +  G  +    +MA E         ASD+WA G
Sbjct: 168 NCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFG 227

Query: 183 CTVIEMAS--GGAPWPNAADPMTVLYKIAYSRELPEV-----PAFLSKQANDFLSNCLRR 235
            T+ E+       P+    D   +     + R+         P    +   + +  C  R
Sbjct: 228 VTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSR 287

Query: 236 DPKERWAASQLLKHPFLEE 254
           D +ER + S +  H FL E
Sbjct: 288 DCRERPSFSDI--HAFLTE 304

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 57.5 bits (139), Expect = 3e-09
 Identities = 62/240 (25%), Positives = 96/240 (40%), Gaps = 52/240 (21%)

Query: 38  KSEFLQREQKFLSSLNSPHIVGYKG-CDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGR 96
           +++F QRE   ++  + P+IV   G C V     K M  LF EY   G LN+ +     R
Sbjct: 52  QADF-QREAALMAEFDHPNIVKLLGVCAV----GKPMCLLF-EYMAYGDLNEFLRHRSPR 105

Query: 97  LDESLI---------------------VSYTRQILQGLEYLHSNRVVHCDIKSRNILMAE 135
              SL                      +   +Q+  G+ YL   + VH D+ +RN L+ E
Sbjct: 106 AQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGE 165

Query: 136 SGA-KIADFG----------CAKWESEALQSGGTPM-FMAPEVARGEHQGFASDIWAVGC 183
           +   KIADFG              E++A+     P+ +M PE          SD+WA G 
Sbjct: 166 NMVVKIADFGLSRNIYSADYYKASENDAI-----PIRWMPPESIFYNRYTTESDVWAYGV 220

Query: 184 TVIEMASGG-APWPNAADPMTVLYKIAYSRE--LPEVPAFLSKQANDFLSNCLRRDPKER 240
            + E+ S G  P+      M     I Y R+  +   P     +  + +  C  + P +R
Sbjct: 221 VLWEIFSYGMQPYYG----MAHEEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDR 276

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 57.2 bits (138), Expect = 3e-09
 Identities = 56/217 (25%), Positives = 98/217 (45%), Gaps = 16/217 (7%)

Query: 32  KSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIH 91
           K   +    FL  E   +  L  P +V      VT E    +Y +  EY   G+L D + 
Sbjct: 39  KQGSMSPEAFLA-EANLMKQLQHPRLVRLYAV-VTQEP---IY-IITEYMENGSLVDFLK 92

Query: 92  RNGG-RLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES-GAKIADFGCAKW- 148
              G +L  + ++    QI +G+ ++     +H D+++ NIL++E+   KIADFG A+  
Sbjct: 93  TPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLI 152

Query: 149 ---ESEALQSGGTPM-FMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMT 203
              E  A +    P+ + APE          SD+W+ G  + E+ + G  P+P   +P  
Sbjct: 153 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP-E 211

Query: 204 VLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKER 240
           V+  +     +P  P    ++  + +  C +  P+ER
Sbjct: 212 VIQNLERGYRMPR-PDNCPEELYELMRLCWKEKPEER 247

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 56.8 bits (137), Expect = 4e-09
 Identities = 59/219 (26%), Positives = 104/219 (47%), Gaps = 22/219 (10%)

Query: 34  TELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRN 93
           TE  + +FL  E   +   + P+I+  +G  V ++   +M  +  EY   G+L+  + ++
Sbjct: 45  TEKQRRDFL-SEASIMGQFDHPNIIHLEG--VVTKSKPVM--IVTEYMENGSLDAFLRKH 99

Query: 94  GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES-GAKIADFGCAKW---- 148
            G+     +V   R I  G++YL     VH D+ +RNIL+  +   K++DFG ++     
Sbjct: 100 DGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159

Query: 149 -ESEALQSGGT-PM-FMAPEVARGEHQGFASDIWAVGCTVIE-MASGGAPWPNAADPMTV 204
            E+     GG  P+ + APE         ASD+W+ G  + E M+ G  P+   ++   V
Sbjct: 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN-QDV 218

Query: 205 LYKIAYSRELP---EVPAFLSKQANDFLSNCLRRDPKER 240
           +  I     LP   + PA L +     + +C ++D  ER
Sbjct: 219 IKAIEEGYRLPAPMDCPAALHQ----LMLDCWQKDRNER 253

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 56.6 bits (136), Expect = 4e-09
 Identities = 42/173 (24%), Positives = 84/173 (48%), Gaps = 10/173 (5%)

Query: 76  LFMEYAPGGTLNDEIHRN-GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMA 134
           +  E+   G+L D +  + G +     ++ ++ QI +G+ ++     +H D+++ NIL++
Sbjct: 77  IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVS 136

Query: 135 ES-GAKIADFGCAKW----ESEALQSGGTPM-FMAPEVARGEHQGFASDIWAVGCTVIEM 188
            S   KIADFG A+     E  A +    P+ + APE          SD+W+ G  ++E+
Sbjct: 137 ASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEI 196

Query: 189 AS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKER 240
            + G  P+P  ++P  V+  +     +P       ++  + +  C +  P+ER
Sbjct: 197 VTYGRIPYPGMSNP-EVIRALERGYRMPRPEN-CPEELYNIMMRCWKNRPEER 247

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 56.9 bits (137), Expect = 6e-09
 Identities = 82/316 (25%), Positives = 120/316 (37%), Gaps = 82/316 (25%)

Query: 8   TIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTS 67
           T+G G+   V LA  + +  ++A K+  L K + L R Q         H+   +  D+ +
Sbjct: 8   TLGIGAFGEVCLACKVDTHALYAMKT--LRKKDVLNRNQ-------VAHVKAER--DILA 56

Query: 68  E-DN----KLMY------NLF--MEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLE 114
           E DN    KL Y      NL+  M+Y PGG +   + R      E L   Y  ++   +E
Sbjct: 57  EADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRME-VFPEVLARFYIAELTLAIE 115

Query: 115 YLHSNRVVHCDIKSRNILMAESG-AKIADFG-CA--KW--ESEALQSG------------ 156
            +H    +H DIK  NIL+   G  K+ DFG C   +W   S+  Q G            
Sbjct: 116 SVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSD 175

Query: 157 ----------------------------------GTPMFMAPEVARGEHQGFASDIWAVG 182
                                             GTP ++APEV   +      D W+VG
Sbjct: 176 LWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235

Query: 183 CTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPA--FLSKQANDFLSN--CLRRDPK 238
             + EM  G  P+       T L  I +   L  +P    LS +A D ++   C   +  
Sbjct: 236 VILFEMLVGQPPFLAPTPTETQLKVINWENTL-HIPPQVKLSPEAVDLITKLCCSAEERL 294

Query: 239 ERWAASQLLKHPFLEE 254
            R  A  +  HPF  E
Sbjct: 295 GRNGADDIKAHPFFSE 310

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 55.6 bits (134), Expect = 1e-08
 Identities = 44/158 (27%), Positives = 75/158 (47%), Gaps = 9/158 (5%)

Query: 97  LDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAK---WESEA 152
           LD   ++ ++ Q+ QG+++L S   +H D+ +RN+L+ +   AKI DFG A+    +S  
Sbjct: 209 LDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY 268

Query: 153 LQSGGTPM---FMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKI 208
           +  G   +   +MAPE          SD+W+ G  + E+ S G +P+P      +  YK+
Sbjct: 269 VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN-SKFYKM 327

Query: 209 AYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQL 246
                    P F   +    +  C   +P ER   SQ+
Sbjct: 328 VKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQI 365

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 69/280 (24%), Positives = 112/280 (40%), Gaps = 62/280 (22%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQ--------KFLSSLN 53
           D+     IG+G+   V L     +G V+A K   L K++ L++EQ          L   +
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKI--LRKADMLEKEQVGHIRAERDILVEAD 59

Query: 54  SPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGL 113
           S  +V        S  +KL   L ME+ PGG +   + +    L E     Y  + +  +
Sbjct: 60  SLWVVKM----FYSFQDKLNLYLIMEFLPGGDMMTLLMKKD-TLTEEETQFYIAETVLAI 114

Query: 114 EYLHSNRVVHCDIKSRNILMAESG-AKIADFGC--------------------------- 145
           + +H    +H DIK  N+L+   G  K++DFG                            
Sbjct: 115 DSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQ 174

Query: 146 ---AKWESE---------ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGA 193
              +K ++E         A  + GTP ++APEV          D W++G  + EM  G  
Sbjct: 175 NMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234

Query: 194 PWPNAADPMTVLYKIAYSREL----PEVPAFLSKQANDFL 229
           P+ +   P     K+   +E     PEVP  +S++A D +
Sbjct: 235 PFCSET-PQETYKKVMNWKETLIFPPEVP--ISEKAKDLI 271

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 54.6 bits (131), Expect = 2e-08
 Identities = 57/209 (27%), Positives = 90/209 (43%), Gaps = 22/209 (10%)

Query: 4   TRGHTIGQGSSATV---SLATSLRSGDVFAAKS-----TELPKSEFLQREQKFLSSLNSP 55
           T+   IG G    V    L    R     A K+     TE  + +FL  E   +   +  
Sbjct: 8   TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLS-EASIMGQFSHH 66

Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
           +I+  +G  V ++    M  +  EY   G L+  +  + G      +V   R I  G++Y
Sbjct: 67  NIIRLEG--VVTKFKPAM--IITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKY 122

Query: 116 LHSNRVVHCDIKSRNILMAES-GAKIADFGCAKW-----ESEALQSGGT-PM-FMAPEVA 167
           L     VH D+ +RNIL+  +   K++DFG ++      E     SGG  P+ + APE  
Sbjct: 123 LSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAI 182

Query: 168 RGEHQGFASDIWAVGCTVIE-MASGGAPW 195
                  ASD+W+ G  + E M+ G  P+
Sbjct: 183 AYRKFTSASDVWSFGIVMWEVMSFGERPY 211

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 54.5 bits (131), Expect = 2e-08
 Identities = 57/246 (23%), Positives = 110/246 (44%), Gaps = 35/246 (14%)

Query: 32  KSTELPKSE--FLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDE 89
           +++  P  +  FLQ  Q +   LN P+++   G  + S    + Y L +E+ P G L + 
Sbjct: 31  RASATPDEQLLFLQEVQPY-RELNHPNVLQCLGQCIES----IPYLLVLEFCPLGDLKNY 85

Query: 90  IHRNGGRL----DESLIVSYTRQILQGLEYLHSNRVVHCDIKSRN-ILMAESGAKIADFG 144
           +  N G +     + ++     ++  GL +LH    +H D+  RN  L A+   KI D+G
Sbjct: 86  LRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYG 145

Query: 145 CA--KWESEALQSGGTPMF----MAPEVARGEHQGF-------ASDIWAVGCTVIEMASG 191
            A  ++  +   +          +APE+     Q          S+IW++G T+ E+ + 
Sbjct: 146 LALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTA 205

Query: 192 GA-PWPNAADPMTVLYKIAYSREL----PEVPAFLSKQANDFLSNCLRRDPKERWAASQ- 245
              P+P+ +D   VL ++   +++    P++    S +  + +  C   DP+ R  A + 
Sbjct: 206 ADQPYPDLSD-EQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEV 263

Query: 246 --LLKH 249
             LL +
Sbjct: 264 HELLTY 269

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 54.1 bits (130), Expect = 3e-08
 Identities = 47/169 (27%), Positives = 79/169 (46%), Gaps = 15/169 (8%)

Query: 34  TELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRN 93
           TE  + +FL  E   +   + P+I+  +G  VT     ++   FME    G L+  + +N
Sbjct: 45  TEKQRRDFLS-EASIMGQFDHPNIIHLEGV-VTKSRPVMIITEFME---NGALDSFLRQN 99

Query: 94  GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES-GAKIADFGCAKWESEA 152
            G+     +V   R I  G++YL     VH D+ +RNIL+  +   K++DFG +++  + 
Sbjct: 100 DGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159

Query: 153 LQS--------GGTPM-FMAPEVARGEHQGFASDIWAVGCTVIEMASGG 192
                      G  P+ + APE         ASD+W+ G  + E+ S G
Sbjct: 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYG 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 53.8 bits (129), Expect = 4e-08
 Identities = 50/205 (24%), Positives = 94/205 (45%), Gaps = 13/205 (6%)

Query: 49  LSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQ 108
           L   +  +IV  +G  V +  N +M  +  EY   G L+  + ++ G+L    ++     
Sbjct: 60  LGQFDHSNIVRLEG--VITRGNTMM--IVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPG 115

Query: 109 ILQGLEYLHSNRVVHCDIKSRNILMAES-GAKIADFGCAKWE-SEAL---QSGGTP-MFM 162
           +  G++YL     VH  + +  +L+      KI+ F   + + SEA+    SG +P ++ 
Sbjct: 116 LASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWA 175

Query: 163 APEVARGEHQGFASDIWAVGCTVIE-MASGGAPWPNAADPMTVLYKIAYSRELPEVPAFL 221
           APE  +  H   ASD+W+ G  + E M+ G  P+ + +    V+  +     LP  P   
Sbjct: 176 APEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG-QDVIKAVEDGFRLP-APRNC 233

Query: 222 SKQANDFLSNCLRRDPKERWAASQL 246
               +  + +C +++  ER   SQ+
Sbjct: 234 PNLLHQLMLDCWQKERGERPRFSQI 258

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 53.5 bits (128), Expect = 5e-08
 Identities = 48/180 (26%), Positives = 80/180 (44%), Gaps = 26/180 (14%)

Query: 35  ELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEI---- 90
           E P  E  + E    S L  P+IV   G  V +++  L  ++   Y     L++ +    
Sbjct: 48  EGPLREEFKHEAMMRSRLQHPNIVCLLG--VVTKEQPL--SMIFSYCSHSDLHEFLVMRS 103

Query: 91  -HRNGGRLDESLIVSYT----------RQILQGLEYLHSNRVVHCDIKSRNILMAES-GA 138
            H + G  D+   V  T           QI  G+E+L S+ VVH D+ +RN+L+ +    
Sbjct: 104 PHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNV 163

Query: 139 KIADFGCAK--WESEALQSGGTPM----FMAPEVARGEHQGFASDIWAVGCTVIEMASGG 192
           KI+D G  +  + ++  +  G  +    +M+PE          SDIW+ G  + E+ S G
Sbjct: 164 KISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYG 223

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 52.3 bits (125), Expect = 1e-07
 Identities = 47/167 (28%), Positives = 80/167 (47%), Gaps = 21/167 (12%)

Query: 40  EFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGG-------TLNDEIHR 92
           EFL  E   +   N  H+V   G  V S+    +  + ME    G       +L  E+  
Sbjct: 55  EFLN-EASVMKEFNCHHVVRLLG--VVSQGQPTL--VIMELMTRGDLKSYLRSLRPEMEN 109

Query: 93  NGGRLDESL--IVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES-GAKIADFGCAK-- 147
           N  +   SL  ++    +I  G+ YL++N+ VH D+ +RN ++AE    KI DFG  +  
Sbjct: 110 NPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI 169

Query: 148 WESEALQSGGTPM----FMAPEVARGEHQGFASDIWAVGCTVIEMAS 190
           +E++  + GG  +    +M+PE  +       SD+W+ G  + E+A+
Sbjct: 170 YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 54/176 (30%), Positives = 80/176 (45%), Gaps = 23/176 (13%)

Query: 31  AKSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLND-- 88
           A  T+  +++FL +E K +S L +P+I+   G  V   D+ L   +  EY   G LN   
Sbjct: 54  ADVTKTARNDFL-KEIKIMSRLKNPNIIRLLG--VCVSDDPLC--MITEYMENGDLNQFL 108

Query: 89  ---EIHRNGGRLDESLIVSYTR------QILQGLEYLHSNRVVHCDIKSRNILMAES-GA 138
              EI       +    VS         QI  G++YL S   VH D+ +RN L+      
Sbjct: 109 SQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTI 168

Query: 139 KIADFGCAK--WESEALQSGGTPM----FMAPEVARGEHQGFASDIWAVGCTVIEM 188
           KIADFG ++  +  +  +  G  +    +MA E         ASD+WA G T+ EM
Sbjct: 169 KIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEM 224

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 51.1 bits (122), Expect = 3e-07
 Identities = 34/115 (29%), Positives = 60/115 (52%), Gaps = 9/115 (7%)

Query: 85  TLNDEIHRNGGRLDESL--IVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGA-KIA 141
           +L  E   N GR   +L  ++    +I  G+ YL++ + VH D+ +RN ++A     KI 
Sbjct: 102 SLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIG 161

Query: 142 DFGCAK--WESEALQSGGTPM----FMAPEVARGEHQGFASDIWAVGCTVIEMAS 190
           DFG  +  +E++  + GG  +    +MAPE  +      +SD+W+ G  + E+ S
Sbjct: 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 52.2 bits (125), Expect = 3e-07
 Identities = 43/156 (27%), Positives = 70/156 (44%), Gaps = 32/156 (20%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFL--------QREQKFLSSLNSPHIVGY 60
           I +G+   V L     +  ++A K  +  K++ +        Q E+  L+   SP IV  
Sbjct: 12  ISRGAFGKVYLGRKKNNSKLYAVKVVK--KADMINKNMVHQVQAERDALALSKSPFIV-- 67

Query: 61  KGCDVTSEDNKLMYNL--------FMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQG 112
                      L Y+L         MEY  GG +   +H  G   DE + V Y  ++   
Sbjct: 68  ----------HLYYSLQSANNVYLVMEYLIGGDVKSLLHIYG-YFDEEMAVKYISEVALA 116

Query: 113 LEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAK 147
           L+YLH + ++H D+K  N+L++  G  K+ DFG +K
Sbjct: 117 LDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 51.1 bits (122), Expect = 3e-07
 Identities = 57/250 (22%), Positives = 102/250 (40%), Gaps = 37/250 (14%)

Query: 77  FMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES 136
           FM Y    +L       G  + E+LI +     L+GL YLH N  +H +IK+ +IL++  
Sbjct: 80  FMAYGSANSLLKTYFPEG--MSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGD 137

Query: 137 G----AKIADFGC---------AKWESEALQSGGTPMFMAPEVARGEHQGF--ASDIWAV 181
           G    + ++               ++     +   P   +PE+ R +  G+   SDI++V
Sbjct: 138 GLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWL-SPELLRQDLYGYNVKSDIYSV 196

Query: 182 GCTVIEMASGGAPWPNAADPMTVLYKIA-------YSRELP--EVPAFLSKQANDF-LSN 231
           G T  E+A+G  P+ +      +L K+             P  E     S+   D  +  
Sbjct: 197 GITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGE 256

Query: 232 CLRRDPKERWAASQLLKHPFLEEFCS--------CTKQIQESNCSPTSILDQGIWNSV-E 282
            +      +   S+ L+ P  + F          C +Q  E   S +S+L    +  V E
Sbjct: 257 SVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE 316

Query: 283 ETEESLGNLI 292
           +T+ S+ +L+
Sbjct: 317 QTQGSILSLL 326

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 50.9 bits (122), Expect = 4e-07
 Identities = 39/159 (24%), Positives = 75/159 (47%), Gaps = 8/159 (5%)

Query: 97  LDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRN-ILMAESGAKIADFGCAK--WESEAL 153
           L     V+   QI  G+++L + R VH D+ +RN ++ ++   K++    +K  + SE  
Sbjct: 114 LSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYY 173

Query: 154 QSGGTPM---FMAPEVARGEHQGFASDIWAVGCTVIEM-ASGGAPWPNAADPMTVLYKIA 209
           +     +   ++APE  + +     SD+W+ G  + E+   G  P+   +D   +    A
Sbjct: 174 KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQA 233

Query: 210 YSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLK 248
              ELP VP     +    ++ C   +PK+R + S+L+ 
Sbjct: 234 GKLELP-VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVS 271

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 51.0 bits (122), Expect = 6e-07
 Identities = 30/100 (30%), Positives = 48/100 (48%), Gaps = 7/100 (7%)

Query: 97  LDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCA-----KWES 150
           L  + + +  RQ+L  ++Y+H   ++H DIK+ N+L+       + DFG A      W +
Sbjct: 257 LGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST 316

Query: 151 EALQS-GGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMA 189
                  GT    APEV  G+    + DIW+ G  + E A
Sbjct: 317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAA 356

Length = 461

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 49.8 bits (119), Expect = 7e-07
 Identities = 41/208 (19%), Positives = 92/208 (44%), Gaps = 29/208 (13%)

Query: 49  LSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQ 108
           +S L+  H+V   G  V  +++ ++     EY   G+L+  + +N   ++ S  +   +Q
Sbjct: 53  MSQLSHKHLVLNYGVCVCGDESIMV----QEYVKFGSLDTYLKKNKNLINISWKLEVAKQ 108

Query: 109 ILQGLEYLHSNRVVHCDIKSRNILMAESGA---------KIADFGCA------KWESEAL 153
           +   L +L    + H ++ ++N+L+              K++D G +      +   E +
Sbjct: 109 LAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERI 168

Query: 154 QSGGTPMFMAPE-VARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSR 212
                  ++ PE +   ++   A+D W+ G T+ E+ SGG    +A D      K+ +  
Sbjct: 169 P------WVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK---KLQFYE 219

Query: 213 ELPEVPAFLSKQANDFLSNCLRRDPKER 240
           +  ++PA    +  + ++ C+  +P  R
Sbjct: 220 DRHQLPAPKWTELANLINQCMDYEPDFR 247

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 49.4 bits (118), Expect = 1e-06
 Identities = 61/262 (23%), Positives = 106/262 (40%), Gaps = 24/262 (9%)

Query: 8   TIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTS 67
            + Q   + + +A      D+      E    EFL  E   +   + P+++   G    +
Sbjct: 19  QLSQDDGSQLKVAVKTMKLDIHTYSEIE----EFL-SEAACMKDFDHPNVMKLIGVCFEA 73

Query: 68  EDN----KLMYNL-FMEYAPGGT--LNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNR 120
                  K M  L FM++    +  L   +     +L    ++ +   I  G+EYL +  
Sbjct: 74  SSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN 133

Query: 121 VVHCDIKSRNILMAES-GAKIADFGCAKW---ESEALQSGGTPM---FMAPEVARGEHQG 173
            +H D+ +RN ++ E     +ADFG +K         Q     M   ++A E        
Sbjct: 134 FIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYT 193

Query: 174 FASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNC 232
             SD+WA G T+ E+A+ G  P+P   +     Y    +R L +    L +   D + +C
Sbjct: 194 SKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNR-LKQPEDCLDE-LYDLMYSC 251

Query: 233 LRRDPKERWAASQLLKHPFLEE 254
            R DPK+R   ++L +   LE 
Sbjct: 252 WRADPKDRPTFTKLREV--LEN 271

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 48.1 bits (114), Expect = 3e-06
 Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 10/152 (6%)

Query: 97  LDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES-GAKIADFGCAK--WESEAL 153
           L   ++V +   I  G+EYL S   +H D+ +RN ++ E+    +ADFG +K  +  +  
Sbjct: 109 LPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYY 168

Query: 154 QSG---GTPM-FMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKI 208
           + G     P+ ++A E          SD+W+ G T+ E+A+ G  P+P   +     Y +
Sbjct: 169 RQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDY-L 227

Query: 209 AYSRELPEVPAFLSKQANDFLSNCLRRDPKER 240
                L + P  L       +S+C   +PK+R
Sbjct: 228 RQGNRLKQPPDCLDG-LYSLMSSCWLLNPKDR 258

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 48.1 bits (114), Expect = 3e-06
 Identities = 55/222 (24%), Positives = 90/222 (40%), Gaps = 28/222 (12%)

Query: 42  LQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPG---------------GTL 86
            Q+E   ++ L+ P+IV   G  VT E    M  LF     G               G  
Sbjct: 54  FQQEASLMAELHHPNIVCLLGV-VTQEQPVCM--LFEYLNQGDLHEFLIMRSPHSDVGCS 110

Query: 87  NDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES-GAKIADFGC 145
           +DE       LD    +    QI  G+EYL S+  VH D+ +RNIL+ E    KI+D G 
Sbjct: 111 SDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGL 170

Query: 146 AK--WESEALQSGGTPM----FMAPEVARGEHQGFASDIWAVGCTVIEMASGG-APWPNA 198
           ++  + ++  +     +    +M PE          SDIW+ G  + E+ S G  P+   
Sbjct: 171 SREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGF 230

Query: 199 ADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKER 240
           ++   +  ++   R+L         +    ++ C +  P  R
Sbjct: 231 SNQEVI--EMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRR 270

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 47.8 bits (113), Expect = 7e-06
 Identities = 31/90 (34%), Positives = 49/90 (54%), Gaps = 6/90 (6%)

Query: 107 RQILQGLEYLHSNRVVHCDIKSRNILMAESGAKI-ADFGCA---KWESEALQSG--GTPM 160
           +Q+L  +EY+H  +++H DIK  NI +   G  +  DFG A   + E EA   G  GT  
Sbjct: 274 KQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVA 333

Query: 161 FMAPEVARGEHQGFASDIWAVGCTVIEMAS 190
             +PE+  G+     +DIW+ G  +++M S
Sbjct: 334 TNSPEILAGDGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated

 Score = 46.8 bits (112), Expect = 1e-05
 Identities = 37/160 (23%), Positives = 62/160 (38%), Gaps = 32/160 (20%)

Query: 6   GHTIGQGSSATVSLATSLRSGDVF---AAKSTELPK------SEFLQREQKFLSSL---- 52
            H IG+G+ A +     L    V      K    P+      +E  + E + LS      
Sbjct: 338 DHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAG 397

Query: 53  -NSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQ 111
             +P I  Y   DV  E+  ++    MEY  G  L D +  N   +         R++ +
Sbjct: 398 VPTPVI--Y---DVDPEEKTIV----MEYIGGKDLKDVLEGNPELV---------RKVGE 439

Query: 112 GLEYLHSNRVVHCDIKSRNILMAESGAKIADFGCAKWESE 151
            +  LH   +VH D+ + N ++ +    + DFG  K+   
Sbjct: 440 IVAKLHKAGIVHGDLTTSNFIVRDDRLYLIDFGLGKYSDL 479

Length = 535

>gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32

 Score = 44.5 bits (106), Expect = 2e-05
 Identities = 38/154 (24%), Positives = 60/154 (38%), Gaps = 31/154 (20%)

Query: 8   TIGQGSSATVSLATSLRSGDVF---AAKSTELPK------SEFLQREQKFLSSL-----N 53
            I +G+ A + L   L    V      KS   P+       E  + E + LS       N
Sbjct: 1   LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVN 60

Query: 54  SPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGL 113
           +P +      DV  ++  ++    MEY  G  L D I        E       R+I + +
Sbjct: 61  TPVVY-----DVDPDNKTIV----MEYIEGKPLKDVI--------EEGNDELLREIGRLV 103

Query: 114 EYLHSNRVVHCDIKSRNILMAESGAKIADFGCAK 147
             LH   +VH D+ + NI++ +    + DFG  K
Sbjct: 104 GKLHKAGIVHGDLTTSNIIVRDDKLYLIDFGLGK 137

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 46.0 bits (109), Expect = 3e-05
 Identities = 33/97 (34%), Positives = 49/97 (50%), Gaps = 4/97 (4%)

Query: 157 GTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSREL-- 214
           GTP ++APE+  G+  G A D WA+G  + E  +G  P+ N   P  V   I  +R++  
Sbjct: 542 GTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPF-NDETPQQVFQNI-LNRDIPW 599

Query: 215 PEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPF 251
           PE    LS  A + +   L  DP +R    +L +HP 
Sbjct: 600 PEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHPL 636

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 44.9 bits (106), Expect = 3e-05
 Identities = 50/205 (24%), Positives = 92/205 (44%), Gaps = 22/205 (10%)

Query: 48  FLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTR 107
            +S ++  H+    G  V   +N +M   F+E+ P   L+  + +  GR+  +  ++  +
Sbjct: 69  LMSQVSHIHLAFVHGVCVRGSEN-IMVEEFVEHGP---LDVCLRKEKGRVPVAWKITVAQ 124

Query: 108 QILQGLEYLHSNRVVHCDIKSRNILMAESG--------AKIADFGCAKWESEALQSGGTP 159
           Q+   L YL    +VH ++ ++NIL+A  G         K++D G +       +     
Sbjct: 125 QLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREERVERI 184

Query: 160 MFMAPE-VARGEHQGFASDIWAVGCTVIEMA-SGGAPWPNAADPMTVLYKIAYSRE--LP 215
            ++APE V  G     A+D W+ G T++E+   G  P           +   Y ++  LP
Sbjct: 185 PWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERF---YEKKHRLP 241

Query: 216 EVPAFLSKQANDFLSNCLRRDPKER 240
           E P+   K+    +S CL  +P +R
Sbjct: 242 E-PS--CKELATLISQCLTYEPTQR 263

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 44.9 bits (106), Expect = 3e-05
 Identities = 49/199 (24%), Positives = 84/199 (42%), Gaps = 26/199 (13%)

Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
           HIV   G  V   +N +M   F+E+ P   L+  +HR    L         +Q+   L Y
Sbjct: 65  HIVLLYGVCVRDVEN-IMVEEFVEFGP---LDLFMHRKSDVLTTPWKFKVAKQLASALSY 120

Query: 116 LHSNRVVHCDIKSRNILMAESGAKIADFGCAKWESEALQSGGTPM-------------FM 162
           L    +VH ++ ++NIL+A  G    D  C  +    L   G P+             ++
Sbjct: 121 LEDKDLVHGNVCTKNILLAREG---IDGECGPFIK--LSDPGIPITVLSRQECVERIPWI 175

Query: 163 APE-VARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFL 221
           APE V   ++   A+D W+ G T+ E+   G   P     +    +    + +   P+  
Sbjct: 176 APECVEDSKNLSIAADKWSFGTTLWEICYNGEI-PLKDKTLAEKERFYEGQCMLVTPS-- 232

Query: 222 SKQANDFLSNCLRRDPKER 240
            K+  D +++C+  DP +R
Sbjct: 233 CKELADLMTHCMNYDPNQR 251

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 43.4 bits (102), Expect = 1e-04
 Identities = 42/156 (26%), Positives = 72/156 (46%), Gaps = 23/156 (14%)

Query: 74  YNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTR------QILQGLEYLHSNRVVHCDIK 127
           Y L ME+ P G L   +     R  E +    T       +I  GL +LH N  +H D+ 
Sbjct: 70  YLLVMEFCPLGDLKGYLR--SCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLA 127

Query: 128 SRNILM-AESGAKIADFGCA--KWESEALQSGG---TPM-FMAPEVARGEH-------QG 173
            RN L+ A+   KI D+G +  K++ +   +      P+ ++APE+    H       Q 
Sbjct: 128 LRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQT 187

Query: 174 FASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKI 208
             S++W++G T+ E+   G  P+ + +D   + Y +
Sbjct: 188 KESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTV 223

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 43.9 bits (103), Expect = 1e-04
 Identities = 23/50 (46%), Positives = 29/50 (58%), Gaps = 1/50 (2%)

Query: 98  DESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCA 146
           D ++I    RQ+L GL  LH   +VH DIK  N+L+   G  KI DFG A
Sbjct: 307 DINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356

Length = 507

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 42.9 bits (101), Expect = 2e-04
 Identities = 27/95 (28%), Positives = 46/95 (48%), Gaps = 7/95 (7%)

Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQS----- 155
            ++  R++L+ L YLH   ++H D+K+ NI + E   A + DFG A        +     
Sbjct: 187 AITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYG 246

Query: 156 -GGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMA 189
             GT    +PE+   +     +DIW+ G  + EM+
Sbjct: 247 WSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMS 281

Length = 392

>gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional

 Score = 41.8 bits (99), Expect = 2e-04
 Identities = 23/75 (30%), Positives = 37/75 (49%), Gaps = 5/75 (6%)

Query: 78  MEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG 137
           MEY  G  L D I+ NG    E   +S     L G   LHS  ++H D+ + N++++   
Sbjct: 78  MEYIEGEPLKDLINSNGMEELE---LSREIGRLVGK--LHSAGIIHGDLTTSNMILSGGK 132

Query: 138 AKIADFGCAKWESEA 152
             + DFG A++  + 
Sbjct: 133 IYLIDFGLAEFSKDL 147

Length = 211

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 41.1 bits (96), Expect = 7e-04
 Identities = 30/105 (28%), Positives = 49/105 (46%), Gaps = 23/105 (21%)

Query: 108 QILQGLEYLHSN-RVVHCDIKSRNILMAESGA-----------------KIADFG--CAK 147
           Q    L+Y H+   ++H D+K  NILM  S                   +I D G  C +
Sbjct: 239 QTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDE 298

Query: 148 WESE-ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASG 191
             S  A+ S  T  + +PEV  G    +++D+W++GC + E+ +G
Sbjct: 299 RHSRTAIVS--TRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTG 341

Length = 467

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 39.7 bits (93), Expect = 7e-04
 Identities = 25/124 (20%), Positives = 42/124 (33%), Gaps = 24/124 (19%)

Query: 38  KSEFLQRE---QKFLSSLN--SPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHR 92
           K    +RE    + L+      P ++          ++     L ME+  G TL      
Sbjct: 34  KGADREREVAILQLLARKGLPVPKVLASG-------ESDGWSYLLMEWIEGETL------ 80

Query: 93  NGGRLDESLIVSYTRQILQGLEYLHS---NRVVHCDIKSRNILMAESG-AKIADFGCAKW 148
               + E        Q+ + L  LH      + H D+   NIL+ +     I D+  A +
Sbjct: 81  --DEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138

Query: 149 ESEA 152
              A
Sbjct: 139 GPPA 142

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 40.5 bits (95), Expect = 0.001
 Identities = 22/55 (40%), Positives = 31/55 (56%), Gaps = 2/55 (3%)

Query: 94  GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGA--KIADFGCA 146
           G   +  +I +  RQIL  L+ LHS  +VH D+K +NI+ +E     KI D G A
Sbjct: 249 GLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAA 303

Length = 566

>gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

 Score = 39.2 bits (92), Expect = 0.002
 Identities = 20/80 (25%), Positives = 33/80 (41%), Gaps = 11/80 (13%)

Query: 68  EDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIK 127
            DN L+    MEY  G  L D +                R++ + +  LH   +VH D+ 
Sbjct: 71  PDNGLIV---MEYIEGELLKDALEEARP--------DLLREVGRLVGKLHKAGIVHGDLT 119

Query: 128 SRNILMAESGAKIADFGCAK 147
           + NI+++       DFG  +
Sbjct: 120 TSNIILSGGRIYFIDFGLGE 139

Length = 204

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	405
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG1167	418	consensus Serine/threonine protein kinase of the C	100.0
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.97
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.97
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.95
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.94
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.94
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.94
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.94
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.93
PRK09188	365	serine/threonine protein kinase; Provisional	99.93
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.92
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.9
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.89
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.89
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.89
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.88
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.88
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.87
PRK12274	218	serine/threonine protein kinase; Provisional	99.87
PRK10345	210	hypothetical protein; Provisional	99.87
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.84
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.82
smart00090	237	RIO RIO-like kinase.	99.82
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.81
PRK14879	211	serine/threonine protein kinase; Provisional	99.8
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.79
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.78
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.78
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.76
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.76
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.7
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.69
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.68
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.61
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.52
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.51
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.45
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.45
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.42
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.4
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.4
KOG1243	690	consensus Protein kinase [General function predict	99.39
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.33
KOG3087	229	consensus Serine/threonine protein kinase [General	99.21
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.2
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.15
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.1
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.03
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.95
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.91
COG4248	637	Uncharacterized protein with protein kinase and he	98.9
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.83
PRK09902	216	hypothetical protein; Provisional	98.83
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.75
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.58
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.57
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.38
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.36
PF01636	239	APH: Phosphotransferase enzyme family This family	98.34
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.33
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.26
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.26
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.18
PLN02876	822	acyl-CoA dehydrogenase	98.02
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	98.02
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.97
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.97
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.96
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.74
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.73
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.69
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.53
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.5
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.48
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.39
PRK05231	319	homoserine kinase; Provisional	97.34
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.26
KOG2270	520	consensus Serine/threonine protein kinase involved	97.22
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.21
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.91
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.89
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.86
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.73
PRK10593	297	hypothetical protein; Provisional	96.63
PRK12396	409	5-methylribose kinase; Reviewed	96.29
PLN02756	418	S-methyl-5-thioribose kinase	96.1
PLN02236	344	choline kinase	96.1
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	95.96
KOG1236	565	consensus Predicted unusual protein kinase [Genera	95.89
PTZ00384	383	choline kinase; Provisional	95.85
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	95.79
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	95.28
COG2334	331	Putative homoserine kinase type II (protein kinase	95.14
PRK11768	325	serine/threonine protein kinase; Provisional	94.92
PRK06148	1013	hypothetical protein; Provisional	93.98
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	93.97
PTZ00296	442	choline kinase; Provisional	93.95
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	93.51
PRK10271	188	thiK thiamine kinase; Provisional	92.45

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-58  Score=443.21  Aligned_cols=253  Identities=50%  Similarity=0.861  Sum_probs=228.7

Q ss_pred             CCcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC---hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEE
Q 015500            1 MDWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK---SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLF   77 (405)
Q Consensus         1 ~~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~---~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv   77 (405)
                      ++|..++.||+|+||+||++.++.+|+.+|||.+....   .+.+.+|+++|++|+|||||+++|.....++  ..|+++
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~--~~~~i~   94 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSREN--DEYNIF   94 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccC--eeeEee
Confidence            47999999999999999999999999999999988776   5569999999999999999999997554444  568899


Q ss_pred             EeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcc-CC-ceEeeecccccccc----
Q 015500           78 MEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAE-SG-AKIADFGCAKWESE----  151 (405)
Q Consensus        78 ~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~-~~-vkL~DFGla~~~~~----  151 (405)
                      |||++||+|.+++++.+++++|..++.+++||++||+|||++||+||||||+|||++. ++ +||+|||+++....    
T Consensus        95 mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~  174 (313)
T KOG0198|consen   95 MEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTK  174 (313)
T ss_pred             eeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccccc
Confidence            9999999999999998778999999999999999999999999999999999999999 56 99999999986552    


Q ss_pred             ---cccCCCCCCccChhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHH
Q 015500          152 ---ALQSGGTPMFMAPEVARG-EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQAND  227 (405)
Q Consensus       152 ---~~~~~gt~~Y~APE~l~~-~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~d  227 (405)
                         .....|||.|||||++.. ...++++|||||||+++||+||+.||.........+.++......|.+|..+|+++++
T Consensus       175 ~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a~~  254 (313)
T KOG0198|consen  175 SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEAKD  254 (313)
T ss_pred             ccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHHHH
Confidence               234669999999999995 4455799999999999999999999976556677788888888889999999999999


Q ss_pred             HHHHhcccCccccCCHHHHhcCcccccc
Q 015500          228 FLSNCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       228 ll~~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      ||.+||++||.+||||++||+|||+...
T Consensus       255 Fl~~C~~~~p~~Rpta~eLL~hpf~~~~  282 (313)
T KOG0198|consen  255 FLRKCFKRDPEKRPTAEELLEHPFLKQN  282 (313)
T ss_pred             HHHHHhhcCcccCcCHHHHhhChhhhcc
Confidence            9999999999999999999999999764

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3e-58  Score=441.47  Aligned_cols=248  Identities=31%  Similarity=0.456  Sum_probs=216.5

Q ss_pred             cccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC----------hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCce
Q 015500            3 WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK----------SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKL   72 (405)
Q Consensus         3 y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~----------~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~   72 (405)
                      |.+.+.||+|+||.|-+|..+.||+.||||++.+..          ...+++|++||++|+|||||++++++...+.   
T Consensus       174 yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds---  250 (475)
T KOG0615|consen  174 YIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS---  250 (475)
T ss_pred             eEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc---
Confidence            778999999999999999999999999999887532          2346799999999999999999998876654   


Q ss_pred             EEEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC----ceEeeeccccc
Q 015500           73 MYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG----AKIADFGCAKW  148 (405)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~----vkL~DFGla~~  148 (405)
                       +|+||||++||+|.+.+..++ .+.|...+.+++|++.|+.|||++||+||||||+|||+..+.    +||+|||+|+.
T Consensus       251 -~YmVlE~v~GGeLfd~vv~nk-~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~  328 (475)
T KOG0615|consen  251 -SYMVLEYVEGGELFDKVVANK-YLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKV  328 (475)
T ss_pred             -eEEEEEEecCccHHHHHHhcc-ccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhc
Confidence             679999999999999999884 899999999999999999999999999999999999998762    89999999998


Q ss_pred             ccc---cccCCCCCCccChhhhcCCC---CCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCC--CCCCchh
Q 015500          149 ESE---ALQSGGTPMFMAPEVARGEH---QGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRE--LPEVPAF  220 (405)
Q Consensus       149 ~~~---~~~~~gt~~Y~APE~l~~~~---~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~--~~~~p~~  220 (405)
                      ...   ..+.||||.|.|||++.+..   +..++|||||||++|-+++|.+||.+.........+|..++.  .|.....
T Consensus       329 ~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~  408 (475)
T KOG0615|consen  329 SGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDR  408 (475)
T ss_pred             cccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhh
Confidence            644   56789999999999998754   334789999999999999999999876665555555554432  2233456


Q ss_pred             ccHHHHHHHHHhcccCccccCCHHHHhcCcccccc
Q 015500          221 LSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       221 ~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      +++++.+||++||..||++|||++++|+||||+..
T Consensus       409 Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~  443 (475)
T KOG0615|consen  409 ISEEALDLINWMLVVDPENRPSADEALNHPWFKDA  443 (475)
T ss_pred             hhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcc
Confidence            89999999999999999999999999999999865

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-56  Score=427.32  Aligned_cols=249  Identities=36%  Similarity=0.620  Sum_probs=221.9

Q ss_pred             cccccccceeCCeeEEEEEEcCCCCEEEEEEccCC----ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEE
Q 015500            3 WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP----KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFM   78 (405)
Q Consensus         3 y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~----~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (405)
                      ...++.||+|..|+||+++|+.|++.+|+|.+...    ...++.+|+++|++.+|||||+|||+|.....   ..+++|
T Consensus        81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~---~isI~m  157 (364)
T KOG0581|consen   81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE---EISICM  157 (364)
T ss_pred             hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc---eEEeeh
Confidence            45788999999999999999999999999998433    34678999999999999999999999987664   256999


Q ss_pred             eecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCCEEEccCC-ceEeeecccccccc--ccc
Q 015500           79 EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHS-NRVVHCDIKSRNILMAESG-AKIADFGCAKWESE--ALQ  154 (405)
Q Consensus        79 Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~-~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~--~~~  154 (405)
                      |||.||+|.++++.. |+++|.....++.+|++||.|||. ++||||||||+||||+..| +||||||.++..-.  ..+
T Consensus       158 EYMDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS~a~t  236 (364)
T KOG0581|consen  158 EYMDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNSIANT  236 (364)
T ss_pred             hhcCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhhhccc
Confidence            999999999999876 589999999999999999999996 8999999999999999998 99999999886433  467


Q ss_pred             CCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCC----CChHHHHHHHHhcCCCCCCchh-ccHHHHHHH
Q 015500          155 SGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNA----ADPMTVLYKIAYSRELPEVPAF-LSKQANDFL  229 (405)
Q Consensus       155 ~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~----~~~~~~l~~i~~~~~~~~~p~~-~s~~l~dll  229 (405)
                      ..||..|||||.+.+..|+.++||||||++++||++|+.||...    .+..+.+..|. ....|.+|.. +|+++++|+
T Consensus       237 fvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv-~~ppP~lP~~~fS~ef~~FV  315 (364)
T KOG0581|consen  237 FVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIV-DEPPPRLPEGEFSPEFRSFV  315 (364)
T ss_pred             ccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHh-cCCCCCCCcccCCHHHHHHH
Confidence            78999999999999999999999999999999999999999763    24455555554 5567888886 999999999


Q ss_pred             HHhcccCccccCCHHHHhcCccccccc
Q 015500          230 SNCLRRDPKERWAASQLLKHPFLEEFC  256 (405)
Q Consensus       230 ~~~L~~dP~~Rpt~~elL~hp~~~~~~  256 (405)
                      ..||++||.+|||+.||++|||+++..
T Consensus       316 ~~CL~Kdp~~R~s~~qLl~Hpfi~~~~  342 (364)
T KOG0581|consen  316 SCCLRKDPSERPSAKQLLQHPFIKKFE  342 (364)
T ss_pred             HHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence            999999999999999999999998763

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.2e-55  Score=440.03  Aligned_cols=245  Identities=31%  Similarity=0.510  Sum_probs=221.6

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC------ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~------~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~   75 (405)
                      .|.+++.||+|||++||.+++..+|+.||+|++++.      ..+.+.+|++|.++|+|||||+++++|.+.+.    .|
T Consensus        19 ~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~n----VY   94 (592)
T KOG0575|consen   19 RYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNN----VY   94 (592)
T ss_pred             eeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCc----eE
Confidence            399999999999999999999999999999998763      46789999999999999999999999876654    67


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc---
Q 015500           76 LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE---  151 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~---  151 (405)
                      +|+|+|+.++|..+++++ ++++|..++.|++||+.||.|||+++|+|||||..|++++++. +||+|||+|.....   
T Consensus        95 ivLELC~~~sL~el~Krr-k~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E  173 (592)
T KOG0575|consen   95 IVLELCHRGSLMELLKRR-KPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE  173 (592)
T ss_pred             EEEEecCCccHHHHHHhc-CCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCccc
Confidence            999999999999999966 5999999999999999999999999999999999999999995 99999999987552   


Q ss_pred             -cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHH
Q 015500          152 -ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLS  230 (405)
Q Consensus       152 -~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~  230 (405)
                       ..+.||||-|.|||++....+++.+||||+||++|.||+|++||. ..+..+...+|.....  .+|..+|.+++|||.
T Consensus       174 rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFe-tk~vkety~~Ik~~~Y--~~P~~ls~~A~dLI~  250 (592)
T KOG0575|consen  174 RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFE-TKTVKETYNKIKLNEY--SMPSHLSAEAKDLIR  250 (592)
T ss_pred             ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcc-cchHHHHHHHHHhcCc--ccccccCHHHHHHHH
Confidence             567899999999999999999999999999999999999999994 3445566666665543  567799999999999


Q ss_pred             HhcccCccccCCHHHHhcCccccc
Q 015500          231 NCLRRDPKERWAASQLLKHPFLEE  254 (405)
Q Consensus       231 ~~L~~dP~~Rpt~~elL~hp~~~~  254 (405)
                      ++|++||.+|||++++|.|+||..
T Consensus       251 ~lL~~~P~~Rpsl~~vL~h~Ff~~  274 (592)
T KOG0575|consen  251 KLLRPNPSERPSLDEVLDHPFFKS  274 (592)
T ss_pred             HHhcCCcccCCCHHHHhcCHhhhC
Confidence            999999999999999999999943

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-54  Score=414.84  Aligned_cols=248  Identities=35%  Similarity=0.592  Sum_probs=221.7

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      +|...+.||+|+||+||+|+++.++..||||.+....     .+.+..|+.+|+.++|||||+++++....+    +.||
T Consensus        11 ~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~----~i~l   86 (429)
T KOG0595|consen   11 DYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDD----FIYL   86 (429)
T ss_pred             cceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCC----eEEE
Confidence            6889999999999999999999999999999987663     467889999999999999999999876654    4779


Q ss_pred             EEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccC------C-ceEeeecccccc
Q 015500           77 FMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES------G-AKIADFGCAKWE  149 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~------~-vkL~DFGla~~~  149 (405)
                      |||||.||+|.++|++++ .++|.+++.++.||+.||++||+++||||||||+||||+..      - +||+|||+|+..
T Consensus        87 VMEyC~gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L  165 (429)
T KOG0595|consen   87 VMEYCNGGDLSDYIRRRG-RLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL  165 (429)
T ss_pred             EEEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence            999999999999999985 89999999999999999999999999999999999999764      1 799999999986


Q ss_pred             cc---cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCC-CCCCchhccHHH
Q 015500          150 SE---ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRE-LPEVPAFLSKQA  225 (405)
Q Consensus       150 ~~---~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~-~~~~p~~~s~~l  225 (405)
                      ..   ..+.||+|.|||||++...+|+.|+|+||+|+++|+|++|++||. .....+.+..+..... .|.++..++...
T Consensus       166 ~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~-a~t~~eL~~~~~k~~~~~~~~~~~~s~~~  244 (429)
T KOG0595|consen  166 QPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFD-AETPKELLLYIKKGNEIVPVLPAELSNPL  244 (429)
T ss_pred             CchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcc-ccCHHHHHHHHhccccccCchhhhccCch
Confidence            65   557889999999999999999999999999999999999999995 4455666666655544 566677889999


Q ss_pred             HHHHHHhcccCccccCCHHHHhcCcccccc
Q 015500          226 NDFLSNCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       226 ~dll~~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      .+++...|+++|..|.+..+-+.|+++..-
T Consensus       245 ~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~  274 (429)
T KOG0595|consen  245 RELLISLLQRNPKDRISFEDFFDHPFLAAN  274 (429)
T ss_pred             hhhhhHHHhcCccccCchHHhhhhhhcccC
Confidence            999999999999999999999999998754

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-54  Score=409.59  Aligned_cols=250  Identities=32%  Similarity=0.515  Sum_probs=220.7

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC------ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~------~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~   75 (405)
                      +|.+.+.||+|+||+|++++.+.+++.||+|++.+.      ..+...+|..||.+++||.||++.-.|.+.+.    +|
T Consensus        26 dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~k----Ly  101 (357)
T KOG0598|consen   26 DFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEK----LY  101 (357)
T ss_pred             heeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCe----EE
Confidence            588999999999999999999999999999988753      35678899999999999999999877766554    66


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccc----
Q 015500           76 LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWES----  150 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~----  150 (405)
                      +|+||++||.|..+|++. +.++|..++.|+..|+.||.|||++|||||||||+|||++.+| ++|+|||+++..-    
T Consensus       102 lVld~~~GGeLf~hL~~e-g~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~  180 (357)
T KOG0598|consen  102 LVLDYLNGGELFYHLQRE-GRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGD  180 (357)
T ss_pred             EEEeccCCccHHHHHHhc-CCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCC
Confidence            999999999999999887 4999999999999999999999999999999999999999999 9999999998532    


Q ss_pred             ccccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHH
Q 015500          151 EALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLS  230 (405)
Q Consensus       151 ~~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~  230 (405)
                      ...+.|||+.|||||++.+..|+.++|.||||+++|||++|.+||.. .+......++... ..+..|..++.++++||+
T Consensus       181 ~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~-~~~~~~~~~I~~~-k~~~~p~~ls~~ardll~  258 (357)
T KOG0598|consen  181 ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYA-EDVKKMYDKILKG-KLPLPPGYLSEEARDLLK  258 (357)
T ss_pred             ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcC-ccHHHHHHHHhcC-cCCCCCccCCHHHHHHHH
Confidence            24567999999999999999999999999999999999999999954 3444444454443 456777789999999999


Q ss_pred             HhcccCccccC----CHHHHhcCccccccccc
Q 015500          231 NCLRRDPKERW----AASQLLKHPFLEEFCSC  258 (405)
Q Consensus       231 ~~L~~dP~~Rp----t~~elL~hp~~~~~~~~  258 (405)
                      ++|++||.+|.    .+.++.+||||..+...
T Consensus       259 ~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~  290 (357)
T KOG0598|consen  259 KLLKRDPRQRLGGPGDAEEIKRHPFFKGINWE  290 (357)
T ss_pred             HHhccCHHHhcCCCCChHHhhcCcccccCCHH
Confidence            99999999996    68899999999987554

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-53  Score=419.16  Aligned_cols=248  Identities=36%  Similarity=0.581  Sum_probs=218.8

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC------ChHHHHHHHHHHHhC-CCCCeeeeeeeeeecCCCceEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSL-NSPHIVGYKGCDVTSEDNKLMY   74 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~------~~~~l~~E~~iL~~L-~hpnIv~~~~~~~~~~~~~~~~   74 (405)
                      ||..++.||.|+|++|++|+++.+++.||||++++.      +...+.+|..+|.+| .||.|++++-.|.+...    +
T Consensus        74 DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s----L  149 (604)
T KOG0592|consen   74 DFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES----L  149 (604)
T ss_pred             hcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc----e
Confidence            689999999999999999999999999999998753      456788999999999 89999999877765544    5


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc--
Q 015500           75 NLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE--  151 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~--  151 (405)
                      |+|+||+++|+|.++|++. |.|+|..++.|+.||+.||+|||++|||||||||+|||++.++ +||+|||.|+....  
T Consensus       150 YFvLe~A~nGdll~~i~K~-Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~  228 (604)
T KOG0592|consen  150 YFVLEYAPNGDLLDLIKKY-GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ  228 (604)
T ss_pred             EEEEEecCCCcHHHHHHHh-CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence            6899999999999999988 5999999999999999999999999999999999999999999 99999999975322  


Q ss_pred             -----------c----ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCC
Q 015500          152 -----------A----LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPE  216 (405)
Q Consensus       152 -----------~----~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~  216 (405)
                                 .    ...+||..|++||+|.....++.+|||+|||++|+|+.|++||... +....+.+|.... + +
T Consensus       229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~-NeyliFqkI~~l~-y-~  305 (604)
T KOG0592|consen  229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAA-NEYLIFQKIQALD-Y-E  305 (604)
T ss_pred             ccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccc-cHHHHHHHHHHhc-c-c
Confidence                       1    2356999999999999999999999999999999999999999544 3444455554332 2 6


Q ss_pred             CchhccHHHHHHHHHhcccCccccCCHHHHhcCcccccccc
Q 015500          217 VPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCS  257 (405)
Q Consensus       217 ~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~~  257 (405)
                      +|..+++.+.||++++|.+||++|+|+.||.+||||+.+..
T Consensus       306 fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw  346 (604)
T KOG0592|consen  306 FPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDW  346 (604)
T ss_pred             CCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCCh
Confidence            78889999999999999999999999999999999998644

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-53  Score=390.94  Aligned_cols=248  Identities=31%  Similarity=0.551  Sum_probs=222.3

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC------ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~------~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~   75 (405)
                      ||.+.++||.|+||.|.+++++.+|..+|+|++++.      +.+...+|..+|+.+.||.++++.+.+.+...    .+
T Consensus        45 dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~----ly  120 (355)
T KOG0616|consen   45 DFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSN----LY  120 (355)
T ss_pred             hhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCe----EE
Confidence            688999999999999999999999999999998765      35678899999999999999999987765443    67


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc-cc
Q 015500           76 LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE-AL  153 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~-~~  153 (405)
                      +||||++||.|..++++.+ ++++..++.|+.||+.||+|||+++|++|||||+|||+|.+| +||+|||+|+.... ..
T Consensus       121 mvmeyv~GGElFS~Lrk~~-rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~rT~  199 (355)
T KOG0616|consen  121 MVMEYVPGGELFSYLRKSG-RFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGRTW  199 (355)
T ss_pred             EEEeccCCccHHHHHHhcC-CCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCcEE
Confidence            9999999999999999884 999999999999999999999999999999999999999999 99999999998766 56


Q ss_pred             cCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHhc
Q 015500          154 QSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCL  233 (405)
Q Consensus       154 ~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~L  233 (405)
                      +.||||.|+|||+++...|+.++|.||||+++|||+.|.+||.. .++.....+|.... + .+|+.++.+++|||+++|
T Consensus       200 TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~-~~~~~iY~KI~~~~-v-~fP~~fs~~~kdLl~~LL  276 (355)
T KOG0616|consen  200 TLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYD-DNPIQIYEKILEGK-V-KFPSYFSSDAKDLLKKLL  276 (355)
T ss_pred             EecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcC-CChHHHHHHHHhCc-c-cCCcccCHHHHHHHHHHH
Confidence            78999999999999999999999999999999999999999954 44455555555443 2 688999999999999999


Q ss_pred             ccCccccC-----CHHHHhcCcccccccc
Q 015500          234 RRDPKERW-----AASQLLKHPFLEEFCS  257 (405)
Q Consensus       234 ~~dP~~Rp-----t~~elL~hp~~~~~~~  257 (405)
                      ++|-.+|.     ...++..||||+.+..
T Consensus       277 ~vD~t~R~gnlknG~~dIk~H~wF~~v~W  305 (355)
T KOG0616|consen  277 QVDLTKRFGNLKNGVEDIKNHPWFKGVDW  305 (355)
T ss_pred             hhhhHhhhcCcCCCccccccCcccccccH
Confidence            99999994     4689999999997644

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.7e-52  Score=388.22  Aligned_cols=249  Identities=30%  Similarity=0.519  Sum_probs=210.1

Q ss_pred             cccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEE
Q 015500            3 WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLF   77 (405)
Q Consensus         3 y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv   77 (405)
                      |....++|+|+||+||+++++.||+.||||++-.+.     .+-..||+++|++|+|||+|.++.+|.-...    .+||
T Consensus         4 YE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrk----lhLV   79 (396)
T KOG0593|consen    4 YEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRK----LHLV   79 (396)
T ss_pred             HhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcce----eEEE
Confidence            888999999999999999999999999999875432     2457799999999999999999987654332    5699


Q ss_pred             EeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc----c
Q 015500           78 MEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE----A  152 (405)
Q Consensus        78 ~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~----~  152 (405)
                      +|||+. ++.+.+.+....+++..++.|++|++.|+.|+|+++++||||||+||||+.++ +||||||+|+....    .
T Consensus        80 FE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~Y  158 (396)
T KOG0593|consen   80 FEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNY  158 (396)
T ss_pred             eeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchh
Confidence            999976 77778888777899999999999999999999999999999999999999998 99999999997553    3


Q ss_pred             ccCCCCCCccChhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHh-cCC-----------------
Q 015500          153 LQSGGTPMFMAPEVARG-EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAY-SRE-----------------  213 (405)
Q Consensus       153 ~~~~gt~~Y~APE~l~~-~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~-~~~-----------------  213 (405)
                      ...+.|+||+|||++.| -.|++++||||+||++.||++|.+.|++.++.+. ++.|.. .+.                 
T Consensus       159 TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQ-Ly~I~ktLG~L~prhq~iF~~N~~F~G  237 (396)
T KOG0593|consen  159 TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQ-LYLIRKTLGNLIPRHQSIFSSNPFFHG  237 (396)
T ss_pred             hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHH-HHHHHHHHcccCHHHHHHhccCCceee
Confidence            35679999999999988 7899999999999999999999999988776544 333321 111                 


Q ss_pred             --CCCCc---------hhccHHHHHHHHHhcccCccccCCHHHHhcCcccccccc
Q 015500          214 --LPEVP---------AFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCS  257 (405)
Q Consensus       214 --~~~~p---------~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~~  257 (405)
                        +|+.+         +.++.-+.||+++||+.||++|++.+|+|.||||..+..
T Consensus       238 v~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~e  292 (396)
T KOG0593|consen  238 VRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFIE  292 (396)
T ss_pred             eecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHHH
Confidence              11111         125677899999999999999999999999999976643

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-51  Score=408.66  Aligned_cols=245  Identities=31%  Similarity=0.532  Sum_probs=216.2

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC--------ChHHHHHHHHHHHhCC-CCCeeeeeeeeeecCCCce
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP--------KSEFLQREQKFLSSLN-SPHIVGYKGCDVTSEDNKL   72 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~--------~~~~l~~E~~iL~~L~-hpnIv~~~~~~~~~~~~~~   72 (405)
                      .|.+++.||+|+||+|++|.+..+++.||+|+++..        ..+.+.+|+.++++++ ||||++++.++.+...   
T Consensus        18 ~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~---   94 (370)
T KOG0583|consen   18 KYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK---   94 (370)
T ss_pred             ceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe---
Confidence            588999999999999999999999999999987653        2456779999999998 9999999998766554   


Q ss_pred             EEEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccC-C-ceEeeecccccc-
Q 015500           73 MYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES-G-AKIADFGCAKWE-  149 (405)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~-~-vkL~DFGla~~~-  149 (405)
                       +++||||+.||+|.++|.+ .+++.|..++.+++||+.|++|||++||+||||||+|||++.+ + +||+|||++... 
T Consensus        95 -~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~  172 (370)
T KOG0583|consen   95 -IYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP  172 (370)
T ss_pred             -EEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence             6799999999999999999 4699999999999999999999999999999999999999998 5 999999999866 


Q ss_pred             ---cccccCCCCCCccChhhhcCCC-C-CcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhc-cH
Q 015500          150 ---SEALQSGGTPMFMAPEVARGEH-Q-GFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFL-SK  223 (405)
Q Consensus       150 ---~~~~~~~gt~~Y~APE~l~~~~-~-~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~-s~  223 (405)
                         ....+.+|||.|+|||++.+.. | +.++||||+|++||.|++|+.||.+ .+......++. . ....+|.++ |+
T Consensus       173 ~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d-~~~~~l~~ki~-~-~~~~~p~~~~S~  249 (370)
T KOG0583|consen  173 GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD-SNVPNLYRKIR-K-GEFKIPSYLLSP  249 (370)
T ss_pred             CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC-ccHHHHHHHHh-c-CCccCCCCcCCH
Confidence               2356789999999999999866 6 5799999999999999999999965 33333444432 3 334678888 99


Q ss_pred             HHHHHHHHhcccCccccCCHHHHhcCccccc
Q 015500          224 QANDFLSNCLRRDPKERWAASQLLKHPFLEE  254 (405)
Q Consensus       224 ~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~  254 (405)
                      ++++||.+||..||.+|+|+.+++.||||+.
T Consensus       250 ~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  250 EARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             HHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence            9999999999999999999999999999996

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.4e-51  Score=410.78  Aligned_cols=247  Identities=32%  Similarity=0.565  Sum_probs=219.5

Q ss_pred             cccccccceeCCeeEEEEEEcCCCCEEEEEEccCC------ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEE
Q 015500            3 WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         3 y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~------~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      |+.|+.||+|+.|.|-+|+|..||+..|||++.+.      ....+.+|+-||+.+.||||+++++++....    .+|+
T Consensus        14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~----~lyl   89 (786)
T KOG0588|consen   14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQ----HLYL   89 (786)
T ss_pred             eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCc----eEEE
Confidence            89999999999999999999999999999998765      2357899999999999999999998765443    3779


Q ss_pred             EEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc---c
Q 015500           77 FMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE---A  152 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~---~  152 (405)
                      |+||++||.|.+++.++| +++|..++.+++||+.|+.|||..+|+||||||+|+|++..+ +||+|||+|.....   .
T Consensus        90 vlEyv~gGELFdylv~kG-~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklL  168 (786)
T KOG0588|consen   90 VLEYVPGGELFDYLVRKG-PLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLL  168 (786)
T ss_pred             EEEecCCchhHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCccc
Confidence            999999999999999885 999999999999999999999999999999999999999877 99999999986443   4


Q ss_pred             ccCCCCCCccChhhhcCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHH
Q 015500          153 LQSGGTPMFMAPEVARGEHQ-GFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSN  231 (405)
Q Consensus       153 ~~~~gt~~Y~APE~l~~~~~-~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~  231 (405)
                      .+.||+|-|.|||++.|..| +.++||||-|+|||.|+||++||. .++....+.++. . ..-.+|..+|.++++||.+
T Consensus       169 eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd-DdNir~LLlKV~-~-G~f~MPs~Is~eaQdLLr~  245 (786)
T KOG0588|consen  169 ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD-DDNIRVLLLKVQ-R-GVFEMPSNISSEAQDLLRR  245 (786)
T ss_pred             cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC-CccHHHHHHHHH-c-CcccCCCcCCHHHHHHHHH
Confidence            57899999999999999776 789999999999999999999995 444445555544 3 3347889999999999999


Q ss_pred             hcccCccccCCHHHHhcCcccccccc
Q 015500          232 CLRRDPKERWAASQLLKHPFLEEFCS  257 (405)
Q Consensus       232 ~L~~dP~~Rpt~~elL~hp~~~~~~~  257 (405)
                      ||..||.+|.|.+|+++|||+..+..
T Consensus       246 ml~VDp~~RiT~~eI~kHP~l~g~~~  271 (786)
T KOG0588|consen  246 MLDVDPSTRITTEEILKHPFLSGYTS  271 (786)
T ss_pred             HhccCccccccHHHHhhCchhhcCCC
Confidence            99999999999999999999987644

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-51  Score=407.84  Aligned_cols=246  Identities=37%  Similarity=0.618  Sum_probs=222.9

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC---ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP---KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFM   78 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~---~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (405)
                      .|+..+.||+|+.|.||.|+...+++.||||.+++.   +++.+.+|+.+|+.++|+|||.++..+...+.    +++||
T Consensus       274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~de----LWVVM  349 (550)
T KOG0578|consen  274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDE----LWVVM  349 (550)
T ss_pred             hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccce----eEEEE
Confidence            377889999999999999999999999999998764   56789999999999999999999998877644    67999


Q ss_pred             eecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc----cc
Q 015500           79 EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE----AL  153 (405)
Q Consensus        79 Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~----~~  153 (405)
                      ||++||+|.|.+...  .++|.++..+++.++.||+|||.+||+|||||.+|||++.+| +||+|||++.....    ..
T Consensus       350 Eym~ggsLTDvVt~~--~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~  427 (550)
T KOG0578|consen  350 EYMEGGSLTDVVTKT--RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRS  427 (550)
T ss_pred             eecCCCchhhhhhcc--cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCccc
Confidence            999999999999876  599999999999999999999999999999999999999998 99999998876544    44


Q ss_pred             cCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCC-CCchhccHHHHHHHHHh
Q 015500          154 QSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELP-EVPAFLSKQANDFLSNC  232 (405)
Q Consensus       154 ~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~-~~p~~~s~~l~dll~~~  232 (405)
                      +.+|||+|||||+.....|+++.||||||++++||+-|.+||-+ +++...++.|...+... ..|..+|+.++|||.+|
T Consensus       428 TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln-E~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~c  506 (550)
T KOG0578|consen  428 TMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN-ENPLRALYLIATNGTPKLKNPEKLSPELKDFLDRC  506 (550)
T ss_pred             cccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC-CChHHHHHHHhhcCCCCcCCccccCHHHHHHHHHH
Confidence            66799999999999999999999999999999999999999965 67888888887765432 34677999999999999


Q ss_pred             cccCccccCCHHHHhcCccccc
Q 015500          233 LRRDPKERWAASQLLKHPFLEE  254 (405)
Q Consensus       233 L~~dP~~Rpt~~elL~hp~~~~  254 (405)
                      |+.||.+|++|.+||+||||+.
T Consensus       507 L~~dv~~RasA~eLL~HpFl~~  528 (550)
T KOG0578|consen  507 LVVDVEQRASAKELLEHPFLKM  528 (550)
T ss_pred             hhcchhcCCCHHHHhcChhhhh
Confidence            9999999999999999999964

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.4e-52  Score=382.13  Aligned_cols=246  Identities=29%  Similarity=0.489  Sum_probs=212.6

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC-----ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP-----KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~-----~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      +|.+.++||+|+||+||++.+..+|+.+|.|.+...     ..+.+..|+.+|++|+|||||++++..+..+.  ..+++
T Consensus        20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~--evlni   97 (375)
T KOG0591|consen   20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDN--EVLNI   97 (375)
T ss_pred             HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccc--hhhHH
Confidence            588999999999999999999999999999987643     34578899999999999999999984333322  24669


Q ss_pred             EEeecCCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHh--CC--ceeCCCCCCCEEEccCC-ceEeeeccccc
Q 015500           77 FMEYAPGGTLNDEIHR---NGGRLDESLIVSYTRQILQGLEYLHS--NR--VVHCDIKSRNILMAESG-AKIADFGCAKW  148 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~---~~~~l~e~~~~~i~~qIl~~L~yLH~--~g--ivHrDlkp~NILi~~~~-vkL~DFGla~~  148 (405)
                      +||||.+|+|...|+.   .+..++|..+++++.|++.||.++|+  ..  |+||||||.||+++.+| +||+|||+++.
T Consensus        98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~  177 (375)
T KOG0591|consen   98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF  177 (375)
T ss_pred             HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence            9999999999999864   34579999999999999999999999  44  99999999999999999 99999999998


Q ss_pred             ccc----cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCc-hhccH
Q 015500          149 ESE----ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVP-AFLSK  223 (405)
Q Consensus       149 ~~~----~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p-~~~s~  223 (405)
                      ...    +.+.+|||+||+||.+.+..|+++||||||||++|||+.-++||...  ....+.+.....++|.+| ..+|.
T Consensus       178 l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~--n~~~L~~KI~qgd~~~~p~~~YS~  255 (375)
T KOG0591|consen  178 LSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD--NLLSLCKKIEQGDYPPLPDEHYST  255 (375)
T ss_pred             hcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc--cHHHHHHHHHcCCCCCCcHHHhhh
Confidence            665    45678999999999999999999999999999999999999999544  455555555566888888 77999


Q ss_pred             HHHHHHHHhcccCccccCCHHHHhcCccccccc
Q 015500          224 QANDFLSNCLRRDPKERWAASQLLKHPFLEEFC  256 (405)
Q Consensus       224 ~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~  256 (405)
                      ++..+|..|+..||..||+.     +|++..+.
T Consensus       256 ~l~~li~~ci~vd~~~RP~t-----~~~v~di~  283 (375)
T KOG0591|consen  256 DLRELINMCIAVDPEQRPDT-----VPYVQDIQ  283 (375)
T ss_pred             HHHHHHHHHccCCcccCCCc-----chHHHHHH
Confidence            99999999999999999986     56665543

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=2.7e-50  Score=397.94  Aligned_cols=273  Identities=30%  Similarity=0.468  Sum_probs=227.1

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC------ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~------~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~   75 (405)
                      +|..++.||+|+||.||+|+-+.||++||+|++.++      +.+.++.|..+|....+|.||+++-.|.+.+    ++|
T Consensus       142 DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~----~LY  217 (550)
T KOG0605|consen  142 DFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKE----YLY  217 (550)
T ss_pred             cchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCC----eeE
Confidence            688999999999999999999999999999998754      4567889999999999999999997776544    378


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccc-----
Q 015500           76 LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWE-----  149 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~-----  149 (405)
                      |||||++||++..+|.+. +.|+|..++.|+.+++.|++-||+.|+|||||||+|+|||..| +||+|||++.-.     
T Consensus       218 LiMEylPGGD~mTLL~~~-~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~  296 (550)
T KOG0605|consen  218 LIMEYLPGGDMMTLLMRK-DTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHR  296 (550)
T ss_pred             EEEEecCCccHHHHHHhc-CcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhh
Confidence            999999999999999887 4999999999999999999999999999999999999999999 999999987410     


Q ss_pred             -c-------------c--------------------------------cccCCCCCCccChhhhcCCCCCcchhHHHHHH
Q 015500          150 -S-------------E--------------------------------ALQSGGTPMFMAPEVARGEHQGFASDIWAVGC  183 (405)
Q Consensus       150 -~-------------~--------------------------------~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~  183 (405)
                       .             .                                ....+|||.|||||++.+..|+..+|.|||||
T Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~  376 (550)
T KOG0605|consen  297 IESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGC  376 (550)
T ss_pred             hhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHH
Confidence             0             0                                01124999999999999999999999999999


Q ss_pred             HHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCc--hhccHHHHHHHHHhcccCccccCC---HHHHhcCccccccccc
Q 015500          184 TVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVP--AFLSKQANDFLSNCLRRDPKERWA---ASQLLKHPFLEEFCSC  258 (405)
Q Consensus       184 il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p--~~~s~~l~dll~~~L~~dP~~Rpt---~~elL~hp~~~~~~~~  258 (405)
                      |+||||.|.+|| ..+++.+...+|..-+..-..|  ..++++++|||.+||. ||.+|..   ++||.+||||+.+...
T Consensus       377 ImyEmLvGyPPF-~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~  454 (550)
T KOG0605|consen  377 IMYEMLVGYPPF-CSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWD  454 (550)
T ss_pred             HHHHHHhCCCCC-CCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCCcc
Confidence            999999999999 4566777766666555333333  3378999999999999 9999985   8999999999988665


Q ss_pred             cccccccC--CCCCccchhhhccch
Q 015500          259 TKQIQESN--CSPTSILDQGIWNSV  281 (405)
Q Consensus       259 ~~~~~~~~--~sp~~~ld~~~~~~~  281 (405)
                      ........  ....+++|...++..
T Consensus       455 ~l~~~~apfvP~v~~~~DT~yFddF  479 (550)
T KOG0605|consen  455 HLREMPAPFVPQVNSELDTQYFDDF  479 (550)
T ss_pred             hhhcCCCCCCCCCCCcccccccccC
Confidence            33322233  333455665555533

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=6e-50  Score=365.58  Aligned_cols=248  Identities=31%  Similarity=0.463  Sum_probs=212.6

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCCh-----HHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS-----EFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~~-----~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      +|...+.||+|.||.||+|++..||+.||||++...+.     -...||++.|+.++||||+.+.++|.....    +.|
T Consensus         3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~----l~l   78 (318)
T KOG0659|consen    3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSN----LSL   78 (318)
T ss_pred             hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCc----eEE
Confidence            68899999999999999999999999999999886543     368899999999999999999998876655    679


Q ss_pred             EEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc---
Q 015500           77 FMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA---  152 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~---  152 (405)
                      |+||++. +|...|+.+...++..+++.|+.++++||+|||++.|+||||||.|+||+.+| +||+|||+|+.....   
T Consensus        79 VfEfm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~  157 (318)
T KOG0659|consen   79 VFEFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI  157 (318)
T ss_pred             EEEeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence            9999976 99999998888899999999999999999999999999999999999999999 999999999976542   


Q ss_pred             -ccCCCCCCccChhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCC---C-----------
Q 015500          153 -LQSGGTPMFMAPEVARG-EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELP---E-----------  216 (405)
Q Consensus       153 -~~~~gt~~Y~APE~l~~-~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~---~-----------  216 (405)
                       ...+-|.||+|||++.| ..|+..+||||.||++.||+-|.+-|++.++. +++..+...-..|   .           
T Consensus       158 ~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDi-dQL~~If~~LGTP~~~~WP~~~~lpdY~  236 (318)
T KOG0659|consen  158 QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDI-DQLSKIFRALGTPTPDQWPEMTSLPDYV  236 (318)
T ss_pred             cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchH-HHHHHHHHHcCCCCcccCccccccccHH
Confidence             22368999999999988 56999999999999999999998888766554 3333332221111   1           


Q ss_pred             ------------CchhccHHHHHHHHHhcccCccccCCHHHHhcCcccccc
Q 015500          217 ------------VPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       217 ------------~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                                  +-+..++++.||+.+||..||.+|+|+.|+|+|+||...
T Consensus       237 ~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~  287 (318)
T KOG0659|consen  237 KIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSL  287 (318)
T ss_pred             HHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcC
Confidence                        112257889999999999999999999999999999864

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-50  Score=395.39  Aligned_cols=250  Identities=31%  Similarity=0.419  Sum_probs=211.6

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC--ChH--HHHHHHHHHHhCC-CCCeeeeeeeeeecCCCceEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP--KSE--FLQREQKFLSSLN-SPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~--~~~--~l~~E~~iL~~L~-hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      +|...+.||.|+||.||+|+.+.+|+.||||.+...  ..+  .-.||++.|++|. ||||+++..++.+.+.   .+|+
T Consensus        11 RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~---~L~f   87 (538)
T KOG0661|consen   11 RYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDR---ILYF   87 (538)
T ss_pred             HHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCc---eEee
Confidence            588999999999999999999999999999987643  222  3458999999998 9999999988765553   4679


Q ss_pred             EEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc---c
Q 015500           77 FMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE---A  152 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~---~  152 (405)
                      |||||+. +|.++++.++..|++..++.|++||++||+|+|.+|+.|||+||+|||+.... +||+|||+|+.+..   .
T Consensus        88 VfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpPY  166 (538)
T KOG0661|consen   88 VFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKPPY  166 (538)
T ss_pred             eHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccCCCc
Confidence            9999965 99999999888899999999999999999999999999999999999999554 99999999998665   3


Q ss_pred             ccCCCCCCccChhhhc-CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCC------------------
Q 015500          153 LQSGGTPMFMAPEVAR-GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRE------------------  213 (405)
Q Consensus       153 ~~~~gt~~Y~APE~l~-~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~------------------  213 (405)
                      ...+.|+||+|||++. ...|+.+.||||+||+++|+.+-++.|++.++ .+.+++|...-.                  
T Consensus       167 TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE-~Dqi~KIc~VLGtP~~~~~~eg~~La~~mn  245 (538)
T KOG0661|consen  167 TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASE-IDQIYKICEVLGTPDKDSWPEGYNLASAMN  245 (538)
T ss_pred             chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcH-HHHHHHHHHHhCCCccccchhHHHHHHHhc
Confidence            4567999999999875 57899999999999999999999999986654 444554432211                  


Q ss_pred             --CCC--------CchhccHHHHHHHHHhcccCccccCCHHHHhcCccccccc
Q 015500          214 --LPE--------VPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFC  256 (405)
Q Consensus       214 --~~~--------~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~  256 (405)
                        +|.        +-...+.++.++|.+||.+||++||||.|+|+||||+...
T Consensus       246 f~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~  298 (538)
T KOG0661|consen  246 FRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR  298 (538)
T ss_pred             cCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence              111        1123688999999999999999999999999999998643

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.6e-50  Score=399.97  Aligned_cols=245  Identities=31%  Similarity=0.484  Sum_probs=217.3

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCChH-----HHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSE-----FLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~~~-----~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      +|-+.+.||+|+||.||+|+.+.+.+.||+|.+++..+.     .+.+|++|+++|+||||+.++..|.+..+    +++
T Consensus         3 ~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~----~~v   78 (808)
T KOG0597|consen    3 QYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAH----LWV   78 (808)
T ss_pred             chhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccce----EEE
Confidence            588899999999999999999999999999999876544     49999999999999999999988766554    779


Q ss_pred             EEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc---
Q 015500           77 FMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA---  152 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~---  152 (405)
                      |.|||.| +|..++... +.++|+.++.+++|++.||.|||+.+|.|||+||+|||++.++ +|+||||+|+.....   
T Consensus        79 Vte~a~g-~L~~il~~d-~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~v  156 (808)
T KOG0597|consen   79 VTEYAVG-DLFTILEQD-GKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSV  156 (808)
T ss_pred             Eehhhhh-hHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCcee
Confidence            9999977 999999887 4999999999999999999999999999999999999999988 999999999976553   


Q ss_pred             -ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHH
Q 015500          153 -LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSN  231 (405)
Q Consensus       153 -~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~  231 (405)
                       ....|||.|||||+..+..|+..+|+|||||++|||++|++||..  .....+.+.... +.+..|...+.++..||+.
T Consensus       157 ltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a--~si~~Lv~~I~~-d~v~~p~~~S~~f~nfl~g  233 (808)
T KOG0597|consen  157 LTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA--RSITQLVKSILK-DPVKPPSTASSSFVNFLQG  233 (808)
T ss_pred             eeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH--HHHHHHHHHHhc-CCCCCcccccHHHHHHHHH
Confidence             344699999999999999999999999999999999999999942  334444444433 3345677899999999999


Q ss_pred             hcccCccccCCHHHHhcCcccccc
Q 015500          232 CLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       232 ~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      +|.+||.+|.|..+++.|||.+.-
T Consensus       234 LL~kdP~~RltW~~Ll~HpF~k~~  257 (808)
T KOG0597|consen  234 LLIKDPAQRLTWTDLLGHPFWKGK  257 (808)
T ss_pred             HhhcChhhcccHHHHhcChHHhhh
Confidence            999999999999999999999864

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.9e-50  Score=391.03  Aligned_cols=249  Identities=31%  Similarity=0.454  Sum_probs=211.2

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      .|...++||+|.||.||+|++..+|+.||+|++..+.     .-...|||.||++|.||||+++.+..+.....  .+||
T Consensus       118 ~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~--siYl  195 (560)
T KOG0600|consen  118 SFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSG--SIYL  195 (560)
T ss_pred             HHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCc--eEEE
Confidence            4788899999999999999999999999999987654     24678999999999999999999986655332  3569


Q ss_pred             EEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc----
Q 015500           77 FMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE----  151 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~----  151 (405)
                      |+|||+. +|.-++...+-.|++.+++.|++||+.||+|||++||+|||||+.|||||.+| +||+|||+|++...    
T Consensus       196 VFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~  274 (560)
T KOG0600|consen  196 VFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSA  274 (560)
T ss_pred             EEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCCCc
Confidence            9999977 99988887777899999999999999999999999999999999999999999 99999999996544    


Q ss_pred             -cccCCCCCCccChhhhcCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCC--------CCc---
Q 015500          152 -ALQSGGTPMFMAPEVARGE-HQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELP--------EVP---  218 (405)
Q Consensus       152 -~~~~~gt~~Y~APE~l~~~-~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~--------~~p---  218 (405)
                       ....+-|.||+|||++.|. .|++++|+||.||||.||++|++.|+.. +..+++++|...-.-|        .+|   
T Consensus       275 ~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~-tEveQl~kIfklcGSP~e~~W~~~kLP~~~  353 (560)
T KOG0600|consen  275 PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGR-TEVEQLHKIFKLCGSPTEDYWPVSKLPHAT  353 (560)
T ss_pred             ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCc-cHHHHHHHHHHHhCCCChhccccccCCccc
Confidence             2345679999999999985 6999999999999999999999999754 4455555543221111        111   


Q ss_pred             ----------------hhccHHHHHHHHHhcccCccccCCHHHHhcCccccc
Q 015500          219 ----------------AFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEE  254 (405)
Q Consensus       219 ----------------~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~  254 (405)
                                      ..++..+.+|+.+||..||.+|.||.++|+|+||..
T Consensus       354 ~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t  405 (560)
T KOG0600|consen  354 IFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT  405 (560)
T ss_pred             ccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence                            226788999999999999999999999999999953

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-48  Score=376.82  Aligned_cols=247  Identities=30%  Similarity=0.499  Sum_probs=213.0

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC------ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~------~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~   75 (405)
                      +|.+.+.||+|+||+||+|.++.+++.+|+|.+...      ..+.+.+|+.+|++++||||+++++.+....    .++
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~----~~~   77 (291)
T cd05612           2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQR----FLY   77 (291)
T ss_pred             CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCC----eEE
Confidence            689999999999999999999999999999998643      2356889999999999999999987654332    467


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc-cc
Q 015500           76 LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE-AL  153 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~-~~  153 (405)
                      +||||+++|+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++ +||+|||+++.... ..
T Consensus        78 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~  156 (291)
T cd05612          78 MLMEYVPGGELFSYLRNS-GRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTW  156 (291)
T ss_pred             EEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCcc
Confidence            999999999999999876 4899999999999999999999999999999999999999887 99999999986543 33


Q ss_pred             cCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHhc
Q 015500          154 QSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCL  233 (405)
Q Consensus       154 ~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~L  233 (405)
                      ...||+.|+|||++.+..++.++|||||||++|+|++|+.||... +.......+...  ...+|..+++.+++||++||
T Consensus       157 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~-~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~l  233 (291)
T cd05612         157 TLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDD-NPFGIYEKILAG--KLEFPRHLDLYAKDLIKKLL  233 (291)
T ss_pred             cccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhC--CcCCCccCCHHHHHHHHHHc
Confidence            456999999999999988999999999999999999999999654 333333333322  24567778999999999999


Q ss_pred             ccCccccCC-----HHHHhcCccccccc
Q 015500          234 RRDPKERWA-----ASQLLKHPFLEEFC  256 (405)
Q Consensus       234 ~~dP~~Rpt-----~~elL~hp~~~~~~  256 (405)
                      +.||.+|++     ++++++||||..+.
T Consensus       234 ~~dp~~R~~~~~~~~~~~l~h~~~~~~~  261 (291)
T cd05612         234 VVDRTRRLGNMKNGADDVKNHRWFKSVD  261 (291)
T ss_pred             CCCHHHccCCccCCHHHHhcCccccCCC
Confidence            999999995     99999999998653

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-48  Score=378.01  Aligned_cols=252  Identities=34%  Similarity=0.516  Sum_probs=215.2

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLF   77 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv   77 (405)
                      +|.....||.|..++||+|+...++++||||+++.++    .+.+++|++.|+.++||||++++-+|+....    +++|
T Consensus        27 ~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~----LWvV  102 (516)
T KOG0582|consen   27 DYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSE----LWVV  102 (516)
T ss_pred             ceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecce----eEEe
Confidence            5888999999999999999999999999999998754    4689999999999999999999998887664    7799


Q ss_pred             EeecCCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc----
Q 015500           78 MEYAPGGTLNDEIHRN-GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE----  151 (405)
Q Consensus        78 ~Ey~~ggsL~~~i~~~-~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~----  151 (405)
                      |.||.+|++.++++.. ...++|..+..|++++++||.|||.+|.||||||+.||||+.+| |||+|||.......    
T Consensus       103 mpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R  182 (516)
T KOG0582|consen  103 MPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDR  182 (516)
T ss_pred             ehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccCce
Confidence            9999999999999863 23499999999999999999999999999999999999999999 99999997643211    


Q ss_pred             ---c-ccCCCCCCccChhhhcC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCC---Cc----
Q 015500          152 ---A-LQSGGTPMFMAPEVARG--EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPE---VP----  218 (405)
Q Consensus       152 ---~-~~~~gt~~Y~APE~l~~--~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~---~p----  218 (405)
                         . ....|||+|||||++..  ..|+.|+||||||++.+||++|..||.........+.++......+.   ++    
T Consensus       183 ~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~~  262 (516)
T KOG0582|consen  183 QVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDED  262 (516)
T ss_pred             eeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChHHh
Confidence               1 45679999999999654  46889999999999999999999999877665555555443322111   11    


Q ss_pred             hhccHHHHHHHHHhcccCccccCCHHHHhcCcccccccc
Q 015500          219 AFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCS  257 (405)
Q Consensus       219 ~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~~  257 (405)
                      ..++..++.++..||++||.+|||++++|+|+||+....
T Consensus       263 k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~  301 (516)
T KOG0582|consen  263 KKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKS  301 (516)
T ss_pred             hhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccc
Confidence            236778999999999999999999999999999997543

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-49  Score=382.15  Aligned_cols=270  Identities=29%  Similarity=0.482  Sum_probs=214.7

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-----------------hHHHHHHHHHHHhCCCCCeeeeeeee
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-----------------SEFLQREQKFLSSLNSPHIVGYKGCD   64 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-----------------~~~l~~E~~iL~~L~hpnIv~~~~~~   64 (405)
                      +|++++.||+|.||+|-+|++..+++.||||++++..                 .+..++|+.||++|.|||||+++.+-
T Consensus        98 qy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvL  177 (576)
T KOG0585|consen   98 QYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVL  177 (576)
T ss_pred             heehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEee
Confidence            6999999999999999999999999999999987532                 25789999999999999999999875


Q ss_pred             eecCCCceEEEEEEeecCCCCHHHHHHHcCCC-CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEee
Q 015500           65 VTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGR-LDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIAD  142 (405)
Q Consensus        65 ~~~~~~~~~~~lv~Ey~~ggsL~~~i~~~~~~-l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~D  142 (405)
                      -+...  ..+|||+|||..|.+... ... ++ +++.+++.|+++++.||+|||.+||+||||||.|+||+++| +||+|
T Consensus       178 DDP~s--~~~YlVley~s~G~v~w~-p~d-~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsD  253 (576)
T KOG0585|consen  178 DDPES--DKLYLVLEYCSKGEVKWC-PPD-KPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISD  253 (576)
T ss_pred             cCccc--CceEEEEEeccCCccccC-CCC-cccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeec
Confidence            44443  346699999999888642 222 34 89999999999999999999999999999999999999998 99999


Q ss_pred             ecccccccc---------cccCCCCCCccChhhhcCCC----CCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHH
Q 015500          143 FGCAKWESE---------ALQSGGTPMFMAPEVARGEH----QGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA  209 (405)
Q Consensus       143 FGla~~~~~---------~~~~~gt~~Y~APE~l~~~~----~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~  209 (405)
                      ||.+.....         .....|||+|+|||...++.    .+.+.||||||++||.|+.|+.||. .+.......+|.
T Consensus       254 FGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~-~~~~~~l~~KIv  332 (576)
T KOG0585|consen  254 FGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFF-DDFELELFDKIV  332 (576)
T ss_pred             cceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcc-cchHHHHHHHHh
Confidence            998875411         23467999999999987732    4678999999999999999999993 333334444444


Q ss_pred             hcC-CCCCCchhccHHHHHHHHHhcccCccccCCHHHHhcCccccccccccccccccCCCCCccchhhh
Q 015500          210 YSR-ELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSILDQGI  277 (405)
Q Consensus       210 ~~~-~~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~~~~~~~~~~~~sp~~~ld~~~  277 (405)
                      ... .+|..| .+.+.++|||++||.+||.+|.+..++..|||...........+...|+...+.....
T Consensus       333 n~pL~fP~~p-e~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~~~~~s~~~~c~~v~v~eeev  400 (576)
T KOG0585|consen  333 NDPLEFPENP-EINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGDSPQSSEPSSCSRVEVTEEEV  400 (576)
T ss_pred             cCcccCCCcc-cccHHHHHHHHHHhhcChhheeehhhheecceeccCCCCCccCCcccceeeeeecccc
Confidence            332 223333 4789999999999999999999999999999998654433333333455555444333

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=2e-48  Score=382.45  Aligned_cols=246  Identities=27%  Similarity=0.511  Sum_probs=213.5

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC------ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~------~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~   75 (405)
                      +|.+.+.||+|+||+||+|+++.+++.+|+|.+...      ..+.+.+|+.+|++++||||+++++.+....    .++
T Consensus        19 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~----~~~   94 (329)
T PTZ00263         19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDEN----RVY   94 (329)
T ss_pred             heEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCC----EEE
Confidence            588999999999999999999999999999987542      3356889999999999999999998776443    367


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc-cc
Q 015500           76 LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE-AL  153 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~-~~  153 (405)
                      ++|||++||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++ +||+|||+++.... ..
T Consensus        95 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  173 (329)
T PTZ00263         95 FLLEFVVGGELFTHLRKA-GRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTF  173 (329)
T ss_pred             EEEcCCCCChHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCcc
Confidence            999999999999999876 4899999999999999999999999999999999999999887 99999999986544 33


Q ss_pred             cCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHhc
Q 015500          154 QSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCL  233 (405)
Q Consensus       154 ~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~L  233 (405)
                      ...||+.|+|||++.+..++.++|||||||++|+|++|+.||... .......++..  ....+|..++..+++||++||
T Consensus       174 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~-~~~~~~~~i~~--~~~~~p~~~~~~~~~li~~~L  250 (329)
T PTZ00263        174 TLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDD-TPFRIYEKILA--GRLKFPNWFDGRARDLVKGLL  250 (329)
T ss_pred             eecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCC-CHHHHHHHHhc--CCcCCCCCCCHHHHHHHHHHh
Confidence            457999999999999999999999999999999999999999543 33333344332  234567789999999999999


Q ss_pred             ccCccccCC-----HHHHhcCcccccc
Q 015500          234 RRDPKERWA-----ASQLLKHPFLEEF  255 (405)
Q Consensus       234 ~~dP~~Rpt-----~~elL~hp~~~~~  255 (405)
                      +.||.+|++     ++++++||||...
T Consensus       251 ~~dP~~R~~~~~~~~~~ll~hp~f~~~  277 (329)
T PTZ00263        251 QTDHTKRLGTLKGGVADVKNHPYFHGA  277 (329)
T ss_pred             hcCHHHcCCCCCCCHHHHhcCCccCCC
Confidence            999999997     7999999999864

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-49  Score=373.05  Aligned_cols=253  Identities=30%  Similarity=0.425  Sum_probs=208.8

Q ss_pred             cccccccceeCCeeEEEEEEcCCCCEEEEEEccC--C---ChHHHHHHHHHHHhCCCCCeeeeeeeeeec-CCCceEEEE
Q 015500            3 WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL--P---KSEFLQREQKFLSSLNSPHIVGYKGCDVTS-EDNKLMYNL   76 (405)
Q Consensus         3 y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~--~---~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~-~~~~~~~~l   76 (405)
                      |...+.||+|+||.|+.|.++.+|+.||||++..  .   .+.+..||+++|+.++|+||+.+++.+... .+...-.|+
T Consensus        24 y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYi  103 (359)
T KOG0660|consen   24 YVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYL  103 (359)
T ss_pred             ecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEE
Confidence            4446899999999999999999999999998762  2   356788999999999999999999887652 222334669


Q ss_pred             EEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc----
Q 015500           77 FMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE----  151 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~----  151 (405)
                      |+|+| +.+|...|+.. ..|++..++.+++||++||+|+|+.||+||||||.|+|++.+. +||+|||+|+....    
T Consensus       104 V~elM-etDL~~iik~~-~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~  181 (359)
T KOG0660|consen  104 VFELM-ETDLHQIIKSQ-QDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFED  181 (359)
T ss_pred             ehhHH-hhHHHHHHHcC-ccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccCcc
Confidence            99999 55899888775 3699999999999999999999999999999999999999998 99999999997642    


Q ss_pred             --cccCCCCCCccChhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHh------------------
Q 015500          152 --ALQSGGTPMFMAPEVARG-EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAY------------------  210 (405)
Q Consensus       152 --~~~~~gt~~Y~APE~l~~-~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~------------------  210 (405)
                        ....+.|.||+|||++.. ..|+.+.||||+|||+.||++|++.|++.+. ..++..+..                  
T Consensus       182 ~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~-v~Ql~lI~~~lGtP~~e~l~~i~s~~a  260 (359)
T KOG0660|consen  182 GFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDY-VHQLQLILELLGTPSEEDLQKIRSEKA  260 (359)
T ss_pred             cchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCch-HHHHHHHHHhcCCCCHHHHHHhccHHH
Confidence              345668999999999754 6799999999999999999999999975432 222222211                  


Q ss_pred             ---cCCCCCCc--------hhccHHHHHHHHHhcccCccccCCHHHHhcCccccccccc
Q 015500          211 ---SRELPEVP--------AFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSC  258 (405)
Q Consensus       211 ---~~~~~~~p--------~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~~~  258 (405)
                         -...|..|        +..++.+.||+++||..||.+|+|++|+|.||||..+...
T Consensus       261 r~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp  319 (359)
T KOG0660|consen  261 RPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDP  319 (359)
T ss_pred             HHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCC
Confidence               11122221        3478999999999999999999999999999999987643

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.8e-48  Score=365.64  Aligned_cols=250  Identities=30%  Similarity=0.417  Sum_probs=212.4

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCChH-----HHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSE-----FLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~~~-----~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      +|..+..|++|+||.||+|++++|++.||+|.+..+...     ...|||.+|.+.+|||||.+..+.+...-..  +|+
T Consensus        77 efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~--iy~  154 (419)
T KOG0663|consen   77 EFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDK--IYI  154 (419)
T ss_pred             HHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccce--eee
Confidence            478899999999999999999999999999998765432     5679999999999999999998766554433  559


Q ss_pred             EEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc---
Q 015500           77 FMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA---  152 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~---  152 (405)
                      |||||+. +|..++...++++....++.++.|+++||+|||.+.|+||||||+|+|++..| +||+|||+|+.....   
T Consensus       155 VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~  233 (419)
T KOG0663|consen  155 VMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKP  233 (419)
T ss_pred             eHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCccc
Confidence            9999977 99999998888999999999999999999999999999999999999999998 999999999987663   


Q ss_pred             -ccCCCCCCccChhhhcCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCC---------------
Q 015500          153 -LQSGGTPMFMAPEVARGE-HQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELP---------------  215 (405)
Q Consensus       153 -~~~~gt~~Y~APE~l~~~-~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~---------------  215 (405)
                       ...+-|.||+|||++.+. .|+.+.|+||+|||+.||+++++.|++... ..++.+|...-..|               
T Consensus       234 ~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE-~dQl~~If~llGtPte~iwpg~~~lp~~k  312 (419)
T KOG0663|consen  234 YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSE-IDQLDKIFKLLGTPSEAIWPGYSELPAVK  312 (419)
T ss_pred             CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCch-HHHHHHHHHHhCCCccccCCCccccchhh
Confidence             345689999999999984 599999999999999999999999976554 33344333221111               


Q ss_pred             -----C---------Cchh-ccHHHHHHHHHhcccCccccCCHHHHhcCcccccc
Q 015500          216 -----E---------VPAF-LSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       216 -----~---------~p~~-~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                           .         ++.. +++...+|+..+|..||.+|.||+|.|+|+||.+.
T Consensus       313 ~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~  367 (419)
T KOG0663|consen  313 KMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRET  367 (419)
T ss_pred             ccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccC
Confidence                 1         1111 56899999999999999999999999999999874

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.1e-47  Score=371.94  Aligned_cols=250  Identities=29%  Similarity=0.438  Sum_probs=207.1

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLF   77 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv   77 (405)
                      +|.+.+.||+|+||+||+|.++.+++.+|+|.+....    ...+.+|+.+++.++||||+++++++....    .+++|
T Consensus         6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~lv   81 (303)
T cd07869           6 SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKE----TLTLV   81 (303)
T ss_pred             cceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCC----eEEEE
Confidence            5899999999999999999999999999999986432    245778999999999999999998776433    36799


Q ss_pred             EeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc----c
Q 015500           78 MEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE----A  152 (405)
Q Consensus        78 ~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~----~  152 (405)
                      |||++ ++|.+++..+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++ +||+|||+++....    .
T Consensus        82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  160 (303)
T cd07869          82 FEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTY  160 (303)
T ss_pred             EECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccC
Confidence            99995 588888887767899999999999999999999999999999999999999887 99999999875332    2


Q ss_pred             ccCCCCCCccChhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCC---------------
Q 015500          153 LQSGGTPMFMAPEVARG-EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPE---------------  216 (405)
Q Consensus       153 ~~~~gt~~Y~APE~l~~-~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~---------------  216 (405)
                      ....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||....+....+..+......+.               
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (303)
T cd07869         161 SNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKP  240 (303)
T ss_pred             CCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccccc
Confidence            23568999999999876 45788999999999999999999999876665554443322110000               


Q ss_pred             ------Cc---------hhccHHHHHHHHHhcccCccccCCHHHHhcCccccccc
Q 015500          217 ------VP---------AFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFC  256 (405)
Q Consensus       217 ------~p---------~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~  256 (405)
                            .|         ...++++.+||++||+.||++|||+.|+|+||||+...
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~  295 (303)
T cd07869         241 ERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP  295 (303)
T ss_pred             ccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence                  00         01357899999999999999999999999999998753

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=5.2e-49  Score=374.20  Aligned_cols=255  Identities=30%  Similarity=0.445  Sum_probs=215.3

Q ss_pred             CCcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCC-ceEEEEEEe
Q 015500            1 MDWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDN-KLMYNLFME   79 (405)
Q Consensus         1 ~~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~-~~~~~lv~E   79 (405)
                      |.|...+.+|+|+||.||.|+...+++.+|||++-.+. ..-.+|+++|+.++|||||++.-+|....+. ..+.++|||
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~-r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVle  102 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK-RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLE  102 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC-CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHH
Confidence            46788999999999999999999999999999985443 3566899999999999999999888776665 567889999


Q ss_pred             ecCCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC--ceEeeecccccccc---
Q 015500           80 YAPGGTLNDEIHR---NGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG--AKIADFGCAKWESE---  151 (405)
Q Consensus        80 y~~ggsL~~~i~~---~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~--vkL~DFGla~~~~~---  151 (405)
                      |++. +|.++++.   .+.+++.-.++.|++||++||.|||+.||+||||||+|+|+|.+.  +||||||.|+....   
T Consensus       103 ymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ep  181 (364)
T KOG0658|consen  103 YMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEP  181 (364)
T ss_pred             hchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeeccCCC
Confidence            9976 99999874   356899999999999999999999999999999999999999884  99999999987443   


Q ss_pred             cccCCCCCCccChhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCC---------------
Q 015500          152 ALQSGGTPMFMAPEVARG-EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELP---------------  215 (405)
Q Consensus       152 ~~~~~gt~~Y~APE~l~~-~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~---------------  215 (405)
                      +....-|+.|+|||++.| ..|+.+.||||.||++.||+-|++.|++.+ ...++..|...-..|               
T Consensus       182 niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s-~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~  260 (364)
T KOG0658|consen  182 NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDS-SVDQLVEIIKVLGTPTREDIKSMNPNYTEF  260 (364)
T ss_pred             ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCC-HHHHHHHHHHHhCCCCHHHHhhcCcccccc
Confidence            334557999999999988 569999999999999999999999998644 444444433222111               


Q ss_pred             ---C---------CchhccHHHHHHHHHhcccCccccCCHHHHhcCccccccccc
Q 015500          216 ---E---------VPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSC  258 (405)
Q Consensus       216 ---~---------~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~~~  258 (405)
                         .         +....++++.+|+.++|+.+|.+|.++.|+|.||||.++...
T Consensus       261 ~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~  315 (364)
T KOG0658|consen  261 KFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP  315 (364)
T ss_pred             cCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence               1         223468999999999999999999999999999999987654

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=5.8e-48  Score=378.04  Aligned_cols=241  Identities=30%  Similarity=0.461  Sum_probs=206.7

Q ss_pred             cccceeCCeeEEEEEEcCCCCEEEEEEccCC------ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEee
Q 015500            7 HTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEY   80 (405)
Q Consensus         7 ~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~------~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~Ey   80 (405)
                      +.||+|+||+||+|.++.+|+.+|+|++...      ....+.+|+.+|++++||||+++++.+....    .+++||||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~----~~~lv~e~   76 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHD----RLCFVMEY   76 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCC----EEEEEEeC
Confidence            4799999999999999999999999988642      2245778999999999999999988765433    36799999


Q ss_pred             cCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc----cccC
Q 015500           81 APGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE----ALQS  155 (405)
Q Consensus        81 ~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~----~~~~  155 (405)
                      ++||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++ +||+|||+++....    ....
T Consensus        77 ~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  155 (323)
T cd05571          77 ANGGELFFHLSRE-RVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF  155 (323)
T ss_pred             CCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccce
Confidence            9999999999876 4899999999999999999999999999999999999999887 99999999875321    2345


Q ss_pred             CCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHhccc
Q 015500          156 GGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRR  235 (405)
Q Consensus       156 ~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~L~~  235 (405)
                      .||+.|+|||++.+..++.++|||||||++|||++|+.||... +.......+..  ....+|..+++++.+||++||..
T Consensus       156 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~-~~~~~~~~~~~--~~~~~p~~~~~~~~~li~~~L~~  232 (323)
T cd05571         156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-DHEKLFELILM--EEIRFPRTLSPEAKSLLAGLLKK  232 (323)
T ss_pred             ecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCC-CHHHHHHHHHc--CCCCCCCCCCHHHHHHHHHHccC
Confidence            6999999999999999999999999999999999999999543 33333333322  23466778999999999999999


Q ss_pred             CccccC-----CHHHHhcCcccccc
Q 015500          236 DPKERW-----AASQLLKHPFLEEF  255 (405)
Q Consensus       236 dP~~Rp-----t~~elL~hp~~~~~  255 (405)
                      ||++||     ++.++++||||...
T Consensus       233 dP~~R~~~~~~~~~~ll~h~~f~~~  257 (323)
T cd05571         233 DPKQRLGGGPEDAKEIMEHRFFASI  257 (323)
T ss_pred             CHHHcCCCCCCCHHHHHcCCCcCCC
Confidence            999999     89999999999875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2e-47  Score=367.29  Aligned_cols=250  Identities=26%  Similarity=0.427  Sum_probs=210.0

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC------hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK------SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~------~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~   75 (405)
                      .|+..+.||+|+||+||+|.+..+++.||+|.+....      ...+.+|+.+|+.++||||+++.+.+....    .++
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~----~~~   76 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKD----ALC   76 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCC----eEE
Confidence            4888999999999999999999999999999876432      235678999999999999999988765433    367


Q ss_pred             EEEeecCCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc--
Q 015500           76 LFMEYAPGGTLNDEIHRN-GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE--  151 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~-~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~--  151 (405)
                      ++|||+++|+|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++ +||+|||++.....  
T Consensus        77 lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05631          77 LVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE  156 (285)
T ss_pred             EEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence            999999999999888653 23689999999999999999999999999999999999999887 99999999976432  


Q ss_pred             -cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChH--HHHHHHHhcCCCCCCchhccHHHHHH
Q 015500          152 -ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPM--TVLYKIAYSRELPEVPAFLSKQANDF  228 (405)
Q Consensus       152 -~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~--~~l~~i~~~~~~~~~p~~~s~~l~dl  228 (405)
                       .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.......  ...... .......++..+++++.+|
T Consensus       157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~~l  235 (285)
T cd05631         157 TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRR-VKEDQEEYSEKFSEDAKSI  235 (285)
T ss_pred             eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHH-hhcccccCCccCCHHHHHH
Confidence             234568999999999999999999999999999999999999997543321  111111 1223345666789999999


Q ss_pred             HHHhcccCccccCC-----HHHHhcCccccccc
Q 015500          229 LSNCLRRDPKERWA-----ASQLLKHPFLEEFC  256 (405)
Q Consensus       229 l~~~L~~dP~~Rpt-----~~elL~hp~~~~~~  256 (405)
                      |++||+.||.+||+     ++++++||||....
T Consensus       236 i~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~  268 (285)
T cd05631         236 CRMLLTKNPKERLGCRGNGAAGVKQHPIFKNIN  268 (285)
T ss_pred             HHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCC
Confidence            99999999999997     89999999998753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-48  Score=392.56  Aligned_cols=248  Identities=32%  Similarity=0.494  Sum_probs=217.8

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC------ChHHHHHHHHHHHhC-CCCCeeeeeeeeeecCCCceEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSL-NSPHIVGYKGCDVTSEDNKLMY   74 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~------~~~~l~~E~~iL~~L-~hpnIv~~~~~~~~~~~~~~~~   74 (405)
                      +|+..++||+|+||+|++|..+.+++.||||++++.      ..+.+..|.+|+... +||.+++++.+|.+.+.    +
T Consensus       369 ~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~----l  444 (694)
T KOG0694|consen  369 DFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH----L  444 (694)
T ss_pred             ceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe----E
Confidence            688899999999999999999999999999988764      457889999999888 59999999999887665    6


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccc----
Q 015500           75 NLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWE----  149 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~----  149 (405)
                      |+||||+.||++..+++  .+.++|..++.|++.|+.||.|||++||||||||.+|||+|.+| +||+|||+++..    
T Consensus       445 ~fvmey~~Ggdm~~~~~--~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g  522 (694)
T KOG0694|consen  445 FFVMEYVAGGDLMHHIH--TDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQG  522 (694)
T ss_pred             EEEEEecCCCcEEEEEe--cccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCCC
Confidence            78999999999544332  34899999999999999999999999999999999999999999 999999999852    


Q ss_pred             cccccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHH
Q 015500          150 SEALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFL  229 (405)
Q Consensus       150 ~~~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll  229 (405)
                      ..+.+.||||.|||||++.+..|+.++|.|||||+||||++|..||+. ++..+.+..|..  .-+.+|.++|.++.+++
T Consensus       523 ~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~g-ddEee~FdsI~~--d~~~yP~~ls~ea~~il  599 (694)
T KOG0694|consen  523 DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPG-DDEEEVFDSIVN--DEVRYPRFLSKEAIAIM  599 (694)
T ss_pred             CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHhc--CCCCCCCcccHHHHHHH
Confidence            336788999999999999999999999999999999999999999953 344555555543  33578999999999999


Q ss_pred             HHhcccCccccCC-----HHHHhcCccccccccc
Q 015500          230 SNCLRRDPKERWA-----ASQLLKHPFLEEFCSC  258 (405)
Q Consensus       230 ~~~L~~dP~~Rpt-----~~elL~hp~~~~~~~~  258 (405)
                      +++|++||.+|..     ++++.+||||+.+...
T Consensus       600 ~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~  633 (694)
T KOG0694|consen  600 RRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWD  633 (694)
T ss_pred             HHHhccCcccccCCCCCCchhhhhCCccccCCHH
Confidence            9999999999986     5789999999987643

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=2.9e-47  Score=366.66  Aligned_cols=245  Identities=28%  Similarity=0.411  Sum_probs=202.9

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC----ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP----KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLF   77 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~----~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv   77 (405)
                      +|.+.+.||+|+||+||+|.++.+++.||+|.+...    ....+.+|++++++++||||+++++++....    .+++|
T Consensus         6 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~lv   81 (288)
T cd07871           6 TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTER----CLTLV   81 (288)
T ss_pred             cceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCC----eEEEE
Confidence            589999999999999999999999999999988643    2346789999999999999999998765432    36799


Q ss_pred             EeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc----c
Q 015500           78 MEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE----A  152 (405)
Q Consensus        78 ~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~----~  152 (405)
                      |||+++ +|.+++...+..+++..++.++.||+.||+|||++||+||||||+|||++.++ +||+|||+++....    .
T Consensus        82 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~  160 (288)
T cd07871          82 FEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTY  160 (288)
T ss_pred             EeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCccc
Confidence            999975 99999987766789999999999999999999999999999999999999887 99999999875332    2


Q ss_pred             ccCCCCCCccChhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCC------------------
Q 015500          153 LQSGGTPMFMAPEVARG-EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRE------------------  213 (405)
Q Consensus       153 ~~~~gt~~Y~APE~l~~-~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~------------------  213 (405)
                      ....+|+.|+|||++.+ ..++.++|||||||++|+|+||++||..... ...+..+.....                  
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (288)
T cd07871         161 SNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTV-KEELHLIFRLLGTPTEETWPGITSNEEFRS  239 (288)
T ss_pred             cCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCChHHhhccccchhhhc
Confidence            23458999999999876 5688999999999999999999999965432 222222211000                  


Q ss_pred             --CCC--------CchhccHHHHHHHHHhcccCccccCCHHHHhcCccc
Q 015500          214 --LPE--------VPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFL  252 (405)
Q Consensus       214 --~~~--------~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~  252 (405)
                        .|.        ....+++++++||++||+.||.+|||++|+|+||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         240 YLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             cccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence              010        112367899999999999999999999999999997

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=2.5e-47  Score=379.54  Aligned_cols=248  Identities=24%  Similarity=0.361  Sum_probs=207.2

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC------ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~------~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~   75 (405)
                      +|+..+.||+|+||+||+|.++.+++.+|+|++...      ....+.+|+.++..++||||+++++.+....    .++
T Consensus         2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~----~~~   77 (363)
T cd05628           2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKL----NLY   77 (363)
T ss_pred             CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCC----eEE
Confidence            689999999999999999999999999999998642      2356788999999999999999998765433    367


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc---
Q 015500           76 LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE---  151 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~---  151 (405)
                      +||||++||+|.+++.+. +++++..++.++.||+.||+|||++||+||||||+|||++.++ +||+|||+++....   
T Consensus        78 lv~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~  156 (363)
T cd05628          78 LIMEFLPGGDMMTLLMKK-DTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR  156 (363)
T ss_pred             EEEcCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence            999999999999999876 4899999999999999999999999999999999999999887 99999999864321   


Q ss_pred             ------------------------------------cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 015500          152 ------------------------------------ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPW  195 (405)
Q Consensus       152 ------------------------------------~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf  195 (405)
                                                          ....+||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf  236 (363)
T cd05628         157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF  236 (363)
T ss_pred             ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence                                                01346999999999999999999999999999999999999999


Q ss_pred             CCCCChHHHHHHHHhcCCCCCCch--hccHHHHHHHHHhcccCcc---ccCCHHHHhcCccccccc
Q 015500          196 PNAADPMTVLYKIAYSRELPEVPA--FLSKQANDFLSNCLRRDPK---ERWAASQLLKHPFLEEFC  256 (405)
Q Consensus       196 ~~~~~~~~~l~~i~~~~~~~~~p~--~~s~~l~dll~~~L~~dP~---~Rpt~~elL~hp~~~~~~  256 (405)
                      ... .......++........+|.  .+++++++||.+|+. +|.   .||+++|+++||||+...
T Consensus       237 ~~~-~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~~  300 (363)
T cd05628         237 CSE-TPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGVD  300 (363)
T ss_pred             CCC-CHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCCC
Confidence            643 34444444443222222332  378999999999775 454   458999999999998764

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-47  Score=375.47  Aligned_cols=239  Identities=29%  Similarity=0.443  Sum_probs=212.4

Q ss_pred             ccccccceeCCeeEEEEEEcCCCCE-EEEEEccCCC-----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEE
Q 015500            4 TRGHTIGQGSSATVSLATSLRSGDV-FAAKSTELPK-----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLF   77 (405)
Q Consensus         4 ~~~~~LG~G~~g~Vyla~~~~~~~~-vavK~~~~~~-----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv   77 (405)
                      ...+.||+|+||+||.|.++  |+. +|||.+....     ...+.+|+.+|++|+|||||+++|++.....   .+++|
T Consensus        44 ~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~---~~~iV  118 (362)
T KOG0192|consen   44 PIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG---SLCIV  118 (362)
T ss_pred             hhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC---ceEEE
Confidence            45667999999999999986  555 9999987643     4589999999999999999999998765542   36799


Q ss_pred             EeecCCCCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhCC-ceeCCCCCCCEEEccCC--ceEeeecccccccc--
Q 015500           78 MEYAPGGTLNDEIHR-NGGRLDESLIVSYTRQILQGLEYLHSNR-VVHCDIKSRNILMAESG--AKIADFGCAKWESE--  151 (405)
Q Consensus        78 ~Ey~~ggsL~~~i~~-~~~~l~e~~~~~i~~qIl~~L~yLH~~g-ivHrDlkp~NILi~~~~--vkL~DFGla~~~~~--  151 (405)
                      |||+++|+|.+++.. .+..++...+..++.||++||.|||+++ ||||||||+|||++.++  +||+|||+++....  
T Consensus       119 tEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~  198 (362)
T KOG0192|consen  119 TEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK  198 (362)
T ss_pred             EEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence            999999999999988 3678999999999999999999999999 99999999999999885  99999999986543  


Q ss_pred             --cccCCCCCCccChhhhc--CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHH
Q 015500          152 --ALQSGGTPMFMAPEVAR--GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQAND  227 (405)
Q Consensus       152 --~~~~~gt~~Y~APE~l~--~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~d  227 (405)
                        .....||+.|||||+++  ...|+.++||||||+++|||+||+.||.+... ......+......|.+|..+++.+..
T Consensus       199 ~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~~~~~v~~~~~Rp~~p~~~~~~l~~  277 (362)
T KOG0192|consen  199 TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQVASAVVVGGLRPPIPKECPPHLSS  277 (362)
T ss_pred             ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHhcCCCCCCCccCCHHHHH
Confidence              22357999999999999  56899999999999999999999999987766 77778888888899999999999999


Q ss_pred             HHHHhcccCccccCCHHHHhc
Q 015500          228 FLSNCLRRDPKERWAASQLLK  248 (405)
Q Consensus       228 ll~~~L~~dP~~Rpt~~elL~  248 (405)
                      ++.+||..||.+||+..+++.
T Consensus       278 l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  278 LMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             HHHHhCCCCCCcCCCHHHHHH
Confidence            999999999999999999865

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.9e-47  Score=377.54  Aligned_cols=247  Identities=29%  Similarity=0.453  Sum_probs=211.5

Q ss_pred             CcccccccceeCCeeEEEEEEcCCC-CEEEEEEccC------CChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSG-DVFAAKSTEL------PKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMY   74 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~-~~vavK~~~~------~~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~   74 (405)
                      +|.+.+.||+|+||.||+|.++.++ ..+|+|.+..      ...+.+.+|+.+++.++||||+++++++....    .+
T Consensus        31 ~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~----~~  106 (340)
T PTZ00426         31 DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES----YL  106 (340)
T ss_pred             hcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC----EE
Confidence            5889999999999999999977655 7899998753      23456788999999999999999999875543    36


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc-c
Q 015500           75 NLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE-A  152 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~-~  152 (405)
                      ++||||++||+|.+++.+. +++++..+..++.||+.||.|||++||+||||||+|||++.++ +||+|||+++.... .
T Consensus       107 ~lv~Ey~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~~  185 (340)
T PTZ00426        107 YLVLEFVIGGEFFTFLRRN-KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRT  185 (340)
T ss_pred             EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCCc
Confidence            7999999999999999876 4799999999999999999999999999999999999999888 99999999986543 3


Q ss_pred             ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHh
Q 015500          153 LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNC  232 (405)
Q Consensus       153 ~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~  232 (405)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||... +......++..  ....+|..+++.+.++|++|
T Consensus       186 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~-~~~~~~~~i~~--~~~~~p~~~~~~~~~li~~~  262 (340)
T PTZ00426        186 YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYAN-EPLLIYQKILE--GIIYFPKFLDNNCKHLMKKL  262 (340)
T ss_pred             ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCC-CHHHHHHHHhc--CCCCCCCCCCHHHHHHHHHH
Confidence            3557999999999999988999999999999999999999999643 33333333332  23356777899999999999


Q ss_pred             cccCccccC-----CHHHHhcCccccccc
Q 015500          233 LRRDPKERW-----AASQLLKHPFLEEFC  256 (405)
Q Consensus       233 L~~dP~~Rp-----t~~elL~hp~~~~~~  256 (405)
                      |+.||.+|+     |++++++||||..+.
T Consensus       263 l~~dp~~R~~~~~~~~~~~~~hp~f~~~~  291 (340)
T PTZ00426        263 LSHDLTKRYGNLKKGAQNVKEHPWFGNID  291 (340)
T ss_pred             cccCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence            999999996     899999999998653

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-49  Score=383.29  Aligned_cols=247  Identities=37%  Similarity=0.570  Sum_probs=219.3

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLF   77 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv   77 (405)
                      .|+....||+|+||.||+|.+..+++.||+|+++.+.    .+.+++|+.+|..+++|||.++|+.+.....    ++++
T Consensus        14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~----Lwii   89 (467)
T KOG0201|consen   14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTK----LWII   89 (467)
T ss_pred             ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeeccc----HHHH
Confidence            4888899999999999999999999999999998754    4579999999999999999999999876554    6689


Q ss_pred             EeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc----c
Q 015500           78 MEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE----A  152 (405)
Q Consensus        78 ~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~----~  152 (405)
                      ||||.||++.+.++.. +.++|..+..++++++.||.|||.++.+|||||+.|||+..+| +||+|||.+-....    .
T Consensus        90 Mey~~gGsv~~lL~~~-~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr  168 (467)
T KOG0201|consen   90 MEYCGGGSVLDLLKSG-NILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR  168 (467)
T ss_pred             HHHhcCcchhhhhccC-CCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhcc
Confidence            9999999999999875 3669999999999999999999999999999999999999887 99999999876444    3


Q ss_pred             ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHh
Q 015500          153 LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNC  232 (405)
Q Consensus       153 ~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~  232 (405)
                      .+..|||.|||||++.+..|+.++||||||++.|||++|.+||.... +..+++.|.. ..+|.+...+|+.+++|+..|
T Consensus       169 ~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~h-PmrvlflIpk-~~PP~L~~~~S~~~kEFV~~C  246 (467)
T KOG0201|consen  169 KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLH-PMRVLFLIPK-SAPPRLDGDFSPPFKEFVEAC  246 (467)
T ss_pred             ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccC-cceEEEeccC-CCCCccccccCHHHHHHHHHH
Confidence            56789999999999999999999999999999999999999997554 3444444443 345666678999999999999


Q ss_pred             cccCccccCCHHHHhcCcccccc
Q 015500          233 LRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       233 L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      |++||+.||+|.+||+|+|++..
T Consensus       247 L~k~P~~RpsA~~LLKh~FIk~a  269 (467)
T KOG0201|consen  247 LDKNPEFRPSAKELLKHKFIKRA  269 (467)
T ss_pred             hhcCcccCcCHHHHhhhHHHHhc
Confidence            99999999999999999999863

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-47  Score=375.14  Aligned_cols=249  Identities=28%  Similarity=0.456  Sum_probs=211.5

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC------ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~------~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~   75 (405)
                      +|.+.+.||+|+||.||+|++..+++.||+|++...      ....+.+|+.+|+.++||||+++++.+....    .++
T Consensus         2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~----~~~   77 (333)
T cd05600           2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDE----YLY   77 (333)
T ss_pred             CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCC----EEE
Confidence            689999999999999999999999999999998642      2346788999999999999999998765433    367


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc-cc
Q 015500           76 LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE-AL  153 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~-~~  153 (405)
                      +||||++||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++ +||+|||++..... ..
T Consensus        78 lv~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~~~  156 (333)
T cd05600          78 LAMEYVPGGDFRTLLNNL-GVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYAN  156 (333)
T ss_pred             EEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCcccccccC
Confidence            999999999999999776 4799999999999999999999999999999999999999887 99999999986544 34


Q ss_pred             cCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCC---CCCc---hhccHHHHH
Q 015500          154 QSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSREL---PEVP---AFLSKQAND  227 (405)
Q Consensus       154 ~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~---~~~p---~~~s~~l~d  227 (405)
                      ...||+.|+|||++.+..++.++|||||||++|||++|..||... +.......+......   |...   ..+++++.+
T Consensus       157 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~  235 (333)
T cd05600         157 SVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGS-TPNETWENLKYWKETLQRPVYDDPRFNLSDEAWD  235 (333)
T ss_pred             CcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCC-CHHHHHHHHHhccccccCCCCCccccccCHHHHH
Confidence            456999999999999999999999999999999999999999644 333333333322211   1111   246899999


Q ss_pred             HHHHhcccCccccCCHHHHhcCccccccc
Q 015500          228 FLSNCLRRDPKERWAASQLLKHPFLEEFC  256 (405)
Q Consensus       228 ll~~~L~~dP~~Rpt~~elL~hp~~~~~~  256 (405)
                      ||.+||..+|.+||++.++++||||....
T Consensus       236 li~~~l~~~~~rr~s~~~ll~h~~~~~~~  264 (333)
T cd05600         236 LITKLINDPSRRFGSLEDIKNHPFFKEVD  264 (333)
T ss_pred             HHHHHhhChhhhcCCHHHHHhCcccCCCC
Confidence            99999999999999999999999998753

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2e-48  Score=351.05  Aligned_cols=246  Identities=30%  Similarity=0.475  Sum_probs=219.2

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC------hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK------SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~------~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~   75 (405)
                      +|.+++.||+|-||.||+|+.+.++-.+|+|++.+++      ..++.||++|.+.|+||||+++|++|.+...    .|
T Consensus        23 dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~r----iy   98 (281)
T KOG0580|consen   23 DFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKR----IY   98 (281)
T ss_pred             hccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccce----eE
Confidence            5889999999999999999999999999999987654      3589999999999999999999999876554    67


Q ss_pred             EEEeecCCCCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccc--c
Q 015500           76 LFMEYAPGGTLNDEIHR-NGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWES--E  151 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~-~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~--~  151 (405)
                      |++||.++|+|...+.. ...+++|..+..|++|++.||.|+|.++|+||||||+|+|++..+ +||+|||.+...+  .
T Consensus        99 LilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~k  178 (281)
T KOG0580|consen   99 LILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSNK  178 (281)
T ss_pred             EEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecCCCC
Confidence            99999999999999973 335799999999999999999999999999999999999999888 9999999886543  3


Q ss_pred             cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHH
Q 015500          152 ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSN  231 (405)
Q Consensus       152 ~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~  231 (405)
                      ..+.|||..|.|||...+..++..+|+|++|++.||++.|.+||.... ..+...+|...+.  .+|..++.+++|+|.+
T Consensus       179 R~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-~~etYkrI~k~~~--~~p~~is~~a~dlI~~  255 (281)
T KOG0580|consen  179 RKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS-HSETYKRIRKVDL--KFPSTISGGAADLISR  255 (281)
T ss_pred             ceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh-hHHHHHHHHHccc--cCCcccChhHHHHHHH
Confidence            567899999999999999999999999999999999999999996554 4444455554433  5678899999999999


Q ss_pred             hcccCccccCCHHHHhcCccccc
Q 015500          232 CLRRDPKERWAASQLLKHPFLEE  254 (405)
Q Consensus       232 ~L~~dP~~Rpt~~elL~hp~~~~  254 (405)
                      ||.++|.+|.+..|++.|||+..
T Consensus       256 ll~~~p~~r~~l~~v~~hpwI~a  278 (281)
T KOG0580|consen  256 LLVKNPIERLALTEVMDHPWIVA  278 (281)
T ss_pred             HhccCccccccHHHHhhhHHHHh
Confidence            99999999999999999999864

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=4.2e-47  Score=364.10  Aligned_cols=245  Identities=27%  Similarity=0.399  Sum_probs=201.8

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC-----ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP-----KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~-----~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      +|.+.+.||+|+||+||+|+++.+++.+|+|.+...     ..+.+.+|+.+++.++||||+++++++....    .+++
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~l   77 (287)
T cd07848           2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRG----KLYL   77 (287)
T ss_pred             CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCC----EEEE
Confidence            589999999999999999999999999999987643     2356789999999999999999998765433    3679


Q ss_pred             EEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc----
Q 015500           77 FMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE----  151 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~----  151 (405)
                      ||||++++.+..+. ...+.+++..++.++.||+.||.|||+.||+||||||+||+++.++ +||+|||++.....    
T Consensus        78 v~e~~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  156 (287)
T cd07848          78 VFEYVEKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA  156 (287)
T ss_pred             EEecCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccc
Confidence            99999987666544 4445799999999999999999999999999999999999999888 99999999976432    


Q ss_pred             -cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHh-cCC----------------
Q 015500          152 -ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAY-SRE----------------  213 (405)
Q Consensus       152 -~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~-~~~----------------  213 (405)
                       .....||+.|+|||++.+..++.++|||||||++|+|++|++||........ +..+.. ...                
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07848         157 NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQ-LFTIQKVLGPLPAEQMKLFYSNPRFH  235 (287)
T ss_pred             cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhhCCCCHHHHHhhhccchhc
Confidence             1234589999999999998899999999999999999999999976543222 211110 000                


Q ss_pred             ---CCC----------CchhccHHHHHHHHHhcccCccccCCHHHHhcCccc
Q 015500          214 ---LPE----------VPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFL  252 (405)
Q Consensus       214 ---~~~----------~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~  252 (405)
                         .+.          ....+|.++.+||++||++||++|||++++|+||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence               000          112368889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-47  Score=378.67  Aligned_cols=247  Identities=25%  Similarity=0.422  Sum_probs=208.9

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC------ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~------~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~   75 (405)
                      +|++.+.||+|+||+||+|++..+++.||||++...      ....+.+|+.+|+.++||||+++++.+....    .++
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~----~~~   77 (364)
T cd05599           2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDEN----YLY   77 (364)
T ss_pred             CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCC----eEE
Confidence            689999999999999999999999999999998642      2346788999999999999999998776543    367


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc--
Q 015500           76 LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA--  152 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~--  152 (405)
                      +||||++||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++ +||+|||+++.....  
T Consensus        78 lv~E~~~~g~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  156 (364)
T cd05599          78 LIMEYLPGGDMMTLLMKK-DTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR  156 (364)
T ss_pred             EEECCCCCcHHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence            999999999999999876 4799999999999999999999999999999999999999888 999999998643210  


Q ss_pred             ----------------------------------------ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCC
Q 015500          153 ----------------------------------------LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGG  192 (405)
Q Consensus       153 ----------------------------------------~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~  192 (405)
                                                              ...+||+.|+|||++.+..++.++|||||||++|||++|.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~  236 (364)
T cd05599         157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY  236 (364)
T ss_pred             ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence                                                    1235999999999999999999999999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHhcCCCCCCch--hccHHHHHHHHHhcccCccccCC---HHHHhcCcccccc
Q 015500          193 APWPNAADPMTVLYKIAYSRELPEVPA--FLSKQANDFLSNCLRRDPKERWA---ASQLLKHPFLEEF  255 (405)
Q Consensus       193 ~Pf~~~~~~~~~l~~i~~~~~~~~~p~--~~s~~l~dll~~~L~~dP~~Rpt---~~elL~hp~~~~~  255 (405)
                      .||.... .......+.........|.  .+++++++||++||. +|.+|++   +.++++||||+..
T Consensus       237 ~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~  302 (364)
T cd05599         237 PPFCSDN-PQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGV  302 (364)
T ss_pred             CCCCCCC-HHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence            9996443 4444444433222222232  478999999999996 9999998   9999999999865

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=6.8e-47  Score=386.15  Aligned_cols=253  Identities=26%  Similarity=0.426  Sum_probs=205.5

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHhCCCCCeeeeeeeeeecC----CCceEEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSE----DNKLMYNLF   77 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~----~~~~~~~lv   77 (405)
                      +|++++.||+|+||+||+|.+..+++.||||.+... .....+|+.+|+.++||||+++++++....    ....++++|
T Consensus        67 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~-~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lv  145 (440)
T PTZ00036         67 SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD-PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVV  145 (440)
T ss_pred             eEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC-cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEE
Confidence            589999999999999999999999999999987543 344668999999999999999988764422    233467799


Q ss_pred             EeecCCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC--ceEeeecccccccc-
Q 015500           78 MEYAPGGTLNDEIHR---NGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG--AKIADFGCAKWESE-  151 (405)
Q Consensus        78 ~Ey~~ggsL~~~i~~---~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~--vkL~DFGla~~~~~-  151 (405)
                      |||+++ +|.+++..   .+..+++..++.++.||+.||.|||++||+||||||+|||++.++  +||+|||+++.... 
T Consensus       146 mE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~  224 (440)
T PTZ00036        146 MEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAG  224 (440)
T ss_pred             EecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccchhccCC
Confidence            999975 77776653   345799999999999999999999999999999999999998654  99999999986433 


Q ss_pred             --cccCCCCCCccChhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcC----------------
Q 015500          152 --ALQSGGTPMFMAPEVARG-EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSR----------------  212 (405)
Q Consensus       152 --~~~~~gt~~Y~APE~l~~-~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~----------------  212 (405)
                        .....||+.|+|||++.+ ..++.++|||||||++|||++|.+||...... ..+.++....                
T Consensus       225 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~-~~~~~i~~~~~~p~~~~~~~~~~~~~  303 (440)
T PTZ00036        225 QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV-DQLVRIIQVLGTPTEDQLKEMNPNYA  303 (440)
T ss_pred             CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCHHHHHHhchhhh
Confidence              234568999999999876 46899999999999999999999999655433 2222222110                


Q ss_pred             --CCC---------CCchhccHHHHHHHHHhcccCccccCCHHHHhcCcccccccc
Q 015500          213 --ELP---------EVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCS  257 (405)
Q Consensus       213 --~~~---------~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~~  257 (405)
                        .+|         .+|...++++++||.+||++||.+|||+.|+|+||||..+..
T Consensus       304 ~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~  359 (440)
T PTZ00036        304 DIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD  359 (440)
T ss_pred             cccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence              011         123446789999999999999999999999999999987654

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=5.8e-47  Score=379.44  Aligned_cols=249  Identities=25%  Similarity=0.373  Sum_probs=206.5

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC------ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~------~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~   75 (405)
                      +|..++.||+|+||+||+|+++.+++.||+|++...      ....+.+|+.+|+.++||||+++++++....    .++
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~----~~~   77 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKD----NLY   77 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCC----EEE
Confidence            588999999999999999999999999999998643      2346789999999999999999998876433    367


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc---
Q 015500           76 LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE---  151 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~---  151 (405)
                      +||||++||+|.+++.+. +.+++..++.++.||+.||+|||++||+||||||+|||++.++ +||+|||+++....   
T Consensus        78 lv~E~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~  156 (381)
T cd05626          78 FVMDYIPGGDMMSLLIRM-EVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN  156 (381)
T ss_pred             EEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence            999999999999999876 4799999999999999999999999999999999999999887 99999998752210   


Q ss_pred             ------------------------------------------------cccCCCCCCccChhhhcCCCCCcchhHHHHHH
Q 015500          152 ------------------------------------------------ALQSGGTPMFMAPEVARGEHQGFASDIWAVGC  183 (405)
Q Consensus       152 ------------------------------------------------~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~  183 (405)
                                                                      .....||+.|+|||++.+..++.++|||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~  236 (381)
T cd05626         157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV  236 (381)
T ss_pred             cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence                                                            01246999999999999988999999999999


Q ss_pred             HHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCch--hccHHHHHHHHHhc--ccCccccCCHHHHhcCccccccc
Q 015500          184 TVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPA--FLSKQANDFLSNCL--RRDPKERWAASQLLKHPFLEEFC  256 (405)
Q Consensus       184 il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~--~~s~~l~dll~~~L--~~dP~~Rpt~~elL~hp~~~~~~  256 (405)
                      ++|||+||+.||.... ......++.........|.  .+++++++||.+|+  ..+|..|++++++++||||....
T Consensus       237 il~elltG~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~  312 (381)
T cd05626         237 ILFEMLVGQPPFLAPT-PTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVD  312 (381)
T ss_pred             HHHHHHhCCCCCcCCC-HHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCC
Confidence            9999999999996543 3333333332222223332  47999999999955  45556699999999999998653

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.6e-47  Score=368.20  Aligned_cols=239  Identities=31%  Similarity=0.466  Sum_probs=204.5

Q ss_pred             cceeCCeeEEEEEEcCCCCEEEEEEccCC------ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEeecC
Q 015500            9 IGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAP   82 (405)
Q Consensus         9 LG~G~~g~Vyla~~~~~~~~vavK~~~~~------~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~Ey~~   82 (405)
                      ||+|+||+||+|.+..+++.||+|.+...      ....+.+|+.+|++++||||+++++.+....    .+++||||++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~lv~e~~~   76 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPE----KLYLVLAFIN   76 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCC----eEEEEEcCCC
Confidence            79999999999999999999999987532      2346778999999999999999988765433    3669999999


Q ss_pred             CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc----cccCCC
Q 015500           83 GGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE----ALQSGG  157 (405)
Q Consensus        83 ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~----~~~~~g  157 (405)
                      ||+|.+++.+. +++++..++.++.||+.||.|||++||+||||||+|||++.++ +||+|||+++....    .....|
T Consensus        77 ~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g  155 (312)
T cd05585          77 GGELFHHLQRE-GRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCG  155 (312)
T ss_pred             CCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccC
Confidence            99999999876 4899999999999999999999999999999999999999887 99999999875322    223569


Q ss_pred             CCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHhcccCc
Q 015500          158 TPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDP  237 (405)
Q Consensus       158 t~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~L~~dP  237 (405)
                      |+.|+|||++.+..++.++|||||||++|+|++|+.||.... .......+.  .....+|..+++++.+||.+||..||
T Consensus       156 t~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~-~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dp  232 (312)
T cd05585         156 TPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN-VNEMYRKIL--QEPLRFPDGFDRDAKDLLIGLLSRDP  232 (312)
T ss_pred             CcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC-HHHHHHHHH--cCCCCCCCcCCHHHHHHHHHHcCCCH
Confidence            999999999999999999999999999999999999996443 333333332  23345677899999999999999999


Q ss_pred             cccC---CHHHHhcCcccccc
Q 015500          238 KERW---AASQLLKHPFLEEF  255 (405)
Q Consensus       238 ~~Rp---t~~elL~hp~~~~~  255 (405)
                      .+||   ++.++|+||||...
T Consensus       233 ~~R~~~~~~~e~l~hp~~~~~  253 (312)
T cd05585         233 TRRLGYNGAQEIKNHPFFSQL  253 (312)
T ss_pred             HHcCCCCCHHHHHcCCCcCCC
Confidence            9997   58999999999875

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.3e-47  Score=363.46  Aligned_cols=250  Identities=32%  Similarity=0.464  Sum_probs=214.2

Q ss_pred             cccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC------hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEE
Q 015500            3 WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK------SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         3 y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~------~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      |+..+.||+|.-|+||+|..+.++..+|+|++++..      ..+++-|.+||+.++||.++.+|..+.+..    ++|+
T Consensus        79 f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~----~~cl  154 (459)
T KOG0610|consen   79 FRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDK----YSCL  154 (459)
T ss_pred             HHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccc----eeEE
Confidence            677899999999999999999999999999998642      346777999999999999999998876544    5889


Q ss_pred             EEeecCCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccc-----
Q 015500           77 FMEYAPGGTLNDEIHRN-GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWE-----  149 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~-~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~-----  149 (405)
                      +||||+||+|..+.+++ ++.+++..++.|+..|+.||+|||-+|||+|||||+||||-++| +.|.||.++...     
T Consensus       155 ~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt  234 (459)
T KOG0610|consen  155 VMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPT  234 (459)
T ss_pred             EEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCCe
Confidence            99999999999888664 55799999999999999999999999999999999999999998 999999976310     


Q ss_pred             --c---------------------------c-c-------------------------ccCCCCCCccChhhhcCCCCCc
Q 015500          150 --S---------------------------E-A-------------------------LQSGGTPMFMAPEVARGEHQGF  174 (405)
Q Consensus       150 --~---------------------------~-~-------------------------~~~~gt~~Y~APE~l~~~~~~~  174 (405)
                        .                           . .                         ...+||-.|+|||+++|...+.
T Consensus       235 ~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgs  314 (459)
T KOG0610|consen  235 LVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGS  314 (459)
T ss_pred             eeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCc
Confidence              0                           0 0                         0123888899999999999999


Q ss_pred             chhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHh-cCCCCCCchhccHHHHHHHHHhcccCccccCC----HHHHhcC
Q 015500          175 ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAY-SRELPEVPAFLSKQANDFLSNCLRRDPKERWA----ASQLLKH  249 (405)
Q Consensus       175 ~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~-~~~~~~~p~~~s~~l~dll~~~L~~dP~~Rpt----~~elL~h  249 (405)
                      ++|.|+||+.+|||+.|+.||.+.++ .+.+.++.. ...+|..| .++..++|||+++|.+||.+|..    |+||.+|
T Consensus       315 AVDWWtfGIflYEmLyG~TPFKG~~~-~~Tl~NIv~~~l~Fp~~~-~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~H  392 (459)
T KOG0610|consen  315 AVDWWTFGIFLYEMLYGTTPFKGSNN-KETLRNIVGQPLKFPEEP-EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRH  392 (459)
T ss_pred             hhhHHHHHHHHHHHHhCCCCcCCCCc-hhhHHHHhcCCCcCCCCC-cchhHHHHHHHHHhccChhhhhccccchHHhhcC
Confidence            99999999999999999999965544 455555543 34455555 57899999999999999999998    9999999


Q ss_pred             ccccccccc
Q 015500          250 PFLEEFCSC  258 (405)
Q Consensus       250 p~~~~~~~~  258 (405)
                      |||+.+.+.
T Consensus       393 pFF~gVnWa  401 (459)
T KOG0610|consen  393 PFFEGVNWA  401 (459)
T ss_pred             ccccCCChh
Confidence            999988665

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=4.6e-47  Score=379.09  Aligned_cols=247  Identities=26%  Similarity=0.410  Sum_probs=207.1

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC------ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~------~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~   75 (405)
                      +|++.+.||+|+||+||+|+++.+++.||||.+...      ....+.+|+.+|+.++||||+++++.+....    .++
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~----~~~   77 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKD----NLY   77 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCC----EEE
Confidence            699999999999999999999999999999988642      3456889999999999999999998765433    367


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc---
Q 015500           76 LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE---  151 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~---  151 (405)
                      +||||++||+|.+++.+. +.+++..++.++.||+.||+|||++||+||||||+|||++.++ +||+|||+|.....   
T Consensus        78 lv~E~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~  156 (376)
T cd05598          78 FVMDYIPGGDMMSLLIRL-GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD  156 (376)
T ss_pred             EEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence            999999999999999876 4799999999999999999999999999999999999999888 99999999742110   


Q ss_pred             --------------------------------------------cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHH
Q 015500          152 --------------------------------------------ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIE  187 (405)
Q Consensus       152 --------------------------------------------~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~e  187 (405)
                                                                  .....||+.|+|||++.+..++.++|||||||++||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye  236 (376)
T cd05598         157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE  236 (376)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence                                                        012369999999999999999999999999999999


Q ss_pred             HHhCCCCCCCCCChHHHHHHHHhcCCCCCCc--hhccHHHHHHHHHhcccCccccC---CHHHHhcCcccccc
Q 015500          188 MASGGAPWPNAADPMTVLYKIAYSRELPEVP--AFLSKQANDFLSNCLRRDPKERW---AASQLLKHPFLEEF  255 (405)
Q Consensus       188 lltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p--~~~s~~l~dll~~~L~~dP~~Rp---t~~elL~hp~~~~~  255 (405)
                      |++|+.||.... .......+.........|  ..+++++.++|.+|+ .+|.+|+   |+.++++||||+.+
T Consensus       237 ll~G~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~  307 (376)
T cd05598         237 MLVGQPPFLADT-PAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGI  307 (376)
T ss_pred             hhhCCCCCCCCC-HHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCC
Confidence            999999996543 333333333222212222  357899999999976 5999999   99999999999865

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.8e-46  Score=366.64  Aligned_cols=253  Identities=26%  Similarity=0.356  Sum_probs=204.7

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC-----ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCC-CceEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP-----KSEFLQREQKFLSSLNSPHIVGYKGCDVTSED-NKLMYN   75 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~-----~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~-~~~~~~   75 (405)
                      +|++.+.||+|+||.||+|+++.+++.||||.+...     ....+.+|+++|+.++||||+++++++..... ....++
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            589999999999999999999999999999987632     23467899999999999999999987754432 223467


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc---
Q 015500           76 LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE---  151 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~---  151 (405)
                      +||||+. ++|.+++.+. +.+++..+..++.||+.||.|||++||+||||||+|||++.++ +||+|||+++....   
T Consensus        81 lv~e~~~-~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~  158 (338)
T cd07859          81 VVFELME-SDLHQVIKAN-DDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP  158 (338)
T ss_pred             EEEecCC-CCHHHHHHhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccC
Confidence            9999995 6899988775 4799999999999999999999999999999999999999888 99999999875322   


Q ss_pred             ----cccCCCCCCccChhhhcC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHH----------------
Q 015500          152 ----ALQSGGTPMFMAPEVARG--EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA----------------  209 (405)
Q Consensus       152 ----~~~~~gt~~Y~APE~l~~--~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~----------------  209 (405)
                          .....||+.|+|||++.+  ..++.++|||||||++|+|++|++||...... ..+..+.                
T Consensus       159 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~  237 (338)
T cd07859         159 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV-HQLDLITDLLGTPSPETISRVRN  237 (338)
T ss_pred             ccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChH-HHHHHHHHHhCCCCHHHHHHhhh
Confidence                123469999999999876  67889999999999999999999999654321 1111000                


Q ss_pred             ---------hcCCCC-C---CchhccHHHHHHHHHhcccCccccCCHHHHhcCcccccccc
Q 015500          210 ---------YSRELP-E---VPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCS  257 (405)
Q Consensus       210 ---------~~~~~~-~---~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~~  257 (405)
                               .....+ .   ....+++.+.++|.+||+.||++|||++++|+||||+....
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~  298 (338)
T cd07859         238 EKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK  298 (338)
T ss_pred             hhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence                     000000 0   01235788999999999999999999999999999987644

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=9.3e-47  Score=370.54  Aligned_cols=241  Identities=30%  Similarity=0.459  Sum_probs=205.9

Q ss_pred             cccceeCCeeEEEEEEcCCCCEEEEEEccCC------ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEee
Q 015500            7 HTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEY   80 (405)
Q Consensus         7 ~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~------~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~Ey   80 (405)
                      +.||+|+||+||+|.++.+++.||+|++...      ....+.+|+++|+.++||||+++++.+....    .+++||||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~----~~~lv~Ey   76 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKD----RLCFVMEY   76 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCC----EEEEEEeC
Confidence            4799999999999999999999999988642      2346778999999999999999988765443    36799999


Q ss_pred             cCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc----cccC
Q 015500           81 APGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE----ALQS  155 (405)
Q Consensus        81 ~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~----~~~~  155 (405)
                      +++|+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++ +||+|||+++....    ....
T Consensus        77 ~~~g~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~  155 (328)
T cd05593          77 VNGGELFFHLSRE-RVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTF  155 (328)
T ss_pred             CCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccc
Confidence            9999999988775 4799999999999999999999999999999999999999887 99999999875322    2235


Q ss_pred             CCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHhccc
Q 015500          156 GGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRR  235 (405)
Q Consensus       156 ~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~L~~  235 (405)
                      .||+.|+|||++.+..++.++|||||||++|+|++|+.||... +.......+. . ....+|..+++++.+||++||++
T Consensus       156 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~-~~~~~~~~~~-~-~~~~~p~~~~~~~~~li~~~L~~  232 (328)
T cd05593         156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-DHEKLFELIL-M-EDIKFPRTLSADAKSLLSGLLIK  232 (328)
T ss_pred             cCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCC-CHHHHHHHhc-c-CCccCCCCCCHHHHHHHHHHcCC
Confidence            6999999999999989999999999999999999999999644 3333333332 2 23456778999999999999999


Q ss_pred             CccccC-----CHHHHhcCcccccc
Q 015500          236 DPKERW-----AASQLLKHPFLEEF  255 (405)
Q Consensus       236 dP~~Rp-----t~~elL~hp~~~~~  255 (405)
                      ||.+|+     ++.++++||||...
T Consensus       233 dP~~R~~~~~~~~~~il~h~~~~~~  257 (328)
T cd05593         233 DPNKRLGGGPDDAKEIMRHSFFTGV  257 (328)
T ss_pred             CHHHcCCCCCCCHHHHhcCCCcCCC
Confidence            999997     89999999999754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-47  Score=378.17  Aligned_cols=247  Identities=26%  Similarity=0.432  Sum_probs=206.9

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC------ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~------~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~   75 (405)
                      +|++++.||+|+||+||+|.++.+++.||||.+...      ..+.+.+|+++|+.++||||+++++.+....    .+|
T Consensus         2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~----~~~   77 (377)
T cd05629           2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQ----YLY   77 (377)
T ss_pred             CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC----eeE
Confidence            689999999999999999999999999999987542      2346788999999999999999998776433    367


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc---
Q 015500           76 LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE---  151 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~---  151 (405)
                      +||||++||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++ +||+|||+++....   
T Consensus        78 lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~  156 (377)
T cd05629          78 LIMEFLPGGDLMTMLIKY-DTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD  156 (377)
T ss_pred             EEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence            999999999999999875 4799999999999999999999999999999999999999887 99999999852110   


Q ss_pred             ------------------------------------------------cccCCCCCCccChhhhcCCCCCcchhHHHHHH
Q 015500          152 ------------------------------------------------ALQSGGTPMFMAPEVARGEHQGFASDIWAVGC  183 (405)
Q Consensus       152 ------------------------------------------------~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~  183 (405)
                                                                      .....||+.|+|||++.+..++.++|||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv  236 (377)
T cd05629         157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA  236 (377)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence                                                            00246999999999999999999999999999


Q ss_pred             HHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCch--hccHHHHHHHHHhcccCcccc---CCHHHHhcCcccccc
Q 015500          184 TVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPA--FLSKQANDFLSNCLRRDPKER---WAASQLLKHPFLEEF  255 (405)
Q Consensus       184 il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~--~~s~~l~dll~~~L~~dP~~R---pt~~elL~hp~~~~~  255 (405)
                      ++|||++|..||... .......++........+|.  .++.++++||.+||. +|.+|   +|+.++++||||...
T Consensus       237 il~elltG~~Pf~~~-~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~  311 (377)
T cd05629         237 IMFECLIGWPPFCSE-NSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGV  311 (377)
T ss_pred             hhhhhhcCCCCCCCC-CHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence            999999999999644 33444444443222223333  478999999999997 77776   599999999999864

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-46  Score=373.93  Aligned_cols=247  Identities=32%  Similarity=0.484  Sum_probs=214.6

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCCh------HHHHHHHHHHHhCC-CCCeeeeeeeeeecCCCceEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS------EFLQREQKFLSSLN-SPHIVGYKGCDVTSEDNKLMY   74 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~~------~~l~~E~~iL~~L~-hpnIv~~~~~~~~~~~~~~~~   74 (405)
                      .|..++.||+|.||.||+++++.+|+.+|+|++.+...      +.+.+|+++|++|. ||||+.+++.+.+...    +
T Consensus        36 ~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~----~  111 (382)
T KOG0032|consen   36 KYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS----V  111 (382)
T ss_pred             cEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe----E
Confidence            48889999999999999999999999999999876432      58999999999998 9999999998876653    7


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccC-----CceEeeecccccc
Q 015500           75 NLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES-----GAKIADFGCAKWE  149 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~-----~vkL~DFGla~~~  149 (405)
                      ++|||+|.||.|.+.|...  .++|..+..+++||+.++.|||+.||+||||||+|+|+...     .+|++|||++...
T Consensus       112 ~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~  189 (382)
T KOG0032|consen  112 YLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI  189 (382)
T ss_pred             EEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence            7999999999999999877  39999999999999999999999999999999999999543     2999999999876


Q ss_pred             cc---cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCC-C-CCCchhccHH
Q 015500          150 SE---ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRE-L-PEVPAFLSKQ  224 (405)
Q Consensus       150 ~~---~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~-~-~~~p~~~s~~  224 (405)
                      ..   ....+|||.|+|||++.+..|+..+||||+|+++|.|++|.+||...... .....+..... + ......++..
T Consensus       190 ~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~-~~~~~i~~~~~~f~~~~w~~is~~  268 (382)
T KOG0032|consen  190 KPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEF-EIFLAILRGDFDFTSEPWDDISES  268 (382)
T ss_pred             cCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChh-HHHHHHHcCCCCCCCCCccccCHH
Confidence            65   45678999999999999999999999999999999999999999655433 33334443322 1 1222457999


Q ss_pred             HHHHHHHhcccCccccCCHHHHhcCcccccc
Q 015500          225 ANDFLSNCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       225 l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      +++|+++||.+||.+|+|+.++|+|||+...
T Consensus       269 akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~  299 (382)
T KOG0032|consen  269 AKDFIRKLLEFDPRKRLTAAQALQHPWIKSI  299 (382)
T ss_pred             HHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence            9999999999999999999999999998864

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=6.4e-47  Score=378.98  Aligned_cols=247  Identities=27%  Similarity=0.421  Sum_probs=207.7

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC------ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~------~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~   75 (405)
                      .|+.++.||+|+||+||+|+++.+++.+|+|.+...      ....+.+|+.+|+.++||||+++++.+....    .++
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~----~~~   77 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKD----NLY   77 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCC----EEE
Confidence            588999999999999999999999999999998643      2346888999999999999999998876543    367


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc---
Q 015500           76 LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE---  151 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~---  151 (405)
                      +||||++||+|.+++.+. +.+++..++.++.||+.||+|||++||+||||||+|||++.++ +||+|||+++....   
T Consensus        78 lv~E~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~  156 (382)
T cd05625          78 FVMDYIPGGDMMSLLIRM-GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD  156 (382)
T ss_pred             EEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence            999999999999999876 4799999999999999999999999999999999999999888 99999999742110   


Q ss_pred             ------------------------------------------------cccCCCCCCccChhhhcCCCCCcchhHHHHHH
Q 015500          152 ------------------------------------------------ALQSGGTPMFMAPEVARGEHQGFASDIWAVGC  183 (405)
Q Consensus       152 ------------------------------------------------~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~  183 (405)
                                                                      ....+||+.|+|||++.+..++.++|||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv  236 (382)
T cd05625         157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV  236 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence                                                            01235899999999999999999999999999


Q ss_pred             HHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCc--hhccHHHHHHHHHhcccCccccCC---HHHHhcCcccccc
Q 015500          184 TVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVP--AFLSKQANDFLSNCLRRDPKERWA---ASQLLKHPFLEEF  255 (405)
Q Consensus       184 il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p--~~~s~~l~dll~~~L~~dP~~Rpt---~~elL~hp~~~~~  255 (405)
                      ++|||++|+.||... ++.....++.........|  ..+++++.++|.+|+ .+|.+|++   ++++++||||+.+
T Consensus       237 il~elltG~~Pf~~~-~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~  311 (382)
T cd05625         237 ILYEMLVGQPPFLAQ-TPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTI  311 (382)
T ss_pred             HHHHHHhCCCCCCCC-CHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCc
Confidence            999999999999654 3344444443322222222  357999999999987 59999997   9999999999875

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-47  Score=374.11  Aligned_cols=248  Identities=31%  Similarity=0.464  Sum_probs=210.6

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC------ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~------~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~   75 (405)
                      +|.+++.||+|+||+||+|.+..+++.||+|++...      ....+.+|+.+|..++||||+++++.+....    .++
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~----~~~   77 (350)
T cd05573           2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEE----HLY   77 (350)
T ss_pred             CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCC----eEE
Confidence            689999999999999999999999999999998642      3456888999999999999999998765433    367


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc--
Q 015500           76 LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA--  152 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~--  152 (405)
                      +||||++|++|.+++.+. +.+++..++.++.||+.||+|||++||+||||||+|||++.++ +||+|||++......  
T Consensus        78 lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~  156 (350)
T cd05573          78 LVMEYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD  156 (350)
T ss_pred             EEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence            999999999999999876 5899999999999999999999999999999999999999888 999999998754332  


Q ss_pred             -------------------------------ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCh
Q 015500          153 -------------------------------LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADP  201 (405)
Q Consensus       153 -------------------------------~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~  201 (405)
                                                     ....||+.|+|||++.+..++.++|||||||++|||++|+.||.... .
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~-~  235 (350)
T cd05573         157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT-L  235 (350)
T ss_pred             ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC-H
Confidence                                           23458999999999999999999999999999999999999996544 3


Q ss_pred             HHHHHHHHhcCCCCCCch--hccHHHHHHHHHhcccCccccCC-HHHHhcCccccccc
Q 015500          202 MTVLYKIAYSRELPEVPA--FLSKQANDFLSNCLRRDPKERWA-ASQLLKHPFLEEFC  256 (405)
Q Consensus       202 ~~~l~~i~~~~~~~~~p~--~~s~~l~dll~~~L~~dP~~Rpt-~~elL~hp~~~~~~  256 (405)
                      .....++........+|.  .+++++.+||.+||. ||.+||+ ++++++||||+.+.
T Consensus       236 ~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~~  292 (350)
T cd05573         236 QETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGID  292 (350)
T ss_pred             HHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCCC
Confidence            344444433111122222  269999999999997 9999999 99999999998753

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.4e-46  Score=368.34  Aligned_cols=242  Identities=31%  Similarity=0.459  Sum_probs=206.0

Q ss_pred             cccceeCCeeEEEEEEcCCCCEEEEEEccCC------ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEee
Q 015500            7 HTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEY   80 (405)
Q Consensus         7 ~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~------~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~Ey   80 (405)
                      +.||+|+||+||+|.++.+|+.||+|.+...      ....+.+|+++++.++||||+++++++....    .+++||||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~----~~~lv~E~   76 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD----RLCFVMEY   76 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCC----EEEEEEeC
Confidence            5799999999999999999999999987642      2345678999999999999999998776543    36799999


Q ss_pred             cCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc----cccC
Q 015500           81 APGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE----ALQS  155 (405)
Q Consensus        81 ~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~----~~~~  155 (405)
                      ++||+|.+++.+. +.+++..++.++.||+.||.|||++||+||||||+|||++.++ +||+|||+++....    ....
T Consensus        77 ~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~  155 (323)
T cd05595          77 ANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF  155 (323)
T ss_pred             CCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccc
Confidence            9999999988775 4799999999999999999999999999999999999999887 99999999875322    2235


Q ss_pred             CCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHhccc
Q 015500          156 GGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRR  235 (405)
Q Consensus       156 ~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~L~~  235 (405)
                      .||+.|+|||++.+..++.++|||||||++|+|++|+.||... +.......+..  ....+|..+++++.+||++||+.
T Consensus       156 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~-~~~~~~~~~~~--~~~~~p~~~~~~~~~li~~~L~~  232 (323)
T cd05595         156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-DHERLFELILM--EEIRFPRTLSPEAKSLLAGLLKK  232 (323)
T ss_pred             cCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCC-CHHHHHHHHhc--CCCCCCCCCCHHHHHHHHHHccC
Confidence            6999999999999999999999999999999999999999543 33333333322  22356778899999999999999


Q ss_pred             CccccC-----CHHHHhcCccccccc
Q 015500          236 DPKERW-----AASQLLKHPFLEEFC  256 (405)
Q Consensus       236 dP~~Rp-----t~~elL~hp~~~~~~  256 (405)
                      ||.+|+     ++.++++||||....
T Consensus       233 dP~~R~~~~~~~~~~~l~h~~~~~~~  258 (323)
T cd05595         233 DPKQRLGGGPSDAKEVMEHRFFLSIN  258 (323)
T ss_pred             CHHHhCCCCCCCHHHHHcCCCcCCCC
Confidence            999998     899999999998653

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.2e-46  Score=357.96  Aligned_cols=254  Identities=31%  Similarity=0.452  Sum_probs=212.6

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCCh-----HHHHHHHHHHHhCCCCC-eeeeeeeeeecCC--CceE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS-----EFLQREQKFLSSLNSPH-IVGYKGCDVTSED--NKLM   73 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~~-----~~l~~E~~iL~~L~hpn-Iv~~~~~~~~~~~--~~~~   73 (405)
                      .|..+++||+|+||+||+|+++.+|+.||+|++..+..     ....||+.+|++|+|+| |+.+++++.+...  ....
T Consensus        12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~   91 (323)
T KOG0594|consen   12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK   91 (323)
T ss_pred             HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence            47788999999999999999999999999999886543     46789999999999999 9999998776552  2234


Q ss_pred             EEEEEeecCCCCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccc
Q 015500           74 YNLFMEYAPGGTLNDEIHRNG---GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWE  149 (405)
Q Consensus        74 ~~lv~Ey~~ggsL~~~i~~~~---~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~  149 (405)
                      +++|+||+.- +|.+++...+   ..++...++.+++||+.||+|||+++|+||||||+||||+.+| +||+|||+|+..
T Consensus        92 l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~  170 (323)
T KOG0594|consen   92 LYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARAF  170 (323)
T ss_pred             EEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHHh
Confidence            6699999954 9999998865   3588899999999999999999999999999999999999998 999999999854


Q ss_pred             cc----cccCCCCCCccChhhhcCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCC--------
Q 015500          150 SE----ALQSGGTPMFMAPEVARGE-HQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPE--------  216 (405)
Q Consensus       150 ~~----~~~~~gt~~Y~APE~l~~~-~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~--------  216 (405)
                      .-    .....+|.+|+|||++.|. .|+...||||+||+++||+++++.|+...+ ..++.+|...-..|.        
T Consensus       171 ~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se-~~ql~~If~~lGtP~e~~Wp~v~  249 (323)
T KOG0594|consen  171 SIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE-IDQLFRIFRLLGTPNEKDWPGVS  249 (323)
T ss_pred             cCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH-HHHHHHHHHHcCCCCccCCCCcc
Confidence            32    3345689999999999986 799999999999999999999999987665 555555543322221        


Q ss_pred             -----------Cc---------hhccHHHHHHHHHhcccCccccCCHHHHhcCcccccccc
Q 015500          217 -----------VP---------AFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCS  257 (405)
Q Consensus       217 -----------~p---------~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~~  257 (405)
                                 .+         ...++++.+++.+||+.+|.+|.|+..+|.||||.....
T Consensus       250 ~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~  310 (323)
T KOG0594|consen  250 SLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPE  310 (323)
T ss_pred             ccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccccc
Confidence                       11         112358999999999999999999999999999997643

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-48  Score=351.59  Aligned_cols=248  Identities=28%  Similarity=0.414  Sum_probs=210.5

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC-----ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP-----KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~-----~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      +|.+-+.||+|.|+.|+++.+..+|+.||+|+++..     ..+.+.+|++|-+.|+||||+++......    ..+.|+
T Consensus        12 ~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~----~~~~yl   87 (355)
T KOG0033|consen   12 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE----ESFHYL   87 (355)
T ss_pred             hhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcc----cceeEE
Confidence            477889999999999999999999999999987643     45789999999999999999999875432    235779


Q ss_pred             EEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccC--C--ceEeeecccccccc-
Q 015500           77 FMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES--G--AKIADFGCAKWESE-  151 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~--~--vkL~DFGla~~~~~-  151 (405)
                      |+|++.|++|..-|.++ --++|..+-.+++||+.+|.|+|.+||||||+||+|+|+.+.  +  +||+|||+|...+. 
T Consensus        88 vFe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g  166 (355)
T KOG0033|consen   88 VFDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDG  166 (355)
T ss_pred             EEecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCc
Confidence            99999999998777665 368999999999999999999999999999999999999644  3  99999999987664 


Q ss_pred             --cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCC-CC-CCchhccHHHHH
Q 015500          152 --ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRE-LP-EVPAFLSKQAND  227 (405)
Q Consensus       152 --~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~-~~-~~p~~~s~~l~d  227 (405)
                        .....|||.|||||+++..+|+.++|||+-|+++|-|+.|.+||.+. +......+|..... +| .....+++++++
T Consensus       167 ~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~-~~~rlye~I~~g~yd~~~~~w~~is~~Ak~  245 (355)
T KOG0033|consen  167 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE-DQHRLYEQIKAGAYDYPSPEWDTVTPEAKS  245 (355)
T ss_pred             cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCc-cHHHHHHHHhccccCCCCcccCcCCHHHHH
Confidence              23456999999999999999999999999999999999999999542 34444445544332 22 234568999999


Q ss_pred             HHHHhcccCccccCCHHHHhcCcccccc
Q 015500          228 FLSNCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       228 ll~~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      |+++||..||++|.|+.|+|+|||+.+-
T Consensus       246 LvrrML~~dP~kRIta~EAL~HpWi~~r  273 (355)
T KOG0033|consen  246 LIRRMLTVNPKKRITADEALKHPWICNR  273 (355)
T ss_pred             HHHHHhccChhhhccHHHHhCCchhcch
Confidence            9999999999999999999999999753

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=7.1e-46  Score=364.48  Aligned_cols=248  Identities=29%  Similarity=0.511  Sum_probs=207.4

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLF   77 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv   77 (405)
                      +|++.+.||+|+||.||+|++..++..+|+|.+....    ...+.+|+++|++++||||+++++++....    .+++|
T Consensus         6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~lv   81 (331)
T cd06649           6 DFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG----EISIC   81 (331)
T ss_pred             cceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC----EEEEE
Confidence            6899999999999999999999999999999987542    246889999999999999999999876543    36699


Q ss_pred             EeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCCCCEEEccCC-ceEeeecccccccc--cc
Q 015500           78 MEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN-RVVHCDIKSRNILMAESG-AKIADFGCAKWESE--AL  153 (405)
Q Consensus        78 ~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~-givHrDlkp~NILi~~~~-vkL~DFGla~~~~~--~~  153 (405)
                      |||++|++|.+++.... .+++..+..++.|++.||.|||++ +|+||||||+|||++.++ +||+|||++.....  ..
T Consensus        82 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  160 (331)
T cd06649          82 MEHMDGGSLDQVLKEAK-RIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN  160 (331)
T ss_pred             eecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccccccc
Confidence            99999999999998764 799999999999999999999986 699999999999999887 99999999875433  23


Q ss_pred             cCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHH---------------------------
Q 015500          154 QSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLY---------------------------  206 (405)
Q Consensus       154 ~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~---------------------------  206 (405)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||..... .....                           
T Consensus       161 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (331)
T cd06649         161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDA-KELEAIFGRPVVDGEEGEPHSISPRPRPPGRP  239 (331)
T ss_pred             cCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHhcccccccccCCccccCccccccccc
Confidence            45699999999999999999999999999999999999999954321 11110                           


Q ss_pred             ------------------HHHhcCCCCCCc-hhccHHHHHHHHHhcccCccccCCHHHHhcCcccccc
Q 015500          207 ------------------KIAYSRELPEVP-AFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       207 ------------------~i~~~~~~~~~p-~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                                        ........+..+ ..+++++++||.+||++||++|||+.++|+||||+..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~  307 (331)
T cd06649         240 VSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS  307 (331)
T ss_pred             ccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence                              001111112222 2468899999999999999999999999999999854

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=7.7e-47  Score=370.59  Aligned_cols=248  Identities=28%  Similarity=0.458  Sum_probs=209.6

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC------ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~------~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~   75 (405)
                      +|.+.+.||+|+||+||+|.++.+|+.+|+|.+...      ....+.+|+.+++.++||||+++++++....    .++
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~----~~~   77 (330)
T cd05601           2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKD----NLY   77 (330)
T ss_pred             CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCC----eEE
Confidence            689999999999999999999999999999988643      2356889999999999999999988765432    367


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc--
Q 015500           76 LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA--  152 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~--  152 (405)
                      +||||++||+|.+++.+..+.+++..++.++.||+.||.|||++||+||||||+|||++.++ +||+|||++......  
T Consensus        78 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  157 (330)
T cd05601          78 LVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM  157 (330)
T ss_pred             EEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence            99999999999999988766899999999999999999999999999999999999999887 999999999764331  


Q ss_pred             ---ccCCCCCCccChhhhc------CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCc--hhc
Q 015500          153 ---LQSGGTPMFMAPEVAR------GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVP--AFL  221 (405)
Q Consensus       153 ---~~~~gt~~Y~APE~l~------~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p--~~~  221 (405)
                         ....||+.|+|||++.      +..++.++|||||||++|+|++|+.||.... ......++........+|  ..+
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~  236 (330)
T cd05601         158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT-SAKTYNNIMNFQRFLKFPEDPKV  236 (330)
T ss_pred             eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCC-HHHHHHHHHcCCCccCCCCCCCC
Confidence               2346999999999987      4567889999999999999999999996543 333444443322222333  247


Q ss_pred             cHHHHHHHHHhcccCccccCCHHHHhcCcccccc
Q 015500          222 SKQANDFLSNCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       222 s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      ++++.+||++||+ +|.+|||++++++||||...
T Consensus       237 ~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~  269 (330)
T cd05601         237 SSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKI  269 (330)
T ss_pred             CHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCC
Confidence            8999999999998 99999999999999999865

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=3.2e-46  Score=365.39  Aligned_cols=241  Identities=30%  Similarity=0.487  Sum_probs=205.1

Q ss_pred             cccceeCCeeEEEEEEcCCCCEEEEEEccCC------ChHHHHHHHHHHHhC-CCCCeeeeeeeeeecCCCceEEEEEEe
Q 015500            7 HTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSL-NSPHIVGYKGCDVTSEDNKLMYNLFME   79 (405)
Q Consensus         7 ~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~------~~~~l~~E~~iL~~L-~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (405)
                      +.||+|+||+||+|.++.+++.||+|.+...      ..+.+.+|..++..+ +||||+++++++....    .+++|||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~----~~~iv~E   76 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPD----RLFFVME   76 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCC----EEEEEEc
Confidence            4799999999999999999999999987642      234566788888877 7999999998875443    3679999


Q ss_pred             ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc----ccc
Q 015500           80 YAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE----ALQ  154 (405)
Q Consensus        80 y~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~----~~~  154 (405)
                      |++||+|.+++.+. +++++..+..++.||+.||+|||++||+||||||+|||++.++ +||+|||+++....    ...
T Consensus        77 y~~~g~L~~~i~~~-~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~  155 (320)
T cd05590          77 FVNGGDLMFHIQKS-RRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTST  155 (320)
T ss_pred             CCCCchHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccc
Confidence            99999999998776 4799999999999999999999999999999999999999888 99999999875321    234


Q ss_pred             CCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHhcc
Q 015500          155 SGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLR  234 (405)
Q Consensus       155 ~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~L~  234 (405)
                      ..||+.|+|||++.+..++.++|||||||++|+|++|+.||... +.......+..  ..+..|..+++++.+||++||+
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~-~~~~~~~~i~~--~~~~~~~~~~~~~~~li~~~L~  232 (320)
T cd05590         156 FCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAE-NEDDLFEAILN--DEVVYPTWLSQDAVDILKAFMT  232 (320)
T ss_pred             cccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCC-CHHHHHHHHhc--CCCCCCCCCCHHHHHHHHHHcc
Confidence            56999999999999999999999999999999999999999643 33333333332  2345677899999999999999


Q ss_pred             cCccccCCH------HHHhcCcccccc
Q 015500          235 RDPKERWAA------SQLLKHPFLEEF  255 (405)
Q Consensus       235 ~dP~~Rpt~------~elL~hp~~~~~  255 (405)
                      +||.+||++      +++++||||..+
T Consensus       233 ~dP~~R~~~~~~~~~~~~~~h~~f~~~  259 (320)
T cd05590         233 KNPTMRLGSLTLGGEEAILRHPFFKEL  259 (320)
T ss_pred             cCHHHCCCCCCCCCHHHHHcCCCcCCC
Confidence            999999998      999999999865

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=4.3e-46  Score=364.75  Aligned_cols=246  Identities=28%  Similarity=0.442  Sum_probs=208.6

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC------ChHHHHHHHHHHHhCCCC-CeeeeeeeeeecCCCceEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSLNSP-HIVGYKGCDVTSEDNKLMY   74 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~------~~~~l~~E~~iL~~L~hp-nIv~~~~~~~~~~~~~~~~   74 (405)
                      +|++.+.||+|+||.||+|.++.+++.||||++...      ..+.+..|.+++..+.|+ +|+.+++++...+    .+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~----~~   76 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD----RL   76 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCC----EE
Confidence            689999999999999999999999999999987642      234677899999999775 5777877765433    36


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccc---
Q 015500           75 NLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWES---  150 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~---  150 (405)
                      ++||||++||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++ +||+|||+++...   
T Consensus        77 ~lv~E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  155 (324)
T cd05587          77 YFVMEYVNGGDLMYHIQQV-GKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG  155 (324)
T ss_pred             EEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence            7999999999999999776 4799999999999999999999999999999999999999887 9999999986421   


Q ss_pred             -ccccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHH
Q 015500          151 -EALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFL  229 (405)
Q Consensus       151 -~~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll  229 (405)
                       ......||+.|+|||++.+..++.++|||||||++|+|+||+.||... +.......+..  ..+.+|..+++++.+++
T Consensus       156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~-~~~~~~~~i~~--~~~~~~~~~~~~~~~li  232 (324)
T cd05587         156 KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE-DEDELFQSIME--HNVSYPKSLSKEAVSIC  232 (324)
T ss_pred             CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC-CHHHHHHHHHc--CCCCCCCCCCHHHHHHH
Confidence             123456999999999999999999999999999999999999999643 33444444332  33456778999999999


Q ss_pred             HHhcccCccccCCH-----HHHhcCcccccc
Q 015500          230 SNCLRRDPKERWAA-----SQLLKHPFLEEF  255 (405)
Q Consensus       230 ~~~L~~dP~~Rpt~-----~elL~hp~~~~~  255 (405)
                      ++||.+||.+|++.     .++++||||+..
T Consensus       233 ~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~  263 (324)
T cd05587         233 KGLLTKHPAKRLGCGPTGERDIREHAFFRRI  263 (324)
T ss_pred             HHHhhcCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence            99999999999986     899999999865

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=2.7e-46  Score=367.33  Aligned_cols=243  Identities=30%  Similarity=0.540  Sum_probs=205.2

Q ss_pred             cccceeCCeeEEEEEEcCCCCEEEEEEccCC------ChHHHHHHHHHHHhC-CCCCeeeeeeeeeecCCCceEEEEEEe
Q 015500            7 HTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSL-NSPHIVGYKGCDVTSEDNKLMYNLFME   79 (405)
Q Consensus         7 ~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~------~~~~l~~E~~iL~~L-~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (405)
                      +.||+|+||+||+|.++.+++.||+|.+...      ....+.+|..+++.+ +||||+++++++....    .+++|||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~----~~~lv~e   76 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTES----RLFFVIE   76 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCC----EEEEEEe
Confidence            4799999999999999999999999998642      234578899999998 7999999998875543    3679999


Q ss_pred             ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccc----cccc
Q 015500           80 YAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWES----EALQ  154 (405)
Q Consensus        80 y~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~----~~~~  154 (405)
                      |++||+|.+++.+. +++++..++.++.||+.||.|||++||+||||||+|||++.++ +||+|||+++...    ....
T Consensus        77 ~~~~g~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~  155 (329)
T cd05588          77 FVSGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST  155 (329)
T ss_pred             CCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCcccc
Confidence            99999999988765 4899999999999999999999999999999999999999887 9999999987421    1334


Q ss_pred             CCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-------ChHHHHHHHHhcCCCCCCchhccHHHHH
Q 015500          155 SGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAA-------DPMTVLYKIAYSRELPEVPAFLSKQAND  227 (405)
Q Consensus       155 ~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~-------~~~~~l~~i~~~~~~~~~p~~~s~~l~d  227 (405)
                      ..||+.|+|||++.+..+++++|+|||||++|+|++|+.||....       .....+.+.... ....+|..++.++.+
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~p~~~~~~~~~  234 (329)
T cd05588         156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE-KQIRIPRSLSVKASS  234 (329)
T ss_pred             ccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHc-CCCCCCCCCCHHHHH
Confidence            569999999999999999999999999999999999999995311       112223332222 334577789999999


Q ss_pred             HHHHhcccCccccCC------HHHHhcCcccccc
Q 015500          228 FLSNCLRRDPKERWA------ASQLLKHPFLEEF  255 (405)
Q Consensus       228 ll~~~L~~dP~~Rpt------~~elL~hp~~~~~  255 (405)
                      +|++||+.||.+|+|      ++++++||||...
T Consensus       235 li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~  268 (329)
T cd05588         235 VLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNI  268 (329)
T ss_pred             HHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence            999999999999987      7899999999764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-48  Score=413.34  Aligned_cols=248  Identities=42%  Similarity=0.759  Sum_probs=222.2

Q ss_pred             CCcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEE
Q 015500            1 MDWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         1 ~~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~   75 (405)
                      |+|.++.+||.|.||.||.|.+..+|+..|+|-+....     ...+.+|..+|..|+|||+|+++|+.+..+.    .+
T Consensus      1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRek----v~ 1310 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREK----VY 1310 (1509)
T ss_pred             eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHH----HH
Confidence            68999999999999999999999999999999765432     3568899999999999999999998877665    56


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc--
Q 015500           76 LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA--  152 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~--  152 (405)
                      ++||||+||+|++++.. ++..+|...+.|..|++.|+.|||+.|||||||||.||+++.+| +|++|||.|..+...  
T Consensus      1311 IFMEyC~~GsLa~ll~~-gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~ 1389 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEH-GRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQ 1389 (1509)
T ss_pred             HHHHHhccCcHHHHHHh-cchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchh
Confidence            99999999999998865 45789999999999999999999999999999999999999999 999999999875543  


Q ss_pred             ------ccCCCCCCccChhhhcCC---CCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccH
Q 015500          153 ------LQSGGTPMFMAPEVARGE---HQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSK  223 (405)
Q Consensus       153 ------~~~~gt~~Y~APE~l~~~---~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~  223 (405)
                            ....|||+|||||++.+.   ..+-++|||||||++.||+||+.||.+.++.....+++..+ ..|.+|..+|.
T Consensus      1390 ~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~g-h~Pq~P~~ls~ 1468 (1509)
T KOG4645|consen 1390 TMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAG-HKPQIPERLSS 1468 (1509)
T ss_pred             cCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhcc-CCCCCchhhhH
Confidence                  234699999999999863   46679999999999999999999999998888888887754 56789999999


Q ss_pred             HHHHHHHHhcccCccccCCHHHHhcCccccc
Q 015500          224 QANDFLSNCLRRDPKERWAASQLLKHPFLEE  254 (405)
Q Consensus       224 ~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~  254 (405)
                      +.+|||..||..||++||++.|||+|-|-+.
T Consensus      1469 ~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1469 EGRDFLEHCLEQDPKMRWTASQLLEHAFGKS 1499 (1509)
T ss_pred             hHHHHHHHHHhcCchhhhHHHHHHHhhcccc
Confidence            9999999999999999999999999988764

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=2.9e-46  Score=373.24  Aligned_cols=247  Identities=28%  Similarity=0.425  Sum_probs=207.7

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC------ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~------~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~   75 (405)
                      +|++.+.||+|+||+||+|+++.+++.+|+|.+...      ..+.+.+|+.+++.++||||+++++++....    .++
T Consensus        44 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~----~~~  119 (370)
T cd05596          44 DFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDK----YLY  119 (370)
T ss_pred             HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCC----EEE
Confidence            588999999999999999999999999999988532      2345778999999999999999998765433    367


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc---
Q 015500           76 LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE---  151 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~---  151 (405)
                      +||||++||+|.+++...  .+++..+..++.||+.||+|||++||+||||||+|||++.++ +||+|||++.....   
T Consensus       120 lv~Ey~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~  197 (370)
T cd05596         120 MVMEYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM  197 (370)
T ss_pred             EEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCc
Confidence            999999999999988754  689999999999999999999999999999999999999888 99999999876432   


Q ss_pred             --cccCCCCCCccChhhhcCC----CCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCch--hccH
Q 015500          152 --ALQSGGTPMFMAPEVARGE----HQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPA--FLSK  223 (405)
Q Consensus       152 --~~~~~gt~~Y~APE~l~~~----~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~--~~s~  223 (405)
                        .....||+.|+|||++.+.    .++.++|||||||++|||++|+.||.... ......++........+|.  .+|.
T Consensus       198 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~s~  276 (370)
T cd05596         198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS-LVGTYSKIMDHKNSLTFPDDIEISK  276 (370)
T ss_pred             ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCC-HHHHHHHHHcCCCcCCCCCcCCCCH
Confidence              1235699999999998753    37889999999999999999999996443 3344444443332233343  4799


Q ss_pred             HHHHHHHHhcccCccc--cCCHHHHhcCcccccc
Q 015500          224 QANDFLSNCLRRDPKE--RWAASQLLKHPFLEEF  255 (405)
Q Consensus       224 ~l~dll~~~L~~dP~~--Rpt~~elL~hp~~~~~  255 (405)
                      ++++||++||+.+|.+  |+|++++++||||+..
T Consensus       277 ~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~  310 (370)
T cd05596         277 QAKDLICAFLTDREVRLGRNGVDEIKSHPFFKND  310 (370)
T ss_pred             HHHHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence            9999999999999988  9999999999999863

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=6e-46  Score=362.83  Aligned_cols=242  Identities=30%  Similarity=0.503  Sum_probs=205.3

Q ss_pred             cccceeCCeeEEEEEEcCCCCEEEEEEccCC------ChHHHHHHHHHHHhC-CCCCeeeeeeeeeecCCCceEEEEEEe
Q 015500            7 HTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSL-NSPHIVGYKGCDVTSEDNKLMYNLFME   79 (405)
Q Consensus         7 ~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~------~~~~l~~E~~iL~~L-~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (405)
                      +.||+|+||.||+|.++.+|+.||+|.+...      .......|..++..+ +||||+++++.+....    .+++|||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~----~~~lv~E   76 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKE----HLFFVME   76 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCC----EEEEEEC
Confidence            5799999999999999999999999988642      234567788888765 8999999998775433    3679999


Q ss_pred             ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccc----cccc
Q 015500           80 YAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWES----EALQ  154 (405)
Q Consensus        80 y~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~----~~~~  154 (405)
                      |++||+|.+++... +++++..+..++.||+.||+|||++||+||||||+|||++.++ +||+|||+++...    ....
T Consensus        77 ~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (316)
T cd05620          77 FLNGGDLMFHIQDK-GRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST  155 (316)
T ss_pred             CCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceec
Confidence            99999999999775 4799999999999999999999999999999999999999887 9999999987421    1334


Q ss_pred             CCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHhcc
Q 015500          155 SGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLR  234 (405)
Q Consensus       155 ~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~L~  234 (405)
                      ..||+.|+|||++.+..++.++|||||||++|+|++|+.||... +.......+.  ...+.+|..++.++++||++||.
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~-~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~  232 (316)
T cd05620         156 FCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGD-DEDELFESIR--VDTPHYPRWITKESKDILEKLFE  232 (316)
T ss_pred             cCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCC-CHHHHHHHHH--hCCCCCCCCCCHHHHHHHHHHcc
Confidence            56999999999999999999999999999999999999999643 3333333332  23456778899999999999999


Q ss_pred             cCccccCCH-HHHhcCccccccc
Q 015500          235 RDPKERWAA-SQLLKHPFLEEFC  256 (405)
Q Consensus       235 ~dP~~Rpt~-~elL~hp~~~~~~  256 (405)
                      .||.+|+++ +++++||||+...
T Consensus       233 ~dP~~R~~~~~~~~~h~~f~~~~  255 (316)
T cd05620         233 RDPTRRLGVVGNIRGHPFFKTIN  255 (316)
T ss_pred             CCHHHcCCChHHHHcCCCcCCCC
Confidence            999999998 5899999998753

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=2.1e-46  Score=372.39  Aligned_cols=248  Identities=25%  Similarity=0.401  Sum_probs=207.9

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC------ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~------~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~   75 (405)
                      +|+..+.||+|+||+||+|.++.+++.+|+|.+...      ....+.+|+.++..++||||+++++.+....    .++
T Consensus         2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~----~~~   77 (360)
T cd05627           2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKR----NLY   77 (360)
T ss_pred             CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC----EEE
Confidence            689999999999999999999999999999988532      2456788999999999999999998765433    367


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc---
Q 015500           76 LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE---  151 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~---  151 (405)
                      +||||++||+|.+++.+. +.+++..++.++.||+.||+|||++||+||||||+|||++.++ +||+|||+++....   
T Consensus        78 lv~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~  156 (360)
T cd05627          78 LIMEFLPGGDMMTLLMKK-DTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR  156 (360)
T ss_pred             EEEeCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence            999999999999999876 4799999999999999999999999999999999999999888 99999999864321   


Q ss_pred             ------------------------------------cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 015500          152 ------------------------------------ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPW  195 (405)
Q Consensus       152 ------------------------------------~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf  195 (405)
                                                          ....+||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf  236 (360)
T cd05627         157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF  236 (360)
T ss_pred             cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence                                                01246999999999999999999999999999999999999999


Q ss_pred             CCCCChHHHHHHHHhcCCCCCCch--hccHHHHHHHHHhcccCccccC---CHHHHhcCccccccc
Q 015500          196 PNAADPMTVLYKIAYSRELPEVPA--FLSKQANDFLSNCLRRDPKERW---AASQLLKHPFLEEFC  256 (405)
Q Consensus       196 ~~~~~~~~~l~~i~~~~~~~~~p~--~~s~~l~dll~~~L~~dP~~Rp---t~~elL~hp~~~~~~  256 (405)
                      ... ++.....++........+|.  .+++++++||.+|+. ||.+|+   ++.++++||||+...
T Consensus       237 ~~~-~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~~  300 (360)
T cd05627         237 CSE-TPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEGVD  300 (360)
T ss_pred             CCC-CHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCCCC
Confidence            644 34444444443222222332  378999999999874 999998   489999999998753

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=3.6e-46  Score=366.18  Aligned_cols=248  Identities=28%  Similarity=0.496  Sum_probs=206.2

Q ss_pred             CcccccccceeCCeeEEEEEEc---CCCCEEEEEEccCC-------ChHHHHHHHHHHHhC-CCCCeeeeeeeeeecCCC
Q 015500            2 DWTRGHTIGQGSSATVSLATSL---RSGDVFAAKSTELP-------KSEFLQREQKFLSSL-NSPHIVGYKGCDVTSEDN   70 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~---~~~~~vavK~~~~~-------~~~~l~~E~~iL~~L-~hpnIv~~~~~~~~~~~~   70 (405)
                      +|++++.||+|+||+||+|++.   .+++.+|+|++...       ..+.+.+|+.+|+.+ .||||+++++++....  
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~--   78 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEA--   78 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCC--
Confidence            6899999999999999999864   47899999987532       234677899999999 5899999987765432  


Q ss_pred             ceEEEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccc
Q 015500           71 KLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWE  149 (405)
Q Consensus        71 ~~~~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~  149 (405)
                        .+++||||++||+|.+++.++ +.+++..++.++.||+.||.|||++||+||||||+|||++.++ +||+|||+++..
T Consensus        79 --~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~  155 (332)
T cd05614          79 --KLHLILDYVSGGEMFTHLYQR-DNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEF  155 (332)
T ss_pred             --EEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence              366999999999999999776 4799999999999999999999999999999999999999887 999999998753


Q ss_pred             cc-----cccCCCCCCccChhhhcCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCC--ChHHHHHHHHhcCCCCCCchhc
Q 015500          150 SE-----ALQSGGTPMFMAPEVARGE-HQGFASDIWAVGCTVIEMASGGAPWPNAA--DPMTVLYKIAYSRELPEVPAFL  221 (405)
Q Consensus       150 ~~-----~~~~~gt~~Y~APE~l~~~-~~~~~sDIwSLG~il~elltG~~Pf~~~~--~~~~~l~~i~~~~~~~~~p~~~  221 (405)
                      ..     .....||+.|+|||++.+. .++.++|||||||++|||+||+.||....  .....+.... ....+.+|..+
T Consensus       156 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~  234 (332)
T cd05614         156 LSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRI-LKCDPPFPSFI  234 (332)
T ss_pred             cccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHH-hcCCCCCCCCC
Confidence            22     2235699999999999875 47889999999999999999999996432  1222222222 22345667779


Q ss_pred             cHHHHHHHHHhcccCccccC-----CHHHHhcCcccccc
Q 015500          222 SKQANDFLSNCLRRDPKERW-----AASQLLKHPFLEEF  255 (405)
Q Consensus       222 s~~l~dll~~~L~~dP~~Rp-----t~~elL~hp~~~~~  255 (405)
                      ++.+.+||.+||+.||++||     +++++++||||+..
T Consensus       235 ~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~  273 (332)
T cd05614         235 GPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL  273 (332)
T ss_pred             CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence            99999999999999999999     88899999999864

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=4.9e-46  Score=364.39  Aligned_cols=244  Identities=33%  Similarity=0.527  Sum_probs=206.6

Q ss_pred             cccccccceeCCeeEEEEEEcCCCCEEEEEEccCC------ChHHHHHHHHHH---HhCCCCCeeeeeeeeeecCCCceE
Q 015500            3 WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFL---SSLNSPHIVGYKGCDVTSEDNKLM   73 (405)
Q Consensus         3 y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~------~~~~l~~E~~iL---~~L~hpnIv~~~~~~~~~~~~~~~   73 (405)
                      |++.+.||+|+||+||+|.++.+++.||||.+...      ..+.+.+|++++   +.++||||+++++++....    .
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~----~   76 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTED----H   76 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCC----E
Confidence            78899999999999999999999999999998632      234566776665   5668999999999876443    3


Q ss_pred             EEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc-
Q 015500           74 YNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE-  151 (405)
Q Consensus        74 ~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~-  151 (405)
                      +++||||++|++|..++..  +.+++..+..++.||+.||.|||++||+||||||+||+++.++ +||+|||+++.... 
T Consensus        77 ~~lv~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05589          77 VCFVMEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF  154 (324)
T ss_pred             EEEEEcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence            6799999999999988864  4799999999999999999999999999999999999999888 99999999874322 


Q ss_pred             ---cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHH
Q 015500          152 ---ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDF  228 (405)
Q Consensus       152 ---~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dl  228 (405)
                         .....||+.|+|||++.+..++.++|||||||++|+|++|+.||... +.......+...  .+..|..+++++.+|
T Consensus       155 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~-~~~~~~~~i~~~--~~~~p~~~~~~~~~l  231 (324)
T cd05589         155 GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGD-DEEEVFDSIVND--EVRYPRFLSREAISI  231 (324)
T ss_pred             CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhC--CCCCCCCCCHHHHHH
Confidence               23456999999999999999999999999999999999999999643 334444443332  335677789999999


Q ss_pred             HHHhcccCccccC-----CHHHHhcCcccccc
Q 015500          229 LSNCLRRDPKERW-----AASQLLKHPFLEEF  255 (405)
Q Consensus       229 l~~~L~~dP~~Rp-----t~~elL~hp~~~~~  255 (405)
                      |++||+.||.+||     ++.++++||||+..
T Consensus       232 i~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~  263 (324)
T cd05589         232 MRRLLRRNPERRLGSGEKDAEDVKKQPFFRDI  263 (324)
T ss_pred             HHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence            9999999999999     79999999999865

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=2e-46  Score=367.35  Aligned_cols=241  Identities=30%  Similarity=0.463  Sum_probs=204.8

Q ss_pred             cccceeCCeeEEEEEEcCCCCEEEEEEccCC------ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEee
Q 015500            7 HTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEY   80 (405)
Q Consensus         7 ~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~------~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~Ey   80 (405)
                      +.||+|+||+||+|.++.+|+.+|+|.+...      ....+.+|+++++.++||||+++.+.+....    .+++||||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~----~~~lv~E~   76 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD----RLCFVMEY   76 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCC----EEEEEEeC
Confidence            4799999999999999999999999988642      2345678999999999999999988765443    36799999


Q ss_pred             cCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCCEEEccCC-ceEeeecccccccc----ccc
Q 015500           81 APGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHS-NRVVHCDIKSRNILMAESG-AKIADFGCAKWESE----ALQ  154 (405)
Q Consensus        81 ~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~-~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~----~~~  154 (405)
                      ++||+|.+++.+. +.+++..++.++.||+.||.|||+ +||+||||||+|||++.++ +||+|||+++....    ...
T Consensus        77 ~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~  155 (325)
T cd05594          77 ANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT  155 (325)
T ss_pred             CCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccccc
Confidence            9999999988765 479999999999999999999997 7999999999999999888 99999999875321    223


Q ss_pred             CCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHhcc
Q 015500          155 SGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLR  234 (405)
Q Consensus       155 ~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~L~  234 (405)
                      ..||+.|+|||++.+..++.++|||||||++|+|++|+.||.... .......+. . ....+|..+++++.+||++||+
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~-~~~~~~~i~-~-~~~~~p~~~~~~~~~li~~~L~  232 (325)
T cd05594         156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-HEKLFELIL-M-EEIRFPRTLSPEAKSLLSGLLK  232 (325)
T ss_pred             ccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCC-HHHHHHHHh-c-CCCCCCCCCCHHHHHHHHHHhh
Confidence            569999999999999999999999999999999999999996443 333333332 2 2335677789999999999999


Q ss_pred             cCccccC-----CHHHHhcCcccccc
Q 015500          235 RDPKERW-----AASQLLKHPFLEEF  255 (405)
Q Consensus       235 ~dP~~Rp-----t~~elL~hp~~~~~  255 (405)
                      .||++|+     ++.++++||||...
T Consensus       233 ~dP~~R~~~~~~~~~~il~h~~~~~~  258 (325)
T cd05594         233 KDPKQRLGGGPDDAKEIMQHKFFAGI  258 (325)
T ss_pred             cCHHHhCCCCCCCHHHHhcCCCcCCC
Confidence            9999997     99999999999864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=5.2e-46  Score=363.76  Aligned_cols=241  Identities=29%  Similarity=0.467  Sum_probs=205.2

Q ss_pred             cccceeCCeeEEEEEEcCCCCEEEEEEccCC------ChHHHHHHHHHHHhC-CCCCeeeeeeeeeecCCCceEEEEEEe
Q 015500            7 HTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSL-NSPHIVGYKGCDVTSEDNKLMYNLFME   79 (405)
Q Consensus         7 ~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~------~~~~l~~E~~iL~~L-~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (405)
                      +.||+|+||+||+|+++.+++.||+|.+...      ..+.+..|.+++..+ +||||+++++++....    .+++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~----~~~lv~E   76 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKD----RLFFVME   76 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCC----eEEEEEe
Confidence            4799999999999999999999999987642      234566788888876 8999999998876543    3679999


Q ss_pred             ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc----ccc
Q 015500           80 YAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE----ALQ  154 (405)
Q Consensus        80 y~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~----~~~  154 (405)
                      |++||+|.+++.+. +.+++..++.++.||+.||.|||++||+||||||+|||++.++ +||+|||++.....    ...
T Consensus        77 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~  155 (321)
T cd05591          77 YVNGGDLMFQIQRS-RKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTT  155 (321)
T ss_pred             CCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccc
Confidence            99999999998776 4799999999999999999999999999999999999999888 99999999875322    233


Q ss_pred             CCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHhcc
Q 015500          155 SGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLR  234 (405)
Q Consensus       155 ~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~L~  234 (405)
                      ..||+.|+|||++.+..++.++|||||||++|+|++|+.||... +.......+...  ....|..+++++.++|++||+
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~-~~~~~~~~i~~~--~~~~p~~~~~~~~~ll~~~L~  232 (321)
T cd05591         156 FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEAD-NEDDLFESILHD--DVLYPVWLSKEAVSILKAFMT  232 (321)
T ss_pred             cccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCC-CHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHHhc
Confidence            46899999999999999999999999999999999999999644 334444444322  235667789999999999999


Q ss_pred             cCccccC-------CHHHHhcCcccccc
Q 015500          235 RDPKERW-------AASQLLKHPFLEEF  255 (405)
Q Consensus       235 ~dP~~Rp-------t~~elL~hp~~~~~  255 (405)
                      .||++|+       ++.++++||||...
T Consensus       233 ~dp~~R~~~~~~~~~~~~~~~hp~~~~~  260 (321)
T cd05591         233 KNPNKRLGCVASQGGEDAIKQHPFFKEI  260 (321)
T ss_pred             cCHHHcCCCCCCCCCHHHHhcCCccCCC
Confidence            9999999       99999999999764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.1e-45  Score=354.16  Aligned_cols=242  Identities=29%  Similarity=0.436  Sum_probs=201.6

Q ss_pred             cceeCCeeEEEEEEcCCCCEEEEEEccCCC------hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEeecC
Q 015500            9 IGQGSSATVSLATSLRSGDVFAAKSTELPK------SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAP   82 (405)
Q Consensus         9 LG~G~~g~Vyla~~~~~~~~vavK~~~~~~------~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~Ey~~   82 (405)
                      ||+|+||+||+|.++.+++.+|+|.+....      .+.+.+|+++|+.++||||+++.+++....    .++++|||++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~----~~~lv~e~~~   76 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKT----DLCLVMTIMN   76 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCC----eEEEEEeCCC
Confidence            799999999999999999999999876432      245678999999999999999987765433    3679999999


Q ss_pred             CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc----ccc
Q 015500           83 GGTLNDEIHR---NGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE----ALQ  154 (405)
Q Consensus        83 ggsL~~~i~~---~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~----~~~  154 (405)
                      ||+|.+++..   ....+++..+..++.||+.||.|||++||+||||||+||+++.++ +||+|||++.....    ...
T Consensus        77 ~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~  156 (280)
T cd05608          77 GGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKG  156 (280)
T ss_pred             CCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccc
Confidence            9999988754   334699999999999999999999999999999999999998887 99999999875433    123


Q ss_pred             CCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChH--HHHHHHHhcCCCCCCchhccHHHHHHHHHh
Q 015500          155 SGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPM--TVLYKIAYSRELPEVPAFLSKQANDFLSNC  232 (405)
Q Consensus       155 ~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~--~~l~~i~~~~~~~~~p~~~s~~l~dll~~~  232 (405)
                      ..||+.|+|||++.+..++.++|||||||++|+|++|+.||.......  ....... ......+|..+++.+.+++.+|
T Consensus       157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~  235 (280)
T cd05608         157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRI-LNDSVTYPDKFSPASKSFCEAL  235 (280)
T ss_pred             cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhh-cccCCCCcccCCHHHHHHHHHH
Confidence            468999999999999999999999999999999999999996543221  1111111 1223345667899999999999


Q ss_pred             cccCccccC-----CHHHHhcCcccccc
Q 015500          233 LRRDPKERW-----AASQLLKHPFLEEF  255 (405)
Q Consensus       233 L~~dP~~Rp-----t~~elL~hp~~~~~  255 (405)
                      |+.||.+||     |++++++||||+..
T Consensus       236 l~~~P~~R~~~~~~~~~~~l~h~~~~~~  263 (280)
T cd05608         236 LAKDPEKRLGFRDGNCDGLRTHPLFRDL  263 (280)
T ss_pred             hcCCHHHhcCCCCCCHHHHhcChhhhcC
Confidence            999999999     88999999999874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-47  Score=382.04  Aligned_cols=244  Identities=37%  Similarity=0.628  Sum_probs=221.7

Q ss_pred             ccceeCCeeEEEEEEcCCCCEEEEEEccCCC---hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEeecCCC
Q 015500            8 TIGQGSSATVSLATSLRSGDVFAAKSTELPK---SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGG   84 (405)
Q Consensus         8 ~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~---~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~Ey~~gg   84 (405)
                      +||+|.||+||.|++..|....|||-++...   .+.+.+|+.+-++|+|.|||+|+|++-  +++  ++-++||-++||
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~s--enG--f~kIFMEqVPGG  657 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVS--ENG--FFKIFMEQVPGG  657 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccC--CCC--eEEEEeecCCCC
Confidence            6999999999999999999999999887543   457899999999999999999999843  222  566999999999


Q ss_pred             CHHHHHHHcCCCC--CHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccC-C-ceEeeecccccccc----cccCC
Q 015500           85 TLNDEIHRNGGRL--DESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES-G-AKIADFGCAKWESE----ALQSG  156 (405)
Q Consensus        85 sL~~~i~~~~~~l--~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~-~-vkL~DFGla~~~~~----~~~~~  156 (405)
                      +|.++++..-|++  +|.++-.|.+||++||.|||.+.|||||||.+||||+.- | +||.|||-+++...    ..+..
T Consensus       658 SLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFT  737 (1226)
T KOG4279|consen  658 SLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFT  737 (1226)
T ss_pred             cHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCccccccc
Confidence            9999999988899  899999999999999999999999999999999999875 4 99999998776433    34566


Q ss_pred             CCCCccChhhhcCC--CCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHhcc
Q 015500          157 GTPMFMAPEVARGE--HQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLR  234 (405)
Q Consensus       157 gt~~Y~APE~l~~~--~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~L~  234 (405)
                      ||..|||||++..+  .|+.++|||||||++.||+||++||-....+...+++...-+.-|++|..++.+++.||.+|+.
T Consensus       738 GTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcFe  817 (1226)
T KOG4279|consen  738 GTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFE  817 (1226)
T ss_pred             cchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcC
Confidence            99999999999764  5899999999999999999999999999999999999998889999999999999999999999


Q ss_pred             cCccccCCHHHHhcCcccccc
Q 015500          235 RDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       235 ~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      +||..||+|.+||++||++.-
T Consensus       818 pd~~~R~sA~~LL~DpFlq~~  838 (1226)
T KOG4279|consen  818 PDPCDRPSAKDLLQDPFLQHN  838 (1226)
T ss_pred             CCcccCccHHHhccCcccccC
Confidence            999999999999999999854

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.5e-46  Score=371.00  Aligned_cols=250  Identities=29%  Similarity=0.484  Sum_probs=222.4

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      +|..++.+|+|+||.+++++++..++.+++|.+...+     +....+|+.++++++|||||.+++.++....   +.++
T Consensus         5 ~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~---~l~I   81 (426)
T KOG0589|consen    5 NYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQ---LLCI   81 (426)
T ss_pred             hhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCc---eEEE
Confidence            5889999999999999999999999999999987653     3467899999999999999999998765432   5779


Q ss_pred             EEeecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc---
Q 015500           77 FMEYAPGGTLNDEIHRNG-GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE---  151 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~~-~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~---  151 (405)
                      +|+||+||+|.+.|.+.. .-++|+.+..++.|++.|+.|||++.|+|||||+.||+++.++ +||+|||+|+....   
T Consensus        82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~  161 (426)
T KOG0589|consen   82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS  161 (426)
T ss_pred             EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCchh
Confidence            999999999999997644 5699999999999999999999999999999999999999887 99999999997655   


Q ss_pred             -cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHH
Q 015500          152 -ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLS  230 (405)
Q Consensus       152 -~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~  230 (405)
                       +.+..|||.||.||++.+.+|+.++|||||||++|||++-+++|. ..+......++.... ...+|...+.+++.+++
T Consensus       162 ~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~-a~~m~~Li~ki~~~~-~~Plp~~ys~el~~lv~  239 (426)
T KOG0589|consen  162 LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFK-ASNMSELILKINRGL-YSPLPSMYSSELRSLVK  239 (426)
T ss_pred             hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccC-ccchHHHHHHHhhcc-CCCCCccccHHHHHHHH
Confidence             446779999999999999999999999999999999999999994 445555555555444 67789999999999999


Q ss_pred             HhcccCccccCCHHHHhcCccccccc
Q 015500          231 NCLRRDPKERWAASQLLKHPFLEEFC  256 (405)
Q Consensus       231 ~~L~~dP~~Rpt~~elL~hp~~~~~~  256 (405)
                      .||+.+|..||++.+||.+|.+....
T Consensus       240 ~~l~~~P~~RPsa~~LL~~P~l~~~~  265 (426)
T KOG0589|consen  240 SMLRKNPEHRPSALELLRRPHLLRYL  265 (426)
T ss_pred             HHhhcCCccCCCHHHHhhChhhhhHH
Confidence            99999999999999999999988654

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.1e-45  Score=361.03  Aligned_cols=242  Identities=31%  Similarity=0.471  Sum_probs=205.3

Q ss_pred             cccceeCCeeEEEEEEcCCCCEEEEEEccCC------ChHHHHHHHHHHHhC-CCCCeeeeeeeeeecCCCceEEEEEEe
Q 015500            7 HTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSL-NSPHIVGYKGCDVTSEDNKLMYNLFME   79 (405)
Q Consensus         7 ~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~------~~~~l~~E~~iL~~L-~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (405)
                      +.||+|+||+||+|.++.+++.||+|.+...      .......|..+++.+ +||||+++++++....    .+++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~----~~~lv~e   76 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKE----NLFFVME   76 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCC----EEEEEEe
Confidence            4799999999999999999999999987642      234566778888764 9999999998876543    3679999


Q ss_pred             ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccc----cccc
Q 015500           80 YAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWES----EALQ  154 (405)
Q Consensus        80 y~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~----~~~~  154 (405)
                      |++||+|.+++... .++++..+..++.||+.||.|||++||+||||||+|||++.++ +||+|||+++...    ....
T Consensus        77 y~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (316)
T cd05619          77 YLNGGDLMFHIQSC-HKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT  155 (316)
T ss_pred             CCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceee
Confidence            99999999999875 4799999999999999999999999999999999999999887 9999999987421    1234


Q ss_pred             CCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHhcc
Q 015500          155 SGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLR  234 (405)
Q Consensus       155 ~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~L~  234 (405)
                      ..||+.|+|||++.+..++.++|||||||++|+|++|+.||... +.......+...  .+.+|..++.++++||.+||+
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~-~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~l~  232 (316)
T cd05619         156 FCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGH-DEEELFQSIRMD--NPCYPRWLTREAKDILVKLFV  232 (316)
T ss_pred             ecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhC--CCCCCccCCHHHHHHHHHHhc
Confidence            56999999999999989999999999999999999999999643 344444444332  345677899999999999999


Q ss_pred             cCccccCCHH-HHhcCccccccc
Q 015500          235 RDPKERWAAS-QLLKHPFLEEFC  256 (405)
Q Consensus       235 ~dP~~Rpt~~-elL~hp~~~~~~  256 (405)
                      .||.+||++. ++++||||+...
T Consensus       233 ~~P~~R~~~~~~l~~h~~~~~~~  255 (316)
T cd05619         233 REPERRLGVKGDIRQHPFFREID  255 (316)
T ss_pred             cCHhhcCCChHHHHcCcccCCCC
Confidence            9999999996 899999998754

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=7.2e-46  Score=364.41  Aligned_cols=243  Identities=30%  Similarity=0.544  Sum_probs=204.5

Q ss_pred             cccceeCCeeEEEEEEcCCCCEEEEEEccCC------ChHHHHHHHHHHHhC-CCCCeeeeeeeeeecCCCceEEEEEEe
Q 015500            7 HTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSL-NSPHIVGYKGCDVTSEDNKLMYNLFME   79 (405)
Q Consensus         7 ~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~------~~~~l~~E~~iL~~L-~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (405)
                      +.||+|+||+||+|.++.+++.+|+|.+...      ....+.+|+.++.++ +||||+++++++....    .+++|||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~----~~~lv~E   76 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES----RLFFVIE   76 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCC----EEEEEEe
Confidence            5799999999999999999999999988643      224577899988877 8999999999876543    3679999


Q ss_pred             ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc----ccc
Q 015500           80 YAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE----ALQ  154 (405)
Q Consensus        80 y~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~----~~~  154 (405)
                      |+++|+|.+++.+. +++++..++.++.||+.||.|||++||+||||||+|||++.++ +||+|||+++....    ...
T Consensus        77 ~~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~  155 (329)
T cd05618          77 YVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST  155 (329)
T ss_pred             CCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCcccc
Confidence            99999999988765 4899999999999999999999999999999999999999888 99999999875321    234


Q ss_pred             CCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-------ChHHHHHHHHhcCCCCCCchhccHHHHH
Q 015500          155 SGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAA-------DPMTVLYKIAYSRELPEVPAFLSKQAND  227 (405)
Q Consensus       155 ~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~-------~~~~~l~~i~~~~~~~~~p~~~s~~l~d  227 (405)
                      ..||+.|+|||++.+..++.++|||||||++|+|++|+.||....       .....+.+.... ....+|..++..+.+
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~-~~~~~p~~~~~~~~~  234 (329)
T cd05618         156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE-KQIRIPRSLSVKAAS  234 (329)
T ss_pred             ccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc-CCCCCCCCCCHHHHH
Confidence            569999999999999999999999999999999999999995211       112223333322 334577789999999


Q ss_pred             HHHHhcccCccccCC------HHHHhcCcccccc
Q 015500          228 FLSNCLRRDPKERWA------ASQLLKHPFLEEF  255 (405)
Q Consensus       228 ll~~~L~~dP~~Rpt------~~elL~hp~~~~~  255 (405)
                      +|++||+.||++|||      ++++++||||...
T Consensus       235 ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~  268 (329)
T cd05618         235 VLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV  268 (329)
T ss_pred             HHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence            999999999999998      5799999999865

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=8.4e-46  Score=362.74  Aligned_cols=242  Identities=28%  Similarity=0.465  Sum_probs=204.9

Q ss_pred             ccccceeCCeeEEEEEEc---CCCCEEEEEEccCC-------ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEE
Q 015500            6 GHTIGQGSSATVSLATSL---RSGDVFAAKSTELP-------KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         6 ~~~LG~G~~g~Vyla~~~---~~~~~vavK~~~~~-------~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~   75 (405)
                      .+.||+|+||+||+|++.   .+++.+|+|.+...       ....+.+|+.+|+.++||||+++++.+....    .++
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~----~~~   76 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGG----KLY   76 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCC----eEE
Confidence            368999999999999864   47899999987632       2245678999999999999999998775433    367


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc---
Q 015500           76 LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE---  151 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~---  151 (405)
                      ++|||++|++|.+++.+. +.+++..+..++.||+.||+|||++||+||||||+|||++.++ +||+|||+++....   
T Consensus        77 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  155 (323)
T cd05584          77 LILEYLSGGELFMHLERE-GIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT  155 (323)
T ss_pred             EEEeCCCCchHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence            999999999999999876 4789999999999999999999999999999999999999887 99999999874322   


Q ss_pred             -cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHH
Q 015500          152 -ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLS  230 (405)
Q Consensus       152 -~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~  230 (405)
                       .....||+.|+|||++.+..++.++|||||||++|||++|+.||.... .......+..  ....+|..+++++.+||+
T Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~-~~~~~~~~~~--~~~~~~~~~~~~~~~li~  232 (323)
T cd05584         156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN-RKKTIDKILK--GKLNLPPYLTPEARDLLK  232 (323)
T ss_pred             cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC-HHHHHHHHHc--CCCCCCCCCCHHHHHHHH
Confidence             233569999999999999889999999999999999999999996543 3333444332  234567788999999999


Q ss_pred             HhcccCccccC-----CHHHHhcCcccccc
Q 015500          231 NCLRRDPKERW-----AASQLLKHPFLEEF  255 (405)
Q Consensus       231 ~~L~~dP~~Rp-----t~~elL~hp~~~~~  255 (405)
                      +||++||.+||     +++++++||||...
T Consensus       233 ~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~  262 (323)
T cd05584         233 KLLKRNPSSRLGAGPGDAAEVQSHPFFRHV  262 (323)
T ss_pred             HHcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence            99999999999     89999999999764

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.3e-45  Score=360.55  Aligned_cols=241  Identities=32%  Similarity=0.518  Sum_probs=203.3

Q ss_pred             cccceeCCeeEEEEEEcCCCCEEEEEEccCC------ChHHHHHHHHHHHhC-CCCCeeeeeeeeeecCCCceEEEEEEe
Q 015500            7 HTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSL-NSPHIVGYKGCDVTSEDNKLMYNLFME   79 (405)
Q Consensus         7 ~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~------~~~~l~~E~~iL~~L-~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (405)
                      +.||+|+||+||+|.+..+++.||+|.+...      ..+....|..++..+ +||||+++++.+....    .+++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~----~~~lv~e   76 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKE----HLFFVME   76 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCC----EEEEEEc
Confidence            4799999999999999999999999987642      233455677777654 8999999998765433    3679999


Q ss_pred             ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc----ccc
Q 015500           80 YAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE----ALQ  154 (405)
Q Consensus        80 y~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~----~~~  154 (405)
                      |++||+|.+++... +++++..+..++.||+.||.|||++||+||||||+|||++.++ +||+|||+++....    ...
T Consensus        77 ~~~gg~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~  155 (316)
T cd05592          77 YLNGGDLMFHIQSS-GRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST  155 (316)
T ss_pred             CCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCcccc
Confidence            99999999999876 4899999999999999999999999999999999999999887 99999999875322    234


Q ss_pred             CCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHhcc
Q 015500          155 SGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLR  234 (405)
Q Consensus       155 ~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~L~  234 (405)
                      ..||+.|+|||++.+..++.++|||||||++|+|++|+.||... +.......+.  ...+.+|..+++++.+||.+||+
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~-~~~~~~~~i~--~~~~~~~~~~~~~~~~ll~~~l~  232 (316)
T cd05592         156 FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGE-DEDELFDSIL--NDRPHFPRWISKEAKDCLSKLFE  232 (316)
T ss_pred             ccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCC-CHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHHcc
Confidence            56999999999999999999999999999999999999999644 3333333333  34556778899999999999999


Q ss_pred             cCccccCCH-HHHhcCcccccc
Q 015500          235 RDPKERWAA-SQLLKHPFLEEF  255 (405)
Q Consensus       235 ~dP~~Rpt~-~elL~hp~~~~~  255 (405)
                      .||.+||++ .++++||||...
T Consensus       233 ~~P~~R~~~~~~l~~h~~~~~~  254 (316)
T cd05592         233 RDPTKRLGVDGDIRQHPFFRGI  254 (316)
T ss_pred             CCHHHcCCChHHHHcCcccCCC
Confidence            999999986 588999999865

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-45  Score=346.16  Aligned_cols=245  Identities=40%  Similarity=0.716  Sum_probs=212.8

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC--------ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP--------KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLM   73 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~--------~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~   73 (405)
                      +|..++.||+|++|.||.|.+..+++.+|+|.+...        ....+.+|++++++++||||+++++++...+    .
T Consensus         3 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~   78 (263)
T cd06625           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDE----T   78 (263)
T ss_pred             cccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCC----e
Confidence            689999999999999999999999999999987542        1246788999999999999999999876543    4


Q ss_pred             EEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc
Q 015500           74 YNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA  152 (405)
Q Consensus        74 ~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~  152 (405)
                      .++++||++|++|.+++... +.+++..++.++.|++.||.|||+.|++||||||+||+++.++ ++|+|||+++.....
T Consensus        79 ~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~  157 (263)
T cd06625          79 LSIFMEYMPGGSVKDQLKAY-GALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI  157 (263)
T ss_pred             EEEEEEECCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence            67999999999999999876 4799999999999999999999999999999999999999877 999999998754321


Q ss_pred             -------ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHH
Q 015500          153 -------LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQA  225 (405)
Q Consensus       153 -------~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l  225 (405)
                             ....|++.|+|||++.+..++.++|||||||++|+|++|+.||.... ......+.......+.+|..++..+
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  236 (263)
T cd06625         158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFE-AMAAIFKIATQPTNPQLPSHVSPDA  236 (263)
T ss_pred             ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccc-hHHHHHHHhccCCCCCCCccCCHHH
Confidence                   23457889999999999889999999999999999999999996543 3444445554555567788899999


Q ss_pred             HHHHHHhcccCccccCCHHHHhcCccc
Q 015500          226 NDFLSNCLRRDPKERWAASQLLKHPFL  252 (405)
Q Consensus       226 ~dll~~~L~~dP~~Rpt~~elL~hp~~  252 (405)
                      .++|++||..+|.+|||+.++++||||
T Consensus       237 ~~li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         237 RNFLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             HHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence            999999999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=7e-46  Score=370.57  Aligned_cols=247  Identities=28%  Similarity=0.433  Sum_probs=206.5

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC------ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~------~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~   75 (405)
                      +|++.+.||+|+||+||+|.++.+++.+|+|.+...      ....+.+|+.+++.++||||+++++++....    .++
T Consensus        44 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~----~~~  119 (370)
T cd05621          44 DYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK----YLY  119 (370)
T ss_pred             HCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC----EEE
Confidence            588999999999999999999999999999987531      2346789999999999999999998765433    367


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc---
Q 015500           76 LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE---  151 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~---  151 (405)
                      +||||++||+|.+++...  .+++..++.++.||+.||+|||++||+||||||+|||++.++ +||+|||++.....   
T Consensus       120 lv~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~  197 (370)
T cd05621         120 MVMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM  197 (370)
T ss_pred             EEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCc
Confidence            999999999999999754  689999999999999999999999999999999999999887 99999999976432   


Q ss_pred             --cccCCCCCCccChhhhcCC----CCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCch--hccH
Q 015500          152 --ALQSGGTPMFMAPEVARGE----HQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPA--FLSK  223 (405)
Q Consensus       152 --~~~~~gt~~Y~APE~l~~~----~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~--~~s~  223 (405)
                        .....||+.|+|||++.+.    .++.++|||||||++|+|++|+.||... +......++........+|.  .+++
T Consensus       198 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~-~~~~~~~~i~~~~~~~~~p~~~~~s~  276 (370)
T cd05621         198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYAD-SLVGTYSKIMDHKNSLNFPEDVEISK  276 (370)
T ss_pred             eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCC-CHHHHHHHHHhCCcccCCCCcccCCH
Confidence              1245699999999999764    3778999999999999999999999644 33444444444333333443  4699


Q ss_pred             HHHHHHHHhcccCccc--cCCHHHHhcCcccccc
Q 015500          224 QANDFLSNCLRRDPKE--RWAASQLLKHPFLEEF  255 (405)
Q Consensus       224 ~l~dll~~~L~~dP~~--Rpt~~elL~hp~~~~~  255 (405)
                      .+++++.+||+.+|.+  |+|+.++++||||+..
T Consensus       277 ~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~  310 (370)
T cd05621         277 HAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND  310 (370)
T ss_pred             HHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence            9999999999866544  8999999999999863

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.3e-45  Score=361.22  Aligned_cols=247  Identities=28%  Similarity=0.426  Sum_probs=209.1

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC------hHHHHHHHHHHHhC-CCCCeeeeeeeeeecCCCceEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK------SEFLQREQKFLSSL-NSPHIVGYKGCDVTSEDNKLMY   74 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~------~~~l~~E~~iL~~L-~hpnIv~~~~~~~~~~~~~~~~   74 (405)
                      +|.+.+.||+|+||+||+|.++.+++.+|+|.+....      ......|..++..+ .||+|+.+.+++...+    .+
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~----~~   76 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMD----RL   76 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCC----EE
Confidence            6899999999999999999999999999999876431      23456788888877 5789998888765443    36


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc--
Q 015500           75 NLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE--  151 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~--  151 (405)
                      ++||||++||+|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||++.++ +||+|||+++....  
T Consensus        77 ~lv~E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~  155 (323)
T cd05616          77 YFVMEYVNGGDLMYQIQQV-GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG  155 (323)
T ss_pred             EEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence            7999999999999998776 4799999999999999999999999999999999999999988 99999999875321  


Q ss_pred             --cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHH
Q 015500          152 --ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFL  229 (405)
Q Consensus       152 --~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll  229 (405)
                        .....||+.|+|||++.+..++.++|||||||++|||+||+.||... +.......+...  ...+|..+++++.+++
T Consensus       156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~-~~~~~~~~i~~~--~~~~p~~~s~~~~~li  232 (323)
T cd05616         156 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE-DEDELFQSIMEH--NVAYPKSMSKEAVAIC  232 (323)
T ss_pred             CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCC-CHHHHHHHHHhC--CCCCCCcCCHHHHHHH
Confidence              23456999999999999999999999999999999999999999643 334444444332  2356778999999999


Q ss_pred             HHhcccCccccCCH-----HHHhcCccccccc
Q 015500          230 SNCLRRDPKERWAA-----SQLLKHPFLEEFC  256 (405)
Q Consensus       230 ~~~L~~dP~~Rpt~-----~elL~hp~~~~~~  256 (405)
                      ++||+.||.+|+++     .++++||||+...
T Consensus       233 ~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~  264 (323)
T cd05616         233 KGLMTKHPGKRLGCGPEGERDIKEHAFFRYID  264 (323)
T ss_pred             HHHcccCHHhcCCCCCCCHHHHhcCCCcCCCC
Confidence            99999999999984     8999999998653

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=3.1e-45  Score=360.45  Aligned_cols=249  Identities=30%  Similarity=0.527  Sum_probs=207.3

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLF   77 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv   77 (405)
                      +|++.+.||+|+||.||+|.++.++..+|+|.+....    ...+.+|+++|+.++||||+++++++....    .+++|
T Consensus         6 ~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~lv   81 (333)
T cd06650           6 DFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG----EISIC   81 (333)
T ss_pred             hhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECC----EEEEE
Confidence            6899999999999999999999999999999876542    246889999999999999999999876643    36799


Q ss_pred             EeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCCCCEEEccCC-ceEeeecccccccc--cc
Q 015500           78 MEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN-RVVHCDIKSRNILMAESG-AKIADFGCAKWESE--AL  153 (405)
Q Consensus        78 ~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~-givHrDlkp~NILi~~~~-vkL~DFGla~~~~~--~~  153 (405)
                      |||++|++|.+++.+. +.+++..+..++.||+.||.|||+. +++||||||+|||++.++ +||+|||++.....  ..
T Consensus        82 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~  160 (333)
T cd06650          82 MEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN  160 (333)
T ss_pred             EecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhccc
Confidence            9999999999999876 4799999999999999999999985 799999999999999887 99999999875433  23


Q ss_pred             cCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHH-----------------------------
Q 015500          154 QSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTV-----------------------------  204 (405)
Q Consensus       154 ~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~-----------------------------  204 (405)
                      ...||+.|+|||++.+..++.++|+|||||++|+|++|+.||.........                             
T Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (333)
T cd06650         161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSS  240 (333)
T ss_pred             cCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhh
Confidence            456899999999999988999999999999999999999999643221110                             


Q ss_pred             -------------HHHHHhcCCCCCCch-hccHHHHHHHHHhcccCccccCCHHHHhcCcccccc
Q 015500          205 -------------LYKIAYSRELPEVPA-FLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       205 -------------l~~i~~~~~~~~~p~-~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                                   +.........+..+. .++.++++||.+||+.||++|||+.|+++||||+..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~  305 (333)
T cd06650         241 YGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  305 (333)
T ss_pred             hcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence                         001111112222222 367889999999999999999999999999999854

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.7e-46  Score=359.11  Aligned_cols=243  Identities=30%  Similarity=0.478  Sum_probs=211.5

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCCh------HHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS------EFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~~------~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~   75 (405)
                      .|.+.+.||+|.||+|.+|+....|+.||||.+.++..      -.++||++||+.|+||||+.++.+|...+.    ..
T Consensus        54 RyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdK----Iv  129 (668)
T KOG0611|consen   54 RYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDK----IV  129 (668)
T ss_pred             HHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCce----EE
Confidence            48889999999999999999999999999999876532      368899999999999999999988754433    45


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc---
Q 015500           76 LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE---  151 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~---  151 (405)
                      +||||..+|.|.|+|.+++ .|+|..++.+++||+.|+.|||.++++|||||.+|||+|.++ +||+|||++.....   
T Consensus       130 ivMEYaS~GeLYDYiSer~-~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kf  208 (668)
T KOG0611|consen  130 IVMEYASGGELYDYISERG-SLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKF  208 (668)
T ss_pred             EEEEecCCccHHHHHHHhc-cccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccccH
Confidence            8999999999999999985 899999999999999999999999999999999999999987 99999999976544   


Q ss_pred             cccCCCCCCccChhhhcCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHH
Q 015500          152 ALQSGGTPMFMAPEVARGEHQ-GFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLS  230 (405)
Q Consensus       152 ~~~~~gt~~Y~APE~l~~~~~-~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~  230 (405)
                      .++.||+|.|.+||++.|..| ++.+|-||||++||-|+.|..||. ..+....+.+|..+. +.+  +.-+.++.-||+
T Consensus       209 LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFD-G~Dhk~lvrQIs~Ga-YrE--P~~PSdA~gLIR  284 (668)
T KOG0611|consen  209 LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFD-GRDHKRLVRQISRGA-YRE--PETPSDASGLIR  284 (668)
T ss_pred             HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccC-CchHHHHHHHhhccc-ccC--CCCCchHHHHHH
Confidence            568999999999999999776 789999999999999999999995 445455555554443 222  124668889999


Q ss_pred             HhcccCccccCCHHHHhcCcccc
Q 015500          231 NCLRRDPKERWAASQLLKHPFLE  253 (405)
Q Consensus       231 ~~L~~dP~~Rpt~~elL~hp~~~  253 (405)
                      .||..||++|.|++++..|=|++
T Consensus       285 wmLmVNP~RRATieDiAsHWWvN  307 (668)
T KOG0611|consen  285 WMLMVNPERRATIEDIASHWWVN  307 (668)
T ss_pred             HHHhcCcccchhHHHHhhhheee
Confidence            99999999999999999998886

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=2.7e-45  Score=356.20  Aligned_cols=250  Identities=28%  Similarity=0.417  Sum_probs=205.3

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLF   77 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv   77 (405)
                      +|...+.||+|+||+||+|+++.+++.+|+|.+....    ...+.+|++++++++||||+++++++....    .+++|
T Consensus         7 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~lv   82 (309)
T cd07872           7 TYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDK----SLTLV   82 (309)
T ss_pred             ceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCC----eEEEE
Confidence            5899999999999999999999999999999876432    346778999999999999999999876543    36799


Q ss_pred             EeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc----c
Q 015500           78 MEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE----A  152 (405)
Q Consensus        78 ~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~----~  152 (405)
                      |||+++ +|.+++...+..+++..++.++.||+.||+|||++||+||||||+||+++.++ +||+|||+++....    .
T Consensus        83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  161 (309)
T cd07872          83 FEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTY  161 (309)
T ss_pred             EeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcccc
Confidence            999975 89888887766789999999999999999999999999999999999999887 99999999875332    2


Q ss_pred             ccCCCCCCccChhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhc--------------------
Q 015500          153 LQSGGTPMFMAPEVARG-EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYS--------------------  211 (405)
Q Consensus       153 ~~~~gt~~Y~APE~l~~-~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~--------------------  211 (405)
                      ....+|+.|+|||++.+ ..++.++|||||||++|+|+||++||...... ..+..+...                    
T Consensus       162 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (309)
T cd07872         162 SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVE-DELHLIFRLLGTPTEETWPGISSNDEFKN  240 (309)
T ss_pred             ccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCHHHHhhhcchhhhhh
Confidence            23458999999999876 45889999999999999999999999654332 221111100                    


Q ss_pred             CCCCC--------CchhccHHHHHHHHHhcccCccccCCHHHHhcCcccccccc
Q 015500          212 RELPE--------VPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCS  257 (405)
Q Consensus       212 ~~~~~--------~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~~  257 (405)
                      ...+.        ....+++++++||.+||+.||.+|||+.|+|+||||+....
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~  294 (309)
T cd07872         241 YNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGT  294 (309)
T ss_pred             hhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhccc
Confidence            00011        11236889999999999999999999999999999987643

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=2.2e-45  Score=352.69  Aligned_cols=249  Identities=30%  Similarity=0.413  Sum_probs=199.9

Q ss_pred             CcccccccceeCCeeEEEEEEcC-CCCEEEEEEccCC-----ChHHHHHHHHHHHhC---CCCCeeeeeeeeeecC-CCc
Q 015500            2 DWTRGHTIGQGSSATVSLATSLR-SGDVFAAKSTELP-----KSEFLQREQKFLSSL---NSPHIVGYKGCDVTSE-DNK   71 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~-~~~~vavK~~~~~-----~~~~l~~E~~iL~~L---~hpnIv~~~~~~~~~~-~~~   71 (405)
                      +|++.+.||+|+||+||+|.+.. +++.+|+|.+...     ......+|+.+++.+   +||||+++++++.... ...
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~   81 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   81 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence            68999999999999999999865 4688999987642     223566788877766   6999999998775322 122


Q ss_pred             eEEEEEEeecCCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccc
Q 015500           72 LMYNLFMEYAPGGTLNDEIHRN-GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWE  149 (405)
Q Consensus        72 ~~~~lv~Ey~~ggsL~~~i~~~-~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~  149 (405)
                      ..++++|||++ ++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++ +||+|||+++..
T Consensus        82 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  160 (290)
T cd07862          82 TKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY  160 (290)
T ss_pred             CcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEec
Confidence            34679999996 5999998764 23589999999999999999999999999999999999999887 999999999754


Q ss_pred             cc---cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCC-----------
Q 015500          150 SE---ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELP-----------  215 (405)
Q Consensus       150 ~~---~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~-----------  215 (405)
                      ..   .....||+.|+|||++.+..++.++|||||||++|||++|++||....+ ...+..+......|           
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~  239 (290)
T cd07862         161 SFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD-VDQLGKILDVIGLPGEEDWPRDVAL  239 (290)
T ss_pred             cCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCH-HHHHHHHHHHhCCCChhhchhhhcc
Confidence            33   2234589999999999988899999999999999999999999965443 33333332111100           


Q ss_pred             --------------CCchhccHHHHHHHHHhcccCccccCCHHHHhcCccc
Q 015500          216 --------------EVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFL  252 (405)
Q Consensus       216 --------------~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~  252 (405)
                                    .+...+++.+++|+.+||+.||++|||+.++|+||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         240 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             cchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence                          1112467889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-45  Score=352.99  Aligned_cols=249  Identities=28%  Similarity=0.431  Sum_probs=209.7

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC------hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK------SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~------~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~   75 (405)
                      +|++.+.||+|+||+||+|.+..+++.||+|.+....      ...+.+|+.+++.++||||+++++.+....    .++
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~   76 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKD----ALC   76 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCC----eEE
Confidence            5889999999999999999999999999999886432      235678999999999999999988765443    367


Q ss_pred             EEEeecCCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc-
Q 015500           76 LFMEYAPGGTLNDEIHRN-GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA-  152 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~-~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~-  152 (405)
                      ++|||++||+|.+++... ...+++..+..++.|++.||.|||+.|++||||||+||+++.++ ++|+|||++...... 
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05605          77 LVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE  156 (285)
T ss_pred             EEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence            999999999999988664 34699999999999999999999999999999999999999887 999999998764332 


Q ss_pred             --ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChH--HHHHHHHhcCCCCCCchhccHHHHHH
Q 015500          153 --LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPM--TVLYKIAYSRELPEVPAFLSKQANDF  228 (405)
Q Consensus       153 --~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~--~~l~~i~~~~~~~~~p~~~s~~l~dl  228 (405)
                        ....||+.|+|||++.+..++.++||||+||++|+|++|+.||.......  ..+... .....+..+..+++.+.+|
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l  235 (285)
T cd05605         157 TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERR-VKEDQEEYSEKFSEAARSI  235 (285)
T ss_pred             ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHH-hhhcccccCcccCHHHHHH
Confidence              23468999999999998889999999999999999999999996543321  111111 1223345566789999999


Q ss_pred             HHHhcccCccccC-----CHHHHhcCcccccc
Q 015500          229 LSNCLRRDPKERW-----AASQLLKHPFLEEF  255 (405)
Q Consensus       229 l~~~L~~dP~~Rp-----t~~elL~hp~~~~~  255 (405)
                      +.+||..||++||     +++++++||||...
T Consensus       236 i~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~  267 (285)
T cd05605         236 CRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTA  267 (285)
T ss_pred             HHHHccCCHHHhcCCCCCCHHHHhcCcCccCC
Confidence            9999999999999     89999999999874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.1e-45  Score=366.22  Aligned_cols=245  Identities=32%  Similarity=0.547  Sum_probs=202.7

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLF   77 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv   77 (405)
                      +|..++.||+|+||+||+|++..+++.||||.+....    ...+.+|+++|+.++||||+++++++....    .+++|
T Consensus        75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~lv  150 (353)
T PLN00034         75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNG----EIQVL  150 (353)
T ss_pred             HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCC----eEEEE
Confidence            4778899999999999999999999999999986432    346889999999999999999998765433    36699


Q ss_pred             EeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc----
Q 015500           78 MEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA----  152 (405)
Q Consensus        78 ~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~----  152 (405)
                      |||+++++|.+.     ...++..+..++.||+.||+|||++||+||||||+|||++.++ +||+|||+++.....    
T Consensus       151 ~e~~~~~~L~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~  225 (353)
T PLN00034        151 LEFMDGGSLEGT-----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPC  225 (353)
T ss_pred             EecCCCCccccc-----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccccccc
Confidence            999999998752     2467888899999999999999999999999999999999887 999999998764432    


Q ss_pred             ccCCCCCCccChhhhcC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-hHHHHHHHHhcCCCCCCchhccHHHH
Q 015500          153 LQSGGTPMFMAPEVARG-----EHQGFASDIWAVGCTVIEMASGGAPWPNAAD-PMTVLYKIAYSRELPEVPAFLSKQAN  226 (405)
Q Consensus       153 ~~~~gt~~Y~APE~l~~-----~~~~~~sDIwSLG~il~elltG~~Pf~~~~~-~~~~l~~i~~~~~~~~~p~~~s~~l~  226 (405)
                      ....||+.|+|||++..     ...+.++|||||||++|||++|+.||..... ....+.........+..+..++.+++
T Consensus       226 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  305 (353)
T PLN00034        226 NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREFR  305 (353)
T ss_pred             cccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHHH
Confidence            34569999999998843     3456789999999999999999999963322 12222222223344556677899999


Q ss_pred             HHHHHhcccCccccCCHHHHhcCcccccc
Q 015500          227 DFLSNCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       227 dll~~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      +||.+||+.||++|||+.|+|+||||...
T Consensus       306 ~li~~~l~~~P~~Rpt~~ell~hp~~~~~  334 (353)
T PLN00034        306 HFISCCLQREPAKRWSAMQLLQHPFILRA  334 (353)
T ss_pred             HHHHHHccCChhhCcCHHHHhcCcccccC
Confidence            99999999999999999999999999875

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.9e-45  Score=370.10  Aligned_cols=245  Identities=22%  Similarity=0.301  Sum_probs=200.5

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEeec
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYA   81 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~Ey~   81 (405)
                      .|.+.+.||+|+||.||+|.+..+++.||+|...   ...+.+|+++|++|+||||+++++++....    ..++++|++
T Consensus        93 ~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~----~~~lv~e~~  165 (391)
T PHA03212         93 GFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ---RGGTATEAHILRAINHPSIIQLKGTFTYNK----FTCLILPRY  165 (391)
T ss_pred             CcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh---hhhhHHHHHHHHhCCCCCCCCEeEEEEECC----eeEEEEecC
Confidence            5899999999999999999999999999999754   345789999999999999999999876533    367999999


Q ss_pred             CCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc-----cccC
Q 015500           82 PGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE-----ALQS  155 (405)
Q Consensus        82 ~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~-----~~~~  155 (405)
                      . ++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ +||+|||+|+....     ....
T Consensus       166 ~-~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~~  243 (391)
T PHA03212        166 K-TDLYCYLAAK-RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGW  243 (391)
T ss_pred             C-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccccccccc
Confidence            5 6898888775 4799999999999999999999999999999999999999887 99999999965322     2234


Q ss_pred             CCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC------hHHHHHHHHhc------------------
Q 015500          156 GGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAAD------PMTVLYKIAYS------------------  211 (405)
Q Consensus       156 ~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~------~~~~l~~i~~~------------------  211 (405)
                      .||+.|+|||++.+..+++++|||||||++|||++|+.||.....      ....+..+...                  
T Consensus       244 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~  323 (391)
T PHA03212        244 AGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDE  323 (391)
T ss_pred             cCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHH
Confidence            699999999999999999999999999999999999988743211      11111111000                  


Q ss_pred             ----------CCCCCCc-----hhccHHHHHHHHHhcccCccccCCHHHHhcCcccccc
Q 015500          212 ----------RELPEVP-----AFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       212 ----------~~~~~~p-----~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                                ......|     ..++.++.+||.+||+.||.+|||+.|+|+||||..+
T Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~  382 (391)
T PHA03212        324 IYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDI  382 (391)
T ss_pred             HHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccC
Confidence                      0000011     1246789999999999999999999999999999865

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=2.4e-45  Score=358.73  Aligned_cols=241  Identities=31%  Similarity=0.512  Sum_probs=205.7

Q ss_pred             cccceeCCeeEEEEEEcCCCCEEEEEEccCC------ChHHHHHHHHHHHhC-CCCCeeeeeeeeeecCCCceEEEEEEe
Q 015500            7 HTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSL-NSPHIVGYKGCDVTSEDNKLMYNLFME   79 (405)
Q Consensus         7 ~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~------~~~~l~~E~~iL~~L-~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (405)
                      +.||+|+||+||+|.++.+++.||||.+...      ....+.+|..+++.+ +||||+++++++....    .+++|||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~----~~~lv~e   76 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKD----RLFFVME   76 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCC----EEEEEEc
Confidence            4799999999999999999999999987642      234567899999888 7999999999876433    3679999


Q ss_pred             ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc----ccc
Q 015500           80 YAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE----ALQ  154 (405)
Q Consensus        80 y~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~----~~~  154 (405)
                      |++||+|.+++.+. +.+++..+..++.||+.||.|||++||+||||||+||+++.++ +||+|||+++....    ...
T Consensus        77 ~~~~~~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (318)
T cd05570          77 YVNGGDLMFHIQRS-GRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTST  155 (318)
T ss_pred             CCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccc
Confidence            99999999998776 4899999999999999999999999999999999999999888 99999999864211    223


Q ss_pred             CCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHhcc
Q 015500          155 SGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLR  234 (405)
Q Consensus       155 ~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~L~  234 (405)
                      .+||+.|+|||++.+..++.++|||||||++|+|++|+.||... +.......+..  ..+.+|..+++++.+||++||+
T Consensus       156 ~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~-~~~~~~~~i~~--~~~~~~~~~~~~~~~li~~~l~  232 (318)
T cd05570         156 FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGD-DEDELFQSILE--DEVRYPRWLSKEAKSILKSFLT  232 (318)
T ss_pred             eecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCC-CHHHHHHHHHc--CCCCCCCcCCHHHHHHHHHHcc
Confidence            46899999999999999999999999999999999999999643 33333333322  2345677789999999999999


Q ss_pred             cCccccCCH-----HHHhcCcccccc
Q 015500          235 RDPKERWAA-----SQLLKHPFLEEF  255 (405)
Q Consensus       235 ~dP~~Rpt~-----~elL~hp~~~~~  255 (405)
                      .||++|||+     .++++||||...
T Consensus       233 ~dP~~R~s~~~~~~~~ll~~~~~~~~  258 (318)
T cd05570         233 KNPEKRLGCLPTGEQDIKGHPFFREI  258 (318)
T ss_pred             CCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence            999999999     999999999865

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=3.6e-45  Score=378.47  Aligned_cols=255  Identities=27%  Similarity=0.392  Sum_probs=215.5

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCC----Cce
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-----SEFLQREQKFLSSLNSPHIVGYKGCDVTSED----NKL   72 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~----~~~   72 (405)
                      +|.+.+.||+|+||+||+|.+..+++.||||.+....     ...+.+|+.+|..++|+||+++...+.....    ...
T Consensus        33 rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~  112 (496)
T PTZ00283         33 KYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVL  112 (496)
T ss_pred             CEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccce
Confidence            6899999999999999999999999999999986542     2467789999999999999998876654332    223


Q ss_pred             EEEEEEeecCCCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccc
Q 015500           73 MYNLFMEYAPGGTLNDEIHRN---GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKW  148 (405)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~i~~~---~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~  148 (405)
                      ++++||||+++|+|.+++..+   ...+++..+..++.||+.||.|||++||+||||||+|||++.++ +||+|||+++.
T Consensus       113 ~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGls~~  192 (496)
T PTZ00283        113 MIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKM  192 (496)
T ss_pred             EEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecccCee
Confidence            567999999999999998653   34689999999999999999999999999999999999999887 99999999875


Q ss_pred             ccc------cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhcc
Q 015500          149 ESE------ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLS  222 (405)
Q Consensus       149 ~~~------~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s  222 (405)
                      ...      .....||+.|+|||++.+..++.++|||||||++|||++|+.||... +....+.++. ....+.+|..++
T Consensus       193 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~-~~~~~~~~~~-~~~~~~~~~~~~  270 (496)
T PTZ00283        193 YAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE-NMEEVMHKTL-AGRYDPLPPSIS  270 (496)
T ss_pred             ccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC-CHHHHHHHHh-cCCCCCCCCCCC
Confidence            432      23456999999999999999999999999999999999999999643 3334443333 344455777899


Q ss_pred             HHHHHHHHHhcccCccccCCHHHHhcCccccccccc
Q 015500          223 KQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSC  258 (405)
Q Consensus       223 ~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~~~  258 (405)
                      +++.+++.+||..||.+||++.++++|||++.+...
T Consensus       271 ~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~~~~  306 (496)
T PTZ00283        271 PEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFISG  306 (496)
T ss_pred             HHHHHHHHHHcccChhhCcCHHHHHhCHHHHHhhhh
Confidence            999999999999999999999999999998875443

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=2.1e-45  Score=377.81  Aligned_cols=251  Identities=21%  Similarity=0.305  Sum_probs=198.6

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC--ChHHHHHHHHHHHhCCCC------CeeeeeeeeeecCCCceE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP--KSEFLQREQKFLSSLNSP------HIVGYKGCDVTSEDNKLM   73 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~--~~~~l~~E~~iL~~L~hp------nIv~~~~~~~~~~~~~~~   73 (405)
                      +|++.+.||+|+||+||+|.+..+++.||||++...  ......+|+++++.++|+      +++.++.++....   ..
T Consensus       130 ~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~---~~  206 (467)
T PTZ00284        130 RFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNET---GH  206 (467)
T ss_pred             cEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCC---ce
Confidence            488999999999999999999999999999998642  234567788888887654      4777776654322   24


Q ss_pred             EEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCCEEEccCC---------------
Q 015500           74 YNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHS-NRVVHCDIKSRNILMAESG---------------  137 (405)
Q Consensus        74 ~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~-~givHrDlkp~NILi~~~~---------------  137 (405)
                      +++|||++ |++|.+++.+. +.+++..++.|+.||+.||+|||+ .||+||||||+|||++.++               
T Consensus       207 ~~iv~~~~-g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~  284 (467)
T PTZ00284        207 MCIVMPKY-GPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDP  284 (467)
T ss_pred             EEEEEecc-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCC
Confidence            77999998 77999998876 489999999999999999999998 5999999999999997653               


Q ss_pred             --ceEeeecccccccc-cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhc-CC
Q 015500          138 --AKIADFGCAKWESE-ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYS-RE  213 (405)
Q Consensus       138 --vkL~DFGla~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~-~~  213 (405)
                        +||+|||.+..... .....||+.|+|||++.+..++.++|||||||++|||++|++||..... ...+..+... ..
T Consensus       285 ~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~-~~~~~~i~~~~g~  363 (467)
T PTZ00284        285 CRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDN-LEHLHLMEKTLGR  363 (467)
T ss_pred             ceEEECCCCccccCccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHcCC
Confidence              89999998764332 3456799999999999999999999999999999999999999965433 2222211110 00


Q ss_pred             CC------------------------C-Cc--------------hhccHHHHHHHHHhcccCccccCCHHHHhcCccccc
Q 015500          214 LP------------------------E-VP--------------AFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEE  254 (405)
Q Consensus       214 ~~------------------------~-~p--------------~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~  254 (405)
                      +|                        . .+              ...++.+.|||.+||++||.+|||++|+|+||||..
T Consensus       364 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~  443 (467)
T PTZ00284        364 LPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLK  443 (467)
T ss_pred             CCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCccccc
Confidence            00                        0 00              011456789999999999999999999999999998


Q ss_pred             cccc
Q 015500          255 FCSC  258 (405)
Q Consensus       255 ~~~~  258 (405)
                      +...
T Consensus       444 ~~~~  447 (467)
T PTZ00284        444 YYPE  447 (467)
T ss_pred             cCCc
Confidence            6543

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=2.5e-45  Score=360.12  Aligned_cols=244  Identities=30%  Similarity=0.543  Sum_probs=206.3

Q ss_pred             cccceeCCeeEEEEEEcCCCCEEEEEEccCC------ChHHHHHHHHHHHhC-CCCCeeeeeeeeeecCCCceEEEEEEe
Q 015500            7 HTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSL-NSPHIVGYKGCDVTSEDNKLMYNLFME   79 (405)
Q Consensus         7 ~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~------~~~~l~~E~~iL~~L-~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (405)
                      +.||+|+||+||+|.++.+++.+|+|++...      ..+.+.+|+.++.++ +||||+++++++....    .+++|||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~----~~~lv~e   76 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTS----RLFLVIE   76 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCC----EEEEEEe
Confidence            4799999999999999999999999998753      234577899999888 6999999998876543    3679999


Q ss_pred             ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccc----cccc
Q 015500           80 YAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWES----EALQ  154 (405)
Q Consensus        80 y~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~----~~~~  154 (405)
                      |++||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++ +||+|||+++...    ....
T Consensus        77 ~~~~~~L~~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (327)
T cd05617          77 YVNGGDLMFHMQRQ-RKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTST  155 (327)
T ss_pred             CCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceec
Confidence            99999999988765 4799999999999999999999999999999999999999887 9999999987522    1334


Q ss_pred             CCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-----ChHHHHHHHHhcCCCCCCchhccHHHHHHH
Q 015500          155 SGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAA-----DPMTVLYKIAYSRELPEVPAFLSKQANDFL  229 (405)
Q Consensus       155 ~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~-----~~~~~l~~i~~~~~~~~~p~~~s~~l~dll  229 (405)
                      .+||+.|+|||++.+..++.++|||||||++|+|++|+.||....     .....+.+..... ...+|..++..+.++|
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~p~~~~~~~~~li  234 (327)
T cd05617         156 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK-PIRIPRFLSVKASHVL  234 (327)
T ss_pred             ccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC-CCCCCCCCCHHHHHHH
Confidence            569999999999999999999999999999999999999995321     2233333433333 3357778999999999


Q ss_pred             HHhcccCccccCC------HHHHhcCccccccc
Q 015500          230 SNCLRRDPKERWA------ASQLLKHPFLEEFC  256 (405)
Q Consensus       230 ~~~L~~dP~~Rpt------~~elL~hp~~~~~~  256 (405)
                      ++||..||++|++      +.++++||||..+.
T Consensus       235 ~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~  267 (327)
T cd05617         235 KGFLNKDPKERLGCQPQTGFSDIKSHTFFRSID  267 (327)
T ss_pred             HHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCC
Confidence            9999999999998      57999999998754

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.4e-45  Score=361.09  Aligned_cols=241  Identities=27%  Similarity=0.437  Sum_probs=200.6

Q ss_pred             cccceeCCeeEEEEEEcCCCCEEEEEEccCCC------hHHHHHHHH-HHHhCCCCCeeeeeeeeeecCCCceEEEEEEe
Q 015500            7 HTIGQGSSATVSLATSLRSGDVFAAKSTELPK------SEFLQREQK-FLSSLNSPHIVGYKGCDVTSEDNKLMYNLFME   79 (405)
Q Consensus         7 ~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~------~~~l~~E~~-iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (405)
                      +.||+|+||+||+|+++.+|+.||+|.+....      ...+.+|.. +++.++||||+++++.+....    .+++|||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~----~~~lv~e   76 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTAD----KLYFVLD   76 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCC----EEEEEEc
Confidence            47999999999999999999999999986431      223444444 568899999999988765433    3679999


Q ss_pred             ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc----ccc
Q 015500           80 YAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE----ALQ  154 (405)
Q Consensus        80 y~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~----~~~  154 (405)
                      |++||+|.+++.+. +.+++..++.++.||+.||.|||++||+||||||+|||++.++ +||+|||+++....    ...
T Consensus        77 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (323)
T cd05575          77 YVNGGELFFHLQRE-RSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST  155 (323)
T ss_pred             CCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcccc
Confidence            99999999999775 4899999999999999999999999999999999999999887 99999999875322    233


Q ss_pred             CCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHhcc
Q 015500          155 SGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLR  234 (405)
Q Consensus       155 ~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~L~  234 (405)
                      ..||+.|+|||++.+..++.++|||||||++|+|++|+.||... +.......+. .. ...++..+++.+.++|++||+
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~-~~~~~~~~i~-~~-~~~~~~~~~~~~~~li~~~l~  232 (323)
T cd05575         156 FCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR-DTAEMYDNIL-NK-PLRLKPNISVSARHLLEGLLQ  232 (323)
T ss_pred             ccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCC-CHHHHHHHHH-cC-CCCCCCCCCHHHHHHHHHHhh
Confidence            46999999999999999999999999999999999999999643 3333333332 22 234556689999999999999


Q ss_pred             cCccccCCH----HHHhcCcccccc
Q 015500          235 RDPKERWAA----SQLLKHPFLEEF  255 (405)
Q Consensus       235 ~dP~~Rpt~----~elL~hp~~~~~  255 (405)
                      +||.+||++    .++++||||...
T Consensus       233 ~~p~~R~~~~~~~~~il~~~~~~~~  257 (323)
T cd05575         233 KDRTKRLGAKDDFLEIKNHVFFSSI  257 (323)
T ss_pred             cCHHhCCCCCCCHHHHHcCCCcCCC
Confidence            999999998    699999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=7e-45  Score=348.56  Aligned_cols=249  Identities=30%  Similarity=0.385  Sum_probs=201.5

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-----hHHHHHHHHHHHhC---CCCCeeeeeeeeeecC-CCce
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-----SEFLQREQKFLSSL---NSPHIVGYKGCDVTSE-DNKL   72 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-----~~~l~~E~~iL~~L---~hpnIv~~~~~~~~~~-~~~~   72 (405)
                      +|++.+.||+|+||+||+|.++.+++.+|+|.+....     .....+|+.+++.+   +||||+++++++.... ....
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            5899999999999999999999999999999876431     23566788877766   6999999998765432 2234


Q ss_pred             EEEEEEeecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccc
Q 015500           73 MYNLFMEYAPGGTLNDEIHRNG-GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWES  150 (405)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~i~~~~-~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~  150 (405)
                      .++++|||+++ +|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||+++.++ +||+|||+++...
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~  159 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYS  159 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCcccccc
Confidence            56799999975 8988887643 3589999999999999999999999999999999999999887 9999999997654


Q ss_pred             c---cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCC--------------
Q 015500          151 E---ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRE--------------  213 (405)
Q Consensus       151 ~---~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~--------------  213 (405)
                      .   .....||+.|+|||++.+..++.++|||||||++|+|++|++||..... ...+.++.....              
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T cd07863         160 CQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE-ADQLGKIFDLIGLPPEDDWPRDVTLP  238 (288)
T ss_pred             CcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCH-HHHHHHHHHHhCCCChhhCccccccc
Confidence            3   2234589999999999998899999999999999999999999965433 222222211100              


Q ss_pred             ---C--------CCCchhccHHHHHHHHHhcccCccccCCHHHHhcCccc
Q 015500          214 ---L--------PEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFL  252 (405)
Q Consensus       214 ---~--------~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~  252 (405)
                         .        ......+++.+.++|.+||+.||.+|||+.+++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         239 RGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             ccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence               0        01112467889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=6.6e-45  Score=356.55  Aligned_cols=247  Identities=28%  Similarity=0.430  Sum_probs=207.7

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC------ChHHHHHHHHHHHhCCC-CCeeeeeeeeeecCCCceEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSLNS-PHIVGYKGCDVTSEDNKLMY   74 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~------~~~~l~~E~~iL~~L~h-pnIv~~~~~~~~~~~~~~~~   74 (405)
                      +|...+.||+|+||+||+|.++.+|+.||+|.+...      ..+.+.+|..+++.+.| |+|+++.+++...+    .+
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~----~~   76 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVD----RL   76 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCC----EE
Confidence            578899999999999999999999999999987642      23456788899988865 67777877765433    36


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc--
Q 015500           75 NLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE--  151 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~--  151 (405)
                      ++||||++||+|.+++.+. +++++..++.++.||+.||.|||++||+||||||+|||++.++ +||+|||+++....  
T Consensus        77 ~lv~Ey~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~  155 (323)
T cd05615          77 YFVMEYVNGGDLMYHIQQV-GKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG  155 (323)
T ss_pred             EEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence            7999999999999999776 4799999999999999999999999999999999999999888 99999999875321  


Q ss_pred             --cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHH
Q 015500          152 --ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFL  229 (405)
Q Consensus       152 --~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll  229 (405)
                        .....||+.|+|||++.+..++.++|||||||++|+|++|+.||... ........+..  ....+|..+++++.+++
T Consensus       156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~-~~~~~~~~i~~--~~~~~p~~~~~~~~~li  232 (323)
T cd05615         156 VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGE-DEDELFQSIME--HNVSYPKSLSKEAVSIC  232 (323)
T ss_pred             ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCC-CHHHHHHHHHh--CCCCCCccCCHHHHHHH
Confidence              23456999999999999988999999999999999999999999644 33444444332  22356777899999999


Q ss_pred             HHhcccCccccCC-----HHHHhcCccccccc
Q 015500          230 SNCLRRDPKERWA-----ASQLLKHPFLEEFC  256 (405)
Q Consensus       230 ~~~L~~dP~~Rpt-----~~elL~hp~~~~~~  256 (405)
                      .+||+++|.+|++     ..++++||||..+.
T Consensus       233 ~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~  264 (323)
T cd05615         233 KGLMTKHPSKRLGCGPEGERDIREHAFFRRID  264 (323)
T ss_pred             HHHcccCHhhCCCCCCCCHHHHhcCcccCCCC
Confidence            9999999999997     47899999998753

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5e-45  Score=358.61  Aligned_cols=249  Identities=24%  Similarity=0.379  Sum_probs=205.8

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC------ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~------~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~   75 (405)
                      +|++++.||+|+||+||+|+++.+++.||+|.+...      ..+.+.+|+.+++.++||||+++++++....    .++
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~----~~~   77 (331)
T cd05597           2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDEN----NLY   77 (331)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCC----eEE
Confidence            689999999999999999999999999999998631      2345788999999999999999998776443    367


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc--
Q 015500           76 LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA--  152 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~--  152 (405)
                      +||||++||+|.+++.+.+..+++..++.++.||+.||+|||++||+||||||+|||++.++ +||+|||++......  
T Consensus        78 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  157 (331)
T cd05597          78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT  157 (331)
T ss_pred             EEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence            99999999999999987666899999999999999999999999999999999999998887 999999998754321  


Q ss_pred             ---ccCCCCCCccChhhhcC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcC---CCCCCchhc
Q 015500          153 ---LQSGGTPMFMAPEVARG-----EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSR---ELPEVPAFL  221 (405)
Q Consensus       153 ---~~~~gt~~Y~APE~l~~-----~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~---~~~~~p~~~  221 (405)
                         ....||+.|+|||++..     ..++.++|||||||++|+|++|+.||... .......++....   ..+.....+
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~  236 (331)
T cd05597         158 VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE-SLVETYGKIMNHKEHFQFPPDVTDV  236 (331)
T ss_pred             ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC-CHHHHHHHHHcCCCcccCCCccCCC
Confidence               12459999999999973     45788999999999999999999999643 3333333333222   223333457


Q ss_pred             cHHHHHHHHHhcccCccc--cCCHHHHhcCcccccc
Q 015500          222 SKQANDFLSNCLRRDPKE--RWAASQLLKHPFLEEF  255 (405)
Q Consensus       222 s~~l~dll~~~L~~dP~~--Rpt~~elL~hp~~~~~  255 (405)
                      ++++++||++||..++++  |+++.++++||||...
T Consensus       237 ~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~  272 (331)
T cd05597         237 SEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGI  272 (331)
T ss_pred             CHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence            999999999988764443  7899999999999764

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8e-46  Score=363.04  Aligned_cols=247  Identities=30%  Similarity=0.457  Sum_probs=217.0

Q ss_pred             cccccccceeCCeeEEEEEEcCCCCEEEEEEccCCCh-----HHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEE
Q 015500            3 WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS-----EFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLF   77 (405)
Q Consensus         3 y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~~-----~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv   77 (405)
                      |...+.||+|-|+.|-+|+|--||+.||||++++.+.     ..+.+|++.|+.++|||||++|.+.-+...    +|||
T Consensus        20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTK----lyLi   95 (864)
T KOG4717|consen   20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTK----LYLI   95 (864)
T ss_pred             ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccce----EEEE
Confidence            7788999999999999999999999999999987653     478899999999999999999986533322    5699


Q ss_pred             EeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccC-C-ceEeeecccccccc---c
Q 015500           78 MEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES-G-AKIADFGCAKWESE---A  152 (405)
Q Consensus        78 ~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~-~-vkL~DFGla~~~~~---~  152 (405)
                      +|.-.+|+|.|+|-++...+.|..+++|++||+.|+.|||+..+|||||||+||++.+. | +||+|||++..+..   .
T Consensus        96 LELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL  175 (864)
T KOG4717|consen   96 LELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKL  175 (864)
T ss_pred             EEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcchh
Confidence            99999999999999888889999999999999999999999999999999999988765 4 99999999976544   4


Q ss_pred             ccCCCCCCccChhhhcCCCCC-cchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHH
Q 015500          153 LQSGGTPMFMAPEVARGEHQG-FASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSN  231 (405)
Q Consensus       153 ~~~~gt~~Y~APE~l~~~~~~-~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~  231 (405)
                      .+.||+..|-|||++.|..|+ +++||||||+|||-|++|++||...++..... .|...+  -.+|..++.++++||..
T Consensus       176 ~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLT-mImDCK--YtvPshvS~eCrdLI~s  252 (864)
T KOG4717|consen  176 TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLT-MIMDCK--YTVPSHVSKECRDLIQS  252 (864)
T ss_pred             hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhh-hhhccc--ccCchhhhHHHHHHHHH
Confidence            578999999999999998775 68999999999999999999998776655443 333222  25788899999999999


Q ss_pred             hcccCccccCCHHHHhcCccccccc
Q 015500          232 CLRRDPKERWAASQLLKHPFLEEFC  256 (405)
Q Consensus       232 ~L~~dP~~Rpt~~elL~hp~~~~~~  256 (405)
                      ||.+||++|.+.++|..|+|++...
T Consensus       253 MLvRdPkkRAslEeI~s~~Wlq~~D  277 (864)
T KOG4717|consen  253 MLVRDPKKRASLEEIVSTSWLQAGD  277 (864)
T ss_pred             HHhcCchhhccHHHHhccccccCCC
Confidence            9999999999999999999998754

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.2e-44  Score=346.54  Aligned_cols=243  Identities=26%  Similarity=0.429  Sum_probs=200.4

Q ss_pred             cceeCCeeEEEEEEcCCCCEEEEEEccCC------ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEeecC
Q 015500            9 IGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAP   82 (405)
Q Consensus         9 LG~G~~g~Vyla~~~~~~~~vavK~~~~~------~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~Ey~~   82 (405)
                      ||+|+||+||++.++.+|+.+|+|.+...      ....+..|+++|++++||||+++.+.+....    .++++|||++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~----~~~lv~e~~~   76 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKT----HLCLVMSLMN   76 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCC----eEEEEEecCC
Confidence            79999999999999999999999987632      1234567999999999999999988765432    3679999999


Q ss_pred             CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc---ccCCC
Q 015500           83 GGTLNDEIHRNG-GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA---LQSGG  157 (405)
Q Consensus        83 ggsL~~~i~~~~-~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~---~~~~g  157 (405)
                      |++|.+++...+ ..+++..+..++.||+.||+|||+.||+||||||+||+++.++ ++|+|||++......   ....|
T Consensus        77 g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~  156 (277)
T cd05607          77 GGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAG  156 (277)
T ss_pred             CCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCC
Confidence            999999886543 3589999999999999999999999999999999999999887 999999998764432   23468


Q ss_pred             CCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCh--HHHHHHHHhcCCCCCCchhccHHHHHHHHHhccc
Q 015500          158 TPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADP--MTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRR  235 (405)
Q Consensus       158 t~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~--~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~L~~  235 (405)
                      |+.|+|||++.+..++.++|||||||++|+|++|+.||......  .....+.......+.....+++++.+|+++||+.
T Consensus       157 ~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  236 (277)
T cd05607         157 TNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAK  236 (277)
T ss_pred             CCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhcc
Confidence            99999999999888999999999999999999999999654321  1222222222222222346899999999999999


Q ss_pred             CccccCCH----HHHhcCcccccc
Q 015500          236 DPKERWAA----SQLLKHPFLEEF  255 (405)
Q Consensus       236 dP~~Rpt~----~elL~hp~~~~~  255 (405)
                      ||.+||++    ++++.||||+.+
T Consensus       237 ~P~~R~~~~~~~~~~~~h~~f~~~  260 (277)
T cd05607         237 KPEDRLGSREKNDDPRKHEFFKTI  260 (277)
T ss_pred             CHhhCCCCccchhhhhcChhhcCC
Confidence            99999999    678899999875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.9e-45  Score=359.17  Aligned_cols=242  Identities=28%  Similarity=0.444  Sum_probs=205.1

Q ss_pred             ccccceeCCeeEEEEEE---cCCCCEEEEEEccCC-----ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEE
Q 015500            6 GHTIGQGSSATVSLATS---LRSGDVFAAKSTELP-----KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLF   77 (405)
Q Consensus         6 ~~~LG~G~~g~Vyla~~---~~~~~~vavK~~~~~-----~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv   77 (405)
                      ++.||+|+||+||++++   +.+|+.+|+|++...     ....+.+|+++|++++||||+++++.+....    .+++|
T Consensus         1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~lv   76 (318)
T cd05582           1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEG----KLYLI   76 (318)
T ss_pred             CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCC----EEEEE
Confidence            36899999999999986   357899999988642     2345678999999999999999998775433    36799


Q ss_pred             EeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc----c
Q 015500           78 MEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE----A  152 (405)
Q Consensus        78 ~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~----~  152 (405)
                      |||+++|+|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++ +||+|||+++....    .
T Consensus        77 ~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~  155 (318)
T cd05582          77 LDFLRGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA  155 (318)
T ss_pred             EcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCce
Confidence            9999999999999765 4799999999999999999999999999999999999999887 99999999875432    2


Q ss_pred             ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHh
Q 015500          153 LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNC  232 (405)
Q Consensus       153 ~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~  232 (405)
                      ....||+.|+|||++.+..++.++|||||||++|+|++|+.||... +.......+..  ....+|..+++++.+||++|
T Consensus       156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~-~~~~~~~~i~~--~~~~~p~~~~~~~~~li~~~  232 (318)
T cd05582         156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGK-DRKETMTMILK--AKLGMPQFLSPEAQSLLRAL  232 (318)
T ss_pred             ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCC-CHHHHHHHHHc--CCCCCCCCCCHHHHHHHHHH
Confidence            3456999999999999988999999999999999999999999644 33444444332  22356777899999999999


Q ss_pred             cccCccccCC-----HHHHhcCcccccc
Q 015500          233 LRRDPKERWA-----ASQLLKHPFLEEF  255 (405)
Q Consensus       233 L~~dP~~Rpt-----~~elL~hp~~~~~  255 (405)
                      |+.||.+|||     +.++++||||...
T Consensus       233 l~~~P~~R~~a~~~~~~~~~~~~~~~~~  260 (318)
T cd05582         233 FKRNPANRLGAGPDGVEEIKRHPFFSTI  260 (318)
T ss_pred             hhcCHhHcCCCCCCCHHHHhCCCCcCCC
Confidence            9999999999     7789999999864

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=9.1e-45  Score=360.32  Aligned_cols=250  Identities=27%  Similarity=0.376  Sum_probs=201.7

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC-----ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCC--CceEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP-----KSEFLQREQKFLSSLNSPHIVGYKGCDVTSED--NKLMY   74 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~-----~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~--~~~~~   74 (405)
                      +|++.+.||+|+||+||+|.+..+|+.+|+|.+...     ....+.+|+.+++.++||||+++++++.....  ....+
T Consensus        22 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  101 (359)
T cd07876          22 RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDV  101 (359)
T ss_pred             ceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccccee
Confidence            588999999999999999999999999999988542     24567799999999999999999988754432  11235


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc--
Q 015500           75 NLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE--  151 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~--  151 (405)
                      +++|||+++ +|.+.+..   .+++..+..++.||+.||.|||++||+||||||+|||++.++ +||+|||+++....  
T Consensus       102 ~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~  177 (359)
T cd07876         102 YLVMELMDA-NLCQVIHM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNF  177 (359)
T ss_pred             EEEEeCCCc-CHHHHHhc---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccccCc
Confidence            799999965 67666642   589999999999999999999999999999999999999888 99999999975433  


Q ss_pred             -cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHH--------------------h
Q 015500          152 -ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA--------------------Y  210 (405)
Q Consensus       152 -~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~--------------------~  210 (405)
                       .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .....+.                    .
T Consensus       178 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (359)
T cd07876         178 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHI-DQWNKVIEQLGTPSAEFMNRLQPTVRNY  256 (359)
T ss_pred             cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCcHHHHHHHHHHHHHH
Confidence             23456899999999999999999999999999999999999999754321 1111100                    0


Q ss_pred             cCCCCC--------------------CchhccHHHHHHHHHhcccCccccCCHHHHhcCccccccc
Q 015500          211 SRELPE--------------------VPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFC  256 (405)
Q Consensus       211 ~~~~~~--------------------~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~  256 (405)
                      ....+.                    .+...++++++||.+||+.||++|||+.|+|+||||....
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~  322 (359)
T cd07876         257 VENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWY  322 (359)
T ss_pred             HhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhc
Confidence            000000                    1112467899999999999999999999999999998643

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1e-44  Score=361.72  Aligned_cols=251  Identities=28%  Similarity=0.370  Sum_probs=204.3

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC-----ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCC-CceEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP-----KSEFLQREQKFLSSLNSPHIVGYKGCDVTSED-NKLMYN   75 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~-----~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~-~~~~~~   75 (405)
                      +|..++.||+|+||+||+|.+..+++.||+|.+...     ....+.+|+.+|+.++||||+++++++..... .....+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            688999999999999999999999999999987642     23467899999999999999999988765441 112467


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc---
Q 015500           76 LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE---  151 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~---  151 (405)
                      +||||+. ++|.+++... +.+++..++.++.||+.||.|||++|++||||||+|||++.++ +||+|||+++....   
T Consensus        81 lv~e~~~-~~l~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~  158 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSP-QPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES  158 (372)
T ss_pred             EEeeccc-cCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCcc
Confidence            9999996 5888888655 4799999999999999999999999999999999999999888 99999999975432   


Q ss_pred             --cccCCCCCCccChhhhcCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHh------------------
Q 015500          152 --ALQSGGTPMFMAPEVARGE-HQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAY------------------  210 (405)
Q Consensus       152 --~~~~~gt~~Y~APE~l~~~-~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~------------------  210 (405)
                        .....+|+.|+|||++.+. .++.++|||||||++|||++|+.||.... +...+..+..                  
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-~~~~~~~i~~~~g~~~~~~~~~~~~~~~  237 (372)
T cd07853         159 KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQS-PIQQLDLITDLLGTPSLEAMRSACEGAR  237 (372)
T ss_pred             ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCC-HHHHHHHHHHHcCCCCHHHHHHhhHHHH
Confidence              1234579999999999874 47899999999999999999999996543 2222222211                  


Q ss_pred             ------cCCCC------CCchhccHHHHHHHHHhcccCccccCCHHHHhcCcccccc
Q 015500          211 ------SRELP------EVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       211 ------~~~~~------~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                            ....+      ......++++.+||.+||+.||.+|||+.++|+||||...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  294 (372)
T cd07853         238 AHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG  294 (372)
T ss_pred             HHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence                  00111      1223357899999999999999999999999999999874

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.1e-44  Score=373.47  Aligned_cols=249  Identities=25%  Similarity=0.379  Sum_probs=212.3

Q ss_pred             cccccccceeCCeeEEEEEEcCC-CCEEEEEEccCCC---hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEE
Q 015500            3 WTRGHTIGQGSSATVSLATSLRS-GDVFAAKSTELPK---SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFM   78 (405)
Q Consensus         3 y~~~~~LG~G~~g~Vyla~~~~~-~~~vavK~~~~~~---~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (405)
                      |.+.+.||+|+||.||+|.+..+ ++.+|+|.+....   ...+.+|+.+|+.++||||+++++.+....    .+++||
T Consensus        69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~----~~~lv~  144 (478)
T PTZ00267         69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDD----KLLLIM  144 (478)
T ss_pred             EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECC----EEEEEE
Confidence            78899999999999999998887 7889999875543   346778999999999999999999876543    367999


Q ss_pred             eecCCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc---
Q 015500           79 EYAPGGTLNDEIHR---NGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE---  151 (405)
Q Consensus        79 Ey~~ggsL~~~i~~---~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~---  151 (405)
                      ||++||+|.+++.+   ...++++..+..++.||+.||.|||++||+||||||+|||++.++ +||+|||+++....   
T Consensus       145 E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~  224 (478)
T PTZ00267        145 EYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS  224 (478)
T ss_pred             ECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence            99999999998864   234689999999999999999999999999999999999999888 99999999986433   


Q ss_pred             ---cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHH
Q 015500          152 ---ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDF  228 (405)
Q Consensus       152 ---~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dl  228 (405)
                         ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||... +....+..+.. ...+..|..+++++++|
T Consensus       225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~-~~~~~~~~~~~-~~~~~~~~~~s~~~~~l  302 (478)
T PTZ00267        225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGP-SQREIMQQVLY-GKYDPFPCPVSSGMKAL  302 (478)
T ss_pred             cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHh-CCCCCCCccCCHHHHHH
Confidence               22345999999999999999999999999999999999999999543 33444444443 34445677789999999


Q ss_pred             HHHhcccCccccCCHHHHhcCcccccccc
Q 015500          229 LSNCLRRDPKERWAASQLLKHPFLEEFCS  257 (405)
Q Consensus       229 l~~~L~~dP~~Rpt~~elL~hp~~~~~~~  257 (405)
                      |.+||..||++|||+.+++.|||++.+..
T Consensus       303 i~~~L~~dP~~Rps~~~~l~~~~~~~~~~  331 (478)
T PTZ00267        303 LDPLLSKNPALRPTTQQLLHTEFLKYVAN  331 (478)
T ss_pred             HHHHhccChhhCcCHHHHHhCHHHHHHHH
Confidence            99999999999999999999999986543

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=6.3e-45  Score=363.77  Aligned_cols=247  Identities=27%  Similarity=0.413  Sum_probs=205.0

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC------ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~------~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~   75 (405)
                      +|++.+.||+|+||+||+|.++.+++.+|+|.+...      ....+.+|+.+++.++||||+++++.+....    .++
T Consensus        44 ~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~----~~~  119 (371)
T cd05622          44 DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR----YLY  119 (371)
T ss_pred             hcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC----EEE
Confidence            589999999999999999999999999999987532      2345778999999999999999998765432    467


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc---
Q 015500           76 LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE---  151 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~---  151 (405)
                      +||||++||+|.+++...  .+++..++.++.||+.||+|||++||+||||||+|||++.++ +||+|||+++....   
T Consensus       120 lv~Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~  197 (371)
T cd05622         120 MVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM  197 (371)
T ss_pred             EEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCc
Confidence            999999999999998764  589999999999999999999999999999999999999888 99999999976432   


Q ss_pred             --cccCCCCCCccChhhhcCCC----CCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCc--hhccH
Q 015500          152 --ALQSGGTPMFMAPEVARGEH----QGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVP--AFLSK  223 (405)
Q Consensus       152 --~~~~~gt~~Y~APE~l~~~~----~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p--~~~s~  223 (405)
                        .....||+.|+|||++.+..    ++.++|||||||++|||++|+.||... +......++........+|  ..+++
T Consensus       198 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~  276 (371)
T cd05622         198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD-SLVGTYSKIMNHKNSLTFPDDNDISK  276 (371)
T ss_pred             ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCC-CHHHHHHHHHcCCCcccCCCcCCCCH
Confidence              12456999999999997643    788999999999999999999999643 3344444444333222333  35899


Q ss_pred             HHHHHHHHhcccCccc--cCCHHHHhcCcccccc
Q 015500          224 QANDFLSNCLRRDPKE--RWAASQLLKHPFLEEF  255 (405)
Q Consensus       224 ~l~dll~~~L~~dP~~--Rpt~~elL~hp~~~~~  255 (405)
                      .++++|.+||..++.+  |++++++++||||+..
T Consensus       277 ~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~  310 (371)
T cd05622         277 EAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND  310 (371)
T ss_pred             HHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence            9999999999854443  7899999999999764

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=6.5e-46  Score=340.11  Aligned_cols=249  Identities=27%  Similarity=0.439  Sum_probs=208.8

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-----------hHHHHHHHHHHHhC-CCCCeeeeeeeeeecCC
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-----------SEFLQREQKFLSSL-NSPHIVGYKGCDVTSED   69 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-----------~~~l~~E~~iL~~L-~hpnIv~~~~~~~~~~~   69 (405)
                      .|.-.+.||+|..++|-++.++.+|+.+|+|+++...           .+.-.+|+.||+++ .||||+.+.+++.+.. 
T Consensus        18 ~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s-   96 (411)
T KOG0599|consen   18 KYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA-   96 (411)
T ss_pred             hcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc-
Confidence            3677789999999999999999999999999886421           23556799999999 7999999998775543 


Q ss_pred             CceEEEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccc
Q 015500           70 NKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKW  148 (405)
Q Consensus        70 ~~~~~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~  148 (405)
                         ++++|+|.|+.|.|.|++... -.++|...+.|++|++.|++|||.++||||||||+|||++++. +||+|||+|..
T Consensus        97 ---F~FlVFdl~prGELFDyLts~-VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~  172 (411)
T KOG0599|consen   97 ---FVFLVFDLMPRGELFDYLTSK-VTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQ  172 (411)
T ss_pred             ---hhhhhhhhcccchHHHHhhhh-eeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeec
Confidence               466999999999999999876 3799999999999999999999999999999999999999886 99999999987


Q ss_pred             ccc---cccCCCCCCccChhhhcC------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCC-CCc
Q 015500          149 ESE---ALQSGGTPMFMAPEVARG------EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELP-EVP  218 (405)
Q Consensus       149 ~~~---~~~~~gt~~Y~APE~l~~------~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~-~~p  218 (405)
                      ...   ....||||+|+|||.+..      ..|+..+|+||.|+++|-|+.|.+||-..  ....+.+....+.+. ..|
T Consensus       173 l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR--kQmlMLR~ImeGkyqF~sp  250 (411)
T KOG0599|consen  173 LEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR--KQMLMLRMIMEGKYQFRSP  250 (411)
T ss_pred             cCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH--HHHHHHHHHHhcccccCCc
Confidence            544   457799999999999863      35777899999999999999999999433  233333333333221 222


Q ss_pred             --hhccHHHHHHHHHhcccCccccCCHHHHhcCcccccccc
Q 015500          219 --AFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCS  257 (405)
Q Consensus       219 --~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~~  257 (405)
                        ..+|...+|||.+||+.||.+|.|++|+|.||||.++..
T Consensus       251 eWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~  291 (411)
T KOG0599|consen  251 EWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQ  291 (411)
T ss_pred             chhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHH
Confidence              458999999999999999999999999999999987643

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.7e-44  Score=341.71  Aligned_cols=247  Identities=36%  Similarity=0.724  Sum_probs=211.9

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC---------hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCce
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK---------SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKL   72 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~---------~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~   72 (405)
                      +|++++.||+|+||.||+|.+..+++.+|+|.+....         ...+.+|+++|++++||||+++++.+....    
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----   76 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDS----   76 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCC----
Confidence            6999999999999999999999999999999886432         356889999999999999999999865443    


Q ss_pred             EEEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC--ceEeeeccccccc
Q 015500           73 MYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG--AKIADFGCAKWES  150 (405)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~--vkL~DFGla~~~~  150 (405)
                      .+++|+||++|++|.+++.+. +++++..+..++.||+.||.|||++|++|+||||+||+++.++  +||+|||.+....
T Consensus        77 ~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~  155 (268)
T cd06630          77 HFNLFVEWMAGGSVSHLLSKY-GAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLA  155 (268)
T ss_pred             eEEEEEeccCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence            367999999999999999875 4899999999999999999999999999999999999998765  8999999987543


Q ss_pred             cc--------ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC--ChHHHHHHHHhcCCCCCCchh
Q 015500          151 EA--------LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAA--DPMTVLYKIAYSRELPEVPAF  220 (405)
Q Consensus       151 ~~--------~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~--~~~~~l~~i~~~~~~~~~p~~  220 (405)
                      ..        ....||..|+|||.+.+..++.++|+|||||++|+|++|..||....  ........+......+..|..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (268)
T cd06630         156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEH  235 (268)
T ss_pred             cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchh
Confidence            21        12357889999999998889999999999999999999999996433  223333344444455677788


Q ss_pred             ccHHHHHHHHHhcccCccccCCHHHHhcCcccc
Q 015500          221 LSKQANDFLSNCLRRDPKERWAASQLLKHPFLE  253 (405)
Q Consensus       221 ~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~  253 (405)
                      +++++.+++.+||+.+|.+|||+.++++||||+
T Consensus       236 ~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         236 LSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             hCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence            999999999999999999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-46  Score=369.90  Aligned_cols=246  Identities=36%  Similarity=0.553  Sum_probs=219.9

Q ss_pred             cccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC------hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEE
Q 015500            3 WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK------SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         3 y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~------~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      |.-++.||.|+||.||.|++.++.++||||++.-+.      ...+..|+++|++|+|||++.|.|||.-...    .+|
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~T----aWL  103 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHT----AWL  103 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccch----HHH
Confidence            556789999999999999999999999999987543      3567889999999999999999999986654    568


Q ss_pred             EEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccccccC
Q 015500           77 FMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQS  155 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~~~~  155 (405)
                      |||||-| +-.|++.-+..++.|-.+..|+.+.+.||+|||+.+.||||||..|||+++.| |||+|||.|.........
T Consensus       104 VMEYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAnsF  182 (948)
T KOG0577|consen  104 VMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPANSF  182 (948)
T ss_pred             HHHHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCchhcc
Confidence            9999955 88898887777999999999999999999999999999999999999999999 999999999999999999


Q ss_pred             CCCCCccChhhhc---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCc-hhccHHHHHHHHH
Q 015500          156 GGTPMFMAPEVAR---GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVP-AFLSKQANDFLSN  231 (405)
Q Consensus       156 ~gt~~Y~APE~l~---~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p-~~~s~~l~dll~~  231 (405)
                      +|||+|||||++.   .+.|+-++||||||++.+||+-.++|+.++ +..+.++.|..... |.++ ..+|+.+..|+..
T Consensus       183 vGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnM-NAMSALYHIAQNes-PtLqs~eWS~~F~~Fvd~  260 (948)
T KOG0577|consen  183 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNES-PTLQSNEWSDYFRNFVDS  260 (948)
T ss_pred             cCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCc-hHHHHHHHHHhcCC-CCCCCchhHHHHHHHHHH
Confidence            9999999999975   367888999999999999999999998665 56788888876654 3443 5589999999999


Q ss_pred             hcccCccccCCHHHHhcCcccccc
Q 015500          232 CLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       232 ~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      ||++-|.+|||.+++|.|+|+..-
T Consensus       261 CLqKipqeRptse~ll~H~fv~R~  284 (948)
T KOG0577|consen  261 CLQKIPQERPTSEELLKHRFVLRE  284 (948)
T ss_pred             HHhhCcccCCcHHHHhhcchhccC
Confidence            999999999999999999998753

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.7e-44  Score=359.00  Aligned_cols=250  Identities=26%  Similarity=0.368  Sum_probs=202.6

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC-----ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCC--CceEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP-----KSEFLQREQKFLSSLNSPHIVGYKGCDVTSED--NKLMY   74 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~-----~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~--~~~~~   74 (405)
                      +|.+.+.||+|+||.||+|.+..+++.+|||.+...     ....+.+|+.+++.++||||+++++++.....  ....+
T Consensus        25 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~  104 (364)
T cd07875          25 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDV  104 (364)
T ss_pred             ceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeE
Confidence            588999999999999999999999999999988642     23567889999999999999999987654321  12246


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc-
Q 015500           75 NLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA-  152 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~-  152 (405)
                      ++||||+++ +|.+.+..   .+++..+..++.|++.||+|||++||+||||||+|||++.++ +||+|||+++..... 
T Consensus       105 ~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~  180 (364)
T cd07875         105 YIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF  180 (364)
T ss_pred             EEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCCCC
Confidence            799999965 78777753   488999999999999999999999999999999999999887 999999999865442 


Q ss_pred             --ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcC------------------
Q 015500          153 --LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSR------------------  212 (405)
Q Consensus       153 --~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~------------------  212 (405)
                        ....||+.|+|||++.+..++.++|||||||++|+|++|+.||..... .....++....                  
T Consensus       181 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (364)
T cd07875         181 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH-IDQWNKVIEQLGTPCPEFMKKLQPTVRTY  259 (364)
T ss_pred             cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHhcCCCCHHHHHhhhHHHHHH
Confidence              345689999999999999999999999999999999999999965432 22222211100                  


Q ss_pred             --CCCC--------------------CchhccHHHHHHHHHhcccCccccCCHHHHhcCccccccc
Q 015500          213 --ELPE--------------------VPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFC  256 (405)
Q Consensus       213 --~~~~--------------------~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~  256 (405)
                        ..|.                    .....+.++++||.+||+.||.+|||+.|+|+||||....
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~  325 (364)
T cd07875         260 VENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY  325 (364)
T ss_pred             HhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccccc
Confidence              0000                    0111356789999999999999999999999999998653

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=8.8e-45  Score=356.83  Aligned_cols=249  Identities=24%  Similarity=0.376  Sum_probs=207.4

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC------ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~------~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~   75 (405)
                      +|.+.+.||+|+||+||++.++.+++.+|+|.+...      ....+.+|+.++..++||||+++++++....    .++
T Consensus         2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~----~~~   77 (332)
T cd05623           2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDEN----NLY   77 (332)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC----EEE
Confidence            689999999999999999999999999999997532      2335788999999999999999998775443    367


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc---
Q 015500           76 LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE---  151 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~---  151 (405)
                      +||||++||+|.+++.+.++.+++..++.++.||+.||.|||++||+||||||+|||++.++ +||+|||++.....   
T Consensus        78 lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~  157 (332)
T cd05623          78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT  157 (332)
T ss_pred             EEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence            99999999999999988666899999999999999999999999999999999999999887 99999999865322   


Q ss_pred             --cccCCCCCCccChhhhcC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCC---CCCCchhc
Q 015500          152 --ALQSGGTPMFMAPEVARG-----EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRE---LPEVPAFL  221 (405)
Q Consensus       152 --~~~~~gt~~Y~APE~l~~-----~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~---~~~~p~~~  221 (405)
                        .....||+.|+|||++.+     ..++.++|||||||++|||++|+.||... +......++.....   .|..+..+
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~-~~~~~~~~i~~~~~~~~~p~~~~~~  236 (332)
T cd05623         158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE-SLVETYGKIMNHKERFQFPAQVTDV  236 (332)
T ss_pred             ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC-CHHHHHHHHhCCCccccCCCccccC
Confidence              123469999999999863     45788999999999999999999999644 34444444443322   33334467


Q ss_pred             cHHHHHHHHHhcccCccc--cCCHHHHhcCcccccc
Q 015500          222 SKQANDFLSNCLRRDPKE--RWAASQLLKHPFLEEF  255 (405)
Q Consensus       222 s~~l~dll~~~L~~dP~~--Rpt~~elL~hp~~~~~  255 (405)
                      ++++++||++||..+|.+  |++++++++||||..+
T Consensus       237 s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~  272 (332)
T cd05623         237 SEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGI  272 (332)
T ss_pred             CHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCC
Confidence            999999999999765544  6899999999999865

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=2.7e-44  Score=340.45  Aligned_cols=245  Identities=41%  Similarity=0.699  Sum_probs=208.5

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC---------hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCce
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK---------SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKL   72 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~---------~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~   72 (405)
                      +|+.++.||+|+||+||+|.+ .+++.+|+|.+....         ...+.+|+++|++++||||+++.+++....    
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----   75 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDN----   75 (265)
T ss_pred             CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCC----
Confidence            699999999999999999986 578999999876432         246888999999999999999998865432    


Q ss_pred             EEEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc
Q 015500           73 MYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE  151 (405)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~  151 (405)
                      .+++++||++|++|.+++.+. +++++..+..++.|++.||+|||+.|++|+||||+||+++.++ +||+|||++.....
T Consensus        76 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  154 (265)
T cd06631          76 TISIFMEFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW  154 (265)
T ss_pred             eEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence            467999999999999999876 4789999999999999999999999999999999999999887 99999999875321


Q ss_pred             ----------cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhc
Q 015500          152 ----------ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFL  221 (405)
Q Consensus       152 ----------~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~  221 (405)
                                .....|++.|+|||.+.+..++.++|+|||||++|+|++|..||...................+..+..+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (265)
T cd06631         155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSF  234 (265)
T ss_pred             ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCC
Confidence                      1234589999999999998899999999999999999999999965543333222222224456677789


Q ss_pred             cHHHHHHHHHhcccCccccCCHHHHhcCccc
Q 015500          222 SKQANDFLSNCLRRDPKERWAASQLLKHPFL  252 (405)
Q Consensus       222 s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~  252 (405)
                      +.++.+||++||..+|.+|||+.++|+||||
T Consensus       235 ~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         235 SAAAIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             CHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            9999999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.2e-44  Score=356.01  Aligned_cols=244  Identities=25%  Similarity=0.358  Sum_probs=199.7

Q ss_pred             CcccccccceeCCeeEEEEEEc-----CCCCEEEEEEccCCC----hHHHHHHHHHHHhC-CCCCeeeeeeeeeecCCCc
Q 015500            2 DWTRGHTIGQGSSATVSLATSL-----RSGDVFAAKSTELPK----SEFLQREQKFLSSL-NSPHIVGYKGCDVTSEDNK   71 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~-----~~~~~vavK~~~~~~----~~~l~~E~~iL~~L-~hpnIv~~~~~~~~~~~~~   71 (405)
                      +|.+++.||+|+||+||+|.+.     .+++.||||.+....    ...+.+|+.+|+.+ +||||+++++.+.....  
T Consensus         8 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~--   85 (338)
T cd05102           8 RLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG--   85 (338)
T ss_pred             HceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC--
Confidence            5889999999999999999753     345789999986432    24688899999999 89999999987654322  


Q ss_pred             eEEEEEEeecCCCCHHHHHHHcC---------------------------------------------------------
Q 015500           72 LMYNLFMEYAPGGTLNDEIHRNG---------------------------------------------------------   94 (405)
Q Consensus        72 ~~~~lv~Ey~~ggsL~~~i~~~~---------------------------------------------------------   94 (405)
                       .++++|||+++|+|.+++....                                                         
T Consensus        86 -~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (338)
T cd05102          86 -PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD  164 (338)
T ss_pred             -ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence             3568999999999999987532                                                         


Q ss_pred             ----CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc------cccCCCCCCccC
Q 015500           95 ----GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE------ALQSGGTPMFMA  163 (405)
Q Consensus        95 ----~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~------~~~~~gt~~Y~A  163 (405)
                          .++++..+..++.||+.||+|||++||+||||||+|||++.++ +||+|||+++....      .....+++.|+|
T Consensus       165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~a  244 (338)
T cd05102         165 DLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMA  244 (338)
T ss_pred             ccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccC
Confidence                2477888999999999999999999999999999999999887 99999999975422      112345678999


Q ss_pred             hhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHhcccCccccCC
Q 015500          164 PEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWA  242 (405)
Q Consensus       164 PE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~L~~dP~~Rpt  242 (405)
                      ||++.+..++.++|||||||++|||++ |..||......... .........+..|..+++++.+++.+||+.||.+|||
T Consensus       245 PE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs  323 (338)
T cd05102         245 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEF-CQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPT  323 (338)
T ss_pred             cHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHH-HHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcC
Confidence            999999899999999999999999997 99999765433332 2333333445567778999999999999999999999


Q ss_pred             HHHHhcC
Q 015500          243 ASQLLKH  249 (405)
Q Consensus       243 ~~elL~h  249 (405)
                      +.++++.
T Consensus       324 ~~el~~~  330 (338)
T cd05102         324 FSALVEI  330 (338)
T ss_pred             HHHHHHH
Confidence            9999763

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-47  Score=351.74  Aligned_cols=248  Identities=33%  Similarity=0.510  Sum_probs=217.3

Q ss_pred             cccccccceeCCeeEEEEEEcCCCCEEEEEEccCC-ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEeec
Q 015500            3 WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP-KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYA   81 (405)
Q Consensus         3 y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~-~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~Ey~   81 (405)
                      |.++.+||.|+||.||+|.|+.+|+++|+|.++.+ +.+.+-.|+.||++.++|++|+|||.+....+    +++|||||
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sD----LWIVMEYC  110 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSD----LWIVMEYC  110 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCc----eEeehhhc
Confidence            57889999999999999999999999999999865 56778899999999999999999998876665    67999999


Q ss_pred             CCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc----cccCC
Q 015500           82 PGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE----ALQSG  156 (405)
Q Consensus        82 ~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~----~~~~~  156 (405)
                      ..|++.|.++.+..+|+|..+..+++..++||+|||...-+|||||..|||++.+| +||+|||.|-....    ..+..
T Consensus       111 GAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNTVI  190 (502)
T KOG0574|consen  111 GAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNTVI  190 (502)
T ss_pred             CCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCccc
Confidence            99999999998888999999999999999999999999999999999999999999 99999999976443    44567


Q ss_pred             CCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcC-CCCCCchhccHHHHHHHHHhccc
Q 015500          157 GTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSR-ELPEVPAFLSKQANDFLSNCLRR  235 (405)
Q Consensus       157 gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~-~~~~~p~~~s~~l~dll~~~L~~  235 (405)
                      |||.|||||++..-.|+.++||||||++.+||+.|++||.+... ...++.|.... ..-.-|..+|.++.||+++||.+
T Consensus       191 GTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHP-MRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~CLiK  269 (502)
T KOG0574|consen  191 GTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHP-MRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSCLIK  269 (502)
T ss_pred             cCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccc-cceeEeccCCCCCCCCChHhhhhHHHHHHHHHhcC
Confidence            99999999999999999999999999999999999999975543 33333332221 11123566899999999999999


Q ss_pred             CccccCCHHHHhcCcccccc
Q 015500          236 DPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       236 dP~~Rpt~~elL~hp~~~~~  255 (405)
                      +|++|-|+.+|++|||++..
T Consensus       270 ~PE~R~TA~~L~~H~FiknA  289 (502)
T KOG0574|consen  270 KPEERKTALRLCEHTFIKNA  289 (502)
T ss_pred             CHHHHHHHHHHhhhhhhcCC
Confidence            99999999999999999864

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.6e-44  Score=347.21  Aligned_cols=249  Identities=29%  Similarity=0.463  Sum_probs=207.7

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC------hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK------SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~------~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~   75 (405)
                      .|++.+.||+|+||+||+|.+..+++.+|+|.+....      ...+.+|+.++++++||+|+.+.+.+....    .++
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~----~~~   76 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKD----ALC   76 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCC----EEE
Confidence            4788999999999999999999999999999876431      235678999999999999999988765433    367


Q ss_pred             EEEeecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc-
Q 015500           76 LFMEYAPGGTLNDEIHRNG-GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA-  152 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~~-~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~-  152 (405)
                      ++|||++|++|.+++...+ ..+++..+..++.|++.||.|||+.||+||||||+||+++.++ ++|+|||++...... 
T Consensus        77 lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05630          77 LVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ  156 (285)
T ss_pred             EEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence            9999999999999886543 3589999999999999999999999999999999999999887 999999998754332 


Q ss_pred             --ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChH--HHHHHHHhcCCCCCCchhccHHHHHH
Q 015500          153 --LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPM--TVLYKIAYSRELPEVPAFLSKQANDF  228 (405)
Q Consensus       153 --~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~--~~l~~i~~~~~~~~~p~~~s~~l~dl  228 (405)
                        ....||+.|+|||++.+..++.++|||||||++|+|++|+.||.......  ........ ......+..+++++.+|
T Consensus       157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l  235 (285)
T cd05630         157 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK-EVQEEYSEKFSPDARSL  235 (285)
T ss_pred             cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhh-hhhhhcCccCCHHHHHH
Confidence              23468999999999999899999999999999999999999997543221  11111111 11223456688999999


Q ss_pred             HHHhcccCccccCC-----HHHHhcCcccccc
Q 015500          229 LSNCLRRDPKERWA-----ASQLLKHPFLEEF  255 (405)
Q Consensus       229 l~~~L~~dP~~Rpt-----~~elL~hp~~~~~  255 (405)
                      +++||+.||.+|||     ++++++||||++.
T Consensus       236 i~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~  267 (285)
T cd05630         236 CKMLLCKDPKERLGCQGGGAREVKEHPLFKQI  267 (285)
T ss_pred             HHHHhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence            99999999999999     9999999999874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=8.9e-45  Score=356.81  Aligned_cols=249  Identities=23%  Similarity=0.368  Sum_probs=207.3

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC------ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~------~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~   75 (405)
                      +|.+.+.||+|+||+||+|+++.+++.+|+|.+...      ....+.+|+.++..++||||+++++++....    .++
T Consensus         2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~----~~~   77 (331)
T cd05624           2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDEN----YLY   77 (331)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC----EEE
Confidence            689999999999999999999999999999987642      2345778999999999999999998765433    367


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc--
Q 015500           76 LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA--  152 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~--  152 (405)
                      +||||++||+|.+++.+..+.+++..++.++.||+.||+|||++||+||||||+|||++.++ +||+|||+++.....  
T Consensus        78 lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  157 (331)
T cd05624          78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT  157 (331)
T ss_pred             EEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence            99999999999999988666899999999999999999999999999999999999999887 999999998754331  


Q ss_pred             ---ccCCCCCCccChhhhcC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCC---CCCCchhc
Q 015500          153 ---LQSGGTPMFMAPEVARG-----EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRE---LPEVPAFL  221 (405)
Q Consensus       153 ---~~~~gt~~Y~APE~l~~-----~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~---~~~~p~~~  221 (405)
                         ....||+.|+|||++.+     ..++.++|||||||++|+|++|+.||... +......++.....   +|.....+
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~-~~~~~~~~i~~~~~~~~~p~~~~~~  236 (331)
T cd05624         158 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE-SLVETYGKIMNHEERFQFPSHITDV  236 (331)
T ss_pred             eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCC-CHHHHHHHHHcCCCcccCCCccccC
Confidence               23469999999999876     45788999999999999999999999643 33444444443322   22323446


Q ss_pred             cHHHHHHHHHhcccCccc--cCCHHHHhcCcccccc
Q 015500          222 SKQANDFLSNCLRRDPKE--RWAASQLLKHPFLEEF  255 (405)
Q Consensus       222 s~~l~dll~~~L~~dP~~--Rpt~~elL~hp~~~~~  255 (405)
                      ++++++||.+||..++.+  |++++++++||||+..
T Consensus       237 ~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~  272 (331)
T cd05624         237 SEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGI  272 (331)
T ss_pred             CHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCC
Confidence            899999999999876654  5689999999999864

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=3e-44  Score=349.68  Aligned_cols=247  Identities=29%  Similarity=0.404  Sum_probs=192.2

Q ss_pred             CcccccccceeCCeeEEEEEEc--CCCCEEEEEEccCCC-hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSL--RSGDVFAAKSTELPK-SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFM   78 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~--~~~~~vavK~~~~~~-~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (405)
                      +|. +++||+|+||+||+|+++  .+++.+|+|.+.... ...+.+|+++|++++||||+++++.+....+  ..++++|
T Consensus         3 ~~~-~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--~~~~lv~   79 (317)
T cd07868           3 EYE-GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHAD--RKVWLLF   79 (317)
T ss_pred             ccc-ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecCCC--cEEEEEE
Confidence            344 678999999999999965  467899999887543 4568899999999999999999987754433  2466999


Q ss_pred             eecCCCCHHHHHHHc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEc----cCC-ceEeeecc
Q 015500           79 EYAPGGTLNDEIHRN--------GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMA----ESG-AKIADFGC  145 (405)
Q Consensus        79 Ey~~ggsL~~~i~~~--------~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~----~~~-vkL~DFGl  145 (405)
                      ||+. ++|.+++...        ...+++..++.++.||+.||.|||++||+||||||+|||+.    .++ +||+|||+
T Consensus        80 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~  158 (317)
T cd07868          80 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF  158 (317)
T ss_pred             eccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence            9995 4888887532        22589999999999999999999999999999999999994    333 99999999


Q ss_pred             cccccc-------cccCCCCCCccChhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCh--------HHHHHHHH
Q 015500          146 AKWESE-------ALQSGGTPMFMAPEVARG-EHQGFASDIWAVGCTVIEMASGGAPWPNAADP--------MTVLYKIA  209 (405)
Q Consensus       146 a~~~~~-------~~~~~gt~~Y~APE~l~~-~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~--------~~~l~~i~  209 (405)
                      ++....       .....||+.|+|||++.+ ..++.++|||||||++|+|++|++||......        ...+.++.
T Consensus       159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~  238 (317)
T cd07868         159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF  238 (317)
T ss_pred             eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHH
Confidence            976433       123468999999999987 45899999999999999999999999643211        11111111


Q ss_pred             hcCC------------CCC------------------------CchhccHHHHHHHHHhcccCccccCCHHHHhcCccc
Q 015500          210 YSRE------------LPE------------------------VPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFL  252 (405)
Q Consensus       210 ~~~~------------~~~------------------------~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~  252 (405)
                      ....            .+.                        .....+..+.+||++||+.||.+|||++|+|+||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         239 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             HhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            0000            000                        001134678999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=9.8e-45  Score=355.32  Aligned_cols=241  Identities=26%  Similarity=0.414  Sum_probs=199.3

Q ss_pred             cccceeCCeeEEEEEEcCCCCEEEEEEccCCC------hHHHHHH-HHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEe
Q 015500            7 HTIGQGSSATVSLATSLRSGDVFAAKSTELPK------SEFLQRE-QKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFME   79 (405)
Q Consensus         7 ~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~------~~~l~~E-~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (405)
                      +.||+|+||+||+|+++.+++.+|+|.+....      ...+.+| ..+++.++||||+++++.+....    .+++|||
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~----~~~lv~e   76 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD----KLYFVLD   76 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCC----eEEEEEe
Confidence            47999999999999999999999999986421      1233334 34578899999999988765443    3679999


Q ss_pred             ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc----ccc
Q 015500           80 YAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE----ALQ  154 (405)
Q Consensus        80 y~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~----~~~  154 (405)
                      |++||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++ +||+|||+++....    ...
T Consensus        77 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~  155 (325)
T cd05602          77 YINGGELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST  155 (325)
T ss_pred             CCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCccc
Confidence            99999999999775 4789999999999999999999999999999999999999887 99999999875321    234


Q ss_pred             CCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHhcc
Q 015500          155 SGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLR  234 (405)
Q Consensus       155 ~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~L~  234 (405)
                      ..||+.|+|||++.+..++.++|||||||++|+|++|+.||... +.......+. ... ...+..+++.+.++|++||+
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~-~~~~~~~~i~-~~~-~~~~~~~~~~~~~li~~~l~  232 (325)
T cd05602         156 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR-NTAEMYDNIL-NKP-LQLKPNITNSARHLLEGLLQ  232 (325)
T ss_pred             ccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCC-CHHHHHHHHH-hCC-cCCCCCCCHHHHHHHHHHcc
Confidence            56999999999999999999999999999999999999999643 3333333332 222 23455689999999999999


Q ss_pred             cCccccCCHH----HHhcCcccccc
Q 015500          235 RDPKERWAAS----QLLKHPFLEEF  255 (405)
Q Consensus       235 ~dP~~Rpt~~----elL~hp~~~~~  255 (405)
                      +||.+|+++.    ++++|+||..+
T Consensus       233 ~~p~~R~~~~~~~~~i~~~~~~~~~  257 (325)
T cd05602         233 KDRTKRLGAKDDFMEIKNHIFFSPI  257 (325)
T ss_pred             cCHHHCCCCCCCHHHHhcCcccCCC
Confidence            9999999876    89999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=5.9e-45  Score=356.88  Aligned_cols=241  Identities=28%  Similarity=0.428  Sum_probs=200.0

Q ss_pred             cccceeCCeeEEEEEEcCCCCEEEEEEccCC------ChHHHHHHHH-HHHhCCCCCeeeeeeeeeecCCCceEEEEEEe
Q 015500            7 HTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQK-FLSSLNSPHIVGYKGCDVTSEDNKLMYNLFME   79 (405)
Q Consensus         7 ~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~------~~~~l~~E~~-iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (405)
                      +.||+|+||+||+|.++.+|+.+|+|++...      ....+.+|.. +++.++||||+++++.+....    .+++|||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~----~~~lv~e   76 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTE----KLYFVLD   76 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCC----EEEEEEc
Confidence            5799999999999999999999999988643      1223444544 577899999999988765443    3679999


Q ss_pred             ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc----ccc
Q 015500           80 YAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE----ALQ  154 (405)
Q Consensus        80 y~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~----~~~  154 (405)
                      |++||+|.+++... +++++..++.++.||+.||+|||++||+||||||+|||++.++ +||+|||+++....    ...
T Consensus        77 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~  155 (325)
T cd05604          77 FVNGGELFFHLQRE-RSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTT  155 (325)
T ss_pred             CCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCccc
Confidence            99999999988765 4899999999999999999999999999999999999999888 99999999875321    234


Q ss_pred             CCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHhcc
Q 015500          155 SGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLR  234 (405)
Q Consensus       155 ~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~L~  234 (405)
                      ..||+.|+|||++.+..++.++|||||||++|+|++|+.||... +.......+. ... ...+...+..+.++|++||+
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~-~~~~~~~~~~-~~~-~~~~~~~~~~~~~ll~~ll~  232 (325)
T cd05604         156 FCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCR-DVAEMYDNIL-HKP-LVLRPGASLTAWSILEELLE  232 (325)
T ss_pred             ccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCC-CHHHHHHHHH-cCC-ccCCCCCCHHHHHHHHHHhc
Confidence            56999999999999999999999999999999999999999643 3333333333 222 23445689999999999999


Q ss_pred             cCccccCCH----HHHhcCcccccc
Q 015500          235 RDPKERWAA----SQLLKHPFLEEF  255 (405)
Q Consensus       235 ~dP~~Rpt~----~elL~hp~~~~~  255 (405)
                      .+|.+||++    .++++||||...
T Consensus       233 ~~p~~R~~~~~~~~~i~~h~~f~~~  257 (325)
T cd05604         233 KDRQRRLGAKEDFLEIQEHPFFESL  257 (325)
T ss_pred             cCHHhcCCCCCCHHHHhcCCCcCCC
Confidence            999999987    599999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.8e-44  Score=355.73  Aligned_cols=251  Identities=26%  Similarity=0.422  Sum_probs=203.7

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC-----ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCC--CceEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP-----KSEFLQREQKFLSSLNSPHIVGYKGCDVTSED--NKLMY   74 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~-----~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~--~~~~~   74 (405)
                      +|.+.+.||+|+||+||+|.+..+++.||||.+...     ....+.+|+++|+.++||||+++++++.....  ....+
T Consensus        16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   95 (343)
T cd07878          16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEV   95 (343)
T ss_pred             hhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcE
Confidence            588999999999999999999999999999998643     23457789999999999999999987653321  12346


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc-c
Q 015500           75 NLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE-A  152 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~-~  152 (405)
                      ++++|++ +++|.+++..  +.+++..++.++.||+.||.|||++||+||||||+|||++.++ +||+|||+++.... .
T Consensus        96 ~~~~~~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  172 (343)
T cd07878          96 YLVTNLM-GADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEM  172 (343)
T ss_pred             EEEeecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCCCc
Confidence            7899988 7799887754  3699999999999999999999999999999999999999887 99999999986544 3


Q ss_pred             ccCCCCCCccChhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhc--------------------
Q 015500          153 LQSGGTPMFMAPEVARG-EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYS--------------------  211 (405)
Q Consensus       153 ~~~~gt~~Y~APE~l~~-~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~--------------------  211 (405)
                      ....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..... ...+.++...                    
T Consensus       173 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (343)
T cd07878         173 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDY-IDQLKRIMEVVGTPSPEVLKKISSEHARKY  251 (343)
T ss_pred             CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHHHhCCCCHHHHHhcchhhHHHH
Confidence            34568999999999977 5688999999999999999999999965432 2222221110                    


Q ss_pred             -CCCCCCc--------hhccHHHHHHHHHhcccCccccCCHHHHhcCccccccc
Q 015500          212 -RELPEVP--------AFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFC  256 (405)
Q Consensus       212 -~~~~~~p--------~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~  256 (405)
                       ...+..+        ...++.+.+||.+||..||.+|||+.|+|+||||....
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~  305 (343)
T cd07878         252 IQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYH  305 (343)
T ss_pred             hhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccC
Confidence             0111111        23466789999999999999999999999999998754

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=7.7e-45  Score=341.88  Aligned_cols=245  Identities=34%  Similarity=0.524  Sum_probs=202.8

Q ss_pred             cccccccceeCCeeEEEEEEcCCCCEEEEEEccCCChH-----HHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEE
Q 015500            3 WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSE-----FLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLF   77 (405)
Q Consensus         3 y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~~~-----~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv   77 (405)
                      |+.++.||+|+||+||+|.+..+++.+|+|.+......     ...+|+.++++++||||+++++.+....    ..+++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~----~~~~v   76 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDN----YLYIV   76 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESS----EEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccc----ccccc
Confidence            78899999999999999999999999999999876543     2345999999999999999998876633    35699


Q ss_pred             EeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccc----cccc
Q 015500           78 MEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKW----ESEA  152 (405)
Q Consensus        78 ~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~----~~~~  152 (405)
                      |||+++++|.+++... +.+++..+..++.||+.||++||+.|++|+||||+||+++.++ ++|+|||.+..    ....
T Consensus        77 ~~~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~  155 (260)
T PF00069_consen   77 MEYCPGGSLQDYLQKN-KPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENF  155 (260)
T ss_dssp             EEEETTEBHHHHHHHH-SSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEB
T ss_pred             cccccccccccccccc-ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            9999999999999854 4799999999999999999999999999999999999999877 99999999864    2223


Q ss_pred             ccCCCCCCccChhhhc-CCCCCcchhHHHHHHHHHHHHhCCCCCCCCC--ChHHHHHHHHhcCCCC--CCchhccHHHHH
Q 015500          153 LQSGGTPMFMAPEVAR-GEHQGFASDIWAVGCTVIEMASGGAPWPNAA--DPMTVLYKIAYSRELP--EVPAFLSKQAND  227 (405)
Q Consensus       153 ~~~~gt~~Y~APE~l~-~~~~~~~sDIwSLG~il~elltG~~Pf~~~~--~~~~~l~~i~~~~~~~--~~p~~~s~~l~d  227 (405)
                      ....+|+.|+|||++. +..++.++|+||||+++|+|++|..||....  +......+........  ......++.+.+
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  235 (260)
T PF00069_consen  156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRD  235 (260)
T ss_dssp             SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHH
Confidence            4566899999999998 7889999999999999999999999997552  1122222221111000  011112489999


Q ss_pred             HHHHhcccCccccCCHHHHhcCccc
Q 015500          228 FLSNCLRRDPKERWAASQLLKHPFL  252 (405)
Q Consensus       228 ll~~~L~~dP~~Rpt~~elL~hp~~  252 (405)
                      +|.+||+.||++|||+.++++||||
T Consensus       236 li~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  236 LIKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             HHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             HHHHHccCChhHCcCHHHHhcCCCC
Confidence            9999999999999999999999997

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=6.6e-44  Score=335.61  Aligned_cols=246  Identities=28%  Similarity=0.534  Sum_probs=209.4

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC-----ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP-----KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~-----~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      .|++.+.||+|++|.||+|.++.+++.+|+|.+...     ..+.+.+|++++++++|||++++.+.+...+   ..+++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~l   77 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGED---GLLYI   77 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCC---CEEEE
Confidence            589999999999999999999999999999987643     2346788999999999999999987653222   24679


Q ss_pred             EEeecCCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc---
Q 015500           77 FMEYAPGGTLNDEIHRN-GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE---  151 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~-~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~---  151 (405)
                      +|||+++++|.+++... +..+++.++..++.|++.||++||++|++||||||+||+++.++ ++|+|||++.....   
T Consensus        78 v~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~  157 (257)
T cd08223          78 VMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD  157 (257)
T ss_pred             EecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence            99999999999999763 34689999999999999999999999999999999999999887 99999999875432   


Q ss_pred             -cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHH
Q 015500          152 -ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLS  230 (405)
Q Consensus       152 -~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~  230 (405)
                       .....+++.|+|||++.+..++.++|+|||||++++|++|+.||... +.......+ .....+..+...++.+.+|+.
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~  235 (257)
T cd08223         158 MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK-DMNSLVYRI-IEGKLPPMPKDYSPELGELIA  235 (257)
T ss_pred             ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCC-CHHHHHHHH-HhcCCCCCccccCHHHHHHHH
Confidence             22345899999999999988999999999999999999999999643 333333333 234455667778999999999


Q ss_pred             HhcccCccccCCHHHHhcCccc
Q 015500          231 NCLRRDPKERWAASQLLKHPFL  252 (405)
Q Consensus       231 ~~L~~dP~~Rpt~~elL~hp~~  252 (405)
                      +||+.||.+|||+.++++||||
T Consensus       236 ~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         236 TMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             HHhccCcccCCCHHHHhcCCCC
Confidence            9999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=2.1e-44  Score=356.93  Aligned_cols=250  Identities=26%  Similarity=0.345  Sum_probs=201.8

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC-----ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCC--CceEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP-----KSEFLQREQKFLSSLNSPHIVGYKGCDVTSED--NKLMY   74 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~-----~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~--~~~~~   74 (405)
                      +|.+.+.||+|+||.||+|.+..+++.+|||.+...     ....+.+|+.+++.++||||+++++++.....  ....+
T Consensus        18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   97 (355)
T cd07874          18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDV   97 (355)
T ss_pred             ceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccccee
Confidence            588999999999999999999999999999988643     23467789999999999999999988754332  12246


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc-
Q 015500           75 NLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA-  152 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~-  152 (405)
                      +++|||+++ +|.+.+..   .+++..+..++.||+.||.|||++||+||||||+|||++.++ +||+|||+++..... 
T Consensus        98 ~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~  173 (355)
T cd07874          98 YLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF  173 (355)
T ss_pred             EEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCCcc
Confidence            799999965 67776643   588999999999999999999999999999999999999887 999999999865432 


Q ss_pred             --ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhc-------------------
Q 015500          153 --LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYS-------------------  211 (405)
Q Consensus       153 --~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~-------------------  211 (405)
                        ....||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .....+...                   
T Consensus       174 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (355)
T cd07874         174 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI-DQWNKVIEQLGTPCPEFMKKLQPTVRNY  252 (355)
T ss_pred             ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHHHhhcHHHHHH
Confidence              3456899999999999999999999999999999999999999654321 111110000                   


Q ss_pred             -CCCC--------------------CCchhccHHHHHHHHHhcccCccccCCHHHHhcCccccccc
Q 015500          212 -RELP--------------------EVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFC  256 (405)
Q Consensus       212 -~~~~--------------------~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~  256 (405)
                       ...+                    ..+...+.++++||.+||+.||.+|||+.|+|+||||....
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~  318 (355)
T cd07874         253 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWY  318 (355)
T ss_pred             HhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhccc
Confidence             0000                    01122456789999999999999999999999999998653

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=7.6e-44  Score=334.69  Aligned_cols=245  Identities=31%  Similarity=0.481  Sum_probs=211.2

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC-----ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP-----KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~-----~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      +|...+.||+|++|.||+|.++.+++.+++|.+...     ....+.+|+++++.++||||+++++.+....    .+++
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~l   76 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKG----KLNI   76 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCC----EEEE
Confidence            688999999999999999999999999999987642     2456888999999999999999998766443    3679


Q ss_pred             EEeecCCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc--
Q 015500           77 FMEYAPGGTLNDEIHRN-GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA--  152 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~-~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~--  152 (405)
                      +|||++|++|.+++... +..+++..+..++.||+.||.|||+.|++|+||||+||+++.++ +||+|||+++.....  
T Consensus        77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~  156 (256)
T cd08529          77 VMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN  156 (256)
T ss_pred             EEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence            99999999999999774 45799999999999999999999999999999999999999877 999999998764432  


Q ss_pred             --ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHH
Q 015500          153 --LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLS  230 (405)
Q Consensus       153 --~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~  230 (405)
                        ....|++.|+|||++.+..++.++|+|||||++++|++|+.||.... ......++ .....+.++..++.++.+++.
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~  234 (256)
T cd08529         157 FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN-QGALILKI-IRGVFPPVSQMYSQQLAQLID  234 (256)
T ss_pred             hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC-HHHHHHHH-HcCCCCCCccccCHHHHHHHH
Confidence              23458899999999999889999999999999999999999996443 33333333 344556667678999999999


Q ss_pred             HhcccCccccCCHHHHhcCccc
Q 015500          231 NCLRRDPKERWAASQLLKHPFL  252 (405)
Q Consensus       231 ~~L~~dP~~Rpt~~elL~hp~~  252 (405)
                      +||+.+|++||++.++++|||+
T Consensus       235 ~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         235 QCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             HHccCCcccCcCHHHHhhCCCC
Confidence            9999999999999999999985

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-45  Score=357.52  Aligned_cols=239  Identities=29%  Similarity=0.470  Sum_probs=197.0

Q ss_pred             cceeCCeeEEEEEEcCCCCEEEEEEccCCC------hHHHHHHHHHHHhC---CCCCeeeeeeeeeecCCCceEEEEEEe
Q 015500            9 IGQGSSATVSLATSLRSGDVFAAKSTELPK------SEFLQREQKFLSSL---NSPHIVGYKGCDVTSEDNKLMYNLFME   79 (405)
Q Consensus         9 LG~G~~g~Vyla~~~~~~~~vavK~~~~~~------~~~l~~E~~iL~~L---~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (405)
                      ||+|+||+||+|+++.+++.||||.+....      .....+|..++..+   .||||++++..+....    .+++|||
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~----~~~lv~e   76 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDS----DLYLVTD   76 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCC----eEEEEEc
Confidence            799999999999999999999999986421      12344566777665   6999999988765543    3679999


Q ss_pred             ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc----ccc
Q 015500           80 YAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE----ALQ  154 (405)
Q Consensus        80 y~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~----~~~  154 (405)
                      |+++|+|.+++.+. +.+++..++.++.||+.||+|||++||+||||||+|||++.++ +||+|||+++....    ...
T Consensus        77 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~  155 (330)
T cd05586          77 YMSGGELFWHLQKE-GRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT  155 (330)
T ss_pred             CCCCChHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccC
Confidence            99999999998775 4899999999999999999999999999999999999999887 99999999875322    234


Q ss_pred             CCCCCCccChhhhcCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCc-hhccHHHHHHHHHh
Q 015500          155 SGGTPMFMAPEVARGE-HQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVP-AFLSKQANDFLSNC  232 (405)
Q Consensus       155 ~~gt~~Y~APE~l~~~-~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p-~~~s~~l~dll~~~  232 (405)
                      .+||+.|+|||++.+. .++.++|||||||++|+|++|+.||... +.......+.... . .+| ..+++++.+||++|
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~-~~~~~~~~i~~~~-~-~~~~~~~~~~~~~li~~~  232 (330)
T cd05586         156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAE-DTQQMYRNIAFGK-V-RFPKNVLSDEGRQFVKGL  232 (330)
T ss_pred             ccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCC-CHHHHHHHHHcCC-C-CCCCccCCHHHHHHHHHH
Confidence            5699999999999764 4789999999999999999999999543 3333334443322 2 233 34789999999999


Q ss_pred             cccCccccC----CHHHHhcCcccccc
Q 015500          233 LRRDPKERW----AASQLLKHPFLEEF  255 (405)
Q Consensus       233 L~~dP~~Rp----t~~elL~hp~~~~~  255 (405)
                      |+.||.+||    ++.++++||||...
T Consensus       233 L~~~P~~R~~~~~~~~~ll~h~~~~~~  259 (330)
T cd05586         233 LNRNPQHRLGAHRDAVELKEHPFFADI  259 (330)
T ss_pred             cCCCHHHCCCCCCCHHHHhcCccccCC
Confidence            999999998    79999999999864

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=5.6e-44  Score=339.20  Aligned_cols=250  Identities=31%  Similarity=0.509  Sum_probs=207.0

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC--ChHHHHHHHHHHHhC-CCCCeeeeeeeeeecCCC--ceEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP--KSEFLQREQKFLSSL-NSPHIVGYKGCDVTSEDN--KLMYNL   76 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~--~~~~l~~E~~iL~~L-~hpnIv~~~~~~~~~~~~--~~~~~l   76 (405)
                      .|+..+.||+|+||.||+|.+..+++.+|+|.+...  ....+.+|+.+++++ +||||+++.+.+......  ...+++
T Consensus         7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~i   86 (272)
T cd06637           7 IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWL   86 (272)
T ss_pred             hhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEE
Confidence            478899999999999999999999999999998654  345788999999999 799999999987654321  235679


Q ss_pred             EEeecCCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc---
Q 015500           77 FMEYAPGGTLNDEIHRN-GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE---  151 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~-~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~---  151 (405)
                      +|||+++++|.+++... +..+++..+..++.|++.||+|||++||+|+||||+||+++.++ +||+|||++.....   
T Consensus        87 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~~  166 (272)
T cd06637          87 VMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG  166 (272)
T ss_pred             EEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceecccccc
Confidence            99999999999999874 34689999999999999999999999999999999999999887 99999999875432   


Q ss_pred             -cccCCCCCCccChhhhcC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHH
Q 015500          152 -ALQSGGTPMFMAPEVARG-----EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQA  225 (405)
Q Consensus       152 -~~~~~gt~~Y~APE~l~~-----~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l  225 (405)
                       .....|++.|+|||++.+     ..++.++|||||||++|+|++|+.||.... .................+..++.++
T Consensus       167 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  245 (272)
T cd06637         167 RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH-PMRALFLIPRNPAPRLKSKKWSKKF  245 (272)
T ss_pred             cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccC-HHHHHHHHhcCCCCCCCCCCcCHHH
Confidence             223468999999999863     357889999999999999999999996443 2222233222222222334578999


Q ss_pred             HHHHHHhcccCccccCCHHHHhcCccc
Q 015500          226 NDFLSNCLRRDPKERWAASQLLKHPFL  252 (405)
Q Consensus       226 ~dll~~~L~~dP~~Rpt~~elL~hp~~  252 (405)
                      .+||.+||..||.+|||+.++++||||
T Consensus       246 ~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         246 QSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             HHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence            999999999999999999999999997

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=6.8e-44  Score=338.41  Aligned_cols=248  Identities=40%  Similarity=0.735  Sum_probs=210.6

Q ss_pred             CCcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC--------hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCce
Q 015500            1 MDWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK--------SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKL   72 (405)
Q Consensus         1 ~~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~--------~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~   72 (405)
                      .+|..++.||+|+||.||+|.+..++..+|+|.+....        ...+.+|+.++++++||||+++++++.....  .
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--~   79 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAE--K   79 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCC--C
Confidence            47999999999999999999999999999999875421        2467889999999999999999987654322  2


Q ss_pred             EEEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc
Q 015500           73 MYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE  151 (405)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~  151 (405)
                      .+++++||+++++|.+++...+ .+++..+..++.||+.||+|||++|++||||||+||+++.++ +||+|||+++....
T Consensus        80 ~~~l~~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~  158 (266)
T cd06651          80 TLTIFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT  158 (266)
T ss_pred             EEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence            4569999999999999997753 799999999999999999999999999999999999999887 99999999875432


Q ss_pred             -------cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHH
Q 015500          152 -------ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQ  224 (405)
Q Consensus       152 -------~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~  224 (405)
                             .....++..|+|||.+.+..++.++|+|||||++|+|++|+.||..... .............+.+|..+++.
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  237 (266)
T cd06651         159 ICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA-MAAIFKIATQPTNPQLPSHISEH  237 (266)
T ss_pred             ccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch-HHHHHHHhcCCCCCCCchhcCHH
Confidence                   1123488899999999988899999999999999999999999975543 33334444444557778888999


Q ss_pred             HHHHHHHhcccCccccCCHHHHhcCcccc
Q 015500          225 ANDFLSNCLRRDPKERWAASQLLKHPFLE  253 (405)
Q Consensus       225 l~dll~~~L~~dP~~Rpt~~elL~hp~~~  253 (405)
                      ++++| +||..+|++|||++++++||||+
T Consensus       238 ~~~li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         238 ARDFL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             HHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence            99999 57778999999999999999986

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=6.8e-44  Score=337.74  Aligned_cols=244  Identities=39%  Similarity=0.719  Sum_probs=209.1

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC------------hHHHHHHHHHHHhCCCCCeeeeeeeeeecCC
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK------------SEFLQREQKFLSSLNSPHIVGYKGCDVTSED   69 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~------------~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~   69 (405)
                      .|.+++.||+|++|.||+|.+..+++.+|+|.+....            .+.+.+|+.++++++||||+++.+.+.... 
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-   79 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDAD-   79 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC-
Confidence            5899999999999999999999899999999875431            145788999999999999999998765543 


Q ss_pred             CceEEEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccc
Q 015500           70 NKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKW  148 (405)
Q Consensus        70 ~~~~~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~  148 (405)
                         .++++|||+++++|.+++... +.+++..+..++.|++.||+|||++|++||||+|+||+++.++ +||+|||+++.
T Consensus        80 ---~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~  155 (267)
T cd06628          80 ---HLNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKK  155 (267)
T ss_pred             ---ccEEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence               366999999999999999876 4799999999999999999999999999999999999999887 99999999876


Q ss_pred             cccc----------ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCc
Q 015500          149 ESEA----------LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVP  218 (405)
Q Consensus       149 ~~~~----------~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p  218 (405)
                      ....          ....|++.|+|||.+.+..++.++|+|||||++|+|++|+.||..... ......+.. ...+..|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~-~~~~~~~  233 (267)
T cd06628         156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ-LQAIFKIGE-NASPEIP  233 (267)
T ss_pred             cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH-HHHHHHHhc-cCCCcCC
Confidence            5421          123478899999999988899999999999999999999999975533 233333322 3445677


Q ss_pred             hhccHHHHHHHHHhcccCccccCCHHHHhcCccc
Q 015500          219 AFLSKQANDFLSNCLRRDPKERWAASQLLKHPFL  252 (405)
Q Consensus       219 ~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~  252 (405)
                      ..++..+.++|++||+.||.+||++.++++||||
T Consensus       234 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         234 SNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             cccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence            7789999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=6e-44  Score=335.41  Aligned_cols=246  Identities=36%  Similarity=0.540  Sum_probs=209.7

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEee
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEY   80 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~Ey   80 (405)
                      +|+..+.||+|+||.||+|.+..+++.+++|.+.... .+.+.+|++++++++||||+++++.+....    .+++++||
T Consensus         4 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~----~~~l~~e~   79 (256)
T cd06612           4 VFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFKNT----DLWIVMEY   79 (256)
T ss_pred             cchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCC----cEEEEEec
Confidence            5889999999999999999999889999999987543 568999999999999999999999876543    36799999


Q ss_pred             cCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc----ccC
Q 015500           81 APGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA----LQS  155 (405)
Q Consensus        81 ~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~----~~~  155 (405)
                      +++++|.+++...+..+++..+..++.||+.||.|||+.|++|+||+|+||+++.++ +||+|||++......    ...
T Consensus        80 ~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~  159 (256)
T cd06612          80 CGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTV  159 (256)
T ss_pred             CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCccccccc
Confidence            999999999987667899999999999999999999999999999999999999888 999999998764432    233


Q ss_pred             CCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHh-cCCCCCCchhccHHHHHHHHHhcc
Q 015500          156 GGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAY-SRELPEVPAFLSKQANDFLSNCLR  234 (405)
Q Consensus       156 ~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~-~~~~~~~p~~~s~~l~dll~~~L~  234 (405)
                      .+++.|+|||++.+..++.++|||||||++|+|++|+.||........ ...+.. .......+..++..+.+||.+||+
T Consensus       160 ~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  238 (256)
T cd06612         160 IGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA-IFMIPNKPPPTLSDPEKWSPEFNDFVKKCLV  238 (256)
T ss_pred             cCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh-hhhhccCCCCCCCchhhcCHHHHHHHHHHHh
Confidence            488999999999998899999999999999999999999965433222 222111 111122345578899999999999


Q ss_pred             cCccccCCHHHHhcCccc
Q 015500          235 RDPKERWAASQLLKHPFL  252 (405)
Q Consensus       235 ~dP~~Rpt~~elL~hp~~  252 (405)
                      .||++|||+.++|+||||
T Consensus       239 ~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         239 KDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             cChhhCcCHHHHhcCCCC
Confidence            999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.7e-44  Score=352.90  Aligned_cols=241  Identities=28%  Similarity=0.430  Sum_probs=199.7

Q ss_pred             cccceeCCeeEEEEEEcCCCCEEEEEEccCCC------hHHHHHHH-HHHHhCCCCCeeeeeeeeeecCCCceEEEEEEe
Q 015500            7 HTIGQGSSATVSLATSLRSGDVFAAKSTELPK------SEFLQREQ-KFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFME   79 (405)
Q Consensus         7 ~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~------~~~l~~E~-~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (405)
                      +.||+|+||+||+|+++.+++.+|+|.+....      ...+.+|. .+++.++||||+++++.+....    .+++|||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~----~~~lv~e   76 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAE----KLYFVLD   76 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCC----EEEEEEc
Confidence            47999999999999999999999999876421      22344444 4688899999999988765433    3679999


Q ss_pred             ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc----ccc
Q 015500           80 YAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE----ALQ  154 (405)
Q Consensus        80 y~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~----~~~  154 (405)
                      |++|++|.+.+.+. +.+++..++.++.||+.||.|||++||+||||||+||+++.++ +||+|||+++....    ...
T Consensus        77 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (321)
T cd05603          77 YVNGGELFFHLQRE-RCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST  155 (321)
T ss_pred             CCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCcccc
Confidence            99999999988765 4799999999999999999999999999999999999999887 99999999875321    233


Q ss_pred             CCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHhcc
Q 015500          155 SGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLR  234 (405)
Q Consensus       155 ~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~L~  234 (405)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||... +.......+. . ....+|...+..+.++|.+||+
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~-~~~~~~~~i~-~-~~~~~~~~~~~~~~~li~~~l~  232 (321)
T cd05603         156 FCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSR-DVSQMYDNIL-H-KPLQLPGGKTVAACDLLVGLLH  232 (321)
T ss_pred             ccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCC-CHHHHHHHHh-c-CCCCCCCCCCHHHHHHHHHHcc
Confidence            56899999999999988999999999999999999999999644 3333333332 2 2345666789999999999999


Q ss_pred             cCccccCCH----HHHhcCcccccc
Q 015500          235 RDPKERWAA----SQLLKHPFLEEF  255 (405)
Q Consensus       235 ~dP~~Rpt~----~elL~hp~~~~~  255 (405)
                      +||.+|+++    .++++||||...
T Consensus       233 ~~p~~R~~~~~~~~~~~~~~~~~~~  257 (321)
T cd05603         233 KDQRRRLGAKADFLEIKNHVFFSPI  257 (321)
T ss_pred             CCHhhcCCCCCCHHHHhCCCCcCCC
Confidence            999999976    499999999754

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-44  Score=341.68  Aligned_cols=249  Identities=35%  Similarity=0.526  Sum_probs=209.6

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCCh---HHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS---EFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFM   78 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~~---~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (405)
                      +|.+.+.||.|+||+||+|.+..+++.+|+|.+.....   +.+.+|++++++++||||+++++.+....    .+++||
T Consensus         6 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~   81 (280)
T cd06611           6 IWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYEN----KLWILI   81 (280)
T ss_pred             HHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCC----eEEEEe
Confidence            58899999999999999999998999999999875433   46778999999999999999999876433    367999


Q ss_pred             eecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc----cc
Q 015500           79 EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE----AL  153 (405)
Q Consensus        79 Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~----~~  153 (405)
                      ||+++++|.+++...+..+++..++.++.|++.||.|||++||+|+||||+||+++.++ ++|+|||++.....    ..
T Consensus        82 e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~  161 (280)
T cd06611          82 EFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRD  161 (280)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccccccc
Confidence            99999999999988666899999999999999999999999999999999999999887 99999998865332    22


Q ss_pred             cCCCCCCccChhhhcC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCC-CCCCchhccHHHHH
Q 015500          154 QSGGTPMFMAPEVARG-----EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRE-LPEVPAFLSKQAND  227 (405)
Q Consensus       154 ~~~gt~~Y~APE~l~~-----~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~-~~~~p~~~s~~l~d  227 (405)
                      ...+|+.|+|||.+..     ..++.++|+|||||++|+|++|+.||... +......++..... ....|..++.++.+
T Consensus       162 ~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (280)
T cd06611         162 TFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL-NPMRVLLKILKSEPPTLDQPSKWSSSFND  240 (280)
T ss_pred             eeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccC-CHHHHHHHHhcCCCCCcCCcccCCHHHHH
Confidence            3458999999999853     34677999999999999999999999654 33343444332221 12335568899999


Q ss_pred             HHHHhcccCccccCCHHHHhcCcccccc
Q 015500          228 FLSNCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       228 ll~~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      +|.+||+.+|.+||++.++++||||...
T Consensus       241 li~~~l~~~p~~Rps~~~il~~~~~~~~  268 (280)
T cd06611         241 FLKSCLVKDPDDRPTAAELLKHPFVSDQ  268 (280)
T ss_pred             HHHHHhccChhhCcCHHHHhcChhhccc
Confidence            9999999999999999999999999865

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=6e-44  Score=343.07  Aligned_cols=251  Identities=27%  Similarity=0.417  Sum_probs=209.3

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC------hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK------SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~------~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~   75 (405)
                      .|++.+.||+|+||+||+|.+..+++.+|+|.+....      ...+.+|+++|+.++||||+++.+.+...+    ..+
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~----~~~   76 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKD----ALC   76 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCC----EEE
Confidence            4788999999999999999999999999999886432      235678999999999999999988765433    367


Q ss_pred             EEEeecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc--
Q 015500           76 LFMEYAPGGTLNDEIHRNG-GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE--  151 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~~-~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~--  151 (405)
                      ++|||+++++|.+++...+ .++++..+..++.|++.||.|||++||+||||||+||+++.++ +||+|||++.....  
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05632          77 LVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE  156 (285)
T ss_pred             EEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence            9999999999999886543 3699999999999999999999999999999999999998887 99999999865432  


Q ss_pred             -cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHH-HHHHHhcCCCCCCchhccHHHHHHH
Q 015500          152 -ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTV-LYKIAYSRELPEVPAFLSKQANDFL  229 (405)
Q Consensus       152 -~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~-l~~i~~~~~~~~~p~~~s~~l~dll  229 (405)
                       .....|++.|+|||.+.+..++.++|+|||||++|+|++|..||......... ..........+.++..+++++.+|+
T Consensus       157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  236 (285)
T cd05632         157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSIC  236 (285)
T ss_pred             cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHH
Confidence             22346899999999999888999999999999999999999999654332211 1111112223345667889999999


Q ss_pred             HHhcccCccccCC-----HHHHhcCccccccc
Q 015500          230 SNCLRRDPKERWA-----ASQLLKHPFLEEFC  256 (405)
Q Consensus       230 ~~~L~~dP~~Rpt-----~~elL~hp~~~~~~  256 (405)
                      .+||+.||.+|||     +.+++.||||....
T Consensus       237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~  268 (285)
T cd05632         237 KMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMN  268 (285)
T ss_pred             HHHccCCHhHcCCCcccChHHHHcChhhhcCC
Confidence            9999999999999     89999999998763

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=3.8e-44  Score=342.77  Aligned_cols=246  Identities=28%  Similarity=0.432  Sum_probs=202.4

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      +|...+.||+|+||+||+|++..+|+.+|+|.+....     ...+.+|+.++++++||||+++++.+....    .+++
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~----~~~l   76 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDK----KLTL   76 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCC----ceEE
Confidence            5889999999999999999999999999999886432     246788999999999999999998875433    3679


Q ss_pred             EEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc---
Q 015500           77 FMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA---  152 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~---  152 (405)
                      ++||++ ++|.+++...++++++..++.++.||+.||.|||++|++||||||+||+++.++ +||+|||+++.....   
T Consensus        77 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~  155 (284)
T cd07839          77 VFEYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC  155 (284)
T ss_pred             EEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC
Confidence            999996 488888877667899999999999999999999999999999999999999887 999999998754321   


Q ss_pred             -ccCCCCCCccChhhhcCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhc------------------C
Q 015500          153 -LQSGGTPMFMAPEVARGE-HQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYS------------------R  212 (405)
Q Consensus       153 -~~~~gt~~Y~APE~l~~~-~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~------------------~  212 (405)
                       ....+++.|+|||++.+. .++.++|||||||++|+|+||..||....+....+..+...                  .
T Consensus       156 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd07839         156 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYK  235 (284)
T ss_pred             cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccc
Confidence             234578999999998774 47889999999999999999999975554443333322110                  0


Q ss_pred             CCCC---------CchhccHHHHHHHHHhcccCccccCCHHHHhcCccc
Q 015500          213 ELPE---------VPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFL  252 (405)
Q Consensus       213 ~~~~---------~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~  252 (405)
                      ..+.         ....+++++.+||++||+.||.+|||++++++||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         236 PYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             ccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence            0111         112368899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-45  Score=368.18  Aligned_cols=249  Identities=33%  Similarity=0.495  Sum_probs=218.2

Q ss_pred             cccccccceeCCeeEEEEEEcCCCCEEEEEEccCCCh---HHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEe
Q 015500            3 WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS---EFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFME   79 (405)
Q Consensus         3 y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~~---~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (405)
                      |.++..||.|+||+||+|.++.++-..|-|+++....   +.+.-||.||...+||+||++++.|.....    ++++.|
T Consensus        34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enk----LwiliE  109 (1187)
T KOG0579|consen   34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENK----LWILIE  109 (1187)
T ss_pred             HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCc----eEEEEe
Confidence            8899999999999999999999999999999987654   456679999999999999999998765544    568999


Q ss_pred             ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc----ccc
Q 015500           80 YAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE----ALQ  154 (405)
Q Consensus        80 y~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~----~~~  154 (405)
                      ||.||-+...+..-+..|++.++..+++|++.||.|||+++|||||||..|||++.+| ++|+|||.+.....    ...
T Consensus       110 FC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRDs  189 (1187)
T KOG0579|consen  110 FCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRDS  189 (1187)
T ss_pred             ecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhhhcc
Confidence            9999999999988888899999999999999999999999999999999999999998 99999998754322    345


Q ss_pred             CCCCCCccChhhhc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCC-CCchhccHHHHHH
Q 015500          155 SGGTPMFMAPEVAR-----GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELP-EVPAFLSKQANDF  228 (405)
Q Consensus       155 ~~gt~~Y~APE~l~-----~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~-~~p~~~s~~l~dl  228 (405)
                      ..|||+|||||++.     ..+|++++||||||++|+||+-+.+|-. .-++..++.++..+.+.. ..|+.++..+.||
T Consensus       190 FIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHh-elnpMRVllKiaKSePPTLlqPS~Ws~~F~Df  268 (1187)
T KOG0579|consen  190 FIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHH-ELNPMRVLLKIAKSEPPTLLQPSHWSRSFSDF  268 (1187)
T ss_pred             ccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcc-ccchHHHHHHHhhcCCCcccCcchhhhHHHHH
Confidence            67999999999864     5689999999999999999999999984 446777788877665432 3477899999999


Q ss_pred             HHHhcccCccccCCHHHHhcCccccccc
Q 015500          229 LSNCLRRDPKERWAASQLLKHPFLEEFC  256 (405)
Q Consensus       229 l~~~L~~dP~~Rpt~~elL~hp~~~~~~  256 (405)
                      |++||.+||..||+++|||+||||....
T Consensus       269 Lk~cL~Knp~~Rp~aaqll~Hpfv~~~~  296 (1187)
T KOG0579|consen  269 LKRCLVKNPRNRPPAAQLLKHPFVQNAP  296 (1187)
T ss_pred             HHHHHhcCCccCCCHHHHhhCcccccCC
Confidence            9999999999999999999999998653

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3e-44  Score=356.88  Aligned_cols=245  Identities=24%  Similarity=0.328  Sum_probs=198.2

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEeec
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYA   81 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~Ey~   81 (405)
                      +|++++.||+|+||.||+|.+..+++.||+|.....   ...+|+.+|++++||||+++++++....    ..++||||+
T Consensus        67 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~lv~e~~  139 (357)
T PHA03209         67 GYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---TTLIEAMLLQNVNHPSVIRMKDTLVSGA----ITCMVLPHY  139 (357)
T ss_pred             CcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---ccHHHHHHHHhCCCCCCcChhheEEeCC----eeEEEEEcc
Confidence            589999999999999999999999999999985433   3467999999999999999999876543    366899999


Q ss_pred             CCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc---cccCCC
Q 015500           82 PGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE---ALQSGG  157 (405)
Q Consensus        82 ~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~---~~~~~g  157 (405)
                      . ++|.+++.....++++..++.++.||+.||.|||++||+||||||+|||++.++ +||+|||+++....   .....|
T Consensus       140 ~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~g  218 (357)
T PHA03209        140 S-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAG  218 (357)
T ss_pred             C-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCcccccccc
Confidence            5 589998887767899999999999999999999999999999999999999887 99999999975322   234569


Q ss_pred             CCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-Ch--------HHHHHHHHhc-CC-CCCCc--------
Q 015500          158 TPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAA-DP--------MTVLYKIAYS-RE-LPEVP--------  218 (405)
Q Consensus       158 t~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~-~~--------~~~l~~i~~~-~~-~~~~p--------  218 (405)
                      |+.|+|||++.+..++.++|||||||++|||+++..|+.... ..        ...+.++... .. ...+|        
T Consensus       219 t~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  298 (357)
T PHA03209        219 TVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLV  298 (357)
T ss_pred             cccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHH
Confidence            999999999999899999999999999999998665542221 11        1111111110 00 00011        


Q ss_pred             ----------------------hhccHHHHHHHHHhcccCccccCCHHHHhcCccccc
Q 015500          219 ----------------------AFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEE  254 (405)
Q Consensus       219 ----------------------~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~  254 (405)
                                            ..++.++.+||.+||+.||.+|||+.|+|+||||++
T Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~  356 (357)
T PHA03209        299 RGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ  356 (357)
T ss_pred             HHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence                                  134667888999999999999999999999999975

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=7.7e-44  Score=344.51  Aligned_cols=249  Identities=27%  Similarity=0.411  Sum_probs=204.4

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLF   77 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv   77 (405)
                      +|...+.||+|+||.||+|.++.+++.||+|.+....    ...+.+|+.+++.++||||+++++++....    .+++|
T Consensus         7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~----~~~lv   82 (301)
T cd07873           7 TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEK----SLTLV   82 (301)
T ss_pred             ceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCC----eEEEE
Confidence            5889999999999999999999999999999876432    346778999999999999999999875433    36799


Q ss_pred             EeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc----c
Q 015500           78 MEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE----A  152 (405)
Q Consensus        78 ~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~----~  152 (405)
                      |||++ ++|.+++...+..+++..++.++.||+.||.|||+.|++||||||+||+++.++ +||+|||++.....    .
T Consensus        83 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  161 (301)
T cd07873          83 FEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY  161 (301)
T ss_pred             Eeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCcc
Confidence            99997 599999887666899999999999999999999999999999999999999887 99999999875332    1


Q ss_pred             ccCCCCCCccChhhhcCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhc--------------------
Q 015500          153 LQSGGTPMFMAPEVARGE-HQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYS--------------------  211 (405)
Q Consensus       153 ~~~~gt~~Y~APE~l~~~-~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~--------------------  211 (405)
                      ....+++.|+|||++.+. .++.++|||||||++|+|+||++||..... ......+...                    
T Consensus       162 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (301)
T cd07873         162 SNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTV-EEQLHFIFRILGTPTEETWPGILSNEEFKS  240 (301)
T ss_pred             cccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHcCCCChhhchhhhccccccc
Confidence            234578999999998764 578899999999999999999999965432 2222211110                    


Q ss_pred             CCCCC--------CchhccHHHHHHHHHhcccCccccCCHHHHhcCccccccc
Q 015500          212 RELPE--------VPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFC  256 (405)
Q Consensus       212 ~~~~~--------~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~  256 (405)
                      ...+.        ....+++++++||.+||+.||.+|||++++|+||||+.+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~  293 (301)
T cd07873         241 YNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG  293 (301)
T ss_pred             cccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence            00111        1124688999999999999999999999999999998653

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.1e-43  Score=339.85  Aligned_cols=248  Identities=33%  Similarity=0.510  Sum_probs=207.9

Q ss_pred             cccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC---hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEe
Q 015500            3 WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK---SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFME   79 (405)
Q Consensus         3 y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~---~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (405)
                      |++.+.||.|+||+||+|.+..++..+++|.+....   .+.+.+|+++++.++||||+++++.+....    .+++++|
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~----~~~~v~e   82 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN----NLWILIE   82 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCC----EEEEEEE
Confidence            678899999999999999999999999999986543   346778999999999999999998876543    3669999


Q ss_pred             ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc----ccc
Q 015500           80 YAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE----ALQ  154 (405)
Q Consensus        80 y~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~----~~~  154 (405)
                      |+++++|..++.+..+++++..+..++.||+.||.|||+.|++||||||+||+++.++ +||+|||++.....    ...
T Consensus        83 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~  162 (282)
T cd06643          83 FCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS  162 (282)
T ss_pred             ecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccccccccc
Confidence            9999999998876556899999999999999999999999999999999999998887 99999999865432    223


Q ss_pred             CCCCCCccChhhhc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcC-CCCCCchhccHHHHHH
Q 015500          155 SGGTPMFMAPEVAR-----GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSR-ELPEVPAFLSKQANDF  228 (405)
Q Consensus       155 ~~gt~~Y~APE~l~-----~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~-~~~~~p~~~s~~l~dl  228 (405)
                      ..+|+.|+|||++.     +..++.++|+|||||++|+|++|++||.... .......+.... .....|..++.++.+|
T Consensus       163 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  241 (282)
T cd06643         163 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN-PMRVLLKIAKSEPPTLAQPSRWSSEFKDF  241 (282)
T ss_pred             ccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC-HHHHHHHHhhcCCCCCCCccccCHHHHHH
Confidence            45899999999984     3456789999999999999999999996543 333333333222 1223456688999999


Q ss_pred             HHHhcccCccccCCHHHHhcCcccccc
Q 015500          229 LSNCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       229 l~~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      |.+||..||.+|||++++++||||...
T Consensus       242 i~~~l~~~p~~Rp~~~~il~~~~~~~~  268 (282)
T cd06643         242 LKKCLEKNVDARWTTTQLLQHPFVTVN  268 (282)
T ss_pred             HHHHccCChhhCcCHHHHhcCCCEecc
Confidence            999999999999999999999999854

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-45  Score=361.10  Aligned_cols=245  Identities=30%  Similarity=0.461  Sum_probs=215.6

Q ss_pred             ccccceeCCeeEEEEEEcCCCCEEEEEEccC-----CChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEee
Q 015500            6 GHTIGQGSSATVSLATSLRSGDVFAAKSTEL-----PKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEY   80 (405)
Q Consensus         6 ~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~-----~~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~Ey   80 (405)
                      .++||+|.||+||-|+++++|+.||||++++     .+..++++|+.||+++.||.||.+.-.+.+.+.    .++|||.
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~er----vFVVMEK  644 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPER----VFVVMEK  644 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCce----EEEEehh
Confidence            5789999999999999999999999999875     346789999999999999999999877666554    5589999


Q ss_pred             cCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC----ceEeeecccccccc---cc
Q 015500           81 APGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG----AKIADFGCAKWESE---AL  153 (405)
Q Consensus        81 ~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~----vkL~DFGla~~~~~---~~  153 (405)
                      +.|.-|.-.+....|+|+|...+.++.||+.||.|||-+||+||||||+|||+.+..    +||||||+|+.+.+   ..
T Consensus       645 l~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRr  724 (888)
T KOG4236|consen  645 LHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRR  724 (888)
T ss_pred             hcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhh
Confidence            977666666666678999999999999999999999999999999999999997654    89999999998776   45


Q ss_pred             cCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHhc
Q 015500          154 QSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCL  233 (405)
Q Consensus       154 ~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~L  233 (405)
                      ..+|||.|+|||+++...|+...|+||.|+++|.-+.|..||...++..+++....+.- .|.....+++.+.|||.++|
T Consensus       725 sVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMy-Pp~PW~eis~~AidlIn~LL  803 (888)
T KOG4236|consen  725 SVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMY-PPNPWSEISPEAIDLINNLL  803 (888)
T ss_pred             hhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhcccccc-CCCchhhcCHHHHHHHHHHH
Confidence            67799999999999999999999999999999999999999988777777666554432 23344679999999999999


Q ss_pred             ccCccccCCHHHHhcCcccccc
Q 015500          234 RRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       234 ~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      +..-.+|.|+++.|.|||++.+
T Consensus       804 qVkm~kRysvdk~lsh~Wlq~y  825 (888)
T KOG4236|consen  804 QVKMRKRYSVDKSLSHPWLQDY  825 (888)
T ss_pred             HHHHHHhcchHhhccchhhhcc
Confidence            9999999999999999999864

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=7.7e-44  Score=337.68  Aligned_cols=244  Identities=35%  Similarity=0.507  Sum_probs=202.8

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC---hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK---SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFM   78 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~---~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (405)
                      +|.+.+.||+|+||.||+|.+..+++.+|+|.+....   ...+.+|+.+++.++||||+++++.+....    .++++|
T Consensus        10 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~----~~~lv~   85 (267)
T cd06645          10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRD----KLWICM   85 (267)
T ss_pred             HHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC----EEEEEE
Confidence            5888999999999999999999999999999876543   345788999999999999999998776543    367999


Q ss_pred             eecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc----cc
Q 015500           79 EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE----AL  153 (405)
Q Consensus        79 Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~----~~  153 (405)
                      ||+++++|.+++... +.+++..++.++.|++.||.|||++|++|+||||+||+++.++ +||+|||++.....    ..
T Consensus        86 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~  164 (267)
T cd06645          86 EFCGGGSLQDIYHVT-GPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRK  164 (267)
T ss_pred             eccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcccccc
Confidence            999999999998776 4899999999999999999999999999999999999999887 99999999865432    22


Q ss_pred             cCCCCCCccChhhhc---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCC-CCC--chhccHHHHH
Q 015500          154 QSGGTPMFMAPEVAR---GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSREL-PEV--PAFLSKQAND  227 (405)
Q Consensus       154 ~~~gt~~Y~APE~l~---~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~-~~~--p~~~s~~l~d  227 (405)
                      ...|++.|+|||.+.   ...++.++|+|||||++|+|++|..||....... ........... +..  ...++..+.+
T Consensus       165 ~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (267)
T cd06645         165 SFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR-ALFLMTKSNFQPPKLKDKMKWSNSFHH  243 (267)
T ss_pred             cccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh-hHHhhhccCCCCCcccccCCCCHHHHH
Confidence            346899999999985   4457889999999999999999999996543322 22222222211 111  1246789999


Q ss_pred             HHHHhcccCccccCCHHHHhcCcc
Q 015500          228 FLSNCLRRDPKERWAASQLLKHPF  251 (405)
Q Consensus       228 ll~~~L~~dP~~Rpt~~elL~hp~  251 (405)
                      ||.+||+.+|.+|||++++++|||
T Consensus       244 li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         244 FVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             HHHHHccCCchhCcCHHHHhcCCC
Confidence            999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1e-43  Score=343.55  Aligned_cols=247  Identities=37%  Similarity=0.574  Sum_probs=209.3

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC---hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK---SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFM   78 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~---~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (405)
                      +|+..+.||+|+||.||+|++..+++.+|+|.+....   .+.+.+|+.+++.++||||+++++.+....    .+++||
T Consensus        21 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~----~~~lv~   96 (296)
T cd06654          21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD----ELWVVM   96 (296)
T ss_pred             ceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCC----EEEEee
Confidence            5889999999999999999999999999999886543   457889999999999999999998876533    367999


Q ss_pred             eecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc----cc
Q 015500           79 EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE----AL  153 (405)
Q Consensus        79 Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~----~~  153 (405)
                      ||++|++|.+++.+.  .+++..+..++.|++.||.|||++||+||||||+||+++.++ +||+|||++.....    ..
T Consensus        97 e~~~~~~L~~~~~~~--~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  174 (296)
T cd06654          97 EYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS  174 (296)
T ss_pred             cccCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccccccC
Confidence            999999999998653  689999999999999999999999999999999999999887 99999999875432    22


Q ss_pred             cCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcC-CCCCCchhccHHHHHHHHHh
Q 015500          154 QSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSR-ELPEVPAFLSKQANDFLSNC  232 (405)
Q Consensus       154 ~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~-~~~~~p~~~s~~l~dll~~~  232 (405)
                      ...|++.|+|||.+.+..++.++|||||||++|+|++|+.||.... +...+..+.... .....+..++..+.+++.+|
T Consensus       175 ~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  253 (296)
T cd06654         175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN-PLRALYLIATNGTPELQNPEKLSAIFRDFLNRC  253 (296)
T ss_pred             cccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCC-HHHhHHHHhcCCCCCCCCccccCHHHHHHHHHH
Confidence            3468999999999998888999999999999999999999996443 333333332222 12234556889999999999


Q ss_pred             cccCccccCCHHHHhcCcccccc
Q 015500          233 LRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       233 L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      |..+|.+|||+.++++||||...
T Consensus       254 l~~~p~~Rpt~~eil~~~~~~~~  276 (296)
T cd06654         254 LDMDVEKRGSAKELLQHQFLKIA  276 (296)
T ss_pred             CcCCcccCcCHHHHhhChhhhcc
Confidence            99999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.3e-43  Score=341.22  Aligned_cols=247  Identities=32%  Similarity=0.528  Sum_probs=213.3

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC------ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~------~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~   75 (405)
                      +|++.+.||+|+||.||+|.+..+++.+|+|.+...      ..+.+.+|+++|++++||||+++++++....    .++
T Consensus         2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~   77 (290)
T cd05580           2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDS----NLY   77 (290)
T ss_pred             ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCC----eEE
Confidence            689999999999999999999999999999987542      3456889999999999999999998765433    367


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc-cc
Q 015500           76 LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE-AL  153 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~-~~  153 (405)
                      ++|||+++++|.+++... +.+++..+..++.||+.||.|||++|++|+||+|.||+++.++ +||+|||++..... ..
T Consensus        78 ~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~  156 (290)
T cd05580          78 LVMEYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTY  156 (290)
T ss_pred             EEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCCCC
Confidence            999999999999999876 4899999999999999999999999999999999999999887 99999999876543 33


Q ss_pred             cCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHhc
Q 015500          154 QSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCL  233 (405)
Q Consensus       154 ~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~L  233 (405)
                      ...+++.|+|||.+.+...+.++||||||+++|+|++|+.||.... ......++.  ...+.+|..++..++++|++||
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l  233 (290)
T cd05580         157 TLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN-PIQIYEKIL--EGKVRFPSFFSPDAKDLIRNLL  233 (290)
T ss_pred             CCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHh--cCCccCCccCCHHHHHHHHHHc
Confidence            4568999999999988888999999999999999999999996543 333333333  2334567778999999999999


Q ss_pred             ccCccccC-----CHHHHhcCccccccc
Q 015500          234 RRDPKERW-----AASQLLKHPFLEEFC  256 (405)
Q Consensus       234 ~~dP~~Rp-----t~~elL~hp~~~~~~  256 (405)
                      ..||.+|+     +++++++||||+...
T Consensus       234 ~~~p~~R~~~~~~~~~~l~~~~~~~~~~  261 (290)
T cd05580         234 QVDLTKRLGNLKNGVNDIKNHPWFAGID  261 (290)
T ss_pred             cCCHHHccCcccCCHHHHHcCcccccCC
Confidence            99999999     999999999998653

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1.7e-43  Score=340.39  Aligned_cols=250  Identities=34%  Similarity=0.495  Sum_probs=208.3

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC---hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK---SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFM   78 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~---~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (405)
                      .|++++.||+|+||.||+|.+..+++.+++|......   .+.+.+|+.+++.++||||+++++.+....    .+++||
T Consensus        13 ~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~   88 (292)
T cd06644          13 VWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDG----KLWIMI   88 (292)
T ss_pred             hhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCC----eEEEEE
Confidence            4889999999999999999999999999999987554   346778999999999999999999876543    367999


Q ss_pred             eecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc----cc
Q 015500           79 EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE----AL  153 (405)
Q Consensus        79 Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~----~~  153 (405)
                      ||++|++|..++.+....+++..+..++.||+.||.|||+.|++||||||+||+++.++ +||+|||++.....    ..
T Consensus        89 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~  168 (292)
T cd06644          89 EFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRD  168 (292)
T ss_pred             ecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccccccccc
Confidence            99999999998877666799999999999999999999999999999999999998777 99999999865332    12


Q ss_pred             cCCCCCCccChhhhcC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCC-CCCCchhccHHHHH
Q 015500          154 QSGGTPMFMAPEVARG-----EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRE-LPEVPAFLSKQAND  227 (405)
Q Consensus       154 ~~~gt~~Y~APE~l~~-----~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~-~~~~p~~~s~~l~d  227 (405)
                      ...+++.|+|||++.+     ..++.++|+|||||++|+|++|.+||.... ......++..... ....+..++.++.+
T Consensus       169 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (292)
T cd06644         169 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN-PMRVLLKIAKSEPPTLSQPSKWSMEFRD  247 (292)
T ss_pred             eecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcccc-HHHHHHHHhcCCCccCCCCcccCHHHHH
Confidence            3458899999999853     346779999999999999999999996443 3333333322211 12234567899999


Q ss_pred             HHHHhcccCccccCCHHHHhcCccccccc
Q 015500          228 FLSNCLRRDPKERWAASQLLKHPFLEEFC  256 (405)
Q Consensus       228 ll~~~L~~dP~~Rpt~~elL~hp~~~~~~  256 (405)
                      ||++||..||++||+++++++||||..+.
T Consensus       248 li~~~l~~~p~~Rp~~~~il~~~~~~~~~  276 (292)
T cd06644         248 FLKTALDKHPETRPSAAQLLEHPFVSSVT  276 (292)
T ss_pred             HHHHHhcCCcccCcCHHHHhcCccccccc
Confidence            99999999999999999999999998653

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.4e-43  Score=338.66  Aligned_cols=246  Identities=28%  Similarity=0.429  Sum_probs=200.3

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC-----ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP-----KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~-----~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      +|++.+.||+|++|+||+|+++.+++.+|+|.+...     ....+.+|+.++++++||||+++++.+....    .+++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~~   76 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQES----RLYL   76 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCC----eEEE
Confidence            689999999999999999999999999999987643     2356889999999999999999999876533    3679


Q ss_pred             EEeecCCCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc--
Q 015500           77 FMEYAPGGTLNDEIHRNG--GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE--  151 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~~--~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~--  151 (405)
                      ||||++ ++|.+++....  +.+++..++.++.||+.||.|||++|++||||||+||+++.++ +||+|||++.....  
T Consensus        77 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  155 (285)
T cd07861          77 IFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV  155 (285)
T ss_pred             EEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence            999997 58988886532  5799999999999999999999999999999999999999888 99999999875432  


Q ss_pred             --cccCCCCCCccChhhhcCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHh------------------
Q 015500          152 --ALQSGGTPMFMAPEVARGE-HQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAY------------------  210 (405)
Q Consensus       152 --~~~~~gt~~Y~APE~l~~~-~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~------------------  210 (405)
                        .....+++.|+|||++.+. .++.++|||||||++|+|+||+.||...............                  
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (285)
T cd07861         156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDY  235 (285)
T ss_pred             ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHH
Confidence              1223578999999998764 4788999999999999999999999654332221111000                  


Q ss_pred             cCCCC--------CCchhccHHHHHHHHHhcccCccccCCHHHHhcCccc
Q 015500          211 SRELP--------EVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFL  252 (405)
Q Consensus       211 ~~~~~--------~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~  252 (405)
                      ....+        .....+++++.+||++||..||.+|||+.++++||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         236 KNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             HhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence            00000        1123368899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=2.2e-43  Score=334.48  Aligned_cols=247  Identities=38%  Similarity=0.663  Sum_probs=210.0

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC--------hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK--------SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLM   73 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~--------~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~   73 (405)
                      +|++++.||+|+||+||+|.+..+++.||+|.+....        .+.+.+|++++++++||||+++++++.....  ..
T Consensus         3 ~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~--~~   80 (265)
T cd06652           3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPME--RT   80 (265)
T ss_pred             cceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCC--ce
Confidence            6999999999999999999999999999999875321        2467889999999999999999987654332  24


Q ss_pred             EEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc-
Q 015500           74 YNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE-  151 (405)
Q Consensus        74 ~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~-  151 (405)
                      ++++|||++|++|.+++.+. +.+++..+..++.|++.||.|||++|++|+||||+||+++.++ ++|+|||+++.... 
T Consensus        81 ~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~  159 (265)
T cd06652          81 LSIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTI  159 (265)
T ss_pred             EEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccc
Confidence            66899999999999999876 4789999999999999999999999999999999999999887 99999999875332 


Q ss_pred             ------cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHH
Q 015500          152 ------ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQA  225 (405)
Q Consensus       152 ------~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l  225 (405)
                            .....|+..|+|||.+.+..++.++|+|||||++|+|++|+.||..... .....+.......+..|..++..+
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  238 (265)
T cd06652         160 CLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA-MAAIFKIATQPTNPVLPPHVSDHC  238 (265)
T ss_pred             cccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch-HHHHHHHhcCCCCCCCchhhCHHH
Confidence                  2234588999999999988899999999999999999999999965533 333444444444566778889999


Q ss_pred             HHHHHHhcccCccccCCHHHHhcCcccc
Q 015500          226 NDFLSNCLRRDPKERWAASQLLKHPFLE  253 (405)
Q Consensus       226 ~dll~~~L~~dP~~Rpt~~elL~hp~~~  253 (405)
                      .++|++|+. +|++||+++++++|||+.
T Consensus       239 ~~~i~~~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         239 RDFLKRIFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             HHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence            999999995 899999999999999973

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=2.3e-44  Score=364.06  Aligned_cols=248  Identities=30%  Similarity=0.446  Sum_probs=206.7

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC--hHHHHHHHHHHHhCC-C-----CCeeeeeeeeeecCCCceE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK--SEFLQREQKFLSSLN-S-----PHIVGYKGCDVTSEDNKLM   73 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~--~~~l~~E~~iL~~L~-h-----pnIv~~~~~~~~~~~~~~~   73 (405)
                      .|.+.+.||+|+||.|-+|.+..|++.||||+++...  ..+...|+++|..|+ |     -|+|+++++|.....    
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H----  262 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH----  262 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc----
Confidence            4789999999999999999999999999999997654  356778999999997 4     589999999887654    


Q ss_pred             EEEEEeecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC---ceEeeecccccc
Q 015500           74 YNLFMEYAPGGTLNDEIHRNG-GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG---AKIADFGCAKWE  149 (405)
Q Consensus        74 ~~lv~Ey~~ggsL~~~i~~~~-~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~---vkL~DFGla~~~  149 (405)
                      .|||+|.+ +.+|.++|+.+. ..++...++.++.||+.||..||+.|||||||||+|||+.+-+   +||+|||.+...
T Consensus       263 lciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~  341 (586)
T KOG0667|consen  263 LCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE  341 (586)
T ss_pred             eeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence            88999999 559999998752 3589999999999999999999999999999999999997654   999999999876


Q ss_pred             cc-cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCC------------
Q 015500          150 SE-ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPE------------  216 (405)
Q Consensus       150 ~~-~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~------------  216 (405)
                      .. ..+..-++.|+|||++.|..|+.+.||||||||++||++|.+.|++.+ ..+++.+|......|.            
T Consensus       342 ~q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~n-e~DQl~~I~e~lG~Pp~~mL~~~~~~~k  420 (586)
T KOG0667|consen  342 SQRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDN-EYDQLARIIEVLGLPPPKMLDTAKKAHK  420 (586)
T ss_pred             CCcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCC-HHHHHHHHHHHhCCCCHHHHHhccccce
Confidence            65 346778999999999999999999999999999999999988887544 3333333321111110            


Q ss_pred             --------------------------------------Cc-----------hhccHHHHHHHHHhcccCccccCCHHHHh
Q 015500          217 --------------------------------------VP-----------AFLSKQANDFLSNCLRRDPKERWAASQLL  247 (405)
Q Consensus       217 --------------------------------------~p-----------~~~s~~l~dll~~~L~~dP~~Rpt~~elL  247 (405)
                                                            .|           ..-...+.|||++||.+||.+|+|+.|+|
T Consensus       421 ff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal  500 (586)
T KOG0667|consen  421 FFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQAL  500 (586)
T ss_pred             ehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHh
Confidence                                                  11           01134579999999999999999999999


Q ss_pred             cCcccccc
Q 015500          248 KHPFLEEF  255 (405)
Q Consensus       248 ~hp~~~~~  255 (405)
                      +||||...
T Consensus       501 ~Hpfl~~~  508 (586)
T KOG0667|consen  501 NHPFLTGT  508 (586)
T ss_pred             cCcccccc
Confidence            99999854

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-45  Score=338.06  Aligned_cols=248  Identities=26%  Similarity=0.408  Sum_probs=210.8

Q ss_pred             cccceeCCeeEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHhC-CCCCeeeeeeeeeecCCCceEEEEEEeecCCCC
Q 015500            7 HTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSL-NSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGT   85 (405)
Q Consensus         7 ~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~~~~l~~E~~iL~~L-~hpnIv~~~~~~~~~~~~~~~~~lv~Ey~~ggs   85 (405)
                      ++||-|-.|+|-.+.+++|++.||+|++.  +....+||+++--.. .|||||.+++++....++...+-+|||.|+||.
T Consensus        68 qvLG~GinGkV~~C~~k~T~ekfALKvL~--Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGe  145 (400)
T KOG0604|consen   68 QVLGAGINGKVVQCVHKRTQEKFALKVLL--DSPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGE  145 (400)
T ss_pred             hhhccccCCceEEEEeccchhhhHHHHHh--cCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccchH
Confidence            68999999999999999999999999964  445677888765444 799999999998877777888889999999999


Q ss_pred             HHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC----ceEeeecccccccc---cccCCC
Q 015500           86 LNDEIHRNG-GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG----AKIADFGCAKWESE---ALQSGG  157 (405)
Q Consensus        86 L~~~i~~~~-~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~----vkL~DFGla~~~~~---~~~~~g  157 (405)
                      |...|..++ +.++|..+..|++||..|+.|||+++|.||||||+|+|....+    +||+|||+|+....   ..+.+-
T Consensus       146 Lfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~~L~TPc~  225 (400)
T KOG0604|consen  146 LFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPGDLMTPCF  225 (400)
T ss_pred             HHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccCCCccccCCcc
Confidence            999998764 3599999999999999999999999999999999999997664    89999999987553   457789


Q ss_pred             CCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC---hHHHHHHHHhcCC-CCC-CchhccHHHHHHHHHh
Q 015500          158 TPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAAD---PMTVLYKIAYSRE-LPE-VPAFLSKQANDFLSNC  232 (405)
Q Consensus       158 t~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~---~~~~l~~i~~~~~-~~~-~p~~~s~~l~dll~~~  232 (405)
                      ||+|.|||++..++|+...|+||||+++|-|++|.+||.....   +.....+|..... +|. -...+|++++|+|+++
T Consensus       226 TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~L  305 (400)
T KOG0604|consen  226 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKL  305 (400)
T ss_pred             cccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhHHHHHHHHHHHHH
Confidence            9999999999999999999999999999999999999964432   1222334443332 221 1245899999999999


Q ss_pred             cccCccccCCHHHHhcCccccccc
Q 015500          233 LRRDPKERWAASQLLKHPFLEEFC  256 (405)
Q Consensus       233 L~~dP~~Rpt~~elL~hp~~~~~~  256 (405)
                      |+.+|.+|.|+.+++.|||+....
T Consensus       306 Lkt~PteRlTI~~~m~hpwi~~~~  329 (400)
T KOG0604|consen  306 LKTEPTERLTIEEVMDHPWINQYE  329 (400)
T ss_pred             hcCCchhheeHHHhhcCchhcccc
Confidence            999999999999999999998753

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=2e-43  Score=337.97  Aligned_cols=245  Identities=29%  Similarity=0.525  Sum_probs=203.9

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLF   77 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv   77 (405)
                      +|...+.||+|+||+||+|.+..+++.+|+|.+....    ...+.+|+++|++++||||+++++.+.....    ++++
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~----~~lv   77 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENR----ISIC   77 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCE----EEEE
Confidence            5788999999999999999999999999999886542    2467789999999999999999998766432    6699


Q ss_pred             EeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc--ccc
Q 015500           78 MEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE--ALQ  154 (405)
Q Consensus        78 ~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~--~~~  154 (405)
                      |||+++++|..+     ..+++..+..++.|++.||.|||+.||+|+||||+||+++.++ +||+|||++.....  ...
T Consensus        78 ~e~~~~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~~~  152 (279)
T cd06619          78 TEFMDGGSLDVY-----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKT  152 (279)
T ss_pred             EecCCCCChHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccccccC
Confidence            999999999654     2588999999999999999999999999999999999999888 99999999875433  234


Q ss_pred             CCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChH-----HHHHHHHhcCCCCCC-chhccHHHHHH
Q 015500          155 SGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPM-----TVLYKIAYSRELPEV-PAFLSKQANDF  228 (405)
Q Consensus       155 ~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~-----~~l~~i~~~~~~~~~-p~~~s~~l~dl  228 (405)
                      ..||+.|+|||.+.+..++.++|+|||||++|+|++|+.||.......     ............+.. ....++++.+|
T Consensus       153 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  232 (279)
T cd06619         153 YVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHF  232 (279)
T ss_pred             CCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHH
Confidence            579999999999999889999999999999999999999996432211     111111112222222 23478899999


Q ss_pred             HHHhcccCccccCCHHHHhcCcccccc
Q 015500          229 LSNCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       229 l~~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      +.+||+.+|.+||+++++++||||...
T Consensus       233 i~~~l~~~P~~Rp~~~eil~~~~~~~~  259 (279)
T cd06619         233 ITQCMRKQPKERPAPENLMDHPFIVQY  259 (279)
T ss_pred             HHHHhhCChhhCCCHHHHhcCcccccc
Confidence            999999999999999999999999765

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=3e-43  Score=334.05  Aligned_cols=244  Identities=37%  Similarity=0.646  Sum_probs=207.3

Q ss_pred             cccccceeCCeeEEEEEEcCCCCEEEEEEccCCC---hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEeec
Q 015500            5 RGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK---SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYA   81 (405)
Q Consensus         5 ~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~---~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~Ey~   81 (405)
                      ....||+|+||.||+|.+..++..+|+|.+....   .+.+.+|+.++++++||||+++++++....    .+++++||+
T Consensus        12 ~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~lv~e~~   87 (268)
T cd06624          12 ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENG----FFKIFMEQV   87 (268)
T ss_pred             ceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCC----EEEEEEecC
Confidence            4468999999999999999999999999876543   347889999999999999999998765443    366999999


Q ss_pred             CCCCHHHHHHHcCCCC--CHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcc-CC-ceEeeecccccccc----cc
Q 015500           82 PGGTLNDEIHRNGGRL--DESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAE-SG-AKIADFGCAKWESE----AL  153 (405)
Q Consensus        82 ~ggsL~~~i~~~~~~l--~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~-~~-vkL~DFGla~~~~~----~~  153 (405)
                      ++++|.+++....+++  ++..+..++.||+.||.|||++||+||||||+||+++. ++ +||+|||++.....    ..
T Consensus        88 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~  167 (268)
T cd06624          88 PGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTE  167 (268)
T ss_pred             CCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCccc
Confidence            9999999998754566  88999999999999999999999999999999999976 33 99999999875432    22


Q ss_pred             cCCCCCCccChhhhcCCC--CCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHH
Q 015500          154 QSGGTPMFMAPEVARGEH--QGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSN  231 (405)
Q Consensus       154 ~~~gt~~Y~APE~l~~~~--~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~  231 (405)
                      ...|++.|+|||.+.+..  ++.++|+||||+++|+|++|+.||...................+.+|..+++++.+|+++
T Consensus       168 ~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  247 (268)
T cd06624         168 TFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILR  247 (268)
T ss_pred             cCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHHHHH
Confidence            345899999999987643  788999999999999999999999765554444444444455667788899999999999


Q ss_pred             hcccCccccCCHHHHhcCccc
Q 015500          232 CLRRDPKERWAASQLLKHPFL  252 (405)
Q Consensus       232 ~L~~dP~~Rpt~~elL~hp~~  252 (405)
                      ||+.+|.+|||+.+++.||||
T Consensus       248 ~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         248 CFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             HcCCCchhCCCHHHHHhCCCC
Confidence            999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=2e-43  Score=337.74  Aligned_cols=250  Identities=31%  Similarity=0.504  Sum_probs=206.5

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC--hHHHHHHHHHHHhC-CCCCeeeeeeeeeecC--CCceEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK--SEFLQREQKFLSSL-NSPHIVGYKGCDVTSE--DNKLMYNL   76 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~--~~~l~~E~~iL~~L-~hpnIv~~~~~~~~~~--~~~~~~~l   76 (405)
                      .|++.+.||+|+||.||+|.+..+++.+|+|.+....  ...+.+|+.+++++ +||||+++++++....  .....+++
T Consensus        17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~i   96 (282)
T cd06636          17 IFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWL   96 (282)
T ss_pred             hhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEE
Confidence            4788999999999999999999999999999987653  34678899999999 7999999999876432  12345779


Q ss_pred             EEeecCCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc---
Q 015500           77 FMEYAPGGTLNDEIHRN-GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE---  151 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~-~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~---  151 (405)
                      +|||+++|+|.+++... +..+++..+..++.||+.||.|||+.|++|+||||+||+++.++ ++|+|||++.....   
T Consensus        97 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~~  176 (282)
T cd06636          97 VMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG  176 (282)
T ss_pred             EEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhhhcccc
Confidence            99999999999998763 34689999999999999999999999999999999999999888 99999999875432   


Q ss_pred             -cccCCCCCCccChhhhc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHH
Q 015500          152 -ALQSGGTPMFMAPEVAR-----GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQA  225 (405)
Q Consensus       152 -~~~~~gt~~Y~APE~l~-----~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l  225 (405)
                       .....|++.|+|||.+.     ...++.++|+|||||++|+|++|+.||.... +......+.........+..++.++
T Consensus       177 ~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  255 (282)
T cd06636         177 RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMH-PMRALFLIPRNPPPKLKSKKWSKKF  255 (282)
T ss_pred             CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccC-HHhhhhhHhhCCCCCCcccccCHHH
Confidence             22345899999999986     3457789999999999999999999996543 2333333332222222334578999


Q ss_pred             HHHHHHhcccCccccCCHHHHhcCccc
Q 015500          226 NDFLSNCLRRDPKERWAASQLLKHPFL  252 (405)
Q Consensus       226 ~dll~~~L~~dP~~Rpt~~elL~hp~~  252 (405)
                      .+||.+||..||.+|||+.+||+||||
T Consensus       256 ~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         256 IDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             HHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence            999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=2.3e-43  Score=342.85  Aligned_cols=248  Identities=32%  Similarity=0.552  Sum_probs=207.0

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLF   77 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv   77 (405)
                      +|.+.+.||+|+||.||+|.+..++..+|+|.+....    ...+.+|++++++++||||+++++++....    .++++
T Consensus         2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~lv   77 (308)
T cd06615           2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDG----EISIC   77 (308)
T ss_pred             CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC----EEEEE
Confidence            6899999999999999999999999999999876542    245788999999999999999999876543    36799


Q ss_pred             EeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCCEEEccCC-ceEeeecccccccc--cc
Q 015500           78 MEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHS-NRVVHCDIKSRNILMAESG-AKIADFGCAKWESE--AL  153 (405)
Q Consensus        78 ~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~-~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~--~~  153 (405)
                      |||++|++|.+++.+. +++++..+..++.||+.||.|||+ .+++||||||+||+++.++ +||+|||++.....  ..
T Consensus        78 ~ey~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~  156 (308)
T cd06615          78 MEHMDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN  156 (308)
T ss_pred             eeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccccc
Confidence            9999999999999876 489999999999999999999998 5999999999999999887 99999999875433  33


Q ss_pred             cCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHH-------------------------
Q 015500          154 QSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKI-------------------------  208 (405)
Q Consensus       154 ~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i-------------------------  208 (405)
                      ...|++.|+|||.+.+..++.++|+|||||++|+|++|+.||.... ........                         
T Consensus       157 ~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (308)
T cd06615         157 SFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD-AKELEAMFGRPVSEGEAKESHRPVSGHPPDSPR  235 (308)
T ss_pred             cCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcc-hhhHHHhhcCccccccccCCcccccCCCCCccc
Confidence            4568999999999988889999999999999999999999995432 11111100                         


Q ss_pred             ----------HhcCCCCCCch-hccHHHHHHHHHhcccCccccCCHHHHhcCcccccc
Q 015500          209 ----------AYSRELPEVPA-FLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       209 ----------~~~~~~~~~p~-~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                                ......|..|. .++.++++|+.+||..+|++|||+.++++||||...
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~  293 (308)
T cd06615         236 PMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA  293 (308)
T ss_pred             hhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence                      11111222222 367889999999999999999999999999999764

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.6e-43  Score=334.45  Aligned_cols=249  Identities=33%  Similarity=0.582  Sum_probs=212.8

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLF   77 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv   77 (405)
                      +|+..+.||+|+||.||+|.++.+++.+|+|.+....    ...+.+|++++++++||||+++++.+....    .++++
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~----~~~lv   77 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNG----DISIC   77 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCC----EEEEE
Confidence            5788999999999999999999999999999876542    346788999999999999999998776542    36799


Q ss_pred             EeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCCEEEccCC-ceEeeecccccccc--cc
Q 015500           78 MEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHS-NRVVHCDIKSRNILMAESG-AKIADFGCAKWESE--AL  153 (405)
Q Consensus        78 ~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~-~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~--~~  153 (405)
                      +||+++++|.+++.....++++..+..++.|++.||+|||+ .|++|+||||+||+++.++ ++|+|||.+.....  ..
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~  157 (265)
T cd06605          78 MEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK  157 (265)
T ss_pred             EEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh
Confidence            99999999999998765689999999999999999999999 9999999999999999887 99999999875433  22


Q ss_pred             cCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC----ChHHHHHHHHhcCCCCCCchh-ccHHHHHH
Q 015500          154 QSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAA----DPMTVLYKIAYSRELPEVPAF-LSKQANDF  228 (405)
Q Consensus       154 ~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~----~~~~~l~~i~~~~~~~~~p~~-~s~~l~dl  228 (405)
                      ...+++.|+|||.+.+..+++++|+|||||++|+|++|+.||....    .....+..+ .....+..+.. +++++.+|
T Consensus       158 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l  236 (265)
T cd06605         158 TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYI-VNEPPPRLPSGKFSPDFQDF  236 (265)
T ss_pred             cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHH-hcCCCCCCChhhcCHHHHHH
Confidence            3668999999999999999999999999999999999999996542    222333222 23344555555 89999999


Q ss_pred             HHHhcccCccccCCHHHHhcCcccccc
Q 015500          229 LSNCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       229 l~~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      |.+||..||.+|||+.+++.||||+.+
T Consensus       237 i~~~l~~~p~~Rpt~~~ll~~~~~~~~  263 (265)
T cd06605         237 VNLCLIKDPRERPSYKELLEHPFIKKY  263 (265)
T ss_pred             HHHHcCCCchhCcCHHHHhhCchhhcc
Confidence            999999999999999999999999865

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-43  Score=333.97  Aligned_cols=250  Identities=34%  Similarity=0.543  Sum_probs=207.2

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC--hHHHHHHHHHHHhC-CCCCeeeeeeeeeecCC--CceEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK--SEFLQREQKFLSSL-NSPHIVGYKGCDVTSED--NKLMYNL   76 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~--~~~l~~E~~iL~~L-~hpnIv~~~~~~~~~~~--~~~~~~l   76 (405)
                      +|++.+.||+|++|+||+|.++.+++.+++|.+....  .+.+.+|+.+++++ .||||+++++++.....  ....+++
T Consensus         7 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~l   86 (275)
T cd06608           7 IFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWL   86 (275)
T ss_pred             heeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEE
Confidence            5899999999999999999999999999999987543  35788999999999 79999999998876542  3445779


Q ss_pred             EEeecCCCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc-
Q 015500           77 FMEYAPGGTLNDEIHRN---GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE-  151 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~---~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~-  151 (405)
                      +|||+++++|.+++...   +..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ +||+|||++..... 
T Consensus        87 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~  166 (275)
T cd06608          87 VMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDST  166 (275)
T ss_pred             EEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccceecccc
Confidence            99999999999988652   35799999999999999999999999999999999999999887 99999999875433 


Q ss_pred             ---cccCCCCCCccChhhhcCC-----CCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCC-CCCCchhcc
Q 015500          152 ---ALQSGGTPMFMAPEVARGE-----HQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRE-LPEVPAFLS  222 (405)
Q Consensus       152 ---~~~~~gt~~Y~APE~l~~~-----~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~-~~~~p~~~s  222 (405)
                         .....|++.|+|||++...     .++.++|||||||++|+|++|+.||.... ....+.++..... ....+..++
T Consensus       167 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  245 (275)
T cd06608         167 LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMH-PMRALFKIPRNPPPTLKSPENWS  245 (275)
T ss_pred             hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccc-hHHHHHHhhccCCCCCCchhhcC
Confidence               2234589999999998642     46778999999999999999999996443 3333333332211 111223478


Q ss_pred             HHHHHHHHHhcccCccccCCHHHHhcCccc
Q 015500          223 KQANDFLSNCLRRDPKERWAASQLLKHPFL  252 (405)
Q Consensus       223 ~~l~dll~~~L~~dP~~Rpt~~elL~hp~~  252 (405)
                      +.+++||++||..||.+|||+.++++|||+
T Consensus       246 ~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         246 KKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             HHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence            899999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.7e-43  Score=362.08  Aligned_cols=245  Identities=22%  Similarity=0.307  Sum_probs=199.3

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEeec
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYA   81 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~Ey~   81 (405)
                      .|.+.+.||+|+||.||+|.+..+++.||||...   ...+.+|+++|++|+||||+++++++....    ..+++||++
T Consensus       170 gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~---~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~----~~~lv~e~~  242 (461)
T PHA03211        170 GFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW---YASSVHEARLLRRLSHPAVLALLDVRVVGG----LTCLVLPKY  242 (461)
T ss_pred             CeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc---ccCHHHHHHHHHHCCCCCCCcEEEEEEECC----EEEEEEEcc
Confidence            5889999999999999999999999999999643   234678999999999999999998765433    356899999


Q ss_pred             CCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc------cc
Q 015500           82 PGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA------LQ  154 (405)
Q Consensus        82 ~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~------~~  154 (405)
                      . ++|.+++....+.+++..++.++.||+.||.|||++||+||||||+||||+.++ +||+|||+++.....      ..
T Consensus       243 ~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~  321 (461)
T PHA03211        243 R-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYG  321 (461)
T ss_pred             C-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccccccc
Confidence            5 689998877666899999999999999999999999999999999999999877 999999999754321      13


Q ss_pred             CCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC------hHHHHHHHHhcC-----CCCCC------
Q 015500          155 SGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAAD------PMTVLYKIAYSR-----ELPEV------  217 (405)
Q Consensus       155 ~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~------~~~~l~~i~~~~-----~~~~~------  217 (405)
                      ..||+.|+|||++.+..++.++|||||||++|||++|..|+.....      ....+.++....     .++..      
T Consensus       322 ~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~  401 (461)
T PHA03211        322 IAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLV  401 (461)
T ss_pred             cCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHH
Confidence            4599999999999999999999999999999999998876532211      112222221111     11100      


Q ss_pred             -----------------c-----hhccHHHHHHHHHhcccCccccCCHHHHhcCccccc
Q 015500          218 -----------------P-----AFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEE  254 (405)
Q Consensus       218 -----------------p-----~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~  254 (405)
                                       +     ..++.++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus       402 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        402 SQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             HHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence                             0     024568999999999999999999999999999963

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.7e-43  Score=346.58  Aligned_cols=245  Identities=26%  Similarity=0.397  Sum_probs=198.6

Q ss_pred             ccccccee--CCeeEEEEEEcCCCCEEEEEEccCCC-----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEE
Q 015500            5 RGHTIGQG--SSATVSLATSLRSGDVFAAKSTELPK-----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLF   77 (405)
Q Consensus         5 ~~~~LG~G--~~g~Vyla~~~~~~~~vavK~~~~~~-----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv   77 (405)
                      ++++||+|  +|++||++.++.+|+.||+|.++...     ...+++|+.+++.++||||+++++++....    .+++|
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~----~~~lv   77 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN----ELWVV   77 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECC----EEEEE
Confidence            56789999  67899999999999999999987542     356888999999999999999999876554    36799


Q ss_pred             EeecCCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc----
Q 015500           78 MEYAPGGTLNDEIHRN-GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE----  151 (405)
Q Consensus        78 ~Ey~~ggsL~~~i~~~-~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~----  151 (405)
                      |||+++|+|.+++..+ ...+++..++.++.||+.||+|||++||+||||||+|||++.++ +++.||+.+.....    
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~  157 (327)
T cd08227          78 TSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR  157 (327)
T ss_pred             EeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence            9999999999999764 34589999999999999999999999999999999999999887 99999986532211    


Q ss_pred             -------cccCCCCCCccChhhhcC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCC-------
Q 015500          152 -------ALQSGGTPMFMAPEVARG--EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELP-------  215 (405)
Q Consensus       152 -------~~~~~gt~~Y~APE~l~~--~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~-------  215 (405)
                             .....++..|+|||++.+  ..++.++|||||||++|||++|+.||..............  ...+       
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~  235 (327)
T cd08227         158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN--GTVPCLLDTTT  235 (327)
T ss_pred             ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhc--CCccccccccc
Confidence                   112346778999999976  4588999999999999999999999975443322221111  0000       


Q ss_pred             --------------------------------------CCchhccHHHHHHHHHhcccCccccCCHHHHhcCcccccc
Q 015500          216 --------------------------------------EVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       216 --------------------------------------~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                                                            .....+++.+.+||.+||+.||++|||++++++||||+..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~  313 (327)
T cd08227         236 IPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI  313 (327)
T ss_pred             hhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence                                                  0112357789999999999999999999999999999864

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.5e-43  Score=330.21  Aligned_cols=245  Identities=44%  Similarity=0.782  Sum_probs=212.3

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC--------ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP--------KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLM   73 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~--------~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~   73 (405)
                      +|+..+.||+|+||+||+|.+..+++.+++|.+...        ....+.+|+.+++.++||||+++++.+....    .
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~----~   76 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREED----N   76 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCC----e
Confidence            588999999999999999999989999999987542        2356889999999999999999998765433    3


Q ss_pred             EEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc-
Q 015500           74 YNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE-  151 (405)
Q Consensus        74 ~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~-  151 (405)
                      +++++||+++++|.+++.+. +.+++..+..++.||+.||+|||+.|++|+||+|+||+++.++ +||+|||++..... 
T Consensus        77 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~  155 (258)
T cd06632          77 LYIFLELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF  155 (258)
T ss_pred             EEEEEEecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence            67999999999999999876 4799999999999999999999999999999999999998887 99999999875433 


Q ss_pred             --cccCCCCCCccChhhhcCCC-CCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHH
Q 015500          152 --ALQSGGTPMFMAPEVARGEH-QGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDF  228 (405)
Q Consensus       152 --~~~~~gt~~Y~APE~l~~~~-~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dl  228 (405)
                        .....|++.|+|||.+.... ++.++|+|||||++|+|++|+.||.... ......++......+.++..+++++.+|
T Consensus       156 ~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l  234 (258)
T cd06632         156 SFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE-GVAAVFKIGRSKELPPIPDHLSDEAKDF  234 (258)
T ss_pred             ccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc-HHHHHHHHHhcccCCCcCCCcCHHHHHH
Confidence              23455899999999998766 8899999999999999999999996554 4444555555456677788899999999


Q ss_pred             HHHhcccCccccCCHHHHhcCccc
Q 015500          229 LSNCLRRDPKERWAASQLLKHPFL  252 (405)
Q Consensus       229 l~~~L~~dP~~Rpt~~elL~hp~~  252 (405)
                      +.+||+.+|.+|||+.+++.|||+
T Consensus       235 i~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         235 ILKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             HHHHhhcCcccCcCHHHHhcCCCC
Confidence            999999999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.6e-43  Score=342.27  Aligned_cols=248  Identities=38%  Similarity=0.573  Sum_probs=209.4

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC---ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP---KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFM   78 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~---~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (405)
                      +|++++.||+|+||.||+|.+..+++.||+|.+...   ..+.+.+|+.+++.++||||+++++.+....    .+++||
T Consensus        20 ~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~----~~~lv~   95 (297)
T cd06656          20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD----ELWVVM   95 (297)
T ss_pred             hceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCC----EEEEee
Confidence            589999999999999999999999999999988653   3456788999999999999999998876433    367999


Q ss_pred             eecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc----c
Q 015500           79 EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA----L  153 (405)
Q Consensus        79 Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~----~  153 (405)
                      ||+++++|.+++.+.  .+++..+..++.|++.||.|||+.|++||||||+|||++.++ ++|+|||++......    .
T Consensus        96 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~  173 (297)
T cd06656          96 EYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS  173 (297)
T ss_pred             cccCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccCcC
Confidence            999999999998654  689999999999999999999999999999999999999887 999999998754331    2


Q ss_pred             cCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhc-CCCCCCchhccHHHHHHHHHh
Q 015500          154 QSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYS-RELPEVPAFLSKQANDFLSNC  232 (405)
Q Consensus       154 ~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~-~~~~~~p~~~s~~l~dll~~~  232 (405)
                      ...+++.|+|||.+.+..++.++|+|||||++|+|++|+.||..... ...+..+... ......|..++..+.+|+.+|
T Consensus       174 ~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  252 (297)
T cd06656         174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP-LRALYLIATNGTPELQNPERLSAVFRDFLNRC  252 (297)
T ss_pred             cccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc-chheeeeccCCCCCCCCccccCHHHHHHHHHH
Confidence            34689999999999998899999999999999999999999954432 2222222221 222234566889999999999


Q ss_pred             cccCccccCCHHHHhcCccccccc
Q 015500          233 LRRDPKERWAASQLLKHPFLEEFC  256 (405)
Q Consensus       233 L~~dP~~Rpt~~elL~hp~~~~~~  256 (405)
                      |..+|++|||+.++++||||+...
T Consensus       253 l~~~p~~Rps~~~il~~~~~~~~~  276 (297)
T cd06656         253 LEMDVDRRGSAKELLQHPFLKLAK  276 (297)
T ss_pred             ccCChhhCcCHHHHhcCchhcccc
Confidence            999999999999999999998653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=3.2e-43  Score=340.16  Aligned_cols=248  Identities=38%  Similarity=0.586  Sum_probs=210.2

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC---ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP---KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFM   78 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~---~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (405)
                      +|+..+.||.|+||+||+|.+..+++.+++|.+...   ..+.+.+|+.+++.++||||+++++.+....    .+++|+
T Consensus        20 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~lv~   95 (296)
T cd06655          20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGD----ELFVVM   95 (296)
T ss_pred             eEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCc----eEEEEE
Confidence            488899999999999999999999999999987643   3457889999999999999999998875433    367999


Q ss_pred             eecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc----cc
Q 015500           79 EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE----AL  153 (405)
Q Consensus        79 Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~----~~  153 (405)
                      ||+++++|.+++...  .+++..+..++.|++.||+|||++|++||||||+||+++.++ +||+|||++.....    ..
T Consensus        96 e~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~  173 (296)
T cd06655          96 EYLAGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRS  173 (296)
T ss_pred             EecCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccccCC
Confidence            999999999988754  689999999999999999999999999999999999998887 99999999875433    12


Q ss_pred             cCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcC-CCCCCchhccHHHHHHHHHh
Q 015500          154 QSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSR-ELPEVPAFLSKQANDFLSNC  232 (405)
Q Consensus       154 ~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~-~~~~~p~~~s~~l~dll~~~  232 (405)
                      ...+++.|+|||.+.+..++.++|+|||||++|+|++|+.||.... .......+.... .....+..+++.+.+||++|
T Consensus       174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  252 (296)
T cd06655         174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN-PLRALYLIATNGTPELQNPEKLSPIFRDFLNRC  252 (296)
T ss_pred             CcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhcCCcccCCcccCCHHHHHHHHHH
Confidence            3468999999999998889999999999999999999999996543 333333333222 22234566889999999999


Q ss_pred             cccCccccCCHHHHhcCccccccc
Q 015500          233 LRRDPKERWAASQLLKHPFLEEFC  256 (405)
Q Consensus       233 L~~dP~~Rpt~~elL~hp~~~~~~  256 (405)
                      |..||.+|||+.++++||||+...
T Consensus       253 l~~dp~~Rpt~~~il~~~~~~~~~  276 (296)
T cd06655         253 LEMDVEKRGSAKELLQHPFLKLAK  276 (296)
T ss_pred             hhcChhhCCCHHHHhhChHhhhcc
Confidence            999999999999999999998643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.9e-43  Score=334.92  Aligned_cols=244  Identities=36%  Similarity=0.510  Sum_probs=202.0

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC---ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP---KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFM   78 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~---~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (405)
                      +|++++.||+|+||.||+|+++.+++.+|+|.....   ....+++|+.++++++||||+++++.+....    .+++||
T Consensus        10 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~----~~~iv~   85 (267)
T cd06646          10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSRE----KLWICM   85 (267)
T ss_pred             hcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC----EEEEEE
Confidence            589999999999999999999999999999988643   3356788999999999999999998876543    367999


Q ss_pred             eecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc----cc
Q 015500           79 EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE----AL  153 (405)
Q Consensus        79 Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~----~~  153 (405)
                      ||+++++|.+++.+. +++++..+..++.|++.||.|||+.||+||||||+||+++.++ +||+|||++.....    ..
T Consensus        86 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~  164 (267)
T cd06646          86 EYCGGGSLQDIYHVT-GPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRK  164 (267)
T ss_pred             eCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccccccC
Confidence            999999999998765 4799999999999999999999999999999999999999887 99999999876432    12


Q ss_pred             cCCCCCCccChhhhc---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcC-CCC--CCchhccHHHHH
Q 015500          154 QSGGTPMFMAPEVAR---GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSR-ELP--EVPAFLSKQAND  227 (405)
Q Consensus       154 ~~~gt~~Y~APE~l~---~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~-~~~--~~p~~~s~~l~d  227 (405)
                      ...|++.|+|||.+.   ...++.++|+|||||++|+|++|+.||..... ......+.... ..+  ..+..++..+.+
T Consensus       165 ~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (267)
T cd06646         165 SFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHP-MRALFLMSKSNFQPPKLKDKTKWSSTFHN  243 (267)
T ss_pred             ccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccch-hhhheeeecCCCCCCCCccccccCHHHHH
Confidence            345889999999985   34467899999999999999999999954432 22222211111 111  112346889999


Q ss_pred             HHHHhcccCccccCCHHHHhcCcc
Q 015500          228 FLSNCLRRDPKERWAASQLLKHPF  251 (405)
Q Consensus       228 ll~~~L~~dP~~Rpt~~elL~hp~  251 (405)
                      ||++||+.+|.+|||++++|+|+|
T Consensus       244 li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         244 FVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             HHHHHhhCChhhCcCHHHHhcCCC
Confidence            999999999999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-43  Score=330.61  Aligned_cols=245  Identities=36%  Similarity=0.535  Sum_probs=207.1

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC---ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP---KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFM   78 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~---~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (405)
                      +|...+.||.|+||.||+|.+..+++.+++|.+...   ..+.+.+|+.++++++||||+++++.+....    .++++|
T Consensus         4 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~----~~~l~~   79 (262)
T cd06613           4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRD----KLWIVM   79 (262)
T ss_pred             ceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCC----EEEEEE
Confidence            588999999999999999999999999999988754   3467889999999999999999998765533    367999


Q ss_pred             eecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc----cc
Q 015500           79 EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE----AL  153 (405)
Q Consensus        79 Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~----~~  153 (405)
                      ||+++++|.+++.....++++..+..++.|++.||.|||++|++|+||||+||+++.++ +||+|||++.....    ..
T Consensus        80 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~  159 (262)
T cd06613          80 EYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRK  159 (262)
T ss_pred             eCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhccc
Confidence            99999999999987656899999999999999999999999999999999999999887 99999999876443    22


Q ss_pred             cCCCCCCccChhhhcCC---CCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcC---CCCCCchhccHHHHH
Q 015500          154 QSGGTPMFMAPEVARGE---HQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSR---ELPEVPAFLSKQAND  227 (405)
Q Consensus       154 ~~~gt~~Y~APE~l~~~---~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~---~~~~~p~~~s~~l~d  227 (405)
                      ...++..|+|||.+.+.   .++.++|+|||||++|+|++|+.||...... .....+....   .....+...+.++.+
T Consensus       160 ~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (262)
T cd06613         160 SFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPM-RALFLISKSNFPPPKLKDKEKWSPVFHD  238 (262)
T ss_pred             cccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhccCCCccccchhhhhHHHHH
Confidence            34588899999999776   7888999999999999999999999654432 2222222221   111223456788999


Q ss_pred             HHHHhcccCccccCCHHHHhcCcc
Q 015500          228 FLSNCLRRDPKERWAASQLLKHPF  251 (405)
Q Consensus       228 ll~~~L~~dP~~Rpt~~elL~hp~  251 (405)
                      |+++||..+|.+|||+.+++.|||
T Consensus       239 li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         239 FIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             HHHHHcCCChhhCCCHHHHhcCCC
Confidence            999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-43  Score=334.69  Aligned_cols=246  Identities=39%  Similarity=0.594  Sum_probs=211.8

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLF   77 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv   77 (405)
                      +|...+.||.|+||.||+|.+..+++.+|+|.+....    ...+.+|+++++.++||||+++.+.+....    .++++
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~~v   77 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGS----KLWII   77 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECC----eEEEE
Confidence            5889999999999999999999999999999886543    346789999999999999999998776542    46799


Q ss_pred             EeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc----
Q 015500           78 MEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA----  152 (405)
Q Consensus        78 ~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~----  152 (405)
                      +||+++++|.+++...  ++++..+..++.|++.||.|||++|++||||+|+||+++.++ ++|+|||+++.....    
T Consensus        78 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~  155 (274)
T cd06609          78 MEYCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKR  155 (274)
T ss_pred             EEeeCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccccc
Confidence            9999999999999765  799999999999999999999999999999999999999887 999999998765432    


Q ss_pred             ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchh-ccHHHHHHHHH
Q 015500          153 LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAF-LSKQANDFLSN  231 (405)
Q Consensus       153 ~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~-~s~~l~dll~~  231 (405)
                      ....+++.|+|||.+.+..+++++|||||||++|+|+||+.||.... +......+.. ...+.++.. +++++.+++.+
T Consensus       156 ~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~  233 (274)
T cd06609         156 NTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLH-PMRVLFLIPK-NNPPSLEGNKFSKPFKDFVSL  233 (274)
T ss_pred             ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCc-hHHHHHHhhh-cCCCCCcccccCHHHHHHHHH
Confidence            23458899999999999889999999999999999999999995433 3333333332 334455555 88999999999


Q ss_pred             hcccCccccCCHHHHhcCcccccc
Q 015500          232 CLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       232 ~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      ||..+|++|||++++++||||...
T Consensus       234 ~l~~~p~~Rpt~~~il~~~~~~~~  257 (274)
T cd06609         234 CLNKDPKERPSAKELLKHKFIKKA  257 (274)
T ss_pred             HhhCChhhCcCHHHHhhChhhcCC
Confidence            999999999999999999999864

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=4.9e-43  Score=329.80  Aligned_cols=247  Identities=28%  Similarity=0.442  Sum_probs=212.2

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      +|.+.+.||.|+||.||+|.+..+++.+|+|.+....     .+.+.+|++++++++||||+++++.+.....  ..+++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~--~~~~~   78 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSN--QTLYI   78 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCC--CEEEE
Confidence            5899999999999999999999999999999876432     3467789999999999999999987654333  23569


Q ss_pred             EEeecCCCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHH-----hCCceeCCCCCCCEEEccCC-ceEeeecccc
Q 015500           77 FMEYAPGGTLNDEIHRN---GGRLDESLIVSYTRQILQGLEYLH-----SNRVVHCDIKSRNILMAESG-AKIADFGCAK  147 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~---~~~l~e~~~~~i~~qIl~~L~yLH-----~~givHrDlkp~NILi~~~~-vkL~DFGla~  147 (405)
                      +|||+++++|.+++.+.   ++++++..+..++.||+.||.|||     +.+++|+||||+||+++.++ +||+|||++.
T Consensus        79 ~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~  158 (265)
T cd08217          79 VMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAK  158 (265)
T ss_pred             EehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccc
Confidence            99999999999999763   457999999999999999999999     89999999999999999887 9999999988


Q ss_pred             ccccc----ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccH
Q 015500          148 WESEA----LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSK  223 (405)
Q Consensus       148 ~~~~~----~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~  223 (405)
                      .....    ....+++.|+|||.+.+..++.++|+||||+++++|++|+.||.... .. .+.........+.++..++.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-~~-~~~~~~~~~~~~~~~~~~~~  236 (265)
T cd08217         159 ILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN-QL-QLASKIKEGKFRRIPYRYSS  236 (265)
T ss_pred             cccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC-HH-HHHHHHhcCCCCCCccccCH
Confidence            65432    23468999999999998889999999999999999999999996543 33 33333344556677888999


Q ss_pred             HHHHHHHHhcccCccccCCHHHHhcCccc
Q 015500          224 QANDFLSNCLRRDPKERWAASQLLKHPFL  252 (405)
Q Consensus       224 ~l~dll~~~L~~dP~~Rpt~~elL~hp~~  252 (405)
                      .+.+++.+||+.+|++|||+.++++|||+
T Consensus       237 ~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         237 ELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             HHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence            99999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=4.5e-43  Score=337.33  Aligned_cols=239  Identities=16%  Similarity=0.197  Sum_probs=202.0

Q ss_pred             cccceeCCeeEEEEEEcCCCCEEEEEEccCCC------hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEee
Q 015500            7 HTIGQGSSATVSLATSLRSGDVFAAKSTELPK------SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEY   80 (405)
Q Consensus         7 ~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~------~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~Ey   80 (405)
                      ..||+|+++.||+|..  +|+.||||.+....      .+.+.+|+.+|++++||||+++++++.........++++|||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            6799999999999987  68999999886532      256779999999999999999999876633333346799999


Q ss_pred             cCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCCEEEccCC-ceEeeecccccccc-cccCCC
Q 015500           81 APGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHS-NRVVHCDIKSRNILMAESG-AKIADFGCAKWESE-ALQSGG  157 (405)
Q Consensus        81 ~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~-~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~-~~~~~g  157 (405)
                      ++||+|.+++... +.+++.....++.|++.||.|||+ .+++||||||+|||++.++ +||+|||+++.... .....|
T Consensus       104 ~~~g~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~  182 (283)
T PHA02988        104 CTRGYLREVLDKE-KDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVN  182 (283)
T ss_pred             CCCCcHHHHHhhC-CCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccccccccC
Confidence            9999999999875 479999999999999999999998 4999999999999999888 99999999875443 234568


Q ss_pred             CCCccChhhhcC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHhccc
Q 015500          158 TPMFMAPEVARG--EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRR  235 (405)
Q Consensus       158 t~~Y~APE~l~~--~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~L~~  235 (405)
                      |+.|+|||++.+  ..++.++|||||||++|||++|+.||... +.......+......+..|...++.+++|+.+||+.
T Consensus       183 ~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~  261 (283)
T PHA02988        183 FMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL-TTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSH  261 (283)
T ss_pred             cccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCC-CHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHHhcC
Confidence            999999999976  67899999999999999999999999654 344444444444444566667899999999999999


Q ss_pred             CccccCCHHHHhcC
Q 015500          236 DPKERWAASQLLKH  249 (405)
Q Consensus       236 dP~~Rpt~~elL~h  249 (405)
                      ||.+|||++++++.
T Consensus       262 dp~~Rps~~ell~~  275 (283)
T PHA02988        262 DSIKRPNIKEILYN  275 (283)
T ss_pred             CcccCcCHHHHHHH
Confidence            99999999999864

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.7e-43  Score=337.49  Aligned_cols=250  Identities=27%  Similarity=0.450  Sum_probs=208.9

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLF   77 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv   77 (405)
                      +|...+.||+|+||+||+|.+..+++.+|+|.+....    ...+.+|+.++++++||||+++++.+....    .++++
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~----~~~lv   77 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEG----AVYMC   77 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCC----eEEEE
Confidence            6889999999999999999999999999999876432    246788999999999999999998766533    36799


Q ss_pred             EeecCCCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCCEEEccCC-ceEeeecccccccc--
Q 015500           78 MEYAPGGTLNDEIHRN--GGRLDESLIVSYTRQILQGLEYLHS-NRVVHCDIKSRNILMAESG-AKIADFGCAKWESE--  151 (405)
Q Consensus        78 ~Ey~~ggsL~~~i~~~--~~~l~e~~~~~i~~qIl~~L~yLH~-~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~--  151 (405)
                      |||++|++|..++...  .+.+++..+..++.||+.||.|||+ .|++|+||||+||+++.++ +||+|||++.....  
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  157 (286)
T cd06622          78 MEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL  157 (286)
T ss_pred             EeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence            9999999999888763  2379999999999999999999997 5999999999999999887 99999999875432  


Q ss_pred             cccCCCCCCccChhhhcCCC------CCcchhHHHHHHHHHHHHhCCCCCCCCCChH--HHHHHHHhcCCCCCCchhccH
Q 015500          152 ALQSGGTPMFMAPEVARGEH------QGFASDIWAVGCTVIEMASGGAPWPNAADPM--TVLYKIAYSRELPEVPAFLSK  223 (405)
Q Consensus       152 ~~~~~gt~~Y~APE~l~~~~------~~~~sDIwSLG~il~elltG~~Pf~~~~~~~--~~l~~i~~~~~~~~~p~~~s~  223 (405)
                      .....+++.|+|||.+.+..      ++.++|+|||||++|+|++|+.||.......  ..+..+ .....+.+|..+++
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  236 (286)
T cd06622         158 AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAI-VDGDPPTLPSGYSD  236 (286)
T ss_pred             cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHH-hhcCCCCCCcccCH
Confidence            33445889999999986543      4789999999999999999999996543221  112222 23345567777999


Q ss_pred             HHHHHHHHhcccCccccCCHHHHhcCccccccc
Q 015500          224 QANDFLSNCLRRDPKERWAASQLLKHPFLEEFC  256 (405)
Q Consensus       224 ~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~  256 (405)
                      ++.+||.+||+.+|++||++.+++.||||....
T Consensus       237 ~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~  269 (286)
T cd06622         237 DAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK  269 (286)
T ss_pred             HHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence            999999999999999999999999999998653

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=3.6e-43  Score=336.33  Aligned_cols=250  Identities=31%  Similarity=0.530  Sum_probs=204.8

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC--hHHHHHHHHHHHhC-CCCCeeeeeeeeeecC-CCceEEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK--SEFLQREQKFLSSL-NSPHIVGYKGCDVTSE-DNKLMYNLF   77 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~--~~~l~~E~~iL~~L-~hpnIv~~~~~~~~~~-~~~~~~~lv   77 (405)
                      +|.+.+.||+|+||+||+|.++.+++.+|+|......  ...+.+|+.+++++ +||||+++++++.... .....++++
T Consensus        19 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv   98 (286)
T cd06638          19 TWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLV   98 (286)
T ss_pred             ceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEE
Confidence            6899999999999999999999999999999876432  35688999999999 6999999999775432 222356799


Q ss_pred             EeecCCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc--
Q 015500           78 MEYAPGGTLNDEIHR---NGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE--  151 (405)
Q Consensus        78 ~Ey~~ggsL~~~i~~---~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~--  151 (405)
                      |||++|++|.+++..   ..+.+++..+..++.|++.||.|||+++++||||||+||+++.++ +||+|||+++....  
T Consensus        99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~  178 (286)
T cd06638          99 LELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR  178 (286)
T ss_pred             EeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCceeecccCC
Confidence            999999999998753   335789999999999999999999999999999999999999887 99999999875432  


Q ss_pred             --cccCCCCCCccChhhhcC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcC-CCCCCchhccH
Q 015500          152 --ALQSGGTPMFMAPEVARG-----EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSR-ELPEVPAFLSK  223 (405)
Q Consensus       152 --~~~~~gt~~Y~APE~l~~-----~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~-~~~~~p~~~s~  223 (405)
                        .....|++.|+|||++..     ..++.++|||||||++|+|++|+.||..... ...+....... .....|..++.
T Consensus       179 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  257 (286)
T cd06638         179 LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP-MRALFKIPRNPPPTLHQPELWSN  257 (286)
T ss_pred             CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch-hHHHhhccccCCCcccCCCCcCH
Confidence              123458999999999863     3478899999999999999999999965533 22232222211 11123455688


Q ss_pred             HHHHHHHHhcccCccccCCHHHHhcCccc
Q 015500          224 QANDFLSNCLRRDPKERWAASQLLKHPFL  252 (405)
Q Consensus       224 ~l~dll~~~L~~dP~~Rpt~~elL~hp~~  252 (405)
                      ++.+||.+||+.||++|||+.++++|+||
T Consensus       258 ~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         258 EFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             HHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence            99999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.9e-43  Score=340.42  Aligned_cols=250  Identities=29%  Similarity=0.445  Sum_probs=208.2

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC------hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK------SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~------~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~   75 (405)
                      +|...+.||+|+||+||+|.+..+++.+|+|.+....      ...+.+|+++|+.++||||+++++.+....    ..+
T Consensus         2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~   77 (316)
T cd05574           2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTET----YLC   77 (316)
T ss_pred             ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCC----EEE
Confidence            6889999999999999999999999999999887542      245788999999999999999998765432    367


Q ss_pred             EEEeecCCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc-
Q 015500           76 LFMEYAPGGTLNDEIHRN-GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA-  152 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~-~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~-  152 (405)
                      ++|||+.|++|.+++.+. +..+++..++.++.||+.||+|||+.|++|+||||+||+++.++ ++|+|||++...... 
T Consensus        78 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~  157 (316)
T cd05574          78 LVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP  157 (316)
T ss_pred             EEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence            999999999999998763 35799999999999999999999999999999999999999887 999999987643211 


Q ss_pred             --------------------------------ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 015500          153 --------------------------------LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAAD  200 (405)
Q Consensus       153 --------------------------------~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~  200 (405)
                                                      ....||..|+|||++.+..++.++|||||||++|+|++|+.||.... 
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~-  236 (316)
T cd05574         158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN-  236 (316)
T ss_pred             cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc-
Confidence                                            12247889999999999889999999999999999999999996543 


Q ss_pred             hHHHHHHHHhcCCCCCCchhccHHHHHHHHHhcccCccccCC----HHHHhcCccccccc
Q 015500          201 PMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWA----ASQLLKHPFLEEFC  256 (405)
Q Consensus       201 ~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~L~~dP~~Rpt----~~elL~hp~~~~~~  256 (405)
                      ....+..+............+++.+.+||++||..||++|||    ++++|+||||+...
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~  296 (316)
T cd05574         237 RDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVN  296 (316)
T ss_pred             hHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCC
Confidence            333344333222111111227899999999999999999999    99999999998754

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=4.7e-43  Score=330.98  Aligned_cols=245  Identities=38%  Similarity=0.584  Sum_probs=205.5

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLF   77 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv   77 (405)
                      +|++++.||.|+||+||+|.+..++..+|+|.+....    ...+.+|+.+|+.++||||+++++.+....    .++++
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~iv   77 (267)
T cd06610           2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGD----ELWLV   77 (267)
T ss_pred             cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCC----EEEEE
Confidence            6899999999999999999998899999999986542    457889999999999999999998765433    36799


Q ss_pred             EeecCCCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc--
Q 015500           78 MEYAPGGTLNDEIHRNG--GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA--  152 (405)
Q Consensus        78 ~Ey~~ggsL~~~i~~~~--~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~--  152 (405)
                      |||++|++|.+++....  +.+++..+..++.||+.||+|||++|++||||||+||++++++ ++|+|||++......  
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          78 MPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             EeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            99999999999997642  4689999999999999999999999999999999999999887 999999998654331  


Q ss_pred             ------ccCCCCCCccChhhhcCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCc-----hh
Q 015500          153 ------LQSGGTPMFMAPEVARGE-HQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVP-----AF  220 (405)
Q Consensus       153 ------~~~~gt~~Y~APE~l~~~-~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p-----~~  220 (405)
                            ....|++.|+|||++... .++.++|+|||||++++|++|+.||...... ....+.... ..+.++     ..
T Consensus       158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~  235 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM-KVLMLTLQN-DPPSLETGADYKK  235 (267)
T ss_pred             ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh-hhHHHHhcC-CCCCcCCcccccc
Confidence                  223589999999998876 7888999999999999999999999654332 223332222 222222     25


Q ss_pred             ccHHHHHHHHHhcccCccccCCHHHHhcCccc
Q 015500          221 LSKQANDFLSNCLRRDPKERWAASQLLKHPFL  252 (405)
Q Consensus       221 ~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~  252 (405)
                      +++.+.+|+.+||..||.+|||+.++++||||
T Consensus       236 ~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         236 YSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             ccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence            68899999999999999999999999999997

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=7.4e-43  Score=326.47  Aligned_cols=248  Identities=53%  Similarity=0.901  Sum_probs=220.0

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      +|+..+.||+|++|.||+|.+..+++.+++|.+....     .+.+.+|+.++++++||||+++++......  ...+++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~~~l   78 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE--KNTLNI   78 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC--CCeEEE
Confidence            5889999999999999999999999999999987654     567889999999999999999998776542  124679


Q ss_pred             EEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc---
Q 015500           77 FMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA---  152 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~---  152 (405)
                      ++||+++++|.+++.+.. .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ ++|+|||.+......   
T Consensus        79 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  157 (260)
T cd06606          79 FLEYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG  157 (260)
T ss_pred             EEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence            999999999999998765 899999999999999999999999999999999999999877 999999998765442   


Q ss_pred             ---ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHH
Q 015500          153 ---LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFL  229 (405)
Q Consensus       153 ---~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll  229 (405)
                         ....++..|+|||.+.+..++.++|+||||+++|+|++|..||....+.......+......+.+|..++..+.+||
T Consensus       158 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i  237 (260)
T cd06606         158 EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFL  237 (260)
T ss_pred             ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHH
Confidence               23458899999999998889999999999999999999999997776566666666655667778888999999999


Q ss_pred             HHhcccCccccCCHHHHhcCccc
Q 015500          230 SNCLRRDPKERWAASQLLKHPFL  252 (405)
Q Consensus       230 ~~~L~~dP~~Rpt~~elL~hp~~  252 (405)
                      .+||..||.+||++.++++||||
T Consensus       238 ~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         238 RKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             HHhCcCChhhCCCHHHHhhCCCC
Confidence            99999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.7e-43  Score=333.58  Aligned_cols=244  Identities=28%  Similarity=0.419  Sum_probs=210.5

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC------ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~------~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~   75 (405)
                      +|.+.+.||.|+||.||+|.+..+++.+|+|.+...      ..+.+.+|++++++++||||+++++++....    .++
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~   76 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEE----NMY   76 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCC----eEE
Confidence            589999999999999999999999999999988642      2457889999999999999999988765333    367


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc--
Q 015500           76 LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA--  152 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~--  152 (405)
                      +++||++|++|.+++... +++++..+..++.||+.||.|||++|++|+||||+||+++.++ ++|+|||++......  
T Consensus        77 lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~  155 (258)
T cd05578          77 LVVDLLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL  155 (258)
T ss_pred             EEEeCCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCcc
Confidence            999999999999999876 5899999999999999999999999999999999999999887 999999998764432  


Q ss_pred             -ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC--hHHHHHHHHhcCCCCCCchhccHHHHHHH
Q 015500          153 -LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAAD--PMTVLYKIAYSRELPEVPAFLSKQANDFL  229 (405)
Q Consensus       153 -~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~--~~~~l~~i~~~~~~~~~p~~~s~~l~dll  229 (405)
                       ....|+..|+|||.+.+..++.++|+|||||++|+|++|..||.....  ..... .. .....+..|..++.++.++|
T Consensus       156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~i  233 (258)
T cd05578         156 TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR-AK-QETADVLYPATWSTEAIDAI  233 (258)
T ss_pred             ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHH-HH-hccccccCcccCcHHHHHHH
Confidence             335588899999999988899999999999999999999999975543  22222 22 22245567777899999999


Q ss_pred             HHhcccCccccCCH--HHHhcCccc
Q 015500          230 SNCLRRDPKERWAA--SQLLKHPFL  252 (405)
Q Consensus       230 ~~~L~~dP~~Rpt~--~elL~hp~~  252 (405)
                      .+||+.||.+||++  .++++||||
T Consensus       234 ~~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         234 NKLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             HHHccCChhHcCCccHHHHhcCCCC
Confidence            99999999999999  999999997

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.4e-43  Score=356.53  Aligned_cols=247  Identities=21%  Similarity=0.248  Sum_probs=199.4

Q ss_pred             CcccccccceeCCeeEEEEEEc--CCCCEEEEEEccCCChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEe
Q 015500            2 DWTRGHTIGQGSSATVSLATSL--RSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFME   79 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~--~~~~~vavK~~~~~~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (405)
                      +|.+++.||+|+||+||+|...  .+++.+|+|.+...  ....+|+++|+.|+||||+++++.+....    .++++||
T Consensus        93 ~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--~~~~~E~~il~~l~h~~iv~~~~~~~~~~----~~~lv~e  166 (392)
T PHA03207         93 QYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--KTPGREIDILKTISHRAIINLIHAYRWKS----TVCMVMP  166 (392)
T ss_pred             ceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--ccHHHHHHHHHhcCCCCccceeeeEeeCC----EEEEEeh
Confidence            6999999999999999999754  35678999987643  35678999999999999999998765433    3679999


Q ss_pred             ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc------
Q 015500           80 YAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA------  152 (405)
Q Consensus        80 y~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~------  152 (405)
                      ++. ++|.+++... +++++..++.++.||+.||.|||++||+||||||+|||++.++ +||+|||+++.....      
T Consensus       167 ~~~-~~l~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~  244 (392)
T PHA03207        167 KYK-CDLFTYVDRS-GPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQC  244 (392)
T ss_pred             hcC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccccccc
Confidence            995 5888888554 5899999999999999999999999999999999999999887 999999998754331      


Q ss_pred             ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCh--HHHHHHHHhc-------------------
Q 015500          153 LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADP--MTVLYKIAYS-------------------  211 (405)
Q Consensus       153 ~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~--~~~l~~i~~~-------------------  211 (405)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||......  ...+..+...                   
T Consensus       245 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~  324 (392)
T PHA03207        245 YGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKH  324 (392)
T ss_pred             cccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHH
Confidence            2346999999999999999999999999999999999999999643221  1111111100                   


Q ss_pred             ------CCCC--CCc-----hhccHHHHHHHHHhcccCccccCCHHHHhcCccccccc
Q 015500          212 ------RELP--EVP-----AFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFC  256 (405)
Q Consensus       212 ------~~~~--~~p-----~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~  256 (405)
                            ...+  ..|     ..++.++.+||++||+.||.+|||+.++|.||||.+..
T Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~  382 (392)
T PHA03207        325 FKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEP  382 (392)
T ss_pred             HHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccc
Confidence                  0000  011     12467899999999999999999999999999998653

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=7.1e-43  Score=330.16  Aligned_cols=242  Identities=29%  Similarity=0.501  Sum_probs=208.2

Q ss_pred             cceeCCeeEEEEEEcCCCCEEEEEEccCC------ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEeecC
Q 015500            9 IGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAP   82 (405)
Q Consensus         9 LG~G~~g~Vyla~~~~~~~~vavK~~~~~------~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~Ey~~   82 (405)
                      ||.|+||.||+|++..+++.+|+|.+...      ..+.+.+|+.+++.++||||+++++.+....    .+++++||++
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~   76 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKK----YIYMLMEYCL   76 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCC----ccEEEEecCC
Confidence            79999999999999999999999988643      2356889999999999999999998765433    3669999999


Q ss_pred             CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc---ccCCCC
Q 015500           83 GGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA---LQSGGT  158 (405)
Q Consensus        83 ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~---~~~~gt  158 (405)
                      +++|.+++.+. ..+++..+..++.||+.||.|||++|++|+||||+||+++.++ ++|+|||++......   ....++
T Consensus        77 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~  155 (262)
T cd05572          77 GGELWTILRDR-GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGT  155 (262)
T ss_pred             CCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCC
Confidence            99999999876 3689999999999999999999999999999999999999887 999999998865432   234689


Q ss_pred             CCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-hHHHHHHHHhcCCCCCCchhccHHHHHHHHHhcccCc
Q 015500          159 PMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAAD-PMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDP  237 (405)
Q Consensus       159 ~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~-~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~L~~dP  237 (405)
                      +.|+|||.+.+..++.++|+||||+++|+|++|..||..... .......+......+..|...++++.+||.+||..+|
T Consensus       156 ~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p  235 (262)
T cd05572         156 PEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNP  235 (262)
T ss_pred             cCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCCh
Confidence            999999999888899999999999999999999999965542 3334444443345556677779999999999999999


Q ss_pred             cccCC-----HHHHhcCcccccc
Q 015500          238 KERWA-----ASQLLKHPFLEEF  255 (405)
Q Consensus       238 ~~Rpt-----~~elL~hp~~~~~  255 (405)
                      .+||+     +.|+++||||+.+
T Consensus       236 ~~R~~~~~~~~~~l~~~~~~~~~  258 (262)
T cd05572         236 EERLGNLKGGIKDIKKHKWFNGF  258 (262)
T ss_pred             hhCcCCcccCHHHHhcChhhhCC
Confidence            99999     9999999999865

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.6e-44  Score=353.87  Aligned_cols=246  Identities=27%  Similarity=0.459  Sum_probs=203.1

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC-----ChHHHHHHHHHHHhC-CCCCeeeeeeeeeecCCCceEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP-----KSEFLQREQKFLSSL-NSPHIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~-----~~~~l~~E~~iL~~L-~hpnIv~~~~~~~~~~~~~~~~~   75 (405)
                      +|.+.+.||+||.+.||++.... ...+|+|.+...     ...-+.+|+..|.+| .|.+|++++++.+++.    ++|
T Consensus       362 ~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~----~lY  436 (677)
T KOG0596|consen  362 EYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDG----YLY  436 (677)
T ss_pred             hhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCc----eEE
Confidence            58999999999999999998754 455666554332     235688999999999 6899999999877632    577


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCCceEeeeccccccccc---
Q 015500           76 LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGAKIADFGCAKWESEA---  152 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~vkL~DFGla~~~~~~---  152 (405)
                      +||||- ..+|..+|++..+.++...++.|.+|++.|+.++|..||||.||||.|+|+-.+.+||+|||+|..+...   
T Consensus       437 mvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVkG~LKLIDFGIA~aI~~DTTs  515 (677)
T KOG0596|consen  437 MVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVKGRLKLIDFGIANAIQPDTTS  515 (677)
T ss_pred             EEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEeeeEEeeeechhcccCccccc
Confidence            999987 4499999998876677678999999999999999999999999999999999888999999999876552   


Q ss_pred             ---ccCCCCCCccChhhhcCCC-----------CCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcC---CCC
Q 015500          153 ---LQSGGTPMFMAPEVARGEH-----------QGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSR---ELP  215 (405)
Q Consensus       153 ---~~~~gt~~Y~APE~l~~~~-----------~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~---~~~  215 (405)
                         ...+||+-||+||.+....           .++++||||||||||+|+.|++||....+....+..|....   ++|
T Consensus       516 I~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp  595 (677)
T KOG0596|consen  516 IVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEFP  595 (677)
T ss_pred             eeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCcccccc
Confidence               2457999999999985422           46799999999999999999999976665566666665442   445


Q ss_pred             CCchhccHHHHHHHHHhcccCccccCCHHHHhcCcccccc
Q 015500          216 EVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       216 ~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      .+|..  .++.++++.||++||++|||+.+||+|||++.+
T Consensus       596 ~~~~~--~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~  633 (677)
T KOG0596|consen  596 DIPEN--DELIDVMKCCLARDPKKRWSIPELLQHPFLQIQ  633 (677)
T ss_pred             CCCCc--hHHHHHHHHHHhcCcccCCCcHHHhcCcccccc
Confidence            55543  239999999999999999999999999999863

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1e-42  Score=334.55  Aligned_cols=251  Identities=32%  Similarity=0.518  Sum_probs=206.4

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC--ChHHHHHHHHHHHhC-CCCCeeeeeeeeeecCC-CceEEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP--KSEFLQREQKFLSSL-NSPHIVGYKGCDVTSED-NKLMYNLF   77 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~--~~~~l~~E~~iL~~L-~hpnIv~~~~~~~~~~~-~~~~~~lv   77 (405)
                      +|.+.+.||+|+||.||+|.+..+++.+|+|.+...  ....+.+|+.+++++ +|||++++++.+...+. ....+++|
T Consensus        23 ~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv  102 (291)
T cd06639          23 TWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLV  102 (291)
T ss_pred             CeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEE
Confidence            588999999999999999999999999999998653  245778899999999 89999999998765432 12346799


Q ss_pred             EeecCCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc--
Q 015500           78 MEYAPGGTLNDEIHR---NGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE--  151 (405)
Q Consensus        78 ~Ey~~ggsL~~~i~~---~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~--  151 (405)
                      |||++|++|.+++..   .+..+++..++.++.|++.||.|||+.|++||||||+||+++.++ +||+|||++.....  
T Consensus       103 ~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~  182 (291)
T cd06639         103 LELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR  182 (291)
T ss_pred             EEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchhccccc
Confidence            999999999998864   345799999999999999999999999999999999999998887 99999999875432  


Q ss_pred             --cccCCCCCCccChhhhcCCC-----CCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCC-CCCchhccH
Q 015500          152 --ALQSGGTPMFMAPEVARGEH-----QGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSREL-PEVPAFLSK  223 (405)
Q Consensus       152 --~~~~~gt~~Y~APE~l~~~~-----~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~-~~~p~~~s~  223 (405)
                        .....|++.|+|||.+....     ++.++|||||||++|+|++|+.||..... ...+.++...... ...+...+.
T Consensus       183 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  261 (291)
T cd06639         183 LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP-VKTLFKIPRNPPPTLLHPEKWCR  261 (291)
T ss_pred             ccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH-HHHHHHHhcCCCCCCCcccccCH
Confidence              12345889999999986533     57899999999999999999999965433 3333333222111 122445678


Q ss_pred             HHHHHHHHhcccCccccCCHHHHhcCcccc
Q 015500          224 QANDFLSNCLRRDPKERWAASQLLKHPFLE  253 (405)
Q Consensus       224 ~l~dll~~~L~~dP~~Rpt~~elL~hp~~~  253 (405)
                      .+.++|.+||+.+|.+||++.++++||||+
T Consensus       262 ~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         262 SFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             HHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence            899999999999999999999999999984

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=7.4e-43  Score=333.60  Aligned_cols=246  Identities=30%  Similarity=0.476  Sum_probs=203.8

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      +|.+++.||.|+||.||+|.+..+|+.+|+|.+....     ...+.+|+.++++++||||+++++.+....    .+++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~----~~~~   76 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGS----GFVL   76 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCC----eeEE
Confidence            5899999999999999999999999999999886543     357889999999999999999998775532    3679


Q ss_pred             EEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc---
Q 015500           77 FMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA---  152 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~---  152 (405)
                      |+||+ +++|.+++......+++..++.++.||+.||.|||+.|++|+||||+||+++.++ ++|+|||++......   
T Consensus        77 v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~  155 (286)
T cd07832          77 VMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR  155 (286)
T ss_pred             Eeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC
Confidence            99999 9999999987666899999999999999999999999999999999999999887 999999998764432   


Q ss_pred             --ccCCCCCCccChhhhcCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCC---------------
Q 015500          153 --LQSGGTPMFMAPEVARGE-HQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSREL---------------  214 (405)
Q Consensus       153 --~~~~gt~~Y~APE~l~~~-~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~---------------  214 (405)
                        ....|++.|+|||.+.+. .+++++|||||||++|+|++|.+||....+ ...+.++...-..               
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd07832         156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND-IEQLAIVFRTLGTPNEETWPGLTSLPDY  234 (286)
T ss_pred             ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH-HHHHHHHHHHcCCCChHHHhhccCcchh
Confidence              234589999999998764 468899999999999999999888854433 2222222111000               


Q ss_pred             -----C--------CCchhccHHHHHHHHHhcccCccccCCHHHHhcCcccc
Q 015500          215 -----P--------EVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLE  253 (405)
Q Consensus       215 -----~--------~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~  253 (405)
                           +        ......+..+.+||++||+.+|.+|||++++|+||||.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             hcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence                 0        01123578999999999999999999999999999984

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1e-42  Score=330.81  Aligned_cols=246  Identities=37%  Similarity=0.735  Sum_probs=204.9

Q ss_pred             CCcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-------------hHHHHHHHHHHHhCCCCCeeeeeeeeeec
Q 015500            1 MDWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-------------SEFLQREQKFLSSLNSPHIVGYKGCDVTS   67 (405)
Q Consensus         1 ~~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-------------~~~l~~E~~iL~~L~hpnIv~~~~~~~~~   67 (405)
                      ++|...+.||.|+||.||+|.+..+|+.+|+|.+....             .+.+.+|+.+++.++||||+++++++...
T Consensus         1 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   80 (272)
T cd06629           1 FKWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTE   80 (272)
T ss_pred             CceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccC
Confidence            57999999999999999999999999999999875321             13577899999999999999999876543


Q ss_pred             CCCceEEEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccc
Q 015500           68 EDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCA  146 (405)
Q Consensus        68 ~~~~~~~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla  146 (405)
                      .    .+++||||++|++|.+++.+. +++++..++.++.||+.||.|||++|++||||+|+||+++.++ ++|+|||++
T Consensus        81 ~----~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~  155 (272)
T cd06629          81 E----YLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGIS  155 (272)
T ss_pred             C----ceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccc
Confidence            3    366999999999999999876 4899999999999999999999999999999999999999887 999999998


Q ss_pred             ccccc------cccCCCCCCccChhhhcCCC--CCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCc
Q 015500          147 KWESE------ALQSGGTPMFMAPEVARGEH--QGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVP  218 (405)
Q Consensus       147 ~~~~~------~~~~~gt~~Y~APE~l~~~~--~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p  218 (405)
                      +....      .....|+..|+|||.+....  ++.++|+||||+++++|++|..||..... ......+......+.++
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~  234 (272)
T cd06629         156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA-IAAMFKLGNKRSAPPIP  234 (272)
T ss_pred             ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch-HHHHHHhhccccCCcCC
Confidence            75432      12345888999999988754  78899999999999999999999964433 23333332222222222


Q ss_pred             ----hhccHHHHHHHHHhcccCccccCCHHHHhcCccc
Q 015500          219 ----AFLSKQANDFLSNCLRRDPKERWAASQLLKHPFL  252 (405)
Q Consensus       219 ----~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~  252 (405)
                          ..++.++.++|.+||..+|.+|||++++|+||||
T Consensus       235 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         235 PDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence                3468999999999999999999999999999996

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=7.9e-43  Score=334.50  Aligned_cols=243  Identities=26%  Similarity=0.397  Sum_probs=196.7

Q ss_pred             ccceeCCeeEEEEEEcCCCCEEEEEEccCCC------hHHHHHHHHHH---HhCCCCCeeeeeeeeeecCCCceEEEEEE
Q 015500            8 TIGQGSSATVSLATSLRSGDVFAAKSTELPK------SEFLQREQKFL---SSLNSPHIVGYKGCDVTSEDNKLMYNLFM   78 (405)
Q Consensus         8 ~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~------~~~l~~E~~iL---~~L~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (405)
                      .||+|+||.||+|.+..+++.+|+|.+....      .....+|..++   ....||||+.+++.+...+    .+++||
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~----~~~lv~   76 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPD----KLCFIL   76 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCC----eEEEEE
Confidence            4899999999999999999999999875432      12334444433   3447999999887765443    366999


Q ss_pred             eecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc--cccC
Q 015500           79 EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE--ALQS  155 (405)
Q Consensus        79 Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~--~~~~  155 (405)
                      ||++|++|.+++..+ +.+++..+..++.|++.||.|||++|++||||||+|||++.++ ++|+|||++.....  ....
T Consensus        77 e~~~~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~  155 (279)
T cd05633          77 DLMNGGDLHYHLSQH-GVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS  155 (279)
T ss_pred             ecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCccCc
Confidence            999999999998876 4799999999999999999999999999999999999999887 99999999865432  2234


Q ss_pred             CCCCCccChhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCh-HHHHHHHHhcCCCCCCchhccHHHHHHHHHhc
Q 015500          156 GGTPMFMAPEVARG-EHQGFASDIWAVGCTVIEMASGGAPWPNAADP-MTVLYKIAYSRELPEVPAFLSKQANDFLSNCL  233 (405)
Q Consensus       156 ~gt~~Y~APE~l~~-~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~-~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~L  233 (405)
                      .||+.|+|||.+.+ ..++.++|+||+||++|+|++|..||...... ...+.... ....+.+|..+++++.++|++||
T Consensus       156 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l  234 (279)
T cd05633         156 VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT-LTVNVELPDSFSPELKSLLEGLL  234 (279)
T ss_pred             CCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh-hcCCcCCccccCHHHHHHHHHHh
Confidence            68999999999864 56889999999999999999999999644322 22222222 22234566778999999999999


Q ss_pred             ccCccccC-----CHHHHhcCccccccc
Q 015500          234 RRDPKERW-----AASQLLKHPFLEEFC  256 (405)
Q Consensus       234 ~~dP~~Rp-----t~~elL~hp~~~~~~  256 (405)
                      +.||++||     |+.++++||||+.+.
T Consensus       235 ~~~p~~R~~~~~~~~~~~~~h~~~~~~~  262 (279)
T cd05633         235 QRDVSKRLGCLGRGAQEVKEHVFFKGID  262 (279)
T ss_pred             cCCHHHhcCCCCCCHHHHHhCccccCCC
Confidence            99999999     699999999998754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.5e-42  Score=326.51  Aligned_cols=245  Identities=29%  Similarity=0.516  Sum_probs=210.8

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC-----ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP-----KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~-----~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      +|+..+.||.|+||.||++++..+++.+++|.+...     ....+.+|+++|++++||||+++++++....    .+++
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~----~~~~   76 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDN----TLLI   76 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCC----eEEE
Confidence            589999999999999999999999999999987643     2346789999999999999999999876543    3669


Q ss_pred             EEeecCCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc--
Q 015500           77 FMEYAPGGTLNDEIHRN-GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA--  152 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~-~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~--  152 (405)
                      +|||+++++|.+++.+. +..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ +||+|||++......  
T Consensus        77 ~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~  156 (256)
T cd08221          77 EMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS  156 (256)
T ss_pred             EEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence            99999999999999875 45689999999999999999999999999999999999999887 999999998764332  


Q ss_pred             --ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHH
Q 015500          153 --LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLS  230 (405)
Q Consensus       153 --~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~  230 (405)
                        ....+++.|+|||.+.+..++.++|+|||||++++|++|..||... +.......+. ....+..+..++.++.++|.
T Consensus       157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~  234 (256)
T cd08221         157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDAT-NPLNLVVKIV-QGNYTPVVSVYSSELISLVH  234 (256)
T ss_pred             cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCC-CHHHHHHHHH-cCCCCCCccccCHHHHHHHH
Confidence              2345899999999999888899999999999999999999999543 3444444443 33444555678999999999


Q ss_pred             HhcccCccccCCHHHHhcCccc
Q 015500          231 NCLRRDPKERWAASQLLKHPFL  252 (405)
Q Consensus       231 ~~L~~dP~~Rpt~~elL~hp~~  252 (405)
                      +||..+|.+|||+.++|+|||+
T Consensus       235 ~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         235 SLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             HHcccCcccCCCHHHHhhCcCC
Confidence            9999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=9.6e-43  Score=327.21  Aligned_cols=245  Identities=29%  Similarity=0.470  Sum_probs=208.8

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC-----ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP-----KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~-----~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      +|...+.||+|+||.||+|.+..+++.+|+|.+...     ....+.+|+++|++++||||+++++.+....    .+++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~----~~~l   76 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDK----ALMI   76 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCC----EEEE
Confidence            589999999999999999999999999999987643     2357889999999999999999988764322    3679


Q ss_pred             EEeecCCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC--ceEeeeccccccccc-
Q 015500           77 FMEYAPGGTLNDEIHRN-GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG--AKIADFGCAKWESEA-  152 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~-~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~--vkL~DFGla~~~~~~-  152 (405)
                      ||||++|++|.+++... +..+++..+..++.|++.||+|||++|++|+||||+||+++.++  +||+|||++...... 
T Consensus        77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (256)
T cd08220          77 VMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS  156 (256)
T ss_pred             EEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence            99999999999999774 33589999999999999999999999999999999999998654  799999998765432 


Q ss_pred             --ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHH
Q 015500          153 --LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLS  230 (405)
Q Consensus       153 --~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~  230 (405)
                        ....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||..... ......+. ....+.++..++.++.+++.
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~l~~li~  234 (256)
T cd08220         157 KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL-PALVLKIM-SGTFAPISDRYSPDLRQLIL  234 (256)
T ss_pred             cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch-HHHHHHHH-hcCCCCCCCCcCHHHHHHHH
Confidence              234589999999999988889999999999999999999999965433 33333333 33444566778999999999


Q ss_pred             HhcccCccccCCHHHHhcCccc
Q 015500          231 NCLRRDPKERWAASQLLKHPFL  252 (405)
Q Consensus       231 ~~L~~dP~~Rpt~~elL~hp~~  252 (405)
                      +||..+|.+|||+.++++||||
T Consensus       235 ~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         235 SMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             HHccCChhhCCCHHHHhhCCCC
Confidence            9999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.3e-42  Score=331.92  Aligned_cols=245  Identities=30%  Similarity=0.495  Sum_probs=201.1

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC-----ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP-----KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~-----~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      +|+..+.||+|+||.||+|.++.+++.+|+|.+...     ..+.+.+|++++++++||||+++++.+....    .+++
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~----~~~~   77 (286)
T cd07847           2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKR----KLHL   77 (286)
T ss_pred             ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCC----EEEE
Confidence            588999999999999999999999999999987532     2245788999999999999999998876543    3679


Q ss_pred             EEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccccc--
Q 015500           77 FMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEAL--  153 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~~--  153 (405)
                      +|||+++++|..++... ..+++..++.++.||+.||.|||++|++||||||+||+++.++ +||+|||++.......  
T Consensus        78 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~  156 (286)
T cd07847          78 VFEYCDHTVLNELEKNP-RGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD  156 (286)
T ss_pred             EEeccCccHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCccc
Confidence            99999998887776554 4799999999999999999999999999999999999999888 9999999997654322  


Q ss_pred             --cCCCCCCccChhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHh-cC-----------------
Q 015500          154 --QSGGTPMFMAPEVARG-EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAY-SR-----------------  212 (405)
Q Consensus       154 --~~~gt~~Y~APE~l~~-~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~-~~-----------------  212 (405)
                        ...++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||...... ..+..+.. ..                 
T Consensus       157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T cd07847         157 YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDV-DQLYLIRKTLGDLIPRHQQIFSTNQFFK  235 (286)
T ss_pred             ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCChHHhhhcccccccc
Confidence              3457889999999876 45788999999999999999999999755433 22222111 00                 


Q ss_pred             --CCCC---------CchhccHHHHHHHHHhcccCccccCCHHHHhcCccc
Q 015500          213 --ELPE---------VPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFL  252 (405)
Q Consensus       213 --~~~~---------~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~  252 (405)
                        ..|.         ....++..+.+|+.+||+.+|++|||+.|++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         236 GLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             cccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence              0010         012357889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.3e-42  Score=330.02  Aligned_cols=241  Identities=18%  Similarity=0.272  Sum_probs=200.6

Q ss_pred             CcccccccceeCCeeEEEEEEc---CCCCEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSL---RSGDVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMY   74 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~---~~~~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~   74 (405)
                      +|++.+.||+|+||.||+|.++   ..+..+|+|.+....    ...+.+|+.+|+.++||||+++++++....    .+
T Consensus         6 ~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~   81 (266)
T cd05064           6 SIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGN----TM   81 (266)
T ss_pred             HeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCC----Cc
Confidence            4788999999999999999875   456789999887542    236778999999999999999998865433    26


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc-
Q 015500           75 NLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA-  152 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~-  152 (405)
                      ++||||+++|+|.+++....+.+++..++.++.||+.||+|||++|++||||||+||+++.++ +|++|||.+...... 
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~  161 (266)
T cd05064          82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA  161 (266)
T ss_pred             EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence            699999999999999988666899999999999999999999999999999999999999887 999999987643221 


Q ss_pred             ----ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHH
Q 015500          153 ----LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQAND  227 (405)
Q Consensus       153 ----~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~d  227 (405)
                          ....+++.|+|||.+.+..++.++|||||||++|||++ |..||..... ...+..+... ..+..|..++..+.+
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~~  239 (266)
T cd05064         162 IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG-QDVIKAVEDG-FRLPAPRNCPNLLHQ  239 (266)
T ss_pred             hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH-HHHHHHHHCC-CCCCCCCCCCHHHHH
Confidence                12235678999999999999999999999999999775 9999965433 3333443332 333456778999999


Q ss_pred             HHHHhcccCccccCCHHHHhc
Q 015500          228 FLSNCLRRDPKERWAASQLLK  248 (405)
Q Consensus       228 ll~~~L~~dP~~Rpt~~elL~  248 (405)
                      ++.+||+.+|.+|||+++|++
T Consensus       240 li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         240 LMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             HHHHHcCCCchhCCCHHHHHH
Confidence            999999999999999999976

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.2e-42  Score=337.80  Aligned_cols=245  Identities=29%  Similarity=0.395  Sum_probs=189.6

Q ss_pred             cccccceeCCeeEEEEEEcC--CCCEEEEEEccCCC-hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEeec
Q 015500            5 RGHTIGQGSSATVSLATSLR--SGDVFAAKSTELPK-SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYA   81 (405)
Q Consensus         5 ~~~~LG~G~~g~Vyla~~~~--~~~~vavK~~~~~~-~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~Ey~   81 (405)
                      .+.+||+|+||+||+|+++.  ++..+|+|.+.... ...+.+|+++|+.++||||+++++++....+.  .++++|||+
T Consensus         5 ~g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~--~~~lv~e~~   82 (317)
T cd07867           5 EGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSDR--KVWLLFDYA   82 (317)
T ss_pred             eceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCC--eEEEEEeee
Confidence            35789999999999999654  56889999886543 45688999999999999999999987654433  356999999


Q ss_pred             CCCCHHHHHHHc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEc----cCC-ceEeeeccccc
Q 015500           82 PGGTLNDEIHRN--------GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMA----ESG-AKIADFGCAKW  148 (405)
Q Consensus        82 ~ggsL~~~i~~~--------~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~----~~~-vkL~DFGla~~  148 (405)
                      ++ +|.+++...        ...+++..++.++.||+.||.|||++||+||||||+|||+.    .++ +||+|||+++.
T Consensus        83 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~  161 (317)
T cd07867          83 EH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL  161 (317)
T ss_pred             CC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence            65 888877532        22588999999999999999999999999999999999994    334 99999999976


Q ss_pred             cccc-------ccCCCCCCccChhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCh--------HHHHHHHHhcC
Q 015500          149 ESEA-------LQSGGTPMFMAPEVARG-EHQGFASDIWAVGCTVIEMASGGAPWPNAADP--------MTVLYKIAYSR  212 (405)
Q Consensus       149 ~~~~-------~~~~gt~~Y~APE~l~~-~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~--------~~~l~~i~~~~  212 (405)
                      ....       ....||+.|+|||++.+ ..++.++|||||||++|||+||++||......        ...+.++....
T Consensus       162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  241 (317)
T cd07867         162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVM  241 (317)
T ss_pred             cCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhc
Confidence            4331       23458999999999977 45789999999999999999999999643211        00111000000


Q ss_pred             C------------CC------------------------CCchhccHHHHHHHHHhcccCccccCCHHHHhcCccc
Q 015500          213 E------------LP------------------------EVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFL  252 (405)
Q Consensus       213 ~------------~~------------------------~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~  252 (405)
                      .            .+                        ......+..+.+||.+||+.||.+|||++|+|+||||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         242 GFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             CCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            0            00                        0011235678899999999999999999999999997

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.4e-42  Score=327.57  Aligned_cols=245  Identities=41%  Similarity=0.769  Sum_probs=209.8

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      +|.+.+.||+|+||.||+|.+..+++.+++|.+....     ...+.+|+.++++++||||+++++.+....    .+++
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~----~~~l   76 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHRE----KVYI   76 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCC----EEEE
Confidence            5899999999999999999999999999999876542     357889999999999999999998765433    3669


Q ss_pred             EEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccccc--
Q 015500           77 FMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEAL--  153 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~~--  153 (405)
                      ++||+++++|.+++... +.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ +||+|||++.......  
T Consensus        77 v~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~  155 (264)
T cd06626          77 FMEYCSGGTLEELLEHG-RILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT  155 (264)
T ss_pred             EEecCCCCcHHHHHhhc-CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence            99999999999999775 4689999999999999999999999999999999999999887 9999999987643311  


Q ss_pred             ------cCCCCCCccChhhhcCCC---CCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhc--c
Q 015500          154 ------QSGGTPMFMAPEVARGEH---QGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFL--S  222 (405)
Q Consensus       154 ------~~~gt~~Y~APE~l~~~~---~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~--s  222 (405)
                            ...+++.|+|||.+.+..   ++.++|||||||++++|++|+.||............+.. ...+.+|...  +
T Consensus       156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  234 (264)
T cd06626         156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GHKPPIPDSLQLS  234 (264)
T ss_pred             ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CCCCCCCcccccC
Confidence                  235788999999998766   788999999999999999999999766555555444443 4445556554  8


Q ss_pred             HHHHHHHHHhcccCccccCCHHHHhcCccc
Q 015500          223 KQANDFLSNCLRRDPKERWAASQLLKHPFL  252 (405)
Q Consensus       223 ~~l~dll~~~L~~dP~~Rpt~~elL~hp~~  252 (405)
                      +.+.+||++||+.+|.+|||+.+++.|||+
T Consensus       235 ~~~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         235 PEGKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             HHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            999999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=4.5e-43  Score=334.72  Aligned_cols=247  Identities=38%  Similarity=0.616  Sum_probs=208.9

Q ss_pred             cccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEE
Q 015500            3 WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFM   78 (405)
Q Consensus         3 y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (405)
                      |+..+.||+|+||.||+|.+..+++.+|+|.+....    .+.+.+|+.++++++||||+++++.+....    .+++||
T Consensus         6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~   81 (277)
T cd06642           6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGT----KLWIIM   81 (277)
T ss_pred             HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCC----ceEEEE
Confidence            678899999999999999999999999999887443    346889999999999999999999876433    367999


Q ss_pred             eecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc----c
Q 015500           79 EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA----L  153 (405)
Q Consensus        79 Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~----~  153 (405)
                      ||+++++|.+++..  +.+++..++.++.||+.||.|||++|++|+||+|+||+++.++ ++|+|||++......    .
T Consensus        82 e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~  159 (277)
T cd06642          82 EYLGGGSALDLLKP--GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRN  159 (277)
T ss_pred             EccCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhhh
Confidence            99999999998864  4799999999999999999999999999999999999999887 999999998754332    2


Q ss_pred             cCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHhc
Q 015500          154 QSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCL  233 (405)
Q Consensus       154 ~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~L  233 (405)
                      ...|+..|+|||++.+..++.++|+|||||++|||++|+.||.... +......+ .....+..+..++.++.++|.+||
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l  237 (277)
T cd06642         160 TFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLH-PMRVLFLI-PKNSPPTLEGQYSKPFKEFVEACL  237 (277)
T ss_pred             cccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccc-hhhHHhhh-hcCCCCCCCcccCHHHHHHHHHHc
Confidence            2358889999999999889999999999999999999999995432 22222222 222344555668899999999999


Q ss_pred             ccCccccCCHHHHhcCcccccccc
Q 015500          234 RRDPKERWAASQLLKHPFLEEFCS  257 (405)
Q Consensus       234 ~~dP~~Rpt~~elL~hp~~~~~~~  257 (405)
                      +.+|++|||+.++++||||..+..
T Consensus       238 ~~~p~~Rp~~~~il~~~~~~~~~~  261 (277)
T cd06642         238 NKDPRFRPTAKELLKHKFITRYTK  261 (277)
T ss_pred             cCCcccCcCHHHHHHhHHHHHHhh
Confidence            999999999999999999987643

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.5e-42  Score=326.58  Aligned_cols=245  Identities=27%  Similarity=0.503  Sum_probs=209.9

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC-----ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP-----KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~-----~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      +|++.+.||+|+||+||++.+..+|+.+|+|.+...     ....+.+|+.++++++||||+++.+++....    .+++
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~l   76 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENG----NLYI   76 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCC----eEEE
Confidence            589999999999999999999999999999987532     2346889999999999999999998764432    3679


Q ss_pred             EEeecCCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc--
Q 015500           77 FMEYAPGGTLNDEIHRN-GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA--  152 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~-~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~--  152 (405)
                      ++||+++++|.+++... +..+++..+..++.|++.||.|||++|++|+||+|+||+++.++ ++|+|||++......  
T Consensus        77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~  156 (256)
T cd08218          77 VMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE  156 (256)
T ss_pred             EEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence            99999999999998764 33689999999999999999999999999999999999998877 999999998754332  


Q ss_pred             --ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHH
Q 015500          153 --LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLS  230 (405)
Q Consensus       153 --~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~  230 (405)
                        ....|++.|+|||++.+..++.++|+|||||++++|++|+.||... +.......+. ....+..+..++.++.++|.
T Consensus       157 ~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~  234 (256)
T cd08218         157 LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG-NMKNLVLKII-RGSYPPVSSHYSYDLRNLVS  234 (256)
T ss_pred             hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC-CHHHHHHHHh-cCCCCCCcccCCHHHHHHHH
Confidence              2345889999999999888899999999999999999999999644 3344443433 34455667788999999999


Q ss_pred             HhcccCccccCCHHHHhcCccc
Q 015500          231 NCLRRDPKERWAASQLLKHPFL  252 (405)
Q Consensus       231 ~~L~~dP~~Rpt~~elL~hp~~  252 (405)
                      +||+.+|++||++.++++||||
T Consensus       235 ~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         235 QLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             HHhhCChhhCcCHHHHhhCcCC
Confidence            9999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-43  Score=349.10  Aligned_cols=238  Identities=27%  Similarity=0.425  Sum_probs=202.8

Q ss_pred             cccccccceeCCeeEEEEEEcCCCCEEEEEEccCC--ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEee
Q 015500            3 WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP--KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEY   80 (405)
Q Consensus         3 y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~--~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~Ey   80 (405)
                      .+.++.||+|-||.||+|.+.. ...||+|.+...  ..+.+.+|+++|++|+|+|||++++++...+.    ++|||||
T Consensus       208 l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~p----iyIVtE~  282 (468)
T KOG0197|consen  208 LKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEP----IYIVTEY  282 (468)
T ss_pred             HHHHHHhcCCccceEEEEEEcC-CCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCc----eEEEEEe
Confidence            3567899999999999999863 347899987642  34678899999999999999999998766553    6699999


Q ss_pred             cCCCCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccccc--cCC
Q 015500           81 APGGTLNDEIHR-NGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEAL--QSG  156 (405)
Q Consensus        81 ~~ggsL~~~i~~-~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~~--~~~  156 (405)
                      |+.|+|.++++. .++.+.-...+.++.||++|++||+++++|||||-++||||+++. +||+|||+|+...+..  ...
T Consensus       283 m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~  362 (468)
T KOG0197|consen  283 MPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASE  362 (468)
T ss_pred             cccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCceeecC
Confidence            999999999997 566799999999999999999999999999999999999999998 9999999999654421  111


Q ss_pred             C---CCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHh
Q 015500          157 G---TPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNC  232 (405)
Q Consensus       157 g---t~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~  232 (405)
                      |   ..-|.|||.+....++.+|||||||++|+||+| |+.|++.+. ..+++..+..+..+| .|..+|+.+.++++.|
T Consensus       363 ~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms-n~ev~~~le~GyRlp-~P~~CP~~vY~lM~~C  440 (468)
T KOG0197|consen  363 GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS-NEEVLELLERGYRLP-RPEGCPDEVYELMKSC  440 (468)
T ss_pred             CCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC-HHHHHHHHhccCcCC-CCCCCCHHHHHHHHHH
Confidence            2   334999999999999999999999999999999 888987654 456666666555554 5778999999999999


Q ss_pred             cccCccccCCHHHHh
Q 015500          233 LRRDPKERWAASQLL  247 (405)
Q Consensus       233 L~~dP~~Rpt~~elL  247 (405)
                      |..+|++|||++.+.
T Consensus       441 W~~~P~~RPtF~~L~  455 (468)
T KOG0197|consen  441 WHEDPEDRPTFETLR  455 (468)
T ss_pred             hhCCcccCCCHHHHH
Confidence            999999999999764

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.3e-42  Score=331.66  Aligned_cols=248  Identities=28%  Similarity=0.493  Sum_probs=202.5

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC----hHHHHHHHHH-HHhCCCCCeeeeeeeeeecCCCceEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK----SEFLQREQKF-LSSLNSPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~----~~~l~~E~~i-L~~L~hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      +|++.+.||+|+||.||+|.++.+|+.||+|.+....    ...+..|..+ ++.++||||+++++.+.....    .++
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~----~~l   77 (283)
T cd06617           2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGD----VWI   77 (283)
T ss_pred             CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCc----EEE
Confidence            6899999999999999999999999999999886542    2244455554 667799999999998754332    669


Q ss_pred             EEeecCCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCCCCEEEccCC-ceEeeecccccccc
Q 015500           77 FMEYAPGGTLNDEIHR---NGGRLDESLIVSYTRQILQGLEYLHSN-RVVHCDIKSRNILMAESG-AKIADFGCAKWESE  151 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~---~~~~l~e~~~~~i~~qIl~~L~yLH~~-givHrDlkp~NILi~~~~-vkL~DFGla~~~~~  151 (405)
                      +|||++ |+|.+++..   .+..+++..+..++.||+.||+|||++ +++||||||+||+++.++ +||+|||++.....
T Consensus        78 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          78 CMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             Ehhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            999996 588887754   234689999999999999999999997 999999999999999887 99999999876433


Q ss_pred             c---ccCCCCCCccChhhhcC----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCc-hhccH
Q 015500          152 A---LQSGGTPMFMAPEVARG----EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVP-AFLSK  223 (405)
Q Consensus       152 ~---~~~~gt~~Y~APE~l~~----~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p-~~~s~  223 (405)
                      .   ....++..|+|||.+.+    ..++.++|+|||||++|+|++|+.||.........+..... ...+.+| ..+|+
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  235 (283)
T cd06617         157 SVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE-EPSPQLPAEKFSP  235 (283)
T ss_pred             ccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHh-cCCCCCCccccCH
Confidence            2   22458899999999865    34688999999999999999999999755444444444432 2333343 35789


Q ss_pred             HHHHHHHHhcccCccccCCHHHHhcCcccccc
Q 015500          224 QANDFLSNCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       224 ~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      ++.+||.+||..+|.+|||+.++++||||...
T Consensus       236 ~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  267 (283)
T cd06617         236 EFQDFVNKCLKKNYKERPNYPELLQHPFFELH  267 (283)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhcCchhhhc
Confidence            99999999999999999999999999999865

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=2.3e-42  Score=325.75  Aligned_cols=248  Identities=36%  Similarity=0.613  Sum_probs=215.5

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLF   77 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv   77 (405)
                      +|.+.+.||+|++|.||+|.+..+++.+++|.+....    ...+.+|+.++++++||||+++++++....    .++++
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~lv   77 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEG----EISIV   77 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCC----eEEEE
Confidence            6889999999999999999999999999999987653    467889999999999999999998876543    36799


Q ss_pred             EeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCCEEEccCC-ceEeeecccccccccc--
Q 015500           78 MEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHS-NRVVHCDIKSRNILMAESG-AKIADFGCAKWESEAL--  153 (405)
Q Consensus        78 ~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~-~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~~--  153 (405)
                      |||+++++|.+++... +++++..+..++.||+.||.|||+ +|++||||+|+||+++.++ ++|+|||++.......  
T Consensus        78 ~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~  156 (264)
T cd06623          78 LEYMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ  156 (264)
T ss_pred             EEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence            9999999999999876 589999999999999999999999 9999999999999999887 9999999987654322  


Q ss_pred             --cCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC--ChHHHHHHHHhcCCCCCCchh-ccHHHHHH
Q 015500          154 --QSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAA--DPMTVLYKIAYSRELPEVPAF-LSKQANDF  228 (405)
Q Consensus       154 --~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~--~~~~~l~~i~~~~~~~~~p~~-~s~~l~dl  228 (405)
                        ...++..|+|||.+.+..++.++|+||||+++|+|+||+.||....  ........+. ....+..+.. ++..+.++
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~l  235 (264)
T cd06623         157 CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC-DGPPPSLPAEEFSPEFRDF  235 (264)
T ss_pred             ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh-cCCCCCCCcccCCHHHHHH
Confidence              3357899999999999889999999999999999999999996654  3333333333 4445556666 89999999


Q ss_pred             HHHhcccCccccCCHHHHhcCcccccc
Q 015500          229 LSNCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       229 l~~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      |++||..+|++|||+.++++|||++.+
T Consensus       236 i~~~l~~~p~~R~~~~~ll~~~~~~~~  262 (264)
T cd06623         236 ISACLQKDPKKRPSAAELLQHPFIKKA  262 (264)
T ss_pred             HHHHccCChhhCCCHHHHHhCHHHHhc
Confidence            999999999999999999999999764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1e-42  Score=375.28  Aligned_cols=250  Identities=30%  Similarity=0.457  Sum_probs=208.0

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC-----ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP-----KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~-----~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      +|.+++.||+|+||+||+|.+..+++.+|+|.+...     ....+.+|+.+|+.|+||||+++++.+......  .+++
T Consensus        14 ~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~--~lyI   91 (1021)
T PTZ00266         14 EYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ--KLYI   91 (1021)
T ss_pred             CEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC--EEEE
Confidence            689999999999999999999999999999987643     235688999999999999999999987654432  4669


Q ss_pred             EEeecCCCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC-------CceeCCCCCCCEEEccC----------
Q 015500           77 FMEYAPGGTLNDEIHRN---GGRLDESLIVSYTRQILQGLEYLHSN-------RVVHCDIKSRNILMAES----------  136 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~---~~~l~e~~~~~i~~qIl~~L~yLH~~-------givHrDlkp~NILi~~~----------  136 (405)
                      ||||+++|+|.++|...   .+.+++..++.|+.||+.||.|||+.       +|+||||||+||||+.+          
T Consensus        92 VMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~  171 (1021)
T PTZ00266         92 LMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQ  171 (1021)
T ss_pred             EEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccc
Confidence            99999999999998752   35799999999999999999999985       49999999999999631          


Q ss_pred             -------C-ceEeeecccccccc---cccCCCCCCccChhhhcC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHH
Q 015500          137 -------G-AKIADFGCAKWESE---ALQSGGTPMFMAPEVARG--EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMT  203 (405)
Q Consensus       137 -------~-vkL~DFGla~~~~~---~~~~~gt~~Y~APE~l~~--~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~  203 (405)
                             . +||+|||++.....   .....||+.|+|||++.+  ..+++++|||||||++|+|+||+.||........
T Consensus       172 ~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~q  251 (1021)
T PTZ00266        172 ANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQ  251 (1021)
T ss_pred             ccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHH
Confidence                   2 79999999976433   234569999999999865  4578899999999999999999999976554444


Q ss_pred             HHHHHHhcCCCCCCc-hhccHHHHHHHHHhcccCccccCCHHHHhcCccccccc
Q 015500          204 VLYKIAYSRELPEVP-AFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFC  256 (405)
Q Consensus       204 ~l~~i~~~~~~~~~p-~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~  256 (405)
                      .+..+...   |.+| ...+.++.+||.+||..+|.+|||+.|+|.|||+....
T Consensus       252 li~~lk~~---p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~  302 (1021)
T PTZ00266        252 LISELKRG---PDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVG  302 (1021)
T ss_pred             HHHHHhcC---CCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcC
Confidence            43333322   2222 34689999999999999999999999999999998653

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.7e-42  Score=330.92  Aligned_cols=247  Identities=36%  Similarity=0.567  Sum_probs=211.0

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLF   77 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv   77 (405)
                      .|+..+.||.|+||.||+|.+..+++.+|+|.+....    ...+.+|+.+++++.||||+++++++....    .+++|
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv   80 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGT----KLWII   80 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC----EEEEE
Confidence            3788899999999999999999999999999887543    346888999999999999999999876543    36799


Q ss_pred             EeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc----c
Q 015500           78 MEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE----A  152 (405)
Q Consensus        78 ~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~----~  152 (405)
                      |||++|++|.+++..  +++++..+..++.|++.||+|||+.|++|+||+|+||+++.++ ++|+|||++.....    .
T Consensus        81 ~e~~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~  158 (277)
T cd06640          81 MEYLGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR  158 (277)
T ss_pred             EecCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcccc
Confidence            999999999999865  3799999999999999999999999999999999999999887 99999999875433    1


Q ss_pred             ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHh
Q 015500          153 LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNC  232 (405)
Q Consensus       153 ~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~  232 (405)
                      ....++..|+|||++.+..++.++|+|||||++|+|+||..||.... +......+ .....+.++..++..+.+|+.+|
T Consensus       159 ~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~  236 (277)
T cd06640         159 NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMH-PMRVLFLI-PKNNPPTLTGEFSKPFKEFIDAC  236 (277)
T ss_pred             ccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcC-hHhHhhhh-hcCCCCCCchhhhHHHHHHHHHH
Confidence            22357889999999998889999999999999999999999996443 33333322 23345566677899999999999


Q ss_pred             cccCccccCCHHHHhcCccccccc
Q 015500          233 LRRDPKERWAASQLLKHPFLEEFC  256 (405)
Q Consensus       233 L~~dP~~Rpt~~elL~hp~~~~~~  256 (405)
                      |+.+|.+||++.++++||||....
T Consensus       237 l~~~p~~Rp~~~~il~~~~~~~~~  260 (277)
T cd06640         237 LNKDPSFRPTAKELLKHKFIVKNA  260 (277)
T ss_pred             cccCcccCcCHHHHHhChHhhhcc
Confidence            999999999999999999997653

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-42  Score=332.75  Aligned_cols=246  Identities=30%  Similarity=0.462  Sum_probs=201.0

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLF   77 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv   77 (405)
                      +|++.+.||+|++|+||+|.++.+++.||+|.+....    ...+.+|+++++.++||||+++++++....    .+++|
T Consensus         6 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~----~~~lv   81 (291)
T cd07844           6 TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKK----TLTLV   81 (291)
T ss_pred             ceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCC----eEEEE
Confidence            5899999999999999999999999999999876432    245678999999999999999998865433    36799


Q ss_pred             EeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc----c
Q 015500           78 MEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE----A  152 (405)
Q Consensus        78 ~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~----~  152 (405)
                      |||+.+ +|.+++.+.++.+++..++.++.||+.||.|||++|++||||||+||+++.++ +||+|||+++....    .
T Consensus        82 ~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~  160 (291)
T cd07844          82 FEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTY  160 (291)
T ss_pred             EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCccc
Confidence            999975 99999988766899999999999999999999999999999999999999888 99999999875322    1


Q ss_pred             ccCCCCCCccChhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCC----------------
Q 015500          153 LQSGGTPMFMAPEVARG-EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELP----------------  215 (405)
Q Consensus       153 ~~~~gt~~Y~APE~l~~-~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~----------------  215 (405)
                      ....+++.|+|||++.+ ..++.++||||+||++|+|++|+.||.........+..+......+                
T Consensus       161 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (291)
T cd07844         161 SNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKP  240 (291)
T ss_pred             cccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccccc
Confidence            22346889999999876 4578899999999999999999999965553433333221100000                


Q ss_pred             ------------CCchhcc--HHHHHHHHHhcccCccccCCHHHHhcCccc
Q 015500          216 ------------EVPAFLS--KQANDFLSNCLRRDPKERWAASQLLKHPFL  252 (405)
Q Consensus       216 ------------~~p~~~s--~~l~dll~~~L~~dP~~Rpt~~elL~hp~~  252 (405)
                                  .....++  .++.+++.+||..+|.+|||+.++++||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         241 YSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             ccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence                        0001233  788999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-42  Score=327.68  Aligned_cols=247  Identities=38%  Similarity=0.676  Sum_probs=211.0

Q ss_pred             CCcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC--------ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCce
Q 015500            1 MDWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP--------KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKL   72 (405)
Q Consensus         1 ~~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~--------~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~   72 (405)
                      .+|++++.||+|+||.||+|.+..+++.+|+|.+...        ....+.+|+.++++++||||+++++++.....  .
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~--~   79 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEE--K   79 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCC--C
Confidence            3799999999999999999999999999999986432        12468889999999999999999997654433  2


Q ss_pred             EEEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc
Q 015500           73 MYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE  151 (405)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~  151 (405)
                      .+++++||+++++|.+++...+ .+++..+..++.||+.||.|||++|++|+||||+||+++.++ ++|+|||+++....
T Consensus        80 ~~~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  158 (264)
T cd06653          80 KLSIFVEYMPGGSIKDQLKAYG-ALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQT  158 (264)
T ss_pred             EEEEEEEeCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence            3568999999999999998754 689999999999999999999999999999999999999887 99999999875432


Q ss_pred             -------cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHH
Q 015500          152 -------ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQ  224 (405)
Q Consensus       152 -------~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~  224 (405)
                             .....++..|+|||.+.+..++.++|+|||||++|+|++|+.||..... .....++......+.+|..+++.
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~p~~~~~~  237 (264)
T cd06653         159 ICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA-MAAIFKIATQPTKPMLPDGVSDA  237 (264)
T ss_pred             ccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH-HHHHHHHHcCCCCCCCCcccCHH
Confidence                   1224588999999999988889999999999999999999999965533 34444555455556788889999


Q ss_pred             HHHHHHHhcccCccccCCHHHHhcCccc
Q 015500          225 ANDFLSNCLRRDPKERWAASQLLKHPFL  252 (405)
Q Consensus       225 l~dll~~~L~~dP~~Rpt~~elL~hp~~  252 (405)
                      +.++|++||+ +|..|||+.+++.|||+
T Consensus       238 ~~~~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         238 CRDFLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             HHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence            9999999999 57999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=2.1e-42  Score=335.26  Aligned_cols=248  Identities=28%  Similarity=0.420  Sum_probs=207.8

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC------hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK------SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~------~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~   75 (405)
                      +|...+.||+|+||.||+|.+..+++.|++|.+....      ...+.+|+++++.++||||+++++.+....    .++
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~----~~~   77 (305)
T cd05609           2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKR----HLC   77 (305)
T ss_pred             CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCC----EEE
Confidence            6889999999999999999999999999999876432      346778999999999999999998765432    367


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc---
Q 015500           76 LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE---  151 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~---  151 (405)
                      ++|||++|++|.+++... +++++..+..++.|++.||.|||++|++||||||+||+++.++ +||+|||+++....   
T Consensus        78 lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~  156 (305)
T cd05609          78 MVMEYVEGGDCATLLKNI-GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT  156 (305)
T ss_pred             EEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence            999999999999999776 4799999999999999999999999999999999999999887 99999998863110   


Q ss_pred             ----------------cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcC-CC
Q 015500          152 ----------------ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSR-EL  214 (405)
Q Consensus       152 ----------------~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~-~~  214 (405)
                                      .....+++.|+|||.+.+..++.++|+|||||++|||++|..||... .......++.... ..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~-~~~~~~~~~~~~~~~~  235 (305)
T cd05609         157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD-TPEELFGQVISDDIEW  235 (305)
T ss_pred             ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhcccCC
Confidence                            01234788899999998888999999999999999999999999643 3344444433222 23


Q ss_pred             CCCchhccHHHHHHHHHhcccCccccCC---HHHHhcCcccccc
Q 015500          215 PEVPAFLSKQANDFLSNCLRRDPKERWA---ASQLLKHPFLEEF  255 (405)
Q Consensus       215 ~~~p~~~s~~l~dll~~~L~~dP~~Rpt---~~elL~hp~~~~~  255 (405)
                      |..+..++.++.+||++||+.||.+||+   +.++|+||||...
T Consensus       236 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~  279 (305)
T cd05609         236 PEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGL  279 (305)
T ss_pred             CCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCC
Confidence            3333467899999999999999999998   7999999999764

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-44  Score=335.46  Aligned_cols=248  Identities=30%  Similarity=0.479  Sum_probs=215.9

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC------ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~------~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~   75 (405)
                      +|..++.||+|.||+|-+++.+.+++.+|+|++.++      ..+.-..|-++|+.-+||.+..+.-.|.+.+.    +|
T Consensus       169 dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~dr----lC  244 (516)
T KOG0690|consen  169 DFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDR----LC  244 (516)
T ss_pred             hhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCce----EE
Confidence            578899999999999999999999999999987754      23456679999999999999988877666554    78


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccc----cc
Q 015500           76 LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKW----ES  150 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~----~~  150 (405)
                      +||||+.||.|.-++.+. ..++|..++.|-..|+.||.|||+++||+||||.+|.|++.+| +||+|||+.+.    ..
T Consensus       245 FVMeyanGGeLf~HLsre-r~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~  323 (516)
T KOG0690|consen  245 FVMEYANGGELFFHLSRE-RVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGD  323 (516)
T ss_pred             EEEEEccCceEeeehhhh-hcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcccccc
Confidence            999999999999988775 3799999999999999999999999999999999999999999 99999999874    23


Q ss_pred             ccccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHH
Q 015500          151 EALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLS  230 (405)
Q Consensus       151 ~~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~  230 (405)
                      ...+.||||.|+|||++....|+.++|.|.+|+++|||++|++||.+.. .. .++......++ .+|..++++++.||.
T Consensus       324 t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~d-h~-kLFeLIl~ed~-kFPr~ls~eAktLLs  400 (516)
T KOG0690|consen  324 TTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKD-HE-KLFELILMEDL-KFPRTLSPEAKTLLS  400 (516)
T ss_pred             eeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccc-hh-HHHHHHHhhhc-cCCccCCHHHHHHHH
Confidence            3668899999999999999999999999999999999999999996543 23 33333333333 678899999999999


Q ss_pred             HhcccCccccCC-----HHHHhcCcccccccc
Q 015500          231 NCLRRDPKERWA-----ASQLLKHPFLEEFCS  257 (405)
Q Consensus       231 ~~L~~dP~~Rpt-----~~elL~hp~~~~~~~  257 (405)
                      .+|.+||++|..     +.++.+|+||..+..
T Consensus       401 GLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W  432 (516)
T KOG0690|consen  401 GLLKKDPKKRLGGGPDDAKEIMRHRFFASVDW  432 (516)
T ss_pred             HHhhcChHhhcCCCchhHHHHHhhhhhccCCH
Confidence            999999999984     789999999998654

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=2.3e-42  Score=329.17  Aligned_cols=242  Identities=25%  Similarity=0.380  Sum_probs=199.3

Q ss_pred             ccccccc--ceeCCeeEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHhC-CCCCeeeeeeeeeecCCCceEEEEEEe
Q 015500            3 WTRGHTI--GQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSL-NSPHIVGYKGCDVTSEDNKLMYNLFME   79 (405)
Q Consensus         3 y~~~~~L--G~G~~g~Vyla~~~~~~~~vavK~~~~~~~~~l~~E~~iL~~L-~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (405)
                      |++.+.+  |+|+||.||++.++.+++.+|+|.+........  |..+...+ +||||+++++.+....    .+++|||
T Consensus        16 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--e~~~~~~~~~h~~iv~~~~~~~~~~----~~~iv~e   89 (267)
T PHA03390         16 CEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI--EPMVHQLMKDNPNFIKLYYSVTTLK----GHVLIMD   89 (267)
T ss_pred             hccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh--hHHHHHHhhcCCCEEEEEEEEecCC----eeEEEEE
Confidence            4555555  999999999999999999999999865432222  23233223 7999999998876544    3679999


Q ss_pred             ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC--ceEeeecccccccccccCCC
Q 015500           80 YAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG--AKIADFGCAKWESEALQSGG  157 (405)
Q Consensus        80 y~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~--vkL~DFGla~~~~~~~~~~g  157 (405)
                      |++|++|.+++..+. ++++..+..++.||+.||.|||+.|++||||||+||+++.++  ++|+|||+++.........+
T Consensus        90 ~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~  168 (267)
T PHA03390         90 YIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYDG  168 (267)
T ss_pred             cCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCccCCC
Confidence            999999999998764 899999999999999999999999999999999999998876  99999999987665556679


Q ss_pred             CCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChH---HHHHHHHhcCCCCCCchhccHHHHHHHHHhcc
Q 015500          158 TPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPM---TVLYKIAYSRELPEVPAFLSKQANDFLSNCLR  234 (405)
Q Consensus       158 t~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~---~~l~~i~~~~~~~~~p~~~s~~l~dll~~~L~  234 (405)
                      ++.|+|||++.+..++.++|+|||||++|+|++|+.||.......   ..+....  ......+..+++.+.+||.+||+
T Consensus       169 ~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~  246 (267)
T PHA03390        169 TLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ--QKKLPFIKNVSKNANDFVQSMLK  246 (267)
T ss_pred             CCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh--cccCCcccccCHHHHHHHHHHhc
Confidence            999999999999889999999999999999999999996443221   1122211  22234455789999999999999


Q ss_pred             cCccccCC-HHHHhcCcccc
Q 015500          235 RDPKERWA-ASQLLKHPFLE  253 (405)
Q Consensus       235 ~dP~~Rpt-~~elL~hp~~~  253 (405)
                      .+|.+||+ ++++|+||||+
T Consensus       247 ~~p~~R~~~~~~~l~h~~~~  266 (267)
T PHA03390        247 YNINYRLTNYNEIIKHPFLK  266 (267)
T ss_pred             cChhhCCchHHHHhcCCccc
Confidence            99999996 59999999996

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.7e-42  Score=325.74  Aligned_cols=245  Identities=27%  Similarity=0.500  Sum_probs=208.3

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC-----ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP-----KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~-----~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      +|...+.||+|+||.||+|.++.+|..+|+|.+...     ..+.+.+|+++++.++||||+++++.+....    .+++
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~----~~~l   76 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENG----RLFI   76 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCC----eEEE
Confidence            588999999999999999999999999999987643     3457889999999999999999998765432    3679


Q ss_pred             EEeecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC--ceEeeeccccccccc-
Q 015500           77 FMEYAPGGTLNDEIHRNG-GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG--AKIADFGCAKWESEA-  152 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~~-~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~--vkL~DFGla~~~~~~-  152 (405)
                      ++||+++++|.+++.+.. ..+++..+..++.|++.||.|||+.+++|+||||+||+++.++  +||+|||.+...... 
T Consensus        77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (257)
T cd08225          77 VMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM  156 (257)
T ss_pred             EEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence            999999999999997643 3589999999999999999999999999999999999998876  799999998764432 


Q ss_pred             ---ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHH
Q 015500          153 ---LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFL  229 (405)
Q Consensus       153 ---~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll  229 (405)
                         ....|++.|+|||.+.+..++.++|+|||||++++|++|..||.... .......+ .....+..+..++.++.+++
T Consensus       157 ~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~~i  234 (257)
T cd08225         157 ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-LHQLVLKI-CQGYFAPISPNFSRDLRSLI  234 (257)
T ss_pred             ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-HHHHHHHH-hcccCCCCCCCCCHHHHHHH
Confidence               23458999999999988889999999999999999999999996443 23333332 23344455667889999999


Q ss_pred             HHhcccCccccCCHHHHhcCccc
Q 015500          230 SNCLRRDPKERWAASQLLKHPFL  252 (405)
Q Consensus       230 ~~~L~~dP~~Rpt~~elL~hp~~  252 (405)
                      .+||..+|++|||+.++++||||
T Consensus       235 ~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         235 SQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             HHHhccChhhCcCHHHHhhCCCC
Confidence            99999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.2e-42  Score=347.76  Aligned_cols=243  Identities=28%  Similarity=0.374  Sum_probs=199.0

Q ss_pred             CcccccccceeCCeeEEEEEE-----cCCCCEEEEEEccCC----ChHHHHHHHHHHHhC-CCCCeeeeeeeeeecCCCc
Q 015500            2 DWTRGHTIGQGSSATVSLATS-----LRSGDVFAAKSTELP----KSEFLQREQKFLSSL-NSPHIVGYKGCDVTSEDNK   71 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~-----~~~~~~vavK~~~~~----~~~~l~~E~~iL~~L-~hpnIv~~~~~~~~~~~~~   71 (405)
                      +|++++.||+|+||+||+|++     ..++..||||.+...    ..+.+.+|+.+|+.+ +||||+++++.+.....  
T Consensus        36 ~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~--  113 (375)
T cd05104          36 RLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP--  113 (375)
T ss_pred             HeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc--
Confidence            488899999999999999974     345678999988643    234678999999999 89999999998755443  


Q ss_pred             eEEEEEEeecCCCCHHHHHHHcC---------------------------------------------------------
Q 015500           72 LMYNLFMEYAPGGTLNDEIHRNG---------------------------------------------------------   94 (405)
Q Consensus        72 ~~~~lv~Ey~~ggsL~~~i~~~~---------------------------------------------------------   94 (405)
                        .++||||++||+|.+++.+..                                                         
T Consensus       114 --~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (375)
T cd05104         114 --TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS  191 (375)
T ss_pred             --ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence              569999999999999986532                                                         


Q ss_pred             -----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccccc---
Q 015500           95 -----------------GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEAL---  153 (405)
Q Consensus        95 -----------------~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~~---  153 (405)
                                       ..+++..+..++.||+.||.|||++||+||||||+|||++.++ +||+|||+++......   
T Consensus       192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  271 (375)
T cd05104         192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV  271 (375)
T ss_pred             ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence                             2478888999999999999999999999999999999999877 9999999997543311   


Q ss_pred             ---cCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHH
Q 015500          154 ---QSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFL  229 (405)
Q Consensus       154 ---~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll  229 (405)
                         ...+++.|+|||++.+..+++++|||||||++|||++ |..||....... ...+.......+..|...+.++.+||
T Consensus       272 ~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li  350 (375)
T cd05104         272 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS-KFYKMIKEGYRMLSPECAPSEMYDIM  350 (375)
T ss_pred             ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH-HHHHHHHhCccCCCCCCCCHHHHHHH
Confidence               1234567999999999999999999999999999998 899996554333 23333333333445666789999999


Q ss_pred             HHhcccCccccCCHHHHhcC
Q 015500          230 SNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       230 ~~~L~~dP~~Rpt~~elL~h  249 (405)
                      .+||+.||++|||+.++++.
T Consensus       351 ~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         351 KSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             HHHccCChhHCcCHHHHHHH
Confidence            99999999999999999875

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-44  Score=346.80  Aligned_cols=250  Identities=27%  Similarity=0.446  Sum_probs=214.6

Q ss_pred             cccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC------hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEE
Q 015500            3 WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK------SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         3 y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~------~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      |+.-++||+|+||.||-++-+.||+.+|.|.+++.+      .....+|.+||.+++.|.||.+.-.+.+.+.    +|+
T Consensus       187 F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~----LCl  262 (591)
T KOG0986|consen  187 FRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDA----LCL  262 (591)
T ss_pred             eeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCc----eEE
Confidence            667789999999999999999999999999887543      2457789999999999999999877776665    889


Q ss_pred             EEeecCCCCHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccccc-
Q 015500           77 FMEYAPGGTLNDEIHRNGG-RLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEAL-  153 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~~~-~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~~-  153 (405)
                      ||..|+||+|.-+|.+.+. .++|..++.|+.+|+.||++||+.+||+||+||+|||+|+.| ++|.|+|+|..+.... 
T Consensus       263 VLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~  342 (591)
T KOG0986|consen  263 VLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKP  342 (591)
T ss_pred             EEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCCCc
Confidence            9999999999999987653 499999999999999999999999999999999999999998 9999999998765532 


Q ss_pred             --cCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCh--HHHHHHHHhcCCCCCCchhccHHHHHHH
Q 015500          154 --QSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADP--MTVLYKIAYSRELPEVPAFLSKQANDFL  229 (405)
Q Consensus       154 --~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~--~~~l~~i~~~~~~~~~p~~~s~~l~dll  229 (405)
                        ..+||.+|||||++..+.|++..|.|||||++|||+.|+.||......  .+.+.+... ....++|..+|+++++|.
T Consensus       343 ~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~-~~~~ey~~kFS~eakslc  421 (591)
T KOG0986|consen  343 IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTL-EDPEEYSDKFSEEAKSLC  421 (591)
T ss_pred             cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHh-cchhhcccccCHHHHHHH
Confidence              347999999999999999999999999999999999999999644321  212222222 233467788999999999


Q ss_pred             HHhcccCccccCC-----HHHHhcCcccccccc
Q 015500          230 SNCLRRDPKERWA-----ASQLLKHPFLEEFCS  257 (405)
Q Consensus       230 ~~~L~~dP~~Rpt-----~~elL~hp~~~~~~~  257 (405)
                      +.+|++||.+|..     ++++.+||||+.+..
T Consensus       422 ~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw  454 (591)
T KOG0986|consen  422 EGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNW  454 (591)
T ss_pred             HHHHccCHHHhccCCCcCcchhhhCcccccCCH
Confidence            9999999999984     679999999998644

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.5e-42  Score=347.04  Aligned_cols=243  Identities=27%  Similarity=0.374  Sum_probs=199.0

Q ss_pred             CcccccccceeCCeeEEEEEEcCCC-----CEEEEEEccCCC----hHHHHHHHHHHHhC-CCCCeeeeeeeeeecCCCc
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSG-----DVFAAKSTELPK----SEFLQREQKFLSSL-NSPHIVGYKGCDVTSEDNK   71 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~-----~~vavK~~~~~~----~~~l~~E~~iL~~L-~hpnIv~~~~~~~~~~~~~   71 (405)
                      +|.+++.||+|+||.||+|++..++     ..||+|.+....    .+.+.+|+++|+.+ +||||+++++.+.....  
T Consensus        39 ~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~--  116 (374)
T cd05106          39 NLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP--  116 (374)
T ss_pred             HceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC--
Confidence            4789999999999999999865444     579999986532    34678899999999 89999999998765433  


Q ss_pred             eEEEEEEeecCCCCHHHHHHHcC---------------------------------------------------------
Q 015500           72 LMYNLFMEYAPGGTLNDEIHRNG---------------------------------------------------------   94 (405)
Q Consensus        72 ~~~~lv~Ey~~ggsL~~~i~~~~---------------------------------------------------------   94 (405)
                        +++||||+++|+|.+++..+.                                                         
T Consensus       117 --~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (374)
T cd05106         117 --VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS  194 (374)
T ss_pred             --eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence              669999999999999986431                                                         


Q ss_pred             ------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccccc------cC
Q 015500           95 ------------GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEAL------QS  155 (405)
Q Consensus        95 ------------~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~~------~~  155 (405)
                                  .++++..++.++.||+.||.|||++||+||||||+|||++.++ +||+|||+++......      ..
T Consensus       195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~  274 (374)
T cd05106         195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA  274 (374)
T ss_pred             ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence                        2478889999999999999999999999999999999999887 9999999987543211      12


Q ss_pred             CCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHhcc
Q 015500          156 GGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLR  234 (405)
Q Consensus       156 ~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~L~  234 (405)
                      .+++.|||||++.+..++.++|||||||++|+|++ |+.||....... ...........+..|...++++.+++.+||+
T Consensus       275 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~  353 (374)
T cd05106         275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-KFYKMVKRGYQMSRPDFAPPEIYSIMKMCWN  353 (374)
T ss_pred             CCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-HHHHHHHcccCccCCCCCCHHHHHHHHHHcC
Confidence            34567999999998889999999999999999997 999997654322 2333333333344566689999999999999


Q ss_pred             cCccccCCHHHHhcC
Q 015500          235 RDPKERWAASQLLKH  249 (405)
Q Consensus       235 ~dP~~Rpt~~elL~h  249 (405)
                      .||.+|||+.++++.
T Consensus       354 ~dp~~RPs~~~l~~~  368 (374)
T cd05106         354 LEPTERPTFSQISQL  368 (374)
T ss_pred             CChhhCcCHHHHHHH
Confidence            999999999999764

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=3e-42  Score=324.55  Aligned_cols=242  Identities=27%  Similarity=0.499  Sum_probs=206.5

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC----ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP----KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLF   77 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~----~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv   77 (405)
                      +|.+.+.||.|+||.||++.+..+++.+|+|.+...    ..+.+.+|+.+++.++||||+++.+.+....    .++++
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv   76 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADG----HLYIV   76 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECC----EEEEE
Confidence            689999999999999999999999999999987543    2356788999999999999999998775443    36799


Q ss_pred             EeecCCCCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc----
Q 015500           78 MEYAPGGTLNDEIHR-NGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE----  151 (405)
Q Consensus        78 ~Ey~~ggsL~~~i~~-~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~----  151 (405)
                      |||+++++|.+++.. .+..+++..+..++.||+.||.|||++|++|+||||+||+++.++ ++|+|||++.....    
T Consensus        77 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~  156 (255)
T cd08219          77 MEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY  156 (255)
T ss_pred             EeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccccc
Confidence            999999999998875 344689999999999999999999999999999999999999887 99999999875433    


Q ss_pred             cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHH
Q 015500          152 ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSN  231 (405)
Q Consensus       152 ~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~  231 (405)
                      .....|++.|+|||++.+..++.++|+||||+++|+|++|..||... +.......+. ....+..|..++..+.+||.+
T Consensus       157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~  234 (255)
T cd08219         157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQAN-SWKNLILKVC-QGSYKPLPSHYSYELRSLIKQ  234 (255)
T ss_pred             cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCC-CHHHHHHHHh-cCCCCCCCcccCHHHHHHHHH
Confidence            22345899999999999888999999999999999999999999643 3333333333 344455677789999999999


Q ss_pred             hcccCccccCCHHHHhcC
Q 015500          232 CLRRDPKERWAASQLLKH  249 (405)
Q Consensus       232 ~L~~dP~~Rpt~~elL~h  249 (405)
                      ||+.||.+|||+.+++.-
T Consensus       235 ~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         235 MFKRNPRSRPSATTILSR  252 (255)
T ss_pred             HHhCCcccCCCHHHHhhc
Confidence            999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=2.1e-42  Score=330.78  Aligned_cols=245  Identities=32%  Similarity=0.475  Sum_probs=200.1

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      +|+..+.||.|++|.||+|+++.+++.+|||.+....     ...+.+|++++++++||||+++.+++....    .+++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~----~~~~   76 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN----KLYL   76 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCC----cEEE
Confidence            5899999999999999999999999999999886432     246889999999999999999998765432    3669


Q ss_pred             EEeecCCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc---
Q 015500           77 FMEYAPGGTLNDEIHRN-GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE---  151 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~-~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~---  151 (405)
                      +|||+. ++|.+++... ++.+++..+..++.||+.||+|||+.|++|+||+|+||+++.++ +||+|||++.....   
T Consensus        77 v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~  155 (284)
T cd07860          77 VFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR  155 (284)
T ss_pred             Eeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence            999996 5898888653 35689999999999999999999999999999999999999888 99999999875432   


Q ss_pred             -cccCCCCCCccChhhhcCCC-CCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCC----------------
Q 015500          152 -ALQSGGTPMFMAPEVARGEH-QGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRE----------------  213 (405)
Q Consensus       152 -~~~~~gt~~Y~APE~l~~~~-~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~----------------  213 (405)
                       .....+++.|+|||++.+.. ++.++|||||||++|+|+||+.||....... .+.++.....                
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07860         156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID-QLFRIFRTLGTPDEVVWPGVTSLPDY  234 (284)
T ss_pred             ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHhCCCChhhhhhhhHHHHH
Confidence             12334788999999987644 6889999999999999999999996554322 2222111100                


Q ss_pred             ---CC--------CCchhccHHHHHHHHHhcccCccccCCHHHHhcCccc
Q 015500          214 ---LP--------EVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFL  252 (405)
Q Consensus       214 ---~~--------~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~  252 (405)
                         ++        .....+++++.++|.+||+.||++|||++++++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         235 KPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             HhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence               00        1112367889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=3.6e-42  Score=330.88  Aligned_cols=250  Identities=30%  Similarity=0.428  Sum_probs=201.4

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-----hHHHHHHHHHHHhCC-CCCeeeeeeeeeecCC-CceEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-----SEFLQREQKFLSSLN-SPHIVGYKGCDVTSED-NKLMY   74 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-----~~~l~~E~~iL~~L~-hpnIv~~~~~~~~~~~-~~~~~   74 (405)
                      +|++.+.||+|+||.||+|.+..+++.||+|......     ...+.+|+.+++.+. ||||+++++++..... ....+
T Consensus         2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~   81 (295)
T cd07837           2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL   81 (295)
T ss_pred             CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence            6899999999999999999999999999999876432     246788999999995 6999999988765543 23346


Q ss_pred             EEEEeecCCCCHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcc-CC-ceEeeeccccc
Q 015500           75 NLFMEYAPGGTLNDEIHRN----GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAE-SG-AKIADFGCAKW  148 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~i~~~----~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~-~~-vkL~DFGla~~  148 (405)
                      +++|||+++ +|.+++...    +..+++..++.++.||+.||.|||++|++||||||+||+++. ++ +||+|||+++.
T Consensus        82 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~  160 (295)
T cd07837          82 YLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA  160 (295)
T ss_pred             EEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeeccccee
Confidence            799999986 898888653    235899999999999999999999999999999999999998 55 99999999875


Q ss_pred             ccc----cccCCCCCCccChhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCC----------
Q 015500          149 ESE----ALQSGGTPMFMAPEVARG-EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRE----------  213 (405)
Q Consensus       149 ~~~----~~~~~gt~~Y~APE~l~~-~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~----------  213 (405)
                      ...    .....+++.|+|||++.+ ..++.++|+|||||++|+|++|..||......... .++.....          
T Consensus       161 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  239 (295)
T cd07837         161 FSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQL-LHIFKLLGTPTEQVWPGV  239 (295)
T ss_pred             cCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH-HHHHHHhCCCChhhCcch
Confidence            432    122357889999999875 45788999999999999999999999765443322 22111000          


Q ss_pred             --------CCC--------CchhccHHHHHHHHHhcccCccccCCHHHHhcCcccc
Q 015500          214 --------LPE--------VPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLE  253 (405)
Q Consensus       214 --------~~~--------~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~  253 (405)
                              .+.        ....+++.+.+||.+||..||.+|||+.++|.||||+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         240 SKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             hhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence                    000        0123688999999999999999999999999999985

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=3.1e-42  Score=329.38  Aligned_cols=242  Identities=25%  Similarity=0.316  Sum_probs=203.0

Q ss_pred             CcccccccceeCCeeEEEEEEcCCC-----CEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCce
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSG-----DVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKL   72 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~-----~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~   72 (405)
                      +|+..+.||+|+||.||+|.+...+     ..+|+|.+....    ...+.+|+.++++++||||+++++++....    
T Consensus         6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~----   81 (283)
T cd05048           6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQ----   81 (283)
T ss_pred             HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCC----
Confidence            4889999999999999999976655     679999886443    246789999999999999999998765433    


Q ss_pred             EEEEEEeecCCCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC
Q 015500           73 MYNLFMEYAPGGTLNDEIHRNG---------------GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG  137 (405)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~i~~~~---------------~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~  137 (405)
                      ..+++|||+++++|.+++....               ..+++..+..++.||+.||.|||++|++||||||+||+++.++
T Consensus        82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGL  161 (283)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCC
Confidence            2568999999999999997642               3588899999999999999999999999999999999999887


Q ss_pred             -ceEeeecccccccc------cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHH
Q 015500          138 -AKIADFGCAKWESE------ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIA  209 (405)
Q Consensus       138 -vkL~DFGla~~~~~------~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~  209 (405)
                       +||+|||+++....      .....+++.|+|||.+.+..++.++|||||||++|||++ |..||.... ....... .
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~-~~~~~~~-i  239 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFS-NQEVIEM-I  239 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCC-HHHHHHH-H
Confidence             99999999875422      123346788999999998889999999999999999998 999996443 3333333 3


Q ss_pred             hcCCCCCCchhccHHHHHHHHHhcccCccccCCHHHHhcC
Q 015500          210 YSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       210 ~~~~~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      .....+..|..+++++.+|+.+||+.||.+|||+.+++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         240 RSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             HcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            3455566778899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=4.8e-42  Score=327.89  Aligned_cols=245  Identities=38%  Similarity=0.598  Sum_probs=209.5

Q ss_pred             cccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEE
Q 015500            3 WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFM   78 (405)
Q Consensus         3 y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (405)
                      |+..+.||+|+||.||+|.+..+++.+|+|......    ...+.+|+.++++++||||+++++.+....    .+++||
T Consensus         6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~lv~   81 (277)
T cd06641           6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT----KLWIIM   81 (277)
T ss_pred             hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCC----eEEEEE
Confidence            678899999999999999999999999999876543    246888999999999999999999876543    367999


Q ss_pred             eecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc----c
Q 015500           79 EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA----L  153 (405)
Q Consensus        79 Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~----~  153 (405)
                      ||+++++|.+++..  +.+++..+..++.|++.|+.|||+.|++|+||||+||+++.++ ++|+|||++......    .
T Consensus        82 e~~~~~~l~~~i~~--~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~  159 (277)
T cd06641          82 EYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN  159 (277)
T ss_pred             EeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhc
Confidence            99999999999865  3689999999999999999999999999999999999999888 999999998754332    2


Q ss_pred             cCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHhc
Q 015500          154 QSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCL  233 (405)
Q Consensus       154 ~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~L  233 (405)
                      ...++..|+|||.+.+..++.++|+|||||++|+|++|..||.... .......+ .....+.++..++.++.+++.+||
T Consensus       160 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~l  237 (277)
T cd06641         160 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELH-PMKVLFLI-PKNNPPTLEGNYSKPLKEFVEACL  237 (277)
T ss_pred             cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccc-hHHHHHHH-hcCCCCCCCcccCHHHHHHHHHHc
Confidence            2358899999999988888999999999999999999999996433 33333332 233455666778999999999999


Q ss_pred             ccCccccCCHHHHhcCcccccc
Q 015500          234 RRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       234 ~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      +.+|.+||++.++++||||...
T Consensus       238 ~~~p~~Rp~~~~~l~~~~~~~~  259 (277)
T cd06641         238 NKEPSFRPTAKELLKHKFIVRF  259 (277)
T ss_pred             cCChhhCcCHHHHHhCHHHhhh
Confidence            9999999999999999999865

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=4.2e-42  Score=330.30  Aligned_cols=246  Identities=30%  Similarity=0.426  Sum_probs=200.4

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLF   77 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv   77 (405)
                      +|++.+.||+|+||.||+|.++.+++.+|+|.+....    ...+.+|+.+|+.++||||+++.+++....    .++++
T Consensus         6 ~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~----~~~lv   81 (291)
T cd07870           6 SYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKE----TLTFV   81 (291)
T ss_pred             eeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCC----eEEEE
Confidence            5899999999999999999999999999999876432    235778999999999999999998865432    36699


Q ss_pred             EeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc----c
Q 015500           78 MEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE----A  152 (405)
Q Consensus        78 ~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~----~  152 (405)
                      |||+. ++|.+++....+.+++..++.++.||+.||.|||+.||+|+||||+||+++.++ +||+|||+++....    .
T Consensus        82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~  160 (291)
T cd07870          82 FEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTY  160 (291)
T ss_pred             Eeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCC
Confidence            99995 688777766556789999999999999999999999999999999999999887 99999999875332    2


Q ss_pred             ccCCCCCCccChhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCC------------CC---
Q 015500          153 LQSGGTPMFMAPEVARG-EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSREL------------PE---  216 (405)
Q Consensus       153 ~~~~gt~~Y~APE~l~~-~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~------------~~---  216 (405)
                      ....+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||....+....+..+......            |.   
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (291)
T cd07870         161 SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKP  240 (291)
T ss_pred             CCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccc
Confidence            23347899999999876 457889999999999999999999997665544444333211000            00   


Q ss_pred             ------Cc-------h--hccHHHHHHHHHhcccCccccCCHHHHhcCccc
Q 015500          217 ------VP-------A--FLSKQANDFLSNCLRRDPKERWAASQLLKHPFL  252 (405)
Q Consensus       217 ------~p-------~--~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~  252 (405)
                            .+       .  ..+.++.+++.+||+.||++|||+.|++.||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         241 EWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             hhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence                  00       0  125688999999999999999999999999997

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=3.1e-42  Score=334.48  Aligned_cols=250  Identities=30%  Similarity=0.404  Sum_probs=203.7

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      +|.+.+.||+|+||.||+|.++.+|+.||+|.+....     .....+|+.++++++||||+++++++.....  ..+++
T Consensus         8 ~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~--~~~~l   85 (309)
T cd07845           8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHL--DSIFL   85 (309)
T ss_pred             ceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCC--CeEEE
Confidence            6899999999999999999999999999999876432     2246689999999999999999988754332  23569


Q ss_pred             EEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc---
Q 015500           77 FMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA---  152 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~---  152 (405)
                      ||||+.+ +|.+++......+++..+..++.||+.||.|||+.|++||||||+||+++.++ +||+|||++......   
T Consensus        86 v~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~  164 (309)
T cd07845          86 VMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP  164 (309)
T ss_pred             EEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCccCC
Confidence            9999965 89998887656899999999999999999999999999999999999999887 999999998764432   


Q ss_pred             -ccCCCCCCccChhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCC-----------------
Q 015500          153 -LQSGGTPMFMAPEVARG-EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRE-----------------  213 (405)
Q Consensus       153 -~~~~gt~~Y~APE~l~~-~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~-----------------  213 (405)
                       ....+++.|+|||.+.+ ..++.++|||||||++|+|++|++||.... ....+..+.....                 
T Consensus       165 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (309)
T cd07845         165 MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKS-EIEQLDLIIQLLGTPNESIWPGFSDLPLVG  243 (309)
T ss_pred             CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHhcCCCChhhchhhhcccccc
Confidence             22346788999999876 557899999999999999999999997543 3333333222100                 


Q ss_pred             ---CCCC--------chhccHHHHHHHHHhcccCccccCCHHHHhcCcccccc
Q 015500          214 ---LPEV--------PAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       214 ---~~~~--------p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                         .+..        ....++++.+||.+||+.||.+|||+.+++.||||+..
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~  296 (309)
T cd07845         244 KFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK  296 (309)
T ss_pred             cccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccC
Confidence               0000        01258899999999999999999999999999999853

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=7.3e-42  Score=318.44  Aligned_cols=244  Identities=37%  Similarity=0.602  Sum_probs=209.6

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC---hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK---SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFM   78 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~---~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (405)
                      +|+..+.||+|++|.||+|.+..+++.+++|......   ...+.+|+++++.++||||+++.+.+....    .+++++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~l~~   76 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKD----ELWIVM   76 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC----eEEEEE
Confidence            6899999999999999999999899999999987653   467889999999999999999999776543    366999


Q ss_pred             eecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc---cc
Q 015500           79 EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA---LQ  154 (405)
Q Consensus        79 Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~---~~  154 (405)
                      ||++|++|.+++......+++..+..++.|++.||.|||++|++||||+|+||+++.++ ++|+|||.+......   ..
T Consensus        77 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~  156 (253)
T cd05122          77 EFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNT  156 (253)
T ss_pred             ecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccccccccccccc
Confidence            99999999999987656899999999999999999999999999999999999999887 999999998765543   34


Q ss_pred             CCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchh--ccHHHHHHHHHh
Q 015500          155 SGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAF--LSKQANDFLSNC  232 (405)
Q Consensus       155 ~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~--~s~~l~dll~~~  232 (405)
                      ..++..|+|||.+.+..++.++|+||||+++|+|++|+.||...... ........ ...+..+..  ++..+.++|.+|
T Consensus       157 ~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~  234 (253)
T cd05122         157 MVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM-KALFKIAT-NGPPGLRNPEKWSDEFKDFLKKC  234 (253)
T ss_pred             eecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH-HHHHHHHh-cCCCCcCcccccCHHHHHHHHHH
Confidence            56899999999999888999999999999999999999999655332 22222222 333344433  389999999999


Q ss_pred             cccCccccCCHHHHhcCcc
Q 015500          233 LRRDPKERWAASQLLKHPF  251 (405)
Q Consensus       233 L~~dP~~Rpt~~elL~hp~  251 (405)
                      |+.||++|||+.++++|||
T Consensus       235 l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         235 LQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             ccCChhhCCCHHHHhcCCC
Confidence            9999999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=5.6e-42  Score=332.66  Aligned_cols=248  Identities=35%  Similarity=0.518  Sum_probs=207.8

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC------hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK------SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~------~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~   75 (405)
                      .|...+.||+|+||+||+|.+..+++.||+|.+....      ...+.+|+.+++.++||||+++.+++.....    .+
T Consensus        16 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~----~~   91 (307)
T cd06607          16 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHT----AW   91 (307)
T ss_pred             hhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCe----EE
Confidence            3788899999999999999999999999999875321      2457889999999999999999998765443    56


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccccc
Q 015500           76 LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQ  154 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~~~  154 (405)
                      +|+||++ |+|.+.+....+++++..+..++.||+.||.|||+.|++||||+|+||+++.++ +||+|||++........
T Consensus        92 lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~~~  170 (307)
T cd06607          92 LVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANS  170 (307)
T ss_pred             EEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCCCC
Confidence            9999996 588888876666899999999999999999999999999999999999999887 99999999987665556


Q ss_pred             CCCCCCccChhhhc---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHH
Q 015500          155 SGGTPMFMAPEVAR---GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSN  231 (405)
Q Consensus       155 ~~gt~~Y~APE~l~---~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~  231 (405)
                      ..+++.|+|||++.   ...++.++||||||+++|+|++|+.||.... .......+.........+..+++.+.++|.+
T Consensus       171 ~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  249 (307)
T cd06607         171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-AMSALYHIAQNDSPTLSSNDWSDYFRNFVDS  249 (307)
T ss_pred             ccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCcc-HHHHHHHHhcCCCCCCCchhhCHHHHHHHHH
Confidence            67899999999874   3557889999999999999999999996543 3333344333322222234578899999999


Q ss_pred             hcccCccccCCHHHHhcCcccccc
Q 015500          232 CLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       232 ~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      ||..+|++||++.+++.||||...
T Consensus       250 ~l~~~p~~Rp~~~~il~~~~~~~~  273 (307)
T cd06607         250 CLQKIPQDRPSSEELLKHRFVLRE  273 (307)
T ss_pred             HhcCChhhCcCHHHHhcChhhccc
Confidence            999999999999999999999753

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.6e-42  Score=329.93  Aligned_cols=248  Identities=28%  Similarity=0.480  Sum_probs=207.7

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLF   77 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv   77 (405)
                      +|++.+.||+|+||+||+|.+..+++.+|+|.+....    ...+.+|+++++.++||||+++++.+....    .+++|
T Consensus         6 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~----~~~lv   81 (284)
T cd06620           6 DLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNEN----NICMC   81 (284)
T ss_pred             HHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCC----EEEEE
Confidence            5889999999999999999999999999999875432    357889999999999999999998876543    36799


Q ss_pred             EeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCCEEEccCC-ceEeeecccccccc--cc
Q 015500           78 MEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHS-NRVVHCDIKSRNILMAESG-AKIADFGCAKWESE--AL  153 (405)
Q Consensus        78 ~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~-~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~--~~  153 (405)
                      |||+++++|.+++.+. +.+++..+..++.|++.||.|||+ .|++||||||+||+++.++ ++|+|||++.....  ..
T Consensus        82 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~~  160 (284)
T cd06620          82 MEFMDCGSLDRIYKKG-GPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIAD  160 (284)
T ss_pred             EecCCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhccC
Confidence            9999999999988775 479999999999999999999997 5999999999999999887 99999999865322  23


Q ss_pred             cCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCh----------HHHHHHHHhcCCCCCCchh-cc
Q 015500          154 QSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADP----------MTVLYKIAYSRELPEVPAF-LS  222 (405)
Q Consensus       154 ~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~----------~~~l~~i~~~~~~~~~p~~-~s  222 (405)
                      ...|+..|+|||++.+..++.++|+|||||++|+|+||+.||......          ......+. ....+.++.. ++
T Consensus       161 ~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  239 (284)
T cd06620         161 TFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIV-QEPPPRLPSSDFP  239 (284)
T ss_pred             ccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHh-hccCCCCCchhcC
Confidence            356899999999998888999999999999999999999999644321          11222222 2223333333 78


Q ss_pred             HHHHHHHHHhcccCccccCCHHHHhcCcccccc
Q 015500          223 KQANDFLSNCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       223 ~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      .++.+|+.+||+.||.+|||+.++++||||.+.
T Consensus       240 ~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~  272 (284)
T cd06620         240 EDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA  272 (284)
T ss_pred             HHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence            899999999999999999999999999999754

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=4.2e-42  Score=328.25  Aligned_cols=243  Identities=30%  Similarity=0.479  Sum_probs=202.3

Q ss_pred             cceeCCeeEEEEEEcCCCCEEEEEEccCC------ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEeecC
Q 015500            9 IGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAP   82 (405)
Q Consensus         9 LG~G~~g~Vyla~~~~~~~~vavK~~~~~------~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~Ey~~   82 (405)
                      ||+|+||+||+|.+..+|+.+|+|.+...      ....+.+|+.+|+.++||||+++++.+....    .+++||||++
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~lv~e~~~   76 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKD----DLCLVMTLMN   76 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCC----eEEEEEecCC
Confidence            79999999999999999999999987642      1335678999999999999999988765433    3679999999


Q ss_pred             CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc---cccCCC
Q 015500           83 GGTLNDEIHRNG-GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE---ALQSGG  157 (405)
Q Consensus        83 ggsL~~~i~~~~-~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~---~~~~~g  157 (405)
                      |++|.+++.+.+ ..+++..+..++.|++.||.|||+.|++||||+|+||+++.++ +||+|||++.....   .....+
T Consensus        77 ~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  156 (277)
T cd05577          77 GGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAG  156 (277)
T ss_pred             CCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccC
Confidence            999999997653 3689999999999999999999999999999999999999887 99999999875432   223457


Q ss_pred             CCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC--hHHHHHHHHhcCCCCCCchhccHHHHHHHHHhccc
Q 015500          158 TPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAAD--PMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRR  235 (405)
Q Consensus       158 t~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~--~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~L~~  235 (405)
                      +..|+|||.+.+..++.++|+|||||++|+|++|+.||.....  ....+..... ......+..+++.+.++|++||+.
T Consensus       157 ~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~  235 (277)
T cd05577         157 TPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTL-EMAVEYPDKFSPEAKDLCEALLQK  235 (277)
T ss_pred             CCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccc-cccccCCccCCHHHHHHHHHHccC
Confidence            8899999999888899999999999999999999999965432  1122222111 223345666899999999999999


Q ss_pred             CccccC-----CHHHHhcCccccccc
Q 015500          236 DPKERW-----AASQLLKHPFLEEFC  256 (405)
Q Consensus       236 dP~~Rp-----t~~elL~hp~~~~~~  256 (405)
                      ||.+||     ++.++++||||..+.
T Consensus       236 ~p~~R~~~~~~~~~~ll~h~~~~~~~  261 (277)
T cd05577         236 DPEKRLGCRGGSADEVREHPLFKDLN  261 (277)
T ss_pred             ChhHccCCCcccHHHHHhChhhhcCC
Confidence            999999     899999999998653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=6.8e-42  Score=324.17  Aligned_cols=242  Identities=22%  Similarity=0.341  Sum_probs=203.3

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC--hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEe
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK--SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFME   79 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~--~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (405)
                      +|.+.+.||+|+||.||+|.++.+++.+|+|......  ...+.+|+++|++++||||+++++.+.....    ++++||
T Consensus         7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~lv~e   82 (263)
T cd05052           7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP----FYIITE   82 (263)
T ss_pred             HeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCC----cEEEEE
Confidence            4778899999999999999999999999999987543  3568899999999999999999987654432    569999


Q ss_pred             ecCCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccccc----
Q 015500           80 YAPGGTLNDEIHRN-GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEAL----  153 (405)
Q Consensus        80 y~~ggsL~~~i~~~-~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~~----  153 (405)
                      |+++++|.+++... ...+++..++.++.|++.||+|||++|++||||||+||+++.++ +||+|||++.......    
T Consensus        83 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~  162 (263)
T cd05052          83 FMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH  162 (263)
T ss_pred             eCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceeecc
Confidence            99999999999764 33589999999999999999999999999999999999998887 9999999987654321    


Q ss_pred             -cCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHH
Q 015500          154 -QSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSN  231 (405)
Q Consensus       154 -~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~  231 (405)
                       ...+++.|+|||.+.+..++.++|||||||++|||++ |..||... +.......+ .....+..|..++.++.+++.+
T Consensus       163 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~  240 (263)
T cd05052         163 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-DLSQVYELL-EKGYRMERPEGCPPKVYELMRA  240 (263)
T ss_pred             CCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHH-HCCCCCCCCCCCCHHHHHHHHH
Confidence             1224567999999999999999999999999999998 99999643 333333333 3333455677789999999999


Q ss_pred             hcccCccccCCHHHHhcC
Q 015500          232 CLRRDPKERWAASQLLKH  249 (405)
Q Consensus       232 ~L~~dP~~Rpt~~elL~h  249 (405)
                      ||+.||++|||+.++++.
T Consensus       241 cl~~~p~~Rp~~~~l~~~  258 (263)
T cd05052         241 CWQWNPSDRPSFAEIHQA  258 (263)
T ss_pred             HccCCcccCCCHHHHHHH
Confidence            999999999999999764

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=2e-42  Score=334.03  Aligned_cols=246  Identities=33%  Similarity=0.501  Sum_probs=204.7

Q ss_pred             cccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC---hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEe
Q 015500            3 WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK---SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFME   79 (405)
Q Consensus         3 y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~---~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (405)
                      |.....||.|+||.||+|.+..++..+|||.+....   .+.+.+|+.+++.++||||+++++.+...+    .++++||
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~----~~~lv~e   99 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGD----ELWVVME   99 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCC----eEEEEEe
Confidence            556788999999999999999999999999876533   356889999999999999999998765433    3679999


Q ss_pred             ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc----ccc
Q 015500           80 YAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE----ALQ  154 (405)
Q Consensus        80 y~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~----~~~  154 (405)
                      |+++++|.+++..  +.+++..+..++.||+.||.|||++|++||||||+||+++.++ +||+|||++.....    ...
T Consensus       100 ~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~  177 (292)
T cd06658         100 FLEGGALTDIVTH--TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS  177 (292)
T ss_pred             CCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCce
Confidence            9999999998854  3689999999999999999999999999999999999999887 99999999865332    223


Q ss_pred             CCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcC-CCCCCchhccHHHHHHHHHhc
Q 015500          155 SGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSR-ELPEVPAFLSKQANDFLSNCL  233 (405)
Q Consensus       155 ~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~-~~~~~p~~~s~~l~dll~~~L  233 (405)
                      ..|++.|+|||.+.+..++.++|+||||+++|||++|+.||.... ....+..+.... ........++..+.+|+.+||
T Consensus       178 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  256 (292)
T cd06658         178 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEP-PLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLML  256 (292)
T ss_pred             eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhcCCCccccccccCHHHHHHHHHHc
Confidence            458999999999998889999999999999999999999996443 333333322211 111122347889999999999


Q ss_pred             ccCccccCCHHHHhcCcccccc
Q 015500          234 RRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       234 ~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      ..||.+|||++++++||||+..
T Consensus       257 ~~~P~~Rpt~~~il~~~~~~~~  278 (292)
T cd06658         257 VREPSQRATAQELLQHPFLKLA  278 (292)
T ss_pred             cCChhHCcCHHHHhhChhhhcc
Confidence            9999999999999999999854

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=7.2e-42  Score=327.48  Aligned_cols=243  Identities=26%  Similarity=0.412  Sum_probs=197.4

Q ss_pred             ccceeCCeeEEEEEEcCCCCEEEEEEccCCCh------HHHHHHH---HHHHhCCCCCeeeeeeeeeecCCCceEEEEEE
Q 015500            8 TIGQGSSATVSLATSLRSGDVFAAKSTELPKS------EFLQREQ---KFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFM   78 (405)
Q Consensus         8 ~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~~------~~l~~E~---~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (405)
                      .||+|+||+||+|.+..+++.||+|.+.....      .....|.   +.++...||+|+.+.+.+...+    .+++||
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~----~~~~v~   76 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD----KLSFIL   76 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCC----EEEEEE
Confidence            48999999999999999999999998764321      1233333   3455568999999887765433    367999


Q ss_pred             eecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc--cccC
Q 015500           79 EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE--ALQS  155 (405)
Q Consensus        79 Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~--~~~~  155 (405)
                      ||++|++|.+++... +.+++..++.++.|++.||.|||+.+++||||||+||+++.++ +||+|||++.....  ....
T Consensus        77 e~~~g~~L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~  155 (278)
T cd05606          77 DLMNGGDLHYHLSQH-GVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS  155 (278)
T ss_pred             ecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCCcCc
Confidence            999999999988765 4899999999999999999999999999999999999999887 99999999875432  2345


Q ss_pred             CCCCCccChhhhcCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCChH-HHHHHHHhcCCCCCCchhccHHHHHHHHHhc
Q 015500          156 GGTPMFMAPEVARGE-HQGFASDIWAVGCTVIEMASGGAPWPNAADPM-TVLYKIAYSRELPEVPAFLSKQANDFLSNCL  233 (405)
Q Consensus       156 ~gt~~Y~APE~l~~~-~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~-~~l~~i~~~~~~~~~p~~~s~~l~dll~~~L  233 (405)
                      .|++.|+|||.+.+. .++.++||||+||++|+|++|+.||....... ....+.. ....+.+|..+++++.+++.+||
T Consensus       156 ~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~~li~~~l  234 (278)
T cd05606         156 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT-LTMAVELPDSFSPELRSLLEGLL  234 (278)
T ss_pred             CCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHh-hccCCCCCCcCCHHHHHHHHHHh
Confidence            699999999999754 68899999999999999999999996543221 1222222 22334566678999999999999


Q ss_pred             ccCccccC-----CHHHHhcCccccccc
Q 015500          234 RRDPKERW-----AASQLLKHPFLEEFC  256 (405)
Q Consensus       234 ~~dP~~Rp-----t~~elL~hp~~~~~~  256 (405)
                      ..+|.+||     ++.++++||||+...
T Consensus       235 ~~~p~~R~~~~~~~~~~ll~~~~~~~~~  262 (278)
T cd05606         235 QRDVNRRLGCLGRGAQEVKEHPFFRSLD  262 (278)
T ss_pred             hcCHHhccCCCCCCHHHHHhCccccCCC
Confidence            99999999     999999999998764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1e-41  Score=327.48  Aligned_cols=252  Identities=31%  Similarity=0.557  Sum_probs=208.1

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLF   77 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv   77 (405)
                      +|...+.||.|++|.||+|.+..+++.+|+|.+....    ...+.+|++++++++||||+++++++......  .++++
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~--~~~lv   79 (287)
T cd06621           2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSS--SIGIA   79 (287)
T ss_pred             ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCC--eEEEE
Confidence            5888999999999999999999999999999887542    35688999999999999999999987654432  35699


Q ss_pred             EeecCCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc--
Q 015500           78 MEYAPGGTLNDEIHR---NGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE--  151 (405)
Q Consensus        78 ~Ey~~ggsL~~~i~~---~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~--  151 (405)
                      |||++|++|.+++..   ....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++ ++|+|||++.....  
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  159 (287)
T cd06621          80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL  159 (287)
T ss_pred             EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccccc
Confidence            999999999988653   345689999999999999999999999999999999999999887 99999999875432  


Q ss_pred             cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC----ChHHHHHHHHhcCCCCCCc------hhc
Q 015500          152 ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAA----DPMTVLYKIAYSRELPEVP------AFL  221 (405)
Q Consensus       152 ~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~----~~~~~l~~i~~~~~~~~~p------~~~  221 (405)
                      .....++..|+|||.+.+..++.++|||||||++|+|++|+.||....    ........+.. ...+.++      ...
T Consensus       160 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  238 (287)
T cd06621         160 AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN-MPNPELKDEPGNGIKW  238 (287)
T ss_pred             cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc-CCchhhccCCCCCCch
Confidence            223457889999999999899999999999999999999999997552    22333222221 1122222      235


Q ss_pred             cHHHHHHHHHhcccCccccCCHHHHhcCccccccc
Q 015500          222 SKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFC  256 (405)
Q Consensus       222 s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~  256 (405)
                      ++.+.+||.+||..+|.+|||+.|+++||||....
T Consensus       239 ~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~  273 (287)
T cd06621         239 SEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM  273 (287)
T ss_pred             HHHHHHHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence            67899999999999999999999999999997543

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=6.6e-42  Score=324.12  Aligned_cols=243  Identities=27%  Similarity=0.444  Sum_probs=203.3

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC------ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~------~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~   75 (405)
                      +|++.+.||+|+||.||+|+++.+++.+|||.+...      ....+.+|+.+++.++||||+++++.+....    .++
T Consensus         3 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~   78 (267)
T cd08228           3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDN----ELN   78 (267)
T ss_pred             ceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECC----eEE
Confidence            689999999999999999999999999999976531      1245788999999999999999998876543    366


Q ss_pred             EEEeecCCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc
Q 015500           76 LFMEYAPGGTLNDEIHR---NGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE  151 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~---~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~  151 (405)
                      +++||+++++|.+++..   ....+++..+..++.||+.||.|||++|++|+||||+||+++.++ ++|+|||++.....
T Consensus        79 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          79 IVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            99999999999988853   334589999999999999999999999999999999999999887 99999999876543


Q ss_pred             c----ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCh-HHHHHHHHhcCCCCCC-chhccHHH
Q 015500          152 A----LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADP-MTVLYKIAYSRELPEV-PAFLSKQA  225 (405)
Q Consensus       152 ~----~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~-~~~l~~i~~~~~~~~~-p~~~s~~l  225 (405)
                      .    ....|++.|+|||.+.+..++.++|+||||+++|+|++|+.||...... ......+. ....+.. +...+..+
T Consensus       159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  237 (267)
T cd08228         159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIE-QCDYPPLPTEHYSEKL  237 (267)
T ss_pred             hhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHh-cCCCCCCChhhcCHHH
Confidence            2    2346889999999999888999999999999999999999999654433 23333333 2233333 34678899


Q ss_pred             HHHHHHhcccCccccCCHHHHhcC
Q 015500          226 NDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       226 ~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      .+++.+||+.+|++||++.++++.
T Consensus       238 ~~li~~cl~~~p~~Rp~~~~vl~~  261 (267)
T cd08228         238 RELVSMCIYPDPDQRPDIGYVHQI  261 (267)
T ss_pred             HHHHHHHCCCCcccCcCHHHHHHH
Confidence            999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=7e-42  Score=331.31  Aligned_cols=241  Identities=25%  Similarity=0.303  Sum_probs=193.3

Q ss_pred             CcccccccceeCCeeEEEEEEcC----------------CCCEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeee
Q 015500            2 DWTRGHTIGQGSSATVSLATSLR----------------SGDVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYK   61 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~----------------~~~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~   61 (405)
                      +|++.+.||+|+||.||+|.+..                ++..+|+|.+....    ...+.+|+++|++++||||++++
T Consensus         6 ~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~   85 (304)
T cd05096           6 HLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLL   85 (304)
T ss_pred             hCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEE
Confidence            58899999999999999998532                34579999886542    24688999999999999999999


Q ss_pred             eeeeecCCCceEEEEEEeecCCCCHHHHHHHcC------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 015500           62 GCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNG------------------GRLDESLIVSYTRQILQGLEYLHSNRVVH  123 (405)
Q Consensus        62 ~~~~~~~~~~~~~~lv~Ey~~ggsL~~~i~~~~------------------~~l~e~~~~~i~~qIl~~L~yLH~~givH  123 (405)
                      +++.....    ++++|||+++|+|.+++....                  ..+++..+..++.||+.||.|||+.||+|
T Consensus        86 ~~~~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH  161 (304)
T cd05096          86 GVCVDEDP----LCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVH  161 (304)
T ss_pred             EEEecCCc----eEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccc
Confidence            98765433    679999999999999986531                  23677889999999999999999999999


Q ss_pred             CCCCCCCEEEccCC-ceEeeecccccccc------cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh--CCCC
Q 015500          124 CDIKSRNILMAESG-AKIADFGCAKWESE------ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS--GGAP  194 (405)
Q Consensus       124 rDlkp~NILi~~~~-vkL~DFGla~~~~~------~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt--G~~P  194 (405)
                      |||||+|||++.++ +||+|||+++....      .....+++.|+|||++.+..+++++|||||||++|||++  +..|
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p  241 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP  241 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence            99999999999887 99999999875432      112345788999999998889999999999999999987  5678


Q ss_pred             CCCCCChHHHHHHHH------hcCCCCCCchhccHHHHHHHHHhcccCccccCCHHHHh
Q 015500          195 WPNAADPMTVLYKIA------YSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLL  247 (405)
Q Consensus       195 f~~~~~~~~~l~~i~------~~~~~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL  247 (405)
                      |...... ..+....      .....+..|..+++.+.+|+.+||+.||.+|||+.++.
T Consensus       242 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~  299 (304)
T cd05096         242 YGELTDE-QVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIH  299 (304)
T ss_pred             CCcCCHH-HHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence            8654332 2222111      01112233456789999999999999999999999994

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=4e-42  Score=331.32  Aligned_cols=249  Identities=32%  Similarity=0.463  Sum_probs=203.7

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC--------hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK--------SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLM   73 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~--------~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~   73 (405)
                      +|.+.+.||+|+||.||+|.+..+++.+|+|.+....        ...+.+|++++++++||||+++++++....    .
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~----~   76 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKS----N   76 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCC----E
Confidence            5889999999999999999999999999999886542        235678999999999999999999876532    3


Q ss_pred             EEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc
Q 015500           74 YNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA  152 (405)
Q Consensus        74 ~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~  152 (405)
                      .++||||+ +++|.+++......+++..+..++.||+.||.|||++|++|+||||+||+++.++ +||+|||+++.....
T Consensus        77 ~~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~  155 (298)
T cd07841          77 INLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP  155 (298)
T ss_pred             EEEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence            67999999 8899999977644799999999999999999999999999999999999999888 999999998765432


Q ss_pred             ----ccCCCCCCccChhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCC-------------
Q 015500          153 ----LQSGGTPMFMAPEVARG-EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSREL-------------  214 (405)
Q Consensus       153 ----~~~~gt~~Y~APE~l~~-~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~-------------  214 (405)
                          ....+++.|+|||.+.+ ..++.++|+|||||++|+|++|.+||....+ ...+.++......             
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (298)
T cd07841         156 NRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD-IDQLGKIFEALGTPTEENWPGVTSLP  234 (298)
T ss_pred             CccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCcc-HHHHHHHHHHcCCCchhhhhhccccc
Confidence                22346788999999865 4578899999999999999999888865443 2222222111000             


Q ss_pred             --------C-----CCchhccHHHHHHHHHhcccCccccCCHHHHhcCccccccc
Q 015500          215 --------P-----EVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFC  256 (405)
Q Consensus       215 --------~-----~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~  256 (405)
                              +     ......+..+.+||.+||+.||++|||+.++++||||++..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~  289 (298)
T cd07841         235 DYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDP  289 (298)
T ss_pred             ccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCC
Confidence                    0     01133578899999999999999999999999999998753

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=4.2e-42  Score=335.07  Aligned_cols=241  Identities=24%  Similarity=0.358  Sum_probs=201.7

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCE----EEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDV----FAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLM   73 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~----vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~   73 (405)
                      +|+..+.||+|+||+||+|++..+++.    +|+|.+....    .+.+.+|+.+++.++||||+++++++....     
T Consensus         8 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~~-----   82 (316)
T cd05108           8 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-----   82 (316)
T ss_pred             hceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCCC-----
Confidence            689999999999999999998766664    8999886432    346788999999999999999999875432     


Q ss_pred             EEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc
Q 015500           74 YNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA  152 (405)
Q Consensus        74 ~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~  152 (405)
                      .++++||+++|+|.+++..+...+++..+..++.||+.||+|||++||+||||||+|||++.++ +||+|||+++.....
T Consensus        83 ~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~  162 (316)
T cd05108          83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD  162 (316)
T ss_pred             ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCC
Confidence            4589999999999999988766799999999999999999999999999999999999998887 999999999865431


Q ss_pred             c------cCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHH
Q 015500          153 L------QSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQA  225 (405)
Q Consensus       153 ~------~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l  225 (405)
                      .      ...++..|+|||.+.+..++.++|||||||++|||++ |+.||....  ...+..+......+..|..++.++
T Consensus       163 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  240 (316)
T cd05108         163 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP--ASEISSILEKGERLPQPPICTIDV  240 (316)
T ss_pred             CcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC--HHHHHHHHhCCCCCCCCCCCCHHH
Confidence            1      1224667999999999999999999999999999997 999996442  223333333333344456688999


Q ss_pred             HHHHHHhcccCccccCCHHHHhcC
Q 015500          226 NDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       226 ~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      .+++.+||..+|.+|||+.+++.+
T Consensus       241 ~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         241 YMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             HHHHHHHccCChhhCcCHHHHHHH
Confidence            999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=4.2e-42  Score=340.42  Aligned_cols=251  Identities=27%  Similarity=0.382  Sum_probs=202.7

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC-----ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCC--CceEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP-----KSEFLQREQKFLSSLNSPHIVGYKGCDVTSED--NKLMY   74 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~-----~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~--~~~~~   74 (405)
                      +|+..+.||+|+||+||+|.+..+++.+|+|.+...     ....+.+|+.++++++||||+++++++.....  ....+
T Consensus        17 ~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   96 (353)
T cd07850          17 RYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDV   96 (353)
T ss_pred             ceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcE
Confidence            488899999999999999999999999999987542     23467789999999999999999987654332  12245


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc-
Q 015500           75 NLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA-  152 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~-  152 (405)
                      ++||||+.+ +|.+.+...   +++..+..++.||+.||+|||++||+||||||+||+++.++ +||+|||+++..... 
T Consensus        97 ~lv~e~~~~-~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~  172 (353)
T cd07850          97 YLVMELMDA-NLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF  172 (353)
T ss_pred             EEEEeccCC-CHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCCCC
Confidence            799999964 888887643   89999999999999999999999999999999999999888 999999999865442 


Q ss_pred             --ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCC-----------------
Q 015500          153 --LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRE-----------------  213 (405)
Q Consensus       153 --~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~-----------------  213 (405)
                        ....+|+.|+|||.+.+..++.++|||||||++|+|++|+.||..... .....++.....                 
T Consensus       173 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (353)
T cd07850         173 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDH-IDQWNKIIEQLGTPSDEFMSRLQPTVRNY  251 (353)
T ss_pred             CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHHhcCCCCHHHHHHhhhhhhHH
Confidence              234588999999999999999999999999999999999999965432 211111110000                 


Q ss_pred             ---CC---------------------CCchhccHHHHHHHHHhcccCccccCCHHHHhcCcccccccc
Q 015500          214 ---LP---------------------EVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCS  257 (405)
Q Consensus       214 ---~~---------------------~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~~  257 (405)
                         .+                     ..+...++.+.+||.+||+.||++|||+.|+|+||||+....
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~  319 (353)
T cd07850         252 VENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYD  319 (353)
T ss_pred             hhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccC
Confidence               00                     001234667899999999999999999999999999986543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=3.6e-42  Score=333.02  Aligned_cols=246  Identities=34%  Similarity=0.520  Sum_probs=206.0

Q ss_pred             cccccccceeCCeeEEEEEEcCCCCEEEEEEccCC---ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEe
Q 015500            3 WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP---KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFME   79 (405)
Q Consensus         3 y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~---~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (405)
                      |.....||+|+||.||+|.+..+++.+|+|.+...   ..+.+.+|+.+++.++||||+++++.+....    .++++||
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~----~~~iv~e   98 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGE----ELWVLME   98 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCC----eEEEEEe
Confidence            45567899999999999999999999999987542   3457889999999999999999998876543    3679999


Q ss_pred             ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc----ccc
Q 015500           80 YAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE----ALQ  154 (405)
Q Consensus        80 y~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~----~~~  154 (405)
                      |+++++|.+++...  .+++..+..++.|++.||.|||++|++||||||+||+++.++ +||+|||++.....    ...
T Consensus        99 ~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~  176 (297)
T cd06659          99 FLQGGALTDIVSQT--RLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS  176 (297)
T ss_pred             cCCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccc
Confidence            99999999987653  689999999999999999999999999999999999999887 99999999864332    223


Q ss_pred             CCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcC-CCCCCchhccHHHHHHHHHhc
Q 015500          155 SGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSR-ELPEVPAFLSKQANDFLSNCL  233 (405)
Q Consensus       155 ~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~-~~~~~p~~~s~~l~dll~~~L  233 (405)
                      ..|++.|+|||++.+..++.++|||||||++|||++|+.||.... ....+..+.... .....+..++..+.++|.+||
T Consensus       177 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l  255 (297)
T cd06659         177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDS-PVQAMKRLRDSPPPKLKNAHKISPVLRDFLERML  255 (297)
T ss_pred             eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHhccCCCCccccCCCCHHHHHHHHHHh
Confidence            468999999999998889999999999999999999999996443 333333332221 112233457889999999999


Q ss_pred             ccCccccCCHHHHhcCcccccc
Q 015500          234 RRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       234 ~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      +.+|.+||++.++++||||.+.
T Consensus       256 ~~~P~~Rps~~~ll~~~~~~~~  277 (297)
T cd06659         256 TREPQERATAQELLDHPFLLQT  277 (297)
T ss_pred             cCCcccCcCHHHHhhChhhccC
Confidence            9999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=8.4e-42  Score=319.75  Aligned_cols=245  Identities=31%  Similarity=0.567  Sum_probs=212.2

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC-----ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP-----KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~-----~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      +|...+.||+|+||.||+|.+..+++.+++|.+...     ....+.+|+++++.++|||++++.+.+...    ..+++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~----~~~~l   76 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK----GKLCI   76 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC----CEEEE
Confidence            689999999999999999999999999999998754     335688999999999999999999876544    24669


Q ss_pred             EEeecCCCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc
Q 015500           77 FMEYAPGGTLNDEIHRN---GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA  152 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~---~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~  152 (405)
                      ++||+++++|.+++.+.   +..+++..+..++.|++.||.|||++|++|+||+|+||+++.++ ++|+|||++......
T Consensus        77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  156 (258)
T cd08215          77 VMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST  156 (258)
T ss_pred             EEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccC
Confidence            99999999999999874   36899999999999999999999999999999999999999877 999999998764432


Q ss_pred             ----ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHH
Q 015500          153 ----LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDF  228 (405)
Q Consensus       153 ----~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dl  228 (405)
                          ....|++.|+|||.+.+..++.++|+||+|+++++|++|+.||.... ........ .....+.+|..++.++.++
T Consensus       157 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~~  234 (258)
T cd08215         157 VDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN-LLELALKI-LKGQYPPIPSQYSSELRNL  234 (258)
T ss_pred             cceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc-HHHHHHHH-hcCCCCCCCCCCCHHHHHH
Confidence                23458899999999998889999999999999999999999996543 33333333 3445667777899999999


Q ss_pred             HHHhcccCccccCCHHHHhcCccc
Q 015500          229 LSNCLRRDPKERWAASQLLKHPFL  252 (405)
Q Consensus       229 l~~~L~~dP~~Rpt~~elL~hp~~  252 (405)
                      +++||..+|++|||+.++|+||||
T Consensus       235 i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         235 VSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             HHHHcCCChhhCcCHHHHhcCCCC
Confidence            999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=6.9e-42  Score=330.63  Aligned_cols=249  Identities=27%  Similarity=0.389  Sum_probs=198.6

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCC----Cce
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-----SEFLQREQKFLSSLNSPHIVGYKGCDVTSED----NKL   72 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~----~~~   72 (405)
                      +|++.+.||+|+||.||+|.+..+++.+|||.+....     .....+|++++++++||||+++++++.....    ...
T Consensus        13 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   92 (310)
T cd07865          13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKG   92 (310)
T ss_pred             heEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCc
Confidence            4889999999999999999999999999999875432     2356789999999999999999987665432    123


Q ss_pred             EEEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc
Q 015500           73 MYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE  151 (405)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~  151 (405)
                      .++++|||+. ++|.+.+...+..+++..++.++.||+.||.|||++|++|+||||+||+++.++ +||+|||++.....
T Consensus        93 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  171 (310)
T cd07865          93 SFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSL  171 (310)
T ss_pred             eEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcccccC
Confidence            4679999996 488888877666799999999999999999999999999999999999999888 99999999875432


Q ss_pred             c--------ccCCCCCCccChhhhcCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHh-cCCC-------
Q 015500          152 A--------LQSGGTPMFMAPEVARGE-HQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAY-SREL-------  214 (405)
Q Consensus       152 ~--------~~~~gt~~Y~APE~l~~~-~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~-~~~~-------  214 (405)
                      .        ....++..|+|||.+.+. .++.++||||||+++|+|++|..||..... ...+..+.. ....       
T Consensus       172 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  250 (310)
T cd07865         172 SKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTE-QHQLTLISQLCGSITPEVWPG  250 (310)
T ss_pred             CcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCChhhccc
Confidence            1        123478889999998764 468899999999999999999999965432 222111111 0000       


Q ss_pred             ------------CC-----C-----chhccHHHHHHHHHhcccCccccCCHHHHhcCccc
Q 015500          215 ------------PE-----V-----PAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFL  252 (405)
Q Consensus       215 ------------~~-----~-----p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~  252 (405)
                                  +.     .     +...+..+.+||.+||..||.+|||++++|+||||
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         251 VDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             ccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence                        00     0     01135678899999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-43  Score=371.96  Aligned_cols=250  Identities=30%  Similarity=0.424  Sum_probs=212.3

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccC------CChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL------PKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~------~~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~   75 (405)
                      ||.+++.||+|+||.|.+++++.|+++||+|++++      .....|..|..+|..-+.+=|+++.-.|.+..    ++|
T Consensus        76 DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~----~LY  151 (1317)
T KOG0612|consen   76 DFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER----YLY  151 (1317)
T ss_pred             hhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc----ceE
Confidence            68999999999999999999999999999998875      23467889999999999999999876654433    367


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc---
Q 015500           76 LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE---  151 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~---  151 (405)
                      +||||++||+|..++.+.+ +++|..++.|+..|+.||+-||++|+|||||||+||||+..| +||+|||.+-....   
T Consensus       152 lVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~  230 (1317)
T KOG0612|consen  152 LVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGT  230 (1317)
T ss_pred             EEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCc
Confidence            9999999999999999886 999999999999999999999999999999999999999999 99999997654432   


Q ss_pred             --cccCCCCCCccChhhhc----C-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCc--hhcc
Q 015500          152 --ALQSGGTPMFMAPEVAR----G-EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVP--AFLS  222 (405)
Q Consensus       152 --~~~~~gt~~Y~APE~l~----~-~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p--~~~s  222 (405)
                        ....+|||.|.+||+++    + +.|++.+|.||||+++|||+.|..||.. +......-+|..-...-.+|  ..+|
T Consensus       231 V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa-dslveTY~KIm~hk~~l~FP~~~~VS  309 (1317)
T KOG0612|consen  231 VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA-DSLVETYGKIMNHKESLSFPDETDVS  309 (1317)
T ss_pred             EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH-HHHHHHHHHHhchhhhcCCCcccccC
Confidence              33567999999999996    2 5689999999999999999999999943 33344444554443333444  4499


Q ss_pred             HHHHHHHHHhcccCccccCC---HHHHhcCccccccccc
Q 015500          223 KQANDFLSNCLRRDPKERWA---ASQLLKHPFLEEFCSC  258 (405)
Q Consensus       223 ~~l~dll~~~L~~dP~~Rpt---~~elL~hp~~~~~~~~  258 (405)
                      +++++||.+++. +|..|..   ++++..||||..+.+.
T Consensus       310 eeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~  347 (1317)
T KOG0612|consen  310 EEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWD  347 (1317)
T ss_pred             HHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChh
Confidence            999999999884 6899998   9999999999987663

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=9e-42  Score=326.09  Aligned_cols=245  Identities=29%  Similarity=0.471  Sum_probs=201.6

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC----ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP----KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLF   77 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~----~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv   77 (405)
                      +|+..+.||.|++|+||+|++..+|+.+|+|.+...    ..+.+.+|+.+++.++||||+++++.+.....    +++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~----~~lv   76 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENK----LMLV   76 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCc----EEEE
Confidence            689999999999999999999999999999987653    23567789999999999999999998766543    5699


Q ss_pred             EeecCCCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc---
Q 015500           78 MEYAPGGTLNDEIHRNG--GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE---  151 (405)
Q Consensus        78 ~Ey~~ggsL~~~i~~~~--~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~---  151 (405)
                      |||+++ +|.+++...+  .++++..+..++.||+.||.|||++|++||||||+||+++.++ +||+|||++.....   
T Consensus        77 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~  155 (284)
T cd07836          77 FEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN  155 (284)
T ss_pred             EecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence            999975 8988887654  4689999999999999999999999999999999999999887 99999999875432   


Q ss_pred             -cccCCCCCCccChhhhcCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhc------------------
Q 015500          152 -ALQSGGTPMFMAPEVARGE-HQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYS------------------  211 (405)
Q Consensus       152 -~~~~~gt~~Y~APE~l~~~-~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~------------------  211 (405)
                       .....+|+.|+|||.+.+. .++.++|+|||||++|+|++|+.||....... ...++...                  
T Consensus       156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07836         156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED-QLLKIFRIMGTPTESTWPGISQLPEY  234 (284)
T ss_pred             ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCCCChhhHHHHhcCchh
Confidence             1234578999999998764 57889999999999999999999997554332 22111100                  


Q ss_pred             -CCCCC--------CchhccHHHHHHHHHhcccCccccCCHHHHhcCccc
Q 015500          212 -RELPE--------VPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFL  252 (405)
Q Consensus       212 -~~~~~--------~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~  252 (405)
                       ...+.        +...++..+.+++.+||+.||.+||++.++++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence             01111        112357889999999999999999999999999997

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-42  Score=327.78  Aligned_cols=245  Identities=33%  Similarity=0.504  Sum_probs=202.1

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC-----ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP-----KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~-----~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      +|++.+.||+|+||.||+|.++.+++.+|+|.+...     ..+.+.+|++++++++||||+++.+++....    .+++
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~i   77 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKG----RLYL   77 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECC----EEEE
Confidence            689999999999999999999999999999987642     2357889999999999999999999876533    3679


Q ss_pred             EEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc---
Q 015500           77 FMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA---  152 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~---  152 (405)
                      +|||++++.+..++.+ ...+++..+..++.||+.||.|||+.|++||||+|+||+++.++ +||+|||++......   
T Consensus        78 v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~  156 (288)
T cd07833          78 VFEYVERTLLELLEAS-PGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS  156 (288)
T ss_pred             EEecCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccc
Confidence            9999988666655544 45799999999999999999999999999999999999999887 999999998764432   


Q ss_pred             --ccCCCCCCccChhhhcCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHh-cC----------------
Q 015500          153 --LQSGGTPMFMAPEVARGE-HQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAY-SR----------------  212 (405)
Q Consensus       153 --~~~~gt~~Y~APE~l~~~-~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~-~~----------------  212 (405)
                        ....+++.|+|||++.+. .++.++|+||||+++|+|++|++||....... .+..+.. ..                
T Consensus       157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07833         157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID-QLYLIQKCLGPLPPSHQELFSSNPRF  235 (288)
T ss_pred             cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHhhhcccCccc
Confidence              234578999999999887 78999999999999999999999997544332 2221110 00                


Q ss_pred             ---CCC----------CCchhccHHHHHHHHHhcccCccccCCHHHHhcCccc
Q 015500          213 ---ELP----------EVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFL  252 (405)
Q Consensus       213 ---~~~----------~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~  252 (405)
                         ..+          ..+..++.++.+||++||..+|++|||++++++||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             cccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence               000          1223358899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1e-41  Score=320.32  Aligned_cols=236  Identities=24%  Similarity=0.358  Sum_probs=196.4

Q ss_pred             cccceeCCeeEEEEEEcCCCCEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEeecC
Q 015500            7 HTIGQGSSATVSLATSLRSGDVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAP   82 (405)
Q Consensus         7 ~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~Ey~~   82 (405)
                      +.||+|+||+||+|+++.+++.+|+|.+....    ...+.+|+++|+.++||||+++++++....    .+++||||++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~   76 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ----PIYIVMELVQ   76 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCC----CeEEEEeecc
Confidence            47999999999999999999999999875432    356889999999999999999998765443    2669999999


Q ss_pred             CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccccc------cC
Q 015500           83 GGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEAL------QS  155 (405)
Q Consensus        83 ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~~------~~  155 (405)
                      +++|.+++.+.+..+++..+..++.|++.||.|||++|++||||||+||+++.++ +||+|||++.......      ..
T Consensus        77 ~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  156 (252)
T cd05084          77 GGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK  156 (252)
T ss_pred             CCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence            9999999987666799999999999999999999999999999999999999887 9999999987533211      11


Q ss_pred             CCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHhcc
Q 015500          156 GGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLR  234 (405)
Q Consensus       156 ~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~L~  234 (405)
                      .++..|+|||.+.+..++.++|||||||++|+|++ |..||..... ......+. ....+..+..++..+.+|+.+||+
T Consensus       157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~  234 (252)
T cd05084         157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN-QQTREAIE-QGVRLPCPELCPDAVYRLMERCWE  234 (252)
T ss_pred             CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH-HHHHHHHH-cCCCCCCcccCCHHHHHHHHHHcC
Confidence            12456999999998889999999999999999998 8899954432 22222222 233345566789999999999999


Q ss_pred             cCccccCCHHHHhc
Q 015500          235 RDPKERWAASQLLK  248 (405)
Q Consensus       235 ~dP~~Rpt~~elL~  248 (405)
                      .+|++|||+.++++
T Consensus       235 ~~p~~Rps~~~~~~  248 (252)
T cd05084         235 YDPGQRPSFSTVHQ  248 (252)
T ss_pred             CChhhCcCHHHHHH
Confidence            99999999999975

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-41  Score=321.93  Aligned_cols=244  Identities=30%  Similarity=0.456  Sum_probs=199.9

Q ss_pred             ccccceeCCeeEEEEEEcCCCCEEEEEEccCCCh------HHHHHHHHH-HHhCCCCCeeeeeeeeeecCCCceEEEEEE
Q 015500            6 GHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS------EFLQREQKF-LSSLNSPHIVGYKGCDVTSEDNKLMYNLFM   78 (405)
Q Consensus         6 ~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~~------~~l~~E~~i-L~~L~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (405)
                      .+.||.|+||.||+|.+..+++.+|+|.+.....      ..+..|..+ ...++||||+++++.+...+    .+++++
T Consensus         1 ~~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~----~~~lv~   76 (260)
T cd05611           1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKD----YLYLVM   76 (260)
T ss_pred             CccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCC----eEEEEE
Confidence            3679999999999999999999999998865321      123344444 44558999999998875433    367999


Q ss_pred             eecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccccccCCC
Q 015500           79 EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSGG  157 (405)
Q Consensus        79 Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~~~~~g  157 (405)
                      ||++|++|.+++... +.+++..+..++.||+.||.|||+.|++||||+|+||+++.++ +||+|||+++.........+
T Consensus        77 e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~  155 (260)
T cd05611          77 EYLNGGDCASLIKTL-GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFVG  155 (260)
T ss_pred             eccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccccccCCC
Confidence            999999999999876 4799999999999999999999999999999999999999887 99999999886555555678


Q ss_pred             CCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcC--CCCCCchhccHHHHHHHHHhccc
Q 015500          158 TPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSR--ELPEVPAFLSKQANDFLSNCLRR  235 (405)
Q Consensus       158 t~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~--~~~~~p~~~s~~l~dll~~~L~~  235 (405)
                      ++.|+|||.+.+..++.++||||||+++|+|++|..||... +.......+....  ..+..+..+++.+.+++.+||+.
T Consensus       156 ~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  234 (260)
T cd05611         156 TPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAE-TPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCM  234 (260)
T ss_pred             CcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCC-CHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccC
Confidence            99999999999888899999999999999999999999644 3333333333221  11223345789999999999999


Q ss_pred             CccccCC---HHHHhcCcccccc
Q 015500          236 DPKERWA---ASQLLKHPFLEEF  255 (405)
Q Consensus       236 dP~~Rpt---~~elL~hp~~~~~  255 (405)
                      +|++|||   ++|+|.||||+..
T Consensus       235 ~p~~R~~~~~~~~~l~~~~~~~~  257 (260)
T cd05611         235 DPAKRLGANGYQEIKSHPFFKSI  257 (260)
T ss_pred             CHHHccCCCcHHHHHcChHhhcC
Confidence            9999995   5799999999764

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=8.5e-42  Score=328.52  Aligned_cols=247  Identities=30%  Similarity=0.420  Sum_probs=202.1

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      +|++.+.||.|+||.||+|.+..+++.+|+|.+....     ...+.+|+.++++++||||+++++++.....  ..+++
T Consensus         6 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~--~~~~l   83 (293)
T cd07843           6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNL--DKIYM   83 (293)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCC--CcEEE
Confidence            5889999999999999999999999999999886432     2346789999999999999999987765432  24669


Q ss_pred             EEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc---
Q 015500           77 FMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA---  152 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~---  152 (405)
                      +|||+++ +|.+++......+++..++.++.||+.||+|||++|++|+||||+||+++.++ +||+|||++......   
T Consensus        84 v~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~  162 (293)
T cd07843          84 VMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKP  162 (293)
T ss_pred             EehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCccc
Confidence            9999975 99999887665799999999999999999999999999999999999999888 999999998764432   


Q ss_pred             -ccCCCCCCccChhhhcCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcC------------------
Q 015500          153 -LQSGGTPMFMAPEVARGE-HQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSR------------------  212 (405)
Q Consensus       153 -~~~~gt~~Y~APE~l~~~-~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~------------------  212 (405)
                       ....+++.|+|||.+.+. .++.++|+|||||++|+|++|..||..... .....++...-                  
T Consensus       163 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (293)
T cd07843         163 YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSE-IDQLNKIFKLLGTPTEKIWPGFSELPGAK  241 (293)
T ss_pred             cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCchHHHHHhhccchhc
Confidence             233478899999998764 468899999999999999999999965433 22222211100                  


Q ss_pred             -----------CCCCCchh-ccHHHHHHHHHhcccCccccCCHHHHhcCccc
Q 015500          213 -----------ELPEVPAF-LSKQANDFLSNCLRRDPKERWAASQLLKHPFL  252 (405)
Q Consensus       213 -----------~~~~~p~~-~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~  252 (405)
                                 ....++.. +++.+.+||++||+.||++|||+.|+|+||||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         242 KKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             ccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence                       00112222 58889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.1e-41  Score=326.53  Aligned_cols=250  Identities=39%  Similarity=0.635  Sum_probs=211.8

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC--hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEe
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK--SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFME   79 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~--~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (405)
                      .|+..+.||.|++|.||+|.+..+++.+++|.+....  .+.+.+|+++++.++||||+++++.+....    ..++++|
T Consensus        20 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~lv~e   95 (286)
T cd06614          20 LYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGD----ELWVVME   95 (286)
T ss_pred             cchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECC----EEEEEEe
Confidence            4778899999999999999999899999999987654  567889999999999999999999877653    3679999


Q ss_pred             ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc----cc
Q 015500           80 YAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA----LQ  154 (405)
Q Consensus        80 y~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~----~~  154 (405)
                      |++|++|.+++......+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ ++|+|||++......    ..
T Consensus        96 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~  175 (286)
T cd06614          96 YMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS  175 (286)
T ss_pred             ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhhhcc
Confidence            9999999999988655799999999999999999999999999999999999999887 999999987643321    23


Q ss_pred             CCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCC--chhccHHHHHHHHHh
Q 015500          155 SGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEV--PAFLSKQANDFLSNC  232 (405)
Q Consensus       155 ~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~--p~~~s~~l~dll~~~  232 (405)
                      ..+++.|+|||.+.+..++.++|+|||||++|+|++|+.||... ++......+... ..+..  +..++..+.+||++|
T Consensus       176 ~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~-~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~  253 (286)
T cd06614         176 VVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLRE-PPLRALFLITTK-GIPPLKNPEKWSPEFKDFLNKC  253 (286)
T ss_pred             ccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhc-CCCCCcchhhCCHHHHHHHHHH
Confidence            34788999999999888999999999999999999999999644 333333333322 22222  233789999999999


Q ss_pred             cccCccccCCHHHHhcCcccccccc
Q 015500          233 LRRDPKERWAASQLLKHPFLEEFCS  257 (405)
Q Consensus       233 L~~dP~~Rpt~~elL~hp~~~~~~~  257 (405)
                      |+.+|.+|||+.++++||||++.+.
T Consensus       254 l~~~p~~Rpt~~~il~~~~~~~~~~  278 (286)
T cd06614         254 LVKDPEKRPSAEELLQHPFLKKACP  278 (286)
T ss_pred             hccChhhCcCHHHHhhChHhhccCc
Confidence            9999999999999999999997543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.2e-43  Score=350.27  Aligned_cols=249  Identities=31%  Similarity=0.472  Sum_probs=216.7

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      .|.+.++||+|.|++|.+|++..++..||+|.+++..     .+.+.+|+++|+.|+|||||+++.+..+...    +|+
T Consensus        57 ~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~----lyl  132 (596)
T KOG0586|consen   57 LYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEAT----LYL  132 (596)
T ss_pred             ceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecce----eEE
Confidence            4889999999999999999999999999999988653     3568999999999999999999998776554    779


Q ss_pred             EEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc---c
Q 015500           77 FMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE---A  152 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~---~  152 (405)
                      ||||+.+|.+.+++.+++ ++.+..++.++.|+++|++|||+++|||||||++|||++.+. +||+|||++..+..   .
T Consensus       133 V~eya~~ge~~~yl~~~g-r~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~l  211 (596)
T KOG0586|consen  133 VMEYASGGELFDYLVKHG-RMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLML  211 (596)
T ss_pred             EEEeccCchhHHHHHhcc-cchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecccccc
Confidence            999999999999999985 888899999999999999999999999999999999999987 99999999987655   4


Q ss_pred             ccCCCCCCccChhhhcCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHH
Q 015500          153 LQSGGTPMFMAPEVARGEHQ-GFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSN  231 (405)
Q Consensus       153 ~~~~gt~~Y~APE~l~~~~~-~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~  231 (405)
                      .+.+|+|.|.|||++.+..| ++.+|+||||+++|.|+.|.+||.... ....-.+....  .-.+|-.++-++.++|++
T Consensus       212 qt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~-lk~Lr~rvl~g--k~rIp~~ms~dce~lLrk  288 (596)
T KOG0586|consen  212 QTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN-LKELRPRVLRG--KYRIPFYMSCDCEDLLRK  288 (596)
T ss_pred             cccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc-cccccchheee--eecccceeechhHHHHHH
Confidence            57889999999999999664 789999999999999999999995432 22222222211  224666789999999999


Q ss_pred             hcccCccccCCHHHHhcCccccccccc
Q 015500          232 CLRRDPKERWAASQLLKHPFLEEFCSC  258 (405)
Q Consensus       232 ~L~~dP~~Rpt~~elL~hp~~~~~~~~  258 (405)
                      +|..+|.+|++.+|+++|.|.......
T Consensus       289 ~lvl~Pskr~~~dqim~~~W~n~~~~~  315 (596)
T KOG0586|consen  289 FLVLNPSKRGPCDQIMKDRWRNDLLEA  315 (596)
T ss_pred             hhccCccccCCHHHhhhhcccchhhhh
Confidence            999999999999999999999765443

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.5e-41  Score=320.20  Aligned_cols=240  Identities=23%  Similarity=0.371  Sum_probs=199.8

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC--ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEe
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP--KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFME   79 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~--~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (405)
                      +|++.+.||+|+||.||+|.++ .+..+|+|.+...  ..+.+.+|+.+|++++||||+++++++.....    ++++||
T Consensus         5 ~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~iv~e   79 (256)
T cd05114           5 ELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKP----LYIVTE   79 (256)
T ss_pred             HcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCC----EEEEEE
Confidence            4788999999999999999875 4567999987643  24578899999999999999999987654332    679999


Q ss_pred             ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccccc-----
Q 015500           80 YAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEAL-----  153 (405)
Q Consensus        80 y~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~~-----  153 (405)
                      |+++|+|.+++....+.+++..+..++.|++.||+|||++|++||||||+||+++.++ +||+|||+++......     
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~  159 (256)
T cd05114          80 FMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSS  159 (256)
T ss_pred             cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceeccC
Confidence            9999999999987656799999999999999999999999999999999999999887 9999999987543211     


Q ss_pred             cCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHh
Q 015500          154 QSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNC  232 (405)
Q Consensus       154 ~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~  232 (405)
                      ...++..|+|||.+.+..++.++|+|||||++|+|++ |+.||.... ....+..+... ..+..|...+..+.+++.+|
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~-~~~~~~~i~~~-~~~~~~~~~~~~~~~li~~c  237 (256)
T cd05114         160 GAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS-NYEVVEMISRG-FRLYRPKLASMTVYEVMYSC  237 (256)
T ss_pred             CCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC-HHHHHHHHHCC-CCCCCCCCCCHHHHHHHHHH
Confidence            1224567999999998889999999999999999999 899996443 33344444332 23345566788999999999


Q ss_pred             cccCccccCCHHHHhc
Q 015500          233 LRRDPKERWAASQLLK  248 (405)
Q Consensus       233 L~~dP~~Rpt~~elL~  248 (405)
                      |+.+|++|||++++++
T Consensus       238 ~~~~p~~Rps~~~l~~  253 (256)
T cd05114         238 WHEKPEGRPTFAELLR  253 (256)
T ss_pred             ccCCcccCcCHHHHHH
Confidence            9999999999999975

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.4e-41  Score=326.66  Aligned_cols=246  Identities=33%  Similarity=0.533  Sum_probs=206.6

Q ss_pred             cccccccceeCCeeEEEEEEcCCCCEEEEEEccCC---ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEe
Q 015500            3 WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP---KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFME   79 (405)
Q Consensus         3 y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~---~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (405)
                      |...+.||+|++|.||+|.+..+++.+++|.+...   ..+.+.+|+.+++.++||||+++++.+....    .+++++|
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~----~~~~v~e   96 (285)
T cd06648          21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGD----ELWVVME   96 (285)
T ss_pred             hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCC----eEEEEEe
Confidence            55678999999999999999999999999987643   2346789999999999999999998766433    3679999


Q ss_pred             ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc----ccc
Q 015500           80 YAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE----ALQ  154 (405)
Q Consensus        80 y~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~----~~~  154 (405)
                      |++|++|.+++..  +++++..+..++.||+.||+|||++|++||||+|+||+++.++ ++|+|||++.....    ...
T Consensus        97 ~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~  174 (285)
T cd06648          97 FLEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS  174 (285)
T ss_pred             ccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCccccc
Confidence            9999999999877  4799999999999999999999999999999999999999887 99999998765332    223


Q ss_pred             CCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCC--chhccHHHHHHHHHh
Q 015500          155 SGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEV--PAFLSKQANDFLSNC  232 (405)
Q Consensus       155 ~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~--p~~~s~~l~dll~~~  232 (405)
                      ..|++.|+|||.+.+..++.++|+|||||++|+|++|+.||... ++.....++... ..+..  +..++..+.+|+.+|
T Consensus       175 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~-~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~  252 (285)
T cd06648         175 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNE-PPLQAMKRIRDN-LPPKLKNLHKVSPRLRSFLDRM  252 (285)
T ss_pred             ccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCC-CHHHHHHHHHhc-CCCCCcccccCCHHHHHHHHHH
Confidence            45899999999999888999999999999999999999999543 333333333322 22222  333788999999999


Q ss_pred             cccCccccCCHHHHhcCccccccc
Q 015500          233 LRRDPKERWAASQLLKHPFLEEFC  256 (405)
Q Consensus       233 L~~dP~~Rpt~~elL~hp~~~~~~  256 (405)
                      |+.+|++|||+.++++||||+...
T Consensus       253 l~~~p~~Rpt~~~il~~~~~~~~~  276 (285)
T cd06648         253 LVRDPAQRATAAELLNHPFLAKAG  276 (285)
T ss_pred             cccChhhCcCHHHHccCcccccCC
Confidence            999999999999999999998754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=7.5e-42  Score=327.82  Aligned_cols=249  Identities=25%  Similarity=0.403  Sum_probs=201.0

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC----hHHHHHHHHHHHhCC-CCCeeeeeeeeeecCCCceEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK----SEFLQREQKFLSSLN-SPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~----~~~l~~E~~iL~~L~-hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      +|...+.||+|+||.||++.+..+++.+|+|.+....    ...+.+|+.++.++. ||||+++++.+.....    .++
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~----~~~   80 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGD----CWI   80 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCc----EEE
Confidence            4667889999999999999999999999999886532    346788999999996 9999999997654332    558


Q ss_pred             EEeecCCCCHHHHHH---H-cCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCCCCEEEccCC-ceEeeeccccccc
Q 015500           77 FMEYAPGGTLNDEIH---R-NGGRLDESLIVSYTRQILQGLEYLHSN-RVVHCDIKSRNILMAESG-AKIADFGCAKWES  150 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~---~-~~~~l~e~~~~~i~~qIl~~L~yLH~~-givHrDlkp~NILi~~~~-vkL~DFGla~~~~  150 (405)
                      +|||+.+ +|.++..   . ..+.+++..+..++.|++.||+|||+. |++||||||+||+++.++ +||+|||+++...
T Consensus        81 ~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  159 (288)
T cd06616          81 CMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV  159 (288)
T ss_pred             EEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence            9999854 6555432   2 235799999999999999999999975 999999999999999887 9999999987543


Q ss_pred             c---cccCCCCCCccChhhhcCC---CCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCc----hh
Q 015500          151 E---ALQSGGTPMFMAPEVARGE---HQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVP----AF  220 (405)
Q Consensus       151 ~---~~~~~gt~~Y~APE~l~~~---~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p----~~  220 (405)
                      .   .....|++.|+|||++.+.   .++.++|||||||++|+|++|+.||.........+.++.. ...+.++    ..
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  238 (288)
T cd06616         160 DSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVK-GDPPILSNSEERE  238 (288)
T ss_pred             cCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcC-CCCCcCCCcCCCc
Confidence            2   2234589999999999876   6888999999999999999999999765433333333322 2222222    24


Q ss_pred             ccHHHHHHHHHhcccCccccCCHHHHhcCccccccc
Q 015500          221 LSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFC  256 (405)
Q Consensus       221 ~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~  256 (405)
                      ++.++.+||++||+.||++|||++++++||||+...
T Consensus       239 ~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~  274 (288)
T cd06616         239 FSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYE  274 (288)
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchh
Confidence            789999999999999999999999999999998643

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-41  Score=320.86  Aligned_cols=242  Identities=23%  Similarity=0.337  Sum_probs=201.3

Q ss_pred             CCcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC--ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEE
Q 015500            1 MDWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP--KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFM   78 (405)
Q Consensus         1 ~~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~--~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (405)
                      ++|++++.||+|+||.||+|.++ ++..+|+|.+...  ..+.+.+|+++++.++||||+++++.+....    .++++|
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~lv~   78 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQR----PIFIVT   78 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC----ceEEEE
Confidence            36899999999999999999875 5678999987643  3456888999999999999999988764332    356999


Q ss_pred             eecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccccc--cC
Q 015500           79 EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEAL--QS  155 (405)
Q Consensus        79 Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~~--~~  155 (405)
                      ||++|++|.+++..+.+.+++..+..++.||+.||+|||++|++||||||+||+++.++ +||+|||+++......  ..
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~  158 (256)
T cd05059          79 EYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS  158 (256)
T ss_pred             ecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccccccc
Confidence            99999999999987666899999999999999999999999999999999999999888 9999999987643321  11


Q ss_pred             C---CCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHH
Q 015500          156 G---GTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSN  231 (405)
Q Consensus       156 ~---gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~  231 (405)
                      .   ++..|+|||.+.+..++.++|+|||||++|+|++ |+.||.... .......+.. ...+..|...+..+.+++.+
T Consensus       159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~  236 (256)
T cd05059         159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFS-NSEVVESVSA-GYRLYRPKLAPTEVYTIMYS  236 (256)
T ss_pred             CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCC-HHHHHHHHHc-CCcCCCCCCCCHHHHHHHHH
Confidence            2   3447999999999899999999999999999999 899996443 3333333332 22334556689999999999


Q ss_pred             hcccCccccCCHHHHhcC
Q 015500          232 CLRRDPKERWAASQLLKH  249 (405)
Q Consensus       232 ~L~~dP~~Rpt~~elL~h  249 (405)
                      ||..+|++|||+.++++.
T Consensus       237 cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         237 CWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             HhcCChhhCcCHHHHHHH
Confidence            999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.5e-41  Score=324.49  Aligned_cols=242  Identities=23%  Similarity=0.309  Sum_probs=200.7

Q ss_pred             CcccccccceeCCeeEEEEEEcC-----CCCEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCce
Q 015500            2 DWTRGHTIGQGSSATVSLATSLR-----SGDVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKL   72 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~-----~~~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~   72 (405)
                      +|.+.+.||+|+||.||+|.+..     ++..+|+|......    ...+.+|+.+++.++||||+++++++.....   
T Consensus         7 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~---   83 (277)
T cd05036           7 SITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP---   83 (277)
T ss_pred             HcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC---
Confidence            47889999999999999999987     77899999876432    2357889999999999999999987655433   


Q ss_pred             EEEEEEeecCCCCHHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC----ceEee
Q 015500           73 MYNLFMEYAPGGTLNDEIHRNG------GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG----AKIAD  142 (405)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~i~~~~------~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~----vkL~D  142 (405)
                       ++++|||++|++|.+++.+..      ..+++..+..++.||+.||.|||++|++||||||+||+++.++    +||+|
T Consensus        84 -~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~d  162 (277)
T cd05036          84 -RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIAD  162 (277)
T ss_pred             -cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEecc
Confidence             569999999999999997653      2589999999999999999999999999999999999998653    89999


Q ss_pred             ecccccccccc------cCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCC
Q 015500          143 FGCAKWESEAL------QSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELP  215 (405)
Q Consensus       143 FGla~~~~~~~------~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~  215 (405)
                      ||+++......      ....++.|+|||++.+..++.++|||||||++|+|++ |..||..... ... .........+
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~-~~~-~~~~~~~~~~  240 (277)
T cd05036         163 FGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN-QEV-MEFVTGGGRL  240 (277)
T ss_pred             CccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-HHH-HHHHHcCCcC
Confidence            99997643211      1123467999999998889999999999999999997 9999965433 222 2333333445


Q ss_pred             CCchhccHHHHHHHHHhcccCccccCCHHHHhcC
Q 015500          216 EVPAFLSKQANDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       216 ~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      ..|..++..+.+|+.+||+.+|++|||+.++++|
T Consensus       241 ~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         241 DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            5677789999999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=6.4e-42  Score=330.45  Aligned_cols=247  Identities=38%  Similarity=0.584  Sum_probs=206.6

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC---ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP---KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFM   78 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~---~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (405)
                      +|.+.+.||+|+||+||+|.+..+++.+|+|.+...   ..+.+.+|+.+++.++||||+++++.+...+.    +++|+
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~----~~lv~   95 (293)
T cd06647          20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDE----LWVVM   95 (293)
T ss_pred             hceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCc----EEEEE
Confidence            588999999999999999999889999999987643   34568889999999999999999988765443    66999


Q ss_pred             eecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc----cc
Q 015500           79 EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE----AL  153 (405)
Q Consensus        79 Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~----~~  153 (405)
                      ||+++++|.+++.+.  .+++..+..++.|++.||.|||++|++|+||||+||+++.++ +||+|||++.....    ..
T Consensus        96 e~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~  173 (293)
T cd06647          96 EYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS  173 (293)
T ss_pred             ecCCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccccccc
Confidence            999999999998764  588999999999999999999999999999999999999887 99999998765432    12


Q ss_pred             cCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCC-CCCCchhccHHHHHHHHHh
Q 015500          154 QSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRE-LPEVPAFLSKQANDFLSNC  232 (405)
Q Consensus       154 ~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~-~~~~p~~~s~~l~dll~~~  232 (405)
                      ...+++.|+|||.+.+..++.++|+|||||++|+|++|+.||..... ...+..+..... ....+..++..+++++.+|
T Consensus       174 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  252 (293)
T cd06647         174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP-LRALYLIATNGTPELQNPEKLSAIFRDFLNRC  252 (293)
T ss_pred             cccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-hhheeehhcCCCCCCCCccccCHHHHHHHHHH
Confidence            33588899999999888889999999999999999999999965433 222222221111 1122345788999999999


Q ss_pred             cccCccccCCHHHHhcCcccccc
Q 015500          233 LRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       233 L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      |+.+|.+||++.+++.||||+..
T Consensus       253 l~~~p~~Rp~~~~il~h~~~~~~  275 (293)
T cd06647         253 LEMDVEKRGSAKELLQHPFLKIA  275 (293)
T ss_pred             ccCChhhCcCHHHHhcCHHHhcC
Confidence            99999999999999999999854

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-41  Score=321.07  Aligned_cols=242  Identities=23%  Similarity=0.318  Sum_probs=201.8

Q ss_pred             CcccccccceeCCeeEEEEEEcCC---CCEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRS---GDVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMY   74 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~---~~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~   74 (405)
                      +|++.+.||+|+||+||+|.++.+   ...+|+|.+....    ...+.+|+.++++++||||+++++.+.....    +
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~   80 (266)
T cd05033           5 YVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRP----V   80 (266)
T ss_pred             HceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCc----e
Confidence            588999999999999999998754   4589999876542    2457789999999999999999987654332    5


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc--
Q 015500           75 NLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE--  151 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~--  151 (405)
                      +++|||+++++|.+++....+.+++..+..++.|++.||.|||++||+||||||+||+++.++ +||+|||+++....  
T Consensus        81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~  160 (266)
T cd05033          81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE  160 (266)
T ss_pred             EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence            699999999999999988767899999999999999999999999999999999999999887 99999999986531  


Q ss_pred             ----cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHH
Q 015500          152 ----ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQAN  226 (405)
Q Consensus       152 ----~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~  226 (405)
                          .....+++.|+|||.+.+..++.++|||||||++|+|++ |..||..... ......+.. ...+..+..+++.+.
T Consensus       161 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~l~  238 (266)
T cd05033         161 ATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN-QDVIKAVED-GYRLPPPMDCPSALY  238 (266)
T ss_pred             cceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH-HHHHHHHHc-CCCCCCCCCCCHHHH
Confidence                111234678999999999889999999999999999998 9999965432 333333332 223344566899999


Q ss_pred             HHHHHhcccCccccCCHHHHhcC
Q 015500          227 DFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       227 dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      +++.+||+.+|++||++.+++++
T Consensus       239 ~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         239 QLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             HHHHHHcCCCcccCcCHHHHHHH
Confidence            99999999999999999999876

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.4e-41  Score=324.17  Aligned_cols=241  Identities=24%  Similarity=0.388  Sum_probs=201.2

Q ss_pred             CcccccccceeCCeeEEEEEEcC-----CCCEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCce
Q 015500            2 DWTRGHTIGQGSSATVSLATSLR-----SGDVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKL   72 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~-----~~~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~   72 (405)
                      +|.+.+.||+|+||.||+|.+..     +++.+|+|.+....    .+.+.+|+++|++++||||+++++.+....    
T Consensus         6 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----   81 (280)
T cd05049           6 TIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGD----   81 (280)
T ss_pred             HhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCC----
Confidence            47888999999999999998753     46789999986542    357889999999999999999999876543    


Q ss_pred             EEEEEEeecCCCCHHHHHHHcC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-c
Q 015500           73 MYNLFMEYAPGGTLNDEIHRNG-------------GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-A  138 (405)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~i~~~~-------------~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-v  138 (405)
                      ..+++|||++|++|.+++...+             ..+++..+..++.||+.||.|||++|++||||||+||+++.++ +
T Consensus        82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeE
Confidence            2679999999999999997643             2478899999999999999999999999999999999999888 9


Q ss_pred             eEeeecccccccc------cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhc
Q 015500          139 KIADFGCAKWESE------ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYS  211 (405)
Q Consensus       139 kL~DFGla~~~~~------~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~  211 (405)
                      ||+|||+++....      .....+++.|+|||++.+..+++++|||||||++|||++ |..||.... .......+. .
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~-~~~~~~~~~-~  239 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLS-NEEVIECIT-Q  239 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCC-HHHHHHHHH-c
Confidence            9999999875322      112335778999999999999999999999999999998 999996543 333333333 3


Q ss_pred             CCCCCCchhccHHHHHHHHHhcccCccccCCHHHHhc
Q 015500          212 RELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLK  248 (405)
Q Consensus       212 ~~~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~  248 (405)
                      ...+..+..++..+.+++.+||+.||++|||+.++++
T Consensus       240 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         240 GRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             CCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            4444556678999999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.6e-41  Score=323.67  Aligned_cols=246  Identities=29%  Similarity=0.380  Sum_probs=197.1

Q ss_pred             cccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC----hHHHHHHHHHHHhCC-CCCeeeeeeeeeecCCCceEEEEE
Q 015500            3 WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK----SEFLQREQKFLSSLN-SPHIVGYKGCDVTSEDNKLMYNLF   77 (405)
Q Consensus         3 y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~----~~~l~~E~~iL~~L~-hpnIv~~~~~~~~~~~~~~~~~lv   77 (405)
                      |++.+.||+|+||.||+|.+..+++.+|+|.+....    .....+|+.+++++. ||||+++++++.....+  .+++|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~--~~~lv   78 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTG--RLALV   78 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCC--cEEEE
Confidence            788999999999999999999999999999876431    123457888999985 99999999987654322  35699


Q ss_pred             EeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCCceEeeeccccccccc---cc
Q 015500           78 MEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGAKIADFGCAKWESEA---LQ  154 (405)
Q Consensus        78 ~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~vkL~DFGla~~~~~~---~~  154 (405)
                      |||+++ +|.+.+....+.+++..+..++.||+.||.|||+.|++||||||+||+++...+||+|||+++.....   ..
T Consensus        79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~~~~kl~dfg~~~~~~~~~~~~~  157 (282)
T cd07831          79 FELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKDDILKLADFGSCRGIYSKPPYTE  157 (282)
T ss_pred             EecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcCCCeEEEecccccccccCCCcCC
Confidence            999974 88888877656899999999999999999999999999999999999999933999999998764332   23


Q ss_pred             CCCCCCccChhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhc-C------------------CC
Q 015500          155 SGGTPMFMAPEVARG-EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYS-R------------------EL  214 (405)
Q Consensus       155 ~~gt~~Y~APE~l~~-~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~-~------------------~~  214 (405)
                      ..+++.|+|||.+.+ ..++.++|||||||++|||++|..||...+. ......+... .                  ..
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (282)
T cd07831         158 YISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE-LDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNF  236 (282)
T ss_pred             CCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH-HHHHHHHHHHcCCCCHHHHHhhcccccccccC
Confidence            457899999998754 5578899999999999999999999965432 2221111100 0                  00


Q ss_pred             C--------CCchhccHHHHHHHHHhcccCccccCCHHHHhcCccc
Q 015500          215 P--------EVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFL  252 (405)
Q Consensus       215 ~--------~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~  252 (405)
                      +        .....++..+.+||++||.++|.+|||++++++||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         237 PSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             cccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence            0        0112468999999999999999999999999999997

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=2.9e-41  Score=316.82  Aligned_cols=237  Identities=25%  Similarity=0.397  Sum_probs=203.1

Q ss_pred             cccceeCCeeEEEEEEcCC---CCEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEe
Q 015500            7 HTIGQGSSATVSLATSLRS---GDVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFME   79 (405)
Q Consensus         7 ~~LG~G~~g~Vyla~~~~~---~~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (405)
                      +.||+|+||.||+|.+...   +..+++|.+....    .+.+.+|+++++.++||||+++++++....    .++++||
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~----~~~lv~e   76 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEE----PLYLVLE   76 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCC----ceEEEEE
Confidence            5799999999999999866   8999999987543    467889999999999999999998776522    3679999


Q ss_pred             ecCCCCHHHHHHHc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccc
Q 015500           80 YAPGGTLNDEIHRN--------GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWES  150 (405)
Q Consensus        80 y~~ggsL~~~i~~~--------~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~  150 (405)
                      |+++++|.+++...        +..+++..+..++.|++.||+|||++|++||||||+||+++.++ +||+|||.+....
T Consensus        77 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~  156 (262)
T cd00192          77 YMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVY  156 (262)
T ss_pred             eccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccc
Confidence            99999999999876        46899999999999999999999999999999999999999987 9999999998654


Q ss_pred             c------cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccH
Q 015500          151 E------ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSK  223 (405)
Q Consensus       151 ~------~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~  223 (405)
                      .      .....+++.|+|||.+.+..++.++|||||||++|+|++ |..||... ........+.. ......|..++.
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~-~~~~~~~~~~~-~~~~~~~~~~~~  234 (262)
T cd00192         157 DDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL-SNEEVLEYLRK-GYRLPKPEYCPD  234 (262)
T ss_pred             cccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHHc-CCCCCCCccCCh
Confidence            3      223457889999999998889999999999999999999 69999655 33333333332 444566777899


Q ss_pred             HHHHHHHHhcccCccccCCHHHHhcC
Q 015500          224 QANDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       224 ~l~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      ++.+++.+||+.+|.+|||+.|++++
T Consensus       235 ~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         235 ELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             HHHHHHHHHccCCcccCcCHHHHHHh
Confidence            99999999999999999999999876

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-41  Score=323.49  Aligned_cols=246  Identities=33%  Similarity=0.548  Sum_probs=205.3

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC----ChHHHHHHHHHHHhCC---CCCeeeeeeeeeecCCCceEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP----KSEFLQREQKFLSSLN---SPHIVGYKGCDVTSEDNKLMY   74 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~----~~~~l~~E~~iL~~L~---hpnIv~~~~~~~~~~~~~~~~   74 (405)
                      .|...+.||+|+||.||+|.+..+++.+|+|.+...    ..+.+.+|+.++++++   |||++++++++....    .+
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~----~~   77 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGP----RL   77 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCC----EE
Confidence            488899999999999999999999999999987643    2356889999999996   999999998765432    36


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc-
Q 015500           75 NLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA-  152 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~-  152 (405)
                      +++|||++|++|.+++...  .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ ++|+|||++...... 
T Consensus        78 ~lv~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06917          78 WIIMEYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS  155 (277)
T ss_pred             EEEEecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence            7999999999999998653  799999999999999999999999999999999999999887 999999998764332 


Q ss_pred             ---ccCCCCCCccChhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchh-ccHHHHH
Q 015500          153 ---LQSGGTPMFMAPEVARG-EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAF-LSKQAND  227 (405)
Q Consensus       153 ---~~~~gt~~Y~APE~l~~-~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~-~s~~l~d  227 (405)
                         ....|++.|+|||.+.+ ..++.++|+|||||++|+|++|..||..... ......+. ....+.++.. ++.++.+
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~  233 (277)
T cd06917         156 SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA-FRAMMLIP-KSKPPRLEDNGYSKLLRE  233 (277)
T ss_pred             cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh-hhhhhccc-cCCCCCCCcccCCHHHHH
Confidence               23458899999999875 4578899999999999999999999965432 22222221 2233444443 7889999


Q ss_pred             HHHHhcccCccccCCHHHHhcCcccccc
Q 015500          228 FLSNCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       228 ll~~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      |+.+||+.||++|||+.++++||||++.
T Consensus       234 ~i~~~l~~~p~~R~~~~~il~~~~~~~~  261 (277)
T cd06917         234 FVAACLDEEPKERLSAEELLKSKWIKAH  261 (277)
T ss_pred             HHHHHcCCCcccCcCHHHHhhChHhhcc
Confidence            9999999999999999999999999764

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=8.3e-42  Score=326.65  Aligned_cols=245  Identities=34%  Similarity=0.501  Sum_probs=200.2

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC-----ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP-----KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~-----~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      +|...+.||+|+||+||+|.++.+++.+|+|.+...     ..+.+.+|+++++.++||||+++++++....    .+++
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~l   77 (286)
T cd07846           2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKK----RLYL   77 (286)
T ss_pred             ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCC----eEEE
Confidence            588999999999999999999999999999987542     2346788999999999999999998875432    3679


Q ss_pred             EEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc---
Q 015500           77 FMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA---  152 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~---  152 (405)
                      ++||+++++|.++.... +.+++..+..++.||+.||+|||+.|++|+||+|+||+++.++ ++|+|||++......   
T Consensus        78 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~  156 (286)
T cd07846          78 VFEFVDHTVLDDLEKYP-NGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV  156 (286)
T ss_pred             EEecCCccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccc
Confidence            99999998888776554 4699999999999999999999999999999999999999887 999999998754331   


Q ss_pred             -ccCCCCCCccChhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHh--------------------
Q 015500          153 -LQSGGTPMFMAPEVARG-EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAY--------------------  210 (405)
Q Consensus       153 -~~~~gt~~Y~APE~l~~-~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~--------------------  210 (405)
                       ....+++.|+|||.+.+ ..++.++|||||||++|+|++|++||..... .....++..                    
T Consensus       157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T cd07846         157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD-IDQLYHIIKCLGNLIPRHQEIFQKNPLFA  235 (286)
T ss_pred             cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCch-HHHHHHHHHHhCCCchhhHHHhccchHhh
Confidence             22347889999999876 4578899999999999999999999964432 222222111                    


Q ss_pred             cCCCCC---------CchhccHHHHHHHHHhcccCccccCCHHHHhcCccc
Q 015500          211 SRELPE---------VPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFL  252 (405)
Q Consensus       211 ~~~~~~---------~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~  252 (405)
                      ....+.         .+..++..+.+|+.+||..+|.+|||+.++++||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         236 GMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             ccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence            001111         123468899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=2e-41  Score=320.87  Aligned_cols=243  Identities=27%  Similarity=0.441  Sum_probs=202.3

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC------ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~------~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~   75 (405)
                      +|.+.+.||+|+||.||+|.+..+++.+|||.+...      ....+.+|+.+++.++||||+++++++....    .++
T Consensus         3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~----~~~   78 (267)
T cd08229           3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN----ELN   78 (267)
T ss_pred             hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCC----eEE
Confidence            688999999999999999999999999999976542      2246778999999999999999998876543    366


Q ss_pred             EEEeecCCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc
Q 015500           76 LFMEYAPGGTLNDEIHR---NGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE  151 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~---~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~  151 (405)
                      ++|||++|++|.+++..   ....+++..+..++.||+.||.|||++|++|+||||+||+++.++ ++|+|||++.....
T Consensus        79 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          79 IVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            99999999999998864   234689999999999999999999999999999999999999887 99999999875433


Q ss_pred             c----ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCC-CchhccHHHH
Q 015500          152 A----LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPE-VPAFLSKQAN  226 (405)
Q Consensus       152 ~----~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~-~p~~~s~~l~  226 (405)
                      .    ....|++.|+|||.+.+..++.++|+||||+++|+|++|..||...........+.......+. .+..+++.+.
T Consensus       159 ~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (267)
T cd08229         159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELR  238 (267)
T ss_pred             CCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHH
Confidence            2    2346899999999999988999999999999999999999999654433223222222222333 3346889999


Q ss_pred             HHHHHhcccCccccCCHHHHhc
Q 015500          227 DFLSNCLRRDPKERWAASQLLK  248 (405)
Q Consensus       227 dll~~~L~~dP~~Rpt~~elL~  248 (405)
                      +++.+||+.||.+|||+.++++
T Consensus       239 ~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         239 QLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             HHHHHhcCCCcccCCCHHHHHH
Confidence            9999999999999999998865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=2.6e-41  Score=319.36  Aligned_cols=241  Identities=23%  Similarity=0.335  Sum_probs=200.1

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC--hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEe
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK--SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFME   79 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~--~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (405)
                      +|++.+.||+|+||+||+|.+.. +..+|+|.+....  .+.+.+|+.++++++||||+++++++.....    ++++||
T Consensus         5 ~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~lv~e   79 (256)
T cd05113           5 DLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRP----IYIVTE   79 (256)
T ss_pred             HeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCC----cEEEEE
Confidence            48899999999999999998753 4569999877543  4578899999999999999999998654332    569999


Q ss_pred             ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccccc-----
Q 015500           80 YAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEAL-----  153 (405)
Q Consensus        80 y~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~~-----  153 (405)
                      |+++|+|.+++......+++..+..++.||+.||.|||+.|++|+||||.||+++.++ +||+|||+++......     
T Consensus        80 ~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~  159 (256)
T cd05113          80 YMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSV  159 (256)
T ss_pred             cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceeecC
Confidence            9999999999987656799999999999999999999999999999999999999887 9999999987543211     


Q ss_pred             cCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHh
Q 015500          154 QSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNC  232 (405)
Q Consensus       154 ~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~  232 (405)
                      ...++..|+|||.+.+..++.++|||||||++|+|++ |..||..... ......+.. ...+..+...++.+.+++.+|
T Consensus       160 ~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~li~~c  237 (256)
T cd05113         160 GSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN-SETVEKVSQ-GLRLYRPHLASEKVYAIMYSC  237 (256)
T ss_pred             CCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH-HHHHHHHhc-CCCCCCCCCCCHHHHHHHHHH
Confidence            1224567999999998889999999999999999999 9999965443 233333332 233344556789999999999


Q ss_pred             cccCccccCCHHHHhcC
Q 015500          233 LRRDPKERWAASQLLKH  249 (405)
Q Consensus       233 L~~dP~~Rpt~~elL~h  249 (405)
                      |..+|.+|||+.+++++
T Consensus       238 l~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         238 WHEKAEERPTFQQLLSS  254 (256)
T ss_pred             cCCCcccCCCHHHHHHh
Confidence            99999999999999875

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-41  Score=315.64  Aligned_cols=244  Identities=40%  Similarity=0.685  Sum_probs=211.6

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      +|++.+.||+|++|.||+|.+..+++.+++|.+....     .+.+.+|++++++++|||++++.+++....    .+++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~~   76 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSD----SLYI   76 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCC----EEEE
Confidence            5889999999999999999999999999999886543     357889999999999999999998765432    3679


Q ss_pred             EEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccccc--
Q 015500           77 FMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEAL--  153 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~~--  153 (405)
                      +|||+++++|.+++.+. +++++..+..++.|++.||.|||+.|++||||||+||+++.++ ++|+|||++.......  
T Consensus        77 v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  155 (254)
T cd06627          77 ILEYAENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD  155 (254)
T ss_pred             EEecCCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence            99999999999999876 5899999999999999999999999999999999999999877 9999999988654422  


Q ss_pred             --cCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHH
Q 015500          154 --QSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSN  231 (405)
Q Consensus       154 --~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~  231 (405)
                        ...+++.|+|||.+.+..++.++|+||||+++|+|++|..||.... ......... ....+..+..+++.+.+++.+
T Consensus       156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~  233 (254)
T cd06627         156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN-PMAALFRIV-QDDHPPLPEGISPELKDFLMQ  233 (254)
T ss_pred             ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc-HHHHHHHHh-ccCCCCCCCCCCHHHHHHHHH
Confidence              3458899999999988888999999999999999999999996544 333333333 344556777889999999999


Q ss_pred             hcccCccccCCHHHHhcCccc
Q 015500          232 CLRRDPKERWAASQLLKHPFL  252 (405)
Q Consensus       232 ~L~~dP~~Rpt~~elL~hp~~  252 (405)
                      ||..+|++|||+.+++.||||
T Consensus       234 ~l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         234 CFQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             HHhCChhhCcCHHHHhcCCCC
Confidence            999999999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.2e-41  Score=335.68  Aligned_cols=244  Identities=24%  Similarity=0.368  Sum_probs=199.7

Q ss_pred             CcccccccceeCCeeEEEEEEcC-----CCCEEEEEEccCCC----hHHHHHHHHHHHhC-CCCCeeeeeeeeeecCCCc
Q 015500            2 DWTRGHTIGQGSSATVSLATSLR-----SGDVFAAKSTELPK----SEFLQREQKFLSSL-NSPHIVGYKGCDVTSEDNK   71 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~-----~~~~vavK~~~~~~----~~~l~~E~~iL~~L-~hpnIv~~~~~~~~~~~~~   71 (405)
                      +|++++.||+|+||.||+|.+..     +++.||+|.+....    ...+.+|+.+++++ +||||+++++++.....  
T Consensus         8 ~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~--   85 (337)
T cd05054           8 RLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG--   85 (337)
T ss_pred             HhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC--
Confidence            48899999999999999997543     45789999886432    23577899999999 89999999987654432  


Q ss_pred             eEEEEEEeecCCCCHHHHHHHcC---------------------------------------------------------
Q 015500           72 LMYNLFMEYAPGGTLNDEIHRNG---------------------------------------------------------   94 (405)
Q Consensus        72 ~~~~lv~Ey~~ggsL~~~i~~~~---------------------------------------------------------   94 (405)
                       .++++|||+++++|.+++....                                                         
T Consensus        86 -~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (337)
T cd05054          86 -PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE  164 (337)
T ss_pred             -CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence             3568999999999999986431                                                         


Q ss_pred             ---CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc------cccCCCCCCccCh
Q 015500           95 ---GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE------ALQSGGTPMFMAP  164 (405)
Q Consensus        95 ---~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~------~~~~~gt~~Y~AP  164 (405)
                         .++++..+..++.||+.||+|||++||+||||||+|||++.++ +||+|||+++....      .....++..|+||
T Consensus       165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP  244 (337)
T cd05054         165 LYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP  244 (337)
T ss_pred             HhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCc
Confidence               2678999999999999999999999999999999999999887 99999999976432      1123456789999


Q ss_pred             hhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHhcccCccccCCH
Q 015500          165 EVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAA  243 (405)
Q Consensus       165 E~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~  243 (405)
                      |++.+..++.++|||||||++|||++ |..||...... ..+.........+..|...++++.+++.+||+.+|++||++
T Consensus       245 E~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~  323 (337)
T cd05054         245 ESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID-EEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTF  323 (337)
T ss_pred             HHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc-HHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCcCH
Confidence            99999999999999999999999998 99999654322 22333333334445566788999999999999999999999


Q ss_pred             HHHhcC
Q 015500          244 SQLLKH  249 (405)
Q Consensus       244 ~elL~h  249 (405)
                      .++++|
T Consensus       324 ~ell~~  329 (337)
T cd05054         324 SELVEI  329 (337)
T ss_pred             HHHHHH
Confidence            999987

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.8e-41  Score=319.20  Aligned_cols=239  Identities=33%  Similarity=0.537  Sum_probs=201.6

Q ss_pred             cceeCCeeEEEEEEcCCCCEEEEEEccCCC------hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEeecC
Q 015500            9 IGQGSSATVSLATSLRSGDVFAAKSTELPK------SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAP   82 (405)
Q Consensus         9 LG~G~~g~Vyla~~~~~~~~vavK~~~~~~------~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~Ey~~   82 (405)
                      ||+|+||.||+|.+..+|+.+++|.+....      .+.+.+|++++++++||||+++++.+....    .+++++||++
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~----~~~lv~e~~~   76 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKK----NLYLVMEYLP   76 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCc----EEEEEEecCC
Confidence            699999999999999999999999886532      357888999999999999999988764332    3679999999


Q ss_pred             CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc---------
Q 015500           83 GGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA---------  152 (405)
Q Consensus        83 ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~---------  152 (405)
                      +++|.+++.+.+ .+++..+..++.||+.||.|||++|++|+||+|+||+++.++ ++|+|||++......         
T Consensus        77 ~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  155 (265)
T cd05579          77 GGDLASLLENVG-SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE  155 (265)
T ss_pred             CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence            999999998764 899999999999999999999999999999999999999888 999999998753221         


Q ss_pred             ---ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchh--ccHHHHH
Q 015500          153 ---LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAF--LSKQAND  227 (405)
Q Consensus       153 ---~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~--~s~~l~d  227 (405)
                         ....+++.|+|||.+.+...+.++|+||||+++|+|++|..||... ........+....  ...|..  ++..+.+
T Consensus       156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~-~~~~~~~~~~~~~--~~~~~~~~~~~~~~~  232 (265)
T cd05579         156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGE-TPEEIFQNILNGK--IEWPEDVEVSDEAID  232 (265)
T ss_pred             ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhcCC--cCCCccccCCHHHHH
Confidence               2234788999999999888999999999999999999999999544 3344444433322  223333  4899999


Q ss_pred             HHHHhcccCccccCCH---HHHhcCcccccc
Q 015500          228 FLSNCLRRDPKERWAA---SQLLKHPFLEEF  255 (405)
Q Consensus       228 ll~~~L~~dP~~Rpt~---~elL~hp~~~~~  255 (405)
                      |+++||+.+|++|||+   .++|+||||+++
T Consensus       233 ~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~  263 (265)
T cd05579         233 LISKLLVPDPEKRLGAKSIEEIKNHPFFKGI  263 (265)
T ss_pred             HHHHHhcCCHhhcCCCccHHHHhcCccccCC
Confidence            9999999999999999   999999999864

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=4.5e-41  Score=317.82  Aligned_cols=243  Identities=30%  Similarity=0.491  Sum_probs=204.1

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC------ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~------~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~   75 (405)
                      +|+..+.||.|+||.||+|.+..+|+.+|+|.+...      ..+.+.+|++++++++||||+++++.+....    .++
T Consensus         3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~----~~~   78 (267)
T cd08224           3 NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENN----ELN   78 (267)
T ss_pred             ceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCC----eEE
Confidence            589999999999999999999999999999977531      2457889999999999999999999876543    366


Q ss_pred             EEEeecCCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc
Q 015500           76 LFMEYAPGGTLNDEIHR---NGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE  151 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~---~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~  151 (405)
                      ++|||+++++|.+++..   .+..+++..+..++.||+.||.|||+.|++||||||+||+++.++ ++|+|||++.....
T Consensus        79 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          79 IVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            99999999999999864   234689999999999999999999999999999999999999887 99999999875433


Q ss_pred             ----cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCch-hccHHHH
Q 015500          152 ----ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPA-FLSKQAN  226 (405)
Q Consensus       152 ----~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~-~~s~~l~  226 (405)
                          .....+++.|+|||.+.+..++.++|+|||||++|+|++|+.||.........+.........+..|. .++..+.
T Consensus       159 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (267)
T cd08224         159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELR  238 (267)
T ss_pred             CCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHH
Confidence                22345899999999999888999999999999999999999999654433322322222334444554 6888999


Q ss_pred             HHHHHhcccCccccCCHHHHhc
Q 015500          227 DFLSNCLRRDPKERWAASQLLK  248 (405)
Q Consensus       227 dll~~~L~~dP~~Rpt~~elL~  248 (405)
                      ++|.+||..+|++|||+.++++
T Consensus       239 ~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         239 DLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             HHHHHHcCCCcccCCCHHHHHH
Confidence            9999999999999999999876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=8.6e-42  Score=335.56  Aligned_cols=253  Identities=29%  Similarity=0.387  Sum_probs=205.7

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC-----ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP-----KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~-----~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      +|.+.+.||+|+||.||+|.++.+|+.||+|.+...     ....+.+|+.+|++++||||+++++++.........+++
T Consensus         6 ~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l   85 (334)
T cd07855           6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYV   85 (334)
T ss_pred             ceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEE
Confidence            588999999999999999999999999999987643     235677899999999999999999876654444445679


Q ss_pred             EEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc---
Q 015500           77 FMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA---  152 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~---  152 (405)
                      ||||+. ++|.+++... +.+++..+..++.||+.||.|||++|++||||||+||+++.++ +||+|||++......   
T Consensus        86 v~e~~~-~~l~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~  163 (334)
T cd07855          86 VMDLME-SDLHHIIHSD-QPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTE  163 (334)
T ss_pred             EEehhh-hhHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCcC
Confidence            999995 5899888765 4699999999999999999999999999999999999999988 999999998754321   


Q ss_pred             -----ccCCCCCCccChhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHh----------------
Q 015500          153 -----LQSGGTPMFMAPEVARG-EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAY----------------  210 (405)
Q Consensus       153 -----~~~~gt~~Y~APE~l~~-~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~----------------  210 (405)
                           ....|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||....... .+..+..                
T Consensus       164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~-~~~~~~~~~g~~~~~~~~~~~~~  242 (334)
T cd07855         164 HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVH-QLKLILSVLGSPSEEVLNRIGSD  242 (334)
T ss_pred             CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHH-HHHHHHHHhCCChhHhhhhhchh
Confidence                 12358899999999866 468899999999999999999999996543221 1111100                


Q ss_pred             --------cCCCCCC-----chhccHHHHHHHHHhcccCccccCCHHHHhcCcccccccc
Q 015500          211 --------SRELPEV-----PAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCS  257 (405)
Q Consensus       211 --------~~~~~~~-----p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~~  257 (405)
                              ....+..     ....++++.++|++||+.+|.+|||+++++.||||++...
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~  302 (334)
T cd07855         243 RVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHD  302 (334)
T ss_pred             hHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccC
Confidence                    0011111     1336889999999999999999999999999999987643

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=3.1e-41  Score=322.35  Aligned_cols=241  Identities=23%  Similarity=0.334  Sum_probs=199.7

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCC----EEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGD----VFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLM   73 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~----~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~   73 (405)
                      +|...+.||+|+||+||+|.+..+++    .||+|......    ...+.+|+.+++.+.||||+++++.+....     
T Consensus         8 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-----   82 (279)
T cd05109           8 ELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTST-----   82 (279)
T ss_pred             heeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCCC-----
Confidence            57889999999999999999877776    47999876432    346778999999999999999998765322     


Q ss_pred             EEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc
Q 015500           74 YNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA  152 (405)
Q Consensus        74 ~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~  152 (405)
                      .++++||+++|+|.+++..+.+.+++..+..++.||+.||.|||++||+||||||+|||++.++ +||+|||+++.....
T Consensus        83 ~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~  162 (279)
T cd05109          83 VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDID  162 (279)
T ss_pred             cEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecccc
Confidence            4489999999999999987666899999999999999999999999999999999999998877 999999999764321


Q ss_pred             c------cCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHH
Q 015500          153 L------QSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQA  225 (405)
Q Consensus       153 ~------~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l  225 (405)
                      .      ...+++.|+|||.+.+..++.++|||||||++|||++ |..||.... .... .........+..+..++.++
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~  240 (279)
T cd05109         163 ETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP-AREI-PDLLEKGERLPQPPICTIDV  240 (279)
T ss_pred             cceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC-HHHH-HHHHHCCCcCCCCccCCHHH
Confidence            1      1224678999999998889999999999999999998 999995432 2222 22233333444566789999


Q ss_pred             HHHHHHhcccCccccCCHHHHhcC
Q 015500          226 NDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       226 ~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      .+++.+||..||.+||++.++++.
T Consensus       241 ~~li~~~l~~dp~~Rp~~~~l~~~  264 (279)
T cd05109         241 YMIMVKCWMIDSECRPRFRELVDE  264 (279)
T ss_pred             HHHHHHHcCCChhhCcCHHHHHHH
Confidence            999999999999999999999853

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=5.7e-41  Score=327.38  Aligned_cols=247  Identities=36%  Similarity=0.535  Sum_probs=208.9

Q ss_pred             cccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC------hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEE
Q 015500            3 WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK------SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         3 y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~------~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      |...+.||+|+||+||+|++..++..+|+|.+....      ...+.+|+++++.++|||++++++++.....    +++
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~----~~l  102 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHT----AWL  102 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCe----EEE
Confidence            678889999999999999999999999999876431      2367889999999999999999998765432    669


Q ss_pred             EEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccccccC
Q 015500           77 FMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQS  155 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~~~~  155 (405)
                      ||||++| +|.+.+.....++++..+..++.||+.||.|||++|++||||+|+||+++.++ +||+|||++.........
T Consensus       103 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~  181 (317)
T cd06635         103 VMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSF  181 (317)
T ss_pred             EEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCCcccc
Confidence            9999975 88888876666899999999999999999999999999999999999998887 999999998766655566


Q ss_pred             CCCCCccChhhhc---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHh
Q 015500          156 GGTPMFMAPEVAR---GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNC  232 (405)
Q Consensus       156 ~gt~~Y~APE~l~---~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~  232 (405)
                      .|++.|+|||.+.   ...++.++|+|||||++|+|++|+.||... +.......+......+..+..+++.+++|+.+|
T Consensus       182 ~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  260 (317)
T cd06635         182 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNESPTLQSNEWSDYFRNFVDSC  260 (317)
T ss_pred             cCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCc-cHHHHHHHHHhccCCCCCCccccHHHHHHHHHH
Confidence            7999999999974   456788999999999999999999999654 334444444444333333456788999999999


Q ss_pred             cccCccccCCHHHHhcCcccccc
Q 015500          233 LRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       233 L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      |+.+|.+||++.++++|+|+...
T Consensus       261 l~~~p~~Rpt~~~il~~~~~~~~  283 (317)
T cd06635         261 LQKIPQDRPTSEELLKHMFVLRE  283 (317)
T ss_pred             ccCCcccCcCHHHHHhChhhhcc
Confidence            99999999999999999999653

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=2.9e-41  Score=322.19  Aligned_cols=242  Identities=22%  Similarity=0.303  Sum_probs=197.9

Q ss_pred             CcccccccceeCCeeEEEEEEcC-----CCCEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCce
Q 015500            2 DWTRGHTIGQGSSATVSLATSLR-----SGDVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKL   72 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~-----~~~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~   72 (405)
                      +|+..+.||+|+||+||+|.++.     ++..+|+|.+....    ...+.+|+.+++.++||||+++++++....    
T Consensus         7 ~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~----   82 (277)
T cd05062           7 KITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ----   82 (277)
T ss_pred             HceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC----
Confidence            58899999999999999998652     35679999875432    235778999999999999999998764332    


Q ss_pred             EEEEEEeecCCCCHHHHHHHcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEee
Q 015500           73 MYNLFMEYAPGGTLNDEIHRNG---------GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIAD  142 (405)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~i~~~~---------~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~D  142 (405)
                      .++++|||+++++|.+++.+..         ..++...+..++.|++.||.|||+.|++||||||+||+++.++ +||+|
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~d  162 (277)
T cd05062          83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGD  162 (277)
T ss_pred             CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEECC
Confidence            2568999999999999997632         1357788999999999999999999999999999999999887 99999


Q ss_pred             eccccccccc------ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCC
Q 015500          143 FGCAKWESEA------LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELP  215 (405)
Q Consensus       143 FGla~~~~~~------~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~  215 (405)
                      ||+++.....      ....+++.|+|||++.+..+++++|||||||++|||++ |..||.... ..... +.......+
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~-~~~~~-~~~~~~~~~  240 (277)
T cd05062         163 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS-NEQVL-RFVMEGGLL  240 (277)
T ss_pred             CCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC-HHHHH-HHHHcCCcC
Confidence            9998754321      12335778999999999889999999999999999999 789996543 23333 333334455


Q ss_pred             CCchhccHHHHHHHHHhcccCccccCCHHHHhcC
Q 015500          216 EVPAFLSKQANDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       216 ~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      ..+..+++.+.+++.+||+.||++|||+.+++++
T Consensus       241 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         241 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            6677789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=5e-41  Score=327.36  Aligned_cols=247  Identities=36%  Similarity=0.535  Sum_probs=206.0

Q ss_pred             cccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC------hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEE
Q 015500            3 WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK------SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         3 y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~------~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      |...+.||+|+||+||+|++..+++.+++|.+....      ...+.+|+++++.++|||++++.+++....    ..++
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~l   98 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEH----TAWL   98 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCC----EEEE
Confidence            445678999999999999999999999999876421      245778999999999999999999876543    3669


Q ss_pred             EEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccccccC
Q 015500           77 FMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQS  155 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~~~~  155 (405)
                      +|||+. |+|.+++.....++++..+..++.||+.||.|||++|++|+||||+||+++.++ +||+|||++.........
T Consensus        99 v~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~~~~  177 (313)
T cd06633          99 VMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSF  177 (313)
T ss_pred             EEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCCCCCc
Confidence            999996 588888877666899999999999999999999999999999999999999887 999999998765555556


Q ss_pred             CCCCCccChhhhc---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHh
Q 015500          156 GGTPMFMAPEVAR---GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNC  232 (405)
Q Consensus       156 ~gt~~Y~APE~l~---~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~  232 (405)
                      .|++.|+|||.+.   ...++.++|||||||++|+|++|..||.... ......++............++..+++|+.+|
T Consensus       178 ~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  256 (313)
T cd06633         178 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-AMSALYHIAQNDSPTLQSNEWTDSFRGFVDYC  256 (313)
T ss_pred             cccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHhcCCCCCCccccCHHHHHHHHHH
Confidence            7899999999984   3567889999999999999999999996543 34444444333322222345778899999999


Q ss_pred             cccCccccCCHHHHhcCcccccc
Q 015500          233 LRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       233 L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      |+.+|.+||++.+++.||||+..
T Consensus       257 l~~~P~~Rp~~~~~l~~~~~~~~  279 (313)
T cd06633         257 LQKIPQERPASAELLRHDFVRRD  279 (313)
T ss_pred             ccCChhhCcCHHHHhcCcccCCC
Confidence            99999999999999999999853

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=4.2e-41  Score=323.38  Aligned_cols=241  Identities=26%  Similarity=0.408  Sum_probs=200.1

Q ss_pred             CcccccccceeCCeeEEEEEEc-----CCCCEEEEEEccCCC---hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceE
Q 015500            2 DWTRGHTIGQGSSATVSLATSL-----RSGDVFAAKSTELPK---SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLM   73 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~-----~~~~~vavK~~~~~~---~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~   73 (405)
                      +|.+.+.||+|+||+||++.+.     .++..+|+|.+....   ...+.+|+.++++++||||+++++++....    .
T Consensus         6 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~   81 (288)
T cd05093           6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD----P   81 (288)
T ss_pred             HeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC----c
Confidence            5889999999999999999853     345678999886543   346889999999999999999998876433    3


Q ss_pred             EEEEEeecCCCCHHHHHHHcC------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceE
Q 015500           74 YNLFMEYAPGGTLNDEIHRNG------------GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKI  140 (405)
Q Consensus        74 ~~lv~Ey~~ggsL~~~i~~~~------------~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL  140 (405)
                      ++++|||+++++|.+++...+            ..+++..+..++.||+.||+|||++|++||||||+||+++.++ +||
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl  161 (288)
T cd05093          82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKI  161 (288)
T ss_pred             cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEe
Confidence            679999999999999997543            2489999999999999999999999999999999999999888 999


Q ss_pred             eeeccccccccc------ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCC
Q 015500          141 ADFGCAKWESEA------LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRE  213 (405)
Q Consensus       141 ~DFGla~~~~~~------~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~  213 (405)
                      +|||+++.....      ....+++.|+|||++.+..++.++|||||||++|+|++ |..||.... .......+. ...
T Consensus       162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~-~~~~~~~i~-~~~  239 (288)
T cd05093         162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS-NNEVIECIT-QGR  239 (288)
T ss_pred             ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHHH-cCC
Confidence            999998754321      12335778999999999899999999999999999998 999995443 334444443 333


Q ss_pred             CCCCchhccHHHHHHHHHhcccCccccCCHHHHhc
Q 015500          214 LPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLK  248 (405)
Q Consensus       214 ~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~  248 (405)
                      .+..+..++.++.+|+.+||+.||.+|||+.++++
T Consensus       240 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         240 VLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            44556678899999999999999999999999954

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=2.1e-41  Score=319.61  Aligned_cols=240  Identities=23%  Similarity=0.323  Sum_probs=202.7

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC---hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK---SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFM   78 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~---~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (405)
                      +|++++.||.|+||+||+|.++. +..+|+|.+....   ...+.+|+.+++.++||||+++++.+.....    ++++|
T Consensus         7 ~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~----~~lv~   81 (261)
T cd05148           7 EFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEP----VYIIT   81 (261)
T ss_pred             HHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCC----eEEEE
Confidence            68999999999999999999987 8999999987543   4578899999999999999999987654432    66999


Q ss_pred             eecCCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc----
Q 015500           79 EYAPGGTLNDEIHRN-GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA----  152 (405)
Q Consensus        79 Ey~~ggsL~~~i~~~-~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~----  152 (405)
                      ||+++++|.+++... +..+++..+..++.||+.||.|||++|++|+||||+||+++.++ +||+|||.+......    
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~  161 (261)
T cd05148          82 ELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLS  161 (261)
T ss_pred             eecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCccccc
Confidence            999999999999763 34689999999999999999999999999999999999999887 999999998754331    


Q ss_pred             ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHH
Q 015500          153 LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSN  231 (405)
Q Consensus       153 ~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~  231 (405)
                      ....+++.|+|||.+.+..++.++|||||||++|+|++ |+.||.... ....+..+. ....+..+..+++.+.+++.+
T Consensus       162 ~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~  239 (261)
T cd05148         162 SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN-NHEVYDQIT-AGYRMPCPAKCPQEIYKIMLE  239 (261)
T ss_pred             cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC-HHHHHHHHH-hCCcCCCCCCCCHHHHHHHHH
Confidence            12235678999999998889999999999999999998 899996443 334444443 223344566789999999999


Q ss_pred             hcccCccccCCHHHHhc
Q 015500          232 CLRRDPKERWAASQLLK  248 (405)
Q Consensus       232 ~L~~dP~~Rpt~~elL~  248 (405)
                      ||+.||.+|||+.++++
T Consensus       240 ~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         240 CWAAEPEDRPSFKALRE  256 (261)
T ss_pred             HcCCCchhCcCHHHHHH
Confidence            99999999999999976

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=3.6e-41  Score=322.61  Aligned_cols=242  Identities=22%  Similarity=0.292  Sum_probs=199.6

Q ss_pred             CcccccccceeCCeeEEEEEEc----CCCCEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceE
Q 015500            2 DWTRGHTIGQGSSATVSLATSL----RSGDVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLM   73 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~----~~~~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~   73 (405)
                      +|++.+.||+|+||+||+|.+.    .++..+|+|.+....    ...+.+|+.++++++||||+++++++.....    
T Consensus         6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~----   81 (283)
T cd05090           6 AVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQP----   81 (283)
T ss_pred             hceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCc----
Confidence            4788899999999999999853    456789999886432    2468889999999999999999987654433    


Q ss_pred             EEEEEeecCCCCHHHHHHHcC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC
Q 015500           74 YNLFMEYAPGGTLNDEIHRNG----------------GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG  137 (405)
Q Consensus        74 ~~lv~Ey~~ggsL~~~i~~~~----------------~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~  137 (405)
                      .+++|||+++++|.+++....                ..+++..+..++.|++.||.|||++|++||||||+|||++.++
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~  161 (283)
T cd05090          82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQL  161 (283)
T ss_pred             eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCC
Confidence            569999999999999986431                2478899999999999999999999999999999999999887


Q ss_pred             -ceEeeecccccccc------cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHH
Q 015500          138 -AKIADFGCAKWESE------ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIA  209 (405)
Q Consensus       138 -vkL~DFGla~~~~~------~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~  209 (405)
                       +||+|||+++....      .....++..|+|||.+.+..++.++|+|||||++|||++ |..||.... .......+ 
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~-~~~~~~~~-  239 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS-NQEVIEMV-  239 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC-HHHHHHHH-
Confidence             99999999975422      122345678999999998889999999999999999998 999996443 33333333 


Q ss_pred             hcCCCCCCchhccHHHHHHHHHhcccCccccCCHHHHhcC
Q 015500          210 YSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       210 ~~~~~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      .....+..+..+++.+.+++.+||+.||.+||++.+++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         240 RKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             HcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            3344455677789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.9e-41  Score=327.63  Aligned_cols=249  Identities=32%  Similarity=0.456  Sum_probs=198.6

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCC----ce
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDN----KL   72 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~----~~   72 (405)
                      +|++.+.||+|+||.||+|.++.+++.+|+|.+....     .....+|++++++++||||+++++.+......    ..
T Consensus         9 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   88 (311)
T cd07866           9 DYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRG   88 (311)
T ss_pred             cEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCc
Confidence            6899999999999999999999999999999875321     23578899999999999999998876543321    23


Q ss_pred             EEEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc
Q 015500           73 MYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE  151 (405)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~  151 (405)
                      .++++|||+.+ +|...+......+++..++.++.||++||+|||++|++|+||||+||+++.++ +||+|||+++....
T Consensus        89 ~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  167 (311)
T cd07866          89 SVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDG  167 (311)
T ss_pred             eEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhccC
Confidence            56799999965 78877776556899999999999999999999999999999999999999888 99999999875332


Q ss_pred             cc---------------cCCCCCCccChhhhcCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhc-CC-
Q 015500          152 AL---------------QSGGTPMFMAPEVARGE-HQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYS-RE-  213 (405)
Q Consensus       152 ~~---------------~~~gt~~Y~APE~l~~~-~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~-~~-  213 (405)
                      ..               ...+++.|+|||.+.+. .++.++|||||||++|+|++|++||..... ......+... .. 
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~-~~~~~~~~~~~~~~  246 (311)
T cd07866         168 PPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSD-IDQLHLIFKLCGTP  246 (311)
T ss_pred             CCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCC
Confidence            11               12368889999988764 578899999999999999999999964433 2222221110 00 


Q ss_pred             ----------CC---------CCc-------hhccHHHHHHHHHhcccCccccCCHHHHhcCccc
Q 015500          214 ----------LP---------EVP-------AFLSKQANDFLSNCLRRDPKERWAASQLLKHPFL  252 (405)
Q Consensus       214 ----------~~---------~~p-------~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~  252 (405)
                                .+         ..+       ..+++.+.+||++||+.||.+|||+.+++.||||
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         247 TEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             ChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence                      00         011       1245788999999999999999999999999997

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=4.7e-41  Score=319.11  Aligned_cols=245  Identities=20%  Similarity=0.309  Sum_probs=198.7

Q ss_pred             cccccccceeCCeeEEEEEEcCCCC--EEEEEEccCC-----ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCC--CceE
Q 015500            3 WTRGHTIGQGSSATVSLATSLRSGD--VFAAKSTELP-----KSEFLQREQKFLSSLNSPHIVGYKGCDVTSED--NKLM   73 (405)
Q Consensus         3 y~~~~~LG~G~~g~Vyla~~~~~~~--~vavK~~~~~-----~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~--~~~~   73 (405)
                      +.+++.||+|+||.||+|.+..++.  .+|+|.+...     ..+.+.+|+.+++.++||||+++++.+.....  ....
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            4678999999999999999887775  5899987643     23567889999999999999999986543321  1223


Q ss_pred             EEEEEeecCCCCHHHHHHH-----cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccc
Q 015500           74 YNLFMEYAPGGTLNDEIHR-----NGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAK  147 (405)
Q Consensus        74 ~~lv~Ey~~ggsL~~~i~~-----~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~  147 (405)
                      .+++|||+++|+|.+++..     +...+++..+..++.||+.||.|||++||+||||||+|||++.++ +||+|||+++
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  160 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK  160 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence            5689999999999988743     223589999999999999999999999999999999999999887 9999999988


Q ss_pred             ccccc------ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchh
Q 015500          148 WESEA------LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAF  220 (405)
Q Consensus       148 ~~~~~------~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~  220 (405)
                      .....      ....+++.|+|||.+.+..++.++|||||||++|+|++ |+.||.... .......+. ....+..+..
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-~~~~~~~~~-~~~~~~~~~~  238 (272)
T cd05075         161 KIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVE-NSEIYDYLR-QGNRLKQPPD  238 (272)
T ss_pred             ccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCC-HHHHHHHHH-cCCCCCCCCC
Confidence            64331      12236778999999999899999999999999999999 899996543 333333333 3333445667


Q ss_pred             ccHHHHHHHHHhcccCccccCCHHHHhcC
Q 015500          221 LSKQANDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       221 ~s~~l~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      ++..+.++|.+||+.||.+|||+.+++++
T Consensus       239 ~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         239 CLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             CCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            88999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=5.3e-41  Score=321.45  Aligned_cols=241  Identities=24%  Similarity=0.331  Sum_probs=198.5

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCC----EEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGD----VFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLM   73 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~----~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~   73 (405)
                      +|++.+.||+|+||+||+|.+..+++    .+++|.+....    ...+..|+.+++++.||||+++++++..  .   .
T Consensus         8 ~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~--~---~   82 (279)
T cd05111           8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG--A---S   82 (279)
T ss_pred             hceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC--C---c
Confidence            58889999999999999999987776    47777765432    2356677888999999999999987532  1   1


Q ss_pred             EEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc
Q 015500           74 YNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA  152 (405)
Q Consensus        74 ~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~  152 (405)
                      .++++||+++|+|.+++....+.+++..+..++.||+.||.|||++|++||||||+||+++.++ +||+|||+++.....
T Consensus        83 ~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~  162 (279)
T cd05111          83 LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD  162 (279)
T ss_pred             cEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence            4589999999999999988767899999999999999999999999999999999999999887 999999999754321


Q ss_pred             ------ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHH
Q 015500          153 ------LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQA  225 (405)
Q Consensus       153 ------~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l  225 (405)
                            ....++..|+|||.+.+..++.++|||||||++|||++ |+.||.... ... ...+......+..+...+.++
T Consensus       163 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~~  240 (279)
T cd05111         163 DKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMR-PHE-VPDLLEKGERLAQPQICTIDV  240 (279)
T ss_pred             CcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCC-HHH-HHHHHHCCCcCCCCCCCCHHH
Confidence                  12346778999999998889999999999999999998 999996443 222 233333444445566678899


Q ss_pred             HHHHHHhcccCccccCCHHHHhcC
Q 015500          226 NDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       226 ~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      .+++.+||..||.+|||+.++++.
T Consensus       241 ~~li~~c~~~~p~~Rps~~el~~~  264 (279)
T cd05111         241 YMVMVKCWMIDENVRPTFKELANE  264 (279)
T ss_pred             HHHHHHHcCCCcccCcCHHHHHHH
Confidence            999999999999999999999773

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=5.9e-41  Score=322.36  Aligned_cols=248  Identities=22%  Similarity=0.307  Sum_probs=200.7

Q ss_pred             CcccccccceeCCeeEEEEEEcC-----CCCEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCce
Q 015500            2 DWTRGHTIGQGSSATVSLATSLR-----SGDVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKL   72 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~-----~~~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~   72 (405)
                      +|++.+.||+|+||.||+|.++.     .+..+|+|.+....    ...+.+|+.+++.++||||+++++.+....    
T Consensus         7 ~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----   82 (288)
T cd05061           7 KITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ----   82 (288)
T ss_pred             HceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC----
Confidence            58899999999999999997652     34589999876443    235678999999999999999998765433    


Q ss_pred             EEEEEEeecCCCCHHHHHHHcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEee
Q 015500           73 MYNLFMEYAPGGTLNDEIHRNG---------GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIAD  142 (405)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~i~~~~---------~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~D  142 (405)
                      ..+++|||+++|+|.+++.+.+         ..++...+..++.||+.||.|||++||+||||||+||+++.++ +||+|
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~D  162 (288)
T cd05061          83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGD  162 (288)
T ss_pred             CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECc
Confidence            2569999999999999997532         2346678899999999999999999999999999999999887 99999


Q ss_pred             eccccccccc------ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCC
Q 015500          143 FGCAKWESEA------LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELP  215 (405)
Q Consensus       143 FGla~~~~~~------~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~  215 (405)
                      ||+++.....      ....++..|+|||.+.+..++.++|+|||||++|||++ |..||.... ..... +.......+
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~-~~~~~-~~~~~~~~~  240 (288)
T cd05061         163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS-NEQVL-KFVMDGGYL  240 (288)
T ss_pred             CCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCC-HHHHH-HHHHcCCCC
Confidence            9998753321      12235677999999998889999999999999999999 788996433 33333 333334455


Q ss_pred             CCchhccHHHHHHHHHhcccCccccCCHHHHhc------Ccccccc
Q 015500          216 EVPAFLSKQANDFLSNCLRRDPKERWAASQLLK------HPFLEEF  255 (405)
Q Consensus       216 ~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~------hp~~~~~  255 (405)
                      ..+...++.+.+++.+||+.||++|||+.++++      ||||..+
T Consensus       241 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~  286 (288)
T cd05061         241 DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV  286 (288)
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCC
Confidence            566678899999999999999999999999987      7877653

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=4e-41  Score=323.98  Aligned_cols=249  Identities=29%  Similarity=0.445  Sum_probs=200.9

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      +|...+.||+|++|+||+|.++.+|+.+|+|.+....     ...+.+|++++++++||||+++++++....    .+++
T Consensus         3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~l   78 (294)
T PLN00009          3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEK----RLYL   78 (294)
T ss_pred             ceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCC----eEEE
Confidence            5889999999999999999999999999999876432     356788999999999999999999876443    3679


Q ss_pred             EEeecCCCCHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC--ceEeeecccccccc--
Q 015500           77 FMEYAPGGTLNDEIHRNGG-RLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG--AKIADFGCAKWESE--  151 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~~~-~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~--vkL~DFGla~~~~~--  151 (405)
                      ||||++ ++|.+++..... .+++..+..++.||+.||+|||++|++||||||+||+++.++  +||+|||++.....  
T Consensus        79 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~  157 (294)
T PLN00009         79 VFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV  157 (294)
T ss_pred             EEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence            999996 588888765432 368899999999999999999999999999999999998543  89999999875432  


Q ss_pred             --cccCCCCCCccChhhhcCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhc-----------------
Q 015500          152 --ALQSGGTPMFMAPEVARGE-HQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYS-----------------  211 (405)
Q Consensus       152 --~~~~~gt~~Y~APE~l~~~-~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~-----------------  211 (405)
                        .....+++.|+|||.+.+. .++.++|||||||++|+|+||..||...... ..+.++...                 
T Consensus       158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (294)
T PLN00009        158 RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI-DELFKIFRILGTPNEETWPGVTSLPD  236 (294)
T ss_pred             cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCChhhccccccchh
Confidence              1234578999999998764 5788999999999999999999999654433 222222110                 


Q ss_pred             --CCCCC--------CchhccHHHHHHHHHhcccCccccCCHHHHhcCccccccc
Q 015500          212 --RELPE--------VPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFC  256 (405)
Q Consensus       212 --~~~~~--------~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~  256 (405)
                        ...+.        ....+++.+.+++.+||+.+|.+||++.++++||||....
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~  291 (294)
T PLN00009        237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG  291 (294)
T ss_pred             hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence              00010        1124688899999999999999999999999999998753

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-41  Score=332.52  Aligned_cols=252  Identities=28%  Similarity=0.367  Sum_probs=200.7

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC----ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCC-CceEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP----KSEFLQREQKFLSSLNSPHIVGYKGCDVTSED-NKLMYNL   76 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~----~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~-~~~~~~l   76 (405)
                      +|.+.+.||+|+||+||+|.+..+|+.||+|.+...    ....+.+|+.++++++||||+++++....... .....++
T Consensus         6 ~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l   85 (336)
T cd07849           6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYI   85 (336)
T ss_pred             ceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEE
Confidence            689999999999999999999999999999987532    23457789999999999999999887544321 2224569


Q ss_pred             EEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc---
Q 015500           77 FMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA---  152 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~---  152 (405)
                      ++||+.+ +|.+++..  +++++..++.++.||+.||.|||+.||+||||||+||+++.++ +||+|||++......   
T Consensus        86 v~e~~~~-~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~  162 (336)
T cd07849          86 VQELMET-DLYKLIKT--QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDH  162 (336)
T ss_pred             Eehhccc-CHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccccccc
Confidence            9999964 88887754  3699999999999999999999999999999999999999887 999999998754321   


Q ss_pred             ----ccCCCCCCccChhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHh-----------------
Q 015500          153 ----LQSGGTPMFMAPEVARG-EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAY-----------------  210 (405)
Q Consensus       153 ----~~~~gt~~Y~APE~l~~-~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~-----------------  210 (405)
                          ....||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||..... ......+..                 
T Consensus       163 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (336)
T cd07849         163 TGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY-LHQLNLILGVLGTPSQEDLNCIISLR  241 (336)
T ss_pred             cCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHcCCCCHHHHHHhhchh
Confidence                12458999999998765 5688999999999999999999999964321 111111000                 


Q ss_pred             ----cCCCC---C-----CchhccHHHHHHHHHhcccCccccCCHHHHhcCcccccccc
Q 015500          211 ----SRELP---E-----VPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCS  257 (405)
Q Consensus       211 ----~~~~~---~-----~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~~  257 (405)
                          ....+   .     .....++++.+|+.+||+.+|.+|||+.++++||||+....
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~  300 (336)
T cd07849         242 ARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD  300 (336)
T ss_pred             hhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence                00000   0     11235788999999999999999999999999999997643

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=5.7e-41  Score=316.78  Aligned_cols=235  Identities=27%  Similarity=0.342  Sum_probs=195.4

Q ss_pred             cccceeCCeeEEEEEE--cCCCCEEEEEEccCCC-----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEe
Q 015500            7 HTIGQGSSATVSLATS--LRSGDVFAAKSTELPK-----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFME   79 (405)
Q Consensus         7 ~~LG~G~~g~Vyla~~--~~~~~~vavK~~~~~~-----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (405)
                      +.||+|+||+||+|.+  +.++..+|+|.+....     .+.+.+|+.+++.++||||+++++.+.. +    .++++||
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~----~~~lv~e   75 (257)
T cd05116           1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-E----SWMLVME   75 (257)
T ss_pred             CcCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-C----CcEEEEe
Confidence            3699999999999965  4577899999876432     3468889999999999999999986532 1    2468999


Q ss_pred             ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc------
Q 015500           80 YAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA------  152 (405)
Q Consensus        80 y~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~------  152 (405)
                      |+++++|.+++... +.+++..+..++.|++.||+|||++|++||||||.||+++.++ +||+|||+++.....      
T Consensus        76 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  154 (257)
T cd05116          76 LAELGPLNKFLQKN-KHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA  154 (257)
T ss_pred             cCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence            99999999999765 4799999999999999999999999999999999999999888 999999998754321      


Q ss_pred             -ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHH
Q 015500          153 -LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLS  230 (405)
Q Consensus       153 -~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~  230 (405)
                       ....+++.|+|||.+....++.++|+|||||++|||++ |+.||.... .......+. ....+..|..+++++.++|.
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-~~~~~~~i~-~~~~~~~~~~~~~~l~~li~  232 (257)
T cd05116         155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMK-GNEVTQMIE-SGERMECPQRCPPEMYDLMK  232 (257)
T ss_pred             cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHHH-CCCCCCCCCCCCHHHHHHHH
Confidence             11224578999999988889999999999999999998 999996543 333444443 34456677789999999999


Q ss_pred             HhcccCccccCCHHHHhcC
Q 015500          231 NCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       231 ~~L~~dP~~Rpt~~elL~h  249 (405)
                      +||+.||.+||+++++.+.
T Consensus       233 ~~~~~~p~~Rp~~~~i~~~  251 (257)
T cd05116         233 LCWTYGVDERPGFAVVELR  251 (257)
T ss_pred             HHhccCchhCcCHHHHHHH
Confidence            9999999999999998653

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=5.6e-41  Score=316.37  Aligned_cols=241  Identities=25%  Similarity=0.373  Sum_probs=200.2

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEee
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEY   80 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~Ey   80 (405)
                      +|.+.+.||+|+||.||+|...  |..+|+|...... .+.+.+|+.++++++|||++++++++.....   .++++|||
T Consensus         7 ~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~---~~~lv~e~   81 (256)
T cd05082           7 ELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG---GLYIVTEY   81 (256)
T ss_pred             hCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCC---ceEEEEEC
Confidence            5888999999999999999764  7889999886543 4578899999999999999999987654332   25689999


Q ss_pred             cCCCCHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc-ccCCC
Q 015500           81 APGGTLNDEIHRNGG-RLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA-LQSGG  157 (405)
Q Consensus        81 ~~ggsL~~~i~~~~~-~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~-~~~~g  157 (405)
                      +++++|.+++...+. .+++..+..++.||+.||.|||++|++||||||+||+++.++ +||+|||+++..... ....+
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  161 (256)
T cd05082          82 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL  161 (256)
T ss_pred             CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccCCCCcc
Confidence            999999999987543 488999999999999999999999999999999999999888 999999998754432 23345


Q ss_pred             CCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHhcccC
Q 015500          158 TPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRD  236 (405)
Q Consensus       158 t~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~L~~d  236 (405)
                      +..|+|||++.+..++.++|||||||++|+|++ |+.||... +.......+ .....+..+..+++.+.+++.+||+.+
T Consensus       162 ~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~  239 (256)
T cd05082         162 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRV-EKGYKMDAPDGCPPVVYDVMKQCWHLD  239 (256)
T ss_pred             ceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHH-hcCCCCCCCCCCCHHHHHHHHHHhcCC
Confidence            668999999999889999999999999999997 99999643 223333333 233344566778999999999999999


Q ss_pred             ccccCCHHHHhcC
Q 015500          237 PKERWAASQLLKH  249 (405)
Q Consensus       237 P~~Rpt~~elL~h  249 (405)
                      |++|||+.+++++
T Consensus       240 p~~Rpt~~~l~~~  252 (256)
T cd05082         240 AATRPSFLQLREQ  252 (256)
T ss_pred             hhhCcCHHHHHHH
Confidence            9999999999763

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.9e-41  Score=318.54  Aligned_cols=245  Identities=21%  Similarity=0.310  Sum_probs=200.8

Q ss_pred             cccccccceeCCeeEEEEEEcCC---CCEEEEEEccCCC-----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCC--Cce
Q 015500            3 WTRGHTIGQGSSATVSLATSLRS---GDVFAAKSTELPK-----SEFLQREQKFLSSLNSPHIVGYKGCDVTSED--NKL   72 (405)
Q Consensus         3 y~~~~~LG~G~~g~Vyla~~~~~---~~~vavK~~~~~~-----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~--~~~   72 (405)
                      |.+++.||+|+||.||+|....+   +..+|+|.+....     .+.+.+|+.+++.++||||+++++.+.....  ...
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            67899999999999999987653   4789999876532     2467889999999999999999987654332  223


Q ss_pred             EEEEEEeecCCCCHHHHHHHc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccc
Q 015500           73 MYNLFMEYAPGGTLNDEIHRN-----GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCA  146 (405)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~i~~~-----~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla  146 (405)
                      ..+++|||+++|+|..++...     ...+++..+..++.|++.||.|||++|++||||||+||+++.++ +||+|||++
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~  160 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS  160 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence            456999999999999988542     23589999999999999999999999999999999999999887 999999999


Q ss_pred             cccccc------ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCch
Q 015500          147 KWESEA------LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPA  219 (405)
Q Consensus       147 ~~~~~~------~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~  219 (405)
                      +.....      ....++..|+|||.+.+..++.++|||||||++|||++ |..||..... ......+ .....+..|.
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~-~~~~~~~-~~~~~~~~~~  238 (273)
T cd05035         161 KKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN-HEIYDYL-RHGNRLKQPE  238 (273)
T ss_pred             eeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHH-HcCCCCCCCc
Confidence            764321      11235678999999988889999999999999999999 8899965433 3333333 3334556677


Q ss_pred             hccHHHHHHHHHhcccCccccCCHHHHhcC
Q 015500          220 FLSKQANDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       220 ~~s~~l~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      .+++++.+++.+||+.||++|||+.+++++
T Consensus       239 ~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         239 DCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1.9e-41  Score=322.16  Aligned_cols=243  Identities=33%  Similarity=0.539  Sum_probs=207.5

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC------ChHHHHHHHHHHHhCC-CCCeeeeeeeeeecCCCceEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSLN-SPHIVGYKGCDVTSEDNKLMY   74 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~------~~~~l~~E~~iL~~L~-hpnIv~~~~~~~~~~~~~~~~   74 (405)
                      +|...+.||+|+||.||+|.++.+++.+|+|++...      ....+.+|..+++++. ||||+++++.+....    .+
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~----~~   77 (280)
T cd05581           2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEE----NL   77 (280)
T ss_pred             CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCc----eE
Confidence            689999999999999999999999999999988652      2356788999999998 999999998765433    36


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccccc
Q 015500           75 NLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEAL  153 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~~  153 (405)
                      +++|||+++++|.+++.+.+ .+++..+..++.|++.||.|||+.|++|+||||+||+++.++ ++|+|||++.......
T Consensus        78 ~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~  156 (280)
T cd05581          78 YFVLEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS  156 (280)
T ss_pred             EEEEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence            69999999999999998764 799999999999999999999999999999999999999887 9999999987543311


Q ss_pred             ------------------------cCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHH
Q 015500          154 ------------------------QSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA  209 (405)
Q Consensus       154 ------------------------~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~  209 (405)
                                              ...+++.|+|||.+.+..++.++|+|||||++++|++|..||..... ...+..+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-~~~~~~~~  235 (280)
T cd05581         157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE-YLTFQKIL  235 (280)
T ss_pred             ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH-HHHHHHHH
Confidence                                    22478899999999988899999999999999999999999965542 22233322


Q ss_pred             hcCCCCCCchhccHHHHHHHHHhcccCccccCCH----HHHhcCccc
Q 015500          210 YSRELPEVPAFLSKQANDFLSNCLRRDPKERWAA----SQLLKHPFL  252 (405)
Q Consensus       210 ~~~~~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~----~elL~hp~~  252 (405)
                        .....+|..+++.+.+||++||+.+|.+|||+    .++++||||
T Consensus       236 --~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         236 --KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             --hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence              22335566789999999999999999999999    999999997

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=4.7e-41  Score=315.40  Aligned_cols=245  Identities=31%  Similarity=0.519  Sum_probs=209.6

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC-----ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP-----KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~-----~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      +|++.+.||.|+||.||++.++.+++.+|+|.+...     ....+.+|+++++.++||||+++.+.+...    ..+++
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----~~~~~   76 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDG----NKLCI   76 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC----CEEEE
Confidence            588999999999999999999999999999987643     234677899999999999999998876544    24679


Q ss_pred             EEeecCCCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc
Q 015500           77 FMEYAPGGTLNDEIHRN---GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA  152 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~---~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~  152 (405)
                      ++||+++++|.+++.+.   +..+++..+..++.|++.||.|||+.|++|+||+|.||+++.++ +||+|||++......
T Consensus        77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~  156 (256)
T cd08530          77 VMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN  156 (256)
T ss_pred             EehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence            99999999999998662   34689999999999999999999999999999999999999887 999999998765432


Q ss_pred             --ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHH
Q 015500          153 --LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLS  230 (405)
Q Consensus       153 --~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~  230 (405)
                        ....+++.|+|||.+.+..+++++|+||||+++++|++|+.||.... ....... ......+..+..++.++.+++.
T Consensus       157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~~~~li~  234 (256)
T cd08530         157 MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARS-MQDLRYK-VQRGKYPPIPPIYSQDLQNFIR  234 (256)
T ss_pred             CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHH-HhcCCCCCCchhhCHHHHHHHH
Confidence              23458899999999999889999999999999999999999996443 3333333 3345566677789999999999


Q ss_pred             HhcccCccccCCHHHHhcCccc
Q 015500          231 NCLRRDPKERWAASQLLKHPFL  252 (405)
Q Consensus       231 ~~L~~dP~~Rpt~~elL~hp~~  252 (405)
                      +||..+|++|||+.++++||++
T Consensus       235 ~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         235 SMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             HHcCCCcccCCCHHHHhcCCCC
Confidence            9999999999999999999975

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.1e-42  Score=347.33  Aligned_cols=246  Identities=30%  Similarity=0.468  Sum_probs=210.7

Q ss_pred             cccccceeCCeeEEEEEEcCCCCEEEE---EEccC--C--ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEE
Q 015500            5 RGHTIGQGSSATVSLATSLRSGDVFAA---KSTEL--P--KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLF   77 (405)
Q Consensus         5 ~~~~LG~G~~g~Vyla~~~~~~~~vav---K~~~~--~--~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv   77 (405)
                      ....||+|+|-+||+|.|..+|-.||-   |.-+.  .  ..+++..|+.+|+.|+||||++++..+++...  ...++|
T Consensus        44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n--~~in~i  121 (632)
T KOG0584|consen   44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDN--KTINFI  121 (632)
T ss_pred             hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCC--ceeeee
Confidence            346899999999999999999988873   33222  2  24789999999999999999999998776555  456799


Q ss_pred             EeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC--CceeCCCCCCCEEEccCC--ceEeeecccccccc--
Q 015500           78 MEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN--RVVHCDIKSRNILMAESG--AKIADFGCAKWESE--  151 (405)
Q Consensus        78 ~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~--givHrDlkp~NILi~~~~--vkL~DFGla~~~~~--  151 (405)
                      .|.+.+|+|+.|+++.+ +++...++.|++||++||.|||++  .|+|||||-+||+|+.+.  |||+|+|+|.....  
T Consensus       122 TEL~TSGtLr~Y~kk~~-~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~  200 (632)
T KOG0584|consen  122 TELFTSGTLREYRKKHR-RVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH  200 (632)
T ss_pred             eecccCCcHHHHHHHhc-cCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence            99999999999999985 899999999999999999999998  599999999999998874  99999999986544  


Q ss_pred             cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHH
Q 015500          152 ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSN  231 (405)
Q Consensus       152 ~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~  231 (405)
                      .....|||.|||||+.. +.|+..+||||||+.+.||+|+..||..-.++.....++.-+..+..+..--.+++++||.+
T Consensus       201 aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fIek  279 (632)
T KOG0584|consen  201 AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREFIEK  279 (632)
T ss_pred             cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHHHH
Confidence            34467999999999998 78999999999999999999999999887777666555554443333444457899999999


Q ss_pred             hcccCccccCCHHHHhcCcccccc
Q 015500          232 CLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       232 ~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      ||.. .++|+|+.|||+||||...
T Consensus       280 Cl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  280 CLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             HhcC-chhccCHHHHhhChhhccc
Confidence            9999 9999999999999999874

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.7e-41  Score=330.72  Aligned_cols=254  Identities=28%  Similarity=0.360  Sum_probs=208.1

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC-----ChHHHHHHHHHHHhCCCCCeeeeeeeeeecC-CCceEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP-----KSEFLQREQKFLSSLNSPHIVGYKGCDVTSE-DNKLMYN   75 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~-----~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~-~~~~~~~   75 (405)
                      +|.+.+.||+|++|.||+|++..+++.+|+|.+...     ..+.+.+|+.+++.++||||+++.+++.... .....++
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            589999999999999999999999999999987643     2357889999999999999999998766554 1222467


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccccc-
Q 015500           76 LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEAL-  153 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~~-  153 (405)
                      ++|||++ ++|.+++.+.. ++++..++.++.||+.||+|||++||+||||||.||+++.++ ++|+|||++....... 
T Consensus        81 lv~e~~~-~~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~  158 (330)
T cd07834          81 IVTELME-TDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED  158 (330)
T ss_pred             EEecchh-hhHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence            9999997 48998887654 899999999999999999999999999999999999999888 9999999998654322 


Q ss_pred             ------cCCCCCCccChhhhcCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCC------------
Q 015500          154 ------QSGGTPMFMAPEVARGE-HQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSREL------------  214 (405)
Q Consensus       154 ------~~~gt~~Y~APE~l~~~-~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~------------  214 (405)
                            ...+|+.|+|||++.+. .++.++|+|||||++|+|++|+.||..... ......+......            
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~  237 (330)
T cd07834         159 EKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDY-IDQLNLIVEVLGTPSEEDLKFITSE  237 (330)
T ss_pred             ccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCH-HHHHHHHHHhcCCCChhHhhhcccc
Confidence                  33478999999999887 789999999999999999999999965432 2222221111000            


Q ss_pred             -----------------CCCchhccHHHHHHHHHhcccCccccCCHHHHhcCccccccccc
Q 015500          215 -----------------PEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSC  258 (405)
Q Consensus       215 -----------------~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~~~  258 (405)
                                       ......++.++.+||.+||+++|.+|||+++++.||||+.....
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~  298 (330)
T cd07834         238 KARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP  298 (330)
T ss_pred             chhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence                             00112367889999999999999999999999999999976543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.8e-41  Score=331.32  Aligned_cols=252  Identities=27%  Similarity=0.404  Sum_probs=205.0

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCC--ceEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDN--KLMY   74 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~--~~~~   74 (405)
                      +|++.+.||+|+||+||+|.+..+++.||||.+....     ...+.+|+.+|+.++||||+++++++......  ...+
T Consensus        16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   95 (343)
T cd07880          16 RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDF   95 (343)
T ss_pred             ceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceE
Confidence            5889999999999999999999999999999875421     24678999999999999999999887654321  2346


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc-
Q 015500           75 NLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA-  152 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~-  152 (405)
                      ++||||+ |++|.+++..  ..+++..++.++.||+.||.|||+.||+||||||+||+++.++ +||+|||++...... 
T Consensus        96 ~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~  172 (343)
T cd07880          96 YLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEM  172 (343)
T ss_pred             EEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccccCc
Confidence            7999999 7799988864  3799999999999999999999999999999999999999887 999999999865442 


Q ss_pred             ccCCCCCCccChhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhc-C------------------
Q 015500          153 LQSGGTPMFMAPEVARG-EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYS-R------------------  212 (405)
Q Consensus       153 ~~~~gt~~Y~APE~l~~-~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~-~------------------  212 (405)
                      ....+++.|+|||.+.+ ..++.++|+|||||++|+|++|+.||..... ......+... .                  
T Consensus       173 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (343)
T cd07880         173 TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDH-LDQLMEIMKVTGTPSKEFVQKLQSEDAKNY  251 (343)
T ss_pred             cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHhcCCCCHHHHHhhcchhHHHH
Confidence            23468999999999876 4578899999999999999999999965432 2222111110 0                  


Q ss_pred             --CCC--------CCchhccHHHHHHHHHhcccCccccCCHHHHhcCcccccccc
Q 015500          213 --ELP--------EVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCS  257 (405)
Q Consensus       213 --~~~--------~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~~  257 (405)
                        ..+        .....+++++.++|.+||..||.+|||+.+++.||||+....
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~  306 (343)
T cd07880         252 VKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD  306 (343)
T ss_pred             HHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcC
Confidence              000        112346788999999999999999999999999999997643

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=2.6e-41  Score=333.55  Aligned_cols=250  Identities=26%  Similarity=0.368  Sum_probs=200.3

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC---hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCc-------
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK---SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNK-------   71 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~---~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~-------   71 (405)
                      +|.+.+.||.|+||.||+|.++.+|+.||+|.+....   ...+.+|+++|+.++||||+++++++.......       
T Consensus         6 ~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~   85 (342)
T cd07854           6 RYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSL   85 (342)
T ss_pred             ceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccc
Confidence            5889999999999999999999999999999876543   456889999999999999999987655433211       


Q ss_pred             ---eEEEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC--ceEeeeccc
Q 015500           72 ---LMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG--AKIADFGCA  146 (405)
Q Consensus        72 ---~~~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~--vkL~DFGla  146 (405)
                         ..++++|||++ ++|.+++..  +++++..++.++.||+.||.|||+.|++||||||+||+++..+  +||+|||++
T Consensus        86 ~~~~~~~lv~e~~~-~~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~~  162 (342)
T cd07854          86 TELNSVYIVQEYME-TDLANVLEQ--GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLA  162 (342)
T ss_pred             cccceEEEEeeccc-ccHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCcccc
Confidence               24679999997 589888764  3699999999999999999999999999999999999998554  899999998


Q ss_pred             cccccc-------ccCCCCCCccChhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhc-------
Q 015500          147 KWESEA-------LQSGGTPMFMAPEVARG-EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYS-------  211 (405)
Q Consensus       147 ~~~~~~-------~~~~gt~~Y~APE~l~~-~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~-------  211 (405)
                      +.....       ....+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||........ ...+...       
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~  241 (342)
T cd07854         163 RIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ-MQLILESVPVVREE  241 (342)
T ss_pred             eecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCChH
Confidence            754321       12357889999998754 5678899999999999999999999965433222 1111100       


Q ss_pred             ----------------CCCCC-----CchhccHHHHHHHHHhcccCccccCCHHHHhcCcccccc
Q 015500          212 ----------------RELPE-----VPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       212 ----------------~~~~~-----~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                                      ...+.     ....++.++.+||.+||+.||.+|||+.++|+||||+.+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~  306 (342)
T cd07854         242 DRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY  306 (342)
T ss_pred             HhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence                            00111     112467899999999999999999999999999999865

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=5.1e-41  Score=321.28  Aligned_cols=242  Identities=22%  Similarity=0.277  Sum_probs=199.6

Q ss_pred             CcccccccceeCCeeEEEEEEcCC-----CCEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCce
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRS-----GDVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKL   72 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~-----~~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~   72 (405)
                      +|.+.+.||+|+||+||+|.+..+     ++.+|+|.+....    .+.+.+|+.+++.++||||+++++.+.....   
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~---   82 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQP---   82 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCc---
Confidence            478899999999999999987543     5789999987543    2457889999999999999999987655443   


Q ss_pred             EEEEEEeecCCCCHHHHHHHc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC
Q 015500           73 MYNLFMEYAPGGTLNDEIHRN---------------GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG  137 (405)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~i~~~---------------~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~  137 (405)
                       .++++||+++++|.+++...               ...+++..+..++.|++.||.|||++|++||||||.||+++.++
T Consensus        83 -~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~  161 (283)
T cd05091          83 -LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKL  161 (283)
T ss_pred             -eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCC
Confidence             55899999999999998532               23588889999999999999999999999999999999999887


Q ss_pred             -ceEeeeccccccccc------ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHH
Q 015500          138 -AKIADFGCAKWESEA------LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIA  209 (405)
Q Consensus       138 -vkL~DFGla~~~~~~------~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~  209 (405)
                       +||+|||+++.....      ....+++.|+|||.+.+..++.++|||||||++|||++ |..||... ........+.
T Consensus       162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~-~~~~~~~~i~  240 (283)
T cd05091         162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY-SNQDVIEMIR  240 (283)
T ss_pred             ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHH
Confidence             999999998754321      12345788999999988889999999999999999998 88888543 3333333333


Q ss_pred             hcCCCCCCchhccHHHHHHHHHhcccCccccCCHHHHhcC
Q 015500          210 YSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       210 ~~~~~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                       ....+..+..++..+.+|+.+||+.+|.+||++++++..
T Consensus       241 -~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~  279 (283)
T cd05091         241 -NRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR  279 (283)
T ss_pred             -cCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence             344455677899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-41  Score=320.49  Aligned_cols=244  Identities=33%  Similarity=0.482  Sum_probs=202.2

Q ss_pred             cccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEE
Q 015500            3 WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLF   77 (405)
Q Consensus         3 y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv   77 (405)
                      |.+.+.||.|++|.||+|.+..+++.+++|.+....     ...+.+|+++|++++||||+++++.+....    .++++
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~~v   76 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKG----DLYLV   76 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCC----CEEEE
Confidence            678899999999999999999999999999876542     347888999999999999999998765543    36699


Q ss_pred             EeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccccc---
Q 015500           78 MEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEAL---  153 (405)
Q Consensus        78 ~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~~---  153 (405)
                      +||+++ +|.+++....+.+++..+..++.||+.||.|||+.|++|+||||+||+++.++ +||+|||++.......   
T Consensus        77 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~  155 (283)
T cd05118          77 FEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPY  155 (283)
T ss_pred             EeccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccc
Confidence            999975 89888877656899999999999999999999999999999999999999877 9999999987654322   


Q ss_pred             -cCCCCCCccChhhhcCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCC------------------
Q 015500          154 -QSGGTPMFMAPEVARGE-HQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRE------------------  213 (405)
Q Consensus       154 -~~~gt~~Y~APE~l~~~-~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~------------------  213 (405)
                       ...++..|+|||.+.+. .++.++|+|||||++|+|+||+.||...+. ...+.++.....                  
T Consensus       156 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd05118         156 THYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSE-IDQLFKIFRTLGTPDPEVWPKFTSLARNYK  234 (283)
T ss_pred             cCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHcCCCchHhcccchhhhhhhh
Confidence             24478899999999876 788999999999999999999999965443 222222211100                  


Q ss_pred             ----------CCCCchhccHHHHHHHHHhcccCccccCCHHHHhcCccc
Q 015500          214 ----------LPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFL  252 (405)
Q Consensus       214 ----------~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~  252 (405)
                                .+.....++.++.+||.+||++||.+||++.+++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             hhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence                      001123468899999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=6.1e-41  Score=323.82  Aligned_cols=246  Identities=33%  Similarity=0.492  Sum_probs=203.3

Q ss_pred             ccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC---hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEee
Q 015500            4 TRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK---SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEY   80 (405)
Q Consensus         4 ~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~---~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~Ey   80 (405)
                      .....||+|+||.||+|.++.+++.+|+|.+....   ...+.+|+.+++.++||||+++++.+...+    .++++|||
T Consensus        23 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~lv~e~   98 (292)
T cd06657          23 DNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD----ELWVVMEF   98 (292)
T ss_pred             hhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCC----EEEEEEec
Confidence            44568999999999999999999999999876432   346888999999999999999998876543    36799999


Q ss_pred             cCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc----cccC
Q 015500           81 APGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE----ALQS  155 (405)
Q Consensus        81 ~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~----~~~~  155 (405)
                      +++++|.+++..  +++++..+..++.|++.||+|||+.|++|+||||+||+++.++ ++|+|||++.....    ....
T Consensus        99 ~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~  176 (292)
T cd06657          99 LEGGALTDIVTH--TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL  176 (292)
T ss_pred             CCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccccccccc
Confidence            999999998754  3689999999999999999999999999999999999999887 99999998765432    2234


Q ss_pred             CCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcC-CCCCCchhccHHHHHHHHHhcc
Q 015500          156 GGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSR-ELPEVPAFLSKQANDFLSNCLR  234 (405)
Q Consensus       156 ~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~-~~~~~p~~~s~~l~dll~~~L~  234 (405)
                      .|++.|+|||.+.+..+++++|+||+|+++|+|++|..||.... .......+.... ........++..+.+++.+||+
T Consensus       177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  255 (292)
T cd06657         177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP-PLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLV  255 (292)
T ss_pred             ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHh
Confidence            58899999999988888999999999999999999999996433 233222222111 1111223578899999999999


Q ss_pred             cCccccCCHHHHhcCccccccc
Q 015500          235 RDPKERWAASQLLKHPFLEEFC  256 (405)
Q Consensus       235 ~dP~~Rpt~~elL~hp~~~~~~  256 (405)
                      .+|.+||++.++++||||....
T Consensus       256 ~~P~~R~~~~~ll~~~~~~~~~  277 (292)
T cd06657         256 RDPAQRATAAELLKHPFLAKAG  277 (292)
T ss_pred             CCcccCcCHHHHhcChHHhccC
Confidence            9999999999999999998653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-41  Score=320.88  Aligned_cols=244  Identities=31%  Similarity=0.485  Sum_probs=199.4

Q ss_pred             cccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEE
Q 015500            3 WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLF   77 (405)
Q Consensus         3 y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv   77 (405)
                      |++.+.||.|++|+||+|.++.+|+.||+|.+....     ...+.+|+++++.++|||++++++.+....    ..+++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~----~~~iv   76 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSEN----KLYLV   76 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCC----eEEEE
Confidence            678899999999999999999999999999876432     346788999999999999999998865432    36799


Q ss_pred             EeecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc----
Q 015500           78 MEYAPGGTLNDEIHRNG-GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE----  151 (405)
Q Consensus        78 ~Ey~~ggsL~~~i~~~~-~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~----  151 (405)
                      |||++ ++|.+++.... ..+++..+..++.||+.||+|||++|++||||+|+||+++.++ ++|+|||++.....    
T Consensus        77 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~  155 (283)
T cd07835          77 FEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT  155 (283)
T ss_pred             EeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence            99995 69999987653 3689999999999999999999999999999999999999887 99999999875432    


Q ss_pred             cccCCCCCCccChhhhcCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhc-------------------
Q 015500          152 ALQSGGTPMFMAPEVARGE-HQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYS-------------------  211 (405)
Q Consensus       152 ~~~~~gt~~Y~APE~l~~~-~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~-------------------  211 (405)
                      .....+++.|+|||++.+. .++.++|+|||||++|+|++|++||....+ ...+.++...                   
T Consensus       156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd07835         156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSE-IDQLFRIFRTLGTPDEDVWPGVTSLPDYK  234 (283)
T ss_pred             cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCChHHhhhhhhchhhh
Confidence            1223468899999988764 568899999999999999999999965433 2222221110                   


Q ss_pred             CCC--------CCCchhccHHHHHHHHHhcccCccccCCHHHHhcCccc
Q 015500          212 REL--------PEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFL  252 (405)
Q Consensus       212 ~~~--------~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~  252 (405)
                      ...        ......++..+.++|.+||+.||.+|||+.++++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         235 PTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             hhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence            000        11123467899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=4.3e-41  Score=326.22  Aligned_cols=242  Identities=26%  Similarity=0.372  Sum_probs=196.4

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCE--EEEEEccCC----ChHHHHHHHHHHHhC-CCCCeeeeeeeeeecCCCceEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDV--FAAKSTELP----KSEFLQREQKFLSSL-NSPHIVGYKGCDVTSEDNKLMY   74 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~--vavK~~~~~----~~~~l~~E~~iL~~L-~hpnIv~~~~~~~~~~~~~~~~   74 (405)
                      +|.+.+.||+|+||+||+|.++.++..  +++|.....    ....+.+|+.++.++ +||||+++++++....    .+
T Consensus         8 ~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~----~~   83 (303)
T cd05088           8 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG----YL   83 (303)
T ss_pred             hceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCC----Cc
Confidence            578889999999999999999877764  477765432    224678899999999 8999999999765433    36


Q ss_pred             EEEEeecCCCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-c
Q 015500           75 NLFMEYAPGGTLNDEIHRNG---------------GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-A  138 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~i~~~~---------------~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-v  138 (405)
                      +++|||+++++|.+++.+.+               ..+++..++.++.||+.||+|||++|++||||||+|||++.++ +
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~  163 (303)
T cd05088          84 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA  163 (303)
T ss_pred             eEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcE
Confidence            79999999999999997542               2578999999999999999999999999999999999998887 9


Q ss_pred             eEeeecccccccc---cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCC
Q 015500          139 KIADFGCAKWESE---ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSREL  214 (405)
Q Consensus       139 kL~DFGla~~~~~---~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~  214 (405)
                      ||+|||+++....   .....++..|+|||.+.+..+++++|||||||++|+|+| |..||..... ......+ .....
T Consensus       164 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-~~~~~~~-~~~~~  241 (303)
T cd05088         164 KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-AELYEKL-PQGYR  241 (303)
T ss_pred             EeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh-HHHHHHH-hcCCc
Confidence            9999999864322   111224667999999988889999999999999999998 9999954332 2222222 22223


Q ss_pred             CCCchhccHHHHHHHHHhcccCccccCCHHHHhcC
Q 015500          215 PEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       215 ~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      +..+..+++++.+|+.+||+.+|++||++++++++
T Consensus       242 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         242 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            34556678999999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=8.5e-41  Score=324.89  Aligned_cols=247  Identities=34%  Similarity=0.533  Sum_probs=206.6

Q ss_pred             cccccccceeCCeeEEEEEEcCCCCEEEEEEccCC------ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEE
Q 015500            3 WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         3 y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~------~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      |...+.||+|+||+||+|+++.+++.+|+|.+...      ....+.+|+++++.++|||++++.+++....    .+++
T Consensus        17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~l   92 (308)
T cd06634          17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH----TAWL   92 (308)
T ss_pred             HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCC----eeEE
Confidence            66788999999999999999999999999987532      1235678999999999999999999876543    3669


Q ss_pred             EEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccccccC
Q 015500           77 FMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQS  155 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~~~~  155 (405)
                      ||||+. |+|.+++.....++++..+..++.|++.||.|||+.|++||||||+||+++.++ +||+|||++.........
T Consensus        93 v~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~  171 (308)
T cd06634          93 VMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF  171 (308)
T ss_pred             EEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCcccc
Confidence            999996 588888876666799999999999999999999999999999999999999887 999999998876655566


Q ss_pred             CCCCCccChhhhc---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHh
Q 015500          156 GGTPMFMAPEVAR---GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNC  232 (405)
Q Consensus       156 ~gt~~Y~APE~l~---~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~  232 (405)
                      .+++.|+|||.+.   ...++.++|||||||++|+|++|..||.... .......+.........+..++..+.+||++|
T Consensus       172 ~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  250 (308)
T cd06634         172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-AMSALYHIAQNESPALQSGHWSEYFRNFVDSC  250 (308)
T ss_pred             cCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCcccc-HHHHHHHHhhcCCCCcCcccccHHHHHHHHHH
Confidence            7899999999985   3457889999999999999999999996543 33333333333222223446889999999999


Q ss_pred             cccCccccCCHHHHhcCcccccc
Q 015500          233 LRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       233 L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      |+.+|.+||+++++++|||+...
T Consensus       251 l~~~P~~Rp~~~~ll~~~~~~~~  273 (308)
T cd06634         251 LQKIPQDRPTSEVLLKHRFVLRE  273 (308)
T ss_pred             hhCCcccCCCHHHHhhCcccccc
Confidence            99999999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.3e-41  Score=331.96  Aligned_cols=252  Identities=25%  Similarity=0.341  Sum_probs=203.6

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC-----ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCC-CceEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP-----KSEFLQREQKFLSSLNSPHIVGYKGCDVTSED-NKLMYN   75 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~-----~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~-~~~~~~   75 (405)
                      .|.+.+.||+|+||+||+|++..+++.||||.+...     ....+.+|+.+|+.++||||+++++++..... .....+
T Consensus         6 ~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~   85 (337)
T cd07858           6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVY   85 (337)
T ss_pred             ceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEE
Confidence            588999999999999999999999999999987542     23467789999999999999999987654332 122467


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc--
Q 015500           76 LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA--  152 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~--  152 (405)
                      +++||+. ++|.+++... +++++..+..++.||+.||.|||++|++||||||+||+++.++ +||+|||++......  
T Consensus        86 lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~  163 (337)
T cd07858          86 IVYELMD-TDLHQIIRSS-QTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGD  163 (337)
T ss_pred             EEEeCCC-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCcc
Confidence            9999995 6899888765 4899999999999999999999999999999999999999887 999999998764332  


Q ss_pred             --ccCCCCCCccChhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHh-------------------
Q 015500          153 --LQSGGTPMFMAPEVARG-EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAY-------------------  210 (405)
Q Consensus       153 --~~~~gt~~Y~APE~l~~-~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~-------------------  210 (405)
                        ....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||..... ......+..                   
T Consensus       164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (337)
T cd07858         164 FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY-VHQLKLITELLGSPSEEDLGFIRNEKAR  242 (337)
T ss_pred             cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHHHHHhCCCChHHhhhcCchhhh
Confidence              23458899999998865 5688999999999999999999999965422 111110000                   


Q ss_pred             -----cCCC-----CCCchhccHHHHHHHHHhcccCccccCCHHHHhcCccccccc
Q 015500          211 -----SREL-----PEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFC  256 (405)
Q Consensus       211 -----~~~~-----~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~  256 (405)
                           ....     ......+++++.+||++||+.+|.+|||++++++||||..+.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~  298 (337)
T cd07858         243 RYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH  298 (337)
T ss_pred             HHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence                 0000     011234788999999999999999999999999999998764

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=4.6e-41  Score=329.59  Aligned_cols=247  Identities=25%  Similarity=0.354  Sum_probs=196.1

Q ss_pred             ccccee--CCeeEEEEEEcCCCCEEEEEEccCCC-----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEe
Q 015500            7 HTIGQG--SSATVSLATSLRSGDVFAAKSTELPK-----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFME   79 (405)
Q Consensus         7 ~~LG~G--~~g~Vyla~~~~~~~~vavK~~~~~~-----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (405)
                      ..||+|  +||+||+|.+..+|+.||+|......     .+.+.+|+.+++.++||||+++++++....    .+++++|
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~----~~~~v~e   79 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGS----WLWVISP   79 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCC----ceEEEEe
Confidence            467777  99999999999999999999986532     356889999999999999999999876543    3679999


Q ss_pred             ecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc----c-
Q 015500           80 YAPGGTLNDEIHRNG-GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE----A-  152 (405)
Q Consensus        80 y~~ggsL~~~i~~~~-~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~----~-  152 (405)
                      |+.+++|.+++.+.. ..+++..+..++.||+.||+|||++|++||||||+||+++.++ ++++||+.+.....    . 
T Consensus        80 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~  159 (328)
T cd08226          80 FMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK  159 (328)
T ss_pred             cccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence            999999999988642 3589999999999999999999999999999999999999887 99999985432111    0 


Q ss_pred             ------ccCCCCCCccChhhhcCC--CCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCC-----------
Q 015500          153 ------LQSGGTPMFMAPEVARGE--HQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRE-----------  213 (405)
Q Consensus       153 ------~~~~gt~~Y~APE~l~~~--~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~-----------  213 (405)
                            ....++..|+|||++.+.  .++.++|||||||++|+|++|+.||..................           
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (328)
T cd08226         160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCE  239 (328)
T ss_pred             ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchh
Confidence                  012246679999999774  4688999999999999999999999755433322222111000           


Q ss_pred             ---------------------------------CCCCchhccHHHHHHHHHhcccCccccCCHHHHhcCcccccccc
Q 015500          214 ---------------------------------LPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCS  257 (405)
Q Consensus       214 ---------------------------------~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~~  257 (405)
                                                       ....+..+++.+.+||++||+.||.+|||++++|+||||.....
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~  316 (328)
T cd08226         240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE  316 (328)
T ss_pred             hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence                                             00112236778999999999999999999999999999987643

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=7e-41  Score=337.74  Aligned_cols=243  Identities=26%  Similarity=0.350  Sum_probs=197.9

Q ss_pred             CcccccccceeCCeeEEEEEEcCC-----CCEEEEEEccCCC----hHHHHHHHHHHHhCC-CCCeeeeeeeeeecCCCc
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRS-----GDVFAAKSTELPK----SEFLQREQKFLSSLN-SPHIVGYKGCDVTSEDNK   71 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~-----~~~vavK~~~~~~----~~~l~~E~~iL~~L~-hpnIv~~~~~~~~~~~~~   71 (405)
                      +|++++.||+|+||+||+|.+...     +..||||.+....    .+.+.+|+++|+++. ||||+++++++....   
T Consensus        38 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~---  114 (400)
T cd05105          38 GLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG---  114 (400)
T ss_pred             ceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC---
Confidence            477899999999999999987533     3469999986532    356889999999996 999999999875433   


Q ss_pred             eEEEEEEeecCCCCHHHHHHHcC---------------------------------------------------------
Q 015500           72 LMYNLFMEYAPGGTLNDEIHRNG---------------------------------------------------------   94 (405)
Q Consensus        72 ~~~~lv~Ey~~ggsL~~~i~~~~---------------------------------------------------------   94 (405)
                       ..++|||||++|+|.+++.++.                                                         
T Consensus       115 -~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (400)
T cd05105         115 -PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE  193 (400)
T ss_pred             -ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence             2679999999999999886531                                                         


Q ss_pred             --------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccC
Q 015500           95 --------------------------------------GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES  136 (405)
Q Consensus        95 --------------------------------------~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~  136 (405)
                                                            ..+++..+..++.||+.||+|||+.||+||||||+|||++.+
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~  273 (400)
T cd05105         194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQG  273 (400)
T ss_pred             hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCC
Confidence                                                  247788889999999999999999999999999999999988


Q ss_pred             C-ceEeeeccccccccc------ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHH
Q 015500          137 G-AKIADFGCAKWESEA------LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKI  208 (405)
Q Consensus       137 ~-vkL~DFGla~~~~~~------~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i  208 (405)
                      + +||+|||+++.....      ....+++.|+|||.+.+..+++++|||||||++|||++ |..||....... .+...
T Consensus       274 ~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~-~~~~~  352 (400)
T cd05105         274 KIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS-TFYNK  352 (400)
T ss_pred             CEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH-HHHHH
Confidence            7 999999998754321      12346788999999999889999999999999999997 999996543322 22333


Q ss_pred             HhcCCCCCCchhccHHHHHHHHHhcccCccccCCHHHHhcC
Q 015500          209 AYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       209 ~~~~~~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      ......+..+..++.++.+++.+||+.||++|||+.++.+.
T Consensus       353 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~  393 (400)
T cd05105         353 IKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDI  393 (400)
T ss_pred             HhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHH
Confidence            33333345566789999999999999999999999998663

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=5.2e-41  Score=317.01  Aligned_cols=245  Identities=27%  Similarity=0.505  Sum_probs=204.6

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccC--------CChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL--------PKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLM   73 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~--------~~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~   73 (405)
                      .|.+.+.||+|+||+||+|.+..++..+++|....        .....+.+|+.++++++||||+++++.+....    .
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~   76 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERD----A   76 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCC----c
Confidence            48899999999999999999988877776666432        12335678999999999999999998765433    2


Q ss_pred             EEEEEeecCCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCCceEeeeccccccc
Q 015500           74 YNLFMEYAPGGTLNDEIHR---NGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGAKIADFGCAKWES  150 (405)
Q Consensus        74 ~~lv~Ey~~ggsL~~~i~~---~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~vkL~DFGla~~~~  150 (405)
                      +++++||+++++|.+++..   .+..+++..++.++.|++.||.|||++|++|+||||+||+++.+.+||+|||++....
T Consensus        77 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~~~~~l~d~g~~~~~~  156 (260)
T cd08222          77 FCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNNLLKIGDFGVSRLLM  156 (260)
T ss_pred             eEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeecCCEeecccCceeecC
Confidence            6699999999999998864   3457999999999999999999999999999999999999987779999999987543


Q ss_pred             c----cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHH
Q 015500          151 E----ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQAN  226 (405)
Q Consensus       151 ~----~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~  226 (405)
                      .    .....|++.|+|||.+.+..++.++|+||||+++|+|++|..||... .......++ .....+..+..++.++.
T Consensus       157 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~~  234 (260)
T cd08222         157 GSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ-NFLSVVLRI-VEGPTPSLPETYSRQLN  234 (260)
T ss_pred             CCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCc-cHHHHHHHH-HcCCCCCCcchhcHHHH
Confidence            2    22345889999999998888899999999999999999999999543 333333333 33456667778899999


Q ss_pred             HHHHHhcccCccccCCHHHHhcCccc
Q 015500          227 DFLSNCLRRDPKERWAASQLLKHPFL  252 (405)
Q Consensus       227 dll~~~L~~dP~~Rpt~~elL~hp~~  252 (405)
                      ++|.+||+.+|++||++.++++||||
T Consensus       235 ~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         235 SIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             HHHHHHhcCChhhCcCHHHHhhCCCC
Confidence            99999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=9e-41  Score=315.60  Aligned_cols=240  Identities=21%  Similarity=0.336  Sum_probs=198.3

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC--ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEe
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP--KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFME   79 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~--~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (405)
                      +|++.+.||+|+||.||+|.+. ++..+|+|.+...  ..+.+.+|+.++++++||||+++++.+....    ..+++||
T Consensus         7 ~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e   81 (261)
T cd05072           7 SIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEE----PIYIITE   81 (261)
T ss_pred             HeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC----CcEEEEe
Confidence            5889999999999999999864 5677999987643  3467889999999999999999988764432    2569999


Q ss_pred             ecCCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccccc----
Q 015500           80 YAPGGTLNDEIHRN-GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEAL----  153 (405)
Q Consensus        80 y~~ggsL~~~i~~~-~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~~----  153 (405)
                      |+++++|.+++.+. +..+++..+..++.|++.||+|||+.|++||||||+||+++.++ +||+|||++.......    
T Consensus        82 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~  161 (261)
T cd05072          82 YMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAR  161 (261)
T ss_pred             cCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCceecc
Confidence            99999999999763 45689999999999999999999999999999999999999888 9999999997654321    


Q ss_pred             -cCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHH
Q 015500          154 -QSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSN  231 (405)
Q Consensus       154 -~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~  231 (405)
                       ...++..|+|||.+.+..+++++|||||||++|+|++ |+.||.... .......+...... ..+..++.++.+++.+
T Consensus       162 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~  239 (261)
T cd05072         162 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS-NSDVMSALQRGYRM-PRMENCPDELYDIMKT  239 (261)
T ss_pred             CCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCC-HHHHHHHHHcCCCC-CCCCCCCHHHHHHHHH
Confidence             2235667999999998889999999999999999998 999996543 33334443333222 3344578999999999


Q ss_pred             hcccCccccCCHHHHhc
Q 015500          232 CLRRDPKERWAASQLLK  248 (405)
Q Consensus       232 ~L~~dP~~Rpt~~elL~  248 (405)
                      ||..+|++|||++++++
T Consensus       240 ~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         240 CWKEKAEERPTFDYLQS  256 (261)
T ss_pred             HccCCcccCcCHHHHHH
Confidence            99999999999999865

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=9.4e-41  Score=322.55  Aligned_cols=242  Identities=25%  Similarity=0.352  Sum_probs=197.7

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCC--EEEEEEccCC----ChHHHHHHHHHHHhC-CCCCeeeeeeeeeecCCCceEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGD--VFAAKSTELP----KSEFLQREQKFLSSL-NSPHIVGYKGCDVTSEDNKLMY   74 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~--~vavK~~~~~----~~~~l~~E~~iL~~L-~hpnIv~~~~~~~~~~~~~~~~   74 (405)
                      +|++.+.||+|+||.||+|.++.++.  .+++|.+...    ..+.+.+|+++++++ +||||+++++++....    .+
T Consensus         3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~----~~   78 (297)
T cd05089           3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRG----YL   78 (297)
T ss_pred             cceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCC----cc
Confidence            68899999999999999999887765  4688876532    124678899999999 7999999998765433    26


Q ss_pred             EEEEeecCCCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-c
Q 015500           75 NLFMEYAPGGTLNDEIHRNG---------------GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-A  138 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~i~~~~---------------~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-v  138 (405)
                      +++|||+++++|.+++....               +.+++..++.++.||+.||+|||++|++||||||+|||++.++ +
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          79 YIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             eEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeE
Confidence            69999999999999997532               3588999999999999999999999999999999999999887 9


Q ss_pred             eEeeeccccccccc---ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCC
Q 015500          139 KIADFGCAKWESEA---LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSREL  214 (405)
Q Consensus       139 kL~DFGla~~~~~~---~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~  214 (405)
                      ||+|||++......   .....+..|+|||.+.+..++.++|||||||++|||++ |..||.... ......++. ....
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~-~~~~~~~~~-~~~~  236 (297)
T cd05089         159 KIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT-CAELYEKLP-QGYR  236 (297)
T ss_pred             EECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC-HHHHHHHHh-cCCC
Confidence            99999998643321   11223456999999998889999999999999999997 999996443 333333333 2333


Q ss_pred             CCCchhccHHHHHHHHHhcccCccccCCHHHHhcC
Q 015500          215 PEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       215 ~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      +..|..++..+.+|+.+||+.+|.+|||++++++.
T Consensus       237 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         237 MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            45566789999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=6e-41  Score=325.20  Aligned_cols=248  Identities=29%  Similarity=0.379  Sum_probs=197.4

Q ss_pred             CcccccccceeCCeeEEEEEEcC--CCCEEEEEEccCC------ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLR--SGDVFAAKSTELP------KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLM   73 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~--~~~~vavK~~~~~------~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~   73 (405)
                      .|.+.+.||+|+||.||+|.++.  +++.+|+|.+...      ..+.+.+|+.+++.++||||+++++.+.....  ..
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--~~   78 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHAD--KS   78 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCC--ce
Confidence            47889999999999999999988  8999999988762      24577889999999999999999998765422  24


Q ss_pred             EEEEEeecCCCCHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcc----CC-ceEeeec
Q 015500           74 YNLFMEYAPGGTLNDEIHRN----GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAE----SG-AKIADFG  144 (405)
Q Consensus        74 ~~lv~Ey~~ggsL~~~i~~~----~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~----~~-vkL~DFG  144 (405)
                      +++||||+++ +|.+++...    ...+++..++.++.||+.||.|||++|++||||||+||+++.    ++ +||+|||
T Consensus        79 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg  157 (316)
T cd07842          79 VYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLG  157 (316)
T ss_pred             EEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence            6799999965 777776532    236899999999999999999999999999999999999998    66 9999999


Q ss_pred             cccccccc-------ccCCCCCCccChhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChH--------HHHHHH
Q 015500          145 CAKWESEA-------LQSGGTPMFMAPEVARG-EHQGFASDIWAVGCTVIEMASGGAPWPNAADPM--------TVLYKI  208 (405)
Q Consensus       145 la~~~~~~-------~~~~gt~~Y~APE~l~~-~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~--------~~l~~i  208 (405)
                      +++.....       ....+|+.|+|||++.+ ..++.++|||||||++|+|++|++||.......        ..+..+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
T cd07842         158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI  237 (316)
T ss_pred             cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence            98764331       12357899999998876 457889999999999999999999996443211        000000


Q ss_pred             Hh------------------------cCCCCCCc-----------hhccHHHHHHHHHhcccCccccCCHHHHhcCccc
Q 015500          209 AY------------------------SRELPEVP-----------AFLSKQANDFLSNCLRRDPKERWAASQLLKHPFL  252 (405)
Q Consensus       209 ~~------------------------~~~~~~~p-----------~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~  252 (405)
                      ..                        .......+           ...+..+.++|.+||+.||++|||+.++++||||
T Consensus       238 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence            00                        00000111           0456789999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.5e-40  Score=314.54  Aligned_cols=235  Identities=24%  Similarity=0.328  Sum_probs=194.3

Q ss_pred             ccceeCCeeEEEEEEc--CCCCEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEeec
Q 015500            8 TIGQGSSATVSLATSL--RSGDVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYA   81 (405)
Q Consensus         8 ~LG~G~~g~Vyla~~~--~~~~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~Ey~   81 (405)
                      .||+|+||.||+|.++  ..+..+|+|......    .+.+.+|+.++++++||||+++++++..  .   .+++||||+
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~--~---~~~lv~e~~   76 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA--E---ALMLVMEMA   76 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC--C---CeEEEEEeC
Confidence            4899999999999875  345579999886543    2468899999999999999999987532  1   256999999


Q ss_pred             CCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc-------c
Q 015500           82 PGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA-------L  153 (405)
Q Consensus        82 ~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~-------~  153 (405)
                      ++++|.+++..+.+.+++..+..++.||+.||.|||++|++||||||+||+++.++ +||+|||++......       .
T Consensus        77 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05115          77 SGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS  156 (257)
T ss_pred             CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence            99999999987666899999999999999999999999999999999999999887 999999998753221       1


Q ss_pred             cCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHh
Q 015500          154 QSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNC  232 (405)
Q Consensus       154 ~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~  232 (405)
                      ...+++.|+|||.+.+..++.++|||||||++|+|++ |..||..... ......+ .....+..|...++++.++|.+|
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~l~~li~~c  234 (257)
T cd05115         157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG-PEVMSFI-EQGKRLDCPAECPPEMYALMKDC  234 (257)
T ss_pred             CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH-HHHHHHH-HCCCCCCCCCCCCHHHHHHHHHH
Confidence            1223578999999998889999999999999999996 9999965533 3333333 33344567777899999999999


Q ss_pred             cccCccccCCHHHHhcC
Q 015500          233 LRRDPKERWAASQLLKH  249 (405)
Q Consensus       233 L~~dP~~Rpt~~elL~h  249 (405)
                      |..+|++||++.++++.
T Consensus       235 ~~~~~~~Rp~~~~i~~~  251 (257)
T cd05115         235 WIYKWEDRPNFAKVEER  251 (257)
T ss_pred             cCCChhhCcCHHHHHHH
Confidence            99999999999998653

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=6.5e-41  Score=322.10  Aligned_cols=242  Identities=25%  Similarity=0.402  Sum_probs=200.4

Q ss_pred             CcccccccceeCCeeEEEEEEcCC-----CCEEEEEEccCCCh----HHHHHHHHHHHhC-CCCCeeeeeeeeeecCCCc
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRS-----GDVFAAKSTELPKS----EFLQREQKFLSSL-NSPHIVGYKGCDVTSEDNK   71 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~-----~~~vavK~~~~~~~----~~l~~E~~iL~~L-~hpnIv~~~~~~~~~~~~~   71 (405)
                      +|+..+.||+|+||.||+|.+...     ...+|+|.+.....    ..+.+|+.+++++ +||||+++++.+....   
T Consensus        13 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~---   89 (293)
T cd05053          13 RLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG---   89 (293)
T ss_pred             HeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC---
Confidence            478889999999999999997643     37899998865422    3577899999999 8999999998765433   


Q ss_pred             eEEEEEEeecCCCCHHHHHHHc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccC
Q 015500           72 LMYNLFMEYAPGGTLNDEIHRN---------------GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES  136 (405)
Q Consensus        72 ~~~~lv~Ey~~ggsL~~~i~~~---------------~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~  136 (405)
                       .++++|||+++|+|.+++.+.               .+.+++..+..++.||+.||+|||+.||+||||||+||+++.+
T Consensus        90 -~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~  168 (293)
T cd05053          90 -PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTED  168 (293)
T ss_pred             -CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCC
Confidence             267999999999999999642               3468999999999999999999999999999999999999988


Q ss_pred             C-ceEeeeccccccccc------ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHH
Q 015500          137 G-AKIADFGCAKWESEA------LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKI  208 (405)
Q Consensus       137 ~-vkL~DFGla~~~~~~------~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i  208 (405)
                      + +||+|||+++.....      ....++..|+|||.+.+..++.++|||||||++|||++ |..||....  .......
T Consensus       169 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~--~~~~~~~  246 (293)
T cd05053         169 HVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP--VEELFKL  246 (293)
T ss_pred             CeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCC--HHHHHHH
Confidence            8 999999999764331      11234567999999998889999999999999999997 999996543  2233333


Q ss_pred             HhcCCCCCCchhccHHHHHHHHHhcccCccccCCHHHHhcC
Q 015500          209 AYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       209 ~~~~~~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      ......+..|...+..+.+|+.+||..||++|||+.+++++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         247 LKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             HHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            33444556677789999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=9.6e-41  Score=327.87  Aligned_cols=246  Identities=29%  Similarity=0.435  Sum_probs=198.8

Q ss_pred             cc-cccccceeCCeeEEEEEEcCCCCEEEEEEccCCCh-----------------HHHHHHHHHHHhCCCCCeeeeeeee
Q 015500            3 WT-RGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS-----------------EFLQREQKFLSSLNSPHIVGYKGCD   64 (405)
Q Consensus         3 y~-~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~~-----------------~~l~~E~~iL~~L~hpnIv~~~~~~   64 (405)
                      |. +.+.||.|+||+||+|.++.+++.+|||.+.....                 ..+.+|+++++.++||||+++++++
T Consensus        10 y~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   89 (335)
T PTZ00024         10 YIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVY   89 (335)
T ss_pred             hhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEE
Confidence            54 45779999999999999999999999998754321                 1467899999999999999999887


Q ss_pred             eecCCCceEEEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeee
Q 015500           65 VTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADF  143 (405)
Q Consensus        65 ~~~~~~~~~~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DF  143 (405)
                      ....    .++++|||+. |+|.+++... ..+++..+..++.||+.||.|||+.|++|+||||+||+++.++ +||+||
T Consensus        90 ~~~~----~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~df  163 (335)
T PTZ00024         90 VEGD----FINLVMDIMA-SDLKKVVDRK-IRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADF  163 (335)
T ss_pred             ecCC----cEEEEEeccc-cCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCc
Confidence            5433    4679999996 5999998765 4799999999999999999999999999999999999999887 999999


Q ss_pred             cccccccc------------------cccCCCCCCccChhhhcCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHH
Q 015500          144 GCAKWESE------------------ALQSGGTPMFMAPEVARGE-HQGFASDIWAVGCTVIEMASGGAPWPNAADPMTV  204 (405)
Q Consensus       144 Gla~~~~~------------------~~~~~gt~~Y~APE~l~~~-~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~  204 (405)
                      |+++....                  .....+++.|+|||.+.+. .++.++|+|||||++|+|++|++||....+. ..
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~-~~  242 (335)
T PTZ00024        164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI-DQ  242 (335)
T ss_pred             cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HH
Confidence            99875431                  1123468889999998764 4688999999999999999999999755432 22


Q ss_pred             HHHHHhcCCCC--------------------------CCchhccHHHHHHHHHhcccCccccCCHHHHhcCcccccc
Q 015500          205 LYKIAYSRELP--------------------------EVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       205 l~~i~~~~~~~--------------------------~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      +..+......|                          ......++++.++|++||+.+|++|||++++|.||||+..
T Consensus       243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~  319 (335)
T PTZ00024        243 LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSD  319 (335)
T ss_pred             HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCC
Confidence            22221110000                          0112357889999999999999999999999999999865

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1.2e-40  Score=320.77  Aligned_cols=242  Identities=27%  Similarity=0.410  Sum_probs=200.5

Q ss_pred             CcccccccceeCCeeEEEEEEcC-----CCCEEEEEEccCCC---hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLR-----SGDVFAAKSTELPK---SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLM   73 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~-----~~~~vavK~~~~~~---~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~   73 (405)
                      +|...+.||+|+||.||+|.+..     ++..+++|.+....   ...+.+|+.++++++||||+++++.+....    .
T Consensus         6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~   81 (291)
T cd05094           6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGD----P   81 (291)
T ss_pred             HeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC----c
Confidence            57888999999999999998543     45678999886543   256889999999999999999999775433    2


Q ss_pred             EEEEEeecCCCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-
Q 015500           74 YNLFMEYAPGGTLNDEIHRNG---------------GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-  137 (405)
Q Consensus        74 ~~lv~Ey~~ggsL~~~i~~~~---------------~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-  137 (405)
                      +++||||+++++|.+++..++               +.+++..++.++.||+.||+|||++|++||||||+||+++.++ 
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          82 LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLL  161 (291)
T ss_pred             eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc
Confidence            669999999999999997642               3488999999999999999999999999999999999999888 


Q ss_pred             ceEeeecccccccc------cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHh
Q 015500          138 AKIADFGCAKWESE------ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAY  210 (405)
Q Consensus       138 vkL~DFGla~~~~~------~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~  210 (405)
                      +||+|||++.....      .....+++.|+|||.+.+..++.++|||||||++|+|+| |+.||.... ....... ..
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~-~~~~~~~-~~  239 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS-NTEVIEC-IT  239 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC-HHHHHHH-Hh
Confidence            99999999875432      122346788999999999999999999999999999999 999995443 3333333 33


Q ss_pred             cCCCCCCchhccHHHHHHHHHhcccCccccCCHHHHhcC
Q 015500          211 SRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       211 ~~~~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      ....+..+..++..+.+++.+||+.+|++|||+.++++.
T Consensus       240 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~  278 (291)
T cd05094         240 QGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKI  278 (291)
T ss_pred             CCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            344455666789999999999999999999999999664

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.3e-40  Score=315.58  Aligned_cols=239  Identities=25%  Similarity=0.359  Sum_probs=196.9

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC--hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEe
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK--SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFME   79 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~--~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (405)
                      +|++.+.||+|+||+||+|.+..+ ..+|+|.+....  .+.+.+|++++++++||||+++++.+.  ..   .++++||
T Consensus         7 ~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~--~~---~~~lv~e   80 (262)
T cd05071           7 SLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS--EE---PIYIVTE   80 (262)
T ss_pred             HeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC--CC---CcEEEEE
Confidence            588999999999999999998655 459999887532  457889999999999999999987642  22   2469999


Q ss_pred             ecCCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccccc----
Q 015500           80 YAPGGTLNDEIHRN-GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEAL----  153 (405)
Q Consensus        80 y~~ggsL~~~i~~~-~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~~----  153 (405)
                      |+++|+|.+++.+. +..+++..+..++.|++.||+|||+.|++||||||+||+++.++ +||+|||+++......    
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~  160 (262)
T cd05071          81 YMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR  160 (262)
T ss_pred             cCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccccccc
Confidence            99999999999764 33589999999999999999999999999999999999999887 9999999987543311    


Q ss_pred             -cCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHH
Q 015500          154 -QSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSN  231 (405)
Q Consensus       154 -~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~  231 (405)
                       ...++..|+|||.+.+..++.++|||||||++|+|+| |..||.... .......+..... ...+..+++.+.+++.+
T Consensus       161 ~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~  238 (262)
T cd05071         161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-NREVLDQVERGYR-MPCPPECPESLHDLMCQ  238 (262)
T ss_pred             cCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC-hHHHHHHHhcCCC-CCCccccCHHHHHHHHH
Confidence             2235677999999998889999999999999999999 888996543 3333334332222 23455688999999999


Q ss_pred             hcccCccccCCHHHHhc
Q 015500          232 CLRRDPKERWAASQLLK  248 (405)
Q Consensus       232 ~L~~dP~~Rpt~~elL~  248 (405)
                      ||++||++|||+.++++
T Consensus       239 ~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         239 CWRKEPEERPTFEYLQA  255 (262)
T ss_pred             HccCCcccCCCHHHHHH
Confidence            99999999999999865

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-40  Score=316.94  Aligned_cols=242  Identities=23%  Similarity=0.289  Sum_probs=201.2

Q ss_pred             CcccccccceeCCeeEEEEEEcCCC-----CEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCce
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSG-----DVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKL   72 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~-----~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~   72 (405)
                      +|++.+.||+|+||.||+|.++..+     ..+|+|......    ...+.+|+.+|+.++||||+++++++....    
T Consensus         7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~----   82 (277)
T cd05032           7 KITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ----   82 (277)
T ss_pred             HeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC----
Confidence            5889999999999999999987544     789999976442    235778999999999999999999865442    


Q ss_pred             EEEEEEeecCCCCHHHHHHHcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEee
Q 015500           73 MYNLFMEYAPGGTLNDEIHRNG---------GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIAD  142 (405)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~i~~~~---------~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~D  142 (405)
                      .++++|||+++|+|.+++....         +.+++..+..++.||+.||.|||+.|++||||||+||+++.++ +||+|
T Consensus        83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~d  162 (277)
T cd05032          83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGD  162 (277)
T ss_pred             CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEECC
Confidence            3568999999999999997532         2467889999999999999999999999999999999999888 99999


Q ss_pred             ecccccccc------cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCC
Q 015500          143 FGCAKWESE------ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELP  215 (405)
Q Consensus       143 FGla~~~~~------~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~  215 (405)
                      ||+++....      .....++..|+|||.+.+..+++++|||||||++|||++ |..||... +.......+. ....+
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~-~~~~~~~~~~-~~~~~  240 (277)
T cd05032         163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGL-SNEEVLKFVI-DGGHL  240 (277)
T ss_pred             cccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccC-CHHHHHHHHh-cCCCC
Confidence            999875432      123346788999999998889999999999999999998 99999543 3333333333 44556


Q ss_pred             CCchhccHHHHHHHHHhcccCccccCCHHHHhcC
Q 015500          216 EVPAFLSKQANDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       216 ~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      ..|..++..+.+++.+||+.+|++|||+.++++.
T Consensus       241 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~  274 (277)
T cd05032         241 DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSS  274 (277)
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            6777789999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.4e-40  Score=318.52  Aligned_cols=242  Identities=26%  Similarity=0.414  Sum_probs=195.6

Q ss_pred             cccccccceeCCeeEEEEE----EcCCCCEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEE
Q 015500            3 WTRGHTIGQGSSATVSLAT----SLRSGDVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMY   74 (405)
Q Consensus         3 y~~~~~LG~G~~g~Vyla~----~~~~~~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~   74 (405)
                      |...+.||+|+||+||++.    ...++..+|+|.+....    ...+.+|+++|++++||||+++++++.....  ..+
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~--~~~   83 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG--KGL   83 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC--ceE
Confidence            3788999999999998865    33578899999886532    3567889999999999999999987654332  245


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc-
Q 015500           75 NLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA-  152 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~-  152 (405)
                      +++|||+++++|.+++...  .+++..++.++.|++.||.|||++||+||||||+||+++.++ +||+|||+++..... 
T Consensus        84 ~lv~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~  161 (283)
T cd05080          84 QLIMEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH  161 (283)
T ss_pred             EEEecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcc
Confidence            6999999999999999764  599999999999999999999999999999999999999887 999999998764331 


Q ss_pred             ------ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHH-------------HHHHHhcCC
Q 015500          153 ------LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTV-------------LYKIAYSRE  213 (405)
Q Consensus       153 ------~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~-------------l~~i~~~~~  213 (405)
                            ....++..|+|||.+.+..++.++|||||||++|+|+||..||.........             +........
T Consensus       162 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (283)
T cd05080         162 EYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGM  241 (283)
T ss_pred             hhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCC
Confidence                  1223566799999999888999999999999999999999998543321111             111111112


Q ss_pred             CCCCchhccHHHHHHHHHhcccCccccCCHHHHhc
Q 015500          214 LPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLK  248 (405)
Q Consensus       214 ~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~  248 (405)
                      .+..+..++..+.+++.+||+.+|++|||++++++
T Consensus       242 ~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         242 RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             CCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            22345667899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.8e-40  Score=317.71  Aligned_cols=246  Identities=28%  Similarity=0.414  Sum_probs=198.1

Q ss_pred             CcccccccceeCCeeEEEEE----EcCCCCEEEEEEccCCC---hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEE
Q 015500            2 DWTRGHTIGQGSSATVSLAT----SLRSGDVFAAKSTELPK---SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMY   74 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~----~~~~~~~vavK~~~~~~---~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~   74 (405)
                      +|++.+.||+|+||+||+|.    +..+++.+|+|.+....   ...+.+|+++|+.++||||+++.+++......  .+
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~--~~   82 (284)
T cd05081           5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR--NL   82 (284)
T ss_pred             cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC--ce
Confidence            57889999999999999997    44678999999986543   34678999999999999999999876544332  36


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccccc
Q 015500           75 NLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEAL  153 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~~  153 (405)
                      ++||||+++++|.+++.+..+.+++..+..++.||+.||.|||++|++||||||+||+++.++ +||+|||+++......
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  162 (284)
T cd05081          83 RLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK  162 (284)
T ss_pred             EEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccCCC
Confidence            699999999999999987666799999999999999999999999999999999999999887 9999999988643311


Q ss_pred             -------cCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChH--------------HHHHHHHhcC
Q 015500          154 -------QSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPM--------------TVLYKIAYSR  212 (405)
Q Consensus       154 -------~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~--------------~~l~~i~~~~  212 (405)
                             ...++..|+|||.+.+..++.++|||||||++|||++|..|+.......              ..+.......
T Consensus       163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (284)
T cd05081         163 EYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNN  242 (284)
T ss_pred             cceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcC
Confidence                   1123446999999998889999999999999999999987764322110              0011111222


Q ss_pred             CCCCCchhccHHHHHHHHHhcccCccccCCHHHHhcC
Q 015500          213 ELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       213 ~~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      ..+..+..++.++.+|+.+||..+|++|||+.++++.
T Consensus       243 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  279 (284)
T cd05081         243 GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQ  279 (284)
T ss_pred             CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence            2223445678999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=5.6e-41  Score=325.96  Aligned_cols=248  Identities=24%  Similarity=0.339  Sum_probs=195.4

Q ss_pred             cccccccceeCCeeEEEEEEcCCCCEEEEEEccCC-----ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEE
Q 015500            3 WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP-----KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLF   77 (405)
Q Consensus         3 y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~-----~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv   77 (405)
                      |.+++.+|.|  |.||+++++.+++.+|||.+...     ....+.+|+++++.++||||+++++++.....    ++++
T Consensus         4 ~~i~~~~~~~--~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~----~~~~   77 (314)
T cd08216           4 TLIGKCFEDL--MIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSE----LYVV   77 (314)
T ss_pred             hhhhHhhcCC--ceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCe----EEEE
Confidence            4444545444  55666777779999999987643     23578899999999999999999998765433    6799


Q ss_pred             EeecCCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc----
Q 015500           78 MEYAPGGTLNDEIHRN-GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE----  151 (405)
Q Consensus        78 ~Ey~~ggsL~~~i~~~-~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~----  151 (405)
                      |||+++++|.+++... +..+++..++.+++||+.||.|||++||+||||||+||+++.++ +||+|||.+.....    
T Consensus        78 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~  157 (314)
T cd08216          78 SPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKR  157 (314)
T ss_pred             EeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccc
Confidence            9999999999999763 34689999999999999999999999999999999999999877 99999998764321    


Q ss_pred             -------cccCCCCCCccChhhhcCC--CCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcC----------
Q 015500          152 -------ALQSGGTPMFMAPEVARGE--HQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSR----------  212 (405)
Q Consensus       152 -------~~~~~gt~~Y~APE~l~~~--~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~----------  212 (405)
                             .....++..|+|||++.+.  .++.++|+|||||++|||++|+.||.........+.++....          
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (314)
T cd08216         158 QRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYP  237 (314)
T ss_pred             ccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchh
Confidence                   1123467889999999763  578899999999999999999999976554433332221000          


Q ss_pred             ---------------------CCCCCchhccHHHHHHHHHhcccCccccCCHHHHhcCccccccc
Q 015500          213 ---------------------ELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFC  256 (405)
Q Consensus       213 ---------------------~~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~  256 (405)
                                           .....+..++.++.+|+.+||+.||++|||+.++|+||||+...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~  302 (314)
T cd08216         238 LYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK  302 (314)
T ss_pred             hhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence                                 00011223567899999999999999999999999999998764

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-41  Score=353.71  Aligned_cols=244  Identities=25%  Similarity=0.427  Sum_probs=197.9

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCCh---HHHHHHHHHHHhCC-CCCeeeeee-eeeecC-CC-ceEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS---EFLQREQKFLSSLN-SPHIVGYKG-CDVTSE-DN-KLMY   74 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~~---~~l~~E~~iL~~L~-hpnIv~~~~-~~~~~~-~~-~~~~   74 (405)
                      +.++.+.|.+|||+.||+|.+...|..||+|.+-..+.   ..+.+|+++|+.|+ |||||.|++ ...... ++ ..-+
T Consensus        38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Ev  117 (738)
T KOG1989|consen   38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEV  117 (738)
T ss_pred             EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEE
Confidence            46788999999999999999988889999998755443   56789999999996 999999998 333322 22 2456


Q ss_pred             EEEEeecCCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCCCCEEEccCC-ceEeeeccccccc
Q 015500           75 NLFMEYAPGGTLNDEIHRN-GGRLDESLIVSYTRQILQGLEYLHSNR--VVHCDIKSRNILMAESG-AKIADFGCAKWES  150 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~i~~~-~~~l~e~~~~~i~~qIl~~L~yLH~~g--ivHrDlkp~NILi~~~~-vkL~DFGla~~~~  150 (405)
                      .|+||||.||.|.|++.++ ..+|+|..+++|++|+++|+.+||...  |||||||-+||||+.++ .||||||.|....
T Consensus       118 llLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~  197 (738)
T KOG1989|consen  118 LLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSATTKI  197 (738)
T ss_pred             EeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCccccccccc
Confidence            6999999999999999752 335999999999999999999999997  99999999999999998 9999999986321


Q ss_pred             c-------------cccCCCCCCccChhhh---cCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCC
Q 015500          151 E-------------ALQSGGTPMFMAPEVA---RGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSREL  214 (405)
Q Consensus       151 ~-------------~~~~~gt~~Y~APE~l---~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~  214 (405)
                      .             .....-||.|+|||.+   ++..++.|+|||||||+||-|+....||...... . +..  ..-.+
T Consensus       198 ~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l-a-Iln--g~Y~~  273 (738)
T KOG1989|consen  198 LSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL-A-ILN--GNYSF  273 (738)
T ss_pred             CCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce-e-EEe--ccccC
Confidence            1             1122369999999986   5778999999999999999999999999654221 1 111  11234


Q ss_pred             CCCchhccHHHHHHHHHhcccCccccCCHHHHhcCc
Q 015500          215 PEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHP  250 (405)
Q Consensus       215 ~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp  250 (405)
                      |.. ..++..+++||+.||+.||.+||++.|++.+-
T Consensus       274 P~~-p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~  308 (738)
T KOG1989|consen  274 PPF-PNYSDRLKDLIRTMLQPNPDERPNIYQVLEEI  308 (738)
T ss_pred             CCC-ccHHHHHHHHHHHHhccCcccCCCHHHHHHHH
Confidence            444 34899999999999999999999999988764

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.5e-40  Score=315.73  Aligned_cols=241  Identities=22%  Similarity=0.321  Sum_probs=199.4

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCC---EEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGD---VFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMY   74 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~---~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~   74 (405)
                      +|++++.||+|+||.||+|.++.++.   .+|+|.+....    ...+.+|+.+|++++||||+++++++....    ..
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~   80 (267)
T cd05066           5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSK----PV   80 (267)
T ss_pred             HeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC----cc
Confidence            58899999999999999999875554   79999886532    346888999999999999999998765433    35


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccccc
Q 015500           75 NLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEAL  153 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~~  153 (405)
                      +++|||+++++|.+++.+..+.+++..+..++.|++.||.|||++|++||||||+||+++.++ ++|+|||++.......
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd05066          81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP  160 (267)
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence            699999999999999988767899999999999999999999999999999999999999887 9999999987643311


Q ss_pred             -------cCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHH
Q 015500          154 -------QSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQA  225 (405)
Q Consensus       154 -------~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l  225 (405)
                             ...++..|+|||.+.+..++.++|+|||||++|+|++ |..||.... .......+... ..+..+..+++.+
T Consensus       161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~~  238 (267)
T cd05066         161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMS-NQDVIKAIEEG-YRLPAPMDCPAAL  238 (267)
T ss_pred             ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCC-HHHHHHHHhCC-CcCCCCCCCCHHH
Confidence                   1123567999999998889999999999999999886 999996543 23333333322 2233455678999


Q ss_pred             HHHHHHhcccCccccCCHHHHhc
Q 015500          226 NDFLSNCLRRDPKERWAASQLLK  248 (405)
Q Consensus       226 ~dll~~~L~~dP~~Rpt~~elL~  248 (405)
                      .+++.+||+++|.+||++.++++
T Consensus       239 ~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         239 HQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             HHHHHHHcccCchhCCCHHHHHH
Confidence            99999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.6e-40  Score=322.27  Aligned_cols=243  Identities=26%  Similarity=0.366  Sum_probs=199.1

Q ss_pred             CcccccccceeCCeeEEEEEEc-----CCCCEEEEEEccCCC----hHHHHHHHHHHHhC-CCCCeeeeeeeeeecCCCc
Q 015500            2 DWTRGHTIGQGSSATVSLATSL-----RSGDVFAAKSTELPK----SEFLQREQKFLSSL-NSPHIVGYKGCDVTSEDNK   71 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~-----~~~~~vavK~~~~~~----~~~l~~E~~iL~~L-~hpnIv~~~~~~~~~~~~~   71 (405)
                      +|...+.||+|+||.||+|.+.     .++..+|+|.+....    .+.+.+|+.+++++ +||||+++++.+.....  
T Consensus        36 ~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~--  113 (302)
T cd05055          36 NLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP--  113 (302)
T ss_pred             HeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc--
Confidence            4778999999999999999853     345689999876532    24688999999999 79999999987754432  


Q ss_pred             eEEEEEEeecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccc
Q 015500           72 LMYNLFMEYAPGGTLNDEIHRNG-GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWE  149 (405)
Q Consensus        72 ~~~~lv~Ey~~ggsL~~~i~~~~-~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~  149 (405)
                        .+++|||+++|+|.+++.+.. ..+++.++..++.||+.||.|||++|++|+||||+|||++.++ +||+|||+++..
T Consensus       114 --~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~  191 (302)
T cd05055         114 --ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDI  191 (302)
T ss_pred             --eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcccccc
Confidence              569999999999999997643 3489999999999999999999999999999999999998887 999999998754


Q ss_pred             cccc------cCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhcc
Q 015500          150 SEAL------QSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLS  222 (405)
Q Consensus       150 ~~~~------~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s  222 (405)
                      ....      ...+++.|+|||.+.+..++.++|||||||++|+|++ |..||....... .+.+.......+..+...+
T Consensus       192 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~  270 (302)
T cd05055         192 MNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS-KFYKLIKEGYRMAQPEHAP  270 (302)
T ss_pred             cCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH-HHHHHHHcCCcCCCCCCCC
Confidence            3211      2235778999999999889999999999999999998 999996554332 2333332333334556678


Q ss_pred             HHHHHHHHHhcccCccccCCHHHHhcC
Q 015500          223 KQANDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       223 ~~l~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      +.+.+|+.+||.++|++|||+.++++.
T Consensus       271 ~~~~~li~~cl~~~p~~Rpt~~ell~~  297 (302)
T cd05055         271 AEIYDIMKTCWDADPLKRPTFKQIVQL  297 (302)
T ss_pred             HHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.1e-40  Score=323.64  Aligned_cols=242  Identities=24%  Similarity=0.391  Sum_probs=199.0

Q ss_pred             CcccccccceeCCeeEEEEEEcC-------CCCEEEEEEccCCC----hHHHHHHHHHHHhC-CCCCeeeeeeeeeecCC
Q 015500            2 DWTRGHTIGQGSSATVSLATSLR-------SGDVFAAKSTELPK----SEFLQREQKFLSSL-NSPHIVGYKGCDVTSED   69 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~-------~~~~vavK~~~~~~----~~~l~~E~~iL~~L-~hpnIv~~~~~~~~~~~   69 (405)
                      +|.+++.||+|+||+||+|.+..       ++..+|+|.+....    ...+.+|+.+++.+ +||||+++++++.... 
T Consensus        19 ~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~-   97 (307)
T cd05098          19 RLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG-   97 (307)
T ss_pred             HeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC-
Confidence            48899999999999999998653       23579999987542    23577899999999 7999999998765443 


Q ss_pred             CceEEEEEEeecCCCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEc
Q 015500           70 NKLMYNLFMEYAPGGTLNDEIHRNG---------------GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMA  134 (405)
Q Consensus        70 ~~~~~~lv~Ey~~ggsL~~~i~~~~---------------~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~  134 (405)
                         .+++||||+++|+|.+++..+.               ..++...++.++.||+.||+|||++|++||||||+||+++
T Consensus        98 ---~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~  174 (307)
T cd05098          98 ---PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT  174 (307)
T ss_pred             ---ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEc
Confidence               2669999999999999997642               2488899999999999999999999999999999999999


Q ss_pred             cCC-ceEeeeccccccccc------ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHH
Q 015500          135 ESG-AKIADFGCAKWESEA------LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLY  206 (405)
Q Consensus       135 ~~~-vkL~DFGla~~~~~~------~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~  206 (405)
                      .++ +||+|||+++.....      ....+++.|+|||++.+..++.++|+|||||++|+|++ |..||... . ...+.
T Consensus       175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~-~-~~~~~  252 (307)
T cd05098         175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-P-VEELF  252 (307)
T ss_pred             CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcC-C-HHHHH
Confidence            888 999999998754321      11224578999999999889999999999999999998 88998533 3 33333


Q ss_pred             HHHhcCCCCCCchhccHHHHHHHHHhcccCccccCCHHHHhcC
Q 015500          207 KIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       207 ~i~~~~~~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      ........+..|..++.++.+|+.+||..+|.+|||+.+++++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         253 KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             HHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            3333444456677789999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=9.5e-41  Score=320.05  Aligned_cols=245  Identities=25%  Similarity=0.377  Sum_probs=198.1

Q ss_pred             cccccccceeCCeeEEEEEE----cCCCCEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEE
Q 015500            3 WTRGHTIGQGSSATVSLATS----LRSGDVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMY   74 (405)
Q Consensus         3 y~~~~~LG~G~~g~Vyla~~----~~~~~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~   74 (405)
                      |.+.+.||+|+||.||+|..    +.++..+|+|.+....    ...+.+|+++++.++||||+++.+++.....  ..+
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--~~~   83 (284)
T cd05079           6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGG--NGI   83 (284)
T ss_pred             hhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC--Cce
Confidence            68899999999999999974    4578899999986432    3578899999999999999999987655322  235


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc-
Q 015500           75 NLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA-  152 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~-  152 (405)
                      +++|||++|++|.+++.+....+++..+..++.||+.||+|||++|++||||||+||+++.++ +||+|||+++..... 
T Consensus        84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~  163 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK  163 (284)
T ss_pred             EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccCc
Confidence            699999999999999977655789999999999999999999999999999999999998887 999999998754321 


Q ss_pred             ------ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-------------hHHHHHHHHhcCC
Q 015500          153 ------LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAAD-------------PMTVLYKIAYSRE  213 (405)
Q Consensus       153 ------~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~-------------~~~~l~~i~~~~~  213 (405)
                            ....++..|+|||.+.+..++.++|||||||++|+|+|++.|+.....             .............
T Consensus       164 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (284)
T cd05079         164 EYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGK  243 (284)
T ss_pred             cceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcCc
Confidence                  123467789999999988899999999999999999998776532110             1111111111222


Q ss_pred             CCCCchhccHHHHHHHHHhcccCccccCCHHHHhcC
Q 015500          214 LPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       214 ~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      ....+..++..+.+|+.+||+.||.+|||+.+++++
T Consensus       244 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         244 RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            233456689999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=4e-41  Score=318.23  Aligned_cols=235  Identities=20%  Similarity=0.320  Sum_probs=193.2

Q ss_pred             cccceeCCeeEEEEEEcCCCCE-------EEEEEccCCC---hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEE
Q 015500            7 HTIGQGSSATVSLATSLRSGDV-------FAAKSTELPK---SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         7 ~~LG~G~~g~Vyla~~~~~~~~-------vavK~~~~~~---~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      +.||+|+||+||+|.++..+..       +|+|......   .+.+.+|..+++.++||||+++++.+.....    .++
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~----~~l   76 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDE----SIM   76 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCC----cEE
Confidence            4799999999999998765543       8888876543   3467889999999999999999998765443    568


Q ss_pred             EEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC---------ceEeeecccc
Q 015500           77 FMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG---------AKIADFGCAK  147 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~---------vkL~DFGla~  147 (405)
                      ||||+++|+|.+++..++..+++..++.++.||+.||+|||++||+||||||+||+++.++         ++++|||++.
T Consensus        77 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~  156 (258)
T cd05078          77 VQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI  156 (258)
T ss_pred             EEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence            9999999999999987766789999999999999999999999999999999999997654         5999999987


Q ss_pred             cccccccCCCCCCccChhhhcC-CCCCcchhHHHHHHHHHHHHhCC-CCCCCCCChHHHHHHHHhcCCCCCCchhccHHH
Q 015500          148 WESEALQSGGTPMFMAPEVARG-EHQGFASDIWAVGCTVIEMASGG-APWPNAADPMTVLYKIAYSRELPEVPAFLSKQA  225 (405)
Q Consensus       148 ~~~~~~~~~gt~~Y~APE~l~~-~~~~~~sDIwSLG~il~elltG~-~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l  225 (405)
                      .........+++.|+|||.+.+ ..++.++|||||||++|+|++|. .||... +........   ...+.+|...+.++
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~-~~~~~~~~~---~~~~~~~~~~~~~~  232 (258)
T cd05078         157 TVLPKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSAL-DSQKKLQFY---EDRHQLPAPKWTEL  232 (258)
T ss_pred             ccCCchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhc-cHHHHHHHH---HccccCCCCCcHHH
Confidence            6655555678999999999987 45788999999999999999995 555433 332222211   12334555677899


Q ss_pred             HHHHHHhcccCccccCCHHHHhcC
Q 015500          226 NDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       226 ~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      .+++.+||+.||++|||++++++.
T Consensus       233 ~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         233 ANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             HHHHHHHhccChhhCCCHHHHHHh
Confidence            999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.3e-40  Score=327.36  Aligned_cols=251  Identities=30%  Similarity=0.401  Sum_probs=202.4

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccC-----CChHHHHHHHHHHHhC-CCCCeeeeeeeeeecCCCceEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL-----PKSEFLQREQKFLSSL-NSPHIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~-----~~~~~l~~E~~iL~~L-~hpnIv~~~~~~~~~~~~~~~~~   75 (405)
                      +|++.+.||+|+||.||+|.+..+|+.+|+|.+..     .....+.+|+.+++++ +||||+++++++.....  ..++
T Consensus         8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~--~~~~   85 (337)
T cd07852           8 KYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEND--KDIY   85 (337)
T ss_pred             HHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCC--ceEE
Confidence            58899999999999999999999999999998743     2234577899999999 99999999987654332  2356


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc--
Q 015500           76 LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA--  152 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~--  152 (405)
                      +||||+++ +|.+++...  .+++..+..++.||+.||.|||+.||+||||||+||+++.++ +||+|||++......  
T Consensus        86 lv~e~~~~-~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~  162 (337)
T cd07852          86 LVFEYMET-DLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEE  162 (337)
T ss_pred             EEeccccc-CHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccccc
Confidence            99999974 999888764  789999999999999999999999999999999999999988 999999998754321  


Q ss_pred             -------ccCCCCCCccChhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcC------------
Q 015500          153 -------LQSGGTPMFMAPEVARG-EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSR------------  212 (405)
Q Consensus       153 -------~~~~gt~~Y~APE~l~~-~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~------------  212 (405)
                             ....||+.|+|||.+.+ ..++.++|+|||||++|+|+||+.||....... ...++....            
T Consensus       163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  241 (337)
T cd07852         163 NPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLN-QLEKIIEVIGPPSAEDIESIK  241 (337)
T ss_pred             cccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCHHHHHHHH
Confidence                   12358999999998765 557889999999999999999999996543322 211111110            


Q ss_pred             -----------------CCCCCchhccHHHHHHHHHhcccCccccCCHHHHhcCccccccccc
Q 015500          213 -----------------ELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSC  258 (405)
Q Consensus       213 -----------------~~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~~~  258 (405)
                                       ........++.++.+||.+||+.||++|||+.++++||||+.+...
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~  304 (337)
T cd07852         242 SPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNP  304 (337)
T ss_pred             hhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccC
Confidence                             0011112368899999999999999999999999999999987443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-41  Score=295.16  Aligned_cols=249  Identities=28%  Similarity=0.448  Sum_probs=208.5

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      +|...++||+|.||+|++|+++.+++.||+|.+..+.     .....||+-+|+.|+|.|||+++++.....  +  +.+
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdk--k--ltl   78 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDK--K--LTL   78 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCc--e--eEE
Confidence            5778899999999999999999999999999987653     347889999999999999999998654333  2  458


Q ss_pred             EEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc---
Q 015500           77 FMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA---  152 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~---  152 (405)
                      |+|||. .+|..+....+|.++.+.++.++.|+++||.++|+.++.|||+||+|.||+.+| +|++|||+|+.+.-.   
T Consensus        79 vfe~cd-qdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrc  157 (292)
T KOG0662|consen   79 VFEFCD-QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC  157 (292)
T ss_pred             eHHHhh-HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEe
Confidence            999995 489999988888999999999999999999999999999999999999999999 999999999865442   


Q ss_pred             -ccCCCCCCccChhhhcCCC-CCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCC---------------
Q 015500          153 -LQSGGTPMFMAPEVARGEH-QGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELP---------------  215 (405)
Q Consensus       153 -~~~~gt~~Y~APE~l~~~~-~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~---------------  215 (405)
                       ....-|.+|.+|.++.|.+ |+...|+||.||++.|+.....|.....+...++.+|...-..|               
T Consensus       158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk  237 (292)
T KOG0662|consen  158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYK  237 (292)
T ss_pred             eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCc
Confidence             2345799999999998854 88899999999999999985555445667777777665332211               


Q ss_pred             ---CCc---------hhccHHHHHHHHHhcccCccccCCHHHHhcCcccccc
Q 015500          216 ---EVP---------AFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       216 ---~~p---------~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                         .+|         +.++...+|+++++|.-+|.+|.+++++|+||||...
T Consensus       238 ~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~  289 (292)
T KOG0662|consen  238 PYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF  289 (292)
T ss_pred             ccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence               122         1145567899999999999999999999999999865

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=2.3e-40  Score=312.88  Aligned_cols=238  Identities=24%  Similarity=0.345  Sum_probs=197.4

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC--ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEe
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP--KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFME   79 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~--~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (405)
                      +|++.+.||+|+||+||+|.+. .+..+|+|.+...  ..+.+.+|+.++++++||||+++++...  .. .  .+++||
T Consensus         7 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~--~~-~--~~lv~e   80 (260)
T cd05070           7 SLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS--EE-P--IYIVTE   80 (260)
T ss_pred             HhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC--CC-C--cEEEEE
Confidence            5889999999999999999875 5667999988653  3467889999999999999999987652  22 1  459999


Q ss_pred             ecCCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccccc----
Q 015500           80 YAPGGTLNDEIHRN-GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEAL----  153 (405)
Q Consensus        80 y~~ggsL~~~i~~~-~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~~----  153 (405)
                      |+++++|.+++... ...+++..+..++.|++.||.|||++|++||||||+||+++.++ ++|+|||++.......    
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~  160 (260)
T cd05070          81 YMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTAR  160 (260)
T ss_pred             ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcccccc
Confidence            99999999999764 34589999999999999999999999999999999999999887 9999999987543311    


Q ss_pred             -cCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHH
Q 015500          154 -QSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSN  231 (405)
Q Consensus       154 -~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~  231 (405)
                       ...++..|+|||.+.+..++.++|+|||||++|+|++ |.+||... +.......+.. ...+..+...+..+.+|+.+
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~-~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~  238 (260)
T cd05070         161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM-NNREVLEQVER-GYRMPCPQDCPISLHELMLQ  238 (260)
T ss_pred             cCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHHc-CCCCCCCCcCCHHHHHHHHH
Confidence             1234567999999998889999999999999999999 89999654 33444444432 23344566788999999999


Q ss_pred             hcccCccccCCHHHHh
Q 015500          232 CLRRDPKERWAASQLL  247 (405)
Q Consensus       232 ~L~~dP~~Rpt~~elL  247 (405)
                      ||..+|++|||+++++
T Consensus       239 ~l~~~p~~Rpt~~~l~  254 (260)
T cd05070         239 CWKKDPEERPTFEYLQ  254 (260)
T ss_pred             HcccCcccCcCHHHHH
Confidence            9999999999999986

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=2.2e-40  Score=325.30  Aligned_cols=252  Identities=26%  Similarity=0.352  Sum_probs=201.6

Q ss_pred             CcccccccceeCCeeEEEEEEcCC--CCEEEEEEccCC-----ChHHHHHHHHHHHhC-CCCCeeeeeeeeeecCCCceE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRS--GDVFAAKSTELP-----KSEFLQREQKFLSSL-NSPHIVGYKGCDVTSEDNKLM   73 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~--~~~vavK~~~~~-----~~~~l~~E~~iL~~L-~hpnIv~~~~~~~~~~~~~~~   73 (405)
                      +|++.+.||+|+||.||+|.+..+  +..+|+|.+...     ....+.+|+.+++++ .||||+++++...........
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            588999999999999999999888  899999987642     134677899999999 599999999876544333334


Q ss_pred             EEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc-
Q 015500           74 YNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE-  151 (405)
Q Consensus        74 ~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~-  151 (405)
                      +++++||+. ++|.+++... ..+++..++.++.||+.||.|||++|++||||||+||+++.++ +||+|||+++.... 
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~  158 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSG-QPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN  158 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence            668999985 6899988765 4799999999999999999999999999999999999999888 99999999875432 


Q ss_pred             -------cccCCCCCCccChhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhc------------
Q 015500          152 -------ALQSGGTPMFMAPEVARG-EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYS------------  211 (405)
Q Consensus       152 -------~~~~~gt~~Y~APE~l~~-~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~------------  211 (405)
                             .....||+.|+|||.+.+ ..++.++|||||||++|+|++|++||..... ...+..+...            
T Consensus       159 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~  237 (332)
T cd07857         159 PGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDY-VDQLNQILQVLGTPDEETLSRI  237 (332)
T ss_pred             cccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCH-HHHHHHHHHHhCCCCHHHHHhh
Confidence                   122358999999998866 5688999999999999999999999965432 1111111000            


Q ss_pred             ------------CC-----CCCCchhccHHHHHHHHHhcccCccccCCHHHHhcCccccccc
Q 015500          212 ------------RE-----LPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFC  256 (405)
Q Consensus       212 ------------~~-----~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~  256 (405)
                                  ..     ++......+..+.+|+.+||+.||.+|||+.+++.||||.++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~  299 (332)
T cd07857         238 GSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWH  299 (332)
T ss_pred             hhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhc
Confidence                        00     0111123578999999999999999999999999999998764

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=5.1e-41  Score=318.56  Aligned_cols=238  Identities=28%  Similarity=0.426  Sum_probs=195.4

Q ss_pred             cccccceeCCeeEEEEEEc----CCCCEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEE
Q 015500            5 RGHTIGQGSSATVSLATSL----RSGDVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         5 ~~~~LG~G~~g~Vyla~~~----~~~~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      ..+.||.|+||.||+|.+.    ..+..|+||.+....    .+.+.+|++++++++||||++++|++.....    +++
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~----~~l   78 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEP----LFL   78 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSS----EEE
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccc----ccc
Confidence            5688999999999999988    456789999985432    3678899999999999999999998873333    569


Q ss_pred             EEeecCCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc---
Q 015500           77 FMEYAPGGTLNDEIHRN-GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE---  151 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~-~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~---  151 (405)
                      |+||+++|+|.+++... ...+++..+..++.||+.||.|||+++++|++|+++||+++.++ +||+|||++.....   
T Consensus        79 v~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~  158 (259)
T PF07714_consen   79 VMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK  158 (259)
T ss_dssp             EEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            99999999999999886 56899999999999999999999999999999999999999888 99999999876521   


Q ss_pred             ---cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHH
Q 015500          152 ---ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQAND  227 (405)
Q Consensus       152 ---~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~d  227 (405)
                         .........|+|||.+.+..++.++||||||+++|||++ |+.||.+. +......++ .....+..+..++..+.+
T Consensus       159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~~~  236 (259)
T PF07714_consen  159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY-DNEEIIEKL-KQGQRLPIPDNCPKDIYS  236 (259)
T ss_dssp             EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS-CHHHHHHHH-HTTEETTSBTTSBHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccc-ccccccccc-cccccceeccchhHHHHH
Confidence               122346778999999999889999999999999999999 78999665 445555555 334445567789999999


Q ss_pred             HHHHhcccCccccCCHHHHhc
Q 015500          228 FLSNCLRRDPKERWAASQLLK  248 (405)
Q Consensus       228 ll~~~L~~dP~~Rpt~~elL~  248 (405)
                      ++.+||..||.+|||+.++++
T Consensus       237 li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  237 LIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             HHHHHT-SSGGGS--HHHHHH
T ss_pred             HHHHHcCCChhhCcCHHHHHh
Confidence            999999999999999999975

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1.2e-40  Score=319.99  Aligned_cols=249  Identities=28%  Similarity=0.479  Sum_probs=205.2

Q ss_pred             CcccccccceeCCeeEEEEEEc---CCCCEEEEEEccCC-------ChHHHHHHHHHHHhC-CCCCeeeeeeeeeecCCC
Q 015500            2 DWTRGHTIGQGSSATVSLATSL---RSGDVFAAKSTELP-------KSEFLQREQKFLSSL-NSPHIVGYKGCDVTSEDN   70 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~---~~~~~vavK~~~~~-------~~~~l~~E~~iL~~L-~hpnIv~~~~~~~~~~~~   70 (405)
                      +|++.+.||.|+||.||+|.+.   .+|+.||+|.+...       ..+.+.+|+++|+++ +||||+++++++....  
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~--   78 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDT--   78 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCC--
Confidence            5899999999999999999875   47899999987642       235678899999999 5899999988765432  


Q ss_pred             ceEEEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccc
Q 015500           71 KLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWE  149 (405)
Q Consensus        71 ~~~~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~  149 (405)
                        .++++|||+++++|.+++... +++++..+..++.||+.||.|||+.|++||||||+|||++.++ +||+|||++...
T Consensus        79 --~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  155 (290)
T cd05613          79 --KLHLILDYINGGELFTHLSQR-ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF  155 (290)
T ss_pred             --eEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence              366999999999999999876 4799999999999999999999999999999999999999888 999999998754


Q ss_pred             cc-----cccCCCCCCccChhhhcCC--CCCcchhHHHHHHHHHHHHhCCCCCCCCCCh--HHHHHHHHhcCCCCCCchh
Q 015500          150 SE-----ALQSGGTPMFMAPEVARGE--HQGFASDIWAVGCTVIEMASGGAPWPNAADP--MTVLYKIAYSRELPEVPAF  220 (405)
Q Consensus       150 ~~-----~~~~~gt~~Y~APE~l~~~--~~~~~sDIwSLG~il~elltG~~Pf~~~~~~--~~~l~~i~~~~~~~~~p~~  220 (405)
                      ..     .....|++.|+|||.+.+.  .++.++|||||||++|+|++|..||......  ...+..... ...+..|..
T Consensus       156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~  234 (290)
T cd05613         156 HEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRIL-KSEPPYPQE  234 (290)
T ss_pred             ccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhh-ccCCCCCcc
Confidence            33     1234589999999998753  4678999999999999999999999643221  122222221 223455667


Q ss_pred             ccHHHHHHHHHhcccCccccC-----CHHHHhcCccccccc
Q 015500          221 LSKQANDFLSNCLRRDPKERW-----AASQLLKHPFLEEFC  256 (405)
Q Consensus       221 ~s~~l~dll~~~L~~dP~~Rp-----t~~elL~hp~~~~~~  256 (405)
                      +++.+.+++++||+.||++||     ++++++.||||....
T Consensus       235 ~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~  275 (290)
T cd05613         235 MSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN  275 (290)
T ss_pred             CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence            899999999999999999997     899999999998763

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.3e-40  Score=329.12  Aligned_cols=252  Identities=25%  Similarity=0.385  Sum_probs=202.7

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCC--CceEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-----SEFLQREQKFLSSLNSPHIVGYKGCDVTSED--NKLMY   74 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~--~~~~~   74 (405)
                      +|.+.+.||+|+||.||+|.+..+++.||+|.+....     .+.+.+|+.++++++||||+++.+++.....  ....+
T Consensus        18 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   97 (345)
T cd07877          18 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV   97 (345)
T ss_pred             ceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccE
Confidence            5889999999999999999999999999999886432     3567789999999999999999987654322  11235


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc-
Q 015500           75 NLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA-  152 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~-  152 (405)
                      +++++++ |++|.+++...  .+++..+..++.||+.||.|||++||+||||||+||+++.++ +||+|||+++..... 
T Consensus        98 ~lv~~~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~~  174 (345)
T cd07877          98 YLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM  174 (345)
T ss_pred             EEEehhc-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccccccc
Confidence            6888887 78998887643  699999999999999999999999999999999999999888 999999998765432 


Q ss_pred             ccCCCCCCccChhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcC-------------------
Q 015500          153 LQSGGTPMFMAPEVARG-EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSR-------------------  212 (405)
Q Consensus       153 ~~~~gt~~Y~APE~l~~-~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~-------------------  212 (405)
                      ....+|+.|+|||.+.+ ..++.++|||||||++|+|++|+.||..... ...+..+....                   
T Consensus       175 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (345)
T cd07877         175 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH-IDQLKLILRLVGTPGAELLKKISSESARNY  253 (345)
T ss_pred             cccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCCHHHHhhcccHhHHHH
Confidence            33568999999999876 5678899999999999999999999965432 22221111100                   


Q ss_pred             --CCCCC--------chhccHHHHHHHHHhcccCccccCCHHHHhcCcccccccc
Q 015500          213 --ELPEV--------PAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCS  257 (405)
Q Consensus       213 --~~~~~--------p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~~  257 (405)
                        ..+..        ....++++.+||.+||+.||.+|||+.+++.||||.+...
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~  308 (345)
T cd07877         254 IQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD  308 (345)
T ss_pred             HHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCC
Confidence              00111        1135788999999999999999999999999999997643

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1e-40  Score=329.46  Aligned_cols=244  Identities=23%  Similarity=0.357  Sum_probs=199.1

Q ss_pred             CcccccccceeCCeeEEEEEE-----cCCCCEEEEEEccCCC----hHHHHHHHHHHHhC-CCCCeeeeeeeeeecCCCc
Q 015500            2 DWTRGHTIGQGSSATVSLATS-----LRSGDVFAAKSTELPK----SEFLQREQKFLSSL-NSPHIVGYKGCDVTSEDNK   71 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~-----~~~~~~vavK~~~~~~----~~~l~~E~~iL~~L-~hpnIv~~~~~~~~~~~~~   71 (405)
                      +|++++.||+|+||+||+|.+     ..+++.||||.+....    ...+.+|+.+|.++ +||||+++++++.....  
T Consensus         8 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~--   85 (343)
T cd05103           8 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG--   85 (343)
T ss_pred             HhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC--
Confidence            488999999999999999984     3467899999986532    24577899999999 68999999987654332  


Q ss_pred             eEEEEEEeecCCCCHHHHHHHcC---------------------------------------------------------
Q 015500           72 LMYNLFMEYAPGGTLNDEIHRNG---------------------------------------------------------   94 (405)
Q Consensus        72 ~~~~lv~Ey~~ggsL~~~i~~~~---------------------------------------------------------   94 (405)
                       .++++|||+++|+|.+++..+.                                                         
T Consensus        86 -~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (343)
T cd05103          86 -PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE  164 (343)
T ss_pred             -ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence             3568999999999999986532                                                         


Q ss_pred             ---------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc------ccCCCC
Q 015500           95 ---------GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA------LQSGGT  158 (405)
Q Consensus        95 ---------~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~------~~~~gt  158 (405)
                               ..++...+..++.||+.||+|||++||+||||||+|||++.++ +||+|||++......      ....++
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~  244 (343)
T cd05103         165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP  244 (343)
T ss_pred             hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCC
Confidence                     2367788899999999999999999999999999999999877 999999998754221      122356


Q ss_pred             CCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHhcccCc
Q 015500          159 PMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDP  237 (405)
Q Consensus       159 ~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~L~~dP  237 (405)
                      +.|+|||.+.+..++.++|||||||++|+|++ |..||......... .........+..|...++++.+++.+||+.||
T Consensus       245 ~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p  323 (343)
T cd05103         245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF-CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEP  323 (343)
T ss_pred             cceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHH-HHHHhccCCCCCCCCCCHHHHHHHHHHccCCh
Confidence            77999999998889999999999999999997 99999765433332 22223333445566788999999999999999


Q ss_pred             cccCCHHHHhcC
Q 015500          238 KERWAASQLLKH  249 (405)
Q Consensus       238 ~~Rpt~~elL~h  249 (405)
                      .+|||+.++++|
T Consensus       324 ~~Rps~~eil~~  335 (343)
T cd05103         324 SQRPTFSELVEH  335 (343)
T ss_pred             hhCcCHHHHHHH
Confidence            999999999987

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.9e-40  Score=311.71  Aligned_cols=234  Identities=26%  Similarity=0.356  Sum_probs=194.7

Q ss_pred             cccceeCCeeEEEEEEcCCC---CEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEe
Q 015500            7 HTIGQGSSATVSLATSLRSG---DVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFME   79 (405)
Q Consensus         7 ~~LG~G~~g~Vyla~~~~~~---~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (405)
                      +.||+|+||.||+|.+..++   ..+|+|.+....    .+.+.+|+++++.++||||+++++++.. .    .++++||
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~----~~~~v~e   75 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG-E----PLMLVME   75 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-C----ceEEEEE
Confidence            57999999999999876655   789999887543    3467889999999999999999986532 1    2569999


Q ss_pred             ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccccc----
Q 015500           80 YAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQ----  154 (405)
Q Consensus        80 y~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~~~----  154 (405)
                      |+++++|.+++...+ .+++..+..++.|++.||+|||..|++|+||||+||+++.++ +||+|||+++.......    
T Consensus        76 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~  154 (257)
T cd05060          76 LAPLGPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA  154 (257)
T ss_pred             eCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCccccc
Confidence            999999999998764 799999999999999999999999999999999999999888 99999999876433211    


Q ss_pred             ---CCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHH
Q 015500          155 ---SGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLS  230 (405)
Q Consensus       155 ---~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~  230 (405)
                         ..++..|+|||.+.+..++.++|||||||++|+|++ |..||.... .......+. .......|..++..+.++|.
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~l~~li~  232 (257)
T cd05060         155 TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK-GAEVIAMLE-SGERLPRPEECPQEIYSIML  232 (257)
T ss_pred             ccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCC-HHHHHHHHH-cCCcCCCCCCCCHHHHHHHH
Confidence               113457999999998889999999999999999998 999996543 333333333 33334566778999999999


Q ss_pred             HhcccCccccCCHHHHhc
Q 015500          231 NCLRRDPKERWAASQLLK  248 (405)
Q Consensus       231 ~~L~~dP~~Rpt~~elL~  248 (405)
                      +||..+|++||++.++++
T Consensus       233 ~cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         233 SCWKYRPEDRPTFSELES  250 (257)
T ss_pred             HHhcCChhhCcCHHHHHH
Confidence            999999999999999965

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=2e-40  Score=317.39  Aligned_cols=241  Identities=25%  Similarity=0.384  Sum_probs=198.4

Q ss_pred             CcccccccceeCCeeEEEEEEc-----CCCCEEEEEEccCCC---hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceE
Q 015500            2 DWTRGHTIGQGSSATVSLATSL-----RSGDVFAAKSTELPK---SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLM   73 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~-----~~~~~vavK~~~~~~---~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~   73 (405)
                      +++..+.||+|+||.||+|...     .++..+|+|.+....   .+.+.+|+++++.++||||+++++.+....    .
T Consensus         6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~   81 (280)
T cd05092           6 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGR----P   81 (280)
T ss_pred             hceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC----c
Confidence            5678899999999999999743     356789999876533   357889999999999999999998765433    2


Q ss_pred             EEEEEeecCCCCHHHHHHHcC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-c
Q 015500           74 YNLFMEYAPGGTLNDEIHRNG--------------GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-A  138 (405)
Q Consensus        74 ~~lv~Ey~~ggsL~~~i~~~~--------------~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-v  138 (405)
                      ++++|||+++++|.+++...+              ..+++..+..++.||+.||+|||++|++||||||+|||++.++ +
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          82 LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCE
Confidence            679999999999999997653              2488999999999999999999999999999999999999887 9


Q ss_pred             eEeeecccccccc------cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhc
Q 015500          139 KIADFGCAKWESE------ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYS  211 (405)
Q Consensus       139 kL~DFGla~~~~~------~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~  211 (405)
                      ||+|||+++....      .....+++.|+|||.+.+..++.++|||||||++|+|++ |++||..... ......+...
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-~~~~~~~~~~  240 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN-TEAIECITQG  240 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH-HHHHHHHHcC
Confidence            9999999875422      112235678999999999899999999999999999998 9999965433 3333333322


Q ss_pred             CCCCCCchhccHHHHHHHHHhcccCccccCCHHHHhc
Q 015500          212 RELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLK  248 (405)
Q Consensus       212 ~~~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~  248 (405)
                       ..+..+..+++.+.+|+.+||+.||.+||++.++++
T Consensus       241 -~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         241 -RELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             -ccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence             334556678999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-41  Score=311.89  Aligned_cols=247  Identities=28%  Similarity=0.458  Sum_probs=207.3

Q ss_pred             ccccccceeCCeeEEEEEEcCCCCEEEEEEccCC-ChHH---HHHHHHHHH-hCCCCCeeeeeeeeeecCCCceEEEEEE
Q 015500            4 TRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP-KSEF---LQREQKFLS-SLNSPHIVGYKGCDVTSEDNKLMYNLFM   78 (405)
Q Consensus         4 ~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~-~~~~---l~~E~~iL~-~L~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (405)
                      ..+..||+|+-|+|++++.+.+|...|||.+... .++.   +...+.++. .-++|+||+++|+|+.+.+    ..+.|
T Consensus        95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~d----V~IcM  170 (391)
T KOG0983|consen   95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTD----VFICM  170 (391)
T ss_pred             hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCch----HHHHH
Confidence            3466799999999999999999999999988653 3333   333444433 3358999999999998776    44788


Q ss_pred             eecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCCCCEEEccCC-ceEeeecccccccc---cc
Q 015500           79 EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN-RVVHCDIKSRNILMAESG-AKIADFGCAKWESE---AL  153 (405)
Q Consensus        79 Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~-givHrDlkp~NILi~~~~-vkL~DFGla~~~~~---~~  153 (405)
                      |.| +.-+..++++..++++|..+-.+...+++||.||..+ ||+|||+||+|||+|..| +||||||++-+.-.   ..
T Consensus       171 elM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAht  249 (391)
T KOG0983|consen  171 ELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAHT  249 (391)
T ss_pred             HHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecccccc
Confidence            988 4467777888778999999999999999999999976 899999999999999988 99999999876433   33


Q ss_pred             cCCCCCCccChhhhcCC---CCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCch--hccHHHHHH
Q 015500          154 QSGGTPMFMAPEVARGE---HQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPA--FLSKQANDF  228 (405)
Q Consensus       154 ~~~gt~~Y~APE~l~~~---~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~--~~s~~l~dl  228 (405)
                      ...|-+.|||||-+...   .|+.++||||||++++||+||..||.......+.+-++.. .+.|.+|.  .+|+++++|
T Consensus       250 rsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln-~ePP~L~~~~gFSp~F~~f  328 (391)
T KOG0983|consen  250 RSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN-EEPPLLPGHMGFSPDFQSF  328 (391)
T ss_pred             cccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh-cCCCCCCcccCcCHHHHHH
Confidence            45699999999998653   6888999999999999999999999887777888877776 44466664  389999999


Q ss_pred             HHHhcccCccccCCHHHHhcCccccccc
Q 015500          229 LSNCLRRDPKERWAASQLLKHPFLEEFC  256 (405)
Q Consensus       229 l~~~L~~dP~~Rpt~~elL~hp~~~~~~  256 (405)
                      ++.||++|+.+||...+||+|||+..+.
T Consensus       329 v~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye  356 (391)
T KOG0983|consen  329 VKDCLTKDHRKRPKYNKLLEHPFIKRYE  356 (391)
T ss_pred             HHHHhhcCcccCcchHHHhcCcceeecc
Confidence            9999999999999999999999998653

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.7e-40  Score=310.53  Aligned_cols=240  Identities=26%  Similarity=0.401  Sum_probs=200.9

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC--hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEe
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK--SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFME   79 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~--~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (405)
                      +|...+.||+|+||.||+|...  |+.+|+|.+....  .+.+.+|+.++++++||||+++++.+....    ..+++||
T Consensus         7 ~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~~v~e   80 (256)
T cd05039           7 ELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGN----PLYIVTE   80 (256)
T ss_pred             hccceeeeecCCCceEEEEEec--CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCC----CeEEEEE
Confidence            5888999999999999999875  8899999987653  457889999999999999999998765422    2669999


Q ss_pred             ecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccccc-cCC
Q 015500           80 YAPGGTLNDEIHRNG-GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEAL-QSG  156 (405)
Q Consensus        80 y~~ggsL~~~i~~~~-~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~~-~~~  156 (405)
                      |+++++|.+++.... ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++ +||+|||.++...... ...
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~~~~  160 (256)
T cd05039          81 YMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGK  160 (256)
T ss_pred             ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccccccCC
Confidence            999999999997653 2689999999999999999999999999999999999999887 9999999998654322 223


Q ss_pred             CCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHhccc
Q 015500          157 GTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRR  235 (405)
Q Consensus       157 gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~L~~  235 (405)
                      ++..|+|||.+.+..++.++|+|||||++|+|++ |..||.... ..... ........+..+..+++.+.++|.+||..
T Consensus       161 ~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~  238 (256)
T cd05039         161 LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-LKDVV-PHVEKGYRMEAPEGCPPEVYKVMKDCWEL  238 (256)
T ss_pred             CcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC-HHHHH-HHHhcCCCCCCccCCCHHHHHHHHHHhcc
Confidence            4567999999998889999999999999999997 999996442 23322 22223334456677899999999999999


Q ss_pred             CccccCCHHHHhcC
Q 015500          236 DPKERWAASQLLKH  249 (405)
Q Consensus       236 dP~~Rpt~~elL~h  249 (405)
                      +|.+|||+.++++.
T Consensus       239 ~p~~Rp~~~~l~~~  252 (256)
T cd05039         239 DPAKRPTFKQLREQ  252 (256)
T ss_pred             ChhhCcCHHHHHHH
Confidence            99999999999763

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8e-41  Score=330.16  Aligned_cols=252  Identities=28%  Similarity=0.436  Sum_probs=204.5

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC-----ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCC--CceEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP-----KSEFLQREQKFLSSLNSPHIVGYKGCDVTSED--NKLMY   74 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~-----~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~--~~~~~   74 (405)
                      +|.+.+.||+|++|+||+|++..+++.+|+|.+...     ....+.+|+.+++.++||||+++.+++.....  ....+
T Consensus        16 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   95 (343)
T cd07851          16 RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDV   95 (343)
T ss_pred             ceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccE
Confidence            588999999999999999999999999999987642     23457789999999999999998876644332  12236


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc-c
Q 015500           75 NLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE-A  152 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~-~  152 (405)
                      ++|+||+ +++|.+++..  +++++..+..++.||+.||.|||++||+||||||+||+++.++ +||+|||++..... .
T Consensus        96 ~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~  172 (343)
T cd07851          96 YLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEM  172 (343)
T ss_pred             EEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccccccccc
Confidence            6999999 6799998875  3799999999999999999999999999999999999999887 99999999876543 2


Q ss_pred             ccCCCCCCccChhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCC-----------------
Q 015500          153 LQSGGTPMFMAPEVARG-EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSREL-----------------  214 (405)
Q Consensus       153 ~~~~gt~~Y~APE~l~~-~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~-----------------  214 (405)
                      ....+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||..... ...+..+......                 
T Consensus       173 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  251 (343)
T cd07851         173 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH-IDQLKRIMNLVGTPDEELLQKISSESARNY  251 (343)
T ss_pred             cCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHhcCCCCHHHHhhccchhHHHH
Confidence            34568999999999876 4678899999999999999999999965443 2222222111000                 


Q ss_pred             ----C--------CCchhccHHHHHHHHHhcccCccccCCHHHHhcCcccccccc
Q 015500          215 ----P--------EVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCS  257 (405)
Q Consensus       215 ----~--------~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~~  257 (405)
                          +        .....+++.+.+||.+||..||.+|||+.++++||||.+...
T Consensus       252 ~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~  306 (343)
T cd07851         252 IQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHD  306 (343)
T ss_pred             HHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCC
Confidence                0        111235889999999999999999999999999999997643

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=2.5e-40  Score=312.59  Aligned_cols=239  Identities=22%  Similarity=0.340  Sum_probs=198.7

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC--hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEe
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK--SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFME   79 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~--~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (405)
                      +|.++++||+|+||.||+|..+ +++.+|+|.+....  .+.+.+|+.++++++||||+++++.+. . .   .++++||
T Consensus         7 ~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~-~---~~~~v~e   80 (260)
T cd05067           7 TLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-Q-E---PIYIITE   80 (260)
T ss_pred             HceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-c-C---CcEEEEE
Confidence            5889999999999999999864 57889999887543  467889999999999999999987642 1 1   2569999


Q ss_pred             ecCCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc-----c
Q 015500           80 YAPGGTLNDEIHRN-GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE-----A  152 (405)
Q Consensus        80 y~~ggsL~~~i~~~-~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~-----~  152 (405)
                      |+++++|.+++... +..+++..+..++.|++.||+|||+.|++||||||+||+++.++ ++|+|||++.....     .
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~  160 (260)
T cd05067          81 YMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAR  160 (260)
T ss_pred             cCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcccc
Confidence            99999999998763 34689999999999999999999999999999999999999887 99999999875442     1


Q ss_pred             ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHH
Q 015500          153 LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSN  231 (405)
Q Consensus       153 ~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~  231 (405)
                      ....++..|+|||.+.+..+++++||||||+++|+|++ |++||..... ......+. ....+..+...+.++.+++.+
T Consensus       161 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~li~~  238 (260)
T cd05067         161 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN-PEVIQNLE-RGYRMPRPDNCPEELYELMRL  238 (260)
T ss_pred             cCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh-HHHHHHHH-cCCCCCCCCCCCHHHHHHHHH
Confidence            12235678999999998889999999999999999999 9999965543 33333332 222334566788999999999


Q ss_pred             hcccCccccCCHHHHhc
Q 015500          232 CLRRDPKERWAASQLLK  248 (405)
Q Consensus       232 ~L~~dP~~Rpt~~elL~  248 (405)
                      ||..+|++|||++++++
T Consensus       239 ~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         239 CWKEKPEERPTFEYLRS  255 (260)
T ss_pred             HccCChhhCCCHHHHHH
Confidence            99999999999999865

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.8e-40  Score=312.46  Aligned_cols=240  Identities=22%  Similarity=0.344  Sum_probs=198.5

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC--ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEe
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP--KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFME   79 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~--~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (405)
                      +|+..+.||+|++|.||+|.+. +++.+|+|.+...  ..+.+.+|++++++++||||+++++++.....    .+++||
T Consensus         7 ~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~lv~e   81 (261)
T cd05068           7 SIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEP----IYIVTE   81 (261)
T ss_pred             heeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCC----eeeeee
Confidence            4788899999999999999975 4578999998654  34678899999999999999999987654332    568999


Q ss_pred             ecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccccc--cC
Q 015500           80 YAPGGTLNDEIHRNG-GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEAL--QS  155 (405)
Q Consensus        80 y~~ggsL~~~i~~~~-~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~~--~~  155 (405)
                      |+++++|.+++.... ..+++..+..++.|++.||.|||++|++||||||+||+++.++ +||+|||+++......  ..
T Consensus        82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~  161 (261)
T cd05068          82 LMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAR  161 (261)
T ss_pred             cccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCccccc
Confidence            999999999997643 4689999999999999999999999999999999999999888 9999999987654311  11


Q ss_pred             CC---CCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHH
Q 015500          156 GG---TPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSN  231 (405)
Q Consensus       156 ~g---t~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~  231 (405)
                      .|   +..|+|||.+.+..++.++|+|||||++|+|++ |+.||... ........+... .....+..+++.+.+++.+
T Consensus       162 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~-~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~  239 (261)
T cd05068         162 EGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGM-TNAEVLQQVDQG-YRMPCPPGCPKELYDIMLD  239 (261)
T ss_pred             CCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHHcC-CCCCCCCcCCHHHHHHHHH
Confidence            22   357999999999889999999999999999999 99999644 333444444322 2233455688999999999


Q ss_pred             hcccCccccCCHHHHhc
Q 015500          232 CLRRDPKERWAASQLLK  248 (405)
Q Consensus       232 ~L~~dP~~Rpt~~elL~  248 (405)
                      ||+.+|.+||++.++++
T Consensus       240 ~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         240 CWKEDPDDRPTFETLQW  256 (261)
T ss_pred             HhhcCcccCCCHHHHHH
Confidence            99999999999999865

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=3.8e-40  Score=310.35  Aligned_cols=236  Identities=28%  Similarity=0.425  Sum_probs=197.7

Q ss_pred             cccceeCCeeEEEEEEcC-CCC--EEEEEEccCCCh----HHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEe
Q 015500            7 HTIGQGSSATVSLATSLR-SGD--VFAAKSTELPKS----EFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFME   79 (405)
Q Consensus         7 ~~LG~G~~g~Vyla~~~~-~~~--~vavK~~~~~~~----~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (405)
                      +.||+|++|+||+|.+.. +++  .+|+|.+.....    +.+.+|++++++++||||+++++.+..     ..++++||
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~v~e   75 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-----HPLMMVTE   75 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-----CeEEEEEE
Confidence            479999999999999865 333  689999876543    467889999999999999999987654     23669999


Q ss_pred             ecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc-----
Q 015500           80 YAPGGTLNDEIHRNG-GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA-----  152 (405)
Q Consensus        80 y~~ggsL~~~i~~~~-~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~-----  152 (405)
                      |+++++|.+++.+.. ..+++..+..++.|++.||.|||++|++|+||||+||+++.++ +||+|||+++.....     
T Consensus        76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  155 (257)
T cd05040          76 LAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV  155 (257)
T ss_pred             ecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEecccccccccccccccee
Confidence            999999999998764 5789999999999999999999999999999999999999888 999999998764331     


Q ss_pred             --ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHH
Q 015500          153 --LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFL  229 (405)
Q Consensus       153 --~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll  229 (405)
                        ....++..|+|||.+.+..++.++|||||||++|+|++ |+.||... ........+.........+..++..+.+++
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  234 (257)
T cd05040         156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL-SGSQILKKIDKEGERLERPEACPQDIYNVM  234 (257)
T ss_pred             cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHhcCCcCCCCccCCHHHHHHH
Confidence              12346788999999999899999999999999999998 99999544 334444444433334445566889999999


Q ss_pred             HHhcccCccccCCHHHHhc
Q 015500          230 SNCLRRDPKERWAASQLLK  248 (405)
Q Consensus       230 ~~~L~~dP~~Rpt~~elL~  248 (405)
                      .+||+.+|++|||+.++++
T Consensus       235 ~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         235 LQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             HHHCCCCcccCCCHHHHHH
Confidence            9999999999999999975

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=3.5e-40  Score=312.74  Aligned_cols=242  Identities=21%  Similarity=0.299  Sum_probs=199.7

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCC---EEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGD---VFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMY   74 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~---~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~   74 (405)
                      +|+..+.||+|+||.||+|.++.+++   .+|+|.+....    .+.+.+|++++++++||||+++.+++.....    +
T Consensus         6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~   81 (268)
T cd05063           6 HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP----A   81 (268)
T ss_pred             HceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC----c
Confidence            57889999999999999999876665   79999886542    3467889999999999999999987754432    5


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccccc
Q 015500           75 NLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEAL  153 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~~  153 (405)
                      +++|||+++++|.+++..+.+.+++..+..++.|++.||+|||+.|++||||||+||+++.++ +||+|||++.......
T Consensus        82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~  161 (268)
T cd05063          82 MIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP  161 (268)
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccccc
Confidence            699999999999999987767899999999999999999999999999999999999999887 9999999987543211


Q ss_pred             -------cCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHH
Q 015500          154 -------QSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQA  225 (405)
Q Consensus       154 -------~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l  225 (405)
                             ....++.|+|||++.+..++.++|||||||++|||++ |+.||.... .......+.... ....+..++..+
T Consensus       162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~-~~~~~~~i~~~~-~~~~~~~~~~~~  239 (268)
T cd05063         162 EGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMS-NHEVMKAINDGF-RLPAPMDCPSAV  239 (268)
T ss_pred             ccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCC-HHHHHHHHhcCC-CCCCCCCCCHHH
Confidence                   1123457999999998889999999999999999997 999996443 333444443322 223344578999


Q ss_pred             HHHHHHhcccCccccCCHHHHhcC
Q 015500          226 NDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       226 ~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      .+++.+||+.+|++||++.++++.
T Consensus       240 ~~li~~c~~~~p~~Rp~~~~i~~~  263 (268)
T cd05063         240 YQLMLQCWQQDRARRPRFVDIVNL  263 (268)
T ss_pred             HHHHHHHcCCCcccCcCHHHHHHH
Confidence            999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.5e-40  Score=314.13  Aligned_cols=235  Identities=20%  Similarity=0.290  Sum_probs=188.8

Q ss_pred             cccceeCCeeEEEEEEcC------------CCCEEEEEEccCCC---hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCc
Q 015500            7 HTIGQGSSATVSLATSLR------------SGDVFAAKSTELPK---SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNK   71 (405)
Q Consensus         7 ~~LG~G~~g~Vyla~~~~------------~~~~vavK~~~~~~---~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~   71 (405)
                      +.||+|+||+||+|+...            ....+++|......   ...+.+|+.+++.++||||+++++++.....  
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~--   78 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE--   78 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC--
Confidence            468999999999998532            22358889876543   2367788999999999999999998764433  


Q ss_pred             eEEEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC--------ceEeee
Q 015500           72 LMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG--------AKIADF  143 (405)
Q Consensus        72 ~~~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~--------vkL~DF  143 (405)
                        ++++|||+++++|..++.+..+.+++..+..++.||+.||+|||++||+||||||+|||++.++        +|++||
T Consensus        79 --~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~  156 (262)
T cd05077          79 --NIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDP  156 (262)
T ss_pred             --CEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence              4699999999999999887666899999999999999999999999999999999999997543        799999


Q ss_pred             cccccccccccCCCCCCccChhhhc-CCCCCcchhHHHHHHHHHHHH-hCCCCCCCCCChHHHHHHHHhcCCCCCCchhc
Q 015500          144 GCAKWESEALQSGGTPMFMAPEVAR-GEHQGFASDIWAVGCTVIEMA-SGGAPWPNAADPMTVLYKIAYSRELPEVPAFL  221 (405)
Q Consensus       144 Gla~~~~~~~~~~gt~~Y~APE~l~-~~~~~~~sDIwSLG~il~ell-tG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~  221 (405)
                      |++..........++..|+|||.+. +..++.++|||||||++|||+ +|..||......  ...+... ... ......
T Consensus       157 g~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~--~~~~~~~-~~~-~~~~~~  232 (262)
T cd05077         157 GIPITVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA--EKERFYE-GQC-MLVTPS  232 (262)
T ss_pred             CCCccccCcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh--HHHHHHh-cCc-cCCCCC
Confidence            9987665555567899999999987 467889999999999999998 588888543321  1112111 111 122235


Q ss_pred             cHHHHHHHHHhcccCccccCCHHHHhcC
Q 015500          222 SKQANDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       222 s~~l~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      ++++.+||.+||+.||.+||++.+|+++
T Consensus       233 ~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         233 CKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             hHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence            6789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=2.5e-40  Score=319.14  Aligned_cols=249  Identities=30%  Similarity=0.438  Sum_probs=201.1

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCC------C
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-----SEFLQREQKFLSSLNSPHIVGYKGCDVTSED------N   70 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~------~   70 (405)
                      +|.+.+.||.|+||+||+|.++.+|+.+|+|.+....     ...+.+|++++++++||||+++++.+....+      .
T Consensus         8 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~   87 (302)
T cd07864           8 KFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKD   87 (302)
T ss_pred             hhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcccc
Confidence            5889999999999999999999999999999886432     2467789999999999999999987765431      1


Q ss_pred             ceEEEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccc
Q 015500           71 KLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWE  149 (405)
Q Consensus        71 ~~~~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~  149 (405)
                      ...+++++||+++ +|.+.+......+++..++.++.||+.||.|||+.||+|+||||+||+++.++ +||+|||++...
T Consensus        88 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~  166 (302)
T cd07864          88 KGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLY  166 (302)
T ss_pred             CCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccccccc
Confidence            1256799999976 78777776655799999999999999999999999999999999999999887 999999998754


Q ss_pred             cccc-----cCCCCCCccChhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhc--CCCC------
Q 015500          150 SEAL-----QSGGTPMFMAPEVARG-EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYS--RELP------  215 (405)
Q Consensus       150 ~~~~-----~~~gt~~Y~APE~l~~-~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~--~~~~------  215 (405)
                      ....     ...+++.|+|||.+.+ ..++.++|||||||++++|++|++||..... ...+..+...  ...+      
T Consensus       167 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  245 (302)
T cd07864         167 NSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE-LAQLELISRLCGSPCPAVWPDV  245 (302)
T ss_pred             cCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCChhhcccc
Confidence            3311     1235788999998875 4578899999999999999999999965433 2222222111  1000      


Q ss_pred             --------------------CCchhccHHHHHHHHHhcccCccccCCHHHHhcCccc
Q 015500          216 --------------------EVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFL  252 (405)
Q Consensus       216 --------------------~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~  252 (405)
                                          .....++..+.+++.+||+.||.+|||+.+++.||||
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         246 IKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             cccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence                                0112368899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=3e-40  Score=315.42  Aligned_cols=248  Identities=29%  Similarity=0.406  Sum_probs=200.6

Q ss_pred             cccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-----hHHHHHHHHHHHhC---CCCCeeeeeeeeeecCC-CceE
Q 015500            3 WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-----SEFLQREQKFLSSL---NSPHIVGYKGCDVTSED-NKLM   73 (405)
Q Consensus         3 y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-----~~~l~~E~~iL~~L---~hpnIv~~~~~~~~~~~-~~~~   73 (405)
                      |++.+.||+|+||.||+|.++.+++.+|+|.+....     ...+.+|+.+++++   .||||+++.+++...+. +...
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            678999999999999999999899999999886432     23466788877766   59999999998776543 3345


Q ss_pred             EEEEEeecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc
Q 015500           74 YNLFMEYAPGGTLNDEIHRNG-GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE  151 (405)
Q Consensus        74 ~~lv~Ey~~ggsL~~~i~~~~-~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~  151 (405)
                      ++++|||+.+ +|.+++.+.. ..+++..++.++.||+.||.|||+.|++|+||+|+||+++.++ +||+|||++.....
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~  159 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSF  159 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccC
Confidence            7799999975 8999887753 3589999999999999999999999999999999999999888 99999999876433


Q ss_pred             c---ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCC--------------
Q 015500          152 A---LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSREL--------------  214 (405)
Q Consensus       152 ~---~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~--------------  214 (405)
                      .   ....+++.|+|||.+.+..++.++|+|||||++|+|++|.+||..... ...+.++......              
T Consensus       160 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (287)
T cd07838         160 EMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE-ADQLDKIFDVIGLPSEEEWPRNVSLPR  238 (287)
T ss_pred             CcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh-HHHHHHHHHHcCCCChHhcCCCcccch
Confidence            2   223478899999999998899999999999999999999999965433 3333332211000              


Q ss_pred             -----------CCCchhccHHHHHHHHHhcccCccccCCHHHHhcCccc
Q 015500          215 -----------PEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFL  252 (405)
Q Consensus       215 -----------~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~  252 (405)
                                 ......+++.+.++|.+||+.||++||++.+++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         239 SSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             hhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence                       00112356788999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=3.5e-40  Score=317.26  Aligned_cols=242  Identities=25%  Similarity=0.307  Sum_probs=197.2

Q ss_pred             CcccccccceeCCeeEEEEEEcCCC----------------CEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeee
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSG----------------DVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYK   61 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~----------------~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~   61 (405)
                      +|++++.||+|+||.||+|.+..++                ..+|+|.+....    .+.+.+|++++++++||||++++
T Consensus         6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~   85 (296)
T cd05051           6 PLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLL   85 (296)
T ss_pred             hCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence            5899999999999999999877544                457999876542    35678899999999999999999


Q ss_pred             eeeeecCCCceEEEEEEeecCCCCHHHHHHHcC----------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCE
Q 015500           62 GCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNG----------GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNI  131 (405)
Q Consensus        62 ~~~~~~~~~~~~~~lv~Ey~~ggsL~~~i~~~~----------~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NI  131 (405)
                      +++....    .++++|||+++++|.+++.+..          ..+++..+..++.|++.||+|||+.|++||||||+||
T Consensus        86 ~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Ni  161 (296)
T cd05051          86 GVCTVDP----PLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNC  161 (296)
T ss_pred             EEEecCC----CcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhce
Confidence            8775543    3669999999999999997653          2689999999999999999999999999999999999


Q ss_pred             EEccCC-ceEeeecccccccc------cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh--CCCCCCCCCChH
Q 015500          132 LMAESG-AKIADFGCAKWESE------ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS--GGAPWPNAADPM  202 (405)
Q Consensus       132 Li~~~~-vkL~DFGla~~~~~------~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt--G~~Pf~~~~~~~  202 (405)
                      +++.++ ++|+|||+++....      .....+++.|+|||.+.+..++.++|||||||++|||++  |..||..... .
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~-~  240 (296)
T cd05051         162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD-Q  240 (296)
T ss_pred             eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh-H
Confidence            999887 99999999875322      122346778999999998889999999999999999998  7788865433 2


Q ss_pred             HHHHHHHhc------CCCCCCchhccHHHHHHHHHhcccCccccCCHHHHhc
Q 015500          203 TVLYKIAYS------RELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLK  248 (405)
Q Consensus       203 ~~l~~i~~~------~~~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~  248 (405)
                      ..+......      ......+..++.++.+++.+||+.||.+|||+.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         241 QVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             HHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            222222211      1112334557899999999999999999999999965

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.3e-40  Score=357.50  Aligned_cols=243  Identities=25%  Similarity=0.302  Sum_probs=195.9

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC------hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK------SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~------~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~   75 (405)
                      +|++++.||+|+||+||+|++..+|+.||+|.+....      ...+.+|++++++++||||+++++++....    ..+
T Consensus         3 rYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~----~ly   78 (932)
T PRK13184          3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGD----PVY   78 (932)
T ss_pred             CeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCC----EEE
Confidence            6899999999999999999999999999999886431      246788999999999999999998765433    356


Q ss_pred             EEEeecCCCCHHHHHHHc----------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeec
Q 015500           76 LFMEYAPGGTLNDEIHRN----------GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFG  144 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~----------~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFG  144 (405)
                      ++|||++||+|.+++...          ...++...+..++.||+.||+|||++||+||||||+||+++.++ +||+|||
T Consensus        79 LVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         79 YTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecC
Confidence            999999999999998642          12355677889999999999999999999999999999999887 9999999


Q ss_pred             ccccccc----------------------cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChH
Q 015500          145 CAKWESE----------------------ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPM  202 (405)
Q Consensus       145 la~~~~~----------------------~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~  202 (405)
                      +++....                      .....||+.|+|||++.+..++.++|||||||++|||+||+.||..... .
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~-~  237 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKG-R  237 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcch-h
Confidence            9975411                      0123589999999999999999999999999999999999999965332 2


Q ss_pred             HHHHHHHhcCCCC-CCchhccHHHHHHHHHhcccCccccCCHHHHhcC
Q 015500          203 TVLYKIAYSRELP-EVPAFLSKQANDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       203 ~~l~~i~~~~~~~-~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      ............. .....+++.+.+++.+||..||++|++..+.+.+
T Consensus       238 ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~  285 (932)
T PRK13184        238 KISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ  285 (932)
T ss_pred             hhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            2222111111111 1113578899999999999999999887766654

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=8.9e-41  Score=312.59  Aligned_cols=227  Identities=22%  Similarity=0.350  Sum_probs=190.1

Q ss_pred             eCCeeEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEeecCCCCHHHHHH
Q 015500           12 GSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIH   91 (405)
Q Consensus        12 G~~g~Vyla~~~~~~~~vavK~~~~~~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~Ey~~ggsL~~~i~   91 (405)
                      |.+|+||+|.++.+++.+|+|.+....  ...+|...+....||||+++++.+....    .++++|||++||+|.+++.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--~~~~~~~~~~~~~~~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~   77 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS--EYSRERLTIIPHCVPNMVCLHKYIVSED----SVFLVLQHAEGGKLWSHIS   77 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh--hhhhHHHHHHhcCCCceeehhhheecCC----eEEEEEecCCCCCHHHHHH
Confidence            889999999999999999999986543  3445666666778999999998765433    3679999999999999997


Q ss_pred             HcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc-cccCCCCCCccChhhhcC
Q 015500           92 RNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE-ALQSGGTPMFMAPEVARG  169 (405)
Q Consensus        92 ~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~-~~~~~gt~~Y~APE~l~~  169 (405)
                      +.. .+++..+..++.|++.||.|||++|++||||||+||+++.++ ++++|||.+..... .....+++.|+|||.+.+
T Consensus        78 ~~~-~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~y~aPE~~~~  156 (237)
T cd05576          78 KFL-NIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYCAPEVGGI  156 (237)
T ss_pred             Hhc-CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccccccCCcCccccCCcccCC
Confidence            764 699999999999999999999999999999999999999888 99999998765433 223456788999999988


Q ss_pred             CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHhcccCccccCCH-----H
Q 015500          170 EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAA-----S  244 (405)
Q Consensus       170 ~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~-----~  244 (405)
                      ..+++++|+||+||++|||++|+.||.......       .......+|..+++.++++|.+||+.||++|||+     +
T Consensus       157 ~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~  229 (237)
T cd05576         157 SEETEACDWWSLGAILFELLTGKTLVECHPSGI-------NTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVE  229 (237)
T ss_pred             CCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-------ccccccCCcccCCHHHHHHHHHHccCCHHHhcCCCccchH
Confidence            889999999999999999999999885332111       0111224567789999999999999999999996     9


Q ss_pred             HHhcCccc
Q 015500          245 QLLKHPFL  252 (405)
Q Consensus       245 elL~hp~~  252 (405)
                      ++++||||
T Consensus       230 ~~~~h~~~  237 (237)
T cd05576         230 DIKSHPFF  237 (237)
T ss_pred             HHHcCCCC
Confidence            99999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=4.2e-40  Score=311.33  Aligned_cols=239  Identities=23%  Similarity=0.332  Sum_probs=196.6

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC--ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEe
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP--KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFME   79 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~--~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (405)
                      +|.+.+.||+|+||+||+|.+..+ ..+|+|.+...  ..+.+.+|++++++++|||++++++++.  ..   ..+++||
T Consensus         7 ~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~---~~~~v~e   80 (260)
T cd05069           7 SLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS--EE---PIYIVTE   80 (260)
T ss_pred             HeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc--CC---CcEEEEE
Confidence            478899999999999999988655 45899987643  3457889999999999999999987653  22   2459999


Q ss_pred             ecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccccc----
Q 015500           80 YAPGGTLNDEIHRNG-GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEAL----  153 (405)
Q Consensus        80 y~~ggsL~~~i~~~~-~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~~----  153 (405)
                      |+++++|.+++.... ..+++..+..++.||+.||.|||+.|++|+||||+||+++.++ ++|+|||+++......    
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~  160 (260)
T cd05069          81 FMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTAR  160 (260)
T ss_pred             cCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCccccc
Confidence            999999999997643 3589999999999999999999999999999999999999888 9999999997543211    


Q ss_pred             -cCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHH
Q 015500          154 -QSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSN  231 (405)
Q Consensus       154 -~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~  231 (405)
                       ...++..|+|||.+.+..++.++|||||||++|+|++ |..||..... ......+.. ...+..+...+..+.+++++
T Consensus       161 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~li~~  238 (260)
T cd05069         161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN-REVLEQVER-GYRMPCPQGCPESLHELMKL  238 (260)
T ss_pred             CCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHc-CCCCCCCcccCHHHHHHHHH
Confidence             2235677999999998889999999999999999999 9999965433 333333332 22334566789999999999


Q ss_pred             hcccCccccCCHHHHhc
Q 015500          232 CLRRDPKERWAASQLLK  248 (405)
Q Consensus       232 ~L~~dP~~Rpt~~elL~  248 (405)
                      ||.+||.+||+++++++
T Consensus       239 ~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         239 CWKKDPDERPTFEYIQS  255 (260)
T ss_pred             HccCCcccCcCHHHHHH
Confidence            99999999999999864

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=4.4e-40  Score=308.80  Aligned_cols=240  Identities=28%  Similarity=0.401  Sum_probs=202.4

Q ss_pred             cccccccceeCCeeEEEEEEcCCC----CEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEE
Q 015500            3 WTRGHTIGQGSSATVSLATSLRSG----DVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMY   74 (405)
Q Consensus         3 y~~~~~LG~G~~g~Vyla~~~~~~----~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~   74 (405)
                      +++.+.||.|+||.||+|.+...+    ..+|+|.+....    ...+.+|+.+++.++||||+++++.+....    .+
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~   76 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEE----PL   76 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC----ee
Confidence            357899999999999999998766    899999987543    457889999999999999999998776543    36


Q ss_pred             EEEEeecCCCCHHHHHHHcCCC-CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc
Q 015500           75 NLFMEYAPGGTLNDEIHRNGGR-LDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA  152 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~i~~~~~~-l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~  152 (405)
                      +++|||+++++|.+++...... +++..+..++.||+.||+|||+.|++|+||||+||+++.++ ++|+|||+++.....
T Consensus        77 ~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  156 (258)
T smart00219       77 MIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD  156 (258)
T ss_pred             EEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccc
Confidence            7999999999999999875434 99999999999999999999999999999999999999988 999999998764432


Q ss_pred             c-----cCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHH
Q 015500          153 L-----QSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQAN  226 (405)
Q Consensus       153 ~-----~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~  226 (405)
                      .     ...+++.|+|||.+.+..++.++|+|||||++|+|++ |.+||.. .+.......+. ....+..+...+.++.
T Consensus       157 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~-~~~~~~~~~~~-~~~~~~~~~~~~~~~~  234 (258)
T smart00219      157 DYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPG-MSNEEVLEYLK-KGYRLPKPENCPPEIY  234 (258)
T ss_pred             cccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHh-cCCCCCCCCcCCHHHH
Confidence            1     1236789999999988889999999999999999998 7888854 33333333333 3344556667899999


Q ss_pred             HHHHHhcccCccccCCHHHHhc
Q 015500          227 DFLSNCLRRDPKERWAASQLLK  248 (405)
Q Consensus       227 dll~~~L~~dP~~Rpt~~elL~  248 (405)
                      +++.+||..||.+|||+.|+++
T Consensus       235 ~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      235 KLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             HHHHHHCcCChhhCcCHHHHHh
Confidence            9999999999999999999986

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=4.7e-40  Score=316.14  Aligned_cols=242  Identities=27%  Similarity=0.416  Sum_probs=197.4

Q ss_pred             CcccccccceeCCeeEEEEEEcC-----CCCEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCce
Q 015500            2 DWTRGHTIGQGSSATVSLATSLR-----SGDVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKL   72 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~-----~~~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~   72 (405)
                      +|.+.+.||+|+||+||+|.+..     ....+++|.+....    ...+.+|+++++.++||||+++++.+.....   
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---   77 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGP---   77 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCC---
Confidence            58899999999999999998753     23578898876443    3468889999999999999999987654332   


Q ss_pred             EEEEEEeecCCCCHHHHHHHc-----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCC
Q 015500           73 MYNLFMEYAPGGTLNDEIHRN-----------------------GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSR  129 (405)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~i~~~-----------------------~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~  129 (405)
                       .++++||+++++|.+++...                       ..++++..+..++.|++.||+|||+.|++||||||+
T Consensus        78 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~  156 (290)
T cd05045          78 -LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAAR  156 (290)
T ss_pred             -cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhh
Confidence             56899999999999998642                       124788999999999999999999999999999999


Q ss_pred             CEEEccCC-ceEeeeccccccccc------ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCh
Q 015500          130 NILMAESG-AKIADFGCAKWESEA------LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADP  201 (405)
Q Consensus       130 NILi~~~~-vkL~DFGla~~~~~~------~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~  201 (405)
                      |||+++++ +||+|||+++.....      ....++..|+|||.+.+..++.++|||||||++|+|++ |..||... .+
T Consensus       157 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~-~~  235 (290)
T cd05045         157 NVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI-AP  235 (290)
T ss_pred             eEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCC-CH
Confidence            99999887 999999998753221      12235678999999988889999999999999999998 99999543 23


Q ss_pred             HHHHHHHHhcCCCCCCchhccHHHHHHHHHhcccCccccCCHHHHhcC
Q 015500          202 MTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       202 ~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      .. +.........+..|..++.++.+|+.+||+.+|.+||++.++++.
T Consensus       236 ~~-~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~  282 (290)
T cd05045         236 ER-LFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKE  282 (290)
T ss_pred             HH-HHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHH
Confidence            33 233333333344567789999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.8e-40  Score=327.53  Aligned_cols=251  Identities=29%  Similarity=0.439  Sum_probs=201.5

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC-----ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCC--CceEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP-----KSEFLQREQKFLSSLNSPHIVGYKGCDVTSED--NKLMY   74 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~-----~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~--~~~~~   74 (405)
                      +|.+.+.||+|+||+||+|++..+|+.+|+|.+...     ....+.+|+.+++.++||||+++.+++.....  ....+
T Consensus        16 ~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   95 (342)
T cd07879          16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDF   95 (342)
T ss_pred             ceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceE
Confidence            588899999999999999999999999999987642     13457899999999999999999988764432  12246


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc-
Q 015500           75 NLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA-  152 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~-  152 (405)
                      ++++||+.+ +|..++   +..+++..+..++.|++.||+|||++|++||||||+||+++.++ +||+|||+++..... 
T Consensus        96 ~lv~e~~~~-~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~~  171 (342)
T cd07879          96 YLVMPYMQT-DLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEM  171 (342)
T ss_pred             EEEeccccc-CHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCCC
Confidence            799999964 776654   23689999999999999999999999999999999999999888 999999998764432 


Q ss_pred             ccCCCCCCccChhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhc--------------------
Q 015500          153 LQSGGTPMFMAPEVARG-EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYS--------------------  211 (405)
Q Consensus       153 ~~~~gt~~Y~APE~l~~-~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~--------------------  211 (405)
                      ....+|+.|+|||.+.+ ..++.++|+|||||++|||++|+.||.... ....+..+...                    
T Consensus       172 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (342)
T cd07879         172 TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD-YLDQLTQILKVTGVPGPEFVQKLEDKAAKSY  250 (342)
T ss_pred             CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHhcCCCCHHHHHHhcccchHHH
Confidence            23457899999999876 468889999999999999999999996543 22222221110                    


Q ss_pred             -CCCCCCc--------hhccHHHHHHHHHhcccCccccCCHHHHhcCcccccccc
Q 015500          212 -RELPEVP--------AFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCS  257 (405)
Q Consensus       212 -~~~~~~p--------~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~~  257 (405)
                       ...+..+        ...++++.+||.+||+.||.+||++++++.||||+.+..
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~  305 (342)
T cd07879         251 IKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD  305 (342)
T ss_pred             HhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence             0011111        236788999999999999999999999999999998754

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=5.2e-42  Score=307.66  Aligned_cols=250  Identities=24%  Similarity=0.389  Sum_probs=212.9

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHhCC-CCCeeeeeeeeeecCCCceEEEEEEee
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLN-SPHIVGYKGCDVTSEDNKLMYNLFMEY   80 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~~~~l~~E~~iL~~L~-hpnIv~~~~~~~~~~~~~~~~~lv~Ey   80 (405)
                      +|.+.+++|+|.|+.|+.|.+..+++.++||++..-+...+.||+.||..|+ ||||+++++...+...  ....||+||
T Consensus        39 dYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~S--ktpaLiFE~  116 (338)
T KOG0668|consen   39 DYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPES--KTPSLIFEY  116 (338)
T ss_pred             hHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccc--cCchhHhhh
Confidence            6889999999999999999999999999999999888899999999999996 9999999987655443  345689999


Q ss_pred             cCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC--ceEeeeccccccccc---ccC
Q 015500           81 APGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG--AKIADFGCAKWESEA---LQS  155 (405)
Q Consensus        81 ~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~--vkL~DFGla~~~~~~---~~~  155 (405)
                      +++.+...+.    ..|+...++.++.++++||.|||++||+|||+||.|++|+...  ++|+|+|+|.+....   ...
T Consensus       117 v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYnVR  192 (338)
T KOG0668|consen  117 VNNTDFKQLY----PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR  192 (338)
T ss_pred             hccccHHHHh----hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCCceeeee
Confidence            9987777654    3688999999999999999999999999999999999999876  999999999875543   345


Q ss_pred             CCCCCccChhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcC--------------CCC-CC--
Q 015500          156 GGTPMFMAPEVARG-EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSR--------------ELP-EV--  217 (405)
Q Consensus       156 ~gt~~Y~APE~l~~-~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~--------------~~~-~~--  217 (405)
                      +.+..|..||++-. ..|++..|+|||||++..|+..+.||..+.++..++.+|...-              .++ .+  
T Consensus       193 VASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~  272 (338)
T KOG0668|consen  193 VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFED  272 (338)
T ss_pred             eehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhh
Confidence            68999999999876 6789999999999999999999999988887777766654221              111 00  


Q ss_pred             ------------------chhccHHHHHHHHHhcccCccccCCHHHHhcCcccccccc
Q 015500          218 ------------------PAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCS  257 (405)
Q Consensus       218 ------------------p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~~  257 (405)
                                        ..-.++++.|||.++|..|-.+|+||.|++.||||.....
T Consensus       273 i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~  330 (338)
T KOG0668|consen  273 ILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVRE  330 (338)
T ss_pred             HhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHHH
Confidence                              0114689999999999999999999999999999987643

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3.3e-40  Score=310.49  Aligned_cols=233  Identities=21%  Similarity=0.311  Sum_probs=191.8

Q ss_pred             cccceeCCeeEEEEEEcCCC----------CEEEEEEccCCC--hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEE
Q 015500            7 HTIGQGSSATVSLATSLRSG----------DVFAAKSTELPK--SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMY   74 (405)
Q Consensus         7 ~~LG~G~~g~Vyla~~~~~~----------~~vavK~~~~~~--~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~   74 (405)
                      +.||+|+||.||+|.++.++          ..+++|......  ...+.+|+.+|++++||||+++++.+.. ..    .
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~----~   75 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DE----N   75 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CC----c
Confidence            47999999999999998776          357888765443  4678899999999999999999998765 22    4


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC--------ceEeeeccc
Q 015500           75 NLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG--------AKIADFGCA  146 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~--------vkL~DFGla  146 (405)
                      ++||||+++|+|.+++...+..+++..+..++.||+.||+|||++||+||||||+||+++.++        +||+|||++
T Consensus        76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a  155 (259)
T cd05037          76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP  155 (259)
T ss_pred             EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence            689999999999999987655799999999999999999999999999999999999998765        899999999


Q ss_pred             ccccccccCCCCCCccChhhhcCC--CCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccH
Q 015500          147 KWESEALQSGGTPMFMAPEVARGE--HQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSK  223 (405)
Q Consensus       147 ~~~~~~~~~~gt~~Y~APE~l~~~--~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~  223 (405)
                      ..........++..|+|||++.+.  .+++++|||||||++++|++ |..||.... ............   ..+.....
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~-~~~~~~~~~~~~---~~~~~~~~  231 (259)
T cd05037         156 ITVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS-SSEKERFYQDQH---RLPMPDCA  231 (259)
T ss_pred             cccccccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC-chhHHHHHhcCC---CCCCCCch
Confidence            876554455678889999999876  78899999999999999999 578885543 222222221111   22222348


Q ss_pred             HHHHHHHHhcccCccccCCHHHHhc
Q 015500          224 QANDFLSNCLRRDPKERWAASQLLK  248 (405)
Q Consensus       224 ~l~dll~~~L~~dP~~Rpt~~elL~  248 (405)
                      .+.+++.+||..+|.+|||+.++++
T Consensus       232 ~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         232 ELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             HHHHHHHHHhccChhhCCCHHHHHH
Confidence            9999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=2.1e-40  Score=319.78  Aligned_cols=249  Identities=28%  Similarity=0.462  Sum_probs=202.7

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC----hHHHHHHHHHHHhC-CCCCeeeeeeeeeecCCCceEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK----SEFLQREQKFLSSL-NSPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~----~~~l~~E~~iL~~L-~hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      +|++.+.||+|+||+||+|.+..+++.+|||.+....    ...+.+|+.++.++ .||||+++++++....    .+++
T Consensus        16 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~----~~~~   91 (296)
T cd06618          16 DLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDS----DVFI   91 (296)
T ss_pred             hheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCC----eEEE
Confidence            6889999999999999999999999999999986432    23455677766666 5999999999876543    3679


Q ss_pred             EEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCCEEEccCC-ceEeeecccccccc---
Q 015500           77 FMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHS-NRVVHCDIKSRNILMAESG-AKIADFGCAKWESE---  151 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~-~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~---  151 (405)
                      +|||++ ++|.+++....+.+++..+..++.||+.||.|||+ .||+||||+|+||+++.++ +||+|||++.....   
T Consensus        92 v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~  170 (296)
T cd06618          92 CMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA  170 (296)
T ss_pred             EeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc
Confidence            999985 48888887756689999999999999999999997 5999999999999999887 99999999875432   


Q ss_pred             cccCCCCCCccChhhhcCCC----CCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCch--hccHHH
Q 015500          152 ALQSGGTPMFMAPEVARGEH----QGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPA--FLSKQA  225 (405)
Q Consensus       152 ~~~~~gt~~Y~APE~l~~~~----~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~--~~s~~l  225 (405)
                      .....+++.|+|||.+.+..    ++.++||||||+++|+|++|+.||.........+.++... ..+..+.  .+++++
T Consensus       171 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l  249 (296)
T cd06618         171 KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQE-EPPSLPPNEGFSPDF  249 (296)
T ss_pred             ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcC-CCCCCCCCCCCCHHH
Confidence            22334788999999987654    7889999999999999999999996544444444443332 2233332  368899


Q ss_pred             HHHHHHhcccCccccCCHHHHhcCccccccc
Q 015500          226 NDFLSNCLRRDPKERWAASQLLKHPFLEEFC  256 (405)
Q Consensus       226 ~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~  256 (405)
                      .+|+.+||..||.+|||++++++||||....
T Consensus       250 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  280 (296)
T cd06618         250 CSFVDLCLTKDHRKRPKYRELLQHPFIRRYE  280 (296)
T ss_pred             HHHHHHHccCChhhCCCHHHHhcChhhhccc
Confidence            9999999999999999999999999998653

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=4.7e-40  Score=320.31  Aligned_cols=242  Identities=24%  Similarity=0.358  Sum_probs=197.2

Q ss_pred             CcccccccceeCCeeEEEEEEcC-------CCCEEEEEEccCCC----hHHHHHHHHHHHhC-CCCCeeeeeeeeeecCC
Q 015500            2 DWTRGHTIGQGSSATVSLATSLR-------SGDVFAAKSTELPK----SEFLQREQKFLSSL-NSPHIVGYKGCDVTSED   69 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~-------~~~~vavK~~~~~~----~~~l~~E~~iL~~L-~hpnIv~~~~~~~~~~~   69 (405)
                      +|.+++.||+|+||.||+|.+..       ....+|+|.+....    ...+.+|+++++++ +||||+++++++.... 
T Consensus        13 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-   91 (314)
T cd05099          13 RLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG-   91 (314)
T ss_pred             HeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC-
Confidence            47889999999999999998642       34578999876432    23577899999999 6999999998765432 


Q ss_pred             CceEEEEEEeecCCCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEc
Q 015500           70 NKLMYNLFMEYAPGGTLNDEIHRNG---------------GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMA  134 (405)
Q Consensus        70 ~~~~~~lv~Ey~~ggsL~~~i~~~~---------------~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~  134 (405)
                         .++++|||+++|+|.+++....               ..+++..+..++.||+.||.|||++|++||||||+|||++
T Consensus        92 ---~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~  168 (314)
T cd05099          92 ---PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVT  168 (314)
T ss_pred             ---ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEc
Confidence               3679999999999999997632               3588899999999999999999999999999999999999


Q ss_pred             cCC-ceEeeeccccccccc------ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHH
Q 015500          135 ESG-AKIADFGCAKWESEA------LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLY  206 (405)
Q Consensus       135 ~~~-vkL~DFGla~~~~~~------~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~  206 (405)
                      .++ +||+|||+++.....      ....+++.|+|||++.+..++.++|||||||++|+|++ |..||... .......
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~-~~~~~~~  247 (314)
T cd05099         169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI-PVEELFK  247 (314)
T ss_pred             CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCC-CHHHHHH
Confidence            887 999999999754321      11224567999999998889999999999999999999 89999543 2333333


Q ss_pred             HHHhcCCCCCCchhccHHHHHHHHHhcccCccccCCHHHHhcC
Q 015500          207 KIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       207 ~i~~~~~~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      .+ .....+..+..++.++.+++.+||..+|++|||+.++++.
T Consensus       248 ~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~  289 (314)
T cd05099         248 LL-REGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEA  289 (314)
T ss_pred             HH-HcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            33 3333445667788999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.7e-40  Score=308.06  Aligned_cols=236  Identities=24%  Similarity=0.379  Sum_probs=196.2

Q ss_pred             cccceeCCeeEEEEEEcCCCCEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEeecC
Q 015500            7 HTIGQGSSATVSLATSLRSGDVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAP   82 (405)
Q Consensus         7 ~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~Ey~~   82 (405)
                      +.||.|+||.||+|.+.. ++.+|+|.+....    ...+.+|++++++++||||+++++++.....    .+++|||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~----~~~v~e~~~   75 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQP----IYIVMELVP   75 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCC----eEEEEEcCC
Confidence            479999999999999877 9999999876542    3478899999999999999999987654433    568999999


Q ss_pred             CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccccc------cC
Q 015500           83 GGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEAL------QS  155 (405)
Q Consensus        83 ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~~------~~  155 (405)
                      |++|.+++......+++..+..++.|++.||.|||++|++||||||+||+++.++ +||+|||++.......      ..
T Consensus        76 ~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (251)
T cd05041          76 GGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK  155 (251)
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence            9999999987666789999999999999999999999999999999999999887 9999999987544211      12


Q ss_pred             CCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHhcc
Q 015500          156 GGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLR  234 (405)
Q Consensus       156 ~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~L~  234 (405)
                      .++..|+|||.+.+..+++++|+|||||++|+|+| |..||..... ......+.. ......|..++..+.+|+.+||.
T Consensus       156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~  233 (251)
T cd05041         156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN-QQTRERIES-GYRMPAPQLCPEEIYRLMLQCWA  233 (251)
T ss_pred             cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH-HHHHHHHhc-CCCCCCCccCCHHHHHHHHHHhc
Confidence            23566999999998889999999999999999999 8899965432 222233322 22234456788999999999999


Q ss_pred             cCccccCCHHHHhcC
Q 015500          235 RDPKERWAASQLLKH  249 (405)
Q Consensus       235 ~dP~~Rpt~~elL~h  249 (405)
                      .+|.+|||+.++++.
T Consensus       234 ~~p~~Rp~~~ell~~  248 (251)
T cd05041         234 YDPENRPSFSEIYNE  248 (251)
T ss_pred             cChhhCcCHHHHHHH
Confidence            999999999999863

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=5.3e-40  Score=310.24  Aligned_cols=238  Identities=23%  Similarity=0.342  Sum_probs=192.3

Q ss_pred             cccceeCCeeEEEEEEcC---CCCEEEEEEccCC-C---hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEe
Q 015500            7 HTIGQGSSATVSLATSLR---SGDVFAAKSTELP-K---SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFME   79 (405)
Q Consensus         7 ~~LG~G~~g~Vyla~~~~---~~~~vavK~~~~~-~---~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (405)
                      +.||+|+||+||+|.+..   .+..+|+|.+... .   .+.+.+|+.+++.++||||+++++.+...+.   ..+++||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~---~~~lv~e   77 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEG---SPLVVLP   77 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCC---CcEEEEe
Confidence            479999999999998653   3457999987532 2   3567789999999999999999986553332   2458999


Q ss_pred             ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc-------
Q 015500           80 YAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE-------  151 (405)
Q Consensus        80 y~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~-------  151 (405)
                      |+++++|.+++.+....+++..+..++.||+.||.|||+.|++||||||+|||++.++ +||+|||+++....       
T Consensus        78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~  157 (262)
T cd05058          78 YMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH  157 (262)
T ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence            9999999999987666678888899999999999999999999999999999999887 99999999875322       


Q ss_pred             -cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhC-CCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHH
Q 015500          152 -ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASG-GAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFL  229 (405)
Q Consensus       152 -~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG-~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll  229 (405)
                       .....+++.|+|||.+.+..++.++|||||||++|||++| .+||... +.......+ .....+..+..+++.+.+++
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~~~li  235 (262)
T cd05058         158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-DSFDITVYL-LQGRRLLQPEYCPDPLYEVM  235 (262)
T ss_pred             ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHH-hcCCCCCCCCcCCHHHHHHH
Confidence             1122357789999999988899999999999999999995 5666543 333333332 33334455666789999999


Q ss_pred             HHhcccCccccCCHHHHhcC
Q 015500          230 SNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       230 ~~~L~~dP~~Rpt~~elL~h  249 (405)
                      .+||..+|++||++.++++.
T Consensus       236 ~~cl~~~p~~Rp~~~~il~~  255 (262)
T cd05058         236 LSCWHPKPEMRPTFSELVSR  255 (262)
T ss_pred             HHHcCCChhhCCCHHHHHHH
Confidence            99999999999999999875

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=8.1e-40  Score=306.82  Aligned_cols=236  Identities=23%  Similarity=0.356  Sum_probs=195.8

Q ss_pred             cccceeCCeeEEEEEEcCCCCEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEeecC
Q 015500            7 HTIGQGSSATVSLATSLRSGDVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAP   82 (405)
Q Consensus         7 ~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~Ey~~   82 (405)
                      +.||+|+||.||+|... ++..+|+|.+....    ...+.+|+++++.++||||+++++.+.....    ++++|||++
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~lv~e~~~   75 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQP----IYIVMELVP   75 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCc----cEEEEECCC
Confidence            47999999999999864 68899999876543    2357789999999999999999987654432    569999999


Q ss_pred             CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccccc-----cCC
Q 015500           83 GGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEAL-----QSG  156 (405)
Q Consensus        83 ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~~-----~~~  156 (405)
                      +++|.+++......+++..+..++.|++.||.|+|++|++||||||+||+++.++ +||+|||++.......     ...
T Consensus        76 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (250)
T cd05085          76 GGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ  155 (250)
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCC
Confidence            9999999987666789999999999999999999999999999999999999888 9999999987533211     223


Q ss_pred             CCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHhccc
Q 015500          157 GTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRR  235 (405)
Q Consensus       157 gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~L~~  235 (405)
                      +++.|+|||++.+..++.++|||||||++|+|++ |..||..... ......+. .......+..++..+.+|+.+||..
T Consensus       156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~  233 (250)
T cd05085         156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN-QQAREQVE-KGYRMSCPQKCPDDVYKVMQRCWDY  233 (250)
T ss_pred             CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH-HHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHccc
Confidence            4567999999998889999999999999999998 9999965432 33333333 2333455667899999999999999


Q ss_pred             CccccCCHHHHhcC
Q 015500          236 DPKERWAASQLLKH  249 (405)
Q Consensus       236 dP~~Rpt~~elL~h  249 (405)
                      +|.+||++.++++.
T Consensus       234 ~p~~Rp~~~~l~~~  247 (250)
T cd05085         234 KPENRPKFSELQKE  247 (250)
T ss_pred             CcccCCCHHHHHHH
Confidence            99999999999763

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.6e-41  Score=347.28  Aligned_cols=249  Identities=22%  Similarity=0.243  Sum_probs=187.5

Q ss_pred             CcccccccceeCCeeEEEEEEcCCC-CEEEEE------------------EccCC--ChHHHHHHHHHHHhCCCCCeeee
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSG-DVFAAK------------------STELP--KSEFLQREQKFLSSLNSPHIVGY   60 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~-~~vavK------------------~~~~~--~~~~l~~E~~iL~~L~hpnIv~~   60 (405)
                      +|++++.||+|+||+||+|..+... ...++|                  .+...  ....+.+|+.+|++++||||+++
T Consensus       149 ~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l  228 (501)
T PHA03210        149 HFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKI  228 (501)
T ss_pred             ccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCcE
Confidence            5899999999999999999765432 222222                  11111  13467899999999999999999


Q ss_pred             eeeeeecCCCceEEEEEEeecCCCCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccC
Q 015500           61 KGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNG----GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES  136 (405)
Q Consensus        61 ~~~~~~~~~~~~~~~lv~Ey~~ggsL~~~i~~~~----~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~  136 (405)
                      ++++.....    .++++|++. ++|.+++....    .......++.++.||+.||+|||++||+||||||+|||++.+
T Consensus       229 ~~~~~~~~~----~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~  303 (501)
T PHA03210        229 EEILRSEAN----TYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCD  303 (501)
T ss_pred             eEEEEECCe----eEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC
Confidence            998765443    568999985 57777765421    234466788999999999999999999999999999999988


Q ss_pred             C-ceEeeeccccccccc-----ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCC-CCCC-CChHHHHHHH
Q 015500          137 G-AKIADFGCAKWESEA-----LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAP-WPNA-ADPMTVLYKI  208 (405)
Q Consensus       137 ~-vkL~DFGla~~~~~~-----~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~P-f~~~-~~~~~~l~~i  208 (405)
                      + +||+|||+++.....     ....||+.|+|||++.+..++.++|||||||++|||++|..+ |... ..+...+.++
T Consensus       304 ~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~  383 (501)
T PHA03210        304 GKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKI  383 (501)
T ss_pred             CCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHH
Confidence            7 999999999765431     234699999999999999999999999999999999998854 4322 2222222222


Q ss_pred             Hhc-----CCCCC--------------------Cc-----hhccHHHHHHHHHhcccCccccCCHHHHhcCcccccc
Q 015500          209 AYS-----RELPE--------------------VP-----AFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       209 ~~~-----~~~~~--------------------~p-----~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      ...     ..+|.                    ++     ..++.++.++|.+||+.||.+|||+.|+|.||||...
T Consensus       384 ~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~  460 (501)
T PHA03210        384 IDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE  460 (501)
T ss_pred             HHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence            111     01111                    00     1246678889999999999999999999999999754

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.2e-40  Score=309.15  Aligned_cols=240  Identities=25%  Similarity=0.355  Sum_probs=199.5

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC--ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEe
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP--KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFME   79 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~--~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (405)
                      +|++.+.||+|+||+||+|.+. ++..+|||.+...  ..+.+.+|+.++++++||||+++++.+....    .++++||
T Consensus         7 ~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~~v~e   81 (261)
T cd05034           7 SLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEE----PIYIVTE   81 (261)
T ss_pred             heeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCC----ceEEEEe
Confidence            5889999999999999999975 5578999988753  3467899999999999999999998765432    2569999


Q ss_pred             ecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc-----
Q 015500           80 YAPGGTLNDEIHRNG-GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA-----  152 (405)
Q Consensus        80 y~~ggsL~~~i~~~~-~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~-----  152 (405)
                      |+++++|.+++.... ..+++..+..++.||+.||.|||++|++|+||||+||+++.++ +||+|||+++.....     
T Consensus        82 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~  161 (261)
T cd05034          82 YMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAR  161 (261)
T ss_pred             ccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhhhhh
Confidence            999999999997653 4689999999999999999999999999999999999999888 999999998764421     


Q ss_pred             ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHH
Q 015500          153 LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSN  231 (405)
Q Consensus       153 ~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~  231 (405)
                      ....++..|+|||.+.+..+++++|+|||||++|+|++ |+.||... .....+..+... .....+...+.++.+++.+
T Consensus       162 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~-~~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~  239 (261)
T cd05034         162 EGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGM-TNREVLEQVERG-YRMPRPPNCPEELYDLMLQ  239 (261)
T ss_pred             hccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHcC-CCCCCCCCCCHHHHHHHHH
Confidence            12234568999999999889999999999999999999 99999644 334444444332 2233455578999999999


Q ss_pred             hcccCccccCCHHHHhc
Q 015500          232 CLRRDPKERWAASQLLK  248 (405)
Q Consensus       232 ~L~~dP~~Rpt~~elL~  248 (405)
                      ||+.+|.+||+++++++
T Consensus       240 ~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         240 CWDKDPEERPTFEYLQS  256 (261)
T ss_pred             HcccCcccCCCHHHHHH
Confidence            99999999999999864

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-40  Score=314.77  Aligned_cols=246  Identities=30%  Similarity=0.448  Sum_probs=200.6

Q ss_pred             cccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEE
Q 015500            3 WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLF   77 (405)
Q Consensus         3 y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv   77 (405)
                      |.+.+.||+|+||.||+|.+..+++.+|+|.+....     ...+.+|+++++.++|||++++++.+....  ....++|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~~~lv   78 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG--KGSIYMV   78 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC--CCcEEEE
Confidence            678999999999999999999999999999987542     346788999999999999999998876542  1236699


Q ss_pred             EeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc----
Q 015500           78 MEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA----  152 (405)
Q Consensus        78 ~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~----  152 (405)
                      +||+++ +|.+++.+....+++..++.++.||+.||+|||++|++|+||||+||+++.++ +||+|||++......    
T Consensus        79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~  157 (287)
T cd07840          79 FEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSAD  157 (287)
T ss_pred             eccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCccc
Confidence            999975 89998877656899999999999999999999999999999999999999888 999999998765432    


Q ss_pred             -ccCCCCCCccChhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCC----------------
Q 015500          153 -LQSGGTPMFMAPEVARG-EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSREL----------------  214 (405)
Q Consensus       153 -~~~~gt~~Y~APE~l~~-~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~----------------  214 (405)
                       ....+++.|+|||.+.+ ..+++++|||||||++|+|++|+.||..... ...+..+......                
T Consensus       158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (287)
T cd07840         158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE-LEQLEKIFELCGSPTDENWPGVSKLPWFE  236 (287)
T ss_pred             ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCchhhccccccchhhh
Confidence             22346888999998775 4578899999999999999999999965443 2222222110000                


Q ss_pred             -----CCC-------chh-ccHHHHHHHHHhcccCccccCCHHHHhcCccc
Q 015500          215 -----PEV-------PAF-LSKQANDFLSNCLRRDPKERWAASQLLKHPFL  252 (405)
Q Consensus       215 -----~~~-------p~~-~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~  252 (405)
                           +..       ... +++.+.+++++||..+|.+||++.++++||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         237 NLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             hccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence                 000       011 38889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=3.4e-40  Score=319.50  Aligned_cols=242  Identities=25%  Similarity=0.388  Sum_probs=198.5

Q ss_pred             CcccccccceeCCeeEEEEEEc-------CCCCEEEEEEccCC----ChHHHHHHHHHHHhC-CCCCeeeeeeeeeecCC
Q 015500            2 DWTRGHTIGQGSSATVSLATSL-------RSGDVFAAKSTELP----KSEFLQREQKFLSSL-NSPHIVGYKGCDVTSED   69 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~-------~~~~~vavK~~~~~----~~~~l~~E~~iL~~L-~hpnIv~~~~~~~~~~~   69 (405)
                      +|.+++.||+|+||.||+|++.       ..+..+|+|.....    ....+.+|+.+++.+ +||||+++++.+.... 
T Consensus        16 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~-   94 (304)
T cd05101          16 KLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG-   94 (304)
T ss_pred             HeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCC-
Confidence            5889999999999999999753       23457999987643    234688999999999 8999999998765433 


Q ss_pred             CceEEEEEEeecCCCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEc
Q 015500           70 NKLMYNLFMEYAPGGTLNDEIHRNG---------------GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMA  134 (405)
Q Consensus        70 ~~~~~~lv~Ey~~ggsL~~~i~~~~---------------~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~  134 (405)
                         .++++|||+++|+|.+++.+..               ..++...+..++.||+.||.|||++|++||||||+||+++
T Consensus        95 ---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~  171 (304)
T cd05101          95 ---PLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVT  171 (304)
T ss_pred             ---ceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEc
Confidence               3569999999999999997642               2477888999999999999999999999999999999999


Q ss_pred             cCC-ceEeeecccccccc------cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHH
Q 015500          135 ESG-AKIADFGCAKWESE------ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLY  206 (405)
Q Consensus       135 ~~~-vkL~DFGla~~~~~------~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~  206 (405)
                      .++ +||+|||+++....      .....+++.|+|||++.+..++.++|||||||++|+|++ |..||... .......
T Consensus       172 ~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~~  250 (304)
T cd05101         172 ENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEELFK  250 (304)
T ss_pred             CCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC-CHHHHHH
Confidence            887 99999999976533      112335678999999998889999999999999999998 78888543 3333333


Q ss_pred             HHHhcCCCCCCchhccHHHHHHHHHhcccCccccCCHHHHhcC
Q 015500          207 KIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       207 ~i~~~~~~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      .+ .....+..+..++..+.+|+.+||..+|.+|||+.++++.
T Consensus       251 ~~-~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         251 LL-KEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             HH-HcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            33 3333445566789999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=3.9e-40  Score=323.57  Aligned_cols=250  Identities=27%  Similarity=0.393  Sum_probs=201.5

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC-----ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP-----KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~-----~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      +|.+.+.||.|+||.||+|.++.+++.+|+|.+...     ....+.+|+.+++.++||||+++.+++.....   .+++
T Consensus        11 ~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~---~~~l   87 (328)
T cd07856          11 RYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE---DIYF   87 (328)
T ss_pred             ceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC---cEEE
Confidence            588999999999999999999999999999987532     24578899999999999999999988754332   2568


Q ss_pred             EEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc-cc
Q 015500           77 FMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA-LQ  154 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~-~~  154 (405)
                      ++||+ +++|.+++..  +++++..+..++.||+.||.|||++|++||||||.||+++.++ +||+|||++...... ..
T Consensus        88 v~e~~-~~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~~~  164 (328)
T cd07856          88 VTELL-GTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTG  164 (328)
T ss_pred             Eeehh-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCCcCC
Confidence            99998 5689888764  3689999999999999999999999999999999999999887 999999998754432 33


Q ss_pred             CCCCCCccChhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHH--HHHH---------------------Hh
Q 015500          155 SGGTPMFMAPEVARG-EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTV--LYKI---------------------AY  210 (405)
Q Consensus       155 ~~gt~~Y~APE~l~~-~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~--l~~i---------------------~~  210 (405)
                      ..+++.|+|||.+.+ ..+++++|+|||||++|+|++|+.||.........  +...                     ..
T Consensus       165 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (328)
T cd07856         165 YVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQS  244 (328)
T ss_pred             CcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhh
Confidence            457889999999876 56899999999999999999999999654321100  0000                     00


Q ss_pred             cCCCCC-----CchhccHHHHHHHHHhcccCccccCCHHHHhcCcccccccc
Q 015500          211 SRELPE-----VPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCS  257 (405)
Q Consensus       211 ~~~~~~-----~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~~  257 (405)
                      ......     ....+++.+.++|++||+.+|.+|||+++++.||||.....
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~  296 (328)
T cd07856         245 LPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHD  296 (328)
T ss_pred             ccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccC
Confidence            000001     11246789999999999999999999999999999986543

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-40  Score=307.86  Aligned_cols=236  Identities=36%  Similarity=0.561  Sum_probs=202.3

Q ss_pred             cceeCCeeEEEEEEcCCCCEEEEEEccCCC------hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEeecC
Q 015500            9 IGQGSSATVSLATSLRSGDVFAAKSTELPK------SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAP   82 (405)
Q Consensus         9 LG~G~~g~Vyla~~~~~~~~vavK~~~~~~------~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~Ey~~   82 (405)
                      ||.|+||.||++.+..+++.+|+|.+....      .+.+.+|+.++++++||||+++++.+....    ..+++|||++
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~~v~e~~~   76 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEE----KLYLVLEYAP   76 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCC----eeEEEEecCC
Confidence            799999999999999899999999876532      347889999999999999999987764332    3679999999


Q ss_pred             CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc----cccCCC
Q 015500           83 GGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE----ALQSGG  157 (405)
Q Consensus        83 ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~----~~~~~g  157 (405)
                      +++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ ++|+|||++.....    .....+
T Consensus        77 ~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~  155 (250)
T cd05123          77 GGELFSHLSKEG-RFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCG  155 (250)
T ss_pred             CCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcC
Confidence            999999998764 799999999999999999999999999999999999999887 99999999876433    234458


Q ss_pred             CCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHhcccCc
Q 015500          158 TPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDP  237 (405)
Q Consensus       158 t~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~L~~dP  237 (405)
                      +..|+|||...+...+.++|+||||+++|+|++|..||.... .......+..  ....+|..+++.+.+||++||..||
T Consensus       156 ~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~-~~~~~~~~~~--~~~~~~~~~~~~l~~~i~~~l~~~p  232 (250)
T cd05123         156 TPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAED-RKEIYEKILK--DPLRFPEFLSPEARDLISGLLQKDP  232 (250)
T ss_pred             CccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC-HHHHHHHHhc--CCCCCCCCCCHHHHHHHHHHhcCCH
Confidence            899999999998888999999999999999999999995443 2333333322  3345677789999999999999999


Q ss_pred             cccCCH---HHHhcCccc
Q 015500          238 KERWAA---SQLLKHPFL  252 (405)
Q Consensus       238 ~~Rpt~---~elL~hp~~  252 (405)
                      .+|||+   +++++||||
T Consensus       233 ~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         233 TKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             hhCCCcccHHHHHhCCCC
Confidence            999999   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.8e-40  Score=312.68  Aligned_cols=240  Identities=23%  Similarity=0.358  Sum_probs=200.5

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCC----EEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGD----VFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLM   73 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~----~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~   73 (405)
                      +|..++.||+|+||+||+|.++.+|+    .+|+|......    ...+.+|+.++++++||||+++++++.. .    .
T Consensus         8 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~----~   82 (279)
T cd05057           8 ELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-S----Q   82 (279)
T ss_pred             HcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-C----c
Confidence            57889999999999999999877665    58999876543    2467889999999999999999998765 2    2


Q ss_pred             EEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc
Q 015500           74 YNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA  152 (405)
Q Consensus        74 ~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~  152 (405)
                      .+++|||+++|+|.+++.++.+.+++..+..++.||+.||+|||++|++||||||+||+++.++ +||+|||+++.....
T Consensus        83 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~  162 (279)
T cd05057          83 VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD  162 (279)
T ss_pred             eEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence            5689999999999999988767899999999999999999999999999999999999998877 999999999764432


Q ss_pred             cc------CCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHH
Q 015500          153 LQ------SGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQA  225 (405)
Q Consensus       153 ~~------~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l  225 (405)
                      ..      ..++..|+|||.+....++.++|+|||||++|||++ |+.||... ........+. .......|...+.++
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~~  240 (279)
T cd05057         163 EKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGI-PAVEIPDLLE-KGERLPQPPICTIDV  240 (279)
T ss_pred             ccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCC-CHHHHHHHHh-CCCCCCCCCCCCHHH
Confidence            11      123567999999988889999999999999999998 99999544 3333333333 333334556688999


Q ss_pred             HHHHHHhcccCccccCCHHHHhc
Q 015500          226 NDFLSNCLRRDPKERWAASQLLK  248 (405)
Q Consensus       226 ~dll~~~L~~dP~~Rpt~~elL~  248 (405)
                      .+++.+||..||.+|||+.++++
T Consensus       241 ~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         241 YMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             HHHHHHHcCCChhhCCCHHHHHH
Confidence            99999999999999999999865

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=4.2e-40  Score=312.68  Aligned_cols=242  Identities=23%  Similarity=0.348  Sum_probs=199.0

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCC---EEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGD---VFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMY   74 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~---~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~   74 (405)
                      +|++++.||+|+||.||+|.++.+++   .+|||.+....    ...+.+|+.+++.++||||+++.+++....    .+
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~----~~   80 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSR----PV   80 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCC----ce
Confidence            47889999999999999999887665   69999986542    347889999999999999999998764433    25


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccccc
Q 015500           75 NLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEAL  153 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~~  153 (405)
                      +++|||+++++|.+++...++.+++..++.++.|++.||.|||++|++|+||||+||+++.++ +||+|||++.......
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~  160 (269)
T cd05065          81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  160 (269)
T ss_pred             EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence            699999999999999987767899999999999999999999999999999999999998887 9999999987543211


Q ss_pred             -------cCC--CCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccH
Q 015500          154 -------QSG--GTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSK  223 (405)
Q Consensus       154 -------~~~--gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~  223 (405)
                             ...  .+..|+|||.+.+..++.++|||||||++|||++ |..||.... .......+...... ..+..++.
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~-~~~~~~~i~~~~~~-~~~~~~~~  238 (269)
T cd05065         161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS-NQDVINAIEQDYRL-PPPMDCPT  238 (269)
T ss_pred             cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCC-HHHHHHHHHcCCcC-CCcccCCH
Confidence                   111  2346999999998889999999999999999886 999996443 33344444322222 33456788


Q ss_pred             HHHHHHHHhcccCccccCCHHHHhcC
Q 015500          224 QANDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       224 ~l~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      .+.+++.+||+.+|.+||++.+++..
T Consensus       239 ~~~~li~~~l~~~p~~Rp~~~~i~~~  264 (269)
T cd05065         239 ALHQLMLDCWQKDRNARPKFGQIVST  264 (269)
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            99999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=8.7e-40  Score=307.71  Aligned_cols=241  Identities=24%  Similarity=0.374  Sum_probs=199.6

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC--ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEe
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP--KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFME   79 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~--~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (405)
                      +|+..+.||+|+||.||+|.+. ++..+|+|.+...  ....+.+|++++++++||||+++++.+....    .++++||
T Consensus         5 ~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~~v~e   79 (256)
T cd05112           5 ELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERS----PICLVFE   79 (256)
T ss_pred             HeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCC----ceEEEEE
Confidence            5788999999999999999875 4678999987653  2467889999999999999999998765433    3679999


Q ss_pred             ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccccc-----
Q 015500           80 YAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEAL-----  153 (405)
Q Consensus        80 y~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~~-----  153 (405)
                      |+++++|.+++....+++++..+..++.|++.||+|||+.|++||||||+||+++.++ +||+|||+++......     
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~  159 (256)
T cd05112          80 FMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST  159 (256)
T ss_pred             cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcccccC
Confidence            9999999999987766899999999999999999999999999999999999999887 9999999987543211     


Q ss_pred             cCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHh
Q 015500          154 QSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNC  232 (405)
Q Consensus       154 ~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~  232 (405)
                      ...++..|+|||.+.+..++.++|||||||++|||++ |..||.... .......+... ..+..|...++.+.+|+.+|
T Consensus       160 ~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~  237 (256)
T cd05112         160 GTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS-NSEVVETINAG-FRLYKPRLASQSVYELMQHC  237 (256)
T ss_pred             CCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC-HHHHHHHHhCC-CCCCCCCCCCHHHHHHHHHH
Confidence            1224567999999998889999999999999999998 999995433 33333333222 22234555789999999999


Q ss_pred             cccCccccCCHHHHhcC
Q 015500          233 LRRDPKERWAASQLLKH  249 (405)
Q Consensus       233 L~~dP~~Rpt~~elL~h  249 (405)
                      |+.+|++|||+.+++++
T Consensus       238 l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         238 WKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             cccChhhCCCHHHHHHh
Confidence            99999999999999874

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-41  Score=313.74  Aligned_cols=245  Identities=27%  Similarity=0.429  Sum_probs=204.4

Q ss_pred             ccccceeCCeeEEEEEEcCCCCEEEEEEccCC---ChHHHHHHHHHHHhC-CCCCeeeeeeeeeecCCCceEEEEEEeec
Q 015500            6 GHTIGQGSSATVSLATSLRSGDVFAAKSTELP---KSEFLQREQKFLSSL-NSPHIVGYKGCDVTSEDNKLMYNLFMEYA   81 (405)
Q Consensus         6 ~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~---~~~~l~~E~~iL~~L-~hpnIv~~~~~~~~~~~~~~~~~lv~Ey~   81 (405)
                      .+.||+|+||.|--++...+|..||||++++.   .+.++.||++++... .|+||++++.+|.+...    +|||||-|
T Consensus        83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~----FYLVfEKm  158 (463)
T KOG0607|consen   83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTR----FYLVFEKM  158 (463)
T ss_pred             HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccce----EEEEEecc
Confidence            46899999999999999999999999999875   356888999999998 69999999998765544    67999999


Q ss_pred             CCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC----ceEeeecccccccc------
Q 015500           82 PGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG----AKIADFGCAKWESE------  151 (405)
Q Consensus        82 ~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~----vkL~DFGla~~~~~------  151 (405)
                      .||+|..+|.++. .++|..+..++++|+.||++||.+||.||||||+|||-..-+    +|||||.+..-...      
T Consensus       159 ~GGplLshI~~~~-~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp  237 (463)
T KOG0607|consen  159 RGGPLLSHIQKRK-HFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP  237 (463)
T ss_pred             cCchHHHHHHHhh-hccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence            9999999998874 899999999999999999999999999999999999986543    89999998753221      


Q ss_pred             -----cccCCCCCCccChhhhc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC--------------hHHHHHH
Q 015500          152 -----ALQSGGTPMFMAPEVAR-----GEHQGFASDIWAVGCTVIEMASGGAPWPNAAD--------------PMTVLYK  207 (405)
Q Consensus       152 -----~~~~~gt~~Y~APE~l~-----~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~--------------~~~~l~~  207 (405)
                           ..+.+|+..|||||+..     ...|+.+.|.||||+++|-|+.|.+||.+.=.              ....+..
T Consensus       238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFes  317 (463)
T KOG0607|consen  238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFES  317 (463)
T ss_pred             CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHH
Confidence                 33456888899999863     24689999999999999999999999964211              1223333


Q ss_pred             HHhcCCCCCCc----hhccHHHHHHHHHhcccCccccCCHHHHhcCcccccccc
Q 015500          208 IAYSRELPEVP----AFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCS  257 (405)
Q Consensus       208 i~~~~~~~~~p----~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~~  257 (405)
                      |..+.  -++|    ..+|.+++|++.++|.+||.+|.++.++++|||++.+..
T Consensus       318 IQEGk--YeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~  369 (463)
T KOG0607|consen  318 IQEGK--YEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAP  369 (463)
T ss_pred             HhccC--CcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccch
Confidence            43322  2344    458999999999999999999999999999999987644

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=5e-40  Score=309.50  Aligned_cols=238  Identities=26%  Similarity=0.404  Sum_probs=197.8

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC-ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEee
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP-KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEY   80 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~-~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~Ey   80 (405)
                      +|++++.||+|+||.||++..  +++.+|+|..... ..+.+.+|+.++++++||||+++++++... .    ++++|||
T Consensus         7 ~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~----~~~v~e~   79 (254)
T cd05083           7 KLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHN-G----LYIVMEL   79 (254)
T ss_pred             HceeeeeeccCCCCceEeccc--CCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-C----cEEEEEC
Confidence            588999999999999999864  6889999988654 345788999999999999999999876432 1    4689999


Q ss_pred             cCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc-ccCCC
Q 015500           81 APGGTLNDEIHRNG-GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA-LQSGG  157 (405)
Q Consensus        81 ~~ggsL~~~i~~~~-~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~-~~~~g  157 (405)
                      +++++|.+++.... ..+++..+..++.|++.||.|||+.|++||||||+||+++.++ +||+|||++...... .....
T Consensus        80 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~  159 (254)
T cd05083          80 MSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKL  159 (254)
T ss_pred             CCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccccCCCCCC
Confidence            99999999997653 3589999999999999999999999999999999999999887 999999998754332 22234


Q ss_pred             CCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHhcccC
Q 015500          158 TPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRD  236 (405)
Q Consensus       158 t~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~L~~d  236 (405)
                      +..|+|||.+.+..++.++|+|||||++|+|++ |+.||.... .......+. ....+..+..+++.+.+++.+||+.+
T Consensus       160 ~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~  237 (254)
T cd05083         160 PVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS-LKEVKECVE-KGYRMEPPEGCPADVYVLMTSCWETE  237 (254)
T ss_pred             CceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCC-HHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHHcCCC
Confidence            567999999998889999999999999999998 999996543 333333332 23333445668899999999999999


Q ss_pred             ccccCCHHHHhc
Q 015500          237 PKERWAASQLLK  248 (405)
Q Consensus       237 P~~Rpt~~elL~  248 (405)
                      |.+||+++++++
T Consensus       238 p~~Rp~~~~l~~  249 (254)
T cd05083         238 PKKRPSFHKLRE  249 (254)
T ss_pred             hhhCcCHHHHHH
Confidence            999999999975

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=6.1e-40  Score=317.97  Aligned_cols=241  Identities=24%  Similarity=0.367  Sum_probs=199.3

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCC----EEEEEEccCCCh----HHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGD----VFAAKSTELPKS----EFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLM   73 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~----~vavK~~~~~~~----~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~   73 (405)
                      +|++.+.||+|+||.||+|.+..+++    .+|+|.+.....    ..+.+|+.+++.++||||+++++.+....     
T Consensus         8 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~-----   82 (303)
T cd05110           8 ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPT-----   82 (303)
T ss_pred             hceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCCC-----
Confidence            68889999999999999999887776    468887765432    35778999999999999999999765321     


Q ss_pred             EEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc
Q 015500           74 YNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA  152 (405)
Q Consensus        74 ~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~  152 (405)
                      .++++||+++|+|.+++..+...+++..+..++.||+.||.|||++||+||||||+||+++.++ +||+|||+++.....
T Consensus        83 ~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~  162 (303)
T cd05110          83 IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD  162 (303)
T ss_pred             ceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCc
Confidence            3489999999999999988766799999999999999999999999999999999999998877 999999999764321


Q ss_pred             ------ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHH
Q 015500          153 ------LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQA  225 (405)
Q Consensus       153 ------~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l  225 (405)
                            ....++..|+|||.+.+..++.++|||||||++|||++ |+.||....  .............+..+...+.++
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  240 (303)
T cd05110         163 EKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP--TREIPDLLEKGERLPQPPICTIDV  240 (303)
T ss_pred             ccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHHCCCCCCCCCCCCHHH
Confidence                  12235678999999999899999999999999999997 999995432  222333333333344455678899


Q ss_pred             HHHHHHhcccCccccCCHHHHhcC
Q 015500          226 NDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       226 ~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      .+++.+||..+|++||+++++++.
T Consensus       241 ~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         241 YMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             HHHHHHHcCCChhhCcCHHHHHHH
Confidence            999999999999999999999875

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=3.8e-40  Score=315.07  Aligned_cols=234  Identities=21%  Similarity=0.322  Sum_probs=188.4

Q ss_pred             ccceeCCeeEEEEEEcCCC------------------------CEEEEEEccCCC---hHHHHHHHHHHHhCCCCCeeee
Q 015500            8 TIGQGSSATVSLATSLRSG------------------------DVFAAKSTELPK---SEFLQREQKFLSSLNSPHIVGY   60 (405)
Q Consensus         8 ~LG~G~~g~Vyla~~~~~~------------------------~~vavK~~~~~~---~~~l~~E~~iL~~L~hpnIv~~   60 (405)
                      .||+|+||.||+|....++                        ..+++|.+....   ...+.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            6999999999999854322                        357888876543   2467788999999999999999


Q ss_pred             eeeeeecCCCceEEEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC---
Q 015500           61 KGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG---  137 (405)
Q Consensus        61 ~~~~~~~~~~~~~~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~---  137 (405)
                      ++++.....    .++||||+++|+|..++.+..+.+++..+..++.||+.||+|||++||+||||||+|||++..+   
T Consensus        82 ~~~~~~~~~----~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~  157 (274)
T cd05076          82 HGVCVRGSE----NIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAE  157 (274)
T ss_pred             EEEEEeCCc----eEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCccc
Confidence            998765432    5689999999999999987666899999999999999999999999999999999999997532   


Q ss_pred             -----ceEeeecccccccccccCCCCCCccChhhhcC-CCCCcchhHHHHHHHHHHHH-hCCCCCCCCCChHHHHHHHHh
Q 015500          138 -----AKIADFGCAKWESEALQSGGTPMFMAPEVARG-EHQGFASDIWAVGCTVIEMA-SGGAPWPNAADPMTVLYKIAY  210 (405)
Q Consensus       138 -----vkL~DFGla~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~sDIwSLG~il~ell-tG~~Pf~~~~~~~~~l~~i~~  210 (405)
                           +|++|||++..........+++.|+|||.+.+ ..++.++|||||||++|||+ +|+.||....... .......
T Consensus       158 ~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-~~~~~~~  236 (274)
T cd05076         158 GTSPFIKLSDPGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE-KERFYEK  236 (274)
T ss_pred             CccceeeecCCccccccccccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH-HHHHHHh
Confidence                 79999999875544445568889999998876 56899999999999999994 7999996543322 1111111


Q ss_pred             cCCCCCCchhccHHHHHHHHHhcccCccccCCHHHHhcC
Q 015500          211 SRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       211 ~~~~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                         ....|...++.+.++|.+||+.+|++|||+.++|++
T Consensus       237 ---~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         237 ---KHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             ---ccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence               122334456789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-41  Score=336.94  Aligned_cols=233  Identities=29%  Similarity=0.492  Sum_probs=198.6

Q ss_pred             ccccceeCCeeEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEeecCCCC
Q 015500            6 GHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGT   85 (405)
Q Consensus         6 ~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~Ey~~ggs   85 (405)
                      ++-||+|+.|.||+|+.+  ++.||||+++.    .-..+|+-|++|+||||+.+.|++...    .+||+|||||..|.
T Consensus       129 LeWlGSGaQGAVF~Grl~--netVAVKKV~e----lkETdIKHLRkLkH~NII~FkGVCtqs----PcyCIiMEfCa~Gq  198 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRLH--NETVAVKKVRE----LKETDIKHLRKLKHPNIITFKGVCTQS----PCYCIIMEFCAQGQ  198 (904)
T ss_pred             hhhhccCcccceeeeecc--CceehhHHHhh----hhhhhHHHHHhccCcceeeEeeeecCC----ceeEEeeecccccc
Confidence            556999999999999875  89999998752    334578889999999999999987543    36999999999999


Q ss_pred             HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc---ccCCCCCCc
Q 015500           86 LNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA---LQSGGTPMF  161 (405)
Q Consensus        86 L~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~---~~~~gt~~Y  161 (405)
                      |..+++.. .++.......|..+|+.|+.|||.+.|||||||.-||||..+. +||+|||-++.....   -..+||-.|
T Consensus       199 L~~VLka~-~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSFaGTVaW  277 (904)
T KOG4721|consen  199 LYEVLKAG-RPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMSFAGTVAW  277 (904)
T ss_pred             HHHHHhcc-CccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhhhhhhhhhhhHhh
Confidence            99999875 4899999999999999999999999999999999999998877 999999998865553   346799999


Q ss_pred             cChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHhcccCccccC
Q 015500          162 MAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERW  241 (405)
Q Consensus       162 ~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~L~~dP~~Rp  241 (405)
                      ||||+++.+..+.|+|||||||+||||+||..||.+... ...++-+.....--..|..+++.++-||++||+-.|..||
T Consensus       278 MAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds-sAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRP  356 (904)
T KOG4721|consen  278 MAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS-SAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRP  356 (904)
T ss_pred             hCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch-heeEEeccCCcccccCcccCchHHHHHHHHHHhcCCCCCc
Confidence            999999999999999999999999999999999965432 2222222222222346788999999999999999999999


Q ss_pred             CHHHHhcCc
Q 015500          242 AASQLLKHP  250 (405)
Q Consensus       242 t~~elL~hp  250 (405)
                      ++.|+|.|-
T Consensus       357 SFrqil~Hl  365 (904)
T KOG4721|consen  357 SFRQILLHL  365 (904)
T ss_pred             cHHHHHHHH
Confidence            999999995

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=8.2e-40  Score=310.81  Aligned_cols=241  Identities=26%  Similarity=0.383  Sum_probs=199.7

Q ss_pred             CcccccccceeCCeeEEEEEEcCC---CCEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRS---GDVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMY   74 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~---~~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~   74 (405)
                      +|++.+.||+|+||.||+|.+...   ...+|+|......    .+.+.+|+.++++++||||+++++.+...   .  .
T Consensus         7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~---~--~   81 (270)
T cd05056           7 DITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN---P--V   81 (270)
T ss_pred             hceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC---C--c
Confidence            578899999999999999987644   3568999876543    34688999999999999999999876432   1  4


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccccc
Q 015500           75 NLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEAL  153 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~~  153 (405)
                      +++|||+++++|.+++.+....+++..+..++.||+.||+|||+.|++||||||+||+++.++ +||+|||+++......
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  161 (270)
T cd05056          82 WIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES  161 (270)
T ss_pred             EEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccccc
Confidence            589999999999999987665799999999999999999999999999999999999999887 9999999987543321


Q ss_pred             -----cCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHH
Q 015500          154 -----QSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQAND  227 (405)
Q Consensus       154 -----~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~d  227 (405)
                           ...+++.|+|||.+.+..++.++|||||||++|+|++ |..||..... ......+.... .+..|..++..+.+
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~~~  239 (270)
T cd05056         162 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN-NDVIGRIENGE-RLPMPPNCPPTLYS  239 (270)
T ss_pred             ceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHcCC-cCCCCCCCCHHHHH
Confidence                 2224567999999988889999999999999999986 9999965543 33344443332 33456678999999


Q ss_pred             HHHHhcccCccccCCHHHHhcC
Q 015500          228 FLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       228 ll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      ++.+||..+|.+|||+.+++..
T Consensus       240 li~~~l~~~P~~Rpt~~~~~~~  261 (270)
T cd05056         240 LMTKCWAYDPSKRPRFTELKAQ  261 (270)
T ss_pred             HHHHHcCCChhhCcCHHHHHHH
Confidence            9999999999999999999775

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=8.7e-40  Score=311.15  Aligned_cols=237  Identities=27%  Similarity=0.385  Sum_probs=191.9

Q ss_pred             cccceeCCeeEEEEEEcCCCC--EEEEEEccCC----ChHHHHHHHHHHHhC-CCCCeeeeeeeeeecCCCceEEEEEEe
Q 015500            7 HTIGQGSSATVSLATSLRSGD--VFAAKSTELP----KSEFLQREQKFLSSL-NSPHIVGYKGCDVTSEDNKLMYNLFME   79 (405)
Q Consensus         7 ~~LG~G~~g~Vyla~~~~~~~--~vavK~~~~~----~~~~l~~E~~iL~~L-~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (405)
                      +.||+|+||.||+|+++.++.  .+++|.....    ..+.+.+|+++++++ +||||+++++++....    .++++||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~----~~~lv~e   76 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG----YLYLAIE   76 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCC----CceEEEE
Confidence            469999999999999988776  4588877632    234678899999999 8999999998775433    2569999


Q ss_pred             ecCCCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeee
Q 015500           80 YAPGGTLNDEIHRNG---------------GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADF  143 (405)
Q Consensus        80 y~~ggsL~~~i~~~~---------------~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DF  143 (405)
                      |+++|+|.+++....               ..+++..++.++.|++.||+|||+.|++||||||+||+++.++ +||+||
T Consensus        77 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~df  156 (270)
T cd05047          77 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADF  156 (270)
T ss_pred             eCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCC
Confidence            999999999997532               2478999999999999999999999999999999999999888 999999


Q ss_pred             cccccccc---cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCch
Q 015500          144 GCAKWESE---ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPA  219 (405)
Q Consensus       144 Gla~~~~~---~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~  219 (405)
                      |++.....   ......++.|+|||++....++.++|||||||++|||++ |..||.... .......+. .......+.
T Consensus       157 gl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~-~~~~~~~~~-~~~~~~~~~  234 (270)
T cd05047         157 GLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-CAELYEKLP-QGYRLEKPL  234 (270)
T ss_pred             CCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccC-HHHHHHHHh-CCCCCCCCC
Confidence            99864322   111224567999999998889999999999999999997 999995433 233333332 223334556


Q ss_pred             hccHHHHHHHHHhcccCccccCCHHHHhcC
Q 015500          220 FLSKQANDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       220 ~~s~~l~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      .++.++.+++.+||..||.+|||+.+++..
T Consensus       235 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~  264 (270)
T cd05047         235 NCDDEVYDLMRQCWREKPYERPSFAQILVS  264 (270)
T ss_pred             cCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            688999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=8.6e-40  Score=313.81  Aligned_cols=241  Identities=24%  Similarity=0.337  Sum_probs=198.3

Q ss_pred             CcccccccceeCCeeEEEEEEc-----CCCCEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCce
Q 015500            2 DWTRGHTIGQGSSATVSLATSL-----RSGDVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKL   72 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~-----~~~~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~   72 (405)
                      +|+..+.||+|+||.||+|.+.     .++..+|+|.+....    ...+.+|+.++++++||||+++++++.....   
T Consensus         6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~---   82 (288)
T cd05050           6 NIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP---   82 (288)
T ss_pred             hceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc---
Confidence            5889999999999999999875     367899999887543    3468889999999999999999987654332   


Q ss_pred             EEEEEEeecCCCCHHHHHHHcC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCE
Q 015500           73 MYNLFMEYAPGGTLNDEIHRNG---------------------GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNI  131 (405)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~i~~~~---------------------~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NI  131 (405)
                       ++++|||+++|+|.+++....                     ..+++..+..++.||+.||+|||++|++||||||+||
T Consensus        83 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ni  161 (288)
T cd05050          83 -MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNC  161 (288)
T ss_pred             -cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhhe
Confidence             569999999999999997532                     2478888999999999999999999999999999999


Q ss_pred             EEccCC-ceEeeeccccccccc------ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHH
Q 015500          132 LMAESG-AKIADFGCAKWESEA------LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMT  203 (405)
Q Consensus       132 Li~~~~-vkL~DFGla~~~~~~------~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~  203 (405)
                      +++.++ +||+|||++......      .....++.|+|||.+.+..++.++|||||||++|+|++ |..||... ....
T Consensus       162 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~-~~~~  240 (288)
T cd05050         162 LVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM-AHEE  240 (288)
T ss_pred             EecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-CHHH
Confidence            999887 999999998753321      12234667999999998899999999999999999998 88898544 3344


Q ss_pred             HHHHHHhcCCCCCCchhccHHHHHHHHHhcccCccccCCHHHHhc
Q 015500          204 VLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLK  248 (405)
Q Consensus       204 ~l~~i~~~~~~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~  248 (405)
                      ....+. ....+..|..++.++.+||.+||+.+|.+|||+.|+++
T Consensus       241 ~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         241 VIYYVR-DGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             HHHHHh-cCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            444433 33334456678899999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-40  Score=312.90  Aligned_cols=244  Identities=32%  Similarity=0.516  Sum_probs=200.8

Q ss_pred             cccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEE
Q 015500            3 WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLF   77 (405)
Q Consensus         3 y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv   77 (405)
                      |+..+.||+|+||.||+|++..+++.+|+|.+....     .+.+.+|+.++++++||||+++++++....    .+++|
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~----~~~~v   76 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTER----KLYLV   76 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCC----ceEEE
Confidence            678899999999999999999999999999887532     346778999999999999999998776542    36699


Q ss_pred             EeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc----
Q 015500           78 MEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA----  152 (405)
Q Consensus        78 ~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~----  152 (405)
                      +||++ ++|.+++.+....+++..+..++.|++.||.|||++|++||||+|+||+++.++ +||+|||+++.....    
T Consensus        77 ~e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~  155 (282)
T cd07829          77 FEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY  155 (282)
T ss_pred             ecCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcccc
Confidence            99997 599999988655799999999999999999999999999999999999999887 999999998754332    


Q ss_pred             ccCCCCCCccChhhhcCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHh-------------------cC
Q 015500          153 LQSGGTPMFMAPEVARGE-HQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAY-------------------SR  212 (405)
Q Consensus       153 ~~~~gt~~Y~APE~l~~~-~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~-------------------~~  212 (405)
                      ....+++.|+|||.+.+. .++.++|+|||||+++||++|+.||...... ..+.++..                   ..
T Consensus       156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (282)
T cd07829         156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI-DQLFKIFQILGTPTEESWPGVTKLPDYKP  234 (282)
T ss_pred             CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHH-HHHHHHHHHhCCCcHHHHHhhcccccccc
Confidence            123467889999998776 7899999999999999999999999654332 22222111                   11


Q ss_pred             CCCCC--------chhccHHHHHHHHHhcccCccccCCHHHHhcCccc
Q 015500          213 ELPEV--------PAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFL  252 (405)
Q Consensus       213 ~~~~~--------p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~  252 (405)
                      ..+..        ...++..+.++|++||+.||++||++.++++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         235 TFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             cccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence            11111        11247889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=7.4e-40  Score=330.31  Aligned_cols=243  Identities=28%  Similarity=0.362  Sum_probs=199.3

Q ss_pred             CcccccccceeCCeeEEEEEEc-----CCCCEEEEEEccCCC----hHHHHHHHHHHHhCC-CCCeeeeeeeeeecCCCc
Q 015500            2 DWTRGHTIGQGSSATVSLATSL-----RSGDVFAAKSTELPK----SEFLQREQKFLSSLN-SPHIVGYKGCDVTSEDNK   71 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~-----~~~~~vavK~~~~~~----~~~l~~E~~iL~~L~-hpnIv~~~~~~~~~~~~~   71 (405)
                      +|.+++.||+|+||.||+|++.     .+++.||+|.+....    .+.+.+|+++|.++. ||||+++++.+.....  
T Consensus        38 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~--  115 (401)
T cd05107          38 NLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP--  115 (401)
T ss_pred             HeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC--
Confidence            3678899999999999999864     355789999987542    236778999999997 9999999998765432  


Q ss_pred             eEEEEEEeecCCCCHHHHHHHcCC--------------------------------------------------------
Q 015500           72 LMYNLFMEYAPGGTLNDEIHRNGG--------------------------------------------------------   95 (405)
Q Consensus        72 ~~~~lv~Ey~~ggsL~~~i~~~~~--------------------------------------------------------   95 (405)
                        .++||||+++|+|.+++.+++.                                                        
T Consensus       116 --~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (401)
T cd05107         116 --IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ  193 (401)
T ss_pred             --cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence              5699999999999999975421                                                        


Q ss_pred             -----------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEc
Q 015500           96 -----------------------------------------RLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMA  134 (405)
Q Consensus        96 -----------------------------------------~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~  134 (405)
                                                               .+++..+..++.||+.||+|||++|++||||||+|||++
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~  273 (401)
T cd05107         194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLIC  273 (401)
T ss_pred             cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEe
Confidence                                                     256677889999999999999999999999999999999


Q ss_pred             cCC-ceEeeecccccccc------cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHH
Q 015500          135 ESG-AKIADFGCAKWESE------ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLY  206 (405)
Q Consensus       135 ~~~-vkL~DFGla~~~~~------~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~  206 (405)
                      .++ +||+|||+++....      .....+++.|+|||.+.+..++.++|||||||++|||++ |..||....... .+.
T Consensus       274 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~-~~~  352 (401)
T cd05107         274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE-QFY  352 (401)
T ss_pred             CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH-HHH
Confidence            877 99999999875322      112346788999999998889999999999999999998 899996554333 333


Q ss_pred             HHHhcCCCCCCchhccHHHHHHHHHhcccCccccCCHHHHhcC
Q 015500          207 KIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       207 ~i~~~~~~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      ........+..|..++.++.+|+.+||..+|.+||++.+|++.
T Consensus       353 ~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         353 NAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             HHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            3333333445677789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=6.9e-40  Score=312.88  Aligned_cols=244  Identities=31%  Similarity=0.434  Sum_probs=198.2

Q ss_pred             cccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC----hHHHHHHHHHHHhCC-CCCeeeeeeeeeecCCCceEEEEE
Q 015500            3 WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK----SEFLQREQKFLSSLN-SPHIVGYKGCDVTSEDNKLMYNLF   77 (405)
Q Consensus         3 y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~----~~~l~~E~~iL~~L~-hpnIv~~~~~~~~~~~~~~~~~lv   77 (405)
                      |.+.+.||+|++|+||+|+...+++.+++|.+....    .....+|+..+++++ ||||+++++.+....    ..++|
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~----~~~lv   76 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFREND----ELYFV   76 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCC----cEEEE
Confidence            788999999999999999999899999999876432    234567999999998 999999999876532    36699


Q ss_pred             EeecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc---
Q 015500           78 MEYAPGGTLNDEIHRNG-GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA---  152 (405)
Q Consensus        78 ~Ey~~ggsL~~~i~~~~-~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~---  152 (405)
                      |||+ +|+|.+++.... ..+++..+..++.|++.+|.|||++|++|+||+|+||+++.++ ++|+|||++......   
T Consensus        77 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~  155 (283)
T cd07830          77 FEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY  155 (283)
T ss_pred             EecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCc
Confidence            9999 779999887753 4789999999999999999999999999999999999999887 999999999765432   


Q ss_pred             ccCCCCCCccChhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHh-cCC-----------------
Q 015500          153 LQSGGTPMFMAPEVARG-EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAY-SRE-----------------  213 (405)
Q Consensus       153 ~~~~gt~~Y~APE~l~~-~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~-~~~-----------------  213 (405)
                      ....++..|+|||++.+ ..++.++|+||||+++++|++|++||........ ..++.. ...                 
T Consensus       156 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd07830         156 TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQ-LYKICSVLGTPTKQDWPEGYKLASKLG  234 (283)
T ss_pred             CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHH-HHHHHHhcCCCChhhhhhHhhhhcccc
Confidence            23458899999998854 4578899999999999999999999965543222 221110 000                 


Q ss_pred             --C--------CCCchhccHHHHHHHHHhcccCccccCCHHHHhcCccc
Q 015500          214 --L--------PEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFL  252 (405)
Q Consensus       214 --~--------~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~  252 (405)
                        .        .......+.++.+||.+||+.+|.+|||+.|++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence              0        00111236789999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=8.7e-40  Score=321.33  Aligned_cols=242  Identities=24%  Similarity=0.373  Sum_probs=197.7

Q ss_pred             CcccccccceeCCeeEEEEEEcCCC-------CEEEEEEccCCC----hHHHHHHHHHHHhC-CCCCeeeeeeeeeecCC
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSG-------DVFAAKSTELPK----SEFLQREQKFLSSL-NSPHIVGYKGCDVTSED   69 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~-------~~vavK~~~~~~----~~~l~~E~~iL~~L-~hpnIv~~~~~~~~~~~   69 (405)
                      +|++++.||+|+||.||+|.+...+       ..+|+|.+....    .+.+.+|+++++++ +||||+++++.+.... 
T Consensus        13 ~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-   91 (334)
T cd05100          13 RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG-   91 (334)
T ss_pred             HeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC-
Confidence            4889999999999999999865322       368999876432    34688999999999 8999999998765433 


Q ss_pred             CceEEEEEEeecCCCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEc
Q 015500           70 NKLMYNLFMEYAPGGTLNDEIHRNG---------------GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMA  134 (405)
Q Consensus        70 ~~~~~~lv~Ey~~ggsL~~~i~~~~---------------~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~  134 (405)
                         ..+++|||+++|+|.+++.+..               ..++...+..++.||+.||.|||++|++||||||+|||++
T Consensus        92 ---~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~  168 (334)
T cd05100          92 ---PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVT  168 (334)
T ss_pred             ---ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEc
Confidence               2569999999999999997632               2477888999999999999999999999999999999999


Q ss_pred             cCC-ceEeeeccccccccc------ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHH
Q 015500          135 ESG-AKIADFGCAKWESEA------LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLY  206 (405)
Q Consensus       135 ~~~-vkL~DFGla~~~~~~------~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~  206 (405)
                      .++ +||+|||+++.....      ....++..|+|||++.+..++.++|||||||++|||++ |..||... +......
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~-~~~~~~~  247 (334)
T cd05100         169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI-PVEELFK  247 (334)
T ss_pred             CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCC-CHHHHHH
Confidence            887 999999998754331      11224567999999999999999999999999999998 88999544 3333333


Q ss_pred             HHHhcCCCCCCchhccHHHHHHHHHhcccCccccCCHHHHhcC
Q 015500          207 KIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       207 ~i~~~~~~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      .+ .....+..+...+..+.+++.+||+.+|.+|||+.+++++
T Consensus       248 ~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~  289 (334)
T cd05100         248 LL-KEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED  289 (334)
T ss_pred             HH-HcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            33 3334445666788999999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=6.1e-40  Score=314.84  Aligned_cols=249  Identities=27%  Similarity=0.473  Sum_probs=203.4

Q ss_pred             CcccccccceeCCeeEEEEEEc---CCCCEEEEEEccCC-------ChHHHHHHHHHHHhC-CCCCeeeeeeeeeecCCC
Q 015500            2 DWTRGHTIGQGSSATVSLATSL---RSGDVFAAKSTELP-------KSEFLQREQKFLSSL-NSPHIVGYKGCDVTSEDN   70 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~---~~~~~vavK~~~~~-------~~~~l~~E~~iL~~L-~hpnIv~~~~~~~~~~~~   70 (405)
                      +|.+.+.||+|+||+||+|.+.   .+++.+|||.+...       ....+.+|+.++.++ +||||+++.+.+....  
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~--   78 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDT--   78 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCC--
Confidence            5889999999999999999864   46789999987532       234677899999999 5999999987764432  


Q ss_pred             ceEEEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccc
Q 015500           71 KLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWE  149 (405)
Q Consensus        71 ~~~~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~  149 (405)
                        .+++||||+++++|.+++... +.+++..++.++.|++.||.|||+.|++||||||.||+++.++ ++|+|||+++..
T Consensus        79 --~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~  155 (288)
T cd05583          79 --KLHLILDYVNGGELFTHLYQR-EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEF  155 (288)
T ss_pred             --EEEEEEecCCCCcHHHHHhhc-CCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence              366999999999999998765 4799999999999999999999999999999999999999887 999999998754


Q ss_pred             ccc-----ccCCCCCCccChhhhcCCC--CCcchhHHHHHHHHHHHHhCCCCCCCCCC--hHHHHHHHHhcCCCCCCchh
Q 015500          150 SEA-----LQSGGTPMFMAPEVARGEH--QGFASDIWAVGCTVIEMASGGAPWPNAAD--PMTVLYKIAYSRELPEVPAF  220 (405)
Q Consensus       150 ~~~-----~~~~gt~~Y~APE~l~~~~--~~~~sDIwSLG~il~elltG~~Pf~~~~~--~~~~l~~i~~~~~~~~~p~~  220 (405)
                      ...     ....|++.|+|||.+.+..  .+.++|+||||+++|+|++|..||.....  ....+.+... ...+..|..
T Consensus       156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~  234 (288)
T cd05583         156 LAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRIL-KSKPPFPKT  234 (288)
T ss_pred             ccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHH-ccCCCCCcc
Confidence            321     1235889999999987755  77899999999999999999999954321  1122222222 233456677


Q ss_pred             ccHHHHHHHHHhcccCccccCC---HHHHhcCccccccc
Q 015500          221 LSKQANDFLSNCLRRDPKERWA---ASQLLKHPFLEEFC  256 (405)
Q Consensus       221 ~s~~l~dll~~~L~~dP~~Rpt---~~elL~hp~~~~~~  256 (405)
                      ++..+.++|.+||+.||++|||   +.++|+||||+.+.
T Consensus       235 ~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~  273 (288)
T cd05583         235 MSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGID  273 (288)
T ss_pred             cCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCC
Confidence            8999999999999999999998   57889999998754

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=3.2e-41  Score=314.00  Aligned_cols=250  Identities=31%  Similarity=0.425  Sum_probs=200.4

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCC----EEEEEEccCCC-----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCce
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGD----VFAAKSTELPK-----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKL   72 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~----~vavK~~~~~~-----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~   72 (405)
                      .|...+.||+|.||.||+|..+.++.    .+|+|.++.++     +...-||+.+++.|+|||++.+..++...+   .
T Consensus        25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d---~  101 (438)
T KOG0666|consen   25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD---K  101 (438)
T ss_pred             HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC---c
Confidence            58889999999999999997766654    68999987652     457889999999999999999998877652   2


Q ss_pred             EEEEEEeecCCCCHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccC----C-ceEeee
Q 015500           73 MYNLFMEYAPGGTLNDEIHRN----GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES----G-AKIADF  143 (405)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~i~~~----~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~----~-vkL~DF  143 (405)
                      ..++++||++. +|...|+-+    ...++...++.|++||+.|+.|||++-|+||||||.|||+..+    | +||+||
T Consensus       102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDl  180 (438)
T KOG0666|consen  102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADL  180 (438)
T ss_pred             eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecc
Confidence            35699999977 888888642    2358999999999999999999999999999999999999877    5 999999


Q ss_pred             cccccccccc-------cCCCCCCccChhhhcCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCC--------hHHHHHH
Q 015500          144 GCAKWESEAL-------QSGGTPMFMAPEVARGE-HQGFASDIWAVGCTVIEMASGGAPWPNAAD--------PMTVLYK  207 (405)
Q Consensus       144 Gla~~~~~~~-------~~~gt~~Y~APE~l~~~-~~~~~sDIwSLG~il~elltG~~Pf~~~~~--------~~~~l~~  207 (405)
                      |+|+.+....       ..+-|.+|+|||++.|. .|+++.||||+|||+.||+|-.+.|...+.        ....+.+
T Consensus       181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r  260 (438)
T KOG0666|consen  181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR  260 (438)
T ss_pred             cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence            9999765522       22368899999999985 589999999999999999999988864321        1222333


Q ss_pred             HHhcCCCCC---------Cchh--------------------------ccHHHHHHHHHhcccCccccCCHHHHhcCccc
Q 015500          208 IAYSRELPE---------VPAF--------------------------LSKQANDFLSNCLRRDPKERWAASQLLKHPFL  252 (405)
Q Consensus       208 i~~~~~~~~---------~p~~--------------------------~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~  252 (405)
                      |...-..|.         .|.+                          -++.+.+||.+||..||.+|.|++|+|+|+||
T Consensus       261 If~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF  340 (438)
T KOG0666|consen  261 IFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYF  340 (438)
T ss_pred             HHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccccc
Confidence            322211111         1111                          24568899999999999999999999999999


Q ss_pred             ccc
Q 015500          253 EEF  255 (405)
Q Consensus       253 ~~~  255 (405)
                      .+.
T Consensus       341 ~~d  343 (438)
T KOG0666|consen  341 TED  343 (438)
T ss_pred             ccC
Confidence            864

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-41  Score=337.97  Aligned_cols=237  Identities=27%  Similarity=0.437  Sum_probs=202.2

Q ss_pred             cccccccceeCCeeEEEEEEcCCCCEEEEEEccCC-----ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEE
Q 015500            3 WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP-----KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLF   77 (405)
Q Consensus         3 y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~-----~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv   77 (405)
                      ..++..||+|.||+||+|.+.   -.||||.++..     +.+.|++|+.+|++-+|.||+-+.|++....     +.+|
T Consensus       394 v~l~~rIGsGsFGtV~Rg~wh---GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~-----~AIi  465 (678)
T KOG0193|consen  394 VLLGERIGSGSFGTVYRGRWH---GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP-----LAII  465 (678)
T ss_pred             hhccceeccccccceeecccc---cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc-----eeee
Confidence            356889999999999999985   35899988754     3568999999999999999999999876543     3689


Q ss_pred             EeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc-----
Q 015500           78 MEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE-----  151 (405)
Q Consensus        78 ~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~-----  151 (405)
                      .-+|+|-+|..+|.....+|+....+.|++||++|+.|||.++|||||||..||++.+++ |||+|||++....-     
T Consensus       466 TqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~  545 (678)
T KOG0193|consen  466 TQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQ  545 (678)
T ss_pred             ehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeecccc
Confidence            999999999999987667899999999999999999999999999999999999999977 99999999864322     


Q ss_pred             -cccCCCCCCccChhhhcC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCC---CchhccHH
Q 015500          152 -ALQSGGTPMFMAPEVARG---EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPE---VPAFLSKQ  224 (405)
Q Consensus       152 -~~~~~gt~~Y~APE~l~~---~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~---~p~~~s~~  224 (405)
                       .....|...|||||+++.   .+|++.+|||||||++|||+||..||. .......++.+..+...|.   .-..++++
T Consensus       546 q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dqIifmVGrG~l~pd~s~~~s~~pk~  624 (678)
T KOG0193|consen  546 QLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQIIFMVGRGYLMPDLSKIRSNCPKA  624 (678)
T ss_pred             ccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhheEEEecccccCccchhhhccCHHH
Confidence             234457888999999985   458899999999999999999999997 6666777776665533333   33557889


Q ss_pred             HHHHHHHhcccCccccCCHHHHhc
Q 015500          225 ANDFLSNCLRRDPKERWAASQLLK  248 (405)
Q Consensus       225 l~dll~~~L~~dP~~Rpt~~elL~  248 (405)
                      +++|+..||.+++++||.+.+||.
T Consensus       625 mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  625 MKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             HHHHHHHHHhcCcccCccHHHHHH
Confidence            999999999999999999999987

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=8.3e-40  Score=349.55  Aligned_cols=141  Identities=28%  Similarity=0.468  Sum_probs=126.6

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC------hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK------SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~------~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~   75 (405)
                      +|.+.+.||+|+||+||+|.+..+++.||||++....      ...+.+|+.+++.++||||++++..+....    .++
T Consensus         5 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~----~~~   80 (669)
T cd05610           5 EFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSAN----NVY   80 (669)
T ss_pred             CEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECC----EEE
Confidence            5899999999999999999999999999999986532      257889999999999999999997765433    367


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccc
Q 015500           76 LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAK  147 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~  147 (405)
                      +||||++|++|.+++... +.+++..++.|+.||+.||+|||++||+||||||+||||+.++ +||+|||+++
T Consensus        81 lVmEy~~g~~L~~li~~~-~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          81 LVMEYLIGGDVKSLLHIY-GYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            999999999999999775 4799999999999999999999999999999999999999887 9999999874

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-39  Score=314.54  Aligned_cols=242  Identities=24%  Similarity=0.293  Sum_probs=193.3

Q ss_pred             CcccccccceeCCeeEEEEEEcCCC--------------CEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeee
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSG--------------DVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGC   63 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~--------------~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~   63 (405)
                      +|.+.+.||+|+||.||+|++..++              ..+|+|.+....    .+.+.+|+++|++++||||++++++
T Consensus         6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~   85 (295)
T cd05097           6 QLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGV   85 (295)
T ss_pred             hCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEE
Confidence            5889999999999999999875432              358999886532    3468899999999999999999998


Q ss_pred             eeecCCCceEEEEEEeecCCCCHHHHHHHcC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEE
Q 015500           64 DVTSEDNKLMYNLFMEYAPGGTLNDEIHRNG-----------GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNIL  132 (405)
Q Consensus        64 ~~~~~~~~~~~~lv~Ey~~ggsL~~~i~~~~-----------~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NIL  132 (405)
                      +.....    .+++|||+++++|.+++....           ..+++..+..++.|++.||.|||++|++||||||+||+
T Consensus        86 ~~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil  161 (295)
T cd05097          86 CVSDDP----LCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL  161 (295)
T ss_pred             EcCCCc----cEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence            764432    569999999999999986532           13688899999999999999999999999999999999


Q ss_pred             EccCC-ceEeeeccccccccc------ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh--CCCCCCCCCChHH
Q 015500          133 MAESG-AKIADFGCAKWESEA------LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS--GGAPWPNAADPMT  203 (405)
Q Consensus       133 i~~~~-vkL~DFGla~~~~~~------~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt--G~~Pf~~~~~~~~  203 (405)
                      ++.++ +||+|||++......      ....+++.|+|||.+.+..++.++|+|||||++|+|++  |..||..... ..
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~-~~  240 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD-EQ  240 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh-HH
Confidence            99887 999999998753221      11234678999999998889999999999999999998  6678854432 22


Q ss_pred             HHHHHH------hcCCCCCCchhccHHHHHHHHHhcccCccccCCHHHHhc
Q 015500          204 VLYKIA------YSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLK  248 (405)
Q Consensus       204 ~l~~i~------~~~~~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~  248 (405)
                      .+..+.      ........+...++.+.+|+.+||+.||++|||++++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         241 VIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             HHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            222111      111223345557899999999999999999999999965

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.5e-39  Score=309.65  Aligned_cols=243  Identities=22%  Similarity=0.309  Sum_probs=198.1

Q ss_pred             CcccccccceeCCeeEEEEEEcC-----CCCEEEEEEccCCCh----HHHHHHHHHHHhCCCCCeeeeeeeeeecCCCce
Q 015500            2 DWTRGHTIGQGSSATVSLATSLR-----SGDVFAAKSTELPKS----EFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKL   72 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~-----~~~~vavK~~~~~~~----~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~   72 (405)
                      +|++.+.||+|+||+||+|+.+.     +.+.+++|.......    +.+.+|+++|++++||||+++++.+....    
T Consensus         6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----   81 (275)
T cd05046           6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE----   81 (275)
T ss_pred             hceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC----
Confidence            58889999999999999999764     346799998865432    46889999999999999999998764332    


Q ss_pred             EEEEEEeecCCCCHHHHHHHcC--------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeee
Q 015500           73 MYNLFMEYAPGGTLNDEIHRNG--------GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADF  143 (405)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~i~~~~--------~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DF  143 (405)
                      ..+++|||+++|+|.+++....        ..+++..+..++.||+.||.|||+.||+||||||+||+++.++ ++|+||
T Consensus        82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccc
Confidence            3569999999999999997643        1589999999999999999999999999999999999999887 999999


Q ss_pred             cccccccc-----cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCC
Q 015500          144 GCAKWESE-----ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEV  217 (405)
Q Consensus       144 Gla~~~~~-----~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~  217 (405)
                      |+++....     .....+++.|+|||.+.+..+++++|||||||++|+|++ |..||....+ ......+.........
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~-~~~~~~~~~~~~~~~~  240 (275)
T cd05046         162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD-EEVLNRLQAGKLELPV  240 (275)
T ss_pred             ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch-HHHHHHHHcCCcCCCC
Confidence            99864321     122345777999999988888999999999999999999 8889964433 3333333322222233


Q ss_pred             chhccHHHHHHHHHhcccCccccCCHHHHhcC
Q 015500          218 PAFLSKQANDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       218 p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      +..++..+.+++.+||+.+|.+|||+.+++.+
T Consensus       241 ~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         241 PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence            45688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.7e-39  Score=313.86  Aligned_cols=242  Identities=19%  Similarity=0.235  Sum_probs=188.6

Q ss_pred             CcccccccceeCCeeEEEEEEcCC---CCEEEEEEccCCChH--------------HHHHHHHHHHhCCCCCeeeeeeee
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRS---GDVFAAKSTELPKSE--------------FLQREQKFLSSLNSPHIVGYKGCD   64 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~---~~~vavK~~~~~~~~--------------~l~~E~~iL~~L~hpnIv~~~~~~   64 (405)
                      +|.+++.||+|+||+||+|.+..+   +..+|+|........              ....+...+..+.|+||++++++.
T Consensus        13 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~   92 (294)
T PHA02882         13 EWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCG   92 (294)
T ss_pred             ceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEee
Confidence            589999999999999999998877   677888865433211              111223445667899999999877


Q ss_pred             eecCCCceEEEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeee
Q 015500           65 VTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADF  143 (405)
Q Consensus        65 ~~~~~~~~~~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DF  143 (405)
                      ........+.++++|++. .++.+.+... ...++..++.++.|++.||+|||++||+||||||+|||++.++ ++|+||
T Consensus        93 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~DF  170 (294)
T PHA02882         93 SFKRCRMYYRFILLEKLV-ENTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDY  170 (294)
T ss_pred             eEecCCceEEEEEEehhc-cCHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEEc
Confidence            665554455568888874 4777776654 3578999999999999999999999999999999999998877 999999


Q ss_pred             cccccccc-----------cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHH------
Q 015500          144 GCAKWESE-----------ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLY------  206 (405)
Q Consensus       144 Gla~~~~~-----------~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~------  206 (405)
                      |+|+....           .....||+.|+|||++.+..++.++|||||||++|||++|++||...........      
T Consensus       171 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~~  250 (294)
T PHA02882        171 GIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCDF  250 (294)
T ss_pred             CCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHHH
Confidence            99875421           1223599999999999999999999999999999999999999976633222221      


Q ss_pred             --HHHhcCCCCCCchhccHHHHHHHHHhcccCccccCCHHHHhc
Q 015500          207 --KIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLK  248 (405)
Q Consensus       207 --~i~~~~~~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~  248 (405)
                        ++... .  ..+...++.+.++++.|++.+|.+||+++++++
T Consensus       251 ~~~~~~~-~--~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        251 IKRLHEG-K--IKIKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             HHHhhhh-h--hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence              11111 1  112346889999999999999999999999875

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.7e-39  Score=313.36  Aligned_cols=242  Identities=25%  Similarity=0.327  Sum_probs=193.2

Q ss_pred             CcccccccceeCCeeEEEEEEcC----------------CCCEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeee
Q 015500            2 DWTRGHTIGQGSSATVSLATSLR----------------SGDVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYK   61 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~----------------~~~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~   61 (405)
                      +|++.+.||+|+||+||+|.+..                ++..+|+|......    ...+.+|+++|+.++||||++++
T Consensus         6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~   85 (296)
T cd05095           6 RLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLL   85 (296)
T ss_pred             hceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEE
Confidence            48899999999999999986432                34578999886532    34688999999999999999999


Q ss_pred             eeeeecCCCceEEEEEEeecCCCCHHHHHHHcC----------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCE
Q 015500           62 GCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNG----------GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNI  131 (405)
Q Consensus        62 ~~~~~~~~~~~~~~lv~Ey~~ggsL~~~i~~~~----------~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NI  131 (405)
                      +++.....    ++++|||+++++|.+++....          ..+++..+..++.||+.||+|||++|++||||||+||
T Consensus        86 ~~~~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni  161 (296)
T cd05095          86 AVCITSDP----LCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC  161 (296)
T ss_pred             EEEecCCc----cEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence            98765443    579999999999999987642          2367788999999999999999999999999999999


Q ss_pred             EEccCC-ceEeeeccccccccc------ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh--CCCCCCCCCChH
Q 015500          132 LMAESG-AKIADFGCAKWESEA------LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS--GGAPWPNAADPM  202 (405)
Q Consensus       132 Li~~~~-vkL~DFGla~~~~~~------~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt--G~~Pf~~~~~~~  202 (405)
                      |++.++ ++|+|||+++.....      ....+++.|+|||...+..++.++|+|||||++|||++  |..||.......
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ  241 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence            998877 999999998754321      11234678999999888889999999999999999998  778886543322


Q ss_pred             HHHHHHH------hcCCCCCCchhccHHHHHHHHHhcccCccccCCHHHHhc
Q 015500          203 TVLYKIA------YSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLK  248 (405)
Q Consensus       203 ~~l~~i~------~~~~~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~  248 (405)
                       ......      ........+..+++.+.+|+.+||+.||.+|||+.++++
T Consensus       242 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         242 -VIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             -HHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence             111110      111122334567899999999999999999999999865

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.5e-39  Score=308.26  Aligned_cols=236  Identities=24%  Similarity=0.349  Sum_probs=193.0

Q ss_pred             cccceeCCeeEEEEEEcCCC------CEEEEEEccCC----ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEE
Q 015500            7 HTIGQGSSATVSLATSLRSG------DVFAAKSTELP----KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         7 ~~LG~G~~g~Vyla~~~~~~------~~vavK~~~~~----~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      +.||+|+||.||+|+++...      +.+|+|.+...    ....+.+|+++|+.++||||+++++++.....    .++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~~   76 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEP----QYI   76 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCC----eEE
Confidence            47999999999999986544      68999987543    34578899999999999999999987654332    569


Q ss_pred             EEeecCCCCHHHHHHHc------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC------ceEeeec
Q 015500           77 FMEYAPGGTLNDEIHRN------GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG------AKIADFG  144 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~------~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~------vkL~DFG  144 (405)
                      +|||+++++|.+++.+.      ...+++..+..++.||+.||+|||+++++|+||||+||+++.++      ++|+|||
T Consensus        77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg  156 (269)
T cd05044          77 IMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFG  156 (269)
T ss_pred             EEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcc
Confidence            99999999999999752      23478899999999999999999999999999999999998654      8999999


Q ss_pred             cccccccc------ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCC
Q 015500          145 CAKWESEA------LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEV  217 (405)
Q Consensus       145 la~~~~~~------~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~  217 (405)
                      +++.....      ....++..|+|||.+.+..++.++|||||||++|+|++ |+.||.... .......+. ....+..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~-~~~~~~~~~-~~~~~~~  234 (269)
T cd05044         157 LARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN-NQEVLQHVT-AGGRLQK  234 (269)
T ss_pred             cccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccC-HHHHHHHHh-cCCccCC
Confidence            98754221      12235788999999999899999999999999999998 999996443 333333332 2334455


Q ss_pred             chhccHHHHHHHHHhcccCccccCCHHHHhc
Q 015500          218 PAFLSKQANDFLSNCLRRDPKERWAASQLLK  248 (405)
Q Consensus       218 p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~  248 (405)
                      +..++..+.+||.+||..+|.+||+++++++
T Consensus       235 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         235 PENCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             cccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            6678999999999999999999999999875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=3e-39  Score=308.51  Aligned_cols=242  Identities=21%  Similarity=0.257  Sum_probs=198.6

Q ss_pred             CcccccccceeCCeeEEEEEEcC----CCCEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLR----SGDVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLM   73 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~----~~~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~   73 (405)
                      +|.+.+.||+|+||.||+|.+..    ++..+++|.+....    .+.+.+|+.++++++||||++++++......   .
T Consensus         7 ~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~---~   83 (280)
T cd05043           7 RVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE---P   83 (280)
T ss_pred             heEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC---C
Confidence            57889999999999999999876    35889999876432    3567889999999999999999987654322   2


Q ss_pred             EEEEEeecCCCCHHHHHHHcC-------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecc
Q 015500           74 YNLFMEYAPGGTLNDEIHRNG-------GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGC  145 (405)
Q Consensus        74 ~~lv~Ey~~ggsL~~~i~~~~-------~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGl  145 (405)
                      +++++||+++++|.+++....       ..+++..+..++.||+.||+|||++|++||||||+||+++.++ +||+|||+
T Consensus        84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g~  163 (280)
T cd05043          84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNAL  163 (280)
T ss_pred             CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCCC
Confidence            458999999999999987632       3589999999999999999999999999999999999998887 99999999


Q ss_pred             ccccccc------ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCc
Q 015500          146 AKWESEA------LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVP  218 (405)
Q Consensus       146 a~~~~~~------~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p  218 (405)
                      ++.....      ....++..|+|||.+.+..++.++|||||||++|||++ |+.||... ++......+.. ...+..+
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~~~~~~-~~~~~~~  241 (280)
T cd05043         164 SRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEI-DPFEMAAYLKD-GYRLAQP  241 (280)
T ss_pred             cccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcC-CHHHHHHHHHc-CCCCCCC
Confidence            9754221      12335677999999998889999999999999999999 99999644 44443333332 2233345


Q ss_pred             hhccHHHHHHHHHhcccCccccCCHHHHhc
Q 015500          219 AFLSKQANDFLSNCLRRDPKERWAASQLLK  248 (405)
Q Consensus       219 ~~~s~~l~dll~~~L~~dP~~Rpt~~elL~  248 (405)
                      ..+++++.+++.+||..||++|||+.++++
T Consensus       242 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         242 INCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             CcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            567899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=3.9e-39  Score=306.21  Aligned_cols=237  Identities=23%  Similarity=0.316  Sum_probs=185.9

Q ss_pred             cccceeCCeeEEEEEEc--CCCCEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEee
Q 015500            7 HTIGQGSSATVSLATSL--RSGDVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEY   80 (405)
Q Consensus         7 ~~LG~G~~g~Vyla~~~--~~~~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~Ey   80 (405)
                      +.||+|+||.||+|...  .++..+|+|.+....    ...+.+|+.+++.++||||+++++.+.....    +++||||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~----~~lv~e~   76 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTP----YLLVMEF   76 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCC----cEEEEEC
Confidence            46999999999999754  355789999876542    2367789999999999999999987654332    5699999


Q ss_pred             cCCCCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc----
Q 015500           81 APGGTLNDEIHRNG----GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE----  151 (405)
Q Consensus        81 ~~ggsL~~~i~~~~----~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~----  151 (405)
                      +++|+|.+++....    ..+++..++.++.|++.||+|||+.|++||||||+||+++.++ +||+|||+++....    
T Consensus        77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~  156 (269)
T cd05087          77 CPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY  156 (269)
T ss_pred             CCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCccee
Confidence            99999999997532    2457778889999999999999999999999999999999887 99999999865322    


Q ss_pred             --cccCCCCCCccChhhhcCC-------CCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhc---CCCCCCc
Q 015500          152 --ALQSGGTPMFMAPEVARGE-------HQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYS---RELPEVP  218 (405)
Q Consensus       152 --~~~~~gt~~Y~APE~l~~~-------~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~---~~~~~~p  218 (405)
                        .....+++.|+|||++.+.       .++.++|||||||++|||++ |+.||............+...   ...|...
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (269)
T cd05087         157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLK  236 (269)
T ss_pred             ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccC
Confidence              1123467889999998642       35789999999999999996 999997654433322222111   1122333


Q ss_pred             hhccHHHHHHHHHhcccCccccCCHHHHhc
Q 015500          219 AFLSKQANDFLSNCLRRDPKERWAASQLLK  248 (405)
Q Consensus       219 ~~~s~~l~dll~~~L~~dP~~Rpt~~elL~  248 (405)
                      ...++.+.+++++|+ .+|++|||+++|+.
T Consensus       237 ~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         237 LPLSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             CCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence            457889999999999 68999999999964

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=3.8e-39  Score=306.11  Aligned_cols=236  Identities=24%  Similarity=0.375  Sum_probs=185.4

Q ss_pred             cccceeCCeeEEEEEEcC--CCCEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEee
Q 015500            7 HTIGQGSSATVSLATSLR--SGDVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEY   80 (405)
Q Consensus         7 ~~LG~G~~g~Vyla~~~~--~~~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~Ey   80 (405)
                      +.||+|+||+||+|....  ....+|+|.+....    ...+.+|+.+++.++||||+++++.+....    .+++||||
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~----~~~lv~e~   76 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESI----PYLLVLEF   76 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCC----ceEEEEEe
Confidence            469999999999996533  44578999765432    235778999999999999999998765443    26799999


Q ss_pred             cCCCCHHHHHHHcCC----CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc----
Q 015500           81 APGGTLNDEIHRNGG----RLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE----  151 (405)
Q Consensus        81 ~~ggsL~~~i~~~~~----~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~----  151 (405)
                      +++|+|.+++....+    ..++..++.++.||+.||+|||++||+||||||+|||++.++ +||+|||++.....    
T Consensus        77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~  156 (269)
T cd05042          77 CPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY  156 (269)
T ss_pred             CCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchhe
Confidence            999999999976432    346788899999999999999999999999999999999887 99999999864321    


Q ss_pred             --cccCCCCCCccChhhhcC-------CCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcC----CCCCC
Q 015500          152 --ALQSGGTPMFMAPEVARG-------EHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSR----ELPEV  217 (405)
Q Consensus       152 --~~~~~gt~~Y~APE~l~~-------~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~----~~~~~  217 (405)
                        .....+++.|+|||++..       ..++.++|||||||++|||++ |..||....+ ...+.......    ..|..
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~  235 (269)
T cd05042         157 ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD-EQVLKQVVREQDIKLPKPQL  235 (269)
T ss_pred             eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH-HHHHHHHhhccCccCCCCcc
Confidence              122335678999999753       346789999999999999999 7889865543 33333332222    12344


Q ss_pred             chhccHHHHHHHHHhcccCccccCCHHHHhc
Q 015500          218 PAFLSKQANDFLSNCLRRDPKERWAASQLLK  248 (405)
Q Consensus       218 p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~  248 (405)
                      +..+++.+.+++..|+ .||++|||++++++
T Consensus       236 ~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         236 DLKYSDRWYEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             cccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence            5568899999999999 59999999999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.2e-41  Score=320.46  Aligned_cols=249  Identities=29%  Similarity=0.449  Sum_probs=215.4

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC------ChHHHHHHHHHHHhC-CCCCeeeeeeeeeecCCCceEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSL-NSPHIVGYKGCDVTSEDNKLMY   74 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~------~~~~l~~E~~iL~~L-~hpnIv~~~~~~~~~~~~~~~~   74 (405)
                      +|..+.+||+|+||+|.+|..+.+.+.||||++.++      +.+--..|.++|... +-|.++++..++.+.+.    +
T Consensus       350 DFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR----L  425 (683)
T KOG0696|consen  350 DFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR----L  425 (683)
T ss_pred             ccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh----e
Confidence            577889999999999999999999999999987754      345566788888777 55888899988887765    6


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccc----
Q 015500           75 NLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWE----  149 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~----  149 (405)
                      |+||||+.||+|--.|++- |++.|+.+..|+..|+-||-+||++||++||||.+|||++.+| +||+|||+.+..    
T Consensus       426 yFVMEyvnGGDLMyhiQQ~-GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~  504 (683)
T KOG0696|consen  426 YFVMEYVNGGDLMYHIQQV-GKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDG  504 (683)
T ss_pred             eeEEEEecCchhhhHHHHh-cccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccCC
Confidence            6899999999999999887 4999999999999999999999999999999999999999998 999999998742    


Q ss_pred             cccccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHH
Q 015500          150 SEALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFL  229 (405)
Q Consensus       150 ~~~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll  229 (405)
                      ....+.+|||.|+|||++...+|+.++|.||+|++||||+.|++||. .++..+++..|.. .. -.+|..+|.++.++.
T Consensus       505 ~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFd-GeDE~elF~aI~e-hn-vsyPKslSkEAv~ic  581 (683)
T KOG0696|consen  505 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD-GEDEDELFQAIME-HN-VSYPKSLSKEAVAIC  581 (683)
T ss_pred             cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCC-CCCHHHHHHHHHH-cc-CcCcccccHHHHHHH
Confidence            22567899999999999999999999999999999999999999994 4454555544443 32 267889999999999


Q ss_pred             HHhcccCccccCCH-----HHHhcCccccccccc
Q 015500          230 SNCLRRDPKERWAA-----SQLLKHPFLEEFCSC  258 (405)
Q Consensus       230 ~~~L~~dP~~Rpt~-----~elL~hp~~~~~~~~  258 (405)
                      +..|.+.|.+|..+     .++-.||||+.+...
T Consensus       582 kg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWe  615 (683)
T KOG0696|consen  582 KGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWE  615 (683)
T ss_pred             HHHhhcCCccccCCCCccccchhhCcchhhccHH
Confidence            99999999999864     578999999987553

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=2.1e-40  Score=351.65  Aligned_cols=247  Identities=28%  Similarity=0.429  Sum_probs=197.6

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCCh----HHHHHHHHHHHhCCCCCeeeeeeeeee-----------
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS----EFLQREQKFLSSLNSPHIVGYKGCDVT-----------   66 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~~----~~l~~E~~iL~~L~hpnIv~~~~~~~~-----------   66 (405)
                      +|.....||+||||.||+++++-+|+.||||++.....    ..+.+|+.+|++|+|||||+|+..++.           
T Consensus       480 DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~  559 (1351)
T KOG1035|consen  480 DFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIV  559 (1351)
T ss_pred             hhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccccc
Confidence            57788999999999999999999999999999987632    367899999999999999998432211           


Q ss_pred             --------------------------------------------------------------------------------
Q 015500           67 --------------------------------------------------------------------------------   66 (405)
Q Consensus        67 --------------------------------------------------------------------------------   66 (405)
                                                                                                      
T Consensus       560 ~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~  639 (1351)
T KOG1035|consen  560 ASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGS  639 (1351)
T ss_pred             ccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCc
Confidence                                                                                            


Q ss_pred             ----------------cCCCc--------eEEEEEEeecCCCCHHHHHHHcCCCC-CHHHHHHHHHHHHHHHHHHHhCCc
Q 015500           67 ----------------SEDNK--------LMYNLFMEYAPGGTLNDEIHRNGGRL-DESLIVSYTRQILQGLEYLHSNRV  121 (405)
Q Consensus        67 ----------------~~~~~--------~~~~lv~Ey~~ggsL~~~i~~~~~~l-~e~~~~~i~~qIl~~L~yLH~~gi  121 (405)
                                      .+...        .++|+-||||+..+|.++|.++. .. ....+.++++||+.||.|+|++||
T Consensus       640 ~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~-~~~~~d~~wrLFreIlEGLaYIH~~gi  718 (1351)
T KOG1035|consen  640 VILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNH-FNSQRDEAWRLFREILEGLAYIHDQGI  718 (1351)
T ss_pred             cccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcc-cchhhHHHHHHHHHHHHHHHHHHhCce
Confidence                            00001        57789999999988888887753 32 477889999999999999999999


Q ss_pred             eeCCCCCCCEEEccCC-ceEeeeccccccc----------------------ccccCCCCCCccChhhhcCC---CCCcc
Q 015500          122 VHCDIKSRNILMAESG-AKIADFGCAKWES----------------------EALQSGGTPMFMAPEVARGE---HQGFA  175 (405)
Q Consensus       122 vHrDlkp~NILi~~~~-vkL~DFGla~~~~----------------------~~~~~~gt~~Y~APE~l~~~---~~~~~  175 (405)
                      |||||||.||+++.++ |||+|||+|+...                      ......||..|+|||++.+.   .|+.|
T Consensus       719 IHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~K  798 (1351)
T KOG1035|consen  719 IHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSK  798 (1351)
T ss_pred             eeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccch
Confidence            9999999999999887 9999999997511                      01223589999999999774   49999


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCC---chhccHHHHHHHHHhcccCccccCCHHHHhcCccc
Q 015500          176 SDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEV---PAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFL  252 (405)
Q Consensus       176 sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~---p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~  252 (405)
                      +||||||++++||+   .||.........+..+. ...+|..   ...--+.-..+|+.||+.||++||||.|||++.||
T Consensus       799 iDmYSLGIVlFEM~---yPF~TsMERa~iL~~LR-~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~ll  874 (1351)
T KOG1035|consen  799 IDMYSLGIVLFEML---YPFGTSMERASILTNLR-KGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSELL  874 (1351)
T ss_pred             hhhHHHHHHHHHHh---ccCCchHHHHHHHHhcc-cCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhccCC
Confidence            99999999999999   45765555555555554 3344433   22223456789999999999999999999999998


Q ss_pred             c
Q 015500          253 E  253 (405)
Q Consensus       253 ~  253 (405)
                      .
T Consensus       875 p  875 (1351)
T KOG1035|consen  875 P  875 (1351)
T ss_pred             C
Confidence            7

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.7e-39  Score=308.34  Aligned_cols=246  Identities=28%  Similarity=0.440  Sum_probs=199.6

Q ss_pred             CcccccccceeCCeeEEEEEEc----CCCCEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceE
Q 015500            2 DWTRGHTIGQGSSATVSLATSL----RSGDVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLM   73 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~----~~~~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~   73 (405)
                      +|+..+.||+|+||.||+|...    .+++.+|||.+....    .+.+.+|+++++.++||||+++++++.....  ..
T Consensus         5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~--~~   82 (284)
T cd05038           5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGG--RS   82 (284)
T ss_pred             hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCC--Cc
Confidence            4677899999999999999864    348899999987543    3578899999999999999999987644322  23


Q ss_pred             EEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc
Q 015500           74 YNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA  152 (405)
Q Consensus        74 ~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~  152 (405)
                      ++++|||+++++|.+++......+++..+..++.||+.||+|||++|++|+||||+||+++.++ ++|+|||++......
T Consensus        83 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  162 (284)
T cd05038          83 LRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPED  162 (284)
T ss_pred             eEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccccC
Confidence            6699999999999999988766799999999999999999999999999999999999999887 999999999865421


Q ss_pred             -------ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCh-------------HHHHHHHHhcC
Q 015500          153 -------LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADP-------------MTVLYKIAYSR  212 (405)
Q Consensus       153 -------~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~-------------~~~l~~i~~~~  212 (405)
                             ....++..|+|||.+.+..++.++|||||||++|||++|+.||......             ...+.......
T Consensus       163 ~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (284)
T cd05038         163 KDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEG  242 (284)
T ss_pred             CcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHcC
Confidence                   1223456799999999888999999999999999999999998543221             11112222222


Q ss_pred             CCCCCchhccHHHHHHHHHhcccCccccCCHHHHhcC
Q 015500          213 ELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       213 ~~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      .....+..++.++.+++.+||+.+|.+|||+.++++.
T Consensus       243 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  279 (284)
T cd05038         243 ERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILI  279 (284)
T ss_pred             CcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence            2223345578899999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=5.5e-39  Score=303.69  Aligned_cols=239  Identities=21%  Similarity=0.339  Sum_probs=195.9

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC--hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEe
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK--SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFME   79 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~--~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (405)
                      +|...+.||+|+||.||+|.+. .+..+|+|.+....  .+.+.+|++++++++||||+++.+.+.. .    .++++||
T Consensus         7 ~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~----~~~~v~e   80 (260)
T cd05073           7 SLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-E----PIYIITE   80 (260)
T ss_pred             ceeEEeEecCccceEEEEEEec-CCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-C----CeEEEEE
Confidence            4788999999999999999864 45679999876543  3578899999999999999999887644 1    2568999


Q ss_pred             ecCCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccccc----
Q 015500           80 YAPGGTLNDEIHRN-GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEAL----  153 (405)
Q Consensus        80 y~~ggsL~~~i~~~-~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~~----  153 (405)
                      |+++++|.+++... +..+++..+..++.||+.||.|||+.|++|+||||+||+++.++ +||+|||++.......    
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~  160 (260)
T cd05073          81 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAR  160 (260)
T ss_pred             eCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCcccc
Confidence            99999999999763 34678899999999999999999999999999999999999887 9999999987543211    


Q ss_pred             -cCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHH
Q 015500          154 -QSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSN  231 (405)
Q Consensus       154 -~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~  231 (405)
                       ...++..|+|||.+.+..++.++|+|||||++|+|++ |+.||..... ......+.. ......+...+.++.+++.+
T Consensus       161 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~  238 (260)
T cd05073         161 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN-PEVIRALER-GYRMPRPENCPEELYNIMMR  238 (260)
T ss_pred             cCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH-HHHHHHHhC-CCCCCCcccCCHHHHHHHHH
Confidence             1234567999999998889999999999999999999 9999965433 223333322 22334456688999999999


Q ss_pred             hcccCccccCCHHHHhc
Q 015500          232 CLRRDPKERWAASQLLK  248 (405)
Q Consensus       232 ~L~~dP~~Rpt~~elL~  248 (405)
                      ||+.+|++||++.++++
T Consensus       239 ~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         239 CWKNRPEERPTFEYIQS  255 (260)
T ss_pred             HcccCcccCcCHHHHHH
Confidence            99999999999998864

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-40  Score=332.90  Aligned_cols=240  Identities=25%  Similarity=0.346  Sum_probs=204.5

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHhC-CCCCeeeeeeeeeecCCCceEEEEEEee
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSL-NSPHIVGYKGCDVTSEDNKLMYNLFMEY   80 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~~~~l~~E~~iL~~L-~hpnIv~~~~~~~~~~~~~~~~~lv~Ey   80 (405)
                      +|.....+|.|+|+.|..+.+..+++.+++|++... .....+|+.++... +||||+++.+.+....    ..|+|||+
T Consensus       323 ~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~-~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~----~~~~v~e~  397 (612)
T KOG0603|consen  323 SYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR-ADDNQDEIPISLLVRDHPNIVKSHDVYEDGK----EIYLVMEL  397 (612)
T ss_pred             hhccccccCCCCccceeeeeccccccchhheecccc-ccccccccchhhhhcCCCcceeecceecCCc----eeeeeehh
Confidence            467778899999999999999999999999999766 45577788666655 8999999998765433    36799999


Q ss_pred             cCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEE-ccCC-ceEeeeccccccccc-ccCCC
Q 015500           81 APGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILM-AESG-AKIADFGCAKWESEA-LQSGG  157 (405)
Q Consensus        81 ~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi-~~~~-vkL~DFGla~~~~~~-~~~~g  157 (405)
                      +.|+-|.+.+....  .....+..|++||+.|+.|||++|||||||||+|||+ ++.+ ++|+|||.++..... .+.+-
T Consensus       398 l~g~ell~ri~~~~--~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~~~tp~~  475 (612)
T KOG0603|consen  398 LDGGELLRRIRSKP--EFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERSCDTPAL  475 (612)
T ss_pred             ccccHHHHHHHhcc--hhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchhhcccch
Confidence            99999999887763  3337778899999999999999999999999999999 4666 999999999876553 34567


Q ss_pred             CCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHhcccCc
Q 015500          158 TPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDP  237 (405)
Q Consensus       158 t~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~L~~dP  237 (405)
                      |..|.|||++....|++++|+||||++||+|++|+.||....+..+...++.    .+.+...+|+.+++||.+||++||
T Consensus       476 t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~----~~~~s~~vS~~AKdLl~~LL~~dP  551 (612)
T KOG0603|consen  476 TLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQ----MPKFSECVSDEAKDLLQQLLQVDP  551 (612)
T ss_pred             hhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhc----CCccccccCHHHHHHHHHhccCCh
Confidence            8899999999999999999999999999999999999977766544444433    334447899999999999999999


Q ss_pred             cccCCHHHHhcCccc
Q 015500          238 KERWAASQLLKHPFL  252 (405)
Q Consensus       238 ~~Rpt~~elL~hp~~  252 (405)
                      .+|+++.+++.||||
T Consensus       552 ~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  552 ALRLGADEIGAHPWF  566 (612)
T ss_pred             hhCcChhhhccCcch
Confidence            999999999999999

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-41  Score=330.43  Aligned_cols=251  Identities=28%  Similarity=0.425  Sum_probs=221.3

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccC------CChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL------PKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~------~~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~   75 (405)
                      +..++..||-|+||.|=++........+|+|.+++      .+.+.+..|.+||...++|.||++|..|....    +.|
T Consensus       421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~k----yvY  496 (732)
T KOG0614|consen  421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSK----YVY  496 (732)
T ss_pred             hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccch----hhh
Confidence            45678899999999999998765555688887654      34578889999999999999999997654332    466


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc---
Q 015500           76 LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE---  151 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~---  151 (405)
                      ++||-|-||.|...++.+ |.+++.+++.|+..+++|++|||++|||+|||||+|.+++.+| +||.|||+|+....   
T Consensus       497 mLmEaClGGElWTiLrdR-g~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K  575 (732)
T KOG0614|consen  497 MLMEACLGGELWTILRDR-GSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK  575 (732)
T ss_pred             hhHHhhcCchhhhhhhhc-CCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCCc
Confidence            999999999999999887 4999999999999999999999999999999999999999999 99999999997655   


Q ss_pred             cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHH
Q 015500          152 ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSN  231 (405)
Q Consensus       152 ~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~  231 (405)
                      .-+.||||.|.|||++.....+.++|.||||+++|||++|.+||. ..++......|..+-+.-.+|..++..+.+++++
T Consensus       576 TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs-~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik~  654 (732)
T KOG0614|consen  576 TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFS-GVDPMKTYNLILKGIDKIEFPRRITKTATDLIKK  654 (732)
T ss_pred             eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCC-CCchHHHHHHHHhhhhhhhcccccchhHHHHHHH
Confidence            457899999999999999999999999999999999999999995 5566777677777777778999999999999999


Q ss_pred             hcccCccccCC-----HHHHhcCccccccccc
Q 015500          232 CLRRDPKERWA-----ASQLLKHPFLEEFCSC  258 (405)
Q Consensus       232 ~L~~dP~~Rpt-----~~elL~hp~~~~~~~~  258 (405)
                      +.+.+|.+|..     +.+|.+|.||..+...
T Consensus       655 LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdwe  686 (732)
T KOG0614|consen  655 LCRDNPTERLGYQKGGINDIKKHRWFEGFDWE  686 (732)
T ss_pred             HHhcCcHhhhccccCChHHHHhhhhhhcCChh
Confidence            99999999986     8999999999987543

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-40  Score=301.76  Aligned_cols=247  Identities=27%  Similarity=0.397  Sum_probs=199.0

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC---ChHHHHHHHHHHHhCCCCCeeeeeeeeeecC-CCceEEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP---KSEFLQREQKFLSSLNSPHIVGYKGCDVTSE-DNKLMYNLF   77 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~---~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~-~~~~~~~lv   77 (405)
                      +|++.+.||.|||+-||++.+-.+++.||+|++-..   ..+...+|++.-++++|||+++++...+... +.....|++
T Consensus        22 Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll  101 (302)
T KOG2345|consen   22 RYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLL  101 (302)
T ss_pred             eEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEE
Confidence            589999999999999999999999999999987643   4567889999999999999999887654433 355567799


Q ss_pred             EeecCCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCCCCEEEccCC-ceEeeecccccccc
Q 015500           78 MEYAPGGTLNDEIHR---NGGRLDESLIVSYTRQILQGLEYLHSNR--VVHCDIKSRNILMAESG-AKIADFGCAKWESE  151 (405)
Q Consensus        78 ~Ey~~ggsL~~~i~~---~~~~l~e~~~~~i~~qIl~~L~yLH~~g--ivHrDlkp~NILi~~~~-vkL~DFGla~~~~~  151 (405)
                      +.|...|+|.+.|.+   .+..++|.++..|+.+|++||++||+..  ++||||||.|||+.+.+ ++|.|||.++...-
T Consensus       102 ~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i  181 (302)
T KOG2345|consen  102 LPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSATQAPI  181 (302)
T ss_pred             eehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCccccce
Confidence            999999999999976   3446999999999999999999999998  99999999999999877 99999999875322


Q ss_pred             -------------cccCCCCCCccChhhhcC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCh-HHHHHHHHh-cCC
Q 015500          152 -------------ALQSGGTPMFMAPEVARG---EHQGFASDIWAVGCTVIEMASGGAPWPNAADP-MTVLYKIAY-SRE  213 (405)
Q Consensus       152 -------------~~~~~gt~~Y~APE~l~~---~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~-~~~l~~i~~-~~~  213 (405)
                                   .....-|..|+|||++.-   ...+.++|||||||++|+|+.|.-||...... .+....+.. .-.
T Consensus       182 ~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n~q~s  261 (302)
T KOG2345|consen  182 QIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQNAQIS  261 (302)
T ss_pred             EeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeeccccc
Confidence                         112236889999999864   44688999999999999999999999422110 000000000 112


Q ss_pred             CCCCchhccHHHHHHHHHhcccCccccCCHHHHhcC
Q 015500          214 LPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       214 ~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      .|.-+. +|+.+.+||+.||++||.+||++.+++.+
T Consensus       262 ~P~~~~-yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  262 IPNSSR-YSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             cCCCCC-ccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            233223 89999999999999999999999999875

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=6.5e-39  Score=304.22  Aligned_cols=243  Identities=24%  Similarity=0.407  Sum_probs=198.3

Q ss_pred             CcccccccceeCCeeEEEEEEcC-CCCEEEEEEccCCC-------------hHHHHHHHHHHHh-CCCCCeeeeeeeeee
Q 015500            2 DWTRGHTIGQGSSATVSLATSLR-SGDVFAAKSTELPK-------------SEFLQREQKFLSS-LNSPHIVGYKGCDVT   66 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~-~~~~vavK~~~~~~-------------~~~l~~E~~iL~~-L~hpnIv~~~~~~~~   66 (405)
                      +|++.+.||+|+||.||+|.++. +++.+|+|.+....             ...+.+|+.++.+ ++||||+++++.+..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            58999999999999999999987 78899999765321             1346678887765 799999999987654


Q ss_pred             cCCCceEEEEEEeecCCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCCEEEccCC-ceEe
Q 015500           67 SEDNKLMYNLFMEYAPGGTLNDEIHR---NGGRLDESLIVSYTRQILQGLEYLHS-NRVVHCDIKSRNILMAESG-AKIA  141 (405)
Q Consensus        67 ~~~~~~~~~lv~Ey~~ggsL~~~i~~---~~~~l~e~~~~~i~~qIl~~L~yLH~-~givHrDlkp~NILi~~~~-vkL~  141 (405)
                      ..    .++++|||++|++|.+++..   .+..+++..+..++.|++.||.|||+ .|++|+||||+||+++.++ +||+
T Consensus        81 ~~----~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~  156 (269)
T cd08528          81 ND----RLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTIT  156 (269)
T ss_pred             CC----eEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEe
Confidence            33    36799999999999998743   44579999999999999999999996 7899999999999999887 9999


Q ss_pred             eeccccccccc---ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCc
Q 015500          142 DFGCAKWESEA---LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVP  218 (405)
Q Consensus       142 DFGla~~~~~~---~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p  218 (405)
                      |||++......   ....|+..|+|||.+.+..++.++|+||||+++|+|++|+.||... +.......+......+...
T Consensus       157 dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~  235 (269)
T cd08528         157 DFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST-NMLSLATKIVEAVYEPLPE  235 (269)
T ss_pred             cccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCccccc-CHHHHHHHHhhccCCcCCc
Confidence            99998764432   2445899999999999888999999999999999999999999543 3333333333322222223


Q ss_pred             hhccHHHHHHHHHhcccCccccCCHHHHhcC
Q 015500          219 AFLSKQANDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       219 ~~~s~~l~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      ..+++.+.+|+++||+.||++||++.|+..+
T Consensus       236 ~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         236 GMYSEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             ccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence            3578999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-39  Score=320.89  Aligned_cols=243  Identities=30%  Similarity=0.436  Sum_probs=194.1

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC---hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK---SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFM   78 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~---~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (405)
                      +|.....||+|+||.||+|.... |..||||.+....   ...+.+|+.+|.+++|||+|+++|++.....   ...||+
T Consensus        76 ~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~---~~~LVY  151 (361)
T KOG1187|consen   76 NFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGE---HRLLVY  151 (361)
T ss_pred             CCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCc---eEEEEE
Confidence            56777899999999999998754 4899999877543   4569999999999999999999999876553   255999


Q ss_pred             eecCCCCHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCCCCEEEccCC-ceEeeecccccccc-c
Q 015500           79 EYAPGGTLNDEIHRNGG-RLDESLIVSYTRQILQGLEYLHSNR---VVHCDIKSRNILMAESG-AKIADFGCAKWESE-A  152 (405)
Q Consensus        79 Ey~~ggsL~~~i~~~~~-~l~e~~~~~i~~qIl~~L~yLH~~g---ivHrDlkp~NILi~~~~-vkL~DFGla~~~~~-~  152 (405)
                      ||+++|+|.+++....+ ++++....+|+.++++||+|||...   |+||||||.|||+|.+. +||+|||+|+.... .
T Consensus       152 Eym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~  231 (361)
T KOG1187|consen  152 EYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGD  231 (361)
T ss_pred             EccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCccc
Confidence            99999999999987666 8999999999999999999999853   99999999999999886 99999999976543 2


Q ss_pred             c---cC-CCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC--Ch---HHHHHHHHhcCCC-----CCCc
Q 015500          153 L---QS-GGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAA--DP---MTVLYKIAYSREL-----PEVP  218 (405)
Q Consensus       153 ~---~~-~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~--~~---~~~l~~i~~~~~~-----~~~p  218 (405)
                      .   .. .||.+|+|||.+..+..+.++||||||+++.||+||+.|.....  ..   .............     |.+.
T Consensus       232 ~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~  311 (361)
T KOG1187|consen  232 TSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLK  311 (361)
T ss_pred             cceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCcc
Confidence            2   12 79999999999999999999999999999999999998875432  11   1111111111111     1111


Q ss_pred             -hhc-----cHHHHHHHHHhcccCccccCCHHHHhc
Q 015500          219 -AFL-----SKQANDFLSNCLRRDPKERWAASQLLK  248 (405)
Q Consensus       219 -~~~-----s~~l~dll~~~L~~dP~~Rpt~~elL~  248 (405)
                       ...     -..+..+..+|++.+|.+||++.|+++
T Consensus       312 ~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~  347 (361)
T KOG1187|consen  312 EGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK  347 (361)
T ss_pred             CCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence             112     233567888999999999999999744

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=7e-39  Score=304.34  Aligned_cols=245  Identities=22%  Similarity=0.309  Sum_probs=197.0

Q ss_pred             cccccccceeCCeeEEEEEEcC---CCCEEEEEEccCCC-----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCc--e
Q 015500            3 WTRGHTIGQGSSATVSLATSLR---SGDVFAAKSTELPK-----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNK--L   72 (405)
Q Consensus         3 y~~~~~LG~G~~g~Vyla~~~~---~~~~vavK~~~~~~-----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~--~   72 (405)
                      |++++.||+|+||+||+|.++.   +++.+|||.+....     .+.+.+|+++|+.++||||+++++.+.......  .
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            6789999999999999998653   57899999876432     346788999999999999999998776543321  2


Q ss_pred             EEEEEEeecCCCCHHHHHHHc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccc
Q 015500           73 MYNLFMEYAPGGTLNDEIHRN-----GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCA  146 (405)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~i~~~-----~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla  146 (405)
                      ..++++||+++|+|.+++...     ...+++..+..++.||+.||+|||+.||+||||||+||+++.++ +||+|||++
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~  160 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS  160 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence            345889999999999887532     12478999999999999999999999999999999999998877 999999998


Q ss_pred             ccccc------cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCch
Q 015500          147 KWESE------ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPA  219 (405)
Q Consensus       147 ~~~~~------~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~  219 (405)
                      +....      .....+++.|++||.+.+..++.++|||||||++|+|++ |++||.... .......+. .......+.
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~-~~~~~~~~~-~~~~~~~~~  238 (273)
T cd05074         161 KKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVE-NSEIYNYLI-KGNRLKQPP  238 (273)
T ss_pred             ccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCC-HHHHHHHHH-cCCcCCCCC
Confidence            75432      112235678999999998889999999999999999999 889996443 233222232 223334455


Q ss_pred             hccHHHHHHHHHhcccCccccCCHHHHhcC
Q 015500          220 FLSKQANDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       220 ~~s~~l~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      ..++.+.+++.+||+.+|++|||+.+++++
T Consensus       239 ~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~  268 (273)
T cd05074         239 DCLEDVYELMCQCWSPEPKCRPSFQHLRDQ  268 (273)
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-39  Score=325.50  Aligned_cols=240  Identities=28%  Similarity=0.457  Sum_probs=204.0

Q ss_pred             ccccccceeCCeeEEEEEEcCCCC---E-EEEEEccCC------ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceE
Q 015500            4 TRGHTIGQGSSATVSLATSLRSGD---V-FAAKSTELP------KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLM   73 (405)
Q Consensus         4 ~~~~~LG~G~~g~Vyla~~~~~~~---~-vavK~~~~~------~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~   73 (405)
                      ..++.||+|+||.||+|..+..+.   . ||||....+      ....+.+|.++|+.++|||||+++|+.+..+.    
T Consensus       160 ~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P----  235 (474)
T KOG0194|consen  160 ELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP----  235 (474)
T ss_pred             cccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc----
Confidence            356899999999999998876533   3 899987642      23568899999999999999999998877666    


Q ss_pred             EEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc
Q 015500           74 YNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA  152 (405)
Q Consensus        74 ~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~  152 (405)
                      +++|||+|+||+|.++++++++.++..+...++.+.+.||+|||+++++||||-.+|+|++.++ +||+|||+++.....
T Consensus       236 l~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~  315 (474)
T KOG0194|consen  236 LMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQY  315 (474)
T ss_pred             cEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCcce
Confidence            6699999999999999999877899999999999999999999999999999999999999988 699999998865421


Q ss_pred             c----cCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHH
Q 015500          153 L----QSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQAND  227 (405)
Q Consensus       153 ~----~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~d  227 (405)
                      .    ...-...|+|||.+....+++++||||+||++||+.+ |..||++.. ..+...++.........|...+.++..
T Consensus       316 ~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~-~~~v~~kI~~~~~r~~~~~~~p~~~~~  394 (474)
T KOG0194|consen  316 VMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMK-NYEVKAKIVKNGYRMPIPSKTPKELAK  394 (474)
T ss_pred             eeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCC-HHHHHHHHHhcCccCCCCCCCHHHHHH
Confidence            1    1123456999999999999999999999999999999 889997554 455566665555555667778899999


Q ss_pred             HHHHhcccCccccCCHHHHhc
Q 015500          228 FLSNCLRRDPKERWAASQLLK  248 (405)
Q Consensus       228 ll~~~L~~dP~~Rpt~~elL~  248 (405)
                      ++.+|+..+|++|||+.++.+
T Consensus       395 ~~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  395 VMKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             HHHHhccCChhhccCHHHHHH
Confidence            999999999999999999854

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-39  Score=330.01  Aligned_cols=238  Identities=28%  Similarity=0.463  Sum_probs=192.8

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccC----CChHHHHHHHHHHHhCCCCCeeeeeeeeeecC----CCceE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL----PKSEFLQREQKFLSSLNSPHIVGYKGCDVTSE----DNKLM   73 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~----~~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~----~~~~~   73 (405)
                      .|...+.||+||||.||+++++.+|+.||||.++.    ..++..-+|+++|++|+|||||++.++..+..    ..  .
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~--~   91 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTR--L   91 (732)
T ss_pred             ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccc--c
Confidence            37788999999999999999999999999999875    34678899999999999999999987654433    22  2


Q ss_pred             EEEEEeecCCCCHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEc--cCC---ceEeeeccc
Q 015500           74 YNLFMEYAPGGTLNDEIHR--NGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMA--ESG---AKIADFGCA  146 (405)
Q Consensus        74 ~~lv~Ey~~ggsL~~~i~~--~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~--~~~---vkL~DFGla  146 (405)
                      -.+|||||+||+|+.++.+  +.-.|+|..++.++.+++.||.|||++||+||||||.||++-  .+|   -||+|||+|
T Consensus        92 ~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A  171 (732)
T KOG4250|consen   92 PVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA  171 (732)
T ss_pred             ceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence            3389999999999999975  223499999999999999999999999999999999999983  334   699999999


Q ss_pred             cccccc---ccCCCCCCccChhhhc-CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCh---HHHHHHHHhcC-------
Q 015500          147 KWESEA---LQSGGTPMFMAPEVAR-GEHQGFASDIWAVGCTVIEMASGGAPWPNAADP---MTVLYKIAYSR-------  212 (405)
Q Consensus       147 ~~~~~~---~~~~gt~~Y~APE~l~-~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~---~~~l~~i~~~~-------  212 (405)
                      +..++.   ....||+.|++||++. ...|+..+|.|||||++|+++||..||-....+   .+....+....       
T Consensus       172 rel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~  251 (732)
T KOG4250|consen  172 RELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIG  251 (732)
T ss_pred             ccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEe
Confidence            987664   3456999999999998 488999999999999999999999999644433   22444333222       


Q ss_pred             -------------CCCCCchhccHH----HHHHHHHhcccCccccCC
Q 015500          213 -------------ELPEVPAFLSKQ----ANDFLSNCLRRDPKERWA  242 (405)
Q Consensus       213 -------------~~~~~p~~~s~~----l~dll~~~L~~dP~~Rpt  242 (405)
                                   .+| .|..++..    +...|..+|..+|.+|+.
T Consensus       252 ~~~~eNgpv~~s~~lP-~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~  297 (732)
T KOG4250|consen  252 AQEEENGPVEWSSTLP-QPNHLSRGLATRLTKWLASMLEWNPRKRGH  297 (732)
T ss_pred             eecccCCceeeeccCC-CcccccHHHHhhhhHHHHHHHhhhHHHhCC
Confidence                         122 24444443    456788899999999994

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-39  Score=304.58  Aligned_cols=250  Identities=30%  Similarity=0.533  Sum_probs=219.1

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC------ChHHHHHHHHHHHhC-CCCCeeeeeeeeeecCCCceEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSL-NSPHIVGYKGCDVTSEDNKLMY   74 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~------~~~~l~~E~~iL~~L-~hpnIv~~~~~~~~~~~~~~~~   74 (405)
                      +|+.+++||+|+|++|-+++++.|.+.+|+|++.++      +.+..+.|..+.... +||.+|.+..||.+...    +
T Consensus       251 df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesr----l  326 (593)
T KOG0695|consen  251 DFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESR----L  326 (593)
T ss_pred             cceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccce----E
Confidence            688999999999999999999999999999988653      456788899888877 78999999998876554    5


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccc----
Q 015500           75 NLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWE----  149 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~----  149 (405)
                      ++|.||++||+|.-++++. .+++|+.++.|...|..||.|||++||++||||.+|||++..| +||+|+|+.+..    
T Consensus       327 ffvieyv~ggdlmfhmqrq-rklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~g  405 (593)
T KOG0695|consen  327 FFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPG  405 (593)
T ss_pred             EEEEEEecCcceeeehhhh-hcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCCC
Confidence            5799999999998888776 3899999999999999999999999999999999999999998 999999998742    


Q ss_pred             cccccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCC------CCChHHHHHHHHhcCCCCCCchhccH
Q 015500          150 SEALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPN------AADPMTVLYKIAYSRELPEVPAFLSK  223 (405)
Q Consensus       150 ~~~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~------~~~~~~~l~~i~~~~~~~~~p~~~s~  223 (405)
                      +...+.+|||-|.|||++++..|++.+|.|+||++++||+.|+.||.-      ..+....++++...+.. .+|..+|-
T Consensus       406 d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi-riprslsv  484 (593)
T KOG0695|consen  406 DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI-RIPRSLSV  484 (593)
T ss_pred             cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc-cccceeeh
Confidence            336678999999999999999999999999999999999999999952      23456667777766554 67888999


Q ss_pred             HHHHHHHHhcccCccccCC------HHHHhcCcccccccc
Q 015500          224 QANDFLSNCLRRDPKERWA------ASQLLKHPFLEEFCS  257 (405)
Q Consensus       224 ~l~dll~~~L~~dP~~Rpt------~~elL~hp~~~~~~~  257 (405)
                      .+..+++.-|.+||++|..      ..++..|+||+.+..
T Consensus       485 kas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idw  524 (593)
T KOG0695|consen  485 KASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDW  524 (593)
T ss_pred             hhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCH
Confidence            9999999999999999974      689999999996644

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-39  Score=331.92  Aligned_cols=251  Identities=34%  Similarity=0.567  Sum_probs=214.9

Q ss_pred             cccccccceeCCeeEEEEEEcCCCCEEEEEEccCC--ChHHHHHHHHHHHhC-CCCCeeeeeeeeeecC-CCceEEEEEE
Q 015500            3 WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP--KSEFLQREQKFLSSL-NSPHIVGYKGCDVTSE-DNKLMYNLFM   78 (405)
Q Consensus         3 y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~--~~~~l~~E~~iL~~L-~hpnIv~~~~~~~~~~-~~~~~~~lv~   78 (405)
                      |.+...||.|.+|.||+++++.+++..|+|+....  ..+.++.|.++|+.+ .|||++.++|++.... .+..-++|||
T Consensus        21 ~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVM  100 (953)
T KOG0587|consen   21 FEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVM  100 (953)
T ss_pred             cEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEe
Confidence            78899999999999999999999999999987653  456788899999999 6899999999876544 2334577999


Q ss_pred             eecCCCCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc----c
Q 015500           79 EYAPGGTLNDEIHR-NGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE----A  152 (405)
Q Consensus        79 Ey~~ggsL~~~i~~-~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~----~  152 (405)
                      |||.|||..|+++. .++++.|..+..|++.++.||.|||...++|||||..|||++.++ |||+|||++.....    .
T Consensus       101 EfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~grR  180 (953)
T KOG0587|consen  101 EFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTVGRR  180 (953)
T ss_pred             eccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeeeecccccc
Confidence            99999999999976 467899999999999999999999999999999999999999988 99999999876544    4


Q ss_pred             ccCCCCCCccChhhhcCC-----CCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCC-CCchhccHHHH
Q 015500          153 LQSGGTPMFMAPEVARGE-----HQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELP-EVPAFLSKQAN  226 (405)
Q Consensus       153 ~~~~gt~~Y~APE~l~~~-----~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~-~~p~~~s~~l~  226 (405)
                      .+..|||.|||||++...     .|+..+|+||||++.+||.-|.+|+.++. +...+++|.....+. .-|...++++.
T Consensus       181 nT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmH-PmraLF~IpRNPPPkLkrp~kWs~~Fn  259 (953)
T KOG0587|consen  181 NTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMH-PMRALFLIPRNPPPKLKRPKKWSKKFN  259 (953)
T ss_pred             cCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcc-hhhhhccCCCCCCccccchhhHHHHHH
Confidence            567799999999998653     36678999999999999999999997664 455555554332211 23567899999


Q ss_pred             HHHHHhcccCccccCCHHHHhcCccccc
Q 015500          227 DFLSNCLRRDPKERWAASQLLKHPFLEE  254 (405)
Q Consensus       227 dll~~~L~~dP~~Rpt~~elL~hp~~~~  254 (405)
                      +||..||.+|-.+||+..++|+|||+.+
T Consensus       260 dFIs~cL~Kd~e~RP~~~~ll~hpFi~e  287 (953)
T KOG0587|consen  260 DFISTCLVKDYEQRPSTEELLKHPFITE  287 (953)
T ss_pred             HHHHHHHhhccccCcchhhhccCCcccc
Confidence            9999999999999999999999999974

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=9.8e-38  Score=296.89  Aligned_cols=236  Identities=21%  Similarity=0.304  Sum_probs=183.8

Q ss_pred             cccceeCCeeEEEEEEcCC--CCEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEee
Q 015500            7 HTIGQGSSATVSLATSLRS--GDVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEY   80 (405)
Q Consensus         7 ~~LG~G~~g~Vyla~~~~~--~~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~Ey   80 (405)
                      +.||+|+||+||+|.....  ...+++|......    .+.+.+|+.+++.++||||+++++.+....    .++++|||
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~----~~~lv~e~   76 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAI----PYLLVFEY   76 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCC----ccEEEEec
Confidence            4699999999999975433  3456777765432    357888999999999999999999876443    36799999


Q ss_pred             cCCCCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccc------
Q 015500           81 APGGTLNDEIHRNG---GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWES------  150 (405)
Q Consensus        81 ~~ggsL~~~i~~~~---~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~------  150 (405)
                      +++|+|.+++.+..   ..+++..++.++.||+.||+|||+++++||||||+|||++.++ +||+|||++....      
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~  156 (268)
T cd05086          77 CELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE  156 (268)
T ss_pred             CCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhh
Confidence            99999999997642   2467778889999999999999999999999999999999887 9999999986421      


Q ss_pred             ccccCCCCCCccChhhhcC-------CCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcC----CCCCCc
Q 015500          151 EALQSGGTPMFMAPEVARG-------EHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSR----ELPEVP  218 (405)
Q Consensus       151 ~~~~~~gt~~Y~APE~l~~-------~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~----~~~~~p  218 (405)
                      ......+++.|+|||++..       ..++.++|||||||++|||++ |..||..... ......+....    ..|.++
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~  235 (268)
T cd05086         157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD-REVLNHVIKDQQVKLFKPQLE  235 (268)
T ss_pred             cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHhhcccccCCCccC
Confidence            1223457889999999853       235678999999999999997 5678854433 33333322221    123445


Q ss_pred             hhccHHHHHHHHHhcccCccccCCHHHHhc
Q 015500          219 AFLSKQANDFLSNCLRRDPKERWAASQLLK  248 (405)
Q Consensus       219 ~~~s~~l~dll~~~L~~dP~~Rpt~~elL~  248 (405)
                      ..+++.+.+++++|+ .+|++||+++++++
T Consensus       236 ~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         236 LPYSERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             CCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence            557899999999999 67999999999965

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.5e-40  Score=299.51  Aligned_cols=251  Identities=27%  Similarity=0.380  Sum_probs=201.4

Q ss_pred             cccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCC----ceE
Q 015500            3 WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDN----KLM   73 (405)
Q Consensus         3 y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~----~~~   73 (405)
                      |....+||+|.||.||+|+.+.+|+.||+|++-.+.     .....+|+++|..|+|+|++.++..+.+....    ...
T Consensus        19 yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t   98 (376)
T KOG0669|consen   19 YEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRAT   98 (376)
T ss_pred             HHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccce
Confidence            567789999999999999999999999998754322     24678999999999999999988766544322    234


Q ss_pred             EEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc
Q 015500           74 YNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA  152 (405)
Q Consensus        74 ~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~  152 (405)
                      +|+||.+|+. +|+-++.....+++..+++.++.+++.||.|+|+..|+|||+||.|+||+.++ +||+|||+|+.....
T Consensus        99 ~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~fs~~  177 (376)
T KOG0669|consen   99 FYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAFSTS  177 (376)
T ss_pred             eeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccceecc
Confidence            7799999976 89988877667899999999999999999999999999999999999999998 999999999754332


Q ss_pred             c--------cCCCCCCccChhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHH--hc----------
Q 015500          153 L--------QSGGTPMFMAPEVARG-EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA--YS----------  211 (405)
Q Consensus       153 ~--------~~~gt~~Y~APE~l~~-~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~--~~----------  211 (405)
                      .        +.+-|.+|++||.+.| ..|+++.|||+.||++.||.||.+-+....+ ...+..|.  .+          
T Consensus       178 ~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnte-qqql~~Is~LcGs~tkevWP~~  256 (376)
T KOG0669|consen  178 KNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTE-QQQLHLISQLCGSITKEVWPNV  256 (376)
T ss_pred             cccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChH-HHHHHHHHHHhccCCcccCCCc
Confidence            1        2335999999999987 5699999999999999999999998864432 22222221  00          


Q ss_pred             --------CCCCCCchh-------------ccHHHHHHHHHhcccCccccCCHHHHhcCcccccc
Q 015500          212 --------RELPEVPAF-------------LSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       212 --------~~~~~~p~~-------------~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                              -+.+.+|..             -++++.||+.++|..||.+|++++++|+|.||..-
T Consensus       257 d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kd  321 (376)
T KOG0669|consen  257 DNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKD  321 (376)
T ss_pred             ccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcC
Confidence                    011111111             24578899999999999999999999999999754

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-38  Score=335.79  Aligned_cols=239  Identities=25%  Similarity=0.404  Sum_probs=200.5

Q ss_pred             ccccccceeCCeeEEEEEEcCC-CC----EEEEEEccCC----ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEE
Q 015500            4 TRGHTIGQGSSATVSLATSLRS-GD----VFAAKSTELP----KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMY   74 (405)
Q Consensus         4 ~~~~~LG~G~~g~Vyla~~~~~-~~----~vavK~~~~~----~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~   74 (405)
                      +.++.||+|+||.||.|..... |.    .||+|.+...    ....+.+|..+|+.++|||||+++|++.....    +
T Consensus       695 ~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~----~  770 (1025)
T KOG1095|consen  695 TLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP----P  770 (1025)
T ss_pred             EeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC----c
Confidence            4678999999999999986643 33    3899987653    24578899999999999999999999887443    5


Q ss_pred             EEEEeecCCCCHHHHHHHc------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccc
Q 015500           75 NLFMEYAPGGTLNDEIHRN------GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAK  147 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~i~~~------~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~  147 (405)
                      ++++|||+||+|..+|++.      ...++......++.||++|+.||+++++|||||..+|+|++... +||+|||+|+
T Consensus       771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlAr  850 (1025)
T KOG1095|consen  771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLAR  850 (1025)
T ss_pred             EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchhH
Confidence            5899999999999999986      55689999999999999999999999999999999999999887 9999999999


Q ss_pred             cccc-c-ccCC----CCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchh
Q 015500          148 WESE-A-LQSG----GTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAF  220 (405)
Q Consensus       148 ~~~~-~-~~~~----gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~  220 (405)
                      .... . ....    -...|||||.+....++.++|||||||++||++| |..||++..+.. ++....... .-..|..
T Consensus       851 Diy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~-v~~~~~~gg-RL~~P~~  928 (1025)
T KOG1095|consen  851 DIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE-VLLDVLEGG-RLDPPSY  928 (1025)
T ss_pred             hhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH-HHHHHHhCC-ccCCCCC
Confidence            4322 1 1111    1235999999999999999999999999999999 889998765543 333333333 3456889


Q ss_pred             ccHHHHHHHHHhcccCccccCCHHHHhc
Q 015500          221 LSKQANDFLSNCLRRDPKERWAASQLLK  248 (405)
Q Consensus       221 ~s~~l~dll~~~L~~dP~~Rpt~~elL~  248 (405)
                      +++.+.+++..||+.+|++||++..|++
T Consensus       929 CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  929 CPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             CChHHHHHHHHHccCChhhCccHHHHHh
Confidence            9999999999999999999999999988

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.8e-38  Score=317.41  Aligned_cols=249  Identities=27%  Similarity=0.430  Sum_probs=205.9

Q ss_pred             cccccccceeCCeeEEEEEEcCCCCEEEEEEccCC------ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEE
Q 015500            3 WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         3 y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~------~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      |..++.||-|+||.|.++.-..|+..||.|.+++.      +...++.|..||...+.+-||++|-.|.+.+.    +|+
T Consensus       631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdn----LYF  706 (1034)
T KOG0608|consen  631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDN----LYF  706 (1034)
T ss_pred             eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCc----eEE
Confidence            66789999999999999998889999999987653      45678899999999999999999977765554    678


Q ss_pred             EEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccc------
Q 015500           77 FMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWE------  149 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~------  149 (405)
                      ||+|++||++-.+|.+.+ -|.|..++.|+..+.+|++++|.+|+|||||||+|||||.+| +||+|||+..-+      
T Consensus       707 VMdYIPGGDmMSLLIrmg-IFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHds  785 (1034)
T KOG0608|consen  707 VMDYIPGGDMMSLLIRMG-IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  785 (1034)
T ss_pred             EEeccCCccHHHHHHHhc-cCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecccc
Confidence            999999999999998874 899999999999999999999999999999999999999999 999999987310      


Q ss_pred             ---cc-------------------------------------cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHH
Q 015500          150 ---SE-------------------------------------ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMA  189 (405)
Q Consensus       150 ---~~-------------------------------------~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ell  189 (405)
                         ..                                     ....+||+-|+|||++....|+..+|.||.|++||||+
T Consensus       786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~  865 (1034)
T KOG0608|consen  786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEML  865 (1034)
T ss_pred             ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHh
Confidence               00                                     01124899999999999999999999999999999999


Q ss_pred             hCCCCCCCCCChHHHHHHHHhcCCCCCCc--hhccHHHHHHHHHhcccCccccCC---HHHHhcCccccccccc
Q 015500          190 SGGAPWPNAADPMTVLYKIAYSRELPEVP--AFLSKQANDFLSNCLRRDPKERWA---ASQLLKHPFLEEFCSC  258 (405)
Q Consensus       190 tG~~Pf~~~~~~~~~l~~i~~~~~~~~~p--~~~s~~l~dll~~~L~~dP~~Rpt---~~elL~hp~~~~~~~~  258 (405)
                      .|++||-... +....+++..-+.+-.+|  ..+|+++.++|.++. .+++.|..   ++|+..||||+.+...
T Consensus       866 ~g~~pf~~~t-p~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKaHpfFkgIDfs  937 (1034)
T KOG0608|consen  866 VGQPPFLADT-PGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLC-CSADSRLGKNGADQVKAHPFFKGIDFS  937 (1034)
T ss_pred             hCCCCccCCC-CCcceeeeeehhhccccccccccCHHHHHHHHHHh-cChhhhhcccchhhhhcCccccccchH
Confidence            9999995443 333333333222222333  468999999999865 56888874   6789999999987543

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=2.1e-37  Score=324.38  Aligned_cols=251  Identities=21%  Similarity=0.244  Sum_probs=172.2

Q ss_pred             CcccccccceeCCeeEEEEEEcCC----CCEEEEEEccCCChHHHHHHHHHHHhCCCCCeeeeeeeeeec--CCCceEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRS----GDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTS--EDNKLMYN   75 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~----~~~vavK~~~~~~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~--~~~~~~~~   75 (405)
                      +|..++.||+|+||+||+|++..+    +..+|+|.+........... ..++...+.++..+...+...  ......++
T Consensus       133 ~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~-e~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  211 (566)
T PLN03225        133 DFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMN-ERVRRACPNSCADFVYGFLEPVSSKKEDEYW  211 (566)
T ss_pred             CeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHH-HHHHhhchhhHHHHHHhhhcccccccCCceE
Confidence            588999999999999999999988    89999998764332211111 112222233333222211110  11223466


Q ss_pred             EEEeecCCCCHHHHHHHcCCC-------------------CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccC
Q 015500           76 LFMEYAPGGTLNDEIHRNGGR-------------------LDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES  136 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~~~~-------------------l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~  136 (405)
                      +|+||+++++|.+++....-+                   ..+..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus       212 LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NILl~~~  291 (566)
T PLN03225        212 LVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEG  291 (566)
T ss_pred             EEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHEEEeCC
Confidence            999999999999998754211                   1234567899999999999999999999999999999864


Q ss_pred             -C-ceEeeecccccccc-----cccCCCCCCccChhhhcCCC----------------------CCcchhHHHHHHHHHH
Q 015500          137 -G-AKIADFGCAKWESE-----ALQSGGTPMFMAPEVARGEH----------------------QGFASDIWAVGCTVIE  187 (405)
Q Consensus       137 -~-vkL~DFGla~~~~~-----~~~~~gt~~Y~APE~l~~~~----------------------~~~~sDIwSLG~il~e  187 (405)
                       + +||+|||+|+....     .....+|+.|||||++....                      ++.++|||||||++||
T Consensus       292 ~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~e  371 (566)
T PLN03225        292 SGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQ  371 (566)
T ss_pred             CCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHHHH
Confidence             4 99999999975432     23456899999999764322                      2345699999999999


Q ss_pred             HHhCCCCCCCCCChHHHHHHHHhcCC--------------CCC------CchhccHHHHHHHHHhcccCccccCCHHHHh
Q 015500          188 MASGGAPWPNAADPMTVLYKIAYSRE--------------LPE------VPAFLSKQANDFLSNCLRRDPKERWAASQLL  247 (405)
Q Consensus       188 lltG~~Pf~~~~~~~~~l~~i~~~~~--------------~~~------~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL  247 (405)
                      |+++..|+...   ...+.++.....              .+.      .....+..+.+||++||++||.+|||+.|+|
T Consensus       372 l~~~~~~~~~~---~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L  448 (566)
T PLN03225        372 MAFPNLRSDSN---LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAAL  448 (566)
T ss_pred             HHhCcCCCchH---HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCHHHHh
Confidence            99987765321   111111111000              000      0011233456999999999999999999999


Q ss_pred             cCccccccc
Q 015500          248 KHPFLEEFC  256 (405)
Q Consensus       248 ~hp~~~~~~  256 (405)
                      +||||....
T Consensus       449 ~Hpff~~~~  457 (566)
T PLN03225        449 AHPYFDREG  457 (566)
T ss_pred             CCcCcCCCC
Confidence            999998653

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=9.9e-37  Score=281.54  Aligned_cols=234  Identities=38%  Similarity=0.596  Sum_probs=198.6

Q ss_pred             CCeeEEEEEEcCCCCEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEeecCCCCHHH
Q 015500           13 SSATVSLATSLRSGDVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLND   88 (405)
Q Consensus        13 ~~g~Vyla~~~~~~~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~Ey~~ggsL~~   88 (405)
                      +||.||+|.+..+++.+|+|.+....    .+.+.+|++.+++++||||+++.+.+....    .+++++||+++++|.+
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~----~~~l~~e~~~~~~L~~   76 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDED----KLYLVMEYCDGGDLFD   76 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCC----EEEEEEeCCCCCCHHH
Confidence            58999999999899999999987543    578899999999999999999998876543    3679999999999999


Q ss_pred             HHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc---cccCCCCCCccCh
Q 015500           89 EIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE---ALQSGGTPMFMAP  164 (405)
Q Consensus        89 ~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~---~~~~~gt~~Y~AP  164 (405)
                      ++.... .++...+..++.+++.++.|||+.|++|+||+|.||+++.++ ++|+|||.+.....   .....+++.|+||
T Consensus        77 ~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~p  155 (244)
T smart00220       77 LLKKRG-RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAP  155 (244)
T ss_pred             HHHhcc-CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCH
Confidence            998754 489999999999999999999999999999999999999887 99999999886544   2445689999999


Q ss_pred             hhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchh--ccHHHHHHHHHhcccCccccCC
Q 015500          165 EVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAF--LSKQANDFLSNCLRRDPKERWA  242 (405)
Q Consensus       165 E~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~--~s~~l~dll~~~L~~dP~~Rpt  242 (405)
                      |.+.+..+++++|+||||+++++|++|..||....+......... ....+..+..  ++.++.+++.+||..+|++||+
T Consensus       156 E~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~  234 (244)
T smart00220      156 EVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIG-KPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLT  234 (244)
T ss_pred             HHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHh-ccCCCCccccccCCHHHHHHHHHHccCCchhccC
Confidence            999988889999999999999999999999965444444333333 2222222222  7899999999999999999999


Q ss_pred             HHHHhcCccc
Q 015500          243 ASQLLKHPFL  252 (405)
Q Consensus       243 ~~elL~hp~~  252 (405)
                      +.++++||||
T Consensus       235 ~~~~~~~~~~  244 (244)
T smart00220      235 AEEALQHPFF  244 (244)
T ss_pred             HHHHhhCCCC
Confidence            9999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=6e-38  Score=325.17  Aligned_cols=237  Identities=24%  Similarity=0.359  Sum_probs=202.2

Q ss_pred             ccccccceeCCeeEEEEEEcC-----CCCEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEE
Q 015500            4 TRGHTIGQGSSATVSLATSLR-----SGDVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMY   74 (405)
Q Consensus         4 ~~~~~LG~G~~g~Vyla~~~~-----~~~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~   74 (405)
                      ...+.||+|+||+||+|....     .-..||||.++...    .+.|+||+++|..|+|||||+++|++...+.    +
T Consensus       489 ~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P----~  564 (774)
T KOG1026|consen  489 VFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDP----L  564 (774)
T ss_pred             eehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe----e
Confidence            456789999999999998543     23579999887543    3579999999999999999999999887666    7


Q ss_pred             EEEEeecCCCCHHHHHHHcC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceE
Q 015500           75 NLFMEYAPGGTLNDEIHRNG-------------GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKI  140 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~i~~~~-------------~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL  140 (405)
                      ++|+|||..|+|.++++.+.             ++|+..+.+.|+.||+.|+.||-++.+|||||-.+|.||+++- |||
T Consensus       565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~VKI  644 (774)
T KOG1026|consen  565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVVKI  644 (774)
T ss_pred             EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEEEe
Confidence            79999999999999997532             2388899999999999999999999999999999999999987 999


Q ss_pred             eeeccccccccc--ccC----CCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCC
Q 015500          141 ADFGCAKWESEA--LQS----GGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRE  213 (405)
Q Consensus       141 ~DFGla~~~~~~--~~~----~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~  213 (405)
                      +|||+++.+-..  ...    .-...|||||.+..++++.+|||||+||+|+|+++ |+.||.... ..+++..+..++.
T Consensus       645 sDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glS-n~EVIe~i~~g~l  723 (774)
T KOG1026|consen  645 SDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLS-NQEVIECIRAGQL  723 (774)
T ss_pred             cccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccc-hHHHHHHHHcCCc
Confidence            999999864331  111    12456999999999999999999999999999998 899996554 4566666665555


Q ss_pred             CCCCchhccHHHHHHHHHhcccCccccCCHHHH
Q 015500          214 LPEVPAFLSKQANDFLSNCLRRDPKERWAASQL  246 (405)
Q Consensus       214 ~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~el  246 (405)
                       -..|..+|.++.+|+..||+.+|++||++.||
T Consensus       724 -L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI  755 (774)
T KOG1026|consen  724 -LSCPENCPTEVYSLMLECWNENPKRRPSFKEI  755 (774)
T ss_pred             -ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence             56789999999999999999999999999998

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-38  Score=301.33  Aligned_cols=249  Identities=23%  Similarity=0.318  Sum_probs=197.3

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC--ChHHHHHHHHHHHhCCC--CC----eeeeeeeeeecCCCceE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP--KSEFLQREQKFLSSLNS--PH----IVGYKGCDVTSEDNKLM   73 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~--~~~~l~~E~~iL~~L~h--pn----Iv~~~~~~~~~~~~~~~   73 (405)
                      .|.+++.+|+|.||.|-.+.+..++..+|||++..-  ..+...-|+++|.++.+  |+    ++++.++|...    ..
T Consensus        90 Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr----gh  165 (415)
T KOG0671|consen   90 RYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR----GH  165 (415)
T ss_pred             ceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc----Cc
Confidence            488999999999999999999999999999998753  34667779999999943  33    44444444322    23


Q ss_pred             EEEEEeecCCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcc-----------------
Q 015500           74 YNLFMEYAPGGTLNDEIHRN-GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAE-----------------  135 (405)
Q Consensus        74 ~~lv~Ey~~ggsL~~~i~~~-~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~-----------------  135 (405)
                      .|+|+|.+ |.|+.+++..+ -.+++..+++.+++||++++++||+.+++|.||||+|||+.+                 
T Consensus       166 iCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r  244 (415)
T KOG0671|consen  166 ICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIR  244 (415)
T ss_pred             eEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceec
Confidence            77999998 78999999874 346899999999999999999999999999999999999742                 


Q ss_pred             ---C-CceEeeeccccccccc-ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHh
Q 015500          136 ---S-GAKIADFGCAKWESEA-LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAY  210 (405)
Q Consensus       136 ---~-~vkL~DFGla~~~~~~-~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~  210 (405)
                         + .+||+|||.|+...+. ...+.|.-|+|||++.+-..+.++||||+||||+|+.||...|+..++....-.....
T Consensus       245 ~~ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerI  324 (415)
T KOG0671|consen  245 PLKSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERI  324 (415)
T ss_pred             cCCCcceEEEecCCcceeccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHh
Confidence               1 1799999999986663 4557899999999999999999999999999999999999999766543322111111


Q ss_pred             cCCCCC------------------Cch-------------------------hccHHHHHHHHHhcccCccccCCHHHHh
Q 015500          211 SRELPE------------------VPA-------------------------FLSKQANDFLSNCLRRDPKERWAASQLL  247 (405)
Q Consensus       211 ~~~~~~------------------~p~-------------------------~~s~~l~dll~~~L~~dP~~Rpt~~elL  247 (405)
                      .+++|.                  +|.                         ..-.++.|||++||..||.+|+|+.|+|
T Consensus       325 lGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL  404 (415)
T KOG0671|consen  325 LGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREAL  404 (415)
T ss_pred             hCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHh
Confidence            111110                  000                         0123578999999999999999999999


Q ss_pred             cCcccccc
Q 015500          248 KHPFLEEF  255 (405)
Q Consensus       248 ~hp~~~~~  255 (405)
                      .||||+..
T Consensus       405 ~HpFF~~~  412 (415)
T KOG0671|consen  405 SHPFFARL  412 (415)
T ss_pred             cCHHhhcC
Confidence            99999864

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-38  Score=303.31  Aligned_cols=247  Identities=26%  Similarity=0.409  Sum_probs=205.3

Q ss_pred             cccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC----------hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCce
Q 015500            3 WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK----------SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKL   72 (405)
Q Consensus         3 y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~----------~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~   72 (405)
                      |-.++.||+|||+.||+|.+...+++||||+-...+          .....||.+|-+.|+||.||++|+++..+.+   
T Consensus       465 YLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd---  541 (775)
T KOG1151|consen  465 YLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD---  541 (775)
T ss_pred             HHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc---
Confidence            667889999999999999999999999999865432          1356789999999999999999998766554   


Q ss_pred             EEEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC--CceeCCCCCCCEEEccC---C-ceEeeeccc
Q 015500           73 MYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN--RVVHCDIKSRNILMAES---G-AKIADFGCA  146 (405)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~--givHrDlkp~NILi~~~---~-vkL~DFGla  146 (405)
                      .+|-|+|||+|.+|.-+++++. -++|..++.|+.||+.||.||...  .|+|-||||.|||+..+   | +||+|||++
T Consensus       542 sFCTVLEYceGNDLDFYLKQhk-lmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLS  620 (775)
T KOG1151|consen  542 SFCTVLEYCEGNDLDFYLKQHK-LMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLS  620 (775)
T ss_pred             cceeeeeecCCCchhHHHHhhh-hhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence            4789999999999999999874 799999999999999999999986  69999999999999654   3 999999999


Q ss_pred             ccccc-----------cccCCCCCCccChhhhcC----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHH--HH
Q 015500          147 KWESE-----------ALQSGGTPMFMAPEVARG----EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYK--IA  209 (405)
Q Consensus       147 ~~~~~-----------~~~~~gt~~Y~APE~l~~----~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~--i~  209 (405)
                      +.+..           .....||.||++||.+.-    .+.+.++||||+|+++|.++.|+.||.........+..  |.
T Consensus       621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIl  700 (775)
T KOG1151|consen  621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTIL  700 (775)
T ss_pred             hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchh
Confidence            87543           223459999999998753    34678999999999999999999999765544444332  22


Q ss_pred             hcC--CCCCCchhccHHHHHHHHHhcccCccccCCHHHHhcCccccc
Q 015500          210 YSR--ELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEE  254 (405)
Q Consensus       210 ~~~--~~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~  254 (405)
                      ...  .+|.- +.++.++++||++||+..-..|..+.+|..||||..
T Consensus       701 kAtEVqFP~K-PvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP  746 (775)
T KOG1151|consen  701 KATEVQFPPK-PVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP  746 (775)
T ss_pred             cceeccCCCC-CccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence            222  23333 348999999999999999999999999999999974

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-38  Score=289.11  Aligned_cols=246  Identities=26%  Similarity=0.418  Sum_probs=200.9

Q ss_pred             cccccceeCCeeEEEEEEcCCCCEEEEEEccCCC----hHHHHHHHHH-HHhCCCCCeeeeeeeeeecCCCceEEEEEEe
Q 015500            5 RGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK----SEFLQREQKF-LSSLNSPHIVGYKGCDVTSEDNKLMYNLFME   79 (405)
Q Consensus         5 ~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~----~~~l~~E~~i-L~~L~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (405)
                      -+..||+|+||+|++-.++.+|+..|||.+....    ..++..|... ++.-+.||||+++|....+.+    .++.||
T Consensus        68 dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGd----cWiCME  143 (361)
T KOG1006|consen   68 DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGD----CWICME  143 (361)
T ss_pred             HHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc----eeeeHH
Confidence            3567999999999999999999999999987543    2456677765 445578999999998765554    568999


Q ss_pred             ecCCCCHHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCCCCEEEccCC-ceEeeecccccccc--
Q 015500           80 YAPGGTLNDEIHR----NGGRLDESLIVSYTRQILQGLEYLHSN-RVVHCDIKSRNILMAESG-AKIADFGCAKWESE--  151 (405)
Q Consensus        80 y~~ggsL~~~i~~----~~~~l~e~~~~~i~~qIl~~L~yLH~~-givHrDlkp~NILi~~~~-vkL~DFGla~~~~~--  151 (405)
                      .| ..||..+-+.    ....++|..+..|+-..+.||.||... .|+|||+||+|||++..| +||||||+.-....  
T Consensus       144 LM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si  222 (361)
T KOG1006|consen  144 LM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI  222 (361)
T ss_pred             HH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHHH
Confidence            99 4477655432    234799999999999999999999975 899999999999999998 99999998764332  


Q ss_pred             -cccCCCCCCccChhhhcC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCc-----hhccH
Q 015500          152 -ALQSGGTPMFMAPEVARG--EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVP-----AFLSK  223 (405)
Q Consensus       152 -~~~~~gt~~Y~APE~l~~--~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p-----~~~s~  223 (405)
                       .....|-..|||||-+..  ..|+.+||+||||++|||++||+.|+....+..+++..+..+. .|.+-     ..++.
T Consensus       223 AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gd-pp~l~~~~~~~~~s~  301 (361)
T KOG1006|consen  223 AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGD-PPILLFDKECVHYSF  301 (361)
T ss_pred             HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCC-CCeecCcccccccCH
Confidence             334569999999999865  3588899999999999999999999987777777776665543 33322     23789


Q ss_pred             HHHHHHHHhcccCccccCCHHHHhcCccccccc
Q 015500          224 QANDFLSNCLRRDPKERWAASQLLKHPFLEEFC  256 (405)
Q Consensus       224 ~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~  256 (405)
                      .+..||..||.+|-+.||...+|+++||++.+.
T Consensus       302 ~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~  334 (361)
T KOG1006|consen  302 SMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYA  334 (361)
T ss_pred             HHHHHHHHHhhcccccCcchhhhhcCchhhhhh
Confidence            999999999999999999999999999998653

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=2.4e-37  Score=303.93  Aligned_cols=248  Identities=28%  Similarity=0.404  Sum_probs=202.4

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCCh--HHHHHHHHHHHhCCC------CCeeeeeeeeeecCCCceE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS--EFLQREQKFLSSLNS------PHIVGYKGCDVTSEDNKLM   73 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~~--~~l~~E~~iL~~L~h------pnIv~~~~~~~~~~~~~~~   73 (405)
                      .|.+....|+|-|++|..|.+..-|..||||++.....  ..=.+|++||++|..      -|+++++..|....    .
T Consensus       433 RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hkn----H  508 (752)
T KOG0670|consen  433 RYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKN----H  508 (752)
T ss_pred             eeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcc----e
Confidence            37777888999999999999999999999999976542  345679999999953      57888877665443    4


Q ss_pred             EEEEEeecCCCCHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC--ceEeeecccccc
Q 015500           74 YNLFMEYAPGGTLNDEIHRNGG--RLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG--AKIADFGCAKWE  149 (405)
Q Consensus        74 ~~lv~Ey~~ggsL~~~i~~~~~--~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~--vkL~DFGla~~~  149 (405)
                      +|||+|-+ ..+|.+++++.|.  .|....++.|+.|++.||..|...||+|+||||.|||++...  +||||||.|..+
T Consensus       509 LClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~  587 (752)
T KOG0670|consen  509 LCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASFA  587 (752)
T ss_pred             eEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcccccc
Confidence            88999988 5699999988643  378889999999999999999999999999999999999876  999999999876


Q ss_pred             ccc--ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCC-----------
Q 015500          150 SEA--LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPE-----------  216 (405)
Q Consensus       150 ~~~--~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~-----------  216 (405)
                      ..+  .++.-+..|.|||++.|-.|++..|+||+||+||||.||+..|++..++..+-......+.+|.           
T Consensus       588 ~eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dq  667 (752)
T KOG0670|consen  588 SENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQ  667 (752)
T ss_pred             ccccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhh
Confidence            553  3344566799999999999999999999999999999999999887765554333322222221           


Q ss_pred             -------------------------------------------Cc---hhccHHHHHHHHHhcccCccccCCHHHHhcCc
Q 015500          217 -------------------------------------------VP---AFLSKQANDFLSNCLRRDPKERWAASQLLKHP  250 (405)
Q Consensus       217 -------------------------------------------~p---~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp  250 (405)
                                                                 +|   ...-..+++||.+||..||.+|.|+.|+|+||
T Consensus       668 HFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~Hp  747 (752)
T KOG0670|consen  668 HFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKHP  747 (752)
T ss_pred             hcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcCC
Confidence                                                       00   00124588999999999999999999999999


Q ss_pred             cccc
Q 015500          251 FLEE  254 (405)
Q Consensus       251 ~~~~  254 (405)
                      ||..
T Consensus       748 Fi~~  751 (752)
T KOG0670|consen  748 FITE  751 (752)
T ss_pred             cccC
Confidence            9963

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2.3e-35  Score=303.13  Aligned_cols=252  Identities=22%  Similarity=0.271  Sum_probs=180.7

Q ss_pred             CcccccccceeCCeeEEEEEEc----------------CCCCEEEEEEccCCCh-----------------HHHHHHHHH
Q 015500            2 DWTRGHTIGQGSSATVSLATSL----------------RSGDVFAAKSTELPKS-----------------EFLQREQKF   48 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~----------------~~~~~vavK~~~~~~~-----------------~~l~~E~~i   48 (405)
                      +|++.++||+|+||+||+|...                ..++.||||.+.....                 +....|+.+
T Consensus       146 ~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~  225 (507)
T PLN03224        146 DFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYM  225 (507)
T ss_pred             CceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHH
Confidence            6899999999999999999752                3456799998764321                 122346777


Q ss_pred             HHhCCCCCe-----eeeeeeeeecCC----CceEEEEEEeecCCCCHHHHHHHcCC-----------------------C
Q 015500           49 LSSLNSPHI-----VGYKGCDVTSED----NKLMYNLFMEYAPGGTLNDEIHRNGG-----------------------R   96 (405)
Q Consensus        49 L~~L~hpnI-----v~~~~~~~~~~~----~~~~~~lv~Ey~~ggsL~~~i~~~~~-----------------------~   96 (405)
                      +.+++|.++     +.+++++.....    .....++||||+++++|.+++....+                       .
T Consensus       226 l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~  305 (507)
T PLN03224        226 CAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDK  305 (507)
T ss_pred             HHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccccc
Confidence            778876654     455555433211    11235699999999999999864321                       2


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc---c--cCCCCCCccChhhhcCC
Q 015500           97 LDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA---L--QSGGTPMFMAPEVARGE  170 (405)
Q Consensus        97 l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~---~--~~~gt~~Y~APE~l~~~  170 (405)
                      +++..++.++.|++.||.|||+++|+||||||+|||++.++ +||+|||++......   .  ...+||.|+|||++...
T Consensus       306 ~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~  385 (507)
T PLN03224        306 RDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMP  385 (507)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCC
Confidence            35677889999999999999999999999999999999887 999999998654321   1  12358999999998643


Q ss_pred             C--------------------CC--cchhHHHHHHHHHHHHhCCC-CCCCCCChHHHH---------HHHHhcC--CCCC
Q 015500          171 H--------------------QG--FASDIWAVGCTVIEMASGGA-PWPNAADPMTVL---------YKIAYSR--ELPE  216 (405)
Q Consensus       171 ~--------------------~~--~~sDIwSLG~il~elltG~~-Pf~~~~~~~~~l---------~~i~~~~--~~~~  216 (405)
                      .                    ++  .+.||||+||++|+|++|.. ||.........+         .+.....  .++ 
T Consensus       386 ~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~-  464 (507)
T PLN03224        386 QSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDFS-  464 (507)
T ss_pred             CCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCcc-
Confidence            2                    11  24799999999999999986 774321111111         1111111  111 


Q ss_pred             CchhccHHHHHHHHHhcccCc---cccCCHHHHhcCccccc
Q 015500          217 VPAFLSKQANDFLSNCLRRDP---KERWAASQLLKHPFLEE  254 (405)
Q Consensus       217 ~p~~~s~~l~dll~~~L~~dP---~~Rpt~~elL~hp~~~~  254 (405)
                      .....++.++||+.+||.++|   .+|+|++|+|+||||..
T Consensus       465 ~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~  505 (507)
T PLN03224        465 LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP  505 (507)
T ss_pred             cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence            223478999999999999866   68999999999999964

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=9.5e-36  Score=331.18  Aligned_cols=237  Identities=20%  Similarity=0.259  Sum_probs=186.5

Q ss_pred             cccccccceeCCeeEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEeecC
Q 015500            3 WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAP   82 (405)
Q Consensus         3 y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~Ey~~   82 (405)
                      +...+.||+|+||.||+|+++.++..||||.+..... ...+|++++++++||||+++++++.....    +++||||++
T Consensus       692 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~l~~l~HpnIv~~~~~~~~~~~----~~lv~Ey~~  766 (968)
T PLN00113        692 LKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-IPSSEIADMGKLQHPNIVKLIGLCRSEKG----AYLIHEYIE  766 (968)
T ss_pred             CCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-ccHHHHHHHhhCCCCCcceEEEEEEcCCC----CEEEEeCCC
Confidence            4566789999999999999999999999998864332 33467899999999999999998865433    569999999


Q ss_pred             CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCCCCEEEccCC-ceEeeecccccccccccCCCC
Q 015500           83 GGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLH---SNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSGGT  158 (405)
Q Consensus        83 ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH---~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~~~~~gt  158 (405)
                      +|+|.++++    .+++..+..++.||+.||+|||   +.+|+||||||+||+++.++ .++. ||.+..........+|
T Consensus       767 ~g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~~~~~~t  841 (968)
T PLN00113        767 GKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFIS  841 (968)
T ss_pred             CCcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccCCCcccc
Confidence            999999985    3789999999999999999999   67999999999999999877 4544 7766544333445689


Q ss_pred             CCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCh---HHHHHHHHhcC---------C---CCCCchhccH
Q 015500          159 PMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADP---MTVLYKIAYSR---------E---LPEVPAFLSK  223 (405)
Q Consensus       159 ~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~---~~~l~~i~~~~---------~---~~~~p~~~s~  223 (405)
                      +.|+|||++.+..++.++|||||||++|||+||+.||......   .....+.....         .   ....+.....
T Consensus       842 ~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  921 (968)
T PLN00113        842 SAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIV  921 (968)
T ss_pred             ccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHH
Confidence            9999999999999999999999999999999999998432111   11111111000         0   0011222344


Q ss_pred             HHHHHHHHhcccCccccCCHHHHhcC
Q 015500          224 QANDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       224 ~l~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      ++.+++.+||+.||++|||+.|+++.
T Consensus       922 ~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        922 EVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             HHHHHHHhhCcCCchhCcCHHHHHHH
Confidence            67889999999999999999999876

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-35  Score=289.94  Aligned_cols=255  Identities=29%  Similarity=0.381  Sum_probs=198.4

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC--hHHHHHHHHHHHhCC-----C---CCeeeeeeeeeecCCCc
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK--SEFLQREQKFLSSLN-----S---PHIVGYKGCDVTSEDNK   71 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~--~~~l~~E~~iL~~L~-----h---pnIv~~~~~~~~~~~~~   71 (405)
                      .|.+.++||-|-|+|||+|.|..+.+.||+|+....+  .+....||++|++++     |   .+||++++.|.....+.
T Consensus        79 RY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG  158 (590)
T KOG1290|consen   79 RYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNG  158 (590)
T ss_pred             eEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCC
Confidence            4888999999999999999999999999999987543  467888999999983     3   46999999999988889


Q ss_pred             eEEEEEEeecCCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCCCCEEEccC-------------
Q 015500           72 LMYNLFMEYAPGGTLNDEIHRN-GGRLDESLIVSYTRQILQGLEYLHSN-RVVHCDIKSRNILMAES-------------  136 (405)
Q Consensus        72 ~~~~lv~Ey~~ggsL~~~i~~~-~~~l~e~~~~~i~~qIl~~L~yLH~~-givHrDlkp~NILi~~~-------------  136 (405)
                      ...|+|+|++ |.+|..+|+.. -..++...++.|++||+.||.|||+. ||||.||||+|||+..+             
T Consensus       159 ~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~~~a~e  237 (590)
T KOG1290|consen  159 QHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDAREAGE  237 (590)
T ss_pred             cEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhhhhhhcc
Confidence            9999999999 77999999763 33599999999999999999999985 99999999999995310             


Q ss_pred             --------------------------------------------------------------------------------
Q 015500          137 --------------------------------------------------------------------------------  136 (405)
Q Consensus       137 --------------------------------------------------------------------------------  136 (405)
                                                                                                      
T Consensus       238 ~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~~~v~  317 (590)
T KOG1290|consen  238 ATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNESTVE  317 (590)
T ss_pred             ccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCccccchh
Confidence                                                                                            


Q ss_pred             ---------------------------------------------------------------------C-----ceEee
Q 015500          137 ---------------------------------------------------------------------G-----AKIAD  142 (405)
Q Consensus       137 ---------------------------------------------------------------------~-----vkL~D  142 (405)
                                                                                           .     +||+|
T Consensus       318 ~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~vKIaD  397 (590)
T KOG1290|consen  318 RSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRVKIAD  397 (590)
T ss_pred             hcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeEEEee
Confidence                                                                                 0     23444


Q ss_pred             ecccccccc-cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-----ChHHHHHHHH-hcCCCC
Q 015500          143 FGCAKWESE-ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAA-----DPMTVLYKIA-YSRELP  215 (405)
Q Consensus       143 FGla~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~-----~~~~~l~~i~-~~~~~~  215 (405)
                      ||-|.+... ......|..|+|||++.|..|++.+||||++|+++||+||...|...+     .....+..|. ..+.+|
T Consensus       398 lGNACW~~khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ELLG~iP  477 (590)
T KOG1290|consen  398 LGNACWVHKHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIMELLGKIP  477 (590)
T ss_pred             ccchhhhhhhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHHHhhcc
Confidence            444433222 112235788999999999999999999999999999999999985321     1111111110 001111


Q ss_pred             ---------------------------------------CCchhccHHHHHHHHHhcccCccccCCHHHHhcCccccccc
Q 015500          216 ---------------------------------------EVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFC  256 (405)
Q Consensus       216 ---------------------------------------~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~  256 (405)
                                                             .++..-..++.+||.-||+++|.+||||.++|+|||+..+.
T Consensus       478 r~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~hPwLn~~~  557 (590)
T KOG1290|consen  478 RKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLKHPWLNPVA  557 (590)
T ss_pred             HHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhcCccccCCC
Confidence                                                   12222356788999999999999999999999999998764


Q ss_pred             c
Q 015500          257 S  257 (405)
Q Consensus       257 ~  257 (405)
                      .
T Consensus       558 ~  558 (590)
T KOG1290|consen  558 G  558 (590)
T ss_pred             C
Confidence            3

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-37  Score=315.06  Aligned_cols=241  Identities=29%  Similarity=0.418  Sum_probs=190.0

Q ss_pred             ccccccceeCCee-EEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHhC-CCCCeeeeeeeeeecCCCceEEEEEEeec
Q 015500            4 TRGHTIGQGSSAT-VSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSL-NSPHIVGYKGCDVTSEDNKLMYNLFMEYA   81 (405)
Q Consensus         4 ~~~~~LG~G~~g~-Vyla~~~~~~~~vavK~~~~~~~~~l~~E~~iL~~L-~hpnIv~~~~~~~~~~~~~~~~~lv~Ey~   81 (405)
                      .-.+.+|.|+.|+ ||+|...  |+.||||.+-.+-.+..+||++.|+.- .|||||++++...    ...+.|+..|.|
T Consensus       512 ~~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~----d~qF~YIalELC  585 (903)
T KOG1027|consen  512 SPKEILGYGSNGTVVFRGVYE--GREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSEQ----DRQFLYIALELC  585 (903)
T ss_pred             ccHHHcccCCCCcEEEEEeeC--CceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeecc----CCceEEEEehHh
Confidence            3457899999996 8999875  889999998777788999999999988 7999999987532    234577999999


Q ss_pred             CCCCHHHHHHHcCCC---CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcc---CC---ceEeeecccccccc-
Q 015500           82 PGGTLNDEIHRNGGR---LDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAE---SG---AKIADFGCAKWESE-  151 (405)
Q Consensus        82 ~ggsL~~~i~~~~~~---l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~---~~---vkL~DFGla~~~~~-  151 (405)
                      .. +|.++++..+..   ......+.++.|+++||+|||+.+||||||||+||||..   ++   ++|.|||+++.... 
T Consensus       586 ~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~  664 (903)
T KOG1027|consen  586 AC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGG  664 (903)
T ss_pred             hh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCC
Confidence            66 999999874111   111345788999999999999999999999999999976   33   89999999986433 


Q ss_pred             ------cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhC-CCCCCCCCChHHHHHHHHhcC-CCCCCchhccH
Q 015500          152 ------ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASG-GAPWPNAADPMTVLYKIAYSR-ELPEVPAFLSK  223 (405)
Q Consensus       152 ------~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG-~~Pf~~~~~~~~~l~~i~~~~-~~~~~p~~~s~  223 (405)
                            .....||-+|+|||+++......++|||||||++|+.++| .+||...-..   -..|.... .+-.+......
T Consensus       665 ~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R---~~NIl~~~~~L~~L~~~~d~  741 (903)
T KOG1027|consen  665 KSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER---QANILTGNYTLVHLEPLPDC  741 (903)
T ss_pred             cchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh---hhhhhcCccceeeeccCchH
Confidence                  2345599999999999999889999999999999999997 8999643221   11222111 11111111122


Q ss_pred             HHHHHHHHhcccCccccCCHHHHhcCccccc
Q 015500          224 QANDFLSNCLRRDPKERWAASQLLKHPFLEE  254 (405)
Q Consensus       224 ~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~  254 (405)
                      ++.|||.+||..+|..||+|.++|.||||-.
T Consensus       742 eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~  772 (903)
T KOG1027|consen  742 EAKDLISRMLNPDPQLRPSATDVLNHPLFWD  772 (903)
T ss_pred             HHHHHHHHhcCCCcccCCCHHHHhCCCccCC
Confidence            8999999999999999999999999999964

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-36  Score=283.63  Aligned_cols=247  Identities=29%  Similarity=0.390  Sum_probs=200.4

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC-----ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCC--CceEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP-----KSEFLQREQKFLSSLNSPHIVGYKGCDVTSED--NKLMY   74 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~-----~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~--~~~~~   74 (405)
                      .|..++.+|.|+- .|..|.|..+++.+|+|+...+     .+.+.++|..++..+.|+||++++.++.-...  ...-.
T Consensus        18 Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~   96 (369)
T KOG0665|consen   18 RYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEV   96 (369)
T ss_pred             eeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhH
Confidence            5777889999999 8889999999999999987543     45688999999999999999999988754332  11235


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc--
Q 015500           75 NLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE--  151 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~--  151 (405)
                      |+|||||. .+|...+..   .++-.++.+|++|++.|++|||+.||+||||||+||++..+. +||.|||+|+....  
T Consensus        97 y~v~e~m~-~nl~~vi~~---elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~~  172 (369)
T KOG0665|consen   97 YLVMELMD-ANLCQVILM---ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTDF  172 (369)
T ss_pred             HHHHHhhh-hHHHHHHHH---hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCccc
Confidence            69999994 599988873   589999999999999999999999999999999999999988 99999999987554  


Q ss_pred             -cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhc-------------------
Q 015500          152 -ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYS-------------------  211 (405)
Q Consensus       152 -~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~-------------------  211 (405)
                       ......|+.|.|||++.+-.+...+||||+||++.||++|+..|++. +..+...++...                   
T Consensus       173 ~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~-d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~y  251 (369)
T KOG0665|consen  173 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGK-DHIDQWNKIIEQLGTPDPSFMKQLQPTVRNY  251 (369)
T ss_pred             ccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCc-hHHHHHHHHHHHhcCCCHHHHHHhhHHHHHH
Confidence             34566899999999999988999999999999999999999999743 322222222111                   


Q ss_pred             -------------CCCCC--Cc------hhccHHHHHHHHHhcccCccccCCHHHHhcCccccc
Q 015500          212 -------------RELPE--VP------AFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEE  254 (405)
Q Consensus       212 -------------~~~~~--~p------~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~  254 (405)
                                   ..+|+  ++      ..-+..++|++.+||..||++|.+++++|+|||++-
T Consensus       252 v~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~v  315 (369)
T KOG0665|consen  252 VENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKV  315 (369)
T ss_pred             hhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeee
Confidence                         11111  00      112356899999999999999999999999999983

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-36  Score=299.79  Aligned_cols=238  Identities=27%  Similarity=0.403  Sum_probs=200.5

Q ss_pred             ccccccceeCCeeEEEEEEcC--CCC--EEEEEEccC----CChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEE
Q 015500            4 TRGHTIGQGSSATVSLATSLR--SGD--VFAAKSTEL----PKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         4 ~~~~~LG~G~~g~Vyla~~~~--~~~--~vavK~~~~----~~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~   75 (405)
                      +..++||.|-||.||.|....  .|+  -||||.+..    ++.+.+..|..+|+.++||||++++|++....     .+
T Consensus       392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P-----~W  466 (974)
T KOG4257|consen  392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQP-----MW  466 (974)
T ss_pred             cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccc-----ee
Confidence            346789999999999998643  233  478887764    35678999999999999999999999876543     56


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccccc
Q 015500           76 LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQ  154 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~~~  154 (405)
                      +|||.++-|.|+.+++++...|+-.....|++||..||.|||+..+|||||-.+|||+.... +||+|||+++.......
T Consensus       467 ivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~y  546 (974)
T KOG4257|consen  467 IVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAY  546 (974)
T ss_pred             EEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccch
Confidence            99999999999999999888999999999999999999999999999999999999998877 99999999998765322


Q ss_pred             CC-----CCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHH
Q 015500          155 SG-----GTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDF  228 (405)
Q Consensus       155 ~~-----gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dl  228 (405)
                      ..     -..-|||||.+.-..++.++|||.||+.+||++. |..||....+. +++.++..+ +.+..|..+|+.+..+
T Consensus       547 YkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs-DVI~~iEnG-eRlP~P~nCPp~LYsl  624 (974)
T KOG4257|consen  547 YKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNS-DVIGHIENG-ERLPCPPNCPPALYSL  624 (974)
T ss_pred             hhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccccc-ceEEEecCC-CCCCCCCCCChHHHHH
Confidence            22     2334999999999999999999999999999876 99999766543 334444444 4445788899999999


Q ss_pred             HHHhcccCccccCCHHHHhc
Q 015500          229 LSNCLRRDPKERWAASQLLK  248 (405)
Q Consensus       229 l~~~L~~dP~~Rpt~~elL~  248 (405)
                      +.+||..+|.+||++.+|..
T Consensus       625 mskcWayeP~kRPrftei~~  644 (974)
T KOG4257|consen  625 MSKCWAYEPSKRPRFTEIKA  644 (974)
T ss_pred             HHHHhccCcccCCcHHHHHH
Confidence            99999999999999887643

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-36  Score=297.21  Aligned_cols=244  Identities=27%  Similarity=0.306  Sum_probs=199.8

Q ss_pred             ccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEe
Q 015500            4 TRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFME   79 (405)
Q Consensus         4 ~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (405)
                      .++++||+|-||.|.++.-. .+..||||.+....    ...+.+|+++|.+|+||||+.+.|+++.++.    +++|+|
T Consensus       541 ~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DeP----icmI~E  615 (807)
T KOG1094|consen  541 RFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDP----LCMITE  615 (807)
T ss_pred             ehhhhhcCcccceeEEEEec-CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCc----hHHHHH
Confidence            57899999999999999753 36899999987543    3578899999999999999999999998877    889999


Q ss_pred             ecCCCCHHHHHHHcCCCC-CHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc--ccc-
Q 015500           80 YAPGGTLNDEIHRNGGRL-DESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE--ALQ-  154 (405)
Q Consensus        80 y~~ggsL~~~i~~~~~~l-~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~--~~~-  154 (405)
                      |++.|+|.+++.++..+. ......+|+.||+.|++||.+.++|||||.++|+|++.+. +||+|||+++..-.  ... 
T Consensus       616 YmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~v  695 (807)
T KOG1094|consen  616 YMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRV  695 (807)
T ss_pred             HHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCceee
Confidence            999999999998874333 4556677999999999999999999999999999999987 99999999984322  111 


Q ss_pred             ---CCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh--CCCCCCCCCChHHHHHHHH-----hcCCCCCCchhccHH
Q 015500          155 ---SGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS--GGAPWPNAADPMTVLYKIA-----YSRELPEVPAFLSKQ  224 (405)
Q Consensus       155 ---~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt--G~~Pf~~~~~~~~~l~~i~-----~~~~~~~~p~~~s~~  224 (405)
                         .+-...|||||.+..++++.++|+|++|+++||+++  ...||....+....-..-.     -...++..|..++..
T Consensus       696 qgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~~  775 (807)
T KOG1094|consen  696 QGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQG  775 (807)
T ss_pred             ecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcHH
Confidence               123467999999999999999999999999999765  6789976654322221111     112345567889999


Q ss_pred             HHHHHHHhcccCccccCCHHHHhcCccccc
Q 015500          225 ANDFLSNCLRRDPKERWAASQLLKHPFLEE  254 (405)
Q Consensus       225 l~dll~~~L~~dP~~Rpt~~elL~hp~~~~  254 (405)
                      +.+++.+||.++-.+|||++++  |-+|++
T Consensus       776 lyelml~Cw~~es~~RPsFe~l--h~~lq~  803 (807)
T KOG1094|consen  776 LYELMLRCWRRESEQRPSFEQL--HLFLQE  803 (807)
T ss_pred             HHHHHHHHhchhhhcCCCHHHH--HHHHHH
Confidence            9999999999999999999999  555553

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-35  Score=299.65  Aligned_cols=244  Identities=29%  Similarity=0.424  Sum_probs=204.9

Q ss_pred             ccccccceeCCeeEEEEEEcC-CCC--EEEEEEccCC----ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEE
Q 015500            4 TRGHTIGQGSSATVSLATSLR-SGD--VFAAKSTELP----KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         4 ~~~~~LG~G~~g~Vyla~~~~-~~~--~vavK~~~~~----~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      +..+.||+|+||.|+.|.++. +|+  .||||.+...    ....|.+|+.+|.+|+|||++++||+..+. .    .-+
T Consensus       113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~q-p----~mM  187 (1039)
T KOG0199|consen  113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQ-P----AMM  187 (1039)
T ss_pred             HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccc-h----hhH
Confidence            467899999999999999886 343  5799988654    346899999999999999999999986652 2    338


Q ss_pred             EEeecCCCCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccccc
Q 015500           77 FMEYAPGGTLNDEIHR-NGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQ  154 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~-~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~~~  154 (405)
                      |||.+++|+|.+.+++ ....|.......|+.||+.|+.||.++++|||||-.+|+|+..-. +||+|||+.+.......
T Consensus       188 V~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned  267 (1039)
T KOG0199|consen  188 VFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENED  267 (1039)
T ss_pred             HhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence            9999999999999987 556788999999999999999999999999999999999997765 99999999986544221


Q ss_pred             ---C----CCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHH
Q 015500          155 ---S----GGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQAN  226 (405)
Q Consensus       155 ---~----~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~  226 (405)
                         .    .-...|.|||.++-..++.++|+|++||++|||+| |..||... .....+.++. .++.-..|..+++++.
T Consensus       268 ~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~-~g~qIL~~iD-~~erLpRPk~csedIY  345 (1039)
T KOG0199|consen  268 MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGC-RGIQILKNID-AGERLPRPKYCSEDIY  345 (1039)
T ss_pred             ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCC-CHHHHHHhcc-ccccCCCCCCChHHHH
Confidence               1    12446999999999999999999999999999999 77999644 4566777777 4454556888999999


Q ss_pred             HHHHHhcccCccccCCHHHHhcCccccc
Q 015500          227 DFLSNCLRRDPKERWAASQLLKHPFLEE  254 (405)
Q Consensus       227 dll~~~L~~dP~~Rpt~~elL~hp~~~~  254 (405)
                      +++++||..+|.+|||+..|.+.-++.+
T Consensus       346 ~imk~cWah~paDRptFsair~~~~l~e  373 (1039)
T KOG0199|consen  346 QIMKNCWAHNPADRPTFSAIREDLVLAE  373 (1039)
T ss_pred             HHHHHhccCCccccccHHHHHHhHHHHh
Confidence            9999999999999999999976555543

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-36  Score=277.47  Aligned_cols=250  Identities=28%  Similarity=0.362  Sum_probs=195.5

Q ss_pred             cccccccceeCCeeEEEEEEcCCCCEEEEEEccC-----CChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCC-ceEEEE
Q 015500            3 WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL-----PKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDN-KLMYNL   76 (405)
Q Consensus         3 y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~-----~~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~-~~~~~l   76 (405)
                      -.-.+.||-|+||.||.+++.++|+.+|+|++..     .....+.+|+++|..++|.|++..++.-.-..-. ....|+
T Consensus        55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV  134 (449)
T KOG0664|consen   55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV  134 (449)
T ss_pred             CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence            3457899999999999999999999999998753     2346788999999999999999876643211110 011346


Q ss_pred             EEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc---
Q 015500           77 FMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA---  152 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~---  152 (405)
                      +.|.+.. +|...|.. .+.++...++-+++||++||+|||+.||.||||||.|.|++.+. +||||||+|+.....   
T Consensus       135 ~TELmQS-DLHKIIVS-PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~  212 (449)
T KOG0664|consen  135 LTELMQS-DLHKIIVS-PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRL  212 (449)
T ss_pred             HHHHHHh-hhhheecc-CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhh
Confidence            7788844 77776654 45899999999999999999999999999999999999999998 899999999865442   


Q ss_pred             --ccCCCCCCccChhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcC-----------------
Q 015500          153 --LQSGGTPMFMAPEVARG-EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSR-----------------  212 (405)
Q Consensus       153 --~~~~gt~~Y~APE~l~~-~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~-----------------  212 (405)
                        ...+-|.+|+|||++.| ..|+.+.||||.||++.||+-.+..|... .+...+..|...-                 
T Consensus       213 hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq-~PiqQL~lItdLLGTPs~EaMr~ACEGAk~  291 (449)
T KOG0664|consen  213 NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAA-GPIEQLQMIIDLLGTPSQEAMKYACEGAKN  291 (449)
T ss_pred             hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhcc-ChHHHHHHHHHHhCCCcHHHHHHHhhhhHH
Confidence              23346889999999988 46899999999999999999888888543 3444443332111                 


Q ss_pred             -------CCCCCc--------hhccHHHHHHHHHhcccCccccCCHHHHhcCcccccc
Q 015500          213 -------ELPEVP--------AFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       213 -------~~~~~p--------~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                             ..|.++        ..-..+..+++.++|.+||++|.+.++.+.|+++.+.
T Consensus       292 H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~  349 (449)
T KOG0664|consen  292 HVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG  349 (449)
T ss_pred             HhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence                   111211        1123567899999999999999999999999999864

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-34  Score=279.14  Aligned_cols=241  Identities=24%  Similarity=0.357  Sum_probs=197.0

Q ss_pred             ccccccceeCCeeEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHhC--CCCCeeeeeeeeeecCCCceEEEEEEeec
Q 015500            4 TRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSL--NSPHIVGYKGCDVTSEDNKLMYNLFMEYA   81 (405)
Q Consensus         4 ~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~~~~l~~E~~iL~~L--~hpnIv~~~~~~~~~~~~~~~~~lv~Ey~   81 (405)
                      +..+.||+|-||.||+|.++  |+.||||++.........||.+|.+..  +|+||+.+++.+....+...-++||.+|.
T Consensus       214 ~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYH  291 (513)
T KOG2052|consen  214 VLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYH  291 (513)
T ss_pred             EEEEEecCccccceeecccc--CCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecc
Confidence            45789999999999999997  899999999988888899999988764  99999999999888887778889999999


Q ss_pred             CCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC--------CceeCCCCCCCEEEccCC-ceEeeecccccccc-
Q 015500           82 PGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN--------RVVHCDIKSRNILMAESG-AKIADFGCAKWESE-  151 (405)
Q Consensus        82 ~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~--------givHrDlkp~NILi~~~~-vkL~DFGla~~~~~-  151 (405)
                      +.|||.|++.++  .++.....+++..++.||+|||-.        .|+|||||..|||+..++ +-|+|+|+|-...+ 
T Consensus       292 e~GSL~DyL~r~--tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~  369 (513)
T KOG2052|consen  292 EHGSLYDYLNRN--TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSD  369 (513)
T ss_pred             cCCcHHHHHhhc--cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEeccc
Confidence            999999999985  799999999999999999999952        499999999999999998 99999999976433 


Q ss_pred             -------cccCCCCCCccChhhhcCCC----C-C-cchhHHHHHHHHHHHHhC----------CCCCCCC---CChHHHH
Q 015500          152 -------ALQSGGTPMFMAPEVARGEH----Q-G-FASDIWAVGCTVIEMASG----------GAPWPNA---ADPMTVL  205 (405)
Q Consensus       152 -------~~~~~gt~~Y~APE~l~~~~----~-~-~~sDIwSLG~il~elltG----------~~Pf~~~---~~~~~~l  205 (405)
                             ....+||..|||||++...-    + + ..+||||||.+++|++..          ++||.+.   +...+.+
T Consensus       370 t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeM  449 (513)
T KOG2052|consen  370 TDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEM  449 (513)
T ss_pred             CCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHH
Confidence                   33567999999999996532    2 2 269999999999999863          5787543   2233444


Q ss_pred             HHHHh-cCCCCCCchhcc-----HHHHHHHHHhcccCccccCCHHHHhc
Q 015500          206 YKIAY-SRELPEVPAFLS-----KQANDFLSNCLRRDPKERWAASQLLK  248 (405)
Q Consensus       206 ~~i~~-~~~~~~~p~~~s-----~~l~dll~~~L~~dP~~Rpt~~elL~  248 (405)
                      .++.. .+..|.+|....     ..+..+++.||..||.-|.||--+.+
T Consensus       450 rkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK  498 (513)
T KOG2052|consen  450 RKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK  498 (513)
T ss_pred             hcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence            44332 334455554332     34668899999999999999877644

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-36  Score=300.14  Aligned_cols=247  Identities=36%  Similarity=0.534  Sum_probs=211.3

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC---hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK---SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFM   78 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~---~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (405)
                      +|.....+|+|.||.||+|+++++++..|+|+++.+.   ..-+++|+-+++.-+||||+.|+|.+.-.+.    .++.|
T Consensus        16 dyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dk----lwicM   91 (829)
T KOG0576|consen   16 DYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDK----LWICM   91 (829)
T ss_pred             chhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcC----cEEEE
Confidence            5888999999999999999999999999999988753   4578899999999999999999998876655    56899


Q ss_pred             eecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc----cc
Q 015500           79 EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE----AL  153 (405)
Q Consensus        79 Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~----~~  153 (405)
                      |||.||+|.+.-.-. |+++|.++....+..++||+|||++|-+|||||..|||+++.+ +|++|||.+..+..    ..
T Consensus        92 EycgggslQdiy~~T-gplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~Krk  170 (829)
T KOG0576|consen   92 EYCGGGSLQDIYHVT-GPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRK  170 (829)
T ss_pred             EecCCCcccceeeec-ccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhhhh
Confidence            999999999866554 5999999999999999999999999999999999999999988 99999998765433    45


Q ss_pred             cCCCCCCccChhhhc---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCC-C--CCchhccHHHHH
Q 015500          154 QSGGTPMFMAPEVAR---GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSREL-P--EVPAFLSKQAND  227 (405)
Q Consensus       154 ~~~gt~~Y~APE~l~---~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~-~--~~p~~~s~~l~d  227 (405)
                      ...|||+|||||+..   ...|...+|||++|++..|+.--++|-... .+...++....+..- |  +-+...++-+.+
T Consensus       171 sfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdl-hpmr~l~LmTkS~~qpp~lkDk~kws~~fh~  249 (829)
T KOG0576|consen  171 SFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDL-HPMRALFLMTKSGFQPPTLKDKTKWSEFFHN  249 (829)
T ss_pred             cccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCccccc-chHHHHHHhhccCCCCCcccCCccchHHHHH
Confidence            677999999999863   466888999999999999999999886433 345555544444322 2  233457899999


Q ss_pred             HHHHhcccCccccCCHHHHhcCccccc
Q 015500          228 FLSNCLRRDPKERWAASQLLKHPFLEE  254 (405)
Q Consensus       228 ll~~~L~~dP~~Rpt~~elL~hp~~~~  254 (405)
                      |++.+|.++|++|||++.+|.|||+..
T Consensus       250 fvK~altknpKkRptaeklL~h~fvs~  276 (829)
T KOG0576|consen  250 FVKGALTKNPKKRPTAEKLLQHPFVSQ  276 (829)
T ss_pred             HHHHHhcCCCccCCChhhheeceeecc
Confidence            999999999999999999999999875

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-34  Score=285.97  Aligned_cols=243  Identities=22%  Similarity=0.368  Sum_probs=204.5

Q ss_pred             ccccccceeCCeeEEEEEEcCCCCEEEEEEccCC--ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEeec
Q 015500            4 TRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP--KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYA   81 (405)
Q Consensus         4 ~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~--~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~Ey~   81 (405)
                      +.-++||-|.||.||.|++++..-.||||-+..+  ..+.|..|..+|+.++|||+|+++|++.....    +|+|.|||
T Consensus       270 tMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpP----FYIiTEfM  345 (1157)
T KOG4278|consen  270 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP----FYIITEFM  345 (1157)
T ss_pred             eeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCC----eEEEEecc
Confidence            4457899999999999999999999999988655  35689999999999999999999999876655    77999999


Q ss_pred             CCCCHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccccc--cCCC
Q 015500           82 PGGTLNDEIHRNGG-RLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEAL--QSGG  157 (405)
Q Consensus        82 ~ggsL~~~i~~~~~-~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~~--~~~g  157 (405)
                      ..|+|.+|+++++. -++.-..++++.||..|++||..+++|||||-.+|.|+..+. +|++|||+++.+....  ...|
T Consensus       346 ~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHAG  425 (1157)
T KOG4278|consen  346 CYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHAG  425 (1157)
T ss_pred             cCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCceecccC
Confidence            99999999998643 356666778889999999999999999999999999999998 9999999999765422  2223


Q ss_pred             ---CCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHhc
Q 015500          158 ---TPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCL  233 (405)
Q Consensus       158 ---t~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~L  233 (405)
                         ..-|.|||-+..+.++.++|||+||++|||++| |-.||+..+  ....+...-.....+-|..+++.+..|+..||
T Consensus       426 AKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid--lSqVY~LLEkgyRM~~PeGCPpkVYeLMraCW  503 (1157)
T KOG4278|consen  426 AKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID--LSQVYGLLEKGYRMDGPEGCPPKVYELMRACW  503 (1157)
T ss_pred             ccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc--HHHHHHHHhccccccCCCCCCHHHHHHHHHHh
Confidence               345999999999999999999999999999998 778997553  33444444344445678889999999999999


Q ss_pred             ccCccccCCHHHHhcCccccc
Q 015500          234 RRDPKERWAASQLLKHPFLEE  254 (405)
Q Consensus       234 ~~dP~~Rpt~~elL~hp~~~~  254 (405)
                      +++|..||+++++  |--|+.
T Consensus       504 ~WsPsDRPsFaei--HqafEt  522 (1157)
T KOG4278|consen  504 NWSPSDRPSFAEI--HQAFET  522 (1157)
T ss_pred             cCCcccCccHHHH--HHHHHH
Confidence            9999999999988  443443

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-35  Score=298.01  Aligned_cols=240  Identities=24%  Similarity=0.388  Sum_probs=204.8

Q ss_pred             ccccccceeCCeeEEEEEEcCCC---CEEEEEEccCC----ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEE
Q 015500            4 TRGHTIGQGSSATVSLATSLRSG---DVFAAKSTELP----KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         4 ~~~~~LG~G~~g~Vyla~~~~~~---~~vavK~~~~~----~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      .|.++||.|.||.||.|+.+..|   ..||||-++..    ++..|..|..||-+++||||+++.|+......    .-+
T Consensus       632 ~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~P----vMI  707 (996)
T KOG0196|consen  632 KIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKP----VMI  707 (996)
T ss_pred             EEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCce----eEE
Confidence            57889999999999999998877   46899988754    34568889999999999999999997543322    338


Q ss_pred             EEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccccc--
Q 015500           77 FMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEAL--  153 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~~--  153 (405)
                      |.|||++|+|..+|+++.|.++.-+...+++.|+.|++||-++|+|||||-.+|||++.+- +|++|||+++...+..  
T Consensus       708 iTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~  787 (996)
T KOG0196|consen  708 ITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA  787 (996)
T ss_pred             EhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCCCc
Confidence            9999999999999999999999999999999999999999999999999999999999997 8999999999764422  


Q ss_pred             ---cCCC--CCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHH
Q 015500          154 ---QSGG--TPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQAND  227 (405)
Q Consensus       154 ---~~~g--t~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~d  227 (405)
                         +..|  ...|.|||.+.-.+++.++||||+|++|+|.+. |..||-++.+ .+++..+...-.+|. |..+|..+.+
T Consensus       788 ~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN-QdVIkaIe~gyRLPp-PmDCP~aL~q  865 (996)
T KOG0196|consen  788 AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-QDVIKAIEQGYRLPP-PMDCPAALYQ  865 (996)
T ss_pred             cccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch-HHHHHHHHhccCCCC-CCCCcHHHHH
Confidence               1122  345999999999999999999999999999665 9999877754 455666665555543 5679999999


Q ss_pred             HHHHhcccCccccCCHHHHhcC
Q 015500          228 FLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       228 ll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      |+..||++|-.+||+++||+.+
T Consensus       866 LMldCWqkdR~~RP~F~qiV~~  887 (996)
T KOG0196|consen  866 LMLDCWQKDRNRRPKFAQIVST  887 (996)
T ss_pred             HHHHHHHHHhhcCCCHHHHHHH
Confidence            9999999999999999999876

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-34  Score=277.15  Aligned_cols=237  Identities=24%  Similarity=0.349  Sum_probs=190.7

Q ss_pred             cccccceeCCeeEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHh--CCCCCeeeeeeeeeecCCCceEEEEEEeecC
Q 015500            5 RGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSS--LNSPHIVGYKGCDVTSEDNKLMYNLFMEYAP   82 (405)
Q Consensus         5 ~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~~~~l~~E~~iL~~--L~hpnIv~~~~~~~~~~~~~~~~~lv~Ey~~   82 (405)
                      ....||+|.||.||+|...  ++.||||+++....+.+++|.+|.+.  ++|+||+++++..........-|+||+||.+
T Consensus       214 l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~  291 (534)
T KOG3653|consen  214 LLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHP  291 (534)
T ss_pred             hHHHhhcCccceeehhhcc--CceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeecc
Confidence            4578999999999999864  79999999999999999999998775  4899999999875544433556889999999


Q ss_pred             CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh---------CCceeCCCCCCCEEEccCC-ceEeeecccccccc-
Q 015500           83 GGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHS---------NRVVHCDIKSRNILMAESG-AKIADFGCAKWESE-  151 (405)
Q Consensus        83 ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~---------~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~-  151 (405)
                      .|+|.++++.+  .+++....+++..+++||+|||+         ..|+|||||.+||||..|. +-|+|||+|..... 
T Consensus       292 kGsL~dyL~~n--tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~  369 (534)
T KOG3653|consen  292 KGSLCDYLKAN--TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPG  369 (534)
T ss_pred             CCcHHHHHHhc--cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCC
Confidence            99999999987  69999999999999999999996         3699999999999999998 99999999986543 


Q ss_pred             -----cccCCCCCCccChhhhcCCC-CC-----cchhHHHHHHHHHHHHhCCC------------CCC----CCCChHHH
Q 015500          152 -----ALQSGGTPMFMAPEVARGEH-QG-----FASDIWAVGCTVIEMASGGA------------PWP----NAADPMTV  204 (405)
Q Consensus       152 -----~~~~~gt~~Y~APE~l~~~~-~~-----~~sDIwSLG~il~elltG~~------------Pf~----~~~~~~~~  204 (405)
                           ....+||..|||||++.+.- ..     .+.||||+|.+++||++...            ||.    +.....+.
T Consensus       370 ~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~m  449 (534)
T KOG3653|consen  370 KPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEM  449 (534)
T ss_pred             CCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHH
Confidence                 33456999999999998742 22     26899999999999998533            332    11112222


Q ss_pred             HHHHHhcCCCCCCchhc-----cHHHHHHHHHhcccCccccCCHHH
Q 015500          205 LYKIAYSRELPEVPAFL-----SKQANDFLSNCLRRDPKERWAASQ  245 (405)
Q Consensus       205 l~~i~~~~~~~~~p~~~-----s~~l~dll~~~L~~dP~~Rpt~~e  245 (405)
                      .......+..|.+|...     ..-+.+.+..||+.||+-|.|+.=
T Consensus       450 q~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~C  495 (534)
T KOG3653|consen  450 QELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGC  495 (534)
T ss_pred             HHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHH
Confidence            23334445667777543     356789999999999999999753

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-33  Score=292.20  Aligned_cols=240  Identities=28%  Similarity=0.407  Sum_probs=199.2

Q ss_pred             ccccccceeCCeeEEEEEEcC-------CCCEEEEEEccCC----ChHHHHHHHHHHHhC-CCCCeeeeeeeeeecCCCc
Q 015500            4 TRGHTIGQGSSATVSLATSLR-------SGDVFAAKSTELP----KSEFLQREQKFLSSL-NSPHIVGYKGCDVTSEDNK   71 (405)
Q Consensus         4 ~~~~~LG~G~~g~Vyla~~~~-------~~~~vavK~~~~~----~~~~l~~E~~iL~~L-~hpnIv~~~~~~~~~~~~~   71 (405)
                      .+.+.||+|+||+|++|....       ....||||.....    ..+.+..|+++|+.+ +||||+.+.|++....   
T Consensus       299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~---  375 (609)
T KOG0200|consen  299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDG---  375 (609)
T ss_pred             cccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCC---
Confidence            356799999999999997441       1456899987643    346889999999999 6999999999876622   


Q ss_pred             eEEEEEEeecCCCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccC
Q 015500           72 LMYNLFMEYAPGGTLNDEIHRNG---------------GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES  136 (405)
Q Consensus        72 ~~~~lv~Ey~~ggsL~~~i~~~~---------------~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~  136 (405)
                       .+++|+||+..|+|.++++.+.               ..++......+++||+.|++||++.+++||||-++|||+..+
T Consensus       376 -~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~  454 (609)
T KOG0200|consen  376 -PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKN  454 (609)
T ss_pred             -ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCC
Confidence             2558999999999999998875               248899999999999999999999999999999999999999


Q ss_pred             C-ceEeeecccccccc--cc---cCCCCCC--ccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHH
Q 015500          137 G-AKIADFGCAKWESE--AL---QSGGTPM--FMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYK  207 (405)
Q Consensus       137 ~-vkL~DFGla~~~~~--~~---~~~gt~~--Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~  207 (405)
                      . +||+|||+|+....  ..   ...|+..  |||||.+....++.++||||+|+++||+++ |..||++....... ..
T Consensus       455 ~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l-~~  533 (609)
T KOG0200|consen  455 KVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEEL-LE  533 (609)
T ss_pred             CEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHH-HH
Confidence            7 99999999985332  11   1223223  999999999999999999999999999999 78999875434444 44


Q ss_pred             HHhcCCCCCCchhccHHHHHHHHHhcccCccccCCHHHHhc
Q 015500          208 IAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLK  248 (405)
Q Consensus       208 i~~~~~~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~  248 (405)
                      ....+...+.|..+++++.++++.||..+|++||+..++.+
T Consensus       534 ~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~  574 (609)
T KOG0200|consen  534 FLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE  574 (609)
T ss_pred             HHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence            44555666788999999999999999999999999999854

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-33  Score=249.12  Aligned_cols=208  Identities=27%  Similarity=0.465  Sum_probs=170.4

Q ss_pred             cccccceeCCeeEEEEEEcCCCCEEEEEEccCC----ChHHHHHHHHHHHh-CCCCCeeeeeeeeeecCCCceEEEEEEe
Q 015500            5 RGHTIGQGSSATVSLATSLRSGDVFAAKSTELP----KSEFLQREQKFLSS-LNSPHIVGYKGCDVTSEDNKLMYNLFME   79 (405)
Q Consensus         5 ~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~----~~~~l~~E~~iL~~-L~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (405)
                      -+..||+|+||.|-+.++..+|...|+|.+...    ...++.+|+.+..+ ..+|.+|.++|......+    .+++||
T Consensus        50 ~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd----vwIcME  125 (282)
T KOG0984|consen   50 GIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD----VWICME  125 (282)
T ss_pred             hhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc----EEEeHH
Confidence            356799999999999999999999999987643    22456677776544 478999999997654444    568999


Q ss_pred             ecCCCCHHHHHH---HcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCCCCEEEccCC-ceEeeecccccccc--c
Q 015500           80 YAPGGTLNDEIH---RNGGRLDESLIVSYTRQILQGLEYLHSN-RVVHCDIKSRNILMAESG-AKIADFGCAKWESE--A  152 (405)
Q Consensus        80 y~~ggsL~~~i~---~~~~~l~e~~~~~i~~qIl~~L~yLH~~-givHrDlkp~NILi~~~~-vkL~DFGla~~~~~--~  152 (405)
                      .|. .||..+-+   .+++.++|..+-+|+..++.||.|||++ .++|||+||.||||+.+| +|+||||++-...+  +
T Consensus       126 ~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiA  204 (282)
T KOG0984|consen  126 LMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIA  204 (282)
T ss_pred             Hhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhhhH
Confidence            995 47765543   3678999999999999999999999987 899999999999999998 99999999875433  2


Q ss_pred             c-cCCCCCCccChhhhcC----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCc
Q 015500          153 L-QSGGTPMFMAPEVARG----EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVP  218 (405)
Q Consensus       153 ~-~~~gt~~Y~APE~l~~----~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p  218 (405)
                      . ...|-..|||||.+..    ..|+.++||||||++++||++++.||++...+.+++.++... ..|.+|
T Consensus       205 kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee-p~P~Lp  274 (282)
T KOG0984|consen  205 KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE-PSPQLP  274 (282)
T ss_pred             HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC-CCCCCc
Confidence            2 2568899999999864    357889999999999999999999999999999888776543 344554

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=100.00  E-value=7.4e-32  Score=242.31  Aligned_cols=204  Identities=40%  Similarity=0.621  Sum_probs=182.1

Q ss_pred             cceeCCeeEEEEEEcCCCCEEEEEEccCCCh----HHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEeecCCC
Q 015500            9 IGQGSSATVSLATSLRSGDVFAAKSTELPKS----EFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGG   84 (405)
Q Consensus         9 LG~G~~g~Vyla~~~~~~~~vavK~~~~~~~----~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~Ey~~gg   84 (405)
                      ||+|++|.||++.+..+++.+++|.......    +.+.+|++.++.++|++|+++++.+....    ..++++||++|+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~----~~~~~~e~~~~~   76 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDEN----HLYLVMEYCEGG   76 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCC----eEEEEEecCCCC
Confidence            7899999999999988899999999887654    68999999999999999999998776542    366999999999


Q ss_pred             CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcc-CC-ceEeeeccccccccc----ccCCCC
Q 015500           85 TLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAE-SG-AKIADFGCAKWESEA----LQSGGT  158 (405)
Q Consensus        85 sL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~-~~-vkL~DFGla~~~~~~----~~~~gt  158 (405)
                      +|.+++......++...+..++.+++.+|.+||+.|++|+||+|.||+++. ++ ++|+|||.+......    ....+.
T Consensus        77 ~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~  156 (215)
T cd00180          77 SLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGT  156 (215)
T ss_pred             cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCC
Confidence            999999876447899999999999999999999999999999999999998 55 999999998765442    335588


Q ss_pred             CCccChhhhcCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHhcccCc
Q 015500          159 PMFMAPEVARGE-HQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDP  237 (405)
Q Consensus       159 ~~Y~APE~l~~~-~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~L~~dP  237 (405)
                      ..|++||.+... .++.++|+|+||+++++|                                  ..+.+++.+|++.||
T Consensus       157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------~~~~~~l~~~l~~~p  202 (215)
T cd00180         157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------PELKDLIRKMLQKDP  202 (215)
T ss_pred             CCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------HHHHHHHHHHhhCCc
Confidence            899999999887 788999999999999999                                  688999999999999


Q ss_pred             cccCCHHHHhcCc
Q 015500          238 KERWAASQLLKHP  250 (405)
Q Consensus       238 ~~Rpt~~elL~hp  250 (405)
                      ++||++.++++|+
T Consensus       203 ~~R~~~~~l~~~~  215 (215)
T cd00180         203 EKRPSAKEILEHL  215 (215)
T ss_pred             ccCcCHHHHhhCC
Confidence            9999999999885

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-34  Score=282.42  Aligned_cols=191  Identities=29%  Similarity=0.393  Sum_probs=169.7

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCCh-----------HHHHHHHHHHHhCC---CCCeeeeeeeeeec
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS-----------EFLQREQKFLSSLN---SPHIVGYKGCDVTS   67 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~~-----------~~l~~E~~iL~~L~---hpnIv~~~~~~~~~   67 (405)
                      +|+..+.+|.|+||.|++|.++.++..|+||.+.+++.           ..+--|++||..|+   |+||++++.+|...
T Consensus       562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd  641 (772)
T KOG1152|consen  562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD  641 (772)
T ss_pred             cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC
Confidence            68999999999999999999999999999999877642           24556999999997   99999999987654


Q ss_pred             CCCceEEEEEEeec-CCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecc
Q 015500           68 EDNKLMYNLFMEYA-PGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGC  145 (405)
Q Consensus        68 ~~~~~~~~lv~Ey~-~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGl  145 (405)
                      +    +|||+||-. +|.+|.++|..+. +++|..++.|++||+.|+++||++||||||||-+||.++.+| +||+|||.
T Consensus       642 d----~yyl~te~hg~gIDLFd~IE~kp-~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgs  716 (772)
T KOG1152|consen  642 D----YYYLETEVHGEGIDLFDFIEFKP-RMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGS  716 (772)
T ss_pred             C----eeEEEecCCCCCcchhhhhhccC-ccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccc
Confidence            4    488999965 6779999999875 899999999999999999999999999999999999999999 99999999


Q ss_pred             cccccc--cccCCCCCCccChhhhcCCCC-CcchhHHHHHHHHHHHHhCCCCCCC
Q 015500          146 AKWESE--ALQSGGTPMFMAPEVARGEHQ-GFASDIWAVGCTVIEMASGGAPWPN  197 (405)
Q Consensus       146 a~~~~~--~~~~~gt~~Y~APE~l~~~~~-~~~sDIwSLG~il~elltG~~Pf~~  197 (405)
                      |.....  .-..+||..|.|||++.|+.| +..-|||+||+++|.++....||.+
T Consensus       717 aa~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  717 AAYTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             hhhhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            876544  346779999999999999775 7789999999999999999999853

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-33  Score=283.26  Aligned_cols=239  Identities=24%  Similarity=0.339  Sum_probs=199.1

Q ss_pred             cccccccceeCCeeEEEEEEcCCCC----EEEEEEccCC----ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEE
Q 015500            3 WTRGHTIGQGSSATVSLATSLRSGD----VFAAKSTELP----KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMY   74 (405)
Q Consensus         3 y~~~~~LG~G~~g~Vyla~~~~~~~----~vavK~~~~~----~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~   74 (405)
                      .+.+++||+|+||+||+|.+-..|+    +||+|++...    ....+.+|+-+|.+|+|||+++++++.....     .
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-----~  772 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-----L  772 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-----H
Confidence            4568899999999999999876665    5788876543    3467889999999999999999999876654     3


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccccc
Q 015500           75 NLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEAL  153 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~~  153 (405)
                      .||++|+++|+|.|+++.+.+++--...+.|..||++||.|||.+.+|||||-.+|||+..-. +||+|||+|+......
T Consensus       773 qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~  852 (1177)
T KOG1025|consen  773 QLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE  852 (1177)
T ss_pred             HHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence            489999999999999999888999999999999999999999999999999999999998776 9999999998644321


Q ss_pred             ----cC--CCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHH
Q 015500          154 ----QS--GGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQAN  226 (405)
Q Consensus       154 ----~~--~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~  226 (405)
                          ..  .-.+-|||-|.++...|+.++||||+||++||++| |..|+....  ...+.......+.-..|+.++-++.
T Consensus       853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~--~~eI~dlle~geRLsqPpiCtiDVy  930 (1177)
T KOG1025|consen  853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIP--AEEIPDLLEKGERLSQPPICTIDVY  930 (1177)
T ss_pred             ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCC--HHHhhHHHhccccCCCCCCccHHHH
Confidence                11  12455999999999999999999999999999998 889986543  3333333333333456777999999


Q ss_pred             HHHHHhcccCccccCCHHHHhc
Q 015500          227 DFLSNCLRRDPKERWAASQLLK  248 (405)
Q Consensus       227 dll~~~L~~dP~~Rpt~~elL~  248 (405)
                      .++.+||-.|+..||++.++..
T Consensus       931 ~~mvkCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  931 MVMVKCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             HHHHHHhccCcccCccHHHHHH
Confidence            9999999999999999998855

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=100.00  E-value=5.8e-33  Score=268.33  Aligned_cols=246  Identities=30%  Similarity=0.457  Sum_probs=197.1

Q ss_pred             CcccccccceeCCeeEEEEEEcC---CCCEEEEEEccC-CChHHHHHHHHHHHhC-CCCCeeeeeeeeeecCCCceEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLR---SGDVFAAKSTEL-PKSEFLQREQKFLSSL-NSPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~---~~~~vavK~~~~-~~~~~l~~E~~iL~~L-~hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      .|..+++||.|.|++||+|.+..   .++.||+|.+.. +....+.+|+++|..+ .+.||+++.+++...+.    ..+
T Consensus        37 ~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~----v~i  112 (418)
T KOG1167|consen   37 AYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ----VAI  112 (418)
T ss_pred             hhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhccCCe----eEE
Confidence            47889999999999999999887   789999998875 4567899999999999 68999999988765554    568


Q ss_pred             EEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC--ceEeeecccccccc---
Q 015500           77 FMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG--AKIADFGCAKWESE---  151 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~--vkL~DFGla~~~~~---  151 (405)
                      ||||++..+..++..    .++-..++.|++.++.||.++|.+|||||||||.|+|.+...  -.|+|||+|.....   
T Consensus       113 vlp~~~H~~f~~l~~----~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~  188 (418)
T KOG1167|consen  113 VLPYFEHDRFRDLYR----SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQ  188 (418)
T ss_pred             EecccCccCHHHHHh----cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhhh
Confidence            999999988888775    367889999999999999999999999999999999998764  78999999861000   


Q ss_pred             ---------------------------------------------cccCCCCCCccChhhhcC-CCCCcchhHHHHHHHH
Q 015500          152 ---------------------------------------------ALQSGGTPMFMAPEVARG-EHQGFASDIWAVGCTV  185 (405)
Q Consensus       152 ---------------------------------------------~~~~~gt~~Y~APE~l~~-~~~~~~sDIwSLG~il  185 (405)
                                                                   ..+..|||+|+|||++.. ..+++++||||.|+++
T Consensus       189 ~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~  268 (418)
T KOG1167|consen  189 TEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVIL  268 (418)
T ss_pred             hhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecccee
Confidence                                                         001138999999999865 6789999999999999


Q ss_pred             HHHHhCCCCCCCCCChHHHHHHHHh--------------------c-CCCCCCc--------------------------
Q 015500          186 IEMASGGAPWPNAADPMTVLYKIAY--------------------S-RELPEVP--------------------------  218 (405)
Q Consensus       186 ~elltG~~Pf~~~~~~~~~l~~i~~--------------------~-~~~~~~p--------------------------  218 (405)
                      .-+++++.||....+....+..+..                    . ...+.++                          
T Consensus       269 Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~  348 (418)
T KOG1167|consen  269 LSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREI  348 (418)
T ss_pred             ehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeecc
Confidence            9999999999655443222221110                    0 0001000                          


Q ss_pred             --hhccHHHHHHHHHhcccCccccCCHHHHhcCcccccc
Q 015500          219 --AFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       219 --~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                        ...+..+.||+.+||..||.+|.|++++|+||||...
T Consensus       349 ~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~  387 (418)
T KOG1167|consen  349 GSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEA  387 (418)
T ss_pred             ccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcch
Confidence              1134578999999999999999999999999999854

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2e-32  Score=251.36  Aligned_cols=250  Identities=25%  Similarity=0.407  Sum_probs=197.3

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC--hHHHHHHHHHHHhC-CCCCeeeeeeeeeecCCCceEEEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK--SEFLQREQKFLSSL-NSPHIVGYKGCDVTSEDNKLMYNLFM   78 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~--~~~l~~E~~iL~~L-~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (405)
                      .|++.+.||.|.||.+-+|.|+.++..+++|.+..+.  ...+.+|..---.| .|.||+.-|.+.....+   +|.+++
T Consensus        25 ~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d---~YvF~q  101 (378)
T KOG1345|consen   25 VYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSD---AYVFVQ  101 (378)
T ss_pred             hhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCc---eEEEee
Confidence            4899999999999999999999999999999998764  45788888765556 58999977654322222   577899


Q ss_pred             eecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC---ceEeeecccccccccccC
Q 015500           79 EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG---AKIADFGCAKWESEALQS  155 (405)
Q Consensus        79 Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~---vkL~DFGla~~~~~~~~~  155 (405)
                      ||++-|+|..-+...|  +-|...+.++.|+++|+.|+|++++||||||.+||||-...   +||||||..+..+.....
T Consensus       102 E~aP~gdL~snv~~~G--igE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~~  179 (378)
T KOG1345|consen  102 EFAPRGDLRSNVEAAG--IGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVKY  179 (378)
T ss_pred             ccCccchhhhhcCccc--ccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCceehh
Confidence            9999999999887764  88999999999999999999999999999999999995443   999999998866553322


Q ss_pred             -CCCCCccChhhhcCC-----CCCcchhHHHHHHHHHHHHhCCCCCCCCC--ChHHHHHHHHhcCCCCCCc---hhccHH
Q 015500          156 -GGTPMFMAPEVARGE-----HQGFASDIWAVGCTVIEMASGGAPWPNAA--DPMTVLYKIAYSRELPEVP---AFLSKQ  224 (405)
Q Consensus       156 -~gt~~Y~APE~l~~~-----~~~~~sDIwSLG~il~elltG~~Pf~~~~--~~~~~l~~i~~~~~~~~~p---~~~s~~  224 (405)
                       ..+-.|.|||+....     ...+.+|+|.||+++|.++||++||....  ++.-.-+.....+..+..|   ..+++.
T Consensus       180 ~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~fs~~  259 (378)
T KOG1345|consen  180 LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPFSEK  259 (378)
T ss_pred             hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhcccCHH
Confidence             246669999987532     24678999999999999999999997432  1111122222233333444   458999


Q ss_pred             HHHHHHHhcccCcccc---CCHHHHhcCccccccc
Q 015500          225 ANDFLSNCLRRDPKER---WAASQLLKHPFLEEFC  256 (405)
Q Consensus       225 l~dll~~~L~~dP~~R---pt~~elL~hp~~~~~~  256 (405)
                      +..+.++-|..+|++|   +++..-....|.+...
T Consensus       260 a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~~i  294 (378)
T KOG1345|consen  260 ALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEKLI  294 (378)
T ss_pred             HHHHHHHhcCCcccccchhHHHHHHHHHHHHHhhh
Confidence            9999999999999999   7888887888877643

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=1.2e-30  Score=239.07  Aligned_cols=204  Identities=36%  Similarity=0.578  Sum_probs=173.4

Q ss_pred             cccccccceeCCeeEEEEEEcCCCCEEEEEEccCC----ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEE
Q 015500            3 WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP----KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFM   78 (405)
Q Consensus         3 y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~----~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (405)
                      |+.++.||.|++|+||+|.+..+++.+++|.+...    ..+.+.+|++.+++++|+|++++++.+....    .+++++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~----~~~~v~   76 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPE----PLYLVM   76 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCC----ceEEEE
Confidence            67889999999999999999988999999998765    4568889999999999999999998765443    366899


Q ss_pred             eecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc-----
Q 015500           79 EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA-----  152 (405)
Q Consensus        79 Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~-----  152 (405)
                      ||+++++|.+++......+++..+..++.|++.++.+||+.+++|+||+|.||+++.++ ++|+|||.+......     
T Consensus        77 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~  156 (225)
T smart00221       77 EYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALL  156 (225)
T ss_pred             eccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccc
Confidence            99999999999987643389999999999999999999999999999999999999877 999999998765443     


Q ss_pred             ccCCCCCCccChhhh-cCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChH-HHHHHHHh
Q 015500          153 LQSGGTPMFMAPEVA-RGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPM-TVLYKIAY  210 (405)
Q Consensus       153 ~~~~gt~~Y~APE~l-~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~-~~l~~i~~  210 (405)
                      ....++..|++||.+ ....++.++|+|+||+++++|++|+.||....+.. .....+.+
T Consensus       157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~  216 (225)
T smart00221      157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSF  216 (225)
T ss_pred             cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhc
Confidence            345688899999999 66677889999999999999999999996623333 44444443

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.97  E-value=4.7e-32  Score=295.60  Aligned_cols=177  Identities=19%  Similarity=0.247  Sum_probs=138.4

Q ss_pred             EEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcc------------------
Q 015500           74 YNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAE------------------  135 (405)
Q Consensus        74 ~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~------------------  135 (405)
                      +.+++||+ +++|.+++......+++..++.+++||+.||+|||++||+||||||+||||+.                  
T Consensus        55 ~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~  133 (793)
T PLN00181         55 IVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSD  133 (793)
T ss_pred             hhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhEEEcccCcEEEeeccccCccccc
Confidence            44788888 66999999765567999999999999999999999999999999999999953                  


Q ss_pred             -CC-ceEeeecccccccc--------------------cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCC
Q 015500          136 -SG-AKIADFGCAKWESE--------------------ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGA  193 (405)
Q Consensus       136 -~~-vkL~DFGla~~~~~--------------------~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~  193 (405)
                       ++ +|++|||+++....                    .....||++|||||++.+..++.++|||||||++|||++|.+
T Consensus       134 ~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~  213 (793)
T PLN00181        134 EDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVS  213 (793)
T ss_pred             ccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCC
Confidence             23 78888888764211                    011358999999999999999999999999999999999998


Q ss_pred             CCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHhcccCccccCCHHHHhcCcccccc
Q 015500          194 PWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       194 Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      |+......   +..+.. ...|..+....+...+++.+||+++|.+|||+.|+|+||||...
T Consensus       214 ~~~~~~~~---~~~~~~-~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~  271 (793)
T PLN00181        214 SREEKSRT---MSSLRH-RVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEP  271 (793)
T ss_pred             chhhHHHH---HHHHHH-hhcChhhhhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhh
Confidence            87532221   111111 11222111224567789999999999999999999999999763

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.97  E-value=5.6e-31  Score=234.62  Aligned_cols=162  Identities=30%  Similarity=0.367  Sum_probs=131.6

Q ss_pred             CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccccccCCCCCCcc
Q 015500           84 GTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSGGTPMFM  162 (405)
Q Consensus        84 gsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~~~~~gt~~Y~  162 (405)
                      |+|.+++..+++++++..++.++.||+.||.|||+++      ||+|||++.++ +|+  ||+++..... ...||+.||
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~-~~~g~~~y~   71 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE-QSRVDPYFM   71 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc-cCCCccccc
Confidence            6899999887668999999999999999999999999      99999999888 787  9998765443 236899999


Q ss_pred             ChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcC--CCC---CCchhccH--HHHHHHHHhccc
Q 015500          163 APEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSR--ELP---EVPAFLSK--QANDFLSNCLRR  235 (405)
Q Consensus       163 APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~--~~~---~~p~~~s~--~l~dll~~~L~~  235 (405)
                      |||++.+..+++++|||||||++|||+||+.||.........+..+....  ..+   ..+..+++  .+++|+.+||..
T Consensus        72 aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~  151 (176)
T smart00750       72 APEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRVCASR  151 (176)
T ss_pred             ChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHHHHhc
Confidence            99999999999999999999999999999999965433222222222111  111   12233444  699999999999


Q ss_pred             CccccCCHHHHhcCccccc
Q 015500          236 DPKERWAASQLLKHPFLEE  254 (405)
Q Consensus       236 dP~~Rpt~~elL~hp~~~~  254 (405)
                      ||.+|||+.++++|+|+..
T Consensus       152 ~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      152 LPQRREAANHYLAHCRALF  170 (176)
T ss_pred             ccccccCHHHHHHHHHHHH
Confidence            9999999999999998763

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=1.6e-26  Score=226.82  Aligned_cols=244  Identities=22%  Similarity=0.252  Sum_probs=191.0

Q ss_pred             CcccccccceeCCeeEEEEEEcCCC-CEEEEEEccCCC---hHHHHHHHHHHHhCCC----CCeeeeeeeeeecCCCceE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSG-DVFAAKSTELPK---SEFLQREQKFLSSLNS----PHIVGYKGCDVTSEDNKLM   73 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~-~~vavK~~~~~~---~~~l~~E~~iL~~L~h----pnIv~~~~~~~~~~~~~~~   73 (405)
                      .|++++.||+|+||.||+|.+..++ +.+|+|......   ...+..|..+|..+..    +|+..++....   ....+
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~---~~~~~   95 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR---STEDF   95 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc---CCCce
Confidence            5899999999999999999988775 678888766532   2279999999999973    68888877654   22234


Q ss_pred             EEEEEeecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccC------CceEeeeccc
Q 015500           74 YNLFMEYAPGGTLNDEIHRNG-GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES------GAKIADFGCA  146 (405)
Q Consensus        74 ~~lv~Ey~~ggsL~~~i~~~~-~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~------~vkL~DFGla  146 (405)
                      .++||+.+ |.+|.++..... +.++..++..++.|++.+|+++|+.|++||||||.|++++..      .++|.|||++
T Consensus        96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla  174 (322)
T KOG1164|consen   96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA  174 (322)
T ss_pred             eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence            66899988 889999887665 789999999999999999999999999999999999999753      2899999999


Q ss_pred             cccc-----------c---cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCh--HHHHHHHHh
Q 015500          147 KWES-----------E---ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADP--MTVLYKIAY  210 (405)
Q Consensus       147 ~~~~-----------~---~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~--~~~l~~i~~  210 (405)
                      +...           .   .....||..|.++.+..+..++.+.|+||++.++.+|+.|.+||......  ...+.+...
T Consensus       175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~  254 (322)
T KOG1164|consen  175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR  254 (322)
T ss_pred             ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh
Confidence            8211           1   11234999999999999999999999999999999999999999765543  222222222


Q ss_pred             cCCCCCCchhccHHHHHHHHHhcccCccccCCHHHHhcC
Q 015500          211 SRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       211 ~~~~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      ...........+..+.++...+-..+...+|....+...
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~  293 (322)
T KOG1164|consen  255 KLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL  293 (322)
T ss_pred             hhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence            222221233356778888888777888999988877654

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.94  E-value=1.5e-25  Score=212.32  Aligned_cols=245  Identities=37%  Similarity=0.524  Sum_probs=195.8

Q ss_pred             cccccccceeCCeeEEEEEEcCCCCEEEEEEccCC------ChHHHHHHHHHHHhCCCC-CeeeeeeeeeecCCCceEEE
Q 015500            3 WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSLNSP-HIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         3 y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~------~~~~l~~E~~iL~~L~hp-nIv~~~~~~~~~~~~~~~~~   75 (405)
                      |...+.||.|+||.||++.+.   ..+++|.+...      ....+.+|+.+++.+.|+ +|+++...+.....    .+
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~----~~   74 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGS----LY   74 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCE----EE
Confidence            677899999999999999987   78888887643      245688999999999988 79999988733222    56


Q ss_pred             EEEeecCCCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC--ceEeeecccccccc
Q 015500           76 LFMEYAPGGTLNDEIHRNG--GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG--AKIADFGCAKWESE  151 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~~--~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~--vkL~DFGla~~~~~  151 (405)
                      ++++|+.++++.+++....  ..+++..+..++.|++.++.|+|+.|++|||+||+||+++..+  ++++|||.++....
T Consensus        75 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~  154 (384)
T COG0515          75 LVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPD  154 (384)
T ss_pred             EEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCC
Confidence            8999999999997776653  2699999999999999999999999999999999999999876  89999999874332


Q ss_pred             ----------cccCCCCCCccChhhhcC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCC--hHHHHHHHHhcCCCC-
Q 015500          152 ----------ALQSGGTPMFMAPEVARG---EHQGFASDIWAVGCTVIEMASGGAPWPNAAD--PMTVLYKIAYSRELP-  215 (405)
Q Consensus       152 ----------~~~~~gt~~Y~APE~l~~---~~~~~~sDIwSLG~il~elltG~~Pf~~~~~--~~~~l~~i~~~~~~~-  215 (405)
                                .....||+.|+|||.+.+   ..+....|+||+|++++++++|..||.....  ..............+ 
T Consensus       155 ~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~  234 (384)
T COG0515         155 PGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS  234 (384)
T ss_pred             CCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcc
Confidence                      245569999999999988   5788899999999999999999999865543  122222222222222 


Q ss_pred             ---CCchhc----cHHHHHHHHHhcccCccccCCHHHHhcCccccc
Q 015500          216 ---EVPAFL----SKQANDFLSNCLRRDPKERWAASQLLKHPFLEE  254 (405)
Q Consensus       216 ---~~p~~~----s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~  254 (405)
                         ......    ...+.+++.+++..+|..|.+..+...+++...
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~  280 (384)
T COG0515         235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH  280 (384)
T ss_pred             cccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhC
Confidence               111111    257899999999999999999999999866654

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.94  E-value=7e-28  Score=252.68  Aligned_cols=249  Identities=27%  Similarity=0.413  Sum_probs=192.8

Q ss_pred             ccccccceeCCeeEEEEEEcCCCCEEEEEEccC----CCh-----HHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEE
Q 015500            4 TRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL----PKS-----EFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMY   74 (405)
Q Consensus         4 ~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~----~~~-----~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~   74 (405)
                      ..+..+|.|++|.|+.+......+.++.|....    ...     ..+..|.-+-..|.|||++...........   ++
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~---~~  397 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG---IL  397 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc---ch
Confidence            356789999999999998887777777775431    111     124556667778899999766544332222   22


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc--
Q 015500           75 NLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE--  151 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~--  151 (405)
                       -.||||++ +|..++... +.+....+..+++|++.|++|+|++||.|||+||+|+++..++ +||+|||.+.....  
T Consensus       398 -~~mE~~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~  474 (601)
T KOG0590|consen  398 -QSMEYCPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW  474 (601)
T ss_pred             -hhhhcccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence             34999999 999999876 4799999999999999999999999999999999999999998 99999998865332  


Q ss_pred             ------cccCCCCCCccChhhhcCCCCCc-chhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcC------CCCCCc
Q 015500          152 ------ALQSGGTPMFMAPEVARGEHQGF-ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSR------ELPEVP  218 (405)
Q Consensus       152 ------~~~~~gt~~Y~APE~l~~~~~~~-~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~------~~~~~p  218 (405)
                            ....+|+..|+|||++.+..|.+ ..||||.|++++.|++|+.||.................      ....+.
T Consensus       475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~  554 (601)
T KOG0590|consen  475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLL  554 (601)
T ss_pred             chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHH
Confidence                  23456999999999999999877 69999999999999999999965433322211111111      111223


Q ss_pred             hhccHHHHHHHHHhcccCccccCCHHHHhcCccccccccc
Q 015500          219 AFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSC  258 (405)
Q Consensus       219 ~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~~~  258 (405)
                      ..++...+.+|.+||+.||.+|.|+++|++.+||+.+..+
T Consensus       555 ~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~c  594 (601)
T KOG0590|consen  555 SLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIECC  594 (601)
T ss_pred             HhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcceE
Confidence            4478889999999999999999999999999999987543

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.94  E-value=2.1e-26  Score=220.67  Aligned_cols=240  Identities=18%  Similarity=0.240  Sum_probs=189.0

Q ss_pred             ccccccceeCCeeEEEEEEcCCC-----CEEEEEEccCC----ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEE
Q 015500            4 TRGHTIGQGSSATVSLATSLRSG-----DVFAAKSTELP----KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMY   74 (405)
Q Consensus         4 ~~~~~LG~G~~g~Vyla~~~~~~-----~~vavK~~~~~----~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~   74 (405)
                      +....+-+|.||.||.|.++...     +.+.+|-+...    +...+..|.-.|..+.|||+.++.++.......   .
T Consensus       287 ~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~---P  363 (563)
T KOG1024|consen  287 RLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYAT---P  363 (563)
T ss_pred             echhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCc---c
Confidence            34456789999999999776433     23445544332    234677888899999999999999887654432   3


Q ss_pred             EEEEeecCCCCHHHHHHHc-------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccc
Q 015500           75 NLFMEYAPGGTLNDEIHRN-------GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCA  146 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~i~~~-------~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla  146 (405)
                      .+++.++.-|+|..++..+       .+.++..+...++.|++.|++|||+.||||.||-.+|.+|++.- +||+|-.++
T Consensus       364 ~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsaLS  443 (563)
T KOG1024|consen  364 FVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSALS  443 (563)
T ss_pred             eEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccchhc
Confidence            3678899889999999843       22467778888999999999999999999999999999999886 999999998


Q ss_pred             ccccc-cccCC-----CCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCch
Q 015500          147 KWESE-ALQSG-----GTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPA  219 (405)
Q Consensus       147 ~~~~~-~~~~~-----gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~  219 (405)
                      +.... .....     ....||+||.+..+.|+.++|+||||+++|||+| |+.|+.+ -++.+.-.-+..+.. -..|-
T Consensus       444 RDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~Pyae-IDPfEm~~ylkdGyR-laQP~  521 (563)
T KOG1024|consen  444 RDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAE-IDPFEMEHYLKDGYR-LAQPF  521 (563)
T ss_pred             cccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccc-cCHHHHHHHHhccce-ecCCC
Confidence            85333 22222     3456999999999999999999999999999998 8999954 456655554444433 35678


Q ss_pred             hccHHHHHHHHHhcccCccccCCHHHHhc
Q 015500          220 FLSKQANDFLSNCLRRDPKERWAASQLLK  248 (405)
Q Consensus       220 ~~s~~l~dll~~~L~~dP~~Rpt~~elL~  248 (405)
                      ++|+++..++.-||...|++||+.+|+..
T Consensus       522 NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  522 NCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             CCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence            89999999999999999999999999854

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=7.9e-26  Score=213.07  Aligned_cols=239  Identities=22%  Similarity=0.282  Sum_probs=191.0

Q ss_pred             CCcccccccceeCCeeEEEEEEcCCCCEEEEEEccC-CChHHHHHHHHHHHhCC-CCCeeeeeeeeeecCCCceEEEEEE
Q 015500            1 MDWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL-PKSEFLQREQKFLSSLN-SPHIVGYKGCDVTSEDNKLMYNLFM   78 (405)
Q Consensus         1 ~~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~-~~~~~l~~E~~iL~~L~-hpnIv~~~~~~~~~~~~~~~~~lv~   78 (405)
                      .+|++|++||.|+||..++|++.-++++||||..+. +.+.++..|.+..+.|. .++|...+-+.  .+  ..+-.||+
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFG--qe--G~~NiLVi  103 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFG--QE--GKYNILVI  103 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeec--cc--cchhhhhh
Confidence            379999999999999999999999999999998764 56778999999999984 58888776432  22  22334899


Q ss_pred             eecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC------ceEeeecccccccc-
Q 015500           79 EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG------AKIADFGCAKWESE-  151 (405)
Q Consensus        79 Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~------vkL~DFGla~~~~~-  151 (405)
                      |.+ |.||+|++.-++.+|+..++..++.|++.-++|+|++.+|+|||||+|+||..-+      +.|+|||+|+.... 
T Consensus       104 dLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp  182 (449)
T KOG1165|consen  104 DLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDP  182 (449)
T ss_pred             hhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCc
Confidence            988 8999999999999999999999999999999999999999999999999996432      89999999986433 


Q ss_pred             ----------cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC--ChHHHHHHHHhcCCCC---C
Q 015500          152 ----------ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAA--DPMTVLYKIAYSRELP---E  216 (405)
Q Consensus       152 ----------~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~--~~~~~l~~i~~~~~~~---~  216 (405)
                                .....||..||+--...|.+++.+.|+=|||-+++..+-|.+||....  +......+|...+...   .
T Consensus       183 ~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~~  262 (449)
T KOG1165|consen  183 KTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIEV  262 (449)
T ss_pred             cccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHHH
Confidence                      223459999999999999999999999999999999999999998654  3344444554433221   2


Q ss_pred             CchhccHHHHHHHHHhcccCccccCCHH
Q 015500          217 VPAFLSKQANDFLSNCLRRDPKERWAAS  244 (405)
Q Consensus       217 ~p~~~s~~l~dll~~~L~~dP~~Rpt~~  244 (405)
                      +...+|.++...+.-.=..+-.+-|..+
T Consensus       263 Lc~g~P~efa~Yl~yvR~L~F~E~PDYd  290 (449)
T KOG1165|consen  263 LCEGFPEEFATYLRYVRRLDFFETPDYD  290 (449)
T ss_pred             HHhcCHHHHHHHHHHHHhcCcccCCCHH
Confidence            3345677777776655445555555544

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=6.7e-26  Score=205.40  Aligned_cols=237  Identities=23%  Similarity=0.272  Sum_probs=186.4

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-hHHHHHHHHHHHhCCC-CCeeeeeeeeeecCCCceEEEEEEe
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-SEFLQREQKFLSSLNS-PHIVGYKGCDVTSEDNKLMYNLFME   79 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-~~~l~~E~~iL~~L~h-pnIv~~~~~~~~~~~~~~~~~lv~E   79 (405)
                      .|+.+++||+|+||.+|+|.+..+|+.||||+..... -.++..|.++.+.|++ +.|..+..+....    .+-.+||+
T Consensus        16 ky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~----~ynvlVMd   91 (341)
T KOG1163|consen   16 KYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEK----DYNVLVMD   91 (341)
T ss_pred             ceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhcccc----ccceeeee
Confidence            4889999999999999999999999999999976543 3578899999999976 5555554433222    12348999


Q ss_pred             ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC----ceEeeecccccccc----
Q 015500           80 YAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG----AKIADFGCAKWESE----  151 (405)
Q Consensus        80 y~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~----vkL~DFGla~~~~~----  151 (405)
                      .+ |.||.+++.-+...++..+++-++-|++.-++|+|.++++||||||+|+|.+-+.    +.++|||+|+...+    
T Consensus        92 LL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~  170 (341)
T KOG1163|consen   92 LL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTR  170 (341)
T ss_pred             cc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhcccccc
Confidence            98 8999999988877899999999999999999999999999999999999997542    89999999986433    


Q ss_pred             -------cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChH--HHHHHH---HhcCCCCCCch
Q 015500          152 -------ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPM--TVLYKI---AYSRELPEVPA  219 (405)
Q Consensus       152 -------~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~--~~l~~i---~~~~~~~~~p~  219 (405)
                             .....||..|.+--...+..++.+.|+-|+|.++..+.-|.+||.......  ....+|   ..+-.+..+..
T Consensus       171 ~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~LC~  250 (341)
T KOG1163|consen  171 QHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEVLCK  250 (341)
T ss_pred             ccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHHHHhC
Confidence                   223349999999999999999999999999999999999999998654321  111122   12222223445


Q ss_pred             hccHHHHHHHHHhcccCccccCCH
Q 015500          220 FLSKQANDFLSNCLRRDPKERWAA  243 (405)
Q Consensus       220 ~~s~~l~dll~~~L~~dP~~Rpt~  243 (405)
                      .+|.++.-.|.-|=..--.+-|..
T Consensus       251 G~P~EF~myl~Y~R~L~F~E~Pdy  274 (341)
T KOG1163|consen  251 GFPAEFAMYLNYCRGLGFEEKPDY  274 (341)
T ss_pred             CCcHHHHHHHHHHhhcCCCCCCcH
Confidence            678888888888876666666654

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.93  E-value=1.7e-25  Score=221.37  Aligned_cols=154  Identities=18%  Similarity=0.170  Sum_probs=122.1

Q ss_pred             CcccccccceeCCeeEEEEEEcC-CCCEEEEEEccCC--------ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCce
Q 015500            2 DWTRGHTIGQGSSATVSLATSLR-SGDVFAAKSTELP--------KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKL   72 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~-~~~~vavK~~~~~--------~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~   72 (405)
                      +|+.++.||+|+||+||+|+++. +++.+|||.....        ..+.+.+|+++|++|+|+||++.+..   ..    
T Consensus        19 ~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~----   91 (365)
T PRK09188         19 RFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TG----   91 (365)
T ss_pred             CceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cC----
Confidence            58999999999999999999886 7888899986432        13468999999999999999853321   11    


Q ss_pred             EEEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCC-CCCCEEEccCC-ceEeeeccccccc
Q 015500           73 MYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDI-KSRNILMAESG-AKIADFGCAKWES  150 (405)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDl-kp~NILi~~~~-vkL~DFGla~~~~  150 (405)
                      ..++||||++|++|.. +.    +...   ..++.|++.||.|||++||+|||| ||+|||++.++ +||+|||+|+...
T Consensus        92 ~~~LVmE~~~G~~L~~-~~----~~~~---~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~  163 (365)
T PRK09188         92 KDGLVRGWTEGVPLHL-AR----PHGD---PAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFR  163 (365)
T ss_pred             CcEEEEEccCCCCHHH-hC----ccch---HHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecc
Confidence            1469999999999973 21    1111   467899999999999999999999 99999998776 9999999998533


Q ss_pred             c------------cccCCCCCCccChhhhcCC
Q 015500          151 E------------ALQSGGTPMFMAPEVARGE  170 (405)
Q Consensus       151 ~------------~~~~~gt~~Y~APE~l~~~  170 (405)
                      .            .....+++.|+|||.+...
T Consensus       164 ~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        164 RRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             cCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            2            1234578889999998654

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.92  E-value=5.6e-26  Score=229.88  Aligned_cols=237  Identities=24%  Similarity=0.387  Sum_probs=197.0

Q ss_pred             ccceeCCeeEEEEE---EcCCCCEEEEEEccCCC-----hHHHHHHHHHHHhCC-CCCeeeeeeeeeecCCCceEEEEEE
Q 015500            8 TIGQGSSATVSLAT---SLRSGDVFAAKSTELPK-----SEFLQREQKFLSSLN-SPHIVGYKGCDVTSEDNKLMYNLFM   78 (405)
Q Consensus         8 ~LG~G~~g~Vyla~---~~~~~~~vavK~~~~~~-----~~~l~~E~~iL~~L~-hpnIv~~~~~~~~~~~~~~~~~lv~   78 (405)
                      .+|.|+||.|+++.   -...+..+|.|+..+..     ......|..++...+ ||.++.+.-.+.+...    .++++
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~k----l~l~l   76 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGK----LYLIL   76 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccc----hhHhh
Confidence            47999999998864   22356778888765431     234556888999996 9999999877665544    55899


Q ss_pred             eecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccccccCCC
Q 015500           79 EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSGG  157 (405)
Q Consensus        79 Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~~~~~g  157 (405)
                      ++..||.|...+.... .+++...+.+...++.+++++|+.|++|||+|++||+++.+| +++.|||+.+..-.....||
T Consensus        77 d~~rgg~lft~l~~~~-~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~cg  155 (612)
T KOG0603|consen   77 DFLRGGDLFTRLSKEV-MFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIACG  155 (612)
T ss_pred             hhcccchhhhccccCC-chHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhccc
Confidence            9999999998887653 788999999999999999999999999999999999999999 99999999987555444499


Q ss_pred             CCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHhcccCc
Q 015500          158 TPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDP  237 (405)
Q Consensus       158 t~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~L~~dP  237 (405)
                      |..|||||+++  ....++|.||+|++++||+||..||..     +...+|..  .-+..|..++..+++++..++.++|
T Consensus       156 t~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-----~~~~~Il~--~~~~~p~~l~~~a~~~~~~l~~r~p  226 (612)
T KOG0603|consen  156 TYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-----DTMKRILK--AELEMPRELSAEARSLFRQLFKRNP  226 (612)
T ss_pred             chhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-----HHHHHHhh--hccCCchhhhHHHHHHHHHHHhhCH
Confidence            99999999999  567789999999999999999999965     33344433  2346788899999999999999999


Q ss_pred             cccCC-----HHHHhcCccccccccc
Q 015500          238 KERWA-----ASQLLKHPFLEEFCSC  258 (405)
Q Consensus       238 ~~Rpt-----~~elL~hp~~~~~~~~  258 (405)
                      ..|.-     +.++++|+||..+...
T Consensus       227 ~nrLg~~~~~~~eik~h~f~~~i~~~  252 (612)
T KOG0603|consen  227 ENRLGAGPDGVDEIKQHEFFQSIDWN  252 (612)
T ss_pred             HHHhccCcchhHHHhccchheeeeHh
Confidence            99985     4799999999987654

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.90  E-value=3.4e-23  Score=197.52  Aligned_cols=230  Identities=25%  Similarity=0.374  Sum_probs=147.8

Q ss_pred             cccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC------hHHHHHHHHHHHhCCC---C-------C------eeee
Q 015500            3 WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK------SEFLQREQKFLSSLNS---P-------H------IVGY   60 (405)
Q Consensus         3 y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~------~~~l~~E~~iL~~L~h---p-------n------Iv~~   60 (405)
                      ..++..||.|+++.||.+++..||+.+|||+.-...      .+.+++|.-....+.+   |       .      ++++
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i   93 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred             EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence            467899999999999999999999999999864322      2455555544333322   1       1      1111


Q ss_pred             eee--eeecCCCceE-----EEEEEeecCCCCHHHHHHH---cCCC---CCHHHHHHHHHHHHHHHHHHHhCCceeCCCC
Q 015500           61 KGC--DVTSEDNKLM-----YNLFMEYAPGGTLNDEIHR---NGGR---LDESLIVSYTRQILQGLEYLHSNRVVHCDIK  127 (405)
Q Consensus        61 ~~~--~~~~~~~~~~-----~~lv~Ey~~ggsL~~~i~~---~~~~---l~e~~~~~i~~qIl~~L~yLH~~givHrDlk  127 (405)
                      .+-  +.........     ++++|+-+. ++|.+++..   ....   +.......+..|+++.+++||+.|++|+|||
T Consensus        94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~  172 (288)
T PF14531_consen   94 PGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIK  172 (288)
T ss_dssp             TTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-S
T ss_pred             cCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccc
Confidence            110  0111111112     256777774 488777542   2211   2223335567999999999999999999999


Q ss_pred             CCCEEEccCC-ceEeeeccccccccccc-CCCCCCccChhhhcCC--------CCCcchhHHHHHHHHHHHHhCCCCCCC
Q 015500          128 SRNILMAESG-AKIADFGCAKWESEALQ-SGGTPMFMAPEVARGE--------HQGFASDIWAVGCTVIEMASGGAPWPN  197 (405)
Q Consensus       128 p~NILi~~~~-vkL~DFGla~~~~~~~~-~~gt~~Y~APE~l~~~--------~~~~~sDIwSLG~il~elltG~~Pf~~  197 (405)
                      |+|++++.+| ++|+||+.....+.... ...+..|.+||.....        .++++.|.|+||+++|.|.||..||.-
T Consensus       173 ~~nfll~~~G~v~Lg~F~~~~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~  252 (288)
T PF14531_consen  173 PENFLLDQDGGVFLGDFSSLVRAGTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGL  252 (288)
T ss_dssp             GGGEEE-TTS-EEE--GGGEEETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCC
T ss_pred             eeeEEEcCCCCEEEcChHHHeecCceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCC
Confidence            9999999998 99999998877666444 4566789999987432        468899999999999999999999963


Q ss_pred             CCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHhcccCcccc
Q 015500          198 AADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKER  240 (405)
Q Consensus       198 ~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~L~~dP~~R  240 (405)
                      .........      .+.... .+|+.+++||.++|++||.+|
T Consensus       253 ~~~~~~~~~------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  253 SSPEADPEW------DFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             CGGGSTSGG------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             CCccccccc------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            321110000      122223 688999999999999999988

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.89  E-value=1.2e-23  Score=222.44  Aligned_cols=216  Identities=29%  Similarity=0.437  Sum_probs=161.8

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEeec
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYA   81 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~Ey~   81 (405)
                      +|..+|.|..|+||.||+++|+.+.+.||+|+ ++.. --+++   +|.....|.+                   |    
T Consensus        84 df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~-lilRn---ilt~a~npfv-------------------v----  135 (1205)
T KOG0606|consen   84 DFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQN-LILRN---ILTFAGNPFV-------------------V----  135 (1205)
T ss_pred             ccceeEeeccCCCCceeeeeccccccchhhcc-cccc-hhhhc---cccccCCcce-------------------e----
Confidence            68899999999999999999999999999944 3221 11111   1111122222                   2    


Q ss_pred             CCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc---------
Q 015500           82 PGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE---------  151 (405)
Q Consensus        82 ~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~---------  151 (405)
                        |+=...++.. |+++...        +.+++|||+-||+|||+||+|.+|+.-| +|++|||+.+....         
T Consensus       136 --gDc~tllk~~-g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg  204 (1205)
T KOG0606|consen  136 --GDCATLLKNI-GPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEG  204 (1205)
T ss_pred             --chhhhhcccC-CCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhc
Confidence              3444444433 3565543        7899999999999999999999999988 99999998764211         


Q ss_pred             ----------cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHH-HHhcCCCCCCchh
Q 015500          152 ----------ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYK-IAYSRELPEVPAF  220 (405)
Q Consensus       152 ----------~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~-i~~~~~~~~~p~~  220 (405)
                                ....+|||.|.|||++..+.|+..+|.|+||+++||.+.|..||. .+.+.+.+.. +......|+--..
T Consensus       205 ~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpff-Gdtpeelfg~visd~i~wpE~dea  283 (1205)
T KOG0606|consen  205 HIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFF-GDTPEELFGQVISDDIEWPEEDEA  283 (1205)
T ss_pred             chHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeecc-CCCHHHHHhhhhhhhccccccCcC
Confidence                      223479999999999999999999999999999999999999995 3444444433 2233334444445


Q ss_pred             ccHHHHHHHHHhcccCccccC---CHHHHhcCcccccccc
Q 015500          221 LSKQANDFLSNCLRRDPKERW---AASQLLKHPFLEEFCS  257 (405)
Q Consensus       221 ~s~~l~dll~~~L~~dP~~Rp---t~~elL~hp~~~~~~~  257 (405)
                      ++++++++|.++|+.+|..|.   .+-++.+|+||+.+..
T Consensus       284 ~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw  323 (1205)
T KOG0606|consen  284 LPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDW  323 (1205)
T ss_pred             CCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeeccc
Confidence            789999999999999999996   4678899999987644

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.89  E-value=2.8e-23  Score=199.81  Aligned_cols=188  Identities=25%  Similarity=0.395  Sum_probs=145.6

Q ss_pred             CCCCeeeeeeeeeec-----------------------CCCceEEEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHH
Q 015500           53 NSPHIVGYKGCDVTS-----------------------EDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQI  109 (405)
Q Consensus        53 ~hpnIv~~~~~~~~~-----------------------~~~~~~~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qI  109 (405)
                      +|||||++.+.|.+.                       ......+|+||...+. +|..++-.+  ..+....+-++.|+
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~--~~s~r~~~~~laQl  350 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR--HRSYRTGRVILAQL  350 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC--CCchHHHHHHHHHH
Confidence            699999988776431                       1122346689987755 999999765  47888899999999


Q ss_pred             HHHHHHHHhCCceeCCCCCCCEEE--ccCC---ceEeeecccccccc----------cccCCCCCCccChhhhcCCC---
Q 015500          110 LQGLEYLHSNRVVHCDIKSRNILM--AESG---AKIADFGCAKWESE----------ALQSGGTPMFMAPEVARGEH---  171 (405)
Q Consensus       110 l~~L~yLH~~givHrDlkp~NILi--~~~~---vkL~DFGla~~~~~----------~~~~~gt~~Y~APE~l~~~~---  171 (405)
                      ++|+.|||++||.|||+|.+|||+  ++++   +.|+||||+--.+.          .....|...-||||+.....   
T Consensus       351 LEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~  430 (598)
T KOG4158|consen  351 LEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPN  430 (598)
T ss_pred             HHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCc
Confidence            999999999999999999999998  4444   79999998753221          22345888899999986421   


Q ss_pred             --CC-cchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHhcccCccccCCHH
Q 015500          172 --QG-FASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAAS  244 (405)
Q Consensus       172 --~~-~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~  244 (405)
                        .+ .++|.|+.|.+.||+++...||....... .-.+......+|.+|..+++.+++++..+|++||++|++..
T Consensus       431 avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~-L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~  505 (598)
T KOG4158|consen  431 AVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML-LDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPN  505 (598)
T ss_pred             eeeccchhhhhhhhhhHHHHhccCCcccccchhe-echhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence              12 38999999999999999999996532211 11122344578899999999999999999999999999854

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.89  E-value=6.1e-23  Score=186.50  Aligned_cols=136  Identities=22%  Similarity=0.200  Sum_probs=108.3

Q ss_pred             ccccceeCCeeEEEEEEcCCCCEEEEEEccCCCh-----------------------------HHHHHHHHHHHhCCCCC
Q 015500            6 GHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS-----------------------------EFLQREQKFLSSLNSPH   56 (405)
Q Consensus         6 ~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~~-----------------------------~~l~~E~~iL~~L~hpn   56 (405)
                      ...||+|+||.||+|.+. +|+.||||++.....                             ....+|+++|.+|.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            568999999999999986 899999998864311                             12235999999998887


Q ss_pred             eeeeeeeeeecCCCceEEEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH-HhCCceeCCCCCCCEEEcc
Q 015500           57 IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL-HSNRVVHCDIKSRNILMAE  135 (405)
Q Consensus        57 Iv~~~~~~~~~~~~~~~~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yL-H~~givHrDlkp~NILi~~  135 (405)
                      +.......  ...    .++||||++|+++...+... +++++..+..++.|++.+|.++ |+.||+||||||+|||++.
T Consensus        81 v~~p~~~~--~~~----~~iVmE~i~g~~l~~~~~~~-~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~  153 (190)
T cd05147          81 IPCPEPIL--LKS----HVLVMEFIGDDGWAAPRLKD-APLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYHD  153 (190)
T ss_pred             CCCCcEEE--ecC----CEEEEEEeCCCCCcchhhhc-CCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEEC
Confidence            74332221  111    24999999998776554333 4799999999999999999999 7999999999999999996


Q ss_pred             CCceEeeecccccc
Q 015500          136 SGAKIADFGCAKWE  149 (405)
Q Consensus       136 ~~vkL~DFGla~~~  149 (405)
                      +.++|+|||+|...
T Consensus       154 ~~v~LiDFG~a~~~  167 (190)
T cd05147         154 GKLYIIDVSQSVEH  167 (190)
T ss_pred             CcEEEEEccccccC
Confidence            66999999998743

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.88  E-value=3.8e-22  Score=181.12  Aligned_cols=138  Identities=20%  Similarity=0.163  Sum_probs=109.8

Q ss_pred             cccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-----------------------------hHHHHHHHHHHHhCCCC
Q 015500            5 RGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-----------------------------SEFLQREQKFLSSLNSP   55 (405)
Q Consensus         5 ~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-----------------------------~~~l~~E~~iL~~L~hp   55 (405)
                      +...||+|++|+||+|.+. +|+.||||+.....                             ...+.+|.+.+.++.|+
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~   79 (190)
T cd05145           1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA   79 (190)
T ss_pred             CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence            4678999999999999987 89999999876431                             12346789999999999


Q ss_pred             CeeeeeeeeeecCCCceEEEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCCEEEc
Q 015500           56 HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHS-NRVVHCDIKSRNILMA  134 (405)
Q Consensus        56 nIv~~~~~~~~~~~~~~~~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~-~givHrDlkp~NILi~  134 (405)
                      +|.........  .    .++||||++|+++....... .++++..+..++.|++.+|.++|+ +||+||||||+||+++
T Consensus        80 ~i~~p~~~~~~--~----~~lVmE~~~g~~~~~~~l~~-~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~  152 (190)
T cd05145          80 GVPVPEPILLK--K----NVLVMEFIGDDGSPAPRLKD-VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH  152 (190)
T ss_pred             CCCCceEEEec--C----CEEEEEEecCCCchhhhhhh-ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE
Confidence            87544332221  1    25999999988654433232 468899999999999999999999 9999999999999999


Q ss_pred             cCCceEeeeccccccc
Q 015500          135 ESGAKIADFGCAKWES  150 (405)
Q Consensus       135 ~~~vkL~DFGla~~~~  150 (405)
                      .+.++|+|||++....
T Consensus       153 ~~~~~liDFG~a~~~~  168 (190)
T cd05145         153 DGKPYIIDVSQAVELD  168 (190)
T ss_pred             CCCEEEEEcccceecC
Confidence            4449999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.88  E-value=4.2e-23  Score=218.49  Aligned_cols=232  Identities=22%  Similarity=0.257  Sum_probs=170.8

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-------hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-------SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMY   74 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-------~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~   74 (405)
                      ++...+-||++-|=+|.+|++. .|. |+||++-+..       ..+..+|++ ...+++||.+++.-.-++...    .
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kA----A   96 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKA----A   96 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHH----H
Confidence            4566789999999999999875 344 8888765432       123334555 566699999998766444332    4


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccc--cc
Q 015500           75 NLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWE--SE  151 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~--~~  151 (405)
                      |||-+|... +|.|.+..++ -+..-..+.|+.||+.||..+|..||+|||||.+||||+.-+ +.|+||..-+..  ..
T Consensus        97 ylvRqyvkh-nLyDRlSTRP-FL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe  174 (1431)
T KOG1240|consen   97 YLVRQYVKH-NLYDRLSTRP-FLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPE  174 (1431)
T ss_pred             HHHHHHHhh-hhhhhhccch-HHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCC
Confidence            578888855 9999998764 678888999999999999999999999999999999999877 999999765421  11


Q ss_pred             --c-------ccCCCCCCccChhhhcCC----------C-CCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHh
Q 015500          152 --A-------LQSGGTPMFMAPEVARGE----------H-QGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAY  210 (405)
Q Consensus       152 --~-------~~~~gt~~Y~APE~l~~~----------~-~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~  210 (405)
                        .       -+...-..|.|||-+...          . .+++-||||+||++.||++ |++||.     ..++.....
T Consensus       175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~-----LSQL~aYr~  249 (1431)
T KOG1240|consen  175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT-----LSQLLAYRS  249 (1431)
T ss_pred             CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc-----HHHHHhHhc
Confidence              0       012233469999987431          1 4678999999999999998 688883     333333322


Q ss_pred             cCCCCCCch-----hccHHHHHHHHHhcccCccccCCHHHHhcC
Q 015500          211 SRELPEVPA-----FLSKQANDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       211 ~~~~~~~p~-----~~s~~l~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      ..  ...+.     --+..++.+|..|+++||++|.+|++.|+.
T Consensus       250 ~~--~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  250 GN--ADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             cC--ccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence            21  11111     124578999999999999999999999986

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.87  E-value=1.9e-22  Score=187.01  Aligned_cols=169  Identities=17%  Similarity=0.241  Sum_probs=129.0

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC--hH----------HHHHHHHHHHhCCCCCeeeeeeeeeecCC
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK--SE----------FLQREQKFLSSLNSPHIVGYKGCDVTSED   69 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~--~~----------~l~~E~~iL~~L~hpnIv~~~~~~~~~~~   69 (405)
                      +|+..+.||.|+||.||++..  ++..+|+|.+....  .+          .+++|++.+.++.||+|..+...+.....
T Consensus        32 ~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~  109 (232)
T PRK10359         32 NIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAER  109 (232)
T ss_pred             ceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccc
Confidence            588999999999999999755  46789999986421  11          16799999999999999998877654432


Q ss_pred             Cc----eEEEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCCceEeeecc
Q 015500           70 NK----LMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGAKIADFGC  145 (405)
Q Consensus        70 ~~----~~~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~vkL~DFGl  145 (405)
                      ..    ...+++|||++|.+|.++.     .+++.    ...+++.+|..+|+.|++|||+||.||+++.++++|+|||.
T Consensus       110 ~~~~~~~~~~lvmEyi~G~tL~~~~-----~~~~~----~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~gi~liDfg~  180 (232)
T PRK10359        110 KTLRYAHTYIMLIEYIEGVELNDMP-----EISED----VKAKIKASIESLHQHGMVSGDPHKGNFIVSKNGLRIIDLSG  180 (232)
T ss_pred             ccccccCCeEEEEEEECCccHHHhh-----hccHH----HHHHHHHHHHHHHHcCCccCCCChHHEEEeCCCEEEEECCC
Confidence            11    1256899999999998863     23443    45699999999999999999999999999988899999998


Q ss_pred             cccccccccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHH
Q 015500          146 AKWESEALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMA  189 (405)
Q Consensus       146 a~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ell  189 (405)
                      .........        ...+.....++.++|+|+||+++....
T Consensus       181 ~~~~~e~~a--------~d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        181 KRCTAQRKA--------KDRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             cccccchhh--------HHHHHHHhHhcccccccceeEeehHHH
Confidence            764322110        011334445678999999999987655

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.87  E-value=2.4e-21  Score=176.54  Aligned_cols=175  Identities=19%  Similarity=0.192  Sum_probs=136.4

Q ss_pred             ccccccceeCCeeEEEEEEcCCCCEEEEEEccCCCh-------HHHHHHHHHHHhCC-CCCeeeeeeeeeecCCCceEEE
Q 015500            4 TRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS-------EFLQREQKFLSSLN-SPHIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         4 ~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~~-------~~l~~E~~iL~~L~-hpnIv~~~~~~~~~~~~~~~~~   75 (405)
                      ..+..|++|+||+|+++..  .+..++.+.+.....       ..+.+|+++|++|. |++|+++++.    ..    .+
T Consensus         5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~----~~   74 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DG----RH   74 (218)
T ss_pred             ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cC----EE
Confidence            4578899999999998765  577888777664432       25789999999995 4888888764    11    45


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCC-CCCCEEEccCC-ceEeeecccccccccc
Q 015500           76 LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDI-KSRNILMAESG-AKIADFGCAKWESEAL  153 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDl-kp~NILi~~~~-vkL~DFGla~~~~~~~  153 (405)
                      ++|||+.|.+|.+.+..       . ...++.|++.+|.++|++||+|||| ||+|||++.++ ++|+|||+|.......
T Consensus        75 lvmeyI~G~~L~~~~~~-------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~  146 (218)
T PRK12274         75 LDRSYLAGAAMYQRPPR-------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA  146 (218)
T ss_pred             EEEeeecCccHHhhhhh-------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence            89999999998754321       1 1357889999999999999999999 79999998877 9999999997543311


Q ss_pred             -----------------cCCCCCCccChhhhcCC-CCC-cchhHHHHHHHHHHHHhCCCCCC
Q 015500          154 -----------------QSGGTPMFMAPEVARGE-HQG-FASDIWAVGCTVIEMASGGAPWP  196 (405)
Q Consensus       154 -----------------~~~gt~~Y~APE~l~~~-~~~-~~sDIwSLG~il~elltG~~Pf~  196 (405)
                                       -..++|.|++|+..+.- ..+ ...+.++.|+.+|.++|+..|.-
T Consensus       147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~  208 (218)
T PRK12274        147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW  208 (218)
T ss_pred             hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence                             11278999999976542 333 67899999999999999999863

>PRK10345 hypothetical protein; Provisional

Probab=99.87  E-value=1.4e-21  Score=180.00  Aligned_cols=138  Identities=23%  Similarity=0.316  Sum_probs=112.1

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC---ChHHHHHHHHHHHhC-----CCCCeeeeeeeeeecCCCceE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP---KSEFLQREQKFLSSL-----NSPHIVGYKGCDVTSEDNKLM   73 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~---~~~~l~~E~~iL~~L-----~hpnIv~~~~~~~~~~~~~~~   73 (405)
                      +....+.||+|+||.||.  +..++.. +||++...   ..+.+.+|+++++.|     .||||+++++++.+.......
T Consensus         3 ~L~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v   79 (210)
T PRK10345          3 RLSEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV   79 (210)
T ss_pred             ecCCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence            456778999999999995  7767666 69987654   456799999999999     579999999998776554555


Q ss_pred             EEEEEee--cCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHH-HHHHhCCceeCCCCCCCEEEccC-----CceEeeecc
Q 015500           74 YNLFMEY--APGGTLNDEIHRNGGRLDESLIVSYTRQILQGL-EYLHSNRVVHCDIKSRNILMAES-----GAKIADFGC  145 (405)
Q Consensus        74 ~~lv~Ey--~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L-~yLH~~givHrDlkp~NILi~~~-----~vkL~DFGl  145 (405)
                      +.+|+||  +.+++|.+++++.  .+++.  ..++.|++.++ +|||+++|+||||||+|||++..     .++|+||+.
T Consensus        80 ~~~I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G  155 (210)
T PRK10345         80 YDVIADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIG  155 (210)
T ss_pred             EEEEecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence            6689999  5579999999663  57766  35688888888 99999999999999999999632     299999544


Q ss_pred             c
Q 015500          146 A  146 (405)
Q Consensus       146 a  146 (405)
                      +
T Consensus       156 ~  156 (210)
T PRK10345        156 E  156 (210)
T ss_pred             C
Confidence            4

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.84  E-value=4.7e-21  Score=176.64  Aligned_cols=231  Identities=22%  Similarity=0.358  Sum_probs=183.7

Q ss_pred             ccccceeCCeeEEEEEEcCCCCEEEEEEccC-----CChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEee
Q 015500            6 GHTIGQGSSATVSLATSLRSGDVFAAKSTEL-----PKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEY   80 (405)
Q Consensus         6 ~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~-----~~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~Ey   80 (405)
                      .-+|...-.|..|+|++.  |..+++|++..     ..+..+..|.-.|+-+.||||+++++.+....+    ..++..|
T Consensus       195 ~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppn----lv~isq~  268 (448)
T KOG0195|consen  195 ITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPN----LVIISQY  268 (448)
T ss_pred             hhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCC----ceEeeee
Confidence            345667788999999986  34455555442     234578889999999999999999998766544    4589999


Q ss_pred             cCCCCHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCCCCEEEccCC-ceE--eeeccccccccccc
Q 015500           81 APGGTLNDEIHRNGG-RLDESLIVSYTRQILQGLEYLHSNR--VVHCDIKSRNILMAESG-AKI--ADFGCAKWESEALQ  154 (405)
Q Consensus        81 ~~ggsL~~~i~~~~~-~l~e~~~~~i~~qIl~~L~yLH~~g--ivHrDlkp~NILi~~~~-vkL--~DFGla~~~~~~~~  154 (405)
                      |+-|+|...+....+ -.+..++.+++.+|++|++|||+..  |.---|....|+|+++- ++|  +|--++.   +...
T Consensus       269 mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf---qe~g  345 (448)
T KOG0195|consen  269 MPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF---QEVG  345 (448)
T ss_pred             ccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee---eccc
Confidence            999999999976432 3678899999999999999999974  44557889999999885 443  4433322   2223


Q ss_pred             CCCCCCccChhhhcCCCCC---cchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHH
Q 015500          155 SGGTPMFMAPEVARGEHQG---FASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSN  231 (405)
Q Consensus       155 ~~gt~~Y~APE~l~~~~~~---~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~  231 (405)
                      ....|.||+||.+...+-+   .++|+|||.++++||.|...||.+. .+.+.-.++...+..+.+|+.++..+..+++-
T Consensus       346 r~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadl-spmecgmkialeglrv~ippgis~hm~klm~i  424 (448)
T KOG0195|consen  346 RAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADL-SPMECGMKIALEGLRVHIPPGISRHMNKLMNI  424 (448)
T ss_pred             cccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccC-CchhhhhhhhhccccccCCCCccHHHHHHHHH
Confidence            4468999999999876543   4799999999999999999999655 46777888888888889999999999999999


Q ss_pred             hcccCccccCCHHHH
Q 015500          232 CLRRDPKERWAASQL  246 (405)
Q Consensus       232 ~L~~dP~~Rpt~~el  246 (405)
                      |+..||.+||.++++
T Consensus       425 cmnedpgkrpkfdmi  439 (448)
T KOG0195|consen  425 CMNEDPGKRPKFDMI  439 (448)
T ss_pred             HhcCCCCcCCCccee
Confidence            999999999998776

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.82  E-value=2.2e-20  Score=200.81  Aligned_cols=186  Identities=28%  Similarity=0.355  Sum_probs=151.0

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHhCC---CCCeeeeeeeeeecCCCceEEEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLN---SPHIVGYKGCDVTSEDNKLMYNLFM   78 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~~~~l~~E~~iL~~L~---hpnIv~~~~~~~~~~~~~~~~~lv~   78 (405)
                      .|.+-+.||.|+||+||+|.+.. |+.||+|+-.....-.++--.+++.+|+   -|-|..+..+++..+.    -.||+
T Consensus       699 ~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~----S~lv~  773 (974)
T KOG1166|consen  699 KFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNA----SVLVS  773 (974)
T ss_pred             eEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCc----ceeee
Confidence            36788999999999999999876 9999999987666555555566667776   1344444444444433    23899


Q ss_pred             eecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcc--------CCceEeeecccccc-
Q 015500           79 EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAE--------SGAKIADFGCAKWE-  149 (405)
Q Consensus        79 Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~--------~~vkL~DFGla~~~-  149 (405)
                      ||.+.|+|.+++... +-+++..+..+..|++..+++||..+|||+||||+|.||..        .+++|+|||.+--. 
T Consensus       774 ey~~~Gtlld~~N~~-~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~  852 (974)
T KOG1166|consen  774 EYSPYGTLLDLINTN-KVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMK  852 (974)
T ss_pred             eccccccHHHhhccC-CCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceeee
Confidence            999999999999854 57999999999999999999999999999999999999842        13999999987432 


Q ss_pred             --cc---cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCC
Q 015500          150 --SE---ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGA  193 (405)
Q Consensus       150 --~~---~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~  193 (405)
                        ..   ....++|-.+--+|...|...++.+|.|.|..+++-|+.|+.
T Consensus       853 lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  853 LFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             EcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence              11   223458999999999999999999999999999999999864

>smart00090 RIO RIO-like kinase

Probab=99.82  E-value=7.1e-20  Score=171.98  Aligned_cols=138  Identities=22%  Similarity=0.161  Sum_probs=109.7

Q ss_pred             cccccccceeCCeeEEEEE-EcCCCCEEEEEEccCCCh---------------------------HHHHHHHHHHHhCCC
Q 015500            3 WTRGHTIGQGSSATVSLAT-SLRSGDVFAAKSTELPKS---------------------------EFLQREQKFLSSLNS   54 (405)
Q Consensus         3 y~~~~~LG~G~~g~Vyla~-~~~~~~~vavK~~~~~~~---------------------------~~l~~E~~iL~~L~h   54 (405)
                      |.+.+.||+|++|.||+|. +..+|+.||+|.+.....                           ..+.+|+.+++++.+
T Consensus        30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~  109 (237)
T smart00090       30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE  109 (237)
T ss_pred             HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence            7789999999999999999 778999999998764320                           235689999999975


Q ss_pred             CC--eeeeeeeeeecCCCceEEEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC-ceeCCCCCCCE
Q 015500           55 PH--IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNR-VVHCDIKSRNI  131 (405)
Q Consensus        55 pn--Iv~~~~~~~~~~~~~~~~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~g-ivHrDlkp~NI  131 (405)
                      .+  +..++..    ..    .++||||++|++|....... ..+....+..++.||+.+|.+||..| ++||||||+||
T Consensus       110 ~~i~~p~~~~~----~~----~~lV~E~~~g~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NI  180 (237)
T smart00090      110 AGVPVPKPIAW----RR----NVLVMEFIGGDGLPAPRLKD-VEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNI  180 (237)
T ss_pred             cCCCCCeeeEe----cC----ceEEEEEecCCccccccccc-CCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhE
Confidence            33  3333321    11    35999999998887655333 35677778899999999999999999 99999999999


Q ss_pred             EEccCCceEeeecccccc
Q 015500          132 LMAESGAKIADFGCAKWE  149 (405)
Q Consensus       132 Li~~~~vkL~DFGla~~~  149 (405)
                      +++.+.++|+|||.+...
T Consensus       181 li~~~~i~LiDFg~a~~~  198 (237)
T smart00090      181 LVHDGKVVIIDVSQSVEL  198 (237)
T ss_pred             EEECCCEEEEEChhhhcc
Confidence            999444999999998743

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.81  E-value=7.7e-21  Score=189.44  Aligned_cols=173  Identities=27%  Similarity=0.398  Sum_probs=131.5

Q ss_pred             EEEEEEeecCCCCHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccc
Q 015500           73 MYNLFMEYAPGGTLNDEIHR--NGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWE  149 (405)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~i~~--~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~  149 (405)
                      ++|+.|++|...+|.++|.+  .+...+....+.++.|++.|++|   +|.+|+|+||.||+...+. +||.|||+....
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~  406 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQ  406 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeec
Confidence            57799999999999999964  33346777889999999999999   9999999999999998877 999999998754


Q ss_pred             ccc----------ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCch
Q 015500          150 SEA----------LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPA  219 (405)
Q Consensus       150 ~~~----------~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~  219 (405)
                      ...          ....||++||+||++.+..|+.++||||||++++|++.   +|.........+.. ...+.+|+...
T Consensus       407 ~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~---~f~T~~er~~t~~d-~r~g~ip~~~~  482 (516)
T KOG1033|consen  407 DKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI---QFSTQFERIATLTD-IRDGIIPPEFL  482 (516)
T ss_pred             ccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH---HhccHHHHHHhhhh-hhcCCCChHHh
Confidence            332          23459999999999999999999999999999999996   23211111111111 12222331111


Q ss_pred             hccHHHHHHHHHhcccCccccCCHHHHhcCccc
Q 015500          220 FLSKQANDFLSNCLRRDPKERWAASQLLKHPFL  252 (405)
Q Consensus       220 ~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~  252 (405)
                      .--++-..|+.++|...|.+||++.+.--|+|.
T Consensus       483 ~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~  515 (516)
T KOG1033|consen  483 QDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL  515 (516)
T ss_pred             hcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence            123455689999999999999977776666664

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.80  E-value=8.2e-19  Score=161.00  Aligned_cols=132  Identities=25%  Similarity=0.322  Sum_probs=107.7

Q ss_pred             ccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-----------hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEE
Q 015500            6 GHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-----------SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMY   74 (405)
Q Consensus         6 ~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-----------~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~   74 (405)
                      .+.||+|++|.||+|.+  .|..+++|......           ...+.+|+.++..+.|++|.....++.....    .
T Consensus         1 ~~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~----~   74 (211)
T PRK14879          1 MKLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPEN----F   74 (211)
T ss_pred             CcccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCC----C
Confidence            36899999999999987  67789999754321           1357789999999999988766555443332    4


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCCceEeeeccccc
Q 015500           75 NLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGAKIADFGCAKW  148 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~vkL~DFGla~~  148 (405)
                      +++|||++|++|.+++....    . ....++.+++.+|.++|+.|++|||++|.|||++.+.++|+|||++..
T Consensus        75 ~lv~e~~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~~~~~~liDf~~a~~  143 (211)
T PRK14879         75 IIVMEYIEGEPLKDLINSNG----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILSGGKIYLIDFGLAEF  143 (211)
T ss_pred             EEEEEEeCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEECCCEEEEECCcccC
Confidence            58999999999999986542    2 778899999999999999999999999999999954599999999875

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.79  E-value=1.2e-18  Score=158.55  Aligned_cols=127  Identities=25%  Similarity=0.341  Sum_probs=100.8

Q ss_pred             ccceeCCeeEEEEEEcCCCCEEEEEEccCCC-----------hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEE
Q 015500            8 TIGQGSSATVSLATSLRSGDVFAAKSTELPK-----------SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         8 ~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-----------~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      .||+|+||+||+|..  ++..+++|......           ...+.+|+++++.+.|+++......+.....    .++
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~----~~l   74 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDN----KTI   74 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCC----CEE
Confidence            489999999999984  57789999754211           2456789999999998876544433333322    358


Q ss_pred             EEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCCceEeeeccccc
Q 015500           77 FMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGAKIADFGCAKW  148 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~vkL~DFGla~~  148 (405)
                      +|||++|++|.+++.... .       .++.|++.+|.+||+.|++|+|++|.||+++.+.++++|||++..
T Consensus        75 v~e~~~g~~l~~~~~~~~-~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~~~~~~liDfg~a~~  138 (199)
T TIGR03724        75 VMEYIEGKPLKDVIEEGN-D-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVRDDKLYLIDFGLGKY  138 (199)
T ss_pred             EEEEECCccHHHHHhhcH-H-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEECCcEEEEECCCCcC
Confidence            999999999999876532 1       789999999999999999999999999999944499999999875

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.78  E-value=2e-20  Score=196.53  Aligned_cols=249  Identities=29%  Similarity=0.437  Sum_probs=195.4

Q ss_pred             CcccccccceeCCeeEEEEEEcCC-CCEEEEEEccCCC-----hHHHHHHHHHHHhCC-CCCeeeeeeeeeecCCCceEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRS-GDVFAAKSTELPK-----SEFLQREQKFLSSLN-SPHIVGYKGCDVTSEDNKLMY   74 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~-~~~vavK~~~~~~-----~~~l~~E~~iL~~L~-hpnIv~~~~~~~~~~~~~~~~   74 (405)
                      .|...+.||+|+|+.|-++....+ ...+|+|.+....     ......|..+-+.+. |+|++++++.....+    .+
T Consensus        21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~----~~   96 (601)
T KOG0590|consen   21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPR----SY   96 (601)
T ss_pred             cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCc----cc
Confidence            578889999999999988877544 3456677655432     234555888878886 999999988654443    36


Q ss_pred             EEEEeecCCCCHHHHH-HHcCCCCCHHHHHHHHHHHHHHHHHHH-hCCceeCCCCCCCEEEccCC--ceEeeeccccccc
Q 015500           75 NLFMEYAPGGTLNDEI-HRNGGRLDESLIVSYTRQILQGLEYLH-SNRVVHCDIKSRNILMAESG--AKIADFGCAKWES  150 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~i-~~~~~~l~e~~~~~i~~qIl~~L~yLH-~~givHrDlkp~NILi~~~~--vkL~DFGla~~~~  150 (405)
                      +++++|..|+++.+-+ .......+...+..++.|+..++.|+| ..++.|+|+||+|.+++..+  +++.|||+|....
T Consensus        97 ~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~  176 (601)
T KOG0590|consen   97 LLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYR  176 (601)
T ss_pred             ccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence            7999999999999988 443225778888999999999999999 99999999999999998877  9999999997543


Q ss_pred             c-------cccCCC-CCCccChhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCC--CCCCch
Q 015500          151 E-------ALQSGG-TPMFMAPEVARG-EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRE--LPEVPA  219 (405)
Q Consensus       151 ~-------~~~~~g-t~~Y~APE~l~~-~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~--~~~~p~  219 (405)
                      .       ....+| ++.|+|||...+ ...++..|+||.|+++..|++|..||..................  ......
T Consensus       177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (601)
T KOG0590|consen  177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWN  256 (601)
T ss_pred             ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccc
Confidence            3       223458 999999999988 56788999999999999999999999655433322111111111  123345


Q ss_pred             hccHHHHHHHHHhcccCccccCCHHHHhcCccccc
Q 015500          220 FLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEE  254 (405)
Q Consensus       220 ~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~  254 (405)
                      .++....+++.+++..+|..|.+.+++-.+||+..
T Consensus       257 ~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  257 SISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             cCChhhhhcccccccCCchhccccccccccccccc
Confidence            68899999999999999999999999999999987

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.78  E-value=8.7e-19  Score=177.31  Aligned_cols=196  Identities=24%  Similarity=0.399  Sum_probs=154.9

Q ss_pred             HHhCCCCCeeeeeeeeeecCCCceEEEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCc-eeCCCC
Q 015500           49 LSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRV-VHCDIK  127 (405)
Q Consensus        49 L~~L~hpnIv~~~~~~~~~~~~~~~~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~gi-vHrDlk  127 (405)
                      |+.+.|.|+.+++|..+....    +..|.+||..|+|.|.+......++..-...++++|+.||.|+|.-.| .|+.++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~----~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~   76 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPE----MIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALK   76 (484)
T ss_pred             CcccchhhhhhheeeEecCCc----eEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeec
Confidence            467899999999998876632    568999999999999999877789999999999999999999999866 999999


Q ss_pred             CCCEEEccCC-ceEeeecccccccc------cccCCCCCCccChhhhcCCC-------CCcchhHHHHHHHHHHHHhCCC
Q 015500          128 SRNILMAESG-AKIADFGCAKWESE------ALQSGGTPMFMAPEVARGEH-------QGFASDIWAVGCTVIEMASGGA  193 (405)
Q Consensus       128 p~NILi~~~~-vkL~DFGla~~~~~------~~~~~gt~~Y~APE~l~~~~-------~~~~sDIwSLG~il~elltG~~  193 (405)
                      +.|.+++... +||+|||+......      .....-...|.|||.+++..       .+.+.||||+|++++|+++.+.
T Consensus        77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~  156 (484)
T KOG1023|consen   77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG  156 (484)
T ss_pred             cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence            9999999998 99999999875532      11112344599999998742       3557999999999999999999


Q ss_pred             CCCCCC---ChHHHHHHHHhcCCC---CCCch--hccHHHHHHHHHhcccCccccCCHHHHhc
Q 015500          194 PWPNAA---DPMTVLYKIAYSREL---PEVPA--FLSKQANDFLSNCLRRDPKERWAASQLLK  248 (405)
Q Consensus       194 Pf~~~~---~~~~~l~~i~~~~~~---~~~p~--~~s~~l~dll~~~L~~dP~~Rpt~~elL~  248 (405)
                      ||....   ++.+...++......   |.++.  ...+++..+++.||..+|.+||+++++-.
T Consensus       157 ~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~  219 (484)
T KOG1023|consen  157 PFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS  219 (484)
T ss_pred             ccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence            997643   233445554442222   22221  34567999999999999999999998844

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.76  E-value=3.3e-18  Score=156.05  Aligned_cols=131  Identities=22%  Similarity=0.186  Sum_probs=104.0

Q ss_pred             cccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-------------------------hHHHHHHHHHHHhCCCCC-
Q 015500            3 WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-------------------------SEFLQREQKFLSSLNSPH-   56 (405)
Q Consensus         3 y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-------------------------~~~l~~E~~iL~~L~hpn-   56 (405)
                      |..++.||+|+||.||+|.+. +|+.+|||.+....                         .....+|..++..+.|++ 
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   95 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF   95 (198)
T ss_pred             hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence            778899999999999999874 89999999865421                         113567899999998774 


Q ss_pred             -eeeeeeeeeecCCCceEEEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcc
Q 015500           57 -IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAE  135 (405)
Q Consensus        57 -Iv~~~~~~~~~~~~~~~~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~  135 (405)
                       ++..++.    ..    .+++|||++|++|.+....       .....++.+++.++.++|+.|++||||||+||+++.
T Consensus        96 ~v~~~~~~----~~----~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~  160 (198)
T cd05144          96 PVPKPIDW----NR----HAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDD  160 (198)
T ss_pred             CCCceeec----CC----ceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcC
Confidence             3333321    11    3589999999999765321       345678899999999999999999999999999997


Q ss_pred             CC-ceEeeecccccc
Q 015500          136 SG-AKIADFGCAKWE  149 (405)
Q Consensus       136 ~~-vkL~DFGla~~~  149 (405)
                      ++ ++|+|||++...
T Consensus       161 ~~~~~liDfg~~~~~  175 (198)
T cd05144         161 DEKIYIIDWPQMVST  175 (198)
T ss_pred             CCcEEEEECCccccC
Confidence            77 999999998643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.76  E-value=6.8e-18  Score=176.66  Aligned_cols=133  Identities=23%  Similarity=0.332  Sum_probs=103.6

Q ss_pred             cccccccceeCCeeEEEEEEcCCCCEEEEEEccCC---------ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceE
Q 015500            3 WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP---------KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLM   73 (405)
Q Consensus         3 y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~---------~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~   73 (405)
                      |...+.||+|+||+||+|.+......+.++.....         ..+.+.+|+++++.++|++++....+......    
T Consensus       335 ~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~----  410 (535)
T PRK09605        335 KIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE----  410 (535)
T ss_pred             cCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC----
Confidence            35578999999999999987543322222221111         12457899999999999999876655544332    


Q ss_pred             EEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCCceEeeeccccc
Q 015500           74 YNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGAKIADFGCAKW  148 (405)
Q Consensus        74 ~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~vkL~DFGla~~  148 (405)
                      .++||||++|++|.+++.         ....++.|++.+|.+||+.|++||||||+|||++.+.++|+|||+++.
T Consensus       411 ~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~~~~~~liDFGla~~  476 (535)
T PRK09605        411 KTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVRDDRLYLIDFGLGKY  476 (535)
T ss_pred             CEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEECCcEEEEeCccccc
Confidence            358999999999999875         346789999999999999999999999999999655699999999975

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.70  E-value=2.1e-16  Score=148.71  Aligned_cols=135  Identities=18%  Similarity=0.205  Sum_probs=102.9

Q ss_pred             ccccc-eeCCeeEEEEEEcCCCCEEEEEEccCC----------------ChHHHHHHHHHHHhCCCCCe--eeeeeeeee
Q 015500            6 GHTIG-QGSSATVSLATSLRSGDVFAAKSTELP----------------KSEFLQREQKFLSSLNSPHI--VGYKGCDVT   66 (405)
Q Consensus         6 ~~~LG-~G~~g~Vyla~~~~~~~~vavK~~~~~----------------~~~~l~~E~~iL~~L~hpnI--v~~~~~~~~   66 (405)
                      +..|| .|+.|+||.+...  +..++||.+...                ....+.+|+.++..|.|++|  +..++....
T Consensus        36 ~~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~  113 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV  113 (239)
T ss_pred             CceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence            45788 8999999999764  778898866421                12467889999999998875  455554333


Q ss_pred             cCCCceEEEEEEeecCC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeec
Q 015500           67 SEDNKLMYNLFMEYAPG-GTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFG  144 (405)
Q Consensus        67 ~~~~~~~~~lv~Ey~~g-gsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFG  144 (405)
                      ........++|||+++| .+|.+++..  +++++..    +.||+.+|.+||+.||+||||||.|||++.++ ++|+|||
T Consensus       114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg  187 (239)
T PRK01723        114 RHGLFYRADILIERIEGARDLVALLQE--APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFD  187 (239)
T ss_pred             ecCcceeeeEEEEecCCCCCHHHHHhc--CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECC
Confidence            22211112489999997 689988864  3566653    57899999999999999999999999998877 9999999


Q ss_pred             cccc
Q 015500          145 CAKW  148 (405)
Q Consensus       145 la~~  148 (405)
                      .+..
T Consensus       188 ~~~~  191 (239)
T PRK01723        188 RGEL  191 (239)
T ss_pred             Cccc
Confidence            8864

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.69  E-value=1.2e-16  Score=143.79  Aligned_cols=133  Identities=24%  Similarity=0.211  Sum_probs=96.0

Q ss_pred             cccccceeCCeeEEEEEEcCCCCEEEEEEccCCCh-----HH----------------------HHHHHHHHHhCCCCC-
Q 015500            5 RGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS-----EF----------------------LQREQKFLSSLNSPH-   56 (405)
Q Consensus         5 ~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~~-----~~----------------------l~~E~~iL~~L~hpn-   56 (405)
                      +++.||+|+||+||+|.+. +++.||||++.....     ..                      ...|...+.++.+.+ 
T Consensus         1 ~~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~   79 (187)
T cd05119           1 VGGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV   79 (187)
T ss_pred             CCcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence            3678999999999999986 899999998764321     11                      135666666664433 


Q ss_pred             -eeeeeeeeeecCCCceEEEEEEeecCCCCHHH-HHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCCEEE
Q 015500           57 -IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLND-EIHRNGGRLDESLIVSYTRQILQGLEYLHS-NRVVHCDIKSRNILM  133 (405)
Q Consensus        57 -Iv~~~~~~~~~~~~~~~~~lv~Ey~~ggsL~~-~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~-~givHrDlkp~NILi  133 (405)
                       +.+++++.    .    .+++|||++|+.+.. .+....  .. ..++.++.+++.++.++|. .||+|+||||+||++
T Consensus        80 ~~~~~~~~~----~----~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili  148 (187)
T cd05119          80 PVPKPIDLN----R----HVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILV  148 (187)
T ss_pred             CCCceEecC----C----CEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEE
Confidence             33333321    1    359999999954432 122111  11 6678899999999999999 999999999999999


Q ss_pred             ccCCceEeeecccccc
Q 015500          134 AESGAKIADFGCAKWE  149 (405)
Q Consensus       134 ~~~~vkL~DFGla~~~  149 (405)
                      +.+.++|+|||.+...
T Consensus       149 ~~~~~~liDfg~a~~~  164 (187)
T cd05119         149 DDGKVYIIDVPQAVEI  164 (187)
T ss_pred             ECCcEEEEECcccccc
Confidence            9444999999998643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.68  E-value=1.3e-16  Score=136.56  Aligned_cols=132  Identities=20%  Similarity=0.207  Sum_probs=106.9

Q ss_pred             cccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-hHHHHHHHHHHHhCCC--CCeeeeeeeeeecCCCceEEEEEEeec
Q 015500            5 RGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-SEFLQREQKFLSSLNS--PHIVGYKGCDVTSEDNKLMYNLFMEYA   81 (405)
Q Consensus         5 ~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-~~~l~~E~~iL~~L~h--pnIv~~~~~~~~~~~~~~~~~lv~Ey~   81 (405)
                      +++.||+|.++.||++...  +..+++|...... ...+.+|..+++.+++  +++++++......    ...+++|||+
T Consensus         2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~----~~~~~v~e~~   75 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESD----GWSYLLMEWI   75 (155)
T ss_pred             cceecccccccceEEEEec--CCeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCCC----CccEEEEEec
Confidence            5688999999999999975  3789999886544 3578999999999976  4788777654332    2356899999


Q ss_pred             CCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCCCCEEEccCC-ceEeeeccccccc
Q 015500           82 PGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN---RVVHCDIKSRNILMAESG-AKIADFGCAKWES  150 (405)
Q Consensus        82 ~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~---givHrDlkp~NILi~~~~-vkL~DFGla~~~~  150 (405)
                      +|+.+..+        +......++.+++.+|+++|..   +++|+|++|.||+++..+ +++.|||.+....
T Consensus        76 ~g~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~~  140 (155)
T cd05120          76 EGETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYGP  140 (155)
T ss_pred             CCeecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCCC
Confidence            98877653        5566678899999999999985   799999999999999855 9999999987433

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.61  E-value=2.8e-16  Score=167.06  Aligned_cols=254  Identities=26%  Similarity=0.373  Sum_probs=193.9

Q ss_pred             cccccccceeCCeeEEEEEEcCCCCEEEEEEccCC------ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEE
Q 015500            3 WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         3 y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~------~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      +.+.+.+-+|+++.++.+.-..+|..++.|+..+.      +.+...++-.++-...+|-++...-.+.....    .+|
T Consensus       806 ~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP----~~L  881 (1205)
T KOG0606|consen  806 FEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSP----LPL  881 (1205)
T ss_pred             ceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCC----cch
Confidence            45667888999999999998888888877764432      23444555555555566777654433222222    559


Q ss_pred             EEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc----
Q 015500           77 FMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE----  151 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~----  151 (405)
                      +++|+.|++|...+...+ +.++.-++.+...++.+++|||+..+.|+|++|.|+++..++ .+++|||......-    
T Consensus       882 ~~~~~~~~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~  960 (1205)
T KOG0606|consen  882 VGHYLNGGDLPSKLHNSG-CLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPT  960 (1205)
T ss_pred             hhHHhccCCchhhhhcCC-CcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCc
Confidence            999999999999887764 888999999999999999999999999999999999998888 89999984321000    


Q ss_pred             -------------------------------cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 015500          152 -------------------------------ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAAD  200 (405)
Q Consensus       152 -------------------------------~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~  200 (405)
                                                     .....||+.|.+||.+.+...++.+|.|++|++++|.++|.+||. ...
T Consensus       961 ~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~n-a~t 1039 (1205)
T KOG0606|consen  961 TDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFN-AET 1039 (1205)
T ss_pred             CCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCC-Ccc
Confidence                                           111238999999999999999999999999999999999999994 334


Q ss_pred             hHHHHHHHHhc-CCCCCCchhccHHHHHHHHHhcccCccccCCHH---HHhcCccccccccccccc
Q 015500          201 PMTVLYKIAYS-RELPEVPAFLSKQANDFLSNCLRRDPKERWAAS---QLLKHPFLEEFCSCTKQI  262 (405)
Q Consensus       201 ~~~~l~~i~~~-~~~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~---elL~hp~~~~~~~~~~~~  262 (405)
                      +...+..+... ...|.-|...+..+++++.++|..+|.+|..+.   +.-.||||+.........
T Consensus      1040 pq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~l~~ 1105 (1205)
T KOG0606|consen 1040 PQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWENLAL 1105 (1205)
T ss_pred             hhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCcccccc
Confidence            44444443322 233455566899999999999999999999987   889999999876554433

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.52  E-value=8.9e-14  Score=141.84  Aligned_cols=137  Identities=23%  Similarity=0.235  Sum_probs=93.4

Q ss_pred             ccccceeCCeeEEEEEEcCCCCEEEEEEccCCChHH-------------------------------------------H
Q 015500            6 GHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEF-------------------------------------------L   42 (405)
Q Consensus         6 ~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~~~~-------------------------------------------l   42 (405)
                      .+.||+|++|.||+|+.+ +|+.||||+....-.+.                                           +
T Consensus       122 ~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf  200 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL  200 (437)
T ss_pred             CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence            478999999999999874 79999999876543222                                           2


Q ss_pred             HHHHHHHHhC----C-CCCeeeeeeeeeecCCCceEEEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHH-HHHHH
Q 015500           43 QREQKFLSSL----N-SPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQ-GLEYL  116 (405)
Q Consensus        43 ~~E~~iL~~L----~-hpnIv~~~~~~~~~~~~~~~~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~-~L~yL  116 (405)
                      .+|.+.+.++    + +|+|. +...+..... .  .+++|||++|++|.+.........+   ...++.+++. .+..+
T Consensus       201 ~~Ea~n~~~~~~~~~~~~~v~-vP~v~~~~~~-~--~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql  273 (437)
T TIGR01982       201 RREAANASELGENFKNDPGVY-VPEVYWDRTS-E--RVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQV  273 (437)
T ss_pred             HHHHHHHHHHHHhcCCCCCEE-eCCEehhhcC-C--ceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHH
Confidence            2344444443    2 23332 2222221111 1  3489999999999887654221232   2345556655 47889


Q ss_pred             HhCCceeCCCCCCCEEEccCC-ceEeeeccccccc
Q 015500          117 HSNRVVHCDIKSRNILMAESG-AKIADFGCAKWES  150 (405)
Q Consensus       117 H~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~  150 (405)
                      |..|++|+|+||.||+++.++ ++++|||++....
T Consensus       274 ~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       274 LRDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             HhCCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            999999999999999998887 9999999987543

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.51  E-value=1.8e-14  Score=146.36  Aligned_cols=243  Identities=25%  Similarity=0.254  Sum_probs=181.5

Q ss_pred             cccccccce--eCCeeEEEEEE--cCCCCEEEEEEccCCC-----hHHHHHHHHHHHhC-CCCCeeeeeeeeeecCCCce
Q 015500            3 WTRGHTIGQ--GSSATVSLATS--LRSGDVFAAKSTELPK-----SEFLQREQKFLSSL-NSPHIVGYKGCDVTSEDNKL   72 (405)
Q Consensus         3 y~~~~~LG~--G~~g~Vyla~~--~~~~~~vavK~~~~~~-----~~~l~~E~~iL~~L-~hpnIv~~~~~~~~~~~~~~   72 (405)
                      +-+.+.+|+  |.+|.||.+..  ..++..+|+|.-...-     ...-.+|....+.+ .|++.++.+..+...    .
T Consensus       116 ~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~----~  191 (524)
T KOG0601|consen  116 FPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGS----G  191 (524)
T ss_pred             cccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccC----C
Confidence            345678999  99999999998  8899999999744321     22334555555555 578888744433222    2


Q ss_pred             EEEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHH----HHHHHHhCCceeCCCCCCCEEEccC-C-ceEeeeccc
Q 015500           73 MYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQ----GLEYLHSNRVVHCDIKSRNILMAES-G-AKIADFGCA  146 (405)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~----~L~yLH~~givHrDlkp~NILi~~~-~-vkL~DFGla  146 (405)
                      ..++-+|+| |.+|..+......-+++..+..++.+...    ||.++|+.+++|-|+||.||+...+ . .+++|||+.
T Consensus       192 ~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v  270 (524)
T KOG0601|consen  192 ILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLV  270 (524)
T ss_pred             cceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCccee
Confidence            355788888 57898888776555899999999999999    9999999999999999999999988 4 899999988


Q ss_pred             cccccc---------ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-ChHHHHHHHHhcCCCCC
Q 015500          147 KWESEA---------LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAA-DPMTVLYKIAYSRELPE  216 (405)
Q Consensus       147 ~~~~~~---------~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~-~~~~~l~~i~~~~~~~~  216 (405)
                      ......         ....|...|++||..++ -++...|+++||.++.+-.+|..+..... +....+.+..   ...+
T Consensus       271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~---ip~e  346 (524)
T KOG0601|consen  271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY---IPLE  346 (524)
T ss_pred             EEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc---Cchh
Confidence            754331         12247778999999986 46779999999999999999887764331 1122111111   1122


Q ss_pred             CchhccHHHHHHHHHhcccCccccCCHHHHhcCccccc
Q 015500          217 VPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEE  254 (405)
Q Consensus       217 ~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~  254 (405)
                      +....+.++...+..|++.+|..|+++..++.|+++..
T Consensus       347 ~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s  384 (524)
T KOG0601|consen  347 FCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS  384 (524)
T ss_pred             hhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence            33345667777999999999999999999999999875

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.45  E-value=4.3e-14  Score=134.05  Aligned_cols=204  Identities=26%  Similarity=0.312  Sum_probs=144.0

Q ss_pred             HHHHHhCCCCCeeeeeeeeeecCC-CceEEEEEEeecCCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhC--
Q 015500           46 QKFLSSLNSPHIVGYKGCDVTSED-NKLMYNLFMEYAPGGTLNDEIHR---NGGRLDESLIVSYTRQILQGLEYLHSN--  119 (405)
Q Consensus        46 ~~iL~~L~hpnIv~~~~~~~~~~~-~~~~~~lv~Ey~~ggsL~~~i~~---~~~~l~e~~~~~i~~qIl~~L~yLH~~--  119 (405)
                      ..-|-.|-|.|||++..++.+... +.....++.||+..|+|..++++   ++..+....-++|+-||+.||.|||+.  
T Consensus       118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~P  197 (458)
T KOG1266|consen  118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDP  197 (458)
T ss_pred             HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCC
Confidence            344566789999988766543332 22234468999999999999875   445688889999999999999999998  


Q ss_pred             CceeCCCCCCCEEEccCC-ceEeeeccccc---c-----cccccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh
Q 015500          120 RVVHCDIKSRNILMAESG-AKIADFGCAKW---E-----SEALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS  190 (405)
Q Consensus       120 givHrDlkp~NILi~~~~-vkL~DFGla~~---~-----~~~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt  190 (405)
                      -|+|+++..+.|++..++ +|+.---....   +     .+.....+-++|.|||.=..-+.+-++|||++|....+|..
T Consensus       198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai  277 (458)
T KOG1266|consen  198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI  277 (458)
T ss_pred             ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence            599999999999999888 66542111110   0     01222347889999998777677779999999999999999


Q ss_pred             CCCCCCCCCChHHHHHHHHhcCCCCCCchhcc-HHHHHHHHHhcccCccccCCHHHHhcCcccccc
Q 015500          191 GGAPWPNAADPMTVLYKIAYSRELPEVPAFLS-KQANDFLSNCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       191 G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s-~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      |..--.+.......-..+...      ...++ .--++++.+||+..|..||++..+|.||.+-++
T Consensus       278 lEiq~tnseS~~~~ee~ia~~------i~~len~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeV  337 (458)
T KOG1266|consen  278 LEIQSTNSESKVEVEENIANV------IIGLENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEV  337 (458)
T ss_pred             heeccCCCcceeehhhhhhhh------eeeccCccccCcCcccccCCCCCCcchhhhhcCceeeec
Confidence            876533332211111111100      00112 223578999999999999999999999987554

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.45  E-value=3.9e-13  Score=118.68  Aligned_cols=125  Identities=17%  Similarity=0.091  Sum_probs=95.2

Q ss_pred             ccccceeCCeeEEEEEEcCCCCEEEEEEccCCC--hHHHHHHHHHHHhCCCCCee-eeeeeeeecCCCceEEEEEEeecC
Q 015500            6 GHTIGQGSSATVSLATSLRSGDVFAAKSTELPK--SEFLQREQKFLSSLNSPHIV-GYKGCDVTSEDNKLMYNLFMEYAP   82 (405)
Q Consensus         6 ~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~--~~~l~~E~~iL~~L~hpnIv-~~~~~~~~~~~~~~~~~lv~Ey~~   82 (405)
                      .+.|+.|.++.||++...  ++.+++|......  .....+|..+++.+.+.+++ +++...  ...    .++||||++
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~----~~lv~e~i~   74 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD--PET----GVLITEFIE   74 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe--CCC----CeEEEEecC
Confidence            467899999999999864  7889999976543  34578899999998665544 343322  111    248999999


Q ss_pred             CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCc-----eeCCCCCCCEEEccCCceEeeecccc
Q 015500           83 GGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRV-----VHCDIKSRNILMAESGAKIADFGCAK  147 (405)
Q Consensus        83 ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~gi-----vHrDlkp~NILi~~~~vkL~DFGla~  147 (405)
                      |.++.+.      .   .....++.+++.+|+.||+.++     +|+|++|.||+++.+.++++|||.+.
T Consensus        75 G~~l~~~------~---~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~~~~~~liDf~~a~  135 (170)
T cd05151          75 GSELLTE------D---FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLDDGRLWLIDWEYAG  135 (170)
T ss_pred             CCccccc------c---ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEECCeEEEEeccccc
Confidence            9888643      0   1123457899999999999985     99999999999996669999999986

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.42  E-value=1.6e-13  Score=139.49  Aligned_cols=242  Identities=23%  Similarity=0.244  Sum_probs=176.9

Q ss_pred             CcccccccceeCCeeEEEEEEc-CCCCEEEEEEccCCCh-----HHHHHHHHHHHhC-CCCCeeeeeeeeeecCCCceEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSL-RSGDVFAAKSTELPKS-----EFLQREQKFLSSL-NSPHIVGYKGCDVTSEDNKLMY   74 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~-~~~~~vavK~~~~~~~-----~~l~~E~~iL~~L-~hpnIv~~~~~~~~~~~~~~~~   74 (405)
                      +|-.+..||.|.|+.|+...-+ .++..|++|-......     ..-..|+.+...+ .|.|++++...+.....    .
T Consensus       266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~----~  341 (524)
T KOG0601|consen  266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ----G  341 (524)
T ss_pred             CcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc----c
Confidence            4567788999999999887644 6788899986543322     2233566666666 68888887665443333    2


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC--ceEeeecccccccc-
Q 015500           75 NLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG--AKIADFGCAKWESE-  151 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~--vkL~DFGla~~~~~-  151 (405)
                      |+-.|||+++++...+.-. ..+++...+++..|++.++.++|++.++|+|+||.||++..++  .++.|||++..... 
T Consensus       342 ~ip~e~~~~~s~~l~~~~~-~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~  420 (524)
T KOG0601|consen  342 YIPLEFCEGGSSSLRSVTS-QMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS  420 (524)
T ss_pred             cCchhhhcCcchhhhhHHH-HhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccccee
Confidence            3788999999887766333 4688999999999999999999999999999999999998864  79999999875322 


Q ss_pred             cccCC-CCCCc-cChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHH
Q 015500          152 ALQSG-GTPMF-MAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFL  229 (405)
Q Consensus       152 ~~~~~-gt~~Y-~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll  229 (405)
                      ..... ++..| .+|.++....+..++|++|||..+++.++|...=.....    . ........|..|... .++..+.
T Consensus       421 ~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~----~-~~i~~~~~p~~~~~~-~~~q~~~  494 (524)
T KOG0601|consen  421 SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ----S-LTIRSGDTPNLPGLK-LQLQVLL  494 (524)
T ss_pred             cccccccccccccchhhccccccccccccccccccccccccCcccCccccc----c-eeeecccccCCCchH-Hhhhhhh
Confidence            12222 34444 355555566788899999999999999998654322211    1 112233455555544 8999999


Q ss_pred             HHhcccCccccCCHHHHhcCccccc
Q 015500          230 SNCLRRDPKERWAASQLLKHPFLEE  254 (405)
Q Consensus       230 ~~~L~~dP~~Rpt~~elL~hp~~~~  254 (405)
                      +.+...++..|+.+.++..|+=|..
T Consensus       495 kv~~~~~~~~~~l~~~l~~~~~~~~  519 (524)
T KOG0601|consen  495 KVMINPDRKRRPSAVELSLHSEFYR  519 (524)
T ss_pred             hhhcCCccccchhhhhhcccchhhh
Confidence            9999999999999999988876553

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.40  E-value=2.2e-12  Score=117.25  Aligned_cols=133  Identities=15%  Similarity=0.143  Sum_probs=97.0

Q ss_pred             ccccceeCCeeEEEEEEcC------CCCEEEEEEccCCC-------------------------hH----HHHHHHHHHH
Q 015500            6 GHTIGQGSSATVSLATSLR------SGDVFAAKSTELPK-------------------------SE----FLQREQKFLS   50 (405)
Q Consensus         6 ~~~LG~G~~g~Vyla~~~~------~~~~vavK~~~~~~-------------------------~~----~l~~E~~iL~   50 (405)
                      ..+||.|.-+.||.|....      .+..+|||+.....                         ..    ..++|.+.|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            4689999999999998653      35789999643210                         11    2348999999


Q ss_pred             hCCC--CCeeeeeeeeeecCCCceEEEEEEeecCCCCHHH-HHHHcCCCCCHHHHHHHHHHHHHHHHHH-HhCCceeCCC
Q 015500           51 SLNS--PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLND-EIHRNGGRLDESLIVSYTRQILQGLEYL-HSNRVVHCDI  126 (405)
Q Consensus        51 ~L~h--pnIv~~~~~~~~~~~~~~~~~lv~Ey~~ggsL~~-~i~~~~~~l~e~~~~~i~~qIl~~L~yL-H~~givHrDl  126 (405)
                      ++..  -++...+.+   ..     .++||||+.+..+.. .++.  ..+++..+..+..|++.+|..+ |..|+||+||
T Consensus        82 rl~~~Gv~vP~pi~~---~~-----~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDL  151 (197)
T cd05146          82 RMQKAGIPCPEVVVL---KK-----HVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYKECNLVHADL  151 (197)
T ss_pred             HHHHcCCCCCeEEEe---cC-----CEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence            9843  344444432   11     348999997654432 2322  2466667788899999999999 8999999999


Q ss_pred             CCCCEEEccCCceEeeeccccc
Q 015500          127 KSRNILMAESGAKIADFGCAKW  148 (405)
Q Consensus       127 kp~NILi~~~~vkL~DFGla~~  148 (405)
                      ++.||++..+.+.|+|||.+-.
T Consensus       152 s~~NIL~~~~~v~iIDF~qav~  173 (197)
T cd05146         152 SEYNMLWHDGKVWFIDVSQSVE  173 (197)
T ss_pred             CHHHEEEECCcEEEEECCCcee
Confidence            9999999877799999998754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.40  E-value=1.2e-12  Score=135.62  Aligned_cols=137  Identities=19%  Similarity=0.169  Sum_probs=91.7

Q ss_pred             cccccccceeCCeeEEEEEEcCCCCEEEEEEccCCChH-------------------------------------H----
Q 015500            3 WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSE-------------------------------------F----   41 (405)
Q Consensus         3 y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~~~-------------------------------------~----   41 (405)
                      |.. +.||+|++|+||+|+.+.+|+.||||+....-.+                                     .    
T Consensus       122 fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~E  200 (537)
T PRK04750        122 FDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDE  200 (537)
T ss_pred             cCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHh
Confidence            444 7899999999999999888999999988643211                                     1    


Q ss_pred             --HHHHHHHHHhCC----CCCeeeeeeeeeecCCCceEEEEEEeecCCCCHHHH--HHHcCC---CCCHHHHHHHHHHHH
Q 015500           42 --LQREQKFLSSLN----SPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDE--IHRNGG---RLDESLIVSYTRQIL  110 (405)
Q Consensus        42 --l~~E~~iL~~L~----hpnIv~~~~~~~~~~~~~~~~~lv~Ey~~ggsL~~~--i~~~~~---~l~e~~~~~i~~qIl  110 (405)
                        +.+|...+.++.    +.+.+.+-.++..... .  .+|||||+.|+.+.+.  +...+-   .+.+..+..++.|++
T Consensus       201 lD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st-~--~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif  277 (537)
T PRK04750        201 LDLMREAANASQLRRNFEDSDMLYVPEVYWDYCS-E--TVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF  277 (537)
T ss_pred             hCHHHHHHHHHHHHHHccCCCCeecceeecccCC-C--ceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence              223443333332    3332322222221111 1  3489999999999874  333321   355556666666665


Q ss_pred             HHHHHHHhCCceeCCCCCCCEEEccCC-----ceEeeeccccccc
Q 015500          111 QGLEYLHSNRVVHCDIKSRNILMAESG-----AKIADFGCAKWES  150 (405)
Q Consensus       111 ~~L~yLH~~givHrDlkp~NILi~~~~-----vkL~DFGla~~~~  150 (405)
                             ..|++|+|+||.||+++.++     ++++|||++...+
T Consensus       278 -------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        278 -------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             -------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence                   48999999999999998764     8999999987543

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.39  E-value=8.2e-12  Score=128.53  Aligned_cols=164  Identities=21%  Similarity=0.279  Sum_probs=126.7

Q ss_pred             EE-EEEEcCCCCEEEEEEccCCCh---HHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEeecCCCCHHHHHHH
Q 015500           17 VS-LATSLRSGDVFAAKSTELPKS---EFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHR   92 (405)
Q Consensus        17 Vy-la~~~~~~~~vavK~~~~~~~---~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~Ey~~ggsL~~~i~~   92 (405)
                      +| .|..+.++.++.|...+....   +...+-++-|+.|+||||++|+.......    ..|+|+|-+.  .|..++++
T Consensus        27 ~~~~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~----~~ylvTErV~--Pl~~~lk~  100 (690)
T KOG1243|consen   27 LWPDGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEG----TLYLVTERVR--PLETVLKE  100 (690)
T ss_pred             cccccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccC----ceEEEeeccc--cHHHHHHH
Confidence            44 466778889998888765544   66888999999999999999998766544    3679999874  78888876


Q ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHH-hCCceeCCCCCCCEEEccCC-ceEeeeccccccccccc----CCCCCCccChhh
Q 015500           93 NGGRLDESLIVSYTRQILQGLEYLH-SNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQ----SGGTPMFMAPEV  166 (405)
Q Consensus        93 ~~~~l~e~~~~~i~~qIl~~L~yLH-~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~~~----~~gt~~Y~APE~  166 (405)
                      .+    ...+...++||+.||.+|| ..+++|++|.-..|+|+..| .||++|.++........    ..---.|..|+.
T Consensus       101 l~----~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~  176 (690)
T KOG1243|consen  101 LG----KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEE  176 (690)
T ss_pred             hH----HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhh
Confidence            53    7778889999999999998 56899999999999999998 99999998765433221    111223556665


Q ss_pred             hcCCCCCcchhHHHHHHHHHHHHhCC
Q 015500          167 ARGEHQGFASDIWAVGCTVIEMASGG  192 (405)
Q Consensus       167 l~~~~~~~~sDIwSLG~il~elltG~  192 (405)
                      +....  -..|.|.|||++++++.|.
T Consensus       177 ~~~s~--~s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  177 IDPSE--WSIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             cCccc--cchhhhhHHHHHHHHhCcc
Confidence            54332  3469999999999999993

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.33  E-value=1.6e-11  Score=108.93  Aligned_cols=128  Identities=24%  Similarity=0.321  Sum_probs=96.5

Q ss_pred             cccceeCCeeEEEEEEcCCCCEEEEEEccCC-----------ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEE
Q 015500            7 HTIGQGSSATVSLATSLRSGDVFAAKSTELP-----------KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         7 ~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~-----------~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~   75 (405)
                      ..+++|+-+.+|++...  |..+++|.--..           ..+...+|.++|.+++--.|....-++++...    ..
T Consensus         2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~----~~   75 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDN----GL   75 (204)
T ss_pred             chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCC----CE
Confidence            46889999999999663  445666643221           12456789999999865555443333444433    33


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCCceEeeeccccc
Q 015500           76 LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGAKIADFGCAKW  148 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~vkL~DFGla~~  148 (405)
                      ++|||++|..|.+.+...        ...+++.+-.-+.-||..||+|+||.++||++..+++.++|||++..
T Consensus        76 I~me~I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~i~~IDfGLg~~  140 (204)
T COG3642          76 IVMEYIEGELLKDALEEA--------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGRIYFIDFGLGEF  140 (204)
T ss_pred             EEEEEeCChhHHHHHHhc--------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCcEEEEECCcccc
Confidence            899999999999888765        14566777778889999999999999999999999999999999874

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.21  E-value=1.7e-10  Score=102.14  Aligned_cols=137  Identities=23%  Similarity=0.292  Sum_probs=101.6

Q ss_pred             cccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-----------hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceE
Q 015500            5 RGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-----------SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLM   73 (405)
Q Consensus         5 ~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-----------~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~   73 (405)
                      ....|-+|+-+.|+++.+.  |+.+.||.-....           ..+..+|+++|.++.--.|.-..-++.+...+   
T Consensus        11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~---   85 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGG---   85 (229)
T ss_pred             cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCC---
Confidence            3567889999999999874  8888888643321           24677899999888544444322233333332   


Q ss_pred             EEEEEeecCC-CCHHHHHHHcCCCCCHHHH-HHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC----ceEeeecccc
Q 015500           74 YNLFMEYAPG-GTLNDEIHRNGGRLDESLI-VSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG----AKIADFGCAK  147 (405)
Q Consensus        74 ~~lv~Ey~~g-gsL~~~i~~~~~~l~e~~~-~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~----vkL~DFGla~  147 (405)
                       +++|||++| .++.+++......-.+... ..++++|-..+.-||..+|+|+||..+||++..++    +.++|||++.
T Consensus        86 -~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~  164 (229)
T KOG3087|consen   86 -QIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSS  164 (229)
T ss_pred             -eEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchh
Confidence             378999987 4788888765444444443 78899999999999999999999999999997775    5899999975

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.20  E-value=6.1e-10  Score=111.85  Aligned_cols=213  Identities=18%  Similarity=0.179  Sum_probs=156.2

Q ss_pred             CeeEEEEEEcCCCCEEEEEEccCCChH---HHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEeecCC-CCHHHH
Q 015500           14 SATVSLATSLRSGDVFAAKSTELPKSE---FLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPG-GTLNDE   89 (405)
Q Consensus        14 ~g~Vyla~~~~~~~~vavK~~~~~~~~---~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~Ey~~g-gsL~~~   89 (405)
                      ..+.|+|....+|..|++|.+...+..   ....-.++++++.|+|||++..++.+...+...+++|++|.++ ++|.++
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~  368 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL  368 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence            357899999999999999998443322   3344577899999999999999988666666677899999986 578776


Q ss_pred             HHH--------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccccc
Q 015500           90 IHR--------------NGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQ  154 (405)
Q Consensus        90 i~~--------------~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~~~  154 (405)
                      ...              .+...+|..++.|+.||..||.++|+.|+..+-|.|.+|+++.+. ++|...|......... 
T Consensus       369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~-  447 (655)
T KOG3741|consen  369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP-  447 (655)
T ss_pred             HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCCC-
Confidence            532              123478999999999999999999999999999999999999885 6666555443322211 


Q ss_pred             CCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHH-HHHHHhcCCCCCCchhccHHHHHHHHHhc
Q 015500          155 SGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTV-LYKIAYSRELPEVPAFLSKQANDFLSNCL  233 (405)
Q Consensus       155 ~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~-l~~i~~~~~~~~~p~~~s~~l~dll~~~L  233 (405)
                        +       |.+.+   -.+-|.=.||.++..|.||..--.......+. +.         .+-..++.++++++.-+.
T Consensus       448 --~-------~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~---------~I~~~yS~D~rn~v~yl~  506 (655)
T KOG3741|consen  448 --T-------EPLES---QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLT---------RITTTYSTDLRNVVEYLE  506 (655)
T ss_pred             --C-------cchhH---HhhhhHHHHHHHHHHHhhcccccccccchHHHHHH---------HhhhhhhHHHHHHHHHHH
Confidence              1       11222   12569999999999999996531111111111 22         223447899999999999


Q ss_pred             ccCccccCCHHHHhcC
Q 015500          234 RRDPKERWAASQLLKH  249 (405)
Q Consensus       234 ~~dP~~Rpt~~elL~h  249 (405)
                      ..++.+ -++.+++.|
T Consensus       507 s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  507 SLNFRE-KSIQDLLPM  521 (655)
T ss_pred             hcCccc-ccHHHHHHH
Confidence            999887 688888876

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.15  E-value=2.9e-10  Score=104.37  Aligned_cols=139  Identities=20%  Similarity=0.184  Sum_probs=102.7

Q ss_pred             ccccceeCCeeEEEEEEcCCCCEEEEEEccCCC----hHHHHHHHHHHHhCCCCC--eeeeeeeeeecCCCceEEEEEEe
Q 015500            6 GHTIGQGSSATVSLATSLRSGDVFAAKSTELPK----SEFLQREQKFLSSLNSPH--IVGYKGCDVTSEDNKLMYNLFME   79 (405)
Q Consensus         6 ~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~----~~~l~~E~~iL~~L~hpn--Iv~~~~~~~~~~~~~~~~~lv~E   79 (405)
                      .+.||.|.++.||++... +|+.+++|......    ...+.+|.++++.+.+.+  +.+++........ ....+++||
T Consensus         3 ~~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~-~~~~~~v~e   80 (223)
T cd05154           3 VRQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSV-LGTPFYVME   80 (223)
T ss_pred             ceecCCCccceEEEEEec-CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCc-cCCceEEEE
Confidence            467899999999999864 36889999876543    457899999999997633  4445543322110 112458999


Q ss_pred             ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------------
Q 015500           80 YAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHS-----------------------------------------  118 (405)
Q Consensus        80 y~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~-----------------------------------------  118 (405)
                      |++|.++.+.+..  +.+++.....++.+++.+|..||+                                         
T Consensus        81 ~i~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (223)
T cd05154          81 RVDGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME  158 (223)
T ss_pred             EeCCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence            9999888765432  357777777888888888888874                                         


Q ss_pred             ---------------CCceeCCCCCCCEEEcc--CC-ceEeeeccccc
Q 015500          119 ---------------NRVVHCDIKSRNILMAE--SG-AKIADFGCAKW  148 (405)
Q Consensus       119 ---------------~givHrDlkp~NILi~~--~~-vkL~DFGla~~  148 (405)
                                     ..++|+|++|.||+++.  ++ +.|+||+.+..
T Consensus       159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                           24699999999999988  55 78999998864

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.10  E-value=3.9e-11  Score=123.98  Aligned_cols=149  Identities=21%  Similarity=0.314  Sum_probs=110.5

Q ss_pred             HHHHHHHHHHhC-CceeCCCCCCCEEEccCC-ceEeeeccccccccccc-------------CCCCCCccChhhhcCCCC
Q 015500          108 QILQGLEYLHSN-RVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQ-------------SGGTPMFMAPEVARGEHQ  172 (405)
Q Consensus       108 qIl~~L~yLH~~-givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~~~-------------~~gt~~Y~APE~l~~~~~  172 (405)
                      +++.||.|+|.. ++||+.|.|++|.++.++ .||+.|+++........             ..-...|.|||++.+...
T Consensus       107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~~  186 (700)
T KOG2137|consen  107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTTN  186 (700)
T ss_pred             cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccccc
Confidence            344899999986 899999999999999998 99999998654333110             113456999999999888


Q ss_pred             CcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHH-HHHhcCCCCCCchhccHHHHHHHHHhcccCccccCCHHHHhcCc
Q 015500          173 GFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLY-KIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHP  250 (405)
Q Consensus       173 ~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~-~i~~~~~~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp  250 (405)
                      ++++|+|||||++|.+.. |+.-+.........-. .........-....++.++++=|+++|..++..||++.+++..|
T Consensus       187 ~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~~  266 (700)
T KOG2137|consen  187 TPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLSIP  266 (700)
T ss_pred             cccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhccc
Confidence            999999999999999994 4444432222211111 11111111223466889999999999999999999999999999


Q ss_pred             cccccc
Q 015500          251 FLEEFC  256 (405)
Q Consensus       251 ~~~~~~  256 (405)
                      ||..-.
T Consensus       267 ff~D~~  272 (700)
T KOG2137|consen  267 FFSDPG  272 (700)
T ss_pred             ccCCch
Confidence            998754

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.03  E-value=1.4e-09  Score=98.51  Aligned_cols=121  Identities=25%  Similarity=0.279  Sum_probs=80.0

Q ss_pred             eEEEEEEcCCCCEEEEEEccCCC-----------------------------hHHHHHHHHHHHhCCCCC--eeeeeeee
Q 015500           16 TVSLATSLRSGDVFAAKSTELPK-----------------------------SEFLQREQKFLSSLNSPH--IVGYKGCD   64 (405)
Q Consensus        16 ~Vyla~~~~~~~~vavK~~~~~~-----------------------------~~~l~~E~~iL~~L~hpn--Iv~~~~~~   64 (405)
                      .||.|.. ..|..+|||......                             ....++|.+.|.++..-+  +...+.+ 
T Consensus         1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-   78 (188)
T PF01163_consen    1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-   78 (188)
T ss_dssp             EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE-
T ss_pred             CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE-
Confidence            3899986 467899999644210                             135778999999997654  4444432 


Q ss_pred             eecCCCceEEEEEEeecC--CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHH-HHhCCceeCCCCCCCEEEccCCceEe
Q 015500           65 VTSEDNKLMYNLFMEYAP--GGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY-LHSNRVVHCDIKSRNILMAESGAKIA  141 (405)
Q Consensus        65 ~~~~~~~~~~~lv~Ey~~--ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~y-LH~~givHrDlkp~NILi~~~~vkL~  141 (405)
                        ..     ..+||||++  |..+.. +...  .++......++.+++..+.. +|..|++|+||.+.||+++.+++.|+
T Consensus        79 --~~-----~~ivME~I~~~G~~~~~-l~~~--~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~~~~iI  148 (188)
T PF01163_consen   79 --NR-----NVIVMEYIGEDGVPLPR-LKDV--DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDGKVYII  148 (188)
T ss_dssp             --ET-----TEEEEE--EETTEEGGC-HHHC--GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETTCEEE-
T ss_pred             --eC-----CEEEEEecCCCccchhh-HHhc--cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecceEEEE
Confidence              12     138999998  655544 3332  22244566778888885555 57999999999999999999999999


Q ss_pred             eeccccc
Q 015500          142 DFGCAKW  148 (405)
Q Consensus       142 DFGla~~  148 (405)
                      |||.+..
T Consensus       149 Df~qav~  155 (188)
T PF01163_consen  149 DFGQAVD  155 (188)
T ss_dssp             -GTTEEE
T ss_pred             ecCccee
Confidence            9998753

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.95  E-value=1.8e-08  Score=96.25  Aligned_cols=130  Identities=12%  Similarity=0.008  Sum_probs=89.9

Q ss_pred             eEEEEEEcCCCCEEEEEEccCCCh--------------HHHHHHHHHHHhCCCCCeee--eeeeeeecCCC-ceEEEEEE
Q 015500           16 TVSLATSLRSGDVFAAKSTELPKS--------------EFLQREQKFLSSLNSPHIVG--YKGCDVTSEDN-KLMYNLFM   78 (405)
Q Consensus        16 ~Vyla~~~~~~~~vavK~~~~~~~--------------~~l~~E~~iL~~L~hpnIv~--~~~~~~~~~~~-~~~~~lv~   78 (405)
                      .|..+..  .|+.+.||.......              ....+|...+.+|..-+|..  ...+....... ...-++|+
T Consensus        37 rvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt  114 (268)
T PRK15123         37 RTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT  114 (268)
T ss_pred             eEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence            3555543  577899996533221              13778998888874333322  22222221111 12244899


Q ss_pred             eecCCC-CHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcc-------CC-ceEeeecccc
Q 015500           79 EYAPGG-TLNDEIHRN-GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAE-------SG-AKIADFGCAK  147 (405)
Q Consensus        79 Ey~~gg-sL~~~i~~~-~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~-------~~-vkL~DFGla~  147 (405)
                      |++++. +|.+++... ..+.++.....++.+++..+.-||..||+|+|+++.|||++.       +. +.|+||+.+.
T Consensus       115 e~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~  193 (268)
T PRK15123        115 EDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ  193 (268)
T ss_pred             eeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence            999886 899988642 235677788899999999999999999999999999999975       22 8999999875

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.91  E-value=7.5e-09  Score=97.17  Aligned_cols=129  Identities=26%  Similarity=0.271  Sum_probs=97.9

Q ss_pred             cccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-------------------------hHHHHHHHHHHHhCCCC--
Q 015500            3 WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-------------------------SEFLQREQKFLSSLNSP--   55 (405)
Q Consensus         3 y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-------------------------~~~l~~E~~iL~~L~hp--   55 (405)
                      +.++..||-|.-|.||.|.+. .|..+|||.-....                         ....++|.++|.+|...  
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            357889999999999999975 78999999533210                         23577899999999654  


Q ss_pred             CeeeeeeeeeecCCCceEEEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcc
Q 015500           56 HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAE  135 (405)
Q Consensus        56 nIv~~~~~~~~~~~~~~~~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~  135 (405)
                      .|...++.    +    ...+||||++|-.|...      +++...+..++..|+.-+..+-..||||+|+++-||++++
T Consensus       172 ~VP~P~~~----n----RHaVvMe~ieG~eL~~~------r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~  237 (304)
T COG0478         172 KVPKPIAW----N----RHAVVMEYIEGVELYRL------RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTE  237 (304)
T ss_pred             CCCCcccc----c----cceeeeehcccceeecc------cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEec
Confidence            55554432    1    14589999999776642      3345566667777777777777999999999999999999


Q ss_pred             CC-ceEeeeccc
Q 015500          136 SG-AKIADFGCA  146 (405)
Q Consensus       136 ~~-vkL~DFGla  146 (405)
                      +| +.++||--+
T Consensus       238 dg~~~vIDwPQ~  249 (304)
T COG0478         238 DGDIVVIDWPQA  249 (304)
T ss_pred             CCCEEEEeCccc
Confidence            96 999999644

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.90  E-value=4.2e-08  Score=96.68  Aligned_cols=233  Identities=15%  Similarity=0.254  Sum_probs=149.8

Q ss_pred             cccccceeCCeeEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHhC-CCCCeee--------eeeeeeecCCCceEEE
Q 015500            5 RGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSL-NSPHIVG--------YKGCDVTSEDNKLMYN   75 (405)
Q Consensus         5 ~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~~~~l~~E~~iL~~L-~hpnIv~--------~~~~~~~~~~~~~~~~   75 (405)
                      .++.||+|+-+.+|-.-.-   .-.+-|+........-......|... .||-+-.        ++|     .+.....-
T Consensus        15 ~gr~LgqGgea~ly~l~e~---~d~VAKIYh~Pppa~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G-----~~~~~~iG   86 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEV---RDQVAKIYHAPPPAAQAQKVAELAATPDAPLLNYRVAWPQATLHG-----GRRGKVIG   86 (637)
T ss_pred             CCccccCCccceeeecchh---hchhheeecCCCchHHHHHHHHhccCCCCcchhhhhcccHHHhhC-----CCccceeE
Confidence            5788999999999875432   22345666554433333334444444 5665432        122     12222345


Q ss_pred             EEEeecCCCC-HHHHHH-----HcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccc
Q 015500           76 LFMEYAPGGT-LNDEIH-----RNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKW  148 (405)
Q Consensus        76 lv~Ey~~ggs-L~~~i~-----~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~  148 (405)
                      ++|..++|.. +.++..     +.-.-.++....+..+.|+.+.+.||..|.+-+|+.++|+|+.+++ +.|.|-..-..
T Consensus        87 flmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi  166 (637)
T COG4248          87 FLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQI  166 (637)
T ss_pred             EecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccceee
Confidence            7888887752 223221     1112367888999999999999999999999999999999999888 78876543221


Q ss_pred             ccc---cccCCCCCCccChhhhc-----CCCCCcchhHHHHHHHHHHHHhC-CCCCCCCC------ChHH-HHH----HH
Q 015500          149 ESE---ALQSGGTPMFMAPEVAR-----GEHQGFASDIWAVGCTVIEMASG-GAPWPNAA------DPMT-VLY----KI  208 (405)
Q Consensus       149 ~~~---~~~~~gt~~Y~APE~l~-----~~~~~~~sDIwSLG~il~elltG-~~Pf~~~~------~~~~-~l~----~i  208 (405)
                      ...   ..-.+|.+.|.+||..+     +-.-+...|.|.||+++++++.| ++||....      .+.+ .+.    ..
T Consensus       167 ~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~y  246 (637)
T COG4248         167 NANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAY  246 (637)
T ss_pred             ccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeee
Confidence            111   22345899999999876     33456789999999999999997 99996431      1222 110    00


Q ss_pred             --HhcCC---CC-CCc-hhccHHHHHHHHHhccc--CccccCCHHH
Q 015500          209 --AYSRE---LP-EVP-AFLSKQANDFLSNCLRR--DPKERWAASQ  245 (405)
Q Consensus       209 --~~~~~---~~-~~p-~~~s~~l~dll~~~L~~--dP~~Rpt~~e  245 (405)
                        .....   .| .+| ..++++++.++.+|+..  ++.-|||++.
T Consensus       247 a~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a  292 (637)
T COG4248         247 ASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA  292 (637)
T ss_pred             chhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence              01111   11 122 34789999999999976  3568999753

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.83  E-value=5.8e-08  Score=89.26  Aligned_cols=109  Identities=21%  Similarity=0.245  Sum_probs=82.4

Q ss_pred             hHHHHHHHHHHHhCCCCCee--eeeeeeeecCCCceEEEEEEeecCCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHH
Q 015500           39 SEFLQREQKFLSSLNSPHIV--GYKGCDVTSEDNKLMYNLFMEYAPGG-TLNDEIHRNGGRLDESLIVSYTRQILQGLEY  115 (405)
Q Consensus        39 ~~~l~~E~~iL~~L~hpnIv--~~~~~~~~~~~~~~~~~lv~Ey~~gg-sL~~~i~~~~~~l~e~~~~~i~~qIl~~L~y  115 (405)
                      .....+|...+..|..-+|.  ..+.+...........++|+|+++|. +|.+++.... .++......++.+++..+.-
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~-~~~~~~~~~ll~~l~~~i~~  133 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE-QLDPSQRRELLRALARLIAK  133 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc-ccchhhHHHHHHHHHHHHHH
Confidence            44678888888877543332  33333333222223346899999884 7999887743 37777888999999999999


Q ss_pred             HHhCCceeCCCCCCCEEEccCC----ceEeeeccccc
Q 015500          116 LHSNRVVHCDIKSRNILMAESG----AKIADFGCAKW  148 (405)
Q Consensus       116 LH~~givHrDlkp~NILi~~~~----vkL~DFGla~~  148 (405)
                      ||..||+|+|+++.|||++.++    +.++||+-++.
T Consensus       134 lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  134 LHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            9999999999999999998775    89999997753

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=98.83  E-value=1.4e-07  Score=86.40  Aligned_cols=137  Identities=12%  Similarity=0.087  Sum_probs=99.9

Q ss_pred             cceeCCeeEEEEEEcCCCCEEEEEEcc---------CCChHHHHHHHHHHHhCCCCC--eeeeeeeeeecCCCceEEEEE
Q 015500            9 IGQGSSATVSLATSLRSGDVFAAKSTE---------LPKSEFLQREQKFLSSLNSPH--IVGYKGCDVTSEDNKLMYNLF   77 (405)
Q Consensus         9 LG~G~~g~Vyla~~~~~~~~vavK~~~---------~~~~~~l~~E~~iL~~L~hpn--Iv~~~~~~~~~~~~~~~~~lv   77 (405)
                      -|+||-+.|+.....  |+.+-+|.-.         .-....+.+|...|.+|..-+  +.+..............-.||
T Consensus        26 ~~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LV  103 (216)
T PRK09902         26 YRRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLV  103 (216)
T ss_pred             cCCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEE
Confidence            467888889887653  5578888654         224568999999999985422  333332223333333445589


Q ss_pred             EeecCC-CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccC-C--ceEeeecccc
Q 015500           78 MEYAPG-GTLNDEIHRNG-GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES-G--AKIADFGCAK  147 (405)
Q Consensus        78 ~Ey~~g-gsL~~~i~~~~-~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~-~--vkL~DFGla~  147 (405)
                      +|-+.| .+|.+++.+.. .+.++.....++.+++..+.-||..|+.|+|+.+.||+++.+ .  ++++||.-++
T Consensus       104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            997754 48988886532 256788888999999999999999999999999999999744 4  8999998765

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.75  E-value=6.4e-10  Score=114.09  Aligned_cols=236  Identities=22%  Similarity=0.188  Sum_probs=169.3

Q ss_pred             ccccceeCCeeEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHhCCCCC-eeeeeeeeeecCCCceEEEEEEeecCCC
Q 015500            6 GHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPH-IVGYKGCDVTSEDNKLMYNLFMEYAPGG   84 (405)
Q Consensus         6 ~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~~~~l~~E~~iL~~L~hpn-Iv~~~~~~~~~~~~~~~~~lv~Ey~~gg   84 (405)
                      .+-.++|+++++++++...+.... .+.+...  ....-++++|.+++||| .+.+++.    .+...+..+.++++.++
T Consensus       247 fh~fvK~altknpKkRptaeklL~-h~fvs~~--l~~rl~~eLLdK~n~P~~~v~~~~d----~~~E~~~~i~~~i~s~~  319 (829)
T KOG0576|consen  247 FHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--LSRRLAIELLDKVNNPNPVVRYLED----YDGEDYLWIPMRICSTG  319 (829)
T ss_pred             HHHHHHHHhcCCCccCCChhhhee-ceeeccc--hhhHHHHHHHHHccCCCCccccccc----CCcccccchhhhhhcCC
Confidence            456789999999999987776665 7776544  44566789999999999 5544432    33344567899999887


Q ss_pred             -CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCCceEeeecccccccc---cccCCCCCC
Q 015500           85 -TLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGAKIADFGCAKWESE---ALQSGGTPM  160 (405)
Q Consensus        85 -sL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~vkL~DFGla~~~~~---~~~~~gt~~  160 (405)
                       +-........-.+.+.+...+.+.-+++|+++|+..=+|+|    ||+..+...|..||+.+.....   .....+|+.
T Consensus       320 rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~~~~~~~~~~v~~~L~~~~~~~t~~~~~~  395 (829)
T KOG0576|consen  320 RSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSEEEVKLLDFAVPPQLTRTMKPRTAIGTPE  395 (829)
T ss_pred             ccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccccccccccccCCcccCcccccccCCCCCC
Confidence             33333222222466667778888889999999998888999    8888887799999998865443   345669999


Q ss_pred             ccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCch--hccHHH-HHHHHHhcccCc
Q 015500          161 FMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPA--FLSKQA-NDFLSNCLRRDP  237 (405)
Q Consensus       161 Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~--~~s~~l-~dll~~~L~~dP  237 (405)
                      ++|||+.....+....|.|++|.-..+|.-|.+|-..   +...+..+......+.+-.  ..+... .++-..|+..-|
T Consensus       396 ~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~---P~~~~~~~g~~p~s~~L~~~~aw~~~~~~~~~~~~~~g~P  472 (829)
T KOG0576|consen  396 PLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS---PPAVLPMIGNGPNSPMLTDKSAWSPVFHRDFPAPCLNGLP  472 (829)
T ss_pred             CCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC---CccccCCCCCCCCccccchhhhcCcccccCCcccccCCCC
Confidence            9999999999999999999999988899988887533   1222211111111111110  011112 257889999999


Q ss_pred             cccCCHHHHhcCcccccc
Q 015500          238 KERWAASQLLKHPFLEEF  255 (405)
Q Consensus       238 ~~Rpt~~elL~hp~~~~~  255 (405)
                      ..|++...++.|.+|+.+
T Consensus       473 ~~pkv~mgacfsKvfngC  490 (829)
T KOG0576|consen  473 PTPKVHMGACFSKVFNGC  490 (829)
T ss_pred             CCCcchhhHHHHHHhccC
Confidence            999999999999999864

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.58  E-value=1.9e-07  Score=101.84  Aligned_cols=201  Identities=21%  Similarity=0.324  Sum_probs=140.0

Q ss_pred             HHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 015500           41 FLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNR  120 (405)
Q Consensus        41 ~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~g  120 (405)
                      ...-|+..+....|+|++.++.+............+..|+|++-++...+... +..+..+.+.+..++++||+|+|+..
T Consensus       228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v-~~i~~~~~r~~~~~~~~GL~~~h~~~  306 (1351)
T KOG1035|consen  228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV-GSIPLETLRILHQKLLEGLAYLHSLS  306 (1351)
T ss_pred             HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc-cccCHHHHHHHHHHHhhhHHHHHHhc
Confidence            34456777888899999999887665544332233566889998999888776 48999999999999999999999995


Q ss_pred             ceeCCCCCC---CEEEccCC-ceEe--eeccccccccc---ccCCCCCCccChhhhcCCCCCc--chhHHHHHHHHHHHH
Q 015500          121 VVHCDIKSR---NILMAESG-AKIA--DFGCAKWESEA---LQSGGTPMFMAPEVARGEHQGF--ASDIWAVGCTVIEMA  189 (405)
Q Consensus       121 ivHrDlkp~---NILi~~~~-vkL~--DFGla~~~~~~---~~~~gt~~Y~APE~l~~~~~~~--~sDIwSLG~il~ell  189 (405)
                      ..|.-+...   +..++..+ +.+.  ||+..+.....   ....-++.+.|||........+  ..|+|.+|..+..+.
T Consensus       307 l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~  386 (1351)
T KOG1035|consen  307 LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLS  386 (1351)
T ss_pred             cceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhh
Confidence            555444443   22233333 3444  77766543332   1222456688888887766554  479999999999999


Q ss_pred             hCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHhcccCccccCCHHHHhcCccccc
Q 015500          190 SGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEE  254 (405)
Q Consensus       190 tG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~  254 (405)
                      .|..+-.....+..            -++........+++.+|+..++++|+++.+++.|||...
T Consensus       387 ~~~~i~~~~~~~~~------------~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~  439 (1351)
T KOG1035|consen  387 QGEDISEKSAVPVS------------LLDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRF  439 (1351)
T ss_pred             hcCcccccccchhh------------hhccccchhhhhhhhhhcchhhhhccchhhhhhchhccc
Confidence            88655322111111            111112227789999999999999999999999999874

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.57  E-value=1.2e-06  Score=80.59  Aligned_cols=134  Identities=19%  Similarity=0.215  Sum_probs=81.5

Q ss_pred             cccccccceeCCeeEEEEEEcCCCCEEEEEEccCCCh------------HHHHHHHHHHHhCCCCCe---eeeeeeeeec
Q 015500            3 WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS------------EFLQREQKFLSSLNSPHI---VGYKGCDVTS   67 (405)
Q Consensus         3 y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~~------------~~l~~E~~iL~~L~hpnI---v~~~~~~~~~   67 (405)
                      |...+.+-......|.+-  ...|+.+++|.......            ....+.+..+.++...++   ..++.+..-.
T Consensus        33 ~~~~kv~k~~~r~~ValI--ei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk  110 (229)
T PF06176_consen   33 YKIIKVFKNTKRNYVALI--EIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKK  110 (229)
T ss_pred             ceEEEeecCCCccEEEEE--EECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeee
Confidence            334444444443444333  34678888887654321            123344444444432222   2212111111


Q ss_pred             CCC-ceEEEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCCceEeeeccc
Q 015500           68 EDN-KLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGAKIADFGCA  146 (405)
Q Consensus        68 ~~~-~~~~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~vkL~DFGla  146 (405)
                      ..+ ...+.++|||++|..|.+..     .+++.    +...|+.++.-+|+.|++|+|..|.|+++..++++++||+..
T Consensus       111 ~~~~~~~~~ll~EYIeG~~l~d~~-----~i~e~----~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~i~iID~~~k  181 (229)
T PF06176_consen  111 IFRYTSSYVLLMEYIEGVELNDIE-----DIDED----LAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNGIRIIDTQGK  181 (229)
T ss_pred             eccceeEEEEEEEEecCeecccch-----hcCHH----HHHHHHHHHHHHHHcCCccCCCCcCcEEEECCcEEEEECccc
Confidence            111 12355899999998887643     24442    445677889999999999999999999999989999999876


Q ss_pred             c
Q 015500          147 K  147 (405)
Q Consensus       147 ~  147 (405)
                      +
T Consensus       182 ~  182 (229)
T PF06176_consen  182 R  182 (229)
T ss_pred             c
Confidence            5

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.38  E-value=3.4e-06  Score=87.42  Aligned_cols=138  Identities=22%  Similarity=0.205  Sum_probs=86.7

Q ss_pred             cccceeCCeeEEEEEEcCCCCEEEEEEccCCChH-------------------------------------------HHH
Q 015500            7 HTIGQGSSATVSLATSLRSGDVFAAKSTELPKSE-------------------------------------------FLQ   43 (405)
Q Consensus         7 ~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~~~-------------------------------------------~l~   43 (405)
                      ..|+.++-|.||.|+.+ +|+.||||+....-.+                                           .+.
T Consensus       131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            67889999999999985 5999999976543211                                           233


Q ss_pred             HHHHHHHhCC-----CCCeeeeeeeeeecCCCceEEEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh
Q 015500           44 REQKFLSSLN-----SPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHS  118 (405)
Q Consensus        44 ~E~~iL~~L~-----hpnIv~~~~~~~~~~~~~~~~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~  118 (405)
                      +|...+.+++     .|++. +-.++..... ..  .|+|||++|..+.+...-....++...+.....++  -+..+-.
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~-VP~V~we~t~-~~--VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~--f~~q~~~  283 (517)
T COG0661         210 REAANAERFRENFKDDPDVY-VPKVYWEYTT-RR--VLTMEWIDGIKISDIAALKSAGIDRKELAELLVRA--FLRQLLR  283 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeE-eceeehhccC-Cc--EEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHH--HHHHHHh
Confidence            4555454442     23332 2222221112 22  28999999998888742222245533333222222  1233334


Q ss_pred             CCceeCCCCCCCEEEccCC-ceEeeecccccccc
Q 015500          119 NRVVHCDIKSRNILMAESG-AKIADFGCAKWESE  151 (405)
Q Consensus       119 ~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~  151 (405)
                      .|+.|+|..|.||++..++ +-+.|||+....+.
T Consensus       284 dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         284 DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             cCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            7999999999999999998 89999999865443

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.36  E-value=6.4e-06  Score=76.86  Aligned_cols=134  Identities=14%  Similarity=0.141  Sum_probs=78.6

Q ss_pred             cccceeCCeeEEEEEEcCCCCEEEEEEccCC-ChHHHHHHHHHHHhCCCCCe--eeeeeeeeecCCCceEEEEEEeecCC
Q 015500            7 HTIGQGSSATVSLATSLRSGDVFAAKSTELP-KSEFLQREQKFLSSLNSPHI--VGYKGCDVTSEDNKLMYNLFMEYAPG   83 (405)
Q Consensus         7 ~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~-~~~~l~~E~~iL~~L~hpnI--v~~~~~~~~~~~~~~~~~lv~Ey~~g   83 (405)
                      ..||.|..+.||+.    .+..+++|..... ....+.+|.++++.+..-++  .+.+.+.  ...+.  +.++||+++|
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~--~~~~~--~glv~e~i~G   78 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLV--EDGGR--LGLIYELIVG   78 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEE--ecCCe--eeeeeeecCC
Confidence            57899999999984    2556788987653 35678999999998854333  3333322  12211  4579999999


Q ss_pred             CC-HH--------------HHHHH-----cCC---CCCH-HHHHHHHHHH----------HH-HHHHHHh----CCceeC
Q 015500           84 GT-LN--------------DEIHR-----NGG---RLDE-SLIVSYTRQI----------LQ-GLEYLHS----NRVVHC  124 (405)
Q Consensus        84 gs-L~--------------~~i~~-----~~~---~l~e-~~~~~i~~qI----------l~-~L~yLH~----~givHr  124 (405)
                      .+ +.              ..+.+     +.-   ..+. .....+..++          .. ...+|..    ..++|+
T Consensus        79 ~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~Hg  158 (226)
T TIGR02172        79 KRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHG  158 (226)
T ss_pred             ccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEec
Confidence            63 11              11111     100   0110 0011111111          11 1122221    247899


Q ss_pred             CCCCCCEEEccCCceEeeeccccc
Q 015500          125 DIKSRNILMAESGAKIADFGCAKW  148 (405)
Q Consensus       125 Dlkp~NILi~~~~vkL~DFGla~~  148 (405)
                      |+.|.||+++.+++.|+||+.+..
T Consensus       159 D~~~~Nii~~~~~~~iIDwe~a~~  182 (226)
T TIGR02172       159 DFQIGNLITSGKGTYWIDLGDFGY  182 (226)
T ss_pred             CCCCCcEEEcCCCcEEEechhcCc
Confidence            999999999988899999998763

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.34  E-value=2.4e-06  Score=78.49  Aligned_cols=80  Identities=29%  Similarity=0.321  Sum_probs=56.2

Q ss_pred             ccccceeCCeeEEEEEEcCCCCEEEEEEccCC-ChHHHHHHHHHHHhCCCCC--eeeeeeeeeecCCCceEEEEEEeecC
Q 015500            6 GHTIGQGSSATVSLATSLRSGDVFAAKSTELP-KSEFLQREQKFLSSLNSPH--IVGYKGCDVTSEDNKLMYNLFMEYAP   82 (405)
Q Consensus         6 ~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~-~~~~l~~E~~iL~~L~hpn--Iv~~~~~~~~~~~~~~~~~lv~Ey~~   82 (405)
                      ++.|+.|..+.||+.....  ..+++|..... ....+.+|..+++.|....  +..++.......... ..+++|++++
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~-~~~~~~~~i~   78 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNG-FPYLLMEYIP   78 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETS-EEEEEEEEES
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccc-cceEEEEEec
Confidence            4678999999999998754  58999997665 4567889999998885332  445554332222222 3568999999


Q ss_pred             CCCHHH
Q 015500           83 GGTLND   88 (405)
Q Consensus        83 ggsL~~   88 (405)
                      |..+..
T Consensus        79 g~~~~~   84 (239)
T PF01636_consen   79 GRPLDD   84 (239)
T ss_dssp             SEEHHH
T ss_pred             cccccc
Confidence            987777

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.33  E-value=2.9e-06  Score=79.11  Aligned_cols=130  Identities=20%  Similarity=0.216  Sum_probs=90.0

Q ss_pred             ccceeCCeeEEEEEEcCCCCEEEEEEccCCC---------------------------hHHHHHHHHHHHhCCCC--Cee
Q 015500            8 TIGQGSSATVSLATSLRSGDVFAAKSTELPK---------------------------SEFLQREQKFLSSLNSP--HIV   58 (405)
Q Consensus         8 ~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~---------------------------~~~l~~E~~iL~~L~hp--nIv   58 (405)
                      +|.+|.-+.||+|.. .++..+|||+.....                           ......|..-|+++..-  .+.
T Consensus        55 ~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP  133 (268)
T COG1718          55 CISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP  133 (268)
T ss_pred             eecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence            677788889999975 568999999765321                           02455788888888433  333


Q ss_pred             eeeeeeeecCCCceEEEEEEeecCCCCH-HHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCCEEEccC
Q 015500           59 GYKGCDVTSEDNKLMYNLFMEYAPGGTL-NDEIHRNGGRLDESLIVSYTRQILQGLEYLHS-NRVVHCDIKSRNILMAES  136 (405)
Q Consensus        59 ~~~~~~~~~~~~~~~~~lv~Ey~~ggsL-~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~-~givHrDlkp~NILi~~~  136 (405)
                      +.+.+   ..+     .|||||+....+ +=.++..  ++....+..+..++++.+.-|-. .|+||+||+.-|||+..+
T Consensus       134 ~Pi~~---~~n-----VLvMEfIg~~g~pAP~LkDv--~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~~~  203 (268)
T COG1718         134 EPIAF---RNN-----VLVMEFIGDDGLPAPRLKDV--PLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVHDG  203 (268)
T ss_pred             Cceee---cCC-----eEEEEeccCCCCCCCCcccC--CcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEECC
Confidence            33322   111     289999955311 1111111  23333678888999999988887 899999999999999977


Q ss_pred             CceEeeeccccc
Q 015500          137 GAKIADFGCAKW  148 (405)
Q Consensus       137 ~vkL~DFGla~~  148 (405)
                      .+.|+|||-|..
T Consensus       204 ~p~iID~~QaV~  215 (268)
T COG1718         204 EPYIIDVSQAVT  215 (268)
T ss_pred             eEEEEECccccc
Confidence            799999998753

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.26  E-value=8e-06  Score=72.43  Aligned_cols=126  Identities=22%  Similarity=0.256  Sum_probs=92.6

Q ss_pred             cccccceeCCeeEEEEEEcCCCCEEEEEEccCC-ChHHHHHHHHHHHhCCCCCeee-eeeeeeecCCCceEEEEEEeecC
Q 015500            5 RGHTIGQGSSATVSLATSLRSGDVFAAKSTELP-KSEFLQREQKFLSSLNSPHIVG-YKGCDVTSEDNKLMYNLFMEYAP   82 (405)
Q Consensus         5 ~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~-~~~~l~~E~~iL~~L~hpnIv~-~~~~~~~~~~~~~~~~lv~Ey~~   82 (405)
                      ..+.||+|.+|.||++.++  |..+|+|+-..+ ....++.|.++|..+...++.+ ++.+.   .+     ++.|||+.
T Consensus        26 v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg---~~-----~i~me~i~   95 (201)
T COG2112          26 VEKELAKGTTSVVYLGEWR--GGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYG---ED-----FIRMEYID   95 (201)
T ss_pred             hhhhhhcccccEEEEeecc--CceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEec---hh-----hhhhhhhc
Confidence            4578999999999999985  668999987654 4678999999999998766653 33221   11     25699999


Q ss_pred             CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCC--CCEEEccCCceEeeeccccc
Q 015500           83 GGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKS--RNILMAESGAKIADFGCAKW  148 (405)
Q Consensus        83 ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp--~NILi~~~~vkL~DFGla~~  148 (405)
                      |-.|.+.-..    .+..+    ...++..---|-..||-|+.|.-  .||++..+.+.|+||.-|+.
T Consensus        96 G~~L~~~~~~----~~rk~----l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          96 GRPLGKLEIG----GDRKH----LLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             Ccchhhhhhc----ccHHH----HHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            9888765431    12333    34566666667788999999986  56676666799999998873

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.26  E-value=1.2e-05  Score=75.37  Aligned_cols=76  Identities=18%  Similarity=0.073  Sum_probs=50.6

Q ss_pred             cccceeCC-eeEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHhCC-CCCeeeeeeeeeecCCCceEEEEEEeecCCC
Q 015500            7 HTIGQGSS-ATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLN-SPHIVGYKGCDVTSEDNKLMYNLFMEYAPGG   84 (405)
Q Consensus         7 ~~LG~G~~-g~Vyla~~~~~~~~vavK~~~~~~~~~l~~E~~iL~~L~-hpnIv~~~~~~~~~~~~~~~~~lv~Ey~~gg   84 (405)
                      ..|-.|.+ +.||+....  +..++||.........+.+|+++++.|. +--+.+++......  +  ..++|||+++|.
T Consensus         4 ~~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~--~--~~~lv~e~i~G~   77 (244)
T cd05150           4 ERVTEGQSGATVYRLDGK--NPGLYLKIAPSGPTYELEREAERLRWLAGKLPVPEVIDYGSDD--G--RAWLLTSAVPGV   77 (244)
T ss_pred             eecCCCCCcCeEEEEcCC--CCcEEEEecCCCcccchHHHHHHHHHHHhcCCCCeEEEEEecC--C--ccEEEEEeeCCc
Confidence            45566666 689998653  4788999876554556888999998884 32233455443322  1  244899999998


Q ss_pred             CHHH
Q 015500           85 TLND   88 (405)
Q Consensus        85 sL~~   88 (405)
                      +|..
T Consensus        78 ~l~~   81 (244)
T cd05150          78 PAAA   81 (244)
T ss_pred             cHhH
Confidence            7664

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.18  E-value=1.1e-05  Score=83.53  Aligned_cols=135  Identities=24%  Similarity=0.230  Sum_probs=83.9

Q ss_pred             ccccceeCCeeEEEEEEcCCCCEEEEEEccCCCh----------------------------------HHHH------HH
Q 015500            6 GHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS----------------------------------EFLQ------RE   45 (405)
Q Consensus         6 ~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~~----------------------------------~~l~------~E   45 (405)
                      -+.||..+.|.||+|+.+. |+.||||+-...-.                                  +.+.      +|
T Consensus       166 ~~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E  244 (538)
T KOG1235|consen  166 EEPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE  244 (538)
T ss_pred             cchhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence            4689999999999999865 99999997543210                                  1122      22


Q ss_pred             HH----HHHhCCCCC------eeeeeeeeeecCCCceEEEEEEeecCCCCHHH--HHHHcCCCCCHHHHHHHHHHHHHHH
Q 015500           46 QK----FLSSLNSPH------IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLND--EIHRNGGRLDESLIVSYTRQILQGL  113 (405)
Q Consensus        46 ~~----iL~~L~hpn------Iv~~~~~~~~~~~~~~~~~lv~Ey~~ggsL~~--~i~~~~~~l~e~~~~~i~~qIl~~L  113 (405)
                      .+    +.+.+.|-+      |.+++.   .-.. .  -.|+||||+|..+.|  .|.+.+  ++...+..-+.+...  
T Consensus       245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~---~~st-~--RVLtME~~~G~~i~Dl~~i~~~g--i~~~~i~~~l~~~~~--  314 (538)
T KOG1235|consen  245 AKNAERFRENFKDFSLLTYVLVPKVYW---DLST-K--RVLTMEYVDGIKINDLDAIDKRG--ISPHDILNKLVEAYL--  314 (538)
T ss_pred             HHhHHHHHHHHHhcccccceeCCeehh---hcCc-c--eEEEEEecCCccCCCHHHHHHcC--CCHHHHHHHHHHHHH--
Confidence            22    233334444      333332   2111 1  238999999987655  455553  555544333333221  


Q ss_pred             HHHHhCCceeCCCCCCCEEEccC---C--ceEeeecccccccc
Q 015500          114 EYLHSNRVVHCDIKSRNILMAES---G--AKIADFGCAKWESE  151 (405)
Q Consensus       114 ~yLH~~givHrDlkp~NILi~~~---~--vkL~DFGla~~~~~  151 (405)
                      .-+=..|++|+|-.|.||++..+   +  +.+.|||+......
T Consensus       315 ~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  315 EQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             HHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            22234689999999999999842   2  89999999875443

>PLN02876 acyl-CoA dehydrogenase

Probab=98.02  E-value=4.7e-05  Score=84.10  Aligned_cols=143  Identities=17%  Similarity=0.261  Sum_probs=86.1

Q ss_pred             ccccceeCCeeEEEEEEcCCC--CEEEEEEccCC----ChHHHHHHHHHHHhCC-CCCe--eeeeeeeeecCCCceEEEE
Q 015500            6 GHTIGQGSSATVSLATSLRSG--DVFAAKSTELP----KSEFLQREQKFLSSLN-SPHI--VGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         6 ~~~LG~G~~g~Vyla~~~~~~--~~vavK~~~~~----~~~~l~~E~~iL~~L~-hpnI--v~~~~~~~~~~~~~~~~~l   76 (405)
                      .+.|+.|.+..+|+......+  ..+++|+.+..    ....+.+|.++|+.|. |+++  .+++..+....... ..++
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G-~~fl  121 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIG-TAFY  121 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCC-CceE
Confidence            567889999999998765432  46778876532    3457899999999995 6665  45554432221111 2448


Q ss_pred             EEeecCCCCHHH--------------------HHHH-cC-----------CC---CCHHHHHHHHHH-------------
Q 015500           77 FMEYAPGGTLND--------------------EIHR-NG-----------GR---LDESLIVSYTRQ-------------  108 (405)
Q Consensus        77 v~Ey~~ggsL~~--------------------~i~~-~~-----------~~---l~e~~~~~i~~q-------------  108 (405)
                      ||||++|..+.+                    .+.+ +.           ++   .-..++..+..+             
T Consensus       122 VME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~  201 (822)
T PLN02876        122 IMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRN  201 (822)
T ss_pred             EEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCC
Confidence            999998864321                    1111 00           00   011233322222             


Q ss_pred             --HHHHHHHHHh-----------CCceeCCCCCCCEEEccCC---ceEeeecccccc
Q 015500          109 --ILQGLEYLHS-----------NRVVHCDIKSRNILMAESG---AKIADFGCAKWE  149 (405)
Q Consensus       109 --Il~~L~yLH~-----------~givHrDlkp~NILi~~~~---vkL~DFGla~~~  149 (405)
                        +...+++|..           ..+||+|+++.||+++.++   .-|.||+++...
T Consensus       202 ~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G  258 (822)
T PLN02876        202 PKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG  258 (822)
T ss_pred             hhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence              2233556632           2499999999999998532   579999988653

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=98.02  E-value=8.5e-07  Score=98.82  Aligned_cols=208  Identities=15%  Similarity=-0.006  Sum_probs=146.8

Q ss_pred             HHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEeecCCCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHh
Q 015500           42 LQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRN---GGRLDESLIVSYTRQILQGLEYLHS  118 (405)
Q Consensus        42 l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~Ey~~ggsL~~~i~~~---~~~l~e~~~~~i~~qIl~~L~yLH~  118 (405)
                      +..|...++...|+++...+.-....++.  --+..++|+.+|.+.+.|.+.   ..++++.-+.....+.+.+..-+|+
T Consensus      1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~--ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls 1353 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSEST--EEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILS 1353 (2724)
T ss_pred             hhhhhhhhhhhhceeeecccccCCCCCCh--HHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhh
Confidence            34455566677899988765432222222  234789999999999998652   2245555555555565888888886


Q ss_pred             CC-----ceeCCCCCCCEEEccCC-ceEeeecccccccc----cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHH
Q 015500          119 NR-----VVHCDIKSRNILMAESG-AKIADFGCAKWESE----ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEM  188 (405)
Q Consensus       119 ~g-----ivHrDlkp~NILi~~~~-vkL~DFGla~~~~~----~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~el  188 (405)
                      +.     .+|+++|+-|.+|..+. +|++++|+.+....    .....++|.|++|++...-.++.++|+|..|+-+|+.
T Consensus      1354 ~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1354 LTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred             cccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHH
Confidence            51     69999999999998887 99999999983322    2344588999999999988888889999999999999


Q ss_pred             HhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHhcccCccccCCHHHHhcCcccc
Q 015500          189 ASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLE  253 (405)
Q Consensus       189 ltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~  253 (405)
                      -.|..+|-..  ....+..+...+....++...|.++......+|-..-..||.-...+.-+.+.
T Consensus      1434 s~~n~~fi~f--lq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1434 SDGNAYFIFF--LQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFA 1496 (2724)
T ss_pred             hcccHHHHHH--HHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhccccccc
Confidence            9998887221  12223333334444455555566666666666666677899988888877765

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.97  E-value=5.8e-05  Score=70.56  Aligned_cols=76  Identities=14%  Similarity=0.140  Sum_probs=46.1

Q ss_pred             ccccceeCCe-eEEEEEEcCCCCEEEEEEccCC-ChHHHHHHHHHHHhCCCC---CeeeeeeeeeecCCCceEEEEEEee
Q 015500            6 GHTIGQGSSA-TVSLATSLRSGDVFAAKSTELP-KSEFLQREQKFLSSLNSP---HIVGYKGCDVTSEDNKLMYNLFMEY   80 (405)
Q Consensus         6 ~~~LG~G~~g-~Vyla~~~~~~~~vavK~~~~~-~~~~l~~E~~iL~~L~hp---nIv~~~~~~~~~~~~~~~~~lv~Ey   80 (405)
                      +..|+.|+.. .||+.     +..+++|..... ....+.+|.++|..|...   .+..++......+ .....+++|++
T Consensus         2 ~~~~~~gG~~n~vy~~-----~~~~VlR~~~~~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~-~~~~~~~l~~~   75 (235)
T cd05155           2 IEPVDSGGTDNATFRL-----GDDMSVRLPSAAGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGE-GYPWPWSVYRW   75 (235)
T ss_pred             ceeccCCCcccceEEc-----CCceEEEcCCccchHHHHHHHHHHHHHHhccCCCCCCceeecCCCcc-CCCcceEEEEe
Confidence            3567877777 58876     235778876543 345799999999888532   2233332221111 11123578999


Q ss_pred             cCCCCHH
Q 015500           81 APGGTLN   87 (405)
Q Consensus        81 ~~ggsL~   87 (405)
                      ++|.++.
T Consensus        76 i~G~~l~   82 (235)
T cd05155          76 LEGETAT   82 (235)
T ss_pred             ecCCCCC
Confidence            9997653

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.97  E-value=0.00016  Score=65.90  Aligned_cols=125  Identities=23%  Similarity=0.318  Sum_probs=87.9

Q ss_pred             CcccccccceeCC-eeEEEEEEcCCCCEEEEEEccC---C---------------------ChHHHHHHHHHHHhC---C
Q 015500            2 DWTRGHTIGQGSS-ATVSLATSLRSGDVFAAKSTEL---P---------------------KSEFLQREQKFLSSL---N   53 (405)
Q Consensus         2 ~y~~~~~LG~G~~-g~Vyla~~~~~~~~vavK~~~~---~---------------------~~~~l~~E~~iL~~L---~   53 (405)
                      ++...+.||.|.- |.||++.-  .|+.||+|.+..   .                     ..+.+..|-+...+|   .
T Consensus        38 ~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   38 DIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             cEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            3566789999999 99999976  588999998221   0                     012466677766665   4


Q ss_pred             CCCe--eeeeeeeeecC--------------CCceEEEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH
Q 015500           54 SPHI--VGYKGCDVTSE--------------DNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLH  117 (405)
Q Consensus        54 hpnI--v~~~~~~~~~~--------------~~~~~~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH  117 (405)
                      +.++  |+++|+..-..              .....+.+|.||++...          .+....    +.+|++-|..+|
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~~~~----~~~~~~dl~~~~  181 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQIRD----IPQMLRDLKILH  181 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccchhH----HHHHHHHHHHHH
Confidence            5566  89988764331              12234567888876533          233333    456777888999


Q ss_pred             hCCceeCCCCCCCEEEccCCceEeeeccc
Q 015500          118 SNRVVHCDIKSRNILMAESGAKIADFGCA  146 (405)
Q Consensus       118 ~~givHrDlkp~NILi~~~~vkL~DFGla  146 (405)
                      ..||+-+|+++.|..   +| ||+|||.+
T Consensus       182 k~gI~~~Dv~~~ny~---~G-~lvDfs~~  206 (207)
T PF13095_consen  182 KLGIVPRDVKPRNYR---GG-KLVDFSSS  206 (207)
T ss_pred             HCCeeeccCcccccc---CC-EEEecccC
Confidence            999999999999987   33 99999864

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.96  E-value=0.00026  Score=64.70  Aligned_cols=134  Identities=19%  Similarity=0.238  Sum_probs=91.8

Q ss_pred             ccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-------------------hHHHHHHHHHHHhCC------CCCee
Q 015500            4 TRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-------------------SEFLQREQKFLSSLN------SPHIV   58 (405)
Q Consensus         4 ~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-------------------~~~l~~E~~iL~~L~------hpnIv   58 (405)
                      .....||+|+.=.||.--   ...-..||+.....                   .....+|+.-...+.      +.+|.
T Consensus         4 ~~~~~i~~G~~R~cy~HP---~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~   80 (199)
T PF10707_consen    4 SESDLIAQGGERDCYQHP---DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIP   80 (199)
T ss_pred             CCCcccccCCCceEEECC---CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccc
Confidence            345789999999998743   34567888876655                   466777887766665      78999


Q ss_pred             eeeeeeeecCCCceEEEEEEeec--CCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccC
Q 015500           59 GYKGCDVTSEDNKLMYNLFMEYA--PGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES  136 (405)
Q Consensus        59 ~~~~~~~~~~~~~~~~~lv~Ey~--~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~  136 (405)
                      +++|...+...-...+-+|.++-  ...+|.+++++.  .+++ ..   ...+-.-.+||-..+|+.+|++|.||++...
T Consensus        81 r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~--~~~~-~~---~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~  154 (199)
T PF10707_consen   81 RFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG--GLTE-EL---RQALDEFKRYLLDHHIVIRDLNPHNIVVQRR  154 (199)
T ss_pred             cEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC--CccH-HH---HHHHHHHHHHHHHcCCeecCCCcccEEEEec
Confidence            99998877776444333444331  123789988654  4666 33   3344455678889999999999999999644


Q ss_pred             C-----ceEee-eccc
Q 015500          137 G-----AKIAD-FGCA  146 (405)
Q Consensus       137 ~-----vkL~D-FGla  146 (405)
                      .     +.|+| ||..
T Consensus       155 ~~~~~~lvlIDG~G~~  170 (199)
T PF10707_consen  155 DSGEFRLVLIDGLGEK  170 (199)
T ss_pred             CCCceEEEEEeCCCCc
Confidence            2     55665 4443

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.74  E-value=0.00015  Score=65.72  Aligned_cols=98  Identities=20%  Similarity=0.216  Sum_probs=76.4

Q ss_pred             HHHHHHHHhCCC-CCeeeeeeeeeecCCCceEEEEEEeecCCCCHHHH---HHHcCCCCCHHHHHHHHHHHHHHHHHHHh
Q 015500           43 QREQKFLSSLNS-PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDE---IHRNGGRLDESLIVSYTRQILQGLEYLHS  118 (405)
Q Consensus        43 ~~E~~iL~~L~h-pnIv~~~~~~~~~~~~~~~~~lv~Ey~~ggsL~~~---i~~~~~~l~e~~~~~i~~qIl~~L~yLH~  118 (405)
                      ..|.-+|+.+.+ +++++++|.+-.       + ++.||...+++...   +.+- -..++.....|+.+++..+.+++.
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG~-------~-~v~E~~~~~~~~~~~~~l~~~-~~~~w~~R~~iA~~lL~~l~~l~~   77 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCGR-------F-YVVEYVGAGSLYGIYRPLSQF-LQSPWEQRAKIALQLLELLEELDH   77 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECCC-------E-EEEEeecCccccccccccccc-cccCHHHHHHHHHHHHHHHHHHhc
Confidence            458888899976 799999997621       2 58899987765421   1111 136789999999999999999998


Q ss_pred             ---CCceeCCCCCCCEEEccCC-ceEeeecccccc
Q 015500          119 ---NRVVHCDIKSRNILMAESG-AKIADFGCAKWE  149 (405)
Q Consensus       119 ---~givHrDlkp~NILi~~~~-vkL~DFGla~~~  149 (405)
                         ..+.-+|++|+|+-+++++ +|++|...+...
T Consensus        78 ~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   78 GPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             CCCCcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence               3588999999999999886 999999877543

Proteins in this uncharacterised family are described as transmembrane proteins.

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.73  E-value=0.00023  Score=67.40  Aligned_cols=131  Identities=22%  Similarity=0.241  Sum_probs=77.8

Q ss_pred             ccceeCCeeEEEEEEcCCCCEEEEEEccCCChH---HHHHHHHHHHhCCCCCee-eeeeeeeecCCCceEEEEEEeecCC
Q 015500            8 TIGQGSSATVSLATSLRSGDVFAAKSTELPKSE---FLQREQKFLSSLNSPHIV-GYKGCDVTSEDNKLMYNLFMEYAPG   83 (405)
Q Consensus         8 ~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~~~---~l~~E~~iL~~L~hpnIv-~~~~~~~~~~~~~~~~~lv~Ey~~g   83 (405)
                      .+..|-...+|+..  .+++.+++|........   ...+|..+|+.+..-+++ +++..   ..+     .+||||++|
T Consensus         3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~---~~~-----~~v~e~i~G   72 (256)
T TIGR02721         3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILV---NEH-----WLLVEWLEG   72 (256)
T ss_pred             cCCCcCcCCeEEEE--eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEE---eCC-----EEEEEeccC
Confidence            45668888999886  35678889976543222   367899999988543332 22222   111     379999998


Q ss_pred             CCHHH--------------HHHH-c-----CCCCCH-HHHHHHHHHH---------HHHHHHHHh--------CCceeCC
Q 015500           84 GTLND--------------EIHR-N-----GGRLDE-SLIVSYTRQI---------LQGLEYLHS--------NRVVHCD  125 (405)
Q Consensus        84 gsL~~--------------~i~~-~-----~~~l~e-~~~~~i~~qI---------l~~L~yLH~--------~givHrD  125 (405)
                      ..+..              .+.+ +     +.+++. ..+..+..++         ...+..+-.        ..++|+|
T Consensus        73 ~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~D  152 (256)
T TIGR02721        73 EVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMD  152 (256)
T ss_pred             cccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCC
Confidence            66431              1111 1     111121 1222222222         111222221        2589999


Q ss_pred             CCCCCEEEccCCceEeeeccccc
Q 015500          126 IKSRNILMAESGAKIADFGCAKW  148 (405)
Q Consensus       126 lkp~NILi~~~~vkL~DFGla~~  148 (405)
                      +.|.||+++.++++|+||..|..
T Consensus       153 l~~~Nil~~~~~~~lIDwE~a~~  175 (256)
T TIGR02721       153 VHAYNLVVTPQGLKLIDWEYASD  175 (256)
T ss_pred             CCcCcEEEeCCCCEEEeccccCc
Confidence            99999999988899999998763

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.69  E-value=0.00036  Score=64.88  Aligned_cols=73  Identities=15%  Similarity=0.157  Sum_probs=47.6

Q ss_pred             ccccceeCCeeEEEEEEcC-CCCEEEEEEccCCChH--HHHHHHHHHHhCCCCCee-eeeeeeeecCCCceEEEEEEeec
Q 015500            6 GHTIGQGSSATVSLATSLR-SGDVFAAKSTELPKSE--FLQREQKFLSSLNSPHIV-GYKGCDVTSEDNKLMYNLFMEYA   81 (405)
Q Consensus         6 ~~~LG~G~~g~Vyla~~~~-~~~~vavK~~~~~~~~--~l~~E~~iL~~L~hpnIv-~~~~~~~~~~~~~~~~~lv~Ey~   81 (405)
                      .+.|..|-...+|+..... .++.+++|........  ...+|..+++.+...+++ +++..   ...     .++|||+
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~---~~~-----~~l~e~i   74 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYAT---FQN-----GLIYEFI   74 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEE---eCC-----cEEEEee
Confidence            4677888888999987543 3578889977543222  345789999988544443 33321   112     1699999


Q ss_pred             CCCCH
Q 015500           82 PGGTL   86 (405)
Q Consensus        82 ~ggsL   86 (405)
                      +|.++
T Consensus        75 ~G~~l   79 (235)
T cd05157          75 PGRTL   79 (235)
T ss_pred             CCCcC
Confidence            98765

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.53  E-value=0.0018  Score=65.42  Aligned_cols=74  Identities=16%  Similarity=0.044  Sum_probs=50.6

Q ss_pred             ccccceeCCeeEEEEEEcCCCCEEEEEEccC----------CChHHHHHHHHHHHhCC---CCCeeeeeeeeeecCCCce
Q 015500            6 GHTIGQGSSATVSLATSLRSGDVFAAKSTEL----------PKSEFLQREQKFLSSLN---SPHIVGYKGCDVTSEDNKL   72 (405)
Q Consensus         6 ~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~----------~~~~~l~~E~~iL~~L~---hpnIv~~~~~~~~~~~~~~   72 (405)
                      .+.||-|.+..||++.....++.++||....          -..++...|.+.|+.+.   ..++++++.+..  +.   
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~--~~---  105 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE--EL---  105 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC--CC---
Confidence            4678999999999999864446899997431          12356778888888873   245666665422  11   


Q ss_pred             EEEEEEeecCCCC
Q 015500           73 MYNLFMEYAPGGT   85 (405)
Q Consensus        73 ~~~lv~Ey~~ggs   85 (405)
                       .++||||+++..
T Consensus       106 -~~lVME~L~~~~  117 (401)
T PRK09550        106 -AVTVMEDLSDHK  117 (401)
T ss_pred             -CEEEEecCCCcc
Confidence             348999998643

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.50  E-value=0.00087  Score=64.66  Aligned_cols=139  Identities=16%  Similarity=0.130  Sum_probs=82.8

Q ss_pred             cccccceeCCeeEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHhCCCCC--eeeeeee----eeecCCCceEEEEEE
Q 015500            5 RGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPH--IVGYKGC----DVTSEDNKLMYNLFM   78 (405)
Q Consensus         5 ~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~~~~l~~E~~iL~~L~hpn--Iv~~~~~----~~~~~~~~~~~~lv~   78 (405)
                      ..+.|..|....+|+...  .+..+++|.......+.+..|+.++..|.+-+  +.+++..    ......+  ..++++
T Consensus        18 ~i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~--~~~~l~   93 (296)
T cd05153          18 SFEGISAGIENTNYFVTT--DSGRYVLTLFEKVSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAG--KPAALV   93 (296)
T ss_pred             heecccCccccceEEEEe--CCCcEEEEEcCCCChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCC--ceEEEE
Confidence            456778888889999864  34578899877655667888999988884322  3333321    1111112  245899


Q ss_pred             eecCCCCHHH-----------HHH---HcCCCCCH--------HHH------------HHHHHHHHHHHHHHHh------
Q 015500           79 EYAPGGTLND-----------EIH---RNGGRLDE--------SLI------------VSYTRQILQGLEYLHS------  118 (405)
Q Consensus        79 Ey~~ggsL~~-----------~i~---~~~~~l~e--------~~~------------~~i~~qIl~~L~yLH~------  118 (405)
                      +|++|..+..           .+.   .....+..        ...            ......+..++.++..      
T Consensus        94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~  173 (296)
T cd05153          94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL  173 (296)
T ss_pred             EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence            9999876421           111   00000000        000            0011123334444443      


Q ss_pred             -CCceeCCCCCCCEEEccCC-ceEeeecccc
Q 015500          119 -NRVVHCDIKSRNILMAESG-AKIADFGCAK  147 (405)
Q Consensus       119 -~givHrDlkp~NILi~~~~-vkL~DFGla~  147 (405)
                       .+++|+|+.|.||+++.++ ..|+||+.+.
T Consensus       174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         174 PRGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence             4799999999999999888 5799998875

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.48  E-value=0.00052  Score=70.12  Aligned_cols=168  Identities=20%  Similarity=0.223  Sum_probs=104.6

Q ss_pred             ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH
Q 015500           38 KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLH  117 (405)
Q Consensus        38 ~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH  117 (405)
                      .+-++....++++.+.|+|..++......... .  .-+|||++ +.+|.+.+..+.  +-.....              
T Consensus        25 ~s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~-r--~IVV~e~~-~~Sled~~~~~~--l~~~s~~--------------   84 (725)
T KOG1093|consen   25 NSIQILGRFQYLKSLQHDNLCQYLDFSRGKHE-R--VIVVMEHY-TMSLEDILKTGN--LKDESLL--------------   84 (725)
T ss_pred             cHHHHhhhhHHHHhhcCccceeeEeeecCccc-e--EEEEehhh-ccchHHHHHhcc--cchhhhc--------------
Confidence            45567777889999999999999875443322 2  34899999 679999887653  2221111              


Q ss_pred             hCCceeCCCCCCCEEEccCCceEeeecccccccccccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 015500          118 SNRVVHCDIKSRNILMAESGAKIADFGCAKWESEALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPN  197 (405)
Q Consensus       118 ~~givHrDlkp~NILi~~~~vkL~DFGla~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~  197 (405)
                      ..|+.|     .|+      .+++| .++...       .            ...++++|||++|.++.++.-|...|..
T Consensus        85 ~~~~~~-----~~~------~~~td-~~~t~~-------~------------~~~~pKsdVwsl~~i~~el~L~~~l~~~  133 (725)
T KOG1093|consen   85 AHGVLH-----LNI------IYITD-HFLTKY-------P------------SPIGPKSDVWSLGFIILELYLGISLEAE  133 (725)
T ss_pred             ccccce-----ehh------hhccc-cccccC-------C------------CCCCcchhhhhHHHHHHHHHHhhHHHHH
Confidence            122222     222      34444 111100       0            1122599999999999999999887754


Q ss_pred             CCChHHHHHHHHhcCCCC----------CCchhccHHHHHHHHHhcccCccccCCHHHHhcCcccccccc
Q 015500          198 AADPMTVLYKIAYSRELP----------EVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCS  257 (405)
Q Consensus       198 ~~~~~~~l~~i~~~~~~~----------~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~~  257 (405)
                      ...... +..+..-...+          .+--.+++...+++++|+-..|..||...++.+++-|.+.+.
T Consensus       134 ~~~s~~-l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev~~  202 (725)
T KOG1093|consen  134 LTESEY-LEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEVYK  202 (725)
T ss_pred             HHHHHH-HHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHHHh
Confidence            332211 11111111111          011125667789999999999999999999999999987644

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.39  E-value=0.00019  Score=69.60  Aligned_cols=126  Identities=18%  Similarity=0.241  Sum_probs=87.8

Q ss_pred             cccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-------------------------hHHHHHHHHHHHhCCC--C
Q 015500            3 WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-------------------------SEFLQREQKFLSSLNS--P   55 (405)
Q Consensus         3 y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-------------------------~~~l~~E~~iL~~L~h--p   55 (405)
                      +..|..||-|.-+.||++-+ ..|.+.++|.-.+.+                         +-...+|...|+.|..  -
T Consensus        94 ~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            56789999999999999987 468888988533211                         1134578888988843  2


Q ss_pred             CeeeeeeeeeecCCCceEEEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcc
Q 015500           56 HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAE  135 (405)
Q Consensus        56 nIv~~~~~~~~~~~~~~~~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~  135 (405)
                      -|...+++    .    ..++|||++.|-.|...-.-    .+.   ..+...+..-+--|-..|+||||..--||++++
T Consensus       173 pVPkpiD~----~----RH~Vvmelv~g~Pl~~v~~v----~d~---~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~d  237 (465)
T KOG2268|consen  173 PVPKPIDH----N----RHCVVMELVDGYPLRQVRHV----EDP---PTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKD  237 (465)
T ss_pred             CCCCcccc----c----ceeeHHHhhcccceeeeeec----CCh---HHHHHHHHHHHHHHHHcCceecccchheeEEec
Confidence            22222221    1    25689999999888753211    222   234445555666778899999999999999997


Q ss_pred             CC-ceEeeec
Q 015500          136 SG-AKIADFG  144 (405)
Q Consensus       136 ~~-vkL~DFG  144 (405)
                      ++ ++++||-
T Consensus       238 d~~i~vIDFP  247 (465)
T KOG2268|consen  238 DDKIVVIDFP  247 (465)
T ss_pred             CCCEEEeech
Confidence            76 9999995

>PRK05231 homoserine kinase; Provisional

Probab=97.34  E-value=0.0034  Score=61.25  Aligned_cols=138  Identities=17%  Similarity=0.192  Sum_probs=75.6

Q ss_pred             ccccceeCCeeEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHhCCC-----CCeeeee-eeeeecCCCceEEEEEEe
Q 015500            6 GHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNS-----PHIVGYK-GCDVTSEDNKLMYNLFME   79 (405)
Q Consensus         6 ~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~~~~l~~E~~iL~~L~h-----pnIv~~~-~~~~~~~~~~~~~~lv~E   79 (405)
                      .+.|+.|...++|+....  +..+++|+.+....+.+..|..++..|..     |.++.-. |.......+  ..+++++
T Consensus        27 ~~~l~~G~~n~~y~v~t~--~g~~vLK~~~~~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g--~~~~l~~  102 (319)
T PRK05231         27 LKGIAEGIENSNFFLTTT--QGEYVLTLFERLTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAG--KPAAIVT  102 (319)
T ss_pred             cchhccccccceEEEEeC--CCcEEEEEeccCChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCC--EEEEEEE
Confidence            456667777889998643  33688898763345566677777777632     3333211 111111111  2458999


Q ss_pred             ecCCCCHH-----------HHHHH---cCCCC--------C--H--HHHH-----------HHHHH-HHHHHHHHH----
Q 015500           80 YAPGGTLN-----------DEIHR---NGGRL--------D--E--SLIV-----------SYTRQ-ILQGLEYLH----  117 (405)
Q Consensus        80 y~~ggsL~-----------~~i~~---~~~~l--------~--e--~~~~-----------~i~~q-Il~~L~yLH----  117 (405)
                      |++|..+.           ..+.+   ....+        .  .  ....           ..+.+ +-..++.+.    
T Consensus       103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  182 (319)
T PRK05231        103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW  182 (319)
T ss_pred             ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence            99986431           11111   00000        0  0  0000           11111 111222332    


Q ss_pred             ---hCCceeCCCCCCCEEEccCC-ceEeeecccc
Q 015500          118 ---SNRVVHCDIKSRNILMAESG-AKIADFGCAK  147 (405)
Q Consensus       118 ---~~givHrDlkp~NILi~~~~-vkL~DFGla~  147 (405)
                         ..|++|+|+.|.||+++.+. .-|+||+.+.
T Consensus       183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             ccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence               24899999999999999777 4799999875

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.26  E-value=0.0018  Score=62.77  Aligned_cols=74  Identities=15%  Similarity=0.071  Sum_probs=47.4

Q ss_pred             ccccceeCCeeEEEEEEcC------CCCEEEEEEccCC--ChHHHHHHHHHHHhCCCCCee-eeeeeeeecCCCceEEEE
Q 015500            6 GHTIGQGSSATVSLATSLR------SGDVFAAKSTELP--KSEFLQREQKFLSSLNSPHIV-GYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         6 ~~~LG~G~~g~Vyla~~~~------~~~~vavK~~~~~--~~~~l~~E~~iL~~L~hpnIv-~~~~~~~~~~~~~~~~~l   76 (405)
                      .+.|..|-...||+.....      .++.+++|.....  ......+|.++++.|...++. ++++.+  . +     .+
T Consensus         3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~--~-~-----~~   74 (302)
T cd05156           3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIF--P-N-----GR   74 (302)
T ss_pred             EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEe--C-C-----Cc
Confidence            3456667777899987543      2578999987653  224578898898888543333 333322  1 2     15


Q ss_pred             EEeecCCCCHH
Q 015500           77 FMEYAPGGTLN   87 (405)
Q Consensus        77 v~Ey~~ggsL~   87 (405)
                      |+||++|.++.
T Consensus        75 v~e~i~G~~l~   85 (302)
T cd05156          75 IEEFIPSRTLT   85 (302)
T ss_pred             hhheeCCCcCC
Confidence            78999887654

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.22  E-value=0.0019  Score=63.79  Aligned_cols=134  Identities=22%  Similarity=0.248  Sum_probs=93.4

Q ss_pred             cccccceeCCeeEEEEEEcCCCCEEEEEEccCC------C-----------------------hHHHHHHHHHHHhCCCC
Q 015500            5 RGHTIGQGSSATVSLATSLRSGDVFAAKSTELP------K-----------------------SEFLQREQKFLSSLNSP   55 (405)
Q Consensus         5 ~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~------~-----------------------~~~l~~E~~iL~~L~hp   55 (405)
                      +-.+|..|.-+.||.|.. .+|..+|||+...+      +                       .-....|++-|++|..-
T Consensus       148 inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a  226 (520)
T KOG2270|consen  148 INGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA  226 (520)
T ss_pred             cccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence            345788899999999985 57888999965421      0                       12566799999998765


Q ss_pred             CeeeeeeeeeecCCCceEEEEEEeecCCCCHH-HHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCCEEE
Q 015500           56 HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLN-DEIHRNGGRLDESLIVSYTRQILQGLEYLHS-NRVVHCDIKSRNILM  133 (405)
Q Consensus        56 nIv~~~~~~~~~~~~~~~~~lv~Ey~~ggsL~-~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~-~givHrDlkp~NILi  133 (405)
                      .|.-..-. .-..     ..|||+++.+.... -.|+.  -.++...+..+-.|++.-+.-|-. .++||.||.--|+|+
T Consensus       227 GIP~PePI-lLk~-----hVLVM~FlGrdgw~aPkLKd--~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly  298 (520)
T KOG2270|consen  227 GIPCPEPI-LLKN-----HVLVMEFLGRDGWAAPKLKD--ASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY  298 (520)
T ss_pred             CCCCCCce-eeec-----ceEeeeeccCCCCcCccccc--ccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE
Confidence            54321111 1111     23899999542222 12222  357777788888888888887755 589999999999999


Q ss_pred             ccCCceEeeecccc
Q 015500          134 AESGAKIADFGCAK  147 (405)
Q Consensus       134 ~~~~vkL~DFGla~  147 (405)
                      ..+.+.|+|.+-+.
T Consensus       299 hdG~lyiIDVSQSV  312 (520)
T KOG2270|consen  299 HDGKLYIIDVSQSV  312 (520)
T ss_pred             ECCEEEEEEccccc
Confidence            99999999987654

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.21  E-value=0.0038  Score=60.78  Aligned_cols=138  Identities=17%  Similarity=0.202  Sum_probs=79.6

Q ss_pred             ccccceeCCeeEEEEEEcCCCCEEEEEEccCC-ChHHHHHHHHHHHhCCCCC--eeeeeee----eeecCCCceEEEEEE
Q 015500            6 GHTIGQGSSATVSLATSLRSGDVFAAKSTELP-KSEFLQREQKFLSSLNSPH--IVGYKGC----DVTSEDNKLMYNLFM   78 (405)
Q Consensus         6 ~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~-~~~~l~~E~~iL~~L~hpn--Iv~~~~~----~~~~~~~~~~~~lv~   78 (405)
                      .+.++.|....+|+... . +..+++|..... ..+.+..|.+++..|...+  +.+++..    ......+  ..++++
T Consensus        27 i~~~~~G~~n~~y~v~t-~-~~~~vLK~~~~~~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g--~~~~l~  102 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTT-D-VGRYILTLYEKRVKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAG--KPACLV  102 (307)
T ss_pred             ccccCCccccceEEEEe-C-CCcEEEEEecCCCCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCC--eEEEEE
Confidence            56677787789999864 3 345778876543 3456778888888874322  2333221    1111122  245899


Q ss_pred             eecCCCCHH-----------HHH---HHcCCCC--------CHH---H--HH----------HHHHHHHHHHHHHHh---
Q 015500           79 EYAPGGTLN-----------DEI---HRNGGRL--------DES---L--IV----------SYTRQILQGLEYLHS---  118 (405)
Q Consensus        79 Ey~~ggsL~-----------~~i---~~~~~~l--------~e~---~--~~----------~i~~qIl~~L~yLH~---  118 (405)
                      +|++|..+.           ..+   ......+        ...   .  ..          .....+...++++..   
T Consensus       103 e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~  182 (307)
T TIGR00938       103 EFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWP  182 (307)
T ss_pred             EeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhh
Confidence            999885431           111   1100001        000   0  00          011223345555542   


Q ss_pred             ----CCceeCCCCCCCEEEccCC-ceEeeecccc
Q 015500          119 ----NRVVHCDIKSRNILMAESG-AKIADFGCAK  147 (405)
Q Consensus       119 ----~givHrDlkp~NILi~~~~-vkL~DFGla~  147 (405)
                          .+++|+|+.+.||+++.++ ..|+||+.+.
T Consensus       183 ~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       183 RDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             hcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence                5899999999999999888 5899999874

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.91  E-value=0.0096  Score=59.18  Aligned_cols=71  Identities=15%  Similarity=0.054  Sum_probs=46.0

Q ss_pred             cccceeCCeeEEEEEEcCCCCEEEEEEccC----------CChHHHHHHHHHHHhCC--CC-CeeeeeeeeeecCCCceE
Q 015500            7 HTIGQGSSATVSLATSLRSGDVFAAKSTEL----------PKSEFLQREQKFLSSLN--SP-HIVGYKGCDVTSEDNKLM   73 (405)
Q Consensus         7 ~~LG~G~~g~Vyla~~~~~~~~vavK~~~~----------~~~~~l~~E~~iL~~L~--hp-nIv~~~~~~~~~~~~~~~   73 (405)
                      +.||-|....||++.+...++-++||....          -..++...|...|+...  .| ++.+++.+.   ..   .
T Consensus         1 ~EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D---~e---~   74 (370)
T TIGR01767         1 QEVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFD---TE---M   74 (370)
T ss_pred             CcCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEc---cc---c
Confidence            357999999999999864446899996431          12345667888887763  24 455565432   21   1


Q ss_pred             EEEEEeecCC
Q 015500           74 YNLFMEYAPG   83 (405)
Q Consensus        74 ~~lv~Ey~~g   83 (405)
                      ..++||+++.
T Consensus        75 ~~~vMEdL~~   84 (370)
T TIGR01767        75 AVTVMEDLSH   84 (370)
T ss_pred             ceehHhhCcc
Confidence            3489999854

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.89  E-value=0.0085  Score=58.66  Aligned_cols=32  Identities=19%  Similarity=0.337  Sum_probs=27.7

Q ss_pred             CceeCCCCCCCEEEccCC-ceEeeecccccccc
Q 015500          120 RVVHCDIKSRNILMAESG-AKIADFGCAKWESE  151 (405)
Q Consensus       120 givHrDlkp~NILi~~~~-vkL~DFGla~~~~~  151 (405)
                      .++|+|+.+.|++|+.++ +-|.||+++...+.
T Consensus       199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP  231 (321)
T COG3173         199 VLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP  231 (321)
T ss_pred             eeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence            589999999999999888 88999999875443

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.86  E-value=0.015  Score=56.41  Aligned_cols=29  Identities=24%  Similarity=0.398  Sum_probs=25.6

Q ss_pred             CCceeCCCCCCCEEEccCCceEeeecccc
Q 015500          119 NRVVHCDIKSRNILMAESGAKIADFGCAK  147 (405)
Q Consensus       119 ~givHrDlkp~NILi~~~~vkL~DFGla~  147 (405)
                      .+++|+|+.+.||+++.+.+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKDNEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeCCcEEEEECcccc
Confidence            47899999999999998668999998664

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.73  E-value=0.0085  Score=57.63  Aligned_cols=30  Identities=30%  Similarity=0.430  Sum_probs=25.1

Q ss_pred             CceeCCCCCCCEEEccCC--ceEeeecccccc
Q 015500          120 RVVHCDIKSRNILMAESG--AKIADFGCAKWE  149 (405)
Q Consensus       120 givHrDlkp~NILi~~~~--vkL~DFGla~~~  149 (405)
                      .++|+|++|.||+++.++  .-|+||+.+...
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG  217 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG  217 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence            489999999999998744  569999998643

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PRK10593 hypothetical protein; Provisional

Probab=96.63  E-value=0.013  Score=56.84  Aligned_cols=105  Identities=16%  Similarity=0.038  Sum_probs=72.8

Q ss_pred             ccccceeCCeeEEEEEEcCCCCEEEEEEccCC-ChHHHHHHHHHHHhCCC---CCeeeeeeeeeecCCCceEEEEEEeec
Q 015500            6 GHTIGQGSSATVSLATSLRSGDVFAAKSTELP-KSEFLQREQKFLSSLNS---PHIVGYKGCDVTSEDNKLMYNLFMEYA   81 (405)
Q Consensus         6 ~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~-~~~~l~~E~~iL~~L~h---pnIv~~~~~~~~~~~~~~~~~lv~Ey~   81 (405)
                      .+.||.|..+.||..... ++ .+++|..... ....+.+|...|+.|..   ..+.++++.+....... ..++|||++
T Consensus        19 ~~~i~~G~~~~vy~~~~~-~~-~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g-~~~LVmE~i   95 (297)
T PRK10593         19 VECISEQPYAALWALYDS-QG-NPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPG-PDVLLLERL   95 (297)
T ss_pred             eeecCCccceeEEEEEcC-CC-CEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCC-CeEEEEecc
Confidence            467999999999998643 23 4677775442 45689999999998843   34556665443322111 145899999


Q ss_pred             CCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 015500           82 PGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN  119 (405)
Q Consensus        82 ~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~  119 (405)
                      +|+++.+.      ..+......+..+++.+|+-||+.
T Consensus        96 ~G~~~~~~------~~~~~~~~~l~~~l~~~La~LH~~  127 (297)
T PRK10593         96 RGVSVEAP------ARTPERWEQLKDQIVEGLLAWHRI  127 (297)
T ss_pred             CCEecCCC------CCCHHHHHHHHHHHHHHHHHHhCC
Confidence            99888751      233445667778899999999985

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.29  E-value=0.025  Score=57.02  Aligned_cols=72  Identities=17%  Similarity=0.056  Sum_probs=48.1

Q ss_pred             ccccceeCCeeEEEEEEcCCCCEEEEEEccC---------CChHHHHHHHHHHHhCC--CC-CeeeeeeeeeecCCCceE
Q 015500            6 GHTIGQGSSATVSLATSLRSGDVFAAKSTEL---------PKSEFLQREQKFLSSLN--SP-HIVGYKGCDVTSEDNKLM   73 (405)
Q Consensus         6 ~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~---------~~~~~l~~E~~iL~~L~--hp-nIv~~~~~~~~~~~~~~~   73 (405)
                      .+.||-|...-||++.+...++-++||....         -..++...|.+.|+.+.  .| ++.+++.+...      .
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D~e------~  107 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFDSV------M  107 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEECcH------H
Confidence            5788999999999999854456789986431         12356777888888763  24 45556654321      1


Q ss_pred             EEEEEeecCC
Q 015500           74 YNLFMEYAPG   83 (405)
Q Consensus        74 ~~lv~Ey~~g   83 (405)
                      ..+|||+++.
T Consensus       108 ~~~vMEdL~~  117 (409)
T PRK12396        108 NCCVMEDLSD  117 (409)
T ss_pred             hhHHHHhCcc
Confidence            3479999864

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.10  E-value=0.082  Score=53.57  Aligned_cols=70  Identities=19%  Similarity=0.085  Sum_probs=45.8

Q ss_pred             ccccceeCCeeEEEEEEcCCCCEEEEEEccC-----C-----ChHHHHHHHHHHHhCC---CCCeeeeeeeeeecCCCce
Q 015500            6 GHTIGQGSSATVSLATSLRSGDVFAAKSTEL-----P-----KSEFLQREQKFLSSLN---SPHIVGYKGCDVTSEDNKL   72 (405)
Q Consensus         6 ~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~-----~-----~~~~l~~E~~iL~~L~---hpnIv~~~~~~~~~~~~~~   72 (405)
                      .+.||-|....||+..+.  +..++||.-..     .     ...+...|.+.|+.+.   ..++.+++.++.  +.   
T Consensus        37 ~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~---  109 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TM---  109 (418)
T ss_pred             EEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CC---
Confidence            457888999999998863  45688997551     1     2344556677776663   235666665543  11   


Q ss_pred             EEEEEEeecCC
Q 015500           73 MYNLFMEYAPG   83 (405)
Q Consensus        73 ~~~lv~Ey~~g   83 (405)
                       ..++|||+++
T Consensus       110 -~vlvME~L~~  119 (418)
T PLN02756        110 -ALIGMRYLEP  119 (418)
T ss_pred             -CEEEEeecCC
Confidence             3479999977

>PLN02236 choline kinase

Probab=96.10  E-value=0.059  Score=53.52  Aligned_cols=133  Identities=13%  Similarity=0.073  Sum_probs=74.5

Q ss_pred             cccceeCCeeEEEEEEcC----CCCEEEEEEccCCChH--HHHHHHHHHHhCCCCCee-eeeeeeeecCCCceEEEEEEe
Q 015500            7 HTIGQGSSATVSLATSLR----SGDVFAAKSTELPKSE--FLQREQKFLSSLNSPHIV-GYKGCDVTSEDNKLMYNLFME   79 (405)
Q Consensus         7 ~~LG~G~~g~Vyla~~~~----~~~~vavK~~~~~~~~--~l~~E~~iL~~L~hpnIv-~~~~~~~~~~~~~~~~~lv~E   79 (405)
                      ..|-.|-.-.+|++....    .++.+++|........  .-.+|..+++.+..-++. ++++.+   .++     .|.+
T Consensus        42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~---~~g-----~v~e  113 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRF---PNG-----RVEE  113 (344)
T ss_pred             EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEE---CCc-----eEEE
Confidence            445456777899986432    3468899987654322  236788888888543333 233332   121     4788


Q ss_pred             ecCCCCHHHH--------------HHH-cCCC-------CCHHHHHHHHHHH-----------------HHHHHHH----
Q 015500           80 YAPGGTLNDE--------------IHR-NGGR-------LDESLIVSYTRQI-----------------LQGLEYL----  116 (405)
Q Consensus        80 y~~ggsL~~~--------------i~~-~~~~-------l~e~~~~~i~~qI-----------------l~~L~yL----  116 (405)
                      |++|.+|...              +.+ +...       .....+..+..++                 ...+..|    
T Consensus       114 fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~  193 (344)
T PLN02236        114 FIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKEL  193 (344)
T ss_pred             eeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHh
Confidence            8877665311              111 1101       1122333333222                 1111112    


Q ss_pred             H----hCCceeCCCCCCCEEEccC-C-ceEeeecccc
Q 015500          117 H----SNRVVHCDIKSRNILMAES-G-AKIADFGCAK  147 (405)
Q Consensus       117 H----~~givHrDlkp~NILi~~~-~-vkL~DFGla~  147 (405)
                      .    ...++|+|+++.|||++.. + +.++||..+.
T Consensus       194 ~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        194 SGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             cccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence            1    2358999999999999864 4 9999998875

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=95.96  E-value=0.032  Score=55.29  Aligned_cols=115  Identities=19%  Similarity=0.251  Sum_probs=75.8

Q ss_pred             CeeeeeeeeeecCCCceEEEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCCCCEEEc
Q 015500           56 HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN-RVVHCDIKSRNILMA  134 (405)
Q Consensus        56 nIv~~~~~~~~~~~~~~~~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~-givHrDlkp~NILi~  134 (405)
                      .++.+...++...+...+.|++|++- |++|.- ++    .-..+++..++++-+..++-+..+ .+=||++.-.||||+
T Consensus       283 g~~~~e~~~vv~~de~~y~yl~~kdh-gt~is~-ik----~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId  356 (488)
T COG5072         283 GSVFLETLKVVSLDETLYLYLHFKDH-GTPISI-IK----ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID  356 (488)
T ss_pred             cchhhhcceEEecCCceEEEEEEecC-Cceeee-ee----cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee
Confidence            34444444444545566777999886 666652 21    235677888999988888777765 789999999999999


Q ss_pred             cCCceEeeecccccccccccCCCCCC---ccChhhhcCCCCCcchhHHHH
Q 015500          135 ESGAKIADFGCAKWESEALQSGGTPM---FMAPEVARGEHQGFASDIWAV  181 (405)
Q Consensus       135 ~~~vkL~DFGla~~~~~~~~~~gt~~---Y~APE~l~~~~~~~~sDIwSL  181 (405)
                      .+++.|+||-|++....    .|-..   .--|-.+.|.. ++.-+||-+
T Consensus       357 ~GnvtLIDfklsRl~~~----q~~isy~rldhp~lF~G~d-d~QFeIYrl  401 (488)
T COG5072         357 EGNVTLIDFKLSRLSYS----QGIISYNRLDHPDLFNGVD-DYQFEIYRL  401 (488)
T ss_pred             cCceEEEEeeeeecccC----CceeeccccCchhhhcCcc-ceeeeHHHH
Confidence            66699999999983221    12222   22344555433 556677764

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=95.89  E-value=0.027  Score=56.52  Aligned_cols=57  Identities=19%  Similarity=0.288  Sum_probs=42.6

Q ss_pred             EEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH-HhCCceeCCCCCCCEEEc
Q 015500           76 LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL-HSNRVVHCDIKSRNILMA  134 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yL-H~~givHrDlkp~NILi~  134 (405)
                      ++-+|..|.++..+++..+  .+|...+.++.-.+.|+--+ --.+++|.|+.|.||++-
T Consensus       322 l~E~~~~Gl~v~~~v~~~~--~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlir  379 (565)
T KOG1236|consen  322 LVETYERGLSVLRFVKWKS--QPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIR  379 (565)
T ss_pred             eeeeccccccHHhhhhccc--ChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEE
Confidence            5667899999999998764  55666666666656655443 346899999999999984

>PTZ00384 choline kinase; Provisional

Probab=95.85  E-value=0.051  Score=54.76  Aligned_cols=29  Identities=31%  Similarity=0.288  Sum_probs=25.6

Q ss_pred             CCceeCCCCCCCEEEccCCceEeeecccc
Q 015500          119 NRVVHCDIKSRNILMAESGAKIADFGCAK  147 (405)
Q Consensus       119 ~givHrDlkp~NILi~~~~vkL~DFGla~  147 (405)
                      ..++|.|+-+.||+.+.++++++||..|.
T Consensus       227 ~VfCHNDL~~gNIL~~~~~l~lID~EYA~  255 (383)
T PTZ00384        227 VLFCHNDLFFTNILDFNQGIYFIDFDFAG  255 (383)
T ss_pred             eeeeeccCCcccEEecCCCEEEEEecccc
Confidence            46799999999999988889999997764

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=95.79  E-value=0.067  Score=52.77  Aligned_cols=72  Identities=11%  Similarity=0.051  Sum_probs=42.1

Q ss_pred             cccceeCCeeEEEEEEcCC---CCEEEEEEccCCChH--HHHHHHHHHHhCCCCCee-eeeeeeeecCCCceEEEEEEee
Q 015500            7 HTIGQGSSATVSLATSLRS---GDVFAAKSTELPKSE--FLQREQKFLSSLNSPHIV-GYKGCDVTSEDNKLMYNLFMEY   80 (405)
Q Consensus         7 ~~LG~G~~g~Vyla~~~~~---~~~vavK~~~~~~~~--~l~~E~~iL~~L~hpnIv-~~~~~~~~~~~~~~~~~lv~Ey   80 (405)
                      +.|.-|=.-.+|+......   +..+++|........  .-.+|..+++.+..-++. ++++.+  ...      +|.+|
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~--~~G------~i~~f   91 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVF--GNG------MIQSF   91 (330)
T ss_pred             EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEe--CCc------Eeehh
Confidence            4454466678898865432   237889987543222  235788888888654443 233322  111      47888


Q ss_pred             cCCCCH
Q 015500           81 APGGTL   86 (405)
Q Consensus        81 ~~ggsL   86 (405)
                      ++|.+|
T Consensus        92 i~g~~l   97 (330)
T PLN02421         92 INARTL   97 (330)
T ss_pred             hcCCCC
Confidence            877654

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=95.28  E-value=0.18  Score=49.15  Aligned_cols=28  Identities=21%  Similarity=0.297  Sum_probs=25.3

Q ss_pred             CceeCCCCCCCEEEccCC-ceEeeecccc
Q 015500          120 RVVHCDIKSRNILMAESG-AKIADFGCAK  147 (405)
Q Consensus       120 givHrDlkp~NILi~~~~-vkL~DFGla~  147 (405)
                      +++|+|+.++|||++.++ +.++||..+.
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~  225 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKAS  225 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence            799999999999998876 8999998775

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=95.14  E-value=0.14  Score=50.46  Aligned_cols=133  Identities=17%  Similarity=0.197  Sum_probs=79.3

Q ss_pred             CCeeEEEEEEcCCCCEEEEEEccCC-ChHHHHHHHHHHHhCCCCC------eeeeeeeeeecCCCceEEEEEEeecCCCC
Q 015500           13 SSATVSLATSLRSGDVFAAKSTELP-KSEFLQREQKFLSSLNSPH------IVGYKGCDVTSEDNKLMYNLFMEYAPGGT   85 (405)
Q Consensus        13 ~~g~Vyla~~~~~~~~vavK~~~~~-~~~~l~~E~~iL~~L~hpn------Iv~~~~~~~~~~~~~~~~~lv~Ey~~ggs   85 (405)
                      .-..||+.... +|+. ++|+.+.. ....+.-|...|..|.-..      +...-|-....-.....+.-+++|++|..
T Consensus        37 ~eN~~f~~~~~-~g~~-iLki~~~~~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~~  114 (331)
T COG2334          37 EENSNFRVQTE-DGRY-ILKIYRPGWTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGRP  114 (331)
T ss_pred             ccCceEEEEec-CCCe-EEEEecCCCCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCcC
Confidence            34468888753 3444 99998875 6778999999999883211      22222221111111134557889999987


Q ss_pred             HHH-----HH----------HHc--------CCC---CCHH----H---------HHHHHHHHHHHHHHHHh--------
Q 015500           86 LND-----EI----------HRN--------GGR---LDES----L---------IVSYTRQILQGLEYLHS--------  118 (405)
Q Consensus        86 L~~-----~i----------~~~--------~~~---l~e~----~---------~~~i~~qIl~~L~yLH~--------  118 (405)
                      +..     .+          ...        .+.   ..+.    .         -.....++...++.+.+        
T Consensus       115 ~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp~  194 (331)
T COG2334         115 LERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLPA  194 (331)
T ss_pred             cCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCCc
Confidence            772     11          110        000   1111    0         01133445555555554        


Q ss_pred             CC--ceeCCCCCCCEEEccCC--ceEeeecccc
Q 015500          119 NR--VVHCDIKSRNILMAESG--AKIADFGCAK  147 (405)
Q Consensus       119 ~g--ivHrDlkp~NILi~~~~--vkL~DFGla~  147 (405)
                      .+  +||+|+.|.||+++.+.  ..+.||+.+.
T Consensus       195 ~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         195 LGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             ccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence            23  99999999999999886  7899999875

>PRK11768 serine/threonine protein kinase; Provisional

Probab=94.92  E-value=0.51  Score=46.39  Aligned_cols=68  Identities=15%  Similarity=0.170  Sum_probs=40.4

Q ss_pred             eeEEEEEEcCCCCEEEEEEccCC--ChHHHHHHHHHHHhCCCCC--eee---eeeeeeecCCCceEEEEEEeecCCCC
Q 015500           15 ATVSLATSLRSGDVFAAKSTELP--KSEFLQREQKFLSSLNSPH--IVG---YKGCDVTSEDNKLMYNLFMEYAPGGT   85 (405)
Q Consensus        15 g~Vyla~~~~~~~~vavK~~~~~--~~~~l~~E~~iL~~L~hpn--Iv~---~~~~~~~~~~~~~~~~lv~Ey~~ggs   85 (405)
                      ..||.... .++..+++|+....  ....+..|..++..|....  ++.   .-|-.....++  +++.++++++|..
T Consensus        39 N~vy~v~~-~~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g--~~~~l~~~~~G~~  113 (325)
T PRK11768         39 NRVYQFGD-EDGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQG--FRFALFPRRGGRA  113 (325)
T ss_pred             ceEEEEec-CCCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECC--EEEEEEeeeCCCC
Confidence            46888864 45678999987643  3567888999888774322  222   11211111111  3557899998764

>PRK06148 hypothetical protein; Provisional

Probab=93.98  E-value=1  Score=51.26  Aligned_cols=140  Identities=19%  Similarity=0.246  Sum_probs=77.9

Q ss_pred             cccceeCCeeEEEEEEcCCCCEEEEEEccCC-ChHHHHHHHHHHHhCC-------CCCeeeee-eee---eecCCCceEE
Q 015500            7 HTIGQGSSATVSLATSLRSGDVFAAKSTELP-KSEFLQREQKFLSSLN-------SPHIVGYK-GCD---VTSEDNKLMY   74 (405)
Q Consensus         7 ~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~-~~~~l~~E~~iL~~L~-------hpnIv~~~-~~~---~~~~~~~~~~   74 (405)
                      +.|+ |..-.+|+... .+|+.+++|+.+.. ....+..|.++|..|.       -|.+++-. |-.   +...++...+
T Consensus        31 ~~L~-s~~d~nf~v~~-~~g~~yVLKi~~~~~~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~~  108 (1013)
T PRK06148         31 TPLD-GERDLNFRLTT-DDGADYILKIVNPSEPRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPRL  108 (1013)
T ss_pred             eecC-CcCCceEEEEe-CCCCeEEEEEcCCccchhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceEE
Confidence            4554 34567888764 46778999998754 3345566667776552       23444322 111   1112233345


Q ss_pred             EEEEeecCCCCHHHH-------HHH----------------cC---CCCCH-----------------HHHHHHHHHHHH
Q 015500           75 NLFMEYAPGGTLNDE-------IHR----------------NG---GRLDE-----------------SLIVSYTRQILQ  111 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~-------i~~----------------~~---~~l~e-----------------~~~~~i~~qIl~  111 (405)
                      .-+++|++|..+.+.       +.+                ..   ..+.+                 ...+.++.+++.
T Consensus       109 vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~~  188 (1013)
T PRK06148        109 LRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFLA  188 (1013)
T ss_pred             EEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHHH
Confidence            578999999877551       110                00   00101                 111223333333


Q ss_pred             HHHH-----HH--hCCceeCCCCCCCEEEccCC---c-eEeeeccccc
Q 015500          112 GLEY-----LH--SNRVVHCDIKSRNILMAESG---A-KIADFGCAKW  148 (405)
Q Consensus       112 ~L~y-----LH--~~givHrDlkp~NILi~~~~---v-kL~DFGla~~  148 (405)
                      ...-     +.  ..++||+|+.+.|||++.++   + =|+|||-+..
T Consensus       189 ~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        189 RFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             HHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            3321     21  24799999999999998773   4 4999998754

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=93.97  E-value=0.26  Score=45.85  Aligned_cols=86  Identities=20%  Similarity=0.303  Sum_probs=59.2

Q ss_pred             hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh
Q 015500           39 SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHS  118 (405)
Q Consensus        39 ~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~  118 (405)
                      ...+.++.+++.++.  .|+++..     +++. -|-+++|+|-....             ...-.+. -=+++|.-.|+
T Consensus       102 ~~~y~nky~v~Armh--GilrL~N-----Dn~~-~yGvIlE~Cy~~~i-------------~~~N~i~-agi~~L~~fH~  159 (308)
T PF07387_consen  102 DALYFNKYRVFARMH--GILRLKN-----DNNY-KYGVILERCYKIKI-------------NFSNFIT-AGIKDLMDFHS  159 (308)
T ss_pred             hhhhhhhhhHHHHhh--heeEeec-----CCCc-eeEEEEeeccCccc-------------chhHHHH-HhHHHHHHhhc
Confidence            456788899998875  5777762     2333 36689999843211             1111121 12467888895


Q ss_pred             --CCceeCCCCCCCEEEccCC-ceEeeeccc
Q 015500          119 --NRVVHCDIKSRNILMAESG-AKIADFGCA  146 (405)
Q Consensus       119 --~givHrDlkp~NILi~~~~-vkL~DFGla  146 (405)
                        .+.+|+|-.|+||+-+..| +||.|=++.
T Consensus       160 ~~~~~lHGD~np~NiM~D~~G~lKlVDP~~L  190 (308)
T PF07387_consen  160 ENQHCLHGDCNPDNIMCDKFGYLKLVDPVCL  190 (308)
T ss_pred             cCCCeecCCCChhheeecCCCCEEecChhhh
Confidence              4799999999999999999 999998864

The function of this family is unknown.

>PTZ00296 choline kinase; Provisional

Probab=93.95  E-value=0.53  Score=48.40  Aligned_cols=28  Identities=21%  Similarity=0.402  Sum_probs=25.0

Q ss_pred             CceeCCCCCCCEEEccCCceEeeecccc
Q 015500          120 RVVHCDIKSRNILMAESGAKIADFGCAK  147 (405)
Q Consensus       120 givHrDlkp~NILi~~~~vkL~DFGla~  147 (405)
                      .++|.|+-+.|||.+.++++|+||-.|.
T Consensus       285 VfCHNDl~~~NiL~~~~~l~LIDfEYAg  312 (442)
T PTZ00296        285 VFCHNDLQENNIINTNKCLRLIDFEYSG  312 (442)
T ss_pred             eEEeCCCCccceeecCCCEEEEeecccc
Confidence            5799999999999988789999998764

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=93.51  E-value=0.21  Score=48.35  Aligned_cols=74  Identities=14%  Similarity=0.158  Sum_probs=46.1

Q ss_pred             cccccceeCCeeEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHhCC--C-CCeeeeeeeeeecCCCceEEEEEEeec
Q 015500            5 RGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLN--S-PHIVGYKGCDVTSEDNKLMYNLFMEYA   81 (405)
Q Consensus         5 ~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~~~~l~~E~~iL~~L~--h-pnIv~~~~~~~~~~~~~~~~~lv~Ey~   81 (405)
                      ..+.|+-|....+|...  .+++.+.||.-.......+..|..-|+.|.  . -.+.+.++.......    -+|+|||+
T Consensus        21 ~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~----~fLlle~l   94 (288)
T PF03881_consen   21 SIEPVSGGDINEAYRLD--TDGGSYFVKVNSESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDD----AFLLLEFL   94 (288)
T ss_dssp             EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSC----CEEEEE--
T ss_pred             eeEecCCCChhheEEEE--CCCccEEEEecChhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCC----ceEEEEee
Confidence            45677878888999876  678899999887556678999999999883  2 335566665544433    24899998


Q ss_pred             CCC
Q 015500           82 PGG   84 (405)
Q Consensus        82 ~gg   84 (405)
                      +.+
T Consensus        95 ~~~   97 (288)
T PF03881_consen   95 EMG   97 (288)
T ss_dssp             ---
T ss_pred             cCC
Confidence            766

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PRK10271 thiK thiamine kinase; Provisional

Probab=92.45  E-value=0.096  Score=47.34  Aligned_cols=30  Identities=23%  Similarity=0.399  Sum_probs=26.5

Q ss_pred             CceeCCCCCCCEEEccCCceEeeecccccc
Q 015500          120 RVVHCDIKSRNILMAESGAKIADFGCAKWE  149 (405)
Q Consensus       120 givHrDlkp~NILi~~~~vkL~DFGla~~~  149 (405)
                      -.+|+|+.|.||++++++++|+||+.|...
T Consensus        78 ~p~H~D~~~~N~~~~~~~~~lIDwe~a~~g  107 (188)
T PRK10271         78 APLHMDVHAGNLVHSASGLRLIDWEYAGDG  107 (188)
T ss_pred             eeecCCCCCccEEEECCCEEEEeCCcccCC
Confidence            369999999999999989999999998643

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	405
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-36
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		3e-36
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		4e-36
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		4e-36
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-35
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-33
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		1e-32
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-32
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-32
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-32
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-32
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-32
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		3e-32
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-29
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-29
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-29
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-29
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		3e-29
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-28
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-28
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-28
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-28
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-28
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-27
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		4e-27
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		4e-27
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		7e-27
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		7e-27
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		8e-27
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		8e-27
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-26
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-26
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-26
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-26
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		1e-25
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-25
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-25
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-25
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-25
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		5e-25
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		5e-25
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		5e-25
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		9e-25
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-24
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-24
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-24
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-24
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-24
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-24
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-24
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-24
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-24
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-24
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-24
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-24
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-24
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-24
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-24
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-24
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-24
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-24
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-24
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		3e-24
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		3e-24
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		3e-24
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		4e-24
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		4e-24
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		5e-24
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		5e-24
4ae6_A	343	Structure And Function Of The Human Sperm-specific		6e-24
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		7e-24
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		7e-24
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		7e-24
4ae9_A	343	Structure And Function Of The Human Sperm-specific		8e-24
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		8e-24
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		8e-24
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		8e-24
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-23
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		1e-23
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		1e-23
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-23
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-23
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-23
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-23
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-23
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-23
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-23
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-23
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-23
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-23
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-23
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-23
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-23
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-23
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-23
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-23
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-23
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-23
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-23
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-23
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-23
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-23
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		3e-23
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		3e-23
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		3e-23
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		3e-23
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		3e-23
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		3e-23
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-23
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		3e-23
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		3e-23
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-23
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		3e-23
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-23
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		3e-23
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		3e-23
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		3e-23
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		3e-23
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		3e-23
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		3e-23
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		3e-23
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		4e-23
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		4e-23
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		4e-23
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		4e-23
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		4e-23
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		4e-23
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		4e-23
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		4e-23
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		4e-23
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		4e-23
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		4e-23
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		4e-23
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		4e-23
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		4e-23
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		4e-23
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		4e-23
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		4e-23
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		4e-23
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		5e-23
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		5e-23
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		5e-23
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		5e-23
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		6e-23
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		6e-23
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		6e-23
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		7e-23
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		8e-23
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		9e-23
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		9e-23
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		1e-22
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-22
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		1e-22
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-22
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-22
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-22
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-22
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		1e-22
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-22
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-22
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-22
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-22
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-22
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-22
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-22
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		3e-22
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		3e-22
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		3e-22
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		3e-22
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		4e-22
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		5e-22
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		8e-22
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		8e-22
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		9e-22
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		9e-22
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		1e-21
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		1e-21
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		1e-21
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		1e-21
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		1e-21
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		1e-21
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		1e-21
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-21
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-21
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-21
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-21
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-21
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-21
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-21
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-21
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		3e-21
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-21
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-21
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-21
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		4e-21
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-21
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		5e-21
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		5e-21
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		5e-21
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		6e-21
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		6e-21
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		6e-21
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		6e-21
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		6e-21
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		6e-21
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		7e-21
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		7e-21
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		7e-21
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		7e-21
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		7e-21
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		7e-21
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		7e-21
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		7e-21
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		7e-21
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		7e-21
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		7e-21
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		7e-21
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		8e-21
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		8e-21
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		8e-21
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		8e-21
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		8e-21
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		8e-21
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		9e-21
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		9e-21
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		9e-21
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		9e-21
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		9e-21
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		9e-21
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		9e-21
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		9e-21
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		9e-21
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		9e-21
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-20
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-20
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-20
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-20
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-20
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-20
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-20
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-20
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-20
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-20
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-20
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-20
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-20
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-20
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-20
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-20
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-20
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-20
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-20
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-20
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		2e-20
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-20
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-20
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-20
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-20
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		3e-20
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-20
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-20
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		3e-20
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-20
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		3e-20
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		3e-20
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-20
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		3e-20
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		3e-20
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		3e-20
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		4e-20
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		4e-20
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		5e-20
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		5e-20
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		6e-20
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		7e-20
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		7e-20
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		7e-20
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		7e-20
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		8e-20
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		8e-20
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		1e-19
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-19
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		1e-19
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		1e-19
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-19
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-19
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-19
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-19
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-19
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-19
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		2e-19
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-19
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-19
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		3e-19
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		3e-19
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		3e-19
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		3e-19
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		3e-19
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		3e-19
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		3e-19
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		3e-19
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		3e-19
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		4e-19
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		4e-19
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		4e-19
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		4e-19
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-19
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		6e-19
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		7e-19
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-18
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-18
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		2e-18
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		2e-18
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		2e-18
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-18
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-18
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		2e-18
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-18
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-18
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-18
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		3e-18
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		3e-18
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		4e-18
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		4e-18
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		4e-18
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		6e-18
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		6e-18
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		8e-18
4exu_A	371	Mapk13, Inactive Form Length = 371		9e-18
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		9e-18
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-17
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		1e-17
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-17
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-17
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		1e-17
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		1e-17
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-17
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-17
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-17
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-17
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-17
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		2e-17
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-17
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-17
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-17
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		3e-17
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-17
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		3e-17
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		3e-17
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		3e-17
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		3e-17
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		4e-17
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		4e-17
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		4e-17
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		4e-17
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		4e-17
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		4e-17
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		4e-17
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		5e-17
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		5e-17
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		5e-17
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		5e-17
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		5e-17
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		5e-17
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		5e-17
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		6e-17
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		6e-17
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		6e-17
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		6e-17
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		6e-17
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		6e-17
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		6e-17
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		6e-17
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		6e-17
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		6e-17
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		6e-17
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		6e-17
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		7e-17
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		8e-17
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		8e-17
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		8e-17
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		8e-17
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		8e-17
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		8e-17
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		8e-17
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		9e-17
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		9e-17
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		9e-17
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		9e-17
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		9e-17
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		9e-17
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		1e-16
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-16
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-16
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		1e-16
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		1e-16
4h58_A	275	Braf In Complex With Compound 3 Length = 275		1e-16
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		1e-16
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-16
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-16
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		1e-16
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-16
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-16
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-16
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-16
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		2e-16
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-16
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-16
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-16
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-16
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-16
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-16
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-16
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		2e-16
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		3e-16
3g51_A	325	Structural Diversity Of The Active Conformation Of		3e-16
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		3e-16
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		3e-16
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-16
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-16
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		3e-16
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		3e-16
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		3e-16
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		3e-16
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		3e-16
3kk8_A	284	Camkii Substrate Complex A Length = 284		4e-16
3kk9_A	282	Camkii Substrate Complex B Length = 282		4e-16
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		4e-16
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		4e-16
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		4e-16
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-16
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		5e-16
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		5e-16
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		5e-16
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		5e-16
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		9e-16
3soa_A	444	Full-Length Human Camkii Length = 444		1e-15
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-15
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		1e-15
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		2e-15
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-15
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		3e-15
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		3e-15
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		3e-15
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		4e-15
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		4e-15
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		5e-15
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		5e-15
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		6e-15
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		6e-15
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		9e-15
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		9e-15
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-14
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		2e-14
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		3e-14
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		3e-14
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		3e-14
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		4e-14
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		4e-14
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		4e-14
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		5e-14
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		5e-14
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		5e-14
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		6e-14
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		6e-14
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		6e-14
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		7e-14
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-14
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		7e-14
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		8e-14
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		9e-14
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		9e-14
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		9e-14
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		9e-14
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		1e-13
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-13
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-13
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-13
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-13
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-13
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		1e-13
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-13
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-13
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-13
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		2e-13
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-13
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-13
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-13
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-13
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-13
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-13
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-13
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-13
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-13
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-13
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		3e-13
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		3e-13
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		3e-13
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		3e-13
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		3e-13
2oza_B	366	Structure Of P38alpha Complex Length = 366		3e-13
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		3e-13
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		3e-13
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		3e-13
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		3e-13
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		3e-13
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-13
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		3e-13
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		3e-13
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-13
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		4e-13
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		4e-13
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		4e-13
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		4e-13
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		4e-13
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		4e-13
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		4e-13
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		4e-13
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		4e-13
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		4e-13
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		4e-13
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		4e-13
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		4e-13
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		4e-13
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		5e-13
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		5e-13
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		5e-13
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		5e-13
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		5e-13
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		5e-13
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		5e-13
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		5e-13
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		6e-13
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		6e-13
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		6e-13
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		6e-13
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		6e-13
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		6e-13
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		6e-13
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		6e-13
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		6e-13
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		6e-13
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		6e-13
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		6e-13
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		6e-13
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		6e-13
3hec_A	348	P38 In Complex With Imatinib Length = 348		6e-13
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		6e-13
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		6e-13
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		6e-13
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		6e-13
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		6e-13
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		6e-13
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		6e-13
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		6e-13
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		6e-13
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		6e-13
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		6e-13
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		6e-13
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		6e-13
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		6e-13
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		6e-13
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		6e-13
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		6e-13
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		6e-13
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		6e-13
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		6e-13
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		6e-13
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		7e-13
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		7e-13
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		7e-13
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		7e-13
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		7e-13
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		7e-13
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		7e-13
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		8e-13
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		8e-13
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		8e-13
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		8e-13
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		9e-13
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		9e-13
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		9e-13
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		9e-13
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		9e-13
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		9e-13
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-12
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-12
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-12
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-12
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		1e-12
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-12
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-12
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-12
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-12
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-12
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		2e-12
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		2e-12
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		2e-12
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		2e-12
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-12
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-12
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-12
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-12
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-12
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-12
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-12
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-12
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		3e-12
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		3e-12
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		3e-12
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		3e-12
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		3e-12
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		3e-12
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-12
3b2t_A	311	Structure Of Phosphotransferase Length = 311		4e-12
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-12
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-12
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		4e-12
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		4e-12
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		4e-12
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		4e-12
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		4e-12
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		4e-12
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		5e-12
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		5e-12
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		5e-12
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-12
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		5e-12
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		5e-12
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-12
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-12
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-12
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-12
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		5e-12
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-12
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		7e-12
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		8e-12
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		8e-12
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		8e-12
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		8e-12
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		9e-12
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		9e-12
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		9e-12
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		9e-12
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		9e-12
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		9e-12
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-11
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-11
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-11
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		1e-11
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-11
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-11
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-11
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-11
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		1e-11
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-11
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-11
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-11
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-11
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-11
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		1e-11
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-11
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		1e-11
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-11
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		1e-11
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-11
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-11
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-11
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-11
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		2e-11
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-11
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-11
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-11
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		2e-11
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-11
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-11
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-11
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-11
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-11
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-11
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-11
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-11
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-11
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		2e-11
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-11
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-11
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-11
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-11
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		3e-11
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		3e-11
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		3e-11
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		3e-11
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		3e-11
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		3e-11
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		3e-11
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		3e-11
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		3e-11
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		3e-11
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-11
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		3e-11
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		3e-11
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-11
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		3e-11
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		3e-11
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		3e-11
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		3e-11
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-11
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		3e-11
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		3e-11
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		3e-11
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		3e-11
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		3e-11
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		3e-11
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		3e-11
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		3e-11
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		3e-11
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		3e-11
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		4e-11
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		4e-11
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		4e-11
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		4e-11
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		4e-11
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		4e-11
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		4e-11
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		4e-11
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		4e-11
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-11
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		4e-11
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		4e-11
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		4e-11
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		4e-11
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		4e-11
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		4e-11
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		4e-11
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		4e-11
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		5e-11
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		5e-11
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		5e-11
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		5e-11
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		5e-11
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-11
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		5e-11
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		5e-11
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		5e-11
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		5e-11
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		6e-11
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		6e-11
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-11
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		7e-11
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		7e-11
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		8e-11
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		8e-11
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		8e-11
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		8e-11
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		8e-11
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		8e-11
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		9e-11
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		9e-11
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		9e-11
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		1e-10
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		1e-10
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		1e-10
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-10
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-10
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-10
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		1e-10
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		1e-10
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-10
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-10
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-10
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		2e-10
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		2e-10
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-10
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		2e-10
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-10
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		3e-10
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-10
1fvr_A	327	Tie2 Kinase Domain Length = 327		3e-10
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		3e-10
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-10
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		3e-10
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		3e-10
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		4e-10
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		4e-10
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		4e-10
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		4e-10
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		4e-10
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		5e-10
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-10
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		5e-10
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		5e-10
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		5e-10
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		6e-10
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		6e-10
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		6e-10
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		6e-10
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		6e-10
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		6e-10
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		6e-10
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		6e-10
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		6e-10
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		6e-10
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		7e-10
3gni_B	389	Structure Of Strad And Mo25 Length = 389		7e-10
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		7e-10
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		7e-10
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		8e-10
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		9e-10
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		9e-10
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		9e-10
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		9e-10
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		1e-09
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		1e-09
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-09
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		1e-09
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		1e-09
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-09
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-09
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-09
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-09
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		1e-09
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		1e-09
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		1e-09
2oza_A	356	Structure Of P38alpha Complex Length = 356		1e-09
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		1e-09
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		1e-09
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		1e-09
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		1e-09
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		1e-09
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		1e-09
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-09
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-09
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		2e-09
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-09
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-09
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-09
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-09
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-09
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-09
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-09
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-09
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-09
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-09
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-09
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-09
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-09
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-09
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		2e-09
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-09
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-09
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-09
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		3e-09
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		3e-09
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		3e-09
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		3e-09
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		3e-09
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		3e-09
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		3e-09
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		3e-09
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		3e-09
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		3e-09
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		3e-09
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-09
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		3e-09
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		4e-09
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		4e-09
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		4e-09
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		4e-09
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		5e-09
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		5e-09
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		5e-09
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		6e-09
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		6e-09
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		6e-09
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		6e-09
4fl3_A	635	Structural And Biophysical Characterization Of The		7e-09
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		7e-09
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		7e-09
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		7e-09
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		7e-09
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		7e-09
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		7e-09
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		7e-09
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		7e-09
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		7e-09
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		7e-09
4fl2_A	636	Structural And Biophysical Characterization Of The		8e-09
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		8e-09
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		8e-09
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		8e-09
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		9e-09
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		9e-09
2pl0_A	289	Lck Bound To Imatinib Length = 289		9e-09
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		1e-08
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		1e-08
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		1e-08
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		1e-08
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		1e-08
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		1e-08
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		1e-08
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		1e-08
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		1e-08
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		1e-08
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		1e-08
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		1e-08
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		1e-08
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		1e-08
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		1e-08
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		1e-08
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		1e-08
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-08
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		1e-08
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-08
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-08
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		2e-08
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		2e-08
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		2e-08
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		2e-08
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		2e-08
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		2e-08
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		2e-08
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		2e-08
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-08
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		2e-08
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		2e-08
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-08
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		2e-08
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		2e-08
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		2e-08
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		2e-08
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		2e-08
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		2e-08
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		2e-08
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		3e-08
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		3e-08
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		3e-08
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		3e-08
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-08
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		3e-08
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		3e-08
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		3e-08
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		3e-08
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		3e-08
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		3e-08
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		3e-08
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		3e-08
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		3e-08
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		4e-08
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		4e-08
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		4e-08
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		4e-08
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		4e-08
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		4e-08
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-08
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		4e-08
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		4e-08
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		4e-08
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-08
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		4e-08
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		4e-08
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		4e-08
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-08
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		4e-08
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		4e-08
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		4e-08
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		4e-08
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		4e-08
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		4e-08
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		5e-08
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		5e-08
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		5e-08
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		5e-08
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		5e-08
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		5e-08
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		5e-08
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		5e-08
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		5e-08
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		5e-08
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		5e-08
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		5e-08
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		5e-08
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		5e-08
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		6e-08
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		6e-08
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		6e-08
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		6e-08
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		6e-08
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		6e-08
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-08
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		6e-08
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-08
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-08
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		7e-08
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		7e-08
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		8e-08
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		8e-08
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		8e-08
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		8e-08
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		8e-08
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		8e-08

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score =  149 bits (377), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 99/261 (37%), Positives = 141/261 (54%), Gaps = 18/261 (6%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL---PKSEFLQREQKFLSSLNSPHIVG 59
           +TR   IGQG+S TV  A  + +G   A +   L   PK E +  E   +    +P+IV 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 60  YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN 119
           Y    +  ++      + MEY  GG+L D +      +DE  I +  R+ LQ LE+LHSN
Sbjct: 82  YLDSYLVGDE----LWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLHSN 135
Query: 120 RVVHCDIKSRNILMAESGA-KIADFG-CAKWESEALQSG---GTPMFMAPEVARGEHQGF 174
           +V+H DIKS NIL+   G+ K+ DFG CA+   E  +     GTP +MAPEV   +  G 
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGP 195
Query: 175 ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEV--PAFLSKQANDFLSNC 232
             DIW++G   IEM  G  P+ N  +P+  LY IA +   PE+  P  LS    DFL+ C
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLN-ENPLRALYLIA-TNGTPELQNPEKLSAIFRDFLNRC 253
Query: 233 LRRDPKERWAASQLLKHPFLE 253
           L  D ++R +A +LL+H FL+
Sbjct: 254 LEMDVEKRGSAKELLQHQFLK 274

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score =  149 bits (375), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 99/261 (37%), Positives = 143/261 (54%), Gaps = 18/261 (6%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL---PKSEFLQREQKFLSSLNSPHIVG 59
           +TR   IGQG+S TV  A  + +G   A +   L   PK E +  E   +    +P+IV 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 60  YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN 119
           Y    +  ++      + MEY  GG+L D +      +DE  I +  R+ LQ LE+LHSN
Sbjct: 82  YLDSYLVGDE----LWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLHSN 135
Query: 120 RVVHCDIKSRNILMAESGA-KIADFG-CAKW---ESEALQSGGTPMFMAPEVARGEHQGF 174
           +V+H DIKS NIL+   G+ K+ DFG CA+    +S+  +  GTP +MAPEV   +  G 
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVVTRKAYGP 195
Query: 175 ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEV--PAFLSKQANDFLSNC 232
             DIW++G   IEM  G  P+ N  +P+  LY IA +   PE+  P  LS    DFL+ C
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLN-ENPLRALYLIA-TNGTPELQNPEKLSAIFRDFLNRC 253
Query: 233 LRRDPKERWAASQLLKHPFLE 253
           L  D ++R +A +LL+H FL+
Sbjct: 254 LDMDVEKRGSAKELLQHQFLK 274

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score =  149 bits (375), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 99/261 (37%), Positives = 141/261 (54%), Gaps = 18/261 (6%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL---PKSEFLQREQKFLSSLNSPHIVG 59
           +TR   IGQG+S TV  A  + +G   A +   L   PK E +  E   +    +P+IV 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 60  YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN 119
           Y    +  ++      + MEY  GG+L D +      +DE  I +  R+ LQ LE+LHSN
Sbjct: 82  YLDSYLVGDE----LWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLHSN 135
Query: 120 RVVHCDIKSRNILMAESGA-KIADFG-CAKWESEALQSG---GTPMFMAPEVARGEHQGF 174
           +V+H DIKS NIL+   G+ K+ DFG CA+   E  +     GTP +MAPEV   +  G 
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195
Query: 175 ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEV--PAFLSKQANDFLSNC 232
             DIW++G   IEM  G  P+ N  +P+  LY IA +   PE+  P  LS    DFL+ C
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLN-ENPLRALYLIA-TNGTPELQNPEKLSAIFRDFLNRC 253
Query: 233 LRRDPKERWAASQLLKHPFLE 253
           L  D ++R +A +LL+H FL+
Sbjct: 254 LDMDVEKRGSAKELLQHQFLK 274

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  148 bits (374), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 98/261 (37%), Positives = 141/261 (54%), Gaps = 18/261 (6%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL---PKSEFLQREQKFLSSLNSPHIVG 59
           +TR   IGQG+S TV  A  + +G   A +   L   PK E +  E   +    +P+IV 
Sbjct: 23  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 82
Query: 60  YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN 119
           Y    +  ++      + MEY  GG+L D +      +DE  I +  R+ LQ LE+LHSN
Sbjct: 83  YLDSYLVGDE----LWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLHSN 136
Query: 120 RVVHCDIKSRNILMAESGA-KIADFG-CAKWESEALQSG---GTPMFMAPEVARGEHQGF 174
           +V+H DIKS NIL+   G+ K+ DFG CA+   E  +     GTP +MAPEV   +  G 
Sbjct: 137 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGP 196
Query: 175 ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEV--PAFLSKQANDFLSNC 232
             DIW++G   IEM  G  P+ N  +P+  LY IA +   PE+  P  LS    DFL+ C
Sbjct: 197 KVDIWSLGIMAIEMIEGEPPYLN-ENPLRALYLIA-TNGTPELQNPEKLSAIFRDFLNRC 254
Query: 233 LRRDPKERWAASQLLKHPFLE 253
           L  D ++R +A +L++H FL+
Sbjct: 255 LEMDVEKRGSAKELIQHQFLK 275

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  146 bits (369), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 97/261 (37%), Positives = 141/261 (54%), Gaps = 18/261 (6%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL---PKSEFLQREQKFLSSLNSPHIVG 59
           +TR   IGQG+S TV  A  + +G   A +   L   PK E +  E   +    +P+IV 
Sbjct: 23  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 82
Query: 60  YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN 119
           Y    +  ++      + MEY  GG+L D +      +DE  I +  R+ LQ LE+LHSN
Sbjct: 83  YLDSYLVGDE----LWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLHSN 136
Query: 120 RVVHCDIKSRNILMAESGA-KIADFG-CAKWESEALQSG---GTPMFMAPEVARGEHQGF 174
           +V+H +IKS NIL+   G+ K+ DFG CA+   E  +     GTP +MAPEV   +  G 
Sbjct: 137 QVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 196
Query: 175 ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEV--PAFLSKQANDFLSNC 232
             DIW++G   IEM  G  P+ N  +P+  LY IA +   PE+  P  LS    DFL+ C
Sbjct: 197 KVDIWSLGIMAIEMIEGEPPYLN-ENPLRALYLIA-TNGTPELQNPEKLSAIFRDFLNRC 254
Query: 233 LRRDPKERWAASQLLKHPFLE 253
           L  D ++R +A +L++H FL+
Sbjct: 255 LEMDVEKRGSAKELIQHQFLK 275

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score =  140 bits (354), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 98/271 (36%), Positives = 145/271 (53%), Gaps = 17/271 (6%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFL----QREQKFLSSLNSPHIV 58
           +T+   IG+GS   V       + +V A K  +L ++E      Q+E   LS  +SP+I 
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 59  GYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHS 118
            Y G  + S   KL   + MEY  GG+  D +    G L+E+ I +  R+IL+GL+YLHS
Sbjct: 81  RYFGSYLKS--TKLW--IIMEYLGGGSALDLL--KPGPLEETYIATILREILKGLDYLHS 134
Query: 119 NRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG----GTPMFMAPEVARGEHQG 173
            R +H DIK+ N+L++E G  K+ADFG A   ++         GTP +MAPEV +     
Sbjct: 135 ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYD 194
Query: 174 FASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCL 233
           F +DIW++G T IE+A G  P  +   PM VL+ I  +   P +    SK   +F+  CL
Sbjct: 195 FKADIWSLGITAIELAKGEPP-NSDLHPMRVLFLIPKNSP-PTLEGQHSKPFKEFVEACL 252
Query: 234 RRDPKERWAASQLLKHPFLEEFCSCTKQIQE 264
            +DP+ R  A +LLKH F+  +   T  + E
Sbjct: 253 NKDPRFRPTAKELLKHKFITRYTKKTSFLTE 283

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score =  137 bits (345), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 89/254 (35%), Positives = 132/254 (51%), Gaps = 18/254 (7%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ---REQKFLSSLNSPHIVGYKGCDV 65
           +G+GS  +V  A    +G + A K  ++P    LQ   +E   +   +SPH+V Y G   
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIK--QVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYF 94
Query: 66  TSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCD 125
            + D      + MEY   G+++D I      L E  I +  +  L+GLEYLH  R +H D
Sbjct: 95  KNTD----LWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRD 150
Query: 126 IKSRNILMAESG-AKIADFGCAKWESEALQSG----GTPMFMAPEVARGEHQGFASDIWA 180
           IK+ NIL+   G AK+ADFG A   ++ +       GTP +MAPEV +       +DIW+
Sbjct: 151 IKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVIQEIGYNCVADIWS 210
Query: 181 VGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEV--PAFLSKQANDFLSNCLRRDPK 238
           +G T IEMA G  P+ +   PM  ++ I  +   P    P   S    DF+  CL + P+
Sbjct: 211 LGITAIEMAEGKPPYAD-IHPMRAIFMIP-TNPPPTFRKPELWSDNFTDFVKQCLVKSPE 268
Query: 239 ERWAASQLLKHPFL 252
           +R  A+QLL+HPF+
Sbjct: 269 QRATATQLLQHPFV 282

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score =  136 bits (343), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 92/263 (34%), Positives = 140/263 (53%), Gaps = 25/263 (9%)
Query: 8   TIGQGSSATVSLATSLRSGDVFAAKSTELPK-----SEFLQREQKFLSSLNSPHIVGYKG 62
            +G+G+   V     L +    A K  E+P+     S+ L  E      L   +IV Y G
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIK--EIPERDSRYSQPLHEEIALHKHLKHKNIVQYLG 86
Query: 63  CDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRL--DESLIVSYTRQILQGLEYLHSNR 120
              +  +N  +  +FME  PGG+L+  +    G L  +E  I  YT+QIL+GL+YLH N+
Sbjct: 87  ---SFSENGFI-KIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ 142
Query: 121 VVHCDIKSRNILM-AESGA-KIADFGCAKWE------SEALQSGGTPMFMAPEVARGEHQ 172
           +VH DIK  N+L+   SG  KI+DFG +K        +E     GT  +MAPE+     +
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT--GTLQYMAPEIIDKGPR 200
Query: 173 GF--ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLS 230
           G+  A+DIW++GCT+IEMA+G  P+    +P   ++K+   +  PE+P  +S +A  F+ 
Sbjct: 201 GYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFIL 260
Query: 231 NCLRRDPKERWAASQLLKHPFLE 253
            C   DP +R  A+ LL   FL+
Sbjct: 261 KCFEPDPDKRACANDLLVDEFLK 283

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 94/259 (36%), Positives = 140/259 (54%), Gaps = 17/259 (6%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFL----QREQKFLSSLNSPHIV 58
           +T+   IG+GS   V      R+  V A K  +L ++E      Q+E   LS  +SP++ 
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 88
Query: 59  GYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHS 118
            Y G  +  +D KL   + MEY  GG+  D +    G LDE+ I +  R+IL+GL+YLHS
Sbjct: 89  KYYGSYL--KDTKLW--IIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHS 142
Query: 119 NRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG----GTPMFMAPEVARGEHQG 173
            + +H DIK+ N+L++E G  K+ADFG A   ++         GTP +MAPEV +     
Sbjct: 143 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYD 202
Query: 174 FASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCL 233
             +DIW++G T IE+A G  P  +   PM VL+ I  +   P +    SK   +F+  CL
Sbjct: 203 SKADIWSLGITAIELARGEPPH-SELHPMKVLFLIPKNNP-PTLEGNYSKPLKEFVEACL 260
Query: 234 RRDPKERWAASQLLKHPFL 252
            ++P  R  A +LLKH F+
Sbjct: 261 NKEPSFRPTAKELLKHKFI 279

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 94/259 (36%), Positives = 140/259 (54%), Gaps = 17/259 (6%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFL----QREQKFLSSLNSPHIV 58
           +T+   IG+GS   V      R+  V A K  +L ++E      Q+E   LS  +SP++ 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 59  GYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHS 118
            Y G  +  +D KL   + MEY  GG+  D +    G LDE+ I +  R+IL+GL+YLHS
Sbjct: 69  KYYGSYL--KDTKLW--IIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDYLHS 122
Query: 119 NRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG----GTPMFMAPEVARGEHQG 173
            + +H DIK+ N+L++E G  K+ADFG A   ++         GTP +MAPEV +     
Sbjct: 123 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYD 182
Query: 174 FASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCL 233
             +DIW++G T IE+A G  P  +   PM VL+ I  +   P +    SK   +F+  CL
Sbjct: 183 SKADIWSLGITAIELARGEPPH-SELHPMKVLFLIPKNNP-PTLEGNYSKPLKEFVEACL 240
Query: 234 RRDPKERWAASQLLKHPFL 252
            ++P  R  A +LLKH F+
Sbjct: 241 NKEPSFRPTAKELLKHKFI 259

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 94/259 (36%), Positives = 140/259 (54%), Gaps = 17/259 (6%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFL----QREQKFLSSLNSPHIV 58
           +T+   IG+GS   V      R+  V A K  +L ++E      Q+E   LS  +SP++ 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 59  GYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHS 118
            Y G  +  +D KL   + MEY  GG+  D +    G LDE+ I +  R+IL+GL+YLHS
Sbjct: 84  KYYGSYL--KDTKLW--IIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDYLHS 137
Query: 119 NRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG----GTPMFMAPEVARGEHQG 173
            + +H DIK+ N+L++E G  K+ADFG A   ++         GTP +MAPEV +     
Sbjct: 138 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYD 197
Query: 174 FASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCL 233
             +DIW++G T IE+A G  P  +   PM VL+ I  +   P +    SK   +F+  CL
Sbjct: 198 SKADIWSLGITAIELARGEPPH-SELHPMKVLFLIPKNNP-PTLEGNYSKPLKEFVEACL 255
Query: 234 RRDPKERWAASQLLKHPFL 252
            ++P  R  A +LLKH F+
Sbjct: 256 NKEPSFRPTAKELLKHKFI 274

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 94/259 (36%), Positives = 140/259 (54%), Gaps = 17/259 (6%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFL----QREQKFLSSLNSPHIV 58
           +T+   IG+GS   V      R+  V A K  +L ++E      Q+E   LS  +SP++ 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 59  GYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHS 118
            Y G  +  +D KL   + MEY  GG+  D +    G LDE+ I +  R+IL+GL+YLHS
Sbjct: 69  KYYGSYL--KDTKLW--IIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDYLHS 122
Query: 119 NRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG----GTPMFMAPEVARGEHQG 173
            + +H DIK+ N+L++E G  K+ADFG A   ++         GTP +MAPEV +     
Sbjct: 123 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYD 182
Query: 174 FASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCL 233
             +DIW++G T IE+A G  P  +   PM VL+ I  +   P +    SK   +F+  CL
Sbjct: 183 SKADIWSLGITAIELARGEPPH-SELHPMKVLFLIPKNNP-PTLEGNYSKPLKEFVEACL 240
Query: 234 RRDPKERWAASQLLKHPFL 252
            ++P  R  A +LLKH F+
Sbjct: 241 NKEPSFRPTAKELLKHKFI 259

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 92/263 (34%), Positives = 140/263 (53%), Gaps = 25/263 (9%)
Query: 8   TIGQGSSATVSLATSLRSGDVFAAKSTELPK-----SEFLQREQKFLSSLNSPHIVGYKG 62
            +G+G+   V     L +    A K  E+P+     S+ L  E      L   +IV Y G
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIK--EIPERDSRYSQPLHEEIALHKHLKHKNIVQYLG 72
Query: 63  CDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRL--DESLIVSYTRQILQGLEYLHSNR 120
              +  +N  +  +FME  PGG+L+  +    G L  +E  I  YT+QIL+GL+YLH N+
Sbjct: 73  ---SFSENGFI-KIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ 128
Query: 121 VVHCDIKSRNILM-AESGA-KIADFGCAKWE------SEALQSGGTPMFMAPEVARGEHQ 172
           +VH DIK  N+L+   SG  KI+DFG +K        +E     GT  +MAPE+     +
Sbjct: 129 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT--GTLQYMAPEIIDKGPR 186
Query: 173 GF--ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLS 230
           G+  A+DIW++GCT+IEMA+G  P+    +P   ++K+   +  PE+P  +S +A  F+ 
Sbjct: 187 GYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFIL 246
Query: 231 NCLRRDPKERWAASQLLKHPFLE 253
            C   DP +R  A+ LL   FL+
Sbjct: 247 KCFEPDPDKRACANDLLVDEFLK 269

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score =  127 bits (320), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 92/271 (33%), Positives = 141/271 (52%), Gaps = 17/271 (6%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFL----QREQKFLSSLNSPHIV 58
           +T+   IG+GS   V      R+  V A K  +L ++E      Q+E   LS  +S ++ 
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVT 84
Query: 59  GYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHS 118
            Y G  +  + +KL   + MEY  GG+  D +    G  DE  I +  ++IL+GL+YLHS
Sbjct: 85  KYYGSYL--KGSKLW--IIMEYLGGGSALDLLR--AGPFDEFQIATMLKEILKGLDYLHS 138
Query: 119 NRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG----GTPMFMAPEVARGEHQG 173
            + +H DIK+ N+L++E G  K+ADFG A   ++         GTP +MAPEV +     
Sbjct: 139 EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYD 198
Query: 174 FASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCL 233
             +DIW++G T IE+A G  P  +   PM VL+ I  +   P +    +K   +F+  CL
Sbjct: 199 SKADIWSLGITAIELAKGEPPNSD-MHPMRVLFLIPKNNP-PTLVGDFTKSFKEFIDACL 256
Query: 234 RRDPKERWAASQLLKHPFLEEFCSCTKQIQE 264
            +DP  R  A +LLKH F+ +    T  + E
Sbjct: 257 NKDPSFRPTAKELLKHKFIVKNSKKTSYLTE 287

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score =  127 bits (318), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 93/270 (34%), Positives = 141/270 (52%), Gaps = 21/270 (7%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQR---EQKFLSSLNSPHIVG 59
           W     +G G+   V  A +  +G + AAK  E    E L+    E + L++ + P+IV 
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 60  YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN 119
             G      D KL   + +E+ PGG ++  +      L E  I    RQ+L+ L +LHS 
Sbjct: 81  LLGA--YYHDGKLW--IMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK 136
Query: 120 RVVHCDIKSRNILMA-ESGAKIADFGCAKWESEALQSG----GTPMFMAPEVARGEHQ-- 172
           R++H D+K+ N+LM  E   ++ADFG +    + LQ      GTP +MAPEV   E    
Sbjct: 137 RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKD 196
Query: 173 ---GFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEV--PAFLSKQAND 227
               + +DIW++G T+IEMA    P  +  +PM VL KIA S + P +  P+  S +  D
Sbjct: 197 TPYDYKADIWSLGITLIEMAQIEPPH-HELNPMRVLLKIAKS-DPPTLLTPSKWSVEFRD 254
Query: 228 FLSNCLRRDPKERWAASQLLKHPFLEEFCS 257
           FL   L ++P+ R +A+QLL+HPF+    S
Sbjct: 255 FLKIALDKNPETRPSAAQLLEHPFVSSITS 284

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score =  127 bits (318), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 93/270 (34%), Positives = 141/270 (52%), Gaps = 21/270 (7%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQR---EQKFLSSLNSPHIVG 59
           W     +G G+   V  A +  +G + AAK  E    E L+    E + L++ + P+IV 
Sbjct: 13  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 72
Query: 60  YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN 119
             G      D KL   + +E+ PGG ++  +      L E  I    RQ+L+ L +LHS 
Sbjct: 73  LLGA--YYHDGKLW--IMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK 128
Query: 120 RVVHCDIKSRNILMA-ESGAKIADFGCAKWESEALQSG----GTPMFMAPEVARGEHQ-- 172
           R++H D+K+ N+LM  E   ++ADFG +    + LQ      GTP +MAPEV   E    
Sbjct: 129 RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKD 188
Query: 173 ---GFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEV--PAFLSKQAND 227
               + +DIW++G T+IEMA    P  +  +PM VL KIA S + P +  P+  S +  D
Sbjct: 189 TPYDYKADIWSLGITLIEMAQIEPPH-HELNPMRVLLKIAKS-DPPTLLTPSKWSVEFRD 246
Query: 228 FLSNCLRRDPKERWAASQLLKHPFLEEFCS 257
           FL   L ++P+ R +A+QLL+HPF+    S
Sbjct: 247 FLKIALDKNPETRPSAAQLLEHPFVSSITS 276

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 96/290 (33%), Positives = 144/290 (49%), Gaps = 49/290 (16%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEF----LQREQKFLSSLNSPHI 57
           D+     IG G++A V  A      +  A K   L K +     L +E + +S  + P+I
Sbjct: 16  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNI 75
Query: 58  VGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEI-------HRNGGRLDESLIVSYTRQIL 110
           V Y    V  ++      L M+   GG++ D I           G LDES I +  R++L
Sbjct: 76  VSYYTSFVVKDE----LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131
Query: 111 QGLEYLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSG------------- 156
           +GLEYLH N  +H D+K+ NIL+ E G+ +IADFG + +    L +G             
Sbjct: 132 EGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAF----LATGGDITRNKVRKTFV 187
Query: 157 GTPMFMAPEV---ARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRE 213
           GTP +MAPEV    RG    F +DIW+ G T IE+A+G AP+ +   PM VL  +    +
Sbjct: 188 GTPCWMAPEVMEQVRG--YDFKADIWSFGITAIELATGAAPY-HKYPPMKVLM-LTLQND 243
Query: 214 LPEVPA------FLSKQANDF---LSNCLRRDPKERWAASQLLKHPFLEE 254
            P +         L K    F   +S CL++DP++R  A++LL+H F ++
Sbjct: 244 PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQK 293

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score =  125 bits (315), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 96/290 (33%), Positives = 144/290 (49%), Gaps = 49/290 (16%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEF----LQREQKFLSSLNSPHI 57
           D+     IG G++A V  A      +  A K   L K +     L +E + +S  + P+I
Sbjct: 11  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNI 70
Query: 58  VGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEI-------HRNGGRLDESLIVSYTRQIL 110
           V Y    V  ++      L M+   GG++ D I           G LDES I +  R++L
Sbjct: 71  VSYYTSFVVKDE----LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 126
Query: 111 QGLEYLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSG------------- 156
           +GLEYLH N  +H D+K+ NIL+ E G+ +IADFG + +    L +G             
Sbjct: 127 EGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAF----LATGGDITRNKVRKTFV 182
Query: 157 GTPMFMAPEV---ARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRE 213
           GTP +MAPEV    RG    F +DIW+ G T IE+A+G AP+ +   PM VL  +    +
Sbjct: 183 GTPCWMAPEVMEQVRG--YDFKADIWSFGITAIELATGAAPY-HKYPPMKVLM-LTLQND 238
Query: 214 LPEVPA------FLSKQANDF---LSNCLRRDPKERWAASQLLKHPFLEE 254
            P +         L K    F   +S CL++DP++R  A++LL+H F ++
Sbjct: 239 PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQK 288

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 86/255 (33%), Positives = 131/255 (51%), Gaps = 18/255 (7%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSLNSPHIVGYKG 62
           IG GS   V  A  +R+ +V A K           K + + +E +FL  L  P+ + Y+G
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 63  CDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
           C +      L+    MEY  G   +D +  +   L E  I + T   LQGL YLHS+ ++
Sbjct: 83  CYLREHTAWLV----MEYCLGSA-SDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMI 137
Query: 123 HCDIKSRNILMAESG-AKIADFGCAKWESEALQSGGTPMFMAPEVA----RGEHQGFASD 177
           H D+K+ NIL++E G  K+ DFG A   + A    GTP +MAPEV      G++ G   D
Sbjct: 138 HRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGTPYWMAPEVILAMDEGQYDG-KVD 196
Query: 178 IWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDP 237
           +W++G T IE+A    P  N  + M+ LY IA +          S+   +F+ +CL++ P
Sbjct: 197 VWSLGITCIELAERKPPLFN-MNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIP 255
Query: 238 KERWAASQLLKHPFL 252
           ++R  +  LLKH F+
Sbjct: 256 QDRPTSEVLLKHRFV 270

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 90/265 (33%), Positives = 134/265 (50%), Gaps = 21/265 (7%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQR---EQKFLSSLNSPHIVG 59
           W     +G G+   V  A +  +  + AAK  +    E L+    E   L+S + P+IV 
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIV- 97
Query: 60  YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN 119
            K  D    +N L   + +E+  GG ++  +      L ES I    +Q L  L YLH N
Sbjct: 98  -KLLDAFYYENNLW--ILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN 154
Query: 120 RVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG----GTPMFMAPEV-----ARG 169
           +++H D+K+ NIL    G  K+ADFG +   +  +Q      GTP +MAPEV     ++ 
Sbjct: 155 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 214
Query: 170 EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEV--PAFLSKQAND 227
               + +D+W++G T+IEMA    P  +  +PM VL KIA S E P +  P+  S    D
Sbjct: 215 RPYDYKADVWSLGITLIEMAEIEPP-HHELNPMRVLLKIAKS-EPPTLAQPSRWSSNFKD 272
Query: 228 FLSNCLRRDPKERWAASQLLKHPFL 252
           FL  CL ++   RW  SQLL+HPF+
Sbjct: 273 FLKKCLEKNVDARWTTSQLLQHPFV 297

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  123 bits (309), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 90/265 (33%), Positives = 134/265 (50%), Gaps = 21/265 (7%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQR---EQKFLSSLNSPHIVG 59
           W     +G G+   V  A +  +  + AAK  +    E L+    E   L+S + P+IV 
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIV- 97
Query: 60  YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN 119
            K  D    +N L   + +E+  GG ++  +      L ES I    +Q L  L YLH N
Sbjct: 98  -KLLDAFYYENNLW--ILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN 154
Query: 120 RVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG----GTPMFMAPEV-----ARG 169
           +++H D+K+ NIL    G  K+ADFG +   +  +Q      GTP +MAPEV     ++ 
Sbjct: 155 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFIGTPYWMAPEVVMCETSKD 214
Query: 170 EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEV--PAFLSKQAND 227
               + +D+W++G T+IEMA    P  +  +PM VL KIA S E P +  P+  S    D
Sbjct: 215 RPYDYKADVWSLGITLIEMAEIEPP-HHELNPMRVLLKIAKS-EPPTLAQPSRWSSNFKD 272
Query: 228 FLSNCLRRDPKERWAASQLLKHPFL 252
           FL  CL ++   RW  SQLL+HPF+
Sbjct: 273 FLKKCLEKNVDARWTTSQLLQHPFV 297

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 90/265 (33%), Positives = 134/265 (50%), Gaps = 21/265 (7%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQR---EQKFLSSLNSPHIVG 59
           W     +G G+   V  A +  +  + AAK  +    E L+    E   L+S + P+IV 
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIV- 97
Query: 60  YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN 119
            K  D    +N L   + +E+  GG ++  +      L ES I    +Q L  L YLH N
Sbjct: 98  -KLLDAFYYENNLW--ILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN 154
Query: 120 RVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG----GTPMFMAPEV-----ARG 169
           +++H D+K+ NIL    G  K+ADFG +   +  +Q      GTP +MAPEV     ++ 
Sbjct: 155 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEVVMCETSKD 214
Query: 170 EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEV--PAFLSKQAND 227
               + +D+W++G T+IEMA    P  +  +PM VL KIA S E P +  P+  S    D
Sbjct: 215 RPYDYKADVWSLGITLIEMAEIEPP-HHELNPMRVLLKIAKS-EPPTLAQPSRWSSNFKD 272
Query: 228 FLSNCLRRDPKERWAASQLLKHPFL 252
           FL  CL ++   RW  SQLL+HPF+
Sbjct: 273 FLKKCLEKNVDARWTTSQLLQHPFV 297

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 86/255 (33%), Positives = 131/255 (51%), Gaps = 18/255 (7%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSLNSPHIVGYKG 62
           IG GS   V  A  +R+ +V A K           K + + +E +FL  L  P+ + Y+G
Sbjct: 62  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121
Query: 63  CDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
           C +      L+    MEY  G   +D +  +   L E  I + T   LQGL YLHS+ ++
Sbjct: 122 CYLREHTAWLV----MEYCLGSA-SDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMI 176
Query: 123 HCDIKSRNILMAESG-AKIADFGCAKWESEALQSGGTPMFMAPEVA----RGEHQGFASD 177
           H D+K+ NIL++E G  K+ DFG A   + A    GTP +MAPEV      G++ G   D
Sbjct: 177 HRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGTPYWMAPEVILAMDEGQYDG-KVD 235
Query: 178 IWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDP 237
           +W++G T IE+A    P  N  + M+ LY IA +          S+   +F+ +CL++ P
Sbjct: 236 VWSLGITCIELAERKPPLFN-MNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIP 294
Query: 238 KERWAASQLLKHPFL 252
           ++R  +  LLKH F+
Sbjct: 295 QDRPTSEVLLKHRFV 309

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 81/263 (30%), Positives = 138/263 (52%), Gaps = 20/263 (7%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ----REQKFLSSLNSPHI 57
           D+ +   +G G+   V   +   SG V A K   L     ++    RE + L   NSP+I
Sbjct: 10  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 69
Query: 58  VGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLH 117
           VG+ G   +  +     ++ ME+  GG+L D++ +  GR+ E ++   +  +++GL YL 
Sbjct: 70  VGFYGAFYSDGE----ISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLR 124
Query: 118 -SNRVVHCDIKSRNILMAESG-AKIADFGCAKW--ESEALQSGGTPMFMAPEVARGEHQG 173
             ++++H D+K  NIL+   G  K+ DFG +    +  A +  GT  +M+PE  +G H  
Sbjct: 125 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANEFVGTRSYMSPERLQGTHYS 184
Query: 174 FASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAY--SRELPEVP-AFLSKQANDFLS 230
             SDIW++G +++EMA G  P P    PM +   + Y  +   P++P A  S +  DF++
Sbjct: 185 VQSDIWSMGLSLVEMAVGRYPRP----PMAIFELLDYIVNEPPPKLPSAVFSLEFQDFVN 240
Query: 231 NCLRRDPKERWAASQLLKHPFLE 253
            CL ++P ER    QL+ H F++
Sbjct: 241 KCLIKNPAERADLKQLMVHAFIK 263

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 79/269 (29%), Positives = 141/269 (52%), Gaps = 22/269 (8%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ----REQKFLSSLNSPHI 57
           D+ +   +G G+   V   +   SG V A K   L     ++    RE + L   NSP+I
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 58  VGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLH 117
           VG+ G   +  +     ++ ME+  GG+L D++ +  GR+ E ++   +  +++GL YL 
Sbjct: 67  VGFYGAFYSDGE----ISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLR 121
Query: 118 -SNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG--GTPMFMAPEVARGEHQG 173
             ++++H D+K  NIL+   G  K+ DFG +    +++ +   GT  +M+PE  +G H  
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYS 181
Query: 174 FASDIWAVGCTVIEMASGGAPWP------NAADPMTVLYKIAY--SRELPEVPA-FLSKQ 224
             SDIW++G +++EMA G  P P      ++  PM +   + Y  +   P++P+   S +
Sbjct: 182 VQSDIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELLDYIVNEPPPKLPSGVFSLE 241
Query: 225 ANDFLSNCLRRDPKERWAASQLLKHPFLE 253
             DF++ CL ++P ER    QL+ H F++
Sbjct: 242 FQDFVNKCLIKNPAERADLKQLMVHAFIK 270

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 77/263 (29%), Positives = 139/263 (52%), Gaps = 16/263 (6%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ----REQKFLSSLNSPHI 57
           D+ +   +G G+   V   +   SG V A K   L     ++    RE + L   NSP+I
Sbjct: 26  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 85
Query: 58  VGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLH 117
           VG+ G   +  +     ++ ME+  GG+L D++ +  GR+ E ++   +  +++GL YL 
Sbjct: 86  VGFYGAFYSDGE----ISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLR 140
Query: 118 -SNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG--GTPMFMAPEVARGEHQG 173
             ++++H D+K  NIL+   G  K+ DFG +    +++ +   GT  +M+PE  +G H  
Sbjct: 141 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYS 200
Query: 174 FASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAY--SRELPEVPA-FLSKQANDFLS 230
             SDIW++G +++EMA G  P  + +  M +   + Y  +   P++P+   S +  DF++
Sbjct: 201 VQSDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVN 260
Query: 231 NCLRRDPKERWAASQLLKHPFLE 253
            CL ++P ER    QL+ H F++
Sbjct: 261 KCLIKNPAERADLKQLMVHAFIK 283

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score =  118 bits (295), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 91/260 (35%), Positives = 127/260 (48%), Gaps = 30/260 (11%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSE 68
           IG+GS+  V +AT   SG + A K  +L K +  +RE  F    N   I+     D   E
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLF----NEVVIMR----DYQHE 81
Query: 69  DNKLMYN---------LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN 119
           +   MYN         + ME+  GG L D +     R++E  I +    +LQ L  LH+ 
Sbjct: 82  NVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLHAQ 139
Query: 120 RVVHCDIKSRNILMAESG-AKIADFG-CAKWESEALQSG---GTPMFMAPEVARGEHQGF 174
            V+H DIKS +IL+   G  K++DFG CA+   E  +     GTP +MAPE+      G 
Sbjct: 140 GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGP 199
Query: 175 ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAF--LSKQANDFLSNC 232
             DIW++G  VIEM  G  P+ N  +P     K+      P +     +S     FL   
Sbjct: 200 EVDIWSLGIMVIEMVDGEPPYFN--EPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRL 257
Query: 233 LRRDPKERWAASQLLKHPFL 252
           L RDP +R  A++LLKHPFL
Sbjct: 258 LVRDPAQRATAAELLKHPFL 277

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score =  118 bits (295), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 91/260 (35%), Positives = 127/260 (48%), Gaps = 30/260 (11%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSE 68
           IG+GS+  V +AT   SG + A K  +L K +  +RE  F    N   I+     D   E
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLF----NEVVIMR----DYQHE 86
Query: 69  DNKLMYN---------LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN 119
           +   MYN         + ME+  GG L D +     R++E  I +    +LQ L  LH+ 
Sbjct: 87  NVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLHAQ 144
Query: 120 RVVHCDIKSRNILMAESG-AKIADFG-CAKWESEALQSG---GTPMFMAPEVARGEHQGF 174
            V+H DIKS +IL+   G  K++DFG CA+   E  +     GTP +MAPE+      G 
Sbjct: 145 GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGP 204
Query: 175 ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAF--LSKQANDFLSNC 232
             DIW++G  VIEM  G  P+ N  +P     K+      P +     +S     FL   
Sbjct: 205 EVDIWSLGIMVIEMVDGEPPYFN--EPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRL 262
Query: 233 LRRDPKERWAASQLLKHPFL 252
           L RDP +R  A++LLKHPFL
Sbjct: 263 LVRDPAQRATAAELLKHPFL 282

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score =  117 bits (294), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 91/260 (35%), Positives = 127/260 (48%), Gaps = 30/260 (11%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSE 68
           IG+GS+  V +AT   SG + A K  +L K +  +RE  F    N   I+     D   E
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLF----NEVVIMR----DYQHE 77
Query: 69  DNKLMYN---------LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN 119
           +   MYN         + ME+  GG L D +     R++E  I +    +LQ L  LH+ 
Sbjct: 78  NVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLHAQ 135
Query: 120 RVVHCDIKSRNILMAESG-AKIADFG-CAKWESEALQSG---GTPMFMAPEVARGEHQGF 174
            V+H DIKS +IL+   G  K++DFG CA+   E  +     GTP +MAPE+      G 
Sbjct: 136 GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGP 195
Query: 175 ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAF--LSKQANDFLSNC 232
             DIW++G  VIEM  G  P+ N  +P     K+      P +     +S     FL   
Sbjct: 196 EVDIWSLGIMVIEMVDGEPPYFN--EPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRL 253
Query: 233 LRRDPKERWAASQLLKHPFL 252
           L RDP +R  A++LLKHPFL
Sbjct: 254 LVRDPAQRATAAELLKHPFL 273

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score =  117 bits (294), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 91/260 (35%), Positives = 127/260 (48%), Gaps = 30/260 (11%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSE 68
           IG+GS+  V +AT   SG + A K  +L K +  +RE  F    N   I+     D   E
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLF----NEVVIMR----DYQHE 88
Query: 69  DNKLMYN---------LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN 119
           +   MYN         + ME+  GG L D +     R++E  I +    +LQ L  LH+ 
Sbjct: 89  NVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLHAQ 146
Query: 120 RVVHCDIKSRNILMAESG-AKIADFG-CAKWESEALQSG---GTPMFMAPEVARGEHQGF 174
            V+H DIKS +IL+   G  K++DFG CA+   E  +     GTP +MAPE+      G 
Sbjct: 147 GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGP 206
Query: 175 ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAF--LSKQANDFLSNC 232
             DIW++G  VIEM  G  P+ N  +P     K+      P +     +S     FL   
Sbjct: 207 EVDIWSLGIMVIEMVDGEPPYFN--EPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRL 264
Query: 233 LRRDPKERWAASQLLKHPFL 252
           L RDP +R  A++LLKHPFL
Sbjct: 265 LVRDPAQRATAAELLKHPFL 284

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score =  117 bits (292), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 91/260 (35%), Positives = 127/260 (48%), Gaps = 30/260 (11%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSE 68
           IG+GS+  V +AT   SG + A K  +L K +  +RE  F    N   I+     D   E
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLF----NEVVIMR----DYQHE 131
Query: 69  DNKLMYN---------LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN 119
           +   MYN         + ME+  GG L D +     R++E  I +    +LQ L  LH+ 
Sbjct: 132 NVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLHAQ 189
Query: 120 RVVHCDIKSRNILMAESG-AKIADFG-CAKWESEALQSG---GTPMFMAPEVARGEHQGF 174
            V+H DIKS +IL+   G  K++DFG CA+   E  +     GTP +MAPE+      G 
Sbjct: 190 GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGP 249
Query: 175 ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAF--LSKQANDFLSNC 232
             DIW++G  VIEM  G  P+ N  +P     K+      P +     +S     FL   
Sbjct: 250 EVDIWSLGIMVIEMVDGEPPYFN--EPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRL 307
Query: 233 LRRDPKERWAASQLLKHPFL 252
           L RDP +R  A++LLKHPFL
Sbjct: 308 LVRDPAQRATAAELLKHPFL 327

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score =  117 bits (292), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 91/260 (35%), Positives = 127/260 (48%), Gaps = 30/260 (11%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSE 68
           IG+GS+  V +AT   SG + A K  +L K +  +RE  F    N   I+     D   E
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLF----NEVVIMR----DYQHE 208
Query: 69  DNKLMYN---------LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN 119
           +   MYN         + ME+  GG L D +     R++E  I +    +LQ L  LH+ 
Sbjct: 209 NVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLHAQ 266
Query: 120 RVVHCDIKSRNILMAESG-AKIADFG-CAKWESEALQSG---GTPMFMAPEVARGEHQGF 174
            V+H DIKS +IL+   G  K++DFG CA+   E  +     GTP +MAPE+      G 
Sbjct: 267 GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGP 326
Query: 175 ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAF--LSKQANDFLSNC 232
             DIW++G  VIEM  G  P+ N  +P     K+      P +     +S     FL   
Sbjct: 327 EVDIWSLGIMVIEMVDGEPPYFN--EPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRL 384
Query: 233 LRRDPKERWAASQLLKHPFL 252
           L RDP +R  A++LLKHPFL
Sbjct: 385 LVRDPAQRATAAELLKHPFL 404

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 91/258 (35%), Positives = 126/258 (48%), Gaps = 26/258 (10%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKS---EFLQREQKFLSSLNSPHIV-GYKGCD 64
           IG+GS+  V LA    SG   A K  +L K    E L  E   +      ++V  YK   
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 65  VTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHC 124
           V  E       + ME+  GG L D + +   RL+E  I +    +LQ L YLH+  V+H 
Sbjct: 113 VGEE-----LWVLMEFLQGGALTDIVSQV--RLNEEQIATVCEAVLQALAYLHAQGVIHR 165
Query: 125 DIKSRNILMAESG-AKIADFG-CAKWESEALQSG---GTPMFMAPEVARGEHQGFASDIW 179
           DIKS +IL+   G  K++DFG CA+   +  +     GTP +MAPEV          DIW
Sbjct: 166 DIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVISRSLYATEVDIW 225
Query: 180 AVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAF-----LSKQANDFLSNCLR 234
           ++G  VIEM  G  P+  +  P+  + ++   R+ P  P       +S    DFL   L 
Sbjct: 226 SLGIMVIEMVDGEPPY-FSDSPVQAMKRL---RDSPP-PKLKNSHKVSPVLRDFLERMLV 280
Query: 235 RDPKERWAASQLLKHPFL 252
           RDP+ER  A +LL HPFL
Sbjct: 281 RDPQERATAQELLDHPFL 298

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 79/248 (31%), Positives = 123/248 (49%), Gaps = 16/248 (6%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAK------STELPKSEFLQREQKFLSSLNSPH 56
           + R  TIG GS   V L   + +G+ +A K        +L + E    E++ L ++N P 
Sbjct: 43  FERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL 116
           +V     + + +DN  +Y + MEY PGG +   + R G R  E     Y  QI+   EYL
Sbjct: 103 LVK---LEFSFKDNSNLY-MVMEYVPGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYL 157
Query: 117 HSNRVVHCDIKSRNILMAESG-AKIADFGCAK-WESEALQSGGTPMFMAPEVARGEHQGF 174
           HS  +++ D+K  N+L+ + G  K+ADFG AK  +       GTP ++APE+   +    
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 175 ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLR 234
           A D WA+G  + EMA+G  P+  A  P+ +  KI   +     P+  S    D L N L+
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF-FADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQ 274
Query: 235 RDPKERWA 242
            D  +R+ 
Sbjct: 275 VDLTKRFG 282

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 79/248 (31%), Positives = 123/248 (49%), Gaps = 16/248 (6%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAK------STELPKSEFLQREQKFLSSLNSPH 56
           + R  TIG GS   V L   + +G+ +A K        +L + E    E++ L ++N P 
Sbjct: 43  FERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL 116
           +V     + + +DN  +Y + MEY PGG +   + R G R  E     Y  QI+   EYL
Sbjct: 103 LVK---LEFSFKDNSNLY-MVMEYMPGGDMFSHLRRIG-RFSEPHARFYAAQIVLTFEYL 157
Query: 117 HSNRVVHCDIKSRNILMAESG-AKIADFGCAK-WESEALQSGGTPMFMAPEVARGEHQGF 174
           HS  +++ D+K  N+L+ + G  K+ADFG AK  +       GTP ++APE+   +    
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 175 ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLR 234
           A D WA+G  + EMA+G  P+  A  P+ +  KI   +     P+  S    D L N L+
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF-FADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQ 274
Query: 235 RDPKERWA 242
            D  +R+ 
Sbjct: 275 VDLTKRFG 282

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 79/248 (31%), Positives = 123/248 (49%), Gaps = 16/248 (6%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAK------STELPKSEFLQREQKFLSSLNSPH 56
           + R  TIG GS   V L   + +G+ +A K        +L + E    E++ L ++N P 
Sbjct: 43  FERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL 116
           +V     + + +DN  +Y + MEY PGG +   + R G R  E     Y  QI+   EYL
Sbjct: 103 LVK---LEFSFKDNSNLY-MVMEYMPGGDMFSHLRRIG-RFSEPHARFYAAQIVLTFEYL 157
Query: 117 HSNRVVHCDIKSRNILMAESG-AKIADFGCAK-WESEALQSGGTPMFMAPEVARGEHQGF 174
           HS  +++ D+K  N+L+ + G  K+ADFG AK  +       GTP ++APE+   +    
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 175 ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLR 234
           A D WA+G  + EMA+G  P+  A  P+ +  KI   +     P+  S    D L N L+
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF-FADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQ 274
Query: 235 RDPKERWA 242
            D  +R+ 
Sbjct: 275 VDLTKRFG 282

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 82/262 (31%), Positives = 130/262 (49%), Gaps = 18/262 (6%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTE---LPKSEFLQREQ---KFLSSLNSP 55
           D+  G+ +G+GS A V  A S+ +G   A K  +   + K+  +QR Q   K    L  P
Sbjct: 12  DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHP 71
Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
            I+         ED+  +Y L +E    G +N  +        E+    +  QI+ G+ Y
Sbjct: 72  SILELYN---YFEDSNYVY-LVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLY 127
Query: 116 LHSNRVVHCDIKSRNILMAES-GAKIADFGCA---KWESEALQS-GGTPMFMAPEVARGE 170
           LHS+ ++H D+   N+L+  +   KIADFG A   K   E   +  GTP +++PE+A   
Sbjct: 128 LHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRS 187
Query: 171 HQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLS 230
             G  SD+W++GC    +  G  P+       T L K+  +    E+P+FLS +A D + 
Sbjct: 188 AHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT-LNKVVLADY--EMPSFLSIEAKDLIH 244
Query: 231 NCLRRDPKERWAASQLLKHPFL 252
             LRR+P +R + S +L HPF+
Sbjct: 245 QLLRRNPADRLSLSSVLDHPFM 266

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 85/255 (33%), Positives = 125/255 (49%), Gaps = 18/255 (7%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKS---EFLQREQKFLSSLNSPHIVGYKGCDV 65
           IG+GS+  V +AT   +G   A K  +L K    E L  E   +   +  ++V      +
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYL 112
Query: 66  TSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCD 125
             ++      + ME+  GG L D +     R++E  I +    +L+ L YLH+  V+H D
Sbjct: 113 VGDE----LWVVMEFLEGGALTDIVTHT--RMNEEQIATVCLSVLRALSYLHNQGVIHRD 166
Query: 126 IKSRNILMAESG-AKIADFG-CAKWESEALQSG---GTPMFMAPEVARGEHQGFASDIWA 180
           IKS +IL+   G  K++DFG CA+   E  +     GTP +MAPEV      G   DIW+
Sbjct: 167 IKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVISRLPYGTEVDIWS 226
Query: 181 VGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAF--LSKQANDFLSNCLRRDPK 238
           +G  VIEM  G  P+ N   P+  + +I  S   P V     +S     FL   L R+P 
Sbjct: 227 LGIMVIEMIDGEPPYFNEP-PLQAMRRIRDSLP-PRVKDLHKVSSVLRGFLDLMLVREPS 284
Query: 239 ERWAASQLLKHPFLE 253
           +R  A +LL HPFL+
Sbjct: 285 QRATAQELLGHPFLK 299

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 77/248 (31%), Positives = 123/248 (49%), Gaps = 16/248 (6%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAK------STELPKSEFLQREQKFLSSLNSPH 56
           + R  T+G GS   V L   + +G+ +A K        +L + E    E++ L ++N P 
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL 116
           +V     + + +DN  +Y + MEYAPGG +   + R G R  E     Y  QI+   EYL
Sbjct: 103 LVK---LEFSFKDNSNLY-MVMEYAPGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYL 157
Query: 117 HSNRVVHCDIKSRNILMAESG-AKIADFGCAK-WESEALQSGGTPMFMAPEVARGEHQGF 174
           HS  +++ D+K  N+++ + G  K+ DFG AK  +       GTP ++APE+   +    
Sbjct: 158 HSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 175 ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLR 234
           A D WA+G  + EMA+G  P+  A  P+ +  KI   +     P+  S    D L N L+
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF-FADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQ 274
Query: 235 RDPKERWA 242
            D  +R+ 
Sbjct: 275 VDLTKRFG 282

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 77/248 (31%), Positives = 123/248 (49%), Gaps = 16/248 (6%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAK------STELPKSEFLQREQKFLSSLNSPH 56
           + R  T+G GS   V L   + +G+ +A K        +L + E    E++ L ++N P 
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL 116
           +V     + + +DN  +Y + MEYAPGG +   + R G R  E     Y  QI+   EYL
Sbjct: 103 LVK---LEFSFKDNSNLY-MVMEYAPGGEMFSHLRRIG-RFXEPHARFYAAQIVLTFEYL 157
Query: 117 HSNRVVHCDIKSRNILMAESG-AKIADFGCAK-WESEALQSGGTPMFMAPEVARGEHQGF 174
           HS  +++ D+K  N+++ + G  K+ DFG AK  +       GTP ++APE+   +    
Sbjct: 158 HSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 175 ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLR 234
           A D WA+G  + EMA+G  P+  A  P+ +  KI   +     P+  S    D L N L+
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF-FADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQ 274
Query: 235 RDPKERWA 242
            D  +R+ 
Sbjct: 275 VDLTKRFG 282

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 77/248 (31%), Positives = 123/248 (49%), Gaps = 16/248 (6%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAK------STELPKSEFLQREQKFLSSLNSPH 56
           + R  T+G GS   V L   + +G+ +A K        +L + E    E++ L ++N P 
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPF 102
Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL 116
           +V     + + +DN  +Y + MEYAPGG +   + R G R  E     Y  QI+   EYL
Sbjct: 103 LVK---LEFSFKDNSNLY-MVMEYAPGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYL 157
Query: 117 HSNRVVHCDIKSRNILMAESG-AKIADFGCAK-WESEALQSGGTPMFMAPEVARGEHQGF 174
           HS  +++ D+K  N+++ + G  K+ DFG AK  +       GTP ++APE+   +    
Sbjct: 158 HSLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 175 ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLR 234
           A D WA+G  + EMA+G  P+  A  P+ +  KI   +     P+  S    D L N L+
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF-FADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQ 274
Query: 235 RDPKERWA 242
            D  +R+ 
Sbjct: 275 VDLTKRFG 282

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score =  111 bits (277), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 83/266 (31%), Positives = 126/266 (47%), Gaps = 23/266 (8%)
Query: 8   TIGQGSSATVSLATSLRSGDVFAAKSTELPK--------SEFLQREQKFLSSLNSPHIVG 59
            IG+G+ + V    +  +G  FA K  ++ K        +E L+RE      L  PHIV 
Sbjct: 31  VIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV- 89
Query: 60  YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRN---GGRLDESLIVSYTRQILQGLEYL 116
            +  +  S D  ++Y +F E+  G  L  EI +    G    E++   Y RQIL+ L Y 
Sbjct: 90  -ELLETYSSDG-MLYMVF-EFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYC 146
Query: 117 HSNRVVHCDIKSRNILMA----ESGAKIADFGCAKWESEA-LQSG---GTPMFMAPEVAR 168
           H N ++H D+K  N+L+A     +  K+ DFG A    E+ L +G   GTP FMAPEV +
Sbjct: 147 HDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTPHFMAPEVVK 206
Query: 169 GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDF 228
            E  G   D+W  G  +  + SG  P+    + +         +  P   + +S+ A D 
Sbjct: 207 REPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQWSHISESAKDL 266
Query: 229 LSNCLRRDPKERWAASQLLKHPFLEE 254
           +   L  DP ER    + L HP+L+E
Sbjct: 267 VRRMLMLDPAERITVYEALNHPWLKE 292

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 82/265 (30%), Positives = 131/265 (49%), Gaps = 27/265 (10%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQK--------FLSSLNS 54
           + RG  +G+G  A     T + + +VFA K   +PKS  L+  QK           SL++
Sbjct: 28  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKV--VPKSMLLKPHQKEKMSTEIAIHKSLDN 85
Query: 55  PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLE 114
           PH+VG+ G     ED+  +Y + +E     +L  E+H+    + E     + RQ +QG++
Sbjct: 86  PHVVGFHG---FFEDDDFVY-VVLEICRRRSLL-ELHKRRKAVTEPEARYFMRQTIQGVQ 140
Query: 115 YLHSNRVVHCDIKSRNILMAES-GAKIADFGCA-KWESEALQSG---GTPMFMAPEVARG 169
           YLH+NRV+H D+K  N+ + +    KI DFG A K E +  +     GTP ++APEV   
Sbjct: 141 YLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCK 200
Query: 170 EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLY--KIAYSRELPEVPAFLSKQAND 227
           +   F  DIW++GC +  +  G  P+  +    T +   K  YS     VP  ++  A+ 
Sbjct: 201 KGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYS-----VPRHINPVASA 255
Query: 228 FLSNCLRRDPKERWAASQLLKHPFL 252
            +   L  DP  R + ++LL   F 
Sbjct: 256 LIRRMLHADPTLRPSVAELLTDEFF 280

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 76/248 (30%), Positives = 123/248 (49%), Gaps = 16/248 (6%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAK------STELPKSEFLQREQKFLSSLNSPH 56
           + R  T+G GS   V L   + +G+ +A K        +L + E    E++ L ++N P 
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL 116
           +V     + + +DN  +Y + MEYAPGG +   + R G R  E     Y  QI+   EYL
Sbjct: 103 LVK---LEFSFKDNSNLY-MVMEYAPGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYL 157
Query: 117 HSNRVVHCDIKSRNILMAESG-AKIADFGCAK-WESEALQSGGTPMFMAPEVARGEHQGF 174
           HS  +++ D+K  N+++ + G  ++ DFG AK  +       GTP ++APE+   +    
Sbjct: 158 HSLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 175 ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLR 234
           A D WA+G  + EMA+G  P+  A  P+ +  KI   +     P+  S    D L N L+
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF-FADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQ 274
Query: 235 RDPKERWA 242
            D  +R+ 
Sbjct: 275 VDLTKRFG 282

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 76/248 (30%), Positives = 123/248 (49%), Gaps = 16/248 (6%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAK------STELPKSEFLQREQKFLSSLNSPH 56
           + R  T+G GS   V L   + +G+ +A K        +L + E    E++ L ++N P 
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPF 102
Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL 116
           +V     + + +DN  +Y + MEYAPGG +   + R G R  E     Y  QI+   EYL
Sbjct: 103 LVK---LEFSFKDNSNLY-MVMEYAPGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYL 157
Query: 117 HSNRVVHCDIKSRNILMAESG-AKIADFGCAK-WESEALQSGGTPMFMAPEVARGEHQGF 174
           HS  +++ D+K  N+++ + G  ++ DFG AK  +       GTP ++APE+   +    
Sbjct: 158 HSLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 175 ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLR 234
           A D WA+G  + EMA+G  P+  A  P+ +  KI   +     P+  S    D L N L+
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF-FADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQ 274
Query: 235 RDPKERWA 242
            D  +R+ 
Sbjct: 275 VDLTKRFG 282

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 81/265 (30%), Positives = 133/265 (50%), Gaps = 27/265 (10%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQK--------FLSSLNS 54
           + RG  +G+G  A     T + + +VFA K   +PKS  L+  QK           SL++
Sbjct: 44  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKV--VPKSMLLKPHQKEKMSTEIAIHKSLDN 101
Query: 55  PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLE 114
           PH+VG+ G     ED+  +Y + +E     +L  E+H+    + E     + RQ +QG++
Sbjct: 102 PHVVGFHGF---FEDDDFVY-VVLEICRRRSLL-ELHKRRKAVTEPEARYFMRQTIQGVQ 156
Query: 115 YLHSNRVVHCDIKSRNILMAES-GAKIADFGCA---KWESEALQS-GGTPMFMAPEVARG 169
           YLH+NRV+H D+K  N+ + +    KI DFG A   +++ E  ++  GTP ++APEV   
Sbjct: 157 YLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLCGTPNYIAPEVLCK 216
Query: 170 EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLY--KIAYSRELPEVPAFLSKQAND 227
           +   F  DIW++GC +  +  G  P+  +    T +   K  YS     VP  ++  A+ 
Sbjct: 217 KGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYS-----VPRHINPVASA 271
Query: 228 FLSNCLRRDPKERWAASQLLKHPFL 252
            +   L  DP  R + ++LL   F 
Sbjct: 272 LIRRMLHADPTLRPSVAELLTDEFF 296

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 76/248 (30%), Positives = 122/248 (49%), Gaps = 16/248 (6%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAK------STELPKSEFLQREQKFLSSLNSPH 56
           + R  T+G GS   V L   + +G+ +A K        +L + E    E++ L ++N P 
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL 116
           +      + + +DN  +Y + MEYAPGG +   + R G R  E     Y  QI+   EYL
Sbjct: 104 LTK---LEFSFKDNSNLY-MVMEYAPGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYL 158
Query: 117 HSNRVVHCDIKSRNILMAESG-AKIADFGCAK-WESEALQSGGTPMFMAPEVARGEHQGF 174
           HS  +++ D+K  N+++ + G  K+ DFG AK  +       GTP ++APE+   +    
Sbjct: 159 HSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNK 218
Query: 175 ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLR 234
           A D WA+G  + EMA+G  P+  A  P+ +  KI   +     P+  S    D L N L+
Sbjct: 219 AVDWWALGVLIYEMAAGYPPF-FADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQ 275
Query: 235 RDPKERWA 242
            D  +R+ 
Sbjct: 276 VDLTKRFG 283

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 83/270 (30%), Positives = 133/270 (49%), Gaps = 33/270 (12%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELP--KSEFLQREQKFLSSL-NSPHIVGYKGCDV 65
           +G G+   V     +++G + A K  ++   + E +++E   L    +  +I  Y G  +
Sbjct: 32  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 91
Query: 66  TSE----DNKLMYNLFMEYAPGGTLNDEI-HRNGGRLDESLIVSYTRQILQGLEYLHSNR 120
                  D++L   L ME+   G++ D I +  G  L E  I    R+IL+GL +LH ++
Sbjct: 92  KKNPPGMDDQLW--LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK 149
Query: 121 VVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG----GTPMFMAPEVARGEHQ--- 172
           V+H DIK +N+L+ E+   K+ DFG +      +       GTP +MAPEV   +     
Sbjct: 150 VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDA 209
Query: 173 --GFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPA------FLSKQ 224
              F SD+W++G T IEMA G  P  +   PM  L+ I      P  PA        SK+
Sbjct: 210 TYDFKSDLWSLGITAIEMAEGAPPLCD-MHPMRALFLI------PRNPAPRLKSKKWSKK 262
Query: 225 ANDFLSNCLRRDPKERWAASQLLKHPFLEE 254
              F+ +CL ++  +R A  QL+KHPF+ +
Sbjct: 263 FQSFIESCLVKNHSQRPATEQLMKHPFIRD 292

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 76/248 (30%), Positives = 122/248 (49%), Gaps = 16/248 (6%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAK------STELPKSEFLQREQKFLSSLNSPH 56
           + R  T+G GS   V L   + +G+ +A K        +L + E    E++ L ++N P 
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL 116
           +      + + +DN  +Y + MEYAPGG +   + R G R  E     Y  QI+   EYL
Sbjct: 104 LTK---LEFSFKDNSNLY-MVMEYAPGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYL 158
Query: 117 HSNRVVHCDIKSRNILMAESG-AKIADFGCAK-WESEALQSGGTPMFMAPEVARGEHQGF 174
           HS  +++ D+K  N+++ + G  K+ DFG AK  +       GTP ++APE+   +    
Sbjct: 159 HSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNK 218
Query: 175 ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLR 234
           A D WA+G  + EMA+G  P+  A  P+ +  KI   +     P+  S    D L N L+
Sbjct: 219 AVDWWALGVLIYEMAAGYPPF-FADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQ 275
Query: 235 RDPKERWA 242
            D  +R+ 
Sbjct: 276 VDLTKRFG 283

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 76/248 (30%), Positives = 122/248 (49%), Gaps = 16/248 (6%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAK------STELPKSEFLQREQKFLSSLNSPH 56
           + R  T+G GS   V L   + +G+ +A K        +L + E    E++ L ++N P 
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL 116
           +      + + +DN  +Y + MEYAPGG +   + R G R  E     Y  QI+   EYL
Sbjct: 104 LTK---LEFSFKDNSNLY-MVMEYAPGGEMFSHLRRIG-RFXEPHARFYAAQIVLTFEYL 158
Query: 117 HSNRVVHCDIKSRNILMAESG-AKIADFGCAK-WESEALQSGGTPMFMAPEVARGEHQGF 174
           HS  +++ D+K  N+++ + G  K+ DFG AK  +       GTP ++APE+   +    
Sbjct: 159 HSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNK 218
Query: 175 ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLR 234
           A D WA+G  + EMA+G  P+  A  P+ +  KI   +     P+  S    D L N L+
Sbjct: 219 AVDWWALGVLIYEMAAGYPPF-FADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQ 275
Query: 235 RDPKERWA 242
            D  +R+ 
Sbjct: 276 VDLTKRFG 283

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 76/248 (30%), Positives = 122/248 (49%), Gaps = 16/248 (6%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAK------STELPKSEFLQREQKFLSSLNSPH 56
           + R  T+G GS   V L   + +G+ +A K        +L + E    E++ L ++N P 
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL 116
           +V     + + +DN  +Y + MEY PGG +   + R G R  E     Y  QI+   EYL
Sbjct: 103 LVK---LEFSFKDNSNLY-MVMEYVPGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYL 157
Query: 117 HSNRVVHCDIKSRNILMAESG-AKIADFGCAK-WESEALQSGGTPMFMAPEVARGEHQGF 174
           HS  +++ D+K  N+L+ + G  ++ DFG AK  +       GTP ++APE+   +    
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 175 ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLR 234
           A D WA+G  + EMA+G  P+  A  P+ +  KI   +     P+  S    D L N L+
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF-FADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQ 274
Query: 235 RDPKERWA 242
            D  +R+ 
Sbjct: 275 VDLTKRFG 282

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 82/265 (30%), Positives = 131/265 (49%), Gaps = 27/265 (10%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQK--------FLSSLNS 54
           + RG  +G+G  A     T + + +VFA K   +PKS  L+  QK           SL++
Sbjct: 44  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKV--VPKSMLLKPHQKEKMSTEIAIHKSLDN 101
Query: 55  PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLE 114
           PH+VG+ G     ED+  +Y + +E     +L  E+H+    + E     + RQ +QG++
Sbjct: 102 PHVVGFHGF---FEDDDFVY-VVLEICRRRSLL-ELHKRRKAVTEPEARYFMRQTIQGVQ 156
Query: 115 YLHSNRVVHCDIKSRNILMAES-GAKIADFGCA-KWESEALQSG---GTPMFMAPEVARG 169
           YLH+NRV+H D+K  N+ + +    KI DFG A K E +  +     GTP ++APEV   
Sbjct: 157 YLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCK 216
Query: 170 EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLY--KIAYSRELPEVPAFLSKQAND 227
           +   F  DIW++GC +  +  G  P+  +    T +   K  YS     VP  ++  A+ 
Sbjct: 217 KGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYS-----VPRHINPVASA 271
Query: 228 FLSNCLRRDPKERWAASQLLKHPFL 252
            +   L  DP  R + ++LL   F 
Sbjct: 272 LIRRMLHADPTLRPSVAELLTDEFF 296

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 76/248 (30%), Positives = 122/248 (49%), Gaps = 16/248 (6%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAK------STELPKSEFLQREQKFLSSLNSPH 56
           + R  T+G GS   V L   + +G+ +A K        +L + E    E++ L ++N P 
Sbjct: 29  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 88
Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL 116
           +V     + + +DN  +Y + MEY PGG +   + R G R  E     Y  QI+   EYL
Sbjct: 89  LVK---LEFSFKDNSNLY-MVMEYVPGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYL 143
Query: 117 HSNRVVHCDIKSRNILMAESG-AKIADFGCAK-WESEALQSGGTPMFMAPEVARGEHQGF 174
           HS  +++ D+K  N+L+ + G  ++ DFG AK  +       GTP ++APE+   +    
Sbjct: 144 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEYLAPEIILSKGYNK 203
Query: 175 ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLR 234
           A D WA+G  + EMA+G  P+  A  P+ +  KI   +     P+  S    D L N L+
Sbjct: 204 AVDWWALGVLIYEMAAGYPPF-FADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQ 260
Query: 235 RDPKERWA 242
            D  +R+ 
Sbjct: 261 VDLTKRFG 268

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 77/248 (31%), Positives = 122/248 (49%), Gaps = 16/248 (6%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAK------STELPKSEFLQREQKFLSSLNSPH 56
           + R  T+G GS   V L     +G+ +A K        +L + E    E++ L ++N P 
Sbjct: 44  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL 116
           +V     + + +DN  +Y + MEYAPGG +   + R G R  E     Y  QI+   EYL
Sbjct: 104 LVK---LEFSFKDNSNLY-MVMEYAPGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYL 158
Query: 117 HSNRVVHCDIKSRNILMAESG-AKIADFGCAK-WESEALQSGGTPMFMAPEVARGEHQGF 174
           HS  +++ D+K  N+++ + G  K+ DFG AK  +       GTP ++APE+   +    
Sbjct: 159 HSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNK 218
Query: 175 ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLR 234
           A D WA+G  + EMA+G  P+  A  P+ +  KI   +     P+  S    D L N L+
Sbjct: 219 AVDWWALGVLIYEMAAGYPPF-FADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQ 275
Query: 235 RDPKERWA 242
            D  +R+ 
Sbjct: 276 VDLTKRFG 283

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 76/248 (30%), Positives = 122/248 (49%), Gaps = 16/248 (6%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAK------STELPKSEFLQREQKFLSSLNSPH 56
           + R  T+G GS   V L   + +G+ +A K        +L + E    E++ L ++N P 
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL 116
           +V     + + +DN  +Y + MEY PGG +   + R G R  E     Y  QI+   EYL
Sbjct: 104 LVK---LEFSFKDNSNLY-MVMEYVPGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYL 158
Query: 117 HSNRVVHCDIKSRNILMAESG-AKIADFGCAK-WESEALQSGGTPMFMAPEVARGEHQGF 174
           HS  +++ D+K  N+L+ + G  ++ DFG AK  +       GTP ++APE+   +    
Sbjct: 159 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNK 218
Query: 175 ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLR 234
           A D WA+G  + EMA+G  P+  A  P+ +  KI   +     P+  S    D L N L+
Sbjct: 219 AVDWWALGVLIYEMAAGYPPF-FADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQ 275
Query: 235 RDPKERWA 242
            D  +R+ 
Sbjct: 276 VDLTKRFG 283

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 76/248 (30%), Positives = 122/248 (49%), Gaps = 16/248 (6%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAK------STELPKSEFLQREQKFLSSLNSPH 56
           + R  T+G GS   V L   + +G+ +A K        +L + E    E++ L ++N P 
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL 116
           +V     + + +DN  +Y + MEY PGG +   + R G R  E     Y  QI+   EYL
Sbjct: 104 LVK---LEFSFKDNSNLY-MVMEYVPGGEMFSHLRRIG-RFXEPHARFYAAQIVLTFEYL 158
Query: 117 HSNRVVHCDIKSRNILMAESG-AKIADFGCAK-WESEALQSGGTPMFMAPEVARGEHQGF 174
           HS  +++ D+K  N+L+ + G  ++ DFG AK  +       GTP ++APE+   +    
Sbjct: 159 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNK 218
Query: 175 ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLR 234
           A D WA+G  + EMA+G  P+  A  P+ +  KI   +     P+  S    D L N L+
Sbjct: 219 AVDWWALGVLIYEMAAGYPPF-FADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQ 275
Query: 235 RDPKERWA 242
            D  +R+ 
Sbjct: 276 VDLTKRFG 283

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 76/248 (30%), Positives = 122/248 (49%), Gaps = 16/248 (6%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAK------STELPKSEFLQREQKFLSSLNSPH 56
           + R  T+G GS   V L   + +G+ +A K        +L + E    E++ L ++N P 
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL 116
           +V     + + +DN  +Y + MEY PGG +   + R G R  E     Y  QI+   EYL
Sbjct: 103 LVK---LEFSFKDNSNLY-MVMEYVPGGEMFSHLRRIG-RFXEPHARFYAAQIVLTFEYL 157
Query: 117 HSNRVVHCDIKSRNILMAESG-AKIADFGCAK-WESEALQSGGTPMFMAPEVARGEHQGF 174
           HS  +++ D+K  N+L+ + G  ++ DFG AK  +       GTP ++APE+   +    
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 175 ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLR 234
           A D WA+G  + EMA+G  P+  A  P+ +  KI   +     P+  S    D L N L+
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF-FADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQ 274
Query: 235 RDPKERWA 242
            D  +R+ 
Sbjct: 275 VDLTKRFG 282

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 82/265 (30%), Positives = 131/265 (49%), Gaps = 27/265 (10%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQK--------FLSSLNS 54
           + RG  +G+G  A     T + + +VFA K   +PKS  L+  QK           SL++
Sbjct: 44  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKV--VPKSMLLKPHQKEKMSTEIAIHKSLDN 101
Query: 55  PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLE 114
           PH+VG+ G     ED+  +Y + +E     +L  E+H+    + E     + RQ +QG++
Sbjct: 102 PHVVGFHG---FFEDDDFVY-VVLEICRRRSLL-ELHKRRKAVTEPEARYFMRQTIQGVQ 156
Query: 115 YLHSNRVVHCDIKSRNILMAES-GAKIADFGCA-KWESEALQSG---GTPMFMAPEVARG 169
           YLH+NRV+H D+K  N+ + +    KI DFG A K E +  +     GTP ++APEV   
Sbjct: 157 YLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLCGTPNYIAPEVLCK 216
Query: 170 EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLY--KIAYSRELPEVPAFLSKQAND 227
           +   F  DIW++GC +  +  G  P+  +    T +   K  YS     VP  ++  A+ 
Sbjct: 217 KGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYS-----VPRHINPVASA 271
Query: 228 FLSNCLRRDPKERWAASQLLKHPFL 252
            +   L  DP  R + ++LL   F 
Sbjct: 272 LIRRMLHADPTLRPSVAELLTDEFF 296

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 76/248 (30%), Positives = 122/248 (49%), Gaps = 16/248 (6%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAK------STELPKSEFLQREQKFLSSLNSPH 56
           + R  T+G GS   V L   + +G+ +A K        +L + E    E++ L ++N P 
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL 116
           +V     + + +DN  +Y + MEY PGG +   + R G R  E     Y  QI+   EYL
Sbjct: 103 LVK---LEFSFKDNSNLY-MVMEYVPGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYL 157
Query: 117 HSNRVVHCDIKSRNILMAESG-AKIADFGCAK-WESEALQSGGTPMFMAPEVARGEHQGF 174
           HS  +++ D+K  N+L+ + G  ++ DFG AK  +       GTP ++APE+   +    
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 175 ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLR 234
           A D WA+G  + EMA+G  P+  A  P+ +  KI   +     P+  S    D L N L+
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF-FADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQ 274
Query: 235 RDPKERWA 242
            D  +R+ 
Sbjct: 275 VDLTKRFG 282

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 76/248 (30%), Positives = 122/248 (49%), Gaps = 16/248 (6%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAK------STELPKSEFLQREQKFLSSLNSPH 56
           + R  T+G GS   V L   + +G+ +A K        +L + E    E++ L ++N P 
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL 116
           +V     + + +DN  +Y + MEY PGG +   + R G R  E     Y  QI+   EYL
Sbjct: 103 LVK---LEFSFKDNSNLY-MVMEYVPGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYL 157
Query: 117 HSNRVVHCDIKSRNILMAESG-AKIADFGCAK-WESEALQSGGTPMFMAPEVARGEHQGF 174
           HS  +++ D+K  N+L+ + G  ++ DFG AK  +       GTP ++APE+   +    
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 175 ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLR 234
           A D WA+G  + EMA+G  P+  A  P+ +  KI   +     P+  S    D L N L+
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF-FADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQ 274
Query: 235 RDPKERWA 242
            D  +R+ 
Sbjct: 275 VDLTKRFG 282

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 76/248 (30%), Positives = 122/248 (49%), Gaps = 16/248 (6%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAK------STELPKSEFLQREQKFLSSLNSPH 56
           + R  T+G GS   V L   + +G+ +A K        +L + E    E++ L ++N P 
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL 116
           +V     + + +DN  +Y + MEY PGG +   + R G R  E     Y  QI+   EYL
Sbjct: 103 LVK---LEFSFKDNSNLY-MVMEYVPGGEMFSHLRRIG-RFXEPHARFYAAQIVLTFEYL 157
Query: 117 HSNRVVHCDIKSRNILMAESG-AKIADFGCAK-WESEALQSGGTPMFMAPEVARGEHQGF 174
           HS  +++ D+K  N+L+ + G  ++ DFG AK  +       GTP ++APE+   +    
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 175 ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLR 234
           A D WA+G  + EMA+G  P+  A  P+ +  KI   +     P+  S    D L N L+
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF-FADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQ 274
Query: 235 RDPKERWA 242
            D  +R+ 
Sbjct: 275 VDLTKRFG 282

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score =  109 bits (273), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 76/248 (30%), Positives = 122/248 (49%), Gaps = 16/248 (6%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAK------STELPKSEFLQREQKFLSSLNSPH 56
           + R  T+G GS   V L   + +G+ +A K        +L + E    E++ L ++N P 
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL 116
           +V     + + +DN  +Y + MEY PGG +   + R G R  E     Y  QI+   EYL
Sbjct: 104 LVK---LEFSFKDNSNLY-MVMEYVPGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYL 158
Query: 117 HSNRVVHCDIKSRNILMAESG-AKIADFGCAK-WESEALQSGGTPMFMAPEVARGEHQGF 174
           HS  +++ D+K  N+L+ + G  ++ DFG AK  +       GTP ++APE+   +    
Sbjct: 159 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEYLAPEIILSKGYNK 218
Query: 175 ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLR 234
           A D WA+G  + EMA+G  P+  A  P+ +  KI   +     P+  S    D L N L+
Sbjct: 219 AVDWWALGVLIYEMAAGYPPF-FADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQ 275
Query: 235 RDPKERWA 242
            D  +R+ 
Sbjct: 276 VDLTKRFG 283

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 77/248 (31%), Positives = 121/248 (48%), Gaps = 16/248 (6%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAK------STELPKSEFLQREQKFLSSLNSPH 56
           + R  T+G GS   V L     +G+ FA K        +L + E    E++ L ++N P 
Sbjct: 43  FERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL 116
           +V     + + +DN  +Y + MEY PGG +   + R G R  E     Y  QI+   EYL
Sbjct: 103 LVK---LEYSFKDNSNLY-MVMEYVPGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYL 157
Query: 117 HSNRVVHCDIKSRNILMAESG-AKIADFGCAK-WESEALQSGGTPMFMAPEVARGEHQGF 174
           HS  +++ D+K  N+L+ + G  ++ DFG AK  +       GTP ++APE+   +    
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 175 ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLR 234
           A D WA+G  + EMA+G  P+  A  P+ +  KI   +     P+  S    D L N L+
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF-FADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQ 274
Query: 235 RDPKERWA 242
            D  +R+ 
Sbjct: 275 VDLTKRFG 282

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 77/248 (31%), Positives = 121/248 (48%), Gaps = 16/248 (6%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAK------STELPKSEFLQREQKFLSSLNSPH 56
           + R  T+G GS   V L     +G+ FA K        +L + E    E++ L ++N P 
Sbjct: 43  FERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL 116
           +V     + + +DN  +Y + MEY PGG +   + R G R  E     Y  QI+   EYL
Sbjct: 103 LVK---LEYSFKDNSNLY-MVMEYVPGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYL 157
Query: 117 HSNRVVHCDIKSRNILMAESG-AKIADFGCAK-WESEALQSGGTPMFMAPEVARGEHQGF 174
           HS  +++ D+K  N+L+ + G  ++ DFG AK  +       GTP ++APE+   +    
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 175 ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLR 234
           A D WA+G  + EMA+G  P+  A  P+ +  KI   +     P+  S    D L N L+
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF-FADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQ 274
Query: 235 RDPKERWA 242
            D  +R+ 
Sbjct: 275 VDLTKRFG 282

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score =  109 bits (272), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 77/248 (31%), Positives = 121/248 (48%), Gaps = 16/248 (6%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAK------STELPKSEFLQREQKFLSSLNSPH 56
           + R  T+G GS   V L     +G+ FA K        +L + E    E++ L ++N P 
Sbjct: 43  FERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL 116
           +V     + + +DN  +Y + MEY PGG +   + R G R  E     Y  QI+   EYL
Sbjct: 103 LVK---LEYSFKDNSNLY-MVMEYVPGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYL 157
Query: 117 HSNRVVHCDIKSRNILMAESG-AKIADFGCAK-WESEALQSGGTPMFMAPEVARGEHQGF 174
           HS  +++ D+K  N+L+ + G  ++ DFG AK  +       GTP ++APE+   +    
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 175 ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLR 234
           A D WA+G  + EMA+G  P+  A  P+ +  KI   +     P+  S    D L N L+
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF-FADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQ 274
Query: 235 RDPKERWA 242
            D  +R+ 
Sbjct: 275 VDLTKRFG 282

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 76/256 (29%), Positives = 129/256 (50%), Gaps = 16/256 (6%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAK--STELPKSEF-LQREQKFLSSLNSPHIVGYKGCDV 65
           +G G+   V       +G VF AK  +T  P  ++ ++ E   ++ L+ P ++       
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHD--- 115
Query: 66  TSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCD 125
            + ++K    L +E+  GG L D I     ++ E+ +++Y RQ  +GL+++H + +VH D
Sbjct: 116 -AFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLD 174
Query: 126 IKSRNIL---MAESGAKIADFGCA-KWESEAL--QSGGTPMFMAPEVARGEHQGFASDIW 179
           IK  NI+      S  KI DFG A K   + +   +  T  F APE+   E  GF +D+W
Sbjct: 175 IKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMW 234
Query: 180 AVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAF--LSKQANDFLSNCLRRDP 237
           A+G     + SG +P+    D  T+        E  E  AF  +S +A DF+ N L+++P
Sbjct: 235 AIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDE-DAFSSVSPEAKDFIKNLLQKEP 293
Query: 238 KERWAASQLLKHPFLE 253
           ++R      L+HP+L+
Sbjct: 294 RKRLTVHDALEHPWLK 309

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score =  108 bits (271), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 77/248 (31%), Positives = 122/248 (49%), Gaps = 16/248 (6%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAK------STELPKSEFLQREQKFLSSLNSPH 56
           + R  T+G GS   V L     +G+ +A K        +L + E    E++   ++N P 
Sbjct: 44  FERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNFPF 103
Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL 116
           +V     + + +DN  +Y + +EYAPGG +   + R G R  E     Y  QI+   EYL
Sbjct: 104 LVK---LEFSFKDNSNLY-MVLEYAPGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYL 158
Query: 117 HSNRVVHCDIKSRNILMAESG-AKIADFGCAK-WESEALQSGGTPMFMAPEVARGEHQGF 174
           HS  +++ D+K  N+L+ + G  K+ADFG AK  +       GTP ++APE+   +    
Sbjct: 159 HSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNK 218
Query: 175 ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLR 234
           A D WA+G  + EMA+G  P+  A  P+ +  KI   +     P+  S    D L N L+
Sbjct: 219 AVDWWALGVLIYEMAAGYPPF-FADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQ 275
Query: 235 RDPKERWA 242
            D  +R+ 
Sbjct: 276 VDLTKRFG 283

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 81/260 (31%), Positives = 125/260 (48%), Gaps = 17/260 (6%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAK---STELPKSEF---LQREQKFLSSLNSP 55
           D+  G  +G+G    V LA   +S  + A K     +L K+     L+RE +  S L  P
Sbjct: 10  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 69
Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
           +I+   G      D   +Y L +EYAP GT+  E+ +   + DE    +Y  ++   L Y
Sbjct: 70  NILRLYGY---FHDATRVY-LILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSY 124
Query: 116 LHSNRVVHCDIKSRNILMAESGA-KIADFG--CAKWESEALQSGGTPMFMAPEVARGEHQ 172
            HS RV+H DIK  N+L+  +G  KIADFG  C    S      GT  ++ PE+  G   
Sbjct: 125 CHSKRVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRRTTLSGTLDYLPPEMIEGRMH 184
Query: 173 GFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNC 232
               D+W++G    E   G  P+   A+     YK   SR     P F+++ A D +S  
Sbjct: 185 DEKVDLWSLGVLCYEFLVGKPPF--EANTYQETYK-RISRVEFTFPDFVTEGARDLISRL 241
Query: 233 LRRDPKERWAASQLLKHPFL 252
           L+ +P +R    ++L+HP++
Sbjct: 242 LKHNPSQRPMLREVLEHPWI 261

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score =  108 bits (269), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 76/248 (30%), Positives = 121/248 (48%), Gaps = 16/248 (6%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAK------STELPKSEFLQREQKFLSSLNSPH 56
           + R  T+G GS   V L     +G+ +A K        +L + E    E++ L ++N P 
Sbjct: 36  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 95
Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL 116
           +V     + + +DN  +Y + MEY PGG +   + R G R  E     Y  QI+   EYL
Sbjct: 96  LVK---LEFSFKDNSNLY-MVMEYVPGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYL 150
Query: 117 HSNRVVHCDIKSRNILMAESG-AKIADFGCAK-WESEALQSGGTPMFMAPEVARGEHQGF 174
           HS  +++ D+K  N+L+ + G  ++ DFG AK  +       GTP ++APE+   +    
Sbjct: 151 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNK 210
Query: 175 ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLR 234
           A D WA+G  + EMA+G  P+  A  P+ +  KI   +     P+  S    D L N L+
Sbjct: 211 AVDWWALGVLIYEMAAGYPPF-FADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQ 267
Query: 235 RDPKERWA 242
            D  +R+ 
Sbjct: 268 VDLTKRFG 275

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score =  108 bits (269), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 76/248 (30%), Positives = 121/248 (48%), Gaps = 16/248 (6%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAK------STELPKSEFLQREQKFLSSLNSPH 56
           + R  T+G GS   V L     +G+ +A K        +L + E    E++ L ++N P 
Sbjct: 44  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL 116
           +V     + + +DN  +Y + MEY PGG +   + R G R  E     Y  QI+   EYL
Sbjct: 104 LVK---LEFSFKDNSNLY-MVMEYVPGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYL 158
Query: 117 HSNRVVHCDIKSRNILMAESG-AKIADFGCAK-WESEALQSGGTPMFMAPEVARGEHQGF 174
           HS  +++ D+K  N+L+ + G  ++ DFG AK  +       GTP ++APE+   +    
Sbjct: 159 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNK 218
Query: 175 ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLR 234
           A D WA+G  + EMA+G  P+  A  P+ +  KI   +     P+  S    D L N L+
Sbjct: 219 AVDWWALGVLIYEMAAGYPPF-FADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQ 275
Query: 235 RDPKERWA 242
            D  +R+ 
Sbjct: 276 VDLTKRFG 283

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score =  108 bits (269), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 76/248 (30%), Positives = 121/248 (48%), Gaps = 16/248 (6%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAK------STELPKSEFLQREQKFLSSLNSPH 56
           + R  T+G GS   V L     +G+ +A K        +L + E    E++ L ++N P 
Sbjct: 44  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL 116
           +V     + + +DN  +Y + MEY PGG +   + R G R  E     Y  QI+   EYL
Sbjct: 104 LVK---LEFSFKDNSNLY-MVMEYVPGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYL 158
Query: 117 HSNRVVHCDIKSRNILMAESG-AKIADFGCAK-WESEALQSGGTPMFMAPEVARGEHQGF 174
           HS  +++ D+K  N+L+ + G  ++ DFG AK  +       GTP ++APE+   +    
Sbjct: 159 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNK 218
Query: 175 ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLR 234
           A D WA+G  + EMA+G  P+  A  P+ +  KI   +     P+  S    D L N L+
Sbjct: 219 AVDWWALGVLIYEMAAGYPPF-FADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQ 275
Query: 235 RDPKERWA 242
            D  +R+ 
Sbjct: 276 VDLTKRFG 283

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score =  108 bits (269), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 82/301 (27%), Positives = 143/301 (47%), Gaps = 54/301 (17%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ----REQKFLSSLNSPHI 57
           D+ +   +G G+   V   +   SG V A K   L     ++    RE + L   NSP+I
Sbjct: 69  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 128
Query: 58  VGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLH 117
           VG+ G   +  +     ++ ME+  GG+L D++ +  GR+ E ++   +  +++GL YL 
Sbjct: 129 VGFYGAFYSDGE----ISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLR 183
Query: 118 -SNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG--GTPMFMAPEVARGEHQG 173
             ++++H D+K  NIL+   G  K+ DFG +    +++ +   GT  +M+PE  +G H  
Sbjct: 184 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYS 243
Query: 174 FASDIWAVGCTVIEMASGGAPWP-----------------NAAD---------------- 200
             SDIW++G +++EMA G  P P                 +AA+                
Sbjct: 244 VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYG 303
Query: 201 -----PMTVLYKIAY--SRELPEVP-AFLSKQANDFLSNCLRRDPKERWAASQLLKHPFL 252
                PM +   + Y  +   P++P A  S +  DF++ CL ++P ER    QL+ H F+
Sbjct: 304 MDSRPPMAIFELLDYIVNEPPPKLPSAVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 363
Query: 253 E 253
           +
Sbjct: 364 K 364

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score =  108 bits (269), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 76/248 (30%), Positives = 121/248 (48%), Gaps = 16/248 (6%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAK------STELPKSEFLQREQKFLSSLNSPH 56
           + R  T+G GS   V L     +G+ +A K        +L + E    E++ L ++N P 
Sbjct: 36  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 95
Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL 116
           +V     + + +DN  +Y + MEY PGG +   + R G R  E     Y  QI+   EYL
Sbjct: 96  LVK---LEFSFKDNSNLY-MVMEYVPGGEMFSHLRRIG-RFXEPHARFYAAQIVLTFEYL 150
Query: 117 HSNRVVHCDIKSRNILMAESG-AKIADFGCAK-WESEALQSGGTPMFMAPEVARGEHQGF 174
           HS  +++ D+K  N+L+ + G  ++ DFG AK  +       GTP ++APE+   +    
Sbjct: 151 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNK 210
Query: 175 ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLR 234
           A D WA+G  + EMA+G  P+  A  P+ +  KI   +     P+  S    D L N L+
Sbjct: 211 AVDWWALGVLIYEMAAGYPPF-FADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQ 267
Query: 235 RDPKERWA 242
            D  +R+ 
Sbjct: 268 VDLTKRFG 275

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score =  108 bits (269), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 125/271 (46%), Gaps = 27/271 (9%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSLNSP 55
           D+  G  +G+GS +TV LA  L +   +A K  E        K  ++ RE+  +S L+ P
Sbjct: 38  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 97
Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
             V    C    +D KL + L   YA  G L   I R  G  DE+    YT +I+  LEY
Sbjct: 98  FFVKLYFC--FQDDEKLYFGL--SYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEY 152
Query: 116 LHSNRVVHCDIKSRNILMAES-GAKIADFGCAKW------ESEALQSGGTPMFMAPEVAR 168
           LH   ++H D+K  NIL+ E    +I DFG AK       ++ A    GT  +++PE+  
Sbjct: 153 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 212
Query: 169 GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDF 228
            +    +SD+WA+GC + ++ +G  P+    + +     I    + PE   F  K A D 
Sbjct: 213 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE--KFFPK-ARDL 269
Query: 229 LSNCLRRDPKERWAASQ------LLKHPFLE 253
           +   L  D  +R    +      L  HPF E
Sbjct: 270 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 300

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score =  108 bits (269), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 76/248 (30%), Positives = 121/248 (48%), Gaps = 16/248 (6%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAK------STELPKSEFLQREQKFLSSLNSPH 56
           + R  T+G GS   V L     +G+ +A K        +L + E    E++ L ++N P 
Sbjct: 44  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL 116
           +V     + + +DN  +Y + MEY PGG +   + R G R  E     Y  QI+   EYL
Sbjct: 104 LVK---LEFSFKDNSNLY-MVMEYVPGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYL 158
Query: 117 HSNRVVHCDIKSRNILMAESG-AKIADFGCAK-WESEALQSGGTPMFMAPEVARGEHQGF 174
           HS  +++ D+K  N+L+ + G  ++ DFG AK  +       GTP ++APE+   +    
Sbjct: 159 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNK 218
Query: 175 ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLR 234
           A D WA+G  + EMA+G  P+  A  P+ +  KI   +     P+  S    D L N L+
Sbjct: 219 AVDWWALGVLIYEMAAGYPPF-FADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQ 275
Query: 235 RDPKERWA 242
            D  +R+ 
Sbjct: 276 VDLTKRFG 283

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score =  107 bits (268), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 76/248 (30%), Positives = 121/248 (48%), Gaps = 16/248 (6%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAK------STELPKSEFLQREQKFLSSLNSPH 56
           + R  T+G GS   V L     +G+ +A K        +L + E    E++ L ++N P 
Sbjct: 64  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 123
Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL 116
           +V     + + +DN  +Y + MEY PGG +   + R G R  E     Y  QI+   EYL
Sbjct: 124 LVK---LEFSFKDNSNLY-MVMEYVPGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYL 178
Query: 117 HSNRVVHCDIKSRNILMAESG-AKIADFGCAK-WESEALQSGGTPMFMAPEVARGEHQGF 174
           HS  +++ D+K  N+L+ + G  ++ DFG AK  +       GTP ++APE+   +    
Sbjct: 179 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNK 238
Query: 175 ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLR 234
           A D WA+G  + EMA+G  P+  A  P+ +  KI   +     P+  S    D L N L+
Sbjct: 239 AVDWWALGVLIYEMAAGYPPF-FADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQ 295
Query: 235 RDPKERWA 242
            D  +R+ 
Sbjct: 296 VDLTKRFG 303

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 81/301 (26%), Positives = 143/301 (47%), Gaps = 54/301 (17%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ----REQKFLSSLNSPHI 57
           D+ +   +G G+   V   +   SG V A K   L     ++    RE + L   NSP+I
Sbjct: 34  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 93
Query: 58  VGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLH 117
           VG+ G   +  +     ++ ME+  GG+L D++ +  GR+ E ++   +  +++GL YL 
Sbjct: 94  VGFYGAFYSDGE----ISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLR 148
Query: 118 -SNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG--GTPMFMAPEVARGEHQG 173
             ++++H D+K  NIL+   G  K+ DFG +    +++ +   GT  +M+PE  +G H  
Sbjct: 149 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYS 208
Query: 174 FASDIWAVGCTVIEMASGGAPWP-----------------NAAD---------------- 200
             SDIW++G +++EMA G  P P                 +AA+                
Sbjct: 209 VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFG 268
Query: 201 -----PMTVLYKIAY--SRELPEVPA-FLSKQANDFLSNCLRRDPKERWAASQLLKHPFL 252
                PM +   + Y  +   P++P+   S +  DF++ CL ++P ER    QL+ H F+
Sbjct: 269 MDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 328
Query: 253 E 253
           +
Sbjct: 329 K 329

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 77/248 (31%), Positives = 120/248 (48%), Gaps = 16/248 (6%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAK------STELPKSEFLQREQKFLSSLNSPH 56
           + R  T+G GS   V L     SG+ +A K        +L + E    E++ L ++N P 
Sbjct: 30  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 89
Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL 116
           +V     + + +DN  +Y + MEY  GG +   + R G R  E     Y  QI+   EYL
Sbjct: 90  LVK---LEFSFKDNSNLY-MVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYL 144
Query: 117 HSNRVVHCDIKSRNILMAESG-AKIADFGCAK-WESEALQSGGTPMFMAPEVARGEHQGF 174
           HS  +++ D+K  N+L+ E G  ++ DFG AK  +       GTP ++APE+   +    
Sbjct: 145 HSLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNK 204
Query: 175 ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLR 234
           A D WA+G  + EMA+G  P+  A  P+ +  KI   +     P+  S    D L N L+
Sbjct: 205 AVDWWALGVLIYEMAAGYPPF-FADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQ 261
Query: 235 RDPKERWA 242
            D  +R+ 
Sbjct: 262 VDLTKRFG 269

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 76/248 (30%), Positives = 120/248 (48%), Gaps = 16/248 (6%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAK------STELPKSEFLQREQKFLSSLNSPH 56
           + R  T+G GS   V L     SG+ +A K        +L + E    E++ L ++N P 
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL 116
           +V     + + +DN  +Y + MEY  GG +   + R G R  E     Y  QI+   EYL
Sbjct: 103 LVK---LEFSFKDNSNLY-MVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYL 157
Query: 117 HSNRVVHCDIKSRNILMAESG-AKIADFGCAK-WESEALQSGGTPMFMAPEVARGEHQGF 174
           HS  +++ D+K  N+L+ + G  ++ DFG AK  +       GTP ++APE+   +    
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLAGTPEYLAPEIILSKGYNK 217
Query: 175 ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLR 234
           A D WA+G  + EMA+G  P+  A  P+ +  KI   +     P+  S    D L N L+
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF-FADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQ 274
Query: 235 RDPKERWA 242
            D  +R+ 
Sbjct: 275 VDLTKRFG 282

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 125/271 (46%), Gaps = 27/271 (9%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSLNSP 55
           D+  G  +G+GS +TV LA  L +   +A K  E        K  ++ RE+  +S L+ P
Sbjct: 15  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 74
Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
             V  K      +D KL + L   YA  G L   I R  G  DE+    YT +I+  LEY
Sbjct: 75  FFV--KLYFTFQDDEKLYFGL--SYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEY 129
Query: 116 LHSNRVVHCDIKSRNILMAES-GAKIADFGCAKW------ESEALQSGGTPMFMAPEVAR 168
           LH   ++H D+K  NIL+ E    +I DFG AK       ++ A    GT  +++PE+  
Sbjct: 130 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 189
Query: 169 GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDF 228
            +    +SD+WA+GC + ++ +G  P+    + +     I    + PE   F  K A D 
Sbjct: 190 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE--KFFPK-ARDL 246
Query: 229 LSNCLRRDPKERWAASQ------LLKHPFLE 253
           +   L  D  +R    +      L  HPF E
Sbjct: 247 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 277

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 81/301 (26%), Positives = 143/301 (47%), Gaps = 54/301 (17%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ----REQKFLSSLNSPHI 57
           D+ +   +G G+   V   +   SG V A K   L     ++    RE + L   NSP+I
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 58  VGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLH 117
           VG+ G   +  +     ++ ME+  GG+L D++ +  GR+ E ++   +  +++GL YL 
Sbjct: 67  VGFYGAFYSDGE----ISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLR 121
Query: 118 -SNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG--GTPMFMAPEVARGEHQG 173
             ++++H D+K  NIL+   G  K+ DFG +    +++ +   GT  +M+PE  +G H  
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYS 181
Query: 174 FASDIWAVGCTVIEMASGGAPWP-----------------NAAD---------------- 200
             SDIW++G +++EMA G  P P                 +AA+                
Sbjct: 182 VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYG 241
Query: 201 -----PMTVLYKIAY--SRELPEVPA-FLSKQANDFLSNCLRRDPKERWAASQLLKHPFL 252
                PM +   + Y  +   P++P+   S +  DF++ CL ++P ER    QL+ H F+
Sbjct: 242 MDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 301
Query: 253 E 253
           +
Sbjct: 302 K 302

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 81/301 (26%), Positives = 143/301 (47%), Gaps = 54/301 (17%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ----REQKFLSSLNSPHI 57
           D+ +   +G G+   V   +   SG V A K   L     ++    RE + L   NSP+I
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 58  VGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLH 117
           VG+ G   +  +     ++ ME+  GG+L D++ +  GR+ E ++   +  +++GL YL 
Sbjct: 67  VGFYGAFYSDGE----ISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLR 121
Query: 118 -SNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG--GTPMFMAPEVARGEHQG 173
             ++++H D+K  NIL+   G  K+ DFG +    +++ +   GT  +M+PE  +G H  
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYS 181
Query: 174 FASDIWAVGCTVIEMASGGAPWP-----------------NAAD---------------- 200
             SDIW++G +++EMA G  P P                 +AA+                
Sbjct: 182 VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYG 241
Query: 201 -----PMTVLYKIAY--SRELPEVPA-FLSKQANDFLSNCLRRDPKERWAASQLLKHPFL 252
                PM +   + Y  +   P++P+   S +  DF++ CL ++P ER    QL+ H F+
Sbjct: 242 MDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 301
Query: 253 E 253
           +
Sbjct: 302 K 302

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 82/263 (31%), Positives = 126/263 (47%), Gaps = 23/263 (8%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAK---STELPKSEF---LQREQKFLSSLNSP 55
           D+  G  +G+G    V LA   +S  + A K     +L K+     L+RE +  S L  P
Sbjct: 26  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 85
Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
           +I+   G      D   +Y L +EYAP GT+  E+ +   + DE    +Y  ++   L Y
Sbjct: 86  NILRLYGY---FHDATRVY-LILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSY 140
Query: 116 LHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSG-----GTPMFMAPEVARG 169
            HS RV+H DIK  N+L+  +G  KIADFG   W   A  S      GT  ++ PE+  G
Sbjct: 141 CHSKRVIHRDIKPENLLLGSAGELKIADFG---WSVHAPSSRRTTLCGTLDYLPPEMIEG 197
Query: 170 EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFL 229
                  D+W++G    E   G  P+   A+     YK   SR     P F+++ A D +
Sbjct: 198 RMHDEKVDLWSLGVLCYEFLVGKPPF--EANTYQETYK-RISRVEFTFPDFVTEGARDLI 254
Query: 230 SNCLRRDPKERWAASQLLKHPFL 252
           S  L+ +P +R    ++L+HP++
Sbjct: 255 SRLLKHNPSQRPMLREVLEHPWI 277

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 125/271 (46%), Gaps = 27/271 (9%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSLNSP 55
           D+  G  +G+GS +TV LA  L +   +A K  E        K  ++ RE+  +S L+ P
Sbjct: 30  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 89
Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
             V  K      +D KL + L   YA  G L   I R  G  DE+    YT +I+  LEY
Sbjct: 90  FFV--KLYFTFQDDEKLYFGL--SYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEY 144
Query: 116 LHSNRVVHCDIKSRNILMAES-GAKIADFGCAKW------ESEALQSGGTPMFMAPEVAR 168
           LH   ++H D+K  NIL+ E    +I DFG AK       ++ A    GT  +++PE+  
Sbjct: 145 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 204
Query: 169 GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDF 228
            +    +SD+WA+GC + ++ +G  P+    + +     I    + PE   F  K A D 
Sbjct: 205 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE--KFFPK-ARDL 261
Query: 229 LSNCLRRDPKERWAASQ------LLKHPFLE 253
           +   L  D  +R    +      L  HPF E
Sbjct: 262 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 292

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 81/301 (26%), Positives = 143/301 (47%), Gaps = 54/301 (17%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ----REQKFLSSLNSPHI 57
           D+ +   +G G+   V   +   SG V A K   L     ++    RE + L   NSP+I
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 58  VGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLH 117
           VG+ G   +  +     ++ ME+  GG+L D++ +  GR+ E ++   +  +++GL YL 
Sbjct: 67  VGFYGAFYSDGE----ISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLR 121
Query: 118 -SNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG--GTPMFMAPEVARGEHQG 173
             ++++H D+K  NIL+   G  K+ DFG +    +++ +   GT  +M+PE  +G H  
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYS 181
Query: 174 FASDIWAVGCTVIEMASGGAPWP-----------------NAAD---------------- 200
             SDIW++G +++EMA G  P P                 +AA+                
Sbjct: 182 VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYG 241
Query: 201 -----PMTVLYKIAY--SRELPEVPA-FLSKQANDFLSNCLRRDPKERWAASQLLKHPFL 252
                PM +   + Y  +   P++P+   S +  DF++ CL ++P ER    QL+ H F+
Sbjct: 242 MDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 301
Query: 253 E 253
           +
Sbjct: 302 K 302

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 125/271 (46%), Gaps = 27/271 (9%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSLNSP 55
           D+  G  +G+GS +TV LA  L +   +A K  E        K  ++ RE+  +S L+ P
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
             V  K      +D KL + L   YA  G L   I R  G  DE+    YT +I+  LEY
Sbjct: 93  FFV--KLYFTFQDDEKLYFGL--SYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEY 147
Query: 116 LHSNRVVHCDIKSRNILMAES-GAKIADFGCAKW------ESEALQSGGTPMFMAPEVAR 168
           LH   ++H D+K  NIL+ E    +I DFG AK       ++ A    GT  +++PE+  
Sbjct: 148 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 169 GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDF 228
            +    +SD+WA+GC + ++ +G  P+    + +     I    + PE   F  K A D 
Sbjct: 208 EKSAXKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPE--KFFPK-ARDL 264
Query: 229 LSNCLRRDPKERWAASQ------LLKHPFLE 253
           +   L  D  +R    +      L  HPF E
Sbjct: 265 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 295

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 125/271 (46%), Gaps = 27/271 (9%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSLNSP 55
           D+  G  +G+GS +TV LA  L +   +A K  E        K  ++ RE+  +S L+ P
Sbjct: 30  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 89
Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
             V  K      +D KL + L   YA  G L   I R  G  DE+    YT +I+  LEY
Sbjct: 90  FFV--KLYFTFQDDEKLYFGL--SYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEY 144
Query: 116 LHSNRVVHCDIKSRNILMAES-GAKIADFGCAKW------ESEALQSGGTPMFMAPEVAR 168
           LH   ++H D+K  NIL+ E    +I DFG AK       ++ A    GT  +++PE+  
Sbjct: 145 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 204
Query: 169 GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDF 228
            +    +SD+WA+GC + ++ +G  P+    + +     I    + PE   F  K A D 
Sbjct: 205 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE--KFFPK-ARDL 261
Query: 229 LSNCLRRDPKERWAASQ------LLKHPFLE 253
           +   L  D  +R    +      L  HPF E
Sbjct: 262 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 292

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 81/301 (26%), Positives = 143/301 (47%), Gaps = 54/301 (17%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ----REQKFLSSLNSPHI 57
           D+ +   +G G+   V   +   SG V A K   L     ++    RE + L   NSP+I
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 58  VGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLH 117
           VG+ G   +  +     ++ ME+  GG+L D++ +  GR+ E ++   +  +++GL YL 
Sbjct: 67  VGFYGAFYSDGE----ISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLR 121
Query: 118 -SNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG--GTPMFMAPEVARGEHQG 173
             ++++H D+K  NIL+   G  K+ DFG +    +++ +   GT  +M+PE  +G H  
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYS 181
Query: 174 FASDIWAVGCTVIEMASGGAPWP-----------------NAAD---------------- 200
             SDIW++G +++EMA G  P P                 +AA+                
Sbjct: 182 VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYG 241
Query: 201 -----PMTVLYKIAY--SRELPEVPA-FLSKQANDFLSNCLRRDPKERWAASQLLKHPFL 252
                PM +   + Y  +   P++P+   S +  DF++ CL ++P ER    QL+ H F+
Sbjct: 242 MDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 301
Query: 253 E 253
           +
Sbjct: 302 K 302

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 125/271 (46%), Gaps = 27/271 (9%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSLNSP 55
           D+  G  +G+GS +TV LA  L +   +A K  E        K  ++ RE+  +S L+ P
Sbjct: 8   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 67
Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
             V  K      +D KL + L   YA  G L   I R  G  DE+    YT +I+  LEY
Sbjct: 68  FFV--KLYFTFQDDEKLYFGL--SYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEY 122
Query: 116 LHSNRVVHCDIKSRNILMAES-GAKIADFGCAKW------ESEALQSGGTPMFMAPEVAR 168
           LH   ++H D+K  NIL+ E    +I DFG AK       ++ A    GT  +++PE+  
Sbjct: 123 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 182
Query: 169 GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDF 228
            +    +SD+WA+GC + ++ +G  P+    + +     I    + PE   F  K A D 
Sbjct: 183 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE--KFFPK-ARDL 239
Query: 229 LSNCLRRDPKERWAASQ------LLKHPFLE 253
           +   L  D  +R    +      L  HPF E
Sbjct: 240 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 270

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 125/271 (46%), Gaps = 27/271 (9%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSLNSP 55
           D+  G  +G+GS +TV LA  L +   +A K  E        K  ++ RE+  +S L+ P
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
             V  K      +D KL + L   YA  G L   I R  G  DE+    YT +I+  LEY
Sbjct: 69  FFV--KLYFTFQDDEKLYFGL--SYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEY 123
Query: 116 LHSNRVVHCDIKSRNILMAES-GAKIADFGCAKW------ESEALQSGGTPMFMAPEVAR 168
           LH   ++H D+K  NIL+ E    +I DFG AK       ++ A    GT  +++PE+  
Sbjct: 124 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 183
Query: 169 GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDF 228
            +    +SD+WA+GC + ++ +G  P+    + +     I    + PE   F  K A D 
Sbjct: 184 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE--KFFPK-ARDL 240
Query: 229 LSNCLRRDPKERWAASQ------LLKHPFLE 253
           +   L  D  +R    +      L  HPF E
Sbjct: 241 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 271

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 125/271 (46%), Gaps = 27/271 (9%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSLNSP 55
           D+  G  +G+GS +TV LA  L +   +A K  E        K  ++ RE+  +S L+ P
Sbjct: 10  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 69
Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
             V  K      +D KL + L   YA  G L   I R  G  DE+    YT +I+  LEY
Sbjct: 70  FFV--KLYFTFQDDEKLYFGL--SYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEY 124
Query: 116 LHSNRVVHCDIKSRNILMAES-GAKIADFGCAKW------ESEALQSGGTPMFMAPEVAR 168
           LH   ++H D+K  NIL+ E    +I DFG AK       ++ A    GT  +++PE+  
Sbjct: 125 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 184
Query: 169 GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDF 228
            +    +SD+WA+GC + ++ +G  P+    + +     I    + PE   F  K A D 
Sbjct: 185 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE--KFFPK-ARDL 241
Query: 229 LSNCLRRDPKERWAASQ------LLKHPFLE 253
           +   L  D  +R    +      L  HPF E
Sbjct: 242 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 272

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 125/271 (46%), Gaps = 27/271 (9%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSLNSP 55
           D+  G  +G+GS +TV LA  L +   +A K  E        K  ++ RE+  +S L+ P
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
             V  K      +D KL + L   YA  G L   I R  G  DE+    YT +I+  LEY
Sbjct: 93  FFV--KLYFTFQDDEKLYFGL--SYAKNGCLLKYI-RKIGSFDETCTRFYTAEIVSALEY 147
Query: 116 LHSNRVVHCDIKSRNILMAES-GAKIADFGCAKW------ESEALQSGGTPMFMAPEVAR 168
           LH   ++H D+K  NIL+ E    +I DFG AK       ++ A    GT  +++PE+  
Sbjct: 148 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 207
Query: 169 GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDF 228
            +    +SD+WA+GC + ++ +G  P+    + +     I    + PE   F  K A D 
Sbjct: 208 EKSASKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE--KFFPK-ARDL 264
Query: 229 LSNCLRRDPKERWAASQ------LLKHPFLE 253
           +   L  D  +R    +      L  HPF E
Sbjct: 265 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 295

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 82/263 (31%), Positives = 126/263 (47%), Gaps = 23/263 (8%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAK---STELPKSEF---LQREQKFLSSLNSP 55
           D+  G  +G+G    V LA   +S  + A K     +L K+     L+RE +  S L  P
Sbjct: 11  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 70
Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
           +I+   G      D   +Y L +EYAP GT+  E+ +   + DE    +Y  ++   L Y
Sbjct: 71  NILRLYG---YFHDATRVY-LILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSY 125
Query: 116 LHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSG-----GTPMFMAPEVARG 169
            HS RV+H DIK  N+L+  +G  KIADFG   W   A  S      GT  ++ PE+  G
Sbjct: 126 CHSKRVIHRDIKPENLLLGSAGELKIADFG---WSVHAPSSRRXXLCGTLDYLPPEMIEG 182
Query: 170 EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFL 229
                  D+W++G    E   G  P+   A+     YK   SR     P F+++ A D +
Sbjct: 183 RMHDEKVDLWSLGVLCYEFLVGKPPF--EANTYQETYK-RISRVEFTFPDFVTEGARDLI 239
Query: 230 SNCLRRDPKERWAASQLLKHPFL 252
           S  L+ +P +R    ++L+HP++
Sbjct: 240 SRLLKHNPSQRPMLREVLEHPWI 262

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 82/263 (31%), Positives = 126/263 (47%), Gaps = 23/263 (8%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAK---STELPKSEF---LQREQKFLSSLNSP 55
           D+  G  +G+G    V LA   +S  + A K     +L K+     L+RE +  S L  P
Sbjct: 10  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 69
Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
           +I+   G      D   +Y L +EYAP GT+  E+ +   + DE    +Y  ++   L Y
Sbjct: 70  NILRLYG---YFHDATRVY-LILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSY 124
Query: 116 LHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG-----GTPMFMAPEVARG 169
            HS RV+H DIK  N+L+  +G  KIADFG   W   A  S      GT  ++ PE+  G
Sbjct: 125 CHSKRVIHRDIKPENLLLGSAGELKIADFG---WSVHAPSSRRDTLCGTLDYLPPEMIEG 181
Query: 170 EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFL 229
                  D+W++G    E   G  P+   A+     YK   SR     P F+++ A D +
Sbjct: 182 RMHDEKVDLWSLGVLCYEFLVGKPPF--EANTYQETYK-RISRVEFTFPDFVTEGARDLI 238
Query: 230 SNCLRRDPKERWAASQLLKHPFL 252
           S  L+ +P +R    ++L+HP++
Sbjct: 239 SRLLKHNPSQRPMLREVLEHPWI 261

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 82/263 (31%), Positives = 126/263 (47%), Gaps = 23/263 (8%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAK---STELPKSEF---LQREQKFLSSLNSP 55
           D+  G  +G+G    V LA   +S  + A K     +L K+     L+RE +  S L  P
Sbjct: 10  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 69
Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
           +I+   G      D   +Y L +EYAP GT+  E+ +   + DE    +Y  ++   L Y
Sbjct: 70  NILRLYG---YFHDATRVY-LILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSY 124
Query: 116 LHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG-----GTPMFMAPEVARG 169
            HS RV+H DIK  N+L+  +G  KIADFG   W   A  S      GT  ++ PE+  G
Sbjct: 125 CHSKRVIHRDIKPENLLLGSAGELKIADFG---WSVHAPSSRRTDLCGTLDYLPPEMIEG 181
Query: 170 EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFL 229
                  D+W++G    E   G  P+   A+     YK   SR     P F+++ A D +
Sbjct: 182 RMHDEKVDLWSLGVLCYEFLVGKPPF--EANTYQETYK-RISRVEFTFPDFVTEGARDLI 238
Query: 230 SNCLRRDPKERWAASQLLKHPFL 252
           S  L+ +P +R    ++L+HP++
Sbjct: 239 SRLLKHNPSQRPMLREVLEHPWI 261

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 82/263 (31%), Positives = 126/263 (47%), Gaps = 23/263 (8%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAK---STELPKSEF---LQREQKFLSSLNSP 55
           D+  G  +G+G    V LA   +S  + A K     +L K+     L+RE +  S L  P
Sbjct: 12  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 71
Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
           +I+   G      D   +Y L +EYAP GT+  E+ +   + DE    +Y  ++   L Y
Sbjct: 72  NILRLYG---YFHDATRVY-LILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSY 126
Query: 116 LHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG-----GTPMFMAPEVARG 169
            HS RV+H DIK  N+L+  +G  KIADFG   W   A  S      GT  ++ PE+  G
Sbjct: 127 CHSKRVIHRDIKPENLLLGSAGELKIADFG---WSVHAPSSRRTTLCGTLDYLPPEMIEG 183
Query: 170 EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFL 229
                  D+W++G    E   G  P+   A+     YK   SR     P F+++ A D +
Sbjct: 184 RMHDEKVDLWSLGVLCYEFLVGKPPF--EANTYQETYK-RISRVEFTFPDFVTEGARDLI 240
Query: 230 SNCLRRDPKERWAASQLLKHPFL 252
           S  L+ +P +R    ++L+HP++
Sbjct: 241 SRLLKHNPSQRPMLREVLEHPWI 263

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 76/248 (30%), Positives = 120/248 (48%), Gaps = 16/248 (6%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAK------STELPKSEFLQREQKFLSSLNSPH 56
           + R  T+G GS   V L     SG+ +A K        +L + E    E++ L ++N P 
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL 116
           +V     + + +DN  +Y + MEY  GG +   + R G R  E     Y  QI+   EYL
Sbjct: 103 LVK---LEFSFKDNSNLY-MVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYL 157
Query: 117 HSNRVVHCDIKSRNILMAESG-AKIADFGCAK-WESEALQSGGTPMFMAPEVARGEHQGF 174
           HS  +++ D+K  N+L+ + G  ++ DFG AK  +       GTP ++APE+   +    
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLXGTPEYLAPEIILSKGYNK 217
Query: 175 ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLR 234
           A D WA+G  + EMA+G  P+  A  P+ +  KI   +     P+  S    D L N L+
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF-FADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQ 274
Query: 235 RDPKERWA 242
            D  +R+ 
Sbjct: 275 VDLTKRFG 282

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 75/248 (30%), Positives = 121/248 (48%), Gaps = 16/248 (6%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAK------STELPKSEFLQREQKFLSSLNSPH 56
           + R  T+G GS   V L   + +G+ +A K        +L + E    E++ L ++N P 
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL 116
           +V     + + +DN  +Y + MEY  GG +   + R G R  E     Y  QI+   EYL
Sbjct: 103 LVK---LEFSFKDNSNLY-MVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYL 157
Query: 117 HSNRVVHCDIKSRNILMAESG-AKIADFGCAK-WESEALQSGGTPMFMAPEVARGEHQGF 174
           HS  +++ D+K  N+L+ + G  ++ DFG AK  +       GTP ++APE+   +    
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 175 ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLR 234
           A D WA+G  + EMA+G  P+  A  P+ +  KI   +     P+  S    D L N L+
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF-FADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQ 274
Query: 235 RDPKERWA 242
            D  +R+ 
Sbjct: 275 VDLTKRFG 282

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 126/271 (46%), Gaps = 27/271 (9%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSLNSP 55
           D+  G  +G+GS +TV LA  L +   +A K  E        K  ++ RE+  +S L+ P
Sbjct: 36  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 95
Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
             V  K      +D KL + L   YA  G L   I R  G  DE+    YT +I+  LEY
Sbjct: 96  FFV--KLYFTFQDDEKLYFGL--SYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEY 150
Query: 116 LHSNRVVHCDIKSRNILMAES-GAKIADFGCAKW------ESEALQSGGTPMFMAPEVAR 168
           LH   ++H D+K  NIL+ E    +I DFG AK       ++ A    GT  +++PE+  
Sbjct: 151 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 210
Query: 169 GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDF 228
            +    +SD+WA+GC + ++ +G  P+  A +   +  KI       + PA    +A D 
Sbjct: 211 EKSACKSSDLWALGCIIYQLVAGLPPF-RAGNEYLIFQKIIKLEY--DFPAAFFPKARDL 267
Query: 229 LSNCLRRDPKERWAASQ------LLKHPFLE 253
           +   L  D  +R    +      L  HPF E
Sbjct: 268 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 298

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 82/263 (31%), Positives = 126/263 (47%), Gaps = 23/263 (8%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAK---STELPKSEF---LQREQKFLSSLNSP 55
           D+  G  +G+G    V LA   +S  + A K     +L K+     L+RE +  S L  P
Sbjct: 9   DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 68
Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
           +I+   G      D   +Y L +EYAP GT+  E+ +   + DE    +Y  ++   L Y
Sbjct: 69  NILRLYG---YFHDATRVY-LILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSY 123
Query: 116 LHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG-----GTPMFMAPEVARG 169
            HS RV+H DIK  N+L+  +G  KIADFG   W   A  S      GT  ++ PE+  G
Sbjct: 124 CHSKRVIHRDIKPENLLLGSAGELKIADFG---WSVHAPSSRRTDLCGTLDYLPPEMIEG 180
Query: 170 EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFL 229
                  D+W++G    E   G  P+   A+     YK   SR     P F+++ A D +
Sbjct: 181 RMHDEKVDLWSLGVLCYEFLVGKPPF--EANTYQETYK-RISRVEFTFPDFVTEGARDLI 237
Query: 230 SNCLRRDPKERWAASQLLKHPFL 252
           S  L+ +P +R    ++L+HP++
Sbjct: 238 SRLLKHNPSQRPMLREVLEHPWI 260

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 82/263 (31%), Positives = 126/263 (47%), Gaps = 23/263 (8%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAK---STELPKSEF---LQREQKFLSSLNSP 55
           D+  G  +G+G    V LA   +S  + A K     +L K+     L+RE +  S L  P
Sbjct: 9   DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 68
Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
           +I+   G      D   +Y L +EYAP GT+  E+ +   + DE    +Y  ++   L Y
Sbjct: 69  NILRLYG---YFHDATRVY-LILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSY 123
Query: 116 LHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSG-----GTPMFMAPEVARG 169
            HS RV+H DIK  N+L+  +G  KIADFG   W   A  S      GT  ++ PE+  G
Sbjct: 124 CHSKRVIHRDIKPENLLLGSAGELKIADFG---WSVHAPSSRRTELCGTLDYLPPEMIEG 180
Query: 170 EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFL 229
                  D+W++G    E   G  P+   A+     YK   SR     P F+++ A D +
Sbjct: 181 RMHDEKVDLWSLGVLCYEFLVGKPPF--EANTYQETYK-RISRVEFTFPDFVTEGARDLI 237
Query: 230 SNCLRRDPKERWAASQLLKHPFL 252
           S  L+ +P +R    ++L+HP++
Sbjct: 238 SRLLKHNPSQRPMLREVLEHPWI 260

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 82/263 (31%), Positives = 126/263 (47%), Gaps = 23/263 (8%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAK---STELPKSEF---LQREQKFLSSLNSP 55
           D+  G  +G+G    V LA   +S  + A K     +L K+     L+RE +  S L  P
Sbjct: 9   DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 68
Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
           +I+   G      D   +Y L +EYAP GT+  E+ +   + DE    +Y  ++   L Y
Sbjct: 69  NILRLYG---YFHDATRVY-LILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSY 123
Query: 116 LHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG-----GTPMFMAPEVARG 169
            HS RV+H DIK  N+L+  +G  KIADFG   W   A  S      GT  ++ PE+  G
Sbjct: 124 CHSKRVIHRDIKPENLLLGSAGELKIADFG---WSVHAPSSRRTTLCGTLDYLPPEMIEG 180
Query: 170 EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFL 229
                  D+W++G    E   G  P+   A+     YK   SR     P F+++ A D +
Sbjct: 181 RMHDEKVDLWSLGVLCYEFLVGKPPF--EANTYQETYK-RISRVEFTFPDFVTEGARDLI 237
Query: 230 SNCLRRDPKERWAASQLLKHPFL 252
           S  L+ +P +R    ++L+HP++
Sbjct: 238 SRLLKHNPSQRPMLREVLEHPWI 260

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 125/271 (46%), Gaps = 27/271 (9%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSLNSP 55
           D+  G  +G+GS +TV LA  L +   +A K  E        K  ++ RE+  +S L+ P
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
             V  K      +D KL + L   YA  G L   I R  G  DE+    YT +I+  LEY
Sbjct: 93  FFV--KLYFTFQDDEKLYFGL--SYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEY 147
Query: 116 LHSNRVVHCDIKSRNILMAES-GAKIADFGCAKW------ESEALQSGGTPMFMAPEVAR 168
           LH   ++H D+K  NIL+ E    +I DFG AK       ++ A    GT  +++PE+  
Sbjct: 148 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 169 GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDF 228
            +    +SD+WA+GC + ++ +G  P+    + +     I    + PE   F  K A D 
Sbjct: 208 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE--KFFPK-ARDL 264
Query: 229 LSNCLRRDPKERWAASQ------LLKHPFLE 253
           +   L  D  +R    +      L  HPF E
Sbjct: 265 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 295

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 125/271 (46%), Gaps = 27/271 (9%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSLNSP 55
           D+  G  +G+GS +TV LA  L +   +A K  E        K  ++ RE+  +S L+ P
Sbjct: 11  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 70
Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
             V  K      +D KL + L   YA  G L   I R  G  DE+    YT +I+  LEY
Sbjct: 71  FFV--KLYFTFQDDEKLYFGL--SYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEY 125
Query: 116 LHSNRVVHCDIKSRNILMAES-GAKIADFGCAKW------ESEALQSGGTPMFMAPEVAR 168
           LH   ++H D+K  NIL+ E    +I DFG AK       ++ A    GT  +++PE+  
Sbjct: 126 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 185
Query: 169 GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDF 228
            +    +SD+WA+GC + ++ +G  P+    + +     I    + PE   F  K A D 
Sbjct: 186 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE--KFFPK-ARDL 242
Query: 229 LSNCLRRDPKERWAASQ------LLKHPFLE 253
           +   L  D  +R    +      L  HPF E
Sbjct: 243 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 273

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 82/263 (31%), Positives = 126/263 (47%), Gaps = 23/263 (8%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAK---STELPKSEF---LQREQKFLSSLNSP 55
           D+  G  +G+G    V LA   +S  + A K     +L K+     L+RE +  S L  P
Sbjct: 9   DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 68
Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
           +I+   G      D   +Y L +EYAP GT+  E+ +   + DE    +Y  ++   L Y
Sbjct: 69  NILRLYG---YFHDATRVY-LILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSY 123
Query: 116 LHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG-----GTPMFMAPEVARG 169
            HS RV+H DIK  N+L+  +G  KIADFG   W   A  S      GT  ++ PE+  G
Sbjct: 124 CHSKRVIHRDIKPENLLLGSAGELKIADFG---WSVHAPSSRRTDLCGTLDYLPPEMIEG 180
Query: 170 EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFL 229
                  D+W++G    E   G  P+   A+     YK   SR     P F+++ A D +
Sbjct: 181 RMHDEKVDLWSLGVLCYEFLVGKPPF--EANTYQETYK-RISRVEFTFPDFVTEGARDLI 237
Query: 230 SNCLRRDPKERWAASQLLKHPFL 252
           S  L+ +P +R    ++L+HP++
Sbjct: 238 SRLLKHNPSQRPMLREVLEHPWI 260

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 82/263 (31%), Positives = 126/263 (47%), Gaps = 23/263 (8%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAK---STELPKSEF---LQREQKFLSSLNSP 55
           D+  G  +G+G    V LA   +S  + A K     +L K+     L+RE +  S L  P
Sbjct: 35  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 94
Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
           +I+   G      D   +Y L +EYAP GT+  E+ +   + DE    +Y  ++   L Y
Sbjct: 95  NILRLYGY---FHDATRVY-LILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSY 149
Query: 116 LHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSG-----GTPMFMAPEVARG 169
            HS RV+H DIK  N+L+  +G  KIADFG   W   A  S      GT  ++ PE+  G
Sbjct: 150 CHSKRVIHRDIKPENLLLGSAGELKIADFG---WSVHAPSSRRDDLCGTLDYLPPEMIEG 206
Query: 170 EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFL 229
                  D+W++G    E   G  P+   A+     YK   SR     P F+++ A D +
Sbjct: 207 RMHDEKVDLWSLGVLCYEFLVGKPPF--EANTYQETYK-RISRVEFTFPDFVTEGARDLI 263
Query: 230 SNCLRRDPKERWAASQLLKHPFL 252
           S  L+ +P +R    ++L+HP++
Sbjct: 264 SRLLKHNPSQRPMLREVLEHPWI 286

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 82/263 (31%), Positives = 126/263 (47%), Gaps = 23/263 (8%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAK---STELPKSEF---LQREQKFLSSLNSP 55
           D+  G  +G+G    V LA   +S  + A K     +L K+     L+RE +  S L  P
Sbjct: 35  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 94
Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
           +I+   G      D   +Y L +EYAP GT+  E+ +   + DE    +Y  ++   L Y
Sbjct: 95  NILRLYGY---FHDATRVY-LILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSY 149
Query: 116 LHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSG-----GTPMFMAPEVARG 169
            HS RV+H DIK  N+L+  +G  KIADFG   W   A  S      GT  ++ PE+  G
Sbjct: 150 CHSKRVIHRDIKPENLLLGSAGELKIADFG---WSVHAPSSRRTTLCGTLDYLPPEMIEG 206
Query: 170 EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFL 229
                  D+W++G    E   G  P+   A+     YK   SR     P F+++ A D +
Sbjct: 207 RMHDEKVDLWSLGVLCYEFLVGKPPF--EANTYQETYK-RISRVEFTFPDFVTEGARDLI 263
Query: 230 SNCLRRDPKERWAASQLLKHPFL 252
           S  L+ +P +R    ++L+HP++
Sbjct: 264 SRLLKHNPSQRPMLREVLEHPWI 286

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 82/263 (31%), Positives = 126/263 (47%), Gaps = 23/263 (8%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAK---STELPKSEF---LQREQKFLSSLNSP 55
           D+  G  +G+G    V LA   +S  + A K     +L K+     L+RE +  S L  P
Sbjct: 14  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 73
Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
           +I+   G      D   +Y L +EYAP GT+  E+ +   + DE    +Y  ++   L Y
Sbjct: 74  NILRLYG---YFHDATRVY-LILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSY 128
Query: 116 LHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG-----GTPMFMAPEVARG 169
            HS RV+H DIK  N+L+  +G  KIADFG   W   A  S      GT  ++ PE+  G
Sbjct: 129 CHSKRVIHRDIKPENLLLGSAGELKIADFG---WSVHAPSSRRTDLCGTLDYLPPEMIEG 185
Query: 170 EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFL 229
                  D+W++G    E   G  P+   A+     YK   SR     P F+++ A D +
Sbjct: 186 RMHDEKVDLWSLGVLCYEFLVGKPPF--EANTYQETYK-RISRVEFTFPDFVTEGARDLI 242
Query: 230 SNCLRRDPKERWAASQLLKHPFL 252
           S  L+ +P +R    ++L+HP++
Sbjct: 243 SRLLKHNPSQRPMLREVLEHPWI 265

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 82/263 (31%), Positives = 126/263 (47%), Gaps = 23/263 (8%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAK---STELPKSEF---LQREQKFLSSLNSP 55
           D+  G  +G+G    V LA   +S  + A K     +L K+     L+RE +  S L  P
Sbjct: 14  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 73
Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
           +I+   G      D   +Y L +EYAP GT+  E+ +   + DE    +Y  ++   L Y
Sbjct: 74  NILRLYG---YFHDATRVY-LILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSY 128
Query: 116 LHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSG-----GTPMFMAPEVARG 169
            HS RV+H DIK  N+L+  +G  KIADFG   W   A  S      GT  ++ PE+  G
Sbjct: 129 CHSKRVIHRDIKPENLLLGSAGELKIADFG---WSVHAPSSRRTTLCGTLDYLPPEMIEG 185
Query: 170 EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFL 229
                  D+W++G    E   G  P+   A+     YK   SR     P F+++ A D +
Sbjct: 186 RMHDEKVDLWSLGVLCYEFLVGKPPF--EANTYQETYK-RISRVEFTFPDFVTEGARDLI 242
Query: 230 SNCLRRDPKERWAASQLLKHPFL 252
           S  L+ +P +R    ++L+HP++
Sbjct: 243 SRLLKHNPSQRPMLREVLEHPWI 265

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 76/248 (30%), Positives = 121/248 (48%), Gaps = 16/248 (6%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAK------STELPKSEFLQREQKFLSSLNSPH 56
           + R  T+G GS   V L     SG+ +A K        +L + E    E++ L ++N P 
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL 116
           +V     + + +DN  +Y + MEY  GG +   + R G R  E     Y  QI+   EYL
Sbjct: 103 LVK---LEFSFKDNSNLY-MVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYL 157
Query: 117 HSNRVVHCDIKSRNILMAESG-AKIADFGCAK-WESEALQSGGTPMFMAPEVARGEHQGF 174
           HS  +++ D+K  N+L+ + G  ++ DFG AK  +       GTP ++APE+   +    
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 175 ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLR 234
           A D WA+G  + EMA+G  P+  A +P+ +  KI   +     P+  S    D L N L+
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF-FADEPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQ 274
Query: 235 RDPKERWA 242
            D  +R+ 
Sbjct: 275 VDLTKRFG 282

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 125/271 (46%), Gaps = 27/271 (9%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSLNSP 55
           D+  G  +G+GS +TV LA  L +   +A K  E        K  ++ RE+  +S L+ P
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
             V  K      +D KL + L   YA  G L   I R  G  DE+    YT +I+  LEY
Sbjct: 91  FFV--KLYFTFQDDEKLYFGL--SYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEY 145
Query: 116 LHSNRVVHCDIKSRNILMAES-GAKIADFGCAKW------ESEALQSGGTPMFMAPEVAR 168
           LH   ++H D+K  NIL+ E    +I DFG AK       ++ A    GT  +++PE+  
Sbjct: 146 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 205
Query: 169 GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDF 228
            +    +SD+WA+GC + ++ +G  P+    + +     I    + PE   F  K A D 
Sbjct: 206 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE--KFFPK-ARDL 262
Query: 229 LSNCLRRDPKERWAASQ------LLKHPFLE 253
           +   L  D  +R    +      L  HPF E
Sbjct: 263 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 293

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 77/248 (31%), Positives = 121/248 (48%), Gaps = 16/248 (6%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAK------STELPKSEFLQREQKFLSSLNSPH 56
           + R  T+G GS   V L     SG+ +A K        +L + E    E++ L ++N P 
Sbjct: 64  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 123
Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL 116
           +V     + + +DN  +Y + MEY  GG +   + R G R  E     Y  QI+   EYL
Sbjct: 124 LVK---LEFSFKDNSNLY-MVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYL 178
Query: 117 HSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG-GTPMFMAPEVARGEHQGF 174
           HS  +++ D+K  N+L+ + G  ++ DFG AK    A  +  GTP ++APE+   +    
Sbjct: 179 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGATWTLCGTPEYLAPEIILSKGYNK 238
Query: 175 ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLR 234
           A D WA+G  + EMA+G  P+  A  P+ +  KI   +     P+  S    D L N L+
Sbjct: 239 AVDWWALGVLIYEMAAGYPPF-FADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQ 295
Query: 235 RDPKERWA 242
            D  +R+ 
Sbjct: 296 VDLTKRFG 303

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 125/271 (46%), Gaps = 27/271 (9%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSLNSP 55
           D+  G  +G+GS +TV LA  L +   +A K  E        K  ++ RE+  +S L+ P
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
             V  K      +D KL + L   YA  G L   I R  G  DE+    YT +I+  LEY
Sbjct: 91  FFV--KLYFTFQDDEKLYFGL--SYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEY 145
Query: 116 LHSNRVVHCDIKSRNILMAES-GAKIADFGCAKW------ESEALQSGGTPMFMAPEVAR 168
           LH   ++H D+K  NIL+ E    +I DFG AK       ++ A    GT  +++PE+  
Sbjct: 146 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 205
Query: 169 GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDF 228
            +    +SD+WA+GC + ++ +G  P+    + +     I    + PE   F  K A D 
Sbjct: 206 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE--KFFPK-ARDL 262
Query: 229 LSNCLRRDPKERWAASQ------LLKHPFLE 253
           +   L  D  +R    +      L  HPF E
Sbjct: 263 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 293

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 125/271 (46%), Gaps = 27/271 (9%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSLNSP 55
           D+  G  +G+GS +TV LA  L +   +A K  E        K  ++ RE+  +S L+ P
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
             V  K      +D KL + L   YA  G L   I R  G  DE+    YT +I+  LEY
Sbjct: 93  FFV--KLYFTFQDDEKLYFGL--SYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEY 147
Query: 116 LHSNRVVHCDIKSRNILMAES-GAKIADFGCAKW------ESEALQSGGTPMFMAPEVAR 168
           LH   ++H D+K  NIL+ E    +I DFG AK       ++ A    GT  +++PE+  
Sbjct: 148 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 169 GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDF 228
            +    +SD+WA+GC + ++ +G  P+    + +     I    + PE   F  K A D 
Sbjct: 208 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPE--KFFPK-ARDL 264
Query: 229 LSNCLRRDPKERWAASQ------LLKHPFLE 253
           +   L  D  +R    +      L  HPF E
Sbjct: 265 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 295

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 82/263 (31%), Positives = 126/263 (47%), Gaps = 23/263 (8%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAK---STELPKSEF---LQREQKFLSSLNSP 55
           D+  G  +G+G    V LA   +S  + A K     +L K+     L+RE +  S L  P
Sbjct: 12  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 71
Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
           +I+   G      D   +Y L +EYAP GT+  E+ +   + DE    +Y  ++   L Y
Sbjct: 72  NILRLYG---YFHDATRVY-LILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSY 126
Query: 116 LHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG-----GTPMFMAPEVARG 169
            HS RV+H DIK  N+L+  +G  KIADFG   W   A  S      GT  ++ PE+  G
Sbjct: 127 CHSKRVIHRDIKPENLLLGSAGELKIADFG---WSVHAPSSRRAALCGTLDYLPPEMIEG 183
Query: 170 EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFL 229
                  D+W++G    E   G  P+   A+     YK   SR     P F+++ A D +
Sbjct: 184 RMHDEKVDLWSLGVLCYEFLVGKPPF--EANTYQETYK-RISRVEFTFPDFVTEGARDLI 240
Query: 230 SNCLRRDPKERWAASQLLKHPFL 252
           S  L+ +P +R    ++L+HP++
Sbjct: 241 SRLLKHNPSQRPMLREVLEHPWI 263

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 82/263 (31%), Positives = 126/263 (47%), Gaps = 23/263 (8%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAK---STELPKSEF---LQREQKFLSSLNSP 55
           D+  G  +G+G    V LA   +S  + A K     +L K+     L+RE +  S L  P
Sbjct: 12  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 71
Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
           +I+   G      D   +Y L +EYAP GT+  E+ +   + DE    +Y  ++   L Y
Sbjct: 72  NILRLYGY---FHDATRVY-LILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSY 126
Query: 116 LHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG-----GTPMFMAPEVARG 169
            HS RV+H DIK  N+L+  +G  KIADFG   W   A  S      GT  ++ PE+  G
Sbjct: 127 CHSKRVIHRDIKPENLLLGSAGELKIADFG---WSVHAPSSRRTTLCGTLDYLPPEMIEG 183
Query: 170 EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFL 229
                  D+W++G    E   G  P+   A+     YK   SR     P F+++ A D +
Sbjct: 184 RMHDEKVDLWSLGVLCYEFLVGKPPF--EANTYQETYK-RISRVEFTFPDFVTEGARDLI 240
Query: 230 SNCLRRDPKERWAASQLLKHPFL 252
           S  L+ +P +R    ++L+HP++
Sbjct: 241 SRLLKHNPSQRPMLREVLEHPWI 263

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 82/263 (31%), Positives = 125/263 (47%), Gaps = 23/263 (8%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAK---STELPKSEF---LQREQKFLSSLNSP 55
           D+  G  +G+G    V LA   +S  + A K     +L K+     L+RE +  S L  P
Sbjct: 14  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 73
Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
           +I+   G      D   +Y L +EYAP GT+  E+ +   + DE    +Y  ++   L Y
Sbjct: 74  NILRLYG---YFHDATRVY-LILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSY 128
Query: 116 LHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSG-----GTPMFMAPEVARG 169
            HS RV+H DIK  N+L+  +G  KIADFG   W   A  S      GT  ++ PE   G
Sbjct: 129 CHSKRVIHRDIKPENLLLGSAGELKIADFG---WSVHAPSSRRTTLCGTLDYLPPEXIEG 185
Query: 170 EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFL 229
                  D+W++G    E   G  P+   A+     YK   SR     P F+++ A D +
Sbjct: 186 RXHDEKVDLWSLGVLCYEFLVGKPPF--EANTYQETYK-RISRVEFTFPDFVTEGARDLI 242
Query: 230 SNCLRRDPKERWAASQLLKHPFL 252
           S  L+ +P +R    ++L+HP++
Sbjct: 243 SRLLKHNPSQRPXLREVLEHPWI 265

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 82/263 (31%), Positives = 126/263 (47%), Gaps = 23/263 (8%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAK---STELPKSEF---LQREQKFLSSLNSP 55
           D+  G  +G+G    V LA   +S  + A K     +L K+     L+RE +  S L  P
Sbjct: 8   DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 67
Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
           +I+   G      D   +Y L +EYAP GT+  E+ +   + DE    +Y  ++   L Y
Sbjct: 68  NILRLYGY---FHDATRVY-LILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSY 122
Query: 116 LHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG-----GTPMFMAPEVARG 169
            HS RV+H DIK  N+L+  +G  KIADFG   W   A  S      GT  ++ PE+  G
Sbjct: 123 CHSKRVIHRDIKPENLLLGSAGELKIADFG---WSVHAPSSRRTTLCGTLDYLPPEMIEG 179
Query: 170 EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFL 229
                  D+W++G    E   G  P+   A+     YK   SR     P F+++ A D +
Sbjct: 180 RMHDEKVDLWSLGVLCYEFLVGKPPF--EANTYQETYK-RISRVEFTFPDFVTEGARDLI 236
Query: 230 SNCLRRDPKERWAASQLLKHPFL 252
           S  L+ +P +R    ++L+HP++
Sbjct: 237 SRLLKHNPSQRPMLREVLEHPWI 259

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 125/271 (46%), Gaps = 27/271 (9%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSLNSP 55
           D+  G  +G+GS +TV LA  L +   +A K  E        K  ++ RE+  +S L+ P
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
             V  K      +D KL + L   YA  G L   I R  G  DE+    YT +I+  LEY
Sbjct: 91  FFV--KLYFTFQDDEKLYFGL--SYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEY 145
Query: 116 LHSNRVVHCDIKSRNILMAES-GAKIADFGCAKW------ESEALQSGGTPMFMAPEVAR 168
           LH   ++H D+K  NIL+ E    +I DFG AK       ++ A    GT  +++PE+  
Sbjct: 146 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLT 205
Query: 169 GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDF 228
            +    +SD+WA+GC + ++ +G  P+    + +     I    + PE   F  K A D 
Sbjct: 206 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE--KFFPK-ARDL 262
Query: 229 LSNCLRRDPKERWAASQ------LLKHPFLE 253
           +   L  D  +R    +      L  HPF E
Sbjct: 263 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 293

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 82/263 (31%), Positives = 126/263 (47%), Gaps = 23/263 (8%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAK---STELPKSEF---LQREQKFLSSLNSP 55
           D+  G  +G+G    V LA   +S  + A K     +L K+     L+RE +  S L  P
Sbjct: 12  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 71
Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
           +I+   G      D   +Y L +EYAP GT+  E+ +   + DE    +Y  ++   L Y
Sbjct: 72  NILRLYGY---FHDATRVY-LILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSY 126
Query: 116 LHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG-----GTPMFMAPEVARG 169
            HS RV+H DIK  N+L+  +G  KIADFG   W   A  S      GT  ++ PE+  G
Sbjct: 127 CHSKRVIHRDIKPENLLLGSAGELKIADFG---WSVHAPSSRRXXLCGTLDYLPPEMIEG 183
Query: 170 EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFL 229
                  D+W++G    E   G  P+   A+     YK   SR     P F+++ A D +
Sbjct: 184 RMHDEKVDLWSLGVLCYEFLVGKPPF--EANTYQETYK-RISRVEFTFPDFVTEGARDLI 240
Query: 230 SNCLRRDPKERWAASQLLKHPFL 252
           S  L+ +P +R    ++L+HP++
Sbjct: 241 SRLLKHNPSQRPMLREVLEHPWI 263

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 125/271 (46%), Gaps = 27/271 (9%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSLNSP 55
           D+  G  +G+GS +TV LA  L +   +A K  E        K  ++ RE+  +S L+ P
Sbjct: 34  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 93
Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
             V  K      +D KL + L   YA  G L   I R  G  DE+    YT +I+  LEY
Sbjct: 94  FFV--KLYFTFQDDEKLYFGL--SYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEY 148
Query: 116 LHSNRVVHCDIKSRNILMAES-GAKIADFGCAKW------ESEALQSGGTPMFMAPEVAR 168
           LH   ++H D+K  NIL+ E    +I DFG AK       ++ A    GT  +++PE+  
Sbjct: 149 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 208
Query: 169 GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDF 228
            +    +SD+WA+GC + ++ +G  P+    + +     I    + PE   F  K A D 
Sbjct: 209 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE--KFFPK-ARDL 265
Query: 229 LSNCLRRDPKERWAASQ------LLKHPFLE 253
           +   L  D  +R    +      L  HPF E
Sbjct: 266 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 296

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 125/271 (46%), Gaps = 27/271 (9%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSLNSP 55
           D+  G  +G+GS +TV LA  L +   +A K  E        K  ++ RE+  +S L+ P
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
             V  K      +D KL + L   YA  G L   I R  G  DE+    YT +I+  LEY
Sbjct: 93  FFV--KLYFTFQDDEKLYFGL--SYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEY 147
Query: 116 LHSNRVVHCDIKSRNILMAES-GAKIADFGCAKW------ESEALQSGGTPMFMAPEVAR 168
           LH   ++H D+K  NIL+ E    +I DFG AK       ++ A    GT  +++PE+  
Sbjct: 148 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 169 GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDF 228
            +    +SD+WA+GC + ++ +G  P+    + +     I    + PE   F  K A D 
Sbjct: 208 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE--KFFPK-ARDL 264
Query: 229 LSNCLRRDPKERWAASQ------LLKHPFLE 253
           +   L  D  +R    +      L  HPF E
Sbjct: 265 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 295

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 82/263 (31%), Positives = 126/263 (47%), Gaps = 23/263 (8%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAK---STELPKSEF---LQREQKFLSSLNSP 55
           D+  G  +G+G    V LA   +S  + A K     +L K+     L+RE +  S L  P
Sbjct: 9   DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 68
Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
           +I+   G      D   +Y L +EYAP GT+  E+ +   + DE    +Y  ++   L Y
Sbjct: 69  NILRLYGY---FHDATRVY-LILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSY 123
Query: 116 LHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG-----GTPMFMAPEVARG 169
            HS RV+H DIK  N+L+  +G  KIADFG   W   A  S      GT  ++ PE+  G
Sbjct: 124 CHSKRVIHRDIKPENLLLGSAGELKIADFG---WSVHAPSSRRTXLCGTLDYLPPEMIEG 180
Query: 170 EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFL 229
                  D+W++G    E   G  P+   A+     YK   SR     P F+++ A D +
Sbjct: 181 RMHDEKVDLWSLGVLCYEFLVGKPPF--EANTYQETYK-RISRVEFTFPDFVTEGARDLI 237
Query: 230 SNCLRRDPKERWAASQLLKHPFL 252
           S  L+ +P +R    ++L+HP++
Sbjct: 238 SRLLKHNPSQRPMLREVLEHPWI 260

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 82/263 (31%), Positives = 126/263 (47%), Gaps = 23/263 (8%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAK---STELPKSEF---LQREQKFLSSLNSP 55
           D+  G  +G+G    V LA   +S  + A K     +L K+     L+RE +  S L  P
Sbjct: 9   DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 68
Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
           +I+   G      D   +Y L +EYAP GT+  E+ +   + DE    +Y  ++   L Y
Sbjct: 69  NILRLYGY---FHDATRVY-LILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSY 123
Query: 116 LHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG-----GTPMFMAPEVARG 169
            HS RV+H DIK  N+L+  +G  KIADFG   W   A  S      GT  ++ PE+  G
Sbjct: 124 CHSKRVIHRDIKPENLLLGSAGELKIADFG---WSVHAPSSRRXXLCGTLDYLPPEMIEG 180
Query: 170 EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFL 229
                  D+W++G    E   G  P+   A+     YK   SR     P F+++ A D +
Sbjct: 181 RMHDEKVDLWSLGVLCYEFLVGKPPF--EANTYQETYK-RISRVEFTFPDFVTEGARDLI 237
Query: 230 SNCLRRDPKERWAASQLLKHPFL 252
           S  L+ +P +R    ++L+HP++
Sbjct: 238 SRLLKHNPSQRPMLREVLEHPWI 260

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 76/248 (30%), Positives = 120/248 (48%), Gaps = 16/248 (6%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAK------STELPKSEFLQREQKFLSSLNSPH 56
           + R  T+G GS   V L     SG+ +A K        +L + E    E++ L ++N P 
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL 116
           +V     + + +DN  +Y + MEY  GG +   + R G R  E     Y  QI+   EYL
Sbjct: 103 LVK---LEFSFKDNSNLY-MVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYL 157
Query: 117 HSNRVVHCDIKSRNILMAESG-AKIADFGCAK-WESEALQSGGTPMFMAPEVARGEHQGF 174
           HS  +++ D+K  N+L+ + G  ++ DFG AK  +       GTP ++APE+   +    
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 175 ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLR 234
           A D WA+G  + EMA+G  P+  A  P+ +  KI   +     P+  S    D L N L+
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF-FADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQ 274
Query: 235 RDPKERWA 242
            D  +R+ 
Sbjct: 275 VDLTKRFG 282

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 125/271 (46%), Gaps = 27/271 (9%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSLNSP 55
           D+  G  +G+GS +TV LA  L +   +A K  E        K  ++ RE+  +S L+ P
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
             V  K      +D KL + L   YA  G L   I R  G  DE+    YT +I+  LEY
Sbjct: 93  FFV--KLYFTFQDDEKLYFGL--SYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEY 147
Query: 116 LHSNRVVHCDIKSRNILMAES-GAKIADFGCAKW------ESEALQSGGTPMFMAPEVAR 168
           LH   ++H D+K  NIL+ E    +I DFG AK       ++ A    GT  +++PE+  
Sbjct: 148 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 169 GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDF 228
            +    +SD+WA+GC + ++ +G  P+    + +     I    + PE   F  K A D 
Sbjct: 208 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE--KFFPK-ARDL 264
Query: 229 LSNCLRRDPKERWAASQ------LLKHPFLE 253
           +   L  D  +R    +      L  HPF E
Sbjct: 265 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 295

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 76/248 (30%), Positives = 120/248 (48%), Gaps = 16/248 (6%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAK------STELPKSEFLQREQKFLSSLNSPH 56
           + R  T+G GS   V L     SG+ +A K        +L + E    E++ L ++N P 
Sbjct: 38  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 97
Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL 116
           +V     + + +DN  +Y + MEY  GG +   + R G R  E     Y  QI+   EYL
Sbjct: 98  LVK---LEFSFKDNSNLY-MVMEYVAGGEMFSHLRRIG-RFXEPHARFYAAQIVLTFEYL 152
Query: 117 HSNRVVHCDIKSRNILMAESG-AKIADFGCAK-WESEALQSGGTPMFMAPEVARGEHQGF 174
           HS  +++ D+K  N+L+ + G  ++ DFG AK  +       GTP ++APE+   +    
Sbjct: 153 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNK 212
Query: 175 ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLR 234
           A D WA+G  + EMA+G  P+  A  P+ +  KI   +     P+  S    D L N L+
Sbjct: 213 AVDWWALGVLIYEMAAGYPPF-FADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQ 269
Query: 235 RDPKERWA 242
            D  +R+ 
Sbjct: 270 VDLTKRFG 277

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 82/263 (31%), Positives = 126/263 (47%), Gaps = 23/263 (8%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAK---STELPKSEF---LQREQKFLSSLNSP 55
           D+  G  +G+G    V LA   +S  + A K     +L K+     L+RE +  S L  P
Sbjct: 9   DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 68
Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
           +I+   G      D   +Y L +EYAP GT+  E+ +   + DE    +Y  ++   L Y
Sbjct: 69  NILRLYGY---FHDATRVY-LILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSY 123
Query: 116 LHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG-----GTPMFMAPEVARG 169
            HS RV+H DIK  N+L+  +G  KIADFG   W   A  S      GT  ++ PE+  G
Sbjct: 124 CHSKRVIHRDIKPENLLLGSAGELKIADFG---WSVHAPSSRRAALCGTLDYLPPEMIEG 180
Query: 170 EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFL 229
                  D+W++G    E   G  P+   A+     YK   SR     P F+++ A D +
Sbjct: 181 RMHDEKVDLWSLGVLCYEFLVGKPPF--EANTYQETYK-RISRVEFTFPDFVTEGARDLI 237
Query: 230 SNCLRRDPKERWAASQLLKHPFL 252
           S  L+ +P +R    ++L+HP++
Sbjct: 238 SRLLKHNPSQRPMLREVLEHPWI 260

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 125/271 (46%), Gaps = 27/271 (9%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSLNSP 55
           D+  G  +G+GS +TV LA  L +   +A K  E        K  ++ RE+  +S L+ P
Sbjct: 34  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 93
Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
             V  K      +D KL + L   YA  G L   I R  G  DE+    YT +I+  LEY
Sbjct: 94  FFV--KLYFTFQDDEKLYFGL--SYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEY 148
Query: 116 LHSNRVVHCDIKSRNILMAES-GAKIADFGCAKW------ESEALQSGGTPMFMAPEVAR 168
           LH   ++H D+K  NIL+ E    +I DFG AK       ++ A    GT  +++PE+  
Sbjct: 149 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 208
Query: 169 GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDF 228
            +    +SD+WA+GC + ++ +G  P+    + +     I    + PE   F  K A D 
Sbjct: 209 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE--KFFPK-ARDL 265
Query: 229 LSNCLRRDPKERWAASQ------LLKHPFLE 253
           +   L  D  +R    +      L  HPF E
Sbjct: 266 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 296

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 79/283 (27%), Positives = 137/283 (48%), Gaps = 22/283 (7%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-----SEFLQREQKFLSSLNSPHI 57
           + R   IG+GS     L  S   G  +  K   + +      E  +RE   L+++  P+I
Sbjct: 26  YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNI 85
Query: 58  VGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRL-DESLIVSYTRQILQGLEYL 116
           V Y+    + E+N  +Y + M+Y  GG L   I+   G L  E  I+ +  QI   L+++
Sbjct: 86  VQYRE---SFEENGSLY-IVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHV 141
Query: 117 HSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG----GTPMFMAPEVARGEH 171
           H  +++H DIKS+NI + + G  ++ DFG A+  +  ++      GTP +++PE+   + 
Sbjct: 142 HDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKP 201
Query: 172 QGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSN 231
               SDIWA+GC + E+ +    +   +    VL  I+ S   P V    S      +S 
Sbjct: 202 YNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGS--FPPVSLHYSYDLRSLVSQ 259
Query: 232 CLRRDPKERWAASQLLKHPF----LEEFCSCTKQIQESNCSPT 270
             +R+P++R + + +L+  F    +E+F S  + I E  C  T
Sbjct: 260 LFKRNPRDRPSVNSILEKGFIAKRIEKFLS-PQLIAEEFCLKT 301

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 82/263 (31%), Positives = 126/263 (47%), Gaps = 23/263 (8%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAK---STELPKSEF---LQREQKFLSSLNSP 55
           D+  G  +G+G    V LA   +S  + A K     +L K+     L+RE +  S L  P
Sbjct: 13  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 72
Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
           +I+   G      D   +Y L +EYAP GT+  E+ +   + DE    +Y  ++   L Y
Sbjct: 73  NILRLYGY---FHDATRVY-LILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSY 127
Query: 116 LHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG-----GTPMFMAPEVARG 169
            HS RV+H DIK  N+L+  +G  KIADFG   W   A  S      GT  ++ PE+  G
Sbjct: 128 CHSKRVIHRDIKPENLLLGSAGELKIADFG---WSVHAPSSRRTTLCGTLDYLPPEMIEG 184
Query: 170 EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFL 229
                  D+W++G    E   G  P+   A+     YK   SR     P F+++ A D +
Sbjct: 185 RMHDEKVDLWSLGVLCYEFLVGKPPF--EANTYQETYK-RISRVEFTFPDFVTEGARDLI 241
Query: 230 SNCLRRDPKERWAASQLLKHPFL 252
           S  L+ +P +R    ++L+HP++
Sbjct: 242 SRLLKHNPSQRPMLREVLEHPWI 264

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 79/277 (28%), Positives = 130/277 (46%), Gaps = 16/277 (5%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPK---SEFLQREQKFLSSLNSPHIVGYKGCDV 65
           +G G+   V   T   +G+ FAAK    P     E +++E + +S L  P +V     D 
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLH--DA 222
Query: 66  TSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCD 125
             +DN+++  +  E+  GG L +++     ++ E   V Y RQ+ +GL ++H N  VH D
Sbjct: 223 FEDDNEMV--MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLD 280
Query: 126 IKSRNILMAESGA---KIADFGCAKW---ESEALQSGGTPMFMAPEVARGEHQGFASDIW 179
           +K  NI+     +   K+ DFG       +     + GT  F APEVA G+  G+ +D+W
Sbjct: 281 LKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMW 340
Query: 180 AVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAF--LSKQANDFLSNCLRRDP 237
           +VG     + SG +P+    D  T+    +    + +  AF  +S+   DF+   L  DP
Sbjct: 341 SVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDS-AFSGISEDGKDFIRKLLLADP 399
Query: 238 KERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSILD 274
             R    Q L+HP+L    +  +  Q  +   T I D
Sbjct: 400 NTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRD 436

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 79/277 (28%), Positives = 130/277 (46%), Gaps = 16/277 (5%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPK---SEFLQREQKFLSSLNSPHIVGYKGCDV 65
           +G G+   V   T   +G+ FAAK    P     E +++E + +S L  P +V     D 
Sbjct: 59  LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLH--DA 116
Query: 66  TSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCD 125
             +DN+++  +  E+  GG L +++     ++ E   V Y RQ+ +GL ++H N  VH D
Sbjct: 117 FEDDNEMV--MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLD 174
Query: 126 IKSRNILMAESGA---KIADFGCAKW---ESEALQSGGTPMFMAPEVARGEHQGFASDIW 179
           +K  NI+     +   K+ DFG       +     + GT  F APEVA G+  G+ +D+W
Sbjct: 175 LKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMW 234
Query: 180 AVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAF--LSKQANDFLSNCLRRDP 237
           +VG     + SG +P+    D  T+    +    + +  AF  +S+   DF+   L  DP
Sbjct: 235 SVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDS-AFSGISEDGKDFIRKLLLADP 293
Query: 238 KERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSILD 274
             R    Q L+HP+L    +  +  Q  +   T I D
Sbjct: 294 NTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRD 330

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 82/263 (31%), Positives = 126/263 (47%), Gaps = 23/263 (8%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAK---STELPKSEF---LQREQKFLSSLNSP 55
           D+  G  +G+G    V LA   +S  + A K     +L K+     L+RE +  S L  P
Sbjct: 12  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 71
Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
           +I+   G      D   +Y L +EYAP GT+  E+ +   + DE    +Y  ++   L Y
Sbjct: 72  NILRLYGY---FHDATRVY-LILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSY 126
Query: 116 LHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG-----GTPMFMAPEVARG 169
            HS RV+H DIK  N+L+  +G  KIADFG   W   A  S      GT  ++ PE+  G
Sbjct: 127 CHSKRVIHRDIKPENLLLGSAGELKIADFG---WSVHAPSSRRDDLCGTLDYLPPEMIEG 183
Query: 170 EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFL 229
                  D+W++G    E   G  P+   A+     YK   SR     P F+++ A D +
Sbjct: 184 RMHDEKVDLWSLGVLCYEFLVGKPPF--EANTYQETYK-RISRVEFTFPDFVTEGARDLI 240
Query: 230 SNCLRRDPKERWAASQLLKHPFL 252
           S  L+ +P +R    ++L+HP++
Sbjct: 241 SRLLKHNPSQRPMLREVLEHPWI 263

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 76/248 (30%), Positives = 120/248 (48%), Gaps = 16/248 (6%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAK------STELPKSEFLQREQKFLSSLNSPH 56
           + R  T+G GS   V L     SG+ +A K        +L + E    E++ L ++N P 
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL 116
           +V     + + +DN  +Y + MEY  GG +   + R G R  E     Y  QI+   EYL
Sbjct: 103 LVK---LEFSFKDNSNLY-MVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYL 157
Query: 117 HSNRVVHCDIKSRNILMAESG-AKIADFGCAK-WESEALQSGGTPMFMAPEVARGEHQGF 174
           HS  +++ D+K  N+L+ + G  ++ DFG AK  +       GTP ++APE+   +    
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 175 ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLR 234
           A D WA+G  + EMA+G  P+  A  P+ +  KI   +     P+  S    D L N L+
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF-FADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQ 274
Query: 235 RDPKERWA 242
            D  +R+ 
Sbjct: 275 VDLTKRFG 282

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 76/248 (30%), Positives = 120/248 (48%), Gaps = 16/248 (6%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAK------STELPKSEFLQREQKFLSSLNSPH 56
           + R  T+G GS   V L     SG+ +A K        +L + E    E++ L ++N P 
Sbjct: 44  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL 116
           +V     + + +DN  +Y + MEY  GG +   + R G R  E     Y  QI+   EYL
Sbjct: 104 LVK---LEFSFKDNSNLY-MVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYL 158
Query: 117 HSNRVVHCDIKSRNILMAESG-AKIADFGCAK-WESEALQSGGTPMFMAPEVARGEHQGF 174
           HS  +++ D+K  N+L+ + G  ++ DFG AK  +       GTP ++APE+   +    
Sbjct: 159 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNK 218
Query: 175 ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLR 234
           A D WA+G  + EMA+G  P+  A  P+ +  KI   +     P+  S    D L N L+
Sbjct: 219 AVDWWALGVLIYEMAAGYPPF-FADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQ 275
Query: 235 RDPKERWA 242
            D  +R+ 
Sbjct: 276 VDLTKRFG 283

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 76/248 (30%), Positives = 120/248 (48%), Gaps = 16/248 (6%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAK------STELPKSEFLQREQKFLSSLNSPH 56
           + R  T+G GS   V L     SG+ +A K        +L + E    E++ L ++N P 
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL 116
           +V     + + +DN  +Y + MEY  GG +   + R G R  E     Y  QI+   EYL
Sbjct: 103 LVK---LEFSFKDNSNLY-MVMEYVAGGEMFSHLRRIG-RFXEPHARFYAAQIVLTFEYL 157
Query: 117 HSNRVVHCDIKSRNILMAESG-AKIADFGCAK-WESEALQSGGTPMFMAPEVARGEHQGF 174
           HS  +++ D+K  N+L+ + G  ++ DFG AK  +       GTP ++APE+   +    
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 175 ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLR 234
           A D WA+G  + EMA+G  P+  A  P+ +  KI   +     P+  S    D L N L+
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF-FADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQ 274
Query: 235 RDPKERWA 242
            D  +R+ 
Sbjct: 275 VDLTKRFG 282

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 76/248 (30%), Positives = 120/248 (48%), Gaps = 16/248 (6%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAK------STELPKSEFLQREQKFLSSLNSPH 56
           + R  T+G GS   V L     SG+ +A K        +L + E    E++ L ++N P 
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL 116
           +V     + + +DN  +Y + MEY  GG +   + R G R  E     Y  QI+   EYL
Sbjct: 103 LVK---LEFSFKDNSNLY-MVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYL 157
Query: 117 HSNRVVHCDIKSRNILMAESG-AKIADFGCAK-WESEALQSGGTPMFMAPEVARGEHQGF 174
           HS  +++ D+K  N+L+ + G  ++ DFG AK  +       GTP ++APE+   +    
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 175 ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLR 234
           A D WA+G  + EMA+G  P+  A  P+ +  KI   +     P+  S    D L N L+
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF-FADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQ 274
Query: 235 RDPKERWA 242
            D  +R+ 
Sbjct: 275 VDLTKRFG 282

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 82/264 (31%), Positives = 127/264 (48%), Gaps = 23/264 (8%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAK---STELPKSEF---LQREQKFLSSLNSP 55
           D+  G  +G+G    V LA   +S  + A K    T+L K+     L+RE +  S L  P
Sbjct: 13  DFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHP 72
Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
           +I+   G      D   +Y L +EYAP GT+  E+ +   R DE    +Y  ++   L Y
Sbjct: 73  NILRLYGY---FHDATRVY-LILEYAPLGTVYRELQKLS-RFDEQRTATYITELANALSY 127
Query: 116 LHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG-----GTPMFMAPEVARG 169
            HS RV+H DIK  N+L+  +G  KIADFG   W   A  S      GT  ++ PE+  G
Sbjct: 128 CHSKRVIHRDIKPENLLLGSNGELKIADFG---WSVHAPSSRRTTLCGTLDYLPPEMIEG 184
Query: 170 EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFL 229
                  D+W++G    E   G  P+   A      Y+   SR     P F+++ A D +
Sbjct: 185 RMHDEKVDLWSLGVLCYEFLVGMPPF--EAHTYQETYR-RISRVEFTFPDFVTEGARDLI 241
Query: 230 SNCLRRDPKERWAASQLLKHPFLE 253
           S  L+ +  +R   +++L+HP+++
Sbjct: 242 SRLLKHNASQRLTLAEVLEHPWIK 265

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 82/264 (31%), Positives = 127/264 (48%), Gaps = 23/264 (8%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAK---STELPKSEF---LQREQKFLSSLNSP 55
           D+  G  +G+G    V LA   +S  + A K    T+L K+     L+RE +  S L  P
Sbjct: 13  DFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHP 72
Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
           +I+   G      D   +Y L +EYAP GT+  E+ +   R DE    +Y  ++   L Y
Sbjct: 73  NILRLYGY---FHDATRVY-LILEYAPLGTVYRELQKLS-RFDEQRTATYITELANALSY 127
Query: 116 LHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG-----GTPMFMAPEVARG 169
            HS RV+H DIK  N+L+  +G  KIADFG   W   A  S      GT  ++ PE+  G
Sbjct: 128 CHSKRVIHRDIKPENLLLGSNGELKIADFG---WSVHAPSSRRDTLCGTLDYLPPEMIEG 184
Query: 170 EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFL 229
                  D+W++G    E   G  P+   A      Y+   SR     P F+++ A D +
Sbjct: 185 RMHDEKVDLWSLGVLCYEFLVGMPPF--EAHTYQETYR-RISRVEFTFPDFVTEGARDLI 241
Query: 230 SNCLRRDPKERWAASQLLKHPFLE 253
           S  L+ +  +R   +++L+HP+++
Sbjct: 242 SRLLKHNASQRLTLAEVLEHPWIK 265

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 76/248 (30%), Positives = 120/248 (48%), Gaps = 16/248 (6%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAK------STELPKSEFLQREQKFLSSLNSPH 56
           + R  T+G GS   V L     SG+ +A K        +L + E    E++ L ++N P 
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL 116
           +V     + + +DN  +Y + MEY  GG +   + R G R  E     Y  QI+   EYL
Sbjct: 103 LVK---LEFSFKDNSNLY-MVMEYVAGGEMFSHLRRIG-RFXEPHARFYAAQIVLTFEYL 157
Query: 117 HSNRVVHCDIKSRNILMAESG-AKIADFGCAK-WESEALQSGGTPMFMAPEVARGEHQGF 174
           HS  +++ D+K  N+L+ + G  ++ DFG AK  +       GTP ++APE+   +    
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 175 ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLR 234
           A D WA+G  + EMA+G  P+  A  P+ +  KI   +     P+  S    D L N L+
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF-FADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQ 274
Query: 235 RDPKERWA 242
            D  +R+ 
Sbjct: 275 VDLTKRFG 282

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 76/248 (30%), Positives = 120/248 (48%), Gaps = 16/248 (6%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAK------STELPKSEFLQREQKFLSSLNSPH 56
           + R  T+G GS   V L     SG+ +A K        +L + E    E++ L ++N P 
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL 116
           +V     + + +DN  +Y + MEY  GG +   + R G R  E     Y  QI+   EYL
Sbjct: 103 LVK---LEFSFKDNSNLY-MVMEYVAGGEMFSHLRRIG-RFXEPHARFYAAQIVLTFEYL 157
Query: 117 HSNRVVHCDIKSRNILMAESG-AKIADFGCAK-WESEALQSGGTPMFMAPEVARGEHQGF 174
           HS  +++ D+K  N+L+ + G  ++ DFG AK  +       GTP ++APE+   +    
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 175 ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLR 234
           A D WA+G  + EMA+G  P+  A  P+ +  KI   +     P+  S    D L N L+
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF-FADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQ 274
Query: 235 RDPKERWA 242
            D  +R+ 
Sbjct: 275 VDLTKRFG 282

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 76/248 (30%), Positives = 120/248 (48%), Gaps = 16/248 (6%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAK------STELPKSEFLQREQKFLSSLNSPH 56
           + R  T+G GS   V L     SG+ +A K        +L + E    E++ L ++N P 
Sbjct: 64  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 123
Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL 116
           +V     + + +DN  +Y + MEY  GG +   + R G R  E     Y  QI+   EYL
Sbjct: 124 LVK---LEFSFKDNSNLY-MVMEYVAGGEMFSHLRRIG-RFXEPHARFYAAQIVLTFEYL 178
Query: 117 HSNRVVHCDIKSRNILMAESG-AKIADFGCAK-WESEALQSGGTPMFMAPEVARGEHQGF 174
           HS  +++ D+K  N+L+ + G  ++ DFG AK  +       GTP ++APE+   +    
Sbjct: 179 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNK 238
Query: 175 ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLR 234
           A D WA+G  + EMA+G  P+  A  P+ +  KI   +     P+  S    D L N L+
Sbjct: 239 AVDWWALGVLIYEMAAGYPPF-FADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQ 295
Query: 235 RDPKERWA 242
            D  +R+ 
Sbjct: 296 VDLTKRFG 303

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 76/248 (30%), Positives = 120/248 (48%), Gaps = 16/248 (6%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAK------STELPKSEFLQREQKFLSSLNSPH 56
           + R  T+G GS   V L     SG+ +A K        +L + E    E++ L ++N P 
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL 116
           +V     + + +DN  +Y + MEY  GG +   + R G R  E     Y  QI+   EYL
Sbjct: 103 LVK---LEFSFKDNSNLY-MVMEYVAGGEMFSHLRRIG-RFAEPHARFYAAQIVLTFEYL 157
Query: 117 HSNRVVHCDIKSRNILMAESG-AKIADFGCAK-WESEALQSGGTPMFMAPEVARGEHQGF 174
           HS  +++ D+K  N+L+ + G  ++ DFG AK  +       GTP ++APE+   +    
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 175 ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLR 234
           A D WA+G  + EMA+G  P+  A  P+ +  KI   +     P+  S    D L N L+
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF-FADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQ 274
Query: 235 RDPKERWA 242
            D  +R+ 
Sbjct: 275 VDLTKRFG 282

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 81/263 (30%), Positives = 125/263 (47%), Gaps = 23/263 (8%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAK---STELPKSEF---LQREQKFLSSLNSP 55
           D+  G  +G+G    V LA   +S  + A K     +L K+     L+RE +  S L  P
Sbjct: 14  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 73
Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
           +I+   G      D   +Y L +EYAP G +  E+ +   + DE    +Y  ++   L Y
Sbjct: 74  NILRLYGY---FHDATRVY-LILEYAPRGEVYKELQKLS-KFDEQRTATYITELANALSY 128
Query: 116 LHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQS-----GGTPMFMAPEVARG 169
            HS RV+H DIK  N+L+  +G  KIADFG   W   A  S      GT  ++ PE+  G
Sbjct: 129 CHSKRVIHRDIKPENLLLGSAGELKIADFG---WSVHAPSSRRXXLXGTLDYLPPEMIEG 185
Query: 170 EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFL 229
                  D+W++G    E   G  P+   A+     YK   SR     P F+++ A D +
Sbjct: 186 RMHDEKVDLWSLGVLCYEFLVGKPPF--EANTYQETYK-RISRVEFTFPDFVTEGARDLI 242
Query: 230 SNCLRRDPKERWAASQLLKHPFL 252
           S  L+ +P +R    ++L+HP++
Sbjct: 243 SRLLKHNPSQRPMLREVLEHPWI 265

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  105 bits (261), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 81/263 (30%), Positives = 125/263 (47%), Gaps = 23/263 (8%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAK---STELPKSEF---LQREQKFLSSLNSP 55
           D+  G  +G+G    V LA   +S  + A K     +L K+     L+RE +  S L  P
Sbjct: 14  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 73
Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
           +I+   G      D   +Y L +EYAP G +  E+ +   + DE    +Y  ++   L Y
Sbjct: 74  NILRLYG---YFHDATRVY-LILEYAPRGEVYKELQKLS-KFDEQRTATYITELANALSY 128
Query: 116 LHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSG-----GTPMFMAPEVARG 169
            HS RV+H DIK  N+L+  +G  KIADFG   W   A  S      GT  ++ PE+  G
Sbjct: 129 CHSKRVIHRDIKPENLLLGSAGELKIADFG---WSVHAPSSRRTTLCGTLDYLPPEMIEG 185
Query: 170 EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFL 229
                  D+W++G    E   G  P+   A+     YK   SR     P F+++ A D +
Sbjct: 186 RMHDEKVDLWSLGVLCYEFLVGKPPF--EANTYQETYK-RISRVEFTFPDFVTEGARDLI 242
Query: 230 SNCLRRDPKERWAASQLLKHPFL 252
           S  L+ +P +R    ++L+HP++
Sbjct: 243 SRLLKHNPSQRPMLREVLEHPWI 265

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  104 bits (260), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 81/263 (30%), Positives = 126/263 (47%), Gaps = 23/263 (8%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAK---STELPKSEF---LQREQKFLSSLNSP 55
           D+  G  +G+G    V LA   +S  + A K     +L K+     L+RE +  S L  P
Sbjct: 11  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 70
Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
           +I+   G      D   +Y L +EYAP GT+  E+ +   + DE    +Y  ++   L Y
Sbjct: 71  NILRLYG---YFHDATRVY-LILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSY 125
Query: 116 LHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSG-----GTPMFMAPEVARG 169
            HS RV+H DIK  N+L+  +G  KIA+FG   W   A  S      GT  ++ PE+  G
Sbjct: 126 CHSKRVIHRDIKPENLLLGSAGELKIANFG---WSVHAPSSRRTTLCGTLDYLPPEMIEG 182
Query: 170 EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFL 229
                  D+W++G    E   G  P+   A+     YK   SR     P F+++ A D +
Sbjct: 183 RMHDEKVDLWSLGVLCYEFLVGKPPF--EANTYQETYK-RISRVEFTFPDFVTEGARDLI 239
Query: 230 SNCLRRDPKERWAASQLLKHPFL 252
           S  L+ +P +R    ++L+HP++
Sbjct: 240 SRLLKHNPSQRPMLREVLEHPWI 262

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score =  104 bits (259), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 81/266 (30%), Positives = 123/266 (46%), Gaps = 23/266 (8%)
Query: 8   TIGQGSSATVSLATSLRSGDVFAAKSTELPK--------SEFLQREQKFLSSLNSPHIVG 59
            IG+G  + V    +  +G  FA K  ++ K        +E L+RE      L  PHIV 
Sbjct: 31  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV- 89
Query: 60  YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRN---GGRLDESLIVSYTRQILQGLEYL 116
            +  +  S D  ++Y +F E+  G  L  EI +    G    E++   Y RQIL+ L Y 
Sbjct: 90  -ELLETYSSDG-MLYMVF-EFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYC 146
Query: 117 HSNRVVHCDIKSRNILMA----ESGAKIADFGCAKWESEA-LQSG---GTPMFMAPEVAR 168
           H N ++H D+K   +L+A     +  K+  FG A    E+ L +G   GTP FMAPEV +
Sbjct: 147 HDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVK 206
Query: 169 GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDF 228
            E  G   D+W  G  +  + SG  P+    + +         +  P   + +S+ A D 
Sbjct: 207 REPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQWSHISESAKDL 266
Query: 229 LSNCLRRDPKERWAASQLLKHPFLEE 254
           +   L  DP ER    + L HP+L+E
Sbjct: 267 VRRMLMLDPAERITVYEALNHPWLKE 292

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score =  104 bits (259), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 75/248 (30%), Positives = 120/248 (48%), Gaps = 16/248 (6%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAK------STELPKSEFLQREQKFLSSLNSPH 56
           + R  T+G GS   V L     SG+ +A K        +L + E    E++ L ++N P 
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL 116
           +V     + + +DN  +Y + MEY  GG +   + R G R  E     Y  QI+   EYL
Sbjct: 103 LVK---LEFSFKDNSNLY-MVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYL 157
Query: 117 HSNRVVHCDIKSRNILMAESG-AKIADFGCAK-WESEALQSGGTPMFMAPEVARGEHQGF 174
           HS  +++ D+K  N+L+ + G  ++ DFG AK  +       GTP ++APE+   +    
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 175 ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLR 234
           A D WA+G  + +MA+G  P+  A  P+ +  KI   +     P+  S    D L N L+
Sbjct: 218 AVDWWALGVLIYQMAAGYPPF-FADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQ 274
Query: 235 RDPKERWA 242
            D  +R+ 
Sbjct: 275 VDLTKRFG 282

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 75/248 (30%), Positives = 120/248 (48%), Gaps = 16/248 (6%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAK------STELPKSEFLQREQKFLSSLNSPH 56
           + R  T+G GS   V L     SG+ +A K        +L + E    E++ L ++N P 
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL 116
           +V     + + +DN  +Y + MEY  GG +   + R G R  E     Y  QI+   EYL
Sbjct: 103 LVK---LEFSFKDNSNLY-MVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYL 157
Query: 117 HSNRVVHCDIKSRNILMAESG-AKIADFGCAK-WESEALQSGGTPMFMAPEVARGEHQGF 174
           HS  +++ D+K  N+++ + G  ++ DFG AK  +       GTP ++APE+   +    
Sbjct: 158 HSLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIIISKGYNK 217
Query: 175 ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLR 234
           A D WA+G  + EMA+G  P+  A  P+ +  KI   +     P+  S    D L N L+
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF-FADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQ 274
Query: 235 RDPKERWA 242
            D  +R+ 
Sbjct: 275 VDLTKRFG 282

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 81/263 (30%), Positives = 126/263 (47%), Gaps = 23/263 (8%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAK---STELPKSEF---LQREQKFLSSLNSP 55
           D+  G  +G+G    V LA    S  + A K     +L K+     L+RE +  S L  P
Sbjct: 9   DFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 68
Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
           +I+   G      D+  +Y L +EYAP GT+  E+ +   + DE    +Y  ++   L Y
Sbjct: 69  NILRLYGY---FHDSTRVY-LILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSY 123
Query: 116 LHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG-----GTPMFMAPEVARG 169
            HS +V+H DIK  N+L+  +G  KIADFG   W   A  S      GT  ++ PE+  G
Sbjct: 124 CHSKKVIHRDIKPENLLLGSAGELKIADFG---WSVHAPSSRRAALCGTLDYLPPEMIEG 180
Query: 170 EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFL 229
                  D+W++G    E   G  P+   A+     YK   SR     P F+++ A D +
Sbjct: 181 RMHDEKVDLWSLGVLCYEFLVGKPPF--EANTYQDTYK-RISRVEFTFPDFVTEGARDLI 237
Query: 230 SNCLRRDPKERWAASQLLKHPFL 252
           S  L+ +P +R    ++L+HP++
Sbjct: 238 SRLLKHNPSQRPMLREVLEHPWI 260

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 81/266 (30%), Positives = 123/266 (46%), Gaps = 23/266 (8%)
Query: 8   TIGQGSSATVSLATSLRSGDVFAAKSTELPK--------SEFLQREQKFLSSLNSPHIVG 59
            IG+G  + V    +  +G  FA K  ++ K        +E L+RE      L  PHIV 
Sbjct: 33  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV- 91
Query: 60  YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRN---GGRLDESLIVSYTRQILQGLEYL 116
            +  +  S D  ++Y +F E+  G  L  EI +    G    E++   Y RQIL+ L Y 
Sbjct: 92  -ELLETYSSDG-MLYMVF-EFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYC 148
Query: 117 HSNRVVHCDIKSRNILMA----ESGAKIADFGCAKWESEA-LQSG---GTPMFMAPEVAR 168
           H N ++H D+K   +L+A     +  K+  FG A    E+ L +G   GTP FMAPEV +
Sbjct: 149 HDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVK 208
Query: 169 GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDF 228
            E  G   D+W  G  +  + SG  P+    + +         +  P   + +S+ A D 
Sbjct: 209 REPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQWSHISESAKDL 268
Query: 229 LSNCLRRDPKERWAASQLLKHPFLEE 254
           +   L  DP ER    + L HP+L+E
Sbjct: 269 VRRMLMLDPAERITVYEALNHPWLKE 294

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 81/263 (30%), Positives = 126/263 (47%), Gaps = 23/263 (8%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAK---STELPKSEF---LQREQKFLSSLNSP 55
           D+  G  +G+G    V LA   +S  + A K     +L K+     L+RE +  S L  P
Sbjct: 12  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 71
Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
           +I+   G      D   +Y L +EYAP GT+  E+ +   + DE    +Y  ++   L Y
Sbjct: 72  NILRLYGY---FHDATRVY-LILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSY 126
Query: 116 LHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG-----GTPMFMAPEVARG 169
            HS RV+H DIK  N+L+  +G  KIA+FG   W   A  S      GT  ++ PE+  G
Sbjct: 127 CHSKRVIHRDIKPENLLLGSAGELKIANFG---WSVHAPSSRRTTLCGTLDYLPPEMIEG 183
Query: 170 EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFL 229
                  D+W++G    E   G  P+   A+     YK   SR     P F+++ A D +
Sbjct: 184 RMHDEKVDLWSLGVLCYEFLVGKPPF--EANTYQETYK-RISRVEFTFPDFVTEGARDLI 240
Query: 230 SNCLRRDPKERWAASQLLKHPFL 252
           S  L+ +P +R    ++L+HP++
Sbjct: 241 SRLLKHNPSQRPMLREVLEHPWI 263

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 82/271 (30%), Positives = 124/271 (45%), Gaps = 27/271 (9%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSLNSP 55
           D+  G  +G+GS +T  LA  L +   +A K  E        K  ++ RE+  +S L+ P
Sbjct: 31  DFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
             V  K      +D KL + L   YA  G L   I R  G  DE+    YT +I+  LEY
Sbjct: 91  FFV--KLYFTFQDDEKLYFGL--SYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEY 145
Query: 116 LHSNRVVHCDIKSRNILMAES-GAKIADFGCAKW------ESEALQSGGTPMFMAPEVAR 168
           LH   ++H D+K  NIL+ E    +I DFG AK       ++ A    GT  +++PE+  
Sbjct: 146 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 205
Query: 169 GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDF 228
            +    +SD+WA+GC + ++ +G  P+    + +     I    + PE   F  K A D 
Sbjct: 206 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE--KFFPK-ARDL 262
Query: 229 LSNCLRRDPKERWAASQ------LLKHPFLE 253
           +   L  D  +R    +      L  HPF E
Sbjct: 263 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 293

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 81/263 (30%), Positives = 125/263 (47%), Gaps = 23/263 (8%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAK---STELPKSEF---LQREQKFLSSLNSP 55
           D+  G  +G+G    V LA   +   + A K     +L K+     L+RE +  S L  P
Sbjct: 6   DFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 65
Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
           +I+   G      D   +Y L +EYAP GT+  E+ +   + DE    +Y  ++   L Y
Sbjct: 66  NILRLYGY---FHDATRVY-LILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSY 120
Query: 116 LHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG-----GTPMFMAPEVARG 169
            HS RV+H DIK  N+L+  +G  KIADFG   W   A  S      GT  ++ PE+  G
Sbjct: 121 CHSKRVIHRDIKPENLLLGSAGELKIADFG---WSVHAPSSRRTTLCGTLDYLPPEMIEG 177
Query: 170 EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFL 229
                  D+W++G    E   G  P+   A+     YK   SR     P F+++ A D +
Sbjct: 178 RMHDEKVDLWSLGVLCYEFLVGKPPF--EANTYQETYK-RISRVEFTFPDFVTEGARDLI 234
Query: 230 SNCLRRDPKERWAASQLLKHPFL 252
           S  L+ +P +R    ++L+HP++
Sbjct: 235 SRLLKHNPSQRPMLREVLEHPWI 257

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 75/242 (30%), Positives = 117/242 (48%), Gaps = 16/242 (6%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAK------STELPKSEFLQREQKFLSSLNSPH 56
           + R  T+G GS   V L     SG+ +A K        +L + E    E++ L ++N P 
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL 116
           +V     + + +DN  +Y + MEY  GG +   + R G R  E     Y  QI+   EYL
Sbjct: 103 LVK---LEFSFKDNSNLY-MVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYL 157
Query: 117 HSNRVVHCDIKSRNILMAESG-AKIADFGCAK-WESEALQSGGTPMFMAPEVARGEHQGF 174
           HS  +++ D+K  N+L+ + G  ++ DFG AK  +       GTP ++APE+   +    
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 175 ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLR 234
           A D WA+G  + EMA+G  P+  A  P+ +  KI   +     P+  S    D L N L+
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF-FADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQ 274
Query: 235 RD 236
            D
Sbjct: 275 VD 276

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 84/279 (30%), Positives = 137/279 (49%), Gaps = 37/279 (13%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAK--STELPKSE----FLQREQK-FLSSLNS 54
           D+     IG+GS A V L    ++  ++A K    EL   +    ++Q E+  F  + N 
Sbjct: 6   DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNH 65
Query: 55  PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLE 114
           P +VG   C  T  +++L +   +EY  GG L   + R   +L E     Y+ +I   L 
Sbjct: 66  PFLVGLHSCFQT--ESRLFF--VIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALN 120
Query: 115 YLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKWESEALQSG-------GTPMFMAPEV 166
           YLH   +++ D+K  N+L+ +E   K+ D+G  K   E L+ G       GTP ++APE+
Sbjct: 121 YLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPGDTTSXFCGTPNYIAPEI 177
Query: 167 ARGEHQGFASDIWAVGCTVIEMASGGAPWP-----NAADPMT--VLYKIAYSRELPEVPA 219
            RGE  GF+ D WA+G  + EM +G +P+      +  D  T   L+++   +++  +P 
Sbjct: 178 LRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-RIPR 236
Query: 220 FLSKQANDFLSNCLRRDPKERWAA------SQLLKHPFL 252
            LS +A   L + L +DPKER         + +  HPF 
Sbjct: 237 SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 275

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 84/279 (30%), Positives = 137/279 (49%), Gaps = 37/279 (13%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAK--STELPKSE----FLQREQK-FLSSLNS 54
           D+     IG+GS A V L    ++  ++A K    EL   +    ++Q E+  F  + N 
Sbjct: 10  DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNH 69
Query: 55  PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLE 114
           P +VG   C  T  +++L +   +EY  GG L   + R   +L E     Y+ +I   L 
Sbjct: 70  PFLVGLHSCFQT--ESRLFF--VIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALN 124
Query: 115 YLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKWESEALQSG-------GTPMFMAPEV 166
           YLH   +++ D+K  N+L+ +E   K+ D+G  K   E L+ G       GTP ++APE+
Sbjct: 125 YLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPGDTTSXFCGTPNYIAPEI 181
Query: 167 ARGEHQGFASDIWAVGCTVIEMASGGAPWP-----NAADPMT--VLYKIAYSRELPEVPA 219
            RGE  GF+ D WA+G  + EM +G +P+      +  D  T   L+++   +++  +P 
Sbjct: 182 LRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-RIPR 240
Query: 220 FLSKQANDFLSNCLRRDPKERWAA------SQLLKHPFL 252
            LS +A   L + L +DPKER         + +  HPF 
Sbjct: 241 SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 279

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 83/279 (29%), Positives = 137/279 (49%), Gaps = 37/279 (13%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAK--STELPKSE----FLQREQK-FLSSLNS 54
           D+     IG+GS A V L    ++  ++A K    EL   +    ++Q E+  F  + N 
Sbjct: 21  DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNH 80
Query: 55  PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLE 114
           P +VG   C  T  +++L +   +EY  GG L   + R   +L E     Y+ +I   L 
Sbjct: 81  PFLVGLHSCFQT--ESRLFF--VIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALN 135
Query: 115 YLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKWESEALQSG-------GTPMFMAPEV 166
           YLH   +++ D+K  N+L+ +E   K+ D+G  K   E L+ G       GTP ++APE+
Sbjct: 136 YLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPGDTTSXFCGTPNYIAPEI 192
Query: 167 ARGEHQGFASDIWAVGCTVIEMASGGAPWP-----NAADPMT--VLYKIAYSRELPEVPA 219
            RGE  GF+ D WA+G  + EM +G +P+      +  D  T   L+++   +++  +P 
Sbjct: 193 LRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-RIPR 251
Query: 220 FLSKQANDFLSNCLRRDPKERWAA------SQLLKHPFL 252
            +S +A   L + L +DPKER         + +  HPF 
Sbjct: 252 SMSVKAASVLKSFLNKDPKERLGCLPQTGFADIQGHPFF 290

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 75/248 (30%), Positives = 119/248 (47%), Gaps = 16/248 (6%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAK------STELPKSEFLQREQKFLSSLNSPH 56
           + R  T+G GS   V L     SG+ +A K        +L + E    E++ L ++N P 
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL 116
           +V     + + +DN  +Y + MEY  GG +   + R G R  E     Y  QI+   EYL
Sbjct: 103 LVK---LEFSFKDNSNLY-MVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYL 157
Query: 117 HSNRVVHCDIKSRNILMAESG-AKIADFGCAK-WESEALQSGGTPMFMAPEVARGEHQGF 174
           HS  +++ D+K  N+L+ + G  ++ DFG AK  +       GTP ++AP +   +    
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPAIILSKGYNK 217
Query: 175 ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLR 234
           A D WA+G  + EMA+G  P+  A  P+ +  KI   +     P+  S    D L N L+
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF-FADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQ 274
Query: 235 RDPKERWA 242
            D  +R+ 
Sbjct: 275 VDLTKRFG 282

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 76/248 (30%), Positives = 119/248 (47%), Gaps = 16/248 (6%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAK------STELPKSEFLQREQKFLSSLNSPH 56
           + R  T+G GS   V L     SG+ +A K        +L + E    E++ L ++N P 
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL 116
           +V     + + +DN  +Y + MEY  GG +   + R G R  E     Y  QI+   EYL
Sbjct: 103 LVK---LEFSFKDNSNLY-MVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYL 157
Query: 117 HSNRVVHCDIKSRNILMAESG-AKIADFGCAK-WESEALQSGGTPMFMAPEVARGEHQGF 174
           HS  +++ D+K  N+L+ + G  ++ DFG AK  +       GTP  +APE+   +    
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEALAPEIILSKGYNK 217
Query: 175 ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLR 234
           A D WA+G  + EMA+G  P+  A  P+ +  KI   +     P+  S    D L N L+
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF-FADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQ 274
Query: 235 RDPKERWA 242
            D  +R+ 
Sbjct: 275 VDLTKRFG 282

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 78/266 (29%), Positives = 123/266 (46%), Gaps = 25/266 (9%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK---------SEFLQREQKFLSSLN 53
           +  G  +G G  A V       +G  +AAK  +  +          E ++RE   L  + 
Sbjct: 7   YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66
Query: 54  SPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGL 113
            P+I+     D+   +NK    L +E   GG L D +      L E     + +QIL G+
Sbjct: 67  HPNIITLH--DIF--ENKTDVVLILELVSGGELFDFLAEKES-LTEDEATQFLKQILDGV 121
Query: 114 EYLHSNRVVHCDIKSRNILMAESGA-----KIADFGCA-KWES--EALQSGGTPMFMAPE 165
            YLHS R+ H D+K  NI++ +        K+ DFG A K E+  E     GTP F+APE
Sbjct: 122 HYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE 181
Query: 166 VARGEHQGFASDIWAVGCTVIEMASGGAPW--PNAADPMTVLYKIAYSRELPEVPAFLSK 223
           +   E  G  +D+W++G     + SG +P+      + +T +  + Y  +  E  +  S+
Sbjct: 182 IVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFD-EEYFSNTSE 240
Query: 224 QANDFLSNCLRRDPKERWAASQLLKH 249
            A DF+   L +DPK R   +Q L+H
Sbjct: 241 LAKDFIRRLLVKDPKRRMTIAQSLEH 266

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 96/312 (30%), Positives = 153/312 (49%), Gaps = 48/312 (15%)
Query: 8   TIGQGSSATVSLATSLRSGDVFAAK---STEL-PKS-EFLQREQKFLSSLNSPHIVGYKG 62
           TIG+G+ A V LA  + +G   A K    T+L P S + L RE + +  LN P+IV  K 
Sbjct: 19  TIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIV--KL 76
Query: 63  CDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
            +V  E  K +Y L MEYA GG + D +  +G R+ E    S  RQI+  ++Y H  R+V
Sbjct: 77  FEVI-ETEKTLY-LIMEYASGGEVFDYLVAHG-RMKEKEARSKFRQIVSAVQYCHQKRIV 133
Query: 123 HCDIKSRNILM-AESGAKIADFGCAKWESEALQSG------GTPMFMAPEVARG-EHQGF 174
           H D+K+ N+L+ A+   KIADFG   + +E    G      G+P + APE+ +G ++ G 
Sbjct: 134 HRDLKAENLLLDADMNIKIADFG---FSNEFTVGGKLDTFCGSPPYAAPELFQGKKYDGP 190
Query: 175 ASDIWAVGCTVIEMASGGAPW--PNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNC 232
             D+W++G  +  + SG  P+   N  +    + +  Y      +P ++S    + L   
Sbjct: 191 EVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY-----RIPFYMSTDCENLLKRF 245
Query: 233 LRRDPKERWAASQLLK-------------HPFLEEFCSCTKQIQESNCSPTSILDQGIWN 279
           L  +P +R    Q++K              PF+E       ++  S+     I+  G+  
Sbjct: 246 LVLNPIKRGTLEQIMKDRWINAGHEEDELKPFVE------PELDISDQKRIDIM-VGMGY 298
Query: 280 SVEETEESLGNL 291
           S EE +ESL  +
Sbjct: 299 SQEEIQESLSKM 310

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 83/279 (29%), Positives = 137/279 (49%), Gaps = 37/279 (13%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAK--STELPKSE----FLQREQK-FLSSLNS 54
           D+     IG+GS A V L    ++  ++A +    EL   +    ++Q E+  F  + N 
Sbjct: 53  DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNH 112
Query: 55  PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLE 114
           P +VG   C  T  +++L +   +EY  GG L   + R   +L E     Y+ +I   L 
Sbjct: 113 PFLVGLHSCFQT--ESRLFF--VIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALN 167
Query: 115 YLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKWESEALQSG-------GTPMFMAPEV 166
           YLH   +++ D+K  N+L+ +E   K+ D+G  K   E L+ G       GTP ++APE+
Sbjct: 168 YLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPGDTTSTFCGTPNYIAPEI 224
Query: 167 ARGEHQGFASDIWAVGCTVIEMASGGAPWP-----NAADPMT--VLYKIAYSRELPEVPA 219
            RGE  GF+ D WA+G  + EM +G +P+      +  D  T   L+++   +++  +P 
Sbjct: 225 LRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-RIPR 283
Query: 220 FLSKQANDFLSNCLRRDPKERWAA------SQLLKHPFL 252
            LS +A   L + L +DPKER         + +  HPF 
Sbjct: 284 SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 322

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 96/312 (30%), Positives = 152/312 (48%), Gaps = 48/312 (15%)
Query: 8   TIGQGSSATVSLATSLRSGDVFAAK---STEL-PKS-EFLQREQKFLSSLNSPHIVGYKG 62
           TIG+G+ A V LA  + +G   A K    T+L P S + L RE + +  LN P+IV  K 
Sbjct: 22  TIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIV--KL 79
Query: 63  CDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
            +V  E  K +Y L MEYA GG + D +  +G R+ E    S  RQI+  ++Y H  R+V
Sbjct: 80  FEVI-ETEKTLY-LIMEYASGGEVFDYLVAHG-RMKEKEARSKFRQIVSAVQYCHQKRIV 136
Query: 123 HCDIKSRNILM-AESGAKIADFGCAKWESEALQSG------GTPMFMAPEVARG-EHQGF 174
           H D+K+ N+L+ A+   KIADFG   + +E    G      G P + APE+ +G ++ G 
Sbjct: 137 HRDLKAENLLLDADMNIKIADFG---FSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGP 193
Query: 175 ASDIWAVGCTVIEMASGGAPW--PNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNC 232
             D+W++G  +  + SG  P+   N  +    + +  Y      +P ++S    + L   
Sbjct: 194 EVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY-----RIPFYMSTDCENLLKRF 248
Query: 233 LRRDPKERWAASQLLK-------------HPFLEEFCSCTKQIQESNCSPTSILDQGIWN 279
           L  +P +R    Q++K              PF+E       ++  S+     I+  G+  
Sbjct: 249 LVLNPIKRGTLEQIMKDRWINAGHEEDELKPFVE------PELDISDQKRIDIM-VGMGY 301
Query: 280 SVEETEESLGNL 291
           S EE +ESL  +
Sbjct: 302 SQEEIQESLSKM 313

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 88/294 (29%), Positives = 135/294 (45%), Gaps = 19/294 (6%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFL------QREQKFLSSLNSPH 56
           +  G T+G G+   V +     +G   A K     K   L      +RE + L     PH
Sbjct: 18  YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPH 77
Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL 116
           I+  K   V S  + +   + MEY  GG L D I +NG RLDE       +QIL G++Y 
Sbjct: 78  II--KLYQVISTPSDIF--MVMEYVSGGELFDYICKNG-RLDEKESRRLFQQILSGVDYC 132
Query: 117 HSNRVVHCDIKSRNILM-AESGAKIADFGCAKWESEA---LQSGGTPMFMAPEVARGE-H 171
           H + VVH D+K  N+L+ A   AKIADFG +   S+      S G+P + APEV  G  +
Sbjct: 133 HRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSCGSPNYAAPEVISGRLY 192
Query: 172 QGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSN 231
            G   DIW+ G  +  +  G  P+ +   P T+  KI     +   P +L+      L +
Sbjct: 193 AGPEVDIWSSGVILYALLCGTLPFDDDHVP-TLFKKICDG--IFYTPQYLNPSVISLLKH 249
Query: 232 CLRRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSILDQGIWNSVEETE 285
            L+ DP +R     + +H + ++        ++ + S T I D+ +    E+ E
Sbjct: 250 MLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDEALKEVCEKFE 303

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 78/266 (29%), Positives = 123/266 (46%), Gaps = 25/266 (9%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK---------SEFLQREQKFLSSLN 53
           +  G  +G G  A V       +G  +AAK  +  +          E ++RE   L  + 
Sbjct: 14  YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 73
Query: 54  SPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGL 113
            P+I+     D+   +NK    L +E   GG L D +      L E     + +QIL G+
Sbjct: 74  HPNIITLH--DIF--ENKTDVVLILELVSGGELFDFLAEKES-LTEDEATQFLKQILDGV 128
Query: 114 EYLHSNRVVHCDIKSRNILMAESGA-----KIADFGCA-KWES--EALQSGGTPMFMAPE 165
            YLHS R+ H D+K  NI++ +        K+ DFG A K E+  E     GTP F+APE
Sbjct: 129 HYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE 188
Query: 166 VARGEHQGFASDIWAVGCTVIEMASGGAPW--PNAADPMTVLYKIAYSRELPEVPAFLSK 223
           +   E  G  +D+W++G     + SG +P+      + +T +  + Y  +  E  +  S+
Sbjct: 189 IVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFD-EEYFSNTSE 247
Query: 224 QANDFLSNCLRRDPKERWAASQLLKH 249
            A DF+   L +DPK R   +Q L+H
Sbjct: 248 LAKDFIRRLLVKDPKRRMXIAQSLEH 273

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 78/266 (29%), Positives = 123/266 (46%), Gaps = 25/266 (9%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK---------SEFLQREQKFLSSLN 53
           +  G  +G G  A V       +G  +AAK  +  +          E ++RE   L  + 
Sbjct: 28  YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIR 87
Query: 54  SPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGL 113
            P+I+     D+   +NK    L +E   GG L D +      L E     + +QIL G+
Sbjct: 88  HPNIITLH--DIF--ENKTDVVLILELVSGGELFDFLAEKES-LTEDEATQFLKQILDGV 142
Query: 114 EYLHSNRVVHCDIKSRNILMAESGA-----KIADFGCA-KWES--EALQSGGTPMFMAPE 165
            YLHS R+ H D+K  NI++ +        K+ DFG A K E+  E     GTP F+APE
Sbjct: 143 HYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE 202
Query: 166 VARGEHQGFASDIWAVGCTVIEMASGGAPW--PNAADPMTVLYKIAYSRELPEVPAFLSK 223
           +   E  G  +D+W++G     + SG +P+      + +T +  + Y  +  E  +  S+
Sbjct: 203 IVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFD-EEYFSNTSE 261
Query: 224 QANDFLSNCLRRDPKERWAASQLLKH 249
            A DF+   L +DPK R   +Q L+H
Sbjct: 262 LAKDFIRRLLVKDPKRRMXIAQSLEH 287

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 121/269 (44%), Gaps = 23/269 (8%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS---------EFLQREQKFLSSLN 53
           +  G  +G G  A V       +G  +AAK  +  ++         E ++RE   L  + 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 54  SPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGL 113
            P+++          +NK    L +E   GG L D +      L E     + +QIL G+
Sbjct: 73  HPNVITLHEV----YENKTDVILILELVAGGELFDFLAEKES-LTEEEATEFLKQILNGV 127
Query: 114 EYLHSNRVVHCDIKSRNILMAESGA-----KIADFGCAK---WESEALQSGGTPMFMAPE 165
            YLHS ++ H D+K  NI++ +        KI DFG A    + +E     GTP F+APE
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPAFVAPE 187
Query: 166 VARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELP-EVPAFLSKQ 224
           +   E  G  +D+W++G     + SG +P+       T+    A + E   E  +  S  
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 247
Query: 225 ANDFLSNCLRRDPKERWAASQLLKHPFLE 253
           A DF+   L +DPK+R      L+HP+++
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 121/269 (44%), Gaps = 23/269 (8%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS---------EFLQREQKFLSSLN 53
           +  G  +G G  A V       +G  +AAK  +  ++         E ++RE   L  + 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 54  SPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGL 113
            P+++          +NK    L +E   GG L D +      L E     + +QIL G+
Sbjct: 73  HPNVITLHEV----YENKTDVILILELVAGGELFDFLAEKES-LTEEEATEFLKQILNGV 127
Query: 114 EYLHSNRVVHCDIKSRNILMAESGA-----KIADFGCAK---WESEALQSGGTPMFMAPE 165
            YLHS ++ H D+K  NI++ +        KI DFG A    + +E     GTP F+APE
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 166 VARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELP-EVPAFLSKQ 224
           +   E  G  +D+W++G     + SG +P+       T+    A + E   E  +  S  
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 247
Query: 225 ANDFLSNCLRRDPKERWAASQLLKHPFLE 253
           A DF+   L +DPK+R      L+HP+++
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score =  101 bits (251), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 121/269 (44%), Gaps = 23/269 (8%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS---------EFLQREQKFLSSLN 53
           +  G  +G G  A V       +G  +AAK  +  ++         E ++RE   L  + 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 54  SPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGL 113
            P+++          +NK    L +E   GG L D +      L E     + +QIL G+
Sbjct: 73  HPNVITLHEV----YENKTDVILILELVAGGELFDFLAEKES-LTEEEATEFLKQILNGV 127
Query: 114 EYLHSNRVVHCDIKSRNILMAESGA-----KIADFGCAK---WESEALQSGGTPMFMAPE 165
            YLHS ++ H D+K  NI++ +        KI DFG A    + +E     GTP F+APE
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 166 VARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELP-EVPAFLSKQ 224
           +   E  G  +D+W++G     + SG +P+       T+    A + E   E  +  S  
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 247
Query: 225 ANDFLSNCLRRDPKERWAASQLLKHPFLE 253
           A DF+   L +DPK+R      L+HP+++
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score =  101 bits (251), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 121/269 (44%), Gaps = 23/269 (8%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS---------EFLQREQKFLSSLN 53
           +  G  +G G  A V       +G  +AAK  +  ++         E ++RE   L  + 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 54  SPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGL 113
            P+++          +NK    L +E   GG L D +      L E     + +QIL G+
Sbjct: 73  HPNVITLHEV----YENKTDVILILELVAGGELFDFLAEKES-LTEEEATEFLKQILNGV 127
Query: 114 EYLHSNRVVHCDIKSRNILMAESGA-----KIADFGCAK---WESEALQSGGTPMFMAPE 165
            YLHS ++ H D+K  NI++ +        KI DFG A    + +E     GTP F+APE
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 166 VARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELP-EVPAFLSKQ 224
           +   E  G  +D+W++G     + SG +P+       T+    A + E   E  +  S  
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 247
Query: 225 ANDFLSNCLRRDPKERWAASQLLKHPFLE 253
           A DF+   L +DPK+R      L+HP+++
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score =  101 bits (251), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 121/269 (44%), Gaps = 23/269 (8%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS---------EFLQREQKFLSSLN 53
           +  G  +G G  A V       +G  +AAK  +  ++         E ++RE   L  + 
Sbjct: 13  YDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 54  SPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGL 113
            P+++          +NK    L +E   GG L D +      L E     + +QIL G+
Sbjct: 73  HPNVITLHEV----YENKTDVILILELVAGGELFDFLAEKES-LTEEEATEFLKQILNGV 127
Query: 114 EYLHSNRVVHCDIKSRNILMAESGA-----KIADFGCAK---WESEALQSGGTPMFMAPE 165
            YLHS ++ H D+K  NI++ +        KI DFG A    + +E     GTP F+APE
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 166 VARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELP-EVPAFLSKQ 224
           +   E  G  +D+W++G     + SG +P+       T+    A + E   E  +  S  
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 247
Query: 225 ANDFLSNCLRRDPKERWAASQLLKHPFLE 253
           A DF+   L +DPK+R      L+HP+++
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score =  101 bits (251), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 121/269 (44%), Gaps = 23/269 (8%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS---------EFLQREQKFLSSLN 53
           +  G  +G G  A V       +G  +AAK  +  ++         E ++RE   L  + 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 54  SPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGL 113
            P+++          +NK    L +E   GG L D +      L E     + +QIL G+
Sbjct: 73  HPNVITLHEV----YENKTDVILILELVAGGELFDFLAEKES-LTEEEATEFLKQILNGV 127
Query: 114 EYLHSNRVVHCDIKSRNILMAESGA-----KIADFGCAK---WESEALQSGGTPMFMAPE 165
            YLHS ++ H D+K  NI++ +        KI DFG A    + +E     GTP F+APE
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 166 VARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELP-EVPAFLSKQ 224
           +   E  G  +D+W++G     + SG +P+       T+    A + E   E  +  S  
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 247
Query: 225 ANDFLSNCLRRDPKERWAASQLLKHPFLE 253
           A DF+   L +DPK+R      L+HP+++
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 121/269 (44%), Gaps = 23/269 (8%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS---------EFLQREQKFLSSLN 53
           +  G  +G G  A V       +G  +AAK  +  ++         E ++RE   L  + 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 54  SPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGL 113
            P+++          +NK    L +E   GG L D +      L E     + +QIL G+
Sbjct: 73  HPNVITLHEV----YENKTDVILILELVAGGELFDFLAEKES-LTEEEATEFLKQILNGV 127
Query: 114 EYLHSNRVVHCDIKSRNILMAESGA-----KIADFGCAK---WESEALQSGGTPMFMAPE 165
            YLHS ++ H D+K  NI++ +        KI DFG A    + +E     GTP F+APE
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 166 VARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELP-EVPAFLSKQ 224
           +   E  G  +D+W++G     + SG +P+       T+    A + E   E  +  S  
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 247
Query: 225 ANDFLSNCLRRDPKERWAASQLLKHPFLE 253
           A DF+   L +DPK+R      L+HP+++
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 121/269 (44%), Gaps = 23/269 (8%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS---------EFLQREQKFLSSLN 53
           +  G  +G G  A V       +G  +AAK  +  ++         E ++RE   L  + 
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 54  SPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGL 113
            P+++          +NK    L +E   GG L D +      L E     + +QIL G+
Sbjct: 72  HPNVITLHEV----YENKTDVILILELVAGGELFDFLAEKES-LTEEEATEFLKQILNGV 126
Query: 114 EYLHSNRVVHCDIKSRNILMAESGA-----KIADFGCAK---WESEALQSGGTPMFMAPE 165
            YLHS ++ H D+K  NI++ +        KI DFG A    + +E     GTP F+APE
Sbjct: 127 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 186
Query: 166 VARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELP-EVPAFLSKQ 224
           +   E  G  +D+W++G     + SG +P+       T+    A + E   E  +  S  
Sbjct: 187 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 246
Query: 225 ANDFLSNCLRRDPKERWAASQLLKHPFLE 253
           A DF+   L +DPK+R      L+HP+++
Sbjct: 247 AKDFIRRLLVKDPKKRMTIQDSLQHPWIK 275

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 121/269 (44%), Gaps = 23/269 (8%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS---------EFLQREQKFLSSLN 53
           +  G  +G G  A V       +G  +AAK  +  ++         E ++RE   L  + 
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 54  SPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGL 113
            P+++          +NK    L +E   GG L D +      L E     + +QIL G+
Sbjct: 72  HPNVITLHEV----YENKTDVILILELVAGGELFDFLAEKES-LTEEEATEFLKQILNGV 126
Query: 114 EYLHSNRVVHCDIKSRNILMAESGA-----KIADFGCAK---WESEALQSGGTPMFMAPE 165
            YLHS ++ H D+K  NI++ +        KI DFG A    + +E     GTP F+APE
Sbjct: 127 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 186
Query: 166 VARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELP-EVPAFLSKQ 224
           +   E  G  +D+W++G     + SG +P+       T+    A + E   E  +  S  
Sbjct: 187 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 246
Query: 225 ANDFLSNCLRRDPKERWAASQLLKHPFLE 253
           A DF+   L +DPK+R      L+HP+++
Sbjct: 247 AKDFIRRLLVKDPKKRMTIQDSLQHPWIK 275

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 121/269 (44%), Gaps = 23/269 (8%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS---------EFLQREQKFLSSLN 53
           +  G  +G G  A V       +G  +AAK  +  ++         E ++RE   L  + 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 54  SPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGL 113
            P+++          +NK    L +E   GG L D +      L E     + +QIL G+
Sbjct: 73  HPNVITLHEV----YENKTDVILILELVAGGELFDFLAEKES-LTEEEATEFLKQILNGV 127
Query: 114 EYLHSNRVVHCDIKSRNILMAESGA-----KIADFGCAK---WESEALQSGGTPMFMAPE 165
            YLHS ++ H D+K  NI++ +        KI DFG A    + +E     GTP F+APE
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 166 VARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELP-EVPAFLSKQ 224
           +   E  G  +D+W++G     + SG +P+       T+    A + E   E  +  S  
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 247
Query: 225 ANDFLSNCLRRDPKERWAASQLLKHPFLE 253
           A DF+   L +DPK+R      L+HP+++
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 121/269 (44%), Gaps = 23/269 (8%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS---------EFLQREQKFLSSLN 53
           +  G  +G G  A V       +G  +AAK  +  ++         E ++RE   L  + 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 54  SPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGL 113
            P+++          +NK    L +E   GG L D +      L E     + +QIL G+
Sbjct: 73  HPNVITLHEV----YENKTDVILILELVAGGELFDFLAEKES-LTEEEATEFLKQILNGV 127
Query: 114 EYLHSNRVVHCDIKSRNILMAESGA-----KIADFGCAK---WESEALQSGGTPMFMAPE 165
            YLHS ++ H D+K  NI++ +        KI DFG A    + +E     GTP F+APE
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 166 VARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELP-EVPAFLSKQ 224
           +   E  G  +D+W++G     + SG +P+       T+    A + E   E  +  S  
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 247
Query: 225 ANDFLSNCLRRDPKERWAASQLLKHPFLE 253
           A DF+   L +DPK+R      L+HP+++
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 121/269 (44%), Gaps = 23/269 (8%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS---------EFLQREQKFLSSLN 53
           +  G  +G G  A V       +G  +AAK  +  ++         E ++RE   L  + 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 54  SPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGL 113
            P+++          +NK    L +E   GG L D +      L E     + +QIL G+
Sbjct: 73  HPNVITLHEV----YENKTDVILILELVAGGELFDFLAEKES-LTEEEATEFLKQILNGV 127
Query: 114 EYLHSNRVVHCDIKSRNILMAESGA-----KIADFGCAK---WESEALQSGGTPMFMAPE 165
            YLHS ++ H D+K  NI++ +        KI DFG A    + +E     GTP F+APE
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 166 VARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELP-EVPAFLSKQ 224
           +   E  G  +D+W++G     + SG +P+       T+    A + E   E  +  S  
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 247
Query: 225 ANDFLSNCLRRDPKERWAASQLLKHPFLE 253
           A DF+   L +DPK+R      L+HP+++
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 121/269 (44%), Gaps = 23/269 (8%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS---------EFLQREQKFLSSLN 53
           +  G  +G G  A V       +G  +AAK  +  ++         E ++RE   L  + 
Sbjct: 13  YDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 54  SPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGL 113
            P+++          +NK    L +E   GG L D +      L E     + +QIL G+
Sbjct: 73  HPNVITLHEV----YENKTDVILILELVAGGELFDFLAEKES-LTEEEATEFLKQILNGV 127
Query: 114 EYLHSNRVVHCDIKSRNILMAESGA-----KIADFGCAK---WESEALQSGGTPMFMAPE 165
            YLHS ++ H D+K  NI++ +        KI DFG A    + +E     GTP F+APE
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 166 VARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELP-EVPAFLSKQ 224
           +   E  G  +D+W++G     + SG +P+       T+    A + E   E  +  S  
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 247
Query: 225 ANDFLSNCLRRDPKERWAASQLLKHPFLE 253
           A DF+   L +DPK+R      L+HP+++
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 79/253 (31%), Positives = 130/253 (51%), Gaps = 22/253 (8%)
Query: 8   TIGQGSSATVSLATSLRSGDVFAAK---STELPKSEF--LQREQKFLSSLNSPHIVGYKG 62
           TIG+G+ A V LA  + +G   A K    T+L  S    L RE + +  LN P+IV  K 
Sbjct: 21  TIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIV--KL 78
Query: 63  CDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
            +V  E  K +Y L MEYA GG + D +  +G R+ E    +  RQI+  ++Y H   +V
Sbjct: 79  FEVI-ETEKTLY-LVMEYASGGEVFDYLVAHG-RMKEKEARAKFRQIVSAVQYCHQKFIV 135
Query: 123 HCDIKSRNILM-AESGAKIADFGCAK---WESEALQSGGTPMFMAPEVARG-EHQGFASD 177
           H D+K+ N+L+ A+   KIADFG +    + ++     G+P + APE+ +G ++ G   D
Sbjct: 136 HRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVD 195
Query: 178 IWAVGCTVIEMASGGAPW--PNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRR 235
           +W++G  +  + SG  P+   N  +    + +  Y      +P ++S    + L   L  
Sbjct: 196 VWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY-----RIPFYMSTDCENLLKKFLIL 250
Query: 236 DPKERWAASQLLK 248
           +P +R    Q++K
Sbjct: 251 NPSKRGTLEQIMK 263

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 78/253 (30%), Positives = 131/253 (51%), Gaps = 22/253 (8%)
Query: 8   TIGQGSSATVSLATSLRSGDVFAAK---STELPKSEF--LQREQKFLSSLNSPHIVGYKG 62
           TIG+G+ A V LA  + +G   A +    T+L  S    L RE + +  LN P+IV  K 
Sbjct: 21  TIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIV--KL 78
Query: 63  CDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
            +V  E  K +Y L MEYA GG + D +  +G R+ E    +  RQI+  ++Y H   +V
Sbjct: 79  FEVI-ETEKTLY-LVMEYASGGEVFDYLVAHG-RMKEKEARAKFRQIVSAVQYCHQKFIV 135
Query: 123 HCDIKSRNILM-AESGAKIADFGCAK---WESEALQSGGTPMFMAPEVARG-EHQGFASD 177
           H D+K+ N+L+ A+   KIADFG +    + ++  +  G+P + APE+ +G ++ G   D
Sbjct: 136 HRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFCGSPPYAAPELFQGKKYDGPEVD 195
Query: 178 IWAVGCTVIEMASGGAPW--PNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRR 235
           +W++G  +  + SG  P+   N  +    + +  Y      +P ++S    + L   L  
Sbjct: 196 VWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY-----RIPFYMSTDCENLLKKFLIL 250
Query: 236 DPKERWAASQLLK 248
           +P +R    Q++K
Sbjct: 251 NPSKRGTLEQIMK 263

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 79/253 (31%), Positives = 130/253 (51%), Gaps = 22/253 (8%)
Query: 8   TIGQGSSATVSLATSLRSGDVFAAK---STELPKSEF--LQREQKFLSSLNSPHIVGYKG 62
           TIG+G+ A V LA  + +G   A K    T+L  S    L RE + +  LN P+IV  K 
Sbjct: 21  TIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIV--KL 78
Query: 63  CDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
            +V  E  K +Y L MEYA GG + D +  +G R+ E    +  RQI+  ++Y H   +V
Sbjct: 79  FEVI-ETEKTLY-LVMEYASGGEVFDYLVAHG-RMKEKEARAKFRQIVSAVQYCHQKFIV 135
Query: 123 HCDIKSRNILM-AESGAKIADFGCAK---WESEALQSGGTPMFMAPEVARG-EHQGFASD 177
           H D+K+ N+L+ A+   KIADFG +    + ++     G+P + APE+ +G ++ G   D
Sbjct: 136 HRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVD 195
Query: 178 IWAVGCTVIEMASGGAPW--PNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRR 235
           +W++G  +  + SG  P+   N  +    + +  Y      +P ++S    + L   L  
Sbjct: 196 VWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY-----RIPFYMSTDCENLLKKFLIL 250
Query: 236 DPKERWAASQLLK 248
           +P +R    Q++K
Sbjct: 251 NPSKRGTLEQIMK 263

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 87/302 (28%), Positives = 135/302 (44%), Gaps = 47/302 (15%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL-------PKSEFLQREQKFLSSLNS 54
           ++ +   IG+G+   V  A +  +G+V A K   L       P +    RE   L  LN 
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI--REISLLKELNH 64
Query: 55  PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLE 114
           P+IV  K  DV   +NKL       +    T  D     G  L   LI SY  Q+LQGL 
Sbjct: 65  PNIV--KLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPL--PLIKSYLFQLLQGLA 120
Query: 115 YLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSGG----TPMFMAPEVARG 169
           + HS+RV+H D+K +N+L+   GA K+ADFG A+     +++      T  + APE+  G
Sbjct: 121 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 180
Query: 170 -EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPE------------ 216
            ++   A DIW++GC   EM +  A +P  ++ +  L++I  +   P+            
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPDEVVWPGVTSMPD 239
Query: 217 -VPAF--------------LSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQ 261
             P+F              L +     LS  L  DP +R +A   L HPF ++       
Sbjct: 240 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPH 299
Query: 262 IQ 263
           ++
Sbjct: 300 LR 301

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 74/267 (27%), Positives = 124/267 (46%), Gaps = 27/267 (10%)
Query: 6   GHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS---------EFLQREQKFLSSLNSPH 56
           G  +G G  A V       +G  +AAK  +  +S         E ++RE   L  +  P+
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPN 76
Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL 116
           I+     DV   +N+    L +E   GG L D + +    L E    S+ +QIL G+ YL
Sbjct: 77  IITLH--DVY--ENRTDVVLILELVSGGELFDFLAQKES-LSEEEATSFIKQILDGVNYL 131
Query: 117 HSNRVVHCDIKSRNILMAESG-----AKIADFGCAKWESEALQSG---GTPMFMAPEVAR 168
           H+ ++ H D+K  NI++ +        K+ DFG A    + ++     GTP F+APE+  
Sbjct: 132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN 191
Query: 169 GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQ---A 225
            E  G  +D+W++G     + SG +P+       T+    A S +  E   F S+    A
Sbjct: 192 YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDE--EFFSQTSELA 249
Query: 226 NDFLSNCLRRDPKERWAASQLLKHPFL 252
            DF+   L ++ ++R    + L+HP++
Sbjct: 250 KDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 87/302 (28%), Positives = 135/302 (44%), Gaps = 47/302 (15%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL-------PKSEFLQREQKFLSSLNS 54
           ++ +   IG+G+   V  A +  +G+V A K   L       P +    RE   L  LN 
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI--REISLLKELNH 60
Query: 55  PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLE 114
           P+IV  K  DV   +NKL       +    T  D     G  L   LI SY  Q+LQGL 
Sbjct: 61  PNIV--KLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPL--PLIKSYLFQLLQGLA 116
Query: 115 YLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSGG----TPMFMAPEVARG 169
           + HS+RV+H D+K +N+L+   GA K+ADFG A+     +++      T  + APE+  G
Sbjct: 117 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176
Query: 170 -EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPE------------ 216
            ++   A DIW++GC   EM +  A +P  ++ +  L++I  +   P+            
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPDEVVWPGVTSMPD 235
Query: 217 -VPAF--------------LSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQ 261
             P+F              L +     LS  L  DP +R +A   L HPF ++       
Sbjct: 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPH 295
Query: 262 IQ 263
           ++
Sbjct: 296 LR 297

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 79/253 (31%), Positives = 129/253 (50%), Gaps = 22/253 (8%)
Query: 8   TIGQGSSATVSLATSLRSGDVFAAK---STELPKSEF--LQREQKFLSSLNSPHIVGYKG 62
           TIG+G+ A V LA  + +G   A K    T+L  S    L RE + +  LN P+IV  K 
Sbjct: 21  TIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIV--KL 78
Query: 63  CDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
            +V  E  K +Y L MEYA GG + D +  +G R+ E    +  RQI+  ++Y H   +V
Sbjct: 79  FEVI-ETEKTLY-LVMEYASGGEVFDYLVAHG-RMKEKEARAKFRQIVSAVQYCHQKFIV 135
Query: 123 HCDIKSRNILM-AESGAKIADFGCAK---WESEALQSGGTPMFMAPEVARG-EHQGFASD 177
           H D+K+ N+L+ A+   KIADFG +    + ++     G P + APE+ +G ++ G   D
Sbjct: 136 HRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDGPEVD 195
Query: 178 IWAVGCTVIEMASGGAPW--PNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRR 235
           +W++G  +  + SG  P+   N  +    + +  Y      +P ++S    + L   L  
Sbjct: 196 VWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY-----RIPFYMSTDCENLLKKFLIL 250
Query: 236 DPKERWAASQLLK 248
           +P +R    Q++K
Sbjct: 251 NPSKRGTLEQIMK 263

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 77/264 (29%), Positives = 124/264 (46%), Gaps = 23/264 (8%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAK---STELPKSEF---LQREQKFLSSLNSP 55
           D+  G  +G+G    V LA   ++  + A K    ++L K      L+RE +  S L  P
Sbjct: 16  DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHP 75
Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
           +I+          D K +Y L +E+AP G L  E+ ++G R DE    ++  ++   L Y
Sbjct: 76  NILRMYN---YFHDRKRIY-LMLEFAPRGELYKELQKHG-RFDEQRSATFMEELADALHY 130
Query: 116 LHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA-----LQSGGTPMFMAPEVARG 169
            H  +V+H DIK  N+LM   G  KIADFG   W   A         GT  ++ PE+  G
Sbjct: 131 CHERKVIHRDIKPENLLMGYKGELKIADFG---WSVHAPSLRRRXMCGTLDYLPPEMIEG 187
Query: 170 EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFL 229
           +      D+W  G    E   G  P+ + +   T  ++   + +L + P FLS  + D +
Sbjct: 188 KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH--TETHRRIVNVDL-KFPPFLSDGSKDLI 244
Query: 230 SNCLRRDPKERWAASQLLKHPFLE 253
           S  LR  P +R     +++HP+++
Sbjct: 245 SKLLRYHPPQRLPLKGVMEHPWVK 268

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 81/275 (29%), Positives = 125/275 (45%), Gaps = 27/275 (9%)
Query: 8   TIGQGSSATVSLATSLRSGDVFAAKSTELPKSEF------LQREQKFLSSLNSPHIVGYK 61
           T+G G+ + V LA    +G +FA K   +PK         ++ E   L  +   +IV  +
Sbjct: 29  TLGTGAFSEVVLAEEKATGKLFAVKC--IPKKALKGKESSIENEIAVLRKIKHENIVALE 86
Query: 62  GCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNG--GRLDESLIVSYTRQILQGLEYLHSN 119
             D+    N L   L M+   GG L D I   G     D S ++   RQ+L  + YLH  
Sbjct: 87  --DIYESPNHLY--LVMQLVSGGELFDRIVEKGFYTEKDASTLI---RQVLDAVYYLHRM 139
Query: 120 RVVHCDIKSRNILM----AESGAKIADFGCAKWESEA---LQSGGTPMFMAPEVARGEHQ 172
            +VH D+K  N+L      ES   I+DFG +K E +      + GTP ++APEV   +  
Sbjct: 140 GIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACGTPGYVAPEVLAQKPY 199
Query: 173 GFASDIWAVGCTVIEMASGGAPWPNAADPMTV--LYKIAYSRELPEVPAFLSKQANDFLS 230
             A D W++G     +  G  P+ +  D      + K  Y  + P     +S  A DF+ 
Sbjct: 200 SKAVDCWSIGVIAYILLCGYPPFYDENDSKLFEQILKAEYEFDSPYWDD-ISDSAKDFIR 258
Query: 231 NCLRRDPKERWAASQLLKHPFLEEFCSCTKQIQES 265
           N + +DP +R+   Q  +HP++    +  K I ES
Sbjct: 259 NLMEKDPNKRYTCEQAARHPWIAGDTALNKNIHES 293

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 78/253 (30%), Positives = 130/253 (51%), Gaps = 22/253 (8%)
Query: 8   TIGQGSSATVSLATSLRSGDVFAAK---STELPKSEF--LQREQKFLSSLNSPHIVGYKG 62
           TIG+G+ A V LA  + +G   A +    T+L  S    L RE + +  LN P+IV  K 
Sbjct: 21  TIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIV--KL 78
Query: 63  CDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
            +V  E  K +Y L MEYA GG + D +  +G R+ E    +  RQI+  ++Y H   +V
Sbjct: 79  FEVI-ETEKTLY-LVMEYASGGEVFDYLVAHG-RMKEKEARAKFRQIVSAVQYCHQKFIV 135
Query: 123 HCDIKSRNILM-AESGAKIADFGCAK---WESEALQSGGTPMFMAPEVARG-EHQGFASD 177
           H D+K+ N+L+ A+   KIADFG +    + ++     G+P + APE+ +G ++ G   D
Sbjct: 136 HRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVD 195
Query: 178 IWAVGCTVIEMASGGAPW--PNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRR 235
           +W++G  +  + SG  P+   N  +    + +  Y      +P ++S    + L   L  
Sbjct: 196 VWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY-----RIPFYMSTDCENLLKKFLIL 250
Query: 236 DPKERWAASQLLK 248
           +P +R    Q++K
Sbjct: 251 NPSKRGTLEQIMK 263

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 80/259 (30%), Positives = 125/259 (48%), Gaps = 27/259 (10%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFL---QREQKFLS-----SLNSPHIVGY 60
           +G+G  A     +   + +VFA K   +PKS  L   QRE+  +      SL   H+VG+
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKI--VPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 82
Query: 61  KGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNR 120
            G     EDN  ++ + +E     +L  E+H+    L E     Y RQI+ G +YLH NR
Sbjct: 83  HG---FFEDNDFVF-VVLELCRRRSLL-ELHKRRKALTEPEARYYLRQIVLGCQYLHRNR 137
Query: 121 VVHCDIKSRNILMAES-GAKIADFGCA---KWESEALQS-GGTPMFMAPEVARGEHQGFA 175
           V+H D+K  N+ + E    KI DFG A   +++ E  ++  GTP ++APEV   +   F 
Sbjct: 138 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFE 197
Query: 176 SDIWAVGCTVIEMASGGAPWPNAADPMTVLY--KIAYSRELPEVPAFLSKQANDFLSNCL 233
            D+W++GC +  +  G  P+  +    T L   K  YS     +P  ++  A   +   L
Sbjct: 198 VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS-----IPKHINPVAASLIQKML 252
Query: 234 RRDPKERWAASQLLKHPFL 252
           + DP  R   ++LL   F 
Sbjct: 253 QTDPTARPTINELLNDEFF 271

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 120/269 (44%), Gaps = 23/269 (8%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS---------EFLQREQKFLSSLN 53
           +  G  +G G  A V       +G  +AAK  +  ++         E ++RE   L  + 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 54  SPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGL 113
            P+++          +NK    L  E   GG L D +      L E     + +QIL G+
Sbjct: 73  HPNVITLHEV----YENKTDVILIGELVAGGELFDFLAEKES-LTEEEATEFLKQILNGV 127
Query: 114 EYLHSNRVVHCDIKSRNILMAESGA-----KIADFGCAK---WESEALQSGGTPMFMAPE 165
            YLHS ++ H D+K  NI++ +        KI DFG A    + +E     GTP F+APE
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 166 VARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELP-EVPAFLSKQ 224
           +   E  G  +D+W++G     + SG +P+       T+    A + E   E  +  S  
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 247
Query: 225 ANDFLSNCLRRDPKERWAASQLLKHPFLE 253
           A DF+   L +DPK+R      L+HP+++
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 78/259 (30%), Positives = 123/259 (47%), Gaps = 27/259 (10%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQK--------FLSSLNSPHIVGY 60
           +G+G  A     +   + +VFA K   +PKS  L+  Q+           SL   H+VG+
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKI--VPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 82
Query: 61  KGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNR 120
            G     EDN  ++ + +E     +L  E+H+    L E     Y RQI+ G +YLH NR
Sbjct: 83  HG---FFEDNDFVF-VVLELCRRRSLL-ELHKRRKALTEPEARYYLRQIVLGCQYLHRNR 137
Query: 121 VVHCDIKSRNILMAES-GAKIADFGCA---KWESEALQS-GGTPMFMAPEVARGEHQGFA 175
           V+H D+K  N+ + E    KI DFG A   +++ E  ++  GTP ++APEV   +   F 
Sbjct: 138 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFE 197
Query: 176 SDIWAVGCTVIEMASGGAPWPNAADPMTVLY--KIAYSRELPEVPAFLSKQANDFLSNCL 233
            D+W++GC +  +  G  P+  +    T L   K  YS     +P  ++  A   +   L
Sbjct: 198 VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS-----IPKHINPVAASLIQKML 252
Query: 234 RRDPKERWAASQLLKHPFL 252
           + DP  R   ++LL   F 
Sbjct: 253 QTDPTARPTINELLNDEFF 271

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 78/266 (29%), Positives = 124/266 (46%), Gaps = 21/266 (7%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKS------TELPKSEFLQREQKFLSSLNSP 55
           D+    T+G GS   V L  S  +G  +A K         L + E    E+  LS +  P
Sbjct: 7   DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHP 66
Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
            I+   G   T +D + ++ + M+Y  GG L   + R   R    +   Y  ++   LEY
Sbjct: 67  FIIRMWG---TFQDAQQIF-MIMDYIEGGELF-SLLRKSQRFPNPVAKFYAAEVCLALEY 121
Query: 116 LHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG-GTPMFMAPEVARGEHQG 173
           LHS  +++ D+K  NIL+ ++G  KI DFG AK+  +      GTP ++APEV   +   
Sbjct: 122 LHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYXLCGTPDYIAPEVVSTKPYN 181
Query: 174 FASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCL 233
            + D W+ G  + EM +G  P+ ++    T  Y+   + EL   P F ++   D LS  +
Sbjct: 182 KSIDWWSFGILIYEMLAGYTPFYDSNTMKT--YEKILNAEL-RFPPFFNEDVKDLLSRLI 238
Query: 234 RRDPKERWAASQ-----LLKHPFLEE 254
            RD  +R    Q     +  HP+ +E
Sbjct: 239 TRDLSQRLGNLQNGTEDVKNHPWFKE 264

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 77/267 (28%), Positives = 125/267 (46%), Gaps = 23/267 (8%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQR--------EQKFLSSLN 53
           D+     +G+GS   V LA   ++   FA K+  L K   L          E++ LS   
Sbjct: 19  DFELHKMLGKGSFGKVFLAEFKKTNQFFAIKA--LKKDVVLMDDDVECTMVEKRVLSLAW 76
Query: 54  SPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGL 113
               + +  C   +++N       MEY  GG L   I ++  + D S    Y  +I+ GL
Sbjct: 77  EHPFLTHMFCTFQTKENLFFV---MEYLNGGDLMYHI-QSCHKFDLSRATFYAAEIILGL 132
Query: 114 EYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAK----WESEALQSGGTPMFMAPEVAR 168
           ++LHS  +V+ D+K  NIL+ + G  KIADFG  K     +++  +  GTP ++APE+  
Sbjct: 133 QFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILL 192
Query: 169 GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDF 228
           G+    + D W+ G  + EM  G +P+ +  D   + + I      P  P +L K+A D 
Sbjct: 193 GQKYNHSVDWWSFGVLLYEMLIGQSPF-HGQDEEELFHSIRMDN--PFYPRWLEKEAKDL 249
Query: 229 LSNCLRRDPKERWAA-SQLLKHPFLEE 254
           L     R+P++R      + +HP   E
Sbjct: 250 LVKLFVREPEKRLGVRGDIRQHPLFRE 276

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 78/259 (30%), Positives = 123/259 (47%), Gaps = 27/259 (10%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQK--------FLSSLNSPHIVGY 60
           +G+G  A     +   + +VFA K   +PKS  L+  Q+           SL   H+VG+
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKI--VPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 86
Query: 61  KGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNR 120
            G     EDN  ++ + +E     +L  E+H+    L E     Y RQI+ G +YLH NR
Sbjct: 87  HG---FFEDNDFVF-VVLELCRRRSLL-ELHKRRKALTEPEARYYLRQIVLGCQYLHRNR 141
Query: 121 VVHCDIKSRNILMAES-GAKIADFGCA---KWESEALQS-GGTPMFMAPEVARGEHQGFA 175
           V+H D+K  N+ + E    KI DFG A   +++ E  ++  GTP ++APEV   +   F 
Sbjct: 142 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFE 201
Query: 176 SDIWAVGCTVIEMASGGAPWPNAADPMTVLY--KIAYSRELPEVPAFLSKQANDFLSNCL 233
            D+W++GC +  +  G  P+  +    T L   K  YS     +P  ++  A   +   L
Sbjct: 202 VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS-----IPKHINPVAASLIQKML 256
Query: 234 RRDPKERWAASQLLKHPFL 252
           + DP  R   ++LL   F 
Sbjct: 257 QTDPTARPTINELLNDEFF 275

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 86/302 (28%), Positives = 134/302 (44%), Gaps = 47/302 (15%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL-------PKSEFLQREQKFLSSLNS 54
           ++ +   IG+G+   V  A +  +G+V A K   L       P +    RE   L  LN 
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI--REISLLKELNH 61
Query: 55  PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLE 114
           P+IV  K  DV   +NKL       +       D     G  L   LI SY  Q+LQGL 
Sbjct: 62  PNIV--KLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL--PLIKSYLFQLLQGLS 117
Query: 115 YLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSGG----TPMFMAPEVARG 169
           + HS+RV+H D+K +N+L+   GA K+ADFG A+     +++      T  + APE+  G
Sbjct: 118 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 177
Query: 170 -EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPE------------ 216
            ++   A DIW++GC   EM +  A +P  ++ +  L++I  +   P+            
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPDEVVWPGVTSMPD 236
Query: 217 -VPAF--------------LSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQ 261
             P+F              L +     LS  L  DP +R +A   L HPF ++       
Sbjct: 237 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPH 296
Query: 262 IQ 263
           ++
Sbjct: 297 LR 298

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 86/302 (28%), Positives = 134/302 (44%), Gaps = 47/302 (15%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL-------PKSEFLQREQKFLSSLNS 54
           ++ +   IG+G+   V  A +  +G+V A K   L       P +    RE   L  LN 
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI--REISLLKELNH 61
Query: 55  PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLE 114
           P+IV  K  DV   +NKL       +       D     G  L   LI SY  Q+LQGL 
Sbjct: 62  PNIV--KLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL--PLIKSYLFQLLQGLA 117
Query: 115 YLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSGG----TPMFMAPEVARG 169
           + HS+RV+H D+K +N+L+   GA K+ADFG A+     +++      T  + APE+  G
Sbjct: 118 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 177
Query: 170 -EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPE------------ 216
            ++   A DIW++GC   EM +  A +P  ++ +  L++I  +   P+            
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPDEVVWPGVTSMPD 236
Query: 217 -VPAF--------------LSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQ 261
             P+F              L +     LS  L  DP +R +A   L HPF ++       
Sbjct: 237 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPH 296
Query: 262 IQ 263
           ++
Sbjct: 297 LR 298

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 81/259 (31%), Positives = 123/259 (47%), Gaps = 27/259 (10%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFL---QREQKFLS-----SLNSPHIVGY 60
           +G+G  A     +   + +VFA K   +PKS  L   QRE+  +      SL   H+VG+
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKI--VPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 80
Query: 61  KGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNR 120
            G     EDN  ++ + +E     +L  E+H+    L E     Y RQI+ G +YLH NR
Sbjct: 81  HG---FFEDNDFVF-VVLELCRRRSLL-ELHKRRKALTEPEARYYLRQIVLGCQYLHRNR 135
Query: 121 VVHCDIKSRNILMAES-GAKIADFGCA-KWESEALQSG---GTPMFMAPEVARGEHQGFA 175
           V+H D+K  N+ + E    KI DFG A K E +  +     GTP ++APEV   +   F 
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFE 195
Query: 176 SDIWAVGCTVIEMASGGAPWPNAADPMTVLY--KIAYSRELPEVPAFLSKQANDFLSNCL 233
            D+W++GC +  +  G  P+  +    T L   K  YS     +P  ++  A   +   L
Sbjct: 196 VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS-----IPKHINPVAASLIQKML 250
Query: 234 RRDPKERWAASQLLKHPFL 252
           + DP  R   ++LL   F 
Sbjct: 251 QTDPTARPTINELLNDEFF 269

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 86/302 (28%), Positives = 134/302 (44%), Gaps = 47/302 (15%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL-------PKSEFLQREQKFLSSLNS 54
           ++ +   IG+G+   V  A +  +G+V A K   L       P +    RE   L  LN 
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI--REISLLKELNH 60
Query: 55  PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLE 114
           P+IV  K  DV   +NKL       +       D     G  L   LI SY  Q+LQGL 
Sbjct: 61  PNIV--KLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL--PLIKSYLFQLLQGLA 116
Query: 115 YLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSGG----TPMFMAPEVARG 169
           + HS+RV+H D+K +N+L+   GA K+ADFG A+     +++      T  + APE+  G
Sbjct: 117 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176
Query: 170 -EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPE------------ 216
            ++   A DIW++GC   EM +  A +P  ++ +  L++I  +   P+            
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPDEVVWPGVTSMPD 235
Query: 217 -VPAF--------------LSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQ 261
             P+F              L +     LS  L  DP +R +A   L HPF ++       
Sbjct: 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPH 295
Query: 262 IQ 263
           ++
Sbjct: 296 LR 297

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 87/302 (28%), Positives = 134/302 (44%), Gaps = 47/302 (15%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL-------PKSEFLQREQKFLSSLNS 54
           ++ +   IG+G+   V  A +  +G+V A K   L       P +    RE   L  LN 
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI--REISLLKELNH 61
Query: 55  PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLE 114
           P+IV  K  DV   +NKL       +       D     G  L   LI SY  Q+LQGL 
Sbjct: 62  PNIV--KLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL--PLIKSYLFQLLQGLA 117
Query: 115 YLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSGG----TPMFMAPEVARG 169
           + HS+RV+H D+K +N+L+   GA K+ADFG A+     +++      T  + APE+  G
Sbjct: 118 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 177
Query: 170 -EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPE------------ 216
            ++   A DIW++GC   EM +  A +P  ++ +  L++I  +   P+            
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPDEVVWPGVTSMPD 236
Query: 217 -VPAFLSKQANDF--------------LSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQ 261
             P+F      DF              LS  L  DP +R +A   L HPF ++       
Sbjct: 237 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPH 296
Query: 262 IQ 263
           ++
Sbjct: 297 LR 298

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 86/302 (28%), Positives = 134/302 (44%), Gaps = 47/302 (15%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL-------PKSEFLQREQKFLSSLNS 54
           ++ +   IG+G+   V  A +  +G+V A K   L       P +    RE   L  LN 
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI--REISLLKELNH 61
Query: 55  PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLE 114
           P+IV  K  DV   +NKL       +       D     G  L   LI SY  Q+LQGL 
Sbjct: 62  PNIV--KLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL--PLIKSYLFQLLQGLA 117
Query: 115 YLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSGG----TPMFMAPEVARG 169
           + HS+RV+H D+K +N+L+   GA K+ADFG A+     +++      T  + APE+  G
Sbjct: 118 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 177
Query: 170 -EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPE------------ 216
            ++   A DIW++GC   EM +  A +P  ++ +  L++I  +   P+            
Sbjct: 178 XKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPDEVVWPGVTSMPD 236
Query: 217 -VPAF--------------LSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQ 261
             P+F              L +     LS  L  DP +R +A   L HPF ++       
Sbjct: 237 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPH 296
Query: 262 IQ 263
           ++
Sbjct: 297 LR 298

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 86/302 (28%), Positives = 134/302 (44%), Gaps = 47/302 (15%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL-------PKSEFLQREQKFLSSLNS 54
           ++ +   IG+G+   V  A +  +G+V A K   L       P +    RE   L  LN 
Sbjct: 8   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI--REISLLKELNH 65
Query: 55  PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLE 114
           P+IV  K  DV   +NKL       +       D     G  L   LI SY  Q+LQGL 
Sbjct: 66  PNIV--KLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL--PLIKSYLFQLLQGLA 121
Query: 115 YLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSGG----TPMFMAPEVARG 169
           + HS+RV+H D+K +N+L+   GA K+ADFG A+     +++      T  + APE+  G
Sbjct: 122 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 181
Query: 170 -EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPE------------ 216
            ++   A DIW++GC   EM +  A +P  ++ +  L++I  +   P+            
Sbjct: 182 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPDEVVWPGVTSMPD 240
Query: 217 -VPAF--------------LSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQ 261
             P+F              L +     LS  L  DP +R +A   L HPF ++       
Sbjct: 241 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPH 300
Query: 262 IQ 263
           ++
Sbjct: 301 LR 302

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 87/302 (28%), Positives = 134/302 (44%), Gaps = 47/302 (15%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL-------PKSEFLQREQKFLSSLNS 54
           ++ +   IG+G+   V  A +  +G+V A K   L       P +    RE   L  LN 
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI--REISLLKELNH 61
Query: 55  PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLE 114
           P+IV  K  DV   +NKL       +       D     G  L   LI SY  Q+LQGL 
Sbjct: 62  PNIV--KLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL--PLIKSYLFQLLQGLA 117
Query: 115 YLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSGG----TPMFMAPEVARG 169
           + HS+RV+H D+K +N+L+   GA K+ADFG A+     +++      T  + APE+  G
Sbjct: 118 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 177
Query: 170 -EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPE------------ 216
            ++   A DIW++GC   EM +  A +P  ++ +  L++I  +   P+            
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPDEVVWPGVTSMPD 236
Query: 217 -VPAFLSKQANDF--------------LSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQ 261
             P+F      DF              LS  L  DP +R +A   L HPF ++       
Sbjct: 237 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPH 296
Query: 262 IQ 263
           ++
Sbjct: 297 LR 298

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 87/302 (28%), Positives = 134/302 (44%), Gaps = 47/302 (15%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL-------PKSEFLQREQKFLSSLNS 54
           ++ +   IG+G+   V  A +  +G+V A K   L       P +    RE   L  LN 
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI--REISLLKELNH 60
Query: 55  PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLE 114
           P+IV  K  DV   +NKL       +       D     G  L   LI SY  Q+LQGL 
Sbjct: 61  PNIV--KLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL--PLIKSYLFQLLQGLA 116
Query: 115 YLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSGG----TPMFMAPEVARG 169
           + HS+RV+H D+K +N+L+   GA K+ADFG A+     +++      T  + APE+  G
Sbjct: 117 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176
Query: 170 -EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPE------------ 216
            ++   A DIW++GC   EM +  A +P  ++ +  L++I  +   P+            
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPDEVVWPGVTSMPD 235
Query: 217 -VPAFLSKQANDF--------------LSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQ 261
             P+F      DF              LS  L  DP +R +A   L HPF ++       
Sbjct: 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPH 295
Query: 262 IQ 263
           ++
Sbjct: 296 LR 297

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 86/302 (28%), Positives = 134/302 (44%), Gaps = 47/302 (15%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL-------PKSEFLQREQKFLSSLNS 54
           ++ +   IG+G+   V  A +  +G+V A K   L       P +    RE   L  LN 
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI--REISLLKELNH 60
Query: 55  PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLE 114
           P+IV  K  DV   +NKL       +       D     G  L   LI SY  Q+LQGL 
Sbjct: 61  PNIV--KLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL--PLIKSYLFQLLQGLA 116
Query: 115 YLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSGG----TPMFMAPEVARG 169
           + HS+RV+H D+K +N+L+   GA K+ADFG A+     +++      T  + APE+  G
Sbjct: 117 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 176
Query: 170 -EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPE------------ 216
            ++   A DIW++GC   EM +  A +P  ++ +  L++I  +   P+            
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPDEVVWPGVTSMPD 235
Query: 217 -VPAF--------------LSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQ 261
             P+F              L +     LS  L  DP +R +A   L HPF ++       
Sbjct: 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPH 295
Query: 262 IQ 263
           ++
Sbjct: 296 LR 297

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 86/293 (29%), Positives = 132/293 (45%), Gaps = 47/293 (16%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL-------PKSEFLQREQKFLSSLNS 54
           ++ +   IG+G+   V  A +  +G+V A K   L       P +    RE   L  LN 
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI--REISLLKELNH 61
Query: 55  PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLE 114
           P+IV  K  DV   +NKL       +       D     G  L   LI SY  Q+LQGL 
Sbjct: 62  PNIV--KLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL--PLIKSYLFQLLQGLA 117
Query: 115 YLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSGG----TPMFMAPEVARG 169
           + HS+RV+H D+K +N+L+   GA K+ADFG A+     +++      T  + APE+  G
Sbjct: 118 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 177
Query: 170 -EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPE------------ 216
            ++   A DIW++GC   EM +  A +P  ++ +  L++I  +   P+            
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPDEVVWPGVTSMPD 236
Query: 217 -VPAF--------------LSKQANDFLSNCLRRDPKERWAASQLLKHPFLEE 254
             P+F              L +     LS  L  DP +R +A   L HPF ++
Sbjct: 237 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 86/302 (28%), Positives = 134/302 (44%), Gaps = 47/302 (15%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL-------PKSEFLQREQKFLSSLNS 54
           ++ +   IG+G+   V  A +  +G+V A K   L       P +    RE   L  LN 
Sbjct: 11  NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI--REISLLKELNH 68
Query: 55  PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLE 114
           P+IV  K  DV   +NKL       +       D     G  L   LI SY  Q+LQGL 
Sbjct: 69  PNIV--KLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL--PLIKSYLFQLLQGLA 124
Query: 115 YLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSGG----TPMFMAPEVARG 169
           + HS+RV+H D+K +N+L+   GA K+ADFG A+     +++      T  + APE+  G
Sbjct: 125 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 184
Query: 170 -EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPE------------ 216
            ++   A DIW++GC   EM +  A +P  ++ +  L++I  +   P+            
Sbjct: 185 XKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPDEVVWPGVTSMPD 243
Query: 217 -VPAF--------------LSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQ 261
             P+F              L +     LS  L  DP +R +A   L HPF ++       
Sbjct: 244 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPH 303
Query: 262 IQ 263
           ++
Sbjct: 304 LR 305

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 86/302 (28%), Positives = 134/302 (44%), Gaps = 47/302 (15%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL-------PKSEFLQREQKFLSSLNS 54
           ++ +   IG+G+   V  A +  +G+V A K   L       P +    RE   L  LN 
Sbjct: 8   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI--REISLLKELNH 65
Query: 55  PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLE 114
           P+IV  K  DV   +NKL       +       D     G  L   LI SY  Q+LQGL 
Sbjct: 66  PNIV--KLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL--PLIKSYLFQLLQGLA 121
Query: 115 YLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSGG----TPMFMAPEVARG 169
           + HS+RV+H D+K +N+L+   GA K+ADFG A+     +++      T  + APE+  G
Sbjct: 122 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 181
Query: 170 -EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPE------------ 216
            ++   A DIW++GC   EM +  A +P  ++ +  L++I  +   P+            
Sbjct: 182 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPDEVVWPGVTSMPD 240
Query: 217 -VPAF--------------LSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQ 261
             P+F              L +     LS  L  DP +R +A   L HPF ++       
Sbjct: 241 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPH 300
Query: 262 IQ 263
           ++
Sbjct: 301 LR 302

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 77/267 (28%), Positives = 124/267 (46%), Gaps = 23/267 (8%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQR--------EQKFLSSLN 53
           D+     +G+GS   V LA   ++   FA K+  L K   L          E++ LS   
Sbjct: 18  DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKA--LKKDVVLMDDDVECTMVEKRVLSLAW 75
Query: 54  SPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGL 113
               + +  C   +++N       MEY  GG L   I ++  + D S    Y  +I+ GL
Sbjct: 76  EHPFLTHMFCTFQTKENLFFV---MEYLNGGDLMYHI-QSCHKFDLSRATFYAAEIILGL 131
Query: 114 EYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAK----WESEALQSGGTPMFMAPEVAR 168
           ++LHS  +V+ D+K  NIL+ + G  KIADFG  K     +++     GTP ++APE+  
Sbjct: 132 QFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILL 191
Query: 169 GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDF 228
           G+    + D W+ G  + EM  G +P+ +  D   + + I      P  P +L K+A D 
Sbjct: 192 GQKYNHSVDWWSFGVLLYEMLIGQSPF-HGQDEEELFHSIRMDN--PFYPRWLEKEAKDL 248
Query: 229 LSNCLRRDPKERWAA-SQLLKHPFLEE 254
           L     R+P++R      + +HP   E
Sbjct: 249 LVKLFVREPEKRLGVRGDIRQHPLFRE 275

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 79/259 (30%), Positives = 121/259 (46%), Gaps = 27/259 (10%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQK--------FLSSLNSPHIVGY 60
           +G+G  A     +   + +VFA K   +PKS  L+  Q+           SL   H+VG+
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKI--VPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 104
Query: 61  KGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNR 120
            G     EDN  ++ + +E     +L  E+H+    L E     Y RQI+ G +YLH NR
Sbjct: 105 HG---FFEDNDFVF-VVLELCRRRSLL-ELHKRRKALTEPEARYYLRQIVLGCQYLHRNR 159
Query: 121 VVHCDIKSRNILMAES-GAKIADFGCA-KWESEALQSG---GTPMFMAPEVARGEHQGFA 175
           V+H D+K  N+ + E    KI DFG A K E +  +     GTP ++APEV   +   F 
Sbjct: 160 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFE 219
Query: 176 SDIWAVGCTVIEMASGGAPWPNAADPMTVLY--KIAYSRELPEVPAFLSKQANDFLSNCL 233
            D+W++GC +  +  G  P+  +    T L   K  YS     +P  ++  A   +   L
Sbjct: 220 VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS-----IPKHINPVAASLIQKML 274
Query: 234 RRDPKERWAASQLLKHPFL 252
           + DP  R   ++LL   F 
Sbjct: 275 QTDPTARPTINELLNDEFF 293

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 86/302 (28%), Positives = 134/302 (44%), Gaps = 47/302 (15%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL-------PKSEFLQREQKFLSSLNS 54
           ++ +   IG+G+   V  A +  +G+V A K   L       P +    RE   L  LN 
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI--REISLLKELNH 62
Query: 55  PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLE 114
           P+IV  K  DV   +NKL       +       D     G  L   LI SY  Q+LQGL 
Sbjct: 63  PNIV--KLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL--PLIKSYLFQLLQGLA 118
Query: 115 YLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSGG----TPMFMAPEVARG 169
           + HS+RV+H D+K +N+L+   GA K+ADFG A+     +++      T  + APE+  G
Sbjct: 119 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 178
Query: 170 -EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPE------------ 216
            ++   A DIW++GC   EM +  A +P  ++ +  L++I  +   P+            
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPDEVVWPGVTSMPD 237
Query: 217 -VPAF--------------LSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQ 261
             P+F              L +     LS  L  DP +R +A   L HPF ++       
Sbjct: 238 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPH 297
Query: 262 IQ 263
           ++
Sbjct: 298 LR 299

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 86/302 (28%), Positives = 134/302 (44%), Gaps = 47/302 (15%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL-------PKSEFLQREQKFLSSLNS 54
           ++ +   IG+G+   V  A +  +G+V A K   L       P +    RE   L  LN 
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI--REISLLKELNH 62
Query: 55  PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLE 114
           P+IV  K  DV   +NKL       +       D     G  L   LI SY  Q+LQGL 
Sbjct: 63  PNIV--KLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL--PLIKSYLFQLLQGLA 118
Query: 115 YLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSGG----TPMFMAPEVARG 169
           + HS+RV+H D+K +N+L+   GA K+ADFG A+     +++      T  + APE+  G
Sbjct: 119 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 178
Query: 170 -EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPE------------ 216
            ++   A DIW++GC   EM +  A +P  ++ +  L++I  +   P+            
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPDEVVWPGVTSMPD 237
Query: 217 -VPAF--------------LSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQ 261
             P+F              L +     LS  L  DP +R +A   L HPF ++       
Sbjct: 238 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPH 297
Query: 262 IQ 263
           ++
Sbjct: 298 LR 299

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 86/302 (28%), Positives = 134/302 (44%), Gaps = 47/302 (15%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL-------PKSEFLQREQKFLSSLNS 54
           ++ +   IG+G+   V  A +  +G+V A K   L       P +    RE   L  LN 
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI--REISLLKELNH 61
Query: 55  PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLE 114
           P+IV  K  DV   +NKL       +       D     G  L   LI SY  Q+LQGL 
Sbjct: 62  PNIV--KLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL--PLIKSYLFQLLQGLA 117
Query: 115 YLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSGG----TPMFMAPEVARG 169
           + HS+RV+H D+K +N+L+   GA K+ADFG A+     +++      T  + APE+  G
Sbjct: 118 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 177
Query: 170 -EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPE------------ 216
            ++   A DIW++GC   EM +  A +P  ++ +  L++I  +   P+            
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPDEVVWPGVTSMPD 236
Query: 217 -VPAF--------------LSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQ 261
             P+F              L +     LS  L  DP +R +A   L HPF ++       
Sbjct: 237 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPH 296
Query: 262 IQ 263
           ++
Sbjct: 297 LR 298

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 86/302 (28%), Positives = 134/302 (44%), Gaps = 47/302 (15%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL-------PKSEFLQREQKFLSSLNS 54
           ++ +   IG+G+   V  A +  +G+V A K   L       P +    RE   L  LN 
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI--REISLLKELNH 64
Query: 55  PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLE 114
           P+IV  K  DV   +NKL       +       D     G  L   LI SY  Q+LQGL 
Sbjct: 65  PNIV--KLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL--PLIKSYLFQLLQGLA 120
Query: 115 YLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSGG----TPMFMAPEVARG 169
           + HS+RV+H D+K +N+L+   GA K+ADFG A+     +++      T  + APE+  G
Sbjct: 121 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 180
Query: 170 -EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPE------------ 216
            ++   A DIW++GC   EM +  A +P  ++ +  L++I  +   P+            
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPDEVVWPGVTSMPD 239
Query: 217 -VPAF--------------LSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQ 261
             P+F              L +     LS  L  DP +R +A   L HPF ++       
Sbjct: 240 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPH 299
Query: 262 IQ 263
           ++
Sbjct: 300 LR 301

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 86/302 (28%), Positives = 134/302 (44%), Gaps = 47/302 (15%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL-------PKSEFLQREQKFLSSLNS 54
           ++ +   IG+G+   V  A +  +G+V A K   L       P +    RE   L  LN 
Sbjct: 6   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI--REISLLKELNH 63
Query: 55  PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLE 114
           P+IV  K  DV   +NKL       +       D     G  L   LI SY  Q+LQGL 
Sbjct: 64  PNIV--KLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL--PLIKSYLFQLLQGLA 119
Query: 115 YLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSGG----TPMFMAPEVARG 169
           + HS+RV+H D+K +N+L+   GA K+ADFG A+     +++      T  + APE+  G
Sbjct: 120 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 179
Query: 170 -EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPE------------ 216
            ++   A DIW++GC   EM +  A +P  ++ +  L++I  +   P+            
Sbjct: 180 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPDEVVWPGVTSMPD 238
Query: 217 -VPAF--------------LSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQ 261
             P+F              L +     LS  L  DP +R +A   L HPF ++       
Sbjct: 239 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPH 298
Query: 262 IQ 263
           ++
Sbjct: 299 LR 300

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 86/302 (28%), Positives = 134/302 (44%), Gaps = 47/302 (15%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL-------PKSEFLQREQKFLSSLNS 54
           ++ +   IG+G+   V  A +  +G+V A K   L       P +    RE   L  LN 
Sbjct: 6   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI--REISLLKELNH 63
Query: 55  PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLE 114
           P+IV  K  DV   +NKL       +       D     G  L   LI SY  Q+LQGL 
Sbjct: 64  PNIV--KLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL--PLIKSYLFQLLQGLA 119
Query: 115 YLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSGG----TPMFMAPEVARG 169
           + HS+RV+H D+K +N+L+   GA K+ADFG A+     +++      T  + APE+  G
Sbjct: 120 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 179
Query: 170 -EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPE------------ 216
            ++   A DIW++GC   EM +  A +P  ++ +  L++I  +   P+            
Sbjct: 180 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPDEVVWPGVTSMPD 238
Query: 217 -VPAF--------------LSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQ 261
             P+F              L +     LS  L  DP +R +A   L HPF ++       
Sbjct: 239 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPH 298
Query: 262 IQ 263
           ++
Sbjct: 299 LR 300

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 77/263 (29%), Positives = 122/263 (46%), Gaps = 19/263 (7%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFL------QREQKFLSSLNSPH 56
           +  G T+G G+   V +     +G   A K     K   L      +RE + L     PH
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPH 72
Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL 116
           I+       T  D    + + MEY  GG L D I ++G R++E       +QIL  ++Y 
Sbjct: 73  IIKLYQVISTPTD----FFMVMEYVSGGELFDYICKHG-RVEEMEARRLFQQILSAVDYC 127
Query: 117 HSNRVVHCDIKSRNILM-AESGAKIADFGCAKWESEA---LQSGGTPMFMAPEVARGE-H 171
           H + VVH D+K  N+L+ A   AKIADFG +   S+      S G+P + APEV  G  +
Sbjct: 128 HRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSCGSPNYAAPEVISGRLY 187
Query: 172 QGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSN 231
            G   DIW+ G  +  +  G  P+ +   P T+  KI     +  +P +L++     L +
Sbjct: 188 AGPEVDIWSCGVILYALLCGTLPFDDEHVP-TLFKKIRGG--VFYIPEYLNRSVATLLMH 244
Query: 232 CLRRDPKERWAASQLLKHPFLEE 254
            L+ DP +R     + +H + ++
Sbjct: 245 MLQVDPLKRATIKDIREHEWFKQ 267

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 97.8 bits (242), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 86/302 (28%), Positives = 134/302 (44%), Gaps = 47/302 (15%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL-------PKSEFLQREQKFLSSLNS 54
           ++ +   IG+G+   V  A +  +G+V A K   L       P +    RE   L  LN 
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI--REISLLKELNH 64
Query: 55  PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLE 114
           P+IV  K  DV   +NKL       +       D     G  L   LI SY  Q+LQGL 
Sbjct: 65  PNIV--KLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL--PLIKSYLFQLLQGLA 120
Query: 115 YLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSGG----TPMFMAPEVARG 169
           + HS+RV+H D+K +N+L+   GA K+ADFG A+     +++      T  + APE+  G
Sbjct: 121 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 180
Query: 170 -EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPE------------ 216
            ++   A DIW++GC   EM +  A +P  ++ +  L++I  +   P+            
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPDEVVWPGVTSMPD 239
Query: 217 -VPAF--------------LSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQ 261
             P+F              L +     LS  L  DP +R +A   L HPF ++       
Sbjct: 240 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPH 299
Query: 262 IQ 263
           ++
Sbjct: 300 LR 301

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 97.8 bits (242), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 86/293 (29%), Positives = 132/293 (45%), Gaps = 47/293 (16%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL-------PKSEFLQREQKFLSSLNS 54
           ++ +   IG+G+   V  A +  +G+V A K   L       P +    RE   L  LN 
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI--REISLLKELNH 61
Query: 55  PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLE 114
           P+IV  K  DV   +NKL       +       D     G  L   LI SY  Q+LQGL 
Sbjct: 62  PNIV--KLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL--PLIKSYLFQLLQGLA 117
Query: 115 YLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSGG----TPMFMAPEVARG 169
           + HS+RV+H D+K +N+L+   GA K+ADFG A+     +++      T  + APE+  G
Sbjct: 118 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 177
Query: 170 -EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPE------------ 216
            ++   A DIW++GC   EM +  A +P  ++ +  L++I  +   P+            
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPDEVVWPGVTSMPD 236
Query: 217 -VPAF--------------LSKQANDFLSNCLRRDPKERWAASQLLKHPFLEE 254
             P+F              L +     LS  L  DP +R +A   L HPF ++
Sbjct: 237 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 86/293 (29%), Positives = 132/293 (45%), Gaps = 47/293 (16%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL-------PKSEFLQREQKFLSSLNS 54
           ++ +   IG+G+   V  A +  +G+V A K   L       P +    RE   L  LN 
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI--REISLLKELNH 62
Query: 55  PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLE 114
           P+IV  K  DV   +NKL       +       D     G  L   LI SY  Q+LQGL 
Sbjct: 63  PNIV--KLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL--PLIKSYLFQLLQGLA 118
Query: 115 YLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSGG----TPMFMAPEVARG 169
           + HS+RV+H D+K +N+L+   GA K+ADFG A+     +++      T  + APE+  G
Sbjct: 119 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 178
Query: 170 -EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPE------------ 216
            ++   A DIW++GC   EM +  A +P  ++ +  L++I  +   P+            
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPDEVVWPGVTSMPD 237
Query: 217 -VPAF--------------LSKQANDFLSNCLRRDPKERWAASQLLKHPFLEE 254
             P+F              L +     LS  L  DP +R +A   L HPF ++
Sbjct: 238 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 290

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 84/256 (32%), Positives = 126/256 (49%), Gaps = 23/256 (8%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELP---KSEFLQREQKFL---SSLNSPHIVGYKG 62
           +G G  +TV LA         A K+  +P   K E L+R ++ +   S L+  +IV    
Sbjct: 19  LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM-- 76
Query: 63  CDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
            DV  ED+   Y L MEY  G TL++ I  +G  L     +++T QIL G+++ H  R+V
Sbjct: 77  IDVDEEDD--CYYLVMEYIEGPTLSEYIESHGP-LSVDTAINFTNQILDGIKHAHDMRIV 133
Query: 123 HCDIKSRNILM-AESGAKIADFGCAKWESEA--LQSG---GTPMFMAPEVARGEHQGFAS 176
           H DIK +NIL+ +    KI DFG AK  SE    Q+    GT  + +PE A+GE     +
Sbjct: 134 HRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECT 193
Query: 177 DIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRR- 235
           DI+++G  + EM  G  P+ N    +++  K      +P V   + K     LSN + R 
Sbjct: 194 DIYSIGIVLYEMLVGEPPF-NGETAVSIAIK-HIQDSVPNVTTDVRKDIPQSLSNVILRA 251
Query: 236 ---DPKERWAASQLLK 248
              D   R+   Q +K
Sbjct: 252 TEKDKANRYKTIQEMK 267

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 77/263 (29%), Positives = 122/263 (46%), Gaps = 19/263 (7%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFL------QREQKFLSSLNSPH 56
           +  G T+G G+   V +     +G   A K     K   L      +RE + L     PH
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPH 72
Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL 116
           I+       T  D    + + MEY  GG L D I ++G R++E       +QIL  ++Y 
Sbjct: 73  IIKLYQVISTPTD----FFMVMEYVSGGELFDYICKHG-RVEEMEARRLFQQILSAVDYC 127
Query: 117 HSNRVVHCDIKSRNILM-AESGAKIADFGCAKWESEA---LQSGGTPMFMAPEVARGE-H 171
           H + VVH D+K  N+L+ A   AKIADFG +   S+      S G+P + APEV  G  +
Sbjct: 128 HRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLY 187
Query: 172 QGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSN 231
            G   DIW+ G  +  +  G  P+ +   P T+  KI     +  +P +L++     L +
Sbjct: 188 AGPEVDIWSCGVILYALLCGTLPFDDEHVP-TLFKKIRGG--VFYIPEYLNRSVATLLMH 244
Query: 232 CLRRDPKERWAASQLLKHPFLEE 254
            L+ DP +R     + +H + ++
Sbjct: 245 MLQVDPLKRATIKDIREHEWFKQ 267

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 86/293 (29%), Positives = 132/293 (45%), Gaps = 47/293 (16%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL-------PKSEFLQREQKFLSSLNS 54
           ++ +   IG+G+   V  A +  +G+V A K   L       P +    RE   L  LN 
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI--REISLLKELNH 60
Query: 55  PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLE 114
           P+IV  K  DV   +NKL       +       D     G  L   LI SY  Q+LQGL 
Sbjct: 61  PNIV--KLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL--PLIKSYLFQLLQGLA 116
Query: 115 YLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSGG----TPMFMAPEVARG 169
           + HS+RV+H D+K +N+L+   GA K+ADFG A+     +++      T  + APE+  G
Sbjct: 117 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 176
Query: 170 -EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPE------------ 216
            ++   A DIW++GC   EM +  A +P  ++ +  L++I  +   P+            
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPDEVVWPGVTSMPD 235
Query: 217 -VPAF--------------LSKQANDFLSNCLRRDPKERWAASQLLKHPFLEE 254
             P+F              L +     LS  L  DP +R +A   L HPF ++
Sbjct: 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 66/187 (35%), Positives = 97/187 (51%), Gaps = 9/187 (4%)
Query: 76  LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAE 135
           L MEY  GG L D I      L E   + + +QI +G+ ++H   ++H D+K  NIL   
Sbjct: 163 LVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVN 222
Query: 136 SGA---KIADFGCAKWES--EALQSG-GTPMFMAPEVARGEHQGFASDIWAVGCTVIEMA 189
             A   KI DFG A+     E L+   GTP F+APEV   +   F +D+W+VG     + 
Sbjct: 223 RDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLL 282
Query: 190 SGGAPWPNAADPMTVLYKIAYSRELPEVPAF--LSKQANDFLSNCLRRDPKERWAASQLL 247
           SG +P+    D  T L  I   R   E   F  +S++A +F+S  L ++   R +AS+ L
Sbjct: 283 SGLSPFLGDNDAET-LNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEAL 341
Query: 248 KHPFLEE 254
           KHP+L +
Sbjct: 342 KHPWLSD 348

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 79/259 (30%), Positives = 121/259 (46%), Gaps = 27/259 (10%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQK--------FLSSLNSPHIVGY 60
           +G+G  A     +   + +VFA K   +PKS  L+  Q+           SL   H+VG+
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKI--VPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 106
Query: 61  KGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNR 120
            G     EDN  ++ + +E     +L  E+H+    L E     Y RQI+ G +YLH NR
Sbjct: 107 HG---FFEDNDFVF-VVLELCRRRSLL-ELHKRRKALTEPEARYYLRQIVLGCQYLHRNR 161
Query: 121 VVHCDIKSRNILMAES-GAKIADFGCA-KWESEALQSG---GTPMFMAPEVARGEHQGFA 175
           V+H D+K  N+ + E    KI DFG A K E +  +     GTP ++APEV   +   F 
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFE 221
Query: 176 SDIWAVGCTVIEMASGGAPWPNAADPMTVLY--KIAYSRELPEVPAFLSKQANDFLSNCL 233
            D+W++GC +  +  G  P+  +    T L   K  YS     +P  ++  A   +   L
Sbjct: 222 VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS-----IPKHINPVAASLIQKML 276
Query: 234 RRDPKERWAASQLLKHPFL 252
           + DP  R   ++LL   F 
Sbjct: 277 QTDPTARPTINELLNDEFF 295

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 86/302 (28%), Positives = 134/302 (44%), Gaps = 47/302 (15%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL-------PKSEFLQREQKFLSSLNS 54
           ++ +   IG+G+   V  A +  +G+V A K   L       P +    RE   L  LN 
Sbjct: 11  NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI--REISLLKELNH 68
Query: 55  PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLE 114
           P+IV  K  DV   +NKL       +       D     G  L   LI SY  Q+LQGL 
Sbjct: 69  PNIV--KLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL--PLIKSYLFQLLQGLA 124
Query: 115 YLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSGG----TPMFMAPEVARG 169
           + HS+RV+H D+K +N+L+   GA K+ADFG A+     +++      T  + APE+  G
Sbjct: 125 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 184
Query: 170 -EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPE------------ 216
            ++   A DIW++GC   EM +  A +P  ++ +  L++I  +   P+            
Sbjct: 185 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPDEVVWPGVTSMPD 243
Query: 217 -VPAF--------------LSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQ 261
             P+F              L +     LS  L  DP +R +A   L HPF ++       
Sbjct: 244 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPH 303
Query: 262 IQ 263
           ++
Sbjct: 304 LR 305

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 86/302 (28%), Positives = 133/302 (44%), Gaps = 47/302 (15%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL-------PKSEFLQREQKFLSSLNS 54
           ++ +   IG+G+   V  A +  +G+V A K   L       P +    RE   L  LN 
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI--REISLLKELNH 62
Query: 55  PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLE 114
           P+IV  K  DV   +NKL       +       D     G  L   LI SY  Q+LQGL 
Sbjct: 63  PNIV--KLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL--PLIKSYLFQLLQGLA 118
Query: 115 YLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSGG----TPMFMAPEVARG 169
           + HS+RV+H D+K  N+L+   GA K+ADFG A+     +++      T  + APE+  G
Sbjct: 119 FCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 178
Query: 170 -EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPE------------ 216
            ++   A DIW++GC   EM +  A +P  ++ +  L++I  +   P+            
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPDEVVWPGVTSMPD 237
Query: 217 -VPAF--------------LSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQ 261
             P+F              L +     LS  L  DP +R +A   L HPF ++       
Sbjct: 238 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPH 297
Query: 262 IQ 263
           ++
Sbjct: 298 LR 299

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 86/302 (28%), Positives = 133/302 (44%), Gaps = 47/302 (15%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL-------PKSEFLQREQKFLSSLNS 54
           ++ +   IG+G+   V  A +  +G+V A K   L       P +    RE   L  LN 
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI--REISLLKELNH 61
Query: 55  PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLE 114
           P+IV  K  DV   +NKL       +       D     G  L   LI SY  Q+LQGL 
Sbjct: 62  PNIV--KLLDVIHTENKLYLVFEFLHQDLKDFMDASALTGIPL--PLIKSYLFQLLQGLA 117
Query: 115 YLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSGG----TPMFMAPEVARG 169
           + HS+RV+H D+K  N+L+   GA K+ADFG A+     +++      T  + APE+  G
Sbjct: 118 FCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 177
Query: 170 -EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPE------------ 216
            ++   A DIW++GC   EM +  A +P  ++ +  L++I  +   P+            
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPDEVVWPGVTSMPD 236
Query: 217 -VPAF--------------LSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQ 261
             P+F              L +     LS  L  DP +R +A   L HPF ++       
Sbjct: 237 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPH 296
Query: 262 IQ 263
           ++
Sbjct: 297 LR 298

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 86/302 (28%), Positives = 133/302 (44%), Gaps = 47/302 (15%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL-------PKSEFLQREQKFLSSLNS 54
           ++ +   IG+G+   V  A +  +G+V A K   L       P +    RE   L  LN 
Sbjct: 6   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI--REISLLKELNH 63
Query: 55  PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLE 114
           P+IV  K  DV   +NKL       +       D     G  L   LI SY  Q+LQGL 
Sbjct: 64  PNIV--KLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL--PLIKSYLFQLLQGLA 119
Query: 115 YLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSGG----TPMFMAPEVARG 169
           + HS+RV+H D+K  N+L+   GA K+ADFG A+     +++      T  + APE+  G
Sbjct: 120 FCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 179
Query: 170 -EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPE------------ 216
            ++   A DIW++GC   EM +  A +P  ++ +  L++I  +   P+            
Sbjct: 180 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPDEVVWPGVTSMPD 238
Query: 217 -VPAF--------------LSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQ 261
             P+F              L +     LS  L  DP +R +A   L HPF ++       
Sbjct: 239 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPH 298
Query: 262 IQ 263
           ++
Sbjct: 299 LR 300

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 87/303 (28%), Positives = 138/303 (45%), Gaps = 49/303 (16%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL-------PKSEFLQREQKFLSSLNS 54
           ++ +   IG+G+   V  A +  +G+V A K   L       P +    RE   L  LN 
Sbjct: 6   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI--REISLLKELNH 63
Query: 55  PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNG-GRLDESLIVSYTRQILQGL 113
           P+IV  K  DV   +NKL   L  E+     L D +  +    +   LI SY  Q+LQGL
Sbjct: 64  PNIV--KLLDVIHTENKLY--LVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQLLQGL 118
Query: 114 EYLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSGG----TPMFMAPEVAR 168
            + HS+RV+H D+K +N+L+   GA K+ADFG A+     +++      T  + APE+  
Sbjct: 119 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL 178
Query: 169 G-EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPE----------- 216
           G ++   A DIW++GC   EM +  A +P  ++ +  L++I  +   P+           
Sbjct: 179 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPDEVVWPGVTSMP 237
Query: 217 --VPAF--------------LSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSCTK 260
              P+F              L +     LS  L  DP +R +A   L HPF ++      
Sbjct: 238 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVP 297
Query: 261 QIQ 263
            ++
Sbjct: 298 HLR 300

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 79/271 (29%), Positives = 134/271 (49%), Gaps = 25/271 (9%)
Query: 3   WTRGHTIGQGSSATVSLATSL-----RSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHI 57
           + R   +G G+   V L         R+  +    S     +  L  E   L  L+ P+I
Sbjct: 39  YQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNI 98
Query: 58  VGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEI-HR-NGGRLDESLIVSYTRQILQGLEY 115
           +  K  D    ++K  Y L ME   GG L DEI HR     +D ++I+   +Q+L G+ Y
Sbjct: 99  M--KLYDFF--EDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVII---KQVLSGVTY 151
Query: 116 LHSNRVVHCDIKSRNILM----AESGAKIADFGC-AKWESEA--LQSGGTPMFMAPEVAR 168
           LH + +VH D+K  N+L+     ++  KI DFG  A +E++    +  GT  ++APEV R
Sbjct: 152 LHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLR 211
Query: 169 GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAF--LSKQAN 226
            ++     D+W++G  +  + +G  P+    D   +L K+   +   + P +  +S+ A 
Sbjct: 212 KKYDE-KCDVWSIGVILFILLAGYPPFGGQTDQ-EILRKVEKGKYTFDSPEWKNVSEGAK 269
Query: 227 DFLSNCLRRDPKERWAASQLLKHPFLEEFCS 257
           D +   L+ D + R +A Q L+HP+++E CS
Sbjct: 270 DLIKQMLQFDSQRRISAQQALEHPWIKEMCS 300

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 87/303 (28%), Positives = 138/303 (45%), Gaps = 49/303 (16%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL-------PKSEFLQREQKFLSSLNS 54
           ++ +   IG+G+   V  A +  +G+V A K   L       P +    RE   L  LN 
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI--REISLLKELNH 64
Query: 55  PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNG-GRLDESLIVSYTRQILQGL 113
           P+IV  K  DV   +NKL   L  E+     L D +  +    +   LI SY  Q+LQGL
Sbjct: 65  PNIV--KLLDVIHTENKLY--LVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQLLQGL 119
Query: 114 EYLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSGG----TPMFMAPEVAR 168
            + HS+RV+H D+K +N+L+   GA K+ADFG A+     +++      T  + APE+  
Sbjct: 120 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL 179
Query: 169 G-EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPE----------- 216
           G ++   A DIW++GC   EM +  A +P  ++ +  L++I  +   P+           
Sbjct: 180 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPDEVVWPGVTSMP 238
Query: 217 --VPAF--------------LSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSCTK 260
              P+F              L +     LS  L  DP +R +A   L HPF ++      
Sbjct: 239 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVP 298
Query: 261 QIQ 263
            ++
Sbjct: 299 HLR 301

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 64/197 (32%), Positives = 101/197 (51%), Gaps = 17/197 (8%)
Query: 9   IGQGSSATVSL----ATSLRSGDVFAAKSTELPKSEFL---QREQKFLSSLNSPHIVGYK 61
           +G+G+  +V +         +G+V A K  +    E L   +RE + L SL   +IV YK
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 81
Query: 62  GCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRV 121
           G   ++    L   L MEY P G+L D + ++  R+D   ++ YT QI +G+EYL + R 
Sbjct: 82  GVCYSAGRRNL--KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY 139
Query: 122 VHCDIKSRNILMA-ESGAKIADFGCAKW------ESEALQSGGTPMF-MAPEVARGEHQG 173
           +H D+ +RNIL+  E+  KI DFG  K         +  + G +P+F  APE        
Sbjct: 140 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFS 199
Query: 174 FASDIWAVGCTVIEMAS 190
            ASD+W+ G  + E+ +
Sbjct: 200 VASDVWSFGVVLYELFT 216

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 64/197 (32%), Positives = 101/197 (51%), Gaps = 17/197 (8%)
Query: 9   IGQGSSATVSL----ATSLRSGDVFAAKSTELPKSEFL---QREQKFLSSLNSPHIVGYK 61
           +G+G+  +V +         +G+V A K  +    E L   +RE + L SL   +IV YK
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 75
Query: 62  GCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRV 121
           G   ++    L   L MEY P G+L D + ++  R+D   ++ YT QI +G+EYL + R 
Sbjct: 76  GVCYSAGRRNL--KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY 133
Query: 122 VHCDIKSRNILMA-ESGAKIADFGCAKW------ESEALQSGGTPMF-MAPEVARGEHQG 173
           +H D+ +RNIL+  E+  KI DFG  K         +  + G +P+F  APE        
Sbjct: 134 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFS 193
Query: 174 FASDIWAVGCTVIEMAS 190
            ASD+W+ G  + E+ +
Sbjct: 194 VASDVWSFGVVLYELFT 210

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 64/197 (32%), Positives = 101/197 (51%), Gaps = 17/197 (8%)
Query: 9   IGQGSSATVSL----ATSLRSGDVFAAKSTELPKSEFL---QREQKFLSSLNSPHIVGYK 61
           +G+G+  +V +         +G+V A K  +    E L   +RE + L SL   +IV YK
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 62  GCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRV 121
           G   ++    L   L MEY P G+L D + ++  R+D   ++ YT QI +G+EYL + R 
Sbjct: 81  GVCYSAGRRNL--KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY 138
Query: 122 VHCDIKSRNILMA-ESGAKIADFGCAKW------ESEALQSGGTPMF-MAPEVARGEHQG 173
           +H D+ +RNIL+  E+  KI DFG  K         +  + G +P+F  APE        
Sbjct: 139 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFS 198
Query: 174 FASDIWAVGCTVIEMAS 190
            ASD+W+ G  + E+ +
Sbjct: 199 VASDVWSFGVVLYELFT 215

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 64/197 (32%), Positives = 101/197 (51%), Gaps = 17/197 (8%)
Query: 9   IGQGSSATVSL----ATSLRSGDVFAAKSTELPKSEFL---QREQKFLSSLNSPHIVGYK 61
           +G+G+  +V +         +G+V A K  +    E L   +RE + L SL   +IV YK
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 76
Query: 62  GCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRV 121
           G   ++    L   L MEY P G+L D + ++  R+D   ++ YT QI +G+EYL + R 
Sbjct: 77  GVCYSAGRRNL--KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY 134
Query: 122 VHCDIKSRNILMA-ESGAKIADFGCAKW------ESEALQSGGTPMF-MAPEVARGEHQG 173
           +H D+ +RNIL+  E+  KI DFG  K         +  + G +P+F  APE        
Sbjct: 135 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFS 194
Query: 174 FASDIWAVGCTVIEMAS 190
            ASD+W+ G  + E+ +
Sbjct: 195 VASDVWSFGVVLYELFT 211

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 64/197 (32%), Positives = 101/197 (51%), Gaps = 17/197 (8%)
Query: 9   IGQGSSATVSL----ATSLRSGDVFAAKSTELPKSEFL---QREQKFLSSLNSPHIVGYK 61
           +G+G+  +V +         +G+V A K  +    E L   +RE + L SL   +IV YK
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 62  GCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRV 121
           G   ++    L   L MEY P G+L D + ++  R+D   ++ YT QI +G+EYL + R 
Sbjct: 78  GVCYSAGRRNL--KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY 135
Query: 122 VHCDIKSRNILMA-ESGAKIADFGCAKW------ESEALQSGGTPMF-MAPEVARGEHQG 173
           +H D+ +RNIL+  E+  KI DFG  K         +  + G +P+F  APE        
Sbjct: 136 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFS 195
Query: 174 FASDIWAVGCTVIEMAS 190
            ASD+W+ G  + E+ +
Sbjct: 196 VASDVWSFGVVLYELFT 212

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 60/155 (38%), Positives = 85/155 (54%), Gaps = 10/155 (6%)
Query: 42  LQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESL 101
            QRE + L +L+S  IV Y+G  V+    +    L MEY P G L D + R+  RLD S 
Sbjct: 55  FQREIQILKALHSDFIVKYRG--VSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASR 112
Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKW------ESEALQ 154
           ++ Y+ QI +G+EYL S R VH D+ +RNIL+ +E+  KIADFG AK            +
Sbjct: 113 LLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVRE 172
Query: 155 SGGTPMF-MAPEVARGEHQGFASDIWAVGCTVIEM 188
            G +P+F  APE          SD+W+ G  + E+
Sbjct: 173 PGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYEL 207

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 64/197 (32%), Positives = 101/197 (51%), Gaps = 17/197 (8%)
Query: 9   IGQGSSATVSL----ATSLRSGDVFAAKSTELPKSEFL---QREQKFLSSLNSPHIVGYK 61
           +G+G+  +V +         +G+V A K  +    E L   +RE + L SL   +IV YK
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 62  GCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRV 121
           G   ++    L   L MEY P G+L D + ++  R+D   ++ YT QI +G+EYL + R 
Sbjct: 96  GVCYSAGRRNL--KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY 153
Query: 122 VHCDIKSRNILMA-ESGAKIADFGCAKW------ESEALQSGGTPMF-MAPEVARGEHQG 173
           +H D+ +RNIL+  E+  KI DFG  K         +  + G +P+F  APE        
Sbjct: 154 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFS 213
Query: 174 FASDIWAVGCTVIEMAS 190
            ASD+W+ G  + E+ +
Sbjct: 214 VASDVWSFGVVLYELFT 230

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 64/197 (32%), Positives = 101/197 (51%), Gaps = 17/197 (8%)
Query: 9   IGQGSSATVSL----ATSLRSGDVFAAKSTELPKSEFL---QREQKFLSSLNSPHIVGYK 61
           +G+G+  +V +         +G+V A K  +    E L   +RE + L SL   +IV YK
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 62  GCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRV 121
           G   ++    L   L MEY P G+L D + ++  R+D   ++ YT QI +G+EYL + R 
Sbjct: 78  GVCYSAGRRNL--KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY 135
Query: 122 VHCDIKSRNILMA-ESGAKIADFGCAKW------ESEALQSGGTPMF-MAPEVARGEHQG 173
           +H D+ +RNIL+  E+  KI DFG  K         +  + G +P+F  APE        
Sbjct: 136 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFS 195
Query: 174 FASDIWAVGCTVIEMAS 190
            ASD+W+ G  + E+ +
Sbjct: 196 VASDVWSFGVVLYELFT 212

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 64/197 (32%), Positives = 101/197 (51%), Gaps = 17/197 (8%)
Query: 9   IGQGSSATVSL----ATSLRSGDVFAAKSTELPKSEFL---QREQKFLSSLNSPHIVGYK 61
           +G+G+  +V +         +G+V A K  +    E L   +RE + L SL   +IV YK
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 82
Query: 62  GCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRV 121
           G   ++    L   L MEY P G+L D + ++  R+D   ++ YT QI +G+EYL + R 
Sbjct: 83  GVCYSAGRRNL--KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY 140
Query: 122 VHCDIKSRNILMA-ESGAKIADFGCAKW------ESEALQSGGTPMF-MAPEVARGEHQG 173
           +H D+ +RNIL+  E+  KI DFG  K         +  + G +P+F  APE        
Sbjct: 141 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFS 200
Query: 174 FASDIWAVGCTVIEMAS 190
            ASD+W+ G  + E+ +
Sbjct: 201 VASDVWSFGVVLYELFT 217

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 64/197 (32%), Positives = 101/197 (51%), Gaps = 17/197 (8%)
Query: 9   IGQGSSATVSL----ATSLRSGDVFAAKSTELPKSEFL---QREQKFLSSLNSPHIVGYK 61
           +G+G+  +V +         +G+V A K  +    E L   +RE + L SL   +IV YK
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 83
Query: 62  GCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRV 121
           G   ++    L   L MEY P G+L D + ++  R+D   ++ YT QI +G+EYL + R 
Sbjct: 84  GVCYSAGRRNL--KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY 141
Query: 122 VHCDIKSRNILMA-ESGAKIADFGCAKW------ESEALQSGGTPMF-MAPEVARGEHQG 173
           +H D+ +RNIL+  E+  KI DFG  K         +  + G +P+F  APE        
Sbjct: 142 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFS 201
Query: 174 FASDIWAVGCTVIEMAS 190
            ASD+W+ G  + E+ +
Sbjct: 202 VASDVWSFGVVLYELFT 218

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 64/197 (32%), Positives = 101/197 (51%), Gaps = 17/197 (8%)
Query: 9   IGQGSSATVSL----ATSLRSGDVFAAKSTELPKSEFL---QREQKFLSSLNSPHIVGYK 61
           +G+G+  +V +         +G+V A K  +    E L   +RE + L SL   +IV YK
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 62  GCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRV 121
           G   ++    L   L MEY P G+L D + ++  R+D   ++ YT QI +G+EYL + R 
Sbjct: 109 GVCYSAGRRNL--KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY 166
Query: 122 VHCDIKSRNILMA-ESGAKIADFGCAKW------ESEALQSGGTPMF-MAPEVARGEHQG 173
           +H D+ +RNIL+  E+  KI DFG  K         +  + G +P+F  APE        
Sbjct: 167 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFS 226
Query: 174 FASDIWAVGCTVIEMAS 190
            ASD+W+ G  + E+ +
Sbjct: 227 VASDVWSFGVVLYELFT 243

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 78/253 (30%), Positives = 129/253 (50%), Gaps = 22/253 (8%)
Query: 8   TIGQGSSATVSLATSLRSGDVFAAK---STELPKSEF--LQREQKFLSSLNSPHIVGYKG 62
           TIG+G+ A V LA  + +G   A K    T+L  S    L RE + +  LN P+IV  K 
Sbjct: 14  TIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIV--KL 71
Query: 63  CDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
            +V  E  K +Y L MEYA GG + D +  +G  + E    +  RQI+  ++Y H   +V
Sbjct: 72  FEVI-ETEKTLY-LVMEYASGGEVFDYLVAHGW-MKEKEARAKFRQIVSAVQYCHQKFIV 128
Query: 123 HCDIKSRNILM-AESGAKIADFGCAK---WESEALQSGGTPMFMAPEVARG-EHQGFASD 177
           H D+K+ N+L+ A+   KIADFG +    + ++     G+P + APE+ +G ++ G   D
Sbjct: 129 HRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVD 188
Query: 178 IWAVGCTVIEMASGGAPW--PNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRR 235
           +W++G  +  + SG  P+   N  +    + +  Y      +P ++S    + L   L  
Sbjct: 189 VWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY-----RIPFYMSTDCENLLKKFLIL 243
Query: 236 DPKERWAASQLLK 248
           +P +R    Q++K
Sbjct: 244 NPSKRGTLEQIMK 256

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 64/197 (32%), Positives = 101/197 (51%), Gaps = 17/197 (8%)
Query: 9   IGQGSSATVSL----ATSLRSGDVFAAKSTELPKSEFL---QREQKFLSSLNSPHIVGYK 61
           +G+G+  +V +         +G+V A K  +    E L   +RE + L SL   +IV YK
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 62  GCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRV 121
           G   ++    L   L MEY P G+L D + ++  R+D   ++ YT QI +G+EYL + R 
Sbjct: 96  GVCYSAGRRNL--KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY 153
Query: 122 VHCDIKSRNILMA-ESGAKIADFGCAKW------ESEALQSGGTPMF-MAPEVARGEHQG 173
           +H D+ +RNIL+  E+  KI DFG  K         +  + G +P+F  APE        
Sbjct: 154 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFS 213
Query: 174 FASDIWAVGCTVIEMAS 190
            ASD+W+ G  + E+ +
Sbjct: 214 VASDVWSFGVVLYELFT 230

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 64/197 (32%), Positives = 101/197 (51%), Gaps = 17/197 (8%)
Query: 9   IGQGSSATVSL----ATSLRSGDVFAAKSTELPKSEFL---QREQKFLSSLNSPHIVGYK 61
           +G+G+  +V +         +G+V A K  +    E L   +RE + L SL   +IV YK
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 84
Query: 62  GCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRV 121
           G   ++    L   L MEY P G+L D + ++  R+D   ++ YT QI +G+EYL + R 
Sbjct: 85  GVCYSAGRRNL--KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY 142
Query: 122 VHCDIKSRNILMA-ESGAKIADFGCAKW------ESEALQSGGTPMF-MAPEVARGEHQG 173
           +H D+ +RNIL+  E+  KI DFG  K         +  + G +P+F  APE        
Sbjct: 143 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFS 202
Query: 174 FASDIWAVGCTVIEMAS 190
            ASD+W+ G  + E+ +
Sbjct: 203 VASDVWSFGVVLYELFT 219

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 80/278 (28%), Positives = 136/278 (48%), Gaps = 33/278 (11%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEF-------------LQREQKF 48
           ++    T+G G+   V LA   ++    A K   + K +F             ++ E + 
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKI--ISKRKFAIGSAREADPALNVETEIEI 68
Query: 49  LSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQ 108
           L  LN P I+  K     +ED    Y + +E   GG L D++  N  RL E+    Y  Q
Sbjct: 69  LKKLNHPCIIKIKNF-FDAED----YYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQ 122
Query: 109 ILQGLEYLHSNRVVHCDIKSRNILMA----ESGAKIADFGCAKW--ESEALQS-GGTPMF 161
           +L  ++YLH N ++H D+K  N+L++    +   KI DFG +K   E+  +++  GTP +
Sbjct: 123 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTY 182
Query: 162 MAPEVARGE-HQGF--ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRE--LPE 216
           +APEV       G+  A D W++G  +    SG  P+      +++  +I   +   +PE
Sbjct: 183 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPE 242
Query: 217 VPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEE 254
           V A +S++A D +   L  DPK R+   + L+HP+L++
Sbjct: 243 VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 64/197 (32%), Positives = 101/197 (51%), Gaps = 17/197 (8%)
Query: 9   IGQGSSATVSL----ATSLRSGDVFAAKSTELPKSEFL---QREQKFLSSLNSPHIVGYK 61
           +G+G+  +V +         +G+V A K  +    E L   +RE + L SL   +IV YK
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 62  GCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRV 121
           G   ++    L   L MEY P G+L D + ++  R+D   ++ YT QI +G+EYL + R 
Sbjct: 78  GVCYSAGRRNL--KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY 135
Query: 122 VHCDIKSRNILMA-ESGAKIADFGCAKWESE------ALQSGGTPMF-MAPEVARGEHQG 173
           +H D+ +RNIL+  E+  KI DFG  K   +        + G +P+F  APE        
Sbjct: 136 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFS 195
Query: 174 FASDIWAVGCTVIEMAS 190
            ASD+W+ G  + E+ +
Sbjct: 196 VASDVWSFGVVLYELFT 212

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 60/155 (38%), Positives = 85/155 (54%), Gaps = 10/155 (6%)
Query: 42  LQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESL 101
            QRE + L +L+S  IV Y+G  V+    +    L MEY P G L D + R+  RLD S 
Sbjct: 58  FQREIQILKALHSDFIVKYRG--VSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASR 115
Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKW------ESEALQ 154
           ++ Y+ QI +G+EYL S R VH D+ +RNIL+ +E+  KIADFG AK            +
Sbjct: 116 LLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVRE 175
Query: 155 SGGTPMF-MAPEVARGEHQGFASDIWAVGCTVIEM 188
            G +P+F  APE          SD+W+ G  + E+
Sbjct: 176 PGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYEL 210

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 80/278 (28%), Positives = 136/278 (48%), Gaps = 33/278 (11%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEF-------------LQREQKF 48
           ++    T+G G+   V LA   ++    A K   + K +F             ++ E + 
Sbjct: 10  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKI--ISKRKFAIGSAREADPALNVETEIEI 67
Query: 49  LSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQ 108
           L  LN P I+  K     +ED    Y + +E   GG L D++  N  RL E+    Y  Q
Sbjct: 68  LKKLNHPCIIKIKNF-FDAED----YYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQ 121
Query: 109 ILQGLEYLHSNRVVHCDIKSRNILMA----ESGAKIADFGCAKW--ESEALQS-GGTPMF 161
           +L  ++YLH N ++H D+K  N+L++    +   KI DFG +K   E+  +++  GTP +
Sbjct: 122 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTY 181
Query: 162 MAPEVARGE-HQGF--ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRE--LPE 216
           +APEV       G+  A D W++G  +    SG  P+      +++  +I   +   +PE
Sbjct: 182 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPE 241
Query: 217 VPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEE 254
           V A +S++A D +   L  DPK R+   + L+HP+L++
Sbjct: 242 VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 279

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 80/278 (28%), Positives = 136/278 (48%), Gaps = 33/278 (11%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEF-------------LQREQKF 48
           ++    T+G G+   V LA   ++    A K   + K +F             ++ E + 
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKI--ISKRKFAIGSAREADPALNVETEIEI 68
Query: 49  LSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQ 108
           L  LN P I+  K     +ED    Y + +E   GG L D++  N  RL E+    Y  Q
Sbjct: 69  LKKLNHPCIIKIKNF-FDAED----YYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQ 122
Query: 109 ILQGLEYLHSNRVVHCDIKSRNILMA----ESGAKIADFGCAKW--ESEALQS-GGTPMF 161
           +L  ++YLH N ++H D+K  N+L++    +   KI DFG +K   E+  +++  GTP +
Sbjct: 123 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTY 182
Query: 162 MAPEVARGE-HQGF--ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRE--LPE 216
           +APEV       G+  A D W++G  +    SG  P+      +++  +I   +   +PE
Sbjct: 183 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPE 242
Query: 217 VPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEE 254
           V A +S++A D +   L  DPK R+   + L+HP+L++
Sbjct: 243 VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 77/266 (28%), Positives = 123/266 (46%), Gaps = 27/266 (10%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEF--------LQREQKFLSSLN 53
           D+     +G+G    V LA   ++  + A K   L KS+         L+RE +  S L 
Sbjct: 15  DFDIVRPLGKGKFGNVYLAREKQNKFIMALKV--LFKSQLEKEGVEHQLRREIEIQSHLR 72
Query: 54  SPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGL 113
            P+I+          D K +Y L +E+AP G L  E+ ++G R DE    ++  ++   L
Sbjct: 73  HPNILRMYN---YFHDRKRIY-LMLEFAPRGELYKELQKHG-RFDEQRSATFMEELADAL 127
Query: 114 EYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA-----LQSGGTPMFMAPEVA 167
            Y H  +V+H DIK  N+LM   G  KIADFG   W   A         GT  ++ PE+ 
Sbjct: 128 HYCHERKVIHRDIKPENLLMGYKGELKIADFG---WSVHAPSLRRRXMCGTLDYLPPEMI 184
Query: 168 RGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQAND 227
            G+      D+W  G    E   G  P+ + +   T  ++   + +L + P FLS  + D
Sbjct: 185 EGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH--TETHRRIVNVDL-KFPPFLSDGSKD 241
Query: 228 FLSNCLRRDPKERWAASQLLKHPFLE 253
            +S  LR  P +R     +++HP+++
Sbjct: 242 LISKLLRYHPPQRLPLKGVMEHPWVK 267

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 80/278 (28%), Positives = 136/278 (48%), Gaps = 33/278 (11%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEF-------------LQREQKF 48
           ++    T+G G+   V LA   ++    A K   + K +F             ++ E + 
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKI--ISKRKFAIGSAREADPALNVETEIEI 68
Query: 49  LSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQ 108
           L  LN P I+  K     +ED    Y + +E   GG L D++  N  RL E+    Y  Q
Sbjct: 69  LKKLNHPCIIKIKNF-FDAED----YYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQ 122
Query: 109 ILQGLEYLHSNRVVHCDIKSRNILMA----ESGAKIADFGCAKW--ESEALQS-GGTPMF 161
           +L  ++YLH N ++H D+K  N+L++    +   KI DFG +K   E+  +++  GTP +
Sbjct: 123 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTY 182
Query: 162 MAPEVARGE-HQGF--ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRE--LPE 216
           +APEV       G+  A D W++G  +    SG  P+      +++  +I   +   +PE
Sbjct: 183 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPE 242
Query: 217 VPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEE 254
           V A +S++A D +   L  DPK R+   + L+HP+L++
Sbjct: 243 VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 60/155 (38%), Positives = 85/155 (54%), Gaps = 10/155 (6%)
Query: 42  LQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESL 101
            QRE + L +L+S  IV Y+G  V+    +    L MEY P G L D + R+  RLD S 
Sbjct: 71  FQREIQILKALHSDFIVKYRG--VSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASR 128
Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKW------ESEALQ 154
           ++ Y+ QI +G+EYL S R VH D+ +RNIL+ +E+  KIADFG AK            +
Sbjct: 129 LLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVRE 188
Query: 155 SGGTPMF-MAPEVARGEHQGFASDIWAVGCTVIEM 188
            G +P+F  APE          SD+W+ G  + E+
Sbjct: 189 PGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYEL 223

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 86/302 (28%), Positives = 132/302 (43%), Gaps = 47/302 (15%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL-------PKSEFLQREQKFLSSLNS 54
           ++ +   IG+G+   V  A +  +G+V A K   L       P +    RE   L  LN 
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI--REISLLKELNH 62
Query: 55  PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLE 114
           P+IV  K  DV   +NKL               D     G  L   LI SY  Q+LQGL 
Sbjct: 63  PNIV--KLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPL--PLIKSYLFQLLQGLA 118
Query: 115 YLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSGG----TPMFMAPEVARG 169
           + HS+RV+H D+K  N+L+   GA K+ADFG A+     +++      T  + APE+  G
Sbjct: 119 FCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 178
Query: 170 -EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPE------------ 216
            ++   A DIW++GC   EM +  A +P  ++ +  L++I  +   P+            
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPDEVVWPGVTSMPD 237
Query: 217 -VPAF--------------LSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQ 261
             P+F              L +     LS  L  DP +R +A   L HPF ++       
Sbjct: 238 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPH 297
Query: 262 IQ 263
           ++
Sbjct: 298 LR 299

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 86/302 (28%), Positives = 132/302 (43%), Gaps = 47/302 (15%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL-------PKSEFLQREQKFLSSLNS 54
           ++ +   IG+G+   V  A +  +G+V A K   L       P +    RE   L  LN 
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI--REISLLKELNH 64
Query: 55  PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLE 114
           P+IV  K  DV   +NKL               D     G  L   LI SY  Q+LQGL 
Sbjct: 65  PNIV--KLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPL--PLIKSYLFQLLQGLA 120
Query: 115 YLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSGG----TPMFMAPEVARG 169
           + HS+RV+H D+K  N+L+   GA K+ADFG A+     +++      T  + APE+  G
Sbjct: 121 FCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 180
Query: 170 -EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPE------------ 216
            ++   A DIW++GC   EM +  A +P  ++ +  L++I  +   P+            
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPDEVVWPGVTSMPD 239
Query: 217 -VPAF--------------LSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQ 261
             P+F              L +     LS  L  DP +R +A   L HPF ++       
Sbjct: 240 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPH 299
Query: 262 IQ 263
           ++
Sbjct: 300 LR 301

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 60/155 (38%), Positives = 85/155 (54%), Gaps = 10/155 (6%)
Query: 42  LQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESL 101
            QRE + L +L+S  IV Y+G  V+    +    L MEY P G L D + R+  RLD S 
Sbjct: 59  FQREIQILKALHSDFIVKYRG--VSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASR 116
Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKW------ESEALQ 154
           ++ Y+ QI +G+EYL S R VH D+ +RNIL+ +E+  KIADFG AK            +
Sbjct: 117 LLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVRE 176
Query: 155 SGGTPMF-MAPEVARGEHQGFASDIWAVGCTVIEM 188
            G +P+F  APE          SD+W+ G  + E+
Sbjct: 177 PGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYEL 211

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 86/302 (28%), Positives = 133/302 (44%), Gaps = 47/302 (15%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL-------PKSEFLQREQKFLSSLNS 54
           ++ +   IG+G+   V  A +  +G+V A     L       P +    RE   L  LN 
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAI--REISLLKELNH 61
Query: 55  PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLE 114
           P+IV  K  DV   +NKL       +       D     G  L   LI SY  Q+LQGL 
Sbjct: 62  PNIV--KLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL--PLIKSYLFQLLQGLA 117
Query: 115 YLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSGG----TPMFMAPEVARG 169
           + HS+RV+H D+K +N+L+   GA K+ADFG A+     +++      T  + APE+  G
Sbjct: 118 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 177
Query: 170 -EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPE------------ 216
            ++   A DIW++GC   EM +  A +P  ++ +  L++I  +   P+            
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPDEVVWPGVTSMPD 236
Query: 217 -VPAFLSKQANDF--------------LSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQ 261
             P+F      DF              LS  L  DP +R +A   L HPF ++       
Sbjct: 237 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPH 296
Query: 262 IQ 263
           ++
Sbjct: 297 LR 298

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 86/302 (28%), Positives = 133/302 (44%), Gaps = 47/302 (15%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL-------PKSEFLQREQKFLSSLNS 54
           ++ +   IG+G+   V  A +  +G+V A     L       P +    RE   L  LN 
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAI--REISLLKELNH 60
Query: 55  PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLE 114
           P+IV  K  DV   +NKL       +       D     G  L   LI SY  Q+LQGL 
Sbjct: 61  PNIV--KLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL--PLIKSYLFQLLQGLA 116
Query: 115 YLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSGG----TPMFMAPEVARG 169
           + HS+RV+H D+K +N+L+   GA K+ADFG A+     +++      T  + APE+  G
Sbjct: 117 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176
Query: 170 -EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPE------------ 216
            ++   A DIW++GC   EM +  A +P  ++ +  L++I  +   P+            
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPDEVVWPGVTSMPD 235
Query: 217 -VPAFLSKQANDF--------------LSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQ 261
             P+F      DF              LS  L  DP +R +A   L HPF ++       
Sbjct: 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPH 295
Query: 262 IQ 263
           ++
Sbjct: 296 LR 297

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 64/197 (32%), Positives = 100/197 (50%), Gaps = 17/197 (8%)
Query: 9   IGQGSSATVSL----ATSLRSGDVFAAKSTELPKSEFL---QREQKFLSSLNSPHIVGYK 61
           +G+G+  +V +         +G+V A K  +    E L   +RE + L SL   +IV YK
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 62  GCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRV 121
           G   ++    L   L MEY P G+L D +  +  R+D   ++ YT QI +G+EYL + R 
Sbjct: 81  GVCYSAGRRNL--KLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKGMEYLGTKRY 138
Query: 122 VHCDIKSRNILMA-ESGAKIADFGCAKW------ESEALQSGGTPMF-MAPEVARGEHQG 173
           +H D+ +RNIL+  E+  KI DFG  K         +  + G +P+F  APE        
Sbjct: 139 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFS 198
Query: 174 FASDIWAVGCTVIEMAS 190
            ASD+W+ G  + E+ +
Sbjct: 199 VASDVWSFGVVLYELFT 215

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 77/262 (29%), Positives = 120/262 (45%), Gaps = 27/262 (10%)
Query: 8   TIGQGSSATVSLATSLRSGDVFAAKSTELP---KSEFLQREQKFLSSLNSPHIVGYKGCD 64
            +G G+ + V L     +G +FA K  +     +   L+ E   L  +   +IV      
Sbjct: 16  VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIV------ 69
Query: 65  VTSED---NKLMYNLFMEYAPGGTLNDEIHRNG--GRLDESLIVSYTRQILQGLEYLHSN 119
            T ED   +   Y L M+   GG L D I   G     D SL++   +Q+L  ++YLH N
Sbjct: 70  -TLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVI---QQVLSAVKYLHEN 125
Query: 120 RVVHCDIKSRNILMA----ESGAKIADFGCAKWESEALQSG--GTPMFMAPEVARGEHQG 173
            +VH D+K  N+L       S   I DFG +K E   + S   GTP ++APEV   +   
Sbjct: 126 GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYVAPEVLAQKPYS 185
Query: 174 FASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAF--LSKQANDFLSN 231
            A D W++G     +  G  P+    +   +  KI       E P +  +S+ A DF+ +
Sbjct: 186 KAVDCWSIGVITYILLCGYPPFYEETES-KLFEKIKEGYYEFESPFWDDISESAKDFICH 244
Query: 232 CLRRDPKERWAASQLLKHPFLE 253
            L +DP ER+   + L HP+++
Sbjct: 245 LLEKDPNERYTCEKALSHPWID 266

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 80/278 (28%), Positives = 136/278 (48%), Gaps = 33/278 (11%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEF-------------LQREQKF 48
           ++    T+G G+   V LA   ++    A K   + K +F             ++ E + 
Sbjct: 17  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKI--ISKRKFAIGSAREADPALNVETEIEI 74
Query: 49  LSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQ 108
           L  LN P I+  K     +ED    Y + +E   GG L D++  N  RL E+    Y  Q
Sbjct: 75  LKKLNHPCIIKIKNF-FDAED----YYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQ 128
Query: 109 ILQGLEYLHSNRVVHCDIKSRNILMA----ESGAKIADFGCAKW--ESEALQS-GGTPMF 161
           +L  ++YLH N ++H D+K  N+L++    +   KI DFG +K   E+  +++  GTP +
Sbjct: 129 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTY 188
Query: 162 MAPEVARGE-HQGF--ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRE--LPE 216
           +APEV       G+  A D W++G  +    SG  P+      +++  +I   +   +PE
Sbjct: 189 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPE 248
Query: 217 VPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEE 254
           V A +S++A D +   L  DPK R+   + L+HP+L++
Sbjct: 249 VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 286

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 70/248 (28%), Positives = 120/248 (48%), Gaps = 21/248 (8%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTEL-------PKSEFLQREQKFLSSLNSPHIVGYK 61
           IG+G  + V  A  L  G   A K  ++        +++ + +E   L  LN P+++ Y 
Sbjct: 40  IGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCI-KEIDLLKQLNHPNVIKYY 98
Query: 62  GCDVTSEDNKLMYNLFMEYAPGGTLNDEIH---RNGGRLDESLIVSYTRQILQGLEYLHS 118
              +  EDN+L  N+ +E A  G L+  I    +    + E  +  Y  Q+   LE++HS
Sbjct: 99  ASFI--EDNEL--NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS 154
Query: 119 NRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSG----GTPMFMAPEVARGEHQG 173
            RV+H DIK  N+ +  +G  K+ D G  ++ S    +     GTP +M+PE        
Sbjct: 155 RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYN 214
Query: 174 FASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPA-FLSKQANDFLSNC 232
           F SDIW++GC + EMA+  +P+      +  L K     + P +P+   S++    ++ C
Sbjct: 215 FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMC 274
Query: 233 LRRDPKER 240
           +  DP++R
Sbjct: 275 INPDPEKR 282

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 88/304 (28%), Positives = 136/304 (44%), Gaps = 51/304 (16%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL-------PKSEFLQREQKFLSSLNS 54
           ++ +   IG+G+   V  A +  +G+V A K   L       P +    RE   L  LN 
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI--REISLLKELNH 64
Query: 55  PHIVGYKGCDVTSEDNKLMYNLFMEYAPGG--TLNDEIHRNGGRLDESLIVSYTRQILQG 112
           P+IV  K  DV   +NKL   L  E+         D     G  L   LI SY  Q+LQG
Sbjct: 65  PNIV--KLLDVIHTENKLY--LVFEHVDQDLKKFMDASALTGIPL--PLIKSYLFQLLQG 118
Query: 113 LEYLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSGG----TPMFMAPEVA 167
           L + HS+RV+H D+K +N+L+   GA K+ADFG A+     +++      T  + APE+ 
Sbjct: 119 LAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 178
Query: 168 RG-EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPE---------- 216
            G ++   A DIW++GC   EM +  A +P  ++ +  L++I  +   P+          
Sbjct: 179 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPDEVVWPGVTSM 237
Query: 217 ---VPAF--------------LSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSCT 259
               P+F              L +     LS  L  DP +R +A   L HPF ++     
Sbjct: 238 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 297
Query: 260 KQIQ 263
             ++
Sbjct: 298 PHLR 301

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 81/273 (29%), Positives = 135/273 (49%), Gaps = 24/273 (8%)
Query: 8   TIGQGSSATVSLATSLRSGDVFAAKSTE---LPKSEF---LQREQKFLSSLNSPHIVGYK 61
           T+G+GS   V LAT  ++    A K      L KS+    ++RE  +L  L  PHI+  K
Sbjct: 16  TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHII--K 73
Query: 62  GCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRV 121
             DV +    ++  + +EYA GG L D I     R+ E     + +QI+  +EY H +++
Sbjct: 74  LYDVITTPTDIV--MVIEYA-GGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYCHRHKI 129
Query: 122 VHCDIKSRNILMAES-GAKIADFGCAKWESEA---LQSGGTPMFMAPEVARGE-HQGFAS 176
           VH D+K  N+L+ ++   KIADFG +   ++      S G+P + APEV  G+ + G   
Sbjct: 130 VHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEV 189
Query: 177 DIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRD 236
           D+W+ G  +  M  G  P+ +   P   L+K   S  +  +P FLS  A   +   +  D
Sbjct: 190 DVWSCGIVLYVMLVGRLPFDDEFIPN--LFKKVNSC-VYVMPDFLSPGAQSLIRRMIVAD 246
Query: 237 PKERWAASQLLKHPF----LEEFCSCTKQIQES 265
           P +R    ++ + P+    L ++    +++Q S
Sbjct: 247 PMQRITIQEIRRDPWFNVNLPDYLRPMEEVQGS 279

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 82/285 (28%), Positives = 133/285 (46%), Gaps = 27/285 (9%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKS--EFLQREQKFLSSLNSPHIVGYKGCDVT 66
           IG G+     L    ++ ++ A K  E  +   E ++RE     SL  P+IV +K   +T
Sbjct: 27  IGAGNFGVARLMRDKQANELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 86
Query: 67  SEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDI 126
                ++    MEYA GG L + I  N GR  E     + +Q++ G+ Y H+ +V H D+
Sbjct: 87  PTHLAIV----MEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYAHAMQVAHRDL 141
Query: 127 KSRNILMAESGA---KIADFGCAK---WESEALQSGGTPMFMAPEV-ARGEHQGFASDIW 179
           K  N L+  S A   KIADFG +K     S+   + GTP ++APEV  + E+ G  +D+W
Sbjct: 142 KLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAVGTPAYIAPEVLLKKEYDGKVADVW 201
Query: 180 AVGCTVIEMASGGAPWPNAADP----MTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRR 235
           + G T+  M  G  P+ +  +P     T+   +     +P+    +S +    +S     
Sbjct: 202 SCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDY-VHISPECRHLISRIFVA 260
Query: 236 DPKERWAASQLLKHP-FLEEFC-------SCTKQIQESNCSPTSI 272
           DP +R +  ++  H  FL+          + T Q  ES+    SI
Sbjct: 261 DPAKRISIPEIRNHEWFLKNLPADLMNDNTMTTQFDESDQPGQSI 305

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 75/249 (30%), Positives = 121/249 (48%), Gaps = 27/249 (10%)
Query: 9   IGQGSSATV--------SLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGY 60
           IG GS  TV         +A  +     F A+      +EFL RE   +  L  P+IV +
Sbjct: 45  IGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERV----NEFL-REVAIMKRLRHPNIVLF 99
Query: 61  KGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGR--LDESLIVSYTRQILQGLEYLHS 118
            G  VT   N    ++  EY   G+L   +H++G R  LDE   +S    + +G+ YLH+
Sbjct: 100 MGA-VTQPPN---LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN 155
Query: 119 NR--VVHCDIKSRNILM-AESGAKIADFGCAKWESEAL----QSGGTPMFMAPEVARGEH 171
               +VH D+KS N+L+  +   K+ DFG ++ ++        + GTP +MAPEV R E 
Sbjct: 156 RNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAAGTPEWMAPEVLRDEP 215
Query: 172 QGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSN 231
               SD+++ G  + E+A+   PW N  +P  V+  + +  +  E+P  L+ Q    +  
Sbjct: 216 SNEKSDVYSFGVILWELATLQQPWGN-LNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEG 274
Query: 232 CLRRDPKER 240
           C   +P +R
Sbjct: 275 CWTNEPWKR 283

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 136/278 (48%), Gaps = 33/278 (11%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEF-------------LQREQKF 48
           ++    T+G G+   V LA   ++    A +   + K +F             ++ E + 
Sbjct: 150 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRI--ISKRKFAIGSAREADPALNVETEIEI 207
Query: 49  LSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQ 108
           L  LN P I+  K     +ED    Y + +E   GG L D++  N  RL E+    Y  Q
Sbjct: 208 LKKLNHPCIIKIKNF-FDAED----YYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQ 261
Query: 109 ILQGLEYLHSNRVVHCDIKSRNILMA----ESGAKIADFGCAKW--ESEALQS-GGTPMF 161
           +L  ++YLH N ++H D+K  N+L++    +   KI DFG +K   E+  +++  GTP +
Sbjct: 262 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTY 321
Query: 162 MAPEVARGE-HQGF--ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRE--LPE 216
           +APEV       G+  A D W++G  +    SG  P+      +++  +I   +   +PE
Sbjct: 322 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPE 381
Query: 217 VPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEE 254
           V A +S++A D +   L  DPK R+   + L+HP+L++
Sbjct: 382 VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 419

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 72/267 (26%), Positives = 123/267 (46%), Gaps = 27/267 (10%)
Query: 6   GHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS---------EFLQREQKFLSSLNSPH 56
           G  +G G  A V       +G  +AAK  +  +S         E ++RE   L  +   +
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN 76
Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL 116
           ++     DV   +N+    L +E   GG L D + +    L E    S+ +QIL G+ YL
Sbjct: 77  VITLH--DVY--ENRTDVVLILELVSGGELFDFLAQKES-LSEEEATSFIKQILDGVNYL 131
Query: 117 HSNRVVHCDIKSRNILMAESG-----AKIADFGCAKWESEALQSG---GTPMFMAPEVAR 168
           H+ ++ H D+K  NI++ +        K+ DFG A    + ++     GTP F+APE+  
Sbjct: 132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN 191
Query: 169 GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQ---A 225
            E  G  +D+W++G     + SG +P+       T+    A S +  E   F S+    A
Sbjct: 192 YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDE--EFFSQTSELA 249
Query: 226 NDFLSNCLRRDPKERWAASQLLKHPFL 252
            DF+   L ++ ++R    + L+HP++
Sbjct: 250 KDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 82/266 (30%), Positives = 124/266 (46%), Gaps = 31/266 (11%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKS----EFLQREQKFLSSLNSPHIVGYKGCD 64
           +G G+   V L     SG     K+    +S    E ++ E + L SL+ P+I+  K  +
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNII--KIFE 87
Query: 65  VTSEDNKLMYNLFMEYAPGGTLNDEI---HRNGGRLDESLIVSYTRQILQGLEYLHSNRV 121
           V  ED   MY + ME   GG L + I      G  L E  +    +Q++  L Y HS  V
Sbjct: 88  VF-EDYHNMY-IVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHV 145
Query: 122 VHCDIKSRNILMAE----SGAKIADFGCA---KWESEALQSGGTPMFMAPEVARGEHQGF 174
           VH D+K  NIL  +    S  KI DFG A   K +  +  + GT ++MAPEV + +   F
Sbjct: 146 VHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKRD-VTF 204
Query: 175 ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAF------LSKQANDF 228
             DIW+ G  +  + +G  P+   +    V  K  Y       P +      L+ QA D 
Sbjct: 205 KCDIWSAGVVMYFLLTGCLPFTGTSLE-EVQQKATYKE-----PNYAVECRPLTPQAVDL 258
Query: 229 LSNCLRRDPKERWAASQLLKHPFLEE 254
           L   L +DP+ R +A+Q+L H + ++
Sbjct: 259 LKQMLTKDPERRPSAAQVLHHEWFKQ 284

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 76/254 (29%), Positives = 120/254 (47%), Gaps = 19/254 (7%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKS--EFLQREQKFLSSLNSPHIVGYKGCDVT 66
           IG G+     L     + ++ A K  E   +  E +QRE     SL  P+IV +K   +T
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILT 87
Query: 67  SEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDI 126
                ++    MEYA GG L + I  N GR  E     + +Q+L G+ Y HS ++ H D+
Sbjct: 88  PTHLAII----MEYASGGELYERIC-NAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDL 142
Query: 127 KSRNILMAESGA---KIADFGCAK---WESEALQSGGTPMFMAPEV-ARGEHQGFASDIW 179
           K  N L+  S A   KI DFG +K     S+   + GTP ++APEV  R E+ G  +D+W
Sbjct: 143 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVW 202
Query: 180 AVGCTVIEMASGGAPWPNAADP----MTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRR 235
           + G T+  M  G  P+ +  +P     T+   ++    +P+    +S +    +S     
Sbjct: 203 SCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPD-DIRISPECCHLISRIFVA 261
Query: 236 DPKERWAASQLLKH 249
           DP  R +  ++  H
Sbjct: 262 DPATRISIPEIKTH 275

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 72/267 (26%), Positives = 123/267 (46%), Gaps = 27/267 (10%)
Query: 6   GHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS---------EFLQREQKFLSSLNSPH 56
           G  +G G  A V       +G  +AAK  +  +S         E ++RE   L  +   +
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN 76
Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL 116
           ++     DV   +N+    L +E   GG L D + +    L E    S+ +QIL G+ YL
Sbjct: 77  VITLH--DVY--ENRTDVVLILELVSGGELFDFLAQKES-LSEEEATSFIKQILDGVNYL 131
Query: 117 HSNRVVHCDIKSRNILMAESG-----AKIADFGCAKWESEALQSG---GTPMFMAPEVAR 168
           H+ ++ H D+K  NI++ +        K+ DFG A    + ++     GTP F+APE+  
Sbjct: 132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN 191
Query: 169 GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQ---A 225
            E  G  +D+W++G     + SG +P+       T+    A S +  E   F S+    A
Sbjct: 192 YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDE--EFFSQTSELA 249
Query: 226 NDFLSNCLRRDPKERWAASQLLKHPFL 252
            DF+   L ++ ++R    + L+HP++
Sbjct: 250 KDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 136/278 (48%), Gaps = 33/278 (11%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEF-------------LQREQKF 48
           ++    T+G G+   V LA   ++    A +   + K +F             ++ E + 
Sbjct: 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRI--ISKRKFAIGSAREADPALNVETEIEI 193
Query: 49  LSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQ 108
           L  LN P I+  K     +ED    Y + +E   GG L D++  N  RL E+    Y  Q
Sbjct: 194 LKKLNHPCIIKIKNF-FDAED----YYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQ 247
Query: 109 ILQGLEYLHSNRVVHCDIKSRNILMA----ESGAKIADFGCAKW--ESEALQS-GGTPMF 161
           +L  ++YLH N ++H D+K  N+L++    +   KI DFG +K   E+  +++  GTP +
Sbjct: 248 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTY 307
Query: 162 MAPEVARGE-HQGF--ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRE--LPE 216
           +APEV       G+  A D W++G  +    SG  P+      +++  +I   +   +PE
Sbjct: 308 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPE 367
Query: 217 VPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEE 254
           V A +S++A D +   L  DPK R+   + L+HP+L++
Sbjct: 368 VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 74/254 (29%), Positives = 121/254 (47%), Gaps = 19/254 (7%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKS--EFLQREQKFLSSLNSPHIVGYKGCDVT 66
           IG G+     L    +S ++ A K  E  +   E ++RE     SL  P+IV +K   +T
Sbjct: 26  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 85
Query: 67  SEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDI 126
                ++    MEYA GG L + I  N GR  E     + +Q++ G+ Y H+ +V H D+
Sbjct: 86  PTHLAIV----MEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL 140
Query: 127 KSRNILMAESGA---KIADFGCAK---WESEALQSGGTPMFMAPEV-ARGEHQGFASDIW 179
           K  N L+  S A   KI DFG +K     S+   + GTP ++APEV  + E+ G  +D+W
Sbjct: 141 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVADVW 200
Query: 180 AVGCTVIEMASGGAPWPNAADP----MTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRR 235
           + G T+  M  G  P+ +  +P     T+   +     +P+    +S +    +S     
Sbjct: 201 SCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDY-VHISPECRHLISRIFVA 259
Query: 236 DPKERWAASQLLKH 249
           DP +R +  ++  H
Sbjct: 260 DPAKRISIPEIRNH 273

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 101/197 (51%), Gaps = 17/197 (8%)
Query: 9   IGQGSSATVSL----ATSLRSGDVFAAKSTELPKSEFL---QREQKFLSSLNSPHIVGYK 61
           +G+G+  +V +         +G+V A K  +    E L   +RE + L SL   +IV YK
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 78
Query: 62  GCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRV 121
           G   ++    L   L MEY P G+L D + ++  R+D   ++ YT QI +G+EYL + R 
Sbjct: 79  GVCYSAGRRNL--KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY 136
Query: 122 VHCDIKSRNILMA-ESGAKIADFGCAKWESE------ALQSGGTPMF-MAPEVARGEHQG 173
           +H ++ +RNIL+  E+  KI DFG  K   +        + G +P+F  APE        
Sbjct: 137 IHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFS 196
Query: 174 FASDIWAVGCTVIEMAS 190
            ASD+W+ G  + E+ +
Sbjct: 197 VASDVWSFGVVLYELFT 213

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 75/249 (30%), Positives = 121/249 (48%), Gaps = 27/249 (10%)
Query: 9   IGQGSSATV--------SLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGY 60
           IG GS  TV         +A  +     F A+      +EFL RE   +  L  P+IV +
Sbjct: 45  IGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERV----NEFL-REVAIMKRLRHPNIVLF 99
Query: 61  KGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGR--LDESLIVSYTRQILQGLEYLHS 118
            G  VT   N    ++  EY   G+L   +H++G R  LDE   +S    + +G+ YLH+
Sbjct: 100 MGA-VTQPPN---LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN 155
Query: 119 NR--VVHCDIKSRNILM-AESGAKIADFGCAKWESEALQS----GGTPMFMAPEVARGEH 171
               +VH ++KS N+L+  +   K+ DFG ++ ++    S     GTP +MAPEV R E 
Sbjct: 156 RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEP 215
Query: 172 QGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSN 231
               SD+++ G  + E+A+   PW N  +P  V+  + +  +  E+P  L+ Q    +  
Sbjct: 216 SNEKSDVYSFGVILWELATLQQPWGN-LNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEG 274
Query: 232 CLRRDPKER 240
           C   +P +R
Sbjct: 275 CWTNEPWKR 283

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 107/203 (52%), Gaps = 13/203 (6%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ----REQKFLSSLNSPHI 57
           D+ R   +G G+   V+      SG + A K   L     ++    RE + L   NSP+I
Sbjct: 17  DFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 76
Query: 58  VGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLH 117
           VG+ G   +  +     ++ ME+  GG+L D++ +   R+ E ++   +  +L+GL YL 
Sbjct: 77  VGFYGAFYSDGE----ISICMEHMDGGSL-DQVLKEAKRIPEEILGKVSIAVLRGLAYLR 131
Query: 118 -SNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG--GTPMFMAPEVARGEHQG 173
             ++++H D+K  NIL+   G  K+ DFG +    +++ +   GT  +MAPE  +G H  
Sbjct: 132 EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMAPERLQGTHYS 191
Query: 174 FASDIWAVGCTVIEMASGGAPWP 196
             SDIW++G +++E+A G  P P
Sbjct: 192 VQSDIWSMGLSLVELAVGRYPIP 214

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 70/266 (26%), Positives = 125/266 (46%), Gaps = 25/266 (9%)
Query: 6   GHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS---------EFLQREQKFLSSLNSPH 56
           G  +G G  A V       +G  +AAK  +  +S         E ++RE   L  +   +
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN 76
Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL 116
           ++     DV   +N+    L +E   GG L D + +    L E    S+ +QIL G+ YL
Sbjct: 77  VITLH--DVY--ENRTDVVLILELVSGGELFDFLAQKES-LSEEEATSFIKQILDGVNYL 131
Query: 117 HSNRVVHCDIKSRNILMAESG-----AKIADFGCAKWESEALQSG---GTPMFMAPEVAR 168
           H+ ++ H D+K  NI++ +        K+ DFG A    + ++     GTP F+APE+  
Sbjct: 132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN 191
Query: 169 GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTV--LYKIAYSRELPEVPAFLSKQAN 226
            E  G  +D+W++G     + SG +P+       T+  +  ++Y  +  E  +  S+ A 
Sbjct: 192 YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFD-EEFFSHTSELAK 250
Query: 227 DFLSNCLRRDPKERWAASQLLKHPFL 252
           DF+   L ++ ++R    + L+HP++
Sbjct: 251 DFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 111/222 (50%), Gaps = 21/222 (9%)
Query: 40  EFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDE 99
           E +++E K  + L  P+I+  +G  +   +      L ME+A GG LN  +  +G R+  
Sbjct: 51  ENVRQEAKLFAMLKHPNIIALRGVCLKEPN----LCLVMEFARGGPLNRVL--SGKRIPP 104
Query: 100 SLIVSYTRQILQGLEYLHSNRVV---HCDIKSRNILM---AESG------AKIADFGCAK 147
            ++V++  QI +G+ YLH   +V   H D+KS NIL+    E+G       KI DFG A+
Sbjct: 105 DILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR 164
Query: 148 -WE-SEALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVL 205
            W  +  + + G   +MAPEV R       SD+W+ G  + E+ +G  P+    D + V 
Sbjct: 165 EWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPF-RGIDGLAVA 223
Query: 206 YKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLL 247
           Y +A ++    +P+   +     + +C   DP  R + + +L
Sbjct: 224 YGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNIL 265

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/230 (30%), Positives = 113/230 (49%), Gaps = 16/230 (6%)
Query: 44  REQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIV 103
           RE + L  L+ P+I+  K  ++  ED+   Y +  E   GG L DEI +   R  E    
Sbjct: 70  REVELLKKLDHPNIM--KLFEIL-EDSSSFY-IVGELYTGGELFDEIIKRK-RFSEHDAA 124
Query: 104 SYTRQILQGLEYLHSNRVVHCDIKSRNILM----AESGAKIADFG---CAKWESEALQSG 156
              +Q+  G+ Y+H + +VH D+K  NIL+     +   KI DFG   C +  ++     
Sbjct: 125 RIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI 184
Query: 157 GTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPW--PNAADPMTVLYKIAYSREL 214
           GT  ++APEV RG +     D+W+ G  +  + SG  P+   N  D +  +    Y+ +L
Sbjct: 185 GTAYYIAPEVLRGTYDE-KCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDL 243
Query: 215 PEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQIQE 264
           P+    +S  A D +   L   P  R  A+Q L+HP+++++ S T  I +
Sbjct: 244 PQWRT-ISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISD 292

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 70/266 (26%), Positives = 125/266 (46%), Gaps = 25/266 (9%)
Query: 6   GHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS---------EFLQREQKFLSSLNSPH 56
           G  +G G  A V       +G  +AAK  +  +S         E ++RE   L  +   +
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN 76
Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL 116
           ++     DV   +N+    L +E   GG L D + +    L E    S+ +QIL G+ YL
Sbjct: 77  VITLH--DVY--ENRTDVVLILELVSGGELFDFLAQKES-LSEEEATSFIKQILDGVNYL 131
Query: 117 HSNRVVHCDIKSRNILMAESG-----AKIADFGCAKWESEALQSG---GTPMFMAPEVAR 168
           H+ ++ H D+K  NI++ +        K+ DFG A    + ++     GTP F+APE+  
Sbjct: 132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN 191
Query: 169 GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTV--LYKIAYSRELPEVPAFLSKQAN 226
            E  G  +D+W++G     + SG +P+       T+  +  ++Y  +  E  +  S+ A 
Sbjct: 192 YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFD-EEFFSHTSELAK 250
Query: 227 DFLSNCLRRDPKERWAASQLLKHPFL 252
           DF+   L ++ ++R    + L+HP++
Sbjct: 251 DFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 101/197 (51%), Gaps = 17/197 (8%)
Query: 9   IGQGSSATVSL----ATSLRSGDVFAAKSTELPKSEFL---QREQKFLSSLNSPHIVGYK 61
           +G+G+  +V +         +G+V A K  +    E L   +RE + L SL   +IV YK
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 62  GCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRV 121
           G   ++    L   L ME+ P G+L + + ++  R+D   ++ YT QI +G+EYL + R 
Sbjct: 81  GVCYSAGRRNL--KLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY 138
Query: 122 VHCDIKSRNILMA-ESGAKIADFGCAKW------ESEALQSGGTPMF-MAPEVARGEHQG 173
           +H D+ +RNIL+  E+  KI DFG  K         +  + G +P+F  APE        
Sbjct: 139 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFS 198
Query: 174 FASDIWAVGCTVIEMAS 190
            ASD+W+ G  + E+ +
Sbjct: 199 VASDVWSFGVVLYELFT 215

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 80/270 (29%), Positives = 130/270 (48%), Gaps = 36/270 (13%)
Query: 8   TIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ--------REQKFLS-SLNSPHIV 58
            +G+GS   V LA    +GD++A K   L K   LQ         E++ LS + N P + 
Sbjct: 30  VLGKGSFGKVMLARVKETGDLYAVKV--LKKDVILQDDDVECTMTEKRILSLARNHPFLT 87
Query: 59  GYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHS 118
               C  T   ++L +   ME+  GG L   I ++  R DE+    Y  +I+  L +LH 
Sbjct: 88  QLFCCFQTP--DRLFF--VMEFVNGGDLMFHIQKSR-RFDEARARFYAAEIISALMFLHD 142
Query: 119 NRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG-------GTPMFMAPEVARGE 170
             +++ D+K  N+L+   G  K+ADFG  K   E + +G       GTP ++APE+ +  
Sbjct: 143 KGIIYRDLKLDNVLLDHEGHCKLADFGMCK---EGICNGVTTATFCGTPDYIAPEILQEM 199
Query: 171 HQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLS 230
             G A D WA+G  + EM  G AP+   A+    L++   + E+   P +L + A   L 
Sbjct: 200 LYGPAVDWWAMGVLLYEMLCGHAPF--EAENEDDLFEAILNDEV-VYPTWLHEDATGILK 256
Query: 231 NCLRRDPKERWAA------SQLLKHPFLEE 254
           + + ++P  R  +        +L+HPF +E
Sbjct: 257 SFMTKNPTMRLGSLTQGGEHAILRHPFFKE 286

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 70/266 (26%), Positives = 125/266 (46%), Gaps = 25/266 (9%)
Query: 6   GHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS---------EFLQREQKFLSSLNSPH 56
           G  +G G  A V       +G  +AAK  +  +S         E ++RE   L  +   +
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN 76
Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL 116
           ++     DV   +N+    L +E   GG L D + +    L E    S+ +QIL G+ YL
Sbjct: 77  VITLH--DVY--ENRTDVVLILELVSGGELFDFLAQKES-LSEEEATSFIKQILDGVNYL 131
Query: 117 HSNRVVHCDIKSRNILMAESG-----AKIADFGCAKWESEALQSG---GTPMFMAPEVAR 168
           H+ ++ H D+K  NI++ +        K+ DFG A    + ++     GTP F+APE+  
Sbjct: 132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN 191
Query: 169 GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTV--LYKIAYSRELPEVPAFLSKQAN 226
            E  G  +D+W++G     + SG +P+       T+  +  ++Y  +  E  +  S+ A 
Sbjct: 192 YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFD-EEFFSHTSELAK 250
Query: 227 DFLSNCLRRDPKERWAASQLLKHPFL 252
           DF+   L ++ ++R    + L+HP++
Sbjct: 251 DFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 80/270 (29%), Positives = 120/270 (44%), Gaps = 30/270 (11%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTE----LPKSEFLQR--EQKFLSSLNSP 55
           D+     +G+G+   V L     +G  +A K       + K E      E + L +   P
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
            +   K    T   ++L +   MEYA GG L   + R      E     Y  +I+  LEY
Sbjct: 66  FLTALKYAFQTH--DRLCF--VMEYANGGELFFHLSRERV-FTEERARFYGAEIVSALEY 120
Query: 116 LHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG-------GTPMFMAPEVA 167
           LHS  VV+ DIK  N+++ + G  KI DFG  K   E +  G       GTP ++APEV 
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKXFCGTPEYLAPEVL 177
Query: 168 RGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQAND 227
                G A D W +G  + EM  G  P+ N       L+++    E+   P  LS +A  
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER--LFELILMEEI-RFPRTLSPEAKS 234
Query: 228 FLSNCLRRDPKERWA-----ASQLLKHPFL 252
            L+  L++DPK+R       A ++++H F 
Sbjct: 235 LLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 82/254 (32%), Positives = 122/254 (48%), Gaps = 28/254 (11%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSE 68
           +G+GS   V      ++G   A K   L    F   E    + L SP IV   G    + 
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKKVRL--EVFRAEELMACAGLTSPRIVPLYG----AV 154
Query: 69  DNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKS 128
                 N+FME   GG+L   + +  G L E   + Y  Q L+GLEYLHS R++H D+K+
Sbjct: 155 REGPWVNIFMELLEGGSLGQLV-KEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVKA 213
Query: 129 RNILMAESG--AKIADFG---CAKWE--SEALQSG----GTPMFMAPEVARGEHQGFASD 177
            N+L++  G  A + DFG   C + +   ++L +G    GT   MAPEV  G       D
Sbjct: 214 DNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRSCDAKVD 273
Query: 178 IWAVGCTVIEMASGGAPWPN-AADPMTVLYKIAYS----RELPEVPAFLSKQANDFLSNC 232
           +W+  C ++ M +G  PW      P+ +  KIA      RE+P   A L+ QA   +   
Sbjct: 274 VWSSCCMMLHMLNGCHPWTQFFRGPLCL--KIASEPPPVREIPPSCAPLTAQA---IQEG 328
Query: 233 LRRDPKERWAASQL 246
           LR++P  R +A++L
Sbjct: 329 LRKEPIHRVSAAEL 342

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 76/252 (30%), Positives = 126/252 (50%), Gaps = 20/252 (7%)
Query: 8   TIGQGSSATVSLATSLRSGDVFAAKSTE---LPKSEF---LQREQKFLSSLNSPHIVGYK 61
           T+G+GS   V LA    +G   A K      L KS+    ++RE  +L  L  PHI+  K
Sbjct: 20  TLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHII--K 77
Query: 62  GCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRV 121
             DV    ++++  + +EYA G  L D I +   ++ E     + +QI+  +EY H +++
Sbjct: 78  LYDVIKSKDEII--MVIEYA-GNELFDYIVQRD-KMSEQEARRFFQQIISAVEYCHRHKI 133
Query: 122 VHCDIKSRNILMAES-GAKIADFGCAKWESEA---LQSGGTPMFMAPEVARGE-HQGFAS 176
           VH D+K  N+L+ E    KIADFG +   ++      S G+P + APEV  G+ + G   
Sbjct: 134 VHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEV 193
Query: 177 DIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRD 236
           D+W+ G  +  M     P+ + + P  VL+K   S  +  +P FLS  A   +   L  +
Sbjct: 194 DVWSCGVILYVMLCRRLPFDDESIP--VLFK-NISNGVYTLPKFLSPGAAGLIKRMLIVN 250
Query: 237 PKERWAASQLLK 248
           P  R +  ++++
Sbjct: 251 PLNRISIHEIMQ 262

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 76/252 (30%), Positives = 126/252 (50%), Gaps = 20/252 (7%)
Query: 8   TIGQGSSATVSLATSLRSGDVFAAKSTE---LPKSEF---LQREQKFLSSLNSPHIVGYK 61
           T+G+GS   V LA    +G   A K      L KS+    ++RE  +L  L  PHI+  K
Sbjct: 21  TLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHII--K 78
Query: 62  GCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRV 121
             DV    ++++  + +EYA G  L D I +   ++ E     + +QI+  +EY H +++
Sbjct: 79  LYDVIKSKDEII--MVIEYA-GNELFDYIVQRD-KMSEQEARRFFQQIISAVEYCHRHKI 134
Query: 122 VHCDIKSRNILMAES-GAKIADFGCAKWESEA---LQSGGTPMFMAPEVARGE-HQGFAS 176
           VH D+K  N+L+ E    KIADFG +   ++      S G+P + APEV  G+ + G   
Sbjct: 135 VHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEV 194
Query: 177 DIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRD 236
           D+W+ G  +  M     P+ + + P  VL+K   S  +  +P FLS  A   +   L  +
Sbjct: 195 DVWSCGVILYVMLCRRLPFDDESIP--VLFK-NISNGVYTLPKFLSPGAAGLIKRMLIVN 251
Query: 237 PKERWAASQLLK 248
           P  R +  ++++
Sbjct: 252 PLNRISIHEIMQ 263

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 80/270 (29%), Positives = 121/270 (44%), Gaps = 30/270 (11%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTE----LPKSEFLQR--EQKFLSSLNSP 55
           D+     +G+G+   V L     +G  +A K       + K E      E + L +   P
Sbjct: 9   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 68
Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
            +   K    T   ++L +   MEYA GG L   + R     +E     Y  +I+  LEY
Sbjct: 69  FLTALKYAFQTH--DRLCF--VMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEY 123
Query: 116 LHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG-------GTPMFMAPEVA 167
           LHS  VV+ DIK  N+++ + G  KI DFG  K   E +  G       GTP ++APEV 
Sbjct: 124 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLAPEVL 180
Query: 168 RGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQAND 227
                G A D W +G  + EM  G  P+ N       L+++    E+   P  LS +A  
Sbjct: 181 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER--LFELILMEEI-RFPRTLSPEAKS 237
Query: 228 FLSNCLRRDPKERWA-----ASQLLKHPFL 252
            L+  L++DPK+R       A ++++H F 
Sbjct: 238 LLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 267

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 76/252 (30%), Positives = 126/252 (50%), Gaps = 20/252 (7%)
Query: 8   TIGQGSSATVSLATSLRSGDVFAAKSTE---LPKSEF---LQREQKFLSSLNSPHIVGYK 61
           T+G+GS   V LA    +G   A K      L KS+    ++RE  +L  L  PHI+  K
Sbjct: 11  TLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHII--K 68
Query: 62  GCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRV 121
             DV    ++++  + +EYA G  L D I +   ++ E     + +QI+  +EY H +++
Sbjct: 69  LYDVIKSKDEII--MVIEYA-GNELFDYIVQRD-KMSEQEARRFFQQIISAVEYCHRHKI 124
Query: 122 VHCDIKSRNILMAES-GAKIADFGCAKWESEA---LQSGGTPMFMAPEVARGE-HQGFAS 176
           VH D+K  N+L+ E    KIADFG +   ++      S G+P + APEV  G+ + G   
Sbjct: 125 VHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEV 184
Query: 177 DIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRD 236
           D+W+ G  +  M     P+ + + P  VL+K   S  +  +P FLS  A   +   L  +
Sbjct: 185 DVWSCGVILYVMLCRRLPFDDESIP--VLFK-NISNGVYTLPKFLSPGAAGLIKRMLIVN 241
Query: 237 PKERWAASQLLK 248
           P  R +  ++++
Sbjct: 242 PLNRISIHEIMQ 253

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 76/252 (30%), Positives = 126/252 (50%), Gaps = 20/252 (7%)
Query: 8   TIGQGSSATVSLATSLRSGDVFAAKSTE---LPKSEF---LQREQKFLSSLNSPHIVGYK 61
           T+G+GS   V LA    +G   A K      L KS+    ++RE  +L  L  PHI+  K
Sbjct: 15  TLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHII--K 72
Query: 62  GCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRV 121
             DV    ++++  + +EYA G  L D I +   ++ E     + +QI+  +EY H +++
Sbjct: 73  LYDVIKSKDEII--MVIEYA-GNELFDYIVQRD-KMSEQEARRFFQQIISAVEYCHRHKI 128
Query: 122 VHCDIKSRNILMAES-GAKIADFGCAKWESEA---LQSGGTPMFMAPEVARGE-HQGFAS 176
           VH D+K  N+L+ E    KIADFG +   ++      S G+P + APEV  G+ + G   
Sbjct: 129 VHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEV 188
Query: 177 DIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRD 236
           D+W+ G  +  M     P+ + + P  VL+K   S  +  +P FLS  A   +   L  +
Sbjct: 189 DVWSCGVILYVMLCRRLPFDDESIP--VLFK-NISNGVYTLPKFLSPGAAGLIKRMLIVN 245
Query: 237 PKERWAASQLLK 248
           P  R +  ++++
Sbjct: 246 PLNRISIHEIMQ 257

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 80/270 (29%), Positives = 121/270 (44%), Gaps = 30/270 (11%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTE----LPKSEFLQR--EQKFLSSLNSP 55
           D+     +G+G+   V L     +G  +A K       + K E      E + L +   P
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
            +   K    T   ++L +   MEYA GG L   + R     +E     Y  +I+  LEY
Sbjct: 66  FLTALKYAFQTH--DRLCF--VMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEY 120
Query: 116 LHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG-------GTPMFMAPEVA 167
           LHS  VV+ DIK  N+++ + G  KI DFG  K   E +  G       GTP ++APEV 
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKXFCGTPEYLAPEVL 177
Query: 168 RGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQAND 227
                G A D W +G  + EM  G  P+ N       L+++    E+   P  LS +A  
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER--LFELILMEEI-RFPRTLSPEAKS 234
Query: 228 FLSNCLRRDPKERWA-----ASQLLKHPFL 252
            L+  L++DPK+R       A ++++H F 
Sbjct: 235 LLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 80/270 (29%), Positives = 121/270 (44%), Gaps = 30/270 (11%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTE----LPKSEFLQR--EQKFLSSLNSP 55
           D+     +G+G+   V L     +G  +A K       + K E      E + L +   P
Sbjct: 11  DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 70
Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
            +   K    T   ++L +   MEYA GG L   + R     +E     Y  +I+  LEY
Sbjct: 71  FLTALKYAFQTH--DRLCF--VMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEY 125
Query: 116 LHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG-------GTPMFMAPEVA 167
           LHS  VV+ DIK  N+++ + G  KI DFG  K   E +  G       GTP ++APEV 
Sbjct: 126 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKXFCGTPEYLAPEVL 182
Query: 168 RGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQAND 227
                G A D W +G  + EM  G  P+ N       L+++    E+   P  LS +A  
Sbjct: 183 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER--LFELILMEEI-RFPRTLSPEAKS 239
Query: 228 FLSNCLRRDPKERWA-----ASQLLKHPFL 252
            L+  L++DPK+R       A ++++H F 
Sbjct: 240 LLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 269

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 73/254 (28%), Positives = 121/254 (47%), Gaps = 19/254 (7%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPK--SEFLQREQKFLSSLNSPHIVGYKGCDVT 66
           IG G+     L    +S ++ A K  E  +  +  ++RE     SL  P+IV +K   +T
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIAANVKREIINHRSLRHPNIVRFKEVILT 86
Query: 67  SEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDI 126
                ++    MEYA GG L + I  N GR  E     + +Q++ G+ Y H+ +V H D+
Sbjct: 87  PTHLAIV----MEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL 141
Query: 127 KSRNILMAESGA---KIADFGCAK---WESEALQSGGTPMFMAPEV-ARGEHQGFASDIW 179
           K  N L+  S A   KI DFG +K     S+   + GTP ++APEV  + E+ G  +D+W
Sbjct: 142 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVADVW 201
Query: 180 AVGCTVIEMASGGAPWPNAADP----MTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRR 235
           + G T+  M  G  P+ +  +P     T+   +     +P+    +S +    +S     
Sbjct: 202 SCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDY-VHISPECRHLISRIFVA 260
Query: 236 DPKERWAASQLLKH 249
           DP +R +  ++  H
Sbjct: 261 DPAKRISIPEIRNH 274

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 80/270 (29%), Positives = 121/270 (44%), Gaps = 30/270 (11%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTE----LPKSEFLQR--EQKFLSSLNSP 55
           D+     +G+G+   V L     +G  +A K       + K E      E + L +   P
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
            +   K    T   ++L +   MEYA GG L   + R     +E     Y  +I+  LEY
Sbjct: 66  FLTALKYAFQTH--DRLCF--VMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEY 120
Query: 116 LHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG-------GTPMFMAPEVA 167
           LHS  VV+ DIK  N+++ + G  KI DFG  K   E +  G       GTP ++APEV 
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLAPEVL 177
Query: 168 RGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQAND 227
                G A D W +G  + EM  G  P+ N       L+++    E+   P  LS +A  
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER--LFELILMEEI-RFPRTLSPEAKS 234
Query: 228 FLSNCLRRDPKERWA-----ASQLLKHPFL 252
            L+  L++DPK+R       A ++++H F 
Sbjct: 235 LLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 80/270 (29%), Positives = 121/270 (44%), Gaps = 30/270 (11%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTE----LPKSEFLQR--EQKFLSSLNSP 55
           D+     +G+G+   V L     +G  +A K       + K E      E + L +   P
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
            +   K    T   ++L +   MEYA GG L   + R     +E     Y  +I+  LEY
Sbjct: 66  FLTALKYAFQTH--DRLCF--VMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEY 120
Query: 116 LHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG-------GTPMFMAPEVA 167
           LHS  VV+ DIK  N+++ + G  KI DFG  K   E +  G       GTP ++APEV 
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLAPEVL 177
Query: 168 RGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQAND 227
                G A D W +G  + EM  G  P+ N       L+++    E+   P  LS +A  
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER--LFELILMEEI-RFPRTLSPEAKS 234
Query: 228 FLSNCLRRDPKERWA-----ASQLLKHPFL 252
            L+  L++DPK+R       A ++++H F 
Sbjct: 235 LLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 80/270 (29%), Positives = 121/270 (44%), Gaps = 30/270 (11%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTE----LPKSEFLQR--EQKFLSSLNSP 55
           D+     +G+G+   V L     +G  +A K       + K E      E + L +   P
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
            +   K    T   ++L +   MEYA GG L   + R     +E     Y  +I+  LEY
Sbjct: 66  FLTALKYAFQTH--DRLCF--VMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEY 120
Query: 116 LHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG-------GTPMFMAPEVA 167
           LHS  VV+ DIK  N+++ + G  KI DFG  K   E +  G       GTP ++APEV 
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKXFCGTPEYLAPEVL 177
Query: 168 RGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQAND 227
                G A D W +G  + EM  G  P+ N       L+++    E+   P  LS +A  
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER--LFELILMEEI-RFPRTLSPEAKS 234
Query: 228 FLSNCLRRDPKERWA-----ASQLLKHPFL 252
            L+  L++DPK+R       A ++++H F 
Sbjct: 235 LLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 110/223 (49%), Gaps = 16/223 (7%)
Query: 44  REQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIV 103
           RE + L  L+ P+I+  K  ++  ED+   Y +  E   GG L DEI +   R  E    
Sbjct: 70  REVELLKKLDHPNIM--KLFEIL-EDSSSFY-IVGELYTGGELFDEIIKRK-RFSEHDAA 124
Query: 104 SYTRQILQGLEYLHSNRVVHCDIKSRNILM----AESGAKIADFG---CAKWESEALQSG 156
              +Q+  G+ Y+H + +VH D+K  NIL+     +   KI DFG   C +  ++     
Sbjct: 125 RIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI 184
Query: 157 GTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPW--PNAADPMTVLYKIAYSREL 214
           GT  ++APEV RG +     D+W+ G  +  + SG  P+   N  D +  +    Y+ +L
Sbjct: 185 GTAYYIAPEVLRGTYDE-KCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDL 243
Query: 215 PEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCS 257
           P+    +S  A D +   L   P  R  A+Q L+HP+++++ S
Sbjct: 244 PQWRT-ISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 75/258 (29%), Positives = 126/258 (48%), Gaps = 24/258 (9%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAK--STELPK--SEFLQ--REQKFLSSLNSPH 56
           +  G  +G G  + V LA  LR     A K    +L +  S +L+  RE +  ++LN P 
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 57  IVG-YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
           IV  Y   +  +    L Y + MEY  G TL D +H  G  +     +       Q L +
Sbjct: 74  IVAVYDTGEAETPAGPLPY-IVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQALNF 131
Query: 116 LHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSG-------GTPMFMAPEVA 167
            H N ++H D+K  NIL++ + A K+ DFG A+  +++  S        GT  +++PE A
Sbjct: 132 SHQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQA 191
Query: 168 RGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAF----LSK 223
           RG+     SD++++GC + E+ +G  P+     P++V Y+  + RE P  P+     LS 
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPPF-TGDSPVSVAYQ--HVREDPIPPSARHEGLSA 248
Query: 224 QANDFLSNCLRRDPKERW 241
             +  +   L ++P+ R+
Sbjct: 249 DLDAVVLKALAKNPENRY 266

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 110/223 (49%), Gaps = 16/223 (7%)
Query: 44  REQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIV 103
           RE + L  L+ P+I+  K  ++  ED+   Y +  E   GG L DEI +   R  E    
Sbjct: 70  REVELLKKLDHPNIM--KLFEIL-EDSSSFY-IVGELYTGGELFDEIIKRK-RFSEHDAA 124
Query: 104 SYTRQILQGLEYLHSNRVVHCDIKSRNILM----AESGAKIADFG---CAKWESEALQSG 156
              +Q+  G+ Y+H + +VH D+K  NIL+     +   KI DFG   C +  ++     
Sbjct: 125 RIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI 184
Query: 157 GTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPW--PNAADPMTVLYKIAYSREL 214
           GT  ++APEV RG +     D+W+ G  +  + SG  P+   N  D +  +    Y+ +L
Sbjct: 185 GTAYYIAPEVLRGTYDE-KCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDL 243
Query: 215 PEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCS 257
           P+    +S  A D +   L   P  R  A+Q L+HP+++++ S
Sbjct: 244 PQWRT-ISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 82/254 (32%), Positives = 122/254 (48%), Gaps = 28/254 (11%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSE 68
           +G+GS   V      ++G   A K   L    F   E    + L SP IV   G    + 
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVKKVRL--EVFRAEELMACAGLTSPRIVPLYG----AV 135
Query: 69  DNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKS 128
                 N+FME   GG+L  ++ +  G L E   + Y  Q L+GLEYLHS R++H D+K+
Sbjct: 136 REGPWVNIFMELLEGGSLG-QLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVKA 194
Query: 129 RNILMAESG--AKIADFG---CAKWE--SEALQSG----GTPMFMAPEVARGEHQGFASD 177
            N+L++  G  A + DFG   C + +   + L +G    GT   MAPEV  G       D
Sbjct: 195 DNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRSCDAKVD 254
Query: 178 IWAVGCTVIEMASGGAPWPN-AADPMTVLYKIAYS----RELPEVPAFLSKQANDFLSNC 232
           +W+  C ++ M +G  PW      P+ +  KIA      RE+P   A L+ QA   +   
Sbjct: 255 VWSSCCMMLHMLNGCHPWTQFFRGPLCL--KIASEPPPVREIPPSCAPLTAQA---IQEG 309
Query: 233 LRRDPKERWAASQL 246
           LR++P  R +A++L
Sbjct: 310 LRKEPIHRVSAAEL 323

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 78/253 (30%), Positives = 124/253 (49%), Gaps = 22/253 (8%)
Query: 8   TIGQGSSATVSLATSLRSGDVFAAK---STELPKSEF--LQREQKFLSSLNSPHIVGYKG 62
           TIG+G+ A V LA  + +G   A K    T+L  S    L RE +    LN P+IV  K 
Sbjct: 21  TIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIV--KL 78
Query: 63  CDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
            +V  E  K +Y L  EYA GG + D +  +G R  E    +  RQI+  ++Y H   +V
Sbjct: 79  FEVI-ETEKTLY-LVXEYASGGEVFDYLVAHG-RXKEKEARAKFRQIVSAVQYCHQKFIV 135
Query: 123 HCDIKSRNILM-AESGAKIADFGCAK---WESEALQSGGTPMFMAPEVARG-EHQGFASD 177
           H D+K+ N+L+ A+   KIADFG +    + ++     G P + APE+ +G ++ G   D
Sbjct: 136 HRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDGPEVD 195
Query: 178 IWAVGCTVIEMASGGAPW--PNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRR 235
           +W++G  +  + SG  P+   N  +    + +  Y      +P + S    + L   L  
Sbjct: 196 VWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY-----RIPFYXSTDCENLLKKFLIL 250
Query: 236 DPKERWAASQLLK 248
           +P +R    Q+ K
Sbjct: 251 NPSKRGTLEQIXK 263

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 73/254 (28%), Positives = 120/254 (47%), Gaps = 19/254 (7%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPK--SEFLQREQKFLSSLNSPHIVGYKGCDVT 66
           IG G+     L    +S ++ A K  E  +   E ++RE     SL  P+IV +K   +T
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 86
Query: 67  SEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDI 126
                ++    MEYA GG L + I  N GR  E     + +Q++ G+ Y H+ +V H D+
Sbjct: 87  PTHLAIV----MEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL 141
Query: 127 KSRNILMAESGA---KIADFGCAK---WESEALQSGGTPMFMAPEV-ARGEHQGFASDIW 179
           K  N L+  S A   KI  FG +K     S+   + GTP ++APEV  + E+ G  +D+W
Sbjct: 142 KLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPEVLLKKEYDGKVADVW 201
Query: 180 AVGCTVIEMASGGAPWPNAADP----MTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRR 235
           + G T+  M  G  P+ +  +P     T+   +     +P+    +S +    +S     
Sbjct: 202 SCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDY-VHISPECRHLISRIFVA 260
Query: 236 DPKERWAASQLLKH 249
           DP +R +  ++  H
Sbjct: 261 DPAKRISIPEIRNH 274

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 73/254 (28%), Positives = 120/254 (47%), Gaps = 19/254 (7%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKS--EFLQREQKFLSSLNSPHIVGYKGCDVT 66
           IG G+     L    +S ++ A K  E  +   E ++RE     SL  P+IV +K   +T
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 86
Query: 67  SEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDI 126
                ++    MEYA GG L + I  N GR  E     + +Q++ G+ Y H+ +V H D+
Sbjct: 87  PTHLAIV----MEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL 141
Query: 127 KSRNILMAESGA---KIADFGCAK---WESEALQSGGTPMFMAPEV-ARGEHQGFASDIW 179
           K  N L+  S A   KI  FG +K     S+   + GTP ++APEV  + E+ G  +D+W
Sbjct: 142 KLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVADVW 201
Query: 180 AVGCTVIEMASGGAPWPNAADP----MTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRR 235
           + G T+  M  G  P+ +  +P     T+   +     +P+    +S +    +S     
Sbjct: 202 SCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDY-VHISPECRHLISRIFVA 260
Query: 236 DPKERWAASQLLKH 249
           DP +R +  ++  H
Sbjct: 261 DPAKRISIPEIRNH 274

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 74/258 (28%), Positives = 126/258 (48%), Gaps = 24/258 (9%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAK--STELPK--SEFLQ--REQKFLSSLNSPH 56
           +  G  +G G  + V LA  LR     A K    +L +  S +L+  RE +  ++LN P 
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 57  IVG-YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
           IV  Y   +  +    L Y + MEY  G TL D +H  G  +     +       Q L +
Sbjct: 74  IVAVYDTGEAETPAGPLPY-IVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQALNF 131
Query: 116 LHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSG-------GTPMFMAPEVA 167
            H N ++H D+K  NI+++ + A K+ DFG A+  +++  S        GT  +++PE A
Sbjct: 132 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 168 RGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAF----LSK 223
           RG+     SD++++GC + E+ +G  P+     P++V Y+  + RE P  P+     LS 
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPPF-TGDSPVSVAYQ--HVREDPIPPSARHEGLSA 248
Query: 224 QANDFLSNCLRRDPKERW 241
             +  +   L ++P+ R+
Sbjct: 249 DLDAVVLKALAKNPENRY 266

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 69/198 (34%), Positives = 109/198 (55%), Gaps = 15/198 (7%)
Query: 8   TIGQGSSATVSLATSLRSGDVFAAK---STEL-PKS-EFLQREQKFLSSLNSPHIVGYKG 62
           TIG+G+ A V LA  + +G   A K    T+L P S + L RE + +  LN P+IV  K 
Sbjct: 22  TIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIV--KL 79
Query: 63  CDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
            +V  E  K +Y L MEYA GG + D +  +G R+ E    +  RQI+  ++Y H   +V
Sbjct: 80  FEVI-ETEKTLY-LVMEYASGGEVFDYLVAHG-RMKEKEARAKFRQIVSAVQYCHQKYIV 136
Query: 123 HCDIKSRNILM-AESGAKIADFGCAKWESEALQSG---GTPMFMAPEVARG-EHQGFASD 177
           H D+K+ N+L+  +   KIADFG +   +   +     G+P + APE+ +G ++ G   D
Sbjct: 137 HRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFCGSPPYAAPELFQGKKYDGPEVD 196
Query: 178 IWAVGCTVIEMASGGAPW 195
           +W++G  +  + SG  P+
Sbjct: 197 VWSLGVILYTLVSGSLPF 214

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 79/273 (28%), Positives = 124/273 (45%), Gaps = 23/273 (8%)
Query: 8   TIGQGSSATVSLATSLRSGDVFA----AKSTELPKSEFLQREQKFLSSLNSPHIVGYKGC 63
            +G G+ + V LA   R+  + A    AK     K   ++ E   L  +  P+IV     
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVA---L 81
Query: 64  DVTSEDNKLMYNLFMEYAPGGTLNDEIHRNG--GRLDESLIVSYTRQILQGLEYLHSNRV 121
           D   E    +Y L M+   GG L D I   G     D S ++    Q+L  ++YLH   +
Sbjct: 82  DDIYESGGHLY-LIMQLVSGGELFDRIVEKGFYTERDASRLIF---QVLDAVKYLHDLGI 137
Query: 122 VHCDIKSRNILMA----ESGAKIADFGCAKWE---SEALQSGGTPMFMAPEVARGEHQGF 174
           VH D+K  N+L      +S   I+DFG +K E   S    + GTP ++APEV   +    
Sbjct: 138 VHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSK 197
Query: 175 ASDIWAVGCTVIEMASGGAPW--PNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNC 232
           A D W++G     +  G  P+   N A     + K  Y  + P     +S  A DF+ + 
Sbjct: 198 AVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDD-ISDSAKDFIRHL 256
Query: 233 LRRDPKERWAASQLLKHPFLEEFCSCTKQIQES 265
           + +DP++R+   Q L+HP++    +  K I +S
Sbjct: 257 MEKDPEKRFTCEQALQHPWIAGDTALDKNIHQS 289

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 79/273 (28%), Positives = 124/273 (45%), Gaps = 23/273 (8%)
Query: 8   TIGQGSSATVSLATSLRSGDVFA----AKSTELPKSEFLQREQKFLSSLNSPHIVGYKGC 63
            +G G+ + V LA   R+  + A    AK     K   ++ E   L  +  P+IV     
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVA---L 81
Query: 64  DVTSEDNKLMYNLFMEYAPGGTLNDEIHRNG--GRLDESLIVSYTRQILQGLEYLHSNRV 121
           D   E    +Y L M+   GG L D I   G     D S ++    Q+L  ++YLH   +
Sbjct: 82  DDIYESGGHLY-LIMQLVSGGELFDRIVEKGFYTERDASRLIF---QVLDAVKYLHDLGI 137
Query: 122 VHCDIKSRNILM----AESGAKIADFGCAKWE---SEALQSGGTPMFMAPEVARGEHQGF 174
           VH D+K  N+L      +S   I+DFG +K E   S    + GTP ++APEV   +    
Sbjct: 138 VHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSK 197
Query: 175 ASDIWAVGCTVIEMASGGAPW--PNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNC 232
           A D W++G     +  G  P+   N A     + K  Y  + P     +S  A DF+ + 
Sbjct: 198 AVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDD-ISDSAKDFIRHL 256
Query: 233 LRRDPKERWAASQLLKHPFLEEFCSCTKQIQES 265
           + +DP++R+   Q L+HP++    +  K I +S
Sbjct: 257 MEKDPEKRFTCEQALQHPWIAGDTALDKNIHQS 289

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 79/273 (28%), Positives = 124/273 (45%), Gaps = 23/273 (8%)
Query: 8   TIGQGSSATVSLATSLRSGDVFA----AKSTELPKSEFLQREQKFLSSLNSPHIVGYKGC 63
            +G G+ + V LA   R+  + A    AK     K   ++ E   L  +  P+IV     
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVA---L 81
Query: 64  DVTSEDNKLMYNLFMEYAPGGTLNDEIHRNG--GRLDESLIVSYTRQILQGLEYLHSNRV 121
           D   E    +Y L M+   GG L D I   G     D S ++    Q+L  ++YLH   +
Sbjct: 82  DDIYESGGHLY-LIMQLVSGGELFDRIVEKGFYTERDASRLIF---QVLDAVKYLHDLGI 137
Query: 122 VHCDIKSRNILMA----ESGAKIADFGCAKWE---SEALQSGGTPMFMAPEVARGEHQGF 174
           VH D+K  N+L      +S   I+DFG +K E   S    + GTP ++APEV   +    
Sbjct: 138 VHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSK 197
Query: 175 ASDIWAVGCTVIEMASGGAPW--PNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNC 232
           A D W++G     +  G  P+   N A     + K  Y  + P     +S  A DF+ + 
Sbjct: 198 AVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDD-ISDSAKDFIRHL 256
Query: 233 LRRDPKERWAASQLLKHPFLEEFCSCTKQIQES 265
           + +DP++R+   Q L+HP++    +  K I +S
Sbjct: 257 MEKDPEKRFTCEQALQHPWIAGDTALDKNIHQS 289

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 86/290 (29%), Positives = 136/290 (46%), Gaps = 34/290 (11%)
Query: 8   TIGQGSSATVSLATSLRSGDVFAAKST------ELPKSEFLQREQKFLSSLNSPHIVGYK 61
            +G+GS   V L     +G   A K        +    E L RE + L  L+ P+I+   
Sbjct: 33  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 92
Query: 62  GCDVTSEDNKLMYNLFMEYAPGGTLNDEI--HRNGGRLDESLIVSYTRQILQGLEYLHSN 119
                 ED    Y L  E   GG L DEI   +    +D + I+   RQ+L G+ Y+H N
Sbjct: 93  EF---FEDKGYFY-LVGEVYTGGELFDEIISRKRFSEVDAARII---RQVLSGITYMHKN 145
Query: 120 RVVHCDIKSRNILM----AESGAKIADFGCAKW--ESEALQSG-GTPMFMAPEVARGEHQ 172
           ++VH D+K  N+L+     ++  +I DFG +     S+ ++   GT  ++APEV  G + 
Sbjct: 146 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTYD 205
Query: 173 GFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKI---AYSRELPEVPAFLSKQANDFL 229
               D+W+ G  +  + SG  P+ N A+   +L K+    Y+ ELP+    +S+ A D +
Sbjct: 206 E-KCDVWSTGVILYILLSGCPPF-NGANEYDILKKVEKGKYTFELPQWKK-VSESAKDLI 262
Query: 230 SNCLRRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSILDQGIWN 279
              L   P  R +A   L H +++ +   TK+ Q S   P+  LD  I N
Sbjct: 263 RKMLTYVPSMRISARDALDHEWIQTY---TKE-QISVDVPS--LDNAILN 306

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 74/258 (28%), Positives = 126/258 (48%), Gaps = 24/258 (9%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAK--STELPK--SEFLQ--REQKFLSSLNSPH 56
           +  G  +G G  + V LA  LR     A K    +L +  S +L+  RE +  ++LN P 
Sbjct: 14  YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 57  IVG-YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
           IV  Y   +  +    L Y + MEY  G TL D +H  G  +     +       Q L +
Sbjct: 74  IVAVYATGEAETPAGPLPY-IVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQALNF 131
Query: 116 LHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSG-------GTPMFMAPEVA 167
            H N ++H D+K  NI+++ + A K+ DFG A+  +++  S        GT  +++PE A
Sbjct: 132 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 168 RGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAF----LSK 223
           RG+     SD++++GC + E+ +G  P+     P++V Y+  + RE P  P+     LS 
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPPF-TGDSPVSVAYQ--HVREDPIPPSARHEGLSA 248
Query: 224 QANDFLSNCLRRDPKERW 241
             +  +   L ++P+ R+
Sbjct: 249 DLDAVVLKALAKNPENRY 266

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 79/273 (28%), Positives = 124/273 (45%), Gaps = 23/273 (8%)
Query: 8   TIGQGSSATVSLATSLRSGDVFA----AKSTELPKSEFLQREQKFLSSLNSPHIVGYKGC 63
            +G G+ + V LA   R+  + A    AK     K   ++ E   L  +  P+IV     
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVA---L 81
Query: 64  DVTSEDNKLMYNLFMEYAPGGTLNDEIHRNG--GRLDESLIVSYTRQILQGLEYLHSNRV 121
           D   E    +Y L M+   GG L D I   G     D S ++    Q+L  ++YLH   +
Sbjct: 82  DDIYESGGHLY-LIMQLVSGGELFDRIVEKGFYTERDASRLIF---QVLDAVKYLHDLGI 137
Query: 122 VHCDIKSRNILM----AESGAKIADFGCAKWE---SEALQSGGTPMFMAPEVARGEHQGF 174
           VH D+K  N+L      +S   I+DFG +K E   S    + GTP ++APEV   +    
Sbjct: 138 VHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSK 197
Query: 175 ASDIWAVGCTVIEMASGGAPW--PNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNC 232
           A D W++G     +  G  P+   N A     + K  Y  + P     +S  A DF+ + 
Sbjct: 198 AVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDD-ISDSAKDFIRHL 256
Query: 233 LRRDPKERWAASQLLKHPFLEEFCSCTKQIQES 265
           + +DP++R+   Q L+HP++    +  K I +S
Sbjct: 257 MEKDPEKRFTCEQALQHPWIAGDTALDKNIHQS 289

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 77/266 (28%), Positives = 125/266 (46%), Gaps = 28/266 (10%)
Query: 8   TIGQGSSATVSLATSLRSGDVFAAKST------ELPKSEFLQREQKFLSSLNSPHIVGYK 61
            +G+GS   V L     +G   A K        +    E L RE + L  L+ P+I+   
Sbjct: 39  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 98
Query: 62  GCDVTSEDNKLMYNLFMEYAPGGTLNDEI--HRNGGRLDESLIVSYTRQILQGLEYLHSN 119
                 ED    Y L  E   GG L DEI   +    +D + I+   RQ+L G+ Y+H N
Sbjct: 99  EF---FEDKGYFY-LVGEVYTGGELFDEIISRKRFSEVDAARII---RQVLSGITYMHKN 151
Query: 120 RVVHCDIKSRNILM----AESGAKIADFGCAKW--ESEALQSG-GTPMFMAPEVARGEHQ 172
           ++VH D+K  N+L+     ++  +I DFG +     S+ ++   GT  ++APEV  G + 
Sbjct: 152 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTYD 211
Query: 173 GFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKI---AYSRELPEVPAFLSKQANDFL 229
               D+W+ G  +  + SG  P+ N A+   +L K+    Y+ ELP+    +S+ A D +
Sbjct: 212 E-KCDVWSTGVILYILLSGCPPF-NGANEYDILKKVEKGKYTFELPQWKK-VSESAKDLI 268
Query: 230 SNCLRRDPKERWAASQLLKHPFLEEF 255
              L   P  R +A   L H +++ +
Sbjct: 269 RKMLTYVPSMRISARDALDHEWIQTY 294

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 74/258 (28%), Positives = 126/258 (48%), Gaps = 24/258 (9%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAK--STELPK--SEFLQ--REQKFLSSLNSPH 56
           +  G  +G G  + V LA  LR     A K    +L +  S +L+  RE +  ++LN P 
Sbjct: 14  YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 57  IVG-YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
           IV  Y   +  +    L Y + MEY  G TL D +H  G  +     +       Q L +
Sbjct: 74  IVAVYDTGEAETPAGPLPY-IVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQALNF 131
Query: 116 LHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSG-------GTPMFMAPEVA 167
            H N ++H D+K  NI+++ + A K+ DFG A+  +++  S        GT  +++PE A
Sbjct: 132 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 168 RGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAF----LSK 223
           RG+     SD++++GC + E+ +G  P+     P++V Y+  + RE P  P+     LS 
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPPF-TGDSPVSVAYQ--HVREDPIPPSARHEGLSA 248
Query: 224 QANDFLSNCLRRDPKERW 241
             +  +   L ++P+ R+
Sbjct: 249 DLDAVVLKALAKNPENRY 266

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 74/258 (28%), Positives = 126/258 (48%), Gaps = 24/258 (9%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAK--STELPK--SEFLQ--REQKFLSSLNSPH 56
           +  G  +G G  + V LA  LR     A K    +L +  S +L+  RE +  ++LN P 
Sbjct: 31  YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 90
Query: 57  IVG-YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
           IV  Y   +  +    L Y + MEY  G TL D +H  G  +     +       Q L +
Sbjct: 91  IVAVYDTGEAETPAGPLPY-IVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQALNF 148
Query: 116 LHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSG-------GTPMFMAPEVA 167
            H N ++H D+K  NI+++ + A K+ DFG A+  +++  S        GT  +++PE A
Sbjct: 149 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 208
Query: 168 RGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAF----LSK 223
           RG+     SD++++GC + E+ +G  P+     P++V Y+  + RE P  P+     LS 
Sbjct: 209 RGDSVDARSDVYSLGCVLYEVLTGEPPF-TGDSPVSVAYQ--HVREDPIPPSARHEGLSA 265
Query: 224 QANDFLSNCLRRDPKERW 241
             +  +   L ++P+ R+
Sbjct: 266 DLDAVVLKALAKNPENRY 283

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 86/290 (29%), Positives = 136/290 (46%), Gaps = 34/290 (11%)
Query: 8   TIGQGSSATVSLATSLRSGDVFAAKST------ELPKSEFLQREQKFLSSLNSPHIVGYK 61
            +G+GS   V L     +G   A K        +    E L RE + L  L+ P+I+   
Sbjct: 56  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 115
Query: 62  GCDVTSEDNKLMYNLFMEYAPGGTLNDEI--HRNGGRLDESLIVSYTRQILQGLEYLHSN 119
                 ED    Y L  E   GG L DEI   +    +D + I+   RQ+L G+ Y+H N
Sbjct: 116 EF---FEDKGYFY-LVGEVYTGGELFDEIISRKRFSEVDAARII---RQVLSGITYMHKN 168
Query: 120 RVVHCDIKSRNILM----AESGAKIADFGCAKW--ESEALQSG-GTPMFMAPEVARGEHQ 172
           ++VH D+K  N+L+     ++  +I DFG +     S+ ++   GT  ++APEV  G + 
Sbjct: 169 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTYD 228
Query: 173 GFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKI---AYSRELPEVPAFLSKQANDFL 229
               D+W+ G  +  + SG  P+ N A+   +L K+    Y+ ELP+    +S+ A D +
Sbjct: 229 E-KCDVWSTGVILYILLSGCPPF-NGANEYDILKKVEKGKYTFELPQWKK-VSESAKDLI 285
Query: 230 SNCLRRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSILDQGIWN 279
              L   P  R +A   L H +++ +   TK+ Q S   P+  LD  I N
Sbjct: 286 RKMLTYVPSMRISARDALDHEWIQTY---TKE-QISVDVPS--LDNAILN 329

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 86/290 (29%), Positives = 136/290 (46%), Gaps = 34/290 (11%)
Query: 8   TIGQGSSATVSLATSLRSGDVFAAKST------ELPKSEFLQREQKFLSSLNSPHIVGYK 61
            +G+GS   V L     +G   A K        +    E L RE + L  L+ P+I+   
Sbjct: 57  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 116
Query: 62  GCDVTSEDNKLMYNLFMEYAPGGTLNDEI--HRNGGRLDESLIVSYTRQILQGLEYLHSN 119
                 ED    Y L  E   GG L DEI   +    +D + I+   RQ+L G+ Y+H N
Sbjct: 117 EF---FEDKGYFY-LVGEVYTGGELFDEIISRKRFSEVDAARII---RQVLSGITYMHKN 169
Query: 120 RVVHCDIKSRNILM----AESGAKIADFGCAKW--ESEALQSG-GTPMFMAPEVARGEHQ 172
           ++VH D+K  N+L+     ++  +I DFG +     S+ ++   GT  ++APEV  G + 
Sbjct: 170 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTYD 229
Query: 173 GFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKI---AYSRELPEVPAFLSKQANDFL 229
               D+W+ G  +  + SG  P+ N A+   +L K+    Y+ ELP+    +S+ A D +
Sbjct: 230 E-KCDVWSTGVILYILLSGCPPF-NGANEYDILKKVEKGKYTFELPQWKK-VSESAKDLI 286
Query: 230 SNCLRRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSILDQGIWN 279
              L   P  R +A   L H +++ +   TK+ Q S   P+  LD  I N
Sbjct: 287 RKMLTYVPSMRISARDALDHEWIQTY---TKE-QISVDVPS--LDNAILN 330

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 65/190 (34%), Positives = 92/190 (48%), Gaps = 22/190 (11%)
Query: 86  LNDEIHRNGGRLD----ESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGA--- 138
           +N  IH     LD    E LI +  RQI   L YLH+  + H DIK  N L + + +   
Sbjct: 150 INGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEI 209
Query: 139 KIADFGCAKWESEALQSG---------GTPMFMAPEV--ARGEHQGFASDIWAVGCTVIE 187
           K+ DFG +K E   L +G         GTP F+APEV     E  G   D W+ G  +  
Sbjct: 210 KLVDFGLSK-EFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHL 268
Query: 188 MASGGAPWPNAADPMTVLYKIAYSRELPEVPAF--LSKQANDFLSNCLRRDPKERWAASQ 245
           +  G  P+P   D  T+  ++   +   E P +  LS  A D LSN L R+  ER+ A +
Sbjct: 269 LLMGAVPFPGVNDADTI-SQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMR 327
Query: 246 LLKHPFLEEF 255
            L+HP++ +F
Sbjct: 328 ALQHPWISQF 337

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 74/258 (28%), Positives = 125/258 (48%), Gaps = 24/258 (9%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAK--STELPK--SEFLQ--REQKFLSSLNSPH 56
           +  G  +G G  + V LA  LR     A K    +L +  S +L+  RE +  ++LN P 
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 57  IVG-YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
           IV  Y   +  +    L Y + MEY  G TL D +H  G  +     +       Q L +
Sbjct: 74  IVAVYDTGEAETPAGPLPY-IVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQALNF 131
Query: 116 LHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSG-------GTPMFMAPEVA 167
            H N ++H D+K  NI+++ + A K+ DFG A+  +++  S        GT  +++PE A
Sbjct: 132 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 168 RGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAF----LSK 223
           RG+     SD++++GC + E+ +G  P+     P +V Y+  + RE P  P+     LS 
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPPF-TGDSPDSVAYQ--HVREDPIPPSARHEGLSA 248
Query: 224 QANDFLSNCLRRDPKERW 241
             +  +   L ++P+ R+
Sbjct: 249 DLDAVVLKALAKNPENRY 266

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 84/285 (29%), Positives = 126/285 (44%), Gaps = 42/285 (14%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELP-KSEFL----QREQKFLSSLNSPHIVGYKGC 63
           +G G+  +V  A   RSG+  A K    P +SE       RE   L  +   +++G    
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGL--L 89
Query: 64  DVTSEDNKLMYNLFMEYAPGGTLNDEIHR-NGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
           DV +  + L  N +  Y     +  ++ +  G +  E  I     Q+L+GL+Y+HS  VV
Sbjct: 90  DVFTPASSLR-NFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAGVV 148
Query: 123 HCDIKSRNILMAES-GAKIADFGCAKWESEALQSGG--TPMFMAPEVARG-EHQGFASDI 178
           H D+K  N+ + E    KI DFG A+  ++A  +G   T  + APEV     H     DI
Sbjct: 149 HRDLKPGNLAVNEDCELKILDFGLAR-HADAEMTGYVVTRWYRAPEVILSWMHYNQTVDI 207
Query: 179 WAVGCTVIEMASGGAPW--PNAADPMTVLYKI------------------AYSRELPEVP 218
           W+VGC + EM +G   +   +  D +T + K+                  +Y + LP+ P
Sbjct: 208 WSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTP 267
Query: 219 --------AFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
                      S QA D L   L  D  +R  A+Q L HPF E F
Sbjct: 268 RKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 312

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 81/282 (28%), Positives = 126/282 (44%), Gaps = 35/282 (12%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTE----LPKSEFLQR--EQKFLSSLNSPHIVGYKG 62
           +G+G+   V L     +G  +A K  +    + K E      E + L +   P +   K 
Sbjct: 159 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 218
Query: 63  CDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNR-V 121
              T   ++L +   MEYA GG L   + R      E     Y  +I+  L+YLHS + V
Sbjct: 219 SFQTH--DRLCF--VMEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLHSEKNV 273
Query: 122 VHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG-------GTPMFMAPEVARGEHQG 173
           V+ D+K  N+++ + G  KI DFG  K   E ++ G       GTP ++APEV      G
Sbjct: 274 VYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKTFCGTPEYLAPEVLEDNDYG 330
Query: 174 FASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCL 233
            A D W +G  + EM  G  P+ N       L+++    E+   P  L  +A   LS  L
Sbjct: 331 RAVDWWGLGVVMYEMMCGRLPFYNQDHEK--LFELILMEEI-RFPRTLGPEAKSLLSGLL 387
Query: 234 RRDPKERWA-----ASQLLKHPFLEEFCSCT-KQIQESNCSP 269
           ++DPK+R       A ++++H F   F     + + E   SP
Sbjct: 388 KKDPKQRLGGGSEDAKEIMQHRF---FAGIVWQHVYEKKLSP 426

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 81/282 (28%), Positives = 126/282 (44%), Gaps = 35/282 (12%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTE----LPKSEFLQR--EQKFLSSLNSPHIVGYKG 62
           +G+G+   V L     +G  +A K  +    + K E      E + L +   P +   K 
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 215
Query: 63  CDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNR-V 121
              T   ++L +   MEYA GG L   + R      E     Y  +I+  L+YLHS + V
Sbjct: 216 SFQTH--DRLCF--VMEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLHSEKNV 270
Query: 122 VHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG-------GTPMFMAPEVARGEHQG 173
           V+ D+K  N+++ + G  KI DFG  K   E ++ G       GTP ++APEV      G
Sbjct: 271 VYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKTFCGTPEYLAPEVLEDNDYG 327
Query: 174 FASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCL 233
            A D W +G  + EM  G  P+ N       L+++    E+   P  L  +A   LS  L
Sbjct: 328 RAVDWWGLGVVMYEMMCGRLPFYNQDHEK--LFELILMEEI-RFPRTLGPEAKSLLSGLL 384
Query: 234 RRDPKERWA-----ASQLLKHPFLEEFCSCT-KQIQESNCSP 269
           ++DPK+R       A ++++H F   F     + + E   SP
Sbjct: 385 KKDPKQRLGGGSEDAKEIMQHRF---FAGIVWQHVYEKKLSP 423

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 85/290 (29%), Positives = 132/290 (45%), Gaps = 34/290 (11%)
Query: 8   TIGQGSSATVSLATSLRSGDVFAAKST------ELPKSEFLQREQKFLSSLNSPHIVGYK 61
            +G+GS   V L     +G   A K        +    E L RE + L  L+ P+I    
Sbjct: 33  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKLY 92
Query: 62  GCDVTSEDNKLMYNLFMEYAPGGTLNDEI--HRNGGRLDESLIVSYTRQILQGLEYLHSN 119
                 ED    Y L  E   GG L DEI   +    +D + I+   RQ+L G+ Y H N
Sbjct: 93  EF---FEDKGYFY-LVGEVYTGGELFDEIISRKRFSEVDAARII---RQVLSGITYXHKN 145
Query: 120 RVVHCDIKSRNILM----AESGAKIADFGCA---KWESEALQSGGTPMFMAPEVARGEHQ 172
           ++VH D+K  N+L+     ++  +I DFG +   +   +     GT  ++APEV  G + 
Sbjct: 146 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIAPEVLHGTYD 205
Query: 173 GFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKI---AYSRELPEVPAFLSKQANDFL 229
               D+W+ G  +  + SG  P+ N A+   +L K+    Y+ ELP+    +S+ A D +
Sbjct: 206 E-KCDVWSTGVILYILLSGCPPF-NGANEYDILKKVEKGKYTFELPQWKK-VSESAKDLI 262
Query: 230 SNCLRRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSILDQGIWN 279
              L   P  R +A   L H +++ +   TK+ Q S   P+  LD  I N
Sbjct: 263 RKXLTYVPSXRISARDALDHEWIQTY---TKE-QISVDVPS--LDNAILN 306

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 84/285 (29%), Positives = 125/285 (43%), Gaps = 42/285 (14%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELP-KSEFL----QREQKFLSSLNSPHIVGYKGC 63
           +G G+  +V  A   RSG+  A K    P +SE       RE   L  +   +++G    
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGL--L 107
Query: 64  DVTSEDNKLMYNLFMEYAPGGTLNDEIHR-NGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
           DV +  + L  N +  Y     +  ++ +  G    E  I     Q+L+GL+Y+HS  VV
Sbjct: 108 DVFTPASSLR-NFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAGVV 166
Query: 123 HCDIKSRNILMAES-GAKIADFGCAKWESEALQSGG--TPMFMAPEVARG-EHQGFASDI 178
           H D+K  N+ + E    KI DFG A+  ++A  +G   T  + APEV     H     DI
Sbjct: 167 HRDLKPGNLAVNEDCELKILDFGLAR-HADAEMTGYVVTRWYRAPEVILSWMHYNQTVDI 225
Query: 179 WAVGCTVIEMASGGAPW--PNAADPMTVLYKI------------------AYSRELPEVP 218
           W+VGC + EM +G   +   +  D +T + K+                  +Y + LP+ P
Sbjct: 226 WSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTP 285
Query: 219 --------AFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
                      S QA D L   L  D  +R  A+Q L HPF E F
Sbjct: 286 RKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 330

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 81/282 (28%), Positives = 126/282 (44%), Gaps = 35/282 (12%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTE----LPKSEFLQR--EQKFLSSLNSPHIVGYKG 62
           +G+G+   V L     +G  +A K  +    + K E      E + L +   P +   K 
Sbjct: 16  LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 75
Query: 63  CDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNR-V 121
              T   ++L +   MEYA GG L   + R      E     Y  +I+  L+YLHS + V
Sbjct: 76  SFQTH--DRLCF--VMEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLHSEKNV 130
Query: 122 VHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG-------GTPMFMAPEVARGEHQG 173
           V+ D+K  N+++ + G  KI DFG  K   E ++ G       GTP ++APEV      G
Sbjct: 131 VYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKXFCGTPEYLAPEVLEDNDYG 187
Query: 174 FASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCL 233
            A D W +G  + EM  G  P+ N       L+++    E+   P  L  +A   LS  L
Sbjct: 188 RAVDWWGLGVVMYEMMCGRLPFYNQDHEK--LFELILMEEI-RFPRTLGPEAKSLLSGLL 244
Query: 234 RRDPKERWA-----ASQLLKHPFLEEFCSCT-KQIQESNCSP 269
           ++DPK+R       A ++++H F   F     + + E   SP
Sbjct: 245 KKDPKQRLGGGSEDAKEIMQHRF---FAGIVWQHVYEKKLSP 283

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/198 (32%), Positives = 102/198 (51%), Gaps = 20/198 (10%)
Query: 9   IGQGSSATVSL----ATSLRSGDVFAAKSTELPKSEFL----QREQKFLSSLNSPHIVGY 60
           +G+G    VSL     T+  +G++ A K+ +      L    QRE + L +L   HIV Y
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 61  KGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNR 120
           KGC    +  +    L MEY P G+L D + R+   L + L+  + +QI +G+ YLH+  
Sbjct: 76  KGC--CEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLL--FAQQICEGMAYLHAQH 131
Query: 121 VVHCDIKSRNILMA-ESGAKIADFGCAKWESE------ALQSGGTPMF-MAPEVARGEHQ 172
            +H  + +RN+L+  +   KI DFG AK   E        + G +P+F  APE  +    
Sbjct: 132 YIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKF 191
Query: 173 GFASDIWAVGCTVIEMAS 190
            +ASD+W+ G T+ E+ +
Sbjct: 192 YYASDVWSFGVTLYELLT 209

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 83/299 (27%), Positives = 141/299 (47%), Gaps = 51/299 (17%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQK--------FLSSLNSPHIVGY 60
           IG+G+  +V+      SG + A K     +S   ++EQK         + S + P+IV +
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRI---RSTVDEKEQKQLLMDLDVVMRSSDCPYIVQF 86
Query: 61  KG-------CDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGL 113
            G       C +  E     ++ F +Y     L+D I        E ++   T   ++ L
Sbjct: 87  YGALFREGDCWICMELMSTSFDKFYKYV-YSVLDDVIP-------EEILGKITLATVKAL 138
Query: 114 EYLHSN-RVVHCDIKSRNILMAESG-AKIADFGCAKWESEAL---QSGGTPMFMAPEV-- 166
            +L  N +++H DIK  NIL+  SG  K+ DFG +    +++   +  G   +MAPE   
Sbjct: 139 NHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERID 198
Query: 167 ARGEHQGF--ASDIWAVGCTVIEMASGGAPWP---NAADPMTVLYK-----IAYSRELPE 216
                QG+   SD+W++G T+ E+A+G  P+P   +  D +T + K     ++ S E   
Sbjct: 199 PSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREF 258
Query: 217 VPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSILDQ 275
            P+F+     +F++ CL +D  +R    +LLKHPF+  +    ++  E  C    ILDQ
Sbjct: 259 SPSFI-----NFVNLCLTKDESKRPKYKELLKHPFILMY---EERAVEVACYVCKILDQ 309

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 80/290 (27%), Positives = 126/290 (43%), Gaps = 56/290 (19%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKS-----TELPKSEFLQREQKFLSSLNSPHIVGYKGC 63
           +G+GS   V    +  +G + A K       +    +   RE K L  L   ++V     
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNL--L 90
Query: 64  DVTSEDNKLMYNLFMEYAPGGTLND-EIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
           +V  +  +  + L  E+     L+D E+  NG  LD  ++  Y  QI+ G+ + HS+ ++
Sbjct: 91  EVCKKKKR--WYLVFEFVDHTILDDLELFPNG--LDYQVVQKYLFQIINGIGFCHSHNII 146
Query: 123 HCDIKSRNILMAESG-AKIADFGCAK--------WESEALQSGGTPMFMAPEVARGEHQ- 172
           H DIK  NIL+++SG  K+ DFG A+        ++ E      T  + APE+  G+ + 
Sbjct: 147 HRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEV----ATRWYRAPELLVGDVKY 202
Query: 173 GFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAY--------------------SR 212
           G A D+WA+GC V EM  G   +P  +D +  LY I                        
Sbjct: 203 GKAVDVWAIGCLVTEMFMGEPLFPGDSD-IDQLYHIMMCLGNLIPRHQELFNKNPVFAGV 261
Query: 213 ELPEVP---------AFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLE 253
            LPE+            LS+   D    CL  DP +R   ++LL H F +
Sbjct: 262 RLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQ 311

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/198 (32%), Positives = 102/198 (51%), Gaps = 20/198 (10%)
Query: 9   IGQGSSATVSL----ATSLRSGDVFAAKSTELPKSEFL----QREQKFLSSLNSPHIVGY 60
           +G+G    VSL     T+  +G++ A K+ +      L    QRE + L +L   HIV Y
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 61  KGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNR 120
           KGC    +  +    L MEY P G+L D + R+   L + L+  + +QI +G+ YLH+  
Sbjct: 77  KGC--CEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLL--FAQQICEGMAYLHAQH 132
Query: 121 VVHCDIKSRNILMA-ESGAKIADFGCAKWESE------ALQSGGTPMF-MAPEVARGEHQ 172
            +H  + +RN+L+  +   KI DFG AK   E        + G +P+F  APE  +    
Sbjct: 133 YIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKF 192
Query: 173 GFASDIWAVGCTVIEMAS 190
            +ASD+W+ G T+ E+ +
Sbjct: 193 YYASDVWSFGVTLYELLT 210

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 81/282 (28%), Positives = 126/282 (44%), Gaps = 35/282 (12%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTE----LPKSEFLQR--EQKFLSSLNSPHIVGYKG 62
           +G+G+   V L     +G  +A K  +    + K E      E + L +   P +   K 
Sbjct: 17  LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 76
Query: 63  CDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNR-V 121
              T   ++L +   MEYA GG L   + R      E     Y  +I+  L+YLHS + V
Sbjct: 77  SFQTH--DRLCF--VMEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLHSEKNV 131
Query: 122 VHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG-------GTPMFMAPEVARGEHQG 173
           V+ D+K  N+++ + G  KI DFG  K   E ++ G       GTP ++APEV      G
Sbjct: 132 VYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKXFCGTPEYLAPEVLEDNDYG 188
Query: 174 FASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCL 233
            A D W +G  + EM  G  P+ N       L+++    E+   P  L  +A   LS  L
Sbjct: 189 RAVDWWGLGVVMYEMMCGRLPFYNQDHEK--LFELILMEEI-RFPRTLGPEAKSLLSGLL 245
Query: 234 RRDPKERWA-----ASQLLKHPFLEEFCSCT-KQIQESNCSP 269
           ++DPK+R       A ++++H F   F     + + E   SP
Sbjct: 246 KKDPKQRLGGGSEDAKEIMQHRF---FAGIVWQHVYEKKLSP 284

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 81/282 (28%), Positives = 126/282 (44%), Gaps = 35/282 (12%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTE----LPKSEFLQR--EQKFLSSLNSPHIVGYKG 62
           +G+G+   V L     +G  +A K  +    + K E      E + L +   P +   K 
Sbjct: 18  LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 77
Query: 63  CDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNR-V 121
              T   ++L +   MEYA GG L   + R      E     Y  +I+  L+YLHS + V
Sbjct: 78  SFQTH--DRLCF--VMEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLHSEKNV 132
Query: 122 VHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG-------GTPMFMAPEVARGEHQG 173
           V+ D+K  N+++ + G  KI DFG  K   E ++ G       GTP ++APEV      G
Sbjct: 133 VYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKXFCGTPEYLAPEVLEDNDYG 189
Query: 174 FASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCL 233
            A D W +G  + EM  G  P+ N       L+++    E+   P  L  +A   LS  L
Sbjct: 190 RAVDWWGLGVVMYEMMCGRLPFYNQDHEK--LFELILMEEI-RFPRTLGPEAKSLLSGLL 246
Query: 234 RRDPKERWA-----ASQLLKHPFLEEFCSCT-KQIQESNCSP 269
           ++DPK+R       A ++++H F   F     + + E   SP
Sbjct: 247 KKDPKQRLGGGSEDAKEIMQHRF---FAGIVWQHVYEKKLSP 285

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 122/264 (46%), Gaps = 30/264 (11%)
Query: 8   TIGQGSSATVSLA---TSLRSGDVFAAKSTELPKSEFLQR-----EQKFLSSLNSPHIVG 59
            +GQGS   V L    T   SG ++A K  +    +   R     E+  L+ +N P +V 
Sbjct: 35  VLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNHPFVVK 94
Query: 60  YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN 119
                 T  + KL   L +++  GG L   + +     +E  +  Y  ++  GL++LHS 
Sbjct: 95  LHYAFQT--EGKLY--LILDFLRGGDLFTRLSKEVMFTEED-VKFYLAELALGLDHLHSL 149
Query: 120 RVVHCDIKSRNILMAESG-AKIADFGCAK----WESEALQSGGTPMFMAPEVARGEHQGF 174
            +++ D+K  NIL+ E G  K+ DFG +K     E +A    GT  +MAPEV   +    
Sbjct: 150 GIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEVVNRQGHSH 209
Query: 175 ASDIWAVGCTVIEMASGGAPW--PNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNC 232
           ++D W+ G  + EM +G  P+   +  + MT++ K         +P FLS +A   L   
Sbjct: 210 SADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKLG-----MPQFLSTEAQSLLRAL 264
Query: 233 LRRDPKERW-----AASQLLKHPF 251
            +R+P  R       A ++ +H F
Sbjct: 265 FKRNPANRLGSGPDGAEEIKRHVF 288

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/265 (29%), Positives = 123/265 (46%), Gaps = 27/265 (10%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEF--------LQREQKFLSSLN 53
           D+  G  +G+G    V LA   +S  + A K   L KS+         L+RE +  + L+
Sbjct: 24  DFEIGRPLGKGKFGNVYLAREKKSHFIVALKV--LFKSQIEKEGVEHQLRREIEIQAHLH 81
Query: 54  SPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGL 113
            P+I+          D + +Y L +EYAP G L  E+ ++    DE    +   ++   L
Sbjct: 82  HPNILRLYN---YFYDRRRIY-LILEYAPRGELYKELQKSCT-FDEQRTATIMEELADAL 136
Query: 114 EYLHSNRVVHCDIKSRN-ILMAESGAKIADFGCAKWESEA--LQSG---GTPMFMAPEVA 167
            Y H  +V+H DIK  N +L  +   KIADFG   W   A  L+     GT  ++ PE+ 
Sbjct: 137 MYCHGKKVIHRDIKPENLLLGLKGELKIADFG---WSVHAPSLRRKTMCGTLDYLPPEMI 193
Query: 168 RGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQAND 227
            G       D+W +G    E+  G  P+ +A+   T  Y+     +L + PA +   A D
Sbjct: 194 EGRMHNEKVDLWCIGVLCYELLVGNPPFESASHNET--YRRIVKVDL-KFPASVPTGAQD 250
Query: 228 FLSNCLRRDPKERWAASQLLKHPFL 252
            +S  LR +P ER   +Q+  HP++
Sbjct: 251 LISKLLRHNPSERLPLAQVSAHPWV 275

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 103/198 (52%), Gaps = 20/198 (10%)
Query: 9   IGQGSSATVSL----ATSLRSGDVFAAKSTEL---PKSEF-LQREQKFLSSLNSPHIVGY 60
           +G+G    VSL     T+  +G++ A K+ +    P+     ++E   L +L   HI+ Y
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 61  KGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNR 120
           KGC     +  L   L MEY P G+L D + R+   L + L+  + +QI +G+ YLHS  
Sbjct: 82  KGCCEDQGEKSL--QLVMEYVPLGSLRDYLPRHSIGLAQLLL--FAQQICEGMAYLHSQH 137
Query: 121 VVHCDIKSRNILMA-ESGAKIADFGCAKWESE------ALQSGGTPMF-MAPEVARGEHQ 172
            +H ++ +RN+L+  +   KI DFG AK   E        + G +P+F  APE  +    
Sbjct: 138 YIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKF 197
Query: 173 GFASDIWAVGCTVIEMAS 190
            +ASD+W+ G T+ E+ +
Sbjct: 198 YYASDVWSFGVTLYELLT 215

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 123/289 (42%), Gaps = 54/289 (18%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAK----STELPK-SEFLQREQKFLSSLNSPHIVGYKGC 63
           IG+GS   V    +  +G + A K    S + P   +   RE + L  L  P++V     
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNL--L 68
Query: 64  DVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVH 123
           +V     +L  +L  EY     L+ E+ R    + E L+ S T Q LQ + + H +  +H
Sbjct: 69  EVFRRKRRL--HLVFEYCDHTVLH-ELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIH 125
Query: 124 CDIKSRNILMAE-SGAKIADFGCAK--------WESEALQSGGTPMFMAPEVARGEHQ-G 173
            D+K  NIL+ + S  K+ DFG A+        ++ E      T  + +PE+  G+ Q G
Sbjct: 126 RDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEV----ATRWYRSPELLVGDTQYG 181
Query: 174 FASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSR--------------------E 213
              D+WA+GC   E+ SG   WP  +D +  LY I  +                     +
Sbjct: 182 PPVDVWAIGCVFAELLSGVPLWPGKSD-VDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVK 240
Query: 214 LPEVPAF---------LSKQANDFLSNCLRRDPKERWAASQLLKHPFLE 253
           +P+             +S  A   L  CL  DP ER    QLL HP+ E
Sbjct: 241 IPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFE 289

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 17/211 (8%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS----EFLQREQKFLSSLNSPHI 57
           DW    T+G+G+   V LA +  + +  A K  ++ ++    E +++E      LN  ++
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENV 67
Query: 58  VGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLH 117
           V + G      +  + Y LF+EY  GG L D I  + G + E     +  Q++ G+ YLH
Sbjct: 68  VKFYG---HRREGNIQY-LFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMAGVVYLH 122
Query: 118 SNRVVHCDIKSRNILMAE-SGAKIADFGCA------KWESEALQSGGTPMFMAPE-VARG 169
              + H DIK  N+L+ E    KI+DFG A        E    +  GT  ++APE + R 
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRR 182
Query: 170 EHQGFASDIWAVGCTVIEMASGGAPWPNAAD 200
           E      D+W+ G  +  M +G  PW   +D
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/264 (25%), Positives = 127/264 (48%), Gaps = 25/264 (9%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPK------SEFLQREQKFLSSLNSPHIVGYKG 62
           +G+G  A V    S  +G  +AAK  +  +      +E L        + + P ++    
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH- 95
Query: 63  CDVTSEDNKLMYNLFMEYAPGGTLNDE-IHRNGGRLDESLIVSYTRQILQGLEYLHSNRV 121
            +V    ++++  L +EYA GG +    +      + E+ ++   +QIL+G+ YLH N +
Sbjct: 96  -EVYENTSEII--LILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNI 152
Query: 122 VHCDIKSRNILMAE----SGAKIADFGCAK---WESEALQSGGTPMFMAPEVARGEHQGF 174
           VH D+K +NIL++        KI DFG ++      E  +  GTP ++APE+   +    
Sbjct: 153 VHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITT 212
Query: 175 ASDIWAVGCTVIEMASGGAPWPNAADPMTVL----YKIAYSRELPEVPAFLSKQANDFLS 230
           A+D+W +G     + +  +P+    +  T L      + YS    E  + +S+ A DF+ 
Sbjct: 213 ATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSE---ETFSSVSQLATDFIQ 269
Query: 231 NCLRRDPKERWAASQLLKHPFLEE 254
           + L ++P++R  A   L H +L++
Sbjct: 270 SLLVKNPEKRPTAEICLSHSWLQQ 293

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 17/211 (8%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS----EFLQREQKFLSSLNSPHI 57
           DW    T+G+G+   V LA +  + +  A K  ++ ++    E +++E      LN  ++
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENV 66
Query: 58  VGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLH 117
           V + G      +  + Y LF+EY  GG L D I  + G + E     +  Q++ G+ YLH
Sbjct: 67  VKFYG---HRREGNIQY-LFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMAGVVYLH 121
Query: 118 SNRVVHCDIKSRNILMAE-SGAKIADFGCA------KWESEALQSGGTPMFMAPE-VARG 169
              + H DIK  N+L+ E    KI+DFG A        E    +  GT  ++APE + R 
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRR 181
Query: 170 EHQGFASDIWAVGCTVIEMASGGAPWPNAAD 200
           E      D+W+ G  +  M +G  PW   +D
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 91/305 (29%), Positives = 138/305 (45%), Gaps = 49/305 (16%)
Query: 9   IGQGSSATVSLATSLRSGDVFAA------KSTE--LPKSEFLQREQKFLSSLNS---PHI 57
           IG+G+   V  A  L++G  F A      ++ E  +P S    RE   L  L +   P++
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTI--REVAVLRHLETFEHPNV 76
Query: 58  VG-YKGCDVTSEDNKLMYNLFMEYAPGG--TLNDEIHRNGGRLDESLIVSYTRQILQGLE 114
           V  +  C V+  D +    L  E+      T  D++   G  +    I     Q+L+GL+
Sbjct: 77  VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG--VPTETIKDMMFQLLRGLD 134
Query: 115 YLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWES--EALQSGGTPM-FMAPEVARGE 170
           +LHS+RVVH D+K +NIL+  SG  K+ADFG A+  S   AL S    + + APEV    
Sbjct: 135 FLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQS 194
Query: 171 HQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELP---------EVP--A 219
                 D+W+VGC   EM      +  ++D +  L KI     LP          +P  A
Sbjct: 195 SYATPVDLWSVGCIFAEMFRRKPLFRGSSD-VDQLGKILDVIGLPGEEDWPRDVALPRQA 253
Query: 220 FLSKQA--------------NDFLSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQIQES 265
           F SK A               D L  CL  +P +R +A   L HP+ ++   C + + +S
Sbjct: 254 FHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCKENL-DS 312
Query: 266 NCSPT 270
           +  P+
Sbjct: 313 HLPPS 317

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 98/198 (49%), Gaps = 18/198 (9%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSE 68
           +G+GS   V      ++G   A K   L    F   E    + L+SP IV   G    + 
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKVRL--EVFRVEELVACAGLSSPRIVPLYG----AV 135
Query: 69  DNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKS 128
                 N+FME   GG+L   I +  G L E   + Y  Q L+GLEYLH+ R++H D+K+
Sbjct: 136 REGPWVNIFMELLEGGSLGQLI-KQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKA 194
Query: 129 RNILMAESGAKIA--DFG---CAKWE--SEALQSG----GTPMFMAPEVARGEHQGFASD 177
            N+L++  G++ A  DFG   C + +   ++L +G    GT   MAPEV  G+      D
Sbjct: 195 DNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVD 254
Query: 178 IWAVGCTVIEMASGGAPW 195
           IW+  C ++ M +G  PW
Sbjct: 255 IWSSCCMMLHMLNGCHPW 272

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 85/287 (29%), Positives = 125/287 (43%), Gaps = 51/287 (17%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSE-----FLQREQKFLSSLNSPHIVGYKGC 63
           IG+G+   V  A +   G+ FA K   L K +        RE   L  L   +IV  K  
Sbjct: 10  IGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIV--KLY 66
Query: 64  DVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVH 123
           DV     +L+  L  E+     L   +    G L+     S+  Q+L G+ Y H  RV+H
Sbjct: 67  DVIHTKKRLV--LVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLH 123
Query: 124 CDIKSRNILMAESG-AKIADFGCA--------KWESEALQSGGTPMFMAPEVARGEHQGF 174
            D+K +N+L+   G  KIADFG A        K+  E +    T  + AP+V  G  +  
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV----TLWYRAPDVLMGSKKYS 179
Query: 175 AS-DIWAVGCTVIEMASGGAPWPNA--ADPMTVLYKIAYS---------RELPEV-PAF- 220
            + DIW+VGC   EM +G   +P    AD +  +++I  +          ELP+  P F 
Sbjct: 180 TTIDIWSVGCIFAEMVNGAPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFT 239
Query: 221 -------------LSKQANDFLSNCLRRDPKERWAASQLLKHPFLEE 254
                        L +   D LS  L+ DP +R  A Q L+H + +E
Sbjct: 240 VYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 98/198 (49%), Gaps = 18/198 (9%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSE 68
           +G+GS   V      ++G   A K   L    F   E    + L+SP IV   G    + 
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKVRL--EVFRVEELVACAGLSSPRIVPLYG----AV 119
Query: 69  DNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKS 128
                 N+FME   GG+L   I +  G L E   + Y  Q L+GLEYLH+ R++H D+K+
Sbjct: 120 REGPWVNIFMELLEGGSLGQLI-KQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKA 178
Query: 129 RNILMAESGAKIA--DFG---CAKWE--SEALQSG----GTPMFMAPEVARGEHQGFASD 177
            N+L++  G++ A  DFG   C + +   ++L +G    GT   MAPEV  G+      D
Sbjct: 179 DNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVD 238
Query: 178 IWAVGCTVIEMASGGAPW 195
           IW+  C ++ M +G  PW
Sbjct: 239 IWSSCCMMLHMLNGCHPW 256

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 102/198 (51%), Gaps = 20/198 (10%)
Query: 9   IGQGSSATVSL----ATSLRSGDVFAAKSTEL---PKSEF-LQREQKFLSSLNSPHIVGY 60
           +G+G    VSL     T+  +G++ A K+ +    P+     ++E   L +L   HI+ Y
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 61  KGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNR 120
           KGC    +       L MEY P G+L D + R+   L + L+  + +QI +G+ YLH+  
Sbjct: 99  KGC--CEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLL--FAQQICEGMAYLHAQH 154
Query: 121 VVHCDIKSRNILMA-ESGAKIADFGCAKWESE------ALQSGGTPMF-MAPEVARGEHQ 172
            +H D+ +RN+L+  +   KI DFG AK   E        + G +P+F  APE  +    
Sbjct: 155 YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKEYKF 214
Query: 173 GFASDIWAVGCTVIEMAS 190
            +ASD+W+ G T+ E+ +
Sbjct: 215 YYASDVWSFGVTLYELLT 232

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 17/211 (8%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS----EFLQREQKFLSSLNSPHI 57
           DW    T+G+G++  V LA +  + +  A K  ++ ++    E +++E      LN  ++
Sbjct: 7   DWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 58  VGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLH 117
           V + G      +  + Y LF+EY  GG L D I  + G + E     +  Q++ G+ YLH
Sbjct: 67  VKFYG---HRREGNIQY-LFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMAGVVYLH 121
Query: 118 SNRVVHCDIKSRNILMAE-SGAKIADFGCA------KWESEALQSGGTPMFMAPE-VARG 169
              + H DIK  N+L+ E    KI+DFG A        E    +  GT  ++APE + R 
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 170 EHQGFASDIWAVGCTVIEMASGGAPWPNAAD 200
           E      D+W+ G  +  M +G  PW   +D
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 17/211 (8%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS----EFLQREQKFLSSLNSPHI 57
           DW    T+G+G+   V LA +  + +  A K  ++ ++    E +++E      LN  ++
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENV 66
Query: 58  VGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLH 117
           V + G      +  + Y LF+EY  GG L D I  + G + E     +  Q++ G+ YLH
Sbjct: 67  VKFYG---HRREGNIQY-LFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMAGVVYLH 121
Query: 118 SNRVVHCDIKSRNILMAE-SGAKIADFGCA------KWESEALQSGGTPMFMAPE-VARG 169
              + H DIK  N+L+ E    KI+DFG A        E    +  GT  ++APE + R 
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 170 EHQGFASDIWAVGCTVIEMASGGAPWPNAAD 200
           E      D+W+ G  +  M +G  PW   +D
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 103/198 (52%), Gaps = 20/198 (10%)
Query: 9   IGQGSSATVSL----ATSLRSGDVFAAKSTEL---PKSEF-LQREQKFLSSLNSPHIVGY 60
           +G+G    VSL     T+  +G++ A K+ +    P+     ++E   L +L   HI+ Y
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 61  KGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNR 120
           KGC     +  L   L MEY P G+L D + R+   L + L+  + +QI +G+ YLH+  
Sbjct: 82  KGCCEDQGEKSL--QLVMEYVPLGSLRDYLPRHSIGLAQLLL--FAQQICEGMAYLHAQH 137
Query: 121 VVHCDIKSRNILMA-ESGAKIADFGCAKWESE------ALQSGGTPMF-MAPEVARGEHQ 172
            +H ++ +RN+L+  +   KI DFG AK   E        + G +P+F  APE  +    
Sbjct: 138 YIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKF 197
Query: 173 GFASDIWAVGCTVIEMAS 190
            +ASD+W+ G T+ E+ +
Sbjct: 198 YYASDVWSFGVTLYELLT 215

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 123/276 (44%), Gaps = 22/276 (7%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKS-TELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTS 67
           +G+G+++ V       +   +A K   +    + ++ E   L  L+ P+I+  K    T 
Sbjct: 61  LGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETP 120
Query: 68  EDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIK 127
            +     +L +E   GG L D I   G    E       +QIL+ + YLH N +VH D+K
Sbjct: 121 TE----ISLVLELVTGGELFDRIVEKG-YYSERDAADAVKQILEAVAYLHENGIVHRDLK 175
Query: 128 SRNILMA----ESGAKIADFGCAKW-ESEALQSG--GTPMFMAPEVARGEHQGFASDIWA 180
             N+L A    ++  KIADFG +K  E + L     GTP + APE+ RG   G   D+W+
Sbjct: 176 PENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWS 235
Query: 181 VGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAF--LSKQANDFLSNCLRRDPK 238
           VG     +  G  P+ +      +  +I         P +  +S  A D +   +  DPK
Sbjct: 236 VGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPK 295
Query: 239 ERWAASQLLKHPFLE-------EFCSCTKQIQESNC 267
           +R    Q L+HP++           +  K++QE N 
Sbjct: 296 KRLTTFQALQHPWVTGKAANFVHMDTAQKKLQEFNA 331

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 85/287 (29%), Positives = 125/287 (43%), Gaps = 51/287 (17%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSE-----FLQREQKFLSSLNSPHIVGYKGC 63
           IG+G+   V  A +   G+ FA K   L K +        RE   L  L   +IV  K  
Sbjct: 10  IGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIV--KLY 66
Query: 64  DVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVH 123
           DV     +L+  L  E+     L   +    G L+     S+  Q+L G+ Y H  RV+H
Sbjct: 67  DVIHTKKRLV--LVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLH 123
Query: 124 CDIKSRNILMAESG-AKIADFGCA--------KWESEALQSGGTPMFMAPEVARGEHQGF 174
            D+K +N+L+   G  KIADFG A        K+  E +    T  + AP+V  G  +  
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV----TLWYRAPDVLMGSKKYS 179
Query: 175 AS-DIWAVGCTVIEMASGGAPWPNA--ADPMTVLYKIAYS---------RELPEV-PAF- 220
            + DIW+VGC   EM +G   +P    AD +  +++I  +          ELP+  P F 
Sbjct: 180 TTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFT 239
Query: 221 -------------LSKQANDFLSNCLRRDPKERWAASQLLKHPFLEE 254
                        L +   D LS  L+ DP +R  A Q L+H + +E
Sbjct: 240 VYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 105/222 (47%), Gaps = 15/222 (6%)
Query: 45  EQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNG-GRLDESLIV 103
           E++ L  +NS  +V        + + K    L +    GG L   I+  G     E+  V
Sbjct: 234 EKQILEKVNSRFVVSL----AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAV 289
Query: 104 SYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKW--ESEALQSG-GTP 159
            Y  +I  GLE LH  R+V+ D+K  NIL+ + G  +I+D G A    E + ++   GT 
Sbjct: 290 FYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTV 349
Query: 160 MFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELP-EVP 218
            +MAPEV + E   F+ D WA+GC + EM +G +P+      +         +E+P E  
Sbjct: 350 GYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYS 409
Query: 219 AFLSKQANDFLSNCLRRDPKERW-----AASQLLKHPFLEEF 255
              S QA    S  L +DP ER      +A ++ +HP  ++ 
Sbjct: 410 ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL 451

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 17/211 (8%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS----EFLQREQKFLSSLNSPHI 57
           DW    T+G+G+   V LA +  + +  A K  ++ ++    E +++E      LN  ++
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 58  VGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLH 117
           V + G      +  + Y LF+EY  GG L D I  + G + E     +  Q++ G+ YLH
Sbjct: 67  VKFYG---HRREGNIQY-LFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMAGVVYLH 121
Query: 118 SNRVVHCDIKSRNILMAE-SGAKIADFGCA------KWESEALQSGGTPMFMAPE-VARG 169
              + H DIK  N+L+ E    KI+DFG A        E    +  GT  ++APE + R 
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRR 181
Query: 170 EHQGFASDIWAVGCTVIEMASGGAPWPNAAD 200
           E      D+W+ G  +  M +G  PW   +D
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 98/198 (49%), Gaps = 18/198 (9%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSE 68
           +G+GS   V      ++G   A K   L    F   E    + L+SP IV   G    + 
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKVRL--EVFRVEELVACAGLSSPRIVPLYG----AV 133
Query: 69  DNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKS 128
                 N+FME   GG+L   I +  G L E   + Y  Q L+GLEYLH+ R++H D+K+
Sbjct: 134 REGPWVNIFMELLEGGSLGQLI-KQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKA 192
Query: 129 RNILMAESGAKIA--DFG---CAKWE--SEALQSG----GTPMFMAPEVARGEHQGFASD 177
            N+L++  G++ A  DFG   C + +   ++L +G    GT   MAPEV  G+      D
Sbjct: 193 DNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVD 252
Query: 178 IWAVGCTVIEMASGGAPW 195
           IW+  C ++ M +G  PW
Sbjct: 253 IWSSCCMMLHMLNGCHPW 270

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 105/222 (47%), Gaps = 15/222 (6%)
Query: 45  EQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNG-GRLDESLIV 103
           E++ L  +NS  +V        + + K    L +    GG L   I+  G     E+  V
Sbjct: 234 EKQILEKVNSRFVVSL----AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAV 289
Query: 104 SYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKW--ESEALQSG-GTP 159
            Y  +I  GLE LH  R+V+ D+K  NIL+ + G  +I+D G A    E + ++   GT 
Sbjct: 290 FYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTV 349
Query: 160 MFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELP-EVP 218
            +MAPEV + E   F+ D WA+GC + EM +G +P+      +         +E+P E  
Sbjct: 350 GYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYS 409
Query: 219 AFLSKQANDFLSNCLRRDPKERW-----AASQLLKHPFLEEF 255
              S QA    S  L +DP ER      +A ++ +HP  ++ 
Sbjct: 410 ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL 451

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 86/261 (32%), Positives = 127/261 (48%), Gaps = 26/261 (9%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSE 68
           IG GS +         +   FA K  +  K +  +  +  L     P+I+  K  DV  +
Sbjct: 30  IGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLK--DV-YD 86
Query: 69  DNKLMYNLFMEYAPGGTLNDEIHRNGGRLD-ESLIVSYTRQILQGLEYLHSNRVVHCDIK 127
           D K +Y +  E   GG L D+I R     + E+  V +T  I + +EYLH+  VVH D+K
Sbjct: 87  DGKYVY-VVTELMKGGELLDKILRQKFFSEREASAVLFT--ITKTVEYLHAQGVVHRDLK 143
Query: 128 SRNILMA-ESG----AKIADFGCAKW---ESEALQSG-GTPMFMAPEVARGEHQGF--AS 176
             NIL   ESG     +I DFG AK    E+  L +   T  F+APEV   E QG+  A 
Sbjct: 144 PSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVL--ERQGYDAAC 201
Query: 177 DIWAVGCTVIEMASGGAPWPNAAD--PMTVLYKIAYSRELPEVPAF---LSKQANDFLSN 231
           DIW++G  +  M +G  P+ N  D  P  +L +I  S +      +   +S  A D +S 
Sbjct: 202 DIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIG-SGKFSLSGGYWNSVSDTAKDLVSK 260
Query: 232 CLRRDPKERWAASQLLKHPFL 252
            L  DP +R  A+ +L+HP++
Sbjct: 261 MLHVDPHQRLTAALVLRHPWI 281

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 17/211 (8%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS----EFLQREQKFLSSLNSPHI 57
           DW    T+G+G+   V LA +  + +  A K  ++ ++    E +++E      LN  ++
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 58  VGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLH 117
           V + G      +  + Y LF+EY  GG L D I  + G + E     +  Q++ G+ YLH
Sbjct: 67  VKFYG---HRREGNIQY-LFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMAGVVYLH 121
Query: 118 SNRVVHCDIKSRNILMAE-SGAKIADFGCA------KWESEALQSGGTPMFMAPE-VARG 169
              + H DIK  N+L+ E    KI+DFG A        E    +  GT  ++APE + R 
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRR 181
Query: 170 EHQGFASDIWAVGCTVIEMASGGAPWPNAAD 200
           E      D+W+ G  +  M +G  PW   +D
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 17/211 (8%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS----EFLQREQKFLSSLNSPHI 57
           DW    T+G+G+   V LA +  + +  A K  ++ ++    E +++E      LN  ++
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 58  VGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLH 117
           V + G      +  + Y LF+EY  GG L D I  + G + E     +  Q++ G+ YLH
Sbjct: 67  VKFYG---HRREGNIQY-LFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMAGVVYLH 121
Query: 118 SNRVVHCDIKSRNILMAE-SGAKIADFGCA------KWESEALQSGGTPMFMAPE-VARG 169
              + H DIK  N+L+ E    KI+DFG A        E    +  GT  ++APE + R 
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 170 EHQGFASDIWAVGCTVIEMASGGAPWPNAAD 200
           E      D+W+ G  +  M +G  PW   +D
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 85/287 (29%), Positives = 125/287 (43%), Gaps = 51/287 (17%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSE-----FLQREQKFLSSLNSPHIVGYKGC 63
           IG+G+   V  A +   G+ FA K   L K +        RE   L  L   +IV  K  
Sbjct: 10  IGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIV--KLY 66
Query: 64  DVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVH 123
           DV     +L+  L  E+     L   +    G L+     S+  Q+L G+ Y H  RV+H
Sbjct: 67  DVIHTKKRLV--LVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLH 123
Query: 124 CDIKSRNILMAESG-AKIADFGCA--------KWESEALQSGGTPMFMAPEVARGEHQGF 174
            D+K +N+L+   G  KIADFG A        K+  E +    T  + AP+V  G  +  
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV----TLWYRAPDVLMGSKKYS 179
Query: 175 AS-DIWAVGCTVIEMASGGAPWPNA--ADPMTVLYKIAYS---------RELPEV-PAF- 220
            + DIW+VGC   EM +G   +P    AD +  +++I  +          ELP+  P F 
Sbjct: 180 TTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFT 239
Query: 221 -------------LSKQANDFLSNCLRRDPKERWAASQLLKHPFLEE 254
                        L +   D LS  L+ DP +R  A Q L+H + +E
Sbjct: 240 VYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 17/211 (8%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS----EFLQREQKFLSSLNSPHI 57
           DW    T+G+G+   V LA +  + +  A K  ++ ++    E +++E      LN  ++
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 58  VGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLH 117
           V + G      +  + Y LF+EY  GG L D I  + G + E     +  Q++ G+ YLH
Sbjct: 67  VKFYG---HRREGNIQY-LFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMAGVVYLH 121
Query: 118 SNRVVHCDIKSRNILMAE-SGAKIADFGCA------KWESEALQSGGTPMFMAPE-VARG 169
              + H DIK  N+L+ E    KI+DFG A        E    +  GT  ++APE + R 
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 170 EHQGFASDIWAVGCTVIEMASGGAPWPNAAD 200
           E      D+W+ G  +  M +G  PW   +D
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 17/211 (8%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS----EFLQREQKFLSSLNSPHI 57
           DW    T+G+G+   V LA +  + +  A K  ++ ++    E +++E      LN  ++
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 58  VGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLH 117
           V + G      +  + Y LF+EY  GG L D I  + G + E     +  Q++ G+ YLH
Sbjct: 67  VKFYG---HRREGNIQY-LFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMAGVVYLH 121
Query: 118 SNRVVHCDIKSRNILMAE-SGAKIADFGCA------KWESEALQSGGTPMFMAPE-VARG 169
              + H DIK  N+L+ E    KI+DFG A        E    +  GT  ++APE + R 
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRR 181
Query: 170 EHQGFASDIWAVGCTVIEMASGGAPWPNAAD 200
           E      D+W+ G  +  M +G  PW   +D
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 17/211 (8%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS----EFLQREQKFLSSLNSPHI 57
           DW    T+G+G+   V LA +  + +  A K  ++ ++    E +++E      LN  ++
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 58  VGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLH 117
           V + G      +  + Y LF+EY  GG L D I  + G + E     +  Q++ G+ YLH
Sbjct: 68  VKFYG---HRREGNIQY-LFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMAGVVYLH 122
Query: 118 SNRVVHCDIKSRNILMAE-SGAKIADFGCA------KWESEALQSGGTPMFMAPE-VARG 169
              + H DIK  N+L+ E    KI+DFG A        E    +  GT  ++APE + R 
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 170 EHQGFASDIWAVGCTVIEMASGGAPWPNAAD 200
           E      D+W+ G  +  M +G  PW   +D
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 17/211 (8%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS----EFLQREQKFLSSLNSPHI 57
           DW    T+G+G+   V LA +  + +  A K  ++ ++    E +++E    + LN  ++
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENV 67
Query: 58  VGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLH 117
           V + G      +  + Y LF+EY  GG L D I  + G + E     +  Q++ G+ YLH
Sbjct: 68  VKFYG---HRREGNIQY-LFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMAGVVYLH 122
Query: 118 SNRVVHCDIKSRNILMAE-SGAKIADFGCA------KWESEALQSGGTPMFMAPE-VARG 169
              + H DIK  N+L+ E    KI+DFG A        E    +  GT  ++APE + R 
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 170 EHQGFASDIWAVGCTVIEMASGGAPWPNAAD 200
           E      D+W+ G  +  M +G  PW   +D
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 17/211 (8%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS----EFLQREQKFLSSLNSPHI 57
           DW    T+G+G+   V LA +  + +  A K  ++ ++    E +++E      LN  ++
Sbjct: 6   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 65
Query: 58  VGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLH 117
           V + G      +  + Y LF+EY  GG L D I  + G + E     +  Q++ G+ YLH
Sbjct: 66  VKFYG---HRREGNIQY-LFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMAGVVYLH 120
Query: 118 SNRVVHCDIKSRNILMAE-SGAKIADFGCA------KWESEALQSGGTPMFMAPE-VARG 169
              + H DIK  N+L+ E    KI+DFG A        E    +  GT  ++APE + R 
Sbjct: 121 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180
Query: 170 EHQGFASDIWAVGCTVIEMASGGAPWPNAAD 200
           E      D+W+ G  +  M +G  PW   +D
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 211

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 80/298 (26%), Positives = 130/298 (43%), Gaps = 55/298 (18%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL-------PKSEFLQREQKFLSSLNSP 55
           + +   IG+G+  TV  A +  + ++ A K   L       P S    RE   L  L   
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL--REICLLKELKHK 61
Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
           +IV     DV   D KL   L  E+     L        G LD  ++ S+  Q+L+GL +
Sbjct: 62  NIVRLH--DVLHSDKKL--TLVFEFC-DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGF 116
Query: 116 LHSNRVVHCDIKSRNILMAESG-AKIADFGCAK--------WESEALQSGGTPMFMAPEV 166
            HS  V+H D+K +N+L+  +G  K+A+FG A+        + +E +    T  +  P+V
Sbjct: 117 CHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV----TLWYRPPDV 172
Query: 167 ARGEHQGFAS-DIWAVGCTVIEMASGGAP-WP--NAADPMTVLY---------------K 207
             G      S D+W+ GC   E+A+ G P +P  +  D +  ++               K
Sbjct: 173 LFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232
Query: 208 IAYSRELPEVPAF---------LSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFC 256
           +   +  P  PA          L+    D L N L+ +P +R +A + L+HP+  +FC
Sbjct: 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 93/213 (43%), Gaps = 31/213 (14%)
Query: 104 SYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGAKIADFGCAKWESEALQSG------G 157
           SY + +L+ +  +H + +VH D+K  N L+ +   K+ DFG A        S       G
Sbjct: 112 SYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVG 171
Query: 158 TPMFMAPEVARG-----------EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLY 206
           T  +M PE  +                  SD+W++GC +  M  G  P+    + ++ L+
Sbjct: 172 TVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH 231
Query: 207 KIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQIQESN 266
            I       E P    K   D L  CL+RDPK+R +  +LL HP++        QIQ   
Sbjct: 232 AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV--------QIQ--- 280
Query: 267 CSPTSILDQGIWNSVEETEESLGNLIHSTSKTS 299
             P + + +G   + EE +  LG L+   S  S
Sbjct: 281 THPVNQMAKG---TTEEMKYVLGQLVGLNSPNS 310

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 17/211 (8%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS----EFLQREQKFLSSLNSPHI 57
           DW    T+G+G+   V LA +  + +  A K  ++ ++    E +++E      LN  ++
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 58  VGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLH 117
           V + G      +  + Y LF+EY  GG L D I  + G + E     +  Q++ G+ YLH
Sbjct: 67  VKFYG---HRREGNIQY-LFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMAGVVYLH 121
Query: 118 SNRVVHCDIKSRNILMAE-SGAKIADFGCA------KWESEALQSGGTPMFMAPE-VARG 169
              + H DIK  N+L+ E    KI+DFG A        E    +  GT  ++APE + R 
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 170 EHQGFASDIWAVGCTVIEMASGGAPWPNAAD 200
           E      D+W+ G  +  M +G  PW   +D
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 17/211 (8%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS----EFLQREQKFLSSLNSPHI 57
           DW    T+G+G+   V LA +  + +  A K  ++ ++    E +++E      LN  ++
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 58  VGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLH 117
           V + G      +  + Y LF+EY  GG L D I  + G + E     +  Q++ G+ YLH
Sbjct: 67  VKFYG---HRREGNIQY-LFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMAGVVYLH 121
Query: 118 SNRVVHCDIKSRNILMAE-SGAKIADFGCA------KWESEALQSGGTPMFMAPE-VARG 169
              + H DIK  N+L+ E    KI+DFG A        E    +  GT  ++APE + R 
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 170 EHQGFASDIWAVGCTVIEMASGGAPWPNAAD 200
           E      D+W+ G  +  M +G  PW   +D
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 17/211 (8%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS----EFLQREQKFLSSLNSPHI 57
           DW    T+G+G+   V LA +  + +  A K  ++ ++    E +++E      LN  ++
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 58  VGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLH 117
           V + G      +  + Y LF+EY  GG L D I  + G + E     +  Q++ G+ YLH
Sbjct: 68  VKFYG---HRREGNIQY-LFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMAGVVYLH 122
Query: 118 SNRVVHCDIKSRNILMAE-SGAKIADFGCA------KWESEALQSGGTPMFMAPE-VARG 169
              + H DIK  N+L+ E    KI+DFG A        E    +  GT  ++APE + R 
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 170 EHQGFASDIWAVGCTVIEMASGGAPWPNAAD 200
           E      D+W+ G  +  M +G  PW   +D
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 93/213 (43%), Gaps = 31/213 (14%)
Query: 104 SYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGAKIADFGCAKWESEALQSG------G 157
           SY + +L+ +  +H + +VH D+K  N L+ +   K+ DFG A        S       G
Sbjct: 115 SYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVG 174
Query: 158 TPMFMAPEVARG-----------EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLY 206
           T  +M PE  +                  SD+W++GC +  M  G  P+    + ++ L+
Sbjct: 175 TVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH 234
Query: 207 KIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQIQESN 266
            I       E P    K   D L  CL+RDPK+R +  +LL HP++        QIQ   
Sbjct: 235 AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV--------QIQ--- 283
Query: 267 CSPTSILDQGIWNSVEETEESLGNLIHSTSKTS 299
             P + + +G   + EE +  LG L+   S  S
Sbjct: 284 THPVNQMAKG---TTEEMKYVLGQLVGLNSPNS 313

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 75/262 (28%), Positives = 127/262 (48%), Gaps = 27/262 (10%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPK-----SEFLQREQKFLSSLNSPHIVGYKGC 63
           +G+G+ + V     + +G  +AAK     K      + L+RE +    L  P+IV  +  
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIV--RLH 69
Query: 64  DVTSEDNKLMYNLFMEYAPGGTLNDEI--HRNGGRLDESLIVSYTRQILQGLEYLHSNRV 121
           D  SE+    + L  +   GG L ++I         D S  +   +QIL+ + + H N +
Sbjct: 70  DSISEEG--FHYLVFDLVTGGELFEDIVAREYYSEADASHCI---QQILESVNHCHLNGI 124
Query: 122 VHCDIKSRNILMAE----SGAKIADFGCA---KWESEA-LQSGGTPMFMAPEVARGEHQG 173
           VH D+K  N+L+A     +  K+ADFG A   + + +A     GTP +++PEV R +  G
Sbjct: 125 VHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDPYG 184
Query: 174 FASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKI---AYSRELPEVPAFLSKQANDFLS 230
              D+WA G  +  +  G  P+ +  D   +  +I   AY    PE    ++ +A D ++
Sbjct: 185 KPVDMWACGVILYILLVGYPPFWD-EDQHRLYQQIKAGAYDFPSPEWDT-VTPEAKDLIN 242
Query: 231 NCLRRDPKERWAASQLLKHPFL 252
             L  +P +R  AS+ LKHP++
Sbjct: 243 KMLTINPAKRITASEALKHPWI 264

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 92/213 (43%), Gaps = 31/213 (14%)
Query: 104 SYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGAKIADFGCAKWESEALQSG------G 157
           SY + +L+ +  +H + +VH D+K  N L+ +   K+ DFG A        S       G
Sbjct: 159 SYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVG 218
Query: 158 TPMFMAPEVARG-----------EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLY 206
           T  +M PE  +                  SD+W++GC +  M  G  P+    + ++ L+
Sbjct: 219 TVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH 278
Query: 207 KIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQIQESN 266
            I       E P    K   D L  CL+RDPK+R +  +LL HP++        QIQ   
Sbjct: 279 AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV--------QIQ--- 327
Query: 267 CSPTSILDQGIWNSVEETEESLGNLIHSTSKTS 299
              T  ++Q    + EE +  LG L+   S  S
Sbjct: 328 ---THPVNQMAKGTTEEMKYVLGQLVGLNSPNS 357

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 75/262 (28%), Positives = 127/262 (48%), Gaps = 27/262 (10%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPK-----SEFLQREQKFLSSLNSPHIVGYKGC 63
           +G+G+ + V     + +G  +AAK     K      + L+RE +    L  P+IV  +  
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIV--RLH 69
Query: 64  DVTSEDNKLMYNLFMEYAPGGTLNDEI--HRNGGRLDESLIVSYTRQILQGLEYLHSNRV 121
           D  SE+    + L  +   GG L ++I         D S  +   +QIL+ + + H N +
Sbjct: 70  DSISEEG--FHYLVFDLVTGGELFEDIVAREYYSEADASHCI---QQILESVNHCHLNGI 124
Query: 122 VHCDIKSRNILMAE----SGAKIADFGCA---KWESEA-LQSGGTPMFMAPEVARGEHQG 173
           VH D+K  N+L+A     +  K+ADFG A   + + +A     GTP +++PEV R +  G
Sbjct: 125 VHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDPYG 184
Query: 174 FASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKI---AYSRELPEVPAFLSKQANDFLS 230
              D+WA G  +  +  G  P+ +  D   +  +I   AY    PE    ++ +A D ++
Sbjct: 185 KPVDMWACGVILYILLVGYPPFWD-EDQHRLYQQIKAGAYDFPSPEWDT-VTPEAKDLIN 242
Query: 231 NCLRRDPKERWAASQLLKHPFL 252
             L  +P +R  AS+ LKHP++
Sbjct: 243 KMLTINPAKRITASEALKHPWI 264

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 17/211 (8%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS----EFLQREQKFLSSLNSPHI 57
           DW    T+G+G+   V LA +  + +  A K  ++ ++    E +++E      LN  ++
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 58  VGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLH 117
           V + G      +  + Y LF+EY  GG L D I  + G + E     +  Q++ G+ YLH
Sbjct: 67  VKFYG---HRREGNIQY-LFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMAGVVYLH 121
Query: 118 SNRVVHCDIKSRNILMAE-SGAKIADFGCA------KWESEALQSGGTPMFMAPE-VARG 169
              + H DIK  N+L+ E    KI+DFG A        E    +  GT  ++APE + R 
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 170 EHQGFASDIWAVGCTVIEMASGGAPWPNAAD 200
           E      D+W+ G  +  M +G  PW   +D
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 80/298 (26%), Positives = 129/298 (43%), Gaps = 55/298 (18%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL-------PKSEFLQREQKFLSSLNSP 55
           + +   IG+G+  TV  A +  + ++ A K   L       P S    RE   L  L   
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL--REICLLKELKHK 61
Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
           +IV     DV   D KL   L  E+     L        G LD  ++ S+  Q+L+GL +
Sbjct: 62  NIVRLH--DVLHSDKKL--TLVFEFC-DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGF 116
Query: 116 LHSNRVVHCDIKSRNILMAESG-AKIADFGCAK--------WESEALQSGGTPMFMAPEV 166
            HS  V+H D+K +N+L+  +G  K+ADFG A+        + +E +    T  +  P+V
Sbjct: 117 CHSRNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVV----TLWYRPPDV 172
Query: 167 ARGEHQGFAS-DIWAVGCTVIEMASGGAP-WP--NAADPMTVLY---------------K 207
             G      S D+W+ GC   E+A+   P +P  +  D +  ++               K
Sbjct: 173 LFGAKLYSTSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232
Query: 208 IAYSRELPEVPAF---------LSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFC 256
           +   +  P  PA          L+    D L N L+ +P +R +A + L+HP+  +FC
Sbjct: 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 89/293 (30%), Positives = 131/293 (44%), Gaps = 48/293 (16%)
Query: 9   IGQGSSATVSLATSLRSGDVFAA------KSTE--LPKSEFLQREQKFLSSLNS---PHI 57
           IG+G+   V  A  L++G  F A      ++ E  +P S    RE   L  L +   P++
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTI--REVAVLRHLETFEHPNV 76
Query: 58  VG-YKGCDVTSEDNKLMYNLFMEYAPGG--TLNDEIHRNGGRLDESLIVSYTRQILQGLE 114
           V  +  C V+  D +    L  E+      T  D++   G  +    I     Q+L+GL+
Sbjct: 77  VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG--VPTETIKDMMFQLLRGLD 134
Query: 115 YLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWES--EALQSGGTPM-FMAPEVARGE 170
           +LHS+RVVH D+K +NIL+  SG  K+ADFG A+  S   AL S    + + APEV    
Sbjct: 135 FLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQS 194
Query: 171 HQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELP---------EVP--A 219
                 D+W+VGC   EM      +  ++D +  L KI     LP          +P  A
Sbjct: 195 SYATPVDLWSVGCIFAEMFRRKPLFRGSSD-VDQLGKILDVIGLPGEEDWPRDVALPRQA 253
Query: 220 FLSKQA--------------NDFLSNCLRRDPKERWAASQLLKHPFLEEFCSC 258
           F SK A               D L  CL  +P +R +A   L HP+ ++   C
Sbjct: 254 FHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERC 306

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 81/295 (27%), Positives = 128/295 (43%), Gaps = 52/295 (17%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL-------PKSEFLQREQKFLSSLNSP 55
           + +   +G+G+   V  A     G + A K   L       P +    RE   L  L+ P
Sbjct: 23  YQKLEKVGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAI--REISLLKELHHP 79
Query: 56  HIVGYKGCDVTSEDNKLMYNL-FMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLE 114
           +IV     DV   +  L     FME      L   +  N   L +S I  Y  Q+L+G+ 
Sbjct: 80  NIVSL--IDVIHSERCLTLVFEFME----KDLKKVLDENKTGLQDSQIKIYLYQLLRGVA 133
Query: 115 YLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSGG----TPMFMAPEVARG 169
           + H +R++H D+K +N+L+   GA K+ADFG A+     ++S      T  + AP+V  G
Sbjct: 134 HCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMG 193
Query: 170 EHQGFAS-DIWAVGCTVIEMASGGAPWPNAA--DPMTVLYKIAYS---RELPEV------ 217
             +   S DIW++GC   EM +G   +P     D +  ++ I  +   RE P+V      
Sbjct: 194 SKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLW 253
Query: 218 -----------------PAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
                            P F  ++  D LSN L  DP +R +A   + HP+ ++ 
Sbjct: 254 KQRTFQVFEKKPWSSIIPGF-CQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 73/267 (27%), Positives = 127/267 (47%), Gaps = 34/267 (12%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFL--------SSLNSPHIVGY 60
           +G+G+   V     + SG + A K     ++    +EQK L         +++ P  V +
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVKRI---RATVNSQEQKRLLMDLDISMRTVDCPFTVTF 115
Query: 61  KGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHR----NGGRLDESLIVSYTRQILQGLEYL 116
            G      D  +   L        T  D+ ++     G  + E ++      I++ LE+L
Sbjct: 116 YGALFREGDVWICMELM------DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHL 169
Query: 117 HSN-RVVHCDIKSRNILMAESG-AKIADFGCAKW----ESEALQSGGTPMFMAPEVARGE 170
           HS   V+H D+K  N+L+   G  K+ DFG + +     ++ + +G  P +MAPE    E
Sbjct: 170 HSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTIDAGCKP-YMAPERINPE 228
Query: 171 --HQGFA--SDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPA-FLSKQA 225
              +G++  SDIW++G T+IE+A    P+ +   P   L ++      P++PA   S + 
Sbjct: 229 LNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVV-EEPSPQLPADKFSAEF 287
Query: 226 NDFLSNCLRRDPKERWAASQLLKHPFL 252
            DF S CL+++ KER    +L++HPF 
Sbjct: 288 VDFTSQCLKKNSKERPTYPELMQHPFF 314

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 119/262 (45%), Gaps = 26/262 (9%)
Query: 4   TRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL--PKSEFLQ---REQKFLSSLNSPHIV 58
           T G  IG GS  TV        GDV A K   +  P  + LQ    E   L      +I+
Sbjct: 38  TVGQRIGSGSFGTVYKGKW--HGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 94
Query: 59  GYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHS 118
            + G        K    +  ++  G +L   +H    + +   ++   RQ  QG++YLH+
Sbjct: 95  LFMGYS-----TKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 149
Query: 119 NRVVHCDIKSRNILMAES-GAKIADFGCAKWES------EALQSGGTPMFMAPEVARGEH 171
             ++H D+KS NI + E    KI DFG A  +S      +  Q  G+ ++MAPEV R + 
Sbjct: 150 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 209
Query: 172 QG---FASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA---YSRELPEVPAFLSKQA 225
           +    F SD++A G  + E+ +G  P+ N  +   +++ +     S +L +V +   K  
Sbjct: 210 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAM 269
Query: 226 NDFLSNCLRRDPKERWAASQLL 247
              ++ CL++   ER    Q+L
Sbjct: 270 KRLMAECLKKKRDERPLFPQIL 291

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 81/295 (27%), Positives = 128/295 (43%), Gaps = 52/295 (17%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL-------PKSEFLQREQKFLSSLNSP 55
           + +   +G+G+   V  A     G + A K   L       P +    RE   L  L+ P
Sbjct: 23  YQKLEKVGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAI--REISLLKELHHP 79
Query: 56  HIVGYKGCDVTSEDNKLMYNL-FMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLE 114
           +IV     DV   +  L     FME      L   +  N   L +S I  Y  Q+L+G+ 
Sbjct: 80  NIVSL--IDVIHSERCLTLVFEFME----KDLKKVLDENKTGLQDSQIKIYLYQLLRGVA 133
Query: 115 YLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSGG----TPMFMAPEVARG 169
           + H +R++H D+K +N+L+   GA K+ADFG A+     ++S      T  + AP+V  G
Sbjct: 134 HCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMG 193
Query: 170 EHQGFAS-DIWAVGCTVIEMASGGAPWPNAA--DPMTVLYKIAYS---RELPEV------ 217
             +   S DIW++GC   EM +G   +P     D +  ++ I  +   RE P+V      
Sbjct: 194 SKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLW 253
Query: 218 -----------------PAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
                            P F  ++  D LSN L  DP +R +A   + HP+ ++ 
Sbjct: 254 KQRTFQVFEKKPWSSIIPGF-CQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 17/211 (8%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS----EFLQREQKFLSSLNSPHI 57
           DW    T+G+G+   V LA +  + +  A K  ++ ++    E +++E      LN  ++
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 58  VGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLH 117
           V + G      +  + Y LF+EY  GG L D I  + G + E     +  Q++ G+ YLH
Sbjct: 68  VKFYG---HRREGNIQY-LFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMAGVVYLH 122
Query: 118 SNRVVHCDIKSRNILMAE-SGAKIADFGCA------KWESEALQSGGTPMFMAPE-VARG 169
              + H DIK  N+L+ E    KI+DFG A        E    +  GT  ++APE + R 
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 170 EHQGFASDIWAVGCTVIEMASGGAPWPNAAD 200
           E      D+W+ G  +  M +G  PW   +D
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 17/211 (8%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS----EFLQREQKFLSSLNSPHI 57
           DW    T+G+G+   V LA +  + +  A K  ++ ++    E +++E      LN  ++
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 58  VGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLH 117
           V + G      +  + Y LF+EY  GG L D I  + G + E     +  Q++ G+ YLH
Sbjct: 68  VKFYG---HRREGNIQY-LFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMAGVVYLH 122
Query: 118 SNRVVHCDIKSRNILMAE-SGAKIADFGCA------KWESEALQSGGTPMFMAPE-VARG 169
              + H DIK  N+L+ E    KI+DFG A        E    +  GT  ++APE + R 
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 170 EHQGFASDIWAVGCTVIEMASGGAPWPNAAD 200
           E      D+W+ G  +  M +G  PW   +D
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 17/211 (8%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS----EFLQREQKFLSSLNSPHI 57
           DW    T+G+G+   V LA +  + +  A K  ++ ++    E +++E      LN  ++
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 58  VGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLH 117
           V + G      +  + Y LF+EY  GG L D I  + G + E     +  Q++ G+ YLH
Sbjct: 68  VKFYG---HRREGNIQY-LFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMAGVVYLH 122
Query: 118 SNRVVHCDIKSRNILMAE-SGAKIADFGCA------KWESEALQSGGTPMFMAPE-VARG 169
              + H DIK  N+L+ E    KI+DFG A        E    +  GT  ++APE + R 
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 170 EHQGFASDIWAVGCTVIEMASGGAPWPNAAD 200
           E      D+W+ G  +  M +G  PW   +D
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 91/206 (44%), Gaps = 31/206 (15%)
Query: 104 SYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGAKIADFGCAKWESEALQSG------G 157
           SY + +L+ +  +H + +VH D+K  N L+ +   K+ DFG A        S       G
Sbjct: 111 SYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVG 170
Query: 158 TPMFMAPEVARG-----------EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLY 206
           T  +M PE  +                  SD+W++GC +  M  G  P+    + ++ L+
Sbjct: 171 TVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH 230
Query: 207 KIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQIQESN 266
            I       E P    K   D L  CL+RDPK+R +  +LL HP++        QIQ   
Sbjct: 231 AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV--------QIQ--- 279
Query: 267 CSPTSILDQGIWNSVEETEESLGNLI 292
             P + + +G   + EE +  LG L+
Sbjct: 280 THPVNQMAKG---TTEEMKYVLGQLV 302

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 119/262 (45%), Gaps = 26/262 (9%)
Query: 4   TRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL--PKSEFLQ---REQKFLSSLNSPHIV 58
           T G  IG GS  TV        GDV A K   +  P  + LQ    E   L      +I+
Sbjct: 39  TVGQRIGSGSFGTVYKGKW--HGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 95
Query: 59  GYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHS 118
            + G        K    +  ++  G +L   +H    + +   ++   RQ  QG++YLH+
Sbjct: 96  LFMGYS-----TKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 150
Query: 119 NRVVHCDIKSRNILMAES-GAKIADFGCAKWES------EALQSGGTPMFMAPEVARGEH 171
             ++H D+KS NI + E    KI DFG A  +S      +  Q  G+ ++MAPEV R + 
Sbjct: 151 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 210
Query: 172 QG---FASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA---YSRELPEVPAFLSKQA 225
           +    F SD++A G  + E+ +G  P+ N  +   +++ +     S +L +V +   K  
Sbjct: 211 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAM 270
Query: 226 NDFLSNCLRRDPKERWAASQLL 247
              ++ CL++   ER    Q+L
Sbjct: 271 KRLMAECLKKKRDERPLFPQIL 292

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 131/281 (46%), Gaps = 32/281 (11%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPK-----SEFLQREQKFLSSLNSPHIVGYKGC 63
           +G+G+ + V     + +G  +AAK     K      + L+RE +    L  P+IV  +  
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIV--RLH 87
Query: 64  DVTSEDNKLMYNLFMEYAPGGTLNDEI--HRNGGRLDESLIVSYTRQILQGLEYLHSNRV 121
           D  SE+    + L  +   GG L ++I         D S  +   +QIL+ + + H   V
Sbjct: 88  DSISEEGH--HYLIFDLVTGGELFEDIVAREYYSEADASHCI---QQILEAVLHCHQMGV 142
Query: 122 VHCDIKSRNILMAE----SGAKIADFGCAKWESEALQSG-----GTPMFMAPEVARGEHQ 172
           VH D+K  N+L+A     +  K+ADFG A  E E  Q       GTP +++PEV R +  
Sbjct: 143 VHRDLKPENLLLASKLKGAAVKLADFGLA-IEVEGEQQAWFGFAGTPGYLSPEVLRKDPY 201
Query: 173 GFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKI---AYSRELPEVPAFLSKQANDFL 229
           G   D+WA G  +  +  G  P+ +  D   +  +I   AY    PE    ++ +A D +
Sbjct: 202 GKPVDLWACGVILYILLVGYPPFWD-EDQHRLYQQIKAGAYDFPSPEWDT-VTPEAKDLI 259
Query: 230 SNCLRRDPKERWAASQLLKHPFLEE---FCSCTKQIQESNC 267
           +  L  +P +R  A++ LKHP++       SC  + +  +C
Sbjct: 260 NKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDC 300

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 90/326 (27%), Positives = 147/326 (45%), Gaps = 50/326 (15%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAK---STELPK---SEFLQREQKFLSSLNSP 55
           D+     IG+G+   V L     S  V+A K     E+ K   S F   E+  ++  NSP
Sbjct: 76  DYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 135
Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
            +V    C    +D+K +Y + MEY PGG L + +  +   + E     YT +++  L+ 
Sbjct: 136 WVVQL-FC--AFQDDKYLY-MVMEYMPGGDLVNLM--SNYDVPEKWAKFYTAEVVLALDA 189
Query: 116 LHSNRVVHCDIKSRNILMAESG-AKIADFG-CAKWESEAL----QSGGTPMFMAPEVARG 169
           +HS  ++H D+K  N+L+ + G  K+ADFG C K +   +     + GTP +++PEV + 
Sbjct: 190 IHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKS 249
Query: 170 E----HQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLY-KIAYSRE---LPEVPAFL 221
           +    + G   D W+VG  + EM  G  P+   AD +   Y KI   +     PE  A +
Sbjct: 250 QGGDGYYGRECDWWSVGVFLFEMLVGDTPF--YADSLVGTYSKIMDHKNSLCFPE-DAEI 306
Query: 222 SKQANDFLSNCL--RRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSILDQGIWN 279
           SK A + +   L  R     R    ++ +HPF +                    DQ  W+
Sbjct: 307 SKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKN-------------------DQWNWD 347
Query: 280 SVEETEESLGNLIHSTSKTSARERIE 305
           ++ ET   +   + S   +S  + IE
Sbjct: 348 NIRETAAPVVPELSSDIDSSNFDDIE 373

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 67/262 (25%), Positives = 119/262 (45%), Gaps = 26/262 (9%)
Query: 4   TRGHTIGQGSSATVSLA-----TSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIV 58
           T G  IG GS  TV         +++  +V A    +L   +  + E   L      +I+
Sbjct: 13  TVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQL---QAFKNEVGVLRKTRHVNIL 69
Query: 59  GYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHS 118
            + G        K    +  ++  G +L   +H    + +   ++   RQ  QG++YLH+
Sbjct: 70  LFMGYS-----TKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 124
Query: 119 NRVVHCDIKSRNILMAES-GAKIADFGCAKWES------EALQSGGTPMFMAPEVARGEH 171
             ++H D+KS NI + E    KI DFG A  +S      +  Q  G+ ++MAPEV R + 
Sbjct: 125 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 184
Query: 172 QG---FASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA---YSRELPEVPAFLSKQA 225
           +    F SD++A G  + E+ +G  P+ N  +   +++ +     S +L +V +   K  
Sbjct: 185 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAM 244
Query: 226 NDFLSNCLRRDPKERWAASQLL 247
              ++ CL++   ER    Q+L
Sbjct: 245 KRLMAECLKKKRDERPLFPQIL 266

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 67/262 (25%), Positives = 119/262 (45%), Gaps = 26/262 (9%)
Query: 4   TRGHTIGQGSSATVSLA-----TSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIV 58
           T G  IG GS  TV         +++  +V A    +L   +  + E   L      +I+
Sbjct: 31  TVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQL---QAFKNEVGVLRKTRHVNIL 87
Query: 59  GYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHS 118
            + G        K    +  ++  G +L   +H    + +   ++   RQ  QG++YLH+
Sbjct: 88  LFMGYS-----TKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 142
Query: 119 NRVVHCDIKSRNILMAES-GAKIADFGCA----KWES--EALQSGGTPMFMAPEVARGEH 171
             ++H D+KS NI + E    KI DFG A    +W    +  Q  G+ ++MAPEV R + 
Sbjct: 143 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 202
Query: 172 QG---FASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA---YSRELPEVPAFLSKQA 225
           +    F SD++A G  + E+ +G  P+ N  +   +++ +     S +L +V +   K  
Sbjct: 203 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAM 262
Query: 226 NDFLSNCLRRDPKERWAASQLL 247
              ++ CL++   ER    Q+L
Sbjct: 263 KRLMAECLKKKRDERPLFPQIL 284

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/262 (25%), Positives = 119/262 (45%), Gaps = 26/262 (9%)
Query: 4   TRGHTIGQGSSATVSLA-----TSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIV 58
           T G  IG GS  TV         +++  +V A    +L   +  + E   L      +I+
Sbjct: 16  TVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQL---QAFKNEVGVLRKTRHVNIL 72
Query: 59  GYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHS 118
            + G        K    +  ++  G +L   +H    + +   ++   RQ  QG++YLH+
Sbjct: 73  LFMGYS-----TKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 127
Query: 119 NRVVHCDIKSRNILMAES-GAKIADFGCAKWES------EALQSGGTPMFMAPEVARGEH 171
             ++H D+KS NI + E    KI DFG A  +S      +  Q  G+ ++MAPEV R + 
Sbjct: 128 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 187
Query: 172 QG---FASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA---YSRELPEVPAFLSKQA 225
           +    F SD++A G  + E+ +G  P+ N  +   +++ +     S +L +V +   K  
Sbjct: 188 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAM 247
Query: 226 NDFLSNCLRRDPKERWAASQLL 247
              ++ CL++   ER    Q+L
Sbjct: 248 KRLMAECLKKKRDERPLFPQIL 269

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 17/211 (8%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS----EFLQREQKFLSSLNSPHI 57
           DW    T+G+G+   V LA +  + +  A K  ++ ++    E +++E      LN  ++
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 58  VGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLH 117
           V + G      +  + Y LF+EY  GG L D I  + G + E     +  Q++ G+ YLH
Sbjct: 67  VKFYG---HRREGNIQY-LFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMAGVVYLH 121
Query: 118 SNRVVHCDIKSRNILMAE-SGAKIADFGCA------KWESEALQSGGTPMFMAPE-VARG 169
              + H DIK  N+L+ E    KI+DFG A        E    +  GT  ++APE + R 
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 170 EHQGFASDIWAVGCTVIEMASGGAPWPNAAD 200
           E      D+W+ G  +  M +G  PW   +D
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 76/272 (27%), Positives = 126/272 (46%), Gaps = 26/272 (9%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAK------STELPKSEFLQREQKFLSSLNSPH 56
           + R   +G G+   V L     +G   A K       T    S  L  E   L  L+ P+
Sbjct: 6   YQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPN 65
Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEI--HRNGGRLDESLIVSYTRQILQGLE 114
           I+          ++K  Y L ME   GG L DEI   +    +D ++I+   +Q+L G  
Sbjct: 66  IMKL----YEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIM---KQVLSGTT 118
Query: 115 YLHSNRVVHCDIKSRNILMA----ESGAKIADFGC-AKWE--SEALQSGGTPMFMAPEVA 167
           YLH + +VH D+K  N+L+     ++  KI DFG  A +E   +  +  GT  ++APEV 
Sbjct: 119 YLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVL 178
Query: 168 RGEHQGFASDIWAVGCTVIEMASGGAPWPNAADP--MTVLYKIAYSRELPEVPAFLSKQA 225
           R ++     D+W+ G  +  +  G  P+    D   +  + K  +S + P+    +S +A
Sbjct: 179 RKKYDE-KCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQ-VSDEA 236
Query: 226 NDFLSNCLRRDPKERWAASQLLKHPFLEEFCS 257
              +   L  +P +R +A + L HP++ +FCS
Sbjct: 237 KQLVKLMLTYEPSKRISAEEALNHPWIVKFCS 268

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 17/211 (8%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS----EFLQREQKFLSSLNSPHI 57
           DW    T+G+G+   V LA +  + +  A K  ++ ++    E +++E      LN  ++
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 58  VGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLH 117
           V + G      +  + Y LF+EY  GG L D I  + G + E     +  Q++ G+ YLH
Sbjct: 68  VKFYG---HRREGNIQY-LFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMAGVVYLH 122
Query: 118 SNRVVHCDIKSRNILMAE-SGAKIADFGCA------KWESEALQSGGTPMFMAPE-VARG 169
              + H DIK  N+L+ E    KI+DFG A        E    +  GT  ++APE + R 
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 170 EHQGFASDIWAVGCTVIEMASGGAPWPNAAD 200
           E      D+W+ G  +  M +G  PW   +D
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/262 (25%), Positives = 119/262 (45%), Gaps = 26/262 (9%)
Query: 4   TRGHTIGQGSSATVSLA-----TSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIV 58
           T G  IG GS  TV         +++  +V A    +L   +  + E   L      +I+
Sbjct: 11  TVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQL---QAFKNEVGVLRKTRHVNIL 67
Query: 59  GYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHS 118
            + G     +       +  ++  G +L   +H    + +   ++   RQ  QG++YLH+
Sbjct: 68  LFMGYSTAPQ-----LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 122
Query: 119 NRVVHCDIKSRNILMAES-GAKIADFGCAKWES------EALQSGGTPMFMAPEVARGEH 171
             ++H D+KS NI + E    KI DFG A  +S      +  Q  G+ ++MAPEV R + 
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 172 QG---FASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA---YSRELPEVPAFLSKQA 225
           +    F SD++A G  + E+ +G  P+ N  +   +++ +     S +L +V +   K  
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAM 242
Query: 226 NDFLSNCLRRDPKERWAASQLL 247
              ++ CL++   ER    Q+L
Sbjct: 243 KRLMAECLKKKRDERPLFPQIL 264

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/262 (25%), Positives = 119/262 (45%), Gaps = 26/262 (9%)
Query: 4   TRGHTIGQGSSATVSLA-----TSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIV 58
           T G  IG GS  TV         +++  +V A    +L   +  + E   L      +I+
Sbjct: 11  TVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQL---QAFKNEVGVLRKTRHVNIL 67
Query: 59  GYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHS 118
            + G        K    +  ++  G +L   +H    + +   ++   RQ  QG++YLH+
Sbjct: 68  LFMGYS-----TKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 122
Query: 119 NRVVHCDIKSRNILMAES-GAKIADFGCAKWES------EALQSGGTPMFMAPEVARGEH 171
             ++H D+KS NI + E    KI DFG A  +S      +  Q  G+ ++MAPEV R + 
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 172 QG---FASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA---YSRELPEVPAFLSKQA 225
           +    F SD++A G  + E+ +G  P+ N  +   +++ +     S +L +V +   K  
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAM 242
Query: 226 NDFLSNCLRRDPKERWAASQLL 247
              ++ CL++   ER    Q+L
Sbjct: 243 KRLMAECLKKKRDERPLFPQIL 264

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/262 (25%), Positives = 119/262 (45%), Gaps = 26/262 (9%)
Query: 4   TRGHTIGQGSSATVSLA-----TSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIV 58
           T G  IG GS  TV         +++  +V A    +L   +  + E   L      +I+
Sbjct: 16  TVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQL---QAFKNEVGVLRKTRHVNIL 72
Query: 59  GYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHS 118
            + G        K    +  ++  G +L   +H    + +   ++   RQ  QG++YLH+
Sbjct: 73  LFMGYS-----TKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 127
Query: 119 NRVVHCDIKSRNILMAES-GAKIADFGCAKWES------EALQSGGTPMFMAPEVARGEH 171
             ++H D+KS NI + E    KI DFG A  +S      +  Q  G+ ++MAPEV R + 
Sbjct: 128 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 187
Query: 172 QG---FASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA---YSRELPEVPAFLSKQA 225
           +    F SD++A G  + E+ +G  P+ N  +   +++ +     S +L +V +   K  
Sbjct: 188 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAM 247
Query: 226 NDFLSNCLRRDPKERWAASQLL 247
              ++ CL++   ER    Q+L
Sbjct: 248 KRLMAECLKKKRDERPLFPQIL 269

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/262 (25%), Positives = 119/262 (45%), Gaps = 26/262 (9%)
Query: 4   TRGHTIGQGSSATVSLA-----TSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIV 58
           T G  IG GS  TV         +++  +V A    +L   +  + E   L      +I+
Sbjct: 11  TVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQL---QAFKNEVGVLRKTRHVNIL 67
Query: 59  GYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHS 118
            + G        K    +  ++  G +L   +H    + +   ++   RQ  QG++YLH+
Sbjct: 68  LFMGYS-----TKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 122
Query: 119 NRVVHCDIKSRNILMAES-GAKIADFGCA----KWES--EALQSGGTPMFMAPEVARGEH 171
             ++H D+KS NI + E    KI DFG A    +W    +  Q  G+ ++MAPEV R + 
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 172 QG---FASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA---YSRELPEVPAFLSKQA 225
           +    F SD++A G  + E+ +G  P+ N  +   +++ +     S +L +V +   K  
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAM 242
Query: 226 NDFLSNCLRRDPKERWAASQLL 247
              ++ CL++   ER    Q+L
Sbjct: 243 KRLMAECLKKKRDERPLFPQIL 264

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/262 (25%), Positives = 119/262 (45%), Gaps = 26/262 (9%)
Query: 4   TRGHTIGQGSSATVSLA-----TSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIV 58
           T G  IG GS  TV         +++  +V A    +L   +  + E   L      +I+
Sbjct: 39  TVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQL---QAFKNEVGVLRKTRHVNIL 95
Query: 59  GYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHS 118
            + G        K    +  ++  G +L   +H    + +   ++   RQ  QG++YLH+
Sbjct: 96  LFMGYS-----TKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 150
Query: 119 NRVVHCDIKSRNILMAES-GAKIADFGCA----KWES--EALQSGGTPMFMAPEVARGEH 171
             ++H D+KS NI + E    KI DFG A    +W    +  Q  G+ ++MAPEV R + 
Sbjct: 151 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 210
Query: 172 QG---FASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA---YSRELPEVPAFLSKQA 225
           +    F SD++A G  + E+ +G  P+ N  +   +++ +     S +L +V +   K  
Sbjct: 211 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAM 270
Query: 226 NDFLSNCLRRDPKERWAASQLL 247
              ++ CL++   ER    Q+L
Sbjct: 271 KRLMAECLKKKRDERPLFPQIL 292

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 126/272 (46%), Gaps = 26/272 (9%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAK------STELPKSEFLQREQKFLSSLNSPH 56
           + R   +G G+   V L     +G   A K       T    S  L  E   L  L+ P+
Sbjct: 23  YQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPN 82
Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEI--HRNGGRLDESLIVSYTRQILQGLE 114
           I+          ++K  Y L ME   GG L DEI   +    +D ++I+   +Q+L G  
Sbjct: 83  IMKL----YEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIM---KQVLSGTT 135
Query: 115 YLHSNRVVHCDIKSRNILMA----ESGAKIADFGC-AKWE--SEALQSGGTPMFMAPEVA 167
           YLH + +VH D+K  N+L+     ++  KI DFG  A +E   +  +  GT  ++APEV 
Sbjct: 136 YLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVL 195
Query: 168 RGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAF--LSKQA 225
           R ++     D+W+ G  +  +  G  P+    D   +L ++   +   + P +  +S +A
Sbjct: 196 RKKYDE-KCDVWSCGVILYILLCGYPPFGGQTD-QEILKRVEKGKFSFDPPDWTQVSDEA 253
Query: 226 NDFLSNCLRRDPKERWAASQLLKHPFLEEFCS 257
              +   L  +P +R +A + L HP++ +FCS
Sbjct: 254 KQLVKLMLTYEPSKRISAEEALNHPWIVKFCS 285

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 73/267 (27%), Positives = 127/267 (47%), Gaps = 34/267 (12%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFL--------SSLNSPHIVGY 60
           +G+G+   V     + SG + A K     ++    +EQK L         +++ P  V +
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRI---RATVNSQEQKRLLMDLDISMRTVDCPFTVTF 71
Query: 61  KGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRN----GGRLDESLIVSYTRQILQGLEYL 116
            G      D  +   L        T  D+ ++     G  + E ++      I++ LE+L
Sbjct: 72  YGALFREGDVWICMELM------DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHL 125
Query: 117 HSN-RVVHCDIKSRNILMAESG-AKIADFGCAKW----ESEALQSGGTPMFMAPEVARGE 170
           HS   V+H D+K  N+L+   G  K+ DFG + +     ++ + +G  P +MAPE    E
Sbjct: 126 HSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKP-YMAPERINPE 184
Query: 171 --HQGFA--SDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPA-FLSKQA 225
              +G++  SDIW++G T+IE+A    P+ +   P   L ++      P++PA   S + 
Sbjct: 185 LNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVV-EEPSPQLPADKFSAEF 243
Query: 226 NDFLSNCLRRDPKERWAASQLLKHPFL 252
            DF S CL+++ KER    +L++HPF 
Sbjct: 244 VDFTSQCLKKNSKERPTYPELMQHPFF 270

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 76/167 (45%), Gaps = 17/167 (10%)
Query: 104 SYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGAKIADFGCAKWESEALQSG------G 157
           SY + +L+ +  +H + +VH D+K  N L+ +   K+ DFG A        S       G
Sbjct: 131 SYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVG 190
Query: 158 TPMFMAPEVARG-----------EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLY 206
           T  +M PE  +                  SD+W++GC +  M  G  P+    + ++ L+
Sbjct: 191 TVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH 250
Query: 207 KIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLE 253
            I       E P    K   D L  CL+RDPK+R +  +LL HP+++
Sbjct: 251 AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 297

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 76/167 (45%), Gaps = 17/167 (10%)
Query: 104 SYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGAKIADFGCAKWESEALQSG------G 157
           SY + +L+ +  +H + +VH D+K  N L+ +   K+ DFG A        S       G
Sbjct: 159 SYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVG 218
Query: 158 TPMFMAPEVARG-----------EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLY 206
           T  +M PE  +                  SD+W++GC +  M  G  P+    + ++ L+
Sbjct: 219 TVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH 278
Query: 207 KIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLE 253
            I       E P    K   D L  CL+RDPK+R +  +LL HP+++
Sbjct: 279 AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/270 (28%), Positives = 123/270 (45%), Gaps = 30/270 (11%)
Query: 8   TIGQGSSATVSLATSLRSGDVFAAKSTEL------PKS-----EFLQREQKFLSSL-NSP 55
            IG+G S+ V       +G  FA K  E+      P+      E  +RE   L  +   P
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160
Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
           HI+       + E +  M+ +F +    G L D +      L E    S  R +L+ + +
Sbjct: 161 HIITLID---SYESSSFMFLVF-DLMRKGELFDYLTEKVA-LSEKETRSIMRSLLEAVSF 215
Query: 116 LHSNRVVHCDIKSRNILMAES-GAKIADFG--CAKWESEALQS-GGTPMFMAPEVAR--- 168
           LH+N +VH D+K  NIL+ ++   +++DFG  C     E L+   GTP ++APE+ +   
Sbjct: 216 LHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSM 275
Query: 169 -GEHQGFAS--DIWAVGCTVIEMASGGAPWPNAADPMTV--LYKIAYSRELPEVPAFLSK 223
              H G+    D+WA G  +  + +G  P+ +    + +  + +  Y    PE     S 
Sbjct: 276 DETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDD-RSS 334
Query: 224 QANDFLSNCLRRDPKERWAASQLLKHPFLE 253
              D +S  L+ DP+ R  A Q L+HPF E
Sbjct: 335 TVKDLISRLLQVDPEARLTAEQALQHPFFE 364

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 57/191 (29%), Positives = 98/191 (51%), Gaps = 17/191 (8%)
Query: 76  LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMA- 134
           +  E+  G  + + I+ +   L+E  IVSY  Q+ + L++LHS+ + H DI+  NI+   
Sbjct: 78  MIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQT 137
Query: 135 --ESGAKIADFGCAKWESEALQSGG-------TPMFMAPEVARGEHQGFASDIWAVGCTV 185
              S  KI +FG A+     L+ G         P + APEV + +    A+D+W++G  V
Sbjct: 138 RRSSTIKIIEFGQAR----QLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLV 193
Query: 186 IEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAF--LSKQANDFLSNCLRRDPKERWAA 243
             + SG  P+  A     ++  I  +    +  AF  +S +A DF+   L ++ K R  A
Sbjct: 194 YVLLSGINPFL-AETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTA 252
Query: 244 SQLLKHPFLEE 254
           S+ L+HP+L++
Sbjct: 253 SEALQHPWLKQ 263

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 72/253 (28%), Positives = 115/253 (45%), Gaps = 29/253 (11%)
Query: 8   TIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ--------REQKFLSSLNSPHIVG 59
            +GQGS   V L   +   D     + ++ K   L+         E+  L  +N P IV 
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 90
Query: 60  YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN 119
                 T  + KL   L +++  GG L   + +     +E  +  Y  ++   L++LHS 
Sbjct: 91  LHYAFQT--EGKLY--LILDFLRGGDLFTRLSKEVMFTEED-VKFYLAELALALDHLHSL 145
Query: 120 RVVHCDIKSRNILMAESG-AKIADFGCAK----WESEALQSGGTPMFMAPEVA--RGEHQ 172
            +++ D+K  NIL+ E G  K+ DFG +K     E +A    GT  +MAPEV   RG  Q
Sbjct: 146 GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQ 205
Query: 173 GFASDIWAVGCTVIEMASGGAPW--PNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLS 230
             ++D W+ G  + EM +G  P+   +  + MT++ K         +P FLS +A   L 
Sbjct: 206 --SADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLG-----MPQFLSPEAQSLLR 258
Query: 231 NCLRRDPKERWAA 243
              +R+P  R  A
Sbjct: 259 MLFKRNPANRLGA 271

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 85/261 (32%), Positives = 126/261 (48%), Gaps = 26/261 (9%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSE 68
           IG GS +         +   FA K  +  K +  +  +  L     P+I+  K  DV  +
Sbjct: 30  IGVGSYSVCKRCIHKATNXEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLK--DV-YD 86
Query: 69  DNKLMYNLFMEYAPGGTLNDEIHRNGGRLD-ESLIVSYTRQILQGLEYLHSNRVVHCDIK 127
           D K +Y +  E   GG L D+I R     + E+  V +T  I + +EYLH+  VVH D+K
Sbjct: 87  DGKYVY-VVTELXKGGELLDKILRQKFFSEREASAVLFT--ITKTVEYLHAQGVVHRDLK 143
Query: 128 SRNILMA-ESG----AKIADFGCAKW---ESEALQSG-GTPMFMAPEVARGEHQGF--AS 176
             NIL   ESG     +I DFG AK    E+  L +   T  F+APEV   E QG+  A 
Sbjct: 144 PSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCYTANFVAPEVL--ERQGYDAAC 201
Query: 177 DIWAVGCTVIEMASGGAPWPNAAD--PMTVLYKIAYSRELPEVPAF---LSKQANDFLSN 231
           DIW++G  +    +G  P+ N  D  P  +L +I  S +      +   +S  A D +S 
Sbjct: 202 DIWSLGVLLYTXLTGYTPFANGPDDTPEEILARIG-SGKFSLSGGYWNSVSDTAKDLVSK 260
Query: 232 CLRRDPKERWAASQLLKHPFL 252
            L  DP +R  A+ +L+HP++
Sbjct: 261 XLHVDPHQRLTAALVLRHPWI 281

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 72/253 (28%), Positives = 115/253 (45%), Gaps = 29/253 (11%)
Query: 8   TIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ--------REQKFLSSLNSPHIVG 59
            +GQGS   V L   +   D     + ++ K   L+         E+  L  +N P IV 
Sbjct: 32  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 91
Query: 60  YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN 119
                 T  + KL   L +++  GG L   + +     +E  +  Y  ++   L++LHS 
Sbjct: 92  LHYAFQT--EGKLY--LILDFLRGGDLFTRLSKEVMFTEED-VKFYLAELALALDHLHSL 146
Query: 120 RVVHCDIKSRNILMAESG-AKIADFGCAK----WESEALQSGGTPMFMAPEVA--RGEHQ 172
            +++ D+K  NIL+ E G  K+ DFG +K     E +A    GT  +MAPEV   RG  Q
Sbjct: 147 GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQ 206
Query: 173 GFASDIWAVGCTVIEMASGGAPW--PNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLS 230
             ++D W+ G  + EM +G  P+   +  + MT++ K         +P FLS +A   L 
Sbjct: 207 --SADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLG-----MPQFLSPEAQSLLR 259
Query: 231 NCLRRDPKERWAA 243
              +R+P  R  A
Sbjct: 260 MLFKRNPANRLGA 272

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 73/278 (26%), Positives = 120/278 (43%), Gaps = 38/278 (13%)
Query: 1   MDWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGY 60
           MD+     IG G    V  A     G  +  +  +   +E  +RE K L+ L+  +IV Y
Sbjct: 12  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKY-NNEKAEREVKALAKLDHVNIVHY 70
Query: 61  KGC------DVTSEDNKLM---YN--------------LF--MEYAPGGTLNDEIH-RNG 94
            GC      D  + D+ L    Y+              LF  ME+   GTL   I  R G
Sbjct: 71  NGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG 130
Query: 95  GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCA---KWES 150
            +LD+ L +    QI +G++Y+HS +++H D+K  NI + ++   KI DFG     K + 
Sbjct: 131 EKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG 190
Query: 151 EALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAY 210
           +  +S GT  +M+PE    +  G   D++A+G  + E+        +  D      K   
Sbjct: 191 KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL-------HVCDTAFETSKFFT 243
Query: 211 SRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLK 248
                 +     K+    L   L + P++R   S++L+
Sbjct: 244 DLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILR 281

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 84/296 (28%), Positives = 125/296 (42%), Gaps = 52/296 (17%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGYKG 62
           +T    IG GS   V  A  + S +V   K   L    F  RE + +  +  P++V  K 
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDEVAIKKV--LQDKRFKNRELQIMRIVKHPNVVDLKA 99
Query: 63  CDVTSEDNK--LMYNLFMEYAPGGTLNDEIHRNGGRLDES----LIVSYTRQILQGLEYL 116
              ++ D K  +  NL +EY P         R+  +L ++    LI  Y  Q+L+ L Y+
Sbjct: 100 FFYSNGDKKDEVFLNLVLEYVPETVYRAS--RHYAKLKQTMPMLLIKLYMYQLLRSLAYI 157
Query: 117 HSNRVVHCDIKSRNILM-AESGA-KIADFGCAKWESEALQSGGTP--------MFMAPEV 166
           HS  + H DIK +N+L+   SG  K+ DFG AK     +   G P         + APE+
Sbjct: 158 HSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAK-----ILIAGEPNVSXICSRYYRAPEL 212
Query: 167 ARGEHQGFAS-DIWAVGCTVIEMASGGAPWP--NAADPMTVLYKI--AYSRE-------- 213
             G      + DIW+ GC + E+  G   +P  +  D +  + K+    SRE        
Sbjct: 213 IFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPN 272
Query: 214 -----LPEV-PAFLSK--------QANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
                 P++ P   SK         A D +S  L   P  R  A + L HPF +E 
Sbjct: 273 YMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDEL 328

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/266 (25%), Positives = 117/266 (43%), Gaps = 27/266 (10%)
Query: 1   MDWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGY 60
           MD+     IG G    V  A     G  +  K  +   +E  +RE K L+ L+  +IV Y
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKY-NNEKAEREVKALAKLDHVNIVHY 69
Query: 61  KGC-------------DVTSEDNKLMYNLFMEYAPGGTLNDEIH-RNGGRLDESLIVSYT 106
            GC             + +    K ++ + ME+   GTL   I  R G +LD+ L +   
Sbjct: 70  NGCWDGFDYDPETSSKNSSRSKTKCLF-IQMEFCDKGTLEQWIEKRRGEKLDKVLALELF 128
Query: 107 RQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCA---KWESEALQSGGTPMFM 162
            QI +G++Y+HS ++++ D+K  NI + ++   KI DFG     K + +  +S GT  +M
Sbjct: 129 EQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRSKGTLRYM 188
Query: 163 APEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLS 222
           +PE    +  G   D++A+G  + E+        +  D      K         +     
Sbjct: 189 SPEQISSQDYGKEVDLYALGLILAELL-------HVCDTAFETSKFFTDLRDGIISDIFD 241
Query: 223 KQANDFLSNCLRRDPKERWAASQLLK 248
           K+    L   L + P++R   S++L+
Sbjct: 242 KKEKTLLQKLLSKKPEDRPNTSEILR 267

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 103/215 (47%), Gaps = 32/215 (14%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAK---STELPK---SEFLQREQKFLSSLNSP 55
           D+     IG+G+   V L     +  V+A K     E+ K   S F   E+  ++  NSP
Sbjct: 70  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 129
Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTL-----NDEIHRNGGRLDESLIVSYTRQIL 110
            +V         +D++ +Y + MEY PGG L     N ++     R        YT +++
Sbjct: 130 WVVQ---LFYAFQDDRYLY-MVMEYMPGGDLVNLMSNYDVPEKWARF-------YTAEVV 178
Query: 111 QGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFG-CAKWESEAL----QSGGTPMFMAP 164
             L+ +HS   +H D+K  N+L+ +SG  K+ADFG C K   E +     + GTP +++P
Sbjct: 179 LALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISP 238
Query: 165 EVARGE----HQGFASDIWAVGCTVIEMASGGAPW 195
           EV + +    + G   D W+VG  + EM  G  P+
Sbjct: 239 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 273

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 91/213 (42%), Gaps = 31/213 (14%)
Query: 104 SYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGAKIADFGCAKWESEALQSG------G 157
           SY + +L+ +  +H + +VH D+K  N L+ +   K+ DFG A        S       G
Sbjct: 159 SYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVG 218
Query: 158 TPMFMAPEVARG-----------EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLY 206
              +M PE  +                  SD+W++GC +  M  G  P+    + ++ L+
Sbjct: 219 AVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH 278
Query: 207 KIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQIQESN 266
            I       E P    K   D L  CL+RDPK+R +  +LL HP++        QIQ   
Sbjct: 279 AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV--------QIQ--- 327
Query: 267 CSPTSILDQGIWNSVEETEESLGNLIHSTSKTS 299
              T  ++Q    + EE +  LG L+   S  S
Sbjct: 328 ---THPVNQMAKGTTEEMKYVLGQLVGLNSPNS 357

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 113/223 (50%), Gaps = 17/223 (7%)
Query: 40  EFLQREQKFLSSLNSPHIVGYKGCDVTSEDNK-LMYNLFMEYAPGGTLNDEIHRNGGRLD 98
           E + +E   L  L+ P++V  K  +V  + N+  +Y +F     G  +     +    L 
Sbjct: 81  EQVYQEIAILKKLDHPNVV--KLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP---LS 135
Query: 99  ESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAK--WESEALQS 155
           E     Y + +++G+EYLH  +++H DIK  N+L+ E G  KIADFG +     S+AL S
Sbjct: 136 EDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLS 195
Query: 156 G--GTPMFMAPEV---ARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKI-A 209
              GTP FMAPE     R    G A D+WA+G T+     G  P+ +    M +  KI +
Sbjct: 196 NTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER-IMCLHSKIKS 254
Query: 210 YSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFL 252
            + E P+ P  +++   D ++  L ++P+ R    ++  HP++
Sbjct: 255 QALEFPDQPD-IAEDLKDLITRMLDKNPESRIVVPEIKLHPWV 296

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 72/253 (28%), Positives = 115/253 (45%), Gaps = 29/253 (11%)
Query: 8   TIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ--------REQKFLSSLNSPHIVG 59
            +GQGS   V L   +   D     + ++ K   L+         E+  L  +N P IV 
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 90
Query: 60  YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN 119
                 T  + KL   L +++  GG L   + +     +E  +  Y  ++   L++LHS 
Sbjct: 91  LHYAFQT--EGKLY--LILDFLRGGDLFTRLSKEVMFTEED-VKFYLAELALALDHLHSL 145
Query: 120 RVVHCDIKSRNILMAESG-AKIADFGCAK----WESEALQSGGTPMFMAPEVA--RGEHQ 172
            +++ D+K  NIL+ E G  K+ DFG +K     E +A    GT  +MAPEV   RG  Q
Sbjct: 146 GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQ 205
Query: 173 GFASDIWAVGCTVIEMASGGAPW--PNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLS 230
             ++D W+ G  + EM +G  P+   +  + MT++ K         +P FLS +A   L 
Sbjct: 206 --SADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLG-----MPQFLSPEAQSLLR 258
Query: 231 NCLRRDPKERWAA 243
              +R+P  R  A
Sbjct: 259 MLFKRNPANRLGA 271

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 122/265 (46%), Gaps = 25/265 (9%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSE-----FLQREQKFLSSLNSPHIVGYKGC 63
           +G G+   V      ++G V A K      ++      L      L S + P+IV   G 
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 64  DVTSEDNKLMYNLFMEYAPGGTLNDEIH-RNGGRLDESLIVSYTRQILQGLEYLHSNR-V 121
            +T+ D      +F+     GT  +++  R  G + E ++   T  I++ L YL     V
Sbjct: 93  FITNTD------VFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGV 146
Query: 122 VHCDIKSRNILMAESGA-KIADFGCAKW---ESEALQSGGTPMFMAPEV-----ARGEHQ 172
           +H D+K  NIL+ E G  K+ DFG +     +    +S G   +MAPE            
Sbjct: 147 IHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDY 206
Query: 173 GFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFL--SKQANDFLS 230
              +D+W++G +++E+A+G  P+ N      VL K+    E P +P  +  S     F+ 
Sbjct: 207 DIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKV-LQEEPPLLPGHMGFSGDFQSFVK 265
Query: 231 NCLRRDPKERWAASQLLKHPFLEEF 255
           +CL +D ++R   ++LL+H F++ +
Sbjct: 266 DCLTKDHRKRPKYNKLLEHSFIKRY 290

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 114/248 (45%), Gaps = 28/248 (11%)
Query: 45  EQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHR----NGGRLDES 100
           E+K L+ ++S  IV       T  D      L M    GG +   I+     N G   E 
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTD----LCLVMTIMNGGDIRYHIYNVDEDNPG-FQEP 289
Query: 101 LIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQS---- 155
             + YT QI+ GLE+LH   +++ D+K  N+L+ + G  +I+D G A  E +A Q+    
Sbjct: 290 RAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAV-ELKAGQTKTKG 348
Query: 156 -GGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSREL 214
             GTP FMAPE+  GE   F+ D +A+G T+ EM +   P+    +   V  K    R L
Sbjct: 349 YAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGE--KVENKELKQRVL 406
Query: 215 PEV---PAFLSKQANDFLSNCLRRDPKERW-----AASQLLKHPFLEEFCSCTKQIQESN 266
            +    P   S  + DF    L++DP++R      +   L  HP   +     +Q++   
Sbjct: 407 EQAVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI--SWRQLEAGM 464
Query: 267 CSPTSILD 274
            +P  + D
Sbjct: 465 LTPPFVPD 472

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 114/248 (45%), Gaps = 28/248 (11%)
Query: 45  EQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHR----NGGRLDES 100
           E+K L+ ++S  IV       T  D      L M    GG +   I+     N G   E 
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTD----LCLVMTIMNGGDIRYHIYNVDEDNPG-FQEP 289
Query: 101 LIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQS---- 155
             + YT QI+ GLE+LH   +++ D+K  N+L+ + G  +I+D G A  E +A Q+    
Sbjct: 290 RAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAV-ELKAGQTKTKG 348
Query: 156 -GGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSREL 214
             GTP FMAPE+  GE   F+ D +A+G T+ EM +   P+    +   V  K    R L
Sbjct: 349 YAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGE--KVENKELKQRVL 406
Query: 215 PEV---PAFLSKQANDFLSNCLRRDPKERW-----AASQLLKHPFLEEFCSCTKQIQESN 266
            +    P   S  + DF    L++DP++R      +   L  HP   +     +Q++   
Sbjct: 407 EQAVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI--SWRQLEAGM 464
Query: 267 CSPTSILD 274
            +P  + D
Sbjct: 465 LTPPFVPD 472

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 114/248 (45%), Gaps = 28/248 (11%)
Query: 45  EQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHR----NGGRLDES 100
           E+K L+ ++S  IV       T  D      L M    GG +   I+     N G   E 
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTD----LCLVMTIMNGGDIRYHIYNVDEDNPG-FQEP 289
Query: 101 LIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQS---- 155
             + YT QI+ GLE+LH   +++ D+K  N+L+ + G  +I+D G A  E +A Q+    
Sbjct: 290 RAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAV-ELKAGQTKTKG 348
Query: 156 -GGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSREL 214
             GTP FMAPE+  GE   F+ D +A+G T+ EM +   P+    +   V  K    R L
Sbjct: 349 YAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGE--KVENKELKQRVL 406
Query: 215 PEV---PAFLSKQANDFLSNCLRRDPKERW-----AASQLLKHPFLEEFCSCTKQIQESN 266
            +    P   S  + DF    L++DP++R      +   L  HP   +     +Q++   
Sbjct: 407 EQAVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI--SWRQLEAGM 464
Query: 267 CSPTSILD 274
            +P  + D
Sbjct: 465 LTPPFVPD 472

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 103/215 (47%), Gaps = 32/215 (14%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAK---STELPK---SEFLQREQKFLSSLNSP 55
           D+     IG+G+   V L     +  V+A K     E+ K   S F   E+  ++  NSP
Sbjct: 75  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 134
Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTL-----NDEIHRNGGRLDESLIVSYTRQIL 110
            +V         +D++ +Y + MEY PGG L     N ++     R        YT +++
Sbjct: 135 WVVQ---LFYAFQDDRYLY-MVMEYMPGGDLVNLMSNYDVPEKWARF-------YTAEVV 183
Query: 111 QGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFG-CAKWESEAL----QSGGTPMFMAP 164
             L+ +HS   +H D+K  N+L+ +SG  K+ADFG C K   E +     + GTP +++P
Sbjct: 184 LALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISP 243
Query: 165 EVARGE----HQGFASDIWAVGCTVIEMASGGAPW 195
           EV + +    + G   D W+VG  + EM  G  P+
Sbjct: 244 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 103/215 (47%), Gaps = 32/215 (14%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAK---STELPK---SEFLQREQKFLSSLNSP 55
           D+     IG+G+   V L     +  V+A K     E+ K   S F   E+  ++  NSP
Sbjct: 75  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 134
Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTL-----NDEIHRNGGRLDESLIVSYTRQIL 110
            +V         +D++ +Y + MEY PGG L     N ++     R        YT +++
Sbjct: 135 WVVQ---LFYAFQDDRYLY-MVMEYMPGGDLVNLMSNYDVPEKWARF-------YTAEVV 183
Query: 111 QGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFG-CAKWESEAL----QSGGTPMFMAP 164
             L+ +HS   +H D+K  N+L+ +SG  K+ADFG C K   E +     + GTP +++P
Sbjct: 184 LALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISP 243
Query: 165 EVARGE----HQGFASDIWAVGCTVIEMASGGAPW 195
           EV + +    + G   D W+VG  + EM  G  P+
Sbjct: 244 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 83/261 (31%), Positives = 125/261 (47%), Gaps = 20/261 (7%)
Query: 8   TIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTS 67
           TIG GS +         +   +A K  +  K +  +  +  L     P+I+  K  DV  
Sbjct: 34  TIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEILLRYGQHPNIITLK--DVY- 90
Query: 68  EDNKLMYNLFMEYAPGGTLNDEIHRNGGRLD-ESLIVSYTRQILQGLEYLHSNRVVHCDI 126
           +D K +Y L  E   GG L D+I R     + E+  V +T  I + +EYLHS  VVH D+
Sbjct: 91  DDGKHVY-LVTELMRGGELLDKILRQKFFSEREASFVLHT--IGKTVEYLHSQGVVHRDL 147
Query: 127 KSRNILMA-ESG----AKIADFGCAKW---ESEALQSG-GTPMFMAPEVARGEHQGFASD 177
           K  NIL   ESG     +I DFG AK    E+  L +   T  F+APEV + +      D
Sbjct: 148 KPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLKRQGYDEGCD 207
Query: 178 IWAVGCTVIEMASGGAPWPNAAD--PMTVLYKIAYSRELPEVPAF--LSKQANDFLSNCL 233
           IW++G  +  M +G  P+ N     P  +L +I   +       +  +S+ A D +S  L
Sbjct: 208 IWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGKFTLSGGNWNTVSETAKDLVSKML 267
Query: 234 RRDPKERWAASQLLKHPFLEE 254
             DP +R  A Q+L+HP++ +
Sbjct: 268 HVDPHQRLTAKQVLQHPWVTQ 288

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 83/261 (31%), Positives = 125/261 (47%), Gaps = 20/261 (7%)
Query: 8   TIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTS 67
           TIG GS +         +   +A K  +  K +  +  +  L     P+I+  K  DV  
Sbjct: 34  TIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEILLRYGQHPNIITLK--DV-Y 90
Query: 68  EDNKLMYNLFMEYAPGGTLNDEIHRNGGRLD-ESLIVSYTRQILQGLEYLHSNRVVHCDI 126
           +D K +Y L  E   GG L D+I R     + E+  V +T  I + +EYLHS  VVH D+
Sbjct: 91  DDGKHVY-LVTELMRGGELLDKILRQKFFSEREASFVLHT--IGKTVEYLHSQGVVHRDL 147
Query: 127 KSRNILMA-ESG----AKIADFGCAKW---ESEALQSG-GTPMFMAPEVARGEHQGFASD 177
           K  NIL   ESG     +I DFG AK    E+  L +   T  F+APEV + +      D
Sbjct: 148 KPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLKRQGYDEGCD 207
Query: 178 IWAVGCTVIEMASGGAPWPNAAD--PMTVLYKIAYSRELPEVPAF--LSKQANDFLSNCL 233
           IW++G  +  M +G  P+ N     P  +L +I   +       +  +S+ A D +S  L
Sbjct: 208 IWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGKFTLSGGNWNTVSETAKDLVSKML 267
Query: 234 RRDPKERWAASQLLKHPFLEE 254
             DP +R  A Q+L+HP++ +
Sbjct: 268 HVDPHQRLTAKQVLQHPWVTQ 288

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/262 (24%), Positives = 121/262 (46%), Gaps = 26/262 (9%)
Query: 4   TRGHTIGQGSSATVSLA-----TSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIV 58
           T G  IG GS  TV         +++  +V A    +L   +  + E   L      +I+
Sbjct: 15  TVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQL---QAFKNEVGVLRKTRHVNIL 71
Query: 59  GYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHS 118
            + G        K    +  ++  G +L   +H +  + +   ++   RQ  +G++YLH+
Sbjct: 72  LFMGYS-----TKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA 126
Query: 119 NRVVHCDIKSRNILMAESG-AKIADFGCAKWES------EALQSGGTPMFMAPEVARGEH 171
             ++H D+KS NI + E    KI DFG A  +S      +  Q  G+ ++MAPEV R + 
Sbjct: 127 KSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 186
Query: 172 QG---FASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKI---AYSRELPEVPAFLSKQA 225
                F SD++A G  + E+ +G  P+ N  +   ++  +   + S +L +V +   K+ 
Sbjct: 187 SNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRM 246
Query: 226 NDFLSNCLRRDPKERWAASQLL 247
              ++ CL++   ER +  ++L
Sbjct: 247 KRLMAECLKKKRDERPSFPRIL 268

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 77/260 (29%), Positives = 124/260 (47%), Gaps = 24/260 (9%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAK---STELPKSEF--LQREQKFLSSLNSPHIVGYKGC 63
           +G+G+ + V       +G  FAAK   + +L   +F  L+RE +    L  P+IV  +  
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIV--RLH 71
Query: 64  DVTSEDNKLMYNLFMEYAPGGTLNDEI--HRNGGRLDESLIVSYTRQILQGLEYLHSNRV 121
           D   E++   + L  +   GG L ++I         D S  +   +QIL+ + Y HSN +
Sbjct: 72  DSIQEES--FHYLVFDLVTGGELFEDIVAREFYSEADASHCI---QQILESIAYCHSNGI 126
Query: 122 VHCDIKSRNILMAE----SGAKIADFGCAKW--ESEALQS-GGTPMFMAPEVARGEHQGF 174
           VH ++K  N+L+A     +  K+ADFG A    +SEA     GTP +++PEV + +    
Sbjct: 127 VHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSK 186
Query: 175 ASDIWAVGCTVIEMASGGAP-WPNAADPMTVLYKI-AYSRELPEVPAFLSKQANDFLSNC 232
             DIWA G  +  +  G  P W      +    K  AY    PE    ++ +A   + + 
Sbjct: 187 PVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDT-VTPEAKSLIDSM 245
Query: 233 LRRDPKERWAASQLLKHPFL 252
           L  +PK+R  A Q LK P++
Sbjct: 246 LTVNPKKRITADQALKVPWI 265

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 77/260 (29%), Positives = 124/260 (47%), Gaps = 24/260 (9%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAK---STELPKSEF--LQREQKFLSSLNSPHIVGYKGC 63
           +G+G+ + V       +G  FAAK   + +L   +F  L+RE +    L  P+IV  +  
Sbjct: 13  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIV--RLH 70
Query: 64  DVTSEDNKLMYNLFMEYAPGGTLNDEI--HRNGGRLDESLIVSYTRQILQGLEYLHSNRV 121
           D   E++   + L  +   GG L ++I         D S  +   +QIL+ + Y HSN +
Sbjct: 71  DSIQEES--FHYLVFDLVTGGELFEDIVAREFYSEADASHCI---QQILESIAYCHSNGI 125
Query: 122 VHCDIKSRNILMAE----SGAKIADFGCAKW--ESEALQS-GGTPMFMAPEVARGEHQGF 174
           VH ++K  N+L+A     +  K+ADFG A    +SEA     GTP +++PEV + +    
Sbjct: 126 VHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSK 185
Query: 175 ASDIWAVGCTVIEMASGGAP-WPNAADPMTVLYKI-AYSRELPEVPAFLSKQANDFLSNC 232
             DIWA G  +  +  G  P W      +    K  AY    PE    ++ +A   + + 
Sbjct: 186 PVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDT-VTPEAKSLIDSM 244
Query: 233 LRRDPKERWAASQLLKHPFL 252
           L  +PK+R  A Q LK P++
Sbjct: 245 LTVNPKKRITADQALKVPWI 264

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 75/167 (44%), Gaps = 17/167 (10%)
Query: 104 SYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGAKIADFGCAKWESEALQ------SGG 157
           SY + +L+ +  +H + +VH D+K  N L+ +   K+ DFG A                G
Sbjct: 131 SYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDXXXVVKDSQVG 190
Query: 158 TPMFMAPEVARG-----------EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLY 206
           T  +M PE  +                  SD+W++GC +  M  G  P+    + ++ L+
Sbjct: 191 TVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH 250
Query: 207 KIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLE 253
            I       E P    K   D L  CL+RDPK+R +  +LL HP+++
Sbjct: 251 AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 297

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 114/248 (45%), Gaps = 28/248 (11%)
Query: 45  EQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHR----NGGRLDES 100
           E+K L+ ++S  IV       T  D      L M    GG +   I+     N G   E 
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTD----LCLVMTIMNGGDIRYHIYNVDEDNPG-FQEP 289
Query: 101 LIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQS---- 155
             + YT QI+ GLE+LH   +++ D+K  N+L+ + G  +I+D G A  E +A Q+    
Sbjct: 290 RAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAV-ELKAGQTKTKG 348
Query: 156 -GGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSREL 214
             GTP FMAPE+  GE   F+ D +A+G T+ EM +   P+    +   V  K    R L
Sbjct: 349 YAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGE--KVENKELKQRVL 406
Query: 215 PEV---PAFLSKQANDFLSNCLRRDPKERW-----AASQLLKHPFLEEFCSCTKQIQESN 266
            +    P   S  + DF    L++DP++R      +   L  HP   +     +Q++   
Sbjct: 407 EQAVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI--SWRQLEAGM 464
Query: 267 CSPTSILD 274
            +P  + D
Sbjct: 465 LTPPFVPD 472

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 77/260 (29%), Positives = 124/260 (47%), Gaps = 24/260 (9%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAK---STELPKSEF--LQREQKFLSSLNSPHIVGYKGC 63
           +G+G+ + V       +G  FAAK   + +L   +F  L+RE +    L  P+IV  +  
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIV--RLH 71
Query: 64  DVTSEDNKLMYNLFMEYAPGGTLNDEI--HRNGGRLDESLIVSYTRQILQGLEYLHSNRV 121
           D   E++   + L  +   GG L ++I         D S  +   +QIL+ + Y HSN +
Sbjct: 72  DSIQEES--FHYLVFDLVTGGELFEDIVAREFYSEADASHCI---QQILESIAYCHSNGI 126
Query: 122 VHCDIKSRNILMAE----SGAKIADFGCAKW--ESEALQS-GGTPMFMAPEVARGEHQGF 174
           VH ++K  N+L+A     +  K+ADFG A    +SEA     GTP +++PEV + +    
Sbjct: 127 VHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSK 186
Query: 175 ASDIWAVGCTVIEMASGGAP-WPNAADPMTVLYKI-AYSRELPEVPAFLSKQANDFLSNC 232
             DIWA G  +  +  G  P W      +    K  AY    PE    ++ +A   + + 
Sbjct: 187 PVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDT-VTPEAKSLIDSM 245
Query: 233 LRRDPKERWAASQLLKHPFL 252
           L  +PK+R  A Q LK P++
Sbjct: 246 LTVNPKKRITADQALKVPWI 265

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 65/262 (24%), Positives = 121/262 (46%), Gaps = 26/262 (9%)
Query: 4   TRGHTIGQGSSATVSLA-----TSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIV 58
           T G  IG GS  TV         +++  +V A    +L   +  + E   L      +I+
Sbjct: 27  TVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQL---QAFKNEVGVLRKTRHVNIL 83
Query: 59  GYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHS 118
            + G        K    +  ++  G +L   +H +  + +   ++   RQ  +G++YLH+
Sbjct: 84  LFMGYST-----KPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA 138
Query: 119 NRVVHCDIKSRNILMAESG-AKIADFGCA----KWES--EALQSGGTPMFMAPEVARGEH 171
             ++H D+KS NI + E    KI DFG A    +W    +  Q  G+ ++MAPEV R + 
Sbjct: 139 KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198
Query: 172 QG---FASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKI---AYSRELPEVPAFLSKQA 225
                F SD++A G  + E+ +G  P+ N  +   ++  +   + S +L +V +   K+ 
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRM 258
Query: 226 NDFLSNCLRRDPKERWAASQLL 247
              ++ CL++   ER +  ++L
Sbjct: 259 KRLMAECLKKKRDERPSFPRIL 280

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 88/288 (30%), Positives = 129/288 (44%), Gaps = 48/288 (16%)
Query: 9   IGQGSSATVSLATSLRSGDVFAA------KSTE--LPKSEFLQREQKFLSSLNS---PHI 57
           IG+G+   V  A  L++G  F A      ++ E  +P S    RE   L  L +   P++
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTI--REVAVLRHLETFEHPNV 76
Query: 58  VG-YKGCDVTSEDNKLMYNLFMEYAPGG--TLNDEIHRNGGRLDESLIVSYTRQILQGLE 114
           V  +  C V+  D +    L  E+      T  D++   G  +    I     Q+L+GL+
Sbjct: 77  VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG--VPTETIKDMMFQLLRGLD 134
Query: 115 YLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWES--EALQSGGTPM-FMAPEVARGE 170
           +LHS+RVVH D+K +NIL+  SG  K+ADFG A+  S   AL S    + + APEV    
Sbjct: 135 FLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQS 194
Query: 171 HQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELP---------EVP--A 219
                 D+W+VGC   EM      +  ++D +  L KI     LP          +P  A
Sbjct: 195 SYATPVDLWSVGCIFAEMFRRKPLFRGSSD-VDQLGKILDVIGLPGEEDWPRDVALPRQA 253
Query: 220 FLSKQA--------------NDFLSNCLRRDPKERWAASQLLKHPFLE 253
           F SK A               D L  CL  +P +R +A   L HP+ +
Sbjct: 254 FHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 301

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 64/262 (24%), Positives = 121/262 (46%), Gaps = 26/262 (9%)
Query: 4   TRGHTIGQGSSATVSLA-----TSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIV 58
           T G  IG GS  TV         +++  +V A    +L   +  + E   L      +I+
Sbjct: 27  TVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQL---QAFKNEVGVLRKTRHVNIL 83
Query: 59  GYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHS 118
            + G     +       +  ++  G +L   +H +  + +   ++   RQ  +G++YLH+
Sbjct: 84  LFMGYSTAPQ-----LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA 138
Query: 119 NRVVHCDIKSRNILMAESG-AKIADFGCA----KWES--EALQSGGTPMFMAPEVARGEH 171
             ++H D+KS NI + E    KI DFG A    +W    +  Q  G+ ++MAPEV R + 
Sbjct: 139 KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198
Query: 172 QG---FASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKI---AYSRELPEVPAFLSKQA 225
                F SD++A G  + E+ +G  P+ N  +   ++  +   + S +L +V +   K+ 
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRM 258
Query: 226 NDFLSNCLRRDPKERWAASQLL 247
              ++ CL++   ER +  ++L
Sbjct: 259 KRLMAECLKKKRDERPSFPRIL 280

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 77/260 (29%), Positives = 124/260 (47%), Gaps = 24/260 (9%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAK---STELPKSEF--LQREQKFLSSLNSPHIVGYKGC 63
           +G+G+ + V       +G  FAAK   + +L   +F  L+RE +    L  P+IV  +  
Sbjct: 37  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIV--RLH 94
Query: 64  DVTSEDNKLMYNLFMEYAPGGTLNDEI--HRNGGRLDESLIVSYTRQILQGLEYLHSNRV 121
           D   E++   + L  +   GG L ++I         D S  +   +QIL+ + Y HSN +
Sbjct: 95  DSIQEES--FHYLVFDLVTGGELFEDIVAREFYSEADASHCI---QQILESIAYCHSNGI 149
Query: 122 VHCDIKSRNILMAE----SGAKIADFGCAKW--ESEALQS-GGTPMFMAPEVARGEHQGF 174
           VH ++K  N+L+A     +  K+ADFG A    +SEA     GTP +++PEV + +    
Sbjct: 150 VHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSK 209
Query: 175 ASDIWAVGCTVIEMASGGAP-WPNAADPMTVLYKI-AYSRELPEVPAFLSKQANDFLSNC 232
             DIWA G  +  +  G  P W      +    K  AY    PE    ++ +A   + + 
Sbjct: 210 PVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDT-VTPEAKSLIDSM 268
Query: 233 LRRDPKERWAASQLLKHPFL 252
           L  +PK+R  A Q LK P++
Sbjct: 269 LTVNPKKRITADQALKVPWI 288

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 125/269 (46%), Gaps = 27/269 (10%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-----SEFLQREQKFLSSLNSPH 56
           D+     +G+G+ + V           +AAK     K      + L+RE +    L  P+
Sbjct: 32  DYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKHPN 91
Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEI--HRNGGRLDESLIVSYTRQILQGLE 114
           IV  +  D  SE+    + L  +   GG L ++I         D S  +    QIL+ + 
Sbjct: 92  IV--RLHDSISEEG--FHYLVFDLVTGGELFEDIVAREYYSEADASHCI---HQILESVN 144
Query: 115 YLHSNRVVHCDIKSRNILMAE----SGAKIADFGCA---KWESEA-LQSGGTPMFMAPEV 166
           ++H + +VH D+K  N+L+A     +  K+ADFG A   + E +A     GTP +++PEV
Sbjct: 145 HIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEV 204
Query: 167 ARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKI---AYSRELPEVPAFLSK 223
            R +  G   DIWA G  +  +  G  P+ +  D   +  +I   AY    PE    ++ 
Sbjct: 205 LRKDPYGKPVDIWACGVILYILLVGYPPFWD-EDQHKLYQQIKAGAYDFPSPEWDT-VTP 262
Query: 224 QANDFLSNCLRRDPKERWAASQLLKHPFL 252
           +A + ++  L  +P +R  A Q LKHP++
Sbjct: 263 EAKNLINQMLTINPAKRITADQALKHPWV 291

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 79/294 (26%), Positives = 127/294 (43%), Gaps = 53/294 (18%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ----REQKFLSSLNSPHIVGYKGCD 64
           +G G+ ATV    +  +G   A K  +L   E       RE   +  L   +IV  +  D
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIV--RLYD 70
Query: 65  VTSEDNKLMYNL-FMEYAPGGTLNDEIHRNGGR-LDESLIVSYTRQILQGLEYLHSNRVV 122
           V   +NKL     FM+      ++     N  R L+ +L+  +  Q+LQGL + H N+++
Sbjct: 71  VIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKIL 130
Query: 123 HCDIKSRNILMAESGA-KIADFGCAK--------WESEALQSGGTPMFMAPEVARGEHQG 173
           H D+K +N+L+ + G  K+ DFG A+        + SE +    T  + AP+V  G    
Sbjct: 131 HRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV----TLWYRAPDVLMGSRTY 186
Query: 174 FAS-DIWAVGCTVIEMASGGAPWP--NAADPMTVLYKIAYS------------------- 211
             S DIW+ GC + EM +G   +P  N  + + +++ I  +                   
Sbjct: 187 STSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNI 246
Query: 212 -----REL-----PEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
                R+L     P     L     DFL   L+ +P  R +A Q L HP+  E+
Sbjct: 247 QQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEY 300

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 77/281 (27%), Positives = 130/281 (46%), Gaps = 32/281 (11%)
Query: 9   IGQGSSATVSLATSLRSGDVFAA-----KSTELPKSEFLQREQKFLSSLNSPHIVGYKGC 63
           +G+G+ + V     + +G  +AA     K       + L+RE +    L  P+IV  +  
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIV--RLH 76
Query: 64  DVTSEDNKLMYNLFMEYAPGGTLNDEI--HRNGGRLDESLIVSYTRQILQGLEYLHSNRV 121
           D  SE+    + L  +   GG L ++I         D S  +   +QIL+ + + H   V
Sbjct: 77  DSISEEGH--HYLIFDLVTGGELFEDIVAREYYSEADASHCI---QQILEAVLHCHQMGV 131
Query: 122 VHCDIKSRNILMAE----SGAKIADFGCAKWESEALQSG-----GTPMFMAPEVARGEHQ 172
           VH ++K  N+L+A     +  K+ADFG A  E E  Q       GTP +++PEV R +  
Sbjct: 132 VHRNLKPENLLLASKLKGAAVKLADFGLAI-EVEGEQQAWFGFAGTPGYLSPEVLRKDPY 190
Query: 173 GFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKI---AYSRELPEVPAFLSKQANDFL 229
           G   D+WA G  +  +  G  P+ +  D   +  +I   AY    PE    ++ +A D +
Sbjct: 191 GKPVDLWACGVILYILLVGYPPFWD-EDQHRLYQQIKAGAYDFPSPEWDT-VTPEAKDLI 248
Query: 230 SNCLRRDPKERWAASQLLKHPFLEE---FCSCTKQIQESNC 267
           +  L  +P +R  A++ LKHP++       SC  + +  +C
Sbjct: 249 NKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDC 289

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 70/242 (28%), Positives = 117/242 (48%), Gaps = 17/242 (7%)
Query: 40  EFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDE 99
           E +  E   L SL+ P+I+  K  DV  ED K  Y L  E+  GG L ++I  N  + DE
Sbjct: 91  EEIYNEISLLKSLDHPNII--KLFDVF-EDKKYFY-LVTEFYEGGELFEQI-INRHKFDE 145
Query: 100 SLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGA----KIADFGCAKWESEALQ- 154
               +  +QIL G+ YLH + +VH DIK  NIL+    +    KI DFG + + S+  + 
Sbjct: 146 CDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL 205
Query: 155 --SGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPW--PNAADPMTVLYKIAY 210
               GT  ++APEV + ++     D+W+ G  +  +  G  P+   N  D +  + K  Y
Sbjct: 206 RDRLGTAYYIAPEVLKKKYNE-KCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKY 264
Query: 211 SRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFC-SCTKQIQESNCSP 269
             +  +    +S +A + +   L  D  +R  A + L   +++++  +  K  Q++ C  
Sbjct: 265 YFDFNDWKN-ISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGA 323
Query: 270 TS 271
            S
Sbjct: 324 LS 325

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 46/185 (24%), Positives = 90/185 (48%), Gaps = 13/185 (7%)
Query: 76  LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAE 135
           +  ++  G +L   +H    +     ++   RQ  QG++YLH+  ++H D+KS NI + E
Sbjct: 108 IVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHE 167
Query: 136 S-GAKIADFGCAKWES------EALQSGGTPMFMAPEVARGEHQG---FASDIWAVGCTV 185
               KI DFG A  +S      +  Q  G+ ++MAPEV R +      F SD+++ G  +
Sbjct: 168 GLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVL 227
Query: 186 IEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLS---KQANDFLSNCLRRDPKERWA 242
            E+ +G  P+ +  +   +++ +      P++        K     +++C+++  +ER  
Sbjct: 228 YELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPL 287
Query: 243 ASQLL 247
             Q+L
Sbjct: 288 FPQIL 292

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 80/267 (29%), Positives = 116/267 (43%), Gaps = 30/267 (11%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGYKG 62
           + R   +G GS   V    S   G ++A K +  P      R +K L+ + S   VG   
Sbjct: 59  FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARK-LAEVGSHEKVGQHP 117
Query: 63  CDVTSE----DNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHS 118
           C V  E    +  ++Y L  E   G +L       G  L E+ +  Y R  L  L +LHS
Sbjct: 118 CCVRLEQAWEEGGILY-LQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS 175
Query: 119 NRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG----GTPMFMAPEVARGEHQG 173
             +VH D+K  NI +   G  K+ DFG    E     +G    G P +MAPE+ +G + G
Sbjct: 176 QGLVHLDVKPANIFLGPRGRCKLGDFGLLV-ELGTAGAGEVQEGDPRYMAPELLQGSY-G 233
Query: 174 FASDIWAVGCTVIEMA------SGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQAND 227
            A+D++++G T++E+A       GG  W           ++      PE  A LS +   
Sbjct: 234 TAADVFSLGLTILEVACNMELPHGGEGW----------QQLRQGYLPPEFTAGLSSELRS 283
Query: 228 FLSNCLRRDPKERWAASQLLKHPFLEE 254
            L   L  DPK R  A  LL  P L +
Sbjct: 284 VLVMMLEPDPKLRATAEALLALPVLRQ 310

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 76/262 (29%), Positives = 123/262 (46%), Gaps = 27/262 (10%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPK-----SEFLQREQKFLSSLNSPHIVGYKGC 63
           IG+G+ + V     L +G  +AAK     K      + L+RE +    L   +IV     
Sbjct: 12  IGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSNIVRLH-- 69
Query: 64  DVTSEDNKLMYNLFMEYAPGGTLNDEI--HRNGGRLDESLIVSYTRQILQGLEYLHSNRV 121
           D  SE+    + L  +   GG L ++I         D S  +   +QIL+ + + H   V
Sbjct: 70  DSISEEG--FHYLVFDLVTGGELFEDIVAREYYSEADASHCI---QQILEAVLHCHQMGV 124
Query: 122 VHCDIKSRNILMAE----SGAKIADFGCA---KWESEA-LQSGGTPMFMAPEVARGEHQG 173
           VH D+K  N+L+A     +  K+ADFG A   + + +A     GTP +++PEV R E  G
Sbjct: 125 VHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKEAYG 184
Query: 174 FASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKI---AYSRELPEVPAFLSKQANDFLS 230
              DIWA G  +  +  G  P+ +  D   +  +I   AY    PE    ++ +A + ++
Sbjct: 185 KPVDIWACGVILYILLVGYPPFWD-EDQHKLYQQIKAGAYDFPSPEWDT-VTPEAKNLIN 242
Query: 231 NCLRRDPKERWAASQLLKHPFL 252
             L  +P +R  A + LKHP++
Sbjct: 243 QMLTINPAKRITAHEALKHPWV 264

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 85/157 (54%), Gaps = 10/157 (6%)
Query: 42  LQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESL 101
           L++E + L +L   +IV YKG  + +ED      L ME+ P G+L + + +N  +++   
Sbjct: 70  LKKEIEILRNLYHENIVKYKG--ICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQ 127
Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKW-----ESEALQS 155
            + Y  QI +G++YL S + VH D+ +RN+L+ +E   KI DFG  K      E   ++ 
Sbjct: 128 QLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKD 187
Query: 156 G-GTPMF-MAPEVARGEHQGFASDIWAVGCTVIEMAS 190
              +P+F  APE         ASD+W+ G T+ E+ +
Sbjct: 188 DRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/257 (25%), Positives = 111/257 (43%), Gaps = 13/257 (5%)
Query: 9   IGQGSSATVSLATSLRSGDVFA---AKSTELPKSEF--LQREQKFLSSLNSPHIVGYKGC 63
           IG+GS  TV       +    A    +  +L KSE    + E + L  L  P+IV +   
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYDS 93
Query: 64  DVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNR--V 121
             ++   K    L  E    GTL   + R        ++ S+ RQIL+GL++LH+    +
Sbjct: 94  WESTVKGKKCIVLVTELXTSGTLKTYLKRFKV-XKIKVLRSWCRQILKGLQFLHTRTPPI 152
Query: 122 VHCDIKSRNILMA--ESGAKIADFGCAKWESEALQSG--GTPMFMAPEVARGEHQGFASD 177
           +H D+K  NI +       KI D G A  +  +      GTP F APE    ++   + D
Sbjct: 153 IHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFXAPEXYEEKYDE-SVD 211
Query: 178 IWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDP 237
           ++A G   +E A+   P+    +   +  ++    +          +  + +  C+R++ 
Sbjct: 212 VYAFGXCXLEXATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNK 271
Query: 238 KERWAASQLLKHPFLEE 254
            ER++   LL H F +E
Sbjct: 272 DERYSIKDLLNHAFFQE 288

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 85/157 (54%), Gaps = 10/157 (6%)
Query: 42  LQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESL 101
           L++E + L +L   +IV YKG  + +ED      L ME+ P G+L + + +N  +++   
Sbjct: 58  LKKEIEILRNLYHENIVKYKG--ICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQ 115
Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKW-----ESEALQS 155
            + Y  QI +G++YL S + VH D+ +RN+L+ +E   KI DFG  K      E   ++ 
Sbjct: 116 QLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKD 175
Query: 156 G-GTPMF-MAPEVARGEHQGFASDIWAVGCTVIEMAS 190
              +P+F  APE         ASD+W+ G T+ E+ +
Sbjct: 176 DRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 106/231 (45%), Gaps = 27/231 (11%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKS----TELPKSEFLQREQKFLSSLNSPHIV 58
           W     +GQG++A V      ++GD+FA K     + L   +   RE + L  LN  +IV
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 59  GYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHR--NGGRLDESLIVSYTRQILQGLEYL 116
             K   +  E       L ME+ P G+L   +    N   L ES  +   R ++ G+ +L
Sbjct: 71  --KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 117 HSNRVVHCDIKSRNIL--MAESGA---KIADFGCAKW---ESEALQSGGTPMFMAPE--- 165
             N +VH +IK  NI+  + E G    K+ DFG A+    + + +   GT  ++ P+   
Sbjct: 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYE 188
Query: 166 --VARGEHQ---GFASDIWAVGCTVIEMASGGAPWPNAADP---MTVLYKI 208
             V R +HQ   G   D+W++G T    A+G  P+     P     V+YKI
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 72/286 (25%), Positives = 122/286 (42%), Gaps = 43/286 (15%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ-----REQKFLSSLNSPHIVGYKGC 63
           +G G+  +V  +  ++SG   A K    P    +      RE + L  +   +++G    
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL--L 116
Query: 64  DVTSEDNKLM-YN--LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNR 120
           DV +    L  +N    + +  G  LN+ +     +L +  +     QIL+GL+Y+HS  
Sbjct: 117 DVFTPATSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQFLIYQILRGLKYIHSAD 174
Query: 121 VVHCDIKSRNILMAES-GAKIADFGCAKW-ESEALQSGGTPMFMAPEVARG-EHQGFASD 177
           ++H D+K  N+ + E    KI DFG A+  + E      T  + APE+     H     D
Sbjct: 175 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNMTVD 234
Query: 178 IWAVGCTVIEMASGGAPWP--------------NAADPMTVLYKIA------YSRELPEV 217
           IW+VGC + E+ +G   +P                  P +V+ ++       Y   LP++
Sbjct: 235 IWSVGCIMAELLTGRTLFPGTDHINQLQQIMRLTGTPPASVISRMPSHEARNYINSLPQM 294
Query: 218 P------AFLSKQ--ANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
           P       F+     A D L   L  D  +R  AS+ L HP+  ++
Sbjct: 295 PKRNFADVFIGANPLAVDLLEKMLVLDTDKRITASEALAHPYFSQY 340

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 106/231 (45%), Gaps = 27/231 (11%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKS----TELPKSEFLQREQKFLSSLNSPHIV 58
           W     +GQG++A V      ++GD+FA K     + L   +   RE + L  LN  +IV
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 59  GYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHR--NGGRLDESLIVSYTRQILQGLEYL 116
             K   +  E       L ME+ P G+L   +    N   L ES  +   R ++ G+ +L
Sbjct: 71  --KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 117 HSNRVVHCDIKSRNIL--MAESGA---KIADFGCAKW---ESEALQSGGTPMFMAPE--- 165
             N +VH +IK  NI+  + E G    K+ DFG A+    + + +   GT  ++ P+   
Sbjct: 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXLYGTEEYLHPDMYE 188
Query: 166 --VARGEHQ---GFASDIWAVGCTVIEMASGGAPWPNAADP---MTVLYKI 208
             V R +HQ   G   D+W++G T    A+G  P+     P     V+YKI
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 95/201 (47%), Gaps = 33/201 (16%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTEL-PKSEFLQ-------REQKFLSSLNSPHIVGY 60
           +G+G  ATV  A    +  + A K  +L  +SE          RE K L  L+ P+I+G 
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 61  KGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNR 120
                   +  L+++ FME      L   I  N   L  S I +Y    LQGLEYLH + 
Sbjct: 78  LDAFGHKSNISLVFD-FME----TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 132
Query: 121 VVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSGGTPM-----------FMAPEVAR 168
           ++H D+K  N+L+ E+G  K+ADFG AK       S G+P            + APE+  
Sbjct: 133 ILHRDLKPNNLLLDENGVLKLADFGLAK-------SFGSPNRAYXHQVVTRWYRAPELLF 185
Query: 169 GEHQ-GFASDIWAVGCTVIEM 188
           G    G   D+WAVGC + E+
Sbjct: 186 GARMYGVGVDMWAVGCILAEL 206

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 123/266 (46%), Gaps = 23/266 (8%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS-----EFLQREQKFLSSLNSPHI 57
           +T  +TIG+GS   V +A  ++ G      + ++PK      +  ++E + + SL+ P+I
Sbjct: 28  YTLENTIGRGSWGEVKIA--VQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNI 85
Query: 58  VGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEI-HRNGGRLDESLIVSYTRQILQGLEYL 116
           +       T EDN  +Y L ME   GG L + + H+   R  ES      + +L  + Y 
Sbjct: 86  IRLYE---TFEDNTDIY-LVMELCTGGELFERVVHKRVFR--ESDAARIMKDVLSAVAYC 139
Query: 117 HSNRVVHCDIKSRNILM----AESGAKIADFG-CAKWESEALQSG--GTPMFMAPEVARG 169
           H   V H D+K  N L      +S  K+ DFG  A+++   +     GTP +++P+V  G
Sbjct: 140 HKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEG 199
Query: 170 EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAF-LSKQANDF 228
            + G   D W+ G  +  +  G  P+    D   +L     +   PE     +S QA   
Sbjct: 200 LY-GPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLNVSPQAESL 258
Query: 229 LSNCLRRDPKERWAASQLLKHPFLEE 254
           +   L + PK+R  + Q L+H + E+
Sbjct: 259 IRRLLTKSPKQRITSLQALEHEWFEK 284

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 123/266 (46%), Gaps = 23/266 (8%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS-----EFLQREQKFLSSLNSPHI 57
           +T  +TIG+GS   V +A  ++ G      + ++PK      +  ++E + + SL+ P+I
Sbjct: 11  YTLENTIGRGSWGEVKIA--VQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNI 68
Query: 58  VGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEI-HRNGGRLDESLIVSYTRQILQGLEYL 116
           +       T EDN  +Y L ME   GG L + + H+   R  ES      + +L  + Y 
Sbjct: 69  IRLYE---TFEDNTDIY-LVMELCTGGELFERVVHKRVFR--ESDAARIMKDVLSAVAYC 122
Query: 117 HSNRVVHCDIKSRNILM----AESGAKIADFG-CAKWESEALQSG--GTPMFMAPEVARG 169
           H   V H D+K  N L      +S  K+ DFG  A+++   +     GTP +++P+V  G
Sbjct: 123 HKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEG 182
Query: 170 EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAF-LSKQANDF 228
            + G   D W+ G  +  +  G  P+    D   +L     +   PE     +S QA   
Sbjct: 183 LY-GPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLNVSPQAESL 241
Query: 229 LSNCLRRDPKERWAASQLLKHPFLEE 254
           +   L + PK+R  + Q L+H + E+
Sbjct: 242 IRRLLTKSPKQRITSLQALEHEWFEK 267

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 113/265 (42%), Gaps = 35/265 (13%)
Query: 10  GQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQR---------EQKFLSSLNSPHIVGY 60
           G G    V   T   +G +FA K   L K+  ++          E+  L  +  P IV  
Sbjct: 29  GYGKVFQVRKVTGANTGKIFAMKV--LKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDL 86
Query: 61  KGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNR 120
                T    KL   L +EY  GG L  ++ R G  ++++    Y  +I   L +LH   
Sbjct: 87  IYAFQTG--GKLY--LILEYLSGGELFMQLEREGIFMEDTACF-YLAEISMALGHLHQKG 141
Query: 121 VVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG-------GTPMFMAPEVARGEHQ 172
           +++ D+K  NI++   G  K+ DFG  K   E++  G       GT  +MAPE+      
Sbjct: 142 IIYRDLKPENIMLNHQGHVKLTDFGLCK---ESIHDGTVTHXFCGTIEYMAPEILMRSGH 198
Query: 173 GFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNC 232
             A D W++G  + +M +G  P+       T+   +     L   P +L+++A D L   
Sbjct: 199 NRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNL---PPYLTQEARDLLKKL 255
Query: 233 LRRDPKERWA-----ASQLLKHPFL 252
           L+R+   R       A ++  HPF 
Sbjct: 256 LKRNAASRLGAGPGDAGEVQAHPFF 280

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 113/265 (42%), Gaps = 35/265 (13%)
Query: 10  GQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQR---------EQKFLSSLNSPHIVGY 60
           G G    V   T   +G +FA K   L K+  ++          E+  L  +  P IV  
Sbjct: 29  GYGKVFQVRKVTGANTGKIFAMKV--LKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDL 86
Query: 61  KGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNR 120
                T    KL   L +EY  GG L  ++ R G  ++++    Y  +I   L +LH   
Sbjct: 87  IYAFQTG--GKLY--LILEYLSGGELFMQLEREGIFMEDTACF-YLAEISMALGHLHQKG 141
Query: 121 VVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG-------GTPMFMAPEVARGEHQ 172
           +++ D+K  NI++   G  K+ DFG  K   E++  G       GT  +MAPE+      
Sbjct: 142 IIYRDLKPENIMLNHQGHVKLTDFGLCK---ESIHDGTVTHTFCGTIEYMAPEILMRSGH 198
Query: 173 GFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNC 232
             A D W++G  + +M +G  P+       T+   +     L   P +L+++A D L   
Sbjct: 199 NRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNL---PPYLTQEARDLLKKL 255
Query: 233 LRRDPKERWA-----ASQLLKHPFL 252
           L+R+   R       A ++  HPF 
Sbjct: 256 LKRNAASRLGAGPGDAGEVQAHPFF 280

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 82/282 (29%), Positives = 115/282 (40%), Gaps = 42/282 (14%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKS---TELPKSEFLQREQKFLSSLNSPHIV 58
           D+     +GQG+   V  A +      +A K    TE   S  L  E   L+SLN  ++V
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILS-EVMLLASLNHQYVV 65
Query: 59  GYKGC---------DVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQI 109
            Y             +T+   K    + MEY   GTL D IH               RQI
Sbjct: 66  RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQI 125
Query: 110 LQGLEYLHSNRVVHCDIKSRNILMAES-GAKIADFGCAK-----------------WESE 151
           L+ L Y+HS  ++H D+K  NI + ES   KI DFG AK                   S+
Sbjct: 126 LEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185
Query: 152 ALQSG-GTPMFMAPEVARGE-HQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKI- 208
            L S  GT M++A EV  G  H     D++++G    EM     P+    + + +L K+ 
Sbjct: 186 NLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI---YPFSTGMERVNILKKLR 242
Query: 209 AYSRELPEVPAF---LSKQANDFLSNCLRRDPKERWAASQLL 247
           + S E P  P F     K     +   +  DP +R  A  LL
Sbjct: 243 SVSIEFP--PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLL 282

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/175 (30%), Positives = 91/175 (52%), Gaps = 13/175 (7%)
Query: 89  EIHRNGGRLDESLIVSYTRQILQGLEYLHSN-RVVHCDIKSRNILMAESG-AKIADFGCA 146
           ++   G  + E ++      I++ LE+LHS   V+H D+K  N+L+   G  K  DFG +
Sbjct: 125 QVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKXCDFGIS 184
Query: 147 KW----ESEALQSGGTPMFMAPEVARGE--HQGFA--SDIWAVGCTVIEMASGGAPWPNA 198
            +     ++ + +G  P + APE    E   +G++  SDIW++G T IE+A    P+ + 
Sbjct: 185 GYLVDDVAKDIDAGCKP-YXAPERINPELNQKGYSVKSDIWSLGITXIELAILRFPYDSW 243
Query: 199 ADPMTVLYKIAYSRELPEVPA-FLSKQANDFLSNCLRRDPKERWAASQLLKHPFL 252
             P   L ++      P++PA   S +  DF S CL+++ KER    +L +HPF 
Sbjct: 244 GTPFQQLKQVV-EEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELXQHPFF 297

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 129/278 (46%), Gaps = 40/278 (14%)
Query: 8   TIGQGSSATVSLATSLR---SGDVFAAKSTELPKSEFLQR---------EQKFLSSL-NS 54
            +G G+   V L   +    +G ++A K   L K+  +Q+         E++ L  +  S
Sbjct: 61  VLGTGAYGKVFLVRKISGHDTGKLYAMKV--LKKATIVQKAKTTEHTRTERQVLEHIRQS 118
Query: 55  PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLE 114
           P +V       T  + KL  +L ++Y  GG L   + +   R  E  +  Y  +I+  LE
Sbjct: 119 PFLVTLHYAFQT--ETKL--HLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALE 173
Query: 115 YLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKW----ESE-ALQSGGTPMFMAPEVAR 168
           +LH   +++ DIK  NIL+  +G   + DFG +K     E+E A    GT  +MAP++ R
Sbjct: 174 HLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVR 233
Query: 169 GEHQGF--ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSREL----PEVPAFLS 222
           G   G   A D W++G  + E+ +G +P+    +  +   +   SR +    P  P  +S
Sbjct: 234 GGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS---QAEISRRILKSEPPYPQEMS 290
Query: 223 KQANDFLSNCLRRDPKERWA-----ASQLLKHPFLEEF 255
             A D +   L +DPK+R       A ++ +H F ++ 
Sbjct: 291 ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 328

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 69/244 (28%), Positives = 108/244 (44%), Gaps = 29/244 (11%)
Query: 28  VFAAKSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLN 87
           V A K   L   +  QRE + L++L   HIV + G  V  + + L+  +  EY   G LN
Sbjct: 50  VKALKDPTLAARKDFQREAELLTNLQHEHIVKFYG--VCGDGDPLI--MVFEYMKHGDLN 105
Query: 88  DEIHRNG---------------GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNIL 132
             +  +G               G L  S ++    QI  G+ YL S   VH D+ +RN L
Sbjct: 106 KFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCL 165
Query: 133 M-AESGAKIADFGCAK--WESEALQSGGTPMF----MAPEVARGEHQGFASDIWAVGCTV 185
           + A    KI DFG ++  + ++  + GG  M     M PE          SD+W+ G  +
Sbjct: 166 VGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVIL 225
Query: 186 IEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAAS 244
            E+ + G  PW   ++   V+  I   R L E P    K+  D +  C +R+P++R    
Sbjct: 226 WEIFTYGKQPWFQLSN-TEVIECITQGRVL-ERPRVCPKEVYDVMLGCWQREPQQRLNIK 283
Query: 245 QLLK 248
           ++ K
Sbjct: 284 EIYK 287

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 68/271 (25%), Positives = 113/271 (41%), Gaps = 22/271 (8%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL-----PKSEFLQREQKFLSSLNSPH 56
           D+   +TIG GS            G +   K  +       + + L  E   L  L  P+
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66
Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGR---LDESLIVSYTRQILQGL 113
           IV Y    +    N  +Y + MEY  GG L   I +       LDE  ++    Q+   L
Sbjct: 67  IVRYYD-RIIDRTNTTLY-IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 114 EYLH-----SNRVVHCDIKSRNILM-AESGAKIADFGCAKW----ESEALQSGGTPMFMA 163
           +  H      + V+H D+K  N+ +  +   K+ DFG A+     E  A +  GTP +M+
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVGTPYYMS 184
Query: 164 PEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSK 223
           PE          SDIW++GC + E+ +   P+  A     +  KI   +    +P   S 
Sbjct: 185 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPF-TAFSQKELAGKIREGK-FRRIPYRYSD 242
Query: 224 QANDFLSNCLRRDPKERWAASQLLKHPFLEE 254
           + N+ ++  L      R +  ++L++P + E
Sbjct: 243 ELNEIITRMLNLKDYHRPSVEEILENPLILE 273

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 117/274 (42%), Gaps = 39/274 (14%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDV--- 65
           IG G   +V        G ++A K ++ P +  +  EQ  L  + +  ++G     V   
Sbjct: 15  IGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVD-EQNALREVYAHAVLGQHSHVVRYF 73
Query: 66  ---TSEDNKLMYNLFMEYAPGGTLNDEI---HRNGGRLDESLIVSYTRQILQGLEYLHSN 119
                +D+ L+ N   EY  GG+L D I   +R      E+ +     Q+ +GL Y+HS 
Sbjct: 74  SAWAEDDHMLIQN---EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM 130
Query: 120 RVVHCDIKSRNILMAESGA--------------------KIADFGCAKWESEALQSGGTP 159
            +VH DIK  NI ++ +                      KI D G     S      G  
Sbjct: 131 SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDS 190
Query: 160 MFMAPEVARGEHQGF-ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVP 218
            F+A EV +  +     +DI+A+  TV+  A+G  P P   D     ++I   R LP +P
Sbjct: 191 RFLANEVLQENYTHLPKADIFALALTVV-XAAGAEPLPRNGDQW---HEIRQGR-LPRIP 245
Query: 219 AFLSKQANDFLSNCLRRDPKERWAASQLLKHPFL 252
             LS++  + L   +  DP+ R +A  L+KH  L
Sbjct: 246 QVLSQEFTELLKVMIHPDPERRPSAMALVKHSVL 279

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 36/100 (36%), Positives = 58/100 (58%), Gaps = 4/100 (4%)
Query: 101 LIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAE---SGAKIADFGCAKWESEALQSG- 156
           L+  +   ILQ L+ LH NR++HCD+K  NIL+ +   SG K+ DFG + +E + + +  
Sbjct: 201 LVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTXI 260
Query: 157 GTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWP 196
            +  + APEV  G   G   D+W++GC + E+ +G    P
Sbjct: 261 QSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLP 300

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 36/100 (36%), Positives = 58/100 (58%), Gaps = 4/100 (4%)
Query: 101 LIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAE---SGAKIADFGCAKWESEALQSG- 156
           L+  +   ILQ L+ LH NR++HCD+K  NIL+ +   SG K+ DFG + +E + + +  
Sbjct: 201 LVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTXI 260
Query: 157 GTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWP 196
            +  + APEV  G   G   D+W++GC + E+ +G    P
Sbjct: 261 QSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLP 300

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 93/210 (44%), Gaps = 28/210 (13%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKST----ELPKSEFLQREQKFLSSLNSPHI 57
           D   G  +G+G        T   +G+V   K      E  +  FL +E K +  L  P++
Sbjct: 11  DLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFL-KEVKVMRCLEHPNV 69
Query: 58  VGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLH 117
           + + G  V  +D +L  N   EY  GGTL   I     +   S  VS+ + I  G+ YLH
Sbjct: 70  LKFIG--VLYKDKRL--NFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH 125
Query: 118 SNRVVHCDIKSRNILMAES-GAKIADFGCA------KWESEALQS------------GGT 158
           S  ++H D+ S N L+ E+    +ADFG A      K + E L+S             G 
Sbjct: 126 SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGN 185
Query: 159 PMFMAPEVARGEHQGFASDIWAVGCTVIEM 188
           P +MAPE+  G       D+++ G  + E+
Sbjct: 186 PYWMAPEMINGRSYDEKVDVFSFGIVLCEI 215

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 117/274 (42%), Gaps = 39/274 (14%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDV--- 65
           IG G   +V        G ++A K ++ P +  +  EQ  L  + +  ++G     V   
Sbjct: 17  IGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVD-EQNALREVYAHAVLGQHSHVVRYF 75
Query: 66  ---TSEDNKLMYNLFMEYAPGGTLNDEI---HRNGGRLDESLIVSYTRQILQGLEYLHSN 119
                +D+ L+ N   EY  GG+L D I   +R      E+ +     Q+ +GL Y+HS 
Sbjct: 76  SAWAEDDHMLIQN---EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM 132
Query: 120 RVVHCDIKSRNILMAESGA--------------------KIADFGCAKWESEALQSGGTP 159
            +VH DIK  NI ++ +                      KI D G     S      G  
Sbjct: 133 SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDS 192
Query: 160 MFMAPEVARGEHQGF-ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVP 218
            F+A EV +  +     +DI+A+  TV+  A+G  P P   D     ++I   R LP +P
Sbjct: 193 RFLANEVLQENYTHLPKADIFALALTVV-CAAGAEPLPRNGDQW---HEIRQGR-LPRIP 247
Query: 219 AFLSKQANDFLSNCLRRDPKERWAASQLLKHPFL 252
             LS++  + L   +  DP+ R +A  L+KH  L
Sbjct: 248 QVLSQEFTELLKVMIHPDPERRPSAMALVKHSVL 281

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 117/274 (42%), Gaps = 39/274 (14%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDV--- 65
           IG G   +V        G ++A K ++ P +  +  EQ  L  + +  ++G     V   
Sbjct: 19  IGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVD-EQNALREVYAHAVLGQHSHVVRYF 77
Query: 66  ---TSEDNKLMYNLFMEYAPGGTLNDEI---HRNGGRLDESLIVSYTRQILQGLEYLHSN 119
                +D+ L+ N   EY  GG+L D I   +R      E+ +     Q+ +GL Y+HS 
Sbjct: 78  SAWAEDDHMLIQN---EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM 134
Query: 120 RVVHCDIKSRNILMAESGA--------------------KIADFGCAKWESEALQSGGTP 159
            +VH DIK  NI ++ +                      KI D G     S      G  
Sbjct: 135 SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDS 194
Query: 160 MFMAPEVARGEHQGF-ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVP 218
            F+A EV +  +     +DI+A+  TV+  A+G  P P   D     ++I   R LP +P
Sbjct: 195 RFLANEVLQENYTHLPKADIFALALTVV-CAAGAEPLPRNGDQW---HEIRQGR-LPRIP 249
Query: 219 AFLSKQANDFLSNCLRRDPKERWAASQLLKHPFL 252
             LS++  + L   +  DP+ R +A  L+KH  L
Sbjct: 250 QVLSQEFTELLKVMIHPDPERRPSAMALVKHSVL 283

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 69/263 (26%), Positives = 117/263 (44%), Gaps = 25/263 (9%)
Query: 45  EQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVS 104
           E   ++ + SP++    G  +TS        L  +  P G L D +  N GRL    +++
Sbjct: 69  EAYVMAGVGSPYVSRLLGICLTST-----VQLVTQLMPYGCLLDHVRENRGRLGSQDLLN 123
Query: 105 YTRQILQGLEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKW----ESEALQSGG-T 158
           +  QI +G+ YL   R+VH D+ +RN+L+ + +  KI DFG A+     E+E    GG  
Sbjct: 124 WCMQIAKGMSYLEDVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKV 183
Query: 159 PM-FMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEV 217
           P+ +MA E          SD+W+ G TV E+ + GA   +      +   +     LP+ 
Sbjct: 184 PIKWMALESILRRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQ- 242
Query: 218 PAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQ------IQESNCSPTS 271
           P   +      +  C   D + R    +L+      EF    +       IQ  +  P S
Sbjct: 243 PPICTIDVYMIMVKCWMIDSECRPRFRELVS-----EFSRMARDPQRFVVIQNEDLGPAS 297
Query: 272 ILDQGIWNSVEETEESLGNLIHS 294
            LD   + S+ E ++ +G+L+ +
Sbjct: 298 PLDSTFYRSLLE-DDDMGDLVDA 319

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 117/274 (42%), Gaps = 39/274 (14%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDV--- 65
           IG G   +V        G ++A K ++ P +  +  EQ  L  + +  ++G     V   
Sbjct: 17  IGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVD-EQNALREVYAHAVLGQHSHVVRYF 75
Query: 66  ---TSEDNKLMYNLFMEYAPGGTLNDEI---HRNGGRLDESLIVSYTRQILQGLEYLHSN 119
                +D+ L+ N   EY  GG+L D I   +R      E+ +     Q+ +GL Y+HS 
Sbjct: 76  SAWAEDDHMLIQN---EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM 132
Query: 120 RVVHCDIKSRNILMAESGA--------------------KIADFGCAKWESEALQSGGTP 159
            +VH DIK  NI ++ +                      KI D G     S      G  
Sbjct: 133 SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDS 192
Query: 160 MFMAPEVARGEHQGF-ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVP 218
            F+A EV +  +     +DI+A+  TV+  A+G  P P   D     ++I   R LP +P
Sbjct: 193 RFLANEVLQENYTHLPKADIFALALTVV-CAAGAEPLPRNGDQW---HEIRQGR-LPRIP 247
Query: 219 AFLSKQANDFLSNCLRRDPKERWAASQLLKHPFL 252
             LS++  + L   +  DP+ R +A  L+KH  L
Sbjct: 248 QVLSQEFTELLKVMIHPDPERRPSAMALVKHSVL 281

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 36/100 (36%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 101 LIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAE---SGAKIADFGCAKWESEALQSG- 156
           L+  +   ILQ L+ LH NR++HCD+K  NIL+ +   SG K+ DFG + +E + +    
Sbjct: 201 LVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYXXI 260
Query: 157 GTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWP 196
            +  + APEV  G   G   D+W++GC + E+ +G    P
Sbjct: 261 QSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLP 300

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 102/227 (44%), Gaps = 34/227 (14%)
Query: 42  LQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGT--LNDEIHRNGGRLDE 99
           +++E + L  L   +++  +  DV   + K    + MEY   G   + D +     R   
Sbjct: 53  VKKEIQLLRRLRHKNVI--QLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK--RFPV 108
Query: 100 SLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQ---- 154
                Y  Q++ GLEYLHS  +VH DIK  N+L+   G  KI+  G A    EAL     
Sbjct: 109 CQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVA----EALHPFAA 164
Query: 155 ------SGGTPMFMAPEVARG--EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLY 206
                 S G+P F  PE+A G     GF  DIW+ G T+  + +G   +P   D +  L+
Sbjct: 165 DDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGL--YPFEGDNIYKLF 222
Query: 207 ----KIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKH 249
               K +Y+     +P       +D L   L  +P +R++  Q+ +H
Sbjct: 223 ENIGKGSYA-----IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 64/197 (32%), Positives = 87/197 (44%), Gaps = 21/197 (10%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSE-----FLQREQKFLSSLNS---PHIVGY 60
           IG G+  TV  A    SG   A KS  +P  E        RE   L  L +   P++V  
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 61  KG-CDVTSEDNKLMYNLFMEYAPGG--TLNDEIHRNGGRLDESLIVSYTRQILQGLEYLH 117
              C  +  D ++   L  E+      T  D+    G  L    I    RQ L+GL++LH
Sbjct: 72  MDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG--LPAETIKDLMRQFLRGLDFLH 129
Query: 118 SNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSGGTPM-----FMAPEVARGEH 171
           +N +VH D+K  NIL+   G  K+ADFG A+  S   Q    P+     + APEV     
Sbjct: 130 ANCIVHRDLKPENILVTSGGTVKLADFGLARIYS--YQMALAPVVVTLWYRAPEVLLQST 187
Query: 172 QGFASDIWAVGCTVIEM 188
                D+W+VGC   EM
Sbjct: 188 YATPVDMWSVGCIFAEM 204

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 87/200 (43%), Gaps = 24/200 (12%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ--------REQKFLSSLNS---PHI 57
           IG G+  TV  A    SG   A KS  +P              RE   L  L +   P++
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76
Query: 58  VGYKG-CDVTSEDNKLMYNLFMEYAPGG--TLNDEIHRNGGRLDESLIVSYTRQILQGLE 114
           V     C  +  D ++   L  E+      T  D+    G  L    I    RQ L+GL+
Sbjct: 77  VRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG--LPAETIKDLMRQFLRGLD 134
Query: 115 YLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSGGTPM-----FMAPEVAR 168
           +LH+N +VH D+K  NIL+   G  K+ADFG A+  S   Q   TP+     + APEV  
Sbjct: 135 FLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYS--YQMALTPVVVTLWYRAPEVLL 192
Query: 169 GEHQGFASDIWAVGCTVIEM 188
                   D+W+VGC   EM
Sbjct: 193 QSTYATPVDMWSVGCIFAEM 212

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 62/195 (31%), Positives = 86/195 (44%), Gaps = 17/195 (8%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSE-----FLQREQKFLSSLNS---PHIVGY 60
           IG G+  TV  A    SG   A KS  +P  E        RE   L  L +   P++V  
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 61  KG-CDVTSEDNKLMYNLFMEYAPGG--TLNDEIHRNGGRLDESLIVSYTRQILQGLEYLH 117
              C  +  D ++   L  E+      T  D+    G  L    I    RQ L+GL++LH
Sbjct: 72  MDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG--LPAETIKDLMRQFLRGLDFLH 129
Query: 118 SNRVVHCDIKSRNILMAESG-AKIADFGCAK---WESEALQSGGTPMFMAPEVARGEHQG 173
           +N +VH D+K  NIL+   G  K+ADFG A+   ++        T  + APEV       
Sbjct: 130 ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVVTLWYRAPEVLLQSTYA 189
Query: 174 FASDIWAVGCTVIEM 188
              D+W+VGC   EM
Sbjct: 190 TPVDMWSVGCIFAEM 204

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 64/197 (32%), Positives = 87/197 (44%), Gaps = 21/197 (10%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSE-----FLQREQKFLSSLNS---PHIVGY 60
           IG G+  TV  A    SG   A KS  +P  E        RE   L  L +   P++V  
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 61  KG-CDVTSEDNKLMYNLFMEYAPGG--TLNDEIHRNGGRLDESLIVSYTRQILQGLEYLH 117
              C  +  D ++   L  E+      T  D+    G  L    I    RQ L+GL++LH
Sbjct: 72  MDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG--LPAETIKDLMRQFLRGLDFLH 129
Query: 118 SNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSGGTPM-----FMAPEVARGEH 171
           +N +VH D+K  NIL+   G  K+ADFG A+  S   Q    P+     + APEV     
Sbjct: 130 ANCIVHRDLKPENILVTSGGTVKLADFGLARIYS--YQMALDPVVVTLWYRAPEVLLQST 187
Query: 172 QGFASDIWAVGCTVIEM 188
                D+W+VGC   EM
Sbjct: 188 YATPVDMWSVGCIFAEM 204

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 64/249 (25%), Positives = 113/249 (45%), Gaps = 15/249 (6%)
Query: 8   TIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTS 67
            +G+G+   V  A   R+ DV   +     + +    E + LS +N P+IV   G  +  
Sbjct: 15  VVGRGAFGVVCKA-KWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLNP 73
Query: 68  EDNKLMYNLFMEYAPGGTLNDEIH--RNGGRLDESLIVSYTRQILQGLEYLHSNR---VV 122
                   L MEYA GG+L + +H          +  +S+  Q  QG+ YLHS +   ++
Sbjct: 74  ------VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 127
Query: 123 HCDIKSRNILMAESGA--KIADFGCA-KWESEALQSGGTPMFMAPEVARGEHQGFASDIW 179
           H D+K  N+L+   G   KI DFG A   ++    + G+  +MAPEV  G +     D++
Sbjct: 128 HRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVF 187
Query: 180 AVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKE 239
           + G  + E+ +   P+     P   +    ++   P +   L K     ++ C  +DP +
Sbjct: 188 SWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQ 247
Query: 240 RWAASQLLK 248
           R +  +++K
Sbjct: 248 RPSMEEIVK 256

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 76/264 (28%), Positives = 118/264 (44%), Gaps = 24/264 (9%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKS----EFLQREQKFLSSLNSPHIVGYKGCD 64
           +GQG    V + T   +G    A  T  P +     FLQ E + +  L    +V      
Sbjct: 26  LGQGCFGEVWMGTW--NGTTRVAIKTLKPGTMSPEAFLQ-EAQVMKKLRHEKLVQLYA-- 80
Query: 65  VTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGR-LDESLIVSYTRQILQGLEYLHSNRVVH 123
           V SE+      + MEY   G L D +    G+ L    +V    QI  G+ Y+     VH
Sbjct: 81  VVSEEP---IYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 137
Query: 124 CDIKSRNILMAESGA-KIADFGCAKW----ESEALQSGGTPM-FMAPEVARGEHQGFASD 177
            D+++ NIL+ E+   K+ADFG A+     E  A Q    P+ + APE A        SD
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 178 IWAVGCTVIEMASGG-APWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRD 236
           +W+ G  + E+ + G  P+P   +   VL ++     +P  P    +  +D +  C R+D
Sbjct: 198 VWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMP-CPPECPESLHDLMCQCWRKD 255
Query: 237 PKERWAASQLLKHPFLEEFCSCTK 260
           P+ER     L    FLE++ + T+
Sbjct: 256 PEERPTFEYL--QAFLEDYFTSTE 277

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 100/211 (47%), Gaps = 27/211 (12%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQR--------EQKFLSSLN 53
           D+     +G+GS   V LA    + +++A K   L K   +Q         E++ L+ L+
Sbjct: 20  DFNFLMVLGKGSFGKVMLADRKGTEELYAIKI--LKKDVVIQDDDVECTMVEKRVLALLD 77
Query: 54  SP-HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQG 112
            P  +     C  T   ++L +   MEY  GG L   I + G +  E   V Y  +I  G
Sbjct: 78  KPPFLTQLHSCFQTV--DRLYF--VMEYVNGGDLMYHIQQVG-KFKEPQAVFYAAEISIG 132
Query: 113 LEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKWESEALQSG-------GTPMFMAP 164
           L +LH   +++ D+K  N+++ +E   KIADFG  K   E +  G       GTP ++AP
Sbjct: 133 LFFLHKRGIIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMMDGVTTREFCGTPDYIAP 189
Query: 165 EVARGEHQGFASDIWAVGCTVIEMASGGAPW 195
           E+   +  G + D WA G  + EM +G  P+
Sbjct: 190 EIIAYQPYGKSVDWWAYGVLLYEMLAGQPPF 220

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 78/273 (28%), Positives = 122/273 (44%), Gaps = 37/273 (13%)
Query: 8   TIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGYKG----- 62
            IG+G+ + V++    ++G V+A K     K + L+R +  +S       V   G     
Sbjct: 68  VIGRGAFSEVAVVKMKQTGQVYAMKIMN--KWDMLKRGE--VSCFREERDVLVNGDRRWI 123
Query: 63  --CDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNR 120
                  +D   +Y L MEY  GG L   + + G R+   +   Y  +I+  ++ +H   
Sbjct: 124 TQLHFAFQDENYLY-LVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG 182
Query: 121 VVHCDIKSRNILMAESG-AKIADFG-CAKWESE----ALQSGGTPMFMAPEVARGEHQGF 174
            VH DIK  NIL+   G  ++ADFG C K  ++    +L + GTP +++PE+ +    G 
Sbjct: 183 YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGP 242
Query: 175 AS-------DIWAVGCTVIEMASGGAPWPNAADPMTVLY-KIAYSRE---LPEVPAFLSK 223
            +       D WA+G    EM  G  P+   AD     Y KI + +E   LP V   + +
Sbjct: 243 GTGSYGPECDWWALGVFAYEMFYGQTPF--YADSTAETYGKIVHYKEHLSLPLVDEGVPE 300
Query: 224 QANDFLSNCLRRDPKE----RWAASQLLKHPFL 252
           +A DF+   L   P E    R  A     HPF 
Sbjct: 301 EARDFIQRLLC--PPETRLGRGGAGDFRTHPFF 331

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/284 (23%), Positives = 120/284 (42%), Gaps = 39/284 (13%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ-----REQKFLSSLNSPHIVGYKGC 63
           +G G+  +V  A   ++G   A K    P    +      RE + L  +   +++G    
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 64  DVTSEDNKLMYNLFM-EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
              +   +   ++++  +  G  LN+ +     +L +  +     QIL+GL+Y+HS  ++
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIV--KSQKLTDDHVQFLIYQILRGLKYIHSADII 147
Query: 123 HCDIKSRNILMAE-SGAKIADFG-CAKWESEALQSGGTPMFMAPEVARG-EHQGFASDIW 179
           H D+K  N+ + E S  KI DFG C   + E      T  + APE+     H     DIW
Sbjct: 148 HRDLKPSNLAVNEDSELKILDFGLCRHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 207
Query: 180 AVGCTVIEMASGGAPWP--NAADPMTVLYKIA------------------YSRELPEVP- 218
           +VGC + E+ +G   +P  +  D + ++ ++                   Y + L ++P 
Sbjct: 208 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 267
Query: 219 -----AFLSKQ--ANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
                 F+     A D L   L  D  +R  A+Q L H +  ++
Sbjct: 268 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/249 (25%), Positives = 113/249 (45%), Gaps = 15/249 (6%)
Query: 8   TIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTS 67
            +G+G+   V  A   R+ DV   +     + +    E + LS +N P+IV   G  +  
Sbjct: 16  VVGRGAFGVVCKA-KWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLNP 74
Query: 68  EDNKLMYNLFMEYAPGGTLNDEIH--RNGGRLDESLIVSYTRQILQGLEYLHSNR---VV 122
                   L MEYA GG+L + +H          +  +S+  Q  QG+ YLHS +   ++
Sbjct: 75  ------VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 128
Query: 123 HCDIKSRNILMAESGA--KIADFGCA-KWESEALQSGGTPMFMAPEVARGEHQGFASDIW 179
           H D+K  N+L+   G   KI DFG A   ++    + G+  +MAPEV  G +     D++
Sbjct: 129 HRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVF 188
Query: 180 AVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKE 239
           + G  + E+ +   P+     P   +    ++   P +   L K     ++ C  +DP +
Sbjct: 189 SWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQ 248
Query: 240 RWAASQLLK 248
           R +  +++K
Sbjct: 249 RPSMEEIVK 257

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 81/282 (28%), Positives = 114/282 (40%), Gaps = 42/282 (14%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKS---TELPKSEFLQREQKFLSSLNSPHIV 58
           D+     +GQG+   V  A +      +A K    TE   S  L  E   L+SLN  ++V
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILS-EVMLLASLNHQYVV 65
Query: 59  GYKGC---------DVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQI 109
            Y             +T+   K    + MEY    TL D IH               RQI
Sbjct: 66  RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQI 125
Query: 110 LQGLEYLHSNRVVHCDIKSRNILMAES-GAKIADFGCAK-----------------WESE 151
           L+ L Y+HS  ++H D+K  NI + ES   KI DFG AK                   S+
Sbjct: 126 LEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185
Query: 152 ALQSG-GTPMFMAPEVARGE-HQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKI- 208
            L S  GT M++A EV  G  H     D++++G    EM     P+    + + +L K+ 
Sbjct: 186 NLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI---YPFSTGMERVNILKKLR 242
Query: 209 AYSRELPEVPAF---LSKQANDFLSNCLRRDPKERWAASQLL 247
           + S E P  P F     K     +   +  DP +R  A  LL
Sbjct: 243 SVSIEFP--PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLL 282

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/271 (25%), Positives = 112/271 (41%), Gaps = 22/271 (8%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL-----PKSEFLQREQKFLSSLNSPH 56
           D+   +TIG GS            G +   K  +       + + L  E   L  L  P+
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66
Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGR---LDESLIVSYTRQILQGL 113
           IV Y    +    N  +Y + MEY  GG L   I +       LDE  ++    Q+   L
Sbjct: 67  IVRYYD-RIIDRTNTTLY-IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 114 EYLH-----SNRVVHCDIKSRNILM-AESGAKIADFGCAKW----ESEALQSGGTPMFMA 163
           +  H      + V+H D+K  N+ +  +   K+ DFG A+      S A    GTP +M+
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMS 184
Query: 164 PEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSK 223
           PE          SDIW++GC + E+ +   P+  A     +  KI   +    +P   S 
Sbjct: 185 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPF-TAFSQKELAGKIREGK-FRRIPYRYSD 242
Query: 224 QANDFLSNCLRRDPKERWAASQLLKHPFLEE 254
           + N+ ++  L      R +  ++L++P + E
Sbjct: 243 ELNEIITRMLNLKDYHRPSVEEILENPLILE 273

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/271 (25%), Positives = 112/271 (41%), Gaps = 22/271 (8%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL-----PKSEFLQREQKFLSSLNSPH 56
           D+   +TIG GS            G +   K  +       + + L  E   L  L  P+
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66
Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGR---LDESLIVSYTRQILQGL 113
           IV Y    +    N  +Y + MEY  GG L   I +       LDE  ++    Q+   L
Sbjct: 67  IVRYYD-RIIDRTNTTLY-IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 114 EYLH-----SNRVVHCDIKSRNILM-AESGAKIADFGCAKW----ESEALQSGGTPMFMA 163
           +  H      + V+H D+K  N+ +  +   K+ DFG A+      S A    GTP +M+
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMS 184
Query: 164 PEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSK 223
           PE          SDIW++GC + E+ +   P+  A     +  KI   +    +P   S 
Sbjct: 185 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPF-TAFSQKELAGKIREGK-FRRIPYRYSD 242
Query: 224 QANDFLSNCLRRDPKERWAASQLLKHPFLEE 254
           + N+ ++  L      R +  ++L++P + E
Sbjct: 243 ELNEIITRMLNLKDYHRPSVEEILENPLILE 273

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 101/222 (45%), Gaps = 19/222 (8%)
Query: 31  AKSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEI 90
           ++ TE+ + E   RE   +  LN P+++   G  +  E    + ++ + Y   G L   I
Sbjct: 58  SRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEG---LPHVLLPYMCHGDLLQFI 114
Query: 91  ---HRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES-GAKIADFGCA 146
               RN    D   ++S+  Q+ +G+EYL   + VH D+ +RN ++ ES   K+ADFG A
Sbjct: 115 RSPQRNPTVKD---LISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLA 171
Query: 147 K-------WESEALQSGGTPM-FMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNA 198
           +       +  +  +    P+ + A E  +       SD+W+ G  + E+ + GAP    
Sbjct: 172 RDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRH 231
Query: 199 ADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKER 240
            DP  + + +A  R LP+ P +        +  C   DP  R
Sbjct: 232 IDPFDLTHFLAQGRRLPQ-PEYCPDSLYQVMQQCWEADPAVR 272

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/264 (28%), Positives = 119/264 (45%), Gaps = 24/264 (9%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKS----EFLQREQKFLSSLNSPHIVGYKGCD 64
           +GQG    V + T   +G    A  T  P +     FLQ E + +  L    +V      
Sbjct: 26  LGQGCFGEVWMGTW--NGTTRVAIKTLKPGTMSPEAFLQ-EAQVMKKLRHEKLVQLYA-- 80
Query: 65  VTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGR-LDESLIVSYTRQILQGLEYLHSNRVVH 123
           V SE+      + +EY   G+L D +    G+ L    +V    QI  G+ Y+     VH
Sbjct: 81  VVSEEP---IYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 137
Query: 124 CDIKSRNILMAESGA-KIADFGCAKW----ESEALQSGGTPM-FMAPEVARGEHQGFASD 177
            D+++ NIL+ E+   K+ADFG A+     E  A Q    P+ + APE A        SD
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 178 IWAVGCTVIEMASGG-APWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRD 236
           +W+ G  + E+ + G  P+P   +   VL ++     +P  P    +  +D +  C R+D
Sbjct: 198 VWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMP-CPPECPESLHDLMCQCWRKD 255
Query: 237 PKERWAASQLLKHPFLEEFCSCTK 260
           P+ER     L    FLE++ + T+
Sbjct: 256 PEERPTFEYL--QAFLEDYFTSTE 277

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 100/208 (48%), Gaps = 21/208 (10%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQRE-------QKFLSSL-- 52
           D+     +G+GS   V L+    + +++A K   L K   +Q +       +K + +L  
Sbjct: 21  DFNFLMVLGKGSFGKVMLSERKGTDELYAVKI--LKKDVVIQDDDVECTMVEKRVLALPG 78
Query: 53  NSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQG 112
             P +     C  T   ++L +   MEY  GG L   I + G R  E   V Y  +I  G
Sbjct: 79  KPPFLTQLHSCFQTM--DRLYF--VMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIG 133
Query: 113 LEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAK---WESEALQSG-GTPMFMAPEVA 167
           L +L S  +++ D+K  N+++ +E   KIADFG  K   W+    +   GTP ++APE+ 
Sbjct: 134 LFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEII 193
Query: 168 RGEHQGFASDIWAVGCTVIEMASGGAPW 195
             +  G + D WA G  + EM +G AP+
Sbjct: 194 AYQPYGKSVDWWAFGVLLYEMLAGQAPF 221

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/264 (28%), Positives = 119/264 (45%), Gaps = 24/264 (9%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKS----EFLQREQKFLSSLNSPHIVGYKGCD 64
           +GQG    V + T   +G    A  T  P +     FLQ E + +  L    +V      
Sbjct: 26  LGQGCFGEVWMGTW--NGTTRVAIKTLKPGTMSPEAFLQ-EAQVMKKLRHEKLVQLYA-- 80
Query: 65  VTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGR-LDESLIVSYTRQILQGLEYLHSNRVVH 123
           V SE+      + +EY   G+L D +    G+ L    +V    QI  G+ Y+     VH
Sbjct: 81  VVSEEP---IYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 137
Query: 124 CDIKSRNILMAESGA-KIADFGCAKW----ESEALQSGGTPM-FMAPEVARGEHQGFASD 177
            D+++ NIL+ E+   K+ADFG A+     E  A Q    P+ + APE A        SD
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 178 IWAVGCTVIEMASGG-APWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRD 236
           +W+ G  + E+ + G  P+P   +   VL ++     +P  P    +  +D +  C R+D
Sbjct: 198 VWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMP-CPPECPESLHDLMCQCWRKD 255
Query: 237 PKERWAASQLLKHPFLEEFCSCTK 260
           P+ER     L    FLE++ + T+
Sbjct: 256 PEERPTFEYL--QAFLEDYFTSTE 277

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 84/155 (54%), Gaps = 9/155 (5%)
Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAK---WESEALQSGG 157
           ++SY+ Q+ +G+E+L S + +H D+ +RNIL++E+   KI DFG A+      + ++ G 
Sbjct: 201 LISYSFQVARGMEFLSSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGD 260
Query: 158 TPM---FMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRE 213
           T +   +MAPE    +     SD+W+ G  + E+ S GG+P+P          ++     
Sbjct: 261 TRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYPGVQMDEDFCSRLREGMR 320
Query: 214 LPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLK 248
           +   P + + +    + +C  RDPKER   ++L++
Sbjct: 321 M-RAPEYSTPEIYQIMLDCWHRDPKERPRFAELVE 354

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/284 (23%), Positives = 121/284 (42%), Gaps = 39/284 (13%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ-----REQKFLSSLNSPHIVGYKGC 63
           +G G+  +V  A   ++G   A K    P    +      RE + L  +   +++G    
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 64  DVTSEDNKLMYNLFM-EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
              +   +   ++++  +  G  LN+ +     +L +  +     QIL+GL+Y+HS  ++
Sbjct: 92  FTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQFLIYQILRGLKYIHSADII 149
Query: 123 HCDIKSRNILMAE-SGAKIADFGCAKW-ESEALQSGGTPMFMAPEVARG-EHQGFASDIW 179
           H D+K  N+ + E S  KI DFG A+  + E      T  + APE+     H     DIW
Sbjct: 150 HRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 209
Query: 180 AVGCTVIEMASGGAPWP--NAADPMTVLYKIA------------------YSRELPEVP- 218
           +VGC + E+ +G   +P  +  D + ++ ++                   Y + L ++P 
Sbjct: 210 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 269
Query: 219 -----AFLSKQ--ANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
                 F+     A D L   L  D  +R  A+Q L H +  ++
Sbjct: 270 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 313

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 15/208 (7%)
Query: 1   MDWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGY 60
           + +T    IG GS   V  A    SG++ A K   L    F  RE + +  L+  +IV  
Sbjct: 20  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNRELQIMRKLDHCNIVRL 78
Query: 61  KGCDVTSEDNK--LMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTR----QILQGLE 114
           +    +S + K  +  NL ++Y P       + R+  R  ++L V Y +    Q+ + L 
Sbjct: 79  RYFFYSSGEKKDVVYLNLVLDYVPETVY--RVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 115 YLHSNRVVHCDIKSRNILMAESGA--KIADFGCAKWESEA---LQSGGTPMFMAPEVARG 169
           Y+HS  + H DIK +N+L+    A  K+ DFG AK        +    +  + APE+  G
Sbjct: 137 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFG 196
Query: 170 EHQGFAS-DIWAVGCTVIEMASGGAPWP 196
                +S D+W+ GC + E+  G   +P
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPIFP 224

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/284 (23%), Positives = 121/284 (42%), Gaps = 39/284 (13%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ-----REQKFLSSLNSPHIVGYKGC 63
           +G G+  +V  A   ++G   A K    P    +      RE + L  +   +++G    
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 64  DVTSEDNKLMYNLFM-EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
              +   +   ++++  +  G  LN+ +     +L +  +     QIL+GL+Y+HS  ++
Sbjct: 96  FTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQFLIYQILRGLKYIHSADII 153
Query: 123 HCDIKSRNILMAE-SGAKIADFGCAKW-ESEALQSGGTPMFMAPEVARG-EHQGFASDIW 179
           H D+K  N+ + E S  KI DFG A+  + E      T  + APE+     H     DIW
Sbjct: 154 HRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 213
Query: 180 AVGCTVIEMASGGAPWP--NAADPMTVLYKIA------------------YSRELPEVP- 218
           +VGC + E+ +G   +P  +  D + ++ ++                   Y + L ++P 
Sbjct: 214 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 273
Query: 219 -----AFLSKQ--ANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
                 F+     A D L   L  D  +R  A+Q L H +  ++
Sbjct: 274 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 317

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 15/208 (7%)
Query: 1   MDWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGY 60
           + +T    IG GS   V  A    SG++ A K   L    F  RE + +  L+  +IV  
Sbjct: 20  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNRELQIMRKLDHCNIVRL 78
Query: 61  KGCDVTSEDNK--LMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTR----QILQGLE 114
           +    +S + K  +  NL ++Y P       + R+  R  ++L V Y +    Q+ + L 
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVPETVY--RVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 115 YLHSNRVVHCDIKSRNILMAESGA--KIADFGCAKWESEA---LQSGGTPMFMAPEVARG 169
           Y+HS  + H DIK +N+L+    A  K+ DFG AK        +    +  + APE+  G
Sbjct: 137 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFG 196
Query: 170 EHQGFAS-DIWAVGCTVIEMASGGAPWP 196
                +S D+W+ GC + E+  G   +P
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPIFP 224

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 15/208 (7%)
Query: 1   MDWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGY 60
           + +T    IG GS   V  A    SG++ A K   L    F  RE + +  L+  +IV  
Sbjct: 28  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNRELQIMRKLDHCNIVRL 86
Query: 61  KGCDVTSEDNK--LMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTR----QILQGLE 114
           +    +S + K  +  NL ++Y P       + R+  R  ++L V Y +    Q+ + L 
Sbjct: 87  RYFFYSSGEKKDEVYLNLVLDYVPETVY--RVARHYSRAKQTLPVIYVKLYMYQLFRSLA 144
Query: 115 YLHSNRVVHCDIKSRNILMAESGA--KIADFGCAKWESEA---LQSGGTPMFMAPEVARG 169
           Y+HS  + H DIK +N+L+    A  K+ DFG AK        +    +  + APE+  G
Sbjct: 145 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFG 204
Query: 170 EHQGFAS-DIWAVGCTVIEMASGGAPWP 196
                +S D+W+ GC + E+  G   +P
Sbjct: 205 ATDYTSSIDVWSAGCVLAELLLGQPIFP 232

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 15/208 (7%)
Query: 1   MDWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGY 60
           + +T    IG GS   V  A    SG++ A K   L    F  RE + +  L+  +IV  
Sbjct: 20  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNRELQIMRKLDHCNIVRL 78
Query: 61  KGCDVTSEDNK--LMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTR----QILQGLE 114
           +    +S + K  +  NL ++Y P       + R+  R  ++L V Y +    Q+ + L 
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVPETVY--RVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 115 YLHSNRVVHCDIKSRNILMAESGA--KIADFGCAKWESEA---LQSGGTPMFMAPEVARG 169
           Y+HS  + H DIK +N+L+    A  K+ DFG AK        +    +  + APE+  G
Sbjct: 137 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFG 196
Query: 170 EHQGFAS-DIWAVGCTVIEMASGGAPWP 196
                +S D+W+ GC + E+  G   +P
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPIFP 224

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/284 (22%), Positives = 120/284 (42%), Gaps = 39/284 (13%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ-----REQKFLSSLNSPHIVGYKGC 63
           +G G+  +V  A   ++G   A K    P    +      RE + L  +   +++G    
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 64  DVTSEDNKLMYNLFM-EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
              +   +   ++++  +  G  LN+ +     +L +  +     QIL+GL+Y+HS  ++
Sbjct: 86  FTPARSLEEFNDVYLVTHLMGADLNNIV--KCAKLTDDHVQFLIYQILRGLKYIHSADII 143
Query: 123 HCDIKSRNILMAES-GAKIADFGCAKW-ESEALQSGGTPMFMAPEVARG-EHQGFASDIW 179
           H D+K  N+ + E    KI DFG A+  + E      T  + APE+     H     DIW
Sbjct: 144 HRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 203
Query: 180 AVGCTVIEMASGGAPWP--NAADPMTVLYKIA------------------YSRELPEVP- 218
           +VGC + E+ +G   +P  +  D + ++ ++                   Y + L ++P 
Sbjct: 204 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPK 263
Query: 219 -----AFLSKQ--ANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
                 F+     A D L   L  D  +R  A+Q L H +  ++
Sbjct: 264 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 15/208 (7%)
Query: 1   MDWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGY 60
           + +T    IG GS   V  A    SG++ A K   L    F  RE + +  L+  +IV  
Sbjct: 39  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNRELQIMRKLDHCNIVRL 97
Query: 61  KGCDVTSEDNK--LMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTR----QILQGLE 114
           +    +S + K  +  NL ++Y P       + R+  R  ++L V Y +    Q+ + L 
Sbjct: 98  RYFFYSSGEKKDEVYLNLVLDYVPETVY--RVARHYSRAKQTLPVIYVKLYMYQLFRSLA 155
Query: 115 YLHSNRVVHCDIKSRNILMAESGA--KIADFGCAKWESEA---LQSGGTPMFMAPEVARG 169
           Y+HS  + H DIK +N+L+    A  K+ DFG AK        +    +  + APE+  G
Sbjct: 156 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFG 215
Query: 170 EHQGFAS-DIWAVGCTVIEMASGGAPWP 196
                +S D+W+ GC + E+  G   +P
Sbjct: 216 ATDYTSSIDVWSAGCVLAELLLGQPIFP 243

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 15/208 (7%)
Query: 1   MDWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGY 60
           + +T    IG GS   V  A    SG++ A K   L    F  RE + +  L+  +IV  
Sbjct: 21  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNRELQIMRKLDHCNIVRL 79
Query: 61  KGCDVTSEDNK--LMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTR----QILQGLE 114
           +    +S + K  +  NL ++Y P       + R+  R  ++L V Y +    Q+ + L 
Sbjct: 80  RYFFYSSGEKKDEVYLNLVLDYVPETVY--RVARHYSRAKQTLPVIYVKLYMYQLFRSLA 137
Query: 115 YLHSNRVVHCDIKSRNILMAESGA--KIADFGCAKWESEA---LQSGGTPMFMAPEVARG 169
           Y+HS  + H DIK +N+L+    A  K+ DFG AK        +    +  + APE+  G
Sbjct: 138 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFG 197
Query: 170 EHQGFAS-DIWAVGCTVIEMASGGAPWP 196
                +S D+W+ GC + E+  G   +P
Sbjct: 198 ATDYTSSIDVWSAGCVLAELLLGQPIFP 225

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 15/208 (7%)
Query: 1   MDWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGY 60
           + +T    IG GS   V  A    SG++ A K   L    F  RE + +  L+  +IV  
Sbjct: 20  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQGKAFKNRELQIMRKLDHCNIVRL 78
Query: 61  KGCDVTSEDNK--LMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTR----QILQGLE 114
           +    +S + K  +  NL ++Y P       + R+  R  ++L V Y +    Q+ + L 
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVPATVY--RVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 115 YLHSNRVVHCDIKSRNILMAESGA--KIADFGCAKWESEA---LQSGGTPMFMAPEVARG 169
           Y+HS  + H DIK +N+L+    A  K+ DFG AK        +    +  + APE+  G
Sbjct: 137 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFG 196
Query: 170 EHQGFAS-DIWAVGCTVIEMASGGAPWP 196
                +S D+W+ GC + E+  G   +P
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPIFP 224

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 15/208 (7%)
Query: 1   MDWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGY 60
           + +T    IG GS   V  A    SG++ A K   L    F  RE + +  L+  +IV  
Sbjct: 32  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNRELQIMRKLDHCNIVRL 90
Query: 61  KGCDVTSEDNK--LMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTR----QILQGLE 114
           +    +S + K  +  NL ++Y P       + R+  R  ++L V Y +    Q+ + L 
Sbjct: 91  RYFFYSSGEKKDEVYLNLVLDYVPETVY--RVARHYSRAKQTLPVIYVKLYMYQLFRSLA 148
Query: 115 YLHSNRVVHCDIKSRNILMAESGA--KIADFGCAKWESEA---LQSGGTPMFMAPEVARG 169
           Y+HS  + H DIK +N+L+    A  K+ DFG AK        +    +  + APE+  G
Sbjct: 149 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFG 208
Query: 170 EHQGFAS-DIWAVGCTVIEMASGGAPWP 196
                +S D+W+ GC + E+  G   +P
Sbjct: 209 ATDYTSSIDVWSAGCVLAELLLGQPIFP 236

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/284 (22%), Positives = 120/284 (42%), Gaps = 39/284 (13%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ-----REQKFLSSLNSPHIVGYKGC 63
           +G G+  +V  A   ++G   A K    P    +      RE + L  +   +++G    
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 64  DVTSEDNKLMYNLFM-EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
              +   +   ++++  +  G  LN+ +     +L +  +     QIL+GL+Y+HS  ++
Sbjct: 110 FTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQFLIYQILRGLKYIHSADII 167
Query: 123 HCDIKSRNILMAES-GAKIADFGCAKW-ESEALQSGGTPMFMAPEVARG-EHQGFASDIW 179
           H D+K  N+ + E    KI DFG A+  + E      T  + APE+     H     DIW
Sbjct: 168 HRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGXVATRWYRAPEIMLNWMHYNQTVDIW 227
Query: 180 AVGCTVIEMASGGAPWP--NAADPMTVLYKIA------------------YSRELPEVP- 218
           +VGC + E+ +G   +P  +  D + ++ ++                   Y + L ++P 
Sbjct: 228 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPK 287
Query: 219 -----AFLSKQ--ANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
                 F+     A D L   L  D  +R  A+Q L H +  ++
Sbjct: 288 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 331

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 15/208 (7%)
Query: 1   MDWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGY 60
           + +T    IG GS   V  A    SG++ A K   L    F  RE + +  L+  +IV  
Sbjct: 32  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNRELQIMRKLDHCNIVRL 90
Query: 61  KGCDVTSEDNK--LMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTR----QILQGLE 114
           +    +S + K  +  NL ++Y P       + R+  R  ++L V Y +    Q+ + L 
Sbjct: 91  RYFFYSSGEKKDEVYLNLVLDYVPETVY--RVARHYSRAKQTLPVIYVKLYMYQLFRSLA 148
Query: 115 YLHSNRVVHCDIKSRNILMAESGA--KIADFGCAKWESEA---LQSGGTPMFMAPEVARG 169
           Y+HS  + H DIK +N+L+    A  K+ DFG AK        +    +  + APE+  G
Sbjct: 149 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFG 208
Query: 170 EHQGFAS-DIWAVGCTVIEMASGGAPWP 196
                +S D+W+ GC + E+  G   +P
Sbjct: 209 ATDYTSSIDVWSAGCVLAELLLGQPIFP 236

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 96/213 (45%), Gaps = 25/213 (11%)
Query: 1   MDWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGY 60
           + +T    IG GS   V  A    SG++ A K   L    F  RE + +  L+  +IV  
Sbjct: 33  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNRELQIMRKLDHCNIVRL 91
Query: 61  KGCDVTSEDNK--LMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTR----QILQGLE 114
           +    +S + K  +  NL ++Y P       + R+  R  ++L V Y +    Q+ + L 
Sbjct: 92  RYFFYSSGEKKDEVYLNLVLDYVPETVY--RVARHYSRAKQTLPVIYVKLYMYQLFRSLA 149
Query: 115 YLHSNRVVHCDIKSRNILMAESGA--KIADFGCAKWESEALQSGGTP--------MFMAP 164
           Y+HS  + H DIK +N+L+    A  K+ DFG AK         G P         + AP
Sbjct: 150 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-----GEPNVSYICSRYYRAP 204
Query: 165 EVARGEHQGFAS-DIWAVGCTVIEMASGGAPWP 196
           E+  G     +S D+W+ GC + E+  G   +P
Sbjct: 205 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFP 237

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 15/208 (7%)
Query: 1   MDWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGY 60
           + +T    IG GS   V  A    SG++ A K   L    F  RE + +  L+  +IV  
Sbjct: 20  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNRELQIMRKLDHCNIVRL 78
Query: 61  KGCDVTSEDNK--LMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTR----QILQGLE 114
           +    +S + K  +  NL ++Y P       + R+  R  ++L V Y +    Q+ + L 
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVPETVY--RVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 115 YLHSNRVVHCDIKSRNILMAESGA--KIADFGCAKWESEA---LQSGGTPMFMAPEVARG 169
           Y+HS  + H DIK +N+L+    A  K+ DFG AK        +    +  + APE+  G
Sbjct: 137 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG 196
Query: 170 EHQGFAS-DIWAVGCTVIEMASGGAPWP 196
                +S D+W+ GC + E+  G   +P
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPIFP 224

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/284 (22%), Positives = 120/284 (42%), Gaps = 39/284 (13%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ-----REQKFLSSLNSPHIVGYKGC 63
           +G G+  +V  A   ++G   A K    P    +      RE + L  +   +++G    
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 64  DVTSEDNKLMYNLFM-EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
              +   +   ++++  +  G  LN+ +     +L +  +     QIL+GL+Y+HS  ++
Sbjct: 96  FTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQFLIYQILRGLKYIHSADII 153
Query: 123 HCDIKSRNILMAES-GAKIADFGCAKW-ESEALQSGGTPMFMAPEVARG-EHQGFASDIW 179
           H D+K  N+ + E    KI DFG A+  + E      T  + APE+     H     DIW
Sbjct: 154 HRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 213
Query: 180 AVGCTVIEMASGGAPWP--NAADPMTVLYKIA------------------YSRELPEVP- 218
           +VGC + E+ +G   +P  +  D + ++ ++                   Y + L ++P 
Sbjct: 214 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPK 273
Query: 219 -----AFLSKQ--ANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
                 F+     A D L   L  D  +R  A+Q L H +  ++
Sbjct: 274 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 317

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 75/264 (28%), Positives = 118/264 (44%), Gaps = 24/264 (9%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKS----EFLQREQKFLSSLNSPHIVGYKGCD 64
           +GQG    V + T   +G    A  T  P +     FLQ E + +  L    +V      
Sbjct: 17  LGQGCFGEVWMGTW--NGTTRVAIKTLKPGTMSPEAFLQ-EAQVMKKLRHEKLVQLYA-- 71
Query: 65  VTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGR-LDESLIVSYTRQILQGLEYLHSNRVVH 123
           V SE+      +  EY   G+L D +    G+ L    +V    QI  G+ Y+     VH
Sbjct: 72  VVSEEP---IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 128
Query: 124 CDIKSRNILMAESGA-KIADFGCAKW----ESEALQSGGTPM-FMAPEVARGEHQGFASD 177
            D+++ NIL+ E+   K+ADFG A+     E  A Q    P+ + APE A        SD
Sbjct: 129 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 188
Query: 178 IWAVGCTVIEMASGG-APWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRD 236
           +W+ G  + E+ + G  P+P   +   VL ++     +P  P    +  +D +  C R+D
Sbjct: 189 VWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMP-CPPECPESLHDLMCQCWRKD 246
Query: 237 PKERWAASQLLKHPFLEEFCSCTK 260
           P+ER     L    FLE++ + T+
Sbjct: 247 PEERPTFEYL--QAFLEDYFTSTE 268

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 100/208 (48%), Gaps = 21/208 (10%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQRE-------QKFLSSL-- 52
           D+     +G+GS   V L+    + +++A K   L K   +Q +       +K + +L  
Sbjct: 342 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKI--LKKDVVIQDDDVECTMVEKRVLALPG 399
Query: 53  NSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQG 112
             P +     C  T   ++L +   MEY  GG L   I + G R  E   V Y  +I  G
Sbjct: 400 KPPFLTQLHSCFQTM--DRLYF--VMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIG 454
Query: 113 LEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAK---WESEALQSG-GTPMFMAPEVA 167
           L +L S  +++ D+K  N+++ +E   KIADFG  K   W+    +   GTP ++APE+ 
Sbjct: 455 LFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEII 514
Query: 168 RGEHQGFASDIWAVGCTVIEMASGGAPW 195
             +  G + D WA G  + EM +G AP+
Sbjct: 515 AYQPYGKSVDWWAFGVLLYEMLAGQAPF 542

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/284 (22%), Positives = 120/284 (42%), Gaps = 39/284 (13%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ-----REQKFLSSLNSPHIVGYKGC 63
           +G G+  +V  A   ++G   A K    P    +      RE + L  +   +++G    
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 64  DVTSEDNKLMYNLFM-EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
              +   +   ++++  +  G  LN+ +     +L +  +     QIL+GL+Y+HS  ++
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQFLIYQILRGLKYIHSADII 147
Query: 123 HCDIKSRNILMAES-GAKIADFGCAKW-ESEALQSGGTPMFMAPEVARG-EHQGFASDIW 179
           H D+K  N+ + E    KI DFG A+  + E      T  + APE+     H     DIW
Sbjct: 148 HRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 207
Query: 180 AVGCTVIEMASGGAPWP--NAADPMTVLYKIA------------------YSRELPEVP- 218
           +VGC + E+ +G   +P  +  D + ++ ++                   Y + L ++P 
Sbjct: 208 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPK 267
Query: 219 -----AFLSKQ--ANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
                 F+     A D L   L  D  +R  A+Q L H +  ++
Sbjct: 268 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 15/208 (7%)
Query: 1   MDWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGY 60
           + +T    IG GS   V  A    SG++ A K   L    F  RE + +  L+  +IV  
Sbjct: 24  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNRELQIMRKLDHCNIVRL 82
Query: 61  KGCDVTSEDNK--LMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTR----QILQGLE 114
           +    +S + K  +  NL ++Y P       + R+  R  ++L V Y +    Q+ + L 
Sbjct: 83  RYFFYSSGEKKDEVYLNLVLDYVPETVY--RVARHYSRAKQTLPVIYVKLYMYQLFRSLA 140
Query: 115 YLHSNRVVHCDIKSRNILMAESGA--KIADFGCAKWESEA---LQSGGTPMFMAPEVARG 169
           Y+HS  + H DIK +N+L+    A  K+ DFG AK        +    +  + APE+  G
Sbjct: 141 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFG 200
Query: 170 EHQGFAS-DIWAVGCTVIEMASGGAPWP 196
                +S D+W+ GC + E+  G   +P
Sbjct: 201 ATDYTSSIDVWSAGCVLAELLLGQPIFP 228

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 75/264 (28%), Positives = 118/264 (44%), Gaps = 24/264 (9%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKS----EFLQREQKFLSSLNSPHIVGYKGCD 64
           +GQG    V + T   +G    A  T  P +     FLQ E + +  L    +V      
Sbjct: 15  LGQGCFGEVWMGTW--NGTTRVAIKTLKPGTMSPEAFLQ-EAQVMKKLRHEKLVQLYA-- 69
Query: 65  VTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGR-LDESLIVSYTRQILQGLEYLHSNRVVH 123
           V SE+      +  EY   G+L D +    G+ L    +V    QI  G+ Y+     VH
Sbjct: 70  VVSEEP---IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 126
Query: 124 CDIKSRNILMAESGA-KIADFGCAKW----ESEALQSGGTPM-FMAPEVARGEHQGFASD 177
            D+++ NIL+ E+   K+ADFG A+     E  A Q    P+ + APE A        SD
Sbjct: 127 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 186
Query: 178 IWAVGCTVIEMASGG-APWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRD 236
           +W+ G  + E+ + G  P+P   +   VL ++     +P  P    +  +D +  C R+D
Sbjct: 187 VWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMP-CPPECPESLHDLMCQCWRKD 244
Query: 237 PKERWAASQLLKHPFLEEFCSCTK 260
           P+ER     L    FLE++ + T+
Sbjct: 245 PEERPTFEYL--QAFLEDYFTSTE 266

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/284 (23%), Positives = 119/284 (41%), Gaps = 39/284 (13%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ-----REQKFLSSLNSPHIVGYKGC 63
           +G G+  +V  A   ++G   A K    P    +      RE + L  +   +++G    
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 64  DVTSEDNKLMYNLFM-EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
              +   +   ++++  +  G  LN+ +       D    + Y  QIL+GL+Y+HS  ++
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIY--QILRGLKYIHSADII 147
Query: 123 HCDIKSRNILMAESG-AKIADFGCAKW-ESEALQSGGTPMFMAPEVARG-EHQGFASDIW 179
           H D+K  N+ + E    KI DFG A+  + E      T  + APE+     H     DIW
Sbjct: 148 HRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 207
Query: 180 AVGCTVIEMASGGAPWP--NAADPMTVLYKIA------------------YSRELPEVP- 218
           +VGC + E+ +G   +P  +  D + ++ ++                   Y + L ++P 
Sbjct: 208 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 267
Query: 219 -----AFLSKQ--ANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
                 F+     A D L   L  D  +R  A+Q L H +  ++
Sbjct: 268 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/284 (23%), Positives = 120/284 (42%), Gaps = 39/284 (13%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ-----REQKFLSSLNSPHIVGYKGC 63
           IG G+  +V  A   ++G   A K    P    +      RE + L  +   +++G    
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 64  DVTSEDNKLMYNLFM-EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
              +   +   ++++  +  G  LN+ +     +L +  +     QIL+GL+Y+HS  ++
Sbjct: 95  FTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQFLIYQILRGLKYIHSADII 152
Query: 123 HCDIKSRNILMAESG-AKIADFGCAKW-ESEALQSGGTPMFMAPEVARG-EHQGFASDIW 179
           H D+K  N+ + E    KI DFG A+  + E      T  + APE+     H     DIW
Sbjct: 153 HRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 212
Query: 180 AVGCTVIEMASGGAPWP--NAADPMTVLYKIA------------------YSRELPEVP- 218
           +VGC + E+ +G   +P  +  D + ++ ++                   Y + L ++P 
Sbjct: 213 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 272
Query: 219 -----AFLSKQ--ANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
                 F+     A D L   L  D  +R  A+Q L H +  ++
Sbjct: 273 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 316

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/284 (22%), Positives = 120/284 (42%), Gaps = 39/284 (13%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ-----REQKFLSSLNSPHIVGYKGC 63
           +G G+  +V  A   ++G   A K    P    +      RE + L  +   +++G    
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 64  DVTSEDNKLMYNLFM-EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
              +   +   ++++  +  G  LN+ +     +L +  +     QIL+GL+Y+HS  ++
Sbjct: 86  FTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQFLIYQILRGLKYIHSADII 143
Query: 123 HCDIKSRNILMAES-GAKIADFGCAKW-ESEALQSGGTPMFMAPEVARG-EHQGFASDIW 179
           H D+K  N+ + E    KI DFG A+  + E      T  + APE+     H     DIW
Sbjct: 144 HRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 203
Query: 180 AVGCTVIEMASGGAPWP--NAADPMTVLYKIA------------------YSRELPEVP- 218
           +VGC + E+ +G   +P  +  D + ++ ++                   Y + L ++P 
Sbjct: 204 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPK 263
Query: 219 -----AFLSKQ--ANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
                 F+     A D L   L  D  +R  A+Q L H +  ++
Sbjct: 264 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/284 (23%), Positives = 119/284 (41%), Gaps = 39/284 (13%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ-----REQKFLSSLNSPHIVGYKGC 63
           +G G+  +V  A   ++G   A K    P    +      RE + L  +   +++G    
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 64  DVTSEDNKLMYNLFM-EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
              +   +   ++++  +  G  LN+ +       D    + Y  QIL+GL+Y+HS  ++
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIY--QILRGLKYIHSADII 147
Query: 123 HCDIKSRNILMAES-GAKIADFGCAKW-ESEALQSGGTPMFMAPEVARG-EHQGFASDIW 179
           H D+K  N+ + E    KI DFG A+  + E      T  + APE+     H     DIW
Sbjct: 148 HRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 207
Query: 180 AVGCTVIEMASGGAPWP--NAADPMTVLYKIA------------------YSRELPEVP- 218
           +VGC + E+ +G   +P  +  D + ++ ++                   Y + L ++P 
Sbjct: 208 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 267
Query: 219 -----AFLSKQ--ANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
                 F+     A D L   L  D  +R  A+Q L H +  ++
Sbjct: 268 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/284 (22%), Positives = 120/284 (42%), Gaps = 39/284 (13%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ-----REQKFLSSLNSPHIVGYKGC 63
           +G G+  +V  A   ++G   A K    P    +      RE + L  +   +++G    
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 99
Query: 64  DVTSEDNKLMYNLFM-EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
              +   +   ++++  +  G  LN+ +     +L +  +     QIL+GL+Y+HS  ++
Sbjct: 100 FTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQFLIYQILRGLKYIHSADII 157
Query: 123 HCDIKSRNILMAES-GAKIADFGCAKW-ESEALQSGGTPMFMAPEVARG-EHQGFASDIW 179
           H D+K  N+ + E    KI DFG A+  + E      T  + APE+     H     DIW
Sbjct: 158 HRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 217
Query: 180 AVGCTVIEMASGGAPWP--NAADPMTVLYKIA------------------YSRELPEVP- 218
           +VGC + E+ +G   +P  +  D + ++ ++                   Y + L ++P 
Sbjct: 218 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPK 277
Query: 219 -----AFLSKQ--ANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
                 F+     A D L   L  D  +R  A+Q L H +  ++
Sbjct: 278 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 321

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/284 (22%), Positives = 120/284 (42%), Gaps = 39/284 (13%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ-----REQKFLSSLNSPHIVGYKGC 63
           +G G+  +V  A   ++G   A K    P    +      RE + L  +   +++G    
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 108
Query: 64  DVTSEDNKLMYNLFM-EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
              +   +   ++++  +  G  LN+ +     +L +  +     QIL+GL+Y+HS  ++
Sbjct: 109 FTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQFLIYQILRGLKYIHSADII 166
Query: 123 HCDIKSRNILMAES-GAKIADFGCAKW-ESEALQSGGTPMFMAPEVARG-EHQGFASDIW 179
           H D+K  N+ + E    KI DFG A+  + E      T  + APE+     H     DIW
Sbjct: 167 HRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 226
Query: 180 AVGCTVIEMASGGAPWP--NAADPMTVLYKIA------------------YSRELPEVP- 218
           +VGC + E+ +G   +P  +  D + ++ ++                   Y + L ++P 
Sbjct: 227 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPK 286
Query: 219 -----AFLSKQ--ANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
                 F+     A D L   L  D  +R  A+Q L H +  ++
Sbjct: 287 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 330

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/284 (22%), Positives = 120/284 (42%), Gaps = 39/284 (13%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ-----REQKFLSSLNSPHIVGYKGC 63
           +G G+  +V  A   ++G   A K    P    +      RE + L  +   +++G    
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 64  DVTSEDNKLMYNLFM-EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
              +   +   ++++  +  G  LN+ +     +L +  +     QIL+GL+Y+HS  ++
Sbjct: 110 FTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQFLIYQILRGLKYIHSADII 167
Query: 123 HCDIKSRNILMAES-GAKIADFGCAKW-ESEALQSGGTPMFMAPEVARG-EHQGFASDIW 179
           H D+K  N+ + E    KI DFG A+  + E      T  + APE+     H     DIW
Sbjct: 168 HRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 227
Query: 180 AVGCTVIEMASGGAPWP--NAADPMTVLYKIA------------------YSRELPEVP- 218
           +VGC + E+ +G   +P  +  D + ++ ++                   Y + L ++P 
Sbjct: 228 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPK 287
Query: 219 -----AFLSKQ--ANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
                 F+     A D L   L  D  +R  A+Q L H +  ++
Sbjct: 288 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 331

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/260 (23%), Positives = 113/260 (43%), Gaps = 19/260 (7%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKS------TELPKSEFLQREQKFLSSLNSPHIVGYKG 62
           IG+GS   V +     +  ++A K        E  +   + +E + +  L  P +V    
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWY 82
Query: 63  CDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
                ED  ++ +L +    GG L   + +N     E  +  +  +++  L+YL + R++
Sbjct: 83  SFQDEEDMFMVVDLLL----GGDLRYHLQQNV-HFKEETVKLFICELVMALDYLQNQRII 137
Query: 123 HCDIKSRNILMAESG-AKIADFGCAKW---ESEALQSGGTPMFMAPEV---ARGEHQGFA 175
           H D+K  NIL+ E G   I DF  A     E++     GT  +MAPE+    +G    FA
Sbjct: 138 HRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFA 197
Query: 176 SDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRR 235
            D W++G T  E+  G  P+   +   +      +   +   P+  S++    L   L  
Sbjct: 198 VDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLLKKLLEP 257
Query: 236 DPKERWAA-SQLLKHPFLEE 254
           +P +R++  S +   P++ +
Sbjct: 258 NPDQRFSQLSDVQNFPYMND 277

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/284 (22%), Positives = 120/284 (42%), Gaps = 39/284 (13%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ-----REQKFLSSLNSPHIVGYKGC 63
           +G G+  +V  A   ++G   A K    P    +      RE + L  +   +++G    
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 64  DVTSEDNKLMYNLFM-EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
              +   +   ++++  +  G  LN+ +     +L +  +     QIL+GL+Y+HS  ++
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQFLIYQILRGLKYIHSADII 147
Query: 123 HCDIKSRNILMAES-GAKIADFGCAKW-ESEALQSGGTPMFMAPEVA-RGEHQGFASDIW 179
           H D+K  N+ + E    KI DFG A+  + E      T  + APE+     H     DIW
Sbjct: 148 HRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNAMHYNQTVDIW 207
Query: 180 AVGCTVIEMASGGAPWP--NAADPMTVLYKIA------------------YSRELPEVP- 218
           +VGC + E+ +G   +P  +  D + ++ ++                   Y + L ++P 
Sbjct: 208 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 267
Query: 219 -----AFLSKQ--ANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
                 F+     A D L   L  D  +R  A+Q L H +  ++
Sbjct: 268 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 75/264 (28%), Positives = 118/264 (44%), Gaps = 24/264 (9%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKS----EFLQREQKFLSSLNSPHIVGYKGCD 64
           +GQG    V + T   +G    A  T  P +     FLQ E + +  L    +V      
Sbjct: 26  LGQGCFGEVWMGTW--NGTTRVAIKTLKPGTMSPEAFLQ-EAQVMKKLRHEKLVQLYA-- 80
Query: 65  VTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGR-LDESLIVSYTRQILQGLEYLHSNRVVH 123
           V SE+      +  EY   G+L D +    G+ L    +V    QI  G+ Y+     VH
Sbjct: 81  VVSEEP---IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 137
Query: 124 CDIKSRNILMAESGA-KIADFGCAKW----ESEALQSGGTPM-FMAPEVARGEHQGFASD 177
            D+++ NIL+ E+   K+ADFG A+     E  A Q    P+ + APE A        SD
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 178 IWAVGCTVIEMASGG-APWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRD 236
           +W+ G  + E+ + G  P+P   +   VL ++     +P  P    +  +D +  C R+D
Sbjct: 198 VWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMP-CPPECPESLHDLMCQCWRKD 255
Query: 237 PKERWAASQLLKHPFLEEFCSCTK 260
           P+ER     L    FLE++ + T+
Sbjct: 256 PEERPTFEYL--QAFLEDYFTSTE 277

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/284 (22%), Positives = 120/284 (42%), Gaps = 39/284 (13%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ-----REQKFLSSLNSPHIVGYKGC 63
           +G G+  +V  A   ++G   A K    P    +      RE + L  +   +++G    
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 64  DVTSEDNKLMYNLFM-EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
              +   +   ++++  +  G  LN+ +     +L +  +     QIL+GL+Y+HS  ++
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQFLIYQILRGLKYIHSADII 147
Query: 123 HCDIKSRNILMAES-GAKIADFGCAKWESEALQSG-GTPMFMAPEVARG-EHQGFASDIW 179
           H D+K  N+ + E    KI DFG A+   + +     T  + APE+     H     DIW
Sbjct: 148 HRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIW 207
Query: 180 AVGCTVIEMASGGAPWP--NAADPMTVLYKIA------------------YSRELPEVP- 218
           +VGC + E+ +G   +P  +  D + ++ ++                   Y + L ++P 
Sbjct: 208 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 267
Query: 219 -----AFLSKQ--ANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
                 F+     A D L   L  D  +R  A+Q L H +  ++
Sbjct: 268 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/284 (22%), Positives = 120/284 (42%), Gaps = 39/284 (13%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ-----REQKFLSSLNSPHIVGYKGC 63
           +G G+  +V  A   ++G   A K    P    +      RE + L  +   +++G    
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 64  DVTSEDNKLMYNLFM-EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
              +   +   ++++  +  G  LN+ +     +L +  +     QIL+GL+Y+HS  ++
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQFLIYQILRGLKYIHSADII 147
Query: 123 HCDIKSRNILMAES-GAKIADFGCAKWESEALQSG-GTPMFMAPEVARG-EHQGFASDIW 179
           H D+K  N+ + E    KI DFG A+   + +     T  + APE+     H     DIW
Sbjct: 148 HRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIW 207
Query: 180 AVGCTVIEMASGGAPWP--NAADPMTVLYKIA------------------YSRELPEVP- 218
           +VGC + E+ +G   +P  +  D + ++ ++                   Y + L ++P 
Sbjct: 208 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPK 267
Query: 219 -----AFLSKQ--ANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
                 F+     A D L   L  D  +R  A+Q L H +  ++
Sbjct: 268 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 96/213 (45%), Gaps = 25/213 (11%)
Query: 1   MDWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGY 60
           + +T    IG GS   V  A    SG++ A K   L    F  RE + +  L+  +IV  
Sbjct: 48  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNRELQIMRKLDHCNIVRL 106
Query: 61  KGCDVTSEDNK--LMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTR----QILQGLE 114
           +    +S + K  +  NL ++Y P       + R+  R  ++L V Y +    Q+ + L 
Sbjct: 107 RYFFYSSGEKKDEVYLNLVLDYVPETVY--RVARHYSRAKQTLPVIYVKLYMYQLFRSLA 164
Query: 115 YLHSNRVVHCDIKSRNILMAESGA--KIADFGCAKWESEALQSGGTP--------MFMAP 164
           Y+HS  + H DIK +N+L+    A  K+ DFG AK         G P         + AP
Sbjct: 165 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-----GEPNVSYICSRYYRAP 219
Query: 165 EVARGEHQGFAS-DIWAVGCTVIEMASGGAPWP 196
           E+  G     +S D+W+ GC + E+  G   +P
Sbjct: 220 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFP 252

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 15/208 (7%)
Query: 1   MDWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGY 60
           + +T    IG GS   V  A    SG++ A K   L    F  RE + +  L+  +IV  
Sbjct: 54  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNRELQIMRKLDHCNIVRL 112
Query: 61  KGCDVTSEDNK--LMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTR----QILQGLE 114
           +    +S + K  +  NL ++Y P       + R+  R  ++L V Y +    Q+ + L 
Sbjct: 113 RYFFYSSGEKKDEVYLNLVLDYVPETVY--RVARHYSRAKQTLPVIYVKLYMYQLFRSLA 170
Query: 115 YLHSNRVVHCDIKSRNILMAESGA--KIADFGCAKWESEA---LQSGGTPMFMAPEVARG 169
           Y+HS  + H DIK +N+L+    A  K+ DFG AK        +    +  + APE+  G
Sbjct: 171 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFG 230
Query: 170 EHQGFAS-DIWAVGCTVIEMASGGAPWP 196
                +S D+W+ GC + E+  G   +P
Sbjct: 231 ATDYTSSIDVWSAGCVLAELLLGQPIFP 258

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/190 (30%), Positives = 91/190 (47%), Gaps = 12/190 (6%)
Query: 79  EYAPGGTLNDEIHRNGGR-LDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG 137
           EY   G+L D +    G+ L    +V    QI  G+ Y+     VH D+++ NIL+ E+ 
Sbjct: 92  EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL 151
Query: 138 A-KIADFGCAKW----ESEALQSGGTPM-FMAPEVARGEHQGFASDIWAVGCTVIEMASG 191
             K+ADFG A+     E  A Q    P+ + APE A        SD+W+ G  + E+ + 
Sbjct: 152 VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTK 211
Query: 192 G-APWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHP 250
           G  P+P   +   VL ++     +P  P    +  +D +  C R+DP+ER     L    
Sbjct: 212 GRVPYPGMVN-REVLDQVERGYRMP-CPPECPESLHDLMCQCWRKDPEERPTFEYL--QA 267
Query: 251 FLEEFCSCTK 260
           FLE++ + T+
Sbjct: 268 FLEDYFTSTE 277

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/284 (22%), Positives = 120/284 (42%), Gaps = 39/284 (13%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ-----REQKFLSSLNSPHIVGYKGC 63
           +G G+  +V  A   ++G   A K    P    +      RE + L  +   +++G    
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 64  DVTSEDNKLMYNLFM-EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
              +   +   ++++  +  G  LN+ +     +L +  +     QIL+GL+Y+HS  ++
Sbjct: 86  FTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQFLIYQILRGLKYIHSADII 143
Query: 123 HCDIKSRNILMAES-GAKIADFGCAKWESEALQSG-GTPMFMAPEVARG-EHQGFASDIW 179
           H D+K  N+ + E    KI DFG A+   + +     T  + APE+     H     DIW
Sbjct: 144 HRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIW 203
Query: 180 AVGCTVIEMASGGAPWP--NAADPMTVLYKIA------------------YSRELPEVP- 218
           +VGC + E+ +G   +P  +  D + ++ ++                   Y + L ++P 
Sbjct: 204 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPK 263
Query: 219 -----AFLSKQ--ANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
                 F+     A D L   L  D  +R  A+Q L H +  ++
Sbjct: 264 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 96/213 (45%), Gaps = 25/213 (11%)
Query: 1   MDWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGY 60
           + +T    IG GS   V  A    SG++ A K   L    F  RE + +  L+  +IV  
Sbjct: 25  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNRELQIMRKLDHCNIVRL 83
Query: 61  KGCDVTSEDNK--LMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTR----QILQGLE 114
           +    +S + K  +  NL ++Y P       + R+  R  ++L V Y +    Q+ + L 
Sbjct: 84  RYFFYSSGEKKDEVYLNLVLDYVPETVY--RVARHYSRAKQTLPVIYVKLYMYQLFRSLA 141
Query: 115 YLHSNRVVHCDIKSRNILMAESGA--KIADFGCAKWESEALQSGGTP--------MFMAP 164
           Y+HS  + H DIK +N+L+    A  K+ DFG AK         G P         + AP
Sbjct: 142 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-----GEPNVSYICSRYYRAP 196
Query: 165 EVARGEHQGFAS-DIWAVGCTVIEMASGGAPWP 196
           E+  G     +S D+W+ GC + E+  G   +P
Sbjct: 197 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFP 229

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 73/299 (24%), Positives = 125/299 (41%), Gaps = 45/299 (15%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSE----FLQREQKFLSSLNSPHIV 58
           + +   +G+G+ ATV    S  + ++ A K   L   E       RE   L  L   +IV
Sbjct: 4   YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIV 63
Query: 59  GYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHS 118
                D+   +  L   L  EY     L   +   G  ++   +  +  Q+L+GL Y H 
Sbjct: 64  TLH--DIIHTEKSL--TLVFEYL-DKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHR 118
Query: 119 NRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSGG----TPMFMAPEVARGEHQG 173
            +V+H D+K +N+L+ E G  K+ADFG A+ +S   ++      T  +  P++  G    
Sbjct: 119 QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDY 178
Query: 174 FAS-DIWAVGCTVIEMASGGAPWPNAA--DPMTVLYKIAYSRELPEVPAFLSKQ------ 224
               D+W VGC   EMA+G   +P +   + +  +++I  +      P  LS +      
Sbjct: 179 STQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYN 238
Query: 225 -------------------ANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQIQE 264
                                D L+  L+ + + R +A   +KHPF   F S  ++I +
Sbjct: 239 YPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPF---FLSLGERIHK 294

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 75/264 (28%), Positives = 118/264 (44%), Gaps = 24/264 (9%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKS----EFLQREQKFLSSLNSPHIVGYKGCD 64
           +GQG    V + T   +G    A  T  P +     FLQ E + +  L    +V      
Sbjct: 26  LGQGCFGEVWMGTW--NGTTRVAIKTLKPGTMSPEAFLQ-EAQVMKKLRHEKLVQLYA-- 80
Query: 65  VTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGR-LDESLIVSYTRQILQGLEYLHSNRVVH 123
           V SE+      +  EY   G+L D +    G+ L    +V    QI  G+ Y+     VH
Sbjct: 81  VVSEEP---IYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 137
Query: 124 CDIKSRNILMAESGA-KIADFGCAKW----ESEALQSGGTPM-FMAPEVARGEHQGFASD 177
            D+++ NIL+ E+   K+ADFG A+     E  A Q    P+ + APE A        SD
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 178 IWAVGCTVIEMASGG-APWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRD 236
           +W+ G  + E+ + G  P+P   +   VL ++     +P  P    +  +D +  C R+D
Sbjct: 198 VWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMP-CPPECPESLHDLMCQCWRKD 255
Query: 237 PKERWAASQLLKHPFLEEFCSCTK 260
           P+ER     L    FLE++ + T+
Sbjct: 256 PEERPTFEYL--QAFLEDYFTSTE 277

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 96/213 (45%), Gaps = 25/213 (11%)
Query: 1   MDWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGY 60
           + +T    IG GS   V  A    SG++ A K   L    F  RE + +  L+  +IV  
Sbjct: 54  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNRELQIMRKLDHCNIVRL 112
Query: 61  KGCDVTSEDNK--LMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTR----QILQGLE 114
           +    +S + K  +  NL ++Y P       + R+  R  ++L V Y +    Q+ + L 
Sbjct: 113 RYFFYSSGEKKDEVYLNLVLDYVPETVY--RVARHYSRAKQTLPVIYVKLYMYQLFRSLA 170
Query: 115 YLHSNRVVHCDIKSRNILMAESGA--KIADFGCAKWESEALQSGGTP--------MFMAP 164
           Y+HS  + H DIK +N+L+    A  K+ DFG AK         G P         + AP
Sbjct: 171 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-----GEPNVSYICSRYYRAP 225
Query: 165 EVARGEHQGFAS-DIWAVGCTVIEMASGGAPWP 196
           E+  G     +S D+W+ GC + E+  G   +P
Sbjct: 226 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFP 258

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 65/284 (22%), Positives = 120/284 (42%), Gaps = 39/284 (13%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ-----REQKFLSSLNSPHIVGYKGC 63
           +G G+  +V  A   ++G   A K    P    +      RE + L  +   +++G    
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 64  DVTSEDNKLMYNLFM-EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
              +   +   ++++  +  G  LN+ +     +L +  +     QIL+GL+Y+HS  ++
Sbjct: 96  FTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQFLIYQILRGLKYIHSADII 153
Query: 123 HCDIKSRNILMAES-GAKIADFGCAKW-ESEALQSGGTPMFMAPEVARG-EHQGFASDIW 179
           H D+K  N+ + E    KI DFG A+  + E      T  + APE+     H     DIW
Sbjct: 154 HRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 213
Query: 180 AVGCTVIEMASGGAPWP--NAADPMTVLYKIA------------------YSRELPEVP- 218
           +VGC + E+ +G   +P  +  D + ++ ++                   Y + L ++P 
Sbjct: 214 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 273
Query: 219 -----AFLSKQ--ANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
                 F+     A D L   L  D  +R  A+Q L H +  ++
Sbjct: 274 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 317

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 65/284 (22%), Positives = 120/284 (42%), Gaps = 39/284 (13%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ-----REQKFLSSLNSPHIVGYKGC 63
           +G G+  +V  A   ++G   A K    P    +      RE + L  +   +++G    
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 64  DVTSEDNKLMYNLFM-EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
              +   +   ++++  +  G  LN+ +     +L +  +     QIL+GL+Y+HS  ++
Sbjct: 95  FTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQFLIYQILRGLKYIHSADII 152
Query: 123 HCDIKSRNILMAESG-AKIADFGCAKW-ESEALQSGGTPMFMAPEVARG-EHQGFASDIW 179
           H D+K  N+ + E    KI DFG A+  + E      T  + APE+     H     DIW
Sbjct: 153 HRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 212
Query: 180 AVGCTVIEMASGGAPWP--NAADPMTVLYKIA------------------YSRELPEVP- 218
           +VGC + E+ +G   +P  +  D + ++ ++                   Y + L ++P 
Sbjct: 213 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 272
Query: 219 -----AFLSKQ--ANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
                 F+     A D L   L  D  +R  A+Q L H +  ++
Sbjct: 273 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 316

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 65/284 (22%), Positives = 120/284 (42%), Gaps = 39/284 (13%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ-----REQKFLSSLNSPHIVGYKGC 63
           +G G+  +V  A   ++G   A K    P    +      RE + L  +   +++G    
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 64  DVTSEDNKLMYNLFM-EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
              +   +   ++++  +  G  LN+ +     +L +  +     QIL+GL+Y+HS  ++
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQFLIYQILRGLKYIHSADII 147
Query: 123 HCDIKSRNILMAES-GAKIADFGCAKW-ESEALQSGGTPMFMAPEVARG-EHQGFASDIW 179
           H D+K  N+ + E    KI DFG A+  + E      T  + APE+     H     DIW
Sbjct: 148 HRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 207
Query: 180 AVGCTVIEMASGGAPWP--NAADPMTVLYKIA------------------YSRELPEVP- 218
           +VGC + E+ +G   +P  +  D + ++ ++                   Y + L ++P 
Sbjct: 208 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 267
Query: 219 -----AFLSKQ--ANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
                 F+     A D L   L  D  +R  A+Q L H +  ++
Sbjct: 268 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 64/284 (22%), Positives = 121/284 (42%), Gaps = 39/284 (13%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ-----REQKFLSSLNSPHIVGYKGC 63
           +G G+  +V  A   ++G   A K    P    +      RE + L  +   +++G    
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 64  DVTSEDNKLMYNLFM-EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
              +   +   ++++  +  G  LN+ +     +L +  +     QIL+GL+Y+HS  ++
Sbjct: 97  FTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQFLIYQILRGLKYIHSADII 154
Query: 123 HCDIKSRNILMAES-GAKIADFGCAKWESEALQSG-GTPMFMAPEVARG-EHQGFASDIW 179
           H D+K  N+ + E    KI DFG A+  ++ +     T  + APE+     H     DIW
Sbjct: 155 HRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 214
Query: 180 AVGCTVIEMASGGAPWP--NAADPMTVLYKIA------------------YSRELPEVP- 218
           +VGC + E+ +G   +P  +  D + ++ ++                   Y + L ++P 
Sbjct: 215 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 274
Query: 219 -----AFLSKQ--ANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
                 F+     A D L   L  D  +R  A+Q L H +  ++
Sbjct: 275 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 318

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 65/284 (22%), Positives = 120/284 (42%), Gaps = 39/284 (13%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ-----REQKFLSSLNSPHIVGYKGC 63
           +G G+  +V  A   ++G   A K    P    +      RE + L  +   +++G    
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 64  DVTSEDNKLMYNLFM-EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
              +   +   ++++  +  G  LN+ +     +L +  +     QIL+GL+Y+HS  ++
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQFLIYQILRGLKYIHSADII 147
Query: 123 HCDIKSRNILMAES-GAKIADFGCAKW-ESEALQSGGTPMFMAPEVARG-EHQGFASDIW 179
           H D+K  N+ + E    KI DFG A+  + E      T  + APE+     H     DIW
Sbjct: 148 HRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGXVATRWYRAPEIMLNWMHYNQTVDIW 207
Query: 180 AVGCTVIEMASGGAPWP--NAADPMTVLYKIA------------------YSRELPEVP- 218
           +VGC + E+ +G   +P  +  D + ++ ++                   Y + L ++P 
Sbjct: 208 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 267
Query: 219 -----AFLSKQ--ANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
                 F+     A D L   L  D  +R  A+Q L H +  ++
Sbjct: 268 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 70/253 (27%), Positives = 113/253 (44%), Gaps = 22/253 (8%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKST---ELP---KSEFLQREQKFLSSLNSP 55
           D   G  IG+G+   V  +  LR+ +   A  +    LP   K++FLQ E + L   + P
Sbjct: 115 DLVLGEQIGRGNFGEV-FSGRLRADNTLVAVKSCRETLPPDLKAKFLQ-EARILKQYSHP 172
Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
           +IV   G  V ++   +   + ME   GG     +   G RL    ++        G+EY
Sbjct: 173 NIVRLIG--VCTQKQPIY--IVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEY 228
Query: 116 LHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQ--SGG---TPM-FMAPEVAR 168
           L S   +H D+ +RN L+ E    KI+DFG ++ E++ +   SGG    P+ + APE   
Sbjct: 229 LESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALN 288
Query: 169 GEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQAND 227
                  SD+W+ G  + E  S G +P+PN ++  T  + +     LP  P         
Sbjct: 289 YGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREF-VEKGGRLP-CPELCPDAVFR 346
Query: 228 FLSNCLRRDPKER 240
            +  C   +P +R
Sbjct: 347 LMEQCWAYEPGQR 359

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 96/213 (45%), Gaps = 25/213 (11%)
Query: 1   MDWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGY 60
           + +T    IG GS   V  A    SG++ A K   L    F  RE + +  L+  +IV  
Sbjct: 56  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNRELQIMRKLDHCNIVRL 114
Query: 61  KGCDVTSEDNK--LMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTR----QILQGLE 114
           +    +S + K  +  NL ++Y P       + R+  R  ++L V Y +    Q+ + L 
Sbjct: 115 RYFFYSSGEKKDEVYLNLVLDYVPETVY--RVARHYSRAKQTLPVIYVKLYMYQLFRSLA 172
Query: 115 YLHSNRVVHCDIKSRNILMAESGA--KIADFGCAKWESEALQSGGTP--------MFMAP 164
           Y+HS  + H DIK +N+L+    A  K+ DFG AK         G P         + AP
Sbjct: 173 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-----GEPNVSYICSRYYRAP 227
Query: 165 EVARGEHQGFAS-DIWAVGCTVIEMASGGAPWP 196
           E+  G     +S D+W+ GC + E+  G   +P
Sbjct: 228 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFP 260

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 64/284 (22%), Positives = 121/284 (42%), Gaps = 39/284 (13%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ-----REQKFLSSLNSPHIVGYKGC 63
           +G G+  +V  A   ++G   A K    P    +      RE + L  +   +++G    
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 64  DVTSEDNKLMYNLFM-EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
              +   +   ++++  +  G  LN+ +     +L +  +     QIL+GL+Y+HS  ++
Sbjct: 97  FTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQFLIYQILRGLKYIHSADII 154
Query: 123 HCDIKSRNILMAES-GAKIADFGCAKWESEALQSG-GTPMFMAPEVARG-EHQGFASDIW 179
           H D+K  N+ + E    KI DFG A+  ++ +     T  + APE+     H     DIW
Sbjct: 155 HRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 214
Query: 180 AVGCTVIEMASGGAPWP--NAADPMTVLYKIA------------------YSRELPEVP- 218
           +VGC + E+ +G   +P  +  D + ++ ++                   Y + L ++P 
Sbjct: 215 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 274
Query: 219 -----AFLSKQ--ANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
                 F+     A D L   L  D  +R  A+Q L H +  ++
Sbjct: 275 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 318

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/284 (22%), Positives = 120/284 (42%), Gaps = 39/284 (13%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ-----REQKFLSSLNSPHIVGYKGC 63
           +G G+  +V  A   ++G   A K    P    +      RE + L  +   +++G    
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 112
Query: 64  DVTSEDNKLMYNLFM-EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
              +   +   ++++  +  G  LN+ +     +L +  +     QIL+GL+Y+HS  ++
Sbjct: 113 FTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQFLIYQILRGLKYIHSADII 170
Query: 123 HCDIKSRNILMAES-GAKIADFGCAKW-ESEALQSGGTPMFMAPEVARG-EHQGFASDIW 179
           H D+K  N+ + E    KI DFG A+  + E      T  + APE+     H     DIW
Sbjct: 171 HRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGYVATRWYRAPEIMLNWMHYNQTVDIW 230
Query: 180 AVGCTVIEMASGGAPWP--NAADPMTVLYKIA------------------YSRELPEVP- 218
           +VGC + E+ +G   +P  +  D + ++ ++                   Y + L ++P 
Sbjct: 231 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 290
Query: 219 -----AFLSKQ--ANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
                 F+     A D L   L  D  +R  A+Q L H +  ++
Sbjct: 291 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 334

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/284 (22%), Positives = 120/284 (42%), Gaps = 39/284 (13%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ-----REQKFLSSLNSPHIVGYKGC 63
           +G G+  +V  A   ++G   A K    P    +      RE + L  +   +++G    
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 64  DVTSEDNKLMYNLFM-EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
              +   +   ++++  +  G  LN+ +     +L +  +     QIL+GL+Y+HS  ++
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQFLIYQILRGLKYIHSADII 147
Query: 123 HCDIKSRNILMAES-GAKIADFGCAKW-ESEALQSGGTPMFMAPEVARG-EHQGFASDIW 179
           H D+K  N+ + E    KI DFG A+  + E      T  + APE+     H     DIW
Sbjct: 148 HRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 207
Query: 180 AVGCTVIEMASGGAPWP--NAADPMTVLYKIA------------------YSRELPEVP- 218
           +VGC + E+ +G   +P  +  D + ++ ++                   Y + L ++P 
Sbjct: 208 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 267
Query: 219 -----AFLSKQ--ANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
                 F+     A D L   L  D  +R  A+Q L H +  ++
Sbjct: 268 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 70/248 (28%), Positives = 114/248 (45%), Gaps = 18/248 (7%)
Query: 7   HTIGQGSSATVSLATSLRSGDVFAAK--STELPKSEFLQREQKFLSSLNSPHIVGYKGCD 64
            TIG+G    V L      G+  A K    +     FL  E   ++ L   ++V   G  
Sbjct: 199 QTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLA-EASVMTQLRHSNLVQLLG-- 253
Query: 65  VTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGR--LDESLIVSYTRQILQGLEYLHSNRVV 122
           V  E+   +Y +  EY   G+L D + R+ GR  L    ++ ++  + + +EYL  N  V
Sbjct: 254 VIVEEKGGLY-IVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFV 311
Query: 123 HCDIKSRNILMAESG-AKIADFGCAKWESEALQSGGTPM-FMAPEVARGEHQGFASDIWA 180
           H D+ +RN+L++E   AK++DFG  K  S    +G  P+ + APE  R +     SD+W+
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWS 371
Query: 181 VGCTVIEMAS-GGAPWPNAADPMT-VLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPK 238
            G  + E+ S G  P+P    P+  V+ ++    ++ + P        D + NC   D  
Sbjct: 372 FGILLWEIYSFGRVPYPRI--PLKDVVPRVEKGYKM-DAPDGCPPAVYDVMKNCWHLDAA 428
Query: 239 ERWAASQL 246
            R    QL
Sbjct: 429 TRPTFLQL 436

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/284 (22%), Positives = 120/284 (42%), Gaps = 39/284 (13%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ-----REQKFLSSLNSPHIVGYKGC 63
           +G G+  +V  A   ++G   A K    P    +      RE + L  +   +++G    
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 100
Query: 64  DVTSEDNKLMYNLFM-EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
              +   +   ++++  +  G  LN+ +     +L +  +     QIL+GL+Y+HS  ++
Sbjct: 101 FTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQFLIYQILRGLKYIHSADII 158
Query: 123 HCDIKSRNILMAESG-AKIADFGCAKW-ESEALQSGGTPMFMAPEVARG-EHQGFASDIW 179
           H D+K  N+ + E    KI DFG A+  + E      T  + APE+     H     DIW
Sbjct: 159 HRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 218
Query: 180 AVGCTVIEMASGGAPWP--NAADPMTVLYKIA------------------YSRELPEVP- 218
           +VGC + E+ +G   +P  +  D + ++ ++                   Y + L ++P 
Sbjct: 219 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 278
Query: 219 -----AFLSKQ--ANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
                 F+     A D L   L  D  +R  A+Q L H +  ++
Sbjct: 279 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 322

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 96/213 (45%), Gaps = 25/213 (11%)
Query: 1   MDWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGY 60
           + +T    IG GS   V  A    SG++ A K   L    F  RE + +  L+  +IV  
Sbjct: 58  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNRELQIMRKLDHCNIVRL 116
Query: 61  KGCDVTSEDNK--LMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTR----QILQGLE 114
           +    +S + K  +  NL ++Y P       + R+  R  ++L V Y +    Q+ + L 
Sbjct: 117 RYFFYSSGEKKDEVYLNLVLDYVPETVY--RVARHYSRAKQTLPVIYVKLYMYQLFRSLA 174
Query: 115 YLHSNRVVHCDIKSRNILMAESGA--KIADFGCAKWESEALQSGGTP--------MFMAP 164
           Y+HS  + H DIK +N+L+    A  K+ DFG AK         G P         + AP
Sbjct: 175 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-----GEPNVSYICSRYYRAP 229
Query: 165 EVARGEHQGFAS-DIWAVGCTVIEMASGGAPWP 196
           E+  G     +S D+W+ GC + E+  G   +P
Sbjct: 230 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFP 262

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/284 (22%), Positives = 120/284 (42%), Gaps = 39/284 (13%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ-----REQKFLSSLNSPHIVGYKGC 63
           +G G+  +V  A   ++G   A K    P    +      RE + L  +   +++G    
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 64  DVTSEDNKLMYNLFM-EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
              +   +   ++++  +  G  LN+ +     +L +  +     QIL+GL+Y+HS  ++
Sbjct: 95  FTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQFLIYQILRGLKYIHSADII 152
Query: 123 HCDIKSRNILMAES-GAKIADFGCAKW-ESEALQSGGTPMFMAPEVARG-EHQGFASDIW 179
           H D+K  N+ + E    KI DFG A+  + E      T  + APE+     H     DIW
Sbjct: 153 HRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 212
Query: 180 AVGCTVIEMASGGAPWP--NAADPMTVLYKIA------------------YSRELPEVP- 218
           +VGC + E+ +G   +P  +  D + ++ ++                   Y + L ++P 
Sbjct: 213 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 272
Query: 219 -----AFLSKQ--ANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
                 F+     A D L   L  D  +R  A+Q L H +  ++
Sbjct: 273 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 316

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/284 (22%), Positives = 120/284 (42%), Gaps = 39/284 (13%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ-----REQKFLSSLNSPHIVGYKGC 63
           +G G+  +V  A   ++G   A K    P    +      RE + L  +   +++G    
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 64  DVTSEDNKLMYNLFM-EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
              +   +   ++++  +  G  LN+ +     +L +  +     QIL+GL+Y+HS  ++
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQFLIYQILRGLKYIHSADII 147
Query: 123 HCDIKSRNILMAES-GAKIADFGCAKW-ESEALQSGGTPMFMAPEVARG-EHQGFASDIW 179
           H D+K  N+ + E    KI DFG A+  + E      T  + APE+     H     DIW
Sbjct: 148 HRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 207
Query: 180 AVGCTVIEMASGGAPWP--NAADPMTVLYKIA------------------YSRELPEVP- 218
           +VGC + E+ +G   +P  +  D + ++ ++                   Y + L ++P 
Sbjct: 208 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 267
Query: 219 -----AFLSKQ--ANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
                 F+     A D L   L  D  +R  A+Q L H +  ++
Sbjct: 268 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 92/193 (47%), Gaps = 12/193 (6%)
Query: 76  LFMEYAPGGTLNDEIHRNGGR-LDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMA 134
           +  EY   G+L D +    G+ L    +V    QI  G+ Y+     VH D+++ NIL+ 
Sbjct: 255 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG 314
Query: 135 ESGA-KIADFGCAKW----ESEALQSGGTPM-FMAPEVARGEHQGFASDIWAVGCTVIEM 188
           E+   K+ADFG A+     E  A Q    P+ + APE A        SD+W+ G  + E+
Sbjct: 315 ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 374
Query: 189 ASGG-APWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLL 247
            + G  P+P   +   VL ++     +P  P    +  +D +  C R++P+ER     L 
Sbjct: 375 TTKGRVPYPGMVN-REVLDQVERGYRMP-CPPECPESLHDLMCQCWRKEPEERPTFEYL- 431
Query: 248 KHPFLEEFCSCTK 260
              FLE++ + T+
Sbjct: 432 -QAFLEDYFTSTE 443

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/284 (22%), Positives = 120/284 (42%), Gaps = 39/284 (13%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ-----REQKFLSSLNSPHIVGYKGC 63
           +G G+  +V  A   ++G   A K    P    +      RE + L  +   +++G    
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 64  DVTSEDNKLMYNLFM-EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
              +   +   ++++  +  G  LN+ +     +L +  +     QIL+GL+Y+HS  ++
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQFLIYQILRGLKYIHSADII 147
Query: 123 HCDIKSRNILMAES-GAKIADFGCAKW-ESEALQSGGTPMFMAPEVARG-EHQGFASDIW 179
           H D+K  N+ + E    KI DFG A+  + E      T  + APE+     H     DIW
Sbjct: 148 HRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 207
Query: 180 AVGCTVIEMASGGAPWP--NAADPMTVLYKIA------------------YSRELPEVP- 218
           +VGC + E+ +G   +P  +  D + ++ ++                   Y + L ++P 
Sbjct: 208 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 267
Query: 219 -----AFLSKQ--ANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
                 F+     A D L   L  D  +R  A+Q L H +  ++
Sbjct: 268 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 96/213 (45%), Gaps = 25/213 (11%)
Query: 1   MDWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGY 60
           + +T    IG GS   V  A    SG++ A K   L    F  RE + +  L+  +IV  
Sbjct: 20  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQGKAFKNRELQIMRKLDHCNIVRL 78
Query: 61  KGCDVTSEDNK--LMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTR----QILQGLE 114
           +    +S + K  +  NL ++Y P       + R+  R  ++L V Y +    Q+ + L 
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVPETVY--RVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 115 YLHSNRVVHCDIKSRNILMAESGA--KIADFGCAKWESEALQSGGTP--------MFMAP 164
           Y+HS  + H DIK +N+L+    A  K+ DFG AK         G P         + AP
Sbjct: 137 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-----GEPNVSYICSRYYRAP 191
Query: 165 EVARGEHQGFAS-DIWAVGCTVIEMASGGAPWP 196
           E+  G     +S D+W+ GC + E+  G   +P
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFP 224

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/284 (22%), Positives = 120/284 (42%), Gaps = 39/284 (13%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ-----REQKFLSSLNSPHIVGYKGC 63
           +G G+  +V  A   ++G   A K    P    +      RE + L  +   +++G    
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 64  DVTSEDNKLMYNLFM-EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
              +   +   ++++  +  G  LN+ +     +L +  +     QIL+GL+Y+HS  ++
Sbjct: 92  FTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQFLIYQILRGLKYIHSADII 149
Query: 123 HCDIKSRNILMAES-GAKIADFGCAKW-ESEALQSGGTPMFMAPEVARG-EHQGFASDIW 179
           H D+K  N+ + E    KI DFG A+  + E      T  + APE+     H     DIW
Sbjct: 150 HRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 209
Query: 180 AVGCTVIEMASGGAPWP--NAADPMTVLYKIA------------------YSRELPEVP- 218
           +VGC + E+ +G   +P  +  D + ++ ++                   Y + L ++P 
Sbjct: 210 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 269
Query: 219 -----AFLSKQ--ANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
                 F+     A D L   L  D  +R  A+Q L H +  ++
Sbjct: 270 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 313

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/284 (22%), Positives = 120/284 (42%), Gaps = 39/284 (13%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ-----REQKFLSSLNSPHIVGYKGC 63
           +G G+  +V  A   ++G   A K    P    +      RE + L  +   +++G    
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 64  DVTSEDNKLMYNLFM-EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
              +   +   ++++  +  G  LN+ +     +L +  +     QIL+GL+Y+HS  ++
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQFLIYQILRGLKYIHSADII 147
Query: 123 HCDIKSRNILMAES-GAKIADFGCAKW-ESEALQSGGTPMFMAPEVARG-EHQGFASDIW 179
           H D+K  N+ + E    KI DFG A+  + E      T  + APE+     H     DIW
Sbjct: 148 HRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 207
Query: 180 AVGCTVIEMASGGAPWP--NAADPMTVLYKIA------------------YSRELPEVP- 218
           +VGC + E+ +G   +P  +  D + ++ ++                   Y + L ++P 
Sbjct: 208 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 267
Query: 219 -----AFLSKQ--ANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
                 F+     A D L   L  D  +R  A+Q L H +  ++
Sbjct: 268 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/284 (22%), Positives = 120/284 (42%), Gaps = 39/284 (13%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ-----REQKFLSSLNSPHIVGYKGC 63
           +G G+  +V  A   ++G   A K    P    +      RE + L  +   +++G    
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 64  DVTSEDNKLMYNLFM-EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
              +   +   ++++  +  G  LN+ +     +L +  +     QIL+GL+Y+HS  ++
Sbjct: 86  FTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQFLIYQILRGLKYIHSADII 143
Query: 123 HCDIKSRNILMAES-GAKIADFGCAKW-ESEALQSGGTPMFMAPEVARG-EHQGFASDIW 179
           H D+K  N+ + E    KI DFG A+  + E      T  + APE+     H     DIW
Sbjct: 144 HRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 203
Query: 180 AVGCTVIEMASGGAPWP--NAADPMTVLYKIA------------------YSRELPEVP- 218
           +VGC + E+ +G   +P  +  D + ++ ++                   Y + L ++P 
Sbjct: 204 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 263
Query: 219 -----AFLSKQ--ANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
                 F+     A D L   L  D  +R  A+Q L H +  ++
Sbjct: 264 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 15/208 (7%)
Query: 1   MDWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGY 60
           + +T    IG GS   V  A    SG++ A K   L    F  RE + +  L+  +IV  
Sbjct: 20  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQGKAFKNRELQIMRKLDHCNIVRL 78
Query: 61  KGCDVTSEDNK--LMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTR----QILQGLE 114
           +    +S + K  +  NL ++Y P       + R+  R  ++L V Y +    Q+ + L 
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVPETVY--RVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 115 YLHSNRVVHCDIKSRNILMAESGA--KIADFGCAKWESEA---LQSGGTPMFMAPEVARG 169
           Y+HS  + H DIK +N+L+    A  K+ DFG AK        +    +  + APE+  G
Sbjct: 137 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG 196
Query: 170 EHQGFAS-DIWAVGCTVIEMASGGAPWP 196
                +S D+W+ GC + E+  G   +P
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPIFP 224

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/284 (22%), Positives = 120/284 (42%), Gaps = 39/284 (13%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ-----REQKFLSSLNSPHIVGYKGC 63
           +G G+  +V  A   ++G   A K    P    +      RE + L  +   +++G    
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 64  DVTSEDNKLMYNLFM-EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
              +   +   ++++  +  G  LN+ +     +L +  +     QIL+GL+Y+HS  ++
Sbjct: 102 FTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQFLIYQILRGLKYIHSADII 159
Query: 123 HCDIKSRNILMAES-GAKIADFGCAKW-ESEALQSGGTPMFMAPEVARG-EHQGFASDIW 179
           H D+K  N+ + E    KI DFG A+  + E      T  + APE+     H     DIW
Sbjct: 160 HRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 219
Query: 180 AVGCTVIEMASGGAPWP--NAADPMTVLYKIA------------------YSRELPEVP- 218
           +VGC + E+ +G   +P  +  D + ++ ++                   Y + L ++P 
Sbjct: 220 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 279
Query: 219 -----AFLSKQ--ANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
                 F+     A D L   L  D  +R  A+Q L H +  ++
Sbjct: 280 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 323

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/284 (22%), Positives = 120/284 (42%), Gaps = 39/284 (13%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ-----REQKFLSSLNSPHIVGYKGC 63
           +G G+  +V  A   ++G   A K    P    +      RE + L  +   +++G    
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 64  DVTSEDNKLMYNLFM-EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
              +   +   ++++  +  G  LN+ +     +L +  +     QIL+GL+Y+HS  ++
Sbjct: 96  FTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQFLIYQILRGLKYIHSADII 153
Query: 123 HCDIKSRNILMAES-GAKIADFGCAKW-ESEALQSGGTPMFMAPEVARG-EHQGFASDIW 179
           H D+K  N+ + E    KI DFG A+  + E      T  + APE+     H     DIW
Sbjct: 154 HRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 213
Query: 180 AVGCTVIEMASGGAPWP--NAADPMTVLYKIA------------------YSRELPEVP- 218
           +VGC + E+ +G   +P  +  D + ++ ++                   Y + L ++P 
Sbjct: 214 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 273
Query: 219 -----AFLSKQ--ANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
                 F+     A D L   L  D  +R  A+Q L H +  ++
Sbjct: 274 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 317

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 91/193 (47%), Gaps = 12/193 (6%)
Query: 76  LFMEYAPGGTLNDEIHRNGGR-LDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMA 134
           +  EY   G+L D +    G+ L    +V    QI  G+ Y+     VH D+++ NIL+ 
Sbjct: 256 IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG 315
Query: 135 ESGA-KIADFGCAKW----ESEALQSGGTPM-FMAPEVARGEHQGFASDIWAVGCTVIEM 188
           E+   K+ADFG  +     E  A Q    P+ + APE A        SD+W+ G  + E+
Sbjct: 316 ENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 375
Query: 189 ASGG-APWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLL 247
            + G  P+P   +   VL ++     +P  P    +  +D +  C R+DP+ER     L 
Sbjct: 376 TTKGRVPYPGMVN-REVLDQVERGYRMP-CPPECPESLHDLMCQCWRKDPEERPTFEYL- 432
Query: 248 KHPFLEEFCSCTK 260
              FLE++ + T+
Sbjct: 433 -QAFLEDYFTSTE 444

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 64/284 (22%), Positives = 121/284 (42%), Gaps = 39/284 (13%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ-----REQKFLSSLNSPHIVGYKGC 63
           +G G+  +V  A   ++G   A K    P    +      RE + L  +   +++G    
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 64  DVTSEDNKLMYNLFM-EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
              +   +   ++++  +  G  LN+ +     +L +  +     QIL+GL+Y+HS  ++
Sbjct: 97  FTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQFLIYQILRGLKYIHSADII 154
Query: 123 HCDIKSRNILMAES-GAKIADFGCAKWESEALQSG-GTPMFMAPEVARG-EHQGFASDIW 179
           H D+K  N+ + E    KI DFG A+  ++ +     T  + APE+     H     DIW
Sbjct: 155 HRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 214
Query: 180 AVGCTVIEMASGGAPWP--NAADPMTVLYKIA------------------YSRELPEVP- 218
           +VGC + E+ +G   +P  +  D + ++ ++                   Y + L ++P 
Sbjct: 215 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 274
Query: 219 -----AFLSKQ--ANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
                 F+     A D L   L  D  +R  A+Q L H +  ++
Sbjct: 275 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 318

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/284 (22%), Positives = 120/284 (42%), Gaps = 39/284 (13%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ-----REQKFLSSLNSPHIVGYKGC 63
           +G G+  +V  A   ++G   A K    P    +      RE + L  +   +++G    
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 64  DVTSEDNKLMYNLFM-EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
              +   +   ++++  +  G  LN+ +     +L +  +     QIL+GL+Y+HS  ++
Sbjct: 102 FTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQFLIYQILRGLKYIHSADII 159
Query: 123 HCDIKSRNILMAES-GAKIADFGCAKW-ESEALQSGGTPMFMAPEVARG-EHQGFASDIW 179
           H D+K  N+ + E    KI DFG A+  + E      T  + APE+     H     DIW
Sbjct: 160 HRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 219
Query: 180 AVGCTVIEMASGGAPWP--NAADPMTVLYKIA------------------YSRELPEVP- 218
           +VGC + E+ +G   +P  +  D + ++ ++                   Y + L ++P 
Sbjct: 220 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 279
Query: 219 -----AFLSKQ--ANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
                 F+     A D L   L  D  +R  A+Q L H +  ++
Sbjct: 280 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 323

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/284 (22%), Positives = 120/284 (42%), Gaps = 39/284 (13%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ-----REQKFLSSLNSPHIVGYKGC 63
           +G G+  +V  A   ++G   A K    P    +      RE + L  +   +++G    
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 86
Query: 64  DVTSEDNKLMYNLFM-EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
              +   +   ++++  +  G  LN+ +     +L +  +     QIL+GL+Y+HS  ++
Sbjct: 87  FTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQFLIYQILRGLKYIHSADII 144
Query: 123 HCDIKSRNILMAES-GAKIADFGCAKW-ESEALQSGGTPMFMAPEVARG-EHQGFASDIW 179
           H D+K  N+ + E    KI DFG A+  + E      T  + APE+     H     DIW
Sbjct: 145 HRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 204
Query: 180 AVGCTVIEMASGGAPWP--NAADPMTVLYKIA------------------YSRELPEVP- 218
           +VGC + E+ +G   +P  +  D + ++ ++                   Y + L ++P 
Sbjct: 205 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 264
Query: 219 -----AFLSKQ--ANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
                 F+     A D L   L  D  +R  A+Q L H +  ++
Sbjct: 265 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 308

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/284 (22%), Positives = 120/284 (42%), Gaps = 39/284 (13%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ-----REQKFLSSLNSPHIVGYKGC 63
           +G G+  +V  A   ++G   A K    P    +      RE + L  +   +++G    
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 112
Query: 64  DVTSEDNKLMYNLFM-EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
              +   +   ++++  +  G  LN+ +     +L +  +     QIL+GL+Y+HS  ++
Sbjct: 113 FTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQFLIYQILRGLKYIHSADII 170
Query: 123 HCDIKSRNILMAES-GAKIADFGCAKW-ESEALQSGGTPMFMAPEVARG-EHQGFASDIW 179
           H D+K  N+ + E    KI DFG A+  + E      T  + APE+     H     DIW
Sbjct: 171 HRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 230
Query: 180 AVGCTVIEMASGGAPWP--NAADPMTVLYKIA------------------YSRELPEVP- 218
           +VGC + E+ +G   +P  +  D + ++ ++                   Y + L ++P 
Sbjct: 231 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 290
Query: 219 -----AFLSKQ--ANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
                 F+     A D L   L  D  +R  A+Q L H +  ++
Sbjct: 291 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 334

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 75/264 (28%), Positives = 117/264 (44%), Gaps = 24/264 (9%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKS----EFLQREQKFLSSLNSPHIVGYKGCD 64
           +GQG    V + T   +G    A  T  P +     FLQ E + +  L    +V      
Sbjct: 26  LGQGCFGEVWMGTW--NGTTRVAIKTLKPGTMSPEAFLQ-EAQVMKKLRHEKLVQLYA-- 80
Query: 65  VTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGR-LDESLIVSYTRQILQGLEYLHSNRVVH 123
           V SE+      +  EY   G L D +    G+ L    +V    QI  G+ Y+     VH
Sbjct: 81  VVSEEP---IYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 137
Query: 124 CDIKSRNILMAESGA-KIADFGCAKW----ESEALQSGGTPM-FMAPEVARGEHQGFASD 177
            D+++ NIL+ E+   K+ADFG A+     E  A Q    P+ + APE A        SD
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 178 IWAVGCTVIEMASGG-APWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRD 236
           +W+ G  + E+ + G  P+P   +   VL ++     +P  P    +  +D +  C R+D
Sbjct: 198 VWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMP-CPPECPESLHDLMCQCWRKD 255
Query: 237 PKERWAASQLLKHPFLEEFCSCTK 260
           P+ER     L    FLE++ + T+
Sbjct: 256 PEERPTFEYL--QAFLEDYFTSTE 277

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/284 (22%), Positives = 120/284 (42%), Gaps = 39/284 (13%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ-----REQKFLSSLNSPHIVGYKGC 63
           +G G+  +V  A   ++G   A K    P    +      RE + L  +   +++G    
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 64  DVTSEDNKLMYNLFM-EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
              +   +   ++++  +  G  LN+ +     +L +  +     QIL+GL+Y+HS  ++
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQFLIYQILRGLKYIHSADII 147
Query: 123 HCDIKSRNILMAES-GAKIADFGCAKW-ESEALQSGGTPMFMAPEVARG-EHQGFASDIW 179
           H D+K  N+ + E    KI DFG A+  + E      T  + APE+     H     DIW
Sbjct: 148 HRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 207
Query: 180 AVGCTVIEMASGGAPWP--NAADPMTVLYKIA------------------YSRELPEVP- 218
           +VGC + E+ +G   +P  +  D + ++ ++                   Y + L ++P 
Sbjct: 208 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 267
Query: 219 -----AFLSKQ--ANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
                 F+     A D L   L  D  +R  A+Q L H +  ++
Sbjct: 268 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/284 (22%), Positives = 120/284 (42%), Gaps = 39/284 (13%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ-----REQKFLSSLNSPHIVGYKGC 63
           +G G+  +V  A   ++G   A K    P    +      RE + L  +   +++G    
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 100
Query: 64  DVTSEDNKLMYNLFM-EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
              +   +   ++++  +  G  LN+ +     +L +  +     QIL+GL+Y+HS  ++
Sbjct: 101 FTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQFLIYQILRGLKYIHSADII 158
Query: 123 HCDIKSRNILMAES-GAKIADFGCAKW-ESEALQSGGTPMFMAPEVARG-EHQGFASDIW 179
           H D+K  N+ + E    KI DFG A+  + E      T  + APE+     H     DIW
Sbjct: 159 HRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 218
Query: 180 AVGCTVIEMASGGAPWP--NAADPMTVLYKIA------------------YSRELPEVP- 218
           +VGC + E+ +G   +P  +  D + ++ ++                   Y + L ++P 
Sbjct: 219 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 278
Query: 219 -----AFLSKQ--ANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
                 F+     A D L   L  D  +R  A+Q L H +  ++
Sbjct: 279 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 322

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/284 (22%), Positives = 120/284 (42%), Gaps = 39/284 (13%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ-----REQKFLSSLNSPHIVGYKGC 63
           +G G+  +V  A   ++G   A K    P    +      RE + L  +   +++G    
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 64  DVTSEDNKLMYNLFM-EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
              +   +   ++++  +  G  LN+ +     +L +  +     QIL+GL+Y+HS  ++
Sbjct: 92  FTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQFLIYQILRGLKYIHSADII 149
Query: 123 HCDIKSRNILMAES-GAKIADFGCAKW-ESEALQSGGTPMFMAPEVARG-EHQGFASDIW 179
           H D+K  N+ + E    KI DFG A+  + E      T  + APE+     H     DIW
Sbjct: 150 HRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 209
Query: 180 AVGCTVIEMASGGAPWP--NAADPMTVLYKIA------------------YSRELPEVP- 218
           +VGC + E+ +G   +P  +  D + ++ ++                   Y + L ++P 
Sbjct: 210 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 269
Query: 219 -----AFLSKQ--ANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
                 F+     A D L   L  D  +R  A+Q L H +  ++
Sbjct: 270 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 313

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 123/288 (42%), Gaps = 47/288 (16%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ-----REQKFLSSLNSPHIVGYKGC 63
           +G G+  +V  A   R     A K    P    +      RE + L  L   +++G    
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGL--L 93
Query: 64  DVTS-----EDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHS 118
           DV +     ED   +Y   +    G  LN+ +      L +  +     Q+L+GL+Y+HS
Sbjct: 94  DVFTPATSIEDFSEVY--LVTTLMGADLNNIVKSQA--LSDEHVQFLVYQLLRGLKYIHS 149
Query: 119 NRVVHCDIKSRNILMAE-SGAKIADFGCAKWESEALQSG-GTPMFMAPEVARG-EHQGFA 175
             ++H D+K  N+ + E S  +I DFG A+   E +     T  + APE+     H    
Sbjct: 150 AGIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVATRWYRAPEIMLNWMHYNQT 209
Query: 176 SDIWAVGCTVIEMASGGAPWP--NAADPMT------------VLYKIA------YSRELP 215
            DIW+VGC + E+  G A +P  +  D +             VL KI+      Y + LP
Sbjct: 210 VDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQSLP 269
Query: 216 EVP----AFLSKQAN----DFLSNCLRRDPKERWAASQLLKHPFLEEF 255
            +P    + + + AN    D L   L  D  +R +A++ L H +  ++
Sbjct: 270 PMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQY 317

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/284 (22%), Positives = 120/284 (42%), Gaps = 39/284 (13%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ-----REQKFLSSLNSPHIVGYKGC 63
           +G G+  +V  A   ++G   A K    P    +      RE + L  +   +++G    
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 64  DVTSEDNKLMYNLFM-EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
              +   +   ++++  +  G  LN+ +     +L +  +     QIL+GL+Y+HS  ++
Sbjct: 95  FTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQFLIYQILRGLKYIHSADII 152
Query: 123 HCDIKSRNILMAES-GAKIADFGCAKW-ESEALQSGGTPMFMAPEVARG-EHQGFASDIW 179
           H D+K  N+ + E    KI DFG A+  + E      T  + APE+     H     DIW
Sbjct: 153 HRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 212
Query: 180 AVGCTVIEMASGGAPWP--NAADPMTVLYKIA------------------YSRELPEVP- 218
           +VGC + E+ +G   +P  +  D + ++ ++                   Y + L ++P 
Sbjct: 213 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 272
Query: 219 -----AFLSKQ--ANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
                 F+     A D L   L  D  +R  A+Q L H +  ++
Sbjct: 273 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 316

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 92/193 (47%), Gaps = 12/193 (6%)
Query: 76  LFMEYAPGGTLNDEIHRNGGR-LDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMA 134
           +  EY   G+L D +    G+ L    +V    QI  G+ Y+     VH D+++ NIL+ 
Sbjct: 255 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG 314
Query: 135 ESGA-KIADFGCAKW----ESEALQSGGTPM-FMAPEVARGEHQGFASDIWAVGCTVIEM 188
           E+   K+ADFG A+     E  A Q    P+ + APE A        SD+W+ G  + E+
Sbjct: 315 ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 374
Query: 189 ASGG-APWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLL 247
            + G  P+P   +   VL ++     +P  P    +  +D +  C R++P+ER     L 
Sbjct: 375 TTKGRVPYPGMVN-REVLDQVERGYRMP-CPPECPESLHDLMCQCWRKEPEERPTFEYL- 431
Query: 248 KHPFLEEFCSCTK 260
              FLE++ + T+
Sbjct: 432 -QAFLEDYFTSTE 443

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/284 (22%), Positives = 120/284 (42%), Gaps = 39/284 (13%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ-----REQKFLSSLNSPHIVGYKGC 63
           +G G+  +V  A   ++G   A K    P    +      RE + L  +   +++G    
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 88
Query: 64  DVTSEDNKLMYNLFM-EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
              +   +   ++++  +  G  LN+ +     +L +  +     QIL+GL+Y+HS  ++
Sbjct: 89  FTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQFLIYQILRGLKYIHSADII 146
Query: 123 HCDIKSRNILMAES-GAKIADFGCAKW-ESEALQSGGTPMFMAPEVARG-EHQGFASDIW 179
           H D+K  N+ + E    KI DFG A+  + E      T  + APE+     H     DIW
Sbjct: 147 HRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 206
Query: 180 AVGCTVIEMASGGAPWP--NAADPMTVLYKIA------------------YSRELPEVP- 218
           +VGC + E+ +G   +P  +  D + ++ ++                   Y + L ++P 
Sbjct: 207 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 266
Query: 219 -----AFLSKQ--ANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
                 F+     A D L   L  D  +R  A+Q L H +  ++
Sbjct: 267 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 310

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 70/253 (27%), Positives = 113/253 (44%), Gaps = 22/253 (8%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKST---ELP---KSEFLQREQKFLSSLNSP 55
           D   G  IG+G+   V  +  LR+ +   A  +    LP   K++FLQ E + L   + P
Sbjct: 115 DLVLGEQIGRGNFGEV-FSGRLRADNTLVAVKSCRETLPPDLKAKFLQ-EARILKQYSHP 172
Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
           +IV   G  V ++   +   + ME   GG     +   G RL    ++        G+EY
Sbjct: 173 NIVRLIG--VCTQKQPIY--IVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEY 228
Query: 116 LHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQ--SGG---TPM-FMAPEVAR 168
           L S   +H D+ +RN L+ E    KI+DFG ++ E++ +   SGG    P+ + APE   
Sbjct: 229 LESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALN 288
Query: 169 GEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQAND 227
                  SD+W+ G  + E  S G +P+PN ++  T  + +     LP  P         
Sbjct: 289 YGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREF-VEKGGRLP-CPELCPDAVFR 346
Query: 228 FLSNCLRRDPKER 240
            +  C   +P +R
Sbjct: 347 LMEQCWAYEPGQR 359

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/284 (22%), Positives = 120/284 (42%), Gaps = 39/284 (13%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ-----REQKFLSSLNSPHIVGYKGC 63
           +G G+  +V  A   ++G   A K    P    +      RE + L  +   +++G    
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 86
Query: 64  DVTSEDNKLMYNLFM-EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
              +   +   ++++  +  G  LN+ +     +L +  +     QIL+GL+Y+HS  ++
Sbjct: 87  FTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQFLIYQILRGLKYIHSADII 144
Query: 123 HCDIKSRNILMAES-GAKIADFGCAKW-ESEALQSGGTPMFMAPEVARG-EHQGFASDIW 179
           H D+K  N+ + E    KI DFG A+  + E      T  + APE+     H     DIW
Sbjct: 145 HRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 204
Query: 180 AVGCTVIEMASGGAPWP--NAADPMTVLYKIA------------------YSRELPEVP- 218
           +VGC + E+ +G   +P  +  D + ++ ++                   Y + L ++P 
Sbjct: 205 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 264
Query: 219 -----AFLSKQ--ANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
                 F+     A D L   L  D  +R  A+Q L H +  ++
Sbjct: 265 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 308

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/284 (22%), Positives = 120/284 (42%), Gaps = 39/284 (13%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ-----REQKFLSSLNSPHIVGYKGC 63
           +G G+  +V  A   ++G   A K    P    +      RE + L  +   +++G    
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 64  DVTSEDNKLMYNLFM-EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
              +   +   ++++  +  G  LN+ +     +L +  +     QIL+GL+Y+HS  ++
Sbjct: 97  FTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQFLIYQILRGLKYIHSADII 154
Query: 123 HCDIKSRNILMAES-GAKIADFGCAKW-ESEALQSGGTPMFMAPEVARG-EHQGFASDIW 179
           H D+K  N+ + E    KI DFG A+  + E      T  + APE+     H     DIW
Sbjct: 155 HRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 214
Query: 180 AVGCTVIEMASGGAPWP--NAADPMTVLYKIA------------------YSRELPEVP- 218
           +VGC + E+ +G   +P  +  D + ++ ++                   Y + L ++P 
Sbjct: 215 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 274
Query: 219 -----AFLSKQ--ANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
                 F+     A D L   L  D  +R  A+Q L H +  ++
Sbjct: 275 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 318

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 96/213 (45%), Gaps = 25/213 (11%)
Query: 1   MDWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGY 60
           + +T    IG GS   V  A    SG++ A K   L    F  RE + +  L+  +IV  
Sbjct: 99  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNRELQIMRKLDHCNIVRL 157
Query: 61  KGCDVTSEDNK--LMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTR----QILQGLE 114
           +    +S + K  +  NL ++Y P       + R+  R  ++L V Y +    Q+ + L 
Sbjct: 158 RYFFYSSGEKKDEVYLNLVLDYVPETVY--RVARHYSRAKQTLPVIYVKLYMYQLFRSLA 215
Query: 115 YLHSNRVVHCDIKSRNILMAESGA--KIADFGCAKWESEALQSGGTP--------MFMAP 164
           Y+HS  + H DIK +N+L+    A  K+ DFG AK         G P         + AP
Sbjct: 216 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-----GEPNVSYICSRYYRAP 270
Query: 165 EVARGEHQGFAS-DIWAVGCTVIEMASGGAPWP 196
           E+  G     +S D+W+ GC + E+  G   +P
Sbjct: 271 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFP 303

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/284 (22%), Positives = 120/284 (42%), Gaps = 39/284 (13%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ-----REQKFLSSLNSPHIVGYKGC 63
           +G G+  +V  A   ++G   A K    P    +      RE + L  +   +++G    
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 64  DVTSEDNKLMYNLFM-EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
              +   +   ++++  +  G  LN+ +     +L +  +     QIL+GL+Y+HS  ++
Sbjct: 102 FTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQFLIYQILRGLKYIHSADII 159
Query: 123 HCDIKSRNILMAES-GAKIADFGCAKW-ESEALQSGGTPMFMAPEVARG-EHQGFASDIW 179
           H D+K  N+ + E    KI DFG A+  + E      T  + APE+     H     DIW
Sbjct: 160 HRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 219
Query: 180 AVGCTVIEMASGGAPWP--NAADPMTVLYKIA------------------YSRELPEVP- 218
           +VGC + E+ +G   +P  +  D + ++ ++                   Y + L ++P 
Sbjct: 220 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 279
Query: 219 -----AFLSKQ--ANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
                 F+     A D L   L  D  +R  A+Q L H +  ++
Sbjct: 280 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 323

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 56/190 (29%), Positives = 91/190 (47%), Gaps = 12/190 (6%)
Query: 79  EYAPGGTLNDEIHRNGGR-LDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG 137
           EY   G+L D +    G+ L    +V    QI  G+ Y+     VH D+++ NIL+ E+ 
Sbjct: 258 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL 317
Query: 138 A-KIADFGCAKW----ESEALQSGGTPM-FMAPEVARGEHQGFASDIWAVGCTVIEMASG 191
             K+ADFG A+     E  A Q    P+ + APE A        SD+W+ G  + E+ + 
Sbjct: 318 VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTK 377
Query: 192 G-APWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHP 250
           G  P+P   +   VL ++     +P  P    +  +D +  C R++P+ER     L    
Sbjct: 378 GRVPYPGMVN-REVLDQVERGYRMP-CPPECPESLHDLMCQCWRKEPEERPTFEYL--QA 433
Query: 251 FLEEFCSCTK 260
           FLE++ + T+
Sbjct: 434 FLEDYFTSTE 443

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 65/284 (22%), Positives = 120/284 (42%), Gaps = 39/284 (13%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ-----REQKFLSSLNSPHIVGYKGC 63
           +G G+  +V  A   ++G   A K    P    +      RE + L  +   +++G    
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 64  DVTSEDNKLMYNLFM-EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
              +   +   ++++  +  G  LN+ +     +L +  +     QIL+GL+Y+HS  ++
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQFLIYQILRGLKYIHSADII 147
Query: 123 HCDIKSRNILMAES-GAKIADFGCAKW-ESEALQSGGTPMFMAPEVARG-EHQGFASDIW 179
           H D+K  N+ + E    KI DFG A+  + E      T  + APE+     H     DIW
Sbjct: 148 HRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 207
Query: 180 AVGCTVIEMASGGAPWP--NAADPMTVLYKIA------------------YSRELPEVP- 218
           +VGC + E+ +G   +P  +  D + ++ ++                   Y + L ++P 
Sbjct: 208 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 267
Query: 219 -----AFLSKQ--ANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
                 F+     A D L   L  D  +R  A+Q L H +  ++
Sbjct: 268 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 67/250 (26%), Positives = 105/250 (42%), Gaps = 26/250 (10%)
Query: 7   HTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDVT 66
           +T  +G    V++ T          K   L   E    E   + +L+ PHIV   G  + 
Sbjct: 29  YTNHKGEKINVAVKT--------CKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIG--II 78
Query: 67  SEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDI 126
            E+      + ME  P G L   + RN   L    +V Y+ QI + + YL S   VH DI
Sbjct: 79  EEEPTW---IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDI 135
Query: 127 KSRNILMAE-SGAKIADFGCAKW--ESEALQSGGTPM---FMAPEVARGEHQGFASDIWA 180
             RNIL+A     K+ DFG +++  + +  ++  T +   +M+PE         ASD+W 
Sbjct: 136 AVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWM 195
Query: 181 VGCTVIEMASGGAP---WPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDP 237
               + E+ S G     W    D + VL K      LP+ P          ++ C   DP
Sbjct: 196 FAVCMWEILSFGKQPFFWLENKDVIGVLEK---GDRLPK-PDLCPPVLYTLMTRCWDYDP 251
Query: 238 KERWAASQLL 247
            +R   ++L+
Sbjct: 252 SDRPRFTELV 261

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 5   RGHTIGQGSSATVSLATSLRSGD-------VFAAKSTELPKS--EFLQREQKFLSSLNSP 55
           R   +G G+  TV     +  G+       +     T  PK+  EF+  E   ++S++ P
Sbjct: 19  RVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMD-EALIMASMDHP 77
Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
           H+V   G  ++         L  +  P G L + +H +   +   L++++  QI +G+ Y
Sbjct: 78  HLVRLLGVCLSPT-----IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMY 132
Query: 116 LHSNRVVHCDIKSRNILM-AESGAKIADFGCAKW----ESEALQSGG-TPM-FMAPEVAR 168
           L   R+VH D+ +RN+L+ + +  KI DFG A+     E E    GG  P+ +MA E   
Sbjct: 133 LEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 192
Query: 169 GEHQGFASDIWAVGCTVIE-MASGGAPW 195
                  SD+W+ G T+ E M  GG P+
Sbjct: 193 YRKFTHQSDVWSYGVTIWELMTFGGKPY 220

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 65/284 (22%), Positives = 120/284 (42%), Gaps = 39/284 (13%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ-----REQKFLSSLNSPHIVGYKGC 63
           +G G+  +V  A   ++G   A K    P    +      RE + L  +   +++G    
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 87
Query: 64  DVTSEDNKLMYNLFM-EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
              +   +   ++++  +  G  LN+ +     +L +  +     QIL+GL+Y+HS  ++
Sbjct: 88  FTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQFLIYQILRGLKYIHSADII 145
Query: 123 HCDIKSRNILMAES-GAKIADFGCAKW-ESEALQSGGTPMFMAPEVARG-EHQGFASDIW 179
           H D+K  N+ + E    KI DFG A+  + E      T  + APE+     H     DIW
Sbjct: 146 HRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 205
Query: 180 AVGCTVIEMASGGAPWP--NAADPMTVLYKIA------------------YSRELPEVP- 218
           +VGC + E+ +G   +P  +  D + ++ ++                   Y + L ++P 
Sbjct: 206 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 265
Query: 219 -----AFLSKQ--ANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
                 F+     A D L   L  D  +R  A+Q L H +  ++
Sbjct: 266 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 309

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 65/284 (22%), Positives = 120/284 (42%), Gaps = 39/284 (13%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ-----REQKFLSSLNSPHIVGYKGC 63
           +G G+  +V  A   ++G   A K    P    +      RE + L  +   +++G    
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 64  DVTSEDNKLMYNLFM-EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
              +   +   ++++  +  G  LN+ +     +L +  +     QIL+GL+Y+HS  ++
Sbjct: 110 FTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQFLIYQILRGLKYIHSADII 167
Query: 123 HCDIKSRNILMAES-GAKIADFGCAKW-ESEALQSGGTPMFMAPEVARG-EHQGFASDIW 179
           H D+K  N+ + E    KI DFG A+  + E      T  + APE+     H     DIW
Sbjct: 168 HRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 227
Query: 180 AVGCTVIEMASGGAPWP--NAADPMTVLYKIA------------------YSRELPEVP- 218
           +VGC + E+ +G   +P  +  D + ++ ++                   Y + L ++P 
Sbjct: 228 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 287
Query: 219 -----AFLSKQ--ANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
                 F+     A D L   L  D  +R  A+Q L H +  ++
Sbjct: 288 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 331

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 118/264 (44%), Gaps = 24/264 (9%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKS----EFLQREQKFLSSLNSPHIVGYKGCD 64
           +GQG    V + T   +G    A  T  P +     FLQ E + +  L    +V      
Sbjct: 16  LGQGCFGEVWMGTW--NGTTRVAIKTLKPGTMSPEAFLQ-EAQVMKKLRHEKLVQLYA-- 70
Query: 65  VTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGR-LDESLIVSYTRQILQGLEYLHSNRVVH 123
           V SE+      +  EY   G+L D +    G+ L    +V    QI  G+ Y+     VH
Sbjct: 71  VVSEEP---IXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVH 127
Query: 124 CDIKSRNILMAESGA-KIADFGCAKW----ESEALQSGGTPM-FMAPEVARGEHQGFASD 177
            D+++ NIL+ E+   K+ADFG A+     E  A Q    P+ + APE A        SD
Sbjct: 128 RDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSD 187
Query: 178 IWAVGCTVIEMASGG-APWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRD 236
           +W+ G  + E+ + G  P+P   +   VL ++     +P  P    +  +D +  C R++
Sbjct: 188 VWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMP-CPPECPESLHDLMCQCWRKE 245
Query: 237 PKERWAASQLLKHPFLEEFCSCTK 260
           P+ER     L    FLE++ + T+
Sbjct: 246 PEERPTFEYL--QAFLEDYFTSTE 267

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 65/284 (22%), Positives = 120/284 (42%), Gaps = 39/284 (13%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ-----REQKFLSSLNSPHIVGYKGC 63
           +G G+  +V  A   ++G   A K    P    +      RE + L  +   +++G    
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 64  DVTSEDNKLMYNLFM-EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
              +   +   ++++  +  G  LN+ +     +L +  +     QIL+GL+Y+HS  ++
Sbjct: 92  FTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQFLIYQILRGLKYIHSADII 149
Query: 123 HCDIKSRNILMAES-GAKIADFGCAKW-ESEALQSGGTPMFMAPEVARG-EHQGFASDIW 179
           H D+K  N+ + E    KI DFG A+  + E      T  + APE+     H     DIW
Sbjct: 150 HRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 209
Query: 180 AVGCTVIEMASGGAPWP--NAADPMTVLYKIA------------------YSRELPEVP- 218
           +VGC + E+ +G   +P  +  D + ++ ++                   Y + L ++P 
Sbjct: 210 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 269
Query: 219 -----AFLSKQ--ANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
                 F+     A D L   L  D  +R  A+Q L H +  ++
Sbjct: 270 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 313

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 65/284 (22%), Positives = 120/284 (42%), Gaps = 39/284 (13%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ-----REQKFLSSLNSPHIVGYKGC 63
           +G G+  +V  A   ++G   A K    P    +      RE + L  +   +++G    
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 108
Query: 64  DVTSEDNKLMYNLFM-EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
              +   +   ++++  +  G  LN+ +     +L +  +     QIL+GL+Y+HS  ++
Sbjct: 109 FTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQFLIYQILRGLKYIHSADII 166
Query: 123 HCDIKSRNILMAES-GAKIADFGCAKW-ESEALQSGGTPMFMAPEVARG-EHQGFASDIW 179
           H D+K  N+ + E    KI DFG A+  + E      T  + APE+     H     DIW
Sbjct: 167 HRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 226
Query: 180 AVGCTVIEMASGGAPWP--NAADPMTVLYKIA------------------YSRELPEVP- 218
           +VGC + E+ +G   +P  +  D + ++ ++                   Y + L ++P 
Sbjct: 227 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 286
Query: 219 -----AFLSKQ--ANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
                 F+     A D L   L  D  +R  A+Q L H +  ++
Sbjct: 287 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 330

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 89/328 (27%), Positives = 137/328 (41%), Gaps = 57/328 (17%)
Query: 10  GQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKF---LSSLNSPHIVGYKGCDVT 66
           GQG+  TV L     +G   A K   +    F  RE +    L+ L+ P+IV  +    T
Sbjct: 32  GQGTFGTVQLGKEKSTGMSVAIKKV-IQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYT 90
Query: 67  --SEDNKLMY-NLFMEYAPGGTLNDEIHR---NGGRLDES----LIVSYTRQILQGLEYL 116
               D + +Y N+ MEY P     D +HR   N  R   +    LI  +  Q+++ +  L
Sbjct: 91  LGERDRRDIYLNVVMEYVP-----DTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCL 145
Query: 117 H--SNRVVHCDIKSRNILMAESGA--KIADFGCAKWESEALQSGG---TPMFMAPEVARG 169
           H  S  V H DIK  N+L+ E+    K+ DFG AK  S +  +     +  + APE+  G
Sbjct: 146 HLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFG 205
Query: 170 -EHQGFASDIWAVGCTVIEMASG--------------------GAPWPNA---ADPMTVL 205
            +H   A DIW+VGC   EM  G                    G P        +P    
Sbjct: 206 NQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTD 265
Query: 206 YKIAYSRELPEVPAFL------SKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSCT 259
             +  S+ +P    F       +K+A D LS  L+  P+ER    + L HP+ +E     
Sbjct: 266 VDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPA 325
Query: 260 KQIQESNCSPTSILDQGIWNSVEETEES 287
            ++  +   P  +  + + N +E   E+
Sbjct: 326 TKLPNNKDLPEDLF-RFLPNEIEVMSEA 352

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 92/193 (47%), Gaps = 12/193 (6%)
Query: 76  LFMEYAPGGTLNDEIHRNGGR-LDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMA 134
           +  EY   G+L D +    G+ L    +V    QI  G+ Y+     VH D+++ NIL+ 
Sbjct: 338 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG 397
Query: 135 ESGA-KIADFGCAKW----ESEALQSGGTPM-FMAPEVARGEHQGFASDIWAVGCTVIEM 188
           E+   K+ADFG A+     E  A Q    P+ + APE A        SD+W+ G  + E+
Sbjct: 398 ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 457
Query: 189 ASGG-APWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLL 247
            + G  P+P   +   VL ++     +P  P    +  +D +  C R++P+ER     L 
Sbjct: 458 TTKGRVPYPGMVN-REVLDQVERGYRMP-CPPECPESLHDLMCQCWRKEPEERPTFEYL- 514
Query: 248 KHPFLEEFCSCTK 260
              FLE++ + T+
Sbjct: 515 -QAFLEDYFTSTE 526

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 83/310 (26%), Positives = 127/310 (40%), Gaps = 56/310 (18%)
Query: 8   TIGQGSSATVSLATSLRSGDVFAAKSTE-----LPKSEFLQREQKFLSSLNSPHIVGYKG 62
           TIG G+   VS A    +G   A K        +  ++   RE K L      +I+  K 
Sbjct: 61  TIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKD 120
Query: 63  C---DVTSEDNKLMYNLF--MEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLH 117
                V   + K +Y +   ME      L+  IH +   L    +  +  Q+L+GL+Y+H
Sbjct: 121 ILRPTVPYGEFKSVYVVLDLME----SDLHQIIH-SSQPLTLEHVRYFLYQLLRGLKYMH 175
Query: 118 SNRVVHCDIKSRNILMAES-GAKIADFGCAK--------WESEALQSGGTPMFMAPEVAR 168
           S +V+H D+K  N+L+ E+   KI DFG A+         +    +   T  + APE+  
Sbjct: 176 SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELML 235
Query: 169 GEHQGF-ASDIWAVGCTVIEMASG--------------------GAPWPNAADPMTVLYK 207
             H+   A D+W+VGC   EM +                     G P P     +     
Sbjct: 236 SLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERV 295
Query: 208 IAYSRELP---EVP-----AFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSCT 259
            AY + LP    VP         +QA   L   LR +P  R +A+  L+HPFL ++    
Sbjct: 296 RAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPD 355
Query: 260 KQIQESNCSP 269
               E +C+P
Sbjct: 356 ---DEPDCAP 362

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 75/264 (28%), Positives = 121/264 (45%), Gaps = 24/264 (9%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKS----EFLQREQKFLSSLNSPHIVGYKGCD 64
           +GQG    V + T   +G    A  T  P +     FLQ E + +  L    +V      
Sbjct: 23  LGQGCFGEVWMGTW--NGTTRVAIKTLKPGTMSPEAFLQ-EAQVMKKLRHEKLVQLYA-- 77
Query: 65  VTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGR-LDESLIVSYTRQILQGLEYLHSNRVVH 123
           V SE+   +Y +  EY   G+L D +    G+ L    +V  + QI  G+ Y+     VH
Sbjct: 78  VVSEEP--IY-IVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNYVH 134
Query: 124 CDIKSRNILMAESGA-KIADFGCAKW----ESEALQSGGTPM-FMAPEVARGEHQGFASD 177
            D+++ NIL+ E+   K+ADFG A+     E  A Q    P+ + APE A        SD
Sbjct: 135 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 194
Query: 178 IWAVGCTVIEMASGG-APWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRD 236
           +W+ G  + E+ + G  P+P   +   VL ++     +P  P    +  +D +  C R++
Sbjct: 195 VWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMP-CPPECPESLHDLMCQCWRKE 252
Query: 237 PKERWAASQLLKHPFLEEFCSCTK 260
           P+ER     L    FLE++ + T+
Sbjct: 253 PEERPTFEYL--QAFLEDYFTSTE 274

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 123/276 (44%), Gaps = 48/276 (17%)
Query: 6   GHTIGQGSSATVSLATSL----RSGDVFAA----KSTELPKSEF--LQREQKFLSSLNSP 55
           G T+G+G    V  AT+     R+G    A    K    P SE   L  E   L  +N P
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASP-SELRDLLSEFNVLKQVNHP 86
Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEI-----------------------HR 92
           H++   G    S+D  L+  L +EYA  G+L   +                       H 
Sbjct: 87  HVIKLYGA--CSQDGPLL--LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 93  NGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES-GAKIADFGCAK--WE 149
           +   L    ++S+  QI QG++YL   ++VH D+ +RNIL+AE    KI+DFG ++  +E
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYE 202
Query: 150 SEAL---QSGGTPM-FMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTV 204
            ++      G  P+ +MA E          SD+W+ G  + E+ + GG P+P    P   
Sbjct: 203 EDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI--PPER 260
Query: 205 LYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKER 240
           L+ +  +    E P   S++    +  C +++P +R
Sbjct: 261 LFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKR 296

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 67/250 (26%), Positives = 105/250 (42%), Gaps = 26/250 (10%)
Query: 7   HTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDVT 66
           +T  +G    V++ T          K   L   E    E   + +L+ PHIV   G  + 
Sbjct: 33  YTNHKGEKINVAVKT--------CKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIG--II 82
Query: 67  SEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDI 126
            E+      + ME  P G L   + RN   L    +V Y+ QI + + YL S   VH DI
Sbjct: 83  EEEPTW---IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDI 139
Query: 127 KSRNILMAE-SGAKIADFGCAKW--ESEALQSGGTPM---FMAPEVARGEHQGFASDIWA 180
             RNIL+A     K+ DFG +++  + +  ++  T +   +M+PE         ASD+W 
Sbjct: 140 AVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWM 199
Query: 181 VGCTVIEMASGGAP---WPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDP 237
               + E+ S G     W    D + VL K      LP+ P          ++ C   DP
Sbjct: 200 FAVCMWEILSFGKQPFFWLENKDVIGVLEK---GDRLPK-PDLCPPVLYTLMTRCWDYDP 255
Query: 238 KERWAASQLL 247
            +R   ++L+
Sbjct: 256 SDRPRFTELV 265

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 67/250 (26%), Positives = 105/250 (42%), Gaps = 26/250 (10%)
Query: 7   HTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDVT 66
           +T  +G    V++ T          K   L   E    E   + +L+ PHIV   G  + 
Sbjct: 45  YTNHKGEKINVAVKT--------CKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIG--II 94
Query: 67  SEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDI 126
            E+      + ME  P G L   + RN   L    +V Y+ QI + + YL S   VH DI
Sbjct: 95  EEEPTW---IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDI 151
Query: 127 KSRNILMAE-SGAKIADFGCAKW--ESEALQSGGTPM---FMAPEVARGEHQGFASDIWA 180
             RNIL+A     K+ DFG +++  + +  ++  T +   +M+PE         ASD+W 
Sbjct: 152 AVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWM 211
Query: 181 VGCTVIEMASGGAP---WPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDP 237
               + E+ S G     W    D + VL K      LP+ P          ++ C   DP
Sbjct: 212 FAVCMWEILSFGKQPFFWLENKDVIGVLEK---GDRLPK-PDLCPPVLYTLMTRCWDYDP 267
Query: 238 KERWAASQLL 247
            +R   ++L+
Sbjct: 268 SDRPRFTELV 277

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 123/276 (44%), Gaps = 48/276 (17%)
Query: 6   GHTIGQGSSATVSLATSL----RSGDVFAA----KSTELPKSEF--LQREQKFLSSLNSP 55
           G T+G+G    V  AT+     R+G    A    K    P SE   L  E   L  +N P
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASP-SELRDLLSEFNVLKQVNHP 86
Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEI-----------------------HR 92
           H++   G    S+D  L+  L +EYA  G+L   +                       H 
Sbjct: 87  HVIKLYGA--CSQDGPLL--LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 93  NGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES-GAKIADFGCAK--WE 149
           +   L    ++S+  QI QG++YL   ++VH D+ +RNIL+AE    KI+DFG ++  +E
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYE 202
Query: 150 SEAL---QSGGTPM-FMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTV 204
            ++      G  P+ +MA E          SD+W+ G  + E+ + GG P+P    P   
Sbjct: 203 EDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI--PPER 260
Query: 205 LYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKER 240
           L+ +  +    E P   S++    +  C +++P +R
Sbjct: 261 LFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKR 296

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 5   RGHTIGQGSSATVSLATSLRSGD-------VFAAKSTELPKS--EFLQREQKFLSSLNSP 55
           R   +G G+  TV     +  G+       +     T  PK+  EF+  E   ++S++ P
Sbjct: 42  RVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMD-EALIMASMDHP 100
Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
           H+V   G  ++         L  +  P G L + +H +   +   L++++  QI +G+ Y
Sbjct: 101 HLVRLLGVCLSPT-----IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMY 155
Query: 116 LHSNRVVHCDIKSRNILM-AESGAKIADFGCAKW----ESEALQSGG-TPM-FMAPEVAR 168
           L   R+VH D+ +RN+L+ + +  KI DFG A+     E E    GG  P+ +MA E   
Sbjct: 156 LEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 215
Query: 169 GEHQGFASDIWAVGCTVIE-MASGGAPW 195
                  SD+W+ G T+ E M  GG P+
Sbjct: 216 YRKFTHQSDVWSYGVTIWELMTFGGKPY 243

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 75/264 (28%), Positives = 117/264 (44%), Gaps = 24/264 (9%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKS----EFLQREQKFLSSLNSPHIVGYKGCD 64
           +GQG    V + T   +G    A  T  P +     FLQ E + +  L    +V      
Sbjct: 26  LGQGCFGEVWMGTW--NGTTRVAIKTLKPGTMSPEAFLQ-EAQVMKKLRHEKLVQLYA-- 80
Query: 65  VTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGR-LDESLIVSYTRQILQGLEYLHSNRVVH 123
           V SE+      +  EY   G+L D +    G+ L    +V    QI  G+ Y+     VH
Sbjct: 81  VVSEEP---IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 137
Query: 124 CDIKSRNILMAESGA-KIADFGCAKW----ESEALQSGGTPM-FMAPEVARGEHQGFASD 177
            D+ + NIL+ E+   K+ADFG A+     E  A Q    P+ + APE A        SD
Sbjct: 138 RDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 178 IWAVGCTVIEMASGG-APWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRD 236
           +W+ G  + E+ + G  P+P   +   VL ++     +P  P    +  +D +  C R+D
Sbjct: 198 VWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMP-CPPECPESLHDLMCQCWRKD 255
Query: 237 PKERWAASQLLKHPFLEEFCSCTK 260
           P+ER     L    FLE++ + T+
Sbjct: 256 PEERPTFEYL--QAFLEDYFTSTE 277

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 118/264 (44%), Gaps = 24/264 (9%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKS----EFLQREQKFLSSLNSPHIVGYKGCD 64
           +GQG    V + T   +G    A  T  P +     FLQ E + +  L    +V      
Sbjct: 19  LGQGCFGEVWMGTW--NGTTRVAIKTLKPGTMSPEAFLQ-EAQVMKKLRHEKLVQLYA-- 73
Query: 65  VTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGR-LDESLIVSYTRQILQGLEYLHSNRVVH 123
           V SE+      +  EY   G+L D +    G+ L    +V    QI  G+ Y+     VH
Sbjct: 74  VVSEEP---IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVH 130
Query: 124 CDIKSRNILMAESGA-KIADFGCAKW----ESEALQSGGTPM-FMAPEVARGEHQGFASD 177
            D+++ NIL+ E+   K+ADFG A+     E  A Q    P+ + APE A        SD
Sbjct: 131 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 190
Query: 178 IWAVGCTVIEMASGG-APWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRD 236
           +W+ G  + E+ + G  P+P   +   VL ++     +P  P    +  +D +  C R++
Sbjct: 191 VWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMP-CPPECPESLHDLMCQCWRKE 248
Query: 237 PKERWAASQLLKHPFLEEFCSCTK 260
           P+ER     L    FLE++ + T+
Sbjct: 249 PEERPTFEYL--QAFLEDYFTSTE 270

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 96/197 (48%), Gaps = 14/197 (7%)
Query: 7   HTIGQGSSATVSLATSLRSGDVFAAK--STELPKSEFLQREQKFLSSLNSPHIVGYKGCD 64
            TIG+G    V L      G+  A K    +     FL  E   ++ L   ++V   G  
Sbjct: 12  QTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLA-EASVMTQLRHSNLVQLLG-- 66
Query: 65  VTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGR--LDESLIVSYTRQILQGLEYLHSNRVV 122
           V  E+   +Y +  EY   G+L D + R+ GR  L    ++ ++  + + +EYL  N  V
Sbjct: 67  VIVEEKGGLY-IVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFV 124
Query: 123 HCDIKSRNILMAESG-AKIADFGCAKWESEALQSGGTPM-FMAPEVARGEHQGFASDIWA 180
           H D+ +RN+L++E   AK++DFG  K  S    +G  P+ + APE  R +     SD+W+
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWS 184
Query: 181 VGCTVIEMAS-GGAPWP 196
            G  + E+ S G  P+P
Sbjct: 185 FGILLWEIYSFGRVPYP 201

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 75/264 (28%), Positives = 121/264 (45%), Gaps = 24/264 (9%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKS----EFLQREQKFLSSLNSPHIVGYKGCD 64
           +GQG    V + T   +G    A  T  P +     FLQ E + +  L    +V      
Sbjct: 23  LGQGCFGEVWMGTW--NGTTRVAIKTLKPGTMSPEAFLQ-EAQVMKKLRHEKLVQLYA-- 77
Query: 65  VTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGR-LDESLIVSYTRQILQGLEYLHSNRVVH 123
           V SE+   +Y +  EY   G+L D +    G+ L    +V  + QI  G+ Y+     VH
Sbjct: 78  VVSEEP--IY-IVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNYVH 134
Query: 124 CDIKSRNILMAESGA-KIADFGCAKW----ESEALQSGGTPM-FMAPEVARGEHQGFASD 177
            D+++ NIL+ E+   K+ADFG A+     E  A Q    P+ + APE A        SD
Sbjct: 135 RDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPEAALYGRFTIKSD 194
Query: 178 IWAVGCTVIEMASGG-APWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRD 236
           +W+ G  + E+ + G  P+P   +   VL ++     +P  P    +  +D +  C R++
Sbjct: 195 VWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMP-CPPECPESLHDLMCQCWRKE 252
Query: 237 PKERWAASQLLKHPFLEEFCSCTK 260
           P+ER     L    FLE++ + T+
Sbjct: 253 PEERPTFEYL--QAFLEDYFTSTE 274

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/284 (22%), Positives = 120/284 (42%), Gaps = 39/284 (13%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ-----REQKFLSSLNSPHIVGYKGC 63
           +G G+  +V  A   ++G   A K    P    +      RE + L  +   +++G    
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 64  DVTSEDNKLMYNLFM-EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
              +   +   ++++  +  G  LN+ +     +L +  +     QIL+GL+Y+HS  ++
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQFLIYQILRGLKYIHSADII 147
Query: 123 HCDIKSRNILMAES-GAKIADFGCAKW-ESEALQSGGTPMFMAPEVARG-EHQGFASDIW 179
           H D+K  N+ + E    KI D+G A+  + E      T  + APE+     H     DIW
Sbjct: 148 HRDLKPSNLAVNEDCELKILDYGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 207
Query: 180 AVGCTVIEMASGGAPWP--NAADPMTVLYKIA------------------YSRELPEVP- 218
           +VGC + E+ +G   +P  +  D + ++ ++                   Y + L ++P 
Sbjct: 208 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 267
Query: 219 -----AFLSKQ--ANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
                 F+     A D L   L  D  +R  A+Q L H +  ++
Sbjct: 268 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 123/288 (42%), Gaps = 47/288 (16%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ-----REQKFLSSLNSPHIVGYKGC 63
           +G G+  +V  A   R     A K    P    +      RE + L  L   +++G    
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGL--L 93
Query: 64  DVTS-----EDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHS 118
           DV +     ED   +Y   +    G  LN+ +      L +  +     Q+L+GL+Y+HS
Sbjct: 94  DVFTPATSIEDFSEVY--LVTTLMGADLNNIVKCQA--LSDEHVQFLVYQLLRGLKYIHS 149
Query: 119 NRVVHCDIKSRNILMAE-SGAKIADFGCAKWESEALQSG-GTPMFMAPEVARG-EHQGFA 175
             ++H D+K  N+ + E S  +I DFG A+   E +     T  + APE+     H    
Sbjct: 150 AGIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVATRWYRAPEIMLNWMHYNQT 209
Query: 176 SDIWAVGCTVIEMASGGAPWP--NAADPMT------------VLYKIA------YSRELP 215
            DIW+VGC + E+  G A +P  +  D +             VL KI+      Y + LP
Sbjct: 210 VDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQSLP 269
Query: 216 EVP----AFLSKQAN----DFLSNCLRRDPKERWAASQLLKHPFLEEF 255
            +P    + + + AN    D L   L  D  +R +A++ L H +  ++
Sbjct: 270 PMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQY 317

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 96/197 (48%), Gaps = 14/197 (7%)
Query: 7   HTIGQGSSATVSLATSLRSGDVFAAK--STELPKSEFLQREQKFLSSLNSPHIVGYKGCD 64
            TIG+G    V L      G+  A K    +     FL  E   ++ L   ++V   G  
Sbjct: 27  QTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLA-EASVMTQLRHSNLVQLLG-- 81
Query: 65  VTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGR--LDESLIVSYTRQILQGLEYLHSNRVV 122
           V  E+   +Y +  EY   G+L D + R+ GR  L    ++ ++  + + +EYL  N  V
Sbjct: 82  VIVEEKGGLY-IVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFV 139
Query: 123 HCDIKSRNILMAESG-AKIADFGCAKWESEALQSGGTPM-FMAPEVARGEHQGFASDIWA 180
           H D+ +RN+L++E   AK++DFG  K  S    +G  P+ + APE  R +     SD+W+
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWS 199
Query: 181 VGCTVIEMAS-GGAPWP 196
            G  + E+ S G  P+P
Sbjct: 200 FGILLWEIYSFGRVPYP 216

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 101/237 (42%), Gaps = 19/237 (8%)
Query: 13  SSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKL 72
           S  TVS+A      DV +         +F+ RE   + SL+  +++   G  +T      
Sbjct: 37  SGKTVSVAVKCLKPDVLSQPEA---MDDFI-REVNAMHSLDHRNLIRLYGVVLTPP---- 88
Query: 73  MYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNIL 132
              +  E AP G+L D + ++ G      +  Y  Q+ +G+ YL S R +H D+ +RN+L
Sbjct: 89  -MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLL 147
Query: 133 MAESG-AKIADFGCAKW-----ESEALQSGGTPMFM--APEVARGEHQGFASDIWAVGCT 184
           +A     KI DFG  +      +   +Q      F   APE  +      ASD W  G T
Sbjct: 148 LATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVT 207
Query: 185 VIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKER 240
           + EM + G  PW    +   +L+KI    E    P    +   + +  C    P++R
Sbjct: 208 LWEMFTYGQEPW-IGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDR 263

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 83/310 (26%), Positives = 127/310 (40%), Gaps = 56/310 (18%)
Query: 8   TIGQGSSATVSLATSLRSGDVFAAKSTE-----LPKSEFLQREQKFLSSLNSPHIVGYKG 62
           TIG G+   VS A    +G   A K        +  ++   RE K L      +I+  K 
Sbjct: 62  TIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKD 121
Query: 63  C---DVTSEDNKLMYNLF--MEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLH 117
                V   + K +Y +   ME      L+  IH +   L    +  +  Q+L+GL+Y+H
Sbjct: 122 ILRPTVPYGEFKSVYVVLDLME----SDLHQIIH-SSQPLTLEHVRYFLYQLLRGLKYMH 176
Query: 118 SNRVVHCDIKSRNILMAES-GAKIADFGCAK--------WESEALQSGGTPMFMAPEVAR 168
           S +V+H D+K  N+L+ E+   KI DFG A+         +    +   T  + APE+  
Sbjct: 177 SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELML 236
Query: 169 GEHQGF-ASDIWAVGCTVIEMASG--------------------GAPWPNAADPMTVLYK 207
             H+   A D+W+VGC   EM +                     G P P     +     
Sbjct: 237 SLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERV 296
Query: 208 IAYSRELP---EVP-----AFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSCT 259
            AY + LP    VP         +QA   L   LR +P  R +A+  L+HPFL ++    
Sbjct: 297 RAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPD 356
Query: 260 KQIQESNCSP 269
               E +C+P
Sbjct: 357 ---DEPDCAP 363

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/244 (26%), Positives = 108/244 (44%), Gaps = 20/244 (8%)
Query: 55  PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGR-LDESLIVSYTRQILQGL 113
           PHIV            K    + ME   GG L   I   G +   E       R I   +
Sbjct: 63  PHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAI 122
Query: 114 EYLHSNRVVHCDIKSRNILMA----ESGAKIADFGCAKWESE-ALQSG-GTPMFMAPEVA 167
           ++LHS+ + H D+K  N+L      ++  K+ DFG AK  ++ ALQ+   TP ++APEV 
Sbjct: 123 QFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVL 182
Query: 168 RGEHQGFASDIWAVGCTVIEMASGGAP-WPNAADPMTVLYKI-----AYSRELPEVPAFL 221
             E    + D+W++G  +  +  G  P + N    ++   K       Y    PE  + +
Sbjct: 183 GPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEW-SEV 241
Query: 222 SKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSIL--DQGIWN 279
           S+ A   +   L+ DP ER   +Q + HP++ +    +  + ++      +L  D+  W+
Sbjct: 242 SEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ----SMVVPQTPLHTARVLQEDKDHWD 297
Query: 280 SVEE 283
            V+E
Sbjct: 298 EVKE 301

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 101/237 (42%), Gaps = 19/237 (8%)
Query: 13  SSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKL 72
           S  TVS+A      DV +         +F+ RE   + SL+  +++   G  +T      
Sbjct: 33  SGKTVSVAVKCLKPDVLSQPEA---MDDFI-REVNAMHSLDHRNLIRLYGVVLTPP---- 84
Query: 73  MYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNIL 132
              +  E AP G+L D + ++ G      +  Y  Q+ +G+ YL S R +H D+ +RN+L
Sbjct: 85  -MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLL 143
Query: 133 MAESG-AKIADFGCAKW-----ESEALQSGGTPMFM--APEVARGEHQGFASDIWAVGCT 184
           +A     KI DFG  +      +   +Q      F   APE  +      ASD W  G T
Sbjct: 144 LATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVT 203
Query: 185 VIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKER 240
           + EM + G  PW    +   +L+KI    E    P    +   + +  C    P++R
Sbjct: 204 LWEMFTYGQEPW-IGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDR 259

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/244 (26%), Positives = 108/244 (44%), Gaps = 20/244 (8%)
Query: 55  PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGR-LDESLIVSYTRQILQGL 113
           PHIV            K    + ME   GG L   I   G +   E       R I   +
Sbjct: 82  PHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAI 141
Query: 114 EYLHSNRVVHCDIKSRNILMA----ESGAKIADFGCAKWESE-ALQSG-GTPMFMAPEVA 167
           ++LHS+ + H D+K  N+L      ++  K+ DFG AK  ++ ALQ+   TP ++APEV 
Sbjct: 142 QFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVL 201
Query: 168 RGEHQGFASDIWAVGCTVIEMASGGAP-WPNAADPMTVLYKI-----AYSRELPEVPAFL 221
             E    + D+W++G  +  +  G  P + N    ++   K       Y    PE  + +
Sbjct: 202 GPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEW-SEV 260
Query: 222 SKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSIL--DQGIWN 279
           S+ A   +   L+ DP ER   +Q + HP++ +    +  + ++      +L  D+  W+
Sbjct: 261 SEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ----SMVVPQTPLHTARVLQEDKDHWD 316
Query: 280 SVEE 283
            V+E
Sbjct: 317 EVKE 320

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 79/271 (29%), Positives = 121/271 (44%), Gaps = 35/271 (12%)
Query: 8   TIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQR--------EQKFLSSLNSPHIVG 59
            IG+G+   V++     +  VFA K   L K E L+R        E+  L + +S  I  
Sbjct: 81  VIGRGAFGEVAVVKLKNADKVFAMKI--LNKWEMLKRAETACFREERDVLVNGDSKWITT 138
Query: 60  YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN 119
                   +DN L   L M+Y  GG L   + +   RL E +   Y  +++  ++ +H  
Sbjct: 139 LHY--AFQDDNNLY--LVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQL 194
Query: 120 RVVHCDIKSRNILMAESG-AKIADFG-CAK-WESEALQSG---GTPMFMAPEV------A 167
             VH DIK  NILM  +G  ++ADFG C K  E   +QS    GTP +++PE+       
Sbjct: 195 HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGG 254
Query: 168 RGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLY-KIAYSRELPEVPAF---LSK 223
           +G + G   D W++G  + EM  G  P+   A+ +   Y KI   +E  + P     +S+
Sbjct: 255 KGRY-GPECDWWSLGVCMYEMLYGETPF--YAESLVETYGKIMNHKERFQFPTQVTDVSE 311
Query: 224 QANDFLSN--CLRRDPKERWAASQLLKHPFL 252
            A D +    C R     +       KHPF 
Sbjct: 312 NAKDLIRRLICSREHRLGQNGIEDFKKHPFF 342

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 101/237 (42%), Gaps = 19/237 (8%)
Query: 13  SSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKL 72
           S  TVS+A      DV +         +F+ RE   + SL+  +++   G  +T      
Sbjct: 43  SGKTVSVAVKCLKPDVLSQPEA---MDDFI-REVNAMHSLDHRNLIRLYGVVLTPP---- 94
Query: 73  MYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNIL 132
              +  E AP G+L D + ++ G      +  Y  Q+ +G+ YL S R +H D+ +RN+L
Sbjct: 95  -MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLL 153
Query: 133 MAESG-AKIADFGCAKW-----ESEALQSGGTPMFM--APEVARGEHQGFASDIWAVGCT 184
           +A     KI DFG  +      +   +Q      F   APE  +      ASD W  G T
Sbjct: 154 LATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVT 213
Query: 185 VIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKER 240
           + EM + G  PW    +   +L+KI    E    P    +   + +  C    P++R
Sbjct: 214 LWEMFTYGQEPW-IGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDR 269

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 101/237 (42%), Gaps = 19/237 (8%)
Query: 13  SSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKL 72
           S  TVS+A      DV +         +F+ RE   + SL+  +++   G  +T      
Sbjct: 37  SGKTVSVAVKCLKPDVLSQPEA---MDDFI-REVNAMHSLDHRNLIRLYGVVLTPP---- 88
Query: 73  MYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNIL 132
              +  E AP G+L D + ++ G      +  Y  Q+ +G+ YL S R +H D+ +RN+L
Sbjct: 89  -MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLL 147
Query: 133 MAESG-AKIADFGCAKW-----ESEALQSGGTPMFM--APEVARGEHQGFASDIWAVGCT 184
           +A     KI DFG  +      +   +Q      F   APE  +      ASD W  G T
Sbjct: 148 LATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVT 207
Query: 185 VIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKER 240
           + EM + G  PW    +   +L+KI    E    P    +   + +  C    P++R
Sbjct: 208 LWEMFTYGQEPW-IGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDR 263

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 101/237 (42%), Gaps = 19/237 (8%)
Query: 13  SSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKL 72
           S  TVS+A      DV +         +F+ RE   + SL+  +++   G  +T      
Sbjct: 33  SGKTVSVAVKCLKPDVLSQPEA---MDDFI-REVNAMHSLDHRNLIRLYGVVLTPP---- 84
Query: 73  MYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNIL 132
              +  E AP G+L D + ++ G      +  Y  Q+ +G+ YL S R +H D+ +RN+L
Sbjct: 85  -MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLL 143
Query: 133 MAESG-AKIADFGCAKW-----ESEALQSGGTPMFM--APEVARGEHQGFASDIWAVGCT 184
           +A     KI DFG  +      +   +Q      F   APE  +      ASD W  G T
Sbjct: 144 LATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVT 203
Query: 185 VIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKER 240
           + EM + G  PW    +   +L+KI    E    P    +   + +  C    P++R
Sbjct: 204 LWEMFTYGQEPW-IGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDR 259

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 101/237 (42%), Gaps = 19/237 (8%)
Query: 13  SSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKL 72
           S  TVS+A      DV +         +F+ RE   + SL+  +++   G  +T      
Sbjct: 33  SGKTVSVAVKCLKPDVLSQPEA---MDDFI-REVNAMHSLDHRNLIRLYGVVLTPP---- 84
Query: 73  MYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNIL 132
              +  E AP G+L D + ++ G      +  Y  Q+ +G+ YL S R +H D+ +RN+L
Sbjct: 85  -MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLL 143
Query: 133 MAESG-AKIADFGCAKW-----ESEALQSGGTPMFM--APEVARGEHQGFASDIWAVGCT 184
           +A     KI DFG  +      +   +Q      F   APE  +      ASD W  G T
Sbjct: 144 LATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVT 203
Query: 185 VIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKER 240
           + EM + G  PW    +   +L+KI    E    P    +   + +  C    P++R
Sbjct: 204 LWEMFTYGQEPW-IGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDR 259

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/272 (24%), Positives = 122/272 (44%), Gaps = 29/272 (10%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFA-----AKSTELPKSEFLQREQKFLSSLNSPH 56
           D++    IG+G    V       +G ++A      K  ++ + E L   ++ + SL S  
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 249
Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL 116
              +  C   +       +  ++   GG L+  + ++G    E+ +  Y  +I+ GLE++
Sbjct: 250 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV-FSEADMRFYAAEIILGLEHM 308
Query: 117 HSNRVVHCDIKSRNILMAESG-AKIADFG--CAKWESEALQSGGTPMFMAPEV-ARGEHQ 172
           H+  VV+ D+K  NIL+ E G  +I+D G  C   + +   S GT  +MAPEV  +G   
Sbjct: 309 HNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAY 368
Query: 173 GFASDIWAVGCTVIEMASGGAPW-------PNAADPMTVLYKIAYSRELPEVPAFLSKQA 225
             ++D +++GC + ++  G +P+        +  D MT+   +       E+P   S + 
Sbjct: 369 DSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV-------ELPDSFSPEL 421
Query: 226 NDFLSNCLRRDPKERW-----AASQLLKHPFL 252
              L   L+RD   R       A ++ + PF 
Sbjct: 422 RSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 453

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/272 (24%), Positives = 122/272 (44%), Gaps = 29/272 (10%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFA-----AKSTELPKSEFLQREQKFLSSLNSPH 56
           D++    IG+G    V       +G ++A      K  ++ + E L   ++ + SL S  
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 249
Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL 116
              +  C   +       +  ++   GG L+  + ++G    E+ +  Y  +I+ GLE++
Sbjct: 250 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV-FSEADMRFYAAEIILGLEHM 308
Query: 117 HSNRVVHCDIKSRNILMAESG-AKIADFG--CAKWESEALQSGGTPMFMAPEV-ARGEHQ 172
           H+  VV+ D+K  NIL+ E G  +I+D G  C   + +   S GT  +MAPEV  +G   
Sbjct: 309 HNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAY 368
Query: 173 GFASDIWAVGCTVIEMASGGAPW-------PNAADPMTVLYKIAYSRELPEVPAFLSKQA 225
             ++D +++GC + ++  G +P+        +  D MT+   +       E+P   S + 
Sbjct: 369 DSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV-------ELPDSFSPEL 421
Query: 226 NDFLSNCLRRDPKERW-----AASQLLKHPFL 252
              L   L+RD   R       A ++ + PF 
Sbjct: 422 RSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 453

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/272 (24%), Positives = 122/272 (44%), Gaps = 29/272 (10%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFA-----AKSTELPKSEFLQREQKFLSSLNSPH 56
           D++    IG+G    V       +G ++A      K  ++ + E L   ++ + SL S  
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 249
Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL 116
              +  C   +       +  ++   GG L+  + ++G    E+ +  Y  +I+ GLE++
Sbjct: 250 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV-FSEADMRFYAAEIILGLEHM 308
Query: 117 HSNRVVHCDIKSRNILMAESG-AKIADFG--CAKWESEALQSGGTPMFMAPEV-ARGEHQ 172
           H+  VV+ D+K  NIL+ E G  +I+D G  C   + +   S GT  +MAPEV  +G   
Sbjct: 309 HNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAY 368
Query: 173 GFASDIWAVGCTVIEMASGGAPW-------PNAADPMTVLYKIAYSRELPEVPAFLSKQA 225
             ++D +++GC + ++  G +P+        +  D MT+   +       E+P   S + 
Sbjct: 369 DSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV-------ELPDSFSPEL 421
Query: 226 NDFLSNCLRRDPKERW-----AASQLLKHPFL 252
              L   L+RD   R       A ++ + PF 
Sbjct: 422 RSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 453

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 122/276 (44%), Gaps = 48/276 (17%)
Query: 6   GHTIGQGSSATVSLATSL----RSGDVFAA----KSTELPKSEF--LQREQKFLSSLNSP 55
           G T+G+G    V  AT+     R+G    A    K    P SE   L  E   L  +N P
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASP-SELRDLLSEFNVLKQVNHP 86
Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEI-----------------------HR 92
           H++   G    S+D  L+  L +EYA  G+L   +                       H 
Sbjct: 87  HVIKLYGA--CSQDGPLL--LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 93  NGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES-GAKIADFGCAK--WE 149
           +   L    ++S+  QI QG++YL    +VH D+ +RNIL+AE    KI+DFG ++  +E
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYE 202
Query: 150 SEAL---QSGGTPM-FMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTV 204
            ++      G  P+ +MA E          SD+W+ G  + E+ + GG P+P    P   
Sbjct: 203 EDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI--PPER 260
Query: 205 LYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKER 240
           L+ +  +    E P   S++    +  C +++P +R
Sbjct: 261 LFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKR 296

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/272 (24%), Positives = 122/272 (44%), Gaps = 29/272 (10%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFA-----AKSTELPKSEFLQREQKFLSSLNSPH 56
           D++    IG+G    V       +G ++A      K  ++ + E L   ++ + SL S  
Sbjct: 189 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 248
Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL 116
              +  C   +       +  ++   GG L+  + ++G    E+ +  Y  +I+ GLE++
Sbjct: 249 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV-FSEADMRFYAAEIILGLEHM 307
Query: 117 HSNRVVHCDIKSRNILMAESG-AKIADFG--CAKWESEALQSGGTPMFMAPEV-ARGEHQ 172
           H+  VV+ D+K  NIL+ E G  +I+D G  C   + +   S GT  +MAPEV  +G   
Sbjct: 308 HNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAY 367
Query: 173 GFASDIWAVGCTVIEMASGGAPW-------PNAADPMTVLYKIAYSRELPEVPAFLSKQA 225
             ++D +++GC + ++  G +P+        +  D MT+   +       E+P   S + 
Sbjct: 368 DSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV-------ELPDSFSPEL 420
Query: 226 NDFLSNCLRRDPKERW-----AASQLLKHPFL 252
              L   L+RD   R       A ++ + PF 
Sbjct: 421 RSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 452

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/284 (22%), Positives = 119/284 (41%), Gaps = 39/284 (13%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ-----REQKFLSSLNSPHIVGYKGC 63
           +G G+  +V  A   ++G   A K    P    +      RE + L  +   +++G    
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 64  DVTSEDNKLMYNLFM-EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
              +   +   ++++  +  G  LN+ +     +L +  +     QIL+GL+Y+HS  ++
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQFLIYQILRGLKYIHSADII 147
Query: 123 HCDIKSRNILMAES-GAKIADFGCAKW-ESEALQSGGTPMFMAPEVARG-EHQGFASDIW 179
           H D+K  N+ + E    KI DF  A+  + E      T  + APE+     H     DIW
Sbjct: 148 HRDLKPSNLAVNEDCELKILDFYLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 207
Query: 180 AVGCTVIEMASGGAPWP--NAADPMTVLYKIA------------------YSRELPEVP- 218
           +VGC + E+ +G   +P  +  D + ++ ++                   Y + L ++P 
Sbjct: 208 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 267
Query: 219 -----AFLSKQ--ANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
                 F+     A D L   L  D  +R  A+Q L H +  ++
Sbjct: 268 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 101/237 (42%), Gaps = 19/237 (8%)
Query: 13  SSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKL 72
           S  TVS+A      DV +         +F+ RE   + SL+  +++   G  +T      
Sbjct: 43  SGKTVSVAVKCLKPDVLSQPEA---MDDFI-REVNAMHSLDHRNLIRLYGVVLTPP---- 94
Query: 73  MYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNIL 132
              +  E AP G+L D + ++ G      +  Y  Q+ +G+ YL S R +H D+ +RN+L
Sbjct: 95  -MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLL 153
Query: 133 MAESG-AKIADFGCAKW-----ESEALQSGGTPMFM--APEVARGEHQGFASDIWAVGCT 184
           +A     KI DFG  +      +   +Q      F   APE  +      ASD W  G T
Sbjct: 154 LATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVT 213
Query: 185 VIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKER 240
           + EM + G  PW    +   +L+KI    E    P    +   + +  C    P++R
Sbjct: 214 LWEMFTYGQEPW-IGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDR 269

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 81/155 (52%), Gaps = 10/155 (6%)
Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGA-KIADFGCAK-----WESEALQS 155
           +VS T Q+ +G+EYL S + +H D+ +RN+L+ E+   KIADFG A+        +   +
Sbjct: 159 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTN 218
Query: 156 GGTPM-FMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRE 213
           G  P+ +MAPE          SD+W+ G  + E+ + GG+P+P    P+  L+K+     
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI--PVEELFKLLKEGH 276
Query: 214 LPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLK 248
             + PA  + +    + +C    P +R    QL++
Sbjct: 277 RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 73/257 (28%), Positives = 112/257 (43%), Gaps = 26/257 (10%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQK--------FLSSLN 53
           D+     IG+GS   V LA   ++ +VF A      K+   ++E+K         L ++ 
Sbjct: 39  DFHFLKVIGKGSFGKVLLARH-KAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK 97
Query: 54  SPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGL 113
            P +VG      T++  KL + L  +Y  GG L   + R    L E     Y  +I   L
Sbjct: 98  HPFLVGLHFSFQTAD--KLYFVL--DYINGGELFYHLQRERCFL-EPRARFYAAEIASAL 152
Query: 114 EYLHSNRVVHCDIKSRNILMAESGAKI-ADFGCAKWESEALQSG----GTPMFMAPEVAR 168
            YLHS  +V+ D+K  NIL+   G  +  DFG  K   E   +     GTP ++APEV  
Sbjct: 153 GYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLH 212
Query: 169 GEHQGFASDIWAVGCTVIEMASGGAPW--PNAADPMTVLYKIAYSRELPEVPAFLSKQAN 226
            +      D W +G  + EM  G  P+   N A+    +Y    ++ L   P  ++  A 
Sbjct: 213 KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE----MYDNILNKPLQLKPN-ITNSAR 267
Query: 227 DFLSNCLRRDPKERWAA 243
             L   L++D  +R  A
Sbjct: 268 HLLEGLLQKDRTKRLGA 284

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 81/155 (52%), Gaps = 10/155 (6%)
Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGA-KIADFGCAK-----WESEALQS 155
           +VS T Q+ +G+EYL S + +H D+ +RN+L+ E+   KIADFG A+        +   +
Sbjct: 159 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTN 218
Query: 156 GGTPM-FMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRE 213
           G  P+ +MAPE          SD+W+ G  + E+ + GG+P+P    P+  L+K+     
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI--PVEELFKLLKEGH 276
Query: 214 LPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLK 248
             + PA  + +    + +C    P +R    QL++
Sbjct: 277 RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 77/156 (49%), Gaps = 12/156 (7%)
Query: 45  EQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVS 104
           E   ++S+++PH+    G  +TS        L M+  P G L D +  +   +    +++
Sbjct: 68  EAYVMASVDNPHVCRLLGICLTST-----VQLIMQLMPFGXLLDYVREHKDNIGSQYLLN 122
Query: 105 YTRQILQGLEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKW----ESEALQSGG-T 158
           +  QI +G+ YL   R+VH D+ +RN+L+      KI DFG AK     E E    GG  
Sbjct: 123 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 182
Query: 159 PM-FMAPEVARGEHQGFASDIWAVGCTVIEMASGGA 193
           P+ +MA E          SD+W+ G TV E+ + G+
Sbjct: 183 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 218

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 82/155 (52%), Gaps = 10/155 (6%)
Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWES-----EALQS 155
           +VS T Q+ +G+EYL S + +H D+ +RN+L+ E+   KIADFG A+  +     +   +
Sbjct: 146 LVSCTYQLARGMEYLASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 205
Query: 156 GGTPM-FMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRE 213
           G  P+ +MAPE          SD+W+ G  + E+ + GG+P+P    P+  L+K+     
Sbjct: 206 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI--PVEELFKLLKEGH 263
Query: 214 LPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLK 248
             + PA  + +    + +C    P +R    QL++
Sbjct: 264 RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 298

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 77/156 (49%), Gaps = 12/156 (7%)
Query: 45  EQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVS 104
           E   ++S+++PH+    G  +TS        L M+  P G L D +  +   +    +++
Sbjct: 68  EAYVMASVDNPHVCRLLGICLTST-----VQLIMQLMPFGCLLDYVREHKDNIGSQYLLN 122
Query: 105 YTRQILQGLEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKW----ESEALQSGG-T 158
           +  QI +G+ YL   R+VH D+ +RN+L+      KI DFG AK     E E    GG  
Sbjct: 123 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 182
Query: 159 PM-FMAPEVARGEHQGFASDIWAVGCTVIEMASGGA 193
           P+ +MA E          SD+W+ G TV E+ + G+
Sbjct: 183 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 218

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 77/156 (49%), Gaps = 12/156 (7%)
Query: 45  EQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVS 104
           E   ++S+++PH+    G  +TS        L M+  P G L D +  +   +    +++
Sbjct: 67  EAYVMASVDNPHVCRLLGICLTST-----VQLIMQLMPFGCLLDYVREHKDNIGSQYLLN 121
Query: 105 YTRQILQGLEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKW----ESEALQSGG-T 158
           +  QI +G+ YL   R+VH D+ +RN+L+      KI DFG AK     E E    GG  
Sbjct: 122 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 181
Query: 159 PM-FMAPEVARGEHQGFASDIWAVGCTVIEMASGGA 193
           P+ +MA E          SD+W+ G TV E+ + G+
Sbjct: 182 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 217

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 95/197 (48%), Gaps = 14/197 (7%)
Query: 7   HTIGQGSSATVSLATSLRSGDVFAAK--STELPKSEFLQREQKFLSSLNSPHIVGYKGCD 64
            TIG+G    V L      G+  A K    +     FL  E   ++ L   ++V   G  
Sbjct: 18  QTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLA-EASVMTQLRHSNLVQLLG-- 72
Query: 65  VTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGR--LDESLIVSYTRQILQGLEYLHSNRVV 122
           V  E+   +Y +  EY   G+L D + R+ GR  L    ++ ++  + + +EYL  N  V
Sbjct: 73  VIVEEKGGLY-IVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFV 130
Query: 123 HCDIKSRNILMAESG-AKIADFGCAKWESEALQSGGTPM-FMAPEVARGEHQGFASDIWA 180
           H D+ +RN+L++E   AK++DFG  K  S    +G  P+ + APE  R       SD+W+
Sbjct: 131 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREAAFSTKSDVWS 190
Query: 181 VGCTVIEMAS-GGAPWP 196
            G  + E+ S G  P+P
Sbjct: 191 FGILLWEIYSFGRVPYP 207

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 122/288 (42%), Gaps = 47/288 (16%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ-----REQKFLSSLNSPHIVGYKGC 63
           +G G+  +V  A   R     A K    P    +      RE + L  L   +++G    
Sbjct: 28  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGL--L 85
Query: 64  DVTS-----EDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHS 118
           DV +     ED   +Y   +    G  LN+ +      L +  +     Q+L+GL+Y+HS
Sbjct: 86  DVFTPATSIEDFSEVY--LVTTLMGADLNNIVKCQA--LSDEHVQFLVYQLLRGLKYIHS 141
Query: 119 NRVVHCDIKSRNILMAES-GAKIADFGCAKWESEALQSG-GTPMFMAPEVARG-EHQGFA 175
             ++H D+K  N+ + E    +I DFG A+   E +     T  + APE+     H    
Sbjct: 142 AGIIHRDLKPSNVAVNEDCELRILDFGLARQADEEMTGYVATRWYRAPEIMLNWMHYNQT 201
Query: 176 SDIWAVGCTVIEMASGGAPWP--NAADPMT------------VLYKIA------YSRELP 215
            DIW+VGC + E+  G A +P  +  D +             VL KI+      Y + LP
Sbjct: 202 VDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQSLP 261
Query: 216 EVP----AFLSKQAN----DFLSNCLRRDPKERWAASQLLKHPFLEEF 255
            +P    + + + AN    D L   L  D  +R +A++ L H +  ++
Sbjct: 262 PMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQY 309

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 77/156 (49%), Gaps = 12/156 (7%)
Query: 45  EQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVS 104
           E   ++S+++PH+    G  +TS        L M+  P G L D +  +   +    +++
Sbjct: 74  EAYVMASVDNPHVCRLLGICLTST-----VQLIMQLMPFGCLLDYVREHKDNIGSQYLLN 128
Query: 105 YTRQILQGLEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKW----ESEALQSGG-T 158
           +  QI +G+ YL   R+VH D+ +RN+L+      KI DFG AK     E E    GG  
Sbjct: 129 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 188
Query: 159 PM-FMAPEVARGEHQGFASDIWAVGCTVIEMASGGA 193
           P+ +MA E          SD+W+ G TV E+ + G+
Sbjct: 189 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 224

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 82/155 (52%), Gaps = 10/155 (6%)
Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWES-----EALQS 155
           +VS T Q+ +G+EYL S + +H D+ +RN+L+ E+   KIADFG A+  +     +   +
Sbjct: 205 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 264
Query: 156 GGTPM-FMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRE 213
           G  P+ +MAPE          SD+W+ G  + E+ + GG+P+P    P+  L+K+     
Sbjct: 265 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI--PVEELFKLLKEGH 322
Query: 214 LPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLK 248
             + PA  + +    + +C    P +R    QL++
Sbjct: 323 RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 357

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 82/155 (52%), Gaps = 10/155 (6%)
Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWES-----EALQS 155
           +VS T Q+ +G+EYL S + +H D+ +RN+L+ E+   KIADFG A+  +     +   +
Sbjct: 148 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 207
Query: 156 GGTPM-FMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRE 213
           G  P+ +MAPE          SD+W+ G  + E+ + GG+P+P    P+  L+K+     
Sbjct: 208 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI--PVEELFKLLKEGH 265
Query: 214 LPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLK 248
             + PA  + +    + +C    P +R    QL++
Sbjct: 266 RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 300

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 77/156 (49%), Gaps = 12/156 (7%)
Query: 45  EQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVS 104
           E   ++S+++PH+    G  +TS        L M+  P G L D +  +   +    +++
Sbjct: 69  EAYVMASVDNPHVCRLLGICLTST-----VQLIMQLMPFGCLLDYVREHKDNIGSQYLLN 123
Query: 105 YTRQILQGLEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKW----ESEALQSGG-T 158
           +  QI +G+ YL   R+VH D+ +RN+L+      KI DFG AK     E E    GG  
Sbjct: 124 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 183
Query: 159 PM-FMAPEVARGEHQGFASDIWAVGCTVIEMASGGA 193
           P+ +MA E          SD+W+ G TV E+ + G+
Sbjct: 184 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 219

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 82/155 (52%), Gaps = 10/155 (6%)
Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWES-----EALQS 155
           +VS T Q+ +G+EYL S + +H D+ +RN+L+ E+   KIADFG A+  +     +   +
Sbjct: 151 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 210
Query: 156 GGTPM-FMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRE 213
           G  P+ +MAPE          SD+W+ G  + E+ + GG+P+P    P+  L+K+     
Sbjct: 211 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI--PVEELFKLLKEGH 268
Query: 214 LPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLK 248
             + PA  + +    + +C    P +R    QL++
Sbjct: 269 RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 303

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 77/156 (49%), Gaps = 12/156 (7%)
Query: 45  EQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVS 104
           E   ++S+++PH+    G  +TS        L M+  P G L D +  +   +    +++
Sbjct: 71  EAYVMASVDNPHVCRLLGICLTST-----VQLIMQLMPFGCLLDYVREHKDNIGSQYLLN 125
Query: 105 YTRQILQGLEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKW----ESEALQSGG-T 158
           +  QI +G+ YL   R+VH D+ +RN+L+      KI DFG AK     E E    GG  
Sbjct: 126 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 185
Query: 159 PM-FMAPEVARGEHQGFASDIWAVGCTVIEMASGGA 193
           P+ +MA E          SD+W+ G TV E+ + G+
Sbjct: 186 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 221

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 77/156 (49%), Gaps = 12/156 (7%)
Query: 45  EQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVS 104
           E   ++S+++PH+    G  +TS        L M+  P G L D +  +   +    +++
Sbjct: 70  EAYVMASVDNPHVCRLLGICLTST-----VQLIMQLMPFGCLLDYVREHKDNIGSQYLLN 124
Query: 105 YTRQILQGLEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKW----ESEALQSGG-T 158
           +  QI +G+ YL   R+VH D+ +RN+L+      KI DFG AK     E E    GG  
Sbjct: 125 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 184
Query: 159 PM-FMAPEVARGEHQGFASDIWAVGCTVIEMASGGA 193
           P+ +MA E          SD+W+ G TV E+ + G+
Sbjct: 185 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 220

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 82/155 (52%), Gaps = 10/155 (6%)
Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWES-----EALQS 155
           +VS T Q+ +G+EYL S + +H D+ +RN+L+ E+   KIADFG A+  +     +   +
Sbjct: 159 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 156 GGTPM-FMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRE 213
           G  P+ +MAPE          SD+W+ G  + E+ + GG+P+P    P+  L+K+     
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI--PVEELFKLLKEGH 276
Query: 214 LPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLK 248
             + PA  + +    + +C    P +R    QL++
Sbjct: 277 RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 122/283 (43%), Gaps = 41/283 (14%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELP-KSEFL----QREQKFLSSLNSPHIVGYKGC 63
           +G G+   V  A   R+G   A K    P +SE       RE + L  +   +++G    
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGL--L 90
Query: 64  DVTSEDNKL--MYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRV 121
           DV + D  L    + ++     GT   ++ ++  +L E  I     Q+L+GL Y+H+  +
Sbjct: 91  DVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE-KLGEDRIQFLVYQMLKGLRYIHAAGI 149
Query: 122 VHCDIKSRNILMAES-GAKIADFGCAKW-ESEALQSGGTPMFMAPEVARGEHQGFAS-DI 178
           +H D+K  N+ + E    KI DFG A+  +SE      T  + APEV     +   + DI
Sbjct: 150 IHRDLKPGNLAVNEDCELKILDFGLARQADSEMXGXVVTRWYRAPEVILNWMRYTQTVDI 209
Query: 179 WAVGCTVIEMASGGAPWPNA--ADPMTVLYKIA------------------YSRELPEVP 218
           W+VGC + EM +G   +  +   D +  + K+                   Y + LPE+ 
Sbjct: 210 WSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELE 269
Query: 219 A--FLSKQAN------DFLSNCLRRDPKERWAASQLLKHPFLE 253
              F S   N      + L   L  D ++R  A + L HP+ E
Sbjct: 270 KKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFE 312

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 100/219 (45%), Gaps = 26/219 (11%)
Query: 42  LQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNG------- 94
             RE + L++L   HIV + G  V  E + L+  +  EY   G LN  +  +G       
Sbjct: 62  FHREAELLTNLQHEHIVKFYG--VCVEGDPLI--MVFEYMKHGDLNKFLRAHGPDAVLMA 117
Query: 95  -----GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES-GAKIADFGCAK- 147
                  L +S ++   +QI  G+ YL S   VH D+ +RN L+ E+   KI DFG ++ 
Sbjct: 118 EGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRD 177
Query: 148 -WESEALQSGGTPMF----MAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADP 201
            + ++  + GG  M     M PE          SD+W++G  + E+ + G  PW   ++ 
Sbjct: 178 VYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN 237
Query: 202 MTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKER 240
             V+  I   R L + P    ++  + +  C +R+P  R
Sbjct: 238 -EVIECITQGRVL-QRPRTCPQEVYELMLGCWQREPHMR 274

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 82/155 (52%), Gaps = 10/155 (6%)
Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWES-----EALQS 155
           +VS T Q+ +G+EYL S + +H D+ +RN+L+ E+   KIADFG A+  +     +   +
Sbjct: 159 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 156 GGTPM-FMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRE 213
           G  P+ +MAPE          SD+W+ G  + E+ + GG+P+P    P+  L+K+     
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI--PVEELFKLLKEGH 276
Query: 214 LPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLK 248
             + PA  + +    + +C    P +R    QL++
Sbjct: 277 RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 82/155 (52%), Gaps = 10/155 (6%)
Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWES-----EALQS 155
           +VS T Q+ +G+EYL S + +H D+ +RN+L+ E+   KIADFG A+  +     +   +
Sbjct: 159 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 156 GGTPM-FMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRE 213
           G  P+ +MAPE          SD+W+ G  + E+ + GG+P+P    P+  L+K+     
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI--PVEELFKLLKEGH 276
Query: 214 LPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLK 248
             + PA  + +    + +C    P +R    QL++
Sbjct: 277 RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 82/155 (52%), Gaps = 10/155 (6%)
Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWES-----EALQS 155
           +VS T Q+ +G+EYL S + +H D+ +RN+L+ E+   KIADFG A+  +     +   +
Sbjct: 159 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 156 GGTPM-FMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRE 213
           G  P+ +MAPE          SD+W+ G  + E+ + GG+P+P    P+  L+K+     
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI--PVEELFKLLKEGH 276
Query: 214 LPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLK 248
             + PA  + +    + +C    P +R    QL++
Sbjct: 277 RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 82/155 (52%), Gaps = 10/155 (6%)
Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWES-----EALQS 155
           +VS T Q+ +G+EYL S + +H D+ +RN+L+ E+   KIADFG A+  +     +   +
Sbjct: 159 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 156 GGTPM-FMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRE 213
           G  P+ +MAPE          SD+W+ G  + E+ + GG+P+P    P+  L+K+     
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI--PVEELFKLLKEGH 276
Query: 214 LPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLK 248
             + PA  + +    + +C    P +R    QL++
Sbjct: 277 RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/284 (22%), Positives = 119/284 (41%), Gaps = 39/284 (13%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ-----REQKFLSSLNSPHIVGYKGC 63
           +G G+  +V  A   ++G   A K    P    +      RE + L  +   +++G    
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 64  DVTSEDNKLMYNLFM-EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
              +   +   ++++  +  G  LN+ +     +L +  +     QIL+GL+Y+HS  ++
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQFLIYQILRGLKYIHSADII 147
Query: 123 HCDIKSRNILMAES-GAKIADFGCAKW-ESEALQSGGTPMFMAPEVARG-EHQGFASDIW 179
           H D+K  N+ + E    KI  FG A+  + E      T  + APE+     H     DIW
Sbjct: 148 HRDLKPSNLAVNEDCELKILGFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 207
Query: 180 AVGCTVIEMASGGAPWP--NAADPMTVLYKIA------------------YSRELPEVP- 218
           +VGC + E+ +G   +P  +  D + ++ ++                   Y + L ++P 
Sbjct: 208 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 267
Query: 219 -----AFLSKQ--ANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
                 F+     A D L   L  D  +R  A+Q L H +  ++
Sbjct: 268 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 82/155 (52%), Gaps = 10/155 (6%)
Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWES-----EALQS 155
           +VS T Q+ +G+EYL S + +H D+ +RN+L+ E+   KIADFG A+  +     +   +
Sbjct: 159 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTN 218
Query: 156 GGTPM-FMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRE 213
           G  P+ +MAPE          SD+W+ G  + E+ + GG+P+P    P+  L+K+     
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI--PVEELFKLLKEGH 276
Query: 214 LPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLK 248
             + PA  + +    + +C    P +R    QL++
Sbjct: 277 RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 77/156 (49%), Gaps = 12/156 (7%)
Query: 45  EQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVS 104
           E   ++S+++PH+    G  +TS        L M+  P G L D +  +   +    +++
Sbjct: 71  EAYVMASVDNPHVCRLLGICLTST-----VQLIMQLMPFGCLLDYVREHKDNIGSQYLLN 125
Query: 105 YTRQILQGLEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKW----ESEALQSGG-T 158
           +  QI +G+ YL   R+VH D+ +RN+L+      KI DFG AK     E E    GG  
Sbjct: 126 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV 185
Query: 159 PM-FMAPEVARGEHQGFASDIWAVGCTVIEMASGGA 193
           P+ +MA E          SD+W+ G TV E+ + G+
Sbjct: 186 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 221

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 72/307 (23%), Positives = 128/307 (41%), Gaps = 57/307 (18%)
Query: 3   WTRGHTIGQGSSATVSLATS-LRSGDVFAAKSTELPKSEFLQR---EQKFLSSLNSPHIV 58
           +T+   IG+G+   VS A   +R   V   K +      + QR   E + L      +++
Sbjct: 45  YTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVI 104
Query: 59  GYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHR--NGGRLDESLIVSYTRQILQGLEYL 116
           G +   + +   + M ++   Y     +  ++++     +L    I  +  QIL+GL+Y+
Sbjct: 105 GIRDI-LRASTLEAMRDV---YIVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLKYI 160
Query: 117 HSNRVVHCDIKSRNILMAES-GAKIADFGCAKW-ESEALQSG------GTPMFMAPEVAR 168
           HS  V+H D+K  N+L+  +   KI DFG A+  + E   +G       T  + APE+  
Sbjct: 161 HSANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIML 220
Query: 169 GEHQGFAS--DIWAVGCTVIEMASGGAPWP------------------------------ 196
              +G+    DIW+VGC + EM S    +P                              
Sbjct: 221 NS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINMK 279
Query: 197 --NAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEE 254
             N    +    K+A+++  P+       +A D L   L  +P +R    + L HP+LE+
Sbjct: 280 ARNYLQSLPSKTKVAWAKLFPKS----DSKALDLLDRMLTFNPNKRITVEEALAHPYLEQ 335
Query: 255 FCSCTKQ 261
           +   T +
Sbjct: 336 YYDPTDE 342

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 64/284 (22%), Positives = 119/284 (41%), Gaps = 39/284 (13%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ-----REQKFLSSLNSPHIVGYKGC 63
           +G G+  +V  A   ++G   A K    P    +      RE + L  +   +++G    
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 64  DVTSEDNKLMYNLFM-EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
              +   +   ++++  +  G  LN+ +     +L +  +     QIL+GL+Y+HS  ++
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQFLIYQILRGLKYIHSADII 147
Query: 123 HCDIKSRNILMAES-GAKIADFGCAKW-ESEALQSGGTPMFMAPEVARG-EHQGFASDIW 179
           H D+K  N+ + E    KI D G A+  + E      T  + APE+     H     DIW
Sbjct: 148 HRDLKPSNLAVNEDCELKILDAGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 207
Query: 180 AVGCTVIEMASGGAPWP--NAADPMTVLYKIA------------------YSRELPEVP- 218
           +VGC + E+ +G   +P  +  D + ++ ++                   Y + L ++P 
Sbjct: 208 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 267
Query: 219 -----AFLSKQ--ANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
                 F+     A D L   L  D  +R  A+Q L H +  ++
Sbjct: 268 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 66/258 (25%), Positives = 108/258 (41%), Gaps = 27/258 (10%)
Query: 6   GHTIGQGSSATV-----------SLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNS 54
           G  IG+G    V           +LA ++++     + S    + +FLQ E   +   + 
Sbjct: 15  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSV---REKFLQ-EALTMRQFDH 70
Query: 55  PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLE 114
           PHIV   G  V +E+      + ME    G L   +      LD + ++ Y  Q+   L 
Sbjct: 71  PHIVKLIG--VITENPVW---IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALA 125
Query: 115 YLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEAL----QSGGTPM-FMAPEVAR 168
           YL S R VH DI +RN+L++ +   K+ DFG +++  ++       G  P+ +MAPE   
Sbjct: 126 YLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 185
Query: 169 GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDF 228
                 ASD+W  G  + E+   G           V+ +I     LP +P          
Sbjct: 186 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP-MPPNCPPTLYSL 244
Query: 229 LSNCLRRDPKERWAASQL 246
           ++ C   DP  R   ++L
Sbjct: 245 MTKCWAYDPSRRPRFTEL 262

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 64/284 (22%), Positives = 119/284 (41%), Gaps = 39/284 (13%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ-----REQKFLSSLNSPHIVGYKGC 63
           +G G+  +V  A   ++G   A K    P    +      RE + L  +   +++G    
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 64  DVTSEDNKLMYNLFM-EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
              +   +   ++++  +  G  LN+ +     +L +  +     QIL+GL+Y+HS  ++
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQFLIYQILRGLKYIHSADII 147
Query: 123 HCDIKSRNILMAES-GAKIADFGCAKW-ESEALQSGGTPMFMAPEVARG-EHQGFASDIW 179
           H D+K  N+ + E    KI D G A+  + E      T  + APE+     H     DIW
Sbjct: 148 HRDLKPSNLAVNEDCELKILDRGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 207
Query: 180 AVGCTVIEMASGGAPWP--NAADPMTVLYKIA------------------YSRELPEVP- 218
           +VGC + E+ +G   +P  +  D + ++ ++                   Y + L ++P 
Sbjct: 208 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 267
Query: 219 -----AFLSKQ--ANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
                 F+     A D L   L  D  +R  A+Q L H +  ++
Sbjct: 268 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 77/156 (49%), Gaps = 12/156 (7%)
Query: 45  EQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVS 104
           E   ++S+++PH+    G  +TS        L M+  P G L D +  +   +    +++
Sbjct: 69  EAYVMASVDNPHVCRLLGICLTS-----TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLN 123
Query: 105 YTRQILQGLEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKW----ESEALQSGG-T 158
           +  QI +G+ YL   R+VH D+ +RN+L+      KI DFG AK     E E    GG  
Sbjct: 124 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV 183
Query: 159 PM-FMAPEVARGEHQGFASDIWAVGCTVIEMASGGA 193
           P+ +MA E          SD+W+ G TV E+ + G+
Sbjct: 184 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 219

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 66/258 (25%), Positives = 108/258 (41%), Gaps = 27/258 (10%)
Query: 6   GHTIGQGSSATV-----------SLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNS 54
           G  IG+G    V           +LA ++++     + S    + +FLQ E   +   + 
Sbjct: 18  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSV---REKFLQ-EALTMRQFDH 73
Query: 55  PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLE 114
           PHIV   G  V +E+      + ME    G L   +      LD + ++ Y  Q+   L 
Sbjct: 74  PHIVKLIG--VITENPVW---IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALA 128
Query: 115 YLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEAL----QSGGTPM-FMAPEVAR 168
           YL S R VH DI +RN+L++ +   K+ DFG +++  ++       G  P+ +MAPE   
Sbjct: 129 YLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 188
Query: 169 GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDF 228
                 ASD+W  G  + E+   G           V+ +I     LP +P          
Sbjct: 189 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP-MPPNCPPTLYSL 247
Query: 229 LSNCLRRDPKERWAASQL 246
           ++ C   DP  R   ++L
Sbjct: 248 MTKCWAYDPSRRPRFTEL 265

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 77/156 (49%), Gaps = 12/156 (7%)
Query: 45  EQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVS 104
           E   ++S+++PH+    G  +TS        L M+  P G L D +  +   +    +++
Sbjct: 69  EAYVMASVDNPHVCRLLGICLTST-----VQLIMQLMPFGCLLDYVREHKDNIGSQYLLN 123
Query: 105 YTRQILQGLEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKW----ESEALQSGG-T 158
           +  QI +G+ YL   R+VH D+ +RN+L+      KI DFG AK     E E    GG  
Sbjct: 124 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV 183
Query: 159 PM-FMAPEVARGEHQGFASDIWAVGCTVIEMASGGA 193
           P+ +MA E          SD+W+ G TV E+ + G+
Sbjct: 184 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 219

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 92/184 (50%), Gaps = 21/184 (11%)
Query: 79  EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG- 137
           E+ P     ++++++   L+   ++ Y+ Q+ +G+E+L S + +H D+ +RNIL++E   
Sbjct: 129 EFVPYKVAPEDLYKDFLTLEH--LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV 186
Query: 138 AKIADFGCAK---WESEALQSGGTPM---FMAPEVARGEHQGFASDIWAVGCTVIEMAS- 190
            KI DFG A+    + + ++ G   +   +MAPE          SD+W+ G  + E+ S 
Sbjct: 187 VKICDFGLARDIYKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 246
Query: 191 GGAPWPNAADPMTVLYKIAYSRELPE-----VPAFLSKQANDFLSNCLRRDPKERWAASQ 245
           G +P+P       V     + R L E      P + + +    + +C   +P +R   S+
Sbjct: 247 GASPYPG------VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSE 300
Query: 246 LLKH 249
           L++H
Sbjct: 301 LVEH 304

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 92/215 (42%), Gaps = 13/215 (6%)
Query: 38  KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRL 97
           + +FLQ E   +   + PHIV   G  V +E+      + ME    G L   +      L
Sbjct: 55  REKFLQ-EALTMRQFDHPHIVKLIG--VITENPVW---IIMELCTLGELRSFLQVRKFSL 108
Query: 98  DESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKWESEAL--- 153
           D + ++ Y  Q+   L YL S R VH DI +RN+L+ A    K+ DFG +++  ++    
Sbjct: 109 DLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYK 168
Query: 154 -QSGGTPM-FMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYS 211
              G  P+ +MAPE         ASD+W  G  + E+   G           V+ +I   
Sbjct: 169 ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG 228
Query: 212 RELPEVPAFLSKQANDFLSNCLRRDPKERWAASQL 246
             LP +P          ++ C   DP  R   ++L
Sbjct: 229 ERLP-MPPNCPPTLYSLMTKCWAYDPSRRPRFTEL 262

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 48/184 (26%), Positives = 92/184 (50%), Gaps = 21/184 (11%)
Query: 79  EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG- 137
           E+ P     ++++++   L+   ++ Y+ Q+ +G+E+L S + +H D+ +RNIL++E   
Sbjct: 129 EFVPYKVAPEDLYKDFLTLEH--LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV 186
Query: 138 AKIADFGCAK---WESEALQSGGTPM---FMAPEVARGEHQGFASDIWAVGCTVIEMASG 191
            KI DFG A+    + + ++ G   +   +MAPE          SD+W+ G  + E+ S 
Sbjct: 187 VKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 246
Query: 192 GA-PWPNAADPMTVLYKIAYSRELPE-----VPAFLSKQANDFLSNCLRRDPKERWAASQ 245
           GA P+P       V     + R L E      P + + +    + +C   +P +R   S+
Sbjct: 247 GASPYPG------VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSE 300
Query: 246 LLKH 249
           L++H
Sbjct: 301 LVEH 304

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 82/155 (52%), Gaps = 10/155 (6%)
Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWES-----EALQS 155
           +VS T Q+ +G+EYL S + +H D+ +RN+L+ E+   +IADFG A+  +     +   +
Sbjct: 159 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTN 218
Query: 156 GGTPM-FMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRE 213
           G  P+ +MAPE          SD+W+ G  + E+ + GG+P+P    P+  L+K+     
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI--PVEELFKLLKEGH 276
Query: 214 LPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLK 248
             + PA  + +    + +C    P +R    QL++
Sbjct: 277 RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/248 (25%), Positives = 111/248 (44%), Gaps = 16/248 (6%)
Query: 9   IGQGSSATVSLATSLRSGDVFAA--KSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDVT 66
           +G G    V L       DV     K   + + EF Q  Q  +  L+ P +V + G  V 
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMK-LSHPKLVKFYG--VC 72
Query: 67  SEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDI 126
           S++  +   +  EY   G L + +  +G  L+ S ++     + +G+ +L S++ +H D+
Sbjct: 73  SKEYPIY--IVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDL 130
Query: 127 KSRNILM-AESGAKIADFGCAKW--ESEALQSGGTPM---FMAPEVARGEHQGFASDIWA 180
            +RN L+  +   K++DFG  ++  + + + S GT     + APEV         SD+WA
Sbjct: 131 AARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWA 190
Query: 181 VGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKE 239
            G  + E+ S G  P+    +   VL K++    L   P   S      + +C    P++
Sbjct: 191 FGILMWEVFSLGKMPYDLYTNSEVVL-KVSQGHRLYR-PHLASDTIYQIMYSCWHELPEK 248
Query: 240 RWAASQLL 247
           R    QLL
Sbjct: 249 RPTFQQLL 256

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 92/184 (50%), Gaps = 21/184 (11%)
Query: 79  EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG- 137
           E+ P     ++++++   L+   ++ Y+ Q+ +G+E+L S + +H D+ +RNIL++E   
Sbjct: 120 EFVPYKVAPEDLYKDFLTLEH--LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV 177
Query: 138 AKIADFGCAK---WESEALQSGGTPM---FMAPEVARGEHQGFASDIWAVGCTVIEMAS- 190
            KI DFG A+    + + ++ G   +   +MAPE          SD+W+ G  + E+ S 
Sbjct: 178 VKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 237
Query: 191 GGAPWPNAADPMTVLYKIAYSRELPE-----VPAFLSKQANDFLSNCLRRDPKERWAASQ 245
           G +P+P       V     + R L E      P + + +    + +C   +P +R   S+
Sbjct: 238 GASPYPG------VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSE 291
Query: 246 LLKH 249
           L++H
Sbjct: 292 LVEH 295

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/258 (25%), Positives = 108/258 (41%), Gaps = 27/258 (10%)
Query: 6   GHTIGQGSSATV-----------SLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNS 54
           G  IG+G    V           +LA ++++     + S    + +FLQ E   +   + 
Sbjct: 12  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSV---REKFLQ-EALTMRQFDH 67
Query: 55  PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLE 114
           PHIV   G  V +E+      + ME    G L   +      LD + ++ Y  Q+   L 
Sbjct: 68  PHIVKLIG--VITENPVW---IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALA 122
Query: 115 YLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEAL----QSGGTPM-FMAPEVAR 168
           YL S R VH DI +RN+L++ +   K+ DFG +++  ++       G  P+ +MAPE   
Sbjct: 123 YLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 182
Query: 169 GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDF 228
                 ASD+W  G  + E+   G           V+ +I     LP +P          
Sbjct: 183 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP-MPPNCPPTLYSL 241
Query: 229 LSNCLRRDPKERWAASQL 246
           ++ C   DP  R   ++L
Sbjct: 242 MTKCWAYDPSRRPRFTEL 259

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 92/184 (50%), Gaps = 21/184 (11%)
Query: 79  EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG- 137
           E+ P     ++++++   L+   ++ Y+ Q+ +G+E+L S + +H D+ +RNIL++E   
Sbjct: 120 EFVPYKVAPEDLYKDFLTLEH--LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV 177
Query: 138 AKIADFGCAK---WESEALQSGGTPM---FMAPEVARGEHQGFASDIWAVGCTVIEMAS- 190
            KI DFG A+    + + ++ G   +   +MAPE          SD+W+ G  + E+ S 
Sbjct: 178 VKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 237
Query: 191 GGAPWPNAADPMTVLYKIAYSRELPE-----VPAFLSKQANDFLSNCLRRDPKERWAASQ 245
           G +P+P       V     + R L E      P + + +    + +C   +P +R   S+
Sbjct: 238 GASPYPG------VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSE 291
Query: 246 LLKH 249
           L++H
Sbjct: 292 LVEH 295

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/284 (22%), Positives = 119/284 (41%), Gaps = 39/284 (13%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ-----REQKFLSSLNSPHIVGYKGC 63
           +G G+  +V  A   ++G   A K    P    +      RE + L  +   +++G    
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 64  DVTSEDNKLMYNLFM-EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
              +   +   ++++  +  G  LN+ +     +L +  +     QIL+GL+Y+HS  ++
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQFLIYQILRGLKYIHSADII 147
Query: 123 HCDIKSRNILMAES-GAKIADFGCAKW-ESEALQSGGTPMFMAPEVARG-EHQGFASDIW 179
           H D+K  N+ + E    KI D G A+  + E      T  + APE+     H     DIW
Sbjct: 148 HRDLKPSNLAVNEDCELKILDGGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 207
Query: 180 AVGCTVIEMASGGAPWP--NAADPMTVLYKIA------------------YSRELPEVP- 218
           +VGC + E+ +G   +P  +  D + ++ ++                   Y + L ++P 
Sbjct: 208 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 267
Query: 219 -----AFLSKQ--ANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
                 F+     A D L   L  D  +R  A+Q L H +  ++
Sbjct: 268 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 93/215 (43%), Gaps = 13/215 (6%)
Query: 38  KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRL 97
           + +FLQ E   +   + PHIV   G  V +E+      + ME    G L   +      L
Sbjct: 55  REKFLQ-EALTMRQFDHPHIVKLIG--VITENPVW---IIMELCTLGELRSFLQVRKFSL 108
Query: 98  DESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQ-- 154
           D + ++ Y  Q+   L YL S R VH DI +RN+L++ +   K+ DFG +++  ++    
Sbjct: 109 DLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXK 168
Query: 155 --SGGTPM-FMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYS 211
              G  P+ +MAPE         ASD+W  G  + E+   G           V+ +I   
Sbjct: 169 ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG 228
Query: 212 RELPEVPAFLSKQANDFLSNCLRRDPKERWAASQL 246
             LP +P          ++ C   DP  R   ++L
Sbjct: 229 ERLP-MPPNCPPTLYSLMTKCWAYDPSRRPRFTEL 262

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 92/184 (50%), Gaps = 21/184 (11%)
Query: 79  EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG- 137
           E+ P     ++++++   L+   ++ Y+ Q+ +G+E+L S + +H D+ +RNIL++E   
Sbjct: 129 EFVPYKVAPEDLYKDFLTLEH--LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV 186
Query: 138 AKIADFGCAK---WESEALQSGGTPM---FMAPEVARGEHQGFASDIWAVGCTVIEMAS- 190
            KI DFG A+    + + ++ G   +   +MAPE          SD+W+ G  + E+ S 
Sbjct: 187 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 246
Query: 191 GGAPWPNAADPMTVLYKIAYSRELPE-----VPAFLSKQANDFLSNCLRRDPKERWAASQ 245
           G +P+P       V     + R L E      P + + +    + +C   +P +R   S+
Sbjct: 247 GASPYPG------VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSE 300
Query: 246 LLKH 249
           L++H
Sbjct: 301 LVEH 304

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/258 (25%), Positives = 108/258 (41%), Gaps = 27/258 (10%)
Query: 6   GHTIGQGSSATV-----------SLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNS 54
           G  IG+G    V           +LA ++++     + S    + +FLQ E   +   + 
Sbjct: 17  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSV---REKFLQ-EALTMRQFDH 72
Query: 55  PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLE 114
           PHIV   G  V +E+      + ME    G L   +      LD + ++ Y  Q+   L 
Sbjct: 73  PHIVKLIG--VITENPVW---IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALA 127
Query: 115 YLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEAL----QSGGTPM-FMAPEVAR 168
           YL S R VH DI +RN+L++ +   K+ DFG +++  ++       G  P+ +MAPE   
Sbjct: 128 YLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 187
Query: 169 GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDF 228
                 ASD+W  G  + E+   G           V+ +I     LP +P          
Sbjct: 188 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP-MPPNCPPTLYSL 246
Query: 229 LSNCLRRDPKERWAASQL 246
           ++ C   DP  R   ++L
Sbjct: 247 MTKCWAYDPSRRPRFTEL 264

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 114/250 (45%), Gaps = 16/250 (6%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTE--LPKSEFLQREQKFLSSLNSPHIVGYKGCDVT 66
           IG G    V L   L    V      E  + + +F++ E + +  L+ P +V   G  + 
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIE-EAEVMMKLSHPKLVQLYGVCLE 76
Query: 67  SEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDI 126
                L++  FME+   G L+D +    G      ++     + +G+ YL    V+H D+
Sbjct: 77  QAPICLVFE-FMEH---GCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDL 132
Query: 127 KSRNILMAESGA-KIADFGCAKW--ESEALQSGGTPM---FMAPEVARGEHQGFASDIWA 180
            +RN L+ E+   K++DFG  ++  + +   S GT     + +PEV         SD+W+
Sbjct: 133 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 192
Query: 181 VGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKE 239
            G  + E+ S G  P+ N ++   V+  I+    L + P   S      +++C R  P++
Sbjct: 193 FGVLMWEVFSEGKIPYENRSNS-EVVEDISTGFRLYK-PRLASTHVYQIMNHCWRERPED 250
Query: 240 RWAASQLLKH 249
           R A S+LL+ 
Sbjct: 251 RPAFSRLLRQ 260

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 92/184 (50%), Gaps = 21/184 (11%)
Query: 79  EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG- 137
           E+ P     ++++++   L+   ++ Y+ Q+ +G+E+L S + +H D+ +RNIL++E   
Sbjct: 120 EFVPYKVAPEDLYKDFLTLEH--LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV 177
Query: 138 AKIADFGCAK---WESEALQSGGTPM---FMAPEVARGEHQGFASDIWAVGCTVIEMAS- 190
            KI DFG A+    + + ++ G   +   +MAPE          SD+W+ G  + E+ S 
Sbjct: 178 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 237
Query: 191 GGAPWPNAADPMTVLYKIAYSRELPE-----VPAFLSKQANDFLSNCLRRDPKERWAASQ 245
           G +P+P       V     + R L E      P + + +    + +C   +P +R   S+
Sbjct: 238 GASPYPG------VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSE 291
Query: 246 LLKH 249
           L++H
Sbjct: 292 LVEH 295

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 97/215 (45%), Gaps = 20/215 (9%)
Query: 55  PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLE 114
           P+I+  K    T E N   + +F +    G L D +      L E       R +L+ + 
Sbjct: 84  PNIIQLKD---TYETNTFFFLVF-DLMKKGELFDYLTEKVT-LSEKETRKIMRALLEVIC 138
Query: 115 YLHSNRVVHCDIKSRNILMAES-GAKIADFG--CAKWESEALQSG-GTPMFMAPEVAR-- 168
            LH   +VH D+K  NIL+ +    K+ DFG  C     E L+S  GTP ++APE+    
Sbjct: 139 ALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRSVCGTPSYLAPEIIECS 198
Query: 169 --GEHQGFAS--DIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA---YSRELPEVPAFL 221
               H G+    D+W+ G  +  + +G  P+ +    M +L  I    Y    PE   + 
Sbjct: 199 MNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ-MLMLRMIMSGNYQFGSPEWDDY- 256
Query: 222 SKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFC 256
           S    D +S  L   P++R+ A + L HPF +++ 
Sbjct: 257 SDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 291

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/258 (25%), Positives = 108/258 (41%), Gaps = 27/258 (10%)
Query: 6   GHTIGQGSSATV-----------SLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNS 54
           G  IG+G    V           +LA ++++     + S    + +FLQ E   +   + 
Sbjct: 43  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSV---REKFLQ-EALTMRQFDH 98
Query: 55  PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLE 114
           PHIV   G  V +E+      + ME    G L   +      LD + ++ Y  Q+   L 
Sbjct: 99  PHIVKLIG--VITENPVW---IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALA 153
Query: 115 YLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEAL----QSGGTPM-FMAPEVAR 168
           YL S R VH DI +RN+L++ +   K+ DFG +++  ++       G  P+ +MAPE   
Sbjct: 154 YLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 213
Query: 169 GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDF 228
                 ASD+W  G  + E+   G           V+ +I     LP +P          
Sbjct: 214 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP-MPPNCPPTLYSL 272
Query: 229 LSNCLRRDPKERWAASQL 246
           ++ C   DP  R   ++L
Sbjct: 273 MTKCWAYDPSRRPRFTEL 290

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 92/184 (50%), Gaps = 21/184 (11%)
Query: 79  EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG- 137
           E+ P     ++++++   L+   ++ Y+ Q+ +G+E+L S + +H D+ +RNIL++E   
Sbjct: 120 EFVPYKVAPEDLYKDFLTLEH--LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV 177
Query: 138 AKIADFGCAK---WESEALQSGGTPM---FMAPEVARGEHQGFASDIWAVGCTVIEMAS- 190
            KI DFG A+    + + ++ G   +   +MAPE          SD+W+ G  + E+ S 
Sbjct: 178 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 237
Query: 191 GGAPWPNAADPMTVLYKIAYSRELPE-----VPAFLSKQANDFLSNCLRRDPKERWAASQ 245
           G +P+P       V     + R L E      P + + +    + +C   +P +R   S+
Sbjct: 238 GASPYPG------VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSE 291
Query: 246 LLKH 249
           L++H
Sbjct: 292 LVEH 295

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 90/193 (46%), Gaps = 12/193 (6%)
Query: 76  LFMEYAPGGTLNDEIHRNGGR-LDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMA 134
           +  EY   G+L D +    GR L    +V    Q+  G+ Y+     +H D++S NIL+ 
Sbjct: 80  IVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVG 139
Query: 135 ESG-AKIADFGCAKW----ESEALQSGGTPM-FMAPEVARGEHQGFASDIWAVGCTVIEM 188
                KIADFG A+     E  A Q    P+ + APE A        SD+W+ G  + E+
Sbjct: 140 NGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 199
Query: 189 ASGG-APWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLL 247
            + G  P+P   +   VL ++     +P  P       ++ + +C ++DP+ER     L 
Sbjct: 200 VTKGRVPYPGMNN-REVLEQVERGYRMP-CPQDCPISLHELMIHCWKKDPEERPTFEYL- 256
Query: 248 KHPFLEEFCSCTK 260
              FLE++ + T+
Sbjct: 257 -QSFLEDYFTATE 268

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/258 (25%), Positives = 108/258 (41%), Gaps = 27/258 (10%)
Query: 6   GHTIGQGSSATV-----------SLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNS 54
           G  IG+G    V           +LA ++++     + S    + +FLQ E   +   + 
Sbjct: 20  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSV---REKFLQ-EALTMRQFDH 75
Query: 55  PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLE 114
           PHIV   G  V +E+      + ME    G L   +      LD + ++ Y  Q+   L 
Sbjct: 76  PHIVKLIG--VITENPVW---IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALA 130
Query: 115 YLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEAL----QSGGTPM-FMAPEVAR 168
           YL S R VH DI +RN+L++ +   K+ DFG +++  ++       G  P+ +MAPE   
Sbjct: 131 YLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 190
Query: 169 GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDF 228
                 ASD+W  G  + E+   G           V+ +I     LP +P          
Sbjct: 191 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP-MPPNCPPTLYSL 249
Query: 229 LSNCLRRDPKERWAASQL 246
           ++ C   DP  R   ++L
Sbjct: 250 MTKCWAYDPSRRPRFTEL 267

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/184 (26%), Positives = 92/184 (50%), Gaps = 21/184 (11%)
Query: 79  EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG- 137
           E+ P     ++++++   L+   ++ Y+ Q+ +G+E+L S + +H D+ +RNIL++E   
Sbjct: 166 EFVPYKVAPEDLYKDFLTLEH--LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV 223
Query: 138 AKIADFGCAK---WESEALQSGGTPM---FMAPEVARGEHQGFASDIWAVGCTVIEMASG 191
            KI DFG A+    + + ++ G   +   +MAPE          SD+W+ G  + E+ S 
Sbjct: 224 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 283
Query: 192 GA-PWPNAADPMTVLYKIAYSRELPE-----VPAFLSKQANDFLSNCLRRDPKERWAASQ 245
           GA P+P       V     + R L E      P + + +    + +C   +P +R   S+
Sbjct: 284 GASPYPG------VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSE 337
Query: 246 LLKH 249
           L++H
Sbjct: 338 LVEH 341

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 93/215 (43%), Gaps = 13/215 (6%)
Query: 38  KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRL 97
           + +FLQ E   +   + PHIV   G  V +E+      + ME    G L   +      L
Sbjct: 55  REKFLQ-EALTMRQFDHPHIVKLIG--VITENPVW---IIMELCTLGELRSFLQVRKYSL 108
Query: 98  DESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEAL--- 153
           D + ++ Y  Q+   L YL S R VH DI +RN+L++ +   K+ DFG +++  ++    
Sbjct: 109 DLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK 168
Query: 154 -QSGGTPM-FMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYS 211
              G  P+ +MAPE         ASD+W  G  + E+   G           V+ +I   
Sbjct: 169 ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG 228
Query: 212 RELPEVPAFLSKQANDFLSNCLRRDPKERWAASQL 246
             LP +P          ++ C   DP  R   ++L
Sbjct: 229 ERLP-MPPNCPPTLYSLMTKCWAYDPSRRPRFTEL 262

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 99/240 (41%), Gaps = 48/240 (20%)
Query: 97  LDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKWESEALQS 155
           LD   +     Q+L G+++LHS  ++H D+K  NI++ +++  KI DFG A+    +   
Sbjct: 123 LDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMM 182
Query: 156 GG---TPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWP---------------- 196
                T  + APEV  G       DIW+VGC + EM  GG  +P                
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLG 242
Query: 197 -------NAADPMTVLYK--------IAYSRELPEV--PA------FLSKQANDFLSNCL 233
                      P    Y          ++ +  P+V  PA        + QA D LS  L
Sbjct: 243 TPSPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKML 302
Query: 234 RRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSILDQGIWNSVEETEESLGNLIH 293
             D  +R +  + L+HP++  +   +    E+   P  I D+ + +  E T E    LI+
Sbjct: 303 VIDASKRISVDEALQHPYINVWYDPS----EAEAPPPKIPDKQL-DEREHTIEEWKELIY 357

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/188 (26%), Positives = 94/188 (50%), Gaps = 26/188 (13%)
Query: 75  NLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMA 134
           N F+ Y P     ++++++   L+   ++ Y+ Q+ +G+E+L S + +H D+ +RNIL++
Sbjct: 130 NEFVPYKP-----EDLYKDFLTLEH--LIXYSFQVAKGMEFLASRKXIHRDLAARNILLS 182
Query: 135 ESG-AKIADFGCAK---WESEALQSGGTPM---FMAPEVARGEHQGFASDIWAVGCTVIE 187
           E    KI DFG A+    + + ++ G   +   +MAPE          SD+W+ G  + E
Sbjct: 183 EKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE 242
Query: 188 MAS-GGAPWPNAADPMTVLYKIAYSRELPE-----VPAFLSKQANDFLSNCLRRDPKERW 241
           + S G +P+P       V     + R L E      P + + +    + +C   +P +R 
Sbjct: 243 IFSLGASPYPG------VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP 296
Query: 242 AASQLLKH 249
             S+L++H
Sbjct: 297 TFSELVEH 304

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 92/215 (42%), Gaps = 13/215 (6%)
Query: 38  KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRL 97
           + +FLQ E   +   + PHIV   G  V +E+      + ME    G L   +      L
Sbjct: 435 REKFLQ-EALTMRQFDHPHIVKLIG--VITENPVW---IIMELCTLGELRSFLQVRKFSL 488
Query: 98  DESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKWESEAL--- 153
           D + ++ Y  Q+   L YL S R VH DI +RN+L+ A    K+ DFG +++  ++    
Sbjct: 489 DLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYK 548
Query: 154 -QSGGTPM-FMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYS 211
              G  P+ +MAPE         ASD+W  G  + E+   G           V+ +I   
Sbjct: 549 ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG 608
Query: 212 RELPEVPAFLSKQANDFLSNCLRRDPKERWAASQL 246
             LP +P          ++ C   DP  R   ++L
Sbjct: 609 ERLP-MPPNCPPTLYSLMTKCWAYDPSRRPRFTEL 642

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 91/196 (46%), Gaps = 25/196 (12%)
Query: 76  LFMEYAPGGTLNDEI---------------HRNGGRLDESLIVSYTRQILQGLEYLHSNR 120
           + +EYA  G L + +               H    +L    +VS   Q+ +G+EYL S +
Sbjct: 111 VIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK 170
Query: 121 VVHCDIKSRNILMAESGA-KIADFGCAK-----WESEALQSGGTPM-FMAPEVARGEHQG 173
            +H D+ +RN+L+ E    KIADFG A+        +   +G  P+ +MAPE        
Sbjct: 171 CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNGRLPVKWMAPEALFDRIYT 230
Query: 174 FASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNC 232
             SD+W+ G  + E+ + GG+P+P    P+  L+K+       + P+  + +    + +C
Sbjct: 231 HQSDVWSFGVLLWEIFTLGGSPYPGV--PVEELFKLLKEGHRMDKPSNCTNELYMMMRDC 288
Query: 233 LRRDPKERWAASQLLK 248
               P +R    QL++
Sbjct: 289 WHAVPSQRPTFKQLVE 304

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 95/208 (45%), Gaps = 22/208 (10%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGD-------VFAAKSTELPKS--EFLQREQKFLSSL 52
           ++ +   +G G+  TV     +  G+       +   +    PK+  E L  E   ++S+
Sbjct: 50  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILD-EAYVMASV 108
Query: 53  NSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQG 112
           ++PH+    G  +TS        L  +  P G L D +  +   +    ++++  QI +G
Sbjct: 109 DNPHVCRLLGICLTST-----VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 163
Query: 113 LEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKW----ESEALQSGG-TPM-FMAPE 165
           + YL   R+VH D+ +RN+L+      KI DFG AK     E E    GG  P+ +MA E
Sbjct: 164 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 223
Query: 166 VARGEHQGFASDIWAVGCTVIEMASGGA 193
                     SD+W+ G TV E+ + G+
Sbjct: 224 SILHRIYTHQSDVWSYGVTVWELMTFGS 251

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 76/156 (48%), Gaps = 12/156 (7%)
Query: 45  EQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVS 104
           E   ++S+++PH+    G  +TS        L  +  P G L D +  +   +    +++
Sbjct: 61  EAYVMASVDNPHVCRLLGICLTST-----VQLITQLMPFGCLLDYVREHKDNIGSQYLLN 115
Query: 105 YTRQILQGLEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKW----ESEALQSGG-T 158
           +  QI +G+ YL   R+VH D+ +RN+L+      KI DFG AK     E E    GG  
Sbjct: 116 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 175
Query: 159 PM-FMAPEVARGEHQGFASDIWAVGCTVIEMASGGA 193
           P+ +MA E          SD+W+ G TV E+ + G+
Sbjct: 176 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 211

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 92/184 (50%), Gaps = 21/184 (11%)
Query: 79  EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG- 137
           E+ P     ++++++   L+   ++ Y+ Q+ +G+E+L S + +H D+ +RNIL++E   
Sbjct: 131 EFVPYKEAPEDLYKDFLTLEH--LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV 188
Query: 138 AKIADFGCAK---WESEALQSGGTPM---FMAPEVARGEHQGFASDIWAVGCTVIEMAS- 190
            KI DFG A+    + + ++ G   +   +MAPE          SD+W+ G  + E+ S 
Sbjct: 189 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 248
Query: 191 GGAPWPNAADPMTVLYKIAYSRELPE-----VPAFLSKQANDFLSNCLRRDPKERWAASQ 245
           G +P+P       V     + R L E      P + + +    + +C   +P +R   S+
Sbjct: 249 GASPYPG------VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSE 302
Query: 246 LLKH 249
           L++H
Sbjct: 303 LVEH 306

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 93/215 (43%), Gaps = 13/215 (6%)
Query: 38  KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRL 97
           + +FLQ E   +   + PHIV   G  V +E+      + ME    G L   +      L
Sbjct: 435 REKFLQ-EALTMRQFDHPHIVKLIG--VITENPVW---IIMELCTLGELRSFLQVRKFSL 488
Query: 98  DESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEAL--- 153
           D + ++ Y  Q+   L YL S R VH DI +RN+L++ +   K+ DFG +++  ++    
Sbjct: 489 DLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK 548
Query: 154 -QSGGTPM-FMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYS 211
              G  P+ +MAPE         ASD+W  G  + E+   G           V+ +I   
Sbjct: 549 ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG 608
Query: 212 RELPEVPAFLSKQANDFLSNCLRRDPKERWAASQL 246
             LP +P          ++ C   DP  R   ++L
Sbjct: 609 ERLP-MPPNCPPTLYSLMTKCWAYDPSRRPRFTEL 642

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/182 (31%), Positives = 87/182 (47%), Gaps = 15/182 (8%)
Query: 33  STELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHR 92
           +TE  K +F Q E K ++     ++V   G     +D  L+Y     Y P G+L D +  
Sbjct: 69  TTEELKQQFDQ-EIKVMAKCQHENLVELLGFSSDGDDLCLVY----VYMPNGSLLDRLSC 123
Query: 93  NGGR--LDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES-GAKIADFGCAKWE 149
             G   L   +     +    G+ +LH N  +H DIKS NIL+ E+  AKI+DFG A+  
Sbjct: 124 LDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARAS 183
Query: 150 SEALQS------GGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMT 203
            +  Q+       GT  +MAPE  RGE     SDI++ G  ++E+ +G        +P  
Sbjct: 184 EKFAQTVMXSRIVGTTAYMAPEALRGEITP-KSDIYSFGVVLLEIITGLPAVDEHREPQL 242
Query: 204 VL 205
           +L
Sbjct: 243 LL 244

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/182 (31%), Positives = 87/182 (47%), Gaps = 15/182 (8%)
Query: 33  STELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHR 92
           +TE  K +F Q E K ++     ++V   G     +D  L+Y     Y P G+L D +  
Sbjct: 69  TTEELKQQFDQ-EIKVMAKCQHENLVELLGFSSDGDDLCLVY----VYMPNGSLLDRLSC 123
Query: 93  NGGR--LDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES-GAKIADFGCAKWE 149
             G   L   +     +    G+ +LH N  +H DIKS NIL+ E+  AKI+DFG A+  
Sbjct: 124 LDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARAS 183
Query: 150 SEALQS------GGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMT 203
            +  Q+       GT  +MAPE  RGE     SDI++ G  ++E+ +G        +P  
Sbjct: 184 EKFAQTVMXXRIVGTTAYMAPEALRGEITP-KSDIYSFGVVLLEIITGLPAVDEHREPQL 242
Query: 204 VL 205
           +L
Sbjct: 243 LL 244

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 76/156 (48%), Gaps = 12/156 (7%)
Query: 45  EQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVS 104
           E   ++S+++PH+    G  +TS        L  +  P G L D +  +   +    +++
Sbjct: 77  EAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGCLLDYVREHKDNIGSQYLLN 131
Query: 105 YTRQILQGLEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKW----ESEALQSGG-T 158
           +  QI +G+ YL   R+VH D+ +RN+L+      KI DFG AK     E E    GG  
Sbjct: 132 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 191
Query: 159 PM-FMAPEVARGEHQGFASDIWAVGCTVIEMASGGA 193
           P+ +MA E          SD+W+ G TV E+ + G+
Sbjct: 192 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 227

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/250 (25%), Positives = 114/250 (45%), Gaps = 16/250 (6%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTE--LPKSEFLQREQKFLSSLNSPHIVGYKGCDVT 66
           IG G    V L   L    V      E  + + +F++ E + +  L+ P +V   G  + 
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIE-EAEVMMKLSHPKLVQLYGVCLE 73
Query: 67  SEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDI 126
                L++  FME+   G L+D +    G      ++     + +G+ YL    V+H D+
Sbjct: 74  QAPICLVFE-FMEH---GCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEASVIHRDL 129
Query: 127 KSRNILMAESGA-KIADFGCAKW--ESEALQSGGTPM---FMAPEVARGEHQGFASDIWA 180
            +RN L+ E+   K++DFG  ++  + +   S GT     + +PEV         SD+W+
Sbjct: 130 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 189
Query: 181 VGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKE 239
            G  + E+ S G  P+ N ++   V+  I+    L + P   S      +++C +  P++
Sbjct: 190 FGVLMWEVFSEGKIPYENRSNS-EVVEDISTGFRLYK-PRLASTHVYQIMNHCWKERPED 247
Query: 240 RWAASQLLKH 249
           R A S+LL+ 
Sbjct: 248 RPAFSRLLRQ 257

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 76/156 (48%), Gaps = 12/156 (7%)
Query: 45  EQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVS 104
           E   ++S+++PH+    G  +TS        L  +  P G L D +  +   +    +++
Sbjct: 67  EAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGCLLDYVREHKDNIGSQYLLN 121
Query: 105 YTRQILQGLEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKW----ESEALQSGG-T 158
           +  QI +G+ YL   R+VH D+ +RN+L+      KI DFG AK     E E    GG  
Sbjct: 122 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 181
Query: 159 PM-FMAPEVARGEHQGFASDIWAVGCTVIEMASGGA 193
           P+ +MA E          SD+W+ G TV E+ + G+
Sbjct: 182 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 217

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 76/156 (48%), Gaps = 12/156 (7%)
Query: 45  EQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVS 104
           E   ++S+++PH+    G  +TS        L  +  P G L D +  +   +    +++
Sbjct: 67  EAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGXLLDYVREHKDNIGSQYLLN 121
Query: 105 YTRQILQGLEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKW----ESEALQSGG-T 158
           +  QI +G+ YL   R+VH D+ +RN+L+      KI DFG AK     E E    GG  
Sbjct: 122 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 181
Query: 159 PM-FMAPEVARGEHQGFASDIWAVGCTVIEMASGGA 193
           P+ +MA E          SD+W+ G TV E+ + G+
Sbjct: 182 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 217

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/250 (25%), Positives = 114/250 (45%), Gaps = 16/250 (6%)
Query: 9   IGQGSSATVSLATSLRSGDVF--AAKSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDVT 66
           IG G    V L   L    V     K   + + +F++ E + +  L+ P +V   G  + 
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSEDDFIE-EAEVMMKLSHPKLVQLYGVCLE 93
Query: 67  SEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDI 126
                L++  FME+   G L+D +    G      ++     + +G+ YL    V+H D+
Sbjct: 94  QAPICLVFE-FMEH---GCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDL 149
Query: 127 KSRNILMAESGA-KIADFGCAKW--ESEALQSGGTPM---FMAPEVARGEHQGFASDIWA 180
            +RN L+ E+   K++DFG  ++  + +   S GT     + +PEV         SD+W+
Sbjct: 150 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 209
Query: 181 VGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKE 239
            G  + E+ S G  P+ N ++   V+  I+    L + P   S      +++C +  P++
Sbjct: 210 FGVLMWEVFSEGKIPYENRSNS-EVVEDISTGFRLYK-PRLASTHVYQIMNHCWKERPED 267
Query: 240 RWAASQLLKH 249
           R A S+LL+ 
Sbjct: 268 RPAFSRLLRQ 277

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 82/192 (42%), Gaps = 39/192 (20%)
Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES-GAKIADFGCAKWESEALQSGG--- 157
           I  +  QIL+GL+Y+HS  V+H D+K  N+L+  +   KI DFG A+         G   
Sbjct: 126 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLT 185
Query: 158 ----TPMFMAPEVARGEHQGFAS--DIWAVGCTVIEMASG-------------------- 191
               T  + APE+     +G+    DIW+VGC + EM S                     
Sbjct: 186 EYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 244
Query: 192 GAPWPNAADPMTVLYKIAYSRELP---EVP-----AFLSKQANDFLSNCLRRDPKERWAA 243
           G+P     + +  L    Y   LP   +VP          +A D L   L  +P +R   
Sbjct: 245 GSPSQEDLNXIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEV 304
Query: 244 SQLLKHPFLEEF 255
            Q L HP+LE++
Sbjct: 305 EQALAHPYLEQY 316

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 76/156 (48%), Gaps = 12/156 (7%)
Query: 45  EQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVS 104
           E   ++S+++PH+    G  +TS        L  +  P G L D +  +   +    +++
Sbjct: 67  EAYVMASVDNPHVCRLLGICLTST-----VQLITQLMPFGCLLDYVREHKDNIGSQYLLN 121
Query: 105 YTRQILQGLEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKW----ESEALQSGG-T 158
           +  QI +G+ YL   R+VH D+ +RN+L+      KI DFG AK     E E    GG  
Sbjct: 122 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 181
Query: 159 PM-FMAPEVARGEHQGFASDIWAVGCTVIEMASGGA 193
           P+ +MA E          SD+W+ G TV E+ + G+
Sbjct: 182 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 217

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 91/196 (46%), Gaps = 25/196 (12%)
Query: 76  LFMEYAPGGTLNDEI---------------HRNGGRLDESLIVSYTRQILQGLEYLHSNR 120
           + +EYA  G L + +               H    +L    +VS   Q+ +G+EYL S +
Sbjct: 100 VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK 159
Query: 121 VVHCDIKSRNILMAESGA-KIADFGCAK-----WESEALQSGGTPM-FMAPEVARGEHQG 173
            +H D+ +RN+L+ E    KIADFG A+        +   +G  P+ +MAPE        
Sbjct: 160 CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT 219
Query: 174 FASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNC 232
             SD+W+ G  + E+ + GG+P+P    P+  L+K+       + P+  + +    + +C
Sbjct: 220 HQSDVWSFGVLLWEIFTLGGSPYPGV--PVEELFKLLKEGHRMDKPSNCTNELYMMMRDC 277
Query: 233 LRRDPKERWAASQLLK 248
               P +R    QL++
Sbjct: 278 WHAVPSQRPTFKQLVE 293

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 91/196 (46%), Gaps = 25/196 (12%)
Query: 76  LFMEYAPGGTLNDEI---------------HRNGGRLDESLIVSYTRQILQGLEYLHSNR 120
           + +EYA  G L + +               H    +L    +VS   Q+ +G+EYL S +
Sbjct: 96  VIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK 155
Query: 121 VVHCDIKSRNILMAESGA-KIADFGCAK-----WESEALQSGGTPM-FMAPEVARGEHQG 173
            +H D+ +RN+L+ E    KIADFG A+        +   +G  P+ +MAPE        
Sbjct: 156 CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT 215
Query: 174 FASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNC 232
             SD+W+ G  + E+ + GG+P+P    P+  L+K+       + P+  + +    + +C
Sbjct: 216 HQSDVWSFGVLLWEIFTLGGSPYPGV--PVEELFKLLKEGHRMDKPSNCTNELYMMMRDC 273
Query: 233 LRRDPKERWAASQLLK 248
               P +R    QL++
Sbjct: 274 WHAVPSQRPTFKQLVE 289

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 120/288 (41%), Gaps = 51/288 (17%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSL-------NSPHIVGYK 61
           +G+G+ A V  A SL++G  +A K  E        R  + + +L       N   ++ + 
Sbjct: 21  LGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEF- 79
Query: 62  GCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRV 121
                 ED+   Y +F E   GG++   I +     +E       R +   L++LH+  +
Sbjct: 80  -----FEDDTRFYLVF-EKLQGGSILAHIQKQK-HFNEREASRVVRDVAAALDFLHTKGI 132
Query: 122 VHCDIKSRNILMAE----SGAKIADF----------GCAKWESEALQSG-GTPMFMAPEV 166
            H D+K  NIL       S  KI DF           C    +  L +  G+  +MAPEV
Sbjct: 133 AHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEV 192
Query: 167 AR--GEHQGFAS---DIWAVGCTVIEMASGGAP----------WPNAADPMTVLYKIAYS 211
                +   F     D+W++G  +  M SG  P          W           K+  S
Sbjct: 193 VEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFES 252
Query: 212 -----RELPEVP-AFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLE 253
                 E P+   A +S +A D +S  L RD K+R +A+Q+L+HP+++
Sbjct: 253 IQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQ 300

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 83/192 (43%), Gaps = 39/192 (20%)
Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES-GAKIADFGCAKWESEALQSGG--- 157
           I  +  QIL+GL+Y+HS  V+H D+K  N+L+  +   KI DFG A+         G   
Sbjct: 124 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 183
Query: 158 ----TPMFMAPEVARGEHQGFAS--DIWAVGCTVIEMASGGAPWP--NAADPMTVLYKIA 209
               T  + APE+     +G+    DIW+VGC + EM S    +P  +  D +  +  I 
Sbjct: 184 EYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 242
Query: 210 YSRELPEVPAFLSKQAN--------------------------DFLSNCLRRDPKERWAA 243
            S E  ++   ++ +A                           D L   L  +P +R   
Sbjct: 243 GSPEQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEV 302
Query: 244 SQLLKHPFLEEF 255
            Q L HP+LE++
Sbjct: 303 EQALAHPYLEQY 314

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 76/156 (48%), Gaps = 12/156 (7%)
Query: 45  EQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVS 104
           E   ++S+++PH+    G  +TS        L  +  P G L D +  +   +    +++
Sbjct: 67  EAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGCLLDYVREHKDNIGSQYLLN 121
Query: 105 YTRQILQGLEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKW----ESEALQSGG-T 158
           +  QI +G+ YL   R+VH D+ +RN+L+      KI DFG AK     E E    GG  
Sbjct: 122 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 181
Query: 159 PM-FMAPEVARGEHQGFASDIWAVGCTVIEMASGGA 193
           P+ +MA E          SD+W+ G TV E+ + G+
Sbjct: 182 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 217

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 76/156 (48%), Gaps = 12/156 (7%)
Query: 45  EQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVS 104
           E   ++S+++PH+    G  +TS        L  +  P G L D +  +   +    +++
Sbjct: 74  EAYVMASVDNPHVCRLLGICLTST-----VQLITQLMPFGCLLDYVREHKDNIGSQYLLN 128
Query: 105 YTRQILQGLEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKW----ESEALQSGG-T 158
           +  QI +G+ YL   R+VH D+ +RN+L+      KI DFG AK     E E    GG  
Sbjct: 129 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 188
Query: 159 PM-FMAPEVARGEHQGFASDIWAVGCTVIEMASGGA 193
           P+ +MA E          SD+W+ G TV E+ + G+
Sbjct: 189 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 224

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 91/196 (46%), Gaps = 25/196 (12%)
Query: 76  LFMEYAPGGTLNDEI---------------HRNGGRLDESLIVSYTRQILQGLEYLHSNR 120
           + +EYA  G L + +               H    +L    +VS   Q+ +G+EYL S +
Sbjct: 104 VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK 163
Query: 121 VVHCDIKSRNILMAESGA-KIADFGCAK-----WESEALQSGGTPM-FMAPEVARGEHQG 173
            +H D+ +RN+L+ E    KIADFG A+        +   +G  P+ +MAPE        
Sbjct: 164 CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT 223
Query: 174 FASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNC 232
             SD+W+ G  + E+ + GG+P+P    P+  L+K+       + P+  + +    + +C
Sbjct: 224 HQSDVWSFGVLLWEIFTLGGSPYPGV--PVEELFKLLKEGHRMDKPSNCTNELYMMMRDC 281
Query: 233 LRRDPKERWAASQLLK 248
               P +R    QL++
Sbjct: 282 WHAVPSQRPTFKQLVE 297

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 76/156 (48%), Gaps = 12/156 (7%)
Query: 45  EQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVS 104
           E   ++S+++PH+    G  +TS        L  +  P G L D +  +   +    +++
Sbjct: 64  EAYVMASVDNPHVCRLLGICLTST-----VQLITQLMPFGCLLDYVREHKDNIGSQYLLN 118
Query: 105 YTRQILQGLEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKW----ESEALQSGG-T 158
           +  QI +G+ YL   R+VH D+ +RN+L+      KI DFG AK     E E    GG  
Sbjct: 119 WCVQIAEGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 178
Query: 159 PM-FMAPEVARGEHQGFASDIWAVGCTVIEMASGGA 193
           P+ +MA E          SD+W+ G TV E+ + G+
Sbjct: 179 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 214

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 91/196 (46%), Gaps = 25/196 (12%)
Query: 76  LFMEYAPGGTLNDEI---------------HRNGGRLDESLIVSYTRQILQGLEYLHSNR 120
           + +EYA  G L + +               H    +L    +VS   Q+ +G+EYL S +
Sbjct: 103 VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK 162
Query: 121 VVHCDIKSRNILMAESGA-KIADFGCAK-----WESEALQSGGTPM-FMAPEVARGEHQG 173
            +H D+ +RN+L+ E    KIADFG A+        +   +G  P+ +MAPE        
Sbjct: 163 CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT 222
Query: 174 FASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNC 232
             SD+W+ G  + E+ + GG+P+P    P+  L+K+       + P+  + +    + +C
Sbjct: 223 HQSDVWSFGVLLWEIFTLGGSPYPGV--PVEELFKLLKEGHRMDKPSNCTNELYMMMRDC 280
Query: 233 LRRDPKERWAASQLLK 248
               P +R    QL++
Sbjct: 281 WHAVPSQRPTFKQLVE 296

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 82/192 (42%), Gaps = 39/192 (20%)
Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES-GAKIADFGCAKWESEALQSGG--- 157
           I  +  QIL+GL+Y+HS  V+H D+K  N+L+  +   KI DFG A+         G   
Sbjct: 126 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLT 185
Query: 158 ----TPMFMAPEVARGEHQGFAS--DIWAVGCTVIEMASG-------------------- 191
               T  + APE+     +G+    DIW+VGC + EM S                     
Sbjct: 186 EYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 244
Query: 192 GAPWPNAADPMTVLYKIAYSRELP---EVP-----AFLSKQANDFLSNCLRRDPKERWAA 243
           G+P     + +  L    Y   LP   +VP          +A D L   L  +P +R   
Sbjct: 245 GSPSQEDLNXIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEV 304
Query: 244 SQLLKHPFLEEF 255
            Q L HP+LE++
Sbjct: 305 EQALAHPYLEQY 316

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 76/156 (48%), Gaps = 12/156 (7%)
Query: 45  EQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVS 104
           E   ++S+++PH+    G  +TS        L  +  P G L D +  +   +    +++
Sbjct: 70  EAYVMASVDNPHVCRLLGICLTST-----VQLITQLMPFGCLLDYVREHKDNIGSQYLLN 124
Query: 105 YTRQILQGLEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKW----ESEALQSGG-T 158
           +  QI +G+ YL   R+VH D+ +RN+L+      KI DFG AK     E E    GG  
Sbjct: 125 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 184
Query: 159 PM-FMAPEVARGEHQGFASDIWAVGCTVIEMASGGA 193
           P+ +MA E          SD+W+ G TV E+ + G+
Sbjct: 185 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 220

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 76/156 (48%), Gaps = 12/156 (7%)
Query: 45  EQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVS 104
           E   ++S+++PH+    G  +TS        L  +  P G L D +  +   +    +++
Sbjct: 69  EAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGCLLDYVREHKDNIGSQYLLN 123
Query: 105 YTRQILQGLEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKW----ESEALQSGG-T 158
           +  QI +G+ YL   R+VH D+ +RN+L+      KI DFG AK     E E    GG  
Sbjct: 124 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 183
Query: 159 PM-FMAPEVARGEHQGFASDIWAVGCTVIEMASGGA 193
           P+ +MA E          SD+W+ G TV E+ + G+
Sbjct: 184 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 219

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 79/155 (50%), Gaps = 10/155 (6%)
Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGA-KIADFGCAK-----WESEALQS 155
           +VS   Q+ +G+EYL S + +H D+ +RN+L+ E    KIADFG A+        +   +
Sbjct: 193 LVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 252
Query: 156 GGTPM-FMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRE 213
           G  P+ +MAPE          SD+W+ G  + E+ + GG+P+P    P+  L+K+     
Sbjct: 253 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV--PVEELFKLLKEGH 310
Query: 214 LPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLK 248
             + P+  + +    + +C    P +R    QL++
Sbjct: 311 RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 345

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/184 (26%), Positives = 92/184 (50%), Gaps = 22/184 (11%)
Query: 79  EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG- 137
           E+ P  T  D ++++   L+   ++ Y+ Q+ +G+E+L S + +H D+ +RNIL++E   
Sbjct: 130 EFVPYKTPED-LYKDFLTLEH--LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV 186
Query: 138 AKIADFGCAK---WESEALQSGGTPM---FMAPEVARGEHQGFASDIWAVGCTVIEMAS- 190
            KI DFG A+    + + ++ G   +   +MAPE          SD+W+ G  + E+ S 
Sbjct: 187 VKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 246
Query: 191 GGAPWPNAADPMTVLYKIAYSRELPE-----VPAFLSKQANDFLSNCLRRDPKERWAASQ 245
           G +P+P       V     + R L E      P + + +    + +C   +P +R   S+
Sbjct: 247 GASPYPG------VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSE 300
Query: 246 LLKH 249
           L++H
Sbjct: 301 LVEH 304

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 76/156 (48%), Gaps = 12/156 (7%)
Query: 45  EQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVS 104
           E   ++S+++PH+    G  +TS        L  +  P G L D +  +   +    +++
Sbjct: 73  EAYVMASVDNPHVCRLLGICLTST-----VQLITQLMPFGCLLDYVREHKDNIGSQYLLN 127
Query: 105 YTRQILQGLEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKW----ESEALQSGG-T 158
           +  QI +G+ YL   R+VH D+ +RN+L+      KI DFG AK     E E    GG  
Sbjct: 128 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 187
Query: 159 PM-FMAPEVARGEHQGFASDIWAVGCTVIEMASGGA 193
           P+ +MA E          SD+W+ G TV E+ + G+
Sbjct: 188 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 223

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 112/250 (44%), Gaps = 16/250 (6%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTE--LPKSEFLQREQKFLSSLNSPHIVGYKGCDVT 66
           IG G    V L   L    V      E  + + +F++ E + +  L+ P +V   G  V 
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIE-EAEVMMKLSHPKLVQLYG--VC 72
Query: 67  SEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDI 126
            E   +   L  E+   G L+D +    G      ++     + +G+ YL    V+H D+
Sbjct: 73  LEQAPIC--LVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDL 130
Query: 127 KSRNILMAESGA-KIADFGCAKW--ESEALQSGGTPM---FMAPEVARGEHQGFASDIWA 180
            +RN L+ E+   K++DFG  ++  + +   S GT     + +PEV         SD+W+
Sbjct: 131 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 190
Query: 181 VGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKE 239
            G  + E+ S G  P+ N ++   V+  I+    L + P   S      +++C R  P++
Sbjct: 191 FGVLMWEVFSEGKIPYENRSNS-EVVEDISTGFRLYK-PRLASTHVYQIMNHCWRERPED 248
Query: 240 RWAASQLLKH 249
           R A S+LL+ 
Sbjct: 249 RPAFSRLLRQ 258

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 76/156 (48%), Gaps = 12/156 (7%)
Query: 45  EQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVS 104
           E   ++S+++PH+    G  +TS        L  +  P G L D +  +   +    +++
Sbjct: 70  EAYVMASVDNPHVCRLLGICLTST-----VQLITQLMPFGCLLDYVREHKDNIGSQYLLN 124
Query: 105 YTRQILQGLEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKW----ESEALQSGG-T 158
           +  QI +G+ YL   R+VH D+ +RN+L+      KI DFG AK     E E    GG  
Sbjct: 125 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 184
Query: 159 PM-FMAPEVARGEHQGFASDIWAVGCTVIEMASGGA 193
           P+ +MA E          SD+W+ G TV E+ + G+
Sbjct: 185 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 220

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 91/196 (46%), Gaps = 25/196 (12%)
Query: 76  LFMEYAPGGTLNDEI---------------HRNGGRLDESLIVSYTRQILQGLEYLHSNR 120
           + +EYA  G L + +               H    +L    +VS   Q+ +G+EYL S +
Sbjct: 111 VIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK 170
Query: 121 VVHCDIKSRNILMAESGA-KIADFGCAK-----WESEALQSGGTPM-FMAPEVARGEHQG 173
            +H D+ +RN+L+ E    KIADFG A+        +   +G  P+ +MAPE        
Sbjct: 171 CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT 230
Query: 174 FASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNC 232
             SD+W+ G  + E+ + GG+P+P    P+  L+K+       + P+  + +    + +C
Sbjct: 231 HQSDVWSFGVLLWEIFTLGGSPYPGV--PVEELFKLLKEGHRMDKPSNCTNELYMMMRDC 288
Query: 233 LRRDPKERWAASQLLK 248
               P +R    QL++
Sbjct: 289 WHAVPSQRPTFKQLVE 304

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 79/170 (46%), Gaps = 25/170 (14%)
Query: 107 RQILQGLEYLHSNR-VVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG--GTPMFM 162
           + +L    Y+H+ + + H D+K  NILM ++G  K++DFG +++  +    G  GT  FM
Sbjct: 158 KSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSRGTYEFM 217
Query: 163 APEVARGE--HQGFASDIWAVGCTVIEMASGGAPW---------------PNAADPMT-- 203
            PE    E  + G   DIW++G  +  M     P+                N   P+   
Sbjct: 218 PPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRN 277
Query: 204 -VLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFL 252
             LY +  +++      FLS +  DFL   LR++P ER  +   LKH +L
Sbjct: 278 HFLYPLT-NKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWL 326

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 91/196 (46%), Gaps = 25/196 (12%)
Query: 76  LFMEYAPGGTLNDEI---------------HRNGGRLDESLIVSYTRQILQGLEYLHSNR 120
           + +EYA  G L + +               H    +L    +VS   Q+ +G+EYL S +
Sbjct: 111 VIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK 170
Query: 121 VVHCDIKSRNILMAESGA-KIADFGCAK-----WESEALQSGGTPM-FMAPEVARGEHQG 173
            +H D+ +RN+L+ E    KIADFG A+        +   +G  P+ +MAPE        
Sbjct: 171 CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT 230
Query: 174 FASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNC 232
             SD+W+ G  + E+ + GG+P+P    P+  L+K+       + P+  + +    + +C
Sbjct: 231 HQSDVWSFGVLLWEIFTLGGSPYPGV--PVEELFKLLKEGHRMDKPSNCTNELYMMMRDC 288
Query: 233 LRRDPKERWAASQLLK 248
               P +R    QL++
Sbjct: 289 WHAVPSQRPTFKQLVE 304

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 81/161 (50%), Gaps = 19/161 (11%)
Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAK---WESEALQSGG 157
           ++ Y+ Q+ +G+E+L S + +H D+ +RNIL++E    KI DFG A+    + + ++ G 
Sbjct: 146 LIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGD 205
Query: 158 TPM---FMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRE 213
             +   +MAPE          SD+W+ G  + E+ S G +P+P       V     + R 
Sbjct: 206 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG------VKIDEEFXRR 259
Query: 214 LPE-----VPAFLSKQANDFLSNCLRRDPKERWAASQLLKH 249
           L E      P + + +    + +C   +P +R   S+L++H
Sbjct: 260 LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 300

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 76/156 (48%), Gaps = 12/156 (7%)
Query: 45  EQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVS 104
           E   ++S+++PH+    G  +TS        L  +  P G L D +  +   +    +++
Sbjct: 92  EAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGCLLDYVREHKDNIGSQYLLN 146
Query: 105 YTRQILQGLEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKW----ESEALQSGG-T 158
           +  QI +G+ YL   R+VH D+ +RN+L+      KI DFG AK     E E    GG  
Sbjct: 147 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 206
Query: 159 PM-FMAPEVARGEHQGFASDIWAVGCTVIEMASGGA 193
           P+ +MA E          SD+W+ G TV E+ + G+
Sbjct: 207 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 242

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 91/196 (46%), Gaps = 25/196 (12%)
Query: 76  LFMEYAPGGTLNDEI---------------HRNGGRLDESLIVSYTRQILQGLEYLHSNR 120
           + +EYA  G L + +               H    +L    +VS   Q+ +G+EYL S +
Sbjct: 111 VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK 170
Query: 121 VVHCDIKSRNILMAESGA-KIADFGCAK-----WESEALQSGGTPM-FMAPEVARGEHQG 173
            +H D+ +RN+L+ E    KIADFG A+        +   +G  P+ +MAPE        
Sbjct: 171 CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT 230
Query: 174 FASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNC 232
             SD+W+ G  + E+ + GG+P+P    P+  L+K+       + P+  + +    + +C
Sbjct: 231 HQSDVWSFGVLLWEIFTLGGSPYPGV--PVEELFKLLKEGHRMDKPSNCTNELYMMMRDC 288
Query: 233 LRRDPKERWAASQLLK 248
               P +R    QL++
Sbjct: 289 WHAVPSQRPTFKQLVE 304

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/250 (25%), Positives = 114/250 (45%), Gaps = 16/250 (6%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTE--LPKSEFLQREQKFLSSLNSPHIVGYKGCDVT 66
           IG G    V L   L    V      E  + + +F++ E + +  L+ P +V   G  + 
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIE-EAEVMMKLSHPKLVQLYGVCLE 73
Query: 67  SEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDI 126
                L++  FME+   G L+D +    G      ++     + +G+ YL    V+H D+
Sbjct: 74  QAPICLVFE-FMEH---GCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDL 129
Query: 127 KSRNILMAESGA-KIADFGCAKW--ESEALQSGGTPM---FMAPEVARGEHQGFASDIWA 180
            +RN L+ E+   K++DFG  ++  + +   S GT     + +PEV         SD+W+
Sbjct: 130 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 189
Query: 181 VGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKE 239
            G  + E+ S G  P+ N ++   V+  I+    L + P   S      +++C +  P++
Sbjct: 190 FGVLMWEVFSEGKIPYENRSNS-EVVEDISTGFRLYK-PRLASTHVYQIMNHCWKERPED 247
Query: 240 RWAASQLLKH 249
           R A S+LL+ 
Sbjct: 248 RPAFSRLLRQ 257

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 73/287 (25%), Positives = 118/287 (41%), Gaps = 47/287 (16%)
Query: 8   TIGQGSSATVSLATSLRSGDVFAAKSTELPKSEF---LQREQKFLSSLNSPHIVGYKGCD 64
            +G+G+ A V    +L +   +A K  E         + RE + L        V      
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 65  VTSEDNKLMYNLFMEYAPGGTLNDEIH--RNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
              ED    + L  E   GG++   IH  R+   L+ S++V   + +   L++LH+  + 
Sbjct: 80  FEEEDR---FYLVFEKMRGGSILSHIHKRRHFNELEASVVV---QDVASALDFLHNKGIA 133
Query: 123 HCDIKSRNILMAE----SGAKIADFG----------CAKWES-EALQSGGTPMFMAPEVA 167
           H D+K  NIL       S  KI DFG          C+   + E L   G+  +MAPEV 
Sbjct: 134 HRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVV 193
Query: 168 RGEHQGFA-----SDIWAVGCTVIEMASGGAPWPN---------------AADPMTVLYK 207
               +  +      D+W++G  +  + SG  P+                 A   M     
Sbjct: 194 EAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESI 253
Query: 208 IAYSRELPEVP-AFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLE 253
                E P+   A +S  A D +S  L RD K+R +A+Q+L+HP+++
Sbjct: 254 QEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ 300

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 99/240 (41%), Gaps = 48/240 (20%)
Query: 97  LDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKWESEALQS 155
           LD   +     Q+L G+++LHS  ++H D+K  NI++ +++  KI DFG A+    +   
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMM 182
Query: 156 GG---TPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWP---------------- 196
                T  + APEV  G       DIW+VGC + EM  GG  +P                
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLG 242
Query: 197 -------NAADPMTVLYK--------IAYSRELPEV--PA------FLSKQANDFLSNCL 233
                      P    Y          ++ +  P+V  PA        + QA D LS  L
Sbjct: 243 TPSPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKML 302
Query: 234 RRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSILDQGIWNSVEETEESLGNLIH 293
             D  +R +  + L+HP++  +   +    E+   P  I D+ + +  E T E    LI+
Sbjct: 303 VIDASKRISVDEALQHPYINVWYDPS----EAEAPPPKIPDKQL-DEREHTIEEWKELIY 357

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 83/192 (43%), Gaps = 39/192 (20%)
Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES-GAKIADFGCAKWESEALQSGG--- 157
           I  +  QIL+GL+Y+HS  V+H D+K  N+L+  +   KI DFG A+         G   
Sbjct: 134 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 193
Query: 158 ----TPMFMAPEVARGEHQGFAS--DIWAVGCTVIEMASGGAPWP--NAADPMTVLYKIA 209
               T  + APE+     +G+    DIW+VGC + EM S    +P  +  D +  +  I 
Sbjct: 194 EYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 252
Query: 210 ------------------YSRELP---EVP-----AFLSKQANDFLSNCLRRDPKERWAA 243
                             Y   LP   +VP          +A D L   L  +P +R   
Sbjct: 253 GSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEV 312
Query: 244 SQLLKHPFLEEF 255
            Q L HP+LE++
Sbjct: 313 EQALAHPYLEQY 324

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 83/192 (43%), Gaps = 39/192 (20%)
Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES-GAKIADFGCAKWESEALQSGG--- 157
           I  +  QIL+GL+Y+HS  V+H D+K  N+L+  +   KI DFG A+         G   
Sbjct: 126 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 185
Query: 158 ----TPMFMAPEVARGEHQGFAS--DIWAVGCTVIEMASGGAPWP--NAADPMTVLYKIA 209
               T  + APE+     +G+    DIW+VGC + EM S    +P  +  D +  +  I 
Sbjct: 186 EYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 244
Query: 210 ------------------YSRELP---EVP-----AFLSKQANDFLSNCLRRDPKERWAA 243
                             Y   LP   +VP          +A D L   L  +P +R   
Sbjct: 245 GSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEV 304
Query: 244 SQLLKHPFLEEF 255
            Q L HP+LE++
Sbjct: 305 EQALAHPYLEQY 316

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 76/156 (48%), Gaps = 12/156 (7%)
Query: 45  EQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVS 104
           E   ++S+++PH+    G  +TS        L  +  P G L D +  +   +    +++
Sbjct: 70  EAYVMASVDNPHVCRLLGICLTST-----VQLITQLMPFGCLLDYVREHKDNIGSQYLLN 124
Query: 105 YTRQILQGLEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKW----ESEALQSGG-T 158
           +  QI +G+ YL   R+VH D+ +RN+L+      KI DFG AK     E E    GG  
Sbjct: 125 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 184
Query: 159 PM-FMAPEVARGEHQGFASDIWAVGCTVIEMASGGA 193
           P+ +MA E          SD+W+ G TV E+ + G+
Sbjct: 185 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 220

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/250 (25%), Positives = 114/250 (45%), Gaps = 16/250 (6%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTE--LPKSEFLQREQKFLSSLNSPHIVGYKGCDVT 66
           IG G    V L   L    V      E  + + +F++ E + +  L+ P +V   G  + 
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIE-EAEVMMKLSHPKLVQLYGVCLE 71
Query: 67  SEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDI 126
                L++  FME+   G L+D +    G      ++     + +G+ YL    V+H D+
Sbjct: 72  QAPICLVFE-FMEH---GCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDL 127
Query: 127 KSRNILMAESGA-KIADFGCAKW--ESEALQSGGTPM---FMAPEVARGEHQGFASDIWA 180
            +RN L+ E+   K++DFG  ++  + +   S GT     + +PEV         SD+W+
Sbjct: 128 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 187
Query: 181 VGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKE 239
            G  + E+ S G  P+ N ++   V+  I+    L + P   S      +++C +  P++
Sbjct: 188 FGVLMWEVFSEGKIPYENRSNS-EVVEDISTGFRLYK-PRLASTHVYQIMNHCWKERPED 245
Query: 240 RWAASQLLKH 249
           R A S+LL+ 
Sbjct: 246 RPAFSRLLRQ 255

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 83/192 (43%), Gaps = 39/192 (20%)
Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES-GAKIADFGCAKWESEALQSGG--- 157
           I  +  QIL+GL+Y+HS  V+H D+K  N+L+  +   KI DFG A+         G   
Sbjct: 130 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLT 189
Query: 158 ----TPMFMAPEVARGEHQGFAS--DIWAVGCTVIEMASGGAPWP--NAADPMTVLYKIA 209
               T  + APE+     +G+    DIW+VGC + EM S    +P  +  D +  +  I 
Sbjct: 190 EYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 248
Query: 210 ------------------YSRELP---EVP-----AFLSKQANDFLSNCLRRDPKERWAA 243
                             Y   LP   +VP          +A D L   L  +P +R   
Sbjct: 249 GSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEV 308
Query: 244 SQLLKHPFLEEF 255
            Q L HP+LE++
Sbjct: 309 EQALAHPYLEQY 320

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 76/156 (48%), Gaps = 12/156 (7%)
Query: 45  EQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVS 104
           E   ++S+++PH+    G  +TS        L  +  P G L D +  +   +    +++
Sbjct: 74  EAYVMASVDNPHVCRLLGICLTST-----VQLITQLMPFGCLLDYVREHKDNIGSQYLLN 128
Query: 105 YTRQILQGLEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKW----ESEALQSGG-T 158
           +  QI +G+ YL   R+VH D+ +RN+L+      KI DFG AK     E E    GG  
Sbjct: 129 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 188
Query: 159 PM-FMAPEVARGEHQGFASDIWAVGCTVIEMASGGA 193
           P+ +MA E          SD+W+ G TV E+ + G+
Sbjct: 189 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 224

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 96/214 (44%), Gaps = 20/214 (9%)
Query: 55  PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLE 114
           P+I+  K    T E N   + +F +    G L D +      L E       R +L+ + 
Sbjct: 71  PNIIQLKD---TYETNTFFFLVF-DLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVIC 125
Query: 115 YLHSNRVVHCDIKSRNILMAES-GAKIADFG--CAKWESEALQSG-GTPMFMAPEVAR-- 168
            LH   +VH D+K  NIL+ +    K+ DFG  C     E L+   GTP ++APE+    
Sbjct: 126 ALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECS 185
Query: 169 --GEHQGFAS--DIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA---YSRELPEVPAFL 221
               H G+    D+W+ G  +  + +G  P+ +    M +L  I    Y    PE   + 
Sbjct: 186 MNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ-MLMLRMIMSGNYQFGSPEWDDY- 243
Query: 222 SKQANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
           S    D +S  L   P++R+ A + L HPF +++
Sbjct: 244 SDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 277

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 83/192 (43%), Gaps = 39/192 (20%)
Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES-GAKIADFGCAKWESEALQSGG--- 157
           I  +  QIL+GL+Y+HS  V+H D+K  N+L+  +   KI DFG A+         G   
Sbjct: 126 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 185
Query: 158 ----TPMFMAPEVARGEHQGFAS--DIWAVGCTVIEMASGGAPWP--NAADPMTVLYKIA 209
               T  + APE+     +G+    DIW+VGC + EM S    +P  +  D +  +  I 
Sbjct: 186 EYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 244
Query: 210 ------------------YSRELP---EVP-----AFLSKQANDFLSNCLRRDPKERWAA 243
                             Y   LP   +VP          +A D L   L  +P +R   
Sbjct: 245 GSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEV 304
Query: 244 SQLLKHPFLEEF 255
            Q L HP+LE++
Sbjct: 305 EQALAHPYLEQY 316

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 83/192 (43%), Gaps = 39/192 (20%)
Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES-GAKIADFGCAKWESEALQSGG--- 157
           I  +  QIL+GL+Y+HS  V+H D+K  N+L+  +   KI DFG A+         G   
Sbjct: 126 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLT 185
Query: 158 ----TPMFMAPEVARGEHQGFAS--DIWAVGCTVIEMASGGAPWP--NAADPMTVLYKIA 209
               T  + APE+     +G+    DIW+VGC + EM S    +P  +  D +  +  I 
Sbjct: 186 EYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 244
Query: 210 ------------------YSRELP---EVP-----AFLSKQANDFLSNCLRRDPKERWAA 243
                             Y   LP   +VP          +A D L   L  +P +R   
Sbjct: 245 GSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEV 304
Query: 244 SQLLKHPFLEEF 255
            Q L HP+LE++
Sbjct: 305 EQALAHPYLEQY 316

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 83/192 (43%), Gaps = 39/192 (20%)
Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES-GAKIADFGCAKWESEALQSGG--- 157
           I  +  QIL+GL+Y+HS  V+H D+K  N+L+  +   KI DFG A+         G   
Sbjct: 146 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLT 205
Query: 158 ----TPMFMAPEVARGEHQGFAS--DIWAVGCTVIEMASGGAPWP--NAADPMTVLYKIA 209
               T  + APE+     +G+    DIW+VGC + EM S    +P  +  D +  +  I 
Sbjct: 206 EYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 264
Query: 210 ------------------YSRELP---EVP-----AFLSKQANDFLSNCLRRDPKERWAA 243
                             Y   LP   +VP          +A D L   L  +P +R   
Sbjct: 265 GSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEV 324
Query: 244 SQLLKHPFLEEF 255
            Q L HP+LE++
Sbjct: 325 EQALAHPYLEQY 336

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 83/192 (43%), Gaps = 39/192 (20%)
Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES-GAKIADFGCAKWESEALQSGG--- 157
           I  +  QIL+GL+Y+HS  V+H D+K  N+L+  +   KI DFG A+         G   
Sbjct: 130 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLT 189
Query: 158 ----TPMFMAPEVARGEHQGFAS--DIWAVGCTVIEMASGGAPWP--NAADPMTVLYKIA 209
               T  + APE+     +G+    DIW+VGC + EM S    +P  +  D +  +  I 
Sbjct: 190 EYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 248
Query: 210 ------------------YSRELP---EVP-----AFLSKQANDFLSNCLRRDPKERWAA 243
                             Y   LP   +VP          +A D L   L  +P +R   
Sbjct: 249 GSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEV 308
Query: 244 SQLLKHPFLEEF 255
            Q L HP+LE++
Sbjct: 309 EQALAHPYLEQY 320

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 99/240 (41%), Gaps = 48/240 (20%)
Query: 97  LDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKWESEALQS 155
           LD   +     Q+L G+++LHS  ++H D+K  NI++ +++  KI DFG A+    +   
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMM 182
Query: 156 GG---TPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWP---------------- 196
                T  + APEV  G       DIW+VGC + EM  GG  +P                
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLG 242
Query: 197 -------NAADPMTVLYK--------IAYSRELPEV--PA------FLSKQANDFLSNCL 233
                      P    Y          ++ +  P+V  PA        + QA D LS  L
Sbjct: 243 TPSPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKML 302
Query: 234 RRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSILDQGIWNSVEETEESLGNLIH 293
             D  +R +  + L+HP++  +   +    E+   P  I D+ + +  E T E    LI+
Sbjct: 303 VIDASKRISVDEALQHPYINVWYDPS----EAEAPPPKIPDKQL-DEREHTIEEWKELIY 357

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 83/192 (43%), Gaps = 39/192 (20%)
Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES-GAKIADFGCAKWESEALQSGG--- 157
           I  +  QIL+GL+Y+HS  V+H D+K  N+L+  +   KI DFG A+         G   
Sbjct: 130 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLX 189
Query: 158 ----TPMFMAPEVARGEHQGFAS--DIWAVGCTVIEMASGGAPWP--NAADPMTVLYKIA 209
               T  + APE+     +G+    DIW+VGC + EM S    +P  +  D +  +  I 
Sbjct: 190 EXVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 248
Query: 210 ------------------YSRELP---EVP-----AFLSKQANDFLSNCLRRDPKERWAA 243
                             Y   LP   +VP          +A D L   L  +P +R   
Sbjct: 249 GSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEV 308
Query: 244 SQLLKHPFLEEF 255
            Q L HP+LE++
Sbjct: 309 EQALAHPYLEQY 320

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/182 (31%), Positives = 86/182 (47%), Gaps = 15/182 (8%)
Query: 33  STELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHR 92
           +TE  K +F Q E K ++     ++V   G     +D  L+Y     Y P G+L D +  
Sbjct: 63  TTEELKQQFDQ-EIKVMAKCQHENLVELLGFSSDGDDLCLVY----VYMPNGSLLDRLSC 117
Query: 93  NGGR--LDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES-GAKIADFGCAKWE 149
             G   L   +     +    G+ +LH N  +H DIKS NIL+ E+  AKI+DFG A+  
Sbjct: 118 LDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARAS 177
Query: 150 SEALQS------GGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMT 203
            +  Q        GT  +MAPE  RGE     SDI++ G  ++E+ +G        +P  
Sbjct: 178 EKFAQXVMXXRIVGTTAYMAPEALRGEITP-KSDIYSFGVVLLEIITGLPAVDEHREPQL 236
Query: 204 VL 205
           +L
Sbjct: 237 LL 238

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 83/192 (43%), Gaps = 39/192 (20%)
Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES-GAKIADFGCAKWESEALQSGG--- 157
           I  +  QIL+GL+Y+HS  V+H D+K  N+L+  +   KI DFG A+         G   
Sbjct: 146 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 205
Query: 158 ----TPMFMAPEVARGEHQGFAS--DIWAVGCTVIEMASGGAPWP--NAADPMTVLYKIA 209
               T  + APE+     +G+    DIW+VGC + EM S    +P  +  D +  +  I 
Sbjct: 206 EYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 264
Query: 210 ------------------YSRELP---EVP-----AFLSKQANDFLSNCLRRDPKERWAA 243
                             Y   LP   +VP          +A D L   L  +P +R   
Sbjct: 265 GSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEV 324
Query: 244 SQLLKHPFLEEF 255
            Q L HP+LE++
Sbjct: 325 EQALAHPYLEQY 336

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 96/215 (44%), Gaps = 20/215 (9%)
Query: 55  PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLE 114
           P+I+  K    T E N   + +F +    G L D +      L E       R +L+ + 
Sbjct: 84  PNIIQLKD---TYETNTFFFLVF-DLMKKGELFDYLTEKVT-LSEKETRKIMRALLEVIC 138
Query: 115 YLHSNRVVHCDIKSRNILMAES-GAKIADFG--CAKWESEALQSG-GTPMFMAPEVAR-- 168
            LH   +VH D+K  NIL+ +    K+ DFG  C     E L+   GTP ++APE+    
Sbjct: 139 ALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECS 198
Query: 169 --GEHQGFAS--DIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA---YSRELPEVPAFL 221
               H G+    D+W+ G  +  + +G  P+ +    M +L  I    Y    PE   + 
Sbjct: 199 MNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ-MLMLRMIMSGNYQFGSPEWDDY- 256
Query: 222 SKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFC 256
           S    D +S  L   P++R+ A + L HPF +++ 
Sbjct: 257 SDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 291

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 83/192 (43%), Gaps = 39/192 (20%)
Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES-GAKIADFGCAKWESEALQSGG--- 157
           I  +  QIL+GL+Y+HS  V+H D+K  N+L+  +   KI DFG A+         G   
Sbjct: 131 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLX 190
Query: 158 ----TPMFMAPEVARGEHQGFAS--DIWAVGCTVIEMASGGAPWP--NAADPMTVLYKIA 209
               T  + APE+     +G+    DIW+VGC + EM S    +P  +  D +  +  I 
Sbjct: 191 EXVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 249
Query: 210 ------------------YSRELP---EVP-----AFLSKQANDFLSNCLRRDPKERWAA 243
                             Y   LP   +VP          +A D L   L  +P +R   
Sbjct: 250 GSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEV 309
Query: 244 SQLLKHPFLEEF 255
            Q L HP+LE++
Sbjct: 310 EQALAHPYLEQY 321

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 83/192 (43%), Gaps = 39/192 (20%)
Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES-GAKIADFGCAKWESEALQSGG--- 157
           I  +  QIL+GL+Y+HS  V+H D+K  N+L+  +   KI DFG A+         G   
Sbjct: 124 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 183
Query: 158 ----TPMFMAPEVARGEHQGFAS--DIWAVGCTVIEMASGGAPWP--NAADPMTVLYKIA 209
               T  + APE+     +G+    DIW+VGC + EM S    +P  +  D +  +  I 
Sbjct: 184 EYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 242
Query: 210 ------------------YSRELP---EVP-----AFLSKQANDFLSNCLRRDPKERWAA 243
                             Y   LP   +VP          +A D L   L  +P +R   
Sbjct: 243 GSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEV 302
Query: 244 SQLLKHPFLEEF 255
            Q L HP+LE++
Sbjct: 303 EQALAHPYLEQY 314

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 83/192 (43%), Gaps = 39/192 (20%)
Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES-GAKIADFGCAKWESEALQSGG--- 157
           I  +  QIL+GL+Y+HS  V+H D+K  N+L+  +   KI DFG A+         G   
Sbjct: 131 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 190
Query: 158 ----TPMFMAPEVARGEHQGFAS--DIWAVGCTVIEMASGGAPWP--NAADPMTVLYKIA 209
               T  + APE+     +G+    DIW+VGC + EM S    +P  +  D +  +  I 
Sbjct: 191 EYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 249
Query: 210 ------------------YSRELP---EVP-----AFLSKQANDFLSNCLRRDPKERWAA 243
                             Y   LP   +VP          +A D L   L  +P +R   
Sbjct: 250 GSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEV 309
Query: 244 SQLLKHPFLEEF 255
            Q L HP+LE++
Sbjct: 310 EQALAHPYLEQY 321

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 83/192 (43%), Gaps = 39/192 (20%)
Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES-GAKIADFGCAKWESEALQSGG--- 157
           I  +  QIL+GL+Y+HS  V+H D+K  N+L+  +   KI DFG A+         G   
Sbjct: 128 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 187
Query: 158 ----TPMFMAPEVARGEHQGFAS--DIWAVGCTVIEMASGGAPWP--NAADPMTVLYKIA 209
               T  + APE+     +G+    DIW+VGC + EM S    +P  +  D +  +  I 
Sbjct: 188 EYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 246
Query: 210 ------------------YSRELP---EVP-----AFLSKQANDFLSNCLRRDPKERWAA 243
                             Y   LP   +VP          +A D L   L  +P +R   
Sbjct: 247 GSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEV 306
Query: 244 SQLLKHPFLEEF 255
            Q L HP+LE++
Sbjct: 307 EQALAHPYLEQY 318

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 77/167 (46%), Gaps = 22/167 (13%)
Query: 44  REQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLND-EIHRNGG------R 96
           RE   L  L  P+++  +   ++  D K+   L  +YA     +  + HR         +
Sbjct: 67  REIALLRELKHPNVISLQKVFLSHADRKVW--LLFDYAEHDLWHIIKFHRASKANKKPVQ 124
Query: 97  LDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-----AKIADFGCAKWESE 151
           L   ++ S   QIL G+ YLH+N V+H D+K  NIL+   G      KIAD G A+  + 
Sbjct: 125 LPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 184
Query: 152 ALQSGG-------TPMFMAPEVARG-EHQGFASDIWAVGCTVIEMAS 190
            L+          T  + APE+  G  H   A DIWA+GC   E+ +
Sbjct: 185 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 231

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 83/192 (43%), Gaps = 39/192 (20%)
Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES-GAKIADFGCAKWESEALQSGG--- 157
           I  +  QIL+GL+Y+HS  V+H D+K  N+L+  +   KI DFG A+         G   
Sbjct: 132 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 191
Query: 158 ----TPMFMAPEVARGEHQGFAS--DIWAVGCTVIEMASGGAPWP--NAADPMTVLYKIA 209
               T  + APE+     +G+    DIW+VGC + EM S    +P  +  D +  +  I 
Sbjct: 192 EYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 250
Query: 210 ------------------YSRELP---EVP-----AFLSKQANDFLSNCLRRDPKERWAA 243
                             Y   LP   +VP          +A D L   L  +P +R   
Sbjct: 251 GSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEV 310
Query: 244 SQLLKHPFLEEF 255
            Q L HP+LE++
Sbjct: 311 EQALAHPYLEQY 322

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 83/192 (43%), Gaps = 39/192 (20%)
Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES-GAKIADFGCAKWESEALQSGG--- 157
           I  +  QIL+GL+Y+HS  V+H D+K  N+L+  +   KI DFG A+         G   
Sbjct: 123 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 182
Query: 158 ----TPMFMAPEVARGEHQGFAS--DIWAVGCTVIEMASGGAPWP--NAADPMTVLYKIA 209
               T  + APE+     +G+    DIW+VGC + EM S    +P  +  D +  +  I 
Sbjct: 183 EYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 241
Query: 210 ------------------YSRELP---EVP-----AFLSKQANDFLSNCLRRDPKERWAA 243
                             Y   LP   +VP          +A D L   L  +P +R   
Sbjct: 242 GSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEV 301
Query: 244 SQLLKHPFLEEF 255
            Q L HP+LE++
Sbjct: 302 EQALAHPYLEQY 313

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 83/192 (43%), Gaps = 39/192 (20%)
Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES-GAKIADFGCAKWESEALQSGG--- 157
           I  +  QIL+GL+Y+HS  V+H D+K  N+L+  +   KI DFG A+         G   
Sbjct: 130 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 189
Query: 158 ----TPMFMAPEVARGEHQGFAS--DIWAVGCTVIEMASGGAPWP--NAADPMTVLYKIA 209
               T  + APE+     +G+    DIW+VGC + EM S    +P  +  D +  +  I 
Sbjct: 190 EYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 248
Query: 210 ------------------YSRELP---EVP-----AFLSKQANDFLSNCLRRDPKERWAA 243
                             Y   LP   +VP          +A D L   L  +P +R   
Sbjct: 249 GSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEV 308
Query: 244 SQLLKHPFLEEF 255
            Q L HP+LE++
Sbjct: 309 EQALAHPYLEQY 320

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 83/192 (43%), Gaps = 39/192 (20%)
Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES-GAKIADFGCAKWESEALQSGG--- 157
           I  +  QIL+GL+Y+HS  V+H D+K  N+L+  +   KI DFG A+         G   
Sbjct: 130 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 189
Query: 158 ----TPMFMAPEVARGEHQGFAS--DIWAVGCTVIEMASGGAPWP--NAADPMTVLYKIA 209
               T  + APE+     +G+    DIW+VGC + EM S    +P  +  D +  +  I 
Sbjct: 190 EYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 248
Query: 210 ------------------YSRELP---EVP-----AFLSKQANDFLSNCLRRDPKERWAA 243
                             Y   LP   +VP          +A D L   L  +P +R   
Sbjct: 249 GSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEV 308
Query: 244 SQLLKHPFLEEF 255
            Q L HP+LE++
Sbjct: 309 EQALAHPYLEQY 320

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 83/192 (43%), Gaps = 39/192 (20%)
Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES-GAKIADFGCAKWESEALQSGG--- 157
           I  +  QIL+GL+Y+HS  V+H D+K  N+L+  +   KI DFG A+         G   
Sbjct: 130 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 189
Query: 158 ----TPMFMAPEVARGEHQGFAS--DIWAVGCTVIEMASGGAPWP--NAADPMTVLYKIA 209
               T  + APE+     +G+    DIW+VGC + EM S    +P  +  D +  +  I 
Sbjct: 190 EYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 248
Query: 210 ------------------YSRELP---EVP-----AFLSKQANDFLSNCLRRDPKERWAA 243
                             Y   LP   +VP          +A D L   L  +P +R   
Sbjct: 249 GSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEV 308
Query: 244 SQLLKHPFLEEF 255
            Q L HP+LE++
Sbjct: 309 EQALAHPYLEQY 320

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 91/205 (44%), Gaps = 22/205 (10%)
Query: 46  QKFLSSLNSPHIVG-YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVS 104
           ++FL+ +  P IV  +   + T      +  + MEY  G +L       G +L  +  ++
Sbjct: 130 RQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLK---RSKGQKLPVAEAIA 186
Query: 105 YTRQILQGLEYLHSNRVVHCDIKSRNILMAESGAKIADFGCAKWESEALQSGGTPMFMAP 164
           Y  +IL  L YLHS  +V+ D+K  NI++ E   K+ D G     +      GTP F AP
Sbjct: 187 YLLEILPALSYLHSIGLVYNDLKPENIMLTEEQLKLIDLGAVSRINSFGYLYGTPGFQAP 246
Query: 165 EVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQ 224
           E+ R      A+DI+ VG T+  + +   P  N            Y   LPE    L  +
Sbjct: 247 EIVR-TGPTVATDIYTVGRTLAAL-TLDLPTRNG----------RYVDGLPEDDPVL--K 292
Query: 225 ANDFLSNCLRR----DPKERWAASQ 245
             D     LRR    DP++R+  ++
Sbjct: 293 TYDSYGRLLRRAIDPDPRQRFTTAE 317

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 49/153 (32%), Positives = 81/153 (52%), Gaps = 14/153 (9%)
Query: 49  LSSLNSPHIVGYKG-CDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTR 107
           + SL+  HIV   G C  +S        L  +Y P G+L D + ++ G L   L++++  
Sbjct: 87  IGSLDHAHIVRLLGLCPGSS------LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGV 140
Query: 108 QILQGLEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKW----ESEALQS-GGTPM- 160
           QI +G+ YL  + +VH ++ +RN+L+ + S  ++ADFG A      + + L S   TP+ 
Sbjct: 141 QIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIK 200
Query: 161 FMAPEVARGEHQGFASDIWAVGCTVIEMASGGA 193
           +MA E          SD+W+ G TV E+ + GA
Sbjct: 201 WMALESIHFGKYTHQSDVWSYGVTVWELMTFGA 233

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 49/153 (32%), Positives = 81/153 (52%), Gaps = 14/153 (9%)
Query: 49  LSSLNSPHIVGYKG-CDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTR 107
           + SL+  HIV   G C  +S        L  +Y P G+L D + ++ G L   L++++  
Sbjct: 69  IGSLDHAHIVRLLGLCPGSS------LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGV 122
Query: 108 QILQGLEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKW----ESEALQS-GGTPM- 160
           QI +G+ YL  + +VH ++ +RN+L+ + S  ++ADFG A      + + L S   TP+ 
Sbjct: 123 QIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIK 182
Query: 161 FMAPEVARGEHQGFASDIWAVGCTVIEMASGGA 193
           +MA E          SD+W+ G TV E+ + GA
Sbjct: 183 WMALESIHFGKYTHQSDVWSYGVTVWELMTFGA 215

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 81/161 (50%), Gaps = 19/161 (11%)
Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAK---WESEALQSGG 157
           ++ Y+ Q+ +G+E+L S + +H D+ +RNIL++E    KI DFG A+    + + ++ G 
Sbjct: 200 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 259
Query: 158 TPM---FMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRE 213
             +   +MAPE          SD+W+ G  + E+ S G +P+P       V     + R 
Sbjct: 260 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG------VKIDEEFCRR 313
Query: 214 LPE-----VPAFLSKQANDFLSNCLRRDPKERWAASQLLKH 249
           L E      P + + +    + +C   +P +R   S+L++H
Sbjct: 314 LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 354

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 81/161 (50%), Gaps = 19/161 (11%)
Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAK---WESEALQSGG 157
           ++ Y+ Q+ +G+E+L S + +H D+ +RNIL++E    KI DFG A+    + + ++ G 
Sbjct: 193 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 252
Query: 158 TPM---FMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRE 213
             +   +MAPE          SD+W+ G  + E+ S G +P+P       V     + R 
Sbjct: 253 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG------VKIDEEFCRR 306
Query: 214 LPE-----VPAFLSKQANDFLSNCLRRDPKERWAASQLLKH 249
           L E      P + + +    + +C   +P +R   S+L++H
Sbjct: 307 LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 347

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 81/161 (50%), Gaps = 19/161 (11%)
Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAK---WESEALQSGG 157
           ++ Y+ Q+ +G+E+L S + +H D+ +RNIL++E    KI DFG A+    + + ++ G 
Sbjct: 195 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 254
Query: 158 TPM---FMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRE 213
             +   +MAPE          SD+W+ G  + E+ S G +P+P       V     + R 
Sbjct: 255 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG------VKIDEEFCRR 308
Query: 214 LPE-----VPAFLSKQANDFLSNCLRRDPKERWAASQLLKH 249
           L E      P + + +    + +C   +P +R   S+L++H
Sbjct: 309 LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 81/161 (50%), Gaps = 19/161 (11%)
Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAK---WESEALQSGG 157
           ++ Y+ Q+ +G+E+L S + +H D+ +RNIL++E    KI DFG A+    + + ++ G 
Sbjct: 146 LICYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 205
Query: 158 TPM---FMAPEVARGEHQGFASDIWAVGCTVIEMASGGA-PWPNAADPMTVLYKIAYSRE 213
             +   +MAPE          SD+W+ G  + E+ S GA P+P       V     + R 
Sbjct: 206 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG------VKIDEEFCRR 259
Query: 214 LPE-----VPAFLSKQANDFLSNCLRRDPKERWAASQLLKH 249
           L E      P + + +    + +C   +P +R   S+L++H
Sbjct: 260 LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 300

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 81/161 (50%), Gaps = 19/161 (11%)
Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAK---WESEALQSGG 157
           ++ Y+ Q+ +G+E+L S + +H D+ +RNIL++E    KI DFG A+    + + ++ G 
Sbjct: 202 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 261
Query: 158 TPM---FMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRE 213
             +   +MAPE          SD+W+ G  + E+ S G +P+P       V     + R 
Sbjct: 262 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG------VKIDEEFCRR 315
Query: 214 LPE-----VPAFLSKQANDFLSNCLRRDPKERWAASQLLKH 249
           L E      P + + +    + +C   +P +R   S+L++H
Sbjct: 316 LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 356

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 76/156 (48%), Gaps = 12/156 (7%)
Query: 45  EQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVS 104
           E   ++S+++PH+    G  +TS        L  +  P G L D +  +   +    +++
Sbjct: 67  EAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGCLLDYVREHKDNIGSQYLLN 121
Query: 105 YTRQILQGLEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKW----ESEALQSGG-T 158
           +  QI +G+ YL   R+VH D+ +RN+L+      KI DFG AK     E E    GG  
Sbjct: 122 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV 181
Query: 159 PM-FMAPEVARGEHQGFASDIWAVGCTVIEMASGGA 193
           P+ +MA E          SD+W+ G TV E+ + G+
Sbjct: 182 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 217

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 76/156 (48%), Gaps = 12/156 (7%)
Query: 45  EQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVS 104
           E   ++S+++PH+    G  +TS        L  +  P G L D +  +   +    +++
Sbjct: 69  EAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGCLLDYVREHKDNIGSQYLLN 123
Query: 105 YTRQILQGLEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKW----ESEALQSGG-T 158
           +  QI +G+ YL   R+VH D+ +RN+L+      KI DFG AK     E E    GG  
Sbjct: 124 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV 183
Query: 159 PM-FMAPEVARGEHQGFASDIWAVGCTVIEMASGGA 193
           P+ +MA E          SD+W+ G TV E+ + G+
Sbjct: 184 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 219

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 88/208 (42%), Gaps = 64/208 (30%)
Query: 106 TRQILQGLEYLHSN-RVVHCDIKSRNILMAESGA-------KIADFGCAKWESEAL-QSG 156
           ++Q+L GL+Y+H    ++H DIK  N+LM    +       KIAD G A W  E    S 
Sbjct: 137 SKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI 196
Query: 157 GTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASG--------GAPWPNAADPMTVLYKI 208
            T  + +PEV  G   G  +DIW+  C + E+ +G        G  +    D +  + ++
Sbjct: 197 QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIEL 256
Query: 209 AYSRELPEVPAFL------------------------------------------SKQAN 226
                L E+P++L                                          +K+ +
Sbjct: 257 -----LGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEIS 311
Query: 227 DFLSNCLRRDPKERWAASQLLKHPFLEE 254
           DFLS  L+ DP++R  A  L+ HP+L++
Sbjct: 312 DFLSPMLQLDPRKRADAGGLVNHPWLKD 339

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 88/208 (42%), Gaps = 64/208 (30%)
Query: 106 TRQILQGLEYLHSN-RVVHCDIKSRNILMAESGA-------KIADFGCAKWESEAL-QSG 156
           ++Q+L GL+Y+H    ++H DIK  N+LM    +       KIAD G A W  E    S 
Sbjct: 137 SKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI 196
Query: 157 GTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASG--------GAPWPNAADPMTVLYKI 208
            T  + +PEV  G   G  +DIW+  C + E+ +G        G  +    D +  + ++
Sbjct: 197 QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIEL 256
Query: 209 AYSRELPEVPAFL------------------------------------------SKQAN 226
                L E+P++L                                          +K+ +
Sbjct: 257 -----LGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEIS 311
Query: 227 DFLSNCLRRDPKERWAASQLLKHPFLEE 254
           DFLS  L+ DP++R  A  L+ HP+L++
Sbjct: 312 DFLSPMLQLDPRKRADAGGLVNHPWLKD 339

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 76/156 (48%), Gaps = 12/156 (7%)
Query: 45  EQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVS 104
           E   ++S+++PH+    G  +TS        L  +  P G L D +  +   +    +++
Sbjct: 74  EAYVMASVDNPHVCRLLGICLTST-----VQLITQLMPFGCLLDYVREHKDNIGSQYLLN 128
Query: 105 YTRQILQGLEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKW----ESEALQSGG-T 158
           +  QI +G+ YL   R+VH D+ +RN+L+      KI DFG AK     E E    GG  
Sbjct: 129 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV 188
Query: 159 PM-FMAPEVARGEHQGFASDIWAVGCTVIEMASGGA 193
           P+ +MA E          SD+W+ G TV E+ + G+
Sbjct: 189 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 224

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 11/209 (5%)
Query: 44  REQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGT-LNDEIHRNGGRLDESLI 102
           RE + L+  + P+I+G +   V  E+   M+ L++      T L   IH     +    I
Sbjct: 78  REIRLLNHFHHPNILGLRDIFVHFEEPA-MHKLYLVTELMRTDLAQVIHDQRIVISPQHI 136
Query: 103 VSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSGGTPM- 160
             +   IL GL  LH   VVH D+   NIL+A++    I DF  A+ ++           
Sbjct: 137 QYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTH 196
Query: 161 --FMAPEVARGEHQGFAS--DIWAVGCTVIEMASGGAPWPNAA--DPMTVLYKIAYSREL 214
             + APE+   + +GF    D+W+ GC + EM +  A +  +   + +  + ++  + ++
Sbjct: 197 RWYRAPELVM-QFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI 255
Query: 215 PEVPAFLSKQANDFLSNCLRRDPKERWAA 243
            +V  F S  A D+L N L   P   W A
Sbjct: 256 EDVVMFSSPSARDYLRNSLSNVPARAWTA 284

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 82/192 (42%), Gaps = 39/192 (20%)
Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKWESEALQSGG--- 157
           I  +  QIL+GL+Y+HS  V+H D+K  N+L+   S  KI DFG A+         G   
Sbjct: 128 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLT 187
Query: 158 ----TPMFMAPEVARGEHQGFAS--DIWAVGCTVIEMASGGAPWP--NAADPMTVLYKIA 209
               T  + APE+     +G+    DIW+VGC + EM S    +P  +  D +  +  I 
Sbjct: 188 EYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 246
Query: 210 ------------------YSRELP---EVP-----AFLSKQANDFLSNCLRRDPKERWAA 243
                             Y   LP   +VP          +A D L   L  +P +R   
Sbjct: 247 GSPSQEDLNCGINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEV 306
Query: 244 SQLLKHPFLEEF 255
            Q L HP+L ++
Sbjct: 307 EQALAHPYLAQY 318

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 11/209 (5%)
Query: 44  REQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGT-LNDEIHRNGGRLDESLI 102
           RE + L+  + P+I+G +   V  E+   M+ L++      T L   IH     +    I
Sbjct: 78  REIRLLNHFHHPNILGLRDIFVHFEEPA-MHKLYLVTELMRTDLAQVIHDQRIVISPQHI 136
Query: 103 VSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSGGTPM- 160
             +   IL GL  LH   VVH D+   NIL+A++    I DF  A+ ++           
Sbjct: 137 QYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTH 196
Query: 161 --FMAPEVARGEHQGFAS--DIWAVGCTVIEMASGGAPWPNAA--DPMTVLYKIAYSREL 214
             + APE+   + +GF    D+W+ GC + EM +  A +  +   + +  + ++  + ++
Sbjct: 197 RWYRAPELVM-QFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI 255
Query: 215 PEVPAFLSKQANDFLSNCLRRDPKERWAA 243
            +V  F S  A D+L N L   P   W A
Sbjct: 256 EDVVMFSSPSARDYLRNSLSNVPARAWTA 284

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 103/231 (44%), Gaps = 29/231 (12%)
Query: 32  KSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIH 91
           +++E  + +F QRE + L+ L   HIV + G  V +E   L+  +  EY   G LN  + 
Sbjct: 58  EASESARQDF-QREAELLTMLQHQHIVRFFG--VCTEGRPLL--MVFEYMRHGDLNRFLR 112
Query: 92  RNG--------------GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES- 136
            +G              G L    +++   Q+  G+ YL     VH D+ +RN L+ +  
Sbjct: 113 SHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGL 172
Query: 137 GAKIADFGCAK--WESEALQSGGTPMF----MAPEVARGEHQGFASDIWAVGCTVIEMAS 190
             KI DFG ++  + ++  + GG  M     M PE          SD+W+ G  + E+ +
Sbjct: 173 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 232
Query: 191 -GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKER 240
            G  PW   ++    +  I   REL E P     +    +  C +R+P++R
Sbjct: 233 YGKQPWYQLSN-TEAIDCITQGREL-ERPRACPPEVYAIMRGCWQREPQQR 281

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 68/266 (25%), Positives = 112/266 (42%), Gaps = 36/266 (13%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEF----------LQREQKFLSSLNSPHIV 58
           IG+G    V     ++   V A KS  L  SE            QRE   +S+LN P+IV
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 59  GYKGCDVTSEDNKLMYN---LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
              G         LM+N   + ME+ P G L   +      +  S+ +     I  G+EY
Sbjct: 87  KLYG---------LMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEY 137
Query: 116 LHSNR--VVHCDIKSRNILM------AESGAKIADFGCAKWESEALQSG--GTPMFMAPE 165
           + +    +VH D++S NI +      A   AK+ADFG ++    ++ SG  G   +MAPE
Sbjct: 138 MQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSV-SGLLGNFQWMAPE 196
Query: 166 VARGEHQGFA--SDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSREL-PEVPAFLS 222
               E + +   +D ++    +  + +G  P+   +        +     L P +P    
Sbjct: 197 TIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCP 256
Query: 223 KQANDFLSNCLRRDPKERWAASQLLK 248
            +  + +  C   DPK+R   S ++K
Sbjct: 257 PRLRNVIELCWSGDPKKRPHFSYIVK 282

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 98/240 (40%), Gaps = 48/240 (20%)
Query: 97  LDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKWESEALQS 155
           LD   +     Q+L G+++LHS  ++H D+K  NI++ ++   KI DFG A+    +   
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 182
Query: 156 GG---TPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWP---------------- 196
                T  + APEV  G       DIW+VGC + EM  GG  +P                
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLG 242
Query: 197 -------NAADPMTVLYK--------IAYSRELPEV--PA------FLSKQANDFLSNCL 233
                      P    Y          ++ +  P+V  PA        + QA D LS  L
Sbjct: 243 TPSPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKML 302
Query: 234 RRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSILDQGIWNSVEETEESLGNLIH 293
             D  +R +  + L+HP++  +   +    E+   P  I D+ + +  E T E    LI+
Sbjct: 303 VIDASKRISVDEALQHPYINVWYDPS----EAEAPPPKIPDKQL-DEREHTIEEWKELIY 357

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 68/266 (25%), Positives = 112/266 (42%), Gaps = 36/266 (13%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEF----------LQREQKFLSSLNSPHIV 58
           IG+G    V     ++   V A KS  L  SE            QRE   +S+LN P+IV
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 59  GYKGCDVTSEDNKLMYN---LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
              G         LM+N   + ME+ P G L   +      +  S+ +     I  G+EY
Sbjct: 87  KLYG---------LMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEY 137
Query: 116 LHSNR--VVHCDIKSRNILM------AESGAKIADFGCAKWESEALQSG--GTPMFMAPE 165
           + +    +VH D++S NI +      A   AK+ADFG ++    ++ SG  G   +MAPE
Sbjct: 138 MQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSVHSV-SGLLGNFQWMAPE 196
Query: 166 VARGEHQGFA--SDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSREL-PEVPAFLS 222
               E + +   +D ++    +  + +G  P+   +        +     L P +P    
Sbjct: 197 TIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCP 256
Query: 223 KQANDFLSNCLRRDPKERWAASQLLK 248
            +  + +  C   DPK+R   S ++K
Sbjct: 257 PRLRNVIELCWSGDPKKRPHFSYIVK 282

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 103/231 (44%), Gaps = 29/231 (12%)
Query: 32  KSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIH 91
           +++E  + +F QRE + L+ L   HIV + G  V +E   L+  +  EY   G LN  + 
Sbjct: 81  EASESARQDF-QREAELLTMLQHQHIVRFFG--VCTEGRPLL--MVFEYMRHGDLNRFLR 135
Query: 92  RNG--------------GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES- 136
            +G              G L    +++   Q+  G+ YL     VH D+ +RN L+ +  
Sbjct: 136 SHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGL 195
Query: 137 GAKIADFGCAK--WESEALQSGGTPMF----MAPEVARGEHQGFASDIWAVGCTVIEMAS 190
             KI DFG ++  + ++  + GG  M     M PE          SD+W+ G  + E+ +
Sbjct: 196 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255
Query: 191 -GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKER 240
            G  PW   ++    +  I   REL E P     +    +  C +R+P++R
Sbjct: 256 YGKQPWYQLSN-TEAIDCITQGREL-ERPRACPPEVYAIMRGCWQREPQQR 304

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 75/167 (44%), Gaps = 16/167 (9%)
Query: 45  EQKFLSSLNSPHIVGYKGCDVTSEDNKLMYN----LFMEYAPGGTLNDEIHR--NGGRLD 98
           E + +  LN P++V  +  +V     KL  N    L MEY  GG L   +++  N   L 
Sbjct: 62  EIQIMKKLNHPNVVSAR--EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLK 119
Query: 99  ESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGA----KIADFGCAKWESEA-- 152
           E  I +    I   L YLH NR++H D+K  NI++         KI D G AK   +   
Sbjct: 120 EGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL 179
Query: 153 -LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPW-PN 197
             +  GT  ++APE+   +      D W+ G    E  +G  P+ PN
Sbjct: 180 CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPN 226

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 75/167 (44%), Gaps = 16/167 (9%)
Query: 45  EQKFLSSLNSPHIVGYKGCDVTSEDNKLMYN----LFMEYAPGGTLNDEIHR--NGGRLD 98
           E + +  LN P++V  +  +V     KL  N    L MEY  GG L   +++  N   L 
Sbjct: 63  EIQIMKKLNHPNVVSAR--EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLK 120
Query: 99  ESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGA----KIADFGCAKWESEA-- 152
           E  I +    I   L YLH NR++H D+K  NI++         KI D G AK   +   
Sbjct: 121 EGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL 180
Query: 153 -LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPW-PN 197
             +  GT  ++APE+   +      D W+ G    E  +G  P+ PN
Sbjct: 181 CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPN 227

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 103/231 (44%), Gaps = 29/231 (12%)
Query: 32  KSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIH 91
           +++E  + +F QRE + L+ L   HIV + G  V +E   L+  +  EY   G LN  + 
Sbjct: 52  EASESARQDF-QREAELLTMLQHQHIVRFFG--VCTEGRPLL--MVFEYMRHGDLNRFLR 106
Query: 92  RNG--------------GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES- 136
            +G              G L    +++   Q+  G+ YL     VH D+ +RN L+ +  
Sbjct: 107 SHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGL 166
Query: 137 GAKIADFGCAK--WESEALQSGGTPMF----MAPEVARGEHQGFASDIWAVGCTVIEMAS 190
             KI DFG ++  + ++  + GG  M     M PE          SD+W+ G  + E+ +
Sbjct: 167 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 226
Query: 191 -GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKER 240
            G  PW   ++    +  I   REL E P     +    +  C +R+P++R
Sbjct: 227 YGKQPWYQLSN-TEAIDCITQGREL-ERPRACPPEVYAIMRGCWQREPQQR 275

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 98/240 (40%), Gaps = 48/240 (20%)
Query: 97  LDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKWESEALQS 155
           LD   +     Q+L G+++LHS  ++H D+K  NI++ ++   KI DFG A+    +   
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 182
Query: 156 GG---TPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWP---------------- 196
                T  + APEV  G       DIW+VGC + EM  GG  +P                
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLG 242
Query: 197 -------NAADPMTVLYK--------IAYSRELPEV--PA------FLSKQANDFLSNCL 233
                      P    Y          ++ +  P+V  PA        + QA D LS  L
Sbjct: 243 TPSPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKML 302
Query: 234 RRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSILDQGIWNSVEETEESLGNLIH 293
             D  +R +  + L+HP++  +   +    E+   P  I D+ + +  E T E    LI+
Sbjct: 303 VIDASKRISVDEALQHPYINVWYDPS----EAEAPPPKIPDKQL-DEREHTIEEWKELIY 357

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 70/271 (25%), Positives = 119/271 (43%), Gaps = 33/271 (12%)
Query: 8   TIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQR--------EQKFLSSLNSPHIVG 59
            IG+G+   V++     +  ++A K   L K E L+R        E+  L + +   I  
Sbjct: 81  VIGRGAFGEVAVVKMKNTERIYAMKI--LNKWEMLKRAETACFREERDVLVNGDCQWITA 138
Query: 60  YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN 119
                   +D   +Y L M+Y  GG L   + +   +L E +   Y  +++  ++ +H  
Sbjct: 139 LH---YAFQDENHLY-LVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQL 194
Query: 120 RVVHCDIKSRNILMAESG-AKIADFG-CAKWESEA-LQSG---GTPMFMAPEVARGEHQG 173
             VH DIK  N+L+  +G  ++ADFG C K   +  +QS    GTP +++PE+ +    G
Sbjct: 195 HYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDG 254
Query: 174 FAS-----DIWAVGCTVIEMASGGAPWPNAADPMTVLY-KIAYSRELPEVPAF---LSKQ 224
                   D W++G  + EM  G  P+   A+ +   Y KI    E  + P+    +S++
Sbjct: 255 MGKYGPECDWWSLGVCMYEMLYGETPF--YAESLVETYGKIMNHEERFQFPSHVTDVSEE 312
Query: 225 ANDFLSN--CLRRDPKERWAASQLLKHPFLE 253
           A D +    C R     +       KH F E
Sbjct: 313 AKDLIQRLICSRERRLGQNGIEDFKKHAFFE 343

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 98/240 (40%), Gaps = 48/240 (20%)
Query: 97  LDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKWESEALQS 155
           LD   +     Q+L G+++LHS  ++H D+K  NI++ ++   KI DFG A+    +   
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 182
Query: 156 GG---TPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWP---------------- 196
                T  + APEV  G       DIW+VGC + EM  GG  +P                
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLG 242
Query: 197 -------NAADPMTVLYK--------IAYSRELPEV--PA------FLSKQANDFLSNCL 233
                      P    Y          ++ +  P+V  PA        + QA D LS  L
Sbjct: 243 TPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKML 302
Query: 234 RRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSILDQGIWNSVEETEESLGNLIH 293
             D  +R +  + L+HP++  +   +    E+   P  I D+ + +  E T E    LI+
Sbjct: 303 VIDASKRISVDEALQHPYINVWYDPS----EAEAPPPKIPDKQL-DEREHTIEEWKELIY 357

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 98/240 (40%), Gaps = 48/240 (20%)
Query: 97  LDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKWESEALQS 155
           LD   +     Q+L G+++LHS  ++H D+K  NI++ ++   KI DFG A+    +   
Sbjct: 124 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 183
Query: 156 GG---TPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWP---------------- 196
                T  + APEV  G       DIW+VGC + EM  GG  +P                
Sbjct: 184 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLG 243
Query: 197 -------NAADPMTVLY--------KIAYSRELPEV--PA------FLSKQANDFLSNCL 233
                      P    Y          ++ +  P+V  PA        + QA D LS  L
Sbjct: 244 TPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKML 303
Query: 234 RRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSILDQGIWNSVEETEESLGNLIH 293
             D  +R +  + L+HP++  +   +    E+   P  I D+ + +  E T E    LI+
Sbjct: 304 VIDASKRISVDEALQHPYINVWYDPS----EAEAPPPKIPDKQL-DEREHTIEEWKELIY 358

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 97/240 (40%), Gaps = 48/240 (20%)
Query: 97  LDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKWESEALQS 155
           LD   +     Q+L G+++LHS  ++H D+K  NI++ ++   KI DFG A+    +   
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 182
Query: 156 GG---TPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWP---------------- 196
                T  + APEV  G       DIW+VGC + EM  GG  +P                
Sbjct: 183 TPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLG 242
Query: 197 -------NAADPMTVLYK--------IAYSRELPEV--------PAFLSKQANDFLSNCL 233
                      P    Y          ++ +  P+V         A  + QA D LS  L
Sbjct: 243 TPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNALKASQARDLLSKML 302
Query: 234 RRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSILDQGIWNSVEETEESLGNLIH 293
             D  +R +  + L+HP++  +   +    E+   P  I D+ + +  E T E    LI+
Sbjct: 303 VIDASKRISVDEALQHPYINVWYDPS----EAEAPPPKIPDKQL-DEREHTIEEWKELIY 357

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 70/271 (25%), Positives = 119/271 (43%), Gaps = 33/271 (12%)
Query: 8   TIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQR--------EQKFLSSLNSPHIVG 59
            IG+G+   V++     +  ++A K   L K E L+R        E+  L + +   I  
Sbjct: 97  VIGRGAFGEVAVVKMKNTERIYAMKI--LNKWEMLKRAETACFREERDVLVNGDCQWITA 154
Query: 60  YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN 119
                   +D   +Y L M+Y  GG L   + +   +L E +   Y  +++  ++ +H  
Sbjct: 155 LH---YAFQDENHLY-LVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQL 210
Query: 120 RVVHCDIKSRNILMAESG-AKIADFG-CAKWESEA-LQSG---GTPMFMAPEVARGEHQG 173
             VH DIK  N+L+  +G  ++ADFG C K   +  +QS    GTP +++PE+ +    G
Sbjct: 211 HYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDG 270
Query: 174 FAS-----DIWAVGCTVIEMASGGAPWPNAADPMTVLY-KIAYSRELPEVPAF---LSKQ 224
                   D W++G  + EM  G  P+   A+ +   Y KI    E  + P+    +S++
Sbjct: 271 MGKYGPECDWWSLGVCMYEMLYGETPF--YAESLVETYGKIMNHEERFQFPSHVTDVSEE 328
Query: 225 ANDFLSN--CLRRDPKERWAASQLLKHPFLE 253
           A D +    C R     +       KH F E
Sbjct: 329 AKDLIQRLICSRERRLGQNGIEDFKKHAFFE 359

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 94/198 (47%), Gaps = 22/198 (11%)
Query: 76  LFMEYAPGGTLNDEIHRN-GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMA 134
           +  EY   G+L D +  + GG++    ++ ++ QI +G+ Y+     +H D+++ N+L++
Sbjct: 85  IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVS 144
Query: 135 ES-GAKIADFGCAKW----ESEALQSGGTPM-FMAPEVARGEHQGFASDIWAVGCTVIEM 188
           ES   KIADFG A+     E  A +    P+ + APE          SD+W+ G  + E+
Sbjct: 145 ESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSDVWSFGILLYEI 204
Query: 189 AS-GGAPWP--NAADPMTVL---YKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWA 242
            + G  P+P    AD MT L   Y++      P+       +  D +  C +   +ER  
Sbjct: 205 VTYGKIPYPGRTNADVMTALSQGYRMPRVENCPD-------ELYDIMKMCWKEKAEERPT 257
Query: 243 ASQLLKHPFLEEFCSCTK 260
              L     L++F + T+
Sbjct: 258 FDYL--QSVLDDFYTATE 273

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 98/240 (40%), Gaps = 48/240 (20%)
Query: 97  LDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKWESEALQS 155
           LD   +     Q+L G+++LHS  ++H D+K  NI++ +++  KI DFG A+    +   
Sbjct: 123 LDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMM 182
Query: 156 GG---TPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWP---------------- 196
                T  + APEV  G       DIW+VG  + EM  GG  +P                
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLG 242
Query: 197 -------NAADPMTVLYK--------IAYSRELPEV--PA------FLSKQANDFLSNCL 233
                      P    Y          ++ +  P+V  PA        + QA D LS  L
Sbjct: 243 TPSPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKML 302
Query: 234 RRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSILDQGIWNSVEETEESLGNLIH 293
             D  +R +  + L+HP++  +   +    E+   P  I D+ + +  E T E    LI+
Sbjct: 303 VIDASKRISVDEALQHPYINVWYDPS----EAEAPPPKIPDKQL-DEREHTIEEWKELIY 357

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 98/240 (40%), Gaps = 48/240 (20%)
Query: 97  LDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKWESEALQS 155
           LD   +     Q+L G+++LHS  ++H D+K  NI++ ++   KI DFG A+    +   
Sbjct: 125 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 184
Query: 156 GG---TPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWP---------------- 196
                T  + APEV  G       DIW+VGC + EM  GG  +P                
Sbjct: 185 VPFVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLG 244
Query: 197 -------NAADPMTVLY--------KIAYSRELPEV--PA------FLSKQANDFLSNCL 233
                      P    Y          ++ +  P+V  PA        + QA D LS  L
Sbjct: 245 TPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKML 304
Query: 234 RRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSILDQGIWNSVEETEESLGNLIH 293
             D  +R +  + L+HP++  +   +    E+   P  I D+ + +  E T E    LI+
Sbjct: 305 VIDASKRISVDEALQHPYINVWYDPS----EAEAPPPKIPDKQL-DEREHTIEEWKELIY 359

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 73/301 (24%), Positives = 119/301 (39%), Gaps = 65/301 (21%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSE-----FLQREQKFLSSLNSPHI 57
           + R   +G+G+   V  A    + +  A K   L   E        RE   L  L   +I
Sbjct: 36  YRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNI 95
Query: 58  VGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLH 117
           +  K   V   +++L  +L  EYA    L   + +N   +   +I S+  Q++ G+ + H
Sbjct: 96  IELKS--VIHHNHRL--HLIFEYAEND-LKKYMDKNPD-VSMRVIKSFLYQLINGVNFCH 149
Query: 118 SNRVVHCDIKSRNILMAESGA------KIADFGCAKWESEALQSGGTPM----------- 160
           S R +H D+K +N+L++ S A      KI DFG A+       + G P+           
Sbjct: 150 SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR-------AFGIPIRQFTHEIITLW 202
Query: 161 FMAPEVARG-EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPE--- 216
           +  PE+  G  H   + DIW++ C   EM      +P  ++ +  L+KI     LP+   
Sbjct: 203 YRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSE-IDQLFKIFEVLGLPDDTT 261
Query: 217 -------------VPAFLSKQANDFL------------SNCLRRDPKERWAASQLLKHPF 251
                         P F  K     L            +  L  DP +R +A   L+HP+
Sbjct: 262 WPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPY 321
Query: 252 L 252
Sbjct: 322 F 322

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 85/184 (46%), Gaps = 14/184 (7%)
Query: 32  KSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIH 91
           + TE   +E + RE + +  L++P+IV   G     +   LM  L ME A GG L+  + 
Sbjct: 47  QGTEKADTEEMMREAQIMHQLDNPYIVRLIG---VCQAEALM--LVMEMAGGGPLHKFLV 101
Query: 92  RNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMA-ESGAKIADFGCAKW-- 148
                +  S +     Q+  G++YL     VH D+ +RN+L+     AKI+DFG +K   
Sbjct: 102 GKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 161
Query: 149 ----ESEALQSGGTPM-FMAPEVARGEHQGFASDIWAVGCTVIE-MASGGAPWPNAADPM 202
                  A  +G  P+ + APE          SD+W+ G T+ E ++ G  P+     P 
Sbjct: 162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE 221
Query: 203 TVLY 206
            + +
Sbjct: 222 VMAF 225

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 98/240 (40%), Gaps = 48/240 (20%)
Query: 97  LDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKWESEALQS 155
           LD   +     Q+L G+++LHS  ++H D+K  NI++ +++  KI DFG A+    +   
Sbjct: 123 LDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMM 182
Query: 156 GG---TPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWP---------------- 196
                T  + APEV  G       DIW+VG  + EM  GG  +P                
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLG 242
Query: 197 -------NAADPMTVLYK--------IAYSRELPEV--PA------FLSKQANDFLSNCL 233
                      P    Y          ++ +  P+V  PA        + QA D LS  L
Sbjct: 243 TPSPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKML 302
Query: 234 RRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSILDQGIWNSVEETEESLGNLIH 293
             D  +R +  + L+HP++  +   +    E+   P  I D+ + +  E T E    LI+
Sbjct: 303 VIDASKRISVDEALQHPYINVWYDPS----EAEAPPPKIPDKQL-DEREHTIEEWKELIY 357

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 82/192 (42%), Gaps = 39/192 (20%)
Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES-GAKIADFGCAKWESEALQSGG--- 157
           I  +  QIL+GL+Y+HS  V+H D+K  N+L+  +   KI DFG A+         G   
Sbjct: 128 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 187
Query: 158 ----TPMFMAPEVARGEHQGFAS--DIWAVGCTVIEMASGGAPWP--NAADPMTVLYKIA 209
               T  + APE+     +G+    DIW+VGC + EM S    +P  +  D +  +  I 
Sbjct: 188 EYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 246
Query: 210 ------------------YSRELP---EVP-----AFLSKQANDFLSNCLRRDPKERWAA 243
                             Y   LP   +VP          +A D L   L  +P +R   
Sbjct: 247 GSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEV 306
Query: 244 SQLLKHPFLEEF 255
            Q L HP+L ++
Sbjct: 307 EQALAHPYLAQY 318

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 117/287 (40%), Gaps = 47/287 (16%)
Query: 8   TIGQGSSATVSLATSLRSGDVFAAKSTELPKSEF---LQREQKFLSSLNSPHIVGYKGCD 64
            +G+G+ A V    +L +   +A K  E         + RE + L        V      
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 65  VTSEDNKLMYNLFMEYAPGGTLNDEIH--RNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
              ED    + L  E   GG++   IH  R+   L+ S++V   + +   L++LH+  + 
Sbjct: 80  FEEEDR---FYLVFEKMRGGSILSHIHKRRHFNELEASVVV---QDVASALDFLHNKGIA 133
Query: 123 HCDIKSRNILMAE----SGAKIADF----------GCAKWES-EALQSGGTPMFMAPEVA 167
           H D+K  NIL       S  KI DF           C+   + E L   G+  +MAPEV 
Sbjct: 134 HRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVV 193
Query: 168 RGEHQGFA-----SDIWAVGCTVIEMASGGAPWPN---------------AADPMTVLYK 207
               +  +      D+W++G  +  + SG  P+                 A   M     
Sbjct: 194 EAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESI 253
Query: 208 IAYSRELPEVP-AFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLE 253
                E P+   A +S  A D +S  L RD K+R +A+Q+L+HP+++
Sbjct: 254 QEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ 300

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/252 (25%), Positives = 103/252 (40%), Gaps = 22/252 (8%)
Query: 4   TRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGYKGC 63
            R   + Q   + V +A  +   D+ A+   E    EFL RE   +   + PH+    G 
Sbjct: 39  VREAQLKQEDGSFVKVAVKMLKADIIASSDIE----EFL-REAACMKEFDHPHVAKLVGV 93
Query: 64  DVTSEDN-----KLMYNLFMEYAP--GGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL 116
            + S         ++   FM++       L   I  N   L    +V +   I  G+EYL
Sbjct: 94  SLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYL 153
Query: 117 HSNRVVHCDIKSRNILMAESGAK-IADFGCAK------WESEALQSGGTPMFMAPEVARG 169
            S   +H D+ +RN ++AE     +ADFG ++      +  +   S     ++A E    
Sbjct: 154 SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLAD 213
Query: 170 EHQGFASDIWAVGCTVIE-MASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDF 228
                 SD+WA G T+ E M  G  P+    +     Y I  +R L + P  + ++  D 
Sbjct: 214 NLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNR-LKQPPECM-EEVYDL 271
Query: 229 LSNCLRRDPKER 240
           +  C   DPK+R
Sbjct: 272 MYQCWSADPKQR 283

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/253 (24%), Positives = 111/253 (43%), Gaps = 24/253 (9%)
Query: 6   GHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDV 65
           GH    G         +L+SG       TE  + +FL  E   +   + P+++  +G  V
Sbjct: 52  GHLKLPGKREIFVAIKTLKSG------YTEKQRRDFLS-EASIMGQFDHPNVIHLEGV-V 103
Query: 66  TSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCD 125
           T     ++   FME    G+L+  + +N G+     +V   R I  G++YL     VH D
Sbjct: 104 TKSTPVMIITEFME---NGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRD 160
Query: 126 IKSRNILMAESGA-KIADFGCAKWESE--------ALQSGGTPM-FMAPEVARGEHQGFA 175
           + +RNIL+  +   K++DFG +++  +        +   G  P+ + APE  +      A
Sbjct: 161 LAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSA 220
Query: 176 SDIWAVGCTVIE-MASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLR 234
           SD+W+ G  + E M+ G  P+ +  +   V+  I     LP  P       +  + +C +
Sbjct: 221 SDVWSYGIVMWEVMSYGERPYWDMTN-QDVINAIEQDYRLPP-PMDCPSALHQLMLDCWQ 278
Query: 235 RDPKERWAASQLL 247
           +D   R    Q++
Sbjct: 279 KDRNHRPKFGQIV 291

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 77/328 (23%), Positives = 120/328 (36%), Gaps = 83/328 (25%)
Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQRE---QKFLSSLNSPHIVG 59
           ++ G T+G GS   V     + SG  FA K   L    +  RE    K L  +N   +V 
Sbjct: 9   YSLGKTLGTGSFGIVCEVFDIESGKRFALKKV-LQDPRYKNRELDIMKVLDHVNIIKLVD 67
Query: 60  Y--------------------------------KGCDVTSEDNKLMYNLFMEYAPGGTLN 87
           Y                                K   V    NK + N+ MEY P     
Sbjct: 68  YFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYL-NVIMEYVP----- 121
Query: 88  DEIH-------RNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILM--AESGA 138
           D +H       R+G  +  +LI  Y  Q+ + + ++HS  + H DIK +N+L+   ++  
Sbjct: 122 DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTL 181
Query: 139 KIADFGCAKW---ESEALQSGGTPMFMAPEVARGEHQGFAS-DIWAVGCTVIEMASGGAP 194
           K+ DFG AK       ++    +  + APE+  G  +   S D+W++GC   E+   G P
Sbjct: 182 KLCDFGSAKKLIPSEPSVAXICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELIL-GKP 240
Query: 195 WPNAADPMTVLYKIAYSRELP---------------EVPAFLSKQ------------AND 227
             +    +  L +I      P                 P   +K             A D
Sbjct: 241 LFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAID 300
Query: 228 FLSNCLRRDPKERWAASQLLKHPFLEEF 255
            L   LR +P  R    + + HPF +  
Sbjct: 301 LLEQILRYEPDLRINPYEAMAHPFFDHL 328

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 77/282 (27%), Positives = 109/282 (38%), Gaps = 42/282 (14%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKS---TELPKSEFLQREQKFLSSLNSPHIV 58
           D+     +GQG+   V  A +      +A K    TE   S  L  E   L+SLN  ++V
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILS-EVXLLASLNHQYVV 65
Query: 59  GYKGC---------DVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQI 109
            Y              T+   K    +  EY    TL D IH               RQI
Sbjct: 66  RYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQI 125
Query: 110 LQGLEYLHSNRVVHCDIKSRNILMAES-GAKIADFGCAK-----------------WESE 151
           L+ L Y+HS  ++H ++K  NI + ES   KI DFG AK                   S+
Sbjct: 126 LEALSYIHSQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185
Query: 152 ALQSG-GTPMFMAPEVARGE-HQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKI- 208
            L S  GT  ++A EV  G  H     D +++G    E      P+    + + +L K+ 
Sbjct: 186 NLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI---YPFSTGXERVNILKKLR 242
Query: 209 AYSRELPEVPAF---LSKQANDFLSNCLRRDPKERWAASQLL 247
           + S E P  P F     K     +   +  DP +R  A  LL
Sbjct: 243 SVSIEFP--PDFDDNKXKVEKKIIRLLIDHDPNKRPGARTLL 282

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 98/217 (45%), Gaps = 30/217 (13%)
Query: 53  NSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRN---------------GGRL 97
           + P+I+   G     E    +Y L +EYAP G L D + ++                  L
Sbjct: 74  HHPNIINLLG---ACEHRGYLY-LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 129
Query: 98  DESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQS- 155
               ++ +   + +G++YL   + +H D+ +RNIL+ E+  AKIADFG ++ +   ++  
Sbjct: 130 SSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKT 189
Query: 156 -GGTPM-FMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTV--LYKIAY 210
            G  P+ +MA E          SD+W+ G  + E+ S GG P+      MT   LY+   
Sbjct: 190 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG----MTCAELYEKLP 245
Query: 211 SRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLL 247
                E P     +  D +  C R  P ER + +Q+L
Sbjct: 246 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQIL 282

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 66/255 (25%), Positives = 109/255 (42%), Gaps = 28/255 (10%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTE---LPKSEFLQREQKFLSSLNSPHIV 58
           D T  H +G G    V      +     A K+ +   +   EFL +E   +  +  P++V
Sbjct: 12  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL-KEAAVMKEIKHPNLV 70
Query: 59  GYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHR-NGGRLDESLIVSYTRQILQGLEYLH 117
              G   T E    +   FM Y   G L D +   N   +   +++    QI   +EYL 
Sbjct: 71  QLLGV-CTREPPFYIITEFMTY---GNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 126
Query: 118 SNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSGGT---------PM-FMAPEV 166
               +H D+ +RN L+ E+   K+ADFG ++     L +G T         P+ + APE 
Sbjct: 127 KKNFIHRDLAARNCLVGENHLVKVADFGLSR-----LMTGDTFTAHAGAKFPIKWTAPES 181
Query: 167 ARGEHQGFASDIWAVGCTVIEMASGG-APWPNAADPMTVLYKIAYSRELPEVPAFLSKQA 225
                    SD+WA G  + E+A+ G +P+P   DP  V Y++       E P    ++ 
Sbjct: 182 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYP-GIDPSQV-YELLEKDYRMERPEGCPEKV 239
Query: 226 NDFLSNCLRRDPKER 240
            + +  C + +P +R
Sbjct: 240 YELMRACWQWNPSDR 254

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 98/217 (45%), Gaps = 30/217 (13%)
Query: 53  NSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRN---------------GGRL 97
           + P+I+   G     E    +Y L +EYAP G L D + ++                  L
Sbjct: 84  HHPNIINLLG---ACEHRGYLY-LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 139
Query: 98  DESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQS- 155
               ++ +   + +G++YL   + +H D+ +RNIL+ E+  AKIADFG ++ +   ++  
Sbjct: 140 SSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKT 199
Query: 156 -GGTPM-FMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTV--LYKIAY 210
            G  P+ +MA E          SD+W+ G  + E+ S GG P+      MT   LY+   
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG----MTCAELYEKLP 255
Query: 211 SRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLL 247
                E P     +  D +  C R  P ER + +Q+L
Sbjct: 256 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQIL 292

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 78/295 (26%), Positives = 113/295 (38%), Gaps = 56/295 (18%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELP-----KSEFLQREQKFLSSLNSPHIVGYKGC 63
           IG G+   V  A     G   A K    P      ++   RE   L  +N  +I+     
Sbjct: 30  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 89
Query: 64  ---DVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNR 120
                T E+ + +Y L ME      L   IH     LD   +     Q+L G+++LHS  
Sbjct: 90  FTPQKTLEEFQDVY-LVMELM-DANLCQVIHME---LDHERMSYLLYQMLCGIKHLHSAG 144
Query: 121 VVHCDIKSRNILM-AESGAKIADFGCAKWESEALQSGG---TPMFMAPEVARGEHQGFAS 176
           ++H D+K  NI++ ++   KI DFG A+  S          T  + APEV  G       
Sbjct: 145 IIHRDLKPSNIVVKSDCTLKILDFGLARTASTNFMMTPYVVTRYYRAPEVILGMGYKENV 204
Query: 177 DIWAVGCTVIEMASG--------------------GAP---WPNAADPMTVLYK------ 207
           DIW+VGC + E+  G                    G P   +  A  P    Y       
Sbjct: 205 DIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTVRNYVENRPAY 264
Query: 208 --IAYSRELP--------EVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFL 252
             IA+    P        E     + QA D LS  L  DP +R +  + L+HP++
Sbjct: 265 PGIAFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEALRHPYI 319

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 66/255 (25%), Positives = 109/255 (42%), Gaps = 28/255 (10%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTE---LPKSEFLQREQKFLSSLNSPHIV 58
           D T  H +G G    V      +     A K+ +   +   EFL +E   +  +  P++V
Sbjct: 12  DITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL-KEAAVMKEIKHPNLV 70
Query: 59  GYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHR-NGGRLDESLIVSYTRQILQGLEYLH 117
              G   T E    +   FM Y   G L D +   N   +   +++    QI   +EYL 
Sbjct: 71  QLLGV-CTREPPFYIITEFMTY---GNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 126
Query: 118 SNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSGGT---------PM-FMAPEV 166
               +H D+ +RN L+ E+   K+ADFG ++     L +G T         P+ + APE 
Sbjct: 127 KKNFIHRDLAARNCLVGENHLVKVADFGLSR-----LMTGDTXTAHAGAKFPIKWTAPES 181
Query: 167 ARGEHQGFASDIWAVGCTVIEMASGG-APWPNAADPMTVLYKIAYSRELPEVPAFLSKQA 225
                    SD+WA G  + E+A+ G +P+P   DP  V Y++       E P    ++ 
Sbjct: 182 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYP-GIDPSQV-YELLEKDYRMERPEGCPEKV 239
Query: 226 NDFLSNCLRRDPKER 240
            + +  C + +P +R
Sbjct: 240 YELMRACWQWNPSDR 254

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 78/344 (22%), Positives = 133/344 (38%), Gaps = 68/344 (19%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTE-LPKSEF---LQREQKFLSSLNSPHI 57
           D+     +G+G+   V  AT   +G++ A K  E   K  F     RE K L      +I
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENI 71
Query: 58  VGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHR--NGGRLDESLIVSYTRQILQGLEY 115
           +     ++   D+   +N    Y     +  ++HR  +   L +  I  +  Q L+ ++ 
Sbjct: 72  ITI--FNIQRPDSFENFNEV--YIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKV 127
Query: 116 LHSNRVVHCDIKSRNILM-AESGAKIADFGCAKW---------ESEALQSGGTPM----- 160
           LH + V+H D+K  N+L+ +    K+ DFG A+          E    QSG T       
Sbjct: 128 LHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRW 187
Query: 161 FMAPEVA-RGEHQGFASDIWAVGCTVIEMASGGAPWP--NAADPMTVLYKIA-------- 209
           + APEV         A D+W+ GC + E+      +P  +    + +++ I         
Sbjct: 188 YRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDND 247
Query: 210 -----------YSRELPEVPAF--------LSKQANDFLSNCLRRDPKERWAASQLLKHP 250
                      Y + LP  PA         ++ +  D L   L  DP +R  A + L+HP
Sbjct: 248 LRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHP 307
Query: 251 FLEEFCSCTKQIQESNCSP-------------TSILDQGIWNSV 281
           +L+ +     + +     P             T  L + IWN +
Sbjct: 308 YLQTYHDPNDEPEGEPIPPSFFEFDHYKEALTTKDLKKLIWNEI 351

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 78/344 (22%), Positives = 133/344 (38%), Gaps = 68/344 (19%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTE-LPKSEF---LQREQKFLSSLNSPHI 57
           D+     +G+G+   V  AT   +G++ A K  E   K  F     RE K L      +I
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENI 71
Query: 58  VGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHR--NGGRLDESLIVSYTRQILQGLEY 115
           +     ++   D+   +N    Y     +  ++HR  +   L +  I  +  Q L+ ++ 
Sbjct: 72  ITI--FNIQRPDSFENFNEV--YIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKV 127
Query: 116 LHSNRVVHCDIKSRNILM-AESGAKIADFGCAKW---------ESEALQSGGTPM----- 160
           LH + V+H D+K  N+L+ +    K+ DFG A+          E    QSG T       
Sbjct: 128 LHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRW 187
Query: 161 FMAPEVA-RGEHQGFASDIWAVGCTVIEMASGGAPWP--NAADPMTVLYKIA-------- 209
           + APEV         A D+W+ GC + E+      +P  +    + +++ I         
Sbjct: 188 YRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDND 247
Query: 210 -----------YSRELPEVPAF--------LSKQANDFLSNCLRRDPKERWAASQLLKHP 250
                      Y + LP  PA         ++ +  D L   L  DP +R  A + L+HP
Sbjct: 248 LRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHP 307
Query: 251 FLEEFCSCTKQIQESNCSP-------------TSILDQGIWNSV 281
           +L+ +     + +     P             T  L + IWN +
Sbjct: 308 YLQTYHDPNDEPEGEPIPPSFFEFDHYKEALTTKDLKKLIWNEI 351

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/256 (24%), Positives = 108/256 (42%), Gaps = 30/256 (11%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTE---LPKSEFLQREQKFLSSLNSPHIV 58
           D T  H +G G    V +    +     A K+ +   +   EFL +E   +  +  P++V
Sbjct: 33  DITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVEEFL-KEAAVMKEIKHPNLV 91
Query: 59  GYKG-CDVTSEDNKLMYNLFMEYAPGGTLNDEIHR-NGGRLDESLIVSYTRQILQGLEYL 116
              G C +        + +  EY P G L D +   N   +   +++    QI   +EYL
Sbjct: 92  QLLGVCTLEPP-----FYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYL 146
Query: 117 HSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSGGT---------PM-FMAPE 165
                +H D+ +RN L+ E+   K+ADFG ++     L +G T         P+ + APE
Sbjct: 147 EKKNFIHRDLAARNCLVGENHVVKVADFGLSR-----LMTGDTYTAHAGAKFPIKWTAPE 201
Query: 166 VARGEHQGFASDIWAVGCTVIEMASGG-APWPNAADPMTVLYKIAYSRELPEVPAFLSKQ 224
                     SD+WA G  + E+A+ G +P+P     ++ +Y +       E P     +
Sbjct: 202 SLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI--DLSQVYDLLEKGYRMEQPEGCPPK 259
Query: 225 ANDFLSNCLRRDPKER 240
             + +  C +  P +R
Sbjct: 260 VYELMRACWKWSPADR 275

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 78/344 (22%), Positives = 133/344 (38%), Gaps = 68/344 (19%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTE-LPKSEF---LQREQKFLSSLNSPHI 57
           D+     +G+G+   V  AT   +G++ A K  E   K  F     RE K L      +I
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENI 71
Query: 58  VGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHR--NGGRLDESLIVSYTRQILQGLEY 115
           +     ++   D+   +N    Y     +  ++HR  +   L +  I  +  Q L+ ++ 
Sbjct: 72  ITI--FNIQRPDSFENFNEV--YIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKV 127
Query: 116 LHSNRVVHCDIKSRNILM-AESGAKIADFGCAKW---------ESEALQSG-----GTPM 160
           LH + V+H D+K  N+L+ +    K+ DFG A+          E    QSG      T  
Sbjct: 128 LHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRW 187
Query: 161 FMAPEVA-RGEHQGFASDIWAVGCTVIEMASGGAPWP--NAADPMTVLYKIA-------- 209
           + APEV         A D+W+ GC + E+      +P  +    + +++ I         
Sbjct: 188 YRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDND 247
Query: 210 -----------YSRELPEVPAF--------LSKQANDFLSNCLRRDPKERWAASQLLKHP 250
                      Y + LP  PA         ++ +  D L   L  DP +R  A + L+HP
Sbjct: 248 LRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHP 307
Query: 251 FLEEFCSCTKQIQESNCSP-------------TSILDQGIWNSV 281
           +L+ +     + +     P             T  L + IWN +
Sbjct: 308 YLQTYHDPNDEPEGEPIPPSFFEFDHYKEALTTKDLKKLIWNEI 351

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 69/264 (26%), Positives = 112/264 (42%), Gaps = 24/264 (9%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNS-PHIVGYKGCDVTS 67
           +G+GS +        +S   FA K          Q+E   L      P+IV  K  +V  
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIV--KLHEVFH 76
Query: 68  EDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIK 127
           +  +L   L ME   GG L + I +      E+      R+++  + ++H   VVH D+K
Sbjct: 77  D--QLHTFLVMELLNGGELFERI-KKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLK 133
Query: 128 SRNILMAESG----AKIADFGCAKWESEALQSGGTPMFM----APEVARGEHQGFASDIW 179
             N+L  +       KI DFG A+ +    Q   TP F     APE+        + D+W
Sbjct: 134 PENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLW 193
Query: 180 AVGCTVIEMASGGAPW---------PNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLS 230
           ++G  +  M SG  P+          +A + M  + K  +S E  E    +S++A D + 
Sbjct: 194 SLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFE-GEAWKNVSQEAKDLIQ 252
Query: 231 NCLRRDPKERWAASQLLKHPFLEE 254
             L  DP +R   S L  + +L++
Sbjct: 253 GLLTVDPNKRLKMSGLRYNEWLQD 276

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 67/266 (25%), Positives = 111/266 (41%), Gaps = 36/266 (13%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEF----------LQREQKFLSSLNSPHIV 58
           IG+G    V     ++   V A KS  L  SE            QRE   +S+LN P+IV
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 59  GYKGCDVTSEDNKLMYN---LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
              G         LM+N   + ME+ P G L   +      +  S+ +     I  G+EY
Sbjct: 87  KLYG---------LMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEY 137
Query: 116 LHSNR--VVHCDIKSRNILM------AESGAKIADFGCAKWESEALQSG--GTPMFMAPE 165
           + +    +VH D++S NI +      A   AK+ADF  ++    ++ SG  G   +MAPE
Sbjct: 138 MQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSVHSV-SGLLGNFQWMAPE 196
Query: 166 VARGEHQGFA--SDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSREL-PEVPAFLS 222
               E + +   +D ++    +  + +G  P+   +        +     L P +P    
Sbjct: 197 TIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCP 256
Query: 223 KQANDFLSNCLRRDPKERWAASQLLK 248
            +  + +  C   DPK+R   S ++K
Sbjct: 257 PRLRNVIELCWSGDPKKRPHFSYIVK 282

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 94/241 (39%), Gaps = 48/241 (19%)
Query: 97  LDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKWESEALQS 155
           LD   +     Q+L G+++LHS  ++H D+K  NI++ ++   KI DFG A+    +   
Sbjct: 123 LDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMM 182
Query: 156 GG---TPMFMAPEVARGEHQGFASDIWAVGCTVIEMASG--------------------G 192
                T  + APEV  G       DIW+VGC + EM                       G
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG 242
Query: 193 APWPNAADPMTVLYK-----------IAYSRELPE--VPA------FLSKQANDFLSNCL 233
            P P     +    +           + + +  P+   PA        + QA D LS  L
Sbjct: 243 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKML 302
Query: 234 RRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSILDQGIWNSVEETEESLGNLIH 293
             DP +R +    L+HP++  +        E    P  I D+ + +  E T E    LI+
Sbjct: 303 VIDPAKRISVDDALQHPYINVWYDPA----EVEAPPPQIYDKQL-DEREHTIEEWKELIY 357
Query: 294 S 294
Sbjct: 358 K 358

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 94/241 (39%), Gaps = 48/241 (19%)
Query: 97  LDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKWESEALQS 155
           LD   +     Q+L G+++LHS  ++H D+K  NI++ ++   KI DFG A+    +   
Sbjct: 123 LDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMM 182
Query: 156 GG---TPMFMAPEVARGEHQGFASDIWAVGCTVIEMASG--------------------G 192
                T  + APEV  G       DIW+VGC + EM                       G
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG 242
Query: 193 APWPNAADPMTVLYK-----------IAYSRELPE--VPA------FLSKQANDFLSNCL 233
            P P     +    +           + + +  P+   PA        + QA D LS  L
Sbjct: 243 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKML 302
Query: 234 RRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSILDQGIWNSVEETEESLGNLIH 293
             DP +R +    L+HP++  +        E    P  I D+ + +  E T E    LI+
Sbjct: 303 VIDPAKRISVDDALQHPYINVWYDPA----EVEAPPPQIYDKQL-DEREHTIEEWKELIY 357
Query: 294 S 294
Sbjct: 358 K 358

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 110/255 (43%), Gaps = 28/255 (10%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTE---LPKSEFLQREQKFLSSLNSPHIV 58
           D T  H +G G    V      +     A K+ +   +   EFL +E   +  +  P++V
Sbjct: 12  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL-KEAAVMKEIKHPNLV 70
Query: 59  GYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHR-NGGRLDESLIVSYTRQILQGLEYLH 117
              G   T E     + + +E+   G L D +   N   +   +++    QI   +EYL 
Sbjct: 71  QLLGV-CTREPP---FYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 126
Query: 118 SNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSGGT---------PM-FMAPEV 166
               +H D+ +RN L+ E+   K+ADFG ++     L +G T         P+ + APE 
Sbjct: 127 KKNFIHRDLAARNCLVGENHLVKVADFGLSR-----LMTGDTXTAHAGAKFPIKWTAPES 181
Query: 167 ARGEHQGFASDIWAVGCTVIEMASGG-APWPNAADPMTVLYKIAYSRELPEVPAFLSKQA 225
                    SD+WA G  + E+A+ G +P+P   DP  V Y++       E P    ++ 
Sbjct: 182 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYP-GIDPSQV-YELLEKDYRMERPEGCPEKV 239
Query: 226 NDFLSNCLRRDPKER 240
            + +  C + +P +R
Sbjct: 240 YELMRACWQWNPSDR 254

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 94/241 (39%), Gaps = 48/241 (19%)
Query: 97  LDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKWESEALQS 155
           LD   +     Q+L G+++LHS  ++H D+K  NI++ ++   KI DFG A+    +   
Sbjct: 116 LDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMM 175
Query: 156 GG---TPMFMAPEVARGEHQGFASDIWAVGCTVIEMASG--------------------G 192
                T  + APEV  G       DIW+VGC + EM                       G
Sbjct: 176 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG 235
Query: 193 APWPNAADPMTVLYK-----------IAYSRELPE--VPA------FLSKQANDFLSNCL 233
            P P     +    +           + + +  P+   PA        + QA D LS  L
Sbjct: 236 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKML 295
Query: 234 RRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSILDQGIWNSVEETEESLGNLIH 293
             DP +R +    L+HP++  +        E    P  I D+ + +  E T E    LI+
Sbjct: 296 VIDPAKRISVDDALQHPYINVWYDPA----EVEAPPPQIYDKQL-DEREHTIEEWKELIY 350
Query: 294 S 294
Sbjct: 351 K 351

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/255 (24%), Positives = 110/255 (43%), Gaps = 28/255 (10%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTE---LPKSEFLQREQKFLSSLNSPHIV 58
           D T  H +G G    V      +     A K+ +   +   EFL +E   +  +  P++V
Sbjct: 16  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL-KEAAVMKEIKHPNLV 74
Query: 59  GYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHR-NGGRLDESLIVSYTRQILQGLEYLH 117
              G   T E    +   FM Y   G L D +   N   ++  +++    QI   +EYL 
Sbjct: 75  QLLGV-CTREPPFYIITEFMTY---GNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 130
Query: 118 SNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSGGT---------PM-FMAPEV 166
               +H D+ +RN L+ E+   K+ADFG ++     L +G T         P+ + APE 
Sbjct: 131 KKNFIHRDLAARNCLVGENHLVKVADFGLSR-----LMTGDTYTAPAGAKFPIKWTAPES 185
Query: 167 ARGEHQGFASDIWAVGCTVIEMASGG-APWPNAADPMTVLYKIAYSRELPEVPAFLSKQA 225
                    SD+WA G  + E+A+ G +P+P     ++ +Y++       E P    ++ 
Sbjct: 186 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--LSQVYELLEKDYRMERPEGCPEKV 243
Query: 226 NDFLSNCLRRDPKER 240
            + +  C + +P +R
Sbjct: 244 YELMRACWQWNPSDR 258

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/255 (24%), Positives = 110/255 (43%), Gaps = 28/255 (10%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTE---LPKSEFLQREQKFLSSLNSPHIV 58
           D T  H +G G    V      +     A K+ +   +   EFL +E   +  +  P++V
Sbjct: 15  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL-KEAAVMKEIKHPNLV 73
Query: 59  GYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHR-NGGRLDESLIVSYTRQILQGLEYLH 117
              G   T E    +   FM Y   G L D +   N   ++  +++    QI   +EYL 
Sbjct: 74  QLLGV-CTREPPFYIITEFMTY---GNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 129
Query: 118 SNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSGGT---------PM-FMAPEV 166
               +H D+ +RN L+ E+   K+ADFG ++     L +G T         P+ + APE 
Sbjct: 130 KKNFIHRDLAARNCLVGENHLVKVADFGLSR-----LMTGDTYTAPAGAKFPIKWTAPES 184
Query: 167 ARGEHQGFASDIWAVGCTVIEMASGG-APWPNAADPMTVLYKIAYSRELPEVPAFLSKQA 225
                    SD+WA G  + E+A+ G +P+P     ++ +Y++       E P    ++ 
Sbjct: 185 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--LSQVYELLEKDYRMERPEGCPEKV 242
Query: 226 NDFLSNCLRRDPKER 240
            + +  C + +P +R
Sbjct: 243 YELMRACWQWNPSDR 257

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/255 (24%), Positives = 110/255 (43%), Gaps = 28/255 (10%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTE---LPKSEFLQREQKFLSSLNSPHIV 58
           D T  H +G G    V      +     A K+ +   +   EFL +E   +  +  P++V
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL-KEAAVMKEIKHPNLV 77
Query: 59  GYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHR-NGGRLDESLIVSYTRQILQGLEYLH 117
              G   T E    +   FM Y   G L D +   N   ++  +++    QI   +EYL 
Sbjct: 78  QLLGV-CTREPPFYIITEFMTY---GNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 133
Query: 118 SNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSGGT---------PM-FMAPEV 166
               +H D+ +RN L+ E+   K+ADFG ++     L +G T         P+ + APE 
Sbjct: 134 KKNFIHRDLAARNCLVGENHLVKVADFGLSR-----LMTGDTYTAHAGAKFPIKWTAPES 188
Query: 167 ARGEHQGFASDIWAVGCTVIEMASGG-APWPNAADPMTVLYKIAYSRELPEVPAFLSKQA 225
                    SD+WA G  + E+A+ G +P+P     ++ +Y++       E P    ++ 
Sbjct: 189 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--LSQVYELLEKDYRMERPEGCPEKV 246
Query: 226 NDFLSNCLRRDPKER 240
            + +  C + +P +R
Sbjct: 247 YELMRACWQWNPSDR 261

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/255 (24%), Positives = 110/255 (43%), Gaps = 28/255 (10%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTE---LPKSEFLQREQKFLSSLNSPHIV 58
           D T  H +G G    V      +     A K+ +   +   EFL +E   +  +  P++V
Sbjct: 16  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL-KEAAVMKEIKHPNLV 74
Query: 59  GYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHR-NGGRLDESLIVSYTRQILQGLEYLH 117
              G   T E    +   FM Y   G L D +   N   ++  +++    QI   +EYL 
Sbjct: 75  QLLGV-CTREPPFYIITEFMTY---GNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 130
Query: 118 SNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSGGT---------PM-FMAPEV 166
               +H D+ +RN L+ E+   K+ADFG ++     L +G T         P+ + APE 
Sbjct: 131 KKNFIHRDLAARNCLVGENHLVKVADFGLSR-----LMTGDTYTAHAGAKFPIKWTAPES 185
Query: 167 ARGEHQGFASDIWAVGCTVIEMASGG-APWPNAADPMTVLYKIAYSRELPEVPAFLSKQA 225
                    SD+WA G  + E+A+ G +P+P     ++ +Y++       E P    ++ 
Sbjct: 186 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI--DLSQVYELLEKDYRMERPEGCPEKV 243
Query: 226 NDFLSNCLRRDPKER 240
            + +  C + +P +R
Sbjct: 244 YELMRACWQWNPSDR 258

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 76/298 (25%), Positives = 112/298 (37%), Gaps = 62/298 (20%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELP-----KSEFLQREQKFLSSLNSPHIVGYKGC 63
           IG G+   V  A     G   A K    P      ++   RE   L  +N  +I+     
Sbjct: 32  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 91
Query: 64  ---DVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNR 120
                T E+ + +Y L ME      L   IH     LD   +     Q+L G+++LHS  
Sbjct: 92  FTPQKTLEEFQDVY-LVMELM-DANLCQVIHME---LDHERMSYLLYQMLCGIKHLHSAG 146
Query: 121 VVHCDIKSRNILM-AESGAKIADFGCAKWESEALQSGG---TPMFMAPEVARGEHQGFAS 176
           ++H D+K  NI++ ++   KI DFG A+             T  + APEV  G       
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYAANV 206
Query: 177 DIWAVGCTVIEMASG--------------------GAPWPNAADPMTVLYKIA--YSREL 214
           DIW+VGC + E+  G                    G P   +A+ M  L      Y    
Sbjct: 207 DIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQLGTP---SAEFMAALQPTVRNYVENR 263
Query: 215 PEVPA--------------------FLSKQANDFLSNCLRRDPKERWAASQLLKHPFL 252
           P+ P                       + QA D LS  L  DP +R +  + L+HP++
Sbjct: 264 PKYPGIKFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEALRHPYI 321

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/255 (24%), Positives = 110/255 (43%), Gaps = 28/255 (10%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTE---LPKSEFLQREQKFLSSLNSPHIV 58
           D T  H +G G    V      +     A K+ +   +   EFL +E   +  +  P++V
Sbjct: 27  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL-KEAAVMKEIKHPNLV 85
Query: 59  GYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHR-NGGRLDESLIVSYTRQILQGLEYLH 117
              G   T E    +   FM Y   G L D +   N   ++  +++    QI   +EYL 
Sbjct: 86  QLLGV-CTREPPFYIITEFMTY---GNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 141
Query: 118 SNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSGGT---------PM-FMAPEV 166
               +H D+ +RN L+ E+   K+ADFG ++     L +G T         P+ + APE 
Sbjct: 142 KKNFIHRDLAARNCLVGENHLVKVADFGLSR-----LMTGDTYTAHAGAKFPIKWTAPES 196
Query: 167 ARGEHQGFASDIWAVGCTVIEMASGG-APWPNAADPMTVLYKIAYSRELPEVPAFLSKQA 225
                    SD+WA G  + E+A+ G +P+P     ++ +Y++       E P    ++ 
Sbjct: 197 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI--DLSQVYELLEKDYRMERPEGCPEKV 254
Query: 226 NDFLSNCLRRDPKER 240
            + +  C + +P +R
Sbjct: 255 YELMRACWQWNPSDR 269

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/255 (24%), Positives = 110/255 (43%), Gaps = 28/255 (10%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTE---LPKSEFLQREQKFLSSLNSPHIV 58
           D T  H +G G    V      +     A K+ +   +   EFL +E   +  +  P++V
Sbjct: 16  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL-KEAAVMKEIKHPNLV 74
Query: 59  GYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHR-NGGRLDESLIVSYTRQILQGLEYLH 117
              G   T E    +   FM Y   G L D +   N   ++  +++    QI   +EYL 
Sbjct: 75  QLLGV-CTREPPFYIITEFMTY---GNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 130
Query: 118 SNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSGGT---------PM-FMAPEV 166
               +H D+ +RN L+ E+   K+ADFG ++     L +G T         P+ + APE 
Sbjct: 131 KKNFIHRDLAARNCLVGENHLVKVADFGLSR-----LMTGDTYTAHAGAKFPIKWTAPES 185
Query: 167 ARGEHQGFASDIWAVGCTVIEMASGG-APWPNAADPMTVLYKIAYSRELPEVPAFLSKQA 225
                    SD+WA G  + E+A+ G +P+P     ++ +Y++       E P    ++ 
Sbjct: 186 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI--DLSQVYELLEKDYRMERPEGCPEKV 243
Query: 226 NDFLSNCLRRDPKER 240
            + +  C + +P +R
Sbjct: 244 YELMRACWQWNPSDR 258

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/255 (24%), Positives = 110/255 (43%), Gaps = 28/255 (10%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTE---LPKSEFLQREQKFLSSLNSPHIV 58
           D T  H +G G    V      +     A K+ +   +   EFL +E   +  +  P++V
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL-KEAAVMKEIKHPNLV 72
Query: 59  GYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHR-NGGRLDESLIVSYTRQILQGLEYLH 117
              G   T E    +   FM Y   G L D +   N   ++  +++    QI   +EYL 
Sbjct: 73  QLLGV-CTREPPFYIITEFMTY---GNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 128
Query: 118 SNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSGGT---------PM-FMAPEV 166
               +H D+ +RN L+ E+   K+ADFG ++     L +G T         P+ + APE 
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSR-----LMTGDTYTAHAGAKFPIKWTAPES 183
Query: 167 ARGEHQGFASDIWAVGCTVIEMASGG-APWPNAADPMTVLYKIAYSRELPEVPAFLSKQA 225
                    SD+WA G  + E+A+ G +P+P     ++ +Y++       E P    ++ 
Sbjct: 184 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI--DLSQVYELLEKDYRMERPEGCPEKV 241
Query: 226 NDFLSNCLRRDPKER 240
            + +  C + +P +R
Sbjct: 242 YELMRACWQWNPSDR 256

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/255 (24%), Positives = 110/255 (43%), Gaps = 28/255 (10%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTE---LPKSEFLQREQKFLSSLNSPHIV 58
           D T  H +G G    V      +     A K+ +   +   EFL +E   +  +  P++V
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL-KEAAVMKEIKHPNLV 77
Query: 59  GYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHR-NGGRLDESLIVSYTRQILQGLEYLH 117
              G   T E    +   FM Y   G L D +   N   ++  +++    QI   +EYL 
Sbjct: 78  QLLGV-CTREPPFYIITEFMTY---GNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 133
Query: 118 SNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSGGT---------PM-FMAPEV 166
               +H D+ +RN L+ E+   K+ADFG ++     L +G T         P+ + APE 
Sbjct: 134 KKNFIHRDLAARNCLVGENHLVKVADFGLSR-----LMTGDTXTAHAGAKFPIKWTAPES 188
Query: 167 ARGEHQGFASDIWAVGCTVIEMASGG-APWPNAADPMTVLYKIAYSRELPEVPAFLSKQA 225
                    SD+WA G  + E+A+ G +P+P     ++ +Y++       E P    ++ 
Sbjct: 189 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--LSQVYELLEKDYRMERPEGCPEKV 246
Query: 226 NDFLSNCLRRDPKER 240
            + +  C + +P +R
Sbjct: 247 YELMRACWQWNPSDR 261

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/255 (24%), Positives = 110/255 (43%), Gaps = 28/255 (10%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTE---LPKSEFLQREQKFLSSLNSPHIV 58
           D T  H +G G    V      +     A K+ +   +   EFL +E   +  +  P++V
Sbjct: 18  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL-KEAAVMKEIKHPNLV 76
Query: 59  GYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHR-NGGRLDESLIVSYTRQILQGLEYLH 117
              G   T E    +   FM Y   G L D +   N   ++  +++    QI   +EYL 
Sbjct: 77  QLLGV-CTREPPFYIITEFMTY---GNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 132
Query: 118 SNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSGGT---------PM-FMAPEV 166
               +H D+ +RN L+ E+   K+ADFG ++     L +G T         P+ + APE 
Sbjct: 133 KKNFIHRDLAARNCLVGENHLVKVADFGLSR-----LMTGDTYTAHAGAKFPIKWTAPES 187
Query: 167 ARGEHQGFASDIWAVGCTVIEMASGG-APWPNAADPMTVLYKIAYSRELPEVPAFLSKQA 225
                    SD+WA G  + E+A+ G +P+P     ++ +Y++       E P    ++ 
Sbjct: 188 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--LSQVYELLEKDYRMERPEGCPEKV 245
Query: 226 NDFLSNCLRRDPKER 240
            + +  C + +P +R
Sbjct: 246 YELMRACWQWNPSDR 260

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 79/322 (24%), Positives = 127/322 (39%), Gaps = 89/322 (27%)
Query: 8   TIGQGSS--ATVSLATSLRSGDVFAAKSTELPKSE-----FLQREQKFLSSLNSPHIVGY 60
            IG+G     TV+LA    +G+    +   L         FLQ E       N P+IV Y
Sbjct: 16  VIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPY 75
Query: 61  KGCDVTSEDNKL-MYNLFMEYAPGGTLNDEI--HRNGGRLDESLIVSYTRQILQGLEYLH 117
           +   +   DN+L +   FM Y   G+  D I  H   G ++E  I    + +L+ L+Y+H
Sbjct: 76  RATFIA--DNELWVVTSFMAY---GSAKDLICTHFMDG-MNELAIAYILQGVLKALDYIH 129
Query: 118 SNRVVHCDIKSRNILMAESGAK--------------------IADFGCAKWESEALQSGG 157
               VH  +K+ +IL++  G                      + DF   K+  + L    
Sbjct: 130 HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDF--PKYSVKVLP--- 184
Query: 158 TPMFMAPEVARGEHQGF--ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKI------- 208
              +++PEV +   QG+   SDI++VG T  E+A+G  P+ +      +L K+       
Sbjct: 185 ---WLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCL 241
Query: 209 -------------AYSREL---------------------PEVPAF--LSKQANDFLSNC 232
                        + SR +                     P  P     S   + F+  C
Sbjct: 242 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQC 301
Query: 233 LRRDPKERWAASQLLKHPFLEE 254
           L+R+P  R +AS LL H F ++
Sbjct: 302 LQRNPDARPSASTLLNHSFFKQ 323

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/255 (24%), Positives = 110/255 (43%), Gaps = 28/255 (10%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTE---LPKSEFLQREQKFLSSLNSPHIV 58
           D T  H +G G    V      +     A K+ +   +   EFL +E   +  +  P++V
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL-KEAAVMKEIKHPNLV 77
Query: 59  GYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHR-NGGRLDESLIVSYTRQILQGLEYLH 117
              G   T E    +   FM Y   G L D +   N   ++  +++    QI   +EYL 
Sbjct: 78  QLLGV-CTREPPFYIITEFMTY---GNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 133
Query: 118 SNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSGGT---------PM-FMAPEV 166
               +H D+ +RN L+ E+   K+ADFG ++     L +G T         P+ + APE 
Sbjct: 134 KKNFIHRDLAARNCLVGENHLVKVADFGLSR-----LMTGDTYTAHAGAKFPIKWTAPES 188
Query: 167 ARGEHQGFASDIWAVGCTVIEMASGG-APWPNAADPMTVLYKIAYSRELPEVPAFLSKQA 225
                    SD+WA G  + E+A+ G +P+P     ++ +Y++       E P    ++ 
Sbjct: 189 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--LSQVYELLEKDYRMERPEGCPEKV 246
Query: 226 NDFLSNCLRRDPKER 240
            + +  C + +P +R
Sbjct: 247 YELMRACWQWNPSDR 261

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 63/255 (24%), Positives = 110/255 (43%), Gaps = 28/255 (10%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTE---LPKSEFLQREQKFLSSLNSPHIV 58
           D T  H +G G    V      +     A K+ +   +   EFL +E   +  +  P++V
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL-KEAAVMKEIKHPNLV 72
Query: 59  GYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHR-NGGRLDESLIVSYTRQILQGLEYLH 117
              G   T E    +   FM Y   G L D +   N   ++  +++    QI   +EYL 
Sbjct: 73  QLLGV-CTREPPFYIITEFMTY---GNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 128
Query: 118 SNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSGGT---------PM-FMAPEV 166
               +H D+ +RN L+ E+   K+ADFG ++     L +G T         P+ + APE 
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSR-----LMTGDTYTAHAGAKFPIKWTAPES 183
Query: 167 ARGEHQGFASDIWAVGCTVIEMASGG-APWPNAADPMTVLYKIAYSRELPEVPAFLSKQA 225
                    SD+WA G  + E+A+ G +P+P     ++ +Y++       E P    ++ 
Sbjct: 184 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI--DLSQVYELLEKDYRMERPEGCPEKV 241
Query: 226 NDFLSNCLRRDPKER 240
            + +  C + +P +R
Sbjct: 242 YELMRACWQWNPSDR 256

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 79/322 (24%), Positives = 127/322 (39%), Gaps = 89/322 (27%)
Query: 8   TIGQGSS--ATVSLATSLRSGDVFAAKSTELPKSE-----FLQREQKFLSSLNSPHIVGY 60
            IG+G     TV+LA    +G+    +   L         FLQ E       N P+IV Y
Sbjct: 32  VIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPY 91
Query: 61  KGCDVTSEDNKL-MYNLFMEYAPGGTLNDEI--HRNGGRLDESLIVSYTRQILQGLEYLH 117
           +   +   DN+L +   FM Y   G+  D I  H   G ++E  I    + +L+ L+Y+H
Sbjct: 92  RATFIA--DNELWVVTSFMAY---GSAKDLICTHFMDG-MNELAIAYILQGVLKALDYIH 145
Query: 118 SNRVVHCDIKSRNILMAESGAK--------------------IADFGCAKWESEALQSGG 157
               VH  +K+ +IL++  G                      + DF   K+  + L    
Sbjct: 146 HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDF--PKYSVKVLP--- 200
Query: 158 TPMFMAPEVARGEHQGF--ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKI------- 208
              +++PEV +   QG+   SDI++VG T  E+A+G  P+ +      +L K+       
Sbjct: 201 ---WLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCL 257
Query: 209 -------------AYSREL---------------------PEVPAF--LSKQANDFLSNC 232
                        + SR +                     P  P     S   + F+  C
Sbjct: 258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQC 317
Query: 233 LRRDPKERWAASQLLKHPFLEE 254
           L+R+P  R +AS LL H F ++
Sbjct: 318 LQRNPDARPSASTLLNHSFFKQ 339

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 79/310 (25%), Positives = 136/310 (43%), Gaps = 54/310 (17%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLS-SLNSPHIVGYKGCDVTS 67
           +G GSS TV    S + G   A K   +   +    E K L+ S + P+++ Y   + T 
Sbjct: 41  LGYGSSGTVVFQGSFQ-GRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETT- 98
Query: 68  EDNKLMY------NL-FMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNR 120
             ++ +Y      NL   +      ++DE   N     E   +S  RQI  G+ +LHS +
Sbjct: 99  --DRFLYIALELCNLNLQDLVESKNVSDE---NLKLQKEYNPISLLRQIASGVAHLHSLK 153
Query: 121 VVHCDIKSRNILMA---------ESGAK-----IADFG-CAKWESEAL-------QSGGT 158
           ++H D+K +NIL++         ++GA+     I+DFG C K +S             GT
Sbjct: 154 IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGT 213
Query: 159 PMFMAPEV---ARGEHQGFASDIWAVGCTVIEMASGGA-PWPNAADPMTVLYKIAYSREL 214
             + APE+   +       + DI+++GC    + S G  P+ +     + + +  +S  L
Sbjct: 214 SGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFS--L 271
Query: 215 PEVPAF----LSKQANDFLSNCLRRDPKERWAASQLLKHPF-------LEEFCSCTKQIQ 263
            E+       L  +A D +S  +  DP +R  A ++L+HP        LE     + +++
Sbjct: 272 DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPKSKKLEFLLKVSDRLE 331
Query: 264 ESNCSPTSIL 273
             N  P S L
Sbjct: 332 IENRDPPSAL 341

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 67/294 (22%), Positives = 124/294 (42%), Gaps = 24/294 (8%)
Query: 7   HTIGQGSSATVSLATSLRSGDVFAAKSTE-LPKSEFLQREQKF-LSSLNSPHIVGYKGCD 64
             +G G +  V    + R+ + FA K  +  PK+   +RE +    +   PHIV      
Sbjct: 22  QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKA---RREVELHWRASQCPHIVRIVDVY 78
Query: 65  VTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGR-LDESLIVSYTRQILQGLEYLHSNRVVH 123
                 +    + ME   GG L   I   G +   E       + I + ++YLHS  + H
Sbjct: 79  ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAH 138
Query: 124 CDIKSRNILMAESGA----KIADFGCAKW---ESEALQSGGTPMFMAPEVARGEHQGFAS 176
            D+K  N+L          K+ DFG AK     +   +   TP ++APEV   E    + 
Sbjct: 139 RDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCYTPYYVAPEVLGPEKYDKSC 198
Query: 177 DIWAVGCTVIEMASGGAP-WPNAADPMTVLYKIAYSRELPEVP----AFLSKQANDFLSN 231
           D+W++G  +  +  G  P + N    ++   K        E P    + +S++    + N
Sbjct: 199 DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRN 258
Query: 232 CLRRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSIL--DQGIWNSVEE 283
            L+ +P +R   ++ + HP++ +    + ++ ++    + +L  D+  W  V+E
Sbjct: 259 LLKTEPTQRMTITEFMNHPWIMQ----STKVPQTPLHTSRVLKEDKERWEDVKE 308

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 79/310 (25%), Positives = 136/310 (43%), Gaps = 54/310 (17%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLS-SLNSPHIVGYKGCDVTS 67
           +G GSS TV    S + G   A K   +   +    E K L+ S + P+++ Y   + T 
Sbjct: 41  LGYGSSGTVVFQGSFQ-GRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETT- 98
Query: 68  EDNKLMY------NL-FMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNR 120
             ++ +Y      NL   +      ++DE   N     E   +S  RQI  G+ +LHS +
Sbjct: 99  --DRFLYIALELCNLNLQDLVESKNVSDE---NLKLQKEYNPISLLRQIASGVAHLHSLK 153
Query: 121 VVHCDIKSRNILMA---------ESGAK-----IADFG-CAKWESEAL-------QSGGT 158
           ++H D+K +NIL++         ++GA+     I+DFG C K +S             GT
Sbjct: 154 IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGT 213
Query: 159 PMFMAPEV---ARGEHQGFASDIWAVGCTVIEMASGGA-PWPNAADPMTVLYKIAYSREL 214
             + APE+   +       + DI+++GC    + S G  P+ +     + + +  +S  L
Sbjct: 214 SGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFS--L 271
Query: 215 PEVPAF----LSKQANDFLSNCLRRDPKERWAASQLLKHPF-------LEEFCSCTKQIQ 263
            E+       L  +A D +S  +  DP +R  A ++L+HP        LE     + +++
Sbjct: 272 DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPKSKKLEFLLKVSDRLE 331
Query: 264 ESNCSPTSIL 273
             N  P S L
Sbjct: 332 IENRDPPSAL 341

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 69/295 (23%), Positives = 126/295 (42%), Gaps = 26/295 (8%)
Query: 7   HTIGQGSSATVSLATSLRSGDVFAAKSTE-LPKSEFLQREQKF-LSSLNSPHIVGYKGCD 64
             +G G +  V    + R+ + FA K  +  PK+   +RE +    +   PHIV      
Sbjct: 23  QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKA---RREVELHWRASQCPHIVRIVDVY 79
Query: 65  VTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGR-LDESLIVSYTRQILQGLEYLHSNRVVH 123
                 +    + ME   GG L   I   G +   E       + I + ++YLHS  + H
Sbjct: 80  ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAH 139
Query: 124 CDIKSRNILMAESGA----KIADFGCAKWESEALQSGG----TPMFMAPEVARGEHQGFA 175
            D+K  N+L          K+ DFG AK E+ +  S      TP ++APEV   E    +
Sbjct: 140 RDVKPENLLYTSKRPNAILKLTDFGFAK-ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKS 198
Query: 176 SDIWAVGCTVIEMASGGAP-WPNAADPMTVLYKIAYSRELPEVP----AFLSKQANDFLS 230
            D+W++G  +  +  G  P + N    ++   K        E P    + +S++    + 
Sbjct: 199 CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIR 258
Query: 231 NCLRRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSIL--DQGIWNSVEE 283
           N L+ +P +R   ++ + HP++ +    + ++ ++    + +L  D+  W  V+E
Sbjct: 259 NLLKTEPTQRMTITEFMNHPWIMQ----STKVPQTPLHTSRVLKEDKERWEDVKE 309

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 63/255 (24%), Positives = 109/255 (42%), Gaps = 28/255 (10%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTE---LPKSEFLQREQKFLSSLNSPHIV 58
           D T  H +G G    V      +     A K+ +   +   EFL +E   +  +  P++V
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL-KEAAVMKEIKHPNLV 72
Query: 59  GYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHR-NGGRLDESLIVSYTRQILQGLEYLH 117
              G   T E    +   FM Y   G L D +   N   +   +++    QI   +EYL 
Sbjct: 73  QLLGV-CTREPPFYIITEFMTY---GNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 128
Query: 118 SNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSGGT---------PM-FMAPEV 166
               +H D+ +RN L+ E+   K+ADFG ++     L +G T         P+ + APE 
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSR-----LMTGDTYTAHAGAKFPIKWTAPES 183
Query: 167 ARGEHQGFASDIWAVGCTVIEMASGG-APWPNAADPMTVLYKIAYSRELPEVPAFLSKQA 225
                    SD+WA G  + E+A+ G +P+P     ++ +Y++       E P    ++ 
Sbjct: 184 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI--DLSQVYELLEKDYRMERPEGCPEKV 241
Query: 226 NDFLSNCLRRDPKER 240
            + +  C + +P +R
Sbjct: 242 YELMRACWQWNPSDR 256

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 69/295 (23%), Positives = 126/295 (42%), Gaps = 26/295 (8%)
Query: 7   HTIGQGSSATVSLATSLRSGDVFAAKSTE-LPKSEFLQREQKF-LSSLNSPHIVGYKGCD 64
             +G G +  V    + R+ + FA K  +  PK+   +RE +    +   PHIV      
Sbjct: 22  QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKA---RREVELHWRASQCPHIVRIVDVY 78
Query: 65  VTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGR-LDESLIVSYTRQILQGLEYLHSNRVVH 123
                 +    + ME   GG L   I   G +   E       + I + ++YLHS  + H
Sbjct: 79  ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAH 138
Query: 124 CDIKSRNILMAESGA----KIADFGCAKWESEALQSGG----TPMFMAPEVARGEHQGFA 175
            D+K  N+L          K+ DFG AK E+ +  S      TP ++APEV   E    +
Sbjct: 139 RDVKPENLLYTSKRPNAILKLTDFGFAK-ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKS 197
Query: 176 SDIWAVGCTVIEMASGGAP-WPNAADPMTVLYKIAYSRELPEVP----AFLSKQANDFLS 230
            D+W++G  +  +  G  P + N    ++   K        E P    + +S++    + 
Sbjct: 198 CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIR 257
Query: 231 NCLRRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSIL--DQGIWNSVEE 283
           N L+ +P +R   ++ + HP++ +    + ++ ++    + +L  D+  W  V+E
Sbjct: 258 NLLKTEPTQRMTITEFMNHPWIMQ----STKVPQTPLHTSRVLKEDKERWEDVKE 308

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 95/210 (45%), Gaps = 16/210 (7%)
Query: 32  KSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIH 91
           + TE   +E + RE + +  L++P+IV   G     +   LM  L ME A GG L+  + 
Sbjct: 373 QGTEKADTEEMMREAQIMHQLDNPYIVRLIG---VCQAEALM--LVMEMAGGGPLHKFLV 427
Query: 92  RNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKW-- 148
                +  S +     Q+  G++YL     VH ++ +RN+L+     AKI+DFG +K   
Sbjct: 428 GKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALG 487
Query: 149 ----ESEALQSGGTPM-FMAPEVARGEHQGFASDIWAVGCTVIE-MASGGAPWPNAADPM 202
                  A  +G  P+ + APE          SD+W+ G T+ E ++ G  P+     P 
Sbjct: 488 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE 547
Query: 203 TVLYKIAYSRELPEVPAFLSKQANDFLSNC 232
            + + I   + + E P     +    +S+C
Sbjct: 548 VMAF-IEQGKRM-ECPPECPPELYALMSDC 575

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 90/217 (41%), Gaps = 45/217 (20%)
Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGAK--IADFGCAKWESEALQSG--- 156
           I  Y  +IL+ L+Y HS  ++H D+K  N+++     K  + D+G A++     +     
Sbjct: 133 IRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV 192
Query: 157 GTPMFMAPE-VARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA------ 209
            +  F  PE +   +   ++ D+W++GC +  M     P+ +  D    L +IA      
Sbjct: 193 ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE 252
Query: 210 --------YSRELP---------------------EVPAFLSKQANDFLSNCLRRDPKER 240
                   Y+ EL                      E    +S +A DFL   LR D + R
Sbjct: 253 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSR 312
Query: 241 WAASQLLKHPFLEEFCSCTKQIQESNCSPTSILDQGI 277
             A + ++HP+   F    K+ Q   C+  ++L  G+
Sbjct: 313 LTAREAMEHPY---FYPVVKE-QSQPCADNAVLSSGL 345

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 74/275 (26%), Positives = 122/275 (44%), Gaps = 29/275 (10%)
Query: 8   TIGQGSSATVSLATSLRSGDVFAAKSTELPKS-EFLQREQKFL-SSLNSPHIVGYKGCDV 65
            +G G+  T+       + DV  A    LP+   F  RE + L  S   P+++ Y     
Sbjct: 31  VLGHGAEGTIVYRGMFDNRDV--AVKRILPECFSFADREVQLLRESDEHPNVIRYF---C 85
Query: 66  TSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCD 125
           T +D +  Y + +E     TL + + +          ++  +Q   GL +LHS  +VH D
Sbjct: 86  TEKDRQFQY-IAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRD 143
Query: 126 IKSRNILMAESGAK------IADFG-CAKW----ESEALQSG--GTPMFMAPEVAR---G 169
           +K  NIL++   A       I+DFG C K      S + +SG  GT  ++APE+      
Sbjct: 144 LKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCK 203
Query: 170 EHQGFASDIWAVGCTVIEMASGGA-PWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDF 228
           E+  +  DI++ GC    + S G+ P+  +      +   A S +           A + 
Sbjct: 204 ENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIAREL 263
Query: 229 LSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQIQ 263
           +   +  DP++R +A  +LKHPF   F S  KQ+Q
Sbjct: 264 IEKMIAMDPQKRPSAKHVLKHPF---FWSLEKQLQ 295

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/255 (24%), Positives = 109/255 (42%), Gaps = 28/255 (10%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTE---LPKSEFLQREQKFLSSLNSPHIV 58
           D T  H +G G    V      +     A K+ +   +   EFL +E   +  +  P++V
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL-KEAAVMKEIKHPNLV 72
Query: 59  GYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHR-NGGRLDESLIVSYTRQILQGLEYLH 117
              G   T E    +   FM Y   G L D +   N   +   +++    QI   +EYL 
Sbjct: 73  QLLGV-CTREPPFYIITEFMTY---GNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 128
Query: 118 SNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSGGT---------PM-FMAPEV 166
               +H D+ +RN L+ E+   K+ADFG ++     L +G T         P+ + APE 
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSR-----LMTGDTYTAHAGAKFPIKWTAPES 183
Query: 167 ARGEHQGFASDIWAVGCTVIEMASGG-APWPNAADPMTVLYKIAYSRELPEVPAFLSKQA 225
                    SD+WA G  + E+A+ G +P+P     ++ +Y++       E P    ++ 
Sbjct: 184 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI--DLSQVYELLEKDYRMERPEGCPEKV 241
Query: 226 NDFLSNCLRRDPKER 240
            + +  C + +P +R
Sbjct: 242 YELMRACWQWNPSDR 256

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/293 (21%), Positives = 118/293 (40%), Gaps = 48/293 (16%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNS-PHIVGY 60
           D+     +G+G  + V  A ++ + +    K  +  K   ++RE K L +L   P+I+  
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKNKIKREIKILENLRGGPNIITL 97
Query: 61  KGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNR 120
              D+  +       L  E+      N +  +    L +  I  Y  +IL+ L+Y HS  
Sbjct: 98  --ADIVKDPVSRTPALVFEHVN----NTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMG 151
Query: 121 VVHCDIKSRNILMAESGAK--IADFGCAKWESEALQSG---GTPMFMAPE-VARGEHQGF 174
           ++H D+K  N+++     K  + D+G A++     +      +  F  PE +   +   +
Sbjct: 152 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDY 211
Query: 175 ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA--------------YSRELP----- 215
           + D+W++GC +  M     P+ +  D    L +IA              Y+ EL      
Sbjct: 212 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFND 271
Query: 216 ----------------EVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFL 252
                           E    +S +A DFL   LR D + R  A + ++HP+ 
Sbjct: 272 ILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 69/295 (23%), Positives = 126/295 (42%), Gaps = 26/295 (8%)
Query: 7   HTIGQGSSATVSLATSLRSGDVFAAKSTE-LPKSEFLQREQKF-LSSLNSPHIVGYKGCD 64
             +G G +  V    + R+ + FA K  +  PK+   +RE +    +   PHIV      
Sbjct: 68  QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKA---RREVELHWRASQCPHIVRIVDVY 124
Query: 65  VTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGR-LDESLIVSYTRQILQGLEYLHSNRVVH 123
                 +    + ME   GG L   I   G +   E       + I + ++YLHS  + H
Sbjct: 125 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAH 184
Query: 124 CDIKSRNILMAESGA----KIADFGCAKWESEALQSGG----TPMFMAPEVARGEHQGFA 175
            D+K  N+L          K+ DFG AK E+ +  S      TP ++APEV   E    +
Sbjct: 185 RDVKPENLLYTSKRPNAILKLTDFGFAK-ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKS 243
Query: 176 SDIWAVGCTVIEMASGGAP-WPNAADPMTVLYKIAYSRELPEVP----AFLSKQANDFLS 230
            D+W++G  +  +  G  P + N    ++   K        E P    + +S++    + 
Sbjct: 244 CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIR 303
Query: 231 NCLRRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSIL--DQGIWNSVEE 283
           N L+ +P +R   ++ + HP++ +    + ++ ++    + +L  D+  W  V+E
Sbjct: 304 NLLKTEPTQRMTITEFMNHPWIMQ----STKVPQTPLHTSRVLKEDKERWEDVKE 354

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 98/217 (45%), Gaps = 30/217 (13%)
Query: 53  NSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRN---------------GGRL 97
           + P+I+   G     E    +Y L +EYAP G L D + ++                  L
Sbjct: 81  HHPNIINLLG---ACEHRGYLY-LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 136
Query: 98  DESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQS- 155
               ++ +   + +G++YL   + +H ++ +RNIL+ E+  AKIADFG ++ +   ++  
Sbjct: 137 SSQQLLHFAADVARGMDYLSQKQFIHRNLAARNILVGENYVAKIADFGLSRGQEVYVKKT 196
Query: 156 -GGTPM-FMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTV--LYKIAY 210
            G  P+ +MA E          SD+W+ G  + E+ S GG P+      MT   LY+   
Sbjct: 197 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG----MTCAELYEKLP 252
Query: 211 SRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLL 247
                E P     +  D +  C R  P ER + +Q+L
Sbjct: 253 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQIL 289

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/255 (23%), Positives = 111/255 (43%), Gaps = 28/255 (10%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTE---LPKSEFLQREQKFLSSLNSPHIV 58
           D T  H +G G    V      +     A K+ +   +   EFL +E   +  +  P++V
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL-KEAAVMKEIKHPNLV 77
Query: 59  GYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHR-NGGRLDESLIVSYTRQILQGLEYLH 117
              G   T E     + + +E+   G L D +   N   ++  +++    QI   +EYL 
Sbjct: 78  QLLGV-CTREPP---FYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 133
Query: 118 SNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSGGT---------PM-FMAPEV 166
               +H D+ +RN L+ E+   K+ADFG ++     L +G T         P+ + APE 
Sbjct: 134 KKNFIHRDLAARNCLVGENHLVKVADFGLSR-----LMTGDTYTAHAGAKFPIKWTAPES 188
Query: 167 ARGEHQGFASDIWAVGCTVIEMASGG-APWPNAADPMTVLYKIAYSRELPEVPAFLSKQA 225
                    SD+WA G  + E+A+ G +P+P     ++ +Y++       E P    ++ 
Sbjct: 189 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--LSQVYELLEKDYRMERPEGCPEKV 246
Query: 226 NDFLSNCLRRDPKER 240
            + +  C + +P +R
Sbjct: 247 YELMRACWQWNPSDR 261

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/186 (31%), Positives = 89/186 (47%), Gaps = 23/186 (12%)
Query: 33  STELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHR 92
           +TE  K +F Q E K  +     ++V   G     +D  L+Y     Y P G+L D +  
Sbjct: 60  TTEELKQQFDQ-EIKVXAKCQHENLVELLGFSSDGDDLCLVY----VYXPNGSLLDRL-- 112
Query: 93  NGGRLDESLIVSYTR--QILQG----LEYLHSNRVVHCDIKSRNILMAES-GAKIADFGC 145
               LD +  +S+    +I QG    + +LH N  +H DIKS NIL+ E+  AKI+DFG 
Sbjct: 113 --SCLDGTPPLSWHXRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGL 170
Query: 146 AKWESEALQS------GGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAA 199
           A+   +  Q        GT  + APE  RGE     SDI++ G  ++E+ +G        
Sbjct: 171 ARASEKFAQXVXXSRIVGTTAYXAPEALRGEITP-KSDIYSFGVVLLEIITGLPAVDEHR 229
Query: 200 DPMTVL 205
           +P  +L
Sbjct: 230 EPQLLL 235

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/255 (23%), Positives = 111/255 (43%), Gaps = 28/255 (10%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTE---LPKSEFLQREQKFLSSLNSPHIV 58
           D T  H +G G    V      +     A K+ +   +   EFL +E   +  +  P++V
Sbjct: 15  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL-KEAAVMKEIKHPNLV 73
Query: 59  GYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHR-NGGRLDESLIVSYTRQILQGLEYLH 117
              G   T E     + + +E+   G L D +   N   ++  +++    QI   +EYL 
Sbjct: 74  QLLGV-CTREPP---FYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 129
Query: 118 SNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSGGT---------PM-FMAPEV 166
               +H D+ +RN L+ E+   K+ADFG ++     L +G T         P+ + APE 
Sbjct: 130 KKNFIHRDLAARNCLVGENHLVKVADFGLSR-----LMTGDTXTAHAGAKFPIKWTAPES 184
Query: 167 ARGEHQGFASDIWAVGCTVIEMASGG-APWPNAADPMTVLYKIAYSRELPEVPAFLSKQA 225
                    SD+WA G  + E+A+ G +P+P     ++ +Y++       E P    ++ 
Sbjct: 185 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--LSQVYELLEKDYRMERPEGCPEKV 242
Query: 226 NDFLSNCLRRDPKER 240
            + +  C + +P +R
Sbjct: 243 YELMRACWQWNPSDR 257

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/255 (24%), Positives = 109/255 (42%), Gaps = 28/255 (10%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTE---LPKSEFLQREQKFLSSLNSPHIV 58
           D T  H +G G    V      +     A K+ +   +   EFL +E   +  +  P++V
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL-KEAAVMKEIKHPNLV 77
Query: 59  GYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHR-NGGRLDESLIVSYTRQILQGLEYLH 117
              G   T E    +   FM Y   G L D +   N   +   +++    QI   +EYL 
Sbjct: 78  QLLGV-CTREPPFYIITEFMTY---GNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 133
Query: 118 SNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSGGT---------PM-FMAPEV 166
               +H D+ +RN L+ E+   K+ADFG ++     L +G T         P+ + APE 
Sbjct: 134 KKNFIHRDLAARNCLVGENHLVKVADFGLSR-----LMTGDTYTAHAGAKFPIKWTAPES 188
Query: 167 ARGEHQGFASDIWAVGCTVIEMASGG-APWPNAADPMTVLYKIAYSRELPEVPAFLSKQA 225
                    SD+WA G  + E+A+ G +P+P     ++ +Y++       E P    ++ 
Sbjct: 189 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--LSQVYELLEKDYRMERPEGCPEKV 246
Query: 226 NDFLSNCLRRDPKER 240
            + +  C + +P +R
Sbjct: 247 YELMRACWQWNPSDR 261

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 105/228 (46%), Gaps = 28/228 (12%)
Query: 35  ELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFME-YAPGGTLNDEIHRN 93
           E PK   +  E   LS +   +I+  K  D+   +N+  + L ME +  G  L   I R+
Sbjct: 69  EDPKLGKVTLEIAILSRVEHANII--KVLDIF--ENQGFFQLVMEKHGSGLDLFAFIDRH 124
Query: 94  GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES-GAKIADFGCAKWESEA 152
             RLDE L     RQ++  + YL    ++H DIK  NI++AE    K+ DFG A +    
Sbjct: 125 P-RLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAY---- 179
Query: 153 LQSG-------GTPMFMAPEVARGE-HQGFASDIWAVGCTVIEMASGGAPWPNAADPMTV 204
           L+ G       GT  + APEV  G  ++G   ++W++G T+  +           +P   
Sbjct: 180 LERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVF-------EENPFCE 232
Query: 205 LYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFL 252
           L +   +   P  P  +SK+    +S  L+  P+ R    +L+  P++
Sbjct: 233 LEETVEAAIHP--PYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWV 278

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 69/295 (23%), Positives = 126/295 (42%), Gaps = 26/295 (8%)
Query: 7   HTIGQGSSATVSLATSLRSGDVFAAKSTE-LPKSEFLQREQKF-LSSLNSPHIVGYKGCD 64
             +G G +  V    + R+ + FA K  +  PK+   +RE +    +   PHIV      
Sbjct: 24  QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKA---RREVELHWRASQCPHIVRIVDVY 80
Query: 65  VTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGR-LDESLIVSYTRQILQGLEYLHSNRVVH 123
                 +    + ME   GG L   I   G +   E       + I + ++YLHS  + H
Sbjct: 81  ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAH 140
Query: 124 CDIKSRNILMAESGA----KIADFGCAKWESEALQSGG----TPMFMAPEVARGEHQGFA 175
            D+K  N+L          K+ DFG AK E+ +  S      TP ++APEV   E    +
Sbjct: 141 RDVKPENLLYTSKRPNAILKLTDFGFAK-ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKS 199
Query: 176 SDIWAVGCTVIEMASGGAP-WPNAADPMTVLYKIAYSRELPEVP----AFLSKQANDFLS 230
            D+W++G  +  +  G  P + N    ++   K        E P    + +S++    + 
Sbjct: 200 CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIR 259
Query: 231 NCLRRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSIL--DQGIWNSVEE 283
           N L+ +P +R   ++ + HP++ +    + ++ ++    + +L  D+  W  V+E
Sbjct: 260 NLLKTEPTQRMTITEFMNHPWIMQ----STKVPQTPLHTSRVLKEDKERWEDVKE 310

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 69/295 (23%), Positives = 126/295 (42%), Gaps = 26/295 (8%)
Query: 7   HTIGQGSSATVSLATSLRSGDVFAAKSTE-LPKSEFLQREQKF-LSSLNSPHIVGYKGCD 64
             +G G +  V    + R+ + FA K  +  PK+   +RE +    +   PHIV      
Sbjct: 24  QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKA---RREVELHWRASQCPHIVRIVDVY 80
Query: 65  VTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGR-LDESLIVSYTRQILQGLEYLHSNRVVH 123
                 +    + ME   GG L   I   G +   E       + I + ++YLHS  + H
Sbjct: 81  ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAH 140
Query: 124 CDIKSRNILMAESGA----KIADFGCAKWESEALQSGG----TPMFMAPEVARGEHQGFA 175
            D+K  N+L          K+ DFG AK E+ +  S      TP ++APEV   E    +
Sbjct: 141 RDVKPENLLYTSKRPNAILKLTDFGFAK-ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKS 199
Query: 176 SDIWAVGCTVIEMASGGAP-WPNAADPMTVLYKIAYSRELPEVP----AFLSKQANDFLS 230
            D+W++G  +  +  G  P + N    ++   K        E P    + +S++    + 
Sbjct: 200 CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIR 259
Query: 231 NCLRRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSIL--DQGIWNSVEE 283
           N L+ +P +R   ++ + HP++ +    + ++ ++    + +L  D+  W  V+E
Sbjct: 260 NLLKTEPTQRMTITEFMNHPWIMQ----STKVPQTPLHTSRVLKEDKERWEDVKE 310

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 69/295 (23%), Positives = 126/295 (42%), Gaps = 26/295 (8%)
Query: 7   HTIGQGSSATVSLATSLRSGDVFAAKSTE-LPKSEFLQREQKF-LSSLNSPHIVGYKGCD 64
             +G G +  V    + R+ + FA K  +  PK+   +RE +    +   PHIV      
Sbjct: 74  QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKA---RREVELHWRASQCPHIVRIVDVY 130
Query: 65  VTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGR-LDESLIVSYTRQILQGLEYLHSNRVVH 123
                 +    + ME   GG L   I   G +   E       + I + ++YLHS  + H
Sbjct: 131 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAH 190
Query: 124 CDIKSRNILMAESGA----KIADFGCAKWESEALQSGG----TPMFMAPEVARGEHQGFA 175
            D+K  N+L          K+ DFG AK E+ +  S      TP ++APEV   E    +
Sbjct: 191 RDVKPENLLYTSKRPNAILKLTDFGFAK-ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKS 249
Query: 176 SDIWAVGCTVIEMASGGAP-WPNAADPMTVLYKIAYSRELPEVP----AFLSKQANDFLS 230
            D+W++G  +  +  G  P + N    ++   K        E P    + +S++    + 
Sbjct: 250 CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIR 309
Query: 231 NCLRRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSIL--DQGIWNSVEE 283
           N L+ +P +R   ++ + HP++ +    + ++ ++    + +L  D+  W  V+E
Sbjct: 310 NLLKTEPTQRMTITEFMNHPWIMQ----STKVPQTPLHTSRVLKEDKERWEDVKE 360

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 69/295 (23%), Positives = 126/295 (42%), Gaps = 26/295 (8%)
Query: 7   HTIGQGSSATVSLATSLRSGDVFAAKSTE-LPKSEFLQREQKF-LSSLNSPHIVGYKGCD 64
             +G G +  V    + R+ + FA K  +  PK+   +RE +    +   PHIV      
Sbjct: 28  QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKA---RREVELHWRASQCPHIVRIVDVY 84
Query: 65  VTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGR-LDESLIVSYTRQILQGLEYLHSNRVVH 123
                 +    + ME   GG L   I   G +   E       + I + ++YLHS  + H
Sbjct: 85  ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAH 144
Query: 124 CDIKSRNILMAESGA----KIADFGCAKWESEALQSGG----TPMFMAPEVARGEHQGFA 175
            D+K  N+L          K+ DFG AK E+ +  S      TP ++APEV   E    +
Sbjct: 145 RDVKPENLLYTSKRPNAILKLTDFGFAK-ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKS 203
Query: 176 SDIWAVGCTVIEMASGGAP-WPNAADPMTVLYKIAYSRELPEVP----AFLSKQANDFLS 230
            D+W++G  +  +  G  P + N    ++   K        E P    + +S++    + 
Sbjct: 204 CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIR 263
Query: 231 NCLRRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSIL--DQGIWNSVEE 283
           N L+ +P +R   ++ + HP++ +    + ++ ++    + +L  D+  W  V+E
Sbjct: 264 NLLKTEPTQRMTITEFMNHPWIMQ----STKVPQTPLHTSRVLKEDKERWEDVKE 314

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 69/295 (23%), Positives = 126/295 (42%), Gaps = 26/295 (8%)
Query: 7   HTIGQGSSATVSLATSLRSGDVFAAKSTE-LPKSEFLQREQKF-LSSLNSPHIVGYKGCD 64
             +G G +  V    + R+ + FA K  +  PK+   +RE +    +   PHIV      
Sbjct: 29  QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKA---RREVELHWRASQCPHIVRIVDVY 85
Query: 65  VTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGR-LDESLIVSYTRQILQGLEYLHSNRVVH 123
                 +    + ME   GG L   I   G +   E       + I + ++YLHS  + H
Sbjct: 86  ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAH 145
Query: 124 CDIKSRNILMAESGA----KIADFGCAKWESEALQSGG----TPMFMAPEVARGEHQGFA 175
            D+K  N+L          K+ DFG AK E+ +  S      TP ++APEV   E    +
Sbjct: 146 RDVKPENLLYTSKRPNAILKLTDFGFAK-ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKS 204
Query: 176 SDIWAVGCTVIEMASGGAP-WPNAADPMTVLYKIAYSRELPEVP----AFLSKQANDFLS 230
            D+W++G  +  +  G  P + N    ++   K        E P    + +S++    + 
Sbjct: 205 CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIR 264
Query: 231 NCLRRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSIL--DQGIWNSVEE 283
           N L+ +P +R   ++ + HP++ +    + ++ ++    + +L  D+  W  V+E
Sbjct: 265 NLLKTEPTQRMTITEFMNHPWIMQ----STKVPQTPLHTSRVLKEDKERWEDVKE 315

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 69/295 (23%), Positives = 126/295 (42%), Gaps = 26/295 (8%)
Query: 7   HTIGQGSSATVSLATSLRSGDVFAAKSTE-LPKSEFLQREQKF-LSSLNSPHIVGYKGCD 64
             +G G +  V    + R+ + FA K  +  PK+   +RE +    +   PHIV      
Sbjct: 30  QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKA---RREVELHWRASQCPHIVRIVDVY 86
Query: 65  VTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGR-LDESLIVSYTRQILQGLEYLHSNRVVH 123
                 +    + ME   GG L   I   G +   E       + I + ++YLHS  + H
Sbjct: 87  ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAH 146
Query: 124 CDIKSRNILMAESGA----KIADFGCAKWESEALQSGG----TPMFMAPEVARGEHQGFA 175
            D+K  N+L          K+ DFG AK E+ +  S      TP ++APEV   E    +
Sbjct: 147 RDVKPENLLYTSKRPNAILKLTDFGFAK-ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKS 205
Query: 176 SDIWAVGCTVIEMASGGAP-WPNAADPMTVLYKIAYSRELPEVP----AFLSKQANDFLS 230
            D+W++G  +  +  G  P + N    ++   K        E P    + +S++    + 
Sbjct: 206 CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIR 265
Query: 231 NCLRRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSIL--DQGIWNSVEE 283
           N L+ +P +R   ++ + HP++ +    + ++ ++    + +L  D+  W  V+E
Sbjct: 266 NLLKTEPTQRMTITEFMNHPWIMQ----STKVPQTPLHTSRVLKEDKERWEDVKE 316

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 69/295 (23%), Positives = 126/295 (42%), Gaps = 26/295 (8%)
Query: 7   HTIGQGSSATVSLATSLRSGDVFAAKSTE-LPKSEFLQREQKF-LSSLNSPHIVGYKGCD 64
             +G G +  V    + R+ + FA K  +  PK+   +RE +    +   PHIV      
Sbjct: 38  QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKA---RREVELHWRASQCPHIVRIVDVY 94
Query: 65  VTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGR-LDESLIVSYTRQILQGLEYLHSNRVVH 123
                 +    + ME   GG L   I   G +   E       + I + ++YLHS  + H
Sbjct: 95  ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAH 154
Query: 124 CDIKSRNILMAESGA----KIADFGCAKWESEALQSGG----TPMFMAPEVARGEHQGFA 175
            D+K  N+L          K+ DFG AK E+ +  S      TP ++APEV   E    +
Sbjct: 155 RDVKPENLLYTSKRPNAILKLTDFGFAK-ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKS 213
Query: 176 SDIWAVGCTVIEMASGGAP-WPNAADPMTVLYKIAYSRELPEVP----AFLSKQANDFLS 230
            D+W++G  +  +  G  P + N    ++   K        E P    + +S++    + 
Sbjct: 214 CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIR 273
Query: 231 NCLRRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSIL--DQGIWNSVEE 283
           N L+ +P +R   ++ + HP++ +    + ++ ++    + +L  D+  W  V+E
Sbjct: 274 NLLKTEPTQRMTITEFMNHPWIMQ----STKVPQTPLHTSRVLKEDKERWEDVKE 324

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 107/228 (46%), Gaps = 16/228 (7%)
Query: 29  FAAKSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLND 88
             A  T+  + +FL  E   +   + P+I+  +G  V ++   +M  +  EY   G+L+ 
Sbjct: 50  LKAGYTDKQRRDFLS-EASIMGQFDHPNIIHLEG--VVTKCKPVM--IITEYMENGSLDA 104
Query: 89  EIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGA-KIADFGCAK 147
            + +N GR     +V   R I  G++YL     VH D+ +RNIL+  +   K++DFG ++
Sbjct: 105 FLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSR 164
Query: 148 W---ESEA---LQSGGTPM-FMAPEVARGEHQGFASDIWAVGCTVIE-MASGGAPWPNAA 199
               + EA    + G  P+ + APE         ASD+W+ G  + E M+ G  P+ + +
Sbjct: 165 VLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS 224
Query: 200 DPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLL 247
           +   V+  I     LP  P       +  + +C +++  +R    Q++
Sbjct: 225 N-QDVIKAIEEGYRLPP-PMDCPIALHQLMLDCWQKERSDRPKFGQIV 270

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 107/228 (46%), Gaps = 16/228 (7%)
Query: 29  FAAKSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLND 88
             A  T+  + +FL  E   +   + P+I+  +G  V ++   +M  +  EY   G+L+ 
Sbjct: 65  LKAGYTDKQRRDFLS-EASIMGQFDHPNIIHLEG--VVTKCKPVM--IITEYMENGSLDA 119
Query: 89  EIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGA-KIADFGCAK 147
            + +N GR     +V   R I  G++YL     VH D+ +RNIL+  +   K++DFG ++
Sbjct: 120 FLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSAVHRDLAARNILVNSNLVCKVSDFGMSR 179
Query: 148 W---ESEA---LQSGGTPM-FMAPEVARGEHQGFASDIWAVGCTVIE-MASGGAPWPNAA 199
               + EA    + G  P+ + APE         ASD+W+ G  + E M+ G  P+ + +
Sbjct: 180 VLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS 239
Query: 200 DPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLL 247
           +   V+  I     LP  P       +  + +C +++  +R    Q++
Sbjct: 240 N-QDVIKAIEEGYRLPP-PMDCPIALHQLMLDCWQKERSDRPKFGQIV 285

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 107/228 (46%), Gaps = 16/228 (7%)
Query: 29  FAAKSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLND 88
             A  T+  + +FL  E   +   + P+I+  +G  V ++   +M  +  EY   G+L+ 
Sbjct: 44  LKAGYTDKQRRDFLS-EASIMGQFDHPNIIHLEG--VVTKCKPVM--IITEYMENGSLDA 98
Query: 89  EIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGA-KIADFGCAK 147
            + +N GR     +V   R I  G++YL     VH D+ +RNIL+  +   K++DFG ++
Sbjct: 99  FLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSR 158
Query: 148 W---ESEA---LQSGGTPM-FMAPEVARGEHQGFASDIWAVGCTVIE-MASGGAPWPNAA 199
               + EA    + G  P+ + APE         ASD+W+ G  + E M+ G  P+ + +
Sbjct: 159 VLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS 218
Query: 200 DPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLL 247
           +   V+  I     LP  P       +  + +C +++  +R    Q++
Sbjct: 219 N-QDVIKAIEEGYRLPP-PMDCPIALHQLMLDCWQKERSDRPKFGQIV 264

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/185 (24%), Positives = 78/185 (42%), Gaps = 37/185 (20%)
Query: 105 YTRQILQGLEYLHSNRVVHCDIKSRNILM--AESGAKIADFGCAKWESEALQSGG----- 157
           +  Q+L+GL+Y+HS  V+H D+K  N+ +   +   KI DFG A+         G     
Sbjct: 125 FMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEG 184
Query: 158 --TPMFMAPEVARGEHQGF-ASDIWAVGCTVIEMASGGAPWPNA---------ADPMTVL 205
             T  + +P +    +    A D+WA GC   EM +G   +  A          + + V+
Sbjct: 185 LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVV 244
Query: 206 YKIAYSRELPEVPAF------------------LSKQANDFLSNCLRRDPKERWAASQLL 247
           ++      L  +P +                  +S++A DFL   L   P +R  A + L
Sbjct: 245 HEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEAL 304
Query: 248 KHPFL 252
            HP++
Sbjct: 305 SHPYM 309

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/253 (24%), Positives = 110/253 (43%), Gaps = 24/253 (9%)
Query: 6   GHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDV 65
           GH    G         +L+SG       TE  + +FL  E   +   + P+++  +G  V
Sbjct: 26  GHLKLPGKREIFVAIKTLKSG------YTEKQRRDFLS-EASIMGQFDHPNVIHLEGV-V 77
Query: 66  TSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCD 125
           T     ++   FME    G+L+  + +N G+     +V   R I  G++YL     VH  
Sbjct: 78  TKSTPVMIITEFME---NGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRA 134
Query: 126 IKSRNILMAESGA-KIADFGCAKWESE--------ALQSGGTPM-FMAPEVARGEHQGFA 175
           + +RNIL+  +   K++DFG +++  +        +   G  P+ + APE  +      A
Sbjct: 135 LAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSA 194
Query: 176 SDIWAVGCTVIE-MASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLR 234
           SD+W+ G  + E M+ G  P+ +  +   V+  I     LP  P       +  + +C +
Sbjct: 195 SDVWSYGIVMWEVMSYGERPYWDMTN-QDVINAIEQDYRLPP-PMDCPSALHQLMLDCWQ 252
Query: 235 RDPKERWAASQLL 247
           +D   R    Q++
Sbjct: 253 KDRNHRPKFGQIV 265

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 94/241 (39%), Gaps = 48/241 (19%)
Query: 97  LDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKWESEALQS 155
           LD   +     Q+L G+++LHS  ++H D+K  NI++ ++   KI DFG A+    +   
Sbjct: 124 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 183
Query: 156 GG---TPMFMAPEVARGEHQGFASDIWAVGCTVIEMASG--------------------G 192
                T  + APEV  G       DIW+VGC + EM                       G
Sbjct: 184 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG 243
Query: 193 APWPNAADPMTVLYK-----------IAYSRELPE--VPA------FLSKQANDFLSNCL 233
            P P     +    +           + + +  P+   PA        + QA D LS  L
Sbjct: 244 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKML 303
Query: 234 RRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSILDQGIWNSVEETEESLGNLIH 293
             DP +R +    L+HP++  +        E    P  I D+ + +  E T E    LI+
Sbjct: 304 VIDPAKRISVDDALQHPYINVWYDPA----EVEAPPPQIYDKQL-DEREHTIEEWKELIY 358
Query: 294 S 294
Sbjct: 359 K 359

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 94/241 (39%), Gaps = 48/241 (19%)
Query: 97  LDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKWESEALQS 155
           LD   +     Q+L G+++LHS  ++H D+K  NI++ ++   KI DFG A+    +   
Sbjct: 124 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 183
Query: 156 GG---TPMFMAPEVARGEHQGFASDIWAVGCTVIEMASG--------------------G 192
                T  + APEV  G       DIW+VGC + EM                       G
Sbjct: 184 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG 243
Query: 193 APWPNAADPMTVLYK-----------IAYSRELPE--VPA------FLSKQANDFLSNCL 233
            P P     +    +           + + +  P+   PA        + QA D LS  L
Sbjct: 244 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKML 303
Query: 234 RRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSILDQGIWNSVEETEESLGNLIH 293
             DP +R +    L+HP++  +        E    P  I D+ + +  E T E    LI+
Sbjct: 304 VIDPAKRISVDDALQHPYINVWYDPA----EVEAPPPQIYDKQL-DEREHTIEEWKELIY 358
Query: 294 S 294
Sbjct: 359 K 359

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/255 (23%), Positives = 110/255 (43%), Gaps = 28/255 (10%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTE---LPKSEFLQREQKFLSSLNSPHIV 58
           D T  H +G G    V      +     A K+ +   +   EFL +E   +  +  P++V
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL-KEAAVMKEIKHPNLV 72
Query: 59  GYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHR-NGGRLDESLIVSYTRQILQGLEYLH 117
              G   T E     + + +E+   G L D +   N   +   +++    QI   +EYL 
Sbjct: 73  QLLGV-CTREPP---FYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 128
Query: 118 SNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSGGT---------PM-FMAPEV 166
               +H D+ +RN L+ E+   K+ADFG ++     L +G T         P+ + APE 
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSR-----LMTGDTYTAHAGAKFPIKWTAPES 183
Query: 167 ARGEHQGFASDIWAVGCTVIEMASGG-APWPNAADPMTVLYKIAYSRELPEVPAFLSKQA 225
                    SD+WA G  + E+A+ G +P+P     ++ +Y++       E P    ++ 
Sbjct: 184 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI--DLSQVYELLEKDYRMERPEGCPEKV 241
Query: 226 NDFLSNCLRRDPKER 240
            + +  C + +P +R
Sbjct: 242 YELMRACWQWNPSDR 256

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/255 (23%), Positives = 110/255 (43%), Gaps = 28/255 (10%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTE---LPKSEFLQREQKFLSSLNSPHIV 58
           D T  H +G G    V      +     A K+ +   +   EFL +E   +  +  P++V
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL-KEAAVMKEIKHPNLV 72
Query: 59  GYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHR-NGGRLDESLIVSYTRQILQGLEYLH 117
              G   T E     + + +E+   G L D +   N   +   +++    QI   +EYL 
Sbjct: 73  QLLGV-CTREPP---FYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 128
Query: 118 SNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSGGT---------PM-FMAPEV 166
               +H D+ +RN L+ E+   K+ADFG ++     L +G T         P+ + APE 
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSR-----LMTGDTYTAHAGAKFPIKWTAPES 183
Query: 167 ARGEHQGFASDIWAVGCTVIEMASGG-APWPNAADPMTVLYKIAYSRELPEVPAFLSKQA 225
                    SD+WA G  + E+A+ G +P+P     ++ +Y++       E P    ++ 
Sbjct: 184 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI--DLSQVYELLEKDYRMERPEGCPEKV 241
Query: 226 NDFLSNCLRRDPKER 240
            + +  C + +P +R
Sbjct: 242 YELMRACWQWNPSDR 256

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 94/241 (39%), Gaps = 48/241 (19%)
Query: 97  LDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKWESEALQS 155
           LD   +     Q+L G+++LHS  ++H D+K  NI++ ++   KI DFG A+    +   
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 182
Query: 156 GG---TPMFMAPEVARGEHQGFASDIWAVGCTVIEMASG--------------------G 192
                T  + APEV  G       DIW+VGC + EM                       G
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG 242
Query: 193 APWPNAADPMTVLYK-----------IAYSRELPE--VPA------FLSKQANDFLSNCL 233
            P P     +    +           + + +  P+   PA        + QA D LS  L
Sbjct: 243 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKML 302
Query: 234 RRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSILDQGIWNSVEETEESLGNLIH 293
             DP +R +    L+HP++  +        E    P  I D+ + +  E T E    LI+
Sbjct: 303 VIDPAKRISVDDALQHPYINVWYDPA----EVEAPPPQIYDKQL-DEREHTIEEWKELIY 357
Query: 294 S 294
Sbjct: 358 K 358

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 94/241 (39%), Gaps = 48/241 (19%)
Query: 97  LDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKWESEALQS 155
           LD   +     Q+L G+++LHS  ++H D+K  NI++ ++   KI DFG A+    +   
Sbjct: 122 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 181
Query: 156 GG---TPMFMAPEVARGEHQGFASDIWAVGCTVIEMASG--------------------G 192
                T  + APEV  G       DIW+VGC + EM                       G
Sbjct: 182 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG 241
Query: 193 APWPNAADPMTVLYK-----------IAYSRELPE--VPA------FLSKQANDFLSNCL 233
            P P     +    +           + + +  P+   PA        + QA D LS  L
Sbjct: 242 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKML 301
Query: 234 RRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSILDQGIWNSVEETEESLGNLIH 293
             DP +R +    L+HP++  +        E    P  I D+ + +  E T E    LI+
Sbjct: 302 VIDPAKRISVDDALQHPYINVWYDPA----EVEAPPPQIYDKQL-DEREHTIEEWKELIY 356
Query: 294 S 294
Sbjct: 357 K 357

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 94/241 (39%), Gaps = 48/241 (19%)
Query: 97  LDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKWESEALQS 155
           LD   +     Q+L G+++LHS  ++H D+K  NI++ ++   KI DFG A+    +   
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 182
Query: 156 GG---TPMFMAPEVARGEHQGFASDIWAVGCTVIEMASG--------------------G 192
                T  + APEV  G       DIW+VGC + EM                       G
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG 242
Query: 193 APWPNAADPMTVLYK-----------IAYSRELPE--VPA------FLSKQANDFLSNCL 233
            P P     +    +           + + +  P+   PA        + QA D LS  L
Sbjct: 243 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKML 302
Query: 234 RRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSILDQGIWNSVEETEESLGNLIH 293
             DP +R +    L+HP++  +        E    P  I D+ + +  E T E    LI+
Sbjct: 303 VIDPAKRISVDDALQHPYINVWYDPA----EVEAPPPQIYDKQL-DEREHTIEEWKELIY 357
Query: 294 S 294
Sbjct: 358 K 358

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 90/206 (43%), Gaps = 34/206 (16%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKST--ELPKSEF---LQREQKFLSSLNSPHIVG---- 59
           IGQG+   V  A   ++G   A K    E  K  F     RE K L  L   ++V     
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 60  -------YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQG 112
                  Y  C  +     L+++ F E+   G L++ +     +   S I    + +L G
Sbjct: 86  CRTKASPYNRCKASIY---LVFD-FCEHDLAGLLSNVL----VKFTLSEIKRVMQMLLNG 137
Query: 113 LEYLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSGG--------TPMFMA 163
           L Y+H N+++H D+K+ N+L+   G  K+ADFG A+  S A  S          T  +  
Sbjct: 138 LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRP 197
Query: 164 PEVARGEHQ-GFASDIWAVGCTVIEM 188
           PE+  GE   G   D+W  GC + EM
Sbjct: 198 PELLLGERDYGPPIDLWGAGCIMAEM 223

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 94/241 (39%), Gaps = 48/241 (19%)
Query: 97  LDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKWESEALQS 155
           LD   +     Q+L G+++LHS  ++H D+K  NI++ ++   KI DFG A+    +   
Sbjct: 117 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 176
Query: 156 GG---TPMFMAPEVARGEHQGFASDIWAVGCTVIEMASG--------------------G 192
                T  + APEV  G       DIW+VGC + EM                       G
Sbjct: 177 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG 236
Query: 193 APWPNAADPMTVLYK-----------IAYSRELPE--VPA------FLSKQANDFLSNCL 233
            P P     +    +           + + +  P+   PA        + QA D LS  L
Sbjct: 237 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKML 296
Query: 234 RRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSILDQGIWNSVEETEESLGNLIH 293
             DP +R +    L+HP++  +        E    P  I D+ + +  E T E    LI+
Sbjct: 297 VIDPAKRISVDDALQHPYINVWYDPA----EVEAPPPQIYDKQL-DEREHTIEEWKELIY 351
Query: 294 S 294
Sbjct: 352 K 352

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 94/241 (39%), Gaps = 48/241 (19%)
Query: 97  LDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKWESEALQS 155
           LD   +     Q+L G+++LHS  ++H D+K  NI++ ++   KI DFG A+    +   
Sbjct: 116 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 175
Query: 156 GG---TPMFMAPEVARGEHQGFASDIWAVGCTVIEMASG--------------------G 192
                T  + APEV  G       DIW+VGC + EM                       G
Sbjct: 176 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG 235
Query: 193 APWPNAADPMTVLYK-----------IAYSRELPE--VPA------FLSKQANDFLSNCL 233
            P P     +    +           + + +  P+   PA        + QA D LS  L
Sbjct: 236 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKML 295
Query: 234 RRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSILDQGIWNSVEETEESLGNLIH 293
             DP +R +    L+HP++  +        E    P  I D+ + +  E T E    LI+
Sbjct: 296 VIDPAKRISVDDALQHPYINVWYDPA----EVEAPPPQIYDKQL-DEREHTIEEWKELIY 350
Query: 294 S 294
Sbjct: 351 K 351

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 94/241 (39%), Gaps = 48/241 (19%)
Query: 97  LDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKWESEALQS 155
           LD   +     Q+L G+++LHS  ++H D+K  NI++ ++   KI DFG A+    +   
Sbjct: 117 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 176
Query: 156 GG---TPMFMAPEVARGEHQGFASDIWAVGCTVIEMASG--------------------G 192
                T  + APEV  G       DIW+VGC + EM                       G
Sbjct: 177 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG 236
Query: 193 APWPNAADPMTVLYK-----------IAYSRELPE--VPA------FLSKQANDFLSNCL 233
            P P     +    +           + + +  P+   PA        + QA D LS  L
Sbjct: 237 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKML 296
Query: 234 RRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSILDQGIWNSVEETEESLGNLIH 293
             DP +R +    L+HP++  +        E    P  I D+ + +  E T E    LI+
Sbjct: 297 VIDPAKRISVDDALQHPYINVWYDPA----EVEAPPPQIYDKQL-DEREHTIEEWKELIY 351
Query: 294 S 294
Sbjct: 352 K 352

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 94/240 (39%), Gaps = 48/240 (20%)
Query: 97  LDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKWESEALQS 155
           LD   +     Q+L G+++LHS  ++H D+K  NI++ ++   KI DFG A+    +   
Sbjct: 161 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 220
Query: 156 GG---TPMFMAPEVARGEHQGFASDIWAVGCTVIEMASG--------------------G 192
                T  + APEV  G       DIW+VGC + EM                       G
Sbjct: 221 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG 280
Query: 193 APWP-----------NAADPMTVLYKIAYSRELPE--VPA------FLSKQANDFLSNCL 233
            P P           N  +       + + +  P+   PA        + QA D LS  L
Sbjct: 281 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKML 340
Query: 234 RRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSILDQGIWNSVEETEESLGNLIH 293
             DP +R +    L+HP++  +        E    P  I D+ + +  E T E    LI+
Sbjct: 341 VIDPAKRISVDDALQHPYINVWYDPA----EVEAPPPQIYDKQL-DEREHTIEEWKELIY 395

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/173 (24%), Positives = 85/173 (49%), Gaps = 10/173 (5%)
Query: 76  LFMEYAPGGTLNDEIHRN-GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMA 134
           +  E+   G+L D +  + G +     ++ ++ QI +G+ ++     +H D+++ NIL++
Sbjct: 259 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVS 318
Query: 135 ESGA-KIADFGCAKW----ESEALQSGGTPM-FMAPEVARGEHQGFASDIWAVGCTVIEM 188
            S   KIADFG A+     E  A +    P+ + APE          SD+W+ G  ++E+
Sbjct: 319 ASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEI 378
Query: 189 AS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKER 240
            + G  P+P  ++P  V+  +     +P  P    ++  + +  C +  P+ER
Sbjct: 379 VTYGRIPYPGMSNP-EVIRALERGYRMPR-PENCPEELYNIMMRCWKNRPEER 429

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 80/199 (40%), Gaps = 43/199 (21%)
Query: 97  LDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKWESEALQS 155
           LD   +     Q+L G+++LHS  ++H D+K  NI++ ++   KI DFG A+    +   
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMM 182
Query: 156 GG---TPMFMAPEVARGEHQGFASDIWAVGCTVIEMASG--------------------G 192
                T  + APEV  G       DIW+VGC + EM                       G
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG 242
Query: 193 APWPNAADPMTVLYK-----------IAYSRELPE--VPA------FLSKQANDFLSNCL 233
            P P     +    +           + + +  P+   PA        + QA D LS  L
Sbjct: 243 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKML 302
Query: 234 RRDPKERWAASQLLKHPFL 252
             DP +R +    L+HP++
Sbjct: 303 VIDPAKRISVDDALQHPYI 321

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/173 (24%), Positives = 85/173 (49%), Gaps = 10/173 (5%)
Query: 76  LFMEYAPGGTLNDEIHRN-GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMA 134
           +  E+   G+L D +  + G +     ++ ++ QI +G+ ++     +H D+++ NIL++
Sbjct: 86  IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVS 145
Query: 135 ESGA-KIADFGCAKW----ESEALQSGGTPM-FMAPEVARGEHQGFASDIWAVGCTVIEM 188
            S   KIADFG A+     E  A +    P+ + APE          SD+W+ G  ++E+
Sbjct: 146 ASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEI 205
Query: 189 AS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKER 240
            + G  P+P  ++P  V+  +     +P  P    ++  + +  C +  P+ER
Sbjct: 206 VTYGRIPYPGMSNP-EVIRALERGYRMPR-PENCPEELYNIMMRCWKNRPEER 256

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 94/240 (39%), Gaps = 48/240 (20%)
Query: 97  LDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKWESEALQS 155
           LD   +     Q+L G+++LHS  ++H D+K  NI++ ++   KI DFG A+    +   
Sbjct: 161 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 220
Query: 156 GG---TPMFMAPEVARGEHQGFASDIWAVGCTVIEMASG--------------------G 192
                T  + APEV  G       DIW+VGC + EM                       G
Sbjct: 221 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG 280
Query: 193 APWP-----------NAADPMTVLYKIAYSRELPE--VPA------FLSKQANDFLSNCL 233
            P P           N  +       + + +  P+   PA        + QA D LS  L
Sbjct: 281 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKML 340
Query: 234 RRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSILDQGIWNSVEETEESLGNLIH 293
             DP +R +    L+HP++  +        E    P  I D+ + +  E T E    LI+
Sbjct: 341 VIDPAKRISVDDALQHPYINVWYDPA----EVEAPPPQIYDKQL-DEREHTIEEWKELIY 395

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 79/164 (48%), Gaps = 17/164 (10%)
Query: 38  KSEFLQREQKFLSSLNSPHIVGYKG-CDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGR 96
           K E L  E   +  L++P+IV   G C+  S      + L ME A  G LN  + +N   
Sbjct: 56  KDELLA-EANVMQQLDNPYIVRMIGICEAES------WMLVMEMAELGPLNKYLQQNRHV 108
Query: 97  LDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMA-ESGAKIADFGCAKW------E 149
            D++ I+    Q+  G++YL  +  VH D+ +RN+L+  +  AKI+DFG +K        
Sbjct: 109 KDKN-IIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENX 167
Query: 150 SEALQSGGTPM-FMAPEVARGEHQGFASDIWAVGCTVIEMASGG 192
            +A   G  P+ + APE          SD+W+ G  + E  S G
Sbjct: 168 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYG 211

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 79/164 (48%), Gaps = 17/164 (10%)
Query: 38  KSEFLQREQKFLSSLNSPHIVGYKG-CDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGR 96
           K E L  E   +  L++P+IV   G C+  S      + L ME A  G LN  + +N   
Sbjct: 72  KDELLA-EANVMQQLDNPYIVRMIGICEAES------WMLVMEMAELGPLNKYLQQNRHV 124
Query: 97  LDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMA-ESGAKIADFGCAKW------E 149
            D++ I+    Q+  G++YL  +  VH D+ +RN+L+  +  AKI+DFG +K        
Sbjct: 125 KDKN-IIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 183
Query: 150 SEALQSGGTPM-FMAPEVARGEHQGFASDIWAVGCTVIEMASGG 192
            +A   G  P+ + APE          SD+W+ G  + E  S G
Sbjct: 184 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYG 227

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 79/164 (48%), Gaps = 17/164 (10%)
Query: 38  KSEFLQREQKFLSSLNSPHIVGYKG-CDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGR 96
           K E L  E   +  L++P+IV   G C+  S      + L ME A  G LN  + +N   
Sbjct: 72  KDELLA-EANVMQQLDNPYIVRMIGICEAES------WMLVMEMAELGPLNKYLQQNRHV 124
Query: 97  LDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMA-ESGAKIADFGCAKW------E 149
            D++ I+    Q+  G++YL  +  VH D+ +RN+L+  +  AKI+DFG +K        
Sbjct: 125 KDKN-IIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 183
Query: 150 SEALQSGGTPM-FMAPEVARGEHQGFASDIWAVGCTVIEMASGG 192
            +A   G  P+ + APE          SD+W+ G  + E  S G
Sbjct: 184 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYG 227

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 83/167 (49%), Gaps = 13/167 (7%)
Query: 34  TELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRN 93
           TE  + +FL  E   +   + P+I+  +G  V ++   +M  +  EY   G+L+  + +N
Sbjct: 63  TEKQRRDFLG-EASIMGQFDHPNIIHLEG--VVTKSKPVM--IVTEYMENGSLDTFLKKN 117
Query: 94  GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKW---E 149
            G+     +V   R I  G++YL     VH D+ +RNIL+  +   K++DFG ++    +
Sbjct: 118 DGQFTVIQLVGMLRGISAGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD 177
Query: 150 SEA---LQSGGTPM-FMAPEVARGEHQGFASDIWAVGCTVIEMASGG 192
            EA    + G  P+ + APE         ASD+W+ G  + E+ S G
Sbjct: 178 PEAAYTTRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYG 224

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 79/314 (25%), Positives = 136/314 (43%), Gaps = 58/314 (18%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLS-SLNSPHIVGYKGCDVTS 67
           +G GSS TV    S + G   A K   +   +    E K L+ S + P+++ Y   + T 
Sbjct: 23  LGYGSSGTVVFQGSFQ-GRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETT- 80
Query: 68  EDNKLMY------NL-FMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNR 120
             ++ +Y      NL   +      ++DE   N     E   +S  RQI  G+ +LHS +
Sbjct: 81  --DRFLYIALELCNLNLQDLVESKNVSDE---NLKLQKEYNPISLLRQIASGVAHLHSLK 135
Query: 121 VVHCDIKSRNILMA---------ESGAK-----IADFG-CAKWESEAL-------QSGGT 158
           ++H D+K +NIL++         ++GA+     I+DFG C K +S             GT
Sbjct: 136 IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGT 195
Query: 159 PMFMAPEVARGEHQ-------GFASDIWAVGCTVIEMASGGA-PWPNAADPMTVLYKIAY 210
             + APE+    +          + DI+++GC    + S G  P+ +     + + +  +
Sbjct: 196 SGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIF 255
Query: 211 SRELPEVPAF----LSKQANDFLSNCLRRDPKERWAASQLLKHPF-------LEEFCSCT 259
           S  L E+       L  +A D +S  +  DP +R  A ++L+HP        LE     +
Sbjct: 256 S--LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPKSKKLEFLLKVS 313
Query: 260 KQIQESNCSPTSIL 273
            +++  N  P S L
Sbjct: 314 DRLEIENRDPPSAL 327

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 80/199 (40%), Gaps = 43/199 (21%)
Query: 97  LDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKWESEALQS 155
           LD   +     Q+L G+++LHS  ++H D+K  NI++ ++   KI DFG A+    +   
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMM 182
Query: 156 GG---TPMFMAPEVARGEHQGFASDIWAVGCTVIEMASG--------------------G 192
                T  + APEV  G       DIW+VGC + EM                       G
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG 242
Query: 193 APWPNAADPMTVLYK-----------IAYSRELPE--VPA------FLSKQANDFLSNCL 233
            P P     +    +           + + +  P+   PA        + QA D LS  L
Sbjct: 243 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKML 302
Query: 234 RRDPKERWAASQLLKHPFL 252
             DP +R +    L+HP++
Sbjct: 303 VIDPAKRISVDDALQHPYI 321

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 79/164 (48%), Gaps = 17/164 (10%)
Query: 38  KSEFLQREQKFLSSLNSPHIVGYKG-CDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGR 96
           K E L  E   +  L++P+IV   G C+  S      + L ME A  G LN  + +N   
Sbjct: 52  KDELLA-EANVMQQLDNPYIVRMIGICEAES------WMLVMEMAELGPLNKYLQQNRHV 104
Query: 97  LDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMA-ESGAKIADFGCAKW------E 149
            D++ I+    Q+  G++YL  +  VH D+ +RN+L+  +  AKI+DFG +K        
Sbjct: 105 KDKN-IIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 163
Query: 150 SEALQSGGTPM-FMAPEVARGEHQGFASDIWAVGCTVIEMASGG 192
            +A   G  P+ + APE          SD+W+ G  + E  S G
Sbjct: 164 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYG 207

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 89/236 (37%), Gaps = 67/236 (28%)
Query: 83  GGTLNDEIHRNGG---RLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES--- 136
           G +  D I  NG    RLD    ++Y  QI + + +LHSN++ H D+K  NIL  +S   
Sbjct: 100 GLSTYDFIKENGFLPFRLDHIRKMAY--QICKSVNFLHSNKLTHTDLKPENILFVQSDYT 157
Query: 137 -----------------GAKIADFGCAKWESEALQS-GGTPMFMAPEVARGEHQGFASDI 178
                              K+ DFG A ++ E   +   T  + APEV          D+
Sbjct: 158 EAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDV 217
Query: 179 WAVGCTVIEMASGGAPWP--NAADPMTVLYKI---------------------------- 208
           W++GC +IE   G   +P  ++ + + ++ +I                            
Sbjct: 218 WSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEH 277
Query: 209 -----AYSRELPEVPAFLSKQ------ANDFLSNCLRRDPKERWAASQLLKHPFLE 253
                  SR    +  F+  Q        D +   L  DP +R    + LKHPF +
Sbjct: 278 SSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFD 333

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 79/164 (48%), Gaps = 17/164 (10%)
Query: 38  KSEFLQREQKFLSSLNSPHIVGYKG-CDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGR 96
           K E L  E   +  L++P+IV   G C+  S      + L ME A  G LN  + +N   
Sbjct: 70  KDELLA-EANVMQQLDNPYIVRMIGICEAES------WMLVMEMAELGPLNKYLQQNRHV 122
Query: 97  LDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMA-ESGAKIADFGCAKW------E 149
            D++ I+    Q+  G++YL  +  VH D+ +RN+L+  +  AKI+DFG +K        
Sbjct: 123 KDKN-IIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 181
Query: 150 SEALQSGGTPM-FMAPEVARGEHQGFASDIWAVGCTVIEMASGG 192
            +A   G  P+ + APE          SD+W+ G  + E  S G
Sbjct: 182 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYG 225

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 79/164 (48%), Gaps = 17/164 (10%)
Query: 38  KSEFLQREQKFLSSLNSPHIVGYKG-CDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGR 96
           K E L  E   +  L++P+IV   G C+  S      + L ME A  G LN  + +N   
Sbjct: 62  KDELLA-EANVMQQLDNPYIVRMIGICEAES------WMLVMEMAELGPLNKYLQQNRHV 114
Query: 97  LDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMA-ESGAKIADFGCAKW------E 149
            D++ I+    Q+  G++YL  +  VH D+ +RN+L+  +  AKI+DFG +K        
Sbjct: 115 KDKN-IIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 173
Query: 150 SEALQSGGTPM-FMAPEVARGEHQGFASDIWAVGCTVIEMASGG 192
            +A   G  P+ + APE          SD+W+ G  + E  S G
Sbjct: 174 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYG 217

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 79/314 (25%), Positives = 136/314 (43%), Gaps = 58/314 (18%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLS-SLNSPHIVGYKGCDVTS 67
           +G GSS TV    S + G   A K   +   +    E K L+ S + P+++ Y   + T 
Sbjct: 23  LGYGSSGTVVFQGSFQ-GRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETT- 80
Query: 68  EDNKLMY------NL-FMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNR 120
             ++ +Y      NL   +      ++DE   N     E   +S  RQI  G+ +LHS +
Sbjct: 81  --DRFLYIALELCNLNLQDLVESKNVSDE---NLKLQKEYNPISLLRQIASGVAHLHSLK 135
Query: 121 VVHCDIKSRNILMA---------ESGAK-----IADFG-CAKWES-------EALQSGGT 158
           ++H D+K +NIL++         ++GA+     I+DFG C K +S             GT
Sbjct: 136 IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGT 195
Query: 159 PMFMAPEVARGEHQ-------GFASDIWAVGCTVIEMASGGA-PWPNAADPMTVLYKIAY 210
             + APE+    +          + DI+++GC    + S G  P+ +     + + +  +
Sbjct: 196 SGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIF 255
Query: 211 SRELPEVPAF----LSKQANDFLSNCLRRDPKERWAASQLLKHPF-------LEEFCSCT 259
           S  L E+       L  +A D +S  +  DP +R  A ++L+HP        LE     +
Sbjct: 256 S--LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPKSKKLEFLLKVS 313
Query: 260 KQIQESNCSPTSIL 273
            +++  N  P S L
Sbjct: 314 DRLEIENRDPPSAL 327

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 79/164 (48%), Gaps = 17/164 (10%)
Query: 38  KSEFLQREQKFLSSLNSPHIVGYKG-CDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGR 96
           K E L  E   +  L++P+IV   G C+  S      + L ME A  G LN  + +N   
Sbjct: 50  KDELLA-EANVMQQLDNPYIVRMIGICEAES------WMLVMEMAELGPLNKYLQQNRHV 102
Query: 97  LDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMA-ESGAKIADFGCAKW------E 149
            D++ I+    Q+  G++YL  +  VH D+ +RN+L+  +  AKI+DFG +K        
Sbjct: 103 KDKN-IIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 161
Query: 150 SEALQSGGTPM-FMAPEVARGEHQGFASDIWAVGCTVIEMASGG 192
            +A   G  P+ + APE          SD+W+ G  + E  S G
Sbjct: 162 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYG 205

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 79/164 (48%), Gaps = 17/164 (10%)
Query: 38  KSEFLQREQKFLSSLNSPHIVGYKG-CDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGR 96
           K E L  E   +  L++P+IV   G C+  S      + L ME A  G LN  + +N   
Sbjct: 56  KDELLA-EANVMQQLDNPYIVRMIGICEAES------WMLVMEMAELGPLNKYLQQNRHV 108
Query: 97  LDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMA-ESGAKIADFGCAKW------E 149
            D++ I+    Q+  G++YL  +  VH D+ +RN+L+  +  AKI+DFG +K        
Sbjct: 109 KDKN-IIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 167
Query: 150 SEALQSGGTPM-FMAPEVARGEHQGFASDIWAVGCTVIEMASGG 192
            +A   G  P+ + APE          SD+W+ G  + E  S G
Sbjct: 168 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYG 211

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/261 (24%), Positives = 100/261 (38%), Gaps = 82/261 (31%)
Query: 71  KLMY--NLFMEYAP-GGTLNDEIHRN---GGRLDESLIVSYTRQILQGLEYLHSNRVVHC 124
           K MY  ++ + + P G +L + I RN   G  +++  I  Y  +IL+ L YL    + H 
Sbjct: 104 KFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIED--IKLYCIEILKALNYLRKMSLTHT 161
Query: 125 DIKSRNILMAE--------------------------SGAKIADFGCAKWESEALQSG-G 157
           D+K  NIL+ +                          +G K+ DFGCA ++S+   S   
Sbjct: 162 DLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIIN 221
Query: 158 TPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGG------------------------- 192
           T  + APEV        +SD+W+ GC + E+ +G                          
Sbjct: 222 TRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKN 281
Query: 193 --------------------APWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNC 232
                                 WP  A  +  +  +   + LP       +   DFL + 
Sbjct: 282 MLYEATKTNGSKYVNKDELKLAWPENASSINSIKHV--KKCLPLYKIIKHELFCDFLYSI 339
Query: 233 LRRDPKERWAASQLLKHPFLE 253
           L+ DP  R + ++LLKH FLE
Sbjct: 340 LQIDPTLRPSPAELLKHKFLE 360

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 96/208 (46%), Gaps = 23/208 (11%)
Query: 65  VTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHC 124
           VT E+   +   FM  A G  L+      GG++    ++ ++ QI +G+ Y+     +H 
Sbjct: 76  VTKEEPIYIITEFM--AKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHR 133
Query: 125 DIKSRNILMAES-GAKIADFGCAKW----ESEALQSGGTPM-FMAPEVARGEHQGFASDI 178
           D+++ N+L++ES   KIADFG A+     E  A +    P+ + APE          S++
Sbjct: 134 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSNV 193
Query: 179 WAVGCTVIEMAS-GGAPWP--NAADPMTVL---YKIAYSRELPEVPAFLSKQANDFLSNC 232
           W+ G  + E+ + G  P+P    AD M+ L   Y++      P+       +  D +  C
Sbjct: 194 WSFGILLYEIVTYGKIPYPGRTNADVMSALSQGYRMPRMENCPD-------ELYDIMKMC 246
Query: 233 LRRDPKERWAASQLLKHPFLEEFCSCTK 260
            +   +ER     L     L++F + T+
Sbjct: 247 WKEKAEERPTFDYL--QSVLDDFYTATE 272

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 119/287 (41%), Gaps = 42/287 (14%)
Query: 6   GHTIGQGSSATVSLATSLRSG--DVFAAKSTELPKS-------EFLQREQKFLSSLNS-P 55
           G T+G G+   V  AT+   G  D     + ++ KS       E L  E K +S L    
Sbjct: 43  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 102
Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHR---------NGGRLDESLIVSYT 106
           +IV   G    +    ++  +  EY   G L + + R         +G  L+   ++ ++
Sbjct: 103 NIVNLLGA--CTHGGPVL--VITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFS 158
Query: 107 RQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAK---WESEALQSGGTPM-- 160
            Q+ QG+ +L S   +H D+ +RN+L+     AKI DFG A+    +S  +  G   +  
Sbjct: 159 SQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPV 218
Query: 161 -FMAPEVARGEHQGFASDIWAVGCTVIEMASGGA-PWPNAADPMTVLYKIAYSRELPEVP 218
            +MAPE          SD+W+ G  + E+ S G  P+P      +  YK+         P
Sbjct: 219 KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGIL-VNSKFYKLVKDGYQMAQP 277
Query: 219 AFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCS-CTKQIQE 264
           AF  K     +  C   +P  R         P  ++ CS   +Q QE
Sbjct: 278 AFAPKNIYSIMQACWALEPTHR---------PTFQQICSFLQEQAQE 315

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 90/206 (43%), Gaps = 34/206 (16%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKST--ELPKSEF---LQREQKFLSSLNSPHIVG---- 59
           IGQG+   V  A   ++G   A K    E  K  F     RE K L  L   ++V     
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84
Query: 60  -------YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQG 112
                  Y  C  +     L+++ F E+   G L++ +     +   S I    + +L G
Sbjct: 85  CRTKASPYNRCKGSIY---LVFD-FCEHDLAGLLSNVL----VKFTLSEIKRVMQMLLNG 136
Query: 113 LEYLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSGG--------TPMFMA 163
           L Y+H N+++H D+K+ N+L+   G  K+ADFG A+  S A  S          T  +  
Sbjct: 137 LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRP 196
Query: 164 PEVARGEHQ-GFASDIWAVGCTVIEM 188
           PE+  GE   G   D+W  GC + EM
Sbjct: 197 PELLLGERDYGPPIDLWGAGCIMAEM 222

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 119/287 (41%), Gaps = 42/287 (14%)
Query: 6   GHTIGQGSSATVSLATSLRSG--DVFAAKSTELPKS-------EFLQREQKFLSSLNS-P 55
           G T+G G+   V  AT+   G  D     + ++ KS       E L  E K +S L    
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110
Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHR---------NGGRLDESLIVSYT 106
           +IV   G    +    ++  +  EY   G L + + R         +G  L+   ++ ++
Sbjct: 111 NIVNLLGA--CTHGGPVL--VITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFS 166
Query: 107 RQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAK---WESEALQSGGTPM-- 160
            Q+ QG+ +L S   +H D+ +RN+L+     AKI DFG A+    +S  +  G   +  
Sbjct: 167 SQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPV 226
Query: 161 -FMAPEVARGEHQGFASDIWAVGCTVIEMASGGA-PWPNAADPMTVLYKIAYSRELPEVP 218
            +MAPE          SD+W+ G  + E+ S G  P+P      +  YK+         P
Sbjct: 227 KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGIL-VNSKFYKLVKDGYQMAQP 285
Query: 219 AFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCS-CTKQIQE 264
           AF  K     +  C   +P  R         P  ++ CS   +Q QE
Sbjct: 286 AFAPKNIYSIMQACWALEPTHR---------PTFQQICSFLQEQAQE 323

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 90/206 (43%), Gaps = 34/206 (16%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKST--ELPKSEF---LQREQKFLSSLNSPHIVG---- 59
           IGQG+   V  A   ++G   A K    E  K  F     RE K L  L   ++V     
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 60  -------YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQG 112
                  Y  C  +     L+++ F E+   G L++ +     +   S I    + +L G
Sbjct: 86  CRTKASPYNRCKGSIY---LVFD-FCEHDLAGLLSNVL----VKFTLSEIKRVMQMLLNG 137
Query: 113 LEYLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSGG--------TPMFMA 163
           L Y+H N+++H D+K+ N+L+   G  K+ADFG A+  S A  S          T  +  
Sbjct: 138 LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRP 197
Query: 164 PEVARGEHQ-GFASDIWAVGCTVIEM 188
           PE+  GE   G   D+W  GC + EM
Sbjct: 198 PELLLGERDYGPPIDLWGAGCIMAEM 223

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 90/206 (43%), Gaps = 34/206 (16%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKST--ELPKSEF---LQREQKFLSSLNSPHIVG---- 59
           IGQG+   V  A   ++G   A K    E  K  F     RE K L  L   ++V     
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 60  -------YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQG 112
                  Y  C  +     L+++ F E+   G L++ +     +   S I    + +L G
Sbjct: 86  CRTKASPYNRCKGSIY---LVFD-FCEHDLAGLLSNVL----VKFTLSEIKRVMQMLLNG 137
Query: 113 LEYLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSGG--------TPMFMA 163
           L Y+H N+++H D+K+ N+L+   G  K+ADFG A+  S A  S          T  +  
Sbjct: 138 LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRP 197
Query: 164 PEVARGEHQ-GFASDIWAVGCTVIEM 188
           PE+  GE   G   D+W  GC + EM
Sbjct: 198 PELLLGERDYGPPIDLWGAGCIMAEM 223

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 64/254 (25%), Positives = 107/254 (42%), Gaps = 24/254 (9%)
Query: 5   RGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGYKGCD 64
           RG     G   +     +L+ G       TE  + EFL  E   +     P+I+  +G  
Sbjct: 32  RGRLKAPGKKESCVAIKTLKGG------YTERQRREFLS-EASIMGQFEHPNIIRLEGV- 83
Query: 65  VTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHC 124
           VT+    ++   FME    G L+  +  N G+     +V   R I  G+ YL     VH 
Sbjct: 84  VTNSMPVMILTEFME---NGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEMSYVHR 140
Query: 125 DIKSRNILMAESGA-KIADFGCAKWESE--------ALQSGGTPM-FMAPEVARGEHQGF 174
           D+ +RNIL+  +   K++DFG +++  E        +   G  P+ + APE         
Sbjct: 141 DLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAFRKFTS 200
Query: 175 ASDIWAVGCTVIE-MASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCL 233
           ASD W+ G  + E M+ G  P+ + ++   V+  I     LP  P       +  + +C 
Sbjct: 201 ASDAWSYGIVMWEVMSFGERPYWDMSN-QDVINAIEQDYRLPPPPD-CPTSLHQLMLDCW 258
Query: 234 RRDPKERWAASQLL 247
           ++D   R    Q++
Sbjct: 259 QKDRNARPRFPQVV 272

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 88/197 (44%), Gaps = 22/197 (11%)
Query: 76  LFMEYAPGGTLNDEIHRNGG-RLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMA 134
           +  EY   G+L D +    G +L  + ++    QI +G+ ++     +H D+++ NIL++
Sbjct: 84  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS 143
Query: 135 ES-GAKIADFGCAKW----ESEALQSGGTPM-FMAPEVARGEHQGFASDIWAVGCTVIEM 188
           ++   KIADFG A+     E  A +    P+ + APE          SD+W+ G  + E+
Sbjct: 144 DTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEI 203
Query: 189 ASGG-APWPNAADPMTVL-----YKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWA 242
            + G  P+P   +P  +      Y++      PE       +    +  C +  P++R  
Sbjct: 204 VTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE-------ELYQLMRLCWKERPEDRPT 256
Query: 243 ASQLLKHPFLEEFCSCT 259
              L     LE+F + T
Sbjct: 257 FDYL--RSVLEDFFTAT 271

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 88/197 (44%), Gaps = 22/197 (11%)
Query: 76  LFMEYAPGGTLNDEIHRNGG-RLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMA 134
           +  EY   G+L D +    G +L  + ++    QI +G+ ++     +H D+++ NIL++
Sbjct: 85  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS 144
Query: 135 ES-GAKIADFGCAKW----ESEALQSGGTPM-FMAPEVARGEHQGFASDIWAVGCTVIEM 188
           ++   KIADFG A+     E  A +    P+ + APE          SD+W+ G  + E+
Sbjct: 145 DTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEI 204
Query: 189 ASGG-APWPNAADPMTVL-----YKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWA 242
            + G  P+P   +P  +      Y++      PE       +    +  C +  P++R  
Sbjct: 205 VTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE-------ELYQLMRLCWKERPEDRPT 257
Query: 243 ASQLLKHPFLEEFCSCT 259
              L     LE+F + T
Sbjct: 258 FDYL--RSVLEDFFTAT 272

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/198 (24%), Positives = 89/198 (44%), Gaps = 22/198 (11%)
Query: 76  LFMEYAPGGTLNDEIHRNGG-RLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMA 134
           +  EY   G+L D +    G +L  + ++    QI +G+ ++     +H D+++ NIL++
Sbjct: 89  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS 148
Query: 135 ES-GAKIADFGCAKW----ESEALQSGGTPM-FMAPEVARGEHQGFASDIWAVGCTVIEM 188
           ++   KIADFG A+     E  A +    P+ + APE          SD+W+ G  + E+
Sbjct: 149 DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEI 208
Query: 189 ASGG-APWPNAADPMTVL-----YKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWA 242
            + G  P+P   +P  +      Y++      PE       +    +  C +  P++R  
Sbjct: 209 VTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE-------ELYQLMRLCWKERPEDRPT 261
Query: 243 ASQLLKHPFLEEFCSCTK 260
              L     LE+F + T+
Sbjct: 262 FDYL--RSVLEDFFTATE 277

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 79/164 (48%), Gaps = 17/164 (10%)
Query: 38  KSEFLQREQKFLSSLNSPHIVGYKG-CDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGR 96
           K E L  E   +  L++P+IV   G C+  S      + L ME A  G LN  + +N   
Sbjct: 414 KDELLA-EANVMQQLDNPYIVRMIGICEAES------WMLVMEMAELGPLNKYLQQNRHV 466
Query: 97  LDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMA-ESGAKIADFGCAKW------E 149
            D++ I+    Q+  G++YL  +  VH D+ +RN+L+  +  AKI+DFG +K        
Sbjct: 467 KDKN-IIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 525
Query: 150 SEALQSGGTPM-FMAPEVARGEHQGFASDIWAVGCTVIEMASGG 192
            +A   G  P+ + APE          SD+W+ G  + E  S G
Sbjct: 526 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYG 569

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 88/197 (44%), Gaps = 22/197 (11%)
Query: 76  LFMEYAPGGTLNDEIHRNGG-RLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMA 134
           +  EY   G+L D +    G +L  + ++    QI +G+ ++     +H D+++ NIL++
Sbjct: 86  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS 145
Query: 135 ES-GAKIADFGCAKW----ESEALQSGGTPM-FMAPEVARGEHQGFASDIWAVGCTVIEM 188
           ++   KIADFG A+     E  A +    P+ + APE          SD+W+ G  + E+
Sbjct: 146 DTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEI 205
Query: 189 ASGG-APWPNAADPMTVL-----YKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWA 242
            + G  P+P   +P  +      Y++      PE       +    +  C +  P++R  
Sbjct: 206 VTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE-------ELYQLMRLCWKERPEDRPT 258
Query: 243 ASQLLKHPFLEEFCSCT 259
              L     LE+F + T
Sbjct: 259 FDYL--RSVLEDFFTAT 273

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 48/198 (24%), Positives = 89/198 (44%), Gaps = 22/198 (11%)
Query: 76  LFMEYAPGGTLNDEIHRNGG-RLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMA 134
           +  EY   G+L D +    G +L  + ++    QI +G+ ++     +H D+++ NIL++
Sbjct: 84  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS 143
Query: 135 ES-GAKIADFGCAKW----ESEALQSGGTPM-FMAPEVARGEHQGFASDIWAVGCTVIEM 188
           ++   KIADFG A+     E  A +    P+ + APE          SD+W+ G  + E+
Sbjct: 144 DTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEI 203
Query: 189 ASGG-APWPNAADPMTVL-----YKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWA 242
            + G  P+P   +P  +      Y++      PE       +    +  C +  P++R  
Sbjct: 204 VTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE-------ELYQLMRLCWKERPEDRPT 256
Query: 243 ASQLLKHPFLEEFCSCTK 260
              L     LE+F + T+
Sbjct: 257 FDYL--RSVLEDFFTATE 272

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 97/240 (40%), Gaps = 48/240 (20%)
Query: 97  LDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKWESEALQS 155
           LD   +     Q+L G+++LHS  ++H D+K  NI++ ++   KI DFG A+    +   
Sbjct: 128 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 187
Query: 156 GG---TPMFMAPEVARGEHQGFASDIWAVGCTVIEMASG--------------------G 192
                T  + APEV  G       D+W+VGC + EM                       G
Sbjct: 188 TPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLG 247
Query: 193 APWP---NAADPMTVLYK--------IAYSRELPEV--PA------FLSKQANDFLSNCL 233
            P P       P    Y          ++ +  P+V  PA        + QA D LS  L
Sbjct: 248 TPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKML 307
Query: 234 RRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSILDQGIWNSVEETEESLGNLIH 293
             D  +R +  + L+HP++  +   +    E+   P  I D+ + +  E T E    LI+
Sbjct: 308 VIDASKRISVDEALQHPYINVWYDPS----EAEAPPPKIPDKQL-DEREHTIEEWKELIY 362

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 62/255 (24%), Positives = 110/255 (43%), Gaps = 28/255 (10%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTE---LPKSEFLQREQKFLSSLNSPHIV 58
           D T  H +G G    V      +     A K+ +   +   EFL +E   +  +  P++V
Sbjct: 260 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL-KEAAVMKEIKHPNLV 318
Query: 59  GYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHR-NGGRLDESLIVSYTRQILQGLEYLH 117
              G   T E    +   FM Y   G L D +   N   ++  +++    QI   +EYL 
Sbjct: 319 QLLGV-CTREPPFYIITEFMTY---GNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 374
Query: 118 SNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSGGT---------PM-FMAPEV 166
               +H ++ +RN L+ E+   K+ADFG ++     L +G T         P+ + APE 
Sbjct: 375 KKNFIHRNLAARNCLVGENHLVKVADFGLSR-----LMTGDTYTAHAGAKFPIKWTAPES 429
Query: 167 ARGEHQGFASDIWAVGCTVIEMASGG-APWPNAADPMTVLYKIAYSRELPEVPAFLSKQA 225
                    SD+WA G  + E+A+ G +P+P     ++ +Y++       E P    ++ 
Sbjct: 430 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--LSQVYELLEKDYRMERPEGCPEKV 487
Query: 226 NDFLSNCLRRDPKER 240
            + +  C + +P +R
Sbjct: 488 YELMRACWQWNPSDR 502

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 97/241 (40%), Gaps = 48/241 (19%)
Query: 97  LDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKWESEALQS 155
           LD   +     Q+L G+++LHS  ++H D+K  NI++ ++   KI DFG A+    +   
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 182
Query: 156 GG---TPMFMAPEVARGEHQGFASDIWAVGCTVIEMASG--------------------G 192
                T  + APEV  G       DIW+VGC + EM                       G
Sbjct: 183 EPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLG 242
Query: 193 APWP-----------NAADPMTVLYKIAYSRELPEV--PA------FLSKQANDFLSNCL 233
            P P           N  +        ++ +  P+V  PA        + QA D LS  L
Sbjct: 243 TPCPAFMKKLQPTVRNYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKML 302
Query: 234 RRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSILDQGIWNSVEETEESLGNLIH 293
             D  +R +  + L+HP++  +   +    E+   P  I D+ + +  E T E    LI+
Sbjct: 303 VIDASKRISVDEALQHPYINVWYDPS----EAEAPPPKIPDKQL-DEREHTIEEWKELIY 357
Query: 294 S 294
Sbjct: 358 K 358

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 48/198 (24%), Positives = 89/198 (44%), Gaps = 22/198 (11%)
Query: 76  LFMEYAPGGTLNDEIHRNGG-RLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMA 134
           +  EY   G+L D +    G +L  + ++    QI +G+ ++     +H D+++ NIL++
Sbjct: 92  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS 151
Query: 135 ES-GAKIADFGCAKW----ESEALQSGGTPM-FMAPEVARGEHQGFASDIWAVGCTVIEM 188
           ++   KIADFG A+     E  A +    P+ + APE          SD+W+ G  + E+
Sbjct: 152 DTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEI 211
Query: 189 ASGG-APWPNAADPMTVL-----YKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWA 242
            + G  P+P   +P  +      Y++      PE       +    +  C +  P++R  
Sbjct: 212 VTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE-------ELYQLMRLCWKERPEDRPT 264
Query: 243 ASQLLKHPFLEEFCSCTK 260
              L     LE+F + T+
Sbjct: 265 FDYL--RSVLEDFFTATE 280

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 48/198 (24%), Positives = 89/198 (44%), Gaps = 22/198 (11%)
Query: 76  LFMEYAPGGTLNDEIHRNGG-RLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMA 134
           +  EY   G+L D +    G +L  + ++    QI +G+ ++     +H D+++ NIL++
Sbjct: 93  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS 152
Query: 135 ES-GAKIADFGCAKW----ESEALQSGGTPM-FMAPEVARGEHQGFASDIWAVGCTVIEM 188
           ++   KIADFG A+     E  A +    P+ + APE          SD+W+ G  + E+
Sbjct: 153 DTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEI 212
Query: 189 ASGG-APWPNAADPMTVL-----YKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWA 242
            + G  P+P   +P  +      Y++      PE       +    +  C +  P++R  
Sbjct: 213 VTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE-------ELYQLMRLCWKERPEDRPT 265
Query: 243 ASQLLKHPFLEEFCSCTK 260
              L     LE+F + T+
Sbjct: 266 FDYL--RSVLEDFFTATE 281

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 48/198 (24%), Positives = 89/198 (44%), Gaps = 22/198 (11%)
Query: 76  LFMEYAPGGTLNDEIHRNGG-RLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMA 134
           +  EY   G+L D +    G +L  + ++    QI +G+ ++     +H D+++ NIL++
Sbjct: 90  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS 149
Query: 135 ES-GAKIADFGCAKW----ESEALQSGGTPM-FMAPEVARGEHQGFASDIWAVGCTVIEM 188
           ++   KIADFG A+     E  A +    P+ + APE          SD+W+ G  + E+
Sbjct: 150 DTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEI 209
Query: 189 ASGG-APWPNAADPMTVL-----YKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWA 242
            + G  P+P   +P  +      Y++      PE       +    +  C +  P++R  
Sbjct: 210 VTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE-------ELYQLMRLCWKERPEDRPT 262
Query: 243 ASQLLKHPFLEEFCSCTK 260
              L     LE+F + T+
Sbjct: 263 FDYL--RSVLEDFFTATE 278

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 88/197 (44%), Gaps = 22/197 (11%)
Query: 76  LFMEYAPGGTLNDEIHRNGG-RLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMA 134
           +  EY   G+L D +    G +L  + ++    QI +G+ ++     +H D+++ NIL++
Sbjct: 90  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS 149
Query: 135 ES-GAKIADFGCAKW----ESEALQSGGTPM-FMAPEVARGEHQGFASDIWAVGCTVIEM 188
           ++   KIADFG A+     E  A +    P+ + APE          SD+W+ G  + E+
Sbjct: 150 DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEI 209
Query: 189 ASGG-APWPNAADPMTVL-----YKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWA 242
            + G  P+P   +P  +      Y++      PE       +    +  C +  P++R  
Sbjct: 210 VTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE-------ELYQLMRLCWKERPEDRPT 262
Query: 243 ASQLLKHPFLEEFCSCT 259
              L     LE+F + T
Sbjct: 263 FDYL--RSVLEDFFTAT 277

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 62/255 (24%), Positives = 109/255 (42%), Gaps = 28/255 (10%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTE---LPKSEFLQREQKFLSSLNSPHIV 58
           D T  H +G G    V      +     A K+ +   +   EFL +E   +  +  P++V
Sbjct: 221 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL-KEAAVMKEIKHPNLV 279
Query: 59  GYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHR-NGGRLDESLIVSYTRQILQGLEYLH 117
              G   T E    +   FM Y   G L D +   N   +   +++    QI   +EYL 
Sbjct: 280 QLLGV-CTREPPFYIITEFMTY---GNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 335
Query: 118 SNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSGGT---------PM-FMAPEV 166
               +H ++ +RN L+ E+   K+ADFG ++     L +G T         P+ + APE 
Sbjct: 336 KKNFIHRNLAARNCLVGENHLVKVADFGLSR-----LMTGDTYTAHAGAKFPIKWTAPES 390
Query: 167 ARGEHQGFASDIWAVGCTVIEMASGG-APWPNAADPMTVLYKIAYSRELPEVPAFLSKQA 225
                    SD+WA G  + E+A+ G +P+P     ++ +Y++       E P    ++ 
Sbjct: 391 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--LSQVYELLEKDYRMERPEGCPEKV 448
Query: 226 NDFLSNCLRRDPKER 240
            + +  C + +P +R
Sbjct: 449 YELMRACWQWNPSDR 463

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 79/164 (48%), Gaps = 17/164 (10%)
Query: 38  KSEFLQREQKFLSSLNSPHIVGYKG-CDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGR 96
           K E L  E   +  L++P+IV   G C+  S      + L ME A  G LN  + +N   
Sbjct: 415 KDELLA-EANVMQQLDNPYIVRMIGICEAES------WMLVMEMAELGPLNKYLQQNRHV 467
Query: 97  LDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMA-ESGAKIADFGCAKW------E 149
            D++ I+    Q+  G++YL  +  VH D+ +RN+L+  +  AKI+DFG +K        
Sbjct: 468 KDKN-IIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 526
Query: 150 SEALQSGGTPM-FMAPEVARGEHQGFASDIWAVGCTVIEMASGG 192
            +A   G  P+ + APE          SD+W+ G  + E  S G
Sbjct: 527 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYG 570

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 65/255 (25%), Positives = 109/255 (42%), Gaps = 26/255 (10%)
Query: 5   RGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGYKGCD 64
           RG     G   +     +L+ G       TE  + EFL  E   +     P+I+  +G  
Sbjct: 34  RGRLKAPGKKESCVAIKTLKGG------YTERQRREFLS-EASIMGQFEHPNIIRLEGV- 85
Query: 65  VTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHC 124
           VT+    ++   FME    G L+  +  N G+     +V   R I  G+ YL     VH 
Sbjct: 86  VTNSMPVMILTEFME---NGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEMSYVHR 142
Query: 125 DIKSRNILMAESGA-KIADFGCAKW---------ESEALQSGGTPM-FMAPEVARGEHQG 173
           D+ +RNIL+  +   K++DFG +++         E+ +L  G  P+ + APE        
Sbjct: 143 DLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSL-GGKIPIRWTAPEAIAFRKFT 201
Query: 174 FASDIWAVGCTVIE-MASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNC 232
            ASD W+ G  + E M+ G  P+ + ++   V+  I     LP  P       +  + +C
Sbjct: 202 SASDAWSYGIVMWEVMSFGERPYWDMSN-QDVINAIEQDYRLPPPPD-CPTSLHQLMLDC 259
Query: 233 LRRDPKERWAASQLL 247
            ++D   R    Q++
Sbjct: 260 WQKDRNARPRFPQVV 274

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 88/197 (44%), Gaps = 22/197 (11%)
Query: 76  LFMEYAPGGTLNDEIHRNGG-RLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMA 134
           +  EY   G+L D +    G +L  + ++    QI +G+ ++     +H D+++ NIL++
Sbjct: 84  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS 143
Query: 135 ES-GAKIADFGCAKW----ESEALQSGGTPM-FMAPEVARGEHQGFASDIWAVGCTVIEM 188
           ++   KIADFG A+     E  A +    P+ + APE          SD+W+ G  + E+
Sbjct: 144 DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEI 203
Query: 189 ASGG-APWPNAADPMTVL-----YKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWA 242
            + G  P+P   +P  +      Y++      PE       +    +  C +  P++R  
Sbjct: 204 VTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE-------ELYQLMRLCWKERPEDRPT 256
Query: 243 ASQLLKHPFLEEFCSCT 259
              L     LE+F + T
Sbjct: 257 FDYL--RSVLEDFFTAT 271

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 48/198 (24%), Positives = 89/198 (44%), Gaps = 22/198 (11%)
Query: 76  LFMEYAPGGTLNDEIHRNGG-RLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMA 134
           +  EY   G+L D +    G +L  + ++    QI +G+ ++     +H D+++ NIL++
Sbjct: 84  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS 143
Query: 135 ES-GAKIADFGCAKW----ESEALQSGGTPM-FMAPEVARGEHQGFASDIWAVGCTVIEM 188
           ++   KIADFG A+     E  A +    P+ + APE          SD+W+ G  + E+
Sbjct: 144 DTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEI 203
Query: 189 ASGG-APWPNAADPMTVL-----YKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWA 242
            + G  P+P   +P  +      Y++      PE       +    +  C +  P++R  
Sbjct: 204 VTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE-------ELYQLMRLCWKERPEDRPT 256
Query: 243 ASQLLKHPFLEEFCSCTK 260
              L     LE+F + T+
Sbjct: 257 FDYL--RSVLEDFFTATE 272

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 97/241 (40%), Gaps = 48/241 (19%)
Query: 97  LDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKWESEALQS 155
           LD   +     Q+L G+++LHS  ++H D+K  NI++ ++   KI DFG A+    +   
Sbjct: 117 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 176
Query: 156 GG---TPMFMAPEVARGEHQGFASDIWAVGCTVIEMASG--------------------G 192
                T  + APEV  G       D+W+VGC + EM                       G
Sbjct: 177 TPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLG 236
Query: 193 APWP---NAADPMTVLYK--------IAYSRELPEV--PA------FLSKQANDFLSNCL 233
            P P       P    Y          ++ +  P+V  PA        + QA D LS  L
Sbjct: 237 TPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKML 296
Query: 234 RRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSILDQGIWNSVEETEESLGNLIH 293
             D  +R +  + L+HP++  +   +    E+   P  I D+ + +  E T E    LI+
Sbjct: 297 VIDASKRISVDEALQHPYINVWYDPS----EAEAPPPKIPDKQL-DEREHTIEEWKELIY 351
Query: 294 S 294
Sbjct: 352 K 352

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 84/210 (40%), Gaps = 23/210 (10%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAKST---ELPKSEFLQREQKFLSSLNSPHIVGYKGCDV 65
           +G+G  + V L   L  G  +A K     E    E  QRE       N P+I+      +
Sbjct: 37  LGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCL 96
Query: 66  TSEDNKLMYNLFMEYAPGGTLNDEIHR---NGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
                K    L + +   GTL +EI R    G  L E  I+     I +GLE +H+    
Sbjct: 97  RERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYA 156
Query: 123 HCDIKSRNILMAESGAKI-ADFG-----CAKWESE----ALQSGG----TPMFMAPEVAR 168
           H D+K  NIL+ + G  +  D G     C   E       LQ       T  + APE+  
Sbjct: 157 HRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFS 216
Query: 169 GEHQGFA---SDIWAVGCTVIEMASGGAPW 195
            +        +D+W++GC +  M  G  P+
Sbjct: 217 VQSHCVIDERTDVWSLGCVLYAMMFGEGPY 246

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 48/198 (24%), Positives = 89/198 (44%), Gaps = 22/198 (11%)
Query: 76  LFMEYAPGGTLNDEIHRNGG-RLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMA 134
           +  EY   G+L D +    G +L  + ++    QI +G+ ++     +H D+++ NIL++
Sbjct: 94  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS 153
Query: 135 ES-GAKIADFGCAKW----ESEALQSGGTPM-FMAPEVARGEHQGFASDIWAVGCTVIEM 188
           ++   KIADFG A+     E  A +    P+ + APE          SD+W+ G  + E+
Sbjct: 154 DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEI 213
Query: 189 ASGG-APWPNAADPMTVL-----YKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWA 242
            + G  P+P   +P  +      Y++      PE       +    +  C +  P++R  
Sbjct: 214 VTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE-------ELYQLMRLCWKERPEDRPT 266
Query: 243 ASQLLKHPFLEEFCSCTK 260
              L     LE+F + T+
Sbjct: 267 FDYL--RSVLEDFFTATE 282

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 97/241 (40%), Gaps = 48/241 (19%)
Query: 97  LDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKWESEALQS 155
           LD   +     Q+L G+++LHS  ++H D+K  NI++ ++   KI DFG A+    +   
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 182
Query: 156 GG---TPMFMAPEVARGEHQGFASDIWAVGCTVIEMASG--------------------G 192
                T  + APEV  G       D+W+VGC + EM                       G
Sbjct: 183 EPEVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLG 242
Query: 193 APWP---NAADPMTVLYK--------IAYSRELPEV--PA------FLSKQANDFLSNCL 233
            P P       P    Y          ++ +  P+V  PA        + QA D LS  L
Sbjct: 243 TPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKML 302
Query: 234 RRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSILDQGIWNSVEETEESLGNLIH 293
             D  +R +  + L+HP++  +   +    E+   P  I D+ + +  E T E    LI+
Sbjct: 303 VIDASKRISVDEALQHPYINVWYDPS----EAEAPPPKIPDKQL-DEREHTIEEWKELIY 357
Query: 294 S 294
Sbjct: 358 K 358

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/168 (23%), Positives = 82/168 (48%), Gaps = 10/168 (5%)
Query: 76  LFMEYAPGGTLNDEIHRN-GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMA 134
           +  E+   G+L D +  + G +     ++ ++ QI +G+ ++     +H D+++ NIL++
Sbjct: 253 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVS 312
Query: 135 ESGA-KIADFGCAKWESEALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GG 192
            S   KIADFG A+     + +     + APE          SD+W+ G  ++E+ + G 
Sbjct: 313 ASLVCKIADFGLAR-----VGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGR 367
Query: 193 APWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKER 240
            P+P  ++P  V+  +     +P  P    ++  + +  C +  P+ER
Sbjct: 368 IPYPGMSNP-EVIRALERGYRMPR-PENCPEELYNIMMRCWKNRPEER 413

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 39/132 (29%), Positives = 66/132 (50%), Gaps = 9/132 (6%)
Query: 100 SLIVSYTRQILQGLEYLHSNR--VVHCDIKSRNILM---AESGAKIADFGCA-KWESEAL 153
           +L   + +Q+   L +L +    ++HCD+K  NIL+     S  KI DFG + +      
Sbjct: 138 NLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIY 197
Query: 154 QSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRE 213
           Q   +  + +PEV  G     A D+W++GC ++EM + G P  + A+ +  + KI     
Sbjct: 198 QXIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHT-GEPLFSGANEVDQMNKIVEVLG 256
Query: 214 LPEVPAFLSKQA 225
           +P  PA +  QA
Sbjct: 257 IP--PAHILDQA 266

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/194 (24%), Positives = 81/194 (41%), Gaps = 41/194 (21%)
Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGAK--IADFGCAKWESEALQSG--- 156
           I  Y  ++L+ L+Y HS  ++H D+K  N+++     K  + D+G A++     +     
Sbjct: 129 IRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRV 188
Query: 157 GTPMFMAPEVARG-EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA------ 209
            +  F  PE+    +   ++ D+W++GC    M     P+    D    L KIA      
Sbjct: 189 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD 248
Query: 210 --------YSREL-PEVPA--------------------FLSKQANDFLSNCLRRDPKER 240
                   Y  EL P++ A                     +S +A DFL   LR D +ER
Sbjct: 249 GLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQER 308
Query: 241 WAASQLLKHPFLEE 254
             A + + HP+ ++
Sbjct: 309 LTALEAMTHPYFQQ 322

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/194 (24%), Positives = 81/194 (41%), Gaps = 41/194 (21%)
Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGAK--IADFGCAKWESEALQSG--- 156
           I  Y  ++L+ L+Y HS  ++H D+K  N+++     K  + D+G A++     +     
Sbjct: 127 IRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRV 186
Query: 157 GTPMFMAPEVARG-EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA------ 209
            +  F  PE+    +   ++ D+W++GC    M     P+    D    L KIA      
Sbjct: 187 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD 246
Query: 210 --------YSREL-PEVPA--------------------FLSKQANDFLSNCLRRDPKER 240
                   Y  EL P++ A                     +S +A DFL   LR D +ER
Sbjct: 247 GLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQER 306
Query: 241 WAASQLLKHPFLEE 254
             A + + HP+ ++
Sbjct: 307 LTALEAMTHPYFQQ 320

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/194 (24%), Positives = 81/194 (41%), Gaps = 41/194 (21%)
Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGAK--IADFGCAKWESEALQSG--- 156
           I  Y  ++L+ L+Y HS  ++H D+K  N+++     K  + D+G A++     +     
Sbjct: 127 IRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRV 186
Query: 157 GTPMFMAPEVARG-EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA------ 209
            +  F  PE+    +   ++ D+W++GC    M     P+    D    L KIA      
Sbjct: 187 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD 246
Query: 210 --------YSREL-PEVPA--------------------FLSKQANDFLSNCLRRDPKER 240
                   Y  EL P++ A                     +S +A DFL   LR D +ER
Sbjct: 247 GLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQER 306
Query: 241 WAASQLLKHPFLEE 254
             A + + HP+ ++
Sbjct: 307 LTALEAMTHPYFQQ 320

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/194 (24%), Positives = 81/194 (41%), Gaps = 41/194 (21%)
Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGAK--IADFGCAKWESEALQSG--- 156
           I  Y  ++L+ L+Y HS  ++H D+K  N+++     K  + D+G A++     +     
Sbjct: 128 IRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRV 187
Query: 157 GTPMFMAPEVARG-EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA------ 209
            +  F  PE+    +   ++ D+W++GC    M     P+    D    L KIA      
Sbjct: 188 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD 247
Query: 210 --------YSREL-PEVPA--------------------FLSKQANDFLSNCLRRDPKER 240
                   Y  EL P++ A                     +S +A DFL   LR D +ER
Sbjct: 248 GLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQER 307
Query: 241 WAASQLLKHPFLEE 254
             A + + HP+ ++
Sbjct: 308 LTALEAMTHPYFQQ 321

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/194 (24%), Positives = 81/194 (41%), Gaps = 41/194 (21%)
Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGAK--IADFGCAKWESEALQSG--- 156
           I  Y  ++L+ L+Y HS  ++H D+K  N+++     K  + D+G A++     +     
Sbjct: 127 IRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRV 186
Query: 157 GTPMFMAPEVARG-EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA------ 209
            +  F  PE+    +   ++ D+W++GC    M     P+    D    L KIA      
Sbjct: 187 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD 246
Query: 210 --------YSREL-PEVPA--------------------FLSKQANDFLSNCLRRDPKER 240
                   Y  EL P++ A                     +S +A DFL   LR D +ER
Sbjct: 247 GLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQER 306
Query: 241 WAASQLLKHPFLEE 254
             A + + HP+ ++
Sbjct: 307 LTALEAMTHPYFQQ 320

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 39/132 (29%), Positives = 66/132 (50%), Gaps = 9/132 (6%)
Query: 100 SLIVSYTRQILQGLEYLHSNR--VVHCDIKSRNILM---AESGAKIADFGCA-KWESEAL 153
           +L   + +Q+   L +L +    ++HCD+K  NIL+     S  KI DFG + +      
Sbjct: 157 NLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIY 216
Query: 154 QSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRE 213
           Q   +  + +PEV  G     A D+W++GC ++EM + G P  + A+ +  + KI     
Sbjct: 217 QXIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHT-GEPLFSGANEVDQMNKIVEVLG 275
Query: 214 LPEVPAFLSKQA 225
           +P  PA +  QA
Sbjct: 276 IP--PAHILDQA 285

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/194 (24%), Positives = 81/194 (41%), Gaps = 41/194 (21%)
Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGAK--IADFGCAKWESEALQSG--- 156
           I  Y  ++L+ L+Y HS  ++H D+K  N+++     K  + D+G A++     +     
Sbjct: 127 IRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRV 186
Query: 157 GTPMFMAPEVARG-EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA------ 209
            +  F  PE+    +   ++ D+W++GC    M     P+    D    L KIA      
Sbjct: 187 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD 246
Query: 210 --------YSREL-PEVPA--------------------FLSKQANDFLSNCLRRDPKER 240
                   Y  EL P++ A                     +S +A DFL   LR D +ER
Sbjct: 247 GLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQER 306
Query: 241 WAASQLLKHPFLEE 254
             A + + HP+ ++
Sbjct: 307 LTALEAMTHPYFQQ 320

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/194 (24%), Positives = 81/194 (41%), Gaps = 41/194 (21%)
Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGAK--IADFGCAKWESEALQSG--- 156
           I  Y  ++L+ L+Y HS  ++H D+K  N+++     K  + D+G A++     +     
Sbjct: 127 IRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRV 186
Query: 157 GTPMFMAPEVARG-EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA------ 209
            +  F  PE+    +   ++ D+W++GC    M     P+    D    L KIA      
Sbjct: 187 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD 246
Query: 210 --------YSREL-PEVPA--------------------FLSKQANDFLSNCLRRDPKER 240
                   Y  EL P++ A                     +S +A DFL   LR D +ER
Sbjct: 247 GLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQER 306
Query: 241 WAASQLLKHPFLEE 254
             A + + HP+ ++
Sbjct: 307 LTALEAMTHPYFQQ 320

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/194 (24%), Positives = 81/194 (41%), Gaps = 41/194 (21%)
Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGAK--IADFGCAKWESEALQSG--- 156
           I  Y  ++L+ L+Y HS  ++H D+K  N+++     K  + D+G A++     +     
Sbjct: 127 IRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRV 186
Query: 157 GTPMFMAPEVARG-EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA------ 209
            +  F  PE+    +   ++ D+W++GC    M     P+    D    L KIA      
Sbjct: 187 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD 246
Query: 210 --------YSREL-PEVPA--------------------FLSKQANDFLSNCLRRDPKER 240
                   Y  EL P++ A                     +S +A DFL   LR D +ER
Sbjct: 247 GLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQER 306
Query: 241 WAASQLLKHPFLEE 254
             A + + HP+ ++
Sbjct: 307 LTALEAMTHPYFQQ 320

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/194 (24%), Positives = 81/194 (41%), Gaps = 41/194 (21%)
Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGAK--IADFGCAKWESEALQSG--- 156
           I  Y  ++L+ L+Y HS  ++H D+K  N+++     K  + D+G A++     +     
Sbjct: 128 IRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRV 187
Query: 157 GTPMFMAPEVARG-EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA------ 209
            +  F  PE+    +   ++ D+W++GC    M     P+    D    L KIA      
Sbjct: 188 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD 247
Query: 210 --------YSREL-PEVPA--------------------FLSKQANDFLSNCLRRDPKER 240
                   Y  EL P++ A                     +S +A DFL   LR D +ER
Sbjct: 248 GLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQER 307
Query: 241 WAASQLLKHPFLEE 254
             A + + HP+ ++
Sbjct: 308 LTALEAMTHPYFQQ 321

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 83/193 (43%), Gaps = 19/193 (9%)
Query: 81  APGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AK 139
           APG         +G  L+   ++ ++ Q+ QG+ +L S   +H D+ +RN+L+     AK
Sbjct: 139 APGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAK 198
Query: 140 IADFGCAK---WESEALQSGGTPM---FMAPEVARGEHQGFASDIWAVGCTVIEMASGGA 193
           I DFG A+    +S  +  G   +   +MAPE          SD+W+ G  + E+ S G 
Sbjct: 199 IGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGL 258
Query: 194 -PWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFL 252
            P+P      +  YK+         PAF  K     +  C   +P  R         P  
Sbjct: 259 NPYPGIL-VNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHR---------PTF 308
Query: 253 EEFCS-CTKQIQE 264
           ++ CS   +Q QE
Sbjct: 309 QQICSFLQEQAQE 321

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/217 (21%), Positives = 88/217 (40%), Gaps = 45/217 (20%)
Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGAK--IADFGCAKWESEALQSG--- 156
           I  Y  ++L+ L+Y HS  ++H D+K  N+++     K  + D+G A++   A +     
Sbjct: 134 IRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVRV 193
Query: 157 GTPMFMAPE-VARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELP 215
            +  F  PE +   +   ++ D+W++GC +  M     P+ +  D    L +IA      
Sbjct: 194 ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTE 253
Query: 216 EVPAFLSK-----------------------------------QANDFLSNCLRRDPKER 240
           E+  +L K                                   +A D L   LR D ++R
Sbjct: 254 ELYGYLKKYHIDLDPHFNDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQR 313
Query: 241 WAASQLLKHPFLEEFCSCTKQIQESNCSPTSILDQGI 277
             A + ++HP+   F    K+ Q    +  ++L  G+
Sbjct: 314 LTAKEAMEHPY---FYPVVKE-QSQPSADNAVLSSGL 346

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/194 (24%), Positives = 81/194 (41%), Gaps = 41/194 (21%)
Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGAK--IADFGCAKWESEALQSG--- 156
           I  Y  ++L+ L+Y HS  ++H D+K  N+++     K  + D+G A++     +     
Sbjct: 148 IRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRV 207
Query: 157 GTPMFMAPEVARG-EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA------ 209
            +  F  PE+    +   ++ D+W++GC    M     P+    D    L KIA      
Sbjct: 208 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD 267
Query: 210 --------YSREL-PEVPA--------------------FLSKQANDFLSNCLRRDPKER 240
                   Y  EL P++ A                     +S +A DFL   LR D +ER
Sbjct: 268 GLNAYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQER 327
Query: 241 WAASQLLKHPFLEE 254
             A + + HP+ ++
Sbjct: 328 LTALEAMTHPYFQQ 341

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/192 (23%), Positives = 79/192 (41%), Gaps = 41/192 (21%)
Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGAK--IADFGCAKWESEALQSG--- 156
           I  Y  +IL+ L+Y HS  ++H D+K  N+L+     K  + D+G A++     +     
Sbjct: 133 IRFYMYEILKALDYCHSMGIMHRDVKPHNVLIDHEHRKLRLIDWGLAEFYHPGQEYNVRV 192
Query: 157 GTPMFMAPE-VARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA------ 209
            +  F  PE +   +   ++ D+W++GC +  M     P+ +  D    L +IA      
Sbjct: 193 ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE 252
Query: 210 --------YSRELP---------------------EVPAFLSKQANDFLSNCLRRDPKER 240
                   Y+ EL                      E    +S +A DFL   LR D + R
Sbjct: 253 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSR 312
Query: 241 WAASQLLKHPFL 252
             A + ++HP+ 
Sbjct: 313 LTAREAMEHPYF 324

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 106/223 (47%), Gaps = 16/223 (7%)
Query: 34  TELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRN 93
           TE  + +FL  E   +   + P++V  +G  V +    +M  + +E+   G L+  + ++
Sbjct: 84  TEKQRRDFLC-EASIMGQFDHPNVVHLEG--VVTRGKPVM--IVIEFMENGALDAFLRKH 138
Query: 94  GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKW---E 149
            G+     +V   R I  G+ YL     VH D+ +RNIL+  +   K++DFG ++    +
Sbjct: 139 DGQFTVIQLVGMLRGIAAGMRYLADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDD 198
Query: 150 SEALQS---GGTPM-FMAPEVARGEHQGFASDIWAVGCTVIE-MASGGAPWPNAADPMTV 204
            EA+ +   G  P+ + APE  +      ASD+W+ G  + E M+ G  P+ + ++   V
Sbjct: 199 PEAVYTTTGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-QDV 257
Query: 205 LYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLL 247
           +  I     LP  P       +  + +C +++  ER    Q++
Sbjct: 258 IKAIEEGYRLP-APMDCPAGLHQLMLDCWQKERAERPKFEQIV 299

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 88/376 (23%), Positives = 150/376 (39%), Gaps = 93/376 (24%)
Query: 9   IGQGSSATVSLATSLRSGDVFAAK--------STELPKSEFLQREQKFLSSLNSPHIVGY 60
           +G+G+   V  +   R+G+V A K        ST+  ++    RE   L+ L S H    
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRT---FREIMILTEL-SGHENIV 72
Query: 61  KGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNR 120
              +V   DN     L  +Y     L+  I  N         V Y  Q+++ ++YLHS  
Sbjct: 73  NLLNVLRADNDRDVYLVFDYMETD-LHAVIRANILEPVHKQYVVY--QLIKVIKYLHSGG 129
Query: 121 VVHCDIKSRNILM-AESGAKIADFGCAK-WESEALQSGGTPM------------------ 160
           ++H D+K  NIL+ AE   K+ADFG ++ + +    +   P+                  
Sbjct: 130 LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTD 189
Query: 161 ------FMAPEVARGEHQGFAS-DIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRE 213
                 + APE+  G  +     D+W++GC + E+  G   +P ++  M  L +I    +
Sbjct: 190 YVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS-TMNQLERIIGVID 248
Query: 214 LP---EVPAFLS----------------KQAN--------------------------DF 228
            P   +V +  S                +Q+N                          D 
Sbjct: 249 FPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDL 308
Query: 229 LSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSILDQGIWNSVEETEESL 288
           L   L+ +P +R +A+  LKHPF+  F +     +E NC    I+   I ++V+ + +  
Sbjct: 309 LDKLLQFNPNKRISANDALKHPFVSIFHNPN---EEPNCD--HIITIPINDNVKHSIDDY 363
Query: 289 GNLIHSTSKTSARERI 304
            NL++S      RE I
Sbjct: 364 RNLVYSEISRRKRELI 379

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/137 (27%), Positives = 68/137 (49%), Gaps = 8/137 (5%)
Query: 76  LFMEYAPGGTLNDEIHRNGG-RLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMA 134
           +  EY   G+L D +    G +L  + ++    QI +G+ ++     +H D+++ NIL++
Sbjct: 79  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS 138
Query: 135 ES-GAKIADFGCAKW----ESEALQSGGTPM-FMAPEVARGEHQGFASDIWAVGCTVIEM 188
           ++   KIADFG A+     E  A +    P+ + APE          SD+W+ G  + E+
Sbjct: 139 DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEI 198
Query: 189 ASGG-APWPNAADPMTV 204
            + G  P+P   +P  +
Sbjct: 199 VTHGRIPYPGMTNPEVI 215

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 106/226 (46%), Gaps = 22/226 (9%)
Query: 34  TELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRN 93
           TE  + +FL  E   +   + P+I+  +G  V ++   +M  +  EY   G+L+  + ++
Sbjct: 86  TEKQRRDFLG-EASIMGQFDHPNIIRLEG--VVTKSKPVM--IVTEYMENGSLDSFLRKH 140
Query: 94  GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKW---E 149
             +     +V   R I  G++YL     VH D+ +RNIL+  +   K++DFG A+    +
Sbjct: 141 DAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDD 200
Query: 150 SEA---LQSGGTPM-FMAPEVARGEHQGFASDIWAVGCTVIE-MASGGAPWPNAADPMTV 204
            EA    + G  P+ + +PE         ASD+W+ G  + E M+ G  P+   ++   V
Sbjct: 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDV 259
Query: 205 LYKIAYSRELP---EVPAFLSKQANDFLSNCLRRDPKERWAASQLL 247
           +  +     LP   + PA L +     + +C ++D   R    Q++
Sbjct: 260 IKAVDEGYRLPPPMDCPAALYQ----LMLDCWQKDRNNRPKFEQIV 301

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 80/171 (46%), Gaps = 19/171 (11%)
Query: 104 SYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCA---KWESEALQSGGTP 159
           S++ Q+ +G+ +L S   +H D+ +RNIL+      KI DFG A   K +S  +  G   
Sbjct: 149 SFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNAR 208
Query: 160 M---FMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPM-TVLYKIAYSREL 214
           +   +MAPE        F SD+W+ G  + E+ S G +P+P    P+ +  YK+      
Sbjct: 209 LPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM--PVDSKFYKMIKEGFR 266
Query: 215 PEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQIQES 265
              P     +  D +  C   DP +R    Q+++   +E      KQI ES
Sbjct: 267 MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ--LIE------KQISES 309

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/236 (23%), Positives = 88/236 (37%), Gaps = 67/236 (28%)
Query: 83  GGTLNDEIHRNGG---RLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES--- 136
           G +  D I  NG    RLD    ++Y  QI + + +LHSN++ H D+K  NIL  +S   
Sbjct: 100 GLSTYDFIKENGFLPFRLDHIRKMAY--QICKSVNFLHSNKLTHTDLKPENILFVQSDYT 157
Query: 137 -----------------GAKIADFGCAKWESEALQS-GGTPMFMAPEVARGEHQGFASDI 178
                              K+ DFG A ++ E   +      + APEV          D+
Sbjct: 158 EAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVXXRHYRAPEVILALGWSQPCDV 217
Query: 179 WAVGCTVIEMASGGAPWP--NAADPMTVLYKI---------------------------- 208
           W++GC +IE   G   +P  ++ + + ++ +I                            
Sbjct: 218 WSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEH 277
Query: 209 -----AYSRELPEVPAFLSKQ------ANDFLSNCLRRDPKERWAASQLLKHPFLE 253
                  SR    +  F+  Q        D +   L  DP +R    + LKHPF +
Sbjct: 278 SSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFD 333

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 73/154 (47%), Gaps = 11/154 (7%)
Query: 104 SYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCA---KWESEALQSGGTP 159
           S++ Q+ +G+ +L S   +H D+ +RNIL+      KI DFG A   K +S  +  G   
Sbjct: 167 SFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNAR 226
Query: 160 M---FMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPM-TVLYKIAYSREL 214
           +   +MAPE        F SD+W+ G  + E+ S G +P+P    P+ +  YK+      
Sbjct: 227 LPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM--PVDSKFYKMIKEGFR 284
Query: 215 PEVPAFLSKQANDFLSNCLRRDPKERWAASQLLK 248
              P     +  D +  C   DP +R    Q+++
Sbjct: 285 MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 318

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 73/154 (47%), Gaps = 11/154 (7%)
Query: 104 SYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCA---KWESEALQSGGTP 159
           S++ Q+ +G+ +L S   +H D+ +RNIL+      KI DFG A   K +S  +  G   
Sbjct: 165 SFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNAR 224
Query: 160 M---FMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPM-TVLYKIAYSREL 214
           +   +MAPE        F SD+W+ G  + E+ S G +P+P    P+ +  YK+      
Sbjct: 225 LPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM--PVDSKFYKMIKEGFR 282
Query: 215 PEVPAFLSKQANDFLSNCLRRDPKERWAASQLLK 248
              P     +  D +  C   DP +R    Q+++
Sbjct: 283 MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 316

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 70/296 (23%), Positives = 124/296 (41%), Gaps = 28/296 (9%)
Query: 7   HTIGQGSSATVSLATSLRSGDVFAAKSTE-LPKSEFLQREQKF-LSSLNSPHIVGYKGCD 64
             +G G +  V    + R+ + FA K  +  PK+   +RE +    +   PHIV      
Sbjct: 68  QVLGLGINGKVLQIFNKRTQEKFALKXLQDCPKA---RREVELHWRASQCPHIVRIVDVY 124
Query: 65  VTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGR-LDESLIVSYTRQILQGLEYLHSNRVVH 123
                 +    +  E   GG L   I   G +   E       + I + ++YLHS  + H
Sbjct: 125 ENLYAGRKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYLHSINIAH 184
Query: 124 CDIKSRNILMAESGA----KIADFGCAKWESEALQSGG----TPMFMAPEVARGEHQGFA 175
            D+K  N+L          K+ DFG AK E+ +  S      TP ++APEV   E    +
Sbjct: 185 RDVKPENLLYTSKRPNAILKLTDFGFAK-ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKS 243
Query: 176 SDIWAVGCTVIEMASGGAPWPN----AADP--MTVLYKIAYSRELPEVPAFLSKQANDFL 229
            D W++G     +  G  P+ +    A  P   T +    Y    PE  + +S++    +
Sbjct: 244 CDXWSLGVIXYILLCGYPPFYSNHGLAISPGXKTRIRXGQYEFPNPEW-SEVSEEVKXLI 302
Query: 230 SNCLRRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSIL--DQGIWNSVEE 283
            N L+ +P +R   ++   HP++ +    + ++ ++    + +L  D+  W  V+E
Sbjct: 303 RNLLKTEPTQRXTITEFXNHPWIXQ----STKVPQTPLHTSRVLKEDKERWEDVKE 354

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/192 (23%), Positives = 79/192 (41%), Gaps = 41/192 (21%)
Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGAK--IADFGCAKWESEALQSG--- 156
           I  Y  +IL+ L+Y HS  ++H D+K  N+++     K  + D+G A++     +     
Sbjct: 133 IRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV 192
Query: 157 GTPMFMAPE-VARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA------ 209
            +  F  PE +   +   ++ D+W++GC +  M     P+ +  D    L +IA      
Sbjct: 193 ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE 252
Query: 210 --------YSRELP---------------------EVPAFLSKQANDFLSNCLRRDPKER 240
                   Y+ EL                      E    +S +A DFL   LR D + R
Sbjct: 253 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSR 312
Query: 241 WAASQLLKHPFL 252
             A + ++HP+ 
Sbjct: 313 LTAREAMEHPYF 324

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/192 (23%), Positives = 79/192 (41%), Gaps = 41/192 (21%)
Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGAK--IADFGCAKWESEALQSG--- 156
           I  Y  +IL+ L+Y HS  ++H D+K  N+++     K  + D+G A++     +     
Sbjct: 133 IRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV 192
Query: 157 GTPMFMAPE-VARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA------ 209
            +  F  PE +   +   ++ D+W++GC +  M     P+ +  D    L +IA      
Sbjct: 193 ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE 252
Query: 210 --------YSRELP---------------------EVPAFLSKQANDFLSNCLRRDPKER 240
                   Y+ EL                      E    +S +A DFL   LR D + R
Sbjct: 253 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSR 312
Query: 241 WAASQLLKHPFL 252
             A + ++HP+ 
Sbjct: 313 LTAREAMEHPYF 324

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 80/171 (46%), Gaps = 19/171 (11%)
Query: 104 SYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCA---KWESEALQSGGTP 159
           S++ Q+ +G+ +L S   +H D+ +RNIL+      KI DFG A   K +S  +  G   
Sbjct: 172 SFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNAR 231
Query: 160 M---FMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPM-TVLYKIAYSREL 214
           +   +MAPE        F SD+W+ G  + E+ S G +P+P    P+ +  YK+      
Sbjct: 232 LPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM--PVDSKFYKMIKEGFR 289
Query: 215 PEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQIQES 265
              P     +  D +  C   DP +R    Q+++   +E      KQI ES
Sbjct: 290 MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ--LIE------KQISES 332

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 76/172 (44%), Gaps = 19/172 (11%)
Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAK---WESEALQSGG 157
           ++ ++ Q+ QG+ +L S   +H D+ +RN+L+     AKI DFG A+    +S  +  G 
Sbjct: 166 LLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN 225
Query: 158 TPM---FMAPEVARGEHQGFASDIWAVGCTVIEMASGGA-PWPNAADPMTVLYKIAYSRE 213
             +   +MAPE          SD+W+ G  + E+ S G  P+P      +  YK+     
Sbjct: 226 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGIL-VNSKFYKLVKDGY 284
Query: 214 LPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCS-CTKQIQE 264
               PAF  K     +  C   +P  R         P  ++ CS   +Q QE
Sbjct: 285 QMAQPAFAPKNIYSIMQACWALEPTHR---------PTFQQICSFLQEQAQE 327

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/192 (23%), Positives = 79/192 (41%), Gaps = 41/192 (21%)
Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGAK--IADFGCAKWESEALQSG--- 156
           I  Y  +IL+ L+Y HS  ++H D+K  N+++     K  + D+G A++     +     
Sbjct: 133 IRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV 192
Query: 157 GTPMFMAPE-VARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA------ 209
            +  F  PE +   +   ++ D+W++GC +  M     P+ +  D    L +IA      
Sbjct: 193 ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE 252
Query: 210 --------YSRELP---------------------EVPAFLSKQANDFLSNCLRRDPKER 240
                   Y+ EL                      E    +S +A DFL   LR D + R
Sbjct: 253 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSR 312
Query: 241 WAASQLLKHPFL 252
             A + ++HP+ 
Sbjct: 313 LTAREAMEHPYF 324

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/192 (23%), Positives = 79/192 (41%), Gaps = 41/192 (21%)
Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGAK--IADFGCAKWESEALQSG--- 156
           I  Y  +IL+ L+Y HS  ++H D+K  N+++     K  + D+G A++     +     
Sbjct: 131 IRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV 190
Query: 157 GTPMFMAPE-VARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA------ 209
            +  F  PE +   +   ++ D+W++GC +  M     P+ +  D    L +IA      
Sbjct: 191 ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE 250
Query: 210 --------YSRELP---------------------EVPAFLSKQANDFLSNCLRRDPKER 240
                   Y+ EL                      E    +S +A DFL   LR D + R
Sbjct: 251 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSR 310
Query: 241 WAASQLLKHPFL 252
             A + ++HP+ 
Sbjct: 311 LTAREAMEHPYF 322

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 76/172 (44%), Gaps = 19/172 (11%)
Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAK---WESEALQSGG 157
           ++ ++ Q+ QG+ +L S   +H D+ +RN+L+     AKI DFG A+    +S  +  G 
Sbjct: 166 LLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN 225
Query: 158 TPM---FMAPEVARGEHQGFASDIWAVGCTVIEMASGGA-PWPNAADPMTVLYKIAYSRE 213
             +   +MAPE          SD+W+ G  + E+ S G  P+P      +  YK+     
Sbjct: 226 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGIL-VNSKFYKLVKDGY 284
Query: 214 LPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCS-CTKQIQE 264
               PAF  K     +  C   +P  R         P  ++ CS   +Q QE
Sbjct: 285 QMAQPAFAPKNIYSIMQACWALEPTHR---------PTFQQICSFLQEQAQE 327

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/192 (23%), Positives = 79/192 (41%), Gaps = 41/192 (21%)
Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGAK--IADFGCAKWESEALQSG--- 156
           I  Y  +IL+ L+Y HS  ++H D+K  N+++     K  + D+G A++     +     
Sbjct: 133 IRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV 192
Query: 157 GTPMFMAPE-VARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA------ 209
            +  F  PE +   +   ++ D+W++GC +  M     P+ +  D    L +IA      
Sbjct: 193 ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE 252
Query: 210 --------YSRELP---------------------EVPAFLSKQANDFLSNCLRRDPKER 240
                   Y+ EL                      E    +S +A DFL   LR D + R
Sbjct: 253 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSR 312
Query: 241 WAASQLLKHPFL 252
             A + ++HP+ 
Sbjct: 313 LTAREAMEHPYF 324

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/192 (23%), Positives = 79/192 (41%), Gaps = 41/192 (21%)
Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGAK--IADFGCAKWESEALQSG--- 156
           I  Y  +IL+ L+Y HS  ++H D+K  N+++     K  + D+G A++     +     
Sbjct: 132 IRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV 191
Query: 157 GTPMFMAPE-VARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA------ 209
            +  F  PE +   +   ++ D+W++GC +  M     P+ +  D    L +IA      
Sbjct: 192 ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE 251
Query: 210 --------YSRELP---------------------EVPAFLSKQANDFLSNCLRRDPKER 240
                   Y+ EL                      E    +S +A DFL   LR D + R
Sbjct: 252 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSR 311
Query: 241 WAASQLLKHPFL 252
             A + ++HP+ 
Sbjct: 312 LTAREAMEHPYF 323

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/192 (23%), Positives = 79/192 (41%), Gaps = 41/192 (21%)
Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGAK--IADFGCAKWESEALQSG--- 156
           I  Y  +IL+ L+Y HS  ++H D+K  N+++     K  + D+G A++     +     
Sbjct: 133 IRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV 192
Query: 157 GTPMFMAPE-VARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA------ 209
            +  F  PE +   +   ++ D+W++GC +  M     P+ +  D    L +IA      
Sbjct: 193 ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE 252
Query: 210 --------YSRELP---------------------EVPAFLSKQANDFLSNCLRRDPKER 240
                   Y+ EL                      E    +S +A DFL   LR D + R
Sbjct: 253 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSR 312
Query: 241 WAASQLLKHPFL 252
             A + ++HP+ 
Sbjct: 313 LTAREAMEHPYF 324

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/192 (23%), Positives = 79/192 (41%), Gaps = 41/192 (21%)
Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGAK--IADFGCAKWESEALQSG--- 156
           I  Y  +IL+ L+Y HS  ++H D+K  N+++     K  + D+G A++     +     
Sbjct: 133 IRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV 192
Query: 157 GTPMFMAPE-VARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA------ 209
            +  F  PE +   +   ++ D+W++GC +  M     P+ +  D    L +IA      
Sbjct: 193 ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE 252
Query: 210 --------YSRELP---------------------EVPAFLSKQANDFLSNCLRRDPKER 240
                   Y+ EL                      E    +S +A DFL   LR D + R
Sbjct: 253 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSR 312
Query: 241 WAASQLLKHPFL 252
             A + ++HP+ 
Sbjct: 313 LTAREAMEHPYF 324

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/192 (23%), Positives = 79/192 (41%), Gaps = 41/192 (21%)
Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGAK--IADFGCAKWESEALQSG--- 156
           I  Y  +IL+ L+Y HS  ++H D+K  N+++     K  + D+G A++     +     
Sbjct: 132 IRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV 191
Query: 157 GTPMFMAPE-VARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA------ 209
            +  F  PE +   +   ++ D+W++GC +  M     P+ +  D    L +IA      
Sbjct: 192 ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE 251
Query: 210 --------YSRELP---------------------EVPAFLSKQANDFLSNCLRRDPKER 240
                   Y+ EL                      E    +S +A DFL   LR D + R
Sbjct: 252 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSR 311
Query: 241 WAASQLLKHPFL 252
             A + ++HP+ 
Sbjct: 312 LTAREAMEHPYF 323

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/192 (23%), Positives = 79/192 (41%), Gaps = 41/192 (21%)
Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGAK--IADFGCAKWESEALQSG--- 156
           I  Y  +IL+ L+Y HS  ++H D+K  N+++     K  + D+G A++     +     
Sbjct: 133 IRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV 192
Query: 157 GTPMFMAPE-VARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA------ 209
            +  F  PE +   +   ++ D+W++GC +  M     P+ +  D    L +IA      
Sbjct: 193 ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE 252
Query: 210 --------YSRELP---------------------EVPAFLSKQANDFLSNCLRRDPKER 240
                   Y+ EL                      E    +S +A DFL   LR D + R
Sbjct: 253 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSR 312
Query: 241 WAASQLLKHPFL 252
             A + ++HP+ 
Sbjct: 313 LTAREAMEHPYF 324

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/192 (23%), Positives = 79/192 (41%), Gaps = 41/192 (21%)
Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGAK--IADFGCAKWESEALQSG--- 156
           I  Y  +IL+ L+Y HS  ++H D+K  N+++     K  + D+G A++     +     
Sbjct: 133 IRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV 192
Query: 157 GTPMFMAPE-VARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA------ 209
            +  F  PE +   +   ++ D+W++GC +  M     P+ +  D    L +IA      
Sbjct: 193 ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE 252
Query: 210 --------YSRELP---------------------EVPAFLSKQANDFLSNCLRRDPKER 240
                   Y+ EL                      E    +S +A DFL   LR D + R
Sbjct: 253 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSR 312
Query: 241 WAASQLLKHPFL 252
             A + ++HP+ 
Sbjct: 313 LTAREAMEHPYF 324

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 80/171 (46%), Gaps = 19/171 (11%)
Query: 104 SYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCA---KWESEALQSGGTP 159
           S++ Q+ +G+ +L S   +H D+ +RNIL+      KI DFG A   K +S  +  G   
Sbjct: 172 SFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGNAR 231
Query: 160 M---FMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPM-TVLYKIAYSREL 214
           +   +MAPE        F SD+W+ G  + E+ S G +P+P    P+ +  YK+      
Sbjct: 232 LPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM--PVDSKFYKMIKEGFR 289
Query: 215 PEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQIQES 265
              P     +  D +  C   DP +R    Q+++   +E      KQI ES
Sbjct: 290 MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ--LIE------KQISES 332

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/192 (23%), Positives = 79/192 (41%), Gaps = 41/192 (21%)
Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGAK--IADFGCAKWESEALQSG--- 156
           I  Y  +IL+ L+Y HS  ++H D+K  N+++     K  + D+G A++     +     
Sbjct: 138 IRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV 197
Query: 157 GTPMFMAPE-VARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA------ 209
            +  F  PE +   +   ++ D+W++GC +  M     P+ +  D    L +IA      
Sbjct: 198 ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE 257
Query: 210 --------YSRELP---------------------EVPAFLSKQANDFLSNCLRRDPKER 240
                   Y+ EL                      E    +S +A DFL   LR D + R
Sbjct: 258 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSR 317
Query: 241 WAASQLLKHPFL 252
             A + ++HP+ 
Sbjct: 318 LTAREAMEHPYF 329

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 101/219 (46%), Gaps = 16/219 (7%)
Query: 39  SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLD 98
           S+FL  E   +   + P+++   G  + SE + L+    + Y   G L + I        
Sbjct: 76  SQFLT-EGIIMKDFSHPNVLSLLGICLRSEGSPLV---VLPYMKHGDLRNFIRNETHNPT 131
Query: 99  ESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES-GAKIADFGCAK------WESE 151
              ++ +  Q+ +G++YL S + VH D+ +RN ++ E    K+ADFG A+      + S 
Sbjct: 132 VKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSV 191
Query: 152 ALQSGG-TPM-FMAPEVARGEHQGFASDIWAVGCTVIEMASGGA-PWPNAADPMTVLYKI 208
             ++G   P+ +MA E  + +     SD+W+ G  + E+ + GA P+P+       +Y +
Sbjct: 192 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 251
Query: 209 AYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLL 247
              R L   P +      + +  C     + R + S+L+
Sbjct: 252 QGRRLLQ--PEYCPDPLYEVMLKCWHPKAEMRPSFSELV 288

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/197 (23%), Positives = 88/197 (44%), Gaps = 22/197 (11%)
Query: 76  LFMEYAPGGTLNDEIHRNGG-RLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMA 134
           +  EY   G+L D +    G +L  + ++    QI +G+ ++     +H ++++ NIL++
Sbjct: 80  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRNLRAANILVS 139
Query: 135 ES-GAKIADFGCAKW----ESEALQSGGTPM-FMAPEVARGEHQGFASDIWAVGCTVIEM 188
           ++   KIADFG A+     E  A +    P+ + APE          SD+W+ G  + E+
Sbjct: 140 DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEI 199
Query: 189 ASGG-APWPNAADPMTVL-----YKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWA 242
            + G  P+P   +P  +      Y++      PE       +    +  C +  P++R  
Sbjct: 200 VTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE-------ELYQLMRLCWKERPEDRPT 252
Query: 243 ASQLLKHPFLEEFCSCT 259
              L     LE+F + T
Sbjct: 253 FDYL--RSVLEDFFTAT 267

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 102/226 (45%), Gaps = 16/226 (7%)
Query: 31  AKSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEI 90
           A  TE  + +FL  E   +   + P+I+  +G  V +     M  +  EY   G+L+  +
Sbjct: 87  AGYTERQRRDFLS-EASIMGQFDHPNIIRLEG--VVTRGRLAM--IVTEYMENGSLDTFL 141
Query: 91  HRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKW- 148
             + G+     +V   R +  G+ YL     VH D+ +RN+L+  +   K++DFG ++  
Sbjct: 142 RTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201
Query: 149 ----ESEALQSGG-TPM-FMAPEVARGEHQGFASDIWAVGCTVIE-MASGGAPWPNAADP 201
               ++    +GG  P+ + APE         ASD+W+ G  + E +A G  P+ N  + 
Sbjct: 202 EDDPDAAXTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN- 260
Query: 202 MTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLL 247
             V+  +     LP  P       +  + +C  +D  +R   SQ++
Sbjct: 261 RDVISSVEEGYRLP-APMGCPHALHQLMLDCWHKDRAQRPRFSQIV 305

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 103/219 (47%), Gaps = 16/219 (7%)
Query: 39  SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLD 98
           S+FL  E   +   + P+++   G  + SE + L+   +M++   G L + I        
Sbjct: 68  SQFLT-EGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKH---GDLRNFIRNETHNPT 123
Query: 99  ESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES-GAKIADFGCAK------WESE 151
              ++ +  Q+ +G++YL S + VH D+ +RN ++ E    K+ADFG A+      + S 
Sbjct: 124 VKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSV 183
Query: 152 ALQSGG-TPM-FMAPEVARGEHQGFASDIWAVGCTVIEMASGGA-PWPNAADPMTVLYKI 208
             ++G   P+ +MA E  + +     SD+W+ G  + E+ + GA P+P+       +Y +
Sbjct: 184 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 243
Query: 209 AYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLL 247
              R L   P +      + +  C     + R + S+L+
Sbjct: 244 QGRRLLQ--PEYCPDPLYEVMLKCWHPKAEMRPSFSELV 280

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 73/161 (45%), Gaps = 11/161 (6%)
Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAK---WESEALQSGG 157
           ++ ++ Q+ QG+ +L S   +H D+ +RN+L+     AKI DFG A+    +S  +  G 
Sbjct: 168 LLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN 227
Query: 158 TPM---FMAPEVARGEHQGFASDIWAVGCTVIEMASGGA-PWPNAADPMTVLYKIAYSRE 213
             +   +MAPE          SD+W+ G  + E+ S G  P+P      +  YK+     
Sbjct: 228 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGIL-VNSKFYKLVKDGY 286
Query: 214 LPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEE 254
               PAF  K     +  C   +P  R    Q+    FL+E
Sbjct: 287 QMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICS--FLQE 325

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 101/219 (46%), Gaps = 16/219 (7%)
Query: 39  SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLD 98
           S+FL  E   +   + P+++   G  + SE + L   + + Y   G L + I        
Sbjct: 95  SQFLT-EGIIMKDFSHPNVLSLLGICLRSEGSPL---VVLPYMKHGDLRNFIRNETHNPT 150
Query: 99  ESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES-GAKIADFGCAK------WESE 151
              ++ +  Q+ +G++YL S + VH D+ +RN ++ E    K+ADFG A+      + S 
Sbjct: 151 VKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSV 210
Query: 152 ALQSGG-TPM-FMAPEVARGEHQGFASDIWAVGCTVIEMASGGA-PWPNAADPMTVLYKI 208
             ++G   P+ +MA E  + +     SD+W+ G  + E+ + GA P+P+       +Y +
Sbjct: 211 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 270
Query: 209 AYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLL 247
              R L   P +      + +  C     + R + S+L+
Sbjct: 271 QGRRLLQ--PEYCPDPLYEVMLKCWHPKAEMRPSFSELV 307

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 101/219 (46%), Gaps = 16/219 (7%)
Query: 39  SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLD 98
           S+FL  E   +   + P+++   G  + SE + L+    + Y   G L + I        
Sbjct: 75  SQFLT-EGIIMKDFSHPNVLSLLGICLRSEGSPLV---VLPYMKHGDLRNFIRNETHNPT 130
Query: 99  ESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES-GAKIADFGCAK------WESE 151
              ++ +  Q+ +G++YL S + VH D+ +RN ++ E    K+ADFG A+      + S 
Sbjct: 131 VKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSV 190
Query: 152 ALQSGG-TPM-FMAPEVARGEHQGFASDIWAVGCTVIEMASGGA-PWPNAADPMTVLYKI 208
             ++G   P+ +MA E  + +     SD+W+ G  + E+ + GA P+P+       +Y +
Sbjct: 191 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 250
Query: 209 AYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLL 247
              R L   P +      + +  C     + R + S+L+
Sbjct: 251 QGRRLLQ--PEYCPDPLYEVMLKCWHPKAEMRPSFSELV 287

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/192 (21%), Positives = 78/192 (40%), Gaps = 41/192 (21%)
Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGAK--IADFGCAKWESEALQSG--- 156
           I  Y  ++L+ L+Y HS  ++H D+K  N+++     K  + D+G A++   A +     
Sbjct: 139 IRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVRV 198
Query: 157 GTPMFMAPE-VARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELP 215
            +  F  PE +   +   ++ D+W++GC +  M     P+ +  D    L +IA      
Sbjct: 199 ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTE 258
Query: 216 EVPAFLSK-----------------------------------QANDFLSNCLRRDPKER 240
           E+  +L K                                   +A D L   LR D ++R
Sbjct: 259 ELYGYLKKYHIDLDPHFNDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQR 318
Query: 241 WAASQLLKHPFL 252
             A + ++HP+ 
Sbjct: 319 LTAKEAMEHPYF 330

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 101/219 (46%), Gaps = 16/219 (7%)
Query: 39  SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLD 98
           S+FL  E   +   + P+++   G  + SE + L   + + Y   G L + I        
Sbjct: 73  SQFLT-EGIIMKDFSHPNVLSLLGICLRSEGSPL---VVLPYMKHGDLRNFIRNETHNPT 128
Query: 99  ESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES-GAKIADFGCAK------WESE 151
              ++ +  Q+ +G++YL S + VH D+ +RN ++ E    K+ADFG A+      + S 
Sbjct: 129 VKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSV 188
Query: 152 ALQSGG-TPM-FMAPEVARGEHQGFASDIWAVGCTVIEMASGGA-PWPNAADPMTVLYKI 208
             ++G   P+ +MA E  + +     SD+W+ G  + E+ + GA P+P+       +Y +
Sbjct: 189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 248
Query: 209 AYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLL 247
              R L   P +      + +  C     + R + S+L+
Sbjct: 249 QGRRLLQ--PEYCPDPLYEVMLKCWHPKAEMRPSFSELV 285

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 104/219 (47%), Gaps = 16/219 (7%)
Query: 39  SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLD 98
           S+FL  E   +   + P+++   G  + SE + L+   +M++   G L + I        
Sbjct: 75  SQFLT-EGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKH---GDLRNFIRNETHNPT 130
Query: 99  ESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES-GAKIADFGCAK--WESEAL-- 153
              ++ +  Q+ +G++YL S + VH D+ +RN ++ E    K+ADFG A+  ++ E    
Sbjct: 131 VKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSV 190
Query: 154 --QSGGT-PM-FMAPEVARGEHQGFASDIWAVGCTVIEMASGGA-PWPNAADPMTVLYKI 208
             ++G   P+ +MA E  + +     SD+W+ G  + E+ + GA P+P+       +Y +
Sbjct: 191 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 250
Query: 209 AYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLL 247
              R L   P +      + +  C     + R + S+L+
Sbjct: 251 QGRRLLQ--PEYCPDPLYEVMLKCWHPKAEMRPSFSELV 287

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 103/219 (47%), Gaps = 16/219 (7%)
Query: 39  SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLD 98
           S+FL  E   +   + P+++   G  + SE + L+   +M++   G L + I        
Sbjct: 94  SQFLT-EGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKH---GDLRNFIRNETHNPT 149
Query: 99  ESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES-GAKIADFGCAK------WESE 151
              ++ +  Q+ +G++YL S + VH D+ +RN ++ E    K+ADFG A+      + S 
Sbjct: 150 VKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSV 209
Query: 152 ALQSGG-TPM-FMAPEVARGEHQGFASDIWAVGCTVIEMASGGA-PWPNAADPMTVLYKI 208
             ++G   P+ +MA E  + +     SD+W+ G  + E+ + GA P+P+       +Y +
Sbjct: 210 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 269
Query: 209 AYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLL 247
              R L   P +      + +  C     + R + S+L+
Sbjct: 270 QGRRLLQ--PEYCPDPLYEVMLKCWHPKAEMRPSFSELV 306

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 103/219 (47%), Gaps = 16/219 (7%)
Query: 39  SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLD 98
           S+FL  E   +   + P+++   G  + SE + L+   +M++   G L + I        
Sbjct: 74  SQFLT-EGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKH---GDLRNFIRNETHNPT 129
Query: 99  ESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES-GAKIADFGCAK------WESE 151
              ++ +  Q+ +G++YL S + VH D+ +RN ++ E    K+ADFG A+      + S 
Sbjct: 130 VKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSV 189
Query: 152 ALQSGG-TPM-FMAPEVARGEHQGFASDIWAVGCTVIEMASGGA-PWPNAADPMTVLYKI 208
             ++G   P+ +MA E  + +     SD+W+ G  + E+ + GA P+P+       +Y +
Sbjct: 190 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 249
Query: 209 AYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLL 247
              R L   P +      + +  C     + R + S+L+
Sbjct: 250 QGRRLLQ--PEYCPDPLYEVMLKCWHPKAEMRPSFSELV 286

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 101/219 (46%), Gaps = 16/219 (7%)
Query: 39  SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLD 98
           S+FL  E   +   + P+++   G  + SE + L   + + Y   G L + I        
Sbjct: 76  SQFLT-EGIIMKDFSHPNVLSLLGICLRSEGSPL---VVLPYMKHGDLRNFIRNETHNPT 131
Query: 99  ESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES-GAKIADFGCAK------WESE 151
              ++ +  Q+ +G++YL S + VH D+ +RN ++ E    K+ADFG A+      + S 
Sbjct: 132 VKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSV 191
Query: 152 ALQSGG-TPM-FMAPEVARGEHQGFASDIWAVGCTVIEMASGGA-PWPNAADPMTVLYKI 208
             ++G   P+ +MA E  + +     SD+W+ G  + E+ + GA P+P+       +Y +
Sbjct: 192 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 251
Query: 209 AYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLL 247
              R L   P +      + +  C     + R + S+L+
Sbjct: 252 QGRRLLQ--PEYCPDPLYEVMLKCWHPKAEMRPSFSELV 288

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 106/226 (46%), Gaps = 22/226 (9%)
Query: 34  TELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRN 93
           TE  + +FL  E   +   + P+I+  +G  V ++   +M  +  EY   G+L+  + ++
Sbjct: 57  TEKQRRDFLG-EASIMGQFDHPNIIRLEG--VVTKSKPVM--IVTEYMENGSLDSFLRKH 111
Query: 94  GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKW---E 149
             +     +V   R I  G++YL     VH D+ +RNIL+  +   K++DFG ++    +
Sbjct: 112 DAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD 171
Query: 150 SEA---LQSGGTPM-FMAPEVARGEHQGFASDIWAVGCTVIE-MASGGAPWPNAADPMTV 204
            EA    + G  P+ + +PE         ASD+W+ G  + E M+ G  P+   ++   V
Sbjct: 172 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDV 230
Query: 205 LYKIAYSRELP---EVPAFLSKQANDFLSNCLRRDPKERWAASQLL 247
           +  +     LP   + PA L +     + +C ++D   R    Q++
Sbjct: 231 IKAVDEGYRLPPPMDCPAALYQ----LMLDCWQKDRNNRPKFEQIV 272

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 38/132 (28%), Positives = 65/132 (49%), Gaps = 9/132 (6%)
Query: 100 SLIVSYTRQILQGLEYLHSNR--VVHCDIKSRNILM---AESGAKIADFGCA-KWESEAL 153
           +L   + +Q+   L +L +    ++HCD+K  NIL+        KI DFG + +      
Sbjct: 157 NLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRXAIKIVDFGSSCQLGQRIY 216
Query: 154 QSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRE 213
           Q   +  + +PEV  G     A D+W++GC ++EM + G P  + A+ +  + KI     
Sbjct: 217 QXIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHT-GEPLFSGANEVDQMNKIVEVLG 275
Query: 214 LPEVPAFLSKQA 225
           +P  PA +  QA
Sbjct: 276 IP--PAHILDQA 285

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 101/219 (46%), Gaps = 16/219 (7%)
Query: 39  SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLD 98
           S+FL  E   +   + P+++   G  + SE + L   + + Y   G L + I        
Sbjct: 71  SQFLT-EGIIMKDFSHPNVLSLLGICLRSEGSPL---VVLPYMKHGDLRNFIRNETHNPT 126
Query: 99  ESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES-GAKIADFGCAK------WESE 151
              ++ +  Q+ +G++YL S + VH D+ +RN ++ E    K+ADFG A+      + S 
Sbjct: 127 VKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSV 186
Query: 152 ALQSGG-TPM-FMAPEVARGEHQGFASDIWAVGCTVIEMASGGA-PWPNAADPMTVLYKI 208
             ++G   P+ +MA E  + +     SD+W+ G  + E+ + GA P+P+       +Y +
Sbjct: 187 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 246
Query: 209 AYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLL 247
              R L   P +      + +  C     + R + S+L+
Sbjct: 247 QGRRLLQ--PEYCPDPLYEVMLKCWHPKAEMRPSFSELV 283

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 43/182 (23%), Positives = 84/182 (46%), Gaps = 16/182 (8%)
Query: 95  GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNIL--MAESGAKIADFGCAKWESEA 152
           G L E L  S+  Q+L+ + + H+  V+H DIK  NIL  +     K+ DFG      + 
Sbjct: 109 GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT 168
Query: 153 LQS--GGTPMFMAPEVAR-GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA 209
           + +   GT ++  PE  R   + G ++ +W++G  + +M  G  P+ +  D   +  ++ 
Sbjct: 169 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH--DEEIIRGQVF 226
Query: 210 YSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFC--SCTKQIQESNC 267
           + +        +S +    +  CL   P +R    ++  HP++++      T +I   + 
Sbjct: 227 FRQR-------VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSL 279
Query: 268 SP 269
           SP
Sbjct: 280 SP 281

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/248 (24%), Positives = 104/248 (41%), Gaps = 16/248 (6%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVF--AAKSTELPKSEFLQREQKFLSSLNSPHIVG 59
           D T    +G G    V         DV     K   + + EF++ E K + +L+   +V 
Sbjct: 9   DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIE-EAKVMMNLSHEKLVQ 67
Query: 60  YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN 119
             G  V ++   +   +  EY   G L + +     R     ++   + + + +EYL S 
Sbjct: 68  LYG--VCTKQRPIF--IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 123
Query: 120 RVVHCDIKSRNILMAESG-AKIADFGCAKW--ESEALQSGGTPM---FMAPEVARGEHQG 173
           + +H D+ +RN L+ + G  K++DFG +++  + E   S G+     +  PEV       
Sbjct: 124 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS 183
Query: 174 FASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNC 232
             SDIWA G  + E+ S G  P+    +  T  + IA    L   P   S++    + +C
Sbjct: 184 SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH-IAQGLRLYR-PHLASEKVYTIMYSC 241
Query: 233 LRRDPKER 240
                 ER
Sbjct: 242 WHEKADER 249

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 106/226 (46%), Gaps = 22/226 (9%)
Query: 34  TELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRN 93
           TE  + +FL  E   +   + P+I+  +G  V ++   +M  +  EY   G+L+  + ++
Sbjct: 86  TEKQRRDFLG-EASIMGQFDHPNIIRLEG--VVTKSKPVM--IVTEYMENGSLDSFLRKH 140
Query: 94  GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKW---E 149
             +     +V   R I  G++YL     VH D+ +RNIL+  +   K++DFG ++    +
Sbjct: 141 DAQFTVIQLVGMLRGIASGMKYLSDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDD 200
Query: 150 SEA---LQSGGTPM-FMAPEVARGEHQGFASDIWAVGCTVIE-MASGGAPWPNAADPMTV 204
            EA    + G  P+ + +PE         ASD+W+ G  + E M+ G  P+   ++   V
Sbjct: 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDV 259
Query: 205 LYKIAYSRELP---EVPAFLSKQANDFLSNCLRRDPKERWAASQLL 247
           +  +     LP   + PA L +     + +C ++D   R    Q++
Sbjct: 260 IKAVDEGYRLPPPMDCPAALYQ----LMLDCWQKDRNNRPKFEQIV 301

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 39/165 (23%), Positives = 78/165 (47%), Gaps = 14/165 (8%)
Query: 95  GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNIL--MAESGAKIADFGCAKWESEA 152
           G L E L  S+  Q+L+ + + H+  V+H DIK  NIL  +     K+ DFG      + 
Sbjct: 105 GALQEELARSFFWQVLEAVRHCHNXGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT 164
Query: 153 LQS--GGTPMFMAPEVAR-GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA 209
           + +   GT ++  PE  R   + G ++ +W++G  + +M  G  P+ +  D   +  ++ 
Sbjct: 165 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH--DEEIIRGQVF 222
Query: 210 YSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEE 254
           + +        +S +    +  CL   P +R    ++  HP++++
Sbjct: 223 FRQR-------VSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 260

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/248 (24%), Positives = 104/248 (41%), Gaps = 16/248 (6%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVF--AAKSTELPKSEFLQREQKFLSSLNSPHIVG 59
           D T    +G G    V         DV     K   + + EF++ E K + +L+   +V 
Sbjct: 10  DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIE-EAKVMMNLSHEKLVQ 68
Query: 60  YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN 119
             G  V ++   +   +  EY   G L + +     R     ++   + + + +EYL S 
Sbjct: 69  LYG--VCTKQRPIF--IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 124
Query: 120 RVVHCDIKSRNILMAESG-AKIADFGCAKW--ESEALQSGGTPM---FMAPEVARGEHQG 173
           + +H D+ +RN L+ + G  K++DFG +++  + E   S G+     +  PEV       
Sbjct: 125 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSPPEVLMYSKFS 184
Query: 174 FASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNC 232
             SDIWA G  + E+ S G  P+    +  T  + IA    L   P   S++    + +C
Sbjct: 185 SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH-IAQGLRLYR-PHLASEKVYTIMYSC 242
Query: 233 LRRDPKER 240
                 ER
Sbjct: 243 WHEKADER 250

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 43/182 (23%), Positives = 84/182 (46%), Gaps = 16/182 (8%)
Query: 95  GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNIL--MAESGAKIADFGCAKWESEA 152
           G L E L  S+  Q+L+ + + H+  V+H DIK  NIL  +     K+ DFG      + 
Sbjct: 109 GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT 168
Query: 153 LQS--GGTPMFMAPEVAR-GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA 209
           + +   GT ++  PE  R   + G ++ +W++G  + +M  G  P+ +  D   +  ++ 
Sbjct: 169 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH--DEEIIRGQVF 226
Query: 210 YSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFC--SCTKQIQESNC 267
           + +        +S +    +  CL   P +R    ++  HP++++      T +I   + 
Sbjct: 227 FRQR-------VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSL 279
Query: 268 SP 269
           SP
Sbjct: 280 SP 281

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 102/226 (45%), Gaps = 16/226 (7%)
Query: 31  AKSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEI 90
           A  TE  + +FL  E   +   + P+I+  +G  V +     M  +  EY   G+L+  +
Sbjct: 87  AGYTERQRRDFLS-EASIMGQFDHPNIIRLEG--VVTRGRLAM--IVTEYMENGSLDTFL 141
Query: 91  HRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKW- 148
             + G+     +V   R +  G+ YL     VH D+ +RN+L+  +   K++DFG ++  
Sbjct: 142 RTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201
Query: 149 ----ESEALQSGG-TPM-FMAPEVARGEHQGFASDIWAVGCTVIE-MASGGAPWPNAADP 201
               ++    +GG  P+ + APE         ASD+W+ G  + E +A G  P+ N  + 
Sbjct: 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN- 260
Query: 202 MTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLL 247
             V+  +     LP  P       +  + +C  +D  +R   SQ++
Sbjct: 261 RDVISSVEEGYRLP-APMGCPHALHQLMLDCWHKDRAQRPRFSQIV 305

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/248 (24%), Positives = 104/248 (41%), Gaps = 16/248 (6%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVF--AAKSTELPKSEFLQREQKFLSSLNSPHIVG 59
           D T    +G G    V         DV     K   + + EF++ E K + +L+   +V 
Sbjct: 10  DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIE-EAKVMMNLSHEKLVQ 68
Query: 60  YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN 119
             G  V ++   +   +  EY   G L + +     R     ++   + + + +EYL S 
Sbjct: 69  LYG--VCTKQRPIF--IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 124
Query: 120 RVVHCDIKSRNILMAESG-AKIADFGCAKW--ESEALQSGGTPM---FMAPEVARGEHQG 173
           + +H D+ +RN L+ + G  K++DFG +++  + E   S G+     +  PEV       
Sbjct: 125 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS 184
Query: 174 FASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNC 232
             SDIWA G  + E+ S G  P+    +  T  + IA    L   P   S++    + +C
Sbjct: 185 SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH-IAQGLRLYR-PHLASEKVYTIMYSC 242
Query: 233 LRRDPKER 240
                 ER
Sbjct: 243 WHEKADER 250

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 43/182 (23%), Positives = 84/182 (46%), Gaps = 16/182 (8%)
Query: 95  GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNIL--MAESGAKIADFGCAKWESEA 152
           G L E L  S+  Q+L+ + + H+  V+H DIK  NIL  +     K+ DFG      + 
Sbjct: 110 GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT 169
Query: 153 LQS--GGTPMFMAPEVAR-GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA 209
           + +   GT ++  PE  R   + G ++ +W++G  + +M  G  P+ +  D   +  ++ 
Sbjct: 170 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH--DEEIIRGQVF 227
Query: 210 YSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFC--SCTKQIQESNC 267
           + +        +S +    +  CL   P +R    ++  HP++++      T +I   + 
Sbjct: 228 FRQR-------VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSL 280
Query: 268 SP 269
           SP
Sbjct: 281 SP 282

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 82/167 (49%), Gaps = 13/167 (7%)
Query: 34  TELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRN 93
           TE  + +FL  E   +   + P+I+  +G  V ++   +M  +  EY   G+L+  + ++
Sbjct: 74  TEKQRRDFLG-EASIMGQFDHPNIIRLEG--VVTKSKPVM--IVTEYMENGSLDSFLRKH 128
Query: 94  GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKW---E 149
             +     +V   R I  G++YL     VH D+ +RNIL+  +   K++DFG ++    +
Sbjct: 129 DAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD 188
Query: 150 SEA---LQSGGTPM-FMAPEVARGEHQGFASDIWAVGCTVIEMASGG 192
            EA    + G  P+ + +PE         ASD+W+ G  + E+ S G
Sbjct: 189 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG 235

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 106/226 (46%), Gaps = 22/226 (9%)
Query: 34  TELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRN 93
           TE  + +FL  E   +   + P+I+  +G  V ++   +M  +  EY   G+L+  + ++
Sbjct: 86  TEKQRRDFLG-EASIMGQFDHPNIIRLEG--VVTKSKPVM--IVTEYMENGSLDSFLRKH 140
Query: 94  GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKW---E 149
             +     +V   R I  G++YL     VH D+ +RNIL+  +   K++DFG ++    +
Sbjct: 141 DAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD 200
Query: 150 SEA---LQSGGTPM-FMAPEVARGEHQGFASDIWAVGCTVIE-MASGGAPWPNAADPMTV 204
            EA    + G  P+ + +PE         ASD+W+ G  + E M+ G  P+   ++   V
Sbjct: 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDV 259
Query: 205 LYKIAYSRELP---EVPAFLSKQANDFLSNCLRRDPKERWAASQLL 247
           +  +     LP   + PA L +     + +C ++D   R    Q++
Sbjct: 260 IKAVDEGYRLPPPMDCPAALYQ----LMLDCWQKDRNNRPKFEQIV 301

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 106/226 (46%), Gaps = 22/226 (9%)
Query: 34  TELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRN 93
           TE  + +FL  E   +   + P+I+  +G  V ++   +M  +  EY   G+L+  + ++
Sbjct: 86  TEKQRRDFLG-EASIMGQFDHPNIIRLEG--VVTKSKPVM--IVTEYMENGSLDSFLRKH 140
Query: 94  GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKW---E 149
             +     +V   R I  G++YL     VH D+ +RNIL+  +   K++DFG ++    +
Sbjct: 141 DAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD 200
Query: 150 SEA---LQSGGTPM-FMAPEVARGEHQGFASDIWAVGCTVIE-MASGGAPWPNAADPMTV 204
            EA    + G  P+ + +PE         ASD+W+ G  + E M+ G  P+   ++   V
Sbjct: 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDV 259
Query: 205 LYKIAYSRELP---EVPAFLSKQANDFLSNCLRRDPKERWAASQLL 247
           +  +     LP   + PA L +     + +C ++D   R    Q++
Sbjct: 260 IKAVDEGYRLPPPMDCPAALYQ----LMLDCWQKDRNNRPKFEQIV 301

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 106/226 (46%), Gaps = 22/226 (9%)
Query: 34  TELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRN 93
           TE  + +FL  E   +   + P+I+  +G  V ++   +M  +  EY   G+L+  + ++
Sbjct: 86  TEKQRRDFLG-EASIMGQFDHPNIIRLEG--VVTKSKPVM--IVTEYMENGSLDSFLRKH 140
Query: 94  GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKW---E 149
             +     +V   R I  G++YL     VH D+ +RNIL+  +   K++DFG ++    +
Sbjct: 141 DAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD 200
Query: 150 SEA---LQSGGTPM-FMAPEVARGEHQGFASDIWAVGCTVIE-MASGGAPWPNAADPMTV 204
            EA    + G  P+ + +PE         ASD+W+ G  + E M+ G  P+   ++   V
Sbjct: 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDV 259
Query: 205 LYKIAYSRELP---EVPAFLSKQANDFLSNCLRRDPKERWAASQLL 247
           +  +     LP   + PA L +     + +C ++D   R    Q++
Sbjct: 260 IKAVDEGYRLPPPMDCPAALYQ----LMLDCWQKDRNNRPKFEQIV 301

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 106/226 (46%), Gaps = 22/226 (9%)
Query: 34  TELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRN 93
           TE  + +FL  E   +   + P+I+  +G  V ++   +M  +  EY   G+L+  + ++
Sbjct: 84  TEKQRRDFLG-EASIMGQFDHPNIIRLEG--VVTKSKPVM--IVTEYMENGSLDSFLRKH 138
Query: 94  GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKW---E 149
             +     +V   R I  G++YL     VH D+ +RNIL+  +   K++DFG ++    +
Sbjct: 139 DAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD 198
Query: 150 SEA---LQSGGTPM-FMAPEVARGEHQGFASDIWAVGCTVIE-MASGGAPWPNAADPMTV 204
            EA    + G  P+ + +PE         ASD+W+ G  + E M+ G  P+   ++   V
Sbjct: 199 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDV 257
Query: 205 LYKIAYSRELP---EVPAFLSKQANDFLSNCLRRDPKERWAASQLL 247
           +  +     LP   + PA L +     + +C ++D   R    Q++
Sbjct: 258 IKAVDEGYRLPPPMDCPAALYQ----LMLDCWQKDRNNRPKFEQIV 299

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 106/226 (46%), Gaps = 22/226 (9%)
Query: 34  TELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRN 93
           TE  + +FL  E   +   + P+I+  +G  V ++   +M  +  EY   G+L+  + ++
Sbjct: 86  TEKQRRDFLG-EASIMGQFDHPNIIRLEG--VVTKSKPVM--IVTEYMENGSLDSFLRKH 140
Query: 94  GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKW---E 149
             +     +V   R I  G++YL     VH D+ +RNIL+  +   K++DFG ++    +
Sbjct: 141 DAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD 200
Query: 150 SEA---LQSGGTPM-FMAPEVARGEHQGFASDIWAVGCTVIE-MASGGAPWPNAADPMTV 204
            EA    + G  P+ + +PE         ASD+W+ G  + E M+ G  P+   ++   V
Sbjct: 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDV 259
Query: 205 LYKIAYSRELP---EVPAFLSKQANDFLSNCLRRDPKERWAASQLL 247
           +  +     LP   + PA L +     + +C ++D   R    Q++
Sbjct: 260 IKAVDEGYRLPPPMDCPAALYQ----LMLDCWQKDRNNRPKFEQIV 301

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 43/182 (23%), Positives = 84/182 (46%), Gaps = 16/182 (8%)
Query: 95  GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNIL--MAESGAKIADFGCAKWESEA 152
           G L E L  S+  Q+L+ + + H+  V+H DIK  NIL  +     K+ DFG      + 
Sbjct: 137 GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT 196
Query: 153 LQS--GGTPMFMAPEVAR-GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA 209
           + +   GT ++  PE  R   + G ++ +W++G  + +M  G  P+ +  D   +  ++ 
Sbjct: 197 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH--DEEIIRGQVF 254
Query: 210 YSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFC--SCTKQIQESNC 267
           + +        +S +    +  CL   P +R    ++  HP++++      T +I   + 
Sbjct: 255 FRQR-------VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSL 307
Query: 268 SP 269
           SP
Sbjct: 308 SP 309

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/248 (24%), Positives = 104/248 (41%), Gaps = 16/248 (6%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVF--AAKSTELPKSEFLQREQKFLSSLNSPHIVG 59
           D T    +G G    V         DV     K   + + EF++ E K + +L+   +V 
Sbjct: 5   DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIE-EAKVMMNLSHEKLVQ 63
Query: 60  YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN 119
             G  V ++   +   +  EY   G L + +     R     ++   + + + +EYL S 
Sbjct: 64  LYG--VCTKQRPIF--IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 119
Query: 120 RVVHCDIKSRNILMAESG-AKIADFGCAKW--ESEALQSGGTPM---FMAPEVARGEHQG 173
           + +H D+ +RN L+ + G  K++DFG +++  + E   S G+     +  PEV       
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS 179
Query: 174 FASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNC 232
             SDIWA G  + E+ S G  P+    +  T  + IA    L   P   S++    + +C
Sbjct: 180 SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH-IAQGLRLYR-PHLASEKVYTIMYSC 237
Query: 233 LRRDPKER 240
                 ER
Sbjct: 238 WHEKADER 245

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 43/182 (23%), Positives = 84/182 (46%), Gaps = 16/182 (8%)
Query: 95  GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNIL--MAESGAKIADFGCAKWESEA 152
           G L E L  S+  Q+L+ + + H+  V+H DIK  NIL  +     K+ DFG      + 
Sbjct: 152 GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT 211
Query: 153 LQS--GGTPMFMAPEVAR-GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA 209
           + +   GT ++  PE  R   + G ++ +W++G  + +M  G  P+ +  D   +  ++ 
Sbjct: 212 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH--DEEIIRGQVF 269
Query: 210 YSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFC--SCTKQIQESNC 267
           + +        +S +    +  CL   P +R    ++  HP++++      T +I   + 
Sbjct: 270 FRQR-------VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSL 322
Query: 268 SP 269
           SP
Sbjct: 323 SP 324

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 43/182 (23%), Positives = 84/182 (46%), Gaps = 16/182 (8%)
Query: 95  GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNIL--MAESGAKIADFGCAKWESEA 152
           G L E L  S+  Q+L+ + + H+  V+H DIK  NIL  +     K+ DFG      + 
Sbjct: 152 GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT 211
Query: 153 LQS--GGTPMFMAPEVAR-GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA 209
           + +   GT ++  PE  R   + G ++ +W++G  + +M  G  P+ +  D   +  ++ 
Sbjct: 212 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH--DEEIIRGQVF 269
Query: 210 YSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFC--SCTKQIQESNC 267
           + +        +S +    +  CL   P +R    ++  HP++++      T +I   + 
Sbjct: 270 FRQR-------VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSL 322
Query: 268 SP 269
           SP
Sbjct: 323 SP 324

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 43/182 (23%), Positives = 84/182 (46%), Gaps = 16/182 (8%)
Query: 95  GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNIL--MAESGAKIADFGCAKWESEA 152
           G L E L  S+  Q+L+ + + H+  V+H DIK  NIL  +     K+ DFG      + 
Sbjct: 110 GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT 169
Query: 153 LQS--GGTPMFMAPEVAR-GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA 209
           + +   GT ++  PE  R   + G ++ +W++G  + +M  G  P+ +  D   +  ++ 
Sbjct: 170 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH--DEEIIRGQVF 227
Query: 210 YSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFC--SCTKQIQESNC 267
           + +        +S +    +  CL   P +R    ++  HP++++      T +I   + 
Sbjct: 228 FRQR-------VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSL 280
Query: 268 SP 269
           SP
Sbjct: 281 SP 282

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 43/182 (23%), Positives = 84/182 (46%), Gaps = 16/182 (8%)
Query: 95  GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNIL--MAESGAKIADFGCAKWESEA 152
           G L E L  S+  Q+L+ + + H+  V+H DIK  NIL  +     K+ DFG      + 
Sbjct: 132 GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT 191
Query: 153 LQS--GGTPMFMAPEVAR-GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA 209
           + +   GT ++  PE  R   + G ++ +W++G  + +M  G  P+ +  D   +  ++ 
Sbjct: 192 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH--DEEIIRGQVF 249
Query: 210 YSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFC--SCTKQIQESNC 267
           + +        +S +    +  CL   P +R    ++  HP++++      T +I   + 
Sbjct: 250 FRQR-------VSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSL 302
Query: 268 SP 269
           SP
Sbjct: 303 SP 304

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 43/182 (23%), Positives = 84/182 (46%), Gaps = 16/182 (8%)
Query: 95  GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNIL--MAESGAKIADFGCAKWESEA 152
           G L E L  S+  Q+L+ + + H+  V+H DIK  NIL  +     K+ DFG      + 
Sbjct: 124 GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT 183
Query: 153 LQS--GGTPMFMAPEVAR-GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA 209
           + +   GT ++  PE  R   + G ++ +W++G  + +M  G  P+ +  D   +  ++ 
Sbjct: 184 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH--DEEIIRGQVF 241
Query: 210 YSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFC--SCTKQIQESNC 267
           + +        +S +    +  CL   P +R    ++  HP++++      T +I   + 
Sbjct: 242 FRQR-------VSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSL 294
Query: 268 SP 269
           SP
Sbjct: 295 SP 296

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 43/182 (23%), Positives = 84/182 (46%), Gaps = 16/182 (8%)
Query: 95  GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNIL--MAESGAKIADFGCAKWESEA 152
           G L E L  S+  Q+L+ + + H+  V+H DIK  NIL  +     K+ DFG      + 
Sbjct: 110 GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT 169
Query: 153 LQS--GGTPMFMAPEVAR-GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA 209
           + +   GT ++  PE  R   + G ++ +W++G  + +M  G  P+ +  D   +  ++ 
Sbjct: 170 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH--DEEIIRGQVF 227
Query: 210 YSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFC--SCTKQIQESNC 267
           + +        +S +    +  CL   P +R    ++  HP++++      T +I   + 
Sbjct: 228 FRQR-------VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSL 280
Query: 268 SP 269
           SP
Sbjct: 281 SP 282

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 43/182 (23%), Positives = 84/182 (46%), Gaps = 16/182 (8%)
Query: 95  GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNIL--MAESGAKIADFGCAKWESEA 152
           G L E L  S+  Q+L+ + + H+  V+H DIK  NIL  +     K+ DFG      + 
Sbjct: 124 GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT 183
Query: 153 LQS--GGTPMFMAPEVAR-GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA 209
           + +   GT ++  PE  R   + G ++ +W++G  + +M  G  P+ +  D   +  ++ 
Sbjct: 184 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH--DEEIIRGQVF 241
Query: 210 YSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFC--SCTKQIQESNC 267
           + +        +S +    +  CL   P +R    ++  HP++++      T +I   + 
Sbjct: 242 FRQR-------VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSL 294
Query: 268 SP 269
           SP
Sbjct: 295 SP 296

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 43/182 (23%), Positives = 84/182 (46%), Gaps = 16/182 (8%)
Query: 95  GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNIL--MAESGAKIADFGCAKWESEA 152
           G L E L  S+  Q+L+ + + H+  V+H DIK  NIL  +     K+ DFG      + 
Sbjct: 125 GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT 184
Query: 153 LQS--GGTPMFMAPEVAR-GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA 209
           + +   GT ++  PE  R   + G ++ +W++G  + +M  G  P+ +  D   +  ++ 
Sbjct: 185 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH--DEEIIRGQVF 242
Query: 210 YSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFC--SCTKQIQESNC 267
           + +        +S +    +  CL   P +R    ++  HP++++      T +I   + 
Sbjct: 243 FRQR-------VSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSL 295
Query: 268 SP 269
           SP
Sbjct: 296 SP 297

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 43/182 (23%), Positives = 84/182 (46%), Gaps = 16/182 (8%)
Query: 95  GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNIL--MAESGAKIADFGCAKWESEA 152
           G L E L  S+  Q+L+ + + H+  V+H DIK  NIL  +     K+ DFG      + 
Sbjct: 125 GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT 184
Query: 153 LQS--GGTPMFMAPEVAR-GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA 209
           + +   GT ++  PE  R   + G ++ +W++G  + +M  G  P+ +  D   +  ++ 
Sbjct: 185 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH--DEEIIRGQVF 242
Query: 210 YSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFC--SCTKQIQESNC 267
           + +        +S +    +  CL   P +R    ++  HP++++      T +I   + 
Sbjct: 243 FRQR-------VSXECQHLIRWCLALRPXDRPTFEEIQNHPWMQDVLLPQETAEIHLHSL 295
Query: 268 SP 269
           SP
Sbjct: 296 SP 297

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 104/248 (41%), Gaps = 16/248 (6%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVF--AAKSTELPKSEFLQREQKFLSSLNSPHIVG 59
           D T    +G G    V         DV     K   + + EF++ E K + +L+   +V 
Sbjct: 25  DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIE-EAKVMMNLSHEKLVQ 83
Query: 60  YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN 119
             G  V ++   +   +  EY   G L + +     R     ++   + + + +EYL S 
Sbjct: 84  LYG--VCTKQRPIF--IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 139
Query: 120 RVVHCDIKSRNILMAESG-AKIADFGCAKW-----ESEALQSGGTPMFMAPEVARGEHQG 173
           + +H D+ +RN L+ + G  K++DFG +++     E+ ++ S     +  PEV       
Sbjct: 140 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSPPEVLMYSKFS 199
Query: 174 FASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNC 232
             SDIWA G  + E+ S G  P+    +  T  + IA    L   P   S++    + +C
Sbjct: 200 SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH-IAQGLRLYR-PHLASEKVYTIMYSC 257
Query: 233 LRRDPKER 240
                 ER
Sbjct: 258 WHEKADER 265

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 60/248 (24%), Positives = 104/248 (41%), Gaps = 16/248 (6%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVF--AAKSTELPKSEFLQREQKFLSSLNSPHIVG 59
           D T    +G G    V         DV     K   + + EF++ E K + +L+   +V 
Sbjct: 16  DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIE-EAKVMMNLSHEKLVQ 74
Query: 60  YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN 119
             G  V ++   +   +  EY   G L + +     R     ++   + + + +EYL S 
Sbjct: 75  LYG--VCTKQRPIF--IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 130
Query: 120 RVVHCDIKSRNILMAESG-AKIADFGCAKW--ESEALQSGGTPM---FMAPEVARGEHQG 173
           + +H D+ +RN L+ + G  K++DFG +++  + E   S G+     +  PEV       
Sbjct: 131 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS 190
Query: 174 FASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNC 232
             SDIWA G  + E+ S G  P+    +  T  + IA    L   P   S++    + +C
Sbjct: 191 SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH-IAQGLRLYR-PHLASEKVYTIMYSC 248
Query: 233 LRRDPKER 240
                 ER
Sbjct: 249 WHEKADER 256

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 43/182 (23%), Positives = 84/182 (46%), Gaps = 16/182 (8%)
Query: 95  GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNIL--MAESGAKIADFGCAKWESEA 152
           G L E L  S+  Q+L+ + + H+  V+H DIK  NIL  +     K+ DFG      + 
Sbjct: 157 GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT 216
Query: 153 LQS--GGTPMFMAPEVAR-GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA 209
           + +   GT ++  PE  R   + G ++ +W++G  + +M  G  P+ +  D   +  ++ 
Sbjct: 217 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH--DEEIIRGQVF 274
Query: 210 YSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFC--SCTKQIQESNC 267
           + +        +S +    +  CL   P +R    ++  HP++++      T +I   + 
Sbjct: 275 FRQR-------VSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSL 327
Query: 268 SP 269
           SP
Sbjct: 328 SP 329

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 43/182 (23%), Positives = 84/182 (46%), Gaps = 16/182 (8%)
Query: 95  GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNIL--MAESGAKIADFGCAKWESEA 152
           G L E L  S+  Q+L+ + + H+  V+H DIK  NIL  +     K+ DFG      + 
Sbjct: 125 GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT 184
Query: 153 LQS--GGTPMFMAPEVAR-GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA 209
           + +   GT ++  PE  R   + G ++ +W++G  + +M  G  P+ +  D   +  ++ 
Sbjct: 185 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH--DEEIIRGQVF 242
Query: 210 YSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFC--SCTKQIQESNC 267
           + +        +S +    +  CL   P +R    ++  HP++++      T +I   + 
Sbjct: 243 FRQR-------VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSL 295
Query: 268 SP 269
           SP
Sbjct: 296 SP 297

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 105/226 (46%), Gaps = 22/226 (9%)
Query: 34  TELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRN 93
           TE  + +FL  E   +   + P+I+  +G  V ++   +M  +  EY   G+L+  + ++
Sbjct: 86  TEKQRRDFLG-EASIMGQFDHPNIIRLEG--VVTKSKPVM--IVTEYMENGSLDSFLRKH 140
Query: 94  GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKW---E 149
             +     +V   R I  G++YL     VH D+ +RNIL+  +   K++DFG  +    +
Sbjct: 141 DAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD 200
Query: 150 SEA---LQSGGTPM-FMAPEVARGEHQGFASDIWAVGCTVIE-MASGGAPWPNAADPMTV 204
            EA    + G  P+ + +PE         ASD+W+ G  + E M+ G  P+   ++   V
Sbjct: 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDV 259
Query: 205 LYKIAYSRELP---EVPAFLSKQANDFLSNCLRRDPKERWAASQLL 247
           +  +     LP   + PA L +     + +C ++D   R    Q++
Sbjct: 260 IKAVDEGYRLPPPMDCPAALYQ----LMLDCWQKDRNNRPKFEQIV 301

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 104/219 (47%), Gaps = 16/219 (7%)
Query: 39  SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLD 98
           S+FL  E   +   + P+++   G  + SE + L+   +M++   G L + I        
Sbjct: 76  SQFLT-EGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKH---GDLRNFIRNETHNPT 131
Query: 99  ESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES-GAKIADFGCAK------WESE 151
              ++ +  Q+ +G+++L S + VH D+ +RN ++ E    K+ADFG A+      ++S 
Sbjct: 132 VKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 191
Query: 152 ALQSGG-TPM-FMAPEVARGEHQGFASDIWAVGCTVIEMASGGA-PWPNAADPMTVLYKI 208
             ++G   P+ +MA E  + +     SD+W+ G  + E+ + GA P+P+       +Y +
Sbjct: 192 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 251
Query: 209 AYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLL 247
              R L   P +      + +  C     + R + S+L+
Sbjct: 252 QGRRLLQ--PEYCPDPLYEVMLKCWHPKAEMRPSFSELV 288

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 43/182 (23%), Positives = 84/182 (46%), Gaps = 16/182 (8%)
Query: 95  GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNIL--MAESGAKIADFGCAKWESEA 152
           G L E L  S+  Q+L+ + + H+  V+H DIK  NIL  +     K+ DFG      + 
Sbjct: 152 GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT 211
Query: 153 LQS--GGTPMFMAPEVAR-GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA 209
           + +   GT ++  PE  R   + G ++ +W++G  + +M  G  P+ +  D   +  ++ 
Sbjct: 212 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH--DEEIIRGQVF 269
Query: 210 YSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFC--SCTKQIQESNC 267
           + +        +S +    +  CL   P +R    ++  HP++++      T +I   + 
Sbjct: 270 FRQR-------VSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSL 322
Query: 268 SP 269
           SP
Sbjct: 323 SP 324

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 39/165 (23%), Positives = 78/165 (47%), Gaps = 14/165 (8%)
Query: 95  GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNIL--MAESGAKIADFGCAKWESEA 152
           G L E L  S+  Q+L+ + + H+  V+H DIK  NIL  +     K+ DFG      + 
Sbjct: 108 GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT 167
Query: 153 LQS--GGTPMFMAPEVAR-GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA 209
           + +   GT ++  PE  R   + G ++ +W++G  + +M  G  P+ +  D   +  ++ 
Sbjct: 168 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH--DEEIIRGQVF 225
Query: 210 YSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEE 254
           + +        +S +    +  CL   P +R    ++  HP++++
Sbjct: 226 FRQR-------VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 263

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 43/182 (23%), Positives = 84/182 (46%), Gaps = 16/182 (8%)
Query: 95  GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNIL--MAESGAKIADFGCAKWESEA 152
           G L E L  S+  Q+L+ + + H+  V+H DIK  NIL  +     K+ DFG      + 
Sbjct: 144 GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT 203
Query: 153 LQS--GGTPMFMAPEVAR-GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA 209
           + +   GT ++  PE  R   + G ++ +W++G  + +M  G  P+ +  D   +  ++ 
Sbjct: 204 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH--DEEIIRGQVF 261
Query: 210 YSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFC--SCTKQIQESNC 267
           + +        +S +    +  CL   P +R    ++  HP++++      T +I   + 
Sbjct: 262 FRQR-------VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSL 314
Query: 268 SP 269
           SP
Sbjct: 315 SP 316

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 39/165 (23%), Positives = 78/165 (47%), Gaps = 14/165 (8%)
Query: 95  GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNIL--MAESGAKIADFGCAKWESEA 152
           G L E L  S+  Q+L+ + + H+  V+H DIK  NIL  +     K+ DFG      + 
Sbjct: 105 GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT 164
Query: 153 LQS--GGTPMFMAPEVAR-GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA 209
           + +   GT ++  PE  R   + G ++ +W++G  + +M  G  P+ +  D   +  ++ 
Sbjct: 165 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH--DEEIIRGQVF 222
Query: 210 YSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEE 254
           + +        +S +    +  CL   P +R    ++  HP++++
Sbjct: 223 FRQR-------VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 260

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 104/219 (47%), Gaps = 16/219 (7%)
Query: 39  SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLD 98
           S+FL  E   +   + P+++   G  + SE + L+   +M++   G L + I        
Sbjct: 77  SQFLT-EGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKH---GDLRNFIRNETHNPT 132
Query: 99  ESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES-GAKIADFGCAK------WESE 151
              ++ +  Q+ +G+++L S + VH D+ +RN ++ E    K+ADFG A+      ++S 
Sbjct: 133 VKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSV 192
Query: 152 ALQSGG-TPM-FMAPEVARGEHQGFASDIWAVGCTVIEMASGGA-PWPNAADPMTVLYKI 208
             ++G   P+ +MA E  + +     SD+W+ G  + E+ + GA P+P+       +Y +
Sbjct: 193 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 252
Query: 209 AYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLL 247
              R L   P +      + +  C     + R + S+L+
Sbjct: 253 QGRRLLQ--PEYCPDPLYEVMLKCWHPKAEMRPSFSELV 289

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 104/219 (47%), Gaps = 16/219 (7%)
Query: 39  SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLD 98
           S+FL  E   +   + P+++   G  + SE + L+   +M++   G L + I        
Sbjct: 135 SQFLT-EGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKH---GDLRNFIRNETHNPT 190
Query: 99  ESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES-GAKIADFGCAK------WESE 151
              ++ +  Q+ +G+++L S + VH D+ +RN ++ E    K+ADFG A+      ++S 
Sbjct: 191 VKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 250
Query: 152 ALQSGG-TPM-FMAPEVARGEHQGFASDIWAVGCTVIEMASGGA-PWPNAADPMTVLYKI 208
             ++G   P+ +MA E  + +     SD+W+ G  + E+ + GA P+P+       +Y +
Sbjct: 251 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 310
Query: 209 AYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLL 247
              R L   P +      + +  C     + R + S+L+
Sbjct: 311 QGRRLLQ--PEYCPDPLYEVMLKCWHPKAEMRPSFSELV 347

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 104/219 (47%), Gaps = 16/219 (7%)
Query: 39  SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLD 98
           S+FL  E   +   + P+++   G  + SE + L+   +M++   G L + I        
Sbjct: 77  SQFLT-EGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKH---GDLRNFIRNETHNPT 132
Query: 99  ESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES-GAKIADFGCAK------WESE 151
              ++ +  Q+ +G+++L S + VH D+ +RN ++ E    K+ADFG A+      ++S 
Sbjct: 133 VKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 192
Query: 152 ALQSGG-TPM-FMAPEVARGEHQGFASDIWAVGCTVIEMASGGA-PWPNAADPMTVLYKI 208
             ++G   P+ +MA E  + +     SD+W+ G  + E+ + GA P+P+       +Y +
Sbjct: 193 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 252
Query: 209 AYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLL 247
              R L   P +      + +  C     + R + S+L+
Sbjct: 253 QGRRLLQ--PEYCPDPLYEVMLKCWHPKAEMRPSFSELV 289

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 102/219 (46%), Gaps = 16/219 (7%)
Query: 39  SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLD 98
           S+FL  E   +   + P+++   G  + SE + L   + + Y   G L + I        
Sbjct: 76  SQFLT-EGIIMKDFSHPNVLSLLGICLRSEGSPL---VVLPYMKHGDLRNFIRNETHNPT 131
Query: 99  ESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES-GAKIADFGCAK------WESE 151
              ++ +  Q+ +G+++L S + VH D+ +RN ++ E    K+ADFG A+      ++S 
Sbjct: 132 VKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 191
Query: 152 ALQSGG-TPM-FMAPEVARGEHQGFASDIWAVGCTVIEMASGGA-PWPNAADPMTVLYKI 208
             ++G   P+ +MA E  + +     SD+W+ G  + E+ + GA P+P+       +Y +
Sbjct: 192 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 251
Query: 209 AYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLL 247
              R L   P +      + +  C     + R + S+L+
Sbjct: 252 QGRRLLQ--PEYCPDPLYEVMLKCWHPKAEMRPSFSELV 288

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 102/219 (46%), Gaps = 16/219 (7%)
Query: 39  SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLD 98
           S+FL  E   +   + P+++   G  + SE + L+    + Y   G L + I        
Sbjct: 74  SQFLT-EGIIMKDFSHPNVLSLLGICLRSEGSPLV---VLPYMKHGDLRNFIRNETHNPT 129
Query: 99  ESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES-GAKIADFGCAK------WESE 151
              ++ +  Q+ +G+++L S + VH D+ +RN ++ E    K+ADFG A+      ++S 
Sbjct: 130 VKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 189
Query: 152 ALQSGG-TPM-FMAPEVARGEHQGFASDIWAVGCTVIEMASGGA-PWPNAADPMTVLYKI 208
             ++G   P+ +MA E  + +     SD+W+ G  + E+ + GA P+P+       +Y +
Sbjct: 190 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 249
Query: 209 AYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLL 247
              R L   P +      + +  C     + R + S+L+
Sbjct: 250 QGRRLLQ--PEYCPDPLYEVMLKCWHPKAEMRPSFSELV 286

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 104/219 (47%), Gaps = 16/219 (7%)
Query: 39  SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLD 98
           S+FL  E   +   + P+++   G  + SE + L+   +M++   G L + I        
Sbjct: 81  SQFLT-EGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKH---GDLRNFIRNETHNPT 136
Query: 99  ESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES-GAKIADFGCAK------WESE 151
              ++ +  Q+ +G+++L S + VH D+ +RN ++ E    K+ADFG A+      ++S 
Sbjct: 137 VKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 196
Query: 152 ALQSGG-TPM-FMAPEVARGEHQGFASDIWAVGCTVIEMASGGA-PWPNAADPMTVLYKI 208
             ++G   P+ +MA E  + +     SD+W+ G  + E+ + GA P+P+       +Y +
Sbjct: 197 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 256
Query: 209 AYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLL 247
              R L   P +      + +  C     + R + S+L+
Sbjct: 257 QGRRLLQ--PEYCPDPLYEVMLKCWHPKAEMRPSFSELV 293

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 60/248 (24%), Positives = 104/248 (41%), Gaps = 16/248 (6%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVF--AAKSTELPKSEFLQREQKFLSSLNSPHIVG 59
           D T    +G G    V         DV     K   + + EF++ E K + +L+   +V 
Sbjct: 25  DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIE-EAKVMMNLSHEKLVQ 83
Query: 60  YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN 119
             G  V ++   +   +  EY   G L + +     R     ++   + + + +EYL S 
Sbjct: 84  LYG--VCTKQRPIF--IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 139
Query: 120 RVVHCDIKSRNILMAESG-AKIADFGCAKW--ESEALQSGGTPM---FMAPEVARGEHQG 173
           + +H D+ +RN L+ + G  K++DFG +++  + E   S G+     +  PEV       
Sbjct: 140 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS 199
Query: 174 FASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNC 232
             SDIWA G  + E+ S G  P+    +  T  + IA    L   P   S++    + +C
Sbjct: 200 SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH-IAQGLRLYR-PHLASEKVYTIMYSC 257
Query: 233 LRRDPKER 240
                 ER
Sbjct: 258 WHEKADER 265

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 43/182 (23%), Positives = 84/182 (46%), Gaps = 16/182 (8%)
Query: 95  GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNIL--MAESGAKIADFGCAKWESEA 152
           G L E L  S+  Q+L+ + + H+  V+H DIK  NIL  +     K+ DFG      + 
Sbjct: 138 GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT 197
Query: 153 LQS--GGTPMFMAPEVAR-GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA 209
           + +   GT ++  PE  R   + G ++ +W++G  + +M  G  P+ +  D   +  ++ 
Sbjct: 198 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH--DEEIIGGQVF 255
Query: 210 YSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFC--SCTKQIQESNC 267
           + +        +S +    +  CL   P +R    ++  HP++++      T +I   + 
Sbjct: 256 FRQR-------VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSL 308
Query: 268 SP 269
           SP
Sbjct: 309 SP 310

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 43/182 (23%), Positives = 84/182 (46%), Gaps = 16/182 (8%)
Query: 95  GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNIL--MAESGAKIADFGCAKWESEA 152
           G L E L  S+  Q+L+ + + H+  V+H DIK  NIL  +     K+ DFG      + 
Sbjct: 137 GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT 196
Query: 153 LQS--GGTPMFMAPEVAR-GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA 209
           + +   GT ++  PE  R   + G ++ +W++G  + +M  G  P+ +  D   +  ++ 
Sbjct: 197 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH--DEEIIGGQVF 254
Query: 210 YSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFC--SCTKQIQESNC 267
           + +        +S +    +  CL   P +R    ++  HP++++      T +I   + 
Sbjct: 255 FRQR-------VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSL 307
Query: 268 SP 269
           SP
Sbjct: 308 SP 309

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 43/182 (23%), Positives = 84/182 (46%), Gaps = 16/182 (8%)
Query: 95  GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNIL--MAESGAKIADFGCAKWESEA 152
           G L E L  S+  Q+L+ + + H+  V+H DIK  NIL  +     K+ DFG      + 
Sbjct: 138 GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT 197
Query: 153 LQS--GGTPMFMAPEVAR-GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA 209
           + +   GT ++  PE  R   + G ++ +W++G  + +M  G  P+ +  D   +  ++ 
Sbjct: 198 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH--DEEIIGGQVF 255
Query: 210 YSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFC--SCTKQIQESNC 267
           + +        +S +    +  CL   P +R    ++  HP++++      T +I   + 
Sbjct: 256 FRQR-------VSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSL 308
Query: 268 SP 269
           SP
Sbjct: 309 SP 310

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 43/182 (23%), Positives = 84/182 (46%), Gaps = 16/182 (8%)
Query: 95  GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNIL--MAESGAKIADFGCAKWESEA 152
           G L E L  S+  Q+L+ + + H+  V+H DIK  NIL  +     K+ DFG      + 
Sbjct: 138 GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT 197
Query: 153 LQS--GGTPMFMAPEVAR-GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA 209
           + +   GT ++  PE  R   + G ++ +W++G  + +M  G  P+ +  D   +  ++ 
Sbjct: 198 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH--DEEIIGGQVF 255
Query: 210 YSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFC--SCTKQIQESNC 267
           + +        +S +    +  CL   P +R    ++  HP++++      T +I   + 
Sbjct: 256 FRQR-------VSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSL 308
Query: 268 SP 269
           SP
Sbjct: 309 SP 310

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 43/182 (23%), Positives = 84/182 (46%), Gaps = 16/182 (8%)
Query: 95  GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNIL--MAESGAKIADFGCAKWESEA 152
           G L E L  S+  Q+L+ + + H+  V+H DIK  NIL  +     K+ DFG      + 
Sbjct: 137 GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT 196
Query: 153 LQS--GGTPMFMAPEVAR-GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA 209
           + +   GT ++  PE  R   + G ++ +W++G  + +M  G  P+ +  D   +  ++ 
Sbjct: 197 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH--DEEIIGGQVF 254
Query: 210 YSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFC--SCTKQIQESNC 267
           + +        +S +    +  CL   P +R    ++  HP++++      T +I   + 
Sbjct: 255 FRQR-------VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSL 307
Query: 268 SP 269
           SP
Sbjct: 308 SP 309

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 53/259 (20%), Positives = 107/259 (41%), Gaps = 27/259 (10%)
Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL----------PKSEFLQREQKFLSS 51
           D     ++GQG+   +        GD      TE+            SE        +S 
Sbjct: 9   DLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSK 68
Query: 52  LNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQ 111
           L+  H+V   G  V  ++N L+     E+   G+L+  + +N   ++    +   +Q+  
Sbjct: 69  LSHKHLVLNYGVCVCGDENILV----QEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAA 124
Query: 112 GLEYLHSNRVVHCDIKSRNILMA-ESGAKIADFGCAKWESEALQSGGTPM--------FM 162
            + +L  N ++H ++ ++NIL+  E   K  +    K     +     P         ++
Sbjct: 125 AMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWV 184
Query: 163 APE-VARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFL 221
            PE +   ++   A+D W+ G T+ E+ SGG    +A D      K+ +  +  ++PA  
Sbjct: 185 PPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR---KLQFYEDRHQLPAPK 241
Query: 222 SKQANDFLSNCLRRDPKER 240
           + +  + ++NC+  +P  R
Sbjct: 242 AAELANLINNCMDYEPDHR 260
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	405
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-101
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	8e-95
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-82
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	3e-80
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	4e-78
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	3e-77
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-76
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	6e-75
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	6e-73
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	7e-72
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	9e-72
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-71
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	5e-71
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	1e-70
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-70
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-70
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-67
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	3e-67
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-66
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	3e-66
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	7e-65
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-64
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	6e-62
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	8e-58
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-57
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	4e-57
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	8e-57
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-56
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-56
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-55
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	3e-55
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-54
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-54
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-53
3aln_A	327	Dual specificity mitogen-activated protein kinase;	9e-53
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	5e-52
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	7e-52
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-50
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	4e-50
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	5e-50
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-49
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-49
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	4e-49
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	4e-49
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	5e-49
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-48
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-48
3bhy_A	283	Death-associated protein kinase 3; death associate	8e-48
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-47
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-47
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-47
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-47
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	3e-47
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	4e-47
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	5e-47
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	6e-47
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	6e-47
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	9e-47
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-46
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-46
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-46
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	3e-46
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	3e-46
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	3e-46
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	4e-46
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	5e-46
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-45
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-45
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	3e-45
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	4e-45
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	8e-45
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	8e-45
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	9e-45
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-44
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-44
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-44
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	6e-44
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-43
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	1e-43
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-43
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-43
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-43
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-43
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	3e-43
3ork_A	311	Serine/threonine protein kinase; structural genomi	3e-43
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-42
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-42
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	3e-42
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	3e-42
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	6e-42
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	6e-42
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	6e-42
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-41
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	3e-41
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	4e-41
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	6e-41
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	6e-41
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	7e-41
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	7e-41
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-40
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-40
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	3e-40
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	3e-40
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	4e-40
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	8e-40
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	9e-40
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-39
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-39
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-39
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	3e-39
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	5e-39
3o0g_A	292	Cell division protein kinase 5; kinase activator c	5e-39
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	6e-39
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	7e-39
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	8e-39
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-38
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-38
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-38
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-38
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-38
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-37
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-37
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-37
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-37
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	4e-37
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	5e-37
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	5e-37
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	5e-37
3niz_A	311	Rhodanese family protein; structural genomics, str	6e-37
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	7e-37
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-36
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-36
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-35
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-35
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	4e-35
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	4e-35
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	6e-35
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-34
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-34
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	6e-34
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	8e-34
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	4e-33
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	6e-33
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	9e-33
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-32
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-32
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-32
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	5e-32
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	8e-32
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-31
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-31
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-30
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	4e-30
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	7e-29
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	8e-29
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-28
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-28
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	5e-28
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	6e-28
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	7e-28
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	3e-27
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	4e-27
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	5e-27
3uqc_A	286	Probable conserved transmembrane protein; structur	6e-27
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	6e-27
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	9e-27
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-26
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-26
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	3e-26
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	5e-26
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	7e-26
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	8e-26
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	3e-25
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	3e-25
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	8e-25
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-24
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-24
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-24
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-24
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-24
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-24
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-24
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	6e-24
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	7e-24
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	7e-24
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-23
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-23
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	2e-23
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-23
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-23
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	3e-23
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	3e-23
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	4e-23
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	7e-23
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-22
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-22
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	2e-22
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	3e-22
3rp9_A	458	Mitogen-activated protein kinase; structural genom	3e-22
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	3e-22
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	5e-22
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	6e-22
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-21
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-21
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	3e-21
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	6e-21
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	9e-21
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-20
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	5e-20
4aoj_A	329	High affinity nerve growth factor receptor; transf	9e-20
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-19
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-19
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-19
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	4e-19
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-18
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	7e-06
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-18
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-17
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-17
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-17
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	3e-17
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	3e-17
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	3e-17
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	3e-17
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	5e-17
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	6e-17
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-16
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	1e-16
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-16
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-15
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	3e-15
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	3e-15
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	6e-15
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	9e-15
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-14
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	4e-13
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-05
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	3e-04

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  302 bits (776), Expect = e-101
 Identities = 89/266 (33%), Positives = 133/266 (50%), Gaps = 17/266 (6%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEF---LQREQKFLSSLNSPHIV 58
           +      +G+G+   V     L +    A K      S +   L  E      L   +IV
Sbjct: 23  ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIV 82

Query: 59  GYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRL--DESLIVSYTRQILQGLEYL 116
            Y G     E+  +   +FME  PGG+L+  +    G L  +E  I  YT+QIL+GL+YL
Sbjct: 83  QYLGSFS--ENGFI--KIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYL 138

Query: 117 HSNRVVHCDIKSRNIL-MAESGA-KIADFGCAKWESEALQSG----GTPMFMAPEVARGE 170
           H N++VH DIK  N+L    SG  KI+DFG +K  +          GT  +MAPE+    
Sbjct: 139 HDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKG 198

Query: 171 HQG--FASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDF 228
            +G   A+DIW++GCT+IEMA+G  P+    +P   ++K+   +  PE+P  +S +A  F
Sbjct: 199 PRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAF 258

Query: 229 LSNCLRRDPKERWAASQLLKHPFLEE 254
           +  C   DP +R  A+ LL   FL+ 
Sbjct: 259 ILKCFEPDPDKRACANDLLVDEFLKV 284

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  286 bits (734), Expect = 8e-95
 Identities = 76/264 (28%), Positives = 112/264 (42%), Gaps = 20/264 (7%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGYK 61
             T    +G+GS   V      ++G   A K   L        E    + L+SP IV   
Sbjct: 59  WMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR--VEELVACAGLSSPRIVPLY 116

Query: 62  GCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRV 121
           G     E   +  N+FME   GG+L   I +  G L E   + Y  Q L+GLEYLH+ R+
Sbjct: 117 GAVR--EGPWV--NIFMELLEGGSLGQLI-KQMGCLPEDRALYYLGQALEGLEYLHTRRI 171

Query: 122 VHCDIKSRNILMAESG--AKIADFGCAKWESEALQSG---------GTPMFMAPEVARGE 170
           +H D+K+ N+L++  G  A + DFG A                   GT   MAPEV  G+
Sbjct: 172 LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 231

Query: 171 HQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSR-ELPEVPAFLSKQANDFL 229
                 DIW+  C ++ M +G  PW        +  KIA     + E+P   +      +
Sbjct: 232 PCDAKVDIWSSCCMMLHMLNGCHPWTQ-YFRGPLCLKIASEPPPIREIPPSCAPLTAQAI 290

Query: 230 SNCLRRDPKERWAASQLLKHPFLE 253
              LR++P  R +A +L +     
Sbjct: 291 QEGLRKEPVHRASAMELRRKVGKA 314

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  253 bits (649), Expect = 1e-82
 Identities = 71/264 (26%), Positives = 116/264 (43%), Gaps = 15/264 (5%)

Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKS---TELPKSEF--LQREQKFLSSLNSPHI 57
                 IG+GS  TV       +    A       +L KSE    + E + L  L  P+I
Sbjct: 28  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 87

Query: 58  VGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLH 117
           V +     ++   K    L  E    GTL   + R    +   ++ S+ RQIL+GL++LH
Sbjct: 88  VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH 146

Query: 118 SNR--VVHCDIKSRNIL-MAESG-AKIADFGCAKWESEALQSG--GTPMFMAPEVARGEH 171
           +    ++H D+K  NI     +G  KI D G A  +  +      GTP FMAPE+   ++
Sbjct: 147 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEEKY 206

Query: 172 QGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEV-PAFLSKQANDFLS 230
              + D++A G  ++EMA+   P+         +Y+   S   P         +  + + 
Sbjct: 207 -DESVDVYAFGMCMLEMATSEYPYSE-CQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIE 264

Query: 231 NCLRRDPKERWAASQLLKHPFLEE 254
            C+R++  ER++   LL H F +E
Sbjct: 265 GCIRQNKDERYSIKDLLNHAFFQE 288

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  247 bits (633), Expect = 3e-80
 Identities = 73/281 (25%), Positives = 115/281 (40%), Gaps = 39/281 (13%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS-----EFLQREQKFLSSL-NSP 55
           ++     IG G   +V        G ++A K ++ P +     +   RE    + L    
Sbjct: 12  EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHS 71

Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEI---HRNGGRLDESLIVSYTRQILQG 112
           H+V Y       ED+ +   +  EY  GG+L D I   +R      E+ +     Q+ +G
Sbjct: 72  HVVRYFSAWA--EDDHM--LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127

Query: 113 LEYLHSNRVVHCDIKSRNILMAESG--------------------AKIADFGCAKWESEA 152
           L Y+HS  +VH DIK  NI ++ +                      KI D G     S  
Sbjct: 128 LRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP 187

Query: 153 LQSGGTPMFMAPEVARGEHQ-GFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYS 211
               G   F+A EV +  +     +DI+A+  TV+  A G  P P   D     ++I   
Sbjct: 188 QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAA-GAEPLPRNGDQW---HEIR-Q 242

Query: 212 RELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFL 252
             LP +P  LS++  + L   +  DP+ R +A  L+KH  L
Sbjct: 243 GRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVL 283

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  244 bits (624), Expect = 4e-78
 Identities = 76/337 (22%), Positives = 128/337 (37%), Gaps = 45/337 (13%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKS---TELPKSEF--LQREQKFLSSLN--S 54
            ++    IG G S+ V    +     ++A K     E         + E  +L+ L   S
Sbjct: 10  IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68

Query: 55  PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLE 114
             I+     ++T +       + ME      LN  + +    +D     SY + +L+ + 
Sbjct: 69  DKIIRLYDYEITDQY----IYMVMECG-NIDLNSWLKKKK-SIDPWERKSYWKNMLEAVH 122

Query: 115 YLHSNRVVHCDIKSRNILMAESGAKIADFGCAKWESEALQSG------GTPMFMAPEV-- 166
            +H + +VH D+K  N L+ +   K+ DFG A        S       GT  +M PE   
Sbjct: 123 TIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 182

Query: 167 ---------ARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEV 217
                             SD+W++GC +  M  G  P+    + ++ L+ I       E 
Sbjct: 183 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF 242

Query: 218 PAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSILDQGI 277
           P    K   D L  CL+RDPK+R +  +LL HP+++                T  ++Q  
Sbjct: 243 PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI--------------QTHPVNQMA 288

Query: 278 WNSVEETEESLGNLIHSTSKTSARERIERLSCSQGPS 314
             + EE +  LG L+   S  S  +  + L       
Sbjct: 289 KGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGG 325

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  243 bits (622), Expect = 3e-77
 Identities = 75/337 (22%), Positives = 127/337 (37%), Gaps = 45/337 (13%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKS---TELPKSEF--LQREQKFLSSLN--S 54
            ++    IG G S+ V    +     ++A K     E         + E  +L+ L   S
Sbjct: 57  IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115

Query: 55  PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLE 114
             I+     ++T +       + ME      LN  + +    +D     SY + +L+ + 
Sbjct: 116 DKIIRLYDYEITDQY----IYMVMECG-NIDLNSWLKKKK-SIDPWERKSYWKNMLEAVH 169

Query: 115 YLHSNRVVHCDIKSRNILMAESGAKIADFGCAKWESEALQSG------GTPMFMAPEV-- 166
            +H + +VH D+K  N L+ +   K+ DFG A        S       G   +M PE   
Sbjct: 170 TIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIK 229

Query: 167 ---------ARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEV 217
                             SD+W++GC +  M  G  P+    + ++ L+ I       E 
Sbjct: 230 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF 289

Query: 218 PAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSILDQGI 277
           P    K   D L  CL+RDPK+R +  +LL HP+++                T  ++Q  
Sbjct: 290 PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI--------------QTHPVNQMA 335

Query: 278 WNSVEETEESLGNLIHSTSKTSARERIERLSCSQGPS 314
             + EE +  LG L+   S  S  +  + L       
Sbjct: 336 KGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGG 372

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  238 bits (610), Expect = 2e-76
 Identities = 67/287 (23%), Positives = 115/287 (40%), Gaps = 31/287 (10%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKS---TELPKSEF--LQREQKFLSSLN--S 54
            ++    IG G S+ V    +     ++A K     E         + E  +L+ L   S
Sbjct: 29  IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87

Query: 55  PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLE 114
             I+     ++T +       + ME      LN  + +    +D     SY + +L+ + 
Sbjct: 88  DKIIRLYDYEITDQY----IYMVMECG-NIDLNSWLKKKK-SIDPWERKSYWKNMLEAVH 141

Query: 115 YLHSNRVVHCDIKSRNILMAESGAKIADFGCAKWESEALQSG------GTPMFMAPEVAR 168
            +H + +VH D+K  N L+ +   K+ DFG A        S       GT  +M PE  +
Sbjct: 142 TIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 201

Query: 169 GEHQ-----------GFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEV 217
                             SD+W++GC +  M  G  P+    + ++ L+ I       E 
Sbjct: 202 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF 261

Query: 218 PAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQIQE 264
           P    K   D L  CL+RDPK+R +  +LL HP+++       Q+ +
Sbjct: 262 PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAK 308

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  234 bits (600), Expect = 6e-75
 Identities = 71/263 (26%), Positives = 103/263 (39%), Gaps = 20/263 (7%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSLNSP 55
            + R   +G GS   V    S   G ++A K +  P      ++  L            P
Sbjct: 58  SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117

Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
             V  +      E   L   L  E   G +L       G  L E+ +  Y R  L  L +
Sbjct: 118 CCVRLEQAWE--EGGIL--YLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAH 172

Query: 116 LHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG---GTPMFMAPEVARGEH 171
           LHS  +VH D+K  NI +   G  K+ DFG       A       G P +MAPE+ +G +
Sbjct: 173 LHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGSY 232

Query: 172 QGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSN 231
            G A+D++++G T++E+A                 ++      PE  A LS +    L  
Sbjct: 233 -GTAADVFSLGLTILEVACNMELPHGGEG----WQQLRQGYLPPEFTAGLSSELRSVLVM 287

Query: 232 CLRRDPKERWAASQLLKHPFLEE 254
            L  DPK R  A  LL  P L +
Sbjct: 288 MLEPDPKLRATAEALLALPVLRQ 310

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  229 bits (586), Expect = 6e-73
 Identities = 72/279 (25%), Positives = 124/279 (44%), Gaps = 19/279 (6%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS------EFLQREQKFLSSLNSP 55
           ++     IG+G  + V  A  L  G   A K  ++             +E   L  LN P
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92

Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEI---HRNGGRLDESLIVSYTRQILQG 112
           +++ Y    +  EDN+L  N+ +E A  G L+  I    +    + E  +  Y  Q+   
Sbjct: 93  NVIKYYASFI--EDNEL--NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA 148

Query: 113 LEYLHSNRVVHCDIKSRNILMAESGA-KIADFGCAK---WESEALQSG-GTPMFMAPEVA 167
           LE++HS RV+H DIK  N+ +  +G  K+ D G  +    ++ A  S  GTP +M+PE  
Sbjct: 149 LEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI 208

Query: 168 RGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPA-FLSKQAN 226
                 F SDIW++GC + EMA+  +P+      +  L K     + P +P+   S++  
Sbjct: 209 HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELR 268

Query: 227 DFLSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQIQES 265
             ++ C+  DP++R   + +         C+ +      
Sbjct: 269 QLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLEHHH 307

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  228 bits (582), Expect = 7e-72
 Identities = 72/268 (26%), Positives = 124/268 (46%), Gaps = 25/268 (9%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKS---TELPKSE--FLQREQKFLSSLNSPH 56
            + R   IG+GS     L  S   G  +  K    + +   E    +RE   L+++  P+
Sbjct: 25  KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPN 84

Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEI-HRNGGRLDESLIVSYTRQILQGLEY 115
           IV Y+      E+  L   + M+Y  GG L   I  + G    E  I+ +  QI   L++
Sbjct: 85  IVQYRESFE--ENGSL--YIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKH 140

Query: 116 LHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG--------GTPMFMAPEV 166
           +H  +++H DIKS+NI + + G  ++ DFG A+     L S         GTP +++PE+
Sbjct: 141 VHDRKILHRDIKSQNIFLTKDGTVQLGDFGIAR----VLNSTVELARACIGTPYYLSPEI 196

Query: 167 ARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQAN 226
              +     SDIWA+GC + E+ +    +  A     ++ KI  S   P V    S    
Sbjct: 197 CENKPYNNKSDIWALGCVLYELCTLKHAF-EAGSMKNLVLKII-SGSFPPVSLHYSYDLR 254

Query: 227 DFLSNCLRRDPKERWAASQLLKHPFLEE 254
             +S   +R+P++R + + +L+  F+ +
Sbjct: 255 SLVSQLFKRNPRDRPSVNSILEKGFIAK 282

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  226 bits (578), Expect = 9e-72
 Identities = 100/265 (37%), Positives = 141/265 (53%), Gaps = 18/265 (6%)

Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL---PKSEFLQREQKFLSSLNSPHIVG 59
           +TR   IGQG+S TV  A  + +G   A +   L   PK E +  E   +    +P+IV 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 60  YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN 119
           Y    +    ++L   + MEY  GG+L D +      +DE  I +  R+ LQ LE+LHSN
Sbjct: 82  YLDSYLV--GDELW--VVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSN 135

Query: 120 RVVHCDIKSRNILMAESG-AKIADFG-CAKWESEALQSG---GTPMFMAPEVARGEHQGF 174
           +V+H DIKS NIL+   G  K+ DFG CA+   E  +     GTP +MAPEV   +  G 
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195

Query: 175 ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEV--PAFLSKQANDFLSNC 232
             DIW++G   IEM  G  P+ N  +P+  LY IA +   PE+  P  LS    DFL+ C
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLN-ENPLRALYLIA-TNGTPELQNPEKLSAIFRDFLNRC 253

Query: 233 LRRDPKERWAASQLLKHPFLEEFCS 257
           L  D ++R +A +LL+H FL+    
Sbjct: 254 LEMDVEKRGSAKELLQHQFLKIAKP 278

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  225 bits (575), Expect = 2e-71
 Identities = 94/277 (33%), Positives = 140/277 (50%), Gaps = 22/277 (7%)

Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL---PKSEFLQREQKFLSSLNSPHIVG 59
           W     +G G+   V  A +  +G + AAK  E     + E    E + L++ + P+IV 
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80

Query: 60  YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN 119
             G      D KL   + +E+ PGG ++  +      L E  I    RQ+L+ L +LHS 
Sbjct: 81  LLGAYY--HDGKLW--IMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK 136

Query: 120 RVVHCDIKSRNILMAESG-AKIADFG-CAKWESEALQSG---GTPMFMAPEVARGEHQ-- 172
           R++H D+K+ N+LM   G  ++ADFG  AK      +     GTP +MAPEV   E    
Sbjct: 137 RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKD 196

Query: 173 ---GFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSR--ELPEVPAFLSKQAND 227
               + +DIW++G T+IEMA    P     +PM VL KIA S    L   P+  S +  D
Sbjct: 197 TPYDYKADIWSLGITLIEMAQIEPPHHE-LNPMRVLLKIAKSDPPTLLT-PSKWSVEFRD 254

Query: 228 FLSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQIQE 264
           FL   L ++P+ R +A+QLL+HPF+    S  K ++E
Sbjct: 255 FLKIALDKNPETRPSAAQLLEHPFVSSITS-NKALRE 290

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  224 bits (574), Expect = 5e-71
 Identities = 85/263 (32%), Positives = 130/263 (49%), Gaps = 14/263 (5%)

Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL-PKSEFLQREQKFLSSLNSPHIVGYK 61
           +     +G+GS  +V  A    +G + A K   +    + + +E   +   +SPH+V Y 
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYY 90

Query: 62  GCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRV 121
           G     ++  L   + MEY   G+++D I      L E  I +  +  L+GLEYLH  R 
Sbjct: 91  GS--YFKNTDLW--IVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRK 146

Query: 122 VHCDIKSRNILMAESG-AKIADFG-CAKWESEALQSG---GTPMFMAPEVARGEHQGFAS 176
           +H DIK+ NIL+   G AK+ADFG   +      +     GTP +MAPEV +       +
Sbjct: 147 IHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVA 206

Query: 177 DIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEV--PAFLSKQANDFLSNCLR 234
           DIW++G T IEMA G  P+ +   PM  ++ I  +   P    P   S    DF+  CL 
Sbjct: 207 DIWSLGITAIEMAEGKPPYAD-IHPMRAIFMIP-TNPPPTFRKPELWSDNFTDFVKQCLV 264

Query: 235 RDPKERWAASQLLKHPFLEEFCS 257
           + P++R  A+QLL+HPF+     
Sbjct: 265 KSPEQRATATQLLQHPFVRSAKG 287

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  224 bits (572), Expect = 1e-70
 Identities = 85/265 (32%), Positives = 125/265 (47%), Gaps = 18/265 (6%)

Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL---PKSEFLQREQKFLSSLNSPHIVG 59
                 IG+GS+  V LA    SG   A K  +L    + E L  E   +      ++V 
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106

Query: 60  YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN 119
                +     +L   + ME+  GG L D + +   RL+E  I +    +LQ L YLH+ 
Sbjct: 107 MYKSYLV--GEELW--VLMEFLQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHAQ 160

Query: 120 RVVHCDIKSRNILMAESG-AKIADFG-CAKWESEALQSG---GTPMFMAPEVARGEHQGF 174
            V+H DIKS +IL+   G  K++DFG CA+   +  +     GTP +MAPEV        
Sbjct: 161 GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYAT 220

Query: 175 ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEV--PAFLSKQANDFLSNC 232
             DIW++G  VIEM  G  P+ +   P+  + ++      P++     +S    DFL   
Sbjct: 221 EVDIWSLGIMVIEMVDGEPPYFS-DSPVQAMKRLR-DSPPPKLKNSHKVSPVLRDFLERM 278

Query: 233 LRRDPKERWAASQLLKHPFLEEFCS 257
           L RDP+ER  A +LL HPFL +   
Sbjct: 279 LVRDPQERATAQELLDHPFLLQTGL 303

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  223 bits (570), Expect = 1e-70
 Identities = 96/272 (35%), Positives = 141/272 (51%), Gaps = 17/272 (6%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL----PKSEFLQREQKFLSSLNSPHI 57
            +T+   IG+GS   V      R+  V A K  +L     + E +Q+E   LS  +SP++
Sbjct: 23  LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 82

Query: 58  VGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLH 117
             Y G  +  +D KL   + MEY  GG+  D +    G LDE+ I +  R+IL+GL+YLH
Sbjct: 83  TKYYGSYL--KDTKLW--IIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLH 136

Query: 118 SNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG----GTPMFMAPEVARGEHQ 172
           S + +H DIK+ N+L++E G  K+ADFG A   ++         GTP +MAPEV +    
Sbjct: 137 SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAY 196

Query: 173 GFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNC 232
              +DIW++G T IE+A G  P      PM VL+ I      P +    SK   +F+  C
Sbjct: 197 DSKADIWSLGITAIELARGEPPHSE-LHPMKVLFLIP-KNNPPTLEGNYSKPLKEFVEAC 254

Query: 233 LRRDPKERWAASQLLKHPFLEEFCSCTKQIQE 264
           L ++P  R  A +LLKH F+      T  + E
Sbjct: 255 LNKEPSFRPTAKELLKHKFILRNAKKTSYLTE 286

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  222 bits (568), Expect = 2e-70
 Identities = 67/283 (23%), Positives = 118/283 (41%), Gaps = 28/283 (9%)

Query: 1   MDWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGY 60
           MD+     IG G    V  A     G  +  K  +   +E  +RE K L+ L+  +IV Y
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKY-NNEKAEREVKALAKLDHVNIVHY 69

Query: 61  KGC----------DVTSEDNKLMYNLF--MEYAPGGTLNDEIH-RNGGRLDESLIVSYTR 107
            GC             +        LF  ME+   GTL   I  R G +LD+ L +    
Sbjct: 70  NGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFE 129

Query: 108 QILQGLEYLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKW---ESEALQSGGTPMFMA 163
           QI +G++Y+HS ++++ D+K  NI + ++   KI DFG       + +  +S GT  +M+
Sbjct: 130 QITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMS 189

Query: 164 PEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSK 223
           PE    +  G   D++A+G  + E+          +        +        +     K
Sbjct: 190 PEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK---FFTDLRD----GIISDIFDK 242

Query: 224 QANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQIQESN 266
           +    L   L + P++R   S++L+   + +    + +  E +
Sbjct: 243 KEKTLLQKLLSKKPEDRPNTSEILRTLTVWK---KSPEKNERH 282

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  215 bits (550), Expect = 2e-67
 Identities = 82/274 (29%), Positives = 134/274 (48%), Gaps = 23/274 (8%)

Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEF--LQREQKFLSSL-NSPHIVG 59
           +     +G G+   V     +++G + A K  ++   E   +++E   L    +  +I  
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 85

Query: 60  YKGC----DVTSEDNKLMYNLFMEYAPGGTLNDEIH-RNGGRLDESLIVSYTRQILQGLE 114
           Y G     +    D++L   L ME+   G++ D I    G  L E  I    R+IL+GL 
Sbjct: 86  YYGAFIKKNPPGMDDQLW--LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLS 143

Query: 115 YLHSNRVVHCDIKSRNILMAESG-AKIADFG-CAKWESEALQSG---GTPMFMAPEVARG 169
           +LH ++V+H DIK +N+L+ E+   K+ DFG  A+ +    +     GTP +MAPEV   
Sbjct: 144 HLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIAC 203

Query: 170 EHQ-----GFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEV-PAFLSK 223
           +        F SD+W++G T IEMA G  P  +   PM  L+ I      P +     SK
Sbjct: 204 DENPDATYDFKSDLWSLGITAIEMAEGAPPLCD-MHPMRALFLIP-RNPAPRLKSKKWSK 261

Query: 224 QANDFLSNCLRRDPKERWAASQLLKHPFLEEFCS 257
           +   F+ +CL ++  +R A  QL+KHPF+ +  +
Sbjct: 262 KFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPN 295

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  214 bits (547), Expect = 3e-67
 Identities = 90/281 (32%), Positives = 136/281 (48%), Gaps = 35/281 (12%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS----EFLQREQKFLSSLNSPHI 57
           D+     IG G++A V  A      +  A K   L K     + L +E + +S  + P+I
Sbjct: 16  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNI 75

Query: 58  VGYKGCDVTSEDNKLMYNLFMEYAPGGTLND-------EIHRNGGRLDESLIVSYTRQIL 110
           V Y    V    ++L   L M+   GG++ D       +     G LDES I +  R++L
Sbjct: 76  VSYYTSFV--VKDELW--LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131

Query: 111 QGLEYLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSG---------GTPM 160
           +GLEYLH N  +H D+K+ NIL+ E G+ +IADFG + + +               GTP 
Sbjct: 132 EGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191

Query: 161 FMAPEV-ARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA--------YS 211
           +MAPEV  +     F +DIW+ G T IE+A+G AP+     PM VL              
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHK-YPPMKVLMLTLQNDPPSLETG 250

Query: 212 RELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFL 252
            +  E+     K     +S CL++DP++R  A++LL+H F 
Sbjct: 251 VQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFF 291

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  212 bits (543), Expect = 2e-66
 Identities = 69/282 (24%), Positives = 105/282 (37%), Gaps = 32/282 (11%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEF--LQREQKFLSSLNSPHIVG 59
           D+     +GQG+   V  A +      +A K     + +   +  E   L+SLN  ++V 
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVR 66

Query: 60  YKGCDVTSEDNKLMYNLF---------MEYAPGGTLNDEIHRNGGRLDESLIVSYTRQIL 110
           Y    +   +                 MEY   GTL D IH               RQIL
Sbjct: 67  YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQIL 126

Query: 111 QGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG------------- 156
           + L Y+HS  ++H D+K  NI + ES   KI DFG AK    +L                
Sbjct: 127 EALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDN 186

Query: 157 -----GTPMFMAPEVARGE-HQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAY 210
                GT M++A EV  G  H     D++++G    EM    +      + +  L  ++ 
Sbjct: 187 LTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILKKLRSVSI 246

Query: 211 SRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFL 252
               P+      K     +   +  DP +R  A  LL   +L
Sbjct: 247 -EFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  213 bits (545), Expect = 3e-66
 Identities = 85/266 (31%), Positives = 132/266 (49%), Gaps = 18/266 (6%)

Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS------EFLQREQKFLSSLNSPH 56
           ++    IG GS   V  A  +R+ +V A K             + + +E +FL  L  P+
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115

Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL 116
            + Y+GC +   ++     L MEY  G   +D +  +   L E  I + T   LQGL YL
Sbjct: 116 TIQYRGCYL--REHTAW--LVMEYCLGS-ASDLLEVHKKPLQEVEIAAVTHGALQGLAYL 170

Query: 117 HSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSGGTPMFMAPEVARGEHQ--- 172
           HS+ ++H D+K+ NIL++E G  K+ DFG A   + A    GTP +MAPEV     +   
Sbjct: 171 HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPYWMAPEVILAMDEGQY 230

Query: 173 GFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEV-PAFLSKQANDFLSN 231
               D+W++G T IE+A    P  N  + M+ LY IA   E P +     S+   +F+ +
Sbjct: 231 DGKVDVWSLGITCIELAERKPPLFN-MNAMSALYHIA-QNESPALQSGHWSEYFRNFVDS 288

Query: 232 CLRRDPKERWAASQLLKHPFLEEFCS 257
           CL++ P++R  +  LLKH F+     
Sbjct: 289 CLQKIPQDRPTSEVLLKHRFVLRERP 314

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  208 bits (531), Expect = 7e-65
 Identities = 58/296 (19%), Positives = 103/296 (34%), Gaps = 35/296 (11%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEF----LQREQKFLSSLNSPHI 57
           D+     +G+G    V  A +      +A K   LP  E     + RE K L+ L  P I
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 65

Query: 58  VGYKGCDVTSEDNKLMYN------LF--MEYAPGGTLNDEIHRNGGR--LDESLIVSYTR 107
           V Y    +     + +        L+  M+      L D ++        + S+ +    
Sbjct: 66  VRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFL 125

Query: 108 QILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAK----------------WES 150
           QI + +E+LHS  ++H D+K  NI        K+ DFG                     +
Sbjct: 126 QIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 185

Query: 151 EALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAY 210
                 GT ++M+PE   G       DI+++G  + E+     P  +             
Sbjct: 186 RHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---P-FSTQMERVRTLTDVR 241

Query: 211 SRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQIQESN 266
           + + P +           + + L   P ER  A  ++++   E+     K +    
Sbjct: 242 NLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQR 297

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  207 bits (528), Expect = 1e-64
 Identities = 67/273 (24%), Positives = 112/273 (41%), Gaps = 26/273 (9%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS-------EFLQREQKFLSSLNS 54
           D+   +TIG GS            G +   K  EL          + L  E   L  L  
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWK--ELDYGSMTEAEKQMLVSEVNLLRELKH 64

Query: 55  PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEI---HRNGGRLDESLIVSYTRQILQ 111
           P+IV Y    +   +  L   + MEY  GG L   I    +    LDE  ++    Q+  
Sbjct: 65  PNIVRYYDRIIDRTNTTL--YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122

Query: 112 GLEYLHS-----NRVVHCDIKSRNILMAESG-AKIADFGCAK---WESEALQSG-GTPMF 161
            L+  H      + V+H D+K  N+ +      K+ DFG A+    ++   ++  GTP +
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYY 182

Query: 162 MAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFL 221
           M+PE          SDIW++GC + E+ +   P+  A     +  KI    +   +P   
Sbjct: 183 MSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF-TAFSQKELAGKIR-EGKFRRIPYRY 240

Query: 222 SKQANDFLSNCLRRDPKERWAASQLLKHPFLEE 254
           S + N+ ++  L      R +  ++L++P + E
Sbjct: 241 SDELNEIITRMLNLKDYHRPSVEEILENPLILE 273

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  205 bits (522), Expect = 6e-62
 Identities = 66/281 (23%), Positives = 115/281 (40%), Gaps = 27/281 (9%)

Query: 1   MDWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNS-PHIVG 59
           + +     +G G+  T+ +   +      A K        F  RE + L   +  P+++ 
Sbjct: 24  ISFCPKDVLGHGAEGTI-VYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIR 82

Query: 60  YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN 119
           Y     T +D +  Y + +E     TL + + +          ++  +Q   GL +LHS 
Sbjct: 83  YFC---TEKDRQFQY-IAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSL 137

Query: 120 RVVHCDIKSRNILMAESG------AKIADFGCAKWESEALQS-------GGTPMFMAPEV 166
            +VH D+K  NIL++         A I+DFG  K  +    S        GT  ++APE+
Sbjct: 138 NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEM 197

Query: 167 ARG---EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKI-AYSRELPEVPAFLS 222
                 E+  +  DI++ GC    + S G+     +        + A S +         
Sbjct: 198 LSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHED 257

Query: 223 KQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQIQ 263
             A + +   +  DP++R +A  +LKHPF   F S  KQ+Q
Sbjct: 258 VIARELIEKMIAMDPQKRPSAKHVLKHPF---FWSLEKQLQ 295

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  192 bits (490), Expect = 8e-58
 Identities = 66/317 (20%), Positives = 110/317 (34%), Gaps = 71/317 (22%)

Query: 2   DWTRGHTIGQGSS--ATVSLATSLRSGDVFAAKSTELPKS-----EFLQREQKFLSSLNS 54
            +     IG+G     TV+LA    +G+    +   L         FLQ E       N 
Sbjct: 26  CYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNH 85

Query: 55  PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEI-HRNGGRLDESLIVSYTRQILQGL 113
           P+IV Y+   +   DN+L   +   +   G+  D I       ++E  I    + +L+ L
Sbjct: 86  PNIVPYRATFI--ADNEL--WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKAL 141

Query: 114 EYLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKW-----------ESEALQSGGTPMF 161
           +Y+H    VH  +K+ +IL++  G   ++                        S     +
Sbjct: 142 DYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPW 201

Query: 162 MAPEVARGEHQG--FASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA---------- 209
           ++PEV +   QG    SDI++VG T  E+A+G  P+ +      +L +            
Sbjct: 202 LSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD-MPATQMLLEKLNGTVPCLLDT 260

Query: 210 ----------------------------------YSRELPEVPAFLSKQANDFLSNCLRR 235
                                                         S   + F+  CL+R
Sbjct: 261 STIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQR 320

Query: 236 DPKERWAASQLLKHPFL 252
           +P  R +AS LL H F 
Sbjct: 321 NPDARPSASTLLNHSFF 337

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  190 bits (484), Expect = 1e-57
 Identities = 72/297 (24%), Positives = 115/297 (38%), Gaps = 50/297 (16%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAK----STELPKSEFLQREQKFLSSLNSPHI 57
            W     +GQG++A V      ++GD+FA K     + L   +   RE + L  LN  +I
Sbjct: 10  LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNI 69

Query: 58  VGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNG--GRLDESLIVSYTRQILQGLEY 115
           V  K   +  E       L ME+ P G+L   +        L ES  +   R ++ G+ +
Sbjct: 70  V--KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127

Query: 116 LHSNRVVHCDIKSRNILMAESGA-----KIADFGCAKW--ESEALQSG-GTPMFMAPEV- 166
           L  N +VH +IK  NI+           K+ DFG A+   + E   S  GT  ++ P++ 
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMY 187

Query: 167 -------ARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMT---VLYKI-------- 208
                     +  G   D+W++G T    A+G  P+     P     V+YKI        
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247

Query: 209 ------------AYSRELP---EVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHP 250
                        +S ++P    +   L       L+N L  D ++ W   Q     
Sbjct: 248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  189 bits (481), Expect = 4e-57
 Identities = 61/272 (22%), Positives = 97/272 (35%), Gaps = 23/272 (8%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAK---STELPKSEFLQREQKFLSSLNSPHIV 58
            +     +G+G  + V L   L  G  +A K     E    E  QRE       N P+I+
Sbjct: 30  HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89

Query: 59  GYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEI---HRNGGRLDESLIVSYTRQILQGLEY 115
                 +     K    L + +   GTL +EI      G  L E  I+     I +GLE 
Sbjct: 90  RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149

Query: 116 LHSNRVVHCDIKSRNILMAESG-AKIADFGCAK---------WESEALQSG----GTPMF 161
           +H+    H D+K  NIL+ + G   + D G             ++  LQ       T  +
Sbjct: 150 IHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISY 209

Query: 162 MAPEV---ARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVP 218
            APE+            +D+W++GC +  M  G  P+         +     ++      
Sbjct: 210 RAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQS 269

Query: 219 AFLSKQANDFLSNCLRRDPKERWAASQLLKHP 250
              S      L++ +  DP +R     LL   
Sbjct: 270 PRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL 301

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  186 bits (476), Expect = 8e-57
 Identities = 77/266 (28%), Positives = 124/266 (46%), Gaps = 28/266 (10%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEF--------LQREQKFLSSLN 53
           D+  G+ +G+GS A V  A S+ +G   A K   + K           +Q E K    L 
Sbjct: 12  DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKM--IDKKAMYKAGMVQRVQNEVKIHCQLK 69

Query: 54  SPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGL 113
            P I+         ED+  +Y L +E    G +N  +        E+    +  QI+ G+
Sbjct: 70  HPSILELYNY---FEDSNYVY-LVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGM 125

Query: 114 EYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG-------GTPMFMAPE 165
            YLHS+ ++H D+   N+L+  +   KIADFG     ++            GTP +++PE
Sbjct: 126 LYLHSHGILHRDLTLSNLLLTRNMNIKIADFG---LATQLKMPHEKHYTLCGTPNYISPE 182

Query: 166 VARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQA 225
           +A     G  SD+W++GC    +  G  P+ +       L K+    +  E+P+FLS +A
Sbjct: 183 IATRSAHGLESDVWSLGCMFYTLLIGRPPF-DTDTVKNTLNKV-VLADY-EMPSFLSIEA 239

Query: 226 NDFLSNCLRRDPKERWAASQLLKHPF 251
            D +   LRR+P +R + S +L HPF
Sbjct: 240 KDLIHQLLRRNPADRLSLSSVLDHPF 265

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  186 bits (475), Expect = 1e-56
 Identities = 68/271 (25%), Positives = 118/271 (43%), Gaps = 22/271 (8%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAK--STELPKSEF--LQREQKF-LSSLNSPH 56
           D      +G+G+   V     + SG + A K     +   E   L  +    + +++ P 
Sbjct: 8   DLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPF 67

Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGT--LNDEIHRNGGRLDESLIVSYTRQILQGLE 114
            V + G      +  +   + ME           ++   G  + E ++      I++ LE
Sbjct: 68  TVTFYGALFR--EGDVW--ICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALE 123

Query: 115 YLHSN-RVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG---GTPMFMAPEVARG 169
           +LHS   V+H D+K  N+L+   G  K+ DFG + +  + +      G   +MAPE    
Sbjct: 124 HLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINP 183

Query: 170 EHQG----FASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPA-FLSKQ 224
           E         SDIW++G T+IE+A    P+ +   P   L ++      P++PA   S +
Sbjct: 184 ELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEE-PSPQLPADKFSAE 242

Query: 225 ANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
             DF S CL+++ KER    +L++HPF    
Sbjct: 243 FVDFTSQCLKKNSKERPTYPELMQHPFFTLH 273

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  184 bits (470), Expect = 2e-55
 Identities = 69/273 (25%), Positives = 118/273 (43%), Gaps = 23/273 (8%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAK--STELPKSEF--LQREQKFL-SSLNSPHIVGYKGC 63
           +G G+   V      ++G V A K       K E   +  +   +  S + P+IV   G 
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92

Query: 64  DVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNR-VV 122
            +T  +  +   + ME   G        R  G + E ++   T  I++ L YL     V+
Sbjct: 93  FIT--NTDVF--IAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVI 147

Query: 123 HCDIKSRNILMAESG-AKIADFGCAKWESEALQ---SGGTPMFMAPEV-----ARGEHQG 173
           H D+K  NIL+ E G  K+ DFG +    +      S G   +MAPE             
Sbjct: 148 HRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYD 207

Query: 174 FASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSR--ELPEVPAFLSKQANDFLSN 231
             +D+W++G +++E+A+G  P+ N      VL K+       LP    F S     F+ +
Sbjct: 208 IRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGF-SGDFQSFVKD 266

Query: 232 CLRRDPKERWAASQLLKHPFLEEFCSCTKQIQE 264
           CL +D ++R   ++LL+H F++ + +    +  
Sbjct: 267 CLTKDHRKRPKYNKLLEHSFIKRYETLEVDVAS 299

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  182 bits (465), Expect = 3e-55
 Identities = 78/274 (28%), Positives = 127/274 (46%), Gaps = 21/274 (7%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEF--------LQREQKFLSSLN 53
           D+  G  +G+G    V LA   +S  + A K   L K++         L+RE +  S L 
Sbjct: 10  DFEIGRPLGKGKFGNVYLAREKQSKFILALKV--LFKAQLEKAGVEHQLRREVEIQSHLR 67

Query: 54  SPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGL 113
            P+I+   G      D   +Y L +EYAP GT+  E+ +   + DE    +Y  ++   L
Sbjct: 68  HPNILRLYG---YFHDATRVY-LILEYAPLGTVYREL-QKLSKFDEQRTATYITELANAL 122

Query: 114 EYLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSG--GTPMFMAPEVARGE 170
            Y HS RV+H DIK  N+L+  +G  KIADFG +     + ++   GT  ++ PE+  G 
Sbjct: 123 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGR 182

Query: 171 HQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLS 230
                 D+W++G    E   G  P+  A        +I+        P F+++ A D +S
Sbjct: 183 MHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRVE--FTFPDFVTEGARDLIS 239

Query: 231 NCLRRDPKERWAASQLLKHPFLEEFCSCTKQIQE 264
             L+ +P +R    ++L+HP++    S     Q 
Sbjct: 240 RLLKHNPSQRPMLREVLEHPWITANSSKPSNCQN 273

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  184 bits (469), Expect = 2e-54
 Identities = 72/296 (24%), Positives = 115/296 (38%), Gaps = 50/296 (16%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFA----AKSTELPKSEFLQREQKFLSSLNSPHI 57
            W     +GQG++A V      ++GD+FA       + L   +   RE + L  LN  +I
Sbjct: 10  LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNI 69

Query: 58  VGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEI--HRNGGRLDESLIVSYTRQILQGLEY 115
           V  K   +  E       L ME+ P G+L   +    N   L ES  +   R ++ G+ +
Sbjct: 70  V--KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127

Query: 116 LHSNRVVHCDIKSRNILMAESG-----AKIADFGCAKW--ESEALQSG-GTPMFMAPEV- 166
           L  N +VH +IK  NI+           K+ DFG A+   + E   S  GT  ++ P++ 
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMY 187

Query: 167 -------ARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMT---VLYKI-------- 208
                     +  G   D+W++G T    A+G  P+     P     V+YKI        
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247

Query: 209 ------------AYSRELP---EVPAFLSKQANDFLSNCLRRDPKERWAASQLLKH 249
                        +S ++P    +   L       L+N L  D ++ W   Q    
Sbjct: 248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  180 bits (460), Expect = 2e-54
 Identities = 75/263 (28%), Positives = 118/263 (44%), Gaps = 23/263 (8%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEF--------LQREQKFLSSLN 53
            + RG  +G+G  A     +   + +VFA K   +PKS          +  E     SL 
Sbjct: 16  RYVRGRFLGKGGFAKCFEISDADTKEVFAGKI--VPKSLLLKPHQREKMSMEISIHRSLA 73

Query: 54  SPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGL 113
             H+VG+ G     EDN  ++ + +E     +L +   R    L E     Y RQI+ G 
Sbjct: 74  HQHVVGFHGF---FEDNDFVF-VVLELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGC 128

Query: 114 EYLHSNRVVHCDIKSRNILMAESG-AKIADFGCA---KWESEALQ-SGGTPMFMAPEVAR 168
           +YLH NRV+H D+K  N+ + E    KI DFG A   +++ E  +   GTP ++APEV  
Sbjct: 129 QYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLS 188

Query: 169 GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDF 228
            +   F  D+W++GC +  +  G  P+      +   Y      E   +P  ++  A   
Sbjct: 189 KKGHSFEVDVWSIGCIMYTLLVGKPPFE--TSCLKETYLRIKKNEY-SIPKHINPVAASL 245

Query: 229 LSNCLRRDPKERWAASQLLKHPF 251
           +   L+ DP  R   ++LL   F
Sbjct: 246 IQKMLQTDPTARPTINELLNDEF 268

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  180 bits (458), Expect = 2e-53
 Identities = 75/260 (28%), Positives = 117/260 (45%), Gaps = 23/260 (8%)

Query: 5   RGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEF--------LQREQKFLSSLNSPH 56
           RG  +G+G  A     +   + +VFA K   +PKS          +  E     SL   H
Sbjct: 45  RGRFLGKGGFAKCFEISDADTKEVFAGKI--VPKSLLLKPHQREKMSMEISIHRSLAHQH 102

Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL 116
           +VG+ G     EDN  ++ + +E     +L +   R    L E     Y RQI+ G +YL
Sbjct: 103 VVGFHGF---FEDNDFVF-VVLELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYL 157

Query: 117 HSNRVVHCDIKSRNILMAESG-AKIADFGCA---KWESEALQ-SGGTPMFMAPEVARGEH 171
           H NRV+H D+K  N+ + E    KI DFG A   +++ E  +   GTP ++APEV   + 
Sbjct: 158 HRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKG 217

Query: 172 QGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSN 231
             F  D+W++GC +  +  G  P+      +   Y      E   +P  ++  A   +  
Sbjct: 218 HSFEVDVWSIGCIMYTLLVGKPPFE--TSCLKETYLRIKKNEY-SIPKHINPVAASLIQK 274

Query: 232 CLRRDPKERWAASQLLKHPF 251
            L+ DP  R   ++LL   F
Sbjct: 275 MLQTDPTARPTINELLNDEF 294

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  177 bits (452), Expect = 9e-53
 Identities = 64/267 (23%), Positives = 112/267 (41%), Gaps = 24/267 (8%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAK--STELPKSEF--LQREQKF-LSSLNSPHIVGYKGC 63
           IG+G+  +V+      SG + A K   + + + E   L  +    + S + P+IV + G 
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89

Query: 64  DVTSEDNKLMYNLFMEYAPGG---TLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNR 120
                +      + ME                    + E ++   T   ++ L +L  N 
Sbjct: 90  LFR--EGDCW--ICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL 145

Query: 121 -VVHCDIKSRNILMAESG-AKIADFGCAKWESEALQ---SGGTPMFMAPEVARGEHQG-- 173
            ++H DIK  NIL+  SG  K+ DFG +    +++      G   +MAPE          
Sbjct: 146 KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQG 205

Query: 174 --FASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSR--ELPEVPAFL-SKQANDF 228
               SD+W++G T+ E+A+G  P+P        L ++      +L        S    +F
Sbjct: 206 YDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINF 265

Query: 229 LSNCLRRDPKERWAASQLLKHPFLEEF 255
           ++ CL +D  +R    +LLKHPF+  +
Sbjct: 266 VNLCLTKDESKRPKYKELLKHPFILMY 292

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  176 bits (449), Expect = 5e-52
 Identities = 79/303 (26%), Positives = 131/303 (43%), Gaps = 54/303 (17%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAK--STELPKSEF--LQREQKFLSSLNSPHI 57
           D+ +   +G G+   V   +   SG V A K    E+  +    + RE + L   NSP+I
Sbjct: 34  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 93

Query: 58  VGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLH 117
           VG+ G   +  D ++  ++ ME+  GG+L D++ +  GR+ E ++   +  +++GL YL 
Sbjct: 94  VGFYGAFYS--DGEI--SICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLR 148

Query: 118 SNR-VVHCDIKSRNILMAESG-AKIADFGCAKW--ESEALQSGGTPMFMAPEVARGEHQG 173
               ++H D+K  NIL+   G  K+ DFG +    +S A    GT  +M+PE  +G H  
Sbjct: 149 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYS 208

Query: 174 FASDIWAVGCTVIEMASGGAPWPNAAD--------------------------------- 200
             SDIW++G +++EMA G  P P                                     
Sbjct: 209 VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFG 268

Query: 201 --------PMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFL 252
                      +L  I             S +  DF++ CL ++P ER    QL+ H F+
Sbjct: 269 MDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 328

Query: 253 EEF 255
           +  
Sbjct: 329 KRS 331

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  174 bits (443), Expect = 7e-52
 Identities = 75/257 (29%), Positives = 117/257 (45%), Gaps = 21/257 (8%)

Query: 6   GHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEF--------LQREQKFLSSLNSPHI 57
           G  +G+G    V LA   ++  + A K   L KS+         L+RE +  S L  P+I
Sbjct: 19  GRPLGKGKFGNVYLAREKQNKFIMALKV--LFKSQLEKEGVEHQLRREIEIQSHLRHPNI 76

Query: 58  VGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLH 117
           +          D K +Y L +E+AP G L  E+ +  GR DE    ++  ++   L Y H
Sbjct: 77  LRMYN---YFHDRKRIY-LMLEFAPRGELYKEL-QKHGRFDEQRSATFMEELADALHYCH 131

Query: 118 SNRVVHCDIKSRNILMAESG-AKIADFGCAKW-ESEALQSG-GTPMFMAPEVARGEHQGF 174
             +V+H DIK  N+LM   G  KIADFG +    S   ++  GT  ++ PE+  G+    
Sbjct: 132 ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCGTLDYLPPEMIEGKTHDE 191

Query: 175 ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLR 234
             D+W  G    E   G  P+ ++        +I       + P FLS  + D +S  LR
Sbjct: 192 KVDLWCAGVLCYEFLVGMPPF-DSPSHTETHRRIVNVD--LKFPPFLSDGSKDLISKLLR 248

Query: 235 RDPKERWAASQLLKHPF 251
             P +R     +++HP+
Sbjct: 249 YHPPQRLPLKGVMEHPW 265

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  174 bits (443), Expect = 2e-50
 Identities = 69/318 (21%), Positives = 128/318 (40%), Gaps = 55/318 (17%)

Query: 6   GHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLS-SLNSPHIVGYKGCD 64
              +G GSS TV    S   G   A K   +   +    E K L+ S + P+++ Y    
Sbjct: 20  EKILGYGSSGTVVFQGS-FQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYC-- 76

Query: 65  VTSEDNKLMYNLFMEYAPGGTLNDEIHRNG------GRLDESLIVSYTRQILQGLEYLHS 118
            +   ++ +Y + +E      L D +              E   +S  RQI  G+ +LHS
Sbjct: 77  -SETTDRFLY-IALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS 133

Query: 119 NRVVHCDIKSRNILMAESG--------------AKIADFGCAK--------WESEALQSG 156
            +++H D+K +NIL++ S                 I+DFG  K        + +      
Sbjct: 134 LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPS 193

Query: 157 GTPMFMAPEVARGEHQ-------GFASDIWAVGCTVIEMASGGAP--WPNAADPMTVLYK 207
           GT  + APE+    +          + DI+++GC    + S G        +    ++ +
Sbjct: 194 GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNII-R 252

Query: 208 IAYSRELPEVPAF--LSKQANDFLSNCLRRDPKERWAASQLLKHPF-------LEEFCSC 258
             +S +  +      L  +A D +S  +  DP +R  A ++L+HP        LE     
Sbjct: 253 GIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPKSKKLEFLLKV 312

Query: 259 TKQIQ-ESNCSPTSILDQ 275
           + +++ E+   P+++L +
Sbjct: 313 SDRLEIENRDPPSALLMK 330

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  169 bits (431), Expect = 4e-50
 Identities = 80/268 (29%), Positives = 117/268 (43%), Gaps = 29/268 (10%)

Query: 6   GHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS------EFLQREQKFLSSLNSPHIVG 59
              +G G+   V L     SG     K+  + K       E ++ E + L SL+ P+I+ 
Sbjct: 27  KRKLGSGAFGDVHLVEERSSGLERVIKT--INKDRSQVPMEQIEAEIEVLKSLDHPNIIK 84

Query: 60  YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEI---HRNGGRLDESLIVSYTRQILQGLEYL 116
                   ED   MY + ME   GG L + I      G  L E  +    +Q++  L Y 
Sbjct: 85  IFE---VFEDYHNMY-IVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140

Query: 117 HSNRVVHCDIKSRNILMA----ESGAKIADFGCAKW--ESEALQSG-GTPMFMAPEVARG 169
           HS  VVH D+K  NIL       S  KI DFG A+     E   +  GT ++MAPEV + 
Sbjct: 141 HSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKR 200

Query: 170 EHQGFASDIWAVGCTVIE--MASGGAPWPNAADPMTVLYKIAYSR-ELPEVPAFLSKQAN 226
           +   F  DIW+ G  V+   + +G  P+        V  K  Y           L+ QA 
Sbjct: 201 DV-TFKCDIWSAG--VVMYFLLTGCLPF-TGTSLEEVQQKATYKEPNYAVECRPLTPQAV 256

Query: 227 DFLSNCLRRDPKERWAASQLLKHPFLEE 254
           D L   L +DP+ R +A+Q+L H + ++
Sbjct: 257 DLLKQMLTKDPERRPSAAQVLHHEWFKQ 284

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  170 bits (432), Expect = 5e-50
 Identities = 75/278 (26%), Positives = 117/278 (42%), Gaps = 25/278 (8%)

Query: 6   GHTIGQGSSATVSLATSLRSGDVFAAKS---TELPKSEFLQREQKFLSSLNSPHIVGYKG 62
              +G G+ + V L     +G +FA K    +   +   L+ E   L  +   +IV  + 
Sbjct: 14  MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLED 73

Query: 63  CDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
                E     Y L M+   GG L D I   G    E       +Q+L  ++YLH N +V
Sbjct: 74  ---IYESTTHYY-LVMQLVSGGELFDRILERG-VYTEKDASLVIQQVLSAVKYLHENGIV 128

Query: 123 HCDIKSRNILMA----ESGAKIADFGCAKWESEALQSG--GTPMFMAPEVARGEHQGFAS 176
           H D+K  N+L       S   I DFG +K E   + S   GTP ++APEV   +    A 
Sbjct: 129 HRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYVAPEVLAQKPYSKAV 188

Query: 177 DIWAVGCTVIEMASGGAPWPNAADPMTVLYKI---AY---SRELPEVPAFLSKQANDFLS 230
           D W++G     +  G  P+        +  KI    Y   S    ++    S+ A DF+ 
Sbjct: 189 DCWSIGVITYILLCGYPPF-YEETESKLFEKIKEGYYEFESPFWDDI----SESAKDFIC 243

Query: 231 NCLRRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCS 268
           + L +DP ER+   + L HP+++   +  + I  S   
Sbjct: 244 HLLEKDPNERYTCEKALSHPWIDGNTALHRDIYPSVSL 281

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  170 bits (433), Expect = 1e-49
 Identities = 39/297 (13%), Positives = 76/297 (25%), Gaps = 43/297 (14%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS------EFLQREQKFLSSLNSP 55
                  +  G  + V L   +   + FA K   +         E L       + L   
Sbjct: 63  KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122

Query: 56  HIVGYKGCD--------------------VTSEDNKLMYNLF--MEYAPG-----GTLND 88
                +                          +D+  + N    M  A        +  D
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182

Query: 89  EIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGA-KIADFGCAK 147
            ++   G      +   T Q+++    L S  +VH      N+ +   G   + D     
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALW 242

Query: 148 WESEALQSGGTPMFMAPEV---ARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTV 204
                  +   P+  AP     A       A + W +G ++  +     P+      +  
Sbjct: 243 KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKG 302

Query: 205 LYKIAYSRELPEVP------AFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
            +K    R              L       +   L  D + R    + ++ P   + 
Sbjct: 303 SWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL 359

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  169 bits (430), Expect = 1e-49
 Identities = 73/290 (25%), Positives = 126/290 (43%), Gaps = 33/290 (11%)

Query: 5   RGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS-------EFLQREQKFLSSLNS-PH 56
               +G+G  A V    S  +G  +AAK   L K          +  E   L    S P 
Sbjct: 33  TSKELGRGKFAVVRQCISKSTGQEYAAKF--LKKRRRGQDCRAEILHEIAVLELAKSCPR 90

Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEI-HRNGGRLDESLIVSYTRQILQGLEY 115
           ++         E+   +  L +EYA GG +           + E+ ++   +QIL+G+ Y
Sbjct: 91  VINLHE---VYENTSEII-LILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYY 146

Query: 116 LHSNRVVHCDIKSRNILMA----ESGAKIADFGCAKW--ESEALQSG-GTPMFMAPEVAR 168
           LH N +VH D+K +NIL++        KI DFG ++    +  L+   GTP ++APE+  
Sbjct: 147 LHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILN 206

Query: 169 GEHQGFASDIWAVGCTVIE--MASGGAP-WPNAADPMTVLYKIAYSR-ELPEVPAF--LS 222
            +    A+D+W +G  +I   + +  +P      D       I+    +  E   F  +S
Sbjct: 207 YDPITTATDMWNIG--IIAYMLLTHTSPFV--GEDNQETYLNISQVNVDYSE-ETFSSVS 261

Query: 223 KQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSI 272
           + A DF+ + L ++P++R  A   L H +L+++        E   S +  
Sbjct: 262 QLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHPEETSSSSQT 311

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  169 bits (431), Expect = 4e-49
 Identities = 77/265 (29%), Positives = 126/265 (47%), Gaps = 26/265 (9%)

Query: 6   GHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS-----EFLQREQKFLSSLNSPHIVGY 60
              +G G+   V       +G VF AK   +          ++ E   ++ L+ P ++  
Sbjct: 56  LEELGSGAFGVVHRCVEKATGRVFVAKF--INTPYPLDKYTVKNEISIMNQLHHPKLINL 113

Query: 61  KGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNR 120
                  ED   M  L +E+  GG L D I     ++ E+ +++Y RQ  +GL+++H + 
Sbjct: 114 HD---AFEDKYEMV-LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS 169

Query: 121 VVHCDIKSRNILMA---ESGAKIADFGCAKW--ESEALQSG-GTPMFMAPEVARGEHQGF 174
           +VH DIK  NI+      S  KI DFG A      E ++    T  F APE+   E  GF
Sbjct: 170 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGF 229

Query: 175 ASDIWAVGCTVIE--MASGGAPWPNAADPMTVLYKIAYSR-ELPEVPAF--LSKQANDFL 229
            +D+WA+G  V+   + SG +P+    D +  L  +     E  E  AF  +S +A DF+
Sbjct: 230 YTDMWAIG--VLGYVLLSGLSPF-AGEDDLETLQNVKRCDWEFDE-DAFSSVSPEAKDFI 285

Query: 230 SNCLRRDPKERWAASQLLKHPFLEE 254
            N L+++P++R      L+HP+L+ 
Sbjct: 286 KNLLQKEPRKRLTVHDALEHPWLKG 310

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  169 bits (430), Expect = 4e-49
 Identities = 76/266 (28%), Positives = 122/266 (45%), Gaps = 26/266 (9%)

Query: 5   RGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS-----EFLQREQKFLSSLNSPHIVG 59
           +   +G G    V       +G   AAK   +        E ++ E   ++ L+  +++ 
Sbjct: 93  KTEILGGGRFGQVHKCEETATGLKLAAKI--IKTRGMKDKEEVKNEISVMNQLDHANLIQ 150

Query: 60  YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN 119
                   E    +  L MEY  GG L D I      L E   + + +QI +G+ ++H  
Sbjct: 151 LYD---AFESKNDIV-LVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQM 206

Query: 120 RVVHCDIKSRNILMAESGA---KIADFGCAKW--ESEALQSG-GTPMFMAPEVARGEHQG 173
            ++H D+K  NIL     A   KI DFG A+     E L+   GTP F+APEV   +   
Sbjct: 207 YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVS 266

Query: 174 FASDIWAVGCTVIE--MASGGAPWPNAADPMTVLYKI---AYSRELPEVPAFLSKQANDF 228
           F +D+W+VG  VI   + SG +P+    +    L  I    +  E  E    +S++A +F
Sbjct: 267 FPTDMWSVG--VIAYMLLSGLSPF-LGDNDAETLNNILACRWDLEDEEFQD-ISEEAKEF 322

Query: 229 LSNCLRRDPKERWAASQLLKHPFLEE 254
           +S  L ++   R +AS+ LKHP+L +
Sbjct: 323 ISKLLIKEKSWRISASEALKHPWLSD 348

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  167 bits (426), Expect = 5e-49
 Identities = 65/265 (24%), Positives = 119/265 (44%), Gaps = 27/265 (10%)

Query: 6   GHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS----EFLQREQKFLSSLNSPHIVGYK 61
              +G+G    V       S   + AK   +         +++E   L+     +I+   
Sbjct: 10  AEDLGRGEFGIVHRCVETSSKKTYMAKF--VKVKGTDQVLVKKEISILNIARHRNILHLH 67

Query: 62  GCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRV 121
               + E  + +  +  E+  G  + + I+ +   L+E  IVSY  Q+ + L++LHS+ +
Sbjct: 68  E---SFESMEELV-MIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNI 123

Query: 122 VHCDIKSRNILMA---ESGAKIADFGCAKW--ESEALQSG-GTPMFMAPEVARGEHQGFA 175
            H DI+  NI+      S  KI +FG A+     +  +     P + APEV + +    A
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTA 183

Query: 176 SDIWAVGCTVIE--MASGGAP-WPNAADPMTVLYKIAYSR-ELPEVPAF--LSKQANDFL 229
           +D+W++G   +   + SG  P    A     ++  I  +     E  AF  +S +A DF+
Sbjct: 184 TDMWSLG--TLVYVLLSGINPFL--AETNQQIIENIMNAEYTFDE-EAFKEISIEAMDFV 238

Query: 230 SNCLRRDPKERWAASQLLKHPFLEE 254
              L ++ K R  AS+ L+HP+L++
Sbjct: 239 DRLLVKERKSRMTASEALQHPWLKQ 263

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  167 bits (424), Expect = 1e-48
 Identities = 70/291 (24%), Positives = 121/291 (41%), Gaps = 33/291 (11%)

Query: 6   GHTIGQGSSATVSLATSLRSGDVFAAKS---------TELPKSEFLQREQKFLSSLNSPH 56
           G  +G G  A V       +G  +AAK                E ++RE   L  +   +
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN 76

Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL 116
           ++         E+   +  L +E   GG L D + +    L E    S+ +QIL G+ YL
Sbjct: 77  VITLHD---VYENRTDVV-LILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYL 131

Query: 117 HSNRVVHCDIKSRNILMAESGA-----KIADFGCAKW--ESEALQSG-GTPMFMAPEVAR 168
           H+ ++ H D+K  NI++ +        K+ DFG A    +    ++  GTP F+APE+  
Sbjct: 132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN 191

Query: 169 GEHQGFASDIWAVGCTVIE--MASGGAP-WPNAADPMTVLYKIAYSR-ELPEVPAF--LS 222
            E  G  +D+W++G  VI   + SG +P           L  I     +  E   F   S
Sbjct: 192 YEPLGLEADMWSIG--VITYILLSGASPFL--GDTKQETLANITSVSYDFDE-EFFSHTS 246

Query: 223 KQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSIL 273
           + A DF+   L ++ ++R    + L+HP++    +    ++  +       
Sbjct: 247 ELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVVNLENF 297

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  174 bits (441), Expect = 1e-48
 Identities = 73/343 (21%), Positives = 117/343 (34%), Gaps = 44/343 (12%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS----EFLQREQKFLSSLNSPHI 57
            W     +G G    V       +G+  A K      S    E    E + +  LN P++
Sbjct: 15  PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74

Query: 58  VGYKGCDVTSEDNKLMYN----LFMEYAPGGTLNDEIHRNG--GRLDESLIVSYTRQILQ 111
           V     +V     KL  N    L MEY  GG L   +++      L E  I +    I  
Sbjct: 75  V--SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 132

Query: 112 GLEYLHSNRVVHCDIKSRNILMAESGA----KIADFGCAKW--ESEALQSG-GTPMFMAP 164
            L YLH NR++H D+K  NI++         KI D G AK   + E      GT  ++AP
Sbjct: 133 ALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAP 192

Query: 165 EVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKI---------------- 208
           E+   +      D W+ G    E  +G  P+     P+    K+                
Sbjct: 193 ELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTG 252

Query: 209 --AYSRELPE---VPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEF--CSCTKQ 261
              +S  LP    +   L+ +   +L   L    ++R    Q       +        K 
Sbjct: 253 AVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLKL 312

Query: 262 IQESNCSPTSILDQGIWNSVEETEESLGNLIHSTSKTSARERI 304
           +   N     +    +     E  ++L + +   +     E+ 
Sbjct: 313 LSVMNMVSGRVHTYPVTE--NENLQNLKSWLQQDTGIPEEEQE 353

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  163 bits (415), Expect = 8e-48
 Identities = 76/272 (27%), Positives = 117/272 (43%), Gaps = 33/272 (12%)

Query: 6   GHTIGQGSSATVSLATSLRSGDVFAAKS---------TELPKSEFLQREQKFLSSLNSPH 56
           G  +G G  A V       +G  +AAK                E ++RE   L  +  P+
Sbjct: 10  GEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPN 69

Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL 116
           I+         E+   +  L +E   GG L D +      L E     + +QIL G+ YL
Sbjct: 70  IITLHD---IFENKTDVV-LILELVSGGELFDFLAEKE-SLTEDEATQFLKQILDGVHYL 124

Query: 117 HSNRVVHCDIKSRNILMAESGA-----KIADFGCAKW--ESEALQSG-GTPMFMAPEVAR 168
           HS R+ H D+K  NI++ +        K+ DFG A         ++  GTP F+APE+  
Sbjct: 125 HSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVN 184

Query: 169 GEHQGFASDIWAVGCTVIE--MASGGAP-WPNAADPMTVLYKIAYSR-ELPEVPAF--LS 222
            E  G  +D+W++G  VI   + SG +P           L  I+    +  E   F   S
Sbjct: 185 YEPLGLEADMWSIG--VITYILLSGASPFL--GETKQETLTNISAVNYDFDE-EYFSNTS 239

Query: 223 KQANDFLSNCLRRDPKERWAASQLLKHPFLEE 254
           + A DF+   L +DPK R   +Q L+H +++ 
Sbjct: 240 ELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKA 271

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  163 bits (415), Expect = 1e-47
 Identities = 77/278 (27%), Positives = 122/278 (43%), Gaps = 32/278 (11%)

Query: 6   GHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS-------EFLQREQKFLSSLNSPHIV 58
              +G+G+ + V       +G  FAAK   +          + L+RE +    L  P+IV
Sbjct: 11  KEELGKGAFSVVRRCVHKTTGLEFAAKI--INTKKLSARDFQKLEREARICRKLQHPNIV 68

Query: 59  GYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHS 118
                  + ++    Y L  +   GG L ++I        E+      +QIL+ + Y HS
Sbjct: 69  RLHD---SIQEESFHY-LVFDLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCHS 123

Query: 119 NRVVHCDIKSRNILMA----ESGAKIADFGCAKW--ESEALQSG-GTPMFMAPEVARGEH 171
           N +VH ++K  N+L+A     +  K+ADFG A    +SEA     GTP +++PEV + + 
Sbjct: 124 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDP 183

Query: 172 QGFASDIWAVGCTVIE--MASGGAP-WPNAADPMTVLYKI---AYSRELPEVPAFLSKQA 225
                DIWA G  VI   +  G  P W    D   +  +I   AY    PE    ++ +A
Sbjct: 184 YSKPVDIWACG--VILYILLVGYPPFW--DEDQHRLYAQIKAGAYDYPSPEWDT-VTPEA 238

Query: 226 NDFLSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQIQ 263
              + + L  +PK+R  A Q LK P++         I 
Sbjct: 239 KSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIH 276

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  162 bits (412), Expect = 2e-47
 Identities = 73/263 (27%), Positives = 118/263 (44%), Gaps = 23/263 (8%)

Query: 6   GHTIGQGSSATVSLATSLRSGDVFAAKS---TELPKSEFLQREQKFLSSLNSPHIVGYKG 62
            +TIG+GS   V +A    +    AAK      +   +  ++E + + SL+ P+I+    
Sbjct: 14  ENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYE 73

Query: 63  CDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
              T EDN  +Y L ME   GG L + +        ES      + +L  + Y H   V 
Sbjct: 74  ---TFEDNTDIY-LVMELCTGGELFERVVHKR-VFRESDAARIMKDVLSAVAYCHKLNVA 128

Query: 123 HCDIKSRNILMA----ESGAKIADFGCAKW--ESEALQSG-GTPMFMAPEVARGEHQGFA 175
           H D+K  N L      +S  K+ DFG A      + +++  GTP +++P+V  G + G  
Sbjct: 129 HRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGLY-GPE 187

Query: 176 SDIWAVGCTVIE--MASGGAPWPNAADPMTVLYKIAYSR-ELPEVP-AFLSKQANDFLSN 231
            D W+ G  V+   +  G  P+ +A     V+ KI       PE     +S QA   +  
Sbjct: 188 CDEWSAG--VMMYVLLCGYPPF-SAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRR 244

Query: 232 CLRRDPKERWAASQLLKHPFLEE 254
            L + PK+R  + Q L+H + E+
Sbjct: 245 LLTKSPKQRITSLQALEHEWFEK 267

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  166 bits (422), Expect = 2e-47
 Identities = 72/273 (26%), Positives = 126/273 (46%), Gaps = 31/273 (11%)

Query: 6   GHTIGQGSSATVSLATSLRSGDVFAAKS-----------TELPKSEFLQREQKFLSSLNS 54
             T+G G+   V LA   ++    A +             E   +  ++ E + L  LN 
Sbjct: 140 SKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNH 199

Query: 55  PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLE 114
           P I+  K  +    ++   Y + +E   GG L D++  N  RL E+    Y  Q+L  ++
Sbjct: 200 PCIIKIK--NFFDAED---YYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQ 253

Query: 115 YLHSNRVVHCDIKSRNILMA----ESGAKIADFGCAKW--ESEALQSG-GTPMFMAPEVA 167
           YLH N ++H D+K  N+L++    +   KI DFG +K   E+  +++  GTP ++APEV 
Sbjct: 254 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 313

Query: 168 RGEHQ---GFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA---YSRELPEVPAFL 221
                     A D W++G  +    SG  P+      +++  +I    Y+         +
Sbjct: 314 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAE-V 372

Query: 222 SKQANDFLSNCLRRDPKERWAASQLLKHPFLEE 254
           S++A D +   L  DPK R+   + L+HP+L++
Sbjct: 373 SEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  163 bits (415), Expect = 2e-47
 Identities = 57/328 (17%), Positives = 102/328 (31%), Gaps = 80/328 (24%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEF----LQREQKFLSSLNSPHI 57
           D+     +G+G    V  A +      +A K   LP  E     + RE K L+ L  P I
Sbjct: 7   DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 66

Query: 58  VGYKGC-----------------------DVTSEDNKLMYNLFME--------------- 79
           V Y                          D        M    ++               
Sbjct: 67  VRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQ 126

Query: 80  ---------------YAPGGTLNDEIHRNGGR--LDESLIVSYTRQILQGLEYLHSNRVV 122
                                L D ++R       +  + +    QI + +E+LHS  ++
Sbjct: 127 LQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLM 186

Query: 123 HCDIKSRNILMAESG-AKIADFGCAKWESEALQSG----------------GTPMFMAPE 165
           H D+K  NI        K+ DFG      +  +                  GT ++M+PE
Sbjct: 187 HRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPE 246

Query: 166 VARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQA 225
              G +     DI+++G  + E+        +       +     + + P +      Q 
Sbjct: 247 QIHGNNYSHKVDIFSLGLILFELLYS----FSTQMERVRIITDVRNLKFPLLFTQKYPQE 302

Query: 226 NDFLSNCLRRDPKERWAASQLLKHPFLE 253
           +  + + L   P ER  A+ ++++   E
Sbjct: 303 HMMVQDMLSPSPTERPEATDIIENAIFE 330

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  164 bits (416), Expect = 3e-47
 Identities = 72/286 (25%), Positives = 122/286 (42%), Gaps = 33/286 (11%)

Query: 6   GHTIGQGSSATVSLATSLRSGDVFAAKS---------TELPKSEFLQREQKFLSSLNSPH 56
           G  +G G  A V       +G  +AAK                E ++RE   L  +  P+
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPN 76

Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL 116
           I+         E+   +  L +E   GG L D + +    L E    S+ +QIL G+ YL
Sbjct: 77  IITLHD---VYENRTDVV-LILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYL 131

Query: 117 HSNRVVHCDIKSRNILMAESGA-----KIADFGCAKW--ESEALQSG-GTPMFMAPEVAR 168
           H+ ++ H D+K  NI++ +        K+ DFG A    +    ++  GTP F+APE+  
Sbjct: 132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN 191

Query: 169 GEHQGFASDIWAVGCTVIE--MASGGAP-WPNAADPMTVLYKIAYSR-ELPEVPAF--LS 222
            E  G  +D+W++G  VI   + SG +P           L  I     +  E   F   S
Sbjct: 192 YEPLGLEADMWSIG--VITYILLSGASPFL--GDTKQETLANITAVSYDFDE-EFFSQTS 246

Query: 223 KQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCS 268
           + A DF+   L ++ ++R    + L+HP++    +    ++  +  
Sbjct: 247 ELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESVV 292

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  162 bits (413), Expect = 4e-47
 Identities = 75/274 (27%), Positives = 116/274 (42%), Gaps = 37/274 (13%)

Query: 6   GHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS-----------EFLQREQKFLSSLNS 54
           G  +G G  A V       +G  +AAK   + K            E ++RE   L  +  
Sbjct: 16  GEELGSGQFAVVKKCREKSTGLQYAAKF--IKKRRTKSSRRGVSREDIEREVSILKEIQH 73

Query: 55  PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLE 114
           P+++         E+   +  L +E   GG L D +      L E     + +QIL G+ 
Sbjct: 74  PNVITLHE---VYENKTDVI-LILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVY 128

Query: 115 YLHSNRVVHCDIKSRNILMAESGA-----KIADFGCAKW--ESEALQSG-GTPMFMAPEV 166
           YLHS ++ H D+K  NI++ +        KI DFG A         ++  GTP F+APE+
Sbjct: 129 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI 188

Query: 167 ARGEHQGFASDIWAVGCTVIE--MASGGAP-WPNAADPMTVLYKI---AYSRELPEVPAF 220
              E  G  +D+W++G  VI   + SG +P           L  +    Y  E       
Sbjct: 189 VNYEPLGLEADMWSIG--VITYILLSGASPFL--GDTKQETLANVSAVNYEFEDEYFSN- 243

Query: 221 LSKQANDFLSNCLRRDPKERWAASQLLKHPFLEE 254
            S  A DF+   L +DPK+R      L+HP+++ 
Sbjct: 244 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 277

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  161 bits (410), Expect = 5e-47
 Identities = 73/271 (26%), Positives = 124/271 (45%), Gaps = 31/271 (11%)

Query: 6   GHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS-------EFLQREQKFLSSLNSPHIV 58
              +G+GS   V       +   +A K   + K+         + RE + L  L+ P+I+
Sbjct: 27  VCMLGKGSFGEVLKCKDRITQQEYAVKV--INKASAKNKDTSTILREVELLKKLDHPNIM 84

Query: 59  GYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHS 118
                    ED+   Y +  E   GG L DEI +   R  E       +Q+  G+ Y+H 
Sbjct: 85  KLFE---ILEDSSSFY-IVGELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMHK 139

Query: 119 NRVVHCDIKSRNILMA----ESGAKIADFGCAKW--ESEALQSG-GTPMFMAPEVARGEH 171
           + +VH D+K  NIL+     +   KI DFG +    ++  ++   GT  ++APEV RG +
Sbjct: 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTY 199

Query: 172 QGFASDIWAVGCTVIE--MASGGAPWPNAADPMTVLYKI---AYSRELPEVPAFLSKQAN 226
                D+W+ G  VI   + SG  P+    +   +L ++    Y+ +LP+    +S  A 
Sbjct: 200 -DEKCDVWSAG--VILYILLSGTPPF-YGKNEYDILKRVETGKYAFDLPQWRT-ISDDAK 254

Query: 227 DFLSNCLRRDPKERWAASQLLKHPFLEEFCS 257
           D +   L   P  R  A+Q L+HP+++++ S
Sbjct: 255 DLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  164 bits (415), Expect = 6e-47
 Identities = 45/299 (15%), Positives = 87/299 (29%), Gaps = 53/299 (17%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAK---STELPKSEFLQR------EQKFLSSL 52
              RG  +GQ        AT   +G+ F       TE P S  +++        + L  +
Sbjct: 74  TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133

Query: 53  NSPHIVG--------------------YKGCDVTSEDNKLMYNLFMEYAPG--GTLNDEI 90
            +                          +      +   L              T  + +
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193

Query: 91  H---RNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCA 146
                    L     +  T Q+++ L  LH   +VH  ++  +I++ + G   +  F   
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL 253

Query: 147 KWESEALQSGGTPMFMAPEV-----------ARGEHQGFASDIWAVGCTVIEMASGGAPW 195
             +   + S  +  F  PE+            R     F+ D WA+G  +  +     P 
Sbjct: 254 VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPI 313

Query: 196 PNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEE 254
               D      +  +          + +     L   LR   ++R    Q ++ P  E+
Sbjct: 314 T--KDAALGGSEWIFRS-----CKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 365

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  163 bits (413), Expect = 6e-47
 Identities = 76/320 (23%), Positives = 118/320 (36%), Gaps = 69/320 (21%)

Query: 6   GHTIGQGSSATVSLATSLRSGDVFAAKS--------TELPKSEFLQREQKFLSSLNSPHI 57
              IGQGS   V +A   ++  + A K               E ++ E + +  L+ P+I
Sbjct: 31  KGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNI 90

Query: 58  VGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGR--------------------- 96
                     ED + +  L ME   GG L D+++                          
Sbjct: 91  ARLYEV---YEDEQYIC-LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECN 146

Query: 97  ------------------LDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMA---E 135
                               E LI +  RQI   L YLH+  + H DIK  N L +    
Sbjct: 147 EEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKS 206

Query: 136 SGAKIADFGCAKWESEALQSG--------GTPMFMAPEVARGEHQ--GFASDIWAVGCTV 185
              K+ DFG +K   +             GTP F+APEV    ++  G   D W+ G  +
Sbjct: 207 FEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266

Query: 186 IEMASGGAPWPNAADPMTVLYKI---AYSRELPEVPAFLSKQANDFLSNCLRRDPKERWA 242
             +  G  P+    +    + ++       E P     LS  A D LSN L R+  ER+ 
Sbjct: 267 HLLLMGAVPF-PGVNDADTISQVLNKKLCFENPNYNV-LSPLARDLLSNLLNRNVDERFD 324

Query: 243 ASQLLKHPFLEEFCSCTKQI 262
           A + L+HP++ +F     ++
Sbjct: 325 AMRALQHPWISQFSDKIYKM 344

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  166 bits (422), Expect = 9e-47
 Identities = 73/283 (25%), Positives = 124/283 (43%), Gaps = 25/283 (8%)

Query: 6   GHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS-------EFLQREQKFLSSLNSPHIV 58
              +G G+   V L     +    A K   + K+         L  E   L  L+ P+I+
Sbjct: 42  VKKLGSGAYGEVLLCRDKVTHVERAIKI--IRKTSVSTSSNSKLLEEVAVLKLLDHPNIM 99

Query: 59  GYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHS 118
                    ED +  Y L ME   GG L DEI     + +E       +Q+L G+ YLH 
Sbjct: 100 KLYD---FFEDKRNYY-LVMECYKGGELFDEIIHRM-KFNEVDAAVIIKQVLSGVTYLHK 154

Query: 119 NRVVHCDIKSRNILMA----ESGAKIADFGCAK--WESEALQSG-GTPMFMAPEVARGEH 171
           + +VH D+K  N+L+     ++  KI DFG +      + ++   GT  ++APEV R ++
Sbjct: 155 HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRKKY 214

Query: 172 QGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSR-ELPEVP-AFLSKQANDFL 229
                D+W++G  +  + +G  P+        +L K+   +          +S+ A D +
Sbjct: 215 -DEKCDVWSIGVILFILLAGYPPF-GGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLI 272

Query: 230 SNCLRRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSI 272
              L+ D + R +A Q L+HP+++E CS  +   E      +I
Sbjct: 273 KQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANAI 315

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  166 bits (421), Expect = 1e-46
 Identities = 78/270 (28%), Positives = 122/270 (45%), Gaps = 28/270 (10%)

Query: 6   GHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS--------EFLQREQKFLSSLNSPHI 57
              +G+GS   V L     +G   A K   + K         E L RE + L  L+ P+I
Sbjct: 31  QRVLGKGSFGEVILCKDKITGQECAVKV--ISKRQVKQKTDKESLLREVQLLKQLDHPNI 88

Query: 58  VGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLH 117
           +         ED    Y L  E   GG L DEI     R  E       RQ+L G+ Y+H
Sbjct: 89  MKLYE---FFEDKGYFY-LVGEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYMH 143

Query: 118 SNRVVHCDIKSRNILMA----ESGAKIADFGCAK--WESEALQSG-GTPMFMAPEVARGE 170
            N++VH D+K  N+L+     ++  +I DFG +     S+ ++   GT  ++APEV  G 
Sbjct: 144 KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT 203

Query: 171 HQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKI---AYSRELPEVPAFLSKQAND 227
           +     D+W+ G  +  + SG  P+ N A+   +L K+    Y+ ELP+    +S+ A D
Sbjct: 204 Y-DEKCDVWSTGVILYILLSGCPPF-NGANEYDILKKVEKGKYTFELPQWKK-VSESAKD 260

Query: 228 FLSNCLRRDPKERWAASQLLKHPFLEEFCS 257
            +   L   P  R +A   L H +++ +  
Sbjct: 261 LIRKMLTYVPSMRISARDALDHEWIQTYTK 290

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  162 bits (412), Expect = 1e-46
 Identities = 78/282 (27%), Positives = 114/282 (40%), Gaps = 35/282 (12%)

Query: 6   GHTIGQGSSATVSLATSLRSGDVFAAKS--------TELPKSEFLQREQKFLSSLNSPHI 57
              IG+G  + V    +  +G  FA K         +    +E L+RE      L  PHI
Sbjct: 29  CEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHI 88

Query: 58  VGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNG---GRLDESLIVSYTRQILQGLE 114
           V       T   + ++Y +  E+  G  L  EI +         E++   Y RQIL+ L 
Sbjct: 89  VELLE---TYSSDGMLY-MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALR 144

Query: 115 YLHSNRVVHCDIKSRNILMA----ESGAKIADFGCAKW---ESEALQSG-GTPMFMAPEV 166
           Y H N ++H D+K   +L+A     +  K+  FG A              GTP FMAPEV
Sbjct: 145 YCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEV 204

Query: 167 ARGEHQGFASDIWAVGCTVIE--MASGGAP-WPNAADPMTVLYKI---AYSRELPEVPAF 220
            + E  G   D+W  G  VI   + SG  P +        +   I    Y     +    
Sbjct: 205 VKREPYGKPVDVWGCG--VILFILLSGCLPFY---GTKERLFEGIIKGKYKMNPRQWSH- 258

Query: 221 LSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQI 262
           +S+ A D +   L  DP ER    + L HP+L+E      +I
Sbjct: 259 ISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKI 300

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  166 bits (423), Expect = 2e-46
 Identities = 75/263 (28%), Positives = 123/263 (46%), Gaps = 22/263 (8%)

Query: 6   GHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS---EFLQREQKFLSSLNSPHIVGYKG 62
              +G G+   V   T   +G+ FAAK    P     E +++E + +S L  P +V    
Sbjct: 162 HEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHD 221

Query: 63  CDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
                ED+  M  +  E+  GG L +++     ++ E   V Y RQ+ +GL ++H N  V
Sbjct: 222 ---AFEDDNEMV-MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYV 277

Query: 123 HCDIKSRNILMA---ESGAKIADFGCAKW--ESEALQSG-GTPMFMAPEVARGEHQGFAS 176
           H D+K  NI+      +  K+ DFG        ++++   GT  F APEVA G+  G+ +
Sbjct: 278 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYT 337

Query: 177 DIWAVGCTVIE--MASGGAPWPNAADPMTVLYKIAYSR-ELPEVPAF--LSKQANDFLSN 231
           D+W+VG  V+   + SG +P+    +    L  +      + +  AF  +S+   DF+  
Sbjct: 338 DMWSVG--VLSYILLSGLSPF-GGENDDETLRNVKSCDWNMDD-SAFSGISEDGKDFIRK 393

Query: 232 CLRRDPKERWAASQLLKHPFLEE 254
            L  DP  R    Q L+HP+L  
Sbjct: 394 LLLADPNTRMTIHQALEHPWLTP 416

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  159 bits (404), Expect = 3e-46
 Identities = 65/264 (24%), Positives = 108/264 (40%), Gaps = 23/264 (8%)

Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK----SEFLQREQKFLSSLNSPHIV 58
           W    T+G+G+   V LA +  + +  A K  ++ +     E +++E      LN  ++V
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68

Query: 59  GYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHS 118
            +       E N   Y LF+EY  GG L D I  +   + E     +  Q++ G+ YLH 
Sbjct: 69  KFY--GHRREGNIQ-Y-LFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLHG 123

Query: 119 NRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG------GTPMFMAPEVARG-E 170
             + H DIK  N+L+ E    KI+DFG A       +        GT  ++APE+ +  E
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183

Query: 171 HQGFASDIWAVGCTVI--EMASGGAPWPNAADPMTVLYKIAYSRELPEVP-AFLSKQAND 227
                 D+W+  C ++   M +G  PW   +D           ++    P   +      
Sbjct: 184 FHAEPVDVWS--CGIVLTAMLAGELPWDQPSDSCQEYSDW-KEKKTYLNPWKKIDSAPLA 240

Query: 228 FLSNCLRRDPKERWAASQLLKHPF 251
            L   L  +P  R     + K  +
Sbjct: 241 LLHKILVENPSARITIPDIKKDRW 264

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  161 bits (410), Expect = 3e-46
 Identities = 79/278 (28%), Positives = 124/278 (44%), Gaps = 28/278 (10%)

Query: 6   GHTIGQGSSATVSLATSLRSGDVFAAKS---TELPKSEF--LQREQKFLSSLNSPHIVGY 60
              +G+G+ + V       +G  FAAK     +L   +F  L+RE +    L  P+IV  
Sbjct: 34  KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRL 93

Query: 61  KGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNR 120
                + ++    Y L  +   GG L ++I        E+      +QIL+ + Y HSN 
Sbjct: 94  HD---SIQEESFHY-LVFDLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCHSNG 148

Query: 121 VVHCDIKSRNILMA----ESGAKIADFGCAKW--ESEALQSG-GTPMFMAPEVARGEHQG 173
           +VH ++K  N+L+A     +  K+ADFG A    +SEA     GTP +++PEV + +   
Sbjct: 149 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYS 208

Query: 174 FASDIWAVGCTVIE--MASGGAP-WPNAADPMTVLYKI---AYSRELPEVPAFLSKQAND 227
              DIWA G  VI   +  G  P W    D   +  +I   AY    PE    ++ +A  
Sbjct: 209 KPVDIWACG--VILYILLVGYPPFW--DEDQHRLYAQIKAGAYDYPSPEWDT-VTPEAKS 263

Query: 228 FLSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQIQES 265
            + + L  +PK+R  A Q LK P++         I   
Sbjct: 264 LIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQ 301

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  164 bits (417), Expect = 3e-46
 Identities = 73/284 (25%), Positives = 129/284 (45%), Gaps = 27/284 (9%)

Query: 6   GHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS-------EFLQREQKFLSSLNSPHIV 58
              +G+GS   V       +   +A K   + K+         + RE + L  L+ P+I+
Sbjct: 27  VCMLGKGSFGEVLKCKDRITQQEYAVKV--INKASAKNKDTSTILREVELLKKLDHPNIM 84

Query: 59  GYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHS 118
                    ED+   Y +  E   GG L DEI +   R  E       +Q+  G+ Y+H 
Sbjct: 85  KLFE---ILEDSSSFY-IVGELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMHK 139

Query: 119 NRVVHCDIKSRNILMA----ESGAKIADFGCAK--WESEALQSG-GTPMFMAPEVARGEH 171
           + +VH D+K  NIL+     +   KI DFG +    ++  ++   GT  ++APEV RG +
Sbjct: 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTY 199

Query: 172 QGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKI---AYSRELPEVPAFLSKQANDF 228
                D+W+ G  +  + SG  P+    +   +L ++    Y+ +LP+    +S  A D 
Sbjct: 200 -DEKCDVWSAGVILYILLSGTPPF-YGKNEYDILKRVETGKYAFDLPQWRT-ISDDAKDL 256

Query: 229 LSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSI 272
           +   L   P  R  A+Q L+HP+++++ S T  I +     +++
Sbjct: 257 IRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESAM 300

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  160 bits (406), Expect = 4e-46
 Identities = 81/316 (25%), Positives = 133/316 (42%), Gaps = 41/316 (12%)

Query: 6   GHTIGQGSSATVSLATSLRSGDVFAAKS-----------TELPKSEFLQREQKFLSSLNS 54
             T+G G+   V LA   ++    A K             E   +  ++ E + L  LN 
Sbjct: 15  SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 74

Query: 55  PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLE 114
           P I+  K      +     Y + +E   GG L D++  N  RL E+    Y  Q+L  ++
Sbjct: 75  PCIIKIKN---FFDAED--YYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQ 128

Query: 115 YLHSNRVVHCDIKSRNILMA----ESGAKIADFGCAKW--ESEALQSG-GTPMFMAPEVA 167
           YLH N ++H D+K  N+L++    +   KI DFG +K   E+  +++  GTP ++APEV 
Sbjct: 129 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 188

Query: 168 RGEHQ---GFASDIWAVGCTVIE--MASGGAPWPNAADPMTVLYKI---AYSRELPEVPA 219
                     A D W++G  VI     SG  P+      +++  +I    Y+        
Sbjct: 189 VSVGTAGYNRAVDCWSLG--VILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA- 245

Query: 220 FLSKQANDFLSNCLRRDPKERWAASQLLKHPFL------EEFCSCTKQIQESNCSPTSIL 273
            +S++A D +   L  DPK R+   + L+HP+L       +F     +  ES   P  + 
Sbjct: 246 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENESTALPQVLA 305

Query: 274 DQGIWNSVEETEESLG 289
                       E+ G
Sbjct: 306 QPSTSRKRPREGEAEG 321

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  159 bits (404), Expect = 5e-46
 Identities = 81/279 (29%), Positives = 128/279 (45%), Gaps = 30/279 (10%)

Query: 6   GHTIGQGSSATVSLATSLRSGDVFAAK------STELPKSEFLQREQKFLSSLNSPHIVG 59
              IG GS  TV  A      DV A K            +EF  RE   +  L  P+IV 
Sbjct: 42  KEKIGAGSFGTVHRAE-WHGSDV-AVKILMEQDFHAERVNEF-LREVAIMKRLRHPNIVL 98

Query: 60  YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGR--LDESLIVSYTRQILQGLEYLH 117
           + G  VT   N    ++  EY   G+L   +H++G R  LDE   +S    + +G+ YLH
Sbjct: 99  FMGA-VTQPPN---LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH 154

Query: 118 SNR--VVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG----GTPMFMAPEVARGE 170
           +    +VH ++KS N+L+ +    K+ DFG ++ ++    S     GTP +MAPEV R E
Sbjct: 155 NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDE 214

Query: 171 HQGFASDIWAVGCTVI--EMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDF 228
                SD+++ G  VI  E+A+   PW N  +P  V+  + +  +  E+P  L+ Q    
Sbjct: 215 PSNEKSDVYSFG--VILWELATLQQPWGN-LNPAQVVAAVGFKCKRLEIPRNLNPQVAAI 271

Query: 229 LSNCLRRDPKERWAASQLLKHPFLEEFC-SCTKQIQESN 266
           +  C   +P +R + + ++    L     S       S+
Sbjct: 272 IEGCWTNEPWKRPSFATIMDL--LRPLIKSAVPPPNRSD 308

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  158 bits (402), Expect = 1e-45
 Identities = 77/271 (28%), Positives = 122/271 (45%), Gaps = 31/271 (11%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQR--------EQKFLSSLN 53
           D+  G  +G+GS +TV LA  L +   +A K   L K   ++         E+  +S L+
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRLD 88

Query: 54  SPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGL 113
            P  V       T +D++ +Y   + YA  G L   I + G   DE+    YT +I+  L
Sbjct: 89  HPFFVKLYF---TFQDDEKLY-FGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSAL 143

Query: 114 EYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG------GTPMFMAPEV 166
           EYLH   ++H D+K  NIL+ E    +I DFG AK  S   +        GT  +++PE+
Sbjct: 144 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 203

Query: 167 ARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQAN 226
              +    +SD+WA+GC + ++ +G  P+  A +   +  KI       + P     +A 
Sbjct: 204 LTEKSACKSSDLWALGCIIYQLVAGLPPF-RAGNEYLIFQKIIKLE--YDFPEKFFPKAR 260

Query: 227 DFLSNCLRRDPKERW------AASQLLKHPF 251
           D +   L  D  +R           L  HPF
Sbjct: 261 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 291

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  162 bits (413), Expect = 2e-45
 Identities = 68/279 (24%), Positives = 115/279 (41%), Gaps = 36/279 (12%)

Query: 6   GHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS------------------EFLQREQK 47
              +G G+   V L          A K   + KS                  E +  E  
Sbjct: 41  VRKLGSGAYGEVLLCKEKNGHSEKAIKV--IKKSQFDKGRYSDDNKNIEKFHEEIYNEIS 98

Query: 48  FLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTR 107
            L SL+ P+I+         ED K  Y L  E+  GG L ++I  N  + DE    +  +
Sbjct: 99  LLKSLDHPNIIKLFD---VFEDKKYFY-LVTEFYEGGELFEQI-INRHKFDECDAANIMK 153

Query: 108 QILQGLEYLHSNRVVHCDIKSRNILMA----ESGAKIADFGCAK--WESEALQSG-GTPM 160
           QIL G+ YLH + +VH DIK  NIL+         KI DFG +    +   L+   GT  
Sbjct: 154 QILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAY 213

Query: 161 FMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSR-ELPEVP- 218
           ++APEV + ++     D+W+ G  +  +  G  P+    +   ++ K+   +        
Sbjct: 214 YIAPEVLKKKY-NEKCDVWSCGVIMYILLCGYPPF-GGQNDQDIIKKVEKGKYYFDFNDW 271

Query: 219 AFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCS 257
             +S +A + +   L  D  +R  A + L   +++++ +
Sbjct: 272 KNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYAN 310

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  159 bits (403), Expect = 3e-45
 Identities = 76/265 (28%), Positives = 120/265 (45%), Gaps = 31/265 (11%)

Query: 6   GHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS---EFLQREQKFLSSLNSPHIVGYKG 62
              +G+G+++ V       +   +A K   L K+   + ++ E   L  L+ P+I+  K 
Sbjct: 58  ESELGRGATSIVYRCKQKGTQKPYALKV--LKKTVDKKIVRTEIGVLLRLSHPNIIKLKE 115

Query: 63  CDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
                E    +  L +E   GG L D I   G    E       +QIL+ + YLH N +V
Sbjct: 116 ---IFETPTEIS-LVLELVTGGELFDRIVEKG-YYSERDAADAVKQILEAVAYLHENGIV 170

Query: 123 HCDIKSRNILMA----ESGAKIADFGCAKW--ESEALQSG-GTPMFMAPEVARGEHQGFA 175
           H D+K  N+L A    ++  KIADFG +K       +++  GTP + APE+ RG   G  
Sbjct: 171 HRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPE 230

Query: 176 SDIWAVGCTVIE--MASGGAPWPNAADPMTVLYKI---AY---SRELPEVPAFLSKQAND 227
            D+W+VG  +I   +  G  P+ +      +  +I    Y   S    EV    S  A D
Sbjct: 231 VDMWSVG--IITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEV----SLNAKD 284

Query: 228 FLSNCLRRDPKERWAASQLLKHPFL 252
            +   +  DPK+R    Q L+HP++
Sbjct: 285 LVRKLIVLDPKKRLTTFQALQHPWV 309

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  157 bits (398), Expect = 4e-45
 Identities = 70/281 (24%), Positives = 111/281 (39%), Gaps = 39/281 (13%)

Query: 6   GHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS------------EFLQREQKFLSSLN 53
              +G+G S+ V       +   +A K  ++               E   +E   L  ++
Sbjct: 22  KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS 81

Query: 54  S-PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQG 112
             P+I+  K    T E N   + L  +    G L D +      L E       R +L+ 
Sbjct: 82  GHPNIIQLKD---TYETNTFFF-LVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEV 136

Query: 113 LEYLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKW--ESEALQSG-GTPMFMAPEVAR 168
           +  LH   +VH D+K  NIL+ +    K+ DFG +      E L+   GTP ++APE+  
Sbjct: 137 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIE 196

Query: 169 GEHQ------GFASDIWAVGCTVIE--MASGGAP-WPNAADPMTVLYKI---AYSRELPE 216
                     G   D+W+ G  VI   + +G  P W      M +L  I    Y    PE
Sbjct: 197 CSMNDNHPGYGKEVDMWSTG--VIMYTLLAGSPPFW--HRKQMLMLRMIMSGNYQFGSPE 252

Query: 217 VPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCS 257
                S    D +S  L   P++R+ A + L HPF +++  
Sbjct: 253 WDD-YSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVV 292

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  155 bits (395), Expect = 8e-45
 Identities = 63/277 (22%), Positives = 108/277 (38%), Gaps = 32/277 (11%)

Query: 2   DWTRGHTIGQGSSATVSLAT-----------SLRSGDVFAAKSTELPKSEFLQREQKFLS 50
           +      IG+G    V               SL  GD            EF QRE   +S
Sbjct: 20  EIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEF-QREVFIMS 78

Query: 51  SLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQIL 110
           +LN P+IV   G  + +        + ME+ P G L   +      +  S+ +     I 
Sbjct: 79  NLNHPNIVKLYGL-MHNP-----PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIA 132

Query: 111 QGLEYLHSNR--VVHCDIKSRNILMAESG------AKIADFGCAKWESEALQSG-GTPMF 161
            G+EY+ +    +VH D++S NI +          AK+ADFG ++    ++    G   +
Sbjct: 133 LGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLLGNFQW 192

Query: 162 MAPEVARGEHQGF--ASDIWAVGCTVIEMASGGAPWPN-AADPMTVLYKIAYSRELPEVP 218
           MAPE    E + +   +D ++    +  + +G  P+   +   +  +  I      P +P
Sbjct: 193 MAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIP 252

Query: 219 AFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
                +  + +  C   DPK+R   S ++K   L E 
Sbjct: 253 EDCPPRLRNVIELCWSGDPKKRPHFSYIVKE--LSEL 287

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  159 bits (405), Expect = 8e-45
 Identities = 72/268 (26%), Positives = 120/268 (44%), Gaps = 29/268 (10%)

Query: 6   GHTIGQGSSATVSLATSLRSGDVFAAKS-----TELPKSEFLQREQKFLSSLNSPHIVGY 60
              +G+G+ + V     + +G  +AA             + L+RE +    L  P+IV  
Sbjct: 16  FEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRL 75

Query: 61  KGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNR 120
                +  +    Y L  +   GG L ++I        E+      +QIL+ + + H   
Sbjct: 76  HD---SISEEGHHY-LIFDLVTGGELFEDIVARE-YYSEADASHCIQQILEAVLHCHQMG 130

Query: 121 VVHCDIKSRNILMA----ESGAKIADFGCA---KWESEALQSG-GTPMFMAPEVARGEHQ 172
           VVH ++K  N+L+A     +  K+ADFG A   + E +A     GTP +++PEV R +  
Sbjct: 131 VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPY 190

Query: 173 GFASDIWAVGCTVIE--MASGGAP-WPNAADPMTVLYKI---AYSRELPEVPAFLSKQAN 226
           G   D+WA G  VI   +  G  P W    D   +  +I   AY    PE    ++ +A 
Sbjct: 191 GKPVDLWACG--VILYILLVGYPPFW--DEDQHRLYQQIKAGAYDFPSPEWDT-VTPEAK 245

Query: 227 DFLSNCLRRDPKERWAASQLLKHPFLEE 254
           D ++  L  +P +R  A++ LKHP++  
Sbjct: 246 DLINKMLTINPSKRITAAEALKHPWISH 273

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  156 bits (396), Expect = 9e-45
 Identities = 71/279 (25%), Positives = 122/279 (43%), Gaps = 21/279 (7%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAK--STELPKSEFLQREQKFLSSLNSPHIVG 59
           +      +G+G+   V  A   R+ DV A K   +E  +  F   E + LS +N P+IV 
Sbjct: 9   EIEVEEVVGRGAFGVVCKAK-WRAKDV-AIKQIESESERKAF-IVELRQLSRVNHPNIVK 65

Query: 60  YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIH--RNGGRLDESLIVSYTRQILQGLEYLH 117
             G  +    N +   L MEYA GG+L + +H          +  +S+  Q  QG+ YLH
Sbjct: 66  LYGACL----NPVC--LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLH 119

Query: 118 S---NRVVHCDIKSRNILMAESG--AKIADFGCAKWESEALQSG-GTPMFMAPEVARGEH 171
           S     ++H D+K  N+L+   G   KI DFG A      + +  G+  +MAPEV  G +
Sbjct: 120 SMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAPEVFEGSN 179

Query: 172 QGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSN 231
                D+++ G  + E+ +   P+     P   +    ++   P +   L K     ++ 
Sbjct: 180 YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTR 239

Query: 232 CLRRDPKERWAASQLLKH--PFLEEFCSCTKQIQESNCS 268
           C  +DP +R +  +++K     +  F    + +Q     
Sbjct: 240 CWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQH 278

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  156 bits (396), Expect = 1e-44
 Identities = 70/315 (22%), Positives = 120/315 (38%), Gaps = 29/315 (9%)

Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFA----AKSTELPKSEFLQREQKFLSSLNSPHIV 58
           W    T+G+G+   V LA +  + +  A         +   E +++E      LN  ++V
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68

Query: 59  GYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHS 118
            +       E N   Y LF+EY  GG L D I  +   + E     +  Q++ G+ YLH 
Sbjct: 69  KFY--GHRREGNIQ-Y-LFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLHG 123

Query: 119 NRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG------GTPMFMAPEVARG-E 170
             + H DIK  N+L+ E    KI+DFG A       +        GT  ++APE+ +  E
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183

Query: 171 HQGFASDIWAVGCTVI--EMASGGAPWPNAADPMTVLYKIAYSRELPEVP-AFLSKQAND 227
                 D+W+  C ++   M +G  PW   +D           ++    P   +      
Sbjct: 184 FHAEPVDVWS--CGIVLTAMLAGELPWDQPSDSCQEYSDW-KEKKTYLNPWKKIDSAPLA 240

Query: 228 FLSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSILDQGIWNSVEETEES 287
            L   L  +P  R     + K  +        K +++    P         +    ++  
Sbjct: 241 LLHKILVENPSARITIPDIKKDRW------YNKPLKKGAKRPRVTSGGVSESPSGFSKHI 294

Query: 288 LGNLIHSTSKTSARE 302
             NL  S   +++R 
Sbjct: 295 QSNLDFSPVNSASRT 309

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  155 bits (393), Expect = 2e-44
 Identities = 75/260 (28%), Positives = 119/260 (45%), Gaps = 32/260 (12%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAK--STELPK-SEFL---QREQKFLSSLNSPHIVG-YK 61
           +G G  +TV LA         A K       +  E L   +RE    S L+  +IV    
Sbjct: 19  LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI- 77

Query: 62  GCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRV 121
             DV  E++   Y L MEY  G TL++ I  +G  L     +++T QIL G+++ H  R+
Sbjct: 78  --DV-DEEDDCYY-LVMEYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHAHDMRI 132

Query: 122 VHCDIKSRNILMAESG-AKIADFGCAKWESEA--LQSG---GTPMFMAPEVARGEHQGFA 175
           VH DIK +NIL+  +   KI DFG AK  SE    Q+    GT  + +PE A+GE     
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDEC 192

Query: 176 SDIWAVGCTVIEMASGGAPWPNAADPMTVLYK-------IAYSRELPEVPAFLSKQANDF 228
           +DI+++G  + EM  G  P+ N    +++  K          +    ++P  L    ++ 
Sbjct: 193 TDIYSIGIVLYEMLVGEPPF-NGETAVSIAIKHIQDSVPNVTTDVRKDIPQSL----SNV 247

Query: 229 LSNCLRRDPKERWA-ASQLL 247
           +     +D   R+    ++ 
Sbjct: 248 ILRATEKDKANRYKTIQEMK 267

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  155 bits (393), Expect = 2e-44
 Identities = 74/292 (25%), Positives = 122/292 (41%), Gaps = 52/292 (17%)

Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFL-------------------- 42
           +T    IG+GS   V LA +      +A K   L K + +                    
Sbjct: 15  YTLKDEIGKGSYGVVKLAYNENDNTYYAMK--VLSKKKLIRQAGFPRRPPPRGTRPAPGG 72

Query: 43  -----------QREQKFLSSLNSPHIVG-YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEI 90
                       +E   L  L+ P++V      +V  + N+    +  E    G + +  
Sbjct: 73  CIQPRGPIEQVYQEIAILKKLDHPNVVKLV---EVLDDPNEDHLYMVFELVNQGPVMEVP 129

Query: 91  HRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKW- 148
                 L E     Y + +++G+EYLH  +++H DIK  N+L+ E G  KIADFG +   
Sbjct: 130 TL--KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEF 187

Query: 149 -ESEAL--QSGGTPMFMAPEVARGEHQ---GFASDIWAVGCTVIEMASGGAPWPNAADPM 202
             S+AL   + GTP FMAPE      +   G A D+WA+G T+     G  P+      M
Sbjct: 188 KGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF-MDERIM 246

Query: 203 TVLYKIAYSRELPEVPAF--LSKQANDFLSNCLRRDPKERWAASQLLKHPFL 252
            +  KI    +  E P    +++   D ++  L ++P+ R    ++  HP++
Sbjct: 247 CLHSKI--KSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWV 296

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  155 bits (393), Expect = 6e-44
 Identities = 61/305 (20%), Positives = 113/305 (37%), Gaps = 60/305 (19%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEF-------------------- 41
           D+    T+ QG    + L    +    +A K     KS                      
Sbjct: 32  DYRIIRTLNQGKFNKIILCE--KDNKFYALKK--YEKSLLEKKRDFTKSNNDKISIKSKY 87

Query: 42  --LQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNG----- 94
              + E + ++ + + + +  +G      +   +Y +  EY    ++             
Sbjct: 88  DDFKNELQIITDIKNEYCLTCEG---IITNYDEVY-IIYEYMENDSILKFDEYFFVLDKN 143

Query: 95  --GRLDESLIVSYTRQILQGLEYLHSNR-VVHCDIKSRNILMAESGA-KIADFGCAKWES 150
               +   +I    + +L    Y+H+ + + H D+K  NILM ++G  K++DFG +++  
Sbjct: 144 YTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMV 203

Query: 151 EALQSG--GTPMFMAPEVARGE--HQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLY 206
           +    G  GT  FM PE    E  + G   DIW++G  +  M     P+      + +  
Sbjct: 204 DKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFN 263

Query: 207 KI-----------------AYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKH 249
            I                   +++      FLS +  DFL   LR++P ER  +   LKH
Sbjct: 264 NIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323

Query: 250 PFLEE 254
            +L +
Sbjct: 324 EWLAD 328

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  153 bits (390), Expect = 1e-43
 Identities = 61/270 (22%), Positives = 103/270 (38%), Gaps = 26/270 (9%)

Query: 4   TRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNS-PHIVGYKG 62
            +   +G+GS +        +S   FA K          Q+E   L      P+IV    
Sbjct: 14  LKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHE 73

Query: 63  CDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
                 D    + L ME   GG L + I +      E+      R+++  + ++H   VV
Sbjct: 74  ---VFHDQLHTF-LVMELLNGGELFERIKKKK-HFSETEASYIMRKLVSAVSHMHDVGVV 128

Query: 123 HCDIKSRNILMA----ESGAKIADFGCAKW---ESEALQSG-GTPMFMAPEVARGEHQGF 174
           H D+K  N+L          KI DFG A+    +++ L++   T  + APE+        
Sbjct: 129 HRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDE 188

Query: 175 ASDIWAVGCTVIE--MASGGAP-WPNAADPMTVLYKIAYSR------ELPEVP-AFLSKQ 224
           + D+W++G  VI   M SG  P   +              +               +S++
Sbjct: 189 SCDLWSLG--VILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQE 246

Query: 225 ANDFLSNCLRRDPKERWAASQLLKHPFLEE 254
           A D +   L  DP +R   S L  + +L++
Sbjct: 247 AKDLIQGLLTVDPNKRLKMSGLRYNEWLQD 276

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  156 bits (395), Expect = 1e-43
 Identities = 46/296 (15%), Positives = 84/296 (28%), Gaps = 52/296 (17%)

Query: 4   TRGHTIGQGSSATVSLATSLRSGDVFAAK---STELPKSEFLQREQ------KFLSSLNS 54
            RG  +GQ        AT   +G+ F       TE P S  +++ +      + L  + +
Sbjct: 81  VRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKN 140

Query: 55  PHIVGYKGCDVTSED--------------------NKLMYNLFMEYAPG-----GTLNDE 89
                     +   D                      L                G +   
Sbjct: 141 QKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLS 200

Query: 90  IHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKW 148
                  L     +  T Q+++ L  LH   +VH  ++  +I++ + G   +  F     
Sbjct: 201 HSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 260

Query: 149 ESEALQSG-----GTPMFMAPEVARGEHQG-----FASDIWAVGCTVIEMASGGAPWPNA 198
           +  +  S        P   A  +            FA D W +G  +  +     P    
Sbjct: 261 DGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNT-D 319

Query: 199 ADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEE 254
              +     I   R    +P  +       L   LR   ++R    Q ++ P  E+
Sbjct: 320 DAALGGSEWI--FRSCKNIPQPVR----ALLEGFLRYPKEDRLLPLQAMETPEYEQ 369

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  154 bits (390), Expect = 1e-43
 Identities = 69/262 (26%), Positives = 108/262 (41%), Gaps = 19/262 (7%)

Query: 8   TIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQRE-QKFLSSLNSPHIVGYKGCDVT 66
            +G G +  V      R+G   A K   L  S   ++E      +   PHIV        
Sbjct: 36  VLGLGVNGKVLECFHRRTGQKCALKL--LYDSPKARQEVDHHWQASGGPHIVCILDVYEN 93

Query: 67  SEDNKLMYNLFMEYAPGGTLNDEIHRNG-GRLDESLIVSYTRQILQGLEYLHSNRVVHCD 125
               K    + ME   GG L   I   G     E       R I   +++LHS+ + H D
Sbjct: 94  MHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRD 153

Query: 126 IKSRNILMA----ESGAKIADFGCAK-WESEALQSG-GTPMFMAPEVARGEHQGFASDIW 179
           +K  N+L      ++  K+ DFG AK     ALQ+   TP ++APEV   E    + D+W
Sbjct: 154 VKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMW 213

Query: 180 AVGCTVIE--MASGGAPW---PNAADPMTVLYKIAYSR-ELPEVP-AFLSKQANDFLSNC 232
           ++G  VI   +  G  P+      A    +  +I   +   P    + +S+ A   +   
Sbjct: 214 SLG--VIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLL 271

Query: 233 LRRDPKERWAASQLLKHPFLEE 254
           L+ DP ER   +Q + HP++ +
Sbjct: 272 LKTDPTERLTITQFMNHPWINQ 293

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  153 bits (390), Expect = 1e-43
 Identities = 85/308 (27%), Positives = 145/308 (47%), Gaps = 30/308 (9%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEF-------LQREQKFLSSLNS 54
           ++    TIG+G+ A V LA  + +G   A K   + K++        L RE + +  LN 
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKI--IDKTQLNPTSLQKLFREVRIMKILNH 73

Query: 55  PHIVG-YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGL 113
           P+IV  +   +V   + +    L MEYA GG + D +  +G R+ E    S  RQI+  +
Sbjct: 74  PNIVKLF---EVI--ETEKTLYLIMEYASGGEVFDYLVAHG-RMKEKEARSKFRQIVSAV 127

Query: 114 EYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWES--EALQ-SGGTPMFMAPEVARG 169
           +Y H  R+VH D+K+ N+L+      KIADFG +   +    L    G P + APE+ +G
Sbjct: 128 QYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQG 187

Query: 170 EH-QGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDF 228
           +   G   D+W++G  +  + SG  P+ +  +   +  ++   +    +P ++S    + 
Sbjct: 188 KKYDGPEVDVWSLGVILYTLVSGSLPF-DGQNLKELRERVLRGK--YRIPFYMSTDCENL 244

Query: 229 LSNCLRRDPKERWAASQLLKHPFL----EEFCSCTKQIQESNCSPTSILD--QGIWNSVE 282
           L   L  +P +R    Q++K  ++    EE         E + S    +D   G+  S E
Sbjct: 245 LKRFLVLNPIKRGTLEQIMKDRWINAGHEEDELKPFVEPELDISDQKRIDIMVGMGYSQE 304

Query: 283 ETEESLGN 290
           E +ESL  
Sbjct: 305 EIQESLSK 312

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  153 bits (388), Expect = 1e-43
 Identities = 68/268 (25%), Positives = 109/268 (40%), Gaps = 31/268 (11%)

Query: 6   GHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEF---------LQREQKFLSSLNSPH 56
           G  +G+GS   V       +    A K   L K +          +++E + L  L   +
Sbjct: 10  GDLLGEGSYGKVKEVLDSETLCRRAVKI--LKKKKLRRIPNGEANVKKEIQLLRRLRHKN 67

Query: 57  IVG-YKGCDVTSEDNKLMYNLFMEYAPGGT--LNDEIHRNGGRLDESLIVSYTRQILQGL 113
           ++      DV   + K    + MEY   G   + D +     R        Y  Q++ GL
Sbjct: 68  VIQLV---DVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE--KRFPVCQAHGYFCQLIDGL 122

Query: 114 EYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG------GTPMFMAPEV 166
           EYLHS  +VH DIK  N+L+   G  KI+  G A+               G+P F  PE+
Sbjct: 123 EYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEI 182

Query: 167 ARGEHQ--GFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQ 224
           A G     GF  DIW+ G T+  + +G  P+    D +  L++         +P      
Sbjct: 183 ANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG--DNIYKLFENIGKGSY-AIPGDCGPP 239

Query: 225 ANDFLSNCLRRDPKERWAASQLLKHPFL 252
            +D L   L  +P +R++  Q+ +H + 
Sbjct: 240 LSDLLKGMLEYEPAKRFSIRQIRQHSWF 267

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  152 bits (387), Expect = 2e-43
 Identities = 77/321 (23%), Positives = 116/321 (36%), Gaps = 57/321 (17%)

Query: 1   MD-WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL-------PKSEFLQREQKFLSSL 52
           M+ + +   IG+GS   V    +  +G + A K            K     RE + L  L
Sbjct: 2   MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIAL--REIRMLKQL 59

Query: 53  NSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQG 112
             P++V     +V     +L   L  EY    T+  E+ R    + E L+ S T Q LQ 
Sbjct: 60  KHPNLVNLL--EVFRRKRRLH--LVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQA 114

Query: 113 LEYLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSGGTPM--------FMA 163
           + + H +  +H D+K  NIL+ +    K+ DFG A+     L               + +
Sbjct: 115 VNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFAR----LLTGPSDYYDDEVATRWYRS 170

Query: 164 PEVARGEHQ-GFASDIWAVGCTVIEMASG--------------------GAP----WP-- 196
           PE+  G+ Q G   D+WA+GC   E+ SG                    G          
Sbjct: 171 PELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVF 230

Query: 197 --NAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEE 254
             N       +        L      +S  A   L  CL  DP ER    QLL HP+ E 
Sbjct: 231 STNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFEN 290

Query: 255 FCSCTKQIQESNCSPTSILDQ 275
                   +E +    ++  Q
Sbjct: 291 IREIEDLAKEHDKPAENLYFQ 311

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  152 bits (386), Expect = 3e-43
 Identities = 65/253 (25%), Positives = 105/253 (41%), Gaps = 31/253 (12%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAK--STELPK-SEFL---QREQKFLSSLNSPHIVG-YK 61
           +G+G    V  A       + A K  S  L     F    QRE +    L  PH+V  + 
Sbjct: 42  VGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH- 100

Query: 62  GCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRV 121
             D   E +  +Y + M    G  L   + R G  L     V+  RQI   L+  H+   
Sbjct: 101 --DF-GEIDGQLY-VDMRLINGVDLAAMLRRQG-PLAPPRAVAIVRQIGSALDAAHAAGA 155

Query: 122 VHCDIKSRNILMAESG-AKIADFGCAKWESEAL--QSG---GTPMFMAPEVARGEHQGFA 175
            H D+K  NIL++    A + DFG A   ++    Q G   GT  +MAPE     H  + 
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYR 215

Query: 176 SDIWAVGCTVIEMASGGAPWPNAADPMTVLYK------IAYSRELPEVPAFLSKQANDFL 229
           +DI+A+ C + E  +G  P+    D ++V+           S   P +P       +  +
Sbjct: 216 ADIYALTCVLYECLTGSPPYQ--GDQLSVMGAHINQAIPRPSTVRPGIPVAF----DAVI 269

Query: 230 SNCLRRDPKERWA 242
           +  + ++P++R+ 
Sbjct: 270 ARGMAKNPEDRYV 282

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  152 bits (385), Expect = 3e-43
 Identities = 70/266 (26%), Positives = 122/266 (45%), Gaps = 33/266 (12%)

Query: 6   GHTIGQGSSATVSLATSLRSGDVFAAK--STELPK-SEFL---QREQKFLSSLNSPHIVG 59
           G  +G G  + V LA  LR     A K    +L +   F    +RE +  ++LN P IV 
Sbjct: 17  GEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76

Query: 60  -YKGCDVTSEDNKLMYNLF--MEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL 116
            Y   D    +       +  MEY  G TL D +H  G  +     +       Q L + 
Sbjct: 77  VY---DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFS 132

Query: 117 HSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEAL----QSG---GTPMFMAPEVAR 168
           H N ++H D+K  NI+++ +   K+ DFG A+  +++     Q+    GT  +++PE AR
Sbjct: 133 HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192

Query: 169 GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYK------IAYSRELPEVPAFLS 222
           G+     SD++++GC + E+ +G  P+     P++V Y+      I  S     + A L 
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGEPPF-TGDSPVSVAYQHVREDPIPPSARHEGLSADL- 250

Query: 223 KQANDFLSNCLRRDPKERWA-ASQLL 247
              +  +   L ++P+ R+  A+++ 
Sbjct: 251 ---DAVVLKALAKNPENRYQTAAEMR 273

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  151 bits (384), Expect = 1e-42
 Identities = 77/281 (27%), Positives = 119/281 (42%), Gaps = 25/281 (8%)

Query: 6   GHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDV 65
              IG GS +         +   FA K  +  K +  +  +  L     P+I+  K    
Sbjct: 27  KEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKD--- 83

Query: 66  TSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCD 125
             +D K +Y +  E   GG L D+I R      E    +    I + +EYLH+  VVH D
Sbjct: 84  VYDDGKYVY-VVTELMKGGELLDKILRQK-FFSEREASAVLFTITKTVEYLHAQGVVHRD 141

Query: 126 IKSRNILMAESGA-----KIADFGCAKW---ESEALQSG-GTPMFMAPEVARGEHQGFAS 176
           +K  NIL  +        +I DFG AK    E+  L +   T  F+APEV   +    A 
Sbjct: 142 LKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAAC 201

Query: 177 DIWAVGCTVIE--MASGGAP-WPNAAD-PMTVLYKI---AYSRELPEVPAFLSKQANDFL 229
           DIW++G  V+   M +G  P      D P  +L +I    +S       + +S  A D +
Sbjct: 202 DIWSLG--VLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNS-VSDTAKDLV 258

Query: 230 SNCLRRDPKERWAASQLLKHPFLEEFCS-CTKQIQESNCSP 269
           S  L  DP +R  A+ +L+HP++  +      Q+   +   
Sbjct: 259 SKMLHVDPHQRLTAALVLRHPWIVHWDQLPQYQLNRQDAPH 299

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  149 bits (379), Expect = 1e-42
 Identities = 70/259 (27%), Positives = 107/259 (41%), Gaps = 36/259 (13%)

Query: 6   GHTIGQGSSATVSLATSLRSGDVFAAK--------STELPKSEFLQREQKFLSSLNSPHI 57
              IG G    V  A      +V A K                  Q E K  + L  P+I
Sbjct: 12  EEIIGIGGFGKVYRAF-WIGDEV-AVKAARHDPDEDISQTIENVRQ-EAKLFAMLKHPNI 68

Query: 58  VGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLH 117
           +  +G     E N     L ME+A GG LN  +     R+   ++V++  QI +G+ YLH
Sbjct: 69  IALRGV-CLKEPN---LCLVMEFARGGPLNRVLSGK--RIPPDILVNWAVQIARGMNYLH 122

Query: 118 SNR---VVHCDIKSRNILMAESG---------AKIADFGCAKWESEALQSG--GTPMFMA 163
                 ++H D+KS NIL+ +            KI DFG A+      +    G   +MA
Sbjct: 123 DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMA 182

Query: 164 PEVARGEHQGFASDIWAVGCTVI--EMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFL 221
           PEV R       SD+W+ G  V+  E+ +G  P+    D + V Y +A ++    +P+  
Sbjct: 183 PEVIRASMFSKGSDVWSYG--VLLWELLTGEVPFRG-IDGLAVAYGVAMNKLALPIPSTC 239

Query: 222 SKQANDFLSNCLRRDPKER 240
            +     + +C   DP  R
Sbjct: 240 PEPFAKLMEDCWNPDPHSR 258

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  149 bits (378), Expect = 3e-42
 Identities = 69/269 (25%), Positives = 118/269 (43%), Gaps = 30/269 (11%)

Query: 6   GHTIGQGSSATVSLATSLRSGDVFAAK------STELPKSEFLQREQKFLSSLNSPHIVG 59
           G  IG GS  TV        GDV A K       T      F   E   L      +I+ 
Sbjct: 29  GQRIGSGSFGTVYKGK--WHGDV-AVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNILL 84

Query: 60  YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN 119
           + G   T+        +  ++  G +L   +H +  + +   ++   RQ  +G++YLH+ 
Sbjct: 85  FMGY-STAP----QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK 139

Query: 120 RVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG------GTPMFMAPEVARGEHQ 172
            ++H D+KS NI + E    KI DFG A  +S    S       G+ ++MAPEV R +  
Sbjct: 140 SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDS 199

Query: 173 G---FASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA--YSR-ELPEVPAFLSKQAN 226
               F SD++A G  + E+ +G  P+ N  +   ++  +       +L +V +   K+  
Sbjct: 200 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMK 259

Query: 227 DFLSNCLRRDPKERWAASQLLKHPFLEEF 255
             ++ CL++   ER +  ++L    +EE 
Sbjct: 260 RLMAECLKKKRDERPSFPRILAE--IEEL 286

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  150 bits (380), Expect = 3e-42
 Identities = 58/280 (20%), Positives = 110/280 (39%), Gaps = 38/280 (13%)

Query: 4   TRGHTIGQGSSATVSLATSLRSGDVFAAK---STELPKSEFLQREQKFLSSL-NSPHIVG 59
                + +G  A V  A  + SG  +A K   S E  K+  + +E  F+  L   P+IV 
Sbjct: 31  RVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQ 90

Query: 60  YKGCDVT----SEDNKLMYNLFMEYAPGGTLND-EIHRNGGRLDESLIVSYTRQILQGLE 114
           +          S+  +  + L  E   G  +   +   + G L    ++    Q  + ++
Sbjct: 91  FCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQ 150

Query: 115 YLHSNR--VVHCDIKSRNILMAESGA-KIADFGCAKWES----------------EALQS 155
           ++H  +  ++H D+K  N+L++  G  K+ DFG A   S                E +  
Sbjct: 151 HMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITR 210

Query: 156 GGTPMFMAPEV---ARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSR 212
             TPM+  PE+         G   DIWA+GC +  +     P+ + A       +I   +
Sbjct: 211 NTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA-----KLRIVNGK 265

Query: 213 -ELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPF 251
             +P          +  +   L+ +P+ER + ++++    
Sbjct: 266 YSIPPHDTQ-YTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  147 bits (374), Expect = 6e-42
 Identities = 43/250 (17%), Positives = 96/250 (38%), Gaps = 24/250 (9%)

Query: 6   GHTIGQGSSATVSLATSLRSGDVFAAK------STELPKSEFLQREQKFLSSLNSPHIVG 59
              + +  S  +      +  D+   K       +     +F   E   L   + P+++ 
Sbjct: 15  LTKLNENHSGELWKGR-WQGNDI-VVKVLKVRDWSTRKSRDF-NEECPRLRIFSHPNVLP 71

Query: 60  YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGR-LDESLIVSYTRQILQGLEYLHS 118
             G   +         L   + P G+L + +H      +D+S  V +   + +G+ +LH+
Sbjct: 72  VLGACQSPPAPHPT--LITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT 129

Query: 119 --NRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSGGTPMFMAPEVARGE---HQ 172
               +    + SR++++ E   A+I+                 P ++APE  + +     
Sbjct: 130 LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP-GRMYAPAWVAPEALQKKPEDTN 188

Query: 173 GFASDIWAVGCTVI--EMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLS 230
             ++D+W+    V+  E+ +   P+ +    M +  K+A     P +P  +S   +  + 
Sbjct: 189 RRSADMWSFA--VLLWELVTREVPFADL-SNMEIGMKVALEGLRPTIPPGISPHVSKLMK 245

Query: 231 NCLRRDPKER 240
            C+  DP +R
Sbjct: 246 ICMNEDPAKR 255

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  150 bits (380), Expect = 6e-42
 Identities = 78/276 (28%), Positives = 118/276 (42%), Gaps = 38/276 (13%)

Query: 6   GHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-----------SEFLQREQKFLSSLNS 54
              IG+G S+ V       +G  FA K  E+              E  +RE   L  +  
Sbjct: 99  KDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAG 158

Query: 55  -PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGL 113
            PHI+       + E +  M+ L  +    G L D +      L E    S  R +L+ +
Sbjct: 159 HPHIITLID---SYESSSFMF-LVFDLMRKGELFDYLTEKV-ALSEKETRSIMRSLLEAV 213

Query: 114 EYLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKW--ESEALQSG-GTPMFMAPEVARG 169
            +LH+N +VH D+K  NIL+ ++   +++DFG +      E L+   GTP ++APE+ + 
Sbjct: 214 SFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKC 273

Query: 170 EHQ------GFASDIWAVGCTVIE--MASGGAP-WPNAADPMTVLYKI---AYSRELPEV 217
                    G   D+WA G  VI   + +G  P W      + +L  I    Y    PE 
Sbjct: 274 SMDETHPGYGKEVDLWACG--VILFTLLAGSPPFW--HRRQILMLRMIMEGQYQFSSPEW 329

Query: 218 PAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLE 253
               S    D +S  L+ DP+ R  A Q L+HPF E
Sbjct: 330 DD-RSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  148 bits (377), Expect = 1e-41
 Identities = 79/307 (25%), Positives = 123/307 (40%), Gaps = 68/307 (22%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAK------------STELPKSEFLQREQKFLSSLNSPH 56
           +G+GS   V    +  +G + A K               +       RE K L  L   +
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAM-------REIKLLKQLRHEN 85

Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL 116
           +V     +V  +  +    L  E+    T+ D++      LD  ++  Y  QI+ G+ + 
Sbjct: 86  LVNLL--EVCKKKKRWY--LVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGFC 140

Query: 117 HSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSGGTPM--------FMAPEVA 167
           HS+ ++H DIK  NIL+++SG  K+ DFG A+     L + G           + APE+ 
Sbjct: 141 HSHNIIHRDIKPENILVSQSGVVKLCDFGFAR----TLAAPGEVYDDEVATRWYRAPELL 196

Query: 168 RGEHQ-GFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKI------------------ 208
            G+ + G A D+WA+GC V EM  G   +P  +D    LY I                  
Sbjct: 197 VGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQ-LYHIMMCLGNLIPRHQELFNKN 255

Query: 209 --AYSRELPEVPA---------FLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCS 257
                  LPE+            LS+   D    CL  DP +R   ++LL H F +    
Sbjct: 256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGF 315

Query: 258 CTKQIQE 264
             +  QE
Sbjct: 316 AERFSQE 322

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  148 bits (375), Expect = 3e-41
 Identities = 50/289 (17%), Positives = 95/289 (32%), Gaps = 42/289 (14%)

Query: 6   GHTIGQGSSATVSLATS-----LRSGDVFAAKSTELPK-SEF--LQREQKFLSSLNSPHI 57
            H +G+G+ A V  AT       ++   F  K  +     EF    +  + L        
Sbjct: 70  HHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMF 129

Query: 58  VGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHR----NGGRLDESLIVSYTRQILQGL 113
           + +    +    N  +  L  E    GTL + I+         + + L++S+  ++L  +
Sbjct: 130 MKFYSAHLF--QNGSV--LVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMI 185

Query: 114 EYLHSNRVVHCDIKSRNILM------------AESGAKIADFGCAKW-----ESEALQSG 156
           E +H   ++H DIK  N ++              +G  + D G +       +     + 
Sbjct: 186 EQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAK 245

Query: 157 -GTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELP 215
             T  F   E+   +   +  D + V  TV  M  G        +      +  + R   
Sbjct: 246 CETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM-KVKNEGGECKPEGLFRRL-- 302

Query: 216 EVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCS-CTKQIQ 263
                     N+F    L         +  LL+    + F    T +I+
Sbjct: 303 ----PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIR 347

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  147 bits (374), Expect = 4e-41
 Identities = 77/269 (28%), Positives = 123/269 (45%), Gaps = 25/269 (9%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQR--------EQKFLSSLN 53
            + R  T+G GS   V L     SG+ +A K   L K + ++         E++ L ++N
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKI--LDKQKVVKLKQIEHTLNEKRILQAVN 99

Query: 54  SPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGL 113
            P +V  +    + +DN  +Y + MEY  GG +     R  GR  E     Y  QI+   
Sbjct: 100 FPFLVKLEF---SFKDNSNLY-MVMEYVAGGEMF-SHLRRIGRFSEPHARFYAAQIVLTF 154

Query: 114 EYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQS-GGTPMFMAPEVARGEH 171
           EYLHS  +++ D+K  N+L+ + G  ++ DFG AK       +  GTP  +APE+   + 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKG 214

Query: 172 QGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSN 231
              A D WA+G  + EMA+G  P+  A  P+ +  KI   +     P+  S    D L N
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPF-FADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRN 271

Query: 232 CLRRDPKERW-----AASQLLKHPFLEEF 255
            L+ D  +R+       + +  H +    
Sbjct: 272 LLQVDLTKRFGNLKNGVNDIKNHKWFATT 300

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  146 bits (370), Expect = 6e-41
 Identities = 70/299 (23%), Positives = 113/299 (37%), Gaps = 33/299 (11%)

Query: 6   GHTIGQGSSATVSLATSLRSGDVFAAKSTELP----KSEFLQREQKFLSSLNSPHIVGYK 61
           G  +G+G        T   +G+V   K         +  FL+ E K +  L  P+++ + 
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLK-EVKVMRCLEHPNVLKFI 73

Query: 62  GCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRV 121
           G  V  +D +L      EY  GGTL   I     +   S  VS+ + I  G+ YLHS  +
Sbjct: 74  G--VLYKDKRLN--FITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNI 129

Query: 122 VHCDIKSRNILMAESG-AKIADFGCAKWESE------------------ALQSGGTPMFM 162
           +H D+ S N L+ E+    +ADFG A+   +                       G P +M
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189

Query: 163 APEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSREL-PEVPAFL 221
           APE+  G       D+++ G  + E+       P+   P T+ + +     L    P   
Sbjct: 190 APEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPD-YLPRTMDFGLNVRGFLDRYCPPNC 248

Query: 222 SKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSILDQGIWNS 280
                     C   DP++R +  +L    +LE                   LD+G W +
Sbjct: 249 PPSFFPITVRCCDLDPEKRPSFVKLEH--WLETLRMHLAG-HLPLGPQLEQLDRGFWET 304

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  145 bits (368), Expect = 6e-41
 Identities = 77/264 (29%), Positives = 122/264 (46%), Gaps = 25/264 (9%)

Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEF--------LQREQKFLSSLNS 54
           +  G T+G G+   V +     +G   A K   L + +         ++RE + L     
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKI--LNRQKIRSLDVVGKIKREIQNLKLFRH 70

Query: 55  PHIVG-YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGL 113
           PHI+  Y    V S      + + MEY  GG L D I ++G R++E       +QIL  +
Sbjct: 71  PHIIKLY---QVISTPTDF-F-MVMEYVSGGELFDYICKHG-RVEEMEARRLFQQILSAV 124

Query: 114 EYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWES--EALQ-SGGTPMFMAPEVARG 169
           +Y H + VVH D+K  N+L+     AKIADFG +   S  E L+ S G+P + APEV  G
Sbjct: 125 DYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISG 184

Query: 170 EH-QGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDF 228
               G   DIW+ G  +  +  G  P+ +     T+  KI     +  +P +L++     
Sbjct: 185 RLYAGPEVDIWSCGVILYALLCGTLPF-DDEHVPTLFKKI--RGGVFYIPEYLNRSVATL 241

Query: 229 LSNCLRRDPKERWAASQLLKHPFL 252
           L + L+ DP +R     + +H + 
Sbjct: 242 LMHMLQVDPLKRATIKDIREHEWF 265

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  152 bits (386), Expect = 7e-41
 Identities = 57/250 (22%), Positives = 94/250 (37%), Gaps = 33/250 (13%)

Query: 6   GHTIGQGSSATVSLATSLR-SGDVFAAK---STELPKSEFL---QREQKFLSSLNSPHIV 58
              I  G    + LA     +G     K    +     E       E++FL+ +  P IV
Sbjct: 85  KGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDA--EAQAMAMAERQFLAEVVHPSIV 142

Query: 59  G-Y-KGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL 116
             +          + + Y + MEY  G +L       G +L  +  ++Y  +IL  L YL
Sbjct: 143 QIFNFVEHTDRHGDPVGY-IVMEYVGGQSLKRSK---GQKLPVAEAIAYLLEILPALSYL 198

Query: 117 HSNRVVHCDIKSRNILMAESGAKIADFGCAKWESEAL-QSG---GTPMFMAPEVARGEHQ 172
           HS  +V+ D+K  NI++ E   K+ D G        +   G   GTP F APE+ R    
Sbjct: 199 HSIGLVYNDLKPENIMLTEEQLKLIDLGAVS----RINSFGYLYGTPGFQAPEIVRTG-P 253

Query: 173 GFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNC 232
             A+DI+ VG T+  +                +  +     + +            L   
Sbjct: 254 TVATDIYTVGRTLAALTLDLPTRNGRY-----VDGLPEDDPVLKTYDSY----GRLLRRA 304

Query: 233 LRRDPKERWA 242
           +  DP++R+ 
Sbjct: 305 IDPDPRQRFT 314

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  148 bits (375), Expect = 7e-41
 Identities = 68/287 (23%), Positives = 116/287 (40%), Gaps = 30/287 (10%)

Query: 4   TRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNS-PHIVGYKG 62
                +G G +  V    + R+ + FA K   L      +RE +     +  PHIV    
Sbjct: 65  VTSQVLGLGINGKVLQIFNKRTQEKFALKM--LQDCPKARREVELHWRASQCPHIVRIVD 122

Query: 63  CDVTSEDNKLMYNLFMEYAPGGTLNDEIH-RNGGRLDESLIVSYTRQILQGLEYLHSNRV 121
                   +    + ME   GG L   I  R      E       + I + ++YLHS  +
Sbjct: 123 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINI 182

Query: 122 VHCDIKSRNILMA----ESGAKIADFGCAKW--ESEALQSG-GTPMFMAPEVARGEHQGF 174
            H D+K  N+L       +  K+ DFG AK      +L +   TP ++APEV   E    
Sbjct: 183 AHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDK 242

Query: 175 ASDIWAVGCTVIE--MASGGAP-WPNAADPMT--VLYKIAYSR-ELPEVP-AFLSKQAND 227
           + D+W++G  VI   +  G  P + N    ++  +  +I   + E P    + +S++   
Sbjct: 243 SCDMWSLG--VIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKM 300

Query: 228 FLSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSILD 274
            + N L+ +P +R   ++ + HP+          I +S   P + L 
Sbjct: 301 LIRNLLKTEPTQRMTITEFMNHPW----------IMQSTKVPQTPLH 337

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  145 bits (369), Expect = 1e-40
 Identities = 54/274 (19%), Positives = 98/274 (35%), Gaps = 35/274 (12%)

Query: 6   GHTIGQGSSATVSLATSLRSGDVFAAK------STELPKSEFLQREQKFLSSLNSPHIVG 59
           G  IG+G    V        G+V A +        E     F +RE          ++V 
Sbjct: 38  GELIGKGRFGQVYHGR--WHGEV-AIRLIDIERDNEDQLKAF-KREVMAYRQTRHENVVL 93

Query: 60  YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN 119
           + G         L   +      G TL   +      LD +      ++I++G+ YLH+ 
Sbjct: 94  FMG--ACMSPPHLA--IITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK 149

Query: 120 RVVHCDIKSRNILMAESGAKIADFGCAKWESEALQSG---------GTPMFMAPEVARGE 170
            ++H D+KS+N+        I DFG                     G    +APE+ R  
Sbjct: 150 GILHKDLKSKNVFYDNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQL 209

Query: 171 HQG---------FASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFL 221
                         SD++A+G    E+ +   P+        +++++    +       +
Sbjct: 210 SPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT-QPAEAIIWQMGTGMKPNLSQIGM 268

Query: 222 SKQANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
            K+ +D L  C   + +ER   ++L+    LE+ 
Sbjct: 269 GKEISDILLFCWAFEQEERPTFTKLMDM--LEKL 300

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  145 bits (369), Expect = 2e-40
 Identities = 75/261 (28%), Positives = 113/261 (43%), Gaps = 31/261 (11%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQK---------FLSSLNSPHIVG 59
           +G+GS   V LA   ++   FA K+  L K   L  +              +   P +  
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKA--LKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 82

Query: 60  YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN 119
                 T E   L +   MEY  GG L   I     + D S    Y  +I+ GL++LHS 
Sbjct: 83  MFCTFQTKE--NL-F-FVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLHSK 137

Query: 120 RVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG-------GTPMFMAPEVARGEH 171
            +V+ D+K  NIL+ + G  KIADFG  K   E +          GTP ++APE+  G+ 
Sbjct: 138 GIVYRDLKLDNILLDKDGHIKIADFGMCK---ENMLGDAKTNTFCGTPDYIAPEILLGQK 194

Query: 172 QGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSN 231
              + D W+ G  + EM  G +P+    D   + + I      P  P +L K+A D L  
Sbjct: 195 YNHSVDWWSFGVLLYEMLIGQSPFH-GQDEEELFHSIRMDN--PFYPRWLEKEAKDLLVK 251

Query: 232 CLRRDPKERW-AASQLLKHPF 251
              R+P++R      + +HP 
Sbjct: 252 LFVREPEKRLGVRGDIRQHPL 272

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  145 bits (369), Expect = 3e-40
 Identities = 85/310 (27%), Positives = 131/310 (42%), Gaps = 36/310 (11%)

Query: 6   GHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS----EFLQREQKFLSSLNSPHIVGYK 61
              IG G+     L     + ++ A K   + +     E +QRE     SL  P+IV +K
Sbjct: 25  VKDIGSGNFGVARLMRDKLTKELVAVKY--IERGAAIDENVQREIINHRSLRHPNIVRFK 82

Query: 62  GCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRV 121
             +V      L   + MEYA GG L + I   G R  E     + +Q+L G+ Y HS ++
Sbjct: 83  --EVILTPTHLA--IIMEYASGGELYERICNAG-RFSEDEARFFFQQLLSGVSYCHSMQI 137

Query: 122 VHCDIKSRNILMAESGA---KIADFGCAKWES--EALQSG-GTPMFMAPEVARG-EHQGF 174
            H D+K  N L+  S A   KI DFG +K        +S  GTP ++APEV    E+ G 
Sbjct: 138 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGK 197

Query: 175 ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSR------ELPEVPAFLSKQANDF 228
            +D+W+ G T+  M  G  P+ +  +P    Y+    R       +P+    +S +    
Sbjct: 198 IADVWSCGVTLYVMLVGAYPFEDPEEP--RDYRKTIQRILSVKYSIPD-DIRISPECCHL 254

Query: 229 LSNCLRRDPKERWAASQLLKHPF--------LEEFCSCTKQIQESNCSPTSILDQGIWNS 280
           +S     DP  R +  ++  H +        L    +   Q QE    P   LD  +   
Sbjct: 255 ISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEPE-QPMQSLDTIMQII 313

Query: 281 VEETEESLGN 290
            E T  ++ N
Sbjct: 314 SEATIPAVRN 323

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  145 bits (367), Expect = 3e-40
 Identities = 73/315 (23%), Positives = 122/315 (38%), Gaps = 34/315 (10%)

Query: 6   GHTIGQGSSATVSLATSLRSGDVFAAK-----------STELPKSEFLQREQKFLSSLNS 54
              +G G+   V  A           K             E PK   +  E   LS +  
Sbjct: 29  MSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEH 88

Query: 55  PHIVGYKGCDVTSEDNKLMYNLFME-YAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGL 113
            +I+  K  D+   +N+  + L ME +  G  L   I R+  RLDE L     RQ++  +
Sbjct: 89  ANII--KVLDIF--ENQGFFQLVMEKHGSGLDLFAFIDRHP-RLDEPLASYIFRQLVSAV 143

Query: 114 EYLHSNRVVHCDIKSRNILMAESGA-KIADFG-CAKWESEAL--QSGGTPMFMAPEVARG 169
            YL    ++H DIK  NI++AE    K+ DFG  A  E   L     GT  + APEV  G
Sbjct: 144 GYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMG 203

Query: 170 EH-QGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDF 228
              +G   ++W++G T+  +     P+    + +               P  +SK+    
Sbjct: 204 NPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHP---------PYLVSKELMSL 254

Query: 229 LSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSILDQGIWN--SVEETEE 286
           +S  L+  P+ R    +L+  P++ +  +      E         + G+ +  S+E    
Sbjct: 255 VSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEEVFRVNKP-ESGVLSAASLEMGNR 313

Query: 287 SLGNLIHSTSKTSAR 301
           SL ++  +       
Sbjct: 314 SLSDVAQAQELCGGE 328

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  145 bits (367), Expect = 4e-40
 Identities = 79/273 (28%), Positives = 123/273 (45%), Gaps = 41/273 (15%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQK---------FLSSLNSPHIVG 59
           IG+GS A V L    ++  ++A K   + K      E           F  + N P +VG
Sbjct: 17  IGRGSYAKVLLVRLKKTDRIYAMKV--VKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 74

Query: 60  YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN 119
              C  T    +L     +EY  GG L   + R   +L E     Y+ +I   L YLH  
Sbjct: 75  LHSCFQTES--RLF--FVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLHER 129

Query: 120 RVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG-------GTPMFMAPEVARGEH 171
            +++ D+K  N+L+   G  K+ D+G  K   E L+ G       GTP ++APE+ RGE 
Sbjct: 130 GIIYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPGDTTSTFCGTPNYIAPEILRGED 186

Query: 172 QGFASDIWAVGCTVIEMASGGAPWPNAADPMTV-------LYKIAYSRELPEVPAFLSKQ 224
            GF+ D WA+G  + EM +G +P+                L+++   +++  +P  LS +
Sbjct: 187 YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR-IPRSLSVK 245

Query: 225 ANDFLSNCLRRDPKER------WAASQLLKHPF 251
           A   L + L +DPKER         + +  HPF
Sbjct: 246 AASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 278

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  143 bits (362), Expect = 8e-40
 Identities = 60/271 (22%), Positives = 98/271 (36%), Gaps = 39/271 (14%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAK---------STELPKSEFLQREQKFLSSL 52
           ++  G  +G+G   TV     L      A K          + L  S     E   L  +
Sbjct: 32  EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91

Query: 53  NS----PHIVG-YKGCDVTSEDNKLMYNLFMEYA-PGGTLNDEIHRNGGRLDESLIVSYT 106
            +    P ++      D    + +  + L +E   P   L D I   G  L E     + 
Sbjct: 92  GAGGGHPGVIRLL---DW--FETQEGFMLVLERPLPAQDLFDYITEKG-PLGEGPSRCFF 145

Query: 107 RQILQGLEYLHSNRVVHCDIKSRNILM-AESGA-KIADFGC-AKWESEALQ-SGGTPMFM 162
            Q++  +++ HS  VVH DIK  NIL+    G  K+ DFG  A    E      GT ++ 
Sbjct: 146 GQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFDGTRVYS 205

Query: 163 APEVARGEH-QGFASDIWAVGCTVI--EMASGGAPWPNAADPMTVLYKIAYSRELPEVPA 219
            PE           + +W++G  ++  +M  G  P+    + +               PA
Sbjct: 206 PPEWISRHQYHALPATVWSLG--ILLYDMVCGDIPFERDQEILEAELHF---------PA 254

Query: 220 FLSKQANDFLSNCLRRDPKERWAASQLLKHP 250
            +S      +  CL   P  R +  ++L  P
Sbjct: 255 HVSPDCCALIRRCLAPKPSSRPSLEEILLDP 285

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  143 bits (364), Expect = 9e-40
 Identities = 79/264 (29%), Positives = 115/264 (43%), Gaps = 34/264 (12%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQR--------EQKFLSSLNSPHIVGY 60
           +G+G+   V L     +G  +A K   L K   + +        E + L +   P +   
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKI--LRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70

Query: 61  KGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNR 120
           K    T +  +L     MEYA GG L   + R      E     Y  +I+  LEYLHS  
Sbjct: 71  KYAFQTHD--RL-C-FVMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRD 125

Query: 121 VVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG-------GTPMFMAPEVARGEHQ 172
           VV+ DIK  N+++ + G  KI DFG  K   E +  G       GTP ++APEV      
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLAPEVLEDNDY 182

Query: 173 GFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNC 232
           G A D W +G  + EM  G  P+ N  D   +   I         P  LS +A   L+  
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEE--IRFPRTLSPEAKSLLAGL 239

Query: 233 LRRDPKER-----WAASQLLKHPF 251
           L++DPK+R       A ++++H F
Sbjct: 240 LKKDPKQRLGGGPSDAKEVMEHRF 263

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  142 bits (361), Expect = 1e-39
 Identities = 59/271 (21%), Positives = 103/271 (38%), Gaps = 37/271 (13%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAK---------STELPKSEFLQREQKFLSSL 52
            +  G  +G G   +V     +      A K           ELP    +  E   L  +
Sbjct: 44  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103

Query: 53  NS--PHIVG-YKGCDVTSEDNKLMYNLFMEYA-PGGTLNDEIHRNGGRLDESLIVSYTRQ 108
           +S    ++      D    +    + L +E   P   L D I   G  L E L  S+  Q
Sbjct: 104 SSGFSGVIRLL---DW--FERPDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQ 157

Query: 109 ILQGLEYLHSNRVVHCDIKSRNILM-AESG-AKIADFGC-AKWESEALQ-SGGTPMFMAP 164
           +L+ + + H+  V+H DIK  NIL+    G  K+ DFG  A  +        GT ++  P
Sbjct: 158 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPP 217

Query: 165 EVARGEH-QGFASDIWAVGCTVI--EMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFL 221
           E  R     G ++ +W++G  ++  +M  G  P+ +  + +                  +
Sbjct: 218 EWIRYHRYHGRSAAVWSLG--ILLYDMVCGDIPFEHDEEIIRGQVFF---------RQRV 266

Query: 222 SKQANDFLSNCLRRDPKERWAASQLLKHPFL 252
           S +    +  CL   P +R    ++  HP++
Sbjct: 267 SSECQHLIRWCLALRPSDRPTFEEIQNHPWM 297

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  143 bits (362), Expect = 1e-39
 Identities = 73/266 (27%), Positives = 125/266 (46%), Gaps = 30/266 (11%)

Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEF--------LQREQKFLSSLNS 54
           +    T+G+GS   V LAT  ++    A K   + +           ++RE  +L  L  
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQQKVALKF--ISRQLLKKSDMHMRVEREISYLKLLRH 68

Query: 55  PHIVG-YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGL 113
           PHI+  Y   DV +    +   + +EYA GG L D I     R+ E     + +QI+  +
Sbjct: 69  PHIIKLY---DVITTPTDI-V-MVIEYA-GGELFDYIVEKK-RMTEDEGRRFFQQIICAI 121

Query: 114 EYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWES--EALQ-SGGTPMFMAPEVARG 169
           EY H +++VH D+K  N+L+ ++   KIADFG +   +    L+ S G+P + APEV  G
Sbjct: 122 EYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVING 181

Query: 170 EH-QGFASDIWAVGCTVI--EMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQAN 226
           +   G   D+W+  C ++   M  G  P+ +      +  K+  +  +  +P FLS  A 
Sbjct: 182 KLYAGPEVDVWS--CGIVLYVMLVGRLPF-DDEFIPNLFKKV--NSCVYVMPDFLSPGAQ 236

Query: 227 DFLSNCLRRDPKERWAASQLLKHPFL 252
             +   +  DP +R    ++ + P+ 
Sbjct: 237 SLIRRMIVADPMQRITIQEIRRDPWF 262

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  145 bits (367), Expect = 3e-39
 Identities = 90/310 (29%), Positives = 137/310 (44%), Gaps = 34/310 (10%)

Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEF--------LQREQKFLSSLNS 54
           +  G T+G G+   V +     +G   A K   L + +         ++RE + L     
Sbjct: 18  YILGDTLGVGTFGKVKVGKHELTGHKVAVKI--LNRQKIRSLDVVGKIRREIQNLKLFRH 75

Query: 55  PHIVG-YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGL 113
           PHI+  Y    V S  + + + + MEY  GG L D I +NG RLDE       +QIL G+
Sbjct: 76  PHIIKLY---QVISTPSDI-F-MVMEYVSGGELFDYICKNG-RLDEKESRRLFQQILSGV 129

Query: 114 EYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWES--EALQ-SGGTPMFMAPEVARG 169
           +Y H + VVH D+K  N+L+     AKIADFG +   S  E L+ S G+P + APEV  G
Sbjct: 130 DYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISG 189

Query: 170 EH-QGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDF 228
               G   DIW+ G  +  +  G  P+ +     T+  KI     +   P +L+      
Sbjct: 190 RLYAGPEVDIWSSGVILYALLCGTLPF-DDDHVPTLFKKI--CDGIFYTPQYLNPSVISL 246

Query: 229 LSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSILDQGIWNSV------- 281
           L + L+ DP +R     + +H + ++        ++ + S T I D      V       
Sbjct: 247 LKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMI-DDEALKEVCEKFECS 305

Query: 282 -EETEESLGN 290
            EE    L N
Sbjct: 306 EEEVLSCLYN 315

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  141 bits (359), Expect = 5e-39
 Identities = 76/289 (26%), Positives = 113/289 (39%), Gaps = 52/289 (17%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ--------REQKFLSSLNSPHIVGY 60
           +G+G  ATV  A    +  + A K  +L      +        RE K L  L+ P+I+G 
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77

Query: 61  KGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNR 120
              D     + +  +L  ++     L   I  N   L  S I +Y    LQGLEYLH + 
Sbjct: 78  L--DAFGHKSNI--SLVFDFMETD-LEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 132

Query: 121 VVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSGGTPM--------FMAPEVARG-E 170
           ++H D+K  N+L+ E+G  K+ADFG AK    +  S             + APE+  G  
Sbjct: 133 ILHRDLKPNNLLLDENGVLKLADFGLAK----SFGSPNRAYTHQVVTRWYRAPELLFGAR 188

Query: 171 HQGFASDIWAVGCTVIEMASG--------------------GAP----WPNAAD-PMTVL 205
             G   D+WAVGC + E+                       G P    WP+    P  V 
Sbjct: 189 MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 248

Query: 206 YKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEE 254
           +K      L  + +       D +      +P  R  A+Q LK  +   
Sbjct: 249 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 297

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  140 bits (356), Expect = 5e-39
 Identities = 78/308 (25%), Positives = 126/308 (40%), Gaps = 72/308 (23%)

Query: 1   MD-WTRGHTIGQGSSATVSLATSLRSGDVFAAK------------STELPKSEFLQREQK 47
           M  + +   IG+G+  TV  A +  + ++ A K            S+ L       RE  
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL-------REIC 53

Query: 48  FLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTR 107
            L  L   +IV     DV   D KL   L  E+     L        G LD  ++ S+  
Sbjct: 54  LLKELKHKNIVRLH--DVLHSDKKL--TLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLF 108

Query: 108 QILQGLEYLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSGGTPM------ 160
           Q+L+GL + HS  V+H D+K +N+L+  +G  K+A+FG A+       + G P+      
Sbjct: 109 QLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLAR-------AFGIPVRCYSAE 161

Query: 161 -----FMAPEVARG-EHQGFASDIWAVGCTVIEMASGGAP-------------------- 194
                +  P+V  G +    + D+W+ GC   E+A+ G P                    
Sbjct: 162 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGT 221

Query: 195 -----WPNAAD-PMTVLYKIAYS-RELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLL 247
                WP+    P    Y +  +   L  V   L+    D L N L+ +P +R +A + L
Sbjct: 222 PTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEAL 281

Query: 248 KHPFLEEF 255
           +HP+  +F
Sbjct: 282 QHPYFSDF 289

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  141 bits (357), Expect = 6e-39
 Identities = 74/267 (27%), Positives = 118/267 (44%), Gaps = 29/267 (10%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQR--------EQKFLSSLN 53
           D+    T+G GS   V L  S  +G  +A K   L K   ++         E+  LS + 
Sbjct: 7   DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKV--LKKEIVVRLKQVEHTNDERLMLSIVT 64

Query: 54  SPHIVGYKGCDVTSEDNKLMYNLF--MEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQ 111
            P I+   G    ++       +F  M+Y  GG L   + R   R    +   Y  ++  
Sbjct: 65  HPFIIRMWGTFQDAQ------QIFMIMDYIEGGELFSLL-RKSQRFPNPVAKFYAAEVCL 117

Query: 112 GLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQS-GGTPMFMAPEVARG 169
            LEYLHS  +++ D+K  NIL+ ++G  KI DFG AK+  +   +  GTP ++APEV   
Sbjct: 118 ALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVST 177

Query: 170 EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFL 229
           +    + D W+ G  + EM +G  P+   ++ M    KI  +      P F ++   D L
Sbjct: 178 KPYNKSIDWWSFGILIYEMLAGYTPF-YDSNTMKTYEKILNAE--LRFPPFFNEDVKDLL 234

Query: 230 SNCLRRDPKERW-----AASQLLKHPF 251
           S  + RD  +R          +  HP+
Sbjct: 235 SRLITRDLSQRLGNLQNGTEDVKNHPW 261

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  142 bits (361), Expect = 7e-39
 Identities = 78/273 (28%), Positives = 123/273 (45%), Gaps = 41/273 (15%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQK---------FLSSLNSPHIVG 59
           IG+GS A V L    ++  ++A +   + K      E           F  + N P +VG
Sbjct: 60  IGRGSYAKVLLVRLKKTDRIYAMRV--VKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 117

Query: 60  YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN 119
              C  T    +L     +EY  GG L   + R   +L E     Y+ +I   L YLH  
Sbjct: 118 LHSCFQTES--RLF--FVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLHER 172

Query: 120 RVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG-------GTPMFMAPEVARGEH 171
            +++ D+K  N+L+   G  K+ D+G  K   E L+ G       GTP ++APE+ RGE 
Sbjct: 173 GIIYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPGDTTSTFCGTPNYIAPEILRGED 229

Query: 172 QGFASDIWAVGCTVIEMASGGAPWPNAADPMTV-------LYKIAYSRELPEVPAFLSKQ 224
            GF+ D WA+G  + EM +G +P+                L+++   +++  +P  LS +
Sbjct: 230 YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR-IPRSLSVK 288

Query: 225 ANDFLSNCLRRDPKER------WAASQLLKHPF 251
           A   L + L +DPKER         + +  HPF
Sbjct: 289 AASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 321

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  140 bits (356), Expect = 8e-39
 Identities = 73/294 (24%), Positives = 116/294 (39%), Gaps = 45/294 (15%)

Query: 1   MD-WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ----REQKFLSSLNSP 55
           M+ + +   +G+G+ ATV    S  + ++ A K   L   E       RE   L  L   
Sbjct: 1   METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHA 60

Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
           +IV     D+   +  L   L  EY     L   +   G  ++   +  +  Q+L+GL Y
Sbjct: 61  NIVTLH--DIIHTEKSL--TLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAY 115

Query: 116 LHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSGGTPMFM-----APEVARG 169
            H  +V+H D+K +N+L+ E G  K+ADFG A+ +S   ++      +      P++  G
Sbjct: 116 CHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT-YDNEVVTLWYRPPDILLG 174

Query: 170 -EHQGFASDIWAVGCTVIEMASG--------------------GAP----WPNAA---DP 201
                   D+W VGC   EMA+G                    G P    WP      + 
Sbjct: 175 STDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 234

Query: 202 MTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
            T  Y    +  L      L     D L+  L+ + + R +A   +KHPF    
Sbjct: 235 KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSL 288

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  141 bits (357), Expect = 1e-38
 Identities = 75/266 (28%), Positives = 119/266 (44%), Gaps = 36/266 (13%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQK---------FLSSLNSPHIVG 59
           +G+GS   V LA    +GD++A K   L K   LQ +              + N P +  
Sbjct: 31  LGKGSFGKVMLARVKETGDLYAVKV--LKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 88

Query: 60  YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN 119
              C  T +  +L +   ME+  GG L   I ++  R DE+    Y  +I+  L +LH  
Sbjct: 89  LFCCFQTPD--RL-F-FVMEFVNGGDLMFHIQKSR-RFDEARARFYAAEIISALMFLHDK 143

Query: 120 RVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG-------GTPMFMAPEVARGEH 171
            +++ D+K  N+L+   G  K+ADFG  K   E + +G       GTP ++APE+ +   
Sbjct: 144 GIIYRDLKLDNVLLDHEGHCKLADFGMCK---EGICNGVTTATFCGTPDYIAPEILQEML 200

Query: 172 QGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSN 231
            G A D WA+G  + EM  G AP+  A +   +   I         P +L + A   L +
Sbjct: 201 YGPAVDWWAMGVLLYEMLCGHAPFE-AENEDDLFEAILNDE--VVYPTWLHEDATGILKS 257

Query: 232 CLRRDPKER------WAASQLLKHPF 251
            + ++P  R           +L+HPF
Sbjct: 258 FMTKNPTMRLGSLTQGGEHAILRHPF 283

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  141 bits (358), Expect = 2e-38
 Identities = 60/266 (22%), Positives = 114/266 (42%), Gaps = 27/266 (10%)

Query: 8   TIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQR--------EQKFLSSLNSPHIVG 59
            IG+GS   V +     +  ++A K   + K + ++R        E + +  L  P +V 
Sbjct: 22  AIGKGSFGKVCIVQKNDTKKMYAMK--YMNKQKCVERNEVRNVFKELQIMQGLEHPFLVN 79

Query: 60  YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN 119
                   ED   M+ + ++   GG L   + +N     E  +  +  +++  L+YL + 
Sbjct: 80  LWYSFQDEED---MF-MVVDLLLGGDLRYHLQQNV-HFKEETVKLFICELVMALDYLQNQ 134

Query: 120 RVVHCDIKSRNILMAESG-AKIADFGCAK-WESEALQSG--GTPMFMAPEVARGEHQ--- 172
           R++H D+K  NIL+ E G   I DF  A     E   +   GT  +MAPE+         
Sbjct: 135 RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGY 194

Query: 173 GFASDIWAVGCTVIEMASGGAPW--PNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLS 230
            FA D W++G T  E+  G  P+   ++     +++    +      P+  S++    L 
Sbjct: 195 SFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTV--VTYPSAWSQEMVSLLK 252

Query: 231 NCLRRDPKERWAASQLLK-HPFLEEF 255
             L  +P +R++    ++  P++ + 
Sbjct: 253 KLLEPNPDQRFSQLSDVQNFPYMNDI 278

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  144 bits (364), Expect = 2e-38
 Identities = 72/269 (26%), Positives = 114/269 (42%), Gaps = 36/269 (13%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQR--------EQKFLSSLNSPHIVGY 60
           +G+G    V       +G ++A K   L K    +R        E+K L+ ++S  IV  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKK--LNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250

Query: 61  KGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNG---GRLDESLIVSYTRQILQGLEYLH 117
                T     L   L M    GG +   I+          E   + YT QI+ GLE+LH
Sbjct: 251 AYAFETKT--DL--CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH 306

Query: 118 SNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG-------GTPMFMAPEVARG 169
              +++ D+K  N+L+ + G  +I+D G A    E            GTP FMAPE+  G
Sbjct: 307 QRNIIYRDLKPENVLLDDDGNVRISDLGLAV---ELKAGQTKTKGYAGTPGFMAPELLLG 363

Query: 170 EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTV--LYKIAYSRELPEVPAFLSKQAND 227
           E   F+ D +A+G T+ EM +   P+    + +    L +    + +   P   S  + D
Sbjct: 364 EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV-TYPDKFSPASKD 422

Query: 228 FLSNCLRRDPKER-----WAASQLLKHPF 251
           F    L++DP++R      +   L  HP 
Sbjct: 423 FCEALLQKDPEKRLGFRDGSCDGLRTHPL 451

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  144 bits (365), Expect = 2e-38
 Identities = 75/264 (28%), Positives = 112/264 (42%), Gaps = 29/264 (10%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQR--------EQKFLSSLNSPHIVGY 60
           +G+G    V       +G ++A K   L K    +R        E++ L  +NS  +V  
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKK--LEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 249

Query: 61  KGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNG-GRLDESLIVSYTRQILQGLEYLHSN 119
                T +   L   L +    GG L   I+  G     E+  V Y  +I  GLE LH  
Sbjct: 250 AYAYETKD--AL--CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE 305

Query: 120 RVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG---GTPMFMAPEVARGEHQGFA 175
           R+V+ D+K  NIL+ + G  +I+D G A    E        GT  +MAPEV + E   F+
Sbjct: 306 RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFS 365

Query: 176 SDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSREL---PEVPAFLSKQANDFLSNC 232
            D WA+GC + EM +G +P+        +  +           E     S QA    S  
Sbjct: 366 PDWWALGCLLYEMIAGQSPFQ--QRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQL 423

Query: 233 LRRDPKER-----WAASQLLKHPF 251
           L +DP ER      +A ++ +HP 
Sbjct: 424 LCKDPAERLGCRGGSAREVKEHPL 447

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  137 bits (347), Expect = 1e-37
 Identities = 61/288 (21%), Positives = 101/288 (35%), Gaps = 51/288 (17%)

Query: 8   TIGQGSSATVSLATSLRSGDVFAAKS---TELPKSEFLQREQKFLSSLNS-PHIVGYKGC 63
            +G+G+ A V    +L +   +A K            + RE + L       +++     
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIE- 78

Query: 64  DVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVH 123
               E+    Y L  E   GG++   IH+     +E       + +   L++LH+  + H
Sbjct: 79  --FFEEEDRFY-LVFEKMRGGSILSHIHKRR-HFNELEASVVVQDVASALDFLHNKGIAH 134

Query: 124 CDIKSRNILMA----ESGAKIADFGCAKWESEALQSG-----------GTPMFMAPEVAR 168
            D+K  NIL       S  KI DF                        G+  +MAPEV  
Sbjct: 135 RDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVE 194

Query: 169 GEHQ-----GFASDIWAVGCTVI----------------EMASGGAPWPNAADPMTVLYK 207
              +         D+W++G  VI                            A    +   
Sbjct: 195 AFSEEASIYDKRCDLWSLG--VILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFES 252

Query: 208 I---AYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFL 252
           I    Y     +    +S  A D +S  L RD K+R +A+Q+L+HP++
Sbjct: 253 IQEGKYEFPDKDWAH-ISCAAKDLISKLLVRDAKQRLSAAQVLQHPWV 299

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  136 bits (345), Expect = 1e-37
 Identities = 83/310 (26%), Positives = 119/310 (38%), Gaps = 80/310 (25%)

Query: 1   MD-WTRGHTIGQGSSATVSLATSLRSGDVFAAK------------STELPKSEFLQREQK 47
           M+ +     IG+G+   V  A +   G+ FA K            ST +       RE  
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTI-------REIS 52

Query: 48  FLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTR 107
            L  L   +IV     DV     +L   L  E+     L   +    G L+     S+  
Sbjct: 53  ILKELKHSNIVKLY--DVIHTKKRL--VLVFEHLDQD-LKKLLDVCEGGLESVTAKSFLL 107

Query: 108 QILQGLEYLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSGGTPM------ 160
           Q+L G+ Y H  RV+H D+K +N+L+   G  KIADFG A+       + G P+      
Sbjct: 108 QLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLAR-------AFGIPVRKYTHE 160

Query: 161 -----FMAPEVARG-EHQGFASDIWAVGCTVIEMASG--------------------GAP 194
                + AP+V  G +      DIW+VGC   EM +G                    G P
Sbjct: 161 IVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTP 220

Query: 195 ----WPNAADPMTVL--YKIAY----SRELPEVPAFLSKQANDFLSNCLRRDPKERWAAS 244
               WPN    +T L  Y   +              L +   D LS  L+ DP +R  A 
Sbjct: 221 NSKNWPN----VTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAK 276

Query: 245 QLLKHPFLEE 254
           Q L+H + +E
Sbjct: 277 QALEHAYFKE 286

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  137 bits (347), Expect = 2e-37
 Identities = 71/266 (26%), Positives = 115/266 (43%), Gaps = 36/266 (13%)

Query: 9   IGQGSSATVSLA---TSLRSGDVFAAKSTELPKSEFLQR-------EQKFLSSLNSPHIV 58
           +GQGS   V L    +   +  ++A K   L K+    R       E+  L  +N P IV
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKV--LKKATLKVRDRVRTKMERDILVEVNHPFIV 89

Query: 59  GYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHS 118
                  T    KL Y L +++  GG L   + +      E  +  Y  ++   L++LHS
Sbjct: 90  KLHYAFQTEG--KL-Y-LILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLHS 144

Query: 119 NRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG-------GTPMFMAPEVARGE 170
             +++ D+K  NIL+ E G  K+ DFG +K   E++          GT  +MAPEV    
Sbjct: 145 LGIIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCGTVEYMAPEVVNRR 201

Query: 171 HQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLS 230
               ++D W+ G  + EM +G  P+    D    +  I  ++    +P FLS +A   L 
Sbjct: 202 GHTQSADWWSFGVLMFEMLTGTLPFQ-GKDRKETMTMILKAK--LGMPQFLSPEAQSLLR 258

Query: 231 NCLRRDPKER-----WAASQLLKHPF 251
              +R+P  R         ++ +H F
Sbjct: 259 MLFKRNPANRLGAGPDGVEEIKRHSF 284

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  138 bits (349), Expect = 2e-37
 Identities = 67/264 (25%), Positives = 108/264 (40%), Gaps = 34/264 (12%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQK---------FLSSLNSPHIVG 59
           IG+GS   V LA        +A K   L K   L+++++          L ++  P +VG
Sbjct: 46  IGKGSFGKVLLARHKAEEVFYAVKV--LQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 103

Query: 60  YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN 119
                 T++  KL Y   ++Y  GG L   + R      E     Y  +I   L YLHS 
Sbjct: 104 LHFSFQTAD--KL-Y-FVLDYINGGELFYHLQRER-CFLEPRARFYAAEIASALGYLHSL 158

Query: 120 RVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG-------GTPMFMAPEVARGEH 171
            +V+ D+K  NIL+   G   + DFG  K   E ++         GTP ++APEV   + 
Sbjct: 159 NIVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEHNSTTSTFCGTPEYLAPEVLHKQP 215

Query: 172 QGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSN 231
                D W +G  + EM  G  P+  + +   +   I       ++   ++  A   L  
Sbjct: 216 YDRTVDWWCLGAVLYEMLYGLPPFY-SRNTAEMYDNILNKP--LQLKPNITNSARHLLEG 272

Query: 232 CLRRDPKER----WAASQLLKHPF 251
            L++D  +R        ++  H F
Sbjct: 273 LLQKDRTKRLGAKDDFMEIKSHVF 296

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  136 bits (345), Expect = 4e-37
 Identities = 72/268 (26%), Positives = 115/268 (42%), Gaps = 38/268 (14%)

Query: 9   IGQGSSATVSLA---TSLRSGDVFAAKSTELPKSEFLQR---------EQKFLSSLNSPH 56
           +G+G    V      T   +G +FA K   L K+  ++          E+  L  +  P 
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKV--LKKAMIVRNAKDTAHTKAERNILEEVKHPF 82

Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL 116
           IV       T    KL Y L +EY  GG L  ++ R G    E     Y  +I   L +L
Sbjct: 83  IVDLIYAFQTGG--KL-Y-LILEYLSGGELFMQLEREG-IFMEDTACFYLAEISMALGHL 137

Query: 117 HSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG-------GTPMFMAPEVAR 168
           H   +++ D+K  NI++   G  K+ DFG  K   E++  G       GT  +MAPE+  
Sbjct: 138 HQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK---ESIHDGTVTHTFCGTIEYMAPEILM 194

Query: 169 GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDF 228
                 A D W++G  + +M +G  P+    +    + KI   +    +P +L+++A D 
Sbjct: 195 RSGHNRAVDWWSLGALMYDMLTGAPPFT-GENRKKTIDKILKCK--LNLPPYLTQEARDL 251

Query: 229 LSNCLRRDPKER-----WAASQLLKHPF 251
           L   L+R+   R       A ++  HPF
Sbjct: 252 LKKLLKRNAASRLGAGPGDAGEVQAHPF 279

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  141 bits (358), Expect = 5e-37
 Identities = 68/266 (25%), Positives = 116/266 (43%), Gaps = 31/266 (11%)

Query: 8   TIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQR--------EQKFLSSLNS---PH 56
            IG+G    V       +G ++A K   L K     +        E+  LS +++   P 
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKC--LDKKRIKMKQGETLALNERIMLSLVSTGDCPF 253

Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL 116
           IV       T +  KL     ++   GG L+  + ++G    E+ +  Y  +I+ GLE++
Sbjct: 254 IVCMSYAFHTPD--KL-S-FILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHM 308

Query: 117 HSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG--GTPMFMAPEV-ARGEHQ 172
           H+  VV+ D+K  NIL+ E G  +I+D G A   S+       GT  +MAPEV  +G   
Sbjct: 309 HNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAY 368

Query: 173 GFASDIWAVGCTVIEMASGGAPW--PNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLS 230
             ++D +++GC + ++  G +P+      D   +           E+P   S +    L 
Sbjct: 369 DSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA--VELPDSFSPELRSLLE 426

Query: 231 NCLRRDPKER-----WAASQLLKHPF 251
             L+RD   R       A ++ + PF
Sbjct: 427 GLLQRDVNRRLGCLGRGAQEVKESPF 452

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  136 bits (346), Expect = 5e-37
 Identities = 71/265 (26%), Positives = 110/265 (41%), Gaps = 35/265 (13%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQK---------FLSSLNSPHIVG 59
           +G+GS   V L+    + +++A K   L K   +Q +                  P +  
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKI--LKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 85

Query: 60  YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN 119
              C  T +  +L Y   MEY  GG L   I + G R  E   V Y  +I  GL +L S 
Sbjct: 86  LHSCFQTMD--RL-Y-FVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQSK 140

Query: 120 RVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG-------GTPMFMAPEVARGEH 171
            +++ D+K  N+++   G  KIADFG  K   E +  G       GTP ++APE+   + 
Sbjct: 141 GIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENIWDGVTTKTFCGTPDYIAPEIIAYQP 197

Query: 172 QGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSN 231
            G + D WA G  + EM +G AP+    D   +   I         P  +SK+A      
Sbjct: 198 YGKSVDWWAFGVLLYEMLAGQAPFE-GEDEDELFQSIMEHN--VAYPKSMSKEAVAICKG 254

Query: 232 CLRRDPKER-----WAASQLLKHPF 251
            + + P +R          + +H F
Sbjct: 255 LMTKHPGKRLGCGPEGERDIKEHAF 279

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  135 bits (342), Expect = 5e-37
 Identities = 62/284 (21%), Positives = 106/284 (37%), Gaps = 45/284 (15%)

Query: 4   TRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNS-PHIVGYKG 62
                +G G +  V    + R+ + FA K   L      +RE +     +  PHIV    
Sbjct: 21  VTSQVLGLGINGKVLQIFNKRTQEKFALKM--LQDCPKARREVELHWRASQCPHIVRIVD 78

Query: 63  CDVTSEDNKLMYNLFMEYAPGGTLNDEI-HRNGGRLDESLIVSYTRQILQGLEYLHSNRV 121
                   +    + ME   GG L   I  R      E       + I + ++YLHS  +
Sbjct: 79  VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINI 138

Query: 122 VHCDIKSRNILMA----ESGAKIADFGCAKWESEALQSGGTPMFMAPEVARGEHQGFASD 177
            H D+K  N+L       +  K+ DFG                  A E   GE    + D
Sbjct: 139 AHRDVKPENLLYTSKRPNAILKLTDFG-----------------FAKET-TGEKYDKSCD 180

Query: 178 IWAVGCTVIE--MASGGAP-WPNAADPMT--VLYKIAYSR-ELPEVP-AFLSKQANDFLS 230
           +W++G  VI   +  G  P + N    ++  +  +I   + E P    + +S++    + 
Sbjct: 181 MWSLG--VIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIR 238

Query: 231 NCLRRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSILD 274
           N L+ +P +R   ++ + HP+          I +S   P + L 
Sbjct: 239 NLLKTEPTQRMTITEFMNHPW----------IMQSTKVPQTPLH 272

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  135 bits (342), Expect = 6e-37
 Identities = 75/299 (25%), Positives = 123/299 (41%), Gaps = 72/299 (24%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAK------------STELPKSEFLQREQKFLSSLNSPH 56
           +G+G+   V  A     G + A K            ST +       RE   L  L+ P+
Sbjct: 29  VGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAI-------REISLLKELHHPN 80

Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL 116
           IV     DV   +  L   L  E+     L   +  N   L +S I  Y  Q+L+G+ + 
Sbjct: 81  IVSLI--DVIHSERCL--TLVFEFMEKD-LKKVLDENKTGLQDSQIKIYLYQLLRGVAHC 135

Query: 117 HSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSGGTPM-----------FMAP 164
           H +R++H D+K +N+L+   GA K+ADFG A+       + G P+           + AP
Sbjct: 136 HQHRILHRDLKPQNLLINSDGALKLADFGLAR-------AFGIPVRSYTHEVVTLWYRAP 188

Query: 165 EVARG-EHQGFASDIWAVGCTVIEMASG--------------------GAP----WPNAA 199
           +V  G +    + DIW++GC   EM +G                    G P    WP   
Sbjct: 189 DVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQ 248

Query: 200 D-PM--TVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
           + P+     +++   +    +     ++  D LSN L  DP +R +A   + HP+ ++ 
Sbjct: 249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  138 bits (349), Expect = 7e-37
 Identities = 77/265 (29%), Positives = 119/265 (44%), Gaps = 35/265 (13%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQR--------EQKFLSSLNSPHIVGY 60
           +G+G+   V L     +G  +A K   L K   + +        E + L +   P +   
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKI--LKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 213

Query: 61  KGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNR 120
           K    T +  +L     MEYA GG L   + R      E     Y  +I+  L+YLHS +
Sbjct: 214 KYSFQTHD--RL-C-FVMEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLHSEK 268

Query: 121 -VVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG-------GTPMFMAPEVARGEH 171
            VV+ D+K  N+++ + G  KI DFG  K   E ++ G       GTP ++APEV     
Sbjct: 269 NVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKTFCGTPEYLAPEVLEDND 325

Query: 172 QGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSN 231
            G A D W +G  + EM  G  P+ N       L+++    E+   P  L  +A   LS 
Sbjct: 326 YGRAVDWWGLGVVMYEMMCGRLPFYN--QDHEKLFELILMEEIR-FPRTLGPEAKSLLSG 382

Query: 232 CLRRDPKER-----WAASQLLKHPF 251
            L++DPK+R       A ++++H F
Sbjct: 383 LLKKDPKQRLGGGSEDAKEIMQHRF 407

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  135 bits (341), Expect = 2e-36
 Identities = 73/314 (23%), Positives = 121/314 (38%), Gaps = 85/314 (27%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAK------------STELPKSEFLQREQKFL 49
            + R   +G+G+   V  A    + +  A K             T +       RE   L
Sbjct: 35  RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAI-------REVSLL 87

Query: 50  SSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQI 109
             L   +I+  K   V   +++L  +L  EYA    L   + +N   +   +I S+  Q+
Sbjct: 88  KELQHRNIIELK--SVIHHNHRL--HLIFEYAEN-DLKKYMDKNPD-VSMRVIKSFLYQL 141

Query: 110 LQGLEYLHSNRVVHCDIKSRNILMAESGA------KIADFGCAKWESEALQSGGTPM--- 160
           + G+ + HS R +H D+K +N+L++ S A      KI DFG A+       + G P+   
Sbjct: 142 INGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR-------AFGIPIRQF 194

Query: 161 --------FMAPEVARG-EHQGFASDIWAVGCTVIEMASG-------------------- 191
                   +  PE+  G  H   + DIW++ C   EM                       
Sbjct: 195 THEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVL 254

Query: 192 GAP----WPNAADPMTVL--YKIAYSRELP-----EVPAFLSKQANDFLSNCLRRDPKER 240
           G P    WP     +T L  +K ++ +         + A L  +  D L+  L  DP +R
Sbjct: 255 GLPDDTTWPG----VTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKR 310

Query: 241 WAASQLLKHPFLEE 254
            +A   L+HP+   
Sbjct: 311 ISAKNALEHPYFSH 324

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  134 bits (340), Expect = 2e-36
 Identities = 79/310 (25%), Positives = 126/310 (40%), Gaps = 71/310 (22%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ----REQKFLSSLNSPHI 57
            + +   +G G+ ATV    +  +G   A K  +L   E       RE   +  L   +I
Sbjct: 6   QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENI 65

Query: 58  VGYKGCDVTSEDNKLMYNLFMEYAP---GGTLNDE-IHRNGGRLDESLIVSYTRQILQGL 113
           V     DV   +NKL   L  E+        ++   +      L+ +L+  +  Q+LQGL
Sbjct: 66  VRLY--DVIHTENKL--TLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGL 121

Query: 114 EYLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSGGTPM-----------F 161
            + H N+++H D+K +N+L+ + G  K+ DFG A+       + G P+           +
Sbjct: 122 AFCHENKILHRDLKPQNLLINKRGQLKLGDFGLAR-------AFGIPVNTFSSEVVTLWY 174

Query: 162 MAPEVARG-EHQGFASDIWAVGCTVIEMASG--------------------GAP----WP 196
            AP+V  G      + DIW+ GC + EM +G                    G P    WP
Sbjct: 175 RAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWP 234

Query: 197 NAADPMTVL--YKIAY----SRELPEV-----PAFLSKQANDFLSNCLRRDPKERWAASQ 245
           +    +T L  Y         R+L +V        L     DFL   L+ +P  R +A Q
Sbjct: 235 S----VTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQ 290

Query: 246 LLKHPFLEEF 255
            L HP+  E+
Sbjct: 291 ALHHPWFAEY 300

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  131 bits (332), Expect = 2e-35
 Identities = 75/299 (25%), Positives = 106/299 (35%), Gaps = 66/299 (22%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ--------REQKFLSSLNS---PHI 57
           IG G+  TV  A    SG   A KS  +P              RE   L  L +   P++
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76

Query: 58  VGYKGCDV---TSEDNKLMYNLFMEYAP---GGTLNDEIHRNGGRLDESLIVSYTRQILQ 111
           V     DV   +  D ++   L  E+        L+         L    I    RQ L+
Sbjct: 77  VRLM--DVCATSRTDREIKVTLVFEHVDQDLRTYLDK---APPPGLPAETIKDLMRQFLR 131

Query: 112 GLEYLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSGGTPMFM-------- 162
           GL++LH+N +VH D+K  NIL+   G  K+ADFG A+            M +        
Sbjct: 132 GLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLAR-------IYSYQMALTPVVVTLW 184

Query: 163 --APEVARGEHQGFASDIWAVGCTVIEMASG--------------------GAP----WP 196
             APEV          D+W+VGC   EM                       G P    WP
Sbjct: 185 YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP 244

Query: 197 NAAD-PMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEE 254
                P               VP  + +     L   L  +P +R +A + L+H +L +
Sbjct: 245 RDVSLPRGAFPPRGPRPVQSVVPE-MEESGAQLLLEMLTFNPHKRISAFRALQHSYLHK 302

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  131 bits (331), Expect = 2e-35
 Identities = 64/240 (26%), Positives = 94/240 (39%), Gaps = 34/240 (14%)

Query: 6   GHTIGQGSSATVSLATSLRSGDVFAAK--STELPKSEFLQREQKFLSSLNSPHIVGYKGC 63
              +G+G    V   +  +  +V A K  S+   KS F + E      L   +I+G+   
Sbjct: 13  LECVGKGRYGEVWRGS-WQGENV-AVKIFSSRDEKSWFRETELYNTVMLRHENILGFIAS 70

Query: 64  DVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNR--- 120
           D+TS  +     L   Y   G+L D +      LD    +     I  GL +LH      
Sbjct: 71  DMTSRHSSTQLWLITHYHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLAHLHIEIFGT 128

Query: 121 -----VVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG--------GTPMFMAPEV 166
                + H D+KS+NIL+ ++G   IAD G A   S++            GT  +MAPEV
Sbjct: 129 QGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEV 188

Query: 167 ARGEHQGFA------SDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAF 220
                Q          DIWA G  + E+A          D     YK  +   +P  P+F
Sbjct: 189 LDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVED-----YKPPFYDVVPNDPSF 243

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  133 bits (336), Expect = 4e-35
 Identities = 72/271 (26%), Positives = 113/271 (41%), Gaps = 37/271 (13%)

Query: 8   TIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQR--------EQKFLSSLNSPHIVG 59
            IG+G+   V++     +  VFA K   L K E L+R        E+  L + +S  I  
Sbjct: 81  VIGRGAFGEVAVVKLKNADKVFAMKI--LNKWEMLKRAETACFREERDVLVNGDSKWITT 138

Query: 60  YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN 119
                    DN L Y L M+Y  GG L   + +   RL E +   Y  +++  ++ +H  
Sbjct: 139 LHYAFQD--DNNL-Y-LVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQL 194

Query: 120 RVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG--------GTPMFMAPEVARGE 170
             VH DIK  NILM  +G  ++ADFG      + ++ G        GTP +++PE+ +  
Sbjct: 195 HYVHRDIKPDNILMDMNGHIRLADFGSCL---KLMEDGTVQSSVAVGTPDYISPEILQAM 251

Query: 171 HQ-----GFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRE---LPEVPAFLS 222
                  G   D W++G  + EM  G  P+  A   +    KI   +E    P     +S
Sbjct: 252 EGGKGRYGPECDWWSLGVCMYEMLYGETPF-YAESLVETYGKIMNHKERFQFPTQVTDVS 310

Query: 223 KQANDFLSNCLRRDPKE--RWAASQLLKHPF 251
           + A D +   +        +       KHPF
Sbjct: 311 ENAKDLIRRLICSREHRLGQNGIEDFKKHPF 341

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  136 bits (343), Expect = 4e-35
 Identities = 70/265 (26%), Positives = 109/265 (41%), Gaps = 35/265 (13%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQK---------FLSSLNSPHIVG 59
           +G+GS   V L+    + +++A K   L K   +Q +                  P +  
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKI--LKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 406

Query: 60  YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN 119
              C  T +    +Y   MEY  GG L   I + G R  E   V Y  +I  GL +L S 
Sbjct: 407 LHSCFQTMDR---LY-FVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQSK 461

Query: 120 RVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG-------GTPMFMAPEVARGEH 171
            +++ D+K  N+++   G  KIADFG  K   E +  G       GTP ++APE+   + 
Sbjct: 462 GIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENIWDGVTTKTFCGTPDYIAPEIIAYQP 518

Query: 172 QGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSN 231
            G + D WA G  + EM +G AP+    D   +   I         P  +SK+A      
Sbjct: 519 YGKSVDWWAFGVLLYEMLAGQAPFE-GEDEDELFQSIMEHN--VAYPKSMSKEAVAICKG 575

Query: 232 CLRRDPKER-----WAASQLLKHPF 251
            + + P +R          + +H F
Sbjct: 576 LMTKHPGKRLGCGPEGERDIKEHAF 600

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  131 bits (331), Expect = 6e-35
 Identities = 69/301 (22%), Positives = 111/301 (36%), Gaps = 63/301 (20%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAK------------STELPKSEFLQREQKFLSSLNSPH 56
           IGQG+   V  A   ++G   A K             T L       RE K L  L   +
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITAL-------REIKILQLLKHEN 77

Query: 57  IVGYKGCDVT--SEDNKLMYNLFM--EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQG 112
           +V       T  S  N+   ++++  ++     L   +     +   S I    + +L G
Sbjct: 78  VVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNG 136

Query: 113 LEYLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSGGTPM--------FMA 163
           L Y+H N+++H D+K+ N+L+   G  K+ADFG A+  S A  S             +  
Sbjct: 137 LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 196

Query: 164 PEVARGE-HQGFASDIWAVGCTVIEMASG--------------------GAP----WPNA 198
           PE+  GE   G   D+W  GC + EM +                     G+     WPN 
Sbjct: 197 PELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNV 256

Query: 199 AD-PMTVLYKI--AYSRELPEV--PAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLE 253
            +  +    ++     R++ +          A D +   L  DP +R  +   L H F  
Sbjct: 257 DNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFW 316

Query: 254 E 254
            
Sbjct: 317 S 317

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  131 bits (332), Expect = 1e-34
 Identities = 73/274 (26%), Positives = 116/274 (42%), Gaps = 41/274 (14%)

Query: 8   TIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQR--------EQKFLSSLNSPHIVG 59
            IG+G+ + V++    ++G V+A K   + K + L+R        E+  L + +   I  
Sbjct: 68  VIGRGAFSEVAVVKMKQTGQVYAMKI--MNKWDMLKRGEVSCFREERDVLVNGDRRWITQ 125

Query: 60  YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN 119
                   +D   +Y L MEY  GG L   + + G R+   +   Y  +I+  ++ +H  
Sbjct: 126 LHFA---FQDENYLY-LVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRL 181

Query: 120 RVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG--------GTPMFMAPEVARGE 170
             VH DIK  NIL+   G  ++ADFG      +    G        GTP +++PE+ +  
Sbjct: 182 GYVHRDIKPDNILLDRCGHIRLADFGSCL---KLRADGTVRSLVAVGTPDYLSPEILQAV 238

Query: 171 HQ-------GFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRE---LPEVPAF 220
                    G   D WA+G    EM  G  P+  A        KI + +E   LP V   
Sbjct: 239 GGGPGTGSYGPECDWWALGVFAYEMFYGQTPF-YADSTAETYGKIVHYKEHLSLPLVDEG 297

Query: 221 LSKQANDFLSNCLRRDPKER---WAASQLLKHPF 251
           + ++A DF+   L   P+ R     A     HPF
Sbjct: 298 VPEEARDFIQR-LLCPPETRLGRGGAGDFRTHPF 330

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  129 bits (325), Expect = 2e-34
 Identities = 58/269 (21%), Positives = 100/269 (37%), Gaps = 33/269 (12%)

Query: 4   TRGHTIGQGSSATVSLATSLRSGDVFAAK--STELPKSEFLQREQKFLSSLNSPHIVGYK 61
                  +G    V  A  L +  V A K    +  +S   + E   L  +   +I+ + 
Sbjct: 27  QLLEVKARGRFGCVWKAQ-LLNEYV-AVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFI 84

Query: 62  GCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN-- 119
           G +       +   L   +   G+L+D +  N   +  + +      + +GL YLH +  
Sbjct: 85  GAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLHEDIP 142

Query: 120 --------RVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG------GTPMFMAP 164
                    + H DIKS+N+L+  +  A IADFG A        +G      GT  +MAP
Sbjct: 143 GLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAP 202

Query: 165 EVARGEHQGFA-----SDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPA 219
           EV  G            D++A+G  + E+AS         D     Y + +  E+ + P+
Sbjct: 203 EVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE----YMLPFEEEIGQHPS 258

Query: 220 FLSKQANDFLSNCLRRDPKERWAASQLLK 248
               Q    +    R   ++ W     + 
Sbjct: 259 LEDMQEV-VVHKKKRPVLRDYWQKHAGMA 286

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  129 bits (326), Expect = 8e-34
 Identities = 67/290 (23%), Positives = 109/290 (37%), Gaps = 51/290 (17%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSE 68
           IG GS   V  A    SG++ A K     K  F  RE + +  L+  +IV  +    +S 
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQDK-RFKNRELQIMRKLDHCNIVRLRYFFYSSG 120

Query: 69  D--NKLMYNLFMEYAPGGTLNDEIH---RNGGRLDESLIVSYTRQILQGLEYLHSNRVVH 123
           +  +++  NL ++Y P  T+        R    L    +  Y  Q+ + L Y+HS  + H
Sbjct: 121 EKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICH 179

Query: 124 CDIKSRNILM-AESGA-KIADFGCAKWESEALQSGGTPM--------FMAPEVARGEHQ- 172
            DIK +N+L+  ++   K+ DFG AK         G P         + APE+  G    
Sbjct: 180 RDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-----GEPNVSYICSRYYRAPELIFGATDY 234

Query: 173 GFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKI------------------AYSREL 214
             + D+W+ GC + E+  G   +P     +  L +I                      + 
Sbjct: 235 TSSIDVWSAGCVLAELLLGQPIFP-GDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 293

Query: 215 PEVPA-----FLSKQAN----DFLSNCLRRDPKERWAASQLLKHPFLEEF 255
           P++ A         +         S  L   P  R    +   H F +E 
Sbjct: 294 PQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 343

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  127 bits (320), Expect = 4e-33
 Identities = 78/296 (26%), Positives = 114/296 (38%), Gaps = 64/296 (21%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGYKGC--DVT 66
           IG GS   V  A  + S +V A K     K  F  RE + +  +  P++V  K       
Sbjct: 48  IGNGSFGVVFQAKLVESDEV-AIKKVLQDK-RFKNRELQIMRIVKHPNVVDLKAFFYSNG 105

Query: 67  SEDNKLMYNLFMEYAPGGTLNDEIH---RNGGRLDESLIVSYTRQILQGLEYLHSNRVVH 123
            + +++  NL +EY P  T+        +    +   LI  Y  Q+L+ L Y+HS  + H
Sbjct: 106 DKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICH 164

Query: 124 CDIKSRNILM-AESGA-KIADFGCAKWESEALQSGGTPM--------FMAPEVARG-EHQ 172
            DIK +N+L+   SG  K+ DFG AK     L + G P         + APE+  G  + 
Sbjct: 165 RDIKPQNLLLDPPSGVLKLIDFGSAK----ILIA-GEPNVSYICSRYYRAPELIFGATNY 219

Query: 173 GFASDIWAVGCTVIEMASG--------------------GAP----WPNAADPMTVLYKI 208
               DIW+ GC + E+  G                    G P           M   Y  
Sbjct: 220 TTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKT----MNPNY-- 273

Query: 209 AYSRELPEVPA------F---LSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
               + P++        F       A D +S  L   P  R  A + L HPF +E 
Sbjct: 274 -MEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDEL 328

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  125 bits (317), Expect = 6e-33
 Identities = 73/276 (26%), Positives = 122/276 (44%), Gaps = 44/276 (15%)

Query: 8   TIGQGSSATVSLA---TSLRSGDVFAAKSTELPKSEFLQR---------EQKFLSSLN-S 54
            +G G+   V L    +   +G ++A K   L K+  +Q+         E++ L  +  S
Sbjct: 61  VLGTGAYGKVFLVRKISGHDTGKLYAMKV--LKKATIVQKAKTTEHTRTERQVLEHIRQS 118

Query: 55  PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLE 114
           P +V       T    KL + L ++Y  GG L   + +   R  E  +  Y  +I+  LE
Sbjct: 119 PFLVTLHYAFQTET--KL-H-LILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALE 173

Query: 115 YLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG--------GTPMFMAPE 165
           +LH   +++ DIK  NIL+  +G   + DFG +K   E +           GT  +MAP+
Sbjct: 174 HLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK---EFVADETERAYDFCGTIEYMAPD 230

Query: 166 VARGEHQGF--ASDIWAVGCTVIEMASGGAPW---PNAADPMTVLYKIAYSRELPEVPAF 220
           + RG   G   A D W++G  + E+ +G +P+           +  +I  S   P  P  
Sbjct: 231 IVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE--PPYPQE 288

Query: 221 LSKQANDFLSNCLRRDPKER-----WAASQLLKHPF 251
           +S  A D +   L +DPK+R       A ++ +H F
Sbjct: 289 MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  125 bits (315), Expect = 9e-33
 Identities = 58/240 (24%), Positives = 92/240 (38%), Gaps = 34/240 (14%)

Query: 6   GHTIGQGSSATVSLATSLRSGDVFAAK--STELPKSEFLQREQKFLSSLNSPHIVGYKGC 63
             +IG+G    V      R  +V A K  S+   +S F + E      L   +I+G+   
Sbjct: 47  QESIGKGRFGEVWRGK-WRGEEV-AVKIFSSREERSWFREAEIYQTVMLRHENILGFIAA 104

Query: 64  DVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNR--- 120
           D           L  +Y   G+L D ++R    +    ++        GL +LH      
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGT 162

Query: 121 -----VVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG--------GTPMFMAPEV 166
                + H D+KS+NIL+ ++G   IAD G A     A  +         GT  +MAPEV
Sbjct: 163 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 222

Query: 167 ARGEHQGF------ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAF 220
                          +DI+A+G    E+A   +      D     Y++ Y   +P  P+ 
Sbjct: 223 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED-----YQLPYYDLVPSDPSV 277

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  126 bits (317), Expect = 1e-32
 Identities = 69/318 (21%), Positives = 113/318 (35%), Gaps = 73/318 (22%)

Query: 6   GHTIGQGSSATVSLATSL--RSGDVFAAKSTE---LPKSEFLQREQKFLSSLNSPHIVGY 60
           G  +G+G+   V  A     +    +A K  E   +  S    RE   L  L  P+++  
Sbjct: 26  GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA--CREIALLRELKHPNVISL 83

Query: 61  KGCDVTSEDNKLMYNLFMEYAP-------GGTLNDEIHRNGGRLDESLIVSYTRQILQGL 113
           +   ++  D K+   L  +YA              + ++   +L   ++ S   QIL G+
Sbjct: 84  QKVFLSHADRKVW--LLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 141

Query: 114 EYLHSNRVVHCDIKSRNILMAESGA-----KIADFGCAKWESEALQSGGTPMFM------ 162
            YLH+N V+H D+K  NIL+   G      KIAD G A+  +  L+       +      
Sbjct: 142 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 201

Query: 163 -APEVARG-EHQGFASDIWAVGCTVIEMASG----------------------------- 191
            APE+  G  H   A DIWA+GC   E+ +                              
Sbjct: 202 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM 261

Query: 192 GAP----WPNAAD-----------PMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRD 236
           G P    W +                      +  + + +       +A   L   L  D
Sbjct: 262 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMD 321

Query: 237 PKERWAASQLLKHPFLEE 254
           P +R  + Q ++ P+  E
Sbjct: 322 PIKRITSEQAMQDPYFLE 339

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  123 bits (311), Expect = 2e-32
 Identities = 78/300 (26%), Positives = 113/300 (37%), Gaps = 68/300 (22%)

Query: 9   IGQGSSATVSLATSLRS-GDVFAAKSTELPKSE--F----LQREQKFLSSLNS---PHIV 58
           IG+G+   V  A  L++ G   A K   +   E       + RE   L  L +   P++V
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTI-REVAVLRHLETFEHPNVV 77

Query: 59  GYKGCDV-----TSEDNKLMYNLFMEYAPG--GTLNDEIHRNGGRLDESLIVSYTRQILQ 111
                DV     T  + KL   L  E+      T  D        +    I     Q+L+
Sbjct: 78  RLF--DVCTVSRTDRETKLT--LVFEHVDQDLTTYLD--KVPEPGVPTETIKDMMFQLLR 131

Query: 112 GLEYLHSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSGGTPMFM-------- 162
           GL++LHS+RVVH D+K +NIL+  SG  K+ADFG A+            M +        
Sbjct: 132 GLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR-------IYSFQMALTSVVVTLW 184

Query: 163 --APEVARGEHQGFASDIWAVGCTVIEMASG--------------------GAP----WP 196
             APEV          D+W+VGC   EM                       G P    WP
Sbjct: 185 YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 244

Query: 197 NAAD-PMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
                P    +  +       V   + +   D L  CL  +P +R +A   L HP+ ++ 
Sbjct: 245 RDVALPRQAFHSKSAQPIEKFVTD-IDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 303

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  125 bits (315), Expect = 2e-32
 Identities = 72/270 (26%), Positives = 120/270 (44%), Gaps = 39/270 (14%)

Query: 8   TIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQR--------EQKFLSSLNSPHIVG 59
            IG+G+   V L     +  V+A K   L K E ++R        E+  ++  NSP +V 
Sbjct: 76  VIGRGAFGEVQLVRHKSTRKVYAMKL--LSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 133

Query: 60  YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN 119
                   +D++ +Y + MEY PGG L      +   + E     YT +++  L+ +HS 
Sbjct: 134 LFYA---FQDDRYLY-MVMEYMPGGDLV--NLMSNYDVPEKWARFYTAEVVLALDAIHSM 187

Query: 120 RVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG--------GTPMFMAPEVARGE 170
             +H D+K  N+L+ +SG  K+ADFG      +  + G        GTP +++PEV + +
Sbjct: 188 GFIHRDVKPDNMLLDKSGHLKLADFGTCM---KMNKEGMVRCDTAVGTPDYISPEVLKSQ 244

Query: 171 HQ----GFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVP--AFLSKQ 224
                 G   D W+VG  + EM  G  P+  A   +    KI   +     P    +SK+
Sbjct: 245 GGDGYYGRECDWWSVGVFLYEMLVGDTPF-YADSLVGTYSKIMNHKNSLTFPDDNDISKE 303

Query: 225 ANDFLSNCLRRDPKER---WAASQLLKHPF 251
           A + +   L  D + R       ++ +H F
Sbjct: 304 AKNLICAFL-TDREVRLGRNGVEEIKRHLF 332

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  122 bits (309), Expect = 5e-32
 Identities = 78/289 (26%), Positives = 126/289 (43%), Gaps = 40/289 (13%)

Query: 4   TRGHTIGQGSSATVSLATSLRSGDVF----AAK-----STELPKSEFLQREQKFLSSLNS 54
                +G+G+  +V L      GD      A K       +  + +F  RE + L +L+S
Sbjct: 26  KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQR-DFQ-REIQILKALHS 83

Query: 55  PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLE 114
             IV Y+G        + +  L MEY P G L D + R+  RLD S ++ Y+ QI +G+E
Sbjct: 84  DFIVKYRGV-SYGPGRQSLR-LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGME 141

Query: 115 YLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKW------ESEALQSGGTPMF-MAPEV 166
           YL S R VH D+ +RNIL+      KIADFG AK            + G +P+F  APE 
Sbjct: 142 YLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPES 201

Query: 167 ARGEHQGF--ASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSK 223
                  F   SD+W+ G  + E+ +        +A+ + ++        L  +   L +
Sbjct: 202 LS--DNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEE 259

Query: 224 ------------QANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSCTK 260
                       + ++ +  C    P++R + S L   P L+   S ++
Sbjct: 260 GQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSAL--GPQLDMLWSGSR 306

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  121 bits (305), Expect = 8e-32
 Identities = 74/284 (26%), Positives = 122/284 (42%), Gaps = 39/284 (13%)

Query: 4   TRGHTIGQGSSATVSLAT----SLRSGDVFAAK----STELPKSEFLQREQKFLSSLNSP 55
                +G+G+  +V +         +G+V A K    STE    +F  RE + L SL   
Sbjct: 13  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE-REIEILKSLQHD 71

Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
           +IV YKG    S   + +  L MEY P G+L D + ++  R+D   ++ YT QI +G+EY
Sbjct: 72  NIVKYKGV-CYSAGRRNLK-LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEY 129

Query: 116 LHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE------ALQSGGTPMF-MAPEVA 167
           L + R +H D+ +RNIL+      KI DFG  K   +        + G +P+F  APE  
Sbjct: 130 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESL 189

Query: 168 RGEHQGF--ASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAY----SRELPEV--- 217
                 F  ASD+W+ G  + E+ +         A+ M ++            L E+   
Sbjct: 190 T--ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN 247

Query: 218 ------PAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
                 P     +    ++ C   +  +R +   L     +++ 
Sbjct: 248 NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL--ALRVDQI 289

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  121 bits (306), Expect = 1e-31
 Identities = 53/240 (22%), Positives = 89/240 (37%), Gaps = 34/240 (14%)

Query: 6   GHTIGQGSSATVSLATSLRSGDVFAAK--STELPKSEFLQREQKFLSSLNSPHIVGYKGC 63
              IG+G    V +    R   V A K   T    S F + E      +   +I+G+   
Sbjct: 42  VKQIGKGRYGEVWMGK-WRGEKV-AVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAA 99

Query: 64  DVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNR--- 120
           D+    +     L  +Y   G+L D +      LD   ++      + GL +LH+     
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEIFST 157

Query: 121 -----VVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG--------GTPMFMAPEV 166
                + H D+KS+NIL+ ++G   IAD G A                  GT  +M PEV
Sbjct: 158 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEV 217

Query: 167 ARGEHQGF------ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAF 220
                          +D+++ G  + E+A          +     Y++ Y   +P  P++
Sbjct: 218 LDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEE-----YQLPYHDLVPSDPSY 272

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  121 bits (305), Expect = 1e-31
 Identities = 73/286 (25%), Positives = 121/286 (42%), Gaps = 43/286 (15%)

Query: 4   TRGHTIGQGSSATVSLAT----SLRSGDVFAAK----STELPKSEFLQREQKFLSSLNSP 55
                +G+G+  +V +         +G+V A K    STE    +F  RE + L SL   
Sbjct: 44  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE-REIEILKSLQHD 102

Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
           +IV YKG    S   + +  L MEY P G+L D + ++  R+D   ++ YT QI +G+EY
Sbjct: 103 NIVKYKGV-CYSAGRRNLK-LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEY 160

Query: 116 LHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE------ALQSGGTPMF-MAPEVA 167
           L + R +H D+ +RNIL+      KI DFG  K   +        + G +P+F  APE  
Sbjct: 161 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESL 220

Query: 168 RGEHQGF--ASDIWAVGCTVIEMAS----------------GGAPWPNAADPMTVLYKIA 209
                 F  ASD+W+ G  + E+ +                G            ++  + 
Sbjct: 221 T--ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF-HLIELLK 277

Query: 210 YSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
            +  LP  P     +    ++ C   +  +R +   L     +++ 
Sbjct: 278 NNGRLPR-PDGCPDEIYMIMTECWNNNVNQRPSFRDL--ALRVDQI 320

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  119 bits (300), Expect = 2e-30
 Identities = 77/325 (23%), Positives = 119/325 (36%), Gaps = 89/325 (27%)

Query: 8   TIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQ-----KFLSSLNSPHIVGYKG 62
            +G G  +TV LA  + +    A K   + + + +  E      K L  +N         
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMK---IVRGDKVYTEAAEDEIKLLQRVNDA------- 75

Query: 63  CDVTSEDNKLMYNL------FMEYAPGGT------------LNDEIHRNGGR-LDESLIV 103
            D T ED+    ++      F    P G             L   I +   R +    + 
Sbjct: 76  -DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVK 134

Query: 104 SYTRQILQGLEYLHSN-RVVHCDIKSRNILMAESGA-------KIADFGCAKWESEALQS 155
             ++Q+L GL+Y+H    ++H DIK  N+LM    +       KIAD G A W  E   +
Sbjct: 135 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN 194

Query: 156 GGTPMFM-APEVARGEHQGFASDIWAVGCTVIEMASG--------GAPWPNAAD------ 200
                   +PEV  G   G  +DIW+  C + E+ +G        G  +    D      
Sbjct: 195 SIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII 254

Query: 201 ------PMTVLYKIAYSRE----------------------LPEVPAFLSKQAN---DFL 229
                 P  +L    Y+R                       L E   F   +A    DFL
Sbjct: 255 ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFL 314

Query: 230 SNCLRRDPKERWAASQLLKHPFLEE 254
           S  L+ DP++R  A  L+ HP+L++
Sbjct: 315 SPMLQLDPRKRADAGGLVNHPWLKD 339

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  116 bits (293), Expect = 4e-30
 Identities = 65/285 (22%), Positives = 105/285 (36%), Gaps = 39/285 (13%)

Query: 4   TRGHTIGQGSSATVSLATSLRSGD----VFAAK-----STELPKSEFLQREQKFLSSLNS 54
            R   +G+G    V L      GD      A K     S     ++   +E + L +L  
Sbjct: 24  KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLK-KEIEILRNLYH 82

Query: 55  PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLE 114
            +IV YKG   T +    +  L ME+ P G+L + + +N  +++    + Y  QI +G++
Sbjct: 83  ENIVKYKGI-CTEDGGNGIK-LIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMD 140

Query: 115 YLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE------ALQSGGTPMF-MAPEV 166
           YL S + VH D+ +RN+L+      KI DFG  K                +P+F  APE 
Sbjct: 141 YLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPEC 200

Query: 167 ARGEHQGF--ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYS----RELPEV--- 217
                  F  ASD+W+ G T+ E+ +      +       +    +       L      
Sbjct: 201 LM--QSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKE 258

Query: 218 ------PAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFC 256
                 P     +    +  C    P  R +   L      E   
Sbjct: 259 GKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNL--IEGFEALL 301

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  115 bits (289), Expect = 7e-29
 Identities = 79/338 (23%), Positives = 121/338 (35%), Gaps = 65/338 (19%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELP--KSEFLQ---REQKFLSSLNSPHIVGYKGC 63
           IG G+   V  A         A K    P       +   RE   +  +N  +I+G    
Sbjct: 33  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL-- 90

Query: 64  DV-----TSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHS 118
           +V     + E+ + +Y + ME      L   I      LD   +     Q+L G+++LHS
Sbjct: 91  NVFTPQKSLEEFQDVY-IVMELM-DANLCQVIQME---LDHERMSYLLYQMLCGIKHLHS 145

Query: 119 NRVVHCDIKSRNILM-AESGAKIADFGCAKWESEALQSGG---TPMFMAPEVARGEHQGF 174
             ++H D+K  NI++ ++   KI DFG A+    +        T  + APEV  G     
Sbjct: 146 AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKE 205

Query: 175 ASDIWAVGCTVIEMASG--------------------GAPW--------PNAAD------ 200
             DIW+VGC + EM  G                    G P         P          
Sbjct: 206 NVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRP 265

Query: 201 -----PMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
                    L+         E     + QA D LS  L  D  +R +  + L+HP++  +
Sbjct: 266 KYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 325

Query: 256 CSCTKQIQESNCSPTSILDQGIWNSVEETEESLGNLIH 293
                   E+   P  I D+   +  E T E    LI+
Sbjct: 326 ----YDPSEAEAPPPKIPDK-QLDEREHTIEEWKELIY 358

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  115 bits (289), Expect = 8e-29
 Identities = 67/270 (24%), Positives = 110/270 (40%), Gaps = 36/270 (13%)

Query: 6   GHTIGQGSSATVSLATSLRSGDVFAA------KSTELPKSEFLQREQKFLSSLNSPHIVG 59
           G  IG+G+   V     LR+ +   A            K++FL +E + L   + P+IV 
Sbjct: 119 GEQIGRGNFGEVFSGR-LRADNTLVAVKSCRETLPPDLKAKFL-QEARILKQYSHPNIVR 176

Query: 60  YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN 119
             G  V ++   +   + ME   GG     +   G RL    ++        G+EYL S 
Sbjct: 177 LIG--VCTQKQPIY--IVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK 232

Query: 120 RVVHCDIKSRNILMAESG-AKIADFGCAKWESEAL--QSGGTPMF----MAPEVARGEHQ 172
             +H D+ +RN L+ E    KI+DFG ++ E++ +   SGG         APE       
Sbjct: 233 CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRY 292

Query: 173 GFASDIWAVGCTVIEMASGGA-PWPNAADPMT---VLYKIA--YSRELPE-VPAFLSKQA 225
              SD+W+ G  + E  S GA P+PN    ++       +        PE  P  +    
Sbjct: 293 SSESDVWSFGILLWETFSLGASPYPN----LSNQQTREFVEKGGRLPCPELCPDAVF--- 345

Query: 226 NDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
              +  C   +P +R + S + +   L+  
Sbjct: 346 -RLMEQCWAYEPGQRPSFSTIYQ--ELQSI 372

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  112 bits (282), Expect = 2e-28
 Identities = 71/294 (24%), Positives = 117/294 (39%), Gaps = 41/294 (13%)

Query: 4   TRGHTIGQGSSATVSLATSLRSGDVF----AAK-----STELPKSEFLQREQKFLSSLNS 54
            +   +G+G    VSL     + D      A K     +    +S +  +E   L +L  
Sbjct: 34  KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWK-QEIDILRTLYH 92

Query: 55  PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLE 114
            HI+ YKGC         +  L MEY P G+L D + R+   +  + ++ + +QI +G+ 
Sbjct: 93  EHIIKYKGC-CEDAGAASLQ-LVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMA 148

Query: 115 YLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE------ALQSGGTPMF-MAPEV 166
           YLH+   +H D+ +RN+L+      KI DFG AK   E        + G +P+F  APE 
Sbjct: 149 YLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 208

Query: 167 ARGEHQGF--ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSR-ELPEVPAFL-- 221
            +     F  ASD+W+ G T+ E+ +      +       L  IA  +  +  +   L  
Sbjct: 209 LK--EYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLER 266

Query: 222 ----------SKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQIQES 265
                       +    + NC   +   R     L   P L+      +    S
Sbjct: 267 GERLPRPDKCPAEVYHLMKNCWETEASFRPTFENL--IPILKTVHEKYQGQAPS 318

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  113 bits (283), Expect = 2e-28
 Identities = 56/250 (22%), Positives = 93/250 (37%), Gaps = 44/250 (17%)

Query: 6   GHTIGQGSSATVSLATSLRSGDVFAAK--STELPKSEFLQREQKFLSSLNSPHIVGYKGC 63
              IG+G    V   + L    V A K  S    ++   ++    +  +   +I  +   
Sbjct: 18  LELIGRGRYGAVYKGS-LDERPV-AVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVG 75

Query: 64  DV-TSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHS---- 118
           D   + D ++ Y L MEY P G+L   +  +    D          + +GL YLH+    
Sbjct: 76  DERVTADGRMEYLLVMEYYPNGSLXKYLSLH--TSDWVSSCRLAHSVTRGLAYLHTELPR 133

Query: 119 -----NRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG------------GTPM 160
                  + H D+ SRN+L+   G   I+DFG +   +                  GT  
Sbjct: 134 GDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIR 193

Query: 161 FMAPEVARG-------EHQGFASDIWAVGCTVIEMASG---GAPWPNAADPMTVLYKIAY 210
           +MAPEV  G       E      D++A+G    E+        P  +  +     Y++A+
Sbjct: 194 YMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE-----YQMAF 248

Query: 211 SRELPEVPAF 220
             E+   P F
Sbjct: 249 QTEVGNHPTF 258

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  112 bits (282), Expect = 5e-28
 Identities = 84/300 (28%), Positives = 119/300 (39%), Gaps = 62/300 (20%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQRE---QKFLSSLNSPHIVGYKGC-- 63
            GQG+  TV L     +G   A K        F  RE    + L+ L+ P+IV  +    
Sbjct: 31  AGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSYFY 89

Query: 64  DVTSEDNKLMY-NLFMEYAPGGTLNDEIH---RNGGRLDESLIVSYTRQILQGLEYLH-- 117
            +   D + +Y N+ MEY P  TL+       R        LI  +  Q+++ +  LH  
Sbjct: 90  TLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLP 148

Query: 118 SNRVVHCDIKSRNILMAESGA--KIADFGCAKWESEALQSGGTPM--------FMAPEVA 167
           S  V H DIK  N+L+ E+    K+ DFG AK       S   P         + APE+ 
Sbjct: 149 SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAK-----KLSPSEPNVAYICSRYYRAPELI 203

Query: 168 RG-EHQGFASDIWAVGCTVIEMASG--------------------GAP--------WPNA 198
            G +H   A DIW+VGC   EM  G                    G P         P+ 
Sbjct: 204 FGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSH 263

Query: 199 ADPMTVLYKIA---YSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
            D    LY      +S    +     +K+A D LS  L+  P+ER    + L HP+ +E 
Sbjct: 264 TDVD--LYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDEL 321

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  111 bits (280), Expect = 6e-28
 Identities = 60/294 (20%), Positives = 114/294 (38%), Gaps = 58/294 (19%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSL-NSPHIVGYKGCDVTS 67
           +G+G  + V  A ++ + +    K  +  K + ++RE K L +L   P+I+     D+  
Sbjct: 44  LGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLA--DIVK 101

Query: 68  EDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIK 127
           +       L  E+      N +  +    L +  I  Y  +IL+ L+Y HS  ++H D+K
Sbjct: 102 DPVSRTPALVFEH----VNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVK 157

Query: 128 SRNILMAESGA--KIADFGCAKWESEALQSGGTPM--------FMAPEVARG-EHQGFAS 176
             N+++       ++ D+G A++        G           F  PE+    +   ++ 
Sbjct: 158 PHNVMIDHEHRKLRLIDWGLAEFYHP-----GQEYNVRVASRYFKGPELLVDYQMYDYSL 212

Query: 177 DIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA----------------------YSREL 214
           D+W++GC +  M     P+ +  D    L +IA                      ++  L
Sbjct: 213 DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDIL 272

Query: 215 PEVP-------------AFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
                              +S +A DFL   LR D + R  A + ++HP+    
Sbjct: 273 GRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 326

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  111 bits (279), Expect = 7e-28
 Identities = 56/213 (26%), Positives = 94/213 (44%), Gaps = 27/213 (12%)

Query: 4   TRGHTIGQGSSATVSLATSLRSGDVF----AAK-----STELPKSEFLQREQKFLSSLNS 54
            +   +G G+  TV     +  G+      A K     ++     E L  E   ++S+++
Sbjct: 18  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL-DEAYVMASVDN 76

Query: 55  PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLE 114
           PH+    G    +    +   L  +  P G L D +  +   +    ++++  QI +G+ 
Sbjct: 77  PHVCRLLGI-CLTS--TVQ--LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 131

Query: 115 YLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKW----ESEALQSGG-TPMF-MAPEVA 167
           YL   R+VH D+ +RN+L+      KI DFG AK     E E    GG  P+  MA E  
Sbjct: 132 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191

Query: 168 RGEHQGF--ASDIWAVGCTVIEMAS-GGAPWPN 197
              H+ +   SD+W+ G TV E+ + G  P+  
Sbjct: 192 L--HRIYTHQSDVWSYGVTVWELMTFGSKPYDG 222

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  111 bits (280), Expect = 3e-27
 Identities = 82/346 (23%), Positives = 121/346 (34%), Gaps = 79/346 (22%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELP--KSEFLQ---REQKFLSSLNSPHIVGYKGC 63
           IG G+   V  A         A K    P       +   RE   +  +N  +I+     
Sbjct: 70  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL-- 127

Query: 64  DV-----TSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHS 118
           +V     T E+ + +Y L ME      L   I      LD   +     Q+L G+++LHS
Sbjct: 128 NVFTPQKTLEEFQDVY-LVMELM-DANLCQVIQME---LDHERMSYLLYQMLCGIKHLHS 182

Query: 119 NRVVHCDIKSRNILM-AESGAKIADFGCAKWESEALQSGGTPMFM----------APEVA 167
             ++H D+K  NI++ ++   KI DFG A+       + GT   M          APEV 
Sbjct: 183 AGIIHRDLKPSNIVVKSDCTLKILDFGLAR-------TAGTSFMMTPYVVTRYYRAPEVI 235

Query: 168 RGEHQGFASDIWAVGCTVIEMASG--------------------GAPW--------PNAA 199
            G       DIW+VGC + EM                       G P         P   
Sbjct: 236 LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 295

Query: 200 D-----------PMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLK 248
           +               L+  +      E     + QA D LS  L  DP +R +    L+
Sbjct: 296 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355

Query: 249 HPFLEEFCSCTKQIQESNCSPTSILDQGIWNSVEETEESLGNLIHS 294
           HP++  +        E    P  I D+   +  E T E    LI+ 
Sbjct: 356 HPYINVW----YDPAEVEAPPPQIYDK-QLDEREHTIEEWKELIYK 396

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  109 bits (275), Expect = 4e-27
 Identities = 80/289 (27%), Positives = 114/289 (39%), Gaps = 50/289 (17%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELP--KSEFLQ---REQKFLSSLNSPHIVGYKGC 63
           +G G+  +V  A   RSG+  A K    P     F +   RE   L  +   +++G    
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLL-- 89

Query: 64  DV-----TSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHS 118
           DV     +  +    Y L M +     L   +        E  I     Q+L+GL+Y+HS
Sbjct: 90  DVFTPASSLRNFYDFY-LVMPFM-QTDLQKIMGLK---FSEEKIQYLVYQMLKGLKYIHS 144

Query: 119 NRVVHCDIKSRNILMAESGA-KIADFGCAKWESEAL-QSGGTPMFMAPEVARGEHQ-GFA 175
             VVH D+K  N+ + E    KI DFG A+     +     T  + APEV          
Sbjct: 145 AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYRAPEVILSWMHYNQT 204

Query: 176 SDIWAVGCTVIEMASGGAPWPNAADPMTVLYKI---------------------AYSREL 214
            DIW+VGC + EM +G   +    D +  L +I                     +Y + L
Sbjct: 205 VDIWSVGCIMAEMLTGKTLFK-GKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSL 263

Query: 215 PEVPA--------FLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
           P+ P           S QA D L   L  D  +R  A+Q L HPF E F
Sbjct: 264 PQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 312

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  109 bits (275), Expect = 5e-27
 Identities = 78/331 (23%), Positives = 125/331 (37%), Gaps = 64/331 (19%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELP--KSEFLQ---REQKFLSSLNSPHIVGYKGC 63
           +G G+   V  A   R+G   A K    P     F +   RE + L  +   +++G    
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL-- 90

Query: 64  DVTSEDNKLM-----YNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHS 118
           DV + D  L      Y L M +  G  L   +     +L E  I     Q+L+GL Y+H+
Sbjct: 91  DVFTPDETLDDFTDFY-LVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIHA 146

Query: 119 NRVVHCDIKSRNILM-AESGAKIADFGCAKWESEALQSGGTPMFM-----APEVARGEHQ 172
             ++H D+K  N+ +  +   KI DFG A+     +    T   +     APEV     +
Sbjct: 147 AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM----TGYVVTRWYRAPEVILNWMR 202

Query: 173 -GFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKI---------------------AY 210
                DIW+VGC + EM +G   +   +D +  L +I                      Y
Sbjct: 203 YTQTVDIWSVGCIMAEMITGKTLFK-GSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNY 261

Query: 211 SRELPEVPA--------FLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQI 262
            + LPE+            S  A + L   L  D ++R  A + L HP+ E         
Sbjct: 262 MKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTE--- 318

Query: 263 QESNCSPTSILDQGIWNSVEETEESLGNLIH 293
            E         D   ++ V+ T +    + +
Sbjct: 319 DEPQVQK---YDDS-FDDVDRTLDEWKRVTY 345

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  107 bits (270), Expect = 6e-27
 Identities = 29/252 (11%), Positives = 60/252 (23%), Gaps = 53/252 (21%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAK-------STELPKSEFLQREQKFLSSLNSPHIVG-Y 60
            G         A         A           +    E L      LS ++ P +    
Sbjct: 39  HGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETL-SRTLRLSRIDKPGVARVL 97

Query: 61  KGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNR 120
              DV          +  E+  GG+L +              +   + +    +  H   
Sbjct: 98  ---DVVHTRAGG-L-VVAEWIRGGSLQEVAD---TSPSPVGAIRAMQSLAAAADAAHRAG 149

Query: 121 VVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSGGTPMFMAPEVARGEHQGFASDIW 179
           V         + ++  G   +A                    M     +        DI 
Sbjct: 150 VALSIDHPSRVRVSIDGDVVLAYPA----------------TMPDANPQ-------DDIR 186

Query: 180 AVGCTVIEMASGGAPWP--NAADPMTVLYKIAY------SRELPEVPAFLSKQANDFLSN 231
            +G ++  +     P P       +    +         +    ++P  +S       + 
Sbjct: 187 GIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQIS----AVAAR 242

Query: 232 CLRRDPKERWAA 243
            ++ D   R A+
Sbjct: 243 SVQGDGGIRSAS 254

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  109 bits (275), Expect = 6e-27
 Identities = 69/324 (21%), Positives = 109/324 (33%), Gaps = 87/324 (26%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSE 68
           +G GS   V     + SG  FA K        +  RE   +  L+  +I+       T+ 
Sbjct: 15  LGTGSFGIVCEVFDIESGKRFALKKVLQDPR-YKNRELDIMKVLDHVNIIKLVDYFYTTG 73

Query: 69  DNKLMY----------------------------------NLFMEYAPGGTLNDEIH--- 91
           D +                                     N+ MEY P  TL+  +    
Sbjct: 74  DEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFI 132

Query: 92  RNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILM-AESGA-KIADFGCAKWE 149
           R+G  +  +LI  Y  Q+ + + ++HS  + H DIK +N+L+ ++    K+ DFG AK  
Sbjct: 133 RSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKL 192

Query: 150 SEALQSGGTPM--------FMAPEVARGEHQ-GFASDIWAVGCTVIEMASG--------- 191
                    P         + APE+  G  +   + D+W++GC   E+  G         
Sbjct: 193 IP-----SEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETS 247

Query: 192 -----------GAPWPNAADPMTVLYKIAYSRELPE---------VPAFLSKQANDFLSN 231
                      G P       M   Y        P          +P      A D L  
Sbjct: 248 IDQLVRIIQIMGTPTKEQMIRMNPHYT---EVRFPTLKAKDWRKILPEGTPSLAIDLLEQ 304

Query: 232 CLRRDPKERWAASQLLKHPFLEEF 255
            LR +P  R    + + HPF +  
Sbjct: 305 ILRYEPDLRINPYEAMAHPFFDHL 328

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  108 bits (273), Expect = 9e-27
 Identities = 69/298 (23%), Positives = 114/298 (38%), Gaps = 67/298 (22%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELP--KSEFLQ---REQKFLSSLNSPHIVGYKGC 63
           +G G+  +V  A   ++G   A K    P       +   RE + L  +   +++G    
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 94

Query: 64  DV-----TSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHS 118
           DV     + E+   +Y L      G  LN+ +     +L +  +     QIL+GL+Y+HS
Sbjct: 95  DVFTPARSLEEFNDVY-LVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHS 150

Query: 119 NRVVHCDIKSRNILM-AESGAKIADFGCAKWESEALQSGGTPMFM----------APEVA 167
             ++H D+K  N+ +  +   KI DFG A+          T   M          APE+ 
Sbjct: 151 ADIIHRDLKPSNLAVNEDCELKILDFGLAR---------HTADEMTGYVATRWYRAPEIM 201

Query: 168 RGEHQ-GFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKI------------------ 208
                     DIW+VGC + E+ +G   +P   D +  L  I                  
Sbjct: 202 LNWMHYNQTVDIWSVGCIMAELLTGRTLFP-GTDHIDQLKLILRLVGTPGAELLKKISSE 260

Query: 209 ---AYSRELPEVPA--------FLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
               Y + L ++P           +  A D L   L  D  +R  A+Q L H +  ++
Sbjct: 261 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 318

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  108 bits (271), Expect = 2e-26
 Identities = 73/298 (24%), Positives = 106/298 (35%), Gaps = 63/298 (21%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAK------STELPKSEFLQREQKFLSSLNSPHIVGYKG 62
           IG+G+   V  A    +    A K           +     RE K L      +I+G   
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL--REIKILLRFRHENIIGIN- 91

Query: 63  CDV----TSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHS 118
            D+    T E  K +Y +  +      L   +      L    I  +  QIL+GL+Y+HS
Sbjct: 92  -DIIRAPTIEQMKDVY-IVQDLM-ETDLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHS 146

Query: 119 NRVVHCDIKSRNILM-AESGAKIADFGCAKWESEALQSGGTPMFM----------APEVA 167
             V+H D+K  N+L+      KI DFG A+         G   F+          APE+ 
Sbjct: 147 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG---FLTEYVATRWYRAPEIM 203

Query: 168 RGEHQ-GFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKI------------------ 208
                   + DIW+VGC + EM S    +P     +  L  I                  
Sbjct: 204 LNSKGYTKSIDIWSVGCILAEMLSNRPIFP-GKHYLDQLNHILGILGSPSQEDLNCIINL 262

Query: 209 ---AYSRELPEVPA--------FLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
               Y   LP                +A D L   L  +P +R    Q L HP+LE++
Sbjct: 263 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  106 bits (267), Expect = 2e-26
 Identities = 56/222 (25%), Positives = 96/222 (43%), Gaps = 26/222 (11%)

Query: 33  STELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHR 92
           S      +F+ RE   + SL+  +++   G  V +    +   +  E AP G+L D + +
Sbjct: 60  SQPEAMDDFI-REVNAMHSLDHRNLIRLYGV-VLTP--PMK--MVTELAPLGSLLDRLRK 113

Query: 93  NGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKW--- 148
           + G      +  Y  Q+ +G+ YL S R +H D+ +RN+L+A     KI DFG  +    
Sbjct: 114 HQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173

Query: 149 -ESEALQSGGTPM---FMAPEVARGEHQGF--ASDIWAVGCTVIEMASGGA-PWPNAADP 201
            +   +      +   + APE  +   + F  ASD W  G T+ EM + G  PW      
Sbjct: 174 NDDHYVMQEHRKVPFAWCAPESLK--TRTFSHASDTWMFGVTLWEMFTYGQEPWIG---- 227

Query: 202 MT---VLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKER 240
           +    +L+KI    E    P    +   + +  C    P++R
Sbjct: 228 LNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDR 269

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  106 bits (267), Expect = 3e-26
 Identities = 66/303 (21%), Positives = 108/303 (35%), Gaps = 65/303 (21%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ---REQKFLSSLNSPHIVG------ 59
           +G G +  V  A         A K   L   + ++   RE K +  L+  +IV       
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78

Query: 60  -----YKGCDVTSEDNKLMYNLFMEYAPGGT-LNDEIHRNGGRLDESLIVSYTRQILQGL 113
                      +  +   +Y +  EY    T L + + +    L E     +  Q+L+GL
Sbjct: 79  PSGSQLTDDVGSLTELNSVY-IVQEYM--ETDLANVLEQG--PLLEEHARLFMYQLLRGL 133

Query: 114 EYLHSNRVVHCDIKSRNILMAESG--AKIADFGCAKWESEALQSGGTPMFM--------- 162
           +Y+HS  V+H D+K  N+ +       KI DFG A+         G    +         
Sbjct: 134 KYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKG---HLSEGLVTKWY 190

Query: 163 -APEVARGEHQ-GFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKI------------ 208
            +P +    +    A D+WA GC   EM +G   +   A  +  +  I            
Sbjct: 191 RSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFA-GAHELEQMQLILESIPVVHEEDR 249

Query: 209 --------AYSRELPEVPAF--------LSKQANDFLSNCLRRDPKERWAASQLLKHPFL 252
                    Y R     P          +S++A DFL   L   P +R  A + L HP++
Sbjct: 250 QELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYM 309

Query: 253 EEF 255
             +
Sbjct: 310 SIY 312

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  106 bits (267), Expect = 5e-26
 Identities = 68/304 (22%), Positives = 115/304 (37%), Gaps = 67/304 (22%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAK------STELPKSEFLQREQKFLSSLNSPHIVGYKG 62
           +G+G+   V  AT   +G++ A K                 RE K L      +I+    
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL--REIKILKHFKHENIITIF- 75

Query: 63  CDV----TSEDNKLMYNLFMEYAPGGT-LNDEIHRNGGRLDESLIVSYTRQILQGLEYLH 117
            ++    + E+   +Y +  E     T L+  I      L +  I  +  Q L+ ++ LH
Sbjct: 76  -NIQRPDSFENFNEVY-IIQELM--QTDLHRVISTQ--MLSDDHIQYFIYQTLRAVKVLH 129

Query: 118 SNRVVHCDIKSRNILM-AESGAKIADFGCA----KWESEALQSGGTPMFM---------- 162
            + V+H D+K  N+L+ +    K+ DFG A    +  ++  +  G    M          
Sbjct: 130 GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYR 189

Query: 163 APEVARGEHQ-GFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKI------------- 208
           APEV     +   A D+W+ GC + E+      +P   D    L  I             
Sbjct: 190 APEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFP-GRDYRHQLLLIFGIIGTPHSDNDL 248

Query: 209 ---------AYSRELPEVPA--------FLSKQANDFLSNCLRRDPKERWAASQLLKHPF 251
                     Y + LP  PA         ++ +  D L   L  DP +R  A + L+HP+
Sbjct: 249 RCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPY 308

Query: 252 LEEF 255
           L+ +
Sbjct: 309 LQTY 312

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  105 bits (265), Expect = 7e-26
 Identities = 56/213 (26%), Positives = 95/213 (44%), Gaps = 27/213 (12%)

Query: 4   TRGHTIGQGSSATVSLATSLRSGDVF----AAK-----STELPKSEFLQREQKFLSSLNS 54
            +   +G G+  TV     +  G+      A K     ++     E L  E   ++S+++
Sbjct: 18  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL-DEAYVMASVDN 76

Query: 55  PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLE 114
           PH+    G    +    +   L  +  P G L D +  +   +    ++++  QI +G+ 
Sbjct: 77  PHVCRLLGI-CLTS--TVQ--LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 131

Query: 115 YLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKW----ESEALQSGG-TPM-FMAPEVA 167
           YL   R+VH D+ +RN+L+      KI DFG AK     E E    GG  P+ +MA E  
Sbjct: 132 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191

Query: 168 RGEHQGF--ASDIWAVGCTVIEMAS-GGAPWPN 197
              H+ +   SD+W+ G TV E+ + G  P+  
Sbjct: 192 L--HRIYTHQSDVWSYGVTVWELMTFGSKPYDG 222

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  104 bits (262), Expect = 8e-26
 Identities = 64/245 (26%), Positives = 102/245 (41%), Gaps = 29/245 (11%)

Query: 33  STELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHR 92
            T   K +F+  E   + +L+ PHIV   G  +  E+   +    ME  P G L   + R
Sbjct: 52  CTLDNKEKFM-SEAVIMKNLDHPHIVKLIG--IIEEEPTWI---IMELYPYGELGHYLER 105

Query: 93  NGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKW--E 149
           N   L    +V Y+ QI + + YL S   VH DI  RNIL+A     K+ DFG +++  +
Sbjct: 106 NKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIED 165

Query: 150 SEALQSGGTPMF----MAPEVARGEHQGF--ASDIWAVGCTVIEMAS-GGAPWPNAADPM 202
            +  ++  T       M+PE      + F  ASD+W     + E+ S G  P+      +
Sbjct: 166 EDYYKASVT-RLPIKWMSPESIN--FRRFTTASDVWMFAVCMWEILSFGKQPFFW----L 218

Query: 203 T---VLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSCT 259
               V+  +     LP+ P          ++ C   DP +R   ++L     L +     
Sbjct: 219 ENKDVIGVLEKGDRLPK-PDLCPPVLYTLMTRCWDYDPSDRPRFTEL--VCSLSDVYQME 275

Query: 260 KQIQE 264
           K I  
Sbjct: 276 KDIAM 280

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  103 bits (260), Expect = 3e-25
 Identities = 54/213 (25%), Positives = 90/213 (42%), Gaps = 27/213 (12%)

Query: 4   TRGHTIGQGSSATVSLATSLRSGDVF----AAK-----STELPKSEFLQREQKFLSSLNS 54
            +   +G G   TV     +  G+        K     S               + SL+ 
Sbjct: 16  RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVT-DHMLAIGSLDH 74

Query: 55  PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLE 114
            HIV   G         L   L  +Y P G+L D + ++ G L   L++++  QI +G+ 
Sbjct: 75  AHIVRLLGL-CPGS--SLQ--LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMY 129

Query: 115 YLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKW----ESEALQSGG-TPM-FMAPEVA 167
           YL  + +VH ++ +RN+L+      ++ADFG A      + + L S   TP+ +MA E  
Sbjct: 130 YLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESI 189

Query: 168 RGEHQGF--ASDIWAVGCTVIEMAS-GGAPWPN 197
                 +   SD+W+ G TV E+ + G  P+  
Sbjct: 190 H--FGKYTHQSDVWSYGVTVWELMTFGAEPYAG 220

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  104 bits (262), Expect = 3e-25
 Identities = 59/258 (22%), Positives = 89/258 (34%), Gaps = 58/258 (22%)

Query: 44  REQKFLSSLNSPHIVGYKGCDV----TSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDE 99
           RE + L+  + P+I+G +  D+           +Y L  E      L   IH     +  
Sbjct: 78  REIRLLNHFHHPNILGLR--DIFVHFEEPAMHKLY-LVTELM-RTDLAQVIHDQRIVISP 133

Query: 100 SLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILM-AESGAKIADFGCAKWESEALQSGGT 158
             I  +   IL GL  LH   VVH D+   NIL+   +   I DF  A+           
Sbjct: 134 QHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAR-------EDTA 186

Query: 159 PMFM----------APEVARGEHQ-GFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYK 207
                         APE+           D+W+ GC + EM +  A +   +     L K
Sbjct: 187 DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFR-GSTFYNQLNK 245

Query: 208 I-----------------AYSRE-----LPEVPA--------FLSKQANDFLSNCLRRDP 237
           I                   +R+     L  VPA             A D ++  L  +P
Sbjct: 246 IVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNP 305

Query: 238 KERWAASQLLKHPFLEEF 255
           + R +  Q L+HP+ E  
Sbjct: 306 QRRISTEQALRHPYFESL 323

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  101 bits (254), Expect = 8e-25
 Identities = 65/255 (25%), Positives = 112/255 (43%), Gaps = 34/255 (13%)

Query: 4   TRGHTIGQGSSATVSLATSLRSGDVFAAK-----STELPKSEFLQREQKFLSSLNSPHIV 58
           T    +G G    V L       DV A K     S    + EF Q E + +  L+ P +V
Sbjct: 11  TLLKELGSGQFGVVKLGKWKGQYDV-AVKMIKEGSMS--EDEFFQ-EAQTMMKLSHPKLV 66

Query: 59  GYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHS 118
            + G  V S++  +   +  EY   G L + +  +G  L+ S ++     + +G+ +L S
Sbjct: 67  KFYG--VCSKEYPIY--IVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLES 122

Query: 119 NRVVHCDIKSRNILMAESG-AKIADFGCAKW--ESEALQSGGTPMF----MAPEVARGEH 171
           ++ +H D+ +RN L+      K++DFG  ++  + + + S GT  F     APEV    +
Sbjct: 123 HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGT-KFPVKWSAPEVFH--Y 179

Query: 172 QGF--ASDIWAVGCTVIEMAS-GGAPWPNAADPMT---VLYKIAYSRELPEVPAFLSKQA 225
             +   SD+WA G  + E+ S G  P+       T   V+ K++    L   P   S   
Sbjct: 180 FKYSSKSDVWAFGILMWEVFSLGKMPYDL----YTNSEVVLKVSQGHRLYR-PHLASDTI 234

Query: 226 NDFLSNCLRRDPKER 240
              + +C    P++R
Sbjct: 235 YQIMYSCWHELPEKR 249

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  105 bits (263), Expect = 1e-24
 Identities = 65/255 (25%), Positives = 107/255 (41%), Gaps = 29/255 (11%)

Query: 4   TRGHTIGQGSSATVSLATSLRSGDVF---AAK-----STELPKSEFLQREQKFLSSLNSP 55
             G  IG+G    V     +   +     A K     +++  + +FLQ E   +   + P
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQ-EALTMRQFDHP 451

Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
           HIV   G  V +E+   ++ + ME    G L   +      LD + ++ Y  Q+   L Y
Sbjct: 452 HIVKLIG--VITENP--VW-IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAY 506

Query: 116 LHSNRVVHCDIKSRNILMAESG-AKIADFGCAKW--ESEALQSGGT--PMF-MAPEVARG 169
           L S R VH DI +RN+L++ +   K+ DFG +++  +S   ++     P+  MAPE    
Sbjct: 507 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 566

Query: 170 EHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMT---VLYKIAYSRELPEVPAFLSKQA 225
                ASD+W  G  + E+   G  P+      +    V+ +I     LP  P       
Sbjct: 567 RRFTSASDVWMFGVCMWEILMHGVKPFQG----VKNNDVIGRIENGERLPM-PPNCPPTL 621

Query: 226 NDFLSNCLRRDPKER 240
              ++ C   DP  R
Sbjct: 622 YSLMTKCWAYDPSRR 636

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  102 bits (257), Expect = 2e-24
 Identities = 81/366 (22%), Positives = 141/366 (38%), Gaps = 93/366 (25%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELP--KSEFLQ---REQKFLSSLNS-PHIVGYKG 62
           +G+G+   V  +   R+G+V A K        S   Q   RE   L+ L+   +IV    
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLL- 75

Query: 63  CDV-TSEDNKLMYNLFMEYAPGGT-LNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNR 120
            +V  +++++ +Y L  +Y    T L+  I  N   L+         Q+++ ++YLHS  
Sbjct: 76  -NVLRADNDRDVY-LVFDYM--ETDLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLHSGG 129

Query: 121 VVHCDIKSRNILM-AESGAKIADFGCA---------------KWESEALQSGGTPMFM-- 162
           ++H D+K  NIL+ AE   K+ADFG +                              +  
Sbjct: 130 LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTD 189

Query: 163 --------APEVARGEHQ-GFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKI----- 208
                   APE+  G  +     D+W++GC + E+  G   +P  +  M  L +I     
Sbjct: 190 YVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFP-GSSTMNQLERIIGVID 248

Query: 209 ----------------AYSRELPEVP------------------------AFLSKQANDF 228
                                L E                          A  +++A D 
Sbjct: 249 FPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDL 308

Query: 229 LSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSILDQGIWNSVEETEESL 288
           L   L+ +P +R +A+  LKHPF+  F +     +E NC     +   I ++V+ + +  
Sbjct: 309 LDKLLQFNPNKRISANDALKHPFVSIFHNPN---EEPNCDHIITIP--INDNVKHSIDDY 363

Query: 289 GNLIHS 294
            NL++S
Sbjct: 364 RNLVYS 369

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  102 bits (256), Expect = 2e-24
 Identities = 53/257 (20%), Positives = 102/257 (39%), Gaps = 28/257 (10%)

Query: 4   TRGHTIGQGSSATVSLATSLRSGDVF---AAK-----STELPKSEFLQREQKFLSSLNSP 55
                IG+G    V   T L +       A K     +     S+FL  E   +   + P
Sbjct: 92  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFL-TEGIIMKDFSHP 150

Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
           +++   G      +   +  + + Y   G L + I           ++ +  Q+ +G+++
Sbjct: 151 NVLSLLGI-CLRSEGSPL--VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKF 207

Query: 116 LHSNRVVHCDIKSRNILMAESG-AKIADFGCAKW----ESEALQSGGTPMF----MAPEV 166
           L S + VH D+ +RN ++ E    K+ADFG A+     E +++ +          MA E 
Sbjct: 208 LASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 267

Query: 167 ARGEHQGF--ASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSK 223
            +   Q F   SD+W+ G  + E+ + G  P+P+  +   +   +   R L + P +   
Sbjct: 268 LQ--TQKFTTKSDVWSFGVLLWELMTRGAPPYPD-VNTFDITVYLLQGRRLLQ-PEYCPD 323

Query: 224 QANDFLSNCLRRDPKER 240
              + +  C     + R
Sbjct: 324 PLYEVMLKCWHPKAEMR 340

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  100 bits (251), Expect = 2e-24
 Identities = 63/255 (24%), Positives = 108/255 (42%), Gaps = 34/255 (13%)

Query: 4   TRGHTIGQGSSATVSLATSLRSGDVFAAK-----STELPKSEFLQREQKFLSSLNSPHIV 58
           T    IG G    V L   L    V A K     +    + +F++ E + +  L+ P +V
Sbjct: 11  TFVQEIGSGQFGLVHLGYWLNKDKV-AIKTIREGAMS--EEDFIE-EAEVMMKLSHPKLV 66

Query: 59  GYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHS 118
              G  V  E   +   L  E+   G L+D +    G      ++     + +G+ YL  
Sbjct: 67  QLYG--VCLEQAPIC--LVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 122

Query: 119 NRVVHCDIKSRNILMAESG-AKIADFGCAKW--ESEALQSGGTPMF----MAPEVARGEH 171
             V+H D+ +RN L+ E+   K++DFG  ++  + +   S GT  F     +PEV     
Sbjct: 123 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT-KFPVKWASPEVFS--F 179

Query: 172 QGF--ASDIWAVGCTVIEMAS-GGAPWPNAADPMT---VLYKIAYSRELPEVPAFLSKQA 225
             +   SD+W+ G  + E+ S G  P+ N     +   V+  I+    L + P   S   
Sbjct: 180 SRYSSKSDVWSFGVLMWEVFSEGKIPYEN----RSNSEVVEDISTGFRLYK-PRLASTHV 234

Query: 226 NDFLSNCLRRDPKER 240
              +++C R  P++R
Sbjct: 235 YQIMNHCWRERPEDR 249

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  103 bits (258), Expect = 2e-24
 Identities = 75/275 (27%), Positives = 119/275 (43%), Gaps = 23/275 (8%)

Query: 4   TRGHTIGQGSSATVSLATSLRSGDVFAAK---STELPKSEFLQREQKFLSSLNSPHIVGY 60
                +GQG    V + T   +  V A K      +    FLQ E + +  L    +V  
Sbjct: 187 RLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPEAFLQ-EAQVMKKLRHEKLVQL 244

Query: 61  KGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGR-LDESLIVSYTRQILQGLEYLHSN 119
               V+ E    +Y +  EY   G+L D +    G+ L    +V    QI  G+ Y+   
Sbjct: 245 YAV-VSEEP---IY-IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 299

Query: 120 RVVHCDIKSRNILMAESG-AKIADFGCAKW----ESEALQSGGTPMF-MAPEVARGEHQG 173
             VH D+++ NIL+ E+   K+ADFG A+     E  A Q    P+   APE A      
Sbjct: 300 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 359

Query: 174 FASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNC 232
             SD+W+ G  + E+ + G  P+P   +   VL ++     +P  P    +  +D +  C
Sbjct: 360 IKSDVWSFGILLTELTTKGRVPYPGMVNR-EVLDQVERGYRMPC-PPECPESLHDLMCQC 417

Query: 233 LRRDPKERWAASQLLKHPFLEEFCSCTK-QIQESN 266
            R++P+ER     L    FLE++ + T+ Q Q   
Sbjct: 418 WRKEPEERPTFEYLQA--FLEDYFTSTEPQYQPGE 450

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  100 bits (252), Expect = 2e-24
 Identities = 60/257 (23%), Positives = 100/257 (38%), Gaps = 28/257 (10%)

Query: 4   TRGHTIGQGSSATVSLATSLRSGDVF---AAK-----STELPKSEFLQREQKFLSSLNSP 55
                IG+G    V     +         A K     +       FL RE   +  LN P
Sbjct: 24  HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFL-REGLLMRGLNHP 82

Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
           +++   G  +   +      + + Y   G L   I           ++S+  Q+ +G+EY
Sbjct: 83  NVLALIGI-MLPPEGLPH--VLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEY 139

Query: 116 LHSNRVVHCDIKSRNILMAESG-AKIADFGCAKW----ESEALQSGGTPMF----MAPEV 166
           L   + VH D+ +RN ++ ES   K+ADFG A+     E  ++Q            A E 
Sbjct: 140 LAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALES 199

Query: 167 ARGEHQGF--ASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSK 223
            +     F   SD+W+ G  + E+ + G  P+ +  DP  + + +A  R LP+ P +   
Sbjct: 200 LQ--TYRFTTKSDVWSFGVLLWELLTRGAPPYRH-IDPFDLTHFLAQGRRLPQ-PEYCPD 255

Query: 224 QANDFLSNCLRRDPKER 240
                +  C   DP  R
Sbjct: 256 SLYQVMQQCWEADPAVR 272

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  100 bits (252), Expect = 2e-24
 Identities = 54/257 (21%), Positives = 101/257 (39%), Gaps = 28/257 (10%)

Query: 4   TRGHTIGQGSSATVSLATSLRSGDVF---AAK-----STELPKSEFLQREQKFLSSLNSP 55
                IG+G    V   T L +       A K     +     S+FL  E   +   + P
Sbjct: 28  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFL-TEGIIMKDFSHP 86

Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
           +++   G      +   +  + + Y   G L + I           ++ +  Q+ +G++Y
Sbjct: 87  NVLSLLGI-CLRSEGSPL--VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKY 143

Query: 116 LHSNRVVHCDIKSRNILMAESG-AKIADFGCAKW----ESEALQSGGTPMF----MAPEV 166
           L S + VH D+ +RN ++ E    K+ADFG A+     E  ++ +          MA E 
Sbjct: 144 LASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 203

Query: 167 ARGEHQGF--ASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSK 223
            +   Q F   SD+W+ G  + E+ + G  P+P+  +   +   +   R L + P +   
Sbjct: 204 LQ--TQKFTTKSDVWSFGVLLWELMTRGAPPYPD-VNTFDITVYLLQGRRLLQ-PEYCPD 259

Query: 224 QANDFLSNCLRRDPKER 240
              + +  C     + R
Sbjct: 260 PLYEVMLKCWHPKAEMR 276

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 99.2 bits (248), Expect = 6e-24
 Identities = 59/200 (29%), Positives = 92/200 (46%), Gaps = 16/200 (8%)

Query: 6   GHTIGQGSSATVSLATSLRSGDVFAAKS--TELPKSEFLQREQKFLSSLNSPHIVGYKGC 63
             TIG+G    V L    R   V A K    +     FL  E   ++ L   ++V   G 
Sbjct: 26  LQTIGKGEFGDVMLGD-YRGNKV-AVKCIKNDATAQAFLA-EASVMTQLRHSNLVQLLGV 82

Query: 64  DVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGR-LDESLIVSYTRQILQGLEYLHSNRVV 122
            +  E   L   +  EY   G+L D +   G   L    ++ ++  + + +EYL  N  V
Sbjct: 83  -IVEEKGGLY--IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFV 139

Query: 123 HCDIKSRNILMAESG-AKIADFGCAKWESEALQSGGTPM-FMAPEVARGEHQGF--ASDI 178
           H D+ +RN+L++E   AK++DFG  K  S    +G  P+ + APE  R   + F   SD+
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALR--EKKFSTKSDV 197

Query: 179 WAVGCTVIEMAS-GGAPWPN 197
           W+ G  + E+ S G  P+P 
Sbjct: 198 WSFGILLWEIYSFGRVPYPR 217

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  100 bits (250), Expect = 7e-24
 Identities = 66/285 (23%), Positives = 112/285 (39%), Gaps = 40/285 (14%)

Query: 4   TRGHTIGQGSSATVSLATSLRSG----DVFAAK-----STELPKSEFLQREQKFLSSLNS 54
                IG G S  V        G     V A K      TE  + +FL  E   +   + 
Sbjct: 52  HIEKIIGSGDSGEVCYGRLRVPGQRDVPV-AIKALKAGYTERQRRDFLS-EASIMGQFDH 109

Query: 55  PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLE 114
           P+I+  +G  V +     M  +  EY   G+L+  +  + G+     +V   R +  G+ 
Sbjct: 110 PNIIRLEG--VVTRGRLAM--IVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMR 165

Query: 115 YLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKW----ESEALQSGGTPMF----MAPE 165
           YL     VH D+ +RN+L+  +   K++DFG ++        A  + G         APE
Sbjct: 166 YLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGG-KIPIRWTAPE 224

Query: 166 VARGEHQGF--ASDIWAVGCTVIEMAS-GGAPWPNAADPMT---VLYKIAYSRELPEVPA 219
                 + F  ASD+W+ G  + E+ + G  P+ N    MT   V+  +     LP  P 
Sbjct: 225 AIA--FRTFSSASDVWSFGVVMWEVLAYGERPYWN----MTNRDVISSVEEGYRLPA-PM 277

Query: 220 FLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQIQE 264
                 +  + +C  +D  +R   SQ+     L+      + ++ 
Sbjct: 278 GCPHALHQLMLDCWHKDRAQRPRFSQI--VSVLDALIRSPESLRA 320

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 99.2 bits (248), Expect = 7e-24
 Identities = 60/242 (24%), Positives = 100/242 (41%), Gaps = 29/242 (11%)

Query: 33  STELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHR 92
           +++  + +FLQ E   +   + PHIV   G  +T      ++ + ME    G L   +  
Sbjct: 55  TSDSVREKFLQ-EALTMRQFDHPHIVKLIGV-ITENP---VW-IIMELCTLGELRSFLQV 108

Query: 93  NGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKW--E 149
               LD + ++ Y  Q+   L YL S R VH DI +RN+L++ +   K+ DFG +++  +
Sbjct: 109 RKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 168

Query: 150 SEALQSGGTPMF----MAPEVARGEHQGF--ASDIWAVGCTVIEMAS-GGAPWPNAADPM 202
           S   ++          MAPE      + F  ASD+W  G  + E+   G  P+      +
Sbjct: 169 STYYKASKG-KLPIKWMAPESIN--FRRFTSASDVWMFGVCMWEILMHGVKPFQG----V 221

Query: 203 T---VLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSCT 259
               V+ +I     LP  P          ++ C   DP  R   ++L     L       
Sbjct: 222 KNNDVIGRIENGERLPM-PPNCPPTLYSLMTKCWAYDPSRRPRFTEL--KAQLSTILEEE 278

Query: 260 KQ 261
           K 
Sbjct: 279 KA 280

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 99.7 bits (249), Expect = 1e-23
 Identities = 64/263 (24%), Positives = 106/263 (40%), Gaps = 41/263 (15%)

Query: 4   TRGHTIGQGSSATVSLA-----TSLRSGDVFAAK-----STELPKSEFLQREQKFLSSLN 53
           TR   IG G    V        +  +   V A K      TE  + +FL  E   +   +
Sbjct: 47  TRQKVIGAGEFGEVYKGMLKTSSGKKEVPV-AIKTLKAGYTEKQRVDFLG-EAGIMGQFS 104

Query: 54  SPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGL 113
             +I+  +G  V S+   +M  +  EY   G L+  +    G      +V   R I  G+
Sbjct: 105 HHNIIRLEG--VISKYKPMM--IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGM 160

Query: 114 EYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKW-----ESEALQSGGTPMF----MA 163
           +YL +   VH D+ +RNIL+  +   K++DFG ++      E+    SGG         A
Sbjct: 161 KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGG--KIPIRWTA 218

Query: 164 PEVARGEHQGF--ASDIWAVGCTVIEMAS-GGAPWPNAADPMT---VLYKIAYSRELPEV 217
           PE     ++ F  ASD+W+ G  + E+ + G  P+      ++   V+  I     LP  
Sbjct: 219 PEAIS--YRKFTSASDVWSFGIVMWEVMTYGERPYWE----LSNHEVMKAINDGFRLPT- 271

Query: 218 PAFLSKQANDFLSNCLRRDPKER 240
           P          +  C +++   R
Sbjct: 272 PMDCPSAIYQLMMQCWQQERARR 294

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  100 bits (251), Expect = 1e-23
 Identities = 57/278 (20%), Positives = 114/278 (41%), Gaps = 33/278 (11%)

Query: 33  STELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHR 92
            TE  + +FL  E   +   + P+I+  +G  V ++   +M  +  EY   G+L+  + +
Sbjct: 85  YTEKQRRDFLG-EASIMGQFDHPNIIRLEG--VVTKSKPVM--IVTEYMENGSLDSFLRK 139

Query: 93  NGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKW--- 148
           +  +     +V   R I  G++YL     VH D+ +RNIL+  +   K++DFG  +    
Sbjct: 140 HDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLED 199

Query: 149 -ESEALQSGGTPM---FMAPEVARGEHQGF--ASDIWAVGCTVIEMAS-GGAPWPNAADP 201
               A  + G  +   + +PE     ++ F  ASD+W+ G  + E+ S G  P+      
Sbjct: 200 DPEAAYTTRGGKIPIRWTSPEAIA--YRKFTSASDVWSYGIVLWEVMSYGERPYWE---- 253

Query: 202 MT---VLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKER-------WAASQLLKHPF 251
           M+   V+  +     LP  P          + +C ++D   R           +L+++P 
Sbjct: 254 MSNQDVIKAVDEGYRLPP-PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPG 312

Query: 252 LEEFCSCTKQIQESNCSPTSILDQGIWNSVEETEESLG 289
             +  +       +     S +D   + +  +    + 
Sbjct: 313 SLKIITSAAARPSNLLLDQSNVDITTFRTTGDWLNGVW 350

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 99.3 bits (248), Expect = 2e-23
 Identities = 45/220 (20%), Positives = 67/220 (30%), Gaps = 72/220 (32%)

Query: 100 SLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGA--------------------K 139
             I     QI + + +LHSN++ H D+K  NIL  +S                      K
Sbjct: 118 DHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIK 177

Query: 140 IADFGCAKWESEA----LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASG---- 191
           + DFG A ++ E     + +       APEV          D+W++GC +IE   G    
Sbjct: 178 VVDFGSATYDDEHHSTLVSTRHYR---APEVILALGWSQPCDVWSIGCILIEYYLGFTVF 234

Query: 192 ------------------------------------GAPWPNAADPMTVLYKIAYSRELP 215
                                                  W          Y     + L 
Sbjct: 235 PTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDE--HSSAGRYVSRACKPLK 292

Query: 216 EV---PAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFL 252
           E         ++  D +   L  DP +R    + LKHPF 
Sbjct: 293 EFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFF 332

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 98.1 bits (245), Expect = 2e-23
 Identities = 57/248 (22%), Positives = 98/248 (39%), Gaps = 29/248 (11%)

Query: 33  STELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHR 92
           + +    E ++ E + +  L++P+IV   G    +E   LM  L ME A GG L+  +  
Sbjct: 49  TEKADTEEMMR-EAQIMHQLDNPYIVRLIGV-CQAE--ALM--LVMEMAGGGPLHKFLVG 102

Query: 93  NGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKW--- 148
               +  S +     Q+  G++YL     VH D+ +RN+L+     AKI+DFG +K    
Sbjct: 103 KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162

Query: 149 -ESEALQSGGTPM---FMAPEVARGEHQGF--ASDIWAVGCTVIEMAS-GGAPWPNAADP 201
            +S             + APE      + F   SD+W+ G T+ E  S G  P+      
Sbjct: 163 DDSYYTARSAGKWPLKWYAPECIN--FRKFSSRSDVWSYGVTMWEALSYGQKPYKK---- 216

Query: 202 MT---VLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSC 258
           M    V+  I   + +   P     +    +S+C     ++R     +     +      
Sbjct: 217 MKGPEVMAFIEQGKRMEC-PPECPPELYALMSDCWIYKWEDRPDFLTV--EQRMRACYYS 273

Query: 259 TKQIQESN 266
                E +
Sbjct: 274 LASKVEGH 281

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  101 bits (252), Expect = 2e-23
 Identities = 74/275 (26%), Positives = 119/275 (43%), Gaps = 23/275 (8%)

Query: 4   TRGHTIGQGSSATVSLATSLRSGDVFAAK---STELPKSEFLQREQKFLSSLNSPHIVGY 60
                +GQG    V + T   +  V A K      +    FLQ E + +  L    +V  
Sbjct: 270 RLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPEAFLQ-EAQVMKKLRHEKLVQL 327

Query: 61  KGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGR-LDESLIVSYTRQILQGLEYLHSN 119
               V+ E    +Y +  EY   G+L D +    G+ L    +V    QI  G+ Y+   
Sbjct: 328 YAV-VSEEP---IY-IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 382

Query: 120 RVVHCDIKSRNILMAESG-AKIADFGCAKWESE----ALQSGGTPMF-MAPEVARGEHQG 173
             VH D+++ NIL+ E+   K+ADFG A+   +    A Q    P+   APE A      
Sbjct: 383 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 442

Query: 174 FASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNC 232
             SD+W+ G  + E+ + G  P+P   +   VL ++     +P  P    +  +D +  C
Sbjct: 443 IKSDVWSFGILLTELTTKGRVPYPGMVNR-EVLDQVERGYRMPC-PPECPESLHDLMCQC 500

Query: 233 LRRDPKERWAASQLLKHPFLEEFCSCTK-QIQESN 266
            R++P+ER     L    FLE++ + T+ Q Q   
Sbjct: 501 WRKEPEERPTFEYLQA--FLEDYFTSTEPQYQPGE 533

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 98.9 bits (247), Expect = 3e-23
 Identities = 43/234 (18%), Positives = 66/234 (28%), Gaps = 72/234 (30%)

Query: 100 SLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGA--------------------K 139
             +     Q+   L +LH N++ H D+K  NIL   S                      +
Sbjct: 123 PHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIR 182

Query: 140 IADFGCAKWESEA----LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASG---- 191
           +ADFG A ++ E     + +        PEV          D+W++GC + E   G    
Sbjct: 183 VADFGSATFDHEHHTTIVATRHYR---PPEVILELGWAQPCDVWSIGCILFEYYRGFTLF 239

Query: 192 ------------------------------------GAPWPNAADPMTVLYKIAYSRELP 215
                                               G  W    +     Y     + L 
Sbjct: 240 QTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDE--NSSDGRYVKENCKPLK 297

Query: 216 EVPAFLSK---QANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQIQESN 266
                 S    Q  D +   L  DP +R   ++ L HPF        +    S 
Sbjct: 298 SYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHTSR 351

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  100 bits (251), Expect = 3e-23
 Identities = 49/176 (27%), Positives = 79/176 (44%), Gaps = 19/176 (10%)

Query: 33  STELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHR 92
           + +    E + RE + +  L++P+IV   G    +E   LM  L ME A GG L+  +  
Sbjct: 375 TEKADTEEMM-REAQIMHQLDNPYIVRLIGV-CQAE--ALM--LVMEMAGGGPLHKFLVG 428

Query: 93  NGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKW--- 148
               +  S +     Q+  G++YL     VH ++ +RN+L+     AKI+DFG +K    
Sbjct: 429 KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGA 488

Query: 149 -ESEALQSGGTPM---FMAPEVARGEHQGF--ASDIWAVGCTVIEMAS-GGAPWPN 197
            +S             + APE      + F   SD+W+ G T+ E  S G  P+  
Sbjct: 489 DDSYYTARSAGKWPLKWYAPECIN--FRKFSSRSDVWSYGVTMWEALSYGQKPYKK 542

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 99.4 bits (248), Expect = 4e-23
 Identities = 74/326 (22%), Positives = 113/326 (34%), Gaps = 98/326 (30%)

Query: 8   TIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ--REQKFLSSLN------SPHIV- 58
            IG+GS   V  A   +     A K     K    Q   E + L  L       + +++ 
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIH 163

Query: 59  -----GYKG--CDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGR-LDESLIVSYTRQIL 110
                 ++   C        L  NL+          + I +N  +     L+  +   IL
Sbjct: 164 MLENFTFRNHICMTF---ELLSMNLY----------ELIKKNKFQGFSLPLVRKFAHSIL 210

Query: 111 QGLEYLHSNRVVHCDIKSRNILMAE---SGAKIADFGCAKWESEA----LQSGGTPMF-M 162
           Q L+ LH NR++HCD+K  NIL+ +   SG K+ DFG + +E +     +QS     F  
Sbjct: 211 QCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQS----RFYR 266

Query: 163 APEVARGEHQGFASDIWAVGCTVIEMASG--------------------GAP-------- 194
           APEV  G   G   D+W++GC + E+ +G                    G P        
Sbjct: 267 APEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDAS 326

Query: 195 ----------------WPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNC------ 232
                                   +V+     SR         S++  + L  C      
Sbjct: 327 KRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFL 386

Query: 233 ------LRRDPKERWAASQLLKHPFL 252
                 L  DP  R    Q L+HP+L
Sbjct: 387 DFLKQCLEWDPAVRMTPGQALRHPWL 412

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 96.5 bits (241), Expect = 7e-23
 Identities = 63/255 (24%), Positives = 104/255 (40%), Gaps = 34/255 (13%)

Query: 4   TRGHTIGQGSSATVSLATSLRSGDVFAAK-----STELPKSEFLQREQKFLSSLNSPHIV 58
           T    +G G    V         DV A K     S    + EF++ E K + +L+   +V
Sbjct: 27  TFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMS--EDEFIE-EAKVMMNLSHEKLV 82

Query: 59  GYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHS 118
              G  V ++   +   +  EY   G L + +     R     ++   + + + +EYL S
Sbjct: 83  QLYG--VCTKQRPIF--IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 138

Query: 119 NRVVHCDIKSRNILMAESG-AKIADFGCAKW--ESEALQSGGTPMF----MAPEVARGEH 171
            + +H D+ +RN L+ + G  K++DFG +++  + E   S G+  F      PEV    +
Sbjct: 139 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS-KFPVRWSPPEVLM--Y 195

Query: 172 QGF--ASDIWAVGCTVIEMAS-GGAPWPNAADPMT---VLYKIAYSRELPEVPAFLSKQA 225
             F   SDIWA G  + E+ S G  P+       T       IA    L   P   S++ 
Sbjct: 196 SKFSSKSDIWAFGVLMWEIYSLGKMPYER----FTNSETAEHIAQGLRLYR-PHLASEKV 250

Query: 226 NDFLSNCLRRDPKER 240
              + +C      ER
Sbjct: 251 YTIMYSCWHEKADER 265

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 98.7 bits (246), Expect = 1e-22
 Identities = 55/264 (20%), Positives = 107/264 (40%), Gaps = 22/264 (8%)

Query: 4   TRGHTIGQGSSATVSLATSLRSGDVFAA----KSTELPKSEFLQREQKFLSSLNSPHIVG 59
           T  H +G G    V      +   +  A    K   +   EFL+ E   +  +  P++V 
Sbjct: 223 TMKHKLGGGQYGEVYEGV-WKKYSLTVAVKTLKEDTMEVEEFLK-EAAVMKEIKHPNLVQ 280

Query: 60  YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGR-LDESLIVSYTRQILQGLEYLHS 118
             G  V + +      +  E+   G L D +     + +   +++    QI   +EYL  
Sbjct: 281 LLG--VCTREPPFY--IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 336

Query: 119 NRVVHCDIKSRNILMAESG-AKIADFGCAKWESE----ALQSGGTPM-FMAPEVARGEHQ 172
              +H ++ +RN L+ E+   K+ADFG ++  +     A      P+ + APE       
Sbjct: 337 KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 396

Query: 173 GFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSN 231
              SD+WA G  + E+A+ G +P+P       V   +     +   P    ++  + +  
Sbjct: 397 SIKSDVWAFGVLLWEIATYGMSPYPGIDLS-QVYELLEKDYRMER-PEGCPEKVYELMRA 454

Query: 232 CLRRDPKERWAASQLLKHPFLEEF 255
           C + +P +R + +++ +    E  
Sbjct: 455 CWQWNPSDRPSFAEIHQ--AFETM 476

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 97.0 bits (242), Expect = 1e-22
 Identities = 66/344 (19%), Positives = 109/344 (31%), Gaps = 123/344 (35%)

Query: 8   TIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQ-----KFLSSLNS-----PHI 57
            +G G+   V L   + +   +A K   + ++              L  + +      +I
Sbjct: 42  KMGDGTFGRVLLCQHIDNKKYYAVK---VVRNIKKYTRSAKIEADILKKIQNDDINNNNI 98

Query: 58  V------GYKG--CDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGR-LDESLIVSYTRQ 108
           V       Y    C +      L  +L+          + I RN         I  Y  +
Sbjct: 99  VKYHGKFMYYDHMCLIF---EPLGPSLY----------EIITRNNYNGFHIEDIKLYCIE 145

Query: 109 ILQGLEYLHSNRVVHCDIKSRNILMAESGA--------------------------KIAD 142
           IL+ L YL    + H D+K  NIL+ +                             K+ D
Sbjct: 146 ILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLID 205

Query: 143 FGCAKWESEA----LQSGGTPMFM-APEVARGEHQGFASDIWAVGCTVIEMASG------ 191
           FGCA ++S+     + +        APEV        +SD+W+ GC + E+ +G      
Sbjct: 206 FGCATFKSDYHGSIINT----RQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRT 261

Query: 192 --------------GAP-------------------------WPNAADPMTVLYKIAYSR 212
                                                     WP  A  +  +  +    
Sbjct: 262 HEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCL 321

Query: 213 ELPEV---PAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLE 253
            L ++     F      DFL + L+ DP  R + ++LLKH FLE
Sbjct: 322 PLYKIIKHELFC-----DFLYSILQIDPTLRPSPAELLKHKFLE 360

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 97.3 bits (242), Expect = 2e-22
 Identities = 71/360 (19%), Positives = 117/360 (32%), Gaps = 121/360 (33%)

Query: 7   HTIGQGSSATVSLATSLRSGDVFAAK--STELPKSEFLQREQKFLSSLNS--PHIVGYKG 62
             +G G  +TV L+  ++     A K   +    +E    E + L S+ +  P+    + 
Sbjct: 43  RKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREM 102

Query: 63  CDVTSEDNKLMYNLFMEYAPGGT------------LNDEIHRN-GGRLDESLIVSYTRQI 109
                     + + F      GT            L   I ++    L    +    +Q+
Sbjct: 103 V-------VQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQV 155

Query: 110 LQGLEYLHS-NRVVHCDIKSRNILMA---------------------------------- 134
           LQGL+YLH+  R++H DIK  NIL++                                  
Sbjct: 156 LQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215

Query: 135 ----------------ESGAKIADFGCAKWESEALQSGGTP-MFMAPEVARGEHQGFASD 177
                           +   KIAD G A W  +          + + EV  G      +D
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPAD 275

Query: 178 IWAVGCTVIEMASG--------GAPWPNAAD------------PMTVLYKIAYSRE---- 213
           IW+  C   E+A+G        G  +    D            P  ++    YS+E    
Sbjct: 276 IWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTK 335

Query: 214 ------------------LPEVPAFLSKQAN---DFLSNCLRRDPKERWAASQLLKHPFL 252
                             L E   +  ++A    DFL   L   P++R  A++ L+HP+L
Sbjct: 336 KGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWL 395

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 95.5 bits (238), Expect = 3e-22
 Identities = 59/261 (22%), Positives = 99/261 (37%), Gaps = 31/261 (11%)

Query: 6   GHTIGQGSSATVSLATSLRSGDVF---AAK------STELPKSEFLQREQKFLSSLNSPH 56
           G  +G+G   +V  A   +    F   A K             EFL RE   +   + PH
Sbjct: 28  GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFL-REAACMKEFDHPH 86

Query: 57  IVGYKGCDVTSEDNKLMYNLF--MEYAPGGTLND-----EIHRNGGRLDESLIVSYTRQI 109
           +    G  + S     +      + +   G L+       I  N   L    +V +   I
Sbjct: 87  VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDI 146

Query: 110 LQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKW--ESEALQSGGTPMF----M 162
             G+EYL S   +H D+ +RN ++AE     +ADFG ++     +  + G         +
Sbjct: 147 ACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWL 206

Query: 163 APEVARGEHQGF--ASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPA 219
           A E        +   SD+WA G T+ E+ + G  P+    +   +   +     L + P 
Sbjct: 207 ALESLA--DNLYTVHSDVWAFGVTMWEIMTRGQTPYA-GIENAEIYNYLIGGNRLKQ-PP 262

Query: 220 FLSKQANDFLSNCLRRDPKER 240
              ++  D +  C   DPK+R
Sbjct: 263 ECMEEVYDLMYQCWSADPKQR 283

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 97.2 bits (242), Expect = 3e-22
 Identities = 69/386 (17%), Positives = 111/386 (28%), Gaps = 111/386 (28%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELP--KSEFLQ---REQKFLSSLNSPHIVGYKGC 63
           IG GS   V  A       V A K            +   RE   L+ LN  H+V     
Sbjct: 61  IGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVL-- 118

Query: 64  DVTSEDNKLMYN---LFMEYAPGGT-LNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN 119
           D+    +   ++   + +E A   +       R    L E  I +    +L G++Y+HS 
Sbjct: 119 DIVIPKDVEKFDELYVVLEIA--DSDFKKLF-RTPVYLTELHIKTLLYNLLVGVKYVHSA 175

Query: 120 RVVHCDIKSRNILMAESGA-KIADFGCA---------------------KWESEALQSGG 157
            ++H D+K  N L+ +  + K+ DFG A                             +  
Sbjct: 176 GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKN 235

Query: 158 TPMFM----------APEVARGEHQ-GFASDIWAVGCTVIEM------------------ 188
               +          APE+   +     A D+W++GC   E+                  
Sbjct: 236 LKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLF 295

Query: 189 ------------ASGGAPWPNAADPMTVLYKI---------------------AYSRELP 215
                        +G     +       L  I                      Y R  P
Sbjct: 296 PGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFP 355

Query: 216 EVPA--------FLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQIQESNC 267
           +             S  A   L   L  +P +R   ++ L HPF +E         E+N 
Sbjct: 356 KREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV---RIAEVETNA 412

Query: 268 SPTSILDQGIWNSVEETEESLGNLIH 293
           +    L     + +   E  L     
Sbjct: 413 TEKVRLP--FNDWMNMDEPQLRYAFV 436

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 97.0 bits (242), Expect = 3e-22
 Identities = 59/202 (29%), Positives = 92/202 (45%), Gaps = 16/202 (7%)

Query: 4   TRGHTIGQGSSATVSLATSLRSGDVFAAKS--TELPKSEFLQREQKFLSSLNSPHIVGYK 61
               TIG+G    V L    R   V A K    +     FL  E   ++ L   ++V   
Sbjct: 196 KLLQTIGKGEFGDVMLGD-YRGNKV-AVKCIKNDATAQAFLA-EASVMTQLRHSNLVQLL 252

Query: 62  GCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGR-LDESLIVSYTRQILQGLEYLHSNR 120
           G  +  E   L   +  EY   G+L D +   G   L    ++ ++  + + +EYL  N 
Sbjct: 253 GV-IVEEKGGLY--IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN 309

Query: 121 VVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSGGTPM-FMAPEVARGEHQGF--AS 176
            VH D+ +RN+L++E   AK++DFG  K  S    +G  P+ + APE  R   + F   S
Sbjct: 310 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALR--EKKFSTKS 367

Query: 177 DIWAVGCTVIEMAS-GGAPWPN 197
           D+W+ G  + E+ S G  P+P 
Sbjct: 368 DVWSFGILLWEIYSFGRVPYPR 389

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 96.4 bits (240), Expect = 5e-22
 Identities = 67/378 (17%), Positives = 117/378 (30%), Gaps = 103/378 (27%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELP--KSEFLQ---REQKFLSSLNSPHIVGYKGC 63
           IG+GS   V LA    +    A K            +   RE   L+ L S +I+     
Sbjct: 34  IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLY-- 91

Query: 64  DVTSEDNKLMYN---LFMEYAPGGT-LNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN 119
           D+   D+ L ++   + +E A   + L     +    L E  I +    +L G  ++H +
Sbjct: 92  DLIIPDDLLKFDELYIVLEIA--DSDLKKLF-KTPIFLTEEHIKTILYNLLLGENFIHES 148

Query: 120 RVVHCDIKSRNILM-AESGAKIADFGCA----------------KWESEALQSGGTPMFM 162
            ++H D+K  N L+  +   K+ DFG A                + E     +      +
Sbjct: 149 GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQL 208

Query: 163 ----------APEVARGEHQ-GFASDIWAVGCTVIEMASGGAPWPNAA------------ 199
                     APE+   +     + DIW+ GC   E+ +      N              
Sbjct: 209 TSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSC 268

Query: 200 ---------------DPMTVLYKI---------------------AYSRELPEVPA---- 219
                               L  I                      Y +  P        
Sbjct: 269 FPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLK 328

Query: 220 ----FLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSILDQ 275
                +S    + L + L+ +P +R    Q L HP+L++         E+  +   IL  
Sbjct: 329 QKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKK---LENFSTKKIILP- 384

Query: 276 GIWNSVEETEESLGNLIH 293
              + +  +E  L  +  
Sbjct: 385 -FDDWMVLSETQLRYIFL 401

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 94.2 bits (235), Expect = 6e-22
 Identities = 57/217 (26%), Positives = 91/217 (41%), Gaps = 28/217 (12%)

Query: 38  KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRL 97
           K E L  E   +  L++P+IV   G    +E    M  L ME A  G LN  + +    +
Sbjct: 62  KDELL-AEANVMQQLDNPYIVRMIGI-CEAE--SWM--LVMEMAELGPLNKYL-QQNRHV 114

Query: 98  DESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKW----ESEA 152
            +  I+    Q+  G++YL  +  VH D+ +RN+L+     AKI+DFG +K     E+  
Sbjct: 115 KDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 174

Query: 153 LQSGGTPM---FMAPEVARGEHQGF--ASDIWAVGCTVIEMAS-GGAPWPNAADPMT--- 203
                      + APE     +  F   SD+W+ G  + E  S G  P+      M    
Sbjct: 175 KAQTHGKWPVKWYAPECIN--YYKFSSKSDVWSFGVLMWEAFSYGQKPYRG----MKGSE 228

Query: 204 VLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKER 240
           V   +     +   PA   ++  D ++ C   D + R
Sbjct: 229 VTAMLEKGERMGC-PAGCPREMYDLMNLCWTYDVENR 264

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 93.1 bits (232), Expect = 1e-21
 Identities = 65/251 (25%), Positives = 106/251 (42%), Gaps = 36/251 (14%)

Query: 34  TELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLND----- 88
           T   + +F  RE + L++L   HIV + G      D  +M     EY   G LN      
Sbjct: 57  TLAARKDFQ-REAELLTNLQHEHIVKFYGV-CGDGDPLIM---VFEYMKHGDLNKFLRAH 111

Query: 89  ----------EIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG- 137
                     +  +  G L  S ++    QI  G+ YL S   VH D+ +RN L+  +  
Sbjct: 112 GPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLL 171

Query: 138 AKIADFGCAK--WESEALQSGGTPMF----MAPEVARGEHQGF--ASDIWAVGCTVIEMA 189
            KI DFG ++  + ++  + GG  M     M PE     ++ F   SD+W+ G  + E+ 
Sbjct: 172 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIM--YRKFTTESDVWSFGVILWEIF 229

Query: 190 S-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLK 248
           + G  PW   ++   V+  I   R L   P    K+  D +  C +R+P++R    ++  
Sbjct: 230 TYGKQPWFQLSNTE-VIECITQGRVLER-PRVCPKEVYDVMLGCWQREPQQRLNIKEI-- 285

Query: 249 HPFLEEFCSCT 259
           +  L      T
Sbjct: 286 YKILHALGKAT 296

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 92.7 bits (231), Expect = 2e-21
 Identities = 50/261 (19%), Positives = 101/261 (38%), Gaps = 32/261 (12%)

Query: 6   GHTIGQGSSATVSLATSLRSGDVF---AAK------STELPKSEFLQREQKFLSSLNSPH 56
           G  +G+G   +V      +        A K      S++    EFL  E   +   + P+
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFL-SEAACMKDFSHPN 97

Query: 57  IVGYKGCDVTSEDNKLMYNLF--MEYAPGGTLND-----EIHRNGGRLDESLIVSYTRQI 109
           ++   G       ++ +      + +   G L+       +      +    ++ +   I
Sbjct: 98  VIRLLGV-CIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDI 156

Query: 110 LQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKW--ESEALQSGGTPMF----M 162
             G+EYL +   +H D+ +RN ++ +     +ADFG +K     +  + G         +
Sbjct: 157 ALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 216

Query: 163 APEVARGEHQGF--ASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPA 219
           A E      + +   SD+WA G T+ E+A+ G  P+P       +   + +   L + P 
Sbjct: 217 AIESLA--DRVYTSKSDVWAFGVTMWEIATRGMTPYPG-VQNHEMYDYLLHGHRLKQ-PE 272

Query: 220 FLSKQANDFLSNCLRRDPKER 240
               +  + + +C R DP +R
Sbjct: 273 DCLDELYEIMYSCWRTDPLDR 293

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 92.0 bits (229), Expect = 3e-21
 Identities = 36/191 (18%), Positives = 71/191 (37%), Gaps = 44/191 (23%)

Query: 32  KSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIH 91
           K+       F       +S L+  H+V   G  V    ++ +  L  E+   G+L+  + 
Sbjct: 50  KAHRNYSESFF-EAASMMSKLSHKHLVLNYG--VCVCGDENI--LVQEFVKFGSLDTYLK 104

Query: 92  RNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG---------AKIAD 142
           +N   ++    +   +Q+   + +L  N ++H ++ ++NIL+              K++D
Sbjct: 105 KNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSD 164

Query: 143 FGCA-------------KWESEALQSGGTPMFMAPEVARGEHQGF--ASDIWAVGCTVIE 187
            G +              W             + PE      +    A+D W+ G T+ E
Sbjct: 165 PGISITVLPKDILQERIPW-------------VPPECIE-NPKNLNLATDKWSFGTTLWE 210

Query: 188 MASGGA-PWPN 197
           + SGG  P   
Sbjct: 211 ICSGGDKPLSA 221

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 90.7 bits (226), Expect = 6e-21
 Identities = 66/280 (23%), Positives = 112/280 (40%), Gaps = 37/280 (13%)

Query: 4   TRGHTIGQGSSATVSLATSLRSGDVFAA----KSTELPKSEFLQREQKFLSSLNSPHIVG 59
                +G G    V +        V  A    K   +    FL  E   +  L    +V 
Sbjct: 16  KLVERLGAGQFGEVWMGYYNGHTKV--AVKSLKQGSMSPDAFLA-EANLMKQLQHQRLVR 72

Query: 60  YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGR-LDESLIVSYTRQILQGLEYLHS 118
                VT E    +Y +  EY   G+L D +    G  L  + ++    QI +G+ ++  
Sbjct: 73  LYAV-VTQEP---IY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127

Query: 119 NRVVHCDIKSRNILMAESG-AKIADFGCAKW--ESEALQSGGTPMF----MAPEVARGEH 171
              +H D+++ NIL++++   KIADFG A+   ++E     G   F     APE     +
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGA-KFPIKWTAPEAIN--Y 184

Query: 172 QGF--ASDIWAVGCTVIEMAS-GGAPWPNAADPMT---VLYKIAYSRELPEVPAFLSKQA 225
             F   SD+W+ G  + E+ + G  P+P     MT   V+  +     +   P    ++ 
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPG----MTNPEVIQNLERGYRMVR-PDNCPEEL 239

Query: 226 NDFLSNCLRRDPKERWAASQLLKHPFLEEFCSCTK-QIQE 264
              +  C +  P++R     L     LE+F + T+ Q Q 
Sbjct: 240 YQLMRLCWKERPEDRPTFDYLRS--VLEDFFTATEGQYQP 277

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 90.8 bits (226), Expect = 9e-21
 Identities = 52/208 (25%), Positives = 87/208 (41%), Gaps = 22/208 (10%)

Query: 4   TRGHTIGQGSSATVSLATSLRSGDVFAA----KSTELPKSEFLQREQKFLSSLNSPHIVG 59
           T  H +G G    V      +   +  A    K   +   EFL+ E   +  +  P++V 
Sbjct: 16  TMKHKLGGGQYGEVYEGV-WKKYSLTVAVKTLKEDTMEVEEFLK-EAAVMKEIKHPNLVQ 73

Query: 60  YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIH-RNGGRLDESLIVSYTRQILQGLEYLHS 118
             G  V + +      +  E+   G L D +   N   +   +++    QI   +EYL  
Sbjct: 74  LLG--VCTREPPFY--IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 129

Query: 119 NRVVHCDIKSRNILMAESG-AKIADFGCAKW--ESEALQSGGT--PMF-MAPEVARGEHQ 172
              +H D+ +RN L+ E+   K+ADFG ++           G   P+   APE     + 
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA--YN 187

Query: 173 GF--ASDIWAVGCTVIEMAS-GGAPWPN 197
            F   SD+WA G  + E+A+ G +P+P 
Sbjct: 188 KFSIKSDVWAFGVLLWEIATYGMSPYPG 215

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 92.8 bits (231), Expect = 1e-20
 Identities = 53/207 (25%), Positives = 92/207 (44%), Gaps = 22/207 (10%)

Query: 4   TRGHTIGQGSSATVSLATSLRSGDVFAAK---STELPKSEFLQREQKFLSSLNSPHIVGY 60
                +G G    V +AT  +   V A K      +    FL  E   + +L    +V  
Sbjct: 191 KLEKKLGAGQFGEVWMATYNKHTKV-AVKTMKPGSMSVEAFLA-EANVMKTLQHDKLVKL 248

Query: 61  KGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGR-LDESLIVSYTRQILQGLEYLHSN 119
               VT E    +Y +  E+   G+L D +  + G       ++ ++ QI +G+ ++   
Sbjct: 249 HAV-VTKEP---IY-IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR 303

Query: 120 RVVHCDIKSRNILMAESG-AKIADFGCAKW--ESEALQSGGT--PM-FMAPEVARGEHQG 173
             +H D+++ NIL++ S   KIADFG A+   ++E     G   P+ + APE        
Sbjct: 304 NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAIN--FGS 361

Query: 174 F--ASDIWAVGCTVIEMAS-GGAPWPN 197
           F   SD+W+ G  ++E+ + G  P+P 
Sbjct: 362 FTIKSDVWSFGILLMEIVTYGRIPYPG 388

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 88.9 bits (221), Expect = 5e-20
 Identities = 54/255 (21%), Positives = 98/255 (38%), Gaps = 35/255 (13%)

Query: 33  STELPKSEFLQREQKFLSSLNS-PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLND--- 88
           +T       +  E K L  +    ++V   G   T     LM  + +E+   G L+    
Sbjct: 69  ATHSEHRALM-SELKILIHIGHHLNVVNLLGA-CTKPGGPLM--VIVEFCKFGNLSTYLR 124

Query: 89  ------------EIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES 136
                               L    ++ Y+ Q+ +G+E+L S + +H D+ +RNIL++E 
Sbjct: 125 SKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 184

Query: 137 G-AKIADFGCAK--WESEALQSGGTPMF----MAPEVARGEHQGF--ASDIWAVGCTVIE 187
              KI DFG A+  ++       G        MAPE      + +   SD+W+ G  + E
Sbjct: 185 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWE 242

Query: 188 MAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQL 246
           + S G +P+P          ++     +   P + + +    + +C   +P +R   S+L
Sbjct: 243 IFSLGASPYPGVKIDEEFCRRLKEGTRMRA-PDYTTPEMYQTMLDCWHGEPSQRPTFSEL 301

Query: 247 LKHPFLEEFCSCTKQ 261
                L        Q
Sbjct: 302 --VEHLGNLLQANAQ 314

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 88.5 bits (220), Expect = 9e-20
 Identities = 61/247 (24%), Positives = 101/247 (40%), Gaps = 35/247 (14%)

Query: 34  TELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLND----- 88
           +E  + +F  RE + L+ L   HIV + G   T     LM     EY   G LN      
Sbjct: 83  SESARQDFQ-REAELLTMLQHQHIVRFFGV-CTEGRPLLM---VFEYMRHGDLNRFLRSH 137

Query: 89  ---------EIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-A 138
                          G L    +++   Q+  G+ YL     VH D+ +RN L+ +    
Sbjct: 138 GPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVV 197

Query: 139 KIADFGCAK--WESEALQSGGTPMF----MAPEVARGEHQGF--ASDIWAVGCTVIEMAS 190
           KI DFG ++  + ++  + GG  M     M PE     ++ F   SD+W+ G  + E+ +
Sbjct: 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESIL--YRKFTTESDVWSFGVVLWEIFT 255

Query: 191 -GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKH 249
            G  PW   ++    +  I   REL   P     +    +  C +R+P++R +   +  H
Sbjct: 256 YGKQPWYQLSNTE-AIDCITQGRELER-PRACPPEVYAIMRGCWQREPQQRHSIKDV--H 311

Query: 250 PFLEEFC 256
             L+   
Sbjct: 312 ARLQALA 318

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 87.7 bits (218), Expect = 2e-19
 Identities = 56/230 (24%), Positives = 87/230 (37%), Gaps = 34/230 (14%)

Query: 33  STELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLND---- 88
            +E  + +FL  E   +S  N  +IV   G        + +    ME   GG L      
Sbjct: 72  CSEQDELDFL-MEALIISKFNHQNIVRCIGV-SLQSLPRFI---LMELMAGGDLKSFLRE 126

Query: 89  --EIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG----AKIAD 142
                     L    ++   R I  G +YL  N  +H DI +RN L+   G    AKI D
Sbjct: 127 TRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGD 186

Query: 143 FGCAK--WESEALQSGGTPMF----MAPEVARGEHQGF--ASDIWAVGCTVIEMAS-GGA 193
           FG A+  + +   + GG  M     M PE        F   +D W+ G  + E+ S G  
Sbjct: 187 FGMARDIYRASYYRKGGCAMLPVKWMPPEAFM--EGIFTSKTDTWSFGVLLWEIFSLGYM 244

Query: 194 PWPNAADPMT---VLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKER 240
           P+P+     +   VL  +     +   P          ++ C +  P++R
Sbjct: 245 PYPS----KSNQEVLEFVTSGGRMDP-PKNCPGPVYRIMTQCWQHQPEDR 289

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 86.9 bits (216), Expect = 2e-19
 Identities = 56/236 (23%), Positives = 89/236 (37%), Gaps = 40/236 (16%)

Query: 33  STELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLND---- 88
           +    + EF   E    + L  P++V   G  VT +    M      Y   G L++    
Sbjct: 51  AEGPLREEFR-HEAMLRARLQHPNVVCLLGV-VTKDQPLSM---IFSYCSHGDLHEFLVM 105

Query: 89  -----------EIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG 137
                      +       L+    V    QI  G+EYL S+ VVH D+ +RN+L+ +  
Sbjct: 106 RSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKL 165

Query: 138 -AKIADFGCAK--WESEALQSGGTPMF----MAPEVARGEHQGF--ASDIWAVGCTVIEM 188
             KI+D G  +  + ++  +  G  +     MAPE     +  F   SDIW+ G  + E+
Sbjct: 166 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIM--YGKFSIDSDIWSYGVVLWEV 223

Query: 189 AS-GGAPWPNAADPMT---VLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKER 240
            S G  P+       +   V+  I   + LP  P          +  C    P  R
Sbjct: 224 FSYGLQPYCG----YSNQDVVEMIRNRQVLPC-PDDCPAWVYALMIECWNEFPSRR 274

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 87.0 bits (216), Expect = 2e-19
 Identities = 54/227 (23%), Positives = 92/227 (40%), Gaps = 28/227 (12%)

Query: 33  STELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLND---- 88
           ++   + EFL  E   +   N  H+V   G  V+     L+    ME    G L      
Sbjct: 67  ASMRERIEFL-NEASVMKEFNCHHVVRLLGV-VSQGQPTLV---IMELMTRGDLKSYLRS 121

Query: 89  -----EIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIAD 142
                  +        S ++    +I  G+ YL++N+ VH D+ +RN ++AE    KI D
Sbjct: 122 LRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGD 181

Query: 143 FGCAKW--ESEALQSGGTPMF----MAPEVARGEHQGF--ASDIWAVGCTVIEMAS-GGA 193
           FG  +   E++  + GG  +     M+PE  +     F   SD+W+ G  + E+A+    
Sbjct: 182 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLK--DGVFTTYSDVWSFGVVLWEIATLAEQ 239

Query: 194 PWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKER 240
           P+        VL  +     L + P        + +  C + +PK R
Sbjct: 240 PYQ-GLSNEQVLRFVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMR 284

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 87.1 bits (216), Expect = 4e-19
 Identities = 55/230 (23%), Positives = 87/230 (37%), Gaps = 34/230 (14%)

Query: 33  STELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLND---- 88
            +E  + +FL  E   +S  N  +IV   G        + +    +E   GG L      
Sbjct: 113 CSEQDELDFL-MEALIISKFNHQNIVRCIGV-SLQSLPRFI---LLELMAGGDLKSFLRE 167

Query: 89  --EIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG----AKIAD 142
                     L    ++   R I  G +YL  N  +H DI +RN L+   G    AKI D
Sbjct: 168 TRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGD 227

Query: 143 FGCAK--WESEALQSGGTPMF----MAPEVARGEHQGF--ASDIWAVGCTVIEMAS-GGA 193
           FG A+  + +   + GG  M     M PE        F   +D W+ G  + E+ S G  
Sbjct: 228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFM--EGIFTSKTDTWSFGVLLWEIFSLGYM 285

Query: 194 PWPNAADPMT---VLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKER 240
           P+P+     +   VL  +     +   P          ++ C +  P++R
Sbjct: 286 PYPS----KSNQEVLEFVTSGGRMDP-PKNCPGPVYRIMTQCWQHQPEDR 330

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 85.9 bits (213), Expect = 1e-18
 Identities = 53/210 (25%), Positives = 86/210 (40%), Gaps = 42/210 (20%)

Query: 8   TIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ--REQKFLSSLNSP------HIV- 58
            IG+GS   V  A      +  A K  +  K+   Q   E + L  +N        +IV 
Sbjct: 61  LIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVH 120

Query: 59  -----GYKG--CDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGR-LDESLIVSYTRQIL 110
                 ++   C V      L YNL+          D +     R +  +L   + +Q+ 
Sbjct: 121 LKRHFMFRNHLCLVF---EMLSYNLY----------DLLRNTNFRGVSLNLTRKFAQQMC 167

Query: 111 QGLEYLHSNR--VVHCDIKSRNILMAESGA---KIADFGCAKWESEA----LQSGGTPMF 161
             L +L +    ++HCD+K  NIL+        KI DFG +    +     +QS     +
Sbjct: 168 TALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQS---RFY 224

Query: 162 MAPEVARGEHQGFASDIWAVGCTVIEMASG 191
            +PEV  G     A D+W++GC ++EM +G
Sbjct: 225 RSPEVLLGMPYDLAIDMWSLGCILVEMHTG 254

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 46.6 bits (111), Expect = 7e-06
 Identities = 10/43 (23%), Positives = 16/43 (37%), Gaps = 5/43 (11%)

Query: 212 RELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEE 254
             + +   F      D +   L  DPK R      L+H F ++
Sbjct: 341 HTVADYLKFK-----DLILRMLDYDPKTRIQPYYALQHSFFKK 378

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 84.2 bits (209), Expect = 2e-18
 Identities = 57/257 (22%), Positives = 97/257 (37%), Gaps = 38/257 (14%)

Query: 33  STELPKSEFLQREQKFLSSLNS-PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLND--- 88
           +    +   +  E K LS L +  +IV   G   T     L+     EY   G L +   
Sbjct: 65  AHLTEREALM-SELKVLSYLGNHMNIVNLLGA-CTIGGPTLV---ITEYCCYGDLLNFLR 119

Query: 89  --------------EIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMA 134
                          +  +   LD   ++S++ Q+ +G+ +L S   +H D+ +RNIL+ 
Sbjct: 120 RKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT 179

Query: 135 ESG-AKIADFGCAK--WESEALQSGGTPMF----MAPEVARGEHQGF--ASDIWAVGCTV 185
                KI DFG A+           G        MAPE     +  +   SD+W+ G  +
Sbjct: 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIF--NCVYTFESDVWSYGIFL 237

Query: 186 IEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAAS 244
            E+ S G +P+P           I     +   P     +  D +  C   DP +R    
Sbjct: 238 WELFSLGSSPYPGMPVDSKFYKMIKEGFRMLS-PEHAPAEMYDIMKTCWDADPLKRPTFK 296

Query: 245 QLLKHPFLEEFCSCTKQ 261
           Q+++   +E+  S +  
Sbjct: 297 QIVQL--IEKQISESTN 311

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 82.3 bits (204), Expect = 1e-17
 Identities = 55/223 (24%), Positives = 93/223 (41%), Gaps = 39/223 (17%)

Query: 6   GHTIGQGSSATVSLATSLRSGDVF--AAK-----STELPKSEFLQREQKFLSSLNS-PHI 57
              IG+G+   V  A   + G     A K     +++    +F   E + L  L   P+I
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFA-GELEVLCKLGHHPNI 88

Query: 58  VGYKGCDVTSEDNKLMYNLFMEYAPGGTLND---------------EIHRNGGRLDESLI 102
           +   G     E    +Y L +EYAP G L D                 +     L    +
Sbjct: 89  INLLGA---CEHRGYLY-LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144

Query: 103 VSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSGGTPMF 161
           + +   + +G++YL   + +H D+ +RNIL+ E+  AKIADFG ++ +   ++       
Sbjct: 145 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG-RL 203

Query: 162 ----MAPEVARGEHQGF--ASDIWAVGCTVIEMAS-GGAPWPN 197
               MA E     +  +   SD+W+ G  + E+ S GG P+  
Sbjct: 204 PVRWMAIESLN--YSVYTTNSDVWSYGVLLWEIVSLGGTPYCG 244

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 82.3 bits (204), Expect = 1e-17
 Identities = 56/263 (21%), Positives = 109/263 (41%), Gaps = 43/263 (16%)

Query: 33  STELPKSEFLQREQKFLSSLNS-PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLND--- 88
           +TE   S+ +  E + +  +    +I+   G   T +    +    +EYA  G L +   
Sbjct: 79  ATEKDLSDLV-SEMEMMKMIGKHKNIINLLGA-CTQDGPLYV---IVEYASKGNLREYLR 133

Query: 89  ------------EIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES 136
                              ++    +VS T Q+ +G+EYL S + +H D+ +RN+L+ E+
Sbjct: 134 ARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTEN 193

Query: 137 G-AKIADFGCAK--WESEALQSGGTPMF----MAPEVARGEHQGF--ASDIWAVGCTVIE 187
              KIADFG A+     +  +           MAPE      + +   SD+W+ G  + E
Sbjct: 194 NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALF--DRVYTHQSDVWSFGVLMWE 251

Query: 188 MAS-GGAPWPNAADPMT---VLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAA 243
           + + GG+P+P     +    +   +     + + PA  + +    + +C    P +R   
Sbjct: 252 IFTLGGSPYPG----IPVEELFKLLKEGHRMDK-PANCTNELYMMMRDCWHAVPSQRPTF 306

Query: 244 SQLLKHPFLEEFCSCTKQIQESN 266
            QL++   L+   + T   +  +
Sbjct: 307 KQLVED--LDRILTLTTNEEYLD 327

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 81.5 bits (202), Expect = 2e-17
 Identities = 49/197 (24%), Positives = 83/197 (42%), Gaps = 40/197 (20%)

Query: 33  STELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLND---- 88
           ++     + L  E   L  +N PH++   G   +   +  +  L +EYA  G+L      
Sbjct: 65  ASPSELRDLL-SEFNVLKQVNHPHVIKLYGA-CS--QDGPLL-LIVEYAKYGSLRGFLRE 119

Query: 89  -------------------EIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSR 129
                                H +   L    ++S+  QI QG++YL   ++VH D+ +R
Sbjct: 120 SRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAAR 179

Query: 130 NILMAESG-AKIADFGCAKW--ESEALQSGGTPMF----MAPEVARGEHQGF--ASDIWA 180
           NIL+AE    KI+DFG ++   E ++             MA E        +   SD+W+
Sbjct: 180 NILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLF--DHIYTTQSDVWS 237

Query: 181 VGCTVIEMAS-GGAPWP 196
            G  + E+ + GG P+P
Sbjct: 238 FGVLLWEIVTLGGNPYP 254

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 81.2 bits (201), Expect = 3e-17
 Identities = 52/232 (22%), Positives = 83/232 (35%), Gaps = 32/232 (13%)

Query: 33  STELPKSEFLQREQKFLSSLNS-PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLND--- 88
           +    K   +  E K +S L    +IV   G   T     L+     EY   G L +   
Sbjct: 88  AHADEKEALM-SELKIMSHLGQHENIVNLLGA-CTHGGPVLV---ITEYCCYGDLLNFLR 142

Query: 89  ----------EIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG- 137
                                  ++ ++ Q+ QG+ +L S   +H D+ +RN+L+     
Sbjct: 143 RKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHV 202

Query: 138 AKIADFGCAK--WESEALQSGGTPMF----MAPEVARGEHQGF--ASDIWAVGCTVIEMA 189
           AKI DFG A+           G        MAPE        +   SD+W+ G  + E+ 
Sbjct: 203 AKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIF--DCVYTVQSDVWSYGILLWEIF 260

Query: 190 S-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKER 240
           S G  P+P           +    ++ + PAF  K     +  C   +P  R
Sbjct: 261 SLGLNPYPGILVNSKFYKLVKDGYQMAQ-PAFAPKNIYSIMQACWALEPTHR 311

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 80.7 bits (200), Expect = 3e-17
 Identities = 50/168 (29%), Positives = 82/168 (48%), Gaps = 27/168 (16%)

Query: 40  EFLQREQKFLSSLNSPHIV---GYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGR 96
           EF + E + LS    PH+V   G+  CD   E N+++  L  +Y   G L   ++   G 
Sbjct: 81  EF-ETEIETLSFCRHPHLVSLIGF--CD---ERNEMI--LIYKYMENGNLKRHLY---GS 129

Query: 97  LDESLIVSY-TR-QIL----QGLEYLHSNRVVHCDIKSRNILMAES-GAKIADFGCAKWE 149
              ++ +S+  R +I     +GL YLH+  ++H D+KS NIL+ E+   KI DFG +K  
Sbjct: 130 DLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKG 189

Query: 150 SEALQS------GGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASG 191
           +E  Q+       GT  ++ PE          SD+++ G  + E+   
Sbjct: 190 TELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCA 237

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 81.6 bits (202), Expect = 3e-17
 Identities = 56/255 (21%), Positives = 105/255 (41%), Gaps = 37/255 (14%)

Query: 33  STELPKSEFLQREQKFLSSLNS-PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLND--- 88
           +TE   S+ +  E + +  +    +I+   G       +  +Y + +EYA  G L +   
Sbjct: 125 ATEKDLSDLV-SEMEMMKMIGKHKNIINLLGA---CTQDGPLY-VIVEYASKGNLREYLR 179

Query: 89  ------------EIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES 136
                              ++    +VS T Q+ +G+EYL S + +H D+ +RN+L+ E+
Sbjct: 180 ARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTEN 239

Query: 137 G-AKIADFGCAKW--ESEALQSGGTPMF----MAPEVARGEHQGF--ASDIWAVGCTVIE 187
              KIADFG A+     +  +           MAPE      + +   SD+W+ G  + E
Sbjct: 240 NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALF--DRVYTHQSDVWSFGVLMWE 297

Query: 188 MAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQL 246
           + + GG+P+P       +   +     + + PA  + +    + +C    P +R    QL
Sbjct: 298 IFTLGGSPYPGIPVEE-LFKLLKEGHRMDK-PANCTNELYMMMRDCWHAVPSQRPTFKQL 355

Query: 247 LKHPFLEEFCSCTKQ 261
                L+   + T  
Sbjct: 356 --VEDLDRILTLTTN 368

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 80.5 bits (199), Expect = 3e-17
 Identities = 48/212 (22%), Positives = 78/212 (36%), Gaps = 26/212 (12%)

Query: 6   GHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEF--LQREQKFLSSL-NSPHIVGYKG 62
           G  IG+GS   +   T+L +    A K  E  +S+   L+ E +    L     I     
Sbjct: 15  GRRIGEGSFGVIFEGTNLLNNQQVAIK-FEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYY 73

Query: 63  CDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
                  N L+ +L      G +L D +   G +     +    +Q+L  ++ +H   +V
Sbjct: 74  FGQEGLHNVLVIDLL-----GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLV 128

Query: 123 HCDIKSRNILMAESGAK------IADFGCAKW-----------ESEALQSGGTPMFMAPE 165
           + DIK  N L+    +K      + DFG  K+             E     GT  +M+  
Sbjct: 129 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 188

Query: 166 VARGEHQGFASDIWAVGCTVIEMASGGAPWPN 197
              G  Q    D+ A+G   +    G  PW  
Sbjct: 189 THLGREQSRRDDLEALGHVFMYFLRGSLPWQG 220

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 79.9 bits (198), Expect = 5e-17
 Identities = 52/169 (30%), Positives = 78/169 (46%), Gaps = 31/169 (18%)

Query: 40  EFLQREQKFLSSLNSPHIV---GYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGR 96
           +F Q E K ++     ++V   G+      S+ + L   L   Y P G+L D +    G 
Sbjct: 76  QFDQ-EIKVMAKCQHENLVELLGF--S---SDGDDLC--LVYVYMPNGSLLDRLSCLDGT 127

Query: 97  --LDESLIVSYTRQ-----ILQGLEYLHSNRVVHCDIKSRNILMAES-GAKIADFGCAKW 148
             L         R         G+ +LH N  +H DIKS NIL+ E+  AKI+DFG A+ 
Sbjct: 128 PPLSWH-----MRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARA 182

Query: 149 ESEALQSG------GTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASG 191
             +  Q+       GT  +MAPE  RG      SDI++ G  ++E+ +G
Sbjct: 183 SEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITG 230

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 80.9 bits (200), Expect = 6e-17
 Identities = 48/190 (25%), Positives = 83/190 (43%), Gaps = 33/190 (17%)

Query: 33  STELPKSEFLQREQKFLSSLNS-PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLND--- 88
           +TE   S+ +  E + +  +    +I+   G   T +    +    +EYA  G L +   
Sbjct: 113 ATEKDLSDLI-SEMEMMKMIGKHKNIINLLGA-CTQDGPLYV---IVEYASKGNLREYLQ 167

Query: 89  ------------EIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES 136
                         H    +L    +VS   Q+ +G+EYL S + +H D+ +RN+L+ E 
Sbjct: 168 ARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED 227

Query: 137 G-AKIADFGCAK--WESEALQSGGTPMF----MAPEVARGEHQGF--ASDIWAVGCTVIE 187
              KIADFG A+     +  +           MAPE      + +   SD+W+ G  + E
Sbjct: 228 NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF--DRIYTHQSDVWSFGVLLWE 285

Query: 188 MAS-GGAPWP 196
           + + GG+P+P
Sbjct: 286 IFTLGGSPYP 295

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 79.7 bits (197), Expect = 1e-16
 Identities = 52/267 (19%), Positives = 94/267 (35%), Gaps = 43/267 (16%)

Query: 33  STELPKSEFLQREQKFLSSLNS-PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLND--- 88
           +    +   +  E K ++ L S  +IV   G   T      +     EY   G L +   
Sbjct: 87  ADSSEREALM-SELKMMTQLGSHENIVNLLGA-CTLSGPIYL---IFEYCCYGDLLNYLR 141

Query: 89  -------------------EIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSR 129
                              E   +   L    ++ +  Q+ +G+E+L     VH D+ +R
Sbjct: 142 SKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR 201

Query: 130 NILMAESG-AKIADFGCAK--WESEALQSGGTPMF----MAPEVARGEHQGF--ASDIWA 180
           N+L+      KI DFG A+           G        MAPE        +   SD+W+
Sbjct: 202 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF--EGIYTIKSDVWS 259

Query: 181 VGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKE 239
            G  + E+ S G  P+P           I    ++ + P + +++    + +C   D ++
Sbjct: 260 YGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQ-PFYATEEIYIIMQSCWAFDSRK 318

Query: 240 RWAASQLLKHPFLEEFCSCTKQIQESN 266
           R +   L     L    +  ++    N
Sbjct: 319 RPSFPNLTSF--LGCQLADAEEAMYQN 343

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 79.0 bits (195), Expect = 1e-16
 Identities = 49/210 (23%), Positives = 79/210 (37%), Gaps = 24/210 (11%)

Query: 6   GHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEF--LQREQKFLSSLN-SPHIVGYKG 62
           G  IG GS   + L T + +G+  A K  E  K++   L  E K    +     I   + 
Sbjct: 14  GRKIGSGSFGDIYLGTDIAAGEEVAIK-LECVKTKHPQLHIESKIYKMMQGGVGIPTIRW 72

Query: 63  CDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
           C    + N ++  L      G +L D  +    +     ++    Q++  +EY+HS   +
Sbjct: 73  CGAEGDYNVMVMELL-----GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFI 127

Query: 123 HCDIKSRNILM----AESGAKIADFGCAKW-----------ESEALQSGGTPMFMAPEVA 167
           H D+K  N LM      +   I DFG AK              E     GT  + +    
Sbjct: 128 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTH 187

Query: 168 RGEHQGFASDIWAVGCTVIEMASGGAPWPN 197
            G  Q    D+ ++G  ++    G  PW  
Sbjct: 188 LGIEQSRRDDLESLGYVLMYFNLGSLPWQG 217

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 79.3 bits (196), Expect = 1e-16
 Identities = 44/197 (22%), Positives = 78/197 (39%), Gaps = 40/197 (20%)

Query: 33  STELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLND---- 88
           ++   +++F  RE   ++  ++P+IV   G          +     EY   G LN+    
Sbjct: 89  ASADMQADFQ-REAALMAEFDNPNIVKLLGV-CAVGKPMCL---LFEYMAYGDLNEFLRS 143

Query: 89  -------------------EIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSR 129
                                      L  +  +   RQ+  G+ YL   + VH D+ +R
Sbjct: 144 MSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR 203

Query: 130 NILMAESG-AKIADFGCAK--WESEALQSGGTPMF----MAPEVARGEHQGF--ASDIWA 180
           N L+ E+   KIADFG ++  + ++  ++ G        M PE     +  +   SD+WA
Sbjct: 204 NCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIF--YNRYTTESDVWA 261

Query: 181 VGCTVIEMAS-GGAPWP 196
            G  + E+ S G  P+ 
Sbjct: 262 YGVVLWEIFSYGLQPYY 278

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 76.6 bits (188), Expect = 2e-15
 Identities = 51/210 (24%), Positives = 82/210 (39%), Gaps = 24/210 (11%)

Query: 6   GHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEF--LQREQKFLSSLN-SPHIVGYKG 62
           G  IG GS   + L T++++ +  A K  E  K++   L  E K    L     I   + 
Sbjct: 12  GRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLLYESKIYRILQGGTGIPNVRW 70

Query: 63  CDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
             V  + N L+ +L      G +L D  +    +L    ++    Q++  +E++HS   +
Sbjct: 71  FGVEGDYNVLVMDLL-----GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 125

Query: 123 HCDIKSRNILM----AESGAKIADFGCAKW-----------ESEALQSGGTPMFMAPEVA 167
           H DIK  N LM      +   I DFG AK              E     GT  + +    
Sbjct: 126 HRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTH 185

Query: 168 RGEHQGFASDIWAVGCTVIEMASGGAPWPN 197
            G  Q    D+ ++G  ++    G  PW  
Sbjct: 186 LGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 75.5 bits (186), Expect = 3e-15
 Identities = 58/251 (23%), Positives = 87/251 (34%), Gaps = 43/251 (17%)

Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAK--STELPKSEFLQREQKFLSSLNS------ 54
           W  G  IG G    + LA      +  A      E  ++  L  E KF   +        
Sbjct: 39  WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKK 98

Query: 55  ------------PHIVGYKGCDVTSEDNKLMYN-LFMEYAPGGTLNDEIHRNGGRLDESL 101
                       P   G  G       +   Y  + ME   G  L   I    G   +S 
Sbjct: 99  WIERKQLDYLGIPLFYGS-GLTEFKGRS---YRFMVMERL-GIDLQK-ISGQNGTFKKST 152

Query: 102 IVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGAK---IADFGCAKW---------- 148
           ++    ++L  LEY+H N  VH DIK+ N+L+         +AD+G +            
Sbjct: 153 VLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQY 212

Query: 149 -ESEALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPN-AADPMTVL- 205
            E+      GT  F + +  +G      SD+  +G  ++    G  PW     DP+ V  
Sbjct: 213 QENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQT 272

Query: 206 YKIAYSRELPE 216
            K     ELP+
Sbjct: 273 AKTNLLDELPQ 283

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 75.3 bits (186), Expect = 3e-15
 Identities = 45/190 (23%), Positives = 81/190 (42%), Gaps = 30/190 (15%)

Query: 23  LRSGDVFAAK-----STELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLF 77
           L  G + A K      T+  + +F Q E + +S     +++  +G  +T  +  L+Y   
Sbjct: 51  LADGTLVAVKRLKEERTQGGELQF-QTEVEMISMAVHRNLLRLRGFCMTPTERLLVY--- 106

Query: 78  MEYAPGGTLNDEIHRNGGRLDESLIVS-YTRQ-----ILQGLEYLH--SN-RVVHCDIKS 128
             Y   G++   +     R +    +    RQ       +GL YLH   + +++H D+K+
Sbjct: 107 -PYMANGSVASCLR---ERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKA 162

Query: 129 RNILMAES-GAKIADFGCAKWESEALQSG------GTPMFMAPEVARGEHQGFASDIWAV 181
            NIL+ E   A + DFG AK       +       GT   +APE          +D++  
Sbjct: 163 ANILLDEEFEAVVGDFGLAKLMDYK-DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGY 221

Query: 182 GCTVIEMASG 191
           G  ++E+ +G
Sbjct: 222 GVMLLELITG 231

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 74.3 bits (183), Expect = 6e-15
 Identities = 50/214 (23%), Positives = 80/214 (37%), Gaps = 30/214 (14%)

Query: 6   GHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEF--LQREQKFLSSL-NSPHIVGYKG 62
           G  IG G+   + L  +L + +  A K  E  KS    L  E +F   L +   I     
Sbjct: 14  GKKIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYY 72

Query: 63  CDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
                + N ++  L      G +L D             ++    Q++  +EY+HS  ++
Sbjct: 73  FGPCGKYNAMVLELL-----GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLI 127

Query: 123 HCDIKSRNILMAESGAK------IADFGCAKW-------------ESEALQSGGTPMFMA 163
           + D+K  N L+   G K      I DF  AK              E ++L   GT  +M+
Sbjct: 128 YRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLT--GTARYMS 185

Query: 164 PEVARGEHQGFASDIWAVGCTVIEMASGGAPWPN 197
                G+ Q    D+ A+G   +    G  PW  
Sbjct: 186 INTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQG 219

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 74.0 bits (182), Expect = 9e-15
 Identities = 55/257 (21%), Positives = 85/257 (33%), Gaps = 50/257 (19%)

Query: 3   WTRGHTIGQGS-----SATVSLATSLRSGDVFAAK--STELPKSEFLQREQKFLSSLNS- 54
           W  G  IGQG       A ++ + S+ S      K   ++      L  E KF       
Sbjct: 37  WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGP---LFTELKFYQRAAKP 93

Query: 55  -----------------PHIVGYKGCDVTSEDNKLMYN-LFMEYAPGGTLNDEIHRNGGR 96
                            P   G    D   +     Y  + M+   G  L      N  R
Sbjct: 94  EQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKS----YRFMIMDRF-GSDLQKIYEANAKR 148

Query: 97  LDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGAK---IADFGCAKW----- 148
                ++  + +IL  LEY+H +  VH DIK+ N+L+         + D+G A       
Sbjct: 149 FSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEG 208

Query: 149 ------ESEALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPN-AADP 201
                         GT  F + +   G       D+  +G  +I+  +G  PW +   DP
Sbjct: 209 VHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP 268

Query: 202 MTVLY-KIAYSRELPEV 217
             V   KI Y   +  +
Sbjct: 269 KYVRDSKIRYRENIASL 285

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 72.7 bits (178), Expect = 2e-14
 Identities = 43/185 (23%), Positives = 84/185 (45%), Gaps = 15/185 (8%)

Query: 87  NDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGC 145
                     L    ++ Y+ Q+ +G+E+L S + +H D+ +RNIL++E    KI DFG 
Sbjct: 180 EAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGL 239

Query: 146 AK---WESEALQSGGTPM---FMAPEVARGEHQGF--ASDIWAVGCTVIEMAS-GGAPWP 196
           A+    + + ++ G   +   +MAPE      + +   SD+W+ G  + E+ S G +P+P
Sbjct: 240 ARDIYKDPDYVRKGDARLPLKWMAPET--IFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 297

Query: 197 NAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFC 256
                     ++     +   P + + +    + +C   +P +R   S+L++H  L    
Sbjct: 298 GVKIDEEFCRRLKEGTRMRA-PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH--LGNLL 354

Query: 257 SCTKQ 261
               Q
Sbjct: 355 QANAQ 359

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 69.0 bits (169), Expect = 4e-13
 Identities = 42/254 (16%), Positives = 82/254 (32%), Gaps = 44/254 (17%)

Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL------PKSEFLQREQKFL------- 49
           W       + +   +  A    +    +    +        K   L  EQ F        
Sbjct: 44  WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPL 103

Query: 50  -----SSLNSPHIVG---YKGCDVTSEDNKLMYN-LFMEYAPGGTLNDEIHRNGGR-LDE 99
                  L S  ++      G  V  +     Y  L +    G +L   +  +    L E
Sbjct: 104 QVNKWKKLYSTPLLAIPTCMGFGVHQDK----YRFLVLPSL-GRSLQSALDVSPKHVLSE 158

Query: 100 SLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGAK---IADFGCAK--------- 147
             ++    ++L  LE+LH N  VH ++ + NI +         +A +G A          
Sbjct: 159 RSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHV 218

Query: 148 --WESEALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPN-AADPMTV 204
              E       G   F++ ++ +G      SD+ ++G  +++   G  PW N   +   +
Sbjct: 219 AYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDI 278

Query: 205 LY-KIAYSRELPEV 217
           +  K  +  +    
Sbjct: 279 MKQKQKFVDKPGPF 292

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 45.3 bits (106), Expect = 2e-05
 Identities = 28/203 (13%), Positives = 58/203 (28%), Gaps = 33/203 (16%)

Query: 76  LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN-RVVHCDIKSRNILMA 134
           + +E+  GG   +++         +   S   Q+   L    ++ R  H D+   N+L+ 
Sbjct: 139 IVLEFEFGGIDLEQMRTK--LSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLK 196

Query: 135 ESGA-KIADFGCAK----------------WESEALQSGGTP---MFMAPEVARGEHQGF 174
           ++   K+      K                  S   + G      + M  ++  G+    
Sbjct: 197 KTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDGDYQ 256

Query: 175 ASDIWAVGCTVIEMASGGAPWPNA---ADPMTVLYKIAYSRELPEVPAF--LSKQANDFL 229
                 +            P+ N          + K    +     PA   + ++  +F 
Sbjct: 257 FDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFH 316

Query: 230 SNCLRRDPKERWAASQLLKHPFL 252
              L         A+ LL    L
Sbjct: 317 RTMLNFSS-----ATDLLCQHSL 334

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540

 Score = 41.5 bits (98), Expect = 3e-04
 Identities = 34/162 (20%), Positives = 60/162 (37%), Gaps = 33/162 (20%)

Query: 4   TRGHTIGQGSSATVSLATSLRSGDVF---AAKSTELPK------SEFLQREQKFLSSL-- 52
              H IG+G+ A +   + L    +      K     +           RE ++L+ +  
Sbjct: 339 IPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKD 398

Query: 53  ---NSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQI 109
               +P+I      DV  ++ ++M    M Y  G    D I  N         +    +I
Sbjct: 399 FGIPAPYIF-----DVDLDNKRIM----MSYINGKLAKDVIEDN---------LDIAYKI 440

Query: 110 LQGLEYLHSNRVVHCDIKSRNILMAESGAKIADFGCAKWESE 151
            + +  LH N V+H D+ + N +  +    I DFG  K  + 
Sbjct: 441 GEIVGKLHKNDVIHNDLTTSNFIFDKDLYII-DFGLGKISNL 481

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	405
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.98
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.95
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.92
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.85
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.73
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.36
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.24
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.21
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.11
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.92
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.59
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.55
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.31
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.3
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.25
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.1
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.04
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.79
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.62
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.6
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.56
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.45
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.39
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.24
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.14
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.96
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.82
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.76
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.64
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.23
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	94.7
3mes_A	424	Choline kinase; malaria, structural genomics, stru	93.75
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	91.53

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=8.5e-63  Score=474.93  Aligned_cols=249  Identities=27%  Similarity=0.431  Sum_probs=216.4

Q ss_pred             ccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEE
Q 015500            4 TRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFM   78 (405)
Q Consensus         4 ~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (405)
                      +..+.||+|+||+||+|.++.++..||+|.+....     .+.+.+|+++|++|+|||||++++++.........+++||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            55678999999999999999999999999886432     3568899999999999999999999877655556678999


Q ss_pred             eecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCCCCEEEcc-CC-ceEeeecccccccc--c
Q 015500           79 EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNR--VVHCDIKSRNILMAE-SG-AKIADFGCAKWESE--A  152 (405)
Q Consensus        79 Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~g--ivHrDlkp~NILi~~-~~-vkL~DFGla~~~~~--~  152 (405)
                      |||+||+|.+++.+. +++++..++.|++||+.||+|||++|  |+||||||+||||+. ++ +||+|||+|+....  .
T Consensus       109 Ey~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~~~  187 (290)
T 3fpq_A          109 ELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA  187 (290)
T ss_dssp             ECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTTSB
T ss_pred             eCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCCcc
Confidence            999999999999886 48999999999999999999999998  999999999999975 55 99999999986443  4


Q ss_pred             ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHh
Q 015500          153 LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNC  232 (405)
Q Consensus       153 ~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~  232 (405)
                      ...+|||.|||||++.+ .|++++|||||||++|||+||+.||....+.......+......+.++...++++++||.+|
T Consensus       188 ~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~  266 (290)
T 3fpq_A          188 KAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGC  266 (290)
T ss_dssp             EESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHH
T ss_pred             CCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHHHHHHH
Confidence            46689999999999976 59999999999999999999999997666655555555444444456677899999999999


Q ss_pred             cccCccccCCHHHHhcCccccc
Q 015500          233 LRRDPKERWAASQLLKHPFLEE  254 (405)
Q Consensus       233 L~~dP~~Rpt~~elL~hp~~~~  254 (405)
                      |++||++|||++|+|+||||++
T Consensus       267 L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          267 IRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             SCSSGGGSCCHHHHHTSGGGC-
T ss_pred             ccCChhHCcCHHHHhcCccccC
Confidence            9999999999999999999974

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=3.1e-63  Score=481.42  Aligned_cols=248  Identities=31%  Similarity=0.477  Sum_probs=219.6

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccC------CChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL------PKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~------~~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~   75 (405)
                      ||++++.||+|+||+||+|+++.+|+.||||++.+      ...+.+.+|+++|++|+|||||++++++.+..    .+|
T Consensus        33 dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~----~~y  108 (311)
T 4aw0_A           33 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE----KLY  108 (311)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS----EEE
T ss_pred             ccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC----EEE
Confidence            59999999999999999999999999999999863      34567999999999999999999999876543    367


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc---
Q 015500           76 LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE---  151 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~---  151 (405)
                      +|||||+||+|.++|.+. ++++|..++.|++||+.||+|||++||+||||||+|||++.++ +||+|||+|+....   
T Consensus       109 ivmEy~~gG~L~~~i~~~-~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~  187 (311)
T 4aw0_A          109 FGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK  187 (311)
T ss_dssp             EEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred             EEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence            999999999999999887 4899999999999999999999999999999999999999888 99999999986532   


Q ss_pred             ---cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHH
Q 015500          152 ---ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDF  228 (405)
Q Consensus       152 ---~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dl  228 (405)
                         ..+.+|||.|||||++.+..|++++|||||||++|||+||++||.. .+....+.++....  +.+|..+|+++++|
T Consensus       188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~-~~~~~~~~~i~~~~--~~~p~~~s~~~~dl  264 (311)
T 4aw0_A          188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA-GNEGLIFAKIIKLE--YDFPEKFFPKARDL  264 (311)
T ss_dssp             CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTC--CCCCTTCCHHHHHH
T ss_pred             cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCC--CCCCcccCHHHHHH
Confidence               3356899999999999999999999999999999999999999954 44555555555432  46788899999999


Q ss_pred             HHHhcccCccccCCHHH------HhcCcccccccc
Q 015500          229 LSNCLRRDPKERWAASQ------LLKHPFLEEFCS  257 (405)
Q Consensus       229 l~~~L~~dP~~Rpt~~e------lL~hp~~~~~~~  257 (405)
                      |++||++||++|||++|      +++||||+.+..
T Consensus       265 i~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw  299 (311)
T 4aw0_A          265 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTW  299 (311)
T ss_dssp             HHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCC
T ss_pred             HHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCH
Confidence            99999999999999988      589999987643

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=6.8e-63  Score=486.39  Aligned_cols=247  Identities=27%  Similarity=0.499  Sum_probs=213.7

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      +|++++.||+|+||+||+|+++.+|+.||||++....     .+.+.+|+++|++|+|||||++++++.+..    .+|+
T Consensus        25 ~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~----~~yi  100 (350)
T 4b9d_A           25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENG----SLYI  100 (350)
T ss_dssp             CEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT----EEEE
T ss_pred             ceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECC----EEEE
Confidence            5999999999999999999999999999999987543     357889999999999999999999886543    3679


Q ss_pred             EEeecCCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc---
Q 015500           77 FMEYAPGGTLNDEIHRN-GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE---  151 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~-~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~---  151 (405)
                      |||||+||+|.++|... +..++|..++.|+.||+.||+|||++||+||||||+||||+.++ +||+|||+|+....   
T Consensus       101 VmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~  180 (350)
T 4b9d_A          101 VMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE  180 (350)
T ss_dssp             EEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHH
T ss_pred             EEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCcc
Confidence            99999999999999764 34679999999999999999999999999999999999999888 99999999987654   


Q ss_pred             -cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHH
Q 015500          152 -ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLS  230 (405)
Q Consensus       152 -~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~  230 (405)
                       ....+|||.|||||++.+..|+.++|||||||++|||+||++||.. .+....+.++.. ...|..+..+|+++++||.
T Consensus       181 ~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~-~~~~~~~~~i~~-~~~~~~~~~~s~~~~~li~  258 (350)
T 4b9d_A          181 LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEA-GSMKNLVLKIIS-GSFPPVSLHYSYDLRSLVS  258 (350)
T ss_dssp             HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHH-TCCCCCCTTSCHHHHHHHH
T ss_pred             cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-cCHHHHHHHHHc-CCCCCCCccCCHHHHHHHH
Confidence             2345799999999999999999999999999999999999999954 345555555544 4566778889999999999


Q ss_pred             HhcccCccccCCHHHHhcCccccc
Q 015500          231 NCLRRDPKERWAASQLLKHPFLEE  254 (405)
Q Consensus       231 ~~L~~dP~~Rpt~~elL~hp~~~~  254 (405)
                      +||++||++|||++|+|+||||++
T Consensus       259 ~~L~~dP~~R~s~~e~l~hp~~~~  282 (350)
T 4b9d_A          259 QLFKRNPRDRPSVNSILEKGFIAK  282 (350)
T ss_dssp             HHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred             HHccCChhHCcCHHHHhcCHHhhc
Confidence            999999999999999999999975

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.3e-62  Score=483.65  Aligned_cols=247  Identities=33%  Similarity=0.497  Sum_probs=217.5

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccC---CChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL---PKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFM   78 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~---~~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (405)
                      .|++++.||+|+||+||+|+++.+|+.||||+++.   ...+.+.+|+++|++|+|||||++++++.+...    +||||
T Consensus        75 ~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~----~~ivm  150 (346)
T 4fih_A           75 YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDE----LWVVM  150 (346)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTE----EEEEE
T ss_pred             hcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE----EEEEE
Confidence            38899999999999999999999999999999864   345678999999999999999999998876543    67999


Q ss_pred             eecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc----cc
Q 015500           79 EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE----AL  153 (405)
Q Consensus        79 Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~----~~  153 (405)
                      |||+||+|.+++.+.  ++++..++.|++||+.||+|||++||+||||||+||||+.++ +||+|||+|+....    ..
T Consensus       151 Ey~~gg~L~~~l~~~--~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~  228 (346)
T 4fih_A          151 EFLEGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK  228 (346)
T ss_dssp             CCCTTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBC
T ss_pred             eCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCccc
Confidence            999999999998763  699999999999999999999999999999999999999888 99999999986533    34


Q ss_pred             cCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCC-CCCCchhccHHHHHHHHHh
Q 015500          154 QSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRE-LPEVPAFLSKQANDFLSNC  232 (405)
Q Consensus       154 ~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~-~~~~p~~~s~~l~dll~~~  232 (405)
                      ..+|||.|||||++.+..|++++|||||||++|||++|++||.+ .+....+..+..... ....+..+|+++++||.+|
T Consensus       229 ~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~-~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~  307 (346)
T 4fih_A          229 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRL  307 (346)
T ss_dssp             CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHHH
T ss_pred             ccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-cCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHH
Confidence            56899999999999999999999999999999999999999964 345555555544322 2234467899999999999


Q ss_pred             cccCccccCCHHHHhcCcccccc
Q 015500          233 LRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       233 L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      |++||++|||++|+|+||||++.
T Consensus       308 L~~dP~~R~ta~e~l~Hp~~~~~  330 (346)
T 4fih_A          308 LVRDPAQRATAAELLKHPFLAKA  330 (346)
T ss_dssp             SCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             cCCChhHCcCHHHHhcCHhhcCC
Confidence            99999999999999999999864

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=8.3e-62  Score=464.45  Aligned_cols=244  Identities=27%  Similarity=0.450  Sum_probs=203.7

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC------ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~------~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~   75 (405)
                      +|++++.||+|+||+||+|+++.+|+.||||++...      ....+.+|+++|++|+|||||++++++.+..    .+|
T Consensus        14 ~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~----~~~   89 (275)
T 3hyh_A           14 NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKD----EII   89 (275)
T ss_dssp             CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSS----EEE
T ss_pred             CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC----EEE
Confidence            699999999999999999999999999999998643      2357899999999999999999999876543    367


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc---
Q 015500           76 LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE---  151 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~---  151 (405)
                      +||||| +|+|.+++.++ +++++..++.+++||+.||+|||++||+||||||+|||++.++ +||+|||+|+....   
T Consensus        90 ivmEy~-~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~  167 (275)
T 3hyh_A           90 MVIEYA-GNELFDYIVQR-DKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNF  167 (275)
T ss_dssp             EEEECC-CEEHHHHHHHS-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred             EEEeCC-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCCc
Confidence            999999 67999999876 4899999999999999999999999999999999999999887 99999999986543   


Q ss_pred             cccCCCCCCccChhhhcCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHH
Q 015500          152 ALQSGGTPMFMAPEVARGEHQ-GFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLS  230 (405)
Q Consensus       152 ~~~~~gt~~Y~APE~l~~~~~-~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~  230 (405)
                      ..+.+|||.|||||++.+..+ ++++|||||||++|+|+||+.||.. .+......++...  .+.+|..+|+++++||+
T Consensus       168 ~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~-~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~  244 (275)
T 3hyh_A          168 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD-ESIPVLFKNISNG--VYTLPKFLSPGAAGLIK  244 (275)
T ss_dssp             -------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHT--CCCCCTTSCHHHHHHHH
T ss_pred             cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHcC--CCCCCCCCCHHHHHHHH
Confidence            345679999999999998775 6899999999999999999999964 3444444444432  34678889999999999


Q ss_pred             HhcccCccccCCHHHHhcCccccc
Q 015500          231 NCLRRDPKERWAASQLLKHPFLEE  254 (405)
Q Consensus       231 ~~L~~dP~~Rpt~~elL~hp~~~~  254 (405)
                      +||++||++|||++|+|+||||+.
T Consensus       245 ~~L~~dP~~R~s~~eil~hpw~k~  268 (275)
T 3hyh_A          245 RMLIVNPLNRISIHEIMQDDWFKV  268 (275)
T ss_dssp             HHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred             HHccCChhHCcCHHHHHcCccccc
Confidence            999999999999999999999974

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2.4e-61  Score=485.95  Aligned_cols=247  Identities=33%  Similarity=0.490  Sum_probs=217.5

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC---ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP---KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFM   78 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~---~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (405)
                      .|++++.||+|+||+||+|+++.+|+.||||++...   ..+.+.+|+.+|+.|+|||||++++++....    .+||||
T Consensus       152 ~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~----~~~iVm  227 (423)
T 4fie_A          152 YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD----ELWVVM  227 (423)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETT----EEEEEE
T ss_pred             hcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECC----EEEEEE
Confidence            388999999999999999999999999999998643   4567999999999999999999999987654    367999


Q ss_pred             eecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc----cc
Q 015500           79 EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE----AL  153 (405)
Q Consensus        79 Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~----~~  153 (405)
                      |||+||+|.+++...  ++++..++.|++||+.||+|||++||+||||||+||||+.++ +||+|||+|+....    ..
T Consensus       228 Ey~~gG~L~~~i~~~--~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~  305 (423)
T 4fie_A          228 EFLEGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK  305 (423)
T ss_dssp             ECCTTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBC
T ss_pred             eCCCCCcHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCcccc
Confidence            999999999999764  699999999999999999999999999999999999999888 99999999986543    34


Q ss_pred             cCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCC-CCCCchhccHHHHHHHHHh
Q 015500          154 QSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRE-LPEVPAFLSKQANDFLSNC  232 (405)
Q Consensus       154 ~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~-~~~~p~~~s~~l~dll~~~  232 (405)
                      ..+|||.|||||++.+..|+.++|||||||++|||++|++||.+ .+....+..+..... ....+..+|+++++||.+|
T Consensus       306 ~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~-~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~  384 (423)
T 4fie_A          306 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRL  384 (423)
T ss_dssp             CCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHHH
T ss_pred             ccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-cCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHHH
Confidence            56799999999999999999999999999999999999999964 345555555544322 2233456899999999999


Q ss_pred             cccCccccCCHHHHhcCcccccc
Q 015500          233 LRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       233 L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      |++||++|||++|+|+||||++.
T Consensus       385 L~~dP~~R~ta~ell~Hp~~~~~  407 (423)
T 4fie_A          385 LVRDPAQRATAAELLKHPFLAKA  407 (423)
T ss_dssp             SCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             cCCChhHCcCHHHHhcCHHhcCC
Confidence            99999999999999999999864

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.3e-61  Score=469.19  Aligned_cols=247  Identities=26%  Similarity=0.415  Sum_probs=210.7

Q ss_pred             CcccccccceeCCeeEEEEEEc---CCCCEEEEEEccCC-----ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceE
Q 015500            2 DWTRGHTIGQGSSATVSLATSL---RSGDVFAAKSTELP-----KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLM   73 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~---~~~~~vavK~~~~~-----~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~   73 (405)
                      +|++++.||+|+||+||+|++.   .+++.||||++...     ....+.+|+++|++|+|||||++++++.+..    .
T Consensus        25 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~----~  100 (304)
T 3ubd_A           25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEG----K  100 (304)
T ss_dssp             GEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETT----E
T ss_pred             ccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC----E
Confidence            5999999999999999999984   46889999998653     2346889999999999999999999887644    3


Q ss_pred             EEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc-
Q 015500           74 YNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE-  151 (405)
Q Consensus        74 ~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~-  151 (405)
                      +|+|||||+||+|.+++.+.+ ++++..++.|++||+.||+|||++||+||||||+|||++.++ +||+|||+|+.... 
T Consensus       101 ~~ivmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  179 (304)
T 3ubd_A          101 LYLILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH  179 (304)
T ss_dssp             EEEEECCCTTCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred             EEEEEEcCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence            679999999999999998874 899999999999999999999999999999999999999988 99999999986432 


Q ss_pred             ---cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHH
Q 015500          152 ---ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDF  228 (405)
Q Consensus       152 ---~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dl  228 (405)
                         ....+|||.|||||++.+..|+.++|||||||++|||+||++||.. .+....+.++...  .+.+|..+|+++++|
T Consensus       180 ~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~-~~~~~~~~~i~~~--~~~~p~~~s~~~~~l  256 (304)
T 3ubd_A          180 EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQG-KDRKETMTMILKA--KLGMPQFLSPEAQSL  256 (304)
T ss_dssp             -CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHC--CCCCCTTSCHHHHHH
T ss_pred             CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCC-cCHHHHHHHHHcC--CCCCCCcCCHHHHHH
Confidence               3456799999999999999999999999999999999999999954 4455555555543  346788899999999


Q ss_pred             HHHhcccCccccCC-----HHHHhcCccccccc
Q 015500          229 LSNCLRRDPKERWA-----ASQLLKHPFLEEFC  256 (405)
Q Consensus       229 l~~~L~~dP~~Rpt-----~~elL~hp~~~~~~  256 (405)
                      |++||++||++|||     ++|+++||||+.+.
T Consensus       257 i~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~id  289 (304)
T 3ubd_A          257 LRMLFKRNPANRLGAGPDGVEEIKRHSFFSTID  289 (304)
T ss_dssp             HHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCC
T ss_pred             HHHHcccCHHHCCCCCcCCHHHHHcCccccCCC
Confidence            99999999999998     47999999998763

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=3.2e-61  Score=472.24  Aligned_cols=245  Identities=33%  Similarity=0.492  Sum_probs=210.2

Q ss_pred             cccccccceeCCeeEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEeecC
Q 015500            3 WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAP   82 (405)
Q Consensus         3 y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~Ey~~   82 (405)
                      |++.++||+|+||+||+|+++.+|+.||||+++...  ...+|+.+|++|+|||||++++++.+..    .+|+|||||+
T Consensus        60 ~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~--~~~~E~~il~~l~HpnIV~l~~~~~~~~----~~~ivmEy~~  133 (336)
T 4g3f_A           60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV--FRVEELVACAGLSSPRIVPLYGAVREGP----WVNIFMELLE  133 (336)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT--CCTHHHHTTTTCCCTTBCCEEEEEEETT----EEEEEECCCT
T ss_pred             eEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH--hHHHHHHHHHhCCCCCCCcEEEEEEECC----EEEEEEeccC
Confidence            667889999999999999999999999999987653  2357999999999999999999876543    3679999999


Q ss_pred             CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC--ceEeeecccccccc---------
Q 015500           83 GGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG--AKIADFGCAKWESE---------  151 (405)
Q Consensus        83 ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~--vkL~DFGla~~~~~---------  151 (405)
                      ||+|.++|++.+ ++++..++.|+.||+.||+|||++||+||||||+||||+.++  +||+|||+|+....         
T Consensus       134 gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~  212 (336)
T 4g3f_A          134 GGSLGQLIKQMG-CLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLT  212 (336)
T ss_dssp             TCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----------
T ss_pred             CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceec
Confidence            999999998874 899999999999999999999999999999999999998875  99999999986432         


Q ss_pred             cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcC-CCCCCchhccHHHHHHHH
Q 015500          152 ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSR-ELPEVPAFLSKQANDFLS  230 (405)
Q Consensus       152 ~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~-~~~~~p~~~s~~l~dll~  230 (405)
                      ....+|||.|||||++.+..|+.++|||||||++|||+||++||..... ...+.++.... ..+.+|..+|+++++||.
T Consensus       213 ~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~-~~~~~~i~~~~~~~~~~~~~~s~~~~~li~  291 (336)
T 4g3f_A          213 GDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFR-GPLCLKIASEPPPIREIPPSCAPLTAQAIQ  291 (336)
T ss_dssp             -CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCC-SCCHHHHHHSCCGGGGSCTTSCHHHHHHHH
T ss_pred             CCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH-HHHHHHHHcCCCCchhcCccCCHHHHHHHH
Confidence            1234799999999999999999999999999999999999999965433 33334444332 223567889999999999


Q ss_pred             HhcccCccccCCHHHH-------------hcCcccccc
Q 015500          231 NCLRRDPKERWAASQL-------------LKHPFLEEF  255 (405)
Q Consensus       231 ~~L~~dP~~Rpt~~el-------------L~hp~~~~~  255 (405)
                      +||++||.+|||+.|+             |+|||+.++
T Consensus       292 ~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~  329 (336)
T 4g3f_A          292 EGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEY  329 (336)
T ss_dssp             HHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSC
T ss_pred             HHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCC
Confidence            9999999999999998             568888654

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=5.7e-59  Score=450.62  Aligned_cols=250  Identities=23%  Similarity=0.355  Sum_probs=202.7

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCC--------
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSED--------   69 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~--------   69 (405)
                      ||++++.||+|+||+||+|+++.+|+.||||++....    .+.+.+|+++|++|+|||||++++++...+.        
T Consensus         6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~   85 (299)
T 4g31_A            6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS   85 (299)
T ss_dssp             HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred             hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence            5899999999999999999999999999999986543    2468899999999999999999998876543        


Q ss_pred             CceEEEEEEeecCCCCHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccc
Q 015500           70 NKLMYNLFMEYAPGGTLNDEIHRNGG--RLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCA  146 (405)
Q Consensus        70 ~~~~~~lv~Ey~~ggsL~~~i~~~~~--~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla  146 (405)
                      ...++|+|||||+||+|.+++..++.  ..++..++.|+.||+.||+|||++||+||||||+|||++.++ +||+|||+|
T Consensus        86 ~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGla  165 (299)
T 4g31_A           86 PKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLV  165 (299)
T ss_dssp             -CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCCC
T ss_pred             CCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCccc
Confidence            22346799999999999999987531  245677899999999999999999999999999999999888 999999999


Q ss_pred             cccccc----------------ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHh
Q 015500          147 KWESEA----------------LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAY  210 (405)
Q Consensus       147 ~~~~~~----------------~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~  210 (405)
                      +.....                ...+|||.|||||++.+..|+.++|||||||++|||++   ||....+....+..+ .
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~~-~  241 (299)
T 4g31_A          166 TAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDV-R  241 (299)
T ss_dssp             --------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHH-H
T ss_pred             eecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHHH-h
Confidence            864331                22469999999999999999999999999999999996   785332222223333 2


Q ss_pred             cCCCCCCchhccHHHHHHHHHhcccCccccCCHHHHhcCcccccc
Q 015500          211 SRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       211 ~~~~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      ....|..+...++.+.+||++||++||.+|||+.|+|+||||+.+
T Consensus       242 ~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~  286 (299)
T 4g31_A          242 NLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDL  286 (299)
T ss_dssp             TTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC
T ss_pred             cCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCC
Confidence            344555556678889999999999999999999999999999865

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.7e-57  Score=456.55  Aligned_cols=253  Identities=28%  Similarity=0.373  Sum_probs=210.9

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCC--CceEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-----SEFLQREQKFLSSLNSPHIVGYKGCDVTSED--NKLMY   74 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~--~~~~~   74 (405)
                      +|.+++.||+|+||+||+|+++.+|+.||||++....     ...+.+|+++|+.|+|||||++++++.....  ....+
T Consensus        55 ~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~  134 (398)
T 4b99_A           55 EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSV  134 (398)
T ss_dssp             SEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCE
T ss_pred             CeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEE
Confidence            4899999999999999999999999999999987542     3467799999999999999999998754321  12235


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc--
Q 015500           75 NLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE--  151 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~--  151 (405)
                      |+|||||+ |+|.+++.++ +++++..++.|++||+.||+|||++||+||||||+|||++.++ +||+|||+|+....  
T Consensus       135 ~ivmE~~~-g~L~~~i~~~-~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~  212 (398)
T 4b99_A          135 YVVLDLME-SDLHQIIHSS-QPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSP  212 (398)
T ss_dssp             EEEEECCS-EEHHHHHTSS-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC----
T ss_pred             EEEEeCCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccCc
Confidence            69999996 6899999776 4899999999999999999999999999999999999999888 99999999986422  


Q ss_pred             ------cccCCCCCCccChhhhcCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCC--------
Q 015500          152 ------ALQSGGTPMFMAPEVARGE-HQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPE--------  216 (405)
Q Consensus       152 ------~~~~~gt~~Y~APE~l~~~-~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~--------  216 (405)
                            ..+.+||+.|||||++.+. .++.++||||+||++|||++|++||... +....+.++......|.        
T Consensus       213 ~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~-~~~~~l~~I~~~~g~p~~~~~~~~~  291 (398)
T 4b99_A          213 AEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGK-NYVHQLQLIMMVLGTPSPAVIQAVG  291 (398)
T ss_dssp             ---CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCS-SHHHHHHHHHHHHCCCCGGGTC---
T ss_pred             cccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCC-CHHHHHHHHHHhcCCCChHHhhhhh
Confidence                  2356899999999998875 5799999999999999999999999644 44455544432211111        


Q ss_pred             ---------------------CchhccHHHHHHHHHhcccCccccCCHHHHhcCcccccccc
Q 015500          217 ---------------------VPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCS  257 (405)
Q Consensus       217 ---------------------~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~~  257 (405)
                                           +...++++++|||++||++||.+|||++|+|+||||++...
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  353 (398)
T 4b99_A          292 AERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHD  353 (398)
T ss_dssp             --CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCC
T ss_pred             hhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCC
Confidence                                 01246899999999999999999999999999999997643

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=7.2e-57  Score=446.86  Aligned_cols=246  Identities=27%  Similarity=0.395  Sum_probs=206.3

Q ss_pred             CcccccccceeCCeeEEEEEEc---CCCCEEEEEEccCC-ChHHHHHHHHHHHhC-CCCCeeeeeeeeeecCCCceEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSL---RSGDVFAAKSTELP-KSEFLQREQKFLSSL-NSPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~---~~~~~vavK~~~~~-~~~~l~~E~~iL~~L-~hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      .|++++.||+|+||+||+|+++   .+++.||+|.+... ....+.+|+++|+.+ +||||+++++++...+    .+|+
T Consensus        22 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~----~~~l   97 (361)
T 4f9c_A           22 VFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKND----HVVI   97 (361)
T ss_dssp             TCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETT----EEEE
T ss_pred             cEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEECC----EEEE
Confidence            4899999999999999999986   46789999987654 456788999999999 6999999999876544    3679


Q ss_pred             EEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccC-C-ceEeeecccccccc---
Q 015500           77 FMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES-G-AKIADFGCAKWESE---  151 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~-~-vkL~DFGla~~~~~---  151 (405)
                      |||||+||+|.+++.    .+++..++.|++||+.||+|||++||+||||||+|||++.+ + +||+|||+|+....   
T Consensus        98 vmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~  173 (361)
T 4f9c_A           98 AMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKI  173 (361)
T ss_dssp             EEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSC
T ss_pred             EEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccc
Confidence            999999999999883    59999999999999999999999999999999999999876 4 99999999974321   


Q ss_pred             -----------------------------cccCCCCCCccChhhhcCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCh
Q 015500          152 -----------------------------ALQSGGTPMFMAPEVARGE-HQGFASDIWAVGCTVIEMASGGAPWPNAADP  201 (405)
Q Consensus       152 -----------------------------~~~~~gt~~Y~APE~l~~~-~~~~~sDIwSLG~il~elltG~~Pf~~~~~~  201 (405)
                                                   ..+.+|||.|||||++.+. .|+.++||||+||++|||+||+.||....+.
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~  253 (361)
T 4f9c_A          174 ELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDD  253 (361)
T ss_dssp             GGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH
T ss_pred             cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCH
Confidence                                         1234699999999999875 5899999999999999999999999777766


Q ss_pred             HHHHHHHHhcC--------------------C-------------------CC-------------CCchhccHHHHHHH
Q 015500          202 MTVLYKIAYSR--------------------E-------------------LP-------------EVPAFLSKQANDFL  229 (405)
Q Consensus       202 ~~~l~~i~~~~--------------------~-------------------~~-------------~~p~~~s~~l~dll  229 (405)
                      ...+.++....                    .                   .|             .....+|++++|||
T Consensus       254 ~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl  333 (361)
T 4f9c_A          254 LTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLL  333 (361)
T ss_dssp             HHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHH
T ss_pred             HHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHH
Confidence            66555442110                    0                   00             11234789999999


Q ss_pred             HHhcccCccccCCHHHHhcCcccccc
Q 015500          230 SNCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       230 ~~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      ++||++||++|+|++|+|+||||+++
T Consensus       334 ~~lL~~dP~~R~ta~eaL~Hp~f~~i  359 (361)
T 4f9c_A          334 DKLLDLNPASRITAEEALLHPFFKDM  359 (361)
T ss_dssp             HHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred             HHHCcCChhHCcCHHHHhcCcccCCC
Confidence            99999999999999999999999865

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.6e-57  Score=440.39  Aligned_cols=247  Identities=25%  Similarity=0.409  Sum_probs=209.5

Q ss_pred             CcccccccceeCCeeEEEEEEc-----CCCCEEEEEEccCCC---hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceE
Q 015500            2 DWTRGHTIGQGSSATVSLATSL-----RSGDVFAAKSTELPK---SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLM   73 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~-----~~~~~vavK~~~~~~---~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~   73 (405)
                      +|.+++.||+|+||+||+|++.     .++..||||.+....   .+.+.+|+++|++|+|||||++++++.....    
T Consensus        14 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~----   89 (299)
T 4asz_A           14 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP----   89 (299)
T ss_dssp             GEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS----
T ss_pred             HeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE----
Confidence            5788899999999999999875     367899999987543   3568899999999999999999998875443    


Q ss_pred             EEEEEeecCCCCHHHHHHHcC------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceE
Q 015500           74 YNLFMEYAPGGTLNDEIHRNG------------GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKI  140 (405)
Q Consensus        74 ~~lv~Ey~~ggsL~~~i~~~~------------~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL  140 (405)
                      +++|||||+||+|.++|.+++            .++++..+..|+.||+.||+|||+++|+||||||+|||++.++ +||
T Consensus        90 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           90 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEEE
Confidence            669999999999999997642            4699999999999999999999999999999999999999887 999


Q ss_pred             eeeccccccccc------ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCC
Q 015500          141 ADFGCAKWESEA------LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRE  213 (405)
Q Consensus       141 ~DFGla~~~~~~------~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~  213 (405)
                      +|||+|+.....      ....||+.|||||++.+..++.++|||||||++|||+| |+.||... +..+.+..+.. ..
T Consensus       170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~-~~~~~~~~i~~-~~  247 (299)
T 4asz_A          170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL-SNNEVIECITQ-GR  247 (299)
T ss_dssp             CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS-CHHHHHHHHHH-TC
T ss_pred             CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHHc-CC
Confidence            999999854331      12358999999999999999999999999999999999 89999654 34455555543 44


Q ss_pred             CCCCchhccHHHHHHHHHhcccCccccCCHHHHhcCccccccc
Q 015500          214 LPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFC  256 (405)
Q Consensus       214 ~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~  256 (405)
                      .+..|..+|+++.+|+.+||+.||++|||++++  |++++.+.
T Consensus       248 ~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~~~  288 (299)
T 4asz_A          248 VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQNLA  288 (299)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHHHH
T ss_pred             CCCCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHHHH
Confidence            567788999999999999999999999999999  56777653

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=9.5e-57  Score=435.95  Aligned_cols=240  Identities=24%  Similarity=0.399  Sum_probs=201.0

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      ++.+++.||+|+||+||+|+++   ..+|||++....     .+.+.+|+++|++|+|||||++++++.. +.    +++
T Consensus        37 ~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~----~~i  108 (307)
T 3omv_A           37 EVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DN----LAI  108 (307)
T ss_dssp             SCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SS----CEE
T ss_pred             HeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-Ce----EEE
Confidence            4567899999999999999864   358999986432     3568899999999999999999997532 22    469


Q ss_pred             EEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc----
Q 015500           77 FMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE----  151 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~----  151 (405)
                      |||||+||+|.+++....+++++..+..|+.||+.||+|||++|||||||||+|||++.++ +||+|||+|+....    
T Consensus       109 VmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~  188 (307)
T 3omv_A          109 VTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS  188 (307)
T ss_dssp             EEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred             EEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence            9999999999999988777899999999999999999999999999999999999999887 99999999986432    


Q ss_pred             --cccCCCCCCccChhhhcCC---CCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCC---CCCchhccH
Q 015500          152 --ALQSGGTPMFMAPEVARGE---HQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSREL---PEVPAFLSK  223 (405)
Q Consensus       152 --~~~~~gt~~Y~APE~l~~~---~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~---~~~p~~~s~  223 (405)
                        ....+||+.|||||++.+.   .|+.++|||||||++|||+||+.||............+......   +..+..+|+
T Consensus       189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~  268 (307)
T 3omv_A          189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPK  268 (307)
T ss_dssp             -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCH
T ss_pred             eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchH
Confidence              2345799999999999753   58889999999999999999999997766555544444433333   345677999


Q ss_pred             HHHHHHHHhcccCccccCCHHHHhcC
Q 015500          224 QANDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       224 ~l~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      ++.+|+.+||+.||++|||+.|++++
T Consensus       269 ~l~~li~~cl~~dP~~RPs~~ei~~~  294 (307)
T 3omv_A          269 AMKRLVADCVKKVKEERPLFPQILSS  294 (307)
T ss_dssp             HHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred             HHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            99999999999999999999988665

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.7e-56  Score=470.91  Aligned_cols=250  Identities=26%  Similarity=0.405  Sum_probs=212.8

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC------ChHHHHHH---HHHHHhCCCCCeeeeeeeeeecCCCce
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQRE---QKFLSSLNSPHIVGYKGCDVTSEDNKL   72 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~------~~~~l~~E---~~iL~~L~hpnIv~~~~~~~~~~~~~~   72 (405)
                      +|.+++.||+|+||+||+|+++.+|+.||||++.+.      ....+.+|   +.+++.++|||||++++++.+..    
T Consensus       190 df~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~----  265 (689)
T 3v5w_A          190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD----  265 (689)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS----
T ss_pred             HeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECC----
Confidence            689999999999999999999999999999998642      23344444   56677789999999999887654    


Q ss_pred             EEEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc
Q 015500           73 MYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE  151 (405)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~  151 (405)
                      .+|+|||||+||+|.++|.+. ++++|..++.|++||+.||+|||++|||||||||+||||+.+| +||+|||+|+....
T Consensus       266 ~lylVmEy~~GGdL~~~l~~~-~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~  344 (689)
T 3v5w_A          266 KLSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK  344 (689)
T ss_dssp             EEEEEECCCCSCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             EEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence            367999999999999999887 4899999999999999999999999999999999999999988 99999999986544


Q ss_pred             --cccCCCCCCccChhhhc-CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-hHHHHHHHHhcCCCCCCchhccHHHHH
Q 015500          152 --ALQSGGTPMFMAPEVAR-GEHQGFASDIWAVGCTVIEMASGGAPWPNAAD-PMTVLYKIAYSRELPEVPAFLSKQAND  227 (405)
Q Consensus       152 --~~~~~gt~~Y~APE~l~-~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~-~~~~l~~i~~~~~~~~~p~~~s~~l~d  227 (405)
                        ..+.+|||.|||||++. +..|+.++|||||||++|||++|++||..... ....+.+.... ..+.+|..+|+++++
T Consensus       345 ~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~-~~~~~p~~~S~~a~d  423 (689)
T 3v5w_A          345 KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT-MAVELPDSFSPELRS  423 (689)
T ss_dssp             CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHH-CCCCCCTTSCHHHHH
T ss_pred             CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcC-CCCCCCccCCHHHHH
Confidence              45678999999999996 46799999999999999999999999964322 12223332222 234678889999999


Q ss_pred             HHHHhcccCccccCC-----HHHHhcCcccccccc
Q 015500          228 FLSNCLRRDPKERWA-----ASQLLKHPFLEEFCS  257 (405)
Q Consensus       228 ll~~~L~~dP~~Rpt-----~~elL~hp~~~~~~~  257 (405)
                      ||.+||++||.+|++     ++|+++||||+.+..
T Consensus       424 LI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW  458 (689)
T 3v5w_A          424 LLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDW  458 (689)
T ss_dssp             HHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCH
T ss_pred             HHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCH
Confidence            999999999999998     799999999998643

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=3.7e-56  Score=436.26  Aligned_cols=242  Identities=24%  Similarity=0.356  Sum_probs=202.7

Q ss_pred             CcccccccceeCCeeEEEEEEc-----CCCCEEEEEEccCCC---hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceE
Q 015500            2 DWTRGHTIGQGSSATVSLATSL-----RSGDVFAAKSTELPK---SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLM   73 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~-----~~~~~vavK~~~~~~---~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~   73 (405)
                      ++.+.+.||+|+||+||+|+++     .+++.||||.+....   .+.+.+|+++|++|+|||||++++++.....    
T Consensus        42 d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~----  117 (329)
T 4aoj_A           42 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRP----  117 (329)
T ss_dssp             GEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS----
T ss_pred             HeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE----
Confidence            4567789999999999999865     368899999987654   3568899999999999999999998765443    


Q ss_pred             EEEEEeecCCCCHHHHHHHc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-c
Q 015500           74 YNLFMEYAPGGTLNDEIHRN--------------GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-A  138 (405)
Q Consensus        74 ~~lv~Ey~~ggsL~~~i~~~--------------~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-v  138 (405)
                      +++|||||++|+|.++++++              .+++++..+..|+.||+.||+|||+++|+||||||+||||+.++ +
T Consensus       118 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEE
T ss_pred             EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCcE
Confidence            66999999999999999753              24699999999999999999999999999999999999999988 9


Q ss_pred             eEeeecccccccc------cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhc
Q 015500          139 KIADFGCAKWESE------ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYS  211 (405)
Q Consensus       139 kL~DFGla~~~~~------~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~  211 (405)
                      ||+|||+|+....      .....||+.|||||++.+..++.++|||||||++|||+| |+.||.... ....+..+.. 
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~-~~~~~~~i~~-  275 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS-NTEAIDCITQ-  275 (329)
T ss_dssp             EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSC-HHHHHHHHHH-
T ss_pred             EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCC-HHHHHHHHHc-
Confidence            9999999986432      224569999999999999999999999999999999999 899996553 4445555544 


Q ss_pred             CCCCCCchhccHHHHHHHHHhcccCccccCCHHHHhcC
Q 015500          212 RELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       212 ~~~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      ...+..|..+++++.+|+.+||+.||++|||++|++++
T Consensus       276 g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          276 GRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             CCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            34567788899999999999999999999999999775

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=9.8e-56  Score=429.49  Aligned_cols=241  Identities=22%  Similarity=0.281  Sum_probs=205.9

Q ss_pred             cccccccceeCCeeEEEEEEc-----CCCCEEEEEEccCC----ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceE
Q 015500            3 WTRGHTIGQGSSATVSLATSL-----RSGDVFAAKSTELP----KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLM   73 (405)
Q Consensus         3 y~~~~~LG~G~~g~Vyla~~~-----~~~~~vavK~~~~~----~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~   73 (405)
                      ++..+.||+|+||+||+|...     .+++.||||.+...    ..+.+.+|+.+|++|+|||||+++|++.....    
T Consensus        28 ~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~----  103 (308)
T 4gt4_A           28 VRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQP----  103 (308)
T ss_dssp             EEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS----
T ss_pred             CeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCE----
Confidence            566789999999999999863     46789999998643    24679999999999999999999998765443    


Q ss_pred             EEEEEeecCCCCHHHHHHHc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-
Q 015500           74 YNLFMEYAPGGTLNDEIHRN---------------GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-  137 (405)
Q Consensus        74 ~~lv~Ey~~ggsL~~~i~~~---------------~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-  137 (405)
                      +++|||||++|+|.++|..+               .+.+++..+..|+.||+.||+|||+++||||||||+||||+.++ 
T Consensus       104 ~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~  183 (308)
T 4gt4_A          104 LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLN  183 (308)
T ss_dssp             CEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC
T ss_pred             EEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCC
Confidence            56999999999999999653               23689999999999999999999999999999999999999887 


Q ss_pred             ceEeeecccccccc------cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHh
Q 015500          138 AKIADFGCAKWESE------ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAY  210 (405)
Q Consensus       138 vkL~DFGla~~~~~------~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~  210 (405)
                      +||+|||+|+....      .....||+.|||||++.+..++.++|||||||++|||+| |+.||.... .......+. 
T Consensus       184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~-~~~~~~~i~-  261 (308)
T 4gt4_A          184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS-NQDVVEMIR-  261 (308)
T ss_dssp             EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC-HHHHHHHHH-
T ss_pred             EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC-HHHHHHHHH-
Confidence            99999999986433      223569999999999999999999999999999999998 899996543 444444444 


Q ss_pred             cCCCCCCchhccHHHHHHHHHhcccCccccCCHHHHhcC
Q 015500          211 SRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       211 ~~~~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      ....+..|..+|+++.+|+.+||+.||++|||+.||+++
T Consensus       262 ~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          262 NRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            445566788899999999999999999999999999875

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=9.1e-56  Score=463.64  Aligned_cols=250  Identities=28%  Similarity=0.438  Sum_probs=218.5

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC---hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK---SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFM   78 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~---~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (405)
                      +|.+++.||+|+||+||+|+++.+|+.||+|.+....   .+.+.+|+++|+.|+|||||++++++....    .+|+||
T Consensus       158 ~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~----~~~iv~  233 (573)
T 3uto_A          158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN----EMVMIY  233 (573)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSS----EEEEEE
T ss_pred             ccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECC----EEEEEE
Confidence            5899999999999999999999999999999987654   357889999999999999999999876543    367999


Q ss_pred             eecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccC--C-ceEeeecccccccc---c
Q 015500           79 EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES--G-AKIADFGCAKWESE---A  152 (405)
Q Consensus        79 Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~--~-vkL~DFGla~~~~~---~  152 (405)
                      |||+||+|.++|....+++++..++.|++||+.||+|||++||+||||||+|||++.+  + +||+|||+|+....   .
T Consensus       234 E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~  313 (573)
T 3uto_A          234 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV  313 (573)
T ss_dssp             ECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEE
T ss_pred             eecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCce
Confidence            9999999999997766789999999999999999999999999999999999999864  4 99999999987544   3


Q ss_pred             ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCC--CCCchhccHHHHHHHH
Q 015500          153 LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSREL--PEVPAFLSKQANDFLS  230 (405)
Q Consensus       153 ~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~--~~~p~~~s~~l~dll~  230 (405)
                      ...+||+.|||||++.+..|+.++|||||||++|||++|++||... +....+.++......  +..+..+|+++++||+
T Consensus       314 ~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~  392 (573)
T 3uto_A          314 KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE-NDDETLRNVKSCDWNMDDSAFSGISEDGKDFIR  392 (573)
T ss_dssp             EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS-SHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHHH
T ss_pred             eeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc-CHHHHHHHHHhCCCCCCcccccCCCHHHHHHHH
Confidence            4568999999999999999999999999999999999999999643 455556665544321  2233568999999999


Q ss_pred             HhcccCccccCCHHHHhcCccccccc
Q 015500          231 NCLRRDPKERWAASQLLKHPFLEEFC  256 (405)
Q Consensus       231 ~~L~~dP~~Rpt~~elL~hp~~~~~~  256 (405)
                      +||++||.+|||+.|+|+||||+...
T Consensus       393 ~~L~~dp~~R~t~~e~l~Hpw~~~~~  418 (573)
T 3uto_A          393 KLLLADPNTRMTIHQALEHPWLTPGN  418 (573)
T ss_dssp             TTSCSSGGGSCCHHHHHHSTTTSCCC
T ss_pred             HHccCChhHCcCHHHHhcCcCcCCCC
Confidence            99999999999999999999998653

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=7.9e-55  Score=430.58  Aligned_cols=244  Identities=23%  Similarity=0.356  Sum_probs=207.9

Q ss_pred             CcccccccceeCCeeEEEEEEcCCC-----CEEEEEEccCCC----hHHHHHHHHHHHhCCC-CCeeeeeeeeeecCCCc
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSG-----DVFAAKSTELPK----SEFLQREQKFLSSLNS-PHIVGYKGCDVTSEDNK   71 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~-----~~vavK~~~~~~----~~~l~~E~~iL~~L~h-pnIv~~~~~~~~~~~~~   71 (405)
                      +|++++.||+|+||+||+|.+..++     +.||||.+....    .+.+.+|+++|++++| ||||++++++.....  
T Consensus        65 ~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~--  142 (353)
T 4ase_A           65 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG--  142 (353)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS--
T ss_pred             HeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCC--
Confidence            4778999999999999999987543     689999987543    3468899999999966 999999998754332  


Q ss_pred             eEEEEEEeecCCCCHHHHHHHc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccC
Q 015500           72 LMYNLFMEYAPGGTLNDEIHRN---------------GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES  136 (405)
Q Consensus        72 ~~~~lv~Ey~~ggsL~~~i~~~---------------~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~  136 (405)
                       .+++|||||++|+|.++|+..               ...+++..+..|+.||+.||+|||+++||||||||+|||++.+
T Consensus       143 -~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~  221 (353)
T 4ase_A          143 -PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK  221 (353)
T ss_dssp             -CCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred             -EEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCC
Confidence             245999999999999999763               2358999999999999999999999999999999999999988


Q ss_pred             C-ceEeeecccccccc------cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHH
Q 015500          137 G-AKIADFGCAKWESE------ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKI  208 (405)
Q Consensus       137 ~-vkL~DFGla~~~~~------~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i  208 (405)
                      + +||+|||+|+....      ....+||+.|||||++.+..|+.++|||||||++|||+| |+.||......... .+.
T Consensus       222 ~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~-~~~  300 (353)
T 4ase_A          222 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF-CRR  300 (353)
T ss_dssp             GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH-HHH
T ss_pred             CCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHH-HHH
Confidence            7 99999999986432      223458999999999999999999999999999999998 99999766544443 344


Q ss_pred             HhcCCCCCCchhccHHHHHHHHHhcccCccccCCHHHHhcC
Q 015500          209 AYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       209 ~~~~~~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      ......+..|..+++++.+|+.+||+.||++|||++||++|
T Consensus       301 i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          301 LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            44455667888899999999999999999999999999998

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=6.5e-53  Score=408.93  Aligned_cols=244  Identities=23%  Similarity=0.281  Sum_probs=196.4

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCChHHHHH--HHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEe
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQR--EQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFME   79 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~~~~l~~--E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (405)
                      +|.+.+.||+|+||+||+|++  +|+.||||++.........+  |+..+.+|+|||||++++++.........++||||
T Consensus         4 ~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E   81 (303)
T 3hmm_A            4 TIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD   81 (303)
T ss_dssp             GEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence            477889999999999999987  58999999997665554444  55556788999999999998876655556779999


Q ss_pred             ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC--------CceeCCCCCCCEEEccCC-ceEeeeccccccc
Q 015500           80 YAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN--------RVVHCDIKSRNILMAESG-AKIADFGCAKWES  150 (405)
Q Consensus        80 y~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~--------givHrDlkp~NILi~~~~-vkL~DFGla~~~~  150 (405)
                      ||+||+|.+++++.  ++++..+..++.|++.||+|||++        ||+||||||+||||+.++ +||+|||+|+...
T Consensus        82 y~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~  159 (303)
T 3hmm_A           82 YHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD  159 (303)
T ss_dssp             CCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred             CCCCCcHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcccc
Confidence            99999999999875  699999999999999999999987        999999999999999988 9999999998644


Q ss_pred             cc--------ccCCCCCCccChhhhcCC------CCCcchhHHHHHHHHHHHHhCCCCCCCCC-------------ChHH
Q 015500          151 EA--------LQSGGTPMFMAPEVARGE------HQGFASDIWAVGCTVIEMASGGAPWPNAA-------------DPMT  203 (405)
Q Consensus       151 ~~--------~~~~gt~~Y~APE~l~~~------~~~~~sDIwSLG~il~elltG~~Pf~~~~-------------~~~~  203 (405)
                      ..        ...+||+.|||||++.+.      .++.++|||||||++|||+||++||....             ....
T Consensus       160 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~  239 (303)
T 3hmm_A          160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE  239 (303)
T ss_dssp             TTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHH
T ss_pred             CCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHH
Confidence            31        134699999999999865      35679999999999999999987764211             1122


Q ss_pred             HHHHH-HhcCCCCCCchh-----ccHHHHHHHHHhcccCccccCCHHHHhcC
Q 015500          204 VLYKI-AYSRELPEVPAF-----LSKQANDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       204 ~l~~i-~~~~~~~~~p~~-----~s~~l~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      .+.+. ......|.+|..     .++.+.+|+.+||+.||++|||+.|+++.
T Consensus       240 ~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  291 (303)
T 3hmm_A          240 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             HHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            33333 233334555543     34678999999999999999999999875

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=9e-52  Score=398.35  Aligned_cols=247  Identities=38%  Similarity=0.595  Sum_probs=215.5

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccC---CChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL---PKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFM   78 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~---~~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (405)
                      +|++++.||+|+||+||+|.+..+++.||||.+..   ...+.+.+|+.+++.++||||+++++++.....    +++||
T Consensus        21 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~----~~lv~   96 (297)
T 3fxz_A           21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDE----LWVVM   96 (297)
T ss_dssp             TBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE----EEEEE
T ss_pred             ceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCE----EEEEE
Confidence            58999999999999999999999999999998753   345678999999999999999999998775442    67999


Q ss_pred             eecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc----cc
Q 015500           79 EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE----AL  153 (405)
Q Consensus        79 Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~----~~  153 (405)
                      ||++||+|.+++.+.  .+++..++.++.||+.||.|||++||+||||||+|||++.++ +||+|||++.....    ..
T Consensus        97 e~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  174 (297)
T 3fxz_A           97 EYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS  174 (297)
T ss_dssp             ECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBC
T ss_pred             ECCCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccC
Confidence            999999999999875  699999999999999999999999999999999999999887 99999999876443    23


Q ss_pred             cCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHH-hcCCCCCCchhccHHHHHHHHHh
Q 015500          154 QSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA-YSRELPEVPAFLSKQANDFLSNC  232 (405)
Q Consensus       154 ~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~-~~~~~~~~p~~~s~~l~dll~~~  232 (405)
                      ...||+.|+|||++.+..+++++|||||||++|+|++|+.||.... .......+. ........|..+++.+.+||.+|
T Consensus       175 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  253 (297)
T 3fxz_A          175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN-PLRALYLIATNGTPELQNPEKLSAIFRDFLNRC  253 (297)
T ss_dssp             CCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-HHHHHHHHHHHCSCCCSCGGGSCHHHHHHHHHH
T ss_pred             CccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhCCCCCCCCccccCHHHHHHHHHH
Confidence            4569999999999999999999999999999999999999996544 333333333 23333455778999999999999


Q ss_pred             cccCccccCCHHHHhcCcccccc
Q 015500          233 LRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       233 L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      |+.||.+|||++|+|+||||+..
T Consensus       254 l~~dp~~Rps~~ell~h~~~~~~  276 (297)
T 3fxz_A          254 LEMDVEKRGSAKELLQHQFLKIA  276 (297)
T ss_dssp             SCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             ccCChhHCcCHHHHhhChhhccc
Confidence            99999999999999999999854

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1e-51  Score=404.42  Aligned_cols=247  Identities=28%  Similarity=0.438  Sum_probs=214.6

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      +|++++.||+|+||+||+|.+..+|+.||||++....     .+.+.+|+++|+.++||||+++++++....    .+++
T Consensus        16 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~----~~~l   91 (328)
T 3fe3_A           16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEK----TLYL   91 (328)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS----EEEE
T ss_pred             CEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC----EEEE
Confidence            6899999999999999999999999999999986432     346789999999999999999999875433    3679


Q ss_pred             EEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc---c
Q 015500           77 FMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE---A  152 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~---~  152 (405)
                      ||||++||+|.+++... +++++..++.++.||+.||+|||++||+||||||+|||++.++ +||+|||+++....   .
T Consensus        92 v~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~  170 (328)
T 3fe3_A           92 IMEYASGGEVFDYLVAH-GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL  170 (328)
T ss_dssp             EECCCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCGG
T ss_pred             EEECCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCcc
Confidence            99999999999999877 4899999999999999999999999999999999999999887 99999999975433   3


Q ss_pred             ccCCCCCCccChhhhcCCCCC-cchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHH
Q 015500          153 LQSGGTPMFMAPEVARGEHQG-FASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSN  231 (405)
Q Consensus       153 ~~~~gt~~Y~APE~l~~~~~~-~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~  231 (405)
                      ...+||+.|+|||++.+..+. +++|||||||++|+|++|+.||... +......++...  ...+|..+++++.+||++
T Consensus       171 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~-~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~  247 (328)
T 3fe3_A          171 DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ-NLKELRERVLRG--KYRIPFYMSTDCENLLKR  247 (328)
T ss_dssp             GTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHC--CCCCCTTSCHHHHHHHHH
T ss_pred             ccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCC-CHHHHHHHHHhC--CCCCCCCCCHHHHHHHHH
Confidence            456799999999999987764 7999999999999999999999644 344444444333  335677899999999999


Q ss_pred             hcccCccccCCHHHHhcCccccccc
Q 015500          232 CLRRDPKERWAASQLLKHPFLEEFC  256 (405)
Q Consensus       232 ~L~~dP~~Rpt~~elL~hp~~~~~~  256 (405)
                      ||..||.+|||++|+++||||+...
T Consensus       248 ~L~~dP~~R~t~~eil~h~~~~~~~  272 (328)
T 3fe3_A          248 FLVLNPIKRGTLEQIMKDRWINAGH  272 (328)
T ss_dssp             HCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred             HCCCChhHCcCHHHHhcCHhhcCCC
Confidence            9999999999999999999998653

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=4.1e-51  Score=401.82  Aligned_cols=247  Identities=30%  Similarity=0.448  Sum_probs=216.1

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccC------CChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL------PKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~------~~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~   75 (405)
                      +|++++.||+|+||+||+|+++.+|+.||+|.+..      .....+.+|+++|+.++||||+++++++....    .++
T Consensus         6 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~----~~~   81 (337)
T 1o6l_A            6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD----RLC   81 (337)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSS----EEE
T ss_pred             HeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCC----EEE
Confidence            58999999999999999999999999999998753      34567889999999999999999998876543    367


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc---
Q 015500           76 LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE---  151 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~---  151 (405)
                      +||||++||+|.+++.+. +.+++..++.++.||+.||+|||++||+||||||+|||++.++ +||+|||+++....   
T Consensus        82 lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~  160 (337)
T 1o6l_A           82 FVMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA  160 (337)
T ss_dssp             EEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred             EEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCC
Confidence            999999999999999876 4899999999999999999999999999999999999999888 99999999975322   


Q ss_pred             -cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHH
Q 015500          152 -ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLS  230 (405)
Q Consensus       152 -~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~  230 (405)
                       ....+||+.|+|||++.+..++.++|||||||++|||++|+.||... +.......+...  ...+|..+++++++||+
T Consensus       161 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~-~~~~~~~~i~~~--~~~~p~~~s~~~~~li~  237 (337)
T 1o6l_A          161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-DHERLFELILME--EIRFPRTLSPEAKSLLA  237 (337)
T ss_dssp             CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHC--CCCCCTTSCHHHHHHHH
T ss_pred             cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCC-CHHHHHHHHHcC--CCCCCCCCCHHHHHHHH
Confidence             33556999999999999999999999999999999999999999643 344444444332  34567789999999999


Q ss_pred             HhcccCccccC-----CHHHHhcCccccccc
Q 015500          231 NCLRRDPKERW-----AASQLLKHPFLEEFC  256 (405)
Q Consensus       231 ~~L~~dP~~Rp-----t~~elL~hp~~~~~~  256 (405)
                      +||+.||.+||     +++++++||||..+.
T Consensus       238 ~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~  268 (337)
T 1o6l_A          238 GLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN  268 (337)
T ss_dssp             HHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred             HHhhcCHHHhcCCCCCCHHHHHcCCCcCCCC
Confidence            99999999999     999999999998764

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.9e-51  Score=406.66  Aligned_cols=248  Identities=29%  Similarity=0.468  Sum_probs=214.2

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC------ChHHHHHHHHHHHhC-CCCCeeeeeeeeeecCCCceEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSL-NSPHIVGYKGCDVTSEDNKLMY   74 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~------~~~~l~~E~~iL~~L-~hpnIv~~~~~~~~~~~~~~~~   74 (405)
                      +|++.+.||+|+||+||+|+++.+|+.||||++...      ..+.+.+|..+|+.+ +||||+++++++....    .+
T Consensus        24 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~----~~   99 (353)
T 3txo_A           24 NFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPD----RL   99 (353)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS----EE
T ss_pred             heEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCC----EE
Confidence            589999999999999999999999999999998642      345688999999998 7999999999876543    36


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc--
Q 015500           75 NLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE--  151 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~--  151 (405)
                      ++||||++||+|.+++.+. +.+++..++.++.||+.||+|||++||+||||||+|||++.++ +||+|||+++....  
T Consensus       100 ~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~  178 (353)
T 3txo_A          100 FFVMEFVNGGDLMFHIQKS-RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG  178 (353)
T ss_dssp             EEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred             EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccCC
Confidence            7999999999999999876 4899999999999999999999999999999999999999888 99999999985322  


Q ss_pred             --cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHH
Q 015500          152 --ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFL  229 (405)
Q Consensus       152 --~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll  229 (405)
                        ....+||+.|+|||++.+..++.++|||||||++|||++|+.||... +......++...  ...+|..+++++.+||
T Consensus       179 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~-~~~~~~~~i~~~--~~~~p~~~~~~~~~li  255 (353)
T 3txo_A          179 VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAE-NEDDLFEAILND--EVVYPTWLHEDATGIL  255 (353)
T ss_dssp             -------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHC--CCCCCTTSCHHHHHHH
T ss_pred             ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCC-CHHHHHHHHHcC--CCCCCCCCCHHHHHHH
Confidence              34567999999999999989999999999999999999999999643 445555555433  3356778999999999


Q ss_pred             HHhcccCccccCCH------HHHhcCcccccccc
Q 015500          230 SNCLRRDPKERWAA------SQLLKHPFLEEFCS  257 (405)
Q Consensus       230 ~~~L~~dP~~Rpt~------~elL~hp~~~~~~~  257 (405)
                      ++||++||.+||++      +++++||||+.+..
T Consensus       256 ~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w  289 (353)
T 3txo_A          256 KSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDW  289 (353)
T ss_dssp             HHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCH
T ss_pred             HHHhhhCHHHccCCcccCCHHHHhhCCcccCCCH
Confidence            99999999999998      89999999997643

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=8.6e-51  Score=389.24  Aligned_cols=250  Identities=28%  Similarity=0.436  Sum_probs=211.3

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      +|++++.||+|+||+||+|.++.+++.||||.+....     ...+.+|+.+|++++||||+++++++....    .+++
T Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~l   78 (292)
T 3o0g_A            3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDK----KLTL   78 (292)
T ss_dssp             SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT----EEEE
T ss_pred             CceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCC----EEEE
Confidence            6999999999999999999999999999999886432     257889999999999999999999876543    3679


Q ss_pred             EEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc----
Q 015500           77 FMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE----  151 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~----  151 (405)
                      ||||+++ +|.+.+....+.+++..++.++.||+.||+|||++||+||||||+|||++.++ +||+|||+++....    
T Consensus        79 v~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  157 (292)
T 3o0g_A           79 VFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC  157 (292)
T ss_dssp             EEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSC
T ss_pred             EEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcccc
Confidence            9999976 77777777667899999999999999999999999999999999999999887 99999999976542    


Q ss_pred             cccCCCCCCccChhhhcCCC-CCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCC----------------
Q 015500          152 ALQSGGTPMFMAPEVARGEH-QGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSREL----------------  214 (405)
Q Consensus       152 ~~~~~gt~~Y~APE~l~~~~-~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~----------------  214 (405)
                      .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||....+....+..+......                
T Consensus       158 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  237 (292)
T 3o0g_A          158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK  237 (292)
T ss_dssp             CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred             ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccccc
Confidence            23456899999999998765 7999999999999999999999876666665555554321111                


Q ss_pred             -----------CCCchhccHHHHHHHHHhcccCccccCCHHHHhcCccccccc
Q 015500          215 -----------PEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFC  256 (405)
Q Consensus       215 -----------~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~  256 (405)
                                 ......+++++++||++||+.||.+|||++|+|+||||++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  290 (292)
T 3o0g_A          238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred             ccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence                       112234789999999999999999999999999999998764

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=7.2e-51  Score=396.76  Aligned_cols=247  Identities=29%  Similarity=0.495  Sum_probs=217.8

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccC------CChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL------PKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~------~~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~   75 (405)
                      +|++++.||+|+||+||+|+++.+|+.||+|++..      ...+.+.+|+.+|+.++||||+++++++....    .++
T Consensus         7 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~----~~~   82 (318)
T 1fot_A            7 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ----QIF   82 (318)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSS----EEE
T ss_pred             HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCC----EEE
Confidence            58999999999999999999999999999998753      34567889999999999999999999876433    367


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc-cc
Q 015500           76 LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE-AL  153 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~-~~  153 (405)
                      +||||++||+|.+++.+. +.+++..++.++.||+.||+|||++||+||||||+|||++.++ +||+|||+++.... ..
T Consensus        83 lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~~~  161 (318)
T 1fot_A           83 MIMDYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY  161 (318)
T ss_dssp             EEECCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCBC
T ss_pred             EEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCccc
Confidence            999999999999999876 4899999999999999999999999999999999999999887 99999999986544 34


Q ss_pred             cCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHhc
Q 015500          154 QSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCL  233 (405)
Q Consensus       154 ~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~L  233 (405)
                      ..+||+.|+|||++.+..++.++|||||||++|||++|+.||... +......++...  ...+|..+++++++||++||
T Consensus       162 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~-~~~~~~~~i~~~--~~~~p~~~~~~~~~li~~lL  238 (318)
T 1fot_A          162 TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS-NTMKTYEKILNA--ELRFPPFFNEDVKDLLSRLI  238 (318)
T ss_dssp             CCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS-SHHHHHHHHHHC--CCCCCTTSCHHHHHHHHHHT
T ss_pred             cccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC-CHHHHHHHHHhC--CCCCCCCCCHHHHHHHHHHh
Confidence            567999999999999999999999999999999999999999643 444444444433  24567789999999999999


Q ss_pred             ccCccccC-----CHHHHhcCccccccc
Q 015500          234 RRDPKERW-----AASQLLKHPFLEEFC  256 (405)
Q Consensus       234 ~~dP~~Rp-----t~~elL~hp~~~~~~  256 (405)
                      +.||.+||     +++++++||||+.+.
T Consensus       239 ~~dp~~R~~~~~~~~~~i~~hp~f~~~~  266 (318)
T 1fot_A          239 TRDLSQRLGNLQNGTEDVKNHPWFKEVV  266 (318)
T ss_dssp             CSCTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred             ccCHHHcCCCcCCCHHHHhcCccccCCC
Confidence            99999999     999999999998764

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=5e-51  Score=404.90  Aligned_cols=248  Identities=27%  Similarity=0.446  Sum_probs=212.9

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC---------hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCce
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK---------SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKL   72 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~---------~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~   72 (405)
                      .|.+++.||+|+||+||+|.++.+|+.||+|.+....         .+.+.+|+.+|+.++||||+++++++....    
T Consensus        13 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~----   88 (361)
T 2yab_A           13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRT----   88 (361)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS----
T ss_pred             ceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCC----
Confidence            4899999999999999999999999999999886432         357899999999999999999999875433    


Q ss_pred             EEEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-----ceEeeecccc
Q 015500           73 MYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-----AKIADFGCAK  147 (405)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-----vkL~DFGla~  147 (405)
                      .+++||||++||+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++     +||+|||+++
T Consensus        89 ~~~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~  167 (361)
T 2yab_A           89 DVVLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH  167 (361)
T ss_dssp             EEEEEEECCCSCBHHHHHTTC-SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCE
T ss_pred             EEEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCce
Confidence            367999999999999999775 4899999999999999999999999999999999999997654     8999999998


Q ss_pred             cccc---cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCC-C-CCchhcc
Q 015500          148 WESE---ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSREL-P-EVPAFLS  222 (405)
Q Consensus       148 ~~~~---~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~-~-~~p~~~s  222 (405)
                      ....   .....||+.|+|||++.+..++.++|||||||++|+|++|..||... +....+..+...... + ..+..++
T Consensus       168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s  246 (361)
T 2yab_A          168 EIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD-TKQETLANITAVSYDFDEEFFSQTS  246 (361)
T ss_dssp             ECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS-SHHHHHHHHHTTCCCCCHHHHTTSC
T ss_pred             EcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhcCCCCCchhccCCC
Confidence            6544   23457999999999999999999999999999999999999999643 444444444433211 1 1224579


Q ss_pred             HHHHHHHHHhcccCccccCCHHHHhcCcccccc
Q 015500          223 KQANDFLSNCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       223 ~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      +.+++||.+||..||.+|||+.|+|+||||...
T Consensus       247 ~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  279 (361)
T 2yab_A          247 ELAKDFIRKLLVKETRKRLTIQEALRHPWITPV  279 (361)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred             HHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence            999999999999999999999999999999864

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=9.2e-51  Score=400.60  Aligned_cols=247  Identities=31%  Similarity=0.472  Sum_probs=216.7

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccC------CChHHHHHHHHHHHhC-CCCCeeeeeeeeeecCCCceEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL------PKSEFLQREQKFLSSL-NSPHIVGYKGCDVTSEDNKLMY   74 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~------~~~~~l~~E~~iL~~L-~hpnIv~~~~~~~~~~~~~~~~   74 (405)
                      +|.+++.||+|+||+||+|+++.+|+.||+|.+..      ...+.+.+|..+|+.+ +||||+++++++....    .+
T Consensus        18 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~----~~   93 (345)
T 1xjd_A           18 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE----NL   93 (345)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS----EE
T ss_pred             HeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC----EE
Confidence            68999999999999999999999999999998864      3456788899999887 9999999998876543    36


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccc---
Q 015500           75 NLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWES---  150 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~---  150 (405)
                      ++||||++||+|.+++.+.+ .+++..++.++.||+.||+|||++||+||||||+|||++.++ +||+|||+++...   
T Consensus        94 ~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  172 (345)
T 1xjd_A           94 FFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD  172 (345)
T ss_dssp             EEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCC
Confidence            79999999999999998764 899999999999999999999999999999999999999888 9999999997532   


Q ss_pred             -ccccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHH
Q 015500          151 -EALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFL  229 (405)
Q Consensus       151 -~~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll  229 (405)
                       .....+||+.|+|||++.+..++.++|+|||||++|||++|+.||... +......++...  .+.+|..+++++++||
T Consensus       173 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~-~~~~~~~~i~~~--~~~~p~~~s~~~~~li  249 (345)
T 1xjd_A          173 AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ-DEEELFHSIRMD--NPFYPRWLEKEAKDLL  249 (345)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHC--CCCCCTTSCHHHHHHH
T ss_pred             CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHHhC--CCCCCcccCHHHHHHH
Confidence             234567999999999999999999999999999999999999999643 444555555443  3467788999999999


Q ss_pred             HHhcccCccccCCHH-HHhcCccccccc
Q 015500          230 SNCLRRDPKERWAAS-QLLKHPFLEEFC  256 (405)
Q Consensus       230 ~~~L~~dP~~Rpt~~-elL~hp~~~~~~  256 (405)
                      .+||+.||.+||++. ++++||||+.+.
T Consensus       250 ~~lL~~dp~~R~~~~~~i~~hp~f~~~~  277 (345)
T 1xjd_A          250 VKLFVREPEKRLGVRGDIRQHPLFREIN  277 (345)
T ss_dssp             HHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred             HHHhcCCHhHcCCChHHHHcCccccCCC
Confidence            999999999999998 999999998764

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9e-51  Score=396.16  Aligned_cols=249  Identities=25%  Similarity=0.369  Sum_probs=214.1

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC--hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEe
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK--SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFME   79 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~--~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (405)
                      +|++++.||+|+||+||+|.++.+++.+|+|.+....  ...+.+|+.+|+.++||||+++++++....    .+++|||
T Consensus         6 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~----~~~lv~e   81 (321)
T 1tki_A            6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESME----ELVMIFE   81 (321)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETT----EEEEEEC
T ss_pred             ceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCC----EEEEEEE
Confidence            5899999999999999999999999999999987654  346889999999999999999999876543    3679999


Q ss_pred             ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcc--CC-ceEeeecccccccc---cc
Q 015500           80 YAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAE--SG-AKIADFGCAKWESE---AL  153 (405)
Q Consensus        80 y~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~--~~-vkL~DFGla~~~~~---~~  153 (405)
                      |++||+|.+++...+..+++..+..++.||+.||.|||++||+||||||+|||++.  ++ +||+|||+++....   ..
T Consensus        82 ~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~  161 (321)
T 1tki_A           82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFR  161 (321)
T ss_dssp             CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEE
T ss_pred             eCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCccc
Confidence            99999999999877668999999999999999999999999999999999999986  44 99999999986533   23


Q ss_pred             cCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCC--CchhccHHHHHHHHH
Q 015500          154 QSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPE--VPAFLSKQANDFLSN  231 (405)
Q Consensus       154 ~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~--~p~~~s~~l~dll~~  231 (405)
                      ...||+.|+|||++.+..+++++|||||||++|+|++|..||... .....+..+........  ....+++++.+||.+
T Consensus       162 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~  240 (321)
T 1tki_A          162 LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE-TNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDR  240 (321)
T ss_dssp             EEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS-SHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHT
T ss_pred             cccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCC-CHHHHHHHHHcCCCCCChhhhccCCHHHHHHHHH
Confidence            456999999999999988999999999999999999999999644 34444444443322111  123579999999999


Q ss_pred             hcccCccccCCHHHHhcCcccccc
Q 015500          232 CLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       232 ~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      ||..||.+|||+.|+|+||||++.
T Consensus       241 ~L~~dp~~Rpt~~e~l~hp~~~~~  264 (321)
T 1tki_A          241 LLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             TSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             HcCCChhHCcCHHHHhcChhhccC
Confidence            999999999999999999999864

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.7e-50  Score=405.90  Aligned_cols=250  Identities=30%  Similarity=0.526  Sum_probs=214.1

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC------ChHHHHHHHHHHHhC-CCCCeeeeeeeeeecCCCceEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSL-NSPHIVGYKGCDVTSEDNKLMY   74 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~------~~~~l~~E~~iL~~L-~hpnIv~~~~~~~~~~~~~~~~   74 (405)
                      +|++++.||+|+||+||+|+++.+++.||+|++...      ..+.+.+|..+|.++ +||||+++++++....    .+
T Consensus        53 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~----~~  128 (396)
T 4dc2_A           53 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES----RL  128 (396)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSS----EE
T ss_pred             HcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECC----EE
Confidence            588999999999999999999999999999998643      234688999999887 8999999999876543    36


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccc---
Q 015500           75 NLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWES---  150 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~---  150 (405)
                      ++||||++||+|.+++.+. +++++..++.++.||+.||+|||++||+||||||+|||++.++ +||+|||+++...   
T Consensus       129 ~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~  207 (396)
T 4dc2_A          129 FFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG  207 (396)
T ss_dssp             EEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             EEEEEcCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccCC
Confidence            7999999999999999876 4899999999999999999999999999999999999999888 9999999997522   


Q ss_pred             -ccccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-------ChHHHHHHHHhcCCCCCCchhcc
Q 015500          151 -EALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAA-------DPMTVLYKIAYSRELPEVPAFLS  222 (405)
Q Consensus       151 -~~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~-------~~~~~l~~i~~~~~~~~~p~~~s  222 (405)
                       .....+||+.|+|||++.+..++.++|||||||++|||++|+.||....       .....+...... ....+|..++
T Consensus       208 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~-~~~~~p~~~s  286 (396)
T 4dc2_A          208 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE-KQIRIPRSLS  286 (396)
T ss_dssp             CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHH-CCCCCCTTSC
T ss_pred             CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhc-cccCCCCcCC
Confidence             2445679999999999999999999999999999999999999995321       112223333333 3346778899


Q ss_pred             HHHHHHHHHhcccCccccCCH------HHHhcCcccccccc
Q 015500          223 KQANDFLSNCLRRDPKERWAA------SQLLKHPFLEEFCS  257 (405)
Q Consensus       223 ~~l~dll~~~L~~dP~~Rpt~------~elL~hp~~~~~~~  257 (405)
                      +++++||++||++||.+||++      +|+++||||+.+..
T Consensus       287 ~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w  327 (396)
T 4dc2_A          287 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW  327 (396)
T ss_dssp             HHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCH
T ss_pred             HHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCH
Confidence            999999999999999999995      79999999997643

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=2.6e-50  Score=397.95  Aligned_cols=247  Identities=29%  Similarity=0.458  Sum_probs=217.4

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccC------CChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL------PKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~------~~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~   75 (405)
                      +|++++.||+|+||+||+|+++.+|+.||+|.+..      ...+.+.+|+++|+.++||||+++++++....    .++
T Consensus        42 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~----~~~  117 (350)
T 1rdq_E           42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS----NLY  117 (350)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS----EEE
T ss_pred             HCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC----EEE
Confidence            58899999999999999999999999999998753      34567889999999999999999998876533    367


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc-cc
Q 015500           76 LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE-AL  153 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~-~~  153 (405)
                      +||||++||+|.+++.+.+ ++++..++.++.||+.||+|||++||+||||||+|||++.++ +||+|||+++.... ..
T Consensus       118 lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~~  196 (350)
T 1rdq_E          118 MVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW  196 (350)
T ss_dssp             EEEECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCBC
T ss_pred             EEEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCCcc
Confidence            9999999999999998864 799999999999999999999999999999999999999888 99999999986544 34


Q ss_pred             cCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHhc
Q 015500          154 QSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCL  233 (405)
Q Consensus       154 ~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~L  233 (405)
                      ..+||+.|+|||++.+..++.++|||||||++|+|++|+.||... +......++...  ...+|..+++++.+||.+||
T Consensus       197 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~-~~~~~~~~i~~~--~~~~p~~~~~~~~~li~~lL  273 (350)
T 1rdq_E          197 TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD-QPIQIYEKIVSG--KVRFPSHFSSDLKDLLRNLL  273 (350)
T ss_dssp             CCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHC--CCCCCTTCCHHHHHHHHHHS
T ss_pred             cccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCC-CHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHHh
Confidence            567999999999999999999999999999999999999999643 444444455443  24567789999999999999


Q ss_pred             ccCccccCC-----HHHHhcCccccccc
Q 015500          234 RRDPKERWA-----ASQLLKHPFLEEFC  256 (405)
Q Consensus       234 ~~dP~~Rpt-----~~elL~hp~~~~~~  256 (405)
                      +.||.+||+     ++++++||||+.+.
T Consensus       274 ~~dp~~R~~~~~~~~~ei~~h~~f~~~~  301 (350)
T 1rdq_E          274 QVDLTKRFGNLKNGVNDIKNHKWFATTD  301 (350)
T ss_dssp             CSCTTTCTTSSTTTTHHHHTSGGGTTCC
T ss_pred             hcCHHhccCCccCCHHHHHhCcCcCCCC
Confidence            999999998     99999999998653

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=9.3e-51  Score=396.23  Aligned_cols=250  Identities=25%  Similarity=0.401  Sum_probs=213.1

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLF   77 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv   77 (405)
                      +|++++.||+|+||+||+|.++.+++.||||.+....    .+.+.+|+.+++.++||||+++++++....    .+++|
T Consensus         8 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~----~~~lv   83 (323)
T 3tki_A            8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGN----IQYLF   83 (323)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSS----EEEEE
T ss_pred             hceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCC----eEEEE
Confidence            6999999999999999999999999999999986543    356889999999999999999999775433    36699


Q ss_pred             EeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc-----
Q 015500           78 MEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE-----  151 (405)
Q Consensus        78 ~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~-----  151 (405)
                      |||++||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++ +||+|||+++....     
T Consensus        84 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  162 (323)
T 3tki_A           84 LEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER  162 (323)
T ss_dssp             EECCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred             EEcCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCccc
Confidence            9999999999998765 4799999999999999999999999999999999999999887 99999999975432     


Q ss_pred             -cccCCCCCCccChhhhcCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHH
Q 015500          152 -ALQSGGTPMFMAPEVARGEHQ-GFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFL  229 (405)
Q Consensus       152 -~~~~~gt~~Y~APE~l~~~~~-~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll  229 (405)
                       .....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.........................+++.+.+||
T Consensus       163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  242 (323)
T 3tki_A          163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL  242 (323)
T ss_dssp             CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHH
T ss_pred             ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHHH
Confidence             224579999999999988665 779999999999999999999997665544444444333333334466899999999


Q ss_pred             HHhcccCccccCCHHHHhcCccccccc
Q 015500          230 SNCLRRDPKERWAASQLLKHPFLEEFC  256 (405)
Q Consensus       230 ~~~L~~dP~~Rpt~~elL~hp~~~~~~  256 (405)
                      .+||+.||.+|||+.|+++||||....
T Consensus       243 ~~~L~~dP~~R~t~~eil~h~~~~~~~  269 (323)
T 3tki_A          243 HKILVENPSARITIPDIKKDRWYNKPL  269 (323)
T ss_dssp             HHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             HHHccCChhhCcCHHHHhhChhhcccc
Confidence            999999999999999999999998643

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=3.3e-50  Score=402.21  Aligned_cols=249  Identities=22%  Similarity=0.401  Sum_probs=214.6

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccC------CChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL------PKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~------~~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~   75 (405)
                      +|.+++.||+|+||+||+|.++.+++.||+|.+..      .....+.+|+++|+.++||||+++++++....    .++
T Consensus        16 ~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~----~~~   91 (384)
T 4fr4_A           16 HFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEE----DMF   91 (384)
T ss_dssp             GEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS----EEE
T ss_pred             HeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC----EEE
Confidence            58999999999999999999999999999998753      33467889999999999999999998876543    367


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc---
Q 015500           76 LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE---  151 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~---  151 (405)
                      +||||++||+|.+++.+. +.+++..++.++.||+.||.|||++||+||||||+|||++.++ +||+|||+++....   
T Consensus        92 lv~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~  170 (384)
T 4fr4_A           92 MVVDLLLGGDLRYHLQQN-VHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ  170 (384)
T ss_dssp             EEECCCTTEEHHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTCC
T ss_pred             EEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCCCc
Confidence            999999999999999875 4899999999999999999999999999999999999999888 99999999986433   


Q ss_pred             cccCCCCCCccChhhhcC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCC--hHHHHHHHHhcCCCCCCchhccHHHH
Q 015500          152 ALQSGGTPMFMAPEVARG---EHQGFASDIWAVGCTVIEMASGGAPWPNAAD--PMTVLYKIAYSRELPEVPAFLSKQAN  226 (405)
Q Consensus       152 ~~~~~gt~~Y~APE~l~~---~~~~~~sDIwSLG~il~elltG~~Pf~~~~~--~~~~l~~i~~~~~~~~~p~~~s~~l~  226 (405)
                      ....+||+.|+|||++.+   ..++.++|||||||++|+|++|+.||.....  .......+.  .....+|..+++++.
T Consensus       171 ~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~--~~~~~~p~~~s~~~~  248 (384)
T 4fr4_A          171 ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE--TTVVTYPSAWSQEMV  248 (384)
T ss_dssp             BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHH--HCCCCCCTTSCHHHH
T ss_pred             eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHh--hcccCCCCcCCHHHH
Confidence            345679999999999974   4588999999999999999999999964332  222222322  234567788999999


Q ss_pred             HHHHHhcccCccccCC-HHHHhcCcccccccc
Q 015500          227 DFLSNCLRRDPKERWA-ASQLLKHPFLEEFCS  257 (405)
Q Consensus       227 dll~~~L~~dP~~Rpt-~~elL~hp~~~~~~~  257 (405)
                      +||++||+.||.+||+ ++++++||||..+..
T Consensus       249 ~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w  280 (384)
T 4fr4_A          249 SLLKKLLEPNPDQRFSQLSDVQNFPYMNDINW  280 (384)
T ss_dssp             HHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCH
T ss_pred             HHHHHHhcCCHhHhcccHHHHHcChhhhcCCH
Confidence            9999999999999998 899999999987643

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=4.8e-50  Score=395.22  Aligned_cols=249  Identities=30%  Similarity=0.531  Sum_probs=213.1

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC------hHHHHHHHHHHHhC-CCCCeeeeeeeeeecCCCceEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK------SEFLQREQKFLSSL-NSPHIVGYKGCDVTSEDNKLMY   74 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~------~~~l~~E~~iL~~L-~hpnIv~~~~~~~~~~~~~~~~   74 (405)
                      +|++++.||+|+||+||+|+++.+++.||+|++....      .+.+.+|..+|+++ +||||+++++++....    .+
T Consensus        10 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~----~~   85 (345)
T 3a8x_A           10 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES----RL   85 (345)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS----EE
T ss_pred             heEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCC----EE
Confidence            5899999999999999999999999999999986431      34678899999988 8999999999876543    36


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccc---
Q 015500           75 NLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWES---  150 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~---  150 (405)
                      ++||||++||+|.+++.+. +.+++..++.++.||+.||+|||++||+||||||+|||++.++ +||+|||+++...   
T Consensus        86 ~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~  164 (345)
T 3a8x_A           86 FFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG  164 (345)
T ss_dssp             EEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT
T ss_pred             EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCC
Confidence            7999999999999999876 4899999999999999999999999999999999999999887 9999999997532   


Q ss_pred             -ccccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-------ChHHHHHHHHhcCCCCCCchhcc
Q 015500          151 -EALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAA-------DPMTVLYKIAYSRELPEVPAFLS  222 (405)
Q Consensus       151 -~~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~-------~~~~~l~~i~~~~~~~~~p~~~s  222 (405)
                       .....+||+.|+|||++.+..++.++|||||||++|||++|+.||....       .....+....... ...+|..++
T Consensus       165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~-~~~~p~~~s  243 (345)
T 3a8x_A          165 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK-QIRIPRSLS  243 (345)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC-CCCCCTTSC
T ss_pred             CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC-CCCCCCCCC
Confidence             2345679999999999999999999999999999999999999996421       1122222222222 345778899


Q ss_pred             HHHHHHHHHhcccCccccCCH------HHHhcCccccccc
Q 015500          223 KQANDFLSNCLRRDPKERWAA------SQLLKHPFLEEFC  256 (405)
Q Consensus       223 ~~l~dll~~~L~~dP~~Rpt~------~elL~hp~~~~~~  256 (405)
                      +++++||++||+.||.+||++      +++++||||+.+.
T Consensus       244 ~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~  283 (345)
T 3a8x_A          244 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD  283 (345)
T ss_dssp             HHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCC
T ss_pred             HHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCC
Confidence            999999999999999999995      8999999998764

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.8e-50  Score=410.70  Aligned_cols=252  Identities=25%  Similarity=0.357  Sum_probs=216.3

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccC------CChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL------PKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~------~~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~   75 (405)
                      +|.+++.||+|+||+||+|+++.+++.||+|++..      .....+.+|+.+|..++||||+++++++....    .++
T Consensus        75 ~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~----~~~  150 (437)
T 4aw2_A           75 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDN----NLY  150 (437)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSS----EEE
T ss_pred             heEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC----EEE
Confidence            58899999999999999999999999999998864      22345889999999999999999998876543    367


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc---
Q 015500           76 LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE---  151 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~---  151 (405)
                      +||||++||+|.+++.+..+.+++..++.++.||+.||+|||++||+||||||+|||++.++ +||+|||+++....   
T Consensus       151 lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~  230 (437)
T 4aw2_A          151 LVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT  230 (437)
T ss_dssp             EEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC
T ss_pred             EEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCC
Confidence            99999999999999988667899999999999999999999999999999999999999888 99999999975432   


Q ss_pred             --cccCCCCCCccChhhhc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHh---cCCCCCCchhc
Q 015500          152 --ALQSGGTPMFMAPEVAR-----GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAY---SRELPEVPAFL  221 (405)
Q Consensus       152 --~~~~~gt~~Y~APE~l~-----~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~---~~~~~~~p~~~  221 (405)
                        ....+||+.|+|||++.     ...++.++|||||||++|||++|+.||... +......++..   ...+|..+..+
T Consensus       231 ~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~-~~~~~~~~i~~~~~~~~~p~~~~~~  309 (437)
T 4aw2_A          231 VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE-SLVETYGKIMNHKERFQFPTQVTDV  309 (437)
T ss_dssp             EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCS-SHHHHHHHHHTHHHHCCCCSSCCCS
T ss_pred             cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCC-ChhHHHHhhhhccccccCCcccccC
Confidence              22357999999999997     466899999999999999999999999643 44445545432   23445555568


Q ss_pred             cHHHHHHHHHhcccCccc--cCCHHHHhcCccccccccc
Q 015500          222 SKQANDFLSNCLRRDPKE--RWAASQLLKHPFLEEFCSC  258 (405)
Q Consensus       222 s~~l~dll~~~L~~dP~~--Rpt~~elL~hp~~~~~~~~  258 (405)
                      ++++++||++||..+|++  |++++|+++||||+.+...
T Consensus       310 s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~  348 (437)
T 4aw2_A          310 SENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWD  348 (437)
T ss_dssp             CHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTT
T ss_pred             CHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHH
Confidence            999999999999999988  9999999999999976543

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=6.7e-50  Score=387.74  Aligned_cols=249  Identities=27%  Similarity=0.447  Sum_probs=204.8

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      +|++++.||+|+||+||+|.+. +|+.||+|.+....     ...+.+|+++|++++||||+++++++.....    +++
T Consensus        22 ~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~----~~l   96 (311)
T 3niz_A           22 KYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERC----LTL   96 (311)
T ss_dssp             EEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSC----EEE
T ss_pred             hhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCE----EEE
Confidence            5899999999999999999985 58999999886432     2568899999999999999999998764432    669


Q ss_pred             EEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc----
Q 015500           77 FMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE----  151 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~----  151 (405)
                      ||||+++ +|.+.+......+++..++.++.||+.||+|||++||+||||||+|||++.++ +||+|||+++....    
T Consensus        97 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~  175 (311)
T 3niz_A           97 VFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRS  175 (311)
T ss_dssp             EEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-
T ss_pred             EEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCccc
Confidence            9999975 89998888777799999999999999999999999999999999999999887 99999999986442    


Q ss_pred             cccCCCCCCccChhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHH--HHHHHhcCCCCC------------
Q 015500          152 ALQSGGTPMFMAPEVARG-EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTV--LYKIAYSRELPE------------  216 (405)
Q Consensus       152 ~~~~~gt~~Y~APE~l~~-~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~--l~~i~~~~~~~~------------  216 (405)
                      .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.........  +...........            
T Consensus       176 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  255 (311)
T 3niz_A          176 YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQ  255 (311)
T ss_dssp             --CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHS
T ss_pred             ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhh
Confidence            234568999999999987 56899999999999999999999999755433222  111111111111            


Q ss_pred             -------------CchhccHHHHHHHHHhcccCccccCCHHHHhcCccccccc
Q 015500          217 -------------VPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFC  256 (405)
Q Consensus       217 -------------~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~  256 (405)
                                   ....+++++.+||++||+.||.+|||++|+|+||||+.+.
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  308 (311)
T 3niz_A          256 RTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD  308 (311)
T ss_dssp             CCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred             cccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence                         1123678999999999999999999999999999998753

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=9e-50  Score=395.66  Aligned_cols=248  Identities=27%  Similarity=0.400  Sum_probs=211.9

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      +|++++.||+|+||+||+|.++.+|+.||+|.+....     .+.+.+|+.+|+.|+||||+++++++....    .+++
T Consensus        30 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~----~~~l  105 (362)
T 2bdw_A           30 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEES----FHYL  105 (362)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS----EEEE
T ss_pred             CeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC----EEEE
Confidence            4889999999999999999999999999999986542     256889999999999999999999876433    3679


Q ss_pred             EEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC----ceEeeeccccccccc
Q 015500           77 FMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG----AKIADFGCAKWESEA  152 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~----vkL~DFGla~~~~~~  152 (405)
                      ||||++||+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++    +||+|||++......
T Consensus       106 v~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~  184 (362)
T 2bdw_A          106 VFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS  184 (362)
T ss_dssp             EECCCCSCBHHHHHTTC-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC
T ss_pred             EEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC
Confidence            99999999999999775 4799999999999999999999999999999999999997542    999999999865442


Q ss_pred             ---ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCC-C-CCchhccHHHHH
Q 015500          153 ---LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSREL-P-EVPAFLSKQAND  227 (405)
Q Consensus       153 ---~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~-~-~~p~~~s~~l~d  227 (405)
                         ....||+.|+|||++.+..++.++|||||||++|+|++|..||... +.......+...... + .....+++++++
T Consensus       185 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  263 (362)
T 2bdw_A          185 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE-DQHRLYAQIKAGAYDYPSPEWDTVTPEAKS  263 (362)
T ss_dssp             CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHTCCCCCTTGGGGSCHHHHH
T ss_pred             cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCC-CHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence               3457999999999999999999999999999999999999999644 344444444433221 1 122458999999


Q ss_pred             HHHHhcccCccccCCHHHHhcCcccccc
Q 015500          228 FLSNCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       228 ll~~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      ||.+||+.||.+|||+.++|+||||...
T Consensus       264 li~~~L~~dP~~R~t~~e~l~hp~~~~~  291 (362)
T 2bdw_A          264 LIDSMLTVNPKKRITADQALKVPWICNR  291 (362)
T ss_dssp             HHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred             HHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence            9999999999999999999999999753

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=6e-50  Score=396.00  Aligned_cols=248  Identities=27%  Similarity=0.419  Sum_probs=216.1

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccC------CChHHHHHHHHHHHhC-CCCCeeeeeeeeeecCCCceEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL------PKSEFLQREQKFLSSL-NSPHIVGYKGCDVTSEDNKLMY   74 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~------~~~~~l~~E~~iL~~L-~hpnIv~~~~~~~~~~~~~~~~   74 (405)
                      +|.+++.||+|+||+||+|+++.+++.||+|++..      ...+.+.+|..+|..+ +||||+++++++....    .+
T Consensus        21 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~----~~   96 (353)
T 2i0e_A           21 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD----RL   96 (353)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSS----EE
T ss_pred             HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCC----EE
Confidence            68999999999999999999999999999998764      3456788999999988 8999999998876543    36


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccc---
Q 015500           75 NLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWES---  150 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~---  150 (405)
                      ++||||++||+|.+++.+.+ ++++..++.++.||+.||+|||++||+||||||+|||++.++ +||+|||+++...   
T Consensus        97 ~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  175 (353)
T 2i0e_A           97 YFVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG  175 (353)
T ss_dssp             EEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             EEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC
Confidence            79999999999999998764 799999999999999999999999999999999999999888 9999999998532   


Q ss_pred             -ccccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHH
Q 015500          151 -EALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFL  229 (405)
Q Consensus       151 -~~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll  229 (405)
                       .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.. .+......++...  .+.+|..+++++.+||
T Consensus       176 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~-~~~~~~~~~i~~~--~~~~p~~~s~~~~~li  252 (353)
T 2i0e_A          176 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEH--NVAYPKSMSKEAVAIC  252 (353)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHC--CCCCCTTSCHHHHHHH
T ss_pred             cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCC-CCHHHHHHHHHhC--CCCCCCCCCHHHHHHH
Confidence             23456799999999999999999999999999999999999999954 3444555554433  3456788999999999


Q ss_pred             HHhcccCccccCC-----HHHHhcCcccccccc
Q 015500          230 SNCLRRDPKERWA-----ASQLLKHPFLEEFCS  257 (405)
Q Consensus       230 ~~~L~~dP~~Rpt-----~~elL~hp~~~~~~~  257 (405)
                      ++||.+||.+||+     ++++++||||+.+..
T Consensus       253 ~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w  285 (353)
T 2i0e_A          253 KGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW  285 (353)
T ss_dssp             HHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCH
T ss_pred             HHHhhcCHHHcCCCCCCCHHHHhcCccccCCCH
Confidence            9999999999995     699999999987643

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=2.9e-50  Score=406.00  Aligned_cols=249  Identities=27%  Similarity=0.408  Sum_probs=212.6

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccC------CChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL------PKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~------~~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~   75 (405)
                      +|.+++.||+|+||+||+|+++.+++.||+|++..      ...+.+.+|+.+|+.++||||+++++++....    .++
T Consensus        70 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~----~~~  145 (410)
T 3v8s_A           70 DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR----YLY  145 (410)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS----EEE
T ss_pred             ccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC----EEE
Confidence            58899999999999999999999999999998753      33456889999999999999999998876433    367


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc---
Q 015500           76 LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE---  151 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~---  151 (405)
                      +||||++||+|.+++.+.  .+++..++.++.||+.||+|||++||+||||||+|||++.++ +||+|||+++....   
T Consensus       146 lV~E~~~gg~L~~~l~~~--~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~  223 (410)
T 3v8s_A          146 MVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM  223 (410)
T ss_dssp             EEECCCTTEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSE
T ss_pred             EEEeCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCc
Confidence            999999999999999764  699999999999999999999999999999999999999888 99999999976443   


Q ss_pred             --cccCCCCCCccChhhhcCCC----CCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCc--hhccH
Q 015500          152 --ALQSGGTPMFMAPEVARGEH----QGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVP--AFLSK  223 (405)
Q Consensus       152 --~~~~~gt~~Y~APE~l~~~~----~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p--~~~s~  223 (405)
                        ....+||+.|+|||++.+..    ++.++|||||||++|||++|+.||.. .+......++........+|  ..+++
T Consensus       224 ~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~s~  302 (410)
T 3v8s_A          224 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA-DSLVGTYSKIMNHKNSLTFPDDNDISK  302 (410)
T ss_dssp             EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTHHHHCCCCTTCCCCH
T ss_pred             ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCC-CChhhHHHHHHhccccccCCCcccccH
Confidence              23567999999999998765    78899999999999999999999954 34455555554332111222  35899


Q ss_pred             HHHHHHHHhcccCccc--cCCHHHHhcCcccccccc
Q 015500          224 QANDFLSNCLRRDPKE--RWAASQLLKHPFLEEFCS  257 (405)
Q Consensus       224 ~l~dll~~~L~~dP~~--Rpt~~elL~hp~~~~~~~  257 (405)
                      ++++||++||+.+|.+  |++++|+++||||+.+..
T Consensus       303 ~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w  338 (410)
T 3v8s_A          303 EAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW  338 (410)
T ss_dssp             HHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSC
T ss_pred             HHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCH
Confidence            9999999999999988  999999999999997643

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.8e-49  Score=379.39  Aligned_cols=250  Identities=26%  Similarity=0.426  Sum_probs=216.8

Q ss_pred             cccccccceeCCeeEEEEEEcCCCCEEEEEEccCC-----ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEE
Q 015500            3 WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP-----KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLF   77 (405)
Q Consensus         3 y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~-----~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv   77 (405)
                      |++.+.||+|+||+||+|.+..++..||+|.+...     ..+.+.+|+.+|++++||||+++++++.........+++|
T Consensus        28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv  107 (290)
T 1t4h_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred             EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEE
Confidence            67888999999999999999999999999987643     2356889999999999999999999887665555667899


Q ss_pred             EeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCCCCEEEc-cCC-ceEeeecccccccc--
Q 015500           78 MEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNR--VVHCDIKSRNILMA-ESG-AKIADFGCAKWESE--  151 (405)
Q Consensus        78 ~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~g--ivHrDlkp~NILi~-~~~-vkL~DFGla~~~~~--  151 (405)
                      |||+++++|.+++... +.+++..++.++.||+.||.|||++|  |+||||||+|||++ .++ +||+|||++.....  
T Consensus       108 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~~  186 (290)
T 1t4h_A          108 TELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF  186 (290)
T ss_dssp             EECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTS
T ss_pred             EEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccccc
Confidence            9999999999999876 47999999999999999999999999  99999999999997 555 99999999975443  


Q ss_pred             cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHH
Q 015500          152 ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSN  231 (405)
Q Consensus       152 ~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~  231 (405)
                      .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||............+......+..+...++++.+||.+
T Consensus       187 ~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  265 (290)
T 1t4h_A          187 AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEG  265 (290)
T ss_dssp             BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHH
T ss_pred             cccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHHHHHHHHH
Confidence            334569999999999875 4899999999999999999999999876666665555554444445666788999999999


Q ss_pred             hcccCccccCCHHHHhcCccccc
Q 015500          232 CLRRDPKERWAASQLLKHPFLEE  254 (405)
Q Consensus       232 ~L~~dP~~Rpt~~elL~hp~~~~  254 (405)
                      ||+.||.+|||++++|+||||++
T Consensus       266 ~l~~dp~~Rps~~ell~h~~f~~  288 (290)
T 1t4h_A          266 CIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             HSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             HccCChhhCCCHHHHhhCccccc
Confidence            99999999999999999999975

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.1e-49  Score=389.04  Aligned_cols=248  Identities=28%  Similarity=0.441  Sum_probs=211.4

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC---------ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCce
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP---------KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKL   72 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~---------~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~   72 (405)
                      .|.+++.||+|+||+||+|.++.+|+.||+|.+...         ..+.+.+|+.+|++++||||+++++++....    
T Consensus        12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~----   87 (326)
T 2y0a_A           12 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT----   87 (326)
T ss_dssp             HEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS----
T ss_pred             ceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC----
Confidence            388999999999999999999999999999987643         2467899999999999999999999876433    


Q ss_pred             EEEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-----ceEeeecccc
Q 015500           73 MYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-----AKIADFGCAK  147 (405)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-----vkL~DFGla~  147 (405)
                      .+++||||++|++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++     +||+|||+++
T Consensus        88 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~  166 (326)
T 2y0a_A           88 DVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH  166 (326)
T ss_dssp             EEEEEEECCCSCBHHHHHTTS-SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             EEEEEEEcCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence            367999999999999999765 4899999999999999999999999999999999999997654     8999999998


Q ss_pred             cccc---cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCC-CC-CCchhcc
Q 015500          148 WESE---ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRE-LP-EVPAFLS  222 (405)
Q Consensus       148 ~~~~---~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~-~~-~~p~~~s  222 (405)
                      ....   .....||+.|+|||++.+..++.++|||||||++|+|++|..||... .....+..+..... .+ ..+..++
T Consensus       167 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  245 (326)
T 2y0a_A          167 KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD-TKQETLANVSAVNYEFEDEYFSNTS  245 (326)
T ss_dssp             ECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS-SHHHHHHHHHHTCCCCCHHHHTTSC
T ss_pred             ECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCC-CHHHHHHHHHhcCCCcCccccccCC
Confidence            6543   33456999999999999999999999999999999999999999644 33444444433221 11 1224578


Q ss_pred             HHHHHHHHHhcccCccccCCHHHHhcCcccccc
Q 015500          223 KQANDFLSNCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       223 ~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      +.+.+||++||+.||.+|||+.|+|+||||...
T Consensus       246 ~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~  278 (326)
T 2y0a_A          246 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK  278 (326)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence            999999999999999999999999999999753

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=7.9e-50  Score=382.09  Aligned_cols=246  Identities=30%  Similarity=0.438  Sum_probs=204.9

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      +|++++.||+|+||+||+|.+ .+|+.+|+|.+....     ...+.+|+++|++++||||+++++++.....    +++
T Consensus         3 ~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~----~~l   77 (288)
T 1ob3_A            3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKR----LVL   77 (288)
T ss_dssp             SEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSC----EEE
T ss_pred             cchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCe----EEE
Confidence            599999999999999999998 689999999986543     3578899999999999999999998765433    679


Q ss_pred             EEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc----
Q 015500           77 FMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE----  151 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~----  151 (405)
                      ||||+++ +|.+++....+.+++..++.++.||+.||.|||++||+||||||+|||++.++ +||+|||+++....    
T Consensus        78 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  156 (288)
T 1ob3_A           78 VFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK  156 (288)
T ss_dssp             EEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred             EEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccccc
Confidence            9999976 99999988767899999999999999999999999999999999999999887 99999999976432    


Q ss_pred             cccCCCCCCccChhhhcCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhc-CC--C---------C---
Q 015500          152 ALQSGGTPMFMAPEVARGE-HQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYS-RE--L---------P---  215 (405)
Q Consensus       152 ~~~~~gt~~Y~APE~l~~~-~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~-~~--~---------~---  215 (405)
                      .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||..... ...+.++... ..  .         +   
T Consensus       157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T 1ob3_A          157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE-ADQLMRIFRILGTPNSKNWPNVTELPKYD  235 (288)
T ss_dssp             -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred             cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHHCCCChhhchhhhcccccc
Confidence            2344689999999999764 589999999999999999999999965543 3333333211 00  0         0   


Q ss_pred             ------------CCchhccHHHHHHHHHhcccCccccCCHHHHhcCccccc
Q 015500          216 ------------EVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEE  254 (405)
Q Consensus       216 ------------~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~  254 (405)
                                  .....+++++.+||++||+.||++|||++|+|+||||++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~  286 (288)
T 1ob3_A          236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (288)
T ss_dssp             TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             cccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence                        112347899999999999999999999999999999975

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=3e-50  Score=386.52  Aligned_cols=247  Identities=27%  Similarity=0.411  Sum_probs=205.0

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-----------------------------hHHHHHHHHHHHhC
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-----------------------------SEFLQREQKFLSSL   52 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-----------------------------~~~l~~E~~iL~~L   52 (405)
                      +|++++.||+|+||+||+|++..+++.||||.+....                             .+.+.+|+++|+++
T Consensus        14 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l   93 (298)
T 2zv2_A           14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKL   93 (298)
T ss_dssp             TEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTC
T ss_pred             ceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhC
Confidence            5899999999999999999999999999999886432                             24688999999999


Q ss_pred             CCCCeeeeeeeeeecCCCceEEEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEE
Q 015500           53 NSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNIL  132 (405)
Q Consensus        53 ~hpnIv~~~~~~~~~~~~~~~~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NIL  132 (405)
                      +||||+++++++.....  ..+++||||+++++|.+++..  +++++..++.++.||+.||+|||++||+||||||+|||
T Consensus        94 ~h~~iv~~~~~~~~~~~--~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil  169 (298)
T 2zv2_A           94 DHPNVVKLVEVLDDPNE--DHLYMVFELVNQGPVMEVPTL--KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLL  169 (298)
T ss_dssp             CCTTBCCEEEEEECSSS--SEEEEEEECCTTCBSCCSSCS--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred             CCCCCCeEEEEEEcCCC--CEEEEEEecCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEE
Confidence            99999999998765332  246699999999999886543  47999999999999999999999999999999999999


Q ss_pred             EccCC-ceEeeecccccccc----cccCCCCCCccChhhhcCCC---CCcchhHHHHHHHHHHHHhCCCCCCCCCChHHH
Q 015500          133 MAESG-AKIADFGCAKWESE----ALQSGGTPMFMAPEVARGEH---QGFASDIWAVGCTVIEMASGGAPWPNAADPMTV  204 (405)
Q Consensus       133 i~~~~-vkL~DFGla~~~~~----~~~~~gt~~Y~APE~l~~~~---~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~  204 (405)
                      ++.++ +||+|||+++....    .....||+.|+|||++.+..   ++.++|||||||++|+|++|+.||... .....
T Consensus       170 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~-~~~~~  248 (298)
T 2zv2_A          170 VGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE-RIMCL  248 (298)
T ss_dssp             ECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS-SHHHH
T ss_pred             ECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc-cHHHH
Confidence            99887 99999999976443    23457999999999998765   377899999999999999999999644 33333


Q ss_pred             HHHHHhcCCCCCCchhccHHHHHHHHHhcccCccccCCHHHHhcCcccc
Q 015500          205 LYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLE  253 (405)
Q Consensus       205 l~~i~~~~~~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~  253 (405)
                      ...+.........+..+++++.+||.+||+.||.+|||+.|+|+||||.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~  297 (298)
T 2zv2_A          249 HSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT  297 (298)
T ss_dssp             HHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred             HHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence            3333333222222346899999999999999999999999999999996

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=5.9e-50  Score=399.53  Aligned_cols=250  Identities=27%  Similarity=0.393  Sum_probs=200.4

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC-----ChHHHHHHHHHHHhCC-CCCeeeeeeeeeecCCCceEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP-----KSEFLQREQKFLSSLN-SPHIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~-----~~~~l~~E~~iL~~L~-hpnIv~~~~~~~~~~~~~~~~~   75 (405)
                      +|++++.||+|+||+||+|.++.+|+.||||++...     ....+.+|+.+|+.+. ||||+++++++......  .++
T Consensus        10 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~--~~~   87 (388)
T 3oz6_A           10 KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDR--DVY   87 (388)
T ss_dssp             TEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS--CEE
T ss_pred             ceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC--EEE
Confidence            689999999999999999999999999999987542     2346778999999997 99999999987654332  356


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc---
Q 015500           76 LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE---  151 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~---  151 (405)
                      +||||++ ++|.+++...  .+++..++.++.||+.||+|||++||+||||||+|||++.++ +||+|||+++....   
T Consensus        88 lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  164 (388)
T 3oz6_A           88 LVFDYME-TDLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRR  164 (388)
T ss_dssp             EEEECCS-EEHHHHHHHT--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCC
T ss_pred             EEecccC-cCHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccccc
Confidence            9999997 5899998764  799999999999999999999999999999999999999888 99999999975321   


Q ss_pred             ----------------------cccCCCCCCccChhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHH
Q 015500          152 ----------------------ALQSGGTPMFMAPEVARG-EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKI  208 (405)
Q Consensus       152 ----------------------~~~~~gt~~Y~APE~l~~-~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i  208 (405)
                                            ....+||++|+|||++.+ ..++.++|||||||++|||++|++||... +....+.++
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~-~~~~~~~~i  243 (388)
T 3oz6_A          165 VTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS-STMNQLERI  243 (388)
T ss_dssp             CCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS-SHHHHHHHH
T ss_pred             ccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHH
Confidence                                  123469999999999987 67899999999999999999999999654 344444443


Q ss_pred             HhcCCCCC---------------------------------------------CchhccHHHHHHHHHhcccCccccCCH
Q 015500          209 AYSRELPE---------------------------------------------VPAFLSKQANDFLSNCLRRDPKERWAA  243 (405)
Q Consensus       209 ~~~~~~~~---------------------------------------------~p~~~s~~l~dll~~~L~~dP~~Rpt~  243 (405)
                      ......|.                                             .+..+++++.+||++||+.||.+|||+
T Consensus       244 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~  323 (388)
T 3oz6_A          244 IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISA  323 (388)
T ss_dssp             HHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred             HHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCH
Confidence            32211111                                             011468899999999999999999999


Q ss_pred             HHHhcCcccccccc
Q 015500          244 SQLLKHPFLEEFCS  257 (405)
Q Consensus       244 ~elL~hp~~~~~~~  257 (405)
                      +|+|+||||+.+..
T Consensus       324 ~e~l~Hp~~~~~~~  337 (388)
T 3oz6_A          324 NDALKHPFVSIFHN  337 (388)
T ss_dssp             HHHTTSTTTTTTCC
T ss_pred             HHHhCCHHHHHhcC
Confidence            99999999987654

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.5e-50  Score=404.18  Aligned_cols=250  Identities=27%  Similarity=0.389  Sum_probs=212.2

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC------ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~------~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~   75 (405)
                      +|++++.||+|+||+||+|+++.+|+.||+|++...      ..+.+.+|..+|..++||||+++++++....    .+|
T Consensus        62 ~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~----~~~  137 (412)
T 2vd5_A           62 DFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDEN----YLY  137 (412)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSS----EEE
T ss_pred             hEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC----EEE
Confidence            588999999999999999999999999999998642      2345889999999999999999998876543    367


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc---
Q 015500           76 LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE---  151 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~---  151 (405)
                      +||||++||+|.+++.+.+..+++..++.++.||+.||+|||++||+||||||+|||++.++ +||+|||+++....   
T Consensus       138 lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~  217 (412)
T 2vd5_A          138 LVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT  217 (412)
T ss_dssp             EEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC
T ss_pred             EEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCCc
Confidence            99999999999999988766899999999999999999999999999999999999999888 99999999976433   


Q ss_pred             --cccCCCCCCccChhhhc-------CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHh---cCCCCCCch
Q 015500          152 --ALQSGGTPMFMAPEVAR-------GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAY---SRELPEVPA  219 (405)
Q Consensus       152 --~~~~~gt~~Y~APE~l~-------~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~---~~~~~~~p~  219 (405)
                        ....+||+.|+|||++.       +..++.++|||||||++|||++|+.||... +......++..   ....|..+.
T Consensus       218 ~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~-~~~~~~~~i~~~~~~~~~p~~~~  296 (412)
T 2vd5_A          218 VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYAD-STAETYGKIVHYKEHLSLPLVDE  296 (412)
T ss_dssp             EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCS-SHHHHHHHHHTHHHHCCCC----
T ss_pred             cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCC-CHHHHHHHHHhcccCcCCCcccc
Confidence              22357999999999997       356899999999999999999999999644 44444444432   233455556


Q ss_pred             hccHHHHHHHHHhcccCcccc---CCHHHHhcCcccccccc
Q 015500          220 FLSKQANDFLSNCLRRDPKER---WAASQLLKHPFLEEFCS  257 (405)
Q Consensus       220 ~~s~~l~dll~~~L~~dP~~R---pt~~elL~hp~~~~~~~  257 (405)
                      .+|+++++||++||. +|.+|   ++++++++||||+.+..
T Consensus       297 ~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w  336 (412)
T 2vd5_A          297 GVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDW  336 (412)
T ss_dssp             CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCS
T ss_pred             CCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCH
Confidence            799999999999999 99998   59999999999997644

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=9.2e-50  Score=406.26  Aligned_cols=248  Identities=25%  Similarity=0.375  Sum_probs=210.8

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      +|++++.||+|+||+||+|.++.+|+.+|+|.+....     .+.+.+|+.+|+.|+||||+++++++....    .+++
T Consensus        12 ~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~----~~~l   87 (444)
T 3soa_A           12 EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEG----HHYL   87 (444)
T ss_dssp             HEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSS----EEEE
T ss_pred             CeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECC----EEEE
Confidence            4889999999999999999999999999999987643     346889999999999999999999875433    3679


Q ss_pred             EEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcc---CC-ceEeeeccccccccc
Q 015500           77 FMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAE---SG-AKIADFGCAKWESEA  152 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~---~~-vkL~DFGla~~~~~~  152 (405)
                      ||||++||+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.   ++ +||+|||++......
T Consensus        88 v~E~~~gg~L~~~i~~~-~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~  166 (444)
T 3soa_A           88 IFDLVTGGELFEDIVAR-EYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE  166 (444)
T ss_dssp             EECCCBCCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT
T ss_pred             EEEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC
Confidence            99999999999999876 48999999999999999999999999999999999999984   33 999999999765432


Q ss_pred             ----ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCC--CchhccHHHH
Q 015500          153 ----LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPE--VPAFLSKQAN  226 (405)
Q Consensus       153 ----~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~--~p~~~s~~l~  226 (405)
                          ....||+.|+|||++.+..++.++|||||||++|+|++|.+||... +.......+........  ....++++++
T Consensus       167 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  245 (444)
T 3soa_A          167 QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDE-DQHRLYQQIKAGAYDFPSPEWDTVTPEAK  245 (444)
T ss_dssp             CCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCS-SHHHHHHHHHHTCCCCCTTTTTTSCHHHH
T ss_pred             CceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCc-cHHHHHHHHHhCCCCCCccccccCCHHHH
Confidence                3457999999999999999999999999999999999999999543 44444444444332211  1246899999


Q ss_pred             HHHHHhcccCccccCCHHHHhcCcccccc
Q 015500          227 DFLSNCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       227 dll~~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      +||.+||+.||.+|||+.|+|+||||...
T Consensus       246 ~li~~~L~~dP~~Rpta~e~L~hp~~~~~  274 (444)
T 3soa_A          246 DLINKMLTINPSKRITAAEALKHPWISHR  274 (444)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred             HHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence            99999999999999999999999999754

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=2e-49  Score=387.27  Aligned_cols=247  Identities=26%  Similarity=0.438  Sum_probs=206.9

Q ss_pred             CcccccccceeCCeeEEEEEEc---CCCCEEEEEEccCC-------ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCc
Q 015500            2 DWTRGHTIGQGSSATVSLATSL---RSGDVFAAKSTELP-------KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNK   71 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~---~~~~~vavK~~~~~-------~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~   71 (405)
                      +|++++.||+|+||+||+|++.   .+|+.||+|++...       ....+.+|+.+|+.++||||+++++++.....  
T Consensus        18 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~--   95 (327)
T 3a62_A           18 CFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK--   95 (327)
T ss_dssp             GEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC--
T ss_pred             HeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE--
Confidence            5899999999999999999985   68999999998653       23467889999999999999999988765443  


Q ss_pred             eEEEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccc
Q 015500           72 LMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWES  150 (405)
Q Consensus        72 ~~~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~  150 (405)
                        +++||||++|++|.+++.+.+ .+++..++.++.||+.||.|||++||+||||||+|||++.++ +||+|||+++...
T Consensus        96 --~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~  172 (327)
T 3a62_A           96 --LYLILEYLSGGELFMQLEREG-IFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESI  172 (327)
T ss_dssp             --EEEEEECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC----
T ss_pred             --EEEEEeCCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccccc
Confidence              669999999999999998764 799999999999999999999999999999999999999887 9999999987532


Q ss_pred             c----cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHH
Q 015500          151 E----ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQAN  226 (405)
Q Consensus       151 ~----~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~  226 (405)
                      .    ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||... +......++...  ...+|..+++++.
T Consensus       173 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~-~~~~~~~~i~~~--~~~~p~~~~~~~~  249 (327)
T 3a62_A          173 HDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGE-NRKKTIDKILKC--KLNLPPYLTQEAR  249 (327)
T ss_dssp             ------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS-SHHHHHHHHHHT--CCCCCTTSCHHHH
T ss_pred             cCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCC-CHHHHHHHHHhC--CCCCCCCCCHHHH
Confidence            2    23457999999999999999999999999999999999999999644 334444444332  3356778999999


Q ss_pred             HHHHHhcccCccccC-----CHHHHhcCccccccc
Q 015500          227 DFLSNCLRRDPKERW-----AASQLLKHPFLEEFC  256 (405)
Q Consensus       227 dll~~~L~~dP~~Rp-----t~~elL~hp~~~~~~  256 (405)
                      +||++||+.||.+||     ++.++++||||+.+.
T Consensus       250 ~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~  284 (327)
T 3a62_A          250 DLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHIN  284 (327)
T ss_dssp             HHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCC
T ss_pred             HHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCC
Confidence            999999999999999     889999999998753

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.7e-50  Score=398.84  Aligned_cols=247  Identities=31%  Similarity=0.476  Sum_probs=209.9

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC--------ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP--------KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLM   73 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~--------~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~   73 (405)
                      .|++++.||+|+||+||+|.++.+|+.||||++...        ..+.+.+|+.+|+.++||||+++++++....    .
T Consensus        25 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~----~  100 (351)
T 3c0i_A           25 VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDG----M  100 (351)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT----E
T ss_pred             ceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC----E
Confidence            488999999999999999999999999999987531        3567999999999999999999999876543    3


Q ss_pred             EEEEEeecCCCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC----ceEeeeccc
Q 015500           74 YNLFMEYAPGGTLNDEIHRN---GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG----AKIADFGCA  146 (405)
Q Consensus        74 ~~lv~Ey~~ggsL~~~i~~~---~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~----vkL~DFGla  146 (405)
                      +++||||++|++|.+++.+.   +..+++..++.++.||+.||.|||++||+||||||+|||++.++    +||+|||++
T Consensus       101 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a  180 (351)
T 3c0i_A          101 LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA  180 (351)
T ss_dssp             EEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred             EEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcce
Confidence            67999999999999888653   33589999999999999999999999999999999999997643    899999999


Q ss_pred             ccccc----cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCc---h
Q 015500          147 KWESE----ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVP---A  219 (405)
Q Consensus       147 ~~~~~----~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p---~  219 (405)
                      +....    .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...  .......+... .....+   .
T Consensus       181 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~--~~~~~~~i~~~-~~~~~~~~~~  257 (351)
T 3c0i_A          181 IQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT--KERLFEGIIKG-KYKMNPRQWS  257 (351)
T ss_dssp             EECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS--HHHHHHHHHHT-CCCCCHHHHT
T ss_pred             eEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc--HHHHHHHHHcC-CCCCCccccc
Confidence            76544    22456999999999999999999999999999999999999999653  33333333332 222222   4


Q ss_pred             hccHHHHHHHHHhcccCccccCCHHHHhcCcccccc
Q 015500          220 FLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       220 ~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      .+++++++||++||+.||.+|||+.++|+||||+..
T Consensus       258 ~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~  293 (351)
T 3c0i_A          258 HISESAKDLVRRMLMLDPAERITVYEALNHPWLKER  293 (351)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred             cCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence            579999999999999999999999999999999864

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1e-49  Score=395.05  Aligned_cols=249  Identities=27%  Similarity=0.395  Sum_probs=202.4

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC--ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEe
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP--KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFME   79 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~--~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (405)
                      +|++++.||+|+||+||+|+++.+++.||||.+...  ..+.+.+|+.+++.++||||+++++++....    .+++|||
T Consensus        21 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~----~~~lv~e   96 (361)
T 3uc3_A           21 RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPT----HLAIIME   96 (361)
T ss_dssp             TEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSS----EEEEEEE
T ss_pred             cEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCC----EEEEEEE
Confidence            589999999999999999999999999999998754  3467899999999999999999999876543    3679999


Q ss_pred             ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC---ceEeeecccccccc---cc
Q 015500           80 YAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG---AKIADFGCAKWESE---AL  153 (405)
Q Consensus        80 y~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~---vkL~DFGla~~~~~---~~  153 (405)
                      |++||+|.+++...+ ++++..++.++.||+.||+|||++||+||||||+|||++.++   +||+|||+++....   ..
T Consensus        97 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~~  175 (361)
T 3uc3_A           97 YASGGELYERICNAG-RFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK  175 (361)
T ss_dssp             CCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC----------
T ss_pred             eCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccCCCC
Confidence            999999999998764 799999999999999999999999999999999999998664   89999999974322   34


Q ss_pred             cCCCCCCccChhhhcCCCCCcc-hhHHHHHHHHHHHHhCCCCCCCCCC---hHHHHHHHHhcCCCCCCchhccHHHHHHH
Q 015500          154 QSGGTPMFMAPEVARGEHQGFA-SDIWAVGCTVIEMASGGAPWPNAAD---PMTVLYKIAYSRELPEVPAFLSKQANDFL  229 (405)
Q Consensus       154 ~~~gt~~Y~APE~l~~~~~~~~-sDIwSLG~il~elltG~~Pf~~~~~---~~~~l~~i~~~~~~~~~p~~~s~~l~dll  229 (405)
                      ...||+.|+|||++.+..+..+ +|||||||++|+|++|+.||.....   ....+..+.........+..+++++.+||
T Consensus       176 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  255 (361)
T 3uc3_A          176 STVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLI  255 (361)
T ss_dssp             -----CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHHHHH
T ss_pred             CCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHHHHH
Confidence            4569999999999988777655 8999999999999999999975432   23333333322222222235799999999


Q ss_pred             HHhcccCccccCCHHHHhcCcccccc
Q 015500          230 SNCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       230 ~~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      ++||+.||.+|||+.|+++||||...
T Consensus       256 ~~~L~~dP~~Rps~~ell~hp~f~~~  281 (361)
T 3uc3_A          256 SRIFVADPATRISIPEIKTHSWFLKN  281 (361)
T ss_dssp             HHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred             HHHccCChhHCcCHHHHHhCcchhcC
Confidence            99999999999999999999999764

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1e-49  Score=387.31  Aligned_cols=251  Identities=27%  Similarity=0.416  Sum_probs=196.3

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC----ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP----KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLF   77 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~----~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv   77 (405)
                      +|++++.||+|+||+||+|.++.+|+.||+|.+...    ..+.+.+|+++|++++||||+++++++....    .+++|
T Consensus         6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~----~~~lv   81 (317)
T 2pmi_A            6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTEN----KLTLV   81 (317)
T ss_dssp             -------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTT----EEEEE
T ss_pred             ceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECC----eEEEE
Confidence            589999999999999999999999999999988643    2367889999999999999999999875433    36799


Q ss_pred             EeecCCCCHHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc
Q 015500           78 MEYAPGGTLNDEIHRNG-----GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE  151 (405)
Q Consensus        78 ~Ey~~ggsL~~~i~~~~-----~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~  151 (405)
                      |||++ |+|.+++....     ..+++..++.++.||+.||.|||++||+||||||+|||++.++ +||+|||+++....
T Consensus        82 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  160 (317)
T 2pmi_A           82 FEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI  160 (317)
T ss_dssp             EECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred             EEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence            99997 59999987642     3589999999999999999999999999999999999999887 99999999986432


Q ss_pred             ----cccCCCCCCccChhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhc-CCC-----------
Q 015500          152 ----ALQSGGTPMFMAPEVARG-EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYS-REL-----------  214 (405)
Q Consensus       152 ----~~~~~gt~~Y~APE~l~~-~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~-~~~-----------  214 (405)
                          .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..... ...+..+... ...           
T Consensus       161 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~  239 (317)
T 2pmi_A          161 PVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTND-EEQLKLIFDIMGTPNESLWPSVTKL  239 (317)
T ss_dssp             CCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCSCCTTTCGGGGGC
T ss_pred             CcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCChhHhhhhhhh
Confidence                234568999999999987 4689999999999999999999999965443 3333333211 000           


Q ss_pred             --------------------CCCchhccHHHHHHHHHhcccCccccCCHHHHhcCccccccccc
Q 015500          215 --------------------PEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSC  258 (405)
Q Consensus       215 --------------------~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~~~  258 (405)
                                          +..+..+++++.+||.+||+.||.+|||++|+|+||||+++...
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~  303 (317)
T 2pmi_A          240 PKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHH  303 (317)
T ss_dssp             TTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC-
T ss_pred             hhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccch
Confidence                                00112468899999999999999999999999999999987543

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.5e-49  Score=383.37  Aligned_cols=252  Identities=29%  Similarity=0.388  Sum_probs=207.7

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC--------hHHHHHHHHHHHhCC---CCCeeeeeeeeeecCC-
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK--------SEFLQREQKFLSSLN---SPHIVGYKGCDVTSED-   69 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~--------~~~l~~E~~iL~~L~---hpnIv~~~~~~~~~~~-   69 (405)
                      +|++++.||+|+||+||+|++..+++.||||.+....        ...+.+|+.+++.++   ||||+++++++..... 
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~   89 (308)
T 3g33_A           10 RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTD   89 (308)
T ss_dssp             CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSS
T ss_pred             ceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCC
Confidence            6999999999999999999999999999999876321        346788888888775   9999999998876543 


Q ss_pred             CceEEEEEEeecCCCCHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccc
Q 015500           70 NKLMYNLFMEYAPGGTLNDEIHRNGG-RLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAK  147 (405)
Q Consensus        70 ~~~~~~lv~Ey~~ggsL~~~i~~~~~-~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~  147 (405)
                      ....++++|||+. ++|.+++..... .+++..++.++.||+.||+|||++||+||||||+|||++.++ +||+|||+++
T Consensus        90 ~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  168 (308)
T 3g33_A           90 REIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLAR  168 (308)
T ss_dssp             SEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSCTT
T ss_pred             CceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCcccc
Confidence            3445779999996 599999987542 399999999999999999999999999999999999998887 9999999997


Q ss_pred             cccc---cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCC---C-----
Q 015500          148 WESE---ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELP---E-----  216 (405)
Q Consensus       148 ~~~~---~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~---~-----  216 (405)
                      ....   .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.... ....+.++......+   .     
T Consensus       169 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~  247 (308)
T 3g33_A          169 IYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS-EADQLGKIFDLIGLPPEDDWPRDV  247 (308)
T ss_dssp             TSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSS-HHHHHHHHHHHHCCCCTTTSCSSC
T ss_pred             ccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhCCCChhhccchh
Confidence            6543   234569999999999999999999999999999999999999996543 334443332211110   0     


Q ss_pred             -----------------CchhccHHHHHHHHHhcccCccccCCHHHHhcCcccccc
Q 015500          217 -----------------VPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       217 -----------------~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                                       ....+++++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~  303 (308)
T 3g33_A          248 SLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD  303 (308)
T ss_dssp             SSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred             hccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence                             112478999999999999999999999999999999864

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=4e-50  Score=394.70  Aligned_cols=245  Identities=29%  Similarity=0.457  Sum_probs=210.5

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccC------CChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL------PKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~------~~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~   75 (405)
                      +|++++.||+|+||+||+|.+..+++.||||.+..      .....+.+|+.+|+.++||||+++++++....    .++
T Consensus        10 ~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~----~~~   85 (336)
T 3h4j_B           10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPT----DIV   85 (336)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSS----EEE
T ss_pred             CEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC----EEE
Confidence            58999999999999999999999999999998753      23457899999999999999999999876543    366


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc---
Q 015500           76 LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE---  151 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~---  151 (405)
                      +||||+ +|+|.+++...+ ++++..++.++.||+.||.|||++||+||||||+|||++.++ +||+|||++.....   
T Consensus        86 lv~E~~-~g~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~  163 (336)
T 3h4j_B           86 MVIEYA-GGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF  163 (336)
T ss_dssp             EEECCC-CEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBT
T ss_pred             EEEECC-CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCcc
Confidence            999999 779999998764 899999999999999999999999999999999999999887 99999999986443   


Q ss_pred             cccCCCCCCccChhhhcCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHH
Q 015500          152 ALQSGGTPMFMAPEVARGEHQ-GFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLS  230 (405)
Q Consensus       152 ~~~~~gt~~Y~APE~l~~~~~-~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~  230 (405)
                      ....+||+.|+|||++.+..+ ++++|||||||++|+|++|+.||....... ...+  ........|..+++++.+||+
T Consensus       164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~-~~~~--i~~~~~~~p~~~s~~~~~li~  240 (336)
T 3h4j_B          164 LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN-LFKK--VNSCVYVMPDFLSPGAQSLIR  240 (336)
T ss_dssp             TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT-CBCC--CCSSCCCCCTTSCHHHHHHHH
T ss_pred             cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH-HHHH--HHcCCCCCcccCCHHHHHHHH
Confidence            345679999999999998775 789999999999999999999996543211 1111  112234567789999999999


Q ss_pred             HhcccCccccCCHHHHhcCcccccc
Q 015500          231 NCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       231 ~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      +||+.||.+|||++|+++||||+..
T Consensus       241 ~~L~~dP~~Rpt~~eil~hp~~~~~  265 (336)
T 3h4j_B          241 RMIVADPMQRITIQEIRRDPWFNVN  265 (336)
T ss_dssp             TTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred             HHcCCChhHCcCHHHHHhChhhccC
Confidence            9999999999999999999999864

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=7.7e-50  Score=387.32  Aligned_cols=249  Identities=23%  Similarity=0.328  Sum_probs=206.7

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCC--------
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSED--------   69 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~--------   69 (405)
                      +|++++.||+|+||+||+|+++.+|+.||||.+....    .+.+.+|+++|++|+||||+++++++.....        
T Consensus         7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~   86 (332)
T 3qd2_B            7 DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMD   86 (332)
T ss_dssp             HEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHH
T ss_pred             cCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhh
Confidence            5889999999999999999999999999999986432    3578899999999999999999998765432        


Q ss_pred             ---------------------------------------------CceEEEEEEeecCCCCHHHHHHHcCC--CCCHHHH
Q 015500           70 ---------------------------------------------NKLMYNLFMEYAPGGTLNDEIHRNGG--RLDESLI  102 (405)
Q Consensus        70 ---------------------------------------------~~~~~~lv~Ey~~ggsL~~~i~~~~~--~l~e~~~  102 (405)
                                                                   ...+++++|||++|++|.+++.+...  ..++..+
T Consensus        87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~  166 (332)
T 3qd2_B           87 EIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVC  166 (332)
T ss_dssp             C--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHH
T ss_pred             hhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHH
Confidence                                                         12246799999999999999987532  3566678


Q ss_pred             HHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc----------------ccCCCCCCccChh
Q 015500          103 VSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA----------------LQSGGTPMFMAPE  165 (405)
Q Consensus       103 ~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~----------------~~~~gt~~Y~APE  165 (405)
                      ..++.||+.||+|||++||+||||||+|||++.++ +||+|||+++.....                ....||+.|+|||
T Consensus       167 ~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE  246 (332)
T 3qd2_B          167 LHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPE  246 (332)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCHH
T ss_pred             HHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccChH
Confidence            99999999999999999999999999999999887 999999999764432                2345999999999


Q ss_pred             hhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHhcccCccccCCHHH
Q 015500          166 VARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQ  245 (405)
Q Consensus       166 ~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~e  245 (405)
                      ++.+..+++++|||||||++|+|++|..|+..    .............|..+...++++.+||.+||+.||.+|||++|
T Consensus       247 ~~~~~~~~~~~Di~slG~il~el~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  322 (332)
T 3qd2_B          247 QIHGNNYSHKVDIFSLGLILFELLYSFSTQME----RVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATD  322 (332)
T ss_dssp             HHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH----HHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHH
T ss_pred             HhcCCCCcchhhHHHHHHHHHHHHHcCCChhH----HHHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcCCCHHH
Confidence            99999999999999999999999998777521    12222222334445555667889999999999999999999999


Q ss_pred             HhcCccccc
Q 015500          246 LLKHPFLEE  254 (405)
Q Consensus       246 lL~hp~~~~  254 (405)
                      +|+||||+.
T Consensus       323 ~l~~~~f~~  331 (332)
T 3qd2_B          323 IIENAIFEN  331 (332)
T ss_dssp             HHHSTTCCC
T ss_pred             Hhhchhhhc
Confidence            999999975

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.6e-49  Score=391.71  Aligned_cols=249  Identities=28%  Similarity=0.395  Sum_probs=200.2

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC-ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEee
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP-KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEY   80 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~-~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~Ey   80 (405)
                      .|++.+.||+|+||+||+|.++.+++.||||.+... ..+.+.+|+.+|++++||||+++++++....    .+++||||
T Consensus        54 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~lv~e~  129 (349)
T 2w4o_A           54 FFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPT----EISLVLEL  129 (349)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEECSS----EEEEEECC
T ss_pred             cEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEecCC----eEEEEEEe
Confidence            388899999999999999999999999999998754 3457889999999999999999999876533    36699999


Q ss_pred             cCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcc---CC-ceEeeecccccccc---cc
Q 015500           81 APGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAE---SG-AKIADFGCAKWESE---AL  153 (405)
Q Consensus        81 ~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~---~~-vkL~DFGla~~~~~---~~  153 (405)
                      ++||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.   ++ +||+|||+++....   ..
T Consensus       130 ~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~  208 (349)
T 2w4o_A          130 VTGGELFDRIVEK-GYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMK  208 (349)
T ss_dssp             CCSCBHHHHHTTC-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC------------
T ss_pred             CCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcccccc
Confidence            9999999999775 47999999999999999999999999999999999999975   44 99999999986543   23


Q ss_pred             cCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCC--CCCchhccHHHHHHHHH
Q 015500          154 QSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSREL--PEVPAFLSKQANDFLSN  231 (405)
Q Consensus       154 ~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~--~~~p~~~s~~l~dll~~  231 (405)
                      ...||+.|+|||++.+..+++++|||||||++|+|++|+.||............+......  +.....++.++.+||++
T Consensus       209 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~  288 (349)
T 2w4o_A          209 TVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRK  288 (349)
T ss_dssp             ----CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHT
T ss_pred             cccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHHHHHH
Confidence            4569999999999999999999999999999999999999997666554444444433221  12235689999999999


Q ss_pred             hcccCccccCCHHHHhcCcccccc
Q 015500          232 CLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       232 ~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      ||+.||++|||+.|+|+||||...
T Consensus       289 ~L~~dP~~Rpt~~e~l~hp~~~~~  312 (349)
T 2w4o_A          289 LIVLDPKKRLTTFQALQHPWVTGK  312 (349)
T ss_dssp             TSCSSGGGSCCHHHHHHSTTTTST
T ss_pred             HccCChhhCcCHHHHhcCcccCCC
Confidence            999999999999999999999854

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.6e-49  Score=396.30  Aligned_cols=252  Identities=25%  Similarity=0.365  Sum_probs=206.5

Q ss_pred             Cccccccccee--CCeeEEEEEEcCCCCEEEEEEccCCC-----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEE
Q 015500            2 DWTRGHTIGQG--SSATVSLATSLRSGDVFAAKSTELPK-----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMY   74 (405)
Q Consensus         2 ~y~~~~~LG~G--~~g~Vyla~~~~~~~~vavK~~~~~~-----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~   74 (405)
                      +|++++.||+|  +||+||+|+++.+|+.||||.+....     .+.+.+|+.+|+.++||||+++++++....    .+
T Consensus        26 ~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~  101 (389)
T 3gni_B           26 CYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN----EL  101 (389)
T ss_dssp             GEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT----EE
T ss_pred             cEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECC----EE
Confidence            58999999999  99999999999999999999986432     356888999999999999999999877544    36


Q ss_pred             EEEEeecCCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc-
Q 015500           75 NLFMEYAPGGTLNDEIHRN-GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE-  151 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~i~~~-~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~-  151 (405)
                      ++||||+++|+|.+++... .+.+++..++.++.||+.||+|||++||+||||||+|||++.++ +||+|||++..... 
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~  181 (389)
T 3gni_B          102 WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISH  181 (389)
T ss_dssp             EEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEET
T ss_pred             EEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeeccc
Confidence            7999999999999999874 34799999999999999999999999999999999999999887 99999998764321 


Q ss_pred             ----------cccCCCCCCccChhhhcC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhc--------
Q 015500          152 ----------ALQSGGTPMFMAPEVARG--EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYS--------  211 (405)
Q Consensus       152 ----------~~~~~gt~~Y~APE~l~~--~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~--------  211 (405)
                                .....||+.|+|||++.+  ..++.++|||||||++|+|++|+.||................        
T Consensus       182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  261 (389)
T 3gni_B          182 GQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTS  261 (389)
T ss_dssp             TEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC------------
T ss_pred             cccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccccc
Confidence                      122368999999999988  578999999999999999999999997654332221111000        


Q ss_pred             -----------------------------------CCCCCCchhccHHHHHHHHHhcccCccccCCHHHHhcCccccccc
Q 015500          212 -----------------------------------RELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFC  256 (405)
Q Consensus       212 -----------------------------------~~~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~  256 (405)
                                                         ......+..+++++.+||++||+.||.+|||++|+|+||||+.+.
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~  341 (389)
T 3gni_B          262 TIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK  341 (389)
T ss_dssp             --------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC-
T ss_pred             ccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHh
Confidence                                               000123455789999999999999999999999999999998764


Q ss_pred             c
Q 015500          257 S  257 (405)
Q Consensus       257 ~  257 (405)
                      .
T Consensus       342 ~  342 (389)
T 3gni_B          342 R  342 (389)
T ss_dssp             -
T ss_pred             h
Confidence            3

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-49  Score=397.33  Aligned_cols=249  Identities=27%  Similarity=0.451  Sum_probs=214.3

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC---hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK---SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFM   78 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~---~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (405)
                      +|.+++.||+|+||+||+|.++.+|+.+|+|.+....   ...+.+|+.+|+.|+||||+++++++....    .+++||
T Consensus        52 ~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~----~~~lv~  127 (387)
T 1kob_A           52 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY----EMVLIL  127 (387)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSS----EEEEEE
T ss_pred             ceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCC----EEEEEE
Confidence            4889999999999999999999999999999987653   346889999999999999999999876433    367999


Q ss_pred             eecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccC--C-ceEeeecccccccc---c
Q 015500           79 EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES--G-AKIADFGCAKWESE---A  152 (405)
Q Consensus        79 Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~--~-vkL~DFGla~~~~~---~  152 (405)
                      ||++||+|.+++...+..+++..+..++.||+.||+|||++||+||||||+|||++.+  + +||+|||+++....   .
T Consensus       128 E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~  207 (387)
T 1kob_A          128 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV  207 (387)
T ss_dssp             ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCE
T ss_pred             EcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcce
Confidence            9999999999998766689999999999999999999999999999999999999753  3 99999999986543   2


Q ss_pred             ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCC--CCCCchhccHHHHHHHH
Q 015500          153 LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRE--LPEVPAFLSKQANDFLS  230 (405)
Q Consensus       153 ~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~--~~~~p~~~s~~l~dll~  230 (405)
                      ....||+.|+|||++.+..++.++|||||||++|+|++|..||... +....+..+.....  .+..+..+++++++||.
T Consensus       208 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~  286 (387)
T 1kob_A          208 KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE-DDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIK  286 (387)
T ss_dssp             EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS-SHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHH
T ss_pred             eeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCC-CHHHHHHHHHhCCCCCCccccccCCHHHHHHHH
Confidence            3457999999999999999999999999999999999999999654 34444444443321  12334568999999999


Q ss_pred             HhcccCccccCCHHHHhcCcccccc
Q 015500          231 NCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       231 ~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      +||+.||.+|||+.|+|+||||+..
T Consensus       287 ~~L~~dP~~Rpt~~ell~hp~~~~~  311 (387)
T 1kob_A          287 NLLQKEPRKRLTVHDALEHPWLKGD  311 (387)
T ss_dssp             TTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             HHcCCChhHCcCHHHHhhCccccCC
Confidence            9999999999999999999999864

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=5e-49  Score=383.46  Aligned_cols=246  Identities=34%  Similarity=0.504  Sum_probs=211.1

Q ss_pred             cccccccceeCCeeEEEEEEcCCCCEEEEEEccCC---ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEe
Q 015500            3 WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP---KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFME   79 (405)
Q Consensus         3 y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~---~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (405)
                      |...+.||+|+||+||+|+++.+|+.||||.+...   ..+.+.+|+.+|++++||||+++++++....    .+++|||
T Consensus        47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~lv~e  122 (321)
T 2c30_A           47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGE----ELWVLME  122 (321)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETT----EEEEEEC
T ss_pred             hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECC----EEEEEEe
Confidence            56778999999999999999999999999998643   3567889999999999999999999877644    2679999


Q ss_pred             ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc----ccc
Q 015500           80 YAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE----ALQ  154 (405)
Q Consensus        80 y~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~----~~~  154 (405)
                      |++|++|.+++.+.  ++++..+..++.||+.||.|||++||+||||||+|||++.++ +||+|||++.....    ...
T Consensus       123 ~~~~~~L~~~l~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  200 (321)
T 2c30_A          123 FLQGGALTDIVSQV--RLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS  200 (321)
T ss_dssp             CCCSCBHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCC
T ss_pred             cCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcccccc
Confidence            99999999988653  699999999999999999999999999999999999999887 99999999876443    234


Q ss_pred             CCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCC-CCCCchhccHHHHHHHHHhc
Q 015500          155 SGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRE-LPEVPAFLSKQANDFLSNCL  233 (405)
Q Consensus       155 ~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~-~~~~p~~~s~~l~dll~~~L  233 (405)
                      ..||+.|+|||++.+..++.++|||||||++|+|++|+.||... ........+..... ....+..+++.+.+||.+||
T Consensus       201 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  279 (321)
T 2c30_A          201 LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSD-SPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERML  279 (321)
T ss_dssp             CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS-CHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHS
T ss_pred             ccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHc
Confidence            56999999999999999999999999999999999999999644 34444444433321 11234568999999999999


Q ss_pred             ccCccccCCHHHHhcCcccccc
Q 015500          234 RRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       234 ~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      +.||.+|||+.++++||||...
T Consensus       280 ~~dp~~Rps~~ell~hp~~~~~  301 (321)
T 2c30_A          280 VRDPQERATAQELLDHPFLLQT  301 (321)
T ss_dssp             CSSTTTSCCHHHHHTSGGGGGC
T ss_pred             cCChhhCcCHHHHhcChhhccC
Confidence            9999999999999999999753

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=3.7e-49  Score=375.14  Aligned_cols=247  Identities=29%  Similarity=0.473  Sum_probs=212.0

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC------ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~------~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~   75 (405)
                      +|++++.||+|+||+||+|.+..+++.+|+|.+...      ....+.+|+.++++++||||+++++++....    .++
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~   85 (279)
T 3fdn_A           10 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT----RVY   85 (279)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS----EEE
T ss_pred             cEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCC----EEE
Confidence            589999999999999999999999999999987532      3457889999999999999999999875443    367


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc--c
Q 015500           76 LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE--A  152 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~--~  152 (405)
                      +||||+++++|.+++...+ ++++..+..++.||+.||.|||++||+||||||+||+++.++ +||+|||++.....  .
T Consensus        86 lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~~  164 (279)
T 3fdn_A           86 LILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR  164 (279)
T ss_dssp             EEECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC-----
T ss_pred             EEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcccc
Confidence            9999999999999998764 799999999999999999999999999999999999998887 99999999865443  3


Q ss_pred             ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHh
Q 015500          153 LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNC  232 (405)
Q Consensus       153 ~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~  232 (405)
                      ....||+.|+|||++.+..++.++|||||||++|+|++|+.||... ........+..  .....|..+++.+.+||.+|
T Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~  241 (279)
T 3fdn_A          165 TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN-TYQETYKRISR--VEFTFPDFVTEGARDLISRL  241 (279)
T ss_dssp             ---CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS-SHHHHHHHHHH--TCCCCCTTSCHHHHHHHHHH
T ss_pred             cccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCC-cHHHHHHHHHh--CCCCCCCcCCHHHHHHHHHH
Confidence            3457999999999999999999999999999999999999999643 33333333332  23356777899999999999


Q ss_pred             cccCccccCCHHHHhcCccccccc
Q 015500          233 LRRDPKERWAASQLLKHPFLEEFC  256 (405)
Q Consensus       233 L~~dP~~Rpt~~elL~hp~~~~~~  256 (405)
                      |+.||.+|||+.|+|+||||+...
T Consensus       242 l~~~p~~Rps~~e~l~h~~~~~~~  265 (279)
T 3fdn_A          242 LKHNPSQRPMLREVLEHPWITANS  265 (279)
T ss_dssp             CCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred             hccChhhCCCHHHHhhCccccCCc
Confidence            999999999999999999998754

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=2e-49  Score=386.33  Aligned_cols=250  Identities=28%  Similarity=0.413  Sum_probs=204.3

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCChH----HHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSE----FLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLF   77 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~~~----~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv   77 (405)
                      +|++++.||+|+||+||+|.++.+++.||||.+......    .+.+|+++|++++||||+++++++.....    +++|
T Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~----~~lv   78 (324)
T 3mtl_A            3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKS----LTLV   78 (324)
T ss_dssp             SEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSC----EEEE
T ss_pred             ceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCE----EEEE
Confidence            699999999999999999999999999999998754322    45579999999999999999998765443    6699


Q ss_pred             EeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc----c
Q 015500           78 MEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE----A  152 (405)
Q Consensus        78 ~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~----~  152 (405)
                      |||++ |+|.+++...+..+++..++.++.||+.||.|||++||+||||||+|||++.++ +||+|||+++....    .
T Consensus        79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~  157 (324)
T 3mtl_A           79 FEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY  157 (324)
T ss_dssp             EECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred             ecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcccc
Confidence            99997 499999988777899999999999999999999999999999999999999887 99999999975443    2


Q ss_pred             ccCCCCCCccChhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCC---CC-----------
Q 015500          153 LQSGGTPMFMAPEVARG-EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELP---EV-----------  217 (405)
Q Consensus       153 ~~~~gt~~Y~APE~l~~-~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~---~~-----------  217 (405)
                      ....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.... ....+..+......|   .+           
T Consensus       158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  236 (324)
T 3mtl_A          158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGST-VEEQLHFIFRILGTPTEETWPGILSNEEFKT  236 (324)
T ss_dssp             -----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHHHCCCCTTTSTTGGGCHHHHH
T ss_pred             ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhCCCChHhchhhhcchhhcc
Confidence            23468999999999987 568999999999999999999999996543 333333322211110   11           


Q ss_pred             --------------chhccHHHHHHHHHhcccCccccCCHHHHhcCcccccccc
Q 015500          218 --------------PAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCS  257 (405)
Q Consensus       218 --------------p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~~  257 (405)
                                    +..+++++.+||++||+.||.+|||++|+|+||||.....
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  290 (324)
T 3mtl_A          237 YNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE  290 (324)
T ss_dssp             TCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred             cccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence                          1236889999999999999999999999999999997654

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=5.5e-49  Score=387.99  Aligned_cols=247  Identities=34%  Similarity=0.531  Sum_probs=215.1

Q ss_pred             cccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC------hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEE
Q 015500            3 WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK------SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         3 y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~------~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      |...+.||+|+||+||+|.+..+|+.||||.+....      .+.+.+|+++|++++||||+++++++....    .+++
T Consensus        56 y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~----~~~l  131 (348)
T 1u5q_A           56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH----TAWL  131 (348)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT----EEEE
T ss_pred             eeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC----eEEE
Confidence            778899999999999999999999999999986532      246789999999999999999999876543    3669


Q ss_pred             EEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccccccC
Q 015500           77 FMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQS  155 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~~~~  155 (405)
                      ||||+. |+|.+++....+++++..+..++.||+.||.|||++||+||||||+|||++.++ +||+|||+++........
T Consensus       132 v~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~  210 (348)
T 1u5q_A          132 VMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSF  210 (348)
T ss_dssp             EEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBCCC
T ss_pred             EEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCCCcc
Confidence            999997 589888877667899999999999999999999999999999999999999888 999999999887766677


Q ss_pred             CCCCCccChhhhc---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHh
Q 015500          156 GGTPMFMAPEVAR---GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNC  232 (405)
Q Consensus       156 ~gt~~Y~APE~l~---~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~  232 (405)
                      .||+.|+|||++.   +..++.++|||||||++|||++|+.||... +....+..+......+..+..+++.+.+||.+|
T Consensus       211 ~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  289 (348)
T 1u5q_A          211 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNESPALQSGHWSEYFRNFVDSC  289 (348)
T ss_dssp             CSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS-CHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHH
T ss_pred             cCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHH
Confidence            8999999999985   467889999999999999999999999654 344455555544444444567899999999999


Q ss_pred             cccCccccCCHHHHhcCcccccc
Q 015500          233 LRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       233 L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      |+.||.+|||++++|+||||...
T Consensus       290 l~~dP~~Rps~~~ll~h~~~~~~  312 (348)
T 1u5q_A          290 LQKIPQDRPTSEVLLKHRFVLRE  312 (348)
T ss_dssp             TCSSGGGSCCHHHHTTCHHHHSC
T ss_pred             cccChhhCcCHHHHhhChhhhcc
Confidence            99999999999999999999753

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=2.9e-49  Score=384.47  Aligned_cols=249  Identities=23%  Similarity=0.375  Sum_probs=211.9

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHhCC-CCCeeeeeeeeeecCCCceEEEEEEee
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLN-SPHIVGYKGCDVTSEDNKLMYNLFMEY   80 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~~~~l~~E~~iL~~L~-hpnIv~~~~~~~~~~~~~~~~~lv~Ey   80 (405)
                      +|++++.||+|+||+||+|.+..+++.||||.+.....+.+.+|+.+|++++ ||||+++++++......  .+++||||
T Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~--~~~lv~e~  114 (330)
T 3nsz_A           37 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSR--TPALVFEH  114 (330)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTC--CEEEEEEC
T ss_pred             ceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCC--ceEEEEec
Confidence            5889999999999999999999999999999998888889999999999997 99999999987653332  35699999


Q ss_pred             cCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC--ceEeeecccccccc---cccC
Q 015500           81 APGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG--AKIADFGCAKWESE---ALQS  155 (405)
Q Consensus        81 ~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~--vkL~DFGla~~~~~---~~~~  155 (405)
                      +++++|.+++.    .+++..++.++.||+.||+|||++||+||||||+|||++.++  +||+|||+++....   ....
T Consensus       115 ~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~  190 (330)
T 3nsz_A          115 VNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR  190 (330)
T ss_dssp             CCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSC
T ss_pred             cCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCccccc
Confidence            99999998874    489999999999999999999999999999999999998665  99999999976443   3345


Q ss_pred             CCCCCccChhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcC------------C---------
Q 015500          156 GGTPMFMAPEVARG-EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSR------------E---------  213 (405)
Q Consensus       156 ~gt~~Y~APE~l~~-~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~------------~---------  213 (405)
                      .||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....+....+..+....            .         
T Consensus       191 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (330)
T 3nsz_A          191 VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFND  270 (330)
T ss_dssp             CSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHH
T ss_pred             cccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhh
Confidence            69999999999987 6789999999999999999999999976655544443322110            0         


Q ss_pred             --------------CCCCchhccHHHHHHHHHhcccCccccCCHHHHhcCccccccc
Q 015500          214 --------------LPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFC  256 (405)
Q Consensus       214 --------------~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~  256 (405)
                                    ....+..+++++.+||.+||+.||.+|||++|+|+||||+.+.
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  327 (330)
T 3nsz_A          271 ILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV  327 (330)
T ss_dssp             HHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred             hhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence                          0112233799999999999999999999999999999998764

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=2.7e-49  Score=386.17  Aligned_cols=245  Identities=24%  Similarity=0.329  Sum_probs=192.1

Q ss_pred             ccccceeCCeeEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHhCC-CCCeeeeeeeeeecCCCceEEEEEEeecCCC
Q 015500            6 GHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLN-SPHIVGYKGCDVTSEDNKLMYNLFMEYAPGG   84 (405)
Q Consensus         6 ~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~~~~l~~E~~iL~~L~-hpnIv~~~~~~~~~~~~~~~~~lv~Ey~~gg   84 (405)
                      ++.||+|+||+||+|.++.+++.||||.+.......+.+|+.+|+.+. ||||+++++++....    .+++||||++||
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~----~~~lv~e~~~~~   91 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQL----HTFLVMELLNGG   91 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS----EEEEEECCCCSC
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCC----EEEEEEEccCCC
Confidence            588999999999999999999999999998777788999999999997 999999999876433    367999999999


Q ss_pred             CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC----ceEeeecccccccc----cccCC
Q 015500           85 TLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG----AKIADFGCAKWESE----ALQSG  156 (405)
Q Consensus        85 sL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~----vkL~DFGla~~~~~----~~~~~  156 (405)
                      +|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++    +||+|||+++....    ....+
T Consensus        92 ~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  170 (325)
T 3kn6_A           92 ELFERIKKK-KHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC  170 (325)
T ss_dssp             BHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC---------
T ss_pred             cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcccccC
Confidence            999999876 4899999999999999999999999999999999999997653    89999999975433    23456


Q ss_pred             CCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC------hHHHHHHHHhcCCCCCC--chhccHHHHHH
Q 015500          157 GTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAAD------PMTVLYKIAYSRELPEV--PAFLSKQANDF  228 (405)
Q Consensus       157 gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~------~~~~l~~i~~~~~~~~~--p~~~s~~l~dl  228 (405)
                      ||+.|+|||++.+..++.++|||||||++|+|++|+.||.....      ....+.++.........  ...+++++++|
T Consensus       171 ~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  250 (325)
T 3kn6_A          171 FTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDL  250 (325)
T ss_dssp             -------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSCHHHHHH
T ss_pred             CCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCCHHHHHH
Confidence            89999999999999999999999999999999999999965332      23333343332211111  13589999999


Q ss_pred             HHHhcccCccccCCHHHHhcCcccccc
Q 015500          229 LSNCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       229 l~~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      |.+||+.||.+|||++++++||||+..
T Consensus       251 i~~~L~~dP~~Rpt~~ell~h~w~~~~  277 (325)
T 3kn6_A          251 IQGLLTVDPNKRLKMSGLRYNEWLQDG  277 (325)
T ss_dssp             HHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred             HHHHCCCChhHCCCHHHHhcChhhccC
Confidence            999999999999999999999999864

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=2e-49  Score=403.30  Aligned_cols=247  Identities=29%  Similarity=0.453  Sum_probs=207.5

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC------ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~------~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~   75 (405)
                      +|++++.||+|+||+||+|.++.+|+.||||.+...      ....+.+|+.+|+.++||||+++++++....    .++
T Consensus       149 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~----~~~  224 (446)
T 4ejn_A          149 EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD----RLC  224 (446)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETT----EEE
T ss_pred             HcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCC----EEE
Confidence            488999999999999999999999999999987532      2356778999999999999999999876544    267


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCCEEEccCC-ceEeeecccccccc--
Q 015500           76 LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHS-NRVVHCDIKSRNILMAESG-AKIADFGCAKWESE--  151 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~-~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~--  151 (405)
                      +||||++||+|.+++.+.+ .+++..++.++.||+.||+|||+ +||+||||||+|||++.++ +||+|||+++....  
T Consensus       225 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  303 (446)
T 4ejn_A          225 FVMEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG  303 (446)
T ss_dssp             EEECCCSSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC--
T ss_pred             EEEeeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCC
Confidence            9999999999999998764 89999999999999999999998 9999999999999999887 99999999975322  


Q ss_pred             --cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHH
Q 015500          152 --ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFL  229 (405)
Q Consensus       152 --~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll  229 (405)
                        ....+||+.|+|||++.+..++.++|||||||++|||++|+.||... +.......+...  ...+|..+++++.+||
T Consensus       304 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~-~~~~~~~~i~~~--~~~~p~~~~~~~~~li  380 (446)
T 4ejn_A          304 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-DHEKLFELILME--EIRFPRTLGPEAKSLL  380 (446)
T ss_dssp             ---CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHC--CCCCCTTSCHHHHHHH
T ss_pred             cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCC-CHHHHHHHHHhC--CCCCCccCCHHHHHHH
Confidence              33567999999999999999999999999999999999999999644 334444444332  2356778999999999


Q ss_pred             HHhcccCccccC-----CHHHHhcCccccccc
Q 015500          230 SNCLRRDPKERW-----AASQLLKHPFLEEFC  256 (405)
Q Consensus       230 ~~~L~~dP~~Rp-----t~~elL~hp~~~~~~  256 (405)
                      .+||+.||.+||     |++|+++||||+.+.
T Consensus       381 ~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~  412 (446)
T 4ejn_A          381 SGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIV  412 (446)
T ss_dssp             HHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred             HHHcccCHHHhCCCCCCCHHHHHhCccccCCC
Confidence            999999999999     999999999999764

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=7.6e-49  Score=399.98  Aligned_cols=255  Identities=26%  Similarity=0.329  Sum_probs=193.8

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC-----ChHHHHHHHHHHHhCCCCCeeeeeeeeeecC-CCceEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP-----KSEFLQREQKFLSSLNSPHIVGYKGCDVTSE-DNKLMYN   75 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~-----~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~-~~~~~~~   75 (405)
                      +|++++.||+|+||+||+|+++.+++.||||++...     ..+.+.+|+++|+.|+||||+++++++.... .....+|
T Consensus        54 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  133 (458)
T 3rp9_A           54 RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELY  133 (458)
T ss_dssp             TEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEE
T ss_pred             CeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEE
Confidence            589999999999999999999999999999988643     2356889999999999999999999875543 2223466


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc---
Q 015500           76 LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE---  151 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~---  151 (405)
                      +||||+ +++|.+++... +.+++..++.+++||+.||+|||++||+||||||+||||+.++ +||+|||+++....   
T Consensus       134 lv~e~~-~~~L~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~  211 (458)
T 3rp9_A          134 VVLEIA-DSDFKKLFRTP-VYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPEN  211 (458)
T ss_dssp             EEECCC-SEEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTT
T ss_pred             EEEecc-ccchhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCccc
Confidence            999998 56999998765 4899999999999999999999999999999999999999987 99999999986431   


Q ss_pred             ----------------------------cccCCCCCCccChhhh-cCCCCCcchhHHHHHHHHHHHHh-----------C
Q 015500          152 ----------------------------ALQSGGTPMFMAPEVA-RGEHQGFASDIWAVGCTVIEMAS-----------G  191 (405)
Q Consensus       152 ----------------------------~~~~~gt~~Y~APE~l-~~~~~~~~sDIwSLG~il~ellt-----------G  191 (405)
                                                  ....+||++|+|||++ .+..++.++|||||||++|||++           |
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~  291 (458)
T 3rp9_A          212 GNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADR  291 (458)
T ss_dssp             CCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGC
T ss_pred             cccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccccc
Confidence                                        1234689999999986 45679999999999999999999           6


Q ss_pred             CCCCCCCCC-------------------hHHHHHHHHhc---------------------CCCC--------CCchhccH
Q 015500          192 GAPWPNAAD-------------------PMTVLYKIAYS---------------------RELP--------EVPAFLSK  223 (405)
Q Consensus       192 ~~Pf~~~~~-------------------~~~~l~~i~~~---------------------~~~~--------~~p~~~s~  223 (405)
                      +++|+....                   ....+..+...                     ...+        ......++
T Consensus       292 ~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  371 (458)
T 3rp9_A          292 GPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSA  371 (458)
T ss_dssp             CCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCH
T ss_pred             cccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCH
Confidence            777754321                   01111111100                     0011        11234589


Q ss_pred             HHHHHHHHhcccCccccCCHHHHhcCccccccccc
Q 015500          224 QANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSC  258 (405)
Q Consensus       224 ~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~~~  258 (405)
                      ++.+||++||++||.+|||++|+|+||||+.+...
T Consensus       372 ~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~  406 (458)
T 3rp9_A          372 DAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIA  406 (458)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCG
T ss_pred             HHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCC
Confidence            99999999999999999999999999999987543

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=4.3e-49  Score=376.74  Aligned_cols=247  Identities=29%  Similarity=0.443  Sum_probs=203.9

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC----ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP----KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLF   77 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~----~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv   77 (405)
                      +|.+.+.||+|+||+||+|.++.+++.+|+|.+...    ..+.+.+|+++|++++||||+++++++....    .+++|
T Consensus        23 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~----~~~lv   98 (285)
T 3is5_A           23 LFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYH----NMYIV   98 (285)
T ss_dssp             HEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS----EEEEE
T ss_pred             heeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCC----eEEEE
Confidence            388999999999999999999999999999987643    3468999999999999999999999875433    36799


Q ss_pred             EeecCCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcc---CC-ceEeeeccccccc
Q 015500           78 MEYAPGGTLNDEIHR---NGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAE---SG-AKIADFGCAKWES  150 (405)
Q Consensus        78 ~Ey~~ggsL~~~i~~---~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~---~~-vkL~DFGla~~~~  150 (405)
                      |||++||+|.+++..   .+..+++..+..++.||+.||+|||++||+||||||+||+++.   ++ +||+|||++....
T Consensus        99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~  178 (285)
T 3is5_A           99 METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK  178 (285)
T ss_dssp             ECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred             EEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence            999999999998854   3457999999999999999999999999999999999999954   34 9999999997644


Q ss_pred             c---cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcC-CCCCCchhccHHHH
Q 015500          151 E---ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSR-ELPEVPAFLSKQAN  226 (405)
Q Consensus       151 ~---~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~-~~~~~p~~~s~~l~  226 (405)
                      .   .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.... ............ ..+.....+++++.
T Consensus       179 ~~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~il~~ll~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (285)
T 3is5_A          179 SDEHSTNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPFTGTS-LEEVQQKATYKEPNYAVECRPLTPQAV  256 (285)
T ss_dssp             --------CTTGGGCCHHHHTT-CCCHHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHCCCCCCC--CCCCHHHH
T ss_pred             CcccCcCcccccCcCChHHhcc-CCCcccCeehHHHHHHHHHhCCCCCCCCC-HHHHHhhhccCCcccccccCcCCHHHH
Confidence            3   334569999999999864 67899999999999999999999996543 333333333322 22222334789999


Q ss_pred             HHHHHhcccCccccCCHHHHhcCccccc
Q 015500          227 DFLSNCLRRDPKERWAASQLLKHPFLEE  254 (405)
Q Consensus       227 dll~~~L~~dP~~Rpt~~elL~hp~~~~  254 (405)
                      +||.+||+.||.+|||+.|+|+||||++
T Consensus       257 ~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          257 DLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             HHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             HHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence            9999999999999999999999999975

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=5.6e-49  Score=395.09  Aligned_cols=252  Identities=23%  Similarity=0.363  Sum_probs=203.1

Q ss_pred             Ccccc-cccceeCCeeEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHH-hCCCCCeeeeeeeeeecCCCceEEEEEEe
Q 015500            2 DWTRG-HTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLS-SLNSPHIVGYKGCDVTSEDNKLMYNLFME   79 (405)
Q Consensus         2 ~y~~~-~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~~~~l~~E~~iL~-~L~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (405)
                      +|.+. +.||+|+||+||+|.++.+|+.||||++..  ...+.+|+.++. .++||||+++++++.........+++|||
T Consensus        62 ~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~--~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E  139 (400)
T 1nxk_A           62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVME  139 (400)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC--SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred             cceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc--chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEE
Confidence            35555 789999999999999999999999999863  456888999875 45899999999987664444556789999


Q ss_pred             ecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcc---CC-ceEeeecccccccc---
Q 015500           80 YAPGGTLNDEIHRNG-GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAE---SG-AKIADFGCAKWESE---  151 (405)
Q Consensus        80 y~~ggsL~~~i~~~~-~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~---~~-vkL~DFGla~~~~~---  151 (405)
                      |++||+|.+++...+ ..+++..++.++.||+.||.|||++||+||||||+|||++.   ++ +||+|||+++....   
T Consensus       140 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~~  219 (400)
T 1nxk_A          140 CLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS  219 (400)
T ss_dssp             CCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC----
T ss_pred             eCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccCCCCc
Confidence            999999999998753 36999999999999999999999999999999999999987   44 99999999986543   


Q ss_pred             cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChH---HHHHHHHhcCC-CC-CCchhccHHHH
Q 015500          152 ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPM---TVLYKIAYSRE-LP-EVPAFLSKQAN  226 (405)
Q Consensus       152 ~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~---~~l~~i~~~~~-~~-~~p~~~s~~l~  226 (405)
                      ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.......   ....++..... .+ .....++++++
T Consensus       220 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  299 (400)
T 1nxk_A          220 LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVK  299 (400)
T ss_dssp             -------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTTSCHHHH
T ss_pred             cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcccccCCHHHH
Confidence            335679999999999999999999999999999999999999996543211   12222222221 11 11245899999


Q ss_pred             HHHHHhcccCccccCCHHHHhcCcccccc
Q 015500          227 DFLSNCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       227 dll~~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      +||++||+.||.+|||+.++|+||||...
T Consensus       300 ~li~~~L~~dP~~Rpt~~eil~hp~~~~~  328 (400)
T 1nxk_A          300 MLIRNLLKTEPTQRMTITEFMNHPWIMQS  328 (400)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             HHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence            99999999999999999999999999753

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=3.5e-49  Score=393.10  Aligned_cols=247  Identities=28%  Similarity=0.410  Sum_probs=205.7

Q ss_pred             ccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC---hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEee
Q 015500            4 TRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK---SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEY   80 (405)
Q Consensus         4 ~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~---~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~Ey   80 (405)
                      ...+.||+|+||+||+|.+..+|+.||+|.+....   .+.+.+|+++|++|+||||+++++++....    .+++||||
T Consensus        92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~----~~~lv~E~  167 (373)
T 2x4f_A           92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKN----DIVLVMEY  167 (373)
T ss_dssp             EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS----EEEEEEEC
T ss_pred             ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECC----EEEEEEeC
Confidence            34678999999999999999999999999987653   457889999999999999999999876543    36799999


Q ss_pred             cCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEc--cCC-ceEeeecccccccc---ccc
Q 015500           81 APGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMA--ESG-AKIADFGCAKWESE---ALQ  154 (405)
Q Consensus        81 ~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~--~~~-vkL~DFGla~~~~~---~~~  154 (405)
                      ++|++|.+++......+++..+..++.||+.||+|||++||+||||||+|||+.  .++ +||+|||+++....   ...
T Consensus       168 ~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~  247 (373)
T 2x4f_A          168 VDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV  247 (373)
T ss_dssp             CTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCC
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccccc
Confidence            999999999987666799999999999999999999999999999999999994  444 99999999986543   234


Q ss_pred             CCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCC--CCCchhccHHHHHHHHHh
Q 015500          155 SGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSREL--PEVPAFLSKQANDFLSNC  232 (405)
Q Consensus       155 ~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~--~~~p~~~s~~l~dll~~~  232 (405)
                      ..||+.|+|||++.+..++.++|||||||++|+|++|+.||... +....+..+......  +.....+++++++||.+|
T Consensus       248 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~  326 (373)
T 2x4f_A          248 NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGD-NDAETLNNILACRWDLEDEEFQDISEEAKEFISKL  326 (373)
T ss_dssp             CCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCS-SHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTT
T ss_pred             ccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhccCCCChhhhccCCHHHHHHHHHH
Confidence            56999999999999999999999999999999999999999654 344444444433221  122345899999999999


Q ss_pred             cccCccccCCHHHHhcCcccccc
Q 015500          233 LRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       233 L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      |+.||.+|||+.|+|+||||...
T Consensus       327 L~~dp~~Rps~~e~l~hp~~~~~  349 (373)
T 2x4f_A          327 LIKEKSWRISASEALKHPWLSDH  349 (373)
T ss_dssp             SCSSGGGSCCHHHHHHSHHHHCH
T ss_pred             cCCChhhCCCHHHHhcCcCcCCC
Confidence            99999999999999999999865

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=4e-49  Score=392.88  Aligned_cols=248  Identities=26%  Similarity=0.379  Sum_probs=206.8

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC------hHHHHHHHHH-HHhCCCCCeeeeeeeeeecCCCceEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK------SEFLQREQKF-LSSLNSPHIVGYKGCDVTSEDNKLMY   74 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~------~~~l~~E~~i-L~~L~hpnIv~~~~~~~~~~~~~~~~   74 (405)
                      +|.+++.||+|+||+||+|+++.+++.||+|++....      ...+.+|..+ ++.++||||+++++++....    .+
T Consensus        39 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~----~~  114 (373)
T 2r5t_A           39 DFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD----KL  114 (373)
T ss_dssp             GEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSS----EE
T ss_pred             heEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCC----EE
Confidence            5889999999999999999999999999999886432      2355667766 57789999999998876543    36


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc--
Q 015500           75 NLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE--  151 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~--  151 (405)
                      |+||||++||+|.+++.+. +.+++..++.++.||+.||+|||++||+||||||+|||++.++ +||+|||+++....  
T Consensus       115 ~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~  193 (373)
T 2r5t_A          115 YFVLDYINGGELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN  193 (373)
T ss_dssp             EEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC
T ss_pred             EEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccCC
Confidence            7999999999999999876 4899999999999999999999999999999999999999888 99999999975322  


Q ss_pred             --cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHH
Q 015500          152 --ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFL  229 (405)
Q Consensus       152 --~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll  229 (405)
                        ....+||+.|+|||++.+..++.++|||||||++|||++|..||... +......++...  ...+|..+++++++||
T Consensus       194 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~-~~~~~~~~i~~~--~~~~~~~~~~~~~~li  270 (373)
T 2r5t_A          194 STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR-NTAEMYDNILNK--PLQLKPNITNSARHLL  270 (373)
T ss_dssp             CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS-BHHHHHHHHHHS--CCCCCSSSCHHHHHHH
T ss_pred             CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHHhc--ccCCCCCCCHHHHHHH
Confidence              34567999999999999999999999999999999999999999543 444444444432  2356677999999999


Q ss_pred             HHhcccCccccCCH----HHHhcCcccccccc
Q 015500          230 SNCLRRDPKERWAA----SQLLKHPFLEEFCS  257 (405)
Q Consensus       230 ~~~L~~dP~~Rpt~----~elL~hp~~~~~~~  257 (405)
                      ++||++||.+||++    .++++||||+.+..
T Consensus       271 ~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w  302 (373)
T 2r5t_A          271 EGLLQKDRTKRLGAKDDFMEIKSHVFFSLINW  302 (373)
T ss_dssp             HHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCH
T ss_pred             HHHcccCHHhCCCCCCCHHHHhCCccccCCCH
Confidence            99999999999997    69999999987643

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=5e-49  Score=384.32  Aligned_cols=247  Identities=27%  Similarity=0.432  Sum_probs=201.7

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      +|++++.||+|+||+||+|.+..+++.||||.+....     ...+.+|+++|++++||||+++++++....    .+++
T Consensus        35 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~l  110 (329)
T 3gbz_A           35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNH----RLHL  110 (329)
T ss_dssp             GEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETT----EEEE
T ss_pred             hEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCC----EEEE
Confidence            5899999999999999999999999999999987543     235679999999999999999999876543    3679


Q ss_pred             EEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcc-----CC-ceEeeeccccccc
Q 015500           77 FMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAE-----SG-AKIADFGCAKWES  150 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~-----~~-vkL~DFGla~~~~  150 (405)
                      ||||++| +|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.     ++ +||+|||+++...
T Consensus       111 v~e~~~~-~L~~~~~~~~-~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~  188 (329)
T 3gbz_A          111 IFEYAEN-DLKKYMDKNP-DVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG  188 (329)
T ss_dssp             EEECCSE-EHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred             EEecCCC-CHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence            9999975 9999998764 7999999999999999999999999999999999999953     33 8999999997643


Q ss_pred             c----cccCCCCCCccChhhhcCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCC---------
Q 015500          151 E----ALQSGGTPMFMAPEVARGE-HQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPE---------  216 (405)
Q Consensus       151 ~----~~~~~gt~~Y~APE~l~~~-~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~---------  216 (405)
                      .    .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.... ....+.++......|.         
T Consensus       189 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  267 (329)
T 3gbz_A          189 IPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDS-EIDQLFKIFEVLGLPDDTTWPGVTA  267 (329)
T ss_dssp             -----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             CcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCC-HHHHHHHHHHHhCCCchhhhhhhhh
Confidence            2    2345689999999999874 48999999999999999999999996544 3344443332211111         


Q ss_pred             -------------------CchhccHHHHHHHHHhcccCccccCCHHHHhcCcccccc
Q 015500          217 -------------------VPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       217 -------------------~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                                         ++..+++++.+||.+||+.||.+|||++|+|+||||+..
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  325 (329)
T 3gbz_A          268 LPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN  325 (329)
T ss_dssp             STTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred             hhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence                               012268999999999999999999999999999999865

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.4e-48  Score=370.44  Aligned_cols=246  Identities=26%  Similarity=0.383  Sum_probs=210.0

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccC---CChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL---PKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFM   78 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~---~~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (405)
                      +|++.+.||+|+||+||+|.++.++..+|+|.+..   ...+.+.+|+++|++++||||+++++++....    .+++||
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~   85 (277)
T 3f3z_A           10 YYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNT----DIYLVM   85 (277)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS----EEEEEE
T ss_pred             hEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCC----eEEEEE
Confidence            48899999999999999999999999999998764   34678999999999999999999999876433    367999


Q ss_pred             eecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEE---ccCC-ceEeeecccccccc---
Q 015500           79 EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILM---AESG-AKIADFGCAKWESE---  151 (405)
Q Consensus        79 Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi---~~~~-vkL~DFGla~~~~~---  151 (405)
                      ||++|++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+||++   +.++ +||+|||++.....   
T Consensus        86 e~~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~  164 (277)
T 3f3z_A           86 ELCTGGELFERVVHKR-VFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM  164 (277)
T ss_dssp             ECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSC
T ss_pred             eccCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccc
Confidence            9999999999998764 79999999999999999999999999999999999999   5555 99999999976443   


Q ss_pred             cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCch----hccHHHHH
Q 015500          152 ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPA----FLSKQAND  227 (405)
Q Consensus       152 ~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~----~~s~~l~d  227 (405)
                      .....||+.|+|||++.+. +++++|||||||++|+|++|+.||.... .......+.....  ..|.    .+++.+.+
T Consensus       165 ~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~-~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~  240 (277)
T 3f3z_A          165 MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPT-DSEVMLKIREGTF--TFPEKDWLNVSPQAES  240 (277)
T ss_dssp             BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHCCC--CCCHHHHTTSCHHHHH
T ss_pred             hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCC-HHHHHHHHHhCCC--CCCchhhhcCCHHHHH
Confidence            3345699999999998765 8899999999999999999999996543 3444444433322  2222    57999999


Q ss_pred             HHHHhcccCccccCCHHHHhcCccccccc
Q 015500          228 FLSNCLRRDPKERWAASQLLKHPFLEEFC  256 (405)
Q Consensus       228 ll~~~L~~dP~~Rpt~~elL~hp~~~~~~  256 (405)
                      ||.+||+.||.+|||+.++|+||||++..
T Consensus       241 li~~~l~~dp~~R~s~~~~l~h~~~~~~~  269 (277)
T 3f3z_A          241 LIRRLLTKSPKQRITSLQALEHEWFEKQL  269 (277)
T ss_dssp             HHHHHTCSSTTTSCCHHHHTTSHHHHHHH
T ss_pred             HHHHHccCChhhCcCHHHHhcCHHHhccc
Confidence            99999999999999999999999998653

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=4.6e-49  Score=404.33  Aligned_cols=246  Identities=31%  Similarity=0.462  Sum_probs=214.6

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC------ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~------~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~   75 (405)
                      +|.+++.||+|+||+||+|.+..+|+.||||++...      ..+.+.+|+.+|+.++||||+++++++....    .++
T Consensus        17 ~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~----~~~   92 (476)
T 2y94_A           17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPS----DIF   92 (476)
T ss_dssp             TEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSS----EEE
T ss_pred             CEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC----EEE
Confidence            589999999999999999999999999999998542      3467899999999999999999999876543    367


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc---
Q 015500           76 LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE---  151 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~---  151 (405)
                      +||||++||+|.+++.++ +++++..++.++.||+.||+|||++||+||||||+|||++.++ +||+|||+++....   
T Consensus        93 lv~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~  171 (476)
T 2y94_A           93 MVMEYVSGGELFDYICKN-GRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF  171 (476)
T ss_dssp             EEEECCSSEEHHHHTTSS-SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCC
T ss_pred             EEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccccc
Confidence            999999999999999765 4899999999999999999999999999999999999999887 99999999986543   


Q ss_pred             cccCCCCCCccChhhhcCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHH
Q 015500          152 ALQSGGTPMFMAPEVARGEHQ-GFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLS  230 (405)
Q Consensus       152 ~~~~~gt~~Y~APE~l~~~~~-~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~  230 (405)
                      ....+||+.|+|||++.+..+ ++++|||||||++|+|++|+.||.... ......++..  .....|..+++++.+||+
T Consensus       172 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~-~~~~~~~i~~--~~~~~p~~~s~~~~~Li~  248 (476)
T 2y94_A          172 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH-VPTLFKKICD--GIFYTPQYLNPSVISLLK  248 (476)
T ss_dssp             BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSS-SHHHHHHHHT--TCCCCCTTCCHHHHHHHH
T ss_pred             ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCC-HHHHHHHHhc--CCcCCCccCCHHHHHHHH
Confidence            345679999999999998765 789999999999999999999996543 3344444432  234567789999999999


Q ss_pred             HhcccCccccCCHHHHhcCcccccc
Q 015500          231 NCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       231 ~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      +||+.||.+|||+.++++||||+..
T Consensus       249 ~~L~~dP~~Rpt~~eil~hp~~~~~  273 (476)
T 2y94_A          249 HMLQVDPMKRATIKDIREHEWFKQD  273 (476)
T ss_dssp             HHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred             HHcCCCchhCcCHHHHHhCHHhhhc
Confidence            9999999999999999999999864

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=8.8e-49  Score=371.75  Aligned_cols=245  Identities=27%  Similarity=0.362  Sum_probs=209.0

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC-----ChHHHHHHHHHHHhC-CCCCeeeeeeeeeecCCCceEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP-----KSEFLQREQKFLSSL-NSPHIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~-----~~~~l~~E~~iL~~L-~hpnIv~~~~~~~~~~~~~~~~~   75 (405)
                      +|++++.||+|+||+||+|.+..+++.||+|.+...     ....+.+|+.++..+ +||||+++++++....    .++
T Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~----~~~   87 (289)
T 1x8b_A           12 EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDD----HML   87 (289)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETT----EEE
T ss_pred             hhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCC----eEE
Confidence            588999999999999999999999999999988753     235677899999999 9999999999876543    367


Q ss_pred             EEEeecCCCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccC----------------
Q 015500           76 LFMEYAPGGTLNDEIHRN---GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES----------------  136 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~---~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~----------------  136 (405)
                      +||||++|++|.+++...   .+.+++..++.++.||+.||.|||++||+||||||+|||++.+                
T Consensus        88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~  167 (289)
T 1x8b_A           88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWA  167 (289)
T ss_dssp             EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC------------------
T ss_pred             EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccccccc
Confidence            999999999999999764   2579999999999999999999999999999999999999733                


Q ss_pred             ---C-ceEeeecccccccccccCCCCCCccChhhhcCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhc
Q 015500          137 ---G-AKIADFGCAKWESEALQSGGTPMFMAPEVARGE-HQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYS  211 (405)
Q Consensus       137 ---~-vkL~DFGla~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~  211 (405)
                         . +||+|||++..........||+.|+|||++.+. .+++++|||||||++|+|++|.+|+....    .... ...
T Consensus       168 ~~~~~~kl~Dfg~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~----~~~~-~~~  242 (289)
T 1x8b_A          168 SNKVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD----QWHE-IRQ  242 (289)
T ss_dssp             --CCCEEECCCTTCEETTCSCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH----HHHH-HHT
T ss_pred             CCceEEEEcccccccccCCccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh----HHHH-HHc
Confidence               2 899999999887776677799999999999876 56689999999999999999998774331    1222 234


Q ss_pred             CCCCCCchhccHHHHHHHHHhcccCccccCCHHHHhcCcccccc
Q 015500          212 RELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       212 ~~~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      ...+.+|..+++++.+||.+||+.||.+|||+.++++||||...
T Consensus       243 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  286 (289)
T 1x8b_A          243 GRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA  286 (289)
T ss_dssp             TCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred             CCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence            45677888899999999999999999999999999999999853

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.7e-48  Score=370.83  Aligned_cols=250  Identities=26%  Similarity=0.383  Sum_probs=212.1

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      +|++++.||+|+||+||+|.++.+++.||+|.+....     .+.+.+|+.++++++||||+++++++....    .+++
T Consensus         7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~~   82 (284)
T 3kk8_A            7 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEES----FHYL   82 (284)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS----EEEE
T ss_pred             hhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCC----EEEE
Confidence            6899999999999999999999999999999986432     356789999999999999999999875433    3569


Q ss_pred             EEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC----ceEeeeccccccccc
Q 015500           77 FMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG----AKIADFGCAKWESEA  152 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~----vkL~DFGla~~~~~~  152 (405)
                      +|||++|++|.+.+... +.+++..+..++.||+.||.|||++||+||||||+||+++.++    +||+|||++......
T Consensus        83 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~  161 (284)
T 3kk8_A           83 VFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS  161 (284)
T ss_dssp             EECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred             EEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence            99999999999998876 4799999999999999999999999999999999999997543    899999999765442


Q ss_pred             ---ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCC--CCCchhccHHHHH
Q 015500          153 ---LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSREL--PEVPAFLSKQAND  227 (405)
Q Consensus       153 ---~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~--~~~p~~~s~~l~d  227 (405)
                         ....||+.|+|||++.+..++.++|||||||++|+|++|+.||... +.......+......  ......+++++.+
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T 3kk8_A          162 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE-DQHRLYAQIKAGAYDYPSPEWDTVTPEAKS  240 (284)
T ss_dssp             CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHTCCCCCTTTTTTSCHHHHH
T ss_pred             ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCC-chhHHHHHHHhccccCCchhhcccCHHHHH
Confidence               2356999999999999999999999999999999999999999654 334444443333221  1222468999999


Q ss_pred             HHHHhcccCccccCCHHHHhcCcccccccc
Q 015500          228 FLSNCLRRDPKERWAASQLLKHPFLEEFCS  257 (405)
Q Consensus       228 ll~~~L~~dP~~Rpt~~elL~hp~~~~~~~  257 (405)
                      ||.+||+.||.+|||++|+|+||||.....
T Consensus       241 li~~~l~~dp~~Rps~~~~l~h~~~~~~~~  270 (284)
T 3kk8_A          241 LIDSMLTVNPKKRITADQALKVPWICNRER  270 (284)
T ss_dssp             HHHHHSCSSTTTSCCHHHHTTSHHHHSCCC
T ss_pred             HHHHHcccChhhCCCHHHHhcCccccCChh
Confidence            999999999999999999999999987543

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.1e-48  Score=395.16  Aligned_cols=253  Identities=26%  Similarity=0.397  Sum_probs=208.0

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHhCCCCCeeeeeeeeeecC--CCceEEEEEEe
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSE--DNKLMYNLFME   79 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~--~~~~~~~lv~E   79 (405)
                      +|+.++.||+|+||+||+|+++.+|+.||||.+.... ....+|+++|+.|+||||+++++++....  ....++++|||
T Consensus        55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e  133 (420)
T 1j1b_A           55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD  133 (420)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT-TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEE
T ss_pred             eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc-hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehh
Confidence            5899999999999999999999999999999886543 34568999999999999999998876543  33456779999


Q ss_pred             ecCCCCHHHHHH---HcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC--ceEeeecccccccc---
Q 015500           80 YAPGGTLNDEIH---RNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG--AKIADFGCAKWESE---  151 (405)
Q Consensus        80 y~~ggsL~~~i~---~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~--vkL~DFGla~~~~~---  151 (405)
                      |+++ +|.+.+.   .....+++..++.++.||+.||.|||++||+||||||+|||++.++  +||+|||+++....   
T Consensus       134 ~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~  212 (420)
T 1j1b_A          134 YVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP  212 (420)
T ss_dssp             CCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCC
T ss_pred             cccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhcccCCC
Confidence            9976 6666654   3456899999999999999999999999999999999999999654  89999999986432   


Q ss_pred             cccCCCCCCccChhhhcCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhc------------------C
Q 015500          152 ALQSGGTPMFMAPEVARGE-HQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYS------------------R  212 (405)
Q Consensus       152 ~~~~~gt~~Y~APE~l~~~-~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~------------------~  212 (405)
                      .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.... ....+.++...                  .
T Consensus       213 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~-~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~  291 (420)
T 1j1b_A          213 NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS-GVDQLVEIIKVLGTPTREQIREMNPNYTEF  291 (420)
T ss_dssp             CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHHHCSCCHHHHHHHCSCCCCC
T ss_pred             ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhCCCCHHHHHhhChhhhhh
Confidence            3345799999999999775 78999999999999999999999997544 33333333221                  0


Q ss_pred             CCCC---------CchhccHHHHHHHHHhcccCccccCCHHHHhcCcccccccc
Q 015500          213 ELPE---------VPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCS  257 (405)
Q Consensus       213 ~~~~---------~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~~  257 (405)
                      .+|.         ++..+++++.+||.+||+.||.+|||+.|+|+||||+.+..
T Consensus       292 ~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  345 (420)
T 1j1b_A          292 KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD  345 (420)
T ss_dssp             CCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred             ccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccccc
Confidence            1111         22356899999999999999999999999999999987654

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=5.5e-49  Score=387.64  Aligned_cols=246  Identities=28%  Similarity=0.418  Sum_probs=205.4

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC--hHHHHHHHHHHHhCC-----CCCeeeeeeeeeecCCCceEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK--SEFLQREQKFLSSLN-----SPHIVGYKGCDVTSEDNKLMY   74 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~--~~~l~~E~~iL~~L~-----hpnIv~~~~~~~~~~~~~~~~   74 (405)
                      +|++++.||+|+||+||+|.+..+++.||||++....  .....+|+.+|+.+.     ||||+++++++....    .+
T Consensus        36 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~----~~  111 (360)
T 3llt_A           36 AFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYD----HM  111 (360)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETT----EE
T ss_pred             EEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECC----ee
Confidence            5899999999999999999999999999999987533  356788999999997     999999999877643    36


Q ss_pred             EEEEeecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcc------------------
Q 015500           75 NLFMEYAPGGTLNDEIHRNG-GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAE------------------  135 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~i~~~~-~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~------------------  135 (405)
                      ++||||+ +++|.+++.+.. ..+++..++.++.||+.||+|||++||+||||||+|||++.                  
T Consensus       112 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~  190 (360)
T 3llt_A          112 CLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKK  190 (360)
T ss_dssp             EEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCE
T ss_pred             EEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccccccc
Confidence            7999999 899999998753 35999999999999999999999999999999999999974                  


Q ss_pred             -------CC-ceEeeecccccccc-cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHH
Q 015500          136 -------SG-AKIADFGCAKWESE-ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLY  206 (405)
Q Consensus       136 -------~~-vkL~DFGla~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~  206 (405)
                             ++ +||+|||+++.... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ...+.
T Consensus       191 ~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-~~~~~  269 (360)
T 3llt_A          191 IQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEH-MEHLA  269 (360)
T ss_dssp             EEEEEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHH
T ss_pred             ccccccCCCCEEEEeccCceecCCCCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcH-HHHHH
Confidence                   44 99999999986544 3456799999999999999999999999999999999999999965432 33332


Q ss_pred             HHHhc-CCCC-------------------------------------------CCchhccHHHHHHHHHhcccCccccCC
Q 015500          207 KIAYS-RELP-------------------------------------------EVPAFLSKQANDFLSNCLRRDPKERWA  242 (405)
Q Consensus       207 ~i~~~-~~~~-------------------------------------------~~p~~~s~~l~dll~~~L~~dP~~Rpt  242 (405)
                      .+... ...|                                           ..+...++.+.+||.+||+.||.+|||
T Consensus       270 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt  349 (360)
T 3llt_A          270 MMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPS  349 (360)
T ss_dssp             HHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCC
T ss_pred             HHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCC
Confidence            22211 1111                                           111122477889999999999999999


Q ss_pred             HHHHhcCcccc
Q 015500          243 ASQLLKHPFLE  253 (405)
Q Consensus       243 ~~elL~hp~~~  253 (405)
                      ++|+|+||||+
T Consensus       350 a~elL~hp~f~  360 (360)
T 3llt_A          350 PAELLKHKFLE  360 (360)
T ss_dssp             HHHHTTSGGGC
T ss_pred             HHHHhcCcccC
Confidence            99999999995

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=7.5e-49  Score=378.43  Aligned_cols=250  Identities=29%  Similarity=0.477  Sum_probs=204.2

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      +|++++.||+|+||+||+|.+..+|+.||||.+....     .+.+.+|++++++++||||+++++++....    .+++
T Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~----~~~l   79 (311)
T 4agu_A            4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKR----RLHL   79 (311)
T ss_dssp             CEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT----EEEE
T ss_pred             cceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCC----eEEE
Confidence            6899999999999999999999999999999876543     345778999999999999999999876543    3669


Q ss_pred             EEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc----
Q 015500           77 FMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE----  151 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~----  151 (405)
                      ||||+++++|.+++... +.+++..+..++.||+.||.|||++||+||||||+||+++.++ +||+|||++.....    
T Consensus        80 v~e~~~~~~l~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  158 (311)
T 4agu_A           80 VFEYCDHTVLHELDRYQ-RGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY  158 (311)
T ss_dssp             EEECCSEEHHHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             EEEeCCCchHHHHHhhh-cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc
Confidence            99999999998887665 4799999999999999999999999999999999999999887 99999999976543    


Q ss_pred             cccCCCCCCccChhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhc-C-----------------
Q 015500          152 ALQSGGTPMFMAPEVARG-EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYS-R-----------------  212 (405)
Q Consensus       152 ~~~~~gt~~Y~APE~l~~-~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~-~-----------------  212 (405)
                      .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..... ......+... .                 
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (311)
T 4agu_A          159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSD-VDQLYLIRKTLGDLIPRHQQVFSTNQYFS  237 (311)
T ss_dssp             -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCSCCHHHHHHHHTCGGGT
T ss_pred             cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhcccccccccccccccccc
Confidence            234568999999999987 5679999999999999999999999965543 3332222110 0                 


Q ss_pred             --CCCCC---------chhccHHHHHHHHHhcccCccccCCHHHHhcCcccccccc
Q 015500          213 --ELPEV---------PAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCS  257 (405)
Q Consensus       213 --~~~~~---------p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~~  257 (405)
                        ..+..         ...+++++.+||.+||+.||.+|||++|+|+||||+.+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  293 (311)
T 4agu_A          238 GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE  293 (311)
T ss_dssp             TCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC-
T ss_pred             cCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccC
Confidence              01100         0347889999999999999999999999999999997643

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.4e-49  Score=388.90  Aligned_cols=252  Identities=26%  Similarity=0.388  Sum_probs=204.8

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCC--CceEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-----SEFLQREQKFLSSLNSPHIVGYKGCDVTSED--NKLMY   74 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~--~~~~~   74 (405)
                      +|++.+.||+|+||+||+|.++.+|+.||||.+....     ...+.+|+++|+.++||||+++++++.....  ....+
T Consensus        26 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~  105 (367)
T 1cm8_A           26 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF  105 (367)
T ss_dssp             SEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCC
T ss_pred             eEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceE
Confidence            5889999999999999999999999999999985432     3467899999999999999999998765432  11235


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc-c
Q 015500           75 NLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE-A  152 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~-~  152 (405)
                      ++||||+ |++|.+++..  +++++..++.++.||+.||+|||++||+||||||+|||++.++ +||+|||+++.... .
T Consensus       106 ~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  182 (367)
T 1cm8_A          106 YLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM  182 (367)
T ss_dssp             EEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSSC
T ss_pred             EEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccccccc
Confidence            6999999 8899999876  3799999999999999999999999999999999999999887 99999999987554 3


Q ss_pred             ccCCCCCCccChhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcC-------------------
Q 015500          153 LQSGGTPMFMAPEVARG-EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSR-------------------  212 (405)
Q Consensus       153 ~~~~gt~~Y~APE~l~~-~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~-------------------  212 (405)
                      ....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... ....+..+....                   
T Consensus       183 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~  261 (367)
T 1cm8_A          183 TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD-HLDQLKEIMKVTGTPPAEFVQRLQSDEAKNY  261 (367)
T ss_dssp             CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHHHCCCCHHHHHTCSCHHHHHH
T ss_pred             CcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHhcCCCCHHHHHHhhhHHHHHH
Confidence            44679999999999987 679999999999999999999999996543 333333332110                   


Q ss_pred             ----------CCCCCchhccHHHHHHHHHhcccCccccCCHHHHhcCcccccccc
Q 015500          213 ----------ELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCS  257 (405)
Q Consensus       213 ----------~~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~~  257 (405)
                                .+..+....++.+.+||.+||+.||.+|||++|+|+||||+.+..
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~  316 (367)
T 1cm8_A          262 MKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD  316 (367)
T ss_dssp             HHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred             HHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcC
Confidence                      111223456899999999999999999999999999999997654

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=7.2e-49  Score=391.24  Aligned_cols=253  Identities=26%  Similarity=0.444  Sum_probs=207.2

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHhCCCCCeeeeeeeeeecC-------------
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSE-------------   68 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~-------------   68 (405)
                      +|++++.||+|+||+||+|.+..+|+.||||.+... .....+|+++|+.++||||+++++++....             
T Consensus         8 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~   86 (383)
T 3eb0_A            8 KYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQD-PRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDH   86 (383)
T ss_dssp             TEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECC-TTSCCHHHHHHTTCCCTTBCCEEEEEEEC--------------
T ss_pred             eEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecC-cchHHHHHHHHHHcCCCCccchhheeeecCccccccccccccc
Confidence            689999999999999999999999999999988644 334568999999999999999999876543             


Q ss_pred             ---------------------CCceEEEEEEeecCCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeC
Q 015500           69 ---------------------DNKLMYNLFMEYAPGGTLNDEIHR---NGGRLDESLIVSYTRQILQGLEYLHSNRVVHC  124 (405)
Q Consensus        69 ---------------------~~~~~~~lv~Ey~~ggsL~~~i~~---~~~~l~e~~~~~i~~qIl~~L~yLH~~givHr  124 (405)
                                           ....++++||||++| +|.+.+..   .++.+++..++.++.||+.||+|||++||+||
T Consensus        87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~  165 (383)
T 3eb0_A           87 NKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHR  165 (383)
T ss_dssp             -----------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECS
T ss_pred             ccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcCccC
Confidence                                 223357799999985 88777653   45689999999999999999999999999999


Q ss_pred             CCCCCCEEEc-cCC-ceEeeecccccccc---cccCCCCCCccChhhhcCC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 015500          125 DIKSRNILMA-ESG-AKIADFGCAKWESE---ALQSGGTPMFMAPEVARGE-HQGFASDIWAVGCTVIEMASGGAPWPNA  198 (405)
Q Consensus       125 Dlkp~NILi~-~~~-vkL~DFGla~~~~~---~~~~~gt~~Y~APE~l~~~-~~~~~sDIwSLG~il~elltG~~Pf~~~  198 (405)
                      ||||+|||++ .++ +||+|||+++....   .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||...
T Consensus       166 Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  245 (383)
T 3eb0_A          166 DIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGE  245 (383)
T ss_dssp             CCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCC
Confidence            9999999997 455 99999999986433   3345689999999999875 4899999999999999999999999654


Q ss_pred             CChHHHHHHHHhcCC------------------CCC---------CchhccHHHHHHHHHhcccCccccCCHHHHhcCcc
Q 015500          199 ADPMTVLYKIAYSRE------------------LPE---------VPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPF  251 (405)
Q Consensus       199 ~~~~~~l~~i~~~~~------------------~~~---------~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~  251 (405)
                      . ....+..+.....                  +|.         +|..+++++.+||.+||+.||.+|||+.|+|+|||
T Consensus       246 ~-~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~  324 (383)
T 3eb0_A          246 T-SIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPF  324 (383)
T ss_dssp             S-HHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGG
T ss_pred             C-hHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHH
Confidence            3 3444433322111                  111         34557899999999999999999999999999999


Q ss_pred             cccccc
Q 015500          252 LEEFCS  257 (405)
Q Consensus       252 ~~~~~~  257 (405)
                      |+.+..
T Consensus       325 f~~~~~  330 (383)
T 3eb0_A          325 FDHLRN  330 (383)
T ss_dssp             GHHHHH
T ss_pred             HHHHHh
Confidence            997654

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=5.1e-49  Score=402.89  Aligned_cols=251  Identities=27%  Similarity=0.358  Sum_probs=201.8

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC-----ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCC--CceEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP-----KSEFLQREQKFLSSLNSPHIVGYKGCDVTSED--NKLMY   74 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~-----~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~--~~~~~   74 (405)
                      +|++++.||+|+||+||+|.+..+++.||||++...     ....+.+|+.+|+.++||||+++++++.....  ....+
T Consensus        63 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~  142 (464)
T 3ttj_A           63 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV  142 (464)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEE
T ss_pred             CeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeE
Confidence            588999999999999999999999999999998643     24568899999999999999999998765431  22346


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc--
Q 015500           75 NLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE--  151 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~--  151 (405)
                      ++||||+++ +|.+.+.   ..+++..++.+++||+.||+|||++||+||||||+|||++.++ +||+|||+++....  
T Consensus       143 ~lv~E~~~~-~l~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  218 (464)
T 3ttj_A          143 YLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF  218 (464)
T ss_dssp             EEEEECCSE-EHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----CC
T ss_pred             EEEEeCCCC-CHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCCCc
Confidence            799999976 5666664   2599999999999999999999999999999999999999887 99999999986554  


Q ss_pred             -cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCC---------------
Q 015500          152 -ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELP---------------  215 (405)
Q Consensus       152 -~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~---------------  215 (405)
                       ....+||+.|+|||++.+..++.++|||||||++|||++|+.||... +....+.++......|               
T Consensus       219 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~-~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~  297 (464)
T 3ttj_A          219 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR-DYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY  297 (464)
T ss_dssp             CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHHHCSCCHHHHTTSCHHHHHH
T ss_pred             ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHhcCCCCHHHHHHcchhhhhH
Confidence             23467999999999999999999999999999999999999999654 3334433332211110               


Q ss_pred             -----C-----C----ch-----------hccHHHHHHHHHhcccCccccCCHHHHhcCcccccccc
Q 015500          216 -----E-----V----PA-----------FLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCS  257 (405)
Q Consensus       216 -----~-----~----p~-----------~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~~  257 (405)
                           .     +    |.           ..++++++||++||+.||.+|||++|+|+||||+....
T Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~  364 (464)
T 3ttj_A          298 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD  364 (464)
T ss_dssp             HTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCC
T ss_pred             hhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccC
Confidence                 0     0    00           12678999999999999999999999999999987543

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=7.9e-49  Score=385.08  Aligned_cols=246  Identities=26%  Similarity=0.443  Sum_probs=209.4

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-----hHHHHHHHHHHHhCCC--CCeeeeeeeeeecCCCceEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-----SEFLQREQKFLSSLNS--PHIVGYKGCDVTSEDNKLMY   74 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-----~~~l~~E~~iL~~L~h--pnIv~~~~~~~~~~~~~~~~   74 (405)
                      +|++++.||+|+||+||+|.+ .+++.||||.+....     .+.+.+|+.+|+.|+|  |||+++++++....    .+
T Consensus        10 ~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~----~~   84 (343)
T 3dbq_A           10 IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ----YI   84 (343)
T ss_dssp             EEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS----EE
T ss_pred             EEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCC----EE
Confidence            489999999999999999988 468999999886542     2568899999999987  99999999876433    46


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCCceEeeeccccccccc--
Q 015500           75 NLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGAKIADFGCAKWESEA--  152 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~vkL~DFGla~~~~~~--  152 (405)
                      ++|||+ .+++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.+.+||+|||+++.....  
T Consensus        85 ~lv~e~-~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~~~~~kl~DFG~a~~~~~~~~  162 (343)
T 3dbq_A           85 YMVMEC-GNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTT  162 (343)
T ss_dssp             EEEECC-CSEEHHHHHHHS-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTEEEECCCSSSCCC-----
T ss_pred             EEEEeC-CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEECCcEEEeecccccccCcccc
Confidence            799995 578999999886 4899999999999999999999999999999999999998655999999999865331  


Q ss_pred             ----ccCCCCCCccChhhhcC-----------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCC
Q 015500          153 ----LQSGGTPMFMAPEVARG-----------EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEV  217 (405)
Q Consensus       153 ----~~~~gt~~Y~APE~l~~-----------~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~  217 (405)
                          ....||+.|+|||++.+           ..++.++|||||||++|+|++|+.||....+....+..+........+
T Consensus       163 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  242 (343)
T 3dbq_A          163 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF  242 (343)
T ss_dssp             -------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCC
T ss_pred             cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccCC
Confidence                24569999999999865           678889999999999999999999998766666666666655555667


Q ss_pred             chhccHHHHHHHHHhcccCccccCCHHHHhcCccccc
Q 015500          218 PAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEE  254 (405)
Q Consensus       218 p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~  254 (405)
                      |...++++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus       243 ~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  279 (343)
T 3dbq_A          243 PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI  279 (343)
T ss_dssp             CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred             cccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccc
Confidence            7778899999999999999999999999999999974

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=6.6e-49  Score=386.67  Aligned_cols=248  Identities=29%  Similarity=0.406  Sum_probs=209.9

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHhC-CCCCeeeeeeeeeecCCCceEEEEEEee
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSL-NSPHIVGYKGCDVTSEDNKLMYNLFMEY   80 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~~~~l~~E~~iL~~L-~hpnIv~~~~~~~~~~~~~~~~~lv~Ey   80 (405)
                      +|.+++.||+|+||+||+|.++.+|+.||||.+..... ...+|+++|.++ +||||+++++++....    .+++||||
T Consensus        23 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~E~~~l~~~~~hp~iv~~~~~~~~~~----~~~lv~E~   97 (342)
T 2qr7_A           23 GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-DPTEEIEILLRYGQHPNIITLKDVYDDGK----YVYVVTEL   97 (342)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-CCHHHHHHHHHHTTSTTBCCEEEEEECSS----EEEEEECC
T ss_pred             cEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-ChHHHHHHHHHhcCCCCcCeEEEEEEcCC----EEEEEEeC
Confidence            48899999999999999999999999999999876543 356788888888 7999999999875432    36799999


Q ss_pred             cCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccC-C----ceEeeecccccccc----
Q 015500           81 APGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES-G----AKIADFGCAKWESE----  151 (405)
Q Consensus        81 ~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~-~----vkL~DFGla~~~~~----  151 (405)
                      ++||+|.+++.+. +.+++..++.++.||+.||+|||++||+||||||+|||+... +    +||+|||+++....    
T Consensus        98 ~~gg~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~  176 (342)
T 2qr7_A           98 MKGGELLDKILRQ-KFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL  176 (342)
T ss_dssp             CCSCBHHHHHHTC-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCC
T ss_pred             CCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCc
Confidence            9999999999876 479999999999999999999999999999999999998543 2    89999999986433    


Q ss_pred             cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCC--CChHHHHHHHHhcCCC--CCCchhccHHHHH
Q 015500          152 ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNA--ADPMTVLYKIAYSREL--PEVPAFLSKQAND  227 (405)
Q Consensus       152 ~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~--~~~~~~l~~i~~~~~~--~~~p~~~s~~l~d  227 (405)
                      ....+||+.|+|||++.+..++.++|||||||++|+|++|..||...  ......+..+......  ...+..+++++++
T Consensus       177 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  256 (342)
T 2qr7_A          177 LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKD  256 (342)
T ss_dssp             BCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCHHHHH
T ss_pred             eeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCCHHHHH
Confidence            33567999999999999888899999999999999999999999753  2344444454433221  1233568999999


Q ss_pred             HHHHhcccCccccCCHHHHhcCcccccc
Q 015500          228 FLSNCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       228 ll~~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      ||++||..||.+|||+.++|+||||...
T Consensus       257 li~~~L~~dP~~R~t~~~il~hp~~~~~  284 (342)
T 2qr7_A          257 LVSKMLHVDPHQRLTAALVLRHPWIVHW  284 (342)
T ss_dssp             HHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred             HHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence            9999999999999999999999999764

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.6e-48  Score=371.73  Aligned_cols=249  Identities=26%  Similarity=0.417  Sum_probs=201.4

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCCh-----HHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS-----EFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~~-----~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      +|++++.||+|+||+||+|.+..+|+.||+|.+.....     ..+.++...++.++||||+++++++.....    +++
T Consensus         8 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~----~~l   83 (290)
T 3fme_A            8 DLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGD----VWI   83 (290)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSS----EEE
T ss_pred             hhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCC----EEE
Confidence            58999999999999999999999999999999875422     234455566888899999999998765443    669


Q ss_pred             EEeecCCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCCCCEEEccCC-ceEeeecccccccc
Q 015500           77 FMEYAPGGTLNDEIHR---NGGRLDESLIVSYTRQILQGLEYLHSN-RVVHCDIKSRNILMAESG-AKIADFGCAKWESE  151 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~---~~~~l~e~~~~~i~~qIl~~L~yLH~~-givHrDlkp~NILi~~~~-vkL~DFGla~~~~~  151 (405)
                      ||||++| +|.+++..   .++.+++..++.++.||+.||+|||++ ||+||||||+||+++.++ +||+|||+++....
T Consensus        84 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  162 (290)
T 3fme_A           84 CMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD  162 (290)
T ss_dssp             EEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred             EEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence            9999975 88877754   456899999999999999999999998 999999999999999877 99999999976543


Q ss_pred             ---cccCCCCCCccChhhh----cCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHH
Q 015500          152 ---ALQSGGTPMFMAPEVA----RGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQ  224 (405)
Q Consensus       152 ---~~~~~gt~~Y~APE~l----~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~  224 (405)
                         .....||+.|+|||++    .+..++.++|||||||++|+|++|+.||.........+............+..++++
T Consensus       163 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (290)
T 3fme_A          163 DVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAE  242 (290)
T ss_dssp             -------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTSCHH
T ss_pred             cccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccccCCHH
Confidence               2234699999999996    456788999999999999999999999987666666666655554444444578999


Q ss_pred             HHHHHHHhcccCccccCCHHHHhcCcccccc
Q 015500          225 ANDFLSNCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       225 l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      +.+||.+||+.||.+|||+.|+++||||+..
T Consensus       243 ~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~  273 (290)
T 3fme_A          243 FVDFTSQCLKKNSKERPTYPELMQHPFFTLH  273 (290)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             HHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence            9999999999999999999999999999864

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=2.7e-48  Score=370.17  Aligned_cols=246  Identities=28%  Similarity=0.470  Sum_probs=213.7

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccC------CChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL------PKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~------~~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~   75 (405)
                      +|.+++.||+|+||+||+|.+..+++.||+|.+..      .....+.+|+.++++++||||+++++++....    .++
T Consensus        15 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~   90 (284)
T 2vgo_A           15 DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRK----RIY   90 (284)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS----EEE
T ss_pred             hceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCC----EEE
Confidence            58899999999999999999999999999998753      23467899999999999999999999876432    367


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc--c
Q 015500           76 LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE--A  152 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~--~  152 (405)
                      +||||+++++|.+++...+ ++++..+..++.||+.||.|||++||+||||||+||+++.++ +||+|||++.....  .
T Consensus        91 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~  169 (284)
T 2vgo_A           91 LMLEFAPRGELYKELQKHG-RFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR  169 (284)
T ss_dssp             EEECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSCB
T ss_pred             EEEEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccccc
Confidence            9999999999999998764 799999999999999999999999999999999999999887 99999999875443  3


Q ss_pred             ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHh
Q 015500          153 LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNC  232 (405)
Q Consensus       153 ~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~  232 (405)
                      ....||+.|+|||++.+..++.++|||||||++|+|++|+.||.... .......+..  ....+|..+++++++||.+|
T Consensus       170 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~  246 (284)
T 2vgo_A          170 RTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS-HTETHRRIVN--VDLKFPPFLSDGSKDLISKL  246 (284)
T ss_dssp             CCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS-HHHHHHHHHT--TCCCCCTTSCHHHHHHHHHH
T ss_pred             ccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCC-HhHHHHHHhc--cccCCCCcCCHHHHHHHHHH
Confidence            34569999999999999999999999999999999999999996443 3333333332  23356778999999999999


Q ss_pred             cccCccccCCHHHHhcCcccccc
Q 015500          233 LRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       233 L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      |+.||.+|||++++++||||+..
T Consensus       247 l~~~p~~Rps~~~ll~h~~~~~~  269 (284)
T 2vgo_A          247 LRYHPPQRLPLKGVMEHPWVKAN  269 (284)
T ss_dssp             SCSSGGGSCCHHHHHTCHHHHHH
T ss_pred             hhcCHhhCCCHHHHhhCHHHHhh
Confidence            99999999999999999999864

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.9e-48  Score=400.18  Aligned_cols=248  Identities=26%  Similarity=0.442  Sum_probs=212.5

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccC-----CChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL-----PKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~-----~~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      +|++++.||+|+||+||+|.++.+++.||||++..     .....+.+|+++|++++||||+++++++....    .+++
T Consensus        23 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~----~~~l   98 (486)
T 3mwu_A           23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSS----SFYI   98 (486)
T ss_dssp             HEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS----EEEE
T ss_pred             ceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCC----EEEE
Confidence            48899999999999999999999999999999742     34568899999999999999999999875433    3679


Q ss_pred             EEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcc---CC-ceEeeecccccccc-
Q 015500           77 FMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAE---SG-AKIADFGCAKWESE-  151 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~---~~-vkL~DFGla~~~~~-  151 (405)
                      ||||++||+|.+.+...+ ++++..++.++.||+.||.|||++||+||||||+|||++.   ++ +||+|||+++.... 
T Consensus        99 v~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~  177 (486)
T 3mwu_A           99 VGELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN  177 (486)
T ss_dssp             EECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred             EEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence            999999999999998764 8999999999999999999999999999999999999964   33 99999999976543 


Q ss_pred             --cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCc--hhccHHHHH
Q 015500          152 --ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVP--AFLSKQAND  227 (405)
Q Consensus       152 --~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p--~~~s~~l~d  227 (405)
                        .....||+.|+|||++.+ .+++++|||||||++|+|++|++||... +....+..+.........|  ..+|+++++
T Consensus       178 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  255 (486)
T 3mwu_A          178 TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGK-NEYDILKRVETGKYAFDLPQWRTISDDAKD  255 (486)
T ss_dssp             ----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHTCCCSCSGGGGGSCHHHHH
T ss_pred             CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhCCCCCCCcccCCCCHHHHH
Confidence              234569999999999987 4899999999999999999999999644 4455555555444333333  458999999


Q ss_pred             HHHHhcccCccccCCHHHHhcCccccccc
Q 015500          228 FLSNCLRRDPKERWAASQLLKHPFLEEFC  256 (405)
Q Consensus       228 ll~~~L~~dP~~Rpt~~elL~hp~~~~~~  256 (405)
                      ||++||+.||.+|||+.|+|+||||+...
T Consensus       256 li~~~L~~dp~~R~t~~~~l~hp~~~~~~  284 (486)
T 3mwu_A          256 LIRKMLTFHPSLRITATQCLEHPWIQKYS  284 (486)
T ss_dssp             HHHHHTCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred             HHHHHcCCChhhCcCHHHHhcCHhhccCc
Confidence            99999999999999999999999998754

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.9e-48  Score=378.40  Aligned_cols=249  Identities=27%  Similarity=0.429  Sum_probs=211.9

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC---------ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCce
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP---------KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKL   72 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~---------~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~   72 (405)
                      +|++++.||+|+||+||+|.++.+|+.||+|.+...         ..+.+.+|+.+|++++||||+++++++....    
T Consensus        13 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----   88 (321)
T 2a2a_A           13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRT----   88 (321)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS----
T ss_pred             cEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCC----
Confidence            488999999999999999999999999999987643         2457899999999999999999999875433    


Q ss_pred             EEEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-----ceEeeecccc
Q 015500           73 MYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-----AKIADFGCAK  147 (405)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-----vkL~DFGla~  147 (405)
                      .+++||||++|++|.+++... +.+++..+..++.||+.||.|||++||+||||||+||+++.++     +||+|||++.
T Consensus        89 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~  167 (321)
T 2a2a_A           89 DVVLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH  167 (321)
T ss_dssp             EEEEEECCCCSCBHHHHHHTC-SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred             EEEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence            367999999999999999875 4799999999999999999999999999999999999998765     8999999997


Q ss_pred             cccc---cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCC--CCCchhcc
Q 015500          148 WESE---ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSREL--PEVPAFLS  222 (405)
Q Consensus       148 ~~~~---~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~--~~~p~~~s  222 (405)
                      ....   .....||+.|+|||++.+..++.++|||||||++|+|++|+.||... .....+..+......  +..+..++
T Consensus       168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~  246 (321)
T 2a2a_A          168 EIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD-TKQETLANITSVSYDFDEEFFSHTS  246 (321)
T ss_dssp             ECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS-SHHHHHHHHHTTCCCCCHHHHTTCC
T ss_pred             ecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCC-CHHHHHHHHHhcccccChhhhcccC
Confidence            6543   23456999999999999999999999999999999999999999644 334444444332211  11224578


Q ss_pred             HHHHHHHHHhcccCccccCCHHHHhcCccccccc
Q 015500          223 KQANDFLSNCLRRDPKERWAASQLLKHPFLEEFC  256 (405)
Q Consensus       223 ~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~  256 (405)
                      +.+.+||.+||..||.+|||+.++|+||||....
T Consensus       247 ~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~  280 (321)
T 2a2a_A          247 ELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD  280 (321)
T ss_dssp             HHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSS
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHhcCccccCCC
Confidence            9999999999999999999999999999998653

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=2.1e-48  Score=373.43  Aligned_cols=250  Identities=34%  Similarity=0.503  Sum_probs=210.3

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC---ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP---KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFM   78 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~---~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (405)
                      +|++++.||+|+||+||+|.+..+++.+|+|.+...   ..+.+.+|+++++.++||||+++++++.....    +++||
T Consensus        20 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~lv~   95 (302)
T 2j7t_A           20 VWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGK----LWIMI   95 (302)
T ss_dssp             TEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-C----EEEEE
T ss_pred             ceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCe----EEEEE
Confidence            488999999999999999999999999999988643   34678899999999999999999998765433    66999


Q ss_pred             eecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc----cc
Q 015500           79 EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE----AL  153 (405)
Q Consensus        79 Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~----~~  153 (405)
                      ||+++++|.+++....+.+++..+..++.||+.||.|||++|++||||||+||+++.++ +||+|||++.....    ..
T Consensus        96 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  175 (302)
T 2j7t_A           96 EFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRD  175 (302)
T ss_dssp             ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC--
T ss_pred             EeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccccccc
Confidence            99999999999987667899999999999999999999999999999999999999877 99999999764322    23


Q ss_pred             cCCCCCCccChhhhc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCC-CCCCchhccHHHHH
Q 015500          154 QSGGTPMFMAPEVAR-----GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRE-LPEVPAFLSKQAND  227 (405)
Q Consensus       154 ~~~gt~~Y~APE~l~-----~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~-~~~~p~~~s~~l~d  227 (405)
                      ...||+.|+|||++.     +..++.++|||||||++|+|++|+.||.... .......+..... ....+..++..+.+
T Consensus       176 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~  254 (302)
T 2j7t_A          176 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN-PMRVLLKIAKSDPPTLLTPSKWSVEFRD  254 (302)
T ss_dssp             ---CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSC-HHHHHHHHHHSCCCCCSSGGGSCHHHHH
T ss_pred             cccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCC-HHHHHHHHhccCCcccCCccccCHHHHH
Confidence            456999999999983     5678899999999999999999999996543 3444444433322 22346778999999


Q ss_pred             HHHHhcccCccccCCHHHHhcCccccccc
Q 015500          228 FLSNCLRRDPKERWAASQLLKHPFLEEFC  256 (405)
Q Consensus       228 ll~~~L~~dP~~Rpt~~elL~hp~~~~~~  256 (405)
                      ||.+||..||.+|||+.++++||||....
T Consensus       255 li~~~l~~dp~~Rps~~~ll~h~~~~~~~  283 (302)
T 2j7t_A          255 FLKIALDKNPETRPSAAQLLEHPFVSSIT  283 (302)
T ss_dssp             HHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred             HHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence            99999999999999999999999998653

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.6e-48  Score=370.26  Aligned_cols=247  Identities=30%  Similarity=0.492  Sum_probs=191.3

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC------ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~------~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~   75 (405)
                      +|++++.||+|+||+||+|.+..+|+.||||.+...      ..+.+.+|+.++++++||||+++++++....    .++
T Consensus        12 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~   87 (278)
T 3cok_A           12 DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSN----YVY   87 (278)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSS----EEE
T ss_pred             cceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCC----eEE
Confidence            589999999999999999999999999999998532      2467899999999999999999999875432    367


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc---
Q 015500           76 LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE---  151 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~---  151 (405)
                      +||||+++++|.+++....+++++..++.++.||+.||.|||++|++||||||+||+++.++ +||+|||++.....   
T Consensus        88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~  167 (278)
T 3cok_A           88 LVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE  167 (278)
T ss_dssp             EEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred             EEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC
Confidence            99999999999999988767899999999999999999999999999999999999999887 99999999976432   


Q ss_pred             -cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHH
Q 015500          152 -ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLS  230 (405)
Q Consensus       152 -~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~  230 (405)
                       .....||+.|+|||++.+..+++++|||||||++|+|++|+.||...... ..+.++.  ......|..++.++.+||.
T Consensus       168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~--~~~~~~~~~~~~~~~~li~  244 (278)
T 3cok_A          168 KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVK-NTLNKVV--LADYEMPSFLSIEAKDLIH  244 (278)
T ss_dssp             ------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------CC--SSCCCCCTTSCHHHHHHHH
T ss_pred             cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHH-HHHHHHh--hcccCCccccCHHHHHHHH
Confidence             23456999999999999988999999999999999999999999654332 2222211  1223456778999999999


Q ss_pred             HhcccCccccCCHHHHhcCcccccc
Q 015500          231 NCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       231 ~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      +||+.||.+|||++++|+||||...
T Consensus       245 ~~l~~dp~~Rps~~~~l~h~~~~~~  269 (278)
T 3cok_A          245 QLLRRNPADRLSLSSVLDHPFMSRN  269 (278)
T ss_dssp             HHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred             HHcccCHhhCCCHHHHhcCccccCC
Confidence            9999999999999999999999864

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=9.9e-49  Score=401.81  Aligned_cols=248  Identities=28%  Similarity=0.450  Sum_probs=213.4

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC------ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~------~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~   75 (405)
                      +|++++.||+|+||+||+|.++.+|+.||||++...      ..+.+.+|+.+|++++||||+++++++....    .++
T Consensus        27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~----~~~  102 (484)
T 3nyv_A           27 RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKG----YFY  102 (484)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS----EEE
T ss_pred             ceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC----EEE
Confidence            388999999999999999999999999999997532      3567999999999999999999999876433    367


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEc---cCC-ceEeeecccccccc
Q 015500           76 LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMA---ESG-AKIADFGCAKWESE  151 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~---~~~-vkL~DFGla~~~~~  151 (405)
                      +||||+.||+|.+++... +++++..++.++.||+.||.|||++||+||||||+|||++   .++ +||+|||+++....
T Consensus       103 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~  181 (484)
T 3nyv_A          103 LVGEVYTGGELFDEIISR-KRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA  181 (484)
T ss_dssp             EEECCCCSCBHHHHHHTC-SCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred             EEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence            999999999999999876 4899999999999999999999999999999999999995   344 99999999976443


Q ss_pred             ---cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCc--hhccHHHH
Q 015500          152 ---ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVP--AFLSKQAN  226 (405)
Q Consensus       152 ---~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p--~~~s~~l~  226 (405)
                         .....||+.|+|||++.+ .+++++|||||||++|+|++|.+||... +....+..+.........|  ..+|++++
T Consensus       182 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  259 (484)
T 3nyv_A          182 SKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGA-NEYDILKKVEKGKYTFELPQWKKVSESAK  259 (484)
T ss_dssp             CCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHCCCCCCSGGGGGSCHHHH
T ss_pred             ccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCC-CHHHHHHHHHcCCCCCCCcccccCCHHHH
Confidence               234569999999999987 5899999999999999999999999643 4455555555544333333  45899999


Q ss_pred             HHHHHhcccCccccCCHHHHhcCccccccc
Q 015500          227 DFLSNCLRRDPKERWAASQLLKHPFLEEFC  256 (405)
Q Consensus       227 dll~~~L~~dP~~Rpt~~elL~hp~~~~~~  256 (405)
                      +||++||+.||.+|||+.|+|+||||+...
T Consensus       260 ~li~~~L~~dp~~R~s~~e~l~h~~~~~~~  289 (484)
T 3nyv_A          260 DLIRKMLTYVPSMRISARDALDHEWIQTYT  289 (484)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHTSHHHHHHT
T ss_pred             HHHHHHCCCChhHCcCHHHHhhChhhcccc
Confidence            999999999999999999999999998754

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=8.8e-49  Score=370.92  Aligned_cols=249  Identities=25%  Similarity=0.398  Sum_probs=212.0

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC----ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP----KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLF   77 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~----~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv   77 (405)
                      +|++++.||+|+||+||+|.++.+++.||||.+...    ..+.+.+|+.+++.++||||+++++++....    .+++|
T Consensus         8 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv   83 (276)
T 2yex_A            8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGN----IQYLF   83 (276)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT----EEEEE
T ss_pred             ceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCC----EEEEE
Confidence            589999999999999999999999999999997643    2467889999999999999999999876533    36699


Q ss_pred             EeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc-----
Q 015500           78 MEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE-----  151 (405)
Q Consensus        78 ~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~-----  151 (405)
                      |||+++++|.+++... ..+++..+..++.||+.||.|||++|++||||||+||+++.++ +||+|||++.....     
T Consensus        84 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  162 (276)
T 2yex_A           84 LEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER  162 (276)
T ss_dssp             EECCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred             EEecCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchh
Confidence            9999999999988765 4799999999999999999999999999999999999999887 99999999975432     


Q ss_pred             -cccCCCCCCccChhhhcCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHH
Q 015500          152 -ALQSGGTPMFMAPEVARGEHQ-GFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFL  229 (405)
Q Consensus       152 -~~~~~gt~~Y~APE~l~~~~~-~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll  229 (405)
                       .....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||......................+..+++.+.+||
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  242 (276)
T 2yex_A          163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL  242 (276)
T ss_dssp             CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHH
T ss_pred             cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHH
Confidence             234568999999999987664 779999999999999999999997655443333333333333333456899999999


Q ss_pred             HHhcccCccccCCHHHHhcCcccccc
Q 015500          230 SNCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       230 ~~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      .+||..||.+|||++|+++||||+..
T Consensus       243 ~~~l~~~p~~Rps~~~il~~~~~~~~  268 (276)
T 2yex_A          243 HKILVENPSARITIPDIKKDRWYNKP  268 (276)
T ss_dssp             HHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred             HHHCCCCchhCCCHHHHhcCccccCh
Confidence            99999999999999999999999865

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.3e-48  Score=374.41  Aligned_cols=249  Identities=33%  Similarity=0.540  Sum_probs=211.2

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC-ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEee
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP-KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEY   80 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~-~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~Ey   80 (405)
                      +|.+++.||+|+||+||+|.+..+|+.||+|.+... ..+.+.+|+.+++.++||||+++++++....    .+++||||
T Consensus        30 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~  105 (314)
T 3com_A           30 VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNT----DLWIVMEY  105 (314)
T ss_dssp             CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEETT----EEEEEEEC
T ss_pred             hhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCC----EEEEEeec
Confidence            588999999999999999999999999999998754 3577899999999999999999999876543    36799999


Q ss_pred             cCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc----cccC
Q 015500           81 APGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE----ALQS  155 (405)
Q Consensus        81 ~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~----~~~~  155 (405)
                      +++++|.+++....+.+++..+..++.||+.||.|||++|++||||||+||+++.++ +||+|||++.....    ....
T Consensus       106 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  185 (314)
T 3com_A          106 CGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTV  185 (314)
T ss_dssp             CTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSCBCCC
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhccccCcc
Confidence            999999999986667899999999999999999999999999999999999998887 99999999976443    2345


Q ss_pred             CCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcC-CCCCCchhccHHHHHHHHHhcc
Q 015500          156 GGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSR-ELPEVPAFLSKQANDFLSNCLR  234 (405)
Q Consensus       156 ~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~-~~~~~p~~~s~~l~dll~~~L~  234 (405)
                      .||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ......+.... .....+..+++.+.+||.+||.
T Consensus       186 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  264 (314)
T 3com_A          186 IGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP-MRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLV  264 (314)
T ss_dssp             CSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH-HHHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHTC
T ss_pred             CCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHhcCCCcccCCcccCCHHHHHHHHHHcc
Confidence            689999999999998999999999999999999999999965443 33333332222 2223466789999999999999


Q ss_pred             cCccccCCHHHHhcCcccccc
Q 015500          235 RDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       235 ~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      .||.+|||+.++|+||||...
T Consensus       265 ~dp~~Rpt~~~ll~~~~~~~~  285 (314)
T 3com_A          265 KSPEQRATATQLLQHPFVRSA  285 (314)
T ss_dssp             SCTTTSCCHHHHTTSHHHHTC
T ss_pred             CChhhCcCHHHHHhCHHHhcC
Confidence            999999999999999999864

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=8e-48  Score=390.23  Aligned_cols=255  Identities=23%  Similarity=0.294  Sum_probs=202.6

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC-----ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCC-CceEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP-----KSEFLQREQKFLSSLNSPHIVGYKGCDVTSED-NKLMYN   75 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~-----~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~-~~~~~~   75 (405)
                      +|++++.||+|+||+||+|.++.+++.||||++...     ....+.+|+++|+.++||||+++++++..... ....+|
T Consensus        27 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  106 (432)
T 3n9x_A           27 NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELY  106 (432)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEE
T ss_pred             CEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEE
Confidence            589999999999999999999999999999998643     13578899999999999999999998765431 112366


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc---
Q 015500           76 LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE---  151 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~---  151 (405)
                      +||||+. ++|.+++... +.+++..++.+++||+.||+|||++||+||||||+|||++.++ +||+|||+++....   
T Consensus       107 lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  184 (432)
T 3n9x_A          107 IVLEIAD-SDLKKLFKTP-IFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKD  184 (432)
T ss_dssp             EEEECCS-EEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC-----
T ss_pred             EEEecCC-cCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccccccccc
Confidence            9999996 5999999765 4799999999999999999999999999999999999999987 99999999986432   


Q ss_pred             -----------------------cccCCCCCCccChhhh-cCCCCCcchhHHHHHHHHHHHHhCCCC-----------CC
Q 015500          152 -----------------------ALQSGGTPMFMAPEVA-RGEHQGFASDIWAVGCTVIEMASGGAP-----------WP  196 (405)
Q Consensus       152 -----------------------~~~~~gt~~Y~APE~l-~~~~~~~~sDIwSLG~il~elltG~~P-----------f~  196 (405)
                                             ....+||++|+|||++ .+..++.++|||||||++|||++|..|           |.
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~  264 (432)
T 3n9x_A          185 TNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFP  264 (432)
T ss_dssp             --------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCC
T ss_pred             ccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccccCC
Confidence                                   1455799999999986 556799999999999999999985444           32


Q ss_pred             CCCC----------------hHHHHHHHHhc------------------------CCCCC-----CchhccHHHHHHHHH
Q 015500          197 NAAD----------------PMTVLYKIAYS------------------------RELPE-----VPAFLSKQANDFLSN  231 (405)
Q Consensus       197 ~~~~----------------~~~~l~~i~~~------------------------~~~~~-----~p~~~s~~l~dll~~  231 (405)
                      ....                ....+..+...                        .....     ....+++++.+||++
T Consensus       265 g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~  344 (432)
T 3n9x_A          265 GSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLES  344 (432)
T ss_dssp             CSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHH
T ss_pred             CccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHH
Confidence            2210                01111111100                        00000     013479999999999


Q ss_pred             hcccCccccCCHHHHhcCccccccccc
Q 015500          232 CLRRDPKERWAASQLLKHPFLEEFCSC  258 (405)
Q Consensus       232 ~L~~dP~~Rpt~~elL~hp~~~~~~~~  258 (405)
                      ||+.||.+|||++|+|+||||+.+...
T Consensus       345 mL~~dP~~R~ta~e~L~Hp~f~~~~~~  371 (432)
T 3n9x_A          345 MLKFNPNKRITIDQALDHPYLKDVRKK  371 (432)
T ss_dssp             HSCSSTTTSCCHHHHHTCGGGTTTCCT
T ss_pred             HhcCCcccCCCHHHHhcChhhhhccCc
Confidence            999999999999999999999987543

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=9.6e-49  Score=383.09  Aligned_cols=251  Identities=30%  Similarity=0.454  Sum_probs=207.2

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccC--------CChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL--------PKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLM   73 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~--------~~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~   73 (405)
                      +|++++.||+|+||+||+|.+..+++.+|+|.+..        ...+.+.+|+++|++++||||+++++++....    .
T Consensus        27 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~----~  102 (345)
T 3hko_A           27 KYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ----Y  102 (345)
T ss_dssp             HEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS----E
T ss_pred             heeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC----e
Confidence            48899999999999999999999999999998753        23467889999999999999999999875433    3


Q ss_pred             EEEEEeecCCCCHHHHHHHc---------------------------------------CCCCCHHHHHHHHHHHHHHHH
Q 015500           74 YNLFMEYAPGGTLNDEIHRN---------------------------------------GGRLDESLIVSYTRQILQGLE  114 (405)
Q Consensus        74 ~~lv~Ey~~ggsL~~~i~~~---------------------------------------~~~l~e~~~~~i~~qIl~~L~  114 (405)
                      +++||||++||+|.+++...                                       ...+++..++.++.||+.||+
T Consensus       103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~  182 (345)
T 3hko_A          103 ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH  182 (345)
T ss_dssp             EEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence            67999999999999988521                                       112467889999999999999


Q ss_pred             HHHhCCceeCCCCCCCEEEccCC---ceEeeecccccccc--------cccCCCCCCccChhhhcC--CCCCcchhHHHH
Q 015500          115 YLHSNRVVHCDIKSRNILMAESG---AKIADFGCAKWESE--------ALQSGGTPMFMAPEVARG--EHQGFASDIWAV  181 (405)
Q Consensus       115 yLH~~givHrDlkp~NILi~~~~---vkL~DFGla~~~~~--------~~~~~gt~~Y~APE~l~~--~~~~~~sDIwSL  181 (405)
                      |||++||+||||||+|||++.++   +||+|||+++....        .....||+.|+|||++.+  ..+++++|||||
T Consensus       183 ~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diwsl  262 (345)
T 3hko_A          183 YLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSA  262 (345)
T ss_dssp             HHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHH
T ss_pred             HHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHH
Confidence            99999999999999999997654   99999999975432        234569999999999976  678899999999


Q ss_pred             HHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCc--hhccHHHHHHHHHhcccCccccCCHHHHhcCcccccccc
Q 015500          182 GCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVP--AFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCS  257 (405)
Q Consensus       182 G~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p--~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~~  257 (405)
                      ||++|+|++|+.||.... .......+.........+  ..+++++.+||.+||+.||.+|||+.++|+||||+.+..
T Consensus       263 G~il~el~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~~  339 (345)
T 3hko_A          263 GVLLHLLLMGAVPFPGVN-DADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSD  339 (345)
T ss_dssp             HHHHHHHHHSSCSSCCSS-HHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTSS
T ss_pred             HHHHHHHHHCCCCCCCCC-hHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccChH
Confidence            999999999999996544 344444444433322223  347999999999999999999999999999999987643

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=3e-48  Score=399.72  Aligned_cols=249  Identities=28%  Similarity=0.432  Sum_probs=209.6

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC-----ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP-----KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~-----~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      .|++++.||+|+||+||+|+++.++..+|+|++...     ....+.+|+.+|+.++||||+++++++....    .+++
T Consensus        38 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~----~~~l  113 (494)
T 3lij_A           38 MYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKR----NYYL  113 (494)
T ss_dssp             HEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSS----EEEE
T ss_pred             CeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC----EEEE
Confidence            388999999999999999999999999999988643     3467899999999999999999999876433    3679


Q ss_pred             EEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccC---C-ceEeeecccccccc-
Q 015500           77 FMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES---G-AKIADFGCAKWESE-  151 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~---~-vkL~DFGla~~~~~-  151 (405)
                      ||||++||+|.+++... +++++..++.++.||+.||.|||++||+||||||+|||++..   + +||+|||+++.... 
T Consensus       114 v~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~  192 (494)
T 3lij_A          114 VMECYKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ  192 (494)
T ss_dssp             EEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred             EEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence            99999999999999876 479999999999999999999999999999999999999753   2 89999999976543 


Q ss_pred             --cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCc--hhccHHHHH
Q 015500          152 --ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVP--AFLSKQAND  227 (405)
Q Consensus       152 --~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p--~~~s~~l~d  227 (405)
                        .....||+.|+|||++.+ .+++++|||||||++|+|++|.+||... .....+..+.........+  ..+++.+++
T Consensus       193 ~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  270 (494)
T 3lij_A          193 KKMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQ-TDQEILRKVEKGKYTFDSPEWKNVSEGAKD  270 (494)
T ss_dssp             BCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHTCCCCCSGGGTTSCHHHHH
T ss_pred             ccccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhCCCCCCchhcccCCHHHHH
Confidence              334569999999999874 5899999999999999999999999644 4455555555443332222  458999999


Q ss_pred             HHHHhcccCccccCCHHHHhcCcccccccc
Q 015500          228 FLSNCLRRDPKERWAASQLLKHPFLEEFCS  257 (405)
Q Consensus       228 ll~~~L~~dP~~Rpt~~elL~hp~~~~~~~  257 (405)
                      ||++||+.||.+|||+.|+|+||||+....
T Consensus       271 li~~~L~~dp~~R~s~~e~l~hp~~~~~~~  300 (494)
T 3lij_A          271 LIKQMLQFDSQRRISAQQALEHPWIKEMCS  300 (494)
T ss_dssp             HHHHHTCSSTTTSCCHHHHHTCHHHHHHHH
T ss_pred             HHHHHCCCChhhCccHHHHhcCcccccCcc
Confidence            999999999999999999999999987543

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=2.9e-48  Score=400.73  Aligned_cols=249  Identities=24%  Similarity=0.402  Sum_probs=211.2

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC----------------ChHHHHHHHHHHHhCCCCCeeeeeeeee
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP----------------KSEFLQREQKFLSSLNSPHIVGYKGCDV   65 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~----------------~~~~l~~E~~iL~~L~hpnIv~~~~~~~   65 (405)
                      +|++++.||+|+||+||+|.++.+++.+|+|++...                ..+.+.+|+.+|++|+||||+++++++.
T Consensus        37 ~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~  116 (504)
T 3q5i_A           37 SYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFE  116 (504)
T ss_dssp             TEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             ceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            589999999999999999999999999999988643                2356889999999999999999999876


Q ss_pred             ecCCCceEEEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC----ceEe
Q 015500           66 TSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG----AKIA  141 (405)
Q Consensus        66 ~~~~~~~~~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~----vkL~  141 (405)
                      ...    .+++|||||+||+|.+++... +++++..++.++.||+.||.|||++||+||||||+|||++.++    +||+
T Consensus       117 ~~~----~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~  191 (504)
T 3q5i_A          117 DKK----YFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIV  191 (504)
T ss_dssp             CSS----EEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEEC
T ss_pred             cCC----EEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEE
Confidence            433    367999999999999999876 4799999999999999999999999999999999999998764    8999


Q ss_pred             eecccccccc---cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCc
Q 015500          142 DFGCAKWESE---ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVP  218 (405)
Q Consensus       142 DFGla~~~~~---~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p  218 (405)
                      |||+++....   .....||+.|+|||++.+ .++.++|||||||++|+|++|.+||... +....+..+.........+
T Consensus       192 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~~i~~~~~~~~~~  269 (504)
T 3q5i_A          192 DFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQ-NDQDIIKKVEKGKYYFDFN  269 (504)
T ss_dssp             CCTTCEECCTTSCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHCCCCCCHH
T ss_pred             ECCCCEEcCCCCccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHcCCCCCCcc
Confidence            9999986543   335579999999999875 5889999999999999999999999643 4455555555443322222


Q ss_pred             --hhccHHHHHHHHHhcccCccccCCHHHHhcCcccccccc
Q 015500          219 --AFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCS  257 (405)
Q Consensus       219 --~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~~  257 (405)
                        ..+|+++++||++||+.||.+|||++|+|+||||+....
T Consensus       270 ~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~  310 (504)
T 3q5i_A          270 DWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYAN  310 (504)
T ss_dssp             HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCC
T ss_pred             ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchh
Confidence              458999999999999999999999999999999987643

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.6e-48  Score=390.45  Aligned_cols=247  Identities=26%  Similarity=0.438  Sum_probs=209.8

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-----hHHHHHHHHHHHhCC--CCCeeeeeeeeeecCCCceEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-----SEFLQREQKFLSSLN--SPHIVGYKGCDVTSEDNKLMY   74 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-----~~~l~~E~~iL~~L~--hpnIv~~~~~~~~~~~~~~~~   74 (405)
                      +|++++.||+|+||+||+|.+.. ++.||||.+....     .+.+.+|+.+|++|+  ||||+++++++....    .+
T Consensus        57 ~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~----~~  131 (390)
T 2zmd_A           57 IYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ----YI  131 (390)
T ss_dssp             EEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS----EE
T ss_pred             ceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCC----EE
Confidence            38999999999999999999865 9999999986542     356889999999996  599999998876543    36


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCCceEeeecccccccc---
Q 015500           75 NLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGAKIADFGCAKWESE---  151 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~vkL~DFGla~~~~~---  151 (405)
                      ++||| +.+++|.+++.+.+ .+++..++.++.||+.||.|||++||+||||||+|||++.+.+||+|||+++....   
T Consensus       132 ~lv~E-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~kl~DFG~a~~~~~~~~  209 (390)
T 2zmd_A          132 YMVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTT  209 (390)
T ss_dssp             EEEEE-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEESSSCEEECCCSSSCCC-----
T ss_pred             EEEEe-cCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEECCeEEEEecCccccccCCCc
Confidence            79999 56889999998764 89999999999999999999999999999999999999766699999999986543   


Q ss_pred             ---cccCCCCCCccChhhhcC-----------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCC
Q 015500          152 ---ALQSGGTPMFMAPEVARG-----------EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEV  217 (405)
Q Consensus       152 ---~~~~~gt~~Y~APE~l~~-----------~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~  217 (405)
                         .....||+.|+|||++.+           ..+++++|||||||++|||++|+.||....+....+..+.........
T Consensus       210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~  289 (390)
T 2zmd_A          210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF  289 (390)
T ss_dssp             ----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCC
T ss_pred             cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCC
Confidence               224569999999999975           368889999999999999999999997766666666666555545566


Q ss_pred             chhccHHHHHHHHHhcccCccccCCHHHHhcCcccccc
Q 015500          218 PAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       218 p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      |...++++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus       290 ~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~  327 (390)
T 2zmd_A          290 PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  327 (390)
T ss_dssp             CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred             CccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence            77778999999999999999999999999999999853

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.7e-48  Score=384.40  Aligned_cols=249  Identities=31%  Similarity=0.530  Sum_probs=209.4

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLF   77 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv   77 (405)
                      +|++++.||+|+||+||+|.+..+++.||+|.+....    .+.+.+|+.+|+.++||||+++++++....    .+++|
T Consensus        34 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~lv  109 (360)
T 3eqc_A           34 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG----EISIC  109 (360)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETT----EEEEE
T ss_pred             cceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECC----EEEEE
Confidence            5899999999999999999999999999999987542    356889999999999999999999876543    36799


Q ss_pred             EeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCCCCEEEccCC-ceEeeecccccccc--cc
Q 015500           78 MEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN-RVVHCDIKSRNILMAESG-AKIADFGCAKWESE--AL  153 (405)
Q Consensus        78 ~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~-givHrDlkp~NILi~~~~-vkL~DFGla~~~~~--~~  153 (405)
                      |||++|++|.+++...+ .+++..+..++.||+.||.|||++ ||+||||||+|||++.++ +||+|||++.....  ..
T Consensus       110 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  188 (360)
T 3eqc_A          110 MEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN  188 (360)
T ss_dssp             ECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC--
T ss_pred             EECCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCccccccccc
Confidence            99999999999998764 799999999999999999999996 999999999999999887 99999999975433  33


Q ss_pred             cCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHH------------------------------
Q 015500          154 QSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMT------------------------------  203 (405)
Q Consensus       154 ~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~------------------------------  203 (405)
                      ...||+.|+|||++.+..++.++|||||||++|+|++|+.||........                              
T Consensus       189 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (360)
T 3eqc_A          189 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFG  268 (360)
T ss_dssp             --CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------------------
T ss_pred             CCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccc
Confidence            45799999999999999999999999999999999999999965432111                              


Q ss_pred             -----------HHHHHHhcCCCCCCc-hhccHHHHHHHHHhcccCccccCCHHHHhcCccccccc
Q 015500          204 -----------VLYKIAYSRELPEVP-AFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFC  256 (405)
Q Consensus       204 -----------~l~~i~~~~~~~~~p-~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~  256 (405)
                                 .+..+. ....+..+ ..+++++.+||++||+.||.+|||++|+|+||||+...
T Consensus       269 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  332 (360)
T 3eqc_A          269 MDSRPPMAIFELLDYIV-NEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD  332 (360)
T ss_dssp             -----CCCHHHHHHHHH-HSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred             cCCCCcccchhhhhHHh-ccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcch
Confidence                       111111 12222222 34789999999999999999999999999999998653

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=2.6e-48  Score=376.34  Aligned_cols=243  Identities=28%  Similarity=0.357  Sum_probs=199.3

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-----hHHHHHHHHHHHhC-CCCCeeeeeeeeeecCCCceEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-----SEFLQREQKFLSSL-NSPHIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-----~~~l~~E~~iL~~L-~hpnIv~~~~~~~~~~~~~~~~~   75 (405)
                      +|.+.+.||+|+||+||+|.++.+|+.||||++....     .....+|+..+.++ +||||+++++++....    .++
T Consensus        58 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~----~~~  133 (311)
T 3p1a_A           58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGG----ILY  133 (311)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT----EEE
T ss_pred             heeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCC----EEE
Confidence            3788999999999999999999999999999875432     12334455444444 9999999999876433    367


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc---
Q 015500           76 LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE---  151 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~---  151 (405)
                      +||||+ +++|.+++...+.++++..++.++.||+.||+|||++||+||||||+|||++.++ +||+|||++.....   
T Consensus       134 lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~  212 (311)
T 3p1a_A          134 LQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA  212 (311)
T ss_dssp             EEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC----
T ss_pred             EEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCCC
Confidence            999999 6799999988777899999999999999999999999999999999999998887 99999999876543   


Q ss_pred             cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHH
Q 015500          152 ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSN  231 (405)
Q Consensus       152 ~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~  231 (405)
                      .....||+.|+|||++.+ .++.++|||||||++|||++|..||...    .....+......+.++..+++++.+||.+
T Consensus       213 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~l~~li~~  287 (311)
T 3p1a_A          213 GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG----EGWQQLRQGYLPPEFTAGLSSELRSVLVM  287 (311)
T ss_dssp             --CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH----HHHHHHTTTCCCHHHHTTSCHHHHHHHHH
T ss_pred             CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc----cHHHHHhccCCCcccccCCCHHHHHHHHH
Confidence            234569999999999987 6899999999999999999997766332    22222222222334456689999999999


Q ss_pred             hcccCccccCCHHHHhcCccccc
Q 015500          232 CLRRDPKERWAASQLLKHPFLEE  254 (405)
Q Consensus       232 ~L~~dP~~Rpt~~elL~hp~~~~  254 (405)
                      ||+.||.+|||++|+|+||||++
T Consensus       288 ~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          288 MLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             HSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             HcCCChhhCcCHHHHHhCccccC
Confidence            99999999999999999999974

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=2.5e-48  Score=406.00  Aligned_cols=250  Identities=29%  Similarity=0.447  Sum_probs=215.0

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccC------CChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL------PKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~------~~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~   75 (405)
                      +|.+.+.||+|+||+||+|.++.+|+.||+|.+..      .....+.+|+++|+.++||||+++++++....    .++
T Consensus       185 ~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~----~l~  260 (576)
T 2acx_A          185 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKD----ALC  260 (576)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS----EEE
T ss_pred             ceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCC----EEE
Confidence            48899999999999999999999999999999753      23456889999999999999999998876543    367


Q ss_pred             EEEeecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc--
Q 015500           76 LFMEYAPGGTLNDEIHRNG-GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE--  151 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~~-~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~--  151 (405)
                      +||||++||+|.+++...+ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ +||+|||+++....  
T Consensus       261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~  340 (576)
T 2acx_A          261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ  340 (576)
T ss_dssp             EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccCc
Confidence            9999999999999997653 2499999999999999999999999999999999999999888 99999999986543  


Q ss_pred             -cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC--hHHHHHHHHhcCCCCCCchhccHHHHHH
Q 015500          152 -ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAAD--PMTVLYKIAYSRELPEVPAFLSKQANDF  228 (405)
Q Consensus       152 -~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~--~~~~l~~i~~~~~~~~~p~~~s~~l~dl  228 (405)
                       ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.....  ....+...... ....+|..+++++++|
T Consensus       341 ~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~-~~~~~p~~~s~~~~dL  419 (576)
T 2acx_A          341 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE-VPEEYSERFSPQARSL  419 (576)
T ss_dssp             CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHH-CCCCCCTTSCHHHHHH
T ss_pred             cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhc-ccccCCccCCHHHHHH
Confidence             2346799999999999999999999999999999999999999975432  22223332222 2345677899999999


Q ss_pred             HHHhcccCccccC-----CHHHHhcCccccccc
Q 015500          229 LSNCLRRDPKERW-----AASQLLKHPFLEEFC  256 (405)
Q Consensus       229 l~~~L~~dP~~Rp-----t~~elL~hp~~~~~~  256 (405)
                      |++||+.||.+||     +++|+++||||+.+.
T Consensus       420 I~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~  452 (576)
T 2acx_A          420 CSQLLCKDPAERLGCRGGSAREVKEHPLFKKLN  452 (576)
T ss_dssp             HHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCC
T ss_pred             HHHhccCCHHHcCCCCCCCHHHHHhChhhccCC
Confidence            9999999999999     899999999999754

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=2.6e-48  Score=375.43  Aligned_cols=247  Identities=25%  Similarity=0.398  Sum_probs=202.2

Q ss_pred             Cccc-ccccceeCCeeEEEEEEcCCCCEEEEEEccCC---ChHHHHHHHHHHHhC-CCCCeeeeeeeeeecCCCceEEEE
Q 015500            2 DWTR-GHTIGQGSSATVSLATSLRSGDVFAAKSTELP---KSEFLQREQKFLSSL-NSPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         2 ~y~~-~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~---~~~~l~~E~~iL~~L-~hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      .|.+ .+.||+|+||+||+|.+..+++.||||.+...   ..+.+.+|+++|+++ +||||+++++++....    .+++
T Consensus        13 ~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~----~~~l   88 (316)
T 2ac3_A           13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEED----RFYL   88 (316)
T ss_dssp             SCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT----EEEE
T ss_pred             eEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC----EEEE
Confidence            3666 47899999999999999999999999998653   356789999999995 7999999999876543    3679


Q ss_pred             EEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC----ceEeeecccccccc-
Q 015500           77 FMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG----AKIADFGCAKWESE-  151 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~----vkL~DFGla~~~~~-  151 (405)
                      ||||++|++|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++    +||+|||++..... 
T Consensus        89 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~  167 (316)
T 2ac3_A           89 VFEKMRGGSILSHIHKR-RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN  167 (316)
T ss_dssp             EEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred             EEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence            99999999999999876 4799999999999999999999999999999999999998764    89999999875421 


Q ss_pred             ----------cccCCCCCCccChhhhcC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCh--------------H
Q 015500          152 ----------ALQSGGTPMFMAPEVARG-----EHQGFASDIWAVGCTVIEMASGGAPWPNAADP--------------M  202 (405)
Q Consensus       152 ----------~~~~~gt~~Y~APE~l~~-----~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~--------------~  202 (405)
                                .....||+.|+|||++.+     ..++.++|||||||++|+|++|+.||......              .
T Consensus       168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  247 (316)
T 2ac3_A          168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQN  247 (316)
T ss_dssp             --------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHH
T ss_pred             CccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHH
Confidence                      123459999999999975     45788999999999999999999999654321              1


Q ss_pred             HHHHHHHhcCCCCCCc----hhccHHHHHHHHHhcccCccccCCHHHHhcCcccccc
Q 015500          203 TVLYKIAYSRELPEVP----AFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       203 ~~l~~i~~~~~~~~~p----~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      .....+... . ..+|    ..+++++++||++||+.||.+|||++|+|+||||+..
T Consensus       248 ~~~~~i~~~-~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~  302 (316)
T 2ac3_A          248 MLFESIQEG-K-YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC  302 (316)
T ss_dssp             HHHHHHHHC-C-CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC--
T ss_pred             HHHHHHhcc-C-cccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCC
Confidence            222222222 2 2233    3478999999999999999999999999999999865

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=6.9e-49  Score=385.08  Aligned_cols=240  Identities=25%  Similarity=0.348  Sum_probs=207.5

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC-----------ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCC
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP-----------KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDN   70 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~-----------~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~   70 (405)
                      +|++++.||+|+||+||+|.++.+++.||||.+...           ....+.+|+.+|++++||||+++++++....  
T Consensus        25 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~--  102 (335)
T 3dls_A           25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG--  102 (335)
T ss_dssp             HEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS--
T ss_pred             ceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC--
Confidence            488999999999999999999999999999988654           2346778999999999999999999875433  


Q ss_pred             ceEEEEEEeecCCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccc
Q 015500           71 KLMYNLFMEYAPGG-TLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKW  148 (405)
Q Consensus        71 ~~~~~lv~Ey~~gg-sL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~  148 (405)
                        .+++||||+.+| +|.+++... +++++..++.++.||+.||.|||++||+||||||+|||++.++ +||+|||+++.
T Consensus       103 --~~~lv~e~~~~g~~l~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~  179 (335)
T 3dls_A          103 --FFQLVMEKHGSGLDLFAFIDRH-PRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAY  179 (335)
T ss_dssp             --EEEEEEECCTTSCBHHHHHHTC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             --EEEEEEEeCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceE
Confidence              367999999766 999999876 4799999999999999999999999999999999999999887 99999999986


Q ss_pred             ccc---cccCCCCCCccChhhhcCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHH
Q 015500          149 ESE---ALQSGGTPMFMAPEVARGEHQ-GFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQ  224 (405)
Q Consensus       149 ~~~---~~~~~gt~~Y~APE~l~~~~~-~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~  224 (405)
                      ...   .....||+.|+|||++.+..+ ++++|||||||++|+|++|+.||.....         ........|..++++
T Consensus       180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---------~~~~~~~~~~~~~~~  250 (335)
T 3dls_A          180 LERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE---------TVEAAIHPPYLVSKE  250 (335)
T ss_dssp             CCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG---------GTTTCCCCSSCCCHH
T ss_pred             CCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH---------HHhhccCCCcccCHH
Confidence            543   234569999999999998776 8899999999999999999999964321         112223445668999


Q ss_pred             HHHHHHHhcccCccccCCHHHHhcCcccccc
Q 015500          225 ANDFLSNCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       225 l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      +.+||.+||+.||.+|||++++++||||+..
T Consensus       251 l~~li~~~L~~dP~~Rps~~ell~hp~~~~~  281 (335)
T 3dls_A          251 LMSLVSGLLQPVPERRTTLEKLVTDPWVTQP  281 (335)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred             HHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence            9999999999999999999999999999763

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=9.2e-49  Score=379.02  Aligned_cols=252  Identities=25%  Similarity=0.436  Sum_probs=211.3

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC------hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK------SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~------~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~   75 (405)
                      +|++++.||+|+||+||+|.+..+++.||||.+....      ...+.+|++++++++||||+++++++.........++
T Consensus        13 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   92 (311)
T 3ork_A           13 RYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY   92 (311)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             cEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccE
Confidence            5899999999999999999999999999999987542      2367899999999999999999998877766555668


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc---
Q 015500           76 LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE---  151 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~---  151 (405)
                      +||||++|++|.+++...+ ++++..+..++.||+.||+|||++||+||||||+|||++.++ +||+|||+++....   
T Consensus        93 lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  171 (311)
T 3ork_A           93 IVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN  171 (311)
T ss_dssp             EEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC--------
T ss_pred             EEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccccccc
Confidence            9999999999999998764 899999999999999999999999999999999999998887 99999999975433   


Q ss_pred             ----cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCC--CchhccHHH
Q 015500          152 ----ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPE--VPAFLSKQA  225 (405)
Q Consensus       152 ----~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~--~p~~~s~~l  225 (405)
                          .....||+.|+|||++.+..++.++|||||||++|+|++|+.||... ...............+.  .+..+++++
T Consensus       172 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l  250 (311)
T 3ork_A          172 SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD-SPVSVAYQHVREDPIPPSARHEGLSADL  250 (311)
T ss_dssp             ----------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS-SHHHHHHHHHHCCCCCHHHHSTTCCHHH
T ss_pred             ccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHhcCCCCCcccccCCCCHHH
Confidence                12345899999999999999999999999999999999999999644 34444444443333221  123489999


Q ss_pred             HHHHHHhcccCccccCCHHHHhcCcccccc
Q 015500          226 NDFLSNCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       226 ~dll~~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      .+||.+||+.||.+||++.+++.|+|++..
T Consensus       251 ~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  280 (311)
T 3ork_A          251 DAVVLKALAKNPENRYQTAAEMRADLVRVH  280 (311)
T ss_dssp             HHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             HHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence            999999999999999999999999999754

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=6.7e-48  Score=378.89  Aligned_cols=252  Identities=26%  Similarity=0.315  Sum_probs=206.2

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCC----ce
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDN----KL   72 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~----~~   72 (405)
                      +|++++.||+|+||+||+|+++.+|+.||||.+....     ...+.+|+.+|+.++||||+++++++......    ..
T Consensus        18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   97 (351)
T 3mi9_A           18 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKG   97 (351)
T ss_dssp             GEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------C
T ss_pred             ceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCc
Confidence            5899999999999999999999999999999875432     34678999999999999999999987764321    23


Q ss_pred             EEEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc
Q 015500           73 MYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE  151 (405)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~  151 (405)
                      .+++||||+++ +|.+.+....+.+++..++.++.||+.||+|||++||+||||||+|||++.++ +||+|||+++....
T Consensus        98 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~  176 (351)
T 3mi9_A           98 SIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSL  176 (351)
T ss_dssp             EEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCC
T ss_pred             eEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcccccc
Confidence            46799999975 88888877666899999999999999999999999999999999999999887 99999999975432


Q ss_pred             --------cccCCCCCCccChhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhc-CC-CCCCchh
Q 015500          152 --------ALQSGGTPMFMAPEVARG-EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYS-RE-LPEVPAF  220 (405)
Q Consensus       152 --------~~~~~gt~~Y~APE~l~~-~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~-~~-~~~~p~~  220 (405)
                              .....||+.|+|||++.+ ..++.++|||||||++|+|++|++||.... ....+..+... .. .+.....
T Consensus       177 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~  255 (351)
T 3mi9_A          177 AKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT-EQHQLALISQLCGSITPEVWPN  255 (351)
T ss_dssp             CSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHHHCCCCTTTSTT
T ss_pred             cccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCChhhccc
Confidence                    223468999999999987 458999999999999999999999996543 33333332211 11 1111111


Q ss_pred             ----------------------------ccHHHHHHHHHhcccCccccCCHHHHhcCcccccc
Q 015500          221 ----------------------------LSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       221 ----------------------------~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                                                  .++.+.+||.+||+.||.+|||++|+|+||||...
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  318 (351)
T 3mi9_A          256 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD  318 (351)
T ss_dssp             GGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSS
T ss_pred             cccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCC
Confidence                                        26789999999999999999999999999999754

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=5.7e-48  Score=401.57  Aligned_cols=249  Identities=27%  Similarity=0.394  Sum_probs=214.0

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccC------CChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL------PKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~------~~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~   75 (405)
                      +|...+.||+|+||+||+|+++.+|+.||+|++..      ...+.+.+|+++|++++||||+++++++....    .+|
T Consensus       186 ~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~----~l~  261 (543)
T 3c4z_A          186 WFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKT----DLC  261 (543)
T ss_dssp             GEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS----EEE
T ss_pred             heEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCC----EEE
Confidence            47888999999999999999999999999999854      23457889999999999999999998876543    367


Q ss_pred             EEEeecCCCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc
Q 015500           76 LFMEYAPGGTLNDEIHRN---GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE  151 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~---~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~  151 (405)
                      +||||++||+|.+++...   ...+++..++.++.||+.||.|||++||+||||||+|||++.++ +||+|||+++....
T Consensus       262 lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~  341 (543)
T 3c4z_A          262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA  341 (543)
T ss_dssp             EEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence            999999999999999764   24699999999999999999999999999999999999999888 99999999986543


Q ss_pred             ----cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC---ChHHHHHHHHhcCCCCCCchhccHH
Q 015500          152 ----ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAA---DPMTVLYKIAYSRELPEVPAFLSKQ  224 (405)
Q Consensus       152 ----~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~---~~~~~l~~i~~~~~~~~~p~~~s~~  224 (405)
                          ....+||+.|+|||++.+..++.++|||||||++|||++|+.||....   ........+..  ....+|..++++
T Consensus       342 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~--~~~~~p~~~s~~  419 (543)
T 3c4z_A          342 GQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLE--QAVTYPDKFSPA  419 (543)
T ss_dssp             TCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHH--CCCCCCTTSCHH
T ss_pred             CCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhh--cccCCCcccCHH
Confidence                223479999999999999999999999999999999999999997543   22333333332  234567889999


Q ss_pred             HHHHHHHhcccCccccCC-----HHHHhcCccccccc
Q 015500          225 ANDFLSNCLRRDPKERWA-----ASQLLKHPFLEEFC  256 (405)
Q Consensus       225 l~dll~~~L~~dP~~Rpt-----~~elL~hp~~~~~~  256 (405)
                      +++||++||++||.+||+     ++++++||||+.+.
T Consensus       420 ~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~  456 (543)
T 3c4z_A          420 SKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDIS  456 (543)
T ss_dssp             HHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCC
T ss_pred             HHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCC
Confidence            999999999999999996     58999999999764

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=4.2e-48  Score=372.67  Aligned_cols=248  Identities=28%  Similarity=0.437  Sum_probs=210.1

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC---ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP---KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFM   78 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~---~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (405)
                      +|.+++.||+|+||+||+|.++.+|+.||+|.+...   ..+.+.+|+.+|++++||||+++++++....    .+++||
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~   85 (304)
T 2jam_A           10 TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTT----HYYLVM   85 (304)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSS----EEEEEE
T ss_pred             cceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCC----EEEEEE
Confidence            488999999999999999999999999999998754   3456889999999999999999999875433    367999


Q ss_pred             eecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEE---ccCC-ceEeeecccccccc--c
Q 015500           79 EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILM---AESG-AKIADFGCAKWESE--A  152 (405)
Q Consensus        79 Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi---~~~~-vkL~DFGla~~~~~--~  152 (405)
                      ||++|++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+||++   +.++ +||+|||++.....  .
T Consensus        86 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~  164 (304)
T 2jam_A           86 QLVSGGELFDRILERG-VYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM  164 (304)
T ss_dssp             CCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBTT
T ss_pred             EcCCCccHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCcc
Confidence            9999999999998764 79999999999999999999999999999999999999   4455 99999999875443  2


Q ss_pred             ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCC--CCCCchhccHHHHHHHH
Q 015500          153 LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRE--LPEVPAFLSKQANDFLS  230 (405)
Q Consensus       153 ~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~--~~~~p~~~s~~l~dll~  230 (405)
                      ....||+.|+|||++.+..++.++|||||||++|+|++|+.||... ........+.....  ....+..+++++.+||.
T Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~  243 (304)
T 2jam_A          165 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEE-TESKLFEKIKEGYYEFESPFWDDISESAKDFIC  243 (304)
T ss_dssp             HHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTS-CHHHHHHHHHHCCCCCCTTTTTTSCHHHHHHHH
T ss_pred             ccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCC-CHHHHHHHHHcCCCCCCccccccCCHHHHHHHH
Confidence            2345999999999999999999999999999999999999999644 33444444433321  12334568999999999


Q ss_pred             HhcccCccccCCHHHHhcCcccccc
Q 015500          231 NCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       231 ~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      +||..||.+|||+.++|+||||+..
T Consensus       244 ~~l~~dp~~Rps~~~~l~h~~~~~~  268 (304)
T 2jam_A          244 HLLEKDPNERYTCEKALSHPWIDGN  268 (304)
T ss_dssp             HHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred             HHcCCChhHCcCHHHHhcCccccCC
Confidence            9999999999999999999999864

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=3.7e-48  Score=384.94  Aligned_cols=251  Identities=26%  Similarity=0.331  Sum_probs=207.1

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC--hHHHHHHHHHHHhCC--------CCCeeeeeeeeeecCCCc
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK--SEFLQREQKFLSSLN--------SPHIVGYKGCDVTSEDNK   71 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~--~~~l~~E~~iL~~L~--------hpnIv~~~~~~~~~~~~~   71 (405)
                      +|++++.||+|+||+||+|++..+++.||||.+....  .+.+.+|+.+|+.++        ||||+++++.+.......
T Consensus        38 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~  117 (397)
T 1wak_A           38 RYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNG  117 (397)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTE
T ss_pred             eEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCC
Confidence            5899999999999999999999999999999987543  357889999999996        788999999887655455


Q ss_pred             eEEEEEEeecCCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCCCCEEEccC-------------
Q 015500           72 LMYNLFMEYAPGGTLNDEIHRN-GGRLDESLIVSYTRQILQGLEYLHSN-RVVHCDIKSRNILMAES-------------  136 (405)
Q Consensus        72 ~~~~lv~Ey~~ggsL~~~i~~~-~~~l~e~~~~~i~~qIl~~L~yLH~~-givHrDlkp~NILi~~~-------------  136 (405)
                      ..+++||||+ +++|.+.+.+. .+.+++..++.++.||+.||.|||++ ||+||||||+|||++.+             
T Consensus       118 ~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~~~  196 (397)
T 1wak_A          118 THICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATE  196 (397)
T ss_dssp             EEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHHC-
T ss_pred             ceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhhHH
Confidence            5688999999 56776666554 35799999999999999999999998 99999999999999855             


Q ss_pred             -------------------------------------CceEeeecccccccc-cccCCCCCCccChhhhcCCCCCcchhH
Q 015500          137 -------------------------------------GAKIADFGCAKWESE-ALQSGGTPMFMAPEVARGEHQGFASDI  178 (405)
Q Consensus       137 -------------------------------------~vkL~DFGla~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~sDI  178 (405)
                                                           .+||+|||+++.... .....||+.|+|||++.+..++.++||
T Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di  276 (397)
T 1wak_A          197 WQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPADI  276 (397)
T ss_dssp             --------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCSCCSCGGGCCHHHHHTSCCCTHHHH
T ss_pred             HhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCccCCCCCcccCChhhcCCCCCcHHHH
Confidence                                                 389999999986544 344579999999999999999999999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCCC-----hHHHHHHHHh-cCCC--------------------------------------
Q 015500          179 WAVGCTVIEMASGGAPWPNAAD-----PMTVLYKIAY-SREL--------------------------------------  214 (405)
Q Consensus       179 wSLG~il~elltG~~Pf~~~~~-----~~~~l~~i~~-~~~~--------------------------------------  214 (405)
                      |||||++|+|+||+.||.....     ....+..+.. ....                                      
T Consensus       277 wslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  356 (397)
T 1wak_A          277 WSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVE  356 (397)
T ss_dssp             HHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHH
T ss_pred             HHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhh
Confidence            9999999999999999964432     1122211111 0110                                      


Q ss_pred             -CCCchhccHHHHHHHHHhcccCccccCCHHHHhcCcccc
Q 015500          215 -PEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLE  253 (405)
Q Consensus       215 -~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~  253 (405)
                       ...+...++.+.+||.+||+.||.+|||++|+|+||||+
T Consensus       357 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~  396 (397)
T 1wak_A          357 KYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN  396 (397)
T ss_dssp             TSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred             hcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence             123455678899999999999999999999999999996

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.9e-48  Score=380.62  Aligned_cols=249  Identities=29%  Similarity=0.409  Sum_probs=205.8

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC--------hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK--------SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLM   73 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~--------~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~   73 (405)
                      +|++++.||+|+||+||+|.+..+|+.||||.+....        ...+.+|+++++.++||||+++++++.....    
T Consensus        11 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~----   86 (346)
T 1ua2_A           11 RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN----   86 (346)
T ss_dssp             --CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC----
T ss_pred             ccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc----
Confidence            5899999999999999999999999999999986432        2467899999999999999999998754433    


Q ss_pred             EEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc-
Q 015500           74 YNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE-  151 (405)
Q Consensus        74 ~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~-  151 (405)
                      +++||||+++ +|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++ +||+|||+++.... 
T Consensus        87 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  165 (346)
T 1ua2_A           87 ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP  165 (346)
T ss_dssp             CEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred             eEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCC
Confidence            5699999976 89999988767899999999999999999999999999999999999999887 99999999986533 


Q ss_pred             ---cccCCCCCCccChhhhcCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCC-------------
Q 015500          152 ---ALQSGGTPMFMAPEVARGE-HQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSREL-------------  214 (405)
Q Consensus       152 ---~~~~~gt~~Y~APE~l~~~-~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~-------------  214 (405)
                         .....||+.|+|||++.+. .++.++|||||||++|+|++|.+||.... ....+.++......             
T Consensus       166 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~  244 (346)
T 1ua2_A          166 NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS-DLDQLTRIFETLGTPTEEQWPDMCSLP  244 (346)
T ss_dssp             CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHHHCCCCTTTSSSTTSST
T ss_pred             cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCC-HHHHHHHHHHHcCCCChhhhhhhccCc
Confidence               2345699999999999764 58999999999999999999999996543 34444443321111             


Q ss_pred             --------CCCc-----hhccHHHHHHHHHhcccCccccCCHHHHhcCccccccc
Q 015500          215 --------PEVP-----AFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFC  256 (405)
Q Consensus       215 --------~~~p-----~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~  256 (405)
                              +..|     ..+++++.+||++||+.||.+|||++|+|+||||....
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~  299 (346)
T 1ua2_A          245 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP  299 (346)
T ss_dssp             TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred             ccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCC
Confidence                    1111     34678999999999999999999999999999998653

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=4.6e-48  Score=387.49  Aligned_cols=254  Identities=28%  Similarity=0.442  Sum_probs=203.6

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHhCCCCCeeeeeeeeeecC--CCceEEEEEEe
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSE--DNKLMYNLFME   79 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~--~~~~~~~lv~E   79 (405)
                      +|++++.||+|+||+||+|++..+++ +|+|++... .....+|+++|+.++||||+++++++....  ....++++|||
T Consensus        41 ~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~-~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e  118 (394)
T 4e7w_A           41 AYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQD-KRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLE  118 (394)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECC-TTSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEE
T ss_pred             eEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecC-cchHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEee
Confidence            58999999999999999999987776 777766433 233458999999999999999999886654  33456779999


Q ss_pred             ecCCCCHHHHH--HHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEc-cCC-ceEeeecccccccc---c
Q 015500           80 YAPGGTLNDEI--HRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMA-ESG-AKIADFGCAKWESE---A  152 (405)
Q Consensus        80 y~~ggsL~~~i--~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~-~~~-vkL~DFGla~~~~~---~  152 (405)
                      |++++.+....  ....+.+++..++.++.||+.||+|||++||+||||||+|||++ .++ +||+|||+++....   .
T Consensus       119 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~~  198 (394)
T 4e7w_A          119 YVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN  198 (394)
T ss_dssp             CCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCCC
T ss_pred             ccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCCCC
Confidence            99875443322  22345899999999999999999999999999999999999998 566 99999999986432   3


Q ss_pred             ccCCCCCCccChhhhcCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhc------------------CC
Q 015500          153 LQSGGTPMFMAPEVARGE-HQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYS------------------RE  213 (405)
Q Consensus       153 ~~~~gt~~Y~APE~l~~~-~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~------------------~~  213 (405)
                      ....||+.|+|||++.+. .++.++|||||||++|||++|+.||.... ....+..+...                  ..
T Consensus       199 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~-~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~  277 (394)
T 4e7w_A          199 VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGES-GIDQLVEIIKVLGTPSREQIKTMNPNYMEHK  277 (394)
T ss_dssp             CSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHHHCCCCHHHHHHHCGGGSSSC
T ss_pred             cccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhCCCCHHHHHhhChhhhhhc
Confidence            355689999999999775 58999999999999999999999997544 33333333221                  11


Q ss_pred             CCC---------CchhccHHHHHHHHHhcccCccccCCHHHHhcCccccccccc
Q 015500          214 LPE---------VPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSC  258 (405)
Q Consensus       214 ~~~---------~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~~~  258 (405)
                      +|.         ++..+++++.+||.+||+.||.+|||+.|+|+||||+.+...
T Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  331 (394)
T 4e7w_A          278 FPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTG  331 (394)
T ss_dssp             CCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSS
T ss_pred             cccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhccc
Confidence            111         223478999999999999999999999999999999987543

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=9.8e-49  Score=395.54  Aligned_cols=247  Identities=30%  Similarity=0.474  Sum_probs=201.2

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-----------hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCC
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-----------SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDN   70 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-----------~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~   70 (405)
                      +|.+++.||+|+||+||+|.++.+++.||||.+....           ...+.+|+.+|++++||||+++++++.. .  
T Consensus       136 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~--  212 (419)
T 3i6u_A          136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-E--  212 (419)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-S--
T ss_pred             cEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-C--
Confidence            5889999999999999999999999999999876421           2357899999999999999999987532 1  


Q ss_pred             ceEEEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC----ceEeeeccc
Q 015500           71 KLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG----AKIADFGCA  146 (405)
Q Consensus        71 ~~~~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~----vkL~DFGla  146 (405)
                        .+++||||+++|+|.+++... +++++..++.++.||+.||+|||++||+||||||+|||++.++    +||+|||++
T Consensus       213 --~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a  289 (419)
T 3i6u_A          213 --DYYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS  289 (419)
T ss_dssp             --EEEEEEECCTTCBGGGGTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTT
T ss_pred             --ceEEEEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccc
Confidence              156999999999999988765 4899999999999999999999999999999999999997542    999999999


Q ss_pred             ccccc---cccCCCCCCccChhhhcC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCc--
Q 015500          147 KWESE---ALQSGGTPMFMAPEVARG---EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVP--  218 (405)
Q Consensus       147 ~~~~~---~~~~~gt~~Y~APE~l~~---~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p--  218 (405)
                      +....   ....+||+.|+|||++.+   ..++.++|||||||++|+|++|+.||............+. ....+..|  
T Consensus       290 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~-~~~~~~~~~~  368 (419)
T 3i6u_A          290 KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT-SGKYNFIPEV  368 (419)
T ss_dssp             TSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHH-TTCCCCCHHH
T ss_pred             eecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHh-cCCCCCCchh
Confidence            87544   234569999999999864   5678899999999999999999999976544333333332 22222222  


Q ss_pred             -hhccHHHHHHHHHhcccCccccCCHHHHhcCcccccc
Q 015500          219 -AFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       219 -~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                       ..+++.+.+||++||+.||.+|||++|+|+||||+..
T Consensus       369 ~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~  406 (419)
T 3i6u_A          369 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE  406 (419)
T ss_dssp             HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred             hcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence             4579999999999999999999999999999999753

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=7.9e-48  Score=366.05  Aligned_cols=249  Identities=29%  Similarity=0.455  Sum_probs=210.0

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC---------ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCce
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP---------KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKL   72 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~---------~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~   72 (405)
                      +|++++.||+|+||+||+|.++.+++.+|+|.+...         ..+.+.+|+.+|++++||||+++++++....    
T Consensus         6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~----   81 (283)
T 3bhy_A            6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKT----   81 (283)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS----
T ss_pred             hhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCC----
Confidence            488999999999999999999999999999987543         2467899999999999999999999876433    


Q ss_pred             EEEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-----ceEeeecccc
Q 015500           73 MYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-----AKIADFGCAK  147 (405)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-----vkL~DFGla~  147 (405)
                      .+++||||+++++|.+++... +.+++..+..++.||+.||.|||++|++||||||+||+++.++     +||+|||++.
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~  160 (283)
T 3bhy_A           82 DVVLILELVSGGELFDFLAEK-ESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH  160 (283)
T ss_dssp             EEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             eEEEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence            367999999999999999876 4799999999999999999999999999999999999997654     8999999997


Q ss_pred             cccc---cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCC--CCCchhcc
Q 015500          148 WESE---ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSREL--PEVPAFLS  222 (405)
Q Consensus       148 ~~~~---~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~--~~~p~~~s  222 (405)
                      ....   .....||+.|+|||++.+..++.++|||||||++|+|++|+.||... .....+..+......  +..+..++
T Consensus       161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  239 (283)
T 3bhy_A          161 KIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGE-TKQETLTNISAVNYDFDEEYFSNTS  239 (283)
T ss_dssp             ECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS-SHHHHHHHHHTTCCCCCHHHHTTCC
T ss_pred             eccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCc-chHHHHHHhHhcccCCcchhcccCC
Confidence            6543   23456999999999999999999999999999999999999999654 334444443322211  11224578


Q ss_pred             HHHHHHHHHhcccCccccCCHHHHhcCccccccc
Q 015500          223 KQANDFLSNCLRRDPKERWAASQLLKHPFLEEFC  256 (405)
Q Consensus       223 ~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~  256 (405)
                      +.+.+||++||..||.+|||+.++|+||||+...
T Consensus       240 ~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  273 (283)
T 3bhy_A          240 ELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR  273 (283)
T ss_dssp             HHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred             HHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence            9999999999999999999999999999998764

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=5.7e-48  Score=411.97  Aligned_cols=248  Identities=27%  Similarity=0.419  Sum_probs=216.8

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccC------CChHHHHHHHHHHHhC-CCCCeeeeeeeeeecCCCceEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL------PKSEFLQREQKFLSSL-NSPHIVGYKGCDVTSEDNKLMY   74 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~------~~~~~l~~E~~iL~~L-~hpnIv~~~~~~~~~~~~~~~~   74 (405)
                      +|.+++.||+|+||+||+|.++.+++.||||++..      ...+.+.+|..+|..+ +||+|+.+++++....    .+
T Consensus       342 ~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~----~~  417 (674)
T 3pfq_A          342 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD----RL  417 (674)
T ss_dssp             TEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSS----EE
T ss_pred             ceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCC----EE
Confidence            58899999999999999999999999999998763      3456788999999988 7999999998765433    36


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccc---
Q 015500           75 NLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWES---  150 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~---  150 (405)
                      |+||||++||+|.+++.+.+ ++++..++.|+.||+.||+|||++||+||||||+||||+.++ +||+|||+++...   
T Consensus       418 ~lV~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~  496 (674)
T 3pfq_A          418 YFVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG  496 (674)
T ss_dssp             EEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTT
T ss_pred             EEEEeCcCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCC
Confidence            79999999999999998864 899999999999999999999999999999999999999988 9999999998532   


Q ss_pred             -ccccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHH
Q 015500          151 -EALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFL  229 (405)
Q Consensus       151 -~~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll  229 (405)
                       .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.. .+......++...  ...+|..+++++++||
T Consensus       497 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~-~~~~~~~~~i~~~--~~~~p~~~s~~~~~li  573 (674)
T 3pfq_A          497 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEH--NVAYPKSMSKEAVAIC  573 (674)
T ss_dssp             CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHSS--CCCCCTTSCHHHHHHH
T ss_pred             cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCC-CCHHHHHHHHHhC--CCCCCccCCHHHHHHH
Confidence             23456799999999999999999999999999999999999999964 3445555555432  3467788999999999


Q ss_pred             HHhcccCccccCCH-----HHHhcCcccccccc
Q 015500          230 SNCLRRDPKERWAA-----SQLLKHPFLEEFCS  257 (405)
Q Consensus       230 ~~~L~~dP~~Rpt~-----~elL~hp~~~~~~~  257 (405)
                      ++||++||.+||++     +++++||||+.+..
T Consensus       574 ~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w  606 (674)
T 3pfq_A          574 KGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW  606 (674)
T ss_dssp             HHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCH
T ss_pred             HHHccCCHHHCCCCCCCcHHHHhcCccccCCCH
Confidence            99999999999997     99999999997643

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=9.7e-48  Score=368.07  Aligned_cols=246  Identities=28%  Similarity=0.450  Sum_probs=213.0

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC------ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~------~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~   75 (405)
                      +|.+++.||+|+||+||+|.+..+++.+|+|.+...      ..+.+.+|+.+++.++||||+++++++....    .++
T Consensus        16 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~   91 (294)
T 2rku_A           16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDND----FVF   91 (294)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS----EEE
T ss_pred             ceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCC----EEE
Confidence            488999999999999999999999999999987543      2356889999999999999999999875433    367


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc---
Q 015500           76 LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE---  151 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~---  151 (405)
                      +||||+++++|.+++... +.+++..+..++.||+.||+|||++|++||||||+||+++.++ +||+|||++.....   
T Consensus        92 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~  170 (294)
T 2rku_A           92 VVLELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE  170 (294)
T ss_dssp             EEEECCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             EEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCcc
Confidence            999999999999998876 4799999999999999999999999999999999999999887 99999999976432   


Q ss_pred             -cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHH
Q 015500          152 -ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLS  230 (405)
Q Consensus       152 -~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~  230 (405)
                       .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.... .......+..  ....+|..+++.+.++|.
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-~~~~~~~~~~--~~~~~~~~~~~~~~~li~  247 (294)
T 2rku_A          171 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC-LKETYLRIKK--NEYSIPKHINPVAASLIQ  247 (294)
T ss_dssp             CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS-HHHHHHHHHT--TCCCCCTTSCHHHHHHHH
T ss_pred             ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHhh--ccCCCccccCHHHHHHHH
Confidence             234569999999999999889999999999999999999999996543 3333333332  234567789999999999


Q ss_pred             HhcccCccccCCHHHHhcCcccccc
Q 015500          231 NCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       231 ~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      +||+.||.+|||++++++||||...
T Consensus       248 ~~l~~~p~~Rps~~~ll~~~~~~~~  272 (294)
T 2rku_A          248 KMLQTDPTARPTINELLNDEFFTSG  272 (294)
T ss_dssp             HHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred             HHcccChhhCcCHHHHhhChheecC
Confidence            9999999999999999999999864

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=8.1e-48  Score=367.78  Aligned_cols=249  Identities=35%  Similarity=0.571  Sum_probs=212.8

Q ss_pred             cccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC---hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEe
Q 015500            3 WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK---SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFME   79 (405)
Q Consensus         3 y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~---~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (405)
                      |.....||+|+||+||+|.+..+++.||||.+....   .+.+.+|+.+++.++||||+++++++....    .+++|||
T Consensus        24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~lv~e   99 (295)
T 2clq_A           24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENG----FIKIFME   99 (295)
T ss_dssp             TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETT----EEEEEEE
T ss_pred             CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCC----cEEEEEE
Confidence            344559999999999999999999999999886543   467889999999999999999999876543    3669999


Q ss_pred             ecCCCCHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcc-CC-ceEeeecccccccc----
Q 015500           80 YAPGGTLNDEIHRNGG--RLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAE-SG-AKIADFGCAKWESE----  151 (405)
Q Consensus        80 y~~ggsL~~~i~~~~~--~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~-~~-vkL~DFGla~~~~~----  151 (405)
                      |+++++|.+++....+  .+++..+..++.||+.||.|||++||+||||||+||+++. ++ +||+|||++.....    
T Consensus       100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~  179 (295)
T 2clq_A          100 QVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC  179 (295)
T ss_dssp             CCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred             eCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCCc
Confidence            9999999999987533  4679999999999999999999999999999999999986 55 99999999976543    


Q ss_pred             cccCCCCCCccChhhhcCCC--CCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHH
Q 015500          152 ALQSGGTPMFMAPEVARGEH--QGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFL  229 (405)
Q Consensus       152 ~~~~~gt~~Y~APE~l~~~~--~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll  229 (405)
                      .....||+.|+|||++.+..  ++.++|||||||++|+|++|+.||...................+.+|..+++++.+||
T Consensus       180 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  259 (295)
T 2clq_A          180 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFI  259 (295)
T ss_dssp             -CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHHHH
T ss_pred             ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHHHHH
Confidence            23456999999999997643  7889999999999999999999997666655555555555566778888999999999


Q ss_pred             HHhcccCccccCCHHHHhcCcccccc
Q 015500          230 SNCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       230 ~~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      .+||..||.+|||++++|+||||+..
T Consensus       260 ~~~l~~dp~~Rps~~~ll~~~~~~~~  285 (295)
T 2clq_A          260 LKCFEPDPDKRACANDLLVDEFLKVS  285 (295)
T ss_dssp             HHTTCSSTTTSCCHHHHHTSGGGCC-
T ss_pred             HHHccCChhhCCCHHHHhcChhhhhc
Confidence            99999999999999999999999854

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=7.8e-48  Score=381.89  Aligned_cols=247  Identities=28%  Similarity=0.452  Sum_probs=208.7

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-----------hHHHHHHHHHHHhC-CCCCeeeeeeeeeecCC
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-----------SEFLQREQKFLSSL-NSPHIVGYKGCDVTSED   69 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-----------~~~l~~E~~iL~~L-~hpnIv~~~~~~~~~~~   69 (405)
                      +|.+.+.||+|+||+||+|.++.+|+.||||++....           .+.+.+|+.+++++ +||||+++++++.... 
T Consensus        95 ~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~-  173 (365)
T 2y7j_A           95 KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS-  173 (365)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS-
T ss_pred             hcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC-
Confidence            4788899999999999999999999999999886543           34678999999999 8999999998765432 


Q ss_pred             CceEEEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccc
Q 015500           70 NKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKW  148 (405)
Q Consensus        70 ~~~~~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~  148 (405)
                         .+++||||++|++|.+++... +.+++..++.++.||+.||.|||+.||+||||||+|||++.++ +||+|||++..
T Consensus       174 ---~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~  249 (365)
T 2y7j_A          174 ---FMFLVFDLMRKGELFDYLTEK-VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCH  249 (365)
T ss_dssp             ---EEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             ---EEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccc
Confidence               367999999999999999876 4799999999999999999999999999999999999999887 99999999876


Q ss_pred             ccc---cccCCCCCCccChhhhcC------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCc-
Q 015500          149 ESE---ALQSGGTPMFMAPEVARG------EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVP-  218 (405)
Q Consensus       149 ~~~---~~~~~gt~~Y~APE~l~~------~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p-  218 (405)
                      ...   .....||+.|+|||++.+      ..++.++|||||||++|+|++|+.||... .....+..+.........| 
T Consensus       250 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~  328 (365)
T 2y7j_A          250 LEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHR-RQILMLRMIMEGQYQFSSPE  328 (365)
T ss_dssp             CCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHTCCCCCHHH
T ss_pred             cCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCC-CHHHHHHHHHhCCCCCCCcc
Confidence            543   334579999999999864      35788999999999999999999999644 3344444443333222222 


Q ss_pred             -hhccHHHHHHHHHhcccCccccCCHHHHhcCccccc
Q 015500          219 -AFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEE  254 (405)
Q Consensus       219 -~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~  254 (405)
                       ..+++.+.+||++||+.||.+|||+.++|+||||++
T Consensus       329 ~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r  365 (365)
T 2y7j_A          329 WDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER  365 (365)
T ss_dssp             HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence             347889999999999999999999999999999973

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1e-47  Score=363.92  Aligned_cols=246  Identities=29%  Similarity=0.462  Sum_probs=205.5

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccC------CChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL------PKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~------~~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~   75 (405)
                      +|++++.||+|+||+||+|.++.+|+.||||.+..      ...+.+.+|+.+++.++||||+++++++....    .++
T Consensus        12 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~   87 (276)
T 2h6d_A           12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPT----DFF   87 (276)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS----EEE
T ss_pred             cEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC----eEE
Confidence            58999999999999999999999999999998753      23457889999999999999999999875433    367


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc---
Q 015500           76 LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE---  151 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~---  151 (405)
                      +||||+++++|.+++...+ ++++..+..++.||+.||.|||++|++||||||+||+++.++ +||+|||++.....   
T Consensus        88 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  166 (276)
T 2h6d_A           88 MVMEYVSGGELFDYICKHG-RVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF  166 (276)
T ss_dssp             EEEECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC---
T ss_pred             EEEeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCcc
Confidence            9999999999999998764 799999999999999999999999999999999999999887 99999999976543   


Q ss_pred             cccCCCCCCccChhhhcCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHH
Q 015500          152 ALQSGGTPMFMAPEVARGEHQ-GFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLS  230 (405)
Q Consensus       152 ~~~~~gt~~Y~APE~l~~~~~-~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~  230 (405)
                      .....||+.|+|||++.+..+ ++++|||||||++|+|++|+.||... ........+..  .....|..+++.+.++|.
T Consensus       167 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~-~~~~~~~~~~~--~~~~~~~~~~~~l~~li~  243 (276)
T 2h6d_A          167 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE-HVPTLFKKIRG--GVFYIPEYLNRSVATLLM  243 (276)
T ss_dssp             ----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHH--CCCCCCTTSCHHHHHHHH
T ss_pred             eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCC-cHHHHHHHhhc--CcccCchhcCHHHHHHHH
Confidence            234568999999999988765 68999999999999999999999643 33333333332  234567778999999999


Q ss_pred             HhcccCccccCCHHHHhcCcccccc
Q 015500          231 NCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       231 ~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      +||+.||.+|||+.++++||||++.
T Consensus       244 ~~l~~~p~~Rps~~~~l~h~~~~~~  268 (276)
T 2h6d_A          244 HMLQVDPLKRATIKDIREHEWFKQD  268 (276)
T ss_dssp             HHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             HHccCChhhCCCHHHHHhChhhccC
Confidence            9999999999999999999999864

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=4.8e-48  Score=377.22  Aligned_cols=248  Identities=30%  Similarity=0.464  Sum_probs=203.2

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      +|++++.||+|+||+||+|.+..+|+.||||.+....     ...+.+|+.++++++||||+++++++....    .+++
T Consensus        26 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~l  101 (331)
T 4aaa_A           26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKK----RWYL  101 (331)
T ss_dssp             GEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT----EEEE
T ss_pred             hheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCC----EEEE
Confidence            5889999999999999999999999999999875432     245778999999999999999999876543    3679


Q ss_pred             EEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc----
Q 015500           77 FMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE----  151 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~----  151 (405)
                      ||||+++++|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++ +||+|||+++....    
T Consensus       102 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  180 (331)
T 4aaa_A          102 VFEFVDHTILDDLELFP-NGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV  180 (331)
T ss_dssp             EEECCSEEHHHHHHHST-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred             EEecCCcchHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCccc
Confidence            99999998888876554 4799999999999999999999999999999999999999887 99999999976433    


Q ss_pred             cccCCCCCCccChhhhcCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhc-C-----------------
Q 015500          152 ALQSGGTPMFMAPEVARGE-HQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYS-R-----------------  212 (405)
Q Consensus       152 ~~~~~gt~~Y~APE~l~~~-~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~-~-----------------  212 (405)
                      .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||...... ..+..+... .                 
T Consensus       181 ~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (331)
T 4aaa_A          181 YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDI-DQLYHIMMCLGNLIPRHQELFNKNPVFA  259 (331)
T ss_dssp             ---CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCSCCHHHHHHHHHCGGGT
T ss_pred             cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCChhhhhHhhhccccc
Confidence            2345699999999999875 6899999999999999999999999755433 333222111 0                 


Q ss_pred             --CCCCC---------chhccHHHHHHHHHhcccCccccCCHHHHhcCcccccc
Q 015500          213 --ELPEV---------PAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       213 --~~~~~---------p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                        ..+..         ...+++.+.+||.+||+.||.+|||++|+|+||||+..
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  313 (331)
T 4aaa_A          260 GVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD  313 (331)
T ss_dssp             TCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred             cccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence              11111         12468999999999999999999999999999999853

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.5e-47  Score=371.73  Aligned_cols=253  Identities=31%  Similarity=0.507  Sum_probs=209.0

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC--ChHHHHHHHHHHHhC-CCCCeeeeeeeeeecCC--CceEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP--KSEFLQREQKFLSSL-NSPHIVGYKGCDVTSED--NKLMYNL   76 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~--~~~~l~~E~~iL~~L-~hpnIv~~~~~~~~~~~--~~~~~~l   76 (405)
                      +|++++.||+|+||+||+|.+..+|+.||||.+...  ..+.+.+|+.+++++ +||||+++++++.....  ....+++
T Consensus        25 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~l  104 (326)
T 2x7f_A           25 IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWL  104 (326)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEE
T ss_pred             cEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEE
Confidence            588999999999999999999999999999998653  456899999999999 89999999998876431  1234679


Q ss_pred             EEeecCCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc---
Q 015500           77 FMEYAPGGTLNDEIHRN-GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE---  151 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~-~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~---  151 (405)
                      ||||+++++|.+++... +..+++..++.++.||+.||.|||++||+||||||+||+++.++ +||+|||++.....   
T Consensus       105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  184 (326)
T 2x7f_A          105 VMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG  184 (326)
T ss_dssp             EEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC-------
T ss_pred             EEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCceecCcCcc
Confidence            99999999999999864 34799999999999999999999999999999999999999887 99999999876443   


Q ss_pred             -cccCCCCCCccChhhhc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHH
Q 015500          152 -ALQSGGTPMFMAPEVAR-----GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQA  225 (405)
Q Consensus       152 -~~~~~gt~~Y~APE~l~-----~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l  225 (405)
                       .....||+.|+|||++.     +..++.++|||||||++|+|++|+.||.... .......+.........+..+++.+
T Consensus       185 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l  263 (326)
T 2x7f_A          185 RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH-PMRALFLIPRNPAPRLKSKKWSKKF  263 (326)
T ss_dssp             ------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC-HHHHHHHHHHSCCCCCSCSCSCHHH
T ss_pred             ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc-HHHHHHHhhcCccccCCccccCHHH
Confidence             23456999999999997     4568899999999999999999999996543 3444444444333333456689999


Q ss_pred             HHHHHHhcccCccccCCHHHHhcCcccccc
Q 015500          226 NDFLSNCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       226 ~dll~~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      .+||.+||..||.+|||++++++||||...
T Consensus       264 ~~li~~~l~~dp~~Rps~~~ll~hp~~~~~  293 (326)
T 2x7f_A          264 QSFIESCLVKNHSQRPATEQLMKHPFIRDQ  293 (326)
T ss_dssp             HHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred             HHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence            999999999999999999999999999864

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.6e-47  Score=380.08  Aligned_cols=251  Identities=26%  Similarity=0.356  Sum_probs=199.1

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCC--CceEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-----SEFLQREQKFLSSLNSPHIVGYKGCDVTSED--NKLMY   74 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~--~~~~~   74 (405)
                      +|++++.||+|+||+||+|.+..+++.||||.+....     ...+.+|+.+++.++||||+++++++.....  ....+
T Consensus        26 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~  105 (371)
T 2xrw_A           26 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDV  105 (371)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEE
T ss_pred             heeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccce
Confidence            5889999999999999999999999999999986532     3467899999999999999999998765431  22346


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc--
Q 015500           75 NLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE--  151 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~--  151 (405)
                      ++||||+++ +|.+.+.   ..+++..+..++.||+.||.|||++||+||||||+|||++.++ +||+|||+++....  
T Consensus       106 ~lv~e~~~~-~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~  181 (371)
T 2xrw_A          106 YIVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF  181 (371)
T ss_dssp             EEEEECCSE-EHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC--------
T ss_pred             EEEEEcCCC-CHHHHHh---hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccccccc
Confidence            799999975 7888885   3599999999999999999999999999999999999999887 99999999986544  


Q ss_pred             -cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCC----------------
Q 015500          152 -ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSREL----------------  214 (405)
Q Consensus       152 -~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~----------------  214 (405)
                       .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.... ....+.++......                
T Consensus       182 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  260 (371)
T 2xrw_A          182 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD-HIDQWNKVIEQLGTPCPEFMKKLQPTVRTY  260 (371)
T ss_dssp             --------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHC-CCCCCHHHHTTSCHHHHHH
T ss_pred             ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhCCCCHHHHHHhhhHHHHH
Confidence             234579999999999999999999999999999999999999996543 33333333221110                


Q ss_pred             ----CCC--------------------chhccHHHHHHHHHhcccCccccCCHHHHhcCcccccccc
Q 015500          215 ----PEV--------------------PAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCS  257 (405)
Q Consensus       215 ----~~~--------------------p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~~  257 (405)
                          +..                    +...++++++||++||+.||.+|||++|+|+||||+....
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~  327 (371)
T 2xrw_A          261 VENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYD  327 (371)
T ss_dssp             HHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCC
T ss_pred             HhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcC
Confidence                000                    0113678999999999999999999999999999987543

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.1e-47  Score=375.68  Aligned_cols=246  Identities=28%  Similarity=0.450  Sum_probs=213.3

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC------ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~------~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~   75 (405)
                      +|.+++.||+|+||+||+|.+..+++.+|+|.+...      ..+.+.+|+.+++.++||||+++++++....    .++
T Consensus        42 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~  117 (335)
T 2owb_A           42 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDND----FVF  117 (335)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS----EEE
T ss_pred             ceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC----eEE
Confidence            488999999999999999999999999999987643      2457889999999999999999999876433    367


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc---
Q 015500           76 LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE---  151 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~---  151 (405)
                      +||||+++++|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++ +||+|||+++....   
T Consensus       118 lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  196 (335)
T 2owb_A          118 VVLELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE  196 (335)
T ss_dssp             EEECCCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             EEEecCCCCCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCcc
Confidence            999999999999998876 4899999999999999999999999999999999999999887 99999999976432   


Q ss_pred             -cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHH
Q 015500          152 -ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLS  230 (405)
Q Consensus       152 -~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~  230 (405)
                       .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.... .......+...  ...+|..+++.+.+||+
T Consensus       197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-~~~~~~~~~~~--~~~~~~~~~~~~~~li~  273 (335)
T 2owb_A          197 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC-LKETYLRIKKN--EYSIPKHINPVAASLIQ  273 (335)
T ss_dssp             CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS-HHHHHHHHHHT--CCCCCTTSCHHHHHHHH
T ss_pred             cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC-HHHHHHHHhcC--CCCCCccCCHHHHHHHH
Confidence             234569999999999999999999999999999999999999996443 33333333322  23566788999999999


Q ss_pred             HhcccCccccCCHHHHhcCcccccc
Q 015500          231 NCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       231 ~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      +||+.||.+|||++|+|+||||...
T Consensus       274 ~~l~~dp~~Rps~~ell~~~~~~~~  298 (335)
T 2owb_A          274 KMLQTDPTARPTINELLNDEFFTSG  298 (335)
T ss_dssp             HHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred             HHccCChhHCcCHHHHhcCccccCC
Confidence            9999999999999999999999864

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=2.4e-47  Score=365.35  Aligned_cols=249  Identities=24%  Similarity=0.380  Sum_probs=210.2

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC------------hHHHHHHHHHHHhCC-CCCeeeeeeeeeecC
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK------------SEFLQREQKFLSSLN-SPHIVGYKGCDVTSE   68 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~------------~~~l~~E~~iL~~L~-hpnIv~~~~~~~~~~   68 (405)
                      +|++.+.||+|+||+||+|.++.+|+.||||.+....            .+.+.+|+++|+++. ||||+++++++....
T Consensus        18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   97 (298)
T 1phk_A           18 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT   97 (298)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred             ccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCC
Confidence            5899999999999999999999999999999986542            246778999999995 999999999875432


Q ss_pred             CCceEEEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccc
Q 015500           69 DNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAK  147 (405)
Q Consensus        69 ~~~~~~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~  147 (405)
                          .+++||||+++++|.+++... +.+++..+..++.||+.||.|||++|++||||||+||+++.++ +||+|||++.
T Consensus        98 ----~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~  172 (298)
T 1phk_A           98 ----FFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC  172 (298)
T ss_dssp             ----EEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             ----eEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchh
Confidence                367999999999999999876 4799999999999999999999999999999999999999887 9999999997


Q ss_pred             cccc---cccCCCCCCccChhhhc------CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCC--C
Q 015500          148 WESE---ALQSGGTPMFMAPEVAR------GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELP--E  216 (405)
Q Consensus       148 ~~~~---~~~~~gt~~Y~APE~l~------~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~--~  216 (405)
                      ....   .....||+.|+|||++.      ...++.++|||||||++|+|++|+.||.... .......+.......  .
T Consensus       173 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~  251 (298)
T 1phk_A          173 QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK-QMLMLRMIMSGNYQFGSP  251 (298)
T ss_dssp             ECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHTCCCCCTT
T ss_pred             hcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc-HHHHHHHHhcCCcccCcc
Confidence            6443   23456999999999985      4567889999999999999999999996543 333333333332221  1


Q ss_pred             CchhccHHHHHHHHHhcccCccccCCHHHHhcCccccccc
Q 015500          217 VPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFC  256 (405)
Q Consensus       217 ~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~  256 (405)
                      ....+++.+.+||.+||+.||.+|||+.++|+||||++..
T Consensus       252 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  291 (298)
T 1phk_A          252 EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV  291 (298)
T ss_dssp             TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred             cccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence            2246899999999999999999999999999999998653

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=8.5e-48  Score=373.28  Aligned_cols=248  Identities=26%  Similarity=0.397  Sum_probs=206.6

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccC----CChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL----PKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLF   77 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~----~~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv   77 (405)
                      +|++++.||+|+||+||+|.+..+++.||||++..    ...+.+.+|+++|++++||||+++++++......  .+++|
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~--~~~lv   87 (319)
T 4euu_A           10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTR--HKVLI   87 (319)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTC--CEEEE
T ss_pred             CEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCc--eEEEE
Confidence            48999999999999999999999999999999864    2346788999999999999999999987654432  35699


Q ss_pred             EeecCCCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEE----ccCC-ceEeeeccccccc
Q 015500           78 MEYAPGGTLNDEIHRNG--GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILM----AESG-AKIADFGCAKWES  150 (405)
Q Consensus        78 ~Ey~~ggsL~~~i~~~~--~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi----~~~~-vkL~DFGla~~~~  150 (405)
                      |||++|++|.+++....  ..+++..++.++.||+.||+|||++||+||||||+|||+    +.++ +||+|||+++...
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~  167 (319)
T 4euu_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE  167 (319)
T ss_dssp             EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECC
T ss_pred             EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecC
Confidence            99999999999998643  239999999999999999999999999999999999998    5555 8999999998654


Q ss_pred             c---cccCCCCCCccChhhhc--------CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC---hHHHHHHHHhcCCC--
Q 015500          151 E---ALQSGGTPMFMAPEVAR--------GEHQGFASDIWAVGCTVIEMASGGAPWPNAAD---PMTVLYKIAYSREL--  214 (405)
Q Consensus       151 ~---~~~~~gt~~Y~APE~l~--------~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~---~~~~l~~i~~~~~~--  214 (405)
                      .   .....||+.|+|||++.        +..++.++|||||||++|||++|+.||.....   ....+.++......  
T Consensus       168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~  247 (319)
T 4euu_A          168 DDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA  247 (319)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTC
T ss_pred             CCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCccc
Confidence            3   23456999999999986        56788999999999999999999999964332   23444444432211  


Q ss_pred             ---------------------CCCchhccHHHHHHHHHhcccCccccCCHHHHhcCcc
Q 015500          215 ---------------------PEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPF  251 (405)
Q Consensus       215 ---------------------~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~  251 (405)
                                           ..++..+++.+.+||++||+.||.+|||++|+|+||-
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~  305 (319)
T 4euu_A          248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS  305 (319)
T ss_dssp             CEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred             chhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence                                 1234567889999999999999999999999999983

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=5.1e-48  Score=383.86  Aligned_cols=252  Identities=25%  Similarity=0.381  Sum_probs=191.7

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCC--CceEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-----SEFLQREQKFLSSLNSPHIVGYKGCDVTSED--NKLMY   74 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~--~~~~~   74 (405)
                      +|++++.||+|+||+||+|.+..+|+.||||++....     ...+.+|+++|+.++||||+++++++.....  ....+
T Consensus        30 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  109 (367)
T 2fst_X           30 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV  109 (367)
T ss_dssp             TEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCC
T ss_pred             ceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeE
Confidence            5899999999999999999999999999999986532     3567799999999999999999998754321  11235


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc-c
Q 015500           75 NLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE-A  152 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~-~  152 (405)
                      ++++||+ +++|.+++..  +++++..++.++.||+.||+|||++||+||||||+|||++.++ +||+|||+++.... .
T Consensus       110 ~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~  186 (367)
T 2fst_X          110 YLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEM  186 (367)
T ss_dssp             EEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC-----------
T ss_pred             EEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccccccC
Confidence            6999999 7899998875  4799999999999999999999999999999999999999887 99999999986544 3


Q ss_pred             ccCCCCCCccChhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcC-------------------
Q 015500          153 LQSGGTPMFMAPEVARG-EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSR-------------------  212 (405)
Q Consensus       153 ~~~~gt~~Y~APE~l~~-~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~-------------------  212 (405)
                      ....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.... ....+..+....                   
T Consensus       187 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~  265 (367)
T 2fst_X          187 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD-HIDQLKLILRLVGTPGAELLKKISSESARNY  265 (367)
T ss_dssp             ----CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHHHCSCCHHHHTTCCCHHHHHH
T ss_pred             CCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhCCCCHHHHHHhhhHHHHHH
Confidence            44579999999999987 678999999999999999999999996543 333333322110                   


Q ss_pred             --CCCCC--------chhccHHHHHHHHHhcccCccccCCHHHHhcCcccccccc
Q 015500          213 --ELPEV--------PAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCS  257 (405)
Q Consensus       213 --~~~~~--------p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~~  257 (405)
                        ..+..        ....++.+.+||++||+.||.+|||+.|+|+||||+.+..
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~  320 (367)
T 2fst_X          266 IQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD  320 (367)
T ss_dssp             HHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred             HhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccC
Confidence              01111        1235889999999999999999999999999999997654

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.9e-47  Score=367.57  Aligned_cols=246  Identities=37%  Similarity=0.580  Sum_probs=214.3

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC----ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP----KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLF   77 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~----~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv   77 (405)
                      .|.+++.||+|+||+||+|.+..+++.||||.+...    ..+.+.+|+.+++.++||||+++++++....    .+++|
T Consensus        23 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv   98 (303)
T 3a7i_A           23 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT----KLWII   98 (303)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETT----EEEEE
T ss_pred             HHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC----eEEEE
Confidence            388999999999999999999999999999998643    3467899999999999999999999876543    36799


Q ss_pred             EeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc----c
Q 015500           78 MEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE----A  152 (405)
Q Consensus        78 ~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~----~  152 (405)
                      |||++|++|.+++..  +++++..+..++.||+.||.|||++||+||||||+||+++.++ +||+|||++.....    .
T Consensus        99 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  176 (303)
T 3a7i_A           99 MEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR  176 (303)
T ss_dssp             EECCTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCB
T ss_pred             EEeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcccccc
Confidence            999999999999865  4799999999999999999999999999999999999999887 99999999976443    2


Q ss_pred             ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHh
Q 015500          153 LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNC  232 (405)
Q Consensus       153 ~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~  232 (405)
                      ....||+.|+|||++.+..++.++|||||||++|+|++|+.||... ........+. ....+.++..+++.+.+||.+|
T Consensus       177 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~  254 (303)
T 3a7i_A          177 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL-HPMKVLFLIP-KNNPPTLEGNYSKPLKEFVEAC  254 (303)
T ss_dssp             CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS-CHHHHHHHHH-HSCCCCCCSSCCHHHHHHHHHH
T ss_pred             CccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCc-CHHHHHHHhh-cCCCCCCccccCHHHHHHHHHH
Confidence            3456899999999999999999999999999999999999999654 3333333333 3445567778999999999999


Q ss_pred             cccCccccCCHHHHhcCcccccc
Q 015500          233 LRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       233 L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      |..||.+|||+.++++||||...
T Consensus       255 l~~dp~~Rps~~~ll~~~~~~~~  277 (303)
T 3a7i_A          255 LNKEPSFRPTAKELLKHKFILRN  277 (303)
T ss_dssp             CCSSGGGSCCHHHHTTCHHHHHH
T ss_pred             cCCChhhCcCHHHHhhChhhhcC
Confidence            99999999999999999999754

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.4e-47  Score=379.12  Aligned_cols=252  Identities=27%  Similarity=0.359  Sum_probs=207.3

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecC-CCceEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSE-DNKLMYNL   76 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~-~~~~~~~l   76 (405)
                      +|++++.||+|+||+||+|.+..+++.||||.+....    .+.+.+|+++|++++||||+++++++.... .....+++
T Consensus        28 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i  107 (364)
T 3qyz_A           28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYI  107 (364)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred             cEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEE
Confidence            5899999999999999999999999999999987533    256789999999999999999999876543 12234669


Q ss_pred             EEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc---
Q 015500           77 FMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA---  152 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~---  152 (405)
                      ||||+.| +|.+++...  ++++..++.++.||+.||+|||++||+||||||+|||++.++ +||+|||+++.....   
T Consensus       108 v~e~~~~-~L~~~l~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~  184 (364)
T 3qyz_A          108 VQDLMET-DLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH  184 (364)
T ss_dssp             EEECCSE-EHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCB
T ss_pred             EEcccCc-CHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCCCc
Confidence            9999974 999998764  699999999999999999999999999999999999999887 999999999865432   


Q ss_pred             ----ccCCCCCCccChhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhc-CC-------------
Q 015500          153 ----LQSGGTPMFMAPEVARG-EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYS-RE-------------  213 (405)
Q Consensus       153 ----~~~~gt~~Y~APE~l~~-~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~-~~-------------  213 (405)
                          ....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....... .+..+... ..             
T Consensus       185 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~  263 (364)
T 3qyz_A          185 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD-QLNHILGILGSPSQEDLNCIINLK  263 (364)
T ss_dssp             CCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG-HHHHHHHHHCSCCHHHHHTCCCHH
T ss_pred             cccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH-HHHHHHHHhCCCCHHHHHHhhhhh
Confidence                23469999999998765 558999999999999999999999996554322 22222110 00             


Q ss_pred             -------CC--------CCchhccHHHHHHHHHhcccCccccCCHHHHhcCcccccccc
Q 015500          214 -------LP--------EVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCS  257 (405)
Q Consensus       214 -------~~--------~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~~  257 (405)
                             .+        ..+..+++++.+||.+||+.||.+|||+.|+|+||||+....
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~  322 (364)
T 3qyz_A          264 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD  322 (364)
T ss_dssp             HHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred             HHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccC
Confidence                   00        112346899999999999999999999999999999998644

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.2e-47  Score=374.24  Aligned_cols=249  Identities=26%  Similarity=0.410  Sum_probs=206.8

Q ss_pred             cccc-cccceeCCeeEEEEEEcCCCCEEEEEEccCC-----ChHHHHHHHHHHHhC-CCCCeeeeeeeeeecCCCceEEE
Q 015500            3 WTRG-HTIGQGSSATVSLATSLRSGDVFAAKSTELP-----KSEFLQREQKFLSSL-NSPHIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         3 y~~~-~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~-----~~~~l~~E~~iL~~L-~hpnIv~~~~~~~~~~~~~~~~~   75 (405)
                      |.+. +.||+|+||+||+|.++.+++.||+|.+...     ....+.+|+.+++.+ .||||+++++++....    .++
T Consensus        30 y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~----~~~  105 (327)
T 3lm5_A           30 YILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTS----EII  105 (327)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS----EEE
T ss_pred             EeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCC----eEE
Confidence            4555 8999999999999999999999999987643     246788999999999 5699999999875433    366


Q ss_pred             EEEeecCCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcc---CC-ceEeeeccccccc
Q 015500           76 LFMEYAPGGTLNDEIHRN-GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAE---SG-AKIADFGCAKWES  150 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~-~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~---~~-vkL~DFGla~~~~  150 (405)
                      +||||++||+|.+++... .+.+++..++.++.||+.||+|||++||+||||||+|||++.   ++ +||+|||+++...
T Consensus       106 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~  185 (327)
T 3lm5_A          106 LILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG  185 (327)
T ss_dssp             EEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC-
T ss_pred             EEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccC
Confidence            999999999999988543 357999999999999999999999999999999999999987   44 9999999998654


Q ss_pred             cc---ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcC--CCCCCchhccHHH
Q 015500          151 EA---LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSR--ELPEVPAFLSKQA  225 (405)
Q Consensus       151 ~~---~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~--~~~~~p~~~s~~l  225 (405)
                      ..   ....||+.|+|||++.+..+++++|||||||++|+|++|+.||.... .......+....  ..+..+..+++.+
T Consensus       186 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~  264 (327)
T 3lm5_A          186 HACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGED-NQETYLNISQVNVDYSEETFSSVSQLA  264 (327)
T ss_dssp             --------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHTCCCCCTTTTTTSCHHH
T ss_pred             CccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-chHHHHHHHhcccccCchhhcccCHHH
Confidence            42   34569999999999999999999999999999999999999996543 333333333222  2223345689999


Q ss_pred             HHHHHHhcccCccccCCHHHHhcCccccccc
Q 015500          226 NDFLSNCLRRDPKERWAASQLLKHPFLEEFC  256 (405)
Q Consensus       226 ~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~  256 (405)
                      .+||.+||+.||.+|||++++|+||||+...
T Consensus       265 ~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~  295 (327)
T 3lm5_A          265 TDFIQSLLVKNPEKRPTAEICLSHSWLQQWD  295 (327)
T ss_dssp             HHHHHHHSCSSGGGSCCHHHHTTCGGGCCCC
T ss_pred             HHHHHHHcCCChhhCcCHHHHhCCHhhcccc
Confidence            9999999999999999999999999998753

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=4.2e-48  Score=375.92  Aligned_cols=247  Identities=31%  Similarity=0.468  Sum_probs=205.5

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-----------hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCC
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-----------SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDN   70 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-----------~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~   70 (405)
                      +|++++.||+|+||+||+|.++.+++.||||.+....           ...+.+|+++|++++||||+++++++... . 
T Consensus        11 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~-   88 (322)
T 2ycf_A           11 EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE-D-   88 (322)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS-S-
T ss_pred             ceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC-c-
Confidence            4889999999999999999999999999999876432           23578999999999999999999876432 2 


Q ss_pred             ceEEEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC----ceEeeeccc
Q 015500           71 KLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG----AKIADFGCA  146 (405)
Q Consensus        71 ~~~~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~----vkL~DFGla  146 (405)
                         +++||||+++++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++    +||+|||++
T Consensus        89 ---~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~  164 (322)
T 2ycf_A           89 ---YYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS  164 (322)
T ss_dssp             ---EEEEEECCTTEETHHHHSTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTC
T ss_pred             ---eEEEEecCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccc
Confidence               56999999999999998765 4899999999999999999999999999999999999998653    999999999


Q ss_pred             cccccc---ccCCCCCCccChhhhc---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCC---CC
Q 015500          147 KWESEA---LQSGGTPMFMAPEVAR---GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELP---EV  217 (405)
Q Consensus       147 ~~~~~~---~~~~gt~~Y~APE~l~---~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~---~~  217 (405)
                      +.....   ....||+.|+|||++.   ...++.++|||||||++|+|++|..||............+.. ...+   ..
T Consensus       165 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~  243 (322)
T 2ycf_A          165 KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS-GKYNFIPEV  243 (322)
T ss_dssp             EECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHH-TCCCCCHHH
T ss_pred             eecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHh-CccccCchh
Confidence            865442   2346999999999974   466889999999999999999999999755443222222222 2222   22


Q ss_pred             chhccHHHHHHHHHhcccCccccCCHHHHhcCcccccc
Q 015500          218 PAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       218 p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      +..+++.+.+||.+||+.||.+|||++++|+||||+..
T Consensus       244 ~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~  281 (322)
T 2ycf_A          244 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE  281 (322)
T ss_dssp             HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred             hhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence            34579999999999999999999999999999999753

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=3.2e-47  Score=374.44  Aligned_cols=255  Identities=29%  Similarity=0.364  Sum_probs=196.8

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC--ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCC---CceEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP--KSEFLQREQKFLSSLNSPHIVGYKGCDVTSED---NKLMYNL   76 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~--~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~---~~~~~~l   76 (405)
                      +|++++.||+|+||+||+|.++.+|+.||||.+...  ......++++.++.++||||+++++++.....   ...++++
T Consensus        24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~l  103 (360)
T 3e3p_A           24 RFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNV  103 (360)
T ss_dssp             TEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEE
T ss_pred             ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEE
Confidence            589999999999999999999999999999987543  34567788888999999999999998765432   3445779


Q ss_pred             EEeecCCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHH--hCCceeCCCCCCCEEEcc-CC-ceEeeecccccc
Q 015500           77 FMEYAPGGTLNDEIHR---NGGRLDESLIVSYTRQILQGLEYLH--SNRVVHCDIKSRNILMAE-SG-AKIADFGCAKWE  149 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~---~~~~l~e~~~~~i~~qIl~~L~yLH--~~givHrDlkp~NILi~~-~~-vkL~DFGla~~~  149 (405)
                      ||||+++ +|.+.+..   ....+++..++.++.||+.||.|||  ++||+||||||+|||++. ++ +||+|||+++..
T Consensus       104 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~  182 (360)
T 3e3p_A          104 VMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL  182 (360)
T ss_dssp             EEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTCBCC
T ss_pred             Eeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCceec
Confidence            9999976 55544432   3457999999999999999999999  999999999999999986 56 999999999865


Q ss_pred             cc---cccCCCCCCccChhhhcCCC-CCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCC------------
Q 015500          150 SE---ALQSGGTPMFMAPEVARGEH-QGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRE------------  213 (405)
Q Consensus       150 ~~---~~~~~gt~~Y~APE~l~~~~-~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~------------  213 (405)
                      ..   .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.... ....+..+.....            
T Consensus       183 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  261 (360)
T 3e3p_A          183 SPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDN-SAGQLHEIVRVLGCPSREVLRKLNP  261 (360)
T ss_dssp             CTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHHHCCCCHHHHHHHCT
T ss_pred             CCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCC-hHHHHHHHHHHcCCCCHHHHHhccc
Confidence            44   23456899999999997654 8999999999999999999999996543 3333333321110            


Q ss_pred             ------------------CCCCchhccHHHHHHHHHhcccCccccCCHHHHhcCccccccccc
Q 015500          214 ------------------LPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSC  258 (405)
Q Consensus       214 ------------------~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~~~  258 (405)
                                        ++..+...++++.+||.+||+.||.+|||+.|+|+||||+.....
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~  324 (360)
T 3e3p_A          262 SHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDP  324 (360)
T ss_dssp             TCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCT
T ss_pred             chhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCc
Confidence                              112222357899999999999999999999999999999987543

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.6e-47  Score=377.47  Aligned_cols=253  Identities=26%  Similarity=0.340  Sum_probs=202.7

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC--------------hHHHHHHHHHHHhCCCCCeeeeeeeeeec
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK--------------SEFLQREQKFLSSLNSPHIVGYKGCDVTS   67 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~--------------~~~l~~E~~iL~~L~hpnIv~~~~~~~~~   67 (405)
                      +|++++.||+|+||+||+|.+.. |+.||||.+....              .+.+.+|+++|++++||||+++++++...
T Consensus        23 ~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  101 (362)
T 3pg1_A           23 PYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHF  101 (362)
T ss_dssp             SCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEEC
T ss_pred             ceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEec
Confidence            58999999999999999999864 9999999875321              16788999999999999999999987664


Q ss_pred             C-CCceEEEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecc
Q 015500           68 E-DNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGC  145 (405)
Q Consensus        68 ~-~~~~~~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGl  145 (405)
                      . .....+++||||++ |+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++ +||+|||+
T Consensus       102 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~  180 (362)
T 3pg1_A          102 EEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNL  180 (362)
T ss_dssp             CTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCTTC
T ss_pred             cCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEecCc
Confidence            4 23345679999997 589998887767899999999999999999999999999999999999999887 99999999


Q ss_pred             cccccc---cccCCCCCCccChhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCC------
Q 015500          146 AKWESE---ALQSGGTPMFMAPEVARG-EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELP------  215 (405)
Q Consensus       146 a~~~~~---~~~~~gt~~Y~APE~l~~-~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~------  215 (405)
                      ++....   .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.... ....+..+......+      
T Consensus       181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~  259 (362)
T 3pg1_A          181 AREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST-FYNQLNKIVEVVGTPKIEDVV  259 (362)
T ss_dssp             ---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHHHCCCCHHHHH
T ss_pred             ccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHcCCCChHHhh
Confidence            975433   334569999999999987 678999999999999999999999996543 333333322111111      


Q ss_pred             ----------------C--------CchhccHHHHHHHHHhcccCccccCCHHHHhcCcccccccc
Q 015500          216 ----------------E--------VPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCS  257 (405)
Q Consensus       216 ----------------~--------~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~~  257 (405)
                                      .        .+...++.+.+||.+||+.||.+|||+.|+|+||||+.+..
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  325 (362)
T 3pg1_A          260 MFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFD  325 (362)
T ss_dssp             HTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred             hccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccC
Confidence                            1        12345888999999999999999999999999999998643

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=4.3e-48  Score=373.58  Aligned_cols=245  Identities=24%  Similarity=0.364  Sum_probs=206.6

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC---hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK---SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFM   78 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~---~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (405)
                      +|.+++.||+|+||+||+|.+..+++.+|+|.+....   .+.+.+|+++|++++||||+++++++....    .+++||
T Consensus        11 ~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~----~~~lv~   86 (310)
T 3s95_A           11 DLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDK----RLNFIT   86 (310)
T ss_dssp             GEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT----EEEEEE
T ss_pred             HeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCC----eeEEEE
Confidence            5889999999999999999999999999999876543   356889999999999999999999876543    366999


Q ss_pred             eecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccccc----
Q 015500           79 EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEAL----  153 (405)
Q Consensus        79 Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~~----  153 (405)
                      ||++||+|.+++....+.+++..+..++.||+.||+|||++||+||||||+|||++.++ +||+|||+++......    
T Consensus        87 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  166 (310)
T 3s95_A           87 EYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPE  166 (310)
T ss_dssp             ECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-------
T ss_pred             EecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccccccc
Confidence            99999999999998777899999999999999999999999999999999999999887 9999999997543211    


Q ss_pred             --------------cCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHH----HHHHHHhcCCCC
Q 015500          154 --------------QSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMT----VLYKIAYSRELP  215 (405)
Q Consensus       154 --------------~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~----~l~~i~~~~~~~  215 (405)
                                    ...||+.|+|||++.+..++.++|||||||++|+|++|..||........    .......    +
T Consensus       167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~----~  242 (310)
T 3s95_A          167 GLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD----R  242 (310)
T ss_dssp             -------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH----H
T ss_pred             ccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc----c
Confidence                          34699999999999999999999999999999999999999865322110    0001110    1


Q ss_pred             CCchhccHHHHHHHHHhcccCccccCCHHHHhcCccccccc
Q 015500          216 EVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFC  256 (405)
Q Consensus       216 ~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~  256 (405)
                      ..|..+++.+.++|.+||+.||.+|||+.++++  +++.+.
T Consensus       243 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~l~  281 (310)
T 3s95_A          243 YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLETLR  281 (310)
T ss_dssp             TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHH
T ss_pred             cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHHHHH
Confidence            234567889999999999999999999999987  566543

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=2.9e-47  Score=369.26  Aligned_cols=240  Identities=29%  Similarity=0.490  Sum_probs=201.4

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      +|++++.||+|+||+||+|.+  +|+.||||.+....     .+.+.+|+++|++++||||+++++++.....    +++
T Consensus        38 ~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~----~~l  111 (309)
T 3p86_A           38 DLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN----LSI  111 (309)
T ss_dssp             GEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTC----CEE
T ss_pred             HceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCc----eEE
Confidence            588999999999999999987  58899999986543     2467899999999999999999998754443    569


Q ss_pred             EEeecCCCCHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCCCCEEEccCC-ceEeeecccccccc
Q 015500           77 FMEYAPGGTLNDEIHRNGG--RLDESLIVSYTRQILQGLEYLHSNR--VVHCDIKSRNILMAESG-AKIADFGCAKWESE  151 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~~~--~l~e~~~~~i~~qIl~~L~yLH~~g--ivHrDlkp~NILi~~~~-vkL~DFGla~~~~~  151 (405)
                      ||||++||+|.+++.+.+.  .+++..+..++.||+.||+|||++|  |+||||||+|||++.++ +||+|||+++....
T Consensus       112 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~  191 (309)
T 3p86_A          112 VTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS  191 (309)
T ss_dssp             EEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-------
T ss_pred             EEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccccc
Confidence            9999999999999986532  3999999999999999999999999  99999999999999887 99999999975433


Q ss_pred             ----cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHH
Q 015500          152 ----ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQAND  227 (405)
Q Consensus       152 ----~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~d  227 (405)
                          .....||+.|+|||++.+..++.++|||||||++|+|++|+.||... +.......+.........|..+++++.+
T Consensus       192 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~  270 (309)
T 3p86_A          192 TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNL-NPAQVVAAVGFKCKRLEIPRNLNPQVAA  270 (309)
T ss_dssp             ----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTS-CHHHHHHHHHHSCCCCCCCTTSCHHHHH
T ss_pred             cccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhcCCCCCCCccCCHHHHH
Confidence                23456999999999999999999999999999999999999999654 4455555555566667788889999999


Q ss_pred             HHHHhcccCccccCCHHHHhc
Q 015500          228 FLSNCLRRDPKERWAASQLLK  248 (405)
Q Consensus       228 ll~~~L~~dP~~Rpt~~elL~  248 (405)
                      ||++||+.||.+|||++++++
T Consensus       271 li~~~l~~dP~~Rps~~~ll~  291 (309)
T 3p86_A          271 IIEGCWTNEPWKRPSFATIMD  291 (309)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHccCChhhCcCHHHHHH
Confidence            999999999999999999987

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=6.6e-49  Score=389.65  Aligned_cols=254  Identities=15%  Similarity=0.072  Sum_probs=191.6

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC------hHHHHHHHHHHHhC--CCCCeeeeeeee-------ee
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK------SEFLQREQKFLSSL--NSPHIVGYKGCD-------VT   66 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~------~~~l~~E~~iL~~L--~hpnIv~~~~~~-------~~   66 (405)
                      +|++++.||+|+||+||+|.+..+|+.||||.+....      .+.+.+|+.+++.|  +||||++++..+       ..
T Consensus        63 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~  142 (371)
T 3q60_A           63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAV  142 (371)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEE
T ss_pred             eeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheec
Confidence            4889999999999999999999999999999987643      34667885544444  699988755322       21


Q ss_pred             cCC-------------CceEEEEEEeecCCCCHHHHHHHcCCCCCHHHH------HHHHHHHHHHHHHHHhCCceeCCCC
Q 015500           67 SED-------------NKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLI------VSYTRQILQGLEYLHSNRVVHCDIK  127 (405)
Q Consensus        67 ~~~-------------~~~~~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~------~~i~~qIl~~L~yLH~~givHrDlk  127 (405)
                      ...             ....+++||||++ |+|.+++...+..+++...      ..++.||+.||+|||++||+|||||
T Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDik  221 (371)
T 3q60_A          143 QSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFT  221 (371)
T ss_dssp             TTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred             CCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCC
Confidence            111             0134679999998 7999999875445655555      6777999999999999999999999


Q ss_pred             CCCEEEccCC-ceEeeecccccccccc-cCCCCCCccChhhhcC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHH
Q 015500          128 SRNILMAESG-AKIADFGCAKWESEAL-QSGGTPMFMAPEVARG--EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMT  203 (405)
Q Consensus       128 p~NILi~~~~-vkL~DFGla~~~~~~~-~~~gt~~Y~APE~l~~--~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~  203 (405)
                      |+|||++.++ +||+|||+++...... ...+|+.|+|||++.+  ..++.++|||||||++|+|+||+.||........
T Consensus       222 p~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~  301 (371)
T 3q60_A          222 PDNLFIMPDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIK  301 (371)
T ss_dssp             GGGEEECTTSCEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCT
T ss_pred             HHHEEECCCCCEEEEecceeeecCCCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccc
Confidence            9999999887 9999999998766544 5667899999999987  6799999999999999999999999965532111


Q ss_pred             HHHH----HHhc--CCCCCCchhccHHHHHHHHHhcccCccccCCHHHHhcCccccccc
Q 015500          204 VLYK----IAYS--RELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFC  256 (405)
Q Consensus       204 ~l~~----i~~~--~~~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~  256 (405)
                      ....    ....  ......+..+++.+.+||.+||+.||++|||+.++|+||||+.+.
T Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~  360 (371)
T 3q60_A          302 GSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQ  360 (371)
T ss_dssp             TCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHH
T ss_pred             cchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHH
Confidence            0000    0000  111112246899999999999999999999999999999998764

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.7e-47  Score=387.70  Aligned_cols=249  Identities=27%  Similarity=0.413  Sum_probs=205.2

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC--hHHHHHHHHHHHhC------CCCCeeeeeeeeeecCCCceE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK--SEFLQREQKFLSSL------NSPHIVGYKGCDVTSEDNKLM   73 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~--~~~l~~E~~iL~~L------~hpnIv~~~~~~~~~~~~~~~   73 (405)
                      +|++++.||+|+||+||+|.+..+++.||||.+....  ...+.+|+++++.+      .||||+++++.+....    .
T Consensus        98 ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~----~  173 (429)
T 3kvw_A           98 RYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN----H  173 (429)
T ss_dssp             TEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT----E
T ss_pred             cEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC----e
Confidence            5899999999999999999999999999999987654  25677899988887      5679999998876543    3


Q ss_pred             EEEEEeecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC---ceEeeecccccc
Q 015500           74 YNLFMEYAPGGTLNDEIHRNG-GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG---AKIADFGCAKWE  149 (405)
Q Consensus        74 ~~lv~Ey~~ggsL~~~i~~~~-~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~---vkL~DFGla~~~  149 (405)
                      +++||||+. ++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++   +||+|||++...
T Consensus       174 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~  252 (429)
T 3kvw_A          174 ICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE  252 (429)
T ss_dssp             EEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred             EEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceec
Confidence            679999996 59999988753 3599999999999999999999999999999999999998875   899999999765


Q ss_pred             cc-cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCC------------
Q 015500          150 SE-ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPE------------  216 (405)
Q Consensus       150 ~~-~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~------------  216 (405)
                      .. .....||+.|+|||++.+..++.++|||||||++|||++|++||.... ....+..+......|.            
T Consensus       253 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~-~~~~l~~i~~~~~~p~~~~~~~~~~~~~  331 (429)
T 3kvw_A          253 HQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED-EGDQLACMIELLGMPSQKLLDASKRAKN  331 (429)
T ss_dssp             TCCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHHHCCCCHHHHHTBTTHHH
T ss_pred             CCcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHcCCCCHHHHHhhhhhhh
Confidence            44 345679999999999999999999999999999999999999996554 3333332221100000            


Q ss_pred             ---------------------------------------------CchhccHHHHHHHHHhcccCccccCCHHHHhcCcc
Q 015500          217 ---------------------------------------------VPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPF  251 (405)
Q Consensus       217 ---------------------------------------------~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~  251 (405)
                                                                   ++...++.+.+||++||+.||.+|||++|+|+|||
T Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw  411 (429)
T 3kvw_A          332 FVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPW  411 (429)
T ss_dssp             HBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTT
T ss_pred             ccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCChh
Confidence                                                         11123788999999999999999999999999999


Q ss_pred             ccccc
Q 015500          252 LEEFC  256 (405)
Q Consensus       252 ~~~~~  256 (405)
                      |++..
T Consensus       412 ~~~~~  416 (429)
T 3kvw_A          412 LRRRL  416 (429)
T ss_dssp             TC---
T ss_pred             hccCC
Confidence            98653

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=5.8e-48  Score=369.79  Aligned_cols=250  Identities=34%  Similarity=0.535  Sum_probs=189.7

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC----ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP----KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLF   77 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~----~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv   77 (405)
                      +|++++.||+|+||+||+|.+..+++.||||.+...    ..+.+.+|+.++++++||||+++++++.....    +++|
T Consensus        16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~lv   91 (303)
T 2vwi_A           16 DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDE----LWLV   91 (303)
T ss_dssp             CCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSC----EEEE
T ss_pred             hhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCC----cEEE
Confidence            589999999999999999999999999999988643    23567899999999999999999998765543    6699


Q ss_pred             EeecCCCCHHHHHHH-------cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccc
Q 015500           78 MEYAPGGTLNDEIHR-------NGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWE  149 (405)
Q Consensus        78 ~Ey~~ggsL~~~i~~-------~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~  149 (405)
                      |||++|++|.+++..       ..+.+++..+..++.||+.||.|||++|++||||||+||+++.++ +||+|||++...
T Consensus        92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  171 (303)
T 2vwi_A           92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFL  171 (303)
T ss_dssp             EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHHC
T ss_pred             ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchhee
Confidence            999999999999975       245699999999999999999999999999999999999999887 999999998654


Q ss_pred             cc---------cccCCCCCCccChhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCC------
Q 015500          150 SE---------ALQSGGTPMFMAPEVARG-EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRE------  213 (405)
Q Consensus       150 ~~---------~~~~~gt~~Y~APE~l~~-~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~------  213 (405)
                      ..         .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.......... .......      
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~  250 (303)
T 2vwi_A          172 ATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLM-LTLQNDPPSLETG  250 (303)
T ss_dssp             C---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH-HHHTSSCCCTTC-
T ss_pred             ccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHH-HHhccCCCccccc
Confidence            32         123469999999999976 568999999999999999999999997654433222 2221111      


Q ss_pred             --CCCCchhccHHHHHHHHHhcccCccccCCHHHHhcCccccccc
Q 015500          214 --LPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFC  256 (405)
Q Consensus       214 --~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~  256 (405)
                        .+.....+++++.+||.+||+.||.+|||+.++++||||+...
T Consensus       251 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  295 (303)
T 2vwi_A          251 VQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK  295 (303)
T ss_dssp             ----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC----
T ss_pred             cccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCC
Confidence              1122345789999999999999999999999999999998653

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.4e-47  Score=363.50  Aligned_cols=249  Identities=25%  Similarity=0.411  Sum_probs=211.7

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      +|++++.||+|+||+||+|.++.+++.+|+|.+....     .+.+.+|+.++++++||||+++++++......  .+++
T Consensus         7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~--~~~l   84 (279)
T 2w5a_A            7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNT--TLYI   84 (279)
T ss_dssp             GEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGT--EEEE
T ss_pred             heeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCc--eEEE
Confidence            5899999999999999999999999999999986532     35688999999999999999999977654332  3669


Q ss_pred             EEeecCCCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCC-----ceeCCCCCCCEEEccCC-ceEeeecccc
Q 015500           77 FMEYAPGGTLNDEIHRN---GGRLDESLIVSYTRQILQGLEYLHSNR-----VVHCDIKSRNILMAESG-AKIADFGCAK  147 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~---~~~l~e~~~~~i~~qIl~~L~yLH~~g-----ivHrDlkp~NILi~~~~-vkL~DFGla~  147 (405)
                      ||||++|++|.+++...   ...+++..+..++.||+.||.|||++|     |+||||||+||+++.++ +||+|||+++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~  164 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  164 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence            99999999999999753   235999999999999999999999999     99999999999999887 9999999987


Q ss_pred             ccccc----ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccH
Q 015500          148 WESEA----LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSK  223 (405)
Q Consensus       148 ~~~~~----~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~  223 (405)
                      .....    ....||+.|+|||++.+..++.++|||||||++|+|++|+.||.... .......+ .....+.+|..+++
T Consensus       165 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-~~~~~~~i-~~~~~~~~~~~~~~  242 (279)
T 2w5a_A          165 ILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS-QKELAGKI-REGKFRRIPYRYSD  242 (279)
T ss_dssp             HC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHH-HHTCCCCCCTTSCH
T ss_pred             eeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC-HHHHHHHH-hhcccccCCcccCH
Confidence            64432    23468999999999999999999999999999999999999996543 33333333 33455677788999


Q ss_pred             HHHHHHHHhcccCccccCCHHHHhcCccccc
Q 015500          224 QANDFLSNCLRRDPKERWAASQLLKHPFLEE  254 (405)
Q Consensus       224 ~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~  254 (405)
                      ++.++|.+||+.||.+|||+.|+++|+|+..
T Consensus       243 ~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~  273 (279)
T 2w5a_A          243 ELNEIITRMLNLKDYHRPSVEEILENPLILE  273 (279)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred             HHHHHHHHHcCCCcccCCCHHHHHhChhhhh
Confidence            9999999999999999999999999999975

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.8e-47  Score=359.39  Aligned_cols=241  Identities=25%  Similarity=0.385  Sum_probs=208.0

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC--ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEe
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP--KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFME   79 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~--~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (405)
                      +|++++.||+|+||+||+|.+. +++.||+|.+...  ..+.+.+|++++++++||||+++++++.....    +++|||
T Consensus        11 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~----~~lv~e   85 (269)
T 4hcu_A           11 ELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP----ICLVFE   85 (269)
T ss_dssp             GEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS----EEEEEE
T ss_pred             hceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCc----eEEEEE
Confidence            5889999999999999999986 5778999998754  35679999999999999999999998755433    569999


Q ss_pred             ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc-----cc
Q 015500           80 YAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE-----AL  153 (405)
Q Consensus        80 y~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~-----~~  153 (405)
                      |+++++|.+++....+.+++..+..++.||+.||+|||++||+||||||+||+++.++ +||+|||+++....     ..
T Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  165 (269)
T 4hcu_A           86 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST  165 (269)
T ss_dssp             CCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTT
T ss_pred             eCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccccccccccc
Confidence            9999999999988777899999999999999999999999999999999999998877 99999999986433     22


Q ss_pred             cCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHh
Q 015500          154 QSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNC  232 (405)
Q Consensus       154 ~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~  232 (405)
                      ...+|+.|+|||++.+..+++++|||||||++|+|++ |+.||... ........+. ....+..|..+++.+.+++.+|
T Consensus       166 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~  243 (269)
T 4hcu_A          166 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR-SNSEVVEDIS-TGFRLYKPRLASTHVYQIMNHC  243 (269)
T ss_dssp             STTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-CHHHHHHHHH-TTCCCCCCTTSCHHHHHHHHHH
T ss_pred             CcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCC-CHHHHHHHHh-cCccCCCCCcCCHHHHHHHHHH
Confidence            3447788999999999999999999999999999999 99999644 3344444443 3344556777899999999999


Q ss_pred             cccCccccCCHHHHhcC
Q 015500          233 LRRDPKERWAASQLLKH  249 (405)
Q Consensus       233 L~~dP~~Rpt~~elL~h  249 (405)
                      |+.||.+|||+.++++|
T Consensus       244 l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          244 WRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             TCSSGGGSCCHHHHHHH
T ss_pred             ccCCcccCcCHHHHHHH
Confidence            99999999999999987

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-47  Score=378.71  Aligned_cols=249  Identities=27%  Similarity=0.457  Sum_probs=209.0

Q ss_pred             CcccccccceeCCeeEEEEEEc---CCCCEEEEEEccCC-------ChHHHHHHHHHHHhC-CCCCeeeeeeeeeecCCC
Q 015500            2 DWTRGHTIGQGSSATVSLATSL---RSGDVFAAKSTELP-------KSEFLQREQKFLSSL-NSPHIVGYKGCDVTSEDN   70 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~---~~~~~vavK~~~~~-------~~~~l~~E~~iL~~L-~hpnIv~~~~~~~~~~~~   70 (405)
                      +|++++.||+|+||+||+|++.   .+++.||||++...       ..+.+.+|+++|+.+ .||||+++++++....  
T Consensus        55 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~--  132 (355)
T 1vzo_A           55 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET--  132 (355)
T ss_dssp             GEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT--
T ss_pred             ceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc--
Confidence            5889999999999999999984   58999999987642       345678899999999 6999999998876543  


Q ss_pred             ceEEEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccc
Q 015500           71 KLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWE  149 (405)
Q Consensus        71 ~~~~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~  149 (405)
                        .+++||||+++|+|.+++...+ ++++..++.++.||+.||.|||++||+||||||+|||++.++ +||+|||+++..
T Consensus       133 --~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~  209 (355)
T 1vzo_A          133 --KLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF  209 (355)
T ss_dssp             --EEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred             --eEEEEeecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeec
Confidence              3679999999999999998764 799999999999999999999999999999999999999887 999999999754


Q ss_pred             cc-----cccCCCCCCccChhhhcCC--CCCcchhHHHHHHHHHHHHhCCCCCCCCC--ChHHHHHHHHhcCCCCCCchh
Q 015500          150 SE-----ALQSGGTPMFMAPEVARGE--HQGFASDIWAVGCTVIEMASGGAPWPNAA--DPMTVLYKIAYSRELPEVPAF  220 (405)
Q Consensus       150 ~~-----~~~~~gt~~Y~APE~l~~~--~~~~~sDIwSLG~il~elltG~~Pf~~~~--~~~~~l~~i~~~~~~~~~p~~  220 (405)
                      ..     .....||+.|+|||++.+.  .++.++|||||||++|+|++|+.||....  .....+.+... ...+.+|..
T Consensus       210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~  288 (355)
T 1vzo_A          210 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL-KSEPPYPQE  288 (355)
T ss_dssp             CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH-HCCCCCCTT
T ss_pred             ccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHh-ccCCCCCcc
Confidence            32     2235699999999999863  47889999999999999999999996432  12222222222 234567778


Q ss_pred             ccHHHHHHHHHhcccCccccC-----CHHHHhcCccccccc
Q 015500          221 LSKQANDFLSNCLRRDPKERW-----AASQLLKHPFLEEFC  256 (405)
Q Consensus       221 ~s~~l~dll~~~L~~dP~~Rp-----t~~elL~hp~~~~~~  256 (405)
                      +++.+.+||.+||..||.+||     |++++++||||+.+.
T Consensus       289 ~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~  329 (355)
T 1vzo_A          289 MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN  329 (355)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred             cCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCC
Confidence            999999999999999999999     999999999998753

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.7e-47  Score=377.86  Aligned_cols=254  Identities=28%  Similarity=0.376  Sum_probs=210.0

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC--hHHHHHHHHHHHhCC-----------CCCeeeeeeeeeecC
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK--SEFLQREQKFLSSLN-----------SPHIVGYKGCDVTSE   68 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~--~~~l~~E~~iL~~L~-----------hpnIv~~~~~~~~~~   68 (405)
                      +|++++.||+|+||+||+|.+..+++.||||.+....  .+.+.+|+.+++++.           ||||+++++++....
T Consensus        20 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~   99 (373)
T 1q8y_A           20 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG   99 (373)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred             eEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccC
Confidence            5899999999999999999999999999999987553  356889999999886           899999999887766


Q ss_pred             CCceEEEEEEeecCCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCCCCEEEcc------CC-ce
Q 015500           69 DNKLMYNLFMEYAPGGTLNDEIHRN-GGRLDESLIVSYTRQILQGLEYLHSN-RVVHCDIKSRNILMAE------SG-AK  139 (405)
Q Consensus        69 ~~~~~~~lv~Ey~~ggsL~~~i~~~-~~~l~e~~~~~i~~qIl~~L~yLH~~-givHrDlkp~NILi~~------~~-vk  139 (405)
                      .+...++++|||+ +++|.+++... .+.+++..++.++.||+.||+|||++ ||+||||||+|||++.      .+ +|
T Consensus       100 ~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~k  178 (373)
T 1q8y_A          100 PNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIK  178 (373)
T ss_dssp             TTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEE
T ss_pred             CCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcceEE
Confidence            5566788999999 88999999874 34699999999999999999999998 9999999999999952      22 89


Q ss_pred             Eeeecccccccc-cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-----hHHHHHHHHh-cC
Q 015500          140 IADFGCAKWESE-ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAAD-----PMTVLYKIAY-SR  212 (405)
Q Consensus       140 L~DFGla~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~-----~~~~l~~i~~-~~  212 (405)
                      |+|||++..... .....||+.|+|||++.+..+++++|||||||++|+|+||+.||.....     ....+..+.. ..
T Consensus       179 l~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  258 (373)
T 1q8y_A          179 IADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLG  258 (373)
T ss_dssp             ECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHC
T ss_pred             EcccccccccCCCCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcC
Confidence            999999986554 3445799999999999999999999999999999999999999964331     1111211110 01


Q ss_pred             C---------------------------------------CCCCchhccHHHHHHHHHhcccCccccCCHHHHhcCcccc
Q 015500          213 E---------------------------------------LPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLE  253 (405)
Q Consensus       213 ~---------------------------------------~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~  253 (405)
                      .                                       ...++..+++++.+||.+||+.||.+|||++|+|+||||+
T Consensus       259 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~  338 (373)
T 1q8y_A          259 ELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLK  338 (373)
T ss_dssp             SCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGT
T ss_pred             CCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhChhhh
Confidence            1                                       1124456788999999999999999999999999999998


Q ss_pred             ccc
Q 015500          254 EFC  256 (405)
Q Consensus       254 ~~~  256 (405)
                      ...
T Consensus       339 ~~~  341 (373)
T 1q8y_A          339 DTL  341 (373)
T ss_dssp             TCT
T ss_pred             ccc
Confidence            754

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=2.3e-47  Score=366.86  Aligned_cols=245  Identities=29%  Similarity=0.427  Sum_probs=202.9

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC------hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK------SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~------~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~   75 (405)
                      +|++++.||+|+||+||+|.+..+++.||+|.+....      .+.+.+|+.++++++||||+++++++....    .++
T Consensus        12 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~----~~~   87 (294)
T 4eqm_A           12 RYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDD----CYY   87 (294)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSS----EEE
T ss_pred             cEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCC----eEE
Confidence            5899999999999999999999999999999875432      246889999999999999999999865433    367


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc---
Q 015500           76 LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE---  151 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~---  151 (405)
                      +||||++|++|.+++...+ ++++..+..++.||+.||+|||++||+||||||+|||++.++ +||+|||+++....   
T Consensus        88 lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  166 (294)
T 4eqm_A           88 LVMEYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL  166 (294)
T ss_dssp             EEEECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-----
T ss_pred             EEEeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccc
Confidence            9999999999999998774 899999999999999999999999999999999999999887 99999999976543   


Q ss_pred             --cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCC----CchhccHHH
Q 015500          152 --ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPE----VPAFLSKQA  225 (405)
Q Consensus       152 --~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~----~p~~~s~~l  225 (405)
                        .....||+.|+|||++.+..++.++|||||||++|+|+||+.||..... .....+... ...+.    .+..+++.+
T Consensus       167 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~~l  244 (294)
T 4eqm_A          167 TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA-VSIAIKHIQ-DSVPNVTTDVRKDIPQSL  244 (294)
T ss_dssp             --------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH-HHHHHHHHS-SCCCCHHHHSCTTSCHHH
T ss_pred             cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHhh-ccCCCcchhcccCCCHHH
Confidence              2234699999999999999999999999999999999999999965433 333333322 22332    235588999


Q ss_pred             HHHHHHhcccCccccCCHHHHhcCcccc
Q 015500          226 NDFLSNCLRRDPKERWAASQLLKHPFLE  253 (405)
Q Consensus       226 ~dll~~~L~~dP~~Rpt~~elL~hp~~~  253 (405)
                      .++|.+||..||.+||+..+.+.+.|..
T Consensus       245 ~~li~~~l~~dp~~R~~~~~~l~~~l~~  272 (294)
T 4eqm_A          245 SNVILRATEKDKANRYKTIQEMKDDLSS  272 (294)
T ss_dssp             HHHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred             HHHHHHHhcCCHhHccccHHHHHHHHHH
Confidence            9999999999999999766666666543

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=4.3e-47  Score=377.00  Aligned_cols=251  Identities=29%  Similarity=0.408  Sum_probs=204.3

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCC--ceEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDN--KLMY   74 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~--~~~~   74 (405)
                      +|.+++.||+|+||+||+|.++.+|+.||||.+....     ...+.+|+.+++.++||||+++++++......  ...+
T Consensus        43 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  122 (371)
T 4exu_A           43 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDF  122 (371)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCC
T ss_pred             cEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeE
Confidence            5889999999999999999999999999999986532     35678999999999999999999987654432  1123


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc-c
Q 015500           75 NLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE-A  152 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~-~  152 (405)
                      ++||||+. ++|.+++.   ..+++..++.++.||+.||+|||++||+||||||+|||++.++ +||+|||+++.... .
T Consensus       123 ~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~  198 (371)
T 4exu_A          123 YLVMPFMQ-TDLQKIMG---MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEM  198 (371)
T ss_dssp             EEEEECCC-EEHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC-------
T ss_pred             EEEEcccc-ccHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccccCc
Confidence            69999997 58887763   3699999999999999999999999999999999999999887 99999999986554 3


Q ss_pred             ccCCCCCCccChhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCC----------------
Q 015500          153 LQSGGTPMFMAPEVARG-EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELP----------------  215 (405)
Q Consensus       153 ~~~~gt~~Y~APE~l~~-~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~----------------  215 (405)
                      ....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.... ....+..+......+                
T Consensus       199 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  277 (371)
T 4exu_A          199 TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD-YLDQLTQILKVTGVPGTEFVQKLNDKAAKSY  277 (371)
T ss_dssp             -CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHHHCCCCHHHHTTCSCHHHHHH
T ss_pred             CCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCcHHHHHHhhhhhhhhh
Confidence            34579999999999987 678999999999999999999999996543 333333322111110                


Q ss_pred             -------------CCchhccHHHHHHHHHhcccCccccCCHHHHhcCcccccccc
Q 015500          216 -------------EVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCS  257 (405)
Q Consensus       216 -------------~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~~  257 (405)
                                   ..+..+++++.+||.+||+.||.+|||++|+|+||||+.+..
T Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  332 (371)
T 4exu_A          278 IQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD  332 (371)
T ss_dssp             HHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCC
T ss_pred             hhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCC
Confidence                         112346899999999999999999999999999999997654

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=5.3e-47  Score=371.88  Aligned_cols=252  Identities=25%  Similarity=0.356  Sum_probs=205.8

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecC-CCceEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSE-DNKLMYNL   76 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~-~~~~~~~l   76 (405)
                      +|.+++.||+|+||+||+|.+..+|+.||||.+....    ...+.+|+++|++++||||+++++++.... .....+++
T Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l   91 (353)
T 2b9h_A           12 DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYI   91 (353)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEE
T ss_pred             ceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEE
Confidence            5899999999999999999999999999999986543    245779999999999999999998765431 11234669


Q ss_pred             EEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc----
Q 015500           77 FMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE----  151 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~----  151 (405)
                      +|||+. ++|.+++...  .+++..++.++.||+.||.|||++||+||||||+|||++.++ +||+|||+++....    
T Consensus        92 v~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~  168 (353)
T 2b9h_A           92 IQELMQ-TDLHRVISTQ--MLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAAD  168 (353)
T ss_dssp             EECCCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC-----
T ss_pred             EEeccC-ccHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccccccccc
Confidence            999997 5999998763  699999999999999999999999999999999999999887 99999999976432    


Q ss_pred             ----------cccCCCCCCccChhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhc-C-------
Q 015500          152 ----------ALQSGGTPMFMAPEVARG-EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYS-R-------  212 (405)
Q Consensus       152 ----------~~~~~gt~~Y~APE~l~~-~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~-~-------  212 (405)
                                .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..... ...+..+... .       
T Consensus       169 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~  247 (353)
T 2b9h_A          169 NSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDY-RHQLLLIFGIIGTPHSDND  247 (353)
T ss_dssp             -----------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCCCCSTTT
T ss_pred             ccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHHHhCCCchhcc
Confidence                      112468999999998765 6789999999999999999999999965442 2222221110 0       


Q ss_pred             --------------CCCC--------CchhccHHHHHHHHHhcccCccccCCHHHHhcCcccccccc
Q 015500          213 --------------ELPE--------VPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCS  257 (405)
Q Consensus       213 --------------~~~~--------~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~~  257 (405)
                                    ..+.        .+..+++++.+||++||+.||.+|||++++|+||||+....
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  314 (353)
T 2b9h_A          248 LRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHD  314 (353)
T ss_dssp             TTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred             ccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCC
Confidence                          0011        12357899999999999999999999999999999997654

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=3.5e-47  Score=369.26  Aligned_cols=249  Identities=26%  Similarity=0.353  Sum_probs=204.8

Q ss_pred             CcccccccceeCCeeEEEEEE-cCCCCEEEEEEccCCC--hHHHHHHHHHHHhCCCCC------eeeeeeeeeecCCCce
Q 015500            2 DWTRGHTIGQGSSATVSLATS-LRSGDVFAAKSTELPK--SEFLQREQKFLSSLNSPH------IVGYKGCDVTSEDNKL   72 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~-~~~~~~vavK~~~~~~--~~~l~~E~~iL~~L~hpn------Iv~~~~~~~~~~~~~~   72 (405)
                      +|++++.||+|+||+||+|.+ +.+++.||||++....  .+.+.+|+++++.++|++      |+++++++....    
T Consensus        15 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~----   90 (339)
T 1z57_A           15 RYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG----   90 (339)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT----
T ss_pred             ceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC----
Confidence            589999999999999999998 5688999999987543  357889999999987654      888888765543    


Q ss_pred             EEEEEEeecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcc----------------
Q 015500           73 MYNLFMEYAPGGTLNDEIHRNG-GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAE----------------  135 (405)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~i~~~~-~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~----------------  135 (405)
                      .+++||||+ +++|.+++...+ .++++..++.++.||+.||+|||++||+||||||+|||++.                
T Consensus        91 ~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~  169 (339)
T 1z57_A           91 HICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDER  169 (339)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEE
T ss_pred             cEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccccc
Confidence            367999999 889999998754 36899999999999999999999999999999999999976                


Q ss_pred             ---CC-ceEeeecccccccc-cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHH-
Q 015500          136 ---SG-AKIADFGCAKWESE-ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA-  209 (405)
Q Consensus       136 ---~~-vkL~DFGla~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~-  209 (405)
                         ++ +||+|||+++.... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..+..+. 
T Consensus       170 ~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-~~~~~~~~  248 (339)
T 1z57_A          170 TLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK-EHLAMMER  248 (339)
T ss_dssp             EESCCCEEECCCSSCEETTSCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH-HHHHHHHH
T ss_pred             cccCCCceEeeCcccccCccccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHH
Confidence               33 89999999986544 33457999999999999999999999999999999999999999754432 2222111 


Q ss_pred             hcCCCC-----------------------------------------CCchhccHHHHHHHHHhcccCccccCCHHHHhc
Q 015500          210 YSRELP-----------------------------------------EVPAFLSKQANDFLSNCLRRDPKERWAASQLLK  248 (405)
Q Consensus       210 ~~~~~~-----------------------------------------~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~  248 (405)
                      .....|                                         ..+...++++.+||.+||+.||.+|||+.|+|+
T Consensus       249 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  328 (339)
T 1z57_A          249 ILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALK  328 (339)
T ss_dssp             HHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             HhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhc
Confidence            111111                                         112234678999999999999999999999999


Q ss_pred             Cccccccc
Q 015500          249 HPFLEEFC  256 (405)
Q Consensus       249 hp~~~~~~  256 (405)
                      ||||+.+.
T Consensus       329 hp~f~~~~  336 (339)
T 1z57_A          329 HPFFDLLK  336 (339)
T ss_dssp             SGGGGGGG
T ss_pred             CHHHHHHh
Confidence            99998753

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=3.9e-47  Score=363.24  Aligned_cols=250  Identities=29%  Similarity=0.386  Sum_probs=204.2

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC--ChHHHHHHHHHHHhCCCCCeeeeeeeeeecC---------CC
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP--KSEFLQREQKFLSSLNSPHIVGYKGCDVTSE---------DN   70 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~--~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~---------~~   70 (405)
                      +|++++.||+|+||+||+|++..+++.||||.+...  ..+.+.+|+.++++++||||+++++++....         ..
T Consensus         7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~   86 (303)
T 1zy4_A            7 DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKK   86 (303)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------C
T ss_pred             cchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccccc
Confidence            588999999999999999999999999999998643  2356889999999999999999998876532         12


Q ss_pred             ceEEEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccc
Q 015500           71 KLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWE  149 (405)
Q Consensus        71 ~~~~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~  149 (405)
                      ...+++||||++||+|.+++...+..+++..+..++.||+.||+|||++||+||||||+|||++.++ +||+|||++...
T Consensus        87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  166 (303)
T 1zy4_A           87 KSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNV  166 (303)
T ss_dssp             EEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCCCSCT
T ss_pred             CCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcchhhc
Confidence            3457799999999999999988766789999999999999999999999999999999999999887 999999998754


Q ss_pred             cc------------------cccCCCCCCccChhhhcCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHh
Q 015500          150 SE------------------ALQSGGTPMFMAPEVARGE-HQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAY  210 (405)
Q Consensus       150 ~~------------------~~~~~gt~~Y~APE~l~~~-~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~  210 (405)
                      ..                  .....||+.|+|||++.+. .++.++|||||||++|+|++   ||....+.......+..
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~~~~  243 (303)
T 1zy4_A          167 HRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKLRS  243 (303)
T ss_dssp             TC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHS
T ss_pred             ccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHHhccc
Confidence            32                  1234589999999999875 68999999999999999998   66433233333333322


Q ss_pred             cC--CCCCCchhccHHHHHHHHHhcccCccccCCHHHHhcCccccc
Q 015500          211 SR--ELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEE  254 (405)
Q Consensus       211 ~~--~~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~  254 (405)
                      ..  ..+.++...++.+.+||++||+.||.+|||+.++++||||..
T Consensus       244 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~  289 (303)
T 1zy4_A          244 VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV  289 (303)
T ss_dssp             TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred             cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence            11  123445567888999999999999999999999999999974

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=6.6e-47  Score=379.75  Aligned_cols=248  Identities=29%  Similarity=0.383  Sum_probs=188.9

Q ss_pred             ccccceeCCeeEEEEEEc--CCCCEEEEEEccCCC-hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEeecC
Q 015500            6 GHTIGQGSSATVSLATSL--RSGDVFAAKSTELPK-SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAP   82 (405)
Q Consensus         6 ~~~LG~G~~g~Vyla~~~--~~~~~vavK~~~~~~-~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~Ey~~   82 (405)
                      +++||+|+||+||+|+++  .+++.||||.+.... ...+.+|+.+|++|+||||+++++++......  .+++||||+.
T Consensus        26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~--~~~lv~e~~~  103 (405)
T 3rgf_A           26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADR--KVWLLFDYAE  103 (405)
T ss_dssp             SCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTT--EEEEEEECCS
T ss_pred             CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCC--eEEEEEeCCC
Confidence            678999999999999976  578999999987643 46788999999999999999999988654443  3569999996


Q ss_pred             CCCHHHHHHHc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEE----ccCC-ceEeeecccccc
Q 015500           83 GGTLNDEIHRN--------GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILM----AESG-AKIADFGCAKWE  149 (405)
Q Consensus        83 ggsL~~~i~~~--------~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi----~~~~-vkL~DFGla~~~  149 (405)
                      | +|.+++...        ...+++..++.++.||+.||+|||++||+||||||+|||+    +.++ +||+|||+++..
T Consensus       104 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~  182 (405)
T 3rgf_A          104 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF  182 (405)
T ss_dssp             E-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC--
T ss_pred             C-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCceec
Confidence            5 888887532        1249999999999999999999999999999999999999    4445 999999999865


Q ss_pred             cc-------cccCCCCCCccChhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCh--------HHHHHHHHhcCC
Q 015500          150 SE-------ALQSGGTPMFMAPEVARG-EHQGFASDIWAVGCTVIEMASGGAPWPNAADP--------MTVLYKIAYSRE  213 (405)
Q Consensus       150 ~~-------~~~~~gt~~Y~APE~l~~-~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~--------~~~l~~i~~~~~  213 (405)
                      ..       .....||+.|+|||++.+ ..++.++|||||||++|+|++|++||......        ...+.++.....
T Consensus       183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g  262 (405)
T 3rgf_A          183 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMG  262 (405)
T ss_dssp             --------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHC
T ss_pred             CCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhC
Confidence            43       234568999999999987 45899999999999999999999999644321        222332221111


Q ss_pred             CCCCc------------------------------------hhccHHHHHHHHHhcccCccccCCHHHHhcCccccccc
Q 015500          214 LPEVP------------------------------------AFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFC  256 (405)
Q Consensus       214 ~~~~p------------------------------------~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~  256 (405)
                      .|...                                    ...++.+.+||.+||+.||.+|||++|+|+||||....
T Consensus       263 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~~~  341 (405)
T 3rgf_A          263 FPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDP  341 (405)
T ss_dssp             CCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTSSS
T ss_pred             CCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhccCC
Confidence            11100                                    01267899999999999999999999999999998653

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.1e-48  Score=389.12  Aligned_cols=245  Identities=16%  Similarity=0.185  Sum_probs=194.9

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC------ChHHHHHHH---HHHHhCCCCCeeeeee-------eee
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQ---KFLSSLNSPHIVGYKG-------CDV   65 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~------~~~~l~~E~---~iL~~L~hpnIv~~~~-------~~~   65 (405)
                      +|++++.||+|+||+||+|+++.+|+.||||.+...      ..+.+.+|+   ++|++++||||+++++       ++.
T Consensus        74 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~  153 (377)
T 3byv_A           74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK  153 (377)
T ss_dssp             EEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEE
T ss_pred             eEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhh
Confidence            478899999999999999999999999999997532      236788999   5556668999999883       322


Q ss_pred             ecC----------CCce---EEEEEEeecCCCCHHHHHHHcCCCCCH-------HHHHHHHHHHHHHHHHHHhCCceeCC
Q 015500           66 TSE----------DNKL---MYNLFMEYAPGGTLNDEIHRNGGRLDE-------SLIVSYTRQILQGLEYLHSNRVVHCD  125 (405)
Q Consensus        66 ~~~----------~~~~---~~~lv~Ey~~ggsL~~~i~~~~~~l~e-------~~~~~i~~qIl~~L~yLH~~givHrD  125 (405)
                      ...          ....   ..+++|||+ +|+|.+++...+ .+++       ..+..++.||+.||+|||++||+|||
T Consensus       154 ~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~-~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrD  231 (377)
T 3byv_A          154 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLL-SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY  231 (377)
T ss_dssp             CTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHH-HTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred             ccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhcc-ccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence            221          1111   256999999 679999998753 4554       78888999999999999999999999


Q ss_pred             CCCCCEEEccCC-ceEeeecccccccc-cccCCCCCCccChhhhcCC-----------CCCcchhHHHHHHHHHHHHhCC
Q 015500          126 IKSRNILMAESG-AKIADFGCAKWESE-ALQSGGTPMFMAPEVARGE-----------HQGFASDIWAVGCTVIEMASGG  192 (405)
Q Consensus       126 lkp~NILi~~~~-vkL~DFGla~~~~~-~~~~~gt~~Y~APE~l~~~-----------~~~~~sDIwSLG~il~elltG~  192 (405)
                      |||+|||++.++ +||+|||+++.... .....| +.|+|||++.+.           .+++++|||||||++|||++|+
T Consensus       232 ikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~  310 (377)
T 3byv_A          232 LRPVDIVLDQRGGVFLTGFEHLVRDGARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD  310 (377)
T ss_dssp             CCGGGEEECTTCCEEECCGGGCEETTCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred             CCHHHEEEcCCCCEEEEechhheecCCcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCC
Confidence            999999999887 99999999986554 334567 999999999887           8999999999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHhcccCccccCCHHHHhcCccccccc
Q 015500          193 APWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFC  256 (405)
Q Consensus       193 ~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~  256 (405)
                      .||...... .....      ....+..+++++.+||.+||+.||.+|||+.|+|+||||+.+.
T Consensus       311 ~Pf~~~~~~-~~~~~------~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~  367 (377)
T 3byv_A          311 LPITKDAAL-GGSEW------IFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLR  367 (377)
T ss_dssp             CCC-------CCSGG------GGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHH
T ss_pred             CCCcccccc-cchhh------hhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHH
Confidence            999543211 11101      1112345789999999999999999999999999999998754

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.4e-46  Score=364.61  Aligned_cols=255  Identities=28%  Similarity=0.399  Sum_probs=209.5

Q ss_pred             CcccccccceeCCeeEEEEEEc-CCCCEEEEEEccCC-----ChHHHHHHHHHHHhC---CCCCeeeeeeeeeecC-CCc
Q 015500            2 DWTRGHTIGQGSSATVSLATSL-RSGDVFAAKSTELP-----KSEFLQREQKFLSSL---NSPHIVGYKGCDVTSE-DNK   71 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~-~~~~~vavK~~~~~-----~~~~l~~E~~iL~~L---~hpnIv~~~~~~~~~~-~~~   71 (405)
                      +|++++.||+|+||+||+|.+. .+|+.||+|.+...     ....+.+|+.+++.+   +||||+++++++.... ...
T Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~   91 (326)
T 1blx_A           12 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   91 (326)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSE
T ss_pred             ceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCC
Confidence            5899999999999999999995 67899999987532     234677888887776   8999999999876332 234


Q ss_pred             eEEEEEEeecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccc
Q 015500           72 LMYNLFMEYAPGGTLNDEIHRNG-GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWE  149 (405)
Q Consensus        72 ~~~~lv~Ey~~ggsL~~~i~~~~-~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~  149 (405)
                      ..+++||||++ |+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||+++.++ +||+|||+++..
T Consensus        92 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~~  170 (326)
T 1blx_A           92 TKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY  170 (326)
T ss_dssp             EEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCC
T ss_pred             ceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcccccc
Confidence            45779999997 59999998753 3599999999999999999999999999999999999999887 999999999765


Q ss_pred             cc---cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCC-------------
Q 015500          150 SE---ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRE-------------  213 (405)
Q Consensus       150 ~~---~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~-------------  213 (405)
                      ..   .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.... ....+.++.....             
T Consensus       171 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~  249 (326)
T 1blx_A          171 SFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS-DVDQLGKILDVIGLPGEEDWPRDVAL  249 (326)
T ss_dssp             CGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHHHCCCCGGGSCTTCSS
T ss_pred             cCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHHHHcCCCCcccCcccccc
Confidence            43   234569999999999999999999999999999999999999996543 3333333321110             


Q ss_pred             ------------CCCCchhccHHHHHHHHHhcccCccccCCHHHHhcCccccccccc
Q 015500          214 ------------LPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSC  258 (405)
Q Consensus       214 ------------~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~~~  258 (405)
                                  ...++..+++.+.+||.+||..||.+|||+.++|+||||+.....
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~  306 (326)
T 1blx_A          250 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERC  306 (326)
T ss_dssp             CGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred             chhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchh
Confidence                        011234578999999999999999999999999999999876543

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.7e-46  Score=357.86  Aligned_cols=242  Identities=25%  Similarity=0.354  Sum_probs=208.0

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCCh----------HHHHHHHHHHHhCCCCCeeeeeeeeeecCCCc
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS----------EFLQREQKFLSSLNSPHIVGYKGCDVTSEDNK   71 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~~----------~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~   71 (405)
                      +|++.+.||+|+||+||+|.+..+++.||+|.+.....          +.+.+|+.++++++||||+++++++....   
T Consensus        20 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---   96 (287)
T 4f0f_A           20 EIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP---   96 (287)
T ss_dssp             TEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT---
T ss_pred             cceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC---
Confidence            58899999999999999999999999999999864321          57889999999999999999998764322   


Q ss_pred             eEEEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCCCCEEEccCC------ceEeee
Q 015500           72 LMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNR--VVHCDIKSRNILMAESG------AKIADF  143 (405)
Q Consensus        72 ~~~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~g--ivHrDlkp~NILi~~~~------vkL~DF  143 (405)
                         ++||||+++|+|.+.+.....++++..+..++.||+.||+|||++|  |+||||||+|||++.++      +||+||
T Consensus        97 ---~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df  173 (287)
T 4f0f_A           97 ---RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF  173 (287)
T ss_dssp             ---EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred             ---eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence               3899999999999999877778999999999999999999999999  99999999999997543      899999


Q ss_pred             cccccccc-cccCCCCCCccChhhhc--CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHH-HHHHHHhcCCCCCCch
Q 015500          144 GCAKWESE-ALQSGGTPMFMAPEVAR--GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMT-VLYKIAYSRELPEVPA  219 (405)
Q Consensus       144 Gla~~~~~-~~~~~gt~~Y~APE~l~--~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~-~l~~i~~~~~~~~~p~  219 (405)
                      |+++.... .....||+.|+|||++.  ...+++++|||||||++|+|++|+.||........ ....+......+..+.
T Consensus       174 g~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  253 (287)
T 4f0f_A          174 GLSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPE  253 (287)
T ss_dssp             TTCBCCSSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCCCCT
T ss_pred             CccccccccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCCCCc
Confidence            99986544 34467999999999994  45578899999999999999999999976554433 3344444555667788


Q ss_pred             hccHHHHHHHHHhcccCccccCCHHHHhcC
Q 015500          220 FLSKQANDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       220 ~~s~~l~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      .+++.+.+||.+||+.||.+|||++++++.
T Consensus       254 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  283 (287)
T 4f0f_A          254 DCPPRLRNVIELCWSGDPKKRPHFSYIVKE  283 (287)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence            899999999999999999999999999863

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=6e-47  Score=376.31  Aligned_cols=242  Identities=25%  Similarity=0.398  Sum_probs=205.3

Q ss_pred             CcccccccceeCCeeEEEEEEc-------CCCCEEEEEEccCCC----hHHHHHHHHHHHhC-CCCCeeeeeeeeeecCC
Q 015500            2 DWTRGHTIGQGSSATVSLATSL-------RSGDVFAAKSTELPK----SEFLQREQKFLSSL-NSPHIVGYKGCDVTSED   69 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~-------~~~~~vavK~~~~~~----~~~l~~E~~iL~~L-~hpnIv~~~~~~~~~~~   69 (405)
                      +|++++.||+|+||+||+|.+.       .++..||||.+....    .+.+.+|+.+|+.+ +||||+++++++.....
T Consensus        82 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~  161 (370)
T 2psq_A           82 KLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP  161 (370)
T ss_dssp             GEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSS
T ss_pred             HCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCC
Confidence            4788999999999999999975       345689999987543    24688999999999 89999999998765433


Q ss_pred             CceEEEEEEeecCCCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEc
Q 015500           70 NKLMYNLFMEYAPGGTLNDEIHRNG---------------GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMA  134 (405)
Q Consensus        70 ~~~~~~lv~Ey~~ggsL~~~i~~~~---------------~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~  134 (405)
                          +++||||++||+|.+++....               ..+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus       162 ----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~  237 (370)
T 2psq_A          162 ----LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT  237 (370)
T ss_dssp             ----CEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC
T ss_pred             ----EEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEEC
Confidence                569999999999999998753               2489999999999999999999999999999999999999


Q ss_pred             cCC-ceEeeecccccccc------cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHH
Q 015500          135 ESG-AKIADFGCAKWESE------ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLY  206 (405)
Q Consensus       135 ~~~-vkL~DFGla~~~~~------~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~  206 (405)
                      .++ +||+|||+++....      .....+|+.|+|||++.+..++.++|||||||++|||+| |+.||.... ..... 
T Consensus       238 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~-~~~~~-  315 (370)
T 2psq_A          238 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEELF-  315 (370)
T ss_dssp             TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-GGGHH-
T ss_pred             CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCC-HHHHH-
Confidence            888 99999999985433      123347889999999999999999999999999999999 999996543 23333 


Q ss_pred             HHHhcCCCCCCchhccHHHHHHHHHhcccCccccCCHHHHhcC
Q 015500          207 KIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       207 ~i~~~~~~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      ........+..|..+++++.+||.+||+.||.+|||+.|++++
T Consensus       316 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          316 KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             HHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            3333444566788899999999999999999999999999886

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.1e-46  Score=359.75  Aligned_cols=247  Identities=26%  Similarity=0.447  Sum_probs=209.3

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccC-----CChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL-----PKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~-----~~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      +|++++.||+|+||+||+|.++.+++.||+|.+..     ...+.+.+|++++++++||||+++++++....    .+++
T Consensus        23 ~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~l   98 (287)
T 2wei_A           23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSS----SFYI   98 (287)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS----EEEE
T ss_pred             cceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCC----eEEE
Confidence            48899999999999999999999999999998753     23567899999999999999999999875432    3669


Q ss_pred             EEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC----ceEeeeccccccccc
Q 015500           77 FMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG----AKIADFGCAKWESEA  152 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~----vkL~DFGla~~~~~~  152 (405)
                      ||||+++++|.+++...+ ++++..+..++.||+.||.|||++|++||||||+||+++.++    +||+|||++......
T Consensus        99 v~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~  177 (287)
T 2wei_A           99 VGELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN  177 (287)
T ss_dssp             EECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC
T ss_pred             EEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCC
Confidence            999999999999987764 799999999999999999999999999999999999997542    999999998765432


Q ss_pred             c---cCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCc--hhccHHHHH
Q 015500          153 L---QSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVP--AFLSKQAND  227 (405)
Q Consensus       153 ~---~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p--~~~s~~l~d  227 (405)
                      .   ...||+.|+|||++.+. ++.++|||||||++|+|++|+.||... +.......+.........+  ..+++++.+
T Consensus       178 ~~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (287)
T 2wei_A          178 TKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGK-NEYDILKRVETGKYAFDLPQWRTISDDAKD  255 (287)
T ss_dssp             SSCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHCCCCCCSGGGTTSCHHHHH
T ss_pred             CccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCC-CHHHHHHHHHcCCCCCCchhhhhcCHHHHH
Confidence            2   23488999999999865 889999999999999999999999654 3444444444433322333  458999999


Q ss_pred             HHHHhcccCccccCCHHHHhcCcccccc
Q 015500          228 FLSNCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       228 ll~~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      ||.+||..||.+|||+.++|+||||++.
T Consensus       256 li~~~l~~dp~~Rps~~ell~hp~~~~~  283 (287)
T 2wei_A          256 LIRKMLTFHPSLRITATQCLEHPWIQKY  283 (287)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred             HHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence            9999999999999999999999999865

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=3.4e-47  Score=372.85  Aligned_cols=253  Identities=24%  Similarity=0.352  Sum_probs=186.3

Q ss_pred             Ccccc-cccceeCCeeEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEee
Q 015500            2 DWTRG-HTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEY   80 (405)
Q Consensus         2 ~y~~~-~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~Ey   80 (405)
                      +|.+. +.||+|+||+||+|.++.+|+.||||++... .....+....++.+.||||+++++++.........+++||||
T Consensus        29 ~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~  107 (336)
T 3fhr_A           29 DYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMEC  107 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEEC
T ss_pred             eeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEec
Confidence            47774 4699999999999999999999999998643 233334445577789999999999887766556667899999


Q ss_pred             cCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccC---C-ceEeeecccccccc--cc
Q 015500           81 APGGTLNDEIHRNG-GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES---G-AKIADFGCAKWESE--AL  153 (405)
Q Consensus        81 ~~ggsL~~~i~~~~-~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~---~-vkL~DFGla~~~~~--~~  153 (405)
                      ++||+|.+++.+.+ ..+++..++.++.||+.||.|||++||+||||||+|||++.+   + +||+|||+++....  ..
T Consensus       108 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~~~  187 (336)
T 3fhr_A          108 MEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQ  187 (336)
T ss_dssp             CTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC------
T ss_pred             cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceeccccccc
Confidence            99999999998754 369999999999999999999999999999999999999753   2 89999999976543  33


Q ss_pred             cCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHH---HHHHHhc--CCCCCCchhccHHHHHH
Q 015500          154 QSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTV---LYKIAYS--RELPEVPAFLSKQANDF  228 (405)
Q Consensus       154 ~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~---l~~i~~~--~~~~~~p~~~s~~l~dl  228 (405)
                      ...||+.|+|||++.+..+++++|||||||++|+|++|+.||.........   ...+...  .........+++++.+|
T Consensus       188 ~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  267 (336)
T 3fhr_A          188 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQL  267 (336)
T ss_dssp             ----------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTSTTCCHHHHHH
T ss_pred             cCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhccCCHHHHHH
Confidence            456899999999999888999999999999999999999999644322110   1111111  11112224689999999


Q ss_pred             HHHhcccCccccCCHHHHhcCcccccc
Q 015500          229 LSNCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       229 l~~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      |.+||+.||.+|||++|+|+||||+..
T Consensus       268 i~~~L~~dP~~Rpt~~ell~hp~~~~~  294 (336)
T 3fhr_A          268 IRLLLKTDPTERLTITQFMNHPWINQS  294 (336)
T ss_dssp             HHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred             HHHHCCCChhHCcCHHHHhcCcccccc
Confidence            999999999999999999999999864

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.4e-46  Score=362.63  Aligned_cols=250  Identities=26%  Similarity=0.366  Sum_probs=199.6

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCCh---HHHHHHHHHHHhCCCCCeeeeeeeeeecC----------
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS---EFLQREQKFLSSLNSPHIVGYKGCDVTSE----------   68 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~~---~~l~~E~~iL~~L~hpnIv~~~~~~~~~~----------   68 (405)
                      +|++++.||+|+||+||+|.+..+++.||+|.+.....   +.+.+|++++++++||||+++++++....          
T Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~   91 (320)
T 2i6l_A           12 RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSL   91 (320)
T ss_dssp             TEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----C
T ss_pred             ceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccc
Confidence            58999999999999999999999999999998876543   46789999999999999999998763221          


Q ss_pred             CCceEEEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcc-CC-ceEeeeccc
Q 015500           69 DNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAE-SG-AKIADFGCA  146 (405)
Q Consensus        69 ~~~~~~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~-~~-vkL~DFGla  146 (405)
                      .....+++||||++ |+|.+++.+  +++++..++.++.||+.||+|||++||+||||||+||+++. ++ +||+|||++
T Consensus        92 ~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~  168 (320)
T 2i6l_A           92 TELNSVYIVQEYME-TDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLA  168 (320)
T ss_dssp             CSCSEEEEEEECCS-EEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             cccCceeEEeeccC-CCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCccc
Confidence            12234679999997 599999864  47999999999999999999999999999999999999974 44 999999999


Q ss_pred             ccccc-------cccCCCCCCccChhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCC----
Q 015500          147 KWESE-------ALQSGGTPMFMAPEVARG-EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSREL----  214 (405)
Q Consensus       147 ~~~~~-------~~~~~gt~~Y~APE~l~~-~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~----  214 (405)
                      +....       .....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.... .......+......    
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~  247 (320)
T 2i6l_A          169 RIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH-ELEQMQLILESIPVVHEE  247 (320)
T ss_dssp             BCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHHSCCCCHH
T ss_pred             cccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHhcCCCchh
Confidence            86532       123347999999999876 678999999999999999999999996544 33333332221110    


Q ss_pred             -------------------C-----CCchhccHHHHHHHHHhcccCccccCCHHHHhcCcccccc
Q 015500          215 -------------------P-----EVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       215 -------------------~-----~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                                         +     ..+..+++++.+||++||+.||.+|||++++|+||||+..
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  312 (320)
T 2i6l_A          248 DRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIY  312 (320)
T ss_dssp             HHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTT
T ss_pred             hhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccc
Confidence                               1     1123478999999999999999999999999999999865

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=9.5e-47  Score=367.99  Aligned_cols=242  Identities=21%  Similarity=0.308  Sum_probs=204.9

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCC---EEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGD---VFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMY   74 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~---~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~   74 (405)
                      +|++++.||+|+||+||+|.+..+++   .||||.+....    .+.+.+|+.+|++++||||+++++++.....    +
T Consensus        50 ~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~----~  125 (325)
T 3kul_A           50 RIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRL----A  125 (325)
T ss_dssp             GEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGC----C
T ss_pred             HeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCc----c
Confidence            58889999999999999999986665   59999987542    3468899999999999999999998754433    5


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc-
Q 015500           75 NLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA-  152 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~-  152 (405)
                      ++||||++||+|.+++....+.+++..+..++.||+.||.|||++||+||||||+|||++.++ +||+|||+++..... 
T Consensus       126 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  205 (325)
T 3kul_A          126 MIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP  205 (325)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC---
T ss_pred             EEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccccCc
Confidence            699999999999999987767899999999999999999999999999999999999999887 999999999865331 


Q ss_pred             ------ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHH
Q 015500          153 ------LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQA  225 (405)
Q Consensus       153 ------~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l  225 (405)
                            ....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.... .......+.. ...+..+..+++.+
T Consensus       206 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~l  283 (325)
T 3kul_A          206 DAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT-NRDVISSVEE-GYRLPAPMGCPHAL  283 (325)
T ss_dssp             -CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSC-HHHHHHHHHT-TCCCCCCTTCCHHH
T ss_pred             cceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCC-HHHHHHHHHc-CCCCCCCCCcCHHH
Confidence                  12236778999999999999999999999999999999 999996543 3344444433 33445677899999


Q ss_pred             HHHHHHhcccCccccCCHHHHhcC
Q 015500          226 NDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       226 ~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      .+||.+||..||.+|||+.++++.
T Consensus       284 ~~li~~~l~~dp~~Rps~~eil~~  307 (325)
T 3kul_A          284 HQLMLDCWHKDRAQRPRFSQIVSV  307 (325)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHccCChhhCcCHHHHHHH
Confidence            999999999999999999999874

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.1e-46  Score=355.76  Aligned_cols=241  Identities=22%  Similarity=0.331  Sum_probs=206.2

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC--ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEe
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP--KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFME   79 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~--~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (405)
                      +|++++.||+|+||+||+|.++ ++..||+|.+...  ..+.+.+|++++++++||||+++++++.....    +++|||
T Consensus         9 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~----~~lv~e   83 (268)
T 3sxs_A            9 EITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYP----IYIVTE   83 (268)
T ss_dssp             GEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS----EEEEEE
T ss_pred             heeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCc----eEEEEE
Confidence            5899999999999999999875 5678999998754  35678999999999999999999998754332    569999


Q ss_pred             ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc-----cc
Q 015500           80 YAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE-----AL  153 (405)
Q Consensus        80 y~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~-----~~  153 (405)
                      |+++++|.+++...+..+++..+..++.||+.||+|||++||+||||||+||+++.++ +||+|||++.....     ..
T Consensus        84 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  163 (268)
T 3sxs_A           84 YISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSV  163 (268)
T ss_dssp             CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECC
T ss_pred             ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhhhccc
Confidence            9999999999988766799999999999999999999999999999999999999887 99999999975433     12


Q ss_pred             cCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHh
Q 015500          154 QSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNC  232 (405)
Q Consensus       154 ~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~  232 (405)
                      ...+|+.|+|||++.+..+++++|||||||++|+|++ |+.||.... .......+. ....+..|...++.+.++|.+|
T Consensus       164 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~  241 (268)
T 3sxs_A          164 GTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT-NSEVVLKVS-QGHRLYRPHLASDTIYQIMYSC  241 (268)
T ss_dssp             SCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSC-HHHHHHHHH-TTCCCCCCTTSCHHHHHHHHHT
T ss_pred             CCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccC-hHHHHHHHH-cCCCCCCCCcChHHHHHHHHHH
Confidence            3346778999999999889999999999999999999 999996443 333333333 3334456677899999999999


Q ss_pred             cccCccccCCHHHHhcC
Q 015500          233 LRRDPKERWAASQLLKH  249 (405)
Q Consensus       233 L~~dP~~Rpt~~elL~h  249 (405)
                      |+.||.+|||+.++++|
T Consensus       242 l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          242 WHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             TCSSGGGSCCHHHHHHH
T ss_pred             cCCChhhCcCHHHHHHH
Confidence            99999999999999987

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.8e-46  Score=360.54  Aligned_cols=250  Identities=25%  Similarity=0.418  Sum_probs=209.4

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC-------ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP-------KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMY   74 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~-------~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~   74 (405)
                      +|++++.||+|+||.||+|.+..+++.+|+|.+...       ..+.+.+|++++++++||||+++++++......  .+
T Consensus         6 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~--~~   83 (305)
T 2wtk_C            6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQ--KM   83 (305)
T ss_dssp             CBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC-----CE
T ss_pred             ceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC--eE
Confidence            699999999999999999999999999999998642       246788999999999999999999987543322  35


Q ss_pred             EEEEeecCCCCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc-
Q 015500           75 NLFMEYAPGGTLNDEIHR-NGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE-  151 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~i~~-~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~-  151 (405)
                      ++||||++++ |.+++.. ..+.+++..+..++.||+.||.|||++||+||||||+||+++.++ +||+|||++..... 
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~  162 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF  162 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred             EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCcc
Confidence            6999999876 7777765 345799999999999999999999999999999999999998887 99999999975432 


Q ss_pred             -----cccCCCCCCccChhhhcCCC--CCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHH
Q 015500          152 -----ALQSGGTPMFMAPEVARGEH--QGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQ  224 (405)
Q Consensus       152 -----~~~~~gt~~Y~APE~l~~~~--~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~  224 (405)
                           .....||+.|+|||++.+..  ++.++|||||||++|+|++|+.||... +.......+...  ...+|..+++.
T Consensus       163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-~~~~~~~~i~~~--~~~~~~~~~~~  239 (305)
T 2wtk_C          163 AADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGD-NIYKLFENIGKG--SYAIPGDCGPP  239 (305)
T ss_dssp             CSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCS-SHHHHHHHHHHC--CCCCCSSSCHH
T ss_pred             ccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCc-hHHHHHHHHhcC--CCCCCCccCHH
Confidence                 23456999999999998754  377999999999999999999999643 334444444332  33566778999


Q ss_pred             HHHHHHHhcccCccccCCHHHHhcCcccccccc
Q 015500          225 ANDFLSNCLRRDPKERWAASQLLKHPFLEEFCS  257 (405)
Q Consensus       225 l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~~  257 (405)
                      +.+||++||..||.+|||+.++++||||+....
T Consensus       240 l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~  272 (305)
T 2wtk_C          240 LSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP  272 (305)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred             HHHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence            999999999999999999999999999987543

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=4.1e-47  Score=377.00  Aligned_cols=246  Identities=24%  Similarity=0.267  Sum_probs=205.7

Q ss_pred             CcccccccceeCCeeEEEEE-----EcCCCCEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCce
Q 015500            2 DWTRGHTIGQGSSATVSLAT-----SLRSGDVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKL   72 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~-----~~~~~~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~   72 (405)
                      +|++++.||+|+||+||+|.     +..+++.||||.+....    ...+.+|+.+|++++||||+++++++.....   
T Consensus        72 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~---  148 (367)
T 3l9p_A           72 NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP---  148 (367)
T ss_dssp             GEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS---
T ss_pred             HeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC---
Confidence            47889999999999999999     45677899999986432    2367889999999999999999998765433   


Q ss_pred             EEEEEEeecCCCCHHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC----ceEee
Q 015500           73 MYNLFMEYAPGGTLNDEIHRNG------GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG----AKIAD  142 (405)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~i~~~~------~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~----vkL~D  142 (405)
                       .++||||++||+|.+++....      ..+++..++.++.||+.||+|||++||+||||||+|||++.++    +||+|
T Consensus       149 -~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~D  227 (367)
T 3l9p_A          149 -RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGD  227 (367)
T ss_dssp             -CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred             -CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECC
Confidence             458999999999999998753      3589999999999999999999999999999999999998543    89999


Q ss_pred             ecccccccc------cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCC
Q 015500          143 FGCAKWESE------ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELP  215 (405)
Q Consensus       143 FGla~~~~~------~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~  215 (405)
                      ||+++....      .....||+.|+|||++.+..++.++|||||||++|||++ |..||... ........+ .....+
T Consensus       228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~-~~~~~~~~i-~~~~~~  305 (367)
T 3l9p_A          228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK-SNQEVLEFV-TSGGRM  305 (367)
T ss_dssp             CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-CHHHHHHHH-HTTCCC
T ss_pred             CccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHH-HcCCCC
Confidence            999975322      223457999999999999999999999999999999998 99999644 334444333 344445


Q ss_pred             CCchhccHHHHHHHHHhcccCccccCCHHHHhcCcccc
Q 015500          216 EVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLE  253 (405)
Q Consensus       216 ~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~  253 (405)
                      ..+..+++.+.+||.+||+.||.+|||+.++++|.++.
T Consensus       306 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~  343 (367)
T 3l9p_A          306 DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  343 (367)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            66778999999999999999999999999999997654

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.5e-46  Score=357.46  Aligned_cols=241  Identities=22%  Similarity=0.315  Sum_probs=204.1

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC--ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEe
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP--KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFME   79 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~--~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (405)
                      +|++++.||+|+||+||+|.+. ++..||+|.+...  ..+.+.+|++++++++||||+++++++.....    +++|||
T Consensus        25 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~----~~lv~e   99 (283)
T 3gen_A           25 DLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRP----IFIITE   99 (283)
T ss_dssp             GEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS----EEEEEC
T ss_pred             HHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCC----eEEEEe
Confidence            5888999999999999999875 6778999998764  35678999999999999999999998754333    569999


Q ss_pred             ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc-----cc
Q 015500           80 YAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE-----AL  153 (405)
Q Consensus        80 y~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~-----~~  153 (405)
                      |+++++|.+++....+++++..+..++.||+.||.|||++||+||||||+||+++.++ +||+|||+++....     ..
T Consensus       100 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~  179 (283)
T 3gen_A          100 YMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV  179 (283)
T ss_dssp             CCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTT
T ss_pred             ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccccccccccccc
Confidence            9999999999987556899999999999999999999999999999999999999887 99999999986433     22


Q ss_pred             cCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHh
Q 015500          154 QSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNC  232 (405)
Q Consensus       154 ~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~  232 (405)
                      ...+|+.|+|||++.+..++.++|||||||++|+|+| |+.||.... .......+. ....+..|...++.+.+||.+|
T Consensus       180 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~  257 (283)
T 3gen_A          180 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT-NSETAEHIA-QGLRLYRPHLASEKVYTIMYSC  257 (283)
T ss_dssp             STTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSC-HHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHT
T ss_pred             CCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccC-hhHHHHHHh-cccCCCCCCcCCHHHHHHHHHH
Confidence            3447788999999999899999999999999999998 999996543 333344433 3334456677899999999999


Q ss_pred             cccCccccCCHHHHhcC
Q 015500          233 LRRDPKERWAASQLLKH  249 (405)
Q Consensus       233 L~~dP~~Rpt~~elL~h  249 (405)
                      |+.||.+|||+.++++|
T Consensus       258 l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          258 WHEKADERPTFKILLSN  274 (283)
T ss_dssp             TCSSGGGSCCHHHHHHH
T ss_pred             ccCChhHCcCHHHHHHH
Confidence            99999999999999987

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=9.1e-47  Score=361.51  Aligned_cols=244  Identities=27%  Similarity=0.385  Sum_probs=202.6

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHh--CCCCCeeeeeeeeeecCCCceEEEEEEe
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSS--LNSPHIVGYKGCDVTSEDNKLMYNLFME   79 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~~~~l~~E~~iL~~--L~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (405)
                      +|++++.||+|+||+||+|.+  +++.||||.+.......+.+|.+++..  ++||||+++++++.........+++|||
T Consensus         9 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e   86 (301)
T 3q4u_A            9 DITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITH   86 (301)
T ss_dssp             GCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEEC
T ss_pred             cEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehh
Confidence            589999999999999999987  589999999987777778888888877  7999999999987766555566789999


Q ss_pred             ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH--------hCCceeCCCCCCCEEEccCC-ceEeeeccccccc
Q 015500           80 YAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLH--------SNRVVHCDIKSRNILMAESG-AKIADFGCAKWES  150 (405)
Q Consensus        80 y~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH--------~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~  150 (405)
                      |+++|+|.++++.  +.+++..+..++.||+.||+|||        ++||+||||||+|||++.++ +||+|||+++...
T Consensus        87 ~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  164 (301)
T 3q4u_A           87 YHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHS  164 (301)
T ss_dssp             CCTTCBHHHHHTT--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred             hccCCCHHHHHhh--cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCeeecc
Confidence            9999999999964  37999999999999999999999        99999999999999999887 9999999997543


Q ss_pred             cc--------ccCCCCCCccChhhhcCC------CCCcchhHHHHHHHHHHHHhC----------CCCCCCCC---ChHH
Q 015500          151 EA--------LQSGGTPMFMAPEVARGE------HQGFASDIWAVGCTVIEMASG----------GAPWPNAA---DPMT  203 (405)
Q Consensus       151 ~~--------~~~~gt~~Y~APE~l~~~------~~~~~sDIwSLG~il~elltG----------~~Pf~~~~---~~~~  203 (405)
                      ..        ....||+.|+|||++.+.      .+++++|||||||++|||+||          +.||....   ....
T Consensus       165 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~  244 (301)
T 3q4u_A          165 QSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFE  244 (301)
T ss_dssp             TTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHH
T ss_pred             cccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcchh
Confidence            31        223799999999999876      345789999999999999999          88885432   1222


Q ss_pred             HHHH-HHhcCCCCCCch-----hccHHHHHHHHHhcccCccccCCHHHHhcC
Q 015500          204 VLYK-IAYSRELPEVPA-----FLSKQANDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       204 ~l~~-i~~~~~~~~~p~-----~~s~~l~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      .... .......+..|.     ..++++.+||.+||+.||.+|||+.++++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~  296 (301)
T 3q4u_A          245 DMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKT  296 (301)
T ss_dssp             HHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             hhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence            2222 223333444443     366889999999999999999999999864

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.6e-46  Score=369.52  Aligned_cols=251  Identities=29%  Similarity=0.409  Sum_probs=205.3

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCC--ceEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDN--KLMY   74 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~--~~~~   74 (405)
                      +|.+.+.||+|+||+||+|.++.+|+.||||.+....     ...+.+|+.+|+.++||||+++++++......  ...+
T Consensus        25 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  104 (353)
T 3coi_A           25 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDF  104 (353)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCC
T ss_pred             eEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeE
Confidence            5889999999999999999999999999999986532     34678999999999999999999987654321  1234


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc-c
Q 015500           75 NLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE-A  152 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~-~  152 (405)
                      +++|||+. ++|.+++.   .++++..+..++.||+.||.|||++||+||||||+||+++.++ +||+|||+++.... .
T Consensus       105 ~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  180 (353)
T 3coi_A          105 YLVMPFMQ-TDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEM  180 (353)
T ss_dssp             EEEEECCS-EEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC-----
T ss_pred             EEEecccc-CCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCCCc
Confidence            69999997 58887763   3599999999999999999999999999999999999999887 99999999986544 3


Q ss_pred             ccCCCCCCccChhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhc--------------------
Q 015500          153 LQSGGTPMFMAPEVARG-EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYS--------------------  211 (405)
Q Consensus       153 ~~~~gt~~Y~APE~l~~-~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~--------------------  211 (405)
                      ....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.... ....+..+...                    
T Consensus       181 ~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  259 (353)
T 3coi_A          181 TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD-YLDQLTQILKVTGVPGTEFVQKLNDKAAKSY  259 (353)
T ss_dssp             ---CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSC-HHHHHHHHHHHHCBCCHHHHTTCSCHHHHHH
T ss_pred             cccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhCCCCHHHHHHHhhHHHHHH
Confidence            34578999999999987 678999999999999999999999996543 33333322110                    


Q ss_pred             ---------CCCCCCchhccHHHHHHHHHhcccCccccCCHHHHhcCcccccccc
Q 015500          212 ---------RELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCS  257 (405)
Q Consensus       212 ---------~~~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~~  257 (405)
                               ...+..+..+++++.+||.+||..||.+|||++++|+||||+.+..
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~  314 (353)
T 3coi_A          260 IQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD  314 (353)
T ss_dssp             HHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCC
T ss_pred             HHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccC
Confidence                     1122334567999999999999999999999999999999987643

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=8.7e-47  Score=369.19  Aligned_cols=251  Identities=20%  Similarity=0.287  Sum_probs=202.0

Q ss_pred             CcccccccceeCCeeEEEEEEcCCC-CEEEEEEccCCC--hHHHHHHHHHHHhCCCCC------eeeeeeeeeecCCCce
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSG-DVFAAKSTELPK--SEFLQREQKFLSSLNSPH------IVGYKGCDVTSEDNKL   72 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~-~~vavK~~~~~~--~~~l~~E~~iL~~L~hpn------Iv~~~~~~~~~~~~~~   72 (405)
                      +|++++.||+|+||+||+|.+..++ +.||+|.+....  .+.+.+|+.+++.++|++      ++.+.+++....    
T Consensus        20 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~----   95 (355)
T 2eu9_A           20 RYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG----   95 (355)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT----
T ss_pred             cEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC----
Confidence            5899999999999999999998877 689999987542  457888999999997765      777777665433    


Q ss_pred             EEEEEEeecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEE------------------
Q 015500           73 MYNLFMEYAPGGTLNDEIHRNG-GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILM------------------  133 (405)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~i~~~~-~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi------------------  133 (405)
                      .+++||||+ +++|.+++.... .++++..++.++.||+.||+|||++||+||||||+|||+                  
T Consensus        96 ~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~  174 (355)
T 2eu9_A           96 HMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEK  174 (355)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEE
T ss_pred             eEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccccccc
Confidence            367999999 667777776643 579999999999999999999999999999999999999                  


Q ss_pred             -ccCC-ceEeeecccccccc-cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHh
Q 015500          134 -AESG-AKIADFGCAKWESE-ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAY  210 (405)
Q Consensus       134 -~~~~-vkL~DFGla~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~  210 (405)
                       +.++ +||+|||+++.... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...............
T Consensus       175 ~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~  254 (355)
T 2eu9_A          175 SVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKI  254 (355)
T ss_dssp             EESCCCEEECCCTTCEETTSCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred             ccCCCcEEEeecCccccccccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence             3444 99999999986544 34557999999999999999999999999999999999999999654432222111111


Q ss_pred             cCCCCC-----------------------------------------CchhccHHHHHHHHHhcccCccccCCHHHHhcC
Q 015500          211 SRELPE-----------------------------------------VPAFLSKQANDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       211 ~~~~~~-----------------------------------------~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      ....|.                                         .....+.++.+||++||+.||.+|||+.|+|+|
T Consensus       255 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h  334 (355)
T 2eu9_A          255 LGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLH  334 (355)
T ss_dssp             HCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             cCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            111110                                         011235689999999999999999999999999


Q ss_pred             cccccccc
Q 015500          250 PFLEEFCS  257 (405)
Q Consensus       250 p~~~~~~~  257 (405)
                      |||+....
T Consensus       335 p~f~~~~~  342 (355)
T 2eu9_A          335 PFFAGLTP  342 (355)
T ss_dssp             GGGGGCCH
T ss_pred             hhhcCCCh
Confidence            99997643

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=3.6e-47  Score=372.34  Aligned_cols=246  Identities=25%  Similarity=0.401  Sum_probs=209.5

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC------h--------------HHHHHHHHHHHhCCCCCeeeee
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK------S--------------EFLQREQKFLSSLNSPHIVGYK   61 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~------~--------------~~l~~E~~iL~~L~hpnIv~~~   61 (405)
                      +|++++.||+|+||+||+|.+  +|+.||||.+....      .              +.+.+|+.++++++||||++++
T Consensus        32 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~  109 (348)
T 2pml_X           32 DYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE  109 (348)
T ss_dssp             TEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred             ceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence            689999999999999999998  89999999875321      1              7899999999999999999999


Q ss_pred             eeeeecCCCceEEEEEEeecCCCCHHHH------HHHc-CCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCCEEE
Q 015500           62 GCDVTSEDNKLMYNLFMEYAPGGTLNDE------IHRN-GGRLDESLIVSYTRQILQGLEYLHS-NRVVHCDIKSRNILM  133 (405)
Q Consensus        62 ~~~~~~~~~~~~~~lv~Ey~~ggsL~~~------i~~~-~~~l~e~~~~~i~~qIl~~L~yLH~-~givHrDlkp~NILi  133 (405)
                      +++....    .+++||||++|++|.++      +... .+.+++..+..++.||+.||.|||+ +||+||||||+||++
T Consensus       110 ~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~  185 (348)
T 2pml_X          110 GIITNYD----EVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILM  185 (348)
T ss_dssp             EEEESSS----EEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEE
T ss_pred             EEEeeCC----eEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEE
Confidence            9876543    36799999999999998      5542 4579999999999999999999999 999999999999999


Q ss_pred             ccCC-ceEeeecccccccc--cccCCCCCCccChhhhcCC-CCCc-chhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHH
Q 015500          134 AESG-AKIADFGCAKWESE--ALQSGGTPMFMAPEVARGE-HQGF-ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKI  208 (405)
Q Consensus       134 ~~~~-vkL~DFGla~~~~~--~~~~~gt~~Y~APE~l~~~-~~~~-~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i  208 (405)
                      +.++ +||+|||++.....  .....||+.|+|||++.+. .++. ++|||||||++|+|++|+.||............+
T Consensus       186 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i  265 (348)
T 2pml_X          186 DKNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNI  265 (348)
T ss_dssp             CTTSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHH
T ss_pred             cCCCcEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Confidence            9887 99999999986433  3456799999999999887 5665 9999999999999999999997665545555444


Q ss_pred             HhcCCCCCCc-------------------hhccHHHHHHHHHhcccCccccCCHHHHhcCcccccc
Q 015500          209 AYSRELPEVP-------------------AFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       209 ~~~~~~~~~p-------------------~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      ...  ....|                   ..+++++.+||.+||+.||.+|||+.|+++||||+..
T Consensus       266 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~  329 (348)
T 2pml_X          266 RTK--NIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT  329 (348)
T ss_dssp             TSC--CCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred             hcc--CcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCC
Confidence            332  12233                   5689999999999999999999999999999999864

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=8.2e-47  Score=366.39  Aligned_cols=252  Identities=22%  Similarity=0.335  Sum_probs=193.9

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCC---EEEEEEccCC-----ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCc--
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGD---VFAAKSTELP-----KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNK--   71 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~---~vavK~~~~~-----~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~--   71 (405)
                      +|++++.||+|+||+||+|.++.++.   .||||.+...     ..+.+.+|++++++++||||+++++++.......  
T Consensus        24 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  103 (323)
T 3qup_A           24 QFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRL  103 (323)
T ss_dssp             -CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC------
T ss_pred             HeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCC
Confidence            58999999999999999999887765   8999998653     2357889999999999999999999876544321  


Q ss_pred             eEEEEEEeecCCCCHHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecc
Q 015500           72 LMYNLFMEYAPGGTLNDEIHRNG-----GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGC  145 (405)
Q Consensus        72 ~~~~lv~Ey~~ggsL~~~i~~~~-----~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGl  145 (405)
                      ...++||||+++|+|.+++....     ..+++..+..++.||+.||+|||++||+||||||+|||++.++ +||+|||+
T Consensus       104 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~Dfg~  183 (323)
T 3qup_A          104 PIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGL  183 (323)
T ss_dssp             -CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC
T ss_pred             CccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEeeccc
Confidence            12368999999999999986532     2599999999999999999999999999999999999999887 99999999


Q ss_pred             ccccccc------ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCc
Q 015500          146 AKWESEA------LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVP  218 (405)
Q Consensus       146 a~~~~~~------~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p  218 (405)
                      ++.....      ....+|+.|+|||++.+..++.++|||||||++|+|++ |..||..... ......+ .....+..+
T Consensus       184 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~-~~~~~~~-~~~~~~~~~  261 (323)
T 3qup_A          184 SRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN-AEIYNYL-IGGNRLKQP  261 (323)
T ss_dssp             -----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG-GGHHHHH-HTTCCCCCC
T ss_pred             cccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccCh-HHHHHHH-hcCCCCCCC
Confidence            9764331      23347788999999999999999999999999999999 9999965443 3333333 333445667


Q ss_pred             hhccHHHHHHHHHhcccCccccCC-------HHHHhcCcccccc
Q 015500          219 AFLSKQANDFLSNCLRRDPKERWA-------ASQLLKHPFLEEF  255 (405)
Q Consensus       219 ~~~s~~l~dll~~~L~~dP~~Rpt-------~~elL~hp~~~~~  255 (405)
                      ..+++++.+||.+||+.||.+|||       ++++++|||+...
T Consensus       262 ~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~  305 (323)
T 3qup_A          262 PECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST  305 (323)
T ss_dssp             TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred             CccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence            789999999999999999999999       7788899998754

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=3.5e-47  Score=374.03  Aligned_cols=244  Identities=23%  Similarity=0.359  Sum_probs=206.8

Q ss_pred             CcccccccceeCCeeEEEEE-----EcCCCCEEEEEEccCCC----hHHHHHHHHHHHhC-CCCCeeeeeeeeeecCCCc
Q 015500            2 DWTRGHTIGQGSSATVSLAT-----SLRSGDVFAAKSTELPK----SEFLQREQKFLSSL-NSPHIVGYKGCDVTSEDNK   71 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~-----~~~~~~~vavK~~~~~~----~~~l~~E~~iL~~L-~hpnIv~~~~~~~~~~~~~   71 (405)
                      +|.+++.||+|+||+||+|.     +..+++.||||.+....    .+.+.+|+++|+++ +||||+++++++.....  
T Consensus        23 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~--  100 (359)
T 3vhe_A           23 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG--  100 (359)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS--
T ss_pred             ceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCC--
Confidence            58899999999999999999     55677999999987643    24688999999999 78999999998755332  


Q ss_pred             eEEEEEEeecCCCCHHHHHHHcCC--------------------------------------------------------
Q 015500           72 LMYNLFMEYAPGGTLNDEIHRNGG--------------------------------------------------------   95 (405)
Q Consensus        72 ~~~~lv~Ey~~ggsL~~~i~~~~~--------------------------------------------------------   95 (405)
                       .+++||||++||+|.+++.....                                                        
T Consensus       101 -~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  179 (359)
T 3vhe_A          101 -PLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE  179 (359)
T ss_dssp             -CCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------------
T ss_pred             -ceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhc
Confidence             24589999999999999976532                                                        


Q ss_pred             ---------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc------cccCCCCC
Q 015500           96 ---------RLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE------ALQSGGTP  159 (405)
Q Consensus        96 ---------~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~------~~~~~gt~  159 (405)
                               .+++..+..++.||+.||+|||++||+||||||+|||++.++ +||+|||+++....      .....||+
T Consensus       180 ~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~  259 (359)
T 3vhe_A          180 EAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL  259 (359)
T ss_dssp             ----CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECG
T ss_pred             ccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCc
Confidence                     189999999999999999999999999999999999998877 99999999975422      22345788


Q ss_pred             CccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHhcccCcc
Q 015500          160 MFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPK  238 (405)
Q Consensus       160 ~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~L~~dP~  238 (405)
                      .|+|||++.+..++.++|||||||++|+|+| |+.||............+ .....+..|..+++++.++|.+||+.||.
T Consensus       260 ~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dP~  338 (359)
T 3vhe_A          260 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL-KEGTRMRAPDYTTPEMYQTMLDCWHGEPS  338 (359)
T ss_dssp             GGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHH-HHTCCCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred             eeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHH-HcCCCCCCCCCCCHHHHHHHHHHccCChh
Confidence            9999999999999999999999999999998 999997665444443333 34445567788999999999999999999


Q ss_pred             ccCCHHHHhcC
Q 015500          239 ERWAASQLLKH  249 (405)
Q Consensus       239 ~Rpt~~elL~h  249 (405)
                      +|||+.|+++|
T Consensus       339 ~Rps~~ell~~  349 (359)
T 3vhe_A          339 QRPTFSELVEH  349 (359)
T ss_dssp             GSCCHHHHHHH
T ss_pred             hCCCHHHHHHH
Confidence            99999999987

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.2e-46  Score=360.66  Aligned_cols=246  Identities=25%  Similarity=0.394  Sum_probs=204.2

Q ss_pred             CcccccccceeCCeeEEEEE----EcCCCCEEEEEEccCCCh---HHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEE
Q 015500            2 DWTRGHTIGQGSSATVSLAT----SLRSGDVFAAKSTELPKS---EFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMY   74 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~----~~~~~~~vavK~~~~~~~---~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~   74 (405)
                      +|++++.||+|+||+||+|+    +..+++.||||.+.....   +.+.+|+++|++++||||+++++++.......  +
T Consensus        11 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~--~   88 (295)
T 3ugc_A           11 HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN--L   88 (295)
T ss_dssp             GEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS--C
T ss_pred             HhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc--e
Confidence            58999999999999999998    567899999999876543   46789999999999999999999875443322  4


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc--
Q 015500           75 NLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE--  151 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~--  151 (405)
                      ++||||+++|+|.+++...+.++++..+..++.||+.||+|||++||+||||||+|||++.++ +||+|||+++....  
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  168 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK  168 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC------
T ss_pred             EEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccccccCCc
Confidence            589999999999999988766799999999999999999999999999999999999999888 99999999986533  


Q ss_pred             -----cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCh--------------HHHHHHHHhcC
Q 015500          152 -----ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADP--------------MTVLYKIAYSR  212 (405)
Q Consensus       152 -----~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~--------------~~~l~~i~~~~  212 (405)
                           .....+|+.|+|||++.+..+++++|||||||++|+|+||..||......              ...+.......
T Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (295)
T 3ugc_A          169 EFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN  248 (295)
T ss_dssp             -------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTT
T ss_pred             ceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhcc
Confidence                 12334777899999999999999999999999999999999998532110              00122222333


Q ss_pred             CCCCCchhccHHHHHHHHHhcccCccccCCHHHHhcC
Q 015500          213 ELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       213 ~~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      ..+..|..+++++.+||.+||+.||.+|||+.++++.
T Consensus       249 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~  285 (295)
T 3ugc_A          249 GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALR  285 (295)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             CcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            4455677899999999999999999999999999864

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-46  Score=366.61  Aligned_cols=242  Identities=24%  Similarity=0.326  Sum_probs=206.2

Q ss_pred             CcccccccceeCCeeEEEEEEc-----CCCCEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCce
Q 015500            2 DWTRGHTIGQGSSATVSLATSL-----RSGDVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKL   72 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~-----~~~~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~   72 (405)
                      +|++++.||+|+||+||+|.+.     .+++.||||.+....    .+.+.+|+.+|++++||||+++++++.....   
T Consensus        48 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~---  124 (343)
T 1luf_A           48 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP---  124 (343)
T ss_dssp             GCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS---
T ss_pred             HCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc---
Confidence            5889999999999999999987     355899999987643    3568899999999999999999998755433   


Q ss_pred             EEEEEEeecCCCCHHHHHHHcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCC
Q 015500           73 MYNLFMEYAPGGTLNDEIHRNG-----------------------GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSR  129 (405)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~i~~~~-----------------------~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~  129 (405)
                       +++||||+++|+|.+++....                       +++++..++.++.||+.||.|||++||+||||||+
T Consensus       125 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~  203 (343)
T 1luf_A          125 -MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR  203 (343)
T ss_dssp             -CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred             -eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcc
Confidence             569999999999999998742                       57999999999999999999999999999999999


Q ss_pred             CEEEccCC-ceEeeecccccccc------cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCh
Q 015500          130 NILMAESG-AKIADFGCAKWESE------ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADP  201 (405)
Q Consensus       130 NILi~~~~-vkL~DFGla~~~~~------~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~  201 (405)
                      |||++.++ +||+|||+++....      .....+|+.|+|||++.+..++.++|||||||++|+|++ |..||... ..
T Consensus       204 NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~-~~  282 (343)
T 1luf_A          204 NCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM-AH  282 (343)
T ss_dssp             GEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS-CH
T ss_pred             eEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCC-Ch
Confidence            99999887 99999999875432      223457889999999999899999999999999999999 99999644 33


Q ss_pred             HHHHHHHHhcCCCCCCchhccHHHHHHHHHhcccCccccCCHHHHhcC
Q 015500          202 MTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       202 ~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      ......+ .....+..|..+++++.+||++||+.||.+|||+.+++++
T Consensus       283 ~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~  329 (343)
T 1luf_A          283 EEVIYYV-RDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI  329 (343)
T ss_dssp             HHHHHHH-HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHH-hCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence            3333333 3445566788899999999999999999999999999875

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=6.6e-47  Score=360.74  Aligned_cols=245  Identities=20%  Similarity=0.318  Sum_probs=206.6

Q ss_pred             CcccccccceeCCeeEEEEEEcCCC-------CEEEEEEccCC---ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCc
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSG-------DVFAAKSTELP---KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNK   71 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~-------~~vavK~~~~~---~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~   71 (405)
                      +|.+++.||+|+||+||+|.++.++       ..+|+|.+...   ..+.+.+|+.+|++++||||+++++++.....  
T Consensus         9 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~--   86 (289)
T 4fvq_A            9 DLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE--   86 (289)
T ss_dssp             GEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC--
T ss_pred             HeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC--
Confidence            5889999999999999999998877       47999998643   34678899999999999999999998765443  


Q ss_pred             eEEEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC---------ceEee
Q 015500           72 LMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG---------AKIAD  142 (405)
Q Consensus        72 ~~~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~---------vkL~D  142 (405)
                        +++||||++||+|.+++.+.+..+++..+..++.||+.||.|||++||+||||||+|||++.++         +||+|
T Consensus        87 --~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~D  164 (289)
T 4fvq_A           87 --NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSD  164 (289)
T ss_dssp             --CEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECC
T ss_pred             --CEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeecc
Confidence              4589999999999999988765699999999999999999999999999999999999997765         89999


Q ss_pred             ecccccccccccCCCCCCccChhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhc
Q 015500          143 FGCAKWESEALQSGGTPMFMAPEVARG-EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFL  221 (405)
Q Consensus       143 FGla~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~  221 (405)
                      ||++..........||+.|+|||++.+ ..+++++|||||||++|+|++|..|+....+.........   ..+..|...
T Consensus       165 fg~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~---~~~~~~~~~  241 (289)
T 4fvq_A          165 PGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE---DRHQLPAPK  241 (289)
T ss_dssp             CCSCTTTSCHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH---TTCCCCCCS
T ss_pred             CcccccccCccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhh---ccCCCCCCC
Confidence            999987666555668999999999988 7789999999999999999996555544444433333322   233455667


Q ss_pred             cHHHHHHHHHhcccCccccCCHHHHhcCcccccc
Q 015500          222 SKQANDFLSNCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       222 s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      ++++.+||.+||+.||.+|||+.++++|  ++.+
T Consensus       242 ~~~l~~li~~~l~~dp~~Rps~~~ll~~--l~~l  273 (289)
T 4fvq_A          242 AAELANLINNCMDYEPDHRPSFRAIIRD--LNSL  273 (289)
T ss_dssp             SCTTHHHHHHHSCSSGGGSCCHHHHHHH--HHTC
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHHHH--HHHh
Confidence            8899999999999999999999999987  4444

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=7.1e-47  Score=376.40  Aligned_cols=242  Identities=24%  Similarity=0.373  Sum_probs=205.8

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLF   77 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv   77 (405)
                      +|.+++.||+|+||+||+|.++.+++.||||.+....    .+.+.+|+++|++++||||+++++++.....    +++|
T Consensus       115 ~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~----~~lv  190 (377)
T 3cbl_A          115 DLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQP----IYIV  190 (377)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSS----CEEE
T ss_pred             HeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCC----cEEE
Confidence            4788999999999999999999999999999987542    2357789999999999999999998754433    5699


Q ss_pred             EeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccccc---
Q 015500           78 MEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEAL---  153 (405)
Q Consensus        78 ~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~~---  153 (405)
                      |||++||+|.+++...+..+++..+..++.||+.||+|||++||+||||||+|||++.++ +||+|||+++......   
T Consensus       191 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~  270 (377)
T 3cbl_A          191 MELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAA  270 (377)
T ss_dssp             EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEEC
T ss_pred             EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceee
Confidence            999999999999988766799999999999999999999999999999999999999887 9999999997643311   


Q ss_pred             ---cCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHH
Q 015500          154 ---QSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFL  229 (405)
Q Consensus       154 ---~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll  229 (405)
                         ...+++.|+|||++.+..++.++|||||||++|||++ |..||..... ......+. ....+..|..+++.+.+||
T Consensus       271 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~l~~li  348 (377)
T 3cbl_A          271 SGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN-QQTREFVE-KGGRLPCPELCPDAVFRLM  348 (377)
T ss_dssp             CSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH-HHHHHHHH-TTCCCCCCTTCCHHHHHHH
T ss_pred             cCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHH-cCCCCCCCCCCCHHHHHHH
Confidence               1124667999999998889999999999999999998 9999975543 33333333 3344556778999999999


Q ss_pred             HHhcccCccccCCHHHHhcC
Q 015500          230 SNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       230 ~~~L~~dP~~Rpt~~elL~h  249 (405)
                      .+||+.||.+|||+.++++.
T Consensus       349 ~~cl~~dP~~Rps~~~i~~~  368 (377)
T 3cbl_A          349 EQCWAYEPGQRPSFSTIYQE  368 (377)
T ss_dssp             HHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHcCCCchhCcCHHHHHHH
Confidence            99999999999999999764

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=2e-46  Score=362.31  Aligned_cols=247  Identities=26%  Similarity=0.437  Sum_probs=207.5

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-----hHHHHHHHHHHHhCC--CCCeeeeeeeeeecCCCceEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-----SEFLQREQKFLSSLN--SPHIVGYKGCDVTSEDNKLMY   74 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-----~~~l~~E~~iL~~L~--hpnIv~~~~~~~~~~~~~~~~   74 (405)
                      +|++++.||+|+||+||+|.+. +++.||||.+....     .+.+.+|+++|++++  ||||+++++++....    .+
T Consensus        29 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~----~~  103 (313)
T 3cek_A           29 IYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ----YI  103 (313)
T ss_dssp             EEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSS----EE
T ss_pred             eEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCC----EE
Confidence            4899999999999999999985 58999999986532     356889999999997  599999998776533    36


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCCceEeeeccccccccc--
Q 015500           75 NLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGAKIADFGCAKWESEA--  152 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~vkL~DFGla~~~~~~--  152 (405)
                      +++|| +.+++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++++.+||+|||+++.....  
T Consensus       104 ~lv~e-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~kL~Dfg~~~~~~~~~~  181 (313)
T 3cek_A          104 YMVME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTT  181 (313)
T ss_dssp             EEEEC-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTEEEECCCSSSCC------
T ss_pred             EEEEe-cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEECCeEEEeeccccccccCccc
Confidence            79999 5588999999876 4899999999999999999999999999999999999997655999999999864432  


Q ss_pred             ----ccCCCCCCccChhhhcC-----------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCC
Q 015500          153 ----LQSGGTPMFMAPEVARG-----------EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEV  217 (405)
Q Consensus       153 ----~~~~gt~~Y~APE~l~~-----------~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~  217 (405)
                          ....||+.|+|||++.+           ..++.++|||||||++|+|++|+.||.........+..+.........
T Consensus       182 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  261 (313)
T 3cek_A          182 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF  261 (313)
T ss_dssp             --------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCC
T ss_pred             cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccccCC
Confidence                23468999999999976           467889999999999999999999997766666666555555555566


Q ss_pred             chhccHHHHHHHHHhcccCccccCCHHHHhcCcccccc
Q 015500          218 PAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       218 p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      |...++++.+||.+||+.||.+|||+.++|+||||+..
T Consensus       262 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~  299 (313)
T 3cek_A          262 PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  299 (313)
T ss_dssp             CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred             cccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence            77789999999999999999999999999999999854

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.7e-46  Score=366.18  Aligned_cols=241  Identities=24%  Similarity=0.357  Sum_probs=200.7

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEE----EEEEccCC----ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVF----AAKSTELP----KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLM   73 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~v----avK~~~~~----~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~   73 (405)
                      +|++.+.||+|+||+||+|++..+++.+    |+|.+...    ....+.+|+.+|++++||||+++++++....     
T Consensus        16 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----   90 (327)
T 3poz_A           16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-----   90 (327)
T ss_dssp             GEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-----
T ss_pred             HcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-----
Confidence            5899999999999999999998887754    77776432    3467889999999999999999999876432     


Q ss_pred             EEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc
Q 015500           74 YNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA  152 (405)
Q Consensus        74 ~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~  152 (405)
                      .++++||+++|+|.+++....+.+++..+..++.||+.||.|||++||+||||||+|||++.++ +||+|||+++.....
T Consensus        91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~  170 (327)
T 3poz_A           91 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE  170 (327)
T ss_dssp             EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTT
T ss_pred             eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccCC
Confidence            4589999999999999998777899999999999999999999999999999999999999888 999999999764331


Q ss_pred             ------ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHH
Q 015500          153 ------LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQA  225 (405)
Q Consensus       153 ------~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l  225 (405)
                            ....+|+.|+|||++.+..++.++|||||||++|||+| |+.||..... .. +.........+..+..++.++
T Consensus       171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~  248 (327)
T 3poz_A          171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SE-ISSILEKGERLPQPPICTIDV  248 (327)
T ss_dssp             CC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG-GG-HHHHHHTTCCCCCCTTBCHHH
T ss_pred             cccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCH-HH-HHHHHHcCCCCCCCccCCHHH
Confidence                  22346889999999999999999999999999999999 9999965432 22 233333344445677799999


Q ss_pred             HHHHHHhcccCccccCCHHHHhcC
Q 015500          226 NDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       226 ~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      .+++.+||+.||.+|||+.+++++
T Consensus       249 ~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          249 YMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             HHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             HHHHHHHcCCChhhCCCHHHHHHH
Confidence            999999999999999999999987

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=3.5e-46  Score=352.49  Aligned_cols=239  Identities=29%  Similarity=0.516  Sum_probs=198.5

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC-------ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP-------KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMY   74 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~-------~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~   74 (405)
                      +|++.+.||+|+||+||+|.+.  ++.+|||.+...       ..+.+.+|+++++.++||||+++++++.....    +
T Consensus         8 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~   81 (271)
T 3dtc_A            8 ELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPN----L   81 (271)
T ss_dssp             SEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC------C
T ss_pred             heeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCc----e
Confidence            6899999999999999999975  889999987643       23578899999999999999999998764432    5


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCCCCEEEcc--------CC-ceEee
Q 015500           75 NLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNR---VVHCDIKSRNILMAE--------SG-AKIAD  142 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~g---ivHrDlkp~NILi~~--------~~-vkL~D  142 (405)
                      ++||||++|++|.+++..  +++++..+..++.||+.||.|||++|   |+||||||+|||++.        ++ +||+|
T Consensus        82 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D  159 (271)
T 3dtc_A           82 CLVMEFARGGPLNRVLSG--KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD  159 (271)
T ss_dssp             EEEEECCTTEEHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred             EEEEEcCCCCCHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence            699999999999998854  47999999999999999999999999   899999999999985        34 99999


Q ss_pred             ecccccccc--cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchh
Q 015500          143 FGCAKWESE--ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAF  220 (405)
Q Consensus       143 FGla~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~  220 (405)
                      ||+++....  .....||+.|+|||++.+..+++++|||||||++|+|++|+.||... +..............+..+..
T Consensus       160 fg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~  238 (271)
T 3dtc_A          160 FGLAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI-DGLAVAYGVAMNKLALPIPST  238 (271)
T ss_dssp             CCC-------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTS-CHHHHHHHHHTSCCCCCCCTT
T ss_pred             CCcccccccccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHhhhcCCCCCCCCcc
Confidence            999976443  23456999999999999999999999999999999999999999654 344445555555555667788


Q ss_pred             ccHHHHHHHHHhcccCccccCCHHHHhcC
Q 015500          221 LSKQANDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       221 ~s~~l~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      +++.+.++|.+||+.||.+|||+.|+++|
T Consensus       239 ~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          239 CPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence            99999999999999999999999999876

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=6.2e-46  Score=349.67  Aligned_cols=241  Identities=25%  Similarity=0.378  Sum_probs=207.3

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC--ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEe
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP--KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFME   79 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~--~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (405)
                      +|++.+.||+|+||+||+|.+. +++.+|+|.+...  ..+.+.+|++++++++||||+++++++.....    ++++||
T Consensus         9 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~lv~e   83 (267)
T 3t9t_A            9 ELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP----ICLVTE   83 (267)
T ss_dssp             GEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS----CEEEEC
T ss_pred             heeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC----eEEEEe
Confidence            5889999999999999999986 6788999998764  35689999999999999999999998765433    569999


Q ss_pred             ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc-----cc
Q 015500           80 YAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE-----AL  153 (405)
Q Consensus        80 y~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~-----~~  153 (405)
                      |+++++|.+++....+.+++..+..++.||+.||.|||++|++||||||+||+++.++ +||+|||++.....     ..
T Consensus        84 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~  163 (267)
T 3t9t_A           84 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST  163 (267)
T ss_dssp             CCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTT
T ss_pred             CCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccccccccc
Confidence            9999999999988767899999999999999999999999999999999999998877 99999999986433     22


Q ss_pred             cCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHh
Q 015500          154 QSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNC  232 (405)
Q Consensus       154 ~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~  232 (405)
                      ...+|+.|+|||++.+..+++++|||||||++|+|++ |+.||... ........+.. ...+..|...++.+.+++.+|
T Consensus       164 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~-~~~~~~~~i~~-~~~~~~~~~~~~~l~~li~~~  241 (267)
T 3t9t_A          164 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR-SNSEVVEDIST-GFRLYKPRLASTHVYQIMNHC  241 (267)
T ss_dssp             STTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-CHHHHHHHHHT-TCCCCCCTTSCHHHHHHHHHH
T ss_pred             cccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCC-CHHHHHHHHhc-CCcCCCCccCcHHHHHHHHHH
Confidence            3457888999999998899999999999999999999 89999644 33444444433 333455677899999999999


Q ss_pred             cccCccccCCHHHHhcC
Q 015500          233 LRRDPKERWAASQLLKH  249 (405)
Q Consensus       233 L~~dP~~Rpt~~elL~h  249 (405)
                      |+.||.+|||+.+++++
T Consensus       242 l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          242 WRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             TCSSGGGSCCHHHHHHH
T ss_pred             ccCChhhCcCHHHHHHH
Confidence            99999999999999876

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=2.4e-46  Score=372.93  Aligned_cols=248  Identities=25%  Similarity=0.357  Sum_probs=201.4

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC--hHHHHHHHHHHHhCC-CC-----CeeeeeeeeeecCCCceE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK--SEFLQREQKFLSSLN-SP-----HIVGYKGCDVTSEDNKLM   73 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~--~~~l~~E~~iL~~L~-hp-----nIv~~~~~~~~~~~~~~~   73 (405)
                      +|++++.||+|+||+||+|.++.+++.||||++....  ...+.+|+.+++.++ |+     +|+++++.+....    .
T Consensus        55 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~----~  130 (382)
T 2vx3_A           55 RYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN----H  130 (382)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT----E
T ss_pred             eEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC----c
Confidence            5889999999999999999999999999999987543  356778999998885 55     4888888776543    3


Q ss_pred             EEEEEeecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHH--hCCceeCCCCCCCEEEcc--CC-ceEeeecccc
Q 015500           74 YNLFMEYAPGGTLNDEIHRNG-GRLDESLIVSYTRQILQGLEYLH--SNRVVHCDIKSRNILMAE--SG-AKIADFGCAK  147 (405)
Q Consensus        74 ~~lv~Ey~~ggsL~~~i~~~~-~~l~e~~~~~i~~qIl~~L~yLH--~~givHrDlkp~NILi~~--~~-vkL~DFGla~  147 (405)
                      +++||||+++ +|.+++.... +.+++..++.++.||+.||.|||  +.||+||||||+|||++.  ++ +||+|||+++
T Consensus       131 ~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~  209 (382)
T 2vx3_A          131 LCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC  209 (382)
T ss_dssp             EEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred             eEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCce
Confidence            6799999965 9999998753 46999999999999999999999  579999999999999954  44 9999999998


Q ss_pred             cccc-cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCC----------
Q 015500          148 WESE-ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPE----------  216 (405)
Q Consensus       148 ~~~~-~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~----------  216 (405)
                      .... .....||+.|+|||++.+..++.++|||||||++|||+||+.||.... ....+.++......+.          
T Consensus       210 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~  288 (382)
T 2vx3_A          210 QLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN-EVDQMNKIVEVLGIPPAHILDQAPKA  288 (382)
T ss_dssp             ETTCCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHHHCSCCHHHHTTCTTH
T ss_pred             ecccccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhCCCCHHHHHhhHHH
Confidence            7554 345679999999999999999999999999999999999999996543 3333333322111100          


Q ss_pred             ------Cc----------------------------------------------hhccHHHHHHHHHhcccCccccCCHH
Q 015500          217 ------VP----------------------------------------------AFLSKQANDFLSNCLRRDPKERWAAS  244 (405)
Q Consensus       217 ------~p----------------------------------------------~~~s~~l~dll~~~L~~dP~~Rpt~~  244 (405)
                            +|                                              ...++++++||.+||+.||++|||++
T Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~  368 (382)
T 2vx3_A          289 RKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPY  368 (382)
T ss_dssp             HHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHH
T ss_pred             HHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCHH
Confidence                  00                                              00124789999999999999999999


Q ss_pred             HHhcCcccccc
Q 015500          245 QLLKHPFLEEF  255 (405)
Q Consensus       245 elL~hp~~~~~  255 (405)
                      |+|+||||+..
T Consensus       369 e~L~hp~f~~~  379 (382)
T 2vx3_A          369 YALQHSFFKKT  379 (382)
T ss_dssp             HHTTSGGGCC-
T ss_pred             HHhcCcccccC
Confidence            99999999864

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=2.1e-46  Score=361.10  Aligned_cols=242  Identities=27%  Similarity=0.391  Sum_probs=205.2

Q ss_pred             CcccccccceeCCeeEEEEEEc-----CCCCEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCce
Q 015500            2 DWTRGHTIGQGSSATVSLATSL-----RSGDVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKL   72 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~-----~~~~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~   72 (405)
                      +|.+++.||+|+||+||+|.+.     .+++.||||.+....    .+.+.+|+++|++++||||+++++++.....   
T Consensus        24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~---  100 (314)
T 2ivs_A           24 NLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP---  100 (314)
T ss_dssp             GEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS---
T ss_pred             heeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc---
Confidence            5889999999999999999984     455899999987543    2568899999999999999999998754433   


Q ss_pred             EEEEEEeecCCCCHHHHHHHcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCC
Q 015500           73 MYNLFMEYAPGGTLNDEIHRNG-----------------------GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSR  129 (405)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~i~~~~-----------------------~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~  129 (405)
                       +++||||++|++|.+++....                       ..+++..+..++.||+.||.|||++||+||||||+
T Consensus       101 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~  179 (314)
T 2ivs_A          101 -LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAAR  179 (314)
T ss_dssp             -CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred             -eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchh
Confidence             569999999999999998753                       23899999999999999999999999999999999


Q ss_pred             CEEEccCC-ceEeeecccccccc------cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCh
Q 015500          130 NILMAESG-AKIADFGCAKWESE------ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADP  201 (405)
Q Consensus       130 NILi~~~~-vkL~DFGla~~~~~------~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~  201 (405)
                      ||+++.++ +||+|||+++....      .....+|+.|+|||++.+..+++++|||||||++|+|++ |..||..... 
T Consensus       180 NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~-  258 (314)
T 2ivs_A          180 NILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP-  258 (314)
T ss_dssp             GEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG-
T ss_pred             eEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH-
Confidence            99999887 99999999975432      223457888999999999889999999999999999999 9999965432 


Q ss_pred             HHHHHHHHhcCCCCCCchhccHHHHHHHHHhcccCccccCCHHHHhcC
Q 015500          202 MTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       202 ~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      .... ........+..+..+++++.++|.+||+.||.+|||+.+++++
T Consensus       259 ~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          259 ERLF-NLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             GGHH-HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHH-HHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            2222 3333444556778899999999999999999999999999886

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=2.8e-46  Score=355.93  Aligned_cols=241  Identities=25%  Similarity=0.360  Sum_probs=196.0

Q ss_pred             CcccccccceeCCeeEEEEEEcCC---CCEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRS---GDVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMY   74 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~---~~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~   74 (405)
                      +|++++.||+|+||+||+|.+..+   +..+|+|......    .+.+.+|+.++++++||||+++++++..   +.  +
T Consensus        16 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~--~   90 (281)
T 1mp8_A           16 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE---NP--V   90 (281)
T ss_dssp             GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS---SS--C
T ss_pred             HeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc---Cc--c
Confidence            588999999999999999998654   4579999986543    3468899999999999999999987532   12  4


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc-
Q 015500           75 NLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA-  152 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~-  152 (405)
                      ++||||+++++|.+++...+..+++..+..++.||+.||.|||++||+||||||+|||++.++ +||+|||+++..... 
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  170 (281)
T 1mp8_A           91 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST  170 (281)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred             EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCccc
Confidence            589999999999999988766899999999999999999999999999999999999999887 999999999865432 


Q ss_pred             ----ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHH
Q 015500          153 ----LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQAND  227 (405)
Q Consensus       153 ----~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~d  227 (405)
                          ....+|+.|+|||++.+..++.++|||||||++|+|++ |..||..... ......+.. ...+..+..+++.+.+
T Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~-~~~~~~i~~-~~~~~~~~~~~~~l~~  248 (281)
T 1mp8_A          171 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-NDVIGRIEN-GERLPMPPNCPPTLYS  248 (281)
T ss_dssp             --------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG-GGHHHHHHT-TCCCCCCTTCCHHHHH
T ss_pred             ccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCH-HHHHHHHHc-CCCCCCCCCCCHHHHH
Confidence                23347789999999999899999999999999999997 9999965443 333334333 3345567789999999


Q ss_pred             HHHHhcccCccccCCHHHHhcC
Q 015500          228 FLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       228 ll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      ||.+||..||.+|||+.+++++
T Consensus       249 li~~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          249 LMTKCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHccCChhhCcCHHHHHHH
Confidence            9999999999999999999875

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.6e-46  Score=365.51  Aligned_cols=244  Identities=22%  Similarity=0.272  Sum_probs=200.3

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCCh--HHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEe
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS--EFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFME   79 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~~--~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (405)
                      +|++++.||+|+||+||+|++.  ++.||||.+.....  ....+|+.+|++++||||+++++++.........+++|||
T Consensus        25 ~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e  102 (322)
T 3soc_A           25 PLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITA  102 (322)
T ss_dssp             EEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred             hchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEe
Confidence            5899999999999999999875  79999999876543  3456688889999999999999998876654555779999


Q ss_pred             ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC----------CceeCCCCCCCEEEccCC-ceEeeeccccc
Q 015500           80 YAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN----------RVVHCDIKSRNILMAESG-AKIADFGCAKW  148 (405)
Q Consensus        80 y~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~----------givHrDlkp~NILi~~~~-vkL~DFGla~~  148 (405)
                      |+++|+|.+++...  ++++..+..++.||+.||+|||+.          ||+||||||+|||++.++ +||+|||+++.
T Consensus       103 ~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~  180 (322)
T 3soc_A          103 FHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALK  180 (322)
T ss_dssp             CCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             cCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcccc
Confidence            99999999999775  599999999999999999999999          999999999999999887 99999999975


Q ss_pred             ccc------cccCCCCCCccChhhhcCC-----CCCcchhHHHHHHHHHHHHhCCCCCCCCCC---------------hH
Q 015500          149 ESE------ALQSGGTPMFMAPEVARGE-----HQGFASDIWAVGCTVIEMASGGAPWPNAAD---------------PM  202 (405)
Q Consensus       149 ~~~------~~~~~gt~~Y~APE~l~~~-----~~~~~sDIwSLG~il~elltG~~Pf~~~~~---------------~~  202 (405)
                      ...      .....||+.|+|||++.+.     .++.++|||||||++|||+||+.||....+               ..
T Consensus       181 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  260 (322)
T 3soc_A          181 FEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLE  260 (322)
T ss_dssp             ECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHH
T ss_pred             cccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchh
Confidence            433      2235699999999999873     455688999999999999999999964321               12


Q ss_pred             HHHHHHHhcCCCCCCchh-----ccHHHHHHHHHhcccCccccCCHHHHhcC
Q 015500          203 TVLYKIAYSRELPEVPAF-----LSKQANDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       203 ~~l~~i~~~~~~~~~p~~-----~s~~l~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      ............|.++..     .++++.+||.+||+.||.+|||+.++++.
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  312 (322)
T 3soc_A          261 DMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGER  312 (322)
T ss_dssp             HHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            222222233333433332     35669999999999999999999999874

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.8e-46  Score=365.83  Aligned_cols=241  Identities=21%  Similarity=0.286  Sum_probs=201.3

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC-ChHHHHHHHHHHHhC-CCCCeeeeeeeeeecCCCceEEEEEEe
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP-KSEFLQREQKFLSSL-NSPHIVGYKGCDVTSEDNKLMYNLFME   79 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~-~~~~l~~E~~iL~~L-~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (405)
                      +|++++.||+|+||+||+|.+..+|+.||||.+... ..+.+.+|+.+++.| +||||+++++++....    .+++|||
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~----~~~lv~e   85 (330)
T 2izr_A           10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGK----YNAMVLE   85 (330)
T ss_dssp             TEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETT----EEEEEEE
T ss_pred             CeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecCC----ccEEEEE
Confidence            589999999999999999999999999999998643 345799999999999 9999999998876533    3679999


Q ss_pred             ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC------ceEeeeccccccccc-
Q 015500           80 YAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG------AKIADFGCAKWESEA-  152 (405)
Q Consensus        80 y~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~------vkL~DFGla~~~~~~-  152 (405)
                      |+ +++|.+++...++.+++..++.++.||+.||+|||++||+||||||+|||++.++      +||+|||+++..... 
T Consensus        86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~  164 (330)
T 2izr_A           86 LL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPE  164 (330)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTT
T ss_pred             eC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCC
Confidence            99 9999999988667899999999999999999999999999999999999998664      899999999864321 


Q ss_pred             ----------ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC--ChHHHHHHHHhcCC-C--CCC
Q 015500          153 ----------LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAA--DPMTVLYKIAYSRE-L--PEV  217 (405)
Q Consensus       153 ----------~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~--~~~~~l~~i~~~~~-~--~~~  217 (405)
                                ....||+.|+|||++.+..++.++|||||||++|||++|+.||....  ........+..... .  ...
T Consensus       165 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~  244 (330)
T 2izr_A          165 TKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVL  244 (330)
T ss_dssp             TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHHHH
T ss_pred             CCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHHHH
Confidence                      24569999999999999999999999999999999999999997643  22333333321111 1  111


Q ss_pred             chhccHHHHHHHHHhcccCccccCCHHHHhc
Q 015500          218 PAFLSKQANDFLSNCLRRDPKERWAASQLLK  248 (405)
Q Consensus       218 p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~  248 (405)
                      ...++ ++.+||.+||..||.+||+++++++
T Consensus       245 ~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          245 CENFP-EMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             TTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             hccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            12245 9999999999999999999999876

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.7e-46  Score=364.93  Aligned_cols=244  Identities=24%  Similarity=0.324  Sum_probs=206.0

Q ss_pred             CcccccccceeCCeeEEEEEEc-----CCCCEEEEEEccCC----ChHHHHHHHHHHHhC-CCCCeeeeeeeeeecCCCc
Q 015500            2 DWTRGHTIGQGSSATVSLATSL-----RSGDVFAAKSTELP----KSEFLQREQKFLSSL-NSPHIVGYKGCDVTSEDNK   71 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~-----~~~~~vavK~~~~~----~~~~l~~E~~iL~~L-~hpnIv~~~~~~~~~~~~~   71 (405)
                      +|.+++.||+|+||+||+|.+.     .++..||||.+...    ..+.+.+|+.+|+++ +||||+++++++.....  
T Consensus        46 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~--  123 (344)
T 1rjb_A           46 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP--  123 (344)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS--
T ss_pred             HceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCc--
Confidence            4788999999999999999973     45678999998643    346789999999999 99999999998765433  


Q ss_pred             eEEEEEEeecCCCCHHHHHHHcCC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCC
Q 015500           72 LMYNLFMEYAPGGTLNDEIHRNGG----------------------RLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSR  129 (405)
Q Consensus        72 ~~~~lv~Ey~~ggsL~~~i~~~~~----------------------~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~  129 (405)
                        +++||||+++|+|.+++.....                      .+++..+..++.||+.||.|||++||+||||||+
T Consensus       124 --~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~  201 (344)
T 1rjb_A          124 --IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR  201 (344)
T ss_dssp             --CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred             --cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChh
Confidence              5699999999999999987543                      3789999999999999999999999999999999


Q ss_pred             CEEEccCC-ceEeeeccccccccc------ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCh
Q 015500          130 NILMAESG-AKIADFGCAKWESEA------LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADP  201 (405)
Q Consensus       130 NILi~~~~-vkL~DFGla~~~~~~------~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~  201 (405)
                      |||++.++ +||+|||++......      ....||+.|+|||++.+..+++++|||||||++|+|+| |..||......
T Consensus       202 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~  281 (344)
T 1rjb_A          202 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD  281 (344)
T ss_dssp             GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred             hEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcH
Confidence            99999888 999999999764332      22347889999999999999999999999999999998 99999766544


Q ss_pred             HHHHHHHHhcCCCCCCchhccHHHHHHHHHhcccCccccCCHHHHhcCc
Q 015500          202 MTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHP  250 (405)
Q Consensus       202 ~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp  250 (405)
                      ... .........+..|..+++++.+||.+||..||.+|||+.++++|.
T Consensus       282 ~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l  329 (344)
T 1rjb_A          282 ANF-YKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL  329 (344)
T ss_dssp             HHH-HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHH-HHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence            333 333334445566778999999999999999999999999999873

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=6.7e-46  Score=355.00  Aligned_cols=243  Identities=19%  Similarity=0.238  Sum_probs=205.1

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC-ChHHHHHHHHHHHhC-CCCCeeeeeeeeeecCCCceEEEEEEe
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP-KSEFLQREQKFLSSL-NSPHIVGYKGCDVTSEDNKLMYNLFME   79 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~-~~~~l~~E~~iL~~L-~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (405)
                      +|++++.||+|+||+||+|.+..+++.||||.+... ..+.+.+|+.+++.+ +|||++++++++....    .+++|||
T Consensus        11 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~----~~~lv~e   86 (298)
T 1csn_A           11 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGL----HNVLVID   86 (298)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETT----EEEEEEE
T ss_pred             ceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCc----eeEEEEE
Confidence            589999999999999999999999999999988643 446789999999999 8999999998765433    3669999


Q ss_pred             ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC------ceEeeecccccccc--
Q 015500           80 YAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG------AKIADFGCAKWESE--  151 (405)
Q Consensus        80 y~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~------vkL~DFGla~~~~~--  151 (405)
                      |+ +++|.+++...+.++++..+..++.||+.||.|||++||+||||||+|||++.++      +||+|||+++....  
T Consensus        87 ~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~  165 (298)
T 1csn_A           87 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV  165 (298)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred             ec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccccc
Confidence            99 9999999998776899999999999999999999999999999999999997543      99999999976433  


Q ss_pred             ---------cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC--ChHHHHHHHHhc---CCCCCC
Q 015500          152 ---------ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAA--DPMTVLYKIAYS---RELPEV  217 (405)
Q Consensus       152 ---------~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~--~~~~~l~~i~~~---~~~~~~  217 (405)
                               .....||+.|+|||++.+..+++++|||||||++|+|++|+.||....  ........+...   ...+..
T Consensus       166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (298)
T 1csn_A          166 TKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL  245 (298)
T ss_dssp             TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHH
T ss_pred             ccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHHH
Confidence                     123459999999999999999999999999999999999999997643  233333333222   222233


Q ss_pred             chhccHHHHHHHHHhcccCccccCCHHHHhcC
Q 015500          218 PAFLSKQANDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       218 p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      +..+++++.+||.+||+.||.+|||++++++.
T Consensus       246 ~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~  277 (298)
T 1csn_A          246 CAGFPEEFYKYMHYARNLAFDATPDYDYLQGL  277 (298)
T ss_dssp             TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred             HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            34689999999999999999999999999765

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=9.5e-46  Score=357.16  Aligned_cols=249  Identities=28%  Similarity=0.446  Sum_probs=194.4

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCCh-----HHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS-----EFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~~-----~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      +|++++.||+|+||+||+|.++.+|+.||||.+.....     ..+.++..+++.++||||+++++++....    .+++
T Consensus        26 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~----~~~l  101 (318)
T 2dyl_A           26 DLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNT----DVFI  101 (318)
T ss_dssp             GEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS----EEEE
T ss_pred             cccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC----cEEE
Confidence            58889999999999999999999999999999875432     23445556788889999999999876543    3679


Q ss_pred             EEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCCCCEEEccCC-ceEeeecccccccc---
Q 015500           77 FMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN-RVVHCDIKSRNILMAESG-AKIADFGCAKWESE---  151 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~-givHrDlkp~NILi~~~~-vkL~DFGla~~~~~---  151 (405)
                      ||||+ ++.+..+.....+.+++..+..++.||+.||.|||++ ||+||||||+||+++.++ +||+|||++.....   
T Consensus       102 v~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  180 (318)
T 2dyl_A          102 AMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA  180 (318)
T ss_dssp             EECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred             EEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCcc
Confidence            99999 6677776666567899999999999999999999996 999999999999999887 99999999975433   


Q ss_pred             cccCCCCCCccChhhhc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCc--hhccHH
Q 015500          152 ALQSGGTPMFMAPEVAR-----GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVP--AFLSKQ  224 (405)
Q Consensus       152 ~~~~~gt~~Y~APE~l~-----~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p--~~~s~~  224 (405)
                      .....||+.|+|||++.     +..+++++|||||||++|+|++|+.||.........+..+... ..+..|  ..++++
T Consensus       181 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  259 (318)
T 2dyl_A          181 KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQE-EPPLLPGHMGFSGD  259 (318)
T ss_dssp             ------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHS-CCCCCCSSSCCCHH
T ss_pred             ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhcc-CCCCCCccCCCCHH
Confidence            23446999999999995     4568889999999999999999999997766655555554433 333333  357999


Q ss_pred             HHHHHHHhcccCccccCCHHHHhcCccccccc
Q 015500          225 ANDFLSNCLRRDPKERWAASQLLKHPFLEEFC  256 (405)
Q Consensus       225 l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~  256 (405)
                      +.+||.+||+.||.+|||++++++||||+...
T Consensus       260 l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  291 (318)
T 2dyl_A          260 FQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYE  291 (318)
T ss_dssp             HHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHH
T ss_pred             HHHHHHHHccCChhHCcCHHHHhhCHHHHhcc
Confidence            99999999999999999999999999998653

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-45  Score=368.25  Aligned_cols=242  Identities=25%  Similarity=0.402  Sum_probs=206.2

Q ss_pred             CcccccccceeCCeeEEEEEEcCC-------CCEEEEEEccCCCh----HHHHHHHHHHHhC-CCCCeeeeeeeeeecCC
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRS-------GDVFAAKSTELPKS----EFLQREQKFLSSL-NSPHIVGYKGCDVTSED   69 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~-------~~~vavK~~~~~~~----~~l~~E~~iL~~L-~hpnIv~~~~~~~~~~~   69 (405)
                      +|.+++.||+|+||+||+|.+..+       +..||||.+.....    ..+.+|+++++++ +||||+++++++.....
T Consensus        70 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~  149 (382)
T 3tt0_A           70 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP  149 (382)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             heEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCc
Confidence            478899999999999999997643       35799999875432    4688999999999 99999999998765433


Q ss_pred             CceEEEEEEeecCCCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEc
Q 015500           70 NKLMYNLFMEYAPGGTLNDEIHRNG---------------GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMA  134 (405)
Q Consensus        70 ~~~~~~lv~Ey~~ggsL~~~i~~~~---------------~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~  134 (405)
                          +++||||++||+|.+++....               ..+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus       150 ----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~  225 (382)
T 3tt0_A          150 ----LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT  225 (382)
T ss_dssp             ----CEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred             ----eEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEc
Confidence                569999999999999998753               3599999999999999999999999999999999999999


Q ss_pred             cCC-ceEeeecccccccc------cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHH
Q 015500          135 ESG-AKIADFGCAKWESE------ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLY  206 (405)
Q Consensus       135 ~~~-vkL~DFGla~~~~~------~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~  206 (405)
                      .++ +||+|||+++....      .....+|+.|+|||++.+..++.++|||||||++|+|++ |..||... .... +.
T Consensus       226 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~-~~~~-~~  303 (382)
T 3tt0_A          226 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEE-LF  303 (382)
T ss_dssp             TTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-CHHH-HH
T ss_pred             CCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-CHHH-HH
Confidence            887 99999999986433      223447889999999999999999999999999999999 99999644 3333 33


Q ss_pred             HHHhcCCCCCCchhccHHHHHHHHHhcccCccccCCHHHHhcC
Q 015500          207 KIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       207 ~i~~~~~~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      ........+..|..+++++.+||.+||+.||.+|||+.|++++
T Consensus       304 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          304 KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             HHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            4444445566778899999999999999999999999999987

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=2.9e-46  Score=369.72  Aligned_cols=246  Identities=21%  Similarity=0.288  Sum_probs=199.2

Q ss_pred             CcccccccceeCCeeEEEEEEcCC-----CCEEEEEEccCCChH--------------HHHHHHHHHHhCCCCCeeeeee
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRS-----GDVFAAKSTELPKSE--------------FLQREQKFLSSLNSPHIVGYKG   62 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~-----~~~vavK~~~~~~~~--------------~l~~E~~iL~~L~hpnIv~~~~   62 (405)
                      +|++++.||+|+||+||+|.++.+     ++.||||.+......              ...+|+..++.++||||+++++
T Consensus        36 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~  115 (364)
T 3op5_A           36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWG  115 (364)
T ss_dssp             EEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEE
T ss_pred             eEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEe
Confidence            589999999999999999998765     588999998765421              2223445666778999999999


Q ss_pred             eeeecCCCceEEEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEc--cCC-ce
Q 015500           63 CDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMA--ESG-AK  139 (405)
Q Consensus        63 ~~~~~~~~~~~~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~--~~~-vk  139 (405)
                      ++.....+..++++||||+ |++|.+++...++++++..++.++.||+.||+|||++||+||||||+|||++  .++ +|
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~k  194 (364)
T 3op5_A          116 SGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVY  194 (364)
T ss_dssp             EEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCEE
T ss_pred             eeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeEE
Confidence            9887766666788999999 9999999988777899999999999999999999999999999999999998  555 99


Q ss_pred             Eeeeccccccccc-----------ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHH--
Q 015500          140 IADFGCAKWESEA-----------LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLY--  206 (405)
Q Consensus       140 L~DFGla~~~~~~-----------~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~--  206 (405)
                      |+|||+++.....           ....||+.|+|||++.+..++.++|||||||++|||+||+.||...........  
T Consensus       195 l~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~~  274 (364)
T 3op5_A          195 LVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDS  274 (364)
T ss_dssp             ECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHH
T ss_pred             EEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHHHH
Confidence            9999999754331           223499999999999999999999999999999999999999975332222211  


Q ss_pred             HHHhcCCCCCC------chhccHHHHHHHHHhcccCccccCCHHHHhc
Q 015500          207 KIAYSRELPEV------PAFLSKQANDFLSNCLRRDPKERWAASQLLK  248 (405)
Q Consensus       207 ~i~~~~~~~~~------p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~  248 (405)
                      ........+.+      +..+++++.+|+.+||..||.+||++.++++
T Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          275 KIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             HHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            11111111111      1346899999999999999999999999976

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.3e-46  Score=366.36  Aligned_cols=241  Identities=23%  Similarity=0.339  Sum_probs=203.0

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCE----EEEEEccCC----ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDV----FAAKSTELP----KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLM   73 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~----vavK~~~~~----~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~   73 (405)
                      +|++++.||+|+||+||+|.+..+++.    +|+|.+...    ....+.+|+.++++++||||+++++++.. ..    
T Consensus        14 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~----   88 (325)
T 3kex_A           14 ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SS----   88 (325)
T ss_dssp             TEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-SS----
T ss_pred             HceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-Cc----
Confidence            689999999999999999999888876    777776432    23567889999999999999999997642 21    


Q ss_pred             EEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc
Q 015500           74 YNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA  152 (405)
Q Consensus        74 ~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~  152 (405)
                      +++||||+++|+|.+++....+.+++..+..++.||+.||+|||++||+||||||+|||++.++ +||+|||+++.....
T Consensus        89 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  168 (325)
T 3kex_A           89 LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD  168 (325)
T ss_dssp             EEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCC
T ss_pred             cEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCcc
Confidence            5589999999999999987666899999999999999999999999999999999999998887 999999999865331


Q ss_pred             ------ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHH
Q 015500          153 ------LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQA  225 (405)
Q Consensus       153 ------~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l  225 (405)
                            ....||+.|+|||++.+..++.++|||||||++|+|+| |+.||...... .....+ .....+..|..++.++
T Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~  246 (325)
T 3kex_A          169 DKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA-EVPDLL-EKGERLAQPQICTIDV  246 (325)
T ss_dssp             TTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT-HHHHHH-HTTCBCCCCTTBCTTT
T ss_pred             cccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH-HHHHHH-HcCCCCCCCCcCcHHH
Confidence                  23457889999999999999999999999999999999 99999654432 222232 3334456677789999


Q ss_pred             HHHHHHhcccCccccCCHHHHhcC
Q 015500          226 NDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       226 ~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      .++|.+||..||.+|||+.++++|
T Consensus       247 ~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          247 YMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             THHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             HHHHHHHcCCChhhCcCHHHHHHH
Confidence            999999999999999999999987

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=7e-46  Score=362.17  Aligned_cols=241  Identities=24%  Similarity=0.361  Sum_probs=201.0

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEE----EEEEccC----CChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVF----AAKSTEL----PKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLM   73 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~v----avK~~~~----~~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~   73 (405)
                      +|++++.||+|+||+||+|.+..+++.+    |+|.+..    .....+.+|+.+|++++||||+++++++....     
T Consensus        16 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-----   90 (327)
T 3lzb_A           16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-----   90 (327)
T ss_dssp             TEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-----
T ss_pred             HceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-----
Confidence            6899999999999999999998888755    6666543    24567899999999999999999999876432     


Q ss_pred             EEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc-
Q 015500           74 YNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE-  151 (405)
Q Consensus        74 ~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~-  151 (405)
                      +++++||+++|+|.+++....+.+++..++.++.||+.||.|||++||+||||||+|||++.++ +||+|||+++.... 
T Consensus        91 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~  170 (327)
T 3lzb_A           91 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE  170 (327)
T ss_dssp             EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-------
T ss_pred             ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCc
Confidence            4589999999999999998777899999999999999999999999999999999999999888 99999999976433 


Q ss_pred             -----cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHH
Q 015500          152 -----ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQA  225 (405)
Q Consensus       152 -----~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l  225 (405)
                           .....+|+.|+|||++.+..+++++|||||||++|+|++ |+.||..... ... .........+..+..++.++
T Consensus       171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~l  248 (327)
T 3lzb_A          171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEI-SSILEKGERLPQPPICTIDV  248 (327)
T ss_dssp             ---------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG-GGH-HHHHHTTCCCCCCTTBCHHH
T ss_pred             cccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCH-HHH-HHHHHcCCCCCCCccCCHHH
Confidence                 122346888999999999999999999999999999999 9999965433 222 23333444455677799999


Q ss_pred             HHHHHHhcccCccccCCHHHHhcC
Q 015500          226 NDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       226 ~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      .+||++||..||.+|||+.++++.
T Consensus       249 ~~li~~~l~~dp~~Rps~~ell~~  272 (327)
T 3lzb_A          249 YMIMRKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHcCCChhHCcCHHHHHHH
Confidence            999999999999999999999874

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=4.4e-46  Score=358.71  Aligned_cols=243  Identities=28%  Similarity=0.368  Sum_probs=206.1

Q ss_pred             CcccccccceeCCeeEEEEEE-----cCCCCEEEEEEccCCC----hHHHHHHHHHHHhC-CCCCeeeeeeeeeecCCCc
Q 015500            2 DWTRGHTIGQGSSATVSLATS-----LRSGDVFAAKSTELPK----SEFLQREQKFLSSL-NSPHIVGYKGCDVTSEDNK   71 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~-----~~~~~~vavK~~~~~~----~~~l~~E~~iL~~L-~hpnIv~~~~~~~~~~~~~   71 (405)
                      +|++++.||+|+||+||+|.+     ..+++.||||.+....    .+.+.+|+.+|+++ +||||+++++++.....  
T Consensus        24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~--  101 (313)
T 1t46_A           24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP--  101 (313)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS--
T ss_pred             hhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC--
Confidence            588999999999999999985     4577899999987543    35788999999999 99999999998765433  


Q ss_pred             eEEEEEEeecCCCCHHHHHHHcCC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEc
Q 015500           72 LMYNLFMEYAPGGTLNDEIHRNGG-----------------RLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMA  134 (405)
Q Consensus        72 ~~~~lv~Ey~~ggsL~~~i~~~~~-----------------~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~  134 (405)
                        +++||||+++|+|.+++.....                 ++++..+..++.||+.||.|||++||+||||||+||+++
T Consensus       102 --~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~  179 (313)
T 1t46_A          102 --TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT  179 (313)
T ss_dssp             --CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE
T ss_pred             --cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEc
Confidence              5699999999999999987543                 489999999999999999999999999999999999999


Q ss_pred             cCC-ceEeeeccccccccc------ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHH
Q 015500          135 ESG-AKIADFGCAKWESEA------LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLY  206 (405)
Q Consensus       135 ~~~-vkL~DFGla~~~~~~------~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~  206 (405)
                      .++ +||+|||+++.....      ....+|+.|+|||++.+..++.++|||||||++|+|+| |+.||......... .
T Consensus       180 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~-~  258 (313)
T 1t46_A          180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF-Y  258 (313)
T ss_dssp             TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH-H
T ss_pred             CCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHH-H
Confidence            888 999999999765432      12346788999999999999999999999999999999 99999765544333 3


Q ss_pred             HHHhcCCCCCCchhccHHHHHHHHHhcccCccccCCHHHHhcC
Q 015500          207 KIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       207 ~i~~~~~~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      ........+..+..+++.+.++|.+||+.||.+|||+.+++++
T Consensus       259 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          259 KMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             HHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            3333333445567789999999999999999999999999886

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.2e-45  Score=347.85  Aligned_cols=242  Identities=17%  Similarity=0.294  Sum_probs=206.4

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      +|.+.+.||+|+||+||+|.+.  ++.+|||.+....     .+.+.+|+.+|++++||||+++++++......  .+++
T Consensus        11 ~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~--~~~l   86 (271)
T 3kmu_A           11 QLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP--HPTL   86 (271)
T ss_dssp             GCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSS--SCEE
T ss_pred             HhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCC--CeEe
Confidence            5889999999999999999985  8899999987543     34688999999999999999999987654322  2458


Q ss_pred             EEeecCCCCHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCCCCEEEccCC-ceEeeeccccccccc
Q 015500           77 FMEYAPGGTLNDEIHRNGG-RLDESLIVSYTRQILQGLEYLHSNR--VVHCDIKSRNILMAESG-AKIADFGCAKWESEA  152 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~~~-~l~e~~~~~i~~qIl~~L~yLH~~g--ivHrDlkp~NILi~~~~-vkL~DFGla~~~~~~  152 (405)
                      ||||++||+|.+++....+ .+++..+..++.||+.||.|||++|  ++||||||+||+++.++ ++|.|||++.... .
T Consensus        87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~-~  165 (271)
T 3kmu_A           87 ITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ-S  165 (271)
T ss_dssp             EEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS-C
T ss_pred             eecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeec-c
Confidence            9999999999999987543 5899999999999999999999999  99999999999999887 8999888875432 2


Q ss_pred             ccCCCCCCccChhhhcCCCCCc---chhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHH
Q 015500          153 LQSGGTPMFMAPEVARGEHQGF---ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFL  229 (405)
Q Consensus       153 ~~~~gt~~Y~APE~l~~~~~~~---~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll  229 (405)
                      ....||+.|+|||++.+..++.   ++|||||||++|+|++|+.||... ........+......+..|..+++++.++|
T Consensus       166 ~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  244 (271)
T 3kmu_A          166 PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADL-SNMEIGMKVALEGLRPTIPPGISPHVSKLM  244 (271)
T ss_dssp             TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTS-CHHHHHHHHHHSCCCCCCCTTCCHHHHHHH
T ss_pred             cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCcccc-ChHHHHHHHHhcCCCCCCCCCCCHHHHHHH
Confidence            3456899999999998865544   799999999999999999999654 344455555556666778888999999999


Q ss_pred             HHhcccCccccCCHHHHhcC
Q 015500          230 SNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       230 ~~~L~~dP~~Rpt~~elL~h  249 (405)
                      .+||+.||.+|||++++++.
T Consensus       245 ~~~l~~~p~~Rps~~~il~~  264 (271)
T 3kmu_A          245 KICMNEDPAKRPKFDMIVPI  264 (271)
T ss_dssp             HHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHcCCChhhCcCHHHHHHH
Confidence            99999999999999999864

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1e-45  Score=354.71  Aligned_cols=246  Identities=25%  Similarity=0.372  Sum_probs=205.5

Q ss_pred             CcccccccceeCCeeEEEEE----EcCCCCEEEEEEccCC----ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceE
Q 015500            2 DWTRGHTIGQGSSATVSLAT----SLRSGDVFAAKSTELP----KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLM   73 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~----~~~~~~~vavK~~~~~----~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~   73 (405)
                      .|++++.||+|+||+||+|.    +..+++.||||.+...    ..+.+.+|+++|+.++||||+++++++......  .
T Consensus        22 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~--~   99 (302)
T 4e5w_A           22 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN--G   99 (302)
T ss_dssp             GEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---C--C
T ss_pred             hhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCc--e
Confidence            47899999999999999999    5678999999998643    346789999999999999999999987654332  2


Q ss_pred             EEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc-
Q 015500           74 YNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE-  151 (405)
Q Consensus        74 ~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~-  151 (405)
                      +++||||+++++|.+++....+.+++..+..++.||+.||+|||++||+||||||+||+++.++ +||+|||++..... 
T Consensus       100 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  179 (302)
T 4e5w_A          100 IKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD  179 (302)
T ss_dssp             EEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred             EEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccccCC
Confidence            5699999999999999987777899999999999999999999999999999999999999888 99999999976433 


Q ss_pred             ------cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCC-------------CChHHHHHHHHhcC
Q 015500          152 ------ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNA-------------ADPMTVLYKIAYSR  212 (405)
Q Consensus       152 ------~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~-------------~~~~~~l~~i~~~~  212 (405)
                            .....||+.|+|||++.+..++.++|||||||++|+|++|..||...             ......+.......
T Consensus       180 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (302)
T 4e5w_A          180 KEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEG  259 (302)
T ss_dssp             CCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTT
T ss_pred             CcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhcc
Confidence                  22345888899999999999999999999999999999999986321             11122223333334


Q ss_pred             CCCCCchhccHHHHHHHHHhcccCccccCCHHHHhcC
Q 015500          213 ELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       213 ~~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      .....|..+++.+.+||.+||+.||.+|||+.++++.
T Consensus       260 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  296 (302)
T 4e5w_A          260 KRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEG  296 (302)
T ss_dssp             CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHH
Confidence            4455677899999999999999999999999999763

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=4.4e-46  Score=353.45  Aligned_cols=244  Identities=25%  Similarity=0.402  Sum_probs=207.3

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHhCCCCCeeeeeeeeeecC------------C
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSE------------D   69 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~------------~   69 (405)
                      +|++++.||+|+||+||+|.+..+++.||+|.+.... +.+.+|++++++++||||+++++++....            .
T Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~   90 (284)
T 2a19_B           12 DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRS   90 (284)
T ss_dssp             HEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CC
T ss_pred             ccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccccccc
Confidence            5889999999999999999999999999999987654 56889999999999999999998765421            1


Q ss_pred             CceEEEEEEeecCCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccc
Q 015500           70 NKLMYNLFMEYAPGGTLNDEIHRN-GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAK  147 (405)
Q Consensus        70 ~~~~~~lv~Ey~~ggsL~~~i~~~-~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~  147 (405)
                      ....+++||||+++++|.+++... +..+++..+..++.||+.||.|||++||+||||||+||+++.++ +||+|||++.
T Consensus        91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  170 (284)
T 2a19_B           91 KTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVT  170 (284)
T ss_dssp             EEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             CcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEECcchhhe
Confidence            234577999999999999999764 35799999999999999999999999999999999999999888 9999999987


Q ss_pred             cccc---cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHH
Q 015500          148 WESE---ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQ  224 (405)
Q Consensus       148 ~~~~---~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~  224 (405)
                      ....   .....||+.|+|||++.+..++.++|||||||++|+|++|..||...   ......+. .   ..++..+++.
T Consensus       171 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~---~~~~~~~~-~---~~~~~~~~~~  243 (284)
T 2a19_B          171 SLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET---SKFFTDLR-D---GIISDIFDKK  243 (284)
T ss_dssp             ESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH---HHHHHHHH-T---TCCCTTSCHH
T ss_pred             eccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH---HHHHHHhh-c---ccccccCCHH
Confidence            6543   23456999999999999999999999999999999999999988421   11111221 1   2345668899


Q ss_pred             HHHHHHHhcccCccccCCHHHHhcCcccc
Q 015500          225 ANDFLSNCLRRDPKERWAASQLLKHPFLE  253 (405)
Q Consensus       225 l~dll~~~L~~dP~~Rpt~~elL~hp~~~  253 (405)
                      +.+||.+||..||.+|||+.++++|++.-
T Consensus       244 ~~~li~~~l~~dp~~Rps~~e~l~~l~~~  272 (284)
T 2a19_B          244 EKTLLQKLLSKKPEDRPNTSEILRTLTVW  272 (284)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            99999999999999999999999997654

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.6e-45  Score=356.18  Aligned_cols=240  Identities=27%  Similarity=0.398  Sum_probs=200.1

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEee
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEY   80 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~Ey   80 (405)
                      +|++.+.||+|+||+||+|.+.  ++.||||.+.... .+.+.+|+++|++++||||+++++++..  .    +++||||
T Consensus         9 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~----~~lv~e~   80 (307)
T 2eva_A            9 EIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLN--P----VCLVMEY   80 (307)
T ss_dssp             GEEEEEEEECCSSSEEEEEEET--TEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--T----TEEEEEC
T ss_pred             HeeeeeEeecCCCceEEEEEEC--CeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--C----cEEEEEc
Confidence            5889999999999999999875  7899999987543 4678899999999999999999987542  2    4589999


Q ss_pred             cCCCCHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCCCCEEEccCC--ceEeeecccccccc-c
Q 015500           81 APGGTLNDEIHRNGG--RLDESLIVSYTRQILQGLEYLHS---NRVVHCDIKSRNILMAESG--AKIADFGCAKWESE-A  152 (405)
Q Consensus        81 ~~ggsL~~~i~~~~~--~l~e~~~~~i~~qIl~~L~yLH~---~givHrDlkp~NILi~~~~--vkL~DFGla~~~~~-~  152 (405)
                      ++||+|.+++.....  .+++..+..++.||+.||+|||+   +||+||||||+|||++.++  +||+|||++..... .
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~  160 (307)
T 2eva_A           81 AEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM  160 (307)
T ss_dssp             CTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------
T ss_pred             CCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc
Confidence            999999999986532  47899999999999999999999   8999999999999998776  79999999976543 3


Q ss_pred             ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHh
Q 015500          153 LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNC  232 (405)
Q Consensus       153 ~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~  232 (405)
                      ....||+.|+|||++.+..++.++|||||||++|+|++|+.||...................+..+..+++.+.++|.+|
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  240 (307)
T 2eva_A          161 TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRC  240 (307)
T ss_dssp             ----CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHHHHHHHHHH
T ss_pred             ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCHHHHHHHHHH
Confidence            34569999999999999999999999999999999999999997655444433333344555667788999999999999


Q ss_pred             cccCccccCCHHHHhcC
Q 015500          233 LRRDPKERWAASQLLKH  249 (405)
Q Consensus       233 L~~dP~~Rpt~~elL~h  249 (405)
                      |+.||.+|||+++++++
T Consensus       241 l~~dp~~Rps~~ell~~  257 (307)
T 2eva_A          241 WSKDPSQRPSMEEIVKI  257 (307)
T ss_dssp             TCSSGGGSCCHHHHHHH
T ss_pred             hcCChhhCcCHHHHHHH
Confidence            99999999999999885

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.7e-45  Score=351.77  Aligned_cols=244  Identities=21%  Similarity=0.279  Sum_probs=202.2

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC-ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEee
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP-KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEY   80 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~-~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~Ey   80 (405)
                      +|++++.||+|+||+||+|++..+++.||||.+... ..+.+.+|+.+++.++|++++..+..+.....   .+++||||
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~---~~~lv~e~   86 (296)
T 3uzp_A           10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGD---YNVMVMEL   86 (296)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETT---EEEEEEEC
T ss_pred             EEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCCCC---ceEEEEEe
Confidence            589999999999999999999999999999987654 34679999999999999887776655443332   45699999


Q ss_pred             cCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEc---cCC-ceEeeeccccccccc----
Q 015500           81 APGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMA---ESG-AKIADFGCAKWESEA----  152 (405)
Q Consensus        81 ~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~---~~~-vkL~DFGla~~~~~~----  152 (405)
                      + +++|.+++....+++++..+..++.||+.||.|||++||+||||||+|||++   .++ +||+|||+++.....    
T Consensus        87 ~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~  165 (296)
T 3uzp_A           87 L-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ  165 (296)
T ss_dssp             C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCC
T ss_pred             c-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccccc
Confidence            9 8999999987667899999999999999999999999999999999999994   455 999999999764432    


Q ss_pred             -------ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-----hHHHHHHHHhcCCCCCCchh
Q 015500          153 -------LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAAD-----PMTVLYKIAYSRELPEVPAF  220 (405)
Q Consensus       153 -------~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~-----~~~~l~~i~~~~~~~~~p~~  220 (405)
                             ....||+.|+|||++.+..+++++|||||||++|+|++|+.||.....     ....+.........+..+..
T Consensus       166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (296)
T 3uzp_A          166 HIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKG  245 (296)
T ss_dssp             BCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTT
T ss_pred             ccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHHHhh
Confidence                   344699999999999999999999999999999999999999975332     11222222222222233456


Q ss_pred             ccHHHHHHHHHhcccCccccCCHHHHhcC
Q 015500          221 LSKQANDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       221 ~s~~l~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      +++++.+||++||+.||.+|||+.++++.
T Consensus       246 ~~~~l~~li~~~l~~dp~~Rps~~~l~~~  274 (296)
T 3uzp_A          246 YPSEFATYLNFCRSLRFDDKPDYSYLRQL  274 (296)
T ss_dssp             SCHHHHHHHHHHHTSCTTCCCCHHHHHHH
T ss_pred             CCHHHHHHHHHHHhcCcCcCCCHHHHHHH
Confidence            88999999999999999999999999764

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=5.7e-46  Score=353.48  Aligned_cols=241  Identities=25%  Similarity=0.329  Sum_probs=202.7

Q ss_pred             CcccccccceeCCeeEEEEEEcC---CCCEEEEEEccCC----ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLR---SGDVFAAKSTELP----KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMY   74 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~---~~~~vavK~~~~~----~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~   74 (405)
                      +|++.+.||+|+||+||+|.+..   ++..||+|.+...    ..+.+.+|+.++++++||||+++++++...   .  .
T Consensus        13 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~--~   87 (281)
T 3cc6_A           13 DVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE---P--T   87 (281)
T ss_dssp             GEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS---S--C
T ss_pred             ceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC---C--C
Confidence            58899999999999999998764   3346999998764    245788999999999999999999875422   1  3


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc-
Q 015500           75 NLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA-  152 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~-  152 (405)
                      ++||||+++++|.+++.+.+..+++..+..++.||+.||.|||++||+||||||+||+++.++ +||+|||++...... 
T Consensus        88 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  167 (281)
T 3cc6_A           88 WIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED  167 (281)
T ss_dssp             EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC----
T ss_pred             EEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccccccc
Confidence            589999999999999988777899999999999999999999999999999999999999888 999999999865432 


Q ss_pred             ----ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHH
Q 015500          153 ----LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQAND  227 (405)
Q Consensus       153 ----~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~d  227 (405)
                          ....+|+.|+|||++.+..+++++|||||||++|+|++ |+.||...... .....+.. ...+..|..+++.+.+
T Consensus       168 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~l~~  245 (281)
T 3cc6_A          168 YYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK-DVIGVLEK-GDRLPKPDLCPPVLYT  245 (281)
T ss_dssp             -----CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG-GHHHHHHH-TCCCCCCTTCCHHHHH
T ss_pred             ccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH-HHHHHHhc-CCCCCCCCCCCHHHHH
Confidence                23457889999999999999999999999999999998 99999654332 22333332 3334566778999999


Q ss_pred             HHHHhcccCccccCCHHHHhcC
Q 015500          228 FLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       228 ll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      +|.+||..||.+|||+.+++++
T Consensus       246 li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          246 LMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHccCCchhCcCHHHHHHH
Confidence            9999999999999999999886

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=2.7e-46  Score=363.59  Aligned_cols=241  Identities=22%  Similarity=0.353  Sum_probs=205.3

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC---------ChHHHHHHHHHHHhCC--CCCeeeeeeeeeecCCC
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP---------KSEFLQREQKFLSSLN--SPHIVGYKGCDVTSEDN   70 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~---------~~~~l~~E~~iL~~L~--hpnIv~~~~~~~~~~~~   70 (405)
                      +|++++.||+|+||+||+|.+..+++.||||.+...         ....+.+|+.++++++  ||||+++++++....  
T Consensus        44 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~--  121 (320)
T 3a99_A           44 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD--  121 (320)
T ss_dssp             TEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS--
T ss_pred             ceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCC--
Confidence            589999999999999999999999999999987643         2246778999999996  599999999876543  


Q ss_pred             ceEEEEEEeecCC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEc-cCC-ceEeeecccc
Q 015500           71 KLMYNLFMEYAPG-GTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMA-ESG-AKIADFGCAK  147 (405)
Q Consensus        71 ~~~~~lv~Ey~~g-gsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~-~~~-vkL~DFGla~  147 (405)
                        .++++|||+.+ ++|.+++.+. +.+++..++.++.||+.||+|||++||+||||||+|||++ .++ +||+|||+++
T Consensus       122 --~~~lv~e~~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~  198 (320)
T 3a99_A          122 --SFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA  198 (320)
T ss_dssp             --EEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             --cEEEEEEcCCCCccHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcccc
Confidence              36699999976 8999999876 4899999999999999999999999999999999999998 555 9999999998


Q ss_pred             cccc--cccCCCCCCccChhhhcCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHH
Q 015500          148 WESE--ALQSGGTPMFMAPEVARGEHQ-GFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQ  224 (405)
Q Consensus       148 ~~~~--~~~~~gt~~Y~APE~l~~~~~-~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~  224 (405)
                      ....  .....||+.|+|||++.+..+ ++++|||||||++|+|++|+.||...   ..    +..  .....+..++++
T Consensus       199 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~---~~----~~~--~~~~~~~~~~~~  269 (320)
T 3a99_A          199 LLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD---EE----IIR--GQVFFRQRVSSE  269 (320)
T ss_dssp             ECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH---HH----HHH--CCCCCSSCCCHH
T ss_pred             ccccccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh---hh----hhc--ccccccccCCHH
Confidence            6544  234569999999999987654 78899999999999999999999532   11    111  123455678999


Q ss_pred             HHHHHHHhcccCccccCCHHHHhcCccccccc
Q 015500          225 ANDFLSNCLRRDPKERWAASQLLKHPFLEEFC  256 (405)
Q Consensus       225 l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~  256 (405)
                      +.+||.+||+.||.+|||++++++||||+...
T Consensus       270 ~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~  301 (320)
T 3a99_A          270 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  301 (320)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             HHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence            99999999999999999999999999998753

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=6.6e-46  Score=353.65  Aligned_cols=242  Identities=21%  Similarity=0.327  Sum_probs=206.9

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC--hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEe
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK--SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFME   79 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~--~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (405)
                      +|++.+.||+|+||+||+|.++.+++.+|+|.+....  .+.+.+|++++++++||||+++++++.....    +++|||
T Consensus        14 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~----~~~v~e   89 (288)
T 3kfa_A           14 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP----FYIITE   89 (288)
T ss_dssp             GEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS----EEEEEE
T ss_pred             ceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC----EEEEEE
Confidence            5889999999999999999999999999999987653  4678899999999999999999998754433    569999


Q ss_pred             ecCCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc-----
Q 015500           80 YAPGGTLNDEIHRN-GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA-----  152 (405)
Q Consensus        80 y~~ggsL~~~i~~~-~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~-----  152 (405)
                      |++|++|.+++... ...+++..+..++.||+.||.|||++||+||||||+||+++.++ +||+|||++......     
T Consensus        90 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  169 (288)
T 3kfa_A           90 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH  169 (288)
T ss_dssp             CCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEE
T ss_pred             cCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCccccc
Confidence            99999999999874 34599999999999999999999999999999999999998887 999999999764431     


Q ss_pred             ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHH
Q 015500          153 LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSN  231 (405)
Q Consensus       153 ~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~  231 (405)
                      ....+|+.|+|||++.+..+++++|||||||++|+|++ |..||..... ...... ......+..|..+++.+.+||.+
T Consensus       170 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~l~~li~~  247 (288)
T 3kfa_A          170 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYEL-LEKDYRMERPEGCPEKVYELMRA  247 (288)
T ss_dssp             TTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG-GGHHHH-HHTTCCCCCCTTCCHHHHHHHHH
T ss_pred             cCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHH-HhccCCCCCCCCCCHHHHHHHHH
Confidence            22346888999999999999999999999999999999 9999965432 222222 23334456677899999999999


Q ss_pred             hcccCccccCCHHHHhcC
Q 015500          232 CLRRDPKERWAASQLLKH  249 (405)
Q Consensus       232 ~L~~dP~~Rpt~~elL~h  249 (405)
                      ||..||.+|||+.++++.
T Consensus       248 ~l~~dp~~Rps~~~~~~~  265 (288)
T 3kfa_A          248 CWQWNPSDRPSFAEIHQA  265 (288)
T ss_dssp             HTCSSGGGSCCHHHHHHH
T ss_pred             HhCCChhhCcCHHHHHHH
Confidence            999999999999999764

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-45  Score=351.41  Aligned_cols=244  Identities=23%  Similarity=0.313  Sum_probs=205.4

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCC---EEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGD---VFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMY   74 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~---~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~   74 (405)
                      .|..++.||+|+||+||+|.+..+++   .+|+|.+....    .+.+.+|+.+|++++||||+++++++.....   ..
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---~~   98 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEG---LP   98 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS---CC
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCC---Cc
Confidence            46778999999999999999766555   79999987543    2567899999999999999999998765443   23


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc--
Q 015500           75 NLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE--  151 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~--  151 (405)
                      +++|||+.+|+|.+++...+..+++..+..++.||+.||+|||++||+||||||+||+++.++ +||+|||+++....  
T Consensus        99 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  178 (298)
T 3pls_A           99 HVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE  178 (298)
T ss_dssp             EEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred             EEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence            589999999999999988667899999999999999999999999999999999999999887 99999999975332  


Q ss_pred             ------cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHH
Q 015500          152 ------ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQA  225 (405)
Q Consensus       152 ------~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l  225 (405)
                            .....+|+.|+|||.+.+..+++++|||||||++|+|++|..||....+.......+... ..+..+..+++.+
T Consensus       179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l  257 (298)
T 3pls_A          179 YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQG-RRLPQPEYCPDSL  257 (298)
T ss_dssp             GGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTT-CCCCCCTTCCHHH
T ss_pred             ccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcC-CCCCCCccchHHH
Confidence                  223457889999999999999999999999999999999666654555555444444433 3445677789999


Q ss_pred             HHHHHHhcccCccccCCHHHHhcC
Q 015500          226 NDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       226 ~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      .+||.+||+.||.+|||+.++++.
T Consensus       258 ~~li~~~l~~~p~~Rps~~~ll~~  281 (298)
T 3pls_A          258 YQVMQQCWEADPAVRPTFRVLVGE  281 (298)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHccCChhhCcCHHHHHHH
Confidence            999999999999999999999874

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=4.1e-45  Score=352.41  Aligned_cols=248  Identities=26%  Similarity=0.436  Sum_probs=197.5

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC------hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK------SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~------~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~   75 (405)
                      +|++.+.||+|+||+||+|.+..+|+.||||.+....      .+.+.+|+.++++++||||+++++++....    .++
T Consensus        33 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~----~~~  108 (310)
T 2wqm_A           33 NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN----ELN  108 (310)
T ss_dssp             GEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT----EEE
T ss_pred             ceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC----cEE
Confidence            5889999999999999999999999999999886421      346889999999999999999999877543    367


Q ss_pred             EEEeecCCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc
Q 015500           76 LFMEYAPGGTLNDEIHR---NGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE  151 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~---~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~  151 (405)
                      +||||+++++|.+++..   ....+++..+..++.||+.||.|||++|++||||||+||+++.++ +||+|||++.....
T Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~  188 (310)
T 2wqm_A          109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  188 (310)
T ss_dssp             EEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred             EEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence            99999999999999865   345799999999999999999999999999999999999999887 99999999876543


Q ss_pred             c----ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCC-chhccHHHH
Q 015500          152 A----LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEV-PAFLSKQAN  226 (405)
Q Consensus       152 ~----~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~-p~~~s~~l~  226 (405)
                      .    ....||+.|+|||++.+..++.++|||||||++|+|++|+.||.........+.........+.. +..+++++.
T Consensus       189 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  268 (310)
T 2wqm_A          189 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELR  268 (310)
T ss_dssp             ----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHHHH
T ss_pred             CCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHHHH
Confidence            2    23468999999999999999999999999999999999999996554333333333333333333 366899999


Q ss_pred             HHHHHhcccCccccCCHHHHhcCcccccc
Q 015500          227 DFLSNCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       227 dll~~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      +||.+||..||.+|||+.+++++  ++.+
T Consensus       269 ~li~~~l~~dp~~Rps~~~il~~--l~~l  295 (310)
T 2wqm_A          269 QLVNMCINPDPEKRPDVTYVYDV--AKRM  295 (310)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHH--HHHH
T ss_pred             HHHHHHcCCChhhCCCHHHHHHH--HHHH
Confidence            99999999999999999999875  4444

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=6.1e-46  Score=361.45  Aligned_cols=246  Identities=28%  Similarity=0.416  Sum_probs=208.8

Q ss_pred             CcccccccceeCCeeEEEEE----EcCCCCEEEEEEccCCCh---HHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEE
Q 015500            2 DWTRGHTIGQGSSATVSLAT----SLRSGDVFAAKSTELPKS---EFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMY   74 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~----~~~~~~~vavK~~~~~~~---~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~   74 (405)
                      +|++++.||+|+||+||+|.    +..+++.||||.+.....   +.+.+|+++|++++||||+++++++.....  ..+
T Consensus        24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~--~~~  101 (327)
T 3lxl_A           24 HLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGR--QSL  101 (327)
T ss_dssp             GEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSS--CEE
T ss_pred             hhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCC--ceE
Confidence            58999999999999999999    567899999999876543   458899999999999999999988764433  245


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc--
Q 015500           75 NLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE--  151 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~--  151 (405)
                      ++||||++|++|.+++....+++++..+..++.||+.||+|||++||+||||||+|||++.++ +||+|||+++....  
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~  181 (327)
T 3lxl_A          102 RLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK  181 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECCTTC
T ss_pred             EEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceecccCC
Confidence            699999999999999988666799999999999999999999999999999999999999888 99999999976432  


Q ss_pred             -----cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-------------hHHHHHHHHhcCC
Q 015500          152 -----ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAAD-------------PMTVLYKIAYSRE  213 (405)
Q Consensus       152 -----~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~-------------~~~~l~~i~~~~~  213 (405)
                           .....||+.|+|||++.+..+++++|||||||++|+|++|..||.....             ....+........
T Consensus       182 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (327)
T 3lxl_A          182 DYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQ  261 (327)
T ss_dssp             SEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTTC
T ss_pred             ccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhccc
Confidence                 2234588889999999999899999999999999999999999853221             1122233333444


Q ss_pred             CCCCchhccHHHHHHHHHhcccCccccCCHHHHhcC
Q 015500          214 LPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       214 ~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      .+..+..+++.+.+||.+||+.||.+|||+.+++++
T Consensus       262 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          262 RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ  297 (327)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            556677899999999999999999999999999876

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.4e-46  Score=377.83  Aligned_cols=246  Identities=24%  Similarity=0.352  Sum_probs=197.4

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHhC-CCCCeeeeeeeeeecCCCceEEEEEEee
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSL-NSPHIVGYKGCDVTSEDNKLMYNLFMEY   80 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~~~~l~~E~~iL~~L-~hpnIv~~~~~~~~~~~~~~~~~lv~Ey   80 (405)
                      +|...+.||+|+||+|+. ....+|+.||||.+.......+.+|+++|+.+ +||||+++++++....    .+++||||
T Consensus        25 ~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~----~~~lv~E~   99 (432)
T 3p23_A           25 SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQ----FQYIAIEL   99 (432)
T ss_dssp             EEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEETT----EEEEEEEC
T ss_pred             EEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCC----EEEEEEEC
Confidence            588899999999999764 44568999999999877667788999999999 8999999998765433    36799999


Q ss_pred             cCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcc---CC---ceEeeecccccccc---
Q 015500           81 APGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAE---SG---AKIADFGCAKWESE---  151 (405)
Q Consensus        81 ~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~---~~---vkL~DFGla~~~~~---  151 (405)
                      +. |+|.+++......+.+..+..++.||+.||.|||++||+||||||+|||++.   ++   +||+|||+++....   
T Consensus       100 ~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~  178 (432)
T 3p23_A          100 CA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRH  178 (432)
T ss_dssp             CS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-----
T ss_pred             CC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCc
Confidence            96 5999999887666777778899999999999999999999999999999953   22   78999999976432   


Q ss_pred             ----cccCCCCCCccChhhhcC---CCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCC--CCCchhc
Q 015500          152 ----ALQSGGTPMFMAPEVARG---EHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSREL--PEVPAFL  221 (405)
Q Consensus       152 ----~~~~~gt~~Y~APE~l~~---~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~--~~~p~~~  221 (405)
                          .....||+.|+|||++.+   ..++.++|||||||++|||++ |..||.........  ........  ...+...
T Consensus       179 ~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~  256 (432)
T 3p23_A          179 SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN--ILLGACSLDCLHPEKHE  256 (432)
T ss_dssp             -------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHH--HHTTCCCCTTSCTTCHH
T ss_pred             ceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHH--HHhccCCccccCccccc
Confidence                234569999999999984   567889999999999999999 99999644332222  22111111  1223446


Q ss_pred             cHHHHHHHHHhcccCccccCCHHHHhcCcccccc
Q 015500          222 SKQANDFLSNCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       222 s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      +..+.+||.+||+.||.+|||+.++++||||...
T Consensus       257 ~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~  290 (432)
T 3p23_A          257 DVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL  290 (432)
T ss_dssp             HHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCH
T ss_pred             cHHHHHHHHHHHhCCHhhCCCHHHHHhCccccCh
Confidence            7789999999999999999999999999999764

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=9e-46  Score=368.36  Aligned_cols=242  Identities=20%  Similarity=0.301  Sum_probs=195.1

Q ss_pred             CcccccccceeCCeeEEEEEEc---CCCCEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSL---RSGDVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMY   74 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~---~~~~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~   74 (405)
                      +|++++.||+|+||+||+|+++   .++..||||.+....    .+.+.+|+.+|++++||||+++++++.....    +
T Consensus        46 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~----~  121 (373)
T 2qol_A           46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKP----V  121 (373)
T ss_dssp             GCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS----C
T ss_pred             hceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCc----e
Confidence            5889999999999999999987   467789999987542    3468899999999999999999998754432    5


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccccc
Q 015500           75 NLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEAL  153 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~~  153 (405)
                      ++||||++||+|.+++.+.+..+++..+..++.||+.||+|||++||+||||||+|||++.++ +||+|||+++......
T Consensus       122 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  201 (373)
T 2qol_A          122 MIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP  201 (373)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             EEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccCC
Confidence            699999999999999988777899999999999999999999999999999999999999887 9999999998654321


Q ss_pred             -------cCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHH
Q 015500          154 -------QSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQA  225 (405)
Q Consensus       154 -------~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l  225 (405)
                             ...+|+.|+|||++.+..++.++|||||||++|||++ |+.||.... .......+.. ...+..+..++..+
T Consensus       202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~-~~~~~~~i~~-~~~~~~~~~~~~~l  279 (373)
T 2qol_A          202 EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS-NQDVIKAVDE-GYRLPPPMDCPAAL  279 (373)
T ss_dssp             ------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCC-HHHHHHHHHT-TEECCCCTTCBHHH
T ss_pred             ccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHHHc-CCCCCCCccccHHH
Confidence                   1235778999999999999999999999999999998 999996543 3333333332 22334466789999


Q ss_pred             HHHHHHhcccCccccCCHHHHhcC
Q 015500          226 NDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       226 ~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      .++|.+||+.||.+|||+.++++.
T Consensus       280 ~~li~~cl~~dp~~RPs~~~i~~~  303 (373)
T 2qol_A          280 YQLMLDCWQKDRNNRPKFEQIVSI  303 (373)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHhCcChhhCcCHHHHHHH
Confidence            999999999999999999999873

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=3.4e-46  Score=360.83  Aligned_cols=247  Identities=24%  Similarity=0.337  Sum_probs=201.9

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC---hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK---SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFM   78 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~---~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (405)
                      +|++++.||+|+||+||+|.+..+++.||||.+....   .+.+.+|+.+++.++||||+++++++.........+++||
T Consensus        30 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~  109 (317)
T 2buj_A           30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLL  109 (317)
T ss_dssp             EEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEE
T ss_pred             EEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEE
Confidence            4899999999999999999999999999999875433   4578899999999999999999998876555555677999


Q ss_pred             eecCCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc--
Q 015500           79 EYAPGGTLNDEIHR---NGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA--  152 (405)
Q Consensus        79 Ey~~ggsL~~~i~~---~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~--  152 (405)
                      ||+++|+|.+++..   .++.+++..+..++.||+.||.|||++||+||||||+|||++.++ +||+|||++......  
T Consensus       110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~  189 (317)
T 2buj_A          110 PFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVE  189 (317)
T ss_dssp             ECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESCEEEE
T ss_pred             EeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhcccccc
Confidence            99999999999976   356799999999999999999999999999999999999998887 999999998754321  


Q ss_pred             -----------ccCCCCCCccChhhhcCCC---CCcchhHHHHHHHHHHHHhCCCCCCCCCCh-HHHHHHHHhcCCCCCC
Q 015500          153 -----------LQSGGTPMFMAPEVARGEH---QGFASDIWAVGCTVIEMASGGAPWPNAADP-MTVLYKIAYSRELPEV  217 (405)
Q Consensus       153 -----------~~~~gt~~Y~APE~l~~~~---~~~~sDIwSLG~il~elltG~~Pf~~~~~~-~~~l~~i~~~~~~~~~  217 (405)
                                 ....||+.|+|||++.+..   +++++|||||||++|+|++|+.||...... ......+. .......
T Consensus       190 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~  268 (317)
T 2buj_A          190 GSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ-NQLSIPQ  268 (317)
T ss_dssp             SHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHH-CC--CCC
T ss_pred             cccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhh-ccCCCCc
Confidence                       1234799999999998654   688999999999999999999999431100 01111111 1222233


Q ss_pred             chhccHHHHHHHHHhcccCccccCCHHHHhcC
Q 015500          218 PAFLSKQANDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       218 p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      +..+++.+.+||.+||+.||.+|||+.+++++
T Consensus       269 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  300 (317)
T 2buj_A          269 SPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ  300 (317)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence            45689999999999999999999999999987

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.9e-45  Score=351.16  Aligned_cols=243  Identities=21%  Similarity=0.282  Sum_probs=200.3

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC-ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEee
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP-KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEY   80 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~-~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~Ey   80 (405)
                      +|++++.||+|+||+||+|.+..+++.||||.+... ....+.+|+.+++.++|++++..+..+.....   .++++|||
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~---~~~lv~e~   86 (296)
T 4hgt_A           10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGD---YNVMVMEL   86 (296)
T ss_dssp             -CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETT---EEEEEEEC
T ss_pred             ceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCCCC---ceEEEEEc
Confidence            589999999999999999999999999999986543 34568999999999999888877765544332   45699999


Q ss_pred             cCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEE---ccCC-ceEeeeccccccccc----
Q 015500           81 APGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILM---AESG-AKIADFGCAKWESEA----  152 (405)
Q Consensus        81 ~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi---~~~~-vkL~DFGla~~~~~~----  152 (405)
                      + +++|.+++....+++++..+..++.||+.||.|||++||+||||||+|||+   +.++ +||+|||+++.....    
T Consensus        87 ~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~  165 (296)
T 4hgt_A           87 L-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ  165 (296)
T ss_dssp             C-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCC
T ss_pred             c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCc
Confidence            9 999999998766789999999999999999999999999999999999999   5555 999999999764332    


Q ss_pred             -------ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCh-----HHHHHHHHhcCCCCCCchh
Q 015500          153 -------LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADP-----MTVLYKIAYSRELPEVPAF  220 (405)
Q Consensus       153 -------~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~-----~~~l~~i~~~~~~~~~p~~  220 (405)
                             ....||+.|+|||++.+..+++++|||||||++|+|++|+.||......     .............+..+..
T Consensus       166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (296)
T 4hgt_A          166 HIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKG  245 (296)
T ss_dssp             BCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTT
T ss_pred             cCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhhhhcc
Confidence                   2346899999999999999999999999999999999999999754321     1222222222222223355


Q ss_pred             ccHHHHHHHHHhcccCccccCCHHHHhc
Q 015500          221 LSKQANDFLSNCLRRDPKERWAASQLLK  248 (405)
Q Consensus       221 ~s~~l~dll~~~L~~dP~~Rpt~~elL~  248 (405)
                      +++++.+||.+||+.||.+|||++++++
T Consensus       246 ~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          246 YPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             SCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             CCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence            7899999999999999999999999976

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.3e-45  Score=357.40  Aligned_cols=242  Identities=22%  Similarity=0.303  Sum_probs=205.0

Q ss_pred             CcccccccceeCCeeEEEEEEc-----CCCCEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCce
Q 015500            2 DWTRGHTIGQGSSATVSLATSL-----RSGDVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKL   72 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~-----~~~~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~   72 (405)
                      +|++++.||+|+||+||+|.++     .+++.||||.+....    ...+.+|+++|+.++||||+++++++.....   
T Consensus        26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~---  102 (322)
T 1p4o_A           26 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP---  102 (322)
T ss_dssp             GEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS---
T ss_pred             heeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCc---
Confidence            4889999999999999999887     467899999987543    2357899999999999999999998754332   


Q ss_pred             EEEEEEeecCCCCHHHHHHHcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEee
Q 015500           73 MYNLFMEYAPGGTLNDEIHRNG---------GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIAD  142 (405)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~i~~~~---------~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~D  142 (405)
                       +++||||++||+|.+++...+         .++++..+..++.||+.||.|||++||+||||||+||+++.++ +||+|
T Consensus       103 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl~D  181 (322)
T 1p4o_A          103 -TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGD  181 (322)
T ss_dssp             -CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECC
T ss_pred             -cEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEECc
Confidence             568999999999999997632         3579999999999999999999999999999999999999887 99999


Q ss_pred             eccccccccc------ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCC
Q 015500          143 FGCAKWESEA------LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELP  215 (405)
Q Consensus       143 FGla~~~~~~------~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~  215 (405)
                      ||+++.....      ....+|+.|+|||++.+..++.++|||||||++|+|++ |..||... ....... .......+
T Consensus       182 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~-~~~~~~~-~~~~~~~~  259 (322)
T 1p4o_A          182 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL-SNEQVLR-FVMEGGLL  259 (322)
T ss_dssp             TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS-CHHHHHH-HHHTTCCC
T ss_pred             CccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccC-CHHHHHH-HHHcCCcC
Confidence            9999754331      23346889999999999999999999999999999999 89999644 3333333 33344556


Q ss_pred             CCchhccHHHHHHHHHhcccCccccCCHHHHhcC
Q 015500          216 EVPAFLSKQANDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       216 ~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      ..+..+++.+.+||.+||+.||.+|||+.++++|
T Consensus       260 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~  293 (322)
T 1p4o_A          260 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  293 (322)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            6778899999999999999999999999999987

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.4e-45  Score=358.79  Aligned_cols=246  Identities=24%  Similarity=0.269  Sum_probs=203.1

Q ss_pred             CcccccccceeCCeeEEEEE-----EcCCCCEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCce
Q 015500            2 DWTRGHTIGQGSSATVSLAT-----SLRSGDVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKL   72 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~-----~~~~~~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~   72 (405)
                      +|++++.||+|+||+||+|+     +..+++.||||.+....    ...+.+|+.++++++||||+++++++.....   
T Consensus        31 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---  107 (327)
T 2yfx_A           31 NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP---  107 (327)
T ss_dssp             GCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS---
T ss_pred             heEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC---
Confidence            58999999999999999999     56788999999986432    3467889999999999999999998765433   


Q ss_pred             EEEEEEeecCCCCHHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC----ceEee
Q 015500           73 MYNLFMEYAPGGTLNDEIHRNG------GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG----AKIAD  142 (405)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~i~~~~------~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~----vkL~D  142 (405)
                       +++||||++|++|.+++....      ..+++..+..++.||+.||.|||++||+||||||+|||++.++    +||+|
T Consensus       108 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~D  186 (327)
T 2yfx_A          108 -RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGD  186 (327)
T ss_dssp             -CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred             -cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECc
Confidence             469999999999999998753      3589999999999999999999999999999999999998432    99999


Q ss_pred             ecccccccc------cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCC
Q 015500          143 FGCAKWESE------ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELP  215 (405)
Q Consensus       143 FGla~~~~~------~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~  215 (405)
                      ||++.....      .....||+.|+|||++.+..+++++|||||||++|+|+| |..||... ........+ .....+
T Consensus       187 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~-~~~~~~~~~-~~~~~~  264 (327)
T 2yfx_A          187 FGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK-SNQEVLEFV-TSGGRM  264 (327)
T ss_dssp             CHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-CHHHHHHHH-HTTCCC
T ss_pred             cccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCc-CHHHHHHHH-hcCCCC
Confidence            999875322      223457899999999999899999999999999999998 99999654 333333333 334455


Q ss_pred             CCchhccHHHHHHHHHhcccCccccCCHHHHhcCcccc
Q 015500          216 EVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLE  253 (405)
Q Consensus       216 ~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~  253 (405)
                      ..+..+++.+.+||.+||+.||.+|||+.++++|.++.
T Consensus       265 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  302 (327)
T 2yfx_A          265 DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  302 (327)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            66778999999999999999999999999999998764

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.2e-46  Score=359.00  Aligned_cols=240  Identities=25%  Similarity=0.390  Sum_probs=201.6

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC---------hHHHHHHHHHHHhC----CCCCeeeeeeeeeecC
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK---------SEFLQREQKFLSSL----NSPHIVGYKGCDVTSE   68 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~---------~~~l~~E~~iL~~L----~hpnIv~~~~~~~~~~   68 (405)
                      +|++++.||+|+||+||+|.+..+++.||||.+....         ...+.+|+.+++++    +||||+++++++....
T Consensus        32 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~  111 (312)
T 2iwi_A           32 EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQE  111 (312)
T ss_dssp             -CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC----
T ss_pred             ceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCC
Confidence            5899999999999999999999999999999986542         23456799999999    8999999999875543


Q ss_pred             CCceEEEEEEee-cCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEc-cCC-ceEeeecc
Q 015500           69 DNKLMYNLFMEY-APGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMA-ESG-AKIADFGC  145 (405)
Q Consensus        69 ~~~~~~~lv~Ey-~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~-~~~-vkL~DFGl  145 (405)
                      .    +++|||| +.+++|.+++.+.+ ++++..+..++.||+.||.|||++||+||||||+||+++ .++ +||+|||+
T Consensus       112 ~----~~~v~e~~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~  186 (312)
T 2iwi_A          112 G----FMLVLERPLPAQDLFDYITEKG-PLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGS  186 (312)
T ss_dssp             -----CEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSS
T ss_pred             e----EEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcch
Confidence            2    5689999 78999999998764 799999999999999999999999999999999999998 566 99999999


Q ss_pred             cccccc--cccCCCCCCccChhhhcCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhcc
Q 015500          146 AKWESE--ALQSGGTPMFMAPEVARGEHQ-GFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLS  222 (405)
Q Consensus       146 a~~~~~--~~~~~gt~~Y~APE~l~~~~~-~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s  222 (405)
                      +.....  .....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...   ..    +.  .....++..++
T Consensus       187 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~---~~----~~--~~~~~~~~~~~  257 (312)
T 2iwi_A          187 GALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD---QE----IL--EAELHFPAHVS  257 (312)
T ss_dssp             CEECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH---HH----HH--HTCCCCCTTSC
T ss_pred             hhhcccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh---HH----Hh--hhccCCcccCC
Confidence            976543  334569999999999987655 45899999999999999999999532   11    11  12234567789


Q ss_pred             HHHHHHHHHhcccCccccCCHHHHhcCcccccc
Q 015500          223 KQANDFLSNCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       223 ~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      +.+.+||.+||+.||.+|||++|+++||||+..
T Consensus       258 ~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~  290 (312)
T 2iwi_A          258 PDCCALIRRCLAPKPSSRPSLEEILLDPWMQTP  290 (312)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC-
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHhcChhhcCc
Confidence            999999999999999999999999999999864

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.4e-45  Score=350.54  Aligned_cols=241  Identities=24%  Similarity=0.301  Sum_probs=204.3

Q ss_pred             ccccc-ccceeCCeeEEEEEEc--CCCCEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEE
Q 015500            3 WTRGH-TIGQGSSATVSLATSL--RSGDVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         3 y~~~~-~LG~G~~g~Vyla~~~--~~~~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~   75 (405)
                      |.+.+ .||+|+||+||+|.++  .++..||||.+....    .+.+.+|+++|++++||||+++++++. ...    ++
T Consensus        11 ~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~----~~   85 (287)
T 1u59_A           11 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEA----LM   85 (287)
T ss_dssp             EEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSS----EE
T ss_pred             hhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec-CCC----cE
Confidence            55555 9999999999999864  467889999987642    356889999999999999999999872 222    56


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc---
Q 015500           76 LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE---  151 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~---  151 (405)
                      +||||+++++|.+++....+.+++..+..++.||+.||.|||++||+||||||+||+++.++ +||+|||++.....   
T Consensus        86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~  165 (287)
T 1u59_A           86 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS  165 (287)
T ss_dssp             EEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC
T ss_pred             EEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccCcc
Confidence            99999999999999987767899999999999999999999999999999999999999888 99999999976432   


Q ss_pred             ----cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHH
Q 015500          152 ----ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQAN  226 (405)
Q Consensus       152 ----~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~  226 (405)
                          .....+|+.|+|||++.+..++.++|||||||++|+|++ |+.||..... ......+. ....+..|..+++++.
T Consensus       166 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-~~~~~~i~-~~~~~~~~~~~~~~l~  243 (287)
T 1u59_A          166 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-PEVMAFIE-QGKRMECPPECPPELY  243 (287)
T ss_dssp             EECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT-HHHHHHHH-TTCCCCCCTTCCHHHH
T ss_pred             eeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH-HHHHHHHh-cCCcCCCCCCcCHHHH
Confidence                122346889999999998889999999999999999998 9999976543 33333333 3445667788999999


Q ss_pred             HHHHHhcccCccccCCHHHHhcCc
Q 015500          227 DFLSNCLRRDPKERWAASQLLKHP  250 (405)
Q Consensus       227 dll~~~L~~dP~~Rpt~~elL~hp  250 (405)
                      ++|.+||+.||.+|||+.++++|.
T Consensus       244 ~li~~~l~~~p~~Rps~~~l~~~l  267 (287)
T 1u59_A          244 ALMSDCWIYKWEDRPDFLTVEQRM  267 (287)
T ss_dssp             HHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHcCCChhhCcCHHHHHHHH
Confidence            999999999999999999999874

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.1e-45  Score=360.00  Aligned_cols=243  Identities=26%  Similarity=0.369  Sum_probs=205.1

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCC-----EEEEEEccCCC----hHHHHHHHHHHHhC-CCCCeeeeeeeeeecCCCc
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGD-----VFAAKSTELPK----SEFLQREQKFLSSL-NSPHIVGYKGCDVTSEDNK   71 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~-----~vavK~~~~~~----~~~l~~E~~iL~~L-~hpnIv~~~~~~~~~~~~~   71 (405)
                      +|.+++.||+|+||+||+|.+..+++     .||+|.+....    .+.+.+|+.+|+.+ +||||+++++++.....  
T Consensus        47 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~--  124 (333)
T 2i1m_A           47 NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP--  124 (333)
T ss_dssp             SEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS--
T ss_pred             HceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc--
Confidence            58889999999999999999987665     79999987543    35688999999999 89999999998754433  


Q ss_pred             eEEEEEEeecCCCCHHHHHHHc-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-
Q 015500           72 LMYNLFMEYAPGGTLNDEIHRN-------------GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-  137 (405)
Q Consensus        72 ~~~~lv~Ey~~ggsL~~~i~~~-------------~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-  137 (405)
                        +++||||+++|+|.+++...             ...+++..+..++.||+.||.|||++||+||||||+|||++.++ 
T Consensus       125 --~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~  202 (333)
T 2i1m_A          125 --VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHV  202 (333)
T ss_dssp             --CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGE
T ss_pred             --eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCCe
Confidence              56999999999999999753             34689999999999999999999999999999999999999887 


Q ss_pred             ceEeeeccccccccc------ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHh
Q 015500          138 AKIADFGCAKWESEA------LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAY  210 (405)
Q Consensus       138 vkL~DFGla~~~~~~------~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~  210 (405)
                      +||+|||+++.....      ....+|+.|+|||++.+..++.++|||||||++|+|+| |..||........ ......
T Consensus       203 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~-~~~~~~  281 (333)
T 2i1m_A          203 AKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK-FYKLVK  281 (333)
T ss_dssp             EEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH-HHHHHH
T ss_pred             EEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH-HHHHHh
Confidence            999999999854331      12346788999999999899999999999999999999 9999976554433 333333


Q ss_pred             cCCCCCCchhccHHHHHHHHHhcccCccccCCHHHHhcC
Q 015500          211 SRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       211 ~~~~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      ....+..|...++.+.++|.+||+.||.+|||+.+++++
T Consensus       282 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  320 (333)
T 2i1m_A          282 DGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF  320 (333)
T ss_dssp             HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence            344445677789999999999999999999999999874

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=3e-45  Score=350.48  Aligned_cols=240  Identities=25%  Similarity=0.436  Sum_probs=193.2

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      +|++++.||+|+||+||+|.+.   ..+|+|.+....     .+.+.+|+.+|++++||||++++++... .  .  +++
T Consensus        25 ~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~--~--~~l   96 (289)
T 3og7_A           25 QITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-P--Q--LAI   96 (289)
T ss_dssp             SCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-S--S--CEE
T ss_pred             ceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccC-C--c--cEE
Confidence            5899999999999999999864   459999886542     2568899999999999999999985422 2  1  458


Q ss_pred             EEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc----
Q 015500           77 FMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE----  151 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~----  151 (405)
                      ||||++|++|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++ +||+|||+++....    
T Consensus        97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  176 (289)
T 3og7_A           97 VTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGS  176 (289)
T ss_dssp             EEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-----------
T ss_pred             EEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccccccccc
Confidence            9999999999999987767899999999999999999999999999999999999999888 99999999875432    


Q ss_pred             --cccCCCCCCccChhhhc---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCC---CCCchhccH
Q 015500          152 --ALQSGGTPMFMAPEVAR---GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSREL---PEVPAFLSK  223 (405)
Q Consensus       152 --~~~~~gt~~Y~APE~l~---~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~---~~~p~~~s~  223 (405)
                        .....||+.|+|||++.   +..++.++|||||||++|+|++|+.||............+......   +..+..+++
T Consensus       177 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (289)
T 3og7_A          177 HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPK  256 (289)
T ss_dssp             -------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSCH
T ss_pred             ccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccCCH
Confidence              22346999999999997   5667889999999999999999999998766655554444433322   234457899


Q ss_pred             HHHHHHHHhcccCccccCCHHHHhcC
Q 015500          224 QANDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       224 ~l~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      .+.+||.+||+.||.+|||+.++++.
T Consensus       257 ~l~~li~~~l~~~p~~Rps~~ell~~  282 (289)
T 3og7_A          257 RMKRLMAECLKKKRDERPSFPRILAE  282 (289)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHccCChhhCCCHHHHHHH
Confidence            99999999999999999999999864

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.1e-45  Score=359.40  Aligned_cols=249  Identities=26%  Similarity=0.409  Sum_probs=183.9

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCCh----HHHHHHHH-HHHhCCCCCeeeeeeeeeecCCCceEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS----EFLQREQK-FLSSLNSPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~~----~~l~~E~~-iL~~L~hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      +|++++.||+|+||+||+|.++.+|+.||||.+.....    ..+.+|+. +++.++||||+++++++....    .+++
T Consensus        23 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~----~~~l   98 (327)
T 3aln_A           23 DLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREG----DCWI   98 (327)
T ss_dssp             SEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSS----EEEE
T ss_pred             HhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCC----ceEE
Confidence            58899999999999999999999999999999875432    23445555 777889999999999876543    3669


Q ss_pred             EEeecCCCCHHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCCCCEEEccCC-ceEeeeccccccc
Q 015500           77 FMEYAPGGTLNDEIHR----NGGRLDESLIVSYTRQILQGLEYLHSN-RVVHCDIKSRNILMAESG-AKIADFGCAKWES  150 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~----~~~~l~e~~~~~i~~qIl~~L~yLH~~-givHrDlkp~NILi~~~~-vkL~DFGla~~~~  150 (405)
                      ||||+++ +|.+++..    ..+.+++..+..++.|++.||.|||++ ||+||||||+|||++.++ +||+|||+++...
T Consensus        99 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~  177 (327)
T 3aln_A           99 CMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV  177 (327)
T ss_dssp             EECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred             EEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence            9999976 88887763    245799999999999999999999999 999999999999999888 9999999997654


Q ss_pred             cc---ccCCCCCCccChhhh----cCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCc----h
Q 015500          151 EA---LQSGGTPMFMAPEVA----RGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVP----A  219 (405)
Q Consensus       151 ~~---~~~~gt~~Y~APE~l----~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p----~  219 (405)
                      ..   ....||+.|+|||++    .+..++.++|||||||++|+|++|+.||.........+..+. ....+.++    .
T Consensus       178 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~  256 (327)
T 3aln_A          178 DSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVV-KGDPPQLSNSEER  256 (327)
T ss_dssp             ----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCC-CSCCCCCCCCSSC
T ss_pred             cccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHh-cCCCCCCCCcccc
Confidence            32   234699999999999    456689999999999999999999999975443322222211 12222222    3


Q ss_pred             hccHHHHHHHHHhcccCccccCCHHHHhcCccccccc
Q 015500          220 FLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFC  256 (405)
Q Consensus       220 ~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~  256 (405)
                      .+++.+.+||.+||+.||.+|||+.++++||||....
T Consensus       257 ~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~  293 (327)
T 3aln_A          257 EFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYE  293 (327)
T ss_dssp             CCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred             cCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhH
Confidence            5899999999999999999999999999999998653

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=2e-45  Score=357.75  Aligned_cols=242  Identities=26%  Similarity=0.376  Sum_probs=203.7

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEE--EEEEccCC----ChHHHHHHHHHHHhC-CCCCeeeeeeeeeecCCCceEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVF--AAKSTELP----KSEFLQREQKFLSSL-NSPHIVGYKGCDVTSEDNKLMY   74 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~v--avK~~~~~----~~~~l~~E~~iL~~L-~hpnIv~~~~~~~~~~~~~~~~   74 (405)
                      +|++++.||+|+||+||+|.++.++..+  |+|.+...    ..+.+.+|+++|+++ +||||+++++++....    .+
T Consensus        26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~----~~  101 (327)
T 1fvr_A           26 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG----YL  101 (327)
T ss_dssp             GCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT----EE
T ss_pred             HccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC----ce
Confidence            5889999999999999999999888865  88987642    345788999999999 9999999999876543    36


Q ss_pred             EEEEeecCCCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-c
Q 015500           75 NLFMEYAPGGTLNDEIHRNG---------------GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-A  138 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~i~~~~---------------~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-v  138 (405)
                      ++||||+++++|.+++...+               ..+++..++.++.||+.||.|||++||+||||||+|||++.++ +
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          102 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCE
T ss_pred             EEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCeE
Confidence            79999999999999997653               4799999999999999999999999999999999999999887 9


Q ss_pred             eEeeecccccccc---cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCC
Q 015500          139 KIADFGCAKWESE---ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSREL  214 (405)
Q Consensus       139 kL~DFGla~~~~~---~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~  214 (405)
                      ||+|||+++....   .....+|+.|+|||++.+..++.++|||||||++|+|++ |+.||... ........+ .....
T Consensus       182 kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~-~~~~~~~~~-~~~~~  259 (327)
T 1fvr_A          182 KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM-TCAELYEKL-PQGYR  259 (327)
T ss_dssp             EECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC-CHHHHHHHG-GGTCC
T ss_pred             EEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCC-cHHHHHHHh-hcCCC
Confidence            9999999875333   223457889999999999889999999999999999998 99999644 333333333 33344


Q ss_pred             CCCchhccHHHHHHHHHhcccCccccCCHHHHhcC
Q 015500          215 PEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       215 ~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      +..+..+++++.+||.+||..||.+|||+++++++
T Consensus       260 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          260 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            56677899999999999999999999999999987

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=9.1e-46  Score=356.96  Aligned_cols=244  Identities=23%  Similarity=0.368  Sum_probs=206.2

Q ss_pred             CcccccccceeCCeeEEEEEE-----cCCCCEEEEEEccCCC----hHHHHHHHHHHHhC-CCCCeeeeeeeeeecCCCc
Q 015500            2 DWTRGHTIGQGSSATVSLATS-----LRSGDVFAAKSTELPK----SEFLQREQKFLSSL-NSPHIVGYKGCDVTSEDNK   71 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~-----~~~~~~vavK~~~~~~----~~~l~~E~~iL~~L-~hpnIv~~~~~~~~~~~~~   71 (405)
                      +|++++.||+|+||+||+|.+     ..+++.||||.+....    ...+.+|+.+|+++ +||||+++++++.....  
T Consensus        28 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~--  105 (316)
T 2xir_A           28 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG--  105 (316)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS--
T ss_pred             heeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCC--
Confidence            588999999999999999985     3567899999987543    24688999999999 78999999998654332  


Q ss_pred             eEEEEEEeecCCCCHHHHHHHcCCC---------------CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccC
Q 015500           72 LMYNLFMEYAPGGTLNDEIHRNGGR---------------LDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES  136 (405)
Q Consensus        72 ~~~~lv~Ey~~ggsL~~~i~~~~~~---------------l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~  136 (405)
                       .+++||||++|++|.+++......               +++..+..++.||+.||.|||++||+||||||+||+++.+
T Consensus       106 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~  184 (316)
T 2xir_A          106 -PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK  184 (316)
T ss_dssp             -CCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred             -ceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCC
Confidence             255899999999999999875432               8999999999999999999999999999999999999887


Q ss_pred             C-ceEeeecccccccc------cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHH
Q 015500          137 G-AKIADFGCAKWESE------ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKI  208 (405)
Q Consensus       137 ~-vkL~DFGla~~~~~------~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i  208 (405)
                      + +||+|||+++....      .....||+.|+|||++.+..++.++|||||||++|+|+| |..||............+
T Consensus       185 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~  264 (316)
T 2xir_A          185 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL  264 (316)
T ss_dssp             GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHH
T ss_pred             CCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHh
Confidence            7 99999999975432      123347889999999999999999999999999999998 999997665444444333


Q ss_pred             HhcCCCCCCchhccHHHHHHHHHhcccCccccCCHHHHhcC
Q 015500          209 AYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       209 ~~~~~~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      . ....+..|..+++.+.++|.+||+.||.+|||+.++++|
T Consensus       265 ~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          265 K-EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             H-HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             c-cCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            3 334456677799999999999999999999999999987

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.3e-45  Score=355.15  Aligned_cols=240  Identities=23%  Similarity=0.340  Sum_probs=194.8

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC------hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK------SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~------~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~   75 (405)
                      +|++++.||+|+||+||+|.+..+++.||+|.+....      .+.+.+|+.++++++||||+++++++....    .++
T Consensus        35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~----~~~  110 (309)
T 2h34_A           35 PYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDG----QLY  110 (309)
T ss_dssp             CEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT----EEE
T ss_pred             cEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCC----eEE
Confidence            5899999999999999999999999999999986432      256889999999999999999999876543    366


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc--
Q 015500           76 LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA--  152 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~--  152 (405)
                      ++|||++|++|.+++... +++++..+..++.||+.||.|||++||+||||||+|||++.++ +||+|||++......  
T Consensus       111 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  189 (309)
T 2h34_A          111 VDMRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKL  189 (309)
T ss_dssp             EEEECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC---------
T ss_pred             EEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccccc
Confidence            999999999999999876 4799999999999999999999999999999999999999887 999999998764432  


Q ss_pred             ---ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCC--CCCCchhccHHHHH
Q 015500          153 ---LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRE--LPEVPAFLSKQAND  227 (405)
Q Consensus       153 ---~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~--~~~~p~~~s~~l~d  227 (405)
                         ....||+.|+|||++.+..++.++|||||||++|+|++|+.||....  ...+........  ....+..+++.+.+
T Consensus       190 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l~~  267 (309)
T 2h34_A          190 TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQ--LSVMGAHINQAIPRPSTVRPGIPVAFDA  267 (309)
T ss_dssp             -------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCH--HHHHHHHHHSCCCCGGGTSTTCCTHHHH
T ss_pred             ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCch--HHHHHHHhccCCCCccccCCCCCHHHHH
Confidence               24469999999999999999999999999999999999999996442  223222222211  12345668999999


Q ss_pred             HHHHhcccCccccC-CHHHHhc
Q 015500          228 FLSNCLRRDPKERW-AASQLLK  248 (405)
Q Consensus       228 ll~~~L~~dP~~Rp-t~~elL~  248 (405)
                      +|.+||+.||.+|| |++++++
T Consensus       268 li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          268 VIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             HHHHHTCSSGGGSCSSHHHHHH
T ss_pred             HHHHhccCCHHHHHHhHHHHHH
Confidence            99999999999999 7888765

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=3.8e-45  Score=350.40  Aligned_cols=243  Identities=21%  Similarity=0.305  Sum_probs=199.6

Q ss_pred             CcccccccceeCCeeEEEEEEcCCC---CEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSG---DVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMY   74 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~---~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~   74 (405)
                      +|.+++.||+|+||+||+|.+..++   ..+|+|.+....    .+.+.+|+.++++++||||+++++++...+.   .+
T Consensus        26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---~~  102 (298)
T 3f66_A           26 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG---SP  102 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS---CC
T ss_pred             ehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCC---ce
Confidence            5888999999999999999975433   368999886533    3568899999999999999999987554332   24


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc--
Q 015500           75 NLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE--  151 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~--  151 (405)
                      +++|||+++|+|.+++...+..+++..+..++.||+.||.|||++||+||||||+||+++.++ +||+|||+++....  
T Consensus       103 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~  182 (298)
T 3f66_A          103 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  182 (298)
T ss_dssp             EEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGG
T ss_pred             EEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccccc
Confidence            589999999999999987777899999999999999999999999999999999999999887 99999999975432  


Q ss_pred             ------cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccHH
Q 015500          152 ------ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQ  224 (405)
Q Consensus       152 ------~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~  224 (405)
                            .....+|+.|+|||++.+..+++++|||||||++|+|++ |.+||..... ......+. ....+..|..+++.
T Consensus       183 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~  260 (298)
T 3f66_A          183 YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FDITVYLL-QGRRLLQPEYCPDP  260 (298)
T ss_dssp             GCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCT-TTHHHHHH-TTCCCCCCTTCCHH
T ss_pred             hhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCH-HHHHHHHh-cCCCCCCCccCCHH
Confidence                  223347788999999999999999999999999999999 5566654433 33333332 23344557778999


Q ss_pred             HHHHHHHhcccCccccCCHHHHhcC
Q 015500          225 ANDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       225 l~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      +.++|.+||+.||.+|||+.++++.
T Consensus       261 l~~li~~~l~~~p~~Rps~~ell~~  285 (298)
T 3f66_A          261 LYEVMLKCWHPKAEMRPSFSELVSR  285 (298)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHH
Confidence            9999999999999999999999874

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=4.6e-45  Score=356.50  Aligned_cols=242  Identities=25%  Similarity=0.402  Sum_probs=203.4

Q ss_pred             CcccccccceeCCeeEEEEEEc-------CCCCEEEEEEccCCC----hHHHHHHHHHHHhC-CCCCeeeeeeeeeecCC
Q 015500            2 DWTRGHTIGQGSSATVSLATSL-------RSGDVFAAKSTELPK----SEFLQREQKFLSSL-NSPHIVGYKGCDVTSED   69 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~-------~~~~~vavK~~~~~~----~~~l~~E~~iL~~L-~hpnIv~~~~~~~~~~~   69 (405)
                      +|++++.||+|+||+||+|.+.       .++..||||.+....    ...+.+|+++|+++ +||||+++++++.....
T Consensus        36 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~  115 (334)
T 2pvf_A           36 KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP  115 (334)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSC
T ss_pred             HeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCc
Confidence            5889999999999999999986       467889999987543    24688999999999 99999999998754432


Q ss_pred             CceEEEEEEeecCCCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEc
Q 015500           70 NKLMYNLFMEYAPGGTLNDEIHRNG---------------GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMA  134 (405)
Q Consensus        70 ~~~~~~lv~Ey~~ggsL~~~i~~~~---------------~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~  134 (405)
                          +++||||+++|+|.+++....               ..+++..+..++.||+.||.|||++||+||||||+||+++
T Consensus       116 ----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~  191 (334)
T 2pvf_A          116 ----LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT  191 (334)
T ss_dssp             ----CEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred             ----eEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEc
Confidence                569999999999999998653               2489999999999999999999999999999999999999


Q ss_pred             cCC-ceEeeecccccccc------cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHH
Q 015500          135 ESG-AKIADFGCAKWESE------ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLY  206 (405)
Q Consensus       135 ~~~-vkL~DFGla~~~~~------~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~  206 (405)
                      .++ +||+|||+++....      .....+|+.|+|||++.+..++.++|||||||++|+|++ |..||... ..... .
T Consensus       192 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~-~~~~~-~  269 (334)
T 2pvf_A          192 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEEL-F  269 (334)
T ss_dssp             TTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC-CHHHH-H
T ss_pred             CCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcC-CHHHH-H
Confidence            887 99999999976443      223447888999999998889999999999999999999 99999654 33333 3


Q ss_pred             HHHhcCCCCCCchhccHHHHHHHHHhcccCccccCCHHHHhcC
Q 015500          207 KIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       207 ~i~~~~~~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      ........+..+..+++++.+||.+||..||.+|||+.+++++
T Consensus       270 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          270 KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            3333344556777899999999999999999999999999886

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.4e-45  Score=362.30  Aligned_cols=246  Identities=22%  Similarity=0.259  Sum_probs=196.2

Q ss_pred             CcccccccceeCCeeEEEEEEcC---CCCEEEEEEccCCCh--------------HHHHHHHHHHHhCCCCCeeeeeeee
Q 015500            2 DWTRGHTIGQGSSATVSLATSLR---SGDVFAAKSTELPKS--------------EFLQREQKFLSSLNSPHIVGYKGCD   64 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~---~~~~vavK~~~~~~~--------------~~l~~E~~iL~~L~hpnIv~~~~~~   64 (405)
                      +|++++.||+|+||+||+|.+..   ++..+|+|.......              ..+.+|+.+++.++||||+++++++
T Consensus        38 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~  117 (345)
T 2v62_A           38 QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSG  117 (345)
T ss_dssp             EEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEE
T ss_pred             eEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeeccc
Confidence            58999999999999999999987   889999998875431              2355788889999999999999988


Q ss_pred             eecCCCceEEEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC---ceEe
Q 015500           65 VTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG---AKIA  141 (405)
Q Consensus        65 ~~~~~~~~~~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~---vkL~  141 (405)
                      .........+++||||+ |++|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.++   +||+
T Consensus       118 ~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL~  195 (345)
T 2v62_A          118 LTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLA  195 (345)
T ss_dssp             EEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEEC
T ss_pred             ccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEEE
Confidence            77555455678999999 999999998765 899999999999999999999999999999999999998653   9999


Q ss_pred             eeccccccccc-----------ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHH--H
Q 015500          142 DFGCAKWESEA-----------LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYK--I  208 (405)
Q Consensus       142 DFGla~~~~~~-----------~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~--i  208 (405)
                      |||+++.....           ....||+.|+|||++.+..++.++|||||||++|||++|+.||............  .
T Consensus       196 Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~  275 (345)
T 2v62_A          196 DYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKT  275 (345)
T ss_dssp             CCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHH
T ss_pred             eCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHHH
Confidence            99999754321           3446999999999999999999999999999999999999999543222222211  1


Q ss_pred             HhcCCCCCC------chhccHHHHHHHHHhcccCccccCCHHHHhcC
Q 015500          209 AYSRELPEV------PAFLSKQANDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       209 ~~~~~~~~~------p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      ......+..      +..+++++.+||.+||..||.+|||++++++.
T Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  322 (345)
T 2v62_A          276 NLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI  322 (345)
T ss_dssp             HHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             hhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence            111122111      11578899999999999999999999999774

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.6e-45  Score=353.63  Aligned_cols=244  Identities=23%  Similarity=0.346  Sum_probs=200.2

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHhC--CCCCeeeeeeeeeecCCCceEEEEEEe
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSL--NSPHIVGYKGCDVTSEDNKLMYNLFME   79 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~~~~l~~E~~iL~~L--~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (405)
                      +|++++.||+|+||+||+|.++  ++.||||.+.........+|.+++..+  +||||+++++++.........+++|||
T Consensus        38 ~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e  115 (337)
T 3mdy_A           38 QIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITD  115 (337)
T ss_dssp             HCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEEC
T ss_pred             ceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEe
Confidence            4899999999999999999885  899999998776666777777777665  999999999988766544345779999


Q ss_pred             ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC--------CceeCCCCCCCEEEccCC-ceEeeeccccccc
Q 015500           80 YAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN--------RVVHCDIKSRNILMAESG-AKIADFGCAKWES  150 (405)
Q Consensus        80 y~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~--------givHrDlkp~NILi~~~~-vkL~DFGla~~~~  150 (405)
                      |+++|+|.++++..  .+++..+..++.||+.||+|||++        ||+||||||+|||++.++ +||+|||+++...
T Consensus       116 ~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~  193 (337)
T 3mdy_A          116 YHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFI  193 (337)
T ss_dssp             CCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             ccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceeec
Confidence            99999999999765  699999999999999999999999        999999999999999887 9999999997543


Q ss_pred             cc--------ccCCCCCCccChhhhcCCCCCcc------hhHHHHHHHHHHHHhC----------CCCCCCCC---ChHH
Q 015500          151 EA--------LQSGGTPMFMAPEVARGEHQGFA------SDIWAVGCTVIEMASG----------GAPWPNAA---DPMT  203 (405)
Q Consensus       151 ~~--------~~~~gt~~Y~APE~l~~~~~~~~------sDIwSLG~il~elltG----------~~Pf~~~~---~~~~  203 (405)
                      ..        ....||+.|+|||++.+......      +|||||||++|||+||          ..||....   ....
T Consensus       194 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~  273 (337)
T 3mdy_A          194 SDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYE  273 (337)
T ss_dssp             ---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHH
T ss_pred             cccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchh
Confidence            31        13469999999999988766654      9999999999999999          77775432   1222


Q ss_pred             HHHH-HHhcCCCCCCch-----hccHHHHHHHHHhcccCccccCCHHHHhcC
Q 015500          204 VLYK-IAYSRELPEVPA-----FLSKQANDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       204 ~l~~-i~~~~~~~~~p~-----~~s~~l~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      .... .......+..|.     .+++++.+||.+||+.||.+|||+.++++|
T Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  325 (337)
T 3mdy_A          274 DMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT  325 (337)
T ss_dssp             HHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             hhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence            2222 222333344443     567889999999999999999999999987

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=4.8e-45  Score=349.10  Aligned_cols=239  Identities=25%  Similarity=0.311  Sum_probs=200.6

Q ss_pred             Cccccc-ccceeCCeeEEEEEE--cCCCCEEEEEEccCCC-----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceE
Q 015500            2 DWTRGH-TIGQGSSATVSLATS--LRSGDVFAAKSTELPK-----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLM   73 (405)
Q Consensus         2 ~y~~~~-~LG~G~~g~Vyla~~--~~~~~~vavK~~~~~~-----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~   73 (405)
                      +|++.+ .||+|+||+||+|.+  +.+++.||||.+....     .+.+.+|+++++.++||||+++++++. ...    
T Consensus        17 ~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~----   91 (291)
T 1xbb_A           17 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AES----   91 (291)
T ss_dssp             GEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-SSS----
T ss_pred             hhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEC-CCC----
Confidence            467777 999999999999954  5677899999987542     357889999999999999999999872 222    


Q ss_pred             EEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc
Q 015500           74 YNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA  152 (405)
Q Consensus        74 ~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~  152 (405)
                      +++||||+++++|.+++... +.+++..+..++.||+.||.|||++||+||||||+||+++.++ +||+|||++......
T Consensus        92 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  170 (291)
T 1xbb_A           92 WMLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD  170 (291)
T ss_dssp             EEEEEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred             cEEEEEeCCCCCHHHHHHhC-cCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccC
Confidence            56999999999999999876 4799999999999999999999999999999999999999888 999999999764331


Q ss_pred             -------ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccHH
Q 015500          153 -------LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQ  224 (405)
Q Consensus       153 -------~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~  224 (405)
                             ....+|+.|+|||++.+..+++++|||||||++|+|++ |+.||.... ....... ......+..|..+++.
T Consensus       171 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~  248 (291)
T 1xbb_A          171 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK-GSEVTAM-LEKGERMGCPAGCPRE  248 (291)
T ss_dssp             CSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC-HHHHHHH-HHTTCCCCCCTTCCHH
T ss_pred             CCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCC-HHHHHHH-HHcCCCCCCCCCCCHH
Confidence                   22346788999999998889999999999999999999 999996543 3333333 3344456677889999


Q ss_pred             HHHHHHHhcccCccccCCHHHHhc
Q 015500          225 ANDFLSNCLRRDPKERWAASQLLK  248 (405)
Q Consensus       225 l~dll~~~L~~dP~~Rpt~~elL~  248 (405)
                      +.++|.+||+.||.+|||+.++++
T Consensus       249 l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          249 MYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHH
Confidence            999999999999999999999986

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=7.5e-45  Score=370.37  Aligned_cols=241  Identities=25%  Similarity=0.385  Sum_probs=204.2

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC-ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEee
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP-KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEY   80 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~-~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~Ey   80 (405)
                      +|++++.||+|+||+||+|.++  |+.||||.+... ..+.+.+|+++|++++||||+++++++.....   .+++||||
T Consensus       194 ~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~~iv~e~  268 (450)
T 1k9a_A          194 ELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG---GLYIVTEY  268 (450)
T ss_dssp             GEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTS---CEEEEEEC
T ss_pred             HeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCC---ceEEEEEe
Confidence            4788999999999999999875  789999998754 45678999999999999999999998665432   25699999


Q ss_pred             cCCCCHHHHHHHcCCC-CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc-ccCCC
Q 015500           81 APGGTLNDEIHRNGGR-LDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA-LQSGG  157 (405)
Q Consensus        81 ~~ggsL~~~i~~~~~~-l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~-~~~~g  157 (405)
                      +++|+|.+++...+.. +++..+..++.||+.||+|||++||+||||||+|||++.++ +||+|||+++..... ....+
T Consensus       269 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~  348 (450)
T 1k9a_A          269 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL  348 (450)
T ss_dssp             CTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC------CC
T ss_pred             cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccccCCCC
Confidence            9999999999876533 79999999999999999999999999999999999999887 999999999864432 23457


Q ss_pred             CCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHhcccC
Q 015500          158 TPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRD  236 (405)
Q Consensus       158 t~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~L~~d  236 (405)
                      |+.|+|||++.+..++.++|||||||++|||+| |+.||...... .....+. ....+..|..+++.+.+||++||+.|
T Consensus       349 ~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~-~~~~~i~-~~~~~~~p~~~~~~l~~li~~cl~~d  426 (450)
T 1k9a_A          349 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-DVVPRVE-KGYKMDAPDGCPPAVYDVMKNCWHLD  426 (450)
T ss_dssp             CTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT-THHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred             CcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHH-cCCCCCCCCcCCHHHHHHHHHHcCCC
Confidence            899999999999999999999999999999998 99999765432 3333333 33345667889999999999999999


Q ss_pred             ccccCCHHHHhcC
Q 015500          237 PKERWAASQLLKH  249 (405)
Q Consensus       237 P~~Rpt~~elL~h  249 (405)
                      |.+|||+.++++.
T Consensus       427 p~~Rpt~~~l~~~  439 (450)
T 1k9a_A          427 AATRPTFLQLREQ  439 (450)
T ss_dssp             GGGSCCHHHHHHH
T ss_pred             hhHCcCHHHHHHH
Confidence            9999999999763

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.4e-45  Score=354.85  Aligned_cols=242  Identities=21%  Similarity=0.271  Sum_probs=199.3

Q ss_pred             CcccccccceeCCeeEEEEEEcCCC----CEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSG----DVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLM   73 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~----~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~   73 (405)
                      +|++.+.||+|+||+||+|.++.++    ..||||.+....    ...+.+|+.++++++||||+++++++.....    
T Consensus        45 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~----  120 (333)
T 1mqb_A           45 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP----  120 (333)
T ss_dssp             TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS----
T ss_pred             HhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCC----
Confidence            4788899999999999999987654    359999987542    3467899999999999999999998754332    


Q ss_pred             EEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc
Q 015500           74 YNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA  152 (405)
Q Consensus        74 ~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~  152 (405)
                      +++||||+++++|.+++....+.+++..+..++.||+.||.|||++||+||||||+||+++.++ +||+|||+++.....
T Consensus       121 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~  200 (333)
T 1mqb_A          121 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  200 (333)
T ss_dssp             EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred             cEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhccc
Confidence            5699999999999999988777899999999999999999999999999999999999999887 999999999865431


Q ss_pred             -------ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccHH
Q 015500          153 -------LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQ  224 (405)
Q Consensus       153 -------~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~  224 (405)
                             ....+|+.|+|||++.+..++.++|||||||++|+|++ |+.||.... .......+.. ...+..+..+++.
T Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~-~~~~~~~~~~-~~~~~~~~~~~~~  278 (333)
T 1mqb_A          201 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS-NHEVMKAIND-GFRLPTPMDCPSA  278 (333)
T ss_dssp             ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-HHHHHHHHHT-TCCCCCCTTCBHH
T ss_pred             cccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCC-HHHHHHHHHC-CCcCCCcccCCHH
Confidence                   12236788999999999999999999999999999999 999996443 3344444433 3334456778999


Q ss_pred             HHHHHHHhcccCccccCCHHHHhcC
Q 015500          225 ANDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       225 l~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      +.++|.+||+.||.+||++.+++++
T Consensus       279 l~~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          279 IYQLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHH
Confidence            9999999999999999999999875

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=6.2e-45  Score=351.66  Aligned_cols=246  Identities=20%  Similarity=0.283  Sum_probs=197.3

Q ss_pred             CcccccccceeCCeeEEEEEEcC---CCCEEEEEEccCCC-----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCC-ce
Q 015500            2 DWTRGHTIGQGSSATVSLATSLR---SGDVFAAKSTELPK-----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDN-KL   72 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~---~~~~vavK~~~~~~-----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~-~~   72 (405)
                      +|.+++.||+|+||+||+|.+..   +++.||+|.+....     .+.+.+|+.++++++||||+++++++...... ..
T Consensus        35 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  114 (313)
T 3brb_A           35 LLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIP  114 (313)
T ss_dssp             GEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------
T ss_pred             HeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCc
Confidence            58899999999999999998775   45689999987542     24688999999999999999999987654432 12


Q ss_pred             EEEEEEeecCCCCHHHHHHH-----cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccc
Q 015500           73 MYNLFMEYAPGGTLNDEIHR-----NGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCA  146 (405)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~i~~-----~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla  146 (405)
                      ..++||||+++++|.+++..     ..+.+++..+..++.||+.||.|||++||+||||||+||+++.++ +||+|||++
T Consensus       115 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~  194 (313)
T 3brb_A          115 KPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLS  194 (313)
T ss_dssp             CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSCSCC
T ss_pred             ccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeecCcc
Confidence            34699999999999999853     235699999999999999999999999999999999999999887 999999999


Q ss_pred             ccccc------cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCch
Q 015500          147 KWESE------ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPA  219 (405)
Q Consensus       147 ~~~~~------~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~  219 (405)
                      +....      .....+++.|+|||++.+..+++++|||||||++|+|++ |..||..... ......+ .....+..+.
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-~~~~~~~-~~~~~~~~~~  272 (313)
T 3brb_A          195 KKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN-HEMYDYL-LHGHRLKQPE  272 (313)
T ss_dssp             ----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG-GGHHHHH-HTTCCCCCBT
T ss_pred             eecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCH-HHHHHHH-HcCCCCCCCc
Confidence            76433      223447889999999999999999999999999999999 8999965443 2233333 3344556778


Q ss_pred             hccHHHHHHHHHhcccCccccCCHHHHhcC
Q 015500          220 FLSKQANDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       220 ~~s~~l~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      .+++.+.+||.+||..||.+|||+.+++++
T Consensus       273 ~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          273 DCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             TCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             cccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            899999999999999999999999999886

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=2.9e-45  Score=348.13  Aligned_cols=241  Identities=25%  Similarity=0.375  Sum_probs=197.3

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC-ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEee
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP-KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEY   80 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~-~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~Ey   80 (405)
                      +|++++.||+|+||+||+|.+.  |+.||||.+... ..+.+.+|++++++++||||+++++++.....   .+++||||
T Consensus        22 ~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---~~~lv~e~   96 (278)
T 1byg_A           22 ELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG---GLYIVTEY   96 (278)
T ss_dssp             GEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC-----CCEEEECC
T ss_pred             hceEEeEEecCCCceEEEEEEc--CCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCC---ceEEEEec
Confidence            5889999999999999999874  889999998765 45678999999999999999999987654332   25699999


Q ss_pred             cCCCCHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc-cccCCC
Q 015500           81 APGGTLNDEIHRNGG-RLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE-ALQSGG  157 (405)
Q Consensus        81 ~~ggsL~~~i~~~~~-~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~-~~~~~g  157 (405)
                      +++++|.+++...+. .+++..+..++.||+.||.|||++|++||||||+||+++.++ +||+|||++..... .....+
T Consensus        97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  176 (278)
T 1byg_A           97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL  176 (278)
T ss_dssp             CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------------C
T ss_pred             CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccccccCCCc
Confidence            999999999976532 389999999999999999999999999999999999999887 99999999976544 234468


Q ss_pred             CCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHhcccC
Q 015500          158 TPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRD  236 (405)
Q Consensus       158 t~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~L~~d  236 (405)
                      |+.|+|||++.+..+++++|||||||++|+|+| |+.||..... ......+. ....+..+..+++.+.++|++||..|
T Consensus       177 ~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~  254 (278)
T 1byg_A          177 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-KDVVPRVE-KGYKMDAPDGCPPAVYEVMKNCWHLD  254 (278)
T ss_dssp             CTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG-GGHHHHHT-TTCCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred             cccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHh-cCCCCCCcccCCHHHHHHHHHHhcCC
Confidence            899999999999999999999999999999998 9999965432 23333332 33345667789999999999999999


Q ss_pred             ccccCCHHHHhcC
Q 015500          237 PKERWAASQLLKH  249 (405)
Q Consensus       237 P~~Rpt~~elL~h  249 (405)
                      |.+|||+.++++.
T Consensus       255 p~~Rps~~~l~~~  267 (278)
T 1byg_A          255 AAMRPSFLQLREQ  267 (278)
T ss_dssp             GGGSCCHHHHHHH
T ss_pred             hhhCCCHHHHHHH
Confidence            9999999999763

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=3.8e-45  Score=377.02  Aligned_cols=242  Identities=21%  Similarity=0.331  Sum_probs=206.7

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC--ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEe
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP--KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFME   79 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~--~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (405)
                      +|++.+.||+|+||+||+|.++.++..||||.+...  ..+.+.+|+.+|++++||||+++++++.....    +++|||
T Consensus       221 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~----~~lv~E  296 (495)
T 1opk_A          221 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP----FYIITE  296 (495)
T ss_dssp             GEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS----CEEEEE
T ss_pred             HceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCc----EEEEEE
Confidence            477889999999999999999999999999998754  45788999999999999999999998765433    569999


Q ss_pred             ecCCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc-----
Q 015500           80 YAPGGTLNDEIHRN-GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA-----  152 (405)
Q Consensus        80 y~~ggsL~~~i~~~-~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~-----  152 (405)
                      |+++|+|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++ +||+|||+++.....     
T Consensus       297 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~  376 (495)
T 1opk_A          297 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH  376 (495)
T ss_dssp             CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECC
T ss_pred             ccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCceeec
Confidence            99999999999874 34699999999999999999999999999999999999998887 999999999865331     


Q ss_pred             ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHH
Q 015500          153 LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSN  231 (405)
Q Consensus       153 ~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~  231 (405)
                      ....+|+.|+|||++.+..++.++|||||||++|||+| |..||..... ......+ ........|..+++.+.+||.+
T Consensus       377 ~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~l~~li~~  454 (495)
T 1opk_A          377 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYELL-EKDYRMERPEGCPEKVYELMRA  454 (495)
T ss_dssp             TTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG-GGHHHHH-HTTCCCCCCTTCCHHHHHHHHH
T ss_pred             CCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH-HHHHHHH-HcCCCCCCCCCCCHHHHHHHHH
Confidence            12336778999999999899999999999999999999 9999975543 2333333 3333445677899999999999


Q ss_pred             hcccCccccCCHHHHhcC
Q 015500          232 CLRRDPKERWAASQLLKH  249 (405)
Q Consensus       232 ~L~~dP~~Rpt~~elL~h  249 (405)
                      ||+.||.+|||+.++++.
T Consensus       455 cl~~dP~~RPs~~el~~~  472 (495)
T 1opk_A          455 CWQWNPSDRPSFAEIHQA  472 (495)
T ss_dssp             HTCSSGGGSCCHHHHHHH
T ss_pred             HcCcChhHCcCHHHHHHH
Confidence            999999999999999763

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=8.9e-46  Score=359.56  Aligned_cols=245  Identities=20%  Similarity=0.270  Sum_probs=199.6

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLF   77 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv   77 (405)
                      +|++.+.||+|+||+||+|.+ .+|+.||||.+....    ...+.+|+++++.++||||+++++++.....    .++|
T Consensus        31 ~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~----~~lv  105 (326)
T 3uim_A           31 NFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE----RLLV  105 (326)
T ss_dssp             SSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSC----CEEE
T ss_pred             ccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCc----eEEE
Confidence            689999999999999999985 468999999987543    2368999999999999999999998765443    4589


Q ss_pred             EeecCCCCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCCCCEEEccCC-ceEeeeccccccc
Q 015500           78 MEYAPGGTLNDEIHRNG---GRLDESLIVSYTRQILQGLEYLHSN---RVVHCDIKSRNILMAESG-AKIADFGCAKWES  150 (405)
Q Consensus        78 ~Ey~~ggsL~~~i~~~~---~~l~e~~~~~i~~qIl~~L~yLH~~---givHrDlkp~NILi~~~~-vkL~DFGla~~~~  150 (405)
                      |||+++|+|.+++....   .++++..+..++.||+.||+|||++   ||+||||||+|||++.++ +||+|||+++...
T Consensus       106 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  185 (326)
T 3uim_A          106 YPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD  185 (326)
T ss_dssp             EECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             EEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccC
Confidence            99999999999998643   3499999999999999999999999   999999999999999887 9999999997543


Q ss_pred             c-----cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCC-----CCC-hH-HHHHHHHhc-------
Q 015500          151 E-----ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPN-----AAD-PM-TVLYKIAYS-------  211 (405)
Q Consensus       151 ~-----~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~-----~~~-~~-~~l~~i~~~-------  211 (405)
                      .     .....||+.|+|||++.+..++.++|||||||++|+|++|+.||..     ... .. .........       
T Consensus       186 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (326)
T 3uim_A          186 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALV  265 (326)
T ss_dssp             SSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSS
T ss_pred             cccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhc
Confidence            2     2234599999999999988899999999999999999999999941     110 00 000000000       


Q ss_pred             --CCCCCCchhccHHHHHHHHHhcccCccccCCHHHHhcCcc
Q 015500          212 --RELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPF  251 (405)
Q Consensus       212 --~~~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~  251 (405)
                        ...+..+...++.+.+++.+||+.||.+|||+.++++|-.
T Consensus       266 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~  307 (326)
T 3uim_A          266 DVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE  307 (326)
T ss_dssp             CTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred             ChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence              0112334456788999999999999999999999999853

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=9.2e-45  Score=344.49  Aligned_cols=239  Identities=20%  Similarity=0.310  Sum_probs=202.1

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC--ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEe
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP--KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFME   79 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~--~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (405)
                      +|++++.||+|+||+||+|.+. ++..+|||.+...  ..+.+.+|+++|++++||||+++++++.. .  .  +++|||
T Consensus        14 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~--~--~~~v~e   87 (279)
T 1qpc_A           14 TLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-E--P--IYIITE   87 (279)
T ss_dssp             GEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-S--S--CEEEEE
T ss_pred             hhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcC-C--C--cEEEEe
Confidence            4788999999999999999975 5678999988754  45788999999999999999999987542 2  1  458999


Q ss_pred             ecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc-----
Q 015500           80 YAPGGTLNDEIHRNG-GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA-----  152 (405)
Q Consensus        80 y~~ggsL~~~i~~~~-~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~-----  152 (405)
                      |++|++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+||+++.++ +||+|||++......     
T Consensus        88 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  167 (279)
T 1qpc_A           88 YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR  167 (279)
T ss_dssp             CCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECC
T ss_pred             cCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcccccc
Confidence            999999999987532 2699999999999999999999999999999999999999887 999999999765431     


Q ss_pred             ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHH
Q 015500          153 LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSN  231 (405)
Q Consensus       153 ~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~  231 (405)
                      ....+|+.|+|||++.+..++.++|||||||++|+|++ |+.||.... .......+. ....+..+..+++++.+||.+
T Consensus       168 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~  245 (279)
T 1qpc_A          168 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT-NPEVIQNLE-RGYRMVRPDNCPEELYQLMRL  245 (279)
T ss_dssp             TTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC-HHHHHHHHH-TTCCCCCCTTCCHHHHHHHHH
T ss_pred             cCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccC-HHHHHHHHh-cccCCCCcccccHHHHHHHHH
Confidence            23347889999999998889999999999999999999 999996543 333333333 333445677899999999999


Q ss_pred             hcccCccccCCHHHHhc
Q 015500          232 CLRRDPKERWAASQLLK  248 (405)
Q Consensus       232 ~L~~dP~~Rpt~~elL~  248 (405)
                      ||..||.+|||++++++
T Consensus       246 ~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          246 CWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             HTCSSGGGSCCHHHHHH
T ss_pred             HhccChhhCCCHHHHHH
Confidence            99999999999999976

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.4e-45  Score=357.97  Aligned_cols=244  Identities=22%  Similarity=0.266  Sum_probs=200.4

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC---hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK---SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFM   78 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~---~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (405)
                      +|+..+.||+|+||+||+|.+ .+++.||||.+....   .+.+.+|+.+|+.++||||+++++++.....    +++||
T Consensus        40 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~----~~lv~  114 (321)
T 2qkw_B           40 NFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNE----MILIY  114 (321)
T ss_dssp             CCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTC----CEEEE
T ss_pred             ccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCe----EEEEE
Confidence            588999999999999999996 478999999876543   3578899999999999999999998654332    56999


Q ss_pred             eecCCCCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc---
Q 015500           79 EYAPGGTLNDEIHRNG---GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE---  151 (405)
Q Consensus        79 Ey~~ggsL~~~i~~~~---~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~---  151 (405)
                      ||++||+|.+++....   ..+++..+..++.||+.||+|||++||+||||||+||+++.++ +||+|||+++....   
T Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  194 (321)
T 2qkw_B          115 KYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQ  194 (321)
T ss_dssp             ECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSC
T ss_pred             EcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccccccc
Confidence            9999999999986542   3589999999999999999999999999999999999999887 99999999975432   


Q ss_pred             ---cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCh-----HHHHHHHHhcC---------CC
Q 015500          152 ---ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADP-----MTVLYKIAYSR---------EL  214 (405)
Q Consensus       152 ---~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~-----~~~l~~i~~~~---------~~  214 (405)
                         .....||+.|+|||++.+..++.++|||||||++|+|++|+.||......     ...........         ..
T Consensus       195 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (321)
T 2qkw_B          195 THLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLA  274 (321)
T ss_dssp             CCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCT
T ss_pred             cccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhc
Confidence               12234899999999999989999999999999999999999999643221     11111111111         11


Q ss_pred             CCCchhccHHHHHHHHHhcccCccccCCHHHHhcCc
Q 015500          215 PEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHP  250 (405)
Q Consensus       215 ~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp  250 (405)
                      ...+...+..+.+++.+||+.||.+|||+.++++|.
T Consensus       275 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L  310 (321)
T 2qkw_B          275 DKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL  310 (321)
T ss_dssp             TCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             cccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence            234456788899999999999999999999999874

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.6e-45  Score=366.44  Aligned_cols=246  Identities=26%  Similarity=0.403  Sum_probs=203.5

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccC----CChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL----PKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLF   77 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~----~~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv   77 (405)
                      +|++++.||+|+||+||+|.++.+|+.||||.+..    ...+.+.+|+++|++++||||+++++++......  .+++|
T Consensus        10 ~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~--~~~lv   87 (396)
T 4eut_A           10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTR--HKVLI   87 (396)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTC--CEEEE
T ss_pred             ceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCC--eeEEE
Confidence            48999999999999999999999999999999864    2346788999999999999999999887654432  35699


Q ss_pred             EeecCCCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEE----ccCC-ceEeeeccccccc
Q 015500           78 MEYAPGGTLNDEIHRNG--GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILM----AESG-AKIADFGCAKWES  150 (405)
Q Consensus        78 ~Ey~~ggsL~~~i~~~~--~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi----~~~~-vkL~DFGla~~~~  150 (405)
                      |||++||+|.+++....  ..+++..++.++.||+.||+|||++||+||||||+|||+    +.++ +||+|||+++...
T Consensus        88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~  167 (396)
T 4eut_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE  167 (396)
T ss_dssp             ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECC
T ss_pred             EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEcc
Confidence            99999999999997643  239999999999999999999999999999999999998    5554 9999999998654


Q ss_pred             c---cccCCCCCCccChhhhcC--------CCCCcchhHHHHHHHHHHHHhCCCCCCCC---CChHHHHHHHHhcCCC--
Q 015500          151 E---ALQSGGTPMFMAPEVARG--------EHQGFASDIWAVGCTVIEMASGGAPWPNA---ADPMTVLYKIAYSREL--  214 (405)
Q Consensus       151 ~---~~~~~gt~~Y~APE~l~~--------~~~~~~sDIwSLG~il~elltG~~Pf~~~---~~~~~~l~~i~~~~~~--  214 (405)
                      .   .....||+.|+|||++.+        ..++.++|||||||++|||++|+.||...   ......+.++......  
T Consensus       168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~  247 (396)
T 4eut_A          168 DDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA  247 (396)
T ss_dssp             CGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTC
T ss_pred             CCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCccc
Confidence            3   234569999999999875        45778999999999999999999999543   2334455555433221  


Q ss_pred             ---------------------CCCchhccHHHHHHHHHhcccCccccCCHHHHhcC
Q 015500          215 ---------------------PEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       215 ---------------------~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                                           ..++..+++.+.++|++||+.||.+|||+++++++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~  303 (396)
T 4eut_A          248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE  303 (396)
T ss_dssp             CEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred             chhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence                                 12335577889999999999999999999998765

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=4.6e-45  Score=370.26  Aligned_cols=244  Identities=26%  Similarity=0.363  Sum_probs=191.0

Q ss_pred             cccccccceeCCeeEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHhC-CCCCeeeeeeeeeecCCCceEEEEEEeec
Q 015500            3 WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSL-NSPHIVGYKGCDVTSEDNKLMYNLFMEYA   81 (405)
Q Consensus         3 y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~~~~l~~E~~iL~~L-~hpnIv~~~~~~~~~~~~~~~~~lv~Ey~   81 (405)
                      |...+.||+|+||+||.+ ...+|+.||||.+.....+.+.+|+++|+++ +||||+++++++....    .+++||||+
T Consensus        17 ~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~----~~~lv~E~~   91 (434)
T 2rio_A           17 VVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDR----FLYIALELC   91 (434)
T ss_dssp             EEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSS----EEEEEECCC
T ss_pred             eeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCC----eEEEEEecC
Confidence            456789999999999875 4568999999998777677889999999986 8999999998765432    367999999


Q ss_pred             CCCCHHHHHHHcCCC------CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccC-------------C-ceEe
Q 015500           82 PGGTLNDEIHRNGGR------LDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES-------------G-AKIA  141 (405)
Q Consensus        82 ~ggsL~~~i~~~~~~------l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~-------------~-vkL~  141 (405)
                      + |+|.+++...+..      .++..+..++.||+.||+|||++||+||||||+|||++.+             . +||+
T Consensus        92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~  170 (434)
T 2rio_A           92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILIS  170 (434)
T ss_dssp             S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEEC
T ss_pred             C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEEc
Confidence            6 5999999765311      1233457799999999999999999999999999999642             2 8999


Q ss_pred             eeccccccccc--------ccCCCCCCccChhhhcC-------CCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHH
Q 015500          142 DFGCAKWESEA--------LQSGGTPMFMAPEVARG-------EHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVL  205 (405)
Q Consensus       142 DFGla~~~~~~--------~~~~gt~~Y~APE~l~~-------~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l  205 (405)
                      |||+++.....        ....||+.|+|||++.+       ..++.++|||||||++|||+| |+.||.........+
T Consensus       171 DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~i  250 (434)
T 2rio_A          171 DFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNI  250 (434)
T ss_dssp             CCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHHHH
T ss_pred             ccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHHHH
Confidence            99999865431        23469999999999976       568899999999999999999 999996554433222


Q ss_pred             HHHHhcCCCCCC----chhccHHHHHHHHHhcccCccccCCHHHHhcCccccc
Q 015500          206 YKIAYSRELPEV----PAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEE  254 (405)
Q Consensus       206 ~~i~~~~~~~~~----p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~  254 (405)
                      ..  .....+..    +..+++++.+||.+||+.||.+|||+.++++||||..
T Consensus       251 ~~--~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~  301 (434)
T 2rio_A          251 IR--GIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP  301 (434)
T ss_dssp             HH--TCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred             hc--CCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence            21  11122221    2356789999999999999999999999999999964

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=5.2e-45  Score=347.62  Aligned_cols=242  Identities=26%  Similarity=0.381  Sum_probs=198.8

Q ss_pred             CcccccccceeCCeeEEEEEEcC-CCC--EEEEEEccCC------ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCce
Q 015500            2 DWTRGHTIGQGSSATVSLATSLR-SGD--VFAAKSTELP------KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKL   72 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~-~~~--~vavK~~~~~------~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~   72 (405)
                      +|++++.||+|+||+||+|.+.. +++  .||||.+...      ..+.+.+|++++++++||||+++++++....    
T Consensus        19 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----   94 (291)
T 1u46_A           19 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP----   94 (291)
T ss_dssp             GEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS----
T ss_pred             HeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC----
Confidence            58999999999999999998654 333  6899987643      2357889999999999999999999875432    


Q ss_pred             EEEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc
Q 015500           73 MYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE  151 (405)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~  151 (405)
                       +++||||+++++|.+++....+.+++..+..++.||+.||.|||++|++||||||+||+++.++ +||+|||++.....
T Consensus        95 -~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  173 (291)
T 1u46_A           95 -MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ  173 (291)
T ss_dssp             -CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred             -ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccccc
Confidence             4589999999999999988666899999999999999999999999999999999999999888 99999999876433


Q ss_pred             c-------ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccH
Q 015500          152 A-------LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSK  223 (405)
Q Consensus       152 ~-------~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~  223 (405)
                      .       ....+|+.|+|||++.+..++.++|||||||++|+|++ |+.||... +.......+......+..+..+++
T Consensus       174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  252 (291)
T 1u46_A          174 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL-NGSQILHKIDKEGERLPRPEDCPQ  252 (291)
T ss_dssp             -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC-CHHHHHHHHHTSCCCCCCCTTCCH
T ss_pred             cccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccC-CHHHHHHHHHccCCCCCCCcCcCH
Confidence            1       23357888999999998889999999999999999999 99999644 445555555555555566778999


Q ss_pred             HHHHHHHHhcccCccccCCHHHHhcC
Q 015500          224 QANDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       224 ~l~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      ++.++|.+||..||.+|||+.+++++
T Consensus       253 ~l~~li~~~l~~~p~~Rps~~~l~~~  278 (291)
T 1u46_A          253 DIYNVMVQCWAHKPEDRPTFVALRDF  278 (291)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHccCCcccCcCHHHHHHH
Confidence            99999999999999999999999874

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.7e-44  Score=368.08  Aligned_cols=239  Identities=21%  Similarity=0.329  Sum_probs=202.6

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC--ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEe
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP--KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFME   79 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~--~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (405)
                      +|.+.+.||+|+||+||+|.+. ++..||||.+...  ..+.+.+|+++|++|+||||+++++++. ...    +++|||
T Consensus       189 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~----~~lv~e  262 (454)
T 1qcf_A          189 SLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEP----IYIITE  262 (454)
T ss_dssp             GEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSS----CEEEEC
T ss_pred             HeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCc----cEEEEe
Confidence            4778899999999999999985 4678999998754  3568999999999999999999998764 221    458999


Q ss_pred             ecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc-----c
Q 015500           80 YAPGGTLNDEIHRNG-GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE-----A  152 (405)
Q Consensus        80 y~~ggsL~~~i~~~~-~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~-----~  152 (405)
                      |+++|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++ +||+|||+++....     .
T Consensus       263 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~  342 (454)
T 1qcf_A          263 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAR  342 (454)
T ss_dssp             CCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTT
T ss_pred             ecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceecc
Confidence            999999999997532 3689999999999999999999999999999999999999887 99999999986543     1


Q ss_pred             ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHH
Q 015500          153 LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSN  231 (405)
Q Consensus       153 ~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~  231 (405)
                      ....+|+.|+|||++.+..++.++|||||||++|||+| |+.||.... .......+... .....|..+++++.+||.+
T Consensus       343 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~-~~~~~~~i~~~-~~~~~~~~~~~~l~~li~~  420 (454)
T 1qcf_A          343 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS-NPEVIRALERG-YRMPRPENCPEELYNIMMR  420 (454)
T ss_dssp             CSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-HHHHHHHHHHT-CCCCCCTTSCHHHHHHHHH
T ss_pred             CCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCC-HHHHHHHHHcC-CCCCCCCCCCHHHHHHHHH
Confidence            22346778999999998899999999999999999999 999997543 34444444433 3345577899999999999


Q ss_pred             hcccCccccCCHHHHhc
Q 015500          232 CLRRDPKERWAASQLLK  248 (405)
Q Consensus       232 ~L~~dP~~Rpt~~elL~  248 (405)
                      ||+.||.+|||++++++
T Consensus       421 cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          421 CWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             HTCSSGGGSCCHHHHHH
T ss_pred             HccCChhHCcCHHHHHH
Confidence            99999999999999976

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=7.1e-45  Score=357.92  Aligned_cols=242  Identities=19%  Similarity=0.259  Sum_probs=197.5

Q ss_pred             CcccccccceeCCeeEEEEEEcCC--------CCEEEEEEccCCChHHHHHHHHHHHhCCCCCeee--------------
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRS--------GDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVG--------------   59 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~--------~~~vavK~~~~~~~~~l~~E~~iL~~L~hpnIv~--------------   59 (405)
                      +|++++.||+|+||+||+|.+..+        ++.||||.+...  +.+.+|++++++++||||++              
T Consensus        43 ~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~  120 (352)
T 2jii_A           43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIP  120 (352)
T ss_dssp             EEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCC
T ss_pred             eEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--chHHHHHHHHHHhcccchhhhhhhhccCCccCcc
Confidence            589999999999999999999874        889999998754  56889999999999999987              


Q ss_pred             -eeeeeeecCCCceEEEEEEeecCCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC
Q 015500           60 -YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRN-GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG  137 (405)
Q Consensus        60 -~~~~~~~~~~~~~~~~lv~Ey~~ggsL~~~i~~~-~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~  137 (405)
                       +++++....   ..+++||||+ +++|.+++... ++.+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus       121 ~~~~~~~~~~---~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~  196 (352)
T 2jii_A          121 TCMGFGVHQD---KYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPED  196 (352)
T ss_dssp             CCCEEEEETT---TEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTE
T ss_pred             chhhccccCC---cEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCC
Confidence             444443322   2467999999 99999999875 35799999999999999999999999999999999999999875


Q ss_pred             ---ceEeeeccccccccc-----------ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHH
Q 015500          138 ---AKIADFGCAKWESEA-----------LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMT  203 (405)
Q Consensus       138 ---vkL~DFGla~~~~~~-----------~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~  203 (405)
                         +||+|||+++.....           ....||+.|+|||++.+..++.++|||||||++|+|++|+.||........
T Consensus       197 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  276 (352)
T 2jii_A          197 QSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTE  276 (352)
T ss_dssp             EEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH
T ss_pred             CceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHH
Confidence               999999999764331           234699999999999999999999999999999999999999976542222


Q ss_pred             HHHHHH--hcCCCCCCc------hhccHHHHHHHHHhcccCccccCCHHHHhcC
Q 015500          204 VLYKIA--YSRELPEVP------AFLSKQANDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       204 ~l~~i~--~~~~~~~~p------~~~s~~l~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      .+....  .....+.++      ..+++++.+||.+||..||.+|||++++++.
T Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  330 (352)
T 2jii_A          277 DIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNN  330 (352)
T ss_dssp             HHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             HHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHH
Confidence            222211  122222222      2468999999999999999999999999874

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.8e-44  Score=351.51  Aligned_cols=244  Identities=23%  Similarity=0.340  Sum_probs=193.9

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHH--hCCCCCeeeeeeeeee-cCCCceEEEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLS--SLNSPHIVGYKGCDVT-SEDNKLMYNLFM   78 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~~~~l~~E~~iL~--~L~hpnIv~~~~~~~~-~~~~~~~~~lv~   78 (405)
                      +|++++.||+|+||+||+|++  +++.||||++.......+.+|.+++.  .++||||+++++.+.. .......+++||
T Consensus        14 ~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~   91 (336)
T 3g2f_A           14 NLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVM   91 (336)
T ss_dssp             SEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEE
T ss_pred             HhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEE
Confidence            589999999999999999976  68999999998776666666666644  5899999999876543 223344567999


Q ss_pred             eecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---------CceeCCCCCCCEEEccCC-ceEeeeccccc
Q 015500           79 EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN---------RVVHCDIKSRNILMAESG-AKIADFGCAKW  148 (405)
Q Consensus        79 Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~---------givHrDlkp~NILi~~~~-vkL~DFGla~~  148 (405)
                      ||+++|+|.+++...  .+++..+..++.||+.||.|||++         ||+||||||+|||++.++ +||+|||+++.
T Consensus        92 e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~  169 (336)
T 3g2f_A           92 EYYPNGSLXKYLSLH--TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMR  169 (336)
T ss_dssp             CCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             ecCCCCcHHHHHhhc--ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccceee
Confidence            999999999999875  468999999999999999999999         999999999999999887 99999999975


Q ss_pred             ccc------------cccCCCCCCccChhhhcC-------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCC---------
Q 015500          149 ESE------------ALQSGGTPMFMAPEVARG-------EHQGFASDIWAVGCTVIEMASGGAPWPNAAD---------  200 (405)
Q Consensus       149 ~~~------------~~~~~gt~~Y~APE~l~~-------~~~~~~sDIwSLG~il~elltG~~Pf~~~~~---------  200 (405)
                      ...            .....||+.|+|||++.+       ..+++++|||||||++|||++|..||.....         
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~  249 (336)
T 3g2f_A          170 LTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQ  249 (336)
T ss_dssp             CSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTH
T ss_pred             cccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhh
Confidence            432            123459999999999987       3556789999999999999999877643221         


Q ss_pred             --------hHHHHHHHHhcCCCCCCchh------ccHHHHHHHHHhcccCccccCCHHHHhcC
Q 015500          201 --------PMTVLYKIAYSRELPEVPAF------LSKQANDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       201 --------~~~~l~~i~~~~~~~~~p~~------~s~~l~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                              ..............+.+|..      +++++.+||.+||+.||.+|||+.|+++.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~  312 (336)
T 3g2f_A          250 TEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEER  312 (336)
T ss_dssp             HHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             cccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHH
Confidence                    11111122222333444433      56689999999999999999999999663

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1e-44  Score=358.60  Aligned_cols=239  Identities=18%  Similarity=0.171  Sum_probs=197.2

Q ss_pred             CcccccccceeCCeeEEEE-----EEcCCCCEEEEEEccCCChHHHHHHHHHHHhCC---CCCeeeeeeeeeecCCCceE
Q 015500            2 DWTRGHTIGQGSSATVSLA-----TSLRSGDVFAAKSTELPKSEFLQREQKFLSSLN---SPHIVGYKGCDVTSEDNKLM   73 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla-----~~~~~~~~vavK~~~~~~~~~l~~E~~iL~~L~---hpnIv~~~~~~~~~~~~~~~   73 (405)
                      +|.+.+.||+|+||+||+|     .+..+++.||||.+.......+.+|+++++.++   ||||+.+++++.....    
T Consensus        66 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~----  141 (365)
T 3e7e_A           66 LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNG----  141 (365)
T ss_dssp             EEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSC----
T ss_pred             EEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCC----
Confidence            4888999999999999999     467889999999999888888999999999997   8999999998766544    


Q ss_pred             EEEEEeecCCCCHHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcc-----------CC-
Q 015500           74 YNLFMEYAPGGTLNDEIHR----NGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAE-----------SG-  137 (405)
Q Consensus        74 ~~lv~Ey~~ggsL~~~i~~----~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~-----------~~-  137 (405)
                      +++||||++||+|.+++..    ..+.+++..++.++.||+.||+|||++||+||||||+|||++.           ++ 
T Consensus       142 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~  221 (365)
T 3e7e_A          142 SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAG  221 (365)
T ss_dssp             EEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CTT
T ss_pred             cEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccCC
Confidence            5699999999999999975    3457999999999999999999999999999999999999987           55 


Q ss_pred             ceEeeeccccccc------ccccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhc
Q 015500          138 AKIADFGCAKWES------EALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYS  211 (405)
Q Consensus       138 vkL~DFGla~~~~------~~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~  211 (405)
                      +||+|||+|+...      .....+||+.|+|||++.+..+++++|||||||++|||+||+.||........     ...
T Consensus       222 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-----~~~  296 (365)
T 3e7e_A          222 LALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC-----KPE  296 (365)
T ss_dssp             EEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE-----EEC
T ss_pred             EEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce-----eec
Confidence            9999999996532      13345699999999999999999999999999999999999999953322100     001


Q ss_pred             CCCCCCchhccHHHHHHHHHhcccCccccCCHHHHhcCcc
Q 015500          212 RELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPF  251 (405)
Q Consensus       212 ~~~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~  251 (405)
                      ..++..  ..++.+.+++.+||..+|.+|++..+.+.+.+
T Consensus       297 ~~~~~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l  334 (365)
T 3e7e_A          297 GLFRRL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKL  334 (365)
T ss_dssp             SCCTTC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHH
T ss_pred             hhcccc--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHH
Confidence            112222  24778999999999999999987666665543

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.8e-44  Score=351.19  Aligned_cols=246  Identities=25%  Similarity=0.384  Sum_probs=203.5

Q ss_pred             CcccccccceeCCeeEEEEE----EcCCCCEEEEEEccCCC---hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEE
Q 015500            2 DWTRGHTIGQGSSATVSLAT----SLRSGDVFAAKSTELPK---SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMY   74 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~----~~~~~~~vavK~~~~~~---~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~   74 (405)
                      +|++++.||+|+||+||+|.    +..+++.||||.+....   .+.+.+|+++|++++||||+++++++......  .+
T Consensus        42 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~--~~  119 (326)
T 2w1i_A           42 HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR--NL  119 (326)
T ss_dssp             GEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC------CC
T ss_pred             HceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCC--ce
Confidence            48899999999999999998    46689999999987543   34688999999999999999999876544322  25


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc-
Q 015500           75 NLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA-  152 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~-  152 (405)
                      ++||||+++++|.+++....+++++..+..++.||+.||.|||++||+||||||+||+++.++ +||+|||++...... 
T Consensus       120 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~  199 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK  199 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCSSC
T ss_pred             EEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhccccc
Confidence            689999999999999998777899999999999999999999999999999999999999887 999999999765331 


Q ss_pred             ------ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCh-----------H---HHHHHHHhcC
Q 015500          153 ------LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADP-----------M---TVLYKIAYSR  212 (405)
Q Consensus       153 ------~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~-----------~---~~l~~i~~~~  212 (405)
                            ....+|+.|+|||++.+..++.++|||||||++|+|+||..||......           .   ..+.......
T Consensus       200 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (326)
T 2w1i_A          200 EYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN  279 (326)
T ss_dssp             SEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTT
T ss_pred             cccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcC
Confidence                  2234778899999999988999999999999999999999998532100           0   0112222233


Q ss_pred             CCCCCchhccHHHHHHHHHhcccCccccCCHHHHhcC
Q 015500          213 ELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       213 ~~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      ..+..|..+++++.+||++||+.||.+|||+.++++.
T Consensus       280 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~  316 (326)
T 2w1i_A          280 GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALR  316 (326)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            3445677899999999999999999999999999763

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=2.8e-44  Score=350.71  Aligned_cols=244  Identities=24%  Similarity=0.322  Sum_probs=202.4

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHh--CCCCCeeeeeeeeeecCCCceEEEEEEe
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSS--LNSPHIVGYKGCDVTSEDNKLMYNLFME   79 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~~~~l~~E~~iL~~--L~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (405)
                      +|++++.||+|+||+||+|.+  +|+.||||.+.......+.+|.++++.  ++||||+++++++.........+++|||
T Consensus        43 ~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e  120 (342)
T 1b6c_B           43 TIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD  120 (342)
T ss_dssp             HCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEEC
T ss_pred             cEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEe
Confidence            488999999999999999998  489999999987777788899999988  7999999999987766543334679999


Q ss_pred             ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH--------hCCceeCCCCCCCEEEccCC-ceEeeeccccccc
Q 015500           80 YAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLH--------SNRVVHCDIKSRNILMAESG-AKIADFGCAKWES  150 (405)
Q Consensus        80 y~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH--------~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~  150 (405)
                      |+++|+|.+++.+.  ++++..+..++.||+.||.|||        +.||+||||||+|||++.++ +||+|||++....
T Consensus       121 ~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~  198 (342)
T 1b6c_B          121 YHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD  198 (342)
T ss_dssp             CCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTCEEEE
T ss_pred             ecCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCceecc
Confidence            99999999999764  6999999999999999999999        89999999999999999887 9999999997644


Q ss_pred             cc--------ccCCCCCCccChhhhcCCC------CCcchhHHHHHHHHHHHHhC----------CCCCCCCCC---hHH
Q 015500          151 EA--------LQSGGTPMFMAPEVARGEH------QGFASDIWAVGCTVIEMASG----------GAPWPNAAD---PMT  203 (405)
Q Consensus       151 ~~--------~~~~gt~~Y~APE~l~~~~------~~~~sDIwSLG~il~elltG----------~~Pf~~~~~---~~~  203 (405)
                      ..        ....||+.|+|||++.+..      ++.++|||||||++|||+||          ..||.....   ...
T Consensus       199 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~  278 (342)
T 1b6c_B          199 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE  278 (342)
T ss_dssp             TTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHH
T ss_pred             ccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHH
Confidence            32        2346999999999998763      33689999999999999999          788865421   223


Q ss_pred             HHHH-HHhcCCCCCCch-----hccHHHHHHHHHhcccCccccCCHHHHhcC
Q 015500          204 VLYK-IAYSRELPEVPA-----FLSKQANDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       204 ~l~~-i~~~~~~~~~p~-----~~s~~l~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      .+.. +......+.+|.     ..++.+.+||.+||+.||.+|||+.++++|
T Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          279 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             HHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence            3333 222333344443     355789999999999999999999999987

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9e-45  Score=361.33  Aligned_cols=243  Identities=21%  Similarity=0.294  Sum_probs=195.0

Q ss_pred             CcccccccceeCCeeEEEEEEcCCC---CEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSG---DVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMY   74 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~---~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~   74 (405)
                      .|..++.||+|+||+||+|.+..++   ..+|+|.+....    .+.+.+|+.+|++++||||+++++++...+.   .+
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~---~~  166 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG---SP  166 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSS---CC
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCC---Ce
Confidence            3677899999999999999876433   468999876432    3578899999999999999999987654332   24


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc--
Q 015500           75 NLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE--  151 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~--  151 (405)
                      ++||||+++|+|.+++...+..+++..+..++.||+.||.|||++||+||||||+|||++.++ +||+|||+++....  
T Consensus       167 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~  246 (373)
T 3c1x_A          167 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  246 (373)
T ss_dssp             EEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             EEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence            589999999999999988777799999999999999999999999999999999999999887 99999999975432  


Q ss_pred             ------cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccHH
Q 015500          152 ------ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQ  224 (405)
Q Consensus       152 ------~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~  224 (405)
                            .....+|+.|+|||++.+..++.++|||||||++|||+| |.+||...... .....+. ....+..|..+++.
T Consensus       247 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~-~~~~~~~-~~~~~~~p~~~~~~  324 (373)
T 3c1x_A          247 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-DITVYLL-QGRRLLQPEYCPDP  324 (373)
T ss_dssp             -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS-CHHHHHH-TTCCCCCCTTCCHH
T ss_pred             cccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH-HHHHHHH-cCCCCCCCCCCCHH
Confidence                  122347788999999999999999999999999999999 67888654432 2222332 23344567789999


Q ss_pred             HHHHHHHhcccCccccCCHHHHhcC
Q 015500          225 ANDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       225 l~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      +.++|.+||+.||.+|||+.+++++
T Consensus       325 l~~li~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          325 LYEVMLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHH
Confidence            9999999999999999999999886

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.8e-44  Score=350.27  Aligned_cols=242  Identities=26%  Similarity=0.413  Sum_probs=201.6

Q ss_pred             cccccccceeCCeeEEEEEE----cCCCCEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEE
Q 015500            3 WTRGHTIGQGSSATVSLATS----LRSGDVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMY   74 (405)
Q Consensus         3 y~~~~~LG~G~~g~Vyla~~----~~~~~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~   74 (405)
                      |++++.||+|+||+||+|..    ..+++.||||.+....    .+.+.+|+++|++++||||+++++++......  .+
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~--~~  110 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAA--SL  110 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTT--EE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCc--eE
Confidence            48899999999999988753    4578999999987653    34688999999999999999999987764332  46


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc--
Q 015500           75 NLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE--  151 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~--  151 (405)
                      ++||||+++|+|.+++.+.  .+++..+..++.||+.||.|||++||+||||||+||+++.++ +||+|||++.....  
T Consensus       111 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~  188 (318)
T 3lxp_A          111 QLVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH  188 (318)
T ss_dssp             EEEECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTC
T ss_pred             EEEEecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccccccc
Confidence            6999999999999999765  599999999999999999999999999999999999999888 99999999986543  


Q ss_pred             -----cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCh-------------HHHHHHHHhcCC
Q 015500          152 -----ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADP-------------MTVLYKIAYSRE  213 (405)
Q Consensus       152 -----~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~-------------~~~l~~i~~~~~  213 (405)
                           .....+|+.|+|||++.+..++.++|||||||++|+|+||+.||......             ...+........
T Consensus       189 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (318)
T 3lxp_A          189 EYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGE  268 (318)
T ss_dssp             SEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTC
T ss_pred             cccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhccc
Confidence                 22345888899999999988999999999999999999999999542111             111222333344


Q ss_pred             CCCCchhccHHHHHHHHHhcccCccccCCHHHHhc
Q 015500          214 LPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLK  248 (405)
Q Consensus       214 ~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~  248 (405)
                      .+..+..+++++.+||++||+.||.+|||+.++++
T Consensus       269 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          269 RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            55667789999999999999999999999999985

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=4.5e-44  Score=364.80  Aligned_cols=239  Identities=25%  Similarity=0.349  Sum_probs=199.3

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC--ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEe
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP--KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFME   79 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~--~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (405)
                      +|++.+.||+|+||+||+|.+.. +..||||.+...  ..+.+.+|+++|++|+||||+++++++.. ..    +++|||
T Consensus       185 ~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~----~~iv~e  258 (452)
T 1fmk_A          185 SLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP----IYIVTE  258 (452)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS----CEEEEC
T ss_pred             HceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-Cc----eEEEeh
Confidence            47788999999999999999864 467999998754  35679999999999999999999987643 21    458999


Q ss_pred             ecCCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc-----
Q 015500           80 YAPGGTLNDEIHRN-GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA-----  152 (405)
Q Consensus        80 y~~ggsL~~~i~~~-~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~-----  152 (405)
                      |+++|+|.+++... +..+++..+..++.||+.||+|||++||+||||||+|||++.++ +||+|||+++.....     
T Consensus       259 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~  338 (452)
T 1fmk_A          259 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR  338 (452)
T ss_dssp             CCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred             hhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCceecc
Confidence            99999999999753 34699999999999999999999999999999999999999887 999999999865431     


Q ss_pred             ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHH
Q 015500          153 LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSN  231 (405)
Q Consensus       153 ~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~  231 (405)
                      ....+|+.|+|||++.+..++.++|||||||++|||++ |+.||.... .......+.. ...+..|..+++.+.+||.+
T Consensus       339 ~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~-~~~~~~~i~~-~~~~~~~~~~~~~l~~li~~  416 (452)
T 1fmk_A          339 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-NREVLDQVER-GYRMPCPPECPESLHDLMCQ  416 (452)
T ss_dssp             ----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC-HHHHHHHHHT-TCCCCCCTTSCHHHHHHHHH
T ss_pred             cCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCC-HHHHHHHHHc-CCCCCCCCCCCHHHHHHHHH
Confidence            22346788999999999899999999999999999999 999996543 3444444433 33345677899999999999


Q ss_pred             hcccCccccCCHHHHhc
Q 015500          232 CLRRDPKERWAASQLLK  248 (405)
Q Consensus       232 ~L~~dP~~Rpt~~elL~  248 (405)
                      ||+.||.+|||++++++
T Consensus       417 cl~~dP~~Rpt~~~l~~  433 (452)
T 1fmk_A          417 CWRKEPEERPTFEYLQA  433 (452)
T ss_dssp             HTCSSGGGSCCHHHHHH
T ss_pred             HccCChhhCcCHHHHHH
Confidence            99999999999999976

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2.7e-44  Score=349.04  Aligned_cols=243  Identities=21%  Similarity=0.361  Sum_probs=185.2

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC---hHHHHHHHHHHHhCC-CCCeeeeeeeeeecC----CCceE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK---SEFLQREQKFLSSLN-SPHIVGYKGCDVTSE----DNKLM   73 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~---~~~l~~E~~iL~~L~-hpnIv~~~~~~~~~~----~~~~~   73 (405)
                      +|++++.||+|+||+||+|.+..+++.||||.+....   ...+.+|+.+++++. ||||+++++++....    .....
T Consensus        29 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~  108 (337)
T 3ll6_A           29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAE  108 (337)
T ss_dssp             EEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEE
T ss_pred             eEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCce
Confidence            5899999999999999999999999999999875443   346789999999996 999999998875322    23445


Q ss_pred             EEEEEeecCCCCHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCCCCEEEccCC-ceEeeeccccc
Q 015500           74 YNLFMEYAPGGTLNDEIHR--NGGRLDESLIVSYTRQILQGLEYLHSNR--VVHCDIKSRNILMAESG-AKIADFGCAKW  148 (405)
Q Consensus        74 ~~lv~Ey~~ggsL~~~i~~--~~~~l~e~~~~~i~~qIl~~L~yLH~~g--ivHrDlkp~NILi~~~~-vkL~DFGla~~  148 (405)
                      ++++|||+. |+|.+++..  ..+++++..+..++.||+.||.|||++|  |+||||||+|||++.++ +||+|||+++.
T Consensus       109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  187 (337)
T 3ll6_A          109 FLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATT  187 (337)
T ss_dssp             EEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTTCBC
T ss_pred             EEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCcccee
Confidence            779999996 699998865  3457999999999999999999999999  99999999999999887 99999999976


Q ss_pred             cccc----------------ccCCCCCCccChhhh---cCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHH
Q 015500          149 ESEA----------------LQSGGTPMFMAPEVA---RGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA  209 (405)
Q Consensus       149 ~~~~----------------~~~~gt~~Y~APE~l---~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~  209 (405)
                      ....                ....||+.|+|||++   .+..++.++|||||||++|+|++|+.||...... ..    .
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-~~----~  262 (337)
T 3ll6_A          188 ISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL-RI----V  262 (337)
T ss_dssp             CSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------------
T ss_pred             ccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH-Hh----h
Confidence            4331                134589999999998   4567889999999999999999999999643321 11    1


Q ss_pred             hcCCCCCCchhccHHHHHHHHHhcccCccccCCHHHHhcCc
Q 015500          210 YSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHP  250 (405)
Q Consensus       210 ~~~~~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp  250 (405)
                      ........+...++.+.+||.+||+.||.+|||+.|+++|.
T Consensus       263 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l  303 (337)
T 3ll6_A          263 NGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQL  303 (337)
T ss_dssp             ---CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred             cCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence            11111223345678899999999999999999999999983

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=4.5e-44  Score=344.34  Aligned_cols=240  Identities=24%  Similarity=0.362  Sum_probs=197.1

Q ss_pred             cccccccceeCCeeEEEEEEcCCCCEEEEEEccCC-------ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEE
Q 015500            3 WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP-------KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         3 y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~-------~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~   75 (405)
                      |..++.||+|+||+||+|.+  +++.+|||.+...       ..+.+.+|+.++++++||||+++++++.....    ++
T Consensus        33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~----~~  106 (307)
T 2nru_A           33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDD----LC  106 (307)
T ss_dssp             TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS----CE
T ss_pred             cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCc----eE
Confidence            45569999999999999986  5889999987542       13578899999999999999999998765433    56


Q ss_pred             EEEeecCCCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc-
Q 015500           76 LFMEYAPGGTLNDEIHRN--GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE-  151 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~--~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~-  151 (405)
                      ++|||+++++|.+++...  ..++++..+..++.||+.||.|||++||+||||||+||+++.++ +||+|||+++.... 
T Consensus       107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~  186 (307)
T 2nru_A          107 LVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKF  186 (307)
T ss_dssp             EEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred             EEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccc
Confidence            999999999999999743  34699999999999999999999999999999999999999887 99999999875433 


Q ss_pred             -----cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChH---HHHHHHH---------hcCCC
Q 015500          152 -----ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPM---TVLYKIA---------YSREL  214 (405)
Q Consensus       152 -----~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~---~~l~~i~---------~~~~~  214 (405)
                           .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.......   .....+.         .....
T Consensus       187 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (307)
T 2nru_A          187 AQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKM  265 (307)
T ss_dssp             SSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSC
T ss_pred             cccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccc
Confidence                 223469999999999876 47889999999999999999999996543221   1111111         11233


Q ss_pred             CCCchhccHHHHHHHHHhcccCccccCCHHHHhcC
Q 015500          215 PEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       215 ~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      +..+...++.+.+++.+||+.||.+|||+.+++++
T Consensus       266 ~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          266 NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            44556678899999999999999999999999875

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=8.8e-44  Score=342.18  Aligned_cols=233  Identities=23%  Similarity=0.373  Sum_probs=189.6

Q ss_pred             Ccccc-cccceeCCeeEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHH-HhCCCCCeeeeeeeeeecCCCceEEEEEEe
Q 015500            2 DWTRG-HTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFL-SSLNSPHIVGYKGCDVTSEDNKLMYNLFME   79 (405)
Q Consensus         2 ~y~~~-~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~~~~l~~E~~iL-~~L~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (405)
                      +|.+. +.||+|+||+||+|.++.+++.||+|.+..  .....+|+.++ +.++||||+++++++.........+++|||
T Consensus        18 ~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e   95 (299)
T 3m2w_A           18 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVME   95 (299)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC--SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEC
T ss_pred             chhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc--cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEe
Confidence            46666 789999999999999999999999999853  45678899988 666999999999988764444556789999


Q ss_pred             ecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcc---CC-ceEeeeccccccccccc
Q 015500           80 YAPGGTLNDEIHRNG-GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAE---SG-AKIADFGCAKWESEALQ  154 (405)
Q Consensus        80 y~~ggsL~~~i~~~~-~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~---~~-vkL~DFGla~~~~~~~~  154 (405)
                      |++||+|.+++...+ ..+++..++.++.||+.||.|||++||+||||||+|||++.   ++ +||+|||++....    
T Consensus        96 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~----  171 (299)
T 3m2w_A           96 CLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT----  171 (299)
T ss_dssp             CCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT----
T ss_pred             ecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc----
Confidence            999999999998754 36999999999999999999999999999999999999987   44 9999999986432    


Q ss_pred             CCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHH--HhcCCCCCCc----hhccHHHHHH
Q 015500          155 SGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKI--AYSRELPEVP----AFLSKQANDF  228 (405)
Q Consensus       155 ~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i--~~~~~~~~~p----~~~s~~l~dl  228 (405)
                                    +..++.++|||||||++|+|++|+.||....... .....  .........|    ..+++++.+|
T Consensus       172 --------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (299)
T 3m2w_A          172 --------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-ISPGMKTRIRMGQYEFPNPEWSEVSEEVKML  236 (299)
T ss_dssp             --------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC--------CCSCCSSCTTCCSSCHHHHTTSCHHHHHH
T ss_pred             --------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchh-hhHHHHHHHhhccccCCchhcccCCHHHHHH
Confidence                          2457789999999999999999999996443211 10000  0011111222    4579999999


Q ss_pred             HHHhcccCccccCCHHHHhcCcccccc
Q 015500          229 LSNCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       229 l~~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      |.+||+.||.+|||+.|+|+||||...
T Consensus       237 i~~~l~~dP~~Rps~~e~l~hp~~~~~  263 (299)
T 3m2w_A          237 IRNLLKTEPTQRMTITEFMNHPWIMQS  263 (299)
T ss_dssp             HHHHTCSSTTTSCCHHHHHTSHHHHTG
T ss_pred             HHHHcccChhhCCCHHHHhcChhhccc
Confidence            999999999999999999999999864

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.7e-43  Score=363.63  Aligned_cols=243  Identities=21%  Similarity=0.286  Sum_probs=198.8

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC-ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEee
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP-KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEY   80 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~-~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~Ey   80 (405)
                      +|++++.||+|+||+||+|.+..+++.||||++... ....+.+|+++++.|+|++++..+..+.....   .+++||||
T Consensus         8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~---~~~lvme~   84 (483)
T 3sv0_A            8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGD---YNVLVMDL   84 (483)
T ss_dssp             TEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETT---EEEEEEEC
T ss_pred             cEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCC---EEEEEEEC
Confidence            599999999999999999999999999999987643 34578999999999988554444333332222   46699999


Q ss_pred             cCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEE---ccCC-ceEeeeccccccccc----
Q 015500           81 APGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILM---AESG-AKIADFGCAKWESEA----  152 (405)
Q Consensus        81 ~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi---~~~~-vkL~DFGla~~~~~~----  152 (405)
                      + +++|.+++....+.+++..++.|+.||+.||+|||++||+||||||+||||   +.++ +||+|||+++.....    
T Consensus        85 ~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~  163 (483)
T 3sv0_A           85 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ  163 (483)
T ss_dssp             C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCC
T ss_pred             C-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcccc
Confidence            9 999999998777789999999999999999999999999999999999999   3555 999999999864432    


Q ss_pred             -------ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC--hHHHHHHHH---hcCCCCCCchh
Q 015500          153 -------LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAAD--PMTVLYKIA---YSRELPEVPAF  220 (405)
Q Consensus       153 -------~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~--~~~~l~~i~---~~~~~~~~p~~  220 (405)
                             ....||+.|+|||++.+..++.++|||||||++|||++|+.||.....  ....+.++.   .......++..
T Consensus       164 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~  243 (483)
T 3sv0_A          164 HIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALCRG  243 (483)
T ss_dssp             BCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHHTT
T ss_pred             ccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHHhcC
Confidence                   145699999999999999999999999999999999999999976443  222222222   12222233456


Q ss_pred             ccHHHHHHHHHhcccCccccCCHHHHhc
Q 015500          221 LSKQANDFLSNCLRRDPKERWAASQLLK  248 (405)
Q Consensus       221 ~s~~l~dll~~~L~~dP~~Rpt~~elL~  248 (405)
                      +++++.+||.+||+.||.+||++.+|++
T Consensus       244 ~p~~l~~li~~cl~~dP~~RPs~~el~~  271 (483)
T 3sv0_A          244 YPTEFASYFHYCRSLRFDDKPDYSYLKR  271 (483)
T ss_dssp             SCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             CcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            7899999999999999999999998765

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=2e-43  Score=373.28  Aligned_cols=234  Identities=24%  Similarity=0.305  Sum_probs=198.5

Q ss_pred             ccceeCCeeEEEEEEcC--CCCEEEEEEccCC----ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEeec
Q 015500            8 TIGQGSSATVSLATSLR--SGDVFAAKSTELP----KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYA   81 (405)
Q Consensus         8 ~LG~G~~g~Vyla~~~~--~~~~vavK~~~~~----~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~Ey~   81 (405)
                      .||+|+||+||+|.++.  ++..||||.+...    ..+.+.+|+++|++++||||+++++++.. +.    +++||||+
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~----~~lv~E~~  417 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA----LMLVMEMA  417 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SS----EEEEEECC
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CC----eEEEEEeC
Confidence            79999999999998764  5567999998753    35678999999999999999999998753 22    56999999


Q ss_pred             CCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc-------c
Q 015500           82 PGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA-------L  153 (405)
Q Consensus        82 ~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~-------~  153 (405)
                      ++|+|.+++....+.+++..+..++.||+.||+|||++||+||||||+|||++.++ +||+|||+++.....       .
T Consensus       418 ~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~  497 (613)
T 2ozo_A          418 GGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS  497 (613)
T ss_dssp             TTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----------
T ss_pred             CCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeecc
Confidence            99999999987767899999999999999999999999999999999999999888 999999999865321       1


Q ss_pred             cCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHh
Q 015500          154 QSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNC  232 (405)
Q Consensus       154 ~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~  232 (405)
                      ...+|+.|+|||++.+..++.++|||||||++|||++ |+.||..... ......+.. ...+..|..+++++.+||.+|
T Consensus       498 ~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~-~~~~~~i~~-~~~~~~p~~~~~~l~~li~~c  575 (613)
T 2ozo_A          498 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-PEVMAFIEQ-GKRMECPPECPPELYALMSDC  575 (613)
T ss_dssp             ----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS-HHHHHHHHT-TCCCCCCTTCCHHHHHHHHHT
T ss_pred             CCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH-HHHHHHHHc-CCCCCCCCcCCHHHHHHHHHH
Confidence            2235689999999999999999999999999999998 9999976544 344444433 344567788999999999999


Q ss_pred             cccCccccCCHHHHhc
Q 015500          233 LRRDPKERWAASQLLK  248 (405)
Q Consensus       233 L~~dP~~Rpt~~elL~  248 (405)
                      |+.||.+|||+.++++
T Consensus       576 l~~dP~~RPs~~~l~~  591 (613)
T 2ozo_A          576 WIYKWEDRPDFLTVEQ  591 (613)
T ss_dssp             TCSSTTTSCCHHHHHH
T ss_pred             cCCChhHCcCHHHHHH
Confidence            9999999999999854

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=4.6e-44  Score=345.82  Aligned_cols=240  Identities=20%  Similarity=0.282  Sum_probs=197.6

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC-----ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP-----KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~-----~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      +|++++.||+|+||+||+|.+..   .+|+|.+...     ..+.+.+|+.++++++||||+++++++.....    +++
T Consensus        34 ~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~----~~i  106 (319)
T 2y4i_B           34 QLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH----LAI  106 (319)
T ss_dssp             CEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC----EEE
T ss_pred             HeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc----eEE
Confidence            58899999999999999999853   4899987643     23567899999999999999999998765443    669


Q ss_pred             EEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCCceEeeecccccccc-----
Q 015500           77 FMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGAKIADFGCAKWESE-----  151 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~vkL~DFGla~~~~~-----  151 (405)
                      +|||++|++|.+++...+..+++..+..++.||+.||.|||++||+||||||+||+++.+.+||+|||+++....     
T Consensus       107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~~~~~~l~Dfg~~~~~~~~~~~~  186 (319)
T 2y4i_B          107 ITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYDNGKVVITDFGLFSISGVLQAGR  186 (319)
T ss_dssp             ECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC--CCEECCCSCCC---------
T ss_pred             EeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEeCCCEEEeecCCccccccccccc
Confidence            999999999999998776689999999999999999999999999999999999999966699999999865321     


Q ss_pred             ----cccCCCCCCccChhhhcC---------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCc
Q 015500          152 ----ALQSGGTPMFMAPEVARG---------EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVP  218 (405)
Q Consensus       152 ----~~~~~gt~~Y~APE~l~~---------~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p  218 (405)
                          .....||+.|+|||++.+         ..++.++|||||||++|+|++|+.||... ........+......+..+
T Consensus       187 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~  265 (319)
T 2y4i_B          187 REDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ-PAEAIIWQMGTGMKPNLSQ  265 (319)
T ss_dssp             -CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSC-CHHHHHHHHHTTCCCCCCC
T ss_pred             cccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHhccCCCCCCCc
Confidence                223358999999999975         34788999999999999999999999644 3444444444443333334


Q ss_pred             hhccHHHHHHHHHhcccCccccCCHHHHhcC
Q 015500          219 AFLSKQANDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       219 ~~~s~~l~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      ..+++++.+||.+||..||.+|||+.++++.
T Consensus       266 ~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~  296 (319)
T 2y4i_B          266 IGMGKEISDILLFCWAFEQEERPTFTKLMDM  296 (319)
T ss_dssp             SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred             CCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence            4688999999999999999999999999874

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=2e-43  Score=374.55  Aligned_cols=235  Identities=25%  Similarity=0.334  Sum_probs=197.6

Q ss_pred             cccceeCCeeEEEEEE--cCCCCEEEEEEccCCC-----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEe
Q 015500            7 HTIGQGSSATVSLATS--LRSGDVFAAKSTELPK-----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFME   79 (405)
Q Consensus         7 ~~LG~G~~g~Vyla~~--~~~~~~vavK~~~~~~-----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (405)
                      +.||+|+||+||+|.+  +.+++.||||.+....     .+.+.+|+++|++|+||||+++++++.. ..    +++|||
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~----~~lv~E  449 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ES----WMLVME  449 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SS----EEEEEE
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CC----EEEEEE
Confidence            5799999999999955  4567899999986432     3678999999999999999999997642 22    559999


Q ss_pred             ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc-------
Q 015500           80 YAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE-------  151 (405)
Q Consensus        80 y~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~-------  151 (405)
                      |+++|+|.+++... +.+++..++.++.||+.||+|||++||+||||||+||||+.++ +||+|||+++....       
T Consensus       450 ~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  528 (635)
T 4fl3_A          450 MAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA  528 (635)
T ss_dssp             CCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred             ccCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccc
Confidence            99999999999775 4799999999999999999999999999999999999999988 99999999976432       


Q ss_pred             cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHH
Q 015500          152 ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLS  230 (405)
Q Consensus       152 ~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~  230 (405)
                      .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||.... .......+. ....+..|..+++++.+||.
T Consensus       529 ~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~-~~~~~~~i~-~~~~~~~p~~~~~~l~~li~  606 (635)
T 4fl3_A          529 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK-GSEVTAMLE-KGERMGCPAGCPREMYDLMN  606 (635)
T ss_dssp             ------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC-HHHHHHHHH-TTCCCCCCTTCCHHHHHHHH
T ss_pred             ccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHHH-cCCCCCCCCCCCHHHHHHHH
Confidence            122346788999999999999999999999999999998 999996543 333333333 44456678889999999999


Q ss_pred             HhcccCccccCCHHHHhcC
Q 015500          231 NCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       231 ~~L~~dP~~Rpt~~elL~h  249 (405)
                      +||+.||.+|||++++++.
T Consensus       607 ~cl~~dP~~RPs~~~l~~~  625 (635)
T 4fl3_A          607 LCWTYDVENRPGFAAVELR  625 (635)
T ss_dssp             HHTCSSTTTSCCHHHHHHH
T ss_pred             HHcCCCHhHCcCHHHHHHH
Confidence            9999999999999999763

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=2.9e-43  Score=366.27  Aligned_cols=240  Identities=25%  Similarity=0.347  Sum_probs=202.7

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC--ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEe
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP--KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFME   79 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~--~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (405)
                      +|++.+.||+|+||+||+|.+.. +..||||.+...  ..+.+.+|+++|++|+||||+++++++.. ..    +++|||
T Consensus       268 ~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~----~~lv~e  341 (535)
T 2h8h_A          268 SLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP----IYIVTE  341 (535)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS----CEEEEC
T ss_pred             hhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-cc----ceEeee
Confidence            47788999999999999999864 467999998754  34679999999999999999999987643 21    459999


Q ss_pred             ecCCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc-----c
Q 015500           80 YAPGGTLNDEIHRN-GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE-----A  152 (405)
Q Consensus        80 y~~ggsL~~~i~~~-~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~-----~  152 (405)
                      |+++|+|.+++... +..+++..+..++.||+.||+|||++||+||||||+|||++.++ +||+|||+++....     .
T Consensus       342 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~  421 (535)
T 2h8h_A          342 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR  421 (535)
T ss_dssp             CCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTT
T ss_pred             hhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecc
Confidence            99999999999753 34699999999999999999999999999999999999998877 99999999986543     1


Q ss_pred             ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHH
Q 015500          153 LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSN  231 (405)
Q Consensus       153 ~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~  231 (405)
                      ....+|+.|+|||++.+..++.++|||||||++|||++ |+.||.... ....+..+.. ......|..+++.+.+||.+
T Consensus       422 ~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~-~~~~~~~i~~-~~~~~~~~~~~~~l~~li~~  499 (535)
T 2h8h_A          422 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-NREVLDQVER-GYRMPCPPECPESLHDLMCQ  499 (535)
T ss_dssp             CSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCC-HHHHHHHHHT-TCCCCCCTTCCHHHHHHHHH
T ss_pred             cCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHHHc-CCCCCCCCCCCHHHHHHHHH
Confidence            23346788999999999899999999999999999999 999996543 3444444433 33345667899999999999


Q ss_pred             hcccCccccCCHHHHhcC
Q 015500          232 CLRRDPKERWAASQLLKH  249 (405)
Q Consensus       232 ~L~~dP~~Rpt~~elL~h  249 (405)
                      ||+.||++|||+++|++.
T Consensus       500 cl~~dP~~RPt~~~l~~~  517 (535)
T 2h8h_A          500 CWRKEPEERPTFEYLQAF  517 (535)
T ss_dssp             HTCSSGGGSCCHHHHHHH
T ss_pred             HcCCChhHCcCHHHHHHH
Confidence            999999999999999763

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=4.2e-45  Score=357.11  Aligned_cols=241  Identities=16%  Similarity=0.165  Sum_probs=188.9

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-----------hHHHHHHHHHHHhCC---------CCCeeeee
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-----------SEFLQREQKFLSSLN---------SPHIVGYK   61 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-----------~~~l~~E~~iL~~L~---------hpnIv~~~   61 (405)
                      +|++++.||+|+||+||+|++  +|+.||||.+....           .+.+.+|+.+|+.|+         ||||+++.
T Consensus        21 ~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~   98 (336)
T 2vuw_A           21 KLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN   98 (336)
T ss_dssp             HHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred             cchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence            488999999999999999998  68999999986542           267899999999886         77777776


Q ss_pred             eeeeecC--------------------------CCceEEEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHH
Q 015500           62 GCDVTSE--------------------------DNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY  115 (405)
Q Consensus        62 ~~~~~~~--------------------------~~~~~~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~y  115 (405)
                      +.+....                          .....+++||||+++|++.+.+.+  +.+++..++.+++||+.||+|
T Consensus        99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL~~  176 (336)
T 2vuw_A           99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASLAV  176 (336)
T ss_dssp             EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHHHH
T ss_pred             ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHHHH
Confidence            6543210                          002236799999999987766644  478999999999999999999


Q ss_pred             HH-hCCceeCCCCCCCEEEccC---------------------CceEeeecccccccccccCCCCCCccChhhhcCCCCC
Q 015500          116 LH-SNRVVHCDIKSRNILMAES---------------------GAKIADFGCAKWESEALQSGGTPMFMAPEVARGEHQG  173 (405)
Q Consensus       116 LH-~~givHrDlkp~NILi~~~---------------------~vkL~DFGla~~~~~~~~~~gt~~Y~APE~l~~~~~~  173 (405)
                      || ++||+||||||+|||++.+                     .+||+|||+|+..... ...||+.|+|||++.+.. +
T Consensus       177 lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-~~~gt~~y~aPE~~~g~~-~  254 (336)
T 2vuw_A          177 AEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-IVVFCDVSMDEDLFTGDG-D  254 (336)
T ss_dssp             HHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-EEECCCCTTCSGGGCCCS-S
T ss_pred             HHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-cEEEeecccChhhhcCCC-c
Confidence            99 9999999999999999876                     4899999999866543 447999999999999876 8


Q ss_pred             cchhHHHHHHH-HHHHHhCCCCCCCCCChHHHHHHHHhcCC-----CCCCchhccHHHHHHHHHhcccCccccCCHHHHh
Q 015500          174 FASDIWAVGCT-VIEMASGGAPWPNAADPMTVLYKIAYSRE-----LPEVPAFLSKQANDFLSNCLRRDPKERWAASQLL  247 (405)
Q Consensus       174 ~~sDIwSLG~i-l~elltG~~Pf~~~~~~~~~l~~i~~~~~-----~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL  247 (405)
                      +++||||||++ .+++++|..||............+.....     .+..+..+++++++||++||++|     |++|+|
T Consensus       255 ~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          255 YQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred             cceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHHHHH
Confidence            89999998777 88899999999431100111122221111     11223468999999999999987     999999


Q ss_pred             -cCcccc
Q 015500          248 -KHPFLE  253 (405)
Q Consensus       248 -~hp~~~  253 (405)
                       +||||+
T Consensus       330 ~~Hp~f~  336 (336)
T 2vuw_A          330 CQHSLFK  336 (336)
T ss_dssp             HHCGGGC
T ss_pred             hcCCCcC
Confidence             999995

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=2.2e-44  Score=380.72  Aligned_cols=255  Identities=24%  Similarity=0.321  Sum_probs=203.9

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecC--CCceEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSE--DNKLMYN   75 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~--~~~~~~~   75 (405)
                      +|++++.||+|+||+||+|.+..+|+.||||.+....    .+.+.+|+++|++++||||+++++++....  .....++
T Consensus        15 rY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~   94 (676)
T 3qa8_A           15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPL   94 (676)
T ss_dssp             --CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCC
T ss_pred             CeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEE
Confidence            5999999999999999999999999999999986542    356889999999999999999998754311  1122356


Q ss_pred             EEEeecCCCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC----ceEeeecccccc
Q 015500           76 LFMEYAPGGTLNDEIHRNG--GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG----AKIADFGCAKWE  149 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~~--~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~----vkL~DFGla~~~  149 (405)
                      +||||++||+|.+++....  ..+++..++.++.||+.||+|||++||+||||||+||+++.++    +||+|||++...
T Consensus        95 LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~  174 (676)
T 3qa8_A           95 LAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL  174 (676)
T ss_dssp             CEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBT
T ss_pred             EEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccccccc
Confidence            9999999999999998643  2689999999999999999999999999999999999998664    899999999865


Q ss_pred             cc---cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHH--------HHHH---------
Q 015500          150 SE---ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVL--------YKIA---------  209 (405)
Q Consensus       150 ~~---~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l--------~~i~---------  209 (405)
                      ..   .....||+.|+|||++.+..++.++|||||||++|+|++|..||.....+....        ..+.         
T Consensus       175 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~  254 (676)
T 3qa8_A          175 DQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAV  254 (676)
T ss_dssp             TSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSSSC
T ss_pred             ccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhcccc
Confidence            44   234569999999999999999999999999999999999999996432221100        0000         


Q ss_pred             -hcCC---CCCCchhccHHHHHHHHHhcccCccccCCHHHHhcCccccccc
Q 015500          210 -YSRE---LPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFC  256 (405)
Q Consensus       210 -~~~~---~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~  256 (405)
                       +...   ...++..+++.+.+||.+||..||.+|||+.++++||||+.+.
T Consensus       255 ~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~  305 (676)
T 3qa8_A          255 KFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALD  305 (676)
T ss_dssp             CCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHH
T ss_pred             ccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHH
Confidence             0000   1123445789999999999999999999999999999998753

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.1e-42  Score=370.06  Aligned_cols=241  Identities=24%  Similarity=0.354  Sum_probs=203.3

Q ss_pred             CcccccccceeCCeeEEEEEEcCC---CCEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRS---GDVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMY   74 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~---~~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~   74 (405)
                      +|.+++.||+|+||+||+|.+..+   +..+|+|.+....    .+.+.+|+.+|++++||||+++++++.. .  .  +
T Consensus       391 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~--~--~  465 (656)
T 2j0j_A          391 RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-N--P--V  465 (656)
T ss_dssp             GEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S--S--C
T ss_pred             cEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-C--c--e
Confidence            477889999999999999998654   4579999976543    2568899999999999999999987632 2  2  4


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc-
Q 015500           75 NLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA-  152 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~-  152 (405)
                      ++||||+++|+|.+++...+..+++..+..++.||+.||.|||++||+||||||+|||++.++ +||+|||+++..... 
T Consensus       466 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~  545 (656)
T 2j0j_A          466 WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST  545 (656)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC--
T ss_pred             EEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCCCc
Confidence            589999999999999988766899999999999999999999999999999999999999888 999999999865432 


Q ss_pred             ----ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHH
Q 015500          153 ----LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQAND  227 (405)
Q Consensus       153 ----~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~d  227 (405)
                          ....+|+.|+|||++.+..++.++|||||||++|||++ |..||... ........+... ..+..|..+++.+.+
T Consensus       546 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~-~~~~~~~~i~~~-~~~~~~~~~~~~l~~  623 (656)
T 2j0j_A          546 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV-KNNDVIGRIENG-ERLPMPPNCPPTLYS  623 (656)
T ss_dssp             --------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-CHHHHHHHHHHT-CCCCCCTTCCHHHHH
T ss_pred             ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHHcC-CCCCCCccccHHHHH
Confidence                12347789999999999999999999999999999997 99999654 344444444433 445577889999999


Q ss_pred             HHHHhcccCccccCCHHHHhcC
Q 015500          228 FLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       228 ll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      ||.+||..||.+|||+.++++.
T Consensus       624 li~~~l~~dP~~RPs~~el~~~  645 (656)
T 2j0j_A          624 LMTKCWAYDPSRRPRFTELKAQ  645 (656)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHcCCChhHCcCHHHHHHH
Confidence            9999999999999999999864

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.1e-43  Score=357.90  Aligned_cols=245  Identities=18%  Similarity=0.189  Sum_probs=190.1

Q ss_pred             cccccccceeCCeeEEEEEEcCCCCEEEEEEccCC------ChHHHHHHHHHHHhCCC-CCeeeeee---------e---
Q 015500            3 WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQREQKFLSSLNS-PHIVGYKG---------C---   63 (405)
Q Consensus         3 y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~------~~~~l~~E~~iL~~L~h-pnIv~~~~---------~---   63 (405)
                      |+.++.||+|+||+||+|.+..+|+.||||++...      ..+.+.+|+.+++.++| +|+.....         .   
T Consensus        80 ~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  159 (413)
T 3dzo_A           80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKD  159 (413)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEEC
T ss_pred             EEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhccc
Confidence            67889999999999999999999999999988732      24678999999999987 32211110         0   


Q ss_pred             ---------eeecC-CCceEEEEEEeecCCCCHHHHHHH------cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCC
Q 015500           64 ---------DVTSE-DNKLMYNLFMEYAPGGTLNDEIHR------NGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIK  127 (405)
Q Consensus        64 ---------~~~~~-~~~~~~~lv~Ey~~ggsL~~~i~~------~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlk  127 (405)
                               +.... .....++++|+++ +++|.+++..      .++.+++..+..++.||+.||+|||++||+|||||
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiK  238 (413)
T 3dzo_A          160 PQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLR  238 (413)
T ss_dssp             CC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCC
T ss_pred             CCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcc
Confidence                     00000 0011245677766 6799999852      23457888999999999999999999999999999


Q ss_pred             CCCEEEccCC-ceEeeecccccccc-cccCCCCCCccChhhh----------cCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 015500          128 SRNILMAESG-AKIADFGCAKWESE-ALQSGGTPMFMAPEVA----------RGEHQGFASDIWAVGCTVIEMASGGAPW  195 (405)
Q Consensus       128 p~NILi~~~~-vkL~DFGla~~~~~-~~~~~gt~~Y~APE~l----------~~~~~~~~sDIwSLG~il~elltG~~Pf  195 (405)
                      |+|||++.++ +||+|||+++.... ....+| +.|+|||++          .+..++.++|||||||++|||+||+.||
T Consensus       239 p~NILl~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf  317 (413)
T 3dzo_A          239 PVDIVLDQRGGVFLTGFEHLVRDGASAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPN  317 (413)
T ss_dssp             GGGEEECTTCCEEECCGGGCEETTEEECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCC
T ss_pred             cceEEEecCCeEEEEeccceeecCCccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCC
Confidence            9999999987 99999999986555 334567 999999999          5556888999999999999999999999


Q ss_pred             CCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHhcccCccccCCHHHHhcCccccccc
Q 015500          196 PNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFC  256 (405)
Q Consensus       196 ~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~  256 (405)
                      ...... .....+     + .....+|+++.+||.+||+.||.+|||+.++++||||+.+.
T Consensus       318 ~~~~~~-~~~~~~-----~-~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~~  371 (413)
T 3dzo_A          318 TDDAAL-GGSEWI-----F-RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLR  371 (413)
T ss_dssp             CTTGGG-SCSGGG-----G-SSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred             CCcchh-hhHHHH-----H-hhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHHH
Confidence            644221 111110     1 11134789999999999999999999999999999998764

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3e-42  Score=368.32  Aligned_cols=239  Identities=23%  Similarity=0.315  Sum_probs=201.1

Q ss_pred             CcccccccceeCCeeEEEEEEcC-CCCEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCC-CceEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLR-SGDVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSED-NKLMYN   75 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~-~~~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~-~~~~~~   75 (405)
                      +|++++.||+|+||+||+|.+.. +|+.||||.+....    ...+.+|+++|++++||||+++++++..... ....+|
T Consensus        81 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~  160 (681)
T 2pzi_A           81 QYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGY  160 (681)
T ss_dssp             TEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred             ceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeE
Confidence            58999999999999999999976 78999999886432    2467899999999999999999998876554 233457


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCCceEeeecccccccccccC
Q 015500           76 LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGAKIADFGCAKWESEALQS  155 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~vkL~DFGla~~~~~~~~~  155 (405)
                      +||||++|++|.+++..   ++++..++.++.||+.||.|||++||+||||||+|||++.+.+||+|||+++........
T Consensus       161 lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~~~kl~DFG~a~~~~~~~~~  237 (681)
T 2pzi_A          161 IVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEEQLKLIDLGAVSRINSFGYL  237 (681)
T ss_dssp             EEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSCEEECCCTTCEETTCCSCC
T ss_pred             EEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCCcEEEEecccchhcccCCcc
Confidence            99999999999987753   699999999999999999999999999999999999999888999999999887766677


Q ss_pred             CCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCC--CchhccHHHHHHHHHhc
Q 015500          156 GGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPE--VPAFLSKQANDFLSNCL  233 (405)
Q Consensus       156 ~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~--~p~~~s~~l~dll~~~L  233 (405)
                      .||+.|+|||++.+.. +.++|||||||++|+|++|..||.....           ...+.  .....++.+.+||.+||
T Consensus       238 ~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~-----------~~~~~~~~~~~~~~~l~~li~~~l  305 (681)
T 2pzi_A          238 YGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYV-----------DGLPEDDPVLKTYDSYGRLLRRAI  305 (681)
T ss_dssp             CCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEEC-----------SSCCTTCHHHHHCHHHHHHHHHHT
T ss_pred             CCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccc-----------ccccccccccccCHHHHHHHhhhc
Confidence            8999999999998754 8899999999999999999999853211           11111  11235788999999999


Q ss_pred             ccCccccCCHHHHhcCcccccc
Q 015500          234 RRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       234 ~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      +.||.+||+..+.+.|+|+...
T Consensus       306 ~~dP~~R~~~~~~l~~~l~~~~  327 (681)
T 2pzi_A          306 DPDPRQRFTTAEEMSAQLTGVL  327 (681)
T ss_dssp             CSSGGGSCSSHHHHHHHHHHHH
T ss_pred             cCChhhCCCHHHHHHHHHHHHH
Confidence            9999999999999999988643

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=4.5e-41  Score=322.56  Aligned_cols=216  Identities=13%  Similarity=0.066  Sum_probs=176.4

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCCh------HHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS------EFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~~------~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~   75 (405)
                      +|++++.||+|+||+||+|.+..+++.||||.+.....      +.+.+|+.++++++||||+++++++....    .++
T Consensus        32 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~----~~~  107 (286)
T 3uqc_A           32 RYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRA----GGL  107 (286)
T ss_dssp             TEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT----EEE
T ss_pred             cEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECC----cEE
Confidence            48999999999999999999999999999999876432      57889999999999999999999876543    367


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccccc
Q 015500           76 LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQ  154 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~~~  154 (405)
                      +||||++|++|.+++++.   ..+..+..++.||+.||+|||++||+||||||+|||++.++ +||+++           
T Consensus       108 lv~e~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~-----------  173 (286)
T 3uqc_A          108 VVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYP-----------  173 (286)
T ss_dssp             EEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSC-----------
T ss_pred             EEEEecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEec-----------
Confidence            999999999999998542   45667889999999999999999999999999999999887 888744           


Q ss_pred             CCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHH--HHHHHhcCCCC---CCchhccHHHHHHH
Q 015500          155 SGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTV--LYKIAYSRELP---EVPAFLSKQANDFL  229 (405)
Q Consensus       155 ~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~--l~~i~~~~~~~---~~p~~~s~~l~dll  229 (405)
                           .|++|       ++.++|||||||++|+|+||+.||.........  ..+.. ....+   ..+..+++++.+||
T Consensus       174 -----~~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li  240 (286)
T 3uqc_A          174 -----ATMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDT-AGQPIEPADIDRDIPFQISAVA  240 (286)
T ss_dssp             -----CCCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCT-TSCBCCHHHHCTTSCHHHHHHH
T ss_pred             -----cccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHh-ccCCCChhhcccCCCHHHHHHH
Confidence                 34443       788999999999999999999999754321100  00000 11111   12345889999999


Q ss_pred             HHhcccCccccCCHHHHhcC
Q 015500          230 SNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       230 ~~~L~~dP~~Rpt~~elL~h  249 (405)
                      .+||+.||.+| |+.++++.
T Consensus       241 ~~~l~~dP~~R-s~~el~~~  259 (286)
T 3uqc_A          241 ARSVQGDGGIR-SASTLLNL  259 (286)
T ss_dssp             HHHHCTTSSCC-CHHHHHHH
T ss_pred             HHHcccCCccC-CHHHHHHH
Confidence            99999999999 99999875

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.98  E-value=3e-34  Score=300.35  Aligned_cols=221  Identities=13%  Similarity=0.117  Sum_probs=151.1

Q ss_pred             cceeCCeeEEEEEEcCCCCEEEEEEccCCC-------------hHHHHHHHHHHHhC-CCCCeeeeeeeeeecCCCceEE
Q 015500            9 IGQGSSATVSLATSLRSGDVFAAKSTELPK-------------SEFLQREQKFLSSL-NSPHIVGYKGCDVTSEDNKLMY   74 (405)
Q Consensus         9 LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-------------~~~l~~E~~iL~~L-~hpnIv~~~~~~~~~~~~~~~~   74 (405)
                      .+.|+.|.+..++..-.|+.+|+|++....             .+.+.+|+++|+++ .||||+++++++.+...    +
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~----~  317 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQS----G  317 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSE----E
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCE----E
Confidence            566777777777777789999999886531             24688999999999 79999999988765443    6


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc--
Q 015500           75 NLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE--  151 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~--  151 (405)
                      ||||||++|++|.++|.+. +++++.   .|+.||+.||+|+|++|||||||||+|||++.++ +||+|||+|+....  
T Consensus       318 yLVMEyv~G~~L~d~i~~~-~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~  393 (569)
T 4azs_A          318 WLVMEKLPGRLLSDMLAAG-EEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC  393 (569)
T ss_dssp             EEEEECCCSEEHHHHHHTT-CCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred             EEEEecCCCCcHHHHHHhC-CCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCC
Confidence            7999999999999999876 578775   4789999999999999999999999999999988 99999999986544  


Q ss_pred             --cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHH
Q 015500          152 --ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFL  229 (405)
Q Consensus       152 --~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll  229 (405)
                        ..+.+||+.|||||++.+. +..++|+||+|+++++|.++..||.          .......    +.  ...+.++.
T Consensus       394 ~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~~~----------~~l~~~~----~~--~~~~~~l~  456 (569)
T 4azs_A          394 SWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSNWL----------YAVWQEP----VE--RWNFVLLL  456 (569)
T ss_dssp             CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHHH----------HHHHTSC----GG--GCSHHHHH
T ss_pred             ccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccchhH----------HHhhcCC----CC--CCcHHHHH
Confidence              2345699999999999874 5678999999999988877654431          1111111    01  11245667


Q ss_pred             HHhcccCccccCCHHHHhcCccccc
Q 015500          230 SNCLRRDPKERWAASQLLKHPFLEE  254 (405)
Q Consensus       230 ~~~L~~dP~~Rpt~~elL~hp~~~~  254 (405)
                      ..+...+|..|+.......|+|...
T Consensus       457 ~~l~~~~~~~~~~~~~~~~~~~~~~  481 (569)
T 4azs_A          457 ALFEKKAKLPSAEQQRGATEQWIIA  481 (569)
T ss_dssp             HHHHTGGGSCCGGGSSCCHHHHHHH
T ss_pred             HHHhCCCCCCCCChhhhccchhHHH
Confidence            7777788888887777777776643

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.95  E-value=4.4e-29  Score=259.77  Aligned_cols=175  Identities=21%  Similarity=0.208  Sum_probs=140.1

Q ss_pred             cccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-----------hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceE
Q 015500            5 RGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-----------SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLM   73 (405)
Q Consensus         5 ~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-----------~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~   73 (405)
                      ..+.||+|+||+||+|.  ..++.+++|......           .+.+.+|+++|++++||||+++..++.....    
T Consensus       340 ~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~----  413 (540)
T 3en9_A          340 PEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDN----  413 (540)
T ss_dssp             --------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTT----
T ss_pred             CCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCc----
Confidence            45789999999999994  457889998754322           2347899999999999999966555554433    


Q ss_pred             EEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCCceEeeeccccccccc-
Q 015500           74 YNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGAKIADFGCAKWESEA-  152 (405)
Q Consensus        74 ~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~vkL~DFGla~~~~~~-  152 (405)
                      .++||||++|++|.+++..         +..++.||+.||.|||++||+||||||+|||++. .+||+|||+++..... 
T Consensus       414 ~~lVmE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~-~~kL~DFGla~~~~~~~  483 (540)
T 3en9_A          414 KRIMMSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK-DLYIIDFGLGKISNLDE  483 (540)
T ss_dssp             TEEEEECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS-SEEECCCTTCEECCCHH
T ss_pred             cEEEEECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC-eEEEEECccCEECCCcc
Confidence            3599999999999998865         5689999999999999999999999999999999 9999999999875541 


Q ss_pred             ----------ccCCCCCCccChhhhcC--CCCCcchhHHHHHHHHHHHHhCCCCC
Q 015500          153 ----------LQSGGTPMFMAPEVARG--EHQGFASDIWAVGCTVIEMASGGAPW  195 (405)
Q Consensus       153 ----------~~~~gt~~Y~APE~l~~--~~~~~~sDIwSLG~il~elltG~~Pf  195 (405)
                                ....||+.|||||++..  ..|+..+|+|+..+-..+.+.++.+|
T Consensus       484 ~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          484 DKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             ccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence                      24569999999999987  55777889999999999988888776

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.92  E-value=8.8e-26  Score=216.07  Aligned_cols=140  Identities=17%  Similarity=0.124  Sum_probs=113.4

Q ss_pred             cccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC---------------------hHHHHHHHHHHHhCCCCCeeeee
Q 015500            3 WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK---------------------SEFLQREQKFLSSLNSPHIVGYK   61 (405)
Q Consensus         3 y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~---------------------~~~l~~E~~iL~~L~hpnIv~~~   61 (405)
                      |.+++.||+|+||.||+|.+ .+|+.||||.+....                     ...+.+|+.+|++++|   +++.
T Consensus        92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v~  167 (282)
T 1zar_A           92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAVP  167 (282)
T ss_dssp             SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSSC
T ss_pred             EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCcC
Confidence            45669999999999999999 889999999986432                     2457899999999994   5555


Q ss_pred             eeeeecCCCceEEEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceE
Q 015500           62 GCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKI  140 (405)
Q Consensus        62 ~~~~~~~~~~~~~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL  140 (405)
                      +++.. ..    .++||||++|++|.+ +.     .  .....++.||+.||.|||++||+||||||+|||++ ++ +||
T Consensus       168 ~~~~~-~~----~~lvmE~~~g~~L~~-l~-----~--~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl  233 (282)
T 1zar_A          168 KVYAW-EG----NAVLMELIDAKELYR-VR-----V--ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWI  233 (282)
T ss_dssp             CEEEE-ET----TEEEEECCCCEEGGG-CC-----C--SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEE
T ss_pred             eEEec-cc----eEEEEEecCCCcHHH-cc-----h--hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEE
Confidence            54322 21    359999999999987 41     1  23457999999999999999999999999999999 66 999


Q ss_pred             eeecccccccccccCCCCCCccChhhhcC
Q 015500          141 ADFGCAKWESEALQSGGTPMFMAPEVARG  169 (405)
Q Consensus       141 ~DFGla~~~~~~~~~~gt~~Y~APE~l~~  169 (405)
                      +|||+|+         .+..|+|||++..
T Consensus       234 ~DFG~a~---------~~~~~~a~e~l~r  253 (282)
T 1zar_A          234 IDFPQSV---------EVGEEGWREILER  253 (282)
T ss_dssp             CCCTTCE---------ETTSTTHHHHHHH
T ss_pred             EECCCCe---------ECCCCCHHHHHHH
Confidence            9999986         3556899999853

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.85  E-value=4.1e-22  Score=187.91  Aligned_cols=135  Identities=20%  Similarity=0.213  Sum_probs=105.9

Q ss_pred             cccccccceeCCeeEEEEEEcCCCCE--EEEEEccCCC---------------------------hHHHHHHHHHHHhCC
Q 015500            3 WTRGHTIGQGSSATVSLATSLRSGDV--FAAKSTELPK---------------------------SEFLQREQKFLSSLN   53 (405)
Q Consensus         3 y~~~~~LG~G~~g~Vyla~~~~~~~~--vavK~~~~~~---------------------------~~~l~~E~~iL~~L~   53 (405)
                      |.+++.||+|+||.||+|.+..+|+.  ||||++....                           ...+.+|+.+|++|.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            56788999999999999999778999  9999864321                           025789999999998


Q ss_pred             CCCeeeeeeeeeecCCCceEEEEEEeecCC-C----CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH-hCCceeCCCC
Q 015500           54 SPHIVGYKGCDVTSEDNKLMYNLFMEYAPG-G----TLNDEIHRNGGRLDESLIVSYTRQILQGLEYLH-SNRVVHCDIK  127 (405)
Q Consensus        54 hpnIv~~~~~~~~~~~~~~~~~lv~Ey~~g-g----sL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH-~~givHrDlk  127 (405)
                      |+++.....+.. . .    .++||||+.+ |    +|.+....    .++..+..++.||+.||.||| +.||+|||||
T Consensus       129 ~~~i~~p~~~~~-~-~----~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~givHrDlk  198 (258)
T 1zth_A          129 EAGVSVPQPYTY-M-K----NVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEAELVHADLS  198 (258)
T ss_dssp             HTTCCCCCEEEE-E-T----TEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCS
T ss_pred             hCCCCCCeEEEc-C-C----CEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCC
Confidence            876532211111 1 1    3589999942 3    67765432    235577899999999999999 9999999999


Q ss_pred             CCCEEEccCCceEeeeccccc
Q 015500          128 SRNILMAESGAKIADFGCAKW  148 (405)
Q Consensus       128 p~NILi~~~~vkL~DFGla~~  148 (405)
                      |+|||++. .++|+|||+|..
T Consensus       199 p~NILl~~-~~~liDFG~a~~  218 (258)
T 1zth_A          199 EYNIMYID-KVYFIDMGQAVT  218 (258)
T ss_dssp             TTSEEESS-SEEECCCTTCEE
T ss_pred             HHHEEEcC-cEEEEECccccc
Confidence            99999999 999999999964

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.73  E-value=3.5e-18  Score=169.58  Aligned_cols=131  Identities=17%  Similarity=0.176  Sum_probs=97.3

Q ss_pred             cccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-----------------h--------HHHHHHHHHHHhCCCCCe
Q 015500            3 WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-----------------S--------EFLQREQKFLSSLNSPHI   57 (405)
Q Consensus         3 y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-----------------~--------~~l~~E~~iL~~L~hpnI   57 (405)
                      |.++++||+|++|.||+|.+. +|+.||||++....                 .        -...+|...|.+|.++++
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            789999999999999999974 79999999865321                 0        012457777888855554


Q ss_pred             eeeeeeeeecCCCceEEEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC
Q 015500           58 VGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG  137 (405)
Q Consensus        58 v~~~~~~~~~~~~~~~~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~  137 (405)
                      .-..-+. ...     .+|||||++|++|.++.       ....+..++.||+.+|.+||+.|||||||||.|||++.++
T Consensus       176 ~vp~p~~-~~~-----~~LVME~i~G~~L~~l~-------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dg  242 (397)
T 4gyi_A          176 PVPEPIA-QSR-----HTIVMSLVDALPMRQVS-------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEK  242 (397)
T ss_dssp             SCCCEEE-EET-----TEEEEECCSCEEGGGCC-------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEE
T ss_pred             CCCeeee-ccC-----ceEEEEecCCccHhhhc-------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCC
Confidence            3221111 111     24899999998886532       1224467889999999999999999999999999998765


Q ss_pred             -----------ceEeeecccc
Q 015500          138 -----------AKIADFGCAK  147 (405)
Q Consensus       138 -----------vkL~DFGla~  147 (405)
                                 +.|+||+-+-
T Consensus       243 d~~d~~~~~~~~~iID~~Q~V  263 (397)
T 4gyi_A          243 DAEDPSSITLTPIIIXFPQMV  263 (397)
T ss_dssp             CSSCTTSEEEEEEECCCTTCE
T ss_pred             CcccccccccceEEEEeCCcc
Confidence                       6899998654

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.36  E-value=2e-12  Score=120.76  Aligned_cols=134  Identities=18%  Similarity=0.151  Sum_probs=104.2

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccC---CChHHHHHHHHHHHhCC-CCCeeeeeeeeeecCCCceEEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL---PKSEFLQREQKFLSSLN-SPHIVGYKGCDVTSEDNKLMYNLF   77 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~---~~~~~l~~E~~iL~~L~-hpnIv~~~~~~~~~~~~~~~~~lv   77 (405)
                      .|+....+|.|+.+.||++...  ++.+++|....   .....+.+|..+|+.|. +..+.++++.....  +  ..++|
T Consensus        15 ~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~--~--~~~lv   88 (263)
T 3tm0_A           15 KYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHD--G--WSNLL   88 (263)
T ss_dssp             TSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEET--T--EEEEE
T ss_pred             cceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecC--C--ceEEE
Confidence            3677788888999999999743  68999999764   44567999999999994 56666777665432  1  35699


Q ss_pred             EeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------
Q 015500           78 MEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHS---------------------------------------  118 (405)
Q Consensus        78 ~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~---------------------------------------  118 (405)
                      |||++|.+|.+.+.      +......++.+++.+|..||+                                       
T Consensus        89 ~e~i~G~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (263)
T 3tm0_A           89 MSEADGVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT  162 (263)
T ss_dssp             EECCSSEEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred             EEecCCeehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence            99999999987531      122334788899999999998                                       


Q ss_pred             --------------------CCceeCCCCCCCEEEccCC-ceEeeecccc
Q 015500          119 --------------------NRVVHCDIKSRNILMAESG-AKIADFGCAK  147 (405)
Q Consensus       119 --------------------~givHrDlkp~NILi~~~~-vkL~DFGla~  147 (405)
                                          ..++|+|++|.||+++.++ +.|+||+.+.
T Consensus       163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                4589999999999998766 5799999875

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.24  E-value=1.4e-11  Score=114.16  Aligned_cols=128  Identities=20%  Similarity=0.141  Sum_probs=92.4

Q ss_pred             cccc-eeCCeeEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHhCCCCCe--eeeeeeeeecCCCceEEEEEEeecCC
Q 015500            7 HTIG-QGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHI--VGYKGCDVTSEDNKLMYNLFMEYAPG   83 (405)
Q Consensus         7 ~~LG-~G~~g~Vyla~~~~~~~~vavK~~~~~~~~~l~~E~~iL~~L~hpnI--v~~~~~~~~~~~~~~~~~lv~Ey~~g   83 (405)
                      ..++ .|..+.||++.. .+|+.+++|.........+.+|..+|+.|.+.++  .+++.......  .  .++||||++|
T Consensus        25 ~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~--~--~~~v~e~i~G   99 (264)
T 1nd4_A           25 AQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAG--R--DWLLLGEVPG   99 (264)
T ss_dssp             EECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSS--C--EEEEEECCSS
T ss_pred             EecccCCCCceEEEEec-CCCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEeccCCC--C--CEEEEEecCC
Confidence            3444 555689999964 5677899999766555678999999999955444  44665543321  2  5589999999


Q ss_pred             CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------------
Q 015500           84 GTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNR-------------------------------------------  120 (405)
Q Consensus        84 gsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~g-------------------------------------------  120 (405)
                      .+|.  ..    ..+.   ..++.+++..|..||+..                                           
T Consensus       100 ~~l~--~~----~~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (264)
T 1nd4_A          100 QDLL--SS----HLAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL  170 (264)
T ss_dssp             EETT--TS----CCCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred             cccC--cC----cCCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHH
Confidence            8884  11    1222   256777888888888753                                           


Q ss_pred             ---------------ceeCCCCCCCEEEccCC-ceEeeeccccc
Q 015500          121 ---------------VVHCDIKSRNILMAESG-AKIADFGCAKW  148 (405)
Q Consensus       121 ---------------ivHrDlkp~NILi~~~~-vkL~DFGla~~  148 (405)
                                     ++|+|++|.||+++.++ +.|+|||.+..
T Consensus       171 ~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          171 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                           99999999999998777 56999999763

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.21  E-value=9.2e-12  Score=119.30  Aligned_cols=181  Identities=17%  Similarity=0.137  Sum_probs=122.9

Q ss_pred             ccccceeCCeeEEEEEEcCCCCEEEEEEccCC-ChHHHHHHHHHHHhCC-CCCe--eeeeeeeeecCCCceEEEEEEeec
Q 015500            6 GHTIGQGSSATVSLATSLRSGDVFAAKSTELP-KSEFLQREQKFLSSLN-SPHI--VGYKGCDVTSEDNKLMYNLFMEYA   81 (405)
Q Consensus         6 ~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~-~~~~l~~E~~iL~~L~-hpnI--v~~~~~~~~~~~~~~~~~lv~Ey~   81 (405)
                      .+.++.|.+..||++.     ..+++|..... ....+.+|..+|+.|. +..+  ..++.... ......+.++||+++
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~-~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGM-PSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECC-CCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecC-CCCCCCcceEEEccc
Confidence            5668999999999863     45888886543 2467899999999883 3332  23332211 111112335899999


Q ss_pred             CCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------------
Q 015500           82 PGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHS-------------------------------------------  118 (405)
Q Consensus        82 ~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~-------------------------------------------  118 (405)
                      +|.+|.+....   .++......++.|++..|..||+                                           
T Consensus        99 ~G~~l~~~~~~---~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  175 (304)
T 3sg8_A           99 KGVPLTPLLLN---NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD  175 (304)
T ss_dssp             CCEECCHHHHH---TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred             CCeECCccccc---cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence            99988764432   47888888899999999999996                                           


Q ss_pred             ---------------CCceeCCCCCCCEEEccC--C-ceEeeecccccccccccCCCCCCc---cChhhhcC-----CCC
Q 015500          119 ---------------NRVVHCDIKSRNILMAES--G-AKIADFGCAKWESEALQSGGTPMF---MAPEVARG-----EHQ  172 (405)
Q Consensus       119 ---------------~givHrDlkp~NILi~~~--~-vkL~DFGla~~~~~~~~~~gt~~Y---~APE~l~~-----~~~  172 (405)
                                     ..++|+|++|.||+++.+  + +.|+||+.+..............+   ..|+....     ...
T Consensus       176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~  255 (304)
T 3sg8_A          176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHK  255 (304)
T ss_dssp             HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCS
T ss_pred             HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCC
Confidence                           136999999999999884  4 789999998764432222222222   34443221     111


Q ss_pred             C---------cchhHHHHHHHHHHHHhCCCCC
Q 015500          173 G---------FASDIWAVGCTVIEMASGGAPW  195 (405)
Q Consensus       173 ~---------~~sDIwSLG~il~elltG~~Pf  195 (405)
                      +         ...+.|++|.+++.+.+|..+|
T Consensus       256 ~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          256 DIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             CcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            1         1268999999999999998887

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.11  E-value=2.1e-10  Score=112.31  Aligned_cols=139  Identities=12%  Similarity=0.163  Sum_probs=102.3

Q ss_pred             cccccceeCCeeEEEEEEcCCCCEEEEEEcc--CC----ChHHHHHHHHHHHhCCC--CCeeeeeeeeeecCCCceEEEE
Q 015500            5 RGHTIGQGSSATVSLATSLRSGDVFAAKSTE--LP----KSEFLQREQKFLSSLNS--PHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         5 ~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~--~~----~~~~l~~E~~iL~~L~h--pnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      ..+.|+.|.++.||++...  +..+++|...  ..    ....+.+|..+|+.|..  ..+.+++..+....... ..++
T Consensus        42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g-~~~~  118 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIG-RAFY  118 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTS-SCEE
T ss_pred             eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccC-CeEE
Confidence            4678899999999998754  4678888876  32    24578899999999974  44566666543322111 2348


Q ss_pred             EEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------
Q 015500           77 FMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHS--------------------------------------  118 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~--------------------------------------  118 (405)
                      ||||++|..+.+..   ...+++.....++.+++..|..||+                                      
T Consensus       119 vme~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (359)
T 3dxp_A          119 IMEFVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP  195 (359)
T ss_dssp             EEECCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred             EEEecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence            99999998875421   1247888889999999999999997                                      


Q ss_pred             --------------------CCceeCCCCCCCEEEccCC---ceEeeecccccc
Q 015500          119 --------------------NRVVHCDIKSRNILMAESG---AKIADFGCAKWE  149 (405)
Q Consensus       119 --------------------~givHrDlkp~NILi~~~~---vkL~DFGla~~~  149 (405)
                                          .+++|+|++|.|||++.++   +.|+||+.+...
T Consensus       196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence                                3689999999999998764   589999998753

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.59  E-value=2.6e-07  Score=88.52  Aligned_cols=134  Identities=18%  Similarity=0.177  Sum_probs=91.3

Q ss_pred             cccccceeCCeeEEEEEEcCCCCEEEEEEccCC-ChHHHHHHHHHHHhCCCC---CeeeeeeeeeecCCCceEEEEEEee
Q 015500            5 RGHTIGQGSSATVSLATSLRSGDVFAAKSTELP-KSEFLQREQKFLSSLNSP---HIVGYKGCDVTSEDNKLMYNLFMEY   80 (405)
Q Consensus         5 ~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~-~~~~l~~E~~iL~~L~hp---nIv~~~~~~~~~~~~~~~~~lv~Ey   80 (405)
                      ..+.++.|....||+.     +..+++|..... ....+.+|..+|+.|.+.   .+...+.... ...+.  .+++|||
T Consensus        23 ~v~~l~~G~~n~v~~v-----g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~-~~~g~--~~~v~e~   94 (306)
T 3tdw_A           23 SVESLGEGFRNYAILV-----NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGK-RSDGN--PFVGYRK   94 (306)
T ss_dssp             CEEEEEECSSEEEEEE-----TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEE-CTTSC--EEEEEEC
T ss_pred             eeeecCCCcceeEEEE-----CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecc-cCCCc--eEEEEec
Confidence            3466888888899988     466888885332 245789999999999652   2334443332 12222  3489999


Q ss_pred             cCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------------
Q 015500           81 APGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN-----------------------------------------  119 (405)
Q Consensus        81 ~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~-----------------------------------------  119 (405)
                      ++|.+|.+....   .++......++.|+...|..||+.                                         
T Consensus        95 i~G~~l~~~~~~---~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~  171 (306)
T 3tdw_A           95 VQGQILGEDGMA---VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY  171 (306)
T ss_dssp             CCSEECHHHHHT---TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred             cCCeECchhhhh---hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence            999888764221   345555666666666666666642                                         


Q ss_pred             -------------------CceeCCCCCCCEEEcc----CC-ceEeeecccccc
Q 015500          120 -------------------RVVHCDIKSRNILMAE----SG-AKIADFGCAKWE  149 (405)
Q Consensus       120 -------------------givHrDlkp~NILi~~----~~-vkL~DFGla~~~  149 (405)
                                         .++|+|++|.||+++.    +. +.|+||+.+...
T Consensus       172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                               3599999999999987    34 589999988643

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.55  E-value=3.6e-07  Score=85.18  Aligned_cols=131  Identities=18%  Similarity=0.065  Sum_probs=92.0

Q ss_pred             cceeCCe-eEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHhCCC-CCeeeeeeeeeecCCCceEEEEEEeecCCCCH
Q 015500            9 IGQGSSA-TVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNS-PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTL   86 (405)
Q Consensus         9 LG~G~~g-~Vyla~~~~~~~~vavK~~~~~~~~~l~~E~~iL~~L~h-pnIv~~~~~~~~~~~~~~~~~lv~Ey~~ggsL   86 (405)
                      +..|..+ .||+......+..+++|.........+.+|..+|+.|.. --+.+++.......    ..++|||+++|.++
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~----~~~lvme~l~G~~~  107 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPD----DAWLLTTAIPGKTA  107 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETT----EEEEEEECCCSEEH
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEEEECC----eEEEEEEeeCCccc
Confidence            4445555 699988777788899999877667789999999998842 12344444433322    24589999999888


Q ss_pred             HHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------------------
Q 015500           87 NDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN-----------------------------------------------  119 (405)
Q Consensus        87 ~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~-----------------------------------------------  119 (405)
                      .+.....     ......+..++...|.-||+.                                               
T Consensus       108 ~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  182 (272)
T 4gkh_A          108 FQVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKE  182 (272)
T ss_dssp             HHHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHH
T ss_pred             cccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHH
Confidence            7765432     122234566666666666631                                               


Q ss_pred             -----------CceeCCCCCCCEEEccCC-ceEeeeccccc
Q 015500          120 -----------RVVHCDIKSRNILMAESG-AKIADFGCAKW  148 (405)
Q Consensus       120 -----------givHrDlkp~NILi~~~~-vkL~DFGla~~  148 (405)
                                 .++|+|+.+.|||++.++ +-|+||+.+..
T Consensus       183 l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          183 MHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                       279999999999999877 56999998863

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.31  E-value=2.3e-06  Score=84.60  Aligned_cols=73  Identities=16%  Similarity=0.023  Sum_probs=47.3

Q ss_pred             ccccceeCCeeEEEEEEcCCCCEEEEEEccCC----------ChHHHHHHHHHHHhCCC--CCe-eeeeeeeeecCCCce
Q 015500            6 GHTIGQGSSATVSLATSLRSGDVFAAKSTELP----------KSEFLQREQKFLSSLNS--PHI-VGYKGCDVTSEDNKL   72 (405)
Q Consensus         6 ~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~----------~~~~l~~E~~iL~~L~h--pnI-v~~~~~~~~~~~~~~   72 (405)
                      .+.||.|.++.||++....+++.++||.....          ..+.+.+|.++|+.+..  |.. ..++..  ..+.   
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~---  109 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEM---  109 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTT---
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCc---
Confidence            56899999999999976656788999975421          23457889999988742  333 344432  2222   


Q ss_pred             EEEEEEeecCCC
Q 015500           73 MYNLFMEYAPGG   84 (405)
Q Consensus        73 ~~~lv~Ey~~gg   84 (405)
                       .++||||++|.
T Consensus       110 -~~lvmE~l~g~  120 (397)
T 2olc_A          110 -AVTVMEDLSHL  120 (397)
T ss_dssp             -TEEEECCCTTS
T ss_pred             -cEEEEEeCCCc
Confidence             24899999874

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.10  E-value=3e-06  Score=82.32  Aligned_cols=81  Identities=11%  Similarity=0.112  Sum_probs=50.8

Q ss_pred             cccc-ceeCCeeEEEEEEc--C----CCCEEEEEEccCCC------hHHHHHHHHHHHhCCC---CCeeeeeeeeeecCC
Q 015500            6 GHTI-GQGSSATVSLATSL--R----SGDVFAAKSTELPK------SEFLQREQKFLSSLNS---PHIVGYKGCDVTSED   69 (405)
Q Consensus         6 ~~~L-G~G~~g~Vyla~~~--~----~~~~vavK~~~~~~------~~~l~~E~~iL~~L~h---pnIv~~~~~~~~~~~   69 (405)
                      .+.| +.|....+|+....  .    +++.+++|......      ...+.+|..+|+.|..   ..+.+++........
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            4566 78888899988653  1    15678999865432      3568899999988842   234555554322210


Q ss_pred             CceEEEEEEeecCCCCHH
Q 015500           70 NKLMYNLFMEYAPGGTLN   87 (405)
Q Consensus        70 ~~~~~~lv~Ey~~ggsL~   87 (405)
                      .. ..++||||++|.++.
T Consensus       105 ~g-~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          105 LG-TPFFLMDYVEGVVPP  121 (357)
T ss_dssp             TS-SCEEEEECCCCBCCC
T ss_pred             cC-CceEEEEecCCCChh
Confidence            01 134799999986643

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.04  E-value=1.6e-05  Score=76.19  Aligned_cols=137  Identities=16%  Similarity=0.118  Sum_probs=75.9

Q ss_pred             ccccceeCCeeEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHhCC-----CCCeeeee-eeeeecCCCceEEEEEEe
Q 015500            6 GHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLN-----SPHIVGYK-GCDVTSEDNKLMYNLFME   79 (405)
Q Consensus         6 ~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~~~~l~~E~~iL~~L~-----hpnIv~~~-~~~~~~~~~~~~~~lv~E   79 (405)
                      .+.|+.|..+.||++...  +..+++|..... ...+..|..+++.|.     .|.++... |.......+  ..+++|+
T Consensus        37 ~~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~-~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~--~~~~l~~  111 (346)
T 2q83_A           37 IDVIQGNQMALVWKVHTD--SGAVCLKRIHRP-EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGS--FLFVVYD  111 (346)
T ss_dssp             EEECC----CEEEEEEET--TEEEEEEEECSC-HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETT--EEEEEEE
T ss_pred             eeeccccccCcEEEEEeC--CCCEEEEecCCC-HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECC--EEEEEEE
Confidence            455666778899998753  345899988753 445666777776663     24444311 111111111  2558999


Q ss_pred             ecCCCCHH-----------HH---HHHcCCCC-------------CHH--------H-----------------------
Q 015500           80 YAPGGTLN-----------DE---IHRNGGRL-------------DES--------L-----------------------  101 (405)
Q Consensus        80 y~~ggsL~-----------~~---i~~~~~~l-------------~e~--------~-----------------------  101 (405)
                      |++|.++.           ..   +......+             ...        .                       
T Consensus       112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  191 (346)
T 2q83_A          112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE  191 (346)
T ss_dssp             CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred             eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence            99986532           11   11110001             010        0                       


Q ss_pred             HHHHHHHHHHHHHHHH-------------hCCceeCCCCCCCEEEccCC-ceEeeecccc
Q 015500          102 IVSYTRQILQGLEYLH-------------SNRVVHCDIKSRNILMAESG-AKIADFGCAK  147 (405)
Q Consensus       102 ~~~i~~qIl~~L~yLH-------------~~givHrDlkp~NILi~~~~-vkL~DFGla~  147 (405)
                      +..+..++..++.+|+             ..+++|+|+++.||+++.++ +.|+||+.+.
T Consensus       192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            1112223444566665             25799999999999997554 9999999874

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.79  E-value=0.00021  Score=64.70  Aligned_cols=121  Identities=13%  Similarity=0.097  Sum_probs=81.7

Q ss_pred             CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCCEEEccCC-ceEeeecccccccccccCCCCCCcc
Q 015500           85 TLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHS-NRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSGGTPMFM  162 (405)
Q Consensus        85 sL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~-~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~~~~~gt~~Y~  162 (405)
                      +|.+++...+++++|++++.++.|.+.+|.-+-. +.-..+=+.|..|++..+| |...+ +.        .......+.
T Consensus        34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~--------s~~~~~~~~  104 (229)
T 2yle_A           34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AA--------DDAGEPPPV  104 (229)
T ss_dssp             EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred             cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cc--------ccccccCCC
Confidence            7999999999999999999999999999887722 1212333456888888887 44332 11        112344677


Q ss_pred             ChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHhccc
Q 015500          163 APEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRR  235 (405)
Q Consensus       163 APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~L~~  235 (405)
                      |||... ...+.+.=|+|||+++|.-+--..|                    +..+..+|+++.+||..|..-
T Consensus       105 ~pe~~~-~~~te~~~IysLG~tLY~ALDygL~--------------------e~eE~eLS~~LE~LL~~Mt~~  156 (229)
T 2yle_A          105 AGKLGY-SQCMETEVIESLGIIIYKALDYGLK--------------------ENEERELSPPLEQLIDHMANT  156 (229)
T ss_dssp             --CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC--------------------TTEEECCCHHHHHHHHHHTTC
T ss_pred             Chhhcc-ccchHHHHHHHHHHHHHHHhhcCCC--------------------cccchhhCHHHHHHHHHHHhc
Confidence            888763 3445678899999999999964332                    234566999999999999866

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.62  E-value=0.00012  Score=69.31  Aligned_cols=72  Identities=10%  Similarity=-0.040  Sum_probs=44.2

Q ss_pred             cccccccceeCCeeEEEEEEcCCCCEEEEEEccCCCh--HHHHHHHHHHHhCCCCCee-eeeeeeeecCCCceEEEEEEe
Q 015500            3 WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS--EFLQREQKFLSSLNSPHIV-GYKGCDVTSEDNKLMYNLFME   79 (405)
Q Consensus         3 y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~~--~~l~~E~~iL~~L~hpnIv-~~~~~~~~~~~~~~~~~lv~E   79 (405)
                      |...+.|+.|....+|+.      +.+++|.......  -...+|..+++.+..-++. +++..  ..+.+    ++++|
T Consensus        20 ~~~i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~----~~v~e   87 (301)
T 3dxq_A           20 YTGPLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHV--DPATG----VMVTR   87 (301)
T ss_dssp             CCSCEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTC----CEEEE
T ss_pred             ccceeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCC----EEEEe
Confidence            556788999999999998      4588887654321  2346788888777432332 33332  22221    27899


Q ss_pred             ec-CCCCH
Q 015500           80 YA-PGGTL   86 (405)
Q Consensus        80 y~-~ggsL   86 (405)
                      |+ +|.+|
T Consensus        88 ~i~~g~~l   95 (301)
T 3dxq_A           88 YIAGAQTM   95 (301)
T ss_dssp             CCTTCEEC
T ss_pred             ecCCCccC
Confidence            99 66544

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.60  E-value=0.00022  Score=68.38  Aligned_cols=76  Identities=14%  Similarity=0.072  Sum_probs=55.3

Q ss_pred             cccccceeCCeeEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHhCC---CCCeeeeeeeeeecCCCceEEEEEEeec
Q 015500            5 RGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLN---SPHIVGYKGCDVTSEDNKLMYNLFMEYA   81 (405)
Q Consensus         5 ~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~~~~l~~E~~iL~~L~---hpnIv~~~~~~~~~~~~~~~~~lv~Ey~   81 (405)
                      ..+.|+.|.+..+|+...  ++..+++|.........+.+|...|+.|.   ...+.+++......  +  ..++||||+
T Consensus        40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~--g--~~~lvme~l  113 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQ--G--HSFLLLEAL  113 (312)
T ss_dssp             EEEEECCSSSSEEEEEES--SSCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECS--S--EEEEEEECC
T ss_pred             eeEEeCCccceeeeEEEE--CCCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecC--C--ceEEEEEec
Confidence            356789999999999874  46788999877666678899999998883   24455665543322  1  256899999


Q ss_pred             CCCCH
Q 015500           82 PGGTL   86 (405)
Q Consensus        82 ~ggsL   86 (405)
                      +|..+
T Consensus       114 ~G~~~  118 (312)
T 3jr1_A          114 NKSKN  118 (312)
T ss_dssp             CCCCC
T ss_pred             cCCCC
Confidence            98754

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.56  E-value=0.00022  Score=70.90  Aligned_cols=34  Identities=9%  Similarity=0.355  Sum_probs=29.3

Q ss_pred             HhCCceeCCCCCCCEEEccCCceEeeeccccccc
Q 015500          117 HSNRVVHCDIKSRNILMAESGAKIADFGCAKWES  150 (405)
Q Consensus       117 H~~givHrDlkp~NILi~~~~vkL~DFGla~~~~  150 (405)
                      +...++|+|++|.|||++.++++|+||+.+....
T Consensus       230 ~~~~liHGDl~~~Nil~~~~~~~lID~e~a~~G~  263 (420)
T 2pyw_A          230 RAQALIHGDLHTGSVMVTQDSTQVIDPEFSFYGP  263 (420)
T ss_dssp             BCCEEECSCCSGGGEEECSSCEEECCCTTCEEEC
T ss_pred             CCCeEEecCCCCCcEEEeCCCCEEEeCcccccCc
Confidence            4568999999999999998889999999887543

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.45  E-value=0.0013  Score=61.72  Aligned_cols=72  Identities=14%  Similarity=0.081  Sum_probs=50.6

Q ss_pred             cccccceeCCeeEEEEEEcCCCCEEEEEEccCC---ChHHHHHHHHHHHhCCCC---CeeeeeeeeeecCCCceEEEEEE
Q 015500            5 RGHTIGQGSSATVSLATSLRSGDVFAAKSTELP---KSEFLQREQKFLSSLNSP---HIVGYKGCDVTSEDNKLMYNLFM   78 (405)
Q Consensus         5 ~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~---~~~~l~~E~~iL~~L~hp---nIv~~~~~~~~~~~~~~~~~lv~   78 (405)
                      ..+.+|.|..+.||+... .+|+.+++|.....   ....+.+|...|+.|.--   .+.+++..   ...     +++|
T Consensus        19 ~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~---~~~-----~lv~   89 (288)
T 3f7w_A           19 AVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW---DDR-----TLAM   89 (288)
T ss_dssp             EEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE---ETT-----EEEE
T ss_pred             EEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec---cCc-----eEEE
Confidence            457789999999999985 57899999986543   235688999999988432   23333332   222     3799


Q ss_pred             eecCCCC
Q 015500           79 EYAPGGT   85 (405)
Q Consensus        79 Ey~~ggs   85 (405)
                      ||++++.
T Consensus        90 e~l~~~~   96 (288)
T 3f7w_A           90 EWVDERP   96 (288)
T ss_dssp             ECCCCCC
T ss_pred             EeecccC
Confidence            9998764

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.39  E-value=0.0005  Score=65.89  Aligned_cols=136  Identities=15%  Similarity=0.137  Sum_probs=71.4

Q ss_pred             ccccceeCCee-EEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHhCCCCC--eeeeeeeeeecCCCceEEEEEEeecC
Q 015500            6 GHTIGQGSSAT-VSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPH--IVGYKGCDVTSEDNKLMYNLFMEYAP   82 (405)
Q Consensus         6 ~~~LG~G~~g~-Vyla~~~~~~~~vavK~~~~~~~~~l~~E~~iL~~L~hpn--Iv~~~~~~~~~~~~~~~~~lv~Ey~~   82 (405)
                      .+.|+.|+... +|+... .++..+++|.......+.+..|..+++.|..-+  +.+++..  .... .   +++||++.
T Consensus        23 ~~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~~~~~~~e~~~l~~L~~~g~~vP~v~~~--d~~~-g---~ll~e~l~   95 (333)
T 3csv_A           23 RTPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEEGGDTQPFVDLAQYLRNLDISAPEIYAE--EHAR-G---LLLIEDLG   95 (333)
T ss_dssp             ECC--------CCEEEEC-TTCCEEEEEECCTTTTCCSHHHHHHHHHHHHTTCBCCCEEEE--ETTT-T---EEEECCCC
T ss_pred             eeECCCCCCCceEEEEEc-CCCCeEEEEECCCCCCccccHHHHHHHHHHhCCCCCCceeee--cCCC-C---EEEEeeCC
Confidence            34566665554 666642 236678888765543355677888887774222  3344433  1222 2   36899997


Q ss_pred             CCCHHHHHHHcC-------------------------CCCCHHHHHH--------HH------------HHHHHHHHHH-
Q 015500           83 GGTLNDEIHRNG-------------------------GRLDESLIVS--------YT------------RQILQGLEYL-  116 (405)
Q Consensus        83 ggsL~~~i~~~~-------------------------~~l~e~~~~~--------i~------------~qIl~~L~yL-  116 (405)
                      +.++.+.+....                         ..++......        +.            ..+...++.+ 
T Consensus        96 ~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~  175 (333)
T 3csv_A           96 DALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQIL  175 (333)
T ss_dssp             SCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHH
T ss_pred             CcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHH
Confidence            766654432110                         0122211110        00            0111222233 


Q ss_pred             -----HhCCceeCCCCCCCEEEccC----C-ceEeeeccccc
Q 015500          117 -----HSNRVVHCDIKSRNILMAES----G-AKIADFGCAKW  148 (405)
Q Consensus       117 -----H~~givHrDlkp~NILi~~~----~-vkL~DFGla~~  148 (405)
                           +...++|+|+.+.||+++.+    + +.|+||+.+..
T Consensus       176 ~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          176 SAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             HHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             HhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence                 23479999999999999873    3 89999998864

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.24  E-value=0.00035  Score=66.42  Aligned_cols=138  Identities=16%  Similarity=0.149  Sum_probs=76.0

Q ss_pred             ccccceeCCeeEEEEEEcCCCCEEEEEEccC-CChHHHHHHHHHHHhCCC-----CCeeeee-eeeeecCCCceEEEEEE
Q 015500            6 GHTIGQGSSATVSLATSLRSGDVFAAKSTEL-PKSEFLQREQKFLSSLNS-----PHIVGYK-GCDVTSEDNKLMYNLFM   78 (405)
Q Consensus         6 ~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~-~~~~~l~~E~~iL~~L~h-----pnIv~~~-~~~~~~~~~~~~~~lv~   78 (405)
                      .+.|+.|....+|+.... +| .+++|.... ...+.+..|..+++.|..     |.++... |.......+  ..++++
T Consensus        27 ~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g--~~~~l~  102 (322)
T 2ppq_A           27 YKGIAEGVENSNFLLHTT-KD-PLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSG--RPAALI  102 (322)
T ss_dssp             EEEECC---EEEEEEEES-SC-CEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETT--EEEEEE
T ss_pred             eeccCCCcccceEEEEeC-Cc-cEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECC--EEEEEE
Confidence            456777888899998753 33 688998776 245677888888887742     3333211 100001111  245899


Q ss_pred             eecCCCCHH-----------HH---HHHcCCCC--------CHHHHHH---------------HHHHHHHHHHHHHh---
Q 015500           79 EYAPGGTLN-----------DE---IHRNGGRL--------DESLIVS---------------YTRQILQGLEYLHS---  118 (405)
Q Consensus        79 Ey~~ggsL~-----------~~---i~~~~~~l--------~e~~~~~---------------i~~qIl~~L~yLH~---  118 (405)
                      +|++|..+.           ..   +......+        ....-..               +...+...++.++.   
T Consensus       103 ~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~  182 (322)
T 2ppq_A          103 SFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWP  182 (322)
T ss_dssp             ECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCC
T ss_pred             EeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCc
Confidence            999986531           11   11110011        1000000               00113444555552   


Q ss_pred             ----CCceeCCCCCCCEEEccCC-ceEeeecccc
Q 015500          119 ----NRVVHCDIKSRNILMAESG-AKIADFGCAK  147 (405)
Q Consensus       119 ----~givHrDlkp~NILi~~~~-vkL~DFGla~  147 (405)
                          .+++|+|+.+.|||++.++ +.|+||+.+.
T Consensus       183 ~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          183 KDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             CSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             ccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence                3699999999999999877 4799999875

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.14  E-value=0.00072  Score=67.67  Aligned_cols=72  Identities=18%  Similarity=0.163  Sum_probs=48.7

Q ss_pred             ccccceeCCeeEEEEEEcC-------CCCEEEEEEccCCCh-HHHHHHHHHHHhCCCCCe-eeeeeeeeecCCCceEEEE
Q 015500            6 GHTIGQGSSATVSLATSLR-------SGDVFAAKSTELPKS-EFLQREQKFLSSLNSPHI-VGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         6 ~~~LG~G~~g~Vyla~~~~-------~~~~vavK~~~~~~~-~~l~~E~~iL~~L~hpnI-v~~~~~~~~~~~~~~~~~l   76 (405)
                      .+.|+.|-...||++....       .++.+++|+...... +.+.+|..+++.|...++ .++++.+   .+     .+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~---~~-----g~  149 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIF---SG-----GR  149 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEE---TT-----EE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEe---CC-----CE
Confidence            4567888889999998642       257899998854333 667789999998854444 3444432   22     16


Q ss_pred             EEeecCCCC
Q 015500           77 FMEYAPGGT   85 (405)
Q Consensus        77 v~Ey~~ggs   85 (405)
                      |+||++|.+
T Consensus       150 v~e~l~G~~  158 (429)
T 1nw1_A          150 LEEYIPSRP  158 (429)
T ss_dssp             EECCCCEEE
T ss_pred             EEEEeCCcc
Confidence            899998743

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.96  E-value=0.001  Score=64.67  Aligned_cols=134  Identities=12%  Similarity=0.094  Sum_probs=74.2

Q ss_pred             ccccceeCCeeEEEEEEcC--------CCCEEEEEEccCCChH--HHHHHHHHHHhCCCCCe-eeeeeeeeecCCCceEE
Q 015500            6 GHTIGQGSSATVSLATSLR--------SGDVFAAKSTELPKSE--FLQREQKFLSSLNSPHI-VGYKGCDVTSEDNKLMY   74 (405)
Q Consensus         6 ~~~LG~G~~g~Vyla~~~~--------~~~~vavK~~~~~~~~--~l~~E~~iL~~L~hpnI-v~~~~~~~~~~~~~~~~   74 (405)
                      .+.|+.|....+|+.....        .+..+++|+.......  ...+|..+++.|...++ .++++.+   .+     
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~---~~-----  109 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF---NG-----  109 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE---TT-----
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec---CC-----
Confidence            4577888888999997643        1368899987543222  24688888888743333 3444332   21     


Q ss_pred             EEEEeecCCCCHH--------------HHHHH-c--------CCCCC-----HHHHHHHHHH------------------
Q 015500           75 NLFMEYAPGGTLN--------------DEIHR-N--------GGRLD-----ESLIVSYTRQ------------------  108 (405)
Q Consensus        75 ~lv~Ey~~ggsL~--------------~~i~~-~--------~~~l~-----e~~~~~i~~q------------------  108 (405)
                      .+||||++|.++.              ..+.+ +        ...++     ...+..+..+                  
T Consensus       110 ~~v~e~i~G~~l~~~~~~~~~~~~~~a~~La~lH~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (369)
T 3c5i_A          110 GRIEEWLYGDPLRIDDLKNPTILIGIANVLGKFHTLSRKRHLPEHWDRTPCIFKMMEKWKNQLFKYKNIEKYNCDIHKYI  189 (369)
T ss_dssp             EEEEECCCSEECCGGGGGCHHHHHHHHHHHHHHHTHHHHSCCCTTSCCSCHHHHHHHHHHHHHTTCSSGGGC-CCHHHHH
T ss_pred             cEEEEEecCCcCChhhcCChHHHHHHHHHHHHHHcCcccccCcccCCCCCcHHHHHHHHHHHHhhhhhHHHHHhhHHHHH
Confidence            2699999885431              11111 0        00111     0111112111                  


Q ss_pred             --HHHHHHHHHh----------CCceeCCCCCCCEEEccCCceEeeecccc
Q 015500          109 --ILQGLEYLHS----------NRVVHCDIKSRNILMAESGAKIADFGCAK  147 (405)
Q Consensus       109 --Il~~L~yLH~----------~givHrDlkp~NILi~~~~vkL~DFGla~  147 (405)
                        +-..+++|..          .+++|+|+.+.|||++.+++.|+||..+.
T Consensus       190 ~~~~~l~~~l~~~~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~lID~e~a~  240 (369)
T 3c5i_A          190 KESDKFIKFMKVYSKSDNLANTIVFCHNDLQENNIINTNKCLRLIDFEYSG  240 (369)
T ss_dssp             HHHHHHHHHHHHHTTSSCGGGCEEEECSCCCGGGEEECC-CEEECCCTTCE
T ss_pred             HHHHHHHHHHHHhhhhcccCCCeEEEeCCCCcccEEecCCcEEEEEecCCC
Confidence              1122334432          25899999999999988779999998875

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.82  E-value=0.0024  Score=62.87  Aligned_cols=134  Identities=16%  Similarity=0.161  Sum_probs=79.5

Q ss_pred             ccccceeCCeeEEEEEEcC-------CCCEEEEEEccC--CChHHHHHHHHHHHhCCCCCe-eeeeeeeeecCCCceEEE
Q 015500            6 GHTIGQGSSATVSLATSLR-------SGDVFAAKSTEL--PKSEFLQREQKFLSSLNSPHI-VGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         6 ~~~LG~G~~g~Vyla~~~~-------~~~~vavK~~~~--~~~~~l~~E~~iL~~L~hpnI-v~~~~~~~~~~~~~~~~~   75 (405)
                      .+.|.-|-...+|++....       .++.+++|....  .......+|.++++.|..-++ .++++.+   .+ .    
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~---~~-g----  126 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVF---PE-G----  126 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEE---TT-E----
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEc---CC-c----
Confidence            3566667778899987632       357899998643  235667799999988843333 3344332   22 1    


Q ss_pred             EEEeecCCCCHH--------------HHHHH---c----CCCCC--HHHHHHHHHHHHH-------------------HH
Q 015500           76 LFMEYAPGGTLN--------------DEIHR---N----GGRLD--ESLIVSYTRQILQ-------------------GL  113 (405)
Q Consensus        76 lv~Ey~~ggsL~--------------~~i~~---~----~~~l~--e~~~~~i~~qIl~-------------------~L  113 (405)
                      +||||++|.+|.              +.+.+   .    +....  ..++..+..++-.                   .+
T Consensus       127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~  206 (379)
T 3feg_A          127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM  206 (379)
T ss_dssp             EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred             cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence            699999985432              11111   1    11122  3556666655422                   23


Q ss_pred             HHHH----h----CCceeCCCCCCCEEEccC-----CceEeeecccc
Q 015500          114 EYLH----S----NRVVHCDIKSRNILMAES-----GAKIADFGCAK  147 (405)
Q Consensus       114 ~yLH----~----~givHrDlkp~NILi~~~-----~vkL~DFGla~  147 (405)
                      +.|.    .    ..++|+|+.+.||+++.+     .+.|+||..+.
T Consensus       207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence            3333    2    258999999999999876     38999998875

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.76  E-value=0.0036  Score=59.51  Aligned_cols=137  Identities=13%  Similarity=0.167  Sum_probs=77.2

Q ss_pred             cccceeCCeeEEEEEEcCCCCEEEEEEccCC--ChHHHHHHHHHHHhCCCCC--eeeeeee---eeecCCCceEEEEEEe
Q 015500            7 HTIGQGSSATVSLATSLRSGDVFAAKSTELP--KSEFLQREQKFLSSLNSPH--IVGYKGC---DVTSEDNKLMYNLFME   79 (405)
Q Consensus         7 ~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~--~~~~l~~E~~iL~~L~hpn--Iv~~~~~---~~~~~~~~~~~~lv~E   79 (405)
                      ..|+ |....||+... .+|+.+++|.....  ..+.+.+|..+++.|...+  +++++..   ......+  ..+++|+
T Consensus        32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g--~~~~l~~  107 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQG--FYFAVFP  107 (328)
T ss_dssp             EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETT--EEEEEEE
T ss_pred             Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECC--EEEEEEE
Confidence            4566 77788998754 34667999998643  4567888999888874222  3333321   0000111  3457999


Q ss_pred             ecCCCCHH-----------HHH---HH--cC------CCCCHHHH----------------------HHHHHHHHHHHHH
Q 015500           80 YAPGGTLN-----------DEI---HR--NG------GRLDESLI----------------------VSYTRQILQGLEY  115 (405)
Q Consensus        80 y~~ggsL~-----------~~i---~~--~~------~~l~e~~~----------------------~~i~~qIl~~L~y  115 (405)
                      +++|.++.           ..+   ..  ..      ..++....                      ...+.+++..++-
T Consensus       108 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~  187 (328)
T 1zyl_A          108 SVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTA  187 (328)
T ss_dssp             CCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHH
T ss_pred             ecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHH
Confidence            99885431           111   11  00      01111110                      1111222222222


Q ss_pred             H----HhCCceeCCCCCCCEEEccCCceEeeeccccc
Q 015500          116 L----HSNRVVHCDIKSRNILMAESGAKIADFGCAKW  148 (405)
Q Consensus       116 L----H~~givHrDlkp~NILi~~~~vkL~DFGla~~  148 (405)
                      +    ....++|+|+++.||++++ .+.|+||+.+..
T Consensus       188 ~~~~~~~~~l~HgD~~~~Nil~~~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          188 HWREDFTVLRLHGDCHAGNILWRD-GPMFVDLDDARN  223 (328)
T ss_dssp             HCCSCSCCEECCSSCSGGGEEESS-SEEECCCTTCCE
T ss_pred             HhhhcCCeeeeeCCCCcccEeEcC-CCEEEECCCCCc
Confidence            2    2346899999999999984 789999988753

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.64  E-value=0.0056  Score=61.77  Aligned_cols=73  Identities=15%  Similarity=0.091  Sum_probs=46.8

Q ss_pred             ccccceeCCeeEEEEEEcCCCCEEEEEEccCCChH--HHHHHHHHHHhCCCCCee-eeeeeeeecCCCceEEEEEEeecC
Q 015500            6 GHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSE--FLQREQKFLSSLNSPHIV-GYKGCDVTSEDNKLMYNLFMEYAP   82 (405)
Q Consensus         6 ~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~~~--~l~~E~~iL~~L~hpnIv-~~~~~~~~~~~~~~~~~lv~Ey~~   82 (405)
                      .+.|+.|-...+|++.....+..+++|+.......  .-.+|..+|+.|...++. ++++.+   .+ .    +||||++
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~---~~-G----~v~e~I~  184 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFF---TN-G----RIEEFMD  184 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEE---TT-E----EEEECCC
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEe---CC-e----EEEEeeC
Confidence            45677888889999987544578899987543222  226899999999655553 455443   22 1    4999998


Q ss_pred             CCCH
Q 015500           83 GGTL   86 (405)
Q Consensus        83 ggsL   86 (405)
                      |.+|
T Consensus       185 G~~l  188 (458)
T 2qg7_A          185 GYAL  188 (458)
T ss_dssp             SEEC
T ss_pred             CccC
Confidence            7543

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.23  E-value=0.028  Score=54.07  Aligned_cols=32  Identities=22%  Similarity=0.330  Sum_probs=26.7

Q ss_pred             CCceeCCCCCCCEEEccCC-ceEeeeccccccc
Q 015500          119 NRVVHCDIKSRNILMAESG-AKIADFGCAKWES  150 (405)
Q Consensus       119 ~givHrDlkp~NILi~~~~-vkL~DFGla~~~~  150 (405)
                      ..++|+|+.+.||+++.++ +.|+||+.+....
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~~  238 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLAP  238 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEEEC
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeCC
Confidence            4699999999999998654 9999998876433

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=93.75  E-value=0.052  Score=54.07  Aligned_cols=72  Identities=10%  Similarity=-0.016  Sum_probs=45.4

Q ss_pred             ccccceeCCeeEEEEEEcCC-------CCEEEEEEccCCCh--HHHHHHHHHHHhCCCCCe-eeeeeeeeecCCCceEEE
Q 015500            6 GHTIGQGSSATVSLATSLRS-------GDVFAAKSTELPKS--EFLQREQKFLSSLNSPHI-VGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         6 ~~~LG~G~~g~Vyla~~~~~-------~~~vavK~~~~~~~--~~l~~E~~iL~~L~hpnI-v~~~~~~~~~~~~~~~~~   75 (405)
                      .+.|.-|-...+|+......       ++.+++|.......  -...+|..+++.|..-++ .++++.   ..+     .
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~---~~~-----~  146 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIAD---FPE-----G  146 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEE---ETT-----E
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEE---cCC-----C
Confidence            45666677788999886521       57899998654321  234688888888843333 233332   122     2


Q ss_pred             EEEeecCCCC
Q 015500           76 LFMEYAPGGT   85 (405)
Q Consensus        76 lv~Ey~~ggs   85 (405)
                      +||||++|.+
T Consensus       147 ~I~efI~G~~  156 (424)
T 3mes_A          147 RIEEFIDGEP  156 (424)
T ss_dssp             EEEECCCSEE
T ss_pred             EEEEEeCCcc
Confidence            6899999865

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=91.53  E-value=0.22  Score=48.89  Aligned_cols=28  Identities=29%  Similarity=0.475  Sum_probs=22.9

Q ss_pred             ceeCCCCCCCEEEcc------CC-ceEeeeccccc
Q 015500          121 VVHCDIKSRNILMAE------SG-AKIADFGCAKW  148 (405)
Q Consensus       121 ivHrDlkp~NILi~~------~~-vkL~DFGla~~  148 (405)
                      ++|+|+.+.|||+..      ++ ++++||..|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            689999999999932      23 89999998763

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	405
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	1e-70
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-69
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-69
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-68
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	4e-67
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	6e-67
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-65
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-65
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	4e-65
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-64
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-64
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-63
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	4e-63
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-61
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	4e-61
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	5e-61
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	3e-60
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-59
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	3e-57
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	5e-57
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	9e-57
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-55
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	3e-55
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	4e-55
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-54
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-54
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	3e-54
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	6e-54
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-53
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-53
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	4e-53
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	5e-53
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-51
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-51
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-51
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-51
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	3e-51
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	5e-51
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	3e-50
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	3e-50
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	4e-50
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	5e-50
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	8e-50
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	9e-50
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-49
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-49
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	4e-49
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	4e-49
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	5e-49
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	9e-49
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-48
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-48
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	4e-47
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-46
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	3e-46
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	7e-45
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-44
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	5e-44
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-43
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-42
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	4e-42
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	7e-37
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	5e-19

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  223 bits (570), Expect = 1e-70
 Identities = 84/320 (26%), Positives = 136/320 (42%), Gaps = 18/320 (5%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS---EFLQREQKFLSSLNSPHIV 58
            +     +G G+   V   T   +G+ FAAK    P     E +++E + +S L  P +V
Sbjct: 27  HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLV 86

Query: 59  GYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHS 118
                    ED+  M  +  E+  GG L +++     ++ E   V Y RQ+ +GL ++H 
Sbjct: 87  NLHDAF---EDDNEMV-MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE 142

Query: 119 NRVVHCDIKSRNILMAESG---AKIADFGCAKWESE---ALQSGGTPMFMAPEVARGEHQ 172
           N  VH D+K  NI+         K+ DFG             + GT  F APEVA G+  
Sbjct: 143 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPV 202

Query: 173 GFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYS--RELPEVPAFLSKQANDFLS 230
           G+ +D+W+VG     + SG +P+    +    L  +            + +S+   DF+ 
Sbjct: 203 GYYTDMWSVGVLSYILLSGLSPFG-GENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIR 261

Query: 231 NCLRRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSILDQGIWNSVEETEESLGN 290
             L  DP  R    Q L+HP+L    +  +  Q  +   T I D  I    +   E L  
Sbjct: 262 KLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDS-IKTKYDAWPEPLPP 320

Query: 291 LIHSTSKTSARE-RIERLSC 309
           L   ++ +S R+ R +  S 
Sbjct: 321 LGRISNYSSLRKHRPQEYSI 340

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  220 bits (561), Expect = 1e-69
 Identities = 84/255 (32%), Positives = 125/255 (49%), Gaps = 16/255 (6%)

Query: 8   TIGQGSSATVSLATSLRSGDVFAAK------STELPKSEFLQREQKFLSSLNSPHIVGYK 61
            IG GS   V  A  +R+ +V A K           K + + +E +FL  L  P+ + Y+
Sbjct: 22  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81

Query: 62  GCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRV 121
           GC          + L MEY  G   +         L E  I + T   LQGL YLHS+ +
Sbjct: 82  GC---YLREHTAW-LVMEYCLGSASDLLEVHKK-PLQEVEIAAVTHGALQGLAYLHSHNM 136

Query: 122 VHCDIKSRNILMAESG-AKIADFGCAKWESEALQSGGTPMFMAPEVARGEHQG---FASD 177
           +H D+K+ NIL++E G  K+ DFG A   + A    GTP +MAPEV     +G      D
Sbjct: 137 IHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVD 196

Query: 178 IWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDP 237
           +W++G T IE+A    P  N  + M+ LY IA +          S+   +F+ +CL++ P
Sbjct: 197 VWSLGITCIELAERKPPLFN-MNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIP 255

Query: 238 KERWAASQLLKHPFL 252
           ++R  +  LLKH F+
Sbjct: 256 QDRPTSEVLLKHRFV 270

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  219 bits (559), Expect = 1e-69
 Identities = 85/265 (32%), Positives = 125/265 (47%), Gaps = 19/265 (7%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQ---REQKFLSSLNSPHIV 58
            W     +G G+   V  A +  +  + AAK  +    E L+    E   L+S + P+IV
Sbjct: 13  FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIV 72

Query: 59  GYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHS 118
                     +      + +E+  GG ++  +      L ES I    +Q L  L YLH 
Sbjct: 73  KLLDAFYYENN----LWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD 128

Query: 119 NRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQS----GGTPMFMAPEVARGEHQ- 172
           N+++H D+K+ NIL    G  K+ADFG +   +  +Q      GTP +MAPEV   E   
Sbjct: 129 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSK 188

Query: 173 ----GFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELP-EVPAFLSKQAND 227
                + +D+W++G T+IEMA    P     +PM VL KIA S       P+  S    D
Sbjct: 189 DRPYDYKADVWSLGITLIEMAEIEPPHHE-LNPMRVLLKIAKSEPPTLAQPSRWSSNFKD 247

Query: 228 FLSNCLRRDPKERWAASQLLKHPFL 252
           FL  CL ++   RW  SQLL+HPF+
Sbjct: 248 FLKKCLEKNVDARWTTSQLLQHPFV 272

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  215 bits (550), Expect = 1e-68
 Identities = 77/260 (29%), Positives = 121/260 (46%), Gaps = 17/260 (6%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAK------STELPKSEFLQREQKFLSSLNSP 55
           D+  G  +G+G    V LA   +S  + A K        +      L+RE +  S L  P
Sbjct: 7   DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 66

Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
           +I+   G      D   +Y L +EYAP GT+  E+ +   + DE    +Y  ++   L Y
Sbjct: 67  NILRLYGY---FHDATRVY-LILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSY 121

Query: 116 LHSNRVVHCDIKSRNILMAESG-AKIADFGCAKW--ESEALQSGGTPMFMAPEVARGEHQ 172
            HS RV+H DIK  N+L+  +G  KIADFG +     S      GT  ++ PE+  G   
Sbjct: 122 CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMH 181

Query: 173 GFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNC 232
               D+W++G    E   G  P+  A        +I  SR     P F+++ A D +S  
Sbjct: 182 DEKVDLWSLGVLCYEFLVGKPPFE-ANTYQETYKRI--SRVEFTFPDFVTEGARDLISRL 238

Query: 233 LRRDPKERWAASQLLKHPFL 252
           L+ +P +R    ++L+HP++
Sbjct: 239 LKHNPSQRPMLREVLEHPWI 258

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  214 bits (547), Expect = 4e-67
 Identities = 78/317 (24%), Positives = 140/317 (44%), Gaps = 17/317 (5%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS---EFLQREQKFLSSLNSPHIV 58
            +     +G G+   V       +G VF AK    P       ++ E   ++ L+ P ++
Sbjct: 30  YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLI 89

Query: 59  GYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHS 118
                    ED   M  L +E+  GG L D I     ++ E+ +++Y RQ  +GL+++H 
Sbjct: 90  NLHDA---FEDKYEMV-LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE 145

Query: 119 NRVVHCDIKSRNILMAESG---AKIADFGCAKWESE---ALQSGGTPMFMAPEVARGEHQ 172
           + +VH DIK  NI+         KI DFG A   +       +  T  F APE+   E  
Sbjct: 146 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPV 205

Query: 173 GFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYS--RELPEVPAFLSKQANDFLS 230
           GF +D+WA+G     + SG +P+    D +  L  +         +  + +S +A DF+ 
Sbjct: 206 GFYTDMWAIGVLGYVLLSGLSPFA-GEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIK 264

Query: 231 NCLRRDPKERWAASQLLKHPFLEEFCS-CTKQIQESNCSPTSILDQGIWNSVEETEESLG 289
           N L+++P++R      L+HP+L+   S  T +I  S  +      +  +      + ++G
Sbjct: 265 NLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYADWPAPQPAIG 324

Query: 290 NLIHSTSKTSARERIER 306
            + + +S    R +  +
Sbjct: 325 RIANFSSLRKHRPQEYQ 341

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  211 bits (539), Expect = 6e-67
 Identities = 63/256 (24%), Positives = 112/256 (43%), Gaps = 13/256 (5%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKS-----EFLQREQKFLSSLNSPHIVGYKGC 63
           IG+GS  TV       +    A    +  K      +  + E + L  L  P+IV +   
Sbjct: 17  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76

Query: 64  DVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN--RV 121
             ++   K    L  E    GTL   + R    +   ++ S+ RQIL+GL++LH+    +
Sbjct: 77  WESTVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHTRTPPI 135

Query: 122 VHCDIKSRNILMAESG--AKIADFGCAKWESEALQSG--GTPMFMAPEVARGEHQGFASD 177
           +H D+K  NI +       KI D G A  +  +      GTP FMAPE+   ++   + D
Sbjct: 136 IHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEEKY-DESVD 194

Query: 178 IWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDP 237
           ++A G  ++EMA+   P+    +   +  ++    +          +  + +  C+R++ 
Sbjct: 195 VYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNK 254

Query: 238 KERWAASQLLKHPFLE 253
            ER++   LL H F +
Sbjct: 255 DERYSIKDLLNHAFFQ 270

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (531), Expect = 1e-65
 Identities = 66/269 (24%), Positives = 108/269 (40%), Gaps = 22/269 (8%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS-----EFLQREQKFLSSLNSPH 56
           D+   +TIG GS            G +   K  +         + L  E   L  L  P+
Sbjct: 5   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64

Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNG---GRLDESLIVSYTRQILQGL 113
           IV Y    +   +  L   + MEY  GG L   I +       LDE  ++    Q+   L
Sbjct: 65  IVRYYDRIIDRTNTTLY--IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122

Query: 114 EYLH-----SNRVVHCDIKSRNILMAESG-AKIADFGCAKW----ESEALQSGGTPMFMA 163
           +  H      + V+H D+K  N+ +      K+ DFG A+      S A    GTP +M+
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMS 182

Query: 164 PEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSK 223
           PE          SDIW++GC + E+ +   P+  A     +  KI    +   +P   S 
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT-AFSQKELAGKIR-EGKFRRIPYRYSD 240

Query: 224 QANDFLSNCLRRDPKERWAASQLLKHPFL 252
           + N+ ++  L      R +  ++L++P +
Sbjct: 241 ELNEIITRMLNLKDYHRPSVEEILENPLI 269

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (530), Expect = 1e-65
 Identities = 63/265 (23%), Positives = 106/265 (40%), Gaps = 17/265 (6%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS----EFLQREQKFLSSLNSPHI 57
           DW    T+G+G+   V LA +  + +  A K  ++ ++    E +++E      LN  ++
Sbjct: 6   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 65

Query: 58  VGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLH 117
           V + G             LF+EY  GG L D I  +   + E     +  Q++ G+ YLH
Sbjct: 66  VKFYGHRREGNI----QYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLH 120

Query: 118 SNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG------GTPMFMAPEVARG- 169
              + H DIK  N+L+ E    KI+DFG A       +        GT  ++APE+ +  
Sbjct: 121 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180

Query: 170 EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFL 229
           E      D+W+ G  +  M +G  PW   +D           +        +       L
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 240

Query: 230 SNCLRRDPKERWAASQLLKHPFLEE 254
              L  +P  R     + K  +  +
Sbjct: 241 HKILVENPSARITIPDIKKDRWYNK 265

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (529), Expect = 4e-65
 Identities = 94/259 (36%), Positives = 135/259 (52%), Gaps = 16/259 (6%)

Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAK---STELPKSEFLQREQKFLSSLNSPHIVG 59
           +TR   IGQG+S TV  A  + +G   A +     + PK E +  E   +    +P+IV 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 60  YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN 119
           Y    +  ++      + MEY  GG+L D +      +DE  I +  R+ LQ LE+LHSN
Sbjct: 82  YLDSYLVGDE----LWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSN 135

Query: 120 RVVHCDIKSRNILMAESG-AKIADFGCAK----WESEALQSGGTPMFMAPEVARGEHQGF 174
           +V+H DIKS NIL+   G  K+ DFG        +S+     GTP +MAPEV   +  G 
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195

Query: 175 ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELP-EVPAFLSKQANDFLSNCL 233
             DIW++G   IEM  G  P+ N  +P+  LY IA +     + P  LS    DFL+ CL
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLN-ENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCL 254

Query: 234 RRDPKERWAASQLLKHPFL 252
             D ++R +A +LL+H FL
Sbjct: 255 DMDVEKRGSAKELLQHQFL 273

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (526), Expect = 1e-64
 Identities = 77/273 (28%), Positives = 125/273 (45%), Gaps = 27/273 (9%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAK------STELPKSEFLQREQKFLSSLNSP 55
           D+  G  +G+GS +TV LA  L +   +A K        +  K  ++ RE+  +S L+ P
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68

Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
             V         +D++ +Y   + YA  G L   I + G   DE+    YT +I+  LEY
Sbjct: 69  FFVKLYFT---FQDDEKLY-FGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEY 123

Query: 116 LHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG------GTPMFMAPEVAR 168
           LH   ++H D+K  NIL+ E    +I DFG AK  S   +        GT  +++PE+  
Sbjct: 124 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 183

Query: 169 GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDF 228
            +    +SD+WA+GC + ++ +G  P+  A +   +  KI   +   + P     +A D 
Sbjct: 184 EKSACKSSDLWALGCIIYQLVAGLPPFR-AGNEYLIFQKII--KLEYDFPEKFFPKARDL 240

Query: 229 LSNCLRRDPKERWAASQ------LLKHPFLEEF 255
           +   L  D  +R    +      L  HPF E  
Sbjct: 241 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 273

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (528), Expect = 1e-64
 Identities = 75/302 (24%), Positives = 129/302 (42%), Gaps = 54/302 (17%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS----EFLQREQKFLSSLNSPHI 57
           D+ +   +G G+   V   +   SG V A K   L         + RE + L   NSP+I
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66

Query: 58  VGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLH 117
           VG+ G   +  +     ++ ME+  GG+L+  + + G R+ E ++   +  +++GL YL 
Sbjct: 67  VGFYGAFYSDGE----ISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLR 121

Query: 118 S-NRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG--GTPMFMAPEVARGEHQG 173
             ++++H D+K  NIL+   G  K+ DFG +    +++ +   GT  +M+PE  +G H  
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYS 181

Query: 174 FASDIWAVGCTVIEMASGGAPWP------------------------------------- 196
             SDIW++G +++EMA G  P P                                     
Sbjct: 182 VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYG 241

Query: 197 ----NAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFL 252
                      +L  I             S +  DF++ CL ++P ER    QL+ H F+
Sbjct: 242 MDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 301

Query: 253 EE 254
           + 
Sbjct: 302 KR 303

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (520), Expect = 2e-63
 Identities = 63/263 (23%), Positives = 115/263 (43%), Gaps = 15/263 (5%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAK--STELPKSEFLQREQKFLSSLNSPHIVG 59
            +     +G+G    V       S   + AK    +      +++E   L+     +I+ 
Sbjct: 6   KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILH 65

Query: 60  YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN 119
                 + E+      +  E+  G  + + I+ +   L+E  IVSY  Q+ + L++LHS+
Sbjct: 66  LHESFESMEE----LVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121

Query: 120 RVVHCDIKSRNILMAESG---AKIADFGCAK---WESEALQSGGTPMFMAPEVARGEHQG 173
            + H DI+  NI+         KI +FG A+              P + APEV + +   
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVS 181

Query: 174 FASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELP--EVPAFLSKQANDFLSN 231
            A+D+W++G  V  + SG  P+  A     ++  I  +      E    +S +A DF+  
Sbjct: 182 TATDMWSLGTLVYVLLSGINPFL-AETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDR 240

Query: 232 CLRRDPKERWAASQLLKHPFLEE 254
            L ++ K R  AS+ L+HP+L++
Sbjct: 241 LLVKERKSRMTASEALQHPWLKQ 263

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (518), Expect = 4e-63
 Identities = 64/317 (20%), Positives = 121/317 (38%), Gaps = 21/317 (6%)

Query: 6   GHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSL-NSPHIVGYKGCD 64
              +G G +  V    + R+ + FA K   L      +RE +        PHIV      
Sbjct: 17  SQVLGLGINGKVLQIFNKRTQEKFALK--MLQDCPKARREVELHWRASQCPHIVRIVDVY 74

Query: 65  VTSEDNKLMYNLFMEYAPGGTLNDEIHRNGG-RLDESLIVSYTRQILQGLEYLHSNRVVH 123
                 +    + ME   GG L   I   G     E       + I + ++YLHS  + H
Sbjct: 75  ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAH 134

Query: 124 CDIKSRNILMAESG----AKIADFGCAKW---ESEALQSGGTPMFMAPEVARGEHQGFAS 176
            D+K  N+L          K+ DFG AK     +       TP ++APEV   E    + 
Sbjct: 135 RDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSC 194

Query: 177 DIWAVGCTVIEMASGGAPWPN-----AADPMTVLYKIAYSRELPEVPAFLSKQANDFLSN 231
           D+W++G  +  +  G  P+ +      +  M    ++          + +S++    + N
Sbjct: 195 DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRN 254

Query: 232 CLRRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSILDQGIWNSVEETEESLGNL 291
            L+ +P +R   ++ + HP+       TK  Q    +   + +       E+ +E + + 
Sbjct: 255 LLKTEPTQRMTITEFMNHPW---IMQSTKVPQTPLHTSRVLKED--KERWEDVKEEMTSA 309

Query: 292 IHSTSKTSARERIERLS 308
           + +      + +I+++ 
Sbjct: 310 LATMRVDYEQIKIKKIE 326

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  197 bits (502), Expect = 2e-61
 Identities = 62/279 (22%), Positives = 108/279 (38%), Gaps = 31/279 (11%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS------------EFLQREQKFL 49
           ++     +G+G S+ V       +   +A K  ++               E   +E   L
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 50  SSLNS-PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQ 108
             ++  P+I+  K      E N   + L  +    G L D +      L E       R 
Sbjct: 64  RKVSGHPNIIQLKDT---YETNTFFF-LVFDLMKKGELFDYLTEKV-TLSEKETRKIMRA 118

Query: 109 ILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG---GTPMFMAP 164
           +L+ +  LH   +VH D+K  NIL+ +    K+ DFG +       +     GTP ++AP
Sbjct: 119 LLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAP 178

Query: 165 EVARGEHQ------GFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVP 218
           E+            G   D+W+ G  +  + +G  P+      M +L  I         P
Sbjct: 179 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW-HRKQMLMLRMIMSGNYQFGSP 237

Query: 219 AF--LSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
            +   S    D +S  L   P++R+ A + L HPF +++
Sbjct: 238 EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 276

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (500), Expect = 4e-61
 Identities = 65/266 (24%), Positives = 114/266 (42%), Gaps = 26/266 (9%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS-----EFLQREQKFLSSLNSPH 56
             T G  IG GS  TV      +     A K   +        +  + E   L      +
Sbjct: 9   QITVGQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65

Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL 116
           I+ + G          +  +  ++  G +L   +H    + +   ++   RQ  QG++YL
Sbjct: 66  ILLFMGY----STAPQLA-IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 120

Query: 117 HSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG------GTPMFMAPEVARG 169
           H+  ++H D+KS NI + E    KI DFG A  +S    S       G+ ++MAPEV R 
Sbjct: 121 HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 180

Query: 170 EHQG---FASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA---YSRELPEVPAFLSK 223
           + +    F SD++A G  + E+ +G  P+ N  +   +++ +     S +L +V +   K
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPK 240

Query: 224 QANDFLSNCLRRDPKERWAASQLLKH 249
                ++ CL++   ER    Q+L  
Sbjct: 241 AMKRLMAECLKKKRDERPLFPQILAS 266

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  197 bits (503), Expect = 5e-61
 Identities = 71/277 (25%), Positives = 117/277 (42%), Gaps = 19/277 (6%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAK----STELPKSEFLQREQKFLSSLNSPHI 57
            +     +G G+ + V LA   R+  + A K         K   ++ E   L  +  P+I
Sbjct: 10  IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNI 69

Query: 58  VGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLH 117
           V         E    +Y L M+   GG L D I   G    E        Q+L  ++YLH
Sbjct: 70  VALDDI---YESGGHLY-LIMQLVSGGELFDRIVEKG-FYTERDASRLIFQVLDAVKYLH 124

Query: 118 SNRVVHCDIKSRNILMAESGA----KIADFGCAKWESEALQSG---GTPMFMAPEVARGE 170
              +VH D+K  N+L           I+DFG +K E          GTP ++APEV   +
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQK 184

Query: 171 HQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAF--LSKQANDF 228
               A D W++G     +  G  P+    +   +  +I  +    + P +  +S  A DF
Sbjct: 185 PYSKAVDCWSIGVIAYILLCGYPPFY-DENDAKLFEQILKAEYEFDSPYWDDISDSAKDF 243

Query: 229 LSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQIQES 265
           + + + +DP++R+   Q L+HP++    +  K I +S
Sbjct: 244 IRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQS 280

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (498), Expect = 3e-60
 Identities = 72/267 (26%), Positives = 112/267 (41%), Gaps = 21/267 (7%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAK-------STELPKSEFLQREQKFLSSLNS 54
           D+     +G+GS   V LA   ++   FA K         +      +  ++    +   
Sbjct: 3   DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62

Query: 55  PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLE 114
           P +        T E+        MEY  GG L   I     + D S    Y  +I+ GL+
Sbjct: 63  PFLTHMFCTFQTKEN----LFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQ 117

Query: 115 YLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG----GTPMFMAPEVARG 169
           +LHS  +V+ D+K  NIL+ + G  KIADFG  K             GTP ++APE+  G
Sbjct: 118 FLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG 177

Query: 170 EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFL 229
           +    + D W+ G  + EM  G +P+    D   + + I      P  P +L K+A D L
Sbjct: 178 QKYNHSVDWWSFGVLLYEMLIGQSPFH-GQDEEELFHSIRMDN--PFYPRWLEKEAKDLL 234

Query: 230 SNCLRRDPKERW-AASQLLKHPFLEEF 255
                R+P++R      + +HP   E 
Sbjct: 235 VKLFVREPEKRLGVRGDIRQHPLFREI 261

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (488), Expect = 2e-59
 Identities = 61/257 (23%), Positives = 104/257 (40%), Gaps = 12/257 (4%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS-EFLQREQKFLSSLNSPHIVGY 60
           +     TIG+G    V L      G+  A K  +   + +    E   ++ L   ++V  
Sbjct: 8   ELKLLQTIGKGEFGDVMLGD--YRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQL 65

Query: 61  KGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGR-LDESLIVSYTRQILQGLEYLHSN 119
            G  V  +       +  EY   G+L D +   G   L    ++ ++  + + +EYL  N
Sbjct: 66  LGVIVEEKGG---LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 122

Query: 120 RVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG-GTPMFMAPEVARGEHQGFASD 177
             VH D+ +RN+L++E   AK++DFG  K  S    +G     + APE  R +     SD
Sbjct: 123 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSD 182

Query: 178 IWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDP 237
           +W+ G  + E+ S G           V+ ++       + P        + + NC   D 
Sbjct: 183 VWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPPAVYEVMKNCWHLDA 241

Query: 238 KERWAASQLLKHPFLEE 254
             R +  QL +   LE 
Sbjct: 242 AMRPSFLQLREQ--LEH 256

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (474), Expect = 3e-57
 Identities = 54/267 (20%), Positives = 103/267 (38%), Gaps = 25/267 (9%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAK---------STELPKSEFLQREQKFLSSL 52
            +  G  +G G   +V     +      A K           ELP    +  E   L  +
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64

Query: 53  NSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQG 112
           +S      +  D     +  +  L +E         +     G L E L  S+  Q+L+ 
Sbjct: 65  SSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVLEA 122

Query: 113 LEYLHSNRVVHCDIKSRNILMAESG--AKIADFGCAKWESEALQSG--GTPMFMAPEVAR 168
           + + H+  V+H DIK  NIL+  +    K+ DFG      + + +   GT ++  PE  R
Sbjct: 123 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIR 182

Query: 169 GE-HQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQAND 227
              + G ++ +W++G  + +M  G  P+ +  + +         R        +S +   
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII---------RGQVFFRQRVSSECQH 233

Query: 228 FLSNCLRRDPKERWAASQLLKHPFLEE 254
            +  CL   P +R    ++  HP++++
Sbjct: 234 LIRWCLALRPSDRPTFEEIQNHPWMQD 260

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  187 bits (476), Expect = 5e-57
 Identities = 75/267 (28%), Positives = 120/267 (44%), Gaps = 21/267 (7%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAK------STELPKSEFLQREQKFLSSLNSP 55
           D+    T+G GS   V L  S  +G  +A K         L + E    E+  LS +  P
Sbjct: 5   DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHP 64

Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
            I+   G     +D + ++   M+Y  GG L   + R   R    +   Y  ++   LEY
Sbjct: 65  FIIRMWGT---FQDAQQIFM-IMDYIEGGELFS-LLRKSQRFPNPVAKFYAAEVCLALEY 119

Query: 116 LHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQS-GGTPMFMAPEVARGEHQG 173
           LHS  +++ D+K  NIL+ ++G  KI DFG AK+  +   +  GTP ++APEV   +   
Sbjct: 120 LHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKPYN 179

Query: 174 FASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCL 233
            + D W+ G  + EM +G  P+   ++ M    KI  +      P F ++   D LS  +
Sbjct: 180 KSIDWWSFGILIYEMLAGYTPFY-DSNTMKTYEKILNAE--LRFPPFFNEDVKDLLSRLI 236

Query: 234 RRDPKERWA-----ASQLLKHPFLEEF 255
            RD  +R          +  HP+ +E 
Sbjct: 237 TRDLSQRLGNLQNGTEDVKNHPWFKEV 263

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  185 bits (471), Expect = 9e-57
 Identities = 64/267 (23%), Positives = 117/267 (43%), Gaps = 18/267 (6%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAK------STELPKSEFLQREQKFLSSLNSP 55
            +  G  +G G  + V LA  LR     A K      + +       +RE +  ++LN P
Sbjct: 8   RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 67

Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
            IV              +  + MEY  G TL D +H  G  +     +       Q L +
Sbjct: 68  AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNF 126

Query: 116 LHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG-------GTPMFMAPEVA 167
            H N ++H D+K  NI+++ +   K+ DFG A+  +++  S        GT  +++PE A
Sbjct: 127 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186

Query: 168 RGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELP--EVPAFLSKQA 225
           RG+     SD++++GC + E+ +G  P+     P++V Y+      +P       LS   
Sbjct: 187 RGDSVDARSDVYSLGCVLYEVLTGEPPFT-GDSPVSVAYQHVREDPIPPSARHEGLSADL 245

Query: 226 NDFLSNCLRRDPKERWAASQLLKHPFL 252
           +  +   L ++P+ R+  +  ++   +
Sbjct: 246 DAVVLKALAKNPENRYQTAAEMRADLV 272

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (461), Expect = 2e-55
 Identities = 51/269 (18%), Positives = 97/269 (36%), Gaps = 20/269 (7%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAK---STELPKSEFLQREQKFLSSLNSPHIV 58
                  +G G    V +          A K      +    FL  E   +  L    +V
Sbjct: 14  TLKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPDAFL-AEANLMKQLQHQRLV 71

Query: 59  GYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGG-RLDESLIVSYTRQILQGLEYLH 117
                        +   +  EY   G+L D +    G +L  + ++    QI +G+ ++ 
Sbjct: 72  RLYAV---VTQEPIY--IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126

Query: 118 SNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA-----LQSGGTPMFMAPEVARGEH 171
               +H D+++ NIL++++   KIADFG A+   +        +     + APE      
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 186

Query: 172 QGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSN 231
               SD+W+ G  + E+ + G           V+  +     +   P    ++    +  
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR-PDNCPEELYQLMRL 245

Query: 232 CLRRDPKERWAASQLLKHPFLEEFCSCTK 260
           C +  P++R     L     LE+F + T+
Sbjct: 246 CWKERPEDRPTFDYLRSV--LEDFFTATE 272

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (462), Expect = 3e-55
 Identities = 72/270 (26%), Positives = 111/270 (41%), Gaps = 25/270 (9%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAK---------STELPKSEFLQREQKFLSSL 52
            +  G  +G G  A V       +G  +AAK         S      E ++RE   L  +
Sbjct: 11  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70

Query: 53  NSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQG 112
             P+++          D      L +E   GG L D +      L E     + +QIL G
Sbjct: 71  QHPNVITLHEVYENKTD----VILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNG 125

Query: 113 LEYLHSNRVVHCDIKSRNILMAESG-----AKIADFGCAKWESEALQSG---GTPMFMAP 164
           + YLHS ++ H D+K  NI++ +        KI DFG A       +     GTP F+AP
Sbjct: 126 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 185

Query: 165 EVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKI--AYSRELPEVPAFLS 222
           E+   E  G  +D+W++G     + SG +P+         L  +         E  +  S
Sbjct: 186 EIVNYEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSAVNYEFEDEYFSNTS 244

Query: 223 KQANDFLSNCLRRDPKERWAASQLLKHPFL 252
             A DF+   L +DPK+R      L+HP++
Sbjct: 245 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 274

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (460), Expect = 4e-55
 Identities = 60/262 (22%), Positives = 100/262 (38%), Gaps = 23/262 (8%)

Query: 9   IGQGSSATVSLAT--SLRSGDVFAAK----STELPKSEFLQREQKFLSSLNSPHIVGYKG 62
           +G G+  +V        +     A K     TE   +E + RE + +  L++P+IV   G
Sbjct: 17  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76

Query: 63  CDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
                +   LM  L ME A GG L+  +      +  S +     Q+  G++YL     V
Sbjct: 77  V---CQAEALM--LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 131

Query: 123 HCDIKSRNILMAESG-AKIADFGCAKWESEALQS-------GGTPMFMAPEVARGEHQGF 174
           H D+ +RN+L+     AKI+DFG +K                    + APE         
Sbjct: 132 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 191

Query: 175 ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLR 234
            SD+W+ G T+ E  S G           V+  I    +  E P     +    +S+C  
Sbjct: 192 RSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECPPECPPELYALMSDCWI 250

Query: 235 RDPKERWAASQL---LKHPFLE 253
              ++R     +   ++  +  
Sbjct: 251 YKWEDRPDFLTVEQRMRACYYS 272

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (454), Expect = 1e-54
 Identities = 57/257 (22%), Positives = 96/257 (37%), Gaps = 16/257 (6%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAK---STELPKSEFLQREQKFLSSLNSPHIV 58
           D T    +G G    V      R     A K      + + EF+  E K + +L+   +V
Sbjct: 5   DLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFI-EEAKVMMNLSHEKLV 62

Query: 59  GYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHS 118
              G             +  EY   G L + +     R     ++   + + + +EYL S
Sbjct: 63  QLYGVCTKQRP----IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 118

Query: 119 NRVVHCDIKSRNILMAESG-AKIADFGCAKWESE-----ALQSGGTPMFMAPEVARGEHQ 172
            + +H D+ +RN L+ + G  K++DFG +++  +     ++ S     +  PEV      
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF 178

Query: 173 GFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNC 232
              SDIWA G  + E+ S G               IA    L   P   S++    + +C
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY-RPHLASEKVYTIMYSC 237

Query: 233 LRRDPKERWAASQLLKH 249
                 ER     LL +
Sbjct: 238 WHEKADERPTFKILLSN 254

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  182 bits (462), Expect = 2e-54
 Identities = 64/272 (23%), Positives = 116/272 (42%), Gaps = 23/272 (8%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKF---------LSSL 52
           D++    IG+G    V       +G ++A K  +  + +  Q E            +S+ 
Sbjct: 5   DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64

Query: 53  NSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQG 112
           + P IV       T +      +  ++   GG L+  + ++G    E+ +  Y  +I+ G
Sbjct: 65  DCPFIVCMSYAFHTPDK----LSFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILG 119

Query: 113 LEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKW--ESEALQSGGTPMFMAPEV-AR 168
           LE++H+  VV+ D+K  NIL+ E G  +I+D G A    + +   S GT  +MAPEV  +
Sbjct: 120 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQK 179

Query: 169 GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDF 228
           G     ++D +++GC + ++  G +P+                    E+P   S +    
Sbjct: 180 GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSL 239

Query: 229 LSNCLRRDPKERW-----AASQLLKHPFLEEF 255
           L   L+RD   R       A ++ + PF    
Sbjct: 240 LEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 271

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (453), Expect = 3e-54
 Identities = 59/262 (22%), Positives = 106/262 (40%), Gaps = 18/262 (6%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAK---STELPKSEFLQREQKFLSSLNSPHIV 58
           + T    IG G    V L     + D  A K      + + +F+  E + +  L+ P +V
Sbjct: 6   ELTFVQEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSEEDFI-EEAEVMMKLSHPKLV 63

Query: 59  GYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHS 118
              G  +          L  E+   G L+D +    G      ++     + +G+ YL  
Sbjct: 64  QLYGVCLEQA----PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 119

Query: 119 NRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQS-----GGTPMFMAPEVARGEHQ 172
             V+H D+ +RN L+ E+   K++DFG  ++  +   +          + +PEV      
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRY 179

Query: 173 GFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNC 232
              SD+W+ G  + E+ S G           V+  I+    L + P   S      +++C
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK-PRLASTHVYQIMNHC 238

Query: 233 LRRDPKERWAASQLLKHPFLEE 254
            +  P++R A S+LL+   L E
Sbjct: 239 WKERPEDRPAFSRLLRQ--LAE 258

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (458), Expect = 6e-54
 Identities = 67/291 (23%), Positives = 107/291 (36%), Gaps = 39/291 (13%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGYK 61
            +T    IG GS   V  A    SG++ A K   L    F  RE + +  L+  +IV  +
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNRELQIMRKLDHCNIVRLR 79

Query: 62  GC--DVTSEDNKLMYNLFMEYAPGGTLNDEIH--RNGGRLDESLIVSYTRQILQGLEYLH 117
                   + +++  NL ++Y P        H  R    L    +  Y  Q+ + L Y+H
Sbjct: 80  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139

Query: 118 SNRVVHCDIKSRNILMAESGA--KIADFGCAKWESEALQSGGT---PMFMAPEVARGEHQ 172
           S  + H DIK +N+L+    A  K+ DFG AK       +        + APE+  G   
Sbjct: 140 SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATD 199

Query: 173 -GFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKI------------------AYSRE 213
              + D+W+ GC + E+  G   +P     +  L +I                      +
Sbjct: 200 YTSSIDVWSAGCVLAELLLGQPIFP-GDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 258

Query: 214 LPEVPA---------FLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
            P++ A             +A    S  L   P  R    +   H F +E 
Sbjct: 259 FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (450), Expect = 1e-53
 Identities = 58/264 (21%), Positives = 101/264 (38%), Gaps = 25/264 (9%)

Query: 8   TIGQGSSATVSLAT--SLRSGDVFAAK-----STELPKSEFLQREQKFLSSLNSPHIVGY 60
            +G G+  TV        +     A K     + +    + L  E   +  L++P+IV  
Sbjct: 14  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73

Query: 61  KGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNR 120
            G           + L ME A  G LN  + +N   + +  I+    Q+  G++YL  + 
Sbjct: 74  IGICEAES-----WMLVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLEESN 127

Query: 121 VVHCDIKSRNILMAESG-AKIADFGCAK-------WESEALQSGGTPMFMAPEVARGEHQ 172
            VH D+ +RN+L+     AKI+DFG +K       +            + APE       
Sbjct: 128 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 187

Query: 173 GFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNC 232
              SD+W+ G  + E  S G           V   +    E    PA   ++  D ++ C
Sbjct: 188 SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPAGCPREMYDLMNLC 246

Query: 233 LRRDPKERWAASQL---LKHPFLE 253
              D + R   + +   L++ + +
Sbjct: 247 WTYDVENRPGFAAVELRLRNYYYD 270

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (453), Expect = 2e-53
 Identities = 75/270 (27%), Positives = 110/270 (40%), Gaps = 24/270 (8%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAK------STELPKSEFLQREQKFLSSLNSP 55
           D+     +G+G+   V L     +G  +A K           +      E + L +   P
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65

Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
            +   K    T +         MEYA GG L   + R      E     Y  +I+  LEY
Sbjct: 66  FLTALKYAFQTHD----RLCFVMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEY 120

Query: 116 LHSNRVVHCDIKSRNILMAESG-AKIADFGCAK----WESEALQSGGTPMFMAPEVARGE 170
           LHS  VV+ DIK  N+++ + G  KI DFG  K      +      GTP ++APEV    
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN 180

Query: 171 HQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLS 230
             G A D W +G  + EM  G  P+    D   +   I    E    P  LS +A   L+
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFY-NQDHERLFELI--LMEEIRFPRTLSPEAKSLLA 237

Query: 231 NCLRRDPKERWA-----ASQLLKHPFLEEF 255
             L++DPK+R       A ++++H F    
Sbjct: 238 GLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (448), Expect = 4e-53
 Identities = 70/286 (24%), Positives = 106/286 (37%), Gaps = 46/286 (16%)

Query: 9   IGQGSSATVSLATSLRSGDVFAAKSTELPKS--------EFLQREQKFLSSLNSPHIVGY 60
           +G+G  ATV  A    +  + A K  +L               RE K L  L+ P+I+G 
Sbjct: 6   LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65

Query: 61  KGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNR 120
                   +     +L  ++         I  N   L  S I +Y    LQGLEYLH + 
Sbjct: 66  LDAFGHKSN----ISLVFDFMETDLE-VIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120

Query: 121 VVHCDIKSRNILMAESG-AKIADFGCAKWESEALQS----GGTPMFMAPEVARGEHQ-GF 174
           ++H D+K  N+L+ E+G  K+ADFG AK      ++      T  + APE+  G    G 
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGV 180

Query: 175 ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA------------------------- 209
             D+WAVGC + E+       P     +  L +I                          
Sbjct: 181 GVDMWAVGCILAELLLRVPFLP-GDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239

Query: 210 -YSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEE 254
                L  + +       D +      +P  R  A+Q LK  +   
Sbjct: 240 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 285

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (445), Expect = 5e-53
 Identities = 62/270 (22%), Positives = 100/270 (37%), Gaps = 24/270 (8%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGD---VFAAK------STELPKSEFLQREQKFLSSL 52
           D      +G GS   V               A K       ++    +   RE   + SL
Sbjct: 9   DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68

Query: 53  NSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQG 112
           +  +++   G  +T         +  E AP G+L D + ++ G      +  Y  Q+ +G
Sbjct: 69  DHRNLIRLYGVVLTPP-----MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 123

Query: 113 LEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQS-------GGTPMFMAP 164
           + YL S R +H D+ +RN+L+A     KI DFG  +   +                + AP
Sbjct: 124 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183

Query: 165 EVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQ 224
           E  +      ASD W  G T+ EM + G       +   +L+KI    E    P    + 
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQD 243

Query: 225 ANDFLSNCLRRDPKERWAASQLLKHPFLEE 254
             + +  C    P++R     L    FL E
Sbjct: 244 IYNVMVQCWAHKPEDRPTFVALRD--FLLE 271

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (436), Expect = 1e-51
 Identities = 60/261 (22%), Positives = 97/261 (37%), Gaps = 19/261 (7%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAA-------KSTELPKSEFLQREQKFLSSLNS 54
               G  IG+G    V     +   +   A         T     E   +E   +   + 
Sbjct: 8   RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 67

Query: 55  PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLE 114
           PHIV   G      +N +   + ME    G L   +      LD + ++ Y  Q+   L 
Sbjct: 68  PHIVKLIGV---ITENPVW--IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALA 122

Query: 115 YLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE-----ALQSGGTPMFMAPEVAR 168
           YL S R VH DI +RN+L++ +   K+ DFG +++  +     A +      +MAPE   
Sbjct: 123 YLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 182

Query: 169 GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDF 228
                 ASD+W  G  + E+   G           V+ +I  + E   +P          
Sbjct: 183 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPPNCPPTLYSL 241

Query: 229 LSNCLRRDPKERWAASQLLKH 249
           ++ C   DP  R   ++L   
Sbjct: 242 MTKCWAYDPSRRPRFTELKAQ 262

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (439), Expect = 2e-51
 Identities = 56/287 (19%), Positives = 99/287 (34%), Gaps = 43/287 (14%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAA---------KSTELPKSEFLQREQKFLSSL 52
           +   G  +G G+   V  AT+        +         +  +  + E L  E K ++ L
Sbjct: 38  NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 97

Query: 53  NS-PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGR--------------- 96
            S  +IV   G    S        L  EY   G L + +     +               
Sbjct: 98  GSHENIVNLLGACTLSGP----IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 153

Query: 97  -------LDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKW 148
                  L    ++ +  Q+ +G+E+L     VH D+ +RN+L+      KI DFG A+ 
Sbjct: 154 EEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARD 213

Query: 149 ESEALQS------GGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPM 202
                             +MAPE          SD+W+ G  + E+ S G          
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273

Query: 203 TVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKH 249
              YK+  +    + P + +++    + +C   D ++R +   L   
Sbjct: 274 ANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (436), Expect = 2e-51
 Identities = 60/268 (22%), Positives = 101/268 (37%), Gaps = 18/268 (6%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAK--STELPKSEFLQREQKFLSSLNSPHIVG 59
                  +GQG    V + T        A K         E   +E + +  L    +V 
Sbjct: 18  SLRLEVKLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 76

Query: 60  YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLD-ESLIVSYTRQILQGLEYLHS 118
                           +  EY   G+L D +    G+      +V    QI  G+ Y+  
Sbjct: 77  LYAVVSEEP-----IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 131

Query: 119 NRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQS-----GGTPMFMAPEVARGEHQ 172
              VH D+++ NIL+ E+   K+ADFG A+   +   +          + APE A     
Sbjct: 132 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 191

Query: 173 GFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNC 232
              SD+W+ G  + E+ + G           VL ++     +P  P    +  +D +  C
Sbjct: 192 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP-CPPECPESLHDLMCQC 250

Query: 233 LRRDPKERWAASQLLKHPFLEEFCSCTK 260
            R++P+ER     L    FLE++ + T+
Sbjct: 251 WRKEPEERPTFEYLQA--FLEDYFTSTE 276

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (436), Expect = 2e-51
 Identities = 80/291 (27%), Positives = 123/291 (42%), Gaps = 43/291 (14%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS-----EFLQREQKFLSSLNSPH 56
           ++ +   IG+G+   V  A +  +G+V A K   L            RE   L  LN P+
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62

Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL 116
           IV  K  DV   +NKL   L  E+                +   LI SY  Q+LQGL + 
Sbjct: 63  IV--KLLDVIHTENKLY--LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118

Query: 117 HSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQ----SGGTPMFMAPEV-ARGE 170
           HS+RV+H D+K +N+L+   G  K+ADFG A+     ++       T  + APE+    +
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 178

Query: 171 HQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA--------------------- 209
           +   A DIW++GC   EM +  A +P     +  L++I                      
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFP-GDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237

Query: 210 ------YSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEE 254
                   ++  +V   L +     LS  L  DP +R +A   L HPF ++
Sbjct: 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (436), Expect = 3e-51
 Identities = 73/296 (24%), Positives = 116/296 (39%), Gaps = 40/296 (13%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAA------KSTELPKSEFLQREQKFLSSLNS- 54
            +     IG+G+   V  A  L++G  F A      ++ E        RE   L  L + 
Sbjct: 8   QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 67

Query: 55  --PHIVGYKG-CDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQ 111
             P++V     C V+  D +    L  E+                +    I     Q+L+
Sbjct: 68  EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLR 127

Query: 112 GLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG---GTPMFMAPEVA 167
           GL++LHS+RVVH D+K +NIL+  SG  K+ADFG A+  S  +       T  + APEV 
Sbjct: 128 GLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVL 187

Query: 168 RGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAY----------------- 210
                    D+W+VGC   EM      +   +  +  L KI                   
Sbjct: 188 LQSSYATPVDLWSVGCIFAEMFRRKPLFR-GSSDVDQLGKILDVIGLPGEEDWPRDVALP 246

Query: 211 --------SRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSC 258
                   ++ + +    + +   D L  CL  +P +R +A   L HP+ ++   C
Sbjct: 247 RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERC 302

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (435), Expect = 5e-51
 Identities = 63/316 (19%), Positives = 120/316 (37%), Gaps = 38/316 (12%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAK--------STELPKSEFLQREQKFLSSLN 53
           ++ +   +G G+  TV     +  G+             +T    ++ +  E   ++S++
Sbjct: 10  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 69

Query: 54  SPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGL 113
           +PH+    G  +TS        L  +  P G L D +  +   +    ++++  QI +G+
Sbjct: 70  NPHVCRLLGICLTST-----VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 124

Query: 114 EYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQS------GGTPMFMAPEV 166
            YL   R+VH D+ +RN+L+      KI DFG AK      +            +MA E 
Sbjct: 125 NYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184

Query: 167 ARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQAN 226
                    SD+W+ G TV E+ + G+  P    P + +  I    E    P   +    
Sbjct: 185 ILHRIYTHQSDVWSYGVTVWELMTFGSK-PYDGIPASEISSILEKGERLPQPPICTIDVY 243

Query: 227 DFLSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQI--------------QESNCSPTSI 272
             +  C   D   R    +L+      +     ++                +SN    ++
Sbjct: 244 MIMVKCWMIDADSRPKFRELIIE--FSKMARDPQRYLVIQGDERMHLPSPTDSNFYR-AL 300

Query: 273 LDQGIWNSVEETEESL 288
           +D+   + V + +E L
Sbjct: 301 MDEEDMDDVVDADEYL 316

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  170 bits (431), Expect = 3e-50
 Identities = 60/292 (20%), Positives = 112/292 (38%), Gaps = 48/292 (16%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLN-SPHIVGY 60
           D+     +G+G  + V  A ++ + +    K  +  K + ++RE K L +L   P+I+  
Sbjct: 36  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITL 95

Query: 61  KGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNR 120
              D+  +       L  E+                L +  I  Y  +IL+ L+Y HS  
Sbjct: 96  A--DIVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSMG 149

Query: 121 VVHCDIKSRNILMAESG--AKIADFGCAKW---ESEALQSGGTPMFMAPEVARG-EHQGF 174
           ++H D+K  N+++       ++ D+G A++     E      +  F  PE+    +   +
Sbjct: 150 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDY 209

Query: 175 ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELP------------------- 215
           + D+W++GC +  M     P+ +  D    L +IA                         
Sbjct: 210 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFND 269

Query: 216 ----------------EVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPF 251
                           E    +S +A DFL   LR D + R  A + ++HP+
Sbjct: 270 ILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 321

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (429), Expect = 3e-50
 Identities = 73/294 (24%), Positives = 110/294 (37%), Gaps = 46/294 (15%)

Query: 6   GHTIGQGSSATVSLATSLR-----SGDVFAAK----STELPKSEFLQREQKFLSSL-NSP 55
           G T+G G+   V  AT+       +    A K    S  L + E L  E K LS L N  
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87

Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNG-----------------GRLD 98
           +IV   G             +  EY   G L + + R                     LD
Sbjct: 88  NIVNLLGACTIGGP----TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143

Query: 99  ESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQS-- 155
              ++S++ Q+ +G+ +L S   +H D+ +RNIL+      KI DFG A+          
Sbjct: 144 LEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203

Query: 156 ----GGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYS 211
                    +MAPE        F SD+W+ G  + E+ S G+         +  YK+   
Sbjct: 204 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKE 263

Query: 212 RELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQIQES 265
                 P     +  D +  C   DP +R    Q+++   +E      KQI ES
Sbjct: 264 GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ--LIE------KQISES 309

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (431), Expect = 4e-50
 Identities = 66/324 (20%), Positives = 120/324 (37%), Gaps = 46/324 (14%)

Query: 8   TIGQGSSATVSLATSLRSGDVFAAKSTELPKS-----EFLQREQKFLSSLNSPHIVGYKG 62
            +G G+   V  A   R+G   A K    P       +   RE + L  +   +++G   
Sbjct: 25  PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84

Query: 63  CDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVV 122
                E      + ++     GT   ++ ++  +L E  I     Q+L+GL Y+H+  ++
Sbjct: 85  VFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE-KLGEDRIQFLVYQMLKGLRYIHAAGII 143

Query: 123 HCDIKSRNILMAESG-AKIADFGCAKWESEALQS-GGTPMFMAPEVARG-EHQGFASDIW 179
           H D+K  N+ + E    KI DFG A+     +     T  + APEV           DIW
Sbjct: 144 HRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIW 203

Query: 180 AVGCTVIEMASGGAPWPNAADPMTVLYKIAY----------------------------- 210
           +VGC + EM +G   +   +D +  L +I                               
Sbjct: 204 SVGCIMAEMITGKTLF-KGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELE 262

Query: 211 SRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPT 270
            ++   +    S  A + L   L  D ++R  A + L HP+        + + ++   P 
Sbjct: 263 KKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF-------ESLHDTEDEPQ 315

Query: 271 SILDQGIWNSVEETEESLGNLIHS 294
                  ++ V+ T +    + + 
Sbjct: 316 VQKYDDSFDDVDRTLDEWKRVTYK 339

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  168 bits (427), Expect = 5e-50
 Identities = 55/277 (19%), Positives = 94/277 (33%), Gaps = 30/277 (10%)

Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP-KSEFLQREQKFLSSLNSPHIVGYK 61
           +  G  IG GS   + L T + +G+  A K   +  K   L  E K    +     +   
Sbjct: 9   YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTI 68

Query: 62  GCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRV 121
                  D  +M    +    G +L D  +    +     ++    Q++  +EY+HS   
Sbjct: 69  RWCGAEGDYNVMVMELL----GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNF 124

Query: 122 VHCDIKSRNILMAESG----AKIADFGCAKWESEALQSG-----------GTPMFMAPEV 166
           +H D+K  N LM          I DFG AK   +A               GT  + +   
Sbjct: 125 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT 184

Query: 167 ARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA------YSRELPEVPAF 220
             G  Q    D+ ++G  ++    G  PW       T   K         S  +  +   
Sbjct: 185 HLGIEQSRRDDLESLGYVLMYFNLGSLPWQG-LKAATKRQKYERISEKKMSTPIEVLCKG 243

Query: 221 LSKQANDFLSNCLRRDPKERWAAS---QLLKHPFLEE 254
              +   +L+ C      ++   S   QL ++ F  +
Sbjct: 244 YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  167 bits (425), Expect = 8e-50
 Identities = 56/276 (20%), Positives = 105/276 (38%), Gaps = 22/276 (7%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAK--STELPKSEFLQREQKFLSSLNSPHIVG 59
           D T  H +G G    V      +     A K    +  + E   +E   +  +  P++V 
Sbjct: 18  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 77

Query: 60  YKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNG-GRLDESLIVSYTRQILQGLEYLHS 118
             G           + +  E+   G L D +       +   +++    QI   +EYL  
Sbjct: 78  LLGVCTREPP----FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 133

Query: 119 NRVVHCDIKSRNILMAESG-AKIADFGCAKWESEAL-----QSGGTPMFMAPEVARGEHQ 172
              +H D+ +RN L+ E+   K+ADFG ++  +         +     + APE       
Sbjct: 134 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 193

Query: 173 GFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNC 232
              SD+WA G  + E+A+ G       D    +Y++       E P    ++  + +  C
Sbjct: 194 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYELLEKDYRMERPEGCPEKVYELMRAC 252

Query: 233 LRRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCS 268
            + +P +R + +++ +    E         QES+ S
Sbjct: 253 WQWNPSDRPSFAEIHQ--AFETM------FQESSIS 280

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (429), Expect = 9e-50
 Identities = 71/333 (21%), Positives = 111/333 (33%), Gaps = 51/333 (15%)

Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS----EFLQREQKFLSSLNSPHIV 58
           +T    IG+G+   V  A    +    A K     +     +   RE K L      +I+
Sbjct: 10  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 69

Query: 59  GYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHS 118
           G           ++     + +  G  L   +      L    I  +  QIL+GL+Y+HS
Sbjct: 70  GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHS 127

Query: 119 NRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG-------GTPMFMAPEVARGE 170
             V+H D+K  N+L+  +   KI DFG A+                 T  + APE+    
Sbjct: 128 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 187

Query: 171 HQ-GFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA-------------------- 209
                + DIW+VGC + EM S    +      +  L  I                     
Sbjct: 188 KGYTKSIDIWSVGCILAEMLSNRPIF-PGKHYLDQLNHILGILGSPSQEDLNCIINLKAR 246

Query: 210 ---------YSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSCTK 260
                           +      +A D L   L  +P +R    Q L HP+LE++   + 
Sbjct: 247 NYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS- 305

Query: 261 QIQESNCSPTSILDQGIWNSVEETEESLGNLIH 293
              E         D       +  +E L  LI 
Sbjct: 306 --DEPIAEAPFKFDM---ELDDLPKEKLKELIF 333

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  168 bits (427), Expect = 2e-49
 Identities = 74/267 (27%), Positives = 117/267 (43%), Gaps = 21/267 (7%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAK------STELPKSEFLQREQKFLSSLNSP 55
            + R  T+G GS   V L     SG+ +A K        +L + E    E++ L ++N P
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101

Query: 56  HIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEY 115
            +V  +     +        + MEY  GG +   + R G R  E     Y  QI+   EY
Sbjct: 102 FLVKLEFSFKDNS----NLYMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEY 156

Query: 116 LHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQS-GGTPMFMAPEVARGEHQG 173
           LHS  +++ D+K  N+L+ + G  ++ DFG AK       +  GTP  +APE+   +   
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKGYN 216

Query: 174 FASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCL 233
            A D WA+G  + EMA+G  P+  A  P+ +  KI         P+  S    D L N L
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFF-ADQPIQIYEKI--VSGKVRFPSHFSSDLKDLLRNLL 273

Query: 234 RRDPKERWA-----ASQLLKHPFLEEF 255
           + D  +R+       + +  H +    
Sbjct: 274 QVDLTKRFGNLKNGVNDIKNHKWFATT 300

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (422), Expect = 2e-49
 Identities = 69/293 (23%), Positives = 115/293 (39%), Gaps = 43/293 (14%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS-----EFLQREQKFLSSLNSPH 56
            + +   IG+G+  TV  A +  + ++ A K   L            RE   L  L   +
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62

Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL 116
           IV       +         L  E+            NG   D  ++ S+  Q+L+GL + 
Sbjct: 63  IVRLHDVLHS----DKKLTLVFEFCDQDLKKYFDSCNGDL-DPEIVKSFLFQLLKGLGFC 117

Query: 117 HSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQS----GGTPMFMAPEVARGE- 170
           HS  V+H D+K +N+L+  +G  K+A+FG A+     ++       T  +  P+V  G  
Sbjct: 118 HSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK 177

Query: 171 HQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAY-------------------- 210
               + D+W+ GC   E+A+ G P     D    L +I                      
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237

Query: 211 -------SRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFC 256
                  +  L  V   L+    D L N L+ +P +R +A + L+HP+  +FC
Sbjct: 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  166 bits (420), Expect = 4e-49
 Identities = 74/293 (25%), Positives = 107/293 (36%), Gaps = 46/293 (15%)

Query: 1   MD-WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS-----EFLQREQKFLSSLNS 54
           M+ +     IG+G+   V  A     G+ FA K   L K          RE   L  L  
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKH 59

Query: 55  PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLE 114
            +IV       T    K    L  E+         +    G L+     S+  Q+L G+ 
Sbjct: 60  SNIVKLYDVIHT----KKRLVLVFEHLDQDLKKL-LDVCEGGLESVTAKSFLLQLLNGIA 114

Query: 115 YLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSGGT----PMFMAPEVARG 169
           Y H  RV+H D+K +N+L+   G  KIADFG A+     ++          + AP+V  G
Sbjct: 115 YCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG 174

Query: 170 EHQ-GFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKI-------------------- 208
             +     DIW+VGC   EM +G   +P        L +I                    
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFP-GVSEADQLMRIFRILGTPNSKNWPNVTELPK 233

Query: 209 -------AYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEE 254
                              L +   D LS  L+ DP +R  A Q L+H + +E
Sbjct: 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  166 bits (421), Expect = 4e-49
 Identities = 60/294 (20%), Positives = 101/294 (34%), Gaps = 46/294 (15%)

Query: 2   DWTRGHTIGQGSSATVSLATS-----LRSGDVFAAKSTELPKS----EFLQREQKFLSSL 52
           +      IG+G+   V  A +          + A K  +   S       QRE   ++  
Sbjct: 14  NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 73

Query: 53  NSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGR---------------- 96
           ++P+IV   G     +       L  EY   G LN+ +                      
Sbjct: 74  DNPNIVKLLGVCAVGKP----MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 129

Query: 97  -------LDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKW 148
                  L  +  +   RQ+  G+ YL   + VH D+ +RN L+ E+   KIADFG ++ 
Sbjct: 130 SSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRN 189

Query: 149 ESEALQS------GGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPM 202
              A              +M PE          SD+WA G  + E+ S G          
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE 249

Query: 203 TVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFC 256
            V+Y +     +   P     +  + +  C  + P +R +   + +   L+  C
Sbjct: 250 EVIYYVR-DGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR--ILQRMC 300

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (421), Expect = 5e-49
 Identities = 64/311 (20%), Positives = 117/311 (37%), Gaps = 38/311 (12%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS------EFLQREQKFLSSL-NS 54
           D      IG+G+   V  A   + G    A    + +            E + L  L + 
Sbjct: 11  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 70

Query: 55  PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRN---------------GGRLDE 99
           P+I+   G             L +EYAP G L D + ++                  L  
Sbjct: 71  PNIINLLGACEHRGY----LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 126

Query: 100 SLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQS--- 155
             ++ +   + +G++YL   + +H D+ +RNIL+ E+  AKIADFG ++ +   ++    
Sbjct: 127 QQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG 186

Query: 156 GGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELP 215
                +MA E          SD+W+ G  + E+ S G           +  K+     L 
Sbjct: 187 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLE 246

Query: 216 EVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSILDQ 275
           + P     +  D +  C R  P ER + +Q+L    L          +      T++ ++
Sbjct: 247 K-PLNCDDEVYDLMRQCWREKPYERPSFAQILVS--LNRMLE-----ERKTYVNTTLYEK 298

Query: 276 GIWNSVEETEE 286
             +  ++ + E
Sbjct: 299 FTYAGIDCSAE 309

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (419), Expect = 9e-49
 Identities = 54/268 (20%), Positives = 105/268 (39%), Gaps = 22/268 (8%)

Query: 6   GHTIGQGSSATVSLATSLRS---GDVFAAK----STELPKSEFLQREQKFLSSLNSPHIV 58
              IG+G    V   T L +       A K     T++ +      E   +   + P+++
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91

Query: 59  GYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHS 118
              G  + SE + L   + + Y   G L + I           ++ +  Q+ +G+++L S
Sbjct: 92  SLLGICLRSEGSPL---VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS 148

Query: 119 NRVVHCDIKSRNILMAESG-AKIADFGCAKW--------ESEALQSGGTPMFMAPEVARG 169
            + VH D+ +RN ++ E    K+ADFG A+               +     +MA E  + 
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 208

Query: 170 EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFL 229
           +     SD+W+ G  + E+ + GAP     +   +   +   R L + P +      + +
Sbjct: 209 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ-PEYCPDPLYEVM 267

Query: 230 SNCLRRDPKERWAASQLLKHPFLEEFCS 257
             C     + R + S+L+    +    S
Sbjct: 268 LKCWHPKAEMRPSFSELVSR--ISAIFS 293

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  165 bits (418), Expect = 1e-48
 Identities = 56/271 (20%), Positives = 101/271 (37%), Gaps = 24/271 (8%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEF-------LQREQKFLSSLNS 54
                  IG G    V        G      + +  KS +          E   +   + 
Sbjct: 27  CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 86

Query: 55  PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLE 114
           P+++  +G    S        +  E+   G+L+  + +N G+     +V   R I  G++
Sbjct: 87  PNVIHLEGVVTKSTP----VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMK 142

Query: 115 YLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE---------ALQSGGTPMFMAP 164
           YL     VH D+ +RNIL+  +   K++DFG +++  +         AL       + AP
Sbjct: 143 YLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAP 202

Query: 165 EVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQ 224
           E  +      ASD+W+ G  + E+ S G           V+  I     LP  P      
Sbjct: 203 EAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPP-PMDCPSA 261

Query: 225 ANDFLSNCLRRDPKERWAASQLLKHPFLEEF 255
            +  + +C ++D   R    Q++    L++ 
Sbjct: 262 LHQLMLDCWQKDRNHRPKFGQIVNT--LDKM 290

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (417), Expect = 2e-48
 Identities = 65/302 (21%), Positives = 101/302 (33%), Gaps = 51/302 (16%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS-----EFLQREQKFLSSLNSPH 56
            + +   IGQG+   V  A   ++G   A K   +            RE K L  L   +
Sbjct: 11  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 70

Query: 57  IVGYKGCDVTSE----DNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQG 112
           +V       T        K    L  ++          +    +   S I    + +L G
Sbjct: 71  VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV-KFTLSEIKRVMQMLLNG 129

Query: 113 LEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG--------GTPMFMA 163
           L Y+H N+++H D+K+ N+L+   G  K+ADFG A+  S A  S          T  +  
Sbjct: 130 LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 189

Query: 164 PEVARGEHQ-GFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA------------- 209
           PE+  GE   G   D+W  GC + EM +              L  I+             
Sbjct: 190 PELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG-NTEQHQLALISQLCGSITPEVWPN 248

Query: 210 ---------------YSRELPEV--PAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFL 252
                            R++ +          A D +   L  DP +R  +   L H F 
Sbjct: 249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 308

Query: 253 EE 254
             
Sbjct: 309 WS 310

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (410), Expect = 4e-47
 Identities = 65/329 (19%), Positives = 120/329 (36%), Gaps = 46/329 (13%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGDVFAAK-----STELPKSEFLQREQKFLSSLNSPH 56
            +     +G G+  +V  A   ++G   A K        +  ++   RE + L  +   +
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 78

Query: 57  IVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYL 116
           ++G       +   +   ++++     G   + I +   +L +  +     QIL+GL+Y+
Sbjct: 79  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYI 137

Query: 117 HSNRVVHCDIKSRNILMAESGA-KIADFGCAKWESEALQSGG-TPMFMAPEVARG-EHQG 173
           HS  ++H D+K  N+ + E    KI DFG A+   + +     T  + APE+     H  
Sbjct: 138 HSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYN 197

Query: 174 FASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA------------------------ 209
              DIW+VGC + E+ +G   +P   D +  L  I                         
Sbjct: 198 QTVDIWSVGCIMAELLTGRTLFP-GTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 256

Query: 210 -----YSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQIQE 264
                       V    +  A D L   L  D  +R  A+Q L H +  ++        E
Sbjct: 257 SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDD---E 313

Query: 265 SNCSPTSILDQGIWNSVEETEESLGNLIH 293
               P        + S +   +   +L +
Sbjct: 314 PVADPYDQ----SFESRDLLIDEWKSLTY 338

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (401), Expect = 2e-46
 Identities = 56/269 (20%), Positives = 100/269 (37%), Gaps = 25/269 (9%)

Query: 4   TRGHTIGQGSSATVSLA----TSLRSGDVFAAK-----STELPKSEFLQREQKFLSSLNS 54
           TR   IG G    V       +S +     A K      TE  + +FL  E   +   + 
Sbjct: 10  TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFL-GEAGIMGQFSH 68

Query: 55  PHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLE 114
            +I+  +G     +       +  EY   G L+  +    G      +V   R I  G++
Sbjct: 69  HNIIRLEGVISKYKP----MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMK 124

Query: 115 YLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQS-------GGTPMFMAPEV 166
           YL +   VH D+ +RNIL+  +   K++DFG ++   +  ++            + APE 
Sbjct: 125 YLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 184

Query: 167 ARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQAN 226
                   ASD+W+ G  + E+ + G           V+  I     LP  P        
Sbjct: 185 ISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLP-TPMDCPSAIY 243

Query: 227 DFLSNCLRRDPKERWAASQLLKHPFLEEF 255
             +  C +++   R   + ++    L++ 
Sbjct: 244 QLMMQCWQQERARRPKFADIVS--ILDKL 270

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (403), Expect = 3e-46
 Identities = 68/280 (24%), Positives = 121/280 (43%), Gaps = 32/280 (11%)

Query: 2   DWTRGHTIGQGSSATVSLATSLR---SGDVFAAK-------STELPKSEFLQREQKFLSS 51
           ++     +G G+   V L   +    +G ++A K         +   +E  + E++ L  
Sbjct: 25  NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84

Query: 52  LN-SPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQIL 110
           +  SP +V       T        +L ++Y  GG L   + +   R  E  +  Y  +I+
Sbjct: 85  IRQSPFLVTLHYAFQTETK----LHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIV 139

Query: 111 QGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE-----ALQSGGTPMFMAP 164
             LE+LH   +++ DIK  NIL+  +G   + DFG +K         A    GT  +MAP
Sbjct: 140 LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAP 199

Query: 165 EVARGEHQGF--ASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA--YSRELPEVPAF 220
           ++ RG   G   A D W++G  + E+ +G +P+           +I+    +  P  P  
Sbjct: 200 DIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT-VDGEKNSQAEISRRILKSEPPYPQE 258

Query: 221 LSKQANDFLSNCLRRDPKERWA-----ASQLLKHPFLEEF 255
           +S  A D +   L +DPK+R       A ++ +H F ++ 
Sbjct: 259 MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 298

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (392), Expect = 7e-45
 Identities = 55/280 (19%), Positives = 103/280 (36%), Gaps = 35/280 (12%)

Query: 2   DWTRGHTIGQGSSATVSLATSLR-----SGDVFAAK-----STELPKSEFLQREQKFLSS 51
               G  +G+G+   V  A +       +    A K     +T       +   +  +  
Sbjct: 14  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 73

Query: 52  LNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGG---------------R 96
            +  ++V   G   T     LM  + +E+   G L+  +                     
Sbjct: 74  GHHLNVVNLLGA-CTKPGGPLM--VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130

Query: 97  LDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQS 155
           L    ++ Y+ Q+ +G+E+L S + +H D+ +RNIL++E    KI DFG A+   +    
Sbjct: 131 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 190

Query: 156 ------GGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIA 209
                      +MAPE          SD+W+ G  + E+ S GA             +  
Sbjct: 191 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 250

Query: 210 YSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKH 249
                   P + + +    + +C   +P +R   S+L++H
Sbjct: 251 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (393), Expect = 2e-44
 Identities = 71/338 (21%), Positives = 109/338 (32%), Gaps = 61/338 (18%)

Query: 8   TIGQGSSATVSLATSLRSGDVFAAKSTELPKS-----EFLQREQKFLSSLNSPHIVGYKG 62
            IG G+   V  A         A K    P       +   RE   +  +N  +I+    
Sbjct: 24  PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83

Query: 63  CDVTSE--DNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNR 120
                +  +      L ME                  D   +     Q+L G+++LHS  
Sbjct: 84  VFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL----DHERMSYLLYQMLCGIKHLHSAG 139

Query: 121 VVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG---GTPMFMAPEVARGEHQGFAS 176
           ++H D+K  NI++      KI DFG A+    +        T  + APEV  G       
Sbjct: 140 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENV 199

Query: 177 DIWAVGCTVIEMASGGAPWPNAADPMTVLYKI---------------------------- 208
           DIW+VGC + EM      +    D +    K+                            
Sbjct: 200 DIWSVGCIMGEMVRHKILF-PGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPK 258

Query: 209 ------------AYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFC 256
                       +      E     + QA D LS  L  DP +R +    L+HP++  + 
Sbjct: 259 YAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 318

Query: 257 SCTKQIQESNCSPTSILDQGIWNSVEETEESLGNLIHS 294
                  E    P  I D+ + +  E T E    LI+ 
Sbjct: 319 ----DPAEVEAPPPQIYDKQL-DEREHTIEEWKELIYK 351

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (386), Expect = 5e-44
 Identities = 62/292 (21%), Positives = 109/292 (37%), Gaps = 41/292 (14%)

Query: 2   DWTRGHTIGQGSSATVSLATSLRSGD-------VFAAK-----STELPKSEFLQREQKFL 49
               G  +G+G+   V LA ++             A K     +TE   S+ +   +   
Sbjct: 14  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 73

Query: 50  SSLNSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNG--------------- 94
                 +I+   G             + +EYA  G L + +                   
Sbjct: 74  MIGKHKNIINLLGACTQDG----PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 129

Query: 95  GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA- 152
            +L    +VS   Q+ +G+EYL S + +H D+ +RN+L+ E    KIADFG A+      
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189

Query: 153 -----LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYK 207
                        +MAPE          SD+W+ G  + E+ + G   P    P+  L+K
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS-PYPGVPVEELFK 248

Query: 208 IAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSCT 259
           +       + P+  + +    + +C    P +R    QL++   L+   + T
Sbjct: 249 LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED--LDRIVALT 298

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  151 bits (382), Expect = 2e-43
 Identities = 53/301 (17%), Positives = 97/301 (32%), Gaps = 40/301 (13%)

Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAKS-TELPKSEFLQREQKFLSSLNS-PHIVGY 60
           +  G  IG+GS   +   T+L +    A K       +  L+ E +    L     I   
Sbjct: 7   YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV 66

Query: 61  KGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNR 120
                        +N+ +    G +L D +   G +     +    +Q+L  ++ +H   
Sbjct: 67  YYFGQEGL-----HNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 121

Query: 121 VVHCDIKSRNILMAESG------AKIADFGCAKWESEALQSG-----------GTPMFMA 163
           +V+ DIK  N L+            + DFG  K+  + +              GT  +M+
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181

Query: 164 PEVARGEHQGFASDIWAVGCTVIEMASGGAPWP--NAADPMTVLYKIAYSRE---LPEVP 218
                G  Q    D+ A+G   +    G  PW    AA       +I   ++   L E+ 
Sbjct: 182 INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELC 241

Query: 219 AFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSCTKQIQESNCSPTSILDQGIW 278
           A   ++   ++                L       +       ++  N +     D   W
Sbjct: 242 AGFPEEFYKYMHYARNLAFDATPDYDYLQG--LFSKV------LERLNTTEDENFD---W 290

Query: 279 N 279
           N
Sbjct: 291 N 291

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (377), Expect = 1e-42
 Identities = 55/284 (19%), Positives = 94/284 (33%), Gaps = 36/284 (12%)

Query: 2   DWTRGHTIGQGSSATVSLAT-----SLRSGDVFAAK----STELPKSEFLQREQKFLSSL 52
             T    +GQGS   V                 A K    +  + +      E   +   
Sbjct: 21  KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF 80

Query: 53  NSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGR---------LDESLIV 103
           N  H+V   G     +       + ME    G L   +                  S ++
Sbjct: 81  NCHHVVRLLGVVSQGQP----TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 136

Query: 104 SYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG------ 156
               +I  G+ YL++N+ VH D+ +RN ++AE    KI DFG  +   E           
Sbjct: 137 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196

Query: 157 GTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPE 216
               +M+PE  +       SD+W+ G  + E+A+             VL  +     L +
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM-EGGLLD 255

Query: 217 VPAFLSKQANDFLSNCLRRDPKERWAASQLLK------HPFLEE 254
            P        + +  C + +PK R +  +++        P   E
Sbjct: 256 KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE 299

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (373), Expect = 4e-42
 Identities = 59/287 (20%), Positives = 99/287 (34%), Gaps = 48/287 (16%)

Query: 6   GHTIGQGSSATVSLATSLRSGDVFAAK--STELPKSEFLQREQKFLSSLNSPHIVGYKGC 63
             +IG+G    V        G+  A K  S+   +S F + E      L   +I+G+   
Sbjct: 8   QESIGKGRFGEVWRGK--WRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAA 65

Query: 64  DVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHS----- 118
           D           L  +Y   G+L D ++R    +    ++        GL +LH      
Sbjct: 66  DNKDNGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGT 123

Query: 119 ---NRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQSG--------GTPMFMAPEV 166
                + H D+KS+NIL+ ++G   IAD G A     A  +         GT  +MAPEV
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183

Query: 167 ARGEHQ------GFASDIWAVGCTVIEMASGGAP--------------WPNAADPMTVLY 206
                          +DI+A+G    E+A   +                P+      +  
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 243

Query: 207 KIAYSRELPEVPAFLS-----KQANDFLSNCLRRDPKERWAASQLLK 248
            +   +  P +P         +     +  C   +   R  A ++ K
Sbjct: 244 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  135 bits (340), Expect = 7e-37
 Identities = 71/319 (22%), Positives = 115/319 (36%), Gaps = 67/319 (21%)

Query: 3   WTRGHTIGQGSSATVSLATSLRSGDVFAAK--STELPKSEFLQREQKFLSSLN------- 53
           +     +G G  +TV LA  + +    A K    +   +E  + E K L  +N       
Sbjct: 15  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 74

Query: 54  ----SPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQI 109
               + HI+           N +   +  E      L          +    +   ++Q+
Sbjct: 75  DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 134

Query: 110 LQGLEYLHSNR-VVHCDIKSRNILMAESG-------AKIADFGCAKWESE-ALQSGGTPM 160
           L GL+Y+H    ++H DIK  N+LM            KIAD G A W  E    S  T  
Sbjct: 135 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 194

Query: 161 FMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAAD-------------------- 200
           + +PEV  G   G  +DIW+  C + E+ +G   +                         
Sbjct: 195 YRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGEL 254

Query: 201 PMTVLYKIAYSR-------------------------ELPEVPAFLSKQANDFLSNCLRR 235
           P  +L    Y+R                         E  +     +K+ +DFLS  L+ 
Sbjct: 255 PSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQL 314

Query: 236 DPKERWAASQLLKHPFLEE 254
           DP++R  A  L+ HP+L++
Sbjct: 315 DPRKRADAGGLVNHPWLKD 333

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 82.1 bits (202), Expect = 5e-19
 Identities = 28/200 (14%), Positives = 56/200 (28%), Gaps = 31/200 (15%)

Query: 6   GHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEF-------------LQREQKFLSSL 52
           G  +G+G  + V    S         K  ++  + F                     +  
Sbjct: 5   GKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 63

Query: 53  NSPHIVGYKGCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQG 112
               +   +G  V          + ME            +   R+           IL+ 
Sbjct: 64  EFRALQKLQGLAVPKVYAWEGNAVLMEL--------IDAKELYRVRVENPDEVLDMILEE 115

Query: 113 LEYLHSNRVVHCDIKSRNILMAESGAKIADFGCAKWESEALQSGGTPMFMAPEVAR---- 168
           +   +   +VH D+   N+L++E G  I DF  +      +   G    +  +V      
Sbjct: 116 VAKFYHRGIVHGDLSQYNVLVSEEGIWIIDFPQSV----EVGEEGWREILERDVRNIITY 171

Query: 169 -GEHQGFASDIWAVGCTVIE 187
                    DI +    +++
Sbjct: 172 FSRTYRTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	405
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.92
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.16
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.95
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.95
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.52
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.27
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	95.83

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-61  Score=461.14  Aligned_cols=248  Identities=25%  Similarity=0.412  Sum_probs=215.6

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLF   77 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv   77 (405)
                      +|++++.||+|+||+||+|+++.+|+.||||++....    .+.+.+|+++|++++||||+++++++....    .+++|
T Consensus         6 dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~----~~~iv   81 (271)
T d1nvra_           6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGN----IQYLF   81 (271)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETT----EEEEE
T ss_pred             ceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCc----eeEEE
Confidence            5999999999999999999999999999999986543    346889999999999999999999887643    36799


Q ss_pred             EeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc-----
Q 015500           78 MEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE-----  151 (405)
Q Consensus        78 ~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~-----  151 (405)
                      ||||+||+|.+++.++ +.+++..++.+++||+.||+|||++||+||||||+|||++.++ +||+|||+|+....     
T Consensus        82 mEy~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~  160 (271)
T d1nvra_          82 LEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER  160 (271)
T ss_dssp             EECCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred             EeccCCCcHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence            9999999999999765 4899999999999999999999999999999999999999887 99999999986432     


Q ss_pred             -cccCCCCCCccChhhhcCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHH
Q 015500          152 -ALQSGGTPMFMAPEVARGEHQ-GFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFL  229 (405)
Q Consensus       152 -~~~~~gt~~Y~APE~l~~~~~-~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll  229 (405)
                       ....+||+.|||||++.+..+ +.++|||||||++|||+||++||....+..............+..+..+|+++++||
T Consensus       161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  240 (271)
T d1nvra_         161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL  240 (271)
T ss_dssp             CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHH
T ss_pred             cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHH
Confidence             234579999999999988765 678999999999999999999997665555555455444444455567899999999


Q ss_pred             HHhcccCccccCCHHHHhcCccccc
Q 015500          230 SNCLRRDPKERWAASQLLKHPFLEE  254 (405)
Q Consensus       230 ~~~L~~dP~~Rpt~~elL~hp~~~~  254 (405)
                      .+||+.||++|||++|+|+||||++
T Consensus       241 ~~~L~~dP~~R~t~~eil~hpwf~~  265 (271)
T d1nvra_         241 HKILVENPSARITIPDIKKDRWYNK  265 (271)
T ss_dssp             HHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred             HHHcCCChhHCcCHHHHhcCHhhCc
Confidence            9999999999999999999999974

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-61  Score=454.32  Aligned_cols=245  Identities=29%  Similarity=0.477  Sum_probs=217.0

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccC------CChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL------PKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~------~~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~   75 (405)
                      +|++++.||+|+||+||+|+++.+++.||+|++..      ...+.+.+|+++|++++||||+++++++....    .++
T Consensus         7 dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~----~~~   82 (263)
T d2j4za1           7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT----RVY   82 (263)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS----EEE
T ss_pred             HeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECC----EEE
Confidence            68899999999999999999999999999998753      33567889999999999999999999876543    367


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc--c
Q 015500           76 LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE--A  152 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~--~  152 (405)
                      +|||||+||+|.+++.+.+ ++++..++.++.||+.||+|||++||+||||||+|||++.++ +||+|||+|+....  .
T Consensus        83 ivmEy~~~g~L~~~l~~~~-~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~~  161 (263)
T d2j4za1          83 LILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR  161 (263)
T ss_dssp             EEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCCC
T ss_pred             EEEeecCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCCcc
Confidence            9999999999999998764 899999999999999999999999999999999999999887 99999999986544  3


Q ss_pred             ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHh
Q 015500          153 LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNC  232 (405)
Q Consensus       153 ~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~  232 (405)
                      ....||+.|||||++.+..+++++|||||||++|||++|+.||.. .+....+.++..  ..+.+|..+|+++++||.+|
T Consensus       162 ~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~--~~~~~p~~~s~~~~~li~~~  238 (263)
T d2j4za1         162 TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA-NTYQETYKRISR--VEFTFPDFVTEGARDLISRL  238 (263)
T ss_dssp             EETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHT--TCCCCCTTSCHHHHHHHHHH
T ss_pred             cccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCC-CCHHHHHHHHHc--CCCCCCccCCHHHHHHHHHH
Confidence            456799999999999999999999999999999999999999954 344555555443  23467788999999999999


Q ss_pred             cccCccccCCHHHHhcCccccc
Q 015500          233 LRRDPKERWAASQLLKHPFLEE  254 (405)
Q Consensus       233 L~~dP~~Rpt~~elL~hp~~~~  254 (405)
                      |++||++|||++|+|+||||..
T Consensus       239 L~~dp~~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         239 LKHNPSQRPMLREVLEHPWITA  260 (263)
T ss_dssp             TCSSGGGSCCHHHHHTCHHHHH
T ss_pred             ccCCHhHCcCHHHHHcCcCcCC
Confidence            9999999999999999999974

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-60  Score=459.14  Aligned_cols=246  Identities=38%  Similarity=0.593  Sum_probs=216.5

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccC---CChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL---PKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFM   78 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~---~~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (405)
                      +|++.+.||+|+||+||+|.++.+|+.||||++..   ...+.+.+|+++|++++||||+++++++....    .+|+||
T Consensus        21 ~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~----~~~ivm   96 (293)
T d1yhwa1          21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD----ELWVVM   96 (293)
T ss_dssp             TBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT----EEEEEE
T ss_pred             ccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECC----EEEEEE
Confidence            49999999999999999999999999999998764   34567999999999999999999999887654    367999


Q ss_pred             eecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc----cc
Q 015500           79 EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE----AL  153 (405)
Q Consensus        79 Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~----~~  153 (405)
                      |||+||+|.+++.++  ++++..++.+++||+.||+|||++||+||||||+|||++.++ +||+|||+|+....    ..
T Consensus        97 Ey~~gg~L~~~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~  174 (293)
T d1yhwa1          97 EYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS  174 (293)
T ss_dssp             ECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBC
T ss_pred             EecCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccccccc
Confidence            999999999988764  699999999999999999999999999999999999999887 99999999986533    33


Q ss_pred             cCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhc-CCCCCCchhccHHHHHHHHHh
Q 015500          154 QSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYS-RELPEVPAFLSKQANDFLSNC  232 (405)
Q Consensus       154 ~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~-~~~~~~p~~~s~~l~dll~~~  232 (405)
                      ..+||+.|||||++.+..+++++|||||||++|+|+||+.||.... ....+..+... ......|..+|+++++||.+|
T Consensus       175 ~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~-~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  253 (293)
T d1yhwa1         175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN-PLRALYLIATNGTPELQNPEKLSAIFRDFLNRC  253 (293)
T ss_dssp             CCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-HHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHH
T ss_pred             ccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCC-HHHHHHHHHhCCCCCCCCcccCCHHHHHHHHHH
Confidence            5569999999999999999999999999999999999999996543 44444444433 333456788999999999999


Q ss_pred             cccCccccCCHHHHhcCccccc
Q 015500          233 LRRDPKERWAASQLLKHPFLEE  254 (405)
Q Consensus       233 L~~dP~~Rpt~~elL~hp~~~~  254 (405)
                      |++||.+|||++|+|+||||+.
T Consensus       254 L~~dP~~R~s~~eil~Hp~~~~  275 (293)
T d1yhwa1         254 LDMDVEKRGSAKELLQHQFLKI  275 (293)
T ss_dssp             TCSSTTTSCCHHHHTTCGGGGG
T ss_pred             ccCChhHCcCHHHHhcCHhhCC
Confidence            9999999999999999999974

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-60  Score=450.80  Aligned_cols=248  Identities=26%  Similarity=0.428  Sum_probs=216.2

Q ss_pred             ccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEE
Q 015500            4 TRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFM   78 (405)
Q Consensus         4 ~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (405)
                      +..+.||+|+||+||+|+++.+++.||+|.+....     .+.+.+|+++|++|+|||||++++++.....+...+++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            55678999999999999999999999999875432     3468899999999999999999999877655556678999


Q ss_pred             eecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCCCCEEEcc-CC-ceEeeecccccccc--c
Q 015500           79 EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNR--VVHCDIKSRNILMAE-SG-AKIADFGCAKWESE--A  152 (405)
Q Consensus        79 Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~g--ivHrDlkp~NILi~~-~~-vkL~DFGla~~~~~--~  152 (405)
                      ||++||+|.+++.+.+ .+++..++.++.||+.||+|||++|  |+||||||+|||++. ++ +||+|||+|+....  .
T Consensus        92 E~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~~~  170 (270)
T d1t4ha_          92 ELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA  170 (270)
T ss_dssp             ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTSB
T ss_pred             eCCCCCcHHHHHhccc-cccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCCcc
Confidence            9999999999998764 8999999999999999999999998  999999999999974 55 99999999986443  4


Q ss_pred             ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHh
Q 015500          153 LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNC  232 (405)
Q Consensus       153 ~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~  232 (405)
                      ...+|||.|||||++.+ .+++++|||||||++|||++|+.||....+......++......+.++...++++++||.+|
T Consensus       171 ~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~  249 (270)
T d1t4ha_         171 KAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGC  249 (270)
T ss_dssp             EESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHH
T ss_pred             CCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHHHHHHH
Confidence            45679999999999976 58999999999999999999999997766666555555544444456677899999999999


Q ss_pred             cccCccccCCHHHHhcCcccc
Q 015500          233 LRRDPKERWAASQLLKHPFLE  253 (405)
Q Consensus       233 L~~dP~~Rpt~~elL~hp~~~  253 (405)
                      |+.||++|||++|+|+||||+
T Consensus       250 l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         250 IRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             SCSSGGGSCCHHHHHTSGGGC
T ss_pred             ccCCHhHCcCHHHHhCCcccC
Confidence            999999999999999999995

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-60  Score=454.14  Aligned_cols=247  Identities=33%  Similarity=0.517  Sum_probs=215.9

Q ss_pred             cccccccceeCCeeEEEEEEcCCCCEEEEEEccCC---ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEe
Q 015500            3 WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP---KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFME   79 (405)
Q Consensus         3 y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~---~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (405)
                      |++++.||+|+||+||+|+++.+|+.||||+++..   ..+.+.+|+++|++|+|||||++++++.....    +++|||
T Consensus        14 Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~----~~lvmE   89 (288)
T d2jfla1          14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENN----LWILIE   89 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTE----EEEEEE
T ss_pred             eEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCe----EEEEEe
Confidence            88999999999999999999999999999998654   34578899999999999999999998876443    679999


Q ss_pred             ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc----ccc
Q 015500           80 YAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE----ALQ  154 (405)
Q Consensus        80 y~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~----~~~  154 (405)
                      ||+||+|.+++.+.++++++..++.++.||+.||.|||++||+||||||+|||++.++ +||+|||+|+....    ...
T Consensus        90 y~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~  169 (288)
T d2jfla1          90 FCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS  169 (288)
T ss_dssp             CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHTC
T ss_pred             cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCcccccc
Confidence            9999999999887767899999999999999999999999999999999999999887 99999999976443    345


Q ss_pred             CCCCCCccChhhhc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcC-CCCCCchhccHHHHHH
Q 015500          155 SGGTPMFMAPEVAR-----GEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSR-ELPEVPAFLSKQANDF  228 (405)
Q Consensus       155 ~~gt~~Y~APE~l~-----~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~-~~~~~p~~~s~~l~dl  228 (405)
                      ..||+.|||||++.     +..++.++|||||||++|||+||+.||.... ....+.++.... .....|..+|+++++|
T Consensus       170 ~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~s~~~~~l  248 (288)
T d2jfla1         170 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELN-PMRVLLKIAKSEPPTLAQPSRWSSNFKDF  248 (288)
T ss_dssp             CCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSC-GGGHHHHHHHSCCCCCSSGGGSCHHHHHH
T ss_pred             cccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCC-HHHHHHHHHcCCCCCCCccccCCHHHHHH
Confidence            67999999999984     4567899999999999999999999996543 445555555443 2334567899999999


Q ss_pred             HHHhcccCccccCCHHHHhcCccccc
Q 015500          229 LSNCLRRDPKERWAASQLLKHPFLEE  254 (405)
Q Consensus       229 l~~~L~~dP~~Rpt~~elL~hp~~~~  254 (405)
                      |++||++||++|||++|+|+||||+.
T Consensus       249 i~~~L~~dp~~R~t~~ell~hp~~~~  274 (288)
T d2jfla1         249 LKKCLEKNVDARWTTSQLLQHPFVTV  274 (288)
T ss_dssp             HHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred             HHHHccCChhHCcCHHHHhcCcccCC
Confidence            99999999999999999999999974

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-59  Score=449.48  Aligned_cols=247  Identities=31%  Similarity=0.484  Sum_probs=216.1

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccC------CChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL------PKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~------~~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~   75 (405)
                      +|++++.||+|+||+||+|+++.+|+.||||++..      ...+.+.+|+++|++++||||+++++++....    .+|
T Consensus         9 dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~----~~~   84 (288)
T d1uu3a_           9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE----KLY   84 (288)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSS----EEE
T ss_pred             CCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECC----EEE
Confidence            59999999999999999999999999999998753      34567899999999999999999999876543    367


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc---
Q 015500           76 LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE---  151 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~---  151 (405)
                      +|||||+||+|.+++... +++++..++.++.||+.||+|||++||+||||||+|||++.++ +||+|||+|+....   
T Consensus        85 ivmEy~~gg~L~~~~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~  163 (288)
T d1uu3a_          85 FGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK  163 (288)
T ss_dssp             EEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             EEEEccCCCCHHHhhhcc-CCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence            999999999999998877 4899999999999999999999999999999999999999887 99999999986532   


Q ss_pred             ---cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHH
Q 015500          152 ---ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDF  228 (405)
Q Consensus       152 ---~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dl  228 (405)
                         ....+||+.|||||++.+..++.++|||||||++|||+||+.||.. .+......++...  .+.+|..+++++++|
T Consensus       164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~-~~~~~~~~~i~~~--~~~~p~~~s~~~~~l  240 (288)
T d1uu3a_         164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA-GNEYLIFQKIIKL--EYDFPEKFFPKARDL  240 (288)
T ss_dssp             ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHTT--CCCCCTTCCHHHHHH
T ss_pred             ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCC-cCHHHHHHHHHcC--CCCCCccCCHHHHHH
Confidence               2345699999999999999999999999999999999999999964 4455555555433  346778899999999


Q ss_pred             HHHhcccCccccCCHHH------HhcCccccccc
Q 015500          229 LSNCLRRDPKERWAASQ------LLKHPFLEEFC  256 (405)
Q Consensus       229 l~~~L~~dP~~Rpt~~e------lL~hp~~~~~~  256 (405)
                      |++||++||++|||++|      +++||||+.+.
T Consensus       241 i~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~  274 (288)
T d1uu3a_         241 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT  274 (288)
T ss_dssp             HHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred             HHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCC
Confidence            99999999999999988      58899998764

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-60  Score=447.69  Aligned_cols=247  Identities=26%  Similarity=0.419  Sum_probs=206.0

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      ||++.+.||+|+||+||+|+++.+|+.||||.+....     .+.+.+|+++|++++||||+++++++....++.  +|+
T Consensus         5 dy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~--~~i   82 (269)
T d2java1           5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTT--LYI   82 (269)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----C--EEE
T ss_pred             hCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCE--EEE
Confidence            6999999999999999999999999999999986543     246889999999999999999999876543332  569


Q ss_pred             EEeecCCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCC-----ceeCCCCCCCEEEccCC-ceEeeecccc
Q 015500           77 FMEYAPGGTLNDEIHR---NGGRLDESLIVSYTRQILQGLEYLHSNR-----VVHCDIKSRNILMAESG-AKIADFGCAK  147 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~---~~~~l~e~~~~~i~~qIl~~L~yLH~~g-----ivHrDlkp~NILi~~~~-vkL~DFGla~  147 (405)
                      |||||+||+|.+++.+   .++.+++..++.++.||+.||.|||++|     |+||||||+||||+.++ +||+|||+|+
T Consensus        83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~  162 (269)
T d2java1          83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  162 (269)
T ss_dssp             EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred             EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence            9999999999999864   3457999999999999999999999976     99999999999999887 9999999998


Q ss_pred             cccc----cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccH
Q 015500          148 WESE----ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSK  223 (405)
Q Consensus       148 ~~~~----~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~  223 (405)
                      ....    .....|||.|||||++.+..+++++|||||||++|||+||+.||... +......++. ....+.+|..+|+
T Consensus       163 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~-~~~~~~~~i~-~~~~~~~~~~~s~  240 (269)
T d2java1         163 ILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF-SQKELAGKIR-EGKFRRIPYRYSD  240 (269)
T ss_dssp             HC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS-SHHHHHHHHH-HTCCCCCCTTSCH
T ss_pred             ecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCC-CHHHHHHHHH-cCCCCCCCcccCH
Confidence            6543    23467999999999999999999999999999999999999999643 4444444443 4456678888999


Q ss_pred             HHHHHHHHhcccCccccCCHHHHhcCccc
Q 015500          224 QANDFLSNCLRRDPKERWAASQLLKHPFL  252 (405)
Q Consensus       224 ~l~dll~~~L~~dP~~Rpt~~elL~hp~~  252 (405)
                      ++++||++||+.||.+|||++|+|+|||+
T Consensus       241 ~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         241 ELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence            99999999999999999999999999996

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.8e-59  Score=452.57  Aligned_cols=246  Identities=33%  Similarity=0.522  Sum_probs=217.3

Q ss_pred             cccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC------hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEE
Q 015500            3 WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK------SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         3 y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~------~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      |+..+.||+|+||+||+|+++.+|+.||||.+....      .+.+.+|+++|++|+|||||++++++....    .+++
T Consensus        17 y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~----~~~i   92 (309)
T d1u5ra_          17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH----TAWL   92 (309)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT----EEEE
T ss_pred             cEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECC----EEEE
Confidence            888999999999999999999999999999987543      245789999999999999999999887644    3679


Q ss_pred             EEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccccccC
Q 015500           77 FMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEALQS  155 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~~~~  155 (405)
                      |||||+||+|..++..+ +++++..++.+++||+.||.|||++||+||||||+|||++.++ +||+|||+|+........
T Consensus        93 v~E~~~~g~l~~~~~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~  171 (309)
T d1u5ra_          93 VMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSF  171 (309)
T ss_dssp             EEECCSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBCCC
T ss_pred             EEEecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCCCCcc
Confidence            99999999997666554 5899999999999999999999999999999999999999888 999999999988777788


Q ss_pred             CCCCCccChhhhcC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHh
Q 015500          156 GGTPMFMAPEVARG---EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNC  232 (405)
Q Consensus       156 ~gt~~Y~APE~l~~---~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~  232 (405)
                      .||+.|||||++.+   ..|+.++|||||||++|||++|+.||.+. .....+.++......+..+..+|+++++||.+|
T Consensus       172 ~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~  250 (309)
T d1u5ra_         172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNESPALQSGHWSEYFRNFVDSC  250 (309)
T ss_dssp             CSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS-CHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHHH
T ss_pred             ccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCC-CHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHH
Confidence            89999999999975   35788999999999999999999999654 445566666655554455667899999999999


Q ss_pred             cccCccccCCHHHHhcCccccc
Q 015500          233 LRRDPKERWAASQLLKHPFLEE  254 (405)
Q Consensus       233 L~~dP~~Rpt~~elL~hp~~~~  254 (405)
                      |+.||.+|||++|+|+||||..
T Consensus       251 L~~dP~~Rpt~~ell~Hp~~~~  272 (309)
T d1u5ra_         251 LQKIPQDRPTSEVLLKHRFVLR  272 (309)
T ss_dssp             TCSSGGGSCCHHHHTTCHHHHS
T ss_pred             CcCChhHCcCHHHHHhCHHhcC
Confidence            9999999999999999999974

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-59  Score=457.36  Aligned_cols=249  Identities=31%  Similarity=0.533  Sum_probs=210.8

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLF   77 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv   77 (405)
                      +|.+++.||+|+||+||+|+++.+|+.||+|.+....    .+.+.+|+.+|++++|||||++++++.....    +++|
T Consensus         7 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~----~~iV   82 (322)
T d1s9ja_           7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE----ISIC   82 (322)
T ss_dssp             GEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSE----EEEE
T ss_pred             CCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE----EEEE
Confidence            5899999999999999999999999999999986432    3578899999999999999999998875443    6799


Q ss_pred             EeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCCCCEEEccCC-ceEeeecccccccc--cc
Q 015500           78 MEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSN-RVVHCDIKSRNILMAESG-AKIADFGCAKWESE--AL  153 (405)
Q Consensus        78 ~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~-givHrDlkp~NILi~~~~-vkL~DFGla~~~~~--~~  153 (405)
                      |||++||+|.+++.+.+ ++++..++.++.||+.||.|||++ ||+||||||+||||+.++ +||+|||+|+....  ..
T Consensus        83 mEy~~gg~L~~~l~~~~-~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~  161 (322)
T d1s9ja_          83 MEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN  161 (322)
T ss_dssp             EECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHTC-
T ss_pred             EEcCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCccc
Confidence            99999999999998774 899999999999999999999975 999999999999999887 99999999986543  34


Q ss_pred             cCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHH---------------------------
Q 015500          154 QSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLY---------------------------  206 (405)
Q Consensus       154 ~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~---------------------------  206 (405)
                      ..+||+.|||||++.+..|++++|||||||++|||++|+.||...........                           
T Consensus       162 ~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (322)
T d1s9ja_         162 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYG  241 (322)
T ss_dssp             --CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------------
T ss_pred             cccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccc
Confidence            56899999999999999999999999999999999999999965443221111                           


Q ss_pred             -------------HHHhcCCCCCCc-hhccHHHHHHHHHhcccCccccCCHHHHhcCcccccc
Q 015500          207 -------------KIAYSRELPEVP-AFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       207 -------------~i~~~~~~~~~p-~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                                   ........|..| ..+|.++++||.+||+.||.+|||++|+|+||||++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~  304 (322)
T d1s9ja_         242 MDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  304 (322)
T ss_dssp             ----CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred             cccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence                         111112223333 2368999999999999999999999999999999864

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.9e-59  Score=448.96  Aligned_cols=246  Identities=26%  Similarity=0.405  Sum_probs=199.9

Q ss_pred             cccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEE
Q 015500            3 WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFM   78 (405)
Q Consensus         3 y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (405)
                      |++++.||+|+||+||+|+++.+|+.||||.+....    ...+.+|+++|++|+||||+++++++....    .+|+||
T Consensus        11 Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----~~~lvm   86 (307)
T d1a06a_          11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGG----HLYLIM   86 (307)
T ss_dssp             EEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSS----EEEEEE
T ss_pred             eEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC----EEEEEE
Confidence            899999999999999999999999999999986532    346789999999999999999999876443    367999


Q ss_pred             eecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcc---CC-ceEeeecccccccc---
Q 015500           79 EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAE---SG-AKIADFGCAKWESE---  151 (405)
Q Consensus        79 Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~---~~-vkL~DFGla~~~~~---  151 (405)
                      |||+||+|.+++.++ +++++..++.++.||+.||+|||++||+||||||+|||+..   ++ +||+|||+|+....   
T Consensus        87 E~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~  165 (307)
T d1a06a_          87 QLVSGGELFDRIVEK-GFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV  165 (307)
T ss_dssp             CCCCSCBHHHHHHTC-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred             eccCCCcHHHhhhcc-cCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCCe
Confidence            999999999999876 48999999999999999999999999999999999999953   44 99999999986544   


Q ss_pred             cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCC--CCchhccHHHHHHH
Q 015500          152 ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELP--EVPAFLSKQANDFL  229 (405)
Q Consensus       152 ~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~--~~p~~~s~~l~dll  229 (405)
                      ....+||+.|||||++.+..+++++|||||||++|||++|++||... ........+......+  ..+..+|+++++||
T Consensus       166 ~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li  244 (307)
T d1a06a_         166 LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDE-NDAKLFEQILKAEYEFDSPYWDDISDSAKDFI  244 (307)
T ss_dssp             -------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS-SHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHH
T ss_pred             eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCC-CHHHHHHHHhccCCCCCCccccCCCHHHHHHH
Confidence            23467999999999999999999999999999999999999999644 3444445554433222  33456899999999


Q ss_pred             HHhcccCccccCCHHHHhcCccccc
Q 015500          230 SNCLRRDPKERWAASQLLKHPFLEE  254 (405)
Q Consensus       230 ~~~L~~dP~~Rpt~~elL~hp~~~~  254 (405)
                      .+||++||++|||++|+|+||||+.
T Consensus       245 ~~~L~~dP~~R~s~~eil~hp~~~~  269 (307)
T d1a06a_         245 RHLMEKDPEKRFTCEQALQHPWIAG  269 (307)
T ss_dssp             HHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred             HHHccCCHhHCcCHHHHhcCHhhCC
Confidence            9999999999999999999999975

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-58  Score=451.31  Aligned_cols=247  Identities=30%  Similarity=0.449  Sum_probs=218.1

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccC------CChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL------PKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~------~~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~   75 (405)
                      +|.+++.||+|+||+||+|+++.+|+.||||++.+      ...+.+.+|+.+|++++||||+++++++....    .+|
T Consensus         6 dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~----~~~   81 (337)
T d1o6la_           6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD----RLC   81 (337)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSS----EEE
T ss_pred             hcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccc----ccc
Confidence            59999999999999999999999999999999863      34567889999999999999999999876544    367


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc---
Q 015500           76 LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE---  151 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~---  151 (405)
                      +|||||+||+|.+++.+.+ .++|..++.+++||+.||+|||++||+||||||+|||++.++ +||+|||+|+....   
T Consensus        82 iv~ey~~gg~L~~~~~~~~-~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~  160 (337)
T d1o6la_          82 FVMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA  160 (337)
T ss_dssp             EEEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred             cceeccCCCchhhhhhccc-CCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCc
Confidence            9999999999999998874 899999999999999999999999999999999999999988 99999999986433   


Q ss_pred             -cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHH
Q 015500          152 -ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLS  230 (405)
Q Consensus       152 -~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~  230 (405)
                       ....+|||.|||||++.+..|++++|||||||++|||++|++||... +......++...  .+.+|..+|+++++||+
T Consensus       161 ~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~-~~~~~~~~i~~~--~~~~p~~~s~~~~dli~  237 (337)
T d1o6la_         161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-DHERLFELILME--EIRFPRTLSPEAKSLLA  237 (337)
T ss_dssp             CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHC--CCCCCTTSCHHHHHHHH
T ss_pred             ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCc-CHHHHHHHHhcC--CCCCCccCCHHHHHHHH
Confidence             23467999999999999999999999999999999999999999643 444444444433  35678889999999999


Q ss_pred             HhcccCccccCC-----HHHHhcCccccccc
Q 015500          231 NCLRRDPKERWA-----ASQLLKHPFLEEFC  256 (405)
Q Consensus       231 ~~L~~dP~~Rpt-----~~elL~hp~~~~~~  256 (405)
                      +||++||.+|++     ++|+++||||+.+.
T Consensus       238 ~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~  268 (337)
T d1o6la_         238 GLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN  268 (337)
T ss_dssp             HHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred             hhccCCchhhcccccccHHHHHcCcccccCC
Confidence            999999999994     89999999998753

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=2.4e-58  Score=453.32  Aligned_cols=249  Identities=28%  Similarity=0.445  Sum_probs=217.6

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC---hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK---SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFM   78 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~---~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (405)
                      +|++++.||+|+||+||+|+++.+|+.||||++....   .+.+.+|+++|++|+|||||++++++....    .+++||
T Consensus        27 ~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~----~~~ivm  102 (350)
T d1koaa2          27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN----EMVMIY  102 (350)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETT----EEEEEE
T ss_pred             CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECC----EEEEEE
Confidence            5899999999999999999999999999999987654   356889999999999999999999877543    367999


Q ss_pred             eecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcc--CC-ceEeeecccccccc---c
Q 015500           79 EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAE--SG-AKIADFGCAKWESE---A  152 (405)
Q Consensus        79 Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~--~~-vkL~DFGla~~~~~---~  152 (405)
                      |||+||+|.+++.+..+++++..++.|++||+.||+|||++||+||||||+|||++.  ++ +||+|||+|+....   .
T Consensus       103 E~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~  182 (350)
T d1koaa2         103 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV  182 (350)
T ss_dssp             CCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCE
T ss_pred             EcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccccccc
Confidence            999999999999766678999999999999999999999999999999999999964  34 99999999986544   3


Q ss_pred             ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCC--CCCchhccHHHHHHHH
Q 015500          153 LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSREL--PEVPAFLSKQANDFLS  230 (405)
Q Consensus       153 ~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~--~~~p~~~s~~l~dll~  230 (405)
                      ....||+.|||||++.+..++.++|||||||++|+|+||+.||.. .+....+..+......  +..+..+|+++++||.
T Consensus       183 ~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~  261 (350)
T d1koaa2         183 KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG-ENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIR  261 (350)
T ss_dssp             EEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHHH
T ss_pred             ceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHH
Confidence            356799999999999999999999999999999999999999964 3555556665544322  2233568999999999


Q ss_pred             HhcccCccccCCHHHHhcCcccccc
Q 015500          231 NCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       231 ~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      +||..||++|||++|+|+||||...
T Consensus       262 ~~L~~dP~~R~t~~eil~hp~~~~~  286 (350)
T d1koaa2         262 KLLLADPNTRMTIHQALEHPWLTPG  286 (350)
T ss_dssp             HHCCSSGGGSCCHHHHHHSTTTSCT
T ss_pred             HHccCChhHCcCHHHHhcCcccCCC
Confidence            9999999999999999999999865

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=4.6e-58  Score=445.30  Aligned_cols=247  Identities=29%  Similarity=0.499  Sum_probs=219.1

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccC------CChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL------PKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~------~~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~   75 (405)
                      ||++++.||+|+||+||+|+++.+|+.||||++..      ...+.+.+|+.+|++++||||+++++++....    .++
T Consensus         5 dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~----~~~   80 (316)
T d1fota_           5 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ----QIF   80 (316)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSS----EEE
T ss_pred             HeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCC----eee
Confidence            69999999999999999999999999999999753      34567899999999999999999999876543    367


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc-cc
Q 015500           76 LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE-AL  153 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~-~~  153 (405)
                      +|||||+||+|..++... +.+++..++.++.||+.||+|||++||+||||||+||||+.++ +||+|||+|+.... ..
T Consensus        81 ivmE~~~gg~l~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~~  159 (316)
T d1fota_          81 MIMDYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY  159 (316)
T ss_dssp             EEECCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCBC
T ss_pred             eEeeecCCcccccccccc-ccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccccc
Confidence            999999999999988876 4899999999999999999999999999999999999999887 99999999987654 44


Q ss_pred             cCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHhc
Q 015500          154 QSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCL  233 (405)
Q Consensus       154 ~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~L  233 (405)
                      ..+||+.|||||++.+..++.++|||||||++|+|+||+.||.. .+......++....  ..+|..+|++++++|++||
T Consensus       160 ~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~-~~~~~~~~~i~~~~--~~~p~~~s~~~~~li~~~L  236 (316)
T d1fota_         160 TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD-SNTMKTYEKILNAE--LRFPPFFNEDVKDLLSRLI  236 (316)
T ss_dssp             CCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHCC--CCCCTTSCHHHHHHHHHHT
T ss_pred             cccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCC-cCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHHHh
Confidence            67799999999999999999999999999999999999999964 34455555554432  3567789999999999999


Q ss_pred             ccCccccC-----CHHHHhcCccccccc
Q 015500          234 RRDPKERW-----AASQLLKHPFLEEFC  256 (405)
Q Consensus       234 ~~dP~~Rp-----t~~elL~hp~~~~~~  256 (405)
                      .+||.+|+     |++++|+||||+.+.
T Consensus       237 ~~dp~~R~~~~r~t~~~il~Hp~f~~i~  264 (316)
T d1fota_         237 TRDLSQRLGNLQNGTEDVKNHPWFKEVV  264 (316)
T ss_dssp             CSCTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred             hhCHHhccccchhhHHHHHcCcccccCC
Confidence            99999996     999999999998764

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=3.3e-58  Score=452.65  Aligned_cols=249  Identities=27%  Similarity=0.452  Sum_probs=217.2

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC---hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK---SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFM   78 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~---~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (405)
                      +|++++.||+|+||+||+|+++.+|+.||||++....   ...+.+|+++|++|+|||||++++++....    .+++||
T Consensus        30 ~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~----~~~ivm  105 (352)
T d1koba_          30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY----EMVLIL  105 (352)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSS----EEEEEE
T ss_pred             ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC----EEEEEE
Confidence            4899999999999999999999999999999987654   346789999999999999999999876543    367999


Q ss_pred             eecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcc--CC-ceEeeecccccccc---c
Q 015500           79 EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAE--SG-AKIADFGCAKWESE---A  152 (405)
Q Consensus        79 Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~--~~-vkL~DFGla~~~~~---~  152 (405)
                      |||+||+|.+++.+.+.++++..++.++.||+.||+|||++||+||||||+|||++.  ++ +||+|||+|+....   .
T Consensus       106 E~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~  185 (352)
T d1koba_         106 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV  185 (352)
T ss_dssp             ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCE
T ss_pred             EcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCce
Confidence            999999999988877778999999999999999999999999999999999999973  34 99999999987544   3


Q ss_pred             ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCC--CCCCchhccHHHHHHHH
Q 015500          153 LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRE--LPEVPAFLSKQANDFLS  230 (405)
Q Consensus       153 ~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~--~~~~p~~~s~~l~dll~  230 (405)
                      ....||+.|||||++.+..+++++|||||||++|+|+||+.||... +....+.++.....  .+..+..+|+++++||.
T Consensus       186 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~  264 (352)
T d1koba_         186 KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE-DDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIK  264 (352)
T ss_dssp             EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS-SHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHH
T ss_pred             eeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhCCCCCCcccccCCCHHHHHHHH
Confidence            3567999999999999999999999999999999999999999644 44555555554432  12344678999999999


Q ss_pred             HhcccCccccCCHHHHhcCcccccc
Q 015500          231 NCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       231 ~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      +||++||.+|||++|+|+||||+..
T Consensus       265 ~~L~~dp~~R~s~~eil~Hp~~~~~  289 (352)
T d1koba_         265 NLLQKEPRKRLTVHDALEHPWLKGD  289 (352)
T ss_dssp             TTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             HHccCChhHCcCHHHHhcCHhhCCC
Confidence            9999999999999999999999854

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-58  Score=440.01  Aligned_cols=248  Identities=28%  Similarity=0.434  Sum_probs=214.3

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC---------ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCce
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP---------KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKL   72 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~---------~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~   72 (405)
                      .|++++.||+|+||+||+|+++.+|+.||||.+...         ..+.+.+|+++|++|+|||||++++++....    
T Consensus        11 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~----   86 (293)
T d1jksa_          11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT----   86 (293)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS----
T ss_pred             CEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC----
Confidence            389999999999999999999999999999987532         2467899999999999999999999876543    


Q ss_pred             EEEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-----ceEeeecccc
Q 015500           73 MYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-----AKIADFGCAK  147 (405)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-----vkL~DFGla~  147 (405)
                      .+++|||||+||+|.+++.+++ ++++..++.+++||+.||+|||++||+||||||+|||++.++     +||+|||+|+
T Consensus        87 ~~~iv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~  165 (293)
T d1jksa_          87 DVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH  165 (293)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             EEEEEEEcCCCccccchhcccc-ccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhh
Confidence            3679999999999999998774 899999999999999999999999999999999999998664     8999999998


Q ss_pred             cccc---cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCC--CCCchhcc
Q 015500          148 WESE---ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSREL--PEVPAFLS  222 (405)
Q Consensus       148 ~~~~---~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~--~~~p~~~s  222 (405)
                      ....   .....||+.|+|||++.+..++.++|||||||++|||+||+.||.. .+....+..+......  +..+..+|
T Consensus       166 ~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s  244 (293)
T d1jksa_         166 KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANVSAVNYEFEDEYFSNTS  244 (293)
T ss_dssp             ECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHTTCCCCCHHHHTTSC
T ss_pred             hcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCC-CCHHHHHHHHHhcCCCCCchhcCCCC
Confidence            6543   3345799999999999999999999999999999999999999964 3445555555443221  12335689


Q ss_pred             HHHHHHHHHhcccCccccCCHHHHhcCcccccc
Q 015500          223 KQANDFLSNCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       223 ~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      +++++||++||+.||++|||++|+|+||||+..
T Consensus       245 ~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  277 (293)
T d1jksa_         245 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK  277 (293)
T ss_dssp             HHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence            999999999999999999999999999999864

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=2.8e-57  Score=447.94  Aligned_cols=250  Identities=25%  Similarity=0.367  Sum_probs=211.5

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC------ChHHHHH---HHHHHHhCCCCCeeeeeeeeeecCCCce
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP------KSEFLQR---EQKFLSSLNSPHIVGYKGCDVTSEDNKL   72 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~------~~~~l~~---E~~iL~~L~hpnIv~~~~~~~~~~~~~~   72 (405)
                      +|++++.||+|+||+||+|+++.+|+.||||++...      ....+.+   |+++++.++|||||++++++....    
T Consensus         5 dy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~----   80 (364)
T d1omwa3           5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD----   80 (364)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS----
T ss_pred             hCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECC----
Confidence            699999999999999999999999999999997532      2233444   467777889999999999876543    


Q ss_pred             EEEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc
Q 015500           73 MYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE  151 (405)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~  151 (405)
                      .+|+|||||+||+|.+++.+. +.+++..++.++.||+.||+|||++||+||||||+|||++.++ +||+|||+|+....
T Consensus        81 ~~~ivmE~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~  159 (364)
T d1omwa3          81 KLSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK  159 (364)
T ss_dssp             EEEEEECCCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred             EEEEEEEecCCCcHHHHHHhc-ccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence            267999999999999999877 4899999999999999999999999999999999999999888 99999999986544


Q ss_pred             --cccCCCCCCccChhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHH
Q 015500          152 --ALQSGGTPMFMAPEVARG-EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDF  228 (405)
Q Consensus       152 --~~~~~gt~~Y~APE~l~~-~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dl  228 (405)
                        ....+||+.|||||++.. ..+++++|||||||++|||+||+.||...................+.+|..+|+++++|
T Consensus       160 ~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  239 (364)
T d1omwa3         160 KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSL  239 (364)
T ss_dssp             SCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHHHH
T ss_pred             CcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHHHH
Confidence              345679999999999974 56899999999999999999999999754432222122222334456778899999999


Q ss_pred             HHHhcccCccccCC-----HHHHhcCccccccc
Q 015500          229 LSNCLRRDPKERWA-----ASQLLKHPFLEEFC  256 (405)
Q Consensus       229 l~~~L~~dP~~Rpt-----~~elL~hp~~~~~~  256 (405)
                      |.+||++||.+|||     ++|+++||||+.+.
T Consensus       240 i~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~  272 (364)
T d1omwa3         240 LEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD  272 (364)
T ss_dssp             HHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCC
T ss_pred             HHHHcccCHHHhCCCcccCHHHHHcCccccCCC
Confidence            99999999999999     79999999998764

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.6e-57  Score=444.90  Aligned_cols=246  Identities=29%  Similarity=0.464  Sum_probs=218.1

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccC------CChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL------PKSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~------~~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~   75 (405)
                      +|++++.||+|+||+||+|+++.+|+.||||++..      ...+.+.+|+++|+.++||||+++++++....    .++
T Consensus        42 ~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~----~~~  117 (350)
T d1rdqe_          42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS----NLY  117 (350)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS----EEE
T ss_pred             CeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccc----ccc
Confidence            48999999999999999999999999999998753      33467889999999999999999999876543    266


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc-cc
Q 015500           76 LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE-AL  153 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~-~~  153 (405)
                      +||||+.||+|.+++.+.+ .+++..++.|+.||+.||.|||++|||||||||+|||++.++ +||+|||+|+.... ..
T Consensus       118 ~v~e~~~~g~l~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~~  196 (350)
T d1rdqe_         118 MVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW  196 (350)
T ss_dssp             EEEECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCBC
T ss_pred             cccccccccchhhhHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccccc
Confidence            9999999999999998874 899999999999999999999999999999999999999888 99999999987654 34


Q ss_pred             cCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHhc
Q 015500          154 QSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCL  233 (405)
Q Consensus       154 ~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~L  233 (405)
                      ...||+.|||||++.+..+++++|||||||++|||+||+.||.. .+....+.++...  .+..|..+++++.+||++||
T Consensus       197 ~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~-~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~~L  273 (350)
T d1rdqe_         197 TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSG--KVRFPSHFSSDLKDLLRNLL  273 (350)
T ss_dssp             CCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHC--CCCCCTTCCHHHHHHHHHHS
T ss_pred             cccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCC-cCHHHHHHHHhcC--CCCCCccCCHHHHHHHHHHh
Confidence            56699999999999999999999999999999999999999964 3455555555543  34567889999999999999


Q ss_pred             ccCccccC-----CHHHHhcCcccccc
Q 015500          234 RRDPKERW-----AASQLLKHPFLEEF  255 (405)
Q Consensus       234 ~~dP~~Rp-----t~~elL~hp~~~~~  255 (405)
                      ++||.+|+     |++++++||||+.+
T Consensus       274 ~~dP~kR~~~~r~t~~ell~Hp~f~~~  300 (350)
T d1rdqe_         274 QVDLTKRFGNLKNGVNDIKNHKWFATT  300 (350)
T ss_dssp             CSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred             hhCHHhccccccccHHHHHcCccccCC
Confidence            99999995     99999999999875

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-57  Score=439.68  Aligned_cols=248  Identities=25%  Similarity=0.372  Sum_probs=216.0

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCCh--HHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEe
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKS--EFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFME   79 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~~--~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (405)
                      +|++++.||+|+||+||+|.++.+|+.||||.+.....  ..+.+|+++|+.++||||+++++++....    .+|+|||
T Consensus         6 rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~----~~~lvmE   81 (321)
T d1tkia_           6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESME----ELVMIFE   81 (321)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETT----EEEEEEC
T ss_pred             ceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECC----EEEEEEe
Confidence            48999999999999999999999999999999987654  35789999999999999999999886544    3679999


Q ss_pred             ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC---ceEeeecccccccc---cc
Q 015500           80 YAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG---AKIADFGCAKWESE---AL  153 (405)
Q Consensus        80 y~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~---vkL~DFGla~~~~~---~~  153 (405)
                      ||+||+|.++|.+++.++++..++.|+.||+.||+|||++||+||||||+|||++.++   +||+|||+++....   ..
T Consensus        82 ~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~  161 (321)
T d1tkia_          82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFR  161 (321)
T ss_dssp             CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEE
T ss_pred             cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCccc
Confidence            9999999999988777899999999999999999999999999999999999997543   89999999986543   33


Q ss_pred             cCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCC--CchhccHHHHHHHHH
Q 015500          154 QSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPE--VPAFLSKQANDFLSN  231 (405)
Q Consensus       154 ~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~--~p~~~s~~l~dll~~  231 (405)
                      ...||+.|+|||.+.+..+++++|||||||++|+|++|+.||... +....+.++........  .+..+|+++++||++
T Consensus       162 ~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~  240 (321)
T d1tkia_         162 LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE-TNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDR  240 (321)
T ss_dssp             EEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS-SHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHT
T ss_pred             ccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhCCCCCChhhccCCCHHHHHHHHH
Confidence            456999999999999999999999999999999999999999643 44555555554432211  123589999999999


Q ss_pred             hcccCccccCCHHHHhcCccccc
Q 015500          232 CLRRDPKERWAASQLLKHPFLEE  254 (405)
Q Consensus       232 ~L~~dP~~Rpt~~elL~hp~~~~  254 (405)
                      ||++||.+|||++|+|+||||++
T Consensus       241 ~L~~dp~~R~s~~eil~hp~~~~  263 (321)
T d1tkia_         241 LLVKERKSRMTASEALQHPWLKQ  263 (321)
T ss_dssp             TSCSSGGGSCCHHHHHHSHHHHS
T ss_pred             HccCChhHCcCHHHHhcCHhhcc
Confidence            99999999999999999999975

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.6e-56  Score=426.72  Aligned_cols=248  Identities=24%  Similarity=0.388  Sum_probs=213.5

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC------------hHHHHHHHHHHHhCC-CCCeeeeeeeeeecC
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK------------SEFLQREQKFLSSLN-SPHIVGYKGCDVTSE   68 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~------------~~~l~~E~~iL~~L~-hpnIv~~~~~~~~~~   68 (405)
                      +|++++.||+|+||+||+|+++.+|+.||||++....            .+.+.+|+.+|++|+ ||||+++++++.+..
T Consensus         4 ~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~   83 (277)
T d1phka_           4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT   83 (277)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred             cCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCc
Confidence            6999999999999999999999999999999986542            135789999999997 999999999876543


Q ss_pred             CCceEEEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccc
Q 015500           69 DNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAK  147 (405)
Q Consensus        69 ~~~~~~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~  147 (405)
                          .+|+|||||+||+|.++|+.++ ++++..++.++.||+.||+|||++||+||||||+|||++.++ +||+|||+++
T Consensus        84 ----~~~ivmE~~~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~  158 (277)
T d1phka_          84 ----FFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC  158 (277)
T ss_dssp             ----EEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             ----ceEEEEEcCCCchHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchhee
Confidence                3679999999999999998764 899999999999999999999999999999999999999887 9999999998


Q ss_pred             cccc---cccCCCCCCccChhhhcC------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCC--CC
Q 015500          148 WESE---ALQSGGTPMFMAPEVARG------EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSREL--PE  216 (405)
Q Consensus       148 ~~~~---~~~~~gt~~Y~APE~l~~------~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~--~~  216 (405)
                      ....   .....||+.|+|||++.+      ..+++++||||+||++|+|+||+.||... +.......+......  ..
T Consensus       159 ~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~-~~~~~~~~i~~~~~~~~~~  237 (277)
T d1phka_         159 QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR-KQMLMLRMIMSGNYQFGSP  237 (277)
T ss_dssp             ECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHTCCCCCTT
T ss_pred             EccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCC-CHHHHHHHHHhCCCCCCCc
Confidence            7554   345669999999999864      34688999999999999999999999654 444455555444322  22


Q ss_pred             CchhccHHHHHHHHHhcccCccccCCHHHHhcCcccccc
Q 015500          217 VPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       217 ~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      .+..+|+++++||++||+.||++|||++|+|+||||+++
T Consensus       238 ~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~  276 (277)
T d1phka_         238 EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY  276 (277)
T ss_dssp             TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred             ccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence            335799999999999999999999999999999999864

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-57  Score=436.63  Aligned_cols=246  Identities=31%  Similarity=0.476  Sum_probs=214.8

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccC------CChHHHHHHHHHHH-hCCCCCeeeeeeeeeecCCCceEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTEL------PKSEFLQREQKFLS-SLNSPHIVGYKGCDVTSEDNKLMY   74 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~------~~~~~l~~E~~iL~-~L~hpnIv~~~~~~~~~~~~~~~~   74 (405)
                      +|.+++.||+|+||+||+|+++.+|+.||||++.+      ...+.+.+|..++. .++||||+++++++....    .+
T Consensus         3 dy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~----~~   78 (320)
T d1xjda_           3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE----NL   78 (320)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS----EE
T ss_pred             CeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCC----ce
Confidence            69999999999999999999999999999999853      33455667777665 689999999999876544    36


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc--
Q 015500           75 NLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE--  151 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~--  151 (405)
                      |+|||||+||+|.+++...+ ++++..++.++.||+.||+|||++||+||||||+|||++.++ +||+|||+++....  
T Consensus        79 yivmEy~~~g~L~~~i~~~~-~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~  157 (320)
T d1xjda_          79 FFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD  157 (320)
T ss_dssp             EEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             eEEEeecCCCcHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccccc
Confidence            79999999999999998764 899999999999999999999999999999999999999887 99999999985432  


Q ss_pred             --cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHH
Q 015500          152 --ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFL  229 (405)
Q Consensus       152 --~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll  229 (405)
                        .....||+.|+|||++.+..+++++|||||||++|||+||+.||.. .+......++...  .+.+|..+|+++++||
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~-~~~~~~~~~i~~~--~~~~p~~~s~~~~dli  234 (320)
T d1xjda_         158 AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG-QDEEELFHSIRMD--NPFYPRWLEKEAKDLL  234 (320)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHC--CCCCCTTSCHHHHHHH
T ss_pred             ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCC-CCHHHHHHHHHcC--CCCCCccCCHHHHHHH
Confidence              3345799999999999999999999999999999999999999954 4455555555433  4577888999999999


Q ss_pred             HHhcccCccccCCHH-HHhcCcccccc
Q 015500          230 SNCLRRDPKERWAAS-QLLKHPFLEEF  255 (405)
Q Consensus       230 ~~~L~~dP~~Rpt~~-elL~hp~~~~~  255 (405)
                      ++||++||++|||+. ++++||||+.+
T Consensus       235 ~~~L~~dP~~R~s~~~~l~~hpff~~~  261 (320)
T d1xjda_         235 VKLFVREPEKRLGVRGDIRQHPLFREI  261 (320)
T ss_dssp             HHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred             HHhcccCCCCCcCHHHHHHhCchhccC
Confidence            999999999999995 89999999875

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-56  Score=437.58  Aligned_cols=252  Identities=24%  Similarity=0.379  Sum_probs=209.1

Q ss_pred             Ccccc-cccceeCCeeEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHhC-CCCCeeeeeeeeeecCCCceEEEEEEe
Q 015500            2 DWTRG-HTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSL-NSPHIVGYKGCDVTSEDNKLMYNLFME   79 (405)
Q Consensus         2 ~y~~~-~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~~~~l~~E~~iL~~L-~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (405)
                      +|.+. +.||+|+||+||+|+++.+++.||||++.  ....+.+|+.++.++ +||||+++++++.+.......+|+|||
T Consensus        12 ~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~--~~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmE   89 (335)
T d2ozaa1          12 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVME   89 (335)
T ss_dssp             TEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEE--CSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred             CEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEEC--CcHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEE
Confidence            57765 56999999999999999999999999985  356788999987654 899999999998776555667889999


Q ss_pred             ecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccC---C-ceEeeecccccccc---
Q 015500           80 YAPGGTLNDEIHRNG-GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES---G-AKIADFGCAKWESE---  151 (405)
Q Consensus        80 y~~ggsL~~~i~~~~-~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~---~-vkL~DFGla~~~~~---  151 (405)
                      ||+||+|.++|.+++ .++++..++.|++||+.||+|||++||+||||||+|||++.+   + +||+|||+|+....   
T Consensus        90 y~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~  169 (335)
T d2ozaa1          90 CLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS  169 (335)
T ss_dssp             CCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCC
T ss_pred             CCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeeccCCCc
Confidence            999999999998753 469999999999999999999999999999999999999753   3 89999999986433   


Q ss_pred             cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChH--HHHH-HHHhcC-CCCC-CchhccHHHH
Q 015500          152 ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPM--TVLY-KIAYSR-ELPE-VPAFLSKQAN  226 (405)
Q Consensus       152 ~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~--~~l~-~i~~~~-~~~~-~p~~~s~~l~  226 (405)
                      .....|||.|||||++.+..|+.++|||||||++|+|+||++||.......  ..+. ++.... .+|. ....+|++++
T Consensus       170 ~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  249 (335)
T d2ozaa1         170 LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVK  249 (335)
T ss_dssp             CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHHHSCHHHH
T ss_pred             cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccccCCHHHH
Confidence            345679999999999999999999999999999999999999996543221  1111 111111 1111 1245899999


Q ss_pred             HHHHHhcccCccccCCHHHHhcCcccccc
Q 015500          227 DFLSNCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       227 dll~~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      +||++||++||++|||+.|+|+||||.+.
T Consensus       250 ~li~~~L~~dP~~R~s~~eil~hp~~~~~  278 (335)
T d2ozaa1         250 MLIRNLLKTEPTQRMTITEFMNHPWIMQS  278 (335)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred             HHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence            99999999999999999999999999753

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-55  Score=423.47  Aligned_cols=255  Identities=27%  Similarity=0.363  Sum_probs=210.8

Q ss_pred             CcccccccceeCCeeEEEEEEcCC-CCEEEEEEccCC-----ChHHHHHHHHHHHhC---CCCCeeeeeeeeeecC-CCc
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRS-GDVFAAKSTELP-----KSEFLQREQKFLSSL---NSPHIVGYKGCDVTSE-DNK   71 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~-~~~vavK~~~~~-----~~~~l~~E~~iL~~L---~hpnIv~~~~~~~~~~-~~~   71 (405)
                      +|++++.||+|+||+||+|++..+ ++.||||.+...     ....+.+|+.+|+.|   +||||+++++++.... ...
T Consensus         8 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~   87 (305)
T d1blxa_           8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   87 (305)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSE
T ss_pred             CEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccC
Confidence            599999999999999999999766 678999987532     234577888887766   7999999999876543 334


Q ss_pred             eEEEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccc
Q 015500           72 LMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWES  150 (405)
Q Consensus        72 ~~~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~  150 (405)
                      ..++++|||+.++.+..........+++..++.+++||+.||+|||++||+||||||+|||++.++ +||+|||+++...
T Consensus        88 ~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~  167 (305)
T d1blxa_          88 TKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS  167 (305)
T ss_dssp             EEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCC
T ss_pred             ceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhhhc
Confidence            567799999998877666666666799999999999999999999999999999999999999887 9999999987643


Q ss_pred             c---cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcC---------------
Q 015500          151 E---ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSR---------------  212 (405)
Q Consensus       151 ~---~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~---------------  212 (405)
                      .   .....||+.|+|||++.+..+++++|||||||++|||+||++||... +....+.++....               
T Consensus       168 ~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~  246 (305)
T d1blxa_         168 FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS-SDVDQLGKILDVIGLPGEEDWPRDVALP  246 (305)
T ss_dssp             GGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS-SHHHHHHHHHHHHCCCCGGGSCTTCSSC
T ss_pred             ccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCC-CHHHHHHHHHHhhCCCchhcccccccch
Confidence            3   34567999999999999999999999999999999999999999654 4444444432210               


Q ss_pred             ----------CCCCCchhccHHHHHHHHHhcccCccccCCHHHHhcCcccccccc
Q 015500          213 ----------ELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCS  257 (405)
Q Consensus       213 ----------~~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~~  257 (405)
                                ..+.++..+++.+++||++||++||++|||++|+|+||||+++..
T Consensus       247 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~  301 (305)
T d1blxa_         247 RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER  301 (305)
T ss_dssp             GGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             hhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchh
Confidence                      011233457899999999999999999999999999999997643

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-56  Score=425.77  Aligned_cols=245  Identities=28%  Similarity=0.380  Sum_probs=202.2

Q ss_pred             cccccceeCCeeEEEEEEcCCCCEEEEEEccCCC--------hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEE
Q 015500            5 RGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK--------SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         5 ~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~--------~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      +++.||+|+||+||+|+++.+|+.||||++....        ...+.+|+++|++++|||||++++++.....    +++
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~----~~i   77 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN----ISL   77 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC----CEE
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCc----eee
Confidence            5689999999999999999999999999986432        2468899999999999999999998765543    569


Q ss_pred             EEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc----
Q 015500           77 FMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE----  151 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~----  151 (405)
                      ||||+.|+++..++ ..++.+++..++.+++||+.||+|||++||+||||||+|||++.++ +||+|||+|+....    
T Consensus        78 vmE~~~~~~~~~~~-~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~  156 (299)
T d1ua2a_          78 VFDFMETDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA  156 (299)
T ss_dssp             EEECCSEEHHHHHT-TCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred             hhhhhcchHHhhhh-hcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCccc
Confidence            99999887766554 4446899999999999999999999999999999999999999887 99999999976543    


Q ss_pred             cccCCCCCCccChhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcC------------------
Q 015500          152 ALQSGGTPMFMAPEVARG-EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSR------------------  212 (405)
Q Consensus       152 ~~~~~gt~~Y~APE~l~~-~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~------------------  212 (405)
                      ....+||+.|+|||++.+ ..++.++|||||||++|||+||.+||.... ..+.+.++....                  
T Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~-~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~  235 (299)
T d1ua2a_         157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS-DLDQLTRIFETLGTPTEEQWPDMCSLPDYV  235 (299)
T ss_dssp             CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHHHCCCCTTTSSSTTSSTTCC
T ss_pred             ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCC-HHHHHHHHHHhcCCCChhhccchhccchhh
Confidence            234569999999999875 467999999999999999999999996543 444444433210                  


Q ss_pred             ---CCCCC-----chhccHHHHHHHHHhcccCccccCCHHHHhcCcccccc
Q 015500          213 ---ELPEV-----PAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       213 ---~~~~~-----p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                         ..+..     ...+++++++||++||+.||++|||++|+|+||||++.
T Consensus       236 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~  286 (299)
T d1ua2a_         236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR  286 (299)
T ss_dssp             CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred             hhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence               00111     12468999999999999999999999999999999864

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-55  Score=422.96  Aligned_cols=249  Identities=30%  Similarity=0.425  Sum_probs=206.1

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC-----ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP-----KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~-----~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      +|++++.||+|+||+||+|+++.+|+.||||++...     ..+.+.+|+++|++++||||+++++++.....    +++
T Consensus         3 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~----~~i   78 (298)
T d1gz8a_           3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK----LYL   78 (298)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTE----EEE
T ss_pred             CCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccc----eeE
Confidence            699999999999999999999999999999998643     24678899999999999999999998876543    679


Q ss_pred             EEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc----
Q 015500           77 FMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE----  151 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~----  151 (405)
                      ||||+.++.+........+.+++..++.++.||+.||+|||++|||||||||+|||++.++ +||+|||+|+....    
T Consensus        79 v~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~  158 (298)
T d1gz8a_          79 VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT  158 (298)
T ss_dssp             EEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBC
T ss_pred             EEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCccc
Confidence            9999976544444445556799999999999999999999999999999999999998887 99999999976533    


Q ss_pred             cccCCCCCCccChhhhcCCC-CCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCC-C--------------
Q 015500          152 ALQSGGTPMFMAPEVARGEH-QGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSREL-P--------------  215 (405)
Q Consensus       152 ~~~~~gt~~Y~APE~l~~~~-~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~-~--------------  215 (405)
                      .....||+.|+|||++.... ++.++|||||||++|+|++|+.||... +....+.++...... .              
T Consensus       159 ~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  237 (298)
T d1gz8a_         159 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD-SEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK  237 (298)
T ss_dssp             TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS-SHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred             ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCC-CHHHHHHHHHHhcCCCchhhccccccccccc
Confidence            23446999999999987755 588999999999999999999999654 444444443221000 0              


Q ss_pred             -CC-----------chhccHHHHHHHHHhcccCccccCCHHHHhcCcccccc
Q 015500          216 -EV-----------PAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       216 -~~-----------p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                       ..           ...+++++++||++||++||++|||++|+|+||||+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~  289 (298)
T d1gz8a_         238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV  289 (298)
T ss_dssp             TTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             cccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence             00           12367899999999999999999999999999999876

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-56  Score=422.66  Aligned_cols=240  Identities=23%  Similarity=0.359  Sum_probs=205.2

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC---------ChHHHHHHHHHHHhCC--CCCeeeeeeeeeecCCC
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP---------KSEFLQREQKFLSSLN--SPHIVGYKGCDVTSEDN   70 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~---------~~~~l~~E~~iL~~L~--hpnIv~~~~~~~~~~~~   70 (405)
                      +|++++.||+|+||+||+|+++.+|+.||||.+...         ....+.+|+.+|++++  ||||+++++++....  
T Consensus         5 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~--   82 (273)
T d1xwsa_           5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD--   82 (273)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS--
T ss_pred             eEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC--
Confidence            599999999999999999999999999999987642         1234679999999996  899999999876544  


Q ss_pred             ceEEEEEEeecCC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccC-C-ceEeeecccc
Q 015500           71 KLMYNLFMEYAPG-GTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES-G-AKIADFGCAK  147 (405)
Q Consensus        71 ~~~~~lv~Ey~~g-gsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~-~-vkL~DFGla~  147 (405)
                        .+++||||+.+ +++.+++.++ +.+++..++.++.||+.||+|||++||+||||||+|||++.+ + +||+|||+|+
T Consensus        83 --~~~lv~e~~~~~~~l~~~~~~~-~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~  159 (273)
T d1xwsa_          83 --SFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA  159 (273)
T ss_dssp             --EEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             --eEEEEEEeccCcchHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccce
Confidence              26699999976 5788888776 489999999999999999999999999999999999999865 4 9999999998


Q ss_pred             cccc--cccCCCCCCccChhhhcCCC-CCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHH
Q 015500          148 WESE--ALQSGGTPMFMAPEVARGEH-QGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQ  224 (405)
Q Consensus       148 ~~~~--~~~~~gt~~Y~APE~l~~~~-~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~  224 (405)
                      ....  .....||+.|+|||++.+.. ++.++|||||||++|||+||+.||...   .    .+..  ....++..+|++
T Consensus       160 ~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~---~----~i~~--~~~~~~~~~s~~  230 (273)
T d1xwsa_         160 LLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD---E----EIIR--GQVFFRQRVSSE  230 (273)
T ss_dssp             ECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH---H----HHHH--CCCCCSSCCCHH
T ss_pred             ecccccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc---h----HHhh--cccCCCCCCCHH
Confidence            6544  34567999999999998765 467899999999999999999999542   1    1111  223566789999


Q ss_pred             HHHHHHHhcccCccccCCHHHHhcCcccccc
Q 015500          225 ANDFLSNCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       225 l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      +++||++||+.||++|||++|+|+||||++.
T Consensus       231 ~~~li~~~L~~dp~~R~s~~eil~hp~~~~~  261 (273)
T d1xwsa_         231 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDV  261 (273)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred             HHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence            9999999999999999999999999999865

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-55  Score=418.11  Aligned_cols=240  Identities=27%  Similarity=0.435  Sum_probs=201.9

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC-----ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP-----KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~-----~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      +|++++.||+|+||+||+|+.+   ..||||++...     ..+.+.+|+.+|++++|||||+++++... .  .  +++
T Consensus         9 ~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~--~--~~l   80 (276)
T d1uwha_           9 QITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-P--Q--LAI   80 (276)
T ss_dssp             CCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-S--S--CEE
T ss_pred             cEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-c--E--EEE
Confidence            5888999999999999999753   46999998643     23578899999999999999999987532 1  2  469


Q ss_pred             EEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc----
Q 015500           77 FMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE----  151 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~----  151 (405)
                      |||||+||+|.+++...++++++..+..++.||+.||+|||++||+||||||+|||++.++ +||+|||+|+....    
T Consensus        81 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~  160 (276)
T d1uwha_          81 VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS  160 (276)
T ss_dssp             EEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred             EEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence            9999999999999988777899999999999999999999999999999999999999887 99999999976432    


Q ss_pred             --cccCCCCCCccChhhhcCC---CCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCC---CCchhccH
Q 015500          152 --ALQSGGTPMFMAPEVARGE---HQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELP---EVPAFLSK  223 (405)
Q Consensus       152 --~~~~~gt~~Y~APE~l~~~---~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~---~~p~~~s~  223 (405)
                        .....||+.|||||++.+.   .++.++|||||||++|||+||+.||............+......|   ..+..+++
T Consensus       161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~  240 (276)
T d1uwha_         161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPK  240 (276)
T ss_dssp             -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCH
T ss_pred             ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchH
Confidence              2345699999999999753   478899999999999999999999987666555444444433333   35567899


Q ss_pred             HHHHHHHHhcccCccccCCHHHHhcC
Q 015500          224 QANDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       224 ~l~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      ++.+||.+||+.||++|||++|++++
T Consensus       241 ~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         241 AMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            99999999999999999999999987

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.9e-55  Score=419.05  Aligned_cols=247  Identities=21%  Similarity=0.319  Sum_probs=211.8

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC--ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEe
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP--KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFME   79 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~--~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (405)
                      +|+.++.||+|+||+||+|+++.+|+.||||++...  ..+.+.+|+++|++|+|||||++++++.....    +++|||
T Consensus        18 ~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~----~~iv~E   93 (287)
T d1opja_          18 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP----FYIITE   93 (287)
T ss_dssp             GEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS----CEEEEE
T ss_pred             HeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCe----eEEEee
Confidence            467789999999999999999999999999998754  45679999999999999999999998765443    569999


Q ss_pred             ecCCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc-----
Q 015500           80 YAPGGTLNDEIHRN-GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA-----  152 (405)
Q Consensus        80 y~~ggsL~~~i~~~-~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~-----  152 (405)
                      ||++|+|.+++.+. ...+++..++.++.||+.||+|||++||+||||||+|||++.++ +||+|||+|+.....     
T Consensus        94 ~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~  173 (287)
T d1opja_          94 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH  173 (287)
T ss_dssp             CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEE
T ss_pred             cccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCCceee
Confidence            99999999999763 45789999999999999999999999999999999999999887 999999999865431     


Q ss_pred             ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHh
Q 015500          153 LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNC  232 (405)
Q Consensus       153 ~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~  232 (405)
                      ....||+.|+|||++.+..++.++|||||||++|||++|..||....+... +.........+..|..+|+++.+||.+|
T Consensus       174 ~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~-~~~~i~~~~~~~~~~~~~~~l~~li~~c  252 (287)
T d1opja_         174 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYELLEKDYRMERPEGCPEKVYELMRAC  252 (287)
T ss_dssp             TTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-HHHHHHTTCCCCCCTTCCHHHHHHHHHH
T ss_pred             ccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH-HHHHHhcCCCCCCCccchHHHHHHHHHH
Confidence            123478999999999999999999999999999999998877755555444 4444444556678888999999999999


Q ss_pred             cccCccccCCHHHHhcCcccccc
Q 015500          233 LRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       233 L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                      |+.||++|||++|+++  +|+.+
T Consensus       253 l~~dP~~Rps~~ei~~--~L~~~  273 (287)
T d1opja_         253 WQWNPSDRPSFAEIHQ--AFETM  273 (287)
T ss_dssp             TCSSGGGSCCHHHHHH--HHHHT
T ss_pred             cCCCHhHCcCHHHHHH--HHHHH
Confidence            9999999999999965  45443

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-54  Score=410.09  Aligned_cols=242  Identities=24%  Similarity=0.343  Sum_probs=202.0

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC--ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEe
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP--KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFME   79 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~--~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (405)
                      +|+.++.||+|+||+||+|+++ +++.||||.+...  ..+.+.+|+++|++++||||+++++++.....    +++|||
T Consensus         6 ~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~----~~lv~E   80 (263)
T d1sm2a_           6 ELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP----ICLVFE   80 (263)
T ss_dssp             CEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS----CEEEEE
T ss_pred             HcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCc----eEEEEE
Confidence            5889999999999999999985 6788999998754  35679999999999999999999998765543    569999


Q ss_pred             ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc-----cc
Q 015500           80 YAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE-----AL  153 (405)
Q Consensus        80 y~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~-----~~  153 (405)
                      |+++|+|.+++......+++..+..++.||+.||+|||+++|+||||||+|||++.++ +||+|||+++....     ..
T Consensus        81 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~  160 (263)
T d1sm2a_          81 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST  160 (263)
T ss_dssp             CCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred             ecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCceeec
Confidence            9999999999987767899999999999999999999999999999999999999887 99999999986543     22


Q ss_pred             cCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHhc
Q 015500          154 QSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCL  233 (405)
Q Consensus       154 ~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~L  233 (405)
                      ...||+.|+|||++.+..++.++|||||||++|||+|+..||.........+..+.. ...+..|..+++++.+||.+||
T Consensus       161 ~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~-~~~~~~p~~~~~~l~~li~~cl  239 (263)
T d1sm2a_         161 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST-GFRLYKPRLASTHVYQIMNHCW  239 (263)
T ss_dssp             ----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHH-TCCCCCCTTSCHHHHHHHHHHT
T ss_pred             ceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHh-cCCCCCccccCHHHHHHHHHHc
Confidence            345899999999999999999999999999999999965554444455555555544 3445667889999999999999


Q ss_pred             ccCccccCCHHHHhcC
Q 015500          234 RRDPKERWAASQLLKH  249 (405)
Q Consensus       234 ~~dP~~Rpt~~elL~h  249 (405)
                      +.||++|||++|+++|
T Consensus       240 ~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         240 KERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             CSSGGGSCCHHHHHHH
T ss_pred             cCCHhHCcCHHHHHHH
Confidence            9999999999999987

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.5e-54  Score=412.44  Aligned_cols=250  Identities=25%  Similarity=0.440  Sum_probs=207.7

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC------hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK------SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~------~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~   75 (405)
                      +|++++.||+|+||+||+|+++.+|+.||||++....      .+.+.+|+++|+.++||||+++++++.........+|
T Consensus         8 rY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~   87 (277)
T d1o6ya_           8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY   87 (277)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred             eeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEE
Confidence            4999999999999999999999999999999986532      2468899999999999999999999887776666678


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc---
Q 015500           76 LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE---  151 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~---  151 (405)
                      +||||++|++|.+++...+ ++++..++.++.||+.||+|||++||+||||||+|||++.++ .+|+|||.+.....   
T Consensus        88 lvmE~~~g~~L~~~~~~~~-~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~  166 (277)
T d1o6ya_          88 IVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN  166 (277)
T ss_dssp             EEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC----
T ss_pred             EEEECCCCCEehhhhcccC-CCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhccccc
Confidence            9999999999999988774 899999999999999999999999999999999999998887 99999998864322   


Q ss_pred             ----cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCC--CCchhccHHH
Q 015500          152 ----ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELP--EVPAFLSKQA  225 (405)
Q Consensus       152 ----~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~--~~p~~~s~~l  225 (405)
                          .....||+.|||||++.+..+++++|||||||++|||+||++||... +....+.++......+  ..+..+|+++
T Consensus       167 ~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~s~~l  245 (277)
T d1o6ya_         167 SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD-SPVSVAYQHVREDPIPPSARHEGLSADL  245 (277)
T ss_dssp             ------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS-SHHHHHHHHHHCCCCCGGGTSSSCCHHH
T ss_pred             cccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCc-CHHHHHHHHHhcCCCCCchhccCCCHHH
Confidence                23456999999999999999999999999999999999999999643 4555555555444333  2335689999


Q ss_pred             HHHHHHhcccCccccCCHHHHhcCcccc
Q 015500          226 NDFLSNCLRRDPKERWAASQLLKHPFLE  253 (405)
Q Consensus       226 ~dll~~~L~~dP~~Rpt~~elL~hp~~~  253 (405)
                      .+||.+||++||.+||+..+.|.|+|.+
T Consensus       246 ~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         246 DAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             HHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             HHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence            9999999999999999544445566654

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-54  Score=423.62  Aligned_cols=255  Identities=26%  Similarity=0.389  Sum_probs=207.5

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHhCCCCCeeeeeeeeeecC--CCceEEEEEEe
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPHIVGYKGCDVTSE--DNKLMYNLFME   79 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~--~~~~~~~lv~E   79 (405)
                      +|+.+++||+|+||+||+|+++.+|+.||||++.... ....+|+++|++|+||||+++++++....  .+..++++|||
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~E   99 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD   99 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc-hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEe
Confidence            5899999999999999999999999999999987543 34568999999999999999999876543  33456779999


Q ss_pred             ecCCCCHHHHHH--HcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC--ceEeeecccccccc---c
Q 015500           80 YAPGGTLNDEIH--RNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG--AKIADFGCAKWESE---A  152 (405)
Q Consensus        80 y~~ggsL~~~i~--~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~--vkL~DFGla~~~~~---~  152 (405)
                      ||+++.+..+..  ....++++..++.+++||+.||+|||++||+||||||+|||++.++  +||+|||+++....   .
T Consensus       100 y~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~~  179 (350)
T d1q5ka_         100 YVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN  179 (350)
T ss_dssp             CCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSCC
T ss_pred             ccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccCCccc
Confidence            998764433322  3445799999999999999999999999999999999999998765  89999999986533   3


Q ss_pred             ccCCCCCCccChhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhc------------------CC
Q 015500          153 LQSGGTPMFMAPEVARG-EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYS------------------RE  213 (405)
Q Consensus       153 ~~~~gt~~Y~APE~l~~-~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~------------------~~  213 (405)
                      ....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... ....+.++...                  ..
T Consensus       180 ~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~-~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~  258 (350)
T d1q5ka_         180 VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS-GVDQLVEIIKVLGTPTREQIREMNPNYTEFK  258 (350)
T ss_dssp             CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSS-HHHHHHHHHHHHCCCCHHHHHHHCC---CCC
T ss_pred             ccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCC-HHHHHHHHHHHhCCChHHhhhhhccchhhcc
Confidence            45679999999999876 568999999999999999999999996544 33333333210                  01


Q ss_pred             CCC---------CchhccHHHHHHHHHhcccCccccCCHHHHhcCccccccccc
Q 015500          214 LPE---------VPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCSC  258 (405)
Q Consensus       214 ~~~---------~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~~~  258 (405)
                      .+.         ....+++++.+||.+||+.||.+|||+.|+|+||||+++...
T Consensus       259 ~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~  312 (350)
T d1q5ka_         259 FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP  312 (350)
T ss_dssp             CCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCT
T ss_pred             ccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCC
Confidence            111         123478999999999999999999999999999999987543

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-54  Score=412.86  Aligned_cols=245  Identities=20%  Similarity=0.277  Sum_probs=209.0

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC--ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEe
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP--KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFME   79 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~--~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (405)
                      +|++++.||+|+||+||+|.++ ++..||||++...  ..+.+.+|+++|++++|||||++++++.. ..    +++|||
T Consensus        14 ~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~----~~iv~E   87 (272)
T d1qpca_          14 TLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EP----IYIITE   87 (272)
T ss_dssp             GEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS----CEEEEE
T ss_pred             HeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CC----eEEEEE
Confidence            4778999999999999999975 6788999998754  35679999999999999999999997532 22    458999


Q ss_pred             ecCCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc-----c
Q 015500           80 YAPGGTLNDEIHRN-GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE-----A  152 (405)
Q Consensus        80 y~~ggsL~~~i~~~-~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~-----~  152 (405)
                      |+++|+|.+++... +.++++..+..|+.||+.||.|||++||+||||||+||||+.++ +||+|||+|+....     .
T Consensus        88 y~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~  167 (272)
T d1qpca_          88 YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR  167 (272)
T ss_dssp             CCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECC
T ss_pred             eCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCccccc
Confidence            99999999977543 23699999999999999999999999999999999999999987 99999999986543     2


Q ss_pred             ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHh
Q 015500          153 LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNC  232 (405)
Q Consensus       153 ~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~  232 (405)
                      ....||+.|||||++.+..++.++|||||||++|||+||..||.........+..+.. ...+..|..+++++.+||.+|
T Consensus       168 ~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~-~~~~~~p~~~~~~l~~li~~c  246 (272)
T d1qpca_         168 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER-GYRMVRPDNCPEELYQLMRLC  246 (272)
T ss_dssp             TTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-TCCCCCCTTCCHHHHHHHHHH
T ss_pred             cccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHh-cCCCCCcccChHHHHHHHHHH
Confidence            2346899999999999999999999999999999999976666555555555555543 445567888999999999999


Q ss_pred             cccCccccCCHHHHhc--Ccccc
Q 015500          233 LRRDPKERWAASQLLK--HPFLE  253 (405)
Q Consensus       233 L~~dP~~Rpt~~elL~--hp~~~  253 (405)
                      |+.||++|||++++++  |+||.
T Consensus       247 l~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         247 WKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             TCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cCCCHhHCcCHHHHHHHhhhhhh
Confidence            9999999999999998  78875

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-54  Score=422.09  Aligned_cols=243  Identities=24%  Similarity=0.335  Sum_probs=207.2

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCC-----EEEEEEccCC----ChHHHHHHHHHHHhC-CCCCeeeeeeeeeecCCCc
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGD-----VFAAKSTELP----KSEFLQREQKFLSSL-NSPHIVGYKGCDVTSEDNK   71 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~-----~vavK~~~~~----~~~~l~~E~~iL~~L-~hpnIv~~~~~~~~~~~~~   71 (405)
                      +|++++.||+|+||+||+|++..+++     .||+|.+...    ....+.+|+.+|+++ +|||||++++++.....  
T Consensus        38 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~--  115 (325)
T d1rjba_          38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP--  115 (325)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS--
T ss_pred             HeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe--
Confidence            46788999999999999999876654     6899987542    345788999999998 89999999998765543  


Q ss_pred             eEEEEEEeecCCCCHHHHHHHcC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCC
Q 015500           72 LMYNLFMEYAPGGTLNDEIHRNG----------------------GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSR  129 (405)
Q Consensus        72 ~~~~lv~Ey~~ggsL~~~i~~~~----------------------~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~  129 (405)
                        +++|||||+||+|.++|+.+.                      +.+++..++.|+.||+.||+|||++||+||||||+
T Consensus       116 --~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~  193 (325)
T d1rjba_         116 --IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR  193 (325)
T ss_dssp             --CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred             --EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchh
Confidence              569999999999999997643                      34899999999999999999999999999999999


Q ss_pred             CEEEccCC-ceEeeeccccccccc------ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCh
Q 015500          130 NILMAESG-AKIADFGCAKWESEA------LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADP  201 (405)
Q Consensus       130 NILi~~~~-vkL~DFGla~~~~~~------~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~  201 (405)
                      |||++.++ +||+|||+|+.....      ....||+.|||||++.+..+++++|||||||++|||+| |++||......
T Consensus       194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~  273 (325)
T d1rjba_         194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD  273 (325)
T ss_dssp             GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred             ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence            99999888 999999999865442      13347999999999999999999999999999999998 89999765443


Q ss_pred             HHHHHHHHhcCCCCCCchhccHHHHHHHHHhcccCccccCCHHHHhcC
Q 015500          202 MTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       202 ~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                       ..+.++......+..|..+|+++++||.+||+.||++|||++||++|
T Consensus       274 -~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         274 -ANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             -HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -HHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence             34455555555667888899999999999999999999999999987

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-54  Score=414.28  Aligned_cols=244  Identities=24%  Similarity=0.304  Sum_probs=206.2

Q ss_pred             ccccc-ccceeCCeeEEEEEEcCC--CCEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEE
Q 015500            3 WTRGH-TIGQGSSATVSLATSLRS--GDVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYN   75 (405)
Q Consensus         3 y~~~~-~LG~G~~g~Vyla~~~~~--~~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~   75 (405)
                      |.+.+ .||+|+||+||+|.++.+  +..||||.+....    .+.+.+|+++|++++|||||++++++.. +.    ++
T Consensus        10 ~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~----~~   84 (285)
T d1u59a_          10 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA----LM   84 (285)
T ss_dssp             EEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SS----EE
T ss_pred             eEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-Ce----EE
Confidence            45566 499999999999987644  4579999986532    3568899999999999999999997643 22    56


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc---
Q 015500           76 LFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE---  151 (405)
Q Consensus        76 lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~---  151 (405)
                      +|||||+||+|.+++....+.+++..+..++.||+.||+|||++||+||||||+|||++.++ +||+|||+++....   
T Consensus        85 lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~  164 (285)
T d1u59a_          85 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS  164 (285)
T ss_dssp             EEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC
T ss_pred             EEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccccccc
Confidence            99999999999999877667899999999999999999999999999999999999999888 99999999986433   


Q ss_pred             ----cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHH
Q 015500          152 ----ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQAN  226 (405)
Q Consensus       152 ----~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~  226 (405)
                          .....||+.|||||++.+..++.++|||||||++|||+| |+.||..... ......+. ....+..|..+|+++.
T Consensus       165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~-~~~~~~i~-~~~~~~~p~~~~~~l~  242 (285)
T d1u59a_         165 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-PEVMAFIE-QGKRMECPPECPPELY  242 (285)
T ss_dssp             EECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT-HHHHHHHH-TTCCCCCCTTCCHHHH
T ss_pred             ccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH-HHHHHHHH-cCCCCCCCCcCCHHHH
Confidence                223458999999999999999999999999999999998 9999976654 34444443 4455678889999999


Q ss_pred             HHHHHhcccCccccCCHHHH---hcCcccc
Q 015500          227 DFLSNCLRRDPKERWAASQL---LKHPFLE  253 (405)
Q Consensus       227 dll~~~L~~dP~~Rpt~~el---L~hp~~~  253 (405)
                      +||.+||+.||++|||+.++   |+|+|+.
T Consensus       243 ~li~~cl~~~p~~RPs~~~i~~~L~~~~~~  272 (285)
T d1u59a_         243 ALMSDCWIYKWEDRPDFLTVEQRMRACYYS  272 (285)
T ss_dssp             HHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            99999999999999999888   6677764

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=6e-54  Score=417.51  Aligned_cols=248  Identities=23%  Similarity=0.366  Sum_probs=210.2

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHhCC-CCCeeeeeeeeeecCCCceEEEEEEee
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLN-SPHIVGYKGCDVTSEDNKLMYNLFMEY   80 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~~~~l~~E~~iL~~L~-hpnIv~~~~~~~~~~~~~~~~~lv~Ey   80 (405)
                      +|++++.||+|+||+||+|+++.+|+.||||++.....+.+.+|+++|+.++ ||||+++++++.......  +++||||
T Consensus        36 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~--~~~v~e~  113 (328)
T d3bqca1          36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRT--PALVFEH  113 (328)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCS--EEEEEEC
T ss_pred             CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCc--eeEEEee
Confidence            5899999999999999999999999999999998888889999999999995 999999999876544332  5589999


Q ss_pred             cCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC--ceEeeecccccccc---cccC
Q 015500           81 APGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG--AKIADFGCAKWESE---ALQS  155 (405)
Q Consensus        81 ~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~--vkL~DFGla~~~~~---~~~~  155 (405)
                      |.+++|....    +++++..++.+++||+.||+|||++||+||||||+||||+.++  +||+|||+|+....   ....
T Consensus       114 ~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~~~~~  189 (328)
T d3bqca1         114 VNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR  189 (328)
T ss_dssp             CCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCCCCSC
T ss_pred             cCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCCccccc
Confidence            9999997653    4799999999999999999999999999999999999998654  89999999986543   3455


Q ss_pred             CCCCCccChhhhcCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhc------------C----------
Q 015500          156 GGTPMFMAPEVARGE-HQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYS------------R----------  212 (405)
Q Consensus       156 ~gt~~Y~APE~l~~~-~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~------------~----------  212 (405)
                      .||+.|+|||.+.+. .++.++|||||||++|+|++|+.||....+.......+...            .          
T Consensus       190 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~  269 (328)
T d3bqca1         190 VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFND  269 (328)
T ss_dssp             CSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGG
T ss_pred             ccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccch
Confidence            699999999998875 47999999999999999999999998776654443322110            0          


Q ss_pred             -------------CCCCCchhccHHHHHHHHHhcccCccccCCHHHHhcCcccccc
Q 015500          213 -------------ELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEF  255 (405)
Q Consensus       213 -------------~~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~  255 (405)
                                   ........++++++|||++||++||.+|||++|+|+||||+.+
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v  325 (328)
T d3bqca1         270 ILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV  325 (328)
T ss_dssp             TCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTS
T ss_pred             hcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence                         0011223478999999999999999999999999999999865

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.8e-54  Score=415.49  Aligned_cols=242  Identities=22%  Similarity=0.338  Sum_probs=197.9

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCC---EEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGD---VFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMY   74 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~---~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~   74 (405)
                      +|++++.||+|+||+||+|.++.+++   .+|||.+....    .+.+.+|+++|++|+|||||++++++.....    +
T Consensus        27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~----~  102 (299)
T d1jpaa_          27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTP----V  102 (299)
T ss_dssp             GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS----C
T ss_pred             hcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE----E
Confidence            36778999999999999999987765   68899876532    2468899999999999999999998765443    5


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc-
Q 015500           75 NLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA-  152 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~-  152 (405)
                      ++|||||+||+|.+++....+.+++..+..++.||+.||+|||++||+||||||+||||+.++ +||+|||+|+..... 
T Consensus       103 ~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~  182 (299)
T d1jpaa_         103 MIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  182 (299)
T ss_dssp             EEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             EEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCCC
Confidence            699999999999999988777899999999999999999999999999999999999999987 999999999864331 


Q ss_pred             --------ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccH
Q 015500          153 --------LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSK  223 (405)
Q Consensus       153 --------~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~  223 (405)
                              ....||+.|||||++.+..++.++|||||||++|||+| |++||.+.. ....+..+.. ...+..|..+++
T Consensus       183 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~-~~~~~~~i~~-~~~~~~~~~~~~  260 (299)
T d1jpaa_         183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT-NQDVINAIEQ-DYRLPPPMDCPS  260 (299)
T ss_dssp             -------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-HHHHHHHHHT-TCCCCCCTTCCH
T ss_pred             CcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCC-HHHHHHHHHc-CCCCCCCccchH
Confidence                    11347899999999999999999999999999999998 899996543 3444444443 344556778999


Q ss_pred             HHHHHHHHhcccCccccCCHHHHhcC
Q 015500          224 QANDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       224 ~l~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      ++.+|+.+||+.||++|||+.|++++
T Consensus       261 ~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         261 ALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             HHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            99999999999999999999999875

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-54  Score=412.05  Aligned_cols=239  Identities=25%  Similarity=0.343  Sum_probs=200.7

Q ss_pred             cccceeCCeeEEEEEEcC--CCCEEEEEEccCCC-----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEe
Q 015500            7 HTIGQGSSATVSLATSLR--SGDVFAAKSTELPK-----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFME   79 (405)
Q Consensus         7 ~~LG~G~~g~Vyla~~~~--~~~~vavK~~~~~~-----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (405)
                      +.||+|+||+||+|.++.  +++.||||.+....     .+.+.+|+++|++|+|||||++++++.. +.    +++|||
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~----~~lvmE   87 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ES----WMLVME   87 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SS----EEEEEE
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CC----EEEEEE
Confidence            579999999999998653  55789999986432     3568899999999999999999998642 22    459999


Q ss_pred             ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc-------
Q 015500           80 YAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE-------  151 (405)
Q Consensus        80 y~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~-------  151 (405)
                      ||++|+|.+++.+. +++++..+..++.||+.||+|||++||+||||||+|||++.++ +||+|||+++....       
T Consensus        88 ~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~  166 (277)
T d1xbba_          88 MAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA  166 (277)
T ss_dssp             CCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred             cCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccc
Confidence            99999999999876 4899999999999999999999999999999999999999988 99999999985432       


Q ss_pred             cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHH
Q 015500          152 ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLS  230 (405)
Q Consensus       152 ~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~  230 (405)
                      .....||+.|||||++.+..++.++|||||||++|||+| |++||.+.. .......+ .....+..|..+|+++.+||.
T Consensus       167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~-~~~~~~~i-~~~~~~~~p~~~~~~~~~li~  244 (277)
T d1xbba_         167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK-GSEVTAML-EKGERMGCPAGCPREMYDLMN  244 (277)
T ss_dssp             ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC-HHHHHHHH-HTTCCCCCCTTCCHHHHHHHH
T ss_pred             ccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCC-HHHHHHHH-HcCCCCCCCcccCHHHHHHHH
Confidence            123458999999999999999999999999999999998 899997543 33444333 345566788899999999999


Q ss_pred             HhcccCccccCCHHHH---hcCcccc
Q 015500          231 NCLRRDPKERWAASQL---LKHPFLE  253 (405)
Q Consensus       231 ~~L~~dP~~Rpt~~el---L~hp~~~  253 (405)
                      +||+.||++|||++++   |+|+|++
T Consensus       245 ~cl~~dp~~RPs~~~i~~~L~~~~~~  270 (277)
T d1xbba_         245 LCWTYDVENRPGFAAVELRLRNYYYD  270 (277)
T ss_dssp             HHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             HHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence            9999999999999998   4566654

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-53  Score=403.16  Aligned_cols=241  Identities=22%  Similarity=0.315  Sum_probs=211.5

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC--ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEe
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP--KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFME   79 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~--~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (405)
                      ||+.++.||+|+||+||+|+++ +++.||||.+...  ..+.+.+|++++++++||||+++++++.....    +++|||
T Consensus         5 ~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~----~~iv~E   79 (258)
T d1k2pa_           5 DLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRP----IFIITE   79 (258)
T ss_dssp             CCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSS----EEEEEE
T ss_pred             HCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCc----eEEEEE
Confidence            6899999999999999999984 7889999998653  45789999999999999999999998765433    569999


Q ss_pred             ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc-----cc
Q 015500           80 YAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE-----AL  153 (405)
Q Consensus        80 y~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~-----~~  153 (405)
                      |+++|+|.+++......+++..+..++.||++||+|||++||+||||||+|||++.++ +||+|||+++....     ..
T Consensus        80 y~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~  159 (258)
T d1k2pa_          80 YMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV  159 (258)
T ss_dssp             CCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCC
T ss_pred             ccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCceeec
Confidence            9999999999877667899999999999999999999999999999999999999987 99999999975433     22


Q ss_pred             cCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHh
Q 015500          154 QSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNC  232 (405)
Q Consensus       154 ~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~  232 (405)
                      ...||+.|+|||++.+..++.++|||||||++|||+| |+.||.... ..+...++. ....+..|..+++++.+||++|
T Consensus       160 ~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~-~~~~~~~i~-~~~~~~~p~~~~~~l~~li~~c  237 (258)
T d1k2pa_         160 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT-NSETAEHIA-QGLRLYRPHLASEKVYTIMYSC  237 (258)
T ss_dssp             CSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC-HHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHT
T ss_pred             ccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCC-HHHHHHHHH-hCCCCCCcccccHHHHHHHHHH
Confidence            3558999999999999999999999999999999998 899996554 445555554 4445667888999999999999


Q ss_pred             cccCccccCCHHHHhcC
Q 015500          233 LRRDPKERWAASQLLKH  249 (405)
Q Consensus       233 L~~dP~~Rpt~~elL~h  249 (405)
                      |+.||++|||++++++|
T Consensus       238 l~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         238 WHEKADERPTFKILLSN  254 (258)
T ss_dssp             TCSSGGGSCCHHHHHHH
T ss_pred             ccCCHhHCcCHHHHHHH
Confidence            99999999999999987

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=8.9e-54  Score=408.54  Aligned_cols=246  Identities=30%  Similarity=0.392  Sum_probs=202.7

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      +|++.+.||+|+||+||+|+++ +|+.||||++....     .+.+.+|+.+|++++||||+++++++.....    +++
T Consensus         3 ~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~----~~i   77 (286)
T d1ob3a_           3 KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKR----LVL   77 (286)
T ss_dssp             SEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSC----EEE
T ss_pred             CceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCc----eeE
Confidence            5899999999999999999985 88999999986543     4578999999999999999999998776544    668


Q ss_pred             EEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc----
Q 015500           77 FMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE----  151 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~----  151 (405)
                      +|||+.++.+..+. ...+.+++..++.+++||+.||+|||++||+||||||+|||++.++ +||+|||++.....    
T Consensus        78 ~~e~~~~~~~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~  156 (286)
T d1ob3a_          78 VFEHLDQDLKKLLD-VCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK  156 (286)
T ss_dssp             EEECCSEEHHHHHH-TSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred             EEEeehhhhHHHHH-hhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCccc
Confidence            99999776555544 4456899999999999999999999999999999999999999887 99999999976443    


Q ss_pred             cccCCCCCCccChhhhcCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCC----------------
Q 015500          152 ALQSGGTPMFMAPEVARGE-HQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSREL----------------  214 (405)
Q Consensus       152 ~~~~~gt~~Y~APE~l~~~-~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~----------------  214 (405)
                      .....||+.|+|||.+.+. .+++++|||||||++|||++|+.||.... ....+.++......                
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T d1ob3a_         157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS-EADQLMRIFRILGTPNSKNWPNVTELPKYD  235 (286)
T ss_dssp             -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred             cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCC-HHHHHHHHHHhhCCCChhhccchhhhhhcc
Confidence            2344699999999999764 57899999999999999999999996543 34444443211100                


Q ss_pred             -----------CCCchhccHHHHHHHHHhcccCccccCCHHHHhcCccccc
Q 015500          215 -----------PEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEE  254 (405)
Q Consensus       215 -----------~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~  254 (405)
                                 +..+..++++++|||++||++||++|||++|+|+||||++
T Consensus       236 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             cccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence                       1123447899999999999999999999999999999974

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-53  Score=418.05  Aligned_cols=252  Identities=26%  Similarity=0.394  Sum_probs=203.2

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCC--CceEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-----SEFLQREQKFLSSLNSPHIVGYKGCDVTSED--NKLMY   74 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~--~~~~~   74 (405)
                      .|++++.||+|+||+||+|+++.+|+.||||++....     .+.+.+|+++|+.++|||||++++++.....  ....+
T Consensus        19 ~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~   98 (346)
T d1cm8a_          19 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF   98 (346)
T ss_dssp             SEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCC
T ss_pred             cEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceE
Confidence            5889999999999999999999999999999987532     3467899999999999999999998765442  22345


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc-c
Q 015500           75 NLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE-A  152 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~-~  152 (405)
                      ++||||+ |.+|..+++..  ++++..++.+++||+.||+|||++||+||||||+|||++.++ +||+|||+|+.... .
T Consensus        99 ~lv~e~~-~~~l~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~~  175 (346)
T d1cm8a_          99 YLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM  175 (346)
T ss_dssp             EEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSSC
T ss_pred             EEEEecc-cccHHHHHHhc--cccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCCcc
Confidence            7999999 66788777553  799999999999999999999999999999999999999888 99999999987655 3


Q ss_pred             ccCCCCCCccChhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhc--------------------
Q 015500          153 LQSGGTPMFMAPEVARG-EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYS--------------------  211 (405)
Q Consensus       153 ~~~~gt~~Y~APE~l~~-~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~--------------------  211 (405)
                      ....||+.|+|||++.+ ..+++++|||||||++|+|++|++||.... ....+..+...                    
T Consensus       176 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (346)
T d1cm8a_         176 TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD-HLDQLKEIMKVTGTPPAEFVQRLQSDEAKNY  254 (346)
T ss_dssp             CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHHHCCCCHHHHHTCSCHHHHHH
T ss_pred             ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCC-hHHHHHHHHhccCCCcHHHHhhhcchhhhhh
Confidence            45679999999999876 457899999999999999999999996543 23332222111                    


Q ss_pred             ---------CCCCCCchhccHHHHHHHHHhcccCccccCCHHHHhcCcccccccc
Q 015500          212 ---------RELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCS  257 (405)
Q Consensus       212 ---------~~~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~~  257 (405)
                               ...+.....+++++.+||.+||..||++|||++|+|+||||+.+..
T Consensus       255 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~  309 (346)
T d1cm8a_         255 MKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD  309 (346)
T ss_dssp             HHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred             hccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCC
Confidence                     0111223457899999999999999999999999999999997643

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-53  Score=403.21  Aligned_cols=250  Identities=28%  Similarity=0.429  Sum_probs=212.4

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~l   76 (405)
                      +|++++.||+|+||+||+|+++.+|+.||||++....     ...+.+|+.+|+.++||||+++++++.....    +++
T Consensus         3 ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~----~~i   78 (292)
T d1unla_           3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKK----LTL   78 (292)
T ss_dssp             SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE----EEE
T ss_pred             CCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccc----eeE
Confidence            5999999999999999999999999999999976432     3578899999999999999999988765543    668


Q ss_pred             EEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc----
Q 015500           77 FMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE----  151 (405)
Q Consensus        77 v~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~----  151 (405)
                      ++|++.|++|..++... +.+++..++.+++|++.||+|||++||+||||||+|||++.++ +||+|||.++....    
T Consensus        79 v~~~~~~~~l~~~~~~~-~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~  157 (292)
T d1unla_          79 VFEFCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC  157 (292)
T ss_dssp             EEECCSEEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC
T ss_pred             Eeeeccccccccccccc-cccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCcc
Confidence            99999998888776654 5899999999999999999999999999999999999999877 99999999986543    


Q ss_pred             cccCCCCCCccChhhhcCCC-CCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcC------------------
Q 015500          152 ALQSGGTPMFMAPEVARGEH-QGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSR------------------  212 (405)
Q Consensus       152 ~~~~~gt~~Y~APE~l~~~~-~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~------------------  212 (405)
                      .....+++.|+|||++.+.. +++++|||||||++|||++|+.||....+....+.++....                  
T Consensus       158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (292)
T d1unla_         158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK  237 (292)
T ss_dssp             CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred             ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccc
Confidence            22345788999999988765 68999999999999999999999877766666555443211                  


Q ss_pred             ---------CCCCCchhccHHHHHHHHHhcccCccccCCHHHHhcCccccccc
Q 015500          213 ---------ELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFC  256 (405)
Q Consensus       213 ---------~~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~  256 (405)
                               .....+..+++.+.+||++||+.||.+|||++|+|+||||+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~  290 (292)
T d1unla_         238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCS
T ss_pred             ccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCC
Confidence                     11123345789999999999999999999999999999998764

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-53  Score=415.35  Aligned_cols=253  Identities=27%  Similarity=0.368  Sum_probs=202.2

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLF   77 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv   77 (405)
                      +|++++.||+|+||+||+|+++.+|+.||||++....    .+.+.+|+.+|++|+||||+++++++.........++++
T Consensus         9 rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l   88 (345)
T d1pmea_           9 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYL   88 (345)
T ss_dssp             TEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred             CeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEE
Confidence            4899999999999999999999999999999987543    246789999999999999999999876543222212245


Q ss_pred             EeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc-----
Q 015500           78 MEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE-----  151 (405)
Q Consensus        78 ~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~-----  151 (405)
                      ++|+.||+|.+++...  ++++..++.++.||+.||+|||++||+||||||+|||++.++ +||+|||+|+....     
T Consensus        89 ~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~  166 (345)
T d1pmea_          89 VTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT  166 (345)
T ss_dssp             EEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBC
T ss_pred             EEeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCccc
Confidence            5667799999999764  699999999999999999999999999999999999999887 99999999975433     


Q ss_pred             --cccCCCCCCccChhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCC---------------
Q 015500          152 --ALQSGGTPMFMAPEVARG-EHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRE---------------  213 (405)
Q Consensus       152 --~~~~~gt~~Y~APE~l~~-~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~---------------  213 (405)
                        ....+||+.|+|||++.. ..++.++||||+||++|+|++|+.||..... ............               
T Consensus       167 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (345)
T d1pmea_         167 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY-LDQLNHILGILGSPSQEDLNCIINLKA  245 (345)
T ss_dssp             CTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCSCCHHHHHTCCCHHH
T ss_pred             eeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCH-HHHHHHHhhhccCCChhhhhhhhhhhh
Confidence              234459999999999854 5678999999999999999999999965432 222221111000               


Q ss_pred             ------CC--------CCchhccHHHHHHHHHhcccCccccCCHHHHhcCcccccccc
Q 015500          214 ------LP--------EVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFCS  257 (405)
Q Consensus       214 ------~~--------~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~~  257 (405)
                            .+        .....+++++++||.+||+.||.+|||++|+|+||||+....
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~  303 (345)
T d1pmea_         246 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD  303 (345)
T ss_dssp             HHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred             hcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCC
Confidence                  00        112346889999999999999999999999999999987643

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-52  Score=400.73  Aligned_cols=242  Identities=20%  Similarity=0.245  Sum_probs=202.5

Q ss_pred             CcccccccceeCCeeEEEEEEcCCC----CEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSG----DVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLM   73 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~----~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~   73 (405)
                      .|++++.||+|+||+||+|.++.++    ..||||.+....    ...+.+|+++|++|+|||||++++++.....    
T Consensus         8 ~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~----   83 (283)
T d1mqba_           8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP----   83 (283)
T ss_dssp             TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS----
T ss_pred             HeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCc----
Confidence            4789999999999999999987655    479999986542    2367899999999999999999998765443    


Q ss_pred             EEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeeccccccccc
Q 015500           74 YNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESEA  152 (405)
Q Consensus        74 ~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~~  152 (405)
                      .++||||+.++++.+.+....+.+++..+..++.||+.||+|||++||+||||||+||||+.++ +||+|||+++.....
T Consensus        84 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~  163 (283)
T d1mqba_          84 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  163 (283)
T ss_dssp             EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred             eEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence            5689999999999999988777899999999999999999999999999999999999999988 999999999864331


Q ss_pred             -------ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHH
Q 015500          153 -------LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQA  225 (405)
Q Consensus       153 -------~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l  225 (405)
                             ....||+.|||||++.++.++.++|||||||++|||++|..||.........+..+ .....+..|..+++.+
T Consensus       164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i-~~~~~~~~~~~~~~~l  242 (283)
T d1mqba_         164 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI-NDGFRLPTPMDCPSAI  242 (283)
T ss_dssp             ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH-HTTCCCCCCTTCBHHH
T ss_pred             CccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHH-hccCCCCCchhhHHHH
Confidence                   12358999999999999999999999999999999999777765555555554444 4445566788899999


Q ss_pred             HHHHHHhcccCccccCCHHHHhc
Q 015500          226 NDFLSNCLRRDPKERWAASQLLK  248 (405)
Q Consensus       226 ~dll~~~L~~dP~~Rpt~~elL~  248 (405)
                      .+||.+||+.||++|||+.|+++
T Consensus       243 ~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         243 YQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHCcCCHhHCcCHHHHHH
Confidence            99999999999999999999987

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-53  Score=408.55  Aligned_cols=242  Identities=24%  Similarity=0.355  Sum_probs=204.3

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCC----EEEEEEccCC----ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGD----VFAAKSTELP----KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLM   73 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~----~vavK~~~~~----~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~   73 (405)
                      +|++++.||+|+||+||+|.+..+|+    .||+|.+...    ..+.+.+|+++|++++|||||++++++....     
T Consensus        10 dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~-----   84 (317)
T d1xkka_          10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-----   84 (317)
T ss_dssp             TEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSS-----
T ss_pred             HCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-----
Confidence            69999999999999999999988876    5788876532    3457899999999999999999999876432     


Q ss_pred             EEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc-
Q 015500           74 YNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE-  151 (405)
Q Consensus        74 ~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~-  151 (405)
                      .++++||+.+|+|.+.+......+++..++.++.||+.||+|||++||+||||||+|||++.++ +||+|||+|+.... 
T Consensus        85 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~  164 (317)
T d1xkka_          85 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE  164 (317)
T ss_dssp             EEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred             eeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence            4578999999999999988877899999999999999999999999999999999999999988 99999999986433 


Q ss_pred             -----cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHH
Q 015500          152 -----ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQA  225 (405)
Q Consensus       152 -----~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l  225 (405)
                           .....||+.|||||++.++.++.++|||||||++|||+| |.+||.... ... +..+...+..+..|..+++++
T Consensus       165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~-~~~-~~~~i~~~~~~~~p~~~~~~~  242 (317)
T d1xkka_         165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-ASE-ISSILEKGERLPQPPICTIDV  242 (317)
T ss_dssp             CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC-GGG-HHHHHHHTCCCCCCTTBCHHH
T ss_pred             cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCC-HHH-HHHHHHcCCCCCCCcccCHHH
Confidence                 122358999999999999999999999999999999998 788886543 223 333334455567788899999


Q ss_pred             HHHHHHhcccCccccCCHHHHhcCc
Q 015500          226 NDFLSNCLRRDPKERWAASQLLKHP  250 (405)
Q Consensus       226 ~dll~~~L~~dP~~Rpt~~elL~hp  250 (405)
                      .+||.+||..||.+|||+.|+++|.
T Consensus       243 ~~li~~cl~~dP~~RPs~~eil~~l  267 (317)
T d1xkka_         243 YMIMVKCWMIDADSRPKFRELIIEF  267 (317)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHhCCCChhhCcCHHHHHHHH
Confidence            9999999999999999999999983

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-53  Score=401.28  Aligned_cols=241  Identities=25%  Similarity=0.358  Sum_probs=197.9

Q ss_pred             CcccccccceeCCeeEEEEEEcCCC---CEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSG---DVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMY   74 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~---~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~   74 (405)
                      +|.+++.||+|+||+||+|++..++   ..||||.+....    .+.+.+|+++|++++||||+++++++..   +.  +
T Consensus         8 ~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~---~~--~   82 (273)
T d1mp8a_           8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE---NP--V   82 (273)
T ss_dssp             GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS---SS--C
T ss_pred             HeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---Ce--E
Confidence            5788999999999999999987544   468899886432    3468899999999999999999997642   12  4


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc--
Q 015500           75 NLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE--  151 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~--  151 (405)
                      ++||||+++|+|.+++....+.+++..++.++.||+.||.|||++||+||||||+||+++.++ +||+|||+|+....  
T Consensus        83 ~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~  162 (273)
T d1mp8a_          83 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST  162 (273)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred             EEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCCc
Confidence            699999999999999888777899999999999999999999999999999999999999988 99999999986443  


Q ss_pred             ---cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHH
Q 015500          152 ---ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQAND  227 (405)
Q Consensus       152 ---~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~d  227 (405)
                         .....||+.|+|||++.+..++.++|||||||++|||+| |.+||.... ......++. ....+..|..+|+++.+
T Consensus       163 ~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~-~~~~~~~i~-~~~~~~~~~~~~~~~~~  240 (273)
T d1mp8a_         163 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK-NNDVIGRIE-NGERLPMPPNCPPTLYS  240 (273)
T ss_dssp             --------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC-GGGHHHHHH-TTCCCCCCTTCCHHHHH
T ss_pred             ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCC-HHHHHHHHH-cCCCCCCCCCCCHHHHH
Confidence               223458999999999999999999999999999999998 899996543 344444444 34455678889999999


Q ss_pred             HHHHhcccCccccCCHHHHhcC
Q 015500          228 FLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       228 ll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      ||.+||..||++|||+.|+++|
T Consensus       241 li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         241 LMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHcCCCHhHCcCHHHHHHH
Confidence            9999999999999999999987

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-53  Score=402.03  Aligned_cols=246  Identities=23%  Similarity=0.305  Sum_probs=206.6

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC--hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEe
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK--SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFME   79 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~--~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (405)
                      +|++++.||+|+||+||+|+++.+ +.||||++....  .+.+.+|+.+|++++|||||++++++.. ++    +++|||
T Consensus        18 ~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~----~~lv~E   91 (285)
T d1fmka3          18 SLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP----IYIVTE   91 (285)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS----CEEEEC
T ss_pred             HEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CC----eEEEEE
Confidence            578899999999999999998654 579999987543  4679999999999999999999997632 22    458999


Q ss_pred             ecCCCCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc-----c
Q 015500           80 YAPGGTLNDEIHR-NGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE-----A  152 (405)
Q Consensus        80 y~~ggsL~~~i~~-~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~-----~  152 (405)
                      |+++|+|..++.. ..+.+++..++.++.||+.||+|||++||+||||||+||||+.++ +||+|||+|+....     .
T Consensus        92 y~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  171 (285)
T d1fmka3          92 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR  171 (285)
T ss_dssp             CCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred             ecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCCceee
Confidence            9999999988864 334799999999999999999999999999999999999999887 99999999986433     2


Q ss_pred             ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHh
Q 015500          153 LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNC  232 (405)
Q Consensus       153 ~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~  232 (405)
                      ....||+.|+|||++.+..++.++|||||||++|||+||..||.......+.+..+.. ...+..+..+++++++||.+|
T Consensus       172 ~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~-~~~~~~~~~~~~~l~~li~~c  250 (285)
T d1fmka3         172 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-GYRMPCPPECPESLHDLMCQC  250 (285)
T ss_dssp             ----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-TCCCCCCTTSCHHHHHHHHHH
T ss_pred             ccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHh-cCCCCCCcccCHHHHHHHHHH
Confidence            2356899999999999999999999999999999999987777666666666655554 344557888999999999999


Q ss_pred             cccCccccCCHHHHhc--Cccccc
Q 015500          233 LRRDPKERWAASQLLK--HPFLEE  254 (405)
Q Consensus       233 L~~dP~~Rpt~~elL~--hp~~~~  254 (405)
                      |+.||++|||++++++  |+||..
T Consensus       251 l~~dP~~Rps~~~i~~~L~~~~~~  274 (285)
T d1fmka3         251 WRKEPEERPTFEYLQAFLEDYFTS  274 (285)
T ss_dssp             TCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             cccCHhHCcCHHHHHHHHhhhhcC
Confidence            9999999999999987  677754

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-52  Score=404.56  Aligned_cols=251  Identities=26%  Similarity=0.318  Sum_probs=200.6

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC-----ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCC----Cce
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP-----KSEFLQREQKFLSSLNSPHIVGYKGCDVTSED----NKL   72 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~-----~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~----~~~   72 (405)
                      +|++++.||+|+||+||+|+++.+|+.||||++...     ....+.+|+++|++++||||+++++.+.....    ...
T Consensus        11 rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~   90 (318)
T d3blha1          11 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKG   90 (318)
T ss_dssp             GEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------
T ss_pred             CEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCc
Confidence            589999999999999999999999999999987543     23568899999999999999999988755321    122


Q ss_pred             EEEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc
Q 015500           73 MYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE  151 (405)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~  151 (405)
                      .++++|||+.++.+. .+......+++..++.+++||+.||.|||++||+||||||+|||++.++ +||+|||+++....
T Consensus        91 ~~~iv~e~~~~~~~~-~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~  169 (318)
T d3blha1          91 SIYLVFDFCEHDLAG-LLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSL  169 (318)
T ss_dssp             CEEEEEECCCEEHHH-HHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCC
T ss_pred             eEEEEEeccCCCccc-hhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeeccc
Confidence            367999999776554 4445556899999999999999999999999999999999999999888 99999999975432


Q ss_pred             --------cccCCCCCCccChhhhcCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhc-CCC-CCCc--
Q 015500          152 --------ALQSGGTPMFMAPEVARGE-HQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYS-REL-PEVP--  218 (405)
Q Consensus       152 --------~~~~~gt~~Y~APE~l~~~-~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~-~~~-~~~p--  218 (405)
                              ....+||+.|+|||++.+. .+++++|||||||++|||++|+.||.... ....+..+... ... +...  
T Consensus       170 ~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~  248 (318)
T d3blha1         170 AKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT-EQHQLALISQLCGSITPEVWPN  248 (318)
T ss_dssp             -----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHHHCCCCTTTSTT
T ss_pred             ccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCC-HHHHHHHHHHhcCCCChhhccc
Confidence                    2335699999999999865 68999999999999999999999996543 33333322211 110 0000  


Q ss_pred             --------------------------hhccHHHHHHHHHhcccCccccCCHHHHhcCccccc
Q 015500          219 --------------------------AFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEE  254 (405)
Q Consensus       219 --------------------------~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~  254 (405)
                                                ...+++++|||.+||+.||++|||++|+|+||||+.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~  310 (318)
T d3blha1         249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS  310 (318)
T ss_dssp             CCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred             cchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence                                      113678899999999999999999999999999985

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-52  Score=405.71  Aligned_cols=249  Identities=26%  Similarity=0.450  Sum_probs=209.7

Q ss_pred             CcccccccceeCCeeEEEEEEc---CCCCEEEEEEccCC-------ChHHHHHHHHHHHhCCC-CCeeeeeeeeeecCCC
Q 015500            2 DWTRGHTIGQGSSATVSLATSL---RSGDVFAAKSTELP-------KSEFLQREQKFLSSLNS-PHIVGYKGCDVTSEDN   70 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~---~~~~~vavK~~~~~-------~~~~l~~E~~iL~~L~h-pnIv~~~~~~~~~~~~   70 (405)
                      +|++++.||+|+||+||+|++.   .+|+.||||.+...       ..+.+.+|+++|++++| |||+++++.+....  
T Consensus        25 ~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~--  102 (322)
T d1vzoa_          25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET--  102 (322)
T ss_dssp             GEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT--
T ss_pred             ceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC--
Confidence            5899999999999999999874   47899999987542       34678899999999977 89999998766544  


Q ss_pred             ceEEEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccc
Q 015500           71 KLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWE  149 (405)
Q Consensus        71 ~~~~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~  149 (405)
                        .++++|||+.||+|.+++...+ .+++..++.+++||+.||+|||++||+||||||+|||++.++ +||+|||+++..
T Consensus       103 --~~~~v~e~~~~~~L~~~i~~~~-~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~  179 (322)
T d1vzoa_         103 --KLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF  179 (322)
T ss_dssp             --EEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred             --ceeeeeecccccHHHHHHHhcc-cccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence              3669999999999999998874 789999999999999999999999999999999999999888 999999999764


Q ss_pred             cc-----cccCCCCCCccChhhhcCC--CCCcchhHHHHHHHHHHHHhCCCCCCCCC--ChHHHHHHHHhcCCCCCCchh
Q 015500          150 SE-----ALQSGGTPMFMAPEVARGE--HQGFASDIWAVGCTVIEMASGGAPWPNAA--DPMTVLYKIAYSRELPEVPAF  220 (405)
Q Consensus       150 ~~-----~~~~~gt~~Y~APE~l~~~--~~~~~sDIwSLG~il~elltG~~Pf~~~~--~~~~~l~~i~~~~~~~~~p~~  220 (405)
                      ..     .....||+.|+|||.+.+.  .++.++|||||||++|+|+||+.||....  +....+.+.... ..+.+|..
T Consensus       180 ~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~-~~~~~~~~  258 (322)
T d1vzoa_         180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK-SEPPYPQE  258 (322)
T ss_dssp             CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH-CCCCCCTT
T ss_pred             cccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhccc-CCCCCccc
Confidence            33     2345699999999999764  46789999999999999999999996543  333333333322 34567778


Q ss_pred             ccHHHHHHHHHhcccCccccC-----CHHHHhcCccccccc
Q 015500          221 LSKQANDFLSNCLRRDPKERW-----AASQLLKHPFLEEFC  256 (405)
Q Consensus       221 ~s~~l~dll~~~L~~dP~~Rp-----t~~elL~hp~~~~~~  256 (405)
                      +|+++.+||++||++||.+||     |++|+|+||||+.+.
T Consensus       259 ~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~  299 (322)
T d1vzoa_         259 MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN  299 (322)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred             CCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCC
Confidence            999999999999999999999     589999999998753

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-52  Score=400.78  Aligned_cols=244  Identities=23%  Similarity=0.355  Sum_probs=195.6

Q ss_pred             CcccccccceeCCeeEEEEEEcC-----CCCEEEEEEccCCC----hHHHHHHHHHHHhC-CCCCeeeeeeeeeecCCCc
Q 015500            2 DWTRGHTIGQGSSATVSLATSLR-----SGDVFAAKSTELPK----SEFLQREQKFLSSL-NSPHIVGYKGCDVTSEDNK   71 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~-----~~~~vavK~~~~~~----~~~l~~E~~iL~~L-~hpnIv~~~~~~~~~~~~~   71 (405)
                      +|.+++.||+|+||+||+|.+..     +++.||||.+....    ...+.+|..++.++ +||||+.+++++.....  
T Consensus        14 ~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~--   91 (299)
T d1ywna1          14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG--   91 (299)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS--
T ss_pred             HEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC--
Confidence            48889999999999999999764     34689999986532    23566777777777 68999999887654332  


Q ss_pred             eEEEEEEeecCCCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccC
Q 015500           72 LMYNLFMEYAPGGTLNDEIHRNG---------------GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES  136 (405)
Q Consensus        72 ~~~~lv~Ey~~ggsL~~~i~~~~---------------~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~  136 (405)
                       .+++|||||++|+|.+++....               ..+++..++.++.||+.||.|||++||+||||||+||||+.+
T Consensus        92 -~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~  170 (299)
T d1ywna1          92 -PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK  170 (299)
T ss_dssp             -CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGG
T ss_pred             -eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCC
Confidence             2558999999999999997532               358999999999999999999999999999999999999988


Q ss_pred             C-ceEeeecccccccc------cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCC-CCCCCCCChHHHHHHH
Q 015500          137 G-AKIADFGCAKWESE------ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGG-APWPNAADPMTVLYKI  208 (405)
Q Consensus       137 ~-vkL~DFGla~~~~~------~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~-~Pf~~~~~~~~~l~~i  208 (405)
                      + +||+|||+|+....      .....||+.|||||++.+..++.++|||||||++|||+||. +||........ +.+.
T Consensus       171 ~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~-~~~~  249 (299)
T d1ywna1         171 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-FCRR  249 (299)
T ss_dssp             GCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH-HHHH
T ss_pred             CcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH-HHHH
Confidence            7 99999999975433      22346999999999999999999999999999999999974 67865544433 3444


Q ss_pred             HhcCCCCCCchhccHHHHHHHHHhcccCccccCCHHHHhcC
Q 015500          209 AYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       209 ~~~~~~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      ......+..|..+++++++||.+||+.||++|||++|+++|
T Consensus       250 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         250 LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            44555677888899999999999999999999999999998

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-52  Score=406.83  Aligned_cols=251  Identities=25%  Similarity=0.370  Sum_probs=202.9

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCC--CceEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-----SEFLQREQKFLSSLNSPHIVGYKGCDVTSED--NKLMY   74 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~--~~~~~   74 (405)
                      +|++++.||+|+||+||+|+++.+|+.||||++....     .+.+.+|+++|++|+||||+++++++.....  ... +
T Consensus        19 rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~-~   97 (348)
T d2gfsa1          19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN-D   97 (348)
T ss_dssp             TEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC-C
T ss_pred             CeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc-e
Confidence            4889999999999999999999999999999987542     2467899999999999999999988754321  112 2


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc-c
Q 015500           75 NLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE-A  152 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~-~  152 (405)
                      +++++|+.||+|.+++..  +++++..++.+++||+.||+|||++||+||||||+|||++.++ +|++|||++..... .
T Consensus        98 ~~i~~~~~gg~L~~~~~~--~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~~  175 (348)
T d2gfsa1          98 VYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM  175 (348)
T ss_dssp             CEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTGGG
T ss_pred             EEEEEeecCCchhhhccc--ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCccc
Confidence            356778889999998865  3799999999999999999999999999999999999999888 99999999976544 4


Q ss_pred             ccCCCCCCccChhhhcCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCC------------------
Q 015500          153 LQSGGTPMFMAPEVARGE-HQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRE------------------  213 (405)
Q Consensus       153 ~~~~gt~~Y~APE~l~~~-~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~------------------  213 (405)
                      ....||+.|+|||++.+. .++.++|||||||++|+|++|++||.... .......+.....                  
T Consensus       176 ~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  254 (348)
T d2gfsa1         176 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD-HIDQLKLILRLVGTPGAELLKKISSESARNY  254 (348)
T ss_dssp             SSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHHHCCCCHHHHTTCCCHHHHHH
T ss_pred             ccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCC-HHHHHHHHHHhcCCCChHHhhhccchhhhhh
Confidence            456799999999997775 56889999999999999999999996543 2222222211111                  


Q ss_pred             ---CCCC--------chhccHHHHHHHHHhcccCccccCCHHHHhcCccccccc
Q 015500          214 ---LPEV--------PAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFC  256 (405)
Q Consensus       214 ---~~~~--------p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~  256 (405)
                         .+..        ...+++++++||++||+.||.+|||++|+|+||||+++.
T Consensus       255 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~  308 (348)
T d2gfsa1         255 IQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH  308 (348)
T ss_dssp             HTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             hhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence               0111        124789999999999999999999999999999999764

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-52  Score=407.63  Aligned_cols=250  Identities=26%  Similarity=0.321  Sum_probs=196.2

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCC--CceEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-----SEFLQREQKFLSSLNSPHIVGYKGCDVTSED--NKLMY   74 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~--~~~~~   74 (405)
                      +|++++.||+|+||+||+|+++.+|+.||||++....     ...+.+|+.+|++++||||+++++++.....  ....+
T Consensus        18 ~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~   97 (355)
T d2b1pa1          18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV   97 (355)
T ss_dssp             TEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEE
T ss_pred             CeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCcee
Confidence            4889999999999999999999999999999987542     2468899999999999999999998765432  23467


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc--
Q 015500           75 NLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE--  151 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~--  151 (405)
                      |+|||||.|+.+ +.+.   ..+++..++.+++||+.||+|||++||+||||||+|||++.++ +|++|||+++....  
T Consensus        98 ~iv~Ey~~~~l~-~~~~---~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~  173 (355)
T d2b1pa1          98 YLVMELMDANLC-QVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF  173 (355)
T ss_dssp             EEEEECCSEEHH-HHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred             EEEEeccchHHH-Hhhh---cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcccccc
Confidence            799999976544 4442   4699999999999999999999999999999999999999887 99999999876443  


Q ss_pred             -cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCC-----------------
Q 015500          152 -ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRE-----------------  213 (405)
Q Consensus       152 -~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~-----------------  213 (405)
                       .....||+.|+|||++.+..+++++||||+||++|+|++|+.||...+ ......++.....                 
T Consensus       174 ~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  252 (355)
T d2b1pa1         174 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD-YIDQWNKVIEQLGTPCPEFMKKLQPTVRNY  252 (355)
T ss_dssp             -------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHHHCCCCHHHHTTSCHHHHHH
T ss_pred             ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCC-HHHHHHHHHHhccCCCHHHHHHhhhhHHHH
Confidence             334569999999999999999999999999999999999999996543 2222222211000                 


Q ss_pred             ------CC-----------------CCchhccHHHHHHHHHhcccCccccCCHHHHhcCccccccc
Q 015500          214 ------LP-----------------EVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEEFC  256 (405)
Q Consensus       214 ------~~-----------------~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~~~  256 (405)
                            ..                 ..+...++++.+||++||..||++||||+|+|+||||+...
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~  318 (355)
T d2b1pa1         253 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY  318 (355)
T ss_dssp             HHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred             hhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence                  00                 00123578899999999999999999999999999998753

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.2e-52  Score=393.16  Aligned_cols=240  Identities=26%  Similarity=0.377  Sum_probs=199.6

Q ss_pred             CcccccccceeCCeeEEEEEEcC-CC--CEEEEEEccCCC------hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCce
Q 015500            2 DWTRGHTIGQGSSATVSLATSLR-SG--DVFAAKSTELPK------SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKL   72 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~-~~--~~vavK~~~~~~------~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~   72 (405)
                      ||++.+.||+|+||+||+|++.. ++  ..||||++....      .+.+.+|+++|++++||||+++++++... .   
T Consensus         9 d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~---   84 (273)
T d1u46a_           9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-P---   84 (273)
T ss_dssp             GEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-S---
T ss_pred             HeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-c---
Confidence            58899999999999999998653 33  368999876431      35788999999999999999999987532 1   


Q ss_pred             EEEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc
Q 015500           73 MYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE  151 (405)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~  151 (405)
                       +++||||+++|+|.+++..+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++ +||+|||+++....
T Consensus        85 -~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~  163 (273)
T d1u46a_          85 -MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ  163 (273)
T ss_dssp             -CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred             -hheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence             4589999999999998887767899999999999999999999999999999999999999988 99999999986433


Q ss_pred             -------cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccH
Q 015500          152 -------ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSK  223 (405)
Q Consensus       152 -------~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~  223 (405)
                             .....||+.|+|||++.+..++.++|||||||++|||+| |+.||.. .+....+.++......++.|..+|+
T Consensus       164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~  242 (273)
T d1u46a_         164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG-LNGSQILHKIDKEGERLPRPEDCPQ  242 (273)
T ss_dssp             -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTSCCCCCCCTTCCH
T ss_pred             CCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCC-cCHHHHHHHHHhCCCCCCCcccccH
Confidence                   123457889999999999999999999999999999998 8999964 4555666677666667778888999


Q ss_pred             HHHHHHHHhcccCccccCCHHHHh
Q 015500          224 QANDFLSNCLRRDPKERWAASQLL  247 (405)
Q Consensus       224 ~l~dll~~~L~~dP~~Rpt~~elL  247 (405)
                      ++.+||++||..||++|||+++|+
T Consensus       243 ~l~~li~~cl~~dp~~RPt~~ei~  266 (273)
T d1u46a_         243 DIYNVMVQCWAHKPEDRPTFVALR  266 (273)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHH
Confidence            999999999999999999999995

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-52  Score=390.73  Aligned_cols=241  Identities=25%  Similarity=0.374  Sum_probs=200.3

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC-hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEee
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK-SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEY   80 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~-~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~Ey   80 (405)
                      +|+.++.||+|+||+||+|.++  |..||||.++.+. .+.+.+|+++|++++||||+++++++.....   .+++||||
T Consensus         8 ~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~---~~~lv~ey   82 (262)
T d1byga_           8 ELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG---GLYIVTEY   82 (262)
T ss_dssp             GEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC-----CCEEEECC
T ss_pred             HeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCC---cEEEEEec
Confidence            5788999999999999999984  7899999997654 5679999999999999999999997754332   25699999


Q ss_pred             cCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc-cccCCC
Q 015500           81 APGGTLNDEIHRNG-GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE-ALQSGG  157 (405)
Q Consensus        81 ~~ggsL~~~i~~~~-~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~-~~~~~g  157 (405)
                      +++|+|.+++..++ ..+++..++.++.||+.||.|||+.+|+||||||+|||++.++ +||+|||+++.... .....+
T Consensus        83 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~~~~~~  162 (262)
T d1byga_          83 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL  162 (262)
T ss_dssp             CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------------C
T ss_pred             cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCCCccccc
Confidence            99999999997542 3589999999999999999999999999999999999999888 99999999987544 344568


Q ss_pred             CCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHHHHhcccC
Q 015500          158 TPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRD  236 (405)
Q Consensus       158 t~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~L~~d  236 (405)
                      |+.|+|||++.+..+++++|||||||++|||+| |++||... ........+ .....+++|..+++.+.+||++||+.|
T Consensus       163 ~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~-~~~~~~~~i-~~~~~~~~~~~~~~~~~~li~~cl~~d  240 (262)
T d1byga_         163 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRV-EKGYKMDAPDGCPPAVYEVMKNCWHLD  240 (262)
T ss_dssp             CTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS-CGGGHHHHH-TTTCCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred             cccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCC-CHHHHHHHH-HcCCCCCCCccCCHHHHHHHHHHcccC
Confidence            999999999999999999999999999999998 68887543 444444444 344566788889999999999999999


Q ss_pred             ccccCCHHHHhcC
Q 015500          237 PKERWAASQLLKH  249 (405)
Q Consensus       237 P~~Rpt~~elL~h  249 (405)
                      |.+|||+.+++++
T Consensus       241 P~~Rps~~~l~~~  253 (262)
T d1byga_         241 AAMRPSFLQLREQ  253 (262)
T ss_dssp             GGGSCCHHHHHHH
T ss_pred             HhHCcCHHHHHHH
Confidence            9999999999885

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6.6e-51  Score=391.89  Aligned_cols=245  Identities=24%  Similarity=0.336  Sum_probs=206.5

Q ss_pred             CcccccccceeCCeeEEEEEEcC-----CCCEEEEEEccCCC----hHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCce
Q 015500            2 DWTRGHTIGQGSSATVSLATSLR-----SGDVFAAKSTELPK----SEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKL   72 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~-----~~~~vavK~~~~~~----~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~   72 (405)
                      +|++++.||+|+||+||+|+++.     +++.||||++....    .+.+.+|+++|++++||||+++++++.....   
T Consensus        14 ~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~---   90 (301)
T d1lufa_          14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP---   90 (301)
T ss_dssp             GCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS---
T ss_pred             HcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc---
Confidence            48889999999999999999763     56789999987543    3468899999999999999999998765443   


Q ss_pred             EEEEEEeecCCCCHHHHHHHcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCC
Q 015500           73 MYNLFMEYAPGGTLNDEIHRNG-----------------------GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSR  129 (405)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~i~~~~-----------------------~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~  129 (405)
                       .+++|||+++|+|.+++....                       ..+++..+..|+.||+.||+|||++||+||||||+
T Consensus        91 -~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~  169 (301)
T d1lufa_          91 -MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR  169 (301)
T ss_dssp             -CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred             -eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEccc
Confidence             558999999999999996532                       24889999999999999999999999999999999


Q ss_pred             CEEEccCC-ceEeeecccccccc------cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCC-CCCCCCCCh
Q 015500          130 NILMAESG-AKIADFGCAKWESE------ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGG-APWPNAADP  201 (405)
Q Consensus       130 NILi~~~~-vkL~DFGla~~~~~------~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~-~Pf~~~~~~  201 (405)
                      |||++.++ +||+|||+++....      .....||+.|+|||.+.+..++.++|||||||++|||++|. +||. ..+.
T Consensus       170 NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~-~~~~  248 (301)
T d1lufa_         170 NCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY-GMAH  248 (301)
T ss_dssp             GEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT-TSCH
T ss_pred             ceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCC-CCCH
Confidence            99999887 99999999975433      22456889999999999999999999999999999999996 5664 4455


Q ss_pred             HHHHHHHHhcCCCCCCchhccHHHHHHHHHhcccCccccCCHHHHhcCccccc
Q 015500          202 MTVLYKIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLEE  254 (405)
Q Consensus       202 ~~~l~~i~~~~~~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~~  254 (405)
                      .+....+. ....+..|..+++++.+||.+||+.||++|||+.|+++  ++++
T Consensus       249 ~e~~~~v~-~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~--~L~~  298 (301)
T d1lufa_         249 EEVIYYVR-DGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR--ILQR  298 (301)
T ss_dssp             HHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHH
T ss_pred             HHHHHHHH-cCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH--HHHH
Confidence            55555544 45567788899999999999999999999999999954  4443

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-51  Score=394.87  Aligned_cols=242  Identities=26%  Similarity=0.358  Sum_probs=204.2

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCE--EEEEEccCC----ChHHHHHHHHHHHhC-CCCCeeeeeeeeeecCCCceEE
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDV--FAAKSTELP----KSEFLQREQKFLSSL-NSPHIVGYKGCDVTSEDNKLMY   74 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~--vavK~~~~~----~~~~l~~E~~iL~~L-~hpnIv~~~~~~~~~~~~~~~~   74 (405)
                      +|++++.||+|+||+||+|+++.+|..  ||||.+...    ..+.+.+|+++|+++ +||||+++++++....    .+
T Consensus        11 ~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~----~~   86 (309)
T d1fvra_          11 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG----YL   86 (309)
T ss_dssp             GCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT----EE
T ss_pred             HcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC----ee
Confidence            578899999999999999999988875  567776432    345789999999999 7999999999887543    36


Q ss_pred             EEEEeecCCCCHHHHHHHc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-c
Q 015500           75 NLFMEYAPGGTLNDEIHRN---------------GGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-A  138 (405)
Q Consensus        75 ~lv~Ey~~ggsL~~~i~~~---------------~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-v  138 (405)
                      ++||||++||+|.++|...               .+.+++..+..++.||+.||.|||++||+||||||+|||++.++ +
T Consensus        87 ~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          87 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCE
T ss_pred             EEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCce
Confidence            7999999999999999653               35799999999999999999999999999999999999999887 9


Q ss_pred             eEeeecccccccc---cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCC-CCCCCCChHHHHHHHHhcCCC
Q 015500          139 KIADFGCAKWESE---ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGA-PWPNAADPMTVLYKIAYSREL  214 (405)
Q Consensus       139 kL~DFGla~~~~~---~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~-Pf~~~~~~~~~l~~i~~~~~~  214 (405)
                      ||+|||+++....   .....||+.|+|||.+.+..++.++|||||||++|||++|.. ||. ..+.......+ .....
T Consensus       167 kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~-~~~~~~~~~~i-~~~~~  244 (309)
T d1fvra_         167 KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC-GMTCAELYEKL-PQGYR  244 (309)
T ss_dssp             EECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTT-TCCHHHHHHHG-GGTCC
T ss_pred             EEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCC-CCCHHHHHHHH-HhcCC
Confidence            9999999976544   234569999999999999999999999999999999999765 564 44444444443 44556


Q ss_pred             CCCchhccHHHHHHHHHhcccCccccCCHHHHhcC
Q 015500          215 PEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       215 ~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      +..|..+++++++||.+||..||++|||++++++|
T Consensus       245 ~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         245 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            77888899999999999999999999999999988

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-50  Score=388.19  Aligned_cols=241  Identities=25%  Similarity=0.408  Sum_probs=199.9

Q ss_pred             CcccccccceeCCeeEEEEEEcCCC-------CEEEEEEccCCCh----HHHHHHHHHHHhC-CCCCeeeeeeeeeecCC
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSG-------DVFAAKSTELPKS----EFLQREQKFLSSL-NSPHIVGYKGCDVTSED   69 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~-------~~vavK~~~~~~~----~~l~~E~~iL~~L-~hpnIv~~~~~~~~~~~   69 (405)
                      +|.+++.||+|+||.||+|++..++       ..||||.+.....    ..+.+|...+.++ +|||||++++++.....
T Consensus        14 ~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~   93 (299)
T d1fgka_          14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP   93 (299)
T ss_dssp             GEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCe
Confidence            4788999999999999999987655       3799999876432    4677888888888 89999999998865433


Q ss_pred             CceEEEEEEeecCCCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEc
Q 015500           70 NKLMYNLFMEYAPGGTLNDEIHRNG---------------GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMA  134 (405)
Q Consensus        70 ~~~~~~lv~Ey~~ggsL~~~i~~~~---------------~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~  134 (405)
                          .++||||+++|+|.++|..+.               ..+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus        94 ----~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~  169 (299)
T d1fgka_          94 ----LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT  169 (299)
T ss_dssp             ----CEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred             ----EEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeec
Confidence                558999999999999997542               3589999999999999999999999999999999999999


Q ss_pred             cCC-ceEeeecccccccc------cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHH
Q 015500          135 ESG-AKIADFGCAKWESE------ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMAS-GGAPWPNAADPMTVLY  206 (405)
Q Consensus       135 ~~~-vkL~DFGla~~~~~------~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~l~  206 (405)
                      .++ +||+|||+++....      .....||+.|+|||.+.++.+++++|||||||++|||++ |.+||... .... +.
T Consensus       170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~-~~~~-~~  247 (299)
T d1fgka_         170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEE-LF  247 (299)
T ss_dssp             TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-CHHH-HH
T ss_pred             CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCC-CHHH-HH
Confidence            987 99999999986544      223468999999999999999999999999999999998 68888543 3333 44


Q ss_pred             HHHhcCCCCCCchhccHHHHHHHHHhcccCccccCCHHHHhc
Q 015500          207 KIAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLK  248 (405)
Q Consensus       207 ~i~~~~~~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~  248 (405)
                      ........+..|..+++++++||.+||+.||.+|||+.|+++
T Consensus       248 ~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         248 KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             HHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            444456667888899999999999999999999999999987

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-50  Score=389.62  Aligned_cols=243  Identities=27%  Similarity=0.324  Sum_probs=205.8

Q ss_pred             CcccccccceeCCeeEEEEEEc-----CCCCEEEEEEccCCC----hHHHHHHHHHHHhC-CCCCeeeeeeeeeecCCCc
Q 015500            2 DWTRGHTIGQGSSATVSLATSL-----RSGDVFAAKSTELPK----SEFLQREQKFLSSL-NSPHIVGYKGCDVTSEDNK   71 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~-----~~~~~vavK~~~~~~----~~~l~~E~~iL~~L-~hpnIv~~~~~~~~~~~~~   71 (405)
                      +|.+++.||+|+||+||+|++.     .+++.||||.+....    ...+.+|+.+++++ +|||||++++++.....  
T Consensus        24 ~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~--  101 (311)
T d1t46a_          24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP--  101 (311)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS--
T ss_pred             HeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE--
Confidence            3567999999999999999864     456799999987543    34678999999999 69999999998765443  


Q ss_pred             eEEEEEEeecCCCCHHHHHHHcC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEc
Q 015500           72 LMYNLFMEYAPGGTLNDEIHRNG-----------------GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMA  134 (405)
Q Consensus        72 ~~~~lv~Ey~~ggsL~~~i~~~~-----------------~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~  134 (405)
                        ++++||||++|+|.+++.+..                 ..+++..+..++.||+.||+|||++|++||||||+||+++
T Consensus       102 --~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~  179 (311)
T d1t46a_         102 --TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT  179 (311)
T ss_dssp             --CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE
T ss_pred             --EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccccc
Confidence              569999999999999997642                 2589999999999999999999999999999999999999


Q ss_pred             cCC-ceEeeeccccccccc------ccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHH
Q 015500          135 ESG-AKIADFGCAKWESEA------LQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYK  207 (405)
Q Consensus       135 ~~~-vkL~DFGla~~~~~~------~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~  207 (405)
                      .++ +||+|||+++.....      ....||+.|+|||++.+..++.++|||||||++|||+|+..||.........+.+
T Consensus       180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~  259 (311)
T d1t46a_         180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK  259 (311)
T ss_dssp             TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHH
T ss_pred             ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            888 999999999865431      2345899999999999999999999999999999999954444344444455555


Q ss_pred             HHhcCCCCCCchhccHHHHHHHHHhcccCccccCCHHHHhc
Q 015500          208 IAYSRELPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLK  248 (405)
Q Consensus       208 i~~~~~~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~  248 (405)
                      +......+..|..+++++.+||.+||+.||++|||++|+++
T Consensus       260 ~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         260 MIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             HHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            55566667788889999999999999999999999999986

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-50  Score=387.05  Aligned_cols=240  Identities=21%  Similarity=0.292  Sum_probs=201.2

Q ss_pred             ccccceeCCeeEEEEEEcCCC---CEEEEEEccCC----ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEE
Q 015500            6 GHTIGQGSSATVSLATSLRSG---DVFAAKSTELP----KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFM   78 (405)
Q Consensus         6 ~~~LG~G~~g~Vyla~~~~~~---~~vavK~~~~~----~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~   78 (405)
                      .++||+|+||+||+|++..++   ..||||.++..    ..+.+.+|+++|++++||||++++|++...+.   .+++||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~---~~~lv~  108 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG---SPLVVL  108 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTT---EEEEEE
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCC---ceEEEE
Confidence            568999999999999986644   36899998643    23568999999999999999999998765443   356999


Q ss_pred             eecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEeeecccccccc------
Q 015500           79 EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIADFGCAKWESE------  151 (405)
Q Consensus        79 Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~DFGla~~~~~------  151 (405)
                      |||++|+|.+++......+++..+..++.|++.||.|||+.||+||||||+|||++.++ +||+|||+++....      
T Consensus       109 E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~  188 (311)
T d1r0pa_         109 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV  188 (311)
T ss_dssp             ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred             EEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence            99999999999987777889999999999999999999999999999999999999887 99999999986433      


Q ss_pred             --cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHhcCCCCCCchhccHHHHHHH
Q 015500          152 --ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTVLYKIAYSRELPEVPAFLSKQANDFL  229 (405)
Q Consensus       152 --~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~l~~i~~~~~~~~~p~~~s~~l~dll  229 (405)
                        .....||+.|+|||.+.+..++.++|||||||++|||+||+.||....+.......+. ....+..|..+++++.+||
T Consensus       189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~-~g~~~~~p~~~~~~l~~li  267 (311)
T d1r0pa_         189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLLQPEYCPDPLYEVM  267 (311)
T ss_dssp             TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHH-TTCCCCCCTTCCHHHHHHH
T ss_pred             eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCCCcccCcHHHHHHH
Confidence              1124589999999999999999999999999999999998888865554444444443 3455677888999999999


Q ss_pred             HHhcccCccccCCHHHHhcC
Q 015500          230 SNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       230 ~~~L~~dP~~Rpt~~elL~h  249 (405)
                      .+||+.||++|||+.|+++|
T Consensus       268 ~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         268 LKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             HHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHcCCCHhHCcCHHHHHHH
Confidence            99999999999999999988

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6.1e-50  Score=384.21  Aligned_cols=248  Identities=21%  Similarity=0.277  Sum_probs=198.6

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC-ChHHHHHHHHHHHhCCCCCeeeeeeeeeecCCCceEEEEEEee
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP-KSEFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKLMYNLFMEY   80 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~-~~~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~Ey   80 (405)
                      .|++++.||+|+||+||+|++..+|+.||||++... ..+.+.+|+++++.++|+|++..+..+....+   .+++||||
T Consensus         8 rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~---~~~ivme~   84 (299)
T d1ckia_           8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGD---YNVMVMEL   84 (299)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETT---EEEEEEEC
T ss_pred             EEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEecCC---EEEEEEEE
Confidence            488999999999999999999999999999987653 34578999999999988776665544433332   36689999


Q ss_pred             cCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccC---C-ceEeeecccccccc-----
Q 015500           81 APGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAES---G-AKIADFGCAKWESE-----  151 (405)
Q Consensus        81 ~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~---~-vkL~DFGla~~~~~-----  151 (405)
                      + +++|.+.+...++.+++..+..++.|++.||+|||++||+||||||+|||++..   . +||+|||+|+....     
T Consensus        85 ~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~  163 (299)
T d1ckia_          85 L-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ  163 (299)
T ss_dssp             C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCC
T ss_pred             c-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccccccc
Confidence            9 668888887777789999999999999999999999999999999999998643   2 99999999986433     


Q ss_pred             ------cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHH--HH---HHHhcCCCCCCchh
Q 015500          152 ------ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADPMTV--LY---KIAYSRELPEVPAF  220 (405)
Q Consensus       152 ------~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~~~~--l~---~i~~~~~~~~~p~~  220 (405)
                            .....||+.|||||++.+..+++++|||||||++|||+||+.||.........  ..   ........+..+..
T Consensus       164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (299)
T d1ckia_         164 HIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKG  243 (299)
T ss_dssp             BCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHTTT
T ss_pred             ceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhccC
Confidence                  12346999999999999999999999999999999999999999754432211  11   11112222334456


Q ss_pred             ccHHHHHHHHHhcccCccccCCHHHH---hcCcccc
Q 015500          221 LSKQANDFLSNCLRRDPKERWAASQL---LKHPFLE  253 (405)
Q Consensus       221 ~s~~l~dll~~~L~~dP~~Rpt~~el---L~hp~~~  253 (405)
                      +|+++.+||++||+.||++||+++++   |+|+|.+
T Consensus       244 ~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~  279 (299)
T d1ckia_         244 YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  279 (299)
T ss_dssp             SCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence            89999999999999999999998754   6666554

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-49  Score=384.69  Aligned_cols=241  Identities=23%  Similarity=0.298  Sum_probs=204.1

Q ss_pred             CcccccccceeCCeeEEEEEEcC-----CCCEEEEEEccCCCh----HHHHHHHHHHHhCCCCCeeeeeeeeeecCCCce
Q 015500            2 DWTRGHTIGQGSSATVSLATSLR-----SGDVFAAKSTELPKS----EFLQREQKFLSSLNSPHIVGYKGCDVTSEDNKL   72 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~-----~~~~vavK~~~~~~~----~~l~~E~~iL~~L~hpnIv~~~~~~~~~~~~~~   72 (405)
                      +|..++.||+|+||+||+|.++.     ++..||||.+.....    ..+.+|++++++++||||+++++++.....   
T Consensus        21 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~---   97 (308)
T d1p4oa_          21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP---   97 (308)
T ss_dssp             GEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS---
T ss_pred             HeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCc---
Confidence            46788999999999999998863     357899999875432    357899999999999999999998765443   


Q ss_pred             EEEEEEeecCCCCHHHHHHHcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCC-ceEee
Q 015500           73 MYNLFMEYAPGGTLNDEIHRNG---------GRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESG-AKIAD  142 (405)
Q Consensus        73 ~~~lv~Ey~~ggsL~~~i~~~~---------~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~-vkL~D  142 (405)
                       +++||||+++|+|.+++....         ..+++..+..++.||+.||.|||+++|+||||||+|||++.++ +||+|
T Consensus        98 -~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~D  176 (308)
T d1p4oa_          98 -TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGD  176 (308)
T ss_dssp             -CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECC
T ss_pred             -eeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEee
Confidence             568999999999999986431         2478999999999999999999999999999999999999987 99999


Q ss_pred             ecccccccc------cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCC-CCCCCCCChHHHHHHHHhcCCCC
Q 015500          143 FGCAKWESE------ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGG-APWPNAADPMTVLYKIAYSRELP  215 (405)
Q Consensus       143 FGla~~~~~------~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~-~Pf~~~~~~~~~l~~i~~~~~~~  215 (405)
                      ||+|+....      .....||+.|+|||.+.+..++.++|||||||++|||+||. +||.. .+....+..+. ....+
T Consensus       177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~-~~~~~~~~~i~-~~~~~  254 (308)
T d1p4oa_         177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG-LSNEQVLRFVM-EGGLL  254 (308)
T ss_dssp             TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT-SCHHHHHHHHH-TTCCC
T ss_pred             cccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCC-CCHHHHHHHHH-hCCCC
Confidence            999986443      22335899999999999999999999999999999999985 66744 44455555444 44566


Q ss_pred             CCchhccHHHHHHHHHhcccCccccCCHHHHhc
Q 015500          216 EVPAFLSKQANDFLSNCLRRDPKERWAASQLLK  248 (405)
Q Consensus       216 ~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~  248 (405)
                      ..|..+++.+.++|.+||+.||++|||+.++++
T Consensus       255 ~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~  287 (308)
T d1p4oa_         255 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS  287 (308)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            778889999999999999999999999999988

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-48  Score=376.56  Aligned_cols=244  Identities=23%  Similarity=0.281  Sum_probs=196.5

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCCChHHHHHHHH--HHHhCCCCCeeeeeeeeeecCCCceEEEEEEe
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPKSEFLQREQK--FLSSLNSPHIVGYKGCDVTSEDNKLMYNLFME   79 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~~~~l~~E~~--iL~~L~hpnIv~~~~~~~~~~~~~~~~~lv~E   79 (405)
                      +|...+.||+|+||+||+|++  +|+.||||++.........+|.+  .++.++||||+++++++.........+++|||
T Consensus         4 ~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~E   81 (303)
T d1vjya_           4 TIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD   81 (303)
T ss_dssp             GEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEe
Confidence            477889999999999999986  58999999987766555555554  45678999999999998887766667789999


Q ss_pred             ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh--------CCceeCCCCCCCEEEccCC-ceEeeeccccccc
Q 015500           80 YAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHS--------NRVVHCDIKSRNILMAESG-AKIADFGCAKWES  150 (405)
Q Consensus        80 y~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~--------~givHrDlkp~NILi~~~~-vkL~DFGla~~~~  150 (405)
                      ||++|+|.+++++.  ++++..+..++.|++.||.|||+        +||+||||||+||||+.++ +||+|||+++...
T Consensus        82 y~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~  159 (303)
T d1vjya_          82 YHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD  159 (303)
T ss_dssp             CCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred             cccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccccc
Confidence            99999999999875  59999999999999999999996        5999999999999999887 9999999998643


Q ss_pred             c--------cccCCCCCCccChhhhcCCC------CCcchhHHHHHHHHHHHHhCCCCCCCCC-------------ChHH
Q 015500          151 E--------ALQSGGTPMFMAPEVARGEH------QGFASDIWAVGCTVIEMASGGAPWPNAA-------------DPMT  203 (405)
Q Consensus       151 ~--------~~~~~gt~~Y~APE~l~~~~------~~~~sDIwSLG~il~elltG~~Pf~~~~-------------~~~~  203 (405)
                      .        .....||+.|||||++.+..      ++.++|||||||++|||+||..||....             ....
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~  239 (303)
T d1vjya_         160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE  239 (303)
T ss_dssp             TTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHH
T ss_pred             CCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHH
Confidence            3        22356999999999998653      4668999999999999999998874221             1122


Q ss_pred             HHHHHHhc-CCCCCCchh-----ccHHHHHHHHHhcccCccccCCHHHHhcC
Q 015500          204 VLYKIAYS-RELPEVPAF-----LSKQANDFLSNCLRRDPKERWAASQLLKH  249 (405)
Q Consensus       204 ~l~~i~~~-~~~~~~p~~-----~s~~l~dll~~~L~~dP~~Rpt~~elL~h  249 (405)
                      .+...... ...|.+|..     .+..+.+|+.+||+.||++|||+.|++++
T Consensus       240 ~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~  291 (303)
T d1vjya_         240 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             HHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            22332222 233444433     34568999999999999999999999875

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=4.3e-48  Score=370.81  Aligned_cols=242  Identities=19%  Similarity=0.241  Sum_probs=201.6

Q ss_pred             CcccccccceeCCeeEEEEEEcCCCCEEEEEEccCC-ChHHHHHHHHHHHhCCC-CCeeeeeeeeeecCCCceEEEEEEe
Q 015500            2 DWTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP-KSEFLQREQKFLSSLNS-PHIVGYKGCDVTSEDNKLMYNLFME   79 (405)
Q Consensus         2 ~y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~-~~~~l~~E~~iL~~L~h-pnIv~~~~~~~~~~~~~~~~~lv~E   79 (405)
                      +|++++.||+|+||+||+|++..+|+.||||++... ....+.+|+++++.|.| |||+.+++++....    .+++|||
T Consensus         6 ~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~----~~~~vme   81 (293)
T d1csna_           6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGL----HNVLVID   81 (293)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETT----EEEEEEE
T ss_pred             ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCC----ccEEEEE
Confidence            599999999999999999999999999999987643 34578999999999976 89999988765433    3679999


Q ss_pred             ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcc-----CC-ceEeeecccccccc--
Q 015500           80 YAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAE-----SG-AKIADFGCAKWESE--  151 (405)
Q Consensus        80 y~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~-----~~-vkL~DFGla~~~~~--  151 (405)
                      |+ |++|.+++...+..+++..+..++.|++.||+|||++||+||||||+|||++.     ++ +||+|||+|+....  
T Consensus        82 ~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~  160 (293)
T d1csna_          82 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV  160 (293)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred             ec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCc
Confidence            99 78999999887778999999999999999999999999999999999999964     23 99999999986432  


Q ss_pred             ---------cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC--hHHHHHHHHhc---CCCCCC
Q 015500          152 ---------ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAAD--PMTVLYKIAYS---RELPEV  217 (405)
Q Consensus       152 ---------~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~--~~~~l~~i~~~---~~~~~~  217 (405)
                               .....||+.|||||++.+..+++++|||||||++|||+||+.||.....  ......++...   ...+++
T Consensus       161 ~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l  240 (293)
T d1csna_         161 TKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL  240 (293)
T ss_dssp             TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHH
T ss_pred             cccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHh
Confidence                     2234699999999999999999999999999999999999999975432  33333332221   122234


Q ss_pred             chhccHHHHHHHHHhcccCccccCCHHHHhc
Q 015500          218 PAFLSKQANDFLSNCLRRDPKERWAASQLLK  248 (405)
Q Consensus       218 p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~  248 (405)
                      +..+|+++.+|+..|+..+|++||+++.+.+
T Consensus       241 ~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         241 CAGFPEEFYKYMHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             cCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence            4568899999999999999999999887744

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.1e-47  Score=375.08  Aligned_cols=252  Identities=27%  Similarity=0.363  Sum_probs=196.1

Q ss_pred             cccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC--hHHHHHHHHHHHhCC-----------CCCeeeeeeeeeecCC
Q 015500            3 WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK--SEFLQREQKFLSSLN-----------SPHIVGYKGCDVTSED   69 (405)
Q Consensus         3 y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~--~~~l~~E~~iL~~L~-----------hpnIv~~~~~~~~~~~   69 (405)
                      |++++.||+|+||+||+|+++.+|+.||||++....  .+.+.+|+++|+.+.           ||||+++++++.....
T Consensus        15 Y~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~   94 (362)
T d1q8ya_          15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGP   94 (362)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEET
T ss_pred             EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccc
Confidence            999999999999999999999999999999998653  356788999998875           4789999988766555


Q ss_pred             CceEEEEEEeecCCCCH--HHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCCEEEccCC-------ce
Q 015500           70 NKLMYNLFMEYAPGGTL--NDEIHRNGGRLDESLIVSYTRQILQGLEYLHS-NRVVHCDIKSRNILMAESG-------AK  139 (405)
Q Consensus        70 ~~~~~~lv~Ey~~ggsL--~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~-~givHrDlkp~NILi~~~~-------vk  139 (405)
                      ...+  ++|+++.++..  ..........+++..++.+++||+.||+|||+ .||+||||||+||||+.++       +|
T Consensus        95 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~k  172 (362)
T d1q8ya_          95 NGVH--VVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIK  172 (362)
T ss_dssp             TEEE--EEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEE
T ss_pred             ccee--eeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceee
Confidence            4444  45555444332  22333344579999999999999999999998 8999999999999997542       79


Q ss_pred             Eeeecccccccc-cccCCCCCCccChhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCh-----HHHHHHHH-hcC
Q 015500          140 IADFGCAKWESE-ALQSGGTPMFMAPEVARGEHQGFASDIWAVGCTVIEMASGGAPWPNAADP-----MTVLYKIA-YSR  212 (405)
Q Consensus       140 L~DFGla~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~sDIwSLG~il~elltG~~Pf~~~~~~-----~~~l~~i~-~~~  212 (405)
                      ++|||.+..... .....||+.|+|||++.+..+++++|||||||++++|++|+.||......     ...+.... ...
T Consensus       173 l~dfg~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg  252 (362)
T d1q8ya_         173 IADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLG  252 (362)
T ss_dssp             ECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHC
T ss_pred             EeecccccccccccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhC
Confidence            999999986544 44567999999999999999999999999999999999999999643221     11111110 000


Q ss_pred             ------------------------C---------------CCCCchhccHHHHHHHHHhcccCccccCCHHHHhcCcccc
Q 015500          213 ------------------------E---------------LPEVPAFLSKQANDFLSNCLRRDPKERWAASQLLKHPFLE  253 (405)
Q Consensus       213 ------------------------~---------------~~~~p~~~s~~l~dll~~~L~~dP~~Rpt~~elL~hp~~~  253 (405)
                                              .               ....+...+++++|||.+||+.||.+|||++|+|+||||+
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~  332 (362)
T d1q8ya_         253 ELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLK  332 (362)
T ss_dssp             SCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGT
T ss_pred             CCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcccC
Confidence                                    0               1112344678899999999999999999999999999998


Q ss_pred             ccc
Q 015500          254 EFC  256 (405)
Q Consensus       254 ~~~  256 (405)
                      +..
T Consensus       333 ~~~  335 (362)
T d1q8ya_         333 DTL  335 (362)
T ss_dssp             TCT
T ss_pred             CCC
Confidence            653

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.92  E-value=3.3e-26  Score=204.11  Aligned_cols=162  Identities=18%  Similarity=0.128  Sum_probs=120.7

Q ss_pred             cccccccceeCCeeEEEEEEcCCCCEEEEEEccCCC---------------------hHHHHHHHHHHHhCCCCCeeeee
Q 015500            3 WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELPK---------------------SEFLQREQKFLSSLNSPHIVGYK   61 (405)
Q Consensus         3 y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~~---------------------~~~l~~E~~iL~~L~hpnIv~~~   61 (405)
                      +.+++.||+|+||+||+|.+. +|+.||||++....                     .....+|...|.++.|++++..+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            568999999999999999985 78999999764311                     12345688999999999998876


Q ss_pred             eeeeecCCCceEEEEEEeecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEccCCceEe
Q 015500           62 GCDVTSEDNKLMYNLFMEYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHSNRVVHCDIKSRNILMAESGAKIA  141 (405)
Q Consensus        62 ~~~~~~~~~~~~~~lv~Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~~givHrDlkp~NILi~~~~vkL~  141 (405)
                      +..   .     .+++|||+++..+.        .+++..+..++.||+.+|+|||++||+||||||+|||++.++++|+
T Consensus        81 ~~~---~-----~~lvme~~~~~~~~--------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~~~li  144 (191)
T d1zara2          81 AWE---G-----NAVLMELIDAKELY--------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEGIWII  144 (191)
T ss_dssp             EEE---T-----TEEEEECCCCEEGG--------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTEEEEC
T ss_pred             Eec---C-----CEEEEEeecccccc--------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCCEEEE
Confidence            532   1     14899999886654        2555667789999999999999999999999999999998889999


Q ss_pred             eecccccccccccCCCCCCccChh--h---hcCCCCCcchhHHHHHHHH
Q 015500          142 DFGCAKWESEALQSGGTPMFMAPE--V---ARGEHQGFASDIWAVGCTV  185 (405)
Q Consensus       142 DFGla~~~~~~~~~~gt~~Y~APE--~---l~~~~~~~~sDIwSLG~il  185 (405)
                      |||+|......    ....|....  .   .....|+.++|+||+.--+
T Consensus       145 DFG~a~~~~~~----~~~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         145 DFPQSVEVGEE----GWREILERDVRNIITYFSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             CCTTCEETTST----THHHHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred             ECCCcccCCCC----CcHHHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence            99998643321    111122111  0   1124578899999975443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.16  E-value=5.7e-06  Score=74.28  Aligned_cols=134  Identities=16%  Similarity=0.130  Sum_probs=81.3

Q ss_pred             cccccccceeCCeeEEEEEEcCCCCEEEEEEccCC---ChHHHHHHHHHHHhCC-CCCeeeeeeeeeecCCCceEEEEEE
Q 015500            3 WTRGHTIGQGSSATVSLATSLRSGDVFAAKSTELP---KSEFLQREQKFLSSLN-SPHIVGYKGCDVTSEDNKLMYNLFM   78 (405)
Q Consensus         3 y~~~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~~---~~~~l~~E~~iL~~L~-hpnIv~~~~~~~~~~~~~~~~~lv~   78 (405)
                      |+..+..+-++.+.||+..  ..++.+++|.....   ....+.+|..+|..|. +--+.+++......  +  ..++||
T Consensus        16 ~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~--~--~~~lv~   89 (263)
T d1j7la_          16 YRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHD--G--WSNLLM   89 (263)
T ss_dssp             SEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEET--T--EEEEEE
T ss_pred             eEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecC--C--ceEEEE
Confidence            4444444434446899875  35667788876532   3456889999988774 21133343332222  2  245899


Q ss_pred             eecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q 015500           79 EYAPGGTLNDEIHRNGGRLDESLIVSYTRQILQGLEYLHS----------------------------------------  118 (405)
Q Consensus        79 Ey~~ggsL~~~i~~~~~~l~e~~~~~i~~qIl~~L~yLH~----------------------------------------  118 (405)
                      ++++|.++.+.....      .....++.++...+..||+                                        
T Consensus        90 ~~l~G~~~~~~~~~~------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (263)
T d1j7la_          90 SEADGVLCSEEYEDE------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP  163 (263)
T ss_dssp             ECCSSEEHHHHTTTC------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCS
T ss_pred             Eeccccccccccccc------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccccccc
Confidence            999998776543211      1112233344444444441                                        


Q ss_pred             -------------------CCceeCCCCCCCEEEccCCc-eEeeeccccc
Q 015500          119 -------------------NRVVHCDIKSRNILMAESGA-KIADFGCAKW  148 (405)
Q Consensus       119 -------------------~givHrDlkp~NILi~~~~v-kL~DFGla~~  148 (405)
                                         ..++|+|+.|.|||++++++ -|+||+.+..
T Consensus       164 ~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             CSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             chHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                               13799999999999998774 6999998863

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.95  E-value=8.7e-06  Score=72.64  Aligned_cols=74  Identities=22%  Similarity=0.130  Sum_probs=49.8

Q ss_pred             ccceeCC-eeEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHhCCCCC--eeeeeeeeeecCCCceEEEEEEeecCCC
Q 015500            8 TIGQGSS-ATVSLATSLRSGDVFAAKSTELPKSEFLQREQKFLSSLNSPH--IVGYKGCDVTSEDNKLMYNLFMEYAPGG   84 (405)
Q Consensus         8 ~LG~G~~-g~Vyla~~~~~~~~vavK~~~~~~~~~l~~E~~iL~~L~hpn--Iv~~~~~~~~~~~~~~~~~lv~Ey~~gg   84 (405)
                      .+..|.. +.||+... .++..+++|.........+.+|..+|+.|...+  +.+++.....  .+.  .+++|++++|.
T Consensus        17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~--~~~--~~~v~~~i~G~   91 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTE--AGR--DWLLLGEVPGQ   91 (255)
T ss_dssp             ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC--SSC--EEEEEECCSSE
T ss_pred             EcCCcccCCeEEEEEe-CCCCEEEEEeCCccCHhHHHHHHHHHHHHHhcCCCCCceeeeccc--ccc--eEEEEEeeecc
Confidence            4455554 57898875 456778999887777778999999998884433  3344443322  222  45899999886


Q ss_pred             CH
Q 015500           85 TL   86 (405)
Q Consensus        85 sL   86 (405)
                      ++
T Consensus        92 ~~   93 (255)
T d1nd4a_          92 DL   93 (255)
T ss_dssp             ET
T ss_pred             cc
Confidence            54

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.95  E-value=1.5e-05  Score=76.52  Aligned_cols=75  Identities=15%  Similarity=0.011  Sum_probs=46.9

Q ss_pred             ccccceeCCeeEEEEEEcCCCCEEEEEEccC------C----ChHHHHHHHHHHHhCC-C-C-CeeeeeeeeeecCCCce
Q 015500            6 GHTIGQGSSATVSLATSLRSGDVFAAKSTEL------P----KSEFLQREQKFLSSLN-S-P-HIVGYKGCDVTSEDNKL   72 (405)
Q Consensus         6 ~~~LG~G~~g~Vyla~~~~~~~~vavK~~~~------~----~~~~l~~E~~iL~~L~-h-p-nIv~~~~~~~~~~~~~~   72 (405)
                      .+.||.|....||++.+..+++.++||....      +    ..++..+|..+|+.+. + | .+.+++.+  ..+.   
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~---  105 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEM---  105 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTT---
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCC---
Confidence            4578999999999998877788999996432      1    2345677888888772 2 3 34445433  2222   


Q ss_pred             EEEEEEeecCCCCH
Q 015500           73 MYNLFMEYAPGGTL   86 (405)
Q Consensus        73 ~~~lv~Ey~~ggsL   86 (405)
                       ..++||++++..+
T Consensus       106 -~~lvmE~L~~~~~  118 (392)
T d2pula1         106 -AVTVMEDLSHLKI  118 (392)
T ss_dssp             -TEEEECCCTTSEE
T ss_pred             -CEEEEeccCCccc
Confidence             2379999987543

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.52  E-value=0.0025  Score=58.70  Aligned_cols=129  Identities=16%  Similarity=0.227  Sum_probs=72.5

Q ss_pred             eeEEEEEEcCCCCEEEEEEccCC--ChHHHHHHHHHHHhCCCCCe-----eeeeeeeeecCCCceEEEEEEeecCCCCHH
Q 015500           15 ATVSLATSLRSGDVFAAKSTELP--KSEFLQREQKFLSSLNSPHI-----VGYKGCDVTSEDNKLMYNLFMEYAPGGTLN   87 (405)
Q Consensus        15 g~Vyla~~~~~~~~vavK~~~~~--~~~~l~~E~~iL~~L~hpnI-----v~~~~~~~~~~~~~~~~~lv~Ey~~ggsL~   87 (405)
                      -.||++.. .+|+.+++|+....  ..+.+..|...|..|..-++     +..-+-.....  ...++.++++++|..+.
T Consensus        36 N~vy~v~~-~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~--~~~~~~l~~~~~G~~~~  112 (325)
T d1zyla1          36 NRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNH--QGFYFAVFPSVGGRQFE  112 (325)
T ss_dssp             SEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEE--TTEEEEEEECCCCEECC
T ss_pred             ceeEEEEc-CCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeee--eeEEEEEEeecCCcCCC
Confidence            37999975 57888999998754  45778899999888743222     22211111111  12456789998774221


Q ss_pred             -----H------HH---HH--cC------CC-------------------CCHHHHHHHHHHHHHHHHHHHh-------C
Q 015500           88 -----D------EI---HR--NG------GR-------------------LDESLIVSYTRQILQGLEYLHS-------N  119 (405)
Q Consensus        88 -----~------~i---~~--~~------~~-------------------l~e~~~~~i~~qIl~~L~yLH~-------~  119 (405)
                           .      .+   ..  ..      ..                   ++......+...+-..++.+..       .
T Consensus       113 ~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~  192 (325)
T d1zyla1         113 ADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTV  192 (325)
T ss_dssp             SSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCC
T ss_pred             CCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCc
Confidence                 1      11   00  00      01                   1111111222222233333322       3


Q ss_pred             CceeCCCCCCCEEEccCCceEeeecccc
Q 015500          120 RVVHCDIKSRNILMAESGAKIADFGCAK  147 (405)
Q Consensus       120 givHrDlkp~NILi~~~~vkL~DFGla~  147 (405)
                      +++|+|+.+.|||+++ +..++||+-+.
T Consensus       193 ~liHgDlh~~NvL~~~-~~~~IDFdd~~  219 (325)
T d1zyla1         193 LRLHGDCHAGNILWRD-GPMFVDLDDAR  219 (325)
T ss_dssp             EECCSSCSGGGEEESS-SEEECCCTTCC
T ss_pred             eeecCCCCcccEEEeC-CceEEechhcc
Confidence            6899999999999974 45689999876

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.27  E-value=0.0054  Score=57.94  Aligned_cols=73  Identities=19%  Similarity=0.161  Sum_probs=47.6

Q ss_pred             ccccceeCCeeEEEEEEcC-------CCCEEEEEEccCC-ChHHHHHHHHHHHhCCCCCee-eeeeeeeecCCCceEEEE
Q 015500            6 GHTIGQGSSATVSLATSLR-------SGDVFAAKSTELP-KSEFLQREQKFLSSLNSPHIV-GYKGCDVTSEDNKLMYNL   76 (405)
Q Consensus         6 ~~~LG~G~~g~Vyla~~~~-------~~~~vavK~~~~~-~~~~l~~E~~iL~~L~hpnIv-~~~~~~~~~~~~~~~~~l   76 (405)
                      ++.|+-|-.-.+|++....       ..+.+.+++.... ..-...+|..+++.+.-.++. ++++++   .+     .+
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~---~~-----g~  118 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIF---SG-----GR  118 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEE---TT-----EE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEc---CC-----ce
Confidence            4567778888999998653       3467888876532 334566899999888543443 455443   22     26


Q ss_pred             EEeecCCCCH
Q 015500           77 FMEYAPGGTL   86 (405)
Q Consensus        77 v~Ey~~ggsL   86 (405)
                      |+||++|.+|
T Consensus       119 I~efi~g~~l  128 (395)
T d1nw1a_         119 LEEYIPSRPL  128 (395)
T ss_dssp             EECCCCEEEC
T ss_pred             EEEEeccccC
Confidence            8999987543

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=95.83  E-value=0.0076  Score=54.73  Aligned_cols=136  Identities=17%  Similarity=0.132  Sum_probs=70.5

Q ss_pred             ccceeCCeeEEEEEEcCCCCEEEEEEccCC-ChHHHHHHHHHHHhCCC-----CCeeeee-eeeeecCCCceEEEEEEee
Q 015500            8 TIGQGSSATVSLATSLRSGDVFAAKSTELP-KSEFLQREQKFLSSLNS-----PHIVGYK-GCDVTSEDNKLMYNLFMEY   80 (405)
Q Consensus         8 ~LG~G~~g~Vyla~~~~~~~~vavK~~~~~-~~~~l~~E~~iL~~L~h-----pnIv~~~-~~~~~~~~~~~~~~lv~Ey   80 (405)
                      .|..|---+.|+.... +| .+++|+.+.. ..+.+..|+++|..|..     |..+... |.....-...  ...++.+
T Consensus        25 ~i~~G~~N~ny~v~t~-~g-~yVLri~~~~~~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~--~~~~~~~  100 (316)
T d2ppqa1          25 GIAEGVENSNFLLHTT-KD-PLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGR--PAALISF  100 (316)
T ss_dssp             EECC---EEEEEEEES-SC-CEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTE--EEEEEEC
T ss_pred             cCCCCcccCeEEEEEC-CC-cEEEEEcCCCCCHHHHHHHHHHHHhhhhccccccccceecCCCcceeeecc--cceeeee
Confidence            3445666788998754 34 4899998753 45678888888888743     2222211 1111111111  2345556


Q ss_pred             cCCCCHH-----H------H---HHHcC----C----CC------------------CHHHHHHHHHHHHHHHHHHHh--
Q 015500           81 APGGTLN-----D------E---IHRNG----G----RL------------------DESLIVSYTRQILQGLEYLHS--  118 (405)
Q Consensus        81 ~~ggsL~-----~------~---i~~~~----~----~l------------------~e~~~~~i~~qIl~~L~yLH~--  118 (405)
                      ..|....     .      .   +....    .    ..                  ........+..+...+.-.+.  
T Consensus       101 ~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  180 (316)
T d2ppqa1         101 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD  180 (316)
T ss_dssp             CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred             cccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhccCccc
Confidence            5553211     0      0   00000    0    00                  011112223333333333332  


Q ss_pred             --CCceeCCCCCCCEEEccCC-ceEeeecccc
Q 015500          119 --NRVVHCDIKSRNILMAESG-AKIADFGCAK  147 (405)
Q Consensus       119 --~givHrDlkp~NILi~~~~-vkL~DFGla~  147 (405)
                        .|+||+|+.+.||+++.+. .-|.||+.+.
T Consensus       181 L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         181 LPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             SCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccccccCCcchhhhhcccccceeEecccccc
Confidence              4799999999999999887 5799999875